{"meta":{"query_hash":"4ef5173adc0b","filters":{"venue":"Neuro-Oncology"},"cohort_total":1994,"direct_labels_cover":3,"predictions_cover":1994,"exported":1994,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/4ef5173adc0b","api":"https://metacan.xera.ac/api/v1/cohort?venue=Neuro-Oncology"},"results":[{"id":"W1493373686","doi":"10.1093/neuonc/nou255.3","title":"ET-03 * CAVITATION-BASED THIRD VENTRICULOSTOMY USING MRI-GUIDED FOCUSED ULTRASOUND","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cerebrospinal fluid and hydrocephalus","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Cavitation; Ultrasound; Medicine; Ventriculostomy; Radiology; Acoustics; Physics; Hydrocephalus","score_opus":0.041038423588780806,"score_gpt":0.3228319592679401,"score_spread":0.2817935356791593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1493373686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9765906,0.00002769685,0.0028253174,0.0028389408,0.0016191253,0.0005048593,0.000016222013,0.00025099612,0.01532626],"genre_scores_gemma":[0.9815167,0.000017613915,0.0011096611,0.016915597,0.00029215045,0.00002848852,0.00000791388,0.000051686366,0.00006017397],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99696976,0.00081617106,0.0004679926,0.00074579084,0.00041392707,0.0005863423],"domain_scores_gemma":[0.99577403,0.003236589,0.00024249764,0.00042908703,0.00009723891,0.0002205618],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004241268,0.0002863234,0.0004179346,0.0002212976,0.00032727912,0.00008659452,0.0004166633,0.00020551417,0.0001491403],"category_scores_gemma":[0.0030110914,0.0002771806,0.00015809252,0.0005594495,0.00021411825,0.00019761662,0.0000722307,0.00043240242,0.00039919847],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007693696,0.00020320967,0.0011367258,0.000019591293,0.0000034306422,0.000091412854,0.00017719874,0.0020141911,0.9894393,0.0028684381,0.0028895992,0.0010799764],"study_design_scores_gemma":[0.0042553484,0.0018335495,0.0020006765,0.000027927688,0.00009359894,0.0005763764,0.00003164049,0.030110035,0.70874834,0.0015008422,0.25017563,0.0006460468],"about_ca_topic_score_codex":0.00008597434,"about_ca_topic_score_gemma":0.000038939717,"teacher_disagreement_score":0.28069097,"about_ca_system_score_codex":0.00024248296,"about_ca_system_score_gemma":0.00038851256,"threshold_uncertainty_score":0.99996805},"labels":[],"label_agreement":null},{"id":"W1847738841","doi":"10.1093/neuonc/nov087","title":"Point/Counterpoint: Stereotactic radiosurgery without whole-brain radiation for patients with a limited number of brain metastases: the current standard of care?","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Radiosurgery; Counterpoint; Medicine; Medical physics; Radiology; Nuclear medicine; Radiation therapy; Psychology","score_opus":0.021836433189772745,"score_gpt":0.3223935530821006,"score_spread":0.30055711989232786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1847738841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9824097,0.00066241395,0.0010124132,0.011064681,0.0007059738,0.0028755947,0.0009895723,0.000035260837,0.000244398],"genre_scores_gemma":[0.9962573,0.000020153655,0.0014344641,0.001468485,0.000109202774,0.00019021361,0.00044870828,0.000054094864,0.000017357284],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975607,0.0006038901,0.0006365181,0.00036754063,0.0005054867,0.0003258958],"domain_scores_gemma":[0.9962242,0.0018647438,0.00051185855,0.00050775113,0.0006887691,0.00020264057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007850351,0.0002714974,0.0009416104,0.0001453079,0.000054652774,0.000012606382,0.00011923855,0.000076510565,0.000031607593],"category_scores_gemma":[0.0012568757,0.00016750622,0.00021591656,0.000266467,0.00020792743,0.00011789043,0.00004826527,0.00022979156,0.0000062792974],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.054264966,0.005549762,0.40415248,0.0014636295,0.0022534684,0.00015052278,0.010614301,0.00009293837,0.0016996283,0.0010720463,0.104665615,0.41402066],"study_design_scores_gemma":[0.046727683,0.034080118,0.014390125,0.0003129872,0.0023513003,0.00023181162,0.0016812163,0.000230197,0.0032346093,0.00021022656,0.89615023,0.00039950517],"about_ca_topic_score_codex":0.000027912314,"about_ca_topic_score_gemma":0.000034523004,"teacher_disagreement_score":0.7914846,"about_ca_system_score_codex":0.0003396726,"about_ca_system_score_gemma":0.0007654537,"threshold_uncertainty_score":0.68307054},"labels":[],"label_agreement":null},{"id":"W1856115540","doi":"10.1093/neuonc/nov143","title":"Comparative genomic and genetic analysis of glioblastoma-derived brain tumor-initiating cells and their parent tumors","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of Calgary","funders":"Terry Fox Research Institute; Consorzio per la Ricerca Sanitaria; Health Research Board","keywords":"Biology; Copy-number variation; Gene; Computational biology; Genetics; Single-nucleotide polymorphism; Glioma; Subtyping; Glioblastoma; SNP; Cancer research; Genome; Genotype","score_opus":0.040932862392032685,"score_gpt":0.30520936905730744,"score_spread":0.26427650666527475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1856115540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979472,0.00059439463,0.00001891246,0.00064135063,0.00006914888,0.00035743846,0.000035329158,0.000020542515,0.00031565587],"genre_scores_gemma":[0.9987065,0.000047951027,0.00035011678,0.00079227646,0.000037389924,0.00003839035,0.000011511481,0.000014417614,0.0000014204472],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99875075,0.00021643224,0.0003606229,0.00034325954,0.00010748605,0.00022146062],"domain_scores_gemma":[0.99857605,0.0006431228,0.00023410961,0.00019109646,0.000098377954,0.00025725647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011490987,0.00019405634,0.00090668583,0.00029552262,0.00004586931,0.000011049646,0.000051503506,0.000055344233,0.000022137985],"category_scores_gemma":[0.00007274899,0.0001495759,0.00008833186,0.00029805442,0.00018229679,0.000024309566,0.00009243366,0.000111114765,0.0000046059236],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024426484,0.0004346185,0.09483314,0.000024457679,0.000802929,0.00048964506,0.0047594127,0.0003287757,0.89519095,0.000017356384,0.00039634603,0.0024781127],"study_design_scores_gemma":[0.0071353232,0.0076697227,0.6311207,0.000042269963,0.002380654,0.00044716717,0.004864741,0.011870058,0.33194578,0.000072650844,0.0021692582,0.00028169627],"about_ca_topic_score_codex":0.00005392244,"about_ca_topic_score_gemma":0.00012420044,"teacher_disagreement_score":0.5632452,"about_ca_system_score_codex":0.000095883435,"about_ca_system_score_gemma":0.0001353559,"threshold_uncertainty_score":0.60995287},"labels":[],"label_agreement":null},{"id":"W1915802091","doi":"10.1093/neuonc/nov122","title":"Blood-brain barrier-associated efflux transporters: a significant but underappreciated obstacle to drug development in glioblastoma","year":2015,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Blood–brain barrier; Efflux; Abcg2; ATP-binding cassette transporter; P-glycoprotein; Cell biology; Transporter; Tight junction; Drug delivery; Drug delivery to the brain; Extracellular matrix; Biology; Drug; Chemistry; Drug resistance; Neuroscience; Cancer research; Pharmacology; Central nervous system; Multiple drug resistance; Biochemistry; Gene","score_opus":0.02114080686092477,"score_gpt":0.26225721460580836,"score_spread":0.2411164077448836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1915802091","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6055626,0.00017501593,0.00012366664,0.38598576,0.0023900324,0.0033238225,0.00025362562,0.0004934499,0.0016919877],"genre_scores_gemma":[0.1544367,0.000057142996,0.0011126663,0.8307203,0.0016525289,0.0008121122,0.0017067111,0.0005140005,0.0089878645],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99354833,0.0005277161,0.001582852,0.0015118044,0.0012247425,0.001604567],"domain_scores_gemma":[0.99715763,0.0006399714,0.0004440308,0.00070324243,0.00035450375,0.0007005974],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0010342166,0.0009868656,0.0022871015,0.0010240615,0.00012659523,0.000036535872,0.0005802944,0.0020467383,0.000311775],"category_scores_gemma":[0.00030132243,0.00093303557,0.0003470272,0.0009915711,0.00016391434,0.00007710782,0.000055179735,0.0034237227,0.00017299522],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017050934,0.0014371866,0.0010335867,0.00051133893,0.00065506157,0.040380027,0.006510871,0.000029866957,0.13862085,0.000008184385,0.806176,0.0029319315],"study_design_scores_gemma":[0.008028118,0.002183899,0.0007829075,0.0005365733,0.00050832314,0.00014407867,0.0004090853,0.000013420666,0.032342426,0.00006906187,0.9540452,0.00093694683],"about_ca_topic_score_codex":0.00012435946,"about_ca_topic_score_gemma":0.0023090409,"teacher_disagreement_score":0.45112595,"about_ca_system_score_codex":0.0015654933,"about_ca_system_score_gemma":0.004086969,"threshold_uncertainty_score":0.99931204},"labels":[],"label_agreement":null},{"id":"W1918959143","doi":"10.1093/neuonc/nov059","title":"Extent of surgical resection of high-grade glioma among the elderly","year":2015,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto","funders":"","keywords":"Surgical resection; Resection; Glioma; Medicine; Surgery; Cancer research","score_opus":0.031363040133051724,"score_gpt":0.30370773858448297,"score_spread":0.2723446984514312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1918959143","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6310849,0.0005397858,9.5302937e-7,0.36489087,0.0011321779,0.00071665057,0.000034603665,0.000026301006,0.0015737413],"genre_scores_gemma":[0.9637407,0.00039984012,0.000053207434,0.03192778,0.0031266226,0.00026397302,0.00023893386,0.0000892862,0.00015966907],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973973,0.00052002695,0.0006485523,0.0004460262,0.0006336302,0.00035445],"domain_scores_gemma":[0.9972457,0.001073529,0.00057342893,0.0007022114,0.0003005441,0.00010452868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002981857,0.00029739042,0.0010901638,0.00030419196,0.00004301641,0.0000069116145,0.00021486952,0.00094266154,0.00013552095],"category_scores_gemma":[0.00014328682,0.00018467322,0.0003210017,0.0003058351,0.00040292606,0.000028091612,0.00010016092,0.0011798551,0.000018911396],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035859644,0.0008476122,0.0019444997,0.0001565492,0.00031271213,0.010963686,0.00010805017,0.0000061811697,0.012056781,0.000073892785,0.9685586,0.004612825],"study_design_scores_gemma":[0.0050283363,0.012189568,0.0029790525,0.00010677561,0.0008023746,0.0014339987,0.00003572279,0.000009213061,0.023413397,0.00018123268,0.95368344,0.00013687537],"about_ca_topic_score_codex":0.0006016723,"about_ca_topic_score_gemma":0.00008037529,"teacher_disagreement_score":0.3329631,"about_ca_system_score_codex":0.00023906452,"about_ca_system_score_gemma":0.000295746,"threshold_uncertainty_score":0.75307554},"labels":[],"label_agreement":null},{"id":"W1969981749","doi":"10.1215/s1152851702000297","title":"Leptomeningeal dissemination at diagnosis of pediatric low-gradeneuroepithelial tumors","year":2003,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"B.C. Women's Hospital & Health Centre; BC Children's Hospital; Children's & Women's Health Centre of British Columbia","funders":"","keywords":"Neuroepithelial cell; Medicine; Biology; Genetics; Embryonic stem cell","score_opus":0.015031234257074607,"score_gpt":0.29728399648744186,"score_spread":0.28225276223036727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969981749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99461645,0.0002955811,0.0000027176015,0.0012704701,0.00051947363,0.00046204714,0.000018762392,0.000047695048,0.0027668085],"genre_scores_gemma":[0.9984539,0.00057213823,0.00013217075,0.0003110195,0.00020397312,0.00021824705,0.000022635702,0.000035560817,0.000050341274],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984022,0.00018736743,0.00041687448,0.00037760002,0.00029054563,0.0003254061],"domain_scores_gemma":[0.9983376,0.0008601768,0.00023647469,0.00027227827,0.000099437384,0.0001939918],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013601943,0.0002015341,0.00049057556,0.00026160097,0.000076554046,0.000005811359,0.00008010646,0.00013363037,0.00035657317],"category_scores_gemma":[0.0006139598,0.00017491444,0.00016481879,0.00036983658,0.00007621762,0.000045060428,0.000048912745,0.00016257045,0.00007580694],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016003869,0.002296185,0.8458837,0.00008293517,0.00005099831,0.00102475,0.0003311942,0.000012288918,0.1339289,0.00037030873,0.010361039,0.0054976554],"study_design_scores_gemma":[0.00507286,0.004308054,0.19530973,0.000039010007,0.0006462831,0.0005013753,0.000074307754,0.000024065863,0.7568543,0.00006338898,0.036860753,0.00024588523],"about_ca_topic_score_codex":0.000007326179,"about_ca_topic_score_gemma":0.000007814572,"teacher_disagreement_score":0.65057397,"about_ca_system_score_codex":0.00025229974,"about_ca_system_score_gemma":0.00012839693,"threshold_uncertainty_score":0.7132804},"labels":[],"label_agreement":null},{"id":"W1971316264","doi":"10.1093/neuonc/nou174.90","title":"O10.09 * REDUCTION IN NEUTROPHIL-LYMPHOCYTE RATIO DURING INITIAL CONCURRENT CHEMORADIOTHERAPY IS PROGNOSTIC FOR SURVIVAL OF GLIOBLASTOMA PATIENTS","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Temozolomide; Internal medicine; Context (archaeology); Hazard ratio; Proportional hazards model; Retrospective cohort study; Univariate analysis; Dexamethasone; Chemoradiotherapy; Neutrophil to lymphocyte ratio; Radiation therapy; Surgery; Survival analysis; Gastroenterology; Multivariate analysis; Lymphocyte; Confidence interval","score_opus":0.01892400630301171,"score_gpt":0.30484886690228746,"score_spread":0.28592486059927574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971316264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962044,0.00008616995,0.000031404434,0.0009644194,0.0011986366,0.0013287594,0.000021936807,0.000030673156,0.00013363175],"genre_scores_gemma":[0.9988533,0.00007791076,0.00008680436,0.00021322067,0.00037747677,0.00031882868,0.00003460715,0.000034371864,0.0000034776713],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99853754,0.0001378039,0.00046313574,0.00037051205,0.00019331294,0.00029771499],"domain_scores_gemma":[0.9990056,0.00027855573,0.0002317205,0.00020312496,0.00017038189,0.00011061985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011709148,0.0001930699,0.0005996488,0.00020508285,0.000050838706,0.000007942806,0.00007042728,0.000137541,0.000036801073],"category_scores_gemma":[0.00020383147,0.00017638157,0.000120449244,0.00018476967,0.00009066413,0.000058671438,0.00002565839,0.00011786885,0.0000072951343],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056162253,0.0068756393,0.15410508,0.00044855417,0.00019404053,0.00010699048,0.0015465317,0.00011442043,0.69884014,0.0003838528,0.0008276099,0.1309409],"study_design_scores_gemma":[0.051280666,0.017680043,0.15119606,0.00013211803,0.0002301106,0.000119915814,0.00007242006,0.0012897003,0.7660084,0.000063580206,0.011645937,0.00028108803],"about_ca_topic_score_codex":0.000020522735,"about_ca_topic_score_gemma":0.00002033946,"teacher_disagreement_score":0.13065982,"about_ca_system_score_codex":0.0003597826,"about_ca_system_score_gemma":0.0001588737,"threshold_uncertainty_score":0.71926314},"labels":[],"label_agreement":null},{"id":"W1971850391","doi":"10.1093/neuonc/nou264.57","title":"NI-59 * TABLET TECHNOLOGY FOR IMPROVED PREOPERATIVE SPEECH MAPPING USING FUNCTIONAL MRI IN PATIENTS WITH LOW-GRADE GLIOMA","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto; Sunnybrook Hospital","funders":"","keywords":"Broca's area; Copying; Functional magnetic resonance imaging; Glioma; Brain mapping; Motor area; Aphasia; Medicine; Awake craniotomy; Neuroscience; Computer science; Craniotomy; Psychology; Radiology","score_opus":0.01613538378701314,"score_gpt":0.2634749658363168,"score_spread":0.24733958204930367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971850391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992816,0.00003053642,0.00092444953,0.0038335351,0.0004603245,0.0016741661,0.000017430393,0.000065043234,0.00017856626],"genre_scores_gemma":[0.99169725,0.000004483229,0.0065333582,0.0011465341,0.00014322509,0.00033151798,0.00009383024,0.00004182996,0.000007956928],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984723,0.000084522144,0.0003299519,0.0005254214,0.00014209811,0.0004457251],"domain_scores_gemma":[0.99899006,0.00026244504,0.00015714132,0.00027684076,0.00021499359,0.000098537705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013884639,0.00023721157,0.00053644105,0.000484553,0.000108044194,0.000013245494,0.00008098657,0.00027710767,0.00003449304],"category_scores_gemma":[0.00019259579,0.00018605313,0.00005788696,0.000494055,0.0001196835,0.00007700769,0.00006380771,0.00026655424,0.000011763917],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011675563,0.003258748,0.4853099,0.000075278906,0.00018798755,0.0001156904,0.00015492317,0.00019538398,0.49856293,0.00051505165,0.0013750306,0.009081523],"study_design_scores_gemma":[0.12019418,0.036476,0.36769795,0.00048613193,0.00086238544,0.00068631483,0.000629988,0.024818158,0.35359722,0.0013793631,0.09186076,0.0013115323],"about_ca_topic_score_codex":0.000027921302,"about_ca_topic_score_gemma":0.00007668586,"teacher_disagreement_score":0.1449657,"about_ca_system_score_codex":0.00036338938,"about_ca_system_score_gemma":0.00018673572,"threshold_uncertainty_score":0.75870264},"labels":[],"label_agreement":null},{"id":"W1973156933","doi":"10.1093/neuonc/nos220","title":"LAB-CELL BIOLOGY AND SIGNALING","year":2012,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Diatoms and Algae Research","field":"Materials Science","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; University of Alberta; University of Calgary","funders":"","keywords":"Cell biology; Biology","score_opus":0.0334672393872021,"score_gpt":0.33314865018790213,"score_spread":0.29968141080070004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973156933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840994,0.00059514795,0.00004904971,0.00045603554,0.00066073355,0.000101543075,0.000007060468,0.00004510105,0.013985943],"genre_scores_gemma":[0.99801165,0.000088441295,0.00070672017,0.0007498871,0.0003441472,0.00001536188,0.000001964765,0.000012813265,0.00006903821],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99876153,0.00025927596,0.00014954727,0.00021804305,0.00008287138,0.00052871625],"domain_scores_gemma":[0.99910915,0.0004791189,0.000053300588,0.00013957053,0.00003173244,0.00018712947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000623228,0.00008977361,0.00018902164,0.000060384933,0.00009146903,0.000025623614,0.00015405501,0.00011660171,0.00074931275],"category_scores_gemma":[0.00011603114,0.00007391047,0.000023513325,0.000080553975,0.00016572846,0.00011812079,0.00019316247,0.00014967578,0.00061010965],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001574879,0.00009357447,0.00520354,0.000010298148,0.0000012355194,0.000009816247,0.0001436147,0.0000013776869,0.9858081,0.0015729602,0.00065153715,0.006488224],"study_design_scores_gemma":[0.00042263482,0.0003719709,0.00048069155,0.0000019059535,0.0000067947785,0.000031437397,0.0000709048,0.000036332345,0.63149905,0.0002667891,0.36671242,0.000099050165],"about_ca_topic_score_codex":0.000039233495,"about_ca_topic_score_gemma":0.0000034289628,"teacher_disagreement_score":0.36606088,"about_ca_system_score_codex":0.00002963739,"about_ca_system_score_gemma":0.00007302088,"threshold_uncertainty_score":0.8204449},"labels":[],"label_agreement":null},{"id":"W1973986864","doi":"10.1093/neuonc/nov022","title":"Response to \"The epidemiology of glioma in adults: a 'state of the science' review\"","year":2015,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Electromagnetic Fields and Biological Effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Cancer Institute; World Health Organization","keywords":"International agency; Incidence (geometry); Glioma; Population; Danish; Epidemiology; Medicine; Cancer; Demography; Pathology; Internal medicine; Environmental health; Sociology; Cancer research; Mathematics","score_opus":0.020224603630742403,"score_gpt":0.30735747055197554,"score_spread":0.28713286692123313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973986864","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38250422,0.0056806984,0.0000063570296,0.609707,0.00055138825,0.0011061082,0.000046724643,0.0000047303392,0.0003927539],"genre_scores_gemma":[0.1180641,0.00183355,0.00021821902,0.878886,0.00056797947,0.00018445055,0.000038517024,0.00003055448,0.00017662902],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99443907,0.0032378726,0.0007949269,0.00067999004,0.00024661407,0.00060153694],"domain_scores_gemma":[0.99686044,0.0011978024,0.00055992976,0.000992414,0.00031139608,0.000078031575],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0043753153,0.00027189348,0.0008382819,0.00012604354,0.00005026369,0.0000021815083,0.001438559,0.00074604416,0.0000119472115],"category_scores_gemma":[0.013758334,0.00014358923,0.00021704857,0.0006880137,0.001132237,0.0000017915696,0.00065929745,0.0010255768,0.000007024705],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000746238,0.0000357444,0.00009549622,0.00014559856,0.000009032568,0.000039281083,0.000025510131,0.0000061151677,0.5477529,0.0000038447024,0.44744045,0.0036997544],"study_design_scores_gemma":[0.0005903557,0.014655838,0.00081526337,0.0004207366,0.000031259508,0.00018996348,0.0000050780536,0.000009189419,0.04390606,0.00022390528,0.9389481,0.00020428322],"about_ca_topic_score_codex":0.00006348621,"about_ca_topic_score_gemma":0.00007683593,"teacher_disagreement_score":0.5038469,"about_ca_system_score_codex":0.000064677595,"about_ca_system_score_gemma":0.00105616,"threshold_uncertainty_score":0.9945492},"labels":[],"label_agreement":null},{"id":"W1974778790","doi":"10.1093/neuonc/nov018","title":"End of the road: confounding results of the CORE trial terminate the arduous journey of cilengitide for glioblastoma","year":2015,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Glioblastoma; Confounding; Medicine; Core (optical fiber); Oncology; Internal medicine; Computer science; Cancer research","score_opus":0.0791450354618834,"score_gpt":0.37028690454280716,"score_spread":0.29114186908092377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974778790","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.41790804,0.00030228074,0.000011346785,0.5449271,0.0072856746,0.010408349,0.0010349343,0.000035290384,0.018086953],"genre_scores_gemma":[0.7498521,0.00032903164,0.00021234625,0.2207802,0.011934668,0.00063791085,0.00016765951,0.00046648507,0.015619558],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99498826,0.0012121935,0.0013720398,0.0004806257,0.001372799,0.0005740755],"domain_scores_gemma":[0.99098366,0.004619846,0.0017736664,0.0015944309,0.00092894025,0.000099449775],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0018417841,0.00035058532,0.0013094251,0.00024710695,0.00012167854,0.000011998194,0.0013684031,0.00089356164,0.00007777171],"category_scores_gemma":[0.008528785,0.00017292786,0.0007298583,0.0003883047,0.001415817,0.000023256933,0.0005969721,0.0027617945,0.0000058079177],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0265491,0.0001482795,0.00002248574,0.0003949348,0.00014433898,0.00023817153,0.0005479257,0.0000072668154,0.16172916,0.000024248404,0.80527836,0.0049157296],"study_design_scores_gemma":[0.029339155,0.0064506405,0.00011481256,0.00025865936,0.00040781664,0.0005046841,0.00015097304,0.00010565706,0.06894761,0.00017164512,0.893418,0.00013031607],"about_ca_topic_score_codex":0.00010052446,"about_ca_topic_score_gemma":0.0000620214,"teacher_disagreement_score":0.3319441,"about_ca_system_score_codex":0.00027927404,"about_ca_system_score_gemma":0.0024385543,"threshold_uncertainty_score":0.9998228},"labels":[],"label_agreement":null},{"id":"W1976206289","doi":"10.1093/neuonc/nov061.72","title":"LG-03 * RADIATION THERAPY IS ASSOCIATED WITH INCREASED LATE MORTALITY IN LONG-TERM ADULT SURVIVORS OF CHILDHOOD LOW GRADE GLIOMA: A POPULATION BASED STUDY","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Kingston General Hospital; McMaster Children's Hospital; London Health Sciences Centre; Agricultural Research Institute of Ontario; Pediatric Oncology Group; Hospital for Sick Children","funders":"","keywords":"Glioma; Medicine; Radiation therapy; Term (time); Childhood cancer; Population; Demography; Pediatrics; Internal medicine; Environmental health; Cancer; Physics; Cancer research","score_opus":0.02522225617413484,"score_gpt":0.3063105496595588,"score_spread":0.28108829348542397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976206289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973776,0.00007182128,0.0000016744444,0.0005056626,0.0001392993,0.0017536526,0.000030492687,0.000055660927,0.00006415686],"genre_scores_gemma":[0.9987851,0.000015867794,0.000013682567,0.0006483164,0.000039343093,0.00015592133,0.0003070747,0.000033883935,8.30519e-7],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99776113,0.0006453757,0.0004887952,0.00040225638,0.0004345956,0.0002678607],"domain_scores_gemma":[0.9985758,0.00028566094,0.0003910582,0.00034749898,0.0002203945,0.00017959255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040395206,0.00023635165,0.0006793641,0.0003138937,0.000037138063,0.000010368736,0.00008115108,0.00017560644,0.000026313557],"category_scores_gemma":[0.00031077495,0.00018571889,0.00008351186,0.0006333503,0.000033956338,0.00008433573,0.000017309592,0.0001816113,0.0000047096187],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052599004,0.013157162,0.9796606,0.000012124325,0.00022703216,0.0007146407,0.0010393218,0.00007736729,0.0029841438,0.0000034883478,0.00002678121,0.0015713702],"study_design_scores_gemma":[0.02824182,0.0053423257,0.9597312,0.000047531154,0.0002172216,0.000012812845,0.00006765083,0.00033575768,0.0058496865,0.000017030812,0.0000045442835,0.00013241639],"about_ca_topic_score_codex":0.004247245,"about_ca_topic_score_gemma":0.007006909,"teacher_disagreement_score":0.027715832,"about_ca_system_score_codex":0.0004060122,"about_ca_system_score_gemma":0.00029551744,"threshold_uncertainty_score":0.75733966},"labels":[],"label_agreement":null},{"id":"W1979467387","doi":"10.1215/15228517-2008-014","title":"FDG-PET imaging for the evaluation of antiglioma agents in a rat model","year":2008,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"U.S. Food and Drug Administration","keywords":"Pet imaging; Nuclear medicine; Computer science; Positron emission tomography; Medicine","score_opus":0.059496857716451544,"score_gpt":0.3494684272412395,"score_spread":0.289971569524788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979467387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931038,0.0023474752,0.0014279897,0.000510491,0.001243836,0.0005924881,0.000018142377,0.0000053586405,0.000750408],"genre_scores_gemma":[0.99665785,0.0012994207,0.00039358923,0.0009769354,0.00043546708,0.00014275528,0.000027356758,0.00001745482,0.000049186194],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990158,0.00013715382,0.00022585891,0.00025864234,0.00015650643,0.00020602957],"domain_scores_gemma":[0.9993596,0.000055918907,0.00011298099,0.00026293035,0.00017452921,0.000034024495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047799954,0.00010201639,0.00017787021,0.00006116891,0.00006668093,0.0000034962106,0.00016909107,0.000068390174,0.0000094062925],"category_scores_gemma":[0.00025695562,0.00008540431,0.00009019179,0.000094271636,0.00011119361,0.000004458462,0.00006502173,0.00007555156,0.0000013590827],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015962368,0.0000777262,0.0005596545,0.0000068158283,0.000012248072,0.0000032312118,0.00014511177,0.004174194,0.9620621,0.000027476315,0.011346349,0.021425463],"study_design_scores_gemma":[0.0061253128,0.0003394467,0.0031015866,0.0000069665894,0.00015367602,0.0002867381,0.00011176897,0.16355012,0.42061424,0.00032843242,0.40515554,0.00022617416],"about_ca_topic_score_codex":0.000022879887,"about_ca_topic_score_gemma":0.00008646151,"teacher_disagreement_score":0.5414479,"about_ca_system_score_codex":0.000028738117,"about_ca_system_score_gemma":0.00042693192,"threshold_uncertainty_score":0.34826866},"labels":[],"label_agreement":null},{"id":"W1985252937","doi":"10.1093/neuonc/nos310","title":"In reference to WKA Yung (Neuro-Oncology 2012; 14:1115)","year":2012,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Impact factor; Clinical Oncology; Bibliometrics; Publishing; Oncology; Medicine; Internal medicine; Library science; Surgical oncology; Cancer; Political science; Computer science","score_opus":0.04566680652855494,"score_gpt":0.33042388083549334,"score_spread":0.2847570743069384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985252937","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.033183545,0.0014180646,0.0000072329176,0.91688067,0.005582817,0.0025472655,0.000122109,0.00017814779,0.04008016],"genre_scores_gemma":[0.031427667,0.000732076,0.0005301675,0.95773023,0.006467197,0.0013903303,0.0004555873,0.00025905893,0.0010076793],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99363554,0.000995423,0.0012047404,0.0015874847,0.00066153135,0.0019153132],"domain_scores_gemma":[0.99449366,0.0026768218,0.00054195285,0.0013980976,0.00024744676,0.0006420429],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.00044928578,0.0009956562,0.002502472,0.0011595457,0.000113696005,0.000033378117,0.00060956134,0.003171938,0.0022037423],"category_scores_gemma":[0.0006670894,0.00088215695,0.000340632,0.00062568777,0.000222401,0.0001926649,0.0004924927,0.0049168607,0.0036062384],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000305196,0.001239024,0.0035499616,0.0001441355,0.00013409505,0.029143382,0.00024988214,0.000003478398,0.032446884,0.00009220645,0.9216202,0.011071566],"study_design_scores_gemma":[0.0043354915,0.004573267,0.0030503194,0.00011120533,0.00057380565,0.002057112,0.000026350006,0.0000037105617,0.0028899622,0.00006822169,0.98172545,0.0005851219],"about_ca_topic_score_codex":0.00020336379,"about_ca_topic_score_gemma":0.00037314667,"teacher_disagreement_score":0.06010524,"about_ca_system_score_codex":0.0017265574,"about_ca_system_score_gemma":0.0009951814,"threshold_uncertainty_score":0.9993629},"labels":[],"label_agreement":null},{"id":"W1986494368","doi":"10.1093/neuonc/nou268.13","title":"PM-13 * IDENTIFICATION OF THERAPEUTIC TARGETS IN AN INTRACRANIAL XENOGRAFT MODEL OF PITUITARY ADENOMA","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Fibroblast growth factor receptor 4; Cancer research; PI3K/AKT/mTOR pathway; Pituitary tumors; Prolactin; Biology; Internal medicine; Medicine; Endocrinology; Receptor; Hormone; Fibroblast growth factor receptor; Signal transduction; Fibroblast growth factor; Cell biology","score_opus":0.023157612856664515,"score_gpt":0.2980853938730076,"score_spread":0.2749277810163431,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986494368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962925,0.00021060175,0.0012598127,0.0005164794,0.0001567175,0.00033468407,0.000015367179,0.000020370797,0.0011935143],"genre_scores_gemma":[0.99884015,0.00009457137,0.00043963187,0.00046247363,0.00005279197,0.000023498935,0.000057268066,0.000017341255,0.00001227416],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99878997,0.00014182422,0.00046940378,0.00025025458,0.00015109745,0.00019746427],"domain_scores_gemma":[0.9992714,0.000101699894,0.00017629014,0.00029487096,0.0000733825,0.000082340965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018216809,0.00012729022,0.00042688483,0.00013877798,0.0000246085,0.0000024162573,0.000112098845,0.00013912811,0.00004661611],"category_scores_gemma":[0.000050102906,0.0001101912,0.00006921154,0.00012514432,0.00009978399,0.00009685162,0.000024130451,0.00013978886,0.000012170477],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015336513,0.0039839097,0.21700071,0.0001221198,0.00008687022,0.000091981376,0.0015687111,0.00085967703,0.693164,0.0006736531,0.00010543832,0.08080932],"study_design_scores_gemma":[0.024622343,0.013027973,0.67217106,0.000061303,0.0007044834,0.00023529261,0.0006352169,0.21736255,0.046968877,0.022253638,0.0014562638,0.0005010233],"about_ca_topic_score_codex":0.00007986993,"about_ca_topic_score_gemma":0.00015661248,"teacher_disagreement_score":0.6461951,"about_ca_system_score_codex":0.000039848583,"about_ca_system_score_gemma":0.00011733998,"threshold_uncertainty_score":0.4493467},"labels":[],"label_agreement":null},{"id":"W1987135361","doi":"10.1093/neuonc/noq016","title":"Temozolomide and MGMT forever?","year":2010,"lang":"en","type":"editorial","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Temozolomide; Medicine; Dacarbazine; Oncology; Internal medicine; Clinical trial; Glioma; Chemotherapy; Clinical endpoint; Progression-free survival; Cancer; Phases of clinical research; Cancer research","score_opus":0.012644030092745465,"score_gpt":0.30513828542901383,"score_spread":0.2924942553362684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987135361","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03290469,0.0008712963,0.0000012945683,0.003932484,0.9533113,0.0008694488,0.00012920241,0.000109833454,0.0078704115],"genre_scores_gemma":[0.0075155203,0.0019689423,0.00053235964,0.001431399,0.98731023,0.00031029363,0.0005080677,0.00013826428,0.00028490182],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99803823,0.000096138334,0.00038335746,0.00068410794,0.00037779927,0.00042034284],"domain_scores_gemma":[0.99656713,0.0021875866,0.00024029078,0.0005119115,0.00017489247,0.0003181663],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00018295224,0.0003930179,0.0010598057,0.00019399292,0.00008938637,0.00002497888,0.0001363283,0.0020053629,0.00015180881],"category_scores_gemma":[0.0014303115,0.0003155457,0.00017012197,0.000094693474,0.00018900345,0.00003556764,0.00015797482,0.0016587465,0.00013092672],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018876429,0.00039099582,0.0008911673,0.00008239904,0.00011912533,0.0017535844,0.00004004062,5.8786227e-8,0.017428081,0.000035985766,0.9563854,0.02268441],"study_design_scores_gemma":[0.004434188,0.0025120322,0.00040133286,0.00004421815,0.0006359253,0.00021618554,0.000010514088,0.0000043511445,0.0024083033,0.00010534489,0.98902726,0.00020032682],"about_ca_topic_score_codex":0.00007091143,"about_ca_topic_score_gemma":0.00026168174,"teacher_disagreement_score":0.03399891,"about_ca_system_score_codex":0.0002129872,"about_ca_system_score_gemma":0.00072014355,"threshold_uncertainty_score":0.99992967},"labels":[],"label_agreement":null},{"id":"W1988652699","doi":"10.1215/15228517-2007-002","title":"Survey of treatment recommendations for anaplastic oligodendroglioma","year":2007,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation; Princess Margaret Cancer Centre; University of Calgary","funders":"","keywords":"Oligodendroglioma; Temozolomide; Medicine; Radiation therapy; Oncology; Internal medicine; Clinical trial; Glioma; Lomustine; Chemotherapy; Family medicine; Astrocytoma; Cancer research; Vincristine","score_opus":0.06895933856419427,"score_gpt":0.36791477270379874,"score_spread":0.29895543413960446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988652699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927269,0.00018950306,0.0004492146,0.0029770504,0.00064550614,0.00095596595,0.00017128298,0.000040735595,0.0018438448],"genre_scores_gemma":[0.99770284,0.00010065326,0.0013023145,0.0004167934,0.00007716961,0.000119874545,0.00023031722,0.00002263798,0.000027380831],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99892753,0.00007796473,0.00038163533,0.00024939154,0.00007957117,0.00028389788],"domain_scores_gemma":[0.99688876,0.0023962467,0.00014688948,0.0002324773,0.00017912258,0.00015650019],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028533317,0.00014338187,0.0004365371,0.00021978444,0.000057532467,0.0000036661424,0.00005053525,0.000111282614,0.000101844525],"category_scores_gemma":[0.00035538082,0.000115483665,0.00011764227,0.00025214895,0.000054957294,0.00002326689,0.00001802459,0.000053881868,0.000020310918],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032641706,0.009697579,0.25474864,0.00008696657,0.00085286476,0.0006287027,0.0006293548,0.000032382268,0.22102214,0.0013287636,0.026508955,0.48119947],"study_design_scores_gemma":[0.016633363,0.03625198,0.35567224,0.000036508718,0.0007051424,0.00031453033,0.00014035229,0.00036924242,0.2414753,0.00007560855,0.34810168,0.00022405025],"about_ca_topic_score_codex":0.00028974473,"about_ca_topic_score_gemma":0.0019991784,"teacher_disagreement_score":0.48097542,"about_ca_system_score_codex":0.00039878392,"about_ca_system_score_gemma":0.00022090905,"threshold_uncertainty_score":0.47092873},"labels":[],"label_agreement":null},{"id":"W1988992782","doi":"10.1093/neuonc/nox029","title":"The Neurologic Assessment in Neuro-Oncology (NANO) scale: a tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology (RANO) criteria","year":2017,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":244,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; London Health Sciences Centre; Sunnybrook Health Science Centre; Western University","funders":"","keywords":"Medicine; Interquartile range; Metric (unit); Clinical trial; Cohen's kappa; Medical physics; Internal medicine; Oncology; Statistics","score_opus":0.10843280071922588,"score_gpt":0.4474707964100835,"score_spread":0.33903799569085763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988992782","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17457917,0.43997476,0.001670911,0.25274378,0.04276344,0.08164984,0.00046896932,0.0010347541,0.0051143705],"genre_scores_gemma":[0.08270829,0.8309948,0.0020561107,0.035639387,0.0019102971,0.04537754,0.0005701832,0.0006315021,0.00011189552],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.97405815,0.015360747,0.003972132,0.0033464085,0.0009782148,0.0022843357],"domain_scores_gemma":[0.96365833,0.029185839,0.002728906,0.0032731327,0.000589334,0.0005644519],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.008294228,0.0020736922,0.0061024916,0.0017228166,0.001267879,0.0004585165,0.0022535203,0.002463175,0.00011187583],"category_scores_gemma":[0.008475445,0.0012928245,0.0014193334,0.0014990505,0.00084342994,0.00034833018,0.0012986696,0.0052716024,0.00009730631],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.008291257,0.0038799946,0.0014811745,0.0010353164,0.00023069391,0.0042209644,0.0004676959,0.00006645987,0.014367117,0.0005768479,0.0062150746,0.9591674],"study_design_scores_gemma":[0.006997328,0.034785576,0.014811747,0.00045826266,0.0021793568,0.0015349153,0.00021731963,0.0007152642,0.000054372602,0.0004135947,0.9369943,0.00083795795],"about_ca_topic_score_codex":0.000201967,"about_ca_topic_score_gemma":0.0030093347,"teacher_disagreement_score":0.95832944,"about_ca_system_score_codex":0.004318918,"about_ca_system_score_gemma":0.0073419027,"threshold_uncertainty_score":0.99987656},"labels":[],"label_agreement":null},{"id":"W1990415925","doi":"10.1093/neuonc/3.1.1","title":"Expression and hypoxic regulation of angiopoietins in humanastrocytomas","year":2001,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"National Cancer Institute","keywords":"Angiopoietin receptor; Angiogenesis; Astrocytoma; Angiopoietin; Vascular endothelial growth factor; Biology; Cancer research; Receptor; Vascular endothelial growth factor A; Tumor progression; Pathology; Glioma; Medicine; Cancer; VEGF receptors; Biochemistry","score_opus":0.017493034651148612,"score_gpt":0.2830974153286691,"score_spread":0.2656043806775205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990415925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966937,0.00078336394,0.00021120171,0.00017073304,0.000088545756,0.0000963165,0.0000027203293,0.000005121696,0.001948326],"genre_scores_gemma":[0.9984661,0.0006170728,0.00042521977,0.00024792523,0.00013442304,0.000013874642,0.000016358863,0.000011897928,0.00006717733],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99931276,0.00007362982,0.00018210415,0.00023044163,0.00005915263,0.00014189773],"domain_scores_gemma":[0.99966264,0.00002138902,0.0000887312,0.00015832146,0.000030618314,0.00003831572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009567192,0.00008331841,0.0001407053,0.00005482791,0.000027384545,0.0000028805289,0.00007172089,0.00015250324,0.0000327137],"category_scores_gemma":[0.000032522028,0.00007985356,0.00004360903,0.00007103899,0.00007232498,0.0000031377947,0.000075305776,0.000044392593,0.0000015764507],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014615731,0.000049514925,0.020544225,0.0000059306008,0.0000041355997,0.000006803503,0.000041634285,0.000039712177,0.97043735,0.000034348228,0.0010320777,0.007658117],"study_design_scores_gemma":[0.00092305924,0.00076586806,0.065836035,0.000011527359,0.000009061682,0.000055965553,0.00006236258,0.000055548546,0.7627981,0.000064684034,0.16931482,0.000102990416],"about_ca_topic_score_codex":0.000014917667,"about_ca_topic_score_gemma":0.0000648557,"teacher_disagreement_score":0.20763926,"about_ca_system_score_codex":0.000016983144,"about_ca_system_score_gemma":0.000042574866,"threshold_uncertainty_score":0.32563338},"labels":[],"label_agreement":null},{"id":"W1991805542","doi":"10.1093/neuonc/nos232","title":"CLIN-ONGOING CLINICAL TRIALS","year":2012,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Clinical Laboratory Practices and Quality Control","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Clinical trial; Medicine; Medical physics; Internal medicine","score_opus":0.39135124536517873,"score_gpt":0.5724785342185139,"score_spread":0.18112728885333518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991805542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8888102,0.0013137568,0.00041007053,0.061343417,0.010227237,0.0014418343,0.00002531689,0.00026064902,0.036167506],"genre_scores_gemma":[0.92867386,0.0004104883,0.0013628412,0.061193924,0.008068624,0.000033906952,0.0000120953555,0.000038440223,0.0002058087],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9907314,0.0058740275,0.002223792,0.0003757827,0.00025810185,0.00053685834],"domain_scores_gemma":[0.9553917,0.04188363,0.0010302153,0.00061366445,0.00019890224,0.0008818736],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.023701126,0.00018062044,0.0016062562,0.00006580281,0.00008431462,0.00001852297,0.00012828127,0.00053694984,0.001029146],"category_scores_gemma":[0.07617128,0.0001391855,0.00050015264,0.00017636563,0.0001584281,0.00020580331,0.0000928738,0.0012187917,0.0010665451],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054535326,0.004267992,0.29179144,0.00007040278,0.00038799786,0.0002681304,0.00031322468,8.3701684e-7,0.06123146,0.00572735,0.052440975,0.5780467],"study_design_scores_gemma":[0.005914201,0.0020467015,0.016067157,0.000012545188,0.00055499375,0.0000793947,0.00010324564,0.00007577344,0.0003517984,0.000059872556,0.97460467,0.00012965623],"about_ca_topic_score_codex":0.0000081908165,"about_ca_topic_score_gemma":0.000009604431,"teacher_disagreement_score":0.92216367,"about_ca_system_score_codex":0.00007141846,"about_ca_system_score_gemma":0.00047160368,"threshold_uncertainty_score":0.99988407},"labels":[],"label_agreement":null},{"id":"W1994228028","doi":"10.1093/neuonc/nov318","title":"Early treatment of HER2-amplified brain tumors with targeted NK-92 cells and focused ultrasound improves survival","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Ultrasound and Hyperthermia Applications","field":"Engineering","cited_by":137,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"National Institute of Biomedical Imaging and Bioengineering; National Institutes of Health","keywords":"Focused ultrasound; Cancer research; Targeted therapy; Medicine; Oncology; Ultrasound; Internal medicine; Radiology; Cancer","score_opus":0.011125601802728364,"score_gpt":0.22232378930529628,"score_spread":0.2111981875025679,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994228028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963765,0.000079456884,0.0008601296,0.00042659993,0.00013583472,0.00035711008,0.000055546512,0.00015871826,0.0015500751],"genre_scores_gemma":[0.9987009,0.0001864849,0.0006797231,0.00006702812,0.000082146296,0.000089600864,0.000004496946,0.00005146666,0.00013814543],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99906856,0.000059271122,0.00023079728,0.00026698387,0.000091561094,0.00028282596],"domain_scores_gemma":[0.9983279,0.0011906896,0.000063851534,0.00026551913,0.000035388635,0.00011662898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005313432,0.00020513096,0.00035338642,0.00006573109,0.000052262643,0.000014443972,0.00010510482,0.00011208511,0.000047380083],"category_scores_gemma":[0.000026066462,0.00013503425,0.000046579782,0.000118288925,0.00015841034,0.000065457425,0.000009690408,0.0000686069,0.000017286207],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005692199,0.00011020508,0.0018450161,0.000014018894,0.00005545747,0.0000073124793,0.00049316767,0.000022445938,0.9837043,0.00019720409,0.00016887992,0.013325015],"study_design_scores_gemma":[0.0059517846,0.004901811,0.045938805,0.000026502352,0.0001237254,0.00010087292,0.0002080039,0.000061052335,0.7933918,0.0004476042,0.1482714,0.0005766369],"about_ca_topic_score_codex":0.00007443325,"about_ca_topic_score_gemma":0.000102815706,"teacher_disagreement_score":0.19031256,"about_ca_system_score_codex":0.00008253951,"about_ca_system_score_gemma":0.000057841706,"threshold_uncertainty_score":0.5506537},"labels":[],"label_agreement":null},{"id":"W1994689818","doi":"10.1093/neuonc/nou209.26","title":"A 3-DIMENSIONAL MATRIX ASSAY THAT MAY HELP PREDICT TREATMENT RESPONSE TO TEMOZOLOMIDE IN PATIENTS WITH GLIOBASTOMA: SUBGROUP ANALYSIS OF PATIENTS UNDERGOING MGMT TESTING","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Temozolomide; Medicine; Glioblastoma; Dacarbazine; Internal medicine; Oncology; Subgroup analysis; Chemotherapy; Drug response; Drug; Cancer research; Pharmacology; Confidence interval","score_opus":0.016905005584578723,"score_gpt":0.27788324809335085,"score_spread":0.2609782425087721,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994689818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976887,0.000020796284,0.000016929616,0.0007518115,0.00013420185,0.0010921549,0.00006587597,0.000049351525,0.00018017403],"genre_scores_gemma":[0.9976789,0.0000027920116,0.0015265169,0.00043055823,0.00002814465,0.00015251912,0.0001261532,0.00004156841,0.00001288269],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99703693,0.0007240007,0.0005690835,0.0006476951,0.0005397416,0.00048256083],"domain_scores_gemma":[0.9948428,0.0038029214,0.00034130987,0.00047843577,0.00024222948,0.00029229003],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00048661913,0.00034388204,0.0010480089,0.0011241119,0.000079825186,0.000011948852,0.00010511852,0.00015893571,0.00003760364],"category_scores_gemma":[0.0012211106,0.00025059184,0.0001700329,0.001368454,0.00007193364,0.000067542074,0.000096380034,0.00014205558,0.000018570108],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0065680747,0.0043460988,0.9771782,0.000019617342,0.0006051903,0.00015071519,0.00017864585,0.0015225054,0.003602566,0.000008446009,0.00013233059,0.00568762],"study_design_scores_gemma":[0.015369704,0.020552658,0.95762444,0.00008540154,0.0015729514,0.0000067569413,0.000041045056,0.00089594786,0.002996425,0.000004078477,0.00068025966,0.00017032202],"about_ca_topic_score_codex":0.00015167466,"about_ca_topic_score_gemma":0.0007011312,"teacher_disagreement_score":0.01955374,"about_ca_system_score_codex":0.0009359817,"about_ca_system_score_gemma":0.00025657975,"threshold_uncertainty_score":0.99999464},"labels":[],"label_agreement":null},{"id":"W1999197607","doi":"10.1093/neuonc/nos229","title":"CLIN-NEURO/MEDICAL ONCOLOGY","year":2012,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Neurological Institute and Hospital; Western University; McGill University","funders":"","keywords":"Medicine; Internal medicine; Oncology; Medical physics","score_opus":0.05223163820791155,"score_gpt":0.4116295984714325,"score_spread":0.35939796026352094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999197607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.736956,0.0015630483,0.00006261559,0.064262345,0.01152512,0.0010190047,0.000015518928,0.00033550602,0.18426083],"genre_scores_gemma":[0.9222938,0.0011314254,0.00044134885,0.0697705,0.004940504,0.00017807925,0.000049798,0.000068925285,0.0011256279],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971672,0.0005123908,0.0005409215,0.00045191066,0.00037441408,0.0009531376],"domain_scores_gemma":[0.99661165,0.0017419863,0.00017999731,0.0003509106,0.00008667542,0.0010287605],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00054436456,0.00029072116,0.0008341857,0.00018424042,0.00010920145,0.000005471992,0.0002133617,0.00068932143,0.0077573042],"category_scores_gemma":[0.0006041561,0.00025028177,0.00021201586,0.0002505237,0.00035675385,0.000098278164,0.00017616742,0.0010414395,0.0016246842],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032705502,0.008864289,0.082128346,0.00008238874,0.0003265498,0.0048810346,0.0013433242,0.0000017238233,0.15683255,0.0012843756,0.4706607,0.27032417],"study_design_scores_gemma":[0.006846753,0.0068242787,0.0066002817,0.000008206355,0.00038690172,0.0038056232,0.000063102205,0.00005242713,0.005358441,0.000044326345,0.9698356,0.00017410715],"about_ca_topic_score_codex":0.000042998294,"about_ca_topic_score_gemma":0.000054354918,"teacher_disagreement_score":0.49917486,"about_ca_system_score_codex":0.0005615454,"about_ca_system_score_gemma":0.0012670171,"threshold_uncertainty_score":0.99999493},"labels":[],"label_agreement":null},{"id":"W2000497085","doi":"10.1093/neuonc/nou174.385","title":"P17.56 * A 3-DIMENSIONAL MATRIX ASSAY TO HELP PREDICT TREATMENT RESPONSE TO TEMOZOLOMIDE IN PATIENTS WITH GLIOBASTOMA: UPDATE OF RESULTS AND SUBGROUP ANALYSIS OF PATIENTS UNDERGOING MGMT TESTING","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Western University","funders":"","keywords":"Temozolomide; Medicine; Dacarbazine; Oncology; Subgroup analysis; Chemotherapy; Internal medicine; Adjuvant; Glioblastoma; Radiation therapy; Cancer research; Confidence interval","score_opus":0.011298805959380678,"score_gpt":0.2697305420073057,"score_spread":0.258431736047925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000497085","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99762607,0.000018534474,0.00001306548,0.000960435,0.00006972974,0.0010327204,0.00017893383,0.000022724835,0.00007776242],"genre_scores_gemma":[0.99678755,0.0000036310316,0.002636654,0.00033746407,0.00001804152,0.00007810614,0.00010684903,0.000026600239,0.0000051286265],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973872,0.00053029496,0.0007401067,0.00058979157,0.00040080244,0.0003518366],"domain_scores_gemma":[0.99573463,0.0029010752,0.0003599427,0.00040970027,0.0003036954,0.00029094898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055330846,0.00026844282,0.0009811708,0.001074944,0.00005065454,0.0000070284673,0.00007810836,0.00011490663,0.000007453787],"category_scores_gemma":[0.0021353716,0.0002002819,0.000107062624,0.0013296964,0.00006423053,0.00004742484,0.000113987466,0.00009381022,0.000005372475],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01835084,0.0028786785,0.96122134,0.000024192,0.0005057207,0.00007382622,0.00029387246,0.0017347651,0.008883131,0.0000075995085,0.00015775954,0.0058682677],"study_design_scores_gemma":[0.018090462,0.026972864,0.94847214,0.00011321853,0.001210503,0.000003914227,0.000032020063,0.00066900626,0.0038115417,0.000004010561,0.00048741582,0.00013289109],"about_ca_topic_score_codex":0.00017425882,"about_ca_topic_score_gemma":0.0007309244,"teacher_disagreement_score":0.024094185,"about_ca_system_score_codex":0.00041581847,"about_ca_system_score_gemma":0.00017580502,"threshold_uncertainty_score":0.81672585},"labels":[],"label_agreement":null},{"id":"W2005333216","doi":"10.1093/neuonc/nov061.9","title":"BI-03 * DLX HOMEOBOX GENES REGULATE NEURONAL VS OLIGODENDROGLIAL CELL FATE DECISIONS: POTENTIAL RELEVANCE TO PEDIATRIC GLIONEURONAL TUMORS AND HIGH GRADE GLIOMAS","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Homeobox; Oligodendroglial Tumor; Biology; Oligodendroglioma; Cell fate determination; DLX5; Glioma; Gene; Neuroscience; Cancer research; Genetics; Transcription factor","score_opus":0.024700836927808747,"score_gpt":0.27975028632441995,"score_spread":0.2550494493966112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005333216","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866555,0.0015588138,0.000044778422,0.008265851,0.0021660188,0.00089798844,0.00006667766,0.00015290594,0.00019148743],"genre_scores_gemma":[0.99290997,0.0013259607,0.0016792539,0.002380692,0.0013365488,0.00014630545,0.00004338104,0.00010123828,0.00007665987],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99617565,0.00032286614,0.00074025284,0.001138154,0.00079696265,0.00082609465],"domain_scores_gemma":[0.99703115,0.0006563829,0.0002729029,0.0005951451,0.00025139833,0.0011930371],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002627742,0.00051721535,0.00089896924,0.0007021392,0.0001973415,0.00006141726,0.00027428515,0.00026142146,0.000055405268],"category_scores_gemma":[0.0005424494,0.00045414685,0.00019673906,0.0007764699,0.00016190631,0.00015002194,0.0003849944,0.00042576232,0.0003212279],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009852775,0.008250996,0.07863387,0.0001933859,0.00024313851,0.0509699,0.0008642503,0.004494977,0.7314899,0.00086040085,0.06365441,0.05049203],"study_design_scores_gemma":[0.049919013,0.03707599,0.4167285,0.0001205974,0.0025182068,0.013630925,0.00022522514,0.0018512561,0.22898999,0.002415412,0.24434243,0.002182469],"about_ca_topic_score_codex":0.00006709143,"about_ca_topic_score_gemma":0.000023754992,"teacher_disagreement_score":0.5024999,"about_ca_system_score_codex":0.00021636835,"about_ca_system_score_gemma":0.00045507922,"threshold_uncertainty_score":0.999791},"labels":[],"label_agreement":null},{"id":"W2006306117","doi":"10.1093/neuonc/nov061.97","title":"MB-21 * INTEGRATED GENOMICS ELUCIDATES RELATIVE SPATIAL HOMOGENEITY OF EMBRYONAL BRAIN TUMORS","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; BC Cancer Agency; University of Toronto; Canada's Michael Smith Genome Sciences Centre; Hospital for Sick Children","funders":"","keywords":"Homogeneity (statistics); Genomics; Computational biology; Biology; Evolutionary biology; Genetics; Genome; Computer science; Gene; Machine learning","score_opus":0.03163584154387048,"score_gpt":0.30107758385039673,"score_spread":0.26944174230652623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006306117","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899956,0.00019351488,0.00012720973,0.005208101,0.0004207684,0.00045904584,0.000068750065,0.000046199355,0.003480821],"genre_scores_gemma":[0.9974726,0.000027730568,0.00091230957,0.0011756354,0.00015991923,0.000044882778,0.00013126267,0.000030165738,0.000045532164],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99849063,0.00024006347,0.00042600845,0.00035064417,0.00021127153,0.00028138136],"domain_scores_gemma":[0.9984051,0.0005215408,0.00023257027,0.00028846067,0.00026902877,0.00028327748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002539134,0.0002089254,0.00061153685,0.00015690376,0.000040369596,0.0000063166863,0.00011135584,0.00018646734,0.00012924256],"category_scores_gemma":[0.0008216442,0.00016815714,0.0001306297,0.00021852065,0.00019966403,0.000055439854,0.00009263862,0.0002852153,0.00008167459],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019778863,0.003392912,0.1510578,0.00004155735,0.00048794335,0.002346543,0.0019370734,0.00014985332,0.7815426,0.0016937366,0.025761664,0.029610412],"study_design_scores_gemma":[0.0164929,0.012911471,0.09886127,0.00007691834,0.0006050796,0.0009737209,0.0008538834,0.001514882,0.69472915,0.0012749471,0.17128311,0.00042269615],"about_ca_topic_score_codex":0.00044300483,"about_ca_topic_score_gemma":0.0002125686,"teacher_disagreement_score":0.14552145,"about_ca_system_score_codex":0.00040129098,"about_ca_system_score_gemma":0.0008484767,"threshold_uncertainty_score":0.6857249},"labels":[],"label_agreement":null},{"id":"W2022784634","doi":"10.1093/neuonc/nou274.3","title":"SO-04 * INTERNATIONAL CONSENSUS GUIDELINES FOR POST-OPERATIVE STEREOTACTIC BODY RADIATION THERAPY (SBRT) FOR MALIGNANT SPINE TUMORS","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Medicine; Spinal cord; Radiation therapy; Cord; Spinal cord compression; Radiology; Nuclear medicine; Surgery","score_opus":0.0560357802697202,"score_gpt":0.38827364017901217,"score_spread":0.332237859909292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022784634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.65178293,0.00038857074,0.025849797,0.30072808,0.005252897,0.010592887,0.00034739275,0.00027696442,0.0047804764],"genre_scores_gemma":[0.87060696,0.00020820009,0.025571043,0.097528145,0.0019981442,0.0013771369,0.0008822853,0.00013301338,0.0016950466],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99808306,0.00023016323,0.0006565583,0.00045065148,0.00026611664,0.00031347314],"domain_scores_gemma":[0.99725544,0.0008861662,0.00033760254,0.0002884408,0.0010702541,0.0001620755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000774605,0.0002312033,0.0004923594,0.00020259847,0.00012007009,0.000037165875,0.00015761917,0.0000800635,0.00020483637],"category_scores_gemma":[0.005283943,0.00019083652,0.00017333998,0.000082253195,0.00009884096,0.000066460496,0.000041915242,0.00012604236,0.00003091812],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012761189,0.0023870226,0.0030406239,0.00045030747,0.0011894447,0.00024863638,0.0010937902,0.00013673409,0.42513868,0.018740797,0.24550141,0.28931135],"study_design_scores_gemma":[0.018393416,0.0074625965,0.0064145434,0.000039004142,0.00032726588,0.000106939886,0.00030360068,0.029841062,0.005429009,0.0007049606,0.93070555,0.00027207134],"about_ca_topic_score_codex":0.000015742313,"about_ca_topic_score_gemma":0.000007179356,"teacher_disagreement_score":0.6852041,"about_ca_system_score_codex":0.00014592706,"about_ca_system_score_gemma":0.00033073514,"threshold_uncertainty_score":0.77820873},"labels":[],"label_agreement":null},{"id":"W2024505394","doi":"10.1215/15228517-2007-035","title":"Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma","year":2007,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":389,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Neurological Disorders and Stroke; National Institutes of Health; National Cancer Institute; University of Manitoba","keywords":"Human cytomegalovirus; Immunosuppression; Medicine; Pathology; Polymerase chain reaction; Viremia; Subclinical infection; In situ hybridization; Cytomegalovirus; Immunology; Immunohistochemistry; Virus; Herpesviridae; Viral disease; Biology; Gene; Gene expression","score_opus":0.013532090483231852,"score_gpt":0.2980262181841068,"score_spread":0.28449412770087495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024505394","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99793154,0.00003276748,0.000020643134,0.000037274578,0.00004161922,0.00055536255,0.0000128044585,0.000017247827,0.0013507658],"genre_scores_gemma":[0.9996458,0.00002803098,0.00006990955,0.00014867417,0.000050620423,0.000012165072,0.0000044567846,0.000027358401,0.000012974072],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984614,0.00012001101,0.00045642626,0.0003025322,0.00031010466,0.00034952207],"domain_scores_gemma":[0.9989043,0.00033697637,0.00019003525,0.00017840216,0.00023661746,0.00015367201],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035790206,0.00015603016,0.0005636831,0.00045422054,0.000047690286,0.00000444199,0.000056364188,0.00013608855,0.00003081694],"category_scores_gemma":[0.00015920379,0.00013454258,0.000051532807,0.00040505984,0.00034467588,0.0000657138,0.000060973063,0.00039328705,0.0000021008852],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005395777,0.0009621302,0.21907373,0.00008800707,0.000042462376,0.0011247043,0.00116942,0.0000029097966,0.7561229,0.000022077695,0.0000075854346,0.0159883],"study_design_scores_gemma":[0.0075431513,0.0146367075,0.50404906,0.000047421116,0.000049291855,0.00013116561,0.0003786449,0.000030075225,0.47236028,0.0000066557177,0.0006705637,0.000097008015],"about_ca_topic_score_codex":0.0006481197,"about_ca_topic_score_gemma":0.0048650214,"teacher_disagreement_score":0.28497532,"about_ca_system_score_codex":0.0001399547,"about_ca_system_score_gemma":0.0001389809,"threshold_uncertainty_score":0.5486487},"labels":[],"label_agreement":null},{"id":"W2026356631","doi":"10.1093/neuonc/nou237.33","title":"AT-33A PHASE II STUDY OF CONCURRENT RADIATION THERAPY, TEMOZOLOMIDE AND THE HISTONE DEACETYLASE INHIBITOR VALPROIC ACID FOR PATIENTS WITH GLIOBLASTOMA MULTIFORME","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lakeridge Health","funders":"","keywords":"Temozolomide; Medicine; Valproic Acid; Internal medicine; Phases of clinical research; Radiation therapy; Oncology; Toxicity; Gastroenterology; Epilepsy","score_opus":0.010233742081879358,"score_gpt":0.3051719867733026,"score_spread":0.2949382446914232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026356631","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99612415,0.00034806255,0.00015024844,0.00025715373,0.00031590162,0.002673294,0.000054277134,0.000016238984,0.000060657265],"genre_scores_gemma":[0.998728,0.000080419486,0.00007196566,0.00020241213,0.00023139888,0.00048691762,0.00008984444,0.000048247817,0.000060812177],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99778277,0.00053278054,0.00046040717,0.0005643132,0.00029174602,0.0003679694],"domain_scores_gemma":[0.99850905,0.00027343573,0.00034095626,0.00045057505,0.00028480438,0.00014118355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054038,0.000262096,0.00044132565,0.000101520425,0.0003478261,0.000012497785,0.0002296239,0.0001852777,0.000009506591],"category_scores_gemma":[0.0005515811,0.00018204904,0.00009198234,0.0001201055,0.0004979751,0.00001091771,0.00023106206,0.00019227534,0.0000038081648],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015543035,0.0036867182,0.00085045065,0.000031670195,0.00010475225,0.00000270987,0.0013798769,0.000017890705,0.8936163,0.000018077935,0.003135325,0.08161317],"study_design_scores_gemma":[0.07149796,0.08546914,0.00036095275,0.000008172249,0.000065418935,0.0000182732,0.0001497379,0.00047474884,0.7206367,0.0000050663416,0.12104994,0.00026386318],"about_ca_topic_score_codex":0.000023248711,"about_ca_topic_score_gemma":0.00018371335,"teacher_disagreement_score":0.17297961,"about_ca_system_score_codex":0.00012989037,"about_ca_system_score_gemma":0.00014341254,"threshold_uncertainty_score":0.7423745},"labels":[],"label_agreement":null},{"id":"W2028516615","doi":"10.1093/neuonc/noq116.s20","title":"Tumor Models (In Vivo/In Vitro)","year":2010,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; University of Calgary","funders":"","keywords":"In vivo; In vitro; Computer science; Computational biology; Biology; Genetics","score_opus":0.015657561006434756,"score_gpt":0.3075053968068196,"score_spread":0.29184783580038487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028516615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897478,0.00011260879,0.000019574843,0.0004844538,0.00025925698,0.00023332583,0.000025523752,0.000007779434,0.0091096265],"genre_scores_gemma":[0.99859476,0.00008675133,0.00026962894,0.0006615138,0.00014019421,0.00010427876,0.000021279699,0.000018444993,0.0001031709],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99893653,0.00007828043,0.00015912164,0.00035838247,0.00009080197,0.00037687918],"domain_scores_gemma":[0.9995274,0.000030727042,0.00003546498,0.0002738452,0.000024740733,0.000107813525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011765839,0.00011484356,0.00016515734,0.00008407831,0.000024176883,0.000009137485,0.00017918945,0.00013874452,0.0000698134],"category_scores_gemma":[0.00007279628,0.00011125021,0.00005284237,0.0000944388,0.0000748191,0.000004417361,0.000109516324,0.00028131972,0.000022652368],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044105266,0.00021407683,0.0012095883,0.0000038337657,0.000007015101,0.00027891836,0.000026566,0.00003952715,0.9903413,0.000052652125,0.0009554903,0.0064299614],"study_design_scores_gemma":[0.002055907,0.00053775776,0.00059654913,0.0000016833283,0.0000033014944,0.000090787646,0.000014171335,0.0004020962,0.86898404,0.00040405948,0.12679845,0.00011118831],"about_ca_topic_score_codex":0.00042345267,"about_ca_topic_score_gemma":0.0058331843,"teacher_disagreement_score":0.12584296,"about_ca_system_score_codex":0.000046461166,"about_ca_system_score_gemma":0.00025334652,"threshold_uncertainty_score":0.4536652},"labels":[],"label_agreement":null},{"id":"W2029534758","doi":"10.1093/neuonc/nos240","title":"CLIN-SYMPTOM MANAGEMENT/QUALITY OF LIFE","year":2012,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Clinical Laboratory Practices and Quality Control","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Quality (philosophy); Psychology; Business; Philosophy; Epistemology","score_opus":0.12508388512826277,"score_gpt":0.44706101564974915,"score_spread":0.32197713052148635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029534758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91889703,0.0004783722,0.00015161434,0.01363394,0.0013741032,0.00055738154,0.000019158746,0.000077667624,0.064810716],"genre_scores_gemma":[0.9724933,0.00021794943,0.00090353115,0.025446024,0.0006874201,0.000019701238,0.000009195848,0.000019304809,0.00020357128],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974589,0.00076044974,0.00091288576,0.00024303302,0.0002676305,0.00035710333],"domain_scores_gemma":[0.99569046,0.0027775767,0.0005018044,0.0004848468,0.00013797627,0.00040735144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020872466,0.00013204,0.0007026364,0.000065878565,0.000040718638,0.000005331054,0.00012071631,0.00020736606,0.00064737134],"category_scores_gemma":[0.0027742854,0.00011370656,0.00016381385,0.00019441408,0.00012843276,0.0001410188,0.00010540924,0.0003938736,0.00024922093],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070542432,0.006914404,0.61946577,0.00083879253,0.0008035444,0.00011077768,0.0007314934,0.0000030500578,0.12579273,0.071898155,0.024470566,0.14191645],"study_design_scores_gemma":[0.004362894,0.0008188183,0.12706465,0.000010174246,0.00025596961,0.000009592596,0.00023323816,0.00001748543,0.00052108587,0.00008211816,0.86651456,0.000109428554],"about_ca_topic_score_codex":0.000020952497,"about_ca_topic_score_gemma":0.000008111003,"teacher_disagreement_score":0.842044,"about_ca_system_score_codex":0.000050881237,"about_ca_system_score_gemma":0.00014861807,"threshold_uncertainty_score":0.7088262},"labels":[],"label_agreement":null},{"id":"W2031120760","doi":"10.1093/neuonc/nou253.4","title":"ED-04 * SURVIVAL RATES AMONG CANADIAN PATIENTS WITH PRIMARY MALIGNANT BRAIN TUMOURS: AN ANALYSIS BASED ON STATISTICS CANADA DATA, 1992-2010","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Cancer registry; Survival analysis; Demography; Proportional hazards model; Population; Confidence interval; Brain tumor; Brain cancer; Cancer; Pathology; Internal medicine; Environmental health","score_opus":0.008608183512767128,"score_gpt":0.264361654253417,"score_spread":0.25575347074064986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031120760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9762813,0.000010375793,0.0060111224,0.012893243,0.0011503834,0.0005326115,0.00095053326,0.00005907915,0.0021113707],"genre_scores_gemma":[0.9639786,0.0000037021023,0.0032766638,0.02599837,0.0002495647,0.000010597615,0.0063683772,0.000059829184,0.00005430831],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972666,0.00055934204,0.00035718858,0.0006573207,0.00055849546,0.0006010664],"domain_scores_gemma":[0.99663895,0.0011325105,0.00020106457,0.00088749774,0.00014143669,0.0009985144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007353685,0.00025753982,0.00068034214,0.00031979382,0.00017404403,0.000037266796,0.00038669567,0.000112813155,0.00014380612],"category_scores_gemma":[0.0014787791,0.00020711079,0.000034231714,0.00037161724,0.0002014749,0.00007752967,0.0000557528,0.00071646454,0.0000048877428],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017870811,0.00019810055,0.93565273,0.000031538468,0.00012130921,0.00059761305,0.000038826656,0.0020807765,0.00021672767,0.000052872143,0.049099404,0.011731407],"study_design_scores_gemma":[0.0020999254,0.0013088289,0.7332459,0.000023642693,0.00052620785,0.000007810983,0.000027064858,0.19206375,0.000017378708,0.0000045064676,0.070453435,0.0002215384],"about_ca_topic_score_codex":0.9027543,"about_ca_topic_score_gemma":0.9778984,"teacher_disagreement_score":0.20240681,"about_ca_system_score_codex":0.0005910582,"about_ca_system_score_gemma":0.0035976982,"threshold_uncertainty_score":0.84457326},"labels":[],"label_agreement":null},{"id":"W2033633603","doi":"10.1093/neuonc/nor147","title":"ANGIOGENESIS AND INVASION","year":2011,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Angiogenesis; Cancer research; Biology","score_opus":0.05369308801299511,"score_gpt":0.27358096457176845,"score_spread":0.21988787655877334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033633603","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9833648,0.0019616112,0.00002860429,0.0002576768,0.0011132743,0.0002926248,0.000020791962,0.000116334435,0.01284427],"genre_scores_gemma":[0.9988275,0.00008957576,0.00011550624,0.00072964514,0.000031199765,0.000044162152,0.000019866196,0.000014774311,0.00012778003],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99884933,0.00033902325,0.00022628315,0.00030178536,0.000019825478,0.00026375346],"domain_scores_gemma":[0.9993297,0.00025516478,0.00009393766,0.00025105485,0.000033718723,0.000036416703],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013377452,0.00012687223,0.00023831503,0.00010037377,0.00011419495,0.0000037797074,0.00016639761,0.00015969956,0.002227],"category_scores_gemma":[0.00009815671,0.00011552133,0.000058435653,0.00007329594,0.00016538781,0.000037866797,0.00019137135,0.00009569515,0.0005853167],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017207574,0.00018211863,0.04658827,0.000014759257,0.000059364953,0.000050241884,0.0005527719,8.1545345e-8,0.91112083,0.0009494826,0.0147134345,0.025596565],"study_design_scores_gemma":[0.002132721,0.0013792538,0.07915049,0.000015442558,0.00013391403,0.0006097491,0.000458377,0.000001582182,0.23512003,0.00054628873,0.68017787,0.0002743198],"about_ca_topic_score_codex":0.000116823074,"about_ca_topic_score_gemma":0.00006629756,"teacher_disagreement_score":0.67600083,"about_ca_system_score_codex":0.00003298923,"about_ca_system_score_gemma":0.000060065668,"threshold_uncertainty_score":0.9986851},"labels":[],"label_agreement":null},{"id":"W2038579109","doi":"10.1093/neuonc/nou070","title":"GERM CELL TUMOURS","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Germ cell; Biology; Genetics","score_opus":0.01379146272724066,"score_gpt":0.28936557910305843,"score_spread":0.2755741163758178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038579109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9489724,0.0003276562,0.000087219196,0.0024460766,0.00045149884,0.00025855371,0.000004101262,0.0001168101,0.047335666],"genre_scores_gemma":[0.9951716,0.000023464161,0.00045883955,0.00385095,0.00021212536,0.000019978552,0.0000148854715,0.00002178956,0.00022635178],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992293,0.00008317169,0.00012984348,0.0002262299,0.000112766334,0.00021866834],"domain_scores_gemma":[0.999217,0.00019675498,0.000072966905,0.00024672895,0.00003626847,0.00023028837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005468369,0.00010855674,0.00023499916,0.000044986562,0.00004074627,0.0000056284093,0.00005447241,0.00007612857,0.00017074213],"category_scores_gemma":[0.00020031142,0.00008724253,0.000092970964,0.00006422772,0.000048099486,0.00001855023,0.0000330797,0.000121069264,0.0005256605],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005397365,0.0038699948,0.6028773,0.00017161806,0.00007194876,0.0037794074,0.00023023234,0.000020795265,0.17429557,0.0012514481,0.024066284,0.18882565],"study_design_scores_gemma":[0.0071640727,0.0048632133,0.32312283,0.000018775012,0.0006213487,0.000639302,0.000036219502,0.00047043432,0.013127867,0.00041808744,0.6493198,0.00019804436],"about_ca_topic_score_codex":0.000016908878,"about_ca_topic_score_gemma":0.0000038353587,"teacher_disagreement_score":0.62525356,"about_ca_system_score_codex":0.00006573897,"about_ca_system_score_gemma":0.00013913745,"threshold_uncertainty_score":0.6756478},"labels":[],"label_agreement":null},{"id":"W2042861076","doi":"10.1093/neuonc/nou240.16","title":"BM-16 * INCREASED ACUTE RADIATION EFFECT (ARE) WITH IPILUMUMAB AND RADIOSURGERY IN PATIENTS WITH MELANOMA BRAIN METASTASES","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Radiosurgery; Melanoma; Radiation therapy; Incidence (geometry); Brain metastasis; Retrospective cohort study; Surgery; Internal medicine; Nuclear medicine; Metastasis; Cancer","score_opus":0.005356560049197767,"score_gpt":0.24016122860155123,"score_spread":0.23480466855235346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042861076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958864,0.00011186344,0.00009755148,0.002444393,0.00009958711,0.0010040309,0.00005260384,0.00004641383,0.00025716727],"genre_scores_gemma":[0.9942466,0.000026496247,0.0005479803,0.0047421968,0.00007124851,0.000104051716,0.00020031608,0.000044235017,0.000016864926],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977229,0.0008606538,0.00028676772,0.00049922767,0.0002729762,0.00035744542],"domain_scores_gemma":[0.9976241,0.0015228463,0.0002283547,0.00033699616,0.000056795263,0.00023091068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005333739,0.00029620007,0.00082432677,0.00024278832,0.000058417645,0.000018217886,0.00005526387,0.00011280777,0.000063491294],"category_scores_gemma":[0.00025668135,0.00019243018,0.00006116336,0.00025216525,0.0001290037,0.00010198088,0.000031813477,0.00022390879,0.000012189426],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067007747,0.0007959326,0.90414983,0.00007020583,0.00043558644,0.00057320355,0.00016272123,0.000004770995,0.00087320764,0.000044470642,0.0030367412,0.08315253],"study_design_scores_gemma":[0.042015508,0.02926357,0.87488335,0.00009271216,0.0011601466,0.00041498817,0.000029094093,0.00012506759,0.0042792913,0.000022725937,0.047398586,0.00031496384],"about_ca_topic_score_codex":0.00016879119,"about_ca_topic_score_gemma":0.00008439637,"teacher_disagreement_score":0.08283757,"about_ca_system_score_codex":0.00020937437,"about_ca_system_score_gemma":0.00013193382,"threshold_uncertainty_score":0.7847075},"labels":[],"label_agreement":null},{"id":"W2044800165","doi":"10.1093/neuonc/2.3.145","title":"Localization of gelatinase-A and gelatinase-B mRNA and protein in humangliomas","year":2000,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Protease and Inhibitor Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Gelatinase A; MMP9; Gelatinase; Glioma; Matrix metalloproteinase; MMP2; Fibroblast activation protein, alpha; Angiogenesis; In situ hybridization; Neovascularization; Biology; Immunohistochemistry; Tumor progression; Cancer research; Pathology; Proteases; Molecular biology; Messenger RNA; Medicine; Enzyme; Immunology; Cancer; Downregulation and upregulation; Gene; Biochemistry","score_opus":0.008914538293406682,"score_gpt":0.2450833308535085,"score_spread":0.23616879256010181,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044800165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956438,0.00050346466,0.00011806685,0.00011626829,0.000032570577,0.00037253217,0.000006301505,0.000008139973,0.0031988733],"genre_scores_gemma":[0.99893486,0.00014456396,0.0003798105,0.00028936515,0.0000738425,0.000039625666,0.000021577855,0.00001538517,0.00010098787],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991282,0.00013401825,0.00022784607,0.00028328696,0.00006489439,0.00016175075],"domain_scores_gemma":[0.9996718,0.000015907992,0.0000751342,0.00015046535,0.000027985065,0.00005866752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013581202,0.000112122994,0.00016739014,0.000059470745,0.00004173291,0.0000060754414,0.000057400757,0.00020168931,0.000060362625],"category_scores_gemma":[0.000064913605,0.00011325329,0.00002233655,0.00008329719,0.00009968349,0.0000066507173,0.000056605048,0.00009438601,0.0000031236923],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013004635,0.00007171619,0.000856026,0.00002322712,0.00000525542,0.000026229114,0.000072809074,0.000016346692,0.9840663,0.0002375091,0.00017061604,0.014323892],"study_design_scores_gemma":[0.0010711418,0.001528057,0.00022357,0.000019123407,0.0000087157305,0.00005969953,0.00002813523,0.0004238857,0.9546713,0.0006839646,0.0411622,0.00012019972],"about_ca_topic_score_codex":0.00002942578,"about_ca_topic_score_gemma":0.000051941017,"teacher_disagreement_score":0.040991586,"about_ca_system_score_codex":0.000011402403,"about_ca_system_score_gemma":0.000050638933,"threshold_uncertainty_score":0.46183354},"labels":[],"label_agreement":null},{"id":"W2047163880","doi":"10.1093/neuonc/nou275.25","title":"SC-25 * INVESTIGATING THE ROLE OF ASCL1 IN REGULATING DIFFERENTIATION OF GLIOBLASTOMA PRECURSOR CELLS","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Neurogenesis; Biology; Immunocytochemistry; Precursor cell; Lineage markers; Cellular differentiation; Neural stem cell; Cell biology; Stem cell; Notch signaling pathway; Cancer research; Signal transduction; Cell; Endocrinology; Genetics; Gene","score_opus":0.00619137974754398,"score_gpt":0.2309472653139939,"score_spread":0.22475588556644993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047163880","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977917,0.000104323466,0.00037701,0.00009853885,0.0001328503,0.00018953097,0.0000058650603,0.0000049854243,0.0012952115],"genre_scores_gemma":[0.99895436,0.000035852056,0.00067552,0.00017513332,0.00009748373,0.000015217716,0.000014700431,0.000016173759,0.000015588881],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988634,0.00028859513,0.0003633332,0.0002248885,0.00008416292,0.00017559988],"domain_scores_gemma":[0.9991823,0.00012020947,0.00032098033,0.00027812464,0.00006531806,0.000033075346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025691453,0.00010945842,0.00020995496,0.000051841165,0.00003390398,0.000004468982,0.00020119698,0.0001811299,0.0000054628376],"category_scores_gemma":[0.00027483643,0.000091878086,0.00006668023,0.00010273999,0.00012408369,0.0000033882268,0.00013002289,0.0001291435,0.0000014761996],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036166584,0.00006492742,0.006934428,0.00002055112,0.000010548668,1.6003155e-7,0.00021055082,0.0002586268,0.97823495,0.0003163399,0.000077038334,0.013835714],"study_design_scores_gemma":[0.00047379016,0.0007153096,0.0034306832,0.000019183948,0.000016431739,0.0000050033123,0.0000904491,0.0056020003,0.98104876,0.00034123243,0.00817903,0.000078109886],"about_ca_topic_score_codex":0.000029103334,"about_ca_topic_score_gemma":0.00023132165,"teacher_disagreement_score":0.013757605,"about_ca_system_score_codex":0.000014730441,"about_ca_system_score_gemma":0.00006763049,"threshold_uncertainty_score":0.37466794},"labels":[],"label_agreement":null},{"id":"W2052524261","doi":"10.1093/neuonc/nou273.6","title":"RM-06 * IN VITRO CLONAL EVOLUTION OF GLIOBLASTOMA (GBM) BRAIN TUMOUR INITIATING CELLS (BTIC) TO MODEL TUMOUR RECURRENCE","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Ontario Institute for Cancer Research","funders":"","keywords":"Temozolomide; Biology; Somatic evolution in cancer; Transcriptome; SOX2; Stem cell; Glioblastoma; Cancer research; Radiation therapy; Genetic heterogeneity; Cancer stem cell; Brain tumor; Oncology; Internal medicine; Pathology; Medicine; Cancer; Gene; Phenotype; Gene expression; Genetics","score_opus":0.022510374755134368,"score_gpt":0.29777659829174596,"score_spread":0.2752662235366116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052524261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98338264,0.000104615065,0.0074564037,0.0036375776,0.000578753,0.00056644884,0.000052530017,0.000046804445,0.0041742013],"genre_scores_gemma":[0.99033886,0.000020461466,0.0059579806,0.0032438515,0.00029093953,0.000049664897,0.000009612709,0.000034498466,0.00005410462],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99775976,0.00029737744,0.0006328545,0.00049273355,0.00032573458,0.00049152476],"domain_scores_gemma":[0.9984653,0.000581871,0.0002534484,0.00027835363,0.00016212597,0.00025890424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068232254,0.00021825523,0.00068088283,0.0003569999,0.00004625985,0.0000076274514,0.00017264328,0.00015172533,0.000046451416],"category_scores_gemma":[0.00090377947,0.00022163782,0.00012783085,0.00047349703,0.00008860039,0.000074287746,0.00012994271,0.0004700246,0.000060279293],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009957511,0.00026795975,0.00032347813,0.000098344295,0.000008975594,0.000053081654,0.00045886883,0.0015612588,0.9748982,0.00024385712,0.0035628916,0.017527314],"study_design_scores_gemma":[0.004272534,0.0035847067,0.001925073,0.00015091104,0.00011209109,0.00018724933,0.00026334898,0.052316003,0.9126835,0.00045222725,0.023727147,0.00032523484],"about_ca_topic_score_codex":0.0001500147,"about_ca_topic_score_gemma":0.00019160323,"teacher_disagreement_score":0.062214743,"about_ca_system_score_codex":0.00045319882,"about_ca_system_score_gemma":0.0006216824,"threshold_uncertainty_score":0.9038128},"labels":[],"label_agreement":null},{"id":"W2052591253","doi":"10.1093/neuonc/nou254.16","title":"EG-16 * ABERRANT Myst4/Brpf1 SIGNALING MISDIRECTS REGIONAL NEUROGENESIS PROGRAMS, SUSTAINING EXPRESSION OF SELF-RENEWAL GENES IN PEDIATRIC BRAIN CANCERS","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Hospital for Sick Children","funders":"","keywords":"Neurogenesis; Biology; Epigenetics; Chromatin; Neural stem cell; DNA methylation; Histone; Neural development; Cancer research; Genetics; Cell biology; Gene expression; Gene; Stem cell","score_opus":0.01447188031355788,"score_gpt":0.2625785312720758,"score_spread":0.24810665095851792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052591253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964723,0.0010473208,0.0002648494,0.0007523952,0.0003787839,0.00040252862,0.0000034019101,0.000045936416,0.0006324724],"genre_scores_gemma":[0.9965574,0.0005412166,0.0009649722,0.0010110377,0.0006379197,0.000099135344,0.000075680386,0.000042955402,0.00006965816],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99767447,0.0005726766,0.0005017144,0.0005850626,0.0002328612,0.00043324314],"domain_scores_gemma":[0.9989248,0.00014911621,0.00033225561,0.00031153255,0.00013690957,0.00014537094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004539043,0.00024401968,0.00033857336,0.00015036196,0.00008547272,0.000014845978,0.000278851,0.0003196041,0.000016434326],"category_scores_gemma":[0.00032958604,0.0002412443,0.00012669945,0.00028093412,0.000085657375,0.000009793349,0.00013849123,0.00017736765,0.0000031580348],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018368871,0.00014106455,0.01130868,0.00006028795,0.000011181603,0.000013712869,0.00013150179,0.0003345416,0.9670151,0.000027986245,0.0017427545,0.019029541],"study_design_scores_gemma":[0.0014630983,0.0011699736,0.00044732363,0.000019996225,0.00002736765,0.000034083125,0.00011716361,0.00018778758,0.8627512,0.00003116381,0.13349316,0.00025767795],"about_ca_topic_score_codex":0.000089047215,"about_ca_topic_score_gemma":0.0001424493,"teacher_disagreement_score":0.1317504,"about_ca_system_score_codex":0.000115514544,"about_ca_system_score_gemma":0.0005342065,"threshold_uncertainty_score":0.9837657},"labels":[],"label_agreement":null},{"id":"W2053284631","doi":"10.1093/neuonc/nou266.8","title":"PT-08 * VERY ENCOURAGING LONG TERM SURVIVAL AND NEUROCOGNITIVE OUTCOME OF YOUNG CHILDREN TREATED FOR MEDULLOBLASTOMA WITH SEQUENTIAL HIGH DOSE CHEMOTHERAPY","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Alberta Children's Hospital","funders":"","keywords":"Medicine; Medulloblastoma; Carboplatin; Chemotherapy; Neurocognitive; ThioTEPA; Radiation therapy; Induction chemotherapy; Internal medicine; Retrospective cohort study; Surgery; Oncology; Pediatrics; Cisplatin; Cyclophosphamide; Pathology","score_opus":0.01663704749605081,"score_gpt":0.28929903276872393,"score_spread":0.2726619852726731,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053284631","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969346,0.000040326002,0.0001358012,0.0010220401,0.00022738344,0.0011653702,0.00003814816,0.000060617072,0.00037573974],"genre_scores_gemma":[0.99862546,0.000050331593,0.00023951408,0.0006084005,0.00020138534,0.0001328078,0.00007409852,0.00005710046,0.000010883529],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984917,0.00013858199,0.000350658,0.00047070568,0.000196416,0.00035195114],"domain_scores_gemma":[0.9987083,0.00052622455,0.0002285459,0.00022866257,0.00014273639,0.00016552393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000148855,0.0002820161,0.0007434939,0.00016453113,0.00008484845,0.000015769589,0.00007898701,0.00013119909,0.000031531934],"category_scores_gemma":[0.00009408933,0.00021148073,0.00011091456,0.00013251616,0.00018974832,0.000066764216,0.000040338553,0.00016007405,0.0000034551445],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018097032,0.0006936062,0.8935187,0.000049887356,0.00033252538,0.00020893959,0.00015952488,0.000003821221,0.07713522,0.00006831322,0.000039751565,0.025980014],"study_design_scores_gemma":[0.019556733,0.005775014,0.9001703,0.00004812034,0.0006065564,0.0005515533,0.000032890595,0.000062822095,0.072848745,0.000017826074,0.00015712733,0.00017225812],"about_ca_topic_score_codex":0.00011013735,"about_ca_topic_score_gemma":0.00012509167,"teacher_disagreement_score":0.025807755,"about_ca_system_score_codex":0.000081937156,"about_ca_system_score_gemma":0.0000719839,"threshold_uncertainty_score":0.8623934},"labels":[],"label_agreement":null},{"id":"W2053550046","doi":"10.1093/neuonc/nov061.6","title":"AT-07 * SUCCESSFUL TREATMENT OF ATRT PATIENTS WITHOUT ADJUVANT RADIATION: A MULTI INSTITUTIONAL CANADIAN EXPERIENCE","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Children's Hospital; Alberta Children's Hospital; Hospital for Sick Children","funders":"","keywords":"Adjuvant; Adjuvant radiotherapy; Medicine; Radiation therapy; Medical physics; Oncology; Internal medicine","score_opus":0.043956571502167585,"score_gpt":0.3232962226601592,"score_spread":0.27933965115799164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053550046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941223,0.00041764535,0.000004013282,0.001214701,0.00066409225,0.0006703882,0.00006507291,0.000022553282,0.0028192003],"genre_scores_gemma":[0.99841577,0.00009531444,0.00032972216,0.00064025697,0.000103146434,0.00022243187,0.00013931126,0.000014570673,0.00003946542],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99875814,0.00007115772,0.00030743508,0.00031759535,0.00024810736,0.00029759668],"domain_scores_gemma":[0.99870265,0.00007419431,0.00013213576,0.0002549431,0.00020233456,0.0006337394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000044399876,0.00018948832,0.00045584192,0.00016476517,0.000098192504,0.0000056153654,0.00007257493,0.00012101403,0.00016372823],"category_scores_gemma":[0.00013909373,0.00014091068,0.00008989901,0.00014364047,0.00015622003,0.00006832421,0.000027665239,0.00005338379,0.00012913137],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021642877,0.0017992624,0.9683231,0.0000065121,0.00005987942,0.0004410515,0.0020578196,0.000048883572,0.0014324567,0.000076310826,0.0009387065,0.024599558],"study_design_scores_gemma":[0.01932023,0.005563999,0.46100393,0.000019593617,0.00017960848,0.00016837123,0.00021213814,0.00036940366,0.015325803,0.0000063465336,0.49765915,0.00017143151],"about_ca_topic_score_codex":0.017756175,"about_ca_topic_score_gemma":0.03083027,"teacher_disagreement_score":0.5073192,"about_ca_system_score_codex":0.0023031777,"about_ca_system_score_gemma":0.0013616165,"threshold_uncertainty_score":0.9887847},"labels":[],"label_agreement":null},{"id":"W2054601242","doi":"10.1093/neuonc/nos136","title":"Response to Weltman and Fleury Malheiros, re Lassman et al.","year":2012,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Western University","funders":"Eisai; Genentech; GlaxoSmithKline; Bristol-Myers Squibb","keywords":"Art","score_opus":0.033870006807490964,"score_gpt":0.3411107219320665,"score_spread":0.3072407151245755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054601242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8446974,0.00031337555,0.0000021424557,0.15037239,0.0004142695,0.00036900348,0.000009872292,0.000057811183,0.0037637167],"genre_scores_gemma":[0.91885054,0.00012097711,0.00046729328,0.08019389,0.000100161,0.000095061245,0.000009902029,0.00003018668,0.0001319629],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986658,0.00032170818,0.00019021537,0.00028929603,0.00014484586,0.00038810313],"domain_scores_gemma":[0.9985125,0.0006327167,0.00005297087,0.00031942283,0.000036253685,0.00044611545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044946987,0.00016175925,0.00032735622,0.00015021933,0.00006478572,0.000011412975,0.00005536253,0.00010575466,0.00015675178],"category_scores_gemma":[0.00035491592,0.00013263282,0.000054994212,0.00013140215,0.000054155025,0.000063610416,0.00010800531,0.00019003474,0.0002560162],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002040313,0.0011146978,0.12236942,0.0000128812235,0.00005435934,0.00089024025,0.0009896924,0.0000011649795,0.55787224,0.0003489738,0.3011315,0.013174536],"study_design_scores_gemma":[0.00185863,0.0019700003,0.22312613,0.000012416345,0.00006376073,0.00037464785,0.00009986782,0.0000030990534,0.0114545785,0.000008420079,0.7609455,0.00008295913],"about_ca_topic_score_codex":0.000015926764,"about_ca_topic_score_gemma":0.000037112823,"teacher_disagreement_score":0.54641765,"about_ca_system_score_codex":0.00011937549,"about_ca_system_score_gemma":0.00007678632,"threshold_uncertainty_score":0.54086095},"labels":[],"label_agreement":null},{"id":"W2055809488","doi":"10.1093/neuonc/nor152","title":"MEDICAL AND NEURO-ONCOLOGY","year":2011,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Medical and Biological Sciences","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Dalhousie University; University of Calgary","funders":"","keywords":"Medicine; Internal medicine; Oncology","score_opus":0.06514576540051202,"score_gpt":0.32648774596965874,"score_spread":0.2613419805691467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055809488","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8257631,0.00028455976,0.000095228526,0.047322325,0.001504453,0.00040145792,0.0000030027707,0.00016070812,0.12446513],"genre_scores_gemma":[0.9381897,0.00081715285,0.0011143431,0.059041493,0.000657535,0.00003567823,0.0000052705104,0.000012095992,0.00012675633],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976323,0.0003616629,0.0004276499,0.0005786676,0.00044989245,0.00054982275],"domain_scores_gemma":[0.99738324,0.001146978,0.000112502144,0.00020688161,0.000059318074,0.0010910811],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00078360934,0.00018733932,0.0005964992,0.000076569464,0.00010421944,0.00000590467,0.00028883963,0.00060416636,0.0059672706],"category_scores_gemma":[0.0034027256,0.00010975055,0.00008315739,0.0002371617,0.001308445,0.000047723595,0.00027757476,0.0007437875,0.00021716117],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096218265,0.0016020158,0.059311707,0.00005523804,0.00004078719,0.00829937,0.00060109707,3.4627476e-8,0.18780065,0.0041375346,0.020809475,0.7163799],"study_design_scores_gemma":[0.002410966,0.012234562,0.041568458,0.000018385055,0.000072092065,0.004220596,0.00015926523,0.00016932779,0.0025876616,0.0022226127,0.9341487,0.00018736006],"about_ca_topic_score_codex":0.00006391261,"about_ca_topic_score_gemma":0.00005331698,"teacher_disagreement_score":0.91333926,"about_ca_system_score_codex":0.00005181026,"about_ca_system_score_gemma":0.00046724838,"threshold_uncertainty_score":0.9949414},"labels":[],"label_agreement":null},{"id":"W2060237761","doi":"10.1093/neuonc/nos102","title":"HIGH GRADE GLIOMAS","year":2012,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto; University of Manitoba; BC Cancer Agency; University of Alberta; University of British Columbia; University of Calgary; McGill University","funders":"","keywords":"Glioma; Medicine; Cancer research","score_opus":0.03150875263397761,"score_gpt":0.31260760397976445,"score_spread":0.2810988513457868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060237761","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9805379,0.00081465434,0.0000052597425,0.010649789,0.0013765115,0.0003015485,0.0000049631194,0.000093514995,0.006215854],"genre_scores_gemma":[0.99485064,0.000085037,0.0005358211,0.003687997,0.00067661377,0.0000844418,0.000017966997,0.000025318812,0.00003615479],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99897045,0.00007986771,0.00018698304,0.00019511124,0.00015003873,0.00041754986],"domain_scores_gemma":[0.99908715,0.00024146849,0.000065685905,0.00027296535,0.00003335428,0.00029934812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009794763,0.00014049099,0.000331331,0.00011683472,0.000054618078,0.0000054818915,0.000058498717,0.00013713933,0.00041137057],"category_scores_gemma":[0.00009493525,0.00010937085,0.00009653558,0.00017077447,0.000060021768,0.000059251055,0.00004836381,0.00015816325,0.00057947857],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017983538,0.005432218,0.24469708,0.000033138655,0.00018311603,0.0017584944,0.0004723123,0.0000028227566,0.6335091,0.009223526,0.054072008,0.05043636],"study_design_scores_gemma":[0.0039493395,0.0014412884,0.09537435,0.00000847342,0.00024702103,0.00088099134,0.000046356676,0.0000063358684,0.14525749,0.00012977497,0.7525417,0.00011686481],"about_ca_topic_score_codex":0.000040688632,"about_ca_topic_score_gemma":0.000008191985,"teacher_disagreement_score":0.6984697,"about_ca_system_score_codex":0.0001509532,"about_ca_system_score_gemma":0.00006268633,"threshold_uncertainty_score":0.7448218},"labels":[],"label_agreement":null},{"id":"W2062039318","doi":"10.1215/15228517-2007-029","title":"Synovial sarcoma of the sellar region","year":2007,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Synovial sarcoma; Cavernous sinus; Medicine; Sarcoma; Resection; Radiosurgery; Pathology; Radiology; Anatomy; Radiation therapy; Surgery","score_opus":0.029731124875033325,"score_gpt":0.308320786164908,"score_spread":0.27858966128987467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062039318","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9774674,0.00035173827,0.000030039184,0.0068916664,0.00060071534,0.0003650973,0.0000014658505,0.000027557184,0.014264308],"genre_scores_gemma":[0.9962901,0.00008968149,0.0001725386,0.0031617426,0.00020830383,0.0000091428665,0.0000019523927,0.000014641797,0.000051910745],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991177,0.000080089514,0.00024538502,0.00017746337,0.00016613337,0.00021326236],"domain_scores_gemma":[0.9989313,0.00047697962,0.00011715642,0.0003361512,0.000058756897,0.00007965499],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016177785,0.00009795236,0.00026804037,0.00005770417,0.00004821316,0.0000019562756,0.00009519657,0.00012336038,0.000041944568],"category_scores_gemma":[0.00014155913,0.00006160398,0.00013160621,0.00016777375,0.000118066724,0.000013739043,0.000056276087,0.0001640496,0.000027303233],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007100148,0.0025825212,0.6628189,0.000041678384,0.0001089901,0.002519226,0.00045156386,0.0000023085327,0.15264367,0.0021154068,0.016852356,0.15915334],"study_design_scores_gemma":[0.003478953,0.001983626,0.3602739,0.000032422937,0.00022995126,0.0016716468,0.000107289154,0.000012976354,0.1555622,0.0001737597,0.47638792,0.000085349246],"about_ca_topic_score_codex":0.000034731318,"about_ca_topic_score_gemma":0.000041862168,"teacher_disagreement_score":0.45953557,"about_ca_system_score_codex":0.00012226077,"about_ca_system_score_gemma":0.0001176464,"threshold_uncertainty_score":0.25121376},"labels":[],"label_agreement":null},{"id":"W2062453374","doi":"10.1093/neuonc/nov061.70","title":"LG-01 * BRAF MUTATION AND CDKN2A DELETION DEFINE A CLINICALLY DISTINCT SUBGROUP OF CHILDHOOD SECONDARY HIGH-GRADE GLIOMA","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group; Hospital for Sick Children","funders":"","keywords":"ATRX; CDKN2A; Glioma; Cancer research; IDH1; Biology; Somatic cell; Oncology; Mutation; Subgroup analysis; Malignant transformation; Medicine; Internal medicine; Gene; Genetics; Confidence interval","score_opus":0.024620677296112774,"score_gpt":0.30267390835281405,"score_spread":0.27805323105670127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062453374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926551,0.00042712144,0.00004154424,0.0048023444,0.00036898188,0.00051743974,0.000033508368,0.00005945927,0.0010945139],"genre_scores_gemma":[0.9974864,0.00006974195,0.00101251,0.000967839,0.00019269163,0.000064214764,0.00017383909,0.000029203606,0.000003566017],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998324,0.00019817078,0.0005951925,0.0003988405,0.00023564402,0.00024819025],"domain_scores_gemma":[0.9984028,0.0006060762,0.00029824497,0.00026340285,0.00014136551,0.00028815758],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003125703,0.00019324887,0.00058274245,0.00016906955,0.000047672165,0.000010842804,0.00006782038,0.00021197458,0.000069248854],"category_scores_gemma":[0.0006478801,0.00016270357,0.00009692466,0.0002176304,0.00015810771,0.00007086402,0.00007030795,0.00024214336,0.000028758139],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032258471,0.015126106,0.36947134,0.00027602518,0.00060348137,0.009033494,0.0024187383,0.000028157196,0.25499704,0.0029260733,0.01401014,0.32788357],"study_design_scores_gemma":[0.029092027,0.019446988,0.9042668,0.000072095194,0.00077232695,0.003966206,0.00020824578,0.0001654725,0.024697846,0.0019131304,0.0151070375,0.00029183988],"about_ca_topic_score_codex":0.000131186,"about_ca_topic_score_gemma":0.00015110784,"teacher_disagreement_score":0.53479546,"about_ca_system_score_codex":0.000111658905,"about_ca_system_score_gemma":0.0002997314,"threshold_uncertainty_score":0.6634859},"labels":[],"label_agreement":null},{"id":"W2067398672","doi":"10.1093/neuonc/nou174.218","title":"P09.02 * ORTERONEL (TAK-700) AND POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME (PRES)","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; Western University","funders":"","keywords":"Medicine; Posterior reversible encephalopathy syndrome; Headaches; Internal medicine; Urology; Endocrinology; Magnetic resonance imaging; Surgery; Radiology","score_opus":0.015984118229160238,"score_gpt":0.269079081431608,"score_spread":0.2530949632024478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067398672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891555,0.0003331389,0.000013305026,0.00524115,0.0005306908,0.00046218798,0.0000094191,0.0000751036,0.004179516],"genre_scores_gemma":[0.9947817,0.00015054551,0.00036618992,0.004386266,0.000115857576,0.000070171176,0.000014983928,0.000030714218,0.000083584964],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985743,0.00014537125,0.00027417697,0.00046856244,0.00017301511,0.00036457213],"domain_scores_gemma":[0.99887073,0.0003059761,0.000108953805,0.00037912023,0.000056892168,0.00027833154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015878811,0.00021078046,0.0005375327,0.00014454062,0.00009484212,0.000019663481,0.00009743979,0.00017581762,0.00025142878],"category_scores_gemma":[0.00015238364,0.00017630446,0.00007974529,0.00013353166,0.00012045373,0.00007795062,0.00011831008,0.00019342871,0.00020312406],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005288606,0.0019473055,0.16444887,0.00020225522,0.0002054129,0.007682785,0.0009810688,0.0000036146898,0.68902045,0.0005357137,0.012555638,0.12188804],"study_design_scores_gemma":[0.017286425,0.021450838,0.43523392,0.00019048864,0.00090839097,0.017784633,0.00028085077,0.0003297107,0.038602047,0.00035562794,0.46697184,0.0006052292],"about_ca_topic_score_codex":0.000040096184,"about_ca_topic_score_gemma":0.000021777823,"teacher_disagreement_score":0.6504184,"about_ca_system_score_codex":0.00010400015,"about_ca_system_score_gemma":0.000076833036,"threshold_uncertainty_score":0.7189487},"labels":[],"label_agreement":null},{"id":"W2070212974","doi":"10.1093/neuonc/nou260.12","title":"MS-13 * NON-CONTIGUOUS LEPTOMENINGEAL METASTASIS OF OLFACTORY NEUROBLASTOMAS: A LONG-TERM MULTI-INSTITUTIONAL EXPERIENCE","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Head and Neck Surgical Oncology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Cribriform plate; Metastasis; Esthesioneuroblastoma; Nasal cavity; Brain metastasis; Radiology; Cancer; Pathology; Surgery; Internal medicine","score_opus":0.047218558161192366,"score_gpt":0.33451698559237353,"score_spread":0.28729842743118117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070212974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875268,0.00007419066,0.0027289356,0.0009565066,0.0014541599,0.00048759626,0.00001314702,0.00010791996,0.006650747],"genre_scores_gemma":[0.99510044,0.00006817001,0.0013626964,0.0027394348,0.00044050033,0.00009326229,0.000018598916,0.00003734155,0.0001395686],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9971631,0.00042093708,0.0007636079,0.0006519732,0.000376612,0.0006237737],"domain_scores_gemma":[0.99765867,0.0009367491,0.0002880431,0.0004510804,0.00019126548,0.00047421857],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00038346797,0.00033795057,0.0012304371,0.00026647857,0.00013318291,0.000008492294,0.00027165,0.00035447566,0.0006838495],"category_scores_gemma":[0.00080434047,0.0002749012,0.00029093734,0.00028776415,0.0007840968,0.00013087264,0.00016300297,0.0006277029,0.00013160073],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001279119,0.0020157623,0.0914282,0.00016632417,0.00011560803,0.0017638094,0.0013827243,0.00004295502,0.8407312,0.00021861924,0.0010217564,0.05983394],"study_design_scores_gemma":[0.015745984,0.013310786,0.5730976,0.00012546628,0.00034944824,0.0029865406,0.000111981346,0.0019207464,0.098956,0.000012855549,0.2927847,0.00059792446],"about_ca_topic_score_codex":0.00004821076,"about_ca_topic_score_gemma":0.000075685435,"teacher_disagreement_score":0.7417752,"about_ca_system_score_codex":0.00019008078,"about_ca_system_score_gemma":0.0005708306,"threshold_uncertainty_score":0.9999703},"labels":[],"label_agreement":null},{"id":"W2070721270","doi":"10.1093/neuonc/nou265.5","title":"NT-05 * PATIENT ACCEPTANCE OF ROUTINE RESAMPLING OF GLIOBLASTOMA: A QUALITATIVE STUDY","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Qualitative research; Medicine; Thematic analysis; Feeling; Glioblastoma; Protocol (science); Grounded theory; Medical physics; Medical education; Psychology; Oncology; Alternative medicine; Pathology; Social psychology","score_opus":0.1265102336613465,"score_gpt":0.46801092470710454,"score_spread":0.34150069104575803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070721270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955013,0.00025775022,0.00050164026,0.0003584729,0.0002882332,0.00045421108,0.000016878574,0.000022253656,0.0025992836],"genre_scores_gemma":[0.9973485,0.00005594213,0.0021093453,0.0003330147,0.000089418594,0.00002336383,0.0000042582997,0.000019072768,0.000017097766],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99790365,0.000598205,0.0007086533,0.00027881935,0.00029963974,0.00021104011],"domain_scores_gemma":[0.99666005,0.0019296318,0.0005639008,0.0003334728,0.00042938587,0.00008358224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048360045,0.00015281125,0.0008666456,0.00015189894,0.000023278273,0.0000013098676,0.00012916862,0.00009828435,0.00005035803],"category_scores_gemma":[0.00239667,0.0001300196,0.00010933989,0.00028176446,0.0001997966,0.000038822243,0.00009439022,0.0002045765,0.0000058794485],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005685471,0.004190962,0.063999526,0.000493389,0.0003799989,0.00011058094,0.41636774,0.0001503823,0.46729764,0.0010190767,0.0022487058,0.03805654],"study_design_scores_gemma":[0.016819367,0.10188607,0.01904806,0.0009254973,0.0006447551,0.00004311465,0.24300838,0.0005246093,0.534176,0.0005781448,0.081861354,0.0004846372],"about_ca_topic_score_codex":0.0001283206,"about_ca_topic_score_gemma":0.00008727221,"teacher_disagreement_score":0.17335935,"about_ca_system_score_codex":0.00006721835,"about_ca_system_score_gemma":0.0001179786,"threshold_uncertainty_score":0.53020453},"labels":[],"label_agreement":null},{"id":"W2073235968","doi":"10.1093/neuonc/nou243.14","title":"CN-14 * RETROSPECTIVE ANALYSIS OF ISCHEMIC CEREBRAL STROKES IN PATIENTS DIAGNOSED WITH A GLIOBLASTOMA DURING THE COURSE OF A BEVACIZUMAB TREATMENT","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Bevacizumab; Stroke (engine); Patent foramen ovale; Internal medicine; Glioma; Oncology; Angiogenesis; Population; Vascular endothelial growth factor; Cardiology; Chemotherapy; VEGF receptors; Cancer research","score_opus":0.006444876826624243,"score_gpt":0.25363041555798244,"score_spread":0.2471855387313582,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073235968","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984104,0.000047602214,0.0000017650768,0.0003121601,0.00004946628,0.00061496056,0.000055832268,0.00001547826,0.0004923466],"genre_scores_gemma":[0.99963695,0.000028392631,0.000043141783,0.00006753012,0.000026451618,0.00015125904,0.000020245627,0.000019776353,0.000006276279],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99857897,0.00015696045,0.000391411,0.0003524744,0.00025178617,0.00026838455],"domain_scores_gemma":[0.9985641,0.00041060627,0.00033677355,0.00044001624,0.00016278707,0.00008567382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000085760345,0.0002184107,0.00094057125,0.00033766395,0.000040828632,0.000004072757,0.00009483318,0.000097978234,0.00005105385],"category_scores_gemma":[0.00011360237,0.00012721794,0.00021174745,0.0007233525,0.00016246055,0.000034686378,0.000040073137,0.00012993316,0.0000021151056],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014844543,0.0037847597,0.9724305,0.000019487092,0.0013584198,0.00007727365,0.0010849666,0.00013177222,0.01699142,0.000022835906,0.000047117515,0.0025669935],"study_design_scores_gemma":[0.013856123,0.011377249,0.90529084,0.000032255473,0.0020566678,0.000009371812,0.00024070301,0.0002865862,0.06654733,0.0000024907008,0.0002198617,0.00008054534],"about_ca_topic_score_codex":0.00019918458,"about_ca_topic_score_gemma":0.0015427084,"teacher_disagreement_score":0.067139685,"about_ca_system_score_codex":0.00046384786,"about_ca_system_score_gemma":0.000104451974,"threshold_uncertainty_score":0.5187797},"labels":[],"label_agreement":null},{"id":"W2074099687","doi":"10.1093/neuonc/nou357","title":"Medulloblastoma subgroup-specific outcomes in irradiated children: who are the true high-risk patients?","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":139,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Medulloblastoma; Medicine; Cohort; Internal medicine; Radiation therapy; Oncology; Cohort study; Chemotherapy; Pediatrics; Pathology","score_opus":0.018042075287536277,"score_gpt":0.262348600671625,"score_spread":0.24430652538408876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074099687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98947024,0.000408537,8.7143354e-7,0.0075006234,0.00086206617,0.0010334963,0.00005725882,0.00007646539,0.0005904107],"genre_scores_gemma":[0.9969831,0.00024312122,0.000042537486,0.0022689071,0.00015759638,0.00017758665,0.00006733005,0.000044006774,0.00001582866],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978597,0.00039916034,0.00045698223,0.00047762302,0.00035052077,0.000456021],"domain_scores_gemma":[0.9982331,0.0005129196,0.00027236738,0.00056721776,0.00013003584,0.00028435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022349466,0.0002912471,0.0007697732,0.00021588219,0.00008921677,0.000021752503,0.00020338624,0.00021268625,0.00006798749],"category_scores_gemma":[0.0004101765,0.00018241856,0.00013672249,0.0003801649,0.00014165636,0.00006473947,0.00009389205,0.00044718437,0.0002201816],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026278984,0.0018834838,0.9709011,0.0000031180475,0.00009358044,0.00029703535,0.00040396518,0.000026737898,0.00018018395,0.00014148423,0.013690607,0.012115915],"study_design_scores_gemma":[0.0125866495,0.0025059385,0.9577633,0.000018760622,0.00011876376,0.000048832255,0.00018788235,0.000026933734,0.00059409294,0.00009111001,0.025914028,0.00014366582],"about_ca_topic_score_codex":0.00035162183,"about_ca_topic_score_gemma":0.0005805989,"teacher_disagreement_score":0.013137758,"about_ca_system_score_codex":0.00042149064,"about_ca_system_score_gemma":0.000119909964,"threshold_uncertainty_score":0.7438813},"labels":[],"label_agreement":null},{"id":"W2075172990","doi":"10.1093/neuonc/nou261.2","title":"ME-03 * BONE MARROW DERIVED MICROGLIA AND THEIR FUNCTION WITHIN TUMOR MICROENVIRONMENT","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neuroinflammation and Neurodegeneration Mechanisms","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Microglia; Minocycline; Glioma; Biology; Tumor microenvironment; Cancer research; Bone marrow; Cell biology; Immunology; Pathology; Medicine; Inflammation; Immune system","score_opus":0.018015014412224487,"score_gpt":0.2287000725872624,"score_spread":0.2106850581750379,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075172990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912008,0.000023463199,0.002764077,0.0028339222,0.001466969,0.0004569882,0.000010774701,0.0001975583,0.0010454213],"genre_scores_gemma":[0.9744363,0.00007264708,0.0005100963,0.024452573,0.00018908833,0.000053428685,0.000005177572,0.000052890693,0.00022781116],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99728596,0.00087353576,0.00045839444,0.0008260772,0.00019232722,0.00036370254],"domain_scores_gemma":[0.9986482,0.00043148713,0.00030069024,0.00039051796,0.000023539384,0.00020555784],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030319838,0.00029657423,0.00033169286,0.00014336858,0.00031645037,0.00007530035,0.00019159152,0.000106398256,0.00016958473],"category_scores_gemma":[0.00040321256,0.00026430548,0.00006894032,0.00014758387,0.00019609385,0.0001835166,0.00014958391,0.0003392401,0.00031760684],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013403557,0.0000840326,0.000034633398,0.000010436616,0.0000020412413,0.000042379,0.00020608696,0.000061298626,0.99315447,0.0020794135,0.00079650123,0.0033946969],"study_design_scores_gemma":[0.0009837069,0.0008998131,0.00016666851,0.0000034558857,0.0000138014975,0.00050437945,0.00004128532,0.003168177,0.90583944,0.0006432716,0.08753626,0.00019976223],"about_ca_topic_score_codex":0.0000016635028,"about_ca_topic_score_gemma":0.000011842137,"teacher_disagreement_score":0.08731502,"about_ca_system_score_codex":0.000056874862,"about_ca_system_score_gemma":0.000048514146,"threshold_uncertainty_score":0.9999809},"labels":[],"label_agreement":null},{"id":"W2077269148","doi":"10.1093/neuonc/nou206.72","title":"COMBINED DRUG SCREENING AND PHOSPHOPROTEOMICS IDENTIFIES CANDIDATE BRAIN TUMOR THERAPEUTICS AND NOVEL TARGETS IN PRIMARY HUMAN BRAIN TUMOR-INITIATING CELLS","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Phosphoproteomics; Cytotoxicity; Biology; Computational biology; Drug discovery; High-content screening; Drug; Cyclin-dependent kinase; Pharmacology; Bioinformatics; Cancer research; Kinase; Cell; Genetics; In vitro; Cell cycle; Protein kinase A","score_opus":0.011000918706793879,"score_gpt":0.25254291518713007,"score_spread":0.2415419964803362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077269148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949109,0.00019389887,0.0016403226,0.0020101657,0.0002102058,0.00042825725,0.00001948371,0.000024601837,0.00056215853],"genre_scores_gemma":[0.9845528,0.000045172656,0.001869755,0.013108875,0.00014954366,0.000040549003,0.00009725694,0.000040942854,0.00009511409],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99840254,0.00025547674,0.00039352305,0.0004976603,0.000114593066,0.00033623338],"domain_scores_gemma":[0.99920595,0.00017175684,0.0002335729,0.00023577169,0.000050452938,0.00010247712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006101011,0.00022998784,0.00031045402,0.00009264242,0.00018398161,0.000061647625,0.00016248092,0.00013137265,0.0000071822938],"category_scores_gemma":[0.00021420262,0.00024032258,0.00004353437,0.00008633735,0.00020686162,0.000016973925,0.00025767353,0.00027712923,0.0000016082308],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010608346,0.000065791995,0.0024941496,0.00003282818,0.000015543861,0.000012582614,0.0001605475,0.000008577678,0.9935117,0.00014385041,0.0011243982,0.002323998],"study_design_scores_gemma":[0.0032354274,0.00068632816,0.0056861667,0.000026793035,0.00001496352,0.000049462567,0.00014078306,0.0007634806,0.9534234,0.00021693924,0.035431385,0.0003249055],"about_ca_topic_score_codex":0.00010134387,"about_ca_topic_score_gemma":0.00020311748,"teacher_disagreement_score":0.040088285,"about_ca_system_score_codex":0.00003120925,"about_ca_system_score_gemma":0.00008605197,"threshold_uncertainty_score":0.98000705},"labels":[],"label_agreement":null},{"id":"W2078913545","doi":"10.1093/neuonc/nou263.8","title":"NC-08 * PREDICTORS OF SURVIVAL AFTER SECOND SURGERY FOR RECURRENT GLIOBLASTOMA MULTIFORME TUMOURS","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Mann–Whitney U test; Surgery; Survival analysis; Log-rank test; Chemotherapy; Proportional hazards model; Retrospective cohort study; Pathological; Internal medicine","score_opus":0.018414958483701185,"score_gpt":0.281143144605249,"score_spread":0.2627281861215478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078913545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99436194,0.00013259544,0.000029794322,0.0015337468,0.0024599433,0.0007385603,0.00010668213,0.00005263825,0.0005841299],"genre_scores_gemma":[0.9983406,0.00003852708,0.00015990905,0.0005175998,0.00043416108,0.00039816322,0.000040295927,0.00004231207,0.000028419361],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99829805,0.00015296608,0.0005164097,0.00039388787,0.00021775826,0.00042092532],"domain_scores_gemma":[0.9970139,0.002020193,0.00023509773,0.00032853274,0.0001647623,0.00023748679],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035680423,0.00023222638,0.0008215889,0.0002327644,0.000043097243,0.0000064353903,0.00007947239,0.0001804293,0.00027077534],"category_scores_gemma":[0.00056498125,0.00017066188,0.00032429548,0.00014289562,0.00011963973,0.000049878498,0.000052604006,0.0001567111,0.00003555494],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009095371,0.004253679,0.8182555,0.00061029044,0.00037929404,0.00035363794,0.0006253167,0.000010130512,0.047622994,0.00020429453,0.03455606,0.08403342],"study_design_scores_gemma":[0.008425637,0.015475496,0.35222617,0.00013167856,0.0005415203,0.00017829551,0.0000885625,0.00038495386,0.105110526,0.000080712656,0.5170377,0.0003187825],"about_ca_topic_score_codex":0.0000062416716,"about_ca_topic_score_gemma":0.00024086765,"teacher_disagreement_score":0.4824816,"about_ca_system_score_codex":0.00012935308,"about_ca_system_score_gemma":0.00017754476,"threshold_uncertainty_score":0.69593894},"labels":[],"label_agreement":null},{"id":"W2079839220","doi":"10.1093/neuonc/nou242.1","title":"CS-01 * THE PHOSPHORYLATION OF ATOH1 LEADS TO ITS DEGRADATION MEDIATED BY THE E3 UBIQUITIN LIGASE HUWE1 IN GRANULE NEURON PROGENITORS","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Sonic hedgehog; Ubiquitin ligase; Patched; Medulloblastoma; Biology; GLI2; Cancer research; Hedgehog signaling pathway; Progenitor cell; Cell biology; Mdm2; Ubiquitin; Signal transduction; Stem cell; Genetics; Cell culture; Gene","score_opus":0.016710118293349886,"score_gpt":0.27039798510562735,"score_spread":0.25368786681227745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079839220","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947782,0.0004089708,0.00014325854,0.0032632514,0.00033362932,0.0006172436,0.000022152164,0.000017805092,0.0004154696],"genre_scores_gemma":[0.9975659,0.00009912941,0.000036877882,0.0018398822,0.00016635828,0.00013005678,0.00008350774,0.000028235303,0.000050054077],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981716,0.0005874201,0.00038667326,0.0003768117,0.00017458793,0.0003028806],"domain_scores_gemma":[0.9989727,0.00031056575,0.00019015603,0.00034216177,0.00011958951,0.00006482278],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063749496,0.0001839206,0.0002317917,0.000053289496,0.00012298489,0.000011593486,0.0003312909,0.00018683978,0.000006394358],"category_scores_gemma":[0.0013126654,0.00012779709,0.00006916692,0.00026012346,0.00014103731,0.0000049296127,0.0001482847,0.00019933605,0.00002139957],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012588702,0.00008093198,0.002660789,0.000010206685,0.000012118651,0.0000021250512,0.0002931868,0.00011289927,0.9859083,0.000034980276,0.004119591,0.006638967],"study_design_scores_gemma":[0.0005267248,0.00099545,0.0021443877,0.0000056963613,0.000020704658,0.00000845994,0.00009517808,0.00022937017,0.8915384,0.000013206415,0.10430805,0.00011437335],"about_ca_topic_score_codex":0.00003971843,"about_ca_topic_score_gemma":0.00026286417,"teacher_disagreement_score":0.10018846,"about_ca_system_score_codex":0.000034296572,"about_ca_system_score_gemma":0.00009957458,"threshold_uncertainty_score":0.5211414},"labels":[],"label_agreement":null},{"id":"W2081042655","doi":"10.1093/neuonc/nou242.16","title":"CS-16 * THE eEF2 KINASE IS CRITICAL FOR BRAIN TUMOURS ADAPTATION TO METABOLIC STRESS","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; University of Toronto; University of British Columbia","funders":"","keywords":"Biology; Kinase; Cancer research; Glioma; Downregulation and upregulation; Translation (biology); Elongation factor; Cell biology; Gene; Messenger RNA; Genetics","score_opus":0.018324121711003286,"score_gpt":0.3090542664178081,"score_spread":0.2907301447068048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081042655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7964931,0.005487655,0.08072206,0.0967462,0.011014583,0.0024302537,0.0005408625,0.00009902271,0.0064662504],"genre_scores_gemma":[0.9556029,0.00026154582,0.0013131778,0.037206486,0.0047936356,0.00033876483,0.00007712315,0.000052065665,0.00035433655],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983908,0.00029089616,0.00025099397,0.00049690285,0.00013602918,0.00043439696],"domain_scores_gemma":[0.9987575,0.00036392742,0.00007413966,0.00044245514,0.00017180528,0.00019018131],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038276974,0.00019428685,0.00028774908,0.00005459207,0.00015868395,0.000030766078,0.0003096097,0.00020644622,0.000036151563],"category_scores_gemma":[0.0016206688,0.00015920341,0.00015928087,0.00010371288,0.00014228237,0.0000055990813,0.00011378013,0.00014761291,0.000023762654],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028350382,0.00011016789,0.000052806947,0.000017507218,0.000025064835,0.0000012032574,0.00032530155,0.00008578494,0.81057775,0.0049957926,0.096889034,0.08663605],"study_design_scores_gemma":[0.0007618365,0.00068182754,0.00042118382,0.0000030067833,0.00006753008,0.000019126894,0.00020498202,0.00018701644,0.17172241,0.00032558612,0.8254524,0.00015308424],"about_ca_topic_score_codex":0.000060832324,"about_ca_topic_score_gemma":0.00035164246,"teacher_disagreement_score":0.72856337,"about_ca_system_score_codex":0.000020634914,"about_ca_system_score_gemma":0.00018905019,"threshold_uncertainty_score":0.64921266},"labels":[],"label_agreement":null},{"id":"W2081102061","doi":"10.1093/neuonc/4.4.253","title":"Leptomeningeal dissemination in children with progressive low-gradeneuroepithelial tumors","year":2002,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"B.C. Women's Hospital & Health Centre; BC Children's Hospital; Children's & Women's Health Centre of British Columbia","funders":"","keywords":"Neuroepithelial cell; Medicine; Radiology; Biology","score_opus":0.010742842905783825,"score_gpt":0.28048321175020574,"score_spread":0.26974036884442193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081102061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942004,0.0001677913,0.000001218669,0.003387146,0.00008884759,0.000814043,0.000007169501,0.00006183946,0.0012715572],"genre_scores_gemma":[0.9988944,0.000050562478,0.000121097095,0.00045702193,0.00014847422,0.0002423283,0.000027071688,0.00003188728,0.000027165037],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99874645,0.00009175516,0.00023373443,0.0003788787,0.00022374808,0.00032541458],"domain_scores_gemma":[0.9993533,0.00014017323,0.00012424402,0.000197852,0.000047265745,0.00013717511],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000049853847,0.00018528425,0.00035211424,0.00021586745,0.00004975325,0.0000134408665,0.0000756609,0.00009278671,0.00018790536],"category_scores_gemma":[0.00008001076,0.00013853116,0.000053308195,0.00029483903,0.00009942077,0.00006213822,0.00003203067,0.0002448175,0.00006240535],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020525986,0.0027884736,0.91102463,0.000014479917,0.00006827781,0.0034397473,0.00062884885,0.00001582625,0.033829138,0.0000616408,0.0016840838,0.046239596],"study_design_scores_gemma":[0.00819865,0.006614528,0.9237368,0.0001413391,0.00016786925,0.003157176,0.00007890808,0.0003273316,0.055431355,0.000014525634,0.001899578,0.00023195375],"about_ca_topic_score_codex":0.000009560451,"about_ca_topic_score_gemma":0.000010778087,"teacher_disagreement_score":0.04600764,"about_ca_system_score_codex":0.00016787404,"about_ca_system_score_gemma":0.000041738254,"threshold_uncertainty_score":0.5649137},"labels":[],"label_agreement":null},{"id":"W2082213986","doi":"10.1093/neuonc/nou310","title":"Druggable targets in pediatric neurocutaneous melanocytosis: Molecular and drug sensitivity studies in xenograft and ex vivo tumor cell culture to identify agents for therapy","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary; University of Lethbridge; Calgary Laboratory Services","funders":"Alberta Children's Hospital Foundation; Children's Hospital Foundation","keywords":"Druggability; Neuroblastoma RAS viral oncogene homolog; Cancer research; In vivo; In vitro; Cell culture; Medicine; Leptomeninges; Ex vivo; Drug discovery; Biology; Bioinformatics; Gene; Mutation; Genetics; Internal medicine; Central nervous system","score_opus":0.02157681325720592,"score_gpt":0.31810879356908406,"score_spread":0.29653198031187816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082213986","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994264,0.001234494,0.000105443,0.0015712362,0.000487768,0.001558035,0.0000056565996,0.000056742047,0.00071662775],"genre_scores_gemma":[0.9911122,0.0018886888,0.0003860762,0.006013894,0.00013610467,0.000117417476,0.000003029926,0.000036263948,0.00030633665],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99819714,0.00033258114,0.00032967012,0.00058619655,0.00016532604,0.00038908416],"domain_scores_gemma":[0.9990875,0.00036176838,0.00010519635,0.00020339809,0.00007161629,0.00017051293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042593633,0.000247771,0.00057866744,0.00036077877,0.000071904295,0.000023850589,0.000059351387,0.00009160043,0.000007816638],"category_scores_gemma":[0.00027165675,0.00022542814,0.00005765479,0.00027404845,0.000057847028,0.000043167856,0.0001353337,0.0002538087,0.00000827253],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021101038,0.00091164105,0.012337669,0.000809929,0.00008282519,0.010817921,0.008112875,0.00026375568,0.9351875,0.00004542924,0.016771562,0.012548785],"study_design_scores_gemma":[0.020100895,0.0109523125,0.015455908,0.00011475849,0.00052796653,0.0063598217,0.004752015,0.0028535938,0.16777433,0.0005008019,0.7693646,0.0012430255],"about_ca_topic_score_codex":0.000051766798,"about_ca_topic_score_gemma":0.0003554822,"teacher_disagreement_score":0.76741314,"about_ca_system_score_codex":0.00010546534,"about_ca_system_score_gemma":0.000031678814,"threshold_uncertainty_score":0.91926926},"labels":[],"label_agreement":null},{"id":"W2083199748","doi":"10.1093/neuonc/nou208.47","title":"FORETINIB IS EFFECTIVE THERAPY FOR METASTATIC SONIC HEDGEHOG MEDULLOBLASTOMA","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Sonic hedgehog; Medicine; Oncology; Cohort; Targeted therapy; Cancer research; In vivo; Internal medicine; Cancer; Biology; Signal transduction","score_opus":0.01911079522570764,"score_gpt":0.30964007314438663,"score_spread":0.290529277918679,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083199748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9825922,0.0010723853,0.009689883,0.0016534613,0.00091395626,0.0016006288,0.000057571935,0.000064066524,0.002355823],"genre_scores_gemma":[0.9895752,0.00019917575,0.0018034443,0.00678944,0.00059349684,0.00078214717,0.00004675796,0.00007736981,0.00013296246],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979468,0.00040315726,0.00031521873,0.0006740947,0.00013210445,0.00052864576],"domain_scores_gemma":[0.99847823,0.000611174,0.00017281709,0.00042757762,0.00018590975,0.00012426938],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005437714,0.0003051482,0.00047352246,0.0000691912,0.00018032768,0.000017156015,0.00029662944,0.00021569853,0.000032335873],"category_scores_gemma":[0.0008484738,0.00027051242,0.0003095432,0.00010174266,0.00022436978,0.0000036115218,0.00012779536,0.00016090761,0.00005136331],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005586514,0.00015916339,0.00032701314,0.00003550116,0.00024685625,0.000005431048,0.000404603,0.00003923085,0.9141579,0.00017263573,0.013428653,0.070464335],"study_design_scores_gemma":[0.002279055,0.005898539,0.00018811284,0.00000578835,0.000049413833,0.000029620856,0.00007481154,0.00028497665,0.46696895,0.00040686165,0.52360326,0.00021059846],"about_ca_topic_score_codex":0.000004694704,"about_ca_topic_score_gemma":0.000023671944,"teacher_disagreement_score":0.51017463,"about_ca_system_score_codex":0.000042360418,"about_ca_system_score_gemma":0.00014654842,"threshold_uncertainty_score":0.9999747},"labels":[],"label_agreement":null},{"id":"W2087675111","doi":"10.1093/neuonc/nov061.138","title":"PM-16 * AN ANIMAL MODEL OF 17p DELETION IN MEDULLOBLASTOMA","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Chromosome 17 (human); Biology; Gene duplication; Genetics; Chromosome 22; Chromosome 21; Chromosome 12; Isochromosome; Chromosome; Molecular biology; Gene; Karyotype","score_opus":0.0524927945389718,"score_gpt":0.32729014625219743,"score_spread":0.2747973517132256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087675111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935646,0.000084130996,0.00003921095,0.002464114,0.00012724467,0.00027656896,0.0000065054196,0.000030034556,0.0034076092],"genre_scores_gemma":[0.99829704,0.00003286304,0.0007357255,0.0007686905,0.00007295486,0.00005140355,0.00001765874,0.000017748747,0.000005903597],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99899703,0.000104707906,0.00026956564,0.00024275317,0.00017584793,0.00021009223],"domain_scores_gemma":[0.99930215,0.00008081943,0.00009063515,0.00021515191,0.000106995314,0.0002042438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016540218,0.00011471317,0.000357898,0.0001644857,0.000012966364,0.000002923118,0.00006506176,0.0001415702,0.000029701896],"category_scores_gemma":[0.0001330623,0.0000983904,0.000050771207,0.00014459973,0.000061646024,0.00006306398,0.00003744293,0.00013277624,0.000025166708],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019421106,0.0049460786,0.09708698,0.000034172266,0.000044360753,0.0007464091,0.0010790648,0.0014822894,0.86511433,0.0020240515,0.005254899,0.020245273],"study_design_scores_gemma":[0.050373517,0.06604556,0.097386,0.00014354596,0.00065581955,0.0012666379,0.0014427651,0.150884,0.587375,0.0038316164,0.039868526,0.00072703103],"about_ca_topic_score_codex":0.000099786244,"about_ca_topic_score_gemma":0.0003119266,"teacher_disagreement_score":0.27773935,"about_ca_system_score_codex":0.00027540053,"about_ca_system_score_gemma":0.00028069224,"threshold_uncertainty_score":0.4012244},"labels":[],"label_agreement":null},{"id":"W2088446974","doi":"10.1215/15228517-2008-058","title":"A novel tool to analyze MRI recurrence patterns in glioblastoma","year":2008,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Gemeinnützige Hertie-Stiftung; Bundesministerium für Bildung und Forschung","keywords":"Temozolomide; Medicine; Radiation therapy; Glioblastoma; Oncology; Internal medicine; Cancer; Glioma; Cohort; Neurology; Clinical trial; Chemotherapy; Cancer research","score_opus":0.02675756273669337,"score_gpt":0.30562463354620145,"score_spread":0.27886707080950807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088446974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99230725,0.00005679041,0.00013097929,0.00580258,0.0003320594,0.00053150445,0.000020791858,0.00004311023,0.00077496626],"genre_scores_gemma":[0.994504,0.00012662097,0.000653668,0.0043661604,0.00012514913,0.00018059196,0.0000062123454,0.000019591735,0.000018003295],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99865174,0.000053629923,0.00031465755,0.00042765867,0.00018888837,0.00036339616],"domain_scores_gemma":[0.9991263,0.00022263874,0.00006730765,0.00032366117,0.000063534855,0.0001965479],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008534033,0.00017226348,0.0004325826,0.000296458,0.000047215875,0.000005490435,0.00010543839,0.00011706341,0.00015994883],"category_scores_gemma":[0.00020223268,0.00015044543,0.00008770567,0.00044553875,0.000043473436,0.00004216111,0.00007763519,0.00021675091,0.00020639239],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077023305,0.004572751,0.5964114,0.000035312878,0.00006821147,0.0115736,0.001322724,0.00010460676,0.31730533,0.00012738236,0.013506266,0.054202214],"study_design_scores_gemma":[0.008726514,0.007818317,0.7592595,0.000109552384,0.00009928564,0.0030474644,0.000092802635,0.0002988998,0.04973054,0.000015161189,0.17048343,0.00031848846],"about_ca_topic_score_codex":0.00012825405,"about_ca_topic_score_gemma":0.0005511768,"teacher_disagreement_score":0.2675748,"about_ca_system_score_codex":0.00024992175,"about_ca_system_score_gemma":0.00017992182,"threshold_uncertainty_score":0.6134986},"labels":[],"label_agreement":null},{"id":"W2089640963","doi":"10.1093/neuonc/nou349","title":"Biopsy versus partial versus gross total resection in older patients with high-grade glioma: a systematic review and meta-analysis","year":2015,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":177,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto; Dalhousie University","funders":"","keywords":"Medicine; Confidence interval; Meta-analysis; Glioma; Relative risk; Internal medicine; Biopsy; Resection; Surgery; Cohort; Cohort study; Gastroenterology","score_opus":0.09481905605422455,"score_gpt":0.37424179547723535,"score_spread":0.27942273942301077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089640963","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020766563,0.990943,6.457299e-7,0.00042687543,0.0005082528,0.0058335336,0.00011304522,0.000037752434,0.000060228955],"genre_scores_gemma":[0.0040982147,0.99102765,0.000063210515,0.00012126195,0.00009142337,0.003951885,0.0005480996,0.00008562678,0.000012611901],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9955412,0.0012458159,0.0012598013,0.00093180273,0.0005746241,0.00044676248],"domain_scores_gemma":[0.9967609,0.00096375047,0.0009445059,0.0007994581,0.00022413873,0.00030723235],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005192917,0.0006874216,0.010029004,0.00074557203,0.000060222326,0.000031804215,0.00013885564,0.0004344396,0.00009970555],"category_scores_gemma":[0.00045507884,0.00040341652,0.0011827437,0.0018195782,0.00014077922,0.00007757692,0.00011233391,0.00045952672,0.00004403549],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001651466,0.004624997,0.00010929982,0.71179706,0.27183518,0.004318594,0.00011591649,0.0000040775344,0.0000015338823,0.0000840388,0.0011526902,0.0043051406],"study_design_scores_gemma":[0.010659638,0.0041642836,0.000040440016,0.0063745244,0.9622338,0.0002618047,0.000016914339,0.0000018357954,0.000001865834,7.837259e-7,0.015922587,0.00032151793],"about_ca_topic_score_codex":0.00014676644,"about_ca_topic_score_gemma":0.00021675529,"teacher_disagreement_score":0.7054225,"about_ca_system_score_codex":0.0007344524,"about_ca_system_score_gemma":0.0003118523,"threshold_uncertainty_score":0.99984175},"labels":[],"label_agreement":null},{"id":"W2091048582","doi":"10.1093/neuonc/nou208.23","title":"C19MC ONCOMIRS CONVERGE ON MULTIPLE CELL CYCLE REGULATORS TO MODULATE NEURAL DIFFERENTIATION AND THE TUMOR EPIGENOME","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Biology; Gene; microRNA; Embryonic stem cell; Epigenetics; Locus (genetics); Cancer research; Genetics","score_opus":0.00758868828872562,"score_gpt":0.2368903498736504,"score_spread":0.2293016615849248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091048582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956296,0.00014041334,0.00096751977,0.0012118527,0.00055053097,0.0004213331,0.000008412832,0.000016606165,0.0010536956],"genre_scores_gemma":[0.99741375,0.000083399646,0.00015834202,0.0018872902,0.0002713653,0.000041752457,0.000036121237,0.000031528158,0.000076467186],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984725,0.0004232424,0.00026817105,0.00044319194,0.0001220893,0.0002707807],"domain_scores_gemma":[0.99898636,0.00028115272,0.00014729681,0.0003924265,0.000055727538,0.00013701495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032828964,0.00018553794,0.00024233368,0.000056416244,0.00015254962,0.00002605683,0.0001715483,0.0001409092,0.000010490612],"category_scores_gemma":[0.00033266106,0.0001433471,0.000080275895,0.000072138144,0.00011369308,0.0000035845076,0.00014086226,0.00013951331,0.000019425119],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060235604,0.00007148912,0.005420402,0.000008786886,0.000011602042,0.0000018452785,0.00013740694,0.0025150839,0.985469,0.00022470934,0.0001229472,0.0054144002],"study_design_scores_gemma":[0.00546632,0.002928619,0.058243,0.0000047254334,0.000048498532,0.000006059446,0.000041220464,0.025720624,0.8119582,0.0008014158,0.09441244,0.00036890383],"about_ca_topic_score_codex":0.000029723013,"about_ca_topic_score_gemma":0.000057412755,"teacher_disagreement_score":0.17351079,"about_ca_system_score_codex":0.000027060787,"about_ca_system_score_gemma":0.000028182249,"threshold_uncertainty_score":0.5845525},"labels":[],"label_agreement":null},{"id":"W2092502301","doi":"10.1093/neuonc/nou237.39","title":"AT-40PROGNOSIS FACTORS IN GLIOBLASTOMA MULTIFORME","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital de l'Enfant-Jésus","funders":"","keywords":"Medicine; Temozolomide; Glioblastoma; Chemotherapy; Biopsy; Internal medicine; Multivariate analysis; Oncology; Surgery","score_opus":0.020894628254573323,"score_gpt":0.29159677943639356,"score_spread":0.2707021511818202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092502301","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920185,0.00004828264,0.000003181462,0.0029570744,0.00037234262,0.00043232515,0.000004719367,0.000077375546,0.0040861536],"genre_scores_gemma":[0.99801594,0.000036267404,0.00012658433,0.0015355519,0.00010038664,0.0001231382,0.000010268663,0.000030162877,0.000021700875],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99863416,0.00011532848,0.00030232576,0.00037812424,0.0001720064,0.00039803534],"domain_scores_gemma":[0.9987839,0.0005828416,0.00009417109,0.00028719433,0.000042013064,0.0002098671],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011896151,0.0001996168,0.00048055235,0.00023051188,0.000060006398,0.0000073572432,0.00008485626,0.000193179,0.00027005325],"category_scores_gemma":[0.00030411992,0.00015540085,0.00012371608,0.00022431806,0.000057401507,0.00004225316,0.00008945286,0.0001955922,0.00027832916],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024214854,0.001307443,0.783509,0.000022192158,0.000035378587,0.00038231094,0.00035294032,0.000009926714,0.1881084,0.00013806269,0.0024610895,0.023431089],"study_design_scores_gemma":[0.0071666464,0.0052778325,0.34692833,0.00003204118,0.00011134901,0.00015718843,0.000089290785,0.00049151585,0.2913068,0.000044176726,0.3482031,0.00019177361],"about_ca_topic_score_codex":0.00008492882,"about_ca_topic_score_gemma":0.00068656146,"teacher_disagreement_score":0.43658072,"about_ca_system_score_codex":0.00039602615,"about_ca_system_score_gemma":0.00005833467,"threshold_uncertainty_score":0.6337062},"labels":[],"label_agreement":null},{"id":"W2096557421","doi":"10.1093/neuonc/nos152","title":"Toward determining the lifetime occurrence of metastatic brain tumors estimated from 2007 United States cancer incidence data","year":2012,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":261,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics; Alberta Hospital Edmonton; University of Alberta","funders":"","keywords":"Brain metastasis; Medicine; Cancer; Incidence (geometry); Metastasis; Population; Oncology; Epidemiology; Lung cancer; Breast cancer; Brain tumor; Internal medicine; Disease; Primary tumor; Pathology; Environmental health","score_opus":0.13296199146793491,"score_gpt":0.4003928831452415,"score_spread":0.2674308916773066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096557421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98953307,0.0015209481,0.0002984882,0.005530564,0.00053402176,0.000563947,0.0018943849,0.000052649426,0.00007191877],"genre_scores_gemma":[0.98514247,0.00030681395,0.004917931,0.0074658412,0.00014187134,0.00005692365,0.0019313728,0.000025732475,0.000011015497],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99795485,0.00048538242,0.00047024703,0.0003581283,0.00028267232,0.00044872874],"domain_scores_gemma":[0.9953434,0.0032005531,0.00033296613,0.0007659181,0.00013038346,0.00022679669],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006446936,0.00022411707,0.0005590289,0.00011267952,0.00007437225,0.000011526123,0.000408281,0.000059219943,0.00055189856],"category_scores_gemma":[0.0015531349,0.0001464365,0.000055025637,0.00036357788,0.00027282367,0.00016463113,0.00032032386,0.00030240667,0.00004577653],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016267156,0.0033932729,0.6148492,0.00035756148,0.001461113,0.0013886994,0.008976746,0.00079737644,0.024796227,0.00012870914,0.13630068,0.20592366],"study_design_scores_gemma":[0.018253544,0.0074531976,0.40798247,0.0009616794,0.006818885,0.0010407579,0.0034627148,0.060489405,0.027293848,0.00032021548,0.46460554,0.0013177613],"about_ca_topic_score_codex":0.0015961785,"about_ca_topic_score_gemma":0.00006617033,"teacher_disagreement_score":0.32830483,"about_ca_system_score_codex":0.00009780505,"about_ca_system_score_gemma":0.00035659067,"threshold_uncertainty_score":0.6042902},"labels":[],"label_agreement":null},{"id":"W2096791202","doi":"10.1093/neuonc/not246","title":"Adult pilocytic astrocytomas: clinical features and molecular analysis","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal","funders":"National Cancer Institute; University of Texas MD Anderson Cancer Center","keywords":"Medicine; Pilocytic astrocytoma; Biopsy; Gene duplication; Internal medicine; Fluorescence in situ hybridization; Oncology; Pathology; Astrocytoma; Cancer research; Glioma; Biology; Gene","score_opus":0.017288700125959552,"score_gpt":0.3341513987799334,"score_spread":0.3168626986539738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096791202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897163,0.00023063328,0.0002028933,0.006246861,0.00018278266,0.00023207627,0.0000036798956,0.000056552595,0.003128229],"genre_scores_gemma":[0.990724,0.00013111433,0.0011223927,0.007776416,0.00015696236,0.000039107086,0.00001980971,0.000018029403,0.000012122607],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985015,0.00027724422,0.0003397042,0.0004516676,0.00016793332,0.00026196035],"domain_scores_gemma":[0.9985248,0.0006133094,0.00011406163,0.00036279287,0.00010156777,0.0002834898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020043226,0.00016904695,0.0006974872,0.00019736505,0.000051478954,0.000015469885,0.000068957226,0.00018939869,0.000051220104],"category_scores_gemma":[0.0005980443,0.00013129904,0.00025018913,0.0002894238,0.00013252803,0.000022275857,0.00006387762,0.00025787298,0.000039386585],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010053419,0.0029407905,0.6985445,0.0000648518,0.0034533455,0.0035285174,0.00017754608,0.0000600506,0.08939928,0.004026757,0.0152314445,0.1815676],"study_design_scores_gemma":[0.020172613,0.017285585,0.7837686,0.000038065176,0.013101537,0.0010760229,0.00011746399,0.0027990413,0.04827902,0.000402572,0.112503074,0.00045638884],"about_ca_topic_score_codex":0.000025758894,"about_ca_topic_score_gemma":0.000064353335,"teacher_disagreement_score":0.1811112,"about_ca_system_score_codex":0.00006548839,"about_ca_system_score_gemma":0.00006927533,"threshold_uncertainty_score":0.53542197},"labels":[],"label_agreement":null},{"id":"W2097210837","doi":"10.1093/neuonc/nov061.87","title":"MB-11 * IMPACT OF MOLECULAR SUB-TYPE AND CRANIOSPINAL IRRADIATION (CSI) DOSE ON RELAPSE OF MEDULLOBLASTOMA","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medulloblastoma; Medicine; Subtyping; Wnt signaling pathway; Internal medicine; Oncology; Nuclear medicine; Pathology; Biology; Genetics","score_opus":0.0250930240704483,"score_gpt":0.32237961042518354,"score_spread":0.29728658635473526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097210837","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99753225,0.00031206323,0.0000021858318,0.000868543,0.00020215263,0.000331483,0.0000090895655,0.000016701097,0.0007255575],"genre_scores_gemma":[0.9994394,0.00007620785,0.00011703267,0.00027870026,0.00003980183,0.000012689093,0.0000139989415,0.000019460545,0.0000027123172],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9989922,0.000117593016,0.00027875663,0.00022305879,0.0002127245,0.00017568149],"domain_scores_gemma":[0.9989659,0.00015919207,0.00018865486,0.00024122982,0.00022021245,0.0002248003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001389835,0.00014493507,0.0004358098,0.00016289554,0.000015043593,0.0000030076067,0.00004892286,0.00013906123,0.00002559598],"category_scores_gemma":[0.000437266,0.0001134275,0.00009106549,0.0002288611,0.00009306738,0.000034280558,0.000029028979,0.0001102797,0.00001259147],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017729684,0.0013947609,0.10016122,0.000034108583,0.00012923601,0.00061615114,0.00035471038,0.00013890852,0.8878038,0.00035665877,0.0023766474,0.004860821],"study_design_scores_gemma":[0.013906697,0.050932955,0.6100192,0.00007112856,0.0004180028,0.00059486623,0.00008077767,0.00034465126,0.3208695,0.00040948397,0.0021755924,0.0001771107],"about_ca_topic_score_codex":0.00013558024,"about_ca_topic_score_gemma":0.000022116186,"teacher_disagreement_score":0.5669343,"about_ca_system_score_codex":0.00017536704,"about_ca_system_score_gemma":0.0003316128,"threshold_uncertainty_score":0.46254393},"labels":[],"label_agreement":null},{"id":"W2097420808","doi":"10.1093/neuonc/noq008","title":"Prolonged survival for patients with newly diagnosed, inoperable glioblastoma with 3-times daily ultrafractionated radiation therapy","year":2010,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre d'expertise et de recherche en infrastructures urbaines","funders":"","keywords":"Medicine; Temozolomide; Tolerability; Regimen; Radiation therapy; Internal medicine; Oncology; Toxicity; Phases of clinical research; Glioma; Surgery; Adverse effect","score_opus":0.009461035278219218,"score_gpt":0.2609985549501183,"score_spread":0.2515375196718991,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097420808","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99388087,0.000040082217,0.00002321827,0.0024516212,0.00053989294,0.0022839454,0.000031828866,0.00010840576,0.00064015074],"genre_scores_gemma":[0.99668205,0.00006550969,0.0008483728,0.0009919362,0.00020031678,0.0009456115,0.00017839305,0.000059366965,0.000028435757],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986153,0.000085649925,0.00023347065,0.00044233855,0.00027126085,0.00035194782],"domain_scores_gemma":[0.9982378,0.00073809124,0.00018394798,0.00029372115,0.000368329,0.00017811908],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011210052,0.0002509267,0.0004254247,0.00014965271,0.0001625228,0.00002790881,0.000083351624,0.00019160367,0.00015559097],"category_scores_gemma":[0.0001715502,0.00016310989,0.000062058316,0.0002454431,0.00009764993,0.00015736512,0.000010775468,0.00030874315,0.00002270759],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014113645,0.00866191,0.7687169,0.000027490678,0.00044353207,0.00023447243,0.00045810646,0.00011618589,0.095036305,0.00016764502,0.00415044,0.1078734],"study_design_scores_gemma":[0.07010124,0.042091057,0.55869675,0.000024537112,0.00030426422,0.00011286643,0.00008759704,0.00021575477,0.0653017,0.000027599239,0.26265612,0.00038049126],"about_ca_topic_score_codex":0.00006695109,"about_ca_topic_score_gemma":0.00040804737,"teacher_disagreement_score":0.2585057,"about_ca_system_score_codex":0.00011071624,"about_ca_system_score_gemma":0.0002979679,"threshold_uncertainty_score":0.66514283},"labels":[],"label_agreement":null},{"id":"W2097499299","doi":"10.1093/neuonc/nov061.81","title":"MB-05 * PHARMACOLOGICAL INHIBITION OF MRK/ZAK KINASE FOR THE TREATMENT OF MEDULLOBLASTOMA","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Mechanisms and Therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medulloblastoma; Cancer research; Cell cycle; Kinase; Cell cycle checkpoint; Malignancy; Medicine; Cell; Biology; Chemistry; Internal medicine; Cell biology; Biochemistry","score_opus":0.06553781742733895,"score_gpt":0.3649615139227598,"score_spread":0.29942369649542083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097499299","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903883,0.0005802892,0.00058174215,0.0056164353,0.0009589971,0.0011832397,0.000036278147,0.00002723641,0.0006275325],"genre_scores_gemma":[0.9968267,0.00043710318,0.00053934444,0.0015177877,0.00037273284,0.00022101014,0.000010654127,0.000015922462,0.00005872756],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991822,0.00007369362,0.0002623343,0.00017359298,0.00014032854,0.00016781047],"domain_scores_gemma":[0.9990667,0.00038096667,0.00015410811,0.00015422604,0.00013349217,0.000110482404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015306711,0.00011165178,0.00038206473,0.00005184796,0.000028840788,0.0000017383538,0.000051798623,0.000106464846,0.00014256818],"category_scores_gemma":[0.00005311012,0.00006718736,0.00014009907,0.000097269025,0.00012098687,0.000019077928,0.0000145548665,0.00006913969,0.0000040827294],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003999106,0.0015377334,0.000044584234,0.00001765308,0.00009163174,0.00006591074,0.0006293632,0.00002051976,0.8990069,0.0008689398,0.0045985454,0.089119114],"study_design_scores_gemma":[0.009260095,0.03375801,0.00010280044,0.000007685986,0.00024437864,0.00007136341,0.00022529617,0.0002790488,0.65082306,0.00048053067,0.30469912,0.000048636433],"about_ca_topic_score_codex":0.00003799315,"about_ca_topic_score_gemma":0.000032039494,"teacher_disagreement_score":0.30010056,"about_ca_system_score_codex":0.00018723316,"about_ca_system_score_gemma":0.00024615045,"threshold_uncertainty_score":0.27398208},"labels":[],"label_agreement":null},{"id":"W2097537392","doi":"10.1093/neuonc/noq094","title":"Neurocognitive outcome 12 months following cerebellar mutism syndrome in pediatric patients with medulloblastoma","year":2010,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Vestibular and auditory disorders","field":"Neuroscience","cited_by":127,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute; Hospital for Sick Children; American Lebanese Syrian Associated Charities; Children's Hospital of Philadelphia","keywords":"Medulloblastoma; Neurocognitive; Pediatrics; Medicine; Cognition; Psychiatry; Pathology","score_opus":0.011816453205970624,"score_gpt":0.2562433562938949,"score_spread":0.24442690308792425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097537392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99108213,0.000007043199,0.00003439797,0.00047825763,0.0036653616,0.00079745444,0.000020910426,0.00014268648,0.0037717586],"genre_scores_gemma":[0.9971244,0.000009006068,0.00010440416,0.0024353045,0.00013168354,0.00007701348,0.0000055859805,0.00007453468,0.000038088467],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969488,0.00038169872,0.00048900576,0.00092775526,0.00049809756,0.00075467164],"domain_scores_gemma":[0.9981717,0.0009075606,0.00024339363,0.00038609948,0.000042142343,0.00024911267],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016984354,0.00036582164,0.0005024667,0.0003689898,0.00020338001,0.000042294207,0.00050375535,0.00026764566,0.000073063435],"category_scores_gemma":[0.0015925042,0.0003332651,0.00012496143,0.00059083896,0.00018433222,0.0003308982,0.00017576915,0.0011720937,0.0002394011],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016818766,0.00093784125,0.9255252,0.000024200646,0.00000764848,0.003591778,0.00034521086,0.00022543958,0.06535405,0.00008248678,0.00027192832,0.0034660653],"study_design_scores_gemma":[0.010846497,0.004850193,0.95450854,0.000018325629,0.00018340295,0.0004201284,0.00008905023,0.00043128457,0.007923321,0.0002888446,0.019254725,0.0011856561],"about_ca_topic_score_codex":0.000015790647,"about_ca_topic_score_gemma":0.0003313927,"teacher_disagreement_score":0.057430733,"about_ca_system_score_codex":0.000061271225,"about_ca_system_score_gemma":0.00019107551,"threshold_uncertainty_score":0.99991196},"labels":[],"label_agreement":null},{"id":"W2098063347","doi":"10.1093/neuonc/nov113","title":"High-definition fiber tractography for the evaluation of perilesional white matter tracts in high-grade glioma surgery","year":2015,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Advanced Neuroimaging Techniques and Applications","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Tractography; Diffusion MRI; White matter; Fiber tract; Medicine; Glioma; Radiology; Magnetic resonance imaging","score_opus":0.28399379551971277,"score_gpt":0.44856462093393445,"score_spread":0.1645708254142217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098063347","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0043520764,0.9703712,0.00079511857,0.0098249065,0.0011792249,0.011676872,0.0006831644,0.0002159934,0.00090143277],"genre_scores_gemma":[0.0043364256,0.97970414,0.0071624056,0.0011338862,0.0005703819,0.0056212633,0.001274049,0.00016988837,0.000027537722],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99728924,0.00046331956,0.0009563176,0.0005214711,0.0004774682,0.0002921861],"domain_scores_gemma":[0.9954012,0.0028233912,0.00076919724,0.00056875544,0.0003468149,0.0000906414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012238858,0.0003364863,0.0015786662,0.00056602753,0.000061009057,0.000009809469,0.00018798458,0.0003853906,0.00020701428],"category_scores_gemma":[0.0003019259,0.00024004039,0.00051365193,0.0006323456,0.000162821,0.00007104128,0.00004653248,0.00059810723,0.000028718501],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011768598,0.0007112948,0.00011922046,0.0022056347,0.0000598846,0.000031638825,0.00003602456,0.000016070293,0.00027422194,0.00048149916,0.034754593,0.96119225],"study_design_scores_gemma":[0.000832625,0.00024649536,0.0015057748,0.0009254103,0.0015830625,0.0004181701,0.000007330426,0.000027848633,0.000042551954,0.0022779566,0.9919434,0.00018937643],"about_ca_topic_score_codex":0.000014045205,"about_ca_topic_score_gemma":0.000005326657,"teacher_disagreement_score":0.9610028,"about_ca_system_score_codex":0.00022665568,"about_ca_system_score_gemma":0.0008426428,"threshold_uncertainty_score":0.97885627},"labels":[],"label_agreement":null},{"id":"W2099184601","doi":"10.1093/neuonc/nov061.78","title":"MB-02 * SONIC HEDGEHOG INDUCES YB-1 IN A YAP-DEPENDENT MANNER TO REGULATE Igf2 EXPRESSION AND PROLIFERATION IN CEREBELLAR GRANULE NEURON PROGENITORS AND MEDULLOBLASTOMA CELLS","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medulloblastoma; Sonic hedgehog; Biology; Cancer research; Progenitor cell; Cerebellum; Gene knockdown; Oncogene; Granule cell; Cell biology; Stem cell; Cell culture; Cell; Neuroscience; Signal transduction; Hippocampal formation; Genetics; Cell cycle","score_opus":0.020695737860071263,"score_gpt":0.27249291537395315,"score_spread":0.25179717751388186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099184601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99729216,0.0006166754,0.000022812043,0.00072343426,0.00038286686,0.00078920287,0.000007360322,0.000021076434,0.00014443537],"genre_scores_gemma":[0.9985819,0.0001619762,0.0003029268,0.0005045741,0.00019021209,0.00014811438,0.000012097891,0.000038556733,0.000059632326],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99784154,0.0004337404,0.00038940372,0.0007333024,0.0001840957,0.0004179329],"domain_scores_gemma":[0.99927944,0.0000483522,0.00011127987,0.00025614892,0.00008377671,0.00022102897],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00043985105,0.00026527396,0.0003469111,0.00018490897,0.000071477574,0.000031665837,0.00014889178,0.00032317266,0.0000019430977],"category_scores_gemma":[0.00022815025,0.0002515683,0.000030707775,0.00015688603,0.00011165853,0.000013790089,0.0003609744,0.00023984083,0.0000075338676],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000338485,0.00013010456,0.009239428,0.000029590688,0.0000083998775,0.00007844526,0.0011908794,0.00022747525,0.9858414,0.0000051065,0.0004929724,0.0024177001],"study_design_scores_gemma":[0.0019534691,0.002122304,0.0039682603,0.00003620609,0.00001421243,0.00007759641,0.00039991728,0.00013008984,0.97992575,0.00006016798,0.011030868,0.0002811639],"about_ca_topic_score_codex":0.000035007408,"about_ca_topic_score_gemma":0.0005666654,"teacher_disagreement_score":0.010537895,"about_ca_system_score_codex":0.00007085397,"about_ca_system_score_gemma":0.00017485375,"threshold_uncertainty_score":0.9999937},"labels":[],"label_agreement":null},{"id":"W2099297620","doi":"10.1093/neuonc/2.4.239","title":"Primary Hodgkin's disease of the CNS in an immunocompetent patient: Acase study and review of the literature","year":2000,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Medicine; Disease; Radiation therapy; Cerebrospinal fluid; Histopathology; Craniotomy; Surgery; Pathology","score_opus":0.013252919533568736,"score_gpt":0.2900304960723284,"score_spread":0.2767775765387597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099297620","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9761436,0.018480256,4.633298e-8,0.003134464,0.00009813018,0.001736716,0.000050862684,0.0000047531653,0.0003511514],"genre_scores_gemma":[0.9893536,0.0049138023,0.000041833908,0.005561408,0.000022021457,0.000064521475,0.00001352834,0.0000108196255,0.000018457087],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99838746,0.0007556555,0.00034125138,0.00020838226,0.0001808375,0.00012643493],"domain_scores_gemma":[0.9990206,0.00012896866,0.00013774219,0.0005859981,0.000048904687,0.000077787874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018855311,0.000121327386,0.00039717523,0.00003023543,0.000038777733,0.0000034256784,0.00011905218,0.000038554732,0.00012499519],"category_scores_gemma":[0.000079450416,0.00005954418,0.00010999798,0.00023976277,0.000112590285,0.00003279264,0.00009233884,0.00022773608,9.585654e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023480018,0.014881534,0.23234768,0.0039917016,0.0002033269,0.0016274907,0.005794441,0.000011647871,0.008796982,0.00009371598,0.001052125,0.7288514],"study_design_scores_gemma":[0.004654188,0.005586825,0.94601774,0.002518004,0.0006725097,0.00021839769,0.00020099516,0.000009359831,0.0003511507,0.000044712855,0.039624467,0.00010166659],"about_ca_topic_score_codex":0.000017100952,"about_ca_topic_score_gemma":0.000013516231,"teacher_disagreement_score":0.7287497,"about_ca_system_score_codex":0.00005405506,"about_ca_system_score_gemma":0.00015906144,"threshold_uncertainty_score":0.24281412},"labels":[],"label_agreement":null},{"id":"W2099513630","doi":"10.1215/15228517-2007-027","title":"Glioblastoma multiforme after stereotactic radiotherapy for acoustic neuroma: Case report and review of the literature","year":2007,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Princess Margaret Cancer Centre; Hospital for Sick Children; University Health Network","funders":"","keywords":"Medicine; Radiation therapy; Radiosurgery; Acoustic neuroma; Radiology; Pathological; Neurofibromatosis type 2; Neurofibromatosis; Oncology; Surgery; Pathology","score_opus":0.015275040700310832,"score_gpt":0.3121390362018543,"score_spread":0.29686399550154347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099513630","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844037,0.009018247,0.00038226764,0.003122475,0.0006839614,0.0018741938,0.000009801205,0.00002916473,0.0004761538],"genre_scores_gemma":[0.9922455,0.00056444807,0.001246515,0.005276738,0.00021939336,0.000095384734,0.0000044838175,0.000034952263,0.00031260456],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99857336,0.000097757955,0.0005451483,0.00033171254,0.00017235076,0.0002796833],"domain_scores_gemma":[0.9985228,0.00042750954,0.00028808395,0.0004939344,0.00014415878,0.00012347182],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064491195,0.00017585552,0.00046587636,0.000108585125,0.000066144064,0.000011300078,0.00007947006,0.00011434904,0.00004006305],"category_scores_gemma":[0.0005303267,0.000114694616,0.00014924933,0.00025282748,0.00009466597,0.000059197184,0.000062927786,0.00024188969,0.0000011218112],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036948663,0.00045609951,0.0032620728,0.011940473,0.00021201785,0.8240938,0.0012582554,0.0000013955608,0.12123013,0.00005594884,0.008064677,0.025730219],"study_design_scores_gemma":[0.0035378402,0.0043859375,0.0077683623,0.0018116328,0.00064792467,0.8085481,0.00007855529,0.0002152516,0.0027000657,0.000018384697,0.17008771,0.00020025446],"about_ca_topic_score_codex":0.0000033763372,"about_ca_topic_score_gemma":0.000012547027,"teacher_disagreement_score":0.16202302,"about_ca_system_score_codex":0.000077247096,"about_ca_system_score_gemma":0.00008065153,"threshold_uncertainty_score":0.46771106},"labels":[],"label_agreement":null},{"id":"W2099577209","doi":"10.1093/neuonc/not163","title":"Benefit from prolonged dose-intensive chemotherapy for infants with malignant brain tumors is restricted to patients with ependymoma: a report of the Pediatric Oncology Group randomized controlled trial 9233/34","year":2013,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Cancer Institute","keywords":"Medulloblastoma; Ependymoma; Medicine; Chemotherapy; Regimen; Chemotherapy regimen; Brain tumor; Internal medicine; Randomized controlled trial; Radiation therapy; Surgery; Oncology; Pathology","score_opus":0.010126360374471033,"score_gpt":0.2641499669893451,"score_spread":0.2540236066148741,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099577209","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94818175,0.000080358244,0.000019765479,0.016796669,0.00054727314,0.034077764,0.00006610426,0.000047275815,0.00018306372],"genre_scores_gemma":[0.9796049,0.0000367323,0.00094076904,0.0075854873,0.0003046079,0.011314931,0.00008949058,0.000080252146,0.000042826596],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99611175,0.00053766696,0.0014041184,0.0008256639,0.0005467251,0.00057409145],"domain_scores_gemma":[0.9912786,0.0046376474,0.0016637946,0.0007377477,0.0013917348,0.0002904915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039371027,0.0004831894,0.0034364886,0.00029808027,0.00011715685,0.000020014788,0.0002390283,0.00031786,0.00013793718],"category_scores_gemma":[0.0026259543,0.00023844604,0.00048451472,0.00050914637,0.00020361187,0.000070887836,0.00008120788,0.00029053137,0.000009937603],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9351632,0.003066672,0.048718363,0.000020620559,0.0010488367,0.00078390405,0.0007533791,0.000004843451,0.004226995,0.000024234194,0.004432443,0.0017565137],"study_design_scores_gemma":[0.8917926,0.0213303,0.0814746,0.000052261414,0.0016592533,0.00023971536,0.00009806885,0.000055207816,0.0019762437,0.00008050856,0.0010214733,0.0002197672],"about_ca_topic_score_codex":0.0008218795,"about_ca_topic_score_gemma":0.00021216105,"teacher_disagreement_score":0.043370597,"about_ca_system_score_codex":0.00028678443,"about_ca_system_score_gemma":0.0006884557,"threshold_uncertainty_score":0.9723547},"labels":[],"label_agreement":null},{"id":"W2099596371","doi":"10.1093/neuonc/3.2.89","title":"Expression and localization of cyclin-dependent kinase 5 in apoptotichuman glioma cells","year":2001,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Cyclin-dependent kinase 5; Cell biology; Biology; ASK1; Activator (genetics); Cyclin-dependent kinase 2; Kinase; Cyclin-dependent kinase 4; Apoptosis; Neurite; Protein kinase A; Cancer research; Gene; Biochemistry; In vitro","score_opus":0.015953619766845287,"score_gpt":0.2857056757996642,"score_spread":0.26975205603281893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099596371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99431425,0.00031767177,0.0014614703,0.00027499016,0.00035701293,0.0004311003,0.0000031372672,0.000034915174,0.0028054519],"genre_scores_gemma":[0.99877644,0.0003244691,0.0002476041,0.0005010644,0.00006938509,0.00001613671,0.00001161919,0.000026524776,0.000026774851],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99879146,0.00014442048,0.00036156605,0.00030635108,0.0001847709,0.0002114101],"domain_scores_gemma":[0.99933213,0.000104685765,0.0001374969,0.00024749403,0.00006098818,0.0001172217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014700768,0.00012475083,0.0003296557,0.00024558275,0.000027611937,0.0000039953857,0.00006011541,0.00022511858,0.00009933627],"category_scores_gemma":[0.00012699544,0.00012228751,0.00004026236,0.000239288,0.000093618466,0.00003888769,0.00007134111,0.0002466223,0.000013079237],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044891852,0.0003230712,0.0028296816,0.000047577563,0.000006543512,0.0012076773,0.00030551606,0.0005096655,0.9870381,0.000031440362,0.00039763472,0.0068541956],"study_design_scores_gemma":[0.004851829,0.0015196077,0.0012996801,0.000101606674,0.000056317356,0.00044907897,0.000110757304,0.0015460254,0.9720199,0.00008208216,0.01785019,0.0001129236],"about_ca_topic_score_codex":0.00005634155,"about_ca_topic_score_gemma":0.000084042564,"teacher_disagreement_score":0.017452557,"about_ca_system_score_codex":0.0001469182,"about_ca_system_score_gemma":0.000116021285,"threshold_uncertainty_score":0.49867404},"labels":[],"label_agreement":null},{"id":"W2100064092","doi":"10.1093/neuonc/3.1.46","title":"Importance of dose intensity in neurooncology clinical trials: SummaryReport of the Sixth Annual Meeting of the Blood-Brain Barrier DisruptionConsortium","year":2001,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Cancer Institute","keywords":"Medicine; Clinical trial; Oncology; Brain tumor; Glioma; Neurooncology; Chemotherapy; Lymphoma; Cancer; Internal medicine; Intensive care medicine; Pathology; Cancer research","score_opus":0.07350066814401848,"score_gpt":0.3996207331363772,"score_spread":0.3261200649923587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100064092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866262,0.00015637824,7.5792065e-7,0.009778644,0.0011269856,0.0010550085,0.00003807411,0.0000122729525,0.0012056534],"genre_scores_gemma":[0.9970475,0.0001405209,0.000056630986,0.0024909112,0.00016117354,0.00004596601,0.0000044509343,0.000020911468,0.000031965723],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9942168,0.0020701583,0.0026328932,0.0004432894,0.00032409752,0.00031277607],"domain_scores_gemma":[0.99165344,0.00497504,0.002067741,0.0008335342,0.0003474426,0.00012281531],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0040893974,0.00020947718,0.0016872914,0.00011735008,0.000049725655,0.0000020850764,0.00028248155,0.0002783372,0.000062126346],"category_scores_gemma":[0.015665425,0.000119546894,0.0006151102,0.0005112108,0.0007535982,0.000043149663,0.00028445676,0.0005403929,0.0000011323051],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010117915,0.002078411,0.8980681,0.000029747958,0.00012783514,0.00046213897,0.00028496695,0.000024590265,0.09361115,0.00007574598,0.001358054,0.002867481],"study_design_scores_gemma":[0.0066033946,0.002093491,0.9537494,0.00008184944,0.00058948476,0.0005978109,0.00034549195,0.00005217282,0.027530309,0.00009735955,0.008173065,0.000086142725],"about_ca_topic_score_codex":0.00018623988,"about_ca_topic_score_gemma":0.0010195528,"teacher_disagreement_score":0.06608084,"about_ca_system_score_codex":0.00007978194,"about_ca_system_score_gemma":0.00069360255,"threshold_uncertainty_score":0.9926261},"labels":[],"label_agreement":null},{"id":"W2101246344","doi":"10.1093/neuonc/not243","title":"Lactate dehydrogenase A silencing in IDH mutant gliomas","year":2013,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":215,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Brain Institute; Foothills Medical Centre","funders":"National Cancer Institute","keywords":"Mutant; Gene silencing; Lactate dehydrogenase; Isocitrate dehydrogenase; Cancer research; Genetics; Biology; Molecular biology; Enzyme; Biochemistry; Gene","score_opus":0.010866409258198205,"score_gpt":0.2599607531004015,"score_spread":0.2490943438422033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101246344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993249,0.0014102992,0.000058490008,0.0005296327,0.0014015833,0.0003827101,0.000010034961,0.000024016752,0.0029342347],"genre_scores_gemma":[0.9949907,0.0009224803,0.00024233155,0.0024386307,0.0010852655,0.00015112951,0.00002407799,0.000037470596,0.00010789248],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983691,0.00016553451,0.00032103204,0.00048647358,0.00011089367,0.0005469931],"domain_scores_gemma":[0.99925035,0.0000454422,0.00011064837,0.00035377865,0.0000698351,0.00016996234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018105538,0.00020163885,0.00029581692,0.00011309647,0.00005913946,0.000020129113,0.00022518334,0.00025591388,0.00012818833],"category_scores_gemma":[0.00017590869,0.00019707988,0.00010476044,0.00018014033,0.00009430929,0.000008714778,0.00016615476,0.00020965906,0.0001252755],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007218134,0.000092879505,0.0003183115,0.000009718404,0.000015138753,0.000042884683,0.00014652607,0.00004534336,0.9780292,0.000032211778,0.003891103,0.017304538],"study_design_scores_gemma":[0.001194429,0.000367973,0.00066686486,0.000004763378,0.0000151417225,0.00017025527,0.00010908587,0.00012876569,0.59385276,0.00010092229,0.40320215,0.00018691759],"about_ca_topic_score_codex":0.00029942597,"about_ca_topic_score_gemma":0.0005434007,"teacher_disagreement_score":0.39931104,"about_ca_system_score_codex":0.00005176845,"about_ca_system_score_gemma":0.00027547067,"threshold_uncertainty_score":0.80366844},"labels":[],"label_agreement":null},{"id":"W2101887300","doi":"10.1093/neuonc/not176","title":"EXPERIMENTAL THERAPEUTICS AND PHARMACOLOGY","year":2013,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pharmacology; Clinical pharmacology; Systems pharmacology; Medicine; Drug","score_opus":0.11912994090894631,"score_gpt":0.45912819782955216,"score_spread":0.33999825692060587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101887300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9253633,0.0012705754,0.000033325316,0.013201314,0.0047620856,0.0009444555,0.000028950446,0.00029578124,0.054100223],"genre_scores_gemma":[0.93014234,0.0010547577,0.00015196635,0.067030184,0.00067378086,0.00037444948,0.000013773105,0.000043218326,0.0005155185],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976662,0.0005972081,0.00039152562,0.0005077017,0.0001263337,0.0007110611],"domain_scores_gemma":[0.9983278,0.00082954066,0.00016562658,0.00017456278,0.00008819487,0.0004142943],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00024259853,0.00032774286,0.00040268054,0.00015313835,0.00037216468,0.000028054144,0.00028696694,0.00045508755,0.010025088],"category_scores_gemma":[0.000019357843,0.00031607592,0.0001010143,0.00019566082,0.0005118498,0.000340757,0.00017846237,0.001227306,0.00152253],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001251656,0.00058690866,0.00093317067,0.000009916256,0.00014612287,0.00009198874,0.0005458828,0.00003717641,0.89169556,0.00033725455,0.07907119,0.026419636],"study_design_scores_gemma":[0.0018123161,0.00027224014,0.00013418843,9.54385e-7,0.00010638821,0.00018606964,0.00031640357,0.0013162326,0.402197,0.0001277659,0.59334236,0.00018803976],"about_ca_topic_score_codex":0.000031484687,"about_ca_topic_score_gemma":0.0000023376097,"teacher_disagreement_score":0.5142712,"about_ca_system_score_codex":0.00019977413,"about_ca_system_score_gemma":0.00018921575,"threshold_uncertainty_score":0.99992913},"labels":[],"label_agreement":null},{"id":"W2103165299","doi":"10.1093/neuonc/nov061.90","title":"MB-14 * DISCOVERING THE TREATMENT REFRACTORY BTIC POPULATION IN GROUP 3 MEDULLOBLASTOMA","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medulloblastoma; Refractory (planetary science); Population; Oncology; Internal medicine; Medicine; Psychology; Biology; Genetics; Environmental health","score_opus":0.035204321916885085,"score_gpt":0.31522327378314124,"score_spread":0.28001895186625614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103165299","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99246347,0.000400603,0.0000048491092,0.0040764753,0.00063883833,0.00058482477,0.000003532846,0.000043037417,0.0017843636],"genre_scores_gemma":[0.9985122,0.00015469502,0.00007806217,0.0007662731,0.00019863482,0.00020472542,0.000035254554,0.000023898223,0.000026229594],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99880475,0.00017289845,0.00027048148,0.0002866145,0.00019685992,0.00026842047],"domain_scores_gemma":[0.999099,0.0003031944,0.000096197866,0.00031588034,0.000029767942,0.00015591446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014696653,0.0001716257,0.0003425523,0.00011835745,0.000049407656,0.000013051002,0.00006740082,0.000109093286,0.000030376352],"category_scores_gemma":[0.00013662563,0.00010479753,0.00008360708,0.00016965225,0.00004795402,0.00007216512,0.00003342455,0.00014725343,0.00006509628],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014170139,0.008996543,0.70898366,0.000034272623,0.00021687511,0.003509392,0.0048089554,0.00049345224,0.06310327,0.0011338898,0.0033621034,0.20394057],"study_design_scores_gemma":[0.015968423,0.0155037595,0.5910822,0.00006594171,0.00037533228,0.00043612774,0.00088655896,0.00075573224,0.005071419,0.00037092777,0.36921972,0.00026381182],"about_ca_topic_score_codex":0.00065049814,"about_ca_topic_score_gemma":0.0017463228,"teacher_disagreement_score":0.36585763,"about_ca_system_score_codex":0.0011665351,"about_ca_system_score_gemma":0.00010112769,"threshold_uncertainty_score":0.42735195},"labels":[],"label_agreement":null},{"id":"W2104513740","doi":"10.1093/neuonc/nos284","title":"Association between glioma susceptibility loci and tumour pathology defines specific molecular etiologies","year":2012,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Institut National Du Cancer; Ligue Contre le Cancer","keywords":"CDKN2A; CDKN2B; Single-nucleotide polymorphism; Biology; Glioma; Allele; Cancer research; IDH1; Mutation; Genetics; Cancer; Genotype; Gene","score_opus":0.03082614546898455,"score_gpt":0.30018493173444205,"score_spread":0.2693587862654575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104513740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98909605,0.0017572051,0.00002627206,0.0071421247,0.00035625687,0.00040421844,0.000020143834,0.00009338566,0.0011043652],"genre_scores_gemma":[0.99800354,0.00029811778,0.0005103143,0.0006801179,0.00035512037,0.000060907827,0.00006157907,0.000022293141,0.000008036652],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99824643,0.0003836832,0.00032425538,0.0003743764,0.00016691312,0.00050431595],"domain_scores_gemma":[0.99841243,0.00083399325,0.00019129689,0.00026167874,0.00010714404,0.00019347464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047342674,0.00020381875,0.00056858925,0.00013030627,0.00008024632,0.000012186131,0.00006482977,0.00034230296,0.00008947709],"category_scores_gemma":[0.0006410073,0.00017035745,0.0001042573,0.00016532828,0.0001248733,0.00007021185,0.00010309908,0.00024567268,0.00009444525],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003631758,0.00031634202,0.6274531,0.000013204859,0.00006641199,0.00029757383,0.00011216148,4.4966967e-7,0.3630115,0.00023838156,0.0023515648,0.006102981],"study_design_scores_gemma":[0.0019741466,0.0012137758,0.8659174,0.00000556598,0.00031594993,0.00029938752,0.0001088774,0.0000017101776,0.09358043,0.00034492186,0.03610346,0.000134411],"about_ca_topic_score_codex":0.00001713255,"about_ca_topic_score_gemma":0.000012354565,"teacher_disagreement_score":0.26943108,"about_ca_system_score_codex":0.00035459828,"about_ca_system_score_gemma":0.000049566,"threshold_uncertainty_score":0.6946975},"labels":[],"label_agreement":null},{"id":"W2105932257","doi":"10.1093/neuonc/nou356","title":"Two cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of the open-label, controlled, randomized phase II CORE study","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":235,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Merck KGaA","keywords":"Medicine; Temozolomide; Internal medicine; Tolerability; Hazard ratio; Clinical endpoint; Oncology; Chemoradiotherapy; Gastroenterology; Progression-free survival; Phases of clinical research; Randomized controlled trial; Chemotherapy; Adverse effect; Confidence interval","score_opus":0.03371996017441568,"score_gpt":0.33467041564900746,"score_spread":0.30095045547459176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105932257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97610456,0.000099587276,0.000010148222,0.0014581869,0.000117190924,0.021893114,0.00015806552,0.000022839378,0.00013630262],"genre_scores_gemma":[0.99623513,0.000032674663,0.00061658723,0.00014245111,0.000017282766,0.0028208664,0.000078347824,0.00003703115,0.000019655085],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9975942,0.000592735,0.000673352,0.00050117576,0.00035469272,0.00028387053],"domain_scores_gemma":[0.99682915,0.0014616692,0.00058202894,0.00040935335,0.0005380277,0.00017976941],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068921765,0.00031402026,0.0016775643,0.00017142567,0.00011446363,0.000022452094,0.00012700404,0.00008402782,0.0000025268832],"category_scores_gemma":[0.00076667435,0.00015980053,0.000060136397,0.00029780294,0.0001935413,0.00008430704,0.0000964121,0.00011364132,3.586878e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9144276,0.046825986,0.023637509,0.000013660187,0.00082526094,0.0003902566,0.0035831651,0.000043737593,0.0022318664,0.000049219703,0.00025834984,0.007713396],"study_design_scores_gemma":[0.7943734,0.19591801,0.001529817,0.000073151736,0.0010571299,0.000018824821,0.00030512706,0.0003297034,0.0057538943,0.000039745508,0.0004870226,0.0001141705],"about_ca_topic_score_codex":0.00026866054,"about_ca_topic_score_gemma":0.0011970067,"teacher_disagreement_score":0.14909202,"about_ca_system_score_codex":0.00050741737,"about_ca_system_score_gemma":0.00045926755,"threshold_uncertainty_score":0.6516476},"labels":[],"label_agreement":null},{"id":"W2106343920","doi":"10.1093/neuonc/noq205","title":"Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children's Oncology Group","year":2011,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":345,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute","keywords":"Temozolomide; Medicine; Internal medicine; Chemoradiotherapy; Adjuvant; Glioma; Oncology; Radiation therapy; Surgery","score_opus":0.02049609708056621,"score_gpt":0.26428218798057207,"score_spread":0.24378609090000586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106343920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98970854,0.000832405,0.00000517242,0.005271912,0.00023397595,0.002607316,0.000056718498,0.00005502425,0.0012289244],"genre_scores_gemma":[0.99524075,0.00083780405,0.000573247,0.0019800973,0.00034479692,0.0007164748,0.00024949823,0.000051278308,0.0000060818775],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99707395,0.00058723596,0.0007867166,0.00070654997,0.00032496644,0.0005206095],"domain_scores_gemma":[0.9963806,0.0016474379,0.00056257145,0.0011717388,0.00007855561,0.00015905057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029343498,0.00043357187,0.0010726355,0.00020078788,0.00011047144,0.000013470855,0.00035331136,0.00026575383,0.00012946092],"category_scores_gemma":[0.00022786058,0.00021000339,0.00023569337,0.00051341276,0.0003908295,0.00006144857,0.000075145246,0.00032875806,0.000023466611],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015736626,0.016809972,0.9050476,0.0000028950706,0.0007039453,0.011399702,0.004325929,0.0000015045641,0.0041618724,0.00011695221,0.0015430418,0.054312933],"study_design_scores_gemma":[0.022599906,0.01946074,0.9354736,0.000027817769,0.0009947452,0.0039223824,0.0003649565,0.000003024895,0.0049299994,0.00007126856,0.011977674,0.00017386432],"about_ca_topic_score_codex":0.007934024,"about_ca_topic_score_gemma":0.006616373,"teacher_disagreement_score":0.05413907,"about_ca_system_score_codex":0.00036622814,"about_ca_system_score_gemma":0.00028673836,"threshold_uncertainty_score":0.99867225},"labels":[],"label_agreement":null},{"id":"W2106824860","doi":"10.1093/neuonc/nor040","title":"International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors","year":2011,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":176,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Calgary; Western University","funders":"","keywords":"Medicine; Temozolomide; Nuclear medicine; Oligodendroglial Tumor; Radiation therapy; Overall survival; Retrospective cohort study; Internal medicine; Glioblastoma; Gastroenterology; Oligodendroglioma; Astrocytoma; Cancer research","score_opus":0.016955196476005404,"score_gpt":0.2768803051008456,"score_spread":0.2599251086248402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106824860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9820179,0.000007977653,0.0000029283283,0.0001263917,0.00038789248,0.00054115854,0.000012729422,0.000029444194,0.016873606],"genre_scores_gemma":[0.9994977,0.0000103889515,0.00010845827,0.00014961479,0.000112332054,0.00008125421,0.000006632152,0.000019705405,0.0000138899895],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99894947,0.000055240245,0.00024198556,0.00031445405,0.00026737325,0.00017150285],"domain_scores_gemma":[0.9993013,0.00008249231,0.00015650806,0.00020758303,0.00015275509,0.000099352146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004631314,0.00014125969,0.00037440602,0.00015394663,0.000027331022,0.000003165521,0.00009439262,0.000060409686,0.0005811586],"category_scores_gemma":[0.00006310305,0.0001035928,0.000050183644,0.00013644261,0.00007832095,0.000044907178,0.000052701354,0.00015056218,0.00002187543],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005418029,0.00948972,0.9674158,0.000012401543,0.0003984497,0.003402347,0.0050157155,0.0000054782763,0.006014173,0.00037763186,0.00051062636,0.0019396198],"study_design_scores_gemma":[0.01477059,0.034467652,0.9360281,0.000042665306,0.00026907396,0.0002913158,0.0010964718,0.000059137925,0.011856105,0.000017338658,0.0009996153,0.0001019014],"about_ca_topic_score_codex":0.00025236624,"about_ca_topic_score_gemma":0.0003504441,"teacher_disagreement_score":0.031387676,"about_ca_system_score_codex":0.00018770069,"about_ca_system_score_gemma":0.00009224131,"threshold_uncertainty_score":0.6363279},"labels":[],"label_agreement":null},{"id":"W2107381090","doi":"10.1093/neuonc/nos330","title":"A multi-disciplinary consensus statement concerning surgical approaches to low-grade, high-grade astrocytomas and diffuse intrinsic pontine gliomas in childhood (CPN Paris 2011) using the Delphi method","year":2013,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Delphi Technique in Research","field":"Social Sciences","cited_by":172,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Montreal Children's Hospital","funders":"","keywords":"Medicine; Clinical trial; Radiation therapy; Biopsy; Glioma; Oncology; Internal medicine","score_opus":0.37602408685821115,"score_gpt":0.48626100427911223,"score_spread":0.11023691742090108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107381090","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04412622,0.9229543,0.0012789267,0.013007412,0.0011887056,0.01632467,0.00015747854,0.0004817595,0.000480505],"genre_scores_gemma":[0.0046190936,0.93074286,0.06129574,0.00016624831,0.00079032336,0.002028409,0.00004550352,0.0002123816,0.00009944653],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98515254,0.009078021,0.0017290446,0.0014778629,0.000976991,0.001585517],"domain_scores_gemma":[0.9905587,0.007023671,0.0009098929,0.000760968,0.0001395036,0.00060727424],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0053838873,0.00079743075,0.002652947,0.00090152986,0.00076030876,0.00025158282,0.0013530917,0.001026439,0.00009381749],"category_scores_gemma":[0.0009515369,0.0005969023,0.00034092038,0.0012973085,0.001274493,0.000137815,0.0018923569,0.0024067713,0.000049367907],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001381857,0.0018869463,0.00022425887,0.0015294402,0.0002957312,0.0029491559,0.01010547,0.000066266024,0.00025846343,0.0010686282,0.0030059896,0.97847146],"study_design_scores_gemma":[0.0021645334,0.00076334894,0.00011245101,0.0011064681,0.00034026837,0.00066862407,0.0032296204,0.000517053,0.000031045798,0.00014846641,0.9901144,0.0008037227],"about_ca_topic_score_codex":0.004123521,"about_ca_topic_score_gemma":0.0018680822,"teacher_disagreement_score":0.9871084,"about_ca_system_score_codex":0.00128791,"about_ca_system_score_gemma":0.0018462596,"threshold_uncertainty_score":0.99989474},"labels":[],"label_agreement":null},{"id":"W2108101104","doi":"10.1093/neuonc/nor202","title":"CD166/Activated leukocyte cell adhesion molecule is expressed on glioblastoma progenitor cells and involved in the regulation of tumor cell invasion","year":2011,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Notre-Dame","funders":"","keywords":"ALCAM; Cancer research; Progenitor cell; Biology; Cell; Cell adhesion molecule; Stem cell; Cell growth; Cell biology","score_opus":0.0327689800479867,"score_gpt":0.2601149394333148,"score_spread":0.22734595938532812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108101104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949643,0.00012527862,0.000008069202,0.00023467669,0.00020205216,0.0009639928,0.0000102818485,0.000024368996,0.003466984],"genre_scores_gemma":[0.99767274,0.000153774,0.00045800183,0.0014974637,0.00007316036,0.000058225633,0.0000073881547,0.000032269094,0.000046957408],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983627,0.00030574048,0.00039655837,0.00041079518,0.00026503662,0.00025915605],"domain_scores_gemma":[0.998901,0.0002272707,0.00028324136,0.0003927474,0.000088910354,0.00010682375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023648914,0.00020220884,0.00041004064,0.00020464438,0.000049020553,0.0000067165593,0.00013177458,0.00014957819,0.00011182999],"category_scores_gemma":[0.000040860694,0.00014903491,0.000085344276,0.00029824412,0.00010325562,0.00006463121,0.00006261467,0.00030048867,0.000017576289],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029430522,0.0007803676,0.0004985047,0.00015697446,0.000007112031,0.00009724531,0.002034959,0.0000029942253,0.98968226,0.000006352097,0.0020409871,0.0017491763],"study_design_scores_gemma":[0.003375496,0.0051103374,0.0023040653,0.000050890652,0.00008617961,0.000018721397,0.00048137698,0.00007182118,0.97827524,0.00002667112,0.01008444,0.0001147854],"about_ca_topic_score_codex":0.00014332164,"about_ca_topic_score_gemma":0.000045847566,"teacher_disagreement_score":0.01140706,"about_ca_system_score_codex":0.000098105535,"about_ca_system_score_gemma":0.00016304638,"threshold_uncertainty_score":0.6077467},"labels":[],"label_agreement":null},{"id":"W2108402757","doi":"10.1093/neuonc/nor183","title":"Evaluation of brain tumor vessels specific contrast agents for glioblastoma imaging","year":2011,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":192,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Bone and Joint Health Institute; University of Calgary; University of Ottawa; National Research Council Canada; National Research Council Institute for Biodiagnostics","funders":"FP7 People: Marie-Curie Actions; Canadian Institutes of Health Research","keywords":"In vivo; Magnetic resonance imaging; Glioma; Fluorescence-lifetime imaging microscopy; Dextran; Glioblastoma; Contrast (vision); Chemistry; Pathology; Imaging agent; Iron oxide nanoparticles; Gadolinium; Brain tumor; Antibody; MRI contrast agent; Nanoparticle; Nuclear magnetic resonance; Fluorescence; Cancer research; Materials science; Medicine; Biology; Immunology; Biochemistry; Nanotechnology; Radiology","score_opus":0.05494187221509492,"score_gpt":0.3088994956444496,"score_spread":0.2539576234293547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108402757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950908,0.00009760822,0.00076322805,0.000411577,0.0014445503,0.00086667895,0.00004573245,0.00006838857,0.001211479],"genre_scores_gemma":[0.9976293,0.0000027230744,0.0011772973,0.0008731675,0.00013816296,0.00013961621,0.0000027557935,0.00002924224,0.000007762326],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99754685,0.0006556969,0.0004830474,0.00042547882,0.00047883412,0.00041011174],"domain_scores_gemma":[0.99801564,0.00067009556,0.00032774667,0.00034029476,0.0005407767,0.00010546928],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0024902301,0.00015310786,0.0003175376,0.00012745221,0.000080934915,0.000019006706,0.0003005913,0.00005261311,0.0010483954],"category_scores_gemma":[0.00079950306,0.00015445561,0.00007577647,0.00015778157,0.0002043884,0.0002253753,0.00007410829,0.00008065076,0.0002076961],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000435342,0.0002795911,0.00023520514,0.000014273789,0.0000059772046,0.000032564785,0.0005429758,0.000058609156,0.98142934,0.00033457606,0.0052763065,0.011355232],"study_design_scores_gemma":[0.00271033,0.0007970585,0.0009607598,0.000012056634,0.000085915235,0.000043845335,0.00015279025,0.0036644812,0.98101777,0.0009482918,0.009470153,0.00013654189],"about_ca_topic_score_codex":0.000019641755,"about_ca_topic_score_gemma":0.000020700847,"teacher_disagreement_score":0.011218691,"about_ca_system_score_codex":0.00020056393,"about_ca_system_score_gemma":0.0003534574,"threshold_uncertainty_score":0.99986476},"labels":[],"label_agreement":null},{"id":"W2108677211","doi":"10.1215/15228517-2006-002","title":"Diffusion tensor imaging of white matter after cranial radiation in children for medulloblastoma: Correlation with IQ","year":2006,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Advanced Neuroimaging Techniques and Applications","field":"Medicine","cited_by":192,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; SickKids Foundation; Hospital for Sick Children; McMaster University; University of Toronto","funders":"","keywords":"White matter; Fractional anisotropy; Internal capsule; Diffusion MRI; Corpus callosum; Effective diffusion coefficient; Nuclear medicine; Medicine; Intelligence quotient; Correlation; Psychology; Magnetic resonance imaging; Pathology; Radiology; Neuroscience; Cognition","score_opus":0.008528242953704352,"score_gpt":0.28372072296481327,"score_spread":0.2751924800111089,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108677211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.958244,0.000025674426,0.035430606,0.004524212,0.000047806658,0.0011565733,0.000018644587,0.00007259825,0.00047985275],"genre_scores_gemma":[0.98664796,0.00000893247,0.011581521,0.0012162462,0.00012685724,0.00027028265,0.000063282394,0.000032794804,0.000052132367],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99914044,0.00003168938,0.0002827057,0.00027124118,0.00009830953,0.00017563286],"domain_scores_gemma":[0.99945706,0.000095079675,0.00015915847,0.0001874168,0.00006811434,0.0000331946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000058481397,0.00011614321,0.0002325648,0.00015702155,0.0000489263,0.000003615888,0.00004994014,0.00006369302,0.000031354797],"category_scores_gemma":[0.000021083268,0.00010029498,0.00004460771,0.00015998777,0.000079235586,0.00007287054,0.000030394482,0.00015619262,0.0000051407706],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052798406,0.0002179573,0.95886624,0.000013772124,0.0000025375982,0.00000919577,0.000049709222,0.00011766608,0.035870176,0.00006974583,0.0010512874,0.003203727],"study_design_scores_gemma":[0.0025674799,0.0004091792,0.9848064,0.000026157317,0.0000551758,0.00022980926,0.000006810171,0.0029885317,0.002223679,0.00035772932,0.0062356037,0.00009341741],"about_ca_topic_score_codex":0.00003092418,"about_ca_topic_score_gemma":0.000014929246,"teacher_disagreement_score":0.033646498,"about_ca_system_score_codex":0.000081313,"about_ca_system_score_gemma":0.000042568132,"threshold_uncertainty_score":0.40899107},"labels":[],"label_agreement":null},{"id":"W2108933679","doi":"10.1093/neuonc/noq145","title":"Epigenetic regulation of glial fibrillary acidic protein by DNA methylation in human malignant gliomas","year":2010,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Glial fibrillary acidic protein; Biology; DNA methylation; Glioma; GFAP stain; Bisulfite sequencing; Molecular biology; Methylation; Epigenetics; Cancer research; Gene silencing; Gene expression; Gene; Genetics; Immunology; Immunohistochemistry","score_opus":0.01111158654251908,"score_gpt":0.27923652522332343,"score_spread":0.26812493868080434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108933679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99649084,0.0004547642,0.0008434255,0.00026729426,0.0003036028,0.0005327825,0.00001828025,0.0000124872695,0.0010765282],"genre_scores_gemma":[0.99842477,0.00007176428,0.0008393952,0.000048306476,0.00024089414,0.000045334677,0.00022826013,0.000033416218,0.00006783988],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99825335,0.00029334563,0.0005415536,0.00045422732,0.00018404375,0.00027349504],"domain_scores_gemma":[0.9990459,0.00004507011,0.00030770374,0.0004022765,0.00011457161,0.000084469495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004787642,0.00018492548,0.00027128292,0.00014777745,0.000066949884,0.000011266927,0.00017564595,0.00049592956,0.00004518263],"category_scores_gemma":[0.00022902108,0.00019496029,0.00008559918,0.00019983042,0.00017952152,0.000007559719,0.00009610967,0.00019557147,0.000004541694],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009209701,0.00010249954,0.0022042259,0.000018716792,0.00001010146,0.0000039039905,0.000047516784,0.00008074436,0.98853445,0.00023213764,0.00010814751,0.008565475],"study_design_scores_gemma":[0.000836998,0.0010712502,0.0071794866,0.0000070194087,0.000014061753,0.000005876137,0.000012763987,0.000103455255,0.9602975,0.0010654232,0.0292326,0.00017355419],"about_ca_topic_score_codex":0.000067753506,"about_ca_topic_score_gemma":0.00033642515,"teacher_disagreement_score":0.029124454,"about_ca_system_score_codex":0.000027700466,"about_ca_system_score_gemma":0.00013327121,"threshold_uncertainty_score":0.795025},"labels":[],"label_agreement":null},{"id":"W2110012351","doi":"10.1093/neuonc/not244","title":"A patient tumor-derived orthotopic xenograft mouse model replicating the group 3 supratentorial primitive neuroectodermal tumor in children","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Diana Helis Henry Medical Research Foundation","keywords":"Primitive neuroectodermal tumor; Cancer research; Medicine; Oncology; Internal medicine; Immunohistochemistry","score_opus":0.014226446399778273,"score_gpt":0.26223197406634263,"score_spread":0.24800552766656436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110012351","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950552,0.000037286154,0.00004008583,0.002057245,0.00030064344,0.0016726069,0.000014722354,0.00009547486,0.0007267202],"genre_scores_gemma":[0.992732,0.000018459563,0.00033586656,0.0058403,0.00032369082,0.0006532609,0.000040440143,0.000051204428,0.000004767027],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99751806,0.0004472132,0.00053450314,0.0006761891,0.00028080522,0.0005432268],"domain_scores_gemma":[0.9984101,0.0004180339,0.0002691368,0.00062905747,0.00008700259,0.00018665261],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002149668,0.0002971982,0.0005486604,0.00013738325,0.00015478699,0.000027812186,0.00017317593,0.00009384447,0.000020884436],"category_scores_gemma":[0.00045386143,0.00020979442,0.00015690124,0.00021181814,0.00013208769,0.00006842594,0.00017312427,0.0004965483,0.000024043882],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056927785,0.0023941733,0.27472854,0.000019952653,0.00009676989,0.00038243586,0.0011256813,0.00070633605,0.7099442,0.0006608701,0.00053199736,0.008839779],"study_design_scores_gemma":[0.02971036,0.013989552,0.56408805,0.00010021322,0.00071003905,0.0022522293,0.0003909908,0.03956418,0.33532202,0.00028651135,0.012612517,0.00097334787],"about_ca_topic_score_codex":0.00016617702,"about_ca_topic_score_gemma":0.000101813035,"teacher_disagreement_score":0.37462214,"about_ca_system_score_codex":0.00019192472,"about_ca_system_score_gemma":0.00014900632,"threshold_uncertainty_score":0.85551685},"labels":[],"label_agreement":null},{"id":"W2110016800","doi":"10.1093/neuonc/nos197","title":"Thromboembolic disease in patients with high-grade glioma","year":2012,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":153,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Bevacizumab; Glioma; Disease; Angiogenesis; Thrombosis; Oncology; Coagulation; Heparin; Anticoagulant; Internal medicine; Immunology; Cancer research; Chemotherapy","score_opus":0.014973374852350266,"score_gpt":0.27478641822282557,"score_spread":0.2598130433704753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110016800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931618,0.0001370459,0.000007859549,0.0024157362,0.00067026715,0.0009738941,0.000008688788,0.00007966968,0.0025450527],"genre_scores_gemma":[0.9946627,0.000060181403,0.00023106493,0.0045025805,0.00030148006,0.00013355374,0.000047890364,0.00004862543,0.0000119371825],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99827504,0.00012652662,0.0002888811,0.0003359159,0.00031728216,0.000656345],"domain_scores_gemma":[0.9988348,0.00010961074,0.00010890268,0.00042172102,0.00005178757,0.00047316862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014547865,0.0002232013,0.0006487069,0.00024184835,0.000059232894,0.000010139932,0.00012503908,0.000102876686,0.00025796168],"category_scores_gemma":[0.000086501095,0.00017548208,0.000064214975,0.00032644646,0.00010351662,0.00015681118,0.000113898226,0.000249089,0.00018222404],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004239708,0.009624505,0.96949404,0.00008745152,0.00009030799,0.0002737665,0.0005067111,0.000020395759,0.0027557712,0.0029201764,0.008814922,0.0049879597],"study_design_scores_gemma":[0.0046820203,0.0014588665,0.9335107,0.000031891686,0.000226322,0.000006163579,0.00003569917,0.00000702979,0.00051698374,0.00006777208,0.05928951,0.00016704058],"about_ca_topic_score_codex":0.0001235925,"about_ca_topic_score_gemma":0.000034885943,"teacher_disagreement_score":0.050474588,"about_ca_system_score_codex":0.00022758308,"about_ca_system_score_gemma":0.00011897058,"threshold_uncertainty_score":0.7155951},"labels":[],"label_agreement":null},{"id":"W2110254666","doi":"10.1093/neuonc/noq203","title":"Clinical trial end points for high-grade glioma: the evolving landscape","year":2011,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":121,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Clinical trial; Medicine; End point; Clinical study design; Medical physics; Clinical endpoint; Surrogate endpoint; Glioma; Intensive care medicine; Oncology; Internal medicine; Computer science","score_opus":0.1380726027225687,"score_gpt":0.42097942613129896,"score_spread":0.2829068234087303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110254666","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00082552596,0.9835718,0.0000052968085,0.001596324,0.005934971,0.0062271855,0.000092241266,0.00008584587,0.0016608003],"genre_scores_gemma":[0.00068552216,0.9917318,0.00043017487,0.0008048009,0.0037660105,0.00219725,0.00022211243,0.00012487172,0.000037429505],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958412,0.0009590022,0.0015297643,0.0008648959,0.00022796483,0.00057716673],"domain_scores_gemma":[0.99034274,0.0074777994,0.00088051404,0.00090542325,0.00011721695,0.00027631017],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001123689,0.00056300533,0.0035097515,0.00023937764,0.00015590875,0.000028659651,0.00040536813,0.0009833343,0.00050498213],"category_scores_gemma":[0.0018137853,0.00031113066,0.0015555103,0.00026973826,0.00018985829,0.000035194666,0.0001797817,0.00085782417,0.00024079772],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002058969,0.002379628,0.000055249315,0.0013393991,0.00076515146,0.0008010582,0.000034314486,1.2163662e-8,0.000005769124,0.0007455851,0.053897694,0.9379172],"study_design_scores_gemma":[0.041600958,0.0068648807,0.000044938475,0.0007509504,0.00622714,0.0006258754,0.00000831475,0.0000021150229,0.000009150528,0.00012953064,0.9435214,0.00021476913],"about_ca_topic_score_codex":0.000020625406,"about_ca_topic_score_gemma":0.000024877518,"teacher_disagreement_score":0.9377024,"about_ca_system_score_codex":0.00018383733,"about_ca_system_score_gemma":0.00092487806,"threshold_uncertainty_score":0.9999341},"labels":[],"label_agreement":null},{"id":"W2110700778","doi":"10.1093/neuonc/nos065","title":"Initial treatment patterns over time for anaplastic oligodendroglial tumors","year":2012,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Western University","funders":"National Cancer Institute; National Brain Tumor Society","keywords":"Oligodendroglial Tumor; Medicine; Cancer research; Glioblastoma; Oligodendroglioma","score_opus":0.029662333022044733,"score_gpt":0.3281192126982717,"score_spread":0.29845687967622697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110700778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950381,0.00008017429,0.00003377133,0.0010375793,0.00092746457,0.00091781875,0.00013402264,0.00007243955,0.0017586539],"genre_scores_gemma":[0.9964601,0.00002773195,0.00017071607,0.0013081298,0.0013260926,0.00047694342,0.00011841723,0.000044471442,0.00006743347],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986683,0.00007045413,0.00027195827,0.00028557543,0.0001434953,0.0005602132],"domain_scores_gemma":[0.9987053,0.00059088453,0.00009718581,0.00023276055,0.000041836312,0.00033199857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006676032,0.00023916927,0.0005089513,0.0001229346,0.00007606384,0.000010033848,0.00005505795,0.00014367994,0.00068481866],"category_scores_gemma":[0.00009386052,0.00018466476,0.00020050799,0.00007198973,0.00004803353,0.00006934383,0.000034163975,0.00008943816,0.00032265318],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005106973,0.021477304,0.5437386,0.00016970436,0.0012715805,0.0035443634,0.0020846566,0.000030734464,0.2584658,0.0014257329,0.028437044,0.13424748],"study_design_scores_gemma":[0.03964981,0.04118379,0.19086115,0.00007884543,0.002248539,0.0018849713,0.00010288802,0.00077558105,0.23725347,0.000071261384,0.48523977,0.00064991484],"about_ca_topic_score_codex":0.00004768099,"about_ca_topic_score_gemma":0.000027844091,"teacher_disagreement_score":0.45680273,"about_ca_system_score_codex":0.0004425011,"about_ca_system_score_gemma":0.00014341171,"threshold_uncertainty_score":0.7530411},"labels":[],"label_agreement":null},{"id":"W2111335317","doi":"10.1093/neuonc/nou091","title":"Phase 2 study of safety and efficacy of nimotuzumab in pediatric patients with progressive diffuse intrinsic pontine glioma","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Toronto","funders":"","keywords":"Nimotuzumab; Medicine; Adverse effect; Internal medicine; Clinical trial; Phases of clinical research; Radiation therapy; Oncology; Glioma; Surgery; Epidermal growth factor receptor; Cancer","score_opus":0.00936498273563688,"score_gpt":0.28408256319033337,"score_spread":0.27471758045469646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111335317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980417,0.00010894365,0.0000011345877,0.00016530849,0.00007279374,0.0014716876,0.000007701332,0.000014181271,0.000116575466],"genre_scores_gemma":[0.9997299,0.000026106069,0.000058685608,0.000049065864,0.000051286082,0.000050198825,0.000014854467,0.000019347794,5.9976077e-7],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99862117,0.00017850331,0.00046501134,0.00031448723,0.00022000045,0.00020081781],"domain_scores_gemma":[0.99864167,0.0004912518,0.00034173048,0.00026971824,0.00014487948,0.00011072864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010976551,0.00016762201,0.0006748133,0.00033797472,0.000024065293,0.0000029347732,0.00006437009,0.00007547724,0.000012314928],"category_scores_gemma":[0.00029160912,0.00011744257,0.000034294575,0.00040314824,0.00008330792,0.00003357372,0.00007343987,0.00013315582,0.0000014425258],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005563677,0.058464658,0.8818046,0.00006397223,0.00006959875,0.00036309575,0.0008251613,0.0000029472033,0.0022525175,0.000017347236,0.000030499119,0.050541967],"study_design_scores_gemma":[0.12604813,0.056864224,0.81438434,0.000024351499,0.00038249814,0.000022031472,0.000088804205,0.00001796937,0.0018715787,0.0000027517792,0.0002147953,0.00007850269],"about_ca_topic_score_codex":0.000028285363,"about_ca_topic_score_gemma":0.00004179549,"teacher_disagreement_score":0.12048446,"about_ca_system_score_codex":0.00006075576,"about_ca_system_score_gemma":0.00006913997,"threshold_uncertainty_score":0.47891688},"labels":[],"label_agreement":null},{"id":"W2111406583","doi":"10.1093/neuonc/not114","title":"Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial","year":2013,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":944,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute","keywords":"Memantine; Medicine; Placebo; Hazard ratio; Randomized controlled trial; Cognition; Clinical endpoint; Cognitive decline; Anesthesia; Internal medicine; Confidence interval; Dementia; Psychiatry","score_opus":0.0253382172890971,"score_gpt":0.3220702013908722,"score_spread":0.29673198410177515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111406583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93669605,0.00028728237,0.0023397557,0.013285106,0.0017096518,0.04455782,0.00000813138,0.000045709825,0.0010705155],"genre_scores_gemma":[0.9840186,0.00014718079,0.000080763966,0.0013130488,0.00047793592,0.013252494,0.000049179434,0.000042820942,0.00061797537],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9972503,0.00079063326,0.0009542293,0.00037997396,0.00028082202,0.00034403638],"domain_scores_gemma":[0.9883455,0.010183491,0.0007114208,0.00016296165,0.00053647894,0.000060127884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001552748,0.00025040956,0.0014785131,0.00029316405,0.00011250698,0.000014188181,0.000082562634,0.00020812091,0.00017969373],"category_scores_gemma":[0.004424839,0.00016825215,0.00041132912,0.00028283722,0.0002565549,0.0001356278,0.000042653475,0.00035734934,0.000013737486],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96127564,0.0011478215,0.0005205096,0.00004260265,0.00086769357,0.0000018376771,0.0008437211,0.000015620426,0.0033352599,0.000013342974,0.0025482185,0.029387763],"study_design_scores_gemma":[0.98487127,0.009232272,0.0011238052,0.00019087514,0.0010134617,0.000005881135,0.00037539878,0.0010285933,0.0005805292,0.000086953725,0.0013625439,0.00012844495],"about_ca_topic_score_codex":0.00007704386,"about_ca_topic_score_gemma":0.00008444463,"teacher_disagreement_score":0.047322575,"about_ca_system_score_codex":0.0002437503,"about_ca_system_score_gemma":0.00021189758,"threshold_uncertainty_score":0.6861124},"labels":[],"label_agreement":null},{"id":"W2112655953","doi":"10.1215/s1152851704000602","title":"Phase 2 study of T138067-sodium in patients with malignant glioma: Trialof the National Cancer Institute of Canada Clinical Trials Group","year":2005,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Baker Hughes (Canada); Queen's University; Princess Margaret Cancer Centre; Nova Scotia Cancer Centre; Ottawa Regional Cancer Foundation; Dalhousie University","funders":"National Cancer Institute","keywords":"Medicine; Anaplastic astrocytoma; Glioma; Chemotherapy; Lomustine; Radiation therapy; Nitrosourea; Internal medicine; Nausea; Oncology; Neutropenia; Phases of clinical research; Surgery; Cancer; Population; Toxicity; Gastroenterology; Astrocytoma; Vincristine; Cyclophosphamide; Cancer research","score_opus":0.08788982790644878,"score_gpt":0.4126054623280511,"score_spread":0.32471563442160234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112655953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943195,0.00008053893,7.0999374e-7,0.0026387146,0.0008018662,0.0018907288,0.000077218865,0.0000051278116,0.00018556842],"genre_scores_gemma":[0.99866194,0.000020973735,0.000036578906,0.00074452546,0.00028478572,0.00021918796,0.000015643207,0.000012273414,0.0000041153435],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969367,0.0007396364,0.0012792113,0.0002860321,0.000554671,0.0002037594],"domain_scores_gemma":[0.997466,0.0013240104,0.0006453593,0.00020116018,0.00026021447,0.000103210456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014358416,0.00015101001,0.0010140642,0.00013359815,0.00004009742,0.000002986629,0.00011978077,0.00008651001,0.00006333768],"category_scores_gemma":[0.0011290901,0.000084531006,0.00009026315,0.0002944821,0.00011637363,0.00004716066,0.000039898867,0.00017711833,8.3577066e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030703176,0.108293466,0.78330684,0.000049986178,0.0012431873,0.0006142225,0.000812056,0.00041416287,0.014104939,0.0003658745,0.016211782,0.04388031],"study_design_scores_gemma":[0.33355862,0.04086024,0.5211509,0.000093280985,0.0011216209,0.000019902987,0.00026507067,0.00012688331,0.0113717215,0.000011759901,0.091189384,0.00023065112],"about_ca_topic_score_codex":0.026894407,"about_ca_topic_score_gemma":0.27790895,"teacher_disagreement_score":0.30285546,"about_ca_system_score_codex":0.00036836517,"about_ca_system_score_gemma":0.001642926,"threshold_uncertainty_score":0.9795856},"labels":[],"label_agreement":null},{"id":"W2112684191","doi":"10.1093/neuonc/nos098","title":"DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)","year":2012,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Pons; Glioma; Medicine; Cancer research; Internal medicine","score_opus":0.023259172035065973,"score_gpt":0.2996466590429815,"score_spread":0.2763874870079155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112684191","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98027176,0.00090018095,0.00000530597,0.00770961,0.0011208872,0.000397156,0.000005477149,0.00011754432,0.009472071],"genre_scores_gemma":[0.9953156,0.000095277894,0.00025958562,0.0033106094,0.0008177813,0.000094360934,0.000020639969,0.000036108813,0.00005003254],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986534,0.00009899218,0.0002723918,0.00025894286,0.0001818047,0.0005344613],"domain_scores_gemma":[0.9987679,0.0003107146,0.000097135424,0.00037551505,0.00006178702,0.00038692588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013542255,0.00019516861,0.0004464995,0.00018680973,0.0000656349,0.00000947123,0.00008223627,0.00016101639,0.00041404276],"category_scores_gemma":[0.00023653528,0.00015268597,0.00012848391,0.00025058523,0.00007630992,0.00008284431,0.00009332234,0.00021554602,0.0006486687],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003424952,0.0069075758,0.22523086,0.000029922865,0.00016021426,0.002214315,0.00040628554,4.0759127e-7,0.63726395,0.001533691,0.03235049,0.09355977],"study_design_scores_gemma":[0.008661509,0.0022029737,0.16120923,0.000015493199,0.00034774558,0.001886944,0.00005886471,0.000009247705,0.09788375,0.000040505995,0.72751015,0.00017361042],"about_ca_topic_score_codex":0.000026279504,"about_ca_topic_score_gemma":0.000012303157,"teacher_disagreement_score":0.6951596,"about_ca_system_score_codex":0.00017158662,"about_ca_system_score_gemma":0.00007711305,"threshold_uncertainty_score":0.833754},"labels":[],"label_agreement":null},{"id":"W2113788299","doi":"10.1093/neuonc/not229","title":"Where are we now? And where are we going? A report from the Accelerate Brain Cancer Cure (ABC2) Low-grade Glioma Research Workshop","year":2013,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Glioma; Glioblastoma; Epigenomics; Clinical trial; Medicine; Brain cancer; Oncology; Cancer; Medical physics; Internal medicine; Psychology; Biology; Cancer research; DNA methylation","score_opus":0.15664274759446073,"score_gpt":0.43526641928163123,"score_spread":0.2786236716871705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113788299","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026118779,0.80043644,4.5666934e-7,0.1915526,0.0011161276,0.0035782335,0.0002476538,0.0000944249,0.0003621851],"genre_scores_gemma":[0.00016030428,0.9913014,0.000059398222,0.0012572746,0.0020793607,0.0037563243,0.00015763869,0.00024750645,0.000980771],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99275845,0.0018407209,0.0013408727,0.0019154737,0.00091612426,0.0012283426],"domain_scores_gemma":[0.9895576,0.00611983,0.001376547,0.0018398622,0.0004921564,0.0006139839],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00076776266,0.001060783,0.0037686406,0.00042472148,0.00044867853,0.00024684056,0.0006900016,0.0015259899,0.0012688936],"category_scores_gemma":[0.0004968597,0.0006482453,0.00064983126,0.0012140608,0.00050126755,0.00013298646,0.00067629345,0.0031416647,0.00032711003],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054886514,0.00054068986,0.0025605126,0.00484909,0.0006273875,0.021080624,0.00020088657,5.967772e-7,0.0001502691,0.000007553266,0.68604565,0.28388184],"study_design_scores_gemma":[0.001925489,0.00039697625,0.00026643652,0.031183902,0.001465696,0.0026207624,0.0004357977,0.000008202373,0.000038788185,0.000054583743,0.9611486,0.0004547357],"about_ca_topic_score_codex":0.00047475082,"about_ca_topic_score_gemma":0.009670877,"teacher_disagreement_score":0.28342712,"about_ca_system_score_codex":0.0009161992,"about_ca_system_score_gemma":0.0016140396,"threshold_uncertainty_score":0.9997702},"labels":[],"label_agreement":null},{"id":"W2113894146","doi":"10.1093/neuonc/nos312","title":"Optic pathway gliomas in adolescence--time to challenge treatment choices?","year":2013,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Children's Hospital; SickKids Foundation; McMaster Children's Hospital; Pediatric Oncology Group","funders":"","keywords":"Medicine; Carboplatin; Neurofibromatosis; Chemotherapy; Cohort; Pediatrics; Natural history; Retrospective cohort study; Radiation therapy; Progression-free survival; Oncology; Internal medicine; Pathology","score_opus":0.02521580444228332,"score_gpt":0.2871038746838031,"score_spread":0.2618880702415198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113894146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9654332,0.00038927983,0.0000010199757,0.01667634,0.0002263267,0.0018350413,0.0000064894757,0.00008602084,0.015346277],"genre_scores_gemma":[0.9959104,0.00013389289,0.00038454344,0.001900264,0.00021425413,0.0011494982,0.00001541569,0.000041052048,0.00025068037],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99820954,0.00012692127,0.00037101514,0.0005551418,0.00019399829,0.0005433872],"domain_scores_gemma":[0.99870485,0.0002638754,0.000089991045,0.00044851747,0.000073267474,0.00041947933],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000078750796,0.0002921434,0.00064206985,0.00034151832,0.00004872171,0.00002009648,0.00011976531,0.00018944712,0.0014841851],"category_scores_gemma":[0.00010104105,0.00022401109,0.00012656476,0.00033200663,0.000051095503,0.00007894432,0.00006967675,0.00015727089,0.006625546],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034709618,0.013213271,0.027374282,0.00006928005,0.00017897775,0.008117662,0.001371054,0.00006959071,0.58085924,0.00030011177,0.0058374973,0.36226192],"study_design_scores_gemma":[0.024939068,0.03913953,0.22572693,0.0002957026,0.00032751114,0.0009056374,0.00029072992,0.0007780453,0.094074406,0.00015729495,0.6125424,0.0008227658],"about_ca_topic_score_codex":0.00023269636,"about_ca_topic_score_gemma":0.00011921609,"teacher_disagreement_score":0.6067049,"about_ca_system_score_codex":0.00070215884,"about_ca_system_score_gemma":0.00019008412,"threshold_uncertainty_score":0.9994286},"labels":[],"label_agreement":null},{"id":"W2114752419","doi":"10.1093/neuonc/nos076","title":"Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis","year":2012,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":314,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medicine; Neurofibromatosis; Chemotherapy; Retrospective cohort study; Visual acuity; Pediatrics; Surgery; Radiology","score_opus":0.012895811532343865,"score_gpt":0.29106390099792934,"score_spread":0.27816808946558547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114752419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974627,0.00008261485,0.0000065788904,0.000591912,0.0003295103,0.0007750998,0.0000151488875,0.00017293192,0.0005635075],"genre_scores_gemma":[0.9979271,0.000011405204,0.0003641878,0.0013735287,0.0000915862,0.000051939238,0.00004909693,0.00009370865,0.00003742125],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99711037,0.0003840612,0.0005764073,0.0006294129,0.00046442333,0.0008353072],"domain_scores_gemma":[0.9985058,0.0003380805,0.00028952817,0.00043239407,0.0001026359,0.00033161105],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030162858,0.00042508254,0.0014044996,0.00069152744,0.0001095589,0.00003698382,0.0001576632,0.00025283496,0.000111534486],"category_scores_gemma":[0.00041546367,0.00033395065,0.00043081885,0.0019698942,0.000091228685,0.00024823975,0.00009123797,0.00046814495,0.000045888595],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044353216,0.0016037432,0.8693466,0.0000074516042,0.0014069924,0.0005458757,0.00032606238,0.0000042607703,0.1260158,0.000017948892,0.00007036494,0.00021135088],"study_design_scores_gemma":[0.0054672877,0.0030771166,0.97296685,0.000024218742,0.0012073484,0.0003906755,0.00008480907,0.00017740707,0.016175086,0.0000026194434,0.00013326365,0.0002932944],"about_ca_topic_score_codex":0.000090992646,"about_ca_topic_score_gemma":0.000038659393,"teacher_disagreement_score":0.10984071,"about_ca_system_score_codex":0.0003505406,"about_ca_system_score_gemma":0.0001478571,"threshold_uncertainty_score":0.99991125},"labels":[],"label_agreement":null},{"id":"W2115408879","doi":"10.1215/15228517-2006-033","title":"Brain and Spinal Tumors of Childhood","year":2007,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Craniopharyngioma; Psychosocial; Cover (algebra); Psychology; Psychoanalysis; Cognitive science; Neuroscience; Medicine; Psychotherapist; Radiology","score_opus":0.01788991397429802,"score_gpt":0.339118790306305,"score_spread":0.321228876332007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115408879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872166,0.00009262284,0.000018275809,0.0029644917,0.00007349771,0.00028299852,0.0000032440614,0.000026037795,0.009322233],"genre_scores_gemma":[0.9977786,0.000028749764,0.00030085276,0.0017091876,0.00008490201,0.0000048289558,0.0000029551848,0.000014955786,0.000074955184],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99904674,0.000057569614,0.00019998358,0.00021343963,0.00017637353,0.00030588414],"domain_scores_gemma":[0.99921805,0.0002721142,0.00006167465,0.00015534762,0.00004373287,0.00024908833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018871462,0.00009600709,0.00026885554,0.0001515785,0.000033838704,0.0000027317149,0.000050690265,0.00006488637,0.000054520387],"category_scores_gemma":[0.0003305979,0.0000795489,0.000045557576,0.00013893507,0.00015751168,0.000028314382,0.00005879813,0.00022282997,0.00002802264],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021931625,0.0012912999,0.031001564,0.00006867941,0.000068219204,0.006106478,0.00020493788,2.1531561e-7,0.7903732,0.00042033225,0.0019916086,0.16628031],"study_design_scores_gemma":[0.007025511,0.022159902,0.75823,0.00004324075,0.000051608586,0.0039154766,0.000086607615,0.00000781888,0.17192674,0.00018987287,0.036265872,0.00009738549],"about_ca_topic_score_codex":0.000016137747,"about_ca_topic_score_gemma":0.000019818148,"teacher_disagreement_score":0.7272284,"about_ca_system_score_codex":0.000043034866,"about_ca_system_score_gemma":0.00016609815,"threshold_uncertainty_score":0.324391},"labels":[],"label_agreement":null},{"id":"W2116357006","doi":"10.1093/neuonc/nou083","title":"Recursive partitioning analysis of prognostic variables in newly diagnosed anaplastic oligodendroglial tumors","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Western University","funders":"National Cancer Institute; Sigma-Tau Pharmaceuticals; Bristol-Myers Squibb","keywords":"Oligodendroglial Tumor; Medicine; Internal medicine; Hazard ratio; Nuclear medicine; Survival analysis; Glioma; Oncology; Oligodendroglioma; Cancer research; Astrocytoma; Confidence interval","score_opus":0.015411115799521001,"score_gpt":0.28146138192603626,"score_spread":0.2660502661265153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116357006","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965593,0.00006581818,0.00014639719,0.0008458656,0.00022303827,0.00042724475,0.000017157343,0.0000321697,0.0016830112],"genre_scores_gemma":[0.9985355,0.000043688953,0.00057537254,0.00047267458,0.00009318543,0.00018088282,0.00007590234,0.0000191032,0.0000036763345],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982585,0.00027451105,0.0005119704,0.0003943557,0.00020874252,0.0003519446],"domain_scores_gemma":[0.9967556,0.0024633904,0.00023705504,0.0002693968,0.00011237112,0.0001622135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022796736,0.00018089452,0.00086718966,0.00067698606,0.00004546697,0.000009743529,0.00008769295,0.00013526682,0.00015876119],"category_scores_gemma":[0.0019988213,0.0001622921,0.00017888295,0.0011333039,0.000107511,0.000048387006,0.00004233246,0.00018368353,0.000020018202],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004150107,0.0023860524,0.9548391,0.00006239373,0.00084021344,0.0014713008,0.00065154716,0.008339262,0.021289583,0.0033033662,0.0005204772,0.005881686],"study_design_scores_gemma":[0.0113311475,0.00763831,0.9308422,0.00024151604,0.0065930765,0.00010287529,0.00027315333,0.018958908,0.01874429,0.0006004045,0.004362276,0.0003118237],"about_ca_topic_score_codex":0.00020743514,"about_ca_topic_score_gemma":0.0006909377,"teacher_disagreement_score":0.023996888,"about_ca_system_score_codex":0.00016682247,"about_ca_system_score_gemma":0.00016518225,"threshold_uncertainty_score":0.66180795},"labels":[],"label_agreement":null},{"id":"W2116533092","doi":"10.1093/neuonc/nor140","title":"High expression of BMP pathway genes distinguishes a subset of atypical teratoid/rhabdoid tumors associated with shorter survival","year":2011,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia","funders":"National Cancer Institute","keywords":"Biology; Gene expression profiling; Gene; Choroid plexus; Downregulation and upregulation; Gene expression; Cancer research; DNA microarray; Bioinformatics; Pathology; Genetics; Medicine; Endocrinology; Central nervous system","score_opus":0.022551593659744924,"score_gpt":0.24856637682079932,"score_spread":0.2260147831610544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116533092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99825066,0.00013962963,0.00031024913,0.00002055302,0.00022954177,0.00012889627,0.000048989943,0.000016640815,0.0008548451],"genre_scores_gemma":[0.9986955,0.000039171733,0.00090831815,0.00008473114,0.00012292173,0.000015708421,0.00008003131,0.000028869074,0.000024758887],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986638,0.00021194125,0.00037999966,0.00034905123,0.00016183374,0.00023338494],"domain_scores_gemma":[0.99907756,0.00006455385,0.00028563183,0.0003113338,0.00018769357,0.00007322902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018264295,0.00017565527,0.00038931877,0.00003339765,0.000040149138,0.0000037371258,0.00019931493,0.0002300521,0.000043236672],"category_scores_gemma":[0.00020804003,0.00013823577,0.00009065013,0.00008008624,0.00019623234,0.0000032566518,0.00010487227,0.00012406931,9.4016707e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000668322,0.00025995943,0.023091683,0.000022651468,0.00003529082,0.000022450091,0.00021669269,0.000032017957,0.9731937,0.000024031056,0.00025978117,0.0021734124],"study_design_scores_gemma":[0.00090581784,0.0018213511,0.014815835,0.000052525927,0.000029337576,0.000021633188,0.00010132768,0.000051392726,0.98078346,0.000041615454,0.0012120384,0.00016367932],"about_ca_topic_score_codex":0.00005669919,"about_ca_topic_score_gemma":0.00010978632,"teacher_disagreement_score":0.008275848,"about_ca_system_score_codex":0.000020863512,"about_ca_system_score_gemma":0.0001973951,"threshold_uncertainty_score":0.5637091},"labels":[],"label_agreement":null},{"id":"W2116833686","doi":"10.1093/neuonc/nou208.52","title":"GLIOMA SPECIFIC PEPTIDES: A PLATFORM FOR MOLECULAR IMAGING AND THERAPEUTIC TARGETING","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Glioma; Biopanning; In vivo; Cancer research; Cancer stem cell; Stem cell; Clonogenic assay; Phage display; Biology; Medicine; Peptide library; Immunology; Antibody; Cell biology","score_opus":0.031213077599937036,"score_gpt":0.3313488975852148,"score_spread":0.3001358199852778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116833686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97590244,0.0018654186,0.0015280069,0.010966439,0.00025091696,0.0005735474,0.000006640782,0.000057754496,0.008848849],"genre_scores_gemma":[0.9912065,0.000176013,0.002898852,0.0050362316,0.0004701556,0.000050807368,0.000018183946,0.00003721425,0.000106000974],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99869794,0.00006930565,0.0002447609,0.00034416042,0.00019428656,0.00044952243],"domain_scores_gemma":[0.9987297,0.00075742905,0.00006500961,0.00015999557,0.00009950255,0.00018834442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000363969,0.00015999476,0.00034419156,0.00012979373,0.00013962344,0.000022943474,0.000100149926,0.00008056955,0.00006688373],"category_scores_gemma":[0.00016818983,0.00012820502,0.00010164685,0.00010776097,0.00017738671,0.00003764839,0.000083632876,0.00026569783,0.00003329443],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063431053,0.00007136132,0.003505137,0.00009509499,0.000029803088,0.00022025459,0.00019083619,0.000002089694,0.8738309,0.0031428218,0.0028743541,0.115403004],"study_design_scores_gemma":[0.0022097311,0.0015138742,0.0019112654,0.00002516054,0.000043125594,0.00085158856,0.00017847227,0.0048100054,0.054489132,0.0022096592,0.9315902,0.00016777682],"about_ca_topic_score_codex":0.000015074502,"about_ca_topic_score_gemma":0.0000020597565,"teacher_disagreement_score":0.9287158,"about_ca_system_score_codex":0.000049690836,"about_ca_system_score_gemma":0.000073096395,"threshold_uncertainty_score":0.5228049},"labels":[],"label_agreement":null},{"id":"W2117036448","doi":"10.1093/neuonc/not064","title":"Spontaneous loss of heterozygosity leading to homozygous R132H in a patient-derived IDH1 mutant cell line","year":2013,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Loss of heterozygosity; Mutant; IDH1; Line (geometry); Genetics; Biology; Gene; Mathematics; Allele","score_opus":0.018505605623414623,"score_gpt":0.26809480366051996,"score_spread":0.24958919803710533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117036448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8626897,0.00020937556,0.0000048699103,0.13330285,0.0009095177,0.0019689372,0.000109256296,0.00005857696,0.00074697036],"genre_scores_gemma":[0.74762595,0.00014102003,0.00027353127,0.25064763,0.00067594275,0.00032138097,0.00016478132,0.00011249681,0.000037274134],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99642944,0.00032333672,0.0009889336,0.0009360668,0.0004562028,0.00086603285],"domain_scores_gemma":[0.9974804,0.00077172153,0.0004970286,0.000788588,0.00019661937,0.0002656741],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000099905665,0.000622697,0.0019155575,0.00067926076,0.000052163934,0.000019487876,0.0002783664,0.0011195114,0.00029186797],"category_scores_gemma":[0.00018043007,0.00054494455,0.00032232678,0.00033693598,0.00013386273,0.000042174608,0.00024411896,0.0016134897,0.0003711824],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030702833,0.0013807811,0.0008047634,0.00029413277,0.0000932855,0.33542684,0.00066532736,0.000032686057,0.52547324,9.199451e-7,0.12930934,0.0062116636],"study_design_scores_gemma":[0.006351313,0.015977059,0.00040446568,0.00042480972,0.00057507254,0.027258174,0.00007615663,0.000047154404,0.26403365,0.000023753877,0.6841261,0.0007022876],"about_ca_topic_score_codex":0.0004218827,"about_ca_topic_score_gemma":0.00022945987,"teacher_disagreement_score":0.5548168,"about_ca_system_score_codex":0.0008080667,"about_ca_system_score_gemma":0.00026949623,"threshold_uncertainty_score":0.9997002},"labels":[],"label_agreement":null},{"id":"W2118286342","doi":"10.1093/neuonc/not299","title":"Analysis of IDH mutation, 1p/19q deletion, and PTEN loss delineates prognosis in clinical low-grade diffuse gliomas","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Princess Margaret Cancer Centre; Toronto Western Hospital; SickKids Foundation; Toronto General Hospital; University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"Brain Tumor Funders' Collaborative","keywords":"PTEN; Internal medicine; Glioma; Medicine; Oncology; Tumor progression; Cancer research; Cancer; Biology; Genetics","score_opus":0.025179496498501534,"score_gpt":0.34138489037211844,"score_spread":0.3162053938736169,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118286342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99353456,0.00022405409,0.000089231435,0.0054624463,0.00012411576,0.0004253981,0.000012037343,0.00003362167,0.00009453897],"genre_scores_gemma":[0.99789524,0.00033255506,0.00044645145,0.0010023459,0.00010180491,0.00011434747,0.00008359566,0.00002066237,0.0000030085669],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977366,0.0003852446,0.0009242806,0.0004841157,0.00020548943,0.00026431415],"domain_scores_gemma":[0.9976696,0.0013497357,0.000285276,0.0002808986,0.00021905506,0.00019547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049317343,0.0001893111,0.0009564568,0.0006260562,0.000041652846,0.000011453342,0.000084566636,0.00023100112,0.000042594333],"category_scores_gemma":[0.0009936959,0.00015445183,0.00022248647,0.00095461204,0.00022024123,0.000049809267,0.000056022112,0.00018844966,0.000010090966],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001769344,0.0031931144,0.9625103,0.00003821044,0.00053745037,0.0004099229,0.00020674616,0.00007577983,0.0064716726,0.00013290651,0.000273601,0.025973367],"study_design_scores_gemma":[0.008311014,0.0023834908,0.9616444,0.000036381538,0.0028512608,0.00010987096,0.00007935792,0.011737055,0.008825397,0.0000979831,0.003771761,0.00015202195],"about_ca_topic_score_codex":0.00011097664,"about_ca_topic_score_gemma":0.0004490369,"teacher_disagreement_score":0.025821345,"about_ca_system_score_codex":0.00006636415,"about_ca_system_score_gemma":0.00007712671,"threshold_uncertainty_score":0.6298363},"labels":[],"label_agreement":null},{"id":"W2119000874","doi":"10.1093/neuonc/nop007","title":"A multigene predictor of outcome in glioblastoma","year":2009,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":383,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Dr. Marnie Rose Foundation; National Cancer Institute; Rose Foundation for Communities and the Environment; V Foundation for Cancer Research","keywords":"Glioma; Oncology; Biology; Gene; Microarray; Biomarker; Internal medicine; Cancer research; Gene expression; Medicine; Bioinformatics; Genetics","score_opus":0.02444063387779733,"score_gpt":0.3186730734403417,"score_spread":0.29423243956254436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119000874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99461925,0.00016744406,0.0000037019852,0.002996023,0.00019424324,0.00040246063,0.0000075163243,0.00003562273,0.0015737121],"genre_scores_gemma":[0.9977692,0.000040539147,0.00028663807,0.0017768071,0.00007105452,0.000030106006,0.0000032530481,0.000010550545,0.000011872458],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998953,0.00006008316,0.00039212624,0.00022543858,0.00014177494,0.0002276096],"domain_scores_gemma":[0.9993217,0.00018071155,0.000103684775,0.00023216194,0.00004571777,0.000116038704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000086736174,0.000121659294,0.0004777373,0.00020518349,0.000013783008,0.000002054201,0.00006548346,0.00012744193,0.00009414486],"category_scores_gemma":[0.0001963694,0.00009905478,0.000094212395,0.00020731575,0.000044399516,0.000025420832,0.0000215886,0.00014284259,0.000030537387],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005378132,0.0030239832,0.36147186,0.000021461468,0.000028510589,0.0016231099,0.00030479455,0.000020216929,0.59730124,0.00017303978,0.0009978184,0.034496114],"study_design_scores_gemma":[0.00950399,0.0098023545,0.82266843,0.000033726817,0.0000947936,0.00018354795,0.00004571637,0.00021950385,0.1361195,0.00008632422,0.021145094,0.000096992284],"about_ca_topic_score_codex":0.000025389418,"about_ca_topic_score_gemma":0.000068071065,"teacher_disagreement_score":0.46119657,"about_ca_system_score_codex":0.00013192881,"about_ca_system_score_gemma":0.0000738676,"threshold_uncertainty_score":0.40393364},"labels":[],"label_agreement":null},{"id":"W2120482752","doi":"10.1093/neuonc/nou006","title":"Examination of risk factors for intellectual and academic outcomes following treatment for pediatric medulloblastoma","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":133,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute","keywords":"Medulloblastoma; Medicine; Intellectual disability; Pediatrics; Hearing loss; Borderline intellectual functioning; Psychological intervention; Cognition; Psychiatry; Audiology; Pathology","score_opus":0.03817207200876447,"score_gpt":0.3307903995224173,"score_spread":0.2926183275136528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120482752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972527,0.00017041156,0.00055827195,0.00036789276,0.00037920554,0.0011304342,0.000038033726,0.000030335177,0.00007270074],"genre_scores_gemma":[0.9985635,0.00022598809,0.00061649753,0.00010040039,0.00011360814,0.00030961362,0.000035530324,0.00002516207,0.000009678148],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989952,0.00009710859,0.00030665845,0.00028220954,0.00010221986,0.00021662268],"domain_scores_gemma":[0.99043727,0.00910218,0.00017257582,0.00012692412,0.00005613834,0.000104890474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020281952,0.0001764411,0.00054642477,0.00020817376,0.00007429068,0.0000037642003,0.000043573007,0.0001795516,0.000008408715],"category_scores_gemma":[0.0031138663,0.00012521325,0.00021264124,0.00008990477,0.00003330726,0.00003379784,0.00002055542,0.000081966806,0.0000021110836],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002661544,0.00084256154,0.8324894,0.00007812673,0.00027829784,0.000006537773,0.0038703308,0.000010428792,0.018019587,0.00021126517,0.00046898035,0.14345834],"study_design_scores_gemma":[0.025451072,0.028399229,0.80960023,0.000022586071,0.004175905,0.00002213057,0.0010526767,0.0016184344,0.1075293,0.00033098971,0.021489691,0.00030777353],"about_ca_topic_score_codex":0.000015043595,"about_ca_topic_score_gemma":0.00001798127,"teacher_disagreement_score":0.14315055,"about_ca_system_score_codex":0.00014898834,"about_ca_system_score_gemma":0.000057753205,"threshold_uncertainty_score":0.51060486},"labels":[],"label_agreement":null},{"id":"W2120820093","doi":"10.1093/neuonc/not035","title":"Treating brain tumor-initiating cells using a combination of myxoma virus and rapamycin","year":2013,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation; University of Calgary","funders":"National Institute of Allergy and Infectious Diseases; Canadian Institutes of Health Research; National Cancer Institute; National Institutes of Health; Alberta Innovates; Killam Trusts; Terry Fox Foundation; V Foundation for Cancer Research","keywords":"Oncolytic virus; Myxoma virus; In vivo; Neurosphere; Temozolomide; Biology; Virotherapy; Cancer research; Stem cell; In vitro; Population; Brain tumor; Glioma; Immunology; Medicine; Virus; Pathology; Cell biology; Tumor cells","score_opus":0.023838565774938793,"score_gpt":0.3136653750383318,"score_spread":0.289826809263393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120820093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980042,0.00020006143,0.00011654566,0.00040607358,0.00008760949,0.0003732074,0.000009349879,0.000012315564,0.00079063926],"genre_scores_gemma":[0.997954,0.000043621854,0.00071652856,0.0010705867,0.00010217912,0.000031215408,0.000016949674,0.000033533765,0.000031384912],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99849373,0.00042833266,0.00030278656,0.00033708458,0.00013393308,0.00030413351],"domain_scores_gemma":[0.9991365,0.00020597123,0.00019548422,0.00023341674,0.00013773562,0.00009090102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033108727,0.00015037143,0.00023705598,0.00009951763,0.000099634555,0.00002057827,0.00014434036,0.00014248239,0.00006580329],"category_scores_gemma":[0.00024105725,0.00015447568,0.0000548226,0.00012315637,0.00015007389,0.000009219291,0.00013540975,0.0001532331,0.000009093972],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023593204,0.00009922197,0.00083939254,0.0000238319,0.000020181737,0.000010138922,0.00012769576,0.000055422224,0.9843815,0.000011274676,0.000374617,0.013820813],"study_design_scores_gemma":[0.0013397677,0.0046466743,0.00043957567,0.000007774419,0.000011197093,0.000049848826,0.00013700666,0.0028318567,0.9891177,0.0000812896,0.001206411,0.0001309361],"about_ca_topic_score_codex":0.00014312314,"about_ca_topic_score_gemma":0.00008442239,"teacher_disagreement_score":0.0136898765,"about_ca_system_score_codex":0.000036489026,"about_ca_system_score_gemma":0.00016497516,"threshold_uncertainty_score":0.62993354},"labels":[],"label_agreement":null},{"id":"W2121396361","doi":"10.1093/neuonc/nos273","title":"Standards of care for treatment of recurrent glioblastoma—are we there yet?","year":2012,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":771,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; National Science Foundation","keywords":"Temozolomide; Bevacizumab; Medicine; Oncology; Glioblastoma; Adjuvant; Concomitant; Clinical trial; Internal medicine; Standard of care; Radiation therapy; Chemotherapy; Cancer research","score_opus":0.07411255517976502,"score_gpt":0.4022211541986221,"score_spread":0.3281085990188571,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121396361","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003083644,0.99135774,0.0000020593409,0.00028630855,0.0010679415,0.0036800925,0.0026667917,0.000028200775,0.00060250086],"genre_scores_gemma":[0.0013282141,0.9966251,0.00013973984,0.000020482721,0.00029072686,0.001272671,0.00020660252,0.000096064025,0.000020354431],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976193,0.00023437434,0.0009053917,0.00047745713,0.0003483303,0.0004151581],"domain_scores_gemma":[0.9967436,0.0008930525,0.0010818971,0.000630673,0.00043798174,0.00021279526],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00011525405,0.0005579244,0.004307805,0.00028747667,0.000045155757,0.0000039167744,0.0001394138,0.000523779,0.00015855787],"category_scores_gemma":[0.0000909311,0.00032824077,0.0012702568,0.00021794434,0.000117457545,0.000021480608,0.000054393262,0.0001264579,0.00000993581],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046639005,0.0023220994,0.000104423496,0.02437035,0.0006939591,0.00011638377,0.00042279743,2.3988218e-7,0.000025278612,0.000055308145,0.0016947513,0.969728],"study_design_scores_gemma":[0.0034773517,0.027255803,0.000009145275,0.006062287,0.008347885,0.00012286597,0.00020411542,4.198378e-7,0.00083829573,0.000005794786,0.9534954,0.00018065468],"about_ca_topic_score_codex":0.000010884651,"about_ca_topic_score_gemma":0.00012797954,"teacher_disagreement_score":0.9695474,"about_ca_system_score_codex":0.0014896491,"about_ca_system_score_gemma":0.0012179891,"threshold_uncertainty_score":0.999917},"labels":[],"label_agreement":null},{"id":"W2123369892","doi":"10.1093/neuonc/nor195","title":"Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells","year":2011,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":239,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Institute of Neurological Disorders and Stroke; National Cancer Institute; U.S. Department of Defense","keywords":"Biology; Comparative genomic hybridization; Stem cell; Phenotype; Cancer research; Fluorescence in situ hybridization; Pathology; Neurosphere; Gene; Genetics; Medicine; Chromosome; Cellular differentiation","score_opus":0.023019584431594242,"score_gpt":0.24826747927005874,"score_spread":0.2252478948384645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123369892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931774,0.0004617294,0.0000037030127,0.00026589993,0.00021850942,0.0003775501,0.0000063105254,0.000021142676,0.005467751],"genre_scores_gemma":[0.9982253,0.00013711424,0.00042913467,0.0011019488,0.00003237825,0.000033357035,7.756601e-7,0.000020104464,0.000019933967],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99903935,0.00007091871,0.00028071742,0.00026909928,0.00009953595,0.00024040233],"domain_scores_gemma":[0.99934286,0.00015076806,0.00012314576,0.00021807545,0.00005878423,0.000106353975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000102490914,0.00013144306,0.0004565575,0.00013299569,0.00001649342,0.0000019774293,0.000064248874,0.00008107963,0.00008211717],"category_scores_gemma":[0.000021116095,0.000106447114,0.00004470018,0.00015491998,0.00011241312,0.000031739804,0.000066844616,0.00013828895,0.000033668457],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001978692,0.0020357994,0.09272524,0.00017354326,0.000060757946,0.0035242918,0.0013073228,0.0000019305828,0.84287566,0.0007144838,0.0014410533,0.05316121],"study_design_scores_gemma":[0.009246663,0.010015586,0.2629127,0.00011176045,0.00019554097,0.00045785913,0.00024879523,0.000060428523,0.69169104,0.00021596187,0.024622602,0.00022109628],"about_ca_topic_score_codex":0.00006812315,"about_ca_topic_score_gemma":0.00009438636,"teacher_disagreement_score":0.17018744,"about_ca_system_score_codex":0.00012024657,"about_ca_system_score_gemma":0.00013240687,"threshold_uncertainty_score":0.43407875},"labels":[],"label_agreement":null},{"id":"W2123970979","doi":"10.1093/neuonc/nou040","title":"MRI biomarkers identify the differential response of glioblastoma multiforme to anti-angiogenic therapy","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Toronto Western Hospital; Hospital for Sick Children; Princess Margaret Cancer Centre","funders":"University of Toronto; AstraZeneca","keywords":"Medicine; Sunitinib; Glioma; Vascularity; Bevacizumab; Effective diffusion coefficient; Radiation therapy; Imaging biomarker; Perfusion; Angiogenesis; Vascular permeability; Magnetic resonance imaging; Pathology; Cancer research; Cancer; Internal medicine; Radiology; Chemotherapy","score_opus":0.018589465615267104,"score_gpt":0.31375092532443666,"score_spread":0.29516145970916957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123970979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98729545,0.00012857819,0.00007906983,0.010749771,0.00067454606,0.0008292995,0.000014370954,0.000048565173,0.00018035587],"genre_scores_gemma":[0.99757826,0.000098454715,0.00011752776,0.0018933951,0.00014651283,0.00011029464,0.0000061405935,0.000034478293,0.000014905971],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980802,0.0005353978,0.00038712515,0.00036477082,0.00027584308,0.00035668205],"domain_scores_gemma":[0.9977148,0.0012433416,0.00016190627,0.0005856663,0.000105768,0.00018847117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041421206,0.00021524701,0.0005054571,0.000261693,0.00010005043,0.000015127138,0.00021348492,0.00014864969,0.00020714264],"category_scores_gemma":[0.00036429375,0.00013345284,0.00029550644,0.00033355717,0.00015308571,0.0000316458,0.00009764099,0.00012810607,0.0001304848],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054743513,0.00084122,0.0169313,0.000009262287,0.0002797801,0.0000999061,0.0003860125,0.0000074664918,0.9490781,0.0000453537,0.005097824,0.021749435],"study_design_scores_gemma":[0.0066008708,0.0067096623,0.39446816,0.000023971112,0.00019777445,0.00016274165,0.000088641485,0.00017756352,0.5085951,0.000021003332,0.08282147,0.00013303562],"about_ca_topic_score_codex":0.000040140803,"about_ca_topic_score_gemma":0.0000368618,"teacher_disagreement_score":0.44048297,"about_ca_system_score_codex":0.00009530043,"about_ca_system_score_gemma":0.00010379347,"threshold_uncertainty_score":0.54420483},"labels":[],"label_agreement":null},{"id":"W2124556650","doi":"10.1093/neuonc/nos302","title":"On-target JAK2/STAT3 inhibition slows disease progression in orthotopic xenografts of human glioblastoma brain tumor stem cells","year":2012,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotchkiss Brain Institute; University of Calgary","funders":"","keywords":"Cancer research; STAT3; Small hairpin RNA; PTEN; STAT protein; Stem cell; Cancer stem cell; Janus kinase 2; Biology; Medicine; PI3K/AKT/mTOR pathway; Gene knockdown; Cell culture; Signal transduction; Cell biology","score_opus":0.01765711850265834,"score_gpt":0.30953239390315995,"score_spread":0.2918752754005016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124556650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958151,0.00025691357,0.0000022389113,0.0016326932,0.00042220135,0.0011502446,0.000026758744,0.00005106745,0.0006427939],"genre_scores_gemma":[0.997712,0.00001176132,0.00009735067,0.0016443869,0.00017707516,0.00027306206,0.00003208088,0.000034519497,0.000017756603],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981665,0.00027930224,0.0004669027,0.00033745606,0.000286229,0.00046360717],"domain_scores_gemma":[0.99866885,0.00032446778,0.00023092424,0.00032954352,0.000056333814,0.00038988286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021670673,0.00022729482,0.0004936294,0.00032939238,0.00006259354,0.000006642981,0.00006166059,0.00011180184,0.00018967912],"category_scores_gemma":[0.00006423859,0.00018424567,0.00012990594,0.00026759342,0.00009738369,0.00010890385,0.00006258963,0.00023603984,0.000055084587],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013185323,0.009631037,0.21812974,0.00024494997,0.00003903625,0.0029210395,0.00068682706,0.00001856006,0.74810874,0.0009450848,0.0071412693,0.010815174],"study_design_scores_gemma":[0.011955763,0.01163378,0.14977573,0.00052959914,0.00017638628,0.000100870486,0.0001712317,0.000072048926,0.79400945,0.00024220512,0.031013548,0.00031936713],"about_ca_topic_score_codex":0.0000123431655,"about_ca_topic_score_gemma":0.000035997702,"teacher_disagreement_score":0.06835401,"about_ca_system_score_codex":0.00020482863,"about_ca_system_score_gemma":0.00011743889,"threshold_uncertainty_score":0.75133204},"labels":[],"label_agreement":null},{"id":"W2125940163","doi":"10.1093/neuonc/nou359","title":"In vitro screen of a small molecule inhibitor drug library identifies multiple compounds that synergize with oncolytic myxoma virus against human brain tumor-initiating cells","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Institute of Allergy and Infectious Diseases; Canadian Institutes of Health Research; National Cancer Institute; National Institutes of Health; University of Calgary; Alberta Innovates; Killam Trusts; Terry Fox Foundation; V Foundation for Cancer Research","keywords":"Oncolytic virus; Myxoma virus; Glioma; Biology; Cancer research; Virus; Virology; Pharmacology","score_opus":0.029046311817346085,"score_gpt":0.2854235973629419,"score_spread":0.25637728554559586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125940163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99596244,0.00028168468,0.0000219537,0.0007442484,0.00018557327,0.0006180902,0.000086115084,0.00004207729,0.0020578008],"genre_scores_gemma":[0.9953648,0.00004339502,0.0005329337,0.003141465,0.00028416558,0.000092819464,0.00020707065,0.00011470817,0.00021863534],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996863,0.00087629684,0.00054026186,0.0007047999,0.0003616969,0.0006539235],"domain_scores_gemma":[0.9983492,0.00030203845,0.00032823146,0.0006140225,0.00012426535,0.00028222686],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00056166755,0.0003548638,0.0005790446,0.000264158,0.00010492364,0.0000563718,0.0006195716,0.00021913325,0.000016265132],"category_scores_gemma":[0.00017776868,0.0003469554,0.0001270449,0.00031515525,0.00039124544,0.000034532073,0.00048303045,0.00043635687,0.000015755866],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004761648,0.00037904803,0.0011373617,0.000037219947,0.00005892545,0.00046569493,0.00046507164,0.0002521724,0.9859638,0.0000036967815,0.0060701817,0.00040515454],"study_design_scores_gemma":[0.004271662,0.004245491,0.00012394234,0.000031664844,0.0000130965345,0.00004381991,0.00054983114,0.0003287871,0.98277277,0.000031210224,0.0072570057,0.0003307004],"about_ca_topic_score_codex":0.0001904205,"about_ca_topic_score_gemma":0.0018151114,"teacher_disagreement_score":0.0038664432,"about_ca_system_score_codex":0.000098621356,"about_ca_system_score_gemma":0.00089839916,"threshold_uncertainty_score":0.99989825},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"bench_or_experimental","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"gpt","categories":[],"domain":null,"study_design":"bench_or_experimental","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W2128083719","doi":"10.1093/neuonc/nor207","title":"An in vivo patient-derived model of endogenous IDH1-mutant glioma","year":2011,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":205,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotchkiss Brain Institute; University of Calgary","funders":"","keywords":"Isocitrate dehydrogenase; Glioma; Cancer research; Endogeny; Cell culture; IDH1; Biology; Mutation; In vivo; Mutant; Biochemistry; Genetics; Enzyme; Gene","score_opus":0.06041709320469471,"score_gpt":0.2824694758448996,"score_spread":0.2220523826402049,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128083719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957295,0.000093932365,0.000015849273,0.00016217801,0.00016341293,0.000519362,0.000026908363,0.00003794549,0.003250912],"genre_scores_gemma":[0.9983492,0.00005148807,0.00088229583,0.0005601989,0.00002564795,0.00009661476,0.000006116021,0.00002830308,1.5448305e-7],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99869275,0.00010823095,0.00040586607,0.00032142928,0.00015535735,0.00031638693],"domain_scores_gemma":[0.9991163,0.00008918291,0.0001534852,0.00038473637,0.000079138925,0.00017712709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007271309,0.00016820994,0.00050096144,0.00023236756,0.000028137132,0.00000249726,0.000104368824,0.00014861827,0.00020181415],"category_scores_gemma":[0.000055875236,0.00014118545,0.00008709369,0.00017939534,0.00008698959,0.000055325087,0.000047156336,0.00013222558,0.000014990438],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004403806,0.0033209655,0.007570331,0.000016775402,0.000036178037,0.0019725238,0.0028001345,0.000067645495,0.9775236,0.00021187811,0.000059027407,0.0059805354],"study_design_scores_gemma":[0.0032741432,0.0053917924,0.00046190247,0.000014189819,0.00009347369,0.00038572997,0.0002276152,0.0014690757,0.98804647,0.00020286985,0.0003366069,0.00009615823],"about_ca_topic_score_codex":0.00020246007,"about_ca_topic_score_gemma":0.00012656339,"teacher_disagreement_score":0.010522818,"about_ca_system_score_codex":0.00012876216,"about_ca_system_score_gemma":0.00019032681,"threshold_uncertainty_score":0.57573754},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"bench_or_experimental","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"bench_or_experimental","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"agree"},{"id":"W2130495311","doi":"10.1093/neuonc/noq031","title":"Oligodendroglioma cell lines containing t(1;19)(q10;p10)","year":2010,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Science Council","keywords":"Oligodendroglioma; Temozolomide; Chromosomal translocation; Cell culture; Cancer research; Biology; Glioma; Genetics; Gene; Astrocytoma","score_opus":0.022648893968583862,"score_gpt":0.30956828045704465,"score_spread":0.28691938648846077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130495311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96559364,0.00022486498,0.000011141284,0.007084817,0.001674655,0.00045037808,0.00000950148,0.00015716597,0.02479386],"genre_scores_gemma":[0.9932026,0.0000715046,0.001027954,0.0046634115,0.00073854695,0.00012512326,0.00002537982,0.00004797515,0.0000974571],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984348,0.00007868152,0.00035609194,0.00045689248,0.00020923156,0.00046433526],"domain_scores_gemma":[0.99829495,0.00057113665,0.00014836442,0.0004615495,0.00012473212,0.00039926395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016287858,0.00024805786,0.00053812814,0.00021393162,0.00012277997,0.000022592798,0.00014316119,0.00030164781,0.00050073944],"category_scores_gemma":[0.00031339691,0.00020547224,0.00016499839,0.00021296852,0.00016399866,0.000056119687,0.00009344893,0.00053076877,0.0003791434],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019573692,0.001109156,0.03745063,0.000028753411,0.000050152106,0.003932564,0.0002881449,0.0000036177046,0.93191767,0.000805717,0.008300527,0.015917337],"study_design_scores_gemma":[0.007097569,0.0033090706,0.008917059,0.000014594488,0.000269115,0.0017196113,0.00016702195,0.00019356555,0.41874468,0.00012773316,0.55921555,0.00022442368],"about_ca_topic_score_codex":0.000060089154,"about_ca_topic_score_gemma":0.00013085143,"teacher_disagreement_score":0.55091506,"about_ca_system_score_codex":0.00008904291,"about_ca_system_score_gemma":0.00027829196,"threshold_uncertainty_score":0.83789146},"labels":[],"label_agreement":null},{"id":"W2130591352","doi":"10.1093/neuonc/nor074","title":"Neurocytomas: Long-term experience of a single institution","year":2011,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Central neurocytoma; Perioperative; Radiation therapy; Surgery; Retrospective cohort study; Radiology; Magnetic resonance imaging","score_opus":0.0641008755961378,"score_gpt":0.31643132499709875,"score_spread":0.25233044940096094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130591352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887219,0.00012343965,0.000040827454,0.00021160996,0.00042653296,0.0002967003,0.00000227651,0.0000491264,0.010127595],"genre_scores_gemma":[0.9988846,0.000051473664,0.00024985697,0.0006883103,0.000055191114,0.000046838017,0.000004518368,0.000012204883,0.0000069985517],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99913466,0.000051958723,0.00024715962,0.000248289,0.00012553562,0.00019240793],"domain_scores_gemma":[0.99935853,0.000072231865,0.00011849768,0.0002664801,0.000068834495,0.00011544318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003639326,0.00011653004,0.0002926432,0.0001068871,0.000036994017,0.0000029389512,0.00008009897,0.00009471014,0.00019782936],"category_scores_gemma":[0.00010835112,0.00009681513,0.000078635545,0.00014878986,0.00017708985,0.000066979745,0.000051743373,0.00009053995,0.000040428127],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026609263,0.0025112124,0.22036147,0.000028023087,0.00002557567,0.0018406505,0.0017981878,5.4232345e-7,0.755306,0.00035545285,0.00012883202,0.017377963],"study_design_scores_gemma":[0.0023585998,0.0044468683,0.29152098,0.00003204293,0.00010588143,0.000622503,0.00007968322,0.000008226031,0.6962791,0.000019248431,0.004446255,0.00008058027],"about_ca_topic_score_codex":0.000034157572,"about_ca_topic_score_gemma":0.00003035169,"teacher_disagreement_score":0.071159504,"about_ca_system_score_codex":0.00009408075,"about_ca_system_score_gemma":0.00010076198,"threshold_uncertainty_score":0.39480063},"labels":[],"label_agreement":null},{"id":"W2130848213","doi":"10.1215/15228517-2008-011","title":"Assessment of benign tumor burden by whole-body MRI in patients with neurofibromatosis 1","year":2008,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":256,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Neurofibromatosis; Medicine; Neurofibroma; Plexiform neurofibroma; Radiology; Magnetic resonance imaging","score_opus":0.012515482150267057,"score_gpt":0.2689377881506768,"score_spread":0.25642230600040977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130848213","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99417627,0.000034371038,0.00001876036,0.0015023956,0.00019695202,0.00078584405,0.0000657957,0.00006718468,0.0031524524],"genre_scores_gemma":[0.9976849,0.000031901756,0.00084542576,0.0011206262,0.000061744795,0.000060817285,0.00007607423,0.000065664135,0.000052872845],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973876,0.0002842036,0.00069832534,0.00060361665,0.00055956165,0.00046669797],"domain_scores_gemma":[0.9983889,0.00034289248,0.0003308439,0.00053945335,0.00015584797,0.00024208458],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000116224925,0.00030974683,0.00092922035,0.0002669135,0.000084438936,0.00000891536,0.00019792431,0.00013016144,0.0001027209],"category_scores_gemma":[0.0000843276,0.00025622695,0.00011656098,0.00043213816,0.00024306563,0.00013098434,0.00010938455,0.0004229177,0.000020530462],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000516691,0.001299944,0.6943121,0.00007680585,0.00003319749,0.00118119,0.000103032806,0.00002137838,0.28971756,0.00005678831,0.012449746,0.00023159476],"study_design_scores_gemma":[0.008571066,0.012459847,0.9240273,0.000079309706,0.000094207906,0.0006967938,0.000056595232,0.00020178856,0.020248448,0.0000052787036,0.033289015,0.00027032284],"about_ca_topic_score_codex":0.00006556229,"about_ca_topic_score_gemma":0.000004100295,"teacher_disagreement_score":0.2694691,"about_ca_system_score_codex":0.00012404849,"about_ca_system_score_gemma":0.0004097064,"threshold_uncertainty_score":0.999989},"labels":[],"label_agreement":null},{"id":"W2131896426","doi":"10.1093/neuonc/nov117","title":"Multicenter imaging outcomes study of The Cancer Genome Atlas glioblastoma patient cohort: imaging predictors of overall and progression-free survival","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre","funders":"University of Texas MD Anderson Cancer Center","keywords":"Glioblastoma; Atlas (anatomy); Medicine; Oncology; Cohort; Progression-free survival; Overall survival; Neuroimaging; Internal medicine; Magnetic resonance imaging; Radiology; Cancer research; Psychiatry","score_opus":0.015959315808974972,"score_gpt":0.3054914232176733,"score_spread":0.28953210740869834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131896426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946886,0.0005184278,5.792108e-7,0.0021372375,0.000917519,0.0014682836,0.000025670195,0.000022577864,0.00022111186],"genre_scores_gemma":[0.9993672,0.000028942013,0.000042255968,0.00031939245,0.00005546424,0.0001562132,0.0000020557147,0.000025049909,0.000003463035],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982771,0.00021515106,0.00044959347,0.00034324327,0.00046900043,0.00024589754],"domain_scores_gemma":[0.9985421,0.00024729822,0.00033666776,0.00049875176,0.00021337191,0.00016184074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018086597,0.00019187483,0.0005530843,0.00010155033,0.00004887336,0.00000804935,0.00016479885,0.000039699986,0.000016173752],"category_scores_gemma":[0.00027427153,0.000114025155,0.00008460178,0.00011393749,0.00016216264,0.000055837838,0.0004146657,0.00014884428,8.339805e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033751898,0.0023916932,0.9773842,0.000026867074,0.00019158481,0.00015174538,0.0025342915,0.000027033211,0.013014055,0.00000396876,0.0005097379,0.0034273022],"study_design_scores_gemma":[0.009766295,0.001912848,0.9800178,0.000051544852,0.00042927885,0.000028835564,0.0010763955,0.0001883803,0.004589046,0.000008458331,0.0018471273,0.00008401357],"about_ca_topic_score_codex":0.0003848881,"about_ca_topic_score_gemma":0.00023304934,"teacher_disagreement_score":0.009428776,"about_ca_system_score_codex":0.000171959,"about_ca_system_score_gemma":0.00014644327,"threshold_uncertainty_score":0.46498108},"labels":[],"label_agreement":null},{"id":"W2132260377","doi":"10.1093/neuonc/nou368","title":"Much debated controversies of diffuse low-grade gliomas","year":2015,"lang":"en","type":"editorial","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto; University Health Network","funders":"","keywords":"Intervention (counseling); Medicine; Intensive care medicine; Psychology; Psychiatry","score_opus":0.018255075580783906,"score_gpt":0.30664264157433213,"score_spread":0.2883875659935482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132260377","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10042729,0.0024169306,0.000001521317,0.0031377573,0.8879338,0.001327561,0.00051818066,0.00016417526,0.0040727644],"genre_scores_gemma":[0.15388744,0.0018989578,0.00017431639,0.0012274612,0.8395928,0.00037710843,0.0022090715,0.0002862648,0.00034654845],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99692714,0.0002659694,0.0006996365,0.00066350785,0.00090854126,0.00053521845],"domain_scores_gemma":[0.99318343,0.0043406296,0.00059723086,0.00069805863,0.00077942637,0.00040122127],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00022634758,0.0005137565,0.0018959972,0.00042873644,0.000053569758,0.000015930098,0.00026379913,0.0015645195,0.00011372295],"category_scores_gemma":[0.0046515344,0.00042200278,0.0003497767,0.00030838564,0.0002784421,0.000048365862,0.00016278922,0.000843561,0.000094399],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009315033,0.0031405727,0.00038491393,0.00017687473,0.00049345294,0.0027970502,0.00018648803,0.000001141859,0.034645256,0.000033568554,0.9558773,0.0013318805],"study_design_scores_gemma":[0.020670237,0.0048332815,0.00008347155,0.00012779032,0.001277353,0.00006806372,0.000080842125,0.000015732117,0.0140236765,0.00005914125,0.9585159,0.0002445107],"about_ca_topic_score_codex":0.00022191084,"about_ca_topic_score_gemma":0.000112883994,"teacher_disagreement_score":0.053460144,"about_ca_system_score_codex":0.00070033723,"about_ca_system_score_gemma":0.0016434403,"threshold_uncertainty_score":0.99982315},"labels":[],"label_agreement":null},{"id":"W2133195344","doi":"10.1093/neuonc/nos106","title":"QUALITY OF LIFE/AFTERCARE","year":2012,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glutathione Transferases and Polymorphisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Quality (philosophy); Quality of life (healthcare); Psychology; Medicine; Psychotherapist; Physics","score_opus":0.029708902673446985,"score_gpt":0.3120218554905155,"score_spread":0.2823129528170685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133195344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99338895,0.0014139375,0.00037177838,0.0005025553,0.00057085586,0.00011579029,0.000040148923,0.000011801654,0.0035841835],"genre_scores_gemma":[0.99693084,0.00017728854,0.00039876136,0.0019757398,0.0003960343,0.000014960894,0.000042695523,0.000018044862,0.000045611218],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99890506,0.00023130234,0.00029289452,0.00018824245,0.000095268115,0.00028723237],"domain_scores_gemma":[0.99933684,0.000061204104,0.00008380762,0.00028971522,0.00005383954,0.00017457681],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024025263,0.00011968577,0.00023650248,0.000027747548,0.000034319135,0.0000028844058,0.00014270183,0.00020499247,0.00011229547],"category_scores_gemma":[0.000138345,0.00011219992,0.00013026486,0.00005406643,0.000091587804,0.0000036678748,0.00006159467,0.00010606501,0.000028958148],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021522403,0.00015500777,0.02312352,0.000018916735,0.000023371182,0.0000016998031,0.00012866595,0.000004959023,0.97023994,0.00026198002,0.0019642313,0.0038624683],"study_design_scores_gemma":[0.0013848535,0.001188748,0.03375245,0.0000032364771,0.000029198072,0.000044097596,0.00014085873,0.0000037713817,0.42964518,0.000034579014,0.5335275,0.0002455534],"about_ca_topic_score_codex":0.000040997264,"about_ca_topic_score_gemma":0.00002829485,"teacher_disagreement_score":0.54059476,"about_ca_system_score_codex":0.000011304538,"about_ca_system_score_gemma":0.000113846545,"threshold_uncertainty_score":0.457538},"labels":[],"label_agreement":null},{"id":"W2133449257","doi":"10.1215/15228517-2006-029","title":"Malignant and benign ganglioglioma: A pathological and molecular study1","year":2007,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University Health Network","funders":"","keywords":"Ganglioglioma; Malignant transformation; Biology; Malignancy; Comparative genomic hybridization; Pathology; Cancer research; Gene; Genetics; Medicine; Neuroscience; Genome; Epilepsy","score_opus":0.019748180447118704,"score_gpt":0.30348766105758634,"score_spread":0.28373948061046766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133449257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925866,0.0015985388,0.000054258562,0.0028958055,0.00012401117,0.00046651508,0.000004010883,0.00005212418,0.0022181172],"genre_scores_gemma":[0.9958327,0.00018753225,0.0008708571,0.0029781505,0.000066409644,0.000036145153,0.000004748788,0.000018320814,0.000005151103],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987637,0.00008712643,0.00023823313,0.00042004054,0.00015058563,0.00034030562],"domain_scores_gemma":[0.99910873,0.0003171989,0.00006263399,0.00019374219,0.00005022832,0.0002674778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002937381,0.00017268497,0.00040090826,0.0001673463,0.0000675665,0.000012594109,0.000040817646,0.00017513664,0.000032186803],"category_scores_gemma":[0.00014822639,0.00012657263,0.00005344156,0.0001654569,0.0001588773,0.000024004486,0.00010141939,0.00016095105,0.000011506533],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029114785,0.0012342191,0.08072937,0.000022860802,0.00006853617,0.05085461,0.000341553,2.893677e-7,0.8272429,0.0020753287,0.0005655113,0.036573634],"study_design_scores_gemma":[0.019554876,0.020001277,0.5556518,0.000061348226,0.00096786296,0.019843584,0.0011155034,0.000046133788,0.2860905,0.0016537356,0.09445121,0.000562169],"about_ca_topic_score_codex":0.000010722365,"about_ca_topic_score_gemma":0.000014374027,"teacher_disagreement_score":0.5411525,"about_ca_system_score_codex":0.00005278535,"about_ca_system_score_gemma":0.000035681707,"threshold_uncertainty_score":0.5161482},"labels":[],"label_agreement":null},{"id":"W2134221589","doi":"10.1093/neuonc/nos222","title":"LAB-EXPERIMENTAL (PRE-CLINICAL) THERAPEUTICS AND PHARMACOLOGY","year":2012,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Ginseng Biological Effects and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Calgary; University of British Columbia","funders":"","keywords":"Pharmacology; Clinical pharmacology; Medicine","score_opus":0.039738524084344695,"score_gpt":0.39115454891691565,"score_spread":0.35141602483257095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134221589","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930892,0.0019776726,0.0002023678,0.0012612144,0.0006668886,0.0002877098,0.000009831209,0.00002724751,0.0024778938],"genre_scores_gemma":[0.98551273,0.0008756893,0.0006109548,0.011925701,0.00086654467,0.000078898316,0.00003069437,0.000017162858,0.00008162455],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987687,0.00031130842,0.00022604445,0.00031405318,0.000046602094,0.00033332853],"domain_scores_gemma":[0.99934566,0.00017357121,0.00008617495,0.00019001118,0.000027144539,0.00017743093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029029325,0.0001455563,0.00020080875,0.000017816403,0.00009521454,0.0000075919284,0.00014297856,0.00031431075,0.000091170936],"category_scores_gemma":[0.00003957285,0.00011750734,0.00006761567,0.000048484235,0.00027616462,0.000003542174,0.00018828826,0.00019523244,0.00003107815],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008537881,0.00044447492,0.0046923445,0.0000027364038,0.000038778857,0.0000018850174,0.00004129212,0.0000011018066,0.97847384,0.00023708506,0.0053067086,0.010674385],"study_design_scores_gemma":[0.0005960314,0.0012542949,0.0029498192,4.4727082e-7,0.000026592561,0.000040490995,0.00002759089,0.000030303785,0.34859017,0.000011177223,0.6463698,0.00010325858],"about_ca_topic_score_codex":0.000004210152,"about_ca_topic_score_gemma":0.0000016900855,"teacher_disagreement_score":0.6410631,"about_ca_system_score_codex":0.000013939082,"about_ca_system_score_gemma":0.000039685463,"threshold_uncertainty_score":0.47918102},"labels":[],"label_agreement":null},{"id":"W2134543408","doi":"10.1093/neuonc/nou239.2","title":"BI-02 * FUNCTIONAL CHARACTERIZATION OF NOVEL BIOMARKERS IN SELECTING FOR SUBTYPE SPECIFIC MEDULLOBLASTOMA PHENOTYPES","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Manitoba","funders":"","keywords":"Sonic hedgehog; Medulloblastoma; Phenotype; Biology; Cancer research; Flow cytometry; Cell sorting; Wnt signaling pathway; Population; Transcriptome; Cell; Computational biology; Molecular biology; Genetics; Gene expression; Gene; Medicine","score_opus":0.02694358005785323,"score_gpt":0.2629105043238488,"score_spread":0.23596692426599558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134543408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97889006,0.000060405124,0.019382041,0.0002798641,0.00064631784,0.00026169137,0.000023352113,0.000015201361,0.0004410591],"genre_scores_gemma":[0.9978134,0.000035918947,0.001204088,0.00029920705,0.00041191035,0.000048788723,0.00013699381,0.000027980734,0.000021724461],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989065,0.00009687464,0.00030995562,0.00035954049,0.00008675963,0.0002403517],"domain_scores_gemma":[0.9992942,0.00016844968,0.00018773605,0.00015569289,0.0001538835,0.000040010993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034089366,0.0001388522,0.00023588595,0.00010960113,0.00006283981,0.0000058492433,0.000108196145,0.00018003704,0.000010254165],"category_scores_gemma":[0.00047714295,0.00014402728,0.00006641488,0.00016732687,0.00009120965,0.000004098507,0.00006140952,0.00008136491,0.000003794761],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040594093,0.00013693652,0.00303271,0.000024591187,0.000045964618,6.650427e-7,0.000075512675,0.000073921525,0.98912287,0.00011826949,0.00029339598,0.006669198],"study_design_scores_gemma":[0.0016026286,0.0012558076,0.011220447,0.000011148185,0.000015791009,0.000014530502,0.00004619353,0.00071413536,0.863167,0.000021545167,0.12176705,0.00016371901],"about_ca_topic_score_codex":0.000005152129,"about_ca_topic_score_gemma":0.00004925369,"teacher_disagreement_score":0.1259559,"about_ca_system_score_codex":0.00003486619,"about_ca_system_score_gemma":0.00011056765,"threshold_uncertainty_score":0.58732617},"labels":[],"label_agreement":null},{"id":"W2135285906","doi":"10.1093/neuonc/not179","title":"MEDICAL RADIATION THERAPIES","year":2013,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Infrared Thermography in Medicine","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Sunnybrook Health Science Centre; Western University; Mount Sinai Hospital","funders":"","keywords":"Medical radiation; Medicine; Medical physics","score_opus":0.012891558357255953,"score_gpt":0.296822660967957,"score_spread":0.28393110261070104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135285906","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8706498,0.00086686463,0.00019625109,0.068631105,0.0015954147,0.0008608148,0.0000017008882,0.00026297587,0.056935042],"genre_scores_gemma":[0.95933115,0.000557757,0.0006843459,0.0378816,0.0012037326,0.00013840983,0.000021463886,0.000037697686,0.00014381003],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984322,0.00018481536,0.00032683884,0.0002484138,0.0004806898,0.00032704527],"domain_scores_gemma":[0.9986666,0.00048379877,0.000097223354,0.0003189231,0.00012536772,0.00030812045],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031280084,0.00014791758,0.00037485734,0.00019354328,0.0000593667,0.00000775048,0.00015099489,0.00031808115,0.008443891],"category_scores_gemma":[0.0007741502,0.000112474074,0.00009483065,0.00024717316,0.00026956157,0.00007668614,0.000036314268,0.0005343242,0.0006747729],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014703187,0.00032213543,0.020097231,0.000036384314,0.00011779801,0.00043234497,0.0015256886,5.724315e-7,0.25652406,0.001121871,0.09226369,0.6274112],"study_design_scores_gemma":[0.0058484045,0.0035320825,0.08227543,0.000049813236,0.00011898793,0.0013862569,0.000490825,0.0004469937,0.0079576,0.0016354368,0.896041,0.00021719436],"about_ca_topic_score_codex":0.000045543446,"about_ca_topic_score_gemma":0.0000031378897,"teacher_disagreement_score":0.8037773,"about_ca_system_score_codex":0.00008478178,"about_ca_system_score_gemma":0.00028523864,"threshold_uncertainty_score":0.9924625},"labels":[],"label_agreement":null},{"id":"W2135404870","doi":"10.1093/neuonc/nou035","title":"GBM's multifaceted landscape: highlighting regional and microenvironmental heterogeneity","year":2014,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":153,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; Toronto Western Hospital; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Geography; Environmental planning; Economic geography","score_opus":0.024952359616641943,"score_gpt":0.3057051957899572,"score_spread":0.28075283617331526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135404870","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004352574,0.99287933,0.000023855497,0.00009945339,0.0017179422,0.0005220203,0.000084093896,0.000023667499,0.0002970328],"genre_scores_gemma":[0.00017618887,0.994391,0.00033893035,0.0008345305,0.003302911,0.000110129586,0.00061318517,0.00009159008,0.00014151166],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973824,0.00046351948,0.0005406864,0.0009962278,0.00014225046,0.00047493321],"domain_scores_gemma":[0.998707,0.00010068681,0.00043398264,0.0005155426,0.000025041112,0.00021774306],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022075842,0.0005274645,0.0013654372,0.00009325187,0.00013311274,0.000026797103,0.00031470272,0.0008594949,0.000031469997],"category_scores_gemma":[0.0000715225,0.0004741423,0.00041034675,0.00006966594,0.00021852969,0.0000036593458,0.00038821108,0.0004059916,0.00004476959],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005582097,0.000107104264,0.000032030548,0.001144242,0.0001950221,0.000014846697,0.000023076525,0.0000013818418,0.09665681,0.000012895182,0.019236535,0.88252026],"study_design_scores_gemma":[0.0008244774,0.00033754177,0.000019624327,0.00013903875,0.00037846822,0.00078711694,0.000007895289,0.0000040834766,0.0011684343,0.0000016123495,0.9959174,0.000414302],"about_ca_topic_score_codex":0.00001046242,"about_ca_topic_score_gemma":0.000036067446,"teacher_disagreement_score":0.9766809,"about_ca_system_score_codex":0.000053806696,"about_ca_system_score_gemma":0.00021788562,"threshold_uncertainty_score":0.999771},"labels":[],"label_agreement":null},{"id":"W2135465849","doi":"10.1093/neuonc/nou087","title":"The epidemiology of glioma in adults: a \"state of the science\" review","year":2014,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2281,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Cancer Institute; National Institutes of Health; Government of Canada; Case Comprehensive Cancer Center, Case Western Reserve University","keywords":"Glioma; Oncology; Medicine; Internal medicine; DNA methylation; Biology; Cancer research; Genetics; Gene","score_opus":0.060195946125080474,"score_gpt":0.3987883958102149,"score_spread":0.33859244968513447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135465849","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007431467,0.99157196,3.4078877e-7,0.0037874428,0.0006201907,0.0024100665,0.000018952336,0.000008074722,0.0008398213],"genre_scores_gemma":[0.0006795688,0.99765867,0.000034454722,0.0011144056,0.00005977264,0.00041391043,0.0000065151494,0.000026407688,0.0000063069115],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99497527,0.0018701517,0.0018684474,0.0005268004,0.00027269626,0.00048664745],"domain_scores_gemma":[0.9902135,0.006459977,0.0018163916,0.0011840711,0.00021142913,0.00011460095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032035362,0.00032924506,0.004016239,0.00026605182,0.000083151885,0.0000016671981,0.00074618007,0.00020588483,0.000017641807],"category_scores_gemma":[0.0077232206,0.00014208032,0.00073841214,0.0013874336,0.0014449608,0.00001891445,0.0003063329,0.00053164084,0.000021004234],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026578284,0.00027254876,0.00036501966,0.02238224,0.000066244924,0.0000633304,0.000026143733,3.185998e-7,0.00003205946,0.00049717946,0.0013863677,0.97488195],"study_design_scores_gemma":[0.00077038794,0.0009293093,0.00038388616,0.045630347,0.0008230894,0.00046199354,0.0000038910794,0.000004082623,0.00005144213,0.00014303147,0.9507098,0.000088738314],"about_ca_topic_score_codex":0.000053876352,"about_ca_topic_score_gemma":0.000074490046,"teacher_disagreement_score":0.97479326,"about_ca_system_score_codex":0.00027894718,"about_ca_system_score_gemma":0.0015229179,"threshold_uncertainty_score":0.92459744},"labels":[],"label_agreement":null},{"id":"W2135637880","doi":"10.1093/neuonc/not052","title":"Enhancing drug delivery for boron neutron capture therapy of brain tumors with focused ultrasound","year":2013,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Boron Compounds in Chemistry","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"National Institute of Biomedical Imaging and Bioengineering; Health Canada; National Institutes of Health","keywords":"Microbubbles; Gliosarcoma; Ultrasound; Collateral damage; Neutron capture; Focused ultrasound; Drug delivery; Brain tumor; Medicine; Chemistry; Nuclear medicine; Glioma; Boron; Cancer research; Pathology; Radiology","score_opus":0.014119299725019612,"score_gpt":0.2718150870366111,"score_spread":0.2576957873115915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135637880","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98970413,0.0003138683,0.00013967094,0.0064118444,0.00023386661,0.0010884979,0.00001120891,0.000088797846,0.0020080858],"genre_scores_gemma":[0.9906459,0.00006660281,0.0042894483,0.0041546295,0.00033156425,0.00020079695,0.000028020751,0.00007391647,0.00020912537],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983593,0.000092127775,0.00041188693,0.00044280422,0.00022477904,0.00046910183],"domain_scores_gemma":[0.9967675,0.0020423518,0.00027020666,0.00048123454,0.00026345105,0.00017526107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021718458,0.0002607239,0.0006099558,0.0000657589,0.00006690936,0.000013210644,0.00020600195,0.00022089721,0.00021206892],"category_scores_gemma":[0.00023010727,0.0002098018,0.00011886725,0.00012989702,0.00021715446,0.000100338766,0.00003359936,0.0004400774,0.000011239133],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007392658,0.00023334948,0.002483002,0.000111848116,0.000058636237,0.00003431195,0.0006932402,0.00000712209,0.9772683,0.000016189548,0.014120219,0.0042345407],"study_design_scores_gemma":[0.005864105,0.0022997248,0.004032962,0.00007773804,0.000054726588,0.00039163834,0.00058827765,0.000051495095,0.95221937,0.00013779888,0.03405711,0.00022503555],"about_ca_topic_score_codex":0.00026114,"about_ca_topic_score_gemma":0.00018942538,"teacher_disagreement_score":0.025048885,"about_ca_system_score_codex":0.00021988493,"about_ca_system_score_gemma":0.0005368598,"threshold_uncertainty_score":0.85554695},"labels":[],"label_agreement":null},{"id":"W2138178015","doi":"10.1093/neuonc/nou362","title":"ADAM-9 is a novel mediator of tenascin-C-stimulated invasiveness of brain tumor–initiating cells","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Canadian Institutes of Health Research; Alberta Innovates; Alberta Cancer Foundation; University of Calgary","keywords":"Glioma; Biology; Gene knockdown; Tenascin C; Cancer research; CYR61; Proteases; Microarray analysis techniques; Extracellular matrix; Cell culture; Gene expression; Cell biology; Molecular biology; Gene; Genetics; Growth factor; Biochemistry","score_opus":0.07177215241205709,"score_gpt":0.3545024900550746,"score_spread":0.2827303376430175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138178015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99130297,0.00009821303,0.0002010919,0.0034087147,0.00033067295,0.00069114583,0.000054434942,0.000040147086,0.0038726127],"genre_scores_gemma":[0.9934035,0.000020652076,0.0022291325,0.0039897263,0.00013354165,0.000021959308,0.000022542456,0.00005900145,0.00011997708],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973366,0.0002994344,0.00074666826,0.00041983966,0.000756482,0.0004409493],"domain_scores_gemma":[0.99587435,0.0019431945,0.00039860702,0.00049241626,0.00083295867,0.00045850268],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007420161,0.00020410337,0.0008338493,0.00035574453,0.000030254268,0.000004935889,0.00028774445,0.000214515,0.00032079476],"category_scores_gemma":[0.0040262337,0.0001816205,0.00014053212,0.00060398213,0.00029712197,0.000053708605,0.00028895398,0.00048219739,0.000076225064],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067898247,0.00058921875,0.0039811167,0.00021944674,0.00004537104,0.0004345673,0.00093282183,0.00008589298,0.98395395,0.000024413792,0.0077316505,0.0013225487],"study_design_scores_gemma":[0.0067009204,0.0035319712,0.0013861619,0.00008597009,0.00007522159,0.00020871652,0.00057710597,0.0033498672,0.9577157,0.000039178696,0.026181014,0.00014815325],"about_ca_topic_score_codex":0.00012948828,"about_ca_topic_score_gemma":0.000019674619,"teacher_disagreement_score":0.02623825,"about_ca_system_score_codex":0.00017579734,"about_ca_system_score_gemma":0.001966006,"threshold_uncertainty_score":0.74062693},"labels":[],"label_agreement":null},{"id":"W2138964047","doi":"10.1093/neuonc/noq032","title":"Sensitivity to temozolomide in brain tumor initiating cells","year":2010,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Brain Institute; University of Calgary","funders":"Fondation pour la Recherche Médicale; Brain Tumour Research; Alberta Cancer Foundation","keywords":"Temozolomide; Methyltransferase; Methylation; Glioblastoma; Cancer research; O-6-methylguanine-DNA methyltransferase; DNA methylation; Brain tumor; Biology; DNA; Medicine; Gene; Gene expression; Genetics; Pathology","score_opus":0.019030961405090408,"score_gpt":0.3058555663106247,"score_spread":0.2868246049055343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138964047","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.975395,0.0000069133407,0.0000061279775,0.018399186,0.0006664396,0.0005219962,0.000008796036,0.000051641182,0.004943894],"genre_scores_gemma":[0.979581,0.0000021996957,0.0011708076,0.018923579,0.00021516395,0.00006757487,0.0000058186647,0.000023742861,0.000010138157],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987339,0.00017813397,0.00026391976,0.00035013407,0.00012342114,0.00035049662],"domain_scores_gemma":[0.99797195,0.0014124127,0.000074752024,0.0002667934,0.000049586557,0.00022449213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037448728,0.00014998979,0.00040329932,0.0001895356,0.000044528468,0.000010023785,0.00004727335,0.00011810736,0.000100848745],"category_scores_gemma":[0.0010157172,0.00013418982,0.00006542307,0.00022649496,0.00004715589,0.000036737125,0.00007913536,0.00045145748,0.00024395018],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007833151,0.0005639656,0.047044013,0.000010095768,0.000009894628,0.0057859914,0.00024158566,0.000010822653,0.9291349,0.00009403216,0.0039395303,0.01308684],"study_design_scores_gemma":[0.004028665,0.0016312803,0.14056978,0.000029382261,0.000048422426,0.00096834754,0.00013164607,0.00027266014,0.7544839,0.00005538508,0.09759162,0.00018894403],"about_ca_topic_score_codex":0.00017261409,"about_ca_topic_score_gemma":0.0019038292,"teacher_disagreement_score":0.17465103,"about_ca_system_score_codex":0.0001153488,"about_ca_system_score_gemma":0.00016344998,"threshold_uncertainty_score":0.5472102},"labels":[],"label_agreement":null},{"id":"W2139004759","doi":"10.1093/neuonc/nou160","title":"Phase I/randomized phase II study of afatinib, an irreversible ErbB family blocker, with or without protracted temozolomide in adults with recurrent glioblastoma","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":185,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; CancerCare Manitoba; Centre Hospitalier Universitaire de Sherbrooke; McGill University; Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Temozolomide; Afatinib; Medicine; Internal medicine; Rash; Dacarbazine; Phases of clinical research; Oncology; Clinical endpoint; Adverse effect; Pharmacokinetics; Epidermal growth factor receptor; Pharmacology; Randomized controlled trial; Clinical trial; Chemotherapy; Erlotinib; Cancer","score_opus":0.022807404650763828,"score_gpt":0.3333385568777372,"score_spread":0.3105311522269734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139004759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910947,0.00004575309,0.000011357182,0.00041684235,0.00014918731,0.00789445,0.000018514776,0.00009861907,0.00027056673],"genre_scores_gemma":[0.99741864,0.000030361703,0.0008647535,0.00026709764,0.00008703955,0.0012068101,0.000044530225,0.000064567546,0.000016204642],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99649376,0.0008797398,0.0008502353,0.0008053691,0.00047425,0.0004966564],"domain_scores_gemma":[0.9974149,0.00074942975,0.0005941233,0.0006365124,0.0002670619,0.00033801186],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000542199,0.00046332754,0.0020395601,0.00046394716,0.00011111027,0.000012795308,0.00017910518,0.00016809927,0.000063791995],"category_scores_gemma":[0.00035871516,0.00025287512,0.000094801086,0.0006699277,0.0002206646,0.00013649637,0.000066629014,0.00042276553,0.0000060579177],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.79521453,0.1163871,0.012132527,0.00013521216,0.00035636613,0.0016795147,0.004578075,0.000016813487,0.023374515,0.00000864808,0.00020039103,0.045916323],"study_design_scores_gemma":[0.65420896,0.33137646,0.0013809451,0.00034055344,0.00076033344,0.0002778055,0.0015633579,0.0015928876,0.007395065,0.000003293617,0.0008648371,0.00023549498],"about_ca_topic_score_codex":0.00036105132,"about_ca_topic_score_gemma":0.00355929,"teacher_disagreement_score":0.21498936,"about_ca_system_score_codex":0.00015737413,"about_ca_system_score_gemma":0.0003405465,"threshold_uncertainty_score":0.9999924},"labels":[],"label_agreement":null},{"id":"W2139872224","doi":"10.1215/15228517-2008-110","title":"The role of the membrane cytoskeleton cross-linker ezrin in medulloblastoma cells","year":2008,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Canadian Institutes of Health Research; Hospital for Sick Children","keywords":"Ezrin; Medulloblastoma; Filopodia; Cell migration; Cytoskeleton; Biology; Transfection; Cancer research; Cell adhesion; Cerebellum; Cell biology; Blot; Cell culture; Cell; Molecular biology; Actin; Gene; Genetics; Neuroscience","score_opus":0.017277212279783245,"score_gpt":0.3132121613440472,"score_spread":0.295934949064264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139872224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97778285,0.0002693139,0.000002581924,0.0034059053,0.000323671,0.0006577482,0.000003365278,0.000024711808,0.017529849],"genre_scores_gemma":[0.99675214,0.0005793121,0.00008389815,0.000999245,0.00011714741,0.00004478683,0.000001693788,0.000036865476,0.0013848944],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99759984,0.00047130085,0.0004916852,0.00034104884,0.0005848759,0.000511227],"domain_scores_gemma":[0.9976561,0.001169833,0.00014507746,0.0007271541,0.00015396913,0.00014786825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004423137,0.00016451834,0.0003871666,0.00011791392,0.00018468975,0.0000088092465,0.00049016834,0.0002247583,0.0002281692],"category_scores_gemma":[0.00066764595,0.00009676939,0.00016934535,0.00048647219,0.0008145814,0.000031028492,0.00033317783,0.00084943976,0.00015426344],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056779536,0.00024172198,0.017579801,0.00002118924,0.000013039985,0.00031404325,0.0002947247,0.00005857928,0.97191334,0.000087278175,0.0011325489,0.007775967],"study_design_scores_gemma":[0.0014793385,0.00062140456,0.027145706,0.000011591196,0.000010348616,0.00032948013,0.000088857414,0.00042468827,0.6765474,0.000055682303,0.29322287,0.000062615654],"about_ca_topic_score_codex":0.00010963846,"about_ca_topic_score_gemma":0.0001954538,"teacher_disagreement_score":0.2953659,"about_ca_system_score_codex":0.00017699713,"about_ca_system_score_gemma":0.00065118575,"threshold_uncertainty_score":0.39461413},"labels":[],"label_agreement":null},{"id":"W2139920423","doi":"10.1093/neuonc/nou052","title":"Germline rearrangements in families with strong family history of glioma and malignant melanoma, colon, and breast cancer","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Medical Research Council; University of Texas MD Anderson Cancer Center; University of Illinois at Urbana-Champaign; National Institutes of Health; Rigshospitalet; Lunds Universitet; Case Comprehensive Cancer Center, Case Western Reserve University; Memorial Sloan-Kettering Cancer Center; Dan L. Duncan Cancer Center, Baylor College of Medicine; School of Medicine, Case Western Reserve University; National Cancer Institute; National Brain Tumor Society; Case Western Reserve University; Brigham and Women's Hospital; University of Southern California; University of California, San Francisco; Cancer Research UK; Yale University","keywords":"Germline; Melanoma; Breast cancer; Family history; Oncology; Colorectal cancer; Medicine; Internal medicine; Cancer; Cancer research; Biology; Genetics; Gene","score_opus":0.016547200599579242,"score_gpt":0.26458794008446856,"score_spread":0.24804073948488933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139920423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950158,0.0017791996,0.00000259727,0.0012203676,0.00012884912,0.0003524476,0.000023264214,0.00001379575,0.001463653],"genre_scores_gemma":[0.99861974,0.00051691703,0.00013449715,0.0005386335,0.000045101053,0.00009362267,0.0000067657284,0.000018702867,0.00002600783],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990355,0.0000912331,0.00023426289,0.0002992205,0.00013230335,0.00020748582],"domain_scores_gemma":[0.9994061,0.00013882147,0.00012154478,0.00016379888,0.00006321192,0.000106543324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011663719,0.00015065748,0.00046394306,0.00018342362,0.000019210309,0.0000029409234,0.000038563903,0.00008654842,0.000028995642],"category_scores_gemma":[0.000019324973,0.0001118386,0.000021989657,0.00008899087,0.00020783397,0.000037544334,0.000044725184,0.00009787991,0.0000012975366],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066850084,0.00054129976,0.6454169,0.00010489339,0.00008291346,0.00041263938,0.0005393422,0.00000518459,0.32331988,0.00013434183,0.0016232985,0.027150817],"study_design_scores_gemma":[0.008516154,0.0028705138,0.9574503,0.00013789884,0.00018872258,0.0003561936,0.00022972663,0.00015400862,0.0026365751,0.000008991872,0.027331838,0.00011909804],"about_ca_topic_score_codex":0.0009149285,"about_ca_topic_score_gemma":0.0009826234,"teacher_disagreement_score":0.3206833,"about_ca_system_score_codex":0.00027321864,"about_ca_system_score_gemma":0.00015186529,"threshold_uncertainty_score":0.45606458},"labels":[],"label_agreement":null},{"id":"W2141349487","doi":"10.1093/neuonc/nou283","title":"The worldwide incidence and prevalence of primary brain tumors: a systematic review and meta-analysis","year":2014,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":351,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Alberta Innovates; Public Health Agency; Public Health Agency of Canada","keywords":"Meta-analysis; Incidence (geometry); Systematic review; Medicine; MEDLINE; Internal medicine; Biology; Mathematics","score_opus":0.057158942761239964,"score_gpt":0.36022683068263095,"score_spread":0.303067887921391,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141349487","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000102786635,0.99252355,0.0000031617283,0.0028327063,0.000026740834,0.0043596937,0.000034476994,0.000015873353,0.00019349567],"genre_scores_gemma":[0.00007629082,0.99485964,0.00008105499,0.0030527688,0.000020451862,0.001724796,0.000014218705,0.000030445157,0.00014032911],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9951656,0.0020487453,0.001577418,0.0006254322,0.0003230339,0.00025979872],"domain_scores_gemma":[0.98813194,0.008913725,0.0016319355,0.0010255313,0.00012818,0.00016868717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018586196,0.0004665042,0.011706145,0.00024727648,0.00008346313,0.000021269156,0.00026560915,0.00016916064,0.00004824984],"category_scores_gemma":[0.0023483715,0.0002240371,0.0014872475,0.0006335153,0.0002666059,0.000033897006,0.00022093127,0.0003306797,0.000011137246],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000038611447,0.00009245027,0.000026290281,0.9484578,0.03709271,0.0001386232,0.000017890841,4.2224674e-8,0.000002886991,0.00007169366,0.0006770667,0.013418713],"study_design_scores_gemma":[0.00017465874,0.00037820986,0.000032430584,0.035843287,0.81679493,0.0007064235,0.0000023695156,0.0000014298582,0.0000011744875,0.000009727154,0.14592867,0.00012669459],"about_ca_topic_score_codex":0.000012501327,"about_ca_topic_score_gemma":0.000025815609,"teacher_disagreement_score":0.91261446,"about_ca_system_score_codex":0.00012971392,"about_ca_system_score_gemma":0.00029722333,"threshold_uncertainty_score":0.91359675},"labels":[],"label_agreement":null},{"id":"W2143173265","doi":"10.1093/neuonc/nov061.14","title":"BT-04 * A STANDARDIZED AUTOPSY PROCUREMENT ALLOWS FOR THE COMPREHENSIVE STUDY OF DIPG BIOLOGY","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Autopsy; Procurement; Biology; Medicine; Pathology; Business","score_opus":0.08772335652876306,"score_gpt":0.37872251970592413,"score_spread":0.29099916317716107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143173265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877066,0.0006089533,0.00010698371,0.00557523,0.0007138451,0.004595837,0.000037128557,0.000045859622,0.00060953695],"genre_scores_gemma":[0.9970737,0.00004226118,0.00038414332,0.001201447,0.00013411332,0.0011070961,0.000016813661,0.000022995278,0.000017391632],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985431,0.00021887293,0.0003967776,0.00033858686,0.00021637154,0.0002863333],"domain_scores_gemma":[0.9978308,0.0009424579,0.00020654975,0.0003951368,0.00048014044,0.00014489914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022700525,0.00018504346,0.0006775018,0.00008383064,0.00007377488,0.000006091337,0.0001366756,0.00010698951,0.000035433837],"category_scores_gemma":[0.00031829724,0.00010905255,0.00012490133,0.00012686124,0.00010631756,0.000018602006,0.00009691677,0.00013753137,0.000008328818],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013925373,0.032602604,0.18462703,0.00021994446,0.0044693993,0.00083135633,0.018314077,0.00025926423,0.58024013,0.004543009,0.055323455,0.10464433],"study_design_scores_gemma":[0.049829505,0.046949077,0.018843807,0.000021594265,0.0013308825,0.00010929377,0.005265143,0.00024216036,0.012344133,0.0003405387,0.8645454,0.00017843618],"about_ca_topic_score_codex":0.00008821443,"about_ca_topic_score_gemma":0.0001454901,"teacher_disagreement_score":0.809222,"about_ca_system_score_codex":0.00020098913,"about_ca_system_score_gemma":0.0003661804,"threshold_uncertainty_score":0.44470337},"labels":[],"label_agreement":null},{"id":"W2143915403","doi":"10.1093/neuonc/nou108","title":"Straying from the path in neuro-oncology","year":2014,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Temozolomide; Medicine; Oncology; Internal medicine; Adjuvant; Clinical trial; Regimen; Radiation therapy; Adjuvant therapy; Cancer; Breast cancer","score_opus":0.05783105793299543,"score_gpt":0.36216589274521915,"score_spread":0.30433483481222373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143915403","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016221751,0.9836861,0.0000055526084,0.004383587,0.0023527518,0.002667982,0.000104242026,0.00010422557,0.0050733816],"genre_scores_gemma":[0.0012869537,0.9893665,0.00014780732,0.006518942,0.0013154633,0.0008939183,0.00030813462,0.0001509113,0.000011426802],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.994418,0.0019007792,0.0013540584,0.001171744,0.00034696504,0.0008084327],"domain_scores_gemma":[0.98836106,0.009307441,0.00078883633,0.0011697285,0.0000735875,0.00029936724],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005572829,0.00079678476,0.004296804,0.00030406547,0.00012850374,0.00003506849,0.00056769757,0.0011466398,0.00033422984],"category_scores_gemma":[0.0010088668,0.0004960147,0.0008062639,0.0004952461,0.00021936456,0.000042725896,0.00030451975,0.0018995121,0.000560334],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047811893,0.0009026342,0.00089050364,0.00084929855,0.00022058754,0.00467299,0.00014436,0.000001421906,0.00019184216,0.0001691664,0.0117117055,0.98019767],"study_design_scores_gemma":[0.002677722,0.001925331,0.00038787187,0.0017191586,0.0021965553,0.0007642503,0.000044826193,0.000014361418,0.000013100098,0.00006435227,0.98988605,0.00030639963],"about_ca_topic_score_codex":0.00025207794,"about_ca_topic_score_gemma":0.0003385472,"teacher_disagreement_score":0.9798913,"about_ca_system_score_codex":0.00090694614,"about_ca_system_score_gemma":0.0014265096,"threshold_uncertainty_score":0.9997491},"labels":[],"label_agreement":null},{"id":"W2144448977","doi":"10.1093/neuonc/not162","title":"A novel C19MC amplified cell line links Lin28/let-7 to mTOR signaling in embryonal tumor with multilayered rosettes","year":2013,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Hospital for Sick Children; University of Toronto; SickKids Foundation; Alberta Children's Hospital","funders":"Alberta Innovates; Brain Tumour Foundation of Canada; University of Calgary","keywords":"LIN28; Gene knockdown; microRNA; PI3K/AKT/mTOR pathway; Cancer research; Biology; Cell culture; Cell biology; Signal transduction; Gene; Genetics; Transcription factor","score_opus":0.013912135614253222,"score_gpt":0.2550834511194518,"score_spread":0.24117131550519857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144448977","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995051,0.000106602354,0.0022958412,0.0011686981,0.00018787601,0.00087485934,0.000039905175,0.000032129265,0.00024306124],"genre_scores_gemma":[0.9844569,0.000007708714,0.010390217,0.00420803,0.00044388723,0.00022527069,0.000116635696,0.000062990235,0.00008838058],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981259,0.00011888873,0.0004243304,0.0006875903,0.00016338254,0.00047991512],"domain_scores_gemma":[0.9988126,0.00010604783,0.00018279755,0.00045908627,0.00019112894,0.00024835186],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014966149,0.00028370673,0.00032076644,0.00013152442,0.00006136242,0.000037707287,0.00033822734,0.00032363256,0.000110639994],"category_scores_gemma":[0.00024666634,0.00026526322,0.0000822256,0.00019062564,0.000080525286,0.000009384781,0.00023746544,0.00034805265,0.00010187259],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034835632,0.00036965127,0.0013494024,0.000027056149,0.000017798644,0.000033107703,0.00006361114,0.0032833014,0.9918469,0.0000041977173,0.0017173355,0.00093925634],"study_design_scores_gemma":[0.0029907532,0.0015258692,0.0074584354,0.000025197605,0.000027809769,0.00008185912,0.00006952679,0.002048492,0.95719814,0.000020405505,0.028142588,0.0004108985],"about_ca_topic_score_codex":0.00007316324,"about_ca_topic_score_gemma":0.00011447699,"teacher_disagreement_score":0.03464876,"about_ca_system_score_codex":0.00008000242,"about_ca_system_score_gemma":0.00029255406,"threshold_uncertainty_score":0.99998},"labels":[],"label_agreement":null},{"id":"W2145256943","doi":"10.1093/neuonc/nos225","title":"LAB-MOLECULAR EPIDEMIOLOGY","year":2012,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"thermodynamics and calorimetric analyses","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Epidemiology; Computer science; Computational biology; Medicine; Biology; Internal medicine","score_opus":0.03668922759514117,"score_gpt":0.3275943521789436,"score_spread":0.29090512458380247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145256943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7803104,0.0023842666,0.0024515877,0.0018013734,0.0008226297,0.00005632821,0.000016096248,0.00015837113,0.21199895],"genre_scores_gemma":[0.99523926,0.0001149741,0.00058839325,0.0030778325,0.0006494391,0.000019036424,0.000020024916,0.000033000066,0.00025802184],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984708,0.00018558807,0.00034298367,0.00028061704,0.00009304441,0.0006270122],"domain_scores_gemma":[0.997982,0.0011760386,0.00017385997,0.00038583807,0.000040523748,0.00024169091],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00042562376,0.00017219971,0.00044156006,0.00008091288,0.0000609652,0.0000041580984,0.00027247609,0.00033020604,0.0016837766],"category_scores_gemma":[0.0009781414,0.00015759295,0.00016227116,0.0001938123,0.000118842305,0.000054301076,0.00013332162,0.00037371158,0.00033384503],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044642413,0.00027089994,0.02417114,0.000020422183,0.00009027965,0.00007821864,0.000093329734,0.000024280136,0.9087716,0.021890696,0.0039280914,0.040616397],"study_design_scores_gemma":[0.00056272536,0.00011931488,0.00101578,0.0000030965855,0.00011357589,0.00016440572,0.00009912154,0.0005013031,0.03158442,0.0018207156,0.963752,0.000263588],"about_ca_topic_score_codex":0.00004838837,"about_ca_topic_score_gemma":0.0000025484026,"teacher_disagreement_score":0.95982385,"about_ca_system_score_codex":0.0001381062,"about_ca_system_score_gemma":0.00006831886,"threshold_uncertainty_score":0.99922884},"labels":[],"label_agreement":null},{"id":"W2145559849","doi":"10.1093/neuonc/nos062","title":"The combined use of surgery and radiotherapy to treat patients with epidural cord compression due to metastatic disease: a cost-utility analysis","year":2012,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Toronto Western Hospital; Sunnybrook Health Science Centre; Toronto Rehabilitation Institute; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Radiation therapy; Cost–utility analysis; Quality of life (healthcare); Spinal cord compression; Quality-adjusted life year; Willingness to pay; Surgery; Cost effectiveness; Spinal cord","score_opus":0.05638970984172216,"score_gpt":0.33026087447607083,"score_spread":0.2738711646343487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145559849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924064,0.00017849705,0.0016576876,0.0034928187,0.00015299696,0.001942475,0.000100217796,0.000028968265,0.00003988423],"genre_scores_gemma":[0.994348,0.000040779425,0.001497099,0.0037630843,0.000020568721,0.00014924309,0.000090875415,0.000025217096,0.00006515518],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99762,0.0007362953,0.00047125967,0.00032993752,0.0004323561,0.0004101539],"domain_scores_gemma":[0.99562526,0.002541844,0.0002191582,0.0006160441,0.00015716115,0.00084055634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050848664,0.00022093077,0.00089338206,0.00029426103,0.0001040849,0.000021193673,0.00010064555,0.000024727355,0.00012583056],"category_scores_gemma":[0.000959014,0.00013648656,0.0001458012,0.0006423072,0.00015825644,0.00012134034,0.00009202153,0.00010789747,0.000005193317],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019070314,0.0017534012,0.9147884,0.00012779848,0.0006734562,0.000094939765,0.00021295497,0.000029983292,0.00044354063,0.000036495363,0.008451039,0.05431767],"study_design_scores_gemma":[0.0026623073,0.0010751394,0.97006804,0.000023198294,0.0027737902,0.000003711399,0.00006021432,0.0007561586,0.00007131259,0.0000059638687,0.022374284,0.00012587028],"about_ca_topic_score_codex":0.000048860617,"about_ca_topic_score_gemma":0.000019361314,"teacher_disagreement_score":0.055279646,"about_ca_system_score_codex":0.00007869126,"about_ca_system_score_gemma":0.00009080078,"threshold_uncertainty_score":0.5565761},"labels":[],"label_agreement":null},{"id":"W2145637828","doi":"10.1093/neuonc/4.4.242","title":"Phosphatidylinositol 3'-kinase and MAPK/ERK kinase 1/2 differentiallyregulate expression of vascular endothelial growth factor in human malignantastrocytoma cells","year":2002,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; SickKids Foundation; Toronto Western Hospital; Hospital for Sick Children","funders":"National Cancer Institute; Heart and Stroke Foundation of Canada","keywords":"Angiogenesis; MAPK/ERK pathway; Vascular endothelial growth factor; Cancer research; Kinase; Biology; Cell growth; Signal transduction; Vascular endothelial growth factor A; Cell culture; Cell biology; Biochemistry","score_opus":0.0112069211047521,"score_gpt":0.23989723686627287,"score_spread":0.22869031576152077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145637828","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962596,0.0018942221,0.00011555517,0.000050737315,0.00093045185,0.00037434444,0.000103873055,0.000015688342,0.00025548943],"genre_scores_gemma":[0.9964656,0.0021811419,0.00026509317,0.00020144711,0.00066217524,0.00004052505,0.000035831406,0.00004187772,0.00010630556],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981418,0.00023332263,0.0004377741,0.0005888719,0.0001812298,0.0004169603],"domain_scores_gemma":[0.9991275,0.000044987453,0.00021019106,0.0003854882,0.00006576836,0.00016605944],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00008510421,0.00029021327,0.00048635778,0.00011952512,0.00008198098,0.00001632201,0.00023825903,0.0003222433,0.00014498174],"category_scores_gemma":[0.000049483173,0.000279136,0.00015407895,0.00009157455,0.00017097473,0.000010154365,0.00021000106,0.0001878025,0.000004390769],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016950247,0.00032115955,0.001509425,0.000054784985,0.00002226676,0.00004128513,0.00017481885,0.0000077486775,0.9919901,0.00003765575,0.001080793,0.004590467],"study_design_scores_gemma":[0.003219445,0.00077100337,0.00415619,0.000023009257,0.000042850796,0.000027302971,0.000027756178,0.000028885064,0.9438702,0.000026101336,0.047575533,0.00023172502],"about_ca_topic_score_codex":0.00004528841,"about_ca_topic_score_gemma":0.000066091896,"teacher_disagreement_score":0.048119895,"about_ca_system_score_codex":0.000026809672,"about_ca_system_score_gemma":0.000046605823,"threshold_uncertainty_score":0.9999661},"labels":[],"label_agreement":null},{"id":"W2146824695","doi":"10.1093/neuonc/nor086","title":" -aminolevulinic acid-induced protoporphyrin IX concentration correlates with histopathologic markers of malignancy in human gliomas: the need for quantitative fluorescence-guided resection to identify regions of increasing malignancy","year":2011,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":159,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"National Institute of Neurological Disorders and Stroke; National Cancer Institute; National Institutes of Health; DUSA Pharmaceuticals","keywords":"Protoporphyrin IX; Malignancy; Ex vivo; Pathology; Glioma; Biopsy; In vivo; Immunohistochemistry; Medicine; Biomarker; Photodynamic therapy; Chemistry; Cancer research; Biology","score_opus":0.10730021034249637,"score_gpt":0.3928206880087695,"score_spread":0.28552047766627314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146824695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99221045,0.0001265997,0.00024857398,0.00062848505,0.00017072538,0.00558032,0.000013416309,0.000036734913,0.000984725],"genre_scores_gemma":[0.99694324,0.00007077684,0.0017127467,0.00012495792,0.000025861671,0.0010564257,0.000012877149,0.000030379537,0.000022740423],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99726033,0.0007948881,0.0007911318,0.000444763,0.0002913112,0.0004175535],"domain_scores_gemma":[0.9976742,0.00075983437,0.00056799414,0.00040504913,0.00050329533,0.000089605666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012001685,0.00022063396,0.0006692098,0.0003464325,0.00014497634,0.0000058472992,0.00024507352,0.00017282086,0.0000173803],"category_scores_gemma":[0.0016982033,0.0001582445,0.00010915408,0.00069149677,0.00046776576,0.00011171986,0.00008522557,0.00034180286,0.0000017892899],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009993899,0.000399278,0.016697776,0.00015968266,0.00007137764,0.000119322016,0.0059141996,0.0000041883186,0.9646706,0.0013099677,0.00009492495,0.0005647821],"study_design_scores_gemma":[0.0061074137,0.02649332,0.17083837,0.0007485177,0.00014981316,0.00029781926,0.005816186,0.00021596282,0.7878701,0.0011841721,0.000057273577,0.00022104458],"about_ca_topic_score_codex":0.0005723861,"about_ca_topic_score_gemma":0.0004988858,"teacher_disagreement_score":0.17680049,"about_ca_system_score_codex":0.000313023,"about_ca_system_score_gemma":0.00034839008,"threshold_uncertainty_score":0.6453023},"labels":[],"label_agreement":null},{"id":"W2146892073","doi":"10.1093/neuonc/not241","title":"Evaluation of amifostine for protection against cisplatin-induced serious hearing loss in children treated for average-risk or high-risk medulloblastoma","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Hearing, Cochlea, Tinnitus, Genetics","field":"Neuroscience","cited_by":93,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute","keywords":"Amifostine; Medicine; Ototoxicity; Medulloblastoma; Hearing loss; Cisplatin; Internal medicine; Oncology; Anesthesia; Audiology; Chemotherapy; Pathology","score_opus":0.05333984520535781,"score_gpt":0.32034138558886,"score_spread":0.2670015403835022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146892073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894637,0.0000052901396,0.0038917903,0.00019726963,0.00046192532,0.005628346,0.00007400376,0.00012862131,0.00014908318],"genre_scores_gemma":[0.99695444,0.000034884062,0.0014708777,0.0002786201,0.00025209328,0.00088214554,0.000017198685,0.00009042884,0.000019316552],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9952261,0.0017636083,0.00085376156,0.00093217613,0.0005828017,0.0006415741],"domain_scores_gemma":[0.9965086,0.0015926446,0.0008117537,0.0005177438,0.0004339581,0.00013532182],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0027222596,0.00032882387,0.00060299283,0.00038664954,0.00027222722,0.000032487387,0.00032347027,0.000360179,0.000016087286],"category_scores_gemma":[0.01974119,0.00031951605,0.00011510954,0.0006009141,0.0001171576,0.000122153,0.0001273339,0.0004928792,0.000014478642],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008693462,0.00023591824,0.007584344,0.00003426107,0.000015415877,0.0000030538893,0.00021760573,0.0130884955,0.7494279,0.000021620617,0.000026085743,0.22847593],"study_design_scores_gemma":[0.008604757,0.0060765794,0.054643396,0.000034797587,0.00017397762,0.00007587953,0.000013168304,0.21005508,0.7187688,0.00039173555,0.00085118384,0.00031069233],"about_ca_topic_score_codex":0.00039731996,"about_ca_topic_score_gemma":0.0008620099,"teacher_disagreement_score":0.22816524,"about_ca_system_score_codex":0.00041704995,"about_ca_system_score_gemma":0.00044350914,"threshold_uncertainty_score":0.9999257},"labels":[],"label_agreement":null},{"id":"W2147149348","doi":"10.1093/neuonc/nov061.161","title":"TR-16 * PERSONALIZED TARGETED THERAPY IN REFRACTORY OR RELAPSED CANCER IN CHILDHOOD (TRICEPS STUDY)","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Refractory (planetary science); Childhood cancer; Medicine; Oncology; Cancer; Internal medicine; Biology","score_opus":0.06703108966690846,"score_gpt":0.37467007608657604,"score_spread":0.3076389864196676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147149348","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9782148,0.0024807188,0.0000042211427,0.0126226265,0.0014649049,0.0022377393,0.000020906604,0.0001550237,0.0027990513],"genre_scores_gemma":[0.98338556,0.0010753501,0.00013005028,0.0138631305,0.0006577751,0.00040791486,0.000021824604,0.000098789074,0.00035961912],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99493533,0.0016920316,0.0010432596,0.0008845615,0.00074612704,0.0006987065],"domain_scores_gemma":[0.9974864,0.0009071574,0.000355275,0.00063476304,0.00017829947,0.000438072],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015821881,0.00041639226,0.0013759133,0.00060172833,0.000053453154,0.000016335121,0.0003383245,0.00039246408,0.00091219146],"category_scores_gemma":[0.0016608821,0.0003501111,0.00014020463,0.0011963719,0.000163303,0.00016435722,0.000101788246,0.0013115447,0.00006254258],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036295015,0.02515343,0.6090301,0.00012435202,0.00047355777,0.004412807,0.17344096,0.00006876895,0.02149963,0.00005891271,0.037187178,0.09225528],"study_design_scores_gemma":[0.09600788,0.019500513,0.5401384,0.00016021164,0.00011718649,0.00019459758,0.018615741,0.000052611013,0.0009114916,0.00013231196,0.3234291,0.0007399085],"about_ca_topic_score_codex":0.004883728,"about_ca_topic_score_gemma":0.016110089,"teacher_disagreement_score":0.28624192,"about_ca_system_score_codex":0.0017261249,"about_ca_system_score_gemma":0.0032117118,"threshold_uncertainty_score":0.9998951},"labels":[],"label_agreement":null},{"id":"W2147818127","doi":"10.1093/neuonc/nou154","title":"Brain Malignancy Steering Committee clinical trials planning workshop: Report from the Targeted Therapies Working Group","year":2014,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Center for Advancing Translational Sciences; National Institute of Neurological Disorders and Stroke; National Cancer Institute; Accelerate Brain Cancer Cure","keywords":"Clinical trial; Medicine; Malignancy; Steering committee; Oncology; Internal medicine; Intensive care medicine","score_opus":0.24002136536680324,"score_gpt":0.46672973236684123,"score_spread":0.226708367000038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147818127","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00080236973,0.9863504,0.0001041953,0.0047567184,0.0042173862,0.002749864,0.000030200814,0.000184741,0.00080407783],"genre_scores_gemma":[0.0013941537,0.9873574,0.00061801844,0.004196571,0.0046798596,0.0008484635,0.00066435745,0.00019553112,0.00004567377],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9866727,0.0071648387,0.003847076,0.001208168,0.00044216448,0.0006650691],"domain_scores_gemma":[0.9365586,0.058653843,0.0029295236,0.0015070273,0.0000718476,0.0002791272],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0077158865,0.0008352165,0.0075138244,0.00018886624,0.00024451723,0.00009533794,0.0005418243,0.0012788574,0.00019660196],"category_scores_gemma":[0.009174867,0.00048281037,0.0020511427,0.0003816902,0.00021663126,0.00003973433,0.00030223862,0.001934756,0.00008031886],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010753801,0.0004296695,0.0037141773,0.00046839679,0.0017278852,0.0070483293,0.00018322819,0.000001444956,0.000037838752,0.000054409335,0.03632096,0.9499061],"study_design_scores_gemma":[0.002484474,0.0005663079,0.00061629486,0.010517516,0.0038385366,0.0007300643,0.00008235689,0.000007216162,0.0000032050677,0.000053379892,0.98075324,0.0003473813],"about_ca_topic_score_codex":0.00003962584,"about_ca_topic_score_gemma":0.00003547236,"teacher_disagreement_score":0.94955873,"about_ca_system_score_codex":0.00025933958,"about_ca_system_score_gemma":0.0004359094,"threshold_uncertainty_score":0.99976236},"labels":[],"label_agreement":null},{"id":"W2148601670","doi":"10.1093/neuonc/2.4.221","title":"Effect of disease burden on health-related quality of life in patientswith malignant gliomas","year":2000,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":191,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Quality of life (healthcare); Disease; Anaplastic astrocytoma; Radiation therapy; Cancer; Physical therapy; Glioma; Internal medicine; Glioblastoma; Astrocytoma; Oncology","score_opus":0.021737943600023013,"score_gpt":0.3278164074486318,"score_spread":0.30607846384860876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148601670","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99363965,0.00048200216,1.2330611e-7,0.0038278596,0.00012171552,0.000959597,0.00003351755,0.000021359514,0.00091418164],"genre_scores_gemma":[0.9990541,0.0001454228,0.000009687201,0.000651386,0.000024669393,0.000054848708,0.00003211457,0.00001806669,0.000009742702],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99746114,0.0008974029,0.00081278745,0.00030581304,0.00026229912,0.0002605806],"domain_scores_gemma":[0.9981165,0.00088454905,0.0003063945,0.0003501068,0.00003926162,0.00030318394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004386801,0.00016797066,0.0009396036,0.00018873504,0.000022274344,0.0000014999337,0.00007048863,0.000100993835,0.00034476622],"category_scores_gemma":[0.000399934,0.000120907825,0.0001367709,0.00029906887,0.00008863211,0.000019395264,0.000021080741,0.00014731033,0.000034740977],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030557897,0.008640082,0.6831302,0.0011485653,0.0002509541,0.0012136339,0.001337825,0.0005501849,0.038146306,0.0003194907,0.001857143,0.2328477],"study_design_scores_gemma":[0.040478658,0.06562086,0.85192543,0.0005806706,0.0002682673,0.000023442475,0.00006023584,0.00022054004,0.03538189,0.000094301016,0.005081591,0.0002641097],"about_ca_topic_score_codex":0.0011891229,"about_ca_topic_score_gemma":0.00006424312,"teacher_disagreement_score":0.23258358,"about_ca_system_score_codex":0.00016030428,"about_ca_system_score_gemma":0.0002566714,"threshold_uncertainty_score":0.4930478},"labels":[],"label_agreement":null},{"id":"W2148970735","doi":"10.1215/15228517-2008-007","title":"Patients' perception of the informed consent process for neurooncology clinical trials","year":2008,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; Toronto Western Hospital; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Informed consent; Clinical trial; Context (archaeology); Autonomy; Qualitative research; Medicine; Safeguarding; Research ethics; Coercion (linguistics); Voluntariness; Deception; Psychology; Alternative medicine; Nursing; Social psychology; Psychiatry","score_opus":0.7314667956714098,"score_gpt":0.6610723385141715,"score_spread":0.07039445715723835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148970735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9742366,0.000012424068,0.00008283418,0.01578147,0.00209577,0.002937608,0.000024194067,0.000034721612,0.004794368],"genre_scores_gemma":[0.98510313,0.0010198881,0.0004100629,0.012348451,0.0005518937,0.00021721204,0.000016328651,0.000030229723,0.0003028319],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9938889,0.0022394995,0.0023221052,0.0004524682,0.0006876987,0.00040932826],"domain_scores_gemma":[0.7836503,0.21197923,0.0012256028,0.00080930843,0.001992561,0.0003430071],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.00838423,0.00015887007,0.0012220936,0.00010046666,0.00016129146,0.0000034572752,0.00039851837,0.0009594586,0.00015445304],"category_scores_gemma":[0.4275408,0.00010181167,0.0005538075,0.00023468844,0.0017670399,0.00004456365,0.0002000875,0.0019766092,0.00003296316],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018200113,0.0066881245,0.82432306,0.0015506349,0.00023838918,0.00009117303,0.0023755725,0.000021505808,0.03330137,0.002317559,0.04517473,0.06571777],"study_design_scores_gemma":[0.043524954,0.050558247,0.6131893,0.00022773033,0.00061750977,0.00041114437,0.00085554214,0.00043453608,0.005220302,0.00885739,0.27571455,0.0003888169],"about_ca_topic_score_codex":0.000010798956,"about_ca_topic_score_gemma":0.00013066214,"teacher_disagreement_score":0.41915658,"about_ca_system_score_codex":0.00016666218,"about_ca_system_score_gemma":0.0074845823,"threshold_uncertainty_score":0.99814206},"labels":[],"label_agreement":null},{"id":"W2149500930","doi":"10.1093/neuonc/not138","title":"Physical functioning in pediatric survivors of childhood posterior fossa brain tumors","year":2013,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cerebral Palsy and Movement Disorders","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Cohort; Medulloblastoma; Normative; Balance (ability); Gross motor skill; Medicine; Psychology; Motor coordination; Physical therapy; Motor skill; Physical medicine and rehabilitation; Developmental psychology; Psychiatry; Internal medicine; Pathology","score_opus":0.0108666998443102,"score_gpt":0.2630655447072013,"score_spread":0.25219884486289107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149500930","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986761,0.000044065877,0.000007367586,0.004950943,0.00029634865,0.0006116549,0.0000022470326,0.000038132697,0.0072882627],"genre_scores_gemma":[0.99586105,0.000023996436,0.000046107158,0.0036305706,0.00024560993,0.000051956347,0.000012507097,0.00002163398,0.000106581894],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99879426,0.0001307896,0.00033944735,0.00027516004,0.00016120166,0.00029915562],"domain_scores_gemma":[0.99916565,0.0003559357,0.00013423561,0.00018777858,0.000051736508,0.00010468171],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013705036,0.00014455752,0.00043900535,0.00020536815,0.000032251246,0.0000060592197,0.00008142558,0.000097663666,0.00031632834],"category_scores_gemma":[0.0003157283,0.0001316745,0.000107039996,0.00033004134,0.00006637985,0.000093352086,0.00006691456,0.00030012612,0.00008450435],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026097565,0.0022557958,0.7313732,0.00017931365,0.00003677527,0.00007934136,0.0029853687,0.000041313957,0.21194859,0.00026664126,0.004312011,0.046260674],"study_design_scores_gemma":[0.004029712,0.0029090769,0.9863504,0.000020557754,0.00006298779,0.00005202721,0.0006901645,0.00015178292,0.0023844882,0.00031838365,0.0028689275,0.0001614717],"about_ca_topic_score_codex":0.00049731915,"about_ca_topic_score_gemma":0.0003032629,"teacher_disagreement_score":0.2549772,"about_ca_system_score_codex":0.000050824063,"about_ca_system_score_gemma":0.00015438862,"threshold_uncertainty_score":0.53695303},"labels":[],"label_agreement":null},{"id":"W2151178589","doi":"10.1093/neuonc/nop001","title":"Genome-wide profiling using single-nucleotide polymorphism arrays identifies novel chromosomal imbalances in pediatric glioblastomas","year":2010,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Hospital for Sick Children; McGill University and Génome Québec Innovation Centre; Montreal Children's Hospital","funders":"Canadian Institutes of Health Research","keywords":"Biology; Loss of heterozygosity; SNP array; Genetics; Single-nucleotide polymorphism; Computational biology; SNP; Copy-number variation; Gene; SNP genotyping; Genome; Cancer research; Genotype; Allele","score_opus":0.024823293944930658,"score_gpt":0.2787654453868649,"score_spread":0.2539421514419342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151178589","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943468,0.00037312217,0.000028483271,0.0013238316,0.0020606809,0.0006858075,0.000013735423,0.000111512454,0.0010560341],"genre_scores_gemma":[0.99555,0.000082296676,0.0023543008,0.0006160527,0.0012313823,0.00007092499,0.000020332132,0.000064335545,0.000010409917],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99769056,0.000074781696,0.0006017539,0.0006557641,0.00030984252,0.0006673087],"domain_scores_gemma":[0.99847597,0.00048347673,0.0002839751,0.00040887317,0.00010360202,0.00024409527],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022009017,0.00033444073,0.00066991505,0.00054697494,0.00013746718,0.00004736514,0.00018848994,0.0002782601,0.000098011435],"category_scores_gemma":[0.0003675573,0.0003080778,0.00016099517,0.0005550545,0.00016579755,0.00016973884,0.0001289545,0.00062664755,0.00006290273],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008734391,0.001100247,0.30180627,0.00003995312,0.000024319377,0.0010160921,0.00016067643,0.000037358946,0.69530916,0.000026570351,0.000031157106,0.00036083264],"study_design_scores_gemma":[0.0077137756,0.0019171241,0.43999454,0.000047392492,0.00047160892,0.0013521143,0.00018809475,0.0006829444,0.5410225,0.00009265979,0.0060078343,0.00050943834],"about_ca_topic_score_codex":0.00009260307,"about_ca_topic_score_gemma":0.00050724554,"teacher_disagreement_score":0.15428673,"about_ca_system_score_codex":0.0002632245,"about_ca_system_score_gemma":0.0003375612,"threshold_uncertainty_score":0.9999371},"labels":[],"label_agreement":null},{"id":"W2151874651","doi":"10.1215/15228517-2005-009","title":"High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendroglioma: Long-term follow-up","year":2006,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre; University of Calgary","funders":"","keywords":"Medicine; ThioTEPA; Lomustine; Procarbazine; Oligodendroglioma; Surgery; Internal medicine; Vincristine; Oncology; Chemotherapy; Glioma; Astrocytoma; Cyclophosphamide","score_opus":0.018358193755660997,"score_gpt":0.2909703553038736,"score_spread":0.2726121615482126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151874651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931823,0.00048453108,0.00009288718,0.0022115358,0.000849637,0.0018676375,0.00003398976,0.0001357303,0.0011417472],"genre_scores_gemma":[0.99541754,0.00019357773,0.00037869153,0.0022884277,0.0006964268,0.0006068664,0.00010868596,0.00011464553,0.00019514379],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979244,0.000106121704,0.000421225,0.0006500098,0.0002975274,0.0006007468],"domain_scores_gemma":[0.9984433,0.0005522092,0.00017844379,0.0004588997,0.00015833485,0.00020882962],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00010200585,0.00040501662,0.0007644969,0.00024446618,0.00014321359,0.000035306326,0.00015613063,0.0002676901,0.00015101701],"category_scores_gemma":[0.0000131058405,0.00030068844,0.0002116077,0.00028059556,0.00013453433,0.00007423691,0.000027850889,0.00021208065,0.0000697858],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.051755667,0.016460113,0.08306726,0.00032883184,0.0010440385,0.018413618,0.00084664125,0.00019521375,0.6558933,0.00168349,0.020215001,0.15009683],"study_design_scores_gemma":[0.1067585,0.040154923,0.067748755,0.000077026874,0.00052978547,0.00141468,0.00006868581,0.000066598805,0.7595996,0.0001578024,0.022868449,0.0005551778],"about_ca_topic_score_codex":0.00015430983,"about_ca_topic_score_gemma":0.00034934486,"teacher_disagreement_score":0.14954165,"about_ca_system_score_codex":0.00023512184,"about_ca_system_score_gemma":0.00035160827,"threshold_uncertainty_score":0.9999445},"labels":[],"label_agreement":null},{"id":"W2152840183","doi":"10.1093/neuonc/nop017","title":"A phase I trial of erlotinib in patients with nonprogressive glioblastoma multiforme postradiation therapy, and recurrent malignant gliomas and meningiomas","year":2009,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"National Center for Research Resources; National Cancer Institute","keywords":"Erlotinib; Medicine; Rash; Toxicity; Pharmacokinetics; Gastroenterology; Diarrhea; Pharmacology; Internal medicine; Chemotherapy; Phases of clinical research; Oncology; Cancer; Epidermal growth factor receptor","score_opus":0.01769246670536518,"score_gpt":0.3037294282658909,"score_spread":0.2860369615605257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152840183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99664605,0.0003682872,7.7205397e-7,0.0009226976,0.00010808948,0.0018571322,0.000018340346,0.000017415232,0.00006122923],"genre_scores_gemma":[0.9993511,0.00012539093,0.0002105507,0.00015654555,0.00004206555,0.00007676226,0.000023882865,0.000013234019,4.6645408e-7],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9988089,0.00009240055,0.0003517889,0.00032109802,0.00019728074,0.00022850708],"domain_scores_gemma":[0.9992406,0.00014725314,0.00025125244,0.00014005257,0.0000867726,0.00013407867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000997436,0.0001851058,0.0004595621,0.00025662602,0.000035857574,0.000009865801,0.00003471697,0.000107571854,0.000007075141],"category_scores_gemma":[0.00006216299,0.00012948766,0.000040223942,0.0002123961,0.000085242435,0.00007026722,0.000015366437,0.000108851025,7.406219e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20548709,0.019838363,0.08452615,0.00002944137,0.00011648059,0.000871049,0.0015589094,0.0000014955452,0.04011722,0.00008360424,0.00007317699,0.647297],"study_design_scores_gemma":[0.45830572,0.20907113,0.30535927,0.00012064792,0.00014455705,0.00011011355,0.00007211017,0.00014400779,0.02553056,0.000032105247,0.0009378902,0.00017189623],"about_ca_topic_score_codex":0.000013495177,"about_ca_topic_score_gemma":0.000026287242,"teacher_disagreement_score":0.6471251,"about_ca_system_score_codex":0.000068294314,"about_ca_system_score_gemma":0.000078917685,"threshold_uncertainty_score":0.52803534},"labels":[],"label_agreement":null},{"id":"W2152981221","doi":"10.1093/neuonc/nop023","title":"Normal human monocytes exposed to glioma cells acquire myeloid-derived suppressor cell-like properties","year":2009,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":241,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Myeloid-derived Suppressor Cell; CD14; Glioma; Immunosuppression; Cancer research; Immunology; Integrin alpha M; Flow cytometry; In vitro; Microglia; Myeloid; Monocyte; Medicine; Cytokine; Biology; Suppressor; Cancer; Inflammation; Internal medicine","score_opus":0.023413105470987645,"score_gpt":0.25911991642882437,"score_spread":0.23570681095783672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152981221","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.981884,0.0021658617,0.00003334483,0.0022902235,0.004368851,0.00097395724,0.000022930799,0.00032749982,0.00793334],"genre_scores_gemma":[0.9897617,0.00009873953,0.00026349784,0.006781425,0.00019266116,0.00013804086,0.00004737042,0.0000703701,0.002646193],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965024,0.00062438834,0.0007273883,0.00087072095,0.00009311171,0.001181989],"domain_scores_gemma":[0.9983721,0.00023487215,0.00026810498,0.0008600893,0.00016329449,0.00010156448],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00024240317,0.0005304988,0.0008164606,0.00030187122,0.0005206211,0.000043840828,0.0009950233,0.0010026544,0.001296812],"category_scores_gemma":[0.0000622172,0.0004924136,0.00020432213,0.0002839205,0.00044336866,0.00020977732,0.0003677015,0.0009202061,0.0020955245],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008698461,0.0004532862,0.000033281634,0.000025227488,0.00005539415,0.00014674761,0.0022674946,0.000077881174,0.9524934,0.000039717463,0.03769724,0.0058404803],"study_design_scores_gemma":[0.0021744682,0.0024959568,0.00037040963,0.000015042057,0.000051086743,0.00012724154,0.00032546843,0.0000028158088,0.7272608,0.000020335037,0.26677036,0.00038601388],"about_ca_topic_score_codex":0.0000492216,"about_ca_topic_score_gemma":0.000025550016,"teacher_disagreement_score":0.22907312,"about_ca_system_score_codex":0.00026255182,"about_ca_system_score_gemma":0.00024400758,"threshold_uncertainty_score":0.99975276},"labels":[],"label_agreement":null},{"id":"W2155161651","doi":"10.1093/neuonc/nov061.142","title":"SG-04 * THE eEF2 KINASE, A MEDIATOR OF MEDULLOBLASTOMA ADAPTATION TO METABOLIC STRESS, SUPPORTS FATTY ACID OXIDATION","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; University of Toronto; University of British Columbia","funders":"","keywords":"Mediator; Adaptation (eye); Beta oxidation; Metabolic adaptation; Kinase; Fatty acid; Chemistry; Biochemistry; Cell biology; Biology; Metabolism; Neuroscience","score_opus":0.017104200326810714,"score_gpt":0.2740844967710045,"score_spread":0.2569802964441938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155161651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98292893,0.0018854955,0.0020912068,0.0018649389,0.009611657,0.00060650386,0.000098272576,0.000026863336,0.0008861194],"genre_scores_gemma":[0.9891814,0.00056927005,0.0012332762,0.001952459,0.0065982365,0.00015830489,0.00019990238,0.000038320908,0.00006881398],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983142,0.00028973073,0.00038684133,0.00041264584,0.00027802822,0.0003185816],"domain_scores_gemma":[0.9986867,0.00004319945,0.00024938004,0.00048268508,0.00029420306,0.00024383732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003861323,0.00020002919,0.00033946987,0.00008433424,0.000058328802,0.000013816058,0.00030110544,0.00022264586,0.000035718283],"category_scores_gemma":[0.0006318901,0.00016197281,0.0001090972,0.00020432645,0.00013483172,0.000011198323,0.00015493153,0.00013850149,0.000025359908],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030419693,0.000106362415,0.0005092599,0.000009664981,0.000037781065,9.565824e-7,0.00072928396,0.00020144552,0.94041526,0.00016536692,0.034608945,0.022911489],"study_design_scores_gemma":[0.00065172993,0.00047532556,0.001677666,0.0000027243818,0.000054465876,0.000018563469,0.0004671003,0.000025932397,0.44083387,0.000033826178,0.5556558,0.00010304315],"about_ca_topic_score_codex":0.00013901814,"about_ca_topic_score_gemma":0.0009180318,"teacher_disagreement_score":0.5210468,"about_ca_system_score_codex":0.000032995074,"about_ca_system_score_gemma":0.00067285955,"threshold_uncertainty_score":0.66050595},"labels":[],"label_agreement":null},{"id":"W2155592661","doi":"10.1093/neuonc/4.2.123","title":"Metastatic papillary craniopharyngioma: Case study and study of tumorangiogenesis","year":2002,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Craniopharyngioma; Vascularity; Pathology; Medicine; Papillary tumor; Craniotomy; Immunohistochemistry; Radiology","score_opus":0.04283373726850656,"score_gpt":0.31071076470264797,"score_spread":0.26787702743414143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155592661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99577504,0.0017405429,0.0000016092674,0.00019984812,0.000117350515,0.0013492089,0.000008818168,0.00003306158,0.00077454],"genre_scores_gemma":[0.99939775,0.00012286774,0.000068003326,0.0002587533,0.000027433909,0.00006763355,0.0000028473721,0.000022030677,0.00003266282],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987186,0.00023201578,0.00033288042,0.00033711764,0.00017173066,0.00020766334],"domain_scores_gemma":[0.99919593,0.00022350255,0.00009499634,0.00028314855,0.00004959046,0.00015280928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000981264,0.00018214626,0.0006056455,0.00015926058,0.00009038163,0.0000047192166,0.00004880597,0.00003786769,0.00015607329],"category_scores_gemma":[0.000048955222,0.00014139613,0.000067349436,0.00021857388,0.00005393283,0.000048879057,0.00005903156,0.00008356925,0.000016313903],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044411595,0.03507953,0.6427842,0.000073169394,0.00088656537,0.28139156,0.008506902,0.0000037183408,0.004584349,0.0000026450598,0.000796629,0.02544667],"study_design_scores_gemma":[0.14226344,0.20362422,0.38626078,0.00003586351,0.0122139845,0.13627875,0.11301913,0.0012115816,0.00063113705,0.00011884218,0.003427774,0.0009145005],"about_ca_topic_score_codex":0.00055224146,"about_ca_topic_score_gemma":0.00026572545,"teacher_disagreement_score":0.25652337,"about_ca_system_score_codex":0.00002629863,"about_ca_system_score_gemma":0.000026740157,"threshold_uncertainty_score":0.5765967},"labels":[],"label_agreement":null},{"id":"W2156531035","doi":"10.1093/neuonc/nou145","title":"SIRT1 is required for oncogenic transformation of neural stem cells and for the survival of “cancer cells with neural stemness” in a p53-dependent manner","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Sirtuins and Resveratrol in Medicine","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Cancer stem cell; Neural stem cell; Cancer research; Glioma; Biology; Stem cell; Cancer; Cancer cell; Neurosphere; Cell biology; Cellular differentiation; Adult stem cell; Genetics; Gene","score_opus":0.0335870261447588,"score_gpt":0.3149489624551224,"score_spread":0.2813619363103636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156531035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898507,0.0004538837,0.0012634819,0.005195398,0.0009164951,0.0021307718,0.000059030335,0.000013313871,0.000116946576],"genre_scores_gemma":[0.9977512,0.00027513524,0.00011772848,0.0012774975,0.00023792176,0.00021069421,0.000006088253,0.000032712906,0.00009106314],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984216,0.00014820631,0.0005903243,0.0002770517,0.00026639536,0.00029639967],"domain_scores_gemma":[0.9980661,0.0011267544,0.00028364058,0.0002495503,0.00018726081,0.000086672844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005819527,0.00018844298,0.0007099125,0.000120148594,0.000053563792,0.0000053656217,0.00013039171,0.00015667295,0.000017236373],"category_scores_gemma":[0.000025067802,0.000109532724,0.00011376342,0.0001375606,0.00022161168,0.000067421206,0.00002120254,0.00020372552,3.5914184e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064116684,0.00023985626,0.001734163,0.00087029225,0.00011255667,0.000010553332,0.0025542856,0.0010112175,0.92344785,0.00013098508,0.00047335675,0.06300321],"study_design_scores_gemma":[0.043973975,0.025174329,0.004487055,0.0002547464,0.0014039008,0.0001323826,0.004270943,0.15162872,0.7373333,0.000059063103,0.030894939,0.00038668522],"about_ca_topic_score_codex":0.00007813953,"about_ca_topic_score_gemma":0.00019435937,"teacher_disagreement_score":0.18611458,"about_ca_system_score_codex":0.000049689916,"about_ca_system_score_gemma":0.00011562502,"threshold_uncertainty_score":0.44666147},"labels":[],"label_agreement":null},{"id":"W2158585200","doi":"10.1215/15228517-2007-028","title":"Neurocognitive function in same-sex twins following focal radiation for medulloblastoma","year":2007,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph; SickKids Foundation; Princess Margaret Cancer Centre; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Neurocognitive; Medulloblastoma; Cognition; Medicine; Social competence; Radiation therapy; Psychology; Pediatrics; Surgery; Psychiatry; Pathology; Social change","score_opus":0.021312282685982502,"score_gpt":0.3162762710732093,"score_spread":0.2949639883872268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158585200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915376,0.000120531455,0.0014118147,0.002322441,0.0011433094,0.0012662471,0.000009506566,0.00006978161,0.0021187796],"genre_scores_gemma":[0.99453056,0.00001918351,0.00032427904,0.004450846,0.0003345557,0.00022352708,0.00006696163,0.000033318585,0.000016740612],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.998635,0.00007747558,0.00034582888,0.0003754314,0.00016848806,0.0003977811],"domain_scores_gemma":[0.9984479,0.001104686,0.00010009357,0.0001369278,0.000059298436,0.00015109223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003211665,0.0001668538,0.0003727546,0.0003017491,0.00006896946,0.000008742499,0.000042833184,0.00018749862,0.0000274321],"category_scores_gemma":[0.00044808138,0.00015641034,0.00018106513,0.00025873104,0.00003219306,0.000074084106,0.00002237645,0.00019316476,0.000030191166],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025082794,0.0021880637,0.14595549,0.000037700927,0.00016875792,0.001989383,0.0008255373,0.000038030306,0.24031357,0.00036958695,0.0026391412,0.6029664],"study_design_scores_gemma":[0.03133432,0.01741463,0.5420952,0.00007057831,0.0008064804,0.00031853243,0.0010438942,0.0011002794,0.13449231,0.00050186063,0.2704325,0.00038946315],"about_ca_topic_score_codex":0.000042798292,"about_ca_topic_score_gemma":0.00038963158,"teacher_disagreement_score":0.602577,"about_ca_system_score_codex":0.0003419991,"about_ca_system_score_gemma":0.00012455048,"threshold_uncertainty_score":0.63782287},"labels":[],"label_agreement":null},{"id":"W2158757736","doi":"10.1093/neuonc/not026","title":"Trends in treatment and outcomes of pediatric craniopharyngioma, 1975-2011","year":2013,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":120,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Craniopharyngioma; Medicine; Diabetes insipidus; Body mass index; Pediatrics; Endocrine system; Obesity; Surgery; Internal medicine","score_opus":0.021566036764271407,"score_gpt":0.2972277741918184,"score_spread":0.27566173742754696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158757736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98924965,0.0008596546,8.4937125e-7,0.0015572221,0.00013237883,0.00031965735,0.000009265272,0.000020348907,0.007850967],"genre_scores_gemma":[0.9981674,0.000677618,0.00013676315,0.00040265155,0.00004839357,0.0000797142,0.000020730738,0.000013046913,0.00045367554],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991707,0.000048234175,0.00025428037,0.00023414618,0.00007405086,0.00021856297],"domain_scores_gemma":[0.99947023,0.00014197027,0.0000707741,0.00017108973,0.00002214563,0.00012379483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000030663796,0.0001576465,0.00050482404,0.00032875282,0.000021836446,0.0000030635556,0.000038563165,0.00009893638,0.0005818211],"category_scores_gemma":[0.000016463846,0.00010767808,0.00008444066,0.0001417462,0.00004360953,0.00005891626,0.000025624688,0.000066150824,0.00006912422],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010471288,0.0012935977,0.9355543,0.000011733702,0.000057200454,0.00019657674,0.00017699254,4.788908e-7,0.0018654693,0.000026045229,0.0010272712,0.0596856],"study_design_scores_gemma":[0.00868342,0.0035504624,0.98377675,0.0000016580767,0.00018705279,0.000069895555,0.00003925383,0.000026164693,0.00020365028,0.00013956078,0.0032441027,0.000078053024],"about_ca_topic_score_codex":0.0010089341,"about_ca_topic_score_gemma":0.00013692025,"teacher_disagreement_score":0.059607547,"about_ca_system_score_codex":0.000056020846,"about_ca_system_score_gemma":0.000057827252,"threshold_uncertainty_score":0.63705325},"labels":[],"label_agreement":null},{"id":"W2159481232","doi":"10.1093/neuonc/nos160","title":"Clinical and neuroanatomical predictors of cerebellar mutism syndrome","year":2012,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Advanced Neuroimaging Techniques and Applications","field":"Medicine","cited_by":141,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; Pediatric Oncology Group; University of Toronto; SickKids Foundation; Hospital for Sick Children; University of Calgary","funders":"Pediatric Oncology Group of Ontario; C17 Council","keywords":"Cerebellum; Medicine; White matter; Medulloblastoma; Magnetic resonance imaging; Psychology; Pathology; Radiology; Internal medicine","score_opus":0.06592830632750624,"score_gpt":0.39698570053557347,"score_spread":0.33105739420806723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159481232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99316806,0.00017501866,0.0006893306,0.0031597393,0.00033386517,0.00040793896,0.00000957687,0.0001554124,0.0019010603],"genre_scores_gemma":[0.99308056,0.00044777544,0.0042401836,0.0019787832,0.00016483245,0.000024943252,0.000005036107,0.000029527779,0.000028375594],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99878603,0.00011677293,0.00043146763,0.00027890693,0.0001163038,0.0002705315],"domain_scores_gemma":[0.9987446,0.0004385704,0.0001357349,0.00035510855,0.00003841924,0.0002875628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021577442,0.000121852,0.0004315549,0.000074258685,0.000039831564,0.0000021550693,0.00009410274,0.00016292813,0.0000296765],"category_scores_gemma":[0.00025323758,0.000109925604,0.00008298633,0.0001305086,0.0004236465,0.000060215974,0.00013431319,0.00045052948,0.000012370837],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001234202,0.0009116626,0.89398247,0.000054655422,0.000032674787,0.00015666478,0.00007374653,5.4136916e-7,0.068225026,0.0036687846,0.0054186527,0.027351698],"study_design_scores_gemma":[0.0015446632,0.0018705975,0.45615566,0.000019940977,0.00019923507,0.004590169,0.00001739649,0.00017132198,0.0068864105,0.0006489974,0.5277437,0.00015190634],"about_ca_topic_score_codex":0.0000035702096,"about_ca_topic_score_gemma":3.1242286e-7,"teacher_disagreement_score":0.52232504,"about_ca_system_score_codex":0.000021738408,"about_ca_system_score_gemma":0.00006389903,"threshold_uncertainty_score":0.44826362},"labels":[],"label_agreement":null},{"id":"W2160069052","doi":"10.1093/neuonc/nou099","title":"Incidence of brain metastasis at initial presentation of lung cancer","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":140,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services; University of Alberta","funders":"National Cancer Institute","keywords":"Lung cancer; Medicine; Cancer registry; Incidence (geometry); Brain metastasis; Cancer; Metastasis; Population; Stage (stratigraphy); Oncology; Internal medicine; Lung; Presentation (obstetrics); Surgery; Biology","score_opus":0.031008955155488592,"score_gpt":0.3815949542672334,"score_spread":0.3505859991117448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160069052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918092,0.0002498994,0.00046900703,0.0046490626,0.0002535972,0.00042031147,0.00004767757,0.000015470807,0.0020857945],"genre_scores_gemma":[0.996955,0.00006762364,0.0012210313,0.0014952563,0.00011260679,0.00005232023,0.000025812642,0.000014285594,0.00005605886],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99876046,0.00033044798,0.0003356478,0.00020466238,0.0002107279,0.00015804498],"domain_scores_gemma":[0.9984697,0.00085471384,0.00025271167,0.00022553695,0.00011400863,0.00008331487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028200314,0.0001034579,0.0004321849,0.000090293535,0.000028321878,0.0000015611224,0.000066320456,0.000072009185,0.00047061898],"category_scores_gemma":[0.00045941529,0.00008541556,0.00009899211,0.00013686599,0.0001293922,0.000041644886,0.00007196641,0.00009545386,0.000005847447],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017537727,0.0008594922,0.07876595,0.0005101119,0.0004777566,0.00017958062,0.0011685349,0.0002028277,0.75519013,0.001638068,0.017174583,0.14207919],"study_design_scores_gemma":[0.010517361,0.0075216396,0.06975228,0.00014341688,0.0016235736,0.00032700485,0.00014855612,0.0027831905,0.8173918,0.00027871024,0.089281596,0.0002308689],"about_ca_topic_score_codex":0.0003829018,"about_ca_topic_score_gemma":0.00022951576,"teacher_disagreement_score":0.14184833,"about_ca_system_score_codex":0.00011939437,"about_ca_system_score_gemma":0.00016277192,"threshold_uncertainty_score":0.5152948},"labels":[],"label_agreement":null},{"id":"W2160137787","doi":"10.1093/neuonc/nop015","title":"A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy","year":2009,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":298,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"National Center for Advancing Translational Sciences; National Center for Research Resources; National Cancer Institute","keywords":"Erlotinib; Medicine; Rash; Glioma; Internal medicine; Epidermal growth factor receptor; Oncology; Anaplastic astrocytoma; Erlotinib Hydrochloride; Gastroenterology; Cancer research; Cancer; Astrocytoma","score_opus":0.016010579187137056,"score_gpt":0.3083108920151955,"score_spread":0.29230031282805846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160137787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99608564,0.00018862082,6.622047e-7,0.0012928545,0.0001721634,0.0021373918,0.000023546434,0.000019703682,0.000079390695],"genre_scores_gemma":[0.99925953,0.00010994892,0.00013325292,0.00029087186,0.00006008495,0.000096966956,0.000035198806,0.000013449887,6.8324596e-7],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99874985,0.00009152389,0.00038273394,0.00030989837,0.00022173523,0.00024427648],"domain_scores_gemma":[0.99920547,0.00011463261,0.00027354006,0.00017298368,0.00010878558,0.00012456853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009050587,0.00018445446,0.00047082122,0.00024853597,0.000046472574,0.0000063094913,0.000046307745,0.000114379574,0.000015043152],"category_scores_gemma":[0.00006527139,0.00012711622,0.000056316334,0.00024811603,0.00006763503,0.00006623738,0.000015568095,0.0001270802,0.0000015755451],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21275759,0.04553742,0.03303514,0.000016228905,0.000081046834,0.0005656628,0.0011232061,0.0000025733693,0.03378293,0.000050506733,0.0001211037,0.6729266],"study_design_scores_gemma":[0.45683923,0.34470004,0.17124407,0.000089317866,0.00009248695,0.00004169205,0.00004062246,0.00008662569,0.025020376,0.000021584734,0.0016864537,0.00013749978],"about_ca_topic_score_codex":0.000012371723,"about_ca_topic_score_gemma":0.000030565923,"teacher_disagreement_score":0.6727891,"about_ca_system_score_codex":0.0000959177,"about_ca_system_score_gemma":0.00011420625,"threshold_uncertainty_score":0.51836485},"labels":[],"label_agreement":null},{"id":"W2163578269","doi":"10.1093/neuonc/nou263.10","title":"NC-10 * TRAINING THE BRAIN TO REPAIR ITSELF: AN EXERCISE TRIAL IN PEDIATRIC BRAIN TUMOR SURVIVORS","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Hospital for Sick Children; McMaster University; University of Toronto","funders":"","keywords":"White matter; Atrophy; Medicine; Fractional anisotropy; Hippocampal formation; Effects of sleep deprivation on cognitive performance; Cognition; Randomized controlled trial; Aerobic exercise; Working memory; Psychology; Physical therapy; Physical medicine and rehabilitation; Internal medicine; Neuroscience; Magnetic resonance imaging","score_opus":0.03290559737874166,"score_gpt":0.3259786453511155,"score_spread":0.2930730479723738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163578269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95050377,0.00009406562,0.000036448273,0.037316527,0.0018089893,0.0026089812,0.0000098323335,0.0003072177,0.0073141516],"genre_scores_gemma":[0.96908206,0.00007322586,0.0001853501,0.026727656,0.0025673492,0.00059491675,0.000015188381,0.00008718115,0.00066709245],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99626,0.0011079208,0.0007067317,0.00076877134,0.0003937867,0.00076278736],"domain_scores_gemma":[0.9950907,0.0037040156,0.00021630814,0.0005187144,0.00014909754,0.00032113335],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022835033,0.00034256416,0.0008925541,0.0004478972,0.00019188436,0.000017661736,0.000255653,0.00019951849,0.00022968516],"category_scores_gemma":[0.0069350083,0.00027181196,0.00020191947,0.00093096535,0.00016518864,0.000102939084,0.00017032445,0.0007700064,0.00016965742],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17572615,0.0045736297,0.049866647,0.00036096375,0.00028445714,0.0020945629,0.058518324,0.00031425024,0.018369,0.00045874406,0.42717373,0.26225954],"study_design_scores_gemma":[0.1324758,0.042005204,0.1030847,0.00015475674,0.0008052761,0.00039889017,0.0056859343,0.0014736899,0.0005231409,0.00029955845,0.71205986,0.0010331998],"about_ca_topic_score_codex":0.00017502496,"about_ca_topic_score_gemma":0.0015823956,"teacher_disagreement_score":0.28488612,"about_ca_system_score_codex":0.00030177805,"about_ca_system_score_gemma":0.0004765559,"threshold_uncertainty_score":0.9999734},"labels":[],"label_agreement":null},{"id":"W2165074304","doi":"10.1093/neuonc/nou253.28","title":"ED-28 * EFFECT OF VALPROIC ACID EXPOSURE ON SURVIVAL IN LOW-GRADE GLIOMA PATIENTS: A RETROSPECTIVE ANALYSIS","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"","keywords":"Valproic Acid; Medicine; Retrospective cohort study; Anticonvulsant; Glioma; Internal medicine; Medical prescription; Histone deacetylase inhibitor; Oncology; Epilepsy; Pediatrics; Pharmacology; Histone deacetylase; Psychiatry; Cancer research","score_opus":0.005730372881801133,"score_gpt":0.27745380481209575,"score_spread":0.27172343193029463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165074304","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974808,0.000051036855,0.00006221062,0.00012883532,0.00033973044,0.0004162547,0.000031401152,0.0000143955585,0.0014753388],"genre_scores_gemma":[0.9993849,0.000025351806,0.00003442614,0.000101609105,0.00019772806,0.000076554345,0.00011480112,0.000035677323,0.000028965225],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965276,0.0014970913,0.0004286937,0.0007073383,0.00039217883,0.00044711403],"domain_scores_gemma":[0.9986163,0.00025057507,0.00019877087,0.0006350352,0.00016799934,0.00013134058],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007506128,0.00025578035,0.0006824797,0.00044118156,0.000054556956,0.000009149425,0.00032593444,0.00039009456,0.000030443643],"category_scores_gemma":[0.0016144385,0.00021415565,0.00028191906,0.0007794714,0.00019739722,0.000004865331,0.00016602698,0.00038651517,0.00003076829],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007724002,0.00048105902,0.10319846,0.0000336518,0.00014029884,0.000031765572,0.000065343454,0.00010701368,0.8916534,0.000013567014,0.0006903617,0.0028126703],"study_design_scores_gemma":[0.0031525681,0.013553581,0.036438987,0.0000122199945,0.00008953456,0.00000503009,0.000011399906,0.00011408211,0.94251555,0.000009056246,0.0038968846,0.00020111793],"about_ca_topic_score_codex":0.00004761271,"about_ca_topic_score_gemma":0.00023458796,"teacher_disagreement_score":0.066759475,"about_ca_system_score_codex":0.00019397153,"about_ca_system_score_gemma":0.00010219169,"threshold_uncertainty_score":0.8733014},"labels":[],"label_agreement":null},{"id":"W2166237244","doi":"10.1093/neuonc/2.2.114","title":"Myeloablative chemotherapy for recurrent aggressiveoligodendroglioma","year":2000,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Health Services; Ottawa Regional Cancer Foundation; Western University","funders":"","keywords":"Medicine; ThioTEPA; Procarbazine; Lomustine; Chemotherapy; Etoposide; Surgery; Vincristine; Induction chemotherapy; Internal medicine; Gastroenterology; Cyclophosphamide","score_opus":0.02391226627360078,"score_gpt":0.32695566301959467,"score_spread":0.3030433967459939,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166237244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9673989,0.0009734022,0.000020369918,0.015089671,0.000439842,0.0014235401,0.000035035362,0.00010421615,0.014515045],"genre_scores_gemma":[0.98866206,0.0012637163,0.0014414992,0.006928018,0.00053871947,0.0007534254,0.0000642615,0.00006259494,0.00028571064],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987609,0.0000659455,0.00026465423,0.00039974818,0.00014611977,0.0003626721],"domain_scores_gemma":[0.99896663,0.00038259267,0.00010693751,0.00026487224,0.000093792914,0.00018519496],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00007802933,0.00020247207,0.00045897765,0.000110255605,0.00009071445,0.000010371231,0.00008435402,0.00015294469,0.0015270705],"category_scores_gemma":[0.00006940361,0.00016310794,0.00018835423,0.00017354415,0.00008795977,0.000041923202,0.000014061235,0.00013946719,0.00018174383],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020630183,0.0017320194,0.0017541436,0.00002614948,0.0001827071,0.0005597207,0.00052724435,0.000007548212,0.047809187,0.00030423416,0.026579402,0.91845465],"study_design_scores_gemma":[0.010810958,0.007277547,0.0041294647,0.000049666705,0.00017872984,0.0003910694,0.000040571267,0.00030760127,0.1137383,0.00036033418,0.8625477,0.00016804466],"about_ca_topic_score_codex":0.0000066333364,"about_ca_topic_score_gemma":0.000010451153,"teacher_disagreement_score":0.91828656,"about_ca_system_score_codex":0.00019078364,"about_ca_system_score_gemma":0.0001363207,"threshold_uncertainty_score":0.99938565},"labels":[],"label_agreement":null},{"id":"W2166733396","doi":"10.1093/neuonc/nor089","title":"Evolution of Mouse Models for Studying CNS Cancer: a Decade of Progress","year":2011,"lang":"en","type":"editorial","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Oncogene; Glioblastoma; Cancer research; Cancer cell; Biology; Neuroscience; Sophistication; Medicine; Bioinformatics; Cell cycle; Genetics","score_opus":0.04377436391679893,"score_gpt":0.344886863664218,"score_spread":0.30111249974741905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166733396","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16552222,0.010237827,0.00023115012,0.00047489387,0.8142266,0.006655213,0.0016705741,0.00011278875,0.0008686938],"genre_scores_gemma":[0.4942203,0.0037778623,0.0031298057,0.00009113177,0.490991,0.0068684956,0.0005068892,0.00029814584,0.00011638817],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99803287,0.00010189402,0.0006321246,0.0004804795,0.00041363237,0.0003389871],"domain_scores_gemma":[0.9971355,0.00088461384,0.00075754855,0.00039547967,0.0007065565,0.00012026285],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018985261,0.00028940223,0.0012561827,0.0002746625,0.000042614833,0.0000031904644,0.00018301074,0.000856083,0.000014596251],"category_scores_gemma":[0.00032195167,0.00024578162,0.00027207396,0.00013889819,0.0001664598,0.000045588164,0.00008990613,0.0003677421,0.0000015082376],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020390209,0.0039263964,0.0025199286,0.0011808444,0.0007079037,0.00005980511,0.00065529934,0.00009014474,0.019804738,0.0003389146,0.9542493,0.014427657],"study_design_scores_gemma":[0.018272303,0.016401006,0.0002538727,0.0006447622,0.004262607,0.000016693099,0.00017903626,0.0009270911,0.053294253,0.00046739844,0.9048646,0.00041637858],"about_ca_topic_score_codex":0.00047252205,"about_ca_topic_score_gemma":0.00021634727,"teacher_disagreement_score":0.32869807,"about_ca_system_score_codex":0.0006512534,"about_ca_system_score_gemma":0.0015209467,"threshold_uncertainty_score":0.99999946},"labels":[],"label_agreement":null},{"id":"W2167082098","doi":"10.1093/neuonc/not174","title":"CELL BIOLOGY AND SIGNALING","year":2013,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"ATP Synthase and ATPases Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Cell biology; Biology; Signal transduction; Cell; Computational biology; Genetics","score_opus":0.01753913539146212,"score_gpt":0.31213581658037276,"score_spread":0.29459668118891064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167082098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884827,0.00070692867,0.00030805884,0.0007880274,0.0001263068,0.00020929496,0.000006509726,0.000014893327,0.009357247],"genre_scores_gemma":[0.9969013,0.00038403747,0.000577366,0.0015073206,0.000300857,0.000054272223,0.000034417935,0.000020731128,0.0002197511],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989089,0.00016895885,0.00015737642,0.00036962732,0.000054319727,0.00034086077],"domain_scores_gemma":[0.9994296,0.00009863706,0.000050099687,0.00021406969,0.00006453297,0.00014307299],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011071762,0.00012395522,0.00015995807,0.00004513566,0.00008141539,0.00001847629,0.00015410726,0.00023750633,0.0002490363],"category_scores_gemma":[0.00010320644,0.00011045554,0.00004666092,0.000054742137,0.00016990626,0.0000038205085,0.00021459731,0.00015956564,0.00014650835],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023195866,0.000048726386,0.0017687633,0.000007701104,0.000009883934,0.000011357954,0.00001818423,0.000004405334,0.97353554,0.000041461328,0.005414737,0.01911603],"study_design_scores_gemma":[0.00044459238,0.00096359994,0.00016640523,0.0000012891813,0.0000063146217,0.000015498375,0.00006631753,0.000094169685,0.6625691,0.00014416306,0.3354149,0.000113679],"about_ca_topic_score_codex":0.000049714676,"about_ca_topic_score_gemma":0.0000052264827,"teacher_disagreement_score":0.33000016,"about_ca_system_score_codex":0.000011161746,"about_ca_system_score_gemma":0.00009779177,"threshold_uncertainty_score":0.45042464},"labels":[],"label_agreement":null},{"id":"W2170174897","doi":"10.1093/neuonc/nor015","title":"Early aging in adult survivors of childhood medulloblastoma: long-term neurocognitive, functional, and physical outcomes","year":2011,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":154,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Neurocognitive; Medicine; Pediatrics; Neuropsychology; Medulloblastoma; Cohort; Cognition; Psychiatry; Internal medicine","score_opus":0.023105340413426587,"score_gpt":0.2784390769293476,"score_spread":0.255333736515921,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170174897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997449,0.000047013426,0.0000036812264,0.0006598333,0.00023757906,0.00041080453,0.00000829436,0.00003236704,0.0011514326],"genre_scores_gemma":[0.9989395,0.000053159485,0.00004428237,0.0007746307,0.000077267505,0.00007270545,0.000007911797,0.000024882458,0.0000056663043],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99883395,0.00011503084,0.0002705052,0.000353787,0.00017392523,0.0002527816],"domain_scores_gemma":[0.9990505,0.00042500603,0.00011849693,0.00016746148,0.000104176615,0.00013438794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005875101,0.00018877929,0.00053379347,0.00020878762,0.000033600132,0.0000044358353,0.000053740056,0.00008607418,0.00004300295],"category_scores_gemma":[0.00016237798,0.00015277287,0.00010375803,0.00017253037,0.00014404238,0.000070393755,0.00007220826,0.00022219113,0.000019014671],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015998175,0.0030392564,0.97402894,0.000028275415,0.00008321551,0.0006879067,0.0015231498,3.90729e-7,0.010630482,0.00012518938,0.000026992211,0.009666221],"study_design_scores_gemma":[0.0047411784,0.0018965843,0.9805727,0.000039157872,0.00015519877,0.00013528902,0.0000967173,0.000008799301,0.012173877,0.00005168646,0.000034184042,0.00009462928],"about_ca_topic_score_codex":0.00018634007,"about_ca_topic_score_gemma":0.00028955127,"teacher_disagreement_score":0.009571592,"about_ca_system_score_codex":0.000038820956,"about_ca_system_score_gemma":0.00006870573,"threshold_uncertainty_score":0.6229897},"labels":[],"label_agreement":null},{"id":"W2170554416","doi":"10.1093/neuonc/nor171","title":"Tumor pseudoprogression following radiosurgery for vestibular schwannoma","year":2011,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":147,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Radiosurgery; Radiation therapy; Adverse effect; Surgery; Schwannoma; Radiology; Neurosurgery; Nuclear medicine; Internal medicine","score_opus":0.057367253044611745,"score_gpt":0.311265809697507,"score_spread":0.25389855665289524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170554416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9803876,0.00030483957,0.0010752276,0.001012796,0.0017533677,0.0011272641,0.0000032673724,0.00020998534,0.014125603],"genre_scores_gemma":[0.98057264,0.0000034851078,0.017391684,0.0011194769,0.00035105247,0.0002529237,0.000021917178,0.00006037932,0.00022644109],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981202,0.00011760627,0.00046166673,0.0005171762,0.00023695052,0.0005463985],"domain_scores_gemma":[0.99876875,0.00024709868,0.00017743297,0.00045142593,0.000073760224,0.00028151748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005615402,0.00023444918,0.00058697787,0.00024573933,0.00016734168,0.00001542474,0.00016773726,0.00014198392,0.00016318161],"category_scores_gemma":[0.0004370408,0.00020542128,0.00023634825,0.00021367703,0.00007974222,0.00011170683,0.00010585808,0.00023251984,0.000083684405],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004613874,0.002038269,0.054659907,0.0005632499,0.0006511795,0.08558441,0.0019142636,0.000005660968,0.6750034,0.0072904103,0.07263479,0.0950406],"study_design_scores_gemma":[0.011968832,0.015913542,0.0272646,0.0003113103,0.0012884737,0.00813802,0.00048290964,0.0019240226,0.07071807,0.00224841,0.85877246,0.00096933416],"about_ca_topic_score_codex":0.000008791905,"about_ca_topic_score_gemma":5.4750603e-7,"teacher_disagreement_score":0.7861377,"about_ca_system_score_codex":0.00011571069,"about_ca_system_score_gemma":0.0002038891,"threshold_uncertainty_score":0.8376837},"labels":[],"label_agreement":null},{"id":"W2171155897","doi":"10.1093/neuonc/not101","title":"Surgical resection of epidural disease improves local control following postoperative spine stereotactic body radiotherapy","year":2013,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":190,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Toronto Western Hospital; Princess Margaret Cancer Centre; Health Sciences Centre","funders":"","keywords":"Medicine; Radiosurgery; Surgery; Disease control; Radiation therapy; Epidural space; Overall survival; Spinal cord","score_opus":0.013121163603996764,"score_gpt":0.3086607069565182,"score_spread":0.2955395433525214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171155897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9755629,0.00062892074,0.0020926527,0.016837753,0.0007365806,0.0021830082,0.000010115229,0.000076794844,0.0018712898],"genre_scores_gemma":[0.99514145,0.000068274625,0.00037623517,0.003670444,0.00016927897,0.00016745643,0.000025092586,0.000038789563,0.00034299586],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9977177,0.00054153113,0.0005542919,0.00042242563,0.0003831927,0.00038088075],"domain_scores_gemma":[0.9984064,0.00039786636,0.00020605075,0.0003931205,0.00015077049,0.00044578002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031261684,0.00023604593,0.00071977975,0.0001815044,0.00006582033,0.000015327898,0.00012020622,0.000089533,0.0007151377],"category_scores_gemma":[0.00047318358,0.00019284635,0.00027945946,0.00017470487,0.00019569424,0.00022148818,0.000044806962,0.00029103702,0.00004463747],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016412918,0.004086442,0.023448922,0.0005799461,0.0016879516,0.006769626,0.00054190785,0.000075964905,0.85356086,0.0015906455,0.010514234,0.08073058],"study_design_scores_gemma":[0.14747693,0.05303871,0.505752,0.00035126417,0.0052802903,0.00076797884,0.0022240125,0.10247745,0.010709356,0.0007442981,0.1695366,0.0016410516],"about_ca_topic_score_codex":0.000081286766,"about_ca_topic_score_gemma":0.000004328062,"teacher_disagreement_score":0.8428515,"about_ca_system_score_codex":0.00018932334,"about_ca_system_score_gemma":0.00024793547,"threshold_uncertainty_score":0.7864046},"labels":[],"label_agreement":null},{"id":"W2171237157","doi":"10.1093/neuonc/noq017","title":"MGMT modulates glioblastoma angiogenesis and response to the tyrosine kinase inhibitor sunitinib","year":2010,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; The Metabolomics Innovation Centre","funders":"Pfizer","keywords":"Sunitinib; Angiogenesis; Temozolomide; Cancer research; Methyltransferase; Tyrosine-kinase inhibitor; Receptor tyrosine kinase; Vascular endothelial growth factor A; Vascular endothelial growth factor; Receptor; Medicine; Biology; Glioma; Internal medicine; Methylation; Cancer; VEGF receptors; Gene","score_opus":0.014411995022644855,"score_gpt":0.2836404248236927,"score_spread":0.2692284298010479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171237157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.955761,0.00020425975,0.0000015821961,0.042565957,0.0006034673,0.00059703685,0.00002735911,0.00006391212,0.00017539244],"genre_scores_gemma":[0.9945181,0.000032728236,0.00028869152,0.004542193,0.0003943165,0.0001526901,0.000006137719,0.00003456882,0.000030599243],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987622,0.00018928813,0.00022236172,0.0003557387,0.00015658722,0.00031382983],"domain_scores_gemma":[0.99816567,0.00092410966,0.00006346838,0.00043710863,0.00010993539,0.0002997384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029918892,0.00019194832,0.00031834035,0.00019145285,0.0001528842,0.000025814737,0.00009659887,0.00015618566,0.00010416748],"category_scores_gemma":[0.0007007486,0.00012716411,0.0000873393,0.0002904378,0.00013288617,0.000035365567,0.00012288055,0.00021552079,0.00010979668],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023414758,0.00046229784,0.01146344,0.0000070737706,0.000035700516,0.00085186324,0.00029959998,0.0000028440668,0.9556552,0.000086412176,0.006627097,0.022166977],"study_design_scores_gemma":[0.0030196498,0.00448771,0.10010234,0.000015866362,0.00016903014,0.0007641117,0.00010831406,0.000056111814,0.52591926,0.000022936532,0.36519998,0.0001346715],"about_ca_topic_score_codex":0.000049244263,"about_ca_topic_score_gemma":0.00044602735,"teacher_disagreement_score":0.42973593,"about_ca_system_score_codex":0.00005565729,"about_ca_system_score_gemma":0.00012019092,"threshold_uncertainty_score":0.5185602},"labels":[],"label_agreement":null},{"id":"W2171777157","doi":"10.1093/neuonc/not033","title":"Can the prognosis of individual patients with glioblastoma be predicted using an online calculator?","year":2013,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"World Health Organization","keywords":"Calculator; Medicine; Glioblastoma; Oncology; Internal medicine; Nomogram; Cancer; Computer science","score_opus":0.03407097024436354,"score_gpt":0.28458604800807713,"score_spread":0.25051507776371357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171777157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99540806,0.000019344807,0.0000013961459,0.0028193702,0.00011936181,0.0013440342,0.00020144558,0.000043056283,0.000043941294],"genre_scores_gemma":[0.9976207,0.0000039251117,0.00042318867,0.0015555675,0.00008606989,0.00012413523,0.00015262725,0.00003267215,0.0000011123873],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985729,0.00014875765,0.00030497837,0.0002902149,0.00038911062,0.00029405943],"domain_scores_gemma":[0.99882036,0.00016121713,0.00020589324,0.00032623435,0.00029096473,0.00019534526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000629021,0.00018601402,0.0003827618,0.00011941986,0.0000841989,0.000014362039,0.00014162895,0.00012713182,0.0001034289],"category_scores_gemma":[0.00007562641,0.00010655164,0.000059959406,0.00028273373,0.00019086446,0.000072518764,0.000077627155,0.00018816964,0.0000018986144],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023473412,0.006668846,0.9622385,0.000025562536,0.00028475022,0.00008086955,0.0009175752,0.00005103394,0.013024139,0.00002196595,0.00089991366,0.015552108],"study_design_scores_gemma":[0.005848069,0.011934466,0.96479475,0.000042306565,0.0006525204,0.000069392496,0.0002823437,0.00069637044,0.013707361,0.000008881091,0.0018445735,0.00011898216],"about_ca_topic_score_codex":0.0003199547,"about_ca_topic_score_gemma":0.0003448303,"teacher_disagreement_score":0.015433126,"about_ca_system_score_codex":0.000106811334,"about_ca_system_score_gemma":0.0002216657,"threshold_uncertainty_score":0.434505},"labels":[],"label_agreement":null},{"id":"W2171839817","doi":"10.1093/neuonc/nou208.33","title":"IDENTIFYING DRUG COMPOUNDS TARGETING TUMOR METABOLISM IN GLIOBLASTOMAS","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Warburg effect; Gene knockdown; Glycolysis; Cancer research; Hexokinase; Anaerobic glycolysis; Biology; Reprogramming; In vivo; Cell culture; Oxidative phosphorylation; Cell biology; Gene; Enzyme; Biochemistry; Genetics","score_opus":0.010587034855781571,"score_gpt":0.26833537957977455,"score_spread":0.257748344723993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171839817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832887,0.0033132078,0.0005474596,0.00051677885,0.0057414686,0.00027337228,0.00001041153,0.00004947851,0.006259118],"genre_scores_gemma":[0.99117094,0.00048606776,0.0012628915,0.0029004067,0.0038177331,0.00006315411,0.00004562351,0.000059004877,0.00019419093],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99769914,0.00043157302,0.00046436454,0.00064578775,0.00018110358,0.0005780364],"domain_scores_gemma":[0.99905634,0.0000937607,0.00020553776,0.0003983079,0.00008496901,0.0001610684],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00064717775,0.00026543112,0.0004825545,0.00016139894,0.000117413314,0.000037628313,0.0003676639,0.00018256326,0.00003667096],"category_scores_gemma":[0.0003866986,0.00027852735,0.0001557835,0.00021223581,0.00013636787,0.000011469708,0.00026822914,0.0003447392,0.000044604134],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012582232,0.00009131914,0.00054829253,0.000019042194,0.000017632437,0.000011642307,0.000202686,0.00006183015,0.97264916,0.00029335293,0.018944794,0.007034421],"study_design_scores_gemma":[0.0013991065,0.000129068,0.0014831356,0.000006556768,0.000028081915,0.00007200717,0.000101129786,0.00011560919,0.18762545,0.00017152452,0.80863285,0.00023547403],"about_ca_topic_score_codex":0.00011879079,"about_ca_topic_score_gemma":0.0005486649,"teacher_disagreement_score":0.78968805,"about_ca_system_score_codex":0.000041979663,"about_ca_system_score_gemma":0.00017828068,"threshold_uncertainty_score":0.9999667},"labels":[],"label_agreement":null},{"id":"W2171964132","doi":"10.1093/neuonc/nov054","title":"The relationship between corticosteroids and symptoms in patients with primary brain tumors: utility of the Dexamethasone Symptom Questionnaire–Chronic","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Adrenal Hormones and Disorders","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Cronbach's alpha; Medicine; Corticosteroid; Analysis of variance; Construct validity; Internal medicine; Dexamethasone; Psychometrics; Physical therapy; Clinical psychology","score_opus":0.024201121743294016,"score_gpt":0.28281930809083605,"score_spread":0.258618186347542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171964132","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99484515,0.0004721681,0.00006193662,0.003353512,0.00008348166,0.000630961,0.0000050179347,0.000018091527,0.0005297034],"genre_scores_gemma":[0.99930644,0.0000055525197,0.0000337828,0.0005461744,0.000041986543,0.000020853031,0.000011436069,0.000015113884,0.000018636018],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985537,0.00038645146,0.00035792604,0.00022015451,0.0002615538,0.00022020546],"domain_scores_gemma":[0.9977896,0.0014480919,0.00019486205,0.00033430467,0.0001093318,0.00012379515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000421172,0.00012524855,0.00030194334,0.000049267062,0.000085465246,0.0000072467096,0.00011630448,0.000111027904,0.0000021389965],"category_scores_gemma":[0.0014939681,0.00006946491,0.00003492569,0.0002491209,0.00048033113,0.0000671203,0.00010505208,0.00035336526,0.0000023622056],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000507532,0.00012506991,0.9810216,0.000027398872,0.000013813191,0.0000038184166,0.00026653663,0.000003298257,0.000049920454,0.00014815113,0.00020242615,0.017630477],"study_design_scores_gemma":[0.004266003,0.0028431893,0.9913833,0.00007695182,0.0000614938,0.000014988263,0.00007645939,0.000055792414,0.000022968718,0.0004804635,0.000653065,0.00006528771],"about_ca_topic_score_codex":0.000072467745,"about_ca_topic_score_gemma":0.00015198255,"teacher_disagreement_score":0.017565189,"about_ca_system_score_codex":0.00019357905,"about_ca_system_score_gemma":0.0005556705,"threshold_uncertainty_score":0.2832697},"labels":[],"label_agreement":null},{"id":"W2175100525","doi":"10.1093/neuonc/nov244","title":"Directly visualized glioblastoma-derived extracellular vesicles transfer RNA to microglia/macrophages in the brain","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":317,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Neurological Disorders and Stroke; National Institute of Diabetes and Digestive and Kidney Diseases; Canadian Institutes of Health Research; National Institute on Aging; National Cancer Institute; National Institutes of Health; Common Fund; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; National Institute of Allergy and Infectious Diseases; Voices Against Brain Cancer","keywords":"Microglia; Extracellular vesicles; Glioblastoma; Extracellular; Chemistry; Cell biology; Microvesicles; Vesicle; RNA; Biophysics; microRNA; Biology; Cancer research; Immunology; Gene; Inflammation; Biochemistry; Membrane","score_opus":0.018230575410621435,"score_gpt":0.30373661421769554,"score_spread":0.2855060388070741,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2175100525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890026,0.0031685564,0.0012925648,0.004388168,0.00038763037,0.00078014954,0.000031482967,0.000049469138,0.0008993807],"genre_scores_gemma":[0.99149424,0.00008230232,0.0009781641,0.0066244244,0.0003687105,0.00016108487,0.000040663846,0.00007910038,0.00017130453],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965646,0.0012190958,0.0005036432,0.00077249715,0.00030407167,0.00063604006],"domain_scores_gemma":[0.9984842,0.00021472611,0.00007628126,0.0007534121,0.00010705914,0.00036432847],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009433851,0.00035686238,0.00038074356,0.00013142309,0.00009318474,0.000056283665,0.0008316094,0.00033135718,0.00003720848],"category_scores_gemma":[0.0007070943,0.00030885622,0.00017967806,0.00033628754,0.000234524,0.0000112288635,0.00018373375,0.00031935208,0.00011261273],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010879353,0.0004508237,0.0001838619,0.000013978286,0.00002834037,0.00063106517,0.001134514,0.0000694636,0.9764438,0.00010040177,0.010999778,0.008856038],"study_design_scores_gemma":[0.001970604,0.0014724437,0.00016658223,0.0000067770775,0.000028096762,0.00010724736,0.0004587895,0.000039291765,0.7257803,0.00009774659,0.26961073,0.00026140455],"about_ca_topic_score_codex":0.000027272452,"about_ca_topic_score_gemma":0.00021480735,"teacher_disagreement_score":0.25861093,"about_ca_system_score_codex":0.00007847544,"about_ca_system_score_gemma":0.00032013192,"threshold_uncertainty_score":0.99993634},"labels":[],"label_agreement":null},{"id":"W2186297468","doi":"10.1093/neuonc/nov266","title":"Different spatial distributions of brain metastases from lung cancer by histological subtype and mutation status of epidermal growth factor receptor","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Japan Society for the Promotion of Science; Life Science Foundation of Japan; Aichi Cancer Research Foundation","keywords":"Epidermal growth factor receptor; Pathology; Lung cancer; Medicine; Exon; Adenocarcinoma; Lung; White matter; Brain metastasis; Cancer; Oncology; Biology; Internal medicine; Magnetic resonance imaging; Radiology; Metastasis; Gene","score_opus":0.03701392400619031,"score_gpt":0.32824155044515824,"score_spread":0.29122762643896793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2186297468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986465,0.0022766665,0.0019389415,0.0034957197,0.00032434158,0.0003841297,0.0050479975,0.000019598474,0.000047618254],"genre_scores_gemma":[0.9973093,0.00025990632,0.00075512455,0.0002910889,0.000064773354,0.000044741937,0.0012530959,0.000012173944,0.000009760998],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984912,0.00040429906,0.0003836226,0.00027324687,0.00019370396,0.0002538821],"domain_scores_gemma":[0.9982747,0.00085503416,0.00028837475,0.00014001084,0.00015284498,0.00028906803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008990911,0.00016222744,0.00061404955,0.00005155541,0.000031390562,0.0000033528024,0.000044203556,0.000111480425,0.0003376],"category_scores_gemma":[0.0010043286,0.00011864069,0.00007919887,0.00007700945,0.00021364204,0.00003840842,0.000048171598,0.00014757627,0.0000016901009],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003714687,0.0033860086,0.4259048,0.00018247051,0.0009397652,0.00025913,0.0013318614,0.000009396672,0.4336278,0.0012475642,0.057599492,0.07179698],"study_design_scores_gemma":[0.02702529,0.017553583,0.4930841,0.00010020188,0.003187298,0.0001554144,0.000683162,0.001078179,0.3530489,0.000673753,0.10279884,0.0006112774],"about_ca_topic_score_codex":0.0036645487,"about_ca_topic_score_gemma":0.00028239322,"teacher_disagreement_score":0.08057893,"about_ca_system_score_codex":0.00030615993,"about_ca_system_score_gemma":0.00030804332,"threshold_uncertainty_score":0.5539726},"labels":[],"label_agreement":null},{"id":"W2215255387","doi":"10.1093/neuonc/nov290","title":"Response to “Insulin-like growth factor 1 receptor signaling via Akt: a general therapeutic target in neurocutaneous melanocytosis?”","year":2015,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Children's Hospital","funders":"Morgan Family Foundation; Silicon Valley Community Foundation","keywords":"Protein kinase B; Insulin receptor; Insulin-like growth factor; Cancer research; Growth factor; Signal transduction; Insulin; Receptor; Medicine; Biology; Cell biology; Internal medicine; Insulin resistance","score_opus":0.023775811184897133,"score_gpt":0.2844800602335965,"score_spread":0.2607042490486994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2215255387","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.62195873,0.0036014887,0.0017272943,0.35471806,0.012874887,0.0030881881,0.0010995053,0.0002878166,0.0006440237],"genre_scores_gemma":[0.14789675,0.00024340622,0.0029645497,0.83725494,0.008581232,0.00052056543,0.0009003991,0.00057039293,0.0010677956],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9919116,0.0027835062,0.0010533491,0.0020677948,0.00071327895,0.0014704937],"domain_scores_gemma":[0.9967932,0.00066532684,0.0005240289,0.0011864633,0.00043713802,0.00039382107],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0007970343,0.0010709601,0.0012629543,0.0005169622,0.00012238757,0.00007864347,0.0014110775,0.0028073853,0.00022232394],"category_scores_gemma":[0.000830345,0.0011163894,0.0003709871,0.00045938516,0.00021254102,0.000011044659,0.00052290346,0.0025679779,0.00024847678],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030060967,0.00008392457,0.000088511675,0.000037157628,0.00010012111,0.0014336783,0.00017037369,0.00028431255,0.6683261,7.012668e-7,0.32543975,0.0010292955],"study_design_scores_gemma":[0.001312425,0.0044258,0.0000134264255,0.000028895502,0.000059927683,0.0005129058,0.000008629558,0.000058238384,0.18554263,0.00007613979,0.8070867,0.00087424926],"about_ca_topic_score_codex":0.000109103676,"about_ca_topic_score_gemma":0.000049981278,"teacher_disagreement_score":0.48278344,"about_ca_system_score_codex":0.00080596376,"about_ca_system_score_gemma":0.0017439341,"threshold_uncertainty_score":0.99973315},"labels":[],"label_agreement":null},{"id":"W2258249884","doi":"10.1093/neuonc/nov321","title":"Core pathway mutations induce de-differentiation of murine astrocytes into glioblastoma stem cells that are sensitive to radiation but resistant to temozolomide","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Neurological Disorders and Stroke; National Cancer Institute; National Institutes of Health; National Science Council; Damon Runyon Cancer Research Foundation; National Institute of Environmental Health Sciences; Cancer Research Society; American Association for Cancer Research; Howard Hughes Medical Institute; U.S. Department of Defense","keywords":"Biology; Temozolomide; Transcriptome; Cancer research; Stem cell; Chromatin; Cellular differentiation; Glioma; Cell biology; Molecular biology; Genetics; Gene expression; Gene","score_opus":0.028498984397421028,"score_gpt":0.28197416509867446,"score_spread":0.2534751807012534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2258249884","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928023,0.000021001319,0.0004430225,0.0053471285,0.0002636887,0.0009125318,0.0000855049,0.00005501877,0.00006976624],"genre_scores_gemma":[0.998115,0.00001985209,0.0005898862,0.00093294546,0.00010634074,0.00015990077,0.000012812786,0.00003038359,0.000032858214],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99854296,0.00017461853,0.0003601432,0.00039127222,0.00023653921,0.00029447448],"domain_scores_gemma":[0.99820167,0.00070611865,0.00028167915,0.00028105892,0.00024189103,0.0002875627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013106117,0.0001997143,0.00045844947,0.00033436634,0.00007651742,0.000009446094,0.000071881324,0.000143807,0.000034727887],"category_scores_gemma":[0.00020549179,0.00014847422,0.000091356065,0.00025599828,0.000047110305,0.000062480576,0.00006731276,0.00009598304,0.000093989176],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009976702,0.00041452475,0.01456221,0.00003066884,0.000067430985,0.0002550506,0.0009303592,0.00004271627,0.94355446,0.00007877618,0.0007171413,0.038348965],"study_design_scores_gemma":[0.0023509425,0.0034988178,0.11125306,0.00012213891,0.00011203338,0.000041700532,0.0005837106,0.00002934455,0.8800398,0.000016977376,0.0018452125,0.00010627462],"about_ca_topic_score_codex":0.00006119884,"about_ca_topic_score_gemma":0.00031863523,"teacher_disagreement_score":0.09669085,"about_ca_system_score_codex":0.0006882509,"about_ca_system_score_gemma":0.00019968442,"threshold_uncertainty_score":0.6054603},"labels":[],"label_agreement":null},{"id":"W2271764074","doi":"10.1093/neuonc/nov327","title":"Exploiting drug repositioning and the brain microenvironment to treat brain metastases","year":2016,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"Canadian Institutes of Health Research; Cure Brain Cancer Foundation; Israel Cancer Research Fund","keywords":"Drug; Brain cancer; Medicine; Brain metastasis; Drug repositioning; Neuroscience; Psychology; Pharmacology; Internal medicine; Metastasis; Cancer","score_opus":0.01845121143797394,"score_gpt":0.27971043668156786,"score_spread":0.2612592252435939,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2271764074","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012389332,0.0010134539,0.00021692956,0.98207,0.00037563115,0.0017368731,0.00018902285,0.000076485405,0.0019322399],"genre_scores_gemma":[0.002665867,0.00025529996,0.0019244638,0.9870291,0.0032157167,0.00056336075,0.00029780576,0.00013023514,0.003918168],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956116,0.0016117089,0.0006547645,0.0010071794,0.0003908512,0.0007238928],"domain_scores_gemma":[0.99268407,0.0058798604,0.00036926972,0.0008115723,0.00003808802,0.0002171542],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00094350684,0.0005694502,0.0012316741,0.00020985097,0.00030547768,0.00006083597,0.00018703981,0.00033803025,0.00030675437],"category_scores_gemma":[0.0006106679,0.00032944293,0.0003322137,0.00011293287,0.0004386003,0.00005738389,0.00028272127,0.001079409,0.0001459489],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045639966,0.000076904995,0.00004459312,0.00010340905,0.0002604108,0.006890714,0.0004851359,0.0000013002286,0.018930757,0.00008504927,0.933812,0.03885331],"study_design_scores_gemma":[0.006780333,0.0011301246,0.00004522252,0.00018639442,0.0009574265,0.003610071,0.00015036786,0.000003147613,0.0039119595,0.00012759828,0.9828262,0.00027120093],"about_ca_topic_score_codex":0.00010037258,"about_ca_topic_score_gemma":0.0000124656335,"teacher_disagreement_score":0.04901414,"about_ca_system_score_codex":0.0004473586,"about_ca_system_score_gemma":0.00014229763,"threshold_uncertainty_score":0.9999158},"labels":[],"label_agreement":null},{"id":"W2273808592","doi":"10.1093/neuonc/nov102","title":"Controversies in neuro-oncology: role of whole-brain radiation therapy in the treatment of newly diagnosed brain metastases","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Radiation therapy; Radiation oncology; Oncology; Internal medicine; Brain tumor; Pathology","score_opus":0.034421594087028815,"score_gpt":0.3224086690616717,"score_spread":0.2879870749746429,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2273808592","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9326869,0.0033591609,0.00001082243,0.060897496,0.00025263033,0.0018928933,0.00011247958,0.000019173649,0.00076842715],"genre_scores_gemma":[0.987686,0.00092436344,0.00034607903,0.010472063,0.00013227364,0.00027867514,0.000107813146,0.000031518226,0.00002125909],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.996188,0.0019413867,0.00072848366,0.000410616,0.0003316134,0.00039989853],"domain_scores_gemma":[0.9887573,0.010101051,0.00040891097,0.00048734577,0.00009835115,0.00014702507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096981245,0.00030349373,0.0011315513,0.00036225136,0.0000317639,0.000008660848,0.00018373411,0.00018835146,0.000043079704],"category_scores_gemma":[0.0017729363,0.00020352262,0.00022135436,0.00047063528,0.00024728524,0.000077737204,0.000027763674,0.00021621531,0.000010274136],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0074056294,0.01593719,0.07797332,0.000037430542,0.00044730128,0.0026859215,0.02053613,0.0005607349,0.20397131,0.001293236,0.026238652,0.64291316],"study_design_scores_gemma":[0.04847175,0.045641586,0.028371232,0.000017920578,0.00022540937,0.00015146055,0.0055570984,0.00024376309,0.015027515,0.00044898165,0.85567886,0.00016442483],"about_ca_topic_score_codex":0.0010238729,"about_ca_topic_score_gemma":0.00090154994,"teacher_disagreement_score":0.82944024,"about_ca_system_score_codex":0.00049577875,"about_ca_system_score_gemma":0.0006761532,"threshold_uncertainty_score":0.8299412},"labels":[],"label_agreement":null},{"id":"W2276391444","doi":"10.1093/neuonc/nov300","title":"Bevacizumab, temozolomide, and radiotherapy for newly diagnosed glioblastoma: comprehensive safety results during and after first-line therapy","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"F. Hoffmann-La Roche; Roche","keywords":"Bevacizumab; Temozolomide; Medicine; Placebo; Radiation therapy; Adverse effect; Surgery; Internal medicine; Oncology; Chemotherapy; Pathology","score_opus":0.01716518308352756,"score_gpt":0.28547534996101476,"score_spread":0.2683101668774872,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2276391444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9726939,0.0035533512,0.000047453937,0.021595085,0.0002519627,0.001582242,0.00013551193,0.000074384014,0.00006608292],"genre_scores_gemma":[0.97979605,0.016186751,0.000633159,0.0024771893,0.00032614224,0.00047417055,0.000009480846,0.00005697736,0.00004010416],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99827886,0.00010071066,0.00043938123,0.00063450064,0.00013288119,0.00041364648],"domain_scores_gemma":[0.9968228,0.0023066534,0.00015804064,0.00033834533,0.00012334327,0.0002508257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010022573,0.00030957075,0.00067437574,0.00015604039,0.00015534667,0.000017494196,0.00006310136,0.00020688666,0.000046187102],"category_scores_gemma":[0.00017566385,0.00019785765,0.00011070793,0.00010162819,0.00021700504,0.00008331156,0.000053216925,0.00011302068,0.0000061767323],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0816634,0.001554129,0.05825385,0.00014249625,0.0005170588,0.0024419895,0.0011839031,0.000007255536,0.50975233,0.00007471465,0.0038120972,0.3405968],"study_design_scores_gemma":[0.12834163,0.01501466,0.4061164,0.00015850998,0.00016233123,0.00085536693,0.000058736037,0.00006961584,0.055339407,0.00009625755,0.3934206,0.0003664843],"about_ca_topic_score_codex":0.000015206026,"about_ca_topic_score_gemma":0.00014901668,"teacher_disagreement_score":0.4544129,"about_ca_system_score_codex":0.00019343685,"about_ca_system_score_gemma":0.000064990294,"threshold_uncertainty_score":0.80684006},"labels":[],"label_agreement":null},{"id":"W2283437114","doi":"10.1093/neuonc/nov165","title":"Neddylation in glioblastomas","year":2015,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Neddylation; NEDD8; Cullin; Ubiquitin ligase; Ubiquitin; Cell biology; Cell cycle; Biology; Cancer cell; Protein degradation; Chemistry; Biochemistry; Cancer; Cell; Genetics","score_opus":0.025477685778436256,"score_gpt":0.2814523645490649,"score_spread":0.2559746787706287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2283437114","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10758277,0.0025880209,0.00022889157,0.7502056,0.0060432046,0.002499093,0.00029344638,0.00017626016,0.13038273],"genre_scores_gemma":[0.02981482,0.0002529506,0.00051594374,0.9528929,0.012124967,0.0002825384,0.0021191558,0.0001841988,0.0018124962],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977486,0.00048734568,0.00037618095,0.0006752605,0.00022034286,0.0004922385],"domain_scores_gemma":[0.9989961,0.00006986338,0.00022225721,0.0005072577,0.000118366894,0.00008619801],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00031593093,0.00032712225,0.00041099716,0.00017815396,0.000036579066,0.000020167447,0.00036412422,0.0020494936,0.0000813531],"category_scores_gemma":[0.00028208227,0.0003430991,0.00011858134,0.00013717635,0.00010450612,0.0000034421926,0.00021453136,0.0013147921,0.00018445506],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008696506,0.00003208913,0.00010307308,0.000028776007,0.000012873302,0.00043426527,0.00004550144,0.000011130991,0.22528756,0.000005882944,0.7693085,0.0046433886],"study_design_scores_gemma":[0.00074753776,0.0013565319,0.000023039718,0.0000122675465,0.000016055912,0.00016327607,0.000008715599,0.000020288428,0.045714926,0.00018451782,0.95145345,0.00029941037],"about_ca_topic_score_codex":0.000031087402,"about_ca_topic_score_gemma":0.00014195456,"teacher_disagreement_score":0.20268734,"about_ca_system_score_codex":0.00012613348,"about_ca_system_score_gemma":0.0006344132,"threshold_uncertainty_score":0.9999021},"labels":[],"label_agreement":null},{"id":"W2288156681","doi":"10.1093/neuonc/nox025","title":"Is more better? The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma: a secondary analysis of EORTC and NRG Oncology/RTOG","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":164,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"EMD Serono; National Cancer Institute; NRG Oncology; Merck KGaA","keywords":"Temozolomide; Glioblastoma; Oncology; Internal medicine; Medicine; Adjuvant; Cancer research","score_opus":0.020283679572136837,"score_gpt":0.34666982465970225,"score_spread":0.3263861450875654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2288156681","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892336,0.0005890916,0.0000016761605,0.008043949,0.00012608158,0.0006800775,0.00013029974,0.000015769372,0.0011794558],"genre_scores_gemma":[0.9980107,0.00038623772,0.000105291714,0.001278089,0.000060069986,0.00010917343,0.000017986584,0.000025764832,0.0000066744365],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978776,0.00025556638,0.0007198605,0.0005114845,0.00022894288,0.0004065528],"domain_scores_gemma":[0.9965913,0.0012331627,0.0008026429,0.0010438538,0.00013672732,0.0001922789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037795783,0.00030064868,0.001633437,0.00058582326,0.00012956353,0.000016675023,0.00030712553,0.00028710047,0.00024246133],"category_scores_gemma":[0.0005046895,0.00019220705,0.00050952233,0.0004065551,0.00065816473,0.00009584725,0.00022716598,0.00040229026,0.000004873081],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013982578,0.0023231579,0.7717508,0.00004389919,0.0023508305,0.0026866272,0.002313375,0.000048816906,0.09994697,0.000021283007,0.0033509913,0.11376497],"study_design_scores_gemma":[0.009440542,0.005688798,0.9653162,0.000038574617,0.0022285795,0.00014309169,0.00034619897,0.00086119754,0.014411703,0.000078344,0.0013180533,0.00012872543],"about_ca_topic_score_codex":0.0017038092,"about_ca_topic_score_gemma":0.0020633757,"teacher_disagreement_score":0.19356537,"about_ca_system_score_codex":0.00029190807,"about_ca_system_score_gemma":0.0005186101,"threshold_uncertainty_score":0.7837976},"labels":[],"label_agreement":null},{"id":"W2290142603","doi":"10.1093/neuonc/nov284.73","title":"PO84WHOLE BRAIN RADIOTHERAPY (WBRT) FOLLOWING RESECTION OF BRAIN METASTASES: WHO DECIDES? AN AUDIT OF OUTCOMES AND CLINICIAN CONFIDENCE","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Christie (Canada)","funders":"","keywords":"Medicine; Whole brain radiotherapy; Confidence interval; Radiation therapy; Demographics; Audit; Brain metastasis; Internal medicine; Surgery; Oncology; Cancer; Metastasis","score_opus":0.05973711623780459,"score_gpt":0.3947136780242664,"score_spread":0.3349765617864618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2290142603","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853016,0.0012384848,0.0013382788,0.010378691,0.00052953867,0.0006853669,0.000043258035,0.000037377245,0.00044741097],"genre_scores_gemma":[0.98735636,0.00012368619,0.005877489,0.0062838607,0.0001259403,0.000028705128,0.00003273777,0.00004053227,0.00013066546],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973607,0.00087247166,0.0006918549,0.00044261108,0.00034416857,0.000288195],"domain_scores_gemma":[0.996501,0.0021357914,0.00040574282,0.00049472373,0.0001490537,0.00031364415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018249477,0.00022375937,0.0010929018,0.00023018451,0.000052029078,0.000010881014,0.0001252052,0.00016307105,0.000053024978],"category_scores_gemma":[0.002109635,0.00018183926,0.00021761938,0.00025569103,0.00022472056,0.00015387626,0.000052009116,0.00022411834,0.0000033142294],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066450066,0.0037510956,0.43426865,0.00030140477,0.002556111,0.0021201149,0.005791846,0.00013209751,0.35165462,0.0048071523,0.0353906,0.1525813],"study_design_scores_gemma":[0.09598218,0.15425241,0.22869062,0.00057404634,0.0035148035,0.0023639684,0.009085148,0.0020059396,0.08907537,0.006060255,0.40699026,0.001405005],"about_ca_topic_score_codex":0.0003942871,"about_ca_topic_score_gemma":0.00029264984,"teacher_disagreement_score":0.37159964,"about_ca_system_score_codex":0.00013269963,"about_ca_system_score_gemma":0.00043307795,"threshold_uncertainty_score":0.741519},"labels":[],"label_agreement":null},{"id":"W2291628201","doi":"10.1093/neuonc/nov125","title":"Metabolic reprogramming in glioblastoma: the influence of cancer metabolism on epigenetics and unanswered questions","year":2015,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":299,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Toronto Western Hospital; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Warburg effect; Reprogramming; Oxidative phosphorylation; Citric acid cycle; Biology; Anaerobic glycolysis; Glycolysis; Epigenetics; Metabolism; Metabolic pathway; Cancer research; Cell biology; Biochemistry; Cell; Gene","score_opus":0.026860976900807056,"score_gpt":0.34926303973691314,"score_spread":0.32240206283610606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2291628201","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018750576,0.9784657,0.000004239663,0.00011174333,0.0014006452,0.0009789248,0.0001201242,0.000014257356,0.00015380977],"genre_scores_gemma":[0.0014116148,0.9962411,0.00012745368,0.0003109329,0.0011915836,0.00056678074,0.00002215731,0.00007463095,0.000053751846],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99686646,0.000760472,0.00084543263,0.00081957644,0.00023381089,0.00047425288],"domain_scores_gemma":[0.9979212,0.00016418904,0.0006423834,0.00088230835,0.0002191143,0.00017075425],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006364287,0.0004962511,0.0017629381,0.00022769754,0.000074476295,0.00002132697,0.00051829085,0.0006964454,0.0000051477887],"category_scores_gemma":[0.00052324426,0.0003670833,0.0002896883,0.00047981177,0.0004249964,0.0000056368644,0.00030431442,0.0006143547,0.0000044944136],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007220018,0.00011423896,0.000013248779,0.00046182275,0.00013607774,0.000006671081,0.000112990194,0.00016986075,0.0068821493,0.00031287997,0.00047816453,0.99123967],"study_design_scores_gemma":[0.00060129893,0.00035991485,0.00015338151,0.00034555222,0.00082055625,0.00007148199,0.000022475488,0.0000016834099,0.0009139391,0.000048076006,0.9963589,0.0003027977],"about_ca_topic_score_codex":0.00031941076,"about_ca_topic_score_gemma":0.0011618637,"teacher_disagreement_score":0.99588066,"about_ca_system_score_codex":0.000052014704,"about_ca_system_score_gemma":0.0014383807,"threshold_uncertainty_score":0.9998781},"labels":[],"label_agreement":null},{"id":"W2293049256","doi":"10.1093/neuonc/now005","title":"Decrease of VEGF-A in myeloid cells attenuates glioma progression and prolongs survival in an experimental glioma model","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute","funders":"Deutsche Krebshilfe","keywords":"Glioma; Cancer research; VEGF receptors; Medicine; Myeloid cells; Myeloid","score_opus":0.01893953465725567,"score_gpt":0.3116228432250211,"score_spread":0.2926833085677654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2293049256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983777,0.00085886475,0.00003341722,0.00021284776,0.00011481654,0.0002508723,0.000016220974,0.0000067865594,0.00012846697],"genre_scores_gemma":[0.9991276,0.00012985666,0.00039289633,0.00014149517,0.00007889747,0.0000860814,0.000010443798,0.000024237928,0.000008438649],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99874884,0.00016343767,0.00027884718,0.00043907808,0.000099351535,0.00027046466],"domain_scores_gemma":[0.9994667,0.00003678118,0.00010995667,0.00021871382,0.00004376122,0.00012405659],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018469515,0.00015817692,0.00024804324,0.000100518046,0.000023480565,0.0000057419516,0.00015035622,0.00023051772,0.000013678704],"category_scores_gemma":[0.00004179924,0.00011954585,0.000047444773,0.000096231466,0.00017506078,0.000011171275,0.00015112656,0.000053608415,0.0000016231784],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074283633,0.00036392806,0.018804654,0.000010806084,0.0000054057923,0.00006329167,0.00011521468,0.000019369634,0.9713403,0.0000231267,0.000081327635,0.008429728],"study_design_scores_gemma":[0.0018193661,0.0015682252,0.0022178977,0.000021634123,0.00000567899,0.000031734555,0.00008554208,0.00032848923,0.9927602,0.00002849472,0.0009863608,0.00014637416],"about_ca_topic_score_codex":0.000027778404,"about_ca_topic_score_gemma":0.00013333892,"teacher_disagreement_score":0.021419892,"about_ca_system_score_codex":0.000039190007,"about_ca_system_score_gemma":0.00016057683,"threshold_uncertainty_score":0.48749384},"labels":[],"label_agreement":null},{"id":"W2295866100","doi":"10.1093/neuonc/now006","title":"M011L-deficient oncolytic myxoma virus induces apoptosis in brain tumor-initiating cells and enhances survival in a novel immunocompetent mouse model of glioblastoma","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Cancer Institute; National Institutes of Health; Alberta Innovates; Killam Trusts; Terry Fox Foundation; Canadian Institutes of Health Research; Moffitt Cancer Center; Accelerate Brain Cancer Cure; V Foundation for Cancer Research","keywords":"Oncolytic virus; Myxoma virus; Apoptosis; Temozolomide; Glioma; Biology; Cancer research; Programmed cell death; Virus; Cell culture; Virology; Genetics","score_opus":0.026498889121921547,"score_gpt":0.29708520331538457,"score_spread":0.270586314193463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2295866100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99825406,0.00015186788,0.00016636497,0.00051754183,0.00011884189,0.0004385604,0.00008017547,0.000011601441,0.00026098578],"genre_scores_gemma":[0.9988085,0.00025644002,0.0002638479,0.00042357837,0.000051820196,0.000104114755,0.0000045672555,0.000041119372,0.000046035355],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975639,0.00040025677,0.0005942704,0.00062430225,0.00025640195,0.000560847],"domain_scores_gemma":[0.9988248,0.00037809394,0.00023065337,0.0003659961,0.00009414184,0.000106367246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007584964,0.0002559321,0.00046347282,0.00027416254,0.00004910867,0.000014578901,0.00036162612,0.00021551432,0.000013511824],"category_scores_gemma":[0.00027404272,0.00021745893,0.00008086127,0.00022613877,0.0002708945,0.000012910303,0.00031778953,0.00023778366,0.0000057040475],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024138459,0.0005110535,0.00033222407,0.00002546683,0.000021642367,0.000009177371,0.00031378606,0.0007166638,0.9915898,0.00002397312,0.00001940219,0.0040229526],"study_design_scores_gemma":[0.0030363696,0.00597604,0.00015363551,0.000034003733,0.0000059162335,0.000009735688,0.00018984002,0.0011313964,0.98886174,0.00002573175,0.00035187023,0.0002237274],"about_ca_topic_score_codex":0.00009303164,"about_ca_topic_score_gemma":0.0017231586,"teacher_disagreement_score":0.0054649864,"about_ca_system_score_codex":0.00015843468,"about_ca_system_score_gemma":0.0005953418,"threshold_uncertainty_score":0.8867718},"labels":[],"label_agreement":null},{"id":"W2299198409","doi":"10.1093/neuonc/nov234.15","title":"STEM-15LONG NONCODING RNA REGULATION OF THE CANCER STEM CELL PHENOTYPE IN GLIOBLASTOMA MULTIFORME","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Biology; Stem cell; Cancer stem cell; Embryonic stem cell; Neural stem cell; Glioma; In silico; Gene knockdown; Cancer research; Cellular differentiation; Phenotype; Long non-coding RNA; Cell biology; RNA; Genetics; Cell culture; Gene","score_opus":0.02437929323960931,"score_gpt":0.29507317186455795,"score_spread":0.27069387862494865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2299198409","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99343526,0.0007280513,0.0010796874,0.0005756757,0.00090599473,0.0005906749,0.000016517599,0.000013547797,0.002654571],"genre_scores_gemma":[0.9989513,0.00012452877,0.00011616727,0.00026654007,0.00015808338,0.00006387868,0.0000051638867,0.000039046878,0.00027524887],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982307,0.00033143844,0.0003540512,0.00042439235,0.00029563444,0.00036380408],"domain_scores_gemma":[0.9989275,0.00004058147,0.00021703696,0.0004966123,0.0002035327,0.00011477376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038555462,0.00016546105,0.0002387725,0.00010288056,0.000051063947,0.0000113290025,0.00040469447,0.00033664212,0.00001971167],"category_scores_gemma":[0.000051083764,0.00014256893,0.00009337771,0.00031934044,0.00012393501,0.000007706036,0.00035015674,0.00030791527,0.0000098654655],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003613346,0.000075098666,0.00025349454,0.000025422869,0.0000146849,0.0000093863455,0.00023563007,0.0046311254,0.97232044,0.000045307585,0.0008093144,0.021218752],"study_design_scores_gemma":[0.0016520704,0.0007247723,0.00028259662,0.00002178139,0.000016540589,0.000014984336,0.00020181581,0.002252331,0.96924394,0.00003426259,0.025420405,0.00013452157],"about_ca_topic_score_codex":0.00015804771,"about_ca_topic_score_gemma":0.00093430595,"teacher_disagreement_score":0.024611091,"about_ca_system_score_codex":0.00028294686,"about_ca_system_score_gemma":0.0007538692,"threshold_uncertainty_score":0.58137923},"labels":[],"label_agreement":null},{"id":"W2299501240","doi":"10.1093/neuonc/nov207.10","title":"ANGI-10GLIOMA-ASSOCIATED MACROPHAGES PROMOTE ENDOTHELIAL CELL DYSFUNCTION","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Angiogenesis; Glioma; Microglia; Endothelial stem cell; Biology; Vasculogenesis; Stromal cell; Cancer research; Downregulation and upregulation; Population; Chemokine; Cell biology; Immunology; Angiopoietin; Neovascularization; Inflammation; Medicine; Vascular endothelial growth factor; Stem cell; Gene; Progenitor cell","score_opus":0.026785272955733647,"score_gpt":0.2874912415900188,"score_spread":0.2607059686342852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2299501240","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9767536,0.00031358082,0.000009962296,0.0031007857,0.0013406825,0.00064818026,0.000032386586,0.0001836453,0.017617196],"genre_scores_gemma":[0.997583,0.00004719527,0.00015405938,0.0013860195,0.00033973888,0.00010505774,0.000062088584,0.000043513723,0.00027936036],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99846333,0.00018150949,0.00028474812,0.0003882735,0.00028641958,0.00039572522],"domain_scores_gemma":[0.9988953,0.00015332247,0.00016186861,0.00027738133,0.00018076219,0.0003313494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002131217,0.0002135182,0.00044352887,0.00017244504,0.00007086124,0.00001831615,0.00008144028,0.0002344836,0.00017074535],"category_scores_gemma":[0.00029811182,0.00017561915,0.00013304633,0.00028085258,0.00006708194,0.00006137996,0.00006012544,0.00022224119,0.0004865289],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004699409,0.0031290764,0.011843925,0.00002106663,0.000117802345,0.0036462392,0.0004595622,0.000011394189,0.92679656,0.00005728869,0.037399504,0.016047671],"study_design_scores_gemma":[0.01884703,0.009328753,0.008178962,0.000017973047,0.000520634,0.0005154919,0.00015513522,0.00018812873,0.6225996,0.00017394454,0.33923787,0.00023645615],"about_ca_topic_score_codex":0.00007465687,"about_ca_topic_score_gemma":0.000036179685,"teacher_disagreement_score":0.30419692,"about_ca_system_score_codex":0.0004757669,"about_ca_system_score_gemma":0.0002926626,"threshold_uncertainty_score":0.7161541},"labels":[],"label_agreement":null},{"id":"W2302893028","doi":"10.1093/neuonc/nov216.14","title":"HCP-14GLIOBLASTOMA MULTIFORME AMONG ELDERLY: A SINGLE INSTITUTION EXPERIENCE","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital de l'Enfant-Jésus; Hôpital Notre-Dame","funders":"","keywords":"Medicine; Internal medicine; Hazard ratio; Temozolomide; Tolerability; Chemoradiotherapy; Concomitant; Proportional hazards model; Glioblastoma; Oncology; Cohort; Log-rank test; Radiation therapy; Surgery; Adverse effect; Confidence interval","score_opus":0.046327098455236033,"score_gpt":0.3162380070478562,"score_spread":0.2699109085926202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2302893028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872393,0.00012366362,0.000059498074,0.0014429452,0.0008162845,0.00047396656,0.000003380756,0.00013460961,0.009706375],"genre_scores_gemma":[0.9981328,0.000018074003,0.00048801844,0.0009267619,0.00018406111,0.00018927372,0.0000114550385,0.000020240892,0.000029313343],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987043,0.00007078897,0.00027347784,0.0003613141,0.00024648037,0.00034365337],"domain_scores_gemma":[0.99895394,0.00011291315,0.00011185918,0.00030515742,0.0001388616,0.00037727706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009549031,0.00018053646,0.00034664702,0.00015145128,0.00007972288,0.000018819748,0.00009150002,0.00017616458,0.00006420587],"category_scores_gemma":[0.00040349705,0.0001489314,0.0000839705,0.00023872429,0.00022764859,0.00015995481,0.000070210845,0.00017403088,0.00020087256],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096818135,0.00602496,0.22239082,0.00004022857,0.00010192031,0.005504172,0.007121827,0.00010442255,0.59099025,0.0006176077,0.011589646,0.15454598],"study_design_scores_gemma":[0.016076326,0.018604731,0.05281281,0.00009796373,0.00023657788,0.001506071,0.0020311428,0.0010937057,0.30518323,0.00011757825,0.6018092,0.00043065223],"about_ca_topic_score_codex":0.00011082338,"about_ca_topic_score_gemma":0.00017698108,"teacher_disagreement_score":0.59021956,"about_ca_system_score_codex":0.00045314233,"about_ca_system_score_gemma":0.00024883062,"threshold_uncertainty_score":0.60732466},"labels":[],"label_agreement":null},{"id":"W2304052286","doi":"10.1093/neuonc/nov204.52","title":"ATPS-52A PRE-CLINICAL COMBINATORIAL STRATEGY TO TARGET THE JAK/STAT AND EGFR PATHWAYS IN GBM","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotchkiss Brain Institute; Ontario Brain Institute","funders":"","keywords":"EGFR inhibitors; Erlotinib; Temozolomide; Cancer research; Lapatinib; Medicine; Gefitinib; Epidermal growth factor receptor; Neurosphere; Biology; Pharmacology; Oncology; Cancer; Glioma; Internal medicine; In vitro; Breast cancer","score_opus":0.09386709093330496,"score_gpt":0.38399712240198525,"score_spread":0.29013003146868027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2304052286","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.976482,0.00012709344,0.000066800014,0.005909933,0.0035814557,0.0006768109,0.00002002924,0.00006135446,0.013074551],"genre_scores_gemma":[0.99459606,0.000042516313,0.00024245252,0.003916684,0.00101878,0.00005547604,0.000016289736,0.00002807385,0.000083676074],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981237,0.0003818772,0.0005551133,0.00039529047,0.00020854331,0.00033547694],"domain_scores_gemma":[0.99817663,0.000853587,0.000115842784,0.0003224872,0.00014747641,0.00038399946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007642533,0.00017232703,0.00048188912,0.000103392034,0.00006795066,0.000027529868,0.00014394283,0.00020846141,0.00013307366],"category_scores_gemma":[0.0012943035,0.00012439088,0.00008363945,0.00020234693,0.00014178459,0.00007168978,0.0001319591,0.0007791792,0.00010164644],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011052973,0.0055202185,0.067509376,0.00009379461,0.00022173824,0.0041009067,0.011284281,0.00063309877,0.48573434,0.02292155,0.3220137,0.06891401],"study_design_scores_gemma":[0.007956372,0.017329697,0.013936027,0.000040088176,0.000079085614,0.00076168607,0.0009656782,0.0010108473,0.005726088,0.0030797163,0.9488794,0.00023529162],"about_ca_topic_score_codex":0.0001771733,"about_ca_topic_score_gemma":0.00013804117,"teacher_disagreement_score":0.62686574,"about_ca_system_score_codex":0.00014373352,"about_ca_system_score_gemma":0.0006063475,"threshold_uncertainty_score":0.5072513},"labels":[],"label_agreement":null},{"id":"W2306472141","doi":"10.1093/neuonc/nov222.22","title":"MPTH-22INTEGRATING MOLECULAR MARKERS INTO THE WORLD HEALTH ORGANIZATION (WHO) CLASSIFICATION OF GLIOMAS: SURVEY RESULTS FROM THE SNO MEMBERSHIP","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Subspecialty; Medicine; Glioma; Family medicine; Oncology; Cancer research","score_opus":0.064574434945345,"score_gpt":0.3356107767125805,"score_spread":0.2710363417672355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2306472141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92269903,0.00044417832,0.00008106429,0.07307462,0.0004732343,0.00081977725,0.000049664035,0.000047336747,0.0023110688],"genre_scores_gemma":[0.9954716,0.000054927536,0.00036550433,0.00343735,0.000106841995,0.000033953405,0.00047268966,0.000032582782,0.000024534287],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99696857,0.001511862,0.0005789759,0.00036983704,0.00034253387,0.00022820964],"domain_scores_gemma":[0.9956728,0.0025862998,0.00050461484,0.0006260987,0.00044913994,0.00016102426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016237341,0.00017194856,0.00038473817,0.00010157375,0.00012881674,0.000022709042,0.00020901162,0.00010113368,0.00003316357],"category_scores_gemma":[0.0048951954,0.00009855843,0.00006183392,0.0009888153,0.00014956896,0.000044254262,0.000066836816,0.00025967564,0.000021262164],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032350775,0.0018390391,0.5231849,0.000052188687,0.0006067003,0.00024241507,0.022277774,0.0001902141,0.20891614,0.003940457,0.17189358,0.063621536],"study_design_scores_gemma":[0.010500996,0.0025996207,0.8469144,0.00016429111,0.00036370134,0.000058499205,0.0058038794,0.0016859394,0.0828331,0.00052555394,0.0482761,0.00027393503],"about_ca_topic_score_codex":0.0043884898,"about_ca_topic_score_gemma":0.008374096,"teacher_disagreement_score":0.32372952,"about_ca_system_score_codex":0.00040369222,"about_ca_system_score_gemma":0.0006111407,"threshold_uncertainty_score":0.66341126},"labels":[],"label_agreement":null},{"id":"W2307113881","doi":"10.1093/neuonc/nov208.05","title":"BMET-05NCCTG N0574 (ALLIANCE): A PHASE III RANDOMIZED TRIAL OF WHOLE BRAIN RADIATION THERAPY (WBRT) IN ADDITION TO RADIOSURGERY (SRS) IN PATIENTS WITH 1 TO 3 BRAIN METASTASES","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Radiosurgery; Internal medicine; Neurocognitive; Quality of life (healthcare); Randomized controlled trial; Oncology; Radiation therapy; Cognition","score_opus":0.02988153141582374,"score_gpt":0.32918399172132823,"score_spread":0.2993024603055045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2307113881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98004663,0.00018416694,0.00040340153,0.011559984,0.00047815047,0.00691071,0.00021476281,0.000032661992,0.00016956248],"genre_scores_gemma":[0.98628527,0.000043137163,0.0017579149,0.009693457,0.00021104128,0.0011931687,0.0007049434,0.000051212897,0.00005986946],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99572086,0.0018325396,0.0009888017,0.0005384979,0.0004902453,0.00042907096],"domain_scores_gemma":[0.99621326,0.0024750642,0.00037478018,0.00038955515,0.0001650733,0.0003822668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023805245,0.00031030583,0.0017577903,0.00061272207,0.0000282667,0.000013639101,0.00010989153,0.00013603551,0.0001261572],"category_scores_gemma":[0.0029186236,0.00023382794,0.00018522769,0.0009082083,0.00008952503,0.00014485349,0.00003459191,0.0002242069,0.000023175602],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8381704,0.0053879456,0.0012134931,0.000014301513,0.00015842132,0.00021435446,0.0010008706,0.0002892578,0.0021830886,0.000033218497,0.031108996,0.12022563],"study_design_scores_gemma":[0.88945454,0.019541096,0.0015340495,0.000058963833,0.00011092405,0.000011248474,0.000105396284,0.000070484326,0.0015467493,0.000049113118,0.08732909,0.00018831759],"about_ca_topic_score_codex":0.00028356025,"about_ca_topic_score_gemma":0.00019162815,"teacher_disagreement_score":0.12003732,"about_ca_system_score_codex":0.00045272982,"about_ca_system_score_gemma":0.0005391184,"threshold_uncertainty_score":0.9535227},"labels":[],"label_agreement":null},{"id":"W2307118212","doi":"10.1093/neuonc/nov206.12","title":"ATCT-12RESULTS OF NRG ONCOLOGY/RTOG 9813- A PHASE III RANDOMIZED STUDY OF RADIATION THERAPY (RT) AND TEMOZOLOMIDE (TMZ) VERSUS RT AND NITROSOUREA (NU) THERAPY FOR ANAPLASTIC ASTROCYTOMA (AA)","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; University of Toronto; Université de Montréal; University of Calgary","funders":"","keywords":"Temozolomide; Nitrosourea; Anaplastic astrocytoma; Medicine; Radiation therapy; Oncology; Internal medicine; Astrocytoma; O-6-methylguanine-DNA methyltransferase; Glioma; Chemotherapy; Cancer research; Biology; Methyltransferase","score_opus":0.051692184720617665,"score_gpt":0.36309870387545695,"score_spread":0.3114065191548393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2307118212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99160266,0.0016862405,0.000035679102,0.0010581996,0.00048344492,0.004785614,0.00005118789,0.00003616362,0.00026079753],"genre_scores_gemma":[0.9971745,0.0013330161,0.00026404654,0.00029293596,0.00016017463,0.0006799899,0.000050594044,0.00003761121,0.0000071035956],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9974635,0.0005960399,0.00081854063,0.0005057593,0.00027608278,0.00034006278],"domain_scores_gemma":[0.9945263,0.003958518,0.0006447536,0.00031665812,0.0002741079,0.00027964366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077704986,0.00032703244,0.0018236034,0.00028205334,0.00007897103,0.000011461134,0.00009964454,0.00024428996,0.000015545143],"category_scores_gemma":[0.0008137514,0.00024306176,0.00016045355,0.00019610334,0.0003005208,0.000075787066,0.0000465086,0.00018143504,0.0000016432118],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.81400883,0.008721037,0.0045330627,0.000026900329,0.0010704681,0.00015978928,0.0036224523,0.000018751403,0.050823044,0.00003919055,0.0017562865,0.11522021],"study_design_scores_gemma":[0.8523679,0.11164458,0.0023392544,0.000017373544,0.0006520239,0.000088146066,0.0011642092,0.0005228407,0.022915058,0.00004885499,0.008089789,0.00014997202],"about_ca_topic_score_codex":0.00009584734,"about_ca_topic_score_gemma":0.0001698408,"teacher_disagreement_score":0.115070246,"about_ca_system_score_codex":0.00018449164,"about_ca_system_score_gemma":0.0003968229,"threshold_uncertainty_score":0.9911771},"labels":[],"label_agreement":null},{"id":"W2307494918","doi":"10.1093/neuonc/now046","title":"Upfront bevacizumab may extend survival for glioblastoma patients who do not receive second-line therapy: an exploratory analysis of AVAglio","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"F. Hoffmann-La Roche; Roche","keywords":"Medicine; Bevacizumab; Internal medicine; Temozolomide; Hazard ratio; Oncology; Proportional hazards model; Post-hoc analysis; Radiation therapy; Progression-free survival; Population; Multivariate analysis; Surgery; Overall survival; Chemotherapy; Confidence interval","score_opus":0.03451598792110212,"score_gpt":0.3149871013163817,"score_spread":0.2804711133952796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2307494918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958264,0.00017824757,0.000050327828,0.0015622824,0.0006107687,0.00096353167,0.0004336838,0.000049399798,0.00032535382],"genre_scores_gemma":[0.9979709,0.00028332366,0.00014239895,0.0008905061,0.00016739208,0.00034190982,0.00009012453,0.000056501754,0.00005695144],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99756473,0.00033164225,0.0006407457,0.00068815594,0.0003369486,0.0004377757],"domain_scores_gemma":[0.9972233,0.0008978096,0.0003993887,0.00068066164,0.0005121824,0.00028665387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002662078,0.00032030643,0.0011900369,0.00060805335,0.00007904015,0.000011239822,0.0001819713,0.000231749,0.0008091853],"category_scores_gemma":[0.00022030942,0.00021145084,0.0003882212,0.00046976714,0.00014821814,0.00015330162,0.00006234768,0.00011784938,0.000025519143],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011745007,0.009112519,0.081967585,0.000056202032,0.0038418057,0.0002461426,0.001879461,0.000021919259,0.5864589,0.00028670742,0.0047202995,0.29966342],"study_design_scores_gemma":[0.034302805,0.042200174,0.17577411,0.00006979013,0.0030158514,0.000015675812,0.0004354081,0.00014780635,0.6149672,0.00009472533,0.12847702,0.00049943716],"about_ca_topic_score_codex":0.000012754358,"about_ca_topic_score_gemma":0.0005151013,"teacher_disagreement_score":0.29916397,"about_ca_system_score_codex":0.0002863417,"about_ca_system_score_gemma":0.00019319815,"threshold_uncertainty_score":0.8860012},"labels":[],"label_agreement":null},{"id":"W2308410138","doi":"10.1093/neuonc/nov214.13","title":"EPIG-13ROBUST MGMT METHYLATION DETECTION USING 450k ARRAY IN CIMP-NEGATIVE GBM","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Methylation; Concordance; DNA methylation; Methyltransferase; Biomarker; Computational biology; Oncology; Confounding; Biology; Bioinformatics; Medicine; Internal medicine; Gene; Genetics; Gene expression","score_opus":0.07507715708103423,"score_gpt":0.3457348808064647,"score_spread":0.27065772372543045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2308410138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99272287,0.00011154896,0.000673844,0.0017636188,0.0007481711,0.00057475525,0.000003323101,0.00005363025,0.003348253],"genre_scores_gemma":[0.9975453,0.000022878368,0.0015788066,0.00054685335,0.00021240108,0.000049741055,0.000008364595,0.000025383037,0.000010296964],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986116,0.00028669732,0.0003088041,0.00033286316,0.0001888988,0.00027112282],"domain_scores_gemma":[0.9989707,0.00035920853,0.00014782783,0.00020001412,0.00014074171,0.0001815382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029472084,0.0001635002,0.00038891236,0.0002872586,0.000051799216,0.000010876541,0.000046639652,0.00019624988,0.000044003362],"category_scores_gemma":[0.0006604944,0.0001448064,0.00006959362,0.00039117338,0.00006209299,0.000106173226,0.000027500595,0.00025852086,0.000057713707],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039619434,0.0008082333,0.035756223,0.000017633025,0.000056202935,0.00050633086,0.0013130802,0.00090331055,0.92868537,0.00006263599,0.0002388374,0.031255975],"study_design_scores_gemma":[0.012742781,0.0039634123,0.04706431,0.00005439297,0.0002981751,0.00047266087,0.0011388472,0.004121189,0.89844567,0.0011132495,0.03029831,0.00028698027],"about_ca_topic_score_codex":0.00037044112,"about_ca_topic_score_gemma":0.0007672367,"teacher_disagreement_score":0.030968994,"about_ca_system_score_codex":0.0008442539,"about_ca_system_score_gemma":0.00022556786,"threshold_uncertainty_score":0.5905034},"labels":[],"label_agreement":null},{"id":"W2312417698","doi":"10.1093/neuonc/3.4.258","title":"IMMUNOTHERAPY TASK FORCE FOR MALIGNANT BRAIN TUMORS April 21, 2001,Toronto, Ontario","year":2001,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Task force; Immunotherapy; Task (project management); Medicine; Oncology; Internal medicine; Political science; Management; Cancer; Economics","score_opus":0.02270342587934088,"score_gpt":0.29757294200660395,"score_spread":0.27486951612726307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2312417698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97041976,0.0012118756,0.00015448328,0.013175453,0.00080799,0.0017333853,0.000021222515,0.000109197674,0.012366635],"genre_scores_gemma":[0.9724039,0.0006538711,0.0014647336,0.020189274,0.00052044407,0.00092224544,0.00011468162,0.00011072053,0.003620142],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980751,0.000107837914,0.0004342044,0.00051021687,0.00019869296,0.00067390077],"domain_scores_gemma":[0.9983971,0.00062956475,0.00016725186,0.00046748962,0.000098468096,0.00024012005],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002723259,0.00029304158,0.00065994356,0.00007768749,0.00015367552,0.00001842743,0.00015084865,0.00020589847,0.0016229491],"category_scores_gemma":[0.00012583585,0.00024000769,0.0002660815,0.00009554199,0.00008273315,0.00008459254,0.000040307714,0.00020647136,0.00007136973],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025882856,0.0031514,0.06913159,0.000040631756,0.00038517555,0.0026127181,0.001755703,0.000017805167,0.6969552,0.0011478014,0.14313172,0.07908195],"study_design_scores_gemma":[0.010331803,0.0057719517,0.026371907,0.000034955585,0.00013620706,0.0009506863,0.00014279573,0.00009106257,0.013437061,0.00029056094,0.9422192,0.00022183656],"about_ca_topic_score_codex":0.009638545,"about_ca_topic_score_gemma":0.057859134,"teacher_disagreement_score":0.79908746,"about_ca_system_score_codex":0.0013388217,"about_ca_system_score_gemma":0.0005212595,"threshold_uncertainty_score":0.9992897},"labels":[],"label_agreement":null},{"id":"W2312847545","doi":"10.1093/neuonc/nou237.31","title":"AT-31A CANADIAN QUESTIONNAIRE ON THE MANAGEMENT OF ADULT DIFFUSE LOW GRADE GLIOMAS","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Magnetic resonance imaging; Perioperative; Neurocognitive; Craniotomy; Surgery; General surgery; Radiology; Cognition; Psychiatry","score_opus":0.013418667239834476,"score_gpt":0.2625075014358827,"score_spread":0.24908883419604821,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2312847545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9502596,0.0000722913,0.0000027358797,0.03712337,0.00039479355,0.0005491517,0.000008717908,0.000031558673,0.011557751],"genre_scores_gemma":[0.99295574,0.00012747967,0.000060840583,0.006530037,0.00009401064,0.00013380173,0.000012159034,0.000022178472,0.00006375848],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99886554,0.00014325914,0.00022200447,0.0002714643,0.00019509495,0.00030260909],"domain_scores_gemma":[0.99891376,0.00020000062,0.000096043375,0.0004714407,0.00006641802,0.00025231476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010254226,0.00015649773,0.00027723276,0.00014863836,0.00011856322,0.0000059640943,0.00012408891,0.00010249428,0.000100318844],"category_scores_gemma":[0.000085437285,0.00010247948,0.000096097945,0.00017380693,0.00010285235,0.000014345045,0.000047073445,0.00013314151,0.0001544241],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010718802,0.011481043,0.23366846,0.0007938648,0.0016213255,0.009844502,0.0018155546,0.00012354473,0.07249679,0.31699824,0.10879305,0.24129176],"study_design_scores_gemma":[0.013672316,0.006682501,0.32716733,0.0005931163,0.0008820036,0.00037470373,0.00021767593,0.00063309766,0.074969046,0.0010030435,0.57341635,0.00038885197],"about_ca_topic_score_codex":0.004461507,"about_ca_topic_score_gemma":0.021976354,"teacher_disagreement_score":0.46462327,"about_ca_system_score_codex":0.00040510425,"about_ca_system_score_gemma":0.00007822993,"threshold_uncertainty_score":0.99587005},"labels":[],"label_agreement":null},{"id":"W2312888579","doi":"10.1093/neuonc/nou238.2","title":"AI-02 * HYPOXIA AS A MEASURE OF FUNCTIONAL STATUS OF GLIOBLASTOMA VASCULATURE","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Hypoxia (environmental); Pathology; CD31; Tumor microenvironment; Glioblastoma; Neovascularization; Tumor hypoxia; Microvessel; Angiogenesis; Blood vessel; Medicine; Biology; Immunohistochemistry; Cancer research; Tumor cells; Chemistry; Internal medicine","score_opus":0.00932098661912247,"score_gpt":0.25092890743919827,"score_spread":0.2416079208200758,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2312888579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.982338,0.0034040348,0.0010820369,0.00046728377,0.0035420484,0.0003006471,0.00006111987,0.000022881375,0.0087819435],"genre_scores_gemma":[0.9954306,0.0006400781,0.00023854336,0.0018696204,0.0015512514,0.000023890518,0.00004355904,0.000033897442,0.000168553],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983813,0.0002252244,0.000344564,0.0004068928,0.00026017043,0.00038183745],"domain_scores_gemma":[0.9987644,0.000053206186,0.00023044404,0.00045131313,0.00033283507,0.00016780137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022175127,0.00019474485,0.00042333177,0.00008871316,0.000043833767,0.0000051668035,0.00016623463,0.00040879185,0.00010528228],"category_scores_gemma":[0.00047615787,0.00018603668,0.00023965442,0.0001483518,0.0002113531,0.0000055043365,0.00011328529,0.00023451663,0.00001337775],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064345804,0.00014613778,0.0002654298,0.000030974374,0.00008752344,0.0000014669714,0.000058928348,0.00015004112,0.95896834,0.0006706009,0.016692063,0.022285007],"study_design_scores_gemma":[0.0015009274,0.0016012033,0.0037977272,0.000006133402,0.000072540446,0.00006810339,0.00002626897,0.000025168163,0.26118076,0.00016903637,0.7314222,0.0001299595],"about_ca_topic_score_codex":0.000047037458,"about_ca_topic_score_gemma":0.00014088287,"teacher_disagreement_score":0.7147301,"about_ca_system_score_codex":0.000023988747,"about_ca_system_score_gemma":0.0005119419,"threshold_uncertainty_score":0.7586356},"labels":[],"label_agreement":null},{"id":"W2313026868","doi":"10.1093/neuonc/nou255.44","title":"ET-46 * ONCOLYTIC VIRAL THERAPY FOR MALIGNANT GLIOMAS USING MYXOMA VIRUS DELETED FOR ANTI-APOPTOTIC M11L GENE","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Myxoma virus; Oncolytic virus; Biology; Apoptosis; Programmed cell death; Small interfering RNA; Virology; Virus; Cancer research; Gene silencing; Cell culture; Gene; Transfection; Genetics","score_opus":0.0413328903918742,"score_gpt":0.3550147754217088,"score_spread":0.3136818850298346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313026868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9820962,0.0005586289,0.01373507,0.00085033604,0.0005946968,0.0018743076,0.00009788134,0.00004911601,0.00014377234],"genre_scores_gemma":[0.98823464,0.00039839596,0.004070549,0.00535441,0.0010601854,0.00043071702,0.00019793127,0.00017237887,0.00008081882],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99672407,0.0006795338,0.0005049723,0.0009096945,0.0002347077,0.00094704435],"domain_scores_gemma":[0.9981307,0.00040195213,0.00023533426,0.0007133142,0.000298108,0.00022059522],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001082954,0.00039917917,0.00056863186,0.00018352972,0.00029847605,0.00005169671,0.0005437421,0.00048365304,0.000027110098],"category_scores_gemma":[0.0004056786,0.00038014585,0.00033161946,0.00018749728,0.00021550946,0.0000107680635,0.00014578676,0.00024319474,0.000014651717],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005515704,0.00031160205,0.00008374887,0.000030167976,0.00012364256,0.00001314326,0.000046061206,0.0005594347,0.9755539,0.00009245094,0.0013404635,0.01632972],"study_design_scores_gemma":[0.0051999446,0.01997313,0.00006454707,0.0000066555076,0.000041465646,0.000079623744,0.000014385323,0.0058773053,0.8398587,0.00026788822,0.12825963,0.00035669605],"about_ca_topic_score_codex":0.000029801133,"about_ca_topic_score_gemma":0.00013082944,"teacher_disagreement_score":0.13569513,"about_ca_system_score_codex":0.00012111469,"about_ca_system_score_gemma":0.0006481668,"threshold_uncertainty_score":0.99986506},"labels":[],"label_agreement":null},{"id":"W2313158881","doi":"10.1093/neuonc/nou208.43","title":"TRANSCRIPTIONAL PROFILING OF GBM INVASIVE GENES IDENTIFIES EFFECTIVE INHIBITORS OF THE LIM KINASE-COFILIN PATHWAY","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cell Image Analysis Techniques","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Cofilin; Biology; Cancer research; Gene expression profiling; Glioma; Gene; Microarray analysis techniques; Immunohistochemistry; Astrocytoma; Microarray; Pathology; Gene expression; Medicine; Actin cytoskeleton; Genetics; Immunology; Cell; Cytoskeleton","score_opus":0.007836307454265322,"score_gpt":0.2506211578571817,"score_spread":0.24278485040291636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313158881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99632406,0.00030524482,0.00074253057,0.00011494281,0.00016395822,0.00042699528,0.000012821631,0.000014807654,0.0018946452],"genre_scores_gemma":[0.9986462,0.00014008547,0.0005247158,0.0003339429,0.0001789709,0.00007384158,0.000036699035,0.000021344777,0.000044183842],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99840933,0.0005076512,0.00039404607,0.00035366847,0.00016192485,0.00017335103],"domain_scores_gemma":[0.99874413,0.0002566659,0.00030383654,0.00042237397,0.00023510994,0.000037882943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037959058,0.00015875277,0.00031701528,0.00007907093,0.0000570166,0.000006627545,0.0003098973,0.00021961363,0.000012430736],"category_scores_gemma":[0.0007331509,0.00012667525,0.00028177546,0.0001486932,0.0003425206,0.000006334641,0.00016018495,0.0001509191,0.0000020541418],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007612684,0.00012271927,0.0037651868,0.00005381384,0.000050474202,0.0000022710258,0.00007331501,0.00003863487,0.99061996,0.00014429296,0.0004376795,0.0046155043],"study_design_scores_gemma":[0.0003489981,0.00071399607,0.0016001072,0.000015651054,0.000066169574,0.000011311559,0.00009232203,0.000034225013,0.9861183,0.00016785662,0.010726724,0.000104331586],"about_ca_topic_score_codex":0.000028581087,"about_ca_topic_score_gemma":0.00012651074,"teacher_disagreement_score":0.010289044,"about_ca_system_score_codex":0.000023057664,"about_ca_system_score_gemma":0.00015014096,"threshold_uncertainty_score":0.5165667},"labels":[],"label_agreement":null},{"id":"W2313382222","doi":"10.1093/neuonc/nou270.16","title":"RT-19 * PROGNOSTIC VALUE OF EARLY CHANGES IN NEUTROPHIL AND LYMPHOCYTE MEASURES DURING CHEMORADIOTHERAPY FOR GLIOBLASTOMA","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Temozolomide; Internal medicine; Dexamethasone; Univariate analysis; Hazard ratio; Proportional hazards model; Chemoradiotherapy; Neutrophil to lymphocyte ratio; Gastroenterology; Lymphocyte; Multivariate analysis; Radiation therapy; Surgery; Confidence interval","score_opus":0.01500429910816527,"score_gpt":0.2792741752585206,"score_spread":0.26426987615035535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313382222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99577606,0.0006914962,0.000035732555,0.0016824275,0.000248855,0.0012758829,0.0000089726755,0.00007328099,0.00020729574],"genre_scores_gemma":[0.9970475,0.00026102836,0.0010112353,0.0009594749,0.00028485974,0.0003662719,0.0000026686416,0.000057723664,0.00000924137],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9983952,0.00021264296,0.0003600517,0.00042605982,0.00020960433,0.0003964488],"domain_scores_gemma":[0.9986513,0.00055529934,0.00019469674,0.00028011604,0.00011613819,0.00020240404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000389761,0.00022097456,0.00063510326,0.00031707174,0.00006141237,0.000010577073,0.00013172854,0.00021663128,0.000012327748],"category_scores_gemma":[0.0007182793,0.00021233779,0.00008909383,0.00020469398,0.0002462829,0.000050026218,0.000057256842,0.00013545898,0.000002352343],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00838212,0.00029374566,0.20522903,0.000877341,0.00009621749,0.00015175945,0.0006911964,0.00001009027,0.7460928,0.00016489101,0.00010717653,0.037903626],"study_design_scores_gemma":[0.024983136,0.009717875,0.51653874,0.00028009503,0.00034752293,0.0005637743,0.00010031733,0.0016757335,0.42490283,0.00030966284,0.020117546,0.00046280076],"about_ca_topic_score_codex":0.000016948026,"about_ca_topic_score_gemma":0.000044509005,"teacher_disagreement_score":0.32119,"about_ca_system_score_codex":0.0002236627,"about_ca_system_score_gemma":0.00023512488,"threshold_uncertainty_score":0.86588836},"labels":[],"label_agreement":null},{"id":"W2313984778","doi":"10.1093/neuonc/nov204.30","title":"ATPS-30INTRATUMORAL MODULATION THERAPY FOR GLIOBLASTOMA","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Glioblastoma; Modulation (music); Cancer research; Chemistry; Medicine; Physics","score_opus":0.04661633066988025,"score_gpt":0.3322674481069172,"score_spread":0.28565111743703697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313984778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885145,0.00022430076,0.000108815984,0.0077776466,0.0006961058,0.00089292356,0.0000080130885,0.00008556967,0.0016921364],"genre_scores_gemma":[0.9960591,0.00003632538,0.00076595036,0.0024039163,0.00039923514,0.00025319817,0.000027595406,0.000027679427,0.000027003744],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991119,0.00005797919,0.00019192728,0.00025651572,0.00014047907,0.00024123333],"domain_scores_gemma":[0.9991895,0.00016703104,0.00007851688,0.000203349,0.00015591244,0.00020566746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012171167,0.0001320572,0.000297087,0.0000886474,0.000043152802,0.000011050743,0.00005119493,0.00011746988,0.00003676762],"category_scores_gemma":[0.0001249467,0.00010399654,0.00009572497,0.000114966475,0.0000433594,0.000049000933,0.000016560449,0.000089784226,0.000057853656],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062881177,0.003798995,0.040381514,0.000029018816,0.00019603975,0.00083387713,0.00088627223,0.00022012273,0.50259167,0.0028046328,0.10431856,0.3376512],"study_design_scores_gemma":[0.0281495,0.02941984,0.025707657,0.00001659008,0.00014153217,0.0004986326,0.00014882591,0.0050149285,0.14116158,0.0017476381,0.7677491,0.000244224],"about_ca_topic_score_codex":0.000011326123,"about_ca_topic_score_gemma":0.00001944111,"teacher_disagreement_score":0.6634305,"about_ca_system_score_codex":0.0001798084,"about_ca_system_score_gemma":0.00019897183,"threshold_uncertainty_score":0.4240856},"labels":[],"label_agreement":null},{"id":"W2314422247","doi":"10.1093/neuonc/nou264.8","title":"NI-08 * OPTIMIZATION OF MOLECULAR MR IMAGING OF GLIOMA","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University of Alberta; University of Calgary","funders":"","keywords":"Glioma; Pulse sequence; Magnetic resonance imaging; Gradient echo; Contrast (vision); Pulse (music); Nuclear medicine; Spin echo; Medicine; Nuclear magnetic resonance; Radiology; Physics; Cancer research; Optics","score_opus":0.008974620497344847,"score_gpt":0.2496329735080082,"score_spread":0.24065835301066335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2314422247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98490274,0.000051580955,0.012642711,0.0005222862,0.0005624888,0.00014484252,0.0000069984535,0.0000503123,0.0011160461],"genre_scores_gemma":[0.9912337,0.0000042033516,0.008221994,0.0004650334,0.000041239782,0.00000920929,0.00000273425,0.000019135674,0.0000027293504],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984952,0.00037757904,0.00040516132,0.00026692636,0.00021212529,0.00024299622],"domain_scores_gemma":[0.99884117,0.00028612875,0.00029156936,0.00034570938,0.00016897808,0.00006644669],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045065093,0.00010676965,0.00029528825,0.00012729522,0.00003177894,0.000009314748,0.00025237305,0.00006374481,0.00021818266],"category_scores_gemma":[0.0004213868,0.00010815378,0.00005123399,0.00022964911,0.00019878053,0.00012270882,0.00011414389,0.00006708628,0.000060033362],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006985853,0.00011597358,0.00054094166,0.00002250105,0.0000024354597,0.000034884968,0.00008103679,0.03328987,0.96388286,0.00046236705,0.000242172,0.0012550931],"study_design_scores_gemma":[0.0007142388,0.0003165605,0.000045645975,0.000008740464,0.000025707082,0.000031661642,0.000022361512,0.024017382,0.973981,0.00013892826,0.00061476795,0.00008301196],"about_ca_topic_score_codex":0.000034066943,"about_ca_topic_score_gemma":0.0000026846192,"teacher_disagreement_score":0.010098127,"about_ca_system_score_codex":0.000045213095,"about_ca_system_score_gemma":0.00010812276,"threshold_uncertainty_score":0.44103828},"labels":[],"label_agreement":null},{"id":"W2314720922","doi":"10.1093/neuonc/nov061.118","title":"OT-05 * H3.3-K27M IS A NEGATIVE PROGNOSTIC MARKER IN THALAMIC PEDIATRIC GLIOMA","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Hospital for Sick Children; BC Children's Hospital; University of Toronto","funders":"","keywords":"Glioma; Medicine; Internal medicine; Oncology; Neuroscience; Psychology; Cancer research","score_opus":0.030934133725999534,"score_gpt":0.3080997552019092,"score_spread":0.2771656214759097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2314720922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98157126,0.00056767784,0.000002280315,0.007919074,0.00065694115,0.0011385633,0.000015004408,0.00007588372,0.008053314],"genre_scores_gemma":[0.9962055,0.00011432609,0.00028727093,0.0026062704,0.00034201742,0.0003347688,0.00001636395,0.000044649583,0.000048847505],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99793404,0.00025920616,0.00042129046,0.00054230477,0.00032266835,0.0005204701],"domain_scores_gemma":[0.9980944,0.00084229844,0.00016340065,0.00035521656,0.00020043831,0.00034425632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024895874,0.00027884034,0.00060005806,0.0004541905,0.00004042336,0.000017016486,0.00013050038,0.0002411732,0.00018405658],"category_scores_gemma":[0.0011603408,0.00022926023,0.00010824138,0.0009292781,0.00008936011,0.00008446191,0.00011256151,0.00034598575,0.00041153934],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005359891,0.0025726778,0.92717695,0.00005307812,0.00008034757,0.011160246,0.0015914657,0.000007520408,0.008947662,0.000118935575,0.040977523,0.0067776106],"study_design_scores_gemma":[0.030639919,0.010793757,0.87931085,0.000078515564,0.0010481292,0.0029235717,0.0008512533,0.0007154584,0.018303795,0.0015332729,0.053178784,0.0006227028],"about_ca_topic_score_codex":0.00013217873,"about_ca_topic_score_gemma":0.00010819873,"teacher_disagreement_score":0.047866102,"about_ca_system_score_codex":0.00043516498,"about_ca_system_score_gemma":0.00063391944,"threshold_uncertainty_score":0.93489605},"labels":[],"label_agreement":null},{"id":"W2314980639","doi":"10.1093/neuonc/nou268.8","title":"PM-08 * INVESTIGATING THE DETERMINANTS OF GBM SUBTYPES USING NOVEL MOUSE MODELS","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"3D Printing in Biomedical Research","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Electroporation; Biology; Gene expression; Cancer research; Gene; Cre recombinase; Transgene; Genetics; Genetically modified mouse","score_opus":0.07031756219139779,"score_gpt":0.3254315452799781,"score_spread":0.2551139830885803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2314980639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98871857,0.0000460976,0.0074651735,0.00021439417,0.00035721666,0.00015284601,0.000004309207,0.00011327932,0.002928111],"genre_scores_gemma":[0.9924226,0.000026062648,0.0070624454,0.00026694007,0.00015134581,0.000010763751,6.922062e-7,0.000044088305,0.0000150822625],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9985961,0.00015045551,0.00035552506,0.00020028367,0.00028586562,0.0004118085],"domain_scores_gemma":[0.99805766,0.001311288,0.00008320688,0.00035398215,0.00006506899,0.00012880036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006763231,0.00013569099,0.00027368826,0.00009629657,0.00008200437,0.000016775086,0.0004524945,0.0001720012,0.000033415672],"category_scores_gemma":[0.0014565677,0.00010713625,0.000050169034,0.0002235645,0.00033913867,0.000077628545,0.00021072713,0.000466532,0.000023587096],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000043758455,0.000031380703,0.0016756314,0.00009149177,0.000011591826,0.0000042061115,0.00038628024,0.02968341,0.94498736,0.0003530865,0.00024813364,0.022523062],"study_design_scores_gemma":[0.00027200932,0.000096116186,0.0001614234,0.000021884436,0.000010007594,0.000028961329,0.000023740131,0.89023477,0.10333446,0.00046629598,0.005254023,0.000096337884],"about_ca_topic_score_codex":0.000047453806,"about_ca_topic_score_gemma":0.000027689433,"teacher_disagreement_score":0.86055136,"about_ca_system_score_codex":0.00007638626,"about_ca_system_score_gemma":0.00006353381,"threshold_uncertainty_score":0.43688893},"labels":[],"label_agreement":null},{"id":"W2315053722","doi":"10.1093/neuonc/nou237.13","title":"AT-13 * R9802: PHASE III STUDY OF RADIATION THERAPY (RT) WITH OR WITHOUT PROCARBAZINE, CCNU, AND VINCRISTINE (PCV) IN LOW-GRADE QLIOMA: RESULTS BY HISTOLOGIC TYPE","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Cancer Care Ontario; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Procarbazine; Internal medicine; Oligodendroglioma; Progression-free survival; Vincristine; Biopsy; Radiation therapy; Histology; Gastroenterology; Temozolomide; Astrocytoma; Overall survival; Glioma; Chemotherapy; Cyclophosphamide","score_opus":0.024425885069715398,"score_gpt":0.32050210966867543,"score_spread":0.29607622459896005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315053722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99571854,0.00060580863,0.0000033787119,0.0012751722,0.00012708185,0.001707837,0.00001109085,0.00004468312,0.00050642056],"genre_scores_gemma":[0.998709,0.000311563,0.00007057543,0.0005281803,0.00006326581,0.00017879844,0.00005805272,0.00003056051,0.000049967926],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9982167,0.00027870107,0.0005022716,0.0005147659,0.00021851162,0.00026903965],"domain_scores_gemma":[0.99866307,0.00044386688,0.00032948164,0.000336353,0.00009434232,0.00013290752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002500834,0.0002456405,0.00077496923,0.00021936052,0.0000630164,0.00000639349,0.000081140475,0.0001397722,0.000024383538],"category_scores_gemma":[0.00028765056,0.00015711268,0.000028009015,0.00040724038,0.00012277544,0.000042174386,0.000039480277,0.00017478742,0.000005498582],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.065466814,0.035927575,0.54027736,0.00011588211,0.00029861796,0.0014753931,0.0042272494,0.00001926358,0.25437078,0.000028065564,0.0110651925,0.08672781],"study_design_scores_gemma":[0.43738142,0.21766472,0.19482808,0.00013920745,0.0007061436,0.0008801645,0.0007299857,0.001841533,0.062815495,0.000026562575,0.08233426,0.00065244397],"about_ca_topic_score_codex":0.0003247342,"about_ca_topic_score_gemma":0.0010767645,"teacher_disagreement_score":0.3719146,"about_ca_system_score_codex":0.00021393273,"about_ca_system_score_gemma":0.00012600039,"threshold_uncertainty_score":0.6406869},"labels":[],"label_agreement":null},{"id":"W2315630015","doi":"10.1093/neuonc/nou275.32","title":"SC-33 * POLYCOMB GROUP PROTEIN Bmi1 CONTROLS NEURAL STEM AND PROGENITOR CELL MAINTENANCE AND GLIOBLASTOMA TUMOUR DEVELOPMENT","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"14-3-3 protein interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Ontario Institute for Cancer Research","funders":"","keywords":"BMI1; Neural stem cell; Progenitor cell; Biology; Stem cell; Clonogenic assay; Cancer research; Carcinogenesis; Gene knockdown; Cell biology; Cell; Cell culture; Cancer; Genetics","score_opus":0.00703507861088516,"score_gpt":0.23308362928129275,"score_spread":0.2260485506704076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315630015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99622506,0.0002867244,0.000634839,0.0007820925,0.000358131,0.0010370923,0.000011980834,0.00003781165,0.00062626385],"genre_scores_gemma":[0.996052,0.000021767293,0.0018626528,0.00088268146,0.0003026654,0.0004520695,0.000010339403,0.000044997843,0.0003708207],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981339,0.00029977364,0.00035541315,0.00063140877,0.00012374418,0.00045575705],"domain_scores_gemma":[0.9991418,0.000076567005,0.00020519242,0.00027559372,0.000097178745,0.00020363096],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022826061,0.0002743411,0.00030959223,0.0000696174,0.00017413845,0.000049333434,0.00019339059,0.0002340261,0.000009401862],"category_scores_gemma":[0.0001383004,0.0002569343,0.0000552935,0.000064665146,0.00018003686,0.000012410733,0.00026789022,0.00027460186,0.000019147563],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004380781,0.00011484903,0.00090629933,0.000032049968,0.00002274718,0.000024885718,0.00005934419,0.000002442558,0.9826116,0.00008564833,0.0005781877,0.0151238805],"study_design_scores_gemma":[0.0018421768,0.0026475438,0.0014289912,0.000016453623,0.000018292345,0.00037054645,0.00006290182,0.00020707346,0.71322614,0.000026763748,0.2798905,0.00026262953],"about_ca_topic_score_codex":0.0000123974605,"about_ca_topic_score_gemma":0.000088359164,"teacher_disagreement_score":0.2793123,"about_ca_system_score_codex":0.000049634586,"about_ca_system_score_gemma":0.00011956522,"threshold_uncertainty_score":0.9999883},"labels":[],"label_agreement":null},{"id":"W2316239168","doi":"10.1093/neuonc/nov061.22","title":"EP-03 * MOLECULAR CLASSIFICATION OF EPENDYMAL TUMORS ACROSS ALL CNS COMPARTMENTS, HISTOPATHOLOGICAL GRADES AND AGE GROUPS","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Ependymoma; Biology; Concordance; Pathology; Histopathology; Brain tumor; Medicine; Bioinformatics","score_opus":0.07876514631944909,"score_gpt":0.3407474629227296,"score_spread":0.26198231660328053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2316239168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964615,0.000848213,0.0004136777,0.00049389875,0.0002521062,0.00025020362,0.000035901605,0.00002654603,0.0012179654],"genre_scores_gemma":[0.9981056,0.0000783999,0.0007731492,0.0007247113,0.000098479104,0.000047804126,0.00011277149,0.00002441302,0.000034696623],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99819595,0.00034943715,0.00038433116,0.00053345726,0.00016932197,0.00036752032],"domain_scores_gemma":[0.9991088,0.000060631653,0.00020821446,0.00032728357,0.000118086195,0.0001769925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040624457,0.00021720782,0.00041236455,0.000039582712,0.00007088104,0.000012601063,0.00022497098,0.00024815532,0.0000033447955],"category_scores_gemma":[0.00039834218,0.00020284361,0.00008245897,0.000076541924,0.00052546785,0.0000050299586,0.00028845647,0.00017964198,0.000011572945],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001470238,0.00020809837,0.005572647,0.00001574063,0.000034309545,0.00030784807,0.0005626672,0.000025216623,0.99029243,0.00040967087,0.0013813067,0.0010430433],"study_design_scores_gemma":[0.0038517343,0.0066009983,0.046772458,0.000017693235,0.00012496703,0.0007142561,0.0016369211,0.00014491277,0.6896186,0.00077600987,0.2490731,0.000668358],"about_ca_topic_score_codex":0.000010688851,"about_ca_topic_score_gemma":0.000028658802,"teacher_disagreement_score":0.30067384,"about_ca_system_score_codex":0.000057338624,"about_ca_system_score_gemma":0.000094535215,"threshold_uncertainty_score":0.8271722},"labels":[],"label_agreement":null},{"id":"W2316561842","doi":"10.1093/neuonc/nou262.4","title":"MR-04 * DICER REGULATES GLIOMA STEM CELL STATE","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Dicer; Biology; Gene knockdown; microRNA; Stem cell; Drosha; Cancer research; Stem cell marker; Phenotype; Molecular biology; RNA interference; Cell biology; Genetics; Cell culture; Gene; RNA","score_opus":0.01021850737443752,"score_gpt":0.2698809551889988,"score_spread":0.25966244781456127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2316561842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9662696,0.00086221506,0.011224681,0.001173876,0.0011500642,0.0006635766,0.000032311567,0.00009403809,0.018529598],"genre_scores_gemma":[0.9959072,0.0002806587,0.00040167602,0.0015054554,0.00039273358,0.00007749747,0.000060655973,0.00009940505,0.0012747376],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973833,0.0005066772,0.00034564506,0.00077836396,0.00029843996,0.0006875707],"domain_scores_gemma":[0.9985471,0.00009042511,0.00015584924,0.00077087065,0.00016825122,0.0002675257],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004089626,0.00028032242,0.00031829393,0.00013629241,0.0001270866,0.000038857288,0.00046973352,0.00043598932,0.00010303654],"category_scores_gemma":[0.00008897142,0.00028362576,0.00015511179,0.00022292824,0.00015778262,0.0000056380313,0.00040913193,0.00038317245,0.00019689281],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024934858,0.000104964194,0.00001160864,0.000024538196,0.0000354191,0.000076144446,0.00005356305,0.00033826736,0.962587,0.00010033625,0.0072707213,0.0291481],"study_design_scores_gemma":[0.0009206592,0.001353231,0.00001951266,0.0000037576256,0.000015980806,0.00008564738,0.000020077003,0.0003735062,0.6128608,0.00013433113,0.38403523,0.00017727798],"about_ca_topic_score_codex":0.00004100659,"about_ca_topic_score_gemma":0.000084533116,"teacher_disagreement_score":0.3767645,"about_ca_system_score_codex":0.00009405861,"about_ca_system_score_gemma":0.00030711113,"threshold_uncertainty_score":0.9999616},"labels":[],"label_agreement":null},{"id":"W2316854871","doi":"10.1093/neuonc/nou208.29","title":"THOR METHYLATION PROVIDES INSIGHT INTO THE TELOMERE MAINTENANCE LANDSCAPE OF MALIGNANT GLIOMAS","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiation Therapy and Dosimetry","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre","funders":"","keywords":"Telomere; Telomerase; Methylation; Cancer research; DNA methylation; Glioma; Biology; Gene; Molecular biology; Gene expression; Genetics","score_opus":0.015022629298450581,"score_gpt":0.28839404061337937,"score_spread":0.27337141131492876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2316854871","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.961705,0.0008086113,0.001019591,0.013834686,0.00058234046,0.0006174285,0.000002261415,0.00006972021,0.021360328],"genre_scores_gemma":[0.99576175,0.000091609174,0.0006167146,0.0030793513,0.00024814392,0.000031292686,0.0000062736135,0.000015324658,0.00014955342],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99879926,0.000325699,0.00031834518,0.00021325372,0.0001725014,0.00017095773],"domain_scores_gemma":[0.9985464,0.0007423771,0.00021504232,0.00031381415,0.000112511436,0.00006984338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049576175,0.000113302085,0.0003138625,0.00013796799,0.000083258965,0.000007261991,0.00012150734,0.00013676702,0.00010891073],"category_scores_gemma":[0.00055179064,0.00006740297,0.000078671124,0.00032420526,0.00012150631,0.000063928426,0.000029122815,0.00019075001,0.00003170495],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068367395,0.00017106267,0.011919669,0.0000646463,0.00005655403,0.000023732196,0.0031037945,0.000039039878,0.8484718,0.0062598023,0.0039879936,0.12521821],"study_design_scores_gemma":[0.0020804706,0.0022872582,0.018619666,0.00002978821,0.000092856855,0.000106552274,0.0002024124,0.0021539347,0.23358683,0.0018087941,0.738913,0.00011845089],"about_ca_topic_score_codex":0.000036935926,"about_ca_topic_score_gemma":0.000025856993,"teacher_disagreement_score":0.734925,"about_ca_system_score_codex":0.000043385324,"about_ca_system_score_gemma":0.00011173932,"threshold_uncertainty_score":0.27486134},"labels":[],"label_agreement":null},{"id":"W2317469671","doi":"10.1093/neuonc/nou260.14","title":"MS-15 * THE IMPACT OF HISTOPATHOLOGIC AND RADIOLOGIC CHARACTERISTICS IN CLINICAL OUTCOME OF PATIENTS WHO UNDERWENT SURGERY FOR INTRACRANIAL MENINGIOMAS","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Meningioma; Incidence (geometry); Pathological; Edema; Surgery; Radiology; Internal medicine","score_opus":0.06489266807695558,"score_gpt":0.36144518560820843,"score_spread":0.29655251753125283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317469671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99721193,0.0000379108,0.00046238137,0.000607262,0.00055185216,0.0007401004,0.000017500955,0.000013842788,0.00035719157],"genre_scores_gemma":[0.999059,0.000026266544,0.00042908042,0.00025424594,0.00013718562,0.000034182936,0.000027571066,0.000015724365,0.000016720103],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99740165,0.00057736906,0.0012741024,0.0003127296,0.00014163651,0.00029252373],"domain_scores_gemma":[0.99603885,0.0027810456,0.00067126064,0.00030745557,0.00010473848,0.00009667406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020758843,0.00017637324,0.001173888,0.00017337748,0.000039081104,0.0000047774474,0.0001320463,0.00019783618,0.000027318087],"category_scores_gemma":[0.0028896788,0.00011053087,0.00027764164,0.00012338506,0.00028833147,0.000029217314,0.00010454076,0.00024322054,0.0000015494564],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012276032,0.00047508613,0.97781974,0.00009750061,0.000039099115,0.00014687724,0.0001511573,0.000003595791,0.0022458332,0.00019258786,0.0011152581,0.016485648],"study_design_scores_gemma":[0.0022311844,0.00558097,0.98849547,0.000019059953,0.00010823679,0.00009750372,0.000020755864,0.0013069385,0.00004171186,0.00020095942,0.0018060287,0.000091170165],"about_ca_topic_score_codex":0.000021302434,"about_ca_topic_score_gemma":0.000003375225,"teacher_disagreement_score":0.016394477,"about_ca_system_score_codex":0.000109975255,"about_ca_system_score_gemma":0.00008657568,"threshold_uncertainty_score":0.45073178},"labels":[],"label_agreement":null},{"id":"W2317611189","doi":"10.1093/neuonc/nou208.14","title":"DETAILED MOLECULAR CHARACTERISATION OF DIFFUSE INTRINSIC PONTINE GLIOMAS IDENTIFIES THREE MOLECULAR SUBGROUPS AND A NOVEL CANCER DRIVER, ACVR1","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"DNA methylation; CpG site; Cancer; Exome sequencing; Methylation; Computational biology; Medicine; Genome; Genetics; Biology; Mutation; Gene; Gene expression","score_opus":0.013628538316084973,"score_gpt":0.27024406593603395,"score_spread":0.256615527619949,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317611189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99505603,0.0004985205,0.0007206222,0.0026389188,0.0003183263,0.0005687371,0.0000141064675,0.000045299304,0.00013946055],"genre_scores_gemma":[0.99832296,0.00017986629,0.0002465789,0.00094087276,0.000084116335,0.0001523282,0.000031861266,0.000037003992,0.000004417931],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99857235,0.00009378782,0.00039196666,0.0004213591,0.00024112874,0.0002793891],"domain_scores_gemma":[0.99886876,0.0001783761,0.000267691,0.0003635924,0.00016545018,0.000156143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014358772,0.00023413477,0.0006193415,0.00023816539,0.000049185783,0.000018538813,0.00009421496,0.00016955614,0.00005879784],"category_scores_gemma":[0.00022136132,0.00020333678,0.000119093995,0.00022091986,0.00014842591,0.00007709301,0.000113793896,0.00015764497,0.000008719506],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020160871,0.0008067584,0.10264477,0.00006014263,0.00014965062,0.00028515063,0.00013832565,0.0000032084615,0.8811706,0.0006104357,0.00005602677,0.013873348],"study_design_scores_gemma":[0.008330966,0.0013065081,0.42526212,0.000053976502,0.0005198275,0.00014192532,0.000026717478,0.00028997645,0.5617145,0.00019273823,0.0020009698,0.00015980637],"about_ca_topic_score_codex":0.00010771027,"about_ca_topic_score_gemma":0.00027037234,"teacher_disagreement_score":0.32261735,"about_ca_system_score_codex":0.00009537231,"about_ca_system_score_gemma":0.00007432933,"threshold_uncertainty_score":0.8291833},"labels":[],"label_agreement":null},{"id":"W2318100480","doi":"10.1093/neuonc/nov061.134","title":"PM-12 * USING A ZEBRAFISH PEDIATRIC BRAIN TUMOR MODEL FOR PRE-CLINICAL DRUG SCREENING","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Zebrafish Biomedical Research Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Zebrafish; Drug; Medicine; Computational biology; Oncology; Pharmacology; Biology; Genetics; Gene","score_opus":0.08179235148346989,"score_gpt":0.40675492001818836,"score_spread":0.3249625685347185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318100480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.76312786,0.00026023082,0.2264069,0.007111462,0.00039798822,0.0014957391,0.00013514493,0.00007530553,0.0009893671],"genre_scores_gemma":[0.91832757,0.000101653575,0.06306517,0.012888195,0.003799428,0.00059117697,0.0003274659,0.00014184263,0.0007574748],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972807,0.00034041557,0.00059013284,0.00077982683,0.00033027286,0.00067865785],"domain_scores_gemma":[0.9976213,0.0005667261,0.00021989862,0.00055408274,0.00028017463,0.00075780804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014982182,0.0002186084,0.00035720732,0.00011183228,0.0001338903,0.0000339804,0.0005870866,0.0003262503,0.000013102357],"category_scores_gemma":[0.0055680154,0.00021980221,0.00020013188,0.0002111226,0.00027927218,0.000010890833,0.00047329787,0.00039521907,0.000019235988],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001049504,0.0007259412,0.0037642044,0.000051478735,0.00007292758,0.000032352513,0.00014692095,0.001316772,0.4779928,0.00016183409,0.5031173,0.011567939],"study_design_scores_gemma":[0.006203762,0.0024603081,0.0005989922,0.000007850423,0.00011765773,0.00012352713,0.00009412433,0.31320462,0.012591156,0.0013145007,0.6627144,0.0005691148],"about_ca_topic_score_codex":0.00002409394,"about_ca_topic_score_gemma":0.000085865904,"teacher_disagreement_score":0.46540165,"about_ca_system_score_codex":0.00007007062,"about_ca_system_score_gemma":0.0015775249,"threshold_uncertainty_score":0.8963274},"labels":[],"label_agreement":null},{"id":"W2318376928","doi":"10.1093/neuonc/nou256.26","title":"GE-27 * THERAPEUTIC IMPLICATIONS OF MEDULLOBLASTOMA SUBGROUPS IN CHILDREN OVER AGE 3: A SINGLE CENTRE POPULATION BASED EXPERIENCE","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Medulloblastoma; Cohort; Internal medicine; Progression-free survival; Overall survival; Population; Oncology; Chemotherapy; Radiation therapy; Cohort study; Survival analysis; Pediatrics; Pathology","score_opus":0.017895215074458206,"score_gpt":0.29100895516235303,"score_spread":0.27311374008789485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318376928","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99646014,0.000054375883,0.000050276773,0.0022750837,0.000098838056,0.0004978876,0.0000071606755,0.000032457603,0.0005237819],"genre_scores_gemma":[0.9980522,0.000006049494,0.00019883842,0.0015448052,0.000045749413,0.00006421421,0.00006622091,0.000018323813,0.00000362569],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989386,0.00013879029,0.00029130784,0.0002826143,0.00013001169,0.00021866192],"domain_scores_gemma":[0.9991565,0.0002589374,0.0001366402,0.00032302237,0.00003690926,0.00008803094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007086962,0.00012798149,0.0003147182,0.00015218912,0.000032948516,0.000005941029,0.000080764876,0.00010766876,0.00011979639],"category_scores_gemma":[0.000089822635,0.000110837354,0.00007565717,0.00023079263,0.0000567898,0.000039792056,0.000023951769,0.00009684238,0.000010386932],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005424351,0.001143368,0.7844757,0.0000063808507,0.000014298498,0.000011263261,0.00024407539,0.000026385325,0.20368475,0.00041142674,0.0000768607,0.009851251],"study_design_scores_gemma":[0.0026429314,0.0007581838,0.97516817,0.000019260684,0.00005988138,0.00002740746,0.000026853586,0.00027006803,0.01869177,0.00012456249,0.002135426,0.000075508506],"about_ca_topic_score_codex":0.00018093169,"about_ca_topic_score_gemma":0.00034709892,"teacher_disagreement_score":0.19069245,"about_ca_system_score_codex":0.0001806372,"about_ca_system_score_gemma":0.00004556429,"threshold_uncertainty_score":0.45198163},"labels":[],"label_agreement":null},{"id":"W2318421360","doi":"10.1093/neuonc/nov061.112","title":"MB-36 * WIP1 AUGMENTS SONIC HEDGEHOG (SHH) SIGNALING AND IS A TARGET IN SHH MEDULLOBLASTOMAS","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Sonic hedgehog; Medulloblastoma; Hedgehog signaling pathway; Cell biology; Hedgehog; Cancer research; Biology; Chemistry; Signal transduction","score_opus":0.0306727920107308,"score_gpt":0.29558523264531783,"score_spread":0.264912440634587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318421360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99293846,0.002445303,0.00023865276,0.0012149564,0.00059308053,0.00033829716,0.00002329911,0.000037673206,0.0021702896],"genre_scores_gemma":[0.9947968,0.00021594104,0.0011395275,0.0031675166,0.00034935612,0.000069956885,0.000029128048,0.00005529101,0.00017649659],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976497,0.00030927567,0.00044279097,0.00076333317,0.00021971588,0.00061516353],"domain_scores_gemma":[0.9989843,0.00009602107,0.00015449896,0.00035611438,0.00013232601,0.00027675732],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00054110267,0.00032390677,0.000470937,0.0001325475,0.000097954,0.000025387604,0.00027739612,0.00037600813,0.000028321167],"category_scores_gemma":[0.000500639,0.00032809642,0.00008527455,0.00018704572,0.00023890242,0.000008991482,0.00042651367,0.00030245163,0.00005037196],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032123952,0.00017728114,0.009627357,0.000027052058,0.00007261507,0.00014601623,0.0012433048,0.0001710809,0.97757196,0.000021243146,0.008026585,0.002594263],"study_design_scores_gemma":[0.0043916944,0.003543708,0.0011861683,0.000039562397,0.000056225443,0.00017753868,0.0010441722,0.0004263318,0.5341585,0.00047358623,0.4538721,0.00063032756],"about_ca_topic_score_codex":0.000040802002,"about_ca_topic_score_gemma":0.000109014734,"teacher_disagreement_score":0.44584554,"about_ca_system_score_codex":0.00011404814,"about_ca_system_score_gemma":0.0004258887,"threshold_uncertainty_score":0.9999171},"labels":[],"label_agreement":null},{"id":"W2318702586","doi":"10.1093/neuonc/nou057","title":"Combined modality therapy versus chemotherapy alone as an induction regimen for primary central nervous system lymphoma: a cost-effectiveness analysis","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; University of Toronto; Sunnybrook Hospital","funders":"American Society of Hematology","keywords":"Medicine; Primary central nervous system lymphoma; Life expectancy; Chemotherapy; Regimen; Quality-adjusted life year; Cost effectiveness; Quality of life (healthcare); Oncology; Chemotherapy regimen; Induction chemotherapy; Internal medicine; Pediatrics; Population","score_opus":0.03151012307357634,"score_gpt":0.3231779386837084,"score_spread":0.2916678156101321,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318702586","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992269,0.00009286719,0.0006320828,0.0017761462,0.0009484279,0.0030881506,0.00002164613,0.00020748997,0.0009642086],"genre_scores_gemma":[0.9961947,0.00013788416,0.0002986639,0.0012555303,0.00038114475,0.0013184398,0.00033871154,0.000060203023,0.000014729554],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99735504,0.00070455676,0.0003994028,0.000745689,0.00027316203,0.0005221559],"domain_scores_gemma":[0.99761117,0.00093635044,0.00026332366,0.0006798775,0.00019139382,0.00031790754],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00051029766,0.00034058,0.0011705683,0.00022679428,0.00017829427,0.000031143645,0.00014073127,0.00031228873,0.000024522915],"category_scores_gemma":[0.0000819272,0.00028992424,0.0003988059,0.00047214178,0.00010726998,0.00010902995,0.000028757631,0.00010253029,0.0000125374445],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.044663616,0.0064799245,0.028039457,0.0001735442,0.003267427,0.00014045063,0.0004835149,0.00018160464,0.044142976,0.0015597553,0.00024091032,0.8706268],"study_design_scores_gemma":[0.06681576,0.017999155,0.8624275,0.00002809973,0.0019990874,0.00014600279,0.00017102939,0.0025872788,0.026855126,0.00011038473,0.020522408,0.00033819964],"about_ca_topic_score_codex":0.0006685125,"about_ca_topic_score_gemma":0.000051929503,"teacher_disagreement_score":0.8702886,"about_ca_system_score_codex":0.0021101122,"about_ca_system_score_gemma":0.00036913503,"threshold_uncertainty_score":0.9999553},"labels":[],"label_agreement":null},{"id":"W2318760583","doi":"10.1093/neuonc/nou275.15","title":"SC-15 * ISOLATING GLIOBLASTOMA TUMOR INITIATING PROGENITOR CELLS FROM THE SUBVENTRICULAR ZONE USING A NOVEL MINIMALLY INVASIVE APPROACH","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Synaptive (Canada); Ottawa Hospital; University of Ottawa","funders":"","keywords":"Subventricular zone; PTEN; Magnetic resonance imaging; Neural stem cell; Glioblastoma; Cancer research; Brain tumor; Pathology; Medicine; Stem cell; Biology; Radiology; Cell biology; PI3K/AKT/mTOR pathway; Signal transduction","score_opus":0.028411320291805077,"score_gpt":0.27011295602981616,"score_spread":0.2417016357380111,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318760583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954765,0.000221001,0.0011237408,0.0008163565,0.00041274822,0.0011630215,0.000028875766,0.000081376835,0.00067641155],"genre_scores_gemma":[0.97117484,0.000006637763,0.024524458,0.003055766,0.0009856719,0.00015850649,0.000027086526,0.000065368586,0.0000016423812],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975983,0.00033104038,0.00055553165,0.0006231886,0.00034708917,0.00054488156],"domain_scores_gemma":[0.9966139,0.0020978008,0.00044487097,0.00044793685,0.00017862923,0.00021682227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032121854,0.00033356284,0.0006476054,0.00012178381,0.0002868684,0.000054673463,0.00021239002,0.00016995166,0.000052603795],"category_scores_gemma":[0.0008845618,0.0002380064,0.00021146896,0.00038277797,0.00012754818,0.000085518885,0.00019677116,0.00040871088,0.000044089298],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021453405,0.0013875999,0.019490669,0.000037042886,0.00017406714,0.0004882028,0.00070867495,0.00015460823,0.97357047,0.000046647987,0.00026007573,0.0034674208],"study_design_scores_gemma":[0.014421131,0.005521122,0.008017482,0.00027139884,0.0015265595,0.0017475486,0.0016638408,0.04237998,0.911853,0.000043110118,0.011951154,0.0006036813],"about_ca_topic_score_codex":0.00016628426,"about_ca_topic_score_gemma":0.00006563731,"teacher_disagreement_score":0.06171746,"about_ca_system_score_codex":0.00024361158,"about_ca_system_score_gemma":0.00034711513,"threshold_uncertainty_score":0.9705619},"labels":[],"label_agreement":null},{"id":"W2319011908","doi":"10.1093/neuonc/nou208.46","title":"BRAIN TUMOUR INITIATING CELLS AND TARGETING STAT3 ONCOGENIC SIGNALLING IN GBM","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Brain Institute; Hotchkiss Brain Institute; University of Calgary","funders":"","keywords":"STAT3; Neurosphere; Cancer research; Biology; STAT protein; Stem cell; Janus kinase; Cell growth; Signal transduction; Medicine; Cellular differentiation; Cell biology; Adult stem cell; Gene","score_opus":0.009283255831808371,"score_gpt":0.2528290315541234,"score_spread":0.24354577572231503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2319011908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947785,0.0002615108,0.002785391,0.00045359143,0.00021969719,0.0001783235,0.000008941229,0.000015910686,0.0012981008],"genre_scores_gemma":[0.99362797,0.00026607327,0.002068243,0.0035840943,0.00032213904,0.000017830745,0.000050023064,0.000036192447,0.00002746605],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984079,0.00032864077,0.000347136,0.00045540213,0.00007226076,0.00038864638],"domain_scores_gemma":[0.9993371,0.00022940383,0.00014547209,0.00014873463,0.0000426713,0.00009663263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053703145,0.00017763363,0.00025134077,0.00007188286,0.00007876515,0.000021293394,0.00015474966,0.00023863296,0.000011754875],"category_scores_gemma":[0.00037001466,0.00019130323,0.000056390916,0.00008077633,0.000066850465,0.000005523531,0.00018202707,0.0002657913,0.000009644141],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004050243,0.000048833335,0.0011633488,0.000020236495,0.000009428704,0.000019153142,0.00014572094,0.00026304045,0.9900057,0.000049220147,0.0009811393,0.007253683],"study_design_scores_gemma":[0.0012234694,0.0008887552,0.00022280563,0.000014369586,0.0000150784335,0.00004816839,0.00018854342,0.0031270408,0.85414517,0.00011187902,0.13973643,0.00027831757],"about_ca_topic_score_codex":0.000029022594,"about_ca_topic_score_gemma":0.00013347638,"teacher_disagreement_score":0.13875529,"about_ca_system_score_codex":0.00003244982,"about_ca_system_score_gemma":0.000112339396,"threshold_uncertainty_score":0.78011197},"labels":[],"label_agreement":null},{"id":"W2319033605","doi":"10.1093/neuonc/nou275.33","title":"SC-34 * A NOVEL VEGF-RESPONSIVE lincRNA ORCHESTRATES GLIOMA STEM CELL-MEDIATED ANGIOGENESIS IN GLIOBLASTOMA","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Angiogenesis; Biology; Glioma; Cancer research; Transdifferentiation; Neovascularization; Pericyte; Progenitor cell; Stem cell; Cell biology; Endothelial stem cell; Genetics; In vitro","score_opus":0.013384943158218553,"score_gpt":0.2738160506370202,"score_spread":0.26043110747880166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2319033605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99183714,0.0006123601,0.0043123,0.0006746247,0.0004514744,0.00061832095,0.00004401428,0.000056116984,0.0013936583],"genre_scores_gemma":[0.9977451,0.00017334917,0.00033839844,0.0010262507,0.0002689355,0.0001679842,0.000060594717,0.00010373774,0.000115659925],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9966299,0.0006574576,0.00051155704,0.0009790523,0.00035243083,0.00086962985],"domain_scores_gemma":[0.99818754,0.00034080545,0.00020348786,0.0006996457,0.00025245594,0.00031607956],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00059968437,0.0003907576,0.00047103752,0.00044338094,0.0001031281,0.00004071374,0.0005804971,0.00081407576,0.000044507793],"category_scores_gemma":[0.00046163995,0.00041892866,0.00020309396,0.00073377904,0.00019022093,0.000008949587,0.00039949047,0.00047437477,0.000110084584],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013308488,0.00031131733,0.000078582,0.000023929615,0.000047645764,0.00025056212,0.000094070005,0.0004062836,0.99061126,0.00007045164,0.00088892085,0.0058861356],"study_design_scores_gemma":[0.0029176704,0.003488072,0.00024498775,0.000014359146,0.000029715562,0.00023805884,0.00011708656,0.001493924,0.91679513,0.000024928255,0.07427009,0.0003659769],"about_ca_topic_score_codex":0.00010890211,"about_ca_topic_score_gemma":0.0005319813,"teacher_disagreement_score":0.07381613,"about_ca_system_score_codex":0.00024460288,"about_ca_system_score_gemma":0.0008324466,"threshold_uncertainty_score":0.99982625},"labels":[],"label_agreement":null},{"id":"W2320193046","doi":"10.1093/neuonc/nou365","title":"Phase II study of PX-866 in recurrent glioblastoma","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":119,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario","funders":"","keywords":"Medicine; Nausea; Internal medicine; Adverse effect; Gastroenterology; Vomiting; Clinical endpoint; Diarrhea; Phases of clinical research; Progression-free survival; Oncology; PTEN; Toxicity; Chemotherapy; PI3K/AKT/mTOR pathway; Clinical trial","score_opus":0.051859229300058984,"score_gpt":0.36931980569683337,"score_spread":0.3174605763967744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320193046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99526095,0.00018815161,5.7641535e-7,0.0016863864,0.0005419122,0.00084212964,0.000005455498,0.000028012226,0.0014464152],"genre_scores_gemma":[0.99939424,0.000023732431,0.000040412004,0.0002930261,0.00008470026,0.00013207879,0.000004897732,0.000016199207,0.00001072027],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99869484,0.00017306572,0.00038234287,0.00029141418,0.00022888427,0.00022945163],"domain_scores_gemma":[0.99910927,0.00015378123,0.00012952062,0.00029723922,0.000105275816,0.00020492614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019135833,0.00014254058,0.00051379343,0.00024289945,0.000025237528,0.0000027217475,0.000081195976,0.00008730673,0.00005210561],"category_scores_gemma":[0.00024059205,0.000103718354,0.000055308334,0.00029872073,0.000045924782,0.00003193474,0.000101791746,0.00018209014,0.000031863266],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011051702,0.29565194,0.10997999,0.000060253547,0.0002602128,0.0100348545,0.014704747,0.000051777108,0.0924832,0.00015457941,0.030012146,0.4355546],"study_design_scores_gemma":[0.14634715,0.6103582,0.012898995,0.00007572032,0.0004683546,0.00037832552,0.004295593,0.00032379106,0.045256298,0.000109555906,0.17921934,0.00026869215],"about_ca_topic_score_codex":0.000070391245,"about_ca_topic_score_gemma":0.00052992965,"teacher_disagreement_score":0.4352859,"about_ca_system_score_codex":0.00021350729,"about_ca_system_score_gemma":0.00019465605,"threshold_uncertainty_score":0.42295116},"labels":[],"label_agreement":null},{"id":"W2321118242","doi":"10.1093/neuonc/nou206.51","title":"SINGLE CELL DERIVED CLONAL ANALYSIS OF HUMAN GLIOBLASTOMA LINKS FUNCTIONAL AND GENOMIC HETEROGENEITY","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":132,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Temozolomide; clone (Java method); Biology; Autocrine signalling; Cancer research; Paracrine signalling; Glioblastoma; Genetics; Gene; Somatic evolution in cancer; Drug resistance; Computational biology; Receptor","score_opus":0.024605639899398343,"score_gpt":0.2779543514618333,"score_spread":0.25334871156243494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321118242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981658,0.00012998852,0.000052526702,0.00047611,0.00012425138,0.00015247674,0.000013119149,0.00002399051,0.0008617346],"genre_scores_gemma":[0.9987421,0.000016365606,0.00018509853,0.0008575802,0.00011111315,0.000020984813,0.000045455337,0.000015069848,0.000006211825],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9989275,0.00012228913,0.00028905852,0.00033065613,0.00014078894,0.00018975427],"domain_scores_gemma":[0.99911654,0.00027438824,0.0001581898,0.00022226837,0.000079726815,0.00014891577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000107154774,0.00014230967,0.0005363195,0.0002949437,0.0000771307,0.0000070876945,0.000046736033,0.00019382799,0.00016423888],"category_scores_gemma":[0.000036787576,0.00012572594,0.00018648639,0.00021816086,0.00012555931,0.00002041462,0.00006349044,0.00016479332,0.000012022039],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015416044,0.00092332653,0.12610511,0.000014924247,0.00039637703,0.000042076408,0.00005384513,0.00007182652,0.86902136,0.00005062279,0.00018744255,0.0029789044],"study_design_scores_gemma":[0.0031437504,0.0049951198,0.5173811,0.0000044252174,0.0022141084,0.000057077294,0.000017550055,0.00078330183,0.46409923,0.00002684558,0.007177382,0.0001001455],"about_ca_topic_score_codex":0.000023846998,"about_ca_topic_score_gemma":0.00021638935,"teacher_disagreement_score":0.40492216,"about_ca_system_score_codex":0.000098334844,"about_ca_system_score_gemma":0.000046054578,"threshold_uncertainty_score":0.5126955},"labels":[],"label_agreement":null},{"id":"W2321212845","doi":"10.1093/neuonc/nou347","title":"Image-guided, intensity-modulated radiation therapy (IG-IMRT) for skull base chordoma and chondrosarcoma: preliminary outcomes","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Bone Tumor Diagnosis and Treatments","field":"Medicine","cited_by":123,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Toronto Western Hospital; University of Toronto; University Health Network; Sunnybrook Health Science Centre; St. Michael's Hospital","funders":"","keywords":"Chordoma; Chondrosarcoma; Medicine; Radiation therapy; Radiology; Malignancy; Surgery; Internal medicine","score_opus":0.027367922206637786,"score_gpt":0.31624736349548194,"score_spread":0.28887944128884413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321212845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98318744,0.00041986463,0.00010340939,0.013663242,0.0006183268,0.0013532013,0.000018699518,0.00011640213,0.00051939505],"genre_scores_gemma":[0.98971105,0.00042542943,0.0021954856,0.0069005666,0.00019686899,0.00024747776,0.00011461522,0.00005922298,0.00014928795],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984589,0.00014792143,0.00038283755,0.00050721323,0.00014479118,0.00035832025],"domain_scores_gemma":[0.9982648,0.0008042673,0.00017210365,0.0003779625,0.0001691425,0.00021172363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002413671,0.00027151738,0.0007196039,0.00014641305,0.00013144435,0.000021546717,0.000081157275,0.00017632528,0.00004667377],"category_scores_gemma":[0.00053501443,0.00021524553,0.00015027846,0.0001112384,0.00012609603,0.00010680205,0.000054770135,0.00020446502,0.000036134286],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004111777,0.0033640645,0.50519973,0.00014209506,0.0003958576,0.00065336976,0.00058623846,0.000004008647,0.20449294,0.00019645787,0.032688122,0.24816534],"study_design_scores_gemma":[0.02437099,0.012109118,0.8317239,0.000028842784,0.0003280493,0.00094486104,0.00003587167,0.0035468652,0.018974254,0.0003940906,0.10725297,0.0002901578],"about_ca_topic_score_codex":0.000066740264,"about_ca_topic_score_gemma":0.000009120416,"teacher_disagreement_score":0.32652423,"about_ca_system_score_codex":0.0001206258,"about_ca_system_score_gemma":0.00007691125,"threshold_uncertainty_score":0.87774575},"labels":[],"label_agreement":null},{"id":"W2321318692","doi":"10.1093/neuonc/nou278.5","title":"TM-05 * PTEN INDUCED KINASE1 (PINK1) NEGATIVELY REGULATES AEROBIC GLYCOLYSIS IN GLIOBLASTOMA","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Occupational Cancer Research Centre; Hospital for Sick Children","funders":"","keywords":"PINK1; Warburg effect; Anaerobic glycolysis; PTEN; Glycolysis; Cell biology; Biology; Cancer research; Kinase; Reprogramming; Cancer cell; Chemistry; Signal transduction; Cell; Apoptosis; Biochemistry; Mitophagy; PI3K/AKT/mTOR pathway; Cancer; Autophagy; Metabolism; Genetics","score_opus":0.011237470775332895,"score_gpt":0.25949066446359614,"score_spread":0.24825319368826326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321318692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99407065,0.0004753851,0.00009034994,0.00094129937,0.0018624746,0.00033660035,0.000009514703,0.00003959481,0.0021741209],"genre_scores_gemma":[0.9943541,0.0003809877,0.000334088,0.0026309825,0.0018212962,0.00010715061,0.00003128718,0.00005672937,0.00028335614],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99762285,0.00043394818,0.00043829,0.0007560666,0.0001673388,0.00058149593],"domain_scores_gemma":[0.9988045,0.000109368295,0.00021974255,0.0005646162,0.000114215116,0.00018752109],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033310306,0.00031665625,0.00053667073,0.00019575164,0.00009548385,0.00002603764,0.00038449562,0.00051238673,0.000054629807],"category_scores_gemma":[0.00044646536,0.0003183538,0.00017483444,0.00034684222,0.00016102097,0.000010909579,0.00022760453,0.00032696646,0.000046373116],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044935875,0.00013552529,0.00022625287,0.000011862058,0.0000345195,0.000015563737,0.00013228772,0.00005616374,0.944766,0.000113129325,0.0055489074,0.048510473],"study_design_scores_gemma":[0.0018113409,0.0013109861,0.0022087265,0.000008002926,0.000036078025,0.00008162685,0.000055208668,0.0001001942,0.44214123,0.00012256797,0.5518727,0.00025133335],"about_ca_topic_score_codex":0.000120576035,"about_ca_topic_score_gemma":0.0012385803,"teacher_disagreement_score":0.5463238,"about_ca_system_score_codex":0.000070392314,"about_ca_system_score_gemma":0.00025269462,"threshold_uncertainty_score":0.99992687},"labels":[],"label_agreement":null},{"id":"W2321475660","doi":"10.1093/neuonc/nou251.23","title":"OP23 * AN AUDIT TO ASSESS PSYCHIATRIC CONDITIONS THAT MANIFEST IN PATIENTS WITH HIGH-GRADE BRAIN TUMOURS DURING TREATMENT","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Psychiatry; Psychiatric history; Referral; Audit; Psychiatric medication; Psychiatric assessment; Family medicine; Mental health; Anxiety","score_opus":0.0257748351272654,"score_gpt":0.3071824537802189,"score_spread":0.2814076186529535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321475660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888818,0.0000114250315,0.00004727235,0.008830436,0.0003946098,0.0011554062,0.0000669529,0.00007288341,0.00053916307],"genre_scores_gemma":[0.99457115,0.000009647684,0.0020107294,0.0025986766,0.00019569675,0.0002340261,0.00026013414,0.00005021031,0.000069722926],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980803,0.0004059491,0.00026954513,0.00055291876,0.00024216351,0.00044912472],"domain_scores_gemma":[0.99869764,0.00030397935,0.00012915756,0.0004572555,0.000044841094,0.0003671313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015443636,0.00028224944,0.000528678,0.000319793,0.00012567196,0.00001894171,0.000103556056,0.000103547194,0.00011902388],"category_scores_gemma":[0.00006068529,0.00021177308,0.000070430244,0.00028767576,0.000055205383,0.000090286645,0.00003558529,0.00018391413,0.0000746096],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009044961,0.006702043,0.98079336,0.000038270755,0.000115974544,0.0007525423,0.0002692865,0.00024432028,0.0033937108,0.0008444854,0.0011290911,0.0048124176],"study_design_scores_gemma":[0.013562814,0.016079703,0.95835716,0.000021397087,0.00022767512,0.000118261654,0.00008205297,0.000017578377,0.0011977588,0.0000663229,0.010081058,0.00018819945],"about_ca_topic_score_codex":0.00020132762,"about_ca_topic_score_gemma":0.00075190776,"teacher_disagreement_score":0.022436183,"about_ca_system_score_codex":0.00051868206,"about_ca_system_score_gemma":0.00014721756,"threshold_uncertainty_score":0.86358553},"labels":[],"label_agreement":null},{"id":"W2321856824","doi":"10.1093/neuonc/nou264.50","title":"NI-52 * TOWARDS IMPROVED INTEGRATION OF ADVANCED IMAGING TECHNIQUES INTO THE NEUROSURGICAL OPERATING SUITE: A CANADIAN EXPERIENCE","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Anatomy and Medical Technology","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Robarts Clinical Trials; London Health Sciences Centre; Western University","funders":"","keywords":"Workflow; Neuronavigation; Health care; Computer science; Medical imaging; Medicine; Medical physics; Artificial intelligence; Radiology; Magnetic resonance imaging","score_opus":0.006797778676993523,"score_gpt":0.2656670459714109,"score_spread":0.25886926729441734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321856824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94763744,0.00041760833,0.018714013,0.0077980063,0.0015837816,0.00072881224,0.000004294337,0.0009641895,0.022151869],"genre_scores_gemma":[0.9942456,0.0001497458,0.0038487206,0.0015043463,0.00008814906,0.00012880996,0.0000032466999,0.000023839493,0.000007556004],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99889296,0.00010795362,0.00032550024,0.00022880087,0.00009971984,0.00034507664],"domain_scores_gemma":[0.9992792,0.00019088252,0.000053857326,0.00027487677,0.00006362381,0.00013753882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025718554,0.00015292787,0.0002642736,0.00012586526,0.00010745581,0.00001374762,0.00035291465,0.00018175272,0.000031219854],"category_scores_gemma":[0.00088441785,0.00011637665,0.000045940997,0.00023514369,0.00028605942,0.000104313986,0.00006772012,0.0005444093,0.0000033721885],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004844515,0.000007919027,0.00008861602,0.000007644033,0.000002418178,0.000014969087,0.0011638859,0.000016700393,0.40183842,0.0019275623,0.00016027913,0.59476674],"study_design_scores_gemma":[0.00041768394,0.00042443792,0.00031227528,0.000026399575,0.000013179085,0.0001145389,0.0013212541,0.069908895,0.30411282,0.0006692179,0.62244296,0.00023635804],"about_ca_topic_score_codex":0.0045156097,"about_ca_topic_score_gemma":0.007841939,"teacher_disagreement_score":0.6222827,"about_ca_system_score_codex":0.0001477673,"about_ca_system_score_gemma":0.00013412128,"threshold_uncertainty_score":0.68262815},"labels":[],"label_agreement":null},{"id":"W2322061949","doi":"10.1093/neuonc/nou242.8","title":"CS-08 * SONIC HEDGEHOG SIGNALING PROTECTS ATOH1 FROM DEGRADATION MEDIATED BY THE HECT DOMAIN E3 UBIQUITIN LIGASE HUWE1 IN CEREBELLAR GRANULE NEURON PROGENITORS","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Ubiquitin ligase; Sonic hedgehog; Transcription factor; Cell biology; Biology; GLI2; Cerebellum; Ubiquitin; Molecular biology; Genetics; Signal transduction; Neuroscience; Gene","score_opus":0.013060896070525319,"score_gpt":0.2491607958643796,"score_spread":0.23609989979385426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2322061949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949087,0.00097516854,0.0005929328,0.0014876985,0.0004768598,0.001139504,0.00006344384,0.000073521616,0.00028215421],"genre_scores_gemma":[0.9964701,0.00011775782,0.00031398283,0.0016441232,0.0005648211,0.00043973565,0.00033368517,0.00008609213,0.000029728983],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9959021,0.0015292008,0.00062155706,0.0009379318,0.000287892,0.0007212826],"domain_scores_gemma":[0.9983017,0.00051287375,0.00032440096,0.00058548455,0.00011514718,0.00016040671],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008989381,0.0004303139,0.00049320207,0.000100584046,0.00029716498,0.000045111818,0.0005273765,0.00047335651,0.000019520621],"category_scores_gemma":[0.001150227,0.00036197074,0.00015350284,0.00031353164,0.00027195315,0.000010358689,0.00027128495,0.0005399037,0.00005594745],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019409813,0.00015753592,0.0015987764,0.00002211676,0.00004822311,0.000031269363,0.000337578,0.00009530443,0.99052584,0.000015098794,0.001994635,0.004979537],"study_design_scores_gemma":[0.001700251,0.0012875521,0.00034932492,0.000021259146,0.000037978873,0.000026944364,0.00020384841,0.00029483045,0.87782043,0.00018919456,0.11772505,0.00034334115],"about_ca_topic_score_codex":0.00017677622,"about_ca_topic_score_gemma":0.00047094686,"teacher_disagreement_score":0.11573041,"about_ca_system_score_codex":0.00010528353,"about_ca_system_score_gemma":0.000254253,"threshold_uncertainty_score":0.99988323},"labels":[],"label_agreement":null},{"id":"W2322556147","doi":"10.1093/neuonc/nou258.26","title":"IT-28 * VACCINATION AGAINST EPIDERMAL GROWTH FACTOR RECEPTOR VARIANT III IN GLIOBLASTOMA: THE RINDOPEPIMUT COMPASSIONATE USE EXPERIENCE","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"","keywords":"Temozolomide; Medicine; Bevacizumab; Internal medicine; Oncology; Epidermal growth factor receptor; Progressive disease; Gastroenterology; Cancer; Radiation therapy; Chemotherapy","score_opus":0.025980043796520597,"score_gpt":0.2979942413213975,"score_spread":0.27201419752487693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2322556147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9751876,0.000036268557,0.00008109945,0.02166319,0.0008042072,0.0007392478,0.000009837598,0.00006221932,0.0014163326],"genre_scores_gemma":[0.99171823,0.00011658089,0.00015846625,0.0074540274,0.00018617931,0.00029690895,0.000015177424,0.000029073357,0.00002537913],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99780226,0.0005104862,0.000493068,0.00048161813,0.00028386363,0.00042872288],"domain_scores_gemma":[0.99745625,0.0016174816,0.00020668098,0.00039157693,0.00013626686,0.00019171131],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024404172,0.00025124924,0.0005077044,0.00019593838,0.00016131287,0.00003355981,0.00019397537,0.00017219162,0.00031393184],"category_scores_gemma":[0.0008854787,0.00016447803,0.00010798305,0.00031445234,0.00008078408,0.00018823746,0.00012681176,0.00035722478,0.000117683354],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003061007,0.0081937825,0.25628266,0.00010186253,0.00022394743,0.00351249,0.01377387,0.00036779256,0.5180402,0.0064229025,0.052616466,0.13740306],"study_design_scores_gemma":[0.018643027,0.003594889,0.47608954,0.00011475715,0.000106963955,0.00042370058,0.00056681875,0.0055390215,0.113315895,0.000091066395,0.38104358,0.00047073478],"about_ca_topic_score_codex":0.00009675703,"about_ca_topic_score_gemma":0.00019850189,"teacher_disagreement_score":0.40472427,"about_ca_system_score_codex":0.0003107455,"about_ca_system_score_gemma":0.000116290685,"threshold_uncertainty_score":0.6707219},"labels":[],"label_agreement":null},{"id":"W2322670822","doi":"10.1093/neuonc/nou306","title":"White matter compromise predicts poor intellectual outcome in survivors of pediatric low-grade glioma","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"White matter; Neurocognitive; Medicine; Diffusion MRI; Cohort; Pediatrics; Neurofibromatosis; Borderline intellectual functioning; Magnetic resonance imaging; Cognition; Radiology; Internal medicine; Psychiatry","score_opus":0.023352206177516245,"score_gpt":0.2866055093431301,"score_spread":0.26325330316561385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2322670822","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929931,0.00009087819,0.000018483162,0.0037182744,0.00061389734,0.00060032064,0.000012953775,0.000045201006,0.001906868],"genre_scores_gemma":[0.9976857,0.000036439866,0.0001634115,0.0016954805,0.00025393875,0.0000784586,0.000020390416,0.00003978467,0.000026412199],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997974,0.00028459897,0.0006680152,0.00041599176,0.00024961436,0.0004077778],"domain_scores_gemma":[0.9980769,0.0010988789,0.00019582342,0.00036003292,0.00006747305,0.00020085514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002625566,0.00024267861,0.00078855775,0.0005416026,0.000029988134,0.000007503326,0.0001541032,0.00021341433,0.0004906092],"category_scores_gemma":[0.000423183,0.00020029498,0.00014786547,0.00048448768,0.000103177,0.000042513173,0.00010518443,0.0002617608,0.0002325606],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025064047,0.0017926857,0.9696685,0.00012454446,0.00003367601,0.0003822485,0.00051734154,0.00003364716,0.0186034,0.000018864288,0.00784815,0.000726281],"study_design_scores_gemma":[0.012925683,0.004007906,0.9508481,0.00003844974,0.00037211538,0.0003011896,0.00010936768,0.0011656443,0.019007195,0.000047884318,0.010898721,0.00027773491],"about_ca_topic_score_codex":0.00009740813,"about_ca_topic_score_gemma":0.00015972974,"teacher_disagreement_score":0.018820412,"about_ca_system_score_codex":0.00013048359,"about_ca_system_score_gemma":0.000082563456,"threshold_uncertainty_score":0.81677926},"labels":[],"label_agreement":null},{"id":"W2323591096","doi":"10.1093/neuonc/nov061.124","title":"PM-01 * NEURAL DERIVATIVES FROM HUMAN EMBRYONIC STEM CELLS: A CELLULAR SYSTEM TO STUDY THE ROLE OF Otx2 IN MEDULLOBLASTOMA PROGRESSION","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Pluripotent Stem Cells Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"SOX2; Homeobox protein NANOG; Biology; Sonic hedgehog; Neural stem cell; Embryonic stem cell; Medulloblastoma; H3K4me3; KLF4; Cancer research; Wnt signaling pathway; Induced pluripotent stem cell; Tumor initiation; Stem cell; Chromatin immunoprecipitation; Cell biology; Gene; Genetics; Promoter; Gene expression; Carcinogenesis","score_opus":0.025879826660594712,"score_gpt":0.31179974253799925,"score_spread":0.2859199158774045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323591096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964025,0.0007749917,0.000027054644,0.00027642984,0.00027240522,0.0014743063,0.000016879198,0.000024308547,0.0007311506],"genre_scores_gemma":[0.9993104,0.000007007912,0.00008659488,0.00009165187,0.00017419491,0.00021999108,0.000017637833,0.00004290164,0.00004966738],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9963499,0.0015430398,0.0005002686,0.0006723016,0.00044427073,0.00049027795],"domain_scores_gemma":[0.9985649,0.000117127434,0.00022789928,0.0007084128,0.00015049722,0.00023117279],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069352385,0.0002583112,0.0004276728,0.00012681501,0.00010029963,0.000023997241,0.0007969469,0.00022295953,0.000008585119],"category_scores_gemma":[0.00006691146,0.00019506189,0.00008716083,0.0002874468,0.00014385536,0.000007531534,0.00077973184,0.00031924268,0.000031336243],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046537377,0.0005704253,0.008252556,0.000019752742,0.000047547484,0.00012452611,0.0012526853,0.00022431726,0.9848417,0.000011324074,0.00023992489,0.003949846],"study_design_scores_gemma":[0.0018431753,0.0053781946,0.0016094698,0.000020726035,0.000028057046,0.0000164274,0.008757112,0.0006436947,0.9707469,0.000012516334,0.01075357,0.00019015516],"about_ca_topic_score_codex":0.00014320012,"about_ca_topic_score_gemma":0.00024395177,"teacher_disagreement_score":0.014094818,"about_ca_system_score_codex":0.00012330423,"about_ca_system_score_gemma":0.00023429324,"threshold_uncertainty_score":0.7954393},"labels":[],"label_agreement":null},{"id":"W2323627059","doi":"10.1093/neuonc/nou275.35","title":"SC-36 * RECIPROCAL INTERACTION OF PGE2 AND WNT SIGNALING REGULATES CANCER STEM CELLS IN GLIOBLASTOMA","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital; SickKids Foundation","funders":"","keywords":"Wnt signaling pathway; Cancer stem cell; Cancer research; Stem cell; Neural stem cell; Biology; Cancer; Oncogene; Glioma; Signal transduction; Cell cycle; Cell biology; Genetics","score_opus":0.007772035712621044,"score_gpt":0.26096428675331773,"score_spread":0.2531922510406967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323627059","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983709,0.000575251,0.000043701868,0.00016758499,0.0003869812,0.00015383628,0.000002417745,0.000009237988,0.00029008827],"genre_scores_gemma":[0.9991386,0.00036676863,0.00008512454,0.00019157925,0.00013751921,0.000020272228,0.000003113794,0.000018565324,0.000038447488],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99897254,0.00022296724,0.00024290079,0.00030295018,0.00006403814,0.0001945922],"domain_scores_gemma":[0.9995333,0.000091391645,0.00013496239,0.00013167327,0.00004302847,0.00006564316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018601923,0.00012710577,0.00023339952,0.00007194863,0.00003069607,0.0000065444456,0.00008362086,0.00030221487,0.0000074485556],"category_scores_gemma":[0.000030362571,0.00011560924,0.000047965015,0.00008286687,0.00010935662,0.000004856386,0.00007992277,0.00020630009,0.000003669847],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005964726,0.00006072069,0.0007237798,0.000025406147,0.000021223723,0.0000096901695,0.00008794162,0.00054849393,0.9716761,0.000021646134,0.00021589025,0.026012594],"study_design_scores_gemma":[0.00076363684,0.0019904738,0.00017999158,0.00003422894,0.000020194639,0.000046322348,0.000051661897,0.00079530367,0.98209053,0.000025172823,0.0138971135,0.00010539655],"about_ca_topic_score_codex":0.000032630767,"about_ca_topic_score_gemma":0.000055106004,"teacher_disagreement_score":0.025907198,"about_ca_system_score_codex":0.000031508007,"about_ca_system_score_gemma":0.000059181246,"threshold_uncertainty_score":0.4714408},"labels":[],"label_agreement":null},{"id":"W2324633735","doi":"10.1093/neuonc/nov061.12","title":"BT-02 * FUNCTIONALLY-DEFINED THERAPEUTIC TARGETS IN DIFFUSE INTRINSIC PONTINE GLIOMA","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Glioma; Neuroscience; Cancer research; Medicine; Biology","score_opus":0.03668093878874632,"score_gpt":0.2957468147592787,"score_spread":0.2590658759705324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324633735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9761891,0.0014858028,0.00001329347,0.015881894,0.0010490471,0.00056650204,0.0000064899164,0.000104424915,0.004703442],"genre_scores_gemma":[0.9946307,0.000073349576,0.00016531491,0.0045109377,0.00029311766,0.00016783293,0.000051781175,0.000039062637,0.0000679174],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983297,0.00016896345,0.00038434073,0.00042134777,0.00028510162,0.0004105509],"domain_scores_gemma":[0.99874634,0.0003609567,0.00011556696,0.00034205755,0.00014139035,0.00029371824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021360665,0.00023715504,0.0005423329,0.00035401684,0.00004023234,0.000013394687,0.00010025594,0.00019208422,0.0002205609],"category_scores_gemma":[0.00031585683,0.00019018797,0.00010785812,0.0003875395,0.00006801293,0.000063186686,0.00007869908,0.00027954616,0.00032197914],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003909622,0.018522792,0.27725095,0.00005339363,0.00043216214,0.014232018,0.0012437564,0.00003758924,0.5336947,0.004866323,0.035418123,0.11033858],"study_design_scores_gemma":[0.051901042,0.009273325,0.18194306,0.00003916672,0.0003796986,0.0017195044,0.00026093383,0.00018815705,0.029857818,0.0014248547,0.7226001,0.00041235477],"about_ca_topic_score_codex":0.00006452922,"about_ca_topic_score_gemma":0.00018484246,"teacher_disagreement_score":0.68718195,"about_ca_system_score_codex":0.0003875425,"about_ca_system_score_gemma":0.00033381835,"threshold_uncertainty_score":0.7755641},"labels":[],"label_agreement":null},{"id":"W2325456385","doi":"10.1093/neuonc/nou238.26","title":"AI-26 * OVERCOMING RESISTANCE TO VEGF-BLOCKADE BY TARGETING THE ANGIOPOIETIN/TIE2 AXIS","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital","funders":"","keywords":"Angiopoietin receptor; Angiogenesis; Bevacizumab; Cancer research; Angiopoietin; Medicine; Receptor tyrosine kinase; Monoclonal antibody; Blockade; Pharmacology; Vascular endothelial growth factor; Immunology; Receptor; Antibody; Internal medicine; Chemotherapy; VEGF receptors","score_opus":0.008825700170887827,"score_gpt":0.26781614054760217,"score_spread":0.2589904403767143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325456385","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92198414,0.006789799,0.008165889,0.04129221,0.0022450173,0.00084382924,0.00006987374,0.00013942904,0.018469844],"genre_scores_gemma":[0.9668864,0.00024369266,0.0011207642,0.02943095,0.0013746795,0.00010059855,0.000031678373,0.00007961554,0.0007315993],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99812424,0.00029358163,0.0003178582,0.0005925951,0.0001689982,0.0005027139],"domain_scores_gemma":[0.9989589,0.00014328265,0.00013800828,0.000519534,0.00009159952,0.00014871448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004647017,0.00023408483,0.00026307354,0.000033057666,0.00025899953,0.000031940624,0.0004665744,0.00025970378,0.00004980195],"category_scores_gemma":[0.00028035598,0.00018954912,0.00017034452,0.00014761167,0.00012117134,0.000004613548,0.00025282076,0.00019421679,0.000062062354],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000106539024,0.00003038486,0.0007497473,0.0000075627113,0.00001898791,0.000002898834,0.00007325312,0.000031766533,0.7136943,0.00006799921,0.28132746,0.0038891237],"study_design_scores_gemma":[0.00028112085,0.00030946298,0.00013095028,0.0000056926515,0.000016210626,0.000007692855,0.00004895468,0.00002522488,0.29782504,0.000035671794,0.7011534,0.00016060528],"about_ca_topic_score_codex":0.000026707397,"about_ca_topic_score_gemma":0.00007005353,"teacher_disagreement_score":0.41982594,"about_ca_system_score_codex":0.00005671238,"about_ca_system_score_gemma":0.00010036373,"threshold_uncertainty_score":0.7729589},"labels":[],"label_agreement":null},{"id":"W2325798815","doi":"10.1093/neuonc/nou264.65","title":"NI-67 * THE ROLE OF FLAIR VOLUME AS A PROGNOSTICATING FACTOR IN PATIENTS WITH GLIOBLASTOMA","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Fluid-attenuated inversion recovery; Magnetic resonance imaging; Nuclear medicine; Medicine; Glioblastoma; Volume (thermodynamics); Radiology","score_opus":0.006353008328689139,"score_gpt":0.2434102231051928,"score_spread":0.23705721477650366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325798815","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953331,0.000038726917,0.0000021427013,0.0012552295,0.00007900909,0.0007304769,0.0000058846026,0.00002511349,0.00253034],"genre_scores_gemma":[0.99913657,0.0000028057123,0.000123675,0.0005305967,0.000046733858,0.000125381,0.0000064510587,0.000021146709,0.0000066421676],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99893624,0.0001315704,0.00024703736,0.00023957615,0.00020338043,0.00024218555],"domain_scores_gemma":[0.9989545,0.00042099625,0.00015654293,0.00028128078,0.000103179984,0.0000835286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007955915,0.0001338919,0.00032148426,0.00008833826,0.00004032432,0.000005637185,0.00009723749,0.00008208985,0.00008911211],"category_scores_gemma":[0.00046335947,0.00007909066,0.000042986598,0.00017917836,0.00009751171,0.00002976363,0.000052433876,0.00016743026,0.000058957357],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033932333,0.0011604623,0.93308777,0.000012323636,0.0000317652,0.000025436566,0.0004067803,0.0000042806937,0.0074953996,0.0001452999,0.000109360655,0.057181805],"study_design_scores_gemma":[0.004795118,0.011663641,0.9409112,0.00005168017,0.00009222771,0.000023767096,0.00011725566,0.00028104286,0.017757928,0.000070190115,0.024149537,0.00008645569],"about_ca_topic_score_codex":0.00007194042,"about_ca_topic_score_gemma":0.00010240187,"teacher_disagreement_score":0.05709535,"about_ca_system_score_codex":0.00007690843,"about_ca_system_score_gemma":0.000095116186,"threshold_uncertainty_score":0.32252234},"labels":[],"label_agreement":null},{"id":"W2326031646","doi":"10.1093/neuonc/nov061.24","title":"EP-05 * POSTERIOR FOSSA EPENDYMOMA SUBGROUPS HAVE DISTINCT THERAPEUTIC AND PROGNOSTIC IMPLICATIONS","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Ependymoma; Posterior fossa; Medicine; Internal medicine; Pathology; Radiology","score_opus":0.023791925440884716,"score_gpt":0.29001840567642334,"score_spread":0.26622648023553863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326031646","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98901856,0.0014948448,0.0002440044,0.0036986892,0.00040888137,0.00037396955,0.000024392477,0.000028275275,0.0047084],"genre_scores_gemma":[0.9975369,0.0001626452,0.000098349665,0.0015617996,0.0002142342,0.00008584817,0.000069637776,0.000026698372,0.00024388375],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99888694,0.00013054989,0.00021025291,0.000403007,0.000081148966,0.00028808886],"domain_scores_gemma":[0.9992727,0.000048111153,0.00010290584,0.00026929044,0.0000963215,0.0002106929],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010922596,0.00016911031,0.00018837512,0.000037010133,0.000091530856,0.000023516368,0.00016950376,0.00025976988,0.000008971298],"category_scores_gemma":[0.00010610422,0.0001386055,0.00006028594,0.00006879318,0.00020154924,0.0000048733687,0.00013414303,0.00017366165,0.00001952733],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003019725,0.00012940835,0.02330795,0.00001823983,0.00008870648,0.0000967686,0.00017849042,0.000013806908,0.9026856,0.00013354355,0.003869683,0.06917585],"study_design_scores_gemma":[0.0046627726,0.008944222,0.11478672,0.000026251222,0.00030962314,0.0069521526,0.00038126245,0.00019846925,0.101682924,0.001772178,0.7594459,0.0008374829],"about_ca_topic_score_codex":0.000029413839,"about_ca_topic_score_gemma":0.00007964125,"teacher_disagreement_score":0.8010027,"about_ca_system_score_codex":0.000044409408,"about_ca_system_score_gemma":0.00022863015,"threshold_uncertainty_score":0.5652168},"labels":[],"label_agreement":null},{"id":"W2326440885","doi":"10.1093/neuonc/nou253.15","title":"ED-15 * LONG-TERM PROPHYLACTIC ANTIEPILEPTIC DRUGS USE IN PATIENTS WITH GLIOMAS: A 7 YEAR RETROSPECTIVE ANALYSIS IN A TERTIARY CARE CENTER","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame","funders":"","keywords":"Medicine; Retrospective cohort study; Perioperative; Neurology; Prophylactic treatment; Epilepsy; Epilepsy surgery; Pediatrics; Surgery; Anesthesia","score_opus":0.005962246150723307,"score_gpt":0.24939971417410506,"score_spread":0.24343746802338176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326440885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983161,0.000037435304,0.000004298729,0.00024215807,0.0001255512,0.00094979675,0.000016067404,0.00003185892,0.00027672964],"genre_scores_gemma":[0.9990108,0.000010856646,0.00008667456,0.000577665,0.000047078873,0.00012700724,0.00010002903,0.000035958874,0.0000039190127],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99808246,0.00026157332,0.00035235408,0.0005984708,0.00029744138,0.00040770104],"domain_scores_gemma":[0.9989341,0.00016541856,0.00015627957,0.00044977808,0.00014913322,0.00014527726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008462275,0.00024890894,0.0006866636,0.0008199992,0.000033628,0.000024680325,0.00009233389,0.00015032968,0.00006333343],"category_scores_gemma":[0.00013418421,0.00018840109,0.00013191663,0.00087215024,0.00008650171,0.00012910103,0.00006703393,0.00030159327,0.000036773286],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060795987,0.0024429446,0.99248564,0.000053730702,0.00020535376,0.0008284763,0.0009099342,0.000010801487,0.00049038936,0.00000670635,0.000045476994,0.0019125688],"study_design_scores_gemma":[0.011556809,0.0030233841,0.98389107,0.0000651868,0.0005950403,0.0000104543515,0.00008694088,0.00004433816,0.0004849295,0.0000030945873,0.00008489614,0.00015382664],"about_ca_topic_score_codex":0.00013465011,"about_ca_topic_score_gemma":0.0011454851,"teacher_disagreement_score":0.010948849,"about_ca_system_score_codex":0.00071789854,"about_ca_system_score_gemma":0.00009016624,"threshold_uncertainty_score":0.76827735},"labels":[],"label_agreement":null},{"id":"W2327002222","doi":"10.1093/neuonc/nov061.91","title":"MB-15 * ACTIVATED Wnt SIGNALING TARGETS Sox2+ TREATMENT-REFRACTORY Shh-DEPENDENT MEDULLOBLASTOMA STEM CELLS","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medulloblastoma; SOX2; Wnt signaling pathway; Cancer research; Stem cell; Refractory (planetary science); Chemistry; Cell biology; Biology; Signal transduction; Biochemistry; Transcription factor; Astrobiology; Gene","score_opus":0.02224597898360645,"score_gpt":0.27185283960649587,"score_spread":0.24960686062288942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327002222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962316,0.0008052616,0.00026722928,0.00022643198,0.00093145086,0.0004890441,0.0000400447,0.00007045439,0.0009384589],"genre_scores_gemma":[0.9981547,0.00007120117,0.00025517526,0.00043505486,0.0005014231,0.00007014402,0.00012946234,0.000069416805,0.00031340533],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99784464,0.00040461836,0.00038008497,0.00067602075,0.00023897886,0.00045563464],"domain_scores_gemma":[0.99862725,0.000069882815,0.0002677754,0.00046685114,0.000181681,0.00038655105],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019429714,0.00033638626,0.00034925563,0.00009250539,0.00008745821,0.000026407268,0.00025658545,0.0004323996,0.00007360301],"category_scores_gemma":[0.000057554527,0.00031824407,0.0001496329,0.000099014476,0.00010187221,0.000012180369,0.00015712826,0.00015922487,0.00014340178],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053207896,0.0004305019,0.00018162811,0.000010748886,0.000112764,0.00010674753,0.00013024575,0.00077093154,0.9878302,0.000008850633,0.0034402807,0.006444974],"study_design_scores_gemma":[0.0018547828,0.0018866386,0.00006467061,0.000005375912,0.00006351293,0.000056906953,0.0001439589,0.00007993875,0.8436434,0.000022932276,0.15193646,0.00024139363],"about_ca_topic_score_codex":0.000027094029,"about_ca_topic_score_gemma":0.000040110703,"teacher_disagreement_score":0.14849617,"about_ca_system_score_codex":0.00042811353,"about_ca_system_score_gemma":0.00066530454,"threshold_uncertainty_score":0.999927},"labels":[],"label_agreement":null},{"id":"W2327242544","doi":"10.1093/neuonc/nou206.16","title":"SOX2 IDENTIFIES THE TREATMENT-REFRACTORY STEM CELL POPULATION IN GROUP 2 MEDULLOBLASTOMA","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Sonic hedgehog; Medulloblastoma; SOX2; Biology; Cancer research; Cancer stem cell; GLI1; Gene knockdown; Chromatin immunoprecipitation; Stem cell; Hedgehog signaling pathway; Signal transduction; Apoptosis; Transcription factor; Cell biology; Gene expression; Gene; Genetics","score_opus":0.017091770971449063,"score_gpt":0.27934100731551537,"score_spread":0.2622492363440663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327242544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99361205,0.0003163915,0.000005840937,0.002277384,0.00065918424,0.00056669296,0.0000035249845,0.000054839213,0.0025040626],"genre_scores_gemma":[0.99832517,0.00019434367,0.000029086863,0.0009051141,0.00020247426,0.00018907261,0.000033135442,0.000026629954,0.000094996445],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985983,0.00030427283,0.0003113188,0.0003297171,0.00017398807,0.00028242686],"domain_scores_gemma":[0.99871516,0.00065617345,0.00013737765,0.00036493046,0.000028486937,0.00009787687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001633272,0.00019043479,0.00038257535,0.0001475919,0.00009061607,0.00001860488,0.00008730329,0.0001430971,0.00007650411],"category_scores_gemma":[0.000030248819,0.00012001214,0.000117418465,0.00015483978,0.000060582526,0.00006360608,0.000028629509,0.00015107346,0.00014092104],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052216265,0.0069771954,0.36624843,0.000060946062,0.0001221938,0.0007036637,0.0022505133,0.00007100671,0.29856154,0.00079308765,0.0037133514,0.3199759],"study_design_scores_gemma":[0.011381563,0.009689288,0.5643963,0.00004111512,0.0004031006,0.00014836804,0.0006204375,0.0005703267,0.04703219,0.00026040542,0.36520404,0.00025284008],"about_ca_topic_score_codex":0.000306492,"about_ca_topic_score_gemma":0.0011964387,"teacher_disagreement_score":0.36149067,"about_ca_system_score_codex":0.00040451126,"about_ca_system_score_gemma":0.000040195577,"threshold_uncertainty_score":0.4893953},"labels":[],"label_agreement":null},{"id":"W2327595442","doi":"10.1093/neuonc/nou260.2","title":"MS-02 * TRANSCRIPTOME ANALYSIS IDENTIFIES THE PI3K/AKT/mTOR PATHWAY AS A TARGETABLE PATHWAY IN SCHWANNOMA","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Schwannoma; PI3K/AKT/mTOR pathway; Transcriptome; Biology; Cancer research; Gene expression profiling; Medicine; Gene; Pathology; Gene expression; Signal transduction; Genetics","score_opus":0.018675225032723602,"score_gpt":0.27265766524453666,"score_spread":0.25398244021181304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327595442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97390777,0.00049480173,0.00009373894,0.006062718,0.0008757881,0.00066700287,0.000036076126,0.000161492,0.017700586],"genre_scores_gemma":[0.9936494,0.000048406313,0.0001612306,0.0046045585,0.00034856616,0.00016331692,0.000044739994,0.0000666981,0.00091305864],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99591416,0.000926998,0.00092066097,0.00087790604,0.00054846634,0.00081182545],"domain_scores_gemma":[0.99727994,0.000965176,0.00026993238,0.0010175238,0.00015720347,0.00031022893],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009561583,0.00042660872,0.0012809944,0.00068625336,0.0002568875,0.00010172939,0.00044758784,0.00030247538,0.0009572621],"category_scores_gemma":[0.00075896067,0.0003086153,0.0005738881,0.0016026517,0.00030506396,0.00022356962,0.000118861244,0.0007636802,0.00035509348],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052647234,0.0006652597,0.015525192,0.000086312386,0.0002911456,0.0019349487,0.0010134594,0.000051007955,0.9681703,0.0019630012,0.004963891,0.0048089977],"study_design_scores_gemma":[0.0038655433,0.0038824622,0.032454662,0.000049395952,0.00078931643,0.0012368017,0.00058437674,0.0010637753,0.2402336,0.0005932168,0.71472216,0.00052466616],"about_ca_topic_score_codex":0.000316057,"about_ca_topic_score_gemma":0.00035035555,"teacher_disagreement_score":0.7279367,"about_ca_system_score_codex":0.00012999785,"about_ca_system_score_gemma":0.00039495243,"threshold_uncertainty_score":0.999956},"labels":[],"label_agreement":null},{"id":"W2327624302","doi":"10.1093/neuonc/nou255.12","title":"ET-12 * PHASE II STUDY OF ONARTUZUMAB PLUS BEVACIZUMAB VERSUS PLACEBO PLUS BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Bevacizumab; Medicine; Clinical endpoint; Internal medicine; Placebo; Oncology; Phases of clinical research; Adverse effect; Gastroenterology; Surgery; Chemotherapy; Clinical trial; Pathology","score_opus":0.022350712068395985,"score_gpt":0.31508402696549154,"score_spread":0.29273331489709553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327624302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940221,0.000053851294,0.000004640677,0.0007886459,0.0008396765,0.0027943128,0.000028848026,0.00007182918,0.0013961219],"genre_scores_gemma":[0.9989905,0.00001814281,0.00009242158,0.0002766626,0.000082776445,0.0004005936,0.000060606282,0.000064733926,0.000013561739],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99668527,0.00050806627,0.00075109425,0.0007844061,0.00068662537,0.00058453775],"domain_scores_gemma":[0.99758637,0.00077145494,0.0004046691,0.0007250009,0.00021535624,0.00029713477],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000270983,0.0004551321,0.0011900886,0.00048219852,0.00012697456,0.0000127424355,0.00021665737,0.00020507598,0.000110812085],"category_scores_gemma":[0.00034891002,0.00033417335,0.00012138612,0.00041279502,0.00012668163,0.0001108168,0.00022521523,0.00049148063,0.00003546362],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.49867046,0.124565706,0.048313808,0.00022569137,0.0011087969,0.0021483637,0.014940191,0.001101684,0.0022103337,0.00035010744,0.0034315567,0.3029333],"study_design_scores_gemma":[0.49766144,0.44515476,0.032701194,0.00014647482,0.0007522679,0.0000565688,0.0009920989,0.00095389667,0.001770264,0.00001272592,0.019358745,0.00043957698],"about_ca_topic_score_codex":0.00010745323,"about_ca_topic_score_gemma":0.0021861526,"teacher_disagreement_score":0.32058904,"about_ca_system_score_codex":0.0013199287,"about_ca_system_score_gemma":0.0005379846,"threshold_uncertainty_score":0.999911},"labels":[],"label_agreement":null},{"id":"W2327965348","doi":"10.1093/neuonc/nov061.62","title":"IM-07 * NK CELL IMMUNOTHERAPY FOR PEDIATRIC BRAIN TUMORS: OVERCOMING RESISTANCE TO EXPAND THERAPEUTIC SUCCESS","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Immunotherapy; Medicine; Resistance (ecology); Cancer research; Immunology; Biology; Immune system; Ecology","score_opus":0.034008418333085134,"score_gpt":0.32691693461399834,"score_spread":0.2929085162809132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327965348","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9786708,0.003465886,0.00022859922,0.012776465,0.00061304617,0.0015082115,0.00002205506,0.00008147078,0.002633473],"genre_scores_gemma":[0.9865223,0.00017067167,0.0010673647,0.010739067,0.00059844856,0.0005213578,0.000015908277,0.00007021634,0.00029462867],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99827653,0.00014300035,0.0003803847,0.0004794455,0.00023558701,0.00048503326],"domain_scores_gemma":[0.9979154,0.001025692,0.00015944925,0.00042662726,0.0001607651,0.0003120848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003343774,0.00025157852,0.0005576085,0.00019888006,0.00010569195,0.000028485962,0.00017953748,0.00014372778,0.000056820412],"category_scores_gemma":[0.00017956954,0.00021250725,0.00014454799,0.00027005354,0.000052296273,0.000070425405,0.000045799174,0.00016414528,0.000085887994],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006272252,0.0037783328,0.106390625,0.0003200029,0.00018231808,0.0011092933,0.0049578506,0.0000564692,0.7199766,0.00068759493,0.13559443,0.020674221],"study_design_scores_gemma":[0.02801343,0.008544418,0.018017896,0.000057744324,0.00034869113,0.00011816754,0.00066854036,0.000059938175,0.14366552,0.00081957545,0.7991355,0.00055056054],"about_ca_topic_score_codex":0.000030252177,"about_ca_topic_score_gemma":0.000059142985,"teacher_disagreement_score":0.6635411,"about_ca_system_score_codex":0.00034008236,"about_ca_system_score_gemma":0.00037750206,"threshold_uncertainty_score":0.8665794},"labels":[],"label_agreement":null},{"id":"W2329476154","doi":"10.1093/neuonc/nov061.51","title":"HG-14 * CLINICAL, RADIOGRAPHIC, AND HISTOLOGIC CHARACTERISTICS OF LONG-TERM SURVIVORS OF DIFFUSE INTRINSIC PONTINE GLIOMA: A REPORT FROM THE INTERNATIONAL DIPG REGISTRY","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Incidence (geometry); Radiation therapy; Radiography; Chemotherapy; Glioma; Biopsy; Radiology; Internal medicine","score_opus":0.047822177833130426,"score_gpt":0.3311451341584273,"score_spread":0.28332295632529686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329476154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99161047,0.00079371885,0.00001093142,0.0052950713,0.001516974,0.0003222566,0.0000579945,0.000024589264,0.00036801834],"genre_scores_gemma":[0.9980468,0.0008432679,0.00014845753,0.0004839825,0.0002815944,0.000022805529,0.00014104774,0.000017325056,0.000014727407],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99804085,0.00020136609,0.0009351597,0.0003768077,0.0002801907,0.0001656111],"domain_scores_gemma":[0.9968025,0.001232045,0.0009111125,0.0005760322,0.00030220265,0.00017610953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052094035,0.00017205965,0.00077538495,0.00013304253,0.000028100812,0.000009346856,0.00020918017,0.00020180392,0.00003510524],"category_scores_gemma":[0.0022262284,0.00011531499,0.00017303912,0.0001822957,0.000541853,0.000033262226,0.00017296986,0.000259946,0.0000027821004],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000628916,0.0019904007,0.9653065,0.000016658183,0.00027251142,0.0061262683,0.000111898014,6.792555e-8,0.011018034,0.00004278525,0.0035877333,0.010898192],"study_design_scores_gemma":[0.005411127,0.0014619315,0.9770269,0.000039316274,0.00040675144,0.0016294137,0.0000440427,0.000008735805,0.0013204349,0.000049744867,0.012517559,0.000084046565],"about_ca_topic_score_codex":0.00031092376,"about_ca_topic_score_gemma":0.00020042839,"teacher_disagreement_score":0.011720361,"about_ca_system_score_codex":0.00006648605,"about_ca_system_score_gemma":0.00018338145,"threshold_uncertainty_score":0.47024092},"labels":[],"label_agreement":null},{"id":"W2329604683","doi":"10.1093/neuonc/nou255.7","title":"ET-07 * DOES OSMOTIC BLOOD-BRAIN BARRIER DISRUPTION ALLOWS EFFLUX PUMP SUBSTRATES DELIVERY TO THE TUMOR AND CNS?","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Parenchyma; P-glycoprotein; Efflux; Drug delivery; Glioma; Blood–brain barrier; Medicine; Nuclear medicine; Pharmacology; Chemistry; Internal medicine; Pathology; Cancer research; Central nervous system; Biochemistry","score_opus":0.013088768464048618,"score_gpt":0.27738852729559954,"score_spread":0.26429975883155093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329604683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9627828,0.00012551731,0.000009765245,0.034951095,0.00040744236,0.00064217317,0.000010478286,0.000053627537,0.0010171159],"genre_scores_gemma":[0.9820062,0.00007447767,0.00011095099,0.017296376,0.0002566892,0.00015809109,0.000015785143,0.00002836373,0.000053058826],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998536,0.0003089019,0.00025226324,0.00040730735,0.00017139698,0.00032412368],"domain_scores_gemma":[0.9979791,0.0012871043,0.00008032629,0.00033435918,0.00006456249,0.0002545562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035708435,0.00020735597,0.00036298422,0.00009245537,0.00012558766,0.00003814143,0.000099240584,0.000096223564,0.00013893789],"category_scores_gemma":[0.0005403102,0.00011599456,0.00008408171,0.00011161057,0.000108936794,0.00005840403,0.00008011211,0.00020603921,0.00017359301],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033786034,0.0015219906,0.22231112,0.00009631526,0.00027839415,0.0009876491,0.0016632134,0.00008833508,0.7384534,0.002318738,0.0075268922,0.024416117],"study_design_scores_gemma":[0.00937909,0.008408469,0.5554814,0.000105873514,0.0012504986,0.0011929739,0.0005724954,0.000726903,0.12952112,0.00075474277,0.29214558,0.0004608456],"about_ca_topic_score_codex":0.00007179261,"about_ca_topic_score_gemma":0.00037483557,"teacher_disagreement_score":0.60893226,"about_ca_system_score_codex":0.000052972424,"about_ca_system_score_gemma":0.00007435553,"threshold_uncertainty_score":0.4730121},"labels":[],"label_agreement":null},{"id":"W2330017471","doi":"10.1093/neuonc/nou260.4","title":"MS-05 * UTILIZING A VIRTUAL REALITY SIMULATOR, NEUROTOUCH, TO DETERMINE PROFICIENCY PERFORMANCE BENCHMARKS FOR RESECTION OF SIMULATED BRAIN TUMORS","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Surgical Simulation and Training","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; NeuroRx Research (Canada)","funders":"","keywords":"Psychomotor learning; Virtual reality; Neurosurgery; Metric (unit); Computer science; Medical physics; Resection; Duration (music); Medicine; Simulation; Cognition; Physical medicine and rehabilitation; Human–computer interaction; Surgery; Operations management; Engineering","score_opus":0.05368099055873142,"score_gpt":0.35252216575143874,"score_spread":0.2988411751927073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2330017471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886025,0.000003983092,0.001152278,0.0014165755,0.0004683057,0.0014679304,0.000006456908,0.0000982602,0.0067836847],"genre_scores_gemma":[0.99583685,0.0000026451228,0.0001706646,0.0035870404,0.00022799168,0.000047765316,0.000037008682,0.0000340329,0.000055996137],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9977757,0.0002614165,0.0007035085,0.00051236124,0.00029644527,0.0004506007],"domain_scores_gemma":[0.996324,0.0025406973,0.00023774175,0.00035241895,0.00026366534,0.00028145604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083646143,0.00021263852,0.00059264974,0.00023974985,0.00014374596,0.0000101196565,0.00013339757,0.00020473877,0.00014317066],"category_scores_gemma":[0.003834976,0.00019286858,0.0001406434,0.00048660557,0.00011043971,0.00009206009,0.000071875256,0.00032292356,0.000007065467],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015129905,0.0012781166,0.041488178,0.0005335982,0.00007105931,0.00010078525,0.0019029786,0.12922202,0.3854221,0.001092339,0.001222327,0.42253658],"study_design_scores_gemma":[0.009067999,0.02053917,0.021733886,0.000095196774,0.00006191107,0.00007652952,0.000120530814,0.7299125,0.02347112,0.000053857548,0.19460025,0.00026704228],"about_ca_topic_score_codex":0.000018807486,"about_ca_topic_score_gemma":0.000013813465,"teacher_disagreement_score":0.6006905,"about_ca_system_score_codex":0.00010827009,"about_ca_system_score_gemma":0.0001525607,"threshold_uncertainty_score":0.78649527},"labels":[],"label_agreement":null},{"id":"W2330539180","doi":"10.1093/neuonc/nou238.5","title":"AI-05 * IMPACT OF GBM MICROENVIRONMENT ON EXPRESSION PROFILE OF BONE MARROW DERIVED PROGENITOR CELLS","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Biology; Progenitor cell; Tumor microenvironment; Cancer research; Bone marrow; Glioma; Stem cell; Cell biology; Immunology; Immune system","score_opus":0.01264049588114713,"score_gpt":0.2826086422830478,"score_spread":0.26996814640190064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2330539180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974178,0.000115072165,0.000007645846,0.0008846973,0.00022114626,0.00084125454,0.000030331095,0.000017701148,0.00046432094],"genre_scores_gemma":[0.99851036,0.00006184991,0.00067463535,0.00047322272,0.000098832286,0.00011042856,0.000023778315,0.00002910127,0.000017800914],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99867857,0.00017447965,0.0003795612,0.00030177104,0.00020861777,0.00025699474],"domain_scores_gemma":[0.99890554,0.00022336196,0.00028081416,0.00038811952,0.000044515353,0.00015762406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010553582,0.00019054893,0.0005903718,0.000117284486,0.000029230941,0.0000024761064,0.00006961987,0.00014567099,0.00032741128],"category_scores_gemma":[0.000062728934,0.00013482154,0.00021997574,0.000071766546,0.000107134525,0.00002302087,0.00006124401,0.00014440871,0.000053789783],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006644514,0.0026382024,0.014351234,0.00006537699,0.000059990427,0.00009284132,0.00011976932,0.00002233538,0.9648366,0.000006007073,0.009213584,0.007929617],"study_design_scores_gemma":[0.0036833887,0.009951593,0.029236725,0.000071370494,0.000119547076,0.000045359517,0.000018774821,0.000055996155,0.9475712,0.000008579314,0.009159586,0.00007784193],"about_ca_topic_score_codex":0.000022949529,"about_ca_topic_score_gemma":0.0000020045175,"teacher_disagreement_score":0.017265355,"about_ca_system_score_codex":0.00018334492,"about_ca_system_score_gemma":0.000092616254,"threshold_uncertainty_score":0.5497863},"labels":[],"label_agreement":null},{"id":"W2330616842","doi":"10.1093/neuonc/nou209.25","title":"PROFICIENCY PERFORMANCE BENCHMARKS FOR REMOVAL OF SIMULATED BRAIN TUMORS USING NEUROTOUCH","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Surgical Simulation and Training","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Neurosurgery; Metric (unit); Virtual reality; Medical physics; Computer science; Set (abstract data type); Task (project management); Quality (philosophy); Medicine; Human–computer interaction; Operations management; Surgery; Engineering; Systems engineering","score_opus":0.04493891550099699,"score_gpt":0.3464016866500638,"score_spread":0.30146277114906683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2330616842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9827167,0.000013003584,0.00060754974,0.00069249305,0.0003133196,0.00073374866,0.0000019525783,0.0000487843,0.014872449],"genre_scores_gemma":[0.9959673,0.0000023094378,0.0012479391,0.0025351467,0.00015619541,0.000008799717,0.00001797455,0.000023348146,0.000040971026],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9986583,0.00012945972,0.00043468847,0.00028957697,0.00017928453,0.0003087162],"domain_scores_gemma":[0.99804634,0.0012855142,0.00018795884,0.00020127703,0.00015220592,0.00012670642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004310468,0.00013408964,0.00042240712,0.00012623738,0.0000878583,0.0000049344953,0.000088097324,0.0001373655,0.00015881371],"category_scores_gemma":[0.0012734906,0.000116856994,0.00010464664,0.00026486607,0.00011432717,0.000053017164,0.00003395019,0.00021993415,0.000004050068],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035108,0.00082271517,0.04733937,0.0004686346,0.000051595387,0.00028579557,0.00086612673,0.032873932,0.5586071,0.0014654546,0.00023647818,0.353472],"study_design_scores_gemma":[0.0072051953,0.0036409812,0.009351597,0.00005047575,0.000055222426,0.00044439436,0.000052347226,0.7486665,0.010306163,0.00006868738,0.2199987,0.00015968744],"about_ca_topic_score_codex":0.000004480156,"about_ca_topic_score_gemma":7.4121783e-7,"teacher_disagreement_score":0.7157926,"about_ca_system_score_codex":0.00005121625,"about_ca_system_score_gemma":0.0001618043,"threshold_uncertainty_score":0.47652897},"labels":[],"label_agreement":null},{"id":"W2331637821","doi":"10.1093/neuonc/nou208.10","title":"TRANSCRIPTIONAL REGULATION OF OLIGODENDROGLIAL CELL FATE BY DLX HOMEOBOX GENES: POTENTIAL RELEVANCE TO HISTONE H3.3 MUTATIONS IN PEDIATRIC HIGH GRADE GLIOMA","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Biology; Homeobox; Chromatin immunoprecipitation; Transcription factor; DLX5; Genetics; Chromatin; ChIP-on-chip; Promoter; Gene; Cell biology; Gene expression; Chromatin remodeling","score_opus":0.011549033156943818,"score_gpt":0.26919508560648625,"score_spread":0.2576460524495424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2331637821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931467,0.0004724971,0.00063070725,0.0041478397,0.0007340516,0.0005534561,0.0000592639,0.00004015666,0.00021528041],"genre_scores_gemma":[0.9974764,0.00019886084,0.0012591854,0.00036961315,0.00032469144,0.00013792473,0.00016377927,0.00003193793,0.000037635684],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99826354,0.00017346942,0.0005215119,0.0004214838,0.00031927478,0.00030074906],"domain_scores_gemma":[0.9990628,0.00023402675,0.00018208116,0.00023666807,0.00011040274,0.00017405974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012892734,0.00019047841,0.0004576569,0.00043466542,0.000060359038,0.0000065792665,0.000097575954,0.00017340986,0.000081239436],"category_scores_gemma":[0.000083284016,0.00019041554,0.00011612609,0.00047646547,0.00007086095,0.0000697686,0.000022351654,0.0001558264,0.00004770095],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025279814,0.0016109052,0.003961157,0.00005573037,0.000015066327,0.00012320989,0.00023881387,0.0015289907,0.9858263,0.00039174705,0.0022745002,0.0037207694],"study_design_scores_gemma":[0.0190332,0.005307674,0.25348136,0.00003124776,0.0007497196,0.0002860163,0.000070517155,0.001569834,0.6828139,0.00081630837,0.03539784,0.00044241082],"about_ca_topic_score_codex":0.00012686996,"about_ca_topic_score_gemma":0.000074707685,"teacher_disagreement_score":0.30301243,"about_ca_system_score_codex":0.0002581105,"about_ca_system_score_gemma":0.00012219865,"threshold_uncertainty_score":0.77649206},"labels":[],"label_agreement":null},{"id":"W2331657830","doi":"10.1093/neuonc/nou278.8","title":"TM-08 * DIFFERENTIAL VASCULAR PATTERN OF GLIOMA STEM CELLS","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Glioma; Vascularity; Biology; Cancer research; Stem cell; Gene knockdown; Angiogenesis; Tumor microenvironment; Brain tumor; In vivo; Pathology; Cell culture; Medicine; Tumor cells; Cell biology; Genetics","score_opus":0.0092734908667788,"score_gpt":0.23843990570939638,"score_spread":0.22916641484261757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2331657830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900121,0.0006003516,0.0041369777,0.000100327845,0.0039033068,0.000201056,0.000026688167,0.000017930768,0.0010012578],"genre_scores_gemma":[0.9963353,0.0005188758,0.0000801957,0.0006422382,0.002234305,0.000026173391,0.000028859211,0.000038070022,0.00009592588],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984422,0.00027149808,0.000324109,0.0004555107,0.00016428447,0.00034241236],"domain_scores_gemma":[0.99902284,0.00004503067,0.00017691207,0.00053475844,0.00008988886,0.00013056156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015378182,0.00020397507,0.0004071217,0.00006732048,0.00004892566,0.000010140574,0.00029949908,0.00030390595,0.00007594918],"category_scores_gemma":[0.000025778143,0.00019358669,0.00023127584,0.000077025186,0.00012419205,0.000003063418,0.00018631163,0.00014617927,0.000031393596],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000065674176,0.0001204056,0.00014572155,0.000027903528,0.000051051087,0.0000036796516,0.00005342008,0.00001518596,0.92240554,0.000036844278,0.0036404328,0.07343413],"study_design_scores_gemma":[0.0010027264,0.00050403306,0.0004754615,0.0000027894607,0.00004954902,0.000022789733,0.000017787694,0.00004333854,0.5117855,0.00000937355,0.48597008,0.00011657315],"about_ca_topic_score_codex":0.000042747964,"about_ca_topic_score_gemma":0.000071887516,"teacher_disagreement_score":0.48232964,"about_ca_system_score_codex":0.000014848395,"about_ca_system_score_gemma":0.00010899274,"threshold_uncertainty_score":0.7894236},"labels":[],"label_agreement":null},{"id":"W2332077409","doi":"10.1093/neuonc/nou262.5","title":"MR-05 * GLIOMA STEM CELL SPECIFIC microRNA-mRNA INTERACTION NETWORK","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Interactome; microRNA; RNA; Biology; Gene silencing; Computational biology; Small RNA; Non-coding RNA; RNA silencing; Argonaute; RNA interference; Messenger RNA; Gene; Small interfering RNA; Genetics; Cell biology","score_opus":0.012854397123284867,"score_gpt":0.2523576612491761,"score_spread":0.2395032641258912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2332077409","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96201247,0.003245912,0.0012586493,0.0005347377,0.016154148,0.00030586706,0.000011947189,0.00005027116,0.016426027],"genre_scores_gemma":[0.9804129,0.0020641547,0.00059920695,0.002682753,0.013293125,0.000042202457,0.00006934536,0.00006918046,0.00076711766],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99815667,0.0003008627,0.00034205496,0.0005944852,0.0001162067,0.00048973155],"domain_scores_gemma":[0.9989379,0.00007560095,0.00022108594,0.0005173549,0.00008519813,0.0001628515],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002548335,0.00024590368,0.0003344015,0.00006636173,0.00011904246,0.000032551565,0.00028146102,0.00034063155,0.00007233057],"category_scores_gemma":[0.000022929082,0.00025102784,0.00016901972,0.00014256216,0.00009468878,0.000007287175,0.00016506283,0.0002826067,0.00013971255],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020890748,0.000075312906,0.000083286686,0.000009250004,0.000013507084,0.000008655417,0.000042534743,0.0001237268,0.78275216,0.00006786644,0.17466548,0.041949343],"study_design_scores_gemma":[0.00082439586,0.00057352375,0.00022068313,0.000003891807,0.000023861521,0.00017936807,0.000037992766,0.000032052678,0.25611317,0.000029699615,0.7417835,0.0001778598],"about_ca_topic_score_codex":0.00001552155,"about_ca_topic_score_gemma":0.00004913903,"teacher_disagreement_score":0.567118,"about_ca_system_score_codex":0.000050340226,"about_ca_system_score_gemma":0.00010882784,"threshold_uncertainty_score":0.9999942},"labels":[],"label_agreement":null},{"id":"W2332145434","doi":"10.1093/neuonc/nou278.10","title":"TM-10 * ALTERATIONS IN METABOLIC PATHWAYS IN GLIOBLASTOMA MULTIFORME CELLS IN RESPONSE TO HEXOKINASE-2 INHIBITION","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Glycolysis; Gene knockdown; Pentose phosphate pathway; Metabolic pathway; Citric acid cycle; Glioma; Hexokinase; Anaerobic glycolysis; Biology; Metabolomics; Biochemistry; Cancer research; Chemistry; Cell biology; Metabolism; Apoptosis; Bioinformatics","score_opus":0.0110285302901276,"score_gpt":0.25984926403877534,"score_spread":0.24882073374864774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2332145434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968551,0.0002545199,0.00016921862,0.0007026198,0.0009059492,0.00048920966,0.000038799764,0.0000152378825,0.000569356],"genre_scores_gemma":[0.996015,0.0002417247,0.00038535285,0.002371049,0.0005872231,0.0002287968,0.00003310259,0.000032748194,0.00010497916],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99764675,0.0007187461,0.0004833803,0.0005591248,0.00011958945,0.00047240054],"domain_scores_gemma":[0.9992015,0.00013480408,0.00009552933,0.00036904702,0.000058945738,0.0001401716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007458454,0.00021588721,0.00038235006,0.00045955295,0.000041996875,0.000018780142,0.00015713746,0.00030597867,0.000034676297],"category_scores_gemma":[0.00055716524,0.0002368765,0.000077373734,0.00042342852,0.00005992569,0.0000130362005,0.00013222349,0.0002567678,0.00006470265],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021078803,0.00024316808,0.0001826794,0.000006831833,0.000003182824,0.00002703549,0.00045524078,0.00085961673,0.98370594,0.00008470688,0.0011510752,0.011172649],"study_design_scores_gemma":[0.0022583834,0.00084152655,0.0046196454,0.000010593572,0.0000055789974,0.000024995112,0.00007155271,0.00020337071,0.47984916,0.000046857534,0.51189,0.00017834251],"about_ca_topic_score_codex":0.00014398464,"about_ca_topic_score_gemma":0.008631633,"teacher_disagreement_score":0.5107389,"about_ca_system_score_codex":0.00008393155,"about_ca_system_score_gemma":0.00026355125,"threshold_uncertainty_score":0.9659543},"labels":[],"label_agreement":null},{"id":"W2332217343","doi":"10.1093/neuonc/nov061.77","title":"MB-01 * NOTCH1 PROMOTES MYC MEDULLOBLASTOMA METASTASIS, INITIATION AND MAINTENANCE","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Cancer research; Flow cytometry; Metastasis; Population; Cell; Downregulation and upregulation; Primary tumor; Cerebrospinal fluid; Western blot; Medicine; Cancer stem cell; Cell culture; Biology; Cancer; Pathology; Oncology; Internal medicine; Immunology; Genetics","score_opus":0.04058908769832843,"score_gpt":0.31218049395169634,"score_spread":0.2715914062533679,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2332217343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9769887,0.0006468224,0.00003495971,0.016362889,0.00041622078,0.00059602555,0.000015671018,0.00008411104,0.0048546167],"genre_scores_gemma":[0.99559176,0.0001495902,0.0011162636,0.0027984702,0.00014982691,0.00012283074,0.00002612672,0.000024739762,0.000020371952],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987774,0.0001360271,0.00025094114,0.00034189768,0.00020258383,0.00029115312],"domain_scores_gemma":[0.99895406,0.00025207945,0.00012237522,0.00022381064,0.00014899351,0.00029867783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022127393,0.00017247463,0.00040347595,0.00011767073,0.000050023267,0.000016074713,0.000056245844,0.00012166373,0.000054558965],"category_scores_gemma":[0.0005983047,0.00013353981,0.00005666812,0.00016029022,0.000104334955,0.00008537971,0.000066609224,0.00016029394,0.00008742827],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021359965,0.005905543,0.13402893,0.0002306409,0.0006973274,0.008166884,0.0040075495,0.000019677256,0.42448905,0.005286015,0.11383566,0.30119672],"study_design_scores_gemma":[0.022150226,0.014433105,0.06518687,0.00012605812,0.0010581356,0.0039046416,0.00085534353,0.0006461314,0.19966576,0.0016052704,0.6898724,0.000496087],"about_ca_topic_score_codex":0.0000310749,"about_ca_topic_score_gemma":0.00007228147,"teacher_disagreement_score":0.5760367,"about_ca_system_score_codex":0.00017285967,"about_ca_system_score_gemma":0.00021837583,"threshold_uncertainty_score":0.54455954},"labels":[],"label_agreement":null},{"id":"W2333308044","doi":"10.1093/neuonc/nou254.9","title":"EG-09 * EPIGENETIC PROFILING REVEALS A CpG HYPERMETHYLATION PHENOTYPE (CIMP) ASSOCIATED WITH WORSE PROGRESSION-FREE SURVIVAL IN MENINGIOMA","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Gestational Trophoblastic Disease Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"DNA methylation; Epigenetics; Methylation; Phenotype; Biology; CpG site; Computational biology; Oncology; Internal medicine; Medicine; Genetics; Gene; Gene expression","score_opus":0.023718342180934833,"score_gpt":0.3102180812113175,"score_spread":0.28649973903038267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333308044","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887373,0.00012307287,0.00031333894,0.0019658946,0.00036309796,0.0009538851,0.000013955517,0.00011711896,0.00741237],"genre_scores_gemma":[0.9936564,0.000011967824,0.005320626,0.00038366418,0.00018220206,0.00025815086,0.00006081066,0.00004488578,0.000081298414],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99744415,0.0005818405,0.00047112806,0.0004863701,0.00055672374,0.0004598082],"domain_scores_gemma":[0.9971733,0.0016987827,0.0002822038,0.00033296738,0.00033172977,0.0001810241],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006416509,0.00024569273,0.0006068592,0.00022424416,0.00010678159,0.000012634459,0.00014244774,0.00015620091,0.00005425879],"category_scores_gemma":[0.007552775,0.00019938484,0.000059870286,0.0005142539,0.00015080547,0.000057135683,0.00011072057,0.00032043108,0.000037217167],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003544247,0.0017208965,0.73782146,0.00021821808,0.00028818764,0.00083413196,0.0010485778,0.0006513775,0.2285831,0.00311874,0.00084858364,0.021322481],"study_design_scores_gemma":[0.008598971,0.0047018924,0.9766684,0.00033549883,0.00034145586,0.000043316773,0.00027291232,0.0022538444,0.0020030157,0.0028573172,0.001585028,0.00033831305],"about_ca_topic_score_codex":0.000012056738,"about_ca_topic_score_gemma":0.000089830115,"teacher_disagreement_score":0.23884697,"about_ca_system_score_codex":0.00024307558,"about_ca_system_score_gemma":0.0003537758,"threshold_uncertainty_score":0.90419227},"labels":[],"label_agreement":null},{"id":"W2333458705","doi":"10.1093/neuonc/nou266.1","title":"PT-01 * THE IMPACT OF INITIAL RADIATION IN INFANTS AND THE RE-IRRADIATION OF RECURRENT DISEASE ON THE SURVIVAL OF EPENDYMOMA PATIENTS AT THE HOSPITAL FOR SICK CHILDREN, TORONTO","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"Medicine; Ependymoma; Radiation therapy; Surgery; Chemotherapy; Overall survival; Retrospective cohort study; Pediatrics","score_opus":0.018357205945140592,"score_gpt":0.34421014244559983,"score_spread":0.3258529365004592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333458705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881509,0.00027252015,0.000006706515,0.008184929,0.00063134934,0.0022097288,0.00016155926,0.0000065954005,0.00037570912],"genre_scores_gemma":[0.9986751,0.000129889,0.0000032061541,0.00072214514,0.00030247873,0.00008372968,0.00006282146,0.000018436265,0.0000021959518],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972264,0.0013328074,0.00061466306,0.0002323944,0.00039163817,0.00020208526],"domain_scores_gemma":[0.99379677,0.0047827368,0.0007072258,0.0005206309,0.000119128854,0.00007349806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001580914,0.0001684304,0.00048006998,0.000037609905,0.00009713767,0.0000061830006,0.00022733078,0.00007418693,0.000041625593],"category_scores_gemma":[0.0034253006,0.00007701771,0.00019848524,0.00010557052,0.0004421758,0.00006706578,0.000094632334,0.00019710076,0.0000010134762],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.035813503,0.0030046438,0.80120176,0.00020759022,0.00047445815,0.0000029584423,0.031234123,0.0002933759,0.0006162025,0.003672568,0.008787032,0.11469181],"study_design_scores_gemma":[0.0075792335,0.0043945652,0.9859278,0.00004445504,0.00012253727,0.0000024126512,0.00024176203,0.0005209453,0.00032943694,0.00034293043,0.00041817242,0.000075717864],"about_ca_topic_score_codex":0.0019802602,"about_ca_topic_score_gemma":0.0023460367,"teacher_disagreement_score":0.18472609,"about_ca_system_score_codex":0.00021243891,"about_ca_system_score_gemma":0.00020836707,"threshold_uncertainty_score":0.4100652},"labels":[],"label_agreement":null},{"id":"W2333948856","doi":"10.1093/neuonc/nov061.94","title":"MB-18 * POST-TRANSLATIONAL REGULATION OF ATOH1: FROM CEREBELLAR DEVELOPMENT TO MEDULLOBLASTOMA FORMATION","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Sonic hedgehog; Transcription factor; Medulloblastoma; Cerebellum; Biology; Ubiquitin ligase; GLI2; Cell biology; Cancer research; Genetics; Ubiquitin; Signal transduction; Neuroscience; Gene","score_opus":0.03505896558823104,"score_gpt":0.28472124382768976,"score_spread":0.24966227823945872,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333948856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895387,0.0001545138,0.006754956,0.0009911852,0.00034495947,0.00027551796,0.000049165228,0.000020085172,0.00187088],"genre_scores_gemma":[0.9906271,0.0000078998855,0.0080579575,0.00063897367,0.00019327759,0.000029435141,0.00039323745,0.000018951276,0.00003312967],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987841,0.00012808098,0.000385957,0.00028440563,0.00022399786,0.00019341033],"domain_scores_gemma":[0.9990848,0.00005881213,0.00014522928,0.00019782924,0.00038512796,0.00012824657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022418573,0.00014250094,0.00020503424,0.00007699471,0.000059548864,0.0000062900804,0.00014518271,0.00018500163,0.000028528231],"category_scores_gemma":[0.0002724726,0.00014591537,0.00004813884,0.000104353414,0.000052895015,0.000007798845,0.00010251639,0.00006886212,0.0000621493],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027997984,0.00006060506,0.0010384142,0.000008483181,0.00003718306,0.000002882677,0.0014244287,0.00072643784,0.9863201,0.000024601586,0.0029707255,0.007106157],"study_design_scores_gemma":[0.0007639572,0.00068096805,0.0037207569,0.0000075982393,0.000017215232,0.000015192375,0.0001597025,0.000109230234,0.7838324,0.0000904341,0.21046422,0.00013832704],"about_ca_topic_score_codex":0.00001678997,"about_ca_topic_score_gemma":0.00012388141,"teacher_disagreement_score":0.2074935,"about_ca_system_score_codex":0.00006128438,"about_ca_system_score_gemma":0.00038826975,"threshold_uncertainty_score":0.59502566},"labels":[],"label_agreement":null},{"id":"W2334286689","doi":"10.1093/neuonc/not182","title":"NEURO/MEDICAL ONCOLOGY","year":2013,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institut Gustave-Roussy; Hospital for Sick Children; Children's Healthcare of Atlanta; Seattle Children's Research Institute; Sidney Kimmel Comprehensive Cancer Center; Novartis Pharmaceuticals Corporation; Johns Hopkins University","keywords":"Medicine; Medical physics; Internal medicine; Oncology","score_opus":0.02381053194504296,"score_gpt":0.31914169082461746,"score_spread":0.2953311588795745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334286689","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8311204,0.00023719674,0.000016409344,0.11679195,0.0015412733,0.0008954472,0.0000036134218,0.0001686072,0.04922512],"genre_scores_gemma":[0.95407844,0.000301914,0.0003834074,0.04397366,0.0006423163,0.0004354147,0.000022718585,0.000047400496,0.000114760034],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99780554,0.00026667674,0.0004481616,0.00051454955,0.0003969464,0.0005681301],"domain_scores_gemma":[0.99728143,0.001311275,0.00012912421,0.0004388507,0.00013494765,0.00070435705],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00017706842,0.00024107419,0.00067862315,0.00016495456,0.00008566105,0.00001547504,0.00019122158,0.00047311166,0.006610861],"category_scores_gemma":[0.0009799498,0.00018740546,0.0001698724,0.00021086883,0.00022447795,0.000068190304,0.00015504862,0.00057195325,0.0034239711],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018389669,0.0046738866,0.035306934,0.000037648824,0.00015546178,0.010690686,0.00025539353,0.0000028630725,0.13971958,0.0011627643,0.38185564,0.42595524],"study_design_scores_gemma":[0.00575472,0.005915779,0.02726697,0.000016594944,0.0001570475,0.0024870206,0.00007136584,0.00031712608,0.0066324137,0.00021989769,0.95100766,0.00015340484],"about_ca_topic_score_codex":0.00013095156,"about_ca_topic_score_gemma":0.000054885822,"teacher_disagreement_score":0.569152,"about_ca_system_score_codex":0.00029009217,"about_ca_system_score_gemma":0.00067960616,"threshold_uncertainty_score":0.997352},"labels":[],"label_agreement":null},{"id":"W2334423299","doi":"10.1093/neuonc/nou240.32","title":"BM-32 * CERITINIB (LDK378) FOR TREATMENT OF PATIENTS WITH ALK-REARRANGED (ALK+) NON-SMALL CELL LUNG CANCER (NSCLC) AND BRAIN METASTASES (BM) IN THE ASCEND-1 TRIAL","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Ceritinib; Medicine; Internal medicine; non-small cell lung cancer (NSCLC); Lung cancer; Cohort; Anaplastic lymphoma kinase; ALK inhibitor; Gastroenterology; Oncology","score_opus":0.020618376259350306,"score_gpt":0.34023702853253257,"score_spread":0.31961865227318226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334423299","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98778623,0.00038836757,0.000111591406,0.0033157659,0.00031867294,0.0041749286,0.00027448506,0.00001700269,0.0036129758],"genre_scores_gemma":[0.995723,0.0001343526,0.00059113605,0.0015719302,0.00024239752,0.0014117763,0.00017058438,0.0000363748,0.00011842905],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99864244,0.00023028879,0.00032474907,0.00035084636,0.00015768278,0.00029397817],"domain_scores_gemma":[0.9984115,0.00093992555,0.00019335214,0.0002577746,0.0001011183,0.00009636909],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001648156,0.00021769614,0.0005807335,0.00010335238,0.00008493386,0.000011925434,0.00007667328,0.000091881986,0.00003878483],"category_scores_gemma":[0.00007622659,0.00013006941,0.00009556206,0.00012987731,0.00009892914,0.000043201755,0.000014879073,0.00007790024,0.0000011469486],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15738587,0.025089396,0.30169544,0.0012424979,0.0022735924,0.00025579624,0.03668634,0.00016583805,0.033129998,0.0004742904,0.022907129,0.4186938],"study_design_scores_gemma":[0.43297184,0.050903134,0.050048083,0.00012816873,0.003737147,0.000022968607,0.0010289365,0.0002999309,0.008216529,0.000034345576,0.45222118,0.0003877462],"about_ca_topic_score_codex":0.0005373616,"about_ca_topic_score_gemma":0.00086095184,"teacher_disagreement_score":0.42931405,"about_ca_system_score_codex":0.00020263997,"about_ca_system_score_gemma":0.00037180932,"threshold_uncertainty_score":0.53040767},"labels":[],"label_agreement":null},{"id":"W2334697425","doi":"10.1093/neuonc/nou275.5","title":"SC-05 * DOPAMINE RECEPTOR ANTAGONISTS ARE SELECTIVE INHIBITORS OF GLIOBLASTOMA STEM CELLS THROUGH IMPAIRMENT OF AUTOPHAGY","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Neural stem cell; Clonogenic assay; Cancer research; Cancer stem cell; Stem cell; Downregulation and upregulation; Autophagy; Biology; Temozolomide; Cell biology; Cell culture; Glioma; Gene; Biochemistry; Genetics","score_opus":0.00806125200810196,"score_gpt":0.24907741021210505,"score_spread":0.2410161582040031,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334697425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966021,0.00015871515,0.00041450816,0.00037104147,0.0010424821,0.0004460842,0.000050538387,0.000026471185,0.0008880389],"genre_scores_gemma":[0.99810547,0.00011414144,0.0007243959,0.00045840922,0.0003671702,0.000036477402,0.000021351763,0.000034143926,0.00013844771],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981013,0.00035746087,0.0005617956,0.00047034235,0.00020505869,0.00030404536],"domain_scores_gemma":[0.99858963,0.000073320705,0.0006052364,0.00039289935,0.00024123635,0.00009766173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002444532,0.00023592035,0.00044738964,0.00008115746,0.000060873997,0.0000069744983,0.00024292772,0.00031464142,0.000034740526],"category_scores_gemma":[0.00009873688,0.00022365416,0.00015773461,0.00020933406,0.00024080166,0.000010352507,0.00017121586,0.00017036677,0.000015287622],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000393054,0.0003394591,0.00044175956,0.00004801244,0.00003902686,0.0000040124123,0.000106263215,0.000034431672,0.97811735,0.000090739326,0.015642107,0.0047437693],"study_design_scores_gemma":[0.001095404,0.005739525,0.0001441141,0.000018818972,0.000017066466,0.000021397422,0.00009229323,0.00003754068,0.83025265,0.000020670132,0.16240819,0.00015235426],"about_ca_topic_score_codex":0.000021027217,"about_ca_topic_score_gemma":0.000026139114,"teacher_disagreement_score":0.14786474,"about_ca_system_score_codex":0.00006943974,"about_ca_system_score_gemma":0.00018977704,"threshold_uncertainty_score":0.91203517},"labels":[],"label_agreement":null},{"id":"W2334751121","doi":"10.1093/neuonc/nou256.16","title":"GE-16 * JAPANESE PEDIATRIC MOLECULAR NEURO-ONCOLOGY GROUP (JPMNG): ESTABLISHMENT OF A NATIONWIDE MOLECULAR DIAGNOSTIC NETWORK FOR PEDIATRIC MALIGNANT BRAIN TUMORS IN JAPAN","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medulloblastoma; Immunohistochemistry; Wnt signaling pathway; Molecular pathology; Fluorescence in situ hybridization; Surgical oncology; Biology; Molecular genetics; Gene; Oncology; Pathology; Internal medicine; Medicine; Cancer research; Genetics; Chromosome","score_opus":0.00966171987199607,"score_gpt":0.26557863059445064,"score_spread":0.2559169107224546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334751121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98531926,0.0016249138,0.000616525,0.00696684,0.0010607394,0.0035236056,0.00004965306,0.00010513852,0.000733342],"genre_scores_gemma":[0.98814386,0.00056203565,0.0013150697,0.0069210385,0.0008899051,0.0018011287,0.00021333201,0.00014562481,0.000008017019],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9944023,0.00095987465,0.0015130487,0.0012240063,0.00062158133,0.0012792267],"domain_scores_gemma":[0.98828435,0.009260847,0.0008128295,0.00081121107,0.00030938422,0.0005213525],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001203741,0.00064974173,0.0016469969,0.0009883052,0.00012134935,0.0000307626,0.00042102823,0.00051542197,0.00007480723],"category_scores_gemma":[0.0063839615,0.00061314617,0.00046041593,0.0014822119,0.0001481037,0.00012260042,0.00024496668,0.0005409783,0.0000236773],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015369087,0.010652719,0.77044404,0.0013411671,0.00030291855,0.006629522,0.0012579586,0.0068359184,0.14670874,0.007142305,0.028391948,0.018755851],"study_design_scores_gemma":[0.12672108,0.09751477,0.4932899,0.0005134511,0.011776392,0.0037278668,0.0012658573,0.013317398,0.052979235,0.007918325,0.18585639,0.0051193302],"about_ca_topic_score_codex":0.0001890817,"about_ca_topic_score_gemma":0.00015656737,"teacher_disagreement_score":0.27715415,"about_ca_system_score_codex":0.0006612176,"about_ca_system_score_gemma":0.00056608714,"threshold_uncertainty_score":0.999632},"labels":[],"label_agreement":null},{"id":"W2334874614","doi":"10.1093/neuonc/nov061.33","title":"GE-09 * COMBINED HEREDITARY AND SOMATIC MUTATIONS OF REPLICATION ERROR REPAIR GENES RESULT IN RAPID ONSET OF ULTRA-HYPERMUTATED MALIGNANT BRAIN TUMORS IN CHILDREN","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Somatic cell; Replication (statistics); Genetics; Gene; Biology; Mutation; Germline mutation; Cancer research; Medicine; Virology","score_opus":0.03043287086740363,"score_gpt":0.3078961192213144,"score_spread":0.27746324835391073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334874614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955157,0.00045181773,0.000004142394,0.0023536675,0.00015316499,0.001120933,0.0000531531,0.000045088134,0.00030231717],"genre_scores_gemma":[0.9982698,0.000050449704,0.0010042853,0.00039238282,0.000023780025,0.00009704161,0.00012414496,0.000025936195,0.0000122027695],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9978598,0.00041653568,0.00083810353,0.00043399478,0.00022424995,0.00022731087],"domain_scores_gemma":[0.99833775,0.00059261406,0.00030843727,0.0004960143,0.00015648862,0.00010869584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064707524,0.00015996017,0.00059802557,0.00032882282,0.00001655079,0.0000021306519,0.00011160219,0.00017195934,0.000023880326],"category_scores_gemma":[0.0020665783,0.00015211942,0.00005415151,0.00042791007,0.00027027805,0.00004648973,0.0000438967,0.00022376172,0.0000029847756],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013698473,0.00064240873,0.4804267,0.00014164191,0.000043691383,0.00016441823,0.002525711,0.0003190968,0.50864035,0.000014000476,0.001466517,0.0042456323],"study_design_scores_gemma":[0.0072006164,0.0049686674,0.8749689,0.00012532128,0.00007973666,0.0010538788,0.00084273075,0.0014609759,0.108546704,0.00036606312,0.0002218838,0.00016456294],"about_ca_topic_score_codex":0.00043550978,"about_ca_topic_score_gemma":0.00025955003,"teacher_disagreement_score":0.40009362,"about_ca_system_score_codex":0.00019463105,"about_ca_system_score_gemma":0.00062554225,"threshold_uncertainty_score":0.620325},"labels":[],"label_agreement":null},{"id":"W2335372520","doi":"10.1093/neuonc/nou255.35","title":"ET-35 * PACRITINIB: A NOVEL JAK/STAT INHIBITOR WITH TRANSLATIONAL RELEVANCE FOR GBM","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Hotchkiss Brain Institute; Ontario Brain Institute; University of Calgary","funders":"","keywords":"Ruxolitinib; STAT protein; Janus kinase; STAT3; JAK-STAT signaling pathway; stat; Cancer research; PTEN; Myelofibrosis; Medicine; Signal transduction; Biology; Pharmacology; PI3K/AKT/mTOR pathway; Oncology; Internal medicine; Tyrosine kinase; Receptor; Bone marrow","score_opus":0.028356472759601962,"score_gpt":0.3231796751110784,"score_spread":0.29482320235147647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335372520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84724396,0.00028563102,0.025164569,0.10144438,0.00096525555,0.003851649,0.00027824138,0.00024286445,0.02052345],"genre_scores_gemma":[0.9639931,0.00008969614,0.022741145,0.011557516,0.0005448871,0.0007633,0.00010888914,0.000056781155,0.00014472417],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985627,0.0000921725,0.00030739346,0.00046794978,0.00023383851,0.0003359781],"domain_scores_gemma":[0.99729925,0.0020113585,0.00011045887,0.00021059063,0.00018901237,0.0001793525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002040507,0.000226893,0.0004863422,0.00007617886,0.000107613945,0.000014740212,0.00005778925,0.00013917762,0.00008063812],"category_scores_gemma":[0.00037243374,0.00016980062,0.000102396574,0.00010856684,0.00011056715,0.00007762436,0.000014117448,0.00023315843,0.00002943343],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014378362,0.010065297,0.08710397,0.0006878293,0.0007338194,0.0004617659,0.004382396,0.00034915472,0.51419204,0.10883144,0.040152162,0.21866174],"study_design_scores_gemma":[0.017779788,0.012032016,0.011614726,0.000113168666,0.000230728,0.00046458136,0.000077029516,0.0010080587,0.03307976,0.00045749175,0.9228777,0.00026490496],"about_ca_topic_score_codex":0.000009102716,"about_ca_topic_score_gemma":0.00018838682,"teacher_disagreement_score":0.8827256,"about_ca_system_score_codex":0.00008364055,"about_ca_system_score_gemma":0.0003417112,"threshold_uncertainty_score":0.69242686},"labels":[],"label_agreement":null},{"id":"W2336100438","doi":"10.1093/neuonc/nov209.42","title":"CBIO-42DOWN REGULATION OF PYRUVATE DEHYDROGENASE ACTIVITY IS ESSENTIAL FOR CELL PROLIFERATION IN IDH1 MUTANT GLIOMA CELLS","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Mutant; Pyruvate dehydrogenase complex; Glioma; IDH1; Isocitrate dehydrogenase; Chemistry; Cell growth; Cell biology; Biochemistry; Cell; Enzyme; Biology; Cancer research; Gene","score_opus":0.01569037873649329,"score_gpt":0.27733027065294036,"score_spread":0.26163989191644704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2336100438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956762,0.0002715748,0.0013562132,0.00025613973,0.0014023801,0.0006749599,0.0000699109,0.000010481154,0.00028209126],"genre_scores_gemma":[0.99802524,0.00012245431,0.0004064212,0.00027317554,0.0009317198,0.00008912221,0.000073712086,0.00002625881,0.00005192113],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99871707,0.00015134606,0.00031170069,0.0004124719,0.00013611853,0.0002712718],"domain_scores_gemma":[0.9991515,0.000030397465,0.00023855691,0.00028895677,0.00017844044,0.00011211583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029074942,0.00016348026,0.00028892653,0.000104645274,0.00003811386,0.000010592676,0.00012917063,0.00030208824,0.000011650919],"category_scores_gemma":[0.000084973086,0.00016954889,0.00010499768,0.0001475883,0.000081770515,0.000011889837,0.00006940001,0.00009622706,0.0000045938746],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011042877,0.00027177137,0.00008945422,0.000033829256,0.000012542408,0.0000028999636,0.00021999935,0.00023726115,0.9901661,0.000018391474,0.0032444778,0.004598971],"study_design_scores_gemma":[0.0026040252,0.00076380477,0.000083636536,0.000002884996,0.000033307213,0.00001336846,0.000029980607,0.0009665554,0.86662656,0.000107264736,0.12863493,0.00013367945],"about_ca_topic_score_codex":0.000055627206,"about_ca_topic_score_gemma":0.00019961965,"teacher_disagreement_score":0.12539046,"about_ca_system_score_codex":0.000049943385,"about_ca_system_score_gemma":0.00045549605,"threshold_uncertainty_score":0.6914003},"labels":[],"label_agreement":null},{"id":"W2336547352","doi":"10.1093/neuonc/nov204.28","title":"ATPS-28COMBINED DRUG SCREENING AND PHOSPHOPROTEOMICS IDENTIFIES CANDIDATE BRAIN TUMOR THERAPEUTICS IN PRIMARY HUMAN BRAIN TUMOR-INITIATING CELLS","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Mount Sinai Hospital; Ontario Brain Institute; Ontario Institute for Cancer Research; Genome British Columbia; Hospital for Sick Children","funders":"","keywords":"Phosphoproteomics; Brain tumor; Drug; Primary (astronomy); Medicine; Tumor cells; Human brain; Pharmacology; Cancer research; Neuroscience; Pathology; Biology; Cell biology","score_opus":0.030993674258538852,"score_gpt":0.3001466175386531,"score_spread":0.2691529432801143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2336547352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873999,0.00044796983,0.000015822445,0.009592756,0.00033197526,0.00092455634,0.000017841152,0.00008746679,0.0011817187],"genre_scores_gemma":[0.982067,0.000035828572,0.0010094465,0.016442288,0.00013376217,0.0001253687,0.00005878102,0.00006782302,0.00005968357],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977392,0.00032382592,0.0005832651,0.00054249057,0.0002855588,0.00052565086],"domain_scores_gemma":[0.998187,0.00080615794,0.0002860569,0.0003437236,0.00009985954,0.00027722362],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00070175435,0.00031943189,0.000722831,0.00024910818,0.00014855423,0.000064617925,0.00014332871,0.00010772748,0.000025488664],"category_scores_gemma":[0.00021801161,0.0002955159,0.000088097986,0.00025262663,0.00017391321,0.00012989149,0.00019706131,0.0004513818,0.000016805376],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004731786,0.00089291605,0.10817179,0.00010755729,0.00012505066,0.004259692,0.0030405049,0.000031546853,0.8691044,0.00015432209,0.007286312,0.006352753],"study_design_scores_gemma":[0.051768836,0.0057032094,0.1689798,0.0005028942,0.00061357464,0.001520942,0.0038168351,0.0019556119,0.7167422,0.0016445698,0.045518506,0.0012329996],"about_ca_topic_score_codex":0.00055418425,"about_ca_topic_score_gemma":0.0005163372,"teacher_disagreement_score":0.15236215,"about_ca_system_score_codex":0.00035574188,"about_ca_system_score_gemma":0.00031417998,"threshold_uncertainty_score":0.9999497},"labels":[],"label_agreement":null},{"id":"W2337058838","doi":"10.1093/neuonc/nov231.03","title":"RTRB-03SHORT DELAY IN INITIATION OF RADIOTHERAPY WITH CONCURRENT CHEMOTHERAPY FOR GLIOBLASTOMA: A SECONDARY ANALYSIS OF NRG ONCOLOGY/RTOG 0525 AND 0825","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Temozolomide; Medicine; Oncology; Radiation therapy; Internal medicine; Hazard ratio; Chemoradiotherapy; Proportional hazards model; Glioblastoma; Confidence interval; Cancer research","score_opus":0.025549606718185732,"score_gpt":0.32969594668032404,"score_spread":0.3041463399621383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2337058838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994985,0.0011580201,0.00022538166,0.0019290819,0.00013203097,0.0009747215,0.000051944196,0.000016854765,0.00052700104],"genre_scores_gemma":[0.99691385,0.0004059448,0.0010724745,0.0012728276,0.00005253484,0.0001994413,0.000054540436,0.00002534792,0.0000030272079],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99855125,0.00015113434,0.00053031347,0.00035206412,0.00018385772,0.00023137154],"domain_scores_gemma":[0.99840325,0.00060659397,0.00035666281,0.00022468893,0.00025377,0.00015503813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034409497,0.0001959374,0.0011658139,0.000625161,0.000020082934,0.000004110194,0.000067667424,0.00020194918,0.00005084005],"category_scores_gemma":[0.00007933844,0.00015433105,0.0001340727,0.00063341804,0.000192554,0.000059273465,0.000018515802,0.0001537671,5.138319e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014426347,0.008775962,0.5510721,0.00026158223,0.005809435,0.0006005179,0.009111855,0.0004902142,0.15416038,0.0004608506,0.0051303376,0.24970038],"study_design_scores_gemma":[0.15004717,0.113379374,0.31763396,0.00019970571,0.009264263,0.0006928406,0.0021725858,0.012008869,0.19217356,0.00017202117,0.20147315,0.00078252156],"about_ca_topic_score_codex":0.000052438372,"about_ca_topic_score_gemma":0.0007356821,"teacher_disagreement_score":0.24891785,"about_ca_system_score_codex":0.000310271,"about_ca_system_score_gemma":0.0005948952,"threshold_uncertainty_score":0.62934375},"labels":[],"label_agreement":null},{"id":"W2337458062","doi":"10.1093/neuonc/nov222.26","title":"MPTH-26MOLECULAR REFINEMENT OF PEDIATRIC POSTERIOR FOSSA EPENDYMOMA","year":2015,"lang":"es","type":"article","venue":"Neuro-Oncology","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Ependymoma; Biology; Medulloblastoma; Pathology; Oncology; Internal medicine; Genetics; Medicine","score_opus":0.016900530523097073,"score_gpt":0.2814769180351891,"score_spread":0.264576387512092,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2337458062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97089154,0.010575153,0.000062751315,0.002176974,0.0020871914,0.00042648672,0.000065779815,0.000019154577,0.013694957],"genre_scores_gemma":[0.99205303,0.0045171967,0.00027571316,0.0015267058,0.0011321893,0.00003666917,0.00009139291,0.00006298229,0.00030413002],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972826,0.00038089548,0.000710693,0.0007239241,0.00034015116,0.00056170626],"domain_scores_gemma":[0.99813586,0.000037821974,0.00051065657,0.0006178693,0.00031374212,0.00038406756],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003222121,0.00038378805,0.0005800072,0.00014725549,0.00006463813,0.000023739269,0.0004618008,0.0008107591,0.000055214823],"category_scores_gemma":[0.00020719289,0.00034890475,0.0002836357,0.00027131903,0.00022787508,0.0000063204616,0.00041801104,0.00038083649,0.00008592814],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009845403,0.0003919857,0.0016364652,0.0001593562,0.00024146748,0.0006934584,0.00014744012,0.00017018324,0.95332134,0.00009082046,0.016569108,0.025593828],"study_design_scores_gemma":[0.003599721,0.008892893,0.00062731904,0.00002567725,0.00043192206,0.0006101177,0.0001269968,0.000037098147,0.38450342,0.000050538783,0.6006332,0.0004610976],"about_ca_topic_score_codex":0.00007899655,"about_ca_topic_score_gemma":0.00001086802,"teacher_disagreement_score":0.5840641,"about_ca_system_score_codex":0.00013191423,"about_ca_system_score_gemma":0.0011967599,"threshold_uncertainty_score":0.9998963},"labels":[],"label_agreement":null},{"id":"W2337562041","doi":"10.1093/neuonc/nov219.08","title":"MTR-08MODELING TMZ RESISTANCE IN PATIENT-DERIVED BRAIN TUMOR- INITIATING CELLS","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Brain tumor; Temozolomide; Internal medicine; Glioblastoma; Cancer research; Pathology","score_opus":0.04195692803620214,"score_gpt":0.3043310493408496,"score_spread":0.26237412130464743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2337562041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9839789,0.00043494813,0.000021510512,0.0059434217,0.0004492471,0.000476993,0.000007869801,0.00006293956,0.008624136],"genre_scores_gemma":[0.99014556,0.000022114604,0.0020910099,0.0074613085,0.00011719885,0.000104961524,0.000015317532,0.000034270877,0.000008273918],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983031,0.00019949947,0.0004545974,0.0004002483,0.0002333715,0.00040915183],"domain_scores_gemma":[0.9986261,0.00054973643,0.00017381346,0.00027972375,0.00012158875,0.00024903406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023881653,0.00018797496,0.0004600863,0.00017413612,0.000049621307,0.00001394646,0.00008386456,0.00011202183,0.00003252025],"category_scores_gemma":[0.00067191967,0.0001725352,0.0000699948,0.00024581584,0.000054885164,0.000074333686,0.000079325524,0.00028393976,0.000074154654],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055633497,0.0013147146,0.014538809,0.00005179351,0.000039620558,0.008591861,0.003981224,0.00036695713,0.94657016,0.00024451886,0.013774537,0.009969475],"study_design_scores_gemma":[0.034418132,0.007948559,0.007897516,0.0005100088,0.00026423833,0.0006117151,0.004762483,0.0038737578,0.6770705,0.0018526331,0.25983864,0.0009518363],"about_ca_topic_score_codex":0.00006286674,"about_ca_topic_score_gemma":0.00033698732,"teacher_disagreement_score":0.2694997,"about_ca_system_score_codex":0.00039760754,"about_ca_system_score_gemma":0.00033212686,"threshold_uncertainty_score":0.7035781},"labels":[],"label_agreement":null},{"id":"W2337727575","doi":"10.1093/neuonc/nov215.10","title":"GENO-10LOSS OF IDH MUTATION IN PATIENT-DERIVED BRAIN TUMOR INITIATING CELLS","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotchkiss Brain Institute; Ontario Brain Institute; University of Calgary","funders":"","keywords":"Biology; IDH1; Glioma; Mutation; Cancer research; Mutant; Epigenetics; Isocitrate dehydrogenase; Phenotype; Genetics; Molecular biology; Gene","score_opus":0.03483767146161917,"score_gpt":0.30767519752115285,"score_spread":0.2728375260595337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2337727575","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950137,0.00010468068,0.000008770478,0.001940556,0.00030845817,0.0004709253,0.000009379687,0.000023717495,0.002119808],"genre_scores_gemma":[0.99684083,0.0000068868467,0.0006244194,0.002360902,0.00005580439,0.00006682043,0.000024044652,0.000018827772,0.0000014559124],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998822,0.00018520873,0.00038514464,0.00021914326,0.0001718106,0.00021673668],"domain_scores_gemma":[0.998924,0.0004557295,0.00020907522,0.00015795174,0.00011819894,0.00013502735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015018533,0.000117021154,0.00035889677,0.00016235856,0.000019081594,0.0000044199364,0.000047326965,0.00007930857,0.00003775941],"category_scores_gemma":[0.00049642654,0.000104926425,0.000052123105,0.00019342233,0.00005337146,0.000049096037,0.000043479387,0.0001332302,0.000035289635],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018292,0.0009881523,0.0151441,0.000031912314,0.00002470476,0.003031583,0.00321143,0.00011348819,0.9571113,0.0000472465,0.0014336372,0.018679544],"study_design_scores_gemma":[0.009749486,0.0063243895,0.014679526,0.000055038854,0.00008407311,0.0003549387,0.0017465542,0.00052867766,0.9586568,0.00019167807,0.007487997,0.00014082754],"about_ca_topic_score_codex":0.00009882634,"about_ca_topic_score_gemma":0.00007151227,"teacher_disagreement_score":0.018538717,"about_ca_system_score_codex":0.00019955549,"about_ca_system_score_gemma":0.00024500018,"threshold_uncertainty_score":0.42787755},"labels":[],"label_agreement":null},{"id":"W2337877636","doi":"10.1093/neuonc/nov204.08","title":"ATPS-08DISCOVERY OF NOVEL GLIOMA-TARGETING PEPTIDES USING A HIGH-THROUGHPUT MICROFLUIDIC MAGNETIC-ACTIVATED SORTER","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Advanced biosensing and bioanalysis techniques","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Glioma; Peptide; Bead; Peptide library; Microfluidics; Brain tissue; Brain cancer; Chemistry; Molecular biology; Cancer research; Cancer; Nanotechnology; Biochemistry; Biology; Materials science; Neuroscience; Peptide sequence; Gene; Genetics","score_opus":0.030398893485916297,"score_gpt":0.3055855659847469,"score_spread":0.2751866724988306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2337877636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992498,0.000801512,0.005644962,0.00020559756,0.0002541913,0.00018923693,0.00003663966,0.000055689216,0.00031418612],"genre_scores_gemma":[0.97276103,0.00020705744,0.026035422,0.0005018035,0.000310084,0.000006317418,0.00009542213,0.00004702058,0.000035850786],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981424,0.00016333534,0.00051069114,0.00058772863,0.00018756956,0.00040825494],"domain_scores_gemma":[0.99879014,0.000049567487,0.0003418167,0.0003968172,0.00028793304,0.0001337319],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00028961545,0.00028307992,0.00046395068,0.0001319635,0.000076028424,0.000018522669,0.00023118104,0.00036331132,0.0000034365878],"category_scores_gemma":[0.0003100705,0.00025869202,0.00016382868,0.00027882124,0.00031196317,0.000013839393,0.00026357165,0.0001850007,0.000002526994],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002733789,0.00024844642,0.0002916752,0.000013750168,0.000054671134,0.000034645996,0.000049834565,0.00003690892,0.99394,0.000013646775,0.0032221798,0.0018208396],"study_design_scores_gemma":[0.0010317606,0.0014083278,0.000039419203,0.000016313696,0.00008379756,0.00017883406,0.00017139885,0.00013225363,0.96579486,0.0000503805,0.030826906,0.00026575522],"about_ca_topic_score_codex":0.0001238446,"about_ca_topic_score_gemma":0.000012001614,"teacher_disagreement_score":0.02814517,"about_ca_system_score_codex":0.00008173238,"about_ca_system_score_gemma":0.0002785863,"threshold_uncertainty_score":0.9999865},"labels":[],"label_agreement":null},{"id":"W2337880004","doi":"10.1093/neuonc/nov206.09","title":"ATCT-09IDH1 R132H MUTATIONS IN NRG ONCOLOGY/RTOG 9802: PHASE III STUDY OF RADIATION THERAPY (RT) ALONE VS RT PLUS PROCARBAZINE, CCNU, AND VINCRISTINE (PCV) IN PATIENTS WITH LOW GRADE GLIOMA (LGG)","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Procarbazine; Medicine; Oncology; Lomustine; Vincristine; Internal medicine; Radiation therapy; Glioma; Cancer research; Chemotherapy; Cyclophosphamide","score_opus":0.03359925267274657,"score_gpt":0.35874757381443195,"score_spread":0.3251483211416854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2337880004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946368,0.00015303135,0.000028317269,0.001891069,0.00008696743,0.0025114007,0.00002381098,0.000048066177,0.0006205535],"genre_scores_gemma":[0.99835706,0.000058845762,0.00018622169,0.00058891636,0.00011479767,0.00049986894,0.00014455814,0.00003320525,0.0000165065],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99785215,0.00024443207,0.00071171724,0.0005273663,0.00031852597,0.0003458299],"domain_scores_gemma":[0.9984758,0.00040315563,0.00029155632,0.00032108466,0.0001956875,0.00031270427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003231756,0.00025929153,0.0007580908,0.00024038175,0.00006395207,0.000008542881,0.00014704079,0.00021850422,0.000023194732],"category_scores_gemma":[0.00027818876,0.00022642253,0.000034943714,0.0008172238,0.00025034155,0.00010863925,0.000047263096,0.0005305764,0.000005744782],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.044646643,0.07095758,0.48270676,0.00027354993,0.0003321215,0.001333847,0.014528854,0.00063458894,0.31550542,0.00012609865,0.002638902,0.06631562],"study_design_scores_gemma":[0.48385784,0.05166267,0.34416535,0.000120458724,0.00063732674,0.00043410322,0.0030108767,0.0053452556,0.085117266,0.0002562643,0.024467807,0.00092478044],"about_ca_topic_score_codex":0.00012795067,"about_ca_topic_score_gemma":0.00012414133,"teacher_disagreement_score":0.4392112,"about_ca_system_score_codex":0.00047823964,"about_ca_system_score_gemma":0.0005840379,"threshold_uncertainty_score":0.9233243},"labels":[],"label_agreement":null},{"id":"W2338509796","doi":"10.1093/neuonc/nov218.04","title":"IMCT-04TOCA 5: PHASE 2/3 RANDOMIZED, OPEN-LABEL STUDY OF TOCA 511 WITH TOCA FC VERSUS STANDARD OF CARE IN PATIENTS UNDERGOING PLANNED RESECTION FOR RECURRENT HIGH GRADE GLIOMA (NCT02414165)","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Temozolomide; Medicine; Glioma; Phases of clinical research; Clinical endpoint; Anaplastic astrocytoma; Internal medicine; Oncology; Bevacizumab; Lomustine; Cancer research; Astrocytoma; Clinical trial; Chemotherapy; Vincristine; Cyclophosphamide","score_opus":0.054354416624144836,"score_gpt":0.38625072241558306,"score_spread":0.33189630579143825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2338509796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99346864,0.00029989265,0.000023087163,0.0001239372,0.0005433159,0.005192249,0.00016961928,0.000009251393,0.00017000338],"genre_scores_gemma":[0.9985652,0.000060435726,0.00026055545,0.00003927967,0.000084801686,0.000676008,0.00025730423,0.000049629944,0.00000681231],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9969335,0.0010193618,0.0006218568,0.00059811055,0.00041982118,0.00040731928],"domain_scores_gemma":[0.9979698,0.00036404174,0.00037712147,0.00050714304,0.0006318029,0.0001500916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082859345,0.00025988862,0.0008586034,0.00022820245,0.00007168455,0.000019718007,0.0004806783,0.00021254562,0.0000056271924],"category_scores_gemma":[0.0006324268,0.00022624916,0.00006960649,0.00030779972,0.00016125331,0.000016350703,0.00027649262,0.00020457903,0.0000010070588],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97238576,0.0037605038,0.00009281368,0.0000675633,0.00021203338,0.000017122182,0.00078443706,0.00020464495,0.015872896,0.000013477654,0.0005999084,0.0059888093],"study_design_scores_gemma":[0.34885532,0.52483517,0.000004001133,0.00001772159,0.000048181588,0.0000019204151,0.00094508764,0.000031446183,0.12444414,0.000018451019,0.0006844126,0.00011417396],"about_ca_topic_score_codex":0.000031646672,"about_ca_topic_score_gemma":0.06660483,"teacher_disagreement_score":0.62353045,"about_ca_system_score_codex":0.00023841171,"about_ca_system_score_gemma":0.0008892307,"threshold_uncertainty_score":0.9504272},"labels":[],"label_agreement":null},{"id":"W2338709534","doi":"10.1093/neuonc/nov215.21","title":"GENO-21BRCA1 PROTEIN EXPRESSION PREDICTS SURVIVAL IN GLIOBLASTOMA PATIENTS FROM A NRG ONCOLOGY/RTOG COHORT","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Temozolomide; Oncology; Medicine; Internal medicine; Hazard ratio; Proportional hazards model; PTEN; Tissue microarray; Survival analysis; Cohort; Biomarker; Glioblastoma; Radiation therapy; Immunohistochemistry; Cancer research; Biology; Confidence interval","score_opus":0.025615418067965134,"score_gpt":0.29080549830708824,"score_spread":0.2651900802391231,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2338709534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98832375,0.00018436828,0.0000063124257,0.0015956013,0.001231506,0.0024405944,0.000065228,0.00012619667,0.0060264478],"genre_scores_gemma":[0.997121,0.00003337729,0.0004804005,0.00091718644,0.000357334,0.00086188817,0.0001291567,0.000060580795,0.000039121674],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99670684,0.00062164234,0.00065934024,0.0008012736,0.0006015001,0.0006094253],"domain_scores_gemma":[0.99790424,0.00041514167,0.0002806235,0.0005521504,0.0002491928,0.0005986693],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00037515172,0.0003608777,0.0009538968,0.00027551965,0.00006540038,0.00001590463,0.00021077567,0.0005249319,0.00020655496],"category_scores_gemma":[0.0007525112,0.00029863053,0.00012082003,0.000315536,0.0001376208,0.00011467688,0.0002473327,0.000507149,0.00032711073],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003180964,0.006639367,0.7932093,0.0000222439,0.000106371546,0.0032448745,0.001009832,0.0000140324755,0.16295812,0.000021681126,0.013768372,0.015824825],"study_design_scores_gemma":[0.050831422,0.026332717,0.4797279,0.0002761794,0.00037934078,0.000098080935,0.00035428378,0.0002713249,0.17094348,0.00029234288,0.269941,0.00055194023],"about_ca_topic_score_codex":0.0003758134,"about_ca_topic_score_gemma":0.00050761114,"teacher_disagreement_score":0.31348145,"about_ca_system_score_codex":0.0011747598,"about_ca_system_score_gemma":0.00073771906,"threshold_uncertainty_score":0.9999466},"labels":[],"label_agreement":null},{"id":"W2338792363","doi":"10.1093/neuonc/nov206.16","title":"ATCT-16CODEL (ALLIANCE-N0577; EORTC-26081/2208; NRG-1071; NCIC-CEC-2): PHASE III RANDOMIZED STUDY OF RT VS. RT + TMZ VS. TMZ FOR NEWLY DIAGNOSED 1p/19q-CODELETED ANAPLASTIC GLIOMA. ANALYSIS OF PATIENTS TREATED ON THE ORIGINAL PROTOCOL DESIGN","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; Princess Margaret Cancer Centre; Toronto General Hospital","funders":"","keywords":"Medicine; Internal medicine; Clinical endpoint; Progression-free survival; Gastroenterology; Glioma; Phases of clinical research; Toxicity; Randomized controlled trial; Surgery; Oncology; Chemotherapy","score_opus":0.05897382743445861,"score_gpt":0.35906162376719264,"score_spread":0.300087796332734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2338792363","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88119596,0.00002339154,0.00059664185,0.00063498155,0.00021369373,0.11690006,0.00018423132,0.0000943934,0.00015663671],"genre_scores_gemma":[0.87806535,0.000021191463,0.00043550075,0.00055643386,0.00010250277,0.120516464,0.0001860342,0.00009180175,0.000024735291],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9928234,0.0019351492,0.0021425423,0.0011397566,0.0011255998,0.0008335493],"domain_scores_gemma":[0.98877877,0.006535667,0.0017435779,0.0010548212,0.0013594656,0.0005277271],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015460897,0.00081979274,0.00424467,0.0010065855,0.00019356929,0.000028752354,0.0005002515,0.000332994,0.00015968808],"category_scores_gemma":[0.002696938,0.00053109846,0.00089821825,0.0023280797,0.0003516558,0.00012976656,0.00010523286,0.00038162587,0.000020300766],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8470346,0.06565001,0.04080235,0.00015613051,0.009813792,0.001002026,0.0019257151,0.0048550116,0.010859485,0.00015051602,0.013446897,0.0043034777],"study_design_scores_gemma":[0.85339373,0.0748536,0.0068270075,0.00012120838,0.015863603,0.000018014152,0.00032585888,0.02516323,0.01796541,0.000059672595,0.004872911,0.00053574296],"about_ca_topic_score_codex":0.0004198504,"about_ca_topic_score_gemma":0.00028488078,"teacher_disagreement_score":0.03397534,"about_ca_system_score_codex":0.00056131644,"about_ca_system_score_gemma":0.00074218377,"threshold_uncertainty_score":0.9997141},"labels":[],"label_agreement":null},{"id":"W2338827745","doi":"10.1093/neuonc/nov206.22","title":"ATCT-22NRG ONCOLOGY/RTOG 1122: PHASE II DOUBLE-BLINDED, PLACEBO-CONTROLLED STUDY OF BEVACIZUMAB WITH OR WITHOUT AMG 386 IN PATIENTS WITH RECURRENT GLIOBLASTOMA OR GLIOSARCOMA","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"","keywords":"Gliosarcoma; Medicine; Bevacizumab; Glioblastoma; Placebo; Double blinded; Oncology; Internal medicine; Phases of clinical research; Clinical trial; Chemotherapy; Pathology; Cancer research","score_opus":0.04835993962501408,"score_gpt":0.3525851682394304,"score_spread":0.30422522861441637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2338827745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874438,0.00008211725,0.0000035285148,0.001062598,0.0005095908,0.009665689,0.000028672725,0.000111370864,0.0010926106],"genre_scores_gemma":[0.99698967,0.000017854869,0.0003505474,0.00042712956,0.00013800155,0.0018718982,0.000036549285,0.000105938176,0.000062416766],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99506336,0.0006715429,0.001277807,0.0010927896,0.0010216442,0.000872825],"domain_scores_gemma":[0.99608,0.00069908943,0.00091174815,0.0009036377,0.00072693935,0.0006786242],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005460733,0.00073792675,0.0028032772,0.00082828506,0.00015070135,0.000023577639,0.00034031927,0.00036380914,0.00013006586],"category_scores_gemma":[0.00029505286,0.00038544493,0.00013638359,0.0011005285,0.00027306884,0.00018231537,0.00024420983,0.00069693575,0.000032848195],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.74493754,0.07930946,0.14445536,0.00004624581,0.0007268486,0.0041335216,0.003521126,0.00005201823,0.00033502982,0.000009922786,0.0010374243,0.021435495],"study_design_scores_gemma":[0.58267736,0.39939177,0.0067508332,0.00013067407,0.0011050892,0.00030691086,0.0018346229,0.00014561763,0.0009779016,0.0000037252346,0.0063524595,0.00032304443],"about_ca_topic_score_codex":0.00019287122,"about_ca_topic_score_gemma":0.012174538,"teacher_disagreement_score":0.3200823,"about_ca_system_score_codex":0.0012014972,"about_ca_system_score_gemma":0.0020599216,"threshold_uncertainty_score":0.99985975},"labels":[],"label_agreement":null},{"id":"W2339255309","doi":"10.1093/neuonc/nov213.20","title":"EPID-20SKULL BASE MENINGIOMAS ARE BIOLOGICALLY MORE BENIGN AND HAVE A LONG-TERM DIVERGING POSTOPERATIVE RECURRENCE PATTERN COMPARED WITH SUPERFICIAL MENINGIOMAS","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Meningioma; Term (time); Base (topology); Radiology; Surgery; Mathematics; Physics","score_opus":0.06886303433676025,"score_gpt":0.3165141168456774,"score_spread":0.24765108250891713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2339255309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883232,0.00033994773,0.00131821,0.006108807,0.00036354785,0.0010960709,0.000031528092,0.00015745292,0.0022612181],"genre_scores_gemma":[0.9962078,0.000012120638,0.0016086398,0.0015749141,0.00022753396,0.00011008236,0.00011612634,0.000046782523,0.00009604638],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967232,0.00048209322,0.0005698206,0.001031161,0.00048070875,0.0007130612],"domain_scores_gemma":[0.9978713,0.00034058676,0.00030983717,0.00047027683,0.00035929136,0.00064871676],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00052379176,0.0005019208,0.0010166989,0.00029371222,0.0002567418,0.00007297029,0.0002697818,0.00023257449,0.00010012177],"category_scores_gemma":[0.0003341445,0.0003782428,0.00010253514,0.00028322582,0.00044032937,0.00017321638,0.00040430058,0.00050150335,0.00003025393],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042564888,0.0007787285,0.8674573,0.00013022084,0.0003685289,0.055761583,0.010816847,0.00009687655,0.039439682,0.00014263226,0.0038986327,0.016852532],"study_design_scores_gemma":[0.04998756,0.059803024,0.7685262,0.0014707542,0.002569745,0.033125386,0.019766988,0.013004997,0.02660405,0.00022131267,0.020851474,0.0040685413],"about_ca_topic_score_codex":0.000075031705,"about_ca_topic_score_gemma":0.00008900258,"teacher_disagreement_score":0.098931074,"about_ca_system_score_codex":0.00025369678,"about_ca_system_score_gemma":0.00024411843,"threshold_uncertainty_score":0.99986696},"labels":[],"label_agreement":null},{"id":"W2339357024","doi":"10.1093/neuonc/nov228.20","title":"PTPS-20THE GD3 ACETYLATION PATHWAY AS A POTENTIAL THERAPEUTIC TARGET FOR PAEDIATRIC MEDULLOBLASTOMA","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Neural crest; Apoptosis; Cancer research; Flow cytometry; Ganglioside; Biology; Medicine; Immunology; Gene; Genetics","score_opus":0.01657375298029374,"score_gpt":0.2760096761176531,"score_spread":0.25943592313735936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2339357024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9423517,0.0155422315,0.016091866,0.0034812938,0.01487861,0.0019219263,0.00015973329,0.00012927235,0.0054433383],"genre_scores_gemma":[0.9854274,0.000713738,0.001570379,0.00357471,0.0075657554,0.000250865,0.00021587177,0.000075857104,0.00060541485],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983487,0.00021671013,0.00029281943,0.0005093223,0.00018860014,0.0004438309],"domain_scores_gemma":[0.99898905,0.00005428074,0.00018052549,0.00035187212,0.0001970021,0.00022724454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035058582,0.00023112797,0.00030127633,0.00008507046,0.000097662814,0.000023059974,0.0002532565,0.0003965157,0.00003205708],"category_scores_gemma":[0.0002711703,0.0002168402,0.00019718878,0.00013545319,0.00009362147,0.00000873428,0.00011291131,0.0001608294,0.0000517195],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007737247,0.00020529471,0.00008507797,0.00001122423,0.000051461513,0.000005487132,0.00015103973,0.00017891378,0.91127163,0.00019580527,0.018978963,0.06809136],"study_design_scores_gemma":[0.003426969,0.0021968423,0.00009588535,0.0000011086976,0.000060276725,0.00011049939,0.00010441306,0.00019406427,0.1257023,0.0008428815,0.8670548,0.0002099447],"about_ca_topic_score_codex":0.000016656393,"about_ca_topic_score_gemma":0.000036501693,"teacher_disagreement_score":0.84807587,"about_ca_system_score_codex":0.00005444897,"about_ca_system_score_gemma":0.00071267603,"threshold_uncertainty_score":0.8842487},"labels":[],"label_agreement":null},{"id":"W2339942369","doi":"10.1093/neuonc/nov205.26","title":"ATNT-26PHASE I/II STUDY OF DIANHYDROGALACTITOL IN PATIENTS WITH RECURRENT MALIGNANT GLIOMA","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Delmar (Canada)","funders":"","keywords":"Medicine; Glioma; Cancer research","score_opus":0.028690499762107004,"score_gpt":0.3070681937722499,"score_spread":0.2783776940101429,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2339942369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996757,0.000066557244,4.752015e-7,0.0004973077,0.0003901489,0.0014422338,0.000009465386,0.000024752644,0.00081205915],"genre_scores_gemma":[0.9995507,0.00000694289,0.00005192383,0.00014016066,0.000046404642,0.00015682631,0.000019766603,0.000024539979,0.0000027238918],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983892,0.00016978338,0.00039464378,0.0003755285,0.00037985554,0.0002909875],"domain_scores_gemma":[0.99887496,0.000116321076,0.0001925304,0.0003705189,0.00018085226,0.00026479646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013990555,0.00019545831,0.00057106675,0.0003149295,0.000033323755,0.0000045377533,0.000090302965,0.000090523194,0.00003217584],"category_scores_gemma":[0.00013010294,0.00013835561,0.000046992507,0.00040772013,0.00005562469,0.00005893806,0.00009048763,0.00016836995,0.000020198822],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002779182,0.03597451,0.93906367,0.000018548975,0.00010148936,0.0020206384,0.0020243279,0.000018187668,0.0034768833,0.000017501361,0.0011793526,0.013325696],"study_design_scores_gemma":[0.10305563,0.17108174,0.6900379,0.00012887189,0.0005756548,0.00011644705,0.0016712038,0.00005980763,0.014318619,0.000020403457,0.018601013,0.0003326742],"about_ca_topic_score_codex":0.0001853034,"about_ca_topic_score_gemma":0.00040078795,"teacher_disagreement_score":0.24902575,"about_ca_system_score_codex":0.00028876343,"about_ca_system_score_gemma":0.00021394217,"threshold_uncertainty_score":0.5641978},"labels":[],"label_agreement":null},{"id":"W2340257747","doi":"10.1093/neuonc/nov223.14","title":"NCO-14PRE-TREATMENT HIPPOCAMPAL VOLUME PREDICTS NEUROCOGNITIVE FUNCTION (NCF) FOR PATIENTS TREATED WITH HIPPOCAMPAL AVOIDANCE WHOLE BRAIN RADIOTHERAPY (HA-WBRT) FOR BRAIN METASTASES: SECONDARY ANALYSIS OF NRG ONCOLOGY/RTOG 0933","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Internal medicine; Nuclear medicine; Radiation therapy; Neurocognitive; Cognition","score_opus":0.02640032616460126,"score_gpt":0.30917014195790976,"score_spread":0.2827698157933085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2340257747","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96792644,0.00052618945,0.010368215,0.006399855,0.00069231575,0.008325639,0.0050449925,0.00020383328,0.0005125307],"genre_scores_gemma":[0.9661852,0.00008902672,0.010029011,0.010173711,0.0005390661,0.003749485,0.008046993,0.00023132983,0.0009561741],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9947436,0.0012736486,0.0011072792,0.0013648659,0.00055156107,0.00095904997],"domain_scores_gemma":[0.9932608,0.0032984565,0.0009498212,0.00073908,0.0010360166,0.0007157956],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009797977,0.0008022207,0.0024457558,0.00080370286,0.00022526887,0.000033323926,0.00021839773,0.0003786413,0.000120564546],"category_scores_gemma":[0.0008824956,0.00061962946,0.00081436895,0.0011421101,0.0004091316,0.00024007195,0.000056118955,0.0003563125,0.000019710327],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.099925295,0.024401221,0.14041233,0.00044527915,0.032083947,0.0008536701,0.004451794,0.0015327984,0.023331141,0.00012347435,0.12189006,0.550549],"study_design_scores_gemma":[0.0862062,0.21658853,0.032849044,0.00006487534,0.01937354,0.00016813699,0.0010790019,0.0059991553,0.0033248542,0.00015142243,0.63348705,0.0007081715],"about_ca_topic_score_codex":0.00016582322,"about_ca_topic_score_gemma":0.00036740335,"teacher_disagreement_score":0.5498408,"about_ca_system_score_codex":0.0015860577,"about_ca_system_score_gemma":0.0017081472,"threshold_uncertainty_score":0.9996255},"labels":[],"label_agreement":null},{"id":"W2340401950","doi":"10.1093/neuonc/now029","title":"PIK3CA mutations in meningioma","year":2016,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Toronto Western Hospital; University Health Network","funders":"","keywords":"Meningioma; Medicine; Genetics; Biology; Pathology","score_opus":0.03513426135567041,"score_gpt":0.3114820821103039,"score_spread":0.2763478207546335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2340401950","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01214125,0.00010742793,0.00008363179,0.8584713,0.0015709725,0.00090200047,0.00001992794,0.00013560256,0.12656794],"genre_scores_gemma":[0.027425447,0.000030498193,0.0014477746,0.9483249,0.008097551,0.00054379285,0.000480105,0.00016943002,0.013480467],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99719113,0.00031982164,0.00064454164,0.00072426634,0.00040252373,0.00071772106],"domain_scores_gemma":[0.9982362,0.00067108596,0.00026347695,0.00062560895,0.0000837687,0.00011989948],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00027775674,0.00037141942,0.0008670195,0.0008276052,0.000066016335,0.000020227682,0.0002646211,0.000955162,0.0009327114],"category_scores_gemma":[0.00023493834,0.00030224756,0.00020142531,0.0003024294,0.00014386598,0.0000626894,0.00015501416,0.0015587664,0.0008536541],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007666582,0.000054733544,0.00028103456,0.0001116757,0.00007213502,0.08471754,0.00017938376,6.3790515e-7,0.009511643,0.0001378351,0.8965703,0.008286372],"study_design_scores_gemma":[0.002051652,0.0010126932,0.00034073793,0.00010998366,0.00019679112,0.0022870766,0.000022953755,0.000022374865,0.00030937736,0.00033830322,0.9930517,0.00025633967],"about_ca_topic_score_codex":0.000022541755,"about_ca_topic_score_gemma":0.000007282381,"teacher_disagreement_score":0.113087475,"about_ca_system_score_codex":0.0004844835,"about_ca_system_score_gemma":0.0003854406,"threshold_uncertainty_score":0.99998057},"labels":[],"label_agreement":null},{"id":"W2340939949","doi":"10.1093/neuonc/nov222.25","title":"MPTH-25AN 18-GENE EXPRESSION SIGNATURE PREDICTS RECURRENCE-FREE SURVIVAL IN MENINGIOMA","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Radiosurgery; Meningioma; Oncology; Artificial intelligence; Radiation therapy; Pathology; Computer science","score_opus":0.062317341077395776,"score_gpt":0.31663116362407295,"score_spread":0.25431382254667717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2340939949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9127797,0.0006245607,0.00018416438,0.003753355,0.0028834606,0.00091980613,0.000014143673,0.00018358201,0.07865725],"genre_scores_gemma":[0.9948434,0.000021154636,0.003327613,0.00051105756,0.0005748155,0.00009921426,0.00007078936,0.00004023463,0.00051169],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970637,0.0004650842,0.0005449947,0.00067945605,0.0006527118,0.0005940331],"domain_scores_gemma":[0.9980942,0.00027198088,0.000194182,0.0008063979,0.00014590954,0.000487317],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00091947545,0.00029512818,0.0006426438,0.00037442258,0.000065376786,0.000022393298,0.0004294242,0.00037234442,0.00018243752],"category_scores_gemma":[0.0011681156,0.0002573122,0.00009982391,0.0004807958,0.000105072686,0.00013575073,0.0004413236,0.00068146514,0.00007747644],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029056354,0.0009846791,0.029411435,0.00012044536,0.00007209638,0.02181006,0.0028178045,0.00010093531,0.67376393,0.0006655322,0.25501046,0.012337001],"study_design_scores_gemma":[0.03334541,0.013743953,0.027746193,0.000473905,0.00036059038,0.0030230929,0.0018056174,0.0018777321,0.15157777,0.003048621,0.76180524,0.0011919086],"about_ca_topic_score_codex":0.000027933806,"about_ca_topic_score_gemma":0.000020277721,"teacher_disagreement_score":0.52218616,"about_ca_system_score_codex":0.00029137495,"about_ca_system_score_gemma":0.00037366006,"threshold_uncertainty_score":0.9999879},"labels":[],"label_agreement":null},{"id":"W2341286435","doi":"10.1093/neuonc/nov213.01","title":"EPID-01CHICKEN POX AND GLIOMA RISK: PRELIMINARY RESULTS FROM THE GLIOGENE INTERNATIONAL CASE-CONTROL STUDY","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Glioma; Shingles; Medicine; Virology; Internal medicine; Oncology; Immunology; Virus; Cancer research","score_opus":0.03630141238346843,"score_gpt":0.3261973745498068,"score_spread":0.2898959621663384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2341286435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890043,0.00019716709,0.000041009655,0.0045904927,0.00107823,0.0008545221,0.0004144809,0.000061005816,0.003758794],"genre_scores_gemma":[0.9980234,0.00004133138,0.00018664934,0.0010040886,0.00057019375,0.00007744573,0.000022424232,0.000021274898,0.000053203843],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99832237,0.0005502186,0.00034538866,0.000393424,0.00019281638,0.00019576907],"domain_scores_gemma":[0.9977283,0.0013910503,0.00016194468,0.00038929356,0.00013042256,0.0001989785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005330112,0.00016363601,0.00029933656,0.000094943345,0.00015911947,0.000022110047,0.000101481586,0.00012542911,0.000063664294],"category_scores_gemma":[0.0012374665,0.00010820433,0.000057990856,0.00013881765,0.00009998146,0.0000616696,0.00010831755,0.0003071631,0.000085315536],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019197177,0.0058495156,0.46148458,0.000004071664,0.0021351147,0.08650433,0.008439475,0.00009195124,0.0026375377,0.000029747847,0.017571863,0.39605463],"study_design_scores_gemma":[0.072489485,0.027447771,0.53579897,0.00002439602,0.0023381484,0.025061576,0.003660807,0.0020549523,0.0009185242,0.00039228506,0.3294608,0.00035229733],"about_ca_topic_score_codex":0.002470196,"about_ca_topic_score_gemma":0.00072912103,"teacher_disagreement_score":0.39570233,"about_ca_system_score_codex":0.00014354342,"about_ca_system_score_gemma":0.00016076112,"threshold_uncertainty_score":0.44124445},"labels":[],"label_agreement":null},{"id":"W2341492001","doi":"10.1093/neuonc/nov210.06","title":"CSIG-06EGFRvIII REQUIRES OSMR AS A CO-RECEPTOR TO DRIVE GLIOBLASTOMA PATHOGENESIS","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Ottawa Hospital","funders":"","keywords":"Glioblastoma; Pathogenesis; Receptor; Cancer research; Neuroscience; Biology; Medicine; Internal medicine; Immunology","score_opus":0.04335322430103913,"score_gpt":0.3515248312104941,"score_spread":0.308171606909455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2341492001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95512414,0.0000817205,0.00022396645,0.010708995,0.0020526662,0.00067278306,0.000082165534,0.000244225,0.030809361],"genre_scores_gemma":[0.98132133,0.000031734387,0.0015082866,0.014402515,0.0015570931,0.00018492059,0.000055388944,0.000086107844,0.00085262646],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99798274,0.00020111646,0.00045702228,0.0005389823,0.00035518975,0.00046494856],"domain_scores_gemma":[0.9979146,0.0003490823,0.00014626344,0.0004611742,0.00037690657,0.00075194583],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00025955876,0.0002609442,0.0005640833,0.00031287596,0.00011084984,0.000026630443,0.0001856238,0.00021962557,0.0011762535],"category_scores_gemma":[0.0013360567,0.00023576625,0.00017960338,0.00037528938,0.000100510275,0.00010626438,0.00011642563,0.00036377757,0.0054181963],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012327284,0.00034190333,0.0006029806,0.000011106802,0.00004210736,0.00041857327,0.0011667461,0.000022690972,0.82944113,0.00016599151,0.1545285,0.012025563],"study_design_scores_gemma":[0.0015852819,0.0096900845,0.00025991115,0.000034974262,0.000082018036,0.0008274368,0.0005944686,0.000054177417,0.22962275,0.000038496553,0.75703543,0.00017497742],"about_ca_topic_score_codex":0.0001224703,"about_ca_topic_score_gemma":0.00008792943,"teacher_disagreement_score":0.60250694,"about_ca_system_score_codex":0.00036905683,"about_ca_system_score_gemma":0.00076471723,"threshold_uncertainty_score":0.9997368},"labels":[],"label_agreement":null},{"id":"W2342006085","doi":"10.1093/neuonc/nov205.10","title":"ATNT-10DOES VALPROIC ACID IMPROVE SURVIVAL IN GLIOBLASTOMA? A META-ANALYSIS OF RANDOMIZED TRIALS IN NEWLY DIAGNOSED GLIOBLASTOMA","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Temozolomide; Medicine; Internal medicine; Hazard ratio; Oncology; Valproic Acid; Progression-free survival; Chemoradiotherapy; Post-hoc analysis; Confidence interval; Cancer; Epilepsy; Overall survival; Chemotherapy; Psychiatry","score_opus":0.06600521054757182,"score_gpt":0.36325196459402653,"score_spread":0.29724675404645473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2342006085","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99386144,0.0020235057,0.00022495937,0.00081111386,0.0005891549,0.001705319,0.00011344147,0.000022129263,0.00064896443],"genre_scores_gemma":[0.9980691,0.00017585461,0.00031872292,0.00026680113,0.00020880916,0.00074074004,0.000048364505,0.000057438287,0.00011418435],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.98563737,0.009621923,0.0023612715,0.0010103757,0.000647961,0.00072109164],"domain_scores_gemma":[0.99443656,0.0031091955,0.00087372883,0.0008679213,0.00039921695,0.00031335597],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.012860567,0.00044463872,0.0059496406,0.0013606123,0.000033373588,0.00002601318,0.00058051245,0.00062029343,0.00011659519],"category_scores_gemma":[0.024213081,0.00036326822,0.002457405,0.0016239592,0.00046298085,0.000015423553,0.0003577455,0.0004993369,0.00002499893],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.056158196,0.00060147664,0.00017947322,0.000021569167,0.011336619,0.00028120825,0.00042619853,0.00095904706,0.9279153,0.00003331979,0.001177656,0.00090997515],"study_design_scores_gemma":[0.10360768,0.0033419663,0.000043469776,0.0000044498647,0.017133905,0.0000149805555,0.00028290402,0.0009875156,0.8657871,0.00008195642,0.008287996,0.00042607696],"about_ca_topic_score_codex":0.00059503823,"about_ca_topic_score_gemma":0.010055189,"teacher_disagreement_score":0.062128156,"about_ca_system_score_codex":0.0002185301,"about_ca_system_score_gemma":0.0009402975,"threshold_uncertainty_score":0.9998819},"labels":[],"label_agreement":null},{"id":"W2342230022","doi":"10.1093/neuonc/nov237.14","title":"TMOD-14CHARACTERIZING SIGNALING PATHWAYS IN A MOUSE MODEL OF GLIOBLASTOMA","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Glioblastoma; Signal transduction; Neuroscience; Biology; Cell biology; Cancer research","score_opus":0.07130521739598808,"score_gpt":0.3041075111655582,"score_spread":0.2328022937695701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2342230022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99544555,0.000101656544,0.00046639657,0.0005378438,0.00022980818,0.00026069625,0.000025931398,0.000039665832,0.0028924698],"genre_scores_gemma":[0.9961474,0.000063260435,0.0021463723,0.001384384,0.0001260888,0.000026980888,0.00000517086,0.00003130814,0.00006906304],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987548,0.00008739546,0.0003997627,0.00026889084,0.0002016244,0.00028751034],"domain_scores_gemma":[0.9991769,0.0001011671,0.00015643497,0.0002393251,0.00011447827,0.0002116781],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032480832,0.00013652781,0.00053297373,0.00019531243,0.00001507869,0.000004584719,0.00009123872,0.00012905576,0.000028369854],"category_scores_gemma":[0.00017329527,0.00012937396,0.00008720541,0.00018725592,0.00006228139,0.000066840475,0.00007534943,0.00027767566,0.000015509318],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009211434,0.00026655546,0.00046550285,0.000052177977,0.000013070204,0.00013610937,0.0013450532,0.0011030132,0.98304373,0.00011259676,0.00023588502,0.012305179],"study_design_scores_gemma":[0.0048748674,0.0025834988,0.00005310963,0.000046903242,0.00007375231,0.00010863547,0.00046767102,0.01185096,0.9632228,0.00017759667,0.016379582,0.00016064175],"about_ca_topic_score_codex":0.00006599924,"about_ca_topic_score_gemma":0.00006639315,"teacher_disagreement_score":0.019820932,"about_ca_system_score_codex":0.00021915571,"about_ca_system_score_gemma":0.00064765866,"threshold_uncertainty_score":0.52757174},"labels":[],"label_agreement":null},{"id":"W2344218142","doi":"10.1093/neuonc/nov223.10","title":"NCO-10INTELLECTUAL OUTCOME IN MOLECULAR SUBGROUPS OF MEDULLOBLASTOMA","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medulloblastoma; Outcome (game theory); Medicine; Oncology; Internal medicine; Cancer research; Mathematics","score_opus":0.0401961044356289,"score_gpt":0.32417700568881447,"score_spread":0.2839809012531856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344218142","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883387,0.00021205301,0.000039127135,0.003405206,0.00036270425,0.00037164649,0.0000041227104,0.00003351303,0.007232904],"genre_scores_gemma":[0.99774784,0.000017592472,0.00045350922,0.0016313498,0.000046428897,0.000052509502,0.000008585232,0.000024831492,0.000017350785],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985796,0.00014977941,0.000447842,0.00028273067,0.00024950888,0.0002905386],"domain_scores_gemma":[0.99891514,0.0003384197,0.00011041342,0.00029376787,0.00010641163,0.00023588087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021177513,0.00016217817,0.00059046363,0.00025604453,0.000011407145,0.0000034889804,0.000101709025,0.00016000637,0.000072648225],"category_scores_gemma":[0.00074780453,0.00013598942,0.000115029485,0.0002983126,0.000105327774,0.00002795981,0.000073864445,0.0002094148,0.00013321025],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009990353,0.00374714,0.4542935,0.000057247158,0.00012897626,0.0076028146,0.0017057566,0.00009989345,0.5077989,0.001276602,0.008185042,0.014105113],"study_design_scores_gemma":[0.028942198,0.01904119,0.06024456,0.00008463767,0.00045160708,0.0016622778,0.0011618077,0.0006960906,0.6767847,0.0007109358,0.20974357,0.00047644466],"about_ca_topic_score_codex":0.0000866641,"about_ca_topic_score_gemma":0.00010313457,"teacher_disagreement_score":0.3940489,"about_ca_system_score_codex":0.00025528058,"about_ca_system_score_gemma":0.0002427568,"threshold_uncertainty_score":0.55454874},"labels":[],"label_agreement":null},{"id":"W2345664732","doi":"10.1093/neuonc/nov204.65","title":"ATPS-65AN ONCOLYTIC MYXOMA VIRUS CONSTRUCT (M011L KNOCK-OUT) INDUCES APOPTOSIS AND IS A POTENT PRO-APOPTOTIC THERAPY IN BOTH HUMAN AND IMMUNOCOMPETENT MURINE GLIOBLASTOMA CANCER STEM CELLS MODELS","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Alberta","funders":"","keywords":"Myxoma virus; Oncolytic virus; Apoptosis; Cancer research; Glioblastoma; Cancer therapy; Virus; Biology; Virology; Cancer; Tumor cells; Genetics","score_opus":0.04976793458508824,"score_gpt":0.32463249997423554,"score_spread":0.2748645653891473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2345664732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938802,0.0034980527,0.000010814367,0.0007656024,0.00027405983,0.0011913634,0.000047962058,0.00003221781,0.00029972984],"genre_scores_gemma":[0.9940911,0.0038819439,0.000095524985,0.0012234799,0.00018802416,0.0003043406,0.000010005943,0.00008418804,0.00012139881],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968504,0.0005497015,0.0005557271,0.0009675357,0.00034382739,0.00073283585],"domain_scores_gemma":[0.99860525,0.00006288953,0.00022761668,0.0005600359,0.00016734289,0.0003768676],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00046399978,0.00045767444,0.0006301664,0.00024206069,0.000150599,0.000067214554,0.00039608657,0.0004005797,0.000032494903],"category_scores_gemma":[0.000013894302,0.0004269891,0.00009727811,0.0002019172,0.0005627902,0.00002296973,0.00039554646,0.0004530734,0.000007830901],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032335867,0.00030798904,0.0007049293,0.000031517426,0.00012873978,0.000038039794,0.00079095725,0.00017415718,0.9623611,0.000014180434,0.00050876715,0.03170601],"study_design_scores_gemma":[0.0059328116,0.01678936,0.00024222644,0.000028440385,0.000027598366,0.00009228375,0.000374415,0.00049718143,0.9702275,0.00016823334,0.005178998,0.00044099148],"about_ca_topic_score_codex":0.0003805892,"about_ca_topic_score_gemma":0.0013214815,"teacher_disagreement_score":0.031265017,"about_ca_system_score_codex":0.00023490895,"about_ca_system_score_gemma":0.00070492766,"threshold_uncertainty_score":0.9998182},"labels":[],"label_agreement":null},{"id":"W2345959150","doi":"10.1093/neuonc/nov208.31","title":"BMET-31DEVELOPMENT AND APPLICATION OF A NOVEL MODEL OF HUMAN LUNG-TO-BRAIN METASTASIS TO IDENTIFY UNIQUE METASTATIC GENE SIGNATURES","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University","funders":"","keywords":"Brain metastasis; Metastasis; Human lung; Medicine; Lung; Gene; Computational biology; Oncology; Cancer research; Internal medicine; Biology; Cancer; Genetics","score_opus":0.07047624249938339,"score_gpt":0.38803375351255237,"score_spread":0.317557511013169,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2345959150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85786986,0.000292691,0.13315892,0.006017269,0.00008141916,0.0020731424,0.00015327899,0.00003405844,0.00031934291],"genre_scores_gemma":[0.86820024,0.000012198292,0.12860692,0.0027730253,0.000022000544,0.00025497112,0.000060997936,0.000030549778,0.00003909321],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982239,0.00017403196,0.00057295535,0.0004389771,0.0003363132,0.000253802],"domain_scores_gemma":[0.99843603,0.0002598317,0.00023869613,0.00039140965,0.00027615728,0.00039788667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080290466,0.00021930959,0.0007535565,0.00034327584,0.00003967344,0.0000064206038,0.00013292194,0.00009026556,0.000011154874],"category_scores_gemma":[0.0003195955,0.00018636373,0.00008495155,0.00035081056,0.000083390965,0.00004259949,0.00016091732,0.00015093986,0.0000041248322],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003365589,0.0010028866,0.000299144,0.00012777578,0.00032065532,0.00003059205,0.0012698976,0.002861853,0.97687536,0.0025367648,0.0027925724,0.011545926],"study_design_scores_gemma":[0.01656363,0.011694296,0.0064675245,0.00011075922,0.0027565653,0.0003037528,0.0009664012,0.018635463,0.9197336,0.0023360155,0.01972707,0.00070494757],"about_ca_topic_score_codex":0.00012612867,"about_ca_topic_score_gemma":0.00006470716,"teacher_disagreement_score":0.057141796,"about_ca_system_score_codex":0.00017724867,"about_ca_system_score_gemma":0.00035277824,"threshold_uncertainty_score":0.75996923},"labels":[],"label_agreement":null},{"id":"W2346226649","doi":"10.1093/neuonc/nov206.29","title":"ATCT-29INVESTIGATING THE EFFECT OF REIRRADIATION OR SYSTEMIC THERAPY IN PATIENTS WITH GBM AFTER TUMOR PROGRESSION: A SECONDARY ANALYSIS OF THE NRG ONCOLOGY/RTOG 0525","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec; Concordia University; McGill University","funders":"","keywords":"Medicine; Systemic therapy; Oncology; Internal medicine; Cancer","score_opus":0.015740877460417347,"score_gpt":0.2956206174277451,"score_spread":0.27987973996732773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2346226649","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996317,0.00036231344,6.0787136e-7,0.0010736565,0.00019104056,0.0017837224,0.0000152023695,0.000013789365,0.00024262915],"genre_scores_gemma":[0.9986443,0.000012192229,0.00007838717,0.00068514654,0.000041036135,0.0004983475,0.000018139575,0.000019336636,0.0000031001437],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99751353,0.0011111051,0.0005165014,0.00029058402,0.00035194904,0.00021635718],"domain_scores_gemma":[0.99766284,0.001007393,0.00059970125,0.00045727115,0.00017109963,0.00010169536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061294006,0.00019335974,0.00083305174,0.0002155547,0.000044180146,0.000005666223,0.0001505234,0.00012488345,0.000037665526],"category_scores_gemma":[0.00039540956,0.000079274076,0.000146232,0.0009761651,0.00022304805,0.00004687084,0.00006123684,0.00026927242,0.0000025267002],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038916052,0.0005285901,0.9716544,0.00006482164,0.00046430257,0.00010928703,0.0012960101,0.00010005494,0.0028845696,0.0000040033256,0.00021434278,0.01878801],"study_design_scores_gemma":[0.014459318,0.019513587,0.9506908,0.00024454755,0.0013462271,0.000041203,0.00022619212,0.00030309704,0.012083248,0.0000060786533,0.0009933002,0.0000924244],"about_ca_topic_score_codex":0.000059677506,"about_ca_topic_score_gemma":0.00022175064,"teacher_disagreement_score":0.020963624,"about_ca_system_score_codex":0.00031726604,"about_ca_system_score_gemma":0.0005370399,"threshold_uncertainty_score":0.3232703},"labels":[],"label_agreement":null},{"id":"W2346516822","doi":"10.1093/neuonc/nov221.08","title":"METB-08INHIBITION OF HEXOKINASE 2 USING TUMOR GLYCOLYSIS INHIBITORS IDENTIFIED THROUGH A DRUG SCREEN INHIBITS GLIOBLASTOMA GROWTH IN VITRO AND IN VIVO","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"In vivo; Glioblastoma; Hexokinase; In vitro; Glycolysis; Drug; Pharmacology; Chemistry; Cancer research; Biochemistry; Enzyme; Biology; Genetics","score_opus":0.01664678465682504,"score_gpt":0.2724587597896256,"score_spread":0.2558119751328005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2346516822","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996334,0.0017161987,0.00006390125,0.00017352813,0.00088289817,0.0004072034,0.00005346272,0.0000126301065,0.0003561526],"genre_scores_gemma":[0.9978673,0.00021130982,0.0006452085,0.0005529571,0.0005915289,0.000045205485,0.00002331337,0.000037415353,0.00002579965],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978537,0.00035259096,0.0005782039,0.00060062006,0.00021166833,0.00040321122],"domain_scores_gemma":[0.99907863,0.000052360905,0.0002776943,0.00026114477,0.00015422136,0.0001759331],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00045036885,0.0002503143,0.0005395147,0.0002787724,0.0000392922,0.000018162697,0.00014379763,0.0002227889,0.00000960253],"category_scores_gemma":[0.00038165832,0.0002723602,0.00010473683,0.00048190434,0.00020800407,0.000032773718,0.00024761938,0.00021938997,0.00000178222],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016838438,0.00020685309,0.00050364574,0.00003063883,0.000019106425,0.000056467255,0.0006261137,0.000058107707,0.9944111,0.000027238753,0.0014526668,0.0009241917],"study_design_scores_gemma":[0.0035764093,0.00039558712,0.00020243821,0.000030411675,0.00005233198,0.00014726026,0.0005541492,0.00009321463,0.98214126,0.00016618542,0.012404583,0.00023616325],"about_ca_topic_score_codex":0.0010859156,"about_ca_topic_score_gemma":0.0015944857,"teacher_disagreement_score":0.012269861,"about_ca_system_score_codex":0.00010258185,"about_ca_system_score_gemma":0.00039446808,"threshold_uncertainty_score":0.9999729},"labels":[],"label_agreement":null},{"id":"W2396892013","doi":"10.1093/neuonc/nov209.22","title":"CBIO-22DICER AND miRNAs REGULATE GLIOMA STEM CELL CHARACTERISTICS","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Dicer; Biology; microRNA; Gene knockdown; Cancer research; SOX2; Stem cell; Glioma; Gene silencing; Stem cell marker; Drosha; Cell growth; Oncomir; BMI1; Cancer stem cell; Small hairpin RNA; RNA interference; Cell culture; Cell biology; Genetics; RNA; Transcription factor; Gene","score_opus":0.01783623406905588,"score_gpt":0.26143247905500505,"score_spread":0.24359624498594917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2396892013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99581176,0.0006342304,0.00011755902,0.00041280224,0.00049523456,0.00022219963,0.00002847898,0.000026962876,0.0022507992],"genre_scores_gemma":[0.9980884,0.0000866993,0.00036325149,0.0006192616,0.00039739694,0.000018110313,0.00010037096,0.000038411585,0.00028809113],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987439,0.00017817205,0.00026161718,0.000425668,0.000119606906,0.00027103547],"domain_scores_gemma":[0.99903107,0.000027143637,0.00017730371,0.0003689475,0.00013161477,0.0002639154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017888796,0.00018162724,0.00021553155,0.000057790545,0.000053090236,0.000024505318,0.0001514907,0.0002884237,0.000015762325],"category_scores_gemma":[0.00005051736,0.00018426335,0.000053461095,0.000079019395,0.00013694724,0.0000058000464,0.00019428758,0.000106312385,0.000045266075],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002096818,0.00008359814,0.0010906798,0.000020907026,0.00001705934,0.00006759909,0.00006526464,0.0000064362207,0.98338693,0.00004199731,0.00746188,0.0075479555],"study_design_scores_gemma":[0.0014628266,0.00082500745,0.005493845,0.0000055199466,0.00005370837,0.00027293293,0.000061819126,0.00018724316,0.4466266,0.00005925106,0.5446999,0.00025133198],"about_ca_topic_score_codex":0.0000060259454,"about_ca_topic_score_gemma":0.0000068374366,"teacher_disagreement_score":0.537238,"about_ca_system_score_codex":0.00005300982,"about_ca_system_score_gemma":0.0002211993,"threshold_uncertainty_score":0.75140417},"labels":[],"label_agreement":null},{"id":"W2399161841","doi":"10.1093/neuonc/nov205.12","title":"ATNT-12PHASE I, TWO-STAGE, OPEN-LABEL, DOSE-ESCALATION STUDY OF BUPARLISIB (BKM120) IN COMBINATION WITH ADJUVANT TEMOZOLOMIDE (TMZ) AND WITH CONCOMITANT RADIATION THERAPY (RT) AND TMZ IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Concomitant; Internal medicine; Adjuvant; Temozolomide; Gastroenterology; Surgery; Oncology; Chemotherapy","score_opus":0.02916867244633596,"score_gpt":0.31367587327141927,"score_spread":0.2845072008250833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2399161841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99455136,0.00019532279,0.0000068149457,0.00052322546,0.000060058806,0.004485122,0.00001388504,0.000023462393,0.00014074362],"genre_scores_gemma":[0.99889743,0.00009766029,0.00023474367,0.00030515183,0.000015719124,0.00035113268,0.000052127954,0.000042259206,0.0000037623558],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978374,0.00039409884,0.0005193504,0.0005661721,0.00039496014,0.00028801782],"domain_scores_gemma":[0.99835247,0.0004599117,0.00042130853,0.0002968032,0.00025182767,0.00021767663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033920858,0.00030896664,0.0008119629,0.000389892,0.00005514926,0.000040831666,0.000098232544,0.0001142221,0.000006398022],"category_scores_gemma":[0.00010697864,0.00020993213,0.000010906813,0.00051871646,0.00014579127,0.00033351473,0.00006563076,0.00022242342,0.0000010701475],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019756652,0.015209669,0.93352187,0.000018469837,0.000093977644,0.00060346496,0.0025006225,0.00019026425,0.001274032,0.00004538202,0.0000631182,0.026722472],"study_design_scores_gemma":[0.22939502,0.07381443,0.693651,0.00008194028,0.00009899949,0.000026717913,0.0009524947,0.0006596588,0.000933924,0.000011246606,0.00020553076,0.00016901529],"about_ca_topic_score_codex":0.0009302584,"about_ca_topic_score_gemma":0.0059170304,"teacher_disagreement_score":0.23987085,"about_ca_system_score_codex":0.00032217303,"about_ca_system_score_gemma":0.000267507,"threshold_uncertainty_score":0.8560784},"labels":[],"label_agreement":null},{"id":"W2403179046","doi":"10.1093/neuonc/nov228.08","title":"PTPS-08HEMATOGENOUS DISSEMINATION OF MEDULLOBLASTOMA METASTASES TO THE LEPTOMENINGES","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency; Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Circulating tumor cell; Primary tumor; Medicine; Pathology; Bone marrow; Haematopoiesis; Cancer research; Cancer; Biology; Stem cell; Metastasis; Internal medicine","score_opus":0.03384460933201084,"score_gpt":0.34060870482053357,"score_spread":0.30676409548852274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2403179046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98124266,0.0004678549,0.000037006488,0.014738804,0.00032314693,0.00054881437,0.000020757712,0.00003886159,0.002582098],"genre_scores_gemma":[0.99825275,0.000026232723,0.00050991494,0.00091159804,0.000094876326,0.00014209951,0.0000145721615,0.000017600634,0.000030348145],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989669,0.00011994799,0.0002402166,0.0002057004,0.000266621,0.00020061467],"domain_scores_gemma":[0.9986467,0.0005667826,0.00011562591,0.00029325526,0.00017679816,0.00020086036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025792295,0.00012469877,0.0003546716,0.0001268715,0.000042830347,0.000006848689,0.00010602447,0.00006183526,0.00006423107],"category_scores_gemma":[0.0007410309,0.000077289325,0.000076400924,0.00024668983,0.000061598046,0.00002933377,0.00007096824,0.000085532774,0.000090761474],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007903647,0.0033943714,0.015998699,0.00007179115,0.00038177994,0.0009985392,0.008605835,0.000121345176,0.6547244,0.0014422813,0.17986572,0.13360487],"study_design_scores_gemma":[0.0021113271,0.007041708,0.0054858527,0.00006294939,0.0004935913,0.00073513045,0.002093338,0.000056163597,0.6121553,0.000074272226,0.36955628,0.00013409034],"about_ca_topic_score_codex":0.000026899897,"about_ca_topic_score_gemma":0.000060549337,"teacher_disagreement_score":0.18969058,"about_ca_system_score_codex":0.0001233485,"about_ca_system_score_gemma":0.00014258179,"threshold_uncertainty_score":0.31517673},"labels":[],"label_agreement":null},{"id":"W2404441765","doi":"10.1093/neuonc/nov223.09","title":"NCO-09THE EFFICACY OF THERAPEUTIC DISCOURSE ANALYSIS DURING BRAIN TUMOUR RESECTION IN AWAKE CRANIOTOMIES","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Anesthetic; Hemiparesis; Resection; Surgical team; Anesthesia; Surgery","score_opus":0.03625146002066268,"score_gpt":0.35142016589073366,"score_spread":0.31516870587007095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2404441765","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901275,0.00019143101,0.000010572515,0.00801354,0.00018308873,0.0004081023,0.0000046394807,0.000031085066,0.00103006],"genre_scores_gemma":[0.99929845,0.00004127228,0.000044351462,0.00038617678,0.00010495702,0.0000584622,0.000012462379,0.000019753958,0.00003412261],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99855584,0.00028617916,0.0003650649,0.00030724765,0.00022977205,0.0002559111],"domain_scores_gemma":[0.99882376,0.0005024104,0.00015268315,0.00030107406,0.00008227478,0.00013779038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030476734,0.00015200843,0.0005990781,0.0005627601,0.00003561087,0.000007922433,0.0000835397,0.00011629993,0.000041561478],"category_scores_gemma":[0.000322934,0.000118296586,0.00018412572,0.00078795565,0.00010198721,0.000050046187,0.000043716445,0.00019819208,0.000024723078],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094248203,0.0025169507,0.5573059,0.000034156667,0.0005996653,0.00071425724,0.0019815816,0.00073513645,0.42985523,0.000108005675,0.00050918123,0.004697462],"study_design_scores_gemma":[0.011236321,0.0017374915,0.9067427,0.00003182014,0.0011154832,0.00010101439,0.0010124972,0.0004382857,0.07472715,0.000096542855,0.0026345584,0.00012615454],"about_ca_topic_score_codex":0.00021262141,"about_ca_topic_score_gemma":0.00064853864,"teacher_disagreement_score":0.35512808,"about_ca_system_score_codex":0.00026182106,"about_ca_system_score_gemma":0.0001601598,"threshold_uncertainty_score":0.48239946},"labels":[],"label_agreement":null},{"id":"W2411936105","doi":"10.1093/neuonc/now110","title":"Medulloblastoma in adults: they're not just big kids","year":2016,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Medicine; Psychology; Pathology","score_opus":0.026978501158919418,"score_gpt":0.2803059266224309,"score_spread":0.2533274254635115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2411936105","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14514008,0.0014243476,0.0001079824,0.82500434,0.008149196,0.0014250457,0.0007450274,0.00016638794,0.017837603],"genre_scores_gemma":[0.12892266,0.0013912054,0.00013862735,0.8456757,0.0212136,0.0004112456,0.00047130487,0.0002917531,0.0014839016],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99584365,0.0006469247,0.00071249646,0.0013882826,0.00033459865,0.001074071],"domain_scores_gemma":[0.99799734,0.0003600838,0.00036358667,0.000971899,0.00018979122,0.00011730307],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0003331838,0.0006992615,0.0009161354,0.0002708826,0.00010437928,0.000020825524,0.0008499877,0.0026343123,0.00006707472],"category_scores_gemma":[0.00072607637,0.00058271753,0.00029719094,0.00013283467,0.0003668052,0.0000033687752,0.0006049643,0.00156243,0.00025022717],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002717433,0.00005039397,0.00019341007,0.00012102652,0.00009153966,0.0012501887,0.00020542453,0.0000022008817,0.3720028,0.0000052326604,0.6144631,0.0113429],"study_design_scores_gemma":[0.001590603,0.0014851455,0.00006506104,0.00014359648,0.00004727874,0.00010917035,0.00007896263,0.0000022522845,0.0581166,0.000021655113,0.9377456,0.0005941234],"about_ca_topic_score_codex":0.000056109824,"about_ca_topic_score_gemma":0.0006646366,"teacher_disagreement_score":0.32328242,"about_ca_system_score_codex":0.00018231821,"about_ca_system_score_gemma":0.00074917806,"threshold_uncertainty_score":0.9996624},"labels":[],"label_agreement":null},{"id":"W2412480588","doi":"10.1093/neuonc/nov234.23","title":"STEM-23PYRVINIUM TARGETS CD133 IN HUMAN GLIOBLASTOMA BRAIN TUMOR-INITIATING CELLS","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Advanced biosensing and bioanalysis techniques","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Glioblastoma; Brain tumor; Stem cell; Human brain; Neural stem cell; Neuroscience; Cancer research; Biology; Medicine; Pathology; Cell biology","score_opus":0.019348667823917125,"score_gpt":0.30357683739481583,"score_spread":0.2842281695708987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2412480588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993071,0.00016697666,0.0003886805,0.0008580528,0.00030087124,0.00025062182,0.000016785687,0.00010329466,0.0048436695],"genre_scores_gemma":[0.993929,0.00002494387,0.0020046313,0.0034340462,0.00035601621,0.000020466105,0.000040020455,0.000042498235,0.00014831962],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978441,0.00039541433,0.00047153232,0.00062963134,0.0001773972,0.00048192556],"domain_scores_gemma":[0.9989126,0.000078802615,0.0002503525,0.00042877236,0.00014380635,0.00018571886],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00052093173,0.00026781234,0.00039508866,0.00016232752,0.0000873267,0.00002244064,0.0002828226,0.0003045381,0.0000037074426],"category_scores_gemma":[0.00017872789,0.00026042486,0.00012125642,0.00024206737,0.00016097285,0.000008466139,0.00025046515,0.00031159603,0.000013736757],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011874856,0.0001408905,0.00064537476,0.000007798576,0.000016655506,0.00019180495,0.00006893044,0.000030503523,0.9859653,0.000031249718,0.009262214,0.003520541],"study_design_scores_gemma":[0.00076084695,0.0020018858,0.000057950812,0.000009979629,0.000014962455,0.00009028098,0.00023202861,0.00009291575,0.8677328,0.00012147944,0.12862581,0.0002590377],"about_ca_topic_score_codex":0.000025911886,"about_ca_topic_score_gemma":0.00031466124,"teacher_disagreement_score":0.1193636,"about_ca_system_score_codex":0.00010182428,"about_ca_system_score_gemma":0.00018354823,"threshold_uncertainty_score":0.9999848},"labels":[],"label_agreement":null},{"id":"W2413758964","doi":"10.1093/neuonc/nov236.10","title":"TMIC-10PLEIOTROPY OF TUMOR-ASSOCIATED MYELOID CELLS WITHIN HUMAN GLIOBLASTOMA","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cellular Mechanics and Interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Glioblastoma; Tumor cells; Myeloid cells; Myeloid; Myeloid leukemia; Cancer research; Medicine; Biology","score_opus":0.01749551330310746,"score_gpt":0.2763200366382071,"score_spread":0.25882452333509964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2413758964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940047,0.00009077576,0.00024354507,0.00017879979,0.0011522043,0.00018437146,0.000031859792,0.000024606883,0.004089103],"genre_scores_gemma":[0.9982814,0.000020869087,0.00025438794,0.0007042608,0.00021192498,0.00001715709,0.000073608215,0.000038944618,0.0003974121],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985686,0.00020362006,0.00041112216,0.0003741283,0.00016036922,0.00028219027],"domain_scores_gemma":[0.99883217,0.00003068233,0.00033958507,0.0003765958,0.00024564605,0.00017529867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027472852,0.00018231613,0.00029732243,0.00008351663,0.00007169003,0.000012849144,0.00026804092,0.00022922984,0.0000699815],"category_scores_gemma":[0.00022522775,0.0001867184,0.00013412569,0.00013261366,0.00006894768,0.0000053099675,0.00018510665,0.00023556035,0.00004291789],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014260893,0.0002865527,0.00008695826,0.0000052792575,0.000043852877,0.000031139964,0.00010773154,0.000065099135,0.9848821,0.00043844586,0.013737342,0.00017285845],"study_design_scores_gemma":[0.0009536307,0.003748679,0.000021844124,0.0000054312977,0.000028305116,0.00005990569,0.00015810411,0.00023451688,0.8472778,0.00014294172,0.14721936,0.0001494291],"about_ca_topic_score_codex":0.00006255408,"about_ca_topic_score_gemma":0.00029469782,"teacher_disagreement_score":0.13760428,"about_ca_system_score_codex":0.00008125148,"about_ca_system_score_gemma":0.00027374038,"threshold_uncertainty_score":0.7614156},"labels":[],"label_agreement":null},{"id":"W2415694895","doi":"10.1093/neuonc/nov228.29","title":"PTPS-29UBIQUITIN CARBOXYL TERMINAL HYDROLASE-L1 (UCH-L1) IS A TUMOR SUPPRESSOR IN ATYPICAL TERATOID RHABDOID TUMORS (ATRTs)","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Winnipeg; Children's Hospital Research Institute of Manitoba; Research Institute in Oncology and Hematology","funders":"","keywords":"Suppressor; Terminal (telecommunication); Cancer research; Hydrolase; Chemistry; Biology; Biochemistry; Enzyme; Computer science; Gene","score_opus":0.019535197296346785,"score_gpt":0.29014322143738575,"score_spread":0.27060802414103896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2415694895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99393857,0.0004728746,0.00008203803,0.0010844509,0.00056872686,0.0003283172,0.000055895372,0.00004621317,0.003422943],"genre_scores_gemma":[0.9932383,0.000038127724,0.000605372,0.0049249567,0.0007518315,0.00011490731,0.000079165344,0.00006482481,0.00018253917],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972993,0.00031955575,0.00058778113,0.00084624725,0.0002712535,0.00067587063],"domain_scores_gemma":[0.99869233,0.00006560409,0.0001874387,0.00058501255,0.00012497282,0.00034462562],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035697568,0.00036079527,0.00051630836,0.00011352862,0.00007217433,0.000037473776,0.0004360137,0.00036581524,0.00007709456],"category_scores_gemma":[0.00029534832,0.00035681587,0.00017012522,0.0001657,0.00020583693,0.000010510545,0.00029190362,0.00046661482,0.00007028759],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000991166,0.0002625968,0.0016563815,0.000032096694,0.000020612626,0.00055084296,0.00039462993,0.00015242137,0.9790806,0.000011425685,0.014052001,0.0027952073],"study_design_scores_gemma":[0.0039489567,0.0024613722,0.0005756466,0.000042560812,0.000042299504,0.0014357044,0.00026909617,0.0034433857,0.8003234,0.00016332632,0.18671246,0.0005817498],"about_ca_topic_score_codex":0.00010306713,"about_ca_topic_score_gemma":0.00014477228,"teacher_disagreement_score":0.17875718,"about_ca_system_score_codex":0.00016269297,"about_ca_system_score_gemma":0.00079275673,"threshold_uncertainty_score":0.99988836},"labels":[],"label_agreement":null},{"id":"W2417583025","doi":"10.1093/neuonc/now101","title":"Pediatric high-grade glioma: biologically and clinically in need of new thinking","year":2016,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":364,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; SickKids Foundation; Hospital for Sick Children","funders":"University of California, San Francisco; Cancer Research UK; Brain Tumour Charity; Rosetrees Trust; Deutsches Krebsforschungszentrum; National Brain Tumor Society","keywords":"Clinical trial; Glioma; Pace; Disease; Perspective (graphical); Bioinformatics; Medicine; Neuroscience; Biology; Internal medicine; Cancer research; Computer science","score_opus":0.06719057590261662,"score_gpt":0.3775193674760006,"score_spread":0.310328791573384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2417583025","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018715857,0.9773964,0.0000033191327,0.0014451399,0.0006074116,0.0013426129,0.00002713883,0.00005303568,0.00040907745],"genre_scores_gemma":[0.00208646,0.9958907,0.0007231888,0.00040516458,0.00069299364,0.00010171281,0.000036143592,0.00005186599,0.00001182225],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965127,0.0004919006,0.0015735057,0.0007554808,0.00022537823,0.0004410209],"domain_scores_gemma":[0.99474627,0.0035264713,0.00091009133,0.00045547241,0.000060910217,0.00030080715],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00048800363,0.00048225094,0.003585086,0.0006406057,0.00003327372,0.000010381751,0.00025785796,0.0010522704,0.000099707344],"category_scores_gemma":[0.0009941852,0.00028086753,0.0004537217,0.00056529546,0.00013943785,0.00003114887,0.0002561868,0.00059719064,0.000056446377],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000090245914,0.000892073,0.0059354613,0.0023292818,0.0001565862,0.0025113088,0.000046628287,5.6036175e-8,0.0002658635,0.00045377077,0.0018624438,0.9854563],"study_design_scores_gemma":[0.0060469243,0.00469273,0.0017761977,0.0023898494,0.002014019,0.0007068789,0.000007426586,3.1326556e-7,0.000020804793,0.0006056662,0.98144394,0.00029526695],"about_ca_topic_score_codex":0.00004882546,"about_ca_topic_score_gemma":0.000013613358,"teacher_disagreement_score":0.985161,"about_ca_system_score_codex":0.00018876648,"about_ca_system_score_gemma":0.0009940033,"threshold_uncertainty_score":0.99996436},"labels":[],"label_agreement":null},{"id":"W2419000433","doi":"10.1093/neuonc/nov234.20","title":"STEM-20MAPPING DYNAMICS OF CELL DIVISION AND GENE EXPRESSION AT THE SINGLE CELL LEVEL TO UNDERSTAND GLIOMA CELL STATES","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Glioma; Epigenetics; Biology; Cell growth; Cell; Cell division; Cancer research; Stem cell; Cancer cell; Cancer stem cell; Cancer; Cell biology; Gene; Genetics","score_opus":0.06289953077619981,"score_gpt":0.28772796588757416,"score_spread":0.22482843511137435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2419000433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99341655,0.00087481976,0.00049364055,0.0020918387,0.00027818332,0.0006009487,0.000058485868,0.000024172208,0.002161349],"genre_scores_gemma":[0.99834275,0.00010411933,0.00080815307,0.00046249514,0.00003730667,0.000017068265,0.000037318172,0.00003211823,0.00015865386],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99857396,0.00015524485,0.00032146715,0.0003742254,0.0002783653,0.00029673154],"domain_scores_gemma":[0.99854064,0.0005103376,0.00018827472,0.0003527075,0.0001192291,0.0002888085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020143899,0.00020079246,0.000395238,0.0001300304,0.00010794352,0.000016478874,0.00010226479,0.00013156523,0.000021519803],"category_scores_gemma":[0.00002662963,0.00013401381,0.00006143098,0.0001798292,0.000100569814,0.000042550644,0.00029459884,0.00012370355,0.000021004993],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024544372,0.0009649878,0.004309757,0.0000697692,0.000011017597,0.0002196919,0.0018863535,0.00022063706,0.9847807,0.0000066918597,0.0048573012,0.002427642],"study_design_scores_gemma":[0.00422535,0.0035965582,0.00090014946,0.00003974046,0.00010327876,0.00005557099,0.0028839386,0.00056021527,0.9817767,0.00006669857,0.0056685787,0.00012318447],"about_ca_topic_score_codex":0.000042301403,"about_ca_topic_score_gemma":0.00009806551,"teacher_disagreement_score":0.004926205,"about_ca_system_score_codex":0.00048334844,"about_ca_system_score_gemma":0.00010680857,"threshold_uncertainty_score":0.54649246},"labels":[],"label_agreement":null},{"id":"W2419781531","doi":"10.1093/neuonc/now076.83","title":"MB-87INTEGRATED GENOMICS REVEALS NOVEL SUBTYPES OF MEDULLOBLASTOMA SUBGROUPS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Viral Infectious Diseases and Gene Expression in Insects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Genomics; Biology; Computational biology; Genetics; Genome; Gene","score_opus":0.0128714110155434,"score_gpt":0.2700454518134656,"score_spread":0.2571740407979222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2419781531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99385554,0.00013252268,0.0009336447,0.0004914283,0.0007239048,0.00020188703,0.00010947123,0.000027003885,0.003524615],"genre_scores_gemma":[0.9973396,0.00030219826,0.00017743836,0.0014575471,0.00030900034,0.000034979268,0.000022400402,0.000035876543,0.00032092578],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99867475,0.00012714317,0.00034013914,0.00044339753,0.00011690657,0.0002976868],"domain_scores_gemma":[0.99891907,0.000121415,0.00021937124,0.00044284025,0.00015216209,0.0001451385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011822281,0.00020051398,0.00027565812,0.000071335875,0.00006485026,0.0000071593786,0.00025272157,0.00028138916,0.00011965065],"category_scores_gemma":[0.00035660953,0.0001386093,0.00015807668,0.00009420225,0.00017385105,0.000004186391,0.00012623817,0.00009738599,0.000053137952],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056741125,0.0002695874,0.0019594303,0.000009905109,0.000035275276,0.000008716577,0.000017177905,0.00001878139,0.97487324,0.0006005679,0.017557187,0.004082729],"study_design_scores_gemma":[0.0011438098,0.002747409,0.001140878,0.000019650728,0.000019102306,0.00004412118,0.000017787175,0.000008107428,0.795283,0.00018349,0.19923101,0.00016164087],"about_ca_topic_score_codex":0.000015337906,"about_ca_topic_score_gemma":0.00003070097,"teacher_disagreement_score":0.18167382,"about_ca_system_score_codex":0.000050755123,"about_ca_system_score_gemma":0.00019025488,"threshold_uncertainty_score":0.56523234},"labels":[],"label_agreement":null},{"id":"W2420161469","doi":"10.1093/neuonc/now067.28","title":"PNR-33MOLECULAR RE-EVALUATION OF INSTITUTIONALLY DIAGNOSED CNS-PNETS: CLINICAL CONSEQUENCES OF CONFINED DIAGNOSTIC GROUPS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cardiac Imaging and Diagnostics","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Psychology; Medicine","score_opus":0.06176851200249761,"score_gpt":0.3793030858820122,"score_spread":0.3175345738795146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2420161469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9797016,0.0009519795,0.0010522103,0.0076279445,0.0016458221,0.00090408145,0.00008051718,0.000056797246,0.007979097],"genre_scores_gemma":[0.9962895,0.00079484197,0.0005068673,0.0019780572,0.00028368735,0.0000803343,0.000036907295,0.00001988571,0.000009938338],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9967457,0.00085247133,0.0010200243,0.0004126192,0.00069961906,0.0002695617],"domain_scores_gemma":[0.98356265,0.014266887,0.000479346,0.00046018654,0.0010449507,0.00018599909],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0018940719,0.00018934708,0.00081671024,0.00016876688,0.00004105134,0.000004688391,0.00014641597,0.0002486608,0.00025060817],"category_scores_gemma":[0.059579477,0.00014199012,0.0002712986,0.0002069317,0.0014835101,0.0000635721,0.00007232693,0.00021982982,0.000047593832],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083764206,0.0017123002,0.42543417,0.00013747577,0.00032687883,0.0009557817,0.00022779357,0.00009043368,0.46837154,0.008192201,0.013703685,0.080010094],"study_design_scores_gemma":[0.036117937,0.00870745,0.6938464,0.0010369163,0.003853596,0.00067172333,0.00026441173,0.0002608018,0.14182954,0.0042860806,0.10850109,0.0006240667],"about_ca_topic_score_codex":0.000056662495,"about_ca_topic_score_gemma":0.000026653313,"teacher_disagreement_score":0.326542,"about_ca_system_score_codex":0.00013643203,"about_ca_system_score_gemma":0.0021115753,"threshold_uncertainty_score":0.9483421},"labels":[],"label_agreement":null},{"id":"W2420294546","doi":"10.1093/neuonc/now073.34","title":"HG-37SECOND RE-IRRADIATION FOR DIPG PROGRESSION, RE-CONSIDERING “OLD STRATEGIES” WITH NEW APPROACHES","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"Medicine; Tumor progression; Glioma; Radiation therapy; Oncology; Internal medicine; Cancer research; Cancer","score_opus":0.07313755008810024,"score_gpt":0.32063548650890306,"score_spread":0.2474979364208028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2420294546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94992477,0.00044359476,0.0004878588,0.039937507,0.00038867941,0.0020554687,0.000017473403,0.00015455877,0.0065901205],"genre_scores_gemma":[0.994959,0.000043873944,0.003012225,0.0010875014,0.0003476838,0.00039170065,0.000024643541,0.000044598342,0.00008879078],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987198,0.00005323371,0.00027822083,0.00045977577,0.00014853873,0.00034042692],"domain_scores_gemma":[0.99862856,0.0005850595,0.0001813356,0.00032557055,0.000054228603,0.00022524585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012472548,0.0002074896,0.00039759374,0.000105920284,0.00008462104,0.000027427053,0.0000682273,0.00016506793,0.00014295294],"category_scores_gemma":[0.00014357218,0.000119700264,0.0000774444,0.00010756257,0.00008301047,0.00015189845,0.000029262203,0.00010480129,0.000024504792],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029358154,0.0023012953,0.112143226,0.0003106953,0.00062110974,0.0009279931,0.0017880704,0.00011390063,0.3133324,0.013901215,0.05886867,0.4927556],"study_design_scores_gemma":[0.043439705,0.023616634,0.08018462,0.00059511396,0.0010962832,0.00080454175,0.0018490386,0.00042516497,0.21794336,0.0051488294,0.62404054,0.00085619144],"about_ca_topic_score_codex":0.000020484364,"about_ca_topic_score_gemma":0.00016412581,"teacher_disagreement_score":0.56517184,"about_ca_system_score_codex":0.0001682103,"about_ca_system_score_gemma":0.0005318157,"threshold_uncertainty_score":0.4881235},"labels":[],"label_agreement":null},{"id":"W2420507009","doi":"10.1093/neuonc/now067.24","title":"PNR-28PRIMARY DISSEMINATED LEPTOMENINGEAL NEUROECTODERMAL TUMORS IN CHILDREN: A CASE SERIES AND REPORT OF A LONG TERM SURVIVOR","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"","keywords":"Series (stratigraphy); Term (time); Medicine; Pediatrics; Physics; Geology","score_opus":0.012616267517200118,"score_gpt":0.2910656890369929,"score_spread":0.2784494215197928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2420507009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961924,0.000318328,0.0000024185051,0.002429434,0.0001175784,0.0005118286,0.000018204439,0.00004482287,0.0003650005],"genre_scores_gemma":[0.99924403,0.0001702758,0.00008554373,0.00026089879,0.000057350815,0.000086030625,0.000018970195,0.000031074815,0.0000458468],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99843913,0.00015278495,0.0004995074,0.00044636938,0.00014277271,0.00031943014],"domain_scores_gemma":[0.9988358,0.00044101058,0.00020191201,0.00031077178,0.00005355679,0.00015693568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015805353,0.00020871901,0.00061457016,0.0001968614,0.000041731586,0.000006177157,0.000054957556,0.00010916097,0.00004800079],"category_scores_gemma":[0.00023531061,0.0001432914,0.00007528558,0.00016902543,0.00022595089,0.00009683629,0.00010988446,0.00015746926,0.0000035981623],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003671581,0.0005719355,0.74255925,0.000025356501,0.00004323599,0.17921525,0.00013256882,1.1059315e-7,0.04327035,0.000007568059,0.0000992531,0.033707924],"study_design_scores_gemma":[0.0024722833,0.001434226,0.7090115,0.00006291634,0.00008543267,0.2672565,0.000026044749,0.0000015995238,0.019413253,0.0000042267184,0.00014243003,0.00008957854],"about_ca_topic_score_codex":0.00015664187,"about_ca_topic_score_gemma":0.00022325962,"teacher_disagreement_score":0.088041246,"about_ca_system_score_codex":0.000108592576,"about_ca_system_score_gemma":0.00015464309,"threshold_uncertainty_score":0.5843254},"labels":[],"label_agreement":null},{"id":"W2420857723","doi":"10.1093/neuonc/nox107","title":"Contemporary survival endpoints: an International Diffuse Intrinsic Pontine Glioma Registry study","year":2017,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":158,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Hospital for Sick Children; Children's National Hospital; Seattle Children's Research Institute; St. Jude Children's Research Hospital; Morgan Adams Foundation; Children's Hospital Colorado; National Cancer Institute; Cincinnati Children's Hospital Medical Center; Texas Children's Hospital; Children's Hospital of Philadelphia","keywords":"Medicine; Glioma; Cancer research","score_opus":0.054751013226552014,"score_gpt":0.3403483265277993,"score_spread":0.28559731330124727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2420857723","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5581517,0.00015847616,0.0000012039609,0.41293374,0.0066698645,0.0015949706,0.000198096,0.00017514512,0.0201168],"genre_scores_gemma":[0.78964156,0.00008860602,0.00006543956,0.19415385,0.012612064,0.0004582455,0.0020906257,0.00020255215,0.00068708987],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99586076,0.000612346,0.00083481707,0.0013144678,0.0008095241,0.0005680749],"domain_scores_gemma":[0.99568534,0.0006098868,0.00095815933,0.002150907,0.00031593395,0.00027979392],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036200864,0.0006966681,0.0016063226,0.0005408669,0.00019122909,0.00014309416,0.0009425639,0.0010816883,0.00033566618],"category_scores_gemma":[0.0007592566,0.00059670606,0.00033559647,0.00010963565,0.0002695177,0.00023207365,0.00041878177,0.0022305422,0.00017759201],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061404926,0.006229391,0.047344606,0.000048578397,0.0008510647,0.17688133,0.00017962542,8.5131866e-8,0.004044311,0.000009518685,0.7589389,0.0048585427],"study_design_scores_gemma":[0.015030347,0.0064624124,0.023667308,0.000077070625,0.00051447976,0.0021102144,0.00013144533,0.0000044734757,0.00064136187,0.000020135447,0.95094097,0.00039977478],"about_ca_topic_score_codex":0.00032339207,"about_ca_topic_score_gemma":0.000082365026,"teacher_disagreement_score":0.23148982,"about_ca_system_score_codex":0.00048058014,"about_ca_system_score_gemma":0.000663867,"threshold_uncertainty_score":0.99964845},"labels":[],"label_agreement":null},{"id":"W2421016690","doi":"10.1093/neuonc/now076.56","title":"MB-59IMAGING OF METASTATIC MEDULLOBLASTOMA IN THE MOLECULAR ERA","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Medicine; Cancer research; Oncology","score_opus":0.018694153933512134,"score_gpt":0.30759999810666017,"score_spread":0.288905844173148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2421016690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96757007,0.00032238037,0.00006571362,0.028634196,0.00012265317,0.00037145382,0.0000047711674,0.000014744946,0.0028940188],"genre_scores_gemma":[0.9961993,0.000056191762,0.00044331714,0.0031675487,0.000024200765,0.00008893959,0.0000017391644,0.000014147787,0.000004621797],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988908,0.00023639709,0.00026000055,0.00020164027,0.00019004065,0.0002210794],"domain_scores_gemma":[0.998739,0.0007718552,0.00009303892,0.00029319467,0.000044834916,0.0000580709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021818088,0.00011260532,0.00033140034,0.0001337709,0.000018504561,0.000003432653,0.00011172702,0.000038488084,0.0001044152],"category_scores_gemma":[0.00026537114,0.00005629843,0.00009107231,0.00018678395,0.000106230844,0.000030856994,0.000037326794,0.00010909565,0.000040973584],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009888342,0.0008935924,0.015353289,0.000022676157,0.00006934549,0.00305964,0.00041556216,0.0000036890333,0.91924405,0.0023562666,0.0011374089,0.057345577],"study_design_scores_gemma":[0.018457048,0.0057160226,0.07660096,0.00022834545,0.00077745755,0.0018458508,0.0006670461,0.00011441134,0.77256006,0.0021117942,0.12064867,0.00027231954],"about_ca_topic_score_codex":0.000027641448,"about_ca_topic_score_gemma":0.000028077728,"teacher_disagreement_score":0.14668399,"about_ca_system_score_codex":0.00007998975,"about_ca_system_score_gemma":0.00011378117,"threshold_uncertainty_score":0.22957835},"labels":[],"label_agreement":null},{"id":"W2422274351","doi":"10.1093/neuonc/now076.20","title":"MB-22ACTIVATED Wnt SIGNALING FOR THE THERAPEUTIC TARGETING OF TREATMENT-REFRACTORY MEDULLOBLASTOMA STEM CELLS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medulloblastoma; Wnt signaling pathway; Refractory (planetary science); Stem cell; Cancer research; Medicine; Biology; Signal transduction; Cell biology","score_opus":0.024150893038898922,"score_gpt":0.2769191817095702,"score_spread":0.25276828867067125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2422274351","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99547684,0.00071740383,0.002225093,0.00049137225,0.0005412312,0.00037483408,0.00003259573,0.000013812167,0.00012679891],"genre_scores_gemma":[0.998283,0.0005619723,0.00007645062,0.0004706323,0.00026279018,0.00008346229,0.000007634491,0.000027716862,0.000226284],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998892,0.00014988956,0.00028113442,0.00032554034,0.000068551366,0.00028286816],"domain_scores_gemma":[0.9988627,0.0004861385,0.0002109813,0.0002640876,0.0001248773,0.00005125057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015349606,0.00017608887,0.00022902805,0.000035123692,0.000086579494,0.000007127055,0.00024117826,0.00018608719,0.00003758817],"category_scores_gemma":[0.00003597773,0.00009726433,0.000165618,0.000046457408,0.00011807876,0.0000056474823,0.00005463913,0.00005873239,0.000012778017],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045791332,0.000092658476,0.00015917353,0.0000064067376,0.00013646024,0.0000026493271,0.00008508601,0.00004521815,0.9369964,0.000011834803,0.00075241143,0.061253775],"study_design_scores_gemma":[0.0008772951,0.004019746,0.000028887005,0.000008547687,0.00005122236,0.0000071680925,0.00016741843,0.00004146124,0.85824656,0.000019829324,0.13643171,0.0001001655],"about_ca_topic_score_codex":0.000013938286,"about_ca_topic_score_gemma":0.000012854981,"teacher_disagreement_score":0.1356793,"about_ca_system_score_codex":0.00006829691,"about_ca_system_score_gemma":0.00020007657,"threshold_uncertainty_score":0.39663243},"labels":[],"label_agreement":null},{"id":"W2422294165","doi":"10.1093/neuonc/now067.33","title":"PNR-39DISTINCT GENE FUSIONS SEGREGATE SUB-CLASSES OF CNS-PNETs","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Children's Hospital of Eastern Ontario; Hospital for Sick Children","funders":"","keywords":"Computational biology; Gene; Biology; Evolutionary biology; Genetics; Neuroscience; Computer science","score_opus":0.019205406672762732,"score_gpt":0.2719143811960665,"score_spread":0.25270897452330376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2422294165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9846073,0.0014292713,0.00021714416,0.00270955,0.0024706165,0.00026393522,0.00010232121,0.000116446165,0.008083432],"genre_scores_gemma":[0.99536645,0.0007718404,0.000068784335,0.0007300163,0.000059990845,0.000031727188,0.00002551226,0.000033915065,0.0029117614],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975713,0.00084583694,0.0005578335,0.0004144609,0.000046642188,0.00056391914],"domain_scores_gemma":[0.9975209,0.0014904845,0.00028244514,0.0004961288,0.00016388632,0.000046143105],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00025789544,0.0002622393,0.0005782516,0.00020802647,0.00015504063,0.000005431897,0.00041008097,0.0004436388,0.0022050142],"category_scores_gemma":[0.0007259659,0.00017656226,0.00018443842,0.00014358392,0.0006569219,0.000081996695,0.00027639215,0.00030213266,0.0017586086],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010596237,0.00023826178,0.00064448983,0.000009582915,0.000096424716,0.000049636168,0.0001270439,3.1467061e-7,0.9424747,0.00061470614,0.015244835,0.039440334],"study_design_scores_gemma":[0.0013827786,0.0012118354,0.001966753,0.00001943609,0.00003494318,0.0003566068,0.000037976286,4.6056496e-7,0.61263365,0.000056623474,0.38217252,0.00012641471],"about_ca_topic_score_codex":0.00004214886,"about_ca_topic_score_gemma":0.00005873519,"teacher_disagreement_score":0.3669277,"about_ca_system_score_codex":0.00009466359,"about_ca_system_score_gemma":0.00031949763,"threshold_uncertainty_score":0.9990186},"labels":[],"label_agreement":null},{"id":"W2422549628","doi":"10.1093/neuonc/now081.41","title":"QOS-41NEURAL NETWORK DISTURBANCES IN CHILDREN TREATED FOR BRAIN TUMOURS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Tumor Detection and Classification","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; Hospital for Sick Children; McMaster University; University of Toronto","funders":"","keywords":"Neuroscience; Computer science; Medicine; Psychology","score_opus":0.03004026631933782,"score_gpt":0.2932533753929637,"score_spread":0.2632131090736259,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2422549628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9768838,0.000021917289,0.00042180475,0.018661857,0.0010742807,0.00078684784,0.000028312703,0.00020192402,0.0019192197],"genre_scores_gemma":[0.99352634,0.000029609439,0.000044348235,0.005161213,0.0004988843,0.00022502085,0.0000040097893,0.000028554095,0.00048203478],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980162,0.00046267628,0.0003171951,0.00060721155,0.00012672173,0.0004700078],"domain_scores_gemma":[0.99770343,0.0017470208,0.00018014257,0.00024774353,0.00002416783,0.000097507094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024247423,0.00016923185,0.00024768102,0.00009942723,0.0001452773,0.000024256253,0.00028668763,0.00011970149,0.000056901932],"category_scores_gemma":[0.0010491125,0.00012375867,0.000083056635,0.00038906003,0.00020744254,0.00014812117,0.000040838448,0.00016497246,0.000067319204],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026532545,0.000120568824,0.04636745,0.000002757194,0.000002239101,0.000014975942,0.00004166177,0.000021526603,0.8961724,0.0020242801,0.017396934,0.037569877],"study_design_scores_gemma":[0.005603402,0.0018509713,0.39101672,0.000024734369,0.00002137296,0.00040862587,0.000030000476,0.00065957237,0.39271757,0.0023646075,0.20479953,0.0005028845],"about_ca_topic_score_codex":0.000010302638,"about_ca_topic_score_gemma":0.00006187287,"teacher_disagreement_score":0.5034548,"about_ca_system_score_codex":0.00014919079,"about_ca_system_score_gemma":0.00006603853,"threshold_uncertainty_score":0.5046732},"labels":[],"label_agreement":null},{"id":"W2423210002","doi":"10.1093/neuonc/now076.51","title":"MB-53hTERT EXPRESSION AND REGULATION IN PEDIATRIC MEDULLOBLASTOMA (MB)","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Expression (computer science); Internal medicine; Biology; Cancer research; Medicine; Computer science; Programming language","score_opus":0.0175855002619027,"score_gpt":0.2892958481699219,"score_spread":0.2717103479080192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2423210002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99102277,0.00045296666,0.000020291527,0.006586754,0.0002413885,0.00030689736,0.000002196941,0.000039669532,0.0013270836],"genre_scores_gemma":[0.99771476,0.0008611905,0.00027716963,0.0007582848,0.00023128976,0.000079270074,0.0000035404594,0.000016962756,0.000057561403],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990214,0.00011008116,0.0002256016,0.00030510916,0.00013143914,0.00020636668],"domain_scores_gemma":[0.99909306,0.0005101187,0.000057658017,0.00019166515,0.000030147768,0.00011736709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010097217,0.00011939861,0.00026199163,0.00017348089,0.000031513177,0.000004500706,0.00003913719,0.00013921771,0.0001314233],"category_scores_gemma":[0.00015242767,0.000074662355,0.000039451876,0.00011499377,0.00004296116,0.00006406144,0.000056375557,0.00008374863,0.000060009243],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025841087,0.00044928337,0.664321,0.000017217431,0.000005937306,0.00037399333,0.00009600571,3.789079e-7,0.2535741,0.00006199948,0.003125099,0.07771658],"study_design_scores_gemma":[0.0054926374,0.0011446379,0.9200298,0.00005181395,0.00006760301,0.0002522496,0.000016261241,0.00001928266,0.04156577,0.00017142676,0.031095013,0.00009351096],"about_ca_topic_score_codex":0.000009404878,"about_ca_topic_score_gemma":0.000039025294,"teacher_disagreement_score":0.2557088,"about_ca_system_score_codex":0.00012486355,"about_ca_system_score_gemma":0.00007883472,"threshold_uncertainty_score":0.30446425},"labels":[],"label_agreement":null},{"id":"W2423401654","doi":"10.1093/neuonc/now070.37","title":"EPN-38RELAPSE PATTERNS IN PEDIATRIC INTRACRANIAL EPENDYMOMA: A CANADIAN EXPERIENCE","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; Queen's University; Centre Hospitalier Universitaire Sainte-Justine; McMaster University; BC Children's Hospital; Children's Hospital of Western Ontario; Children's Hospital of Eastern Ontario; McGill University; Alberta Children's Hospital; Stollery Children's Hospital; Hospital for Sick Children; Vancouver General Hospital","funders":"","keywords":"Ependymoma; Medicine; Radiology","score_opus":0.016705701052413646,"score_gpt":0.2834924554221071,"score_spread":0.26678675436969346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2423401654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847507,0.00010306206,0.00000828032,0.012000613,0.0006945248,0.00040678994,0.000025060628,0.00003333468,0.001977658],"genre_scores_gemma":[0.9970013,0.00027644375,0.00006676056,0.0020215355,0.00037695005,0.00020573763,0.0000053398185,0.000024852206,0.000021109352],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99846995,0.00009842808,0.00030540413,0.00041662474,0.00015798367,0.00055162556],"domain_scores_gemma":[0.99878556,0.0003286644,0.00007069391,0.0002925122,0.000044866185,0.0004776987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000094540694,0.00017826822,0.00035041905,0.00036759963,0.00005144122,0.00000870579,0.00012384876,0.00018897932,0.0006763581],"category_scores_gemma":[0.00024175202,0.00012322466,0.000072757306,0.00023573542,0.000052357445,0.00007421672,0.00004210627,0.0001749809,0.0002771306],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009891255,0.0005498655,0.8943272,0.000011433824,0.000011279799,0.023166956,0.0006433297,5.0056906e-7,0.011122524,0.00009164229,0.0014397517,0.06853659],"study_design_scores_gemma":[0.009810354,0.0019165413,0.9304781,0.000037448546,0.00010887753,0.0021124156,0.00014585206,0.000018954908,0.0056241388,0.000065783126,0.049424466,0.00025708784],"about_ca_topic_score_codex":0.015790958,"about_ca_topic_score_gemma":0.12011156,"teacher_disagreement_score":0.10432061,"about_ca_system_score_codex":0.0006569661,"about_ca_system_score_gemma":0.0006391384,"threshold_uncertainty_score":0.99076295},"labels":[],"label_agreement":null},{"id":"W2423512374","doi":"10.1093/neuonc/now066.02","title":"CMS-02MRI AND SURGICAL PARAMETERS TO DETERMINE THE RISK OF A CEREBELLAR MUTISM","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cerebrospinal fluid and hydrocephalus","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Psychology","score_opus":0.028018140841541722,"score_gpt":0.2829596496953843,"score_spread":0.2549415088538426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2423512374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99203354,0.000050981616,0.00006566149,0.004902736,0.00043109828,0.00032962093,0.000031434643,0.00003925547,0.0021156752],"genre_scores_gemma":[0.99701715,0.00057580695,0.0000989123,0.0020522724,0.000086761975,0.000022380871,1.5481943e-7,0.000020082723,0.00012645309],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99812436,0.00045553464,0.00031442303,0.00050836,0.00021546302,0.00038187363],"domain_scores_gemma":[0.99618566,0.0030904913,0.0001351352,0.00037208392,0.00002658393,0.00019002761],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026799986,0.00018208315,0.00035259972,0.000082172664,0.0001390441,0.000016746824,0.00034935423,0.00011217229,0.00009159644],"category_scores_gemma":[0.0012218689,0.00009367015,0.00009638772,0.00021185016,0.00044646897,0.000068040594,0.00026221736,0.00018887343,0.00009600576],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022757042,0.00007549772,0.0029429365,0.0000067018373,0.000005248859,0.00019940971,0.0002197096,0.0000064751525,0.9314548,0.00079120405,0.00071911805,0.06335136],"study_design_scores_gemma":[0.0025349369,0.0038688758,0.007160815,0.000023980474,0.000080994636,0.0015482022,0.000030030766,0.00035804167,0.5977286,0.001194092,0.38517323,0.00029820844],"about_ca_topic_score_codex":0.000057083304,"about_ca_topic_score_gemma":0.000044314795,"teacher_disagreement_score":0.38445413,"about_ca_system_score_codex":0.000042721913,"about_ca_system_score_gemma":0.00006498053,"threshold_uncertainty_score":0.38197577},"labels":[],"label_agreement":null},{"id":"W2424325921","doi":"10.1093/neuonc/now073.102","title":"HG-106A NOVEL TOOL TO PREDICT THE SURVIVAL OF DIFFUSE INTRINSIC PONTINE GLIOMA PATIENTS: EXTERNAL VALIDATION OF THE SURVIVAL PREDICTION MODEL USING THE INTERNATIONAL DIPG REGISTRY","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Glioma; Medicine; Overall survival; Oncology; Internal medicine; Cancer research","score_opus":0.05479011071907322,"score_gpt":0.31575292182284154,"score_spread":0.2609628111037683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2424325921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97196823,0.000004991255,0.013880248,0.010078884,0.0026604678,0.00079664675,0.000084475476,0.000027880285,0.00049817935],"genre_scores_gemma":[0.9981593,0.000015928814,0.00028458762,0.0003172975,0.00090072764,0.0000065485806,0.000012707957,0.00002100518,0.00028188498],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980647,0.00018604865,0.0006393844,0.00024955662,0.00067932764,0.00018098803],"domain_scores_gemma":[0.9979867,0.0005972988,0.0005403348,0.00049406517,0.00033570215,0.000045899713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005963739,0.00015288341,0.0003035984,0.000110239125,0.00010273181,0.000015585825,0.00039539227,0.0000986266,0.00004475138],"category_scores_gemma":[0.0014434616,0.00006631336,0.00017298065,0.0002585271,0.0001676036,0.00013854822,0.0003479756,0.00014398187,0.0000030895458],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014519515,0.00014424822,0.4981991,0.00002125352,0.00012737645,0.000002460225,0.00025077804,0.0015399755,0.48711,0.0011146613,0.0005562157,0.0094819935],"study_design_scores_gemma":[0.014474593,0.0011922566,0.9021335,0.00019542727,0.0006585084,0.00005112291,0.00024480015,0.015098278,0.0442075,0.00042476653,0.02106568,0.00025356066],"about_ca_topic_score_codex":0.000031890457,"about_ca_topic_score_gemma":0.000012535168,"teacher_disagreement_score":0.44290248,"about_ca_system_score_codex":0.00015881994,"about_ca_system_score_gemma":0.0001347932,"threshold_uncertainty_score":0.27041805},"labels":[],"label_agreement":null},{"id":"W2424472415","doi":"10.1093/neuonc/now083.09","title":"RA-10SUBTLE FINDINGS ON SPINAL MRIs IN CHILDREN NEWLY DIAGNOSED WITH MEDULLOBLASTOMA","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Medicine; Radiology; Pathology","score_opus":0.011910673217263412,"score_gpt":0.2733677644108358,"score_spread":0.2614570911935724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2424472415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98552775,0.000072386225,0.0000060305433,0.011285555,0.00016314135,0.0006751434,0.000011829798,0.000066474175,0.002191682],"genre_scores_gemma":[0.9966724,0.00011269864,0.00017098294,0.0026017705,0.00016299513,0.00019270273,0.000008569202,0.000040732633,0.000037174377],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984277,0.00009743082,0.00026458973,0.00050416373,0.00025370365,0.00045245068],"domain_scores_gemma":[0.99889964,0.00040753916,0.00009064608,0.00033954968,0.00004268838,0.00021991467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000105901614,0.00024626392,0.00048185655,0.0002713268,0.00005109818,0.000009497458,0.000117716845,0.00016646301,0.00027873128],"category_scores_gemma":[0.00018040734,0.00014398544,0.000084751926,0.00024749804,0.000119605014,0.000057599103,0.000046301204,0.00022678742,0.0003442225],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015950511,0.0018500534,0.82821584,0.000008252787,0.00009423687,0.0022527196,0.000113359136,0.0000031268403,0.07848719,0.00026321775,0.0061048903,0.081012085],"study_design_scores_gemma":[0.019191908,0.014829116,0.8952313,0.00018625183,0.00011131227,0.0006366115,0.0000281598,0.000003112352,0.047954362,0.000034134726,0.021609379,0.00018433762],"about_ca_topic_score_codex":0.00011505209,"about_ca_topic_score_gemma":0.00022255817,"teacher_disagreement_score":0.08082775,"about_ca_system_score_codex":0.00035169633,"about_ca_system_score_gemma":0.00020795462,"threshold_uncertainty_score":0.5871556},"labels":[],"label_agreement":null},{"id":"W2425583840","doi":"10.1093/neuonc/now075.68","title":"LG-68THE GENETIC AND CLINICAL LANDSCAPE IN PEDIATRIC LOW GRADE GLIOMA; PRELIMINARY RESULTS FROM PLGG TASKFORCE","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Glioma; Medicine; Oncology; Geography; Internal medicine; Cancer research","score_opus":0.02606347067942976,"score_gpt":0.31517520268498284,"score_spread":0.28911173200555307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2425583840","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896078,0.0010525769,0.0000041438866,0.007596064,0.0005141382,0.00051999016,0.00007186112,0.0000500323,0.00058340287],"genre_scores_gemma":[0.9950404,0.0030029314,0.00032157762,0.0007937259,0.00069766643,0.000060323135,0.000027933174,0.000031688905,0.00002371037],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99780303,0.00029196817,0.00067953597,0.0006670297,0.00018340324,0.00037502506],"domain_scores_gemma":[0.99612963,0.0029354778,0.0001878733,0.00043300964,0.00003923021,0.00027474854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022961285,0.00021702414,0.0005528855,0.00020976261,0.000040981802,0.000009490246,0.00011705627,0.00030992052,0.000059973416],"category_scores_gemma":[0.0007093933,0.00013881206,0.00010917907,0.00021968389,0.00011503099,0.000043505177,0.00012652171,0.00023396952,0.0001100188],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032881654,0.0023383265,0.9053359,0.00002325613,0.00006936154,0.0069725504,0.0002241703,0.00000398768,0.015780289,0.000018374312,0.012270543,0.053675063],"study_design_scores_gemma":[0.022767533,0.006627111,0.9582302,0.00005140999,0.00036234624,0.0003157764,0.000036683014,0.0001461995,0.0022599492,0.00014721,0.008881179,0.00017441541],"about_ca_topic_score_codex":0.00005918096,"about_ca_topic_score_gemma":0.000091974194,"teacher_disagreement_score":0.053500645,"about_ca_system_score_codex":0.000076591234,"about_ca_system_score_gemma":0.00015280252,"threshold_uncertainty_score":0.5660592},"labels":[],"label_agreement":null},{"id":"W2426916527","doi":"10.1093/neuonc/now076.42","title":"MB-44SUBGROUP-SPECIFIC QUANTITATIVE PROTEOMIC ANALYSIS OF MEDULLOBLASTOMA","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Advanced Proteomics Techniques and Applications","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Computational biology; Biology; Cancer research","score_opus":0.024396137609051693,"score_gpt":0.31828356214749126,"score_spread":0.2938874245384396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2426916527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92085767,0.00005755291,0.06799521,0.0013449187,0.000044388657,0.00031901352,0.00014800172,0.00018531404,0.009047951],"genre_scores_gemma":[0.95322627,0.00031090114,0.04556547,0.000121521,0.000056745303,0.00050078944,0.000017971297,0.000036020556,0.00016430258],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986085,0.000049638864,0.00046402798,0.00045980763,0.00014336807,0.00027463477],"domain_scores_gemma":[0.99828774,0.0005202568,0.00039803877,0.0005733895,0.00013062234,0.00008997855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012065302,0.00017691801,0.0004891386,0.00019954842,0.000069359754,0.0000059267454,0.00035738663,0.0002011808,0.0009072336],"category_scores_gemma":[0.00010513067,0.00013663255,0.00020608795,0.0005319819,0.0002611204,0.000077231925,0.00011122529,0.00018666706,0.000050248254],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012225412,0.00012557935,0.000882047,0.000010485641,0.0001373407,0.000007452688,0.00008749434,0.000018685847,0.9699377,0.015532244,0.0004085943,0.012730112],"study_design_scores_gemma":[0.00044432713,0.00021255242,0.00019985512,0.000013203037,0.00016040195,0.00000885622,0.000055758483,0.00016266158,0.9319072,0.0029905753,0.063681334,0.00016329298],"about_ca_topic_score_codex":0.000011901729,"about_ca_topic_score_gemma":0.000020007164,"teacher_disagreement_score":0.06327274,"about_ca_system_score_codex":0.00018197211,"about_ca_system_score_gemma":0.00007456208,"threshold_uncertainty_score":0.99335724},"labels":[],"label_agreement":null},{"id":"W2426931417","doi":"10.1093/neuonc/now076.92","title":"MB-96IMPAIRED NEURAL FUNCTION DURING VISUAL-MOTOR PERFORMANCE IN CHILDREN TREATED FOR BRAIN TUMOURS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Advanced Memory and Neural Computing","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Magnetoencephalography; Motor cortex; Medicine; Audiology; Sick child; Visual cortex; Motor function; Psychology; Neuroscience; Pediatrics; Physical medicine and rehabilitation; Electroencephalography; Internal medicine","score_opus":0.011286423622696344,"score_gpt":0.2500631970886195,"score_spread":0.23877677346592316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2426931417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975249,0.000037775797,0.00064750924,0.00020520152,0.00050379446,0.00050223235,0.0000076033402,0.0004359971,0.00013494262],"genre_scores_gemma":[0.9991796,0.000022969818,0.00007425713,0.00019574401,0.0003192918,0.00007116519,0.000006353515,0.00005517785,0.00007542186],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99876225,0.00007112963,0.00029993022,0.00031014174,0.00007158806,0.00048493396],"domain_scores_gemma":[0.99934316,0.00034540784,0.00006209788,0.00014013717,0.000022624008,0.00008656903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010833707,0.000212837,0.0002749337,0.00016049051,0.00012120967,0.000008628193,0.00011965874,0.000119406395,0.000014923696],"category_scores_gemma":[0.00010006502,0.00017806966,0.0000707886,0.00016797305,0.00004889496,0.0002576648,0.0000392065,0.00019944902,0.000017752956],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003565558,0.000031615808,0.030220704,0.000028205932,0.000009544915,0.000013967534,0.000033618668,0.005540977,0.93459314,0.0000062596378,0.0000689337,0.029096503],"study_design_scores_gemma":[0.006121337,0.0027642057,0.49472764,0.000063494794,0.000028905546,0.00027382103,0.000018494133,0.038373977,0.45481947,0.00004769974,0.002222718,0.0005382345],"about_ca_topic_score_codex":0.0000014500314,"about_ca_topic_score_gemma":0.000006634879,"teacher_disagreement_score":0.47977364,"about_ca_system_score_codex":0.00022630946,"about_ca_system_score_gemma":0.000018357065,"threshold_uncertainty_score":0.726147},"labels":[],"label_agreement":null},{"id":"W2427379911","doi":"10.1093/neuonc/now070.36","title":"EPN-37PAEDIATRIC SPINAL EPENDYMOMA IN CANADA: A MULTICENTRE RETROSPECTIVE STUDY","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Children's Hospital of Eastern Ontario; Vancouver Hospital and Health Sciences Centre; Centre Hospitalier Universitaire Sainte-Justine; Stollery Children's Hospital; Hospital for Sick Children; Izaak Walton Killam Health Centre; BC Cancer Agency; Children's Hospital of Western Ontario; BC Children's Hospital","funders":"","keywords":"Medicine; Ependymoma; Retrospective cohort study; Interquartile range; Pediatrics; Surgery","score_opus":0.016035501306314873,"score_gpt":0.28261371885261516,"score_spread":0.2665782175463003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2427379911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905834,0.00018336366,0.0000012484977,0.0065052,0.00054429256,0.0010693966,0.000015050111,0.000026661372,0.0010713439],"genre_scores_gemma":[0.99881715,0.000049672108,0.000036558933,0.0007194054,0.0001843067,0.0001481043,0.0000019531396,0.000023239067,0.000019610276],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982556,0.00017314305,0.00034154474,0.00048587754,0.0002976795,0.00044616428],"domain_scores_gemma":[0.9989915,0.00026957667,0.000120894096,0.00030893757,0.00008786451,0.00022124879],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000115944116,0.00019815132,0.0005285676,0.00018660992,0.0000437748,0.000004653928,0.0001006939,0.00008000764,0.00021048624],"category_scores_gemma":[0.00037972952,0.00013014092,0.00006442952,0.000311134,0.000033970904,0.000044672393,0.00007500109,0.00019614588,0.000076445736],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046892388,0.0020615263,0.9438568,0.0000067624014,0.000060548657,0.018579815,0.00016491079,8.400539e-7,0.007133327,0.000037196285,0.0018912748,0.025738072],"study_design_scores_gemma":[0.013179381,0.004265277,0.97416496,0.000022578191,0.00015690898,0.00031980893,0.00048044173,0.000012536129,0.0019211349,0.00001830893,0.005334985,0.00012368544],"about_ca_topic_score_codex":0.28117394,"about_ca_topic_score_gemma":0.8472744,"teacher_disagreement_score":0.56610054,"about_ca_system_score_codex":0.0037552775,"about_ca_system_score_gemma":0.0018343327,"threshold_uncertainty_score":0.981992},"labels":[],"label_agreement":null},{"id":"W2427652150","doi":"10.1093/neuonc/now071.01","title":"EPI-01REVIEW OF CLINICAL PRESENTATION AND TRAJECTORY OF PEDIATRIC PATIENTS (0-18 YEARS OF AGE) WITH A DIAGNOSIS OF PRIMARY BRAIN TUMOUR (BT) IN A PEDIATRIC TERTIARY CENTER","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neonatal and fetal brain pathology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Presentation (obstetrics); Center (category theory); Medicine; Pediatrics; Tertiary care; General surgery; Radiology","score_opus":0.032051793791902955,"score_gpt":0.3225421878940098,"score_spread":0.29049039410210686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2427652150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976058,0.0009836964,0.000010714671,0.00033636118,0.00013515215,0.00064051745,0.00004902439,0.000006258108,0.00023245603],"genre_scores_gemma":[0.9946013,0.004411981,0.00037543738,0.00042962216,0.00010235125,0.0000347938,0.000013266092,0.000018197425,0.000013045246],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997722,0.0004949923,0.0010923961,0.0003024509,0.00021211382,0.00017603586],"domain_scores_gemma":[0.9966865,0.0022241124,0.0006993084,0.00019093647,0.000111139416,0.00008795884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043318808,0.00012688858,0.0009557982,0.00028884714,0.0000052123814,4.8275865e-7,0.00010163916,0.00015797078,0.000032269563],"category_scores_gemma":[0.0009878784,0.00008916008,0.00011896372,0.00025893992,0.00025210116,0.00006487086,0.00009714837,0.000170724,0.0000016784954],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008911125,0.0013284541,0.9119784,0.0010583524,0.000017806282,0.00013368898,0.0002036671,1.9239695e-7,0.008702495,0.0000047782505,0.00039493683,0.07528607],"study_design_scores_gemma":[0.0068707825,0.0043127392,0.9869543,0.00009534649,0.00017810431,0.000028225573,0.000012560438,8.2726126e-7,0.0009941716,0.000021384792,0.00046223574,0.000069342954],"about_ca_topic_score_codex":0.000021523696,"about_ca_topic_score_gemma":0.000019649455,"teacher_disagreement_score":0.075216725,"about_ca_system_score_codex":0.000024732746,"about_ca_system_score_gemma":0.00019897101,"threshold_uncertainty_score":0.36358425},"labels":[],"label_agreement":null},{"id":"W2427937521","doi":"10.1093/neuonc/now072.17","title":"GC-17THE CHILDREN'S ONCOLOGY GROUP (COG) CURRENT TREATMENT APPROACH FOR CHILDREN WITH NEWLY DIAGNOSED CENTRAL NERVOUS SYSTEM (CNS) LOCALIZED GERMINOMA (ACNS1123 STRATUM 2)","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Cog; Central nervous system; Germinoma; Medicine; Stratum; Oncology; Pediatrics; Internal medicine; Pathology; Chemotherapy; Biology","score_opus":0.020570507630243734,"score_gpt":0.277393225005239,"score_spread":0.2568227173749953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2427937521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9819386,0.0013135236,0.002001898,0.0023360779,0.0011952216,0.009138804,0.00042840076,0.00043607457,0.0012113707],"genre_scores_gemma":[0.9907845,0.0005023695,0.0023343933,0.0004936344,0.0011755474,0.003910674,0.00059213286,0.00016947952,0.000037251197],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99503475,0.00050157576,0.00091785484,0.0015406795,0.00043247477,0.0015726467],"domain_scores_gemma":[0.99652904,0.0008792439,0.00057118456,0.00097492314,0.00017162203,0.0008739753],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021530408,0.0009227965,0.0018672524,0.0003042063,0.0002815502,0.00004717011,0.0003527383,0.0005280399,0.00006346174],"category_scores_gemma":[0.000090370544,0.0005312263,0.0005567697,0.00030969823,0.00037165434,0.00013252748,0.000107057196,0.00033185992,0.000055707325],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050680027,0.022834873,0.23779729,0.00018844138,0.0026589427,0.0016996439,0.000605741,0.00008686052,0.009921101,0.0024006343,0.0077117197,0.70902675],"study_design_scores_gemma":[0.17358056,0.08521834,0.5942211,0.00047051048,0.008030772,0.008651553,0.0004936789,0.00083466317,0.010917368,0.00006646352,0.11568097,0.0018340191],"about_ca_topic_score_codex":0.00025871178,"about_ca_topic_score_gemma":0.00017884531,"teacher_disagreement_score":0.7071927,"about_ca_system_score_codex":0.002299972,"about_ca_system_score_gemma":0.0008953774,"threshold_uncertainty_score":0.99971396},"labels":[],"label_agreement":null},{"id":"W2427975996","doi":"10.1093/neuonc/now066.03","title":"CMS-03RISK FACTORS FOR LONG TERM SPEECH DEFICITS IN CHILDREN WITH CEREBELLAR MUTISM SYNDROME","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Children's Physical and Motor Development","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Holland Bloorview Kids Rehabilitation Hospital; Hospital for Sick Children","funders":"","keywords":"Term (time); Psychology; Audiology; Medicine; Physics","score_opus":0.017014883502145018,"score_gpt":0.2762731209147251,"score_spread":0.2592582374125801,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2427975996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995115,0.000042481777,0.00022186666,0.0008973912,0.0007442622,0.0013852284,0.00007429996,0.000107333166,0.0014121463],"genre_scores_gemma":[0.9983679,0.00002444659,0.00023146484,0.00055015663,0.00014659994,0.00018869297,0.000038976825,0.000073005074,0.0003787273],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99759746,0.00016849862,0.00042036013,0.0008350281,0.00019175238,0.0007869124],"domain_scores_gemma":[0.99859506,0.0005311673,0.00018123219,0.00044982455,0.00004492796,0.0001978152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013724482,0.00038398302,0.0006155225,0.00019429106,0.00009049252,0.00001451396,0.00036987982,0.00030412865,0.00035509822],"category_scores_gemma":[0.0000562805,0.00023701858,0.00012455517,0.00021956046,0.00016467246,0.000085449086,0.00011819018,0.00028949196,0.0002602096],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026980758,0.0007104784,0.90245485,0.000010223459,0.00017020736,0.00027875855,0.00059593294,8.2077395e-7,0.009781399,0.00079613755,0.0010377464,0.08389362],"study_design_scores_gemma":[0.00425579,0.0017257634,0.9845779,0.000032952932,0.000052034535,0.00085286045,0.000022718143,4.243539e-7,0.00257232,0.00034803918,0.005191904,0.00036727905],"about_ca_topic_score_codex":0.00009674264,"about_ca_topic_score_gemma":0.00019154737,"teacher_disagreement_score":0.08352634,"about_ca_system_score_codex":0.0002254564,"about_ca_system_score_gemma":0.0001392618,"threshold_uncertainty_score":0.9665337},"labels":[],"label_agreement":null},{"id":"W2428638242","doi":"10.1093/neuonc/now081.06","title":"QOS-06REPAIRING THE BRAIN WITH PHYSICAL EXERCISE: AN EXERCISE TRIAL IN PEDIATRIC BRAIN TUMOR SURVIVORS. INSIGHTS FROM CORTICAL THICKNESS ANALYSIS AND DEFORMATION BASED MORPHOMETRY","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hospital for Sick Children","funders":"","keywords":"Physical medicine and rehabilitation; Brain morphometry; Psychology; Medicine; Physical therapy; Neuroscience; Magnetic resonance imaging; Radiology","score_opus":0.01363966597213219,"score_gpt":0.2738022869398728,"score_spread":0.2601626209677406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2428638242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943485,0.000118711585,0.00022646622,0.004007181,0.00018288214,0.0010007782,0.000017261696,0.00006583377,0.000032331613],"genre_scores_gemma":[0.9982224,0.00005665532,0.00015257984,0.00088799983,0.00033594927,0.00026693504,0.000046810517,0.000028309985,0.000002347204],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99774796,0.00054600317,0.0004352943,0.0005549139,0.0003848729,0.00033098596],"domain_scores_gemma":[0.9957607,0.0032338554,0.00019582809,0.0004807307,0.00008308217,0.0002458319],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035150087,0.0002680885,0.0008528342,0.0005662824,0.000121380064,0.000032614047,0.00013092087,0.00014198406,0.00003876928],"category_scores_gemma":[0.00042403684,0.00013608154,0.00014611386,0.0012132403,0.0001583346,0.00019958161,0.000061827486,0.00028583547,0.000013874076],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04337999,0.007256547,0.848651,0.00008653996,0.0003467738,0.0020178724,0.0029142739,0.00014314995,0.054598197,0.00012870095,0.0006035368,0.0398734],"study_design_scores_gemma":[0.07486728,0.004097405,0.89920384,0.0000902963,0.003524046,0.00003814433,0.00036223332,0.007270572,0.009688175,0.00013962114,0.00036101913,0.00035736623],"about_ca_topic_score_codex":0.0004121991,"about_ca_topic_score_gemma":0.0017383137,"teacher_disagreement_score":0.050552823,"about_ca_system_score_codex":0.00015437821,"about_ca_system_score_gemma":0.00020143155,"threshold_uncertainty_score":0.5549244},"labels":[],"label_agreement":null},{"id":"W2429350315","doi":"10.1093/neuonc/now076.14","title":"MB-16NOTCH1 PROMOTES GROUP 3 MEDULLOBLASTOMA METASTASIS, INITIATION AND SELF-RENEWAL","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Electron and X-Ray Spectroscopy Techniques","field":"Materials Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Group (periodic table); Medicine; Biology; Oncology; Cancer research; Chemistry","score_opus":0.013046173712582852,"score_gpt":0.2856148729585675,"score_spread":0.27256869924598465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2429350315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895151,0.00015679564,0.0019222886,0.0038683775,0.00044034573,0.00043524263,0.000022836732,0.00077454926,0.0028644223],"genre_scores_gemma":[0.98647505,0.00036384916,0.011677157,0.0011112919,0.00019630813,0.00011193985,0.0000039997467,0.000033221833,0.000027196496],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980794,0.00038243431,0.00031534967,0.0005188703,0.00021110871,0.00049283844],"domain_scores_gemma":[0.99895644,0.0003923235,0.00018239068,0.00026501072,0.00006637969,0.00013745159],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004935772,0.00021517868,0.00033731648,0.00012339598,0.00013188108,0.000048744696,0.0002390382,0.0001741038,0.00036455845],"category_scores_gemma":[0.00018863994,0.00015194311,0.000048353868,0.00013276815,0.00016933194,0.00029052084,0.00013019862,0.00013532957,0.000107249216],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000700092,0.00017816978,0.00027345796,0.000011220392,0.000008813842,0.000028183895,0.00014246485,4.0712155e-8,0.9855235,0.0049410597,0.0011370946,0.0076859896],"study_design_scores_gemma":[0.0006025611,0.002610294,0.00028881914,0.000011968777,0.000038790167,0.0001290737,0.000012439959,0.0000072987827,0.9357677,0.004119562,0.05623237,0.00017911724],"about_ca_topic_score_codex":0.000027170523,"about_ca_topic_score_gemma":0.0001359764,"teacher_disagreement_score":0.055095278,"about_ca_system_score_codex":0.00016828299,"about_ca_system_score_gemma":0.00013813772,"threshold_uncertainty_score":0.619606},"labels":[],"label_agreement":null},{"id":"W2429582314","doi":"10.1093/neuonc/now075.46","title":"LG-46INFERIOR OUTCOME AND POOR RESPONSE TO CONVENTIONAL THERAPIES IN PEDIATRIC LOW-GRADE GLIOMAS HARBORING THE BRAF V600E MUTATION","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Hospital for Sick Children","funders":"","keywords":"Medicine; Mutation; Oncology; Cancer research; Internal medicine; Genetics; Biology; Gene","score_opus":0.026184051549662392,"score_gpt":0.32052237137071854,"score_spread":0.2943383198210561,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2429582314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93615156,0.0003643398,0.000011770245,0.062462505,0.00032656794,0.00057271967,0.000009416679,0.00003457307,0.000066535526],"genre_scores_gemma":[0.9971209,0.00013454014,0.00011496555,0.0021825251,0.00017592065,0.00020783438,0.000002367298,0.000020661932,0.000040291798],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986493,0.00028573148,0.00032457945,0.00030079042,0.00018346224,0.000256134],"domain_scores_gemma":[0.9978847,0.0016592975,0.00009339768,0.00018573957,0.00005295802,0.00012392418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039176992,0.00015020165,0.00028558387,0.00030653318,0.000072269155,0.000017069902,0.000073430485,0.000093328024,0.000083755454],"category_scores_gemma":[0.00055728864,0.00008516428,0.00006891309,0.0002626893,0.000073374234,0.00006551903,0.000055491506,0.00011139319,0.00006873924],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015125028,0.0005269985,0.65979636,0.00002286114,0.000038908616,0.0010970578,0.0005072547,0.0000032994442,0.3190232,0.00032548868,0.00038686968,0.016759222],"study_design_scores_gemma":[0.0067667905,0.0014037209,0.96440786,0.000024222601,0.0000931479,0.00022459413,0.00009060696,0.000014760702,0.008132245,0.00009538375,0.018642105,0.00010456314],"about_ca_topic_score_codex":0.000019143392,"about_ca_topic_score_gemma":0.000060987375,"teacher_disagreement_score":0.31089094,"about_ca_system_score_codex":0.00016674877,"about_ca_system_score_gemma":0.0001229873,"threshold_uncertainty_score":0.3472899},"labels":[],"label_agreement":null},{"id":"W2429925096","doi":"10.1093/neuonc/now076.102","title":"MB-107REST ELEVATION UNRESTRAINS SHH SIGNALING IN MEDULLOBLASTOMA","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Elevation (ballistics); Biology; Cancer research; Physics; Astronomy","score_opus":0.012492819816505497,"score_gpt":0.26709323942063046,"score_spread":0.25460041960412494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2429925096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953381,0.000106655854,0.0014194817,0.001240823,0.00033797062,0.00020597113,0.000017084303,0.000021335865,0.0013126216],"genre_scores_gemma":[0.99723923,0.0005259304,0.0003400099,0.001346563,0.0003125168,0.00003972682,0.000036189605,0.000031232194,0.00012860076],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986637,0.00015891485,0.00029880495,0.00042892148,0.000091370835,0.00035826428],"domain_scores_gemma":[0.9993747,0.00009220587,0.00010880698,0.0002816237,0.0000561081,0.000086590204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019592982,0.00016562572,0.00018973614,0.00009274227,0.00004429682,0.000009711326,0.00021663184,0.00031379124,0.000048260572],"category_scores_gemma":[0.00023616779,0.00013636836,0.000070951566,0.0001070585,0.00009833914,0.0000063210878,0.00010340305,0.00012751554,0.000043815628],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010464884,0.00009780352,0.004456731,0.000005790511,0.000011900773,0.000033573815,0.00003775323,0.000025538753,0.97648376,0.00024219893,0.0014489605,0.017051324],"study_design_scores_gemma":[0.0015230974,0.0009461935,0.002829102,0.00002042375,0.000012646602,0.00007595452,0.000047607336,0.000042043263,0.7044118,0.00015689358,0.2897041,0.00023013623],"about_ca_topic_score_codex":0.00001886997,"about_ca_topic_score_gemma":0.0005173334,"teacher_disagreement_score":0.28825516,"about_ca_system_score_codex":0.00007399723,"about_ca_system_score_gemma":0.00021338995,"threshold_uncertainty_score":0.556094},"labels":[],"label_agreement":null},{"id":"W2430220433","doi":"10.1093/neuonc/now065.02","title":"AT-03ATYPICAL TERATOID RHABDOID TUMORS IN THE FIRST YEAR OF LIFE: SHOULD WE TREAT?","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre hospitalier de l'Université Laval; Saskatchewan Cancer Agency; Children's Hospital of Eastern Ontario; Montreal Children's Hospital; BC Children's Hospital; Centre Hospitalier Universitaire Sainte-Justine; McMaster Children's Hospital; Hospital for Sick Children; Stollery Children's Hospital; Alberta Children's Hospital","funders":"","keywords":"Medicine; Atypical teratoid rhabdoid tumor; Pathology; Oncology; Medulloblastoma","score_opus":0.021566359668255184,"score_gpt":0.2799995239044143,"score_spread":0.2584331642361591,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2430220433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894487,0.0004784018,0.00008236028,0.006523428,0.00014855682,0.00014262089,0.000017380982,0.000009600519,0.0031489164],"genre_scores_gemma":[0.9971062,0.00068522035,0.00009839326,0.001687455,0.00024177539,0.000031109234,0.000007032818,0.000017796321,0.00012500976],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99898446,0.00012866885,0.00026621262,0.00028776217,0.00011256107,0.00022036787],"domain_scores_gemma":[0.99936223,0.00011843903,0.00008783233,0.00034536884,0.000032186672,0.00005394856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015870317,0.00012596571,0.00020733457,0.000032475888,0.00004356307,0.0000046665073,0.0002598955,0.0001979421,0.00007217276],"category_scores_gemma":[0.0001665724,0.00007401835,0.000087236185,0.00007364685,0.00014060261,0.000002239426,0.00010740988,0.000105478226,0.000027934017],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038376392,0.00013729426,0.008777471,0.000019756288,0.000011892092,0.000019133051,0.0001528182,0.000027921875,0.9601062,0.00008231543,0.021755623,0.008525811],"study_design_scores_gemma":[0.0026330885,0.0014412391,0.0025883005,0.000037056096,0.000019166207,0.000101122154,0.00012165012,0.0000623184,0.25028118,0.00014561247,0.7423578,0.00021145277],"about_ca_topic_score_codex":0.000013488156,"about_ca_topic_score_gemma":0.00018114397,"teacher_disagreement_score":0.7206022,"about_ca_system_score_codex":0.00004551227,"about_ca_system_score_gemma":0.00015365281,"threshold_uncertainty_score":0.30183807},"labels":[],"label_agreement":null},{"id":"W2430680726","doi":"10.1093/neuonc/now071.03","title":"EPI-04DOES DIAGNOSTIC DELAY AFFECT MORBIDITY IN CHILDREN DIAGNOSED WITH BRAIN TUMOURS?","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Affect (linguistics); Medicine; Pediatrics; Audiology; Psychology; Communication","score_opus":0.013317532501619052,"score_gpt":0.28237341118077847,"score_spread":0.2690558786791594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2430680726","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9808863,0.00028578806,0.000023455867,0.016473092,0.00021437944,0.001323678,0.000034477736,0.00010682325,0.0006520477],"genre_scores_gemma":[0.99598175,0.00034309636,0.00012268868,0.0027126702,0.00023512174,0.00050218625,0.000025243091,0.000055696164,0.000021528649],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99780625,0.00035363963,0.00033446195,0.0006389742,0.00026529946,0.0006013687],"domain_scores_gemma":[0.99269754,0.0063203354,0.00014838223,0.0004763776,0.0000600769,0.00029726158],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025250085,0.00033034178,0.00069579406,0.00025311,0.00006491894,0.000013099442,0.00015291748,0.00019562295,0.00023688872],"category_scores_gemma":[0.0020733587,0.000188207,0.00011955796,0.00029753672,0.00020337463,0.00009802017,0.00008005316,0.00025461317,0.00020588594],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022503213,0.0016633515,0.94081026,0.000011095577,0.00008203008,0.0052985447,0.00011139356,0.000006961252,0.025258934,0.0000927086,0.0063481666,0.020091502],"study_design_scores_gemma":[0.012322761,0.004553795,0.95674413,0.00015068297,0.00019015669,0.0010106817,0.000022579823,0.0000061024057,0.020222027,0.000063266416,0.0044906335,0.00022315401],"about_ca_topic_score_codex":0.0003201358,"about_ca_topic_score_gemma":0.0011414624,"teacher_disagreement_score":0.019868348,"about_ca_system_score_codex":0.0003510286,"about_ca_system_score_gemma":0.00023904658,"threshold_uncertainty_score":0.7674859},"labels":[],"label_agreement":null},{"id":"W2430949246","doi":"10.1093/neuonc/now067.34","title":"PNR-40EMBRYONAL TUMOR WITH MULTILAYERED ROSETTES: A UNIQUE NEW CLINICAL ENTITY","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Medical Imaging and Pathology Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Computer science","score_opus":0.0649653169824969,"score_gpt":0.38463471663029764,"score_spread":0.3196693996478007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2430949246","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9041277,0.0002780044,0.0028069192,0.082853,0.001600183,0.0006190285,0.000021388572,0.0003255605,0.007368221],"genre_scores_gemma":[0.9388898,0.00030071638,0.008284102,0.04772166,0.0015765564,0.000059743288,0.000008326554,0.00005845494,0.0031006562],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976881,0.00046425202,0.0005253714,0.00058776746,0.00025524537,0.00047926878],"domain_scores_gemma":[0.99683464,0.0018991885,0.00018509215,0.00041203908,0.00013168644,0.0005373456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060080487,0.0002307999,0.0007863832,0.00008582273,0.000090398964,0.000006108246,0.00016103296,0.0001831036,0.000345282],"category_scores_gemma":[0.0027874487,0.00012810552,0.00014018279,0.00013292898,0.0009119871,0.000055022003,0.00012061177,0.0006437597,0.000307811],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020682,0.001055564,0.554841,0.000053495372,0.0002516795,0.008276551,0.0002890879,4.518875e-7,0.09911439,0.00017347855,0.23645367,0.09742247],"study_design_scores_gemma":[0.0140083,0.0077502048,0.11182077,0.00018107874,0.00036106523,0.0038315202,0.00008415845,0.000044567172,0.003735937,0.0001882928,0.8576821,0.0003119749],"about_ca_topic_score_codex":0.000039468363,"about_ca_topic_score_gemma":0.000077663186,"teacher_disagreement_score":0.62122846,"about_ca_system_score_codex":0.0000806802,"about_ca_system_score_gemma":0.00087719155,"threshold_uncertainty_score":0.5223991},"labels":[],"label_agreement":null},{"id":"W2431153579","doi":"10.1093/neuonc/now075.52","title":"LG-52THEOPHYLLINE IN VISION IMPAIRED CHILDREN WITH OPTIC PATHWAY GLIOMA","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Glioma; Impaired Vision; Medicine; Ophthalmology; Optometry; Neuroscience; Psychology; Cancer research","score_opus":0.011394476047438073,"score_gpt":0.2725541881520989,"score_spread":0.2611597121046608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2431153579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990336,0.00016152061,0.000014621776,0.0078007765,0.00014429922,0.0006826765,0.000013635846,0.00007547397,0.00077101163],"genre_scores_gemma":[0.99862194,0.000057984507,0.0003621002,0.00063144224,0.00014589587,0.00010931768,0.00001503214,0.00003918887,0.000017074006],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998528,0.00012709503,0.0003013653,0.0004515559,0.00020481543,0.0003871536],"domain_scores_gemma":[0.99891025,0.00032935294,0.00010868873,0.0003930701,0.000060198763,0.00019844074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013845383,0.00022015943,0.00047901194,0.00025380097,0.000040982344,0.000008366391,0.00009944298,0.00015347279,0.00016688228],"category_scores_gemma":[0.000108334505,0.00011854032,0.00008255304,0.0003032069,0.00011184559,0.0000689648,0.000058656457,0.00013448343,0.00016763946],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008371434,0.0021813503,0.20640266,0.000009733932,0.00008308007,0.004016737,0.000107251144,0.000004616439,0.6977014,0.0003183686,0.00066941796,0.08766822],"study_design_scores_gemma":[0.027916484,0.019174566,0.74341136,0.0002151347,0.00017855105,0.0031071447,0.000030791514,0.000054688364,0.19597355,0.00018558862,0.009435366,0.00031675916],"about_ca_topic_score_codex":0.000040103263,"about_ca_topic_score_gemma":0.000089432055,"teacher_disagreement_score":0.5370087,"about_ca_system_score_codex":0.0002322994,"about_ca_system_score_gemma":0.00018081238,"threshold_uncertainty_score":0.4833934},"labels":[],"label_agreement":null},{"id":"W2431302499","doi":"10.1093/neuonc/now076.64","title":"MB-68HEALTH-RELATED QUALITY OF LIFE IN MOLECULAR SUBGROUPS OF MEDULLOBLASTOMA","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Mitochondrial Function and Pathology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medulloblastoma; Quality (philosophy); Psychology; Medicine; Cancer research; Philosophy; Epistemology","score_opus":0.020721521298372576,"score_gpt":0.295058266010102,"score_spread":0.2743367447117294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2431302499","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99329025,0.00027766067,0.0016305628,0.0012378932,0.0007886609,0.00023847427,0.000027580216,0.000011689527,0.0024972286],"genre_scores_gemma":[0.99809027,0.00021017637,0.0004295299,0.0010485244,0.000074351854,0.000021629103,0.000017808163,0.000021159078,0.00008657212],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99744076,0.0008696606,0.00086427975,0.00040870038,0.00013282197,0.0002837542],"domain_scores_gemma":[0.99868727,0.00020330712,0.00041979022,0.00043138227,0.00012636189,0.00013188265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051404734,0.00015514027,0.0005171654,0.000120009936,0.000017427268,0.000001236546,0.00021489157,0.00047531005,0.00017626463],"category_scores_gemma":[0.0012930734,0.00012578853,0.00013581458,0.00017078948,0.00025308973,0.000003391905,0.00010849426,0.0001390506,0.000019740362],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009445216,0.00018361023,0.013115532,0.0000304485,0.00002370292,0.000014640114,0.00005437901,0.000014923518,0.98037666,0.0014076744,0.0006884678,0.0031454512],"study_design_scores_gemma":[0.004518007,0.003009665,0.008807933,0.000018472407,0.000015956937,0.000045868073,0.0000584281,0.0000067856427,0.9433985,0.00041791805,0.03948985,0.00021265163],"about_ca_topic_score_codex":0.000092598115,"about_ca_topic_score_gemma":0.000294093,"teacher_disagreement_score":0.038801383,"about_ca_system_score_codex":0.000029774117,"about_ca_system_score_gemma":0.00033676045,"threshold_uncertainty_score":0.5129508},"labels":[],"label_agreement":null},{"id":"W2431568160","doi":"10.1093/neuonc/now084.11","title":"TB-16EXPLORATION OF eEF2K AS A NOVEL THERAPEUTIC TARGET IN MEDULLOBLASTOMA AND NEUROBLASTOMA","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of British Columbia","funders":"","keywords":"Medulloblastoma; Neuroblastoma; Medicine; Computer science; Cancer research; Biology","score_opus":0.028044071829422496,"score_gpt":0.30249892812661566,"score_spread":0.2744548562971932,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2431568160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850641,0.00030718412,0.000083061896,0.012878398,0.00019213064,0.00044948448,0.000008051818,0.000033834596,0.0009837503],"genre_scores_gemma":[0.9966695,0.00028694485,0.00039968055,0.0024293794,0.000058258476,0.00010466671,0.0000027503788,0.000025655467,0.000023220806],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99883646,0.0001058729,0.0003294239,0.00032917553,0.00016369787,0.00023536322],"domain_scores_gemma":[0.9988372,0.0006328337,0.00012928691,0.00022878849,0.00006137336,0.0001105541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000118997814,0.00016047618,0.00041626053,0.00018823557,0.000023863624,0.0000043523837,0.000060424754,0.00012455173,0.000097726464],"category_scores_gemma":[0.000184682,0.00010597996,0.000060512273,0.00016732731,0.00012925915,0.00008096457,0.000048679594,0.00010798187,0.000044016266],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069607294,0.0015207237,0.077755496,0.000023763945,0.000046400903,0.0003107097,0.0003607092,0.0000026457158,0.8440301,0.0010295952,0.00022929214,0.073994525],"study_design_scores_gemma":[0.02435648,0.017150389,0.47961116,0.00024591992,0.00026186235,0.0018815245,0.0002986603,0.000347071,0.373279,0.0017263261,0.10046915,0.0003724684],"about_ca_topic_score_codex":0.000032981367,"about_ca_topic_score_gemma":0.000072773895,"teacher_disagreement_score":0.47075108,"about_ca_system_score_codex":0.00010640406,"about_ca_system_score_gemma":0.000159984,"threshold_uncertainty_score":0.43217373},"labels":[],"label_agreement":null},{"id":"W2431999485","doi":"10.1093/neuonc/now079.18","title":"NU-18NEWLY DIAGNOSED HIGH GRADE GLIOMA AND DIPG: COLLABORATIVE EFFORTS OF PEDIATRIC NEURO-ONCOLOGY AND PALLIATIVE CARE","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Stollery Children's Hospital","funders":"","keywords":"Pediatric oncology; Medicine; Palliative care; Glioma; Oncology; Internal medicine; Cancer; Cancer research; Nursing","score_opus":0.024104502930491694,"score_gpt":0.32566333839239925,"score_spread":0.30155883546190754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2431999485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9759685,0.0026665665,0.00004422839,0.017611591,0.0012025015,0.0014644708,0.00023083024,0.0001146823,0.00069666386],"genre_scores_gemma":[0.990706,0.0036479866,0.00063711323,0.0037667924,0.0009703088,0.0001502381,0.000024320154,0.00007915979,0.000018060931],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959483,0.00096940674,0.0009420414,0.0010110502,0.0004927754,0.0006364272],"domain_scores_gemma":[0.9915314,0.006146668,0.0007476094,0.0005294382,0.0005126433,0.0005322599],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003895871,0.00048483166,0.0015354479,0.0004030177,0.00014789228,0.000016138401,0.00020980494,0.00050990214,0.00007650552],"category_scores_gemma":[0.0022101512,0.00037992015,0.00011983968,0.00071724644,0.00076241733,0.00016596161,0.00029726082,0.000465695,0.00001517312],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004736261,0.0019258014,0.5409409,0.0012578939,0.00053964206,0.005062055,0.043236084,0.00000470007,0.32856548,0.0024888006,0.019290578,0.051951814],"study_design_scores_gemma":[0.04629064,0.03465293,0.6688606,0.0002483807,0.0017816037,0.00069643225,0.007455768,0.000015343776,0.058322947,0.0013482849,0.17900234,0.0013247184],"about_ca_topic_score_codex":0.0002822695,"about_ca_topic_score_gemma":0.00081413373,"teacher_disagreement_score":0.27024254,"about_ca_system_score_codex":0.00034773163,"about_ca_system_score_gemma":0.0011235627,"threshold_uncertainty_score":0.9998653},"labels":[],"label_agreement":null},{"id":"W2432030052","doi":"10.1093/neuonc/now065.21","title":"AT-22ALISERTIB MONOTHERAPY IN THE TREATMENT OF RELAPSED ATYPICAL TERATOID RHABDOID TUMOR (ATRT)","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Children's Hospital of Winnipeg; BC Children's Hospital; CancerCare Manitoba","funders":"","keywords":"Atypical teratoid rhabdoid tumor; Medicine; Etoposide; Chemotherapy; Internal medicine; Oncology; Surgery; Medulloblastoma; Pathology","score_opus":0.015045315156321536,"score_gpt":0.284976254907342,"score_spread":0.2699309397510205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2432030052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99615335,0.0006873404,0.000104048544,0.0017898217,0.000185793,0.00023183129,0.00001434004,0.0000090339945,0.0008244278],"genre_scores_gemma":[0.99653584,0.0013904003,0.0001796075,0.0014353116,0.00020454977,0.0000761628,0.000010695162,0.000019749265,0.00014769506],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988827,0.00021985074,0.0002780704,0.00030780837,0.00009395761,0.00021759505],"domain_scores_gemma":[0.99932086,0.00010867198,0.000101625665,0.00039322613,0.000032410255,0.00004318982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011173713,0.00014405475,0.00022047128,0.000029673047,0.00004118555,0.000004176589,0.00018930637,0.00013852755,0.000053613763],"category_scores_gemma":[0.00003966838,0.00007918938,0.000114177135,0.000060385715,0.000111062254,0.0000021010965,0.00002740458,0.000048338363,0.000014080158],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001008987,0.00031561157,0.0022791822,0.0000037013167,0.000017806171,0.000022112841,0.0002467961,0.000018025135,0.9680714,0.00003073684,0.0016074318,0.026378192],"study_design_scores_gemma":[0.0035015955,0.0036213137,0.0012468968,0.0000090777485,0.000012551343,0.00007298455,0.000037237107,0.0000510405,0.5621781,0.00007691668,0.42907953,0.000112795344],"about_ca_topic_score_codex":0.000020499792,"about_ca_topic_score_gemma":0.00013884359,"teacher_disagreement_score":0.4274721,"about_ca_system_score_codex":0.000109010616,"about_ca_system_score_gemma":0.00012712902,"threshold_uncertainty_score":0.32292494},"labels":[],"label_agreement":null},{"id":"W2432034468","doi":"10.1093/neuonc/now065.18","title":"AT-19SYSTEMATIC RADIOLOGICAL PHENOTYPING OF ATYPICAL TERATOID RHABDOID TUMOURS USING LANGUAGE MODELLED MACHINE LEARNING APPROACHES","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"","keywords":"Radiological weapon; Computer science; Artificial intelligence; Natural language processing; Medicine; Radiology","score_opus":0.03967846761888544,"score_gpt":0.2786656196088555,"score_spread":0.23898715198997006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2432034468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96151906,0.0013308788,0.035993,0.00018498424,0.00014956886,0.0002118715,0.0000111315785,0.00003158144,0.00056790264],"genre_scores_gemma":[0.996988,0.00012495884,0.0023522547,0.00015319264,0.00023307108,0.00001942292,0.000023586212,0.000034184282,0.00007131739],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981908,0.00046045982,0.00044313687,0.00045021257,0.00013227561,0.0003230674],"domain_scores_gemma":[0.9991592,0.00014269992,0.00025333042,0.0003028612,0.000046062585,0.00009579932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003351756,0.00020778988,0.0004584596,0.000048844227,0.00010274163,0.0000068158247,0.0002081607,0.0002773885,0.000052398194],"category_scores_gemma":[0.00031620546,0.00014218132,0.00015349417,0.00006814328,0.00015458577,0.000004383673,0.00020993063,0.000165844,0.000009980001],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000376225,0.00006659114,0.0014012917,0.00007466356,0.00003492518,0.000014297035,0.00018774987,0.007238844,0.9808003,0.000029615323,0.000046576148,0.00972896],"study_design_scores_gemma":[0.003875029,0.0013358842,0.00011489975,0.0001979561,0.00012530158,0.0008321606,0.00027077098,0.32255688,0.66584444,0.0001276738,0.0041176425,0.00060132804],"about_ca_topic_score_codex":0.000013255428,"about_ca_topic_score_gemma":0.000015660471,"teacher_disagreement_score":0.31531805,"about_ca_system_score_codex":0.000105037165,"about_ca_system_score_gemma":0.00011342104,"threshold_uncertainty_score":0.5797986},"labels":[],"label_agreement":null},{"id":"W2432084722","doi":"10.1093/neuonc/now075.58","title":"LG-58THERAPEUTIC IMPLICATIONS OF MOLECULAR BIOMARKERS IN INFANTS WITH PEDIATRIC LOW-GRADE GLIOMA","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"","keywords":"Glioma; Medicine; Oncology; Cancer research","score_opus":0.016110921346911312,"score_gpt":0.2963061148436274,"score_spread":0.28019519349671607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2432084722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892812,0.00045181232,0.00003661349,0.008854166,0.00007914491,0.00056753866,0.000014131558,0.00003100416,0.0006844112],"genre_scores_gemma":[0.9986065,0.0002429692,0.00023434944,0.00066458556,0.000039075472,0.00017840057,0.000005265348,0.000027164486,0.0000016900801],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998828,0.000096396616,0.000315436,0.0003233791,0.00014875295,0.00028804477],"domain_scores_gemma":[0.99886584,0.0003868906,0.00015173329,0.00039049773,0.00007326413,0.00013177085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008420022,0.00015798736,0.00036562327,0.0003948161,0.00002280836,0.0000030851688,0.00010231132,0.00012210138,0.000056020737],"category_scores_gemma":[0.00006669449,0.000098306264,0.00007454026,0.0006268369,0.00010926832,0.000037862083,0.000033534667,0.00007944778,0.00002589188],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001868601,0.00086803734,0.32450354,0.000019728834,0.00008739438,0.00042150336,0.00004408697,0.0000015170184,0.6607818,0.00016261339,0.00016298628,0.01275992],"study_design_scores_gemma":[0.012825942,0.0031448698,0.6202961,0.000061439416,0.00042748777,0.00047965389,0.000033855897,0.000007773063,0.35851246,0.00027226834,0.0037448443,0.00019329286],"about_ca_topic_score_codex":0.000031524585,"about_ca_topic_score_gemma":0.000043985285,"teacher_disagreement_score":0.30226934,"about_ca_system_score_codex":0.00014545365,"about_ca_system_score_gemma":0.0002300375,"threshold_uncertainty_score":0.4008813},"labels":[],"label_agreement":null},{"id":"W2432316501","doi":"10.1093/neuonc/now077.01","title":"LMI-01DEVELOPMENT OF CLINICAL GUIDELINES FOR THE TREATMENT OF LOW GRADE GLIOMAS IN LOWER AND LOWER MIDDLE INCOME COUNTRIES – A SIOP PODC INITIATIVE","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Advances in Oncology and Radiotherapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Low and middle income countries; Middle income country; Medicine; Middle income; Developing country; Economics; Socioeconomics; Economic growth; Demographic economics","score_opus":0.10883218417283468,"score_gpt":0.4574309827104888,"score_spread":0.34859879853765413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2432316501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.966523,0.0030934801,0.0007703335,0.025734311,0.0022179605,0.001334512,0.000054779353,0.00001843441,0.00025319358],"genre_scores_gemma":[0.948305,0.031099785,0.011943459,0.007178714,0.0008188048,0.00031550223,0.0000053374533,0.000044398475,0.00028898002],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981141,0.0001792808,0.0010132932,0.00031045984,0.0001375851,0.0002452826],"domain_scores_gemma":[0.99225307,0.006693909,0.0004099147,0.00025790336,0.0003104025,0.000074829324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005042507,0.00018524246,0.00088908797,0.00011599504,0.000050745173,0.0000015038901,0.00011136151,0.00026626998,0.000072390874],"category_scores_gemma":[0.0011836974,0.000091487505,0.00013081927,0.00013027317,0.001003116,0.000053807096,0.000032934717,0.0001049839,0.000002538118],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04809016,0.01142646,0.49979144,0.0005278142,0.0015836047,0.0012417502,0.006792694,0.000033560525,0.045345493,0.0025688433,0.006493234,0.37610495],"study_design_scores_gemma":[0.026523331,0.03268984,0.059303347,0.00036589606,0.0001866419,0.00020257597,0.00033670064,0.00010892429,0.012469004,0.0010730122,0.8665155,0.00022519562],"about_ca_topic_score_codex":0.000007321092,"about_ca_topic_score_gemma":0.000086766246,"teacher_disagreement_score":0.8600223,"about_ca_system_score_codex":0.00017644776,"about_ca_system_score_gemma":0.0005581697,"threshold_uncertainty_score":0.37307522},"labels":[],"label_agreement":null},{"id":"W2432570899","doi":"10.1093/neuonc/now075.19","title":"LG-19IMMUNOHISTOCHEMISTRY IS HIGHLY SENSITIVE AND SPECIFIC FOR THE DETECTION OF BRAF V600E STATUS IN PEDIATRIC LOW-GRADE GLIOMA","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"S100 Proteins and Annexins","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Glioma; Cancer research; Medicine; Oncology; Internal medicine","score_opus":0.00985870928108466,"score_gpt":0.25103360087558635,"score_spread":0.2411748915945017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2432570899","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959393,0.001496385,0.0010610714,0.0006484175,0.0002439785,0.0003631375,0.00005903769,0.000008277546,0.00018035977],"genre_scores_gemma":[0.99720734,0.0019621695,0.00010427756,0.0002513321,0.00034149582,0.00005844021,0.0000073357473,0.000021378992,0.00004624319],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99897885,0.00006927774,0.00024410001,0.0003592442,0.00007077603,0.0002777428],"domain_scores_gemma":[0.9992476,0.00020326741,0.00014939618,0.0002647164,0.000080281185,0.000054710406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014151329,0.00014302752,0.0001857936,0.000061401806,0.00006587446,0.000007242017,0.00011068898,0.00022474836,0.000007351254],"category_scores_gemma":[0.0001316946,0.00009932693,0.00007947924,0.00011004184,0.00016643587,0.0000048018424,0.0000861441,0.00009607953,0.000002503168],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033109222,0.00006871868,0.00044334505,0.000022214797,0.0000136517565,0.0000105130775,0.000067646906,0.0000011156371,0.97917515,0.000020544498,0.00043510625,0.01941088],"study_design_scores_gemma":[0.0015417372,0.00082150154,0.0030073232,0.000005972722,0.000018557628,0.00005421655,0.00007645317,0.000012954583,0.9367559,0.000062874,0.057523284,0.00011924098],"about_ca_topic_score_codex":0.00002463593,"about_ca_topic_score_gemma":0.000042002972,"teacher_disagreement_score":0.057088178,"about_ca_system_score_codex":0.00004512931,"about_ca_system_score_gemma":0.000103117185,"threshold_uncertainty_score":0.40504345},"labels":[],"label_agreement":null},{"id":"W2433128876","doi":"10.1093/neuonc/now081.22","title":"QOS-22IS A SEPARATE AFTERCARE CLINIC FOR PEDIATRIC CNS TUMOR PATIENTS NECESSARY?","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Tumors and Oncological Cases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster Children's Hospital","funders":"","keywords":"Medicine","score_opus":0.037537654531968445,"score_gpt":0.34171858505013525,"score_spread":0.3041809305181668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2433128876","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889149,0.00015968588,0.000097158176,0.0047800173,0.001700695,0.0012095046,0.00015678752,0.00013955821,0.0028417034],"genre_scores_gemma":[0.98776114,0.0001564598,0.00056251214,0.008917619,0.0016941847,0.0003280623,0.000029630864,0.000048210793,0.0005021746],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.997906,0.0001422694,0.0005653482,0.0005925035,0.00021361677,0.00058021204],"domain_scores_gemma":[0.9973027,0.0014891253,0.00026780865,0.00032695264,0.00026137507,0.00035200373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019945818,0.0002583777,0.00069732155,0.0001310206,0.00010109448,0.000011279576,0.00017743907,0.00022555396,0.0007931034],"category_scores_gemma":[0.001488821,0.00015710935,0.00026359057,0.0002110477,0.00012299356,0.00009209813,0.00012202746,0.00022932093,0.00050169503],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071487552,0.0031160626,0.7589293,0.0003415119,0.000035548517,0.0028142715,0.00024279117,0.0000015620294,0.014683741,0.00016034754,0.15833513,0.05419093],"study_design_scores_gemma":[0.021581607,0.03614985,0.23388438,0.00005711177,0.0005442944,0.00033986178,0.00008296898,0.000012625189,0.0026974361,0.00074715726,0.7034174,0.00048530917],"about_ca_topic_score_codex":0.000006749481,"about_ca_topic_score_gemma":0.00002091478,"teacher_disagreement_score":0.5450823,"about_ca_system_score_codex":0.00031264176,"about_ca_system_score_gemma":0.0005122221,"threshold_uncertainty_score":0.8683926},"labels":[],"label_agreement":null},{"id":"W2433847111","doi":"10.1093/neuonc/now073.49","title":"HG-53HYPERMUTATION AND NEOANTIGEN FORMATION PREDICT RESPONSE TO IMMUNE CHECKPOINT INHIBITION IN CHILDHOOD BIALLELIC MISMATCH REPAIR DEFICIENT GLIOBLASTOMA","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Montreal Children's Hospital; Izaak Walton Killam Health Centre; University of Manitoba; Mount Sinai Hospital; CancerCare Manitoba; Research Institute in Oncology and Hematology; SickKids Foundation; Université Laval; Hospital for Sick Children","funders":"","keywords":"Glioblastoma; DNA mismatch repair; Immune system; Medicine; Cancer research; DNA repair; Immunology; Biology; Genetics; Gene","score_opus":0.01615819160788658,"score_gpt":0.29986809272157305,"score_spread":0.2837099011136865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2433847111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97657394,0.00007106938,0.0006312742,0.021164881,0.000066762695,0.00079844537,0.0000143598245,0.00013956559,0.00053971744],"genre_scores_gemma":[0.99810934,0.00009848367,0.00037809095,0.0010753981,0.00010137437,0.00015893915,0.000014986236,0.000018276665,0.0000451178],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99856657,0.00015556681,0.00050263957,0.00034255793,0.00016868724,0.00026398164],"domain_scores_gemma":[0.99903893,0.0003310786,0.00010660204,0.00024332934,0.00007405305,0.00020599779],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047838243,0.00014331596,0.0002583501,0.00016254494,0.000079557256,0.000009125537,0.000044114702,0.00015794257,0.00005655844],"category_scores_gemma":[0.000619719,0.000114782844,0.0000687944,0.00031321048,0.00007996077,0.00011512137,0.000054041124,0.00018489028,0.00007736907],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021473693,0.00029197798,0.000335751,0.000038626866,0.000007409702,0.00007449999,0.0006561062,0.000018133365,0.98765004,0.000034532546,0.00023399394,0.008511533],"study_design_scores_gemma":[0.0048497105,0.0017295268,0.056979902,0.00013977058,0.000055311386,0.0012483234,0.0001886122,0.0006812545,0.90099025,0.00013669548,0.03283135,0.00016927456],"about_ca_topic_score_codex":0.0000050549925,"about_ca_topic_score_gemma":0.0000056340896,"teacher_disagreement_score":0.0866598,"about_ca_system_score_codex":0.0002676025,"about_ca_system_score_gemma":0.00013147284,"threshold_uncertainty_score":0.46807086},"labels":[],"label_agreement":null},{"id":"W2434544329","doi":"10.1093/neuonc/now068.12","title":"CR-12INTRACYSTIC INTERFERON-ALPHA IN PAEDIATRIC CRANIOPHARYNGIOMA PATIENTS: AN INTERNATIONAL MULTI-CENTRE ASSESSMENT ON BEHALF OF SIOP-E AND ISPN","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Children's Hospital of Eastern Ontario; Children's Hospital of Winnipeg","funders":"","keywords":"Craniopharyngioma; Medicine; Alpha interferon; Pediatrics; Alpha (finance); Internal medicine; Interferon; Virology; Surgery","score_opus":0.01609451955740978,"score_gpt":0.3146385904288811,"score_spread":0.29854407087147133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2434544329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964331,0.00006590401,0.00013603618,0.0012537895,0.0005669931,0.0004043839,0.000062404695,0.000021533797,0.0010558944],"genre_scores_gemma":[0.99866337,0.00024890556,0.00040410343,0.0004889938,0.000071738,0.000021078084,0.000049654464,0.000018849985,0.000033283144],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986807,0.00016925215,0.00035890113,0.00036599018,0.00019305243,0.00023208304],"domain_scores_gemma":[0.999151,0.0002864426,0.00012878195,0.00019612837,0.0000839051,0.00015377357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011423778,0.00017397314,0.00034620453,0.0002471728,0.000024833207,0.000005585787,0.00010611153,0.00011098562,0.00017096265],"category_scores_gemma":[0.00014622735,0.000116756106,0.00005588398,0.000090577785,0.00007053548,0.00014972642,0.000068731126,0.00012996946,0.000019246463],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008745134,0.007138836,0.7961636,0.000023108189,0.00006104507,0.00039751243,0.0002533843,0.0000018861583,0.013954926,0.00009124137,0.00017421939,0.1808657],"study_design_scores_gemma":[0.026361916,0.0077961097,0.9628668,0.000080526144,0.000106917745,0.000038952578,0.00009047858,0.00040181377,0.00079193286,0.00009933292,0.0012225228,0.00014270165],"about_ca_topic_score_codex":0.0000505505,"about_ca_topic_score_gemma":0.00006226335,"teacher_disagreement_score":0.18072301,"about_ca_system_score_codex":0.00018600498,"about_ca_system_score_gemma":0.0000891252,"threshold_uncertainty_score":0.47611758},"labels":[],"label_agreement":null},{"id":"W2434976182","doi":"10.1093/neuonc/now076.99","title":"MB-104GENETIC PREDICTORS OF INTELLECTUAL OUTCOME IN CHILDREN TREATED FOR MEDULLOBLASTOMA","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiation Therapy and Dosimetry","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Outcome (game theory); Pediatrics; Medicine; Psychology; Pathology; Mathematics","score_opus":0.01828709177023061,"score_gpt":0.30129577749920133,"score_spread":0.2830086857289707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2434976182","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971179,0.00009898139,0.0002832117,0.0010560179,0.00023532157,0.0006874481,0.00002694915,0.0000458781,0.00044831596],"genre_scores_gemma":[0.99850506,0.00007646024,0.00015236509,0.00082279945,0.00015989489,0.00005312649,0.000009865617,0.000025117104,0.00019530785],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99884135,0.00011377823,0.00045642955,0.00024322112,0.000112726324,0.00023252695],"domain_scores_gemma":[0.99841213,0.0010978451,0.00012554254,0.00020565906,0.000054086846,0.00010472802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016609566,0.00012804026,0.0004262223,0.00027895914,0.00001932566,0.0000016963946,0.00009968812,0.00018660734,0.00028591682],"category_scores_gemma":[0.0009875934,0.000086971115,0.00010277542,0.00022408414,0.00012178134,0.000031061256,0.000019191359,0.00008909826,0.000022717932],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010940123,0.00024194957,0.7504573,0.000011116754,0.00006487121,0.0000061280334,0.00021845945,0.000003964639,0.22198571,0.000028562954,0.0017007232,0.024187183],"study_design_scores_gemma":[0.0153648425,0.010388168,0.6921572,0.00003958364,0.00015322541,0.00019280906,0.00004636108,0.00013312537,0.24650595,0.0000947932,0.034728028,0.000195929],"about_ca_topic_score_codex":0.000010918434,"about_ca_topic_score_gemma":0.000011189275,"teacher_disagreement_score":0.058300123,"about_ca_system_score_codex":0.0001243128,"about_ca_system_score_gemma":0.00013175726,"threshold_uncertainty_score":0.3546579},"labels":[],"label_agreement":null},{"id":"W2434988104","doi":"10.1093/neuonc/now073.81","title":"HG-85INTER-OBSERVER AGREEMENT IN NEUROPATHOLOGICAL HGG DIAGNOSIS : EXPERIENCE OF THE PRE-RANDOMISATION CENTRAL REVIEW IN THE HERBY TRIAL","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Bevacizumab; Pediatrics; Surgery","score_opus":0.04760235000277003,"score_gpt":0.3328194419502419,"score_spread":0.28521709194747186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2434988104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9712944,0.0011234594,0.000002626439,0.024188777,0.0005065168,0.0025921266,0.0000033885958,0.0000082338065,0.00028048398],"genre_scores_gemma":[0.9884533,0.005378268,0.000013980178,0.004891863,0.00008556768,0.0011595949,0.000001931948,0.000008522831,0.0000069462326],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99724835,0.0012315173,0.0006073599,0.0003344224,0.00028072725,0.00029765078],"domain_scores_gemma":[0.99796987,0.0012712362,0.00021182025,0.0004542532,0.000036675072,0.000056158744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054516987,0.00015874603,0.00051173195,0.00004942367,0.000030411293,0.000005285934,0.00025238132,0.0000865571,0.00026833446],"category_scores_gemma":[0.0012161171,0.00006568359,0.00018897955,0.0002433041,0.00015506444,0.000049777587,0.000092721595,0.00017517137,0.00000991108],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014811773,0.00714641,0.83552194,0.00020556414,0.000031852902,0.0011597328,0.0041151945,0.0000062101353,0.041191682,0.00030783145,0.004733253,0.09076858],"study_design_scores_gemma":[0.088307776,0.0037215804,0.85024005,0.0010765385,0.00016210024,0.00012203185,0.00014214797,0.000008739335,0.0096777,0.00005747403,0.046355672,0.00012819118],"about_ca_topic_score_codex":0.00012077628,"about_ca_topic_score_gemma":0.00028569082,"teacher_disagreement_score":0.090640396,"about_ca_system_score_codex":0.0001761436,"about_ca_system_score_gemma":0.00007923853,"threshold_uncertainty_score":0.29380742},"labels":[],"label_agreement":null},{"id":"W2435047036","doi":"10.1093/neuonc/now067.07","title":"PNR-08NEWLY DISCOVERED ONCOGENES DRIVING AND MAINTAINING CHOROID PLEXUS CARCINOMA PROVIDE POTENTIALLY DRUGGABLE TARGETS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Druggability; Choroid plexus; Biology; Cancer research; Computational biology; Neuroscience; Biochemistry; Gene","score_opus":0.03258160936721553,"score_gpt":0.2625942363159084,"score_spread":0.23001262694869284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2435047036","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98692185,0.0010171693,0.0005082282,0.006653742,0.00043922476,0.0009702411,0.000025518399,0.00012504632,0.0033389598],"genre_scores_gemma":[0.9955186,0.00027445733,0.0018690471,0.00096840045,0.00045836935,0.00014046342,0.000039187882,0.00007731796,0.00065410265],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974647,0.00026935173,0.0004727329,0.0007576195,0.00028761395,0.00074795424],"domain_scores_gemma":[0.99839276,0.00046890893,0.00019594778,0.00041498206,0.000105210165,0.00042220583],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031978157,0.00036854905,0.0006946897,0.0001938727,0.00021639382,0.000043636075,0.00015117372,0.00026046013,0.00023016751],"category_scores_gemma":[0.00029558453,0.00025932162,0.0001783619,0.00016005019,0.00017749252,0.00022809801,0.00020867045,0.00022575684,0.00008384382],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031365367,0.00014491891,0.51954406,0.000031642227,0.00007819697,0.0016742579,0.00029289557,4.5186198e-7,0.40594625,0.000095635674,0.00085266615,0.07102535],"study_design_scores_gemma":[0.01999581,0.009769528,0.16800411,0.0002811492,0.0012622126,0.0029473372,0.0005495379,0.00093620806,0.31341866,0.00071108085,0.48096874,0.0011556527],"about_ca_topic_score_codex":0.00015129386,"about_ca_topic_score_gemma":0.0001542393,"teacher_disagreement_score":0.48011607,"about_ca_system_score_codex":0.00032234262,"about_ca_system_score_gemma":0.00053800526,"threshold_uncertainty_score":0.9999859},"labels":[],"label_agreement":null},{"id":"W2435059843","doi":"10.1093/neuonc/now075.73","title":"LG-73CHARACTERIZATION OF GANGLIOGLIOMA AS A NEURODEVELOPMENTAL DISORDER","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Vascular Malformations Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Ganglioglioma; Neurodevelopmental disorder; Medicine; Psychology; Neuroscience; Psychiatry; Epilepsy","score_opus":0.013215023937970461,"score_gpt":0.2796210293097645,"score_spread":0.26640600537179404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2435059843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99033713,0.000044544093,0.00021948805,0.0057093063,0.00023347732,0.0003716508,0.000011167288,0.000044053715,0.0030291667],"genre_scores_gemma":[0.9978794,0.0002551943,0.00033177144,0.0012945369,0.000043405475,0.00007606695,0.00003238145,0.00001880427,0.00006846836],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9991249,0.000066679015,0.0002941121,0.00018888891,0.00016060074,0.00016481147],"domain_scores_gemma":[0.9993643,0.00012780927,0.0001276843,0.00020782613,0.00008830055,0.00008408461],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000068778696,0.00011326942,0.0002599414,0.00017669074,0.000041649157,0.0000041291873,0.000056505647,0.000081631995,0.00045893152],"category_scores_gemma":[0.00016809008,0.00007388236,0.00009295909,0.00019812232,0.000060177823,0.00010560177,0.000047396425,0.000052225572,0.0002259656],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023185884,0.0015695688,0.12028351,0.00004096777,0.00012592437,0.00028286915,0.00045826312,0.0000012175869,0.6552057,0.0010294878,0.001154032,0.21961655],"study_design_scores_gemma":[0.008928008,0.003832674,0.5259892,0.00008920787,0.00023425458,0.0012933828,0.00011596751,0.000039954688,0.17250253,0.00014116676,0.2866176,0.00021604449],"about_ca_topic_score_codex":0.000010576306,"about_ca_topic_score_gemma":0.0000058115156,"teacher_disagreement_score":0.48270324,"about_ca_system_score_codex":0.000095653435,"about_ca_system_score_gemma":0.00016073651,"threshold_uncertainty_score":0.50249785},"labels":[],"label_agreement":null},{"id":"W2435135167","doi":"10.1093/neuonc/now075.02","title":"LG-02MYB-QKI REARRANGEMENTS IN ANGIOCENTRIC GLIOMA DRIVE TUMORIGENICITY THROUGH A TRIPARTITE MECHANISM","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Mechanisms and Therapy","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Hospital for Sick Children","funders":"","keywords":"Mechanism (biology); Glioma; Biology; Genetics; Philosophy; Epistemology","score_opus":0.02755740331996481,"score_gpt":0.31406896547571256,"score_spread":0.28651156215574775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2435135167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840041,0.00036137048,0.002209264,0.006555183,0.0017942159,0.001102569,0.000030123734,0.00013765419,0.003805518],"genre_scores_gemma":[0.99269354,0.0007351977,0.0007824123,0.0047368933,0.00046320405,0.00014883754,0.000006189279,0.000055374876,0.000378335],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99778736,0.00019021938,0.00046881367,0.00059191824,0.0003183456,0.00064336025],"domain_scores_gemma":[0.9989052,0.00018016662,0.00018660128,0.00044442416,0.000094503885,0.00018914849],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027926214,0.0002576128,0.0006257703,0.00025543882,0.000067754874,0.000010356699,0.00017933111,0.00022567442,0.0010534873],"category_scores_gemma":[0.0001001639,0.00018744895,0.00017447944,0.0005366452,0.000075100856,0.0001403599,0.000090176225,0.00024405148,0.00024165807],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012976067,0.00054071815,0.00089208287,0.00001871144,0.00006614345,0.0017817945,0.00073825556,4.0402773e-7,0.9572275,0.008206601,0.0019840845,0.027246075],"study_design_scores_gemma":[0.025579985,0.005975686,0.002754674,0.00014326218,0.00017079101,0.00071324524,0.00023733372,0.000061054496,0.58632,0.02111437,0.35645905,0.00047057524],"about_ca_topic_score_codex":0.00018779156,"about_ca_topic_score_gemma":0.00021462889,"teacher_disagreement_score":0.37090755,"about_ca_system_score_codex":0.0005782057,"about_ca_system_score_gemma":0.00030155262,"threshold_uncertainty_score":0.9998597},"labels":[],"label_agreement":null},{"id":"W2435392671","doi":"10.1093/neuonc/now075.66","title":"LG-66CLINICAL AND TREATMENT FACTORS DETERMINING LONG-TERM OUTCOMES FOR ADULT SURVIVORS OF CHILDHOOD LOW-GRADE GLIOMA: A POPULATION-BASED STUDY","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Pediatric Oncology Group; SickKids Foundation; Occupational Cancer Research Centre; Hospital for Sick Children","funders":"","keywords":"Glioma; Term (time); Medicine; Pediatrics; Physics; Cancer research","score_opus":0.034365346073860555,"score_gpt":0.3590180884324387,"score_spread":0.32465274235857816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2435392671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99814713,0.000026760226,0.00012279686,0.00029058376,0.0002649039,0.0010280617,0.00008993952,0.000018513105,0.000011306159],"genre_scores_gemma":[0.9993399,0.000014647763,0.00013036905,0.000097957934,0.00011803218,0.0001581207,0.00006703166,0.000043502325,0.00003046121],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980204,0.0003171454,0.000520016,0.00060074596,0.00018071463,0.0003609626],"domain_scores_gemma":[0.99818367,0.0008617972,0.00021163245,0.00041949525,0.00015699204,0.00016641014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018807946,0.0002567915,0.0005064184,0.00013553166,0.00010023098,0.000009993133,0.0001786124,0.00025572182,0.000009645207],"category_scores_gemma":[0.0012291053,0.00017613312,0.00019168525,0.00007983374,0.00012658845,0.0000070950177,0.00009033126,0.000080010526,0.0000022693955],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017858273,0.0011407143,0.69151694,0.000012125011,0.00006810861,0.000024471776,0.0001236998,0.0000027232443,0.3011772,0.0000018198197,0.000017585511,0.0057360255],"study_design_scores_gemma":[0.007114227,0.009515241,0.7200931,0.000017254933,0.000066350585,0.000013179777,0.00008211469,0.00001393997,0.26262555,0.00000405337,0.00023007407,0.00022496046],"about_ca_topic_score_codex":0.00010421451,"about_ca_topic_score_gemma":0.001662987,"teacher_disagreement_score":0.038551643,"about_ca_system_score_codex":0.00009895564,"about_ca_system_score_gemma":0.00022946515,"threshold_uncertainty_score":0.71825004},"labels":[],"label_agreement":null},{"id":"W2435539542","doi":"10.1093/neuonc/now073.69","title":"HG-73SAFETY AND FEASIBILITY OF A MULTI-INSTITUTIONAL PHASE II TRIAL INCOPORATING BIOPSY AND MOLECULARLY DETERMINED TREATMENT OF CHILDREN AND YOUNG ADULTS WITH NEWLY DIAGNOSED DIFFUSE INTRINSIC PONTINE GLIOMAS (DIPG)","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Children's Hospital","funders":"","keywords":"Medicine; Biopsy; Pediatrics; Radiology; Oncology","score_opus":0.020527483600202904,"score_gpt":0.2981912618108964,"score_spread":0.2776637782106935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2435539542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99633735,0.00065848866,0.00008056527,0.0006306288,0.00008999696,0.0020160791,0.00014635823,0.00002572193,0.000014809433],"genre_scores_gemma":[0.9970945,0.00034256454,0.002278011,0.00004632947,0.000076431184,0.000103445396,0.000037156515,0.000019357856,0.0000021890185],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99835324,0.00014205113,0.000527391,0.00055550254,0.0001843786,0.00023741889],"domain_scores_gemma":[0.99864185,0.00036102487,0.00034594358,0.00028544376,0.00013492782,0.00023082744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000120749624,0.00030383564,0.00081820966,0.00018377435,0.000113681504,0.0000088094885,0.000044294877,0.00013533642,0.000007774517],"category_scores_gemma":[0.00032292766,0.00017457725,0.00007717155,0.00016358038,0.0005193106,0.00009874569,0.00008388613,0.00006417589,2.855512e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.051321477,0.014457619,0.28024983,0.0000499915,0.0003019443,0.0013661277,0.0008958842,3.427701e-7,0.48486406,0.000046191693,0.0000053095537,0.16644123],"study_design_scores_gemma":[0.557858,0.057791542,0.33826444,0.00014681481,0.00058187864,0.0015619198,0.00005571557,0.00011289229,0.04337252,0.0000104324945,0.000041217387,0.00020264681],"about_ca_topic_score_codex":0.00040582867,"about_ca_topic_score_gemma":0.0003488566,"teacher_disagreement_score":0.5065365,"about_ca_system_score_codex":0.00012779984,"about_ca_system_score_gemma":0.00020872212,"threshold_uncertainty_score":0.71190536},"labels":[],"label_agreement":null},{"id":"W2435972166","doi":"10.1093/neuonc/now072.03","title":"GC-03AREAS OF NON-CONSENSUS CHALLENGING THE MANAGEMENT OF INTRACRANIAL GERM CELL TUMOURS (ICGCT)","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Germ cell; Consensus conference; Germ; Medicine; Internal medicine; Biology; Cell biology","score_opus":0.01758511183545345,"score_gpt":0.27679278278108105,"score_spread":0.2592076709456276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2435972166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97661597,0.00023667427,0.000030936633,0.010334922,0.00039669406,0.000577409,0.000012253293,0.00002065575,0.011774483],"genre_scores_gemma":[0.9986858,0.00050555624,0.00031768798,0.00026706248,0.00010675491,0.00005699144,0.0000018398521,0.00002298101,0.0000353735],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99877435,0.00008849927,0.000387742,0.0002583842,0.00021297047,0.00027804213],"domain_scores_gemma":[0.9986067,0.0005680119,0.000250022,0.00039875697,0.000085134416,0.00009139321],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020338406,0.0001601407,0.00043832755,0.00010172477,0.000042535008,0.000002396195,0.00013519482,0.000089438916,0.000109413304],"category_scores_gemma":[0.000031418203,0.00008692232,0.00014354533,0.00011956684,0.00016682025,0.000014320323,0.00009149833,0.000104598046,0.000033091215],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008164883,0.0031540564,0.030695014,0.00040829094,0.00040272056,0.004108149,0.0007855997,0.000021074115,0.76531905,0.0015864681,0.0032979262,0.18940516],"study_design_scores_gemma":[0.025542315,0.0066640303,0.26803544,0.0005783418,0.001957776,0.0008208912,0.0015292903,0.00023398997,0.6593178,0.00039095304,0.034542624,0.00038656243],"about_ca_topic_score_codex":0.000027341845,"about_ca_topic_score_gemma":0.000009490831,"teacher_disagreement_score":0.23734042,"about_ca_system_score_codex":0.00009641841,"about_ca_system_score_gemma":0.00007649291,"threshold_uncertainty_score":0.35445893},"labels":[],"label_agreement":null},{"id":"W2436034443","doi":"10.1093/neuonc/now078.09","title":"NS-09NARCOLEPSY AND BRAIN TUMORS: PRESENTATION AND EVOLUTION","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Presentation (obstetrics); Neuroscience; Brain tumor; Cognitive science; Psychology; History; Computer science; Medicine; Pathology; Radiology","score_opus":0.0270223884742118,"score_gpt":0.35236595476827015,"score_spread":0.32534356629405836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2436034443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9430041,0.00015404845,0.0006772204,0.051687825,0.00004014119,0.00028495167,0.000005550023,0.000049399623,0.0040967627],"genre_scores_gemma":[0.99757206,0.00008988492,0.00023848916,0.0015634922,0.00019609627,0.000055618126,0.0000038170137,0.000008318895,0.00027220976],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99938595,0.00004830302,0.000135082,0.00022294708,0.000070495196,0.0001372476],"domain_scores_gemma":[0.9992233,0.0004331233,0.00004145603,0.00011102811,0.000030824853,0.0001602632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000873798,0.00007176155,0.00013390422,0.000028143617,0.00005559356,0.000006450395,0.000029411063,0.00008071847,0.00006183675],"category_scores_gemma":[0.00025661336,0.000052413652,0.000016717728,0.0000691601,0.00018976464,0.00007077505,0.000029311956,0.00010450694,0.000017275463],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011018891,0.000062047875,0.007075363,0.000028639026,0.000006409545,0.000023142555,0.000043374173,1.5786534e-7,0.9620576,0.0010118224,0.0027932515,0.026788026],"study_design_scores_gemma":[0.008590354,0.0014507831,0.14899783,0.00010565259,0.00017955623,0.002593561,0.00022524629,0.00075929414,0.41465965,0.0044654235,0.41767883,0.00029381178],"about_ca_topic_score_codex":0.0000036540644,"about_ca_topic_score_gemma":0.0000010757228,"teacher_disagreement_score":0.5473979,"about_ca_system_score_codex":0.000063271356,"about_ca_system_score_gemma":0.00005947552,"threshold_uncertainty_score":0.21373667},"labels":[],"label_agreement":null},{"id":"W2436093430","doi":"10.1093/neuonc/now081.57","title":"QOS-57BEHAVIOR IN SURVIVORS OF PEDIATRIC MEDULLOBLASTOMA: THE IMPACT OF COGNITIVE FLEXIBILITY, INTELLIGENCE, AND NEGATIVE AFFECT","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Affect (linguistics); Medulloblastoma; Flexibility (engineering); Cognition; Cognitive flexibility; Psychology; Medicine; Neuroscience; Cancer research; Communication","score_opus":0.03962540558939532,"score_gpt":0.3626321325291585,"score_spread":0.3230067269397632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2436093430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978455,0.00021652931,0.000011386399,0.00046841605,0.00013202646,0.00086261885,0.00005544927,0.00001082356,0.0003972855],"genre_scores_gemma":[0.99941915,0.00036095208,0.000017092721,0.000041717325,0.00006288654,0.000078274745,0.0000021559842,0.000013954496,0.000003818173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99859047,0.0003574706,0.0003757667,0.00028957738,0.0001571301,0.00022959583],"domain_scores_gemma":[0.9943312,0.004984381,0.0002240564,0.00020320505,0.00015705018,0.00010012732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032768483,0.00017026879,0.0005466425,0.00022671832,0.00002277733,0.0000023801986,0.00008047521,0.00011752848,0.000105405925],"category_scores_gemma":[0.0011795837,0.00008246015,0.00014568296,0.00038945096,0.00039205968,0.000044504835,0.00008974289,0.00013724387,0.000007561232],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006971205,0.0017191777,0.9364044,0.000024665744,0.00007545207,0.000120235374,0.0009463135,0.000003253012,0.027594712,0.000048385675,0.00010376581,0.032262538],"study_design_scores_gemma":[0.0028033745,0.007673641,0.898774,0.00006307932,0.0002973685,0.000060957336,0.00039055373,0.000012960085,0.08963449,0.00020101927,0.00001095077,0.00007754567],"about_ca_topic_score_codex":0.0006539997,"about_ca_topic_score_gemma":0.0005908874,"teacher_disagreement_score":0.06203978,"about_ca_system_score_codex":0.0001369693,"about_ca_system_score_gemma":0.0002314415,"threshold_uncertainty_score":0.33626276},"labels":[],"label_agreement":null},{"id":"W2436476450","doi":"10.1093/neuonc/now076.87","title":"MB-91OUTCOMES FOR YOUNG CHILDREN WITH BRAIN TUMOURS TREATED ACCORDING TO THE HEAD START PROTOCOLS: A SINGLE-CENTRE EXPERIENCE","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital","funders":"","keywords":"Head start; Head (geology); Medicine; Pediatrics; Psychology; Developmental psychology; Biology","score_opus":0.046497437582261984,"score_gpt":0.33984237233395276,"score_spread":0.29334493475169077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2436476450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9229091,0.00001836183,0.0001117258,0.054024223,0.00010927689,0.022425387,0.000033643428,0.00010379292,0.0002645169],"genre_scores_gemma":[0.9735567,0.0000021123305,0.00042041403,0.0038680674,0.00018209912,0.021799937,0.000010402806,0.000048765527,0.000111481604],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99831253,0.00012361028,0.00028636205,0.0005234205,0.00021832541,0.00053575885],"domain_scores_gemma":[0.9983634,0.0007222257,0.00013241307,0.00043720152,0.00011628589,0.00022851858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013659493,0.00026410067,0.00048020424,0.00010715922,0.00017080511,0.00003272297,0.00018318265,0.00008835835,0.000049064227],"category_scores_gemma":[0.00043994412,0.00012431043,0.00011307339,0.00024013394,0.0001033348,0.0000819692,0.00006761155,0.000092910115,0.000034410226],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010507543,0.00092914084,0.81825083,0.000009634668,0.000089985064,0.00013312428,0.0010930446,0.000002924287,0.13771865,0.00005792882,0.0062515936,0.0344124],"study_design_scores_gemma":[0.035786204,0.026691394,0.41114008,0.0006210501,0.00047463118,0.0011444242,0.0024693683,0.00003357164,0.2662417,0.000031539323,0.2546684,0.0006976054],"about_ca_topic_score_codex":0.000059914517,"about_ca_topic_score_gemma":0.0004952124,"teacher_disagreement_score":0.40711072,"about_ca_system_score_codex":0.0003292552,"about_ca_system_score_gemma":0.00014937895,"threshold_uncertainty_score":0.50692326},"labels":[],"label_agreement":null},{"id":"W2436556474","doi":"10.1093/neuonc/now073.71","title":"HG-75CLINICAL, RADIOLOGICAL, AND HISTO-GENETIC CHARACTERISTICS OF LONG-TERM SURVIVORS OF DIFFUSE INTRINSIC PONTINE GLIOMA: A COLLABORATIVE REPORT FROM THE INTERNATIONAL AND SIOP-E DIPG REGISTRIES","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Children's Hospital; Centre Hospitalier Universitaire Sainte-Justine; Hospital for Sick Children","funders":"","keywords":"Radiological weapon; Term (time); Glioma; Medicine; Oncology; Pediatrics; Radiology; Physics; Cancer research","score_opus":0.02394404100340454,"score_gpt":0.29784512720077844,"score_spread":0.2739010861973739,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2436556474","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897039,0.0008289247,0.000014998665,0.008407607,0.00041435397,0.00037801164,0.00016594114,0.000014734762,0.00007155254],"genre_scores_gemma":[0.9971795,0.0021171807,0.00016040624,0.00027968845,0.0001491823,0.000032185104,0.000043214783,0.000013057656,0.00002559989],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984305,0.00017168581,0.0006925965,0.00037502465,0.00018353444,0.00014668182],"domain_scores_gemma":[0.9958327,0.0027885614,0.0006517608,0.00035378692,0.000266349,0.00010684939],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018972682,0.00016918793,0.00068196544,0.00006859883,0.000044203327,0.000010734404,0.00012251559,0.0001476091,0.00006086824],"category_scores_gemma":[0.00240508,0.00008969391,0.00006385391,0.00012401232,0.0009249892,0.000033686567,0.0001682744,0.000108524,0.0000015216958],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008810787,0.00084962975,0.79471254,0.000015283831,0.00020206388,0.0026065877,0.00026388204,2.5850177e-8,0.17269984,0.000048919464,0.0010619822,0.02665814],"study_design_scores_gemma":[0.0044152695,0.0015813095,0.97708386,0.000071763476,0.00025054353,0.0005841825,0.00006664468,0.000001740434,0.008635537,0.000046651945,0.007180525,0.000081952894],"about_ca_topic_score_codex":0.00019269102,"about_ca_topic_score_gemma":0.00027519793,"teacher_disagreement_score":0.18237132,"about_ca_system_score_codex":0.000074638214,"about_ca_system_score_gemma":0.00017176525,"threshold_uncertainty_score":0.36576116},"labels":[],"label_agreement":null},{"id":"W2436761352","doi":"10.1093/neuonc/now065.10","title":"AT-11CRIBRIFORM NEUROEPITHELIAL TUMOR (CRINET): MOLECULAR CHARACTERIZATION OF A SMARCB1-DEFICIENT NON-RHABDOID TUMOR WITH FAVORABLE LONG-TERM OUTCOME","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"SMARCB1; Neuroepithelial cell; Term (time); Outcome (game theory); Biology; Genetics; Physics; Embryonic stem cell; Astronomy; Gene","score_opus":0.01047996471295197,"score_gpt":0.25944317275410983,"score_spread":0.24896320804115785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2436761352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99373287,0.000054563065,0.004221292,0.0004509086,0.00038109743,0.00041575945,0.000089689194,0.000032934393,0.0006209131],"genre_scores_gemma":[0.997705,0.00007152935,0.00021782581,0.0013425433,0.00017869554,0.000063579304,0.000089013374,0.00007076759,0.00026108825],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980102,0.00010601154,0.0005306441,0.0006330617,0.00025054917,0.00046949455],"domain_scores_gemma":[0.99866366,0.0000337586,0.00038727518,0.0005868107,0.00018061048,0.00014791073],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014761706,0.00030216065,0.00042976247,0.00008544759,0.00008306739,0.000013990034,0.00030946085,0.000106189524,0.00006803629],"category_scores_gemma":[0.000082599916,0.00021696587,0.00014497027,0.00013141657,0.00019073508,0.000010449067,0.00023813896,0.00012280753,0.00003136575],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006330747,0.00016410829,0.017830553,0.00007277832,0.000029676065,0.0001521211,0.00002557353,0.000053538304,0.9773387,0.000012729664,0.00007496423,0.003612201],"study_design_scores_gemma":[0.00232131,0.0024610683,0.01246869,0.00005013439,0.000058648555,0.00056748616,0.000007398192,0.00017075407,0.97153,0.0000055108585,0.010044771,0.00031422687],"about_ca_topic_score_codex":0.00001649682,"about_ca_topic_score_gemma":0.000034443445,"teacher_disagreement_score":0.009969807,"about_ca_system_score_codex":0.00010710677,"about_ca_system_score_gemma":0.0002715365,"threshold_uncertainty_score":0.88476115},"labels":[],"label_agreement":null},{"id":"W2436846717","doi":"10.1093/neuonc/now065.09","title":"AT-10ATYPICAL TERATOID RHABDOID TUMORS AND POORLY DIFFERENTIATED CHORDOMAS: DISTINCT MOLECULAR ENTITIES WITH SMARCB1/INI1 LOSS AND DISMAL PROGNOSIS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine","score_opus":0.0066009340988724035,"score_gpt":0.23163886382254845,"score_spread":0.22503792972367603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2436846717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969567,0.00040727228,0.00069407653,0.0011287667,0.00011281269,0.00024121479,0.00004550576,0.000036391182,0.00037727918],"genre_scores_gemma":[0.9986168,0.00027290723,0.00025228204,0.00043305106,0.00012512451,0.0000789785,0.000043396005,0.00004290606,0.0001345491],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99845654,0.00015068866,0.00025722108,0.0006238679,0.00014164891,0.000370019],"domain_scores_gemma":[0.9993248,0.000062131185,0.000113386064,0.00025157369,0.00006906154,0.00017902201],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000080380465,0.00026923025,0.00031096593,0.000046185014,0.0001310595,0.000035164605,0.00013301213,0.00019697435,0.0000335309],"category_scores_gemma":[0.00007602961,0.00018013055,0.000059561706,0.000060542592,0.00047975226,0.000007637516,0.00025674497,0.00011689462,0.000004308656],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006414126,0.000105256164,0.04885002,0.000040795425,0.000066014174,0.00009916203,0.000058657017,0.0000013556938,0.93981487,0.00007109397,0.00030066713,0.009950688],"study_design_scores_gemma":[0.0071809595,0.005529044,0.049839687,0.00015153448,0.00019545919,0.0014021072,0.00007598137,0.00016465552,0.88767624,0.000292822,0.046559293,0.0009322095],"about_ca_topic_score_codex":0.000011916758,"about_ca_topic_score_gemma":0.000081022794,"teacher_disagreement_score":0.05213863,"about_ca_system_score_codex":0.000043950615,"about_ca_system_score_gemma":0.00010011041,"threshold_uncertainty_score":0.734551},"labels":[],"label_agreement":null},{"id":"W2437260606","doi":"10.1093/neuonc/now067.27","title":"PNR-32UPDATE OF DIAGNOSTICS OF PRIMITIVE NEUROECTODERMAL TUMOURS OF THE CNS - NEUROPATHOLOGICAL RE-EVALUATION OF 99 CASES","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Pathology; Primitive neuroectodermal tumor; Medicine; Sarcoma","score_opus":0.06094340963463505,"score_gpt":0.33819631169282166,"score_spread":0.2772529020581866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2437260606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951478,0.0001853927,0.0000062611794,0.002491342,0.00036940625,0.00069517747,0.00012382695,0.00001092913,0.0009698236],"genre_scores_gemma":[0.9991497,0.000390589,0.00006245634,0.00028402312,0.00004342167,0.000042892647,0.0000058454857,0.000018740571,0.0000023324938],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99751496,0.0008504768,0.0006367692,0.00028316135,0.00050695555,0.00020764749],"domain_scores_gemma":[0.9943154,0.0038543632,0.00071280426,0.00045740357,0.0005876373,0.00007238145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038376532,0.00016644652,0.00065982953,0.00011938216,0.000026241361,0.0000011369575,0.00016081208,0.000114192,0.00011991822],"category_scores_gemma":[0.006836342,0.000090400965,0.0002018263,0.00021641776,0.0005547056,0.00003603453,0.00014661651,0.00012814856,0.0000029565772],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000344279,0.0018519874,0.17864618,0.00005297727,0.000038742564,0.00036223093,0.00020147482,0.000043739958,0.8044396,0.00037456542,0.0006419197,0.013002291],"study_design_scores_gemma":[0.0026784812,0.0030623993,0.4967817,0.000085730986,0.0006572083,0.00022364757,0.000053577074,0.00003558404,0.49603772,0.000066463544,0.00027047106,0.000047001377],"about_ca_topic_score_codex":0.000015132314,"about_ca_topic_score_gemma":0.000019923324,"teacher_disagreement_score":0.31813553,"about_ca_system_score_codex":0.00006172502,"about_ca_system_score_gemma":0.00030248525,"threshold_uncertainty_score":0.8184234},"labels":[],"label_agreement":null},{"id":"W2438121086","doi":"10.1093/neuonc/now065.08","title":"AT-09TREATMENT OF ATYPICAL TERATOID RHABDOID TUMORS (ATRT) OF THE CENTRAL NERVOUS SYSTEM WITH SURGERY, INTENSIVE CHEMOTHERAPY, AND 3-D CONFORMAL RADIATION (ACNS0333). A REPORT FROM THE CHILDREN'S ONCOLOGY GROUP","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital","funders":"","keywords":"Chemotherapy; Medicine; Radiation therapy; Atypical teratoid rhabdoid tumor; Central nervous system; Oncology; Internal medicine","score_opus":0.005730640002571127,"score_gpt":0.21882018653247345,"score_spread":0.21308954652990234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2438121086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967155,0.00042052008,0.00026399485,0.0016591912,0.00030178553,0.0004142566,0.00006846454,0.000011345266,0.00014497578],"genre_scores_gemma":[0.9985562,0.0002838683,0.00008173272,0.0007293053,0.00021445335,0.00003349256,0.00005878858,0.000022333688,0.00001980129],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99849176,0.00024808687,0.0004897504,0.00035777164,0.0001481706,0.00026443272],"domain_scores_gemma":[0.99849254,0.0002628158,0.0005730882,0.00044207208,0.00015641656,0.00007305186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018932235,0.00019218685,0.00042751266,0.000020999496,0.0000865156,0.000005811009,0.00017089368,0.0002077129,0.0000123761],"category_scores_gemma":[0.00013149698,0.00009402008,0.00013518849,0.00006140856,0.00039875408,0.000005514168,0.00013121613,0.0000996859,8.616384e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025110024,0.00014399907,0.16698547,0.000026686508,0.00030959814,0.000058532005,0.00048453544,0.00004159757,0.7697013,0.00005841727,0.003089989,0.056588884],"study_design_scores_gemma":[0.0052140555,0.0032793728,0.40948772,0.00018349367,0.00021228184,0.00427126,0.00057700527,0.00019215477,0.54763913,0.000017925155,0.028564963,0.00036060967],"about_ca_topic_score_codex":0.00035775814,"about_ca_topic_score_gemma":0.00026850222,"teacher_disagreement_score":0.24250226,"about_ca_system_score_codex":0.00016683733,"about_ca_system_score_gemma":0.00040981986,"threshold_uncertainty_score":0.38340273},"labels":[],"label_agreement":null},{"id":"W2438390390","doi":"10.1093/neuonc/now076.95","title":"MB-100DIVERGENT CLONAL SELECTION DOMINATES MEDULLOBLASTOMA AT RECURRENCE","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Selection (genetic algorithm); Biology; Clonal selection; Genetics; Computer science; Artificial intelligence; Immunology","score_opus":0.019034423263387792,"score_gpt":0.2942355282133359,"score_spread":0.2752011049499481,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2438390390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98405594,0.00021449185,0.000022870965,0.01149925,0.0010076604,0.00036740684,0.000015415797,0.000082732266,0.0027342124],"genre_scores_gemma":[0.9977779,0.00040297656,0.00022608771,0.0009781505,0.00023801562,0.00013749005,0.000009186052,0.000019835341,0.00021035632],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986595,0.00011863727,0.0002451196,0.0004132046,0.00021958211,0.00034393612],"domain_scores_gemma":[0.9988899,0.00047261405,0.00011497116,0.00018421619,0.000118669304,0.00021963094],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00011029612,0.000176237,0.0003222738,0.000112125585,0.000109443215,0.000005334382,0.000076206976,0.00014730835,0.0016116056],"category_scores_gemma":[0.0002234686,0.00011145985,0.00011601635,0.00014524431,0.00010928077,0.00005229932,0.00012874922,0.000109792825,0.00090581586],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061044254,0.00077549746,0.09327549,0.000013257724,0.00007617925,0.00042478408,0.0000814948,0.0000011479947,0.7267315,0.0003304921,0.03507871,0.14260101],"study_design_scores_gemma":[0.005461549,0.004151538,0.05331607,0.00005781443,0.00017971567,0.0010324232,0.000015477242,0.000034048502,0.5042918,0.00016930899,0.4311294,0.00016084872],"about_ca_topic_score_codex":0.00001519837,"about_ca_topic_score_gemma":0.00006634739,"teacher_disagreement_score":0.3960507,"about_ca_system_score_codex":0.00067550235,"about_ca_system_score_gemma":0.00014643371,"threshold_uncertainty_score":0.9998721},"labels":[],"label_agreement":null},{"id":"W2438632591","doi":"10.1093/neuonc/now081.58","title":"QOS-58IMPACT OF CRANIAL RADIATION THERAPY ON HIPPOCAMPAL SUBFIELD VOLUMES AND DECLARATIVE MEMORY IN PEDIATRIC BRAIN TUMOR SURVIVORS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Douglas Mental Health University Institute; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Hippocampal formation; Radiation therapy; Medicine; Quality of life (healthcare); Neuroscience; Psychology; Oncology; Internal medicine; Psychotherapist","score_opus":0.01945249584809524,"score_gpt":0.296042248970589,"score_spread":0.2765897531224938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2438632591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908839,0.0004481676,0.0000043662594,0.007194801,0.00036586905,0.00052202516,0.000012615238,0.00001961171,0.00054866326],"genre_scores_gemma":[0.9970664,0.0009837802,0.000022707727,0.0015539144,0.00029190065,0.000047732243,0.0000041761095,0.000017974962,0.000011418671],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998744,0.00028494676,0.00028960806,0.00028858805,0.00016057111,0.00023227767],"domain_scores_gemma":[0.99766946,0.0018414296,0.00015514145,0.00017144514,0.000045206667,0.00011731015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002296801,0.00016295108,0.00043065587,0.0002691976,0.000029438015,0.0000049451237,0.000052599058,0.00012730432,0.000114650415],"category_scores_gemma":[0.00045707254,0.000104960774,0.00006990229,0.00018838047,0.00007503438,0.000060338174,0.000017427044,0.00012977919,0.00001372678],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014799753,0.0011178894,0.7498177,0.000019698105,0.000042790358,0.00047641524,0.0010908324,0.0000030737463,0.10555014,0.00007982679,0.0029648952,0.13735676],"study_design_scores_gemma":[0.013154872,0.00856971,0.92306215,0.000022903654,0.00005814424,0.000079547564,0.00008131815,0.000029307635,0.051598646,0.0001511788,0.0030534077,0.00013884646],"about_ca_topic_score_codex":0.00016755608,"about_ca_topic_score_gemma":0.00035906592,"teacher_disagreement_score":0.17324442,"about_ca_system_score_codex":0.00012287733,"about_ca_system_score_gemma":0.00017990067,"threshold_uncertainty_score":0.42801762},"labels":[],"label_agreement":null},{"id":"W2438991415","doi":"10.1093/neuonc/now070.09","title":"EPN-10UPDATING THE PROGNOSTIC IMPORTANCE OF RESECTION STATUS AND CHROMOSOME 1q GAIN IN CHILDREN TREATED ACCORDING TO THE FIRST SIOP 1999-04 TRIAL FOR PAEDIATRIC INTRACRANIAL EPENDYMOMA","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Particle accelerators and beam dynamics","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Ependymoma; Medicine; Resection; Pediatrics; Surgery","score_opus":0.011645902050972897,"score_gpt":0.24976902485712116,"score_spread":0.23812312280614825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2438991415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971869,0.000106564185,0.00023573975,0.00057110854,0.0003070581,0.0014684745,0.00004090878,0.000056817473,0.000026454363],"genre_scores_gemma":[0.9989817,0.000079523685,0.00009316708,0.00008831926,0.00046434253,0.00025502694,0.0000058878704,0.000030960786,0.000001060242],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987282,0.00009287165,0.00042439625,0.00024063239,0.00010344449,0.00041046157],"domain_scores_gemma":[0.99841136,0.0011788391,0.00011109594,0.00019991206,0.00003427682,0.00006450294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003925516,0.00015178238,0.00025833087,0.00009206587,0.00012006491,0.000025240022,0.00017370417,0.00010809064,0.000005816984],"category_scores_gemma":[0.00070562557,0.00008753083,0.000045581135,0.0003567288,0.00004683256,0.00011856452,0.00006825064,0.00016677154,0.0000026564394],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030666785,0.00014013452,0.8715173,0.0000383393,0.000052815634,0.000027411583,0.00037479788,0.002484156,0.06980128,0.00010238103,0.00030820345,0.05208653],"study_design_scores_gemma":[0.08183663,0.01014992,0.7743865,0.0001324526,0.0003378629,0.00041433066,0.00053657644,0.10049681,0.025404014,0.00067633163,0.0045193043,0.001109209],"about_ca_topic_score_codex":0.0000789387,"about_ca_topic_score_gemma":0.0007168532,"teacher_disagreement_score":0.098012656,"about_ca_system_score_codex":0.00014280165,"about_ca_system_score_gemma":0.000050844985,"threshold_uncertainty_score":0.3569404},"labels":[],"label_agreement":null},{"id":"W2439102632","doi":"10.1093/neuonc/now073.124","title":"HG-128BO25041 - A PHASE II OPEN-LABEL, RANDOMIZED, MULTI CENTRE COMPARATIVE STUDY OF BEVACIZUMAB BASED THERAPY IN PAEDIATRIC PATIENTS WITH NEWLY DIAGNOSED SUPRATENTORIAL, INFRATENTORIAL CEREBELLAR, OR PEDUNCULAR HIGH GRADE GLIOMA","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Bevacizumab; Medicine; Open label; Glioma; Randomized controlled trial; Surgery; Chemotherapy; Cancer research","score_opus":0.0468354923453731,"score_gpt":0.3368309216276485,"score_spread":0.2899954292822754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2439102632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98575014,0.00016823958,0.000015938613,0.0010396256,0.001824282,0.011002129,0.00012301879,0.000053054548,0.000023580007],"genre_scores_gemma":[0.9974699,0.00019758134,0.00046354748,0.0002862912,0.0003711138,0.0010054527,0.000120624296,0.00007283729,0.00001266617],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9943082,0.0019985314,0.0012476537,0.0009881086,0.00075872056,0.0006987891],"domain_scores_gemma":[0.99465245,0.0027837427,0.00082828186,0.00069388794,0.0005901162,0.00045151563],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005252851,0.00065594306,0.0026184095,0.00057684904,0.00017970265,0.000044779645,0.00042511523,0.00028527944,0.00037980027],"category_scores_gemma":[0.0007765997,0.00035232396,0.0001499068,0.0010307014,0.00024142276,0.00024229543,0.0002199454,0.00029019034,0.00001827162],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.58846235,0.23066391,0.1286505,0.000038600712,0.0012013776,0.0042737583,0.004151595,0.000060900107,0.032461885,0.0000397695,0.003141206,0.00685413],"study_design_scores_gemma":[0.9233065,0.0594336,0.0035040262,0.00008253577,0.00077836344,0.00001292214,0.00044361953,0.00014338655,0.009421541,0.00001075487,0.0024900506,0.00037265915],"about_ca_topic_score_codex":0.0009661431,"about_ca_topic_score_gemma":0.00106101,"teacher_disagreement_score":0.33484417,"about_ca_system_score_codex":0.000502162,"about_ca_system_score_gemma":0.00093313796,"threshold_uncertainty_score":0.9998929},"labels":[],"label_agreement":null},{"id":"W2439339516","doi":"10.1093/neuonc/now072.20","title":"GC-20THE CHILDREN'S ONCOLOGY GROUP (COG) CURRENT TREATMENT APPROACH FOR CHILDREN WITH NEWLY DIAGNOSED CENTRAL NERVOUS SYSTEM (CNS) NON-GERMINOMATOUS GERM CELL TUMORS (NGGCTs)","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Cog; Central nervous system; Germ cell tumors; Germ cell; Medicine; Oncology; Pediatric oncology; Internal medicine; Pediatrics; Biology; Chemotherapy; Genetics; Cancer; Computer science; Artificial intelligence; Gene","score_opus":0.014591079027657071,"score_gpt":0.25799895580686005,"score_spread":0.24340787677920298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2439339516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98557496,0.00089823717,0.0008806118,0.0011416164,0.00089096854,0.008411723,0.0003341803,0.00034246102,0.0015252149],"genre_scores_gemma":[0.9913063,0.00041466084,0.0019065554,0.0004832883,0.0011399562,0.0040444043,0.0004616846,0.00020306226,0.000040065985],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.994818,0.00040365694,0.0009916561,0.0016279282,0.0004517127,0.0017070896],"domain_scores_gemma":[0.99604553,0.0010310247,0.00075998134,0.0010540367,0.00016575746,0.00094364135],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023157203,0.0010103586,0.0019908522,0.00036541795,0.00031516593,0.000046122746,0.00039792954,0.00047059724,0.0000438619],"category_scores_gemma":[0.000074126234,0.000593607,0.0005843627,0.00031943142,0.00032056504,0.0001319887,0.00013398581,0.00033683004,0.000094986615],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003307074,0.0254092,0.49205327,0.00033674817,0.0015859781,0.0029438061,0.0010777474,0.0001498482,0.018321054,0.0005036414,0.0075087366,0.44680288],"study_design_scores_gemma":[0.11789954,0.06409013,0.73071265,0.00043686366,0.0058781477,0.00960768,0.000445159,0.0007185183,0.02825637,0.000021716987,0.040130522,0.001802716],"about_ca_topic_score_codex":0.00027121452,"about_ca_topic_score_gemma":0.00010515194,"teacher_disagreement_score":0.44500017,"about_ca_system_score_codex":0.0024835113,"about_ca_system_score_gemma":0.0009966216,"threshold_uncertainty_score":0.99965155},"labels":[],"label_agreement":null},{"id":"W2440039868","doi":"10.1093/neuonc/now080.20","title":"PCM-20PRE-CLINICAL DRUG SCREEN IN A PDX ETMR MOUSE MODEL","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Receptor Mechanisms and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Drug; Chemistry; Pharmacology; Medicine","score_opus":0.02893391120150003,"score_gpt":0.3156152104725266,"score_spread":0.2866812992710266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2440039868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865318,0.0001398043,0.008503894,0.0014165549,0.0004092914,0.00025283563,0.00003038801,0.000029562365,0.0026858929],"genre_scores_gemma":[0.99177253,0.00063555315,0.0025958403,0.0026602282,0.00045411932,0.000041319025,0.000021263832,0.00004925121,0.001769902],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979989,0.00032623258,0.0004984356,0.00062333996,0.00012913827,0.00042398434],"domain_scores_gemma":[0.99906975,0.00013893595,0.000134277,0.00042578828,0.00006242897,0.00016880143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059085735,0.00019890252,0.0003420888,0.00006725232,0.00004683828,0.000011564762,0.00034220025,0.00041117883,0.00015982894],"category_scores_gemma":[0.0003089714,0.00015095563,0.00015785276,0.00006589797,0.00011247817,0.0000068680633,0.00023029007,0.00022687345,0.000076476754],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021539256,0.00014285107,0.0009791411,0.000003074549,0.000016356946,0.000018003677,0.00003861377,0.0001454753,0.9769739,0.0002390198,0.0061235954,0.015104609],"study_design_scores_gemma":[0.0028597352,0.001098468,0.00010258165,0.000013771074,0.000018257295,0.000022350498,0.000038044156,0.0016984971,0.8428536,0.0007537183,0.15020332,0.00033768557],"about_ca_topic_score_codex":0.000027538585,"about_ca_topic_score_gemma":0.0001557467,"teacher_disagreement_score":0.14407972,"about_ca_system_score_codex":0.000041049774,"about_ca_system_score_gemma":0.0002475184,"threshold_uncertainty_score":0.6155792},"labels":[],"label_agreement":null},{"id":"W2440280149","doi":"10.1093/neuonc/now076.46","title":"MB-48PEROXIREDOXIN 1 IS A POTENTIAL THERAPEUTIC TARGET IN GROUP-3 MEDULLOBLASTOMAS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Redox biology and oxidative stress","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; Hospital for Sick Children; University of Manitoba; Research Institute in Oncology and Hematology","funders":"","keywords":"Group (periodic table); Medicine; Chemistry","score_opus":0.009969998070211556,"score_gpt":0.2683085753923063,"score_spread":0.25833857732209475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2440280149","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98793966,0.0008941346,0.0023934448,0.0046029035,0.00081889634,0.00032109302,0.000056649278,0.00003158975,0.0029416268],"genre_scores_gemma":[0.9944256,0.00053073495,0.00037400864,0.0038697163,0.0003477545,0.000068810754,0.00003661301,0.000032345786,0.0003144378],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99788046,0.00047097006,0.00033333318,0.0006805041,0.00011114032,0.00052361697],"domain_scores_gemma":[0.9992098,0.00008709155,0.00012885442,0.00040194494,0.000057193796,0.0001151049],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023056881,0.00025891818,0.0003161952,0.00009777032,0.000074246534,0.000008508417,0.00037065658,0.0005397906,0.00029865513],"category_scores_gemma":[0.00011507951,0.00018450987,0.00013542669,0.00011760926,0.0003773142,0.000008688701,0.00019277782,0.00019437746,0.00009955939],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051129516,0.00017159911,0.007773127,0.0000045743964,0.00004769728,0.00007910561,0.000059585862,0.0000030933097,0.96457225,0.00019089866,0.002728504,0.023858242],"study_design_scores_gemma":[0.0021985555,0.0018948904,0.008163958,0.0000099292,0.000015966594,0.00012360826,0.00005439391,0.000015822217,0.6279895,0.0007047658,0.35855752,0.0002711428],"about_ca_topic_score_codex":0.000013001652,"about_ca_topic_score_gemma":0.000090433896,"teacher_disagreement_score":0.35582903,"about_ca_system_score_codex":0.000050435552,"about_ca_system_score_gemma":0.0001346291,"threshold_uncertainty_score":0.75240946},"labels":[],"label_agreement":null},{"id":"W2440400959","doi":"10.1093/neuonc/now065.20","title":"AT-21INTEGRATED (EPI)GENOMIC ANALYSES IDENTIFY SUB-GROUP SPECIFIC THERAPEUTIC TARGETS IN CNS RHABDOID TUMORS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; Princess Margaret Cancer Centre; Structural Genomics Consortium; McGill University; University Health Network; University of Toronto; SickKids Foundation; Hospital for Sick Children; McGill University and Génome Québec Innovation Centre","funders":"","keywords":"Computational biology; Biology; Medicine; Genetics","score_opus":0.03443928670773086,"score_gpt":0.32575074632890627,"score_spread":0.29131145962117544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2440400959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938416,0.0025826786,0.0011116868,0.0004833253,0.0005353737,0.00022079331,0.000026810696,0.00003753281,0.0011601904],"genre_scores_gemma":[0.9961842,0.0021879438,0.00014034426,0.00081389974,0.00028391764,0.000045248456,0.000072061855,0.000052578136,0.00021981038],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979194,0.00029710535,0.00046820164,0.00068823877,0.00013843128,0.00048866664],"domain_scores_gemma":[0.99905,0.00009337633,0.00017990635,0.00048847095,0.000072662,0.00011557983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024514343,0.0002750259,0.0003958243,0.00012646682,0.00008410139,0.000017718674,0.00033092525,0.00028049396,0.0002080472],"category_scores_gemma":[0.00006801064,0.00020552035,0.00017530499,0.00017460568,0.0001727904,0.000006436336,0.00015822295,0.00017455932,0.00014442984],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002511499,0.00010827526,0.00258265,0.0000074376967,0.000043857763,0.000056339817,0.00005096186,0.00006920198,0.9783572,0.00002015053,0.0026402469,0.015812509],"study_design_scores_gemma":[0.0016943852,0.0006725284,0.008676962,0.00002313786,0.00003058735,0.0001165443,0.000062122344,0.00011908392,0.84369785,0.00020152818,0.14437595,0.00032930184],"about_ca_topic_score_codex":0.00004736635,"about_ca_topic_score_gemma":0.0004905635,"teacher_disagreement_score":0.1417357,"about_ca_system_score_codex":0.00027011088,"about_ca_system_score_gemma":0.00017462239,"threshold_uncertainty_score":0.8380877},"labels":[],"label_agreement":null},{"id":"W2440690658","doi":"10.1093/neuonc/now076.08","title":"MB-08FUNCTIONAL ROLES OF CCL2 IN MEDULLOBLASTOMA LEPTOMENINGEAL METASTASIS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency; Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Metastasis; Medicine; Pathology; Internal medicine; Cancer","score_opus":0.026772565073239933,"score_gpt":0.32840645066902835,"score_spread":0.3016338855957884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2440690658","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98952574,0.000070117276,0.000050261842,0.0049327672,0.00022430871,0.00034311996,0.00004074353,0.000046679175,0.004766266],"genre_scores_gemma":[0.9985881,0.00009935347,0.00042017977,0.00041965162,0.000101308055,0.00007338928,0.0000068970917,0.00002824617,0.00026290893],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980932,0.00024147441,0.0003812594,0.00038879024,0.00042530152,0.00046996426],"domain_scores_gemma":[0.9985116,0.0007363255,0.00011676177,0.0002694435,0.00011377071,0.00025209668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000207214,0.00017819308,0.0005034008,0.0004148484,0.000035164347,0.000003840682,0.0001224011,0.00011753813,0.0006835815],"category_scores_gemma":[0.00043406337,0.00011762377,0.00013056042,0.000301198,0.00023294815,0.00009379251,0.000107362815,0.00022183932,0.00020853804],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002768383,0.0010977377,0.03765625,0.000031114465,0.0001421947,0.0014021329,0.00008458818,0.0000023587666,0.8254431,0.00025980262,0.0024779812,0.12863438],"study_design_scores_gemma":[0.025716325,0.019267574,0.13554324,0.0001603901,0.00021900029,0.001872502,0.00015654063,0.000049702907,0.62573236,0.00054405746,0.19042782,0.00031050958],"about_ca_topic_score_codex":0.000020564252,"about_ca_topic_score_gemma":0.00014471605,"teacher_disagreement_score":0.19971074,"about_ca_system_score_codex":0.00024652155,"about_ca_system_score_gemma":0.00043245827,"threshold_uncertainty_score":0.7484738},"labels":[],"label_agreement":null},{"id":"W2441491525","doi":"10.1093/neuonc/now076.76","title":"MB-80OUTCOME OF CHILDREN WITH POSTERIOR FOSSA MEDULLOBLASTOMA","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"","keywords":"Medulloblastoma; Posterior fossa; Medicine; Anatomy; Pathology","score_opus":0.013573182261581771,"score_gpt":0.27778987312442316,"score_spread":0.2642166908628414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2441491525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879793,0.000093549505,0.000008567271,0.009598376,0.00016130666,0.0004785353,0.000024996642,0.000049216724,0.0016061822],"genre_scores_gemma":[0.99812156,0.000033769735,0.00029677918,0.001313431,0.000091619186,0.000059080092,0.000005363129,0.000028726636,0.000049673028],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99889904,0.000066206085,0.00026762192,0.00029819692,0.00019361694,0.00027531423],"domain_scores_gemma":[0.9989767,0.00026548063,0.0001501874,0.0003555429,0.00008588671,0.00016618393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006467138,0.00017014833,0.00051698484,0.000119482414,0.000030448358,0.000003431955,0.00009421234,0.000111043155,0.00026721408],"category_scores_gemma":[0.00008609708,0.00008956781,0.00009788843,0.00012223062,0.00015636375,0.0000428283,0.000060499526,0.00008112959,0.00009850204],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006713988,0.00070364866,0.53846294,0.000011408772,0.00019352653,0.00036236682,0.00007583039,2.4375194e-7,0.41045797,0.00010173189,0.0011022398,0.04785669],"study_design_scores_gemma":[0.011230864,0.012263018,0.68977416,0.00008306623,0.00033627526,0.0019741973,0.00002024382,0.000001160464,0.2719822,0.000023457294,0.01217138,0.00014000083],"about_ca_topic_score_codex":0.000027022303,"about_ca_topic_score_gemma":0.000054888354,"teacher_disagreement_score":0.15131119,"about_ca_system_score_codex":0.00010895611,"about_ca_system_score_gemma":0.00014747848,"threshold_uncertainty_score":0.36524692},"labels":[],"label_agreement":null},{"id":"W2441823205","doi":"10.1093/neuonc/now075.50","title":"LG-50MULTIPLEX DETECTION OF PEDIATRIC LOW GRADE GLIOMA SIGNATURE FUSION AND DUPLICATION TRANSCRIPTS USING THE NANOSTRING NCOUNTER SYSTEM","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Graphene and Nanomaterials Applications","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Gene duplication; Signature (topology); Computational biology; Computer science; Biology; Cancer research; Genetics; Gene; Mathematics","score_opus":0.013068390478032856,"score_gpt":0.2267489061227185,"score_spread":0.21368051564468565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2441823205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917761,0.00032210624,0.0066558477,0.00010972881,0.00056424836,0.00037853624,0.000018688204,0.00014137322,0.00003337664],"genre_scores_gemma":[0.99931985,0.00024833428,0.00010709518,0.000018370703,0.00021485896,0.00006196836,0.0000018478321,0.000026793809,8.808125e-7],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99917823,0.000075461685,0.00028850688,0.00019305029,0.0000920021,0.00017273237],"domain_scores_gemma":[0.9994266,0.00016861981,0.00010010099,0.00021312678,0.00004968048,0.000041892436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001216949,0.00013050885,0.00018158762,0.00013998715,0.00010601395,0.000012118087,0.000115178365,0.00018347667,0.0000034295438],"category_scores_gemma":[0.000015469283,0.00008678018,0.000047452224,0.0002748546,0.000041116687,0.000097237615,0.000021771857,0.00008707098,0.00000336027],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019600948,0.000016157459,0.0002845532,0.00008619935,0.00000862762,0.0000021564285,0.000110997746,0.00011739998,0.99271923,0.000060963495,0.000030393941,0.006543701],"study_design_scores_gemma":[0.00064831984,0.000093026174,0.0028674433,0.000023241244,0.000076004966,0.00008060775,0.00006085887,0.0047894595,0.9894337,0.0000261397,0.0017831327,0.00011804242],"about_ca_topic_score_codex":0.000015933221,"about_ca_topic_score_gemma":0.00001680452,"teacher_disagreement_score":0.007543755,"about_ca_system_score_codex":0.00008197328,"about_ca_system_score_gemma":0.000017659535,"threshold_uncertainty_score":0.3538793},"labels":[],"label_agreement":null},{"id":"W2441874167","doi":"10.1093/neuonc/now073.76","title":"HG-80ISSUES IN THE MANAGEMENT OF CHILDREN WITH BRAIN TUMORS AND BIALLELIC MISMATCH GENE REPAIR DEFICIENCY SYNDROME","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Hospital for Sick Children","funders":"","keywords":"Medicine; Gene; Genetics; Biology","score_opus":0.01556900489081961,"score_gpt":0.2750987134543119,"score_spread":0.25952970856349233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2441874167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903889,0.00039614708,0.000020895246,0.0063901576,0.00010283177,0.0007891023,0.00000477431,0.000039417253,0.0018678053],"genre_scores_gemma":[0.9967497,0.00025210707,0.0015816923,0.001228055,0.00002949837,0.000057201807,0.0000018266695,0.000020845684,0.00007904483],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99865204,0.00015730334,0.00028855845,0.00036597872,0.00026061878,0.00027548856],"domain_scores_gemma":[0.9991454,0.00026645345,0.00010489117,0.00038636907,0.00003381865,0.00006310385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033224627,0.00015157131,0.0003435306,0.00011105597,0.000032299056,0.0000037638622,0.00017657508,0.000083005485,0.00006736662],"category_scores_gemma":[0.00005876298,0.00008057427,0.000043829714,0.00024368562,0.00025823302,0.000023336052,0.00009420398,0.00013382065,0.000009157396],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014253457,0.0011315945,0.6458204,0.00042414552,0.00030649395,0.0033277757,0.0037252335,0.000025102017,0.28483757,0.0006199087,0.0050739576,0.0532825],"study_design_scores_gemma":[0.0035443713,0.0069242143,0.9715853,0.00014589069,0.00012810297,0.0037600202,0.0003117455,0.000007984694,0.008440142,0.00014652734,0.004842354,0.00016338451],"about_ca_topic_score_codex":0.000057127112,"about_ca_topic_score_gemma":0.00006660319,"teacher_disagreement_score":0.3257649,"about_ca_system_score_codex":0.00009335524,"about_ca_system_score_gemma":0.00009823221,"threshold_uncertainty_score":0.32857233},"labels":[],"label_agreement":null},{"id":"W2442030078","doi":"10.1093/neuonc/now081.21","title":"QOS-21A MODEL OF CARE FOR PEDIATRIC CNS TUMOR PATIENTS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Tracheal and airway disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster Children's Hospital","funders":"","keywords":"Medicine; Computer science","score_opus":0.01922385871963425,"score_gpt":0.28172666478149555,"score_spread":0.26250280606186127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2442030078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937706,0.00013675142,0.0005710017,0.0021557931,0.00045308087,0.0006489871,0.000119771605,0.00004525815,0.0020987315],"genre_scores_gemma":[0.99787134,0.00007383217,0.0006826085,0.000982328,0.0002130729,0.00006333545,0.000014915265,0.00002504365,0.00007352677],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.999123,0.000021704567,0.0002507316,0.00023154968,0.00012275361,0.00025025383],"domain_scores_gemma":[0.9992481,0.00017752821,0.000115529496,0.00016414917,0.0001811089,0.00011358024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000035758614,0.00011174927,0.00032260938,0.000084930834,0.00003521717,0.000001130029,0.000084398474,0.00009492746,0.000028853812],"category_scores_gemma":[0.00020946641,0.00007441069,0.000114784416,0.00007795134,0.000059079095,0.000036572874,0.000032351356,0.000085925174,0.00002030989],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005122878,0.004263283,0.39446044,0.002570285,0.0000826266,0.000052951338,0.0040496886,0.00046256106,0.2756475,0.0021721206,0.021900138,0.28921553],"study_design_scores_gemma":[0.16105644,0.10742887,0.17374249,0.0003494666,0.0029087686,0.000095218806,0.002508334,0.0026514702,0.098059334,0.007420914,0.44159096,0.0021877333],"about_ca_topic_score_codex":0.000008476006,"about_ca_topic_score_gemma":0.000021320147,"teacher_disagreement_score":0.41969082,"about_ca_system_score_codex":0.00009089904,"about_ca_system_score_gemma":0.00035568172,"threshold_uncertainty_score":0.30343798},"labels":[],"label_agreement":null},{"id":"W2442181867","doi":"10.1093/neuonc/now073.67","title":"HG-71ULTRA-SENSITIVE DETECTION OF HOTSPOT MUTATIONS IN PEDIATRIC THALAMIC TUMOURS TO REVEAL NEGATIVE PROGNOSTIC MARKERS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Hospital for Sick Children; BC Children's Hospital; University of Toronto","funders":"","keywords":"Hotspot (geology); Biology; Medicine; Computational biology; Genetics; Geology","score_opus":0.015588353714222262,"score_gpt":0.2911796878861485,"score_spread":0.27559133417192627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2442181867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924259,0.000025157287,0.00019581587,0.0028770647,0.00037370564,0.0011314134,0.000040889587,0.00005037582,0.002879665],"genre_scores_gemma":[0.9986579,0.00006307371,0.00025647483,0.0006080657,0.00017360995,0.00012575045,0.000004200252,0.000026727837,0.0000842412],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986544,0.00023658041,0.0003151564,0.0003410114,0.00016796155,0.00028488014],"domain_scores_gemma":[0.99850446,0.00092671154,0.00013214863,0.00015320517,0.00014639333,0.0001371061],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012767068,0.00015869655,0.00036285273,0.00032955434,0.000036252524,0.0000027875437,0.000055448698,0.00011482601,0.000022832219],"category_scores_gemma":[0.0008140448,0.00011916268,0.000072342,0.0004723269,0.00010703664,0.00006178417,0.000022670607,0.00016448583,0.00006085226],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028760387,0.0005612643,0.23589286,0.000057186426,0.00006238002,0.00053082855,0.0017915952,0.000014020434,0.7107427,0.000020888847,0.0004828065,0.046967413],"study_design_scores_gemma":[0.0051406254,0.005179659,0.8726908,0.000053972133,0.00028877685,0.00020919208,0.00033523736,0.000011720616,0.11562691,0.00015377937,0.0001821536,0.00012716185],"about_ca_topic_score_codex":0.00014283665,"about_ca_topic_score_gemma":0.00026635625,"teacher_disagreement_score":0.63679796,"about_ca_system_score_codex":0.00036369744,"about_ca_system_score_gemma":0.00039115394,"threshold_uncertainty_score":0.4859313},"labels":[],"label_agreement":null},{"id":"W2442220068","doi":"10.1093/neuonc/now066.08","title":"CMS-09BEHAVIOR AND TEMPERAMENT IN CHILDREN TREATED FOR PEDIATRIC MEDULLOBLASTOMA WITH POSTOPERATIVE CEREBELLAR MUTISM SYNDROME","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medulloblastoma; Temperament; Psychology; Cerebellum; Pediatrics; Medicine; Neuroscience; Psychoanalysis; Pathology; Personality","score_opus":0.01025112827025603,"score_gpt":0.2660706033468444,"score_spread":0.25581947507658837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2442220068","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992953,0.00022004498,0.000004422922,0.0045380546,0.000063095446,0.0020495465,0.00006274519,0.000046221223,0.00006284327],"genre_scores_gemma":[0.99817693,0.00024045381,0.00023947639,0.00058291585,0.000049353792,0.0006135298,0.000022149574,0.000040020408,0.000035155314],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986088,0.000090813715,0.00027629323,0.00050955766,0.00014392831,0.00037056857],"domain_scores_gemma":[0.9991006,0.0003176248,0.00009220886,0.00021803992,0.000073489144,0.0001980191],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000082911596,0.00026759852,0.0005591139,0.00024432837,0.000068788366,0.000011527439,0.000059276317,0.00016498615,0.00006023862],"category_scores_gemma":[0.000051859744,0.00014519875,0.000059812373,0.00019164616,0.000095125186,0.000059181315,0.00004078764,0.000111016496,0.00001843517],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042221704,0.0012147139,0.9172548,0.0000115476705,0.00008125048,0.0010521737,0.00013797045,7.1417816e-7,0.06855388,0.00004919119,0.00030941167,0.010912109],"study_design_scores_gemma":[0.01941892,0.0159585,0.93655217,0.000049982154,0.0005496452,0.0037994804,0.000044899003,0.0000062602307,0.02203745,0.000011849614,0.0013534512,0.00021740128],"about_ca_topic_score_codex":0.0000703804,"about_ca_topic_score_gemma":0.00007503173,"teacher_disagreement_score":0.046516426,"about_ca_system_score_codex":0.00027591886,"about_ca_system_score_gemma":0.00014923702,"threshold_uncertainty_score":0.5921033},"labels":[],"label_agreement":null},{"id":"W2442825390","doi":"10.1093/neuonc/now073.61","title":"HG-65END-OF-LIFE CARE OF CHILDREN WITH MALIGNANT PONTINE TUMOURS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiation Therapy and Dosimetry","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Pediatrics","score_opus":0.01327742374877014,"score_gpt":0.27895476617136955,"score_spread":0.26567734242259944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2442825390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99361026,0.0005620717,0.000114174436,0.0027834135,0.0001725208,0.00029268904,0.000030067753,0.0000332774,0.0024015426],"genre_scores_gemma":[0.9980581,0.0001277252,0.0003388716,0.0011906914,0.00015676614,0.0000071821864,0.0000099902845,0.000023211982,0.00008745632],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990119,0.00009501157,0.00031142263,0.00021249455,0.00017932453,0.00018986763],"domain_scores_gemma":[0.9990076,0.00020158703,0.0002490353,0.00027953152,0.00012782928,0.00013443452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009861706,0.0001194225,0.0004432583,0.00013607739,0.000022679233,0.0000013410627,0.00009954885,0.00011070576,0.00025756468],"category_scores_gemma":[0.000155501,0.00007019513,0.00007353713,0.00016599962,0.00015395875,0.000040148014,0.000020879654,0.00009951414,0.000017657585],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012839189,0.00018995284,0.56158966,0.000032072545,0.00008778585,0.000035238827,0.0003857096,0.000004011244,0.40922347,0.00028313213,0.0013285646,0.025556488],"study_design_scores_gemma":[0.010239754,0.0071241558,0.6096778,0.00010139172,0.00018943415,0.00031565625,0.00020397714,0.0000048501333,0.35141432,0.000023402936,0.020535272,0.00017000554],"about_ca_topic_score_codex":0.000027860055,"about_ca_topic_score_gemma":0.000011151648,"teacher_disagreement_score":0.057809137,"about_ca_system_score_codex":0.000047757505,"about_ca_system_score_gemma":0.00037869436,"threshold_uncertainty_score":0.28624743},"labels":[],"label_agreement":null},{"id":"W2443301065","doi":"10.1093/neuonc/now076.21","title":"MB-23RECURRENT SHH/TP53 MUTANT MEDULLOBLASTOMA TREATED WITH A COMBINATION OF LITHIUM AND RADIATION THERAPY","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medulloblastoma; Medicine; Radiation therapy; Chemotherapy; Temozolomide; Oncology; Internal medicine; Surgery; Cancer research","score_opus":0.015319334357111206,"score_gpt":0.2778775796366477,"score_spread":0.26255824527953653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2443301065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926078,0.0004034314,0.000018945726,0.0056323987,0.00012617838,0.00059533294,0.000014306108,0.000039192317,0.00056242576],"genre_scores_gemma":[0.99833125,0.0011446716,0.000047001526,0.00029212944,0.00004180869,0.000100219,0.000014413642,0.000017958975,0.000010555442],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99905586,0.000116098214,0.00022952739,0.00025843282,0.00016899787,0.00017107624],"domain_scores_gemma":[0.99909705,0.00032776405,0.00016967945,0.000173083,0.00012227391,0.000110166686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000088200904,0.00014649506,0.00034716504,0.00014692312,0.000034413137,0.000004986304,0.00003641225,0.00010022494,0.00006848862],"category_scores_gemma":[0.000053944812,0.000080313985,0.000042984044,0.00013318636,0.00011383712,0.00005127186,0.000014206156,0.000064159256,0.000009804335],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011149596,0.0015853554,0.112668626,0.00001669459,0.00012007941,0.00013557509,0.0003066247,4.4582325e-7,0.54742044,0.00035606755,0.00039040466,0.3358847],"study_design_scores_gemma":[0.026302973,0.021268124,0.22981942,0.0001067394,0.00022425166,0.00033350388,0.000057072986,0.00009439731,0.6697173,0.0000975313,0.051821735,0.00015693092],"about_ca_topic_score_codex":0.000027514807,"about_ca_topic_score_gemma":0.000018821142,"teacher_disagreement_score":0.33572778,"about_ca_system_score_codex":0.00013729486,"about_ca_system_score_gemma":0.00008584996,"threshold_uncertainty_score":0.32751092},"labels":[],"label_agreement":null},{"id":"W2443386476","doi":"10.1093/neuonc/now073.72","title":"HG-76SPATIAL AND TEMPORAL HOMOGENEITY OF DRIVER MUTATIONS IN DIFFUSE INTRINSIC PONTINE GLIOMA","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Homogeneity (statistics); Glioma; Neuroscience; Medicine; Psychology; Computer science; Cancer research","score_opus":0.017131208790723065,"score_gpt":0.2852469108530824,"score_spread":0.26811570206235935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2443386476","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937555,0.00013013637,0.000014172576,0.005282183,0.00016334854,0.0003385691,0.000023575796,0.000021096832,0.00027140207],"genre_scores_gemma":[0.9993096,0.00009104347,0.00023234182,0.00022273046,0.0000697699,0.000041373594,0.000010621565,0.00001375764,0.000008752433],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99906707,0.000095892625,0.0002900917,0.0002477292,0.0001114183,0.00018778021],"domain_scores_gemma":[0.99915695,0.0003624466,0.00011218387,0.00018988072,0.00006578491,0.00011277656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007875661,0.000120173725,0.00037075672,0.00023330921,0.000027002608,0.0000031783934,0.000045632543,0.000103631224,0.00008533187],"category_scores_gemma":[0.00020772482,0.000080452744,0.000054145607,0.00018361102,0.00016619144,0.000047610334,0.000062757885,0.00007647173,0.00001490636],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016243714,0.001306819,0.51511663,0.000012683205,0.000028301236,0.0008019386,0.00016242974,2.0968663e-7,0.45230204,0.00014896238,0.00028033816,0.029677251],"study_design_scores_gemma":[0.017317124,0.0023591502,0.8345209,0.000048836122,0.00013365326,0.00030395656,0.000035322573,0.000015282985,0.13729562,0.00015357185,0.0077119945,0.0001046026],"about_ca_topic_score_codex":0.0001686475,"about_ca_topic_score_gemma":0.00064797065,"teacher_disagreement_score":0.3194043,"about_ca_system_score_codex":0.00008772564,"about_ca_system_score_gemma":0.00010255042,"threshold_uncertainty_score":0.32807678},"labels":[],"label_agreement":null},{"id":"W2443447464","doi":"10.1093/neuonc/now076.97","title":"MB-102HEMATOGENOUS DISSEMINATION OF MEDULLOBLASTOMA DRIVES LEPTOMENINGEAL DISEASE","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Medicine; Cancer research","score_opus":0.012751110245929292,"score_gpt":0.30492024255753614,"score_spread":0.29216913231160685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2443447464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99059767,0.00021863716,0.000046779365,0.006955484,0.00024278299,0.0003646116,0.000027155626,0.000056547473,0.0014903283],"genre_scores_gemma":[0.9991854,0.00012635595,0.0001626625,0.00022698204,0.00009970726,0.00010177888,0.000010560961,0.000023478373,0.00006310194],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989038,0.00007509249,0.0002802257,0.00027946627,0.00021975588,0.00024166824],"domain_scores_gemma":[0.99850434,0.0006973559,0.00015353248,0.00027585818,0.000103129074,0.0002657809],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000077618475,0.00014538848,0.0003649343,0.00014715837,0.000043311877,0.0000035662863,0.00007647346,0.00008359816,0.0002891692],"category_scores_gemma":[0.00041057603,0.000092375194,0.00011979357,0.00012389426,0.00014077144,0.000053039344,0.000051216863,0.000058672835,0.00006769487],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000363576,0.0013630416,0.07572928,0.000045947494,0.00006756875,0.00071534055,0.00031931887,7.436796e-7,0.8555821,0.00069512666,0.0027127338,0.062405214],"study_design_scores_gemma":[0.005699385,0.004910562,0.17782521,0.00037849473,0.00061277294,0.00032379897,0.0001678341,0.000041239266,0.7656216,0.00031420033,0.04385261,0.00025229252],"about_ca_topic_score_codex":0.0000035954608,"about_ca_topic_score_gemma":0.0000069791763,"teacher_disagreement_score":0.10209593,"about_ca_system_score_codex":0.0001492956,"about_ca_system_score_gemma":0.0001485589,"threshold_uncertainty_score":0.3766951},"labels":[],"label_agreement":null},{"id":"W2443665052","doi":"10.1093/neuonc/now084.05","title":"TB-08MECHANISMS OF IMMUNE RESISTANCE IN PEDIATRIC POSTERIOR FOSSA TUMORS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Medicine; Atypical teratoid rhabdoid tumor; Cancer; Brain tumor; Fourth ventricle; Internal medicine; Oncology; Cancer research; Pathology; Surgery","score_opus":0.017676016911977174,"score_gpt":0.3032424558516932,"score_spread":0.285566438939716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2443665052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914095,0.00020938937,0.000013172113,0.0035954935,0.00020013956,0.00048943405,0.00001685512,0.000035592995,0.0040304144],"genre_scores_gemma":[0.9982915,0.00029527012,0.00037291428,0.00028972878,0.00008505163,0.00005423875,0.0000024909234,0.0000290823,0.0005797594],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99833167,0.00018468409,0.00043576857,0.00034309376,0.00026228334,0.00044248582],"domain_scores_gemma":[0.9987808,0.0004425543,0.0001581492,0.00036226117,0.00008450723,0.00017176174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017464906,0.00015172556,0.0004643685,0.00030202855,0.000027872184,0.0000033334754,0.00014794845,0.000102584214,0.00013298135],"category_scores_gemma":[0.0004283091,0.00010450299,0.00009655179,0.00031928218,0.000093849776,0.000065385284,0.00010754318,0.00018905051,0.00013222998],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020293035,0.00050599856,0.01569364,0.000086967746,0.000014619614,0.0032954223,0.00007863356,6.320337e-8,0.96882063,0.000214216,0.00037435483,0.008886126],"study_design_scores_gemma":[0.019826677,0.01190814,0.3411299,0.00020171625,0.000110833964,0.00072488625,0.000048348782,0.0000036450967,0.6129678,0.0013042098,0.011498198,0.00027566164],"about_ca_topic_score_codex":0.000017731194,"about_ca_topic_score_gemma":0.00008611827,"teacher_disagreement_score":0.35585287,"about_ca_system_score_codex":0.00017733635,"about_ca_system_score_gemma":0.0003568596,"threshold_uncertainty_score":0.42615083},"labels":[],"label_agreement":null},{"id":"W2443911332","doi":"10.1093/neuonc/now073.53","title":"HG-57RE-IRRADIATION IN PATIENTS WITH DIFFUSE INTRINSIC PONTINE GLIOMAS, AN UPDATE ON THE CANADIAN EXPERIENCE","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba; BC Children's Hospital; Alberta Children's Hospital; Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"Medicine; Irradiation; Physics","score_opus":0.013743315237158566,"score_gpt":0.2572755814521441,"score_spread":0.2435322662149855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2443911332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9819875,0.000012651783,6.246632e-7,0.016458094,0.00020139986,0.0006064019,0.000013846349,0.000023755858,0.000695728],"genre_scores_gemma":[0.9952323,0.000016474582,0.000023137547,0.004477812,0.00006748133,0.0001316092,0.000022681304,0.000021423062,0.0000071249324],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987875,0.00014214213,0.00019470781,0.00032867922,0.00019767492,0.0003492836],"domain_scores_gemma":[0.99897754,0.00019898075,0.00008823482,0.00039241192,0.00007202965,0.00027081545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000912152,0.00015712198,0.00023153455,0.00024589192,0.00010237751,0.000016091763,0.00011161789,0.00009490293,0.00014872928],"category_scores_gemma":[0.0001680913,0.00007771815,0.000027183432,0.00025453264,0.00009821913,0.00009350868,0.000020069772,0.00012338193,0.00008164791],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054206117,0.0015129145,0.9387905,0.0000025415288,0.000023437498,0.00052366225,0.00062283955,0.0000015670568,0.0047493004,0.0010850314,0.0009538284,0.051192343],"study_design_scores_gemma":[0.007182289,0.0035769325,0.9533794,0.000027189093,0.000027313634,0.000015662577,0.00003996662,0.000008331758,0.0030090555,0.000026046973,0.032607418,0.00010039858],"about_ca_topic_score_codex":0.0059225378,"about_ca_topic_score_gemma":0.119175315,"teacher_disagreement_score":0.11325278,"about_ca_system_score_codex":0.0005683601,"about_ca_system_score_gemma":0.0002436274,"threshold_uncertainty_score":0.89689744},"labels":[],"label_agreement":null},{"id":"W2465821987","doi":"10.1093/neuonc/nov229.03","title":"PTCT-03RELAPSE MEDULLOBLASTOMA IN INFANT: COMPLETE RESPONSE WITH TEMOZOLOMIDE AND IRINOTECAN","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Temozolomide; Medulloblastoma; Irinotecan; Chemotherapy; Radiation therapy; Vincristine; Surgery; Internal medicine; Oncology; Cyclophosphamide; Cancer; Pathology","score_opus":0.03170246051936402,"score_gpt":0.29653284553476783,"score_spread":0.2648303850154038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2465821987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849887,0.0002466888,0.0000039306233,0.012208894,0.00014583748,0.00054793514,0.000010524476,0.000056257242,0.0017912454],"genre_scores_gemma":[0.9968108,0.000036537607,0.00049816846,0.0024361522,0.00005394282,0.00010347838,0.000008300441,0.00003025492,0.000022354572],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99842304,0.00033134877,0.00028406657,0.00039917164,0.00020885273,0.000353522],"domain_scores_gemma":[0.9984273,0.0006867183,0.00009889808,0.00031759214,0.000082854014,0.00038666558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035757708,0.00020691697,0.00053289905,0.00027260472,0.00004141927,0.000012382585,0.000074895135,0.00014730987,0.000026648057],"category_scores_gemma":[0.00042722828,0.0001552415,0.000036251924,0.00026229868,0.00020859767,0.000055474287,0.00008631626,0.00027835474,0.000056731405],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05294084,0.0030681274,0.6288326,0.0000576138,0.00019692747,0.02606911,0.0032347217,0.00010305298,0.25024584,0.00048951077,0.011934053,0.022827635],"study_design_scores_gemma":[0.032843806,0.028093223,0.5443347,0.00011246366,0.00022559748,0.005491814,0.0006014972,0.0004185497,0.014045796,0.00011327673,0.37335795,0.00036133608],"about_ca_topic_score_codex":0.00017486002,"about_ca_topic_score_gemma":0.00078203285,"teacher_disagreement_score":0.36142388,"about_ca_system_score_codex":0.00027449397,"about_ca_system_score_gemma":0.00037004717,"threshold_uncertainty_score":0.6330565},"labels":[],"label_agreement":null},{"id":"W2506900921","doi":"10.1093/neuonc/nov228.17","title":"PTPS-17LEPTOMENINGEAL METASTASIS IN MYC-DRIVEN MEDULLOBLASTOMA","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Metastasis; Cancer research; Biology; Medicine; Cancer; Genetics","score_opus":0.055891065716406126,"score_gpt":0.344591528599142,"score_spread":0.2887004628827359,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2506900921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9710574,0.00040500407,0.000099717414,0.011116839,0.0008076307,0.00072471116,0.000027249498,0.00012640284,0.015635014],"genre_scores_gemma":[0.98897165,0.000057966507,0.0069183754,0.0034612848,0.00023836149,0.0001195883,0.00004341367,0.000045452754,0.00014387743],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99786454,0.00038440313,0.0004205603,0.00047278855,0.0003457238,0.00051198323],"domain_scores_gemma":[0.9985829,0.00031225607,0.000126753,0.00039061296,0.0001011646,0.00048632052],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046145837,0.0002488738,0.00071360846,0.00028142481,0.0000387262,0.000011998925,0.0001349295,0.00016824943,0.000284883],"category_scores_gemma":[0.00035118088,0.0002070679,0.00014195897,0.00038429478,0.00012575928,0.00007536187,0.000119674514,0.0003883429,0.00035220952],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007405071,0.009048587,0.14909847,0.00020388936,0.0013651409,0.04143409,0.0076394966,0.0006886533,0.08314538,0.003931826,0.12821506,0.56782436],"study_design_scores_gemma":[0.0185173,0.012007672,0.010635761,0.0000443097,0.00057392905,0.0025220632,0.0011654479,0.0007688303,0.00917609,0.0003696488,0.943845,0.00037395733],"about_ca_topic_score_codex":0.00011350882,"about_ca_topic_score_gemma":0.0001826755,"teacher_disagreement_score":0.81562996,"about_ca_system_score_codex":0.000513381,"about_ca_system_score_gemma":0.00052990316,"threshold_uncertainty_score":0.8443984},"labels":[],"label_agreement":null},{"id":"W2508035026","doi":"10.1093/neuonc/now177","title":"Exercise training for neural recovery in a restricted sample of pediatric brain tumor survivors: a controlled clinical trial with crossover of training versus no training","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":151,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; McMaster University; University of Toronto; University of Alberta","funders":"Canadian Cancer Society","keywords":"Hippocampal formation; White matter; Medicine; Crossover study; Fractional anisotropy; Cognition; Physical therapy; Psychology; Internal medicine; Magnetic resonance imaging; Pathology","score_opus":0.11946614150034127,"score_gpt":0.38698387421663943,"score_spread":0.2675177327162982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2508035026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909327,0.00011999148,0.00024204676,0.0014183305,0.002186415,0.0041643926,0.00019541907,0.00006985852,0.0006708694],"genre_scores_gemma":[0.99613446,0.00021451066,0.0011515184,0.00048159657,0.0012130917,0.00065913924,0.000017084363,0.00007817997,0.00005042484],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99549854,0.00060373044,0.0019604007,0.0007257938,0.000416003,0.00079552847],"domain_scores_gemma":[0.96720564,0.030567946,0.001227324,0.00030391585,0.00048602332,0.00020914296],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016383372,0.00038434204,0.0026765338,0.000540362,0.0000778305,0.000009052704,0.00017827563,0.00030430593,0.000074761076],"category_scores_gemma":[0.02924788,0.0002779384,0.00049770105,0.00067901675,0.0004883152,0.00015560343,0.00007109699,0.00050225615,0.0000025737877],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.91264343,0.0008855799,0.00450534,0.00011191058,0.0003930094,0.00015674948,0.0038881742,0.000034039025,0.0064757355,0.000019143563,0.00075010926,0.070136756],"study_design_scores_gemma":[0.89716977,0.0842809,0.009598234,0.00048414667,0.0014248779,0.000051184124,0.0028955168,0.00049285346,0.0002264096,0.00008558616,0.0028386042,0.00045193286],"about_ca_topic_score_codex":0.00013821086,"about_ca_topic_score_gemma":0.00045764912,"teacher_disagreement_score":0.08339532,"about_ca_system_score_codex":0.0002310049,"about_ca_system_score_gemma":0.0018511935,"threshold_uncertainty_score":0.9999673},"labels":[],"label_agreement":null},{"id":"W2508714157","doi":"10.1093/neuonc/now180","title":"MRI monitoring of monocytes to detect immune stimulating treatment response in brain tumor","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotchkiss Brain Institute; University of Calgary","funders":"Branch Out Neurological Foundation; Alberta Innovates; Alberta Cancer Foundation","keywords":"Immune system; Innate immune system; Microglia; Histopathology; Medicine; Brain tumor; Monocyte; Cancer research; Ferumoxytol; Magnetic resonance imaging; Pathology; Inflammation; Immunology","score_opus":0.026924053841745166,"score_gpt":0.30641636894979374,"score_spread":0.27949231510804856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2508714157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963495,0.00007570884,0.00017205985,0.002339757,0.00054428505,0.00039667956,0.000013859577,0.00007041033,0.0000377265],"genre_scores_gemma":[0.99549246,0.0000072712287,0.004147573,0.00014767403,0.00008053702,0.00006893501,1.5430446e-7,0.000025798494,0.000029595047],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975663,0.00084119523,0.0005477517,0.00041272884,0.0001708178,0.00046124202],"domain_scores_gemma":[0.9946639,0.0045775147,0.00017224874,0.00040716337,0.000058344136,0.00012084797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009167179,0.00017535526,0.00041080738,0.00021671726,0.000048501483,0.000013945031,0.00024377332,0.00006623048,0.00007855837],"category_scores_gemma":[0.0016475489,0.00013151485,0.00006027882,0.000251352,0.000085612875,0.00013357133,0.0001431239,0.000061948675,0.00023221328],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034511215,0.00011277788,0.004803147,0.0000053429408,0.0000033342794,0.00021451029,0.0004296559,0.00157766,0.9750233,0.0000061492174,0.00002110671,0.014351861],"study_design_scores_gemma":[0.0020189912,0.0038655356,0.0093176775,0.000051692885,0.00000905617,0.000019858757,0.00008526474,0.00012424153,0.9833029,0.000040911564,0.0010348123,0.0001290657],"about_ca_topic_score_codex":0.00013911782,"about_ca_topic_score_gemma":0.00002672984,"teacher_disagreement_score":0.014222795,"about_ca_system_score_codex":0.0006647821,"about_ca_system_score_gemma":0.00024560603,"threshold_uncertainty_score":0.53630203},"labels":[],"label_agreement":null},{"id":"W2512098582","doi":"10.1093/neuonc/now187","title":"Baseline pretreatment contrast enhancing tumor volume including central necrosis is a prognostic factor in recurrent glioblastoma: evidence from single and multicenter trials","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Ziering Family Foundation; National Brain Tumor Society; American Cancer Society","keywords":"Medicine; Cabozantinib; Bevacizumab; Context (archaeology); Univariate analysis; Oncology; Internal medicine; Clinical trial; Glioblastoma; Multivariate analysis; Cancer; Chemotherapy; Cancer research","score_opus":0.06216123701157624,"score_gpt":0.3336370899040717,"score_spread":0.2714758528924955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2512098582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879116,0.0015774565,0.00018898309,0.007387171,0.00063346035,0.0020208238,0.00020775868,0.00006211443,0.000010678],"genre_scores_gemma":[0.99741936,0.00040336253,0.00071085646,0.00079543545,0.00024167527,0.0003671205,0.000010572964,0.000039401253,0.000012206896],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965814,0.0006798568,0.000968563,0.00081220915,0.00028692238,0.0006710515],"domain_scores_gemma":[0.99285287,0.0059635164,0.00038794393,0.0003004491,0.00011463968,0.00038059504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044728274,0.0003808178,0.0011891372,0.00020941066,0.000080576974,0.000040825795,0.00009360051,0.00014740475,0.0004527162],"category_scores_gemma":[0.0060059167,0.00022574069,0.00017628616,0.00017697165,0.00010702966,0.00018124854,0.00013757193,0.00018136924,0.000047076173],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016533522,0.0018450075,0.36452124,0.00003441834,0.0001101114,0.0006772596,0.000899511,5.496915e-7,0.5642155,5.0033776e-7,0.0005384201,0.065504156],"study_design_scores_gemma":[0.02410706,0.011769994,0.24377614,0.002940974,0.000911378,0.00011162059,0.00015220724,0.00095921475,0.70815146,0.000020008649,0.006697588,0.00040237702],"about_ca_topic_score_codex":0.00024243318,"about_ca_topic_score_gemma":0.00096605235,"teacher_disagreement_score":0.14393596,"about_ca_system_score_codex":0.0010625552,"about_ca_system_score_gemma":0.00020070728,"threshold_uncertainty_score":0.9205438},"labels":[],"label_agreement":null},{"id":"W2516791304","doi":"10.1093/neuonc/now157","title":"The complex role of transglutaminase 2 in glioblastoma proliferation","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Blood properties and coagulation","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Institute of Neurological Disorders and Stroke; Natural Sciences and Engineering Research Council of Canada; National Institutes of Health; Memorial Sloan-Kettering Cancer Center","keywords":"Context (archaeology); Biology; Cell growth; Cell culture; Cancer research; Tissue transglutaminase; Gene knockdown; Genetics; Biochemistry; Enzyme","score_opus":0.021141702125629568,"score_gpt":0.2745235191540507,"score_spread":0.25338181702842116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2516791304","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98652214,0.00012356261,0.00005411959,0.011103723,0.00008263994,0.00035196645,0.0000021198,0.000017972454,0.0017417842],"genre_scores_gemma":[0.99922496,0.00005995558,0.000046310462,0.00048505355,0.00008048215,0.000033546683,0.0000010225791,0.000009050519,0.00005960631],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992936,0.000111432164,0.00023682752,0.000118539756,0.00010147408,0.00013807154],"domain_scores_gemma":[0.99952275,0.00017327516,0.00006377249,0.00014706777,0.000056809284,0.000036355304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013829979,0.00006206012,0.000167486,0.000044097815,0.000040146424,0.0000029754117,0.000053712363,0.00007232911,0.000048857833],"category_scores_gemma":[0.000081423226,0.000031832264,0.000035157875,0.00008844158,0.00008825202,0.000039068782,0.00001367344,0.00007513718,0.00001369186],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094797305,0.00010337956,0.004850572,0.000008321084,0.0000056679623,0.0000084126295,0.00023015498,0.0000027836352,0.75804245,0.0004963583,0.00017445783,0.23512946],"study_design_scores_gemma":[0.006521903,0.0078061344,0.08647149,0.00006321344,0.00007133742,0.00020066855,0.0003902844,0.0023075666,0.5528843,0.00078807416,0.34236482,0.00013022409],"about_ca_topic_score_codex":0.000013291458,"about_ca_topic_score_gemma":0.00020686473,"teacher_disagreement_score":0.34219036,"about_ca_system_score_codex":0.000044357235,"about_ca_system_score_gemma":0.000095655596,"threshold_uncertainty_score":0.1298082},"labels":[],"label_agreement":null},{"id":"W2520463192","doi":"","title":"A phase III randomized controlled trial of short-course radiotherapy with or without concomitant and adjuvant temozolomide in elderly patients with glioblastoma multiforme","year":2010,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Temozolomide; Concomitant; Glioblastoma; Radiation therapy; Adjuvant; Medicine; Randomized controlled trial; Adjuvant radiotherapy; Internal medicine; Oncology; Cancer research","score_opus":0.009429832833274985,"score_gpt":0.3018228089678068,"score_spread":0.2923929761345318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2520463192","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868673,0.000117540534,0.000022594919,0.0006449631,0.00031147533,0.011824215,0.000013611741,0.0000363367,0.0001619808],"genre_scores_gemma":[0.996966,0.000107415035,0.0008885062,0.00034258858,0.000091237554,0.0015309845,0.0000118583985,0.000050545044,0.000010848165],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.997518,0.0003334966,0.00094252866,0.0004743731,0.0003415454,0.00039006825],"domain_scores_gemma":[0.9968954,0.0018144173,0.00048021527,0.0003587209,0.0001982871,0.00025296482],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005420873,0.0003873642,0.003696764,0.00025940145,0.000052266052,0.000014490444,0.00009062655,0.00022502965,0.00007546565],"category_scores_gemma":[0.00033731468,0.00019343579,0.00017397155,0.00019386916,0.0005370187,0.00008157324,0.00001986689,0.0003964115,0.0000010563795],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.90916413,0.01060161,0.025861131,0.000016954957,0.00065217714,0.00058462046,0.0005077416,0.0000024195351,0.03495676,0.000019321804,0.000040139363,0.01759299],"study_design_scores_gemma":[0.921812,0.06999381,0.0010581526,0.00007123454,0.0009938668,0.0001690344,0.00009514701,0.00095472235,0.0041661565,0.0000033214496,0.00049764203,0.00018492754],"about_ca_topic_score_codex":0.00007371038,"about_ca_topic_score_gemma":0.0017938482,"teacher_disagreement_score":0.059392195,"about_ca_system_score_codex":0.00008048005,"about_ca_system_score_gemma":0.0005032366,"threshold_uncertainty_score":0.7888082},"labels":[],"label_agreement":null},{"id":"W2521163995","doi":"10.1093/neuonc/now200","title":"Old chemotherapy makes a comeback: dual alkylator therapy for pediatric high-grade glioma","year":2016,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Chemotherapy; Medicine; Glioma; Internal medicine; Cancer research","score_opus":0.025006827192347432,"score_gpt":0.2979366192287641,"score_spread":0.27292979203641665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2521163995","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22428717,0.0017306198,0.000010819665,0.7672747,0.0026908538,0.0030574515,0.00040145713,0.00021703287,0.00032990286],"genre_scores_gemma":[0.017228315,0.004597006,0.000593296,0.94162315,0.03192138,0.0023435233,0.0006598518,0.00043951313,0.00059393654],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961251,0.00022847227,0.0007515664,0.0012156527,0.0005356382,0.0011435598],"domain_scores_gemma":[0.99590343,0.0021103774,0.00056354294,0.0009544922,0.00021498602,0.00025314785],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00019263267,0.000871519,0.0018083712,0.0006566344,0.00014676261,0.000043009997,0.00031413254,0.0018816431,0.00065330835],"category_scores_gemma":[0.000094058945,0.000601435,0.00069895695,0.00032856027,0.0001738295,0.00006008879,0.00006295024,0.0010464446,0.00023247581],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006260032,0.0009409586,0.0019842756,0.00015592799,0.00049978954,0.0051788664,0.000078831006,1.18423465e-7,0.03974683,0.000081565486,0.9320086,0.018698221],"study_design_scores_gemma":[0.023006616,0.0060710846,0.0011864764,0.000038206126,0.0005632373,0.0007187567,0.0000059799845,0.0000026166103,0.01773299,0.00024172786,0.94993925,0.00049305917],"about_ca_topic_score_codex":0.000030620366,"about_ca_topic_score_gemma":0.0000059578315,"teacher_disagreement_score":0.20705885,"about_ca_system_score_codex":0.0004803778,"about_ca_system_score_gemma":0.000531603,"threshold_uncertainty_score":0.9996437},"labels":[],"label_agreement":null},{"id":"W2521500918","doi":"10.1093/neuonc/now156","title":"Spinal column chordoma: prognostic significance of clinical variables and<i>T (brachyury</i>) gene SNP rs2305089 for local recurrence and overall survival","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Bone Tumor Diagnosis and Treatments","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto; University of British Columbia; Vancouver Coastal Health","funders":"AOSpine; AO Foundation","keywords":"Brachyury; Medicine; Hazard ratio; SNP; Chordoma; Internal medicine; Oncology; Single-nucleotide polymorphism; Overall survival; Gastroenterology; Clinical significance; Surgery; Confidence interval; Genotype; Biology; Gene","score_opus":0.06497158917130955,"score_gpt":0.36775571272676266,"score_spread":0.30278412355545314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2521500918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920976,0.0008721871,0.0018958698,0.002595676,0.0007195842,0.0013662524,0.000084128995,0.00003652045,0.00033214534],"genre_scores_gemma":[0.9946221,0.001166243,0.0031089245,0.0005021026,0.00025639584,0.00024343199,0.00000960649,0.000028140486,0.00006304408],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99792194,0.00024098209,0.0006782261,0.0006159246,0.000179599,0.0003633468],"domain_scores_gemma":[0.9960603,0.0029430946,0.00030247227,0.00025446134,0.0001652958,0.00027436513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005538696,0.00021147722,0.00089724036,0.00005370679,0.00006541699,0.000008963229,0.00008927032,0.00019599557,0.000027452861],"category_scores_gemma":[0.0014157697,0.0001508228,0.00010255912,0.00008213864,0.00059229915,0.0000739506,0.00008745171,0.00017776554,0.0000052119544],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038060655,0.0019784053,0.70789427,0.00022243899,0.00014875043,0.0003049204,0.00003496697,6.694537e-7,0.031339508,0.001572247,0.0015996253,0.25109816],"study_design_scores_gemma":[0.02200113,0.02748196,0.89005023,0.0003241882,0.0007256585,0.0005160325,0.00002884903,0.00019453782,0.0074542197,0.0013263914,0.049558338,0.0003384628],"about_ca_topic_score_codex":0.00006099492,"about_ca_topic_score_gemma":0.000041644784,"teacher_disagreement_score":0.2507597,"about_ca_system_score_codex":0.000053887554,"about_ca_system_score_gemma":0.0003583164,"threshold_uncertainty_score":0.6150375},"labels":[],"label_agreement":null},{"id":"W2525432357","doi":"10.1093/neuonc/now181","title":"Integrating molecular markers into the World Health Organization classification of CNS tumors: a survey of the neuro-oncology community","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Subspecialty; Specialty; Enthusiasm; Medicine; Oncology; Brain tumor; Internal medicine; Bioinformatics; Family medicine; Psychology; Pathology; Biology","score_opus":0.03696214214732105,"score_gpt":0.3247141807313051,"score_spread":0.287752038583984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2525432357","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9526911,0.000087996494,0.00021023935,0.045014285,0.00029619754,0.00085730496,0.000019051913,0.000028802262,0.0007950471],"genre_scores_gemma":[0.9964411,0.00007297565,0.00020214418,0.003129477,0.000027207067,0.00005126374,0.000032844375,0.00003383429,0.000009109846],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.994254,0.0043162745,0.0006998386,0.00024251683,0.00023894964,0.0002484479],"domain_scores_gemma":[0.99314994,0.00460656,0.0008260697,0.000820044,0.00049733627,0.000100041485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014227749,0.00018225565,0.00056504575,0.00015120018,0.00022237051,0.0000063763814,0.00035558594,0.00011307989,0.000057242985],"category_scores_gemma":[0.0048129326,0.0000915011,0.00009547165,0.0010086469,0.00042966695,0.00004316585,0.0001967423,0.00042924637,0.0000066816087],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017250316,0.0009341823,0.26781264,0.00004368366,0.00006819518,0.000012114667,0.001335038,0.0000048198167,0.69059086,0.00115851,0.0023121047,0.035555314],"study_design_scores_gemma":[0.0024422177,0.002507838,0.8751135,0.00014851915,0.000114974675,0.00006719889,0.00082731916,0.00009148301,0.11281658,0.00014454582,0.0056325467,0.000093276816],"about_ca_topic_score_codex":0.0023881379,"about_ca_topic_score_gemma":0.0086306,"teacher_disagreement_score":0.6073008,"about_ca_system_score_codex":0.0005001431,"about_ca_system_score_gemma":0.0008989798,"threshold_uncertainty_score":0.5761878},"labels":[],"label_agreement":null},{"id":"W2547720966","doi":"10.1093/neuonc/nov213.21","title":"EPID-21ONE-YEAR INSTITUTIONAL REPORT OF THE FIRST CANADIAN ADULT NF1 MULTIDISCIPLINARY CLINIC, REPORTED IN THE CONTEXT OF SYSTEMATICALLY-IDENTIFIED EXPERIENCES OF PREVIOUSLY ESTABLISHED CENTERS","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Multidisciplinary approach; Medicine; Family medicine; Context (archaeology); Biopsychosocial model; MEDLINE; Population; Health care; Gerontology; Psychiatry","score_opus":0.04892053521143061,"score_gpt":0.32048166412468815,"score_spread":0.27156112891325757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2547720966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99132776,0.000081427985,0.000003187367,0.0031876713,0.0009610096,0.0011704568,0.000018500645,0.000009913665,0.0032400663],"genre_scores_gemma":[0.99912316,0.000011196341,0.00010954824,0.0005544481,0.000041904063,0.00009927926,0.000015790029,0.00001222858,0.000032462925],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965696,0.00047420536,0.0018231011,0.00033954758,0.0005293531,0.0002642129],"domain_scores_gemma":[0.9967138,0.00069481944,0.0010846894,0.00082242256,0.00049561355,0.00018864514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013472871,0.00015776862,0.0008009015,0.00016591654,0.00007887306,0.000009101537,0.00036451244,0.00014937576,0.000038491984],"category_scores_gemma":[0.0058912113,0.00009454241,0.00019350824,0.00038683714,0.0007103736,0.00009697431,0.00010913061,0.0002505831,0.0000033441206],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002557807,0.0028008972,0.80519533,0.0026134148,0.0002649858,0.016964642,0.100101575,0.00005381404,0.032708175,0.0019193478,0.034479566,0.00034042363],"study_design_scores_gemma":[0.021260876,0.010866225,0.45662302,0.0052549117,0.0011389381,0.04896211,0.35824758,0.0009007339,0.07692826,0.00024043216,0.018663432,0.00091347867],"about_ca_topic_score_codex":0.008681241,"about_ca_topic_score_gemma":0.01748705,"teacher_disagreement_score":0.34857234,"about_ca_system_score_codex":0.00012787264,"about_ca_system_score_gemma":0.0020039165,"threshold_uncertainty_score":0.99792004},"labels":[],"label_agreement":null},{"id":"W2548753106","doi":"10.1093/neuonc/nov207.09","title":"ANGI-09COMPARISON OF PROGRESSION PATTERN (PP) AND ADVERSE EVENTS (AES) WITH USE OF BEVACIZUMAB (BEV) ACROSS MULTIPLE LINES IN THE TREATMENT IN GLIOBLASTOMA (GBM)","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Bevacizumab; Neutropenia; Glioblastoma; Internal medicine; Adverse effect; First line treatment; Oncology; Chemotherapy","score_opus":0.04996421393103583,"score_gpt":0.3494714222726928,"score_spread":0.29950720834165695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2548753106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99775547,0.00031632796,0.0000023927355,0.0006872878,0.00008185892,0.0011071732,0.000026551492,0.000010655187,0.000012313544],"genre_scores_gemma":[0.9993233,0.00011153744,0.00020080205,0.00010832834,0.000028871878,0.0001947095,0.0000137341185,0.00001670994,0.0000020206294],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99863803,0.00021432842,0.00038079382,0.0002778843,0.00023480481,0.00025417615],"domain_scores_gemma":[0.99891657,0.0004034099,0.00021700063,0.00028242645,0.00008289376,0.000097701144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014034657,0.0001896246,0.0005500753,0.000116692696,0.000022163265,0.0000034212067,0.0000671707,0.000112330425,0.0000030540118],"category_scores_gemma":[0.00009578161,0.00010640626,0.00005543525,0.00023864197,0.00011155406,0.000069637135,0.000047188678,0.00011649006,0.0000026503737],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024698186,0.005325839,0.9416261,0.00003737631,0.00004309372,0.00066858024,0.006213402,0.00008864487,0.0048873103,0.0000013048808,0.00009453588,0.038544],"study_design_scores_gemma":[0.041594055,0.03046688,0.8609915,0.00032195685,0.00018743343,0.00027478125,0.0040817233,0.0017875681,0.052412566,0.000006111223,0.0077054915,0.00016992597],"about_ca_topic_score_codex":0.00062778825,"about_ca_topic_score_gemma":0.005951341,"teacher_disagreement_score":0.08063459,"about_ca_system_score_codex":0.00016662123,"about_ca_system_score_gemma":0.0000997097,"threshold_uncertainty_score":0.43391213},"labels":[],"label_agreement":null},{"id":"W2549115354","doi":"10.1093/neuonc/now260","title":"LTBK-01: PROSPECTIVE, MULTI-CENTER PHASE III TRIAL OF TUMOR TREATING FIELDS TOGETHER WITH TEMOZOLOMIDE COMPARED TO TEMOZOLOMIDE ALONE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Temozolomide; Glioblastoma; Medicine; Oncology; Internal medicine; Center (category theory); Cancer research","score_opus":0.015644065425058112,"score_gpt":0.28934558989492687,"score_spread":0.27370152446986873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549115354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936818,0.000013943516,0.00009673232,0.0014758816,0.0001944344,0.00405985,0.00005389386,0.00006254576,0.0003609092],"genre_scores_gemma":[0.9966902,0.000005407075,0.0015149188,0.000853952,0.000099584184,0.00073010434,0.000015065174,0.00006310566,0.000027658565],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9975171,0.00020419325,0.00069291703,0.0006910491,0.0003521875,0.00054252817],"domain_scores_gemma":[0.99793154,0.0007218382,0.00037338195,0.0004806325,0.00020552374,0.00028711106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014111499,0.0003922883,0.0011823528,0.0003266821,0.000060169616,0.000011200399,0.0001480829,0.00014695984,0.00009584064],"category_scores_gemma":[0.0003080731,0.00022564486,0.00010817376,0.0003832153,0.00015633827,0.00010480172,0.00007633898,0.00020831564,0.000023185403],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.26122668,0.023420926,0.68031704,0.00002612978,0.00022799059,0.0012117705,0.0007778182,0.000023670156,0.019407233,0.000008080194,0.00069184485,0.012660806],"study_design_scores_gemma":[0.77393293,0.054551683,0.12559976,0.0003379182,0.00021396948,0.000051381212,0.00014459911,0.000044872737,0.04368437,0.000004073271,0.0011359677,0.0002984957],"about_ca_topic_score_codex":0.0002284197,"about_ca_topic_score_gemma":0.0019953868,"teacher_disagreement_score":0.5547173,"about_ca_system_score_codex":0.00039411616,"about_ca_system_score_gemma":0.00020005857,"threshold_uncertainty_score":0.9201531},"labels":[],"label_agreement":null},{"id":"W2549359586","doi":"10.1093/neuonc/nov219.13","title":"MTR-13EVALUATION OF p75 EXPRESSION AND PATTERNS OF RECURRENCE IN PATIENTS WITH MALIGNANT GLIOMAS TREATED WITH BEVACIZUMAB","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Bevacizumab; Internal medicine; Univariate analysis; Immunohistochemistry; Neuroradiology; Progression-free survival; Glioblastoma; Oncology; Glioma; Neurology; Gastroenterology; Overall survival; Pathology; Multivariate analysis; Chemotherapy; Cancer research","score_opus":0.029585323006597636,"score_gpt":0.29354574191458965,"score_spread":0.26396041890799204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549359586","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989067,0.00007790976,0.00000804831,0.00015293472,0.000038596532,0.00062029186,0.000018934608,0.000008778471,0.0001678298],"genre_scores_gemma":[0.9995906,0.000021963528,0.000226092,0.00003856727,0.000008654473,0.00005414298,0.000045741395,0.000012605863,0.0000016595066],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99893576,0.00012034702,0.00026895778,0.00024652106,0.00028556163,0.00014282716],"domain_scores_gemma":[0.9991211,0.000108445915,0.00022887997,0.0001956188,0.00024139864,0.0001045091],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000115652976,0.00012771823,0.00038909502,0.00017902374,0.000012014028,0.0000023727407,0.000039437266,0.00007747414,0.00001346376],"category_scores_gemma":[0.00007697067,0.000078969264,0.00001723674,0.00018741215,0.00006217282,0.00005492211,0.000030383204,0.000072975774,0.0000010949099],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022818719,0.0014347221,0.9570202,0.000045100845,0.000023371336,0.0001056407,0.0005217809,0.000014285995,0.029875092,0.000010650739,0.00004800738,0.008619262],"study_design_scores_gemma":[0.019453185,0.015359978,0.8170143,0.00035128137,0.00014613832,0.000031720538,0.00014461322,0.000051678537,0.14720139,0.0000095769765,0.0001559141,0.000080249316],"about_ca_topic_score_codex":0.000115049384,"about_ca_topic_score_gemma":0.00007944911,"teacher_disagreement_score":0.14000593,"about_ca_system_score_codex":0.00009480917,"about_ca_system_score_gemma":0.00015614169,"threshold_uncertainty_score":0.3220273},"labels":[],"label_agreement":null},{"id":"W2551095427","doi":"10.1093/neuonc/now245","title":"Atypical meningioma—is it time to standardize surgical sampling techniques?","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"University of Toronto; National Institute for Health and Care Research","keywords":"Meningioma; Sampling (signal processing); Medicine; Computer science; Medical physics; Radiology; Computer vision","score_opus":0.045138378026306186,"score_gpt":0.350101644243096,"score_spread":0.3049632662167898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551095427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.68905175,0.00006636606,0.007980423,0.12030184,0.0005364735,0.0017791018,0.000039669078,0.0006421054,0.17960227],"genre_scores_gemma":[0.94631934,0.000024535831,0.028048802,0.009625767,0.0013289647,0.0002757123,0.000015806496,0.00011457669,0.014246468],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99767256,0.00016240025,0.0005009476,0.00063217554,0.00044011424,0.0005918025],"domain_scores_gemma":[0.99821836,0.00056400034,0.000101976635,0.0005127012,0.00012929426,0.00047365236],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00059951935,0.00024992818,0.00063800375,0.00025075447,0.00010295301,0.000021473577,0.00021156092,0.00024685785,0.00570495],"category_scores_gemma":[0.0003487605,0.00017309359,0.00018097901,0.0002733107,0.000106274005,0.00006684037,0.00027901994,0.0002279465,0.0024902034],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032875398,0.00024123877,0.00065733783,0.000031744737,0.00010997706,0.009088349,0.00027445922,5.103413e-7,0.6097626,0.0010821118,0.25232646,0.1231377],"study_design_scores_gemma":[0.001800838,0.0025841205,0.00035348884,0.00007450328,0.00008878769,0.001941729,0.000018005012,0.00001505018,0.029735666,0.00010514837,0.9630818,0.00020090185],"about_ca_topic_score_codex":0.000002647489,"about_ca_topic_score_gemma":5.091647e-7,"teacher_disagreement_score":0.7107553,"about_ca_system_score_codex":0.00035172678,"about_ca_system_score_gemma":0.00017531059,"threshold_uncertainty_score":0.9982865},"labels":[],"label_agreement":null},{"id":"W2551691100","doi":"10.1093/neuonc/nov225.27","title":"NIMG-27USING MR PERFUSION TO STRATIFY PATIENTS WITH TREATED HIGH-GRADE GLIOMAS: DOES IT CORRELATE WITH OVERALL SURVIVAL?","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Perfusion; Internal medicine; Radiology; Oncology","score_opus":0.023509079228834145,"score_gpt":0.27948855110707777,"score_spread":0.2559794718782436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2551691100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907293,0.000036017205,0.000014765806,0.005704109,0.0005518933,0.0011667464,0.000023078212,0.0001187771,0.0016553365],"genre_scores_gemma":[0.99712586,0.000018770692,0.00065858033,0.0017392515,0.00012582129,0.000075799304,0.00010814258,0.000069348585,0.000078402874],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977735,0.00019499584,0.0003507213,0.0006333522,0.00054198044,0.00050543464],"domain_scores_gemma":[0.99821764,0.00022865193,0.00018543155,0.0004497883,0.00033766066,0.0005808304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012391176,0.00038008098,0.00068489125,0.00024090782,0.00010781792,0.000038049744,0.000112009075,0.00020313567,0.000093803515],"category_scores_gemma":[0.00009688228,0.00021275152,0.000060188737,0.00039933345,0.00009348255,0.00011423673,0.00007498532,0.000266695,0.00008485713],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005720005,0.0049873483,0.92777824,0.000036109053,0.00027806545,0.0036498068,0.0018444017,0.00040084973,0.042317647,0.00016294145,0.005195828,0.0076287375],"study_design_scores_gemma":[0.064780064,0.05602334,0.7751364,0.00041461346,0.0015306346,0.0003439802,0.00095675647,0.00026579932,0.034236304,0.000076265125,0.06525064,0.000985159],"about_ca_topic_score_codex":0.00059729995,"about_ca_topic_score_gemma":0.0009652044,"teacher_disagreement_score":0.15264182,"about_ca_system_score_codex":0.00042340532,"about_ca_system_score_gemma":0.0002954749,"threshold_uncertainty_score":0.8675755},"labels":[],"label_agreement":null},{"id":"W2553354624","doi":"10.1093/neuonc/nov209.10","title":"CBIO-10Bcl-2 FAMILY MEMBER Mcl-1 EXPRESSION IS REDUCED UNDER HYPOXIA BY THE E3 LIGASE FBW7 CONTRIBUTING TO BNIP3 INDUCED CELL DEATH IN GLIOMA CELLS","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Manitoba","funders":"","keywords":"Ubiquitin ligase; Hypoxia (environmental); Glioma; Chemistry; Cell biology; Family member; DNA ligase; Programmed cell death; Cancer research; Biology; Biochemistry; Ubiquitin; Gene; Oxygen; Medicine; Apoptosis","score_opus":0.033434470887272895,"score_gpt":0.2908826612798435,"score_spread":0.2574481903925706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553354624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99413955,0.00040627297,0.00051813835,0.0013546231,0.00084394065,0.00064363424,0.000028188975,0.000024506648,0.0020411536],"genre_scores_gemma":[0.99487174,0.000064422515,0.00033311456,0.0039011342,0.00027699608,0.00006407749,0.00007650825,0.0000485126,0.00036347838],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975929,0.0003787346,0.00044777695,0.0006851788,0.0002451988,0.0006501808],"domain_scores_gemma":[0.99872434,0.00009817709,0.00019913427,0.0005353395,0.00015976146,0.00028323504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060728344,0.0002976838,0.0003291301,0.00009218002,0.00015525005,0.000038909493,0.00034073903,0.0005686653,0.000020399139],"category_scores_gemma":[0.000114154835,0.0002294846,0.00010429475,0.00022497254,0.00004556688,0.00000956834,0.0003880329,0.0002890828,0.000048751102],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022460432,0.00017196426,0.000043519693,0.000006192109,0.000009763975,0.000027168402,0.0002413129,0.00019938867,0.9820473,0.000026713586,0.015466391,0.00153566],"study_design_scores_gemma":[0.0018877424,0.0008888996,0.00020677173,0.000011107008,0.000022281012,0.000036096782,0.00038764338,0.000185659,0.92490643,0.00014146668,0.071075335,0.00025057138],"about_ca_topic_score_codex":0.00010989103,"about_ca_topic_score_gemma":0.000027749786,"teacher_disagreement_score":0.057140894,"about_ca_system_score_codex":0.00011999838,"about_ca_system_score_gemma":0.00025753383,"threshold_uncertainty_score":0.9358111},"labels":[],"label_agreement":null},{"id":"W2553699491","doi":"10.1093/neuonc/nov204.95","title":"ATPS-95THE PROGNOSTIC AND PREDICTIVE VALUE OF AN EXPLANT ASSAY OF GLIOMAS IN RESPONSE TO TEMOZOLOMIDE","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Temozolomide; Glioma; Explant culture; Medicine; Pathological; Anaplastic astrocytoma; Pathology; Brain tumor; IDH1; Dacarbazine; Predictive marker; Glioblastoma; Cancer research; Oncology; Chemotherapy; Internal medicine; Biology; Astrocytoma; In vitro; Cancer; Mutation","score_opus":0.030364983491246222,"score_gpt":0.3164130155164132,"score_spread":0.286048032025167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553699491","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996155,0.00013938628,0.000010837229,0.0021131372,0.00014266535,0.00092809973,0.000032522123,0.000018142238,0.00046020327],"genre_scores_gemma":[0.9988058,0.000014742028,0.0006555184,0.00032503175,0.00003545664,0.00012992852,0.000010820025,0.000018203686,0.000004490495],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99821705,0.00067243155,0.00037467238,0.00030272634,0.00021561906,0.00021749764],"domain_scores_gemma":[0.9978253,0.0013457238,0.00013632684,0.00027021568,0.0001326302,0.00028979598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082025776,0.00013955816,0.00053246936,0.0003354463,0.000013596334,0.0000029874216,0.000076746794,0.0001292058,0.000008699122],"category_scores_gemma":[0.0022390676,0.00010966508,0.000038332768,0.0002784984,0.00011169757,0.000047895042,0.00007801664,0.00012030686,0.000007161149],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016746288,0.002934402,0.27265254,0.000050202034,0.0000848984,0.0025149442,0.0041967295,0.00017677642,0.6918999,0.00014718823,0.0007752817,0.007820883],"study_design_scores_gemma":[0.013321816,0.043614432,0.6866352,0.00018171854,0.000328018,0.00092642976,0.0015270592,0.0012436366,0.24547246,0.00025727242,0.0063113775,0.00018061277],"about_ca_topic_score_codex":0.00008924163,"about_ca_topic_score_gemma":0.00006742276,"teacher_disagreement_score":0.44642743,"about_ca_system_score_codex":0.00014309344,"about_ca_system_score_gemma":0.00032149022,"threshold_uncertainty_score":0.44720122},"labels":[],"label_agreement":null},{"id":"W2555250050","doi":"10.1093/neuonc/nov216.17","title":"HCP-17RETROSPECTIVE ANALYSIS OF PNEUMOCYSTIS JIROVECI IN BRAIN TUMOR PATIENTS","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Pneumocystis jirovecii pneumonia detection and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Prednisone; Incidence (geometry); Population; Internal medicine; Cohort; Corticosteroid; Pneumonia; Retrospective cohort study; Contraindication; Pediatrics; Pathology","score_opus":0.021319200323444986,"score_gpt":0.30519448300685786,"score_spread":0.2838752826834129,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555250050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99065214,0.000047177033,0.00005196123,0.0019184218,0.0005246702,0.00061636436,0.00005877459,0.00007285398,0.00605766],"genre_scores_gemma":[0.99776936,0.000011694331,0.00020302442,0.0017275559,0.00005274957,0.0000743397,0.00005059153,0.00003351993,0.000077159835],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975961,0.00023642762,0.00068888924,0.000584799,0.00048479208,0.00040898388],"domain_scores_gemma":[0.998141,0.00038897345,0.00034181937,0.0004499054,0.0002894284,0.0003888554],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026010541,0.00027885567,0.0011727827,0.0010754522,0.000035076806,0.000008935326,0.00013585591,0.00016724858,0.00008282835],"category_scores_gemma":[0.0010093836,0.00025430814,0.00027911656,0.0018043173,0.00014725728,0.00008581587,0.0000959044,0.00037416362,0.000069406655],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026575397,0.0046630646,0.81535435,0.000042643132,0.0012062142,0.0020089615,0.001724181,0.00070316734,0.16132343,0.00048078565,0.0007375847,0.009098109],"study_design_scores_gemma":[0.012551671,0.0100474125,0.95466757,0.000029189405,0.001292261,0.00016944094,0.00027455876,0.0008769136,0.010990767,0.00028653466,0.008558553,0.00025510794],"about_ca_topic_score_codex":0.00029673442,"about_ca_topic_score_gemma":0.00071780686,"teacher_disagreement_score":0.15033266,"about_ca_system_score_codex":0.0016951172,"about_ca_system_score_gemma":0.00050740066,"threshold_uncertainty_score":0.99999094},"labels":[],"label_agreement":null},{"id":"W2557786287","doi":"10.1093/neuonc/now212.100","title":"ATIM-35. RESULTS OF THE PHASE IB KEYNOTE-028 MULTI-COHORT TRIAL OF PEMBROLIZUMAB MONOTHERAPY IN PATIENTS WITH RECURRENT PD-L1-POSITIVE GLIOBLASTOMA MULTIFORME (GBM)","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Pembrolizumab; Medicine; Internal medicine; Rash; Clinical endpoint; Cohort; Oncology; Surgery; Clinical trial; Gastroenterology; Immunotherapy; Cancer","score_opus":0.015537324857194883,"score_gpt":0.3030960722070924,"score_spread":0.2875587473498975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557786287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99460286,0.0000639894,0.000042678766,0.001124266,0.0007858595,0.0027757837,0.00023269937,0.000022591477,0.00034926346],"genre_scores_gemma":[0.99878544,0.00021816818,0.0002007238,0.00047958086,0.0000949126,0.00010130492,0.00001619632,0.000040408293,0.000063258056],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9973399,0.0003788895,0.0009888432,0.00047412165,0.00044650296,0.000371757],"domain_scores_gemma":[0.9978037,0.0005256992,0.0007506917,0.0005878124,0.00023908392,0.00009302606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037041516,0.00028410516,0.0007645766,0.00021653155,0.000050962393,0.000004103497,0.00024766565,0.00023175153,0.000055314882],"category_scores_gemma":[0.0002818493,0.0001532458,0.00022797218,0.00038624363,0.00045745485,0.00009021227,0.000057284997,0.00026531782,0.000004122655],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7231946,0.004010451,0.010118887,0.000022432001,0.00017889771,0.000014877859,0.00072182884,0.0000019123788,0.14267965,0.0000034127615,0.00029176503,0.118761316],"study_design_scores_gemma":[0.6651527,0.046952073,0.17260231,0.0003670894,0.00012298576,0.000017158673,0.000057701967,0.00007902625,0.10665966,0.0000044409317,0.0077683176,0.00021647927],"about_ca_topic_score_codex":0.00016134609,"about_ca_topic_score_gemma":0.00028334194,"teacher_disagreement_score":0.16248344,"about_ca_system_score_codex":0.00042847238,"about_ca_system_score_gemma":0.000469872,"threshold_uncertainty_score":0.6249182},"labels":[],"label_agreement":null},{"id":"W2558450726","doi":"10.1093/neuonc/now212.048","title":"ACTR-50. MARIZOMIB (MRZ) WITH BEVACIZUMAB (BEV) IN WHO GRADE IV MALIGNANT GLIOMA (G4 MG): FULL ENROLLMENT RESULTS FROM THE PHASE 1, MULTICENTER, OPEN-LABEL STUDY","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Glioma; Internal medicine; Population; Progressive disease; Cohort; Surgery; Tolerability; Gastroenterology; Adverse effect; Chemotherapy","score_opus":0.05990842500613037,"score_gpt":0.3412815241594815,"score_spread":0.2813730991533511,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558450726","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97275805,0.00027099004,0.00002133404,0.019274669,0.0005020118,0.005586625,0.00021501785,0.00007537782,0.0012958929],"genre_scores_gemma":[0.995746,0.00018499953,0.0005750466,0.0020401445,0.00026268535,0.00065516395,0.00007294428,0.000098317054,0.00036466395],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99478585,0.0011124539,0.0010915664,0.0014119676,0.00069937174,0.0008987907],"domain_scores_gemma":[0.9953581,0.0020169155,0.00048418692,0.0015964147,0.00013742603,0.0004069586],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007222916,0.00061811606,0.0011969255,0.00022028157,0.0001758414,0.00007441392,0.0008629708,0.0002316631,0.00012959467],"category_scores_gemma":[0.00037750913,0.00031352346,0.00010382806,0.00038573163,0.00024864907,0.00020951683,0.0006723197,0.00052578276,0.00016571919],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09357911,0.028583907,0.01525066,0.000019605208,0.0005479517,0.020203559,0.0036836579,0.000002335652,0.78793067,0.000027177155,0.004674006,0.04549735],"study_design_scores_gemma":[0.62359804,0.09620062,0.062311284,0.0005178198,0.0014140283,0.0013230556,0.0025977592,0.00028347143,0.102813125,0.00008242613,0.10793277,0.000925615],"about_ca_topic_score_codex":0.0018486324,"about_ca_topic_score_gemma":0.002392282,"teacher_disagreement_score":0.68511754,"about_ca_system_score_codex":0.0011706572,"about_ca_system_score_gemma":0.0004932527,"threshold_uncertainty_score":0.9999317},"labels":[],"label_agreement":null},{"id":"W2558690325","doi":"10.1093/neuonc/now212.068","title":"ATIM-03. ACT IV: AN INTERNATIONAL, DOUBLE-BLIND, PHASE 3 TRIAL OF RINDOPEPIMUT IN NEWLY DIAGNOSED, EGFRvIII-EXPRESSING GLIOBLASTOMA","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Interim analysis; Temozolomide; Hazard ratio; Internal medicine; Oncology; Cohort; Clinical endpoint; Confidence interval; Randomized controlled trial; Chemotherapy","score_opus":0.052725915880982036,"score_gpt":0.37631285673129805,"score_spread":0.32358694085031603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558690325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901573,0.000057155343,0.000018964132,0.0037191152,0.0012438919,0.0013149178,0.000028050292,0.00005415272,0.0034064252],"genre_scores_gemma":[0.99798965,0.00022547424,0.00024985961,0.0005048159,0.00061629026,0.00032157393,0.000024424127,0.000043126063,0.000024795449],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9977458,0.00021896668,0.0007189716,0.00055475254,0.00036893098,0.00039258512],"domain_scores_gemma":[0.99779314,0.00091293623,0.0003612917,0.00052246766,0.00015575122,0.0002544238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002803198,0.0002667156,0.0007067933,0.000483822,0.000047378646,0.000022647784,0.00027195903,0.00023610015,0.00045454694],"category_scores_gemma":[0.00039806613,0.00018790999,0.00016756573,0.00026164172,0.00015058671,0.0003167443,0.00011641399,0.00021069478,0.00008462609],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.31208465,0.016297452,0.03064968,0.000024211598,0.00018755812,0.0031555388,0.0005117093,0.000026114558,0.4480344,0.00032293366,0.0013464806,0.18735927],"study_design_scores_gemma":[0.7594054,0.016872711,0.003550747,0.00016648091,0.00016319103,0.00015056838,0.00007384422,0.00010046553,0.17009154,0.00005428134,0.0491575,0.00021331596],"about_ca_topic_score_codex":0.000121506004,"about_ca_topic_score_gemma":0.00027921697,"teacher_disagreement_score":0.44732073,"about_ca_system_score_codex":0.00032062284,"about_ca_system_score_gemma":0.0003126173,"threshold_uncertainty_score":0.7662747},"labels":[],"label_agreement":null},{"id":"W2559197523","doi":"10.1093/neuonc/now212.070","title":"ATIM-05. COMPLEMENTARY CLINICAL AND ANCILLARY DATA FROM 123 PATIENTS WITH RECURRENT HIGH GRADE GLIOMA FROM THREE PHASE 1 TRIALS OF TOCA 511 AND TOCA FC: UPDATE AND JUSTIFICATION FOR A PHASE 2/3 TRIAL","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Brain Institute","funders":"","keywords":"Immune system; Tumor microenvironment; Glioma; Cancer research; Medicine; Immunology","score_opus":0.17535777439306974,"score_gpt":0.4485427401079663,"score_spread":0.2731849657148966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559197523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98101884,0.00082708965,0.00083137257,0.0013462084,0.0003824822,0.0022125586,0.013370781,0.000009114653,0.0000015551789],"genre_scores_gemma":[0.98749983,0.001367721,0.0021498613,0.00042609256,0.0006573579,0.00014893032,0.0077115744,0.00003751438,0.0000011214702],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9969013,0.0008171846,0.00088569336,0.0009159977,0.000202763,0.00027711448],"domain_scores_gemma":[0.9973775,0.0010603112,0.00047658317,0.0007604482,0.00013255162,0.00019260385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011852263,0.0002312213,0.00069434295,0.00006578412,0.00009031208,0.000022296763,0.00031684263,0.00021233727,0.00005146622],"category_scores_gemma":[0.0007156711,0.0001636099,0.000057311292,0.00005948121,0.000418388,0.000022352368,0.00035868865,0.00011373178,0.0000015894735],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5211969,0.0009706735,0.00080768403,0.000010883407,0.00019532474,0.0000054363554,0.000015741827,1.1746798e-7,0.270363,0.0000046201862,0.003937481,0.20249215],"study_design_scores_gemma":[0.3713494,0.43261397,0.0014266131,0.000037201153,0.00049344613,0.000006517266,0.000031988155,0.00033724567,0.12940694,0.0007119819,0.0631777,0.00040702778],"about_ca_topic_score_codex":0.000027409857,"about_ca_topic_score_gemma":0.0025475086,"teacher_disagreement_score":0.43164328,"about_ca_system_score_codex":0.000018007648,"about_ca_system_score_gemma":0.0002012168,"threshold_uncertainty_score":0.6671818},"labels":[],"label_agreement":null},{"id":"W2559587137","doi":"10.1093/neuonc/now212.003","title":"ACTR-04. RESULTS OF THE INTERIM ANALYSIS OF THE EORTC RANDOMIZED PHASE III CATNON TRIAL ON CONCURRENT AND ADJUVANT TEMOZOLOMIDE IN ANAPLASTIC GLIOMA WITHOUT 1p/19q CO-DELETION, AN INTERGROUP TRIAL","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Temozolomide; Interim analysis; Medicine; Internal medicine; Oncology; Glioma; Adjuvant; Clinical endpoint; Randomized controlled trial; Chemotherapy; Cancer research","score_opus":0.03145773734539179,"score_gpt":0.3595383140764256,"score_spread":0.3280805767310338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559587137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99325573,0.00007583194,0.000020508163,0.0022087176,0.0010871824,0.0030478241,0.00010207878,0.000014347059,0.00018778755],"genre_scores_gemma":[0.99925625,0.00009857268,0.0000072864796,0.00020047383,0.00012693263,0.0002529976,0.000027158614,0.000018159533,0.000012182584],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9958188,0.0017341838,0.0013470328,0.00049813266,0.00033855994,0.00026328352],"domain_scores_gemma":[0.995146,0.0030096767,0.0009679331,0.0006245619,0.00012364698,0.00012817862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010891847,0.00027054106,0.0018996164,0.0004646843,0.000057381658,0.000009520427,0.00022486174,0.00017364352,0.00005308302],"category_scores_gemma":[0.0025657841,0.00011963551,0.00049171,0.0005627245,0.0006113026,0.000053655105,0.00010032712,0.00021814046,0.0000015781162],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.88694286,0.003462407,0.0010240241,0.000009996774,0.0007369397,0.000048270518,0.0005996115,0.0000075723824,0.09647968,0.00010445659,0.00039776365,0.010186392],"study_design_scores_gemma":[0.9278058,0.014055431,0.0017855321,0.00016448992,0.002759377,0.000023091485,0.00009252713,0.0003231032,0.052064657,0.000026006319,0.00079716655,0.00010284079],"about_ca_topic_score_codex":0.0001781547,"about_ca_topic_score_gemma":0.0010510104,"teacher_disagreement_score":0.04441502,"about_ca_system_score_codex":0.00020301883,"about_ca_system_score_gemma":0.0002166583,"threshold_uncertainty_score":0.48785946},"labels":[],"label_agreement":null},{"id":"W2561692137","doi":"10.1093/neuonc/now265","title":"Long-term control and partial remission after initial pseudoprogression of glioblastoma by anti–PD-1 treatment with nivolumab","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Toronto; National Institute for Health and Care Research","keywords":"Nivolumab; Glioblastoma; Medicine; Oncology; Term (time); Internal medicine; Cancer; Immunotherapy; Cancer research","score_opus":0.010175273140638838,"score_gpt":0.290065638029209,"score_spread":0.27989036488857016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2561692137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99530655,0.0007498485,0.00004195013,0.0028773767,0.00013910222,0.00067555776,0.000045961257,0.000039584967,0.00012406443],"genre_scores_gemma":[0.99886227,0.00041913905,0.000051784282,0.00027819755,0.00013199954,0.00019939976,0.000007875372,0.000030222147,0.0000191099],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99863243,0.00012852171,0.00030298368,0.0004208217,0.00020635714,0.0003088669],"domain_scores_gemma":[0.9989696,0.00024106278,0.0001786196,0.0002703514,0.000084318104,0.00025603402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005681896,0.00024183649,0.00058624474,0.000094039315,0.000051750038,0.00000856705,0.00004376963,0.00017290362,0.00013797608],"category_scores_gemma":[0.000032352087,0.0001239879,0.000078553916,0.000077231554,0.00022680707,0.000071041875,0.000034254514,0.0000709834,0.000012990849],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007259559,0.0016821931,0.34870532,0.00002543918,0.00011898218,0.0021151341,0.00008046021,8.459851e-8,0.45815432,0.0000042879337,0.00042881133,0.18142541],"study_design_scores_gemma":[0.051359825,0.051781286,0.13966432,0.00046150933,0.000775645,0.0010043716,0.000016919508,0.000027373768,0.73984647,0.0000055608916,0.014814554,0.00024216436],"about_ca_topic_score_codex":0.000013340646,"about_ca_topic_score_gemma":0.000018436738,"teacher_disagreement_score":0.28169215,"about_ca_system_score_codex":0.00015832386,"about_ca_system_score_gemma":0.0001317578,"threshold_uncertainty_score":0.505608},"labels":[],"label_agreement":null},{"id":"W2562988259","doi":"10.1093/neuonc/now188.180","title":"P08.47 Dianhydrogalactitol (VAL-083) causes bifunctional alkylation leading to irreparable DNA double-strand breaks, S/G2 phase cell-cycle arrest and tumor cell death in an MGMT independent manner offering a unique treatment paradigm for GBM","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Delmar (Canada); University of British Columbia","funders":"","keywords":"Cell cycle checkpoint; Double strand; Cell cycle; Cell biology; DNA; Programmed cell death; Cancer research; DNA repair; Chemistry; Biology; Cell; Apoptosis; Genetics","score_opus":0.03600810494761814,"score_gpt":0.3269535239535203,"score_spread":0.29094541900590215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562988259","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99447125,0.00014030834,0.00022598836,0.0018958208,0.00045998357,0.002095953,0.00007331513,0.00007311242,0.00056426245],"genre_scores_gemma":[0.9976208,0.00012310126,0.00032494956,0.00035923,0.0002368901,0.001114134,0.00006285104,0.000060279745,0.00009773262],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99788034,0.00011011286,0.00045788975,0.00077871024,0.00020625694,0.0005667103],"domain_scores_gemma":[0.9984801,0.00052383414,0.00016348252,0.00032758698,0.00005725881,0.00044776415],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017060537,0.00037485542,0.0006186591,0.00036342407,0.00015739325,0.000045051478,0.000076424294,0.00017373203,0.000060611183],"category_scores_gemma":[0.000027374344,0.0002769405,0.00011098941,0.00016002536,0.000052266005,0.00025046387,0.00003715421,0.00012529481,0.000030050096],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005279107,0.0064661205,0.12021439,0.000101771424,0.00011170937,0.0012140032,0.0007132104,0.0006415081,0.855877,0.0002531586,0.00034559378,0.00878242],"study_design_scores_gemma":[0.07817532,0.017901065,0.04118382,0.00020087391,0.00066679856,0.00053520774,0.00018778334,0.0009846556,0.810811,0.0002536151,0.04841994,0.000679929],"about_ca_topic_score_codex":0.00031023554,"about_ca_topic_score_gemma":0.0015313261,"teacher_disagreement_score":0.079030566,"about_ca_system_score_codex":0.00083934393,"about_ca_system_score_gemma":0.00026129573,"threshold_uncertainty_score":0.9999683},"labels":[],"label_agreement":null},{"id":"W2564916912","doi":"10.1093/neuonc/now212.106","title":"BMET-06. IMPROVED SURVIVAL AND PROGNOSTIC ABILITY IN LUNG CANCER PATIENTS WITH BRAIN METASTASES: AN UPDATE OF THE GRADED PROGNOSTIC ASSESSMENT FOR LUNG CANCER USING MOLECULAR MARKERS (LUNG-molGPA)","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Lung cancer; Internal medicine; Oncology; Adenocarcinoma; Hazard ratio; Performance status; Lung; Brain metastasis; Cancer; Metastasis; Confidence interval","score_opus":0.013344724573392022,"score_gpt":0.36020624101857973,"score_spread":0.3468615164451877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564916912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98970395,0.00035863323,0.0010259149,0.002683699,0.00034425984,0.005448716,0.00038420726,0.00002314441,0.000027444506],"genre_scores_gemma":[0.9961613,0.000037485643,0.0017431524,0.0005057932,0.000039216924,0.0013999052,0.00005413095,0.00004967846,0.000009363789],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99787635,0.00042401208,0.000434118,0.00057415897,0.00026380332,0.00042758437],"domain_scores_gemma":[0.99822915,0.00066412316,0.0003223337,0.00034347354,0.0002815322,0.00015936285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032245985,0.0002662031,0.0005474468,0.00010701734,0.00010026678,0.000015172081,0.00012284039,0.000102065795,0.000030933672],"category_scores_gemma":[0.00036766325,0.00015118564,0.00008280153,0.00027463213,0.00022839774,0.00015347113,0.000073482544,0.00015789129,5.5352153e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007192446,0.00079111214,0.9281714,0.00037746903,0.000491077,0.000018299408,0.00023784835,0.00010628074,0.06384414,0.000072171475,0.00007903014,0.005091914],"study_design_scores_gemma":[0.023598796,0.0030073281,0.9489917,0.00055716,0.004599952,0.000013958401,0.00019430691,0.013944239,0.004046074,0.00006177616,0.00058758515,0.00039710023],"about_ca_topic_score_codex":0.00067669776,"about_ca_topic_score_gemma":0.0009758676,"teacher_disagreement_score":0.05979806,"about_ca_system_score_codex":0.0009345377,"about_ca_system_score_gemma":0.00156147,"threshold_uncertainty_score":0.6165171},"labels":[],"label_agreement":null},{"id":"W2565057278","doi":"10.1093/neuonc/now236","title":"Phase III randomized study of radiation and temozolomide versus radiation and nitrosourea therapy for anaplastic astrocytoma: results of NRG Oncology RTOG 9813","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame; University of Calgary; Centre Hospitalier de l’Université de Montréal","funders":"University of California, San Francisco; National Cancer Institute; NRG Oncology; Ohio State University","keywords":"Temozolomide; Medicine; Anaplastic astrocytoma; Internal medicine; Nitrosourea; Radiation therapy; Hazard ratio; Oncology; Progression-free survival; Dacarbazine; Phases of clinical research; Toxicity; Astrocytoma; Gastroenterology; Glioma; Chemotherapy; Confidence interval; Cancer research","score_opus":0.027742158024968402,"score_gpt":0.3396604815050475,"score_spread":0.31191832348007914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565057278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939386,0.00052832015,0.000095823976,0.001648719,0.00037818705,0.003182005,0.00007003704,0.000021732803,0.00013652809],"genre_scores_gemma":[0.9980271,0.0011217635,0.00016441285,0.00010366583,0.00012487646,0.0003985634,0.000033624136,0.000020509526,0.000005519025],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99802893,0.00045364513,0.000748365,0.00038555136,0.00015665471,0.00022685775],"domain_scores_gemma":[0.9919216,0.0069412095,0.00064743275,0.00021368595,0.00014399951,0.00013206237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056767184,0.00020056606,0.0012317128,0.0002478285,0.00006141928,0.0000048435013,0.000052183055,0.00017838363,0.000010362394],"category_scores_gemma":[0.0014192433,0.0001308703,0.00010110654,0.00011952888,0.00021107351,0.00006680788,0.000028007635,0.00008216114,9.956256e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.62086135,0.0044121225,0.0014094872,0.000018926858,0.00046044248,0.0000441553,0.0009085193,0.000004282622,0.12900098,0.00005479597,0.00062659726,0.24219835],"study_design_scores_gemma":[0.85859734,0.08434859,0.0027085159,0.000017563052,0.00067857286,0.000036697027,0.00028130235,0.00020711834,0.04909805,0.00003651231,0.0039005177,0.0000892119],"about_ca_topic_score_codex":0.00005167375,"about_ca_topic_score_gemma":0.00010635373,"teacher_disagreement_score":0.24210913,"about_ca_system_score_codex":0.00015917844,"about_ca_system_score_gemma":0.00017733376,"threshold_uncertainty_score":0.53367364},"labels":[],"label_agreement":null},{"id":"W2565096807","doi":"10.1093/neuonc/now212.111","title":"BMET-11. DURAL METASTASES FROM BREAST CANCER - CASE SERIES","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Breast cancer; Headaches; Radiology; Asymptomatic; Cancer; Weakness; Surgery; Quadrantectomy; Radiation therapy; Craniotomy; Internal medicine; Mastectomy","score_opus":0.016235027392855036,"score_gpt":0.319584573768783,"score_spread":0.303349546375928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565096807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89876777,0.00028648984,0.00033639057,0.09799029,0.001243605,0.00018660453,0.0002623155,0.00012707726,0.00079943193],"genre_scores_gemma":[0.98757505,0.00038207497,0.0016368342,0.008644406,0.0011995148,0.000048216065,0.000022838525,0.00004827487,0.00044281362],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.998557,0.00020930567,0.00029186803,0.00038298473,0.00018256942,0.0003762874],"domain_scores_gemma":[0.99861646,0.00058835594,0.00011835213,0.00028838028,0.00007505099,0.00031341158],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018940489,0.00018683173,0.00047715093,0.00009100364,0.00010504403,0.000015457439,0.00010778714,0.00011223623,0.0020260199],"category_scores_gemma":[0.00050630694,0.00011570008,0.000106247615,0.000110521934,0.0003042943,0.00013155257,0.00009169585,0.0003251179,0.00007510062],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005232252,0.00018753155,0.048397467,0.00002892997,0.00014959586,0.033941135,0.00024145063,0.0000053733474,0.4910313,0.00029713436,0.0314784,0.39371848],"study_design_scores_gemma":[0.0049616373,0.0005746599,0.0105284015,0.000099020566,0.0004609935,0.08595032,0.00018464221,0.0002603243,0.0056186486,0.00023070074,0.8908513,0.00027935745],"about_ca_topic_score_codex":0.0012486491,"about_ca_topic_score_gemma":0.00031925607,"teacher_disagreement_score":0.8593729,"about_ca_system_score_codex":0.00015189595,"about_ca_system_score_gemma":0.00025871524,"threshold_uncertainty_score":0.9988863},"labels":[],"label_agreement":null},{"id":"W2565306870","doi":"10.1093/neuonc/now212.202","title":"DDIS-11. MOLECULAR MECHANISMS OF DIANHYDROGALACTITOL (VAL-083) IN OVERCOMING CHEMO-RESISTANCE IN GLIOBLASTOMA","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Delmar (Canada); University of British Columbia","funders":"","keywords":"Temozolomide; Cancer research; DNA repair; Bevacizumab; Medicine; Cell cycle; DNA damage; Methyltransferase; Cancer; Glioma; Chemotherapy; Biology; Internal medicine; DNA; Methylation; Genetics","score_opus":0.008470725462263734,"score_gpt":0.24621537600547874,"score_spread":0.237744650543215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565306870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957641,0.0000532707,0.0009233248,0.0016399551,0.0005631437,0.00034432317,0.000019928424,0.000060212853,0.00063174474],"genre_scores_gemma":[0.99801475,0.000013801995,0.0012918636,0.00051808363,0.00003473112,0.000066686436,4.251471e-7,0.00003635505,0.000023302959],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99734825,0.00044360885,0.0006479274,0.0005907307,0.00033795205,0.0006315475],"domain_scores_gemma":[0.9982778,0.0007626912,0.0002736659,0.00050160254,0.000060730665,0.00012351775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063225784,0.00022565028,0.00052621367,0.0003065767,0.000031351075,0.000015119611,0.00043249465,0.00019496339,0.00028076925],"category_scores_gemma":[0.0005160886,0.00019641312,0.00007880809,0.0004590483,0.00018605494,0.00029073085,0.00019164506,0.00014966547,0.00019891415],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038571408,0.00031627677,0.00078686397,0.000027749602,0.0000023296352,0.0006573987,0.00018026833,0.00006209688,0.99410033,0.0025886446,0.0001244765,0.0007678481],"study_design_scores_gemma":[0.0024166133,0.00032393873,0.0004263289,0.00008137167,0.000010277295,0.000018525909,0.000044868513,0.00008016244,0.99179065,0.0024246494,0.0021833307,0.00019929773],"about_ca_topic_score_codex":0.000118181175,"about_ca_topic_score_gemma":0.0021103364,"teacher_disagreement_score":0.0023096974,"about_ca_system_score_codex":0.00046567997,"about_ca_system_score_gemma":0.00025848954,"threshold_uncertainty_score":0.80094945},"labels":[],"label_agreement":null},{"id":"W2565483775","doi":"10.1093/neuonc/nov225.46","title":"NIMG-46THE USE OF CLINICAL FUNCTIONAL MAGNETIC RESONANCE IMAGING IN BRAIN TUMOUR PATIENTS FOR SURGICAL PLANNING: A SINGLE-SURGEON RETROSPECTIVE COHORT STUDY AT A CANADIAN CENTER","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Magnetic resonance imaging; Retrospective cohort study; Functional magnetic resonance imaging; Cohort; Radiology; Single Center; Craniotomy; Surgery; Internal medicine","score_opus":0.07991805477323974,"score_gpt":0.34432109621601004,"score_spread":0.26440304144277027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565483775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946684,0.00014071402,7.6722444e-7,0.0017665038,0.0007097905,0.0017680752,0.00009180281,0.000016382828,0.00083754],"genre_scores_gemma":[0.9985761,0.000004117759,0.00006260127,0.0008793966,0.00012671777,0.00018783547,0.00008128393,0.000029277388,0.000052675645],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976373,0.0003671556,0.0006958576,0.00055242487,0.000328742,0.0004185521],"domain_scores_gemma":[0.99760926,0.0012249565,0.00018851516,0.00023645599,0.00031657462,0.0004242305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006459954,0.00018674602,0.0007244209,0.00023115666,0.00004850221,0.000010733582,0.00006680451,0.00012006304,0.000047098063],"category_scores_gemma":[0.0018635396,0.00016097544,0.00013510743,0.0001887466,0.00011124074,0.000058005164,0.000067357076,0.00022900089,0.000010374805],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022617867,0.004539487,0.9657517,0.0000043053865,0.000024620043,0.0015143071,0.00025918958,0.000008847797,0.00010298964,0.000011035201,0.022847978,0.0026737647],"study_design_scores_gemma":[0.018508367,0.0058880304,0.87277186,0.000029942023,0.000072598974,0.00010382179,0.00007806723,0.00019418822,0.000042571828,0.000010971598,0.102203615,0.00009594965],"about_ca_topic_score_codex":0.004837115,"about_ca_topic_score_gemma":0.021117192,"teacher_disagreement_score":0.09297981,"about_ca_system_score_codex":0.0011224621,"about_ca_system_score_gemma":0.000475643,"threshold_uncertainty_score":0.9967449},"labels":[],"label_agreement":null},{"id":"W2566232150","doi":"10.1093/neuonc/now212.133","title":"BMET-33. MORBIDITY AND MORTALITY OF OMMAYA RESERVOIR PLACEMENT FOR INTRAVENTRICULAR CHEMOTHERAPY","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Ommaya reservoir; Surgery; Neurosurgery; Catheter; Asymptomatic; Chemotherapy","score_opus":0.046723084578629455,"score_gpt":0.3482639015584887,"score_spread":0.30154081697985924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566232150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98859924,0.00020776596,0.0015493978,0.007893955,0.00019422515,0.0010452351,0.000107995285,0.000023364504,0.0003788073],"genre_scores_gemma":[0.9952477,0.0005507067,0.002518789,0.0012779346,0.00015788624,0.00012308777,0.000017714237,0.000021344356,0.000084802516],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988466,0.00012905574,0.00030498757,0.00031059652,0.00016144737,0.00024732904],"domain_scores_gemma":[0.99879044,0.0004984811,0.00014679809,0.00033278082,0.000088686116,0.0001428302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004261698,0.00014311053,0.00046047327,0.00006056405,0.000039440347,0.0000032165374,0.00006324143,0.00010425342,0.00016142763],"category_scores_gemma":[0.00021750768,0.00008807867,0.00011146435,0.00007664738,0.00013538694,0.000029754805,0.000045980727,0.00007191322,0.000004140729],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054103457,0.0040270807,0.14340076,0.0005580561,0.0014736608,0.00064478145,0.0004261777,0.000010800277,0.6108797,0.0036238246,0.02636299,0.2031818],"study_design_scores_gemma":[0.028240277,0.013412945,0.104137726,0.000077434706,0.00075558294,0.00027617966,0.00012571878,0.000111659014,0.28528038,0.0015892861,0.5657215,0.00027132969],"about_ca_topic_score_codex":0.000050011877,"about_ca_topic_score_gemma":0.000024403356,"teacher_disagreement_score":0.5393585,"about_ca_system_score_codex":0.0001186556,"about_ca_system_score_gemma":0.00011971187,"threshold_uncertainty_score":0.3591744},"labels":[],"label_agreement":null},{"id":"W2566482839","doi":"10.1093/neuonc/nov215.25","title":"GENO-25HYPERMUTATION AND MALIGNANT PROGRESSION IN AN EXPANDED COHORT OF TEMOZOLOMIDE-TREATED LOW-GRADE GLIOMA PATIENTS","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Temozolomide; Somatic hypermutation; Oncology; Medicine; Exome sequencing; Glioma; Cancer research; Cohort; Internal medicine; Mutation; Frameshift mutation; IDH1; DNA mismatch repair; Biology; Gene; Genetics; Cancer; Immunology; Antibody","score_opus":0.0279153896075524,"score_gpt":0.3266087347027697,"score_spread":0.2986933450952173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566482839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99811316,0.00017253355,7.362978e-7,0.00030189753,0.0001594655,0.0010323011,0.000008786977,0.000031916374,0.00017918776],"genre_scores_gemma":[0.9992837,0.00004044872,0.00019774737,0.00015046941,0.000036518606,0.00014353011,0.0001239604,0.000021715985,0.0000019384283],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99861354,0.00022030706,0.0003727707,0.0003082999,0.00023222843,0.00025283857],"domain_scores_gemma":[0.999105,0.00010710435,0.0001714845,0.00019710134,0.0001537872,0.00026555016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018916496,0.0001591298,0.00045395098,0.00023380923,0.000025553578,0.0000066165826,0.000045766752,0.0001796504,0.000008563189],"category_scores_gemma":[0.00016128215,0.00010963111,0.000034573422,0.00022622733,0.00008425534,0.00010387288,0.000042781525,0.000103931816,0.00000570351],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041592974,0.0026279215,0.80433995,0.000023479566,0.000023146898,0.0003710487,0.00052595086,0.0000027214226,0.17562631,0.000007804384,0.00015372998,0.015881985],"study_design_scores_gemma":[0.009549708,0.0053304527,0.774704,0.000068080444,0.00011947668,0.00012467893,0.00018181642,0.00015807844,0.20927945,0.00003146613,0.00035196255,0.000100846955],"about_ca_topic_score_codex":0.00006748513,"about_ca_topic_score_gemma":0.000037121183,"teacher_disagreement_score":0.033653144,"about_ca_system_score_codex":0.00018508086,"about_ca_system_score_gemma":0.00010764177,"threshold_uncertainty_score":0.44706267},"labels":[],"label_agreement":null},{"id":"W2566967253","doi":"10.1093/neuonc/now212.040","title":"ACTR-42. CLINICAL TRIALS OF VAL-083 IN PATIENTS WITH CHEMORESISTANT GLIOBLASTOMA","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Delmar (Canada)","funders":"","keywords":"Temozolomide; Bevacizumab; Medicine; Oncology; Clinical trial; Internal medicine; Phases of clinical research; Biomarker; Chemotherapy; Biology","score_opus":0.05183609190472253,"score_gpt":0.37806067276732785,"score_spread":0.3262245808626053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566967253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942518,0.00004465993,0.0000051931397,0.0038429669,0.00030515864,0.00075669657,0.000033721462,0.000023404202,0.0007364329],"genre_scores_gemma":[0.9989176,0.0000809567,0.00017166653,0.0006041068,0.00011269715,0.00006444455,0.0000062451545,0.000024990155,0.000017332744],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99733096,0.00061530917,0.0011145322,0.00038041075,0.0002680336,0.00029077628],"domain_scores_gemma":[0.99594706,0.002855882,0.0005027187,0.00037107844,0.00013927123,0.00018400511],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010670534,0.00017722907,0.0012391303,0.00017334425,0.000017656253,0.0000032257328,0.00009194659,0.00019997875,0.00022312444],"category_scores_gemma":[0.0024418603,0.00009150011,0.00019351576,0.00018474384,0.00016796023,0.000042189982,0.000052752428,0.00014334806,0.000042202482],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009751142,0.0052279355,0.8391412,0.000026847896,0.0001551046,0.00043578,0.000061044186,3.2893192e-7,0.041353904,0.00010193088,0.003291347,0.10045342],"study_design_scores_gemma":[0.047638714,0.018718474,0.83592904,0.00017649263,0.0003122201,0.000018755427,0.000018280796,0.0000025184902,0.06373155,0.000054074055,0.033263218,0.00013663928],"about_ca_topic_score_codex":0.000009988427,"about_ca_topic_score_gemma":0.000054163153,"teacher_disagreement_score":0.100316785,"about_ca_system_score_codex":0.00015629843,"about_ca_system_score_gemma":0.00025471047,"threshold_uncertainty_score":0.37312663},"labels":[],"label_agreement":null},{"id":"W2573071046","doi":"10.1093/neuonc/nov235.28","title":"SURG-28NEUROSURGICAL INTRAOPERATIVE SPECTROSCOPY: TOWARDS REAL-TIME CNS TUMOUR BIOPSIES","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Spectroscopy Techniques in Biomedical and Chemical Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Gold standard (test); Biomarker; In vivo; Radiology; In vivo magnetic resonance spectroscopy; Pathology; Medical physics; Magnetic resonance imaging; Biology","score_opus":0.024620185100000518,"score_gpt":0.3502899729657816,"score_spread":0.3256697878657811,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2573071046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89017785,0.00018950275,0.00043848573,0.005104699,0.0005211833,0.00042560298,0.000052695974,0.00019394669,0.102896035],"genre_scores_gemma":[0.9832336,0.0024807788,0.0066995635,0.002632488,0.0020788864,0.00021529937,0.00031576375,0.00012394367,0.0022196844],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99710995,0.00040653095,0.000412186,0.00079649,0.0004886299,0.0007862156],"domain_scores_gemma":[0.9984286,0.0001257797,0.00009942634,0.00046899836,0.00023195548,0.00064526644],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005926452,0.0003247737,0.00046995177,0.00009512451,0.000093734925,0.000045292327,0.0006114485,0.0005324851,0.00032621447],"category_scores_gemma":[0.0011412408,0.00027127337,0.00015477266,0.00029422707,0.0007727478,0.00000834811,0.0005804085,0.000548173,0.00017262016],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048768014,0.0002459415,0.00023147126,0.0000070438305,0.000023326997,0.00019445315,0.00004394224,7.897735e-7,0.9163149,0.00018114671,0.08085501,0.0014142786],"study_design_scores_gemma":[0.00061125436,0.0026107237,0.00006269966,0.000004216552,0.000010618634,0.00014132482,0.000030968728,0.000057060173,0.6661692,0.00028384637,0.3298247,0.00019340152],"about_ca_topic_score_codex":0.000053267842,"about_ca_topic_score_gemma":0.000008996506,"teacher_disagreement_score":0.2501457,"about_ca_system_score_codex":0.00018138273,"about_ca_system_score_gemma":0.0007887516,"threshold_uncertainty_score":0.99997395},"labels":[],"label_agreement":null},{"id":"W2579106870","doi":"10.1093/neuonc/now212.066","title":"ANGI-11. BONE MARROW-DERIVED MESENCHYMAL STEM CELLS-MEDIATED RADIORESISTANCE IN GLIOBLASTOMA ANGIOGENESIS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Diatoms and Algae Research","field":"Materials Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Mesenchymal stem cell; Radioresistance; Stromal cell; Cancer research; Angiogenesis; Bone marrow; Tumor microenvironment; Stem cell; Protein kinase B; Umbilical vein; Chemistry; Biology; Medicine; Cell culture; Immunology; Phosphorylation; Cell biology; In vitro","score_opus":0.016252650068417744,"score_gpt":0.2633304459732753,"score_spread":0.24707779590485757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2579106870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951262,0.00039272782,0.00005992152,0.002362242,0.0008242225,0.00038765464,0.00008814554,0.0001461961,0.0006127176],"genre_scores_gemma":[0.99837667,0.0002496756,0.0003328325,0.00040941438,0.00016088452,0.00010484713,0.0000016900601,0.000054432152,0.00030954354],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964753,0.0006493578,0.0005505281,0.00077879033,0.0004946963,0.0010513377],"domain_scores_gemma":[0.9977559,0.0010980838,0.00019230126,0.0005123186,0.000117338284,0.00032408952],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0007841245,0.00028332314,0.00059104455,0.00033659517,0.0001094701,0.000054622153,0.00057333533,0.00025551493,0.0011460129],"category_scores_gemma":[0.00017170292,0.00020941383,0.00013300631,0.0005764502,0.00036348542,0.00026153086,0.00026031453,0.00014448544,0.001177566],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038215876,0.00018444518,0.0027830966,0.000022772814,0.0000056557983,0.0009885156,0.00010667096,0.0000064827814,0.98458904,0.00013478548,0.0040443945,0.006751969],"study_design_scores_gemma":[0.0019462472,0.0006434353,0.003201545,0.000032799548,0.000010617301,0.000057317193,0.00007705817,0.000064538704,0.92248625,0.00004604986,0.071150266,0.00028390164],"about_ca_topic_score_codex":0.00008469584,"about_ca_topic_score_gemma":0.0006856496,"teacher_disagreement_score":0.06710587,"about_ca_system_score_codex":0.0003338984,"about_ca_system_score_gemma":0.000385498,"threshold_uncertainty_score":0.99976707},"labels":[],"label_agreement":null},{"id":"W2583337052","doi":"10.1093/neuonc/nov230.13","title":"QOL-13GLIOBLASTOMAS LOCATED IN THE RIGHT HEMISPHERE ARE ASSOCIATED WITH WORSE QUALITY OF LIFE","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Quality of life (healthcare); Medicine; Glioblastoma; Postcentral gyrus; Brain tumor; Gyrus; Anxiety; Posterior cingulate; Audiology; Radiology; Pathology; Magnetic resonance imaging; Cognition; Psychiatry","score_opus":0.0442714561224834,"score_gpt":0.3164150495918001,"score_spread":0.2721435934693167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2583337052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98941815,0.00022165113,0.0000024325925,0.0055898027,0.00010911495,0.0004986964,0.000015177942,0.000040972434,0.0041039824],"genre_scores_gemma":[0.99771357,0.000015047776,0.000026492886,0.0020407701,0.00005127267,0.00008600383,0.00002783588,0.000019399613,0.000019600095],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980666,0.00058329495,0.00042795757,0.0002779495,0.0003617194,0.0002824574],"domain_scores_gemma":[0.99800617,0.0008226386,0.0003561713,0.00037422194,0.00024425195,0.0001965406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055583165,0.00017895848,0.0006493349,0.0000782498,0.000032281467,0.000007093544,0.00014121488,0.0001848657,0.000089678535],"category_scores_gemma":[0.0013737252,0.00010379911,0.00007172075,0.0005257784,0.00013251058,0.000035850448,0.000037347516,0.00028593087,0.000021730852],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017559235,0.005532159,0.9646682,0.000053152322,0.00022020683,0.0018558333,0.0014953545,0.00010702709,0.0076106777,0.0002258316,0.015595033,0.00088058016],"study_design_scores_gemma":[0.025307985,0.006075425,0.9250428,0.00021503004,0.00033804227,0.00014654757,0.0036826795,0.00013622733,0.015928254,0.00013049948,0.02270978,0.0002867308],"about_ca_topic_score_codex":0.0002186226,"about_ca_topic_score_gemma":0.0029355255,"teacher_disagreement_score":0.03962542,"about_ca_system_score_codex":0.00023455148,"about_ca_system_score_gemma":0.00042883513,"threshold_uncertainty_score":0.42328048},"labels":[],"label_agreement":null},{"id":"W2583786955","doi":"10.1093/neuonc/nov209.14","title":"CBIO-14TARGETING PROTEASOME ACTIVITY WITH MARIZOMIB AS A THERAPEUTIC PERSPECTIVE FOR GLIOMA PATIENTS","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Proteasome; Glioma; Cancer research; Proteasome inhibitor; Bortezomib; In vitro; Biology; Tolerability; Pharmacology; Immunology; Multiple myeloma; Biochemistry","score_opus":0.02663175990436989,"score_gpt":0.29623449634139887,"score_spread":0.269602736437029,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2583786955","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882996,0.00014854994,0.0007986953,0.0010700277,0.00029248872,0.0018281888,0.000043145898,0.000045959663,0.007473315],"genre_scores_gemma":[0.9963443,0.000009012747,0.0015282689,0.0009463373,0.0003563238,0.0005663699,0.00004896063,0.000058620146,0.0001418057],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982434,0.0002801715,0.00017172203,0.00061429973,0.00018354101,0.00050688145],"domain_scores_gemma":[0.99873567,0.00007872221,0.0001921139,0.000323527,0.00045538665,0.00021459654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032370945,0.00025906213,0.00028579467,0.000064420085,0.00014112833,0.000027499787,0.00023701956,0.00028361814,0.000014871523],"category_scores_gemma":[0.00048766972,0.00019867852,0.00010072664,0.00012392714,0.00014043837,0.000010648068,0.00015356415,0.00020868686,0.00002708858],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004006841,0.000552349,0.0032650905,0.000023832083,0.00009890528,0.000023294047,0.00046474137,0.000008079607,0.9693564,0.00028244598,0.00058259646,0.021335429],"study_design_scores_gemma":[0.0052595,0.016454397,0.00071630394,0.000009369407,0.00005458658,0.00010574808,0.000548134,0.000072687835,0.81906176,0.001040482,0.15627326,0.00040375593],"about_ca_topic_score_codex":0.00004899964,"about_ca_topic_score_gemma":0.00003307247,"teacher_disagreement_score":0.15569066,"about_ca_system_score_codex":0.00014616254,"about_ca_system_score_gemma":0.00057080045,"threshold_uncertainty_score":0.8101875},"labels":[],"label_agreement":null},{"id":"W2584272241","doi":"10.1093/neuonc/nov214.06","title":"EPIG-06ATRX DEFICIENCY PROMOTES MIGRATORY BEHAVIOR IN GLIOMA CELLS OF ORIGIN BY DYSREGULATING GENOME-WIDE CHROMATIN ACCESSIBILITY AND MODULATING TRANSCRIPTIONAL PROGRAMS","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"ATRX; Biology; Chromatin; Epigenetics; Genome instability; Carcinogenesis; Genetics; Cancer research; Cell biology; Gene; Mutation; DNA damage; DNA","score_opus":0.029916195504711578,"score_gpt":0.29730958693397663,"score_spread":0.26739339142926505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2584272241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967843,0.0016484637,0.00064949464,0.00004959986,0.0001272356,0.0004833838,0.000026138576,0.000021928943,0.00020942773],"genre_scores_gemma":[0.994528,0.000027207545,0.0050833663,0.00007038035,0.00006933693,0.000093384755,0.00009121815,0.00002582959,0.000011278893],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981804,0.00020637186,0.00054963044,0.00054568995,0.00019909411,0.000318838],"domain_scores_gemma":[0.9992215,0.000043348664,0.0002264407,0.00025837947,0.00012217138,0.00012814956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047908508,0.0002034895,0.00031804794,0.000064922904,0.000055429453,0.000015448091,0.00019190906,0.0002444963,0.000006027668],"category_scores_gemma":[0.000120879224,0.00020009177,0.000071569404,0.00017385547,0.00020090246,0.000014933068,0.00008400679,0.00016226983,8.358552e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005931367,0.0003700155,0.048176147,0.000072708215,0.000006174426,0.0000064425685,0.0003201648,0.00026934597,0.9426662,0.0000039999927,0.00006603531,0.007983492],"study_design_scores_gemma":[0.004519009,0.003704604,0.05499627,0.00006104737,0.00009701654,0.0001481346,0.00093720364,0.01488154,0.9163378,0.0001988868,0.0033407675,0.00077773153],"about_ca_topic_score_codex":0.000095710326,"about_ca_topic_score_gemma":0.00007540457,"teacher_disagreement_score":0.026328376,"about_ca_system_score_codex":0.0000852018,"about_ca_system_score_gemma":0.00031047722,"threshold_uncertainty_score":0.8159506},"labels":[],"label_agreement":null},{"id":"W2584950415","doi":"10.1093/neuonc/nov208.02","title":"BMET-02EVALUATION OF DIFFERENT THERAPEUTIC MODALITIES FOR PRIMARY TREATMENT AND SALVAGE THERAPY AND THEIR RELATIVE COST IN PATIENTS WITH BRAIN METASTASES: A SINGLE INSTITUTION REPORT","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Radiosurgery; Context (archaeology); Brain metastasis; Craniotomy; Salvage therapy; Radiation therapy; Multivariate analysis; Univariate analysis; Modalities; Metastasis; Surgery; Internal medicine; Chemotherapy; Cancer","score_opus":0.0814461831767413,"score_gpt":0.3226828285227238,"score_spread":0.2412366453459825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2584950415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99396026,0.0007324643,0.0009389006,0.0012625341,0.000077376746,0.002728915,0.00008109984,0.000015045068,0.00020339413],"genre_scores_gemma":[0.9976348,0.00010047393,0.0010453055,0.0005609359,0.000022702065,0.00032554136,0.00027077156,0.000018281748,0.000021164455],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9987357,0.00034119718,0.0003213843,0.0003016532,0.00013741684,0.00016263104],"domain_scores_gemma":[0.99880415,0.0005636107,0.00022328905,0.00018480126,0.00012939988,0.00009472825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003633215,0.00020125616,0.0005424228,0.00012229125,0.000039742536,0.000008041543,0.00002169371,0.00007237357,0.0000032534333],"category_scores_gemma":[0.000121425306,0.000116009105,0.000046381298,0.000079680365,0.00017591851,0.0000992206,0.000017912553,0.00006905098,1.6615203e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017251369,0.009477837,0.29726097,0.00014401492,0.0012646179,0.00014520837,0.010156587,0.000048022805,0.018297208,0.0027827197,0.00007703708,0.6430944],"study_design_scores_gemma":[0.11424497,0.13565421,0.69477063,0.0001701076,0.0012204526,0.00043169942,0.002546314,0.00046645562,0.020811314,0.0048954138,0.024257785,0.00053065637],"about_ca_topic_score_codex":0.000056480476,"about_ca_topic_score_gemma":0.00006567491,"teacher_disagreement_score":0.64256376,"about_ca_system_score_codex":0.00042993773,"about_ca_system_score_gemma":0.0002380757,"threshold_uncertainty_score":0.4730714},"labels":[],"label_agreement":null},{"id":"W2584956237","doi":"10.1093/neuonc/nov204.92","title":"ATPS-92Bmi1 IDENTIFIES TREATMENT-REFRACTORY STEM CELLS IN HUMAN GLIOBLASTOMA","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Ontario Institute for Cancer Research","funders":"","keywords":"Glioblastoma; Stem cell; Refractory (planetary science); Cancer research; Chemistry; Medicine; Biology; Cell biology","score_opus":0.05098833965755475,"score_gpt":0.3317710211318321,"score_spread":0.2807826814742774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2584956237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843652,0.00062997954,0.0000068566214,0.0008731548,0.0014911274,0.00048324294,0.000017475191,0.00008567905,0.012047237],"genre_scores_gemma":[0.99497366,0.00026881212,0.00007199099,0.0011795103,0.00037783425,0.000074226,0.000009337469,0.000048273738,0.0029963325],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99830693,0.00019143756,0.00041218498,0.00044191227,0.00023488658,0.0004126727],"domain_scores_gemma":[0.99887574,0.00015131867,0.00014618719,0.0004097988,0.00008614232,0.00033083098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002144625,0.00023225592,0.0006347671,0.00026220485,0.00004855922,0.000018220882,0.00011523087,0.00018047041,0.00021079961],"category_scores_gemma":[0.000024878036,0.00020116115,0.00013624117,0.0002361602,0.00012378594,0.00009289723,0.00006888431,0.0002570075,0.00026510772],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085882004,0.0010993732,0.0025494231,0.00004246246,0.000062895735,0.0019664154,0.0017309566,0.000017805149,0.90157175,0.000049380847,0.023702614,0.06634812],"study_design_scores_gemma":[0.0053875786,0.0056834556,0.00041676103,0.00001789612,0.00011903478,0.00013876904,0.00067033776,0.000009968505,0.28654712,0.000033934117,0.70083815,0.00013701305],"about_ca_topic_score_codex":0.0004100988,"about_ca_topic_score_gemma":0.0014857242,"teacher_disagreement_score":0.6771355,"about_ca_system_score_codex":0.0008889869,"about_ca_system_score_gemma":0.00048623426,"threshold_uncertainty_score":0.82031137},"labels":[],"label_agreement":null},{"id":"W2585041210","doi":"10.1093/neuonc/nov225.51","title":"NIMG-51T1-HYPERINTENSE LESIONS AS A PREDICTOR OF SURVIVAL IN PATIENTS WITH RECURRENT HIGH GRADE GLIOMA ON BEVACIZUMAB","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Bevacizumab; Glioma; Medicine; Oncology; Internal medicine; Cancer research; Chemotherapy","score_opus":0.03453585762652659,"score_gpt":0.29665705357606587,"score_spread":0.26212119594953925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2585041210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99509925,0.000056033216,8.693749e-7,0.002104284,0.00078477844,0.00080514926,0.000047420916,0.000045022083,0.0010572242],"genre_scores_gemma":[0.9993031,0.00001848575,0.0000984354,0.00031976364,0.00007133596,0.00009288926,0.000053043517,0.000033420907,0.000009511235],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982448,0.0002050969,0.0003721544,0.00040212128,0.00045251782,0.00032326241],"domain_scores_gemma":[0.9986046,0.0003064625,0.00016154992,0.00038070342,0.00023572765,0.00031095112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012267617,0.00022610706,0.0006332731,0.00029229312,0.000026145488,0.000004997902,0.0001027345,0.00014222377,0.000050928065],"category_scores_gemma":[0.00044396793,0.00016142288,0.00007437703,0.00033103488,0.000108508015,0.000036297897,0.00006711142,0.00025106056,0.000059571692],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01528191,0.020882292,0.9230178,0.00006903207,0.00025194028,0.0030708008,0.0012210922,0.000057863443,0.011083727,0.00111255,0.0062046214,0.017746398],"study_design_scores_gemma":[0.040546812,0.051236108,0.8817899,0.00017828812,0.0002446704,0.00011720586,0.00020261646,0.000032103922,0.011212349,0.00013380463,0.014081685,0.00022444327],"about_ca_topic_score_codex":0.00019882477,"about_ca_topic_score_gemma":0.00014754519,"teacher_disagreement_score":0.041227862,"about_ca_system_score_codex":0.00036566058,"about_ca_system_score_gemma":0.00031890458,"threshold_uncertainty_score":0.65826344},"labels":[],"label_agreement":null},{"id":"W2585271471","doi":"10.1093/neuonc/nov236.02","title":"TMIC-02CELL AUTONOMOUS AND CELL NON-AUTONOMOUS ROLES OF p75 NEUROTROPHIN RECEPTOR (p75<sup>NTR</sup>) IN GLIOMA INVASION","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Institutes of Health Research; University of Calgary","funders":"","keywords":"Low-affinity nerve growth factor receptor; Neurotrophin; Receptor; Neuroscience; Cell biology; Glioma; Biology; Cancer research; Genetics","score_opus":0.022279289432142912,"score_gpt":0.26806779380799056,"score_spread":0.24578850437584765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2585271471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913432,0.00090372516,0.0000061955884,0.002897837,0.00036123933,0.0010355395,0.000025642445,0.000069052185,0.0033575685],"genre_scores_gemma":[0.9973802,0.00030155573,0.0008092648,0.0010392957,0.00018438179,0.00012900241,0.000039859937,0.0000683186,0.000048148282],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973946,0.0002829438,0.00075161643,0.00073076284,0.00029410163,0.00054598064],"domain_scores_gemma":[0.9980771,0.00043555902,0.00030617084,0.00054404157,0.00014834593,0.00048878003],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031296082,0.0003888315,0.001000962,0.00050568633,0.000059599308,0.00002179211,0.00019844456,0.00035321864,0.00009466394],"category_scores_gemma":[0.00024417686,0.0003450512,0.00013343971,0.0003809045,0.0001985789,0.00010694468,0.00022878921,0.00041180535,0.00013104842],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011911269,0.004086395,0.050706416,0.00016286588,0.000057350422,0.0035834825,0.0026435154,0.00071068614,0.90010977,0.00007371639,0.01015914,0.02651554],"study_design_scores_gemma":[0.035879675,0.02041987,0.020763954,0.00017925446,0.00047352086,0.001487048,0.0012609583,0.0067194053,0.73527765,0.00022128562,0.17651848,0.0007988848],"about_ca_topic_score_codex":0.00027712484,"about_ca_topic_score_gemma":0.00011076964,"teacher_disagreement_score":0.16635935,"about_ca_system_score_codex":0.0003601329,"about_ca_system_score_gemma":0.000583299,"threshold_uncertainty_score":0.99990016},"labels":[],"label_agreement":null},{"id":"W2585674367","doi":"10.1093/neuonc/nov210.10","title":"CSIG-10IMMUNIHISTOCHEMICAL STUDY OF THE EXPRESSION LEVELS OF NF-kB AND ITS REGULATORS ING-4, AEG-1 IN GLIOMAS","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Mechanisms and Therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Expression (computer science); Biology; Cancer research; Cell biology; Chemistry; Computer science","score_opus":0.055482021989065156,"score_gpt":0.33480989660382743,"score_spread":0.2793278746147623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2585674367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99778837,0.00038163006,0.0000053696353,0.00045728928,0.0003233126,0.0005459727,0.000003022577,0.000010864493,0.00048414036],"genre_scores_gemma":[0.99956805,0.000013370741,0.00006340721,0.00024097173,0.000046131878,0.000019448915,5.2197726e-7,0.000015584184,0.000032515356],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989291,0.00018424948,0.00033331956,0.00019758857,0.00021944048,0.00013630356],"domain_scores_gemma":[0.9992262,0.000114551985,0.00017080522,0.00031458837,0.00009175292,0.000082081766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027010223,0.000103729035,0.00041500153,0.00010776655,0.000020515337,0.0000015856732,0.00012786032,0.00012646457,0.0000263154],"category_scores_gemma":[0.0001869599,0.00007274245,0.000038541053,0.00022388434,0.0000749406,0.000029950957,0.00014644062,0.0002281023,5.649176e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006606966,0.00054872996,0.0021090321,0.000020580974,0.000011596318,0.000025274912,0.0050401296,0.0000048393777,0.98895854,0.00015154722,0.000223774,0.002245279],"study_design_scores_gemma":[0.008363908,0.0046098675,0.011787726,0.000080625745,0.0000430446,0.00008537788,0.002137897,0.00007403077,0.9684365,0.00036360548,0.0039309026,0.00008655038],"about_ca_topic_score_codex":0.00006167831,"about_ca_topic_score_gemma":0.000052766656,"teacher_disagreement_score":0.020522056,"about_ca_system_score_codex":0.00009789165,"about_ca_system_score_gemma":0.00018512765,"threshold_uncertainty_score":0.2966351},"labels":[],"label_agreement":null},{"id":"W2586150132","doi":"10.1093/neuonc/now212.343","title":"GENT-37. THE GENETICS DRIVING RADIATION INDUCED MENINGIOMAS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Advanced Radiotherapy Techniques","field":"Physics and Astronomy","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Meningioma; Biology; Exome; Exome sequencing; Carcinogenesis; Meninges; Transcriptome; Cancer research; Cancer; Genetics; Computational biology; Bioinformatics; Gene; Medicine; Mutation; Pathology; Neuroscience; Gene expression","score_opus":0.016005560297162102,"score_gpt":0.3026621306921911,"score_spread":0.286656570395029,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586150132","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8087692,0.0001479108,0.18017511,0.0041663186,0.00066389336,0.0005095948,0.000007132656,0.00018901922,0.005371781],"genre_scores_gemma":[0.9945271,0.00007112747,0.0041145505,0.000440208,0.0006624858,0.00007973068,0.0000023499204,0.000034981487,0.00006743613],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99906623,0.00015125127,0.00019575052,0.00022964922,0.0000987459,0.00025839027],"domain_scores_gemma":[0.9990599,0.00039006304,0.00016086064,0.00030065174,0.00003418964,0.000054290023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011504278,0.00013107352,0.00015628086,0.00003647872,0.0001233343,0.000014381774,0.00023593665,0.00006796533,0.00023156327],"category_scores_gemma":[0.000018332554,0.00008033991,0.000065356595,0.00009681691,0.00006591178,0.00008263618,0.00005814596,0.00014246201,0.000017146687],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000005610669,0.000024121944,0.011404355,4.1358726e-7,0.000018466058,0.0000020584941,0.0001392138,0.0000055231826,0.6522445,0.0020216485,0.0008723284,0.33326176],"study_design_scores_gemma":[0.0006787464,0.00035328424,0.002516039,0.0000057228317,0.00002057605,0.000008258264,0.000035731704,0.00018503112,0.4238546,0.0032340793,0.5689342,0.00017372346],"about_ca_topic_score_codex":0.000007849314,"about_ca_topic_score_gemma":0.0000017729432,"teacher_disagreement_score":0.5680619,"about_ca_system_score_codex":0.0001012865,"about_ca_system_score_gemma":0.000077604374,"threshold_uncertainty_score":0.32761663},"labels":[],"label_agreement":null},{"id":"W2586264038","doi":"10.1093/neuonc/now212.609","title":"PDCT-05. STEADY-STATE VISUAL EVOKED POTENTIALS TO BETTER ASSESS VISUAL FUNCTIONS IN CHILDREN WITH OPTIC PATHWAY GLIOMAS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Force Microscopy Techniques and Applications","field":"Physics and Astronomy","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université du Québec à Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Visual field; Evoked potential; Visual acuity; Medicine; Visual evoked potentials; Contrast (vision); Audiology; Magnetic resonance imaging; Neuroscience; Ophthalmology; Computer science; Psychology; Radiology; Artificial intelligence","score_opus":0.010561665268033153,"score_gpt":0.2964277544339188,"score_spread":0.28586608916588563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586264038","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95128685,0.000003490108,0.044316508,0.0013746942,0.00010924339,0.00082839647,0.0001129646,0.000105188905,0.0018626876],"genre_scores_gemma":[0.99666834,0.0000011163772,0.0015956853,0.00050073495,0.00022123675,0.00050355506,0.000049468366,0.000052018164,0.00040784836],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983457,0.00012226637,0.0003640391,0.0005321706,0.00013839628,0.00049744686],"domain_scores_gemma":[0.99919456,0.00011941941,0.00014507285,0.00030131676,0.00007717316,0.00016243395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001329733,0.00025197899,0.00034227362,0.0001973423,0.00014148635,0.000049238297,0.00023009369,0.00008619069,0.0003619371],"category_scores_gemma":[0.0000059065596,0.00018470343,0.00008365294,0.0003655408,0.00010793168,0.00014367547,0.00014117069,0.00021868825,0.0002608713],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008466267,0.00059085677,0.057591464,0.0000025916272,0.00006224646,0.000012421304,0.00008432807,0.000041476305,0.89866066,0.0015658855,0.0025578162,0.038745612],"study_design_scores_gemma":[0.0074312617,0.008056551,0.09258295,0.00012854568,0.00021791659,0.00015875242,0.00037331032,0.0003051242,0.69566166,0.0028378891,0.19041516,0.00183088],"about_ca_topic_score_codex":0.0001712552,"about_ca_topic_score_gemma":0.000036839156,"teacher_disagreement_score":0.20299898,"about_ca_system_score_codex":0.0001012936,"about_ca_system_score_gemma":0.00016981208,"threshold_uncertainty_score":0.75319874},"labels":[],"label_agreement":null},{"id":"W2586398206","doi":"10.1093/neuonc/now188.212","title":"P09.03 Subependymal giant cell astrocytoma (SEGA) in adults without tuberous sclerosis","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Tuberous Sclerosis Complex Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Cancer Care Ontario; Western University","funders":"","keywords":"Tuberous sclerosis; Subependymal giant cell astrocytoma; Subependymal zone; Medicine; Astrocytoma; Pathology; Glioblastoma; Cancer research","score_opus":0.04450269965826249,"score_gpt":0.3045882948991372,"score_spread":0.2600855952408747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586398206","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97924554,0.00014777711,0.00009765521,0.008227687,0.0004951806,0.00117617,0.000032173706,0.00021648064,0.010361309],"genre_scores_gemma":[0.9951584,0.00017607323,0.0015910935,0.0017357586,0.00039945208,0.00019926621,0.000010651648,0.00012430298,0.0006050268],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9952432,0.00059826503,0.0007953708,0.0011062138,0.00079409697,0.001462845],"domain_scores_gemma":[0.9970371,0.00093708135,0.00018955236,0.0009587609,0.0002467616,0.0006307362],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0005770562,0.0004426529,0.0009938874,0.00053219247,0.00012091214,0.000029756358,0.00052574865,0.00042788583,0.0012781684],"category_scores_gemma":[0.0005816523,0.0003310547,0.0002002852,0.0005528523,0.00042203302,0.00019920125,0.00041445083,0.0008975777,0.0022670676],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038089005,0.0009121989,0.06821718,0.000082679144,0.000023949497,0.000945854,0.00029457957,0.0000024618446,0.86311215,0.000055782653,0.0054112803,0.057132967],"study_design_scores_gemma":[0.03871697,0.01709402,0.62443125,0.0008759856,0.000113925955,0.0024604988,0.00029651713,0.0004322163,0.27744812,0.0000755445,0.037197303,0.00085767364],"about_ca_topic_score_codex":0.00029549727,"about_ca_topic_score_gemma":0.0012338466,"teacher_disagreement_score":0.58566403,"about_ca_system_score_codex":0.00092409924,"about_ca_system_score_gemma":0.000676299,"threshold_uncertainty_score":0.99991417},"labels":[],"label_agreement":null},{"id":"W2587000238","doi":"10.1093/neuonc/now212.409","title":"IMST-53. THE EFFICACY OF CD133 BiTEs AND CAR-T CELLS IN PRECLINICAL MODEL OF RECURRENT GLIOBLASTOMA","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University","funders":"","keywords":"Chimeric antigen receptor; Antigen; Cytotoxic T cell; Monoclonal antibody; Cancer research; Antibody; T cell; Glioma; Biology; Immunology; Immune system; In vitro","score_opus":0.05883081224816337,"score_gpt":0.37817687441619924,"score_spread":0.31934606216803585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587000238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936982,0.00019193927,0.000020146574,0.004019256,0.0001950905,0.00067632506,0.000020257074,0.000013282929,0.0011655147],"genre_scores_gemma":[0.9980602,0.0009919793,0.00013736157,0.00024814784,0.00010733927,0.000028375607,8.467324e-7,0.000024003708,0.00040169907],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981063,0.00038283085,0.0005732127,0.00033682198,0.0002926382,0.0003081684],"domain_scores_gemma":[0.9948985,0.0042137215,0.00016967993,0.0004637807,0.00012819315,0.00012611627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069831643,0.00013731912,0.00058159354,0.00017772634,0.000019060428,0.000002804023,0.00020021768,0.00018776135,0.00030643446],"category_scores_gemma":[0.00089909707,0.000070785834,0.000116937525,0.0002133418,0.00058203266,0.000029941359,0.00017984357,0.00037409854,0.000013731824],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041123754,0.00049527746,0.0038129692,0.000048545728,0.00002580724,0.000022098488,0.00045803897,0.000014889376,0.8779774,0.0000644376,0.00069650187,0.112271674],"study_design_scores_gemma":[0.013244255,0.015160346,0.008723427,0.00018943145,0.0001028658,0.00009997991,0.000114082744,0.0037054608,0.9296714,0.00044420536,0.028367281,0.00017725561],"about_ca_topic_score_codex":0.00001620771,"about_ca_topic_score_gemma":0.00007154377,"teacher_disagreement_score":0.112094425,"about_ca_system_score_codex":0.000083383,"about_ca_system_score_gemma":0.00029613407,"threshold_uncertainty_score":0.33552426},"labels":[],"label_agreement":null},{"id":"W2587113208","doi":"10.1093/neuonc/now212.731","title":"RTHP-05. INTRAOPERATIVE RADIOTHERAPY (IORT) USING LOW-ENERGY X-RAYS IN A COHORT OF PREDOMINANTLY INCOMPLETELY RESECTED NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME (INTRAGO TRIAL)","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Medicine; Tolerability; Radiation therapy; Clinical endpoint; Progression-free survival; Surgery; Radiosurgery; Adverse effect; Chemotherapy; Urology; Internal medicine; Randomized controlled trial","score_opus":0.021988548393148073,"score_gpt":0.30153959285890936,"score_spread":0.2795510444657613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587113208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99468976,0.0002873724,0.00027693744,0.0015282165,0.0007029386,0.0022051472,0.00005187571,0.00006943377,0.00018832949],"genre_scores_gemma":[0.99644995,0.0008083972,0.0011720554,0.00064385147,0.0003430193,0.00047107294,0.000015365897,0.00008097589,0.000015329031],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9962989,0.00065022864,0.0011607235,0.00078048755,0.000410046,0.00069960026],"domain_scores_gemma":[0.9963349,0.0020489427,0.00045879322,0.00060017203,0.0002674544,0.00028971417],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00037889308,0.00045493548,0.0015244352,0.0006217164,0.00009590137,0.000017621973,0.00023284815,0.00038661688,0.00023331062],"category_scores_gemma":[0.0008207874,0.0003103014,0.00024854008,0.0006385868,0.00035711707,0.00017062851,0.000087866734,0.00026176852,0.00000982017],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.038094584,0.0035981312,0.03059073,0.000035639674,0.0003213211,0.0027385298,0.0006796518,0.00006416158,0.8835339,0.00026724738,0.00067068613,0.039405443],"study_design_scores_gemma":[0.34117985,0.030328495,0.03746811,0.0006431457,0.00043969354,0.0008175039,0.00019836803,0.0035628614,0.5665914,0.000100170335,0.01798199,0.0006884294],"about_ca_topic_score_codex":0.00063351175,"about_ca_topic_score_gemma":0.0017910368,"teacher_disagreement_score":0.31694248,"about_ca_system_score_codex":0.0009870512,"about_ca_system_score_gemma":0.00078727235,"threshold_uncertainty_score":0.9999349},"labels":[],"label_agreement":null},{"id":"W2587128244","doi":"10.1093/neuonc/now212.303","title":"EXTH-61. NANOPARTICLE DELIVERY TO THE SPINAL CORD VIA DIRECT ADMINISTRATION TO CEREBROSPINAL FLUID","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Spinal cord; Drug delivery; Medicine; Nanocarriers; Cerebrospinal fluid; Nanoparticle; Central nervous system; Pharmacology; Biomedical engineering; Pathology; Materials science; Nanotechnology; Drug; Internal medicine","score_opus":0.029011009130346495,"score_gpt":0.3195401863804476,"score_spread":0.29052917725010113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587128244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9408684,0.00009569055,0.000115545234,0.056518514,0.0005700787,0.000728035,0.000010029948,0.00006229597,0.0010314472],"genre_scores_gemma":[0.99136424,0.000023946986,0.0002252846,0.0077001643,0.00032772069,0.00026808918,0.0000025805696,0.000021966358,0.00006600066],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985951,0.0001212515,0.00027879383,0.0004052814,0.00022347769,0.00037607967],"domain_scores_gemma":[0.9989098,0.0001787716,0.00006108628,0.0003989697,0.00011103564,0.00034037195],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015379998,0.00017203382,0.00029192865,0.0000796744,0.00015377528,0.000024846282,0.00012967395,0.00008110077,0.00021659708],"category_scores_gemma":[0.00020845594,0.00009693242,0.00008887338,0.00021257976,0.00006741648,0.000053479154,0.000082350765,0.0000781015,0.0011349763],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025257547,0.00049049064,0.005896625,0.0000053949425,0.000028661905,0.000351408,0.00006061881,0.0000017816043,0.8083158,0.00011048813,0.00848958,0.17372338],"study_design_scores_gemma":[0.002094165,0.031625986,0.080177315,0.00005378568,0.00013773268,0.00037490836,0.000032466734,0.000017610671,0.55387735,0.000024524132,0.331443,0.00014112577],"about_ca_topic_score_codex":0.00003811762,"about_ca_topic_score_gemma":0.0002042614,"teacher_disagreement_score":0.32295343,"about_ca_system_score_codex":0.00023785752,"about_ca_system_score_gemma":0.00022200857,"threshold_uncertainty_score":0.9996427},"labels":[],"label_agreement":null},{"id":"W2587227059","doi":"10.1093/neuonc/now212.844","title":"TMIC-04. GLIOBLASTOMA-ASSOCIATED MYELOID CELLS DISPLAY NONPOLARIZED M0 MACROPHAGE PHENOTYPE","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Microglia; Integrin alpha M; Immune system; Myeloid; Flow cytometry; Myeloid-derived Suppressor Cell; Cancer research; Biology; Macrophage; Phenotype; Tumor microenvironment; Immunology; Pathology; Inflammation; Medicine; Cancer; Gene; Suppressor; In vitro","score_opus":0.009582246029461538,"score_gpt":0.2437707076756113,"score_spread":0.23418846164614976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587227059","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992431,0.00007337772,0.0002984684,0.0017544616,0.0032707066,0.00047645532,0.00018744403,0.00040990606,0.0010982235],"genre_scores_gemma":[0.9962479,0.000032715885,0.00053554605,0.0022447351,0.0002810278,0.000056528454,0.0000048064135,0.00008311229,0.0005136421],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99582934,0.000963708,0.0006987687,0.0008940444,0.0004826534,0.0011314772],"domain_scores_gemma":[0.9966117,0.0016494676,0.00042608797,0.00073849905,0.00020039448,0.00037381804],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0008359517,0.00039347602,0.00066752284,0.00016219605,0.00024169286,0.00007586871,0.0007425214,0.00037292912,0.0024926518],"category_scores_gemma":[0.0007447844,0.0002961777,0.0001602204,0.00040635778,0.00039945374,0.00035683918,0.00036258093,0.00028763665,0.008934562],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008061641,0.00044072076,0.00022170565,0.000011247757,0.000016630049,0.00042766077,0.00016653702,0.000015502272,0.9887937,0.00016434408,0.0051615364,0.00377429],"study_design_scores_gemma":[0.0036353169,0.0012669134,0.00032728343,0.000022265642,0.00006550388,0.000031851952,0.00002095288,0.00011150497,0.96495175,0.00016717523,0.029038819,0.00036064035],"about_ca_topic_score_codex":0.00008898434,"about_ca_topic_score_gemma":0.00019217063,"teacher_disagreement_score":0.023877284,"about_ca_system_score_codex":0.00058469595,"about_ca_system_score_gemma":0.00042124584,"threshold_uncertainty_score":0.99994904},"labels":[],"label_agreement":null},{"id":"W2587520421","doi":"10.1093/neuonc/now212.103","title":"BMET-03. METIS: A PHASE III STUDY OF RADIOSURGERY WITH TTFIELDS FOR 1-10 BRAIN METASTASES FROM NSCLC","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Radiosurgery; Neurocognitive; Clinical endpoint; Internal medicine; Oncology; Hazard ratio; Lung cancer; Population; Quality of life (healthcare); Clinical trial; Radiation therapy; Confidence interval; Cognition","score_opus":0.03445901906586992,"score_gpt":0.33311318493526576,"score_spread":0.29865416586939586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587520421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905612,0.00022665164,0.00029319988,0.006320909,0.00026292977,0.0016663783,0.00018232617,0.000050084294,0.00043630405],"genre_scores_gemma":[0.9969432,0.000035722718,0.00082308374,0.0012051148,0.00016320666,0.00068851374,0.000034792956,0.000037840848,0.00006857553],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982651,0.00024910166,0.0004622605,0.00047741077,0.00022923062,0.0003168968],"domain_scores_gemma":[0.9948765,0.004068996,0.0002562268,0.00046783022,0.000145662,0.00018480336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026520604,0.00023592889,0.00097340497,0.00016186843,0.000054859593,0.000006902613,0.000101834325,0.000118245196,0.0007493372],"category_scores_gemma":[0.00054568733,0.00013413759,0.0001566732,0.00019106854,0.00009879281,0.00006441001,0.000044546916,0.00008871269,0.00002549162],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016486036,0.03247826,0.0319287,0.00005034641,0.0029699549,0.0031349068,0.0012072105,0.0000025868787,0.52984196,0.00021403465,0.103964984,0.27772105],"study_design_scores_gemma":[0.25075924,0.086983256,0.00694092,0.00021432547,0.005373105,0.00037653185,0.0019739042,0.00003451774,0.30180728,0.00018311825,0.3447865,0.00056727824],"about_ca_topic_score_codex":0.000175771,"about_ca_topic_score_gemma":0.00017960645,"teacher_disagreement_score":0.27715376,"about_ca_system_score_codex":0.0000815291,"about_ca_system_score_gemma":0.00020853968,"threshold_uncertainty_score":0.8204717},"labels":[],"label_agreement":null},{"id":"W2587566976","doi":"10.1093/neuonc/now188.219","title":"P09.10 Clinical fMRI in low grade glioma patients: impact on surgical decision making and patient outcomes","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Robarts Clinical Trials","funders":"","keywords":"Medicine; Surgical excision; Glioma; Clinical decision making; Physical medicine and rehabilitation; Surgery; Intensive care medicine","score_opus":0.030751750455037627,"score_gpt":0.3819201279125609,"score_spread":0.3511683774575233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587566976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937887,0.000067026696,0.0000021562205,0.004667487,0.0005382781,0.00054214516,0.000019020588,0.00003380498,0.0003413579],"genre_scores_gemma":[0.99826807,0.000114206014,0.00010755661,0.0013580678,0.00006496056,0.000050194223,0.000005821567,0.000027389537,0.000003739935],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977588,0.00029343175,0.0006943119,0.0005409882,0.0003097399,0.00040275077],"domain_scores_gemma":[0.9947124,0.004441699,0.00018216105,0.0003351388,0.00006699595,0.00026156587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020851425,0.00025770825,0.00075510755,0.00026711574,0.00004546798,0.000012188292,0.00007656778,0.00025722245,0.00025494443],"category_scores_gemma":[0.00096138206,0.00012177748,0.00022604087,0.00016795885,0.0001194218,0.000058967827,0.00011379934,0.00021524959,0.000115069815],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012563348,0.0029309085,0.62253773,0.0000037063503,0.00003363546,0.0022488022,0.0000383041,0.0000013412866,0.00027075713,0.000020243324,0.001798761,0.36885947],"study_design_scores_gemma":[0.017465921,0.011598918,0.94941765,0.00021595058,0.000055141867,0.00015719215,0.000013790209,0.000022040844,0.0008286705,0.00013612719,0.019941425,0.00014719623],"about_ca_topic_score_codex":0.000011123369,"about_ca_topic_score_gemma":0.000021132933,"teacher_disagreement_score":0.36871228,"about_ca_system_score_codex":0.0003232258,"about_ca_system_score_gemma":0.00008279639,"threshold_uncertainty_score":0.49659416},"labels":[],"label_agreement":null},{"id":"W2587599577","doi":"10.1093/neuonc/now212.018","title":"ACTR-19. BASELINE PLASMA MATRIX METALLOPROTEINASE 9 (MMP9) PREDICTS OVERALL SURVIVAL (OS) BENEFIT FROM BEVACIZUMAB INDEPENDENTLY OF MOLECULAR SUBTYPES IN NEWLY DIAGNOSED GLIOBLASTOMA: RETROSPECTIVE ANALYSIS OF AVAglio","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Princess Margaret Cancer Centre","funders":"","keywords":"Bevacizumab; Temozolomide; Medicine; Internal medicine; Placebo; Oncology; MMP9; MMP2; Univariate analysis; Post-hoc analysis; Retrospective cohort study; Gastroenterology; Multivariate analysis; Chemotherapy; Pathology; Cancer; Biology","score_opus":0.01112914385499897,"score_gpt":0.27374356113905596,"score_spread":0.262614417284057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587599577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956136,0.0004319003,0.00011063848,0.0015225882,0.00025187145,0.0009870139,0.00073992537,0.00005484489,0.00028764177],"genre_scores_gemma":[0.99864864,0.00032199055,0.00042691242,0.00017923141,0.00007684067,0.00015530664,0.000110893125,0.000057424884,0.000022730846],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9961588,0.00043754937,0.001109814,0.0009298002,0.0008254605,0.00053857634],"domain_scores_gemma":[0.9960179,0.0017256219,0.0007077646,0.0008455992,0.0003601891,0.00034293215],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004955615,0.0004539449,0.0020341433,0.0012974712,0.000038659196,0.000010434095,0.0002903069,0.00042751577,0.0007371322],"category_scores_gemma":[0.0014929145,0.00034449375,0.00056385255,0.001265746,0.00018919873,0.00014126873,0.00019242801,0.00031161733,0.000023375334],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041687232,0.0033012654,0.3263068,0.000042384538,0.003188561,0.0044794567,0.00027109522,0.00045278348,0.652921,0.00058704626,0.00013770029,0.0041431803],"study_design_scores_gemma":[0.028687637,0.0056317234,0.4228247,0.00012747543,0.005288289,0.00003373448,0.00009408076,0.0009029547,0.5348707,0.0004010915,0.00079287565,0.00034476435],"about_ca_topic_score_codex":0.0017945939,"about_ca_topic_score_gemma":0.0054627345,"teacher_disagreement_score":0.11805035,"about_ca_system_score_codex":0.0006760896,"about_ca_system_score_gemma":0.00036490362,"threshold_uncertainty_score":0.9999007},"labels":[],"label_agreement":null},{"id":"W2587747127","doi":"10.1093/neuonc/now212.594","title":"NTOX-08. SAFETY OF INTRA-ARTERIAL CHEMOTHERAPY IN THE TREATMENT OF BRAIN TUMOURS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Medicine; Chemotherapy; Etoposide; Carboplatin; Dissection (medical); Stroke (engine); Internal medicine; Surgery; Radiology; Oncology","score_opus":0.01823928216494433,"score_gpt":0.300666217903724,"score_spread":0.28242693573877964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587747127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95432043,0.000126614,0.0000062814593,0.043560006,0.0002340193,0.00058704655,0.000022146209,0.0000096954345,0.0011337863],"genre_scores_gemma":[0.99760365,0.0007290425,0.000070346396,0.0013409804,0.00014488144,0.000078750345,0.000005649394,0.00001428824,0.00001242308],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99889636,0.00019434905,0.00036129562,0.00020423894,0.00013994674,0.00020378664],"domain_scores_gemma":[0.9985694,0.0008842848,0.000148662,0.00031051197,0.00003460651,0.000052532843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014573168,0.0001392992,0.00049607747,0.00009516072,0.000017263943,0.000001927065,0.00008941224,0.000095403324,0.00024269203],"category_scores_gemma":[0.00006386371,0.000067227,0.00012748643,0.00012782846,0.00014304306,0.000020627667,0.000008433795,0.000041885523,0.000011956368],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018312027,0.0045599174,0.032460645,0.000012221977,0.00008181185,0.00023047387,0.001903819,7.965618e-7,0.79404104,0.00044353912,0.00186389,0.16257064],"study_design_scores_gemma":[0.036352355,0.019560415,0.21665327,0.00006812844,0.00016438236,0.00016745749,0.00026180802,0.000006048977,0.51738566,0.00022322463,0.20903876,0.00011845593],"about_ca_topic_score_codex":0.00005012593,"about_ca_topic_score_gemma":0.000092355134,"teacher_disagreement_score":0.27665535,"about_ca_system_score_codex":0.00019449547,"about_ca_system_score_gemma":0.00012566136,"threshold_uncertainty_score":0.27414376},"labels":[],"label_agreement":null},{"id":"W2587891556","doi":"10.1093/neuonc/now212.906","title":"TMOD-37. CHARACTERIZATION OF A UNIQUE BMIC POPULATION IN HUMAN BRAIN METASTASES","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Infrared Thermography in Medicine","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McMaster University","funders":"","keywords":"Brain metastasis; Metastasis; Cancer research; Primary tumor; Cancer; Melanoma; Mesenchymal stem cell; Biology; Population; Pathology; Medicine; Internal medicine","score_opus":0.019288815707571794,"score_gpt":0.3142241034144528,"score_spread":0.294935287706881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587891556","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99243253,0.000016805629,0.00042816537,0.005413777,0.00022921548,0.0005382213,0.00002491002,0.000055814897,0.000860561],"genre_scores_gemma":[0.9970103,0.00004000011,0.00026994196,0.002255223,0.00015741598,0.000039922405,0.00014446734,0.000028514583,0.000054207234],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984305,0.00039426357,0.00051418535,0.00024993852,0.00018460194,0.00022652537],"domain_scores_gemma":[0.9989412,0.0003308861,0.00026382398,0.00029613648,0.00009113533,0.00007680604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004470796,0.00013963593,0.00047620517,0.0003906726,0.00002709997,0.0000018620824,0.00009174396,0.00017159137,0.00024955822],"category_scores_gemma":[0.00048076813,0.00010152404,0.00007179736,0.00036227587,0.00013595921,0.00009431967,0.000030888885,0.00017891833,0.0000068970417],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021899652,0.00014896484,0.040771518,0.00004089854,0.000019492098,0.0000871161,0.0002124424,4.2491268e-7,0.93393,0.0013577591,0.00016276668,0.02304966],"study_design_scores_gemma":[0.0057463516,0.0029412524,0.77466947,0.00026265383,0.000103663246,0.00016860593,0.000045390938,0.0000197051,0.20128636,0.0012883076,0.013305385,0.00016284097],"about_ca_topic_score_codex":0.000061450715,"about_ca_topic_score_gemma":0.000033019533,"teacher_disagreement_score":0.733898,"about_ca_system_score_codex":0.00013901124,"about_ca_system_score_gemma":0.00009014432,"threshold_uncertainty_score":0.41400304},"labels":[],"label_agreement":null},{"id":"W2587908412","doi":"10.1093/neuonc/now212.317","title":"GENT-11. SMALL MOLECULE EPIGENETIC SCREEN IDENTIFIES NOVEL EZH2 AND HDAC INHIBITORS THAT TARGET GLIOBLASTOMA BRAIN TUMOR-INITIATING CELLS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of Calgary; Hospital for Sick Children","funders":"","keywords":"Epigenetics; In vivo; Cancer research; Biology; In vitro; EZH2; Cytotoxicity; Genetics; Gene","score_opus":0.017561237278052002,"score_gpt":0.2555079050579245,"score_spread":0.23794666777987247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587908412","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869759,0.001016112,0.009044848,0.0011896989,0.00060985674,0.00036600174,0.00007861821,0.00003558256,0.0006833567],"genre_scores_gemma":[0.9953256,0.0003779946,0.0023053274,0.001207192,0.00048224523,0.00004059258,0.00003324246,0.0000743349,0.00015346486],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977253,0.00027539223,0.00045797235,0.00079040806,0.00019974376,0.0005511964],"domain_scores_gemma":[0.99863744,0.00027216817,0.00030588618,0.00042947615,0.00012548688,0.00022952733],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004182325,0.00033136192,0.0003362373,0.00013286785,0.00017198932,0.000053652893,0.00026134963,0.00031604353,0.000042692696],"category_scores_gemma":[0.00038819524,0.00028681578,0.00012747395,0.000113826245,0.00023695714,0.0000118256985,0.00037848728,0.00014129785,0.000024910401],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007913212,0.00008474087,0.004416554,0.000018357461,0.000029311997,0.000032385415,0.00007459399,0.000030869443,0.98849654,0.000031708485,0.0006864087,0.006019406],"study_design_scores_gemma":[0.0012649792,0.0011229479,0.0021609839,0.000020433146,0.000029082681,0.00003073458,0.00007285582,0.00006530403,0.9381847,0.0001464743,0.0565712,0.00033030007],"about_ca_topic_score_codex":0.00004108038,"about_ca_topic_score_gemma":0.00028854955,"teacher_disagreement_score":0.05588479,"about_ca_system_score_codex":0.000041937692,"about_ca_system_score_gemma":0.00014960913,"threshold_uncertainty_score":0.9999584},"labels":[],"label_agreement":null},{"id":"W2587923643","doi":"10.1093/neuonc/now212.484","title":"MPTH-49. IS GANGLIOGLIOMA A CNS TUMOR WITH ARRESTED DEVELOPMENT?","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Synaptophysin; Biology; NeuN; Glial fibrillary acidic protein; Neuroepithelial cell; Neurosphere; OLIG2; Cancer research; Neural stem cell; Progenitor cell; Forebrain; Pathology; Molecular biology; Immunohistochemistry; Stem cell; Embryonic stem cell; Genetics; Central nervous system; Medicine; Oligodendrocyte; Neuroscience; Immunology; Gene; Adult stem cell","score_opus":0.020638729831866983,"score_gpt":0.2785125228437662,"score_spread":0.2578737930118992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587923643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.980178,0.0001268083,0.000029896128,0.012431402,0.00029750282,0.0005649193,0.000011571351,0.00013973289,0.0062201563],"genre_scores_gemma":[0.9924848,0.00003214817,0.0009795736,0.0058660526,0.00015372431,0.00024557995,0.000008437852,0.000052040894,0.00017764438],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99832946,0.000074899035,0.00031714494,0.0005169092,0.00027532974,0.00048626447],"domain_scores_gemma":[0.99866223,0.0003470593,0.00014467562,0.00040405468,0.00013203372,0.00030993682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000092160844,0.00026370192,0.0004879833,0.0002658061,0.00009625007,0.000012822263,0.000116569085,0.00009695626,0.0006070498],"category_scores_gemma":[0.00011373433,0.00014766357,0.00007920983,0.0003513981,0.00013184923,0.00006643398,0.000065840446,0.00012533387,0.00076142256],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013638441,0.0025868542,0.20268302,0.000053998963,0.0004685783,0.0242531,0.00089452264,5.3095226e-7,0.6316968,0.00019967074,0.052336127,0.08346294],"study_design_scores_gemma":[0.009861787,0.0026700313,0.054847963,0.000122036385,0.00018505352,0.0021620227,0.000068286645,0.0000039969464,0.3710173,0.000030993477,0.5588042,0.00022630669],"about_ca_topic_score_codex":0.000012790411,"about_ca_topic_score_gemma":0.000073602656,"teacher_disagreement_score":0.50646806,"about_ca_system_score_codex":0.00027895407,"about_ca_system_score_gemma":0.0005236606,"threshold_uncertainty_score":0.9786801},"labels":[],"label_agreement":null},{"id":"W2587925217","doi":"10.1093/neuonc/now212.893","title":"TMOD-23. DEVELOPMENT AND APPLICATION OF A NOVEL MODEL OF HUMAN LUNG-TO- BRAIN METASTASIS TO IDENTIFY GENETIC REGULATORS OF BRAIN METASTASIS INITIATING CELLS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph's Hospital; Hospital for Sick Children; Occupational Cancer Research Centre; Princess Margaret Cancer Centre; University of Toronto; McMaster University","funders":"","keywords":"Brain metastasis; Metastasis; Biology; Cancer research; Cancer; Gene knockdown; Lung cancer; Cancer stem cell; Pathology; Medicine; Gene; Genetics","score_opus":0.022830547520213424,"score_gpt":0.3167498356188324,"score_spread":0.293919288098619,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587925217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86480296,0.00010107604,0.13371238,0.0006509901,0.000057276757,0.00053989614,0.00007788222,0.0000075570033,0.000049997147],"genre_scores_gemma":[0.97574407,0.00001616977,0.023730058,0.00028656583,0.000041382238,0.000084814405,0.000029291223,0.000036328962,0.000031318417],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99816245,0.0001309284,0.0007427659,0.000515214,0.00020936226,0.00023926939],"domain_scores_gemma":[0.99861306,0.00011722284,0.000493045,0.00042604798,0.0002253978,0.00012522381],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041579534,0.00019564945,0.0004189944,0.00021935612,0.000049077014,0.0000043627783,0.00020916297,0.00020802527,0.00000558578],"category_scores_gemma":[0.00018675248,0.00018460467,0.000086945984,0.00024736894,0.00011595391,0.000007848739,0.00024449578,0.0000562287,0.0000014957899],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009831234,0.00011123669,0.000248377,0.000067648194,0.00010973796,3.2915327e-7,0.00031324616,0.005950783,0.94856197,0.000115187984,0.0004675997,0.04395556],"study_design_scores_gemma":[0.0009998141,0.0005600183,0.0022738685,0.000027901782,0.00008255259,0.000007479708,0.00003655809,0.0014154628,0.991972,0.00005379532,0.002398661,0.00017186133],"about_ca_topic_score_codex":0.000023807937,"about_ca_topic_score_gemma":0.000112075744,"teacher_disagreement_score":0.110941134,"about_ca_system_score_codex":0.000081964434,"about_ca_system_score_gemma":0.00023689783,"threshold_uncertainty_score":0.752796},"labels":[],"label_agreement":null},{"id":"W2587948547","doi":"10.1093/neuonc/nox083.164","title":"MEDU-13. CONVERGENCE OF BMI1 AND CHD7 ON ERK SIGNALLING IN MEDULLOBLASTOMA","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Pluripotent Stem Cells Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"BMI1; Medulloblastoma; Biology; Cancer research; Carcinogenesis; Polycomb-group proteins; Neural stem cell; Gene silencing; Stem cell; Cell biology; Cancer; Genetics; Repressor; Transcription factor","score_opus":0.02329733139993394,"score_gpt":0.3142940085486856,"score_spread":0.29099667714875166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587948547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932406,0.00020013392,0.00004249162,0.00083714875,0.00026998206,0.00021769997,0.000008250819,0.0000051067623,0.0051786127],"genre_scores_gemma":[0.9986492,0.00067502604,0.00011379742,0.0002740978,0.000099232944,0.000020821915,0.0000072307007,0.000017959981,0.00014264496],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99864995,0.00016882695,0.0002521174,0.00043283234,0.00017523137,0.0003210549],"domain_scores_gemma":[0.9990673,0.00010598052,0.0001784138,0.00046587404,0.00006885893,0.00011359436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003404721,0.00013925732,0.00025798305,0.0000795576,0.0001011644,0.000015433747,0.0004442226,0.00023068106,0.00004001993],"category_scores_gemma":[0.00048320505,0.00013578768,0.000048958165,0.00004090457,0.00032512282,0.0000053803665,0.00033573367,0.0002163143,0.00002087496],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003007354,0.000097760036,0.011933441,0.000029262139,0.00001544103,0.00008231216,0.000044978347,0.00006018515,0.9828662,0.000057245477,0.00044752576,0.0040649143],"study_design_scores_gemma":[0.0012736083,0.001882395,0.014638266,0.000025035637,0.000008316044,0.00004015131,0.00003959255,0.00043202055,0.95176977,0.00007283272,0.02966427,0.00015375308],"about_ca_topic_score_codex":0.00006212964,"about_ca_topic_score_gemma":0.00023244937,"teacher_disagreement_score":0.03109644,"about_ca_system_score_codex":0.000024817882,"about_ca_system_score_gemma":0.00015966708,"threshold_uncertainty_score":0.5537261},"labels":[],"label_agreement":null},{"id":"W2588046727","doi":"10.1093/neuonc/now212.834","title":"SURG-36. IMPACT OF MULTIMODALITY MONITORING USING DIRECT ELECTRICAL STIMULATION TO DETERMINE CORTICOSPINAL TRACT SHIFT AND INTEGRITY IN THE iMRI suite","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Advanced MRI Techniques and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Corticospinal tract; Resection; Neurological deficit; Motor cortex; Deep brain stimulation; Surgery; Intraoperative MRI; Stimulation; Brain tumor; Interventional magnetic resonance imaging; Radiology; Magnetic resonance imaging; Diffusion MRI; Internal medicine; Pathology","score_opus":0.07608805098096767,"score_gpt":0.42885488401624416,"score_spread":0.3527668330352765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588046727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9834885,0.00002673765,0.015041367,0.00070737564,0.00003185979,0.0005920443,0.000008301947,0.000032238495,0.00007155128],"genre_scores_gemma":[0.99345976,0.000041643827,0.0062666596,0.0000791146,0.0001004617,0.000037976,0.0000014680219,0.000011365716,0.0000015287785],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99899876,0.00012478145,0.00031362055,0.00023094214,0.000115489194,0.00021639805],"domain_scores_gemma":[0.9986312,0.0008800613,0.0001176229,0.00021926266,0.0000620769,0.00008981299],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030600355,0.00011334872,0.00031183547,0.00009823207,0.000040548977,0.0000048091388,0.000075535485,0.00010444072,0.0000071376467],"category_scores_gemma":[0.0004679493,0.00006594004,0.00006614537,0.00023853991,0.00006517889,0.000068037516,0.0000336618,0.00024608328,7.589843e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000333442,0.00024941933,0.33431467,0.0000056180347,0.0000032299656,0.000027148248,0.00012501817,0.000072210554,0.58216697,0.000026084905,0.0000058560017,0.082670346],"study_design_scores_gemma":[0.00081206945,0.0016576558,0.9738091,0.000038041646,0.00003762919,0.00010411013,0.000010444638,0.0029140098,0.020009998,0.00020425739,0.00032514217,0.00007749184],"about_ca_topic_score_codex":0.00029721722,"about_ca_topic_score_gemma":0.000019268407,"teacher_disagreement_score":0.6394945,"about_ca_system_score_codex":0.0002614454,"about_ca_system_score_gemma":0.000113631446,"threshold_uncertainty_score":0.26889566},"labels":[],"label_agreement":null},{"id":"W2588056316","doi":"10.1093/neuonc/now212.180","title":"CSIG-19. RECEPTOR TYROSINE KINASE PHOSPHORYLATION IN A MODEL SYSTEM OF GBM","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Receptor tyrosine kinase; Platelet-derived growth factor receptor; Phosphorylation; Tyrosine phosphorylation; Cancer research; Growth factor receptor; Tyrosine kinase; Receptor Protein-Tyrosine Kinases; Biology; Epidermal growth factor receptor; Signal transduction; Receptor; Cell biology; Growth factor; Biochemistry","score_opus":0.019677255701058296,"score_gpt":0.2591808319515719,"score_spread":0.23950357625051358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588056316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904854,0.0015862035,0.0021701138,0.0011592521,0.0020298818,0.0004208841,0.000048758913,0.00008950967,0.0020099846],"genre_scores_gemma":[0.9991092,0.00015666116,0.00016278053,0.000119414304,0.000030516374,0.00004889912,0.000035441048,0.000020740612,0.00031631108],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983748,0.0003813724,0.0005634901,0.00032152122,0.000041105515,0.0003177046],"domain_scores_gemma":[0.99885786,0.00042304513,0.0002977676,0.00030402205,0.00008928882,0.000028020673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034269446,0.0001644386,0.00045026053,0.00018637652,0.000058667185,0.0000031311376,0.00018002145,0.00038980192,0.00020473829],"category_scores_gemma":[0.0002518746,0.00012315367,0.000087877444,0.0001477298,0.00016876672,0.00013495641,0.000077765166,0.00016181997,0.00027984858],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005200748,0.0001805695,0.0011420953,0.000027509861,0.000020861049,0.0000034231066,0.00023143485,0.00013621143,0.9704375,0.0022854067,0.003195406,0.021819474],"study_design_scores_gemma":[0.004378992,0.0006882964,0.0025446252,0.000104306535,0.00003178947,0.000040629573,0.00010165886,0.0008310185,0.93081236,0.00010151718,0.060174685,0.00019012982],"about_ca_topic_score_codex":0.00006222035,"about_ca_topic_score_gemma":0.000025841753,"teacher_disagreement_score":0.05697928,"about_ca_system_score_codex":0.00034248733,"about_ca_system_score_gemma":0.0001881255,"threshold_uncertainty_score":0.5022061},"labels":[],"label_agreement":null},{"id":"W2588078539","doi":"10.1093/neuonc/now212.171","title":"CSIG-10. SHH-MEDULLOBLASTOMA PREFERENTIALLY ARISES FROM GRANULE CELL PRECURSORS IN THE LATERAL CEREBELLUM","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Cerebellum; PTCH1; Biology; Sonic hedgehog; Granule cell; Wnt signaling pathway; Cancer research; Population; Cerebellar vermis; Neuroscience; Pathology; Cell biology; Medicine; Central nervous system; Signal transduction; Dentate gyrus","score_opus":0.019022805831571784,"score_gpt":0.26886878116482454,"score_spread":0.24984597533325276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588078539","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97783124,0.00016650508,0.000008406384,0.011770109,0.00054487097,0.0007142084,0.000051528237,0.00006068382,0.008852444],"genre_scores_gemma":[0.99713486,0.0001483536,0.00009962045,0.0018594163,0.00024978045,0.00020240655,0.00003441525,0.00003354837,0.00023757492],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980673,0.00035989936,0.0003690951,0.0004900316,0.00026803376,0.00044560977],"domain_scores_gemma":[0.99822766,0.00096094393,0.00013164806,0.00047885,0.000056721765,0.00014418011],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00013833848,0.00025482153,0.00045380276,0.00013005815,0.00006726853,0.000022744916,0.00024756917,0.0002222753,0.0015475508],"category_scores_gemma":[0.000111152185,0.00013511814,0.00014673307,0.00015158874,0.00013102994,0.000074384516,0.00008486016,0.0002305416,0.0005233395],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017442827,0.0062338645,0.19042692,0.000046590154,0.00017840651,0.0017693366,0.002906158,0.0000068717327,0.6842671,0.00023378823,0.058919337,0.05326733],"study_design_scores_gemma":[0.0183344,0.005994289,0.23612043,0.00013729432,0.0004954164,0.00010731358,0.00023605363,0.000032006308,0.23816656,0.0009106524,0.49907753,0.00038804905],"about_ca_topic_score_codex":0.00023160344,"about_ca_topic_score_gemma":0.00079774385,"teacher_disagreement_score":0.44610056,"about_ca_system_score_codex":0.0001479017,"about_ca_system_score_gemma":0.0001604913,"threshold_uncertainty_score":0.99936515},"labels":[],"label_agreement":null},{"id":"W2588083012","doi":"10.1093/neuonc/now212.333","title":"GENT-27. COMPREHENSIVE MOLECULAR CHARACTERIZATION OF N-ETHYL-N-NITROSOUREA INDUCED RAT GLIOMAS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Health, Environment, Cognitive Aging","field":"Environmental Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"ATRX; Glioma; Offspring; In utero; Immunohistochemistry; Epigenetics; Biology; DNA methylation; Astrocytoma; Pathology; Medicine; Pregnancy; Cancer research; Fetus; Gene; Mutation; Gene expression; Genetics","score_opus":0.023045339494997395,"score_gpt":0.276262590162423,"score_spread":0.2532172506674256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588083012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99151677,0.000008807844,0.0024373927,0.0024312811,0.00045232504,0.0005781438,0.000018394105,0.0000442849,0.0025126159],"genre_scores_gemma":[0.99583197,0.00010042788,0.00028125526,0.0035922094,0.00005682523,0.000038076014,0.000014953686,0.00003969333,0.00004460613],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975156,0.0005785128,0.00043952666,0.0006325595,0.00035474522,0.0004790117],"domain_scores_gemma":[0.9986808,0.00031260934,0.00035072464,0.0004243827,0.000023419989,0.0002080797],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00023176201,0.00022485775,0.0003493715,0.00009167637,0.00008723182,0.000007841896,0.00027080506,0.00020980269,0.0011147755],"category_scores_gemma":[0.0001697948,0.00018863984,0.00007602042,0.0002495289,0.0003293113,0.00022317663,0.00030977817,0.00021673256,0.00094949733],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005096611,0.000115834395,0.007221389,0.0000079391075,0.000009965977,0.00009978025,0.00024300857,0.000008252489,0.95610434,0.000032132804,0.00007842388,0.036027994],"study_design_scores_gemma":[0.0011713823,0.0005893652,0.055138335,0.000015529888,0.000025983647,0.000047296602,0.000037673228,0.00004977233,0.8767382,0.00012504608,0.06584666,0.00021476432],"about_ca_topic_score_codex":0.00004397588,"about_ca_topic_score_gemma":0.00001103056,"teacher_disagreement_score":0.079366125,"about_ca_system_score_codex":0.0003987145,"about_ca_system_score_gemma":0.000052869498,"threshold_uncertainty_score":0.9998284},"labels":[],"label_agreement":null},{"id":"W2588085473","doi":"10.1093/neuonc/now212.700","title":"RARE-37. SURGICAL MANAGEMENT OF INCIDENTAL DIFFUSELY INFILTRATING GLIOMAS: A SINGLE INSTITUTIONAL EXPERIENCE","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Asymptomatic; Astrocytoma; Retrospective cohort study; Oligodendroglioma; Cohort; Glioma; Radiology; Lesion; Surgical pathology; Surgery; Pathology","score_opus":0.03749152960203581,"score_gpt":0.3220791477125561,"score_spread":0.28458761811052025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588085473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9673893,0.00012516495,0.000049724273,0.00072265347,0.00046319395,0.00041310576,0.000012999014,0.00007292366,0.030750975],"genre_scores_gemma":[0.99861914,0.00009480025,0.0006648055,0.00022903505,0.00012577137,0.00013311426,0.0000070907217,0.000016310936,0.00010995723],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99830526,0.000104042214,0.00044829046,0.0004063075,0.0004152234,0.00032086123],"domain_scores_gemma":[0.9989355,0.00039860586,0.0001527701,0.00024268018,0.00007507574,0.00019532438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009879226,0.0001823324,0.0004266521,0.00009374342,0.00007265434,0.000007010484,0.00014166783,0.00012303035,0.0005190313],"category_scores_gemma":[0.00011125833,0.00012517834,0.00013202695,0.0003028362,0.00040210914,0.00013428697,0.00020036442,0.00012048852,0.000048695925],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004565898,0.003282426,0.1930759,0.00013619359,0.00022121311,0.02011983,0.00088642247,0.0000054768525,0.6406073,0.0037330897,0.0002913231,0.13307491],"study_design_scores_gemma":[0.04697597,0.016942397,0.2358105,0.0010138308,0.00043053817,0.012769555,0.0010891963,0.00009268571,0.3689403,0.00046054763,0.3145728,0.000901652],"about_ca_topic_score_codex":0.000021085369,"about_ca_topic_score_gemma":0.000011785671,"teacher_disagreement_score":0.3142815,"about_ca_system_score_codex":0.0006046898,"about_ca_system_score_gemma":0.00015075275,"threshold_uncertainty_score":0.56830287},"labels":[],"label_agreement":null},{"id":"W2588133079","doi":"10.1093/neuonc/now212.641","title":"PDTB-22. THE ROLE OF THE CHROMOSOME 19 microRNA CLUSTER (C19MC) IN EMBRYONAL TUMOR WITH MULTILAYERED ROSETTES (ETMR)","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Calgary","funders":"","keywords":"Neuroepithelial cell; Biology; Embryonic stem cell; Stem cell; Progenitor cell; Neural stem cell; Cell biology; microRNA; Cancer research; Pathology; Genetics; Gene; Medicine","score_opus":0.006132023113742439,"score_gpt":0.23214144638753026,"score_spread":0.2260094232737878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588133079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959311,0.0005163346,0.000031064512,0.0023066904,0.00017542302,0.00048649253,0.000051170482,0.0000090895,0.0004926544],"genre_scores_gemma":[0.9979642,0.00003195644,0.00012436326,0.0014961198,0.00017745905,0.00005966498,0.000011292442,0.000031505555,0.00010345184],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985227,0.0003371558,0.0003050621,0.00038567343,0.00014822489,0.00030117753],"domain_scores_gemma":[0.9988976,0.00013513165,0.00024505277,0.0005720681,0.00008103396,0.00006909833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017359121,0.00018704464,0.00020821435,0.00004042399,0.000069042886,0.000009278232,0.0004487535,0.0001332946,0.000053348293],"category_scores_gemma":[0.00017762605,0.00009298221,0.00010420575,0.00012227717,0.00036125016,0.0000066507664,0.0002530747,0.00013148841,0.00001317161],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039573273,0.000115487,0.012519669,0.000009585753,0.000027547267,0.000010218724,0.000053237432,0.00007389723,0.9837144,0.000029451616,0.0014106036,0.0016401673],"study_design_scores_gemma":[0.0019696287,0.00036138977,0.024756243,0.000025054813,0.000028295011,0.00021354662,0.000052684307,0.00008958885,0.86281955,0.000097120566,0.10943294,0.00015392815],"about_ca_topic_score_codex":0.000020818114,"about_ca_topic_score_gemma":0.00014042923,"teacher_disagreement_score":0.12089483,"about_ca_system_score_codex":0.00006696686,"about_ca_system_score_gemma":0.00030177663,"threshold_uncertainty_score":0.37917045},"labels":[],"label_agreement":null},{"id":"W2588208026","doi":"10.1093/neuonc/now212.816","title":"SURG-15. INTEGRATING MOLECULAR MARKERS AND EXTENT OF RESECTION FOR RISK STRATIFICATION OF PATIENTS WITH NEWLY-DIAGNOSED GLIOBLASTOMA: A MULTICENTRE STUDY","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; Institute of Cancer Research; University of Calgary; Baker Hughes (Canada)","funders":"","keywords":"Risk stratification; Glioblastoma; Medicine; Stratification (seeds); Internal medicine; Oncology; Resection; Surgery; Cancer research; Biology","score_opus":0.010321595971339328,"score_gpt":0.2749552976788803,"score_spread":0.26463370170754097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588208026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970235,0.000045301447,0.0002824855,0.00024601974,0.00008485465,0.002225778,0.000039091094,0.000014141723,0.000038787242],"genre_scores_gemma":[0.9988612,0.00003345837,0.00080858445,0.000024909341,0.000016323464,0.00022513892,0.000009927111,0.000018673976,0.000001816344],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99878824,0.00019931197,0.00036525694,0.00030598935,0.00018566608,0.00015554452],"domain_scores_gemma":[0.99809015,0.00086991646,0.0004021029,0.00022576937,0.0003311949,0.00008085071],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000181796,0.0001364168,0.00035430264,0.00013631798,0.00004174739,0.0000041606268,0.000039813738,0.00007059395,0.000014407166],"category_scores_gemma":[0.00062549894,0.0000829076,0.000055645076,0.0001313428,0.00007737807,0.00004853328,0.000021408903,0.00006687519,6.0744384e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006918194,0.0047397017,0.76181084,0.00006584884,0.00022307948,0.000046182562,0.0005985126,0.000010990751,0.14112546,0.00003533654,0.00013329713,0.08429257],"study_design_scores_gemma":[0.04245483,0.0481923,0.77488214,0.00017437788,0.00085204805,0.000007675025,0.0022741896,0.0002830875,0.13037236,0.000030852378,0.00033210436,0.00014403684],"about_ca_topic_score_codex":0.00008822352,"about_ca_topic_score_gemma":0.00060579117,"teacher_disagreement_score":0.08414853,"about_ca_system_score_codex":0.000093583694,"about_ca_system_score_gemma":0.00007645868,"threshold_uncertainty_score":0.33808738},"labels":[],"label_agreement":null},{"id":"W2588218255","doi":"10.1093/neuonc/now212.478","title":"MPTH-41. MGMT STATUS PREDICTS SURVIVAL OUTCOMES IN NRG ONCOLOGY/RTOG 0424: A PHASE II TRIAL OF TEMOZOLOMIDE-BASED CHEMORADIOTHERAPY FOR HIGH RISK LOW-GRADE GLIOMAS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame; Princess Margaret Cancer Centre; University Health Network; London Health Sciences Centre; Western University","funders":"","keywords":"Temozolomide; Oncology; Glioma; Internal medicine; Medicine; Chemoradiotherapy; Hazard ratio; Methyltransferase; Methylation; Proportional hazards model; Biomarker; Radiation therapy; Oligodendroglioma; O-6-methylguanine-DNA methyltransferase; Astrocytoma; Cancer research; Biology; Confidence interval; Gene","score_opus":0.03660164644227795,"score_gpt":0.3806421536693743,"score_spread":0.34404050722709634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588218255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9777722,0.00025162275,0.00018396054,0.012252733,0.004189058,0.004071914,0.0006884437,0.00013560391,0.00045450736],"genre_scores_gemma":[0.9937429,0.00083034614,0.00083611463,0.0020390889,0.0010186087,0.0010715828,0.00010603516,0.000100096055,0.00025523684],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9958192,0.0007663528,0.0011885252,0.0008552341,0.0003503921,0.0010202589],"domain_scores_gemma":[0.9935759,0.004490469,0.0007818952,0.00056698424,0.00017806991,0.0004067111],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007783374,0.0005164794,0.002313638,0.0005679969,0.00012315939,0.000006516964,0.00027366562,0.00064973335,0.00048535675],"category_scores_gemma":[0.0007844863,0.00037145033,0.0004203154,0.00040896607,0.0005166736,0.000099949735,0.00007351342,0.00044636757,0.000014983887],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.33848214,0.0244433,0.05194776,0.00013189783,0.0006798568,0.00065929815,0.0006070897,0.000013243246,0.46957853,0.00011680046,0.007657505,0.10568258],"study_design_scores_gemma":[0.6432549,0.10155179,0.0063088094,0.000044441822,0.0007697686,0.000040213203,0.000044214477,0.00011771027,0.10211789,0.00027759175,0.14512624,0.00034647167],"about_ca_topic_score_codex":0.00050055777,"about_ca_topic_score_gemma":0.0008803997,"teacher_disagreement_score":0.36746064,"about_ca_system_score_codex":0.0013330196,"about_ca_system_score_gemma":0.0021734575,"threshold_uncertainty_score":0.99987376},"labels":[],"label_agreement":null},{"id":"W2588241938","doi":"10.1093/neuonc/now212.794","title":"STMC-31. STIMULATION OF MICROGLIA AND MACROPHAGES AND GROWTH ATTENUATION OF BRAIN TUMOR-INITIATING CELLS WITH TUMOR NECROSIS FACTOR-ALPHA","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Microglia; Tumor necrosis factor alpha; Cancer research; Biology; Stem cell; Population; Immunology; Cytotoxic T cell; Cell biology; Inflammation; In vitro; Medicine; Genetics","score_opus":0.012801553038251543,"score_gpt":0.25102689195137634,"score_spread":0.2382253389131248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588241938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974871,0.00071170955,0.00020989857,0.0004822166,0.00041379826,0.00035162873,0.000101575264,0.000028713192,0.00021331948],"genre_scores_gemma":[0.99880344,0.00011168797,0.0004952057,0.00038849187,0.000023678595,0.000017229007,0.00001158648,0.000029631896,0.00011906466],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984755,0.00032228854,0.00047251268,0.00037978793,0.000050748244,0.00029919273],"domain_scores_gemma":[0.99753004,0.0014928799,0.00055784464,0.00020801742,0.0001857264,0.000025479014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021983046,0.00021296367,0.0004907899,0.00014050871,0.000092633985,0.000006765564,0.00013086264,0.00017925104,0.00013523245],"category_scores_gemma":[0.00021738852,0.00015867056,0.000040756244,0.00011216979,0.00067217794,0.00013911864,0.000119689,0.0001941509,0.00001413394],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004488048,0.00006831614,0.025436973,0.00008257451,0.00006299731,0.000014015206,0.00067554566,0.0000027412761,0.9621568,0.00007141417,0.00033517712,0.010644675],"study_design_scores_gemma":[0.003332234,0.0015395081,0.038361557,0.00007300696,0.00006271755,0.00014488459,0.000086411186,0.00000661248,0.9545896,0.00009812036,0.0015401309,0.00016520459],"about_ca_topic_score_codex":0.0001069722,"about_ca_topic_score_gemma":0.000017792669,"teacher_disagreement_score":0.012924583,"about_ca_system_score_codex":0.000092216374,"about_ca_system_score_gemma":0.00018940894,"threshold_uncertainty_score":0.6470398},"labels":[],"label_agreement":null},{"id":"W2588309790","doi":"10.1093/neuonc/now212.444","title":"MPTH-06. 1p/19q CO-DELETION STATUS PREDICTS SURVIVAL OUTCOMES IN NRG ONCOLOGY/RTOG 9802: A PHASE III TRIAL OF RT VS RT + PCV IN HIGH RISK LOW-GRADE GLIOMAS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation; Princess Margaret Cancer Centre; Ottawa Hospital; University Health Network","funders":"","keywords":"Internal medicine; Medicine; Oligodendroglioma; Oncology; Hazard ratio; Glioma; Statistical significance; Proportional hazards model; Astrocytoma; Confidence interval; Cancer research","score_opus":0.027275415017648658,"score_gpt":0.3409171157286852,"score_spread":0.3136417007110366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588309790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884283,0.00013730366,0.000017541042,0.0056721848,0.0018501998,0.0026390771,0.00028617494,0.0000966156,0.000872608],"genre_scores_gemma":[0.9970886,0.0010911319,0.00013394977,0.0005251824,0.00036460446,0.00056414836,0.00012477173,0.000065439315,0.00004217639],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99451816,0.0014829414,0.0015022826,0.0008975595,0.0006057172,0.0009933445],"domain_scores_gemma":[0.99457896,0.0034404176,0.00073463045,0.0006843843,0.00014706513,0.0004145473],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011068949,0.0004960381,0.0021324123,0.00092044094,0.00007774253,0.00001090958,0.00023297305,0.00066632894,0.0002315896],"category_scores_gemma":[0.0017821728,0.00035442185,0.0002999785,0.0005833324,0.0003648742,0.00014321531,0.0001272224,0.00063768635,0.00009476527],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0827002,0.028367357,0.7277542,0.000075502685,0.00038694934,0.0051423856,0.0009219727,0.000014814992,0.1066026,0.0004248412,0.0038350152,0.043774158],"study_design_scores_gemma":[0.61615723,0.032179058,0.28097644,0.00015624943,0.0005573392,0.00011044288,0.00020512051,0.000059327613,0.026852777,0.0003345829,0.042005457,0.00040597987],"about_ca_topic_score_codex":0.0015151936,"about_ca_topic_score_gemma":0.0022538672,"teacher_disagreement_score":0.53345704,"about_ca_system_score_codex":0.0013148872,"about_ca_system_score_gemma":0.0009164661,"threshold_uncertainty_score":0.9998908},"labels":[],"label_agreement":null},{"id":"W2588370865","doi":"10.1093/neuonc/now212.438","title":"MNGO-18. MANAGEMENT OF MULTIPLE MENINGIOMAS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Toronto Western Hospital","funders":"","keywords":"Medicine; Asymptomatic; Meningioma; Radiation therapy; Neurofibromatosis; Surgery; Radiology; Epidemiology; Presentation (obstetrics); Disease; Internal medicine","score_opus":0.04275084993859543,"score_gpt":0.30927890025374877,"score_spread":0.26652805031515336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588370865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8629413,0.000115949326,0.0015816574,0.0051466348,0.0006504129,0.00074260397,0.0000058621026,0.00012489529,0.12869066],"genre_scores_gemma":[0.9922436,0.000041577674,0.0047299485,0.0003137793,0.00010735213,0.00006962407,0.000004891411,0.0000308167,0.0024584325],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.998403,0.00009796066,0.00044153197,0.00039370733,0.00029423478,0.0003695427],"domain_scores_gemma":[0.9988202,0.00026052367,0.00017542728,0.00051026704,0.000068822716,0.00016479168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002761619,0.0001755185,0.00043752437,0.00019469882,0.000047367375,0.0000046371492,0.00017796001,0.00010577087,0.00067873386],"category_scores_gemma":[0.00008273908,0.00012044844,0.00013880385,0.00020572073,0.00011752501,0.000058176713,0.00021052593,0.000094017174,0.00020490824],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085187366,0.0005260828,0.010823978,0.00024579748,0.0003717523,0.0070780916,0.00021906482,0.0000024707447,0.8164849,0.0063776327,0.026356585,0.13066174],"study_design_scores_gemma":[0.010209777,0.0032565522,0.021578211,0.00020257887,0.00043776596,0.00080842903,0.00026573302,0.00012574752,0.08757999,0.00039926657,0.8748451,0.00029083484],"about_ca_topic_score_codex":0.00000827692,"about_ca_topic_score_gemma":0.0000015604519,"teacher_disagreement_score":0.8484885,"about_ca_system_score_codex":0.0001301258,"about_ca_system_score_gemma":0.00004716073,"threshold_uncertainty_score":0.74316597},"labels":[],"label_agreement":null},{"id":"W2588543544","doi":"10.1093/neuonc/now212.611","title":"PDCT-07. HERBY (BO25041): A PHASE II OPEN-LABEL, RANDOMIZED, MULTICENTER, COMPARATIVE STUDY OF BEVACIZUMAB (BEV)-BASED THERAPY IN PEDIATRIC PATIENTS WITH NEWLY DIAGNOSED HIGH-GRADE GLIOMA (HGG)","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Temozolomide; Bevacizumab; Internal medicine; Hazard ratio; Glioma; Clinical endpoint; Oncology; Confidence interval; Radiation therapy; Surgery; Randomized controlled trial; Chemotherapy","score_opus":0.037798600402264224,"score_gpt":0.34259248905380585,"score_spread":0.3047938886515416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588543544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876243,0.00032144535,0.0000151377835,0.0014854034,0.00035854598,0.009972875,0.00007457246,0.000053945467,0.000093799514],"genre_scores_gemma":[0.99648994,0.0001941249,0.0004107179,0.00060412684,0.000089623085,0.0020865784,0.00005392492,0.00006356522,0.0000074215873],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9955103,0.0013395997,0.001095697,0.0008874244,0.000572732,0.000594273],"domain_scores_gemma":[0.9946327,0.0032793207,0.0007468202,0.00069279503,0.0003442982,0.00030402446],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00038375607,0.0005584257,0.0023534277,0.00058268587,0.00013947673,0.000025404464,0.00041843313,0.00018606037,0.00017411748],"category_scores_gemma":[0.00030010642,0.000323474,0.00012699382,0.0007026081,0.00024654425,0.00019432044,0.0001837217,0.0002651935,0.000034440345],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.42797148,0.31263068,0.20433319,0.000050929484,0.0008122227,0.0026147775,0.003635779,0.00003993266,0.01896592,0.000031546417,0.0017735366,0.027139988],"study_design_scores_gemma":[0.8945596,0.064844586,0.029681005,0.00008167906,0.0006454834,0.000007969651,0.00024140668,0.00009843185,0.008874526,0.000011682293,0.0006581477,0.00029547024],"about_ca_topic_score_codex":0.00049980177,"about_ca_topic_score_gemma":0.00066794205,"teacher_disagreement_score":0.4665881,"about_ca_system_score_codex":0.00035480215,"about_ca_system_score_gemma":0.00036889582,"threshold_uncertainty_score":0.99992174},"labels":[],"label_agreement":null},{"id":"W2588554523","doi":"10.1093/neuonc/now188.278","title":"P17.04 Radiomics analysis of primary central nervous system lymphoma (PCNSL) - A LOC network study","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Advanced Remanufacturing and Technology Centre; Institut National Du Cancer","keywords":"Primary central nervous system lymphoma; Radiomics; Medicine; Lymphoma; Oncology; Internal medicine; Radiology","score_opus":0.016443559147202684,"score_gpt":0.2644862068795697,"score_spread":0.248042647732367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588554523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995198,0.00046692113,0.00007568949,0.0009599831,0.00070696726,0.0009253765,0.000031668882,0.00009323291,0.0015421265],"genre_scores_gemma":[0.99863213,0.00011382132,0.00016847486,0.00056534,0.00032692417,0.00010988638,0.000024413179,0.000036338068,0.000022675144],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99756765,0.00035118035,0.0006564792,0.00052584993,0.00031601795,0.00058282225],"domain_scores_gemma":[0.99789494,0.0007011768,0.00033754457,0.0006671155,0.00011803613,0.00028115563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025661086,0.00026448627,0.001405438,0.00033534938,0.00007268157,0.00000898773,0.00017109007,0.00017539265,0.00006126065],"category_scores_gemma":[0.00007472594,0.00017315545,0.00037965417,0.00089904264,0.00010746742,0.00004424518,0.00010483108,0.00007822568,0.00002727699],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001076796,0.0053516785,0.7915344,0.000084032195,0.0054670335,0.004012589,0.0005226354,0.00043595245,0.029610353,0.00032339632,0.004228452,0.15735266],"study_design_scores_gemma":[0.011865515,0.0049257004,0.95706517,0.00007643851,0.0099742,0.00029370387,0.00034033658,0.00052091456,0.0017449216,0.0000070250803,0.012975295,0.00021075456],"about_ca_topic_score_codex":0.0001386527,"about_ca_topic_score_gemma":0.00013707257,"teacher_disagreement_score":0.16553077,"about_ca_system_score_codex":0.0010939055,"about_ca_system_score_gemma":0.00033407053,"threshold_uncertainty_score":0.70610744},"labels":[],"label_agreement":null},{"id":"W2588587990","doi":"10.1093/neuonc/now212.606","title":"PDCT-02. MARKED RECOVERY OF VISION IN A CHILD WITH OPTIC PATHWAY GLIOMA TREATED UPFRONT WITH BEVACIZUMAB AND VINBLASTINE","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Ocular Oncology and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Medicine; Bevacizumab; Pilocytic astrocytoma; Optic chiasm; Optic tract; Optic nerve; Glioma; Ophthalmology; Surgery; Astrocytoma; Chemotherapy","score_opus":0.006906730345174112,"score_gpt":0.24713083352935877,"score_spread":0.24022410318418466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588587990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921141,0.0001480377,0.0000343989,0.0020113243,0.00007399912,0.000662278,0.000015588601,0.000040503775,0.0048997593],"genre_scores_gemma":[0.99858284,0.00008832462,0.000873755,0.00016335455,0.00003383489,0.000053647134,0.000014203034,0.000034457044,0.00015557944],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99850625,0.00021887591,0.00032469118,0.00046783406,0.00016217104,0.00032018378],"domain_scores_gemma":[0.99885964,0.0004119531,0.0001917205,0.00030572104,0.000084825224,0.00014614528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001476525,0.00024499404,0.0006828221,0.0002682451,0.000048888433,0.0000037027214,0.00006542242,0.00023764952,0.00010777524],"category_scores_gemma":[0.00012590237,0.0001324089,0.000044143966,0.0002644524,0.00028231958,0.00010080244,0.00005226067,0.00019174081,0.000017876082],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.072416596,0.0048612338,0.32884017,0.00018111304,0.0007544483,0.03709346,0.0004306664,0.000009746748,0.38399446,0.00012631888,0.0002804362,0.17101136],"study_design_scores_gemma":[0.09173206,0.14286207,0.6418177,0.0013788334,0.000924695,0.024475941,0.00013793257,0.00013346477,0.086424276,0.00009555205,0.009458534,0.0005589678],"about_ca_topic_score_codex":0.000045370438,"about_ca_topic_score_gemma":0.00028420062,"teacher_disagreement_score":0.31297752,"about_ca_system_score_codex":0.00021667991,"about_ca_system_score_gemma":0.00024050346,"threshold_uncertainty_score":0.5399478},"labels":[],"label_agreement":null},{"id":"W2588612590","doi":"10.1093/neuonc/now212.293","title":"EXTH-51. BREVICAN-SPECIFIC PEPTIDES FOR THE DEVELOPMENT OF NEXT-GENERATION TARGETED THERANOSTICS FOR MALIGNANT GLIOMAS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Glioma; Flow cytometry; Peptide library; Peptide; Cancer research; Cancer cell; Biology; Molecular biology; Chemistry; Cancer; Biochemistry; Peptide sequence; Gene","score_opus":0.07028637340521543,"score_gpt":0.29122579347149935,"score_spread":0.22093942006628392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588612590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83989626,0.0028337203,0.15077488,0.002386673,0.0010589369,0.0024256243,0.00019593764,0.000026907674,0.00040103638],"genre_scores_gemma":[0.9836505,0.00048556348,0.013718349,0.0005739663,0.0006885982,0.0006224243,0.0000904688,0.000038772465,0.00013134406],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987599,0.00012651747,0.0003905702,0.00034334845,0.0000926709,0.00028695347],"domain_scores_gemma":[0.998792,0.00044376202,0.00019572914,0.0002955565,0.00021634556,0.000056621742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044368248,0.00016634,0.00021326686,0.0000363833,0.00019323551,0.000013912665,0.00025126015,0.00018908897,0.000030413883],"category_scores_gemma":[0.0003041271,0.000099837926,0.000119548895,0.000054353754,0.00011940163,0.0000047353283,0.00006795237,0.00005051104,0.0000059988156],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000274885,0.000057264777,0.000047399695,0.000020871044,0.00004042046,6.50747e-7,0.00014107555,0.0000039885267,0.9042207,0.0006564274,0.0030672655,0.09146906],"study_design_scores_gemma":[0.00067892706,0.0006153077,0.000060255046,0.0000063472053,0.000012953704,0.0000065848712,0.000037475464,0.00003307017,0.5872401,0.00010777028,0.41111404,0.00008719885],"about_ca_topic_score_codex":0.000001057478,"about_ca_topic_score_gemma":0.000033514938,"teacher_disagreement_score":0.40804675,"about_ca_system_score_codex":0.000032083444,"about_ca_system_score_gemma":0.0002748516,"threshold_uncertainty_score":0.40712723},"labels":[],"label_agreement":null},{"id":"W2588614488","doi":"10.1093/neuonc/now212.159","title":"CBIO-21. STAT3 REGULATES AN SL/PL TRANSITION IN BTICs THROUGH AN EMT-LIKE PROCESS MEDIATED BY SLUG","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Brain Institute; University of Calgary","funders":"","keywords":"Slug; Epithelial–mesenchymal transition; Biology; STAT3; Transcription factor; Cancer research; Transcriptome; Twist transcription factor; Cell biology; Signal transduction; Downregulation and upregulation; Gene; Gene expression; Genetics","score_opus":0.015525706795313302,"score_gpt":0.31343715552350254,"score_spread":0.29791144872818925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588614488","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99602145,0.00016545353,0.0008040455,0.002111116,0.00014629828,0.00031261364,0.00008168244,0.000036165016,0.0003211584],"genre_scores_gemma":[0.99661076,0.0007655258,0.00027406687,0.0015461677,0.00017259477,0.000054039087,0.00038589345,0.000045578905,0.00014538507],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99789155,0.00038685184,0.00032651474,0.0006099137,0.00020122108,0.00058394246],"domain_scores_gemma":[0.99908674,0.000082488485,0.00009227552,0.00038665213,0.00013125665,0.0002206089],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028828715,0.00020940843,0.0002645938,0.00006727573,0.00008362332,0.000021654474,0.00030883643,0.00037857253,0.00004676451],"category_scores_gemma":[0.00017175016,0.00016430557,0.000049193543,0.00015769509,0.00020572556,0.000043867418,0.000048172184,0.00019645349,0.000015906062],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048072476,0.0002857448,0.00058778806,0.000018191133,0.000014351613,0.000052466174,0.00033252087,0.000029737705,0.98989844,0.000023013303,0.0015956635,0.006681369],"study_design_scores_gemma":[0.0033869643,0.005722249,0.0006623027,0.000021891177,0.00001688568,0.00007589173,0.00048865395,0.0006984978,0.9083978,0.0004169315,0.07971854,0.00039339988],"about_ca_topic_score_codex":0.00007762831,"about_ca_topic_score_gemma":0.0005382403,"teacher_disagreement_score":0.081500635,"about_ca_system_score_codex":0.00006155911,"about_ca_system_score_gemma":0.0002548381,"threshold_uncertainty_score":0.67001873},"labels":[],"label_agreement":null},{"id":"W2588634924","doi":"10.1093/neuonc/now212.288","title":"EXTH-44. NONE MGMT AND MMR DEPENDENT RADIOSENSITIZATION TO TREAT MALIGNANT GLIOMAS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; Montreal Neurological Institute and Hospital","funders":"","keywords":"Temozolomide; Cancer research; DNA repair; Methyltransferase; Medicine; Radiation therapy; Chemotherapy; Oncology; DNA damage; Internal medicine; Biology; Glioma; Methylation; Gene; DNA","score_opus":0.018118567256439982,"score_gpt":0.2825633519288493,"score_spread":0.2644447846724093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588634924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98128843,0.0002235949,0.00015521627,0.01540327,0.00033943285,0.0006612859,0.000017534278,0.0000743275,0.0018369202],"genre_scores_gemma":[0.9965497,0.00033396584,0.00028253923,0.0023450633,0.00021523747,0.000097320204,0.000010227637,0.000034667068,0.00013123255],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99859047,0.00011429592,0.0002729446,0.00048211537,0.00019504056,0.00034511354],"domain_scores_gemma":[0.9988326,0.00034473278,0.00007691515,0.00031390908,0.00008055902,0.000351284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010834816,0.00020648811,0.00043417083,0.00022092264,0.00007356229,0.000014192462,0.000051937153,0.00014805468,0.00011162675],"category_scores_gemma":[0.000146433,0.00013136517,0.00006337337,0.00016886128,0.00006297062,0.00005555133,0.00007248044,0.00006558702,0.00018261088],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029239908,0.00049044704,0.012040625,0.000018365014,0.000036638772,0.0028865684,0.00015132611,0.0000018523409,0.88964355,0.00028631778,0.002592491,0.091559395],"study_design_scores_gemma":[0.010434478,0.004208767,0.034850307,0.00011202481,0.00033288426,0.0027980097,0.00006780584,0.000029947103,0.90575904,0.00008495337,0.041075826,0.00024594174],"about_ca_topic_score_codex":0.00003150093,"about_ca_topic_score_gemma":0.00007000495,"teacher_disagreement_score":0.09131345,"about_ca_system_score_codex":0.000263367,"about_ca_system_score_gemma":0.00009094169,"threshold_uncertainty_score":0.5356916},"labels":[],"label_agreement":null},{"id":"W2588666144","doi":"10.1093/neuonc/now212.184","title":"CSIG-23. CYTOPLASMIC RNA STRESS GRANULES: A PUTATIVE TRANSLATIONAL MECHANISM OF mTOR REGULATION IN GLIOBLASTOMA","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Protist diversity and phylogeny","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Dalhousie University","funders":"","keywords":"Stress granule; PI3K/AKT/mTOR pathway; Messenger RNA; P-bodies; RNA-binding protein; Cell biology; Molecular biology; Protein biosynthesis; RNA; Translation (biology); Biology; Chemistry; Signal transduction; Gene; Biochemistry","score_opus":0.010780412319912582,"score_gpt":0.24515338094425598,"score_spread":0.2343729686243434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588666144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99059767,0.00004828493,0.007351351,0.0006034059,0.00020144833,0.0002868436,0.00026013842,0.00000966112,0.0006411863],"genre_scores_gemma":[0.9991769,0.00004801606,0.0003960773,0.00016588083,0.000084393476,0.000019007775,0.000044766322,0.000011751855,0.000053195563],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989295,0.0002048595,0.00023501606,0.00031254295,0.00012306713,0.00019503113],"domain_scores_gemma":[0.99946827,0.0001038101,0.00013379946,0.00015597903,0.00008193402,0.00005618464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013059616,0.00012678053,0.00019537717,0.00009703905,0.000041192903,0.000003389901,0.0001688735,0.0002388924,0.000049621503],"category_scores_gemma":[0.000076200646,0.00011131213,0.00007742952,0.000097694996,0.0001324961,0.000009122962,0.000058377387,0.00008009929,0.000015602891],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068323093,0.00011658867,0.002816171,0.000014450823,0.000023395496,0.000016984766,0.00023543261,0.00006680781,0.98864514,0.0025686736,0.0001288078,0.004684337],"study_design_scores_gemma":[0.0020480147,0.0013284767,0.006181402,0.000017198134,0.00001658174,0.000023337427,0.000055323417,0.00008493746,0.98345447,0.0040468522,0.0026046694,0.0001387217],"about_ca_topic_score_codex":0.000010599884,"about_ca_topic_score_gemma":0.00016689888,"teacher_disagreement_score":0.00857923,"about_ca_system_score_codex":0.000033092398,"about_ca_system_score_gemma":0.0001495032,"threshold_uncertainty_score":0.4539177},"labels":[],"label_agreement":null},{"id":"W2588669390","doi":"10.1093/neuonc/now212.543","title":"NIMG-31. RESIDUAL ENHANCING TUMOR VOLUME IS A STRONG PROGNOSTIC BIOMARKER FOR SURVIVAL IN BOTH NEWLY DIAGNOSED AND RECURRENT GBM REGARDLESS OF THERAPY: EVIDENCE FROM 1,535 PATIENTS IN SINGLE AND MULTICENTER TRIALS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Context (archaeology); Oncology; Internal medicine; Biomarker; Chemotherapy; Clinical trial; Overall survival","score_opus":0.108605759923458,"score_gpt":0.3812831153246559,"score_spread":0.2726773554011979,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588669390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99503225,0.00059991505,0.00013700985,0.0023371226,0.00012865807,0.0016201725,0.00010580359,0.000011709455,0.000027374097],"genre_scores_gemma":[0.99850076,0.00043258938,0.00044589056,0.00024707906,0.00009644808,0.00023480669,0.000011553902,0.000017303948,0.000013561812],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99819875,0.00029578054,0.00066413893,0.00044145228,0.00013680906,0.0002630913],"domain_scores_gemma":[0.99357116,0.005807746,0.00024040158,0.00017476674,0.000075533826,0.00013041837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005979948,0.00015681342,0.0006072509,0.000069831316,0.000026422409,0.000009704752,0.0000806632,0.00010863079,0.00003180086],"category_scores_gemma":[0.003939255,0.00011468459,0.000048277157,0.000105728956,0.00016010711,0.00008329518,0.000050331688,0.00014106707,0.0000012013072],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002601348,0.00059765874,0.30597854,0.00007382427,0.000017462718,0.000015593538,0.00030884414,1.3425063e-7,0.6526177,0.0000012513252,0.00020424518,0.03758342],"study_design_scores_gemma":[0.026143635,0.0020561446,0.63455606,0.0010707024,0.00014563816,0.000006204055,0.00016830176,0.00040179686,0.3303822,0.000056007237,0.0047902428,0.0002230638],"about_ca_topic_score_codex":0.00007205172,"about_ca_topic_score_gemma":0.00011112797,"teacher_disagreement_score":0.32857752,"about_ca_system_score_codex":0.00010767202,"about_ca_system_score_gemma":0.00011896681,"threshold_uncertainty_score":0.4715941},"labels":[],"label_agreement":null},{"id":"W2588684378","doi":"10.1093/neuonc/now212.471","title":"MPTH-34. THE PROGNOSTIC VALUE OF POLYSOMY IN OLIGODENDROGLIAL TUMORS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Polysomy; Oligodendroglial Tumor; Internal medicine; Oligodendroglioma; Oncology; Chemotherapy; Medicine; Fluorescence in situ hybridization; Pathology; Cancer research; Biology; Glioma; Astrocytoma; Genetics; Gene","score_opus":0.017654812481901015,"score_gpt":0.28993772677229457,"score_spread":0.27228291429039353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588684378","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9804331,0.00016670601,0.000005053579,0.015342911,0.00030836376,0.0006365199,0.000009523966,0.000025724103,0.0030720748],"genre_scores_gemma":[0.9985129,0.00007098743,0.00007263176,0.0009953819,0.00014663787,0.00015071826,0.0000020146724,0.000019839712,0.000028846018],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987213,0.0001815378,0.00034286978,0.00026391115,0.00018585495,0.00030450578],"domain_scores_gemma":[0.99831,0.0011006651,0.00012578705,0.00031851116,0.00004842439,0.00009660538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016799597,0.00014138246,0.0003990618,0.00012901807,0.00003062985,0.0000034338257,0.0001269156,0.000100181525,0.000116536794],"category_scores_gemma":[0.000500589,0.00007080308,0.000103118415,0.00018995715,0.00018146833,0.000031593572,0.00006779337,0.00013334495,0.00007819914],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028852271,0.0015179353,0.5212826,0.000027303739,0.000068256435,0.0015334131,0.00033829498,0.000004733605,0.4385382,0.004243297,0.0016218948,0.03053555],"study_design_scores_gemma":[0.01279208,0.0052262107,0.62998086,0.00024755194,0.00034600234,0.000930199,0.00019484683,0.0000654989,0.3064019,0.0007325395,0.04287286,0.0002094319],"about_ca_topic_score_codex":0.00009379837,"about_ca_topic_score_gemma":0.000055850578,"teacher_disagreement_score":0.13213626,"about_ca_system_score_codex":0.00016443762,"about_ca_system_score_gemma":0.00022755015,"threshold_uncertainty_score":0.28872657},"labels":[],"label_agreement":null},{"id":"W2588711318","doi":"10.1093/neuonc/now212.178","title":"CSIG-17. COMPENSATORY ACTIVATION OF STAT3 TRIGGERED BY EGFR INHIBITION: A MECHANISM OF RESISTANCE IN GBM BRAIN TUMOR INITIATING CELLS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Brain Institute; University of Calgary","funders":"","keywords":"Afatinib; Cancer research; STAT3; EGFR inhibitors; Signal transduction; In vivo; Biology; Erlotinib; Epidermal growth factor receptor; Cancer; Medicine; Cell biology; Genetics","score_opus":0.026308622111289516,"score_gpt":0.29275581110172444,"score_spread":0.2664471889904349,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588711318","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98802584,0.00003538737,0.00170106,0.004248606,0.00024818844,0.00044841252,0.000111012756,0.00003564474,0.005145843],"genre_scores_gemma":[0.99732196,0.000015778922,0.000681682,0.001726211,0.00007545297,0.000030242312,0.000018140032,0.000022495433,0.00010806098],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99843764,0.00023403186,0.00067668833,0.0002589246,0.00019361607,0.00019912497],"domain_scores_gemma":[0.9977179,0.0013330717,0.00049566454,0.00020302637,0.00018074333,0.00006955861],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032054342,0.00013069097,0.0004823095,0.0002220611,0.000034149365,0.000002941077,0.000059975788,0.000102304,0.0003342502],"category_scores_gemma":[0.0005992266,0.0001088687,0.00008222439,0.00022926075,0.00009708435,0.00011748309,0.0000326894,0.00022866677,0.000007283677],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059140596,0.0003325038,0.00007898782,0.00007062747,0.000015227345,0.00004712616,0.0005052066,0.000001737888,0.9860748,0.0014706015,0.010022043,0.00078970706],"study_design_scores_gemma":[0.0034922177,0.0011506199,0.00022626156,0.00040201808,0.000023421078,0.000024390856,0.00030740717,0.00003472101,0.9697326,0.00047277365,0.024042906,0.00009066287],"about_ca_topic_score_codex":0.000039366052,"about_ca_topic_score_gemma":0.00006499009,"teacher_disagreement_score":0.016342225,"about_ca_system_score_codex":0.00020344798,"about_ca_system_score_gemma":0.0003030262,"threshold_uncertainty_score":0.4439537},"labels":[],"label_agreement":null},{"id":"W2588786146","doi":"10.1093/neuonc/now188.137","title":"P08.04 Antitumor effects of medroxyprogesterone on glial tumor growth in vitro and in vivo and an unexpected contribution of PI3Kinase on anti-invasive effects of steroids","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"","keywords":"Medroxyprogesterone; In vivo; Medicine; In vitro; Cancer research; Pharmacology; Medroxyprogesterone acetate; Oncology; Internal medicine; Chemistry; Biology; Hormone; Biochemistry","score_opus":0.0055843025220749295,"score_gpt":0.25144012844442337,"score_spread":0.24585582592234845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588786146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987867,0.00023208224,0.00005906786,0.00008695888,0.00021538784,0.000561724,0.0000382667,0.000004198913,0.000015613756],"genre_scores_gemma":[0.99921584,0.00041363388,0.000037569534,0.00022076452,0.000046853987,0.00003660405,0.000009061847,0.00001791323,0.0000017782072],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987315,0.00027455488,0.0003012123,0.00036821736,0.0001034815,0.00022106478],"domain_scores_gemma":[0.9991448,0.00028525435,0.00022682865,0.00019380686,0.00007865296,0.000070681774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001364429,0.00017180393,0.00047358632,0.00014595407,0.0000144396845,0.0000029203322,0.000092306225,0.00015966248,0.0000011295793],"category_scores_gemma":[0.00024583066,0.00014006012,0.000038213646,0.00009501854,0.00016969982,0.000007052728,0.00006717243,0.00008385912,1.5672029e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028074975,0.00047682156,0.002230567,0.00018914387,0.000024119367,0.000090013265,0.00007222265,9.047619e-7,0.99166834,0.00022825149,0.0000037145553,0.0022083926],"study_design_scores_gemma":[0.007236181,0.011825628,0.0074769566,0.00014963705,0.000028059409,0.00001932216,0.000013332954,0.000008202982,0.97293687,0.00011499907,0.00007228591,0.00011853168],"about_ca_topic_score_codex":0.000034892346,"about_ca_topic_score_gemma":0.00009825409,"teacher_disagreement_score":0.018731488,"about_ca_system_score_codex":0.000037833994,"about_ca_system_score_gemma":0.00009443586,"threshold_uncertainty_score":0.5711486},"labels":[],"label_agreement":null},{"id":"W2588793449","doi":"10.1093/neuonc/now212.656","title":"QLIF-10. FAMILY CAMP: A MULTI-DISCIPLINARY, HOLISTIC INTERVENTION FOR BRAIN TUMOR PATIENTS AND THEIR FAMILIES","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Columbian Hospital","funders":"","keywords":"Psychological intervention; Anxiety; Psychosocial; Coping (psychology); Medicine; Intervention (counseling); Clinical psychology; Psychology; Psychiatry","score_opus":0.058166473869346244,"score_gpt":0.3619905565929547,"score_spread":0.30382408272360845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588793449","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98132306,0.00022397448,0.003985887,0.0115378015,0.0010402026,0.001266106,0.00022070995,0.00012118942,0.00028105784],"genre_scores_gemma":[0.991656,0.000046094465,0.0007843908,0.006569014,0.0003182923,0.00020415506,0.00005586465,0.00005992395,0.00030625323],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99800974,0.00026661323,0.00056947855,0.0005724277,0.00017765941,0.00040410808],"domain_scores_gemma":[0.9975052,0.0014780472,0.0002683771,0.00033124912,0.00019354213,0.0002235949],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046639517,0.00027339894,0.0006196793,0.00016173112,0.00011993777,0.000015146445,0.00015109095,0.00014762282,0.000053132204],"category_scores_gemma":[0.0019966995,0.00018816584,0.0001951475,0.000105083636,0.00028996915,0.00011314661,0.00020078082,0.00017226068,0.000049960552],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010955394,0.008018905,0.06458203,0.0026296729,0.0005381615,0.0001969221,0.02511263,0.000004724383,0.42224026,0.00092075655,0.074178636,0.39062193],"study_design_scores_gemma":[0.08474861,0.031878073,0.51241654,0.0015826637,0.00038423727,0.00028880243,0.0077114888,0.00035596354,0.009928954,0.0032875417,0.34621686,0.001200258],"about_ca_topic_score_codex":0.000115216564,"about_ca_topic_score_gemma":0.00037382392,"teacher_disagreement_score":0.44783452,"about_ca_system_score_codex":0.00027683086,"about_ca_system_score_gemma":0.00021443068,"threshold_uncertainty_score":0.767318},"labels":[],"label_agreement":null},{"id":"W2588796936","doi":"10.1093/neuonc/now212.613","title":"PDCT-09. HYPERMUTATION AND NEOANTIGEN FORMATION IS DIAGNOSTIC AND PREDICT RESPONSE TO IMMUNE CHECKPOINT INHIBITION IN CHILDHOOD BIALLELIC MISMATCH REPAIR DEFICIENT BRAIN TUMORS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; McGill University Health Centre; Hôpital de l'Enfant-Jésus; Mount Sinai Hospital; CancerCare Manitoba; Montreal Children's Hospital; Izaak Walton Killam Health Centre; Université Laval; Hospital for Sick Children","funders":"","keywords":"Somatic hypermutation; DNA mismatch repair; Immune system; Medicine; Cancer research; Immunology; DNA repair; Biology; Genetics; Antibody; Gene; B cell","score_opus":0.011363064178926135,"score_gpt":0.2617202123091235,"score_spread":0.2503571481301974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588796936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9575409,0.00028837187,0.000044831555,0.04057821,0.000098230215,0.0012575448,0.000029241086,0.00007784935,0.00008478936],"genre_scores_gemma":[0.9970805,0.0003174594,0.00015166607,0.002085733,0.000048185855,0.00025675024,0.000025531404,0.000023917362,0.000010236225],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982995,0.00028407155,0.000524776,0.00041112938,0.00018969072,0.00029086278],"domain_scores_gemma":[0.9980643,0.001311223,0.00014683085,0.0002265069,0.00006653993,0.00018459735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005389264,0.00019067207,0.0003722618,0.00037314216,0.00008140221,0.000016205693,0.000028237726,0.00013192363,0.000030826835],"category_scores_gemma":[0.0022150073,0.00014251702,0.00006687765,0.00023721659,0.00006862038,0.00013688851,0.00007567277,0.00010789444,0.00004126065],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013527226,0.0009793583,0.039641105,0.00006334928,0.000030100662,0.00083199324,0.005118732,0.000011584137,0.90847325,0.000038919796,0.0013301655,0.042128716],"study_design_scores_gemma":[0.008307564,0.0040314025,0.8803178,0.00035370587,0.000081572936,0.0010530131,0.00031573512,0.0001786891,0.09980068,0.00012442059,0.0052656108,0.00016980273],"about_ca_topic_score_codex":0.00006338389,"about_ca_topic_score_gemma":0.00005333697,"teacher_disagreement_score":0.84067667,"about_ca_system_score_codex":0.00026859104,"about_ca_system_score_gemma":0.0001149019,"threshold_uncertainty_score":0.5811675},"labels":[],"label_agreement":null},{"id":"W2588820796","doi":"10.1093/neuonc/now212.499","title":"NCOG-04. IMPAIRED FLUID COGNITION IN PATIENTS WITH GLIOMA OF THE FRONTAL AND PARIETAL LOBES","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Cognition; Working memory; Psychology; Audiology; Wisconsin Card Sorting Test; Cognitive test; Cognitive psychology; Medicine; Neuroscience; Neuropsychology","score_opus":0.009617411132015292,"score_gpt":0.2482412547801868,"score_spread":0.23862384364817152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588820796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954456,0.00007642304,0.000010587429,0.00211608,0.00027851172,0.0007651407,0.00004088306,0.000023727798,0.0012430634],"genre_scores_gemma":[0.9992564,0.0000396049,0.000022499973,0.0005355644,0.00005659761,0.00004607718,0.000006156671,0.00001711448,0.000019992713],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998956,0.00011246462,0.00025193507,0.00024785806,0.00020491247,0.00022678665],"domain_scores_gemma":[0.9992626,0.0002585246,0.00013654886,0.00013672393,0.00014389349,0.000061729246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000081058955,0.00014444222,0.0003400285,0.000072965566,0.00005322411,0.0000028441966,0.000051219766,0.00010261518,0.0000661743],"category_scores_gemma":[0.00025656106,0.00007704872,0.00004620525,0.00015868091,0.0004436062,0.000078577934,0.000098459815,0.00013817949,0.000007712371],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045995754,0.0006942248,0.8430257,0.00003183205,0.00012739158,0.000059588838,0.00047004377,2.5231088e-7,0.11583669,0.000010410481,0.0014336157,0.033710677],"study_design_scores_gemma":[0.015140858,0.0055652717,0.96203804,0.00018330604,0.00019967358,0.00007039803,0.00016851402,0.000005337507,0.014889905,0.00005445255,0.0015812882,0.00010292981],"about_ca_topic_score_codex":0.000033715987,"about_ca_topic_score_gemma":0.00019226335,"teacher_disagreement_score":0.11901237,"about_ca_system_score_codex":0.0001550371,"about_ca_system_score_gemma":0.00010942886,"threshold_uncertainty_score":0.31419554},"labels":[],"label_agreement":null},{"id":"W2588835593","doi":"10.1093/neuonc/now212.152","title":"CBIO-14. EXPLORING THE OTX2 REGULATORY NETWORK: TARGETING THE “GROW AND GO” ARMS OF THE MOST AGGRESSIVE MEDULLOBLASTOMAS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Medicinal Plants and Bioactive Compounds","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; SickKids Foundation; University of Manitoba","funders":"","keywords":"Semaphorin; Biology; Gene knockdown; Axon guidance; Gene; Cancer research; Downregulation and upregulation; Signal transduction; Transcription factor; Progenitor cell; Stem cell; Cell biology; Axon; Genetics; Receptor","score_opus":0.01906391179740932,"score_gpt":0.2471173092619949,"score_spread":0.22805339746458558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588835593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98710203,0.0014552717,0.00007537026,0.008601581,0.0012267447,0.00025881873,0.000011634598,0.000008295566,0.0012602602],"genre_scores_gemma":[0.9960282,0.00092460145,0.000037161433,0.0015956279,0.0011296534,0.00003602724,0.0000039129513,0.000017947954,0.00022686149],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985455,0.00036976844,0.000257065,0.00032011236,0.00017598161,0.00033157066],"domain_scores_gemma":[0.99864936,0.0004115068,0.00035766108,0.00042025655,0.000094418116,0.0000667958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048794708,0.00017253653,0.00020131888,0.000014755756,0.00025926842,0.000011033037,0.0004306993,0.00012487927,0.000015629124],"category_scores_gemma":[0.0005217499,0.000065729626,0.00007878636,0.000099855584,0.0007241934,0.000006467165,0.0004042081,0.00020431913,0.000003076328],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016297522,0.000020699887,0.003373965,0.000007942504,0.000055570716,0.000011399761,0.00014087887,0.000015736568,0.9502023,0.00018924862,0.012702907,0.033116385],"study_design_scores_gemma":[0.0008775115,0.00073755946,0.013193672,0.0000833376,0.00006877637,0.00023897877,0.0004888235,0.000035337438,0.35264745,0.0002162937,0.63122565,0.00018660753],"about_ca_topic_score_codex":0.000008816067,"about_ca_topic_score_gemma":0.000039774124,"teacher_disagreement_score":0.61852276,"about_ca_system_score_codex":0.00002301895,"about_ca_system_score_gemma":0.00012546762,"threshold_uncertainty_score":0.26803765},"labels":[],"label_agreement":null},{"id":"W2588866514","doi":"10.1093/neuonc/now212.238","title":"EPID-12. DEMOGRAPHICS AND LIFESTYLE FACTORS IN GLIOMA RISK: A REPORT FROM THE GLIOMA INTERNATIONAL CASE-CONTROL STUDY","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Science, Research, and Medicine","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Glioma; Demography; Medicine; Overweight; Underweight; Family history; Body mass index; Ethnic group; Internal medicine; Oncology; Gerontology","score_opus":0.0337535961370827,"score_gpt":0.3500503436558549,"score_spread":0.31629674751877224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588866514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863035,0.00013834736,0.0001001286,0.0109091615,0.0009655711,0.0008800726,0.00004392447,0.00004045554,0.0006188512],"genre_scores_gemma":[0.9981543,0.00012537996,0.00003781026,0.0010444942,0.00051633717,0.000054850763,0.0000036970218,0.000017002068,0.000046133602],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99747247,0.0005461206,0.0004847,0.00055037095,0.0005519034,0.00039442777],"domain_scores_gemma":[0.9943533,0.004540544,0.00020330743,0.00045671768,0.00014619825,0.00029994245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017565637,0.00017285101,0.00042674426,0.00038793712,0.00012856165,0.000016808728,0.00024182082,0.00014145362,0.00014944818],"category_scores_gemma":[0.0073474315,0.0000868894,0.000070128925,0.00041368447,0.0005100662,0.000098685596,0.00012595422,0.00044832256,0.000008728166],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003825917,0.00036211486,0.88502616,0.0000021274002,0.00007382677,0.055490263,0.0013717059,2.2710955e-7,0.03840497,0.000008955564,0.00092928024,0.017947754],"study_design_scores_gemma":[0.009340213,0.0020639559,0.9562568,0.000028153732,0.00013373562,0.014415896,0.0024845665,0.00008444291,0.000763815,0.00009445732,0.014231392,0.00010254815],"about_ca_topic_score_codex":0.0017327177,"about_ca_topic_score_gemma":0.0040639285,"teacher_disagreement_score":0.07123064,"about_ca_system_score_codex":0.00011095661,"about_ca_system_score_gemma":0.00031736548,"threshold_uncertainty_score":0.8796093},"labels":[],"label_agreement":null},{"id":"W2588903294","doi":"10.1093/neuonc/now212.342","title":"GENT-36. THE GENOMIC LANDSCAPE OF SCHWANNOMA","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Schwannoma; Biology; Cancer research; Fusion gene; Exome; Schwann cell; MAPK/ERK pathway; Gene; Exome sequencing; Genetics; Medicine; Pathology; Mutation; Signal transduction; Cell biology","score_opus":0.02429780488512628,"score_gpt":0.27985683982979426,"score_spread":0.255559034944668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588903294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9768024,0.0003058561,0.000021425187,0.011538742,0.0005127145,0.00032249905,0.000021410346,0.000055246615,0.010419687],"genre_scores_gemma":[0.9971525,0.000121368495,0.000144809,0.001999675,0.00028039454,0.000024778587,0.0000028525142,0.00003148744,0.00024213256],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99864936,0.00017425067,0.00038733974,0.00030071125,0.00018614826,0.00030221764],"domain_scores_gemma":[0.9983955,0.00068426586,0.00018089631,0.0005272623,0.000081494065,0.00013054976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001917943,0.0001539618,0.0004154388,0.0000979345,0.0000724185,0.0000072141243,0.00020381817,0.000115443974,0.0005341912],"category_scores_gemma":[0.0002443528,0.00007755621,0.00015653919,0.00013817723,0.00022332063,0.00004739713,0.00011962543,0.00016072967,0.00021899007],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044059491,0.0001307069,0.017496042,0.000020929549,0.000032550975,0.0003978621,0.000072895826,4.2363305e-7,0.9473808,0.0006096254,0.018195262,0.015222349],"study_design_scores_gemma":[0.00401246,0.0037926107,0.09627452,0.00004826858,0.00016236212,0.0035089457,0.00012360478,0.000027974264,0.21749143,0.00015828678,0.6742184,0.00018110912],"about_ca_topic_score_codex":0.000007638266,"about_ca_topic_score_gemma":0.000004064599,"teacher_disagreement_score":0.72988933,"about_ca_system_score_codex":0.000046105342,"about_ca_system_score_gemma":0.00025323822,"threshold_uncertainty_score":0.5849019},"labels":[],"label_agreement":null},{"id":"W2588927945","doi":"10.1093/neuonc/now212.891","title":"TMOD-21. DEFINING THE GROWTH FACTOR NICHE THAT SUPPORTS GBM INITIATION","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Platelet-derived growth factor receptor; Biology; Growth factor; Platelet-derived growth factor; Cancer research; Cell biology; Subventricular zone; Stem cell; Immunology; Genetics; Receptor; Neural stem cell","score_opus":0.01857176280874703,"score_gpt":0.27030945880536417,"score_spread":0.25173769599661716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588927945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9749447,0.002551601,0.0011775311,0.005868621,0.005736868,0.00042566666,0.000107713386,0.000058815218,0.00912845],"genre_scores_gemma":[0.9906545,0.0028085131,0.0001068129,0.004405815,0.0015816721,0.00006457284,0.000043909156,0.000037837843,0.00029635048],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99855745,0.00022936425,0.00023161869,0.00043763756,0.00015226369,0.00039168354],"domain_scores_gemma":[0.99904263,0.00017194664,0.00017845049,0.00040555195,0.000093432995,0.000108000546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020490299,0.00019414289,0.00022352111,0.000043728636,0.00012597848,0.000019599214,0.00027094924,0.00028029704,0.00014158965],"category_scores_gemma":[0.00038097426,0.00012139848,0.00012846531,0.000073229974,0.00014855144,0.000010602534,0.00016120274,0.00015429496,0.000065642416],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009900184,0.000042513813,0.004228474,0.0000056260815,0.000027503764,0.0000068499435,0.00012352692,8.318374e-7,0.9268009,0.00053759274,0.02034653,0.04778064],"study_design_scores_gemma":[0.0007813108,0.00030283953,0.006489826,0.0000039186907,0.00002992473,0.00008563554,0.000037558908,0.0000016783346,0.2688451,0.00018261852,0.7230942,0.00014532304],"about_ca_topic_score_codex":0.000019675928,"about_ca_topic_score_gemma":0.000073107345,"teacher_disagreement_score":0.7027477,"about_ca_system_score_codex":0.000038300353,"about_ca_system_score_gemma":0.00030053713,"threshold_uncertainty_score":0.49504864},"labels":[],"label_agreement":null},{"id":"W2588933643","doi":"10.1093/neuonc/now212.475","title":"MPTH-38. TRANSFORMING GROWTH FACTOR-BETA GENE EXPRESSION AS A NEW PROGNOSTIC BIOMARKER FOR GLIOBLASTOMA","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Gene isoform; Biomarker; Downregulation and upregulation; Hazard ratio; Glioblastoma; Phenotype; Proportional hazards model; Medicine; Transforming growth factor; Oncology; Transforming growth factor beta; Cancer research; Internal medicine; Immunohistochemistry; Multivariate analysis; Pathology; Biology; Gene","score_opus":0.019241696195346155,"score_gpt":0.28651515028716795,"score_spread":0.2672734540918218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588933643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9797741,0.00056298665,0.016419705,0.0011196778,0.0005577789,0.0008883229,0.00008819074,0.00008836569,0.0005008687],"genre_scores_gemma":[0.99648905,0.00008475514,0.0015750758,0.0007270225,0.0005598493,0.00019458267,0.0000438195,0.00008185506,0.0002439626],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99806523,0.00013419564,0.000371348,0.0007161966,0.0001688784,0.00054415653],"domain_scores_gemma":[0.9986421,0.00030525742,0.00015561414,0.00038473794,0.00012080028,0.0003915106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000106767206,0.00030271773,0.00029306023,0.00009483222,0.00012798009,0.000021404949,0.00037045783,0.00037365317,0.00012540606],"category_scores_gemma":[0.00088792073,0.00022773378,0.0002108663,0.00008741793,0.0001254557,0.000013428906,0.000118012926,0.00008295636,0.000047741065],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010775346,0.0001482273,0.0014312762,0.000032508084,0.000048350408,0.000028933924,0.00006698902,0.0000013936154,0.9564228,0.000026096346,0.005187835,0.03552805],"study_design_scores_gemma":[0.0019268377,0.0018041212,0.00037459788,0.000033986264,0.000040588646,0.00007054603,0.00001209445,0.0000043511345,0.7918491,0.00011719926,0.20352325,0.00024337687],"about_ca_topic_score_codex":0.0000060031443,"about_ca_topic_score_gemma":0.000013400738,"teacher_disagreement_score":0.19833541,"about_ca_system_score_codex":0.000049880528,"about_ca_system_score_gemma":0.0006844836,"threshold_uncertainty_score":0.92867136},"labels":[],"label_agreement":null},{"id":"W2588958064","doi":"10.1093/neuonc/now212.074","title":"ATIM-09. SUCCESSFUL EXPERIENCE WITH CLINICAL TRIALS FOR HIGH GRADE GLIOMA IN A COMMUNITY SETTING","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Clinical trial; Medicine; Internal medicine; Cancer; Clinical research; Oncology","score_opus":0.13797656034456424,"score_gpt":0.441641530545952,"score_spread":0.3036649702013878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588958064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842644,0.000054611948,0.00011468071,0.013564406,0.00042329606,0.0013120471,0.000026687181,0.000054244956,0.00018564033],"genre_scores_gemma":[0.99632317,0.00005332983,0.0011415645,0.0014377936,0.0002199877,0.0007755959,0.00001245285,0.00002836896,0.000007734145],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99611443,0.0020382516,0.0009336808,0.0003565425,0.00016877938,0.0003883332],"domain_scores_gemma":[0.9858366,0.013011647,0.00037802182,0.00048188315,0.00009731195,0.00019452842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023713831,0.00019812536,0.0010529305,0.00014670898,0.00012432884,0.000012544403,0.00017960677,0.00020956647,0.000068327376],"category_scores_gemma":[0.004951958,0.000110585555,0.00015139287,0.00021186491,0.00024782703,0.00008187986,0.00008545811,0.0003024156,0.000015003177],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029204544,0.0044893255,0.65277267,0.000053805645,0.00013468732,0.0011913137,0.0013256714,0.0000013657975,0.2072407,0.00057099067,0.0026134094,0.12668563],"study_design_scores_gemma":[0.11028294,0.032978628,0.47116938,0.0006409892,0.00071424124,0.0009507195,0.002197944,0.00009343908,0.31548855,0.0012904925,0.06353311,0.0006595781],"about_ca_topic_score_codex":0.00018718006,"about_ca_topic_score_gemma":0.00044563215,"teacher_disagreement_score":0.18160327,"about_ca_system_score_codex":0.0001723602,"about_ca_system_score_gemma":0.00021677873,"threshold_uncertainty_score":0.59283143},"labels":[],"label_agreement":null},{"id":"W2588967704","doi":"10.1093/neuonc/now212.430","title":"MNGO-09. PROGNOSTIC SIGNIFICANCE OF PRE-OPERATIVE ANEMIA AND LEUKOCYTOSIS ON RECURRENCE-FREE SURVIVAL IN MENINGIOMA","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Nanowire Synthesis and Applications","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Leukocytosis; Neutrophilia; Medicine; Anemia; Monocytosis; Gastroenterology; Meningioma; Internal medicine; Univariate analysis; Surgery; Pathology; Multivariate analysis","score_opus":0.019076731040216052,"score_gpt":0.2676742650152167,"score_spread":0.24859753397500062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588967704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921059,0.00010496667,0.0004319485,0.0008096354,0.00017980847,0.0004627809,0.000042884494,0.0000721042,0.005789957],"genre_scores_gemma":[0.9990297,0.00017906772,0.00044443566,0.000023460378,0.000048482372,0.00023652335,0.00000115378,0.000018273837,0.000018929215],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99906075,0.00010788185,0.00026774642,0.00025445718,0.00009923951,0.00020991814],"domain_scores_gemma":[0.99825674,0.0013411717,0.00005558836,0.00025699937,0.00003034875,0.00005917719],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014646386,0.00013707914,0.00027547491,0.0000905337,0.000029005703,0.000006550003,0.00018350748,0.00010222182,0.000027324197],"category_scores_gemma":[0.0003159337,0.000105729116,0.000027492042,0.00017725225,0.0001065881,0.00005752673,0.000043668268,0.00011873278,0.000012373864],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049715243,0.000081874394,0.0047062943,0.000031549338,0.000010253149,0.000009910727,0.0003350074,0.00014644714,0.8985416,0.0017543455,0.00064129493,0.093691684],"study_design_scores_gemma":[0.0019395319,0.0012863446,0.049147427,0.0001899006,0.000038574468,0.000020486481,0.000101642,0.00088944496,0.9095994,0.000985303,0.035358865,0.00044303553],"about_ca_topic_score_codex":0.000015676305,"about_ca_topic_score_gemma":0.0000847039,"teacher_disagreement_score":0.09324865,"about_ca_system_score_codex":0.0000918158,"about_ca_system_score_gemma":0.00005430051,"threshold_uncertainty_score":0.43115082},"labels":[],"label_agreement":null},{"id":"W2589012814","doi":"10.1093/neuonc/now188.231","title":"P10.07 Sialate O-acetylesterase (SIAE) 
over-expression leads to a collapse of the mitochondrial membrane potential and predisposes cells to etoposide treatment in RES256 medulloblastoma cells","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Mitochondrial Function and Pathology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"","keywords":"Etoposide; Medulloblastoma; Cell biology; Medicine; Chemistry; Biology; Cancer research; Molecular biology; Internal medicine; Chemotherapy","score_opus":0.007553555770482347,"score_gpt":0.2497022079037211,"score_spread":0.24214865213323877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589012814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99318403,0.000035033383,0.0003673219,0.0018290823,0.0030441154,0.0011521156,0.000114813505,0.000014065196,0.00025941222],"genre_scores_gemma":[0.99476737,0.0001922113,0.0012075477,0.0017149275,0.00073597586,0.00015848537,0.000011254653,0.00004272995,0.0011695242],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99769545,0.0005562165,0.00047182175,0.00070261856,0.00017135104,0.0004025271],"domain_scores_gemma":[0.99884266,0.00015138024,0.00013414734,0.00055204483,0.000071996554,0.00024776248],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011983235,0.00028719936,0.0004266485,0.00012033717,0.000078857265,0.000014773157,0.00026018315,0.00038158125,0.0001121407],"category_scores_gemma":[0.0001938368,0.00018503875,0.00013525531,0.00015634474,0.00014540482,0.000008358918,0.00031754293,0.00010604229,0.000029464984],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003944158,0.00022845311,0.0004419173,0.0000116222345,0.00001588766,0.000053078107,0.00026098857,0.00022322434,0.9880114,0.000007914028,0.0052071833,0.0015941347],"study_design_scores_gemma":[0.0031979722,0.0038006522,0.0004624636,0.00003235146,0.000031456406,0.000050590093,0.000028616001,0.0000046565365,0.8705855,0.0000071680606,0.12163004,0.00016854561],"about_ca_topic_score_codex":0.000048396912,"about_ca_topic_score_gemma":0.0006275823,"teacher_disagreement_score":0.117425956,"about_ca_system_score_codex":0.00008392863,"about_ca_system_score_gemma":0.00023882095,"threshold_uncertainty_score":0.75456613},"labels":[],"label_agreement":null},{"id":"W2589019650","doi":"10.1093/neuonc/now212.685","title":"RARE-22. MEDULLOBLASTOMA IN A CHILD WITH NEUROFIBROMATOSIS-1: CASE REPORT AND REVIEW","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Vascular Malformations and Hemangiomas","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; BC Children's Hospital; CancerCare Manitoba","funders":"","keywords":"Medulloblastoma; Medicine; Neurofibromatosis; Fourth ventricle; Plexiform neurofibroma; Pathology; Ataxia; Surgery; Neurofibroma","score_opus":0.012669445286428804,"score_gpt":0.27596568427584095,"score_spread":0.2632962389894121,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589019650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9611239,0.003200602,0.000072807976,0.02498635,0.00010048839,0.00087822083,0.000004290188,0.00008082363,0.009552506],"genre_scores_gemma":[0.9903494,0.0035653992,0.0007370096,0.0049757427,0.000088580266,0.00012791186,0.000007922819,0.000038975424,0.00010905116],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99872667,0.00011161479,0.00042318838,0.0003272524,0.00015586455,0.0002553856],"domain_scores_gemma":[0.9990454,0.0001327135,0.00015312155,0.00042569105,0.00006818722,0.00017490868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026743318,0.00015887467,0.00049923256,0.00016178346,0.00006356721,0.0000061621454,0.000049855284,0.0000957147,0.00014016354],"category_scores_gemma":[0.00028945284,0.000094863295,0.00007095345,0.00025167761,0.0001053183,0.00012121575,0.00006215146,0.00016392335,0.000035437373],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029623252,0.00035768625,0.016660448,0.0012007871,0.0000748064,0.9185474,0.00022911308,3.1629452e-7,0.0141657265,0.0005378038,0.0088512935,0.03907837],"study_design_scores_gemma":[0.0023662269,0.0011246194,0.0055850404,0.0010706702,0.0001383541,0.8597962,0.000027900069,0.000010243937,0.0007036017,0.000011971572,0.1290509,0.00011422592],"about_ca_topic_score_codex":0.000021424505,"about_ca_topic_score_gemma":0.00008103372,"teacher_disagreement_score":0.1201996,"about_ca_system_score_codex":0.00006757386,"about_ca_system_score_gemma":0.00015691931,"threshold_uncertainty_score":0.3868413},"labels":[],"label_agreement":null},{"id":"W2589058173","doi":"10.1093/neuonc/now212.155","title":"CBIO-17. STAT3 IS A CENTRAL REGULATOR OF PROLIFERATION, INVASION, MIGRATION AND METABOLISM IN GBM TUMOR INITIATING CELLS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Brain Institute; University of Calgary","funders":"","keywords":"STAT3; STAT protein; Cancer research; Biology; Regulator; Signal transduction; Cell growth; Gene signature; Activator (genetics); Gene expression; Cell biology; Gene; Genetics","score_opus":0.020701241956481303,"score_gpt":0.27673655077037157,"score_spread":0.25603530881389025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589058173","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99244714,0.00036011802,0.0001294863,0.005752718,0.0003157596,0.00054353575,0.00004485628,0.000018776214,0.00038759786],"genre_scores_gemma":[0.9943969,0.00057701516,0.0013287273,0.0033276463,0.00020802171,0.000038865743,0.000007827433,0.000020106654,0.000094885676],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99862325,0.0001393725,0.00048875436,0.00030955853,0.00016342038,0.00027562052],"domain_scores_gemma":[0.99911094,0.00019731435,0.00022568993,0.00018945991,0.00013402282,0.00014259222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022936308,0.00013651523,0.00044234123,0.00015527508,0.00003385913,0.0000075578605,0.00004758673,0.0000881596,0.00019056014],"category_scores_gemma":[0.00022797896,0.0000981533,0.000053722255,0.00018060127,0.00009935801,0.00011778166,0.000040560277,0.00012155888,0.000005204384],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030372234,0.00015419144,0.016314369,0.000070403476,0.000018421648,0.000045001365,0.0013816033,0.0000021873627,0.95519173,0.00012943955,0.004964258,0.021424644],"study_design_scores_gemma":[0.004671585,0.00062858564,0.030837893,0.00008678369,0.00011867286,0.000098728495,0.00020236272,0.00008012803,0.8061919,0.00014752183,0.1568029,0.00013289867],"about_ca_topic_score_codex":0.000129095,"about_ca_topic_score_gemma":0.0005004094,"teacher_disagreement_score":0.15183863,"about_ca_system_score_codex":0.00009614149,"about_ca_system_score_gemma":0.0004180147,"threshold_uncertainty_score":0.40025753},"labels":[],"label_agreement":null},{"id":"W2589106972","doi":"10.1093/neuonc/now212.327","title":"GENT-21. ATRX DEFICIENCY PROMOTES INVASION AND ALTERS THE DIFFERENTIATION CAPACITY OF GLIOMA CELLS OF ORIGIN BY DYSREGULATING GENOME-WIDE CHROMATIN ACCESSIBILITY AND MODULATING TRANSCRIPTIONAL PROGRAMS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"ATRX; Biology; Chromatin; Genome instability; Epigenetics; Carcinogenesis; Cell biology; Cancer research; Genetics; Gene; Mutation; DNA damage; DNA","score_opus":0.0231008421553646,"score_gpt":0.2589544808320386,"score_spread":0.235853638676674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589106972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99473214,0.00036152123,0.0042301435,0.00019885706,0.000076987766,0.00033551987,0.000029283437,0.000009142603,0.000026407213],"genre_scores_gemma":[0.9986297,0.000085736894,0.0011467915,0.000036575675,0.000040282623,0.000019766647,0.000023926701,0.000012330368,0.000004929004],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987542,0.00018077834,0.0003915531,0.00035145227,0.00014411221,0.00017792339],"domain_scores_gemma":[0.9992645,0.00010235492,0.00030257134,0.00019844038,0.00008381231,0.000048353122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029303052,0.00013635245,0.00020653434,0.000027048447,0.0000920088,0.000011767891,0.00012138711,0.00011109242,0.000007277847],"category_scores_gemma":[0.00009943773,0.0000878975,0.00005418243,0.000068275534,0.00028096285,0.000012609212,0.000076068914,0.000064575055,1.5301873e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045512963,0.00008675802,0.021817759,0.00010317391,0.000013732385,2.500713e-7,0.0002492101,0.000027065902,0.95971674,0.000014351317,0.000010371081,0.017915094],"study_design_scores_gemma":[0.0009028827,0.0006292796,0.041541226,0.000041966832,0.00003541469,0.000016219394,0.000073426636,0.0027226205,0.95353943,0.0002352416,0.0001367674,0.00012550973],"about_ca_topic_score_codex":0.00003829627,"about_ca_topic_score_gemma":0.000035685596,"teacher_disagreement_score":0.019723468,"about_ca_system_score_codex":0.00002985503,"about_ca_system_score_gemma":0.000063539,"threshold_uncertainty_score":0.3584356},"labels":[],"label_agreement":null},{"id":"W2589107494","doi":"10.1093/neuonc/now188.249","title":"P13.05 Success Rate and Early Morbidity from Image-Guided Ommaya Reservoir Placement for Intraventricular Chemotherapy: Case Series and Systematic Review","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"","keywords":"Ommaya reservoir; Medicine; Chemotherapy; Series (stratigraphy); Surgery; Geology","score_opus":0.028803636539223968,"score_gpt":0.31696499684220786,"score_spread":0.2881613603029839,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589107494","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96138245,0.010588695,0.000053655964,0.02410222,0.00016067192,0.0035549433,0.00007788371,0.000045265362,0.000034209686],"genre_scores_gemma":[0.9723522,0.021547684,0.0007894877,0.0034094627,0.00017438048,0.0015642204,0.000024288403,0.00005774262,0.000080551545],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99828017,0.00032101272,0.0005268336,0.00045147902,0.00013516637,0.0002853419],"domain_scores_gemma":[0.99799,0.0009968431,0.0002516328,0.0003989341,0.0001521542,0.00021040709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045913114,0.00024656055,0.00102628,0.00007160044,0.000104354534,0.000030918323,0.00007089788,0.00011043977,0.000069348374],"category_scores_gemma":[0.00061973854,0.00014695253,0.00009276444,0.000095277086,0.00012438244,0.000121922276,0.00007214155,0.00008237309,0.000008546679],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031900352,0.0028184445,0.042403683,0.20473313,0.0027320879,0.067810394,0.0013552418,0.0000011376372,0.6006895,0.0005654111,0.06753565,0.006165282],"study_design_scores_gemma":[0.12732726,0.036707,0.033760604,0.1165958,0.021555169,0.08083629,0.0010555891,0.00028026945,0.47028306,0.0017815693,0.10697157,0.0028458354],"about_ca_topic_score_codex":0.0001891299,"about_ca_topic_score_gemma":0.00008391266,"teacher_disagreement_score":0.13040644,"about_ca_system_score_codex":0.0001379364,"about_ca_system_score_gemma":0.000069657115,"threshold_uncertainty_score":0.599255},"labels":[],"label_agreement":null},{"id":"W2589110481","doi":"10.1093/neuonc/now212.872","title":"TMOD-02. Developing models of therapy resistance for the identification of treatment-refractory cell population(s) in human glioblastoma","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University","funders":"","keywords":"SOX2; Biology; Transcriptome; Population; Chemoradiotherapy; BMI1; Stem cell; Glioma; Cancer research; Stem cell marker; Temozolomide; Bioinformatics; Oncology; Cancer; Medicine; Gene expression; Gene; Transcription factor; Genetics","score_opus":0.044592507210841896,"score_gpt":0.3296225224710782,"score_spread":0.2850300152602363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589110481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958961,0.00053523184,0.0005353352,0.0017500367,0.000111489106,0.0009540971,0.000022770682,0.000012967297,0.00018198379],"genre_scores_gemma":[0.99873024,0.000514787,0.00022678658,0.00009441365,0.00003755208,0.00030284305,0.0000092548735,0.000018389735,0.00006572852],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989212,0.00008079048,0.0005161271,0.00022743591,0.00010466949,0.00014978471],"domain_scores_gemma":[0.99843603,0.0007481513,0.0003655598,0.0003055041,0.00011611555,0.000028608476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015564353,0.00011648861,0.0003247479,0.00013335631,0.000053942324,0.0000029268992,0.00008313373,0.00008667449,0.000012072429],"category_scores_gemma":[0.00005088096,0.00006508657,0.00009140682,0.0001320916,0.00006325759,0.00006636409,0.000011895288,0.000033675984,0.0000014476827],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005616256,0.00073845667,0.009055325,0.000032091608,0.000049546798,0.0000067862557,0.0003641707,0.00007192004,0.96414155,0.002408461,0.00013440644,0.02243568],"study_design_scores_gemma":[0.00973002,0.002882808,0.063192286,0.0000802914,0.00009987277,0.000004412175,0.00007943972,0.00021991662,0.9116574,0.0026099554,0.009341387,0.000102220554],"about_ca_topic_score_codex":0.00006708982,"about_ca_topic_score_gemma":0.0003339208,"teacher_disagreement_score":0.054136958,"about_ca_system_score_codex":0.0003805637,"about_ca_system_score_gemma":0.00012741401,"threshold_uncertainty_score":0.26541534},"labels":[],"label_agreement":null},{"id":"W2589113031","doi":"10.1093/neuonc/now212.176","title":"CSIG-15. CIC REGULATES NEURAL STEM/PROGENITOR PROLIFERATION AND DIFFERENTIATION","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neurogenesis and neuroplasticity mechanisms","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Progenitor cell; Neural stem cell; Biology; Stem cell; Progenitor; Lineage (genetic); Cell biology; Oligodendrocyte; Cell fate determination; Neural development; Cancer research; Loss function; Regulator; Genetics; Gene; Phenotype; Neuroscience; Transcription factor; Central nervous system; Myelin","score_opus":0.03510211227290744,"score_gpt":0.26822492547476284,"score_spread":0.2331228132018554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589113031","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99474216,0.000024908179,0.00051474967,0.0022338335,0.0015578214,0.0005720374,0.000019311738,0.00021104231,0.00012416538],"genre_scores_gemma":[0.997156,0.00012581096,0.000039651855,0.0021045806,0.00029399153,0.00008323768,0.0000013611841,0.000053216845,0.00014214621],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99725264,0.0007043024,0.00041078634,0.00085780333,0.00031787125,0.0004566219],"domain_scores_gemma":[0.99801034,0.0011869087,0.00022901247,0.0003141152,0.000059893664,0.00019973467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012518142,0.0002808469,0.0003266759,0.0001595131,0.0002685026,0.00007929123,0.0002336376,0.00016009962,0.000076229124],"category_scores_gemma":[0.00050594937,0.00020012427,0.00007484737,0.00019287746,0.00014737225,0.00031748484,0.00017059699,0.00016943373,0.00009845254],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015297465,0.00011447962,0.00089506136,0.000013173722,0.0000029434107,0.000082702165,0.000052995074,0.0000030129447,0.97616047,0.0016313205,0.00018875701,0.020702092],"study_design_scores_gemma":[0.001065246,0.0011268222,0.001612029,0.000008726579,0.00003066888,0.0004036717,0.000006720865,0.0011998276,0.9890415,0.00021012401,0.005088001,0.00020667451],"about_ca_topic_score_codex":0.0000010687643,"about_ca_topic_score_gemma":0.0000062691706,"teacher_disagreement_score":0.020495418,"about_ca_system_score_codex":0.000057813104,"about_ca_system_score_gemma":0.00006446009,"threshold_uncertainty_score":0.8160831},"labels":[],"label_agreement":null},{"id":"W2590076094","doi":"10.1093/neuonc/now277","title":"A clinical perspective on the 2016 WHO brain tumor classification and routine molecular diagnostics","year":2017,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":148,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Polysomy; Isocitrate dehydrogenase; IDH1; Glioma; Oligodendroglioma; Oncology; Astrocytoma; Medicine; Pathology; Internal medicine; Biology; Bioinformatics; Chromosome; Gene; Mutation; Genetics; Cancer research; Fluorescence in situ hybridization","score_opus":0.13405935324453538,"score_gpt":0.4532913436008192,"score_spread":0.3192319903562838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590076094","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006001282,0.96226704,0.0000052969867,0.027221806,0.00055620755,0.0024596641,0.000058614438,0.000038732298,0.0067925113],"genre_scores_gemma":[0.0011194178,0.99306536,0.000038453298,0.004496383,0.00053528143,0.00056801416,0.000044942062,0.00007048201,0.00006168986],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99691176,0.0010300026,0.00070331414,0.0008101964,0.00022776463,0.00031697928],"domain_scores_gemma":[0.98956,0.008166246,0.0008186228,0.0010647643,0.00016366705,0.0002267054],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006579053,0.00044120674,0.0021291296,0.00014085717,0.00018441254,0.00004622448,0.0002635283,0.00045161208,0.000042935346],"category_scores_gemma":[0.008500226,0.00025075808,0.0005265647,0.000100450416,0.00041486774,0.000022640801,0.00014887036,0.00094364403,0.00017850882],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000642822,0.0012522618,0.00041551434,0.000566816,0.00047850856,0.0027497036,0.0000685129,4.0258072e-8,0.000020144844,0.01417877,0.04741982,0.93278563],"study_design_scores_gemma":[0.0013754325,0.0024161402,0.0010913848,0.0025637788,0.0021266327,0.00041710245,0.000043266456,0.0000101301575,0.0000065848076,0.00014358298,0.9896253,0.00018070692],"about_ca_topic_score_codex":0.000019740408,"about_ca_topic_score_gemma":0.000009135761,"teacher_disagreement_score":0.9422054,"about_ca_system_score_codex":0.00043817345,"about_ca_system_score_gemma":0.0008032279,"threshold_uncertainty_score":0.99999446},"labels":[],"label_agreement":null},{"id":"W2593895879","doi":"10.1093/neuonc/now293.000","title":"PP01. TARGETING MYC/MYCN BY INHIBITION OF CHECKPOINT KINASE 1 (CHK1) SENSITIZES PAEDIATRIC GLIOBLASTOMA (PGBM) CELLS TO TEMOZOLOMIDE","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Synthetic lethality; Cancer research; Kinome; Biology; Gene; ATRX; Downregulation and upregulation; Kinase; Temozolomide; Mutation; Genetics; DNA repair; Glioma","score_opus":0.013021575895404282,"score_gpt":0.27626478331677856,"score_spread":0.2632432074213743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593895879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884358,0.00021259768,0.000017580134,0.007692692,0.0009184048,0.0008225272,0.00006010264,0.00007625512,0.0017640089],"genre_scores_gemma":[0.9965196,0.000176666,0.0009177847,0.0016632576,0.0005116292,0.000087394175,0.000036982125,0.000052152358,0.000034489505],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99781,0.00016477432,0.00062154344,0.00058177934,0.00030758904,0.00051432574],"domain_scores_gemma":[0.99777263,0.00042165382,0.0005431185,0.00066612166,0.00021455369,0.00038192683],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033409693,0.00030889304,0.00077140966,0.0002541928,0.0002560722,0.000035510184,0.00014560031,0.0002525019,0.00013553338],"category_scores_gemma":[0.0008218812,0.00027560032,0.00022453883,0.00017391836,0.0001524115,0.00010061252,0.00023073332,0.00027536254,0.00028764017],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047659292,0.00087558955,0.004686268,0.00006865746,0.00005089923,0.0014492256,0.00020478433,0.000016917787,0.9353398,0.000022598542,0.04792476,0.008883902],"study_design_scores_gemma":[0.0041093566,0.0039295405,0.003989803,0.000056627192,0.00023691551,0.00012436457,0.00013317954,0.0000953414,0.94802225,0.000037786493,0.039060593,0.00020424578],"about_ca_topic_score_codex":0.00016580564,"about_ca_topic_score_gemma":0.00005616918,"teacher_disagreement_score":0.0126824435,"about_ca_system_score_codex":0.00024992359,"about_ca_system_score_gemma":0.00015205503,"threshold_uncertainty_score":0.9999696},"labels":[],"label_agreement":null},{"id":"W2594810701","doi":"10.1093/neuonc/now293.021","title":"PP22. PROGRESSING RADIOTHERAPY-DRUG COMBINATIONS TOWARDS EARLY PHASE CLINICAL TRIALS","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Drug Research and Development","funders":"","keywords":"Context (archaeology); Radiation therapy; Alliance; Clinical trial; Medicine; Drug development; Quality (philosophy); Medical physics; Drug; Pharmacology; Political science; Surgery; Pathology","score_opus":0.0994381586591382,"score_gpt":0.4701017286600177,"score_spread":0.3706635700008795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2594810701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98219407,0.0013546782,0.0010750395,0.0074392366,0.0031544897,0.0006290042,0.00009320848,0.000026093707,0.004034191],"genre_scores_gemma":[0.99155015,0.0022465924,0.0019345214,0.0020088325,0.0019088103,0.00007868252,0.000064477594,0.000044784214,0.00016317588],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978042,0.0005853061,0.0006900569,0.00049775495,0.00011042431,0.00031224062],"domain_scores_gemma":[0.99754065,0.00038887895,0.00065312727,0.0010858517,0.0001379539,0.00019353382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017796461,0.00018613551,0.0005450967,0.000041844636,0.00039023723,0.00017400083,0.00068366504,0.00029566285,0.000038919432],"category_scores_gemma":[0.0055744844,0.00017727594,0.00027743288,0.000030013709,0.00036795417,0.000008404371,0.00029155854,0.00025005688,0.000013887702],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006489402,0.0013387948,0.004470077,0.000010208938,0.00015012035,0.0000845028,0.00012697859,0.0000105660765,0.42473274,0.0006448554,0.04365187,0.52413034],"study_design_scores_gemma":[0.010621,0.0032230038,0.0029096524,0.000010304961,0.000096707125,0.000042270167,0.000020929643,0.0002886381,0.047455534,0.00048529223,0.93456525,0.00028142307],"about_ca_topic_score_codex":0.0000519453,"about_ca_topic_score_gemma":0.00006106597,"teacher_disagreement_score":0.89091337,"about_ca_system_score_codex":0.000048837876,"about_ca_system_score_gemma":0.0006080759,"threshold_uncertainty_score":0.7229103},"labels":[],"label_agreement":null},{"id":"W2598017183","doi":"10.1093/neuonc/nox021","title":"Diffuse intrinsic pontine gliomas—current management and new biologic insights. Is there a glimmer of hope?","year":2017,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":126,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Institut National Du Cancer","keywords":"Neuroscience; Current (fluid); Medicine; Psychology; Engineering; Electrical engineering","score_opus":0.1135008495295115,"score_gpt":0.37857136347351195,"score_spread":0.26507051394400044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2598017183","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0034377459,0.9897182,0.0000016818441,0.00082440116,0.00088617735,0.0022657127,0.000042542393,0.00004427798,0.0027792645],"genre_scores_gemma":[0.001324624,0.99734944,0.00010471052,0.0003262293,0.00033107892,0.0002671936,0.00009115599,0.00007011229,0.00013544307],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972656,0.00025060622,0.0009014358,0.00089966244,0.00024397574,0.00043875445],"domain_scores_gemma":[0.99710536,0.00034104957,0.001020298,0.0011202772,0.00007979386,0.00033323924],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013005684,0.00069369783,0.0033496858,0.00057155645,0.00010212027,0.000031691914,0.00035938996,0.00049027917,0.00015405953],"category_scores_gemma":[0.000110318084,0.00043590818,0.0005824385,0.0002633079,0.00023894598,0.00004482148,0.00054105226,0.00050080556,0.000107679356],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006674354,0.0014057534,0.0002895224,0.005439483,0.0007731757,0.001606709,0.00007694395,8.896256e-9,0.00003656339,0.0003111322,0.00955431,0.98043966],"study_design_scores_gemma":[0.004180115,0.0020232038,0.00083813985,0.0036299236,0.0043491214,0.00038263702,0.000012026128,4.747078e-7,0.000047658872,0.00007040831,0.9841763,0.00028998614],"about_ca_topic_score_codex":0.000040854095,"about_ca_topic_score_gemma":0.000020311436,"teacher_disagreement_score":0.9801497,"about_ca_system_score_codex":0.00019936619,"about_ca_system_score_gemma":0.00033046625,"threshold_uncertainty_score":0.99980927},"labels":[],"label_agreement":null},{"id":"W2604574478","doi":"10.1093/neuonc/nox001","title":"Stereotactic radiosurgery alone for multiple brain metastases? A review of clinical and technical issues","year":2017,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Radiosurgery; Medicine; Quality of life (healthcare); Randomized controlled trial; Radiation therapy; Clinical trial; Adverse effect; Medical physics; Oncology; Intensive care medicine; Internal medicine","score_opus":0.23309846628000067,"score_gpt":0.5094125392764587,"score_spread":0.27631407299645805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604574478","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00000785078,0.9893581,0.000027009803,0.0041207066,0.00069856504,0.005008532,0.00050879415,0.000046466343,0.00022395146],"genre_scores_gemma":[0.000010446839,0.9898346,0.0054789362,0.0026652273,0.00056339445,0.0007605058,0.00045110928,0.0001029373,0.00013284852],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.993976,0.0017619439,0.0025668258,0.00096103334,0.0002847415,0.0004494514],"domain_scores_gemma":[0.9833262,0.012716472,0.002014788,0.0013831429,0.00017511974,0.00038425787],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0040512583,0.0006077947,0.0097391475,0.00020274373,0.000098169796,0.000016618362,0.0002791079,0.0006448262,0.00010337932],"category_scores_gemma":[0.017476533,0.00042234996,0.002006944,0.00013366566,0.00055578555,0.00006136006,0.0002222378,0.00080779224,0.000021240907],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016860389,0.00071168545,0.00007775363,0.096366346,0.0007319306,0.0007194472,0.000002654347,2.2965425e-9,0.000004040815,0.000048255704,0.04401184,0.85715747],"study_design_scores_gemma":[0.0029841787,0.0032435851,0.000035504505,0.035612762,0.01041819,0.0039831395,0.000001759994,0.0000014907185,0.000002864396,0.000013478833,0.94344914,0.0002539042],"about_ca_topic_score_codex":0.000019324401,"about_ca_topic_score_gemma":0.000011803626,"teacher_disagreement_score":0.8994373,"about_ca_system_score_codex":0.000088289846,"about_ca_system_score_gemma":0.0011962889,"threshold_uncertainty_score":0.99982285},"labels":[],"label_agreement":null},{"id":"W2604818452","doi":"10.1093/neuonc/nox030","title":"Point/counterpoint: randomized versus single-arm phase II clinical trials for patients with newly diagnosed glioblastoma","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Counterpoint; Glioblastoma; Medicine; Clinical trial; Randomized controlled trial; Internal medicine; Psychology; Cancer research","score_opus":0.093080814177779,"score_gpt":0.41719902858938845,"score_spread":0.3241182144116095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604818452","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98122174,0.00008019369,0.00012169358,0.0070555094,0.0036765349,0.0060447617,0.00009605452,0.00009049586,0.0016130494],"genre_scores_gemma":[0.99485487,0.00010235806,0.0010863245,0.0017856589,0.0008273985,0.0011587719,0.00008422616,0.00007470734,0.000025695064],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99589115,0.0009979872,0.001474822,0.0007486685,0.00034563977,0.0005417],"domain_scores_gemma":[0.98056155,0.016059507,0.0015364545,0.0009841893,0.00040826932,0.00045003498],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0024339166,0.0004103022,0.0029509827,0.00016587139,0.0004947837,0.00008181711,0.0002808219,0.00032484726,0.0002035703],"category_scores_gemma":[0.026745178,0.0002711865,0.00088276045,0.00006764061,0.0005363178,0.00016412733,0.00015074646,0.00029732662,0.000044975997],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8141676,0.03449484,0.0037327933,0.000032651013,0.0010983519,0.0008071785,0.00017859813,0.0000016637218,0.0017584541,0.00021003844,0.011060218,0.13245763],"study_design_scores_gemma":[0.828968,0.108571805,0.0007443717,0.00007498829,0.0021390114,0.000022296546,0.000028425711,0.00017867195,0.0026024757,0.00007677212,0.056376908,0.0002162955],"about_ca_topic_score_codex":0.000028642255,"about_ca_topic_score_gemma":0.00009982366,"teacher_disagreement_score":0.13224132,"about_ca_system_score_codex":0.00021708041,"about_ca_system_score_gemma":0.0002966289,"threshold_uncertainty_score":0.999974},"labels":[],"label_agreement":null},{"id":"W2605161784","doi":"10.1093/neuonc/nox006","title":"MR-guided radiation therapy: transformative technology and its role in the central nervous system","year":2017,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Advanced MRI Techniques and Applications","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Transformative learning; Magnetic resonance imaging; Radiation therapy; Adaptation (eye); Medical physics; Radiation oncology; Medicine; Central nervous system; Neuroscience; Psychology; Radiology; Pedagogy","score_opus":0.07351655175438969,"score_gpt":0.4049868972735333,"score_spread":0.3314703455191436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2605161784","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011872879,0.9878237,0.00038672297,0.0022793508,0.00011300488,0.0042840983,0.000036883383,0.00018195812,0.0047755465],"genre_scores_gemma":[0.0025146478,0.9950821,0.00027963452,0.0003164592,0.00016140161,0.0015233122,0.000059064372,0.000040158564,0.000023268614],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983754,0.00022167052,0.0005722369,0.00036594507,0.00011534711,0.00034940828],"domain_scores_gemma":[0.9986644,0.00023181849,0.00046859396,0.00051522517,0.000051562773,0.00006844197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002460816,0.00029923164,0.0013255852,0.00034132446,0.0001639662,0.000016254082,0.00035644908,0.00065365713,0.000005247118],"category_scores_gemma":[0.00007210573,0.00019236277,0.00015502806,0.00031546672,0.00012141898,0.00006893927,0.00003879983,0.0008306592,0.000013884102],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013156225,0.000065840926,0.000003693775,0.00095999637,0.000015015657,0.00006302902,0.00025288854,4.8012726e-7,0.000108048655,0.006079085,0.00020651706,0.99223226],"study_design_scores_gemma":[0.00060959044,0.00046340187,0.000017024846,0.0008366813,0.00019987767,0.0017943666,0.00015670461,0.00006235219,0.0000864446,0.0001702778,0.99546444,0.00013880534],"about_ca_topic_score_codex":0.000009070945,"about_ca_topic_score_gemma":0.0000071759237,"teacher_disagreement_score":0.995258,"about_ca_system_score_codex":0.0002925725,"about_ca_system_score_gemma":0.00033660798,"threshold_uncertainty_score":0.7844326},"labels":[],"label_agreement":null},{"id":"W2605166353","doi":"10.1093/neuonc/nox033","title":"The role of angiogenesis in Group 3 medulloblastoma pathogenesis and survival","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; National Institutes of Health; Pediatric Brain Tumor Foundation","keywords":"Vascularity; Angiogenesis; Medulloblastoma; Vascular endothelial growth factor A; Pathogenesis; Neovascularization; Pathology; Medicine; Vascular endothelial growth factor; Cancer research; Oncology; VEGF receptors","score_opus":0.015593175853226776,"score_gpt":0.28333121728378186,"score_spread":0.2677380414305551,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2605166353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932646,0.0016505863,7.826068e-7,0.0025285285,0.00023505354,0.00025524508,0.000006932386,0.000010556232,0.0020477264],"genre_scores_gemma":[0.9988373,0.00081417465,0.00007319674,0.00011813372,0.000065897795,0.00006869077,0.0000019434124,0.000015272375,0.000005393421],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990904,0.00011752678,0.00021692413,0.00022593085,0.00013261702,0.000216623],"domain_scores_gemma":[0.9987614,0.00049429166,0.00015723953,0.00045175877,0.000042598724,0.00009271788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023569618,0.000113819864,0.00034097038,0.000068204354,0.00017779449,0.00001593471,0.00013495868,0.00009913365,0.0000113200795],"category_scores_gemma":[0.000262251,0.00007608516,0.000080213096,0.000053652886,0.00025531976,0.000032778735,0.00011758357,0.0000652639,0.000005176714],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001548861,0.0002782275,0.53285813,0.000006813191,0.000036725094,0.00020824588,0.00007276819,3.8855703e-7,0.32434994,0.0005974077,0.000047958896,0.14138849],"study_design_scores_gemma":[0.0022935546,0.0009984465,0.9035669,0.0000146550665,0.00011001986,0.00008490532,0.00019901998,0.000042546933,0.052491464,0.00020147533,0.039931834,0.000065184475],"about_ca_topic_score_codex":0.00017261297,"about_ca_topic_score_gemma":0.0007857528,"teacher_disagreement_score":0.37070873,"about_ca_system_score_codex":0.00004726206,"about_ca_system_score_gemma":0.00005809482,"threshold_uncertainty_score":0.3102663},"labels":[],"label_agreement":null},{"id":"W2605314376","doi":"10.1093/neuonc/nox055","title":"Advanced radiation therapeutics for the central nervous system","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Central nervous system; Nervous system; Neuroscience; Medicine; Biology","score_opus":0.035752947788498655,"score_gpt":0.33446188871387067,"score_spread":0.29870894092537204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2605314376","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9390029,0.0016838725,0.0004275507,0.047416765,0.004156919,0.0028499775,0.000031882093,0.0001244509,0.0043057064],"genre_scores_gemma":[0.9972433,0.00024648278,0.00017471828,0.0016407468,0.00038287597,0.00026048746,0.000009734023,0.000019250687,0.000022399752],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99928516,0.0000394505,0.00015161588,0.00017971602,0.00009182664,0.00025225084],"domain_scores_gemma":[0.99877566,0.0004493834,0.00017303154,0.0004738231,0.000056961948,0.00007114961],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008420195,0.00010257625,0.00022404136,0.000023514625,0.00037009042,0.000030144218,0.00013551439,0.00008656535,0.000008030838],"category_scores_gemma":[0.000096458614,0.00006306053,0.00010279381,0.000021075242,0.00006129522,0.0000408103,0.000026177971,0.00008476938,0.000015529315],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040993595,0.0003332422,0.018052349,0.00005105874,0.00018487225,0.00014865145,0.000270681,0.00006235126,0.059538424,0.0026355158,0.0019383451,0.91637456],"study_design_scores_gemma":[0.0073380093,0.001925464,0.18454449,0.000024095641,0.00063227606,0.00016725382,0.00023585957,0.0030994136,0.03023261,0.000043242322,0.77165616,0.000101108206],"about_ca_topic_score_codex":0.000021461417,"about_ca_topic_score_gemma":0.000024318426,"teacher_disagreement_score":0.9162735,"about_ca_system_score_codex":0.0001970939,"about_ca_system_score_gemma":0.00009755829,"threshold_uncertainty_score":0.28464738},"labels":[],"label_agreement":null},{"id":"W2607912694","doi":"10.1093/neuonc/nox036.339","title":"P10.21 2-hydroxyglutarate as a biomarker for IDH mutation in low grade gliomas","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Isocitrate dehydrogenase; Glioma; IDH1; Medicine; Biomarker; Internal medicine; Oncology; Metabolite; Cancer research; Pathology; Mutant; Biology; Enzyme; Gene; Genetics","score_opus":0.03857342127761618,"score_gpt":0.35239658617477204,"score_spread":0.3138231648971559,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2607912694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9791327,0.00017908924,0.000020215773,0.0151519375,0.0006901695,0.0012035839,0.00001659912,0.000044840723,0.0035608795],"genre_scores_gemma":[0.9973873,0.000062965846,0.00029531858,0.0014557673,0.00014641539,0.0005105745,0.000047170786,0.00003697959,0.000057505433],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985754,0.000088193476,0.0003342686,0.00044455356,0.00015910059,0.0003984956],"domain_scores_gemma":[0.99861723,0.00037020486,0.00024385177,0.00052375905,0.000077307035,0.00016762843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020480936,0.00020510543,0.00046417146,0.0002534315,0.00018948737,0.000044558852,0.00015661668,0.00021335509,0.000097878175],"category_scores_gemma":[0.0005878591,0.00017688556,0.0001464565,0.000114209135,0.00012878801,0.00011709461,0.00006344372,0.00014175284,0.00015579489],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019500824,0.004794902,0.07086831,0.00019454707,0.00028725326,0.013384862,0.00091144064,0.00004063052,0.7755285,0.0011819847,0.008093996,0.12276353],"study_design_scores_gemma":[0.048443504,0.008847724,0.4440675,0.00023853254,0.00061322167,0.002020348,0.00019442366,0.009282665,0.26819527,0.004114831,0.21335918,0.0006228072],"about_ca_topic_score_codex":0.00018766771,"about_ca_topic_score_gemma":0.000273899,"teacher_disagreement_score":0.5073332,"about_ca_system_score_codex":0.00022036143,"about_ca_system_score_gemma":0.00019841718,"threshold_uncertainty_score":0.72131836},"labels":[],"label_agreement":null},{"id":"W2608349617","doi":"10.1093/neuonc/nox036.114","title":"P02.02 Treatment and Outcomes in Glioblastoma Multiforme: A multi-country chart review study","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Temozolomide; Glioblastoma; Cohort; Censoring (clinical trials); Retrospective cohort study; Demographics; Internal medicine; Pediatrics; Radiation therapy; Demography; Pathology","score_opus":0.041377423338972145,"score_gpt":0.3715245864451838,"score_spread":0.33014716310621167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2608349617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98619473,0.0031050576,3.037863e-7,0.0072610583,0.0003188699,0.0026483508,0.000025352432,0.000042204014,0.00040404563],"genre_scores_gemma":[0.9895894,0.007269993,0.00009736087,0.0021202879,0.000060530663,0.00075610756,0.000006946334,0.000030523755,0.00006883106],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99841505,0.00012288433,0.00042391685,0.00051738333,0.00015677442,0.0003639618],"domain_scores_gemma":[0.9985091,0.0002449111,0.00023149633,0.0007638877,0.000050813705,0.00019976216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019468104,0.00030827735,0.0010714688,0.00013526423,0.00019115531,0.000030952375,0.0001302687,0.00011745511,0.00006755185],"category_scores_gemma":[0.00040850742,0.00021102079,0.000108426415,0.00006878839,0.00010953929,0.00009488183,0.00012180307,0.00016752021,0.0000812644],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001794591,0.009118504,0.9231553,0.00013475229,0.00017219307,0.0028868758,0.00051019323,2.7768982e-7,0.002890473,0.000009513923,0.00046116754,0.060481284],"study_design_scores_gemma":[0.025252087,0.010862162,0.9013674,0.00031764695,0.0005881634,0.00028800618,0.00025057266,0.00006924603,0.0014493259,0.0000032127155,0.059347376,0.00020474661],"about_ca_topic_score_codex":0.00033682972,"about_ca_topic_score_gemma":0.0027829923,"teacher_disagreement_score":0.060276534,"about_ca_system_score_codex":0.00032467782,"about_ca_system_score_gemma":0.00011377315,"threshold_uncertainty_score":0.8605178},"labels":[],"label_agreement":null},{"id":"W2608404108","doi":"10.1093/neuonc/nox036.038","title":"OS06.4 Identification of novel NTRK fusion in glioneuronal tumors and radiographic response following therapy with an NTRK inhibitor","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Exon; Cohort; Trk receptor; Immunohistochemistry; Lesion; Fusion gene; Clinical trial; Oncology; Pathology; Internal medicine; Gene; Biology; Receptor","score_opus":0.026617131222439614,"score_gpt":0.3155662285961126,"score_spread":0.28894909737367297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2608404108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960855,0.00019719385,0.000008964381,0.0028203544,0.00023683376,0.00057394116,0.0000074634913,0.00002107989,0.000048643127],"genre_scores_gemma":[0.99919176,0.00016087761,0.00020964451,0.00026253605,0.000067869296,0.00006883471,0.000010124295,0.000024632249,0.000003694176],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986538,0.00018638682,0.00034347444,0.0003938014,0.00022002672,0.00020246465],"domain_scores_gemma":[0.9987245,0.00029848277,0.00029458984,0.00049910793,0.00005925788,0.00012401388],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046918783,0.0001583111,0.00039554067,0.00035886967,0.00017186563,0.00003186988,0.0001138467,0.00010599377,0.000006810821],"category_scores_gemma":[0.00023618706,0.00012249747,0.000074919815,0.00016684129,0.00017793557,0.00015611803,0.00004244539,0.00016008619,0.0000013396813],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045406837,0.0013376443,0.22722457,0.0000092750015,0.000029638584,0.0005678955,0.00028578597,0.000005098075,0.75955826,0.00004513793,0.00002662185,0.006369403],"study_design_scores_gemma":[0.011794854,0.0052957353,0.8904848,0.000069639274,0.00006507165,0.00021893802,0.00008674934,0.00021025108,0.09086028,0.000023841541,0.00078978535,0.00010006451],"about_ca_topic_score_codex":0.0000834604,"about_ca_topic_score_gemma":0.00009548994,"teacher_disagreement_score":0.66869795,"about_ca_system_score_codex":0.000053669653,"about_ca_system_score_gemma":0.00013437864,"threshold_uncertainty_score":0.4995302},"labels":[],"label_agreement":null},{"id":"W2608465412","doi":"10.1093/neuonc/nox036.246","title":"P08.57 Distinct mechanism-of-action of dianhydrogalactitol (VAL-083) overcomes chemoresistance in glioblastoma","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Delmar (Canada); University of British Columbia","funders":"","keywords":"Temozolomide; Cancer research; DNA repair; Chemotherapy; Bevacizumab; Medicine; Cancer; Glioma; Methyltransferase; DNA damage; Cell cycle; Oncology; Biology; Internal medicine; DNA; Genetics","score_opus":0.028217559550051036,"score_gpt":0.3258876726299398,"score_spread":0.2976701130798888,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2608465412","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922788,0.00008366746,0.000020334133,0.0017519838,0.00059110107,0.00039585988,0.000014521836,0.000023455905,0.0048402343],"genre_scores_gemma":[0.9994082,0.00014929025,0.00013036301,0.00010325322,0.00009185364,0.0000668175,0.000004165786,0.000023447445,0.000022598553],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987429,0.00007116459,0.0003945799,0.0003157258,0.0002218419,0.00025382367],"domain_scores_gemma":[0.9984361,0.00027434554,0.0004981203,0.00060842105,0.000077862256,0.000105137406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013694445,0.0001768547,0.0006522381,0.00018118793,0.000078876656,0.000009700898,0.00016106736,0.00016357735,0.00010559924],"category_scores_gemma":[0.00043679215,0.00015572945,0.00013732075,0.00011093716,0.00015749018,0.00010640613,0.00008374052,0.00017644203,0.000018238026],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013998016,0.00219321,0.17179869,0.00022384222,0.00010130579,0.0011010125,0.00025111248,0.000004935991,0.7916298,0.0019753752,0.00070815854,0.028612748],"study_design_scores_gemma":[0.0045781373,0.001951452,0.19724749,0.00009637823,0.00013424455,0.000087607346,0.000071331524,0.00010717981,0.78794444,0.00036501483,0.007305583,0.000111153975],"about_ca_topic_score_codex":0.00024333398,"about_ca_topic_score_gemma":0.0010628747,"teacher_disagreement_score":0.028501593,"about_ca_system_score_codex":0.00021497918,"about_ca_system_score_gemma":0.00014370192,"threshold_uncertainty_score":0.63504624},"labels":[],"label_agreement":null},{"id":"W2608572471","doi":"10.1093/neuonc/nox036.057","title":"OS08.7 The somatic landscape of Schwannoma","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Schwannoma; Biology; Fusion gene; Cancer research; Somatic cell; Schwann cell; Gene; Exome; MAPK/ERK pathway; Exome sequencing; Genetics; Pathology; Mutation; Cell biology; Medicine; Signal transduction","score_opus":0.03415723211864221,"score_gpt":0.31459880903984044,"score_spread":0.28044157692119825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2608572471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9475879,0.00015288292,0.000005825043,0.010818499,0.0005662462,0.00032939386,0.000008915709,0.000042571653,0.040487763],"genre_scores_gemma":[0.9981019,0.000038290214,0.00021150614,0.0011855043,0.00024169966,0.000024493782,0.0000035131307,0.000025007366,0.00016812379],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99877816,0.00013091958,0.00036107257,0.0002516032,0.00021889196,0.0002593687],"domain_scores_gemma":[0.99783903,0.00046512036,0.00037124995,0.0011224678,0.000088230074,0.000113921604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022921803,0.00014772787,0.00048320353,0.00006913559,0.00031676947,0.00003756002,0.00038619325,0.00011579236,0.00022949514],"category_scores_gemma":[0.0008137839,0.00009300067,0.0001533112,0.000060368915,0.00032227958,0.00008669803,0.00018372884,0.00026864337,0.00010611958],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005028193,0.00051396154,0.10465874,0.00019498433,0.0000934093,0.002014445,0.000401905,0.0000021337396,0.83631444,0.0023641253,0.032315377,0.020623686],"study_design_scores_gemma":[0.0063199797,0.006428253,0.43659317,0.00015210692,0.00045074953,0.0069021326,0.00047424252,0.00071124313,0.19128363,0.00075009477,0.34958875,0.00034564722],"about_ca_topic_score_codex":0.00002152722,"about_ca_topic_score_gemma":0.000009353923,"teacher_disagreement_score":0.6450308,"about_ca_system_score_codex":0.000019038733,"about_ca_system_score_gemma":0.00021569055,"threshold_uncertainty_score":0.37924573},"labels":[],"label_agreement":null},{"id":"W2608950466","doi":"10.1093/neuonc/nox036.336","title":"P10.18 The impact of clinical functional MRI on surgical decision making in low grade glioma - a survey of Canadian neurosurgeons","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Medical Imaging and Analysis","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Neurosurgery; Magnetic resonance imaging; Glioma; Functional magnetic resonance imaging; Medical physics; Radiology","score_opus":0.09249053095513517,"score_gpt":0.3932097951153146,"score_spread":0.30071926416017947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2608950466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961647,0.00002631566,0.000101495396,0.00043344687,0.0008243476,0.00007610603,0.000040390925,0.000017009454,0.0023161909],"genre_scores_gemma":[0.99966985,0.00007825001,0.000030692037,0.000078360164,0.00010717935,0.0000041906055,0.000008050923,0.000018290406,0.000005132023],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980361,0.0004835473,0.00067743356,0.00023501644,0.00024188525,0.0003260093],"domain_scores_gemma":[0.99485755,0.004155346,0.00018475806,0.00051691034,0.00006566432,0.00021979485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015580844,0.00014137528,0.00056062825,0.000439378,0.000097443,0.0000207179,0.00038343802,0.00017778442,0.0002535171],"category_scores_gemma":[0.0033897455,0.00009880171,0.00025505715,0.0004029941,0.00025829632,0.000039395425,0.000054643962,0.00058741105,0.000013982313],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020374153,0.00024151061,0.88520825,0.00001666279,0.000101772865,0.0009796657,0.000054799137,0.035346624,0.001640071,0.000039371032,0.019043155,0.05712439],"study_design_scores_gemma":[0.00074949145,0.00018568223,0.93636465,0.00004352441,0.000017784056,0.000055572506,0.000004049545,0.060567807,0.00010490444,0.000064546395,0.0017580588,0.0000839183],"about_ca_topic_score_codex":0.041629538,"about_ca_topic_score_gemma":0.044534795,"teacher_disagreement_score":0.05704047,"about_ca_system_score_codex":0.00007636179,"about_ca_system_score_gemma":0.00031391036,"threshold_uncertainty_score":0.9729},"labels":[],"label_agreement":null},{"id":"W2610049046","doi":"10.1093/neuonc/nox048","title":"NANO, a practical scale for neurologic assessments in patients with brain tumors?","year":2017,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Scale (ratio); Medicine; Psychology; Cartography; Geography","score_opus":0.03335382686063776,"score_gpt":0.3541556910950491,"score_spread":0.3208018642344113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2610049046","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.32833672,0.00001398239,0.000008835029,0.66607505,0.0007231045,0.0029662019,0.00009617524,0.000050574632,0.0017293305],"genre_scores_gemma":[0.17135109,0.000010232867,0.0014392915,0.82276595,0.0013416206,0.001720413,0.001017961,0.00016390583,0.00018956777],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969382,0.00034296507,0.0004799502,0.0010011805,0.00046090654,0.0007767493],"domain_scores_gemma":[0.996504,0.00172486,0.0005999401,0.00083342486,0.00018225097,0.00015551483],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020312922,0.0005000459,0.0012576896,0.00029988433,0.0001299474,0.00005208814,0.0002407022,0.0010089051,0.000075158445],"category_scores_gemma":[0.00074886245,0.0003656899,0.00018920463,0.00009852668,0.00019187799,0.00010649501,0.0001313286,0.001668711,0.00004938039],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012854848,0.0025433167,0.1866084,0.0001533314,0.00009597,0.012014219,0.000023669993,7.437937e-7,0.0004116842,0.0000067181336,0.7942047,0.002651742],"study_design_scores_gemma":[0.014845814,0.019119576,0.099209264,0.000089842215,0.00043000292,0.00030952075,0.000003906861,0.000020200956,0.0001793725,0.000050858474,0.8654518,0.00028979758],"about_ca_topic_score_codex":0.000028554785,"about_ca_topic_score_gemma":0.000036882768,"teacher_disagreement_score":0.15698564,"about_ca_system_score_codex":0.00036547825,"about_ca_system_score_gemma":0.00067400135,"threshold_uncertainty_score":0.9998795},"labels":[],"label_agreement":null},{"id":"W2610105836","doi":"10.1093/neuonc/nox036.006","title":"OS01.7 MGMT promoter methylation status independently predicts progression-free survival in NRG Oncology/RTOG 9802: a phase III trial of RT vs RT + PCV in high-risk low-grade gliomas","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Oncology; Internal medicine; Medicine; Hazard ratio; Glioma; Progression-free survival; Methylation; Proportional hazards model; Oligodendroglioma; O-6-methylguanine-DNA methyltransferase; Biomarker; Statistical significance; Methyltransferase; Astrocytoma; Overall survival; Confidence interval; Biology; Cancer research; Gene; Genetics","score_opus":0.03174397573926484,"score_gpt":0.359153957720616,"score_spread":0.32740998198135113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2610105836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98753875,0.00020131448,0.000009523542,0.0038469876,0.0023252144,0.004534581,0.00013292645,0.00007094922,0.00133975],"genre_scores_gemma":[0.9974478,0.0003416523,0.0004912755,0.00016816327,0.00047582277,0.0008611573,0.00013161254,0.00006778543,0.000014714977],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99464905,0.0011943362,0.0014028572,0.0009699028,0.00086458557,0.000919276],"domain_scores_gemma":[0.99548113,0.0011038699,0.0013651429,0.0014225796,0.00021678087,0.00041046497],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015522271,0.00048580582,0.0017333104,0.0008262221,0.00018661054,0.00004676389,0.00053456135,0.0008285104,0.000103031954],"category_scores_gemma":[0.0030540002,0.00040329216,0.00023327477,0.0003966479,0.00038808436,0.00030480645,0.00044438586,0.0009818217,0.000021375037],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14306241,0.04104937,0.5198238,0.00019889676,0.00046507185,0.010401409,0.0024302818,0.00003201196,0.09948647,0.00032040718,0.0013297253,0.18140016],"study_design_scores_gemma":[0.61423737,0.037032623,0.27913854,0.00030920363,0.00065486715,0.00012527527,0.00018219871,0.00044812344,0.057871282,0.0011223067,0.008440309,0.00043793442],"about_ca_topic_score_codex":0.0016448719,"about_ca_topic_score_gemma":0.0047174837,"teacher_disagreement_score":0.47117493,"about_ca_system_score_codex":0.0008686603,"about_ca_system_score_gemma":0.0011781575,"threshold_uncertainty_score":0.99984187},"labels":[],"label_agreement":null},{"id":"W2610149674","doi":"10.1093/neuonc/nox036.054","title":"OS08.4 NF2 Disruption by Genomic Rearrangements Drives A Subset of Radiation Induced Meningiomas","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Biology; Exon; Intron; Genetics; Exome sequencing; Neurofibromatosis type 2; Cancer research; Population; Monosomy; Chromosome; Gene; Neurofibromatosis; Medicine; Mutation; Karyotype","score_opus":0.03930666789610876,"score_gpt":0.3311242513452401,"score_spread":0.29181758344913133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2610149674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98443604,0.00009225197,0.00010287305,0.0021955003,0.00063762855,0.000633822,0.000012297444,0.000044340635,0.011845261],"genre_scores_gemma":[0.99881196,0.000040222676,0.00032521388,0.0001812633,0.00016833354,0.000052420688,0.00008555487,0.000028036748,0.0003069912],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985349,0.0001370183,0.0004120498,0.0003707597,0.00025512846,0.00029010169],"domain_scores_gemma":[0.9985513,0.000073538715,0.0005269979,0.00065192446,0.000059003785,0.00013725187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003355989,0.00017094234,0.00042873007,0.00017063656,0.00021140807,0.000032356336,0.00024590534,0.00015685837,0.00012431918],"category_scores_gemma":[0.00023311688,0.00016433411,0.000100575395,0.000069855145,0.000102362574,0.00015435865,0.00014709769,0.00017545838,0.00006136455],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032672303,0.00018465889,0.020330252,0.000046019013,0.00009467364,0.00028810935,0.0006032246,0.0000012042963,0.9370808,0.00018356524,0.0072909165,0.03356983],"study_design_scores_gemma":[0.011825994,0.0060899467,0.5447351,0.00008204684,0.0006868959,0.0003745855,0.00038469012,0.0008372133,0.23312293,0.000263864,0.20110272,0.00049404363],"about_ca_topic_score_codex":0.000079186546,"about_ca_topic_score_gemma":0.000007557227,"teacher_disagreement_score":0.7039579,"about_ca_system_score_codex":0.00016180216,"about_ca_system_score_gemma":0.00008092715,"threshold_uncertainty_score":0.6701351},"labels":[],"label_agreement":null},{"id":"W2611536191","doi":"10.1093/neuonc/nox086","title":"Multicenter phase II study of temozolomide and myeloablative chemotherapy with autologous stem cell transplant for newly diagnosed anaplastic oligodendroglioma","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Cancer Institute","keywords":"Temozolomide; Medicine; Oligodendroglioma; Oligodendroglial Tumor; Oncology; Internal medicine; Lomustine; Progression-free survival; ThioTEPA; Chemotherapy; Glioma; Vincristine; Cancer research; Astrocytoma; Cyclophosphamide","score_opus":0.022672943648378085,"score_gpt":0.31053443560305255,"score_spread":0.2878614919546745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2611536191","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99546117,0.0001128471,0.00006365351,0.0011322435,0.00017895311,0.0027155704,0.00007290294,0.00003674935,0.00022590398],"genre_scores_gemma":[0.99871063,0.00009903137,0.00037882972,0.00029016146,0.00005686751,0.00039185534,0.0000112330135,0.000043178974,0.000018196815],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99851745,0.0000898407,0.00037185152,0.00050894707,0.00016496726,0.00034691082],"domain_scores_gemma":[0.9980336,0.0007914189,0.0003970549,0.0004773251,0.000110592555,0.00019000753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010284509,0.0002883622,0.00083321007,0.00014544788,0.0003129665,0.00001994057,0.00015023375,0.00013452263,0.000016934007],"category_scores_gemma":[0.000035710626,0.00020644927,0.00008191566,0.000058280268,0.00020828506,0.000078402,0.00004266536,0.00014361186,0.0000020236557],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05283902,0.058186244,0.18427166,0.00043513638,0.0017451241,0.010382458,0.024215395,0.000056944933,0.4162494,0.00005638951,0.00095540576,0.25060683],"study_design_scores_gemma":[0.27958193,0.29245523,0.12969428,0.00016476653,0.002320217,0.00053534395,0.002781492,0.0022218504,0.2848404,0.000012817842,0.0049093487,0.00048233097],"about_ca_topic_score_codex":0.00008536736,"about_ca_topic_score_gemma":0.0003778405,"teacher_disagreement_score":0.2501245,"about_ca_system_score_codex":0.00007362285,"about_ca_system_score_gemma":0.00010417065,"threshold_uncertainty_score":0.8418757},"labels":[],"label_agreement":null},{"id":"W2611753127","doi":"10.1093/neuonc/nox091","title":"Global incidence of malignant brain and other central nervous system tumors by histology, 2003–2007","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":232,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Centers for Disease Control and Prevention","keywords":"Incidence (geometry); Medicine; Cancer; Epidemiology; Histology; Cancer registry; Demography; Pathology; Internal medicine","score_opus":0.01623004465886374,"score_gpt":0.2964569871739458,"score_spread":0.28022694251508207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2611753127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873519,0.0010872283,0.000015569942,0.00489419,0.0007632826,0.00046513748,0.00008878923,0.000037191763,0.0052966923],"genre_scores_gemma":[0.99775016,0.000036879308,0.0001483627,0.0018751636,0.00009109306,0.00003422772,0.0000055751657,0.000016537075,0.000042022886],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986618,0.00012205257,0.0003228672,0.0003566293,0.00014755873,0.00038910512],"domain_scores_gemma":[0.9987509,0.00012396932,0.00034345326,0.00046934144,0.00008621962,0.00022610485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014865753,0.00017650712,0.000572466,0.00004170244,0.00012813866,0.000013516366,0.00016917067,0.00016947696,0.000047231537],"category_scores_gemma":[0.00036456017,0.0001419484,0.00005845469,0.00006405542,0.00037463073,0.000043001724,0.000106823325,0.00009911914,0.000016729255],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029561165,0.0005886026,0.8369298,0.00012110709,0.00009311251,0.003550101,0.0001367959,0.0000025004392,0.04998259,0.0027384614,0.09197858,0.013582763],"study_design_scores_gemma":[0.005916549,0.0031153606,0.72996765,0.00019502292,0.0003093685,0.004597929,0.00020184125,0.00020741369,0.009066711,0.000040119838,0.2461474,0.00023461942],"about_ca_topic_score_codex":0.0012326015,"about_ca_topic_score_gemma":0.0002444396,"teacher_disagreement_score":0.1541688,"about_ca_system_score_codex":0.0003462182,"about_ca_system_score_gemma":0.00023616811,"threshold_uncertainty_score":0.5788488},"labels":[],"label_agreement":null},{"id":"W2613777097","doi":"10.1093/neuonc/now256","title":"MRI features predict survival and molecular markers in diffuse lower-grade gliomas","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":357,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"IDH1; Isocitrate dehydrogenase; Proportional hazards model; Medicine; Logistic regression; Glioma; Magnetic resonance imaging; Pathology; Receiver operating characteristic; Progression-free survival; Histology; Survival analysis; Multivariate analysis; Oncology; Nuclear medicine; Internal medicine; Overall survival; Radiology; Biology; Mutation; Cancer research","score_opus":0.011334952769764674,"score_gpt":0.27173107873712293,"score_spread":0.2603961259673583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2613777097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97552717,0.0007833686,0.000011469638,0.01998216,0.0005181697,0.00048189552,0.000016002607,0.000057129946,0.0026226537],"genre_scores_gemma":[0.9979989,0.00060035544,0.00011857754,0.0010335563,0.00009159031,0.000085133885,0.0000060785605,0.000032628046,0.00003318329],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985375,0.00019467858,0.0002363551,0.0004479093,0.0002070936,0.00037650717],"domain_scores_gemma":[0.9987906,0.0005567789,0.000070201866,0.0003166251,0.000031842803,0.00023394935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001412521,0.00021045198,0.00044134806,0.00021829318,0.000033174325,0.000010738547,0.000082582315,0.00020050362,0.000060513346],"category_scores_gemma":[0.00023400795,0.00013637428,0.00008731989,0.00018125922,0.00015880655,0.000046879482,0.00008573881,0.00016595787,0.000019715273],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010095525,0.0026981225,0.19870411,0.00003499611,0.00014582317,0.013965548,0.000104709616,0.0000011439884,0.7401727,0.00068815163,0.007969485,0.03450568],"study_design_scores_gemma":[0.041355297,0.006676187,0.6902253,0.0001766217,0.00035575288,0.0011734013,0.00012360152,0.000027433096,0.10040111,0.00039215334,0.15869631,0.00039683122],"about_ca_topic_score_codex":0.000051032486,"about_ca_topic_score_gemma":0.00012526049,"teacher_disagreement_score":0.6397716,"about_ca_system_score_codex":0.00015914573,"about_ca_system_score_gemma":0.000091309375,"threshold_uncertainty_score":0.55611813},"labels":[],"label_agreement":null},{"id":"W2614088513","doi":"10.1093/neuonc/nox093","title":"Preclinical drug screen reveals topotecan, actinomycin D, and volasertib as potential new therapeutic candidates for ETMR brain tumor patients","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Topotecan; Medicine; Panobinostat; Decitabine; Pharmacology; Paclitaxel; Vincristine; Combination therapy; Cancer research; PLK1; In vivo; Oncology; Internal medicine; Chemotherapy; Cancer; Cell cycle; Biology; Histone deacetylase; Cyclophosphamide; DNA methylation","score_opus":0.031539553965986115,"score_gpt":0.3513405280390305,"score_spread":0.31980097407304436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2614088513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9645795,0.00023614857,0.000016749345,0.032490406,0.0005263992,0.0014829037,0.000045050998,0.000039345843,0.0005834971],"genre_scores_gemma":[0.99163914,0.0000565901,0.0003731334,0.0070500774,0.0003784443,0.00011235584,0.000050876733,0.000040234187,0.00029914067],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983959,0.0001136977,0.0003876658,0.0005278426,0.00017751714,0.0003973457],"domain_scores_gemma":[0.99793625,0.0007087591,0.00033209575,0.0005348215,0.00010572481,0.00038235728],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021350817,0.0002327877,0.00056564744,0.000074529664,0.00031633824,0.000069242284,0.00019508637,0.00015335887,0.0000879156],"category_scores_gemma":[0.0011091908,0.00018903048,0.00014676493,0.000031932832,0.00014850532,0.000109723704,0.00013561195,0.00022652432,0.000036557358],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004672816,0.0026996878,0.606319,0.00011329093,0.00047443967,0.0007569975,0.00044116456,0.000004040206,0.09049336,0.00038497857,0.042904936,0.25073525],"study_design_scores_gemma":[0.03987273,0.011364352,0.7273656,0.00014825328,0.0010257453,0.00029501301,0.000072916184,0.00013805664,0.04971387,0.0028744736,0.166681,0.00044800504],"about_ca_topic_score_codex":0.0007996823,"about_ca_topic_score_gemma":0.00034403664,"teacher_disagreement_score":0.25028726,"about_ca_system_score_codex":0.00011892301,"about_ca_system_score_gemma":0.00042226783,"threshold_uncertainty_score":0.770844},"labels":[],"label_agreement":null},{"id":"W2614125124","doi":"10.1093/neuonc/nox061","title":"NF-κB upregulation through epigenetic silencing of LDOC1 drives tumor biology and specific immunophenotype in Group A ependymoma","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; University of Colorado Denver; Hospital for Sick Children; University of California, San Francisco; St. Jude Children's Research Hospital","keywords":"Gene knockdown; Biology; Downregulation and upregulation; Cancer research; Gene silencing; Tumor necrosis factor alpha; NF-κB; Transcription factor; IκBα; Molecular biology; NFKB1; Cell culture; Signal transduction; Cell biology; Immunology; Gene","score_opus":0.02919074406659024,"score_gpt":0.31895571694718333,"score_spread":0.2897649728805931,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2614125124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944392,0.0019072469,0.000031655527,0.0010520614,0.00040755686,0.00047846473,0.000006463338,0.000017057571,0.0016603313],"genre_scores_gemma":[0.99795187,0.00053980236,0.0011460345,0.00016538847,0.00010625545,0.000051631614,0.00001432414,0.000020441208,0.0000042600795],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99873006,0.00013196142,0.0003844629,0.0003883009,0.000088919405,0.0002762777],"domain_scores_gemma":[0.9987264,0.00034415058,0.00030975303,0.00050447864,0.000050100825,0.00006506665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013454135,0.00017061412,0.0005484429,0.00011878644,0.000123189,0.000014311756,0.00012979803,0.00013441005,0.00007926149],"category_scores_gemma":[0.0001888132,0.00014661723,0.000063591484,0.0000707379,0.00030461507,0.00008637728,0.000126648,0.00015216037,0.0000138054575],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002168095,0.00045076446,0.19815692,0.00003307367,0.00003748486,0.0004932345,0.00065173383,0.0000067653505,0.7702912,0.002427638,0.000050051232,0.02718433],"study_design_scores_gemma":[0.0045120306,0.0024620518,0.8670603,0.000075419,0.00007810625,0.00026279196,0.00016912457,0.000101067184,0.1189551,0.002287261,0.0039101285,0.00012660748],"about_ca_topic_score_codex":0.00027200254,"about_ca_topic_score_gemma":0.0001675813,"teacher_disagreement_score":0.6689034,"about_ca_system_score_codex":0.00010303032,"about_ca_system_score_gemma":0.000067116445,"threshold_uncertainty_score":0.5978877},"labels":[],"label_agreement":null},{"id":"W2614784821","doi":"10.1093/neuonc/nox059","title":"Can telomerase activity be unleashed to refine prognosis within ependymoma subgroups?","year":2017,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Ependymoma; Telomerase; Medicine; Neuroscience; Oncology; Internal medicine; Biology; Pathology; Genetics","score_opus":0.048250475224516,"score_gpt":0.3210736453711343,"score_spread":0.27282317014661833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2614784821","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.26707307,0.00009151727,0.000008476919,0.72213274,0.0033095588,0.002182298,0.00029803443,0.00039321126,0.0045110723],"genre_scores_gemma":[0.21956973,0.00012274423,0.00089370407,0.76482725,0.00802313,0.0006500397,0.0006068328,0.000378723,0.0049278485],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9929878,0.00074521947,0.0010429001,0.002297581,0.0011993925,0.0017270882],"domain_scores_gemma":[0.99392116,0.0009520576,0.0011050595,0.0026646995,0.0004466034,0.00091044756],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0006153092,0.0012686196,0.0027970742,0.0008827402,0.00053152326,0.00013782848,0.0012159182,0.0025930866,0.0006278216],"category_scores_gemma":[0.0021871822,0.0011631594,0.0005078474,0.0005035461,0.0006058865,0.00019070589,0.0005060318,0.0058002374,0.0003822172],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011602623,0.00056894036,0.0040395027,0.00054166844,0.00024145994,0.05337773,0.0006162949,0.0000010210656,0.063027956,0.000018247112,0.84762746,0.02877946],"study_design_scores_gemma":[0.0026916335,0.0037103745,0.007661723,0.00024141399,0.0006009213,0.004296166,0.000037768386,0.000023944342,0.021758,0.00002652181,0.9579106,0.0010409382],"about_ca_topic_score_codex":0.001808397,"about_ca_topic_score_gemma":0.002025493,"teacher_disagreement_score":0.11028314,"about_ca_system_score_codex":0.0009655318,"about_ca_system_score_gemma":0.0021114748,"threshold_uncertainty_score":0.99908185},"labels":[],"label_agreement":null},{"id":"W2615266562","doi":"10.1093/neuonc/nox053","title":"Citation classics in neuro-oncology: assessment of historical trends and scientific progress","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"scientometrics and bibliometrics research","field":"Decision Sciences","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto; University Health Network; Sunnybrook Health Science Centre","funders":"","keywords":"Citation; Medicine; Oncology; Radiation therapy; Clinical trial; Citation analysis; MEDLINE; Internal medicine; Library science; Computer science; Political science","score_opus":0.4991945846804617,"score_gpt":0.58779065215596,"score_spread":0.08859606747549836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2615266562","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9549634,0.0005693853,0.0004224486,0.017210925,0.0053565027,0.0003915476,0.000023221732,0.00002512559,0.021037435],"genre_scores_gemma":[0.9968285,0.00012430408,0.0020936022,0.00013934076,0.00009646772,0.000040435072,0.0000039472507,0.000014345828,0.0006590426],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99172693,0.0009514581,0.001121116,0.0012252671,0.0042826016,0.0006926067],"domain_scores_gemma":[0.9884263,0.0071696173,0.0011196786,0.0012501978,0.001611764,0.0004224417],"candidate_categories":["metaresearch","bibliometrics","scholarly_communication"],"consensus_categories":["bibliometrics"],"category_scores_codex":[0.016850647,0.00019380555,0.0007165135,0.035377312,0.00063921505,0.0015419619,0.002493807,0.0003322177,0.00010278773],"category_scores_gemma":[0.027149508,0.00015259995,0.0001256901,0.036332518,0.0013833124,0.00071889436,0.0013052735,0.00067269447,0.000020743868],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056204193,0.00050945836,0.29938358,0.0000060596813,0.0000050907292,0.00010578696,0.00020880812,0.000009192051,0.01939146,0.0013281165,0.02043296,0.6585633],"study_design_scores_gemma":[0.0013328519,0.0017727611,0.48640075,0.000003872222,0.00000993553,0.000027978822,0.00008676101,0.008626755,0.0003313807,0.00183579,0.49943537,0.00013579537],"about_ca_topic_score_codex":0.000058186848,"about_ca_topic_score_gemma":0.00022743683,"teacher_disagreement_score":0.6584275,"about_ca_system_score_codex":0.0010846553,"about_ca_system_score_gemma":0.0011083011,"threshold_uncertainty_score":0.99949455},"labels":[],"label_agreement":null},{"id":"W2615747491","doi":"10.1093/neuonc/nox089","title":"Prognostic significance of preoperative neutrophilia on recurrence-free survival in meningioma","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Canadian Institutes of Health Research; Brain Tumour Charity","keywords":"Neutrophilia; Medicine; Meningioma; Leukocytosis; Internal medicine; Proportional hazards model; Univariate analysis; Surgical oncology; Anemia; Hazard ratio; Gastroenterology; Surgery; Multivariate analysis; Oncology; Confidence interval","score_opus":0.051604883940859395,"score_gpt":0.32835767448737,"score_spread":0.27675279054651064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2615747491","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9360252,0.00004513785,0.000023483482,0.0038423422,0.0008243648,0.0011181629,0.000009297905,0.00002863454,0.05808338],"genre_scores_gemma":[0.9987265,0.000012672676,0.0006031404,0.000130503,0.00014487884,0.0001416822,0.000006391763,0.000018215078,0.00021605735],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981552,0.0002620502,0.00043818867,0.0004820562,0.00031448706,0.00034805175],"domain_scores_gemma":[0.99798363,0.00044539443,0.0003275316,0.0010097554,0.00011012538,0.00012352987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043612317,0.00019832166,0.00058693305,0.00018574958,0.00012842995,0.000023715565,0.0004958567,0.0001226548,0.000071752685],"category_scores_gemma":[0.0018883107,0.00017295656,0.00008096102,0.0001258292,0.00025412854,0.00009243017,0.00023151512,0.00034862256,0.000032704607],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005514553,0.002682759,0.501128,0.00047343757,0.00021083452,0.017417084,0.003378049,0.00013697273,0.41004196,0.020724066,0.008183047,0.030109242],"study_design_scores_gemma":[0.008625451,0.016184842,0.92185307,0.00034343844,0.00019854214,0.0002269024,0.0003277802,0.00077156327,0.03266502,0.0011351908,0.017251266,0.00041696505],"about_ca_topic_score_codex":0.00005988258,"about_ca_topic_score_gemma":0.00004470196,"teacher_disagreement_score":0.42072502,"about_ca_system_score_codex":0.000116170995,"about_ca_system_score_gemma":0.00021127124,"threshold_uncertainty_score":0.70529634},"labels":[],"label_agreement":null},{"id":"W2616974222","doi":"10.1093/neuonc/nox083.165","title":"MEDU-14. OTX2 CONTROLS AN AXON GUIDANCE GENE EXPRESSION NETWORK TO REGULATE MEDULLOBLASTOMA SELF-RENEWAL","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Ottawa Hospital; SickKids Foundation; University of Manitoba","funders":"","keywords":"Semaphorin; Biology; Axon guidance; Gene knockdown; Signal transduction; Cancer research; Gene; Medulloblastoma; Downregulation and upregulation; Progenitor cell; Stem cell; Axon; Cell biology; Genetics; Receptor","score_opus":0.025085812610992096,"score_gpt":0.3223981051470549,"score_spread":0.29731229253606284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2616974222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9774437,0.00071965216,0.00006329332,0.013384843,0.0017669044,0.0012610891,0.000013773994,0.00022327632,0.0051234774],"genre_scores_gemma":[0.9791997,0.00018975172,0.010687188,0.0074644918,0.0018148391,0.00042646663,0.000021418293,0.00006909451,0.00012702662],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99735105,0.00029015102,0.00048553423,0.0007837733,0.00036512315,0.0007243586],"domain_scores_gemma":[0.99693835,0.0003589318,0.00036548503,0.001504188,0.00016483545,0.00066820695],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035493087,0.00035230588,0.00084254757,0.00008720541,0.0004937243,0.00006579985,0.00043273796,0.00030748014,0.00014136636],"category_scores_gemma":[0.00038804,0.00028621423,0.00016558984,0.00008553091,0.00010932364,0.00014008913,0.00025490543,0.0002539618,0.00017776358],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025686275,0.0025398904,0.10340731,0.000031121817,0.00024843626,0.003890035,0.00049052644,0.000296866,0.76425683,0.00031115854,0.049712013,0.07224721],"study_design_scores_gemma":[0.013298864,0.008729849,0.19570945,0.00022003942,0.0005661629,0.00089445885,0.0000379491,0.00039558907,0.25951847,0.00045339277,0.5196332,0.0005425708],"about_ca_topic_score_codex":0.00006847563,"about_ca_topic_score_gemma":0.00016555974,"teacher_disagreement_score":0.50473833,"about_ca_system_score_codex":0.00027754277,"about_ca_system_score_gemma":0.00022827266,"threshold_uncertainty_score":0.999959},"labels":[],"label_agreement":null},{"id":"W2617029719","doi":"10.1093/neuonc/nox083.065","title":"EPND-07. MOLECULAR HETEROGENEITY AMONG PEDIATRIC POSTERIOR FOSSA EPENDYMOMA","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Ependymoma; Biology; Genetic heterogeneity; Medulloblastoma; Gene; Histogenesis; Disease; Genome; Genetics; Bioinformatics; Pathology; Oncology; Immunohistochemistry; Medicine; Immunology","score_opus":0.02538188241965737,"score_gpt":0.3188123562769149,"score_spread":0.2934304738572575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2617029719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897326,0.00039482067,0.00000641432,0.0036648754,0.0008465888,0.0006442466,0.000016895112,0.00007641524,0.004617118],"genre_scores_gemma":[0.99758667,0.000076218355,0.00020410478,0.0015168594,0.00039675346,0.00013357177,0.000015918584,0.000046439207,0.000023451663],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99824226,0.00012592039,0.00033518847,0.00055864145,0.00025597675,0.0004820151],"domain_scores_gemma":[0.9980363,0.00011779374,0.00031100187,0.0010821642,0.000100734476,0.0003519535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014314424,0.00027158044,0.0005754812,0.00013468615,0.0003068383,0.000066437045,0.00029647353,0.00025379186,0.0001886719],"category_scores_gemma":[0.00031924943,0.00023425763,0.00025321366,0.000064050706,0.00015974217,0.00011262931,0.0002731705,0.0002597485,0.00038953303],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018577093,0.0010457414,0.80005985,0.00004819743,0.00011013539,0.022303196,0.00007251784,0.000002774051,0.15396388,0.000060465594,0.0016432047,0.020504259],"study_design_scores_gemma":[0.004980992,0.002267235,0.864143,0.000013039069,0.00054912345,0.001130661,0.000012873472,0.000036776528,0.11633433,0.000050417726,0.010262242,0.00021931344],"about_ca_topic_score_codex":0.00010803467,"about_ca_topic_score_gemma":0.000095011324,"teacher_disagreement_score":0.06408315,"about_ca_system_score_codex":0.00015125814,"about_ca_system_score_gemma":0.00015582157,"threshold_uncertainty_score":0.9552749},"labels":[],"label_agreement":null},{"id":"W2617056390","doi":"10.1093/neuonc/nox083.179","title":"MEDU-29. A NOVEL MOUSE MODEL OF PI3 KINASE PATHWAY IN METASTATIC SHH MEDULLOBLASTOMA","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Mechanisms and Therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Cancer research; Sonic hedgehog; PTEN; PI3K/AKT/mTOR pathway; Biology; Metastasis; Spinal cord; Medicine; Neuroscience; Signal transduction; Cell biology; Cancer; Genetics","score_opus":0.05278049828140863,"score_gpt":0.32812503171438356,"score_spread":0.27534453343297494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2617056390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905889,0.000096518736,0.0025177938,0.003150182,0.00044858624,0.00059597276,0.00007700146,0.000039592258,0.002485465],"genre_scores_gemma":[0.9927047,0.00010317005,0.004459717,0.0022082615,0.00009528992,0.00009123013,0.000005834067,0.00004875414,0.0002830264],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984868,0.00006295776,0.00044198649,0.00038201388,0.00026108976,0.00036512845],"domain_scores_gemma":[0.99846715,0.0001401141,0.00033791468,0.0007808344,0.000089220186,0.0001847569],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003216846,0.00020696703,0.0007394286,0.00018556784,0.00008173397,0.000012591319,0.00029016042,0.00013982851,0.00012614959],"category_scores_gemma":[0.00029098743,0.0001832886,0.00013475803,0.00006877791,0.00017399395,0.000099596,0.00011477654,0.00035447718,0.000015108079],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092867017,0.0008023119,0.00015032628,0.000059045815,0.000044632026,0.00021157574,0.0006483078,0.00021609443,0.97465396,0.0049518137,0.00016486015,0.017168384],"study_design_scores_gemma":[0.018773519,0.005200755,0.0007162844,0.00009643043,0.00014362141,0.00022045388,0.00021219112,0.035864532,0.9156981,0.003468895,0.019238587,0.00036659883],"about_ca_topic_score_codex":0.00026095632,"about_ca_topic_score_gemma":0.00075245043,"teacher_disagreement_score":0.058955844,"about_ca_system_score_codex":0.000160421,"about_ca_system_score_gemma":0.0005822934,"threshold_uncertainty_score":0.74742925},"labels":[],"label_agreement":null},{"id":"W2617370963","doi":"10.1093/neuonc/nox083.225","title":"TRTH-13. BMI1 IS A THERAPEUTIC TARGET IN RECURRENT MEDULLOBLASTOMA","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Pluripotent Stem Cells Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University","funders":"","keywords":"BMI1; Medulloblastoma; Stem cell; Medicine; In vivo; Cancer research; Metastasis; Oncology; Internal medicine; Biology; Cancer; Genetics","score_opus":0.028078780707230046,"score_gpt":0.33161809138904486,"score_spread":0.30353931068181483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2617370963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97408617,0.0009505617,0.00011174181,0.006176036,0.0009188722,0.0005303398,0.00002678877,0.00001937462,0.017180104],"genre_scores_gemma":[0.9962742,0.0007596146,0.0001943721,0.0017437381,0.0002770304,0.00008892448,0.000027119766,0.00003946231,0.000595554],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99786067,0.00031231233,0.0003101061,0.00066537556,0.00024210135,0.00060946017],"domain_scores_gemma":[0.998511,0.0000599569,0.00018692233,0.0009891677,0.0000846214,0.00016832878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003806387,0.00022592311,0.00031542074,0.00010363436,0.00019812286,0.00005302805,0.0008744151,0.00035490576,0.00017772963],"category_scores_gemma":[0.00027231267,0.0002153752,0.0001265348,0.000066447945,0.00025881684,0.0000084726935,0.0005025155,0.0003868733,0.00019255823],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004151164,0.00026678987,0.008164685,0.000020376243,0.000034788678,0.0001478162,0.000108336215,0.000010359465,0.9485801,0.000029043442,0.007075309,0.035147265],"study_design_scores_gemma":[0.0018878048,0.0019439332,0.009370131,0.000012200688,0.000011763616,0.00008035603,0.00004739871,0.0003731707,0.3281753,0.00018541072,0.65765214,0.00026036246],"about_ca_topic_score_codex":0.000049944563,"about_ca_topic_score_gemma":0.00030126527,"teacher_disagreement_score":0.65057683,"about_ca_system_score_codex":0.00007801299,"about_ca_system_score_gemma":0.00032676623,"threshold_uncertainty_score":0.8782746},"labels":[],"label_agreement":null},{"id":"W2617425553","doi":"10.1093/neuonc/nox083.151","title":"LGG-18. MOLECULAR ALTERATIONS PREDICT RESPONSE TO CHEMOTHERAPY AND OUTCOME OF PEDIATRIC LOW-GRADE GLIOMA","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Neurofibromatosis; Internal medicine; Oncology; Chemotherapy; Glioma; Cohort; Pathology; Cancer research","score_opus":0.031149528030149216,"score_gpt":0.3487051521526879,"score_spread":0.3175556241225387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2617425553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9786993,0.00016539547,0.000034502555,0.019648293,0.00026113598,0.00066267105,0.00002425313,0.000031872918,0.0004725497],"genre_scores_gemma":[0.997049,0.000091710586,0.0005220085,0.002027424,0.00015913504,0.00009789672,0.000005361024,0.000027785309,0.000019728128],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99878496,0.00013063762,0.0003342605,0.0003312142,0.00018375748,0.0002351529],"domain_scores_gemma":[0.99850595,0.00034071767,0.00018946314,0.0006398487,0.000080177524,0.00024382144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020964874,0.00016622353,0.00044248893,0.000248515,0.0001416094,0.000026825533,0.00014112583,0.00012677467,0.00006903954],"category_scores_gemma":[0.00067738415,0.00014176767,0.000097296856,0.00011617252,0.00009328898,0.00005134454,0.00008410126,0.00012417468,0.000017131586],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010179168,0.00091026555,0.23250239,0.00003448328,0.00006664504,0.0012326789,0.00021893789,0.000007615152,0.7590269,0.000091227295,0.0024847742,0.0024061913],"study_design_scores_gemma":[0.011373383,0.005679457,0.6670265,0.000022564811,0.00039911747,0.00034740943,0.000033068114,0.000106910935,0.29370677,0.00007919703,0.021025458,0.00020011578],"about_ca_topic_score_codex":0.00002649557,"about_ca_topic_score_gemma":0.000011029689,"teacher_disagreement_score":0.46532008,"about_ca_system_score_codex":0.00007056327,"about_ca_system_score_gemma":0.00011829506,"threshold_uncertainty_score":0.57811177},"labels":[],"label_agreement":null},{"id":"W2617492910","doi":"10.1093/neuonc/nox083.091","title":"HGG-02. DIANHYDROGALACTITOL (VAL-083) OVERCOMES MGMT- AND P53-MEDIATED CHEMO-RESISTANCE AND DISPLAYS SYNERGY WITH TOPOISOMERASE INHIBITORS","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Delmar (Canada); University of British Columbia","funders":"","keywords":"Temozolomide; Cancer research; Topoisomerase; DNA repair; Medicine; DNA damage; Methyltransferase; Cancer; Cell cycle; Oncology; Internal medicine; Glioma; Biology; In vitro; DNA; Genetics","score_opus":0.010315923296813327,"score_gpt":0.26947952763531335,"score_spread":0.25916360433850005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2617492910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9818992,0.0009781693,0.0000017224057,0.012053447,0.00035184555,0.00048052068,0.00003034967,0.00005997076,0.004144759],"genre_scores_gemma":[0.99738115,0.0009154895,0.0001256613,0.0010333216,0.00022023644,0.00011921858,0.000026399408,0.000044117965,0.00013437704],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984247,0.0000677935,0.00027196913,0.00058671396,0.00023108044,0.00041770982],"domain_scores_gemma":[0.9981871,0.0005011932,0.00026428464,0.0005830067,0.00007047677,0.00039393298],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009881591,0.00031959446,0.00065012387,0.00012293136,0.000362558,0.000088317924,0.000112226335,0.00019920977,0.000043137592],"category_scores_gemma":[0.00034653698,0.00023644554,0.00006170116,0.00008499938,0.00044002765,0.00021070849,0.00013223593,0.0002597011,0.000020610663],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001529062,0.0015892601,0.77051234,0.00024490902,0.0004120875,0.007830783,0.00063251343,0.0000023016405,0.18740557,0.00077415316,0.010752556,0.018314471],"study_design_scores_gemma":[0.021443961,0.0036166387,0.597097,0.00029121945,0.0007792692,0.000994032,0.00027213182,0.00012748234,0.08410953,0.00012548572,0.2904692,0.0006740718],"about_ca_topic_score_codex":0.0001593333,"about_ca_topic_score_gemma":0.00091174676,"teacher_disagreement_score":0.27971664,"about_ca_system_score_codex":0.00013918967,"about_ca_system_score_gemma":0.0001351033,"threshold_uncertainty_score":0.9641969},"labels":[],"label_agreement":null},{"id":"W2617575965","doi":"10.1093/neuonc/nox083.196","title":"MEDU-47. PEROXIREDOXIN1 IS A THERAPEUTIC TARGET IN GROUP-3 MEDULLOBLASTOMAS","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Redox biology and oxidative stress","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; University of Toronto; University of Manitoba; Children's Hospital Research Institute of Manitoba; Research Institute in Oncology and Hematology","funders":"","keywords":"Cancer research; DNA damage; Sensitization; Oxidative stress; Reactive oxygen species; Apoptosis; Ionizing radiation; Radiation therapy; RNA interference; Biology; Medicine; Immunology; DNA; Gene; Irradiation; Internal medicine; Biochemistry; RNA","score_opus":0.018460291911635927,"score_gpt":0.3088351542156031,"score_spread":0.29037486230396714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2617575965","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97814023,0.0010948749,0.00021897555,0.004206017,0.00095747184,0.00035776023,0.00003777064,0.000023755985,0.014963129],"genre_scores_gemma":[0.99415296,0.0005385164,0.00042426807,0.004042789,0.00036620218,0.00008116114,0.00005778495,0.00003439086,0.00030191944],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979562,0.00034923904,0.00032240877,0.0007208046,0.00011727968,0.0005340289],"domain_scores_gemma":[0.99857014,0.000073500734,0.00025926135,0.0009019702,0.00006491109,0.00013024025],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030783145,0.0002855963,0.0003866407,0.00007921851,0.00030155157,0.000035792236,0.00081043475,0.00058872515,0.00016618494],"category_scores_gemma":[0.00028134356,0.00025636455,0.00014220084,0.00005415564,0.0006127239,0.000012846978,0.00036176498,0.00035911333,0.00006868917],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038011235,0.00019588902,0.030461289,0.000009136559,0.00006251882,0.00009563583,0.00017905199,0.000003773282,0.9526491,0.0003365308,0.0039563817,0.011670589],"study_design_scores_gemma":[0.001954551,0.0018604173,0.04588766,0.000010586204,0.000022453836,0.000105200896,0.00012747069,0.000054758857,0.40221325,0.00082092505,0.5465958,0.00034691166],"about_ca_topic_score_codex":0.000047904305,"about_ca_topic_score_gemma":0.00029565243,"teacher_disagreement_score":0.55043584,"about_ca_system_score_codex":0.00004216195,"about_ca_system_score_gemma":0.00016031032,"threshold_uncertainty_score":0.99998885},"labels":[],"label_agreement":null},{"id":"W2617609684","doi":"10.1093/neuonc/nox083.178","title":"MEDU-28. INVESTIGATING THE ROLE OF THE RNA BINDING PROTEIN, MUSASHI, IN GROUP 3 MEDULLOBLASTOMA","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Neural stem cell; Gene knockdown; Biology; Medulloblastoma; Carcinogenesis; Cancer research; Stem cell; Progenitor cell; RNA-binding protein; Cell fate determination; Cancer stem cell; Glioma; Transcriptional regulation; Cell; RNA; Cancer; Gene; Gene expression; Cell biology; Genetics; Transcription factor","score_opus":0.016803526197931504,"score_gpt":0.28814721258951864,"score_spread":0.2713436863915871,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2617609684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99283123,0.00012836933,0.000005468739,0.0023556724,0.00015606926,0.0004655832,0.0000048129373,0.000005562044,0.004047228],"genre_scores_gemma":[0.9990475,0.000033627537,0.00014806326,0.0003326246,0.00016571772,0.000082226616,0.000003393529,0.00002034267,0.0001664966],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998473,0.00035799123,0.0002682864,0.00030421148,0.00020564956,0.0003909006],"domain_scores_gemma":[0.99869424,0.00008615814,0.00029129526,0.00078744686,0.000053103606,0.000087763176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062268035,0.00013455952,0.0001893276,0.00004213776,0.00039735757,0.000039437964,0.0010298508,0.00017990686,0.000009425202],"category_scores_gemma":[0.0018495359,0.00008463781,0.000091060014,0.00008630973,0.0005005395,0.000008677292,0.0006658414,0.0003889738,0.000005760531],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004240932,0.00003584094,0.011908954,0.00000992573,0.000013117549,0.000007760777,0.0000975385,0.000008969933,0.975333,0.00025647096,0.00016505252,0.012120992],"study_design_scores_gemma":[0.0005832482,0.00047021612,0.006541029,0.000034829533,0.000006464856,0.000025415553,0.0003100481,0.00027566706,0.96812886,0.00027779565,0.02324879,0.00009764326],"about_ca_topic_score_codex":0.00021507278,"about_ca_topic_score_gemma":0.0010239842,"teacher_disagreement_score":0.023083737,"about_ca_system_score_codex":0.000035309855,"about_ca_system_score_gemma":0.00022426045,"threshold_uncertainty_score":0.34514296},"labels":[],"label_agreement":null},{"id":"W2617655947","doi":"10.1093/neuonc/nox083.107","title":"HGG-18. GLIOMAS IN ADOLESCENTS AND YOUNG ADULTS SHARE SEVERAL MOLECULAR FEATURES WITH THEIR PEDIATRIC COUNTERPARTS","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; IDH1; Cohort; Population; Internal medicine; Pathology; Young adult; Oncology; Glioma; Gastroenterology; Pediatrics; Mutation; Biology; Cancer research; Genetics","score_opus":0.012602608713378427,"score_gpt":0.2755069452501196,"score_spread":0.26290433653674117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2617655947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99517804,0.00089952466,0.0000015903393,0.001537521,0.00029621946,0.0006368755,0.000027564809,0.000034261488,0.0013884174],"genre_scores_gemma":[0.99840057,0.0002261692,0.000047313293,0.0010126824,0.0001583203,0.00008967659,0.000020181456,0.000034114295,0.000010997108],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986776,0.00007211,0.00019866311,0.00048136432,0.00019904226,0.00037122497],"domain_scores_gemma":[0.9990337,0.00004250993,0.00017114721,0.00048193414,0.00007705724,0.00019365097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000708967,0.00025461667,0.00044451616,0.00017611274,0.00014207776,0.00005798793,0.00015276486,0.00017085145,0.000028779292],"category_scores_gemma":[0.00009961523,0.00018279524,0.000059183185,0.00009144379,0.000097409764,0.00010201424,0.00012519734,0.00028017178,0.000009831379],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010957983,0.00079945364,0.9774294,0.000119573626,0.00004353985,0.009205132,0.0006140869,0.0000051756115,0.0050027277,0.00001862569,0.0017187764,0.0039477316],"study_design_scores_gemma":[0.011050617,0.0019379155,0.9788755,0.00022508371,0.00015506432,0.0012576741,0.00010990469,0.00009450375,0.0037810851,0.000017619072,0.0023019307,0.00019308133],"about_ca_topic_score_codex":0.00021676226,"about_ca_topic_score_gemma":0.0009398757,"teacher_disagreement_score":0.009954819,"about_ca_system_score_codex":0.000116991876,"about_ca_system_score_gemma":0.000115496376,"threshold_uncertainty_score":0.74541736},"labels":[],"label_agreement":null},{"id":"W2617712430","doi":"10.1093/neuonc/nox083.095","title":"HGG-06. CHARACTERIZING TEMPORAL GENOMIC HETEROGENEITY IN PEDIATRIC HIGH-GRADE GLIOMAS","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital; McGill University Health Centre; McGill University","funders":"","keywords":"ATRX; Biology; IDH1; Epigenetics; Cancer research; Mutation; Histone; Genetics; Somatic evolution in cancer; Cancer; Gene","score_opus":0.03799632797195328,"score_gpt":0.3160771669475253,"score_spread":0.278080838975572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2617712430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901016,0.0003437912,0.0000011277106,0.0075289086,0.0008537406,0.00055519963,0.000016880342,0.00005987672,0.0005389072],"genre_scores_gemma":[0.9972047,0.00042905193,0.00022172318,0.0011911872,0.00073529116,0.000119086704,0.00004535346,0.000043033855,0.000010557592],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99822783,0.00012895976,0.00042030626,0.000544264,0.00017856513,0.0005000982],"domain_scores_gemma":[0.9984526,0.00015121998,0.00034571288,0.0007750169,0.000039372782,0.00023606862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019933561,0.00025869644,0.0006423152,0.00030207567,0.0002170672,0.00005305977,0.00026464247,0.0002311419,0.00005051477],"category_scores_gemma":[0.00016078456,0.00023097037,0.00014839339,0.000111498695,0.00009386989,0.00012581362,0.00020757502,0.00031631824,0.00022390597],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009234355,0.00083578454,0.74672616,0.000028515777,0.000028765882,0.0031545516,0.00006758443,0.0000012743197,0.2451867,0.000045241777,0.00044546847,0.0033875883],"study_design_scores_gemma":[0.0053811558,0.0008729008,0.9367232,0.000011652446,0.00015150051,0.00027546065,0.000010002796,0.00002954796,0.029931175,0.000038716415,0.026408602,0.00016608738],"about_ca_topic_score_codex":0.00028146597,"about_ca_topic_score_gemma":0.00037309108,"teacher_disagreement_score":0.21525553,"about_ca_system_score_codex":0.00032925492,"about_ca_system_score_gemma":0.000199136,"threshold_uncertainty_score":0.94186985},"labels":[],"label_agreement":null},{"id":"W2617945496","doi":"10.1093/neuonc/nox083.199","title":"MEDU-50. TRANSCRIPTIONAL REGULATION OF THE HOMEOBOX GENES CRX AND OTX2 - IMPLICATIONS FOR MEDULLOBLASTOMA GROUP 3","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Homeobox; Chromatin immunoprecipitation; Biology; Reporter gene; Enhancer; Psychological repression; Promoter; Regulation of gene expression; DLX5; Cell biology; Transcription factor; Genetics; Molecular biology; Gene; Gene expression","score_opus":0.03666894329806066,"score_gpt":0.3203396037393318,"score_spread":0.28367066044127115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2617945496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9532023,0.00044322317,0.00015695955,0.044357277,0.00036750783,0.00082300225,0.00006750692,0.000016292488,0.0005659038],"genre_scores_gemma":[0.9980727,0.00013943652,0.0007914786,0.0005085204,0.00014404833,0.00028511515,0.000022372207,0.0000137412235,0.000022593747],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9993117,0.00004109238,0.00020306394,0.00021322904,0.00009324409,0.00013767664],"domain_scores_gemma":[0.99901,0.00023082011,0.00018583678,0.00040466822,0.00009650106,0.000072170544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000096103526,0.000096626114,0.00023382374,0.00004998146,0.00030046524,0.000013077084,0.00011680844,0.00009935695,0.00002705605],"category_scores_gemma":[0.00013062159,0.00006655303,0.000107991866,0.000035958805,0.00022225085,0.000056930065,0.00003545881,0.000059742728,0.0000018373995],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012996692,0.000374286,0.056714177,0.0000316204,0.00006099721,0.0000016656198,0.00009820769,0.0000035778814,0.8870551,0.014803182,0.0015034218,0.039223805],"study_design_scores_gemma":[0.0024327894,0.00067569595,0.88337815,0.000014918521,0.00020757272,0.000089607754,0.000018401903,0.00006548419,0.023837982,0.0021213244,0.08710953,0.000048566562],"about_ca_topic_score_codex":0.000024223455,"about_ca_topic_score_gemma":0.00012370323,"teacher_disagreement_score":0.8632171,"about_ca_system_score_codex":0.00005062466,"about_ca_system_score_gemma":0.00007687374,"threshold_uncertainty_score":0.27139542},"labels":[],"label_agreement":null},{"id":"W2618097753","doi":"10.1093/neuonc/nox083.047","title":"DIPG-32. MRI GUIDED FOCUSED ULTRASOUND FOR BRAINSTEM BLOOD BRAIN BARRIER PENETRATION: A DEMONSTRATION OF SAFETY","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Advanced MRI Techniques and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medicine; Microbubbles; Blood–brain barrier; Brainstem; Magnetic resonance imaging; Ultrasound; Pathology; Anesthesia; Radiology; Central nervous system; Internal medicine","score_opus":0.03723628543925391,"score_gpt":0.36314785574727154,"score_spread":0.32591157030801765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2618097753","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1778991,0.00013219051,0.6767201,0.06535241,0.0005261914,0.0071153673,0.00029755972,0.00043624535,0.07152087],"genre_scores_gemma":[0.91318107,0.0001260493,0.083085366,0.002199402,0.0003688789,0.00043280429,0.00010218988,0.00004409808,0.00046014265],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986515,0.00005481746,0.0005351439,0.0003692001,0.00014807901,0.00024126816],"domain_scores_gemma":[0.9976222,0.00074199797,0.00048196362,0.0007715391,0.00024644076,0.00013588245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030487042,0.00016399339,0.00041347527,0.000067474626,0.00037423763,0.000021989921,0.00022837069,0.00023549606,0.000059855123],"category_scores_gemma":[0.00093101786,0.00015601175,0.00014146799,0.00007254486,0.00023528778,0.00014893695,0.00004173959,0.0001847985,0.0000042995616],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002450624,0.0002479013,0.0015438346,0.000044872286,0.000025989346,0.000012781192,0.00012551091,0.00002536865,0.9542354,0.017846707,0.006649737,0.018996844],"study_design_scores_gemma":[0.006715795,0.0030339446,0.00653145,0.00005433897,0.00030646214,0.0004913538,0.000084697225,0.00065898563,0.45102394,0.0043266956,0.52649593,0.00027641127],"about_ca_topic_score_codex":0.000012336114,"about_ca_topic_score_gemma":0.00008116626,"teacher_disagreement_score":0.73528194,"about_ca_system_score_codex":0.000071079245,"about_ca_system_score_gemma":0.00033403843,"threshold_uncertainty_score":0.63619745},"labels":[],"label_agreement":null},{"id":"W2618433710","doi":"10.1093/neuonc/nox083.239","title":"TRTH-29. CONTEXT-SPECIFIC TUMOR SUPPRESSIVE FUNCTION OF THE CANONICAL WNT PATHWAY IN PEDIATRIC MEDULLOBLASTOMA HIGHLIGHTS A THERAPEUTIC STRATEGY FOR TREATMENT-REFRACTORY SUBGROUPS","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Wnt signaling pathway; Medulloblastoma; Cancer research; In vivo; Biology; SOX2; Medicine; Signal transduction; Cell biology; Transcription factor; Gene; Genetics","score_opus":0.032554061361765634,"score_gpt":0.308984839351115,"score_spread":0.27643077798934934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2618433710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952949,0.0018994106,0.00001813687,0.0005231993,0.0005215025,0.0009472841,0.00011955944,0.0000073028573,0.000668671],"genre_scores_gemma":[0.99823064,0.00072717335,0.000005870494,0.0001317852,0.0003211898,0.00038552153,0.000043492393,0.000028538452,0.00012581391],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99843,0.0002263522,0.0002975662,0.0004806733,0.0001540003,0.0004114182],"domain_scores_gemma":[0.99873304,0.000117577074,0.00030696587,0.00062248507,0.000107816915,0.00011209224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000100495185,0.0002223231,0.00033666447,0.000060470462,0.00022742717,0.00003120648,0.00038870625,0.00019292296,0.000024732504],"category_scores_gemma":[0.00006499787,0.00015073243,0.00020399592,0.000052795975,0.00023186236,0.000011877961,0.000108878034,0.00012361325,0.0000053482727],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006156183,0.0016420885,0.018059213,0.000035711622,0.00016840492,0.00011486507,0.00012112467,0.00002013895,0.9068988,0.0015837414,0.0011661899,0.06403352],"study_design_scores_gemma":[0.013758726,0.0168455,0.08560188,0.000011513058,0.000106860134,0.00006946063,0.0001089249,0.000024773813,0.50799865,0.00039400446,0.37477592,0.00030379734],"about_ca_topic_score_codex":0.0003786629,"about_ca_topic_score_gemma":0.008236379,"teacher_disagreement_score":0.39890018,"about_ca_system_score_codex":0.00017874462,"about_ca_system_score_gemma":0.0011691081,"threshold_uncertainty_score":0.614669},"labels":[],"label_agreement":null},{"id":"W2618663579","doi":"10.1093/neuonc/nox168.785","title":"PDTM-21. LARGE SCALE TUMOR MUTATIONAL BURDEN ANALYSIS OF PEDIATRIC TUMORS PROVIDES A DIAGNOSTIC TOOL FOR GERMLINE PREDISPOSITION AND REVEALS NOVEL CANDIDATES FOR IMMUNE CHECKPOINT INHIBITION","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"Somatic hypermutation; Germline; Germline mutation; Mutation; Exome sequencing; Cancer research; Genetics; Biology; DNA mismatch repair; Exome; Cancer; Brain tumor; Medicine; Gene; DNA repair; Pathology; Antibody","score_opus":0.011989964628118854,"score_gpt":0.2901294253353224,"score_spread":0.2781394607072035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2618663579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98032606,0.0002928495,0.016196847,0.0005814557,0.00015815934,0.0009882933,0.0014332567,0.000007356343,0.000015698794],"genre_scores_gemma":[0.9954711,0.00017682643,0.0020345964,0.0002418693,0.00048311797,0.00054653466,0.0009860776,0.000023239076,0.000036599104],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988721,0.000031282198,0.00039473703,0.00037644082,0.00008850693,0.00023691596],"domain_scores_gemma":[0.99876493,0.0002021881,0.0004883955,0.00026729266,0.00022048736,0.000056728924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034170246,0.00014746992,0.00034675933,0.000116913245,0.00021205022,0.000033176002,0.0001175558,0.00012220614,0.000006972616],"category_scores_gemma":[0.0005368619,0.0001475396,0.00018510506,0.000069024514,0.00007168876,0.000012324844,0.000091681766,0.00005573074,2.9439317e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005029089,0.0001563687,0.0012637299,0.00010083303,0.00017005485,0.000002679078,0.00010133385,0.00008964958,0.99626577,0.00018880307,0.00006214495,0.0010957412],"study_design_scores_gemma":[0.0065112095,0.003928014,0.030303238,0.000029786179,0.002496858,0.00004908956,0.00010893087,0.008503018,0.93996334,0.0012279727,0.006466126,0.00041239397],"about_ca_topic_score_codex":0.000034886638,"about_ca_topic_score_gemma":0.00013826544,"teacher_disagreement_score":0.05630239,"about_ca_system_score_codex":0.000033825752,"about_ca_system_score_gemma":0.00015602782,"threshold_uncertainty_score":0.601649},"labels":[],"label_agreement":null},{"id":"W2618842028","doi":"10.1093/neuonc/nox083.180","title":"MEDU-30. GENES PRESERVING STEM CELL STATE IN GROUP 3 MB BTICS CONTRIBUTE TO THERAPY EVASION AND RELAPSE","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medulloblastoma; Biology; Stem cell; Population; Downregulation and upregulation; Cancer research; Gene; Oncology; Internal medicine; Medicine; Genetics","score_opus":0.024109840207844062,"score_gpt":0.2892152730980958,"score_spread":0.26510543289025174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2618842028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99577844,0.0017642525,0.00023702883,0.0007296383,0.0004435577,0.0003400777,0.000021896343,0.000009535585,0.0006755683],"genre_scores_gemma":[0.9903646,0.007631484,0.00014757023,0.0013438481,0.00015058814,0.000042284777,0.000017062592,0.000024435838,0.0002781275],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986539,0.0001699995,0.00026029692,0.00047425056,0.00009789736,0.0003436561],"domain_scores_gemma":[0.9989727,0.000057684032,0.0001523691,0.0005962625,0.00008677288,0.00013422403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027749874,0.00018087856,0.00025527546,0.000057311874,0.00015052143,0.00006183276,0.00043867173,0.00021664011,0.000016740192],"category_scores_gemma":[0.00007300456,0.00016622238,0.000049739774,0.000030004558,0.000079205216,0.000011953747,0.00044451008,0.00016073995,0.000020616384],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038440863,0.000081564016,0.007887673,0.000011960096,0.000014779704,0.00006586495,0.00019414368,0.000053631968,0.9508751,0.0000047787803,0.0019402487,0.03848582],"study_design_scores_gemma":[0.002239657,0.0031749748,0.008886601,0.000021355818,0.00001205672,0.000029503522,0.00010865639,0.00019978262,0.7656845,0.00011651509,0.21925083,0.0002755704],"about_ca_topic_score_codex":0.000116327414,"about_ca_topic_score_gemma":0.00045773902,"teacher_disagreement_score":0.21731058,"about_ca_system_score_codex":0.00002815139,"about_ca_system_score_gemma":0.00007764487,"threshold_uncertainty_score":0.67783517},"labels":[],"label_agreement":null},{"id":"W2618858474","doi":"10.1093/neuonc/nox083.059","title":"EPND-01. THE ACTIVE REGULATORY LANDSCAPE OF EPENDYMAL TUMORS","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Biology; Chromatin; Enhancer; Computational biology; Ependymoma; Lineage (genetic); Epigenomics; Transcription factor; Targeted therapy; Cancer research; DNA methylation; Gene; Genetics; Cancer; Gene expression; Medicine; Pathology","score_opus":0.012587204519635216,"score_gpt":0.27356881161493335,"score_spread":0.2609816070952981,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2618858474","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97658336,0.00022837486,0.000023680574,0.0013234266,0.0006538958,0.00017773073,0.000054666336,0.0000051403385,0.02094973],"genre_scores_gemma":[0.99815416,0.00024554104,0.00007623458,0.0008383635,0.0005000255,0.000020966172,0.000021522435,0.000020002051,0.00012315369],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999162,0.00006747766,0.00018957617,0.00027676197,0.000089055684,0.00021512926],"domain_scores_gemma":[0.9986453,0.00010830458,0.00028851637,0.0008193625,0.00007092992,0.000067573535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015201564,0.00012332766,0.00019993057,0.00002192156,0.00020891459,0.000019910745,0.0005090466,0.00016013734,0.000046562713],"category_scores_gemma":[0.0003842489,0.000098102115,0.00010003796,0.000020160454,0.00029174433,0.0000034970174,0.00033796925,0.00014402364,0.000011386837],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003774159,0.00009424276,0.0055873604,0.000009395139,0.000047822505,0.00003662669,0.00010684053,0.00006615432,0.9602196,0.00093913294,0.01764931,0.014866071],"study_design_scores_gemma":[0.0010563812,0.001075101,0.049862638,0.000005616246,0.00004234808,0.00008046646,0.00012705797,0.000042933323,0.49336752,0.00024412418,0.45393178,0.00016402014],"about_ca_topic_score_codex":0.000042629184,"about_ca_topic_score_gemma":0.0001795222,"teacher_disagreement_score":0.4668521,"about_ca_system_score_codex":0.000020150292,"about_ca_system_score_gemma":0.00028473246,"threshold_uncertainty_score":0.40004882},"labels":[],"label_agreement":null},{"id":"W2618957446","doi":"10.1093/neuonc/nox058","title":"Blood-brain barrier pericyte importance in malignant gliomas: what we can learn from stroke and Alzheimer’s disease","year":2017,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Barrier Structure and Function Studies","field":"Neuroscience","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Pericyte; Glioma; Neuroscience; Disease; Biology; Cell type; Blood–brain barrier; Inflammation; Central nervous system; Pathology; Cell; Medicine; Endothelial stem cell; Cancer research; Immunology; In vitro","score_opus":0.10066816102987128,"score_gpt":0.35593048738543376,"score_spread":0.25526232635556245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2618957446","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00092184497,0.99062204,0.0000012908718,0.0025708156,0.0032604001,0.0010162327,0.0005911255,0.00008486385,0.0009313866],"genre_scores_gemma":[0.0011636402,0.9947413,0.000025025853,0.0025607934,0.0006007,0.00031616702,0.000028208737,0.0001053998,0.0004587435],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949771,0.0010480622,0.0009436956,0.0018701983,0.00038238367,0.0007785402],"domain_scores_gemma":[0.995629,0.0016756821,0.0009474205,0.0011669908,0.00004425072,0.00053661765],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025209363,0.0008391648,0.0025166639,0.00036680218,0.00050587795,0.00031691024,0.00080794736,0.0005286861,0.00021331267],"category_scores_gemma":[0.0015907021,0.00068068784,0.00039050178,0.00028650768,0.00076777366,0.00041360897,0.000633178,0.001173566,0.00005066418],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000090599446,0.0000723003,0.0003674987,0.00051679724,0.00013305538,0.004708158,0.00047855562,4.5649998e-7,0.0017175272,0.00013008853,0.0031178673,0.9886671],"study_design_scores_gemma":[0.00070361595,0.00024956872,0.00010927985,0.0008022162,0.0011443748,0.00024185867,0.000107141794,0.000004595771,0.00013960993,0.00015297726,0.9957752,0.0005695196],"about_ca_topic_score_codex":0.00008255739,"about_ca_topic_score_gemma":0.0005265097,"teacher_disagreement_score":0.99265736,"about_ca_system_score_codex":0.0001026238,"about_ca_system_score_gemma":0.00092910614,"threshold_uncertainty_score":0.9995644},"labels":[],"label_agreement":null},{"id":"W2619000912","doi":"10.1093/neuonc/nox083.184","title":"MEDU-34. INTELLECTUAL OUTCOME IN CHILDREN WITH SENSORINEURAL HEARING LOSS FOLLOWING TREATMENT FOR EMBRYONAL BRAIN TUMORS.","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"Medicine; Sensorineural hearing loss; Hearing loss; Neurocognitive; Audiology; Intellectual disability; Unilateral hearing loss; Pediatrics; Cognition; Psychiatry","score_opus":0.052435687920220055,"score_gpt":0.350994090986927,"score_spread":0.29855840306670695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2619000912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98812944,0.000053975633,0.000013684201,0.0092894295,0.00032656794,0.001390185,0.000016501483,0.000053126492,0.00072707876],"genre_scores_gemma":[0.99770766,0.000014784671,0.0004621071,0.0010039333,0.00026367282,0.00034236195,0.00003885704,0.000054448043,0.0001121534],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982175,0.00007774476,0.00039658262,0.000558496,0.00019406706,0.00055557786],"domain_scores_gemma":[0.99827635,0.0007810513,0.00016932338,0.00052426907,0.000040020248,0.00020899627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016285102,0.00032351637,0.0008179869,0.00018853297,0.0002657813,0.00004832301,0.00016019747,0.00012637657,0.000035961755],"category_scores_gemma":[0.00067096355,0.00023370843,0.00025373543,0.00007578018,0.00011804442,0.00009149002,0.00008882613,0.00019222355,0.000021733511],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006600078,0.0010427642,0.9735039,0.000012404888,0.0002967053,0.0023666762,0.00039355957,0.00002610345,0.010493818,0.00008918503,0.00038458663,0.010730276],"study_design_scores_gemma":[0.030197967,0.011296762,0.9220975,0.000083538966,0.00044915284,0.0028739367,0.00014856552,0.00036816878,0.022291016,0.00004106541,0.009776782,0.00037555327],"about_ca_topic_score_codex":0.00031843825,"about_ca_topic_score_gemma":0.00039568107,"teacher_disagreement_score":0.05140642,"about_ca_system_score_codex":0.00058745954,"about_ca_system_score_gemma":0.00020847228,"threshold_uncertainty_score":0.9530353},"labels":[],"label_agreement":null},{"id":"W2619229835","doi":"10.1093/neuonc/nox083.044","title":"DIPG-29. GENOMIC LANDSCAPE OF DIFFUSE INTRINSIC PONTINE GLIOMA: AN ANALYSIS OF THE DIPG-BATS COHORT","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"PTEN; Biopsy; Medicine; Cohort; KRAS; Glioma; Pathology; Autopsy; Oncology; Biology; Internal medicine; Mutation; Cancer research; Gene; Genetics; PI3K/AKT/mTOR pathway","score_opus":0.017598438854617576,"score_gpt":0.295787125691173,"score_spread":0.2781886868365554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2619229835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99536383,0.00018077128,0.0000019273077,0.0018191474,0.00035654707,0.00048582684,0.000049051196,0.000020196569,0.0017226955],"genre_scores_gemma":[0.9993585,0.00011165489,0.00004238445,0.00024704984,0.0001204622,0.000042869586,0.000034012854,0.00002399916,0.000019119698],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984485,0.00015321853,0.00048437112,0.00038826317,0.0002556684,0.00026998192],"domain_scores_gemma":[0.9973187,0.00024983115,0.0006312077,0.0014994971,0.00014917926,0.00015160446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021980121,0.00019925542,0.0010046037,0.00032930283,0.00015374336,0.000016356767,0.00041093226,0.0001560396,0.00013952382],"category_scores_gemma":[0.00033044565,0.00012932923,0.0003619585,0.00032721148,0.00026398886,0.000060674443,0.00024048149,0.00017429744,0.000008494858],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001986134,0.0016957858,0.74921507,0.000015726595,0.0010287471,0.00021294426,0.00015088833,0.000019573517,0.2436025,0.00011237816,0.00027918618,0.0034685584],"study_design_scores_gemma":[0.0040560546,0.001188464,0.9507192,0.000012682498,0.004670065,0.000055507615,0.000040110797,0.0002961327,0.036587715,0.000018017432,0.0022669542,0.00008910321],"about_ca_topic_score_codex":0.00032919616,"about_ca_topic_score_gemma":0.0007217598,"teacher_disagreement_score":0.20701478,"about_ca_system_score_codex":0.00008661112,"about_ca_system_score_gemma":0.00013109169,"threshold_uncertainty_score":0.5273893},"labels":[],"label_agreement":null},{"id":"W2619372708","doi":"10.1093/neuonc/nox083.150","title":"LGG-17. IMPACT OF STROKE AND STROKE RECURRENCE ON LATE MORTALITY AS WELL AS PSYCHOLOGICAL AND SOCIOECONOMIC OUTCOMES IN CHILDHOOD CANCER SURVIVORS","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cerebral Palsy and Movement Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Stroke (engine); Medicine; Socioeconomic status; Cohort; Odds ratio; Neurocognitive; Pediatrics; Physical therapy; Population; Internal medicine; Psychiatry; Cognition","score_opus":0.03316292017084609,"score_gpt":0.3892392467509061,"score_spread":0.35607632658006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2619372708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.969964,0.00011881163,2.3299091e-7,0.002485731,0.00029429523,0.00046629558,0.000074029296,0.000014593838,0.026582008],"genre_scores_gemma":[0.99609655,0.0013140681,0.000009299171,0.002000203,0.00003759335,0.0000224385,0.0000060862412,0.000012361047,0.00050142396],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99872166,0.000108576336,0.0003291607,0.00044214574,0.00010426355,0.00029417517],"domain_scores_gemma":[0.99896836,0.00020732956,0.00027466138,0.00037415358,0.000021439939,0.00015404221],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00025261965,0.00020840422,0.00065860566,0.00008769778,0.00008994639,0.000017070963,0.00014078473,0.00020256468,0.0009498807],"category_scores_gemma":[0.00022318873,0.00015900453,0.00011918219,0.000018364122,0.00034593494,0.00008370061,0.00009607923,0.00040673887,0.00003259768],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037220292,0.00049783714,0.9842485,0.00001717458,0.00008744049,0.00003531562,0.00022730305,0.000008849582,0.0041048904,0.000071420465,0.00034012503,0.009988918],"study_design_scores_gemma":[0.003924737,0.0033604593,0.9902042,0.000019203817,0.000055228473,0.0000123465725,0.000084981984,0.000019879959,0.0003389711,0.0003512201,0.0015059405,0.00012279049],"about_ca_topic_score_codex":0.004899831,"about_ca_topic_score_gemma":0.0049642576,"teacher_disagreement_score":0.026132524,"about_ca_system_score_codex":0.00008404554,"about_ca_system_score_gemma":0.00012489993,"threshold_uncertainty_score":0.9999634},"labels":[],"label_agreement":null},{"id":"W2619609401","doi":"10.1093/neuonc/nox083.116","title":"IMMU-05. MOLECULAR ANALYSES DEMONSTRATE AN IMMUNOSUPPRESSIVE PHENOTYPE IN THE CYST AND SOLID TUMOR COMPARTMENTS OF ADAMANTINOMATOUS CRANIOPHARYNGIOMA","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Vascular Tumors and Angiosarcomas","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Children's Hospital","funders":"","keywords":"Pathology; Immunohistochemistry; Craniopharyngioma; Cyst; CD163; CD8; Biology; Flow cytometry; Cancer research; Phenotype; Immunology; Medicine; Immune system; Gene; Endocrinology","score_opus":0.043213804506924115,"score_gpt":0.3732326288584201,"score_spread":0.330018824351496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2619609401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99582237,0.0009431467,0.000015207814,0.00090738456,0.00014211495,0.00044767736,0.000014663832,0.000017153965,0.0016902874],"genre_scores_gemma":[0.9985675,0.00006066745,0.0002617811,0.0009776531,0.000059564525,0.000021538019,0.000022625134,0.000024048708,0.0000046203254],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984042,0.00030963583,0.00041070356,0.00033381197,0.00022074491,0.00032088213],"domain_scores_gemma":[0.9985328,0.000110922876,0.0003624084,0.00079096376,0.00007860419,0.00012433449],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024912806,0.00020693985,0.0006669412,0.00011588063,0.00020380746,0.00004563668,0.00040509133,0.00007969381,0.000027231637],"category_scores_gemma":[0.0001715645,0.00014802677,0.00015404164,0.000084582636,0.00036379736,0.0001269772,0.00013626654,0.0002528121,0.0000071680824],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025149432,0.0005855107,0.027204856,0.000050441387,0.00011989532,0.009001814,0.00043101955,0.000009399796,0.9600622,0.0001623051,0.00013184237,0.0019891872],"study_design_scores_gemma":[0.0098458,0.0037139647,0.7714897,0.00015753701,0.00077972846,0.0070864144,0.0010751712,0.0018765507,0.20059325,0.00045099805,0.0025482157,0.0003827125],"about_ca_topic_score_codex":0.00018649985,"about_ca_topic_score_gemma":0.000026994836,"teacher_disagreement_score":0.759469,"about_ca_system_score_codex":0.000020813048,"about_ca_system_score_gemma":0.0001517178,"threshold_uncertainty_score":0.6036356},"labels":[],"label_agreement":null},{"id":"W2619698836","doi":"10.1093/neuonc/nox083.066","title":"EPND-08. EPIGENETIC H3K27ME3 DEREGULATION IN PEDIATRIC POSTERIOR FOSSA EPENDYMOMAS","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Ependymoma; Epigenetics; Biology; DNA methylation; CDKN2A; Genetics; Cancer research; Pathology; Bioinformatics; Cancer; Medicine; Gene; Gene expression","score_opus":0.030541969771129402,"score_gpt":0.32184959386543527,"score_spread":0.2913076240943059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2619698836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98575455,0.0004969735,0.000004927893,0.0076044532,0.0007021104,0.0006653517,0.0000057039283,0.000038103553,0.004727849],"genre_scores_gemma":[0.99822664,0.00023406111,0.0002466882,0.00071133464,0.0003695086,0.000119558725,0.000017084058,0.00003068549,0.0000444402],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998507,0.00011305562,0.00036855685,0.00043722533,0.00019074752,0.0003834192],"domain_scores_gemma":[0.9985814,0.00023985896,0.00024830544,0.00068674877,0.000066398134,0.00017727214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015767975,0.00019879,0.00045519453,0.00023132015,0.00018054928,0.000038653874,0.00017781262,0.00021612286,0.00018745242],"category_scores_gemma":[0.00033502176,0.00017708287,0.00010856727,0.00009919409,0.00008004629,0.00009300049,0.000128356,0.00019387784,0.0002329671],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019784419,0.0008546342,0.8774502,0.000044775225,0.000022129543,0.0026364033,0.00019050366,0.000012304904,0.048915904,0.00008787818,0.00088392635,0.068703465],"study_design_scores_gemma":[0.00513297,0.0013646302,0.97166675,0.000015289706,0.00018213825,0.0003713567,0.000019141025,0.000104342864,0.011672073,0.00019365775,0.009143447,0.00013419244],"about_ca_topic_score_codex":0.0001013687,"about_ca_topic_score_gemma":0.00047507024,"teacher_disagreement_score":0.094216526,"about_ca_system_score_codex":0.00020643408,"about_ca_system_score_gemma":0.0002026004,"threshold_uncertainty_score":0.72212297},"labels":[],"label_agreement":null},{"id":"W2619763457","doi":"10.1093/neuonc/nox083.191","title":"MEDU-41. MANAGEMENT OF MEDULLOBLASTOMA PATIENTS IN PRAGUE PEDIATRIC HEMATOLOGY AND ONCOLOGY CENTER","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Medulloblastoma; Internal medicine; Hematology; Radiation therapy; Incidence (geometry); Chemotherapy; Demographics; Single Center; Oncology; Pediatrics; Pathology","score_opus":0.021463238729196456,"score_gpt":0.30004425347937996,"score_spread":0.2785810147501835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2619763457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97339666,0.00024941243,0.0000041533385,0.002503437,0.00071616913,0.0010157471,0.000009307998,0.000023422894,0.022081694],"genre_scores_gemma":[0.9974455,0.00089961296,0.000802412,0.00050104555,0.00010230449,0.000113608985,0.000019878364,0.000033631874,0.00008197719],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978134,0.0002424974,0.000635214,0.00056755875,0.0002561664,0.00048517025],"domain_scores_gemma":[0.9981788,0.00026120094,0.0005435322,0.0006808872,0.00010926179,0.00022635135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002306963,0.00026544614,0.0009178685,0.0003062487,0.0000952583,0.000009318274,0.00025944132,0.00030996057,0.00007073666],"category_scores_gemma":[0.0001506577,0.0002301669,0.000096584634,0.000099277495,0.00028468907,0.00008169885,0.00043428259,0.00033214776,0.000047257865],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011709308,0.0022766406,0.9594898,0.00039587085,0.000109282075,0.005205392,0.00031396648,0.000001275758,0.0014357937,0.00045937105,0.0015832625,0.027558416],"study_design_scores_gemma":[0.014453033,0.0073771435,0.9533078,0.000052839994,0.00035458576,0.00077837636,0.00014537327,0.000025913263,0.0037354415,0.00011499667,0.019467847,0.00018664432],"about_ca_topic_score_codex":0.00008230559,"about_ca_topic_score_gemma":0.00020098763,"teacher_disagreement_score":0.027371773,"about_ca_system_score_codex":0.00040828422,"about_ca_system_score_gemma":0.00016907444,"threshold_uncertainty_score":0.9385934},"labels":[],"label_agreement":null},{"id":"W2620303175","doi":"10.1093/neuonc/nox083.149","title":"LGG-16. LOCATION AND HISTOLOGY DICTATE THE LIKELIHOOD OF MOLECULAR EVENTS IN PEDIATRIC LOW-GRADE GLIOMA","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Pilocytic astrocytoma; Medicine; Glioma; Cohort; Astrocytoma; Ganglioglioma; Oncology; Pathology; Histology; Internal medicine; Ependymoma; Incidence (geometry); Cancer research","score_opus":0.014194853004454989,"score_gpt":0.2907672175529607,"score_spread":0.2765723645485057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2620303175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881294,0.001135354,0.000015477748,0.009310824,0.00031924018,0.00047207836,0.0000025740542,0.000012103712,0.0006029541],"genre_scores_gemma":[0.9987838,0.00047557493,0.000036927548,0.00052439066,0.00006806385,0.00008443719,0.0000068510326,0.000016701824,0.0000032475823],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988973,0.00015477414,0.00029187012,0.0002774191,0.00013709035,0.00024151496],"domain_scores_gemma":[0.9988543,0.0002176666,0.00028485287,0.0004835452,0.00006875559,0.000090900554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016800292,0.00013561829,0.00036456238,0.00017609794,0.00009527596,0.000005262525,0.00016033926,0.00013767208,0.00001185247],"category_scores_gemma":[0.0003474634,0.00009841013,0.00005709216,0.00012772898,0.00014732523,0.000041892963,0.00010469911,0.00017140996,0.000012413268],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024059285,0.0017561164,0.73396873,0.00013357298,0.000064980864,0.0013650785,0.00043032697,0.0000091267075,0.24168488,0.0004788797,0.0006292478,0.019238457],"study_design_scores_gemma":[0.006711774,0.0015807438,0.943347,0.0000298579,0.0003442716,0.0003698965,0.00004806591,0.000103214676,0.044442568,0.0008024129,0.002108865,0.000111368085],"about_ca_topic_score_codex":0.00019729759,"about_ca_topic_score_gemma":0.00020529097,"teacher_disagreement_score":0.20937823,"about_ca_system_score_codex":0.00012795308,"about_ca_system_score_gemma":0.0001421926,"threshold_uncertainty_score":0.40130487},"labels":[],"label_agreement":null},{"id":"W2620330600","doi":"10.1093/neuonc/nox083.009","title":"ATRT-10. EARLY POST RADIATION CHANGES AND EFFICACY IN CHILDREN WITH ATRT TREATED ON COG ACNS 0333: A COMPARISON OF PROTON VS PHOTON THERAPY","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiation Therapy and Dosimetry","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital","funders":"","keywords":"Medicine; Radiation therapy; Prospective cohort study; Proton therapy; Nuclear medicine; Cog; Radiology; Internal medicine","score_opus":0.02660505966296628,"score_gpt":0.33486905830473795,"score_spread":0.3082639986417717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2620330600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937258,0.00024306026,8.8406983e-7,0.0029106985,0.00006183122,0.0023374602,0.000014363128,0.000040144216,0.00066575315],"genre_scores_gemma":[0.99801403,0.00041121786,0.000027158196,0.0011951877,0.0001245294,0.00010715402,0.00004736448,0.000030110352,0.00004322263],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988191,0.00016976577,0.0002669162,0.0003370713,0.00018549239,0.00022165221],"domain_scores_gemma":[0.99872327,0.00028274322,0.00041221146,0.0004042532,0.0000729035,0.00010459746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017167264,0.00019312267,0.0005658563,0.00023860145,0.00012690273,0.000024733188,0.00013086443,0.00021532115,0.000076250224],"category_scores_gemma":[0.00017580573,0.00014956394,0.000043016353,0.00012813546,0.00016796798,0.00008594217,0.000018463428,0.0002728651,0.000011609097],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009649639,0.0009975396,0.81550574,0.000017010376,0.00010158846,0.000014180075,0.0011693992,0.000006372814,0.091980435,0.000013686384,0.00017319102,0.08037123],"study_design_scores_gemma":[0.012373002,0.01849816,0.8396777,0.000037090394,0.000050562438,0.000028897655,0.000021585898,0.00013577919,0.12268352,0.000002567287,0.0063769943,0.000114176626],"about_ca_topic_score_codex":0.00034878607,"about_ca_topic_score_gemma":0.00008733074,"teacher_disagreement_score":0.08025705,"about_ca_system_score_codex":0.00007079085,"about_ca_system_score_gemma":0.000102720885,"threshold_uncertainty_score":0.60990405},"labels":[],"label_agreement":null},{"id":"W2620791330","doi":"10.1093/neuonc/nox106","title":"miR miR on the wall, who’s the most malignant medulloblastoma miR of them all?","year":2017,"lang":"de","type":"review","venue":"Neuro-Oncology","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute","keywords":"Medulloblastoma; microRNA; Biology; Cancer; Disease; Cancer research; Computational biology; Neuroscience; Bioinformatics; Gene; Genetics; Medicine; Pathology","score_opus":0.054968647001393776,"score_gpt":0.3264144711151832,"score_spread":0.2714458241137894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2620791330","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.044927068,0.9060558,0.00002767189,0.02440045,0.0048810625,0.008194077,0.0012779139,0.00006408952,0.010171833],"genre_scores_gemma":[0.033873588,0.95423454,0.00007728657,0.006870495,0.0017894782,0.00080361293,0.0010885408,0.00032426568,0.0009381881],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9930937,0.0024516967,0.0014754372,0.0014415261,0.0005731715,0.00096443435],"domain_scores_gemma":[0.99183184,0.0010194557,0.002696182,0.0038025905,0.00037792447,0.00027203138],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0011661602,0.0011171167,0.0019541176,0.000106634005,0.00053376344,0.00010411645,0.0031737792,0.0017214195,0.00041263265],"category_scores_gemma":[0.0011349242,0.0006414314,0.001249005,0.00020022289,0.0013180634,0.000009397436,0.0010464363,0.0010411066,0.00060652214],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084128464,0.0010866137,0.000044338543,0.0030240586,0.002413943,0.0002523029,0.00030934662,0.000017258719,0.63471884,0.0013865376,0.1407903,0.2151152],"study_design_scores_gemma":[0.0006812259,0.0012693687,0.00010296375,0.0009901332,0.001210179,0.0002899534,0.000038074966,0.00003430285,0.02542157,0.00008062859,0.9693172,0.0005644094],"about_ca_topic_score_codex":0.000037656057,"about_ca_topic_score_gemma":0.00007833805,"teacher_disagreement_score":0.8285269,"about_ca_system_score_codex":0.00024226098,"about_ca_system_score_gemma":0.0018343794,"threshold_uncertainty_score":0.9996037},"labels":[],"label_agreement":null},{"id":"W2622523903","doi":"10.1093/neuonc/nox109","title":"Phase I study of oral sonidegib (LDE225) in pediatric brain and solid tumors and a phase II study in children and adults with relapsed medulloblastoma","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":174,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Novartis Pharmaceuticals Corporation","keywords":"Medicine; Smoothened; Medulloblastoma; Internal medicine; Pharmacokinetics; Oncology; Adverse effect; Hedgehog; Pathology","score_opus":0.013360371952660523,"score_gpt":0.3147277899684112,"score_spread":0.3013674180157507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2622523903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980866,0.00029714667,0.0000019711028,0.0002023739,0.00004731875,0.001309089,0.000017592058,0.000008748373,0.000029190654],"genre_scores_gemma":[0.9995369,0.00013356881,0.00005063645,0.00009142922,0.00006355632,0.0000823628,0.0000068089666,0.00002777195,0.0000069684747],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99812406,0.0003053908,0.0004118109,0.0007111062,0.00012779825,0.00031982036],"domain_scores_gemma":[0.99906945,0.000080785074,0.00029113537,0.0003900209,0.00005689982,0.000111727386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046151277,0.00026042503,0.00057909504,0.00017753924,0.00020097967,0.000022353785,0.00019600624,0.0001332423,0.0000010752591],"category_scores_gemma":[0.0005012674,0.0002311716,0.000019378684,0.000099840494,0.00027164456,0.000012661109,0.0004969678,0.0002314992,2.1809007e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038974115,0.010163982,0.84394,0.000032179163,0.00010346197,0.00038370365,0.008441089,0.000008827534,0.12072241,0.0000012721679,0.00010059945,0.0122050205],"study_design_scores_gemma":[0.11715918,0.1738782,0.69246584,0.000034633373,0.00017740368,0.00024049856,0.0054908306,0.00010866039,0.009788914,0.0000101047535,0.00012843622,0.0005172999],"about_ca_topic_score_codex":0.00025866853,"about_ca_topic_score_gemma":0.0043279463,"teacher_disagreement_score":0.1637142,"about_ca_system_score_codex":0.000015518037,"about_ca_system_score_gemma":0.00011737304,"threshold_uncertainty_score":0.9426904},"labels":[],"label_agreement":null},{"id":"W2626604659","doi":"10.1093/neuonc/nox112","title":"PET imaging in patients with meningioma—report of the RANO/PET Group","year":2017,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":223,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University Health Network","funders":"","keywords":"Medicine; Radiosurgery; Meningioma; Neuroimaging; Radiology; Radiation therapy; Magnetic resonance imaging; Positron emission tomography; Functional imaging; Medical imaging; Brain tumor; Pet imaging; Modalities; Nuclear medicine; Medical physics; Pathology","score_opus":0.045132691653021785,"score_gpt":0.34367790068421616,"score_spread":0.29854520903119436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2626604659","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02680621,0.8810609,0.000025981324,0.0009149999,0.0039343503,0.008807749,0.00004632066,0.0001166503,0.07828686],"genre_scores_gemma":[0.08037607,0.90748113,0.003351322,0.0009927446,0.0012627352,0.0016342578,0.0011322891,0.00069616386,0.0030733002],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968123,0.0004516634,0.0010858695,0.00066842826,0.00052510825,0.00045662545],"domain_scores_gemma":[0.9964773,0.00022253982,0.0016194702,0.0014538238,0.00010781911,0.00011902275],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007106685,0.00045874942,0.0023925928,0.0003642421,0.0001168804,0.000023180099,0.00059670553,0.000114552095,0.000061584724],"category_scores_gemma":[0.00034408597,0.00027393037,0.0004158457,0.0002586842,0.00023493209,0.00007576396,0.00041968937,0.0006539001,0.000018329103],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003375708,0.00086755696,0.029877938,0.009011154,0.0003839338,0.08165366,0.00014544131,6.476317e-7,0.000027031576,0.00023712544,0.0043307254,0.8731272],"study_design_scores_gemma":[0.0023354176,0.0006048136,0.004679454,0.0035097254,0.0012358134,0.008067099,0.000010562034,0.0000041523654,0.0000014655128,0.000008510455,0.9793198,0.0002231732],"about_ca_topic_score_codex":0.000035822235,"about_ca_topic_score_gemma":0.000012051828,"teacher_disagreement_score":0.9749891,"about_ca_system_score_codex":0.0002724409,"about_ca_system_score_gemma":0.00053763436,"threshold_uncertainty_score":0.9999713},"labels":[],"label_agreement":null},{"id":"W2738871481","doi":"10.1093/neuonc/nox135","title":"Posterior fossa syndrome and long-term neuropsychological outcomes among children treated for medulloblastoma on a multi-institutional, prospective study","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute","keywords":"Neurocognitive; Neuropsychology; Working memory; Medicine; Psychology; Pediatrics; Cognition; Psychiatry","score_opus":0.04034337721608699,"score_gpt":0.38593050187779904,"score_spread":0.34558712466171204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2738871481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99248683,0.0000134481825,0.000026190764,0.0010573087,0.00021434139,0.0053914925,0.000036142672,0.000084245454,0.000689989],"genre_scores_gemma":[0.99801326,0.000012805446,0.00005925375,0.0007610276,0.000066492736,0.0007216643,0.000018577515,0.00002991928,0.00031698245],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979461,0.00019346642,0.00030268045,0.00077720743,0.00031409774,0.0004664537],"domain_scores_gemma":[0.998656,0.00026298178,0.00017304877,0.00046208868,0.00017957501,0.00026631777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002548591,0.0003014073,0.0006339955,0.00017385381,0.0006064125,0.00009684039,0.00024512233,0.00014691992,0.00007341805],"category_scores_gemma":[0.0007713084,0.00020915929,0.00013930188,0.00006246408,0.0006295262,0.00014079451,0.00022432326,0.0003737699,0.00003781401],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002498935,0.0041576587,0.97507465,0.000017948807,0.0002661721,0.0029614002,0.00009203716,1.3139794e-7,0.005203509,0.000009198482,0.000041085135,0.009677288],"study_design_scores_gemma":[0.01664653,0.029439766,0.9514749,0.00002936234,0.0002338907,0.0014394905,0.00003836365,0.000019129166,0.0004688738,0.0000071662816,0.00004127462,0.000161262],"about_ca_topic_score_codex":0.000029415425,"about_ca_topic_score_gemma":0.00008880158,"teacher_disagreement_score":0.02528211,"about_ca_system_score_codex":0.00011084751,"about_ca_system_score_gemma":0.00009761202,"threshold_uncertainty_score":0.8529268},"labels":[],"label_agreement":null},{"id":"W2739747835","doi":"10.1093/neuonc/nox142","title":"Divergent evolution of temozolomide resistance in glioblastoma stem cells is reflected in extracellular vesicles and coupled with radiosensitization","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":149,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; McGill University Health Centre","funders":"Canadian Institutes of Health Research","keywords":"Temozolomide; Extracellular vesicles; Glioblastoma; Cancer research; Microvesicles; Stem cell; Extracellular; Vesicle; Resistance (ecology); Radiation tolerance; Chemistry; Biology; Cell biology; Medicine; Radiation therapy; Internal medicine; Gene; Biochemistry; microRNA; Ecology","score_opus":0.015601166019688023,"score_gpt":0.2664914305790017,"score_spread":0.2508902645593137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739747835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99692863,0.0010054852,0.000023211769,0.0012980279,0.000086761276,0.00051216246,0.0000059882213,0.000010903189,0.00012881428],"genre_scores_gemma":[0.9993832,0.0002537077,0.00021744169,0.00006034055,0.000020464217,0.000027229617,0.0000017626018,0.000014931668,0.000020882297],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989498,0.00010558096,0.0002998045,0.0003065467,0.00014755395,0.00019067067],"domain_scores_gemma":[0.9991263,0.00013581551,0.00026968765,0.0003194397,0.00007806491,0.00007066199],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013656117,0.00012912299,0.0003995004,0.00018183682,0.00007074256,0.000009827814,0.000059090526,0.00011641182,0.000010581765],"category_scores_gemma":[0.000045950335,0.00011047868,0.000025783751,0.00013169067,0.0001327706,0.00007067351,0.000036200752,0.00011456825,0.0000031499999],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015644355,0.00046226394,0.14712058,0.000051991512,0.000024081754,0.0010846559,0.0004325736,0.000033331322,0.84738225,0.0001630754,0.00011865915,0.0015621273],"study_design_scores_gemma":[0.0088096205,0.0019011518,0.39691636,0.00020487912,0.00009966283,0.00006081681,0.00017180805,0.0017040003,0.58887935,0.00006585266,0.0010614411,0.00012507754],"about_ca_topic_score_codex":0.00014886292,"about_ca_topic_score_gemma":0.0023540014,"teacher_disagreement_score":0.2585029,"about_ca_system_score_codex":0.0003312814,"about_ca_system_score_gemma":0.00011379063,"threshold_uncertainty_score":0.450519},"labels":[],"label_agreement":null},{"id":"W2740873526","doi":"10.1093/neuonc/nox141","title":"Pediatric low-grade gliomas: next biologically driven steps","year":2017,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":165,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; Pediatric Low Grade Astrocytoma Foundation; Neurofibromatosis","keywords":"Medicine; Clinical trial; Pediatric oncology; Targeted therapy; Glioma; Oncology; Pace; Intensive care medicine; Internal medicine; Cancer; Cancer research","score_opus":0.13351496864950968,"score_gpt":0.3985664536496137,"score_spread":0.265051485000104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740873526","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010350357,0.9897348,0.000001310778,0.0007291743,0.001732292,0.00242998,0.000079641795,0.0001751355,0.0040825903],"genre_scores_gemma":[0.0004664623,0.9955084,0.00019859754,0.00060203957,0.0019746297,0.0007819622,0.00028597552,0.00011816851,0.00006380778],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959852,0.00057994615,0.0010843516,0.0012066583,0.00033397536,0.00080983265],"domain_scores_gemma":[0.99532723,0.0013955589,0.0011931342,0.0014348819,0.00012656437,0.00052262406],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024893932,0.00087021315,0.00437611,0.00062569126,0.00023752592,0.00008067906,0.00070579926,0.0014533531,0.00030963612],"category_scores_gemma":[0.00076270057,0.0005776695,0.0013178672,0.0003774082,0.00022111401,0.0000945815,0.0003922728,0.0010392747,0.0014014101],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027586064,0.0016161897,0.00066197343,0.0042243036,0.0003466823,0.009539691,0.000020998245,2.0821258e-7,0.0000909746,0.000100022895,0.007547099,0.9758243],"study_design_scores_gemma":[0.0019818956,0.0026916154,0.00019078636,0.0011192865,0.0047098403,0.0015378913,0.0000056071885,0.0000021330256,0.000008134141,0.000021724605,0.98732424,0.00040682565],"about_ca_topic_score_codex":0.000014060841,"about_ca_topic_score_gemma":0.000012998927,"teacher_disagreement_score":0.97977716,"about_ca_system_score_codex":0.0005111974,"about_ca_system_score_gemma":0.0012356387,"threshold_uncertainty_score":0.99984294},"labels":[],"label_agreement":null},{"id":"W2750409203","doi":"10.1093/neuonc/nox123","title":"Intracystic interferon-alpha in pediatric craniopharyngioma patients","year":2017,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Craniopharyngioma; Alpha interferon; Alpha (finance); Medicine; Interferon; Internal medicine; Radiology; Virology; Surgery","score_opus":0.01796820990187612,"score_gpt":0.28847173900155654,"score_spread":0.2705035290996804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2750409203","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.61068696,0.0015262936,0.000008207498,0.3454627,0.0068870666,0.0024056311,0.00018172117,0.00016245879,0.03267898],"genre_scores_gemma":[0.6088497,0.00093272264,0.000076526325,0.38273954,0.0048552635,0.00019409898,0.0015102563,0.00015178428,0.0006901154],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99734145,0.00018568993,0.0005969544,0.0008050226,0.00034729484,0.00072359934],"domain_scores_gemma":[0.9981944,0.0003764215,0.0003899278,0.00077803567,0.00009784839,0.00016335238],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00008831922,0.00052711484,0.0011639518,0.00055733946,0.00010408829,0.000029600209,0.00040042962,0.0011818521,0.00023381776],"category_scores_gemma":[0.00034821636,0.0004491247,0.00023320562,0.00012884082,0.00010656165,0.00011518986,0.00017266284,0.0020150032,0.00054834137],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005478902,0.0011328169,0.14700243,0.00029743213,0.000086087835,0.0289349,0.00010393151,2.9381795e-7,0.00003457463,0.0000011345878,0.8115657,0.010292788],"study_design_scores_gemma":[0.014462052,0.006596726,0.11566425,0.00008802669,0.00081801973,0.00045473705,0.00000558684,0.0000186686,0.000013963863,0.00022042972,0.86119014,0.00046739413],"about_ca_topic_score_codex":0.00012843807,"about_ca_topic_score_gemma":0.00004937587,"teacher_disagreement_score":0.04962442,"about_ca_system_score_codex":0.00037087343,"about_ca_system_score_gemma":0.00045146816,"threshold_uncertainty_score":0.99979603},"labels":[],"label_agreement":null},{"id":"W2754256645","doi":"10.1093/neuonc/nox147","title":"Intracystic interferon-alpha in pediatric craniopharyngioma patients-reply","year":2017,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Craniopharyngioma; Alpha interferon; Alpha (finance); Medicine; Dermatology; Interferon; Immunology; Endocrinology; Surgery","score_opus":0.017173050761528016,"score_gpt":0.28578250013391865,"score_spread":0.2686094493723906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754256645","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.45499098,0.0016411287,0.000009942351,0.5029894,0.0066147577,0.0024813002,0.0001832276,0.00018767327,0.030901546],"genre_scores_gemma":[0.41562766,0.00083264563,0.00008050975,0.57615477,0.0048710643,0.00020446634,0.0013455384,0.00015299412,0.0007303674],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99703425,0.00020755852,0.0006829121,0.0009164189,0.00038035936,0.0007784841],"domain_scores_gemma":[0.99786633,0.0004624337,0.00044911774,0.00092537154,0.0001188554,0.00017787103],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00011058074,0.0005773417,0.0012627984,0.00058865716,0.00011668019,0.00003449134,0.0004357026,0.0010129573,0.00026805737],"category_scores_gemma":[0.0004595373,0.0004924337,0.0002679141,0.00014491993,0.00012475008,0.00012833027,0.00018699856,0.0021504953,0.00056519074],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059897103,0.0010969837,0.112364516,0.00028918602,0.00009499464,0.027685536,0.00011570146,3.5385435e-7,0.00003669207,0.0000013396776,0.8481894,0.009526312],"study_design_scores_gemma":[0.0120717725,0.0061628856,0.07240569,0.0000744467,0.0007748192,0.00046036864,0.0000060323205,0.000016191256,0.00001373729,0.00019052358,0.9073933,0.00043024047],"about_ca_topic_score_codex":0.00020768507,"about_ca_topic_score_gemma":0.000052335607,"teacher_disagreement_score":0.073165305,"about_ca_system_score_codex":0.0004146428,"about_ca_system_score_gemma":0.0005441664,"threshold_uncertainty_score":0.99975276},"labels":[],"label_agreement":null},{"id":"W2759217131","doi":"10.1093/neuonc/nox178","title":"CUX1 stimulates APE1 enzymatic activity and increases the resistance of glioblastoma cells to the mono-alkylating agent temozolomide","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital; McGill University; Université de Montréal; Hôpital Maisonneuve-Rosemont; McGill University Health Centre","funders":"Cancer Research Society","keywords":"Temozolomide; AP site; Gene knockdown; DNA-(apurinic or apyrimidinic site) lyase; Cancer research; Base excision repair; DNA repair; DNA damage; Molecular biology; Methyltransferase; Glioblastoma; DNA; Biology; Chemistry; Gene; Biochemistry; Methylation","score_opus":0.013458208212282243,"score_gpt":0.27580349522216363,"score_spread":0.2623452870098814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2759217131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99679065,0.00019412208,0.00017530013,0.0015160748,0.00020405877,0.00047489945,0.000012657652,0.000013875392,0.00061835017],"genre_scores_gemma":[0.99833137,0.00007788413,0.0005766497,0.0006532891,0.0001343049,0.00004913137,0.0000014442898,0.000023307215,0.00015260497],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99868476,0.00032138338,0.00022902251,0.00037355846,0.00013037882,0.00026090923],"domain_scores_gemma":[0.9981805,0.00035202867,0.0003426963,0.00097371475,0.00006542523,0.00008565233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043841917,0.00017388248,0.00025164618,0.000025611182,0.00042380678,0.00004428336,0.0005631165,0.00013823842,0.000010167733],"category_scores_gemma":[0.0009620893,0.00011474577,0.000075736105,0.00004137786,0.00022361781,0.000007729505,0.00059543166,0.0001491542,0.000008939799],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030453157,0.00006142311,0.00025099592,0.000022482473,0.000031444804,0.000011744827,0.00020785406,0.00011911036,0.9916933,0.000044483393,0.0010965088,0.0061560753],"study_design_scores_gemma":[0.00041220544,0.00084155885,0.0022702878,0.000016016043,0.00004107625,0.000022849541,0.00013243839,0.00045477503,0.9720292,0.00012891956,0.02352838,0.00012227379],"about_ca_topic_score_codex":0.000102588725,"about_ca_topic_score_gemma":0.0007618483,"teacher_disagreement_score":0.02243187,"about_ca_system_score_codex":0.000023777597,"about_ca_system_score_gemma":0.000088219065,"threshold_uncertainty_score":0.4679197},"labels":[],"label_agreement":null},{"id":"W2767204445","doi":"10.1093/neuonc/nox168.154","title":"CMET-05. HEALTH-ECONOMIC ANALYSES OF RADIOTHERAPY FOR PATIENTS WITH BRAIN METASTASES: CAN ECONOMICS GUIDE THE ESTABLISHMENT OF PATIENT CARE PATHWAYS?","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Advances in Oncology and Radiotherapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Radiosurgery; Radiation therapy; MEDLINE; Salvage therapy; Brachytherapy; Surgery; Chemotherapy","score_opus":0.028522268532497418,"score_gpt":0.38427036659704034,"score_spread":0.35574809806454294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767204445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98191833,0.0019790898,0.0007930411,0.0097200675,0.001540763,0.0026633104,0.000790485,0.000021644411,0.00057325786],"genre_scores_gemma":[0.9674027,0.0024850648,0.018216059,0.010991034,0.00035710557,0.00025942724,0.00017423675,0.00008068582,0.00003367798],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99816424,0.00023041652,0.0007614473,0.00039845714,0.000102490514,0.0003429277],"domain_scores_gemma":[0.9961248,0.0010905226,0.0015466722,0.0009295293,0.00017762108,0.00013082499],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003242064,0.00023794523,0.0010481175,0.000121490935,0.00029527562,0.000011421246,0.0003871014,0.0001361096,0.000043061915],"category_scores_gemma":[0.00023092164,0.00015527586,0.00019390495,0.00003861221,0.00066273,0.00010077059,0.000052224055,0.00018421879,4.9784535e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009505748,0.0019942198,0.08027257,0.0004873461,0.0021672074,0.000033751105,0.010549785,0.004560207,0.0080699595,0.0021236073,0.029603435,0.85063213],"study_design_scores_gemma":[0.015782747,0.046941753,0.0068855453,0.00006655313,0.0003149638,0.00004950028,0.0019119919,0.00028865456,0.012701727,0.00018283846,0.914577,0.000296717],"about_ca_topic_score_codex":0.00036308702,"about_ca_topic_score_gemma":0.0006948357,"teacher_disagreement_score":0.8849736,"about_ca_system_score_codex":0.0008471407,"about_ca_system_score_gemma":0.0013428464,"threshold_uncertainty_score":0.6331966},"labels":[],"label_agreement":null},{"id":"W2767214300","doi":"10.1093/neuonc/nox168.247","title":"DDIS-11. TTI-2341: A NOVEL, ORALLY BIOAVAILABLE, BRAIN-PENETRANT, COVALENT EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) INHIBITOR FOR TREATMENT OF GLIOBLASTOMA MULTIFORME (GBM) AND BRAIN METASTASES OF NON-SMALL CELL LUNG CANCER (NSCLC)","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Therapeutics (Canada)","funders":"","keywords":"Erlotinib; Afatinib; Epidermal growth factor receptor; Pharmacology; Bioavailability; EGFR inhibitors; Blood–brain barrier; Cancer research; Gefitinib; Medicine; Cancer; Central nervous system; Internal medicine","score_opus":0.03715621773001542,"score_gpt":0.34614006948822057,"score_spread":0.30898385175820514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767214300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9831252,0.0014154331,0.00016856572,0.007980687,0.0012434223,0.003258498,0.00248606,0.0000422897,0.00027984992],"genre_scores_gemma":[0.99117994,0.0017070546,0.0032483998,0.0015470607,0.00060948986,0.00073699554,0.00011585935,0.000103939594,0.00075128203],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99726385,0.00015055298,0.000878196,0.0007783954,0.0002292884,0.0006997332],"domain_scores_gemma":[0.99625105,0.0015595042,0.00095920183,0.0005226953,0.0003332136,0.00037433175],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022818359,0.00055516267,0.0015991138,0.00029182635,0.00023514283,0.00002437984,0.0002571165,0.00030187704,0.00052726024],"category_scores_gemma":[0.00024628956,0.000456868,0.0003686588,0.00012984495,0.0005057572,0.00015914388,0.0001203794,0.00014864592,0.000006721793],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006788039,0.0034100448,0.0369634,0.00089000055,0.0005867465,0.00009789662,0.0010180166,0.000006525735,0.9193825,0.00002071696,0.019013152,0.01182297],"study_design_scores_gemma":[0.039273992,0.022285823,0.012247246,0.00013860932,0.0013592988,0.000094363066,0.00010748924,0.0005641274,0.7986197,0.0000040111518,0.12491741,0.00038794143],"about_ca_topic_score_codex":0.0016434095,"about_ca_topic_score_gemma":0.0025852367,"teacher_disagreement_score":0.1207628,"about_ca_system_score_codex":0.0005003864,"about_ca_system_score_gemma":0.0010332708,"threshold_uncertainty_score":0.9997883},"labels":[],"label_agreement":null},{"id":"W2767235977","doi":"10.1093/neuonc/nox168.752","title":"PDCT-08. TRAMETINIB AND DABRAFENIB FOR REFRACTORY/INOPERABLE PEDIATRIC LOW GRADE GLIOMAS","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Dabrafenib; Trametinib; Ganglioglioma; Medicine; Pilocytic astrocytoma; Oncology; Refractory (planetary science); Glioma; Internal medicine; Progressive disease; Anaplastic astrocytoma; Astrocytoma; Chemotherapy; Cancer research; Epilepsy; Cancer; MAPK/ERK pathway; Vemurafenib; Metastatic melanoma; Kinase; Biology","score_opus":0.03633574242593025,"score_gpt":0.3325535657413391,"score_spread":0.29621782331540886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767235977","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98556036,0.0009638778,0.00000927655,0.009043786,0.0008381232,0.0010487764,0.000033585588,0.00006509182,0.0024371126],"genre_scores_gemma":[0.9958172,0.0008476791,0.0009067286,0.0012134123,0.0007272363,0.00029545624,0.00002417881,0.000048470738,0.000119644676],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984285,0.00007390095,0.0003147745,0.0005512269,0.00016923863,0.00046235943],"domain_scores_gemma":[0.9980186,0.0006483528,0.0002501373,0.00068536645,0.00009444551,0.0003030729],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002055082,0.00024753535,0.0005953352,0.00017231054,0.00042969754,0.0000745992,0.0001851695,0.00025167075,0.00008454126],"category_scores_gemma":[0.0006971171,0.00020094441,0.0001445471,0.000079366015,0.00014447824,0.00013156972,0.00009331469,0.00023543449,0.00005280144],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019636045,0.009175879,0.33683962,0.00068171485,0.00041735137,0.0041228295,0.00095064606,0.000008470431,0.42501113,0.0022192926,0.067825206,0.15078427],"study_design_scores_gemma":[0.025865017,0.008240422,0.117058754,0.000035399353,0.0011309057,0.0006599997,0.000098438606,0.00023014922,0.049877875,0.0004021203,0.7959549,0.00044601588],"about_ca_topic_score_codex":0.000047112677,"about_ca_topic_score_gemma":0.00003959278,"teacher_disagreement_score":0.7281297,"about_ca_system_score_codex":0.00010469191,"about_ca_system_score_gemma":0.0001889446,"threshold_uncertainty_score":0.81942755},"labels":[],"label_agreement":null},{"id":"W2767242523","doi":"10.1093/neuonc/nox168.065","title":"ACTR-78. TAMIGA: A PHASE II STUDY EVALUATING THE EFFICACY AND SAFETY OF CONTINUOUS BEVACIZUMAB THROUGH MULTIPLE LINES OF TREATMENT FOR GLIOBLASTOMA","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Bevacizumab; Medicine; Temozolomide; Lomustine; Internal medicine; Clinical endpoint; Placebo; Randomization; Adverse effect; Progression-free survival; Oncology; Phases of clinical research; Randomized controlled trial; Chemotherapy; Surgery; Cyclophosphamide; Vincristine; Pathology","score_opus":0.0750547322509103,"score_gpt":0.4181039271747186,"score_spread":0.3430491949238083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767242523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99304736,0.00029582213,0.000012451216,0.0021063774,0.00023809062,0.0040428643,0.00007625413,0.000020311167,0.00016046152],"genre_scores_gemma":[0.99866873,0.00012397263,0.00044301807,0.00010011922,0.00013992039,0.00046888005,0.000009458384,0.000026858967,0.000019016585],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9984713,0.00016374943,0.0005423185,0.00038266723,0.00018002381,0.00025990346],"domain_scores_gemma":[0.9962785,0.0020711804,0.00063803664,0.00071622955,0.00022012189,0.00007589186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029700965,0.00023735594,0.0008903894,0.000055083437,0.00046806858,0.000013179796,0.00015762483,0.000096306074,0.000014894814],"category_scores_gemma":[0.0015304312,0.00014325,0.00015872052,0.000055922963,0.0002541173,0.0000582099,0.0001461753,0.00009160922,0.0000011683442],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02272757,0.029235713,0.036999695,0.00009207891,0.001162061,0.00018547972,0.009680171,0.000033988374,0.48912072,0.000090368165,0.00030246604,0.4103697],"study_design_scores_gemma":[0.22523418,0.5079188,0.049199663,0.00013759137,0.0033904226,0.00019501825,0.0023903626,0.0024579484,0.1942668,0.00006170643,0.014498467,0.00024905993],"about_ca_topic_score_codex":0.00022206757,"about_ca_topic_score_gemma":0.0002826615,"teacher_disagreement_score":0.47868305,"about_ca_system_score_codex":0.00012653318,"about_ca_system_score_gemma":0.00019445129,"threshold_uncertainty_score":0.5841566},"labels":[],"label_agreement":null},{"id":"W2767269234","doi":"10.1093/neuonc/nox168.787","title":"PDTM-23. THE ACTIVE REGULATORY LANDSCAPE OF EPENDYMAL TUMORS","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Biology; Chromatin; Computational biology; Enhancer; Ependymoma; Epigenomics; Lineage (genetic); Transcription factor; Targeted therapy; Cancer research; DNA methylation; Gene; Genetics; Cancer; Gene expression; Medicine; Pathology","score_opus":0.01228482971737915,"score_gpt":0.2726316945119013,"score_spread":0.2603468647945221,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767269234","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97851497,0.00023071076,0.000027911203,0.0014201038,0.00066204264,0.00018025545,0.000057212565,0.000005307051,0.018901499],"genre_scores_gemma":[0.99809426,0.00027644171,0.00007334059,0.00085115794,0.0005022375,0.000021028687,0.000026186477,0.000020031153,0.00013534266],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991652,0.000066416316,0.0001887817,0.000276209,0.00008948338,0.0002139059],"domain_scores_gemma":[0.998641,0.00010464739,0.00028731985,0.00081681623,0.00008314506,0.00006705807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015167767,0.00012272793,0.00019889134,0.000022471208,0.00020781533,0.000020679663,0.0005113926,0.00015948906,0.000034906807],"category_scores_gemma":[0.0004414748,0.00009765,0.000099530866,0.00002060287,0.0002881349,0.0000034915538,0.00033951143,0.00014275525,0.000013929456],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035229523,0.000092374845,0.004588676,0.0000092608425,0.000051925297,0.000034702884,0.000109929744,0.00006652265,0.9612665,0.0009517482,0.016702361,0.015773688],"study_design_scores_gemma":[0.001072542,0.0010932669,0.04057563,0.0000057314787,0.000043721786,0.0000805954,0.00014225859,0.0000466839,0.50636655,0.00024195293,0.45016372,0.00016730686],"about_ca_topic_score_codex":0.00003673736,"about_ca_topic_score_gemma":0.00014136535,"teacher_disagreement_score":0.45489994,"about_ca_system_score_codex":0.00002017378,"about_ca_system_score_gemma":0.00029807357,"threshold_uncertainty_score":0.39820513},"labels":[],"label_agreement":null},{"id":"W2767282654","doi":"10.1093/neuonc/nox168.294","title":"EPID-17. A SINGLE CENTER RESTROSPECTIVE REVIEW OF RECURRENT OR TREATMENT REFRACTORY PEDIATRIC MEDULLOBLASTOMA","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Salvage therapy; Refractory (planetary science); Medulloblastoma; Retrospective cohort study; Surgery; Internal medicine; Oncology; Chemotherapy; Pathology","score_opus":0.053346709267348205,"score_gpt":0.36108596814771104,"score_spread":0.30773925888036285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767282654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9366719,0.01973361,0.00000322103,0.018980399,0.0017675991,0.002473488,0.00012267892,0.000089179506,0.02015789],"genre_scores_gemma":[0.9235776,0.072654955,0.00030945774,0.0021537493,0.00066321116,0.0003693201,0.000041179446,0.000052351315,0.0001781937],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99811035,0.00017422937,0.0005530218,0.0005192754,0.00027199718,0.00037114767],"domain_scores_gemma":[0.9974523,0.00040808477,0.00071595534,0.0009701352,0.00019627722,0.00025725423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015280615,0.00029471578,0.0009981577,0.00013825195,0.00015536795,0.000013350418,0.0001883693,0.00014341513,0.00044714884],"category_scores_gemma":[0.0009316899,0.00019532084,0.00028986883,0.000108640255,0.00014712551,0.00007776716,0.00011076316,0.00018286065,0.00007345773],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005094252,0.046792984,0.35611597,0.0038963535,0.0009202541,0.008996741,0.000753999,8.6362843e-7,0.037142828,0.00019144577,0.16357948,0.37651482],"study_design_scores_gemma":[0.015558366,0.05077877,0.09735583,0.002225655,0.0020512026,0.000933374,0.00005122962,0.0000054622465,0.02077928,0.000041579424,0.80986345,0.00035577762],"about_ca_topic_score_codex":0.00004560177,"about_ca_topic_score_gemma":0.000116112176,"teacher_disagreement_score":0.646284,"about_ca_system_score_codex":0.00088131434,"about_ca_system_score_gemma":0.00039857483,"threshold_uncertainty_score":0.79649526},"labels":[],"label_agreement":null},{"id":"W2767284193","doi":"10.1093/neuonc/nox168.389","title":"GENE-15. CHARACTERIZATION OF DIFFERENTIAL 5-HYDROXYMETHYLCYTOSINE IN IDH1 MUTANT VERSUS IDH1 WILD-TYPE HIGH-GRADE GLIOMAS","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University Health Network","funders":"","keywords":"Biology; Mutant; IDH1; Epigenetics; Wild type; 5-Hydroxymethylcytosine; Gene; DNA methylation; Glioma; CpG site; Phenotype; Molecular biology; Methylation; Genetics; Gene expression; Cancer research","score_opus":0.022445154476185263,"score_gpt":0.2960721161908539,"score_spread":0.2736269617146686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767284193","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964162,0.00018683972,0.00048570067,0.0003862239,0.0019576007,0.00026054468,0.000037103917,0.000010921937,0.00025884327],"genre_scores_gemma":[0.99782676,0.00092984043,0.0002761725,0.00006923589,0.000475146,0.000016570755,0.00035330898,0.00003656858,0.000016415857],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998398,0.00020644045,0.00044138555,0.00047515126,0.00017040115,0.0003086422],"domain_scores_gemma":[0.9985788,0.0000497613,0.00046724704,0.00069384376,0.000118130076,0.00009220969],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018379152,0.00021559377,0.00036498928,0.00012745878,0.00013126568,0.000032261956,0.0003818439,0.00039294947,0.000036356887],"category_scores_gemma":[0.00034434334,0.00022011389,0.0000871644,0.000102892795,0.00016762073,0.0000118522275,0.00023571847,0.0001671363,0.000007661236],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006754994,0.00019560294,0.004205246,0.000013314337,0.00003419025,0.00002743051,0.000045242996,0.00003357876,0.9873346,0.000064656786,0.000010528391,0.0073600807],"study_design_scores_gemma":[0.0027497632,0.0015470159,0.031508844,0.000006793266,0.000040333478,0.0000058198957,0.0000063503844,0.00018511688,0.9521234,0.00007708087,0.011559699,0.00018977509],"about_ca_topic_score_codex":0.00008342186,"about_ca_topic_score_gemma":0.00016447982,"teacher_disagreement_score":0.03521122,"about_ca_system_score_codex":0.000041343446,"about_ca_system_score_gemma":0.00014540828,"threshold_uncertainty_score":0.8975984},"labels":[],"label_agreement":null},{"id":"W2767284462","doi":"10.1093/neuonc/nox168.411","title":"GENE-38. DISRUPTED ENDOTHELIAL CELL GENE EXPRESSION PROFILE PREDICTS GBM CLINICAL RESPONSE TO ANTI-ANGIOGENIC THERAPY","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Angiogenesis; Cancer research; Genetic enhancement; Mesenchymal stem cell; Vascular endothelial growth factor; Biology; Gene expression; Medicine; Pathology; Gene; Immunology; VEGF receptors; Genetics","score_opus":0.02902645458003236,"score_gpt":0.33759156540951646,"score_spread":0.3085651108294841,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767284462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894311,0.001496576,0.00021588548,0.0008516997,0.0058157905,0.000836345,0.00025331482,0.000043997457,0.0010552905],"genre_scores_gemma":[0.9829871,0.0048897252,0.0017566079,0.0023662162,0.006642447,0.00018931618,0.00009776503,0.00009018922,0.000980618],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968954,0.000752525,0.0005470727,0.00097033224,0.00023060593,0.00060411816],"domain_scores_gemma":[0.9974409,0.00013409054,0.0003739613,0.0015099257,0.00014011443,0.00040101487],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007636433,0.00032838757,0.00053572794,0.00008231759,0.00036770545,0.000059613096,0.00083470077,0.00059016654,0.000101357546],"category_scores_gemma":[0.00073412556,0.0002950401,0.00035262515,0.00006035226,0.0002494331,0.00001186414,0.0004933211,0.000281132,0.00008724443],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005093313,0.0003247835,0.0016816647,0.000005121068,0.000038494367,0.000040243995,0.00010085783,0.0000099253775,0.9561701,0.000001134332,0.021821417,0.014712961],"study_design_scores_gemma":[0.0024178217,0.0012431053,0.007109519,0.0000031410723,0.000020228903,0.000038948852,0.000009247558,0.000005922738,0.5303333,0.0000038605112,0.45864666,0.00016827596],"about_ca_topic_score_codex":0.000018629791,"about_ca_topic_score_gemma":0.000015015807,"teacher_disagreement_score":0.43682525,"about_ca_system_score_codex":0.00003117973,"about_ca_system_score_gemma":0.0006036488,"threshold_uncertainty_score":0.9999502},"labels":[],"label_agreement":null},{"id":"W2767301503","doi":"10.1093/neuonc/nox168.561","title":"NCMP-12. GLIOMA RELATED EPILEPSY: CLINICAL AND PATHOLOGICAL CORRELATES","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Medicine; Epilepsy; Glioma; Oligodendroglioma; IDH1; Pathological; Astrocytoma; Temporal lobe; Semiology; Incidence (geometry); Brain tumor; Retrospective cohort study; Neuroimaging; Internal medicine; Radiology; Pathology; Psychiatry","score_opus":0.05411658435647271,"score_gpt":0.36584818869682656,"score_spread":0.31173160434035385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767301503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9723136,0.00040329562,0.0000021631704,0.013269857,0.0012956979,0.00043600274,0.000007804805,0.000098923796,0.012172675],"genre_scores_gemma":[0.99720037,0.0006950833,0.00027044196,0.0014708872,0.00020835403,0.00005178057,0.000014341384,0.000026674918,0.0000620467],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980898,0.00025358715,0.00055236503,0.00059311074,0.00015111694,0.00036000175],"domain_scores_gemma":[0.99770606,0.0008804264,0.00030100424,0.00069591776,0.00006816753,0.00034845722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042199073,0.00021989192,0.0007437002,0.00008397353,0.0003195139,0.00004382912,0.00016881456,0.0005661907,0.00021576427],"category_scores_gemma":[0.0017708469,0.00016030644,0.00018029561,0.000047062418,0.00076855253,0.00007346078,0.00023841055,0.000561221,0.00024407989],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003202266,0.0012390327,0.8942492,0.000009503115,0.00008582186,0.013813984,0.000080718426,3.977877e-7,0.015692454,0.001092895,0.0060051163,0.06741064],"study_design_scores_gemma":[0.0089891525,0.004988731,0.92620057,0.000037820402,0.00035448285,0.0032501256,0.000031732994,0.00015401107,0.0015370746,0.0011631559,0.053128798,0.00016436045],"about_ca_topic_score_codex":0.000011468157,"about_ca_topic_score_gemma":0.000011411299,"teacher_disagreement_score":0.06724627,"about_ca_system_score_codex":0.00004541137,"about_ca_system_score_gemma":0.000089465946,"threshold_uncertainty_score":0.6537107},"labels":[],"label_agreement":null},{"id":"W2767309224","doi":"10.1093/neuonc/nox168.1125","title":"SCDT-45. ANTIBODY-BASED PET IMAGING OF BRAIN CANCER CELLS INFILTRATION","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Canada; Université de Sherbrooke","funders":"","keywords":"Antibody; Blood–brain barrier; Transcytosis; Parenchyma; Cancer research; Infiltration (HVAC); Pathology; Medicine; Immunology; Central nervous system; Receptor; Internal medicine; Endocytosis","score_opus":0.017713653375409078,"score_gpt":0.3687227991134237,"score_spread":0.3510091457380146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767309224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930302,0.00023514648,0.00021436106,0.0026913364,0.00040438425,0.0002491668,0.000107455686,0.000008807895,0.0030591327],"genre_scores_gemma":[0.9982707,0.00022198544,0.00019711939,0.000858021,0.00018398506,0.000040509003,0.0001001025,0.000017931685,0.000109676286],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99906695,0.00009322641,0.00015927959,0.00030113125,0.00012141004,0.00025798246],"domain_scores_gemma":[0.99910456,0.000038519942,0.00018887894,0.00047917257,0.00009545326,0.00009343746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012079409,0.000109008666,0.00016875986,0.00003857237,0.00016378704,0.00004092918,0.0002602186,0.00006562207,0.000081575905],"category_scores_gemma":[0.00014262903,0.00011262487,0.00007885548,0.000028170372,0.00020156028,0.000007903497,0.00010128714,0.000100838566,0.000009078177],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001666256,0.0001016905,0.032897253,0.00001780908,0.000027051636,0.00006458106,0.000010886189,0.00003581533,0.94984686,0.000007100075,0.0060203886,0.010803935],"study_design_scores_gemma":[0.0016229732,0.00057711283,0.0070709293,0.000009489159,0.000016419608,0.000016125952,0.000008227314,0.0001824534,0.88081473,0.000023619232,0.1095601,0.000097817916],"about_ca_topic_score_codex":0.0017434901,"about_ca_topic_score_gemma":0.0023696276,"teacher_disagreement_score":0.10353971,"about_ca_system_score_codex":0.0000431349,"about_ca_system_score_gemma":0.00051175925,"threshold_uncertainty_score":0.4592709},"labels":[],"label_agreement":null},{"id":"W2767312190","doi":"10.1093/neuonc/nox168.903","title":"RTHP-19. DIFFUSE INTRINSIC PONTINE GLIOMA AS A LATE COMPLICATION OF MEDULLOBLASTOMA THERAPY","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Vascular Tumors and Angiosarcomas","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Medicine; Radiation therapy; Malignancy; Oncology; Internal medicine; Pathology","score_opus":0.02686834350270848,"score_gpt":0.3172100132677751,"score_spread":0.2903416697650666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767312190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9814278,0.0003074477,0.000034568286,0.012323288,0.0002788875,0.00046238498,0.000004923591,0.000066334476,0.0050943773],"genre_scores_gemma":[0.9969584,0.0002990419,0.00026511904,0.0019979277,0.0002477876,0.000032103708,0.000014797553,0.000034155622,0.0001507209],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987146,0.000109020475,0.0003434378,0.00032984867,0.00022917091,0.0002739184],"domain_scores_gemma":[0.9982271,0.00012829893,0.00038079044,0.00093068037,0.00014033166,0.0001927898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020250592,0.00017453349,0.00054242957,0.0001436743,0.00017853141,0.0000201895,0.0003053722,0.00014316088,0.00011997878],"category_scores_gemma":[0.00041410088,0.00014394512,0.00020964064,0.00010160361,0.00025147808,0.000073274314,0.00012724541,0.00022965629,0.00010243337],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007449007,0.00087397796,0.01517683,0.000031519143,0.00009105683,0.00054907356,0.0002690631,8.256142e-7,0.9089872,0.0011869931,0.0014646901,0.07062382],"study_design_scores_gemma":[0.017734852,0.006633495,0.34607288,0.00007389594,0.00017375458,0.0025763211,0.00005695638,0.00021593545,0.15611811,0.0010762267,0.46895516,0.0003123931],"about_ca_topic_score_codex":0.00014871657,"about_ca_topic_score_gemma":0.00003336503,"teacher_disagreement_score":0.7528691,"about_ca_system_score_codex":0.000050983566,"about_ca_system_score_gemma":0.00017118394,"threshold_uncertainty_score":0.58699113},"labels":[],"label_agreement":null},{"id":"W2767313442","doi":"10.1093/neuonc/nox168.207","title":"CSIG-12. EXPLORING THE FUNCTIONAL RELATIONSHIP BETWEEN CAPICUA (CIC) AND ATAXIN-1-LIKE (ATXN1L) IN GLIOMA","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency; Genome British Columbia; University of British Columbia","funders":"","keywords":"Biology; Glioma; Gene expression profiling; Microarray analysis techniques; Cancer research; Gene; Gene expression; Genetics","score_opus":0.15486557637539858,"score_gpt":0.33205996342151545,"score_spread":0.17719438704611687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767313442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97893316,0.00021373674,0.0000065404683,0.017671395,0.0006704088,0.00039223282,0.000008854117,0.00003111279,0.0020725797],"genre_scores_gemma":[0.9986743,0.00005090534,0.00006978947,0.00047372864,0.00041353214,0.00022920889,0.000019871686,0.000020775818,0.000047943286],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99884367,0.00012765026,0.0002408158,0.00033581498,0.00018400849,0.00026801284],"domain_scores_gemma":[0.99782264,0.0013441433,0.00014134079,0.0005167645,0.000040783558,0.00013430101],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025595762,0.00015733676,0.0003145056,0.00014873665,0.00044309316,0.000045898923,0.0001281044,0.000117811986,0.00004289489],"category_scores_gemma":[0.00063719176,0.00011221035,0.00007825971,0.00007773541,0.00018544302,0.00016253014,0.00013699706,0.00034494928,0.000071115166],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008806423,0.0001454151,0.98239714,0.000011768283,0.000041567364,0.00050225743,0.00029670153,0.0000040720747,0.0055293613,0.00075617974,0.001987054,0.008240436],"study_design_scores_gemma":[0.0029339893,0.0004415368,0.94139034,0.000024276647,0.00012930529,0.00018331442,0.0000995131,0.000013180109,0.0015700149,0.00030439883,0.0528269,0.00008322678],"about_ca_topic_score_codex":0.00012540902,"about_ca_topic_score_gemma":0.0003489106,"teacher_disagreement_score":0.05083985,"about_ca_system_score_codex":0.00014316957,"about_ca_system_score_gemma":0.00010131873,"threshold_uncertainty_score":0.45758054},"labels":[],"label_agreement":null},{"id":"W2767332947","doi":"10.1093/neuonc/nox168.811","title":"PDTM-49. GLOBAL REDUCTION IN H3K27me3, SIMILAR TO H3K27M MUTANT GLIOMAS, IS A MOLECULAR SURROGATE FOR PEDIATRIC POSTERIOR FOSSA- GROUP A EPENDYMOMAS","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Vancouver General Hospital; Children's & Women's Health Centre of British Columbia; Hospital for Sick Children","funders":"","keywords":"Epigenetics; Immunohistochemistry; DNA methylation; Ependymoma; Biology; Methylation; Pathology; Oncology; Medicine; Genetics; Gene","score_opus":0.024773382624533057,"score_gpt":0.3334404731730753,"score_spread":0.30866709054854224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767332947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97395694,0.00054447213,0.000038885715,0.020626625,0.0013137546,0.0025012137,0.00015130303,0.00007525438,0.0007915722],"genre_scores_gemma":[0.99553895,0.00011378555,0.00089909014,0.0022382522,0.00041989394,0.00069013797,0.000031169075,0.00005574546,0.00001297466],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99721235,0.00013915796,0.0006005192,0.0009506157,0.00033232107,0.00076501415],"domain_scores_gemma":[0.99793994,0.0001485209,0.00032833387,0.00097502477,0.00017656542,0.00043163038],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032535597,0.00040180076,0.00083083834,0.0003169688,0.00025928652,0.000079292746,0.00032595897,0.0003343386,0.000060767776],"category_scores_gemma":[0.0005911595,0.000375666,0.00030381538,0.00035040322,0.000096146454,0.00015089329,0.00023365996,0.0002156538,0.00009942324],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035305747,0.003409021,0.06290418,0.00021937085,0.00017678317,0.013347937,0.0006927658,0.000020300027,0.8672687,0.0003560717,0.005570187,0.04250413],"study_design_scores_gemma":[0.064270146,0.0352006,0.28578913,0.00029766015,0.0029809102,0.009956219,0.0006204163,0.00054928864,0.45027488,0.0026111868,0.14552668,0.0019228619],"about_ca_topic_score_codex":0.00026359243,"about_ca_topic_score_gemma":0.00029322607,"teacher_disagreement_score":0.4169938,"about_ca_system_score_codex":0.00067459093,"about_ca_system_score_gemma":0.0002753471,"threshold_uncertainty_score":0.9998695},"labels":[],"label_agreement":null},{"id":"W2767357331","doi":"10.1093/neuonc/nox168.002","title":"ACTR-02. DCC-2618, A NOVEL pan-KIT AND PDGFRa KINASE SWITCH CONTROL INHIBITOR, SHOWS ENCOURAGING SIGNAL IN A PATIENT (PT) WITH GLIOBLASTOMA (GBM)","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"PDGFRA; Temozolomide; Medicine; Cancer research; Kinase; Internal medicine; Glioma; Oncology; Chemistry","score_opus":0.013906961054350183,"score_gpt":0.2680006799037273,"score_spread":0.2540937188493771,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767357331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99137264,0.00024159842,0.000048723712,0.005796235,0.00028271438,0.0011950483,0.000029596315,0.00005260805,0.0009808575],"genre_scores_gemma":[0.99688786,0.000041516858,0.00020662583,0.00225394,0.00020688405,0.0003362357,0.0000057339007,0.00005084717,0.000010365119],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99778134,0.00010862321,0.00045002706,0.00068982574,0.00035549948,0.0006146887],"domain_scores_gemma":[0.99808496,0.00049826445,0.00035980032,0.00058889523,0.00013072294,0.00033734186],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019997059,0.00038418642,0.00082321005,0.00025938044,0.00025662145,0.00008895079,0.0001641914,0.0002179681,0.000068993875],"category_scores_gemma":[0.00020429962,0.00029000617,0.000095992094,0.00011661624,0.00024215697,0.00017511565,0.0001413019,0.00047423335,0.000020405558],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041753254,0.00442037,0.18155314,0.00008051782,0.00026061843,0.015291536,0.002033186,0.000032604003,0.70478547,0.00015505403,0.0010324543,0.086179726],"study_design_scores_gemma":[0.16288447,0.06784176,0.28312254,0.001247285,0.0019034387,0.0070567317,0.0024206676,0.0058191833,0.39138824,0.00017088564,0.074339,0.0018058037],"about_ca_topic_score_codex":0.00024738527,"about_ca_topic_score_gemma":0.0010891497,"teacher_disagreement_score":0.31339723,"about_ca_system_score_codex":0.00030006355,"about_ca_system_score_gemma":0.00032109494,"threshold_uncertainty_score":0.99995524},"labels":[],"label_agreement":null},{"id":"W2767364701","doi":"10.1093/neuonc/nox168.116","title":"ATIM-21. INTRAVENOUS DELIVERY OF TOCA 511 IN PATIENTS WITH HIGH GRADE GLIOMA RESULTS IN QUANTIFIABLE EXPRESSION OF CYTOSINE DEAMINASE IN TUMOR TISSUE","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Brain Institute","funders":"","keywords":"Cytosine deaminase; Molecular biology; Immunohistochemistry; Biology; Pathology; Cancer research; Genetic enhancement; Medicine; Gene","score_opus":0.01625679268987702,"score_gpt":0.2933595000695888,"score_spread":0.27710270737971177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767364701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99889946,0.00010238692,0.0000037676684,0.00012756062,0.000101402766,0.00057220506,0.00006601102,0.0000034681668,0.00012373086],"genre_scores_gemma":[0.9993267,0.00006941441,0.000345887,0.000055456167,0.00003197827,0.00004164586,0.00008539307,0.000029050212,0.0000144814485],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998025,0.00035217847,0.0005392833,0.0004790248,0.00021936843,0.00038515773],"domain_scores_gemma":[0.99858963,0.00008329878,0.0003668965,0.00076232,0.0001264964,0.00007133508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003957342,0.00018177734,0.00043475418,0.0002599858,0.000045825338,0.000009119407,0.0004825516,0.00020407375,0.0000107674905],"category_scores_gemma":[0.00030729378,0.00016736868,0.000030456999,0.00017259632,0.00023760239,0.000013202313,0.00023633598,0.0002290305,0.0000024549531],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.047859084,0.0011354642,0.01802936,0.000043753163,0.0000073399838,0.00019791244,0.000120614175,0.00027158757,0.92916685,0.0000035105518,0.000094585914,0.0030699375],"study_design_scores_gemma":[0.0074174767,0.035516333,0.04754575,0.0000762442,0.000004266476,0.000006606629,0.000028486236,0.000038028415,0.9087949,0.000015406455,0.000419729,0.00013676997],"about_ca_topic_score_codex":0.0006336605,"about_ca_topic_score_gemma":0.009880304,"teacher_disagreement_score":0.040441606,"about_ca_system_score_codex":0.00006715555,"about_ca_system_score_gemma":0.00027230688,"threshold_uncertainty_score":0.68250966},"labels":[],"label_agreement":null},{"id":"W2767364728","doi":"10.1093/neuonc/nox168.477","title":"IMMU-19. QUANTITATION AND CHARACTERIZATION OF GLIOBLASTOMA-ASSOCIATED MICROGLIA AND MACROPHAGES REVEALS HIGHLY VARIABLE INFLAMMATORY PROFILES AND AN INVERSE RELATIONSHIP TO PERITUMORAL EDEMA VOLUME","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Microglia; Infiltration (HVAC); Immune system; Immunotherapy; Inflammation; Pathology; Flow cytometry; Cancer research; Glioblastoma; CD8; Tumor microenvironment; Phenotype; Medicine; Biology; Immunology","score_opus":0.021612279891535625,"score_gpt":0.29875420961840055,"score_spread":0.2771419297268649,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767364728","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99676836,0.000084407446,0.0000060216557,0.0021801505,0.00013750707,0.000678972,0.000051602954,0.000030190518,0.00006276321],"genre_scores_gemma":[0.9985481,0.0000904216,0.00078114733,0.0003266613,0.00005294801,0.00007039426,0.00006173086,0.0000202461,0.000048339713],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99894875,0.00017233154,0.0002994969,0.0003076211,0.000100885336,0.00017091024],"domain_scores_gemma":[0.9989458,0.00014544428,0.0003428538,0.00023571843,0.0001432118,0.00018700841],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025597043,0.0001439494,0.00036914108,0.00015124382,0.0002732294,0.000058090587,0.000051840678,0.00015722345,0.000013321653],"category_scores_gemma":[0.00075496844,0.00013720157,0.00002034257,0.00007109196,0.00016773138,0.00026904148,0.000078029385,0.000099876765,0.0000043755913],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001718747,0.0001293741,0.4326323,0.000058913603,0.000022609032,0.000053879972,0.0004584964,4.722978e-7,0.5653386,0.00035697524,0.00014239384,0.00063408975],"study_design_scores_gemma":[0.002898928,0.0019696061,0.97032905,0.000069350106,0.00015859146,0.00006887394,0.00010999245,0.00025173355,0.022968775,0.00011213812,0.00095754897,0.000105436004],"about_ca_topic_score_codex":0.000072448864,"about_ca_topic_score_gemma":0.00006225971,"teacher_disagreement_score":0.54236984,"about_ca_system_score_codex":0.00006828045,"about_ca_system_score_gemma":0.00008915045,"threshold_uncertainty_score":0.55949175},"labels":[],"label_agreement":null},{"id":"W2767370381","doi":"10.1093/neuonc/nox164","title":"IDH mutation testing in gliomas—where do we draw the line?","year":2017,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Line (geometry); Mutation; Genetics; Biology; Mathematics","score_opus":0.04592891768764163,"score_gpt":0.32955756888985777,"score_spread":0.28362865120221614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767370381","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05171947,0.0028202792,0.0000019891695,0.93436426,0.0015075775,0.0011870781,0.000023548953,0.00008047517,0.008295319],"genre_scores_gemma":[0.3301805,0.0013127637,0.0006880498,0.6487075,0.016344396,0.0015009413,0.00031486232,0.00035020773,0.0006007863],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976429,0.00032058315,0.00050406053,0.0006500215,0.00035177456,0.00053067826],"domain_scores_gemma":[0.99603283,0.0023057924,0.00052999926,0.00089525245,0.00015603527,0.00008010821],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024205657,0.00040520038,0.00080502214,0.0003122781,0.00021091894,0.000079457684,0.00034322328,0.0009973734,0.000121686804],"category_scores_gemma":[0.0010404944,0.00027217623,0.00017731235,0.00023191815,0.00019631178,0.000058360638,0.00013111238,0.002033147,0.00022215859],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059504615,0.00034171282,0.0063747065,0.00020081027,0.000110084264,0.07016714,0.00034896415,0.000015833877,0.0070821787,0.00001906101,0.82614064,0.08913935],"study_design_scores_gemma":[0.0028818394,0.0013444168,0.0024705376,0.00036642142,0.0003544488,0.0022126453,0.000037815993,0.000095010684,0.0010719893,0.00027770246,0.98868096,0.00020622686],"about_ca_topic_score_codex":0.00021889964,"about_ca_topic_score_gemma":0.0002126026,"teacher_disagreement_score":0.28565675,"about_ca_system_score_codex":0.00036400743,"about_ca_system_score_gemma":0.00044236775,"threshold_uncertainty_score":0.99997306},"labels":[],"label_agreement":null},{"id":"W2767378856","doi":"10.1093/neuonc/nox168.721","title":"PATH-31. ELEVATION OF YKL-40, NORMALIZED TO CERULOPLASMIN, IN CEREBROSPINAL FLUID IS ASSOCIATED WITH GLIOBLASTOMA RECURRENCE","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Ceruloplasmin; Glioblastoma; Cerebrospinal fluid; Elevation (ballistics); Medicine; Internal medicine; Path (computing); Gastroenterology; Oncology; Cancer research; Mathematics; Computer science","score_opus":0.02098088210676914,"score_gpt":0.3094852910920464,"score_spread":0.2885044089852773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767378856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901171,0.000008582398,0.00008291824,0.005000493,0.00008006684,0.0003163336,0.000038802715,0.000034635512,0.0043210895],"genre_scores_gemma":[0.9965539,0.000022385038,0.00029443047,0.0027740519,0.00006618346,0.000038807546,0.000028419556,0.000017457674,0.00020437606],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984122,0.00011808549,0.00046418112,0.00037048466,0.00031955697,0.00031548244],"domain_scores_gemma":[0.99846214,0.00013934856,0.00044797114,0.00045196497,0.00031841197,0.00018014718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028726272,0.00017668644,0.00059043174,0.00029334833,0.00012723461,0.00002059226,0.00017614872,0.00018196365,0.0002823125],"category_scores_gemma":[0.0012088433,0.00015659945,0.000096600044,0.00035642178,0.00014446166,0.00013659864,0.0000749474,0.00028483014,0.00006600446],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038937442,0.0009470397,0.07912889,0.00008658211,0.000093629635,0.0006301872,0.0009790667,0.000017153421,0.89389575,0.00010037043,0.012441298,0.0077862684],"study_design_scores_gemma":[0.022186259,0.018315349,0.48485798,0.002297914,0.00041691982,0.00037543479,0.00043607564,0.0035594665,0.43325445,0.00012702747,0.033410005,0.00076312653],"about_ca_topic_score_codex":0.000095660005,"about_ca_topic_score_gemma":0.00056837575,"teacher_disagreement_score":0.46064132,"about_ca_system_score_codex":0.00021792429,"about_ca_system_score_gemma":0.00033039352,"threshold_uncertainty_score":0.63859403},"labels":[],"label_agreement":null},{"id":"W2767379037","doi":"10.1093/neuonc/nox168.808","title":"PDTM-46. TARGETING METABOLIC ADAPTATION IN MYC DRIVEN PEDIATRIC NEURONAL TUMORS","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of British Columbia","funders":"","keywords":"Gene knockdown; Cancer research; Neuroblastoma; N-Myc; Biology; Pediatric cancer; Synthetic lethality; Cell culture; Cancer; Gene; Genetics; Mutant","score_opus":0.03600549443758412,"score_gpt":0.3385870060092045,"score_spread":0.3025815115716204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767379037","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99099225,0.000113305585,0.000013567046,0.0027217928,0.00044617057,0.0005582804,0.000008665461,0.000060255712,0.0050857197],"genre_scores_gemma":[0.9976247,0.00036393577,0.00054620096,0.00066455075,0.0005261735,0.00007801732,0.000020856343,0.000042755833,0.00013283228],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978952,0.00027287003,0.00036444122,0.00049769226,0.00037401458,0.00059578964],"domain_scores_gemma":[0.9985774,0.00032562934,0.00024935606,0.00044856273,0.00009353035,0.0003055096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020888315,0.0002092033,0.00047709097,0.00033135922,0.00025348848,0.00004327979,0.00026792038,0.000114771065,0.00011794163],"category_scores_gemma":[0.0014199511,0.00018949679,0.00010856164,0.00016699362,0.00011890445,0.00020827989,0.00018440963,0.00059764733,0.00028692064],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021200152,0.0021960838,0.6349436,0.00013436505,0.00009569105,0.016699152,0.0008153634,0.00026804963,0.27786198,0.00055702514,0.004552185,0.05975649],"study_design_scores_gemma":[0.008693822,0.0031459595,0.94299054,0.000017340748,0.00015150546,0.00036492874,0.0000868723,0.0028555468,0.007851996,0.00014672731,0.033460155,0.00023458792],"about_ca_topic_score_codex":0.00012698158,"about_ca_topic_score_gemma":0.00008655201,"teacher_disagreement_score":0.30804697,"about_ca_system_score_codex":0.00010991857,"about_ca_system_score_gemma":0.0005113282,"threshold_uncertainty_score":0.7727455},"labels":[],"label_agreement":null},{"id":"W2767382827","doi":"10.1093/neuonc/nox168.479","title":"IMMU-21. GLIOBLASTOMA CELLS EXPORT TENASCIN-C VIA MICROVESICLES TO SUPPRESS T CELL RESPONSES","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Microvesicles; Tenascin C; Microvesicle; Immune system; Exosome; Cell biology; Cancer research; Stem cell; Biology; Secretion; Cytotoxic T cell; Extracellular matrix; Immunology; microRNA; In vitro; Gene; Biochemistry","score_opus":0.014698198737843459,"score_gpt":0.31314343391781435,"score_spread":0.2984452351799709,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767382827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934019,0.00024870082,0.000058599053,0.0011789016,0.0005341073,0.0004599309,0.000121631245,0.000020830828,0.003975419],"genre_scores_gemma":[0.99627334,0.00022532023,0.0003488149,0.0011834417,0.0003345491,0.00010836352,0.000028115199,0.000047126417,0.0014509391],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99813586,0.00016854749,0.00023947551,0.00066566945,0.00018310147,0.00060732133],"domain_scores_gemma":[0.9981362,0.000067870395,0.00015653917,0.001117558,0.00010498761,0.0004168147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001682678,0.00024348772,0.00028248937,0.00008945361,0.00035390398,0.00008949643,0.00065341545,0.00021354623,0.00010849673],"category_scores_gemma":[0.00020162055,0.0002254429,0.00013804888,0.00004681217,0.00020755055,0.000010516988,0.00062812906,0.00016779808,0.0002207625],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022816998,0.00025845284,0.001194805,0.000012142984,0.0000399136,0.00037582882,0.000054263608,0.0000039253396,0.9598269,0.0000014593023,0.025702752,0.010247867],"study_design_scores_gemma":[0.001098608,0.002646697,0.002066722,0.0000033943231,0.000014182248,0.00006029708,0.000019220306,0.0000029509768,0.67130494,0.0000106375455,0.32262862,0.00014372797],"about_ca_topic_score_codex":0.000214947,"about_ca_topic_score_gemma":0.00038961772,"teacher_disagreement_score":0.29692587,"about_ca_system_score_codex":0.00007155514,"about_ca_system_score_gemma":0.0003635155,"threshold_uncertainty_score":0.91932946},"labels":[],"label_agreement":null},{"id":"W2767387519","doi":"10.1093/neuonc/nox168.041","title":"ACTR-50. CLINICAL TRIALS WITH DIANHYDROGALACTITOL (VAL-083) IN MGMT-UNMETHYLATED GLIOBLASTOMA","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Delmar (Canada)","funders":"","keywords":"Temozolomide; Cancer research; DNA repair; Methyltransferase; Medicine; Cancer; Bevacizumab; Radiation therapy; Glioma; Oncology; Internal medicine; Biology; Chemotherapy; DNA; Genetics; Methylation","score_opus":0.09585768033336821,"score_gpt":0.439147125699677,"score_spread":0.3432894453663088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767387519","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97650975,0.00014060223,0.0000059227505,0.014501084,0.0010808071,0.0012208584,0.000011325389,0.000082329796,0.0064473324],"genre_scores_gemma":[0.9971214,0.0003726158,0.0002726714,0.0014143059,0.00051501475,0.00019089518,0.000010804519,0.000052983003,0.000049313214],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962333,0.0011396754,0.0010755776,0.00069977704,0.00030558882,0.0005460711],"domain_scores_gemma":[0.99449694,0.0030932594,0.00081454276,0.0010880795,0.0000969895,0.0004102028],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001975004,0.0003239662,0.0017390617,0.0002469788,0.00019181472,0.000064152984,0.00028064256,0.00048124426,0.0002508803],"category_scores_gemma":[0.004945558,0.00022710083,0.00030687824,0.00014712311,0.00031968846,0.00015601717,0.00013120021,0.00070037186,0.0002892248],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010019866,0.0062025893,0.67703074,0.000048213344,0.00063147227,0.015058089,0.00024784906,0.000012960501,0.112561144,0.00016237618,0.009094122,0.16893056],"study_design_scores_gemma":[0.049651887,0.021157218,0.5425467,0.00019022038,0.0010664673,0.0007311428,0.000108022796,0.00023744025,0.074660994,0.0001343791,0.30903935,0.00047621524],"about_ca_topic_score_codex":0.00017034405,"about_ca_topic_score_gemma":0.0007614472,"teacher_disagreement_score":0.2999452,"about_ca_system_score_codex":0.00023089175,"about_ca_system_score_gemma":0.00044692412,"threshold_uncertainty_score":0.92609024},"labels":[],"label_agreement":null},{"id":"W2767408185","doi":"10.1093/neuonc/nox168.268","title":"DRES-10. THE DISTINCT CYTOTOXIC MECHANISM OF DIANHYDROGALACTITOL (VAL-083) OVERCOMES CHEMORESISTANCE AND PROVIDES NEW OPPORTUNITIES FOR COMBINATION THERAPY IN THE TREATMENT OF GLIOBLASTOMA","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Delmar (Canada); University of British Columbia","funders":"","keywords":"Temozolomide; Bevacizumab; Cancer research; DNA repair; Glioma; Medicine; Pharmacology; Chemistry; Chemotherapy; Internal medicine; DNA","score_opus":0.06082184004682845,"score_gpt":0.3227176996416961,"score_spread":0.26189585959486766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767408185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98414683,0.0003560301,0.0000072025546,0.01292928,0.00010767578,0.0017164339,0.000025055077,0.00000937012,0.0007020892],"genre_scores_gemma":[0.9976626,0.0015216956,0.00004229245,0.00020073286,0.00005865371,0.00040756958,0.000007719209,0.000015453315,0.000083285675],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990948,0.00010853675,0.00026733667,0.00019927048,0.00016216119,0.000167903],"domain_scores_gemma":[0.9981061,0.00096027576,0.0003589826,0.000458494,0.00006497844,0.00005117413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017152575,0.00016359902,0.0004331209,0.00007940619,0.00015509364,0.000023868657,0.00015623239,0.000076694145,0.000016554539],"category_scores_gemma":[0.00015698526,0.00008675744,0.00011038882,0.000045694156,0.00022489787,0.00006830135,0.000021174286,0.000052464147,5.416741e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008467747,0.013792883,0.058725942,0.00037072203,0.0007452142,0.00067592785,0.012083032,0.0000036709528,0.25938034,0.03240094,0.0045265188,0.60882705],"study_design_scores_gemma":[0.026890779,0.037781917,0.1663438,0.00011679704,0.00043863227,0.00011845568,0.0017943286,0.00026798903,0.7107213,0.0048363376,0.050472174,0.00021748562],"about_ca_topic_score_codex":0.00017978674,"about_ca_topic_score_gemma":0.000513876,"teacher_disagreement_score":0.60860956,"about_ca_system_score_codex":0.00009623559,"about_ca_system_score_gemma":0.00016963642,"threshold_uncertainty_score":0.3537866},"labels":[],"label_agreement":null},{"id":"W2767419466","doi":"10.1093/neuonc/nox168.1129","title":"SCDT-50. SURFACE MODIFIED LIPOSOMES FOR EFFECTIVE DELIVERY OF THERAPEUTIC AGENTS ACROSS THE BLOOD BRAIN BARRIER","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; University of Toronto; Scottish Cot Death Trust; Focused Ultrasound Foundation","keywords":"Blood–brain barrier; Liposome; Doxorubicin; Pharmacology; Glioma; In vitro; Cytotoxicity; Drug delivery; Chemistry; Cancer research; Medicine; Biochemistry; Chemotherapy; Central nervous system; Internal medicine","score_opus":0.029883882044487373,"score_gpt":0.3213690789203492,"score_spread":0.29148519687586183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767419466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937586,0.00020750154,0.00012414128,0.0024786352,0.0014966686,0.0014684468,0.00019227849,0.000066547225,0.00020717653],"genre_scores_gemma":[0.9967364,0.00002766612,0.00023531918,0.0025075697,0.0001525303,0.00016583865,0.000003041627,0.000043990087,0.00012764306],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99731845,0.0006919786,0.00043020363,0.0005731929,0.0003019524,0.00068423233],"domain_scores_gemma":[0.9943983,0.0035722672,0.0005296277,0.0011360003,0.00023361604,0.00013017119],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013831855,0.000244558,0.000516664,0.000029525401,0.0008854941,0.00018141877,0.001177611,0.00019965175,0.00008695638],"category_scores_gemma":[0.0009102448,0.00019411523,0.00018796812,0.0000753105,0.0008312393,0.00030703162,0.00039631495,0.00020647765,0.00008211417],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005776001,0.00027241238,0.0012495966,0.000036788213,0.000055274424,0.000027546565,0.0008918055,0.00058073015,0.9896013,0.00016053981,0.0009497625,0.005596637],"study_design_scores_gemma":[0.003250213,0.0013268717,0.0044228435,0.000015470903,0.00013437025,0.000023977129,0.00014225561,0.0011230715,0.9794202,0.0004990369,0.009432876,0.00020883701],"about_ca_topic_score_codex":0.0003753553,"about_ca_topic_score_gemma":0.00024060441,"teacher_disagreement_score":0.01018113,"about_ca_system_score_codex":0.00008407128,"about_ca_system_score_gemma":0.00023369146,"threshold_uncertainty_score":0.79157895},"labels":[],"label_agreement":null},{"id":"W2767419812","doi":"10.1093/neuonc/nox168.542","title":"MNGI-03. VOXEL-BASED LESION MAPPING TECHNIQUE REVEALS THE SPATIAL DISTRIBUTION OF MENINGIOMAS","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lesion; Medicine; Skull; Meningioma; Magnetic resonance imaging; Anatomy; Neuroradiologist; Voxel; Radiology; Pathology","score_opus":0.05166820794431628,"score_gpt":0.3263073841680365,"score_spread":0.27463917622372025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767419812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94268674,0.000054199812,0.033667643,0.010806434,0.0006110115,0.0014992431,0.00001658036,0.00009015512,0.010567978],"genre_scores_gemma":[0.997948,0.000004779192,0.001233128,0.00025918323,0.00021972643,0.00012975089,0.00005642863,0.000020406567,0.00012858826],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984092,0.00022636913,0.0004491879,0.00032719743,0.00028309872,0.00030493224],"domain_scores_gemma":[0.9980864,0.00023471696,0.00052780664,0.00091696496,0.00013611735,0.00009798257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087159255,0.0001729032,0.0004332131,0.00009947274,0.00040654757,0.000028030203,0.00036033173,0.00018264029,0.00006308307],"category_scores_gemma":[0.00075130555,0.00012561536,0.00014670631,0.00010310687,0.0002476784,0.000062303596,0.00020352082,0.00028108596,0.000026487338],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004172554,0.00019038851,0.0088277515,0.00014041546,0.000045977118,0.001013692,0.00013275958,0.000010970703,0.9662768,0.0012529211,0.007009112,0.014681922],"study_design_scores_gemma":[0.005534093,0.0045811627,0.2390203,0.00042978872,0.0004841814,0.00093575666,0.00018085205,0.0031761813,0.40709004,0.0010183492,0.33709133,0.00045795858],"about_ca_topic_score_codex":0.00008953915,"about_ca_topic_score_gemma":0.0000073254087,"teacher_disagreement_score":0.5591868,"about_ca_system_score_codex":0.0001467984,"about_ca_system_score_gemma":0.0001627412,"threshold_uncertainty_score":0.5122446},"labels":[],"label_agreement":null},{"id":"W2767444421","doi":"10.1093/neuonc/nox168.956","title":"STEM-42. GENOME-WIDE CRISPR SCREENS IN BRAIN TUMOR INITIATING CELLS (BTICS) IDENTIFY POTENT SENSITIZERS OF CONVENTIONAL CHEMORADIOTHERAPY","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University","funders":"","keywords":"CRISPR; Chemoradiotherapy; Cancer research; Genome editing; Frameshift mutation; Temozolomide; Biology; Medicine; Gene; Mutation; Cancer; Genetics; Glioma","score_opus":0.01719811970316495,"score_gpt":0.328887365967081,"score_spread":0.3116892462639161,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767444421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99037933,0.0003107668,0.0060266447,0.00084360334,0.00055336487,0.00028546102,0.000038814313,0.000012747327,0.0015492553],"genre_scores_gemma":[0.99659413,0.00014639022,0.0015115644,0.0013295334,0.00023779448,0.000015217866,0.000034988563,0.000040164014,0.00009020299],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99850816,0.000118846336,0.0004470845,0.0004156142,0.00015335645,0.000356943],"domain_scores_gemma":[0.99888515,0.00011280214,0.00029180408,0.00052006886,0.0001003007,0.00008987965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003682264,0.00020131104,0.00037569832,0.00009478522,0.000109239845,0.000029944504,0.00033223382,0.00017996402,0.000028017264],"category_scores_gemma":[0.00017995638,0.00022846242,0.0001438144,0.000047967747,0.00017168002,0.0000074745167,0.00017243109,0.00020510412,0.000006559847],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009223372,0.000081351085,0.005067914,0.000045313835,0.000040554514,0.00012061319,0.00009216504,0.0013301068,0.9906651,0.000029177347,0.00086690765,0.0015685749],"study_design_scores_gemma":[0.0022343346,0.00053065066,0.025987659,0.00002248455,0.000022437107,0.000097392905,0.00020731922,0.0006849152,0.9422664,0.000035304907,0.027641838,0.00026923913],"about_ca_topic_score_codex":0.000048597234,"about_ca_topic_score_gemma":0.00008913812,"teacher_disagreement_score":0.048398662,"about_ca_system_score_codex":0.000048540856,"about_ca_system_score_gemma":0.00014533644,"threshold_uncertainty_score":0.9316427},"labels":[],"label_agreement":null},{"id":"W2767484600","doi":"10.1093/neuonc/nox168.913","title":"RTHP-31. A 40-YEAR MULTI-INSTITUTIONAL REVIEW OF INTRACRANIAL GERM CELL TUMORS IN ADOLESCENTS AND YOUNG ADULT","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Princess Margaret Cancer Centre; BC Children's Hospital; BC Cancer Agency","funders":"","keywords":"Medicine; Chemotherapy; Germ cell tumors; Germinoma; Radiation therapy; Internal medicine; Cancer; Surgery; Pediatrics","score_opus":0.03156829688521367,"score_gpt":0.3459923063730421,"score_spread":0.31442400948782845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767484600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98717993,0.0017471132,0.000013214376,0.001955859,0.00047733763,0.0011039405,0.00001623709,0.000020556654,0.0074857934],"genre_scores_gemma":[0.9844678,0.013016047,0.00040930804,0.0015627836,0.00023500193,0.00003898366,0.000008656913,0.000024703715,0.0002367146],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99833626,0.00016813993,0.00045019787,0.00036597432,0.00033803875,0.00034137614],"domain_scores_gemma":[0.99880767,0.000078195204,0.00023669741,0.000492455,0.00020760806,0.00017736624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047279245,0.0001725781,0.0006355344,0.00013905716,0.00010624516,0.00001368157,0.0002508602,0.00015816213,0.0002764591],"category_scores_gemma":[0.0011564934,0.00014926157,0.00009840208,0.00009318222,0.00047581282,0.00008321785,0.00017865654,0.0006150271,0.000043393033],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021015424,0.0012852292,0.32071042,0.0057641314,0.000026360027,0.001871731,0.00030354966,8.6267335e-7,0.60206693,0.00009180559,0.0010133052,0.06476408],"study_design_scores_gemma":[0.03504753,0.0036313185,0.8613476,0.011179305,0.00018593605,0.00242075,0.00014421837,0.0010802214,0.026437627,0.000049906772,0.057914365,0.00056119927],"about_ca_topic_score_codex":0.00028783779,"about_ca_topic_score_gemma":0.00030062252,"teacher_disagreement_score":0.57562935,"about_ca_system_score_codex":0.00018187643,"about_ca_system_score_gemma":0.0005873705,"threshold_uncertainty_score":0.608671},"labels":[],"label_agreement":null},{"id":"W2767488657","doi":"10.1093/neuonc/nox168.566","title":"NCOG-05. TIME TO FUNCTIONAL AND COGNITIVE DECLINE IN A PHASE 3 TRIAL OF TUMOR TREATING FIELDS WITH TEMOZOLOMIDE VERSUS TEMOZOLOMIDE ALONE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke; Juravinski Cancer Centre; Centre Hospitalier de l’Université de Montréal; Ottawa Hospital","funders":"","keywords":"Temozolomide; Medicine; Internal medicine; Oncology; Glioblastoma; Cognitive decline; Radiation therapy; Disease; Dementia","score_opus":0.018029607386638117,"score_gpt":0.2984840010863795,"score_spread":0.2804543936997414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767488657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99571294,0.000017992284,0.000007120249,0.0016833047,0.00015638243,0.0018052635,0.000042643333,0.000017503797,0.0005568345],"genre_scores_gemma":[0.9985582,0.0000048135275,0.00029105667,0.00067187654,0.00010284519,0.00029269714,0.000038120823,0.00002872275,0.000011648557],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99834585,0.00012140819,0.00045425937,0.0004826626,0.00026729523,0.0003285187],"domain_scores_gemma":[0.99754643,0.0014708621,0.00035391765,0.0002837377,0.00014856356,0.00019649467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016778534,0.00025579863,0.0008139793,0.000297064,0.000103566934,0.000020217802,0.00008708206,0.00012631269,0.00008531935],"category_scores_gemma":[0.0012345117,0.00019078766,0.000049474525,0.00017527328,0.00017272674,0.00011062423,0.000099374156,0.00023427274,0.000017565564],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5653093,0.007189591,0.38670155,0.000023377937,0.00016675578,0.0027496268,0.00029379225,0.000036405876,0.0023987056,0.0000037189998,0.00030753866,0.03481964],"study_design_scores_gemma":[0.55727583,0.07922041,0.35760087,0.0002058882,0.00028458828,0.000047414767,0.00009907973,0.00012292876,0.0046390095,0.0000050001922,0.00032267068,0.00017631092],"about_ca_topic_score_codex":0.0003312453,"about_ca_topic_score_gemma":0.0030561048,"teacher_disagreement_score":0.07203082,"about_ca_system_score_codex":0.00013739073,"about_ca_system_score_gemma":0.00023936185,"threshold_uncertainty_score":0.7780095},"labels":[],"label_agreement":null},{"id":"W2767506942","doi":"10.1093/neuonc/nox168.022","title":"ACTR-27. COMPLIANCE AND TREATMENT DURATION PREDICT SURVIVAL IN A PHASE 3 EF-14 TRIAL OF TUMOR TREATING FIELDS WITH TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Temozolomide; Medicine; Glioblastoma; Internal medicine; Oncology; Progression-free survival; Adjuvant; Clinical trial; Overall survival; Chemotherapy","score_opus":0.0269714515350125,"score_gpt":0.3109597972464867,"score_spread":0.2839883457114742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767506942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965026,0.00001876462,0.0000053299223,0.0008469904,0.00016735803,0.0019677207,0.000026606456,0.000017248236,0.0004473863],"genre_scores_gemma":[0.9992665,0.00003800592,0.00021149438,0.00008514641,0.000069495465,0.00027586165,0.000025396032,0.000022088001,0.0000059880495],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99850494,0.00014588668,0.00044944213,0.00040870628,0.00021101735,0.0002800091],"domain_scores_gemma":[0.99843985,0.00051867694,0.0004543942,0.00039176914,0.00007498652,0.00012034536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011708925,0.0002438359,0.00077062135,0.00016320113,0.00008816232,0.000023090517,0.00008197883,0.00010657218,0.00001229159],"category_scores_gemma":[0.0002840945,0.00016564113,0.000044272347,0.00010695985,0.00014624737,0.00012619303,0.000033338434,0.00014832479,0.0000015909166],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08793387,0.0070947953,0.87517595,0.000030664814,0.00007818757,0.0013199904,0.0004371318,0.000025599218,0.0019054335,0.000009676591,0.000032476946,0.025956213],"study_design_scores_gemma":[0.36111024,0.067564614,0.56419116,0.00020000675,0.00015123618,0.000027546595,0.00008319212,0.00033656257,0.0059930035,0.000004694792,0.00021178562,0.00012594707],"about_ca_topic_score_codex":0.0005229302,"about_ca_topic_score_gemma":0.0060061933,"teacher_disagreement_score":0.3109848,"about_ca_system_score_codex":0.00024386052,"about_ca_system_score_gemma":0.00018531515,"threshold_uncertainty_score":0.675465},"labels":[],"label_agreement":null},{"id":"W2767510756","doi":"10.1093/neuonc/nox168.578","title":"NCOG-17. COGNITION AND BRAIN STEREOTACTIC RADIOTHERAPY: A PILOT TRIAL","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Clinical endpoint; Quality of life (healthcare); Stereotactic radiotherapy; Montreal Cognitive Assessment; Mini–Mental State Examination; Cognition; Cognitive impairment; Internal medicine; Radiation therapy; Randomized controlled trial; Radiosurgery; Psychiatry","score_opus":0.05814636025567579,"score_gpt":0.359342087700006,"score_spread":0.3011957274443302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767510756","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94496447,0.00035710423,0.00011742377,0.04124582,0.001034131,0.0015979288,0.000022680202,0.00006619368,0.010594259],"genre_scores_gemma":[0.987332,0.00024959,0.00078978954,0.010329576,0.00073635863,0.000098163466,0.000021629457,0.00003187819,0.00041103372],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988856,0.0002101584,0.0002124438,0.00032421772,0.00013190659,0.0002356941],"domain_scores_gemma":[0.99864,0.0005280368,0.00020037557,0.0004188005,0.000039925962,0.00017284381],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024026987,0.0001568672,0.00042422197,0.00006765818,0.00023422357,0.000051637257,0.00007693534,0.000093435854,0.00031245098],"category_scores_gemma":[0.00047290453,0.00012684218,0.0000719239,0.000027492702,0.00018059387,0.00008638743,0.000045165358,0.00021156472,0.000027438196],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16057797,0.004669184,0.0035496885,0.00012835115,0.0009920999,0.005284618,0.00069975277,7.327145e-7,0.28436118,0.00068463094,0.04593343,0.49311838],"study_design_scores_gemma":[0.2751953,0.05285586,0.011832109,0.00004424573,0.0007526302,0.0021120925,0.00006539388,0.00011761161,0.0023038944,0.00046279607,0.6540058,0.00025222465],"about_ca_topic_score_codex":0.000046391982,"about_ca_topic_score_gemma":0.00004819132,"teacher_disagreement_score":0.6080724,"about_ca_system_score_codex":0.00008476796,"about_ca_system_score_gemma":0.00014386029,"threshold_uncertainty_score":0.5172474},"labels":[],"label_agreement":null},{"id":"W2767515057","doi":"10.1093/neuonc/nox168.1043","title":"TMOD-04. A COMPREHENSIVE GENOMIC LANDSCAPE OF GLIOMA SPHEROID CULTURES RECAPITULATES THE HETEROGENEITY OF GLIOBLASTOMA AND IDENTIFIES DNA METHYLATION PREDICTORS OF RADIOTHERAPY RESPONSE","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"DNA methylation; Methylation; Glioma; Biology; Cancer research; Radiation therapy; CpG site; Molecular biology; Oncology; Genetics; Gene; Internal medicine; Medicine; Gene expression","score_opus":0.020316187430553308,"score_gpt":0.3127252702862144,"score_spread":0.2924090828556611,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767515057","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951716,0.0027819024,0.0000035966136,0.0011265028,0.00024105256,0.0005820827,0.000039392286,0.000013787164,0.000040047355],"genre_scores_gemma":[0.9990385,0.00065190514,0.00012299635,0.000068154644,0.00006336437,0.000027162867,0.0000050977924,0.000018872746,0.000003924581],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985622,0.0003807276,0.00044603573,0.00026168243,0.000190885,0.00015842466],"domain_scores_gemma":[0.99763167,0.0008315116,0.0006977954,0.0005709485,0.00019797012,0.00007012858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023484053,0.00017397068,0.0006467312,0.00012295476,0.00012568284,0.00001444273,0.0001769326,0.00014755706,0.000027848626],"category_scores_gemma":[0.00026160397,0.000114316405,0.00014961512,0.00008101948,0.00050902483,0.00006585166,0.00008971859,0.00010192959,8.825833e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043645645,0.00030193495,0.0664582,0.00006791836,0.000370638,0.00006885156,0.0015417619,0.00003895582,0.92471343,0.000023100685,0.0003308262,0.0017198321],"study_design_scores_gemma":[0.0025465759,0.0022687127,0.39639953,0.000029609395,0.00018139412,0.00011381791,0.00015202456,0.00007842239,0.597055,0.00003524022,0.0010916112,0.000048017642],"about_ca_topic_score_codex":0.00009526596,"about_ca_topic_score_gemma":0.00012969068,"teacher_disagreement_score":0.32994133,"about_ca_system_score_codex":0.000042296502,"about_ca_system_score_gemma":0.000083180465,"threshold_uncertainty_score":0.46616876},"labels":[],"label_agreement":null},{"id":"W2767525887","doi":"10.1093/neuonc/nox168.943","title":"STEM-28. DOT1L EPIGENETICALLY REGULATES GBM BRAIN TUMOR STEM CELLS","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Hotchkiss Brain Institute; Ontario Brain Institute","funders":"","keywords":"Biology; Cancer research; Epigenetics; Stem cell; Carcinogenesis; DNA methylation; Gene silencing; Histone; Cancer stem cell; Cancer; Cell biology; Genetics; Gene expression; Gene","score_opus":0.01976916725985499,"score_gpt":0.2873144401354264,"score_spread":0.2675452728755714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767525887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865425,0.0010350571,0.0006863802,0.0024806315,0.0012142955,0.00041533224,0.000031318377,0.000031782514,0.007562667],"genre_scores_gemma":[0.9948173,0.0005116467,0.00090990897,0.0013778181,0.0006593443,0.000042148717,0.000026929329,0.000068800735,0.0015860781],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976969,0.00031984752,0.00047030998,0.0007690602,0.00020848885,0.0005354131],"domain_scores_gemma":[0.9977286,0.00016020387,0.0004106944,0.001291208,0.00016204594,0.00024726774],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004920724,0.00030058535,0.0003808243,0.00006186376,0.00040433405,0.00011529771,0.0007163756,0.00039397657,0.000051245628],"category_scores_gemma":[0.0001352034,0.0002955277,0.0001688682,0.000047018046,0.00030910943,0.000008500366,0.00043202858,0.00023043827,0.000099214376],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011160377,0.00010010655,0.0020849002,0.00001732911,0.000031553373,0.00005578048,0.000038644605,0.000090693844,0.955424,0.0001664518,0.0024346807,0.039444264],"study_design_scores_gemma":[0.00066063955,0.001006365,0.0022630566,0.0000056339977,0.000022791039,0.000014538173,0.000022531409,0.00009106171,0.66489714,0.00020712502,0.3305887,0.00022040625],"about_ca_topic_score_codex":0.000020940455,"about_ca_topic_score_gemma":0.00007943353,"teacher_disagreement_score":0.328154,"about_ca_system_score_codex":0.000042963653,"about_ca_system_score_gemma":0.0002447095,"threshold_uncertainty_score":0.9999497},"labels":[],"label_agreement":null},{"id":"W2767545176","doi":"10.1093/neuonc/nox168.194","title":"CMET-48. CE7 CANADIAN CLINICAL TRIALS GROUP / ALLIANCE FOR CLINICAL TRIALS IN ONCOLOGY. A PHASE III TRIAL OF STEREOTACTIC RADIOSURGERY COMPARED WITH WHOLE BRAIN RADIOTHERAPY (WBRT) FOR 5–15 BRAIN METASTASES","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Queen's University; Princess Margaret Cancer Centre; Université de Montréal","funders":"","keywords":"Medicine; Radiosurgery; Clinical endpoint; Quality of life (healthcare); Clinical trial; Internal medicine; Oncology; Brain metastasis; Radiation therapy; Randomized controlled trial; Cancer; Metastasis","score_opus":0.331819077702643,"score_gpt":0.5391654500192089,"score_spread":0.20734637231656589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767545176","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81670237,0.002535012,0.005050351,0.12781604,0.00950547,0.034268674,0.003750513,0.00010087557,0.00027071848],"genre_scores_gemma":[0.90600514,0.002254765,0.038927805,0.036198463,0.007841578,0.006361719,0.001483414,0.000371034,0.0005560704],"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","domain_scores_codex":[0.97133833,0.018676,0.0069896686,0.0014099404,0.00041521623,0.001170863],"domain_scores_gemma":[0.86915946,0.12232202,0.005470672,0.0015502356,0.0002988973,0.0011987331],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.07877631,0.0006811243,0.0100796735,0.0004651923,0.00035244122,0.00009012319,0.00061004824,0.00083821325,0.00019057153],"category_scores_gemma":[0.093151145,0.0005080957,0.0023139918,0.00023880774,0.00091338024,0.00022400117,0.000061695966,0.0008379544,0.0000074178406],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4364088,0.010342116,0.002878329,0.00015224238,0.0032633727,0.0013055832,0.00020480421,0.000007982573,0.003207721,0.00024481528,0.23516162,0.30682263],"study_design_scores_gemma":[0.38868243,0.041501228,0.0006903511,0.00008839216,0.0016145984,0.00013219997,0.00011025589,0.00044006616,0.00019166566,0.00008735339,0.5661755,0.0002859375],"about_ca_topic_score_codex":0.0033419593,"about_ca_topic_score_gemma":0.030596005,"teacher_disagreement_score":0.33101392,"about_ca_system_score_codex":0.00073477766,"about_ca_system_score_gemma":0.0053451923,"threshold_uncertainty_score":0.9997371},"labels":[],"label_agreement":null},{"id":"W2767564843","doi":"10.1093/neuonc/nox168.099","title":"ATIM-02. DURABLE RESPONSES OBSERVED IN IDH1 WILDTYPE AND MUTANT RECURRENT HIGH GRADE GLIOMA (rHGG) WITH TOCA 511 &amp; TOCA FC TREATMENT","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Brain Institute","funders":"","keywords":"Bevacizumab; Medicine; Cancer; Cytosine deaminase; Cancer research; Immune system; Wild type; Glioma; Internal medicine; Mutant; Immunology; Biology; Chemotherapy; Genetic enhancement; Gene","score_opus":0.03998439439065296,"score_gpt":0.29958813938308226,"score_spread":0.25960374499242933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767564843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99636,0.00028623265,0.00002009811,0.0015632531,0.00046453773,0.00075142045,0.000041569085,0.000031805463,0.00048110183],"genre_scores_gemma":[0.9966221,0.0005088801,0.0017417149,0.00031584676,0.00014559976,0.00021237036,0.00006978155,0.000052428975,0.0003312666],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978925,0.00029917972,0.00033555584,0.0008071327,0.00015729963,0.0005083234],"domain_scores_gemma":[0.9983142,0.00009610217,0.00027638007,0.001058753,0.0000719236,0.00018262994],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023093485,0.00035170626,0.00046737454,0.00009532828,0.00024096567,0.00006631105,0.00036187327,0.0003251004,0.000025685835],"category_scores_gemma":[0.00029096176,0.0002910543,0.000076522134,0.00008041388,0.00020292685,0.000015860647,0.0002574732,0.00017514915,0.000021771833],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024744706,0.00041400312,0.0017173345,0.000018954264,0.00006655565,0.0004966107,0.00016046567,0.00001462864,0.9649958,0.000079039244,0.00046623143,0.00682568],"study_design_scores_gemma":[0.0046191863,0.094091974,0.0058390535,0.000036811427,0.00007306855,0.0005050566,0.000061053965,0.00006388017,0.7803811,0.00017962446,0.11373881,0.00041041514],"about_ca_topic_score_codex":0.00011662879,"about_ca_topic_score_gemma":0.0153663615,"teacher_disagreement_score":0.18461473,"about_ca_system_score_codex":0.0001387811,"about_ca_system_score_gemma":0.0003286698,"threshold_uncertainty_score":0.99995416},"labels":[],"label_agreement":null},{"id":"W2767571548","doi":"10.1093/neuonc/nox168.370","title":"EXTH-80. ENHANCED THERAPEUTIC RESPONSE IN MURINE MEDULLOBLASTOMA TUMOR MODEL USING ADENANTHIN AND TRANSIENT MODULATION OF THE BLOOD-BRAIN BARRIER WITH CADHERIN PEPTIDE","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"","keywords":"Blood–brain barrier; Medulloblastoma; Medicine; Pathology; Cancer research; Internal medicine; Central nervous system","score_opus":0.035785801748048615,"score_gpt":0.3391809613017363,"score_spread":0.3033951595536877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767571548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99283195,0.000038782862,0.00056120334,0.005565698,0.000027592261,0.0004880676,0.00000859618,0.000014303417,0.00046379401],"genre_scores_gemma":[0.9983374,0.000009878474,0.000635731,0.00081711344,0.000035804387,0.000049901053,9.873977e-7,0.00002002514,0.00009316914],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99894166,0.00013931109,0.00027057985,0.0002874027,0.0001564974,0.00020457702],"domain_scores_gemma":[0.99895936,0.00025020505,0.00016808855,0.00045895323,0.000048655384,0.00011475024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027139453,0.00013946155,0.0002880965,0.00003749676,0.00015311393,0.000009750104,0.00015701502,0.000092356255,0.0000187839],"category_scores_gemma":[0.00021463608,0.00009685799,0.000045034405,0.00008470093,0.00039094526,0.00006123756,0.000042584157,0.00032104808,5.2554776e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029561855,0.00017184798,0.0008670012,0.000045364664,0.000019753843,0.000040168543,0.00053080625,0.002962361,0.9916292,0.000045704466,0.0000064669184,0.00072516274],"study_design_scores_gemma":[0.0037961025,0.0005167402,0.03759229,0.00007898398,0.00014023042,0.00035290956,0.00008016013,0.10226862,0.85422117,0.0001274877,0.00070864573,0.000116685165],"about_ca_topic_score_codex":0.000013376836,"about_ca_topic_score_gemma":0.000019492318,"teacher_disagreement_score":0.13740803,"about_ca_system_score_codex":0.00006374612,"about_ca_system_score_gemma":0.0002484356,"threshold_uncertainty_score":0.39497542},"labels":[],"label_agreement":null},{"id":"W2767576218","doi":"10.1093/neuonc/nox168.563","title":"NCOG-02. PRETREATMENT VOLUME OF MRI-DETERMINED WHITE MATTER INJURY (WMI) PREDICTS COGNITIVE DECLINE AFTER HIPPOCAMPAL AVOIDANT (HA) WBRT FOR BRAIN METASTASES: SECONDARY ANALYSIS OF NRG ONCOLOGY RTOG 0933","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Verbal learning; Cognitive decline; Internal medicine; Verbal memory; Oncology; Dementia; Cognition; Disease; Psychiatry","score_opus":0.02179629636757778,"score_gpt":0.35901355443787347,"score_spread":0.3372172580702957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767576218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94394207,0.00010166655,0.012243472,0.035195086,0.0003001428,0.0029435696,0.0028566096,0.00010550433,0.002311876],"genre_scores_gemma":[0.9722203,0.00007925631,0.016560685,0.008486491,0.00019637567,0.0014090113,0.00054925284,0.00005724735,0.0004414094],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99688447,0.00034509564,0.0011550962,0.000748686,0.00035227498,0.00051437586],"domain_scores_gemma":[0.99567205,0.0011621552,0.0010993421,0.001103447,0.0005943892,0.0003686079],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008796279,0.00036568043,0.0017415893,0.00038430776,0.00014900997,0.000020236499,0.00042523321,0.0003293267,0.0016796624],"category_scores_gemma":[0.0012660299,0.0003100963,0.0005092507,0.000320023,0.0010676095,0.00012287158,0.00038262227,0.00047654306,0.000027286744],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011495004,0.0068023996,0.51378924,0.0009715966,0.0061197914,0.0008631329,0.0016649965,0.000006803564,0.16849256,0.0001013324,0.15339926,0.1362939],"study_design_scores_gemma":[0.02154413,0.028830057,0.45082253,0.00049821293,0.029962119,0.00047439424,0.00047018667,0.012817419,0.08074685,0.000986514,0.3718012,0.0010463896],"about_ca_topic_score_codex":0.00008946625,"about_ca_topic_score_gemma":0.00012836003,"teacher_disagreement_score":0.21840194,"about_ca_system_score_codex":0.00019866844,"about_ca_system_score_gemma":0.0006436218,"threshold_uncertainty_score":0.9999351},"labels":[],"label_agreement":null},{"id":"W2767581051","doi":"10.1093/neuonc/nox168.1089","title":"SCDT-06. QUANTIFIABLE LEVELS OF THE TRANSGENE, CYTOSINE DEAMINASE, IN TUMOR SAMPLES FOLLOWING INTRAVENOUS DELIVERY OF TOCA 511 IN PATIENTS WITH RECURRENT HIGH GRADE GLIOMA","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Brain Institute","funders":"","keywords":"Cytosine deaminase; Molecular biology; Glioma; Immunohistochemistry; Biology; Genetic enhancement; Pathology; Cancer research; Medicine; Gene","score_opus":0.03189538344428734,"score_gpt":0.2989544667792111,"score_spread":0.2670590833349238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767581051","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986174,0.00021345384,0.00001258134,0.00016068737,0.00020517324,0.00064129394,0.000103442486,0.0000035945422,0.000042351185],"genre_scores_gemma":[0.99948287,0.00005007506,0.00023361135,0.00008710784,0.000035302877,0.00004098741,0.000030606832,0.000032947224,0.000006464946],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99807507,0.00036791933,0.000442508,0.00042915597,0.00027315153,0.00041220145],"domain_scores_gemma":[0.9986687,0.0000831953,0.00028755076,0.00078417093,0.00011378259,0.0000626109],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037559244,0.00019085708,0.00043352824,0.00012343691,0.00011340888,0.000016367994,0.00070550805,0.00015342333,0.000011571862],"category_scores_gemma":[0.00018059275,0.00015882948,0.00011008302,0.000184408,0.00027954942,0.000010974159,0.00017568689,0.00022878931,9.150199e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071669267,0.0007600339,0.060753386,0.000043891992,0.000046680227,0.000037211852,0.00010396925,0.00013789097,0.92405206,0.000012863215,0.000035708876,0.0068493485],"study_design_scores_gemma":[0.0040338812,0.019006468,0.1649372,0.000059378028,0.00002030473,0.000006118572,0.000031475956,0.00001631192,0.81113714,0.000042185686,0.00055644906,0.00015311326],"about_ca_topic_score_codex":0.0003876442,"about_ca_topic_score_gemma":0.017890316,"teacher_disagreement_score":0.112914965,"about_ca_system_score_codex":0.00006305099,"about_ca_system_score_gemma":0.00042382485,"threshold_uncertainty_score":0.9983216},"labels":[],"label_agreement":null},{"id":"W2767581845","doi":"10.1093/neuonc/nox168.033","title":"ACTR-42. INITIAL EXPERIENCE OF BLOOD-BRAIN BARRIER OPENING FOR CHEMOTHERAPEUTIC-DRUG DELIVERY TO BRAIN TUMOURS BY MR-GUIDED FOCUSED ULTRASOUND","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Ultrasound and Hyperthermia Applications","field":"Engineering","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Microbubbles; Blood–brain barrier; Extravasation; Magnetic resonance imaging; Glioma; Focused ultrasound; Ultrasound; Drug delivery; Radiology; Nuclear medicine; Pathology; Central nervous system; Internal medicine; Cancer research","score_opus":0.027152577380353718,"score_gpt":0.3096478137641074,"score_spread":0.2824952363837537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767581845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905939,0.000080330785,0.0022328522,0.0028112053,0.00036994016,0.0007764342,0.00013921162,0.00014702673,0.0028490645],"genre_scores_gemma":[0.99329954,0.0000305964,0.0026159226,0.0031593775,0.00022055402,0.00041612066,0.000020220401,0.000087936955,0.0001497169],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99848956,0.000056937253,0.00040777778,0.00039209408,0.00014854186,0.0005050868],"domain_scores_gemma":[0.9974216,0.0014833446,0.0001466745,0.0006456446,0.000088132416,0.0002145824],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023150265,0.00025648868,0.00042789703,0.000082747996,0.0003437151,0.00009425435,0.00077977614,0.00016778133,0.00012767111],"category_scores_gemma":[0.000570088,0.0002750705,0.0001171263,0.000091834045,0.00018638915,0.0002288957,0.00006559588,0.00021950573,0.000020135167],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046692814,0.0000697874,0.00035440634,0.00002126737,0.000045490175,0.000003929973,0.0029756438,0.000104825645,0.97664034,0.00012998661,0.014236777,0.005370836],"study_design_scores_gemma":[0.0018445997,0.00025134548,0.00040492121,0.00001691687,0.00006529913,0.000053385775,0.0003344346,0.00046262605,0.73483455,0.00015714524,0.26123568,0.00033907848],"about_ca_topic_score_codex":0.00007761282,"about_ca_topic_score_gemma":0.00010495005,"teacher_disagreement_score":0.24699892,"about_ca_system_score_codex":0.00006334739,"about_ca_system_score_gemma":0.000114415925,"threshold_uncertainty_score":0.99997014},"labels":[],"label_agreement":null},{"id":"W2767591027","doi":"10.1093/neuonc/nox168.444","title":"HOUT-13. PATIENT REPORTED OUTCOME MEASURES IN BRAIN METASTASES PATIENTS – A SYSTEMATIC REVIEW","year":2017,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Grading (engineering); Quality of life (healthcare); Patient-reported outcome; Physical therapy; MEDLINE; Breast cancer; Data extraction; Palliative care; Internal medicine; Cancer; Nursing","score_opus":0.19431350558285893,"score_gpt":0.42684879130251385,"score_spread":0.23253528571965493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767591027","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000028916638,0.9835595,0.0000034610578,0.0007945116,0.00096162973,0.013434223,0.00021685562,0.000084714426,0.00091622677],"genre_scores_gemma":[0.0000738635,0.9914216,0.00017760361,0.0044782446,0.0000872539,0.002737413,0.0007466307,0.00015331639,0.00012411721],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9889888,0.0037963463,0.0043607904,0.0012241302,0.00089285534,0.0007370324],"domain_scores_gemma":[0.9904407,0.001840511,0.0044238307,0.0025884714,0.00029250147,0.0004139404],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022927679,0.0010884821,0.012051101,0.0005520944,0.00013768832,0.00004457526,0.00047834823,0.0005296985,0.000102369944],"category_scores_gemma":[0.015061476,0.00070804666,0.0017600284,0.00039314796,0.00014662636,0.000087384,0.00027964026,0.0010369334,0.00020767857],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002909723,0.0010978314,0.00019089608,0.58394015,0.0009953448,0.0051164534,0.0000317065,7.757809e-8,2.7530496e-7,0.000010757571,0.004869337,0.4037181],"study_design_scores_gemma":[0.0014947626,0.0016355036,0.000026522372,0.2588181,0.01597732,0.0012843072,0.00000747996,3.7131846e-7,4.0574983e-7,0.000004213607,0.7204066,0.00034441845],"about_ca_topic_score_codex":0.00009971122,"about_ca_topic_score_gemma":0.00009782939,"teacher_disagreement_score":0.7155373,"about_ca_system_score_codex":0.0009993885,"about_ca_system_score_gemma":0.0011168998,"threshold_uncertainty_score":0.99953705},"labels":[],"label_agreement":null},{"id":"W2767599002","doi":"10.1093/neuonc/nox168.1101","title":"SCDT-18. EXPRESSION OF ABC TRANSPORTERS AS PROGNOSTIC BIOMARKERS FOR GLIOBLASTOMA","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Glioblastoma; ATP-binding cassette transporter; Transporter; Expression (computer science); Computational biology; Cancer research; Biology; Computer science; Genetics; Gene","score_opus":0.02543192807226448,"score_gpt":0.31868888940940115,"score_spread":0.2932569613371367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767599002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864516,0.000097593314,0.0012145261,0.0023347412,0.0012514554,0.0014354727,0.00004011187,0.00008280963,0.0070916815],"genre_scores_gemma":[0.99675125,0.0000667917,0.0021294362,0.00046260073,0.00014509022,0.00012023914,0.000023996245,0.000046613255,0.0002539894],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99853724,0.000032600998,0.0004168125,0.00040368445,0.00023637047,0.0003733092],"domain_scores_gemma":[0.99859923,0.00017942251,0.00033504888,0.00056150666,0.00011783697,0.00020697765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021728645,0.00019003451,0.0005673843,0.00011467964,0.00024402082,0.000014601758,0.00027376218,0.00025568696,0.00019636317],"category_scores_gemma":[0.00018035699,0.00016604195,0.0002466508,0.00006066761,0.00031529248,0.00009084484,0.000018194127,0.00017109123,0.000011799174],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037892608,0.00035895055,0.009967796,0.0003508542,0.000060321923,0.0004841969,0.00024542445,0.0000012665022,0.9685967,0.00009231709,0.002248869,0.01380403],"study_design_scores_gemma":[0.008805172,0.0071719186,0.029966775,0.00041512933,0.00054791773,0.00016502419,0.0003266517,0.00006536823,0.81664884,0.00059180777,0.13500467,0.00029073237],"about_ca_topic_score_codex":0.000025264693,"about_ca_topic_score_gemma":0.00013823972,"teacher_disagreement_score":0.15194789,"about_ca_system_score_codex":0.00004365444,"about_ca_system_score_gemma":0.0002993446,"threshold_uncertainty_score":0.6770994},"labels":[],"label_agreement":null},{"id":"W2767613513","doi":"10.1093/neuonc/nox168.036","title":"ACTR-45. A PHASE 1, MULTICENTER, OPEN-LABEL STUDY OF MARIZOMIB (MRZ) WITH TEMOZOLOMIDE (TMZ) AND RADIOTHERAPY (RT) IN NEWLY DIAGNOSED WHO GRADE IV MALIGNANT GLIOMA (GLIOBLASTOMA, ndGBM)","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Concomitant; Medicine; Temozolomide; Nausea; Glioma; Internal medicine; Vomiting; Interim analysis; Tolerability; Surgery; Radiation therapy; Adverse effect; Gastroenterology; Clinical trial","score_opus":0.03918978322584706,"score_gpt":0.3592807108428105,"score_spread":0.32009092761696345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767613513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907452,0.000548245,0.000004414357,0.0038283889,0.00026065894,0.0042501464,0.000030831856,0.000039929113,0.00029219833],"genre_scores_gemma":[0.99720204,0.00068514555,0.00053797296,0.00090391695,0.00009399532,0.0004534294,0.0000083179975,0.00008639718,0.000028797564],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9969474,0.00036917333,0.0007426149,0.00095106836,0.00035552357,0.0006342022],"domain_scores_gemma":[0.99691606,0.00068764616,0.00069173996,0.0012035292,0.000113378,0.00038763785],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003731042,0.00050063396,0.0015493839,0.0004227276,0.00026146715,0.00012763657,0.00059776293,0.00023025324,0.000053066386],"category_scores_gemma":[0.0002725285,0.00037658072,0.000070011156,0.00023688027,0.00034256637,0.00029222667,0.0003542222,0.00036865848,0.0000064572732],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017334655,0.07190131,0.29325825,0.00009805459,0.0006915561,0.025774432,0.003320109,0.0000081196895,0.5297383,0.00005600525,0.0016609693,0.05615826],"study_design_scores_gemma":[0.5841918,0.10884404,0.19648135,0.0005030308,0.0009554117,0.0012414121,0.0018546332,0.0019039902,0.088351734,0.000029950625,0.014889071,0.00075358537],"about_ca_topic_score_codex":0.00177831,"about_ca_topic_score_gemma":0.0034150963,"teacher_disagreement_score":0.56685716,"about_ca_system_score_codex":0.00026582304,"about_ca_system_score_gemma":0.00024495393,"threshold_uncertainty_score":0.99986863},"labels":[],"label_agreement":null},{"id":"W2767617427","doi":"10.1093/neuonc/nox168.567","title":"NCOG-06. N107C/CEC.3 (ALLIANCE FOR CLINICAL TRIALS IN ONCOLOGY/CANADIAN CANCER TRIALS GROUP): PHASE III TRIAL OF POST-OPERATIVE RADIOSURGERY COMPARED WITH WHOLE BRAIN RADIOTHERAPY FOR RESECTED METASTATIC BRAIN DISEASE: COGNITIVE FUNCTION OF LONG-TERM SURVIVORS","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Juravinski Cancer Centre; McMaster University; Hôpital Notre-Dame; Université de Montréal","funders":"","keywords":"Medicine; Radiosurgery; Neurocognitive; Clinical endpoint; Radiation therapy; Brain metastasis; Internal medicine; Oncology; Randomized controlled trial; Surgery; Cancer; Metastasis; Cognition","score_opus":0.2090155266997285,"score_gpt":0.5062000524411235,"score_spread":0.29718452574139503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767617427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9436364,0.0017693002,0.0039036572,0.022815632,0.0020338388,0.019740596,0.006036378,0.000029734107,0.000034428376],"genre_scores_gemma":[0.98575616,0.00073375576,0.001658145,0.0038375026,0.0010555066,0.004602352,0.0021004968,0.000113759124,0.0001423243],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9849199,0.009548398,0.003462041,0.0009780631,0.00037212484,0.00071948295],"domain_scores_gemma":[0.9423739,0.051690444,0.0036956882,0.0007015832,0.0008304136,0.0007080146],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.018773025,0.0005216062,0.0059121316,0.0004479403,0.0002800873,0.000044171637,0.00028272445,0.00035590076,0.00017866914],"category_scores_gemma":[0.038956832,0.00039390445,0.001055665,0.00026313533,0.00085673685,0.00022716227,0.000032574502,0.00042881546,0.0000015585912],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7786829,0.006814145,0.008264759,0.0003272986,0.004151493,0.0006081123,0.000551932,0.000022987664,0.022615157,0.00010117978,0.0074396213,0.17042042],"study_design_scores_gemma":[0.83059376,0.08682484,0.041037418,0.00065316935,0.00600477,0.00004343231,0.0005241262,0.0007330794,0.0021952603,0.00010429872,0.030718286,0.0005675668],"about_ca_topic_score_codex":0.0038918012,"about_ca_topic_score_gemma":0.07410789,"teacher_disagreement_score":0.16985285,"about_ca_system_score_codex":0.00054448115,"about_ca_system_score_gemma":0.0049256934,"threshold_uncertainty_score":0.9998513},"labels":[],"label_agreement":null},{"id":"W2767623417","doi":"10.1093/neuonc/nox168.212","title":"CSIG-18. RALOXIFENE SENSITIZES GLIOBLASTOMA CELLS TO HYPOXIA-INDUCED DEATH THROUGH INHIBITION OF RNA STRESS GRANULE DISSOLUTION","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Dalhousie University","funders":"","keywords":"Raloxifene; Stress granule; Hypoxia (environmental); Autophagy; Programmed cell death; Apoptosis; Cancer research; Chemistry; Selective estrogen receptor modulator; Downregulation and upregulation; Pharmacology; Medicine; Cell biology; Biology; Estrogen receptor; Internal medicine; Messenger RNA; Translation (biology); Biochemistry; Gene","score_opus":0.030636578417558593,"score_gpt":0.3197846394331111,"score_spread":0.2891480610155525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767623417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99505585,0.00004278698,0.00074353756,0.0008358052,0.00037701568,0.00037452753,0.000055551496,0.000018267507,0.002496663],"genre_scores_gemma":[0.9983616,0.000107437314,0.00047646498,0.00044807707,0.0003389495,0.000027990822,0.000037778897,0.000030694457,0.00017099344],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99830157,0.0002033404,0.0003063301,0.0004889443,0.00021927041,0.0004805529],"domain_scores_gemma":[0.9986537,0.000056238106,0.00023067238,0.00069565594,0.00017781538,0.0001859377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002148665,0.0002004008,0.00031966556,0.000069728434,0.00030074042,0.000042478234,0.0002929834,0.0002733194,0.000018959136],"category_scores_gemma":[0.00036631167,0.00019551611,0.00012391506,0.0000636226,0.0001293367,0.000019218563,0.00033407137,0.0001938483,0.00002439834],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058772933,0.00013244331,0.00030364865,0.000024017225,0.000024297135,0.000079610894,0.000065885244,0.000078423465,0.99239707,0.00007341879,0.0020318227,0.0042016334],"study_design_scores_gemma":[0.001102594,0.0032142496,0.0017481506,0.000024456389,0.000018108009,0.00003982169,0.000061861814,0.00010546509,0.98901904,0.000079464335,0.0044099106,0.00017687007],"about_ca_topic_score_codex":0.0002513122,"about_ca_topic_score_gemma":0.00038672992,"teacher_disagreement_score":0.0040247636,"about_ca_system_score_codex":0.00005210321,"about_ca_system_score_gemma":0.00014608196,"threshold_uncertainty_score":0.7972916},"labels":[],"label_agreement":null},{"id":"W2767624622","doi":"10.1093/neuonc/nox168.546","title":"MNGI-08. HIGH-RISK MENINGIOMA: INITIAL OUTCOMES FROM NRG ONCOLOGY/RTOG-0539","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences; McGill University Health Centre; Juravinski Cancer Centre; Western University","funders":"","keywords":"Medicine; Internal medicine; Meningioma; Oncology; Surgery","score_opus":0.05114736688437131,"score_gpt":0.3490353599664027,"score_spread":0.2978879930820314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767624622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8873885,0.000111788766,0.00020150219,0.013860338,0.004704806,0.0008211723,0.00006902451,0.00024710188,0.09259573],"genre_scores_gemma":[0.9907038,0.000042267868,0.0042703,0.0023069908,0.0013746591,0.00013352637,0.00009906902,0.000075294236,0.00099409],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99623716,0.0004902841,0.00085373834,0.0010085745,0.0005376527,0.0008725868],"domain_scores_gemma":[0.99570864,0.0010261803,0.000874687,0.0017537063,0.0001517206,0.0004850642],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0006846256,0.0005060452,0.0014460466,0.00030695452,0.00079474656,0.00011519382,0.0008264669,0.00059403694,0.0013385564],"category_scores_gemma":[0.0015654538,0.00043925014,0.00035513716,0.00011696282,0.00045102558,0.00025102703,0.0007765071,0.0009525758,0.0012045453],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055341455,0.003028426,0.35499603,0.00013884308,0.0025160143,0.10047515,0.0034779112,0.000027315578,0.11227229,0.0065362533,0.15719825,0.25379938],"study_design_scores_gemma":[0.017553592,0.006240179,0.30948746,0.000052043804,0.0015779118,0.00085488515,0.00039031927,0.00029819613,0.0065285615,0.0019735962,0.6543541,0.00068916654],"about_ca_topic_score_codex":0.0011391577,"about_ca_topic_score_gemma":0.00019909766,"teacher_disagreement_score":0.49715585,"about_ca_system_score_codex":0.00043086722,"about_ca_system_score_gemma":0.0004371323,"threshold_uncertainty_score":0.9998059},"labels":[],"label_agreement":null},{"id":"W2767629883","doi":"10.1093/neuonc/nox168.173","title":"CMET-25. PROGRESSION-FREE SURVIVAL (PFS) AND SITE OF FIRST PROGRESSION IN HER2+ METASTATIC BREAST CANCER PATIENTS WITH OR WITHOUT BRAIN METASTASES: A POOLED ANALYSIS OF TUCATINIB PHASE I STUDIES","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Metastatic breast cancer; Internal medicine; Capecitabine; Progression-free survival; Breast cancer; Oncology; Cohort; Brain metastasis; Cancer; Gastroenterology; Overall survival; Metastasis; Colorectal cancer","score_opus":0.03978196753042855,"score_gpt":0.4096761115870824,"score_spread":0.36989414405665383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767629883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925201,0.0008828113,0.000014756452,0.0036311643,0.00013929635,0.0017135561,0.0010389145,0.000018369687,0.000041014267],"genre_scores_gemma":[0.99527216,0.00028468866,0.003674093,0.00019968857,0.00003441152,0.00035724265,0.000120480865,0.000038398728,0.000018854877],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99707043,0.0005636698,0.0007897411,0.00061254966,0.0005816836,0.00038191755],"domain_scores_gemma":[0.99629897,0.00090784923,0.0012523736,0.0008985466,0.0004331672,0.00020910203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079654885,0.00037305497,0.0021342775,0.0004813871,0.00018241929,0.000021259842,0.00022229248,0.00008285043,0.0001253251],"category_scores_gemma":[0.0011504496,0.00021527744,0.00016852931,0.0005534162,0.00064729253,0.00015608422,0.0002836223,0.00021046727,7.5506676e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009822281,0.0071423035,0.90819955,0.000563109,0.0062425337,0.000372298,0.0018244047,0.000014123108,0.0012631052,0.000016117645,0.00031798895,0.06422218],"study_design_scores_gemma":[0.089400075,0.028369447,0.8344558,0.0017235318,0.03647821,0.0001179425,0.0021800976,0.0013016104,0.002499448,0.000039901195,0.0028115066,0.000622435],"about_ca_topic_score_codex":0.0005504238,"about_ca_topic_score_gemma":0.009503688,"teacher_disagreement_score":0.079577796,"about_ca_system_score_codex":0.00013358986,"about_ca_system_score_gemma":0.00034389566,"threshold_uncertainty_score":0.8778759},"labels":[],"label_agreement":null},{"id":"W2767635736","doi":"10.1093/neuonc/nox168.410","title":"GENE-37. PATHWAY ANALYSIS OF RADIATION-INDUCED MENINGIOMAS REVEALS THAT TUMOURS WITH NF2-FUSION HAVE UPREGULATION OF INFLAMMATORY PATHWAYS","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Fusion gene; Gene; Downregulation and upregulation; Biology; Cancer research; CDKN2A; Bioconductor; Fold change; Gene expression; Molecular biology; Bioinformatics; Genetics","score_opus":0.03990963570850977,"score_gpt":0.3138341214171201,"score_spread":0.27392448570861033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767635736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972802,0.00004716708,0.00002887407,0.00035521033,0.00009751797,0.00062325,0.00003572864,0.000029729668,0.001502339],"genre_scores_gemma":[0.9993884,0.00004942469,0.00024642728,0.000061257866,0.000059888847,0.00004319818,0.00007031034,0.00003053591,0.000050556107],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980188,0.00025008022,0.00043819353,0.00040494473,0.0005655395,0.00032243377],"domain_scores_gemma":[0.9974538,0.00031760006,0.00089133374,0.0008666447,0.00024535853,0.00022522708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029653995,0.00020603728,0.00077683927,0.00047543482,0.00018426128,0.000016781874,0.00021469704,0.00016404506,0.00005463951],"category_scores_gemma":[0.00035440424,0.00016353723,0.00020655691,0.00023741231,0.0001667205,0.00016954841,0.000109460285,0.00019527954,0.0000065493077],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075534737,0.00022032083,0.30355242,0.000034031927,0.00042643058,0.0004283314,0.00032943074,0.000051480096,0.6839729,0.00004478989,0.000040624214,0.010143868],"study_design_scores_gemma":[0.0022204788,0.0018269012,0.5015795,0.000026793325,0.0005625773,0.00004031237,0.00004698116,0.00035989663,0.4931368,0.00002640078,0.00010494754,0.00006841977],"about_ca_topic_score_codex":0.00007765208,"about_ca_topic_score_gemma":0.00012720819,"teacher_disagreement_score":0.19802707,"about_ca_system_score_codex":0.00014646689,"about_ca_system_score_gemma":0.0004086948,"threshold_uncertainty_score":0.6668855},"labels":[],"label_agreement":null},{"id":"W2767639660","doi":"10.1093/neuonc/nox168.182","title":"CMET-35. PRELIMINARY SCREENING OF A NOVEL EpCAM BISPECIFIC T-CELL ENGAGER (BiTE) ANTIBODY TO TARGET A BMIC POPULATION IN HUMAN BRAIN METASTASES","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University","funders":"","keywords":"Epithelial cell adhesion molecule; Antigen; Population; Monoclonal antibody; Cancer research; Flow cytometry; Antibody; Cancer stem cell; Cancer; Metastasis; Biology; Immunology; Medicine; Genetics","score_opus":0.08009285261940259,"score_gpt":0.40502036812942266,"score_spread":0.3249275155100201,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767639660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898485,0.00015394737,0.0007919404,0.0024804315,0.00023196437,0.0013772744,0.000043323904,0.000045525983,0.005027119],"genre_scores_gemma":[0.99135804,0.000029945886,0.006327184,0.00081844046,0.0002573788,0.00006351063,0.00015728718,0.00007621234,0.0009120024],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99716026,0.0005485174,0.0006356926,0.00062797137,0.00045911837,0.000568461],"domain_scores_gemma":[0.99739164,0.00088760024,0.0003432139,0.0010140557,0.00012844578,0.00023506618],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014389493,0.00026051872,0.0008159246,0.0007683147,0.00025595326,0.000039027207,0.0004279771,0.00022275766,0.00085455517],"category_scores_gemma":[0.00119602,0.00025857138,0.00017100666,0.00029182626,0.00018854321,0.00015871342,0.000329733,0.00079370633,0.00002105055],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001665664,0.0010153909,0.024512269,0.0000935228,0.000037342335,0.00054598897,0.000557223,0.00012491451,0.95765704,0.00008768559,0.0015566119,0.012146371],"study_design_scores_gemma":[0.016329682,0.013466892,0.5119588,0.00027157078,0.00015276605,0.000517011,0.00050106755,0.002151671,0.33600366,0.00009157443,0.117979005,0.00057630864],"about_ca_topic_score_codex":0.000985208,"about_ca_topic_score_gemma":0.00019692494,"teacher_disagreement_score":0.6216534,"about_ca_system_score_codex":0.00019214893,"about_ca_system_score_gemma":0.0001691499,"threshold_uncertainty_score":0.99998665},"labels":[],"label_agreement":null},{"id":"W2767646803","doi":"10.1093/neuonc/nox168.1041","title":"TMOD-02. IDENTIFICATION OF NOVEL MARKERS OF TREATMENT-REFRACTORY RECURRENT GLIOBLASTOMA","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Radiation therapy; Cancer stem cell; Chemoradiotherapy; Cancer research; Stem cell; Glioblastoma; Transcriptome; Temozolomide; Brain tumor; Medicine; Chemotherapy; Oncology; Cancer; Biology; Internal medicine; Pathology; Gene; Gene expression","score_opus":0.03639664062267455,"score_gpt":0.33700299826841007,"score_spread":0.3006063576457355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767646803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948751,0.0002509877,0.000011752794,0.0014509095,0.00073318,0.00054279494,0.00006068953,0.000020032434,0.00205458],"genre_scores_gemma":[0.9990355,0.0005043158,0.0001320842,0.00006123394,0.00008310889,0.0000842366,0.000018474966,0.000020976724,0.00006010536],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987474,0.000059528702,0.0005008761,0.00032227562,0.00017339026,0.00019653395],"domain_scores_gemma":[0.9978682,0.00024273134,0.0007929572,0.0008147068,0.00016406676,0.00011732808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013730426,0.00017006065,0.0005293115,0.00015495252,0.00009309622,0.000010045137,0.00015807177,0.00013856766,0.00007356615],"category_scores_gemma":[0.00032393358,0.0001246822,0.00018325359,0.000063608255,0.00021783338,0.00008019445,0.00005603912,0.0000906025,0.000020657857],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001342891,0.004411426,0.014182807,0.000050138275,0.00019680694,0.00006628391,0.0001727504,0.0000051851075,0.7994494,0.00013957133,0.0008471138,0.17913562],"study_design_scores_gemma":[0.014324328,0.028541004,0.21410076,0.00010781445,0.0008366994,0.00012338188,0.00013567405,0.00055605476,0.64809704,0.000036552814,0.09295925,0.00018142436],"about_ca_topic_score_codex":0.000075387194,"about_ca_topic_score_gemma":0.00008110062,"teacher_disagreement_score":0.19991796,"about_ca_system_score_codex":0.0003267114,"about_ca_system_score_gemma":0.00023450117,"threshold_uncertainty_score":0.5084393},"labels":[],"label_agreement":null},{"id":"W2767664052","doi":"10.1093/neuonc/nox168.028","title":"ACTR-37. PREDICTIVE SIGNIFICANCE OF IDH1/2 MUTATION AND 1p/19q CO-DELETION STATUS IN A POST-HOC ANALYSIS OF NRG ONCOLOGY/RTOG 9802: A PHASE III TRIAL OF RT VS RT + PCV IN HIGH RISK LOW-GRADE GLIOMAS","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation; Princess Margaret Cancer Centre; Ottawa Hospital; University Health Network","funders":"","keywords":"Internal medicine; Oncology; Medicine; Hazard ratio; IDH1; Univariate analysis; Biopsy; Proportional hazards model; Post-hoc analysis; Multivariate analysis; Confidence interval; Biology; Gene; Mutation","score_opus":0.0197238445767333,"score_gpt":0.34599998348462097,"score_spread":0.32627613890788765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767664052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99604046,0.00018119373,0.000023631248,0.00081882067,0.00023496419,0.0019960483,0.00045333392,0.000015649575,0.00023592263],"genre_scores_gemma":[0.99817187,0.0009827247,0.00017508671,0.000090426845,0.00006681282,0.00028978818,0.00019878872,0.0000224627,0.0000020291022],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9968676,0.0006562584,0.0011432202,0.0005788077,0.00036916806,0.00038495092],"domain_scores_gemma":[0.9959939,0.0012717461,0.0017228744,0.00055153685,0.00029177623,0.00016814866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066065666,0.00026738225,0.001735414,0.0010472042,0.00007210143,0.00000929389,0.00015754228,0.00037013425,0.00004681108],"category_scores_gemma":[0.0011169859,0.00024344391,0.00021610991,0.0006739736,0.00050315727,0.00014532538,0.00006831167,0.00033653012,0.0000014600813],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.25332612,0.019086894,0.16480577,0.0001613636,0.0020693673,0.0018392934,0.004687153,0.00044130703,0.49913985,0.00017314668,0.00015896118,0.05411076],"study_design_scores_gemma":[0.3122495,0.06402006,0.5027081,0.000115459516,0.0046120025,0.000037649115,0.00089015433,0.002964688,0.11148591,0.00017812198,0.0004968092,0.0002415776],"about_ca_topic_score_codex":0.003666007,"about_ca_topic_score_gemma":0.0032295617,"teacher_disagreement_score":0.38765395,"about_ca_system_score_codex":0.0004904354,"about_ca_system_score_gemma":0.0006301626,"threshold_uncertainty_score":0.99273545},"labels":[],"label_agreement":null},{"id":"W2767667543","doi":"10.1093/neuonc/nox168.705","title":"PATH-14. SIZE OF INCIDENTALLY DISCOVERED DIFFUSELY INFILTRATING GLIOMAS PREDICTS FUTURE GROWTH RATE","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Glioma; Oligodendroglioma; Asymptomatic; Astrocytoma; Fluid-attenuated inversion recovery; Lesion; Radiology; Nuclear medicine; Pathology; Magnetic resonance imaging","score_opus":0.015952444765943638,"score_gpt":0.28653679596712983,"score_spread":0.2705843512011862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767667543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985606,0.00016461592,0.000003938681,0.006274,0.0010938495,0.00064153067,0.00006927348,0.00005076904,0.006096011],"genre_scores_gemma":[0.997741,0.0002056016,0.00026748757,0.0009633842,0.00063632516,0.000084873274,0.000030951185,0.000042121985,0.000028289329],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99816966,0.00017575221,0.0005075061,0.0004480051,0.00030887497,0.00039018036],"domain_scores_gemma":[0.99754876,0.0006671274,0.00062981795,0.00074026163,0.00017300248,0.0002410528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022232604,0.00028036413,0.000712618,0.00009610716,0.0002711378,0.00005368283,0.0003012089,0.0002517225,0.00009608211],"category_scores_gemma":[0.0017207916,0.00022070625,0.00019504565,0.00010289986,0.00023095914,0.00021098882,0.00021760532,0.0002994565,0.000024790397],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045881953,0.0013252005,0.2989928,0.00012526692,0.00016776162,0.0024728724,0.0006562718,0.000001590498,0.6885854,0.00059810816,0.0033355379,0.0032803663],"study_design_scores_gemma":[0.012565731,0.004097775,0.78853524,0.00014695752,0.000437144,0.0004802022,0.00033505686,0.00006649121,0.18548664,0.00035037432,0.0072562518,0.00024212414],"about_ca_topic_score_codex":0.0001311177,"about_ca_topic_score_gemma":0.00013597403,"teacher_disagreement_score":0.5030987,"about_ca_system_score_codex":0.00015419861,"about_ca_system_score_gemma":0.00030000272,"threshold_uncertainty_score":0.9000139},"labels":[],"label_agreement":null},{"id":"W2767695428","doi":"10.1093/neuonc/nox168.562","title":"NCOG-01. PATIENT-REPORTED COGNITIVE CONCERNS AND QUALITY OF LIFE IN BRAIN METASTASES","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Toronto Western Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Cognition; Anxiety; Quality of life (healthcare); Depression (economics); Distress; Medicine; Intrusiveness; Clinical psychology; Executive functions; Psychiatry; Psychology; Developmental psychology","score_opus":0.10612063900626331,"score_gpt":0.3981331473694413,"score_spread":0.29201250836317794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767695428","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99156564,0.00040121094,0.00002312876,0.0042016767,0.00020196337,0.0006618952,0.00014969279,0.000018412687,0.0027763508],"genre_scores_gemma":[0.99639434,0.00010195622,0.00031146005,0.0029923862,0.00006526042,0.000046887668,0.00004805544,0.000016840626,0.0000227991],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980553,0.00050637696,0.0006192597,0.0003767001,0.00019652939,0.000245874],"domain_scores_gemma":[0.99716127,0.0014352025,0.00067137665,0.00040876828,0.00011794442,0.0002054515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055256457,0.00017269241,0.0008283328,0.000091685266,0.00009501908,0.000013185018,0.000073127,0.00011090203,0.00014245322],"category_scores_gemma":[0.0051924754,0.0001425566,0.00009726008,0.000058421767,0.0004347116,0.000077386656,0.00012629296,0.00020803047,0.0000064299034],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004184292,0.0026077055,0.74821115,0.00022241035,0.00078612275,0.002695227,0.0015149593,0.0000020133737,0.054158535,0.0010855877,0.0025443474,0.18198767],"study_design_scores_gemma":[0.029346853,0.00851623,0.90475434,0.00014506998,0.00073613046,0.00024728148,0.0020686577,0.00004024872,0.019021407,0.00028924478,0.034499943,0.00033456716],"about_ca_topic_score_codex":0.0013568077,"about_ca_topic_score_gemma":0.0007737841,"teacher_disagreement_score":0.1816531,"about_ca_system_score_codex":0.000055474415,"about_ca_system_score_gemma":0.00031529707,"threshold_uncertainty_score":0.62162536},"labels":[],"label_agreement":null},{"id":"W2767697997","doi":"10.1093/neuonc/nox168.217","title":"CSIG-23. CIC PROTEIN INSTABILITY DRIVES CANCER PHENOTYPES IN GLIOBLASTOMA","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"14-3-3 protein interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"MAPK/ERK pathway; Cancer research; Signal transduction; Biology; Receptor tyrosine kinase; Ubiquitin ligase; Kinase; Cell biology; Carcinogenesis; Cancer; Ubiquitin; Genetics; Gene","score_opus":0.016221524313195654,"score_gpt":0.3197615835393039,"score_spread":0.3035400592261082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767697997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910443,0.00021559808,0.00007215328,0.002391558,0.00069945876,0.00068248087,0.00002501225,0.000025302576,0.004844174],"genre_scores_gemma":[0.9978448,0.000081587925,0.0003313311,0.00045682566,0.0003818433,0.0005506002,0.000008137962,0.00003231276,0.00031257005],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983861,0.00023473447,0.00029980007,0.0005937038,0.0001102205,0.00037546427],"domain_scores_gemma":[0.99860525,0.000044576012,0.0002446011,0.0008950276,0.00011101091,0.00009955303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018808592,0.00020448235,0.00026574996,0.000072486866,0.00023468299,0.000048071255,0.0005375473,0.0003045089,0.00014100556],"category_scores_gemma":[0.00094867806,0.00020558442,0.000092213544,0.000058739246,0.00031623014,0.000018744598,0.00036697055,0.00035055427,0.000058874244],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035514968,0.00019671192,0.010673463,0.000017710714,0.0000221089,0.000029935389,0.000101631245,0.000025564113,0.97409624,0.00009006296,0.0007318018,0.013659623],"study_design_scores_gemma":[0.0009056267,0.0010076958,0.0143805975,0.000021438635,0.000011763224,0.000024110188,0.000051881816,0.000035832276,0.7293888,0.00025810665,0.25369665,0.00021750314],"about_ca_topic_score_codex":0.00038601347,"about_ca_topic_score_gemma":0.007846683,"teacher_disagreement_score":0.25296485,"about_ca_system_score_codex":0.00012260926,"about_ca_system_score_gemma":0.00036692232,"threshold_uncertainty_score":0.838349},"labels":[],"label_agreement":null},{"id":"W2767699464","doi":"10.1093/neuonc/nox168.462","title":"IMMU-03. THERAPEUTIC TARGETING OF TUMORIGENIC
EphA2+/EphA3+ BRAIN TUMOR INITIATING CELLS WITH BISPECIFIC ANTIBODY IN HUMAN GLIOBLASTOMA","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Axon Guidance and Neuronal Signaling","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University","funders":"","keywords":"EPH receptor A2; Cancer research; Population; Gene knockdown; Receptor tyrosine kinase; Protein kinase B; Biology; Medicine; Receptor; Cell culture; Phosphorylation; Internal medicine; Cell biology","score_opus":0.03993740797815651,"score_gpt":0.3378708080221566,"score_spread":0.29793340004400004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767699464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941604,0.000081340855,0.000081175815,0.00052340893,0.00059108774,0.00050178013,0.000012499707,0.000083787585,0.003964526],"genre_scores_gemma":[0.9970351,0.00004294879,0.00012527728,0.002406113,0.00024374637,0.00003341525,0.000002001609,0.00008374309,0.000027686237],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9961511,0.00070931896,0.00087068556,0.0009533547,0.0004653093,0.0008502187],"domain_scores_gemma":[0.9963248,0.0015496943,0.0011848927,0.00071951834,0.000082345934,0.00013879927],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006720832,0.00038731005,0.00071906194,0.0003025592,0.0007825486,0.00010217504,0.0011381186,0.00012689474,0.00012737168],"category_scores_gemma":[0.0007343428,0.00035034848,0.00013035766,0.0003730216,0.0006216003,0.00044784576,0.00029767412,0.00078336365,0.000060807743],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033105645,0.00024441603,0.005753535,0.000039236595,0.0000063402535,0.0014974256,0.00041423098,0.00017813496,0.98967826,0.00056093826,0.00008099122,0.0012154547],"study_design_scores_gemma":[0.0017938572,0.0024027613,0.0049964404,0.00008312528,0.000017513164,0.00018293098,0.00017217452,0.00053188816,0.98541284,0.00023261736,0.00382668,0.00034719694],"about_ca_topic_score_codex":0.00006719119,"about_ca_topic_score_gemma":0.00007130078,"teacher_disagreement_score":0.0042654253,"about_ca_system_score_codex":0.000115557144,"about_ca_system_score_gemma":0.0002674145,"threshold_uncertainty_score":0.99989486},"labels":[],"label_agreement":null},{"id":"W2767712841","doi":"10.1093/neuonc/nox168.859","title":"RARE-06. CANADIAN PATTERNS OF PRACTICE FOR INTRACRANIAL GERM CELL TUMOURS IN ADOLESCENTS AND YOUNG ADULTS","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; Princess Margaret Cancer Centre; BC Children's Hospital; BC Cancer Agency","funders":"","keywords":"Medicine; Radiation therapy; Germinoma; Germ cell tumors; Chemotherapy; Specialty; Pediatrics; Surgery; Pathology","score_opus":0.014145325714358219,"score_gpt":0.29411916067015353,"score_spread":0.2799738349557953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767712841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927063,0.00009248824,0.0000025030722,0.0050064153,0.00044914687,0.0008108555,0.000064750486,0.000006628509,0.00086092536],"genre_scores_gemma":[0.99850726,0.00014804758,0.00015649013,0.0009397441,0.00013204209,0.00007511329,0.000014914093,0.000020170111,0.0000062173463],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99900895,0.00006526622,0.00024317479,0.0002749245,0.000099941884,0.0003077308],"domain_scores_gemma":[0.9989308,0.00016955892,0.00025634878,0.00029012945,0.00010386629,0.0002492997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014190077,0.00012940879,0.00034494934,0.00013453807,0.000096886666,0.000018386692,0.00010483218,0.00013362295,0.000010536569],"category_scores_gemma":[0.0006407708,0.00011868201,0.000049391587,0.00002646646,0.000053794716,0.00009376352,0.00003896423,0.00016480789,0.0000054867246],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052876474,0.000830642,0.9755015,0.00012349396,0.000012593731,0.0018936556,0.0005376769,4.953864e-7,0.006586171,0.000018798137,0.00043436245,0.013531883],"study_design_scores_gemma":[0.011464476,0.0018246912,0.9710258,0.00017770045,0.00017210325,0.00032899255,0.0002697549,0.00009901903,0.0059312796,0.000009836339,0.008589322,0.000106981475],"about_ca_topic_score_codex":0.050659794,"about_ca_topic_score_gemma":0.17696872,"teacher_disagreement_score":0.12630892,"about_ca_system_score_codex":0.00017114506,"about_ca_system_score_gemma":0.00031323702,"threshold_uncertainty_score":0.95566195},"labels":[],"label_agreement":null},{"id":"W2767715561","doi":"10.1093/neuonc/nox168.627","title":"NIMG-53. POST-SURGICAL, RESIDUAL ENHANCING TUMOR VOLUME IS PROGNOSTIC FOR OVERALL SURVIVAL IN NEWLY DIAGNOSED GLIOBLASTOMA: EVIDENCE FROM 1,458 PATIENTS POOLED FROM INTERNATIONAL TRIALS, SINGLE INSTITUTION DATABASES, AND MULTICENTER CONSORTIUMS","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Clinical trial; Oncology; Internal medicine; Multivariate analysis; Proportional hazards model; Bevacizumab; Database; Surgery; Chemotherapy","score_opus":0.05642568698006856,"score_gpt":0.34264099931898173,"score_spread":0.2862153123389132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767715561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99009824,0.00035684957,0.000040942567,0.0040468653,0.0019396261,0.0020136004,0.0014042676,0.00004012407,0.000059488655],"genre_scores_gemma":[0.99637645,0.00017463758,0.0009843931,0.0009837784,0.0005548923,0.000273804,0.0006098962,0.000032402942,0.000009769502],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971405,0.00037053527,0.0008985601,0.0008195754,0.0003837273,0.0003870876],"domain_scores_gemma":[0.9934359,0.0048456513,0.0006919644,0.0004921309,0.0003088898,0.0002254492],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00044946623,0.00031226833,0.000924216,0.00016756877,0.00019928897,0.00013204009,0.00023793026,0.00014957428,0.00018124741],"category_scores_gemma":[0.014378432,0.0002728335,0.00013765134,0.000048233833,0.00020900836,0.00048927043,0.00026475734,0.00024672822,0.000033040367],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008351628,0.0037055302,0.8700735,0.00003661352,0.00026307016,0.0019375932,0.000514119,0.000008632211,0.1046824,0.000016374624,0.002020628,0.008389938],"study_design_scores_gemma":[0.049718816,0.003989208,0.8909658,0.00078088505,0.0007704274,0.000024583202,0.00011208655,0.0013407422,0.028284011,0.000023891675,0.02365499,0.00033453517],"about_ca_topic_score_codex":0.003664004,"about_ca_topic_score_gemma":0.0043085227,"teacher_disagreement_score":0.07639839,"about_ca_system_score_codex":0.00034816138,"about_ca_system_score_gemma":0.00028205293,"threshold_uncertainty_score":0.9999724},"labels":[],"label_agreement":null},{"id":"W2767747918","doi":"10.1093/neuonc/nox168.254","title":"DDIS-19. NOVEL PEPTIDE HOMING TO GLIOMA-SPECIFIC ISOFORM OF BREVICAN SELECTIVELY TARGETS MALIGNANT BRAIN TUMORS","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Glioma; Gene isoform; Peptide library; Peptide; Biology; B cell; Cancer research; Molecular biology; Chemistry; Biochemistry; Peptide sequence; Antibody; Immunology; Gene","score_opus":0.027552941740150844,"score_gpt":0.29263625262546733,"score_spread":0.2650833108853165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767747918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9846892,0.00026329875,0.0014646455,0.0025234288,0.00037919308,0.0006468632,0.00012739892,0.000027189884,0.00987878],"genre_scores_gemma":[0.9945225,0.000067550835,0.0027795688,0.00177531,0.00044961655,0.00009059464,0.00003482338,0.000054171724,0.00022583074],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980132,0.00012662218,0.00042892923,0.0006839975,0.00017622655,0.0005710462],"domain_scores_gemma":[0.99822026,0.00009972744,0.00042493155,0.0008075263,0.00016409454,0.00028344346],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000480836,0.00028276435,0.00046293437,0.00011630911,0.00033770708,0.000043298543,0.0007470099,0.00025603757,0.000057898418],"category_scores_gemma":[0.0008713331,0.00027803655,0.00016832296,0.000104310035,0.00023497349,0.000010545666,0.0004790201,0.0002184088,0.000036694382],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003146887,0.00015517912,0.0009344202,0.000032141827,0.000032658645,0.00006657821,0.0002450344,0.000010951987,0.9805199,0.00044124678,0.008581323,0.008665887],"study_design_scores_gemma":[0.00078931643,0.0013839001,0.004463967,0.00001885484,0.000009268847,0.00019001955,0.0000646362,0.000010879514,0.66239446,0.000058438756,0.33040133,0.00021493848],"about_ca_topic_score_codex":0.00007833338,"about_ca_topic_score_gemma":0.00009567321,"teacher_disagreement_score":0.32182002,"about_ca_system_score_codex":0.000070735136,"about_ca_system_score_gemma":0.00034404118,"threshold_uncertainty_score":0.99996716},"labels":[],"label_agreement":null},{"id":"W2767766110","doi":"10.1093/neuonc/nox168.1104","title":"SCDT-21. CEREBRAL INTRAARTERIAL CHEMOTHERAPY IN THE TREATMENT OF MALIGNANT GLIOMAS: READY TO RISE AGAIN","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Medicine; Temozolomide; Carboplatin; Chemotherapy; Complication; Glioma; Concomitant; Cohort; Surgery; Radiation therapy; Oncology; Internal medicine; Cisplatin","score_opus":0.04201072693010514,"score_gpt":0.3734141479719171,"score_spread":0.3314034210418119,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767766110","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9728482,0.00011406438,0.0000021281264,0.020047171,0.0011929193,0.0012172619,0.000024546449,0.000020415191,0.004533336],"genre_scores_gemma":[0.9947555,0.00042564867,0.00015619143,0.0033138439,0.0008632525,0.00025040214,0.00001751427,0.000024989884,0.0001926484],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986132,0.00020698275,0.0003375537,0.00035012525,0.00014158244,0.00035060043],"domain_scores_gemma":[0.9988061,0.00020153548,0.00019365996,0.0006350879,0.000042108,0.00012146206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018580168,0.00019437967,0.00057183864,0.00011689655,0.00011608451,0.000025025614,0.00022450913,0.0001481626,0.00039054677],"category_scores_gemma":[0.00003987677,0.00013502431,0.00011071631,0.000091862865,0.00017700618,0.000045226272,0.000028804185,0.0001146805,0.000036646168],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071361037,0.006252117,0.038905498,0.00002919327,0.00019774187,0.0029039804,0.007929841,0.000003447682,0.7681866,0.00011740523,0.022040127,0.14629793],"study_design_scores_gemma":[0.019155439,0.032019354,0.065099806,0.000023365405,0.0002678771,0.0004532543,0.00023051404,0.000028797074,0.08972976,0.00015002761,0.79265743,0.00018437563],"about_ca_topic_score_codex":0.0010692477,"about_ca_topic_score_gemma":0.001546658,"teacher_disagreement_score":0.7706173,"about_ca_system_score_codex":0.00029978587,"about_ca_system_score_gemma":0.00022185559,"threshold_uncertainty_score":0.5506131},"labels":[],"label_agreement":null},{"id":"W2767800648","doi":"10.1093/neuonc/nox168.654","title":"NIMG-84. TUMOR LOCATION IS PROGNOSTIC FOR OVERALL SURVIVAL IN NEWLY DIAGNOSED GLIOBLASTOMA: EVIDENCE FROM 1,458 PATIENTS POOLED FROM INTERNATIONAL TRIALS, SINGLE INSTITUTION DATABASES, AND MULTICENTER CONSORTIUMS","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Hazard ratio; Database; Internal medicine; Clinical trial; Proportional hazards model; Oncology; Confidence interval","score_opus":0.07433397006595907,"score_gpt":0.35124403931378784,"score_spread":0.2769100692478288,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767800648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99154294,0.00029433935,0.00019651683,0.0031944977,0.001958055,0.002030967,0.00070658297,0.000030292442,0.000045798297],"genre_scores_gemma":[0.99652874,0.00016199361,0.0009002586,0.001079397,0.0003459838,0.0003319541,0.0006249365,0.000023172664,0.000003578083],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99793696,0.00024199406,0.0006592073,0.0006266569,0.00027804732,0.00025711476],"domain_scores_gemma":[0.9952289,0.0033174744,0.0006028688,0.00042829258,0.00027073474,0.00015174055],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.00030399728,0.0002353507,0.000650034,0.0001396289,0.00013492013,0.00008923951,0.00018317955,0.00010977221,0.00007759133],"category_scores_gemma":[0.012165794,0.00020696504,0.00008880976,0.000048907008,0.00015216872,0.00043569182,0.00015149884,0.00015741438,0.0000234517],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039391443,0.0032049923,0.9332145,0.000031686523,0.00017289346,0.0003077785,0.0003379741,0.000015083587,0.043004658,0.000030345467,0.0017662966,0.013974654],"study_design_scores_gemma":[0.032514025,0.0017510956,0.9363543,0.0005052047,0.0005289854,0.0000057758125,0.000050280738,0.0028116019,0.014405903,0.000043005977,0.0108381305,0.00019170326],"about_ca_topic_score_codex":0.0025050608,"about_ca_topic_score_gemma":0.0026895467,"teacher_disagreement_score":0.028598756,"about_ca_system_score_codex":0.00034490673,"about_ca_system_score_gemma":0.00020922866,"threshold_uncertainty_score":0.99615514},"labels":[],"label_agreement":null},{"id":"W2767830059","doi":"10.1093/neuonc/nox168.193","title":"CMET-47. PRECLINICAL VALIDATION OF NOVEL THERAPEUTICS TARGETING A BMIC POPULATION IN HUMAN BRAIN METASTASES","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McMaster University","funders":"","keywords":"Brain metastasis; Population; Cancer research; In vivo; Medicine; Metastasis; Transplantation; Cancer; In silico; Melanoma; Biology; Internal medicine; Gene","score_opus":0.1234532284471749,"score_gpt":0.4313841695183151,"score_spread":0.30793094107114016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767830059","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936761,0.0000976423,0.0002714951,0.004518271,0.00025810322,0.0005567632,0.00003101937,0.000023718498,0.0005668859],"genre_scores_gemma":[0.9934958,0.000028751669,0.005052991,0.0010225845,0.00013695216,0.000029191193,0.00018776543,0.000023495193,0.00002245495],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9983609,0.00032030037,0.0005962986,0.00031481613,0.00018697775,0.0002207352],"domain_scores_gemma":[0.9981873,0.00069115567,0.00052568555,0.00045747636,0.00006923679,0.00006915184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009413897,0.00014973036,0.0005316818,0.0001267338,0.00013752974,0.000017770293,0.00013217678,0.00014516393,0.00006632988],"category_scores_gemma":[0.0009823802,0.00012755123,0.00012938624,0.00006961132,0.00011219073,0.00009719642,0.00007595438,0.00024348607,0.000003851997],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005270376,0.0028539142,0.1777162,0.00009366779,0.00020840007,0.0001310126,0.00034503237,0.00014505102,0.7695335,0.0019044603,0.0005068061,0.0460349],"study_design_scores_gemma":[0.02666483,0.00938014,0.79126525,0.00018128446,0.0013666786,0.00019955767,0.00027050238,0.0023081873,0.11471119,0.0013477948,0.05182832,0.00047629487],"about_ca_topic_score_codex":0.00036653783,"about_ca_topic_score_gemma":0.00011508445,"teacher_disagreement_score":0.65482235,"about_ca_system_score_codex":0.00011113292,"about_ca_system_score_gemma":0.00009543866,"threshold_uncertainty_score":0.5201388},"labels":[],"label_agreement":null},{"id":"W2767847048","doi":"10.1093/neuonc/nox168.834","title":"QLIF-25. EFFECT OF TUMOR TREATING FIELDS (TTFIELDS) ON HEALTH-RELATED QUALITY OF LIFE (HRQoL) IN NEWLY DIAGNOSED GLIOBLASTOMA. RESULTS OF THE EF-14 RANDOMIZED PHASE III TRIAL","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Quality of life (healthcare); Weakness; Clinical trial; Glioblastoma; Internal medicine; Randomized controlled trial; Physical therapy; Surgery","score_opus":0.03203434641964683,"score_gpt":0.36635146413125597,"score_spread":0.33431711771160916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767847048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863939,0.0001758663,0.0000019030964,0.0069874506,0.000839227,0.003690059,0.000045080124,0.000019404428,0.0018470807],"genre_scores_gemma":[0.9989562,0.00009410135,0.000020534215,0.00055678614,0.00010210849,0.00022580213,0.000010349883,0.000020858733,0.000013242503],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9939068,0.0027545795,0.002202023,0.00042028548,0.00038430962,0.0003320003],"domain_scores_gemma":[0.9821671,0.013700586,0.002830676,0.0010219279,0.0001121293,0.00016756308],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0028091082,0.0002811112,0.002966455,0.00019827065,0.00012682684,0.000007824801,0.00029516325,0.00029410707,0.000039037175],"category_scores_gemma":[0.02318956,0.0001737079,0.0005897494,0.00018499755,0.0003622629,0.00004295267,0.00010985684,0.0004669068,0.0000026322275],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9573425,0.0040437686,0.003760508,0.00022933361,0.0002643828,0.00017002365,0.0010445515,0.000050153947,0.01771643,0.00012891105,0.0011373583,0.014112097],"study_design_scores_gemma":[0.8914252,0.022632051,0.0038716546,0.00031637255,0.00024267116,0.0000093564795,0.000052232415,0.00018674611,0.080992535,0.00004023862,0.00013531835,0.0000956315],"about_ca_topic_score_codex":0.004719117,"about_ca_topic_score_gemma":0.0013314803,"teacher_disagreement_score":0.06591729,"about_ca_system_score_codex":0.0001088777,"about_ca_system_score_gemma":0.00042186078,"threshold_uncertainty_score":0.9850385},"labels":[],"label_agreement":null},{"id":"W2767859460","doi":"10.1093/neuonc/nox168.1100","title":"SCDT-17. DECREASED OPERATIVE COMPLICATIONS WITH IMAGE-GUIDED OMMAYA RESERVOIR INSERTION: SYSTEMATIC REVIEW AND META-ANALYSIS","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cerebrospinal fluid and hydrocephalus","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Cancer Care Ontario; Western University","funders":"","keywords":"Medicine; Ommaya reservoir; Meta-analysis; Surgery; Catheter; MEDLINE; Systematic review; Internal medicine; Chemotherapy","score_opus":0.11738547197742422,"score_gpt":0.3855625910165072,"score_spread":0.268177119039083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767859460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.37835172,0.041003298,0.004056394,0.36026016,0.00062538445,0.030830517,0.0009659597,0.0013003004,0.18260628],"genre_scores_gemma":[0.96506464,0.0017186155,0.00084110326,0.029918363,0.000041162002,0.0011269477,0.000016525571,0.000046217094,0.0012264432],"study_design_codex":"bench_or_experimental","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99694055,0.0008855944,0.00066014455,0.0008474663,0.00033515567,0.00033110476],"domain_scores_gemma":[0.99651843,0.00070773263,0.0005933691,0.0016461632,0.00027693604,0.00025736654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004929354,0.00029306218,0.002023038,0.0001372344,0.0012083248,0.00034260968,0.00086483883,0.000088552595,0.00042511176],"category_scores_gemma":[0.0026846163,0.00021208194,0.0003704549,0.0004482092,0.00055944204,0.00043665682,0.00027869883,0.00028532575,0.00009629709],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039738425,0.0021773973,0.0015965975,0.056576412,0.038029715,0.0016767933,0.001200572,0.00025657605,0.849271,0.011248948,0.03749502,0.000073598836],"study_design_scores_gemma":[0.0039828806,0.003201323,0.0062245755,0.0011830834,0.9329716,0.0035058025,0.00014363935,0.004305074,0.027579749,0.0007707985,0.014306322,0.0018251723],"about_ca_topic_score_codex":0.0002341547,"about_ca_topic_score_gemma":0.00078113365,"teacher_disagreement_score":0.89494187,"about_ca_system_score_codex":0.00007921021,"about_ca_system_score_gemma":0.00017257192,"threshold_uncertainty_score":0.92935795},"labels":[],"label_agreement":null},{"id":"W2767868848","doi":"10.1093/neuonc/nox168.978","title":"SURG-22. QUALITY BASED ASSESSMENT OF THE COST-EFFECTIVENESS OF 5-ALA IN HIGH GRADE GLIOMA SURGERY: A SYSTEMATIC REVIEW","year":2017,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Glioma; MEDLINE; Cost effectiveness; Systematic review; Quality-adjusted life year; Quality of life (healthcare); Surgery; Evidence-based medicine; Cost–benefit analysis; Pathology; Alternative medicine","score_opus":0.6133098890715591,"score_gpt":0.5592492630020298,"score_spread":0.05406062606952933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767868848","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00036908584,0.9811183,0.0001104989,0.0018606763,0.0020624334,0.012843136,0.0010379058,0.000021656428,0.0005762594],"genre_scores_gemma":[0.0042157094,0.99013555,0.00011166514,0.0013943153,0.000111300054,0.003800027,0.00012451447,0.00009138856,0.00001553991],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9554985,0.026937565,0.015673677,0.0010341152,0.00028163206,0.0005745107],"domain_scores_gemma":[0.9254371,0.044224143,0.027302455,0.0027000168,0.0001828116,0.0001534716],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.10358426,0.0006002921,0.019244261,0.000835378,0.00013842223,0.00003406145,0.0014527867,0.0006952761,0.000108196946],"category_scores_gemma":[0.035751436,0.00053667463,0.0015860415,0.00065330317,0.0002919957,0.00018554693,0.00023645256,0.0007611676,0.00008228999],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000069540224,0.00035516467,0.0021012397,0.986416,0.00015624089,0.000009036595,0.000023538072,0.000007148971,9.31619e-7,0.008420616,0.0010258827,0.0014772596],"study_design_scores_gemma":[0.0012275566,0.00018972144,0.003997514,0.5848294,0.0007310071,0.000053292206,0.000025576173,0.00012036592,0.0000028992445,0.0007333295,0.40729374,0.00079562154],"about_ca_topic_score_codex":0.0012445603,"about_ca_topic_score_gemma":0.00018591885,"teacher_disagreement_score":0.40626785,"about_ca_system_score_codex":0.0024222862,"about_ca_system_score_gemma":0.0038914194,"threshold_uncertainty_score":0.9997085},"labels":[],"label_agreement":null},{"id":"W2767872427","doi":"10.1093/neuonc/nox168.838","title":"QLIF-29. FUNCTIONAL AND EMPLOYMENT OUTCOMES IN IDH MUTANT GLIOBLASTOMA","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"","keywords":"Medicine; Glioblastoma; Cohort; Internal medicine; IDH1; Confidence interval; Oncology; Performance status; Radiation therapy; Chemotherapy; Surgery; Mutation; Biology","score_opus":0.021158529618510905,"score_gpt":0.33065285029169,"score_spread":0.3094943206731791,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767872427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95593894,0.00006121174,0.000114862494,0.038046453,0.0009546098,0.00020922699,0.0000020058587,0.000040739393,0.0046319766],"genre_scores_gemma":[0.993123,0.00008902035,0.00034293838,0.005883223,0.00025268007,0.000021765078,0.0000028666238,0.000022487591,0.00026203156],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99884504,0.000072778144,0.0002588822,0.0003135539,0.00020159165,0.0003081421],"domain_scores_gemma":[0.99906874,0.00026335465,0.00013251352,0.00031217985,0.00003037408,0.00019286275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034117006,0.00013707888,0.00041220651,0.0001228856,0.0001909388,0.000033789718,0.00011844234,0.00010992877,0.00012189059],"category_scores_gemma":[0.0011932139,0.00011041242,0.000055823515,0.000034875935,0.0002486505,0.00006659339,0.00016334855,0.0005910315,0.000030334531],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004844335,0.00038446163,0.73606706,0.000036085585,0.00005563332,0.0020329345,0.0002768281,0.000019312865,0.09096018,0.0007661681,0.0030331132,0.1658838],"study_design_scores_gemma":[0.005990836,0.0015284513,0.7742077,0.000043195225,0.0000628018,0.0010254327,0.00006410013,0.004112184,0.00095746975,0.0003085337,0.21154054,0.00015872986],"about_ca_topic_score_codex":0.000096335745,"about_ca_topic_score_gemma":0.00008895924,"teacher_disagreement_score":0.20850742,"about_ca_system_score_codex":0.000104744155,"about_ca_system_score_gemma":0.00013348224,"threshold_uncertainty_score":0.45024878},"labels":[],"label_agreement":null},{"id":"W2767882231","doi":"10.1093/neuonc/nox168.796","title":"PDTM-33. FOCUSED ULTRASOUND DISRUPTION OF THE BLOOD BRAIN BARRIER IN THE BRAINSTEM: A FEASIBILITY AND SAFETY STUDY","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Ultrasound and Hyperthermia Applications","field":"Engineering","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Hospital for Sick Children; Occupational Cancer Research Centre","funders":"","keywords":"Medicine; Brainstem; Microbubbles; Ultrasound; Blood–brain barrier; Pathology; Central nervous system; Radiology; Internal medicine","score_opus":0.0245647011193576,"score_gpt":0.28371133266297693,"score_spread":0.25914663154361933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767882231","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936145,0.000048071703,0.000040184877,0.0013337021,0.00015355716,0.0009869108,0.000033608714,0.000034753095,0.0037547003],"genre_scores_gemma":[0.99945515,0.000042189204,0.000031556327,0.00028371628,0.00006276249,0.000087878005,0.0000018032991,0.000017095726,0.000017860264],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99891627,0.00027575868,0.00027466335,0.00022346275,0.0001269442,0.00018289314],"domain_scores_gemma":[0.99785167,0.0011295476,0.00009365372,0.00086230785,0.000023539911,0.000039289273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005437772,0.00013035782,0.00022498915,0.000029902936,0.00031277895,0.00004663626,0.00049205736,0.00009972269,0.00001723342],"category_scores_gemma":[0.00053154497,0.000083451545,0.000055896162,0.00009415848,0.00021851661,0.00009207058,0.000058897927,0.00030276747,0.0000031746465],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006484561,0.00085815554,0.4383853,0.000048187027,0.00006809422,0.000011567977,0.011058674,0.00017440383,0.5373331,0.0012226633,0.0002560314,0.010519014],"study_design_scores_gemma":[0.0022521922,0.00027932273,0.97464174,0.000008025344,0.00007978864,0.000072866664,0.0010029345,0.00017392337,0.0011421902,0.000593745,0.019617233,0.00013605697],"about_ca_topic_score_codex":0.00007008251,"about_ca_topic_score_gemma":0.0022417624,"teacher_disagreement_score":0.53625643,"about_ca_system_score_codex":0.000044502296,"about_ca_system_score_gemma":0.000042722662,"threshold_uncertainty_score":0.34030554},"labels":[],"label_agreement":null},{"id":"W2767890423","doi":"10.1093/neuonc/nox168.543","title":"MNGI-04. PATHWAY ANALYSIS OF RADIATION-INDUCED MENINGIOMAS REVEALS UPREGULATION OF INFLAMMATORY PATHWAYS IN TUMORS WITH NF2-FUSION","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Fusion gene; Downregulation and upregulation; Gene; CDKN2A; Cancer research; Biology; Fold change; Bioconductor; Gene expression; Bioinformatics; Molecular biology; Genetics","score_opus":0.024512767448386215,"score_gpt":0.2897903234897071,"score_spread":0.2652775560413209,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767890423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964361,0.00001883165,0.000081913975,0.00055367866,0.00003175563,0.00026916093,0.000018120445,0.000024816778,0.0025656084],"genre_scores_gemma":[0.99942833,0.0000112808175,0.00019903331,0.00015221597,0.000055071978,0.000022319855,0.000080553626,0.0000173466,0.00003382391],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9981566,0.00020987188,0.00074721035,0.00032999043,0.00034805192,0.0002082388],"domain_scores_gemma":[0.9977182,0.00020885197,0.0010974425,0.0006505049,0.00020502346,0.00011998344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004831975,0.00016569601,0.00089596777,0.0009852918,0.00010089867,0.000010086239,0.00014508741,0.00018264777,0.0001416629],"category_scores_gemma":[0.0004696062,0.00014291858,0.00023521119,0.00063657295,0.00014126858,0.00014580032,0.000057516536,0.00018733904,0.000004981535],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002507366,0.00018360972,0.1802514,0.000044850323,0.00020888828,0.00015408946,0.00063026807,0.00032099642,0.81104374,0.00026355902,0.00003478302,0.006613077],"study_design_scores_gemma":[0.0027710514,0.0008222893,0.68808895,0.00022445287,0.00073514995,0.000023248067,0.00022269698,0.0039354265,0.3027284,0.00006855616,0.00023482983,0.00014495035],"about_ca_topic_score_codex":0.00011158456,"about_ca_topic_score_gemma":0.0002986934,"teacher_disagreement_score":0.5083153,"about_ca_system_score_codex":0.00013577753,"about_ca_system_score_gemma":0.0002903032,"threshold_uncertainty_score":0.5828051},"labels":[],"label_agreement":null},{"id":"W2767903200","doi":"10.1093/neuonc/nox168.1050","title":"TMOD-11. HUMAN STEM CELL BASED MODEL OF MEDULLOBLASTOMA","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medulloblastoma; Stem cell; Biology; Cell biology; Cancer research","score_opus":0.05451383462477289,"score_gpt":0.33058177717688647,"score_spread":0.2760679425521136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767903200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95111835,0.000077977435,0.00071243005,0.0024309473,0.00051535806,0.0003885289,0.000037544927,0.000045056713,0.044673815],"genre_scores_gemma":[0.9963675,0.000031960943,0.0009769266,0.0015384976,0.00015736384,0.000026495782,0.0000059970616,0.000035663736,0.0008595896],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99874765,0.000065551794,0.00032979212,0.00033459938,0.0002270652,0.00029533735],"domain_scores_gemma":[0.9983614,0.000094088056,0.00035274788,0.00087830337,0.00011383878,0.00019960442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019620187,0.00016384701,0.0005708542,0.00009498249,0.00016735571,0.000011905569,0.00026845618,0.00015712726,0.0001999729],"category_scores_gemma":[0.00003305629,0.00014811128,0.00017596564,0.00004016103,0.00021900021,0.00005213973,0.000104976374,0.0002209199,0.000026757361],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027013855,0.00041393776,0.0018520118,0.00016043196,0.000018916136,0.00011593429,0.00014366297,0.00042200767,0.9778536,0.00019147641,0.0057098963,0.012847997],"study_design_scores_gemma":[0.0072809407,0.0025954826,0.001481493,0.00004482997,0.00037236014,0.000041840696,0.00008775839,0.01019468,0.7850378,0.000085761516,0.19255431,0.00022276185],"about_ca_topic_score_codex":0.00013192286,"about_ca_topic_score_gemma":0.00035560262,"teacher_disagreement_score":0.1928158,"about_ca_system_score_codex":0.0001117474,"about_ca_system_score_gemma":0.00047832538,"threshold_uncertainty_score":0.6039803},"labels":[],"label_agreement":null},{"id":"W2767922381","doi":"10.1093/neuonc/nox168.008","title":"ACTR-10. PATTERNS OF TTFIELDS-RELATED SEVERE SKIN TOXICITY IN GBM PATIENTS","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre","funders":"","keywords":"Medicine; Rash; Erythema; Adverse effect; Toxicity; Dermatology; Temozolomide; Internal medicine; Surgery; Chemotherapy","score_opus":0.02514469099222186,"score_gpt":0.3416115326190843,"score_spread":0.3164668416268624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767922381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96847486,0.00001854207,0.000006382269,0.0024640448,0.00023196574,0.000711384,0.000028973682,0.000021440059,0.028042382],"genre_scores_gemma":[0.99808145,0.00007861884,0.000026485553,0.0009050506,0.000044689637,0.000030366577,0.00003166015,0.000028769173,0.0007729081],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981397,0.00023108105,0.00044820583,0.0003962188,0.00035658208,0.0004282042],"domain_scores_gemma":[0.9983375,0.00032071222,0.00025662172,0.00067832164,0.0002550365,0.0001518164],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020631532,0.00018075314,0.0005685469,0.00018641562,0.000115650706,0.000016702894,0.00035016597,0.0003498112,0.0014392169],"category_scores_gemma":[0.0016479859,0.00016733487,0.00010786711,0.00009464505,0.00017660325,0.000093500996,0.00026116194,0.0005228096,0.00010415416],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012511653,0.0015164013,0.90539354,0.00009791905,0.00005403047,0.0006493646,0.0009804615,0.0000065017284,0.04817417,0.00006253043,0.0020464542,0.039767474],"study_design_scores_gemma":[0.01874154,0.008586741,0.90874195,0.00014675157,0.000073667354,0.0006617634,0.00041910328,0.00080462307,0.039543968,0.0003944423,0.021461707,0.0004237126],"about_ca_topic_score_codex":0.00044197822,"about_ca_topic_score_gemma":0.0009457777,"teacher_disagreement_score":0.039343763,"about_ca_system_score_codex":0.0002459496,"about_ca_system_score_gemma":0.00036085595,"threshold_uncertainty_score":0.99947363},"labels":[],"label_agreement":null},{"id":"W2767936668","doi":"10.1093/neuonc/nox168.573","title":"NCOG-12. NEUROCOGNITIVE OUTCOME IN CHILDREN WITH SENSORINEURAL HEARING LOSS FOLLOWING TREATMENT FOR MALIGNANT EMBRYONAL BRAIN TUMORS","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Hospital for Sick Children; Pediatric Oncology Group","funders":"","keywords":"Medicine; Sensorineural hearing loss; Hearing loss; Neurocognitive; Audiology; Neuropsychology; Wechsler Adult Intelligence Scale; Radiation therapy; Intelligence quotient; Pediatrics; Surgery; Cognition","score_opus":0.056629030911943906,"score_gpt":0.3558313937713683,"score_spread":0.29920236285942436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767936668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98839796,0.000029056377,0.000055220007,0.00770106,0.0003211333,0.0023171334,0.0000743911,0.00005896799,0.0010451017],"genre_scores_gemma":[0.99527884,0.000012701385,0.0012753124,0.0023141191,0.0002651015,0.00036784777,0.00007629793,0.00007462091,0.0003351779],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997689,0.00020744243,0.00046089804,0.0007324544,0.00022984289,0.0006803439],"domain_scores_gemma":[0.99827844,0.00059796474,0.0002647285,0.00055121805,0.000052928346,0.00025475086],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00029163048,0.0004055949,0.00092984684,0.00016402885,0.0003739764,0.000053059026,0.00015752247,0.00011574006,0.000020976451],"category_scores_gemma":[0.00040854063,0.00029201587,0.00032178097,0.00006299433,0.00015269437,0.00012280126,0.00009807448,0.0003111478,0.000018035093],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016243847,0.0010117282,0.96264833,0.000025755608,0.00041018953,0.008710081,0.00022820482,0.000032128453,0.0060069715,0.00017781674,0.0000823382,0.019042077],"study_design_scores_gemma":[0.029971052,0.013825614,0.93929434,0.00009220936,0.00064031547,0.005052728,0.00015134421,0.0002128777,0.0050155986,0.000070747345,0.005298109,0.00037507832],"about_ca_topic_score_codex":0.00037455666,"about_ca_topic_score_gemma":0.00028602796,"teacher_disagreement_score":0.028346667,"about_ca_system_score_codex":0.00034272156,"about_ca_system_score_gemma":0.000245793,"threshold_uncertainty_score":0.9999532},"labels":[],"label_agreement":null},{"id":"W2767946275","doi":"10.1093/neuonc/nox168.398","title":"GENE-24. ATRX DEFICIENCY IN GLIOMA CELLS OF ORIGIN PROMOTES DISEASE-DEFINING PHENOTYPES BY WAY OF GLOBAL EPIGENOMIC REMODELING","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"ATRX; Biology; Epigenomics; Epigenetics; Genetics; Carcinogenesis; Histone; Cancer research; DNA methylation; Mutation; Gene; Gene expression","score_opus":0.016781593084476156,"score_gpt":0.290826121728091,"score_spread":0.2740445286436149,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767946275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99516714,0.002604848,0.00045032694,0.00011580841,0.00037977193,0.00017340088,0.000114347546,0.00001022837,0.0009841552],"genre_scores_gemma":[0.9979456,0.00022538628,0.0016060323,0.00006568224,0.00008170931,0.000010370195,0.000027576601,0.00002276021,0.000014865996],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99856555,0.00009421971,0.0004499198,0.00044847175,0.00013216914,0.00030967072],"domain_scores_gemma":[0.99879956,0.000032582368,0.0003980661,0.00059180585,0.00008683928,0.00009112163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022689963,0.00017692735,0.00033392003,0.00003072534,0.00009845161,0.000013696879,0.0004561573,0.00018542,0.000008932876],"category_scores_gemma":[0.00017464708,0.00017750429,0.00011162606,0.00006234779,0.00018516461,0.000006765816,0.00019073162,0.000104425344,0.000004984301],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019252213,0.00013563618,0.01054547,0.00005476301,0.00001157569,0.0000114184195,0.00004992855,0.001849646,0.9777207,0.000047146466,0.00030439688,0.009076813],"study_design_scores_gemma":[0.0015249918,0.0007740046,0.002034033,0.000050043793,0.000057804547,0.000023922426,0.000049693208,0.005112066,0.9851073,0.0005171969,0.004438445,0.00031049512],"about_ca_topic_score_codex":0.00021119983,"about_ca_topic_score_gemma":0.000111087196,"teacher_disagreement_score":0.008766319,"about_ca_system_score_codex":0.00007487746,"about_ca_system_score_gemma":0.00039751825,"threshold_uncertainty_score":0.7238415},"labels":[],"label_agreement":null},{"id":"W2767952516","doi":"10.1093/neuonc/nox168.735","title":"PATH-45. INTEGRATION OF MULTI-REGION (EPI)GENOMICS WITH MULTIMODALITY ADVANCED IMAGING HIGHLIGHTS GLIOMA INTRATUMORAL HETEROGENEITY","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Glioma; Concordance; Radiogenomics; Genetic heterogeneity; Subtyping; Tumour heterogeneity; Biopsy; Magnetic resonance imaging; DNA methylation; Medicine; Pathology; Biology; Cancer research; Bioinformatics; Radiology; Gene; Internal medicine; Genetics; Cancer; Phenotype; Computer science","score_opus":0.0239340452823193,"score_gpt":0.33150609134248915,"score_spread":0.30757204606016986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767952516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9761818,0.00009364129,0.014679229,0.0072403015,0.0006861638,0.0004708865,0.000005145347,0.0000777191,0.00056508346],"genre_scores_gemma":[0.9799168,0.00008836569,0.018891605,0.0007847306,0.0002098221,0.000024402307,0.000026035352,0.000043619923,0.000014603031],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982243,0.0001964765,0.0004702448,0.0005087891,0.0002304966,0.000369672],"domain_scores_gemma":[0.99801046,0.00015489555,0.0006272349,0.00074852235,0.00020930338,0.0002496015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035677906,0.000256983,0.0006506983,0.00012487217,0.00029035562,0.000043806776,0.0003078795,0.00013174774,0.000008236338],"category_scores_gemma":[0.00082851277,0.0001977151,0.00012069914,0.000074742566,0.00056342076,0.00021919815,0.00012393233,0.000670466,0.000005924261],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084110984,0.0004039058,0.0356715,0.0000764472,0.00004482163,0.0011391946,0.00040970772,0.00009196626,0.8365305,0.00028092554,0.0001140261,0.12439586],"study_design_scores_gemma":[0.0234869,0.0035967727,0.2547516,0.0004734415,0.00052185013,0.004182702,0.0003486595,0.268591,0.41403514,0.00023236634,0.028937342,0.00084224937],"about_ca_topic_score_codex":0.00027467762,"about_ca_topic_score_gemma":0.00010270863,"teacher_disagreement_score":0.4224954,"about_ca_system_score_codex":0.00021291283,"about_ca_system_score_gemma":0.00025236956,"threshold_uncertainty_score":0.8062588},"labels":[],"label_agreement":null},{"id":"W2767957180","doi":"10.1093/neuonc/nox168.1068","title":"TMOD-31. RARE SOX9+ CELLS BEHIND MYC-DRIVEN MEDULLOBLASTOMA RECURRENCE","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medulloblastoma; Cancer research; SOX9; Metastasis; Atypical teratoid rhabdoid tumor; Medicine; Biology; Primary tumor; Transcription factor; Pathology; Cancer; Internal medicine; Gene","score_opus":0.01561191008283405,"score_gpt":0.2870952394963436,"score_spread":0.27148332941350956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767957180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903887,0.0002578013,0.00026939093,0.0010939434,0.001352699,0.00040108585,0.00007256739,0.000031286534,0.0061325086],"genre_scores_gemma":[0.9972765,0.00017364408,0.00082569075,0.00058883114,0.00065799005,0.000047592595,0.00010307683,0.00003996354,0.00028672916],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99835175,0.00015685007,0.00028256755,0.0006463323,0.00015897962,0.00040352385],"domain_scores_gemma":[0.9981502,0.000043389908,0.0003631233,0.0011054168,0.00013331971,0.00020453465],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000139947,0.00023846985,0.0002605295,0.000048842106,0.00033830033,0.0000651569,0.00073749025,0.00038862447,0.00009006373],"category_scores_gemma":[0.00030899176,0.0002494364,0.0001416836,0.000028631768,0.00030599508,0.000013592087,0.00045256648,0.00020732281,0.00015251235],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014197946,0.00010656536,0.0012014804,0.000017954473,0.000029269251,0.00006044423,0.000056086712,0.00006134076,0.9641048,0.000030802265,0.022979368,0.011209925],"study_design_scores_gemma":[0.00084588706,0.0005680146,0.00569572,0.000013611981,0.0000381599,0.00006726062,0.00001688803,0.00020869613,0.5940568,0.0000810381,0.39816287,0.0002450937],"about_ca_topic_score_codex":0.000014567871,"about_ca_topic_score_gemma":0.000085620195,"teacher_disagreement_score":0.3751835,"about_ca_system_score_codex":0.00006786251,"about_ca_system_score_gemma":0.00035587346,"threshold_uncertainty_score":0.99999577},"labels":[],"label_agreement":null},{"id":"W2767960979","doi":"10.1093/neuonc/nox168.964","title":"SURG-07. CIRCUMFERENTIAL RESECTION OF GLIOBLASTOMA: A NOVEL SURGICAL TECHNIQUE FOR MAXIMISING EXTENT OF RESECTION AND PROLONGING SURVIVAL","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Medicine; Glioblastoma; Debulking; Resection; Cohort; Surgery; Overall survival; Tumor Debulking; Surgical resection; Survival analysis; Survival rate; Cancer; Internal medicine; Chemotherapy; Ovarian cancer","score_opus":0.04197864441699255,"score_gpt":0.3413437573461191,"score_spread":0.29936511292912654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767960979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99571675,0.000079127436,0.001081711,0.00083783735,0.0005278781,0.0011792294,0.000014532823,0.00002286219,0.0005400683],"genre_scores_gemma":[0.9990333,0.0000651662,0.000434746,0.000010178619,0.00020806203,0.00021214507,0.0000064059486,0.00002311276,0.000006897799],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99876535,0.00008239611,0.00037936567,0.00034283093,0.0001943387,0.00023570242],"domain_scores_gemma":[0.9985439,0.00039718376,0.0003953698,0.00034740916,0.00022658553,0.00008950779],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049482984,0.00014094356,0.00052353466,0.0002116852,0.00018381997,0.000015737955,0.00007814391,0.00020845575,0.000014143307],"category_scores_gemma":[0.00045007133,0.00012430506,0.00013454296,0.00007115329,0.00018668201,0.000076440454,0.00009041402,0.0001640915,4.7260914e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042894366,0.0010618647,0.027376834,0.00023123875,0.00008945755,0.00011723561,0.00008054209,0.000006320663,0.9586405,0.00037913193,0.00007912235,0.0076483223],"study_design_scores_gemma":[0.010524449,0.011036417,0.045424033,0.00018868133,0.00028852906,0.00086581847,0.00006945453,0.00033420118,0.92714256,0.00017054343,0.0038220373,0.00013329246],"about_ca_topic_score_codex":0.0001331178,"about_ca_topic_score_gemma":0.00020279449,"teacher_disagreement_score":0.03149795,"about_ca_system_score_codex":0.00010291329,"about_ca_system_score_gemma":0.00011628965,"threshold_uncertainty_score":0.5069013},"labels":[],"label_agreement":null},{"id":"W2767969226","doi":"10.1093/neuonc/nox168.791","title":"PDTM-27. DIANHYDROGALACTITOL (VAL-083) OVERCOMES CHEMORESISTANCE IN PEDIATRIC MALIGNANT BRAIN TUMORS AND DISPLAYS SYNERGY WITH TOPOISOMERASE INHIBITORS","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Delmar (Canada); University of British Columbia","funders":"","keywords":"Temozolomide; Cancer research; Medulloblastoma; DNA repair; Glioma; Methyltransferase; Cancer; Topoisomerase; Medicine; Cell cycle; Cell cycle checkpoint; Biology; Internal medicine; DNA; Genetics; Methylation","score_opus":0.010187270261392243,"score_gpt":0.2693073971770693,"score_spread":0.25912012691567704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767969226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98154837,0.0006718859,0.0000020152838,0.014319821,0.0003773657,0.00055977755,0.000013029772,0.000040286355,0.0024674414],"genre_scores_gemma":[0.9976635,0.00063845183,0.000082880935,0.000994547,0.00031727293,0.00014244388,0.000012609334,0.000046581405,0.000101727834],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99810565,0.000097801516,0.00037416333,0.0006397934,0.00026883112,0.0005137887],"domain_scores_gemma":[0.9981835,0.000503793,0.00031621772,0.00063929503,0.000047326484,0.00030986685],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016747793,0.0003296433,0.0007075527,0.0002530006,0.00021290462,0.00006354873,0.00016415468,0.00016976998,0.000040602823],"category_scores_gemma":[0.00036875645,0.00024782415,0.00008510694,0.00016664105,0.00022144441,0.0001963694,0.000129489,0.0002965498,0.00001912814],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005209631,0.00094607973,0.96214616,0.00014461306,0.000048223912,0.009624678,0.00026270904,0.000008550742,0.016967857,0.00030348686,0.0055650463,0.0034616098],"study_design_scores_gemma":[0.011003429,0.0019771177,0.9433109,0.00015486048,0.00028773368,0.0006815655,0.00013449985,0.000099165205,0.028110778,0.0000716679,0.013763996,0.00040427156],"about_ca_topic_score_codex":0.00027553132,"about_ca_topic_score_gemma":0.0010693142,"teacher_disagreement_score":0.018835265,"about_ca_system_score_codex":0.00025572247,"about_ca_system_score_gemma":0.00023611881,"threshold_uncertainty_score":0.9999974},"labels":[],"label_agreement":null},{"id":"W2767969574","doi":"10.1093/neuonc/nox168.048","title":"ACTR-57. DOES THE ADDITION OF VALPROIC ACID TO CONCURRENT RADIATION THERAPY AND TEMOZOLOMIDE IMPROVE PATIENT OUTCOME? – CORRELATIVE ANALYSIS OF RTOG 0525, SEER AND A PHASE II NCI TRIAL","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Temozolomide; Internal medicine; Oncology; Radiation therapy; Cohort; Valproic Acid; Population; Proportional hazards model; Dacarbazine; Univariate analysis; Clinical trial; Multivariate analysis; Chemotherapy; Epilepsy","score_opus":0.04166062845634414,"score_gpt":0.36648391616680465,"score_spread":0.3248232877104605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767969574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99409467,0.00026961096,0.00010040179,0.0028768298,0.000535032,0.0016642627,0.00035534476,0.000008127662,0.00009574119],"genre_scores_gemma":[0.9987203,0.00027449906,0.000112727816,0.00058157876,0.000081963255,0.0001254964,0.00007617992,0.000010343042,0.000016944785],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9986093,0.0002930965,0.00046128192,0.00029687383,0.00018482856,0.00015464058],"domain_scores_gemma":[0.9981539,0.0005768543,0.0006680636,0.00037587204,0.00011479338,0.00011046996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034802136,0.00016196686,0.00069994025,0.0001543304,0.00020423194,0.0000134122365,0.00007160618,0.000092250186,0.00010738098],"category_scores_gemma":[0.0006179338,0.00008890851,0.00015648364,0.000112899696,0.00020562184,0.00007155915,0.000076868964,0.00016732347,0.0000011716083],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020829095,0.0018669531,0.008703555,0.000026327456,0.0018421777,0.000029163932,0.0038279989,0.000007974226,0.0901357,0.00017176346,0.0005907577,0.8719685],"study_design_scores_gemma":[0.35290343,0.17543858,0.19401008,0.00007114698,0.015473296,0.00007209397,0.0019853655,0.0047454415,0.17412813,0.00028867304,0.08023545,0.0006483126],"about_ca_topic_score_codex":0.00009157347,"about_ca_topic_score_gemma":0.000057392765,"teacher_disagreement_score":0.87132025,"about_ca_system_score_codex":0.00007020086,"about_ca_system_score_gemma":0.000084322644,"threshold_uncertainty_score":0.3625584},"labels":[],"label_agreement":null},{"id":"W2767987788","doi":"10.1093/neuonc/nox168.1049","title":"TMOD-10. MOLECULAR CHARACTERIZATION OF A NOVEL HUMAN CLIVAL CHORDOMA XENOGRAFT MODEL DEMONSTRATES INHERENT TUMOR GENOMIC INSTABILITY","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Bone Tumor Diagnosis and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Chordoma; Brachyury; Biology; Cancer research; CDKN2A; Genome instability; Primary tumor; FHIT; Tumor suppressor gene; Cancer; Pathology; Gene; Medicine; Genetics; Metastasis; Embryonic stem cell; Carcinogenesis; DNA; DNA damage","score_opus":0.050055093122862694,"score_gpt":0.33601466790559426,"score_spread":0.28595957478273154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767987788","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955231,0.00002979933,0.00015787706,0.0008197149,0.00014359111,0.00084152556,0.0000668882,0.000044396656,0.0023731],"genre_scores_gemma":[0.99861103,0.000025739637,0.0006190023,0.00038059856,0.00006277158,0.00012972277,0.00009225703,0.00004039243,0.00003846557],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984119,0.00007689542,0.0005319374,0.0004694945,0.00019281803,0.00031697055],"domain_scores_gemma":[0.9983027,0.000054830525,0.00053589704,0.0007816554,0.00014794063,0.00017696727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016126264,0.00024569302,0.00066157343,0.000090008056,0.00021583165,0.000028487177,0.00022792805,0.0001325434,0.000092547256],"category_scores_gemma":[0.00013968395,0.00022390991,0.00017108601,0.000052370626,0.0003174387,0.00012094244,0.00016266476,0.00020458378,0.000016019223],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023937855,0.002571206,0.076015316,0.000056888242,0.000070333976,0.00015825838,0.00009113017,0.000018295468,0.917561,0.00039398507,0.000021501886,0.0028026886],"study_design_scores_gemma":[0.009655263,0.003260713,0.7589423,0.00007469466,0.0004366213,0.00019398249,0.000025804848,0.006583062,0.21863244,0.0002003639,0.0017019206,0.00029283803],"about_ca_topic_score_codex":0.00007317421,"about_ca_topic_score_gemma":0.000042630247,"teacher_disagreement_score":0.6989286,"about_ca_system_score_codex":0.00018410361,"about_ca_system_score_gemma":0.0002900106,"threshold_uncertainty_score":0.9130781},"labels":[],"label_agreement":null},{"id":"W2767988375","doi":"10.1093/neuonc/nox168.955","title":"STEM-41. A SUBSET OF GBM BRAIN TUMOR STEM CELL LINES ARE UNIQUELY DEPENDENT ON GLUTAMINE METABOLISM FOR AMINO ACID SYNTHESIS","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Amino Acid Enzymes and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotchkiss Brain Institute; Ontario Brain Institute; University of Calgary","funders":"","keywords":"Glutamine; Glutaminase; Stem cell; Biology; Cancer research; Glutamate receptor; Metabolism; Cancer stem cell; Cell culture; Glutamine synthetase; Amino acid; Biochemistry; Cell biology; Genetics","score_opus":0.022552415273870013,"score_gpt":0.27721480341737686,"score_spread":0.25466238814350683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767988375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930092,0.0015486345,0.00035458998,0.0013829854,0.0010641745,0.0007256184,0.00068206125,0.000026871403,0.001205829],"genre_scores_gemma":[0.9954104,0.00048483777,0.00054514455,0.0018065899,0.00050388405,0.00025479042,0.000055645494,0.00006891662,0.0008698145],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99768245,0.0002638616,0.0005427001,0.0007570358,0.00021068298,0.0005432545],"domain_scores_gemma":[0.9972305,0.0002491185,0.0008861909,0.0012086066,0.0002301178,0.00019542416],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004295926,0.0003978293,0.00081605825,0.00010298057,0.0002354809,0.000039928804,0.0008334112,0.00039238963,0.000017388713],"category_scores_gemma":[0.00033354305,0.00035713072,0.00030768555,0.000048292975,0.00022849931,0.000012981243,0.0003218044,0.00020967661,0.0000145776385],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059311604,0.00029187536,0.00051550404,0.00010035526,0.00006903022,0.000047834103,0.000055621207,0.000019097326,0.97068536,0.00024975167,0.0062117027,0.021160774],"study_design_scores_gemma":[0.0012736749,0.00073787576,0.0020920408,0.000013880036,0.00012086493,0.0000398809,0.00013085938,0.000024561028,0.7376945,0.00002010386,0.25760624,0.00024549992],"about_ca_topic_score_codex":0.000028134587,"about_ca_topic_score_gemma":0.0001068868,"teacher_disagreement_score":0.25139454,"about_ca_system_score_codex":0.000029386223,"about_ca_system_score_gemma":0.00020801219,"threshold_uncertainty_score":0.99988806},"labels":[],"label_agreement":null},{"id":"W2767998816","doi":"10.1093/neuonc/nox168.987","title":"SURG-33. GLIOBLASTOMA IN THE ELDERLY: THE IMPACT OF EXTENT OF RESECTION ON SURVIVAL","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Temozolomide; Glioblastoma; Radiation therapy; Univariate analysis; Retrospective cohort study; Surgery; Cohort; Multivariate analysis; Biopsy; Overall survival; Survival analysis; Internal medicine","score_opus":0.04096120519906606,"score_gpt":0.3646573981336439,"score_spread":0.32369619293457785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767998816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903326,0.000051957017,5.609493e-7,0.0043780366,0.00032847957,0.00045339513,0.000008388707,0.0000058530445,0.0044407435],"genre_scores_gemma":[0.9996301,0.00009047495,0.0000032129337,0.0000977243,0.00011531257,0.000045009907,0.0000017426431,0.000010523705,0.000005915601],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988296,0.00032520283,0.00025639366,0.00017500044,0.00022747944,0.00018630973],"domain_scores_gemma":[0.9979587,0.0009241299,0.0002772762,0.000724747,0.00007477462,0.00004035736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050468434,0.000114073235,0.00034958418,0.00010184006,0.00010444536,0.00001038626,0.00021663637,0.000089797024,0.000041927917],"category_scores_gemma":[0.0004854743,0.000054047854,0.00018082354,0.00010074683,0.00017185404,0.000030260924,0.000048015463,0.0002141598,0.0000072937164],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006049611,0.006617307,0.6040413,0.000054781853,0.00031740783,0.0011143925,0.00222035,0.00022485123,0.2786954,0.0012742195,0.009658893,0.08973152],"study_design_scores_gemma":[0.0033841378,0.022777919,0.9327896,0.00004207092,0.000077416975,0.000101462334,0.00030551798,0.000060901377,0.03778349,0.0001241133,0.0025046808,0.00004869153],"about_ca_topic_score_codex":0.0013273174,"about_ca_topic_score_gemma":0.0008639322,"teacher_disagreement_score":0.32874835,"about_ca_system_score_codex":0.00010918169,"about_ca_system_score_gemma":0.0001272598,"threshold_uncertainty_score":0.22040077},"labels":[],"label_agreement":null},{"id":"W2768011387","doi":"10.1093/neuonc/nox168.170","title":"CMET-22. PCV VS TEMOZOLOMIDE CHEMOTHERAPY FOR PATIENTS WITH LGG: A SYSTEMATIC REVIEW AND META-ANALYSIS","year":2017,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Temozolomide; Medicine; Lomustine; Internal medicine; Procarbazine; Oncology; IDH1; Context (archaeology); Chemotherapy; Progression-free survival; Vincristine; Cyclophosphamide; Mutation","score_opus":0.10376185774952087,"score_gpt":0.3950014492157143,"score_spread":0.2912395914661934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2768011387","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000008830796,0.9838185,0.0000064447354,0.0012302685,0.000074253265,0.014344133,0.00022211156,0.000036927133,0.0002585372],"genre_scores_gemma":[0.00002802919,0.9868894,0.00037376894,0.003716314,0.000048939182,0.008315181,0.00034745605,0.00010957663,0.00017130075],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9963944,0.0005588483,0.0013355302,0.00096253294,0.0003271678,0.00042154288],"domain_scores_gemma":[0.9942187,0.0014933938,0.0021655043,0.0015571316,0.00029195036,0.00027331713],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0005464026,0.0008192815,0.018388871,0.0004103185,0.00015200228,0.00004918327,0.00031255218,0.00039318635,0.0002088057],"category_scores_gemma":[0.0006433829,0.0004252074,0.0031635808,0.0003567034,0.00011698256,0.000053631255,0.00007337723,0.00029212964,0.000040601248],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051313316,0.0008966397,0.000056538884,0.73641235,0.23750351,0.00013271534,0.000014612526,3.1550375e-8,1.9976443e-7,0.00002156062,0.0034138681,0.021496654],"study_design_scores_gemma":[0.0012113261,0.0014425811,0.0000075516314,0.008549112,0.5589764,0.00007148174,8.294562e-7,5.0612783e-7,5.778869e-7,0.000001993619,0.4295579,0.00017971186],"about_ca_topic_score_codex":0.000009043951,"about_ca_topic_score_gemma":0.0000114022405,"teacher_disagreement_score":0.72786325,"about_ca_system_score_codex":0.00025106143,"about_ca_system_score_gemma":0.00032212192,"threshold_uncertainty_score":0.99982},"labels":[],"label_agreement":null},{"id":"W2768037202","doi":"10.1093/neuonc/nox168.216","title":"CSIG-22. A CD133-Akt-Wnt SIGNALING AXIS PROVIDES FUNCTIONAL INSIGHT INTO THE ROLE OF CD133 IN GLIOBLASTOMA BRAIN TUMOR-INITIATING CELLS","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; McMaster University","funders":"","keywords":"Wnt signaling pathway; Cancer research; Protein kinase B; Beta-catenin; Biology; LRP5; LRP6; Cell culture; Context (archaeology); Signal transduction; Stem cell; Cell biology; Chemistry; Genetics","score_opus":0.021117243486009272,"score_gpt":0.28466382831586007,"score_spread":0.26354658482985077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2768037202","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98365486,0.00078972825,0.000062120205,0.0046372456,0.0008127819,0.00071350456,0.000011869291,0.00004029323,0.0092776045],"genre_scores_gemma":[0.995548,0.0000494029,0.00053970655,0.0030318256,0.00057814276,0.00010678466,0.00000461374,0.00004335349,0.00009814571],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978139,0.00028489987,0.0006320745,0.00048102005,0.00036606513,0.0004220507],"domain_scores_gemma":[0.99746454,0.0010628919,0.0005578201,0.00058501714,0.00017513013,0.00015462837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006865531,0.0002495633,0.00064277276,0.00021085469,0.00030698185,0.000045065754,0.00031004965,0.00014342731,0.00033054975],"category_scores_gemma":[0.0010412879,0.0001905133,0.00018880154,0.00018927941,0.00033503136,0.00015937054,0.00024104552,0.0005885434,0.00003123989],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091528177,0.00026519972,0.0036702203,0.00010031657,0.000056931527,0.00026074096,0.0028199132,0.000102949314,0.9282168,0.00028614918,0.00072083663,0.06258466],"study_design_scores_gemma":[0.0030480023,0.002338731,0.0025582055,0.00013341634,0.00014633578,0.00018593023,0.0012571617,0.0005668161,0.7255233,0.0004822714,0.26355088,0.00020898446],"about_ca_topic_score_codex":0.0008706421,"about_ca_topic_score_gemma":0.0012356425,"teacher_disagreement_score":0.26283005,"about_ca_system_score_codex":0.00022368348,"about_ca_system_score_gemma":0.00074507523,"threshold_uncertainty_score":0.7768907},"labels":[],"label_agreement":null},{"id":"W2768038963","doi":"10.1093/neuonc/nox168.736","title":"PATH-46. AUTOMATED HISTOPATHOLOGIC CLASSIFICATION OF BRAIN TUMORS USING ARTIFICIAL INTELLIGENCE","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Convolutional neural network; Artificial intelligence; Classifier (UML); Computer science; Digital pathology; Glioblastoma; Brain tumor; Workflow; Pathology; Pattern recognition (psychology); Medicine; Database","score_opus":0.07108547680609452,"score_gpt":0.3889134789199807,"score_spread":0.3178280021138862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2768038963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9720612,0.000048560945,0.009619719,0.012579794,0.00087355694,0.00027405875,0.0000029426487,0.00019063427,0.0043495162],"genre_scores_gemma":[0.99237406,0.000019306577,0.006014154,0.0013062863,0.000221236,0.000007678502,0.000009140463,0.000023645325,0.000024466228],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99849874,0.00020267481,0.0004980203,0.00033728452,0.00019887245,0.00026440102],"domain_scores_gemma":[0.99834365,0.00029938258,0.00057036744,0.00054092734,0.00010891743,0.0001367593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007021563,0.00013743967,0.00044569792,0.00012781497,0.00023761738,0.00002381223,0.00027748148,0.00016375004,0.00007142813],"category_scores_gemma":[0.004696674,0.00012271141,0.000087838554,0.00008434129,0.00057128497,0.000070508264,0.00009935197,0.0005182355,0.000022274608],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000101543286,0.00019190603,0.005682317,0.000052372157,0.000008032858,0.00047974085,0.00019425669,0.00008336658,0.88286597,0.0031624143,0.00062046864,0.10655759],"study_design_scores_gemma":[0.00069215975,0.0014963519,0.0716315,0.00015633166,0.0001408076,0.0013762317,0.00026278454,0.886696,0.020446153,0.0027586462,0.01408066,0.00026237313],"about_ca_topic_score_codex":0.0000701261,"about_ca_topic_score_gemma":0.0000034226855,"teacher_disagreement_score":0.88661265,"about_ca_system_score_codex":0.00016674396,"about_ca_system_score_gemma":0.00029531817,"threshold_uncertainty_score":0.5622697},"labels":[],"label_agreement":null},{"id":"W2768057131","doi":"10.1093/neuonc/nox168.058","title":"ACTR-71. FULL ENROLLMENT RESULTS FROM THE PHASE 1/2, MULTICENTER, OPEN-LABEL STUDY OF MARIZOMIB (MRZ) ± BEVACIZUMAB (BEV) IN RECURRENT WHO GRADE IV MALIGNANT GLIOMA (GLIOBLASTOMA, RGBM)","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Glioma; Lethargy; Bevacizumab; Adverse effect; Internal medicine; Phases of clinical research; Surgery; Gastroenterology; Toxicity; Chemotherapy","score_opus":0.0698189916436657,"score_gpt":0.3799224895923255,"score_spread":0.31010349794865977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2768057131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9811778,0.00039094046,0.0000013805483,0.011376202,0.0013004296,0.004701477,0.00036615698,0.000036626,0.00064896094],"genre_scores_gemma":[0.9977978,0.00036061762,0.00014970372,0.00068283983,0.00021409501,0.00063528644,0.000072392475,0.000061943465,0.000025351985],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9953774,0.0007139951,0.0013698013,0.0011879965,0.0006262765,0.0007245065],"domain_scores_gemma":[0.99474645,0.0013215055,0.0011582072,0.0022712192,0.00017371106,0.00032892096],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007349506,0.00054274744,0.0013967662,0.00025977584,0.00041226042,0.00014680208,0.0013404606,0.0002495599,0.000078143414],"category_scores_gemma":[0.0009989243,0.00037305657,0.00015184261,0.00024020404,0.00024667778,0.00021618005,0.0012024174,0.00058899436,0.00005431656],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0763161,0.19936347,0.024791032,0.00006641356,0.0012167336,0.015124441,0.0107133435,0.00001285561,0.46032307,0.00010406038,0.016325189,0.19564329],"study_design_scores_gemma":[0.6167019,0.091603465,0.08548096,0.000746247,0.0017109991,0.00028844477,0.0037898137,0.0020193504,0.11672434,0.00013061128,0.07996746,0.0008363973],"about_ca_topic_score_codex":0.0028492105,"about_ca_topic_score_gemma":0.006190776,"teacher_disagreement_score":0.5403858,"about_ca_system_score_codex":0.0004998342,"about_ca_system_score_gemma":0.00027227946,"threshold_uncertainty_score":0.99987215},"labels":[],"label_agreement":null},{"id":"W2768067250","doi":"10.1093/neuonc/nox168.933","title":"STEM-17. CHARACTERIZATION OF THE CELL SURFACE PROTEOME IN RECURRENT GLIOBLASTOMA INITIATING CELLS","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; McMaster University","funders":"","keywords":"Cancer research; Proteome; Temozolomide; Biology; Stem cell; Glioblastoma; Proteomics; Medicine; Bioinformatics; Computational biology; Gene; Genetics","score_opus":0.02019094331397455,"score_gpt":0.26558763587814643,"score_spread":0.24539669256417188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2768067250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953686,0.000030282768,0.000037348615,0.00040108417,0.00054804125,0.00060952455,0.00004245933,0.00000678621,0.0029558782],"genre_scores_gemma":[0.99917084,0.000070004346,0.00011709006,0.0002631674,0.00013051878,0.000038941558,0.000012604016,0.000019547913,0.00017729755],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99879974,0.00027054315,0.0002954298,0.0002950101,0.000106773055,0.00023248445],"domain_scores_gemma":[0.99881446,0.000029375722,0.000495719,0.00054604764,0.00006845082,0.00004593185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002661844,0.00013597611,0.00019650107,0.000025910484,0.00014496561,0.000022203527,0.00045329623,0.00020551839,0.00001799092],"category_scores_gemma":[0.0000752638,0.00010317768,0.00007056922,0.00005342574,0.00011680156,0.0000080355885,0.00032914247,0.00020630493,0.000008286732],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014949078,0.00010691633,0.002306913,0.000039731945,0.000003885327,0.000005949968,0.00014269816,0.000016736978,0.99324566,0.0000067185733,0.0000803882,0.003894935],"study_design_scores_gemma":[0.0006036422,0.001042116,0.0033684713,0.000023704131,0.000006051731,0.000008430283,0.000024835374,0.00007958002,0.96770096,0.000010041868,0.027025562,0.00010658332],"about_ca_topic_score_codex":0.000008540428,"about_ca_topic_score_gemma":0.000053819273,"teacher_disagreement_score":0.026945174,"about_ca_system_score_codex":0.000025464284,"about_ca_system_score_gemma":0.00016603348,"threshold_uncertainty_score":0.42074636},"labels":[],"label_agreement":null},{"id":"W2768078130","doi":"10.1093/neuonc/nox168.1006","title":"TMIC-16. THE IMMUNO-PROTECTIVE FUNCTION OF GLIOMA-ASSOCIATED BONE MARROW DERIVED CELLS DEPENDS ON THE STAGE OF TUMOR GROWTH AND IS INFLUENCED BY TREATMENT WITH MINOCYCLINE","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Microglia; Minocycline; Glioma; Immune system; Bone marrow; Cancer research; Macrophage; Angiogenesis; Monocyte; Cytotoxic T cell; Immunology; Medicine; Biology; Inflammation; Antibiotics; In vitro; Microbiology","score_opus":0.012878817596248288,"score_gpt":0.24647474518465412,"score_spread":0.23359592758840583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2768078130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949079,0.0010865637,0.000017412323,0.0013271389,0.0005871144,0.00085479696,0.00017881152,0.000021065238,0.00101921],"genre_scores_gemma":[0.9984293,0.00024379289,0.000011762737,0.00065649353,0.000013767216,0.00014486317,0.000019619583,0.000029251672,0.00045117468],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980746,0.000681103,0.00042715334,0.00039199696,0.000073651514,0.00035149473],"domain_scores_gemma":[0.9969534,0.0009874145,0.0011078919,0.00077693205,0.00015621506,0.000018107463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031340733,0.0002912623,0.0005905373,0.000075142154,0.0005142699,0.000015730491,0.00043048649,0.00028021645,0.0002631388],"category_scores_gemma":[0.0002058297,0.00016460476,0.000101594356,0.00009561727,0.0013271545,0.000074340576,0.00015812223,0.00043723115,0.000018101651],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032350328,0.000338463,0.00091025257,0.00001573713,0.00046446043,0.000015546852,0.00071276946,0.0000023172427,0.9904847,0.000053346568,0.00070782873,0.00305954],"study_design_scores_gemma":[0.004622004,0.0068189674,0.0056135845,0.000024859559,0.00018570162,0.000041349365,0.00042279717,0.0000026657165,0.9747795,0.000058035912,0.0072848685,0.00014570239],"about_ca_topic_score_codex":0.0012371592,"about_ca_topic_score_gemma":0.0002002945,"teacher_disagreement_score":0.01570524,"about_ca_system_score_codex":0.0001935143,"about_ca_system_score_gemma":0.0001648156,"threshold_uncertainty_score":0.6712388},"labels":[],"label_agreement":null},{"id":"W2768086853","doi":"10.1093/neuonc/nox168.209","title":"CSIG-15. PROTEOMIC AND PHOSPHOPROTEOMIC ANALYSIS OF HUMAN MEDULLOBLASTOMA REVEALS DISTINCT ACTIVATED PATHWAYS BETWEEN SUBGROUPS","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Bioinformatics and Genomic Networks","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medulloblastoma; Biology; Wnt signaling pathway; Phosphorylation; Computational biology; RNA; Signal transduction; Gene; Genetics; Bioinformatics","score_opus":0.017618228351958257,"score_gpt":0.2745906689369452,"score_spread":0.25697244058498697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2768086853","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971941,0.000068730624,0.00042257397,0.00016809645,0.0001170175,0.0005210154,0.00011122518,0.000014975685,0.0013822647],"genre_scores_gemma":[0.99887174,0.00005505433,0.00040724,0.00014763766,0.00020124899,0.00004961294,0.00019313647,0.00002902088,0.000045312718],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998348,0.0001207595,0.0005712213,0.00045850957,0.00012562577,0.0003758863],"domain_scores_gemma":[0.99798566,0.000053864285,0.0008028503,0.00090212043,0.00009162702,0.00016384841],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042277464,0.00026089625,0.00068911986,0.00012308593,0.0003634845,0.00005219814,0.0005284291,0.0004279592,0.000032878233],"category_scores_gemma":[0.0001623036,0.00024453178,0.0001956738,0.00011149965,0.00038933326,0.000011687508,0.00046442283,0.0002556187,0.000004470847],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012588981,0.000050179908,0.04013531,0.000028847737,0.00048789222,0.000007099301,0.00010147887,0.000008672821,0.9517154,0.0001083,0.00040018238,0.0068307645],"study_design_scores_gemma":[0.0018404584,0.002106689,0.23527373,0.000021805283,0.0008477523,0.000021391408,0.000055671884,0.00043577436,0.75333613,0.00054333184,0.0050475365,0.00046973603],"about_ca_topic_score_codex":0.00008512017,"about_ca_topic_score_gemma":0.0001518249,"teacher_disagreement_score":0.19837926,"about_ca_system_score_codex":0.00003788702,"about_ca_system_score_gemma":0.00009718798,"threshold_uncertainty_score":0.9971716},"labels":[],"label_agreement":null},{"id":"W2768087876","doi":"10.1093/neuonc/nox168.1045","title":"TMOD-06. CLONAL DYNAMICS OF HUMAN GLIOBLASTOMA IN RESPONSE TO CHEMORADIOTHERAPY","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; University of Toronto; McMaster University","funders":"","keywords":"Chemoradiotherapy; In vivo; Biology; Glioblastoma; Cell therapy; U87; Cancer research; Medicine; Bioinformatics; Stem cell; Oncology; Chemotherapy; Genetics","score_opus":0.021847730523955267,"score_gpt":0.3445237378440317,"score_spread":0.3226760073200764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2768087876","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98077965,0.000036962036,0.000003671792,0.016949452,0.00017950163,0.00044587892,0.000015546173,0.000020442838,0.0015688713],"genre_scores_gemma":[0.99819416,0.000020257437,0.0002958554,0.0012334794,0.00009122209,0.000070975395,0.000007211444,0.0000278856,0.000058979327],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99882984,0.0001239836,0.0003023516,0.0003063935,0.00017168083,0.00026574364],"domain_scores_gemma":[0.99872196,0.0002636731,0.0001765662,0.0006361714,0.000066503635,0.00013513757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000267538,0.00015239684,0.0005575711,0.0002330028,0.00009919934,0.000013272215,0.00020657471,0.0001507058,0.000096969816],"category_scores_gemma":[0.00030718886,0.00013759448,0.00009633501,0.00009712464,0.00013615875,0.000040014587,0.00007848516,0.00017039588,0.000032363278],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048297187,0.0014999112,0.11607685,0.000019678004,0.000045557634,0.0016843873,0.0003678974,0.000011136224,0.8602558,0.000826649,0.0015440297,0.012838413],"study_design_scores_gemma":[0.015185976,0.01474352,0.8208996,0.00007872802,0.00007370505,0.00029991212,0.00008711225,0.00042511203,0.111635156,0.00026688675,0.036094364,0.00020993719],"about_ca_topic_score_codex":0.000091082075,"about_ca_topic_score_gemma":0.0007830121,"teacher_disagreement_score":0.7486206,"about_ca_system_score_codex":0.00041411768,"about_ca_system_score_gemma":0.00017346107,"threshold_uncertainty_score":0.56109405},"labels":[],"label_agreement":null},{"id":"W2770221757","doi":"10.1093/neuonc/nox209","title":"A randomized phase II study of everolimus in combination with chemoradiation in newly diagnosed glioblastoma: results of NRG Oncology RTOG 0913","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":148,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation; Ottawa Hospital","funders":"National Cancer Institute; Novartis","keywords":"Everolimus; Temozolomide; Medicine; Internal medicine; Randomized controlled trial; Clinical endpoint; Oncology; Radiation therapy; Fluorouracil; Chemotherapy","score_opus":0.02356305569362439,"score_gpt":0.3342553056209731,"score_spread":0.31069224992734873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2770221757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992202,0.000057656103,0.000002719032,0.0030475094,0.00022060887,0.003262381,0.000013036123,0.00001752763,0.001176557],"genre_scores_gemma":[0.9990307,0.00009141346,0.000091665555,0.00015039257,0.00003982404,0.0005432478,0.000023436263,0.000022808777,0.000006525062],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9973177,0.0006593872,0.001010639,0.0004382161,0.00029559212,0.00027848993],"domain_scores_gemma":[0.99625427,0.0016698901,0.0011839629,0.00057881715,0.00021123393,0.00010185157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009298111,0.0002245336,0.0016807901,0.0005444446,0.00008170031,0.000007524699,0.00017820949,0.00021818126,0.000015034215],"category_scores_gemma":[0.0022384287,0.00017901201,0.000096561605,0.00027609762,0.00023819442,0.00012148964,0.00009442566,0.00026035594,0.0000030001916],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7251136,0.10414221,0.052623328,0.000088586305,0.00031925415,0.0043431846,0.011633707,0.00030908288,0.047936495,0.00012663422,0.0005346123,0.052829325],"study_design_scores_gemma":[0.86831814,0.057355024,0.05625111,0.00007666263,0.00032635374,0.0000429147,0.000563685,0.0008987607,0.015552504,0.0000502191,0.0004530473,0.000111597335],"about_ca_topic_score_codex":0.0015336362,"about_ca_topic_score_gemma":0.0064854794,"teacher_disagreement_score":0.14320454,"about_ca_system_score_codex":0.00038056256,"about_ca_system_score_gemma":0.00036609292,"threshold_uncertainty_score":0.7299898},"labels":[],"label_agreement":null},{"id":"W2774008421","doi":"10.1093/neuonc/nox211","title":"Altered brain morphology after focal radiation reveals impact of off-target effects: implications for white matter development and neurogenesis","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neurogenesis and neuroplasticity mechanisms","field":"Neuroscience","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; McGill University; Health Sciences Centre; University of Waterloo; Sunnybrook Health Science Centre; Hospital for Sick Children; University Health Network; University of Toronto","funders":"Canadian Institutes of Health Research; Ontario Institute for Cancer Research","keywords":"Anterior commissure; Subventricular zone; Neurogenesis; White matter; Corpus callosum; Doublecortin; Brain size; Neuroscience; Biology; Anatomy; Medicine; Central nervous system; Magnetic resonance imaging; Neural stem cell; Dentate gyrus; Stem cell; Radiology","score_opus":0.03149845053249184,"score_gpt":0.32536106771125817,"score_spread":0.2938626171787663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2774008421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99283123,0.00004149522,0.0018855869,0.0031058232,0.0007013045,0.0011373978,0.00014076069,0.00004470452,0.0001117095],"genre_scores_gemma":[0.9924955,0.000052388557,0.0010514818,0.0056332373,0.0001263323,0.00051937904,0.000006888274,0.00007234809,0.00004248702],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99728334,0.00051836896,0.0005861416,0.0009021777,0.0001484823,0.00056146964],"domain_scores_gemma":[0.99616194,0.0021867421,0.00061641476,0.0007322862,0.00007880866,0.00022380745],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025831434,0.00033343383,0.0005938881,0.00020215005,0.00045525172,0.0000754848,0.00049585983,0.0001889288,0.00006757031],"category_scores_gemma":[0.0015776556,0.00030734396,0.00018949242,0.00009989124,0.00024064844,0.00021250144,0.00028334442,0.00017081152,0.000033195836],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004620934,0.00017418568,0.038025297,0.0000555294,0.0000146173425,0.000044781333,0.000097955024,0.000015404643,0.94910204,0.00016196279,0.0015650851,0.010281049],"study_design_scores_gemma":[0.0011126698,0.0011825152,0.39112812,0.0000069874145,0.000036616173,0.00026255587,0.0000013503388,0.00014757087,0.6011127,0.00019298245,0.0046330136,0.00018290857],"about_ca_topic_score_codex":0.0000045790634,"about_ca_topic_score_gemma":0.000004877394,"teacher_disagreement_score":0.3531028,"about_ca_system_score_codex":0.00008138701,"about_ca_system_score_gemma":0.00018396275,"threshold_uncertainty_score":0.9999379},"labels":[],"label_agreement":null},{"id":"W2790593643","doi":"10.1093/neuonc/noy017","title":"Short delay in initiation of radiotherapy for patients with glioblastoma-effect of concurrent chemotherapy: a secondary analysis from the NRG Oncology/Radiation Therapy Oncology Group database","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute; NRG Oncology","keywords":"Radiation therapy; Oncology; Glioblastoma; Medicine; Chemotherapy; Internal medicine; Radiation oncology; Cancer research","score_opus":0.01526650856507893,"score_gpt":0.3146568014977567,"score_spread":0.29939029293267777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790593643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941922,0.00073778693,0.0003737167,0.0011313052,0.00036283906,0.0027092507,0.00033331293,0.000022901764,0.0001367184],"genre_scores_gemma":[0.99523187,0.0007337173,0.00048816547,0.0019264682,0.00022791098,0.0005864205,0.00076432095,0.000040623694,5.13288e-7],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974066,0.0007461322,0.00072715,0.0005237302,0.00027552087,0.00032085212],"domain_scores_gemma":[0.99532276,0.003247474,0.0005757006,0.0004790943,0.00027015264,0.00010480405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057703553,0.00030348604,0.001290055,0.00041235378,0.000071597104,0.000006669054,0.00018528168,0.0002878916,0.00021212318],"category_scores_gemma":[0.00012991492,0.00019323634,0.00024492652,0.00075036776,0.00035416655,0.00010749889,0.000029286428,0.00025098954,0.0000019712238],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012284588,0.003960592,0.49882695,0.000027842747,0.0019498694,0.000033293338,0.0015391854,0.000014637084,0.03978311,0.000033482174,0.0011515046,0.44039497],"study_design_scores_gemma":[0.05996902,0.1280765,0.6534951,0.00006283499,0.0024738314,0.00001861648,0.00014475989,0.001808656,0.08046658,0.000022456892,0.073160544,0.00030111734],"about_ca_topic_score_codex":0.00016701098,"about_ca_topic_score_gemma":0.0013123915,"teacher_disagreement_score":0.44009385,"about_ca_system_score_codex":0.0004946207,"about_ca_system_score_gemma":0.00036863802,"threshold_uncertainty_score":0.7879949},"labels":[],"label_agreement":null},{"id":"W2793420290","doi":"10.1093/neuonc/noy047","title":"Population description and clinical response assessment for spinal metastases: part 2 of the SPIne response assessment in Neuro-Oncology (SPINO) group report","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of British Columbia; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Clinical trial; Population; MEDLINE; Physical therapy; Oncology; Clinical Oncology; Radiation therapy; Internal medicine; Medical physics; Cancer","score_opus":0.07819303377128087,"score_gpt":0.44114222550863613,"score_spread":0.3629491917373553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793420290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9711847,0.000043840722,0.004931017,0.018035188,0.0021313298,0.0032288316,0.000035671354,0.000051713552,0.00035772723],"genre_scores_gemma":[0.97068685,0.00005530716,0.02352956,0.004835661,0.00033111346,0.00033062775,0.00007364358,0.000053139414,0.000104081904],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9899337,0.005888755,0.0020952348,0.0009444468,0.00061883015,0.0005190076],"domain_scores_gemma":[0.9953159,0.0018609166,0.0012182004,0.0010065653,0.0003159134,0.00028251467],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.012112135,0.00033587395,0.001146047,0.00041234694,0.00015254952,0.000026248645,0.00024688873,0.00025927462,0.0001069282],"category_scores_gemma":[0.008831728,0.00027180585,0.0002916829,0.0004447633,0.0005713714,0.00018096136,0.0003231637,0.0006172525,0.000004037973],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16463499,0.011140689,0.33085316,0.00064442813,0.0005969833,0.004557387,0.0003388355,0.000026816608,0.39859697,0.0037945833,0.014106065,0.07070907],"study_design_scores_gemma":[0.008449283,0.02446302,0.8293216,0.00008252059,0.0008059997,0.00045866048,0.00025096454,0.0017070636,0.00019170617,0.0003253376,0.13376428,0.0001795338],"about_ca_topic_score_codex":0.000058969505,"about_ca_topic_score_gemma":0.00016574882,"teacher_disagreement_score":0.49846846,"about_ca_system_score_codex":0.00061224087,"about_ca_system_score_gemma":0.0012222455,"threshold_uncertainty_score":0.9999734},"labels":[],"label_agreement":null},{"id":"W2795148659","doi":"10.1093/neuonc/noy025","title":"The multiforme of glioblastoma","year":2018,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Glioblastoma; Medicine; Cancer research","score_opus":0.02024346833750616,"score_gpt":0.298153919884979,"score_spread":0.27791045154747285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2795148659","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05168241,0.00045566133,0.0000014382723,0.93616664,0.0022020715,0.00090834027,0.00005003233,0.00006073299,0.0084726615],"genre_scores_gemma":[0.037674814,0.00059382035,0.00020201513,0.9522568,0.00808462,0.00035156534,0.00011538518,0.00014104364,0.00057994225],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99822885,0.00015536288,0.000453038,0.00038395092,0.00033113605,0.00044766866],"domain_scores_gemma":[0.9972348,0.0014150392,0.00036507956,0.00069857156,0.00020768605,0.00007877319],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013408817,0.0002882051,0.00071507605,0.00014618693,0.00011209909,0.000011466396,0.0002345099,0.0008145279,0.00019692427],"category_scores_gemma":[0.0002714224,0.00017002295,0.00028185043,0.00014299508,0.000416047,0.000017865665,0.00011262249,0.0009397749,0.000336067],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017572165,0.00021126417,0.00042802544,0.000063701715,0.00019222422,0.0024131464,0.00006473506,1.2359662e-7,0.008471372,0.000015110525,0.97348547,0.0144791175],"study_design_scores_gemma":[0.0018808558,0.004902538,0.0003907136,0.00004974171,0.0003595744,0.0004884371,0.0000144681635,0.000013775477,0.01685289,0.000041630392,0.97489715,0.000108252054],"about_ca_topic_score_codex":0.000025641395,"about_ca_topic_score_gemma":0.00005189829,"teacher_disagreement_score":0.016090142,"about_ca_system_score_codex":0.00019573013,"about_ca_system_score_gemma":0.00029518062,"threshold_uncertainty_score":0.69333345},"labels":[],"label_agreement":null},{"id":"W2795436270","doi":"10.1093/neuonc/noy053","title":"Validation of postoperative residual contrast-enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastoma","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":96,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; American Cancer Society","keywords":"Medicine; Oncology; Bevacizumab; Internal medicine; Clinical trial; Hazard ratio; Chemoradiotherapy; Radiation therapy; Chemotherapy; Confidence interval","score_opus":0.021608684250580254,"score_gpt":0.31122815373392815,"score_spread":0.2896194694833479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2795436270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99519074,0.000030330784,0.000071414936,0.0015395791,0.00057308085,0.002227103,0.00009036125,0.000045488658,0.00023192019],"genre_scores_gemma":[0.9979868,0.0000072774715,0.00036128255,0.00091389084,0.00027446754,0.00034624242,0.000053566713,0.00004188756,0.000014603092],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99784833,0.00031848627,0.0005776167,0.0005255379,0.00030654346,0.0004235087],"domain_scores_gemma":[0.9977752,0.0010743303,0.0002580457,0.00026257624,0.00043077517,0.00019908512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026799546,0.00025003002,0.0006765978,0.00025143463,0.000078833575,0.00002297262,0.000113127244,0.00017219882,0.00022312884],"category_scores_gemma":[0.0014838058,0.00022089746,0.00009226192,0.00017414198,0.00013156883,0.00016876732,0.000051720494,0.0001964351,0.000035010933],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031717368,0.002776907,0.20221832,0.00004559312,0.00010393863,0.0008070536,0.0028960393,0.000024666824,0.78188974,0.00031603788,0.00039944236,0.005350535],"study_design_scores_gemma":[0.015390865,0.03586664,0.3033018,0.00008494488,0.00015951991,0.00012513222,0.0005168837,0.00034002628,0.64180076,0.00012259264,0.002077686,0.00021313662],"about_ca_topic_score_codex":0.00028797745,"about_ca_topic_score_gemma":0.0022346578,"teacher_disagreement_score":0.14008896,"about_ca_system_score_codex":0.0003073755,"about_ca_system_score_gemma":0.00052692427,"threshold_uncertainty_score":0.90079373},"labels":[],"label_agreement":null},{"id":"W2801833597","doi":"10.1093/neuonc/noy064","title":"Post-chemoradiation volumetric response predicts survival in newly diagnosed glioblastoma treated with radiation, temozolomide, and bevacizumab or placebo","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; National Brain Tumor Society; National Institutes of Health; American Cancer Society","keywords":"Medicine; Temozolomide; Bevacizumab; Placebo; Internal medicine; Glioblastoma; Hazard ratio; Chemoradiotherapy; Oncology; Radiation therapy; Proportional hazards model; Nuclear medicine; Urology; Chemotherapy; Pathology; Confidence interval; Cancer research","score_opus":0.013235475480703791,"score_gpt":0.2745462852982913,"score_spread":0.2613108098175875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2801833597","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939592,0.0001915146,0.000008377591,0.003806648,0.00023036812,0.00131477,0.000038374274,0.00011474082,0.00033601382],"genre_scores_gemma":[0.99800545,0.00014811079,0.00022445632,0.0010010261,0.00022269097,0.00022899293,0.000046692432,0.00005133196,0.000071261806],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976479,0.00055884407,0.00044492653,0.0006033477,0.00030045124,0.0004445759],"domain_scores_gemma":[0.99644697,0.0024132472,0.00022092485,0.00035415214,0.00026545508,0.0002992414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043399664,0.0002999087,0.0006349484,0.00089380663,0.00011773868,0.000031279837,0.000088958775,0.00026986664,0.00012053446],"category_scores_gemma":[0.0024604187,0.00022478557,0.000048248996,0.0012741903,0.00021287808,0.00014643029,0.000046670957,0.00021794885,0.000057929017],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13399652,0.0021682633,0.6933999,0.000047656402,0.00020234931,0.005926988,0.0013124943,0.000025005607,0.06887701,0.000021209109,0.004057799,0.08996481],"study_design_scores_gemma":[0.049962994,0.039891567,0.864308,0.00005054998,0.000290445,0.00078070356,0.0002484516,0.0011939248,0.02791494,0.00000573154,0.015089071,0.00026365105],"about_ca_topic_score_codex":0.00027372522,"about_ca_topic_score_gemma":0.0017684809,"teacher_disagreement_score":0.17090808,"about_ca_system_score_codex":0.0005604833,"about_ca_system_score_gemma":0.0006098064,"threshold_uncertainty_score":0.916649},"labels":[],"label_agreement":null},{"id":"W2804790935","doi":"10.1093/neuonc/noy056","title":"Corticosteroid use endpoints in neuro-oncology: Response Assessment in Neuro-Oncology Working Group","year":2018,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Cancer Institute","keywords":"Medicine; Corticosteroid; Dexamethasone; Clinical trial; Clinical endpoint; Internal medicine; Oncology","score_opus":0.09571002492667882,"score_gpt":0.3967424660630512,"score_spread":0.3010324411363724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804790935","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14423816,0.8083908,0.000026479365,0.010060932,0.0143927485,0.017295193,0.00020570573,0.00060813245,0.0047818376],"genre_scores_gemma":[0.014034231,0.9693899,0.0012328256,0.009561559,0.0011353007,0.0037182155,0.00034844715,0.0005354455,0.000044054275],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.97812986,0.010837571,0.004321444,0.003330081,0.00090956345,0.0024714982],"domain_scores_gemma":[0.9714197,0.022741903,0.0023946879,0.0022342647,0.0002342106,0.000975225],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0031851102,0.002020566,0.008478279,0.0031332232,0.00022409699,0.00013997026,0.0010626293,0.0029607073,0.00036244898],"category_scores_gemma":[0.004980326,0.0017970166,0.0012491156,0.0022213191,0.0007549524,0.00029998686,0.0012415142,0.0049546426,0.00051442574],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004515652,0.010418802,0.014684067,0.001981635,0.0005112863,0.09265785,0.0005361956,0.0000061784294,0.0074547334,0.00013151595,0.00834986,0.85875225],"study_design_scores_gemma":[0.011035042,0.01555326,0.008383831,0.0036076051,0.0020034083,0.006097478,0.00010252387,0.000055433848,0.00006099918,0.000032400894,0.9521039,0.0009641282],"about_ca_topic_score_codex":0.00014986024,"about_ca_topic_score_gemma":0.0016396225,"teacher_disagreement_score":0.943754,"about_ca_system_score_codex":0.008225123,"about_ca_system_score_gemma":0.005409278,"threshold_uncertainty_score":0.9992537},"labels":[],"label_agreement":null},{"id":"W2808721921","doi":"10.1093/neuonc/noy059.037","title":"ATRT-40. IMPACT OF MOLECULAR SUBTYPES ON TREATMENT OUTCOMES IN RHABDOID TUMORS - A REPORT FROM THE RARE TUMOR CONSORTIUM","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; McGill University; BC Children's Hospital; Hospital for Sick Children","funders":"","keywords":"Atypical teratoid rhabdoid tumor; Oncology; Internal medicine; Medicine; Cancer research; Immunohistochemistry; Bioinformatics; Biology","score_opus":0.015882570690064674,"score_gpt":0.31630204613119367,"score_spread":0.300419475441129,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808721921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972965,0.00026211244,0.0000298328,0.00045306343,0.00024678084,0.00027286107,0.00006628955,0.000013654058,0.0013588888],"genre_scores_gemma":[0.9985568,0.00005792335,0.00013274737,0.00087199284,0.00018924703,0.00003851596,0.00006920459,0.00002719953,0.00005636906],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99856585,0.00018613879,0.00041358167,0.00044282878,0.00012657203,0.00026503103],"domain_scores_gemma":[0.99882615,0.00014867607,0.00024571794,0.0006289608,0.000083284234,0.00006722773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013710963,0.00022573603,0.00039781944,0.000037926744,0.000047253827,0.000008513028,0.00020736021,0.00013396486,0.000066231],"category_scores_gemma":[0.0003396967,0.00014150346,0.00024372268,0.000083899904,0.00020957718,0.0000023118123,0.00007312767,0.000111972746,0.000013467578],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000534659,0.00025669232,0.057559866,0.000003429598,0.00011503241,0.00037822465,0.00015915751,0.00026409776,0.936932,0.0000063233615,0.0012409431,0.0025495365],"study_design_scores_gemma":[0.0025757684,0.007952012,0.06415951,0.000030692616,0.000081113074,0.00033862542,0.00014620875,0.00027699964,0.90540504,0.00015780881,0.018565124,0.00031106523],"about_ca_topic_score_codex":0.0010104072,"about_ca_topic_score_gemma":0.000463216,"teacher_disagreement_score":0.031526964,"about_ca_system_score_codex":0.00014076255,"about_ca_system_score_gemma":0.00050839933,"threshold_uncertainty_score":0.5770344},"labels":[],"label_agreement":null},{"id":"W2808731623","doi":"10.1093/neuonc/noy059.089","title":"DEV-14. IMPACT OF A LATIN AMERICA-WIDE TELECONFERENCED BRAIN TUMOR BOARD","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Latin Americans; Pediatric cancer; Pediatric oncology; Cancer; Session (web analytics); Family medicine; Internal medicine; Political science","score_opus":0.03861067467447335,"score_gpt":0.3602474940593308,"score_spread":0.32163681938485744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808731623","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9701551,0.000050406823,0.000302023,0.015661754,0.0005317753,0.0005381013,0.0000318522,0.00013177402,0.01259717],"genre_scores_gemma":[0.9734947,0.000015079942,0.0020340842,0.023497116,0.0007144595,0.000028864419,0.000020855166,0.000052883304,0.00014194261],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99735016,0.00046840994,0.00074951217,0.0005202468,0.0003575678,0.00055412913],"domain_scores_gemma":[0.99643546,0.0017632624,0.00048894284,0.0006409864,0.00031338108,0.00035794405],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00041555954,0.0002848193,0.0010623874,0.00021246394,0.00006822885,0.000011274955,0.00026248596,0.0001677481,0.0012316805],"category_scores_gemma":[0.003658256,0.00025298013,0.0002992301,0.0004300393,0.00061584107,0.00007158277,0.00012373614,0.0004725649,0.00032236817],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031564722,0.0011680521,0.168946,0.00018666594,0.0004134678,0.0003481159,0.00796188,0.000009413154,0.5609555,0.00016624364,0.21623977,0.040448386],"study_design_scores_gemma":[0.010169602,0.037422203,0.5020523,0.00018732084,0.00027359003,0.0005215079,0.0008933183,0.00044638026,0.047723472,0.00062098884,0.39896637,0.00072297954],"about_ca_topic_score_codex":0.0013651253,"about_ca_topic_score_gemma":0.00069526804,"teacher_disagreement_score":0.51323205,"about_ca_system_score_codex":0.00028748997,"about_ca_system_score_gemma":0.0016472379,"threshold_uncertainty_score":0.99999225},"labels":[],"label_agreement":null},{"id":"W2808751302","doi":"10.1093/neuonc/noy059.255","title":"GERM-08. EARLIER RECOGNITION OF SYMPTOMS AND DIAGNOSIS MAY REDUCE TREATMENT AND LATE EFFECT BURDEN IN CHILDREN, TEENAGERS AND YOUNG ADULTS WITH INTRACRANIAL GERM CELL TUMOURS","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Germinoma; Diabetes insipidus; Germ cell tumors; Pediatrics; Cohort; Craniopharyngioma; Disease; Internal medicine; Surgery; Radiation therapy; Chemotherapy","score_opus":0.006965573859664291,"score_gpt":0.24921229508734702,"score_spread":0.24224672122768273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808751302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967666,0.000589973,3.036047e-7,0.0008102913,0.00011300914,0.0013085804,0.00003235332,0.000025004376,0.0003538853],"genre_scores_gemma":[0.99724203,0.0020266862,0.00011739146,0.000116705196,0.00017078735,0.00025662265,0.00002958822,0.000032707674,0.000007496502],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986131,0.00018497813,0.00027333005,0.00051358604,0.00011710277,0.00029787121],"domain_scores_gemma":[0.99904597,0.00038091507,0.00016747354,0.00016824252,0.00005701836,0.00018036395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013579153,0.00027257975,0.0005818344,0.00020459382,0.000067514535,0.000017192053,0.000033293963,0.00016210304,0.000029217108],"category_scores_gemma":[0.000053229975,0.00019310226,0.000039979324,0.0001450138,0.00033508698,0.00006889417,0.000039780858,0.00013950918,0.0000066077614],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001447469,0.0005720786,0.8272937,0.000055082997,0.00009283653,0.0003760389,0.0013048926,6.0574615e-7,0.019147314,0.0000010783426,0.000049659517,0.14965926],"study_design_scores_gemma":[0.017816653,0.022920407,0.8748224,0.0002004041,0.00066223665,0.0009251061,0.00008767111,0.000048719754,0.08214407,0.000010041793,0.00017427848,0.00018802332],"about_ca_topic_score_codex":0.0006401893,"about_ca_topic_score_gemma":0.00019303196,"teacher_disagreement_score":0.14947124,"about_ca_system_score_codex":0.00011165692,"about_ca_system_score_gemma":0.000054435393,"threshold_uncertainty_score":0.78744817},"labels":[],"label_agreement":null},{"id":"W2808763881","doi":"10.1093/neuonc/noy059.430","title":"MBCL-34. STRUCTURAL CONNECTIVITY ABNORMALITY IN CHILDREN TREATED FOR MEDULLOBLASTOMA","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Connectome; White matter; Neuropsychology; Abnormality; Neuroscience; Magnetic resonance imaging; Psychology; Diffusion MRI; Human Connectome Project; Medicine; Functional connectivity; Pathology; Psychiatry; Cognition; Radiology","score_opus":0.015643772045529063,"score_gpt":0.31930079029889813,"score_spread":0.30365701825336905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808763881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971699,0.00009567976,0.000024505975,0.0005450983,0.00020050081,0.0010902563,0.00007671573,0.00009429869,0.0007030397],"genre_scores_gemma":[0.99830765,0.000005289763,0.0003386474,0.0008567827,0.00027215393,0.00009181468,0.00008219785,0.000024596666,0.000020853633],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987525,0.00012523873,0.0002368441,0.00040160297,0.00011535057,0.00036847367],"domain_scores_gemma":[0.9990669,0.00024088826,0.00010671964,0.00027746242,0.00010673312,0.00020131373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008949942,0.00018721617,0.00041632168,0.00009171515,0.000087628774,0.000008419047,0.000078448174,0.00014771445,0.00012413712],"category_scores_gemma":[0.0003856406,0.00015296203,0.00012273206,0.00016244828,0.00018103208,0.00006077481,0.000045930607,0.00013421636,0.000036298636],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013185813,0.000507909,0.9720253,0.00001973463,0.00012655635,0.00019498265,0.000064358916,0.0000014820934,0.0063588996,0.00016189062,0.0003509629,0.018869346],"study_design_scores_gemma":[0.008170151,0.004286172,0.9788505,0.000012856529,0.00024307633,0.0007390428,0.00001638297,0.00043141702,0.0054283966,0.0002668089,0.0014304081,0.00012477473],"about_ca_topic_score_codex":0.00036242531,"about_ca_topic_score_gemma":0.00032574026,"teacher_disagreement_score":0.018744571,"about_ca_system_score_codex":0.00026281874,"about_ca_system_score_gemma":0.0002026837,"threshold_uncertainty_score":0.62376106},"labels":[],"label_agreement":null},{"id":"W2808767859","doi":"10.1093/neuonc/noy059.175","title":"EAPH-06. HYPERMUTANT PEDIATRIC HIGH GRADE GLIOMAS ARE DRIVEN BY RAS/MAPK MUTATIONS AND RESPOND TO MEK INHIBITION","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Trametinib; Selumetinib; MAPK/ERK pathway; Medicine; Cancer research; MEK inhibitor; Mutation; Biology; Signal transduction; Genetics; Gene","score_opus":0.018277417631873568,"score_gpt":0.29205844359764394,"score_spread":0.27378102596577036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808767859","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98238796,0.00028572298,0.0000145745,0.015676362,0.0003954665,0.0007187044,0.00013528678,0.00008895454,0.00029697773],"genre_scores_gemma":[0.99556845,0.00015269578,0.00040369167,0.0029531852,0.00054929534,0.00017709553,0.0001277217,0.000038226153,0.000029651821],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99842393,0.00016037912,0.0003235972,0.00050850055,0.00022985521,0.0003537361],"domain_scores_gemma":[0.99862766,0.00044921503,0.00014675254,0.0002697053,0.00015710143,0.00034954798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000102153106,0.00021704337,0.00041425423,0.00041739998,0.0001864946,0.000023561268,0.00005903696,0.00017713483,0.00009208949],"category_scores_gemma":[0.0003076703,0.00018968857,0.0000652532,0.0005834545,0.00013536643,0.00007412587,0.00007608561,0.00016880757,0.00018383657],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041399314,0.0015960902,0.08638793,0.000044664914,0.000082053,0.0025809153,0.0010530126,0.000005179849,0.83813894,0.00039817288,0.06612672,0.00317235],"study_design_scores_gemma":[0.017503718,0.015344032,0.39116457,0.000082984014,0.0014525669,0.0018369637,0.0005807171,0.000113489325,0.31567186,0.00063696236,0.25494474,0.000667375],"about_ca_topic_score_codex":0.000044399316,"about_ca_topic_score_gemma":0.000103898165,"teacher_disagreement_score":0.522467,"about_ca_system_score_codex":0.0001750471,"about_ca_system_score_gemma":0.00011749977,"threshold_uncertainty_score":0.7735275},"labels":[],"label_agreement":null},{"id":"W2808768324","doi":"10.1093/neuonc/noy059.596","title":"QOL-14. IMPACT OF RADIATION DOSE ON PHYSICAL AND EMOTIONAL OUTCOMES IN PEDIATRIC BRAIN TUMOR","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Psychosocial; Neurocognitive; Brain tumor; Quality of life (healthcare); Depression (economics); Radiation therapy; Psychological intervention; Pediatrics; Physical therapy; Psychiatry; Cognition; Internal medicine","score_opus":0.02541853202136992,"score_gpt":0.36709740553769815,"score_spread":0.34167887351632825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808768324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902102,0.000030839754,0.000005937073,0.008051772,0.00035787036,0.00032318974,0.000020769825,0.000029539404,0.0009698897],"genre_scores_gemma":[0.99431294,0.000020564004,0.00006215358,0.0042737746,0.0012684469,0.000009686885,0.000011859771,0.000019635307,0.000020939884],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985266,0.00029224783,0.0003559768,0.000310142,0.0002818011,0.00023323194],"domain_scores_gemma":[0.99805963,0.0013235,0.00019484322,0.00021566711,0.000062853505,0.00014351009],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034503845,0.00015596984,0.0005599358,0.00025050383,0.000030149231,0.0000049088017,0.000073831776,0.00009129454,0.000071195325],"category_scores_gemma":[0.0012848801,0.00013255316,0.00012291166,0.0002445921,0.00014956038,0.000063055195,0.00004438496,0.00028394474,0.000037373775],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011711679,0.0017348549,0.9574273,0.000098917015,0.00005275632,0.00007129627,0.0039058279,0.000016412905,0.015053242,0.00027412773,0.008469034,0.0117250495],"study_design_scores_gemma":[0.004178115,0.006399788,0.98694086,0.000014875533,0.00003810733,0.000052071766,0.00003548019,0.00018397802,0.0010178059,0.00029449514,0.0007460101,0.00009838649],"about_ca_topic_score_codex":0.00019610545,"about_ca_topic_score_gemma":0.00011645217,"teacher_disagreement_score":0.029513573,"about_ca_system_score_codex":0.00020483279,"about_ca_system_score_gemma":0.0004158837,"threshold_uncertainty_score":0.5405361},"labels":[],"label_agreement":null},{"id":"W2808774077","doi":"10.1093/neuonc/noy059.497","title":"MBRS-52. TARGETING PRUNE-1 IN A GEMM OF METASTATIC MEDULLOBLASTOMA: A POTENTIAL ROUTE OF INHIBITION FOR NEW FUTURE THERAPIES","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Mechanisms of cancer metastasis","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medulloblastoma; Cancer research; In vivo; Biology; Metastasis; PTEN; Cancer; Signal transduction; Cell biology; PI3K/AKT/mTOR pathway; Genetics","score_opus":0.013760489795522258,"score_gpt":0.2890519646922945,"score_spread":0.27529147489677225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808774077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9782413,0.0009940038,0.017994061,0.0011831255,0.00070034066,0.00063047843,0.000079645644,0.0000111765285,0.0001658416],"genre_scores_gemma":[0.9704693,0.00016970502,0.027912527,0.00050198083,0.0007643381,0.000060437495,0.00006214937,0.000033997265,0.000025572366],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984885,0.00020130405,0.00049846066,0.00036896075,0.00015175264,0.00029105684],"domain_scores_gemma":[0.9990183,0.00005459006,0.0003921364,0.0002506966,0.00021161871,0.00007262384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037288637,0.00017571426,0.00041521285,0.00011924831,0.00003542147,0.0000057399598,0.00017991784,0.00017756903,0.000050139988],"category_scores_gemma":[0.00023931835,0.00016815365,0.0001493405,0.00015136598,0.00014533589,0.000009105339,0.000100564364,0.00010189219,0.0000017982336],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008827111,0.00011735435,0.000040909577,0.00006229146,0.000076032346,0.00000647644,0.0003111376,0.000024640418,0.9802319,0.0003428741,0.0027120207,0.015191699],"study_design_scores_gemma":[0.0023783809,0.0034416586,0.0000905329,0.000015314628,0.00007458832,0.000026648151,0.0003875012,0.000087964494,0.9196673,0.0009130693,0.0727858,0.00013123808],"about_ca_topic_score_codex":0.000042342675,"about_ca_topic_score_gemma":0.00021410045,"teacher_disagreement_score":0.07007378,"about_ca_system_score_codex":0.000028930986,"about_ca_system_score_gemma":0.00036661094,"threshold_uncertainty_score":0.6857107},"labels":[],"label_agreement":null},{"id":"W2808794853","doi":"10.1093/neuonc/noy059.672","title":"RONC-10. OUTCOMES OF STEREOTACTIC RADIOSURGERY FOR PILOCYTIC ASTROCYTOMA: AN INTERNATIONAL MULTICENTER STUDY","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Medicine; Pilocytic astrocytoma; Radiosurgery; Radiation therapy; Progression-free survival; Multivariate analysis; Astrocytoma; Chemotherapy; Internal medicine; Surgery; Radiology; Oncology; Glioma","score_opus":0.04505295938036096,"score_gpt":0.3632696258776428,"score_spread":0.3182166664972818,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808794853","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957033,0.000014817337,0.000023215987,0.0011192348,0.0013329484,0.0011136951,0.000022168746,0.00003902227,0.00063162553],"genre_scores_gemma":[0.9980306,0.0000047163676,0.000520727,0.000804514,0.00033136032,0.00020202057,0.00002488091,0.000029414878,0.0000517821],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986237,0.000114452916,0.00042907626,0.00035857977,0.00021723857,0.00025695085],"domain_scores_gemma":[0.9983455,0.00066757883,0.00020882985,0.00036126617,0.0002734641,0.00014337845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018141115,0.00017671315,0.0005585085,0.00019359033,0.00005321477,0.000012158283,0.00013781771,0.00007489278,0.00036444332],"category_scores_gemma":[0.00036761753,0.00013820917,0.00014417336,0.00007675819,0.00010254605,0.00011507637,0.000060758237,0.00009060247,0.00004878053],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002491168,0.010046428,0.95879644,0.00002116441,0.00064647605,0.00029794427,0.0006262544,0.0000016925633,0.015585668,0.00003817644,0.0015398787,0.009908704],"study_design_scores_gemma":[0.028512282,0.032801386,0.8849957,0.000021201939,0.00081408623,0.00011719714,0.0006171191,0.00074919884,0.017328866,0.000015401358,0.033847995,0.00017956727],"about_ca_topic_score_codex":0.000020885565,"about_ca_topic_score_gemma":0.00006365341,"teacher_disagreement_score":0.07380075,"about_ca_system_score_codex":0.00023523763,"about_ca_system_score_gemma":0.00012458935,"threshold_uncertainty_score":0.5636006},"labels":[],"label_agreement":null},{"id":"W2808821352","doi":"10.1093/neuonc/noy059.010","title":"ATRT-11. MOLECULAR SUBGROUPS OF ATYPICAL TERATOID/RHABDOID TUMOR (ATRT): TOWARDS A CONSENSUS","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; SickKids Foundation; Occupational Cancer Research Centre; Hospital for Sick Children","funders":"","keywords":"Atypical teratoid rhabdoid tumor; DNA methylation; SMARCB1; Biology; Cancer research; Transcriptome; Wnt signaling pathway; Bioinformatics; Epigenetics; Gene; Genetics; Gene expression; Chromatin remodeling; Medulloblastoma","score_opus":0.012532817835923868,"score_gpt":0.2871141989230279,"score_spread":0.27458138108710406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808821352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931859,0.00049984927,0.0009629113,0.0008247572,0.0006592084,0.0002272029,0.000033717217,0.000035076682,0.0035713918],"genre_scores_gemma":[0.9943047,0.000060332142,0.002322799,0.0025275385,0.00062081864,0.000025557789,0.000033172426,0.00004588427,0.000059180893],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981258,0.00022443262,0.0004654026,0.00057071296,0.00019756962,0.00041608998],"domain_scores_gemma":[0.9987571,0.000055492128,0.0002016079,0.00055851723,0.00026894093,0.00015832685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022023372,0.00024855285,0.0003973077,0.00005898608,0.0000791652,0.0000128818965,0.00030512395,0.00030470485,0.00010465896],"category_scores_gemma":[0.00031900153,0.00023902471,0.00019685674,0.00013300369,0.0005014818,0.0000022310128,0.00020957657,0.00018490532,0.000035331817],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047558534,0.00013101946,0.0005786465,0.000027714601,0.00004198109,0.00008260113,0.00007343656,0.000031214437,0.9840807,0.00013801409,0.0066538914,0.007685212],"study_design_scores_gemma":[0.0012803576,0.0020976472,0.00030892703,0.000013970464,0.000043195243,0.00037359828,0.00005383096,0.00050272467,0.7809952,0.00012599757,0.21396852,0.00023605692],"about_ca_topic_score_codex":0.00006193443,"about_ca_topic_score_gemma":0.000111685804,"teacher_disagreement_score":0.20731463,"about_ca_system_score_codex":0.00005091578,"about_ca_system_score_gemma":0.00053547596,"threshold_uncertainty_score":0.9747145},"labels":[],"label_agreement":null},{"id":"W2808835217","doi":"10.1093/neuonc/noy059.390","title":"LGG-49. MOLECULAR ALTERATIONS IN PREGNANT ADOLESCENT AND YOUNG ADULT WOMEN WITH GLIOMA","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Graphene and Nanomaterials Applications","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; University Health Network; St. Michael's Hospital; Hospital for Sick Children","funders":"","keywords":"Glioma; Medicine; Pregnancy; Anaplastic astrocytoma; Astrocytoma; Loss of heterozygosity; Oncology; Brain tumor; Pilocytic astrocytoma; Population; ATRX; Malignant transformation; Internal medicine; Pathology; Cancer research; Mutation; Biology; Allele; Genetics","score_opus":0.006373913996005289,"score_gpt":0.22388131362768773,"score_spread":0.21750739963168245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808835217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970344,0.000077403274,0.0006488757,0.00018728808,0.00018237032,0.0002948619,0.000008119887,0.00010191141,0.0014648013],"genre_scores_gemma":[0.9988782,0.00006926965,0.00043289422,0.0002451654,0.000066355264,0.00027572614,0.000004212552,0.000025444782,0.0000027789092],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99926716,0.000040317973,0.00018094068,0.0001953744,0.000058999052,0.00025719494],"domain_scores_gemma":[0.99963593,0.000020884727,0.00002731685,0.00018957473,0.000047010082,0.00007928778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004857974,0.00011691143,0.00016250231,0.0001160288,0.00005087296,0.00002267307,0.00008222621,0.00007497527,0.00001967787],"category_scores_gemma":[0.000010383265,0.00010661025,0.000010323233,0.00021841592,0.0000780105,0.00005858251,0.000028920402,0.00008266953,0.00002502326],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038882226,0.000060584072,0.00089992187,0.000021285172,0.000010732891,0.000051224415,0.000716724,0.00009820302,0.99534124,0.00054890284,0.00026563279,0.0019466701],"study_design_scores_gemma":[0.003045537,0.0022878924,0.025215195,0.00012053681,0.00004705308,0.00047010096,0.0003955013,0.0048656915,0.9367106,0.0007079697,0.025518956,0.0006149732],"about_ca_topic_score_codex":0.000023009294,"about_ca_topic_score_gemma":0.0002611818,"teacher_disagreement_score":0.058630645,"about_ca_system_score_codex":0.000072309136,"about_ca_system_score_gemma":0.00003144461,"threshold_uncertainty_score":0.43474397},"labels":[],"label_agreement":null},{"id":"W2808836329","doi":"10.1093/neuonc/noy059.713","title":"TBIO-25. CHOROID PLEXUS PAPILLOMAS IN FAMILIES WITH DICER1 MUTATION ASSOCIATED DISEASE","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Medical Imaging and Pathology Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; McGill University Health Centre; McGill University","funders":"","keywords":"Choroid plexus; Germline mutation; Medicine; Pathology; Germline; Transthyretin; Mutation; Biology; Genetics; Internal medicine; Central nervous system; Gene","score_opus":0.024154737125577995,"score_gpt":0.3186135426539791,"score_spread":0.29445880552840115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808836329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97486645,0.0003302314,0.00005049441,0.009541433,0.0005007397,0.00035857942,0.000011690534,0.00014718312,0.0141932005],"genre_scores_gemma":[0.9901733,0.0001358679,0.00025471172,0.008755991,0.00026218125,0.00006424693,0.000052010964,0.000024971814,0.0002767152],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983737,0.00028993006,0.0002955181,0.00039972406,0.00023950463,0.00040163257],"domain_scores_gemma":[0.99875796,0.00049479096,0.00012825949,0.00022063748,0.00015676305,0.00024156866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003088986,0.00018308425,0.00046074862,0.00015956759,0.00012606294,0.0000067371225,0.00008441127,0.00014870768,0.0000915942],"category_scores_gemma":[0.002138462,0.00013723661,0.00004494991,0.00029899762,0.00086614385,0.000051077473,0.00005560298,0.00040996706,0.00009061027],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010573926,0.000986914,0.9127673,0.00007969506,0.0001368587,0.0061785025,0.004048266,0.000004307358,0.030764898,0.000111035064,0.013001762,0.030863054],"study_design_scores_gemma":[0.0073512406,0.006096332,0.9185771,0.00014127204,0.00031735213,0.0002907056,0.001143224,0.0005614194,0.0008825155,0.00026032748,0.064101584,0.00027697498],"about_ca_topic_score_codex":0.00010116259,"about_ca_topic_score_gemma":0.0004668633,"teacher_disagreement_score":0.051099822,"about_ca_system_score_codex":0.00014638256,"about_ca_system_score_gemma":0.00027685007,"threshold_uncertainty_score":0.5596346},"labels":[],"label_agreement":null},{"id":"W2808866479","doi":"10.1093/neuonc/noy059.148","title":"DIPG-55. TARGETING SENESCENT CELLS WITH ABT-263 ENHANCES CELL DEATH INDUCED BY BMI1 INHIBITION AND IONIZING RADIATION IN DIPG","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"BMI1; Cancer research; Senescence; Apoptosis; Cell culture; Cell growth; Radioresistance; In vivo; Growth inhibition; Programmed cell death; Biology; Cell biology; Genetics","score_opus":0.01562984796073893,"score_gpt":0.26915196416689763,"score_spread":0.2535221162061587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808866479","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996394,0.00042762162,0.00017947372,0.0008685655,0.00045222725,0.0005270044,0.0000060693997,0.00007864484,0.001066426],"genre_scores_gemma":[0.9964628,0.0006368307,0.0007762593,0.0015018168,0.00047341886,0.00003027119,0.000041688214,0.000038136506,0.000038772116],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980458,0.00022208487,0.00043253266,0.00057001953,0.00025545195,0.0004741276],"domain_scores_gemma":[0.99899834,0.0002534842,0.00023953796,0.00019552161,0.00011497723,0.00019815279],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030307344,0.00025338063,0.00044719162,0.00020744676,0.00015886701,0.000028697385,0.00007036827,0.0002315962,0.000047887286],"category_scores_gemma":[0.00011108775,0.00022054394,0.00003434138,0.00032677167,0.00016209137,0.00017835973,0.00005193903,0.00041338915,0.000039557788],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034190892,0.00024925233,0.01641283,0.00007437406,0.000007711219,0.000120629324,0.0013756658,0.000002439409,0.9693731,0.00001205807,0.0008900874,0.011139926],"study_design_scores_gemma":[0.002920409,0.0020794123,0.0108056925,0.00010184459,0.00005000074,0.00007454853,0.0005470139,0.00037266992,0.9689419,0.000020205565,0.013827044,0.00025924537],"about_ca_topic_score_codex":0.00017342463,"about_ca_topic_score_gemma":0.00015933948,"teacher_disagreement_score":0.012936956,"about_ca_system_score_codex":0.00022201077,"about_ca_system_score_gemma":0.00022058381,"threshold_uncertainty_score":0.8993521},"labels":[],"label_agreement":null},{"id":"W2808892392","doi":"10.1093/neuonc/noy059.236","title":"EPID-02. MALIGNANT PRIMARY BRAIN AND OTHER CENTRAL NERVOUS SYSTEM TUMOURS DIAGNOSED AMONG THE CANADIAN PAEDIATRIC POPULATION FROM 2009 TO 2013","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Cancer registry; Pilocytic astrocytoma; Incidence (geometry); Population; Astrocytoma; Confidence interval; Pediatrics; Cancer; Glioma; Internal medicine; Environmental health","score_opus":0.012632431262066184,"score_gpt":0.25065487186158314,"score_spread":0.23802244059951697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808892392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9746762,0.00039591442,0.000004735427,0.021715645,0.00085399294,0.0011665688,0.00008326431,0.000054782497,0.0010489194],"genre_scores_gemma":[0.98469055,0.000024277222,0.00009845057,0.013949182,0.0009885422,0.00013109052,0.000057871766,0.000039880084,0.000020131329],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982046,0.00028471617,0.0003155903,0.00043301462,0.00019544226,0.0005666352],"domain_scores_gemma":[0.9982957,0.00054724404,0.00013105785,0.0003479691,0.00006706941,0.0006109232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020412938,0.00021536248,0.00041094274,0.00019838854,0.00024059384,0.000040356394,0.00011533983,0.00018072917,0.0001041096],"category_scores_gemma":[0.0001583602,0.00014772014,0.0000721903,0.00023850874,0.00010458009,0.00004764258,0.000048612488,0.00015940846,0.00012918565],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008151,0.00014472117,0.92229325,0.000018023196,0.00005182084,0.0010111046,0.0006866458,0.00001644997,0.002308839,0.00012114873,0.052864626,0.02040187],"study_design_scores_gemma":[0.0014790846,0.00088690134,0.952755,0.000039452014,0.00019300848,0.000090939604,0.0001289491,0.00014775623,0.00046886937,0.000018143728,0.04366198,0.00012994332],"about_ca_topic_score_codex":0.33313516,"about_ca_topic_score_gemma":0.44518447,"teacher_disagreement_score":0.112049304,"about_ca_system_score_codex":0.000757116,"about_ca_system_score_gemma":0.00027223185,"threshold_uncertainty_score":0.67130554},"labels":[],"label_agreement":null},{"id":"W2808895529","doi":"10.1093/neuonc/noy059.082","title":"DEV-07. THE LATIN-AMERICAN BRAIN TUMOR BOARD (LATB) TELECONFERENCE: RESULTS OF A WEB-BASED SURVEY TO EVALUATE PARTICIPANT EXPERIENCE AND THE PROGRAM","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Advances in Oncology and Radiotherapy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Teleconference; Attendance; Workload; Medicine; The Internet; Family medicine; Medical education; Multimedia; World Wide Web; Computer science; Political science","score_opus":0.06499398182790816,"score_gpt":0.4315416312288959,"score_spread":0.3665476494009877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808895529","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9679027,0.000090373665,0.00023374887,0.028160335,0.0004986006,0.001608925,0.000017708988,0.00006462459,0.0014229473],"genre_scores_gemma":[0.97544664,0.000056461162,0.0030455322,0.020605873,0.00028050793,0.00045188365,0.0000043295295,0.000022391987,0.00008635121],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99663407,0.0016359349,0.0005568939,0.0004576208,0.0002468711,0.00046864297],"domain_scores_gemma":[0.9932023,0.0054083806,0.00036891905,0.0005771784,0.00027573825,0.00016745819],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0020950574,0.00020432564,0.0006890584,0.00006496025,0.0002196243,0.0000123024365,0.00029910516,0.0000920193,0.00008419449],"category_scores_gemma":[0.005027935,0.000106607076,0.00006778822,0.00042484826,0.0047091683,0.000031545245,0.00007887242,0.00037017153,0.000021455957],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07072477,0.0017011476,0.142403,0.000057625995,0.0003074464,0.00026653727,0.0311596,0.00012406484,0.1026909,0.00069642515,0.023316188,0.6265523],"study_design_scores_gemma":[0.022935677,0.031489637,0.31069815,0.00005676064,0.00019305725,0.00019516479,0.0013562453,0.011939817,0.009926014,0.00018609448,0.61068386,0.0003394852],"about_ca_topic_score_codex":0.00019989577,"about_ca_topic_score_gemma":0.0009036603,"teacher_disagreement_score":0.6262128,"about_ca_system_score_codex":0.000067523404,"about_ca_system_score_gemma":0.00079572125,"threshold_uncertainty_score":0.9979994},"labels":[],"label_agreement":null},{"id":"W2808896472","doi":"10.1093/neuonc/noy059.718","title":"TBIO-30. MOLECULAR LANDSCAPE AND CLINICAL CORRELATIONS OF CNS SARCOMAS","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; Hospital for Sick Children","funders":"","keywords":"Central nervous system; Pathology; Biology; Cancer research; Sarcoma; Mesenchymal stem cell; Immunohistochemistry; Medicine; Internal medicine","score_opus":0.035274858904583074,"score_gpt":0.35987761696791404,"score_spread":0.32460275806333094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808896472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9823537,0.00064254866,0.0000660016,0.0031386765,0.00035632495,0.00027366154,0.000008223302,0.000030788047,0.013130077],"genre_scores_gemma":[0.9964171,0.0002473358,0.0011417489,0.0019258191,0.00020202757,0.000015399193,0.000012099092,0.000015321,0.000023117862],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990022,0.00013293422,0.0003764105,0.00021708738,0.000106433385,0.00016493304],"domain_scores_gemma":[0.99873364,0.0006467173,0.00012423027,0.00025330653,0.00010046297,0.0001416271],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015531345,0.000102609294,0.000375857,0.00006949367,0.000046549878,0.0000036654637,0.00004930846,0.00015722297,0.00034192269],"category_scores_gemma":[0.00027681497,0.00008269839,0.00009676202,0.00010212288,0.0002768367,0.00001740183,0.00006092199,0.00016003675,0.000110229106],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013769079,0.0012413535,0.9387434,0.000010046207,0.0001165814,0.00033353377,0.00014519281,4.2872713e-7,0.010488742,0.00094069564,0.0053261006,0.0425162],"study_design_scores_gemma":[0.0073113204,0.009396899,0.7707274,0.000036571913,0.0007152938,0.0005794261,0.00016441519,0.0005395953,0.007922786,0.00029058158,0.20216426,0.00015146201],"about_ca_topic_score_codex":0.0000144956975,"about_ca_topic_score_gemma":0.000015648011,"teacher_disagreement_score":0.19683816,"about_ca_system_score_codex":0.000024854264,"about_ca_system_score_gemma":0.0001170975,"threshold_uncertainty_score":0.37438136},"labels":[],"label_agreement":null},{"id":"W2808919439","doi":"10.1093/neuonc/noy059.197","title":"EMBR-13. FAVORABLE OUTCOMES IN CHILDREN WITH PINEOBLASTOMA TREATED WITH RISK-ADAPTED CRANIOSPINAL IRRADIATION AND CHEMOTHERAPY: RESULTS AND MOLECULAR ANALYSIS FROM THE SJYC07 AND SJMB03 TRIALS","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Chemotherapy; Radiation therapy; Prospective cohort study; Oncology; Internal medicine; Progression-free survival","score_opus":0.013692587069761666,"score_gpt":0.2793480186785539,"score_spread":0.26565543160879224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808919439","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940371,0.00031699066,0.000027721931,0.004438149,0.000015646494,0.00093655434,0.00008865691,0.00003064826,0.00010855075],"genre_scores_gemma":[0.99779814,0.00034042867,0.00044129655,0.0012178203,0.000052989562,0.00005751528,0.000062697465,0.000024424162,0.0000047007625],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998249,0.00043043346,0.00038439344,0.00052756356,0.00017773906,0.00023089013],"domain_scores_gemma":[0.9985073,0.0006516706,0.00032672854,0.00030560582,0.000077347475,0.00013134145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038386838,0.0002558612,0.00095009245,0.00021755182,0.000115890245,0.000040768537,0.000053017957,0.00012985428,0.000019922036],"category_scores_gemma":[0.0002705389,0.0001380675,0.000054015865,0.00051003817,0.00023099022,0.000056601853,0.00002459236,0.00016688295,0.0000014835863],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003243584,0.0003028855,0.97996694,0.0000025042184,0.0018562025,0.00008786618,0.0005075643,0.0000153283,0.006700014,0.000007129203,0.00007846533,0.007231495],"study_design_scores_gemma":[0.021982068,0.005594633,0.96586716,0.000019237199,0.0021117367,0.00007800138,0.00009150745,0.0005545325,0.003249559,0.00002658758,0.000294175,0.00013082004],"about_ca_topic_score_codex":0.0031367694,"about_ca_topic_score_gemma":0.003382291,"teacher_disagreement_score":0.018738484,"about_ca_system_score_codex":0.000058138627,"about_ca_system_score_gemma":0.0000808781,"threshold_uncertainty_score":0.5630229},"labels":[],"label_agreement":null},{"id":"W2808935777","doi":"10.1093/neuonc/noy059.635","title":"QOL-54. THE RELATIONSHIP BETWEEN MATHEMATICS AND WORKING MEMORY IN PAEDIATRIC BRAIN TUMOUR SURVIVORS TREATED WITH RADIATION","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Adler; SickKids Foundation","funders":"","keywords":"Working memory; Working memory training; Verbal fluency test; Cognition; Fluency; Cognitive skill; Verbal memory; Psychology; Developmental psychology; Neuropsychology; Psychiatry; Mathematics education","score_opus":0.053491160180930704,"score_gpt":0.32436639140838297,"score_spread":0.2708752312274523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808935777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9768643,0.00021128314,0.00015689072,0.019559413,0.00018119834,0.00070275797,0.000004460982,0.000090197405,0.00222951],"genre_scores_gemma":[0.9955451,0.000028797222,0.00067906437,0.0024977333,0.0010925585,0.000034283126,0.00001971029,0.000044841105,0.000057948255],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978249,0.0006351088,0.00053591985,0.00036576926,0.00030924636,0.0003290777],"domain_scores_gemma":[0.9917974,0.007337747,0.0003070412,0.00035188903,0.000065909444,0.00014002723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001501909,0.0002046395,0.0005028169,0.00026810414,0.00016503592,0.00002331989,0.00013483262,0.0002059886,0.000024402549],"category_scores_gemma":[0.0021080496,0.00015084071,0.000046411897,0.00078930764,0.00027488612,0.00008089448,0.00006059021,0.00056483655,0.000030009594],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014872743,0.00010230103,0.9821114,0.00006225073,0.000028522658,0.000037794285,0.0085191475,0.0000047853605,0.0005603106,0.00020469945,0.00084553286,0.007374522],"study_design_scores_gemma":[0.0027532494,0.0012582819,0.9887639,0.00008342939,0.00015937707,0.00012501811,0.0011207069,0.00017853171,0.00046791023,0.0004539358,0.004459143,0.00017645893],"about_ca_topic_score_codex":0.0004925757,"about_ca_topic_score_gemma":0.0030117573,"teacher_disagreement_score":0.018680776,"about_ca_system_score_codex":0.00018815137,"about_ca_system_score_gemma":0.00026648995,"threshold_uncertainty_score":0.6151106},"labels":[],"label_agreement":null},{"id":"W2808959977","doi":"10.1093/neuonc/noy059.455","title":"MBRS-10. RISK STRATIFICATION OF MEDULLOBLASTOMA ON THE BASIS OF MOLECULAR SUBGROUPING; AN EXPERIENCE FROM A SINGLE TERTIARY CARE CENTER FROM A DEVELOPING COUNTRY","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Medicine; Risk stratification; Single Center; Internal medicine; Pediatrics; Oncology; Pathology","score_opus":0.0309419376267085,"score_gpt":0.3223927517377767,"score_spread":0.2914508141110682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808959977","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99762404,0.00009221788,0.00028881396,0.0004596084,0.00012611429,0.00047459546,0.00020186913,0.000023601204,0.0007091591],"genre_scores_gemma":[0.99708813,0.000027646109,0.0018871408,0.0006198437,0.000099468154,0.00006314571,0.00019019029,0.000021585989,0.0000028733054],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982695,0.00038386422,0.00034617813,0.00039098194,0.00036055426,0.00024890676],"domain_scores_gemma":[0.99831665,0.00049846544,0.00023440916,0.0005500449,0.00028129813,0.00011915579],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008698153,0.00015804017,0.00030567,0.00008030084,0.000089558554,0.0000108327595,0.00021137785,0.00012743809,0.0002961038],"category_scores_gemma":[0.00046848546,0.0001130219,0.00006201251,0.00015176124,0.00033888358,0.00006730856,0.000063002306,0.0001733218,0.000023777453],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010765094,0.00052874995,0.08332501,0.000018957084,0.0001112584,0.00009675652,0.005251587,9.3834313e-7,0.8859774,0.000042298932,0.00008983659,0.02348068],"study_design_scores_gemma":[0.00191683,0.0024824217,0.14799759,0.0000961649,0.000064609616,0.000008948892,0.0022001013,0.0003941851,0.8434219,0.00006148983,0.0012675772,0.000088227454],"about_ca_topic_score_codex":0.0012249735,"about_ca_topic_score_gemma":0.0005393555,"teacher_disagreement_score":0.06467257,"about_ca_system_score_codex":0.00018279394,"about_ca_system_score_gemma":0.00024905312,"threshold_uncertainty_score":0.46088994},"labels":[],"label_agreement":null},{"id":"W2808988165","doi":"10.1093/neuonc/noy059.399","title":"LGG-59. REMARKABLE OBJECTIVE RESPONSE AND FAVORABLE SURVIVAL FOR BRAF-V600E CHILDHOOD LOW-GRADE GLIOMAS TO BRAF INHIBITORS COMPARED CONVENTIONAL CHEMOTHERAPY","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Université Laval; Stollery Children's Hospital; Hospital for Sick Children","funders":"","keywords":"Medicine; Oncology; Glioma; Chemotherapy; V600E; Internal medicine; Pilocytic astrocytoma; Discontinuation; Radiation therapy; Cancer research; Astrocytoma; Mutation; Biology","score_opus":0.01906882292449606,"score_gpt":0.30965390601087256,"score_spread":0.2905850830863765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808988165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98370594,0.00019552045,0.00008963518,0.011669141,0.0010559263,0.0020131369,0.00008000087,0.00010122064,0.0010894734],"genre_scores_gemma":[0.99374694,0.00003515701,0.0012676262,0.0036724724,0.00067760266,0.00031591367,0.00005427278,0.000069473994,0.00016055962],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976378,0.00032538365,0.00044306912,0.00073724124,0.00029072212,0.00056579965],"domain_scores_gemma":[0.99745035,0.0013211508,0.00017242659,0.00037449412,0.00028575366,0.00039580383],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005405971,0.00032616768,0.000756662,0.00032378544,0.00023001306,0.000039298342,0.00012256703,0.00022462486,0.00017363373],"category_scores_gemma":[0.00050871656,0.00029638692,0.00021500258,0.00041460994,0.00026021613,0.000088932815,0.00008704416,0.00018921368,0.000070028866],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022574041,0.009665866,0.041096468,0.00010468156,0.0008719365,0.0005297485,0.002762428,0.000014921717,0.82950425,0.00067419495,0.08571659,0.0064848852],"study_design_scores_gemma":[0.04362824,0.025708204,0.19853947,0.0002025036,0.00036058368,0.00080120104,0.0007342665,0.00021716193,0.42156288,0.00088493776,0.30670756,0.0006530092],"about_ca_topic_score_codex":0.00007186209,"about_ca_topic_score_gemma":0.00015810969,"teacher_disagreement_score":0.40794137,"about_ca_system_score_codex":0.00031387576,"about_ca_system_score_gemma":0.00043982887,"threshold_uncertainty_score":0.9999488},"labels":[],"label_agreement":null},{"id":"W2808990415","doi":"10.1093/neuonc/noy059.149","title":"DIPG-56. PRECLINICAL STUDIES OF DIANHYDROGALACTITOL (VAL-083) IN DIPG, AS SINGLE AGENT OR AS A COMBINATION WITH RADIATION OR AZD1775","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Delmar (Canada)","funders":"","keywords":"Temozolomide; Cancer research; DNA repair; Methyltransferase; Cell cycle; Cell cycle checkpoint; DNA damage; Topoisomerase; In vivo; Chemistry; Cancer; Glioma; Biology; DNA; Biochemistry; Genetics","score_opus":0.07938375954229857,"score_gpt":0.40123342556990105,"score_spread":0.32184966602760245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808990415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98948115,0.0002493275,0.000004050383,0.005750656,0.0005802515,0.0010345426,0.0000044095145,0.000043407013,0.002852194],"genre_scores_gemma":[0.9976793,0.00048605763,0.0001601954,0.0010642778,0.00022596594,0.00022894292,0.00001656218,0.000028873807,0.000109827466],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982225,0.00026221428,0.00052723225,0.0004116022,0.00029764636,0.00027884604],"domain_scores_gemma":[0.9975918,0.0014523336,0.00031769802,0.00029258223,0.0002170498,0.0001285563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002441799,0.00020259437,0.00067855034,0.00023330298,0.00006736158,0.000010008877,0.000081393526,0.00017330752,0.00022456728],"category_scores_gemma":[0.001695642,0.00012837345,0.0000804983,0.00040146988,0.00029356364,0.00009973016,0.00006520535,0.00017865688,0.00010616546],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031044697,0.04578022,0.4627189,0.00055761903,0.002210975,0.008081247,0.014305723,0.0000548129,0.12184207,0.001291199,0.01568491,0.29642764],"study_design_scores_gemma":[0.06395855,0.21438119,0.20286366,0.0007827094,0.0020967114,0.0011251022,0.002587953,0.00043385345,0.33256352,0.00061263645,0.17789142,0.0007026887],"about_ca_topic_score_codex":0.0001234949,"about_ca_topic_score_gemma":0.0010914258,"teacher_disagreement_score":0.29572493,"about_ca_system_score_codex":0.00041813054,"about_ca_system_score_gemma":0.00040268412,"threshold_uncertainty_score":0.5234917},"labels":[],"label_agreement":null},{"id":"W2808991402","doi":"10.1093/neuonc/noy059.634","title":"QOL-53. METFORMIN RESULTS IN HIPPOCAMPAL REMODELING AND IMPROVED MEMORY ENCODING IN PAEDIATRIC BRAIN TUMOR SURVIVORS TREATED WITH CRANIAL RADIATION: A PILOT RANDOMIZED CONTROLLED CROSSOVER STUDY","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Hippocampal formation; Medicine; Placebo; Crossover study; Metformin; Brain size; Internal medicine; Anesthesia; Neuroscience; Psychology; Pathology; Magnetic resonance imaging; Radiology","score_opus":0.01816303726408535,"score_gpt":0.29347047248415165,"score_spread":0.2753074352200663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808991402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903528,0.00030848657,0.00006718802,0.0012669477,0.0002946749,0.006755353,0.000018719393,0.000054121338,0.000881692],"genre_scores_gemma":[0.9972488,0.0000788784,0.0006533488,0.0009791504,0.00038985346,0.000518273,0.00002476393,0.000047226116,0.000059673286],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9949585,0.0020761215,0.001309366,0.00078332407,0.0003086081,0.0005640375],"domain_scores_gemma":[0.99403274,0.0047783502,0.0004808376,0.0003496986,0.00015068556,0.0002076711],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0045223446,0.0004117074,0.002500186,0.00061779324,0.00012666221,0.000040842686,0.00010047222,0.00012989073,0.00003832362],"category_scores_gemma":[0.0034169883,0.00028002617,0.00015150223,0.0006708934,0.00025752286,0.00013891821,0.00006629106,0.0004393223,0.000005994109],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9577769,0.0023186847,0.0123387715,0.000030352667,0.00028954344,0.0021303918,0.0033643092,0.00008793063,0.010608144,0.000014154971,0.000061849365,0.010978949],"study_design_scores_gemma":[0.9600044,0.015995346,0.0046927566,0.000036159938,0.0007059062,0.0003202782,0.0010508505,0.01604134,0.00059762306,0.000044603683,0.0002357728,0.000274991],"about_ca_topic_score_codex":0.0019839713,"about_ca_topic_score_gemma":0.004139235,"teacher_disagreement_score":0.015953409,"about_ca_system_score_codex":0.00034138895,"about_ca_system_score_gemma":0.0004491719,"threshold_uncertainty_score":0.9999652},"labels":[],"label_agreement":null},{"id":"W2809011355","doi":"10.1093/neuonc/noy059.506","title":"MBRS-62. REPRESSIVE CHROMATIN REMODELERS IN SHH-DRIVEN MEDULLOBLASTOMA","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Sonic hedgehog; Medulloblastoma; Biology; Cancer research; Chromatin; Neurogenesis; Cell biology; Genetics; Gene; Signal transduction","score_opus":0.02089980429247157,"score_gpt":0.2997165889659222,"score_spread":0.2788167846734506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809011355","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870523,0.00022370716,0.00037290252,0.0008953378,0.0006311674,0.00031192854,0.000014394651,0.00004738982,0.010450845],"genre_scores_gemma":[0.9954943,0.00010098616,0.0015657498,0.0018379238,0.0007237728,0.0000680912,0.000024747047,0.000046069417,0.00013832745],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978851,0.00031464527,0.0004066423,0.0007330675,0.00015490997,0.00050563423],"domain_scores_gemma":[0.99889815,0.00010048669,0.00018213944,0.0005419226,0.00016114976,0.00011613389],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024005726,0.0002495241,0.0003704843,0.00011047655,0.00011670792,0.000013146339,0.0003640046,0.00034950455,0.00004527391],"category_scores_gemma":[0.0007019618,0.00024949736,0.00009637427,0.00018805334,0.0004369881,0.000005596613,0.000350015,0.00023467735,0.00011337198],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001796897,0.000096507,0.00152804,0.000010916112,0.000038645027,0.00011298352,0.0005797741,0.00015626373,0.9846175,0.00003613802,0.0085415635,0.004102029],"study_design_scores_gemma":[0.0016393729,0.0029090513,0.0021235244,0.000032506046,0.000025864916,0.00014819631,0.0002599151,0.00094874523,0.75386924,0.0001142818,0.23754637,0.00038291654],"about_ca_topic_score_codex":0.000035294517,"about_ca_topic_score_gemma":0.0004597336,"teacher_disagreement_score":0.23074819,"about_ca_system_score_codex":0.00008553598,"about_ca_system_score_gemma":0.0002592512,"threshold_uncertainty_score":0.9999957},"labels":[],"label_agreement":null},{"id":"W2809066522","doi":"10.1093/neuonc/noy059.630","title":"QOL-48. SEIZURE IN PEDIATRIC PATIENTS WITH BRAIN TUMORS","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Epilepsy; Medicine; Brain tumor; Retrospective cohort study; Pediatrics; Logistic regression; Single Center; Anesthesia; Surgery; Internal medicine; Pathology; Psychiatry","score_opus":0.010831030798720935,"score_gpt":0.2717483018481258,"score_spread":0.2609172710494049,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809066522","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99048305,0.00004327716,0.000002752391,0.004774223,0.00031520682,0.00052558316,0.000006517976,0.00004286975,0.0038065002],"genre_scores_gemma":[0.9948292,0.000014668621,0.0001576285,0.0044562006,0.00037855652,0.00007019909,0.000024470259,0.00002855544,0.000040553696],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99880236,0.000095650386,0.00022901117,0.00034398498,0.00019430283,0.0003346932],"domain_scores_gemma":[0.9991687,0.0002268882,0.00009740258,0.00024545882,0.0001048721,0.00015667822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008339397,0.00016433775,0.0003474135,0.00022812549,0.00004703228,0.000006807928,0.00007454145,0.00011782822,0.00018631427],"category_scores_gemma":[0.00017310421,0.000119092765,0.000043599048,0.0003984396,0.000086164866,0.00004384075,0.000046063575,0.00019331991,0.00026339298],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003025338,0.001535962,0.96652275,0.000017521204,0.000016729768,0.00093059696,0.00026985098,0.0000011117859,0.00084462797,0.000056230576,0.022023994,0.0074780774],"study_design_scores_gemma":[0.0092635425,0.006423578,0.9166514,0.000017102011,0.00010343392,0.000061172206,0.000033785476,0.000015291886,0.001417138,0.000026551463,0.065860204,0.00012679434],"about_ca_topic_score_codex":0.000028476488,"about_ca_topic_score_gemma":0.00015706648,"teacher_disagreement_score":0.049871363,"about_ca_system_score_codex":0.00016530395,"about_ca_system_score_gemma":0.00019285062,"threshold_uncertainty_score":0.4856462},"labels":[],"label_agreement":null},{"id":"W2809103371","doi":"10.1093/neuonc/noy059.012","title":"ATRT-13. CANCER PREDISPOSITION AMONG CHILDREN WITH RHABDOID TUMORS: A SINGLE-CENTRE RETROSPECTIVE REVIEW","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Children's Hospital of Eastern Ontario; Hospital for Sick Children; University of Ottawa","funders":"","keywords":"SMARCB1; Germline; Genetic testing; Medicine; Atypical teratoid rhabdoid tumor; Family history; Referral; Germline mutation; Retrospective cohort study; Genetic predisposition; Cancer; Medical genetics; Pediatrics; Oncology; Mutation; Internal medicine; Genetics; Biology; Family medicine; Gene; Immunohistochemistry","score_opus":0.008607573678507962,"score_gpt":0.26147640994216104,"score_spread":0.2528688362636531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809103371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99107176,0.0037690548,0.00023114696,0.0008951133,0.00026533369,0.000613575,0.000047576632,0.000049967886,0.0030564594],"genre_scores_gemma":[0.9929909,0.0022734196,0.00028873305,0.0027396374,0.0013119746,0.00008567332,0.000114967384,0.000047538317,0.00014712974],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985084,0.00013740774,0.0002594268,0.0005923871,0.00016716612,0.00033518884],"domain_scores_gemma":[0.99902725,0.000014326861,0.00021724682,0.00037601634,0.00025208676,0.00011307736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011897211,0.00022280903,0.0003129152,0.000029430377,0.00011873005,0.000015851292,0.00018678783,0.00018100071,0.00013941088],"category_scores_gemma":[0.000092170914,0.00019020731,0.000090437374,0.00015366162,0.00026677758,0.000007935097,0.000090757785,0.00018067691,0.000018934996],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003597552,0.00028013674,0.05742025,0.00013740071,0.00017154544,0.000019326444,0.00017744898,0.000055908167,0.8939054,0.00001165271,0.030844046,0.016617104],"study_design_scores_gemma":[0.006811032,0.018134823,0.10589475,0.003227763,0.00093096134,0.00083954376,0.0001338738,0.0008735705,0.72873086,0.00011102729,0.13239956,0.001912251],"about_ca_topic_score_codex":0.00011916466,"about_ca_topic_score_gemma":0.0009347482,"teacher_disagreement_score":0.16517459,"about_ca_system_score_codex":0.00016725078,"about_ca_system_score_gemma":0.00025219278,"threshold_uncertainty_score":0.7756429},"labels":[],"label_agreement":null},{"id":"W2809181226","doi":"10.1093/neuonc/noy059.324","title":"IMMU-08. PHASE I TRIAL (NCT02457845) SAFETY, TOLERABILITY AND PRELIMINARY EFFICACY OF IMMUNOVIROTHERAPY WITH HSV G207 IN CHILDREN WITH PROGRESSIVE MALIGNANT SUPRATENTORIAL BRAIN TUMORS","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Tolerability; Medicine; Oncology; HSL and HSV; Internal medicine; Adverse effect; Immunology","score_opus":0.014841984475284791,"score_gpt":0.31841463782666113,"score_spread":0.30357265335137634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809181226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99249244,0.0002861851,0.00003830241,0.0020094446,0.00027137314,0.0046587572,0.000054514363,0.00003886488,0.0001501251],"genre_scores_gemma":[0.9975422,0.00004718813,0.0010233843,0.00043870028,0.0005832187,0.00021670155,0.00008037273,0.0000516698,0.000016550322],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99722695,0.0006041072,0.000693875,0.0006898332,0.0003203959,0.00046485083],"domain_scores_gemma":[0.99821013,0.0005346267,0.00039427294,0.0005367621,0.000140284,0.0001839369],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006155345,0.00035962803,0.0010473926,0.00016384733,0.000096860764,0.000015326063,0.00013320874,0.00016661374,0.00015912007],"category_scores_gemma":[0.0001649334,0.00022993659,0.00009149301,0.00031178736,0.000926676,0.000087526605,0.00007395921,0.00032989067,0.00000524171],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.831982,0.0134565495,0.060230136,0.00006372609,0.0007184601,0.001084754,0.001546415,0.00000786479,0.032047763,0.00017011685,0.00023553088,0.058456656],"study_design_scores_gemma":[0.49967352,0.31691927,0.15691555,0.00023321278,0.0005297476,0.0025262267,0.00022797959,0.00004822624,0.019154774,0.00004140742,0.0033381702,0.0003919126],"about_ca_topic_score_codex":0.00016443137,"about_ca_topic_score_gemma":0.00003244099,"teacher_disagreement_score":0.3323085,"about_ca_system_score_codex":0.00016860223,"about_ca_system_score_gemma":0.0006570278,"threshold_uncertainty_score":0.9376542},"labels":[],"label_agreement":null},{"id":"W2809184189","doi":"10.1093/neuonc/noy059.196","title":"EMBR-12. IMPROVED DIAGNOSTIC ALGORITHM FOR DIFFERENTIAL DIAGNOSTICS OF CNS EMBRYONAL TUMORS (FORMER CNS-PNET) BY NEUROPATHOLOGICAL RE-EVALUATION OF 256 CASES AND CROSSVALIDATION BY METHYLATION CLASSIFICATION","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Epigenetics; Pathological; Medical diagnosis; Pathology; Atypical teratoid rhabdoid tumor; Differential diagnosis; Immunohistochemistry; Biology; Medicine","score_opus":0.05697243646509697,"score_gpt":0.3509857363044983,"score_spread":0.29401329983940133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809184189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931372,0.00033063215,0.003252993,0.0005751739,0.00041431462,0.0017674289,0.000403061,0.000030564177,0.000088658904],"genre_scores_gemma":[0.9968739,0.0003275674,0.0009078303,0.00017654852,0.0002118624,0.00046162773,0.0009995151,0.000033126653,0.000008016506],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976203,0.0004023337,0.0007548403,0.0005164701,0.0004224392,0.00028365714],"domain_scores_gemma":[0.99292356,0.005276781,0.00063506543,0.00026711595,0.00075838424,0.00013912276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005283724,0.00024980732,0.00058111275,0.00014938212,0.000113836206,0.000020288888,0.00008168559,0.00025149802,0.00009036826],"category_scores_gemma":[0.007204438,0.00021133546,0.000112788264,0.00015960984,0.00040356835,0.00010942233,0.00005181112,0.00014356888,0.0000032817363],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029583278,0.0015898068,0.0112763615,0.00005606867,0.000057909372,0.000013918498,0.0002587515,0.0000028387224,0.8429352,0.000061616985,0.0038532245,0.13959844],"study_design_scores_gemma":[0.012833986,0.01542106,0.2788272,0.00007767298,0.0022576754,0.00017684017,0.00023259327,0.049487673,0.63591284,0.00027535195,0.004158078,0.00033905392],"about_ca_topic_score_codex":0.00002928862,"about_ca_topic_score_gemma":0.00002682442,"teacher_disagreement_score":0.26755083,"about_ca_system_score_codex":0.00014617255,"about_ca_system_score_gemma":0.00016918221,"threshold_uncertainty_score":0.8624906},"labels":[],"label_agreement":null},{"id":"W2809198755","doi":"10.1093/neuonc/noy059.481","title":"MBRS-36. IDENTIFICATION OF TWO PROTEIN-SIGNALING STATES DELINEATING TRANSCRIPTIONALLY HETEROGENEOUS HUMAN MEDULLOBLASTOMA","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medulloblastoma; Biology; Signal transduction; Phosphoprotein; Phosphorylation; Cancer research; Cell cycle; Apoptosis; DNA damage; Cell biology; DNA; Genetics","score_opus":0.024225151844704498,"score_gpt":0.3111506951164242,"score_spread":0.2869255432717197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809198755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99116284,0.00020490735,0.007394794,0.00019321215,0.0002848676,0.00039272933,0.00003646202,0.000039380157,0.00029080754],"genre_scores_gemma":[0.9970341,0.000019321295,0.001604827,0.00040365252,0.00064514193,0.00008716409,0.00010127615,0.000044473953,0.00006007447],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99793166,0.00026454317,0.00071474613,0.0005369369,0.00021268785,0.00033943617],"domain_scores_gemma":[0.998714,0.00005188932,0.00035421373,0.00033612503,0.0004616987,0.00008202863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045841417,0.0002211032,0.00030157165,0.00009232263,0.0002379949,0.000018311523,0.00028603896,0.00016883924,0.000034569854],"category_scores_gemma":[0.00021929423,0.00022905601,0.00012875102,0.00012550547,0.0003677667,0.000006407638,0.000098782315,0.00013548436,0.000017731069],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013441453,0.000117611096,0.00031591734,0.00003237503,0.0000808616,0.000011880761,0.00038992852,0.0005517469,0.99581116,0.00008890827,0.00015039383,0.0023148076],"study_design_scores_gemma":[0.0007635571,0.0018252278,0.00010664166,0.000019740983,0.000038993574,0.000047150876,0.00009820432,0.00035539918,0.9842366,0.0002728019,0.012046305,0.00018935933],"about_ca_topic_score_codex":0.000025304842,"about_ca_topic_score_gemma":0.00017476093,"teacher_disagreement_score":0.011895911,"about_ca_system_score_codex":0.000041023493,"about_ca_system_score_gemma":0.00012734525,"threshold_uncertainty_score":0.9340633},"labels":[],"label_agreement":null},{"id":"W2809211258","doi":"10.1093/neuonc/noab140","title":"Characteristics of patients ≥10 years of age with diffuse intrinsic pontine glioma: a report from the International DIPG/DMG Registry","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; SickKids Foundation; Dalhousie University; University of Toronto; Hospital for Sick Children; Izaak Walton Killam Health Centre","funders":"National Institute of Neurological Disorders and Stroke","keywords":"Medicine; ATRX; Young adult; Radiological weapon; IDH1; Pediatrics; Glioma; Internal medicine; Overall survival; Surgery","score_opus":0.013914175283265417,"score_gpt":0.2630091208160526,"score_spread":0.2490949455327872,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809211258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963663,0.00005876396,0.0000025771024,0.0019251163,0.00041039582,0.00018380188,0.00012682288,0.000011538892,0.00091466826],"genre_scores_gemma":[0.99861574,0.00005369235,0.00021006113,0.00040243292,0.00013930505,0.000022044425,0.00048592623,0.000016854163,0.00005393853],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99888295,0.000057054236,0.0004074035,0.00024818064,0.00028497053,0.00011943969],"domain_scores_gemma":[0.9983819,0.00038822173,0.00043373025,0.0004489058,0.00028645626,0.00006079382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000063976775,0.00010600399,0.00039559323,0.000048920094,0.00001684074,0.00000744069,0.00011715533,0.0000799222,0.00018138185],"category_scores_gemma":[0.000792506,0.00007469732,0.00008043146,0.00014581901,0.00011989294,0.000021643065,0.00009760194,0.00013506957,0.000005989389],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091902877,0.0046196836,0.819767,0.000023216595,0.00040313546,0.029748939,0.00036736758,3.5569582e-7,0.11855688,0.00006332951,0.005577733,0.01995334],"study_design_scores_gemma":[0.004614895,0.00075356616,0.9090535,0.000047415833,0.0002465882,0.00035204113,0.00005133819,0.0000029819444,0.022029294,0.0000133471,0.062778436,0.000056594992],"about_ca_topic_score_codex":0.000078887046,"about_ca_topic_score_gemma":0.00005564391,"teacher_disagreement_score":0.096527584,"about_ca_system_score_codex":0.000068000285,"about_ca_system_score_gemma":0.00018409938,"threshold_uncertainty_score":0.3046068},"labels":[],"label_agreement":null},{"id":"W2809211544","doi":"10.1093/neuonc/noy059.501","title":"MBRS-57. TARGETING METABOLIC ADAPTATION IN MYC/MYCN AMPLIFIED PEDIATRIC MEDULLOBLASTOMA AND NEUROBLASTOMA","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of British Columbia","funders":"","keywords":"Neuroblastoma; Cancer research; Gene knockdown; Medulloblastoma; Pediatric cancer; Biology; Mediator; Synthetic lethality; Cell culture; Gene; Cell biology; Cancer; Genetics; Mutant","score_opus":0.027257636485434604,"score_gpt":0.31862792166595216,"score_spread":0.29137028518051755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809211544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99396825,0.00032728055,0.000067665525,0.0015665796,0.0004974733,0.00084166235,0.000009896242,0.00015065401,0.002570566],"genre_scores_gemma":[0.9956678,0.0005750732,0.0010317973,0.0016684775,0.0007682481,0.000103740706,0.000014820454,0.00007442759,0.0000955737],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9968218,0.0004680945,0.0005719475,0.00082170515,0.00045476801,0.0008616728],"domain_scores_gemma":[0.9980682,0.0006611583,0.00019835528,0.00036039922,0.00020738954,0.0005045023],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003361234,0.00034863973,0.0006646866,0.00070774765,0.00017402571,0.000036583824,0.00016524369,0.00021778325,0.00014288008],"category_scores_gemma":[0.0010300082,0.00031872542,0.000097475044,0.00083585473,0.00028124687,0.00020039215,0.00019676409,0.00061801064,0.00032941287],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070006996,0.0026151086,0.112760514,0.00026555834,0.00018441054,0.007137019,0.0027618038,0.00004306158,0.7541437,0.0007544389,0.0076459995,0.10468769],"study_design_scores_gemma":[0.030007761,0.032335836,0.68524486,0.00008071294,0.0006973855,0.0038523506,0.0008115339,0.0073890616,0.07672212,0.00060416985,0.16112676,0.001127443],"about_ca_topic_score_codex":0.00008958441,"about_ca_topic_score_gemma":0.00022887859,"teacher_disagreement_score":0.67742157,"about_ca_system_score_codex":0.00012487134,"about_ca_system_score_gemma":0.00043202302,"threshold_uncertainty_score":0.9999265},"labels":[],"label_agreement":null},{"id":"W2809215572","doi":"10.1093/neuonc/noy059.469","title":"MBRS-24. INVESTIGATING THE ROLE OF THE RNA BINDING PROTEIN, MUSASHI 1 IN PEDIATRIC GROUP 3 MEDULLOBLASTOMA","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Medulloblastoma; Gene knockdown; Biology; RNA-binding protein; Neural stem cell; Cancer research; Stem cell; Progenitor cell; Translation (biology); microRNA; Messenger RNA; Gene; Cell biology; Genetics","score_opus":0.013225354246410534,"score_gpt":0.25606950424331254,"score_spread":0.24284414999690201,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809215572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99477226,0.00027328628,0.000020044024,0.00084631686,0.00030914225,0.00037018742,0.0000059972776,0.0000074156,0.0033953276],"genre_scores_gemma":[0.9984493,0.000071437644,0.00021460411,0.00048625108,0.000556956,0.00012632467,0.000004675167,0.000018572693,0.000071854185],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988316,0.00025754853,0.0002735157,0.00028126198,0.000119308796,0.00023671673],"domain_scores_gemma":[0.99917847,0.000046220248,0.00022330212,0.00043404909,0.00007388907,0.000044082066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028536096,0.000115233146,0.00012944746,0.000047408248,0.00014481093,0.000011230991,0.00043974913,0.00015818271,0.000016882335],"category_scores_gemma":[0.00028370053,0.00007554447,0.0000658496,0.00031564714,0.00030577317,0.0000045635925,0.000198529,0.00020070525,0.000010131112],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019936824,0.00004391861,0.008414226,0.00000655947,0.0000058873825,6.6174704e-7,0.00016262637,0.000007932068,0.9835493,0.00030832173,0.0005210838,0.00695953],"study_design_scores_gemma":[0.00047883048,0.0006675709,0.0077693523,0.000010063702,0.000021733558,0.000017151506,0.00033403077,0.00013136223,0.8770485,0.00031606134,0.1130771,0.00012823811],"about_ca_topic_score_codex":0.000040177016,"about_ca_topic_score_gemma":0.00032374603,"teacher_disagreement_score":0.11255601,"about_ca_system_score_codex":0.000033062362,"about_ca_system_score_gemma":0.00021087912,"threshold_uncertainty_score":0.30806142},"labels":[],"label_agreement":null},{"id":"W2809234664","doi":"10.1093/neuonc/noy059.228","title":"EPEN-28. HETEROGENEITY WITHIN THE PFB EPENDYMOMA SUBGROUP","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"Proportional hazards model; Oncology; Internal medicine; Survival analysis; Medicine; Biology","score_opus":0.021669296637481406,"score_gpt":0.3301284806921344,"score_spread":0.308459184054653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809234664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94604534,0.00012493154,0.0008765388,0.03197949,0.0021957068,0.0003784713,0.0000023197235,0.00013640265,0.018260825],"genre_scores_gemma":[0.969233,0.000027360966,0.0014351729,0.027370913,0.0016362581,0.000024303352,0.000008915913,0.0000451808,0.00021894297],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981005,0.0003511579,0.0003788422,0.00043333432,0.00030884883,0.00042730971],"domain_scores_gemma":[0.9983989,0.00049238617,0.00018008801,0.0005556416,0.00010410957,0.00026885595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008788437,0.00019708728,0.0004105096,0.00007959763,0.00027528647,0.000029503013,0.00032265618,0.00017547849,0.0003053823],"category_scores_gemma":[0.0012254161,0.00012849402,0.00012410127,0.00020223705,0.0006962425,0.000054002874,0.00016822289,0.0009860836,0.0003623575],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001179752,0.000847229,0.052702617,0.00009504354,0.00028417516,0.004496706,0.0028535917,0.000040654428,0.6761884,0.0061660395,0.07574182,0.17940395],"study_design_scores_gemma":[0.003913486,0.0040262993,0.021403156,0.000043479387,0.0002446146,0.008551339,0.00018021977,0.015178772,0.03160601,0.00076749997,0.9137693,0.0003157974],"about_ca_topic_score_codex":0.00008814524,"about_ca_topic_score_gemma":0.000072545896,"teacher_disagreement_score":0.83802754,"about_ca_system_score_codex":0.00010876399,"about_ca_system_score_gemma":0.00024370599,"threshold_uncertainty_score":0.5239834},"labels":[],"label_agreement":null},{"id":"W2809237232","doi":"10.1093/neuonc/noy059.065","title":"CRAN-29. CONSERVATIVE SURGERY FOLLOWED BY PROTON THERAPY FOR CRANIOPHARYNGIOMA IN CHILDREN: A PHASE II STUDY TO EXAMINE THE FEASIBILITY OF DOSE ESCALATION","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Craniopharyngioma; Medicine; Radiation therapy; Surgery; Nuclear medicine","score_opus":0.05481630075162465,"score_gpt":0.373434532159879,"score_spread":0.31861823140825435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809237232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864184,0.00012255703,0.00004728786,0.0017107556,0.00013795769,0.011357686,0.000069717295,0.000025182999,0.000110437206],"genre_scores_gemma":[0.9972785,0.000019677691,0.00006218173,0.0015076073,0.00007299252,0.00093705143,0.00007833016,0.00001949023,0.000024134322],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984411,0.00030058218,0.0004414733,0.0004029448,0.00015982027,0.00025407752],"domain_scores_gemma":[0.9986066,0.00066700386,0.00015249547,0.0003389789,0.00014318178,0.000091734364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048531243,0.00018739204,0.0005738923,0.00011537065,0.00012622286,0.0000044587714,0.00009341344,0.000076218515,0.000047494195],"category_scores_gemma":[0.00034996282,0.00012164404,0.00011477058,0.000333656,0.00012376117,0.0000629902,0.00003830082,0.00010077074,0.0000034411842],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015789453,0.020288408,0.906838,0.00001334101,0.00014362349,0.000024415038,0.0026952818,2.778101e-7,0.042067368,0.0000028904744,0.002563495,0.0095734475],"study_design_scores_gemma":[0.053370796,0.07716665,0.85677135,0.000018664612,0.0001238854,0.000023576336,0.00038011276,0.00008388716,0.010244326,0.00013987605,0.0015240124,0.00015288232],"about_ca_topic_score_codex":0.00020084136,"about_ca_topic_score_gemma":0.00020417264,"teacher_disagreement_score":0.056878235,"about_ca_system_score_codex":0.00007386379,"about_ca_system_score_gemma":0.00019386565,"threshold_uncertainty_score":0.49605},"labels":[],"label_agreement":null},{"id":"W2809258232","doi":"10.1093/neuonc/noy059.243","title":"EPID-10. EVOLVING SURVIVAL TRENDS IN INFANTS WITH BRAIN TUMORS: A LONGITUDINAL POPULATION BASED STUDY","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Université de Montréal","funders":"","keywords":"Choroid plexus; Medicine; Medulloblastoma; Astrocytoma; Oligodendroglioma; Ependymoma; Population; Radiation therapy; Brain tumor; Survival analysis; Pilocytic astrocytoma; Glioma; Oncology; Pathology; Internal medicine; Central nervous system; Cancer research","score_opus":0.037671086532065856,"score_gpt":0.3442986786295365,"score_spread":0.30662759209747065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809258232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936638,0.00002093911,0.000010951264,0.0034526656,0.00022043969,0.0004917869,0.0000047970766,0.00005890665,0.0020757378],"genre_scores_gemma":[0.99855447,4.9811166e-7,0.00018369904,0.0007856288,0.00025450994,0.00011148814,0.0000472133,0.000030929874,0.000031565072],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99820036,0.00031420385,0.00035235996,0.0004904963,0.00028202313,0.00036053229],"domain_scores_gemma":[0.99876523,0.00050448603,0.00014117117,0.00033571981,0.00011191858,0.0001414837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003372066,0.00021291035,0.000542171,0.00048553452,0.00008160306,0.000016612206,0.00007824791,0.00009251519,0.0008018506],"category_scores_gemma":[0.00031666664,0.00016448376,0.000057027817,0.0006169935,0.000057830784,0.0000837554,0.00004184586,0.0001776811,0.00004286373],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008555313,0.0026060175,0.9786198,0.000007805392,0.000043745742,0.0016746897,0.00027964273,0.00001975711,0.002080913,0.000010596161,0.0010583007,0.012743177],"study_design_scores_gemma":[0.009721837,0.012286474,0.97510505,0.000046923244,0.00010718742,0.00006718529,0.00012775192,0.0006115344,0.00064983923,0.0000064734663,0.0011396509,0.00013007125],"about_ca_topic_score_codex":0.00075840676,"about_ca_topic_score_gemma":0.0069200043,"teacher_disagreement_score":0.012613106,"about_ca_system_score_codex":0.00033264657,"about_ca_system_score_gemma":0.00013889415,"threshold_uncertainty_score":0.87797016},"labels":[],"label_agreement":null},{"id":"W2809268959","doi":"10.1093/neuonc/noy059.352","title":"LGG-10. EPIGENETIC/GENETIC/MORPHOLOGIC ANALYSES REVEAL CLINICAL/PROGNOSTIC INSIGHT OF PEDIATRIC LOW GRADE GLIOMAS","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"CDKN2A; Glioma; Methylation; DNA methylation; Epigenetics; CDKN2B; Biology; Pathology; Oncology; Bioinformatics; Cancer research; Gene; Medicine; Genetics; Gene expression","score_opus":0.0958626000334138,"score_gpt":0.3999463705813813,"score_spread":0.30408377054796754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809268959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99164325,0.0025594814,0.000028825127,0.001545805,0.0010088461,0.0007727804,0.000020165711,0.00008908415,0.0023317514],"genre_scores_gemma":[0.9931187,0.0013967151,0.0021008006,0.0016011077,0.0015658081,0.00008837,0.000029687895,0.000053085187,0.000045694254],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964972,0.0005716265,0.0012052552,0.00079626305,0.0003599661,0.000569699],"domain_scores_gemma":[0.9960957,0.0017507676,0.0005597099,0.000779571,0.0003976689,0.00041656443],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003207633,0.00035622533,0.0011551232,0.00045612003,0.00010137491,0.000012573355,0.0002704977,0.00043411742,0.0008050085],"category_scores_gemma":[0.0017258428,0.000276042,0.0003911216,0.0009750239,0.00054636295,0.00003712176,0.00018094294,0.00030935532,0.0004790551],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043782088,0.0047773495,0.7997205,0.00009057637,0.00030857805,0.003024674,0.00013285484,0.000010713901,0.15849185,0.00003585143,0.018453214,0.014516016],"study_design_scores_gemma":[0.006478228,0.020269938,0.8295062,0.0000323616,0.002321981,0.00041795374,0.000037318645,0.00008393945,0.10400189,0.00017401027,0.036358055,0.00031813807],"about_ca_topic_score_codex":0.000038148883,"about_ca_topic_score_gemma":0.000031729578,"teacher_disagreement_score":0.054489963,"about_ca_system_score_codex":0.000093724055,"about_ca_system_score_gemma":0.00040301293,"threshold_uncertainty_score":0.9999692},"labels":[],"label_agreement":null},{"id":"W2809271078","doi":"10.1093/neuonc/noy059.198","title":"EMBR-14. RECLASSIFICATION OF CENTRAL NERVOUS SYSTEM PRIMITIVE NEUROECTODERMAL TUMOR (CNS-PNET) INTO ENTITIES REFLECTS OUTCOME: RESULTS FROM THE PROSPECTIVE SJYC07 AND SJMB03 TRIALS","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Chemotherapy; Primitive neuroectodermal tumor; Prospective cohort study; Central nervous system; Oncology; Neuroblastoma; Internal medicine; Metastasis; Ganglioneuroblastoma; Pathology; Progression-free survival; Cancer; Biology; Ganglioneuroma","score_opus":0.06106181632952824,"score_gpt":0.3447251826771337,"score_spread":0.2836633663476055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809271078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98790663,0.0003147,0.000014186359,0.0044860407,0.0011832363,0.00196137,0.00015456976,0.00008818685,0.0038911041],"genre_scores_gemma":[0.99771637,0.00007257035,0.00024953642,0.00093442923,0.00069510954,0.00019863388,0.00006841652,0.000035506073,0.000029437095],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9965611,0.0010279985,0.0010461255,0.0006529405,0.000316612,0.000395225],"domain_scores_gemma":[0.9949707,0.003177447,0.0008022598,0.0005210915,0.00035751975,0.00017100772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000604437,0.0002845077,0.0010348894,0.00011774138,0.0002062922,0.00003703701,0.00015312941,0.00015391166,0.000021720498],"category_scores_gemma":[0.003536574,0.00018657166,0.0001613498,0.00022551182,0.00046834862,0.00008827765,0.000105010644,0.00028301074,0.000019677462],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012125284,0.001763268,0.19402651,0.00021104483,0.0008808961,0.001102398,0.015466351,0.000007487891,0.74186873,0.0033345309,0.012343766,0.01686969],"study_design_scores_gemma":[0.0116252685,0.005230505,0.75338495,0.00018053816,0.0008733216,0.00026661906,0.0021566874,0.00017131184,0.21835789,0.00016371229,0.0073783146,0.0002109093],"about_ca_topic_score_codex":0.00066236046,"about_ca_topic_score_gemma":0.00048867275,"teacher_disagreement_score":0.5593584,"about_ca_system_score_codex":0.00042988005,"about_ca_system_score_gemma":0.00031873758,"threshold_uncertainty_score":0.76081717},"labels":[],"label_agreement":null},{"id":"W2809290008","doi":"10.1093/neuonc/noy059.272","title":"GERM-26. LONG-TERM HEALTH-RELATED QUALITY OF LIFE IN ADULT SURVIVORS OF PEDIATRIC INTRACRANIAL GERM CELL TUMOR","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University of British Columbia","funders":"","keywords":"Medicine; Survivorship curve; Quality of life (healthcare); Vitality; SF-36; Germ cell tumors; Mental health; Population; Cohort; Radiation therapy; Pediatrics; Internal medicine; Health related quality of life; Cancer; Chemotherapy; Psychiatry","score_opus":0.02872095459368577,"score_gpt":0.32442525097264696,"score_spread":0.2957042963789612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809290008","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953463,0.00042862652,0.0000032630865,0.0019495842,0.0008119019,0.00075719017,0.000030090423,0.000048170747,0.00062485953],"genre_scores_gemma":[0.99790525,0.00034131057,0.00010266405,0.0012055448,0.00034375058,0.00003922503,0.00001648166,0.00004004735,0.0000056939057],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966251,0.00063642755,0.0015375162,0.00043697018,0.00031545782,0.00044849314],"domain_scores_gemma":[0.9970674,0.00085401646,0.0010600309,0.00042557027,0.00029810605,0.00029485617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000625583,0.00023368528,0.0012479196,0.0003454208,0.000042030642,0.0000035507278,0.00014923152,0.00021900905,0.00024493487],"category_scores_gemma":[0.00073646364,0.0002042671,0.00016993264,0.00054967124,0.0002243353,0.000043901517,0.00007736217,0.0003193444,0.0000622348],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093402044,0.0038076814,0.9634552,0.00042601343,0.000045372464,0.0004252601,0.0008024577,0.0000024881285,0.02609734,0.00007955495,0.0005832023,0.0033414057],"study_design_scores_gemma":[0.008997722,0.005116383,0.9752472,0.000030589305,0.000114989714,0.000060373375,0.00006471606,0.00003612507,0.010052947,0.000026278964,0.00011160524,0.00014106571],"about_ca_topic_score_codex":0.0028691175,"about_ca_topic_score_gemma":0.0034156698,"teacher_disagreement_score":0.016044391,"about_ca_system_score_codex":0.00019019232,"about_ca_system_score_gemma":0.0008281976,"threshold_uncertainty_score":0.83297706},"labels":[],"label_agreement":null},{"id":"W2809299590","doi":"10.1093/neuonc/noy059.406","title":"MBCL-08. MOLECULAR CHARACTERIZATION OF NODULAR DESMOPLASTIC MEDULLOBLASTOMAS IN YOUNG CHILDREN TREATED ON ACNS1221. A REPORT FROM THE CHILDREN ONCOLOGY GROUP","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Alberta Children's Hospital","funders":"","keywords":"Medulloblastoma; Cohort; Sonic hedgehog; Medicine; Oncology; Internal medicine; Pathology; Biology; Genetics; Gene","score_opus":0.01089287699986119,"score_gpt":0.2705299974540069,"score_spread":0.2596371204541457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809299590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99484193,0.00008782431,0.000059275502,0.0021859647,0.000394736,0.0013412001,0.00006753242,0.000068190195,0.00095332146],"genre_scores_gemma":[0.9959485,0.00010489611,0.00019577052,0.0022569054,0.00036598553,0.00018306401,0.0008762653,0.00005934801,0.0000092975415],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972791,0.00048477444,0.00075367437,0.0007214616,0.0003280509,0.00043291363],"domain_scores_gemma":[0.9979434,0.00057491165,0.00048139069,0.0007261927,0.00012550864,0.00014856958],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026275392,0.00034157114,0.0008385524,0.0002170667,0.00009426114,0.000011887941,0.00022138238,0.00036340137,0.00018010479],"category_scores_gemma":[0.00042936447,0.00024745546,0.0001646752,0.00041484044,0.0003172094,0.00005881391,0.00010963324,0.00037774493,0.00009675318],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007410955,0.0021908965,0.7298777,0.0000032016844,0.00025156655,0.0016276153,0.00026542592,0.0000021526264,0.25722542,0.00005664757,0.00019025514,0.0075680525],"study_design_scores_gemma":[0.005044968,0.0046392297,0.9337492,0.00006838825,0.00042577847,0.0015506224,0.00001847655,0.000065021995,0.052415214,0.00003117369,0.0018322464,0.00015968339],"about_ca_topic_score_codex":0.00083893957,"about_ca_topic_score_gemma":0.00048415802,"teacher_disagreement_score":0.2048102,"about_ca_system_score_codex":0.00039910869,"about_ca_system_score_gemma":0.00022363965,"threshold_uncertainty_score":0.9999978},"labels":[],"label_agreement":null},{"id":"W2809322172","doi":"10.1093/neuonc/noy059.289","title":"HGG-17. TUMOR MUTATIONAL BURDEN ANALYSIS OF PEDIATRIC TUMORS PROVIDES A DIAGNOSTIC TOOL FOR GERMLINE REPLICATION REPAIR DEFICIENCY AND PREDICT RESPONSE TO IMMUNE CHECKPOINT INHIBITION","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Children's Hospital; Hospital for Sick Children","funders":"","keywords":"Somatic hypermutation; Germline; Germline mutation; Mutation; Cancer research; DNA mismatch repair; Biology; Exome sequencing; Medicine; Genetics; DNA repair; Gene","score_opus":0.016079143818490918,"score_gpt":0.30489655623109685,"score_spread":0.28881741241260594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809322172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99262226,0.00022626651,0.00026038665,0.0046446095,0.000077147335,0.0019239224,0.00011450748,0.00008313874,0.00004773612],"genre_scores_gemma":[0.99582887,0.000035493766,0.0021065406,0.00049754104,0.00028641566,0.0010506159,0.00015711783,0.000022206053,0.000015207239],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99793553,0.00017099381,0.0007639767,0.00062637054,0.00024802057,0.0002551081],"domain_scores_gemma":[0.9958591,0.0026628636,0.000374825,0.00048105427,0.0004826627,0.00013949312],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.00086807663,0.00017913531,0.0005548445,0.00075425406,0.000110928144,0.000011137356,0.000059288388,0.00008617798,0.000052034677],"category_scores_gemma":[0.009161905,0.00015715118,0.00022822579,0.00102362,0.00013008835,0.00006702529,0.00006576893,0.00008522198,0.000007004682],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071333926,0.002216672,0.1253317,0.00022131445,0.00047465196,0.0003480749,0.0016366336,0.00032662565,0.85416883,0.00017469766,0.0020191825,0.005948232],"study_design_scores_gemma":[0.0042742575,0.012527304,0.92309487,0.00004809892,0.004143642,0.00021497675,0.00013999446,0.004849149,0.048148584,0.000119455435,0.0022398725,0.0001998168],"about_ca_topic_score_codex":0.00004800899,"about_ca_topic_score_gemma":0.000025303943,"teacher_disagreement_score":0.80602026,"about_ca_system_score_codex":0.00020413524,"about_ca_system_score_gemma":0.0003313784,"threshold_uncertainty_score":0.99918437},"labels":[],"label_agreement":null},{"id":"W2809322634","doi":"10.1093/neuonc/noy059.262","title":"GERM-15. A PHASE 2 TRIAL OF RESPONSE-BASED RADIATION THERAPY FOR PATIENTS WITH LOCALIZED CENTRAL NERVOUS SYSTEM GERM CELL TUMORS (CNS GCT): A CHILDREN’S ONCOLOGY GROUP (COG) STUDY","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Germ cell tumors; Cog; Radiation therapy; Internal medicine; Germinoma; Chemotherapy; Oncology; Germ cell; Progression-free survival; Phases of clinical research; Central nervous system; Biology","score_opus":0.015496295709902708,"score_gpt":0.3042077213853403,"score_spread":0.2887114256754376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809322634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985491,0.00008038447,0.0000999944,0.00047236998,0.0008907445,0.012636722,0.0001376581,0.000105096115,0.000086023436],"genre_scores_gemma":[0.99634165,0.000010116003,0.00027181924,0.00073611824,0.0004877105,0.0018829331,0.00018502353,0.00008066006,0.000003977889],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99595666,0.0013417458,0.0009023973,0.00072202086,0.00042426205,0.0006529275],"domain_scores_gemma":[0.99648654,0.0014354408,0.0008720806,0.00056164584,0.00033027073,0.0003140216],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00057320594,0.0004093737,0.001279843,0.00035935722,0.00016825384,0.000016936521,0.00018212508,0.00026788612,0.000054878215],"category_scores_gemma":[0.00024541008,0.00030127968,0.00025568626,0.0003257458,0.00022945883,0.000057925376,0.00003167662,0.00020552328,0.000010981476],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.77435654,0.067813404,0.095948346,0.00006838451,0.00055380975,0.0004263309,0.001423168,0.00002019164,0.014876203,0.000020157167,0.0011854797,0.04330801],"study_design_scores_gemma":[0.5512014,0.3224747,0.10411583,0.00003764908,0.0009240725,0.0000394202,0.0001907007,0.00040410104,0.010629928,0.0000022993547,0.009742223,0.00023771042],"about_ca_topic_score_codex":0.0001458415,"about_ca_topic_score_gemma":0.00009357449,"teacher_disagreement_score":0.25466126,"about_ca_system_score_codex":0.00072091236,"about_ca_system_score_gemma":0.0009956801,"threshold_uncertainty_score":0.9999439},"labels":[],"label_agreement":null},{"id":"W2809357869","doi":"10.1093/neuonc/noy059.270","title":"GERM-23. INTRACRANIAL GROWING TERATOMA SYNDROME (IGTS): AN INTERNATIONAL RETROSPECTIVE STUDY","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Sexual Differentiation and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; BC Children's Hospital; Children's Hospital of Eastern Ontario; Children's Hospital of Winnipeg; Stollery Children's Hospital; Hospital for Sick Children; Alberta Children's Hospital","funders":"","keywords":"Medicine; Chemotherapy; Radiation therapy; Germ cell tumors; Biopsy; Retrospective cohort study; Teratoma; Germinoma; Surgery; Internal medicine","score_opus":0.01380006950805162,"score_gpt":0.3079585571166512,"score_spread":0.2941584876085996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809357869","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935874,0.000010405382,0.00035221677,0.00028422807,0.0019492481,0.00027883553,0.000013184265,0.000043298853,0.003481206],"genre_scores_gemma":[0.9968557,0.000007735835,0.00015860035,0.0019625928,0.00070895284,0.000033795182,0.00016350018,0.000027367325,0.00008180066],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99858576,0.0002054907,0.00024566692,0.00054156577,0.00017601451,0.00024551715],"domain_scores_gemma":[0.99930304,0.000016374177,0.00010198893,0.0003084408,0.00016037708,0.000109762674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014111574,0.000169817,0.00019089598,0.00008601136,0.00012722358,0.000047025092,0.00031920886,0.00017732872,0.00027537468],"category_scores_gemma":[0.00017828666,0.00017163447,0.000056246594,0.00009823371,0.00012243252,0.000023733037,0.0001517407,0.00015111134,0.0000897382],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044668865,0.0012783644,0.09487264,0.0000025421123,0.00013172874,0.00014675745,0.0007613965,0.0000024609342,0.8934239,0.00027152858,0.0011550431,0.0075069186],"study_design_scores_gemma":[0.007688859,0.027729165,0.8231405,0.0000056408317,0.000098873665,0.0008524863,0.0026038913,0.0006592433,0.044414636,0.00042466682,0.091563165,0.00081885216],"about_ca_topic_score_codex":0.000018822266,"about_ca_topic_score_gemma":0.00014660794,"teacher_disagreement_score":0.8490093,"about_ca_system_score_codex":0.00005593095,"about_ca_system_score_gemma":0.00009397828,"threshold_uncertainty_score":0.6999051},"labels":[],"label_agreement":null},{"id":"W2809379977","doi":"10.1093/neuonc/noy059.591","title":"QOL-09. EMOTION RECOGNITION IN PEDIATRIC BRAIN TUMOR PATIENTS: VIEWING PATTERNS AND WHITE MATTER STRUCTURE","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Pediatric Oncology Group; Hospital for Sick Children; University of Toronto","funders":"","keywords":"White matter; Psychology; Voxel; Audiology; Fractional anisotropy; Brain activity and meditation; Neuroimaging; Medicine; Neuroscience; Magnetic resonance imaging; Electroencephalography; Radiology","score_opus":0.01574954987454885,"score_gpt":0.26896320228917375,"score_spread":0.2532136524146249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809379977","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942943,0.00003220237,0.0000109161565,0.0043162657,0.00047385227,0.0004814134,0.000040919444,0.00002400845,0.00032613185],"genre_scores_gemma":[0.9923476,0.00004401433,0.00016400285,0.006854103,0.00041996862,0.000034517547,0.000108709086,0.000023887345,0.000003176968],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99890345,0.00012334321,0.000267234,0.0003443046,0.000120177705,0.00024147918],"domain_scores_gemma":[0.9994462,0.000110680725,0.00011768986,0.00014026258,0.000087346896,0.00009777838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007382399,0.00015410542,0.0002774268,0.00023069317,0.0000501608,0.000014516853,0.00003541839,0.00011369736,0.00036720396],"category_scores_gemma":[0.00009930634,0.00013092757,0.000037649756,0.00017353165,0.00003855815,0.000089160574,0.000044988625,0.00017784825,0.000088507906],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006854974,0.00035377854,0.9791995,0.000068772955,0.000008742041,0.00014142403,0.0005912906,4.981719e-7,0.0030174751,0.0000013062285,0.0014292615,0.015119399],"study_design_scores_gemma":[0.004582347,0.0017514759,0.9899455,0.00005197889,0.00009992509,0.00010649585,0.000049116217,0.000014064385,0.0015670448,0.00013291152,0.0015939159,0.000105280866],"about_ca_topic_score_codex":0.000031451105,"about_ca_topic_score_gemma":0.00013566937,"teacher_disagreement_score":0.015014118,"about_ca_system_score_codex":0.00017195308,"about_ca_system_score_gemma":0.000047384885,"threshold_uncertainty_score":0.5339072},"labels":[],"label_agreement":null},{"id":"W2809384402","doi":"10.1093/neuonc/noy059.163","title":"DIPG-70. CLINICAL, RADIOLOGICAL, PATHOLOGICAL AND MOLECULAR CHARACTERISTICS OF CHILDREN &lt;3 YEARS WITH DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG): A REPORT FROM THE INTERNATIONAL DIPG REGISTRY","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Radiological weapon; Pathological; Radiation therapy; Internal medicine; Pediatrics; Oncology; Surgery","score_opus":0.02935779722875415,"score_gpt":0.3418658147109468,"score_spread":0.31250801748219265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809384402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908964,0.00010790701,0.00016723282,0.006927781,0.00017266665,0.00037268057,0.000079952864,0.000058236135,0.0012171628],"genre_scores_gemma":[0.99424493,0.00025794958,0.0010231481,0.0031887318,0.0010282176,0.00004134451,0.00016776535,0.00001957203,0.000028338836],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99811375,0.00014992536,0.00068890536,0.0005777718,0.00023588438,0.00023375457],"domain_scores_gemma":[0.99786425,0.00073394564,0.00041708807,0.00061389816,0.00015371694,0.00021711778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036170793,0.00019165083,0.0005576872,0.000026767633,0.00007385732,0.000020713283,0.0003335259,0.00028953212,0.00013167564],"category_scores_gemma":[0.0015857025,0.00012282659,0.00010579506,0.00015875195,0.001596892,0.000029056077,0.00020858004,0.00061868044,0.000012073034],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015513914,0.0011735469,0.22015683,0.000009327463,0.0002239504,0.004488357,0.0000656779,1.6377216e-7,0.7568948,0.00022958289,0.0032062067,0.012000136],"study_design_scores_gemma":[0.004467198,0.0021330188,0.85523105,0.00003846746,0.0004315135,0.009434656,0.000030622436,0.000062008956,0.02192258,0.00016416283,0.10585229,0.00023243845],"about_ca_topic_score_codex":0.00000861966,"about_ca_topic_score_gemma":0.0000010669927,"teacher_disagreement_score":0.73497224,"about_ca_system_score_codex":0.000035875662,"about_ca_system_score_gemma":0.00011823306,"threshold_uncertainty_score":0.5883815},"labels":[],"label_agreement":null},{"id":"W2809386381","doi":"10.1093/neuonc/noy059.116","title":"DIPG-23. BRAINSTEM RADIATION EXPOSURE CONFERS SUBSTANTIAL RISK OF DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) IN MEDULLOBLASTOMA SURVIVORS: A REPORT FROM THE INTERNATIONAL DIPG REGISTRY","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Medicine; Radiation therapy; Oncology; Internal medicine; Cancer research","score_opus":0.014141587043497477,"score_gpt":0.27460925563391814,"score_spread":0.26046766859042064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809386381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98929226,0.0002509286,0.000028620985,0.0062748073,0.0019370411,0.0006544706,0.00012181156,0.000050922125,0.0013891195],"genre_scores_gemma":[0.99784154,0.00017963481,0.000087776294,0.00052895455,0.0009981131,0.00007883315,0.0002279681,0.000037792935,0.000019410965],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99730605,0.0003825647,0.00089449674,0.00058384973,0.00050206436,0.00033095232],"domain_scores_gemma":[0.99681383,0.0012260161,0.0008017577,0.000717073,0.00029456508,0.00014673229],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051991415,0.00027389266,0.00063799333,0.0002389349,0.00009317301,0.000028569068,0.00030419952,0.0002681319,0.0001625717],"category_scores_gemma":[0.0017849996,0.00020296487,0.00018094189,0.00039936323,0.00035260528,0.0000989501,0.00013753532,0.00036379028,0.000028530145],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016130289,0.0015586222,0.8163444,0.000012317461,0.00040798011,0.004335318,0.0011170891,0.000004331278,0.1574883,0.0001655232,0.00355394,0.013399182],"study_design_scores_gemma":[0.014804237,0.0025136336,0.84783995,0.00010495275,0.00039091907,0.0010799012,0.0005740295,0.00024151872,0.07435713,0.00008403506,0.057780746,0.00022895627],"about_ca_topic_score_codex":0.0021734717,"about_ca_topic_score_gemma":0.008343833,"teacher_disagreement_score":0.08313117,"about_ca_system_score_codex":0.0002850452,"about_ca_system_score_gemma":0.00029140606,"threshold_uncertainty_score":0.82766676},"labels":[],"label_agreement":null},{"id":"W2809405227","doi":"10.1093/neuonc/noy059.292","title":"HGG-20. DNA METHYLATION ANALYSIS OF HIGH-GRADE GLIOMA IN PATIENTS WITH MISMATCH REPAIR DEFICIENCIES","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Izaak Walton Killam Health Centre; University of Manitoba; University of Toronto; Université Laval; Hospital for Sick Children","funders":"","keywords":"Methylation; Biology; DNA methylation; Epigenetics; CpG site; DNA mismatch repair; Mutation; Cancer research; Gene; Histone; Genetics; DNA repair; Gene expression","score_opus":0.017801524156210596,"score_gpt":0.28663133194678186,"score_spread":0.26882980779057125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809405227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977001,0.000039450522,0.00005993289,0.0003911431,0.00035908786,0.0004055564,0.000013229357,0.000055126726,0.0009764032],"genre_scores_gemma":[0.99719274,0.000004993017,0.00227405,0.00038013878,0.00005608601,0.000025615633,0.00003073388,0.000019760866,0.000015891517],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983001,0.00018001927,0.00043301028,0.00040547372,0.00039880312,0.0002826419],"domain_scores_gemma":[0.9986484,0.00032561523,0.000232176,0.00039689304,0.00031116648,0.00008574272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022807728,0.0001596935,0.00062409835,0.0006401072,0.000041504944,0.000003717782,0.00011768266,0.00017255008,0.0001891773],"category_scores_gemma":[0.000323158,0.00012764904,0.00011064131,0.0019443219,0.0003151749,0.00004188317,0.000059522157,0.00016986365,0.000009946424],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014191741,0.0006963252,0.716602,0.00003736095,0.00034123994,0.000036103127,0.0014397133,0.0002777561,0.2753384,0.000041563006,0.0006011138,0.0031691943],"study_design_scores_gemma":[0.0025845421,0.007518285,0.89024,0.000014031737,0.00089047157,0.000007786454,0.000120092365,0.00072327175,0.09500512,0.00004614019,0.0027175576,0.00013266622],"about_ca_topic_score_codex":0.00018934382,"about_ca_topic_score_gemma":0.0011183947,"teacher_disagreement_score":0.1803333,"about_ca_system_score_codex":0.00030631034,"about_ca_system_score_gemma":0.00022613468,"threshold_uncertainty_score":0.5205377},"labels":[],"label_agreement":null},{"id":"W2809463855","doi":"10.1093/neuonc/noy059.400","title":"LGG-60. THE GENETIC LANDSCAPE OF PEDIATRIC LOW-GRADE GLIOMAS: INCIDENCE, PROGNOSIS AND RESPONSE TO THERAPY","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Cohort; IDH1; Oncology; Internal medicine; Incidence (geometry); Targeted therapy; Glioma; Cumulative incidence; Pathology; Cancer research; Mutation; Cancer; Gene; Biology; Genetics","score_opus":0.02530242724296016,"score_gpt":0.3326451749118376,"score_spread":0.3073427476688774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809463855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99298924,0.00049590576,0.000005093799,0.00498173,0.00014278005,0.0009825532,0.00000752111,0.00003501112,0.00036014375],"genre_scores_gemma":[0.9967904,0.0008261041,0.0002454713,0.0015691402,0.00035257143,0.00012813651,0.0000012113942,0.000026494015,0.000060447306],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99821323,0.0004677215,0.00024746306,0.0003497216,0.00031116593,0.0004106987],"domain_scores_gemma":[0.99821585,0.0009363463,0.00008769786,0.000351971,0.00015295042,0.00025520107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030699058,0.00015530662,0.00029685668,0.0003030756,0.000104465966,0.000013000136,0.00017416912,0.00009287877,0.00007346139],"category_scores_gemma":[0.0005344938,0.00009720347,0.000058247173,0.00063950906,0.00023771416,0.00003390127,0.0001270732,0.00020389186,0.00008612227],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014399824,0.0010809237,0.2804254,0.00004406193,0.00010639084,0.0015897249,0.001265158,0.0000011183846,0.66551065,0.000011857989,0.006459827,0.029105045],"study_design_scores_gemma":[0.0063789394,0.03617211,0.82935995,0.000019392211,0.00012695698,0.0008352958,0.00013337024,0.000068625035,0.10007592,0.000088776455,0.026585603,0.00015503138],"about_ca_topic_score_codex":0.000022342481,"about_ca_topic_score_gemma":0.000035558976,"teacher_disagreement_score":0.56543475,"about_ca_system_score_codex":0.000043441923,"about_ca_system_score_gemma":0.00038823308,"threshold_uncertainty_score":0.39638424},"labels":[],"label_agreement":null},{"id":"W2809494470","doi":"10.1093/neuonc/noy059.715","title":"TBIO-27. GABRIELLA MILLER KIDS FIRST DATA RESOURCE CENTER ADVANCING GENETIC RESEARCH IN CHILDHOOD CANCER AND STRUCTURAL BIRTH DEFECTS THROUGH LARGE SCALE INTEGRATED DATA-DRIVEN DISCOVERY AND CLOUD-BASED PLATFORMS FOR COLLABORATIVE ANALYSIS","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Health, Environment, Cognitive Aging","field":"Environmental Science","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Context (archaeology); Psychological intervention; Resource (disambiguation); Medicine; Early childhood; Translational research; Data science; Psychology; Biology; Computer science; Pathology; Developmental psychology; Psychiatry","score_opus":0.044692356661876716,"score_gpt":0.35197240418239933,"score_spread":0.3072800475205226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809494470","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929663,0.00019610103,0.0015191828,0.000985489,0.0001711903,0.0012478897,0.002618069,0.000019910014,0.00027587864],"genre_scores_gemma":[0.9928226,0.0005123701,0.0039822105,0.0017192293,0.0001581904,0.000069290545,0.0006746563,0.000043517153,0.000017931958],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961742,0.00041707777,0.00043114883,0.0016601834,0.00036798706,0.00094938866],"domain_scores_gemma":[0.9974785,0.001032677,0.00018395955,0.0010576849,0.000032781616,0.0002144262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010380637,0.00028481276,0.00048683965,0.00018228355,0.00053985807,0.00007752418,0.00067373,0.00017638326,0.00017647982],"category_scores_gemma":[0.0003481025,0.00024180129,0.000030187293,0.0011860526,0.0010356187,0.00071346114,0.0017186316,0.00050729467,0.000012728508],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055492966,0.00023575603,0.97373784,0.000059746242,0.00011641477,0.000054877004,0.0051699425,0.0017146933,0.0064310706,0.000006242373,0.0030205648,0.008897919],"study_design_scores_gemma":[0.0064359554,0.0015235622,0.5758384,0.00010682441,0.00024200215,0.00002355937,0.004241598,0.10344354,0.0020803947,0.00014665411,0.3052388,0.0006787073],"about_ca_topic_score_codex":0.0012407615,"about_ca_topic_score_gemma":0.06408907,"teacher_disagreement_score":0.39789945,"about_ca_system_score_codex":0.00055799936,"about_ca_system_score_gemma":0.00020714015,"threshold_uncertainty_score":0.9860371},"labels":[],"label_agreement":null},{"id":"W2809498498","doi":"10.1093/neuonc/noy059.306","title":"HGG-34. EARLY PRECLINICAL OUTCOMES OF INTRATUMORAL MODULATION THERAPY FOR DIFFUSE INTRINSIC PONTINE GLIOMA AND GLIOBLASTOMA","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neuroscience and Neural Engineering","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Temozolomide; Medicine; In vivo; Glioma; Oncology; Cancer; Internal medicine; Cancer research; Biology","score_opus":0.04540121480667646,"score_gpt":0.33567413975282284,"score_spread":0.29027292494614637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809498498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99653226,0.000011735756,0.00020916382,0.0010920047,0.0013366422,0.00058170845,0.000013224251,0.00011323569,0.00011000481],"genre_scores_gemma":[0.99793184,0.000050133563,0.00021937794,0.001451752,0.00024163218,0.000043938457,4.948906e-7,0.00003300072,0.000027831604],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99809736,0.00015163988,0.00048318584,0.00062857725,0.00022184613,0.00041741974],"domain_scores_gemma":[0.9979672,0.0013072252,0.00021382,0.00029910472,0.000073498246,0.00013918064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000205309,0.0002198974,0.00044189868,0.00021419859,0.00013786185,0.00003975622,0.00031326423,0.00013229503,0.000010701672],"category_scores_gemma":[0.0015395702,0.00018399832,0.00009636025,0.0004183444,0.0005294548,0.00030876778,0.00012551341,0.00022294387,0.000008242545],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000624967,0.0002172272,0.0025671977,0.000008292144,0.000002882301,0.00003246438,0.00013998651,0.0000048228385,0.9742678,0.00086658576,0.000077030774,0.021190774],"study_design_scores_gemma":[0.0027890115,0.009941974,0.037695736,0.0000061589435,0.000010889103,0.00013628487,0.000007665593,0.0036565526,0.9406195,0.0004275803,0.004513827,0.00019476199],"about_ca_topic_score_codex":0.0000065875506,"about_ca_topic_score_gemma":0.000008732829,"teacher_disagreement_score":0.035128538,"about_ca_system_score_codex":0.000027240845,"about_ca_system_score_gemma":0.000055297798,"threshold_uncertainty_score":0.75032336},"labels":[],"label_agreement":null},{"id":"W2809550909","doi":"10.1093/neuonc/noy059.092","title":"DEV-17. WHO ARE THE HIGH RISK MEDULLOBLASTOMA SUBGROUPS IN JORDAN?","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Radiation therapy; Wnt signaling pathway; Oncology; Internal medicine; Craniotomy; Medicine; Cohort; Biology; Surgery; Cancer research; Gene","score_opus":0.008217581750055535,"score_gpt":0.2506050405821834,"score_spread":0.24238745883212787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809550909","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99386495,0.00037120056,0.00010350628,0.0019248786,0.0009394585,0.00025228498,0.00005948638,0.000011450377,0.0024727953],"genre_scores_gemma":[0.9917405,0.0011504306,0.00023052057,0.00534214,0.0013196231,0.0000558535,0.000020808944,0.000034957586,0.00010512557],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985549,0.00019919647,0.0002803697,0.00046210835,0.000105353225,0.0003980696],"domain_scores_gemma":[0.99885935,0.00020737955,0.00019600592,0.00053128495,0.00010716161,0.00009882986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026214827,0.00018933495,0.00025651732,0.0000551916,0.00014319076,0.000025326832,0.00039072492,0.0002555498,0.00005978413],"category_scores_gemma":[0.0005115522,0.00015609567,0.00008028213,0.00015573883,0.000317109,0.0000028574916,0.00028346508,0.0002634447,0.000060633523],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014352533,0.0005924485,0.08974215,0.000023357985,0.00014489277,0.00024577757,0.0007300682,0.00068284257,0.64031565,0.0015620169,0.21742667,0.047098894],"study_design_scores_gemma":[0.0015851227,0.0024542757,0.029243719,0.000010482236,0.000041576794,0.00007930423,0.00022145895,0.0002301891,0.08721391,0.0006379244,0.87800676,0.00027525192],"about_ca_topic_score_codex":0.00029293768,"about_ca_topic_score_gemma":0.008698713,"teacher_disagreement_score":0.6605801,"about_ca_system_score_codex":0.00007223884,"about_ca_system_score_gemma":0.00021571295,"threshold_uncertainty_score":0.6365397},"labels":[],"label_agreement":null},{"id":"W2809567172","doi":"10.1093/neuonc/noy059.131","title":"DIPG-38. ID1 EXPRESSION CORRELATES WITH H3F3A K27M MUTATION AND EXTRA-PONTINE INVASION IN DIPG","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Cancer research; Biology; Epigenetics; DNA damage; DNA methylation; Gene expression; Gene; DNA; Genetics","score_opus":0.012122006453099726,"score_gpt":0.2841426731399698,"score_spread":0.2720206666868701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809567172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988846,0.0005429801,0.007138688,0.0005170316,0.00031051994,0.00052064104,0.0000069810358,0.000027681697,0.0020894774],"genre_scores_gemma":[0.99759567,0.00042204076,0.00093087705,0.0004874708,0.00022998564,0.00007671472,0.000078529905,0.000050369414,0.00012834344],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99815625,0.00027854615,0.00027270615,0.00066320744,0.00021465505,0.00041461296],"domain_scores_gemma":[0.9991575,0.0000723506,0.00012437241,0.00035702635,0.00014457737,0.00014417399],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002722138,0.00021609938,0.00023985367,0.00015346048,0.00011276123,0.000027166421,0.00018419602,0.00041726648,0.00007115772],"category_scores_gemma":[0.0002660348,0.0001912559,0.00003797367,0.00021826598,0.0002543772,0.0000125700535,0.00024409624,0.00034255913,0.00002096216],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009005622,0.0001040007,0.00038001835,0.000015779397,0.000013910799,0.00018010779,0.00018200265,0.000055716155,0.9862131,0.000037353355,0.0009089508,0.011008528],"study_design_scores_gemma":[0.0024175784,0.0039955885,0.0006304692,0.000048913047,0.000017077544,0.0003808509,0.00011270216,0.0005660539,0.95099956,0.00012450239,0.04047975,0.00022695295],"about_ca_topic_score_codex":0.000037519705,"about_ca_topic_score_gemma":0.00037301687,"teacher_disagreement_score":0.039570797,"about_ca_system_score_codex":0.0000658324,"about_ca_system_score_gemma":0.00021331506,"threshold_uncertainty_score":0.7799189},"labels":[],"label_agreement":null},{"id":"W2809567626","doi":"10.1093/neuonc/noy059.407","title":"MBCL-09. SALVAGE THERAPY FOR CHILDHOOD MEDULLOBLASTOMA: A SINGLE CENTER EXPERIENCE","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Salvage therapy; Cohort; Vincristine; Medulloblastoma; Refractory (planetary science); Retrospective cohort study; Surgery; Etoposide; Internal medicine; Oncology; Chemotherapy; Cyclophosphamide; Pathology","score_opus":0.02681821576154795,"score_gpt":0.3158897007560264,"score_spread":0.28907148499447843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809567626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98786074,0.00023416153,0.00005779392,0.005306502,0.0009484223,0.0010731453,0.000019406383,0.00010469026,0.004395159],"genre_scores_gemma":[0.9898227,0.00007878656,0.00085861125,0.007943711,0.0007213876,0.00048469356,0.000019208159,0.000043763885,0.000027139999],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986137,0.000063909356,0.00026039017,0.00046103436,0.00016253194,0.00043839228],"domain_scores_gemma":[0.9989546,0.00026319563,0.00010443315,0.00036358702,0.00012195973,0.0001922432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007272918,0.00020967794,0.00039535906,0.000101591075,0.0001325453,0.000016909367,0.00012629185,0.00014457694,0.00028103756],"category_scores_gemma":[0.00014032186,0.00016087519,0.00015815992,0.00014459969,0.00020965288,0.00005816839,0.000050210492,0.00011105972,0.00011814331],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010472176,0.010942918,0.028274827,0.000015280053,0.00016225944,0.000355135,0.005300991,3.431889e-7,0.7953993,0.00023593093,0.02313449,0.13513133],"study_design_scores_gemma":[0.0129390815,0.015392166,0.014604768,0.000026594662,0.00005875037,0.00046472976,0.00027121708,0.000026844002,0.3029448,0.00007661528,0.65302765,0.0001667706],"about_ca_topic_score_codex":0.000010129643,"about_ca_topic_score_gemma":0.00003302798,"teacher_disagreement_score":0.6298932,"about_ca_system_score_codex":0.00015976385,"about_ca_system_score_gemma":0.00012210864,"threshold_uncertainty_score":0.65603},"labels":[],"label_agreement":null},{"id":"W2809581673","doi":"10.1093/neuonc/noy059.373","title":"LGG-32. EVALUATION OF PEDIATRIC GLIOMA OUTCOME USING INTRAOPERATIVE MRI: A COHORT STUDY USING I-MiND (IMRIS MULTICENTER iMRI NEUROSURGERY DATABASE)","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Neurosurgery; Intraoperative MRI; Interventional magnetic resonance imaging; Glioma; Cohort; Resection; Magnetic resonance imaging; Radiology; Surgery; Nuclear medicine; Pathology","score_opus":0.11165254043079617,"score_gpt":0.40890252771754804,"score_spread":0.2972499872867519,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809581673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99487066,0.00012452084,0.00006502937,0.00022323504,0.0015027488,0.0029561901,0.000047514688,0.00002817853,0.0001819007],"genre_scores_gemma":[0.9977375,0.000024265684,0.0009128025,0.00036047073,0.00077098113,0.000102351994,0.000035772984,0.000054068536,0.0000017704001],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959571,0.0009789931,0.0009773741,0.0007741607,0.00085532194,0.00045704833],"domain_scores_gemma":[0.9971125,0.0005728832,0.0005083244,0.0006452103,0.00095318747,0.00020786656],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013592157,0.0003459927,0.0009082376,0.0005900678,0.00018306616,0.000027336353,0.00013003875,0.00015620672,0.00041310844],"category_scores_gemma":[0.0008379605,0.0002939699,0.00015766855,0.000685233,0.00017916194,0.0001980294,0.00018557817,0.0002683756,0.000042571537],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000323843,0.0032840674,0.78348696,0.000022064096,0.00018382385,0.00054019253,0.00074049283,0.00009853055,0.2100154,0.0000015398065,0.00015385258,0.00114925],"study_design_scores_gemma":[0.018087689,0.006983678,0.82080734,0.00005106518,0.009589394,0.0005340461,0.00086920214,0.062469095,0.07937369,0.0000045500124,0.00073595677,0.0004943168],"about_ca_topic_score_codex":0.0002809749,"about_ca_topic_score_gemma":0.00012493144,"teacher_disagreement_score":0.13064173,"about_ca_system_score_codex":0.00046163664,"about_ca_system_score_gemma":0.00054407853,"threshold_uncertainty_score":0.99995124},"labels":[],"label_agreement":null},{"id":"W2809594451","doi":"10.1093/neuonc/noy059.199","title":"EMBR-15. DIAGNOSTIC RE-EVALUATION AND POOLED CLINICAL DATA ANALYSIS OF PATIENTS WITH PREVIOUS DIAGNOSIS OF CNS-PNET","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Oncology; Internal medicine; DNA methylation; Disease; Glioma; Pathology; Cancer research; Biology; Gene; Gene expression","score_opus":0.0650480438436011,"score_gpt":0.3876435477530053,"score_spread":0.32259550390940417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809594451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99703,0.00046256869,0.000013144334,0.0007632913,0.00017677688,0.0010623769,0.00019810746,0.000014607549,0.00027912564],"genre_scores_gemma":[0.9975011,0.0007212777,0.0003938848,0.00053707504,0.0000887801,0.000118689764,0.00061893463,0.000018931692,0.0000013520407],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99756736,0.0004684961,0.0007415951,0.00058850035,0.0004318652,0.00020219754],"domain_scores_gemma":[0.9941567,0.0036144685,0.0005351961,0.0009819425,0.000552788,0.00015887666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006946943,0.00017408936,0.0009966318,0.00029183773,0.00004101806,0.0000059819363,0.00017215763,0.00015743982,0.00032955824],"category_scores_gemma":[0.0042086407,0.0001270624,0.00010194298,0.0006076511,0.00036895822,0.00007425646,0.00019321007,0.00012361105,0.000007833804],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041627066,0.0030100786,0.943752,0.00003237481,0.0016367293,0.000029383593,0.00013094214,0.000008567648,0.0001766548,0.000009830035,0.0029149915,0.047882203],"study_design_scores_gemma":[0.0064878175,0.00849084,0.9609262,0.000054155862,0.018236093,0.0000031983852,0.000030387419,0.0012764685,0.0010888772,0.000014045939,0.00329829,0.000093668525],"about_ca_topic_score_codex":0.000076218894,"about_ca_topic_score_gemma":0.00047402148,"teacher_disagreement_score":0.047788534,"about_ca_system_score_codex":0.000056570432,"about_ca_system_score_gemma":0.00018793736,"threshold_uncertainty_score":0.5181455},"labels":[],"label_agreement":null},{"id":"W2809612791","doi":"10.1093/neuonc/noy059.387","title":"LGG-46. TRAMETINIB THERAPY IN PEDIATRIC PATIENTS WITH LOW-GRADE GLIOMAS (LGG) WITH BRAF GENE FUSION; A DISEASE-SPECIFIC COHORT IN THE FIRST PEDIATRIC TESTING OF TRAMETINIB","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Trametinib; Rash; Cohort; Internal medicine; Adverse effect; Oncology; Pediatrics","score_opus":0.023525267255858396,"score_gpt":0.26173528561534565,"score_spread":0.23821001835948724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809612791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99472487,0.0007919494,0.0000027682827,0.0014298306,0.0001604353,0.0025104696,0.000028249555,0.000047137513,0.00030426763],"genre_scores_gemma":[0.99691814,0.0006936243,0.00065725186,0.00076960865,0.0004317561,0.00042053973,0.000039601862,0.000068276284,0.0000011839657],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99693537,0.00031111363,0.00071179203,0.0007616395,0.0006646562,0.0006154179],"domain_scores_gemma":[0.9968618,0.00160337,0.0004108349,0.00064198254,0.00025434172,0.0002276788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041305515,0.00041088302,0.0007588641,0.0006627399,0.00012527422,0.000023915514,0.0002962317,0.00017209473,0.00006333258],"category_scores_gemma":[0.00028067577,0.0002449944,0.000105144194,0.002511004,0.0002492362,0.00007756198,0.00005110935,0.0004041934,0.000016717006],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018915297,0.007416075,0.97970736,0.00006250724,0.00003340558,0.0010273196,0.0007929321,0.00003580244,0.0005864255,0.000008872816,0.0003482785,0.008089472],"study_design_scores_gemma":[0.01494229,0.011909165,0.96948457,0.00004274941,0.00027299504,0.00005928528,0.000093377384,0.00004996325,0.0005668396,0.000014315262,0.002334776,0.00022964815],"about_ca_topic_score_codex":0.00009058925,"about_ca_topic_score_gemma":0.00030091658,"teacher_disagreement_score":0.01305076,"about_ca_system_score_codex":0.0001568141,"about_ca_system_score_gemma":0.0003711073,"threshold_uncertainty_score":0.9990581},"labels":[],"label_agreement":null},{"id":"W2809620633","doi":"10.1093/neuonc/noy059.104","title":"DIPG-11. TRANSCRIPTIONAL REGULATION OF NEURAL PROGENITOR CELL FATE BY DLX HOMEOBOX GENES - RELEVANCE TO DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cell Image Analysis Techniques","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; University of Alberta","funders":"","keywords":"Biology; OLIG2; Chromatin immunoprecipitation; Transcription factor; Neurosphere; Cancer research; Genetics; Promoter; Cell biology; Cellular differentiation; Gene expression; Gene; Oligodendrocyte; Myelin; Neuroscience","score_opus":0.008048469591676967,"score_gpt":0.26133311822397404,"score_spread":0.25328464863229705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809620633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99556315,0.00048812362,0.0020850126,0.00066661724,0.00018390382,0.0004327035,0.000029010638,0.00005659715,0.0004948699],"genre_scores_gemma":[0.9954812,0.00016766593,0.00218009,0.00094436883,0.000611718,0.00007330963,0.00018644634,0.000048737045,0.0003064449],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981046,0.00020027008,0.00049345323,0.0006353504,0.00021330058,0.00035302417],"domain_scores_gemma":[0.99869937,0.00004554772,0.00024135821,0.00053899555,0.0003363265,0.00013839752],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016922221,0.00025262558,0.00036183067,0.00015770768,0.00008315338,0.000019600418,0.0003464725,0.00025544944,0.000054663982],"category_scores_gemma":[0.00013540857,0.00025553475,0.00017209303,0.00030903355,0.0002465411,0.000014909065,0.00014772594,0.00011975846,0.000019074903],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003463056,0.0003404608,0.0008462987,0.000018214541,0.000029051498,0.000012078283,0.000053361913,0.0000059122676,0.9731872,0.000012417127,0.015503327,0.009645381],"study_design_scores_gemma":[0.00066063186,0.0015517556,0.0010321854,0.0000031161192,0.000054051143,0.00003585486,0.000009971771,0.00009439576,0.7439905,0.000019507252,0.25237635,0.00017168713],"about_ca_topic_score_codex":0.000034516812,"about_ca_topic_score_gemma":0.00012518762,"teacher_disagreement_score":0.23687303,"about_ca_system_score_codex":0.000042699005,"about_ca_system_score_gemma":0.00007900896,"threshold_uncertainty_score":0.9999897},"labels":[],"label_agreement":null},{"id":"W2809629943","doi":"10.1093/neuonc/noy059.275","title":"HGG-03. PREVALENCE OF BIALLELIC MISMATCH REPAIR DEFICIENCY IN CHILDREN WITH MALIGNANT GLIOMA TREATED AT KING FAHAD MEDICAL CITY (KFMC)","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"","keywords":"Medicine; Neurofibromatosis; Pathological; Population; Anaplastic astrocytoma; Glioma; Retrospective cohort study; Pediatrics; Internal medicine; Oncology; Astrocytoma; Pathology; Cancer research","score_opus":0.022955870657520965,"score_gpt":0.29800848588084355,"score_spread":0.2750526152233226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809629943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945103,0.00029329385,0.000016819908,0.0007157182,0.00032571645,0.0008826542,0.000012077895,0.00012902723,0.003114404],"genre_scores_gemma":[0.9980293,0.00013327178,0.0006937024,0.0007465717,0.000194971,0.00006249066,0.0000068440686,0.000040723982,0.000092140115],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969814,0.0002914814,0.0006463277,0.0007514183,0.0007501871,0.00057921105],"domain_scores_gemma":[0.99835634,0.00030341189,0.00025808476,0.00059402286,0.00021764808,0.00027050098],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00050038507,0.0002803888,0.0006633935,0.00025946344,0.00007938477,0.0000042096167,0.00033542927,0.00040607204,0.0012030477],"category_scores_gemma":[0.0007641264,0.00021647396,0.000108194625,0.00073619705,0.00083739863,0.0000380047,0.00024737002,0.00039624225,0.000044974164],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010957797,0.0004443386,0.8289614,0.00011816428,0.000041961637,0.00033586624,0.00052694825,0.000005213291,0.16557595,0.0000100811,0.00068761175,0.0021967147],"study_design_scores_gemma":[0.004278675,0.01068975,0.83531266,0.00023671892,0.00017967867,0.0031905198,0.00003919047,0.00032662187,0.14346138,0.00002055179,0.00200149,0.00026279077],"about_ca_topic_score_codex":0.0004605572,"about_ca_topic_score_gemma":0.00130285,"teacher_disagreement_score":0.022114577,"about_ca_system_score_codex":0.000489694,"about_ca_system_score_gemma":0.0007983095,"threshold_uncertainty_score":0.99970996},"labels":[],"label_agreement":null},{"id":"W2809637362","doi":"10.1093/neuonc/noy059.552","title":"NURS-03. DEVELOPMENT OF A NEURO-ONCOLOGY LONG TERM FOLLOW UP NURSE CLINICIAN AT A TERTIARY HEALTH CARE CENTER","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital","funders":"","keywords":"Medicine; Neurocognitive; Survivorship curve; Pediatrics; Multidisciplinary approach; Family medicine; Psychiatry; Cancer; Internal medicine; Cognition","score_opus":0.04096336180518702,"score_gpt":0.3822045984677057,"score_spread":0.3412412366625187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809637362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9579486,0.00062920706,0.00010733274,0.026060533,0.0069552055,0.0018373736,0.000058865455,0.00023005296,0.006172828],"genre_scores_gemma":[0.9222405,0.000113376664,0.002800286,0.07232639,0.0018261124,0.00013501522,0.00020961699,0.00015707822,0.00019161671],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9933718,0.0012475362,0.002167638,0.0012566566,0.00072136085,0.001235017],"domain_scores_gemma":[0.9955986,0.0008728967,0.001135613,0.0011302939,0.00044487717,0.00081772683],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009386356,0.00058170763,0.0018957765,0.000385689,0.00035614384,0.000014119053,0.0005501179,0.00057136,0.0004586565],"category_scores_gemma":[0.00065625063,0.0005718753,0.0003841288,0.00039427122,0.0007673998,0.00011441659,0.00039649036,0.0008822738,0.00041026983],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067496374,0.0030495094,0.45021328,0.0010707951,0.00046289215,0.0009150078,0.11690817,6.241977e-7,0.036947917,0.00004515416,0.07939246,0.30424455],"study_design_scores_gemma":[0.016348613,0.013271041,0.26090434,0.00039200185,0.00023822836,0.0012017739,0.0036789256,0.000013452423,0.017150907,0.000014871229,0.68615407,0.0006317524],"about_ca_topic_score_codex":0.00015588796,"about_ca_topic_score_gemma":0.008756049,"teacher_disagreement_score":0.60676163,"about_ca_system_score_codex":0.0020990053,"about_ca_system_score_gemma":0.004511643,"threshold_uncertainty_score":0.99967325},"labels":[],"label_agreement":null},{"id":"W2809653498","doi":"10.1093/neuonc/noy059.231","title":"EPEN-31. SUBGROUP SPECIFIC LONG-TERM SURVIVAL AND NEUROCOGNITIVE OUTCOMES IN POSTERIOR FOSSA EPENDYMOMA (PFE)","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Neurocognitive; Medicine; Cohort; Ependymoma; Neuropsychology; Proportional hazards model; Subgroup analysis; Radiation therapy; Prospective cohort study; Internal medicine; Oncology; Surgery; Pediatrics; Cognition; Psychiatry; Confidence interval","score_opus":0.034560012226980595,"score_gpt":0.3201784184600376,"score_spread":0.285618406233057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809653498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98834765,0.00024195382,0.00000402111,0.0042402553,0.0011333994,0.0010476667,0.000025759156,0.00006204525,0.004897267],"genre_scores_gemma":[0.99733204,0.00015814051,0.000081982434,0.0018566129,0.00032323596,0.00011456794,0.000027448583,0.00004885832,0.000057088502],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99783677,0.00022490448,0.0004553336,0.00070219074,0.00023806552,0.0005427198],"domain_scores_gemma":[0.99841785,0.00067424035,0.0001445078,0.00036437187,0.00013111252,0.00026792506],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017782499,0.0003367091,0.00083246507,0.0002849119,0.00009941941,0.00003800264,0.00012443955,0.00020697885,0.00029025084],"category_scores_gemma":[0.0001688231,0.00027944916,0.0001168094,0.00022134917,0.00032891033,0.00010798654,0.00019049994,0.00030662213,0.00024322652],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071728585,0.0013745708,0.868088,0.000027146461,0.00007821555,0.013515527,0.0003696649,4.1676692e-8,0.064341955,0.00009467793,0.00029530202,0.0510976],"study_design_scores_gemma":[0.008268572,0.004821704,0.96676916,0.00004017647,0.00012005911,0.0016535255,0.00010329837,0.000004729654,0.0138057135,0.00004136421,0.0041680075,0.00020371914],"about_ca_topic_score_codex":0.00006739434,"about_ca_topic_score_gemma":0.0007504753,"teacher_disagreement_score":0.098681115,"about_ca_system_score_codex":0.00016419214,"about_ca_system_score_gemma":0.00010979667,"threshold_uncertainty_score":0.9999658},"labels":[],"label_agreement":null},{"id":"W2883055139","doi":"10.1093/neuonc/noy099","title":"Estimating survival for renal cell carcinoma patients with brain metastases: an update of the Renal Graded Prognostic Assessment tool","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; University of Toronto; Sunnybrook Health Science Centre","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; Center for Clinical and Translational Sciences, University of Texas Health Science Center at Houston; National Institutes of Health; Memorial Sloan-Kettering Cancer Center","keywords":"Medicine; Renal cell carcinoma; Hazard ratio; Internal medicine; Retrospective cohort study; Oncology; Cohort; Proportional hazards model; Performance status; Nephrectomy; Overall survival; Kidney; Confidence interval","score_opus":0.026716118426693265,"score_gpt":0.30451959854374994,"score_spread":0.2778034801170567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883055139","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939984,0.0000142159915,0.0013644281,0.0008362588,0.0004868708,0.002521151,0.00008699153,0.000037835296,0.00065383874],"genre_scores_gemma":[0.9727365,4.1987474e-7,0.025754038,0.000743599,0.00028415944,0.00021511964,0.00017824181,0.00005806951,0.000029898743],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99729764,0.00056691136,0.0005628825,0.0005678003,0.0005217091,0.0004830289],"domain_scores_gemma":[0.9974622,0.0007653705,0.0004803746,0.00066031824,0.00044905482,0.00018264478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047787314,0.00031231705,0.00063413003,0.00010554402,0.00018392997,0.00001860757,0.00025339014,0.00011413116,0.000055391374],"category_scores_gemma":[0.00033834128,0.00019168858,0.0001560732,0.0002459679,0.0003339604,0.00010109311,0.0001252129,0.00027263685,0.0000060295893],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047686743,0.006123768,0.58794075,0.00048387476,0.0003587152,0.00031143337,0.0010582934,0.00022511909,0.37824658,0.0004139977,0.003625923,0.016442884],"study_design_scores_gemma":[0.022859808,0.06614085,0.6645687,0.000117743075,0.0019597576,0.00018609763,0.00016648561,0.0045866934,0.23235686,0.00022362114,0.0063218125,0.000511557],"about_ca_topic_score_codex":0.000043914715,"about_ca_topic_score_gemma":0.0000667411,"teacher_disagreement_score":0.14588971,"about_ca_system_score_codex":0.0002695634,"about_ca_system_score_gemma":0.0007578667,"threshold_uncertainty_score":0.7816833},"labels":[],"label_agreement":null},{"id":"W2887130720","doi":"10.1093/neuonc/noy134","title":"Voxel-wise radiogenomic mapping of tumor location with key molecular alterations in patients with glioma","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Glioma; Key (lock); Voxel; Medicine; Computational biology; Pathology; Computer science; Cancer research; Biology; Radiology","score_opus":0.010798399330164533,"score_gpt":0.24855474226089389,"score_spread":0.23775634293072936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887130720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99762565,0.000051428953,0.00021604245,0.0006780138,0.0000783665,0.0007100124,0.0000057351035,0.000017705324,0.00061707024],"genre_scores_gemma":[0.99791956,0.000002401637,0.00133175,0.0005517696,0.00004552766,0.00008899631,0.00003562658,0.000022754944,0.0000016018058],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99906725,0.00007327043,0.00025136198,0.00026289735,0.0001522084,0.00019300492],"domain_scores_gemma":[0.9992116,0.000064212385,0.00014625657,0.00025936269,0.00023498996,0.00008356479],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000057868594,0.00013159151,0.00030243036,0.00026813577,0.00003978173,0.000006159807,0.000055531986,0.000048247417,0.000031526903],"category_scores_gemma":[0.00004462971,0.000098357326,0.000026491696,0.00041901213,0.00012903976,0.0000493232,0.000020302576,0.00008050983,0.000019781399],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013901957,0.002663291,0.5961088,0.000054889588,0.00014357375,0.00079267175,0.0011194688,0.00019867,0.39334452,0.00031520636,0.00027307592,0.0035956712],"study_design_scores_gemma":[0.019769505,0.016123641,0.7024419,0.00020414896,0.00026520615,0.00021781871,0.00014165044,0.00046696677,0.25633705,0.00003359614,0.003764697,0.00023381837],"about_ca_topic_score_codex":0.000058591904,"about_ca_topic_score_gemma":0.00010600517,"teacher_disagreement_score":0.13700746,"about_ca_system_score_codex":0.00018343584,"about_ca_system_score_gemma":0.00020683318,"threshold_uncertainty_score":0.40108955},"labels":[],"label_agreement":null},{"id":"W2889789648","doi":"10.1093/neuonc/noy139.187","title":"P01.145 Tumor growth dynamics in serially-imaged low-grade glioma patients","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Natural history; Asymptomatic; Magnetic resonance imaging; Glioma; Cohort; Proportional hazards model; Radiology; Retrospective cohort study; Lesion; Medical record; Nuclear medicine; Internal medicine; Surgery","score_opus":0.011857030226386189,"score_gpt":0.2754583837170686,"score_spread":0.2636013534906824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889789648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900965,0.000021482083,0.0000037890252,0.00371491,0.0012734832,0.00075642543,0.00002882466,0.00007956241,0.0040250146],"genre_scores_gemma":[0.9963445,0.000019825711,0.00033492118,0.0026771498,0.00035778424,0.00011765454,0.00008482909,0.000049500894,0.000013852849],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980885,0.00019867059,0.0004452515,0.00050653477,0.00025172305,0.00050932146],"domain_scores_gemma":[0.99880546,0.0002498432,0.00016237877,0.00035862534,0.00019790708,0.00022578277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001407678,0.00025968117,0.0005668454,0.00030974363,0.000083547886,0.000017844404,0.00015324912,0.0001688895,0.0001746184],"category_scores_gemma":[0.00044006636,0.0002034984,0.000108111286,0.00044836322,0.00019698738,0.000081248494,0.00011545779,0.0002630437,0.00026933954],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014972572,0.010705839,0.7393639,0.000115915456,0.0001363001,0.008093167,0.00092795334,0.0000013348899,0.21003672,0.0009828384,0.010328202,0.017810557],"study_design_scores_gemma":[0.04655095,0.020684902,0.61466837,0.00018848084,0.00043648962,0.0007929859,0.00046146874,0.0014163351,0.28287524,0.00088643696,0.030245958,0.0007924005],"about_ca_topic_score_codex":0.00015295837,"about_ca_topic_score_gemma":0.0008077383,"teacher_disagreement_score":0.124695554,"about_ca_system_score_codex":0.0007839394,"about_ca_system_score_gemma":0.00020232795,"threshold_uncertainty_score":0.82984245},"labels":[],"label_agreement":null},{"id":"W2890573151","doi":"10.1093/neuonc/noy139.409","title":"P05.83 Tumor Treating Fields and radiosurgery for supra- and/or infratentorial brain metastases (1–10) from NSCLC in the phase 3 METIS study","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Chemical Reactions and Isotopes","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Radiosurgery; Clinical endpoint; Lung cancer; non-small cell lung cancer (NSCLC); Adverse effect; Oncology; Neurocognitive; Internal medicine; Radiology; Clinical trial; Radiation therapy","score_opus":0.13772833863690861,"score_gpt":0.4710848910372112,"score_spread":0.3333565524003026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890573151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99329126,0.0002114947,0.000039821778,0.0029841696,0.0014052882,0.0010142827,0.00015973795,0.000034187593,0.00085975195],"genre_scores_gemma":[0.9913414,0.00009912421,0.00021031727,0.006410516,0.0014503149,0.0003389006,0.000032992473,0.000019589745,0.00009680906],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976185,0.001043327,0.00043481553,0.00043170265,0.000097392774,0.0003742375],"domain_scores_gemma":[0.98746246,0.011979576,0.00015111774,0.00017803455,0.00006682381,0.00016198604],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010914499,0.0002201282,0.0004657709,0.00010423071,0.00028734177,0.0000423228,0.00017859525,0.00022813365,0.0010952991],"category_scores_gemma":[0.0024539554,0.00015257324,0.00006849461,0.00019705386,0.0003051009,0.000118668926,0.00009153867,0.0005387446,0.000010006178],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014559979,0.005711908,0.013474205,0.000040641422,0.00047890365,0.0006233117,0.009451322,0.0000049708206,0.591352,0.00032301602,0.13255453,0.23142524],"study_design_scores_gemma":[0.012884918,0.0058209617,0.0007262969,0.000006844812,0.00038789163,0.000116336385,0.00189049,0.0008841693,0.03001379,0.00037228706,0.9466585,0.00023750427],"about_ca_topic_score_codex":0.00021891954,"about_ca_topic_score_gemma":0.00052726513,"teacher_disagreement_score":0.81410396,"about_ca_system_score_codex":0.000047951566,"about_ca_system_score_gemma":0.00013954638,"threshold_uncertainty_score":0.99981785},"labels":[],"label_agreement":null},{"id":"W2890668257","doi":"10.1093/neuonc/noy139.090","title":"P01.048 A novel transducer array layout for delivering Tumor Treating Fields to the infratentorial brain at therapeutic levels","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neuroscience and Neural Engineering","field":"Neuroscience","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Transducer; Computer science; Medicine; Biomedical engineering; Acoustics; Physics","score_opus":0.07982424291848482,"score_gpt":0.3295257589355382,"score_spread":0.24970151601705337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890668257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96757084,0.000008396863,0.013970814,0.010147713,0.005657799,0.0010177365,0.00004170111,0.0001781562,0.0014068515],"genre_scores_gemma":[0.9649593,0.0000031798181,0.0002703311,0.032927655,0.0014201388,0.00016711926,5.629661e-7,0.00004857637,0.00020312375],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99775475,0.00013446016,0.00035261642,0.00075268804,0.00027278383,0.000732689],"domain_scores_gemma":[0.99751544,0.0017393122,0.00010869964,0.00037654382,0.000055745415,0.00020426915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029732595,0.000273841,0.00029792296,0.00011504455,0.00059651816,0.00007937459,0.00065956486,0.000106635714,0.00008025686],"category_scores_gemma":[0.0014542345,0.00020434125,0.00013373733,0.00045652778,0.0001850156,0.00020205742,0.00012201611,0.0003017514,0.00008464079],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001788838,0.000048340546,0.000014236469,0.000008339993,0.0000027591116,0.000018824283,0.0019445714,0.0005197451,0.991549,0.00035320304,0.00043143058,0.0049306266],"study_design_scores_gemma":[0.0008534215,0.0015602552,0.000089708505,0.000008647987,0.000015573087,0.00015124408,0.000045297405,0.00459026,0.7918688,0.000049132646,0.20055902,0.00020862123],"about_ca_topic_score_codex":0.000018323371,"about_ca_topic_score_gemma":0.00009362116,"teacher_disagreement_score":0.20012759,"about_ca_system_score_codex":0.000128473,"about_ca_system_score_gemma":0.00012075277,"threshold_uncertainty_score":0.83327943},"labels":[],"label_agreement":null},{"id":"W2891211750","doi":"10.1093/neuonc/noy139.025","title":"OS3.6 Development and validation of a DNA methylome-based predictor of meningioma recurrence and meningioma recurrence score","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Nomogram; DNA methylation; Oncology; Internal medicine; Meningioma; Cohort; Medicine; Proportional hazards model; Microarray; Bioinformatics; Computational biology; Biology; Gene; Surgery; Genetics; Gene expression","score_opus":0.027704484369472752,"score_gpt":0.31974196413130257,"score_spread":0.2920374797618298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891211750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948934,0.0003192183,0.0019976052,0.001227485,0.0003545574,0.0003232337,0.000004762414,0.000032199274,0.00084758067],"genre_scores_gemma":[0.9771266,0.00005325441,0.02236478,0.0002838017,0.000108882254,0.00002060612,0.00001635769,0.000014819231,0.000010904218],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983395,0.00019369,0.00054255774,0.0003871639,0.00029381338,0.00024327467],"domain_scores_gemma":[0.9984414,0.0005805482,0.00036798997,0.00020203098,0.00021218274,0.00019584768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079810113,0.00016691741,0.00050600915,0.00024101204,0.00007879971,0.000008648225,0.00011273227,0.00012691748,0.000032121614],"category_scores_gemma":[0.0016483282,0.00014716396,0.00003815355,0.00027077633,0.00064247387,0.000058871363,0.00009372191,0.00027787642,0.0000018104114],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058031466,0.0002238701,0.065849744,0.0004398851,0.000080205966,0.00006381254,0.0035360982,0.0000045283377,0.6446797,0.00030434693,0.0006643507,0.28357315],"study_design_scores_gemma":[0.0059524872,0.0064002676,0.037712194,0.00089847913,0.00030888725,0.00046588818,0.00018625241,0.008576037,0.86033535,0.00023234195,0.07859025,0.0003415811],"about_ca_topic_score_codex":0.000015941474,"about_ca_topic_score_gemma":0.0000023203818,"teacher_disagreement_score":0.28323156,"about_ca_system_score_codex":0.000055952034,"about_ca_system_score_gemma":0.00043033718,"threshold_uncertainty_score":0.6001172},"labels":[],"label_agreement":null},{"id":"W2891484912","doi":"10.1093/neuonc/noy132","title":"MGMT promoter methylation status testing to guide therapy for glioblastoma: refining the approach based on emerging evidence and current challenges","year":2018,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":343,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Epigenetics; Biomarker; DNA methylation; Methylation; Glioblastoma; Oncology; Methyltransferase; Medicine; Clinical Practice; Bioinformatics; Internal medicine; Biology; Gene; Cancer research; Genetics; Gene expression; Family medicine","score_opus":0.23212082194676248,"score_gpt":0.43766612720138737,"score_spread":0.2055453052546249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891484912","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00039491872,0.992292,0.0001350046,0.002452665,0.00047664193,0.0035903384,0.000015748006,0.00006980034,0.000572907],"genre_scores_gemma":[0.00041948527,0.99033153,0.0046352763,0.00069049187,0.0006359666,0.003160958,0.000027457754,0.00009432882,0.0000044806197],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997107,0.0005307437,0.0006591697,0.0009142815,0.0002847521,0.00050402316],"domain_scores_gemma":[0.9935126,0.0049586934,0.0004812651,0.0005576565,0.00029882215,0.00019098722],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010055082,0.00048721553,0.0013569202,0.00032021236,0.00020555328,0.000036987152,0.00016452116,0.00023039455,0.0000059271306],"category_scores_gemma":[0.002991772,0.00028386753,0.00023737218,0.00032613147,0.00007438936,0.000049641512,0.00008718847,0.0003959296,0.000011109656],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000117316216,0.00042424558,0.000033821085,0.002866412,0.00007940281,0.00001829037,0.00027692213,0.0000073511674,0.0000791557,0.000024084098,0.0007673645,0.99530566],"study_design_scores_gemma":[0.0011694651,0.007974372,0.00006863051,0.006912454,0.0007106059,0.00006123118,0.00003667362,0.0006662879,0.00006508918,0.0000088523575,0.98211235,0.000214007],"about_ca_topic_score_codex":0.000008770232,"about_ca_topic_score_gemma":0.000011133349,"teacher_disagreement_score":0.9950916,"about_ca_system_score_codex":0.00036831546,"about_ca_system_score_gemma":0.00053515204,"threshold_uncertainty_score":0.9999614},"labels":[],"label_agreement":null},{"id":"W2891665709","doi":"10.1093/neuonc/noy139.032","title":"OS5.1 Molecular subgroups of low- and high-grade gliomas diagnosed in the first year of life","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"ATP Synthase and ATPases Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Oncology; Internal medicine; Glioma; Retrospective cohort study; Cohort; Population; Histopathology; Pathology; Cancer research","score_opus":0.013562024839118118,"score_gpt":0.28886048042287177,"score_spread":0.27529845558375365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891665709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99762386,0.0004087626,0.00007255518,0.0010072385,0.00007513235,0.00021858212,0.000017153605,0.0000034024602,0.00057330093],"genre_scores_gemma":[0.99866086,0.00030581324,0.00011947306,0.0007045205,0.00014949705,0.000023651355,0.000015010653,0.000016142396,0.00000500043],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99886954,0.00021244251,0.00025410575,0.00027067316,0.00015571894,0.00023750108],"domain_scores_gemma":[0.999232,0.00017531546,0.00009964929,0.00035643342,0.00007260731,0.000063974614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002498948,0.00011213514,0.00022886932,0.00007486649,0.00003737168,0.0000058487626,0.0002892729,0.00018175399,0.000029750809],"category_scores_gemma":[0.0003865807,0.000088173656,0.00005828105,0.00018327266,0.00047156535,0.0000031465074,0.00017145192,0.00012607557,0.000005965364],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021453557,0.00023371103,0.01073854,0.000045844074,0.00002346722,0.0000810556,0.00014937104,0.0000040119257,0.98635757,0.0003229891,0.0009099513,0.00091896934],"study_design_scores_gemma":[0.0018187005,0.0027229688,0.012704639,0.000016930178,0.000016479853,0.000013394345,0.00027309314,0.000040812945,0.9508725,0.00011649979,0.031278837,0.0001251812],"about_ca_topic_score_codex":0.00010831848,"about_ca_topic_score_gemma":0.0002454485,"teacher_disagreement_score":0.03548509,"about_ca_system_score_codex":0.00000829215,"about_ca_system_score_gemma":0.0001221375,"threshold_uncertainty_score":0.3595617},"labels":[],"label_agreement":null},{"id":"W2897975460","doi":"10.1093/neuonc/noy170","title":"Viral and other therapies for recurrent glioblastoma: is a 24-month durable response unusual?","year":2018,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute of Neurological Disorders and Stroke; National Cancer Institute; National Institutes of Health; Amgen","keywords":"Glioblastoma; Medicine; Virology; Oncology; Cancer research","score_opus":0.05805621625914466,"score_gpt":0.3732452274658427,"score_spread":0.31518901120669807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897975460","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022732927,0.9905435,0.0000023793186,0.0023474898,0.0010525865,0.0030060008,0.00032070104,0.000076295415,0.00037777686],"genre_scores_gemma":[0.00008248211,0.99474806,0.00025202657,0.00218571,0.00057333475,0.0016566748,0.00003084092,0.00014388471,0.0003269814],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99725807,0.0005687434,0.0006402829,0.0008214947,0.00019369481,0.000517697],"domain_scores_gemma":[0.99683106,0.0018456848,0.00042745686,0.0005548873,0.00011348909,0.0002274049],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00045603648,0.00058422406,0.0022636766,0.00036350294,0.0001400842,0.000034045846,0.00015456142,0.0005634945,0.00015698501],"category_scores_gemma":[0.0003352353,0.00036062158,0.00054549385,0.00021841843,0.00023468075,0.000037886653,0.00009877594,0.00033616272,0.00011271824],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003990753,0.0010693099,0.00003141037,0.0031758042,0.0006900508,0.00026796584,0.00049878645,1.1530922e-8,0.0001710704,0.000081120575,0.083900265,0.90612346],"study_design_scores_gemma":[0.0034080332,0.021407615,0.000010600689,0.0019340551,0.001969793,0.0006019646,0.000034537683,0.0000042253528,0.00015378742,0.00005382847,0.9701468,0.00027478725],"about_ca_topic_score_codex":0.000009898584,"about_ca_topic_score_gemma":0.00005021034,"teacher_disagreement_score":0.9058487,"about_ca_system_score_codex":0.00034488583,"about_ca_system_score_gemma":0.00057672505,"threshold_uncertainty_score":0.99988455},"labels":[],"label_agreement":null},{"id":"W2899525399","doi":"10.1093/neuonc/noy148.1045","title":"SURG-09. AWAKE CRANIOTOMY FOR BRAIN TUMOR IN OCTOGENARIANS AND NONAGENARIANS","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Propofol; Remifentanil; Surgery; Craniotomy; Institutional review board; Anesthesia","score_opus":0.030455254860467813,"score_gpt":0.3153718078542733,"score_spread":0.2849165529938055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899525399","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9578153,0.000052658103,0.0010487243,0.020194113,0.0007078494,0.0015210344,0.000011845129,0.00007910042,0.018569378],"genre_scores_gemma":[0.98928064,0.0000047821827,0.0022133144,0.00682759,0.0007054076,0.00018671875,0.000017526168,0.000046065634,0.00071794784],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983328,0.00014754864,0.00038637916,0.0005062893,0.00014562122,0.0004813887],"domain_scores_gemma":[0.99879366,0.00052924565,0.000099617195,0.00031378958,0.000080929654,0.00018277057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005966147,0.00019612921,0.0004808468,0.0002552907,0.000110536486,0.000022215887,0.00012249834,0.00013318004,0.00014242649],"category_scores_gemma":[0.00040137686,0.0001806706,0.00007896272,0.00023035223,0.0001906314,0.000062734085,0.000102640864,0.00019242745,0.00004434802],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030862812,0.0012363637,0.087150276,0.0005178314,0.00022837949,0.01835231,0.004663198,0.0000060314956,0.67183506,0.012105042,0.15439896,0.04642023],"study_design_scores_gemma":[0.00704923,0.0040834555,0.02410247,0.000034778455,0.00010490249,0.001555301,0.0003783897,0.001347589,0.0030924126,0.00038040368,0.957626,0.00024508106],"about_ca_topic_score_codex":0.00004678913,"about_ca_topic_score_gemma":0.00013186998,"teacher_disagreement_score":0.803227,"about_ca_system_score_codex":0.000099782286,"about_ca_system_score_gemma":0.00017703022,"threshold_uncertainty_score":0.7367533},"labels":[],"label_agreement":null},{"id":"W2899592545","doi":"10.1093/neuonc/noy148.885","title":"PDTM-46. POLIOVIRUS RECEPTOR (CD155) EXPRESSION IN PEDIATRIC BRAIN TUMORS MEDIATES ONCOLYSIS OF MEDULLOBLASTOMA AND PLEOMORPHIC XANTHOASTROCYTOMA","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Cancer research; Oncolytic virus; Glioma; Biology; Pathology; Medicine; Virology; Immunology; Virus","score_opus":0.012056359443080885,"score_gpt":0.2896964221114844,"score_spread":0.2776400626684035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899592545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978216,0.00041471908,0.000066368695,0.0007619037,0.00018052562,0.00027237032,0.000026953665,0.000015359903,0.00044019535],"genre_scores_gemma":[0.99708885,0.00068396854,0.0008123929,0.0004730939,0.0007230182,0.000046116278,0.000030267556,0.0000348206,0.00010744979],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99771345,0.00044386752,0.0004651081,0.0005640153,0.0002541389,0.0005594389],"domain_scores_gemma":[0.99874043,0.00029147207,0.00022963555,0.00034445702,0.00013429266,0.00025969264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049844926,0.00022367213,0.00042425274,0.0003245462,0.00008986438,0.00001442481,0.00031313646,0.00031132542,0.00008657828],"category_scores_gemma":[0.0011340744,0.00020695258,0.00008177779,0.00037014676,0.00036429646,0.000011379165,0.00036083735,0.0002629868,0.000023802666],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006779713,0.000128657,0.023878513,0.00003252613,0.000012158456,0.00004306855,0.00013420789,0.0000040875516,0.96614283,0.0000071827903,0.0042125448,0.0047262213],"study_design_scores_gemma":[0.0019547627,0.0047484133,0.010410576,0.000021111508,0.000016805498,0.00008284971,0.00018981242,0.00012853154,0.96629107,0.000027124623,0.01591296,0.00021600969],"about_ca_topic_score_codex":0.000101801365,"about_ca_topic_score_gemma":0.0006010535,"teacher_disagreement_score":0.013467937,"about_ca_system_score_codex":0.00005110562,"about_ca_system_score_gemma":0.00036612773,"threshold_uncertainty_score":0.8439281},"labels":[],"label_agreement":null},{"id":"W2899594668","doi":"10.1093/neuonc/noy148.716","title":"NCOG-01. PRESERVATION OF NEUROCOGNITIVE FUNCTION (NCF) WITH HIPPOCAMPAL AVOIDANCE DURING WHOLE-BRAIN RADIOTHERAPY (WBRT) FOR BRAIN METASTASES: PRELIMINARY RESULTS OF PHASE III TRIAL NRG ONCOLOGY CC001","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Hôtel-Dieu de Montréal","funders":"","keywords":"Medicine; Neurocognitive; Internal medicine; Randomized controlled trial; Clinical endpoint; Radiation therapy; Memantine; Oncology; Surgery; Dementia; Disease; Cognition","score_opus":0.03719127935502972,"score_gpt":0.3496399232182937,"score_spread":0.312448643863264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899594668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97139823,0.00022459865,0.008311816,0.012146916,0.0008200982,0.0058503966,0.0006402063,0.00008158927,0.00052613264],"genre_scores_gemma":[0.98698145,0.00005470373,0.0064057405,0.0033583485,0.0012944251,0.00086610613,0.00060192094,0.0001015269,0.0003357941],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9957017,0.0012246894,0.0012244955,0.0008717611,0.00041478485,0.00056262815],"domain_scores_gemma":[0.99346644,0.0038442884,0.0012590992,0.0005966964,0.0006124521,0.00022104093],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013360869,0.0004255779,0.0013658063,0.00035928097,0.00018023109,0.000010858041,0.00018827082,0.00030046454,0.00009048657],"category_scores_gemma":[0.0017080308,0.00034746624,0.00028052673,0.0005087959,0.0005965766,0.00026044328,0.000071500945,0.00037140297,0.0000054162697],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.66414636,0.005157644,0.000056002726,0.00020276866,0.0006517294,0.00021063635,0.0012821575,0.000042486387,0.26439056,0.00008619042,0.01004537,0.053728104],"study_design_scores_gemma":[0.44840702,0.3160236,0.00085855345,0.0001263319,0.0012329994,0.00035591735,0.0006082586,0.000798921,0.06914815,0.00014172128,0.1620146,0.00028391444],"about_ca_topic_score_codex":0.000083447914,"about_ca_topic_score_gemma":0.000108539534,"teacher_disagreement_score":0.31086594,"about_ca_system_score_codex":0.00030143335,"about_ca_system_score_gemma":0.000832988,"threshold_uncertainty_score":0.9998977},"labels":[],"label_agreement":null},{"id":"W2899599875","doi":"10.1093/neuonc/noy148.528","title":"IMMU-25. PROGRAMMED CELL DEATH-LIGAND 1 (PD-L1) IS NOT EXPRESSED IN DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) TUMOR CELLS","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Glioma; Cancer research; Ligand (biochemistry); Programmed cell death; Chemistry; Biology; Apoptosis; Receptor; Biochemistry","score_opus":0.020519272324484906,"score_gpt":0.28258021935772065,"score_spread":0.26206094703323574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899599875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895955,0.00022388238,0.0000047129947,0.005043355,0.0008711145,0.00156072,0.000041839154,0.00013936122,0.0025195638],"genre_scores_gemma":[0.99310744,0.000104664454,0.0005980726,0.0050303815,0.0005414014,0.00041424527,0.000033155742,0.000085943466,0.00008469711],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969413,0.00019583336,0.0007147216,0.00088041974,0.00035978146,0.0009079314],"domain_scores_gemma":[0.9978633,0.00048561438,0.00027715426,0.0007684566,0.00020014141,0.00040531595],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022185376,0.00045975004,0.00095985114,0.00046313257,0.0001116647,0.000045566932,0.00026259624,0.0002731108,0.00027459214],"category_scores_gemma":[0.00017421438,0.00038626537,0.00020686947,0.00055834773,0.00024053638,0.000089779256,0.00021170531,0.00041402582,0.0004912631],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011725934,0.0067481673,0.016062198,0.00006330303,0.000060824903,0.0059537734,0.0007725477,3.5545162e-7,0.95003456,0.00003106119,0.007553996,0.011546601],"study_design_scores_gemma":[0.017750997,0.0049815564,0.018367983,0.000047404756,0.00019635723,0.00026375247,0.00008003431,0.000051151594,0.81083536,0.000030935127,0.14714406,0.00025041576],"about_ca_topic_score_codex":0.0002281035,"about_ca_topic_score_gemma":0.00013182037,"teacher_disagreement_score":0.13959007,"about_ca_system_score_codex":0.00027033433,"about_ca_system_score_gemma":0.00024989742,"threshold_uncertainty_score":0.9998589},"labels":[],"label_agreement":null},{"id":"W2899619720","doi":"10.1093/neuonc/noy148.1076","title":"TMIC-17. IMMUNE MICROENVIRONMENT OF NF2-ALTERED RADIATION-INDUCED MENINGIOMAS","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Western Hospital; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Immunohistochemistry; Immune system; Tumor microenvironment; Radiation therapy; Cancer research; Pathology; Medicine; Exome sequencing; Biology; Gene; Phenotype; Internal medicine; Immunology; Genetics","score_opus":0.027243710967553264,"score_gpt":0.2940254445578332,"score_spread":0.2667817335902799,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899619720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9740496,0.00020657347,0.00017780301,0.003360592,0.0009888348,0.00065258035,0.000004358429,0.000057710247,0.020501912],"genre_scores_gemma":[0.99617124,0.000022324664,0.0016607844,0.0007056191,0.00053203147,0.000043186952,0.000027885259,0.000036025758,0.0008009026],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99809724,0.00015781807,0.0006398001,0.0004278914,0.00027968918,0.00039754843],"domain_scores_gemma":[0.99872994,0.000118698415,0.0003301598,0.00058955717,0.000064723936,0.00016691427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032377394,0.00021340155,0.00056191755,0.00023473124,0.00009880033,0.000009064919,0.00019578682,0.00015295616,0.0008980615],"category_scores_gemma":[0.00011173141,0.00020087996,0.00014815565,0.00020779557,0.0001769308,0.000059415757,0.0001605692,0.00019880995,0.00023315543],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040937506,0.0002943292,0.0012326447,0.00003501397,0.000119996585,0.00037183712,0.000740934,0.0000020692687,0.9725002,0.00021863113,0.011315269,0.012759696],"study_design_scores_gemma":[0.0047892043,0.007112685,0.028378358,0.00003858445,0.0002934435,0.0007083176,0.00020563063,0.00035678706,0.5819618,0.00008159997,0.37582678,0.00024682377],"about_ca_topic_score_codex":0.000031928015,"about_ca_topic_score_gemma":0.00000302167,"teacher_disagreement_score":0.39053842,"about_ca_system_score_codex":0.00020872676,"about_ca_system_score_gemma":0.000114946735,"threshold_uncertainty_score":0.98331434},"labels":[],"label_agreement":null},{"id":"W2899651508","doi":"10.1093/neuonc/noy148.960","title":"RTHP-30. MANAGEMENT OF GLIOBLASTOMA IN THE ELDERLY - A 10-YEAR ANALYSIS OF THE BC CANCER AGENCY POPULATION","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Cohort; Internal medicine; Radiation therapy; Univariate analysis; Cancer; Cancer registry; Multivariate analysis; Population; Glioblastoma; Surgery; Oncology","score_opus":0.02058208041906901,"score_gpt":0.32238060223442394,"score_spread":0.30179852181535494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899651508","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99407625,0.00009894462,0.0000031299578,0.0021039501,0.00014485666,0.00043427668,0.000007607406,0.0000064448477,0.0031245323],"genre_scores_gemma":[0.9993532,0.000114571674,0.000046781748,0.00031485403,0.000046225006,0.000084015934,0.000005266969,0.000007442399,0.000027684144],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989896,0.0001554902,0.0003006084,0.00018613602,0.00022365876,0.00014451734],"domain_scores_gemma":[0.999216,0.00010745915,0.00019219331,0.0003885124,0.00007065584,0.000025161204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015251918,0.00009163118,0.00031856055,0.00020207334,0.00003774411,0.000002980777,0.00014202799,0.000063876985,0.0007991212],"category_scores_gemma":[0.000027597162,0.00005139291,0.00015172023,0.0009967512,0.00008963769,0.000018501216,0.00005054942,0.00007264165,0.000012607321],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059272896,0.0023635975,0.86877334,0.00012862872,0.0019694287,0.00017172768,0.0026989281,0.00033637506,0.017292282,0.002142138,0.003989215,0.09954158],"study_design_scores_gemma":[0.001565318,0.0022061525,0.9828358,0.000038681388,0.0022387756,0.0000043874716,0.00025678257,0.00035675746,0.004135574,0.000085742584,0.00622895,0.000047060486],"about_ca_topic_score_codex":0.0007150249,"about_ca_topic_score_gemma":0.001914084,"teacher_disagreement_score":0.11406245,"about_ca_system_score_codex":0.00009108247,"about_ca_system_score_gemma":0.000033999666,"threshold_uncertainty_score":0.8749817},"labels":[],"label_agreement":null},{"id":"W2899668992","doi":"10.1093/neuonc/noy148.124","title":"CBMT-05. ROLE OF THE let7-eEF2K AXIS IN MYC-DRIVEN MEDULLOBLASTOMA ADAPTATION TO NUTRIENT DEPRIVATION","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"microRNA; Untranslated region; Biology; Three prime untranslated region; Cancer research; Messenger RNA; Molecular biology; Gene; Genetics","score_opus":0.009849345950799797,"score_gpt":0.25543492278454066,"score_spread":0.24558557683374085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899668992","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963351,0.000050559505,0.0012885667,0.0010270653,0.00032416134,0.00047099448,0.000011362984,0.000009366869,0.0004828272],"genre_scores_gemma":[0.99823713,0.000013281614,0.00070905616,0.0006994717,0.00022531766,0.0000483203,0.000029119961,0.000018211807,0.000020075067],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99884635,0.0002041676,0.00029406324,0.00032111374,0.00014160422,0.00019271502],"domain_scores_gemma":[0.9991911,0.0000340729,0.00017026019,0.0003840939,0.00015667106,0.00006380711],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013150721,0.00011567318,0.00014320546,0.000081065366,0.00005096878,0.0000059548283,0.00023921028,0.0001780308,0.000024473677],"category_scores_gemma":[0.00030384975,0.000094063136,0.000065739245,0.00023343737,0.00011444616,0.0000054261727,0.00017671393,0.00007768943,0.00002310648],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021063945,0.00010869453,0.0028646125,0.0000069754064,0.000010098043,0.0000011728064,0.0003811577,0.0005711655,0.986141,0.00015504312,0.001058946,0.008490497],"study_design_scores_gemma":[0.00062327174,0.00082062505,0.031236425,0.000013148437,0.000013683082,0.0000127550475,0.00014569481,0.0011228028,0.84825635,0.00022451188,0.11742727,0.00010346944],"about_ca_topic_score_codex":0.000041000327,"about_ca_topic_score_gemma":0.0004792997,"teacher_disagreement_score":0.13788465,"about_ca_system_score_codex":0.00008811226,"about_ca_system_score_gemma":0.00018363996,"threshold_uncertainty_score":0.38357836},"labels":[],"label_agreement":null},{"id":"W2899678915","doi":"10.1093/neuonc/noy148.946","title":"RTHP-14. TUMOR-TREATING FIELDS FOR GLIOBLASTOMA: NUMERICAL SIMULATION EXPLORES SUB-CELLULAR MECHANISMS","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Photoreceptor and optogenetics research","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Kinesin; Multiphysics; Microtubule; Electric field; Biophysics; Materials science; Physics; Finite element method; Mechanics; Nanotechnology; Chemistry; Biology","score_opus":0.05480316101704988,"score_gpt":0.350625736378356,"score_spread":0.2958225753613061,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899678915","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.914269,0.0000119892575,0.0809966,0.00038938643,0.001308284,0.00077562267,0.000022216816,0.00013180907,0.0020951498],"genre_scores_gemma":[0.9963042,0.0000096037575,0.0012557806,0.0015824708,0.00058346504,0.00015580999,0.000004209629,0.000050727627,0.00005369581],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972951,0.00044237846,0.00041377966,0.00073407206,0.00044791723,0.00066674134],"domain_scores_gemma":[0.9965206,0.0025291217,0.00016164781,0.00038516553,0.00019223792,0.00021122929],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034654723,0.00022341785,0.00033999167,0.00017285858,0.00038175477,0.00006657082,0.0004642679,0.00019606522,0.00028865252],"category_scores_gemma":[0.0028612674,0.00020901948,0.00013964415,0.00036322174,0.00022510315,0.00012799918,0.00020810374,0.00031458677,0.00024059675],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041075642,0.0001518666,0.000073719086,0.000011128772,0.00000343878,0.000041877764,0.00032384665,0.0005875664,0.99062824,0.00070266944,0.00071362604,0.006351275],"study_design_scores_gemma":[0.00081165467,0.0038917053,0.000015895219,0.000004035152,0.000009986567,0.000022348973,0.00003889191,0.089802995,0.8753282,0.0019740008,0.02793047,0.00016982452],"about_ca_topic_score_codex":0.000007916875,"about_ca_topic_score_gemma":0.00001889615,"teacher_disagreement_score":0.11530004,"about_ca_system_score_codex":0.00011087705,"about_ca_system_score_gemma":0.00015101391,"threshold_uncertainty_score":0.8523567},"labels":[],"label_agreement":null},{"id":"W2899680932","doi":"10.1093/neuonc/noy148.404","title":"EXTH-56. CLINICALLY DELIVERABLE DEEP BRAIN STIMULATOR GENERATED ELECTRICAL FIELDS HAVE PROFOUND EFFECTS ON GLIOBLASTOMA MULTIFORME CELL LINES","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neuroscience and Neural Engineering","field":"Neuroscience","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Cell cycle; Viability assay; Cell growth; Deep brain stimulation; Cell; Cell culture; Glioblastoma; Medicine; Cancer research; U87; Biomedical engineering; Pathology; Biology; Internal medicine; Cancer; Parkinson's disease","score_opus":0.02656223905121688,"score_gpt":0.3171566067505411,"score_spread":0.29059436769932423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899680932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99299264,0.000016166548,0.0008539274,0.0012152356,0.0024351196,0.00075949315,0.000004364671,0.0003387024,0.0013843396],"genre_scores_gemma":[0.9740336,0.000050979314,0.0003105814,0.02404858,0.001069633,0.00006537628,0.0000011692368,0.00006546764,0.0003546397],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99614644,0.0004991991,0.0006345528,0.0012274215,0.00045083658,0.0010415638],"domain_scores_gemma":[0.99422127,0.0045790914,0.00020963873,0.0005125005,0.00010597558,0.00037154628],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000297334,0.00042593735,0.0005192744,0.0002675208,0.0004179592,0.00009845638,0.0006885452,0.0003938598,0.00006661697],"category_scores_gemma":[0.003491206,0.00037317254,0.00018600583,0.0007157021,0.0002730867,0.00027437042,0.00020504853,0.0009539222,0.00045180682],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006182444,0.00031850152,0.000102905906,0.000020581285,0.0000027184685,0.0005693031,0.00012479,0.000739227,0.9834685,0.000065930624,0.0017804231,0.012188875],"study_design_scores_gemma":[0.0014929876,0.012346403,0.00009516494,0.000011078125,0.0000159677,0.00011403959,0.000004191846,0.124038406,0.845136,0.000050501178,0.016376156,0.00031912795],"about_ca_topic_score_codex":0.00000757107,"about_ca_topic_score_gemma":0.000026275116,"teacher_disagreement_score":0.13833253,"about_ca_system_score_codex":0.00012670922,"about_ca_system_score_gemma":0.00018963107,"threshold_uncertainty_score":0.999872},"labels":[],"label_agreement":null},{"id":"W2899685235","doi":"10.1093/neuonc/noy148.358","title":"EXTH-09. DIANHYDROGALACTITOL (VAL-083) HAS THE POTENTIAL TO OVERCOME MAJOR CHALLENGES IN THE TREATMENT OF DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Delmar (Canada)","funders":"","keywords":"In vivo; Cancer research; Combination therapy; Medicine; Radiation therapy; Pharmacology; IC50; Cell culture; Biology; Internal medicine; Genetics","score_opus":0.04265341174979834,"score_gpt":0.3047942839018642,"score_spread":0.26214087215206583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899685235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92854375,0.0015613947,0.0000027515619,0.06618323,0.00071485364,0.0014504462,0.00001564942,0.000035796304,0.0014921359],"genre_scores_gemma":[0.99626464,0.0011999604,0.00005784523,0.0011944397,0.0008089161,0.0004064675,0.000008954392,0.000036534664,0.00002224996],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978345,0.00036886567,0.00046082007,0.0004943907,0.0003514428,0.00049000006],"domain_scores_gemma":[0.9980573,0.00067321426,0.00016388993,0.000846926,0.0000985126,0.00016012484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022926477,0.00031675905,0.00066273997,0.00028484873,0.00015243943,0.000026174972,0.00026918243,0.00016747684,0.00014123453],"category_scores_gemma":[0.00013492443,0.00016819274,0.00021734873,0.0003941444,0.00035459723,0.000052842905,0.0000849625,0.00017163948,0.00015952541],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004159372,0.03416923,0.021348013,0.00008243175,0.00084671006,0.009366797,0.02714234,0.0000103425855,0.45251936,0.0013976702,0.006458434,0.4424993],"study_design_scores_gemma":[0.025087865,0.041641258,0.3494256,0.00007261678,0.0010740473,0.0018154113,0.0022364121,0.0000654432,0.09253986,0.00025514068,0.48541918,0.0003671539],"about_ca_topic_score_codex":0.0003336511,"about_ca_topic_score_gemma":0.0012508618,"teacher_disagreement_score":0.47896075,"about_ca_system_score_codex":0.00027475582,"about_ca_system_score_gemma":0.0001343449,"threshold_uncertainty_score":0.6858701},"labels":[],"label_agreement":null},{"id":"W2899686888","doi":"10.1093/neuonc/noy148.1021","title":"STEM-14. GROWTH FACTOR RECEPTOR CO-INHERITANCE DURING ASYMMETRIC CELL DIVISION DRIVES THE CANCER STEM CELL PHENOTYPE","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Stem cell; Biology; Cancer stem cell; Cell biology; Cell division; Mitosis; Asymmetric cell division; Cancer research; Cell fate determination; Growth factor; Receptor; Cell; Transcription factor; Genetics; Gene","score_opus":0.026355352018920933,"score_gpt":0.2953011207182357,"score_spread":0.2689457686993148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899686888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9735844,0.0032883317,0.00010207205,0.0019663428,0.0032587608,0.00080903224,0.000087963665,0.00011634973,0.016786756],"genre_scores_gemma":[0.99129856,0.0030879057,0.0002204524,0.0017850759,0.0012213176,0.000083167215,0.000006383882,0.00008291799,0.002214214],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99750113,0.00027647882,0.00046052077,0.00070867693,0.00042425777,0.0006289204],"domain_scores_gemma":[0.99813104,0.0004013402,0.00032330366,0.00059145514,0.00027800348,0.0002748453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021090619,0.0003285725,0.0006215277,0.00018965387,0.0002970118,0.000032002794,0.00036229074,0.00021413527,0.00084943854],"category_scores_gemma":[0.000034012304,0.00023305243,0.00017340654,0.0006890457,0.00032137698,0.000103062295,0.00015829365,0.00054571725,0.00040847558],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005642949,0.00032767042,0.011446975,0.00024878973,0.000046851586,0.000050864295,0.0016912927,0.0000019664683,0.89347833,0.000017835928,0.0126895765,0.079435535],"study_design_scores_gemma":[0.002334616,0.0015823954,0.010147417,0.000037560258,0.000100044104,0.000014196474,0.00037687196,0.000014678154,0.64009416,0.0000055354144,0.3450717,0.00022080271],"about_ca_topic_score_codex":0.00016662302,"about_ca_topic_score_gemma":0.000105044644,"teacher_disagreement_score":0.3323821,"about_ca_system_score_codex":0.0004582376,"about_ca_system_score_gemma":0.00038335889,"threshold_uncertainty_score":0.95036024},"labels":[],"label_agreement":null},{"id":"W2899687079","doi":"10.1093/neuonc/noy148.628","title":"MNGI-12. EXPRESSION OF PROGRAMMED CELL DEATH LIGAND-1 (PD-L1) IN MENINGIOMA: CLINICAL UTILITY FOR PREDICTION OF TUMOR RECURRENCE AND ASSOCIATION WITH HYPOXIC RESPONSE AND NFKB2 ACTIVATION","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Western Hospital; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Meningioma; Immunohistochemistry; Univariate analysis; Medicine; Hypoxia (environmental); Internal medicine; Oncology; Tumor hypoxia; Pathology; Cancer research; Multivariate analysis; Chemistry","score_opus":0.03096945953902957,"score_gpt":0.2924236436807877,"score_spread":0.26145418414175814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899687079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99677247,0.000045690387,0.002066847,0.00003282978,0.00026527402,0.00065729266,0.000040505343,0.000044688226,0.00007442524],"genre_scores_gemma":[0.99709016,0.000052115167,0.0026925784,0.000014840813,0.00005910974,0.0000618873,0.00000893589,0.00001734722,0.000003048696],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988863,0.000114792296,0.0004587994,0.00021854888,0.0001348709,0.00018670125],"domain_scores_gemma":[0.9980936,0.0013345642,0.0002702677,0.00012905426,0.00011914942,0.000053370288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090375816,0.00011609672,0.00030525815,0.0001069948,0.000031783802,0.000006455199,0.000058519803,0.00019506538,0.0000014443198],"category_scores_gemma":[0.0006897634,0.00010528975,0.000026822483,0.00013716082,0.00009188951,0.00015191972,0.000025797466,0.00017129704,1.7716738e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004511425,0.00011511854,0.10186602,0.000113085705,0.00001132467,0.0000014835094,0.00051606365,0.000017113993,0.88535416,0.0000039423985,0.00007749601,0.0074127675],"study_design_scores_gemma":[0.0032967734,0.0042743343,0.13599545,0.00008831849,0.000038296195,0.0000063501298,0.000053654083,0.0056170803,0.8483685,0.00013304489,0.0020378537,0.00009029905],"about_ca_topic_score_codex":0.000006209456,"about_ca_topic_score_gemma":0.00001938783,"teacher_disagreement_score":0.036985613,"about_ca_system_score_codex":0.00014341202,"about_ca_system_score_gemma":0.00009194971,"threshold_uncertainty_score":0.42935914},"labels":[],"label_agreement":null},{"id":"W2899690379","doi":"10.1093/neuonc/noy148.1121","title":"TMOD-08. GROWTH IMPAIRMENT UNDER CONDITIONS FAVORING MITOCHONDRIAL OXIDATIVE METABOLISM IN A YEAST MODEL OF CANCER-ASSOCIATED ISOCITRATE DEHYDROGENASE MUTATION","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Microbial Metabolic Engineering and Bioproduction","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Isocitrate dehydrogenase; IDH1; Biology; IDH2; Mutant; Biochemistry; Saccharomyces cerevisiae; Isocitrate lyase; Wild type; Yeast; Molecular biology; Gene; Metabolism; Enzyme; Glyoxylate cycle","score_opus":0.012818007117168276,"score_gpt":0.27637479913113006,"score_spread":0.26355679201396176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899690379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962368,0.00013555978,0.0021007515,0.00021472044,0.0007669312,0.00027736364,0.00013873882,0.000020332094,0.000108829845],"genre_scores_gemma":[0.99810296,0.00015841222,0.000755011,0.00020671236,0.00052986364,0.00006978683,0.00011678382,0.000022714203,0.0000377797],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988717,0.00013268889,0.000325564,0.00031980494,0.000091024915,0.00025925066],"domain_scores_gemma":[0.9993917,0.00000878158,0.00019076615,0.00015541297,0.00019173705,0.00006160659],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013574607,0.00015893481,0.00025432685,0.000102712336,0.00005943513,0.0000071749105,0.00010915502,0.00020954234,0.000015031319],"category_scores_gemma":[0.00011043116,0.00016331501,0.0000794119,0.00020811119,0.00012961491,0.000009511959,0.00005005931,0.00013859477,0.0000046113123],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012240923,0.0002037503,0.000061431274,0.000009485646,0.00006877507,0.000001848712,0.00032170344,0.008254215,0.9902736,0.00017366928,0.0002825189,0.00022662361],"study_design_scores_gemma":[0.0014341888,0.00041781808,0.0005955437,0.000010929253,0.00006263369,0.000009943596,0.00010837866,0.0031355321,0.99315375,0.00020968769,0.0007073839,0.000154226],"about_ca_topic_score_codex":0.00022011298,"about_ca_topic_score_gemma":0.00048468192,"teacher_disagreement_score":0.005118683,"about_ca_system_score_codex":0.00008767957,"about_ca_system_score_gemma":0.00022917605,"threshold_uncertainty_score":0.66597927},"labels":[],"label_agreement":null},{"id":"W2899734820","doi":"10.1093/neuonc/noy148.345","title":"EPID-18. MALIGNANT PRIMARY BRAIN AND OTHER CENTRAL NERVOUS SYSTEM TUMOURS DIAGNOSED AMONG THE CANADIAN POPULATION FROM 2009 TO 2013","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Central nervous system; Medicine; Population; Primary (astronomy); Oncology; Internal medicine; Environmental health","score_opus":0.01805945505709355,"score_gpt":0.2682606130221059,"score_spread":0.25020115796501236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899734820","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9707751,0.00018873207,0.0000052971604,0.025203519,0.0007150386,0.0010723447,0.00007100334,0.000049769867,0.0019191945],"genre_scores_gemma":[0.9810791,0.000010808249,0.00009856956,0.017963994,0.0006168818,0.00011798034,0.00004971774,0.000036191417,0.000026752634],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983964,0.00024669152,0.00027797843,0.00039785245,0.00016991558,0.0005111748],"domain_scores_gemma":[0.9985196,0.00042091374,0.00010851255,0.0003392513,0.00005604504,0.0005556693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017218912,0.00019505306,0.00038343962,0.00013532401,0.00022639568,0.00003681475,0.00010391642,0.00015885783,0.00016658456],"category_scores_gemma":[0.000121839264,0.00013312868,0.00006085272,0.00014807886,0.00011895211,0.000042212047,0.000041983458,0.00014015465,0.0001120233],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011049418,0.00016259954,0.88627046,0.000017969423,0.00006833264,0.0012550353,0.0008635141,0.000016508653,0.0059297355,0.0001859879,0.08433591,0.020783458],"study_design_scores_gemma":[0.0013792388,0.0008110515,0.930132,0.0000616981,0.00013424558,0.00009803919,0.00013996844,0.00013867512,0.0009091684,0.000018137825,0.06606369,0.0001141306],"about_ca_topic_score_codex":0.45485422,"about_ca_topic_score_gemma":0.5819518,"teacher_disagreement_score":0.12709755,"about_ca_system_score_codex":0.000739242,"about_ca_system_score_gemma":0.00023297487,"threshold_uncertainty_score":0.548776},"labels":[],"label_agreement":null},{"id":"W2899762883","doi":"10.1093/neuonc/noy148.974","title":"RBTT-04. DOES EXERCISE IMPROVE PROGRESSION FREE SURVIVAL AND QUALITY OF LIFE IN PATIENTS WITH GLIOBLASTOMA? A TRIAL IN PROGRESS","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; McMaster University; Toronto Western Hospital; Princess Margaret Cancer Centre; University of British Columbia","funders":"","keywords":"Medicine; Quality of life (healthcare); Adverse effect; Physical therapy; Neurocognitive; Mood; Randomized controlled trial; Progression-free survival; Actigraphy; Clinical trial; Cognition; Internal medicine; Psychiatry; Overall survival","score_opus":0.019157233636498534,"score_gpt":0.3300420864897643,"score_spread":0.3108848528532658,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899762883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99452734,0.00012564518,0.0000017231725,0.0008655099,0.0007881119,0.0031467283,0.000028623504,0.000038828617,0.00047747872],"genre_scores_gemma":[0.9991001,0.000045734672,0.00014980044,0.00015312909,0.00021022515,0.00029831246,0.0000057074963,0.000027113809,0.000009869131],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976784,0.00034636646,0.00067373354,0.0004915133,0.00042791423,0.00038205125],"domain_scores_gemma":[0.99850386,0.0003601791,0.00039150994,0.00029091636,0.00031359235,0.00013995264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005270757,0.00022721356,0.0009226358,0.0002564677,0.000046515397,0.0000068901995,0.000106024796,0.00020016158,0.000021824952],"category_scores_gemma":[0.0011337538,0.00015094923,0.00004488981,0.0003737926,0.000810794,0.00009459741,0.0002330455,0.00035600446,0.0000025729405],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2662679,0.002185929,0.68955183,0.00017070898,0.00004562363,0.000021961332,0.00090865104,1.0174573e-7,0.0014544592,0.000010717796,0.00016709071,0.03921503],"study_design_scores_gemma":[0.20982812,0.04166866,0.743299,0.0004587226,0.000104496394,0.000001967863,0.000470797,0.000016414246,0.0032619138,0.00005355587,0.0006187083,0.00021762415],"about_ca_topic_score_codex":0.00014454844,"about_ca_topic_score_gemma":0.0021149458,"teacher_disagreement_score":0.05643975,"about_ca_system_score_codex":0.00017061796,"about_ca_system_score_gemma":0.0003080406,"threshold_uncertainty_score":0.6155531},"labels":[],"label_agreement":null},{"id":"W2899768010","doi":"10.1093/neuonc/noz036.198","title":"MEDU-40. MATCHING OF SINGLE CELL TRANSCRIPTOMICS FROM CEREBELLAR DEVELOPMENT IDENTIFIES PUTATIVE SUBGROUP SPECIFIC CELLS OF ORIGIN FOR MEDULLOBLASTOMA","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of Calgary; Hospital for Sick Children; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Biology; Medulloblastoma; Population; Cerebellum; Lineage markers; Single-cell analysis; Cell sorting; Progenitor cell; Stem cell; Genetics; Cell; Neuroscience","score_opus":0.01767454300854074,"score_gpt":0.26982320938251136,"score_spread":0.2521486663739706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899768010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96132153,0.00063245196,0.035174284,0.00007389644,0.001017483,0.00090695475,0.00016486755,0.000012694029,0.00069585006],"genre_scores_gemma":[0.98956156,0.00025102065,0.009430294,0.00012739764,0.000102561855,0.000054151187,0.0002214543,0.00007608,0.00017550601],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978067,0.00019787744,0.0006100986,0.0006485271,0.00030771672,0.00042903],"domain_scores_gemma":[0.99868375,0.00019365993,0.00033134044,0.00042681757,0.00025316613,0.000111269386],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030413066,0.00025830092,0.0005084275,0.0001389363,0.0000536769,0.000015707166,0.00042580094,0.00038171574,0.00009802214],"category_scores_gemma":[0.00003468709,0.0002776758,0.00019744108,0.0001511858,0.00013511076,0.000008541224,0.00015371763,0.0002169322,0.000023702514],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092539075,0.00027499624,0.000018538572,0.00012160268,0.00011263806,0.000008585218,0.0009312229,0.0005826176,0.9940817,0.00005769057,0.0006059082,0.00227916],"study_design_scores_gemma":[0.0017465805,0.0013279216,0.000023042781,0.000020681196,0.000033540604,0.000006144579,0.00052116753,0.000059670805,0.9034704,0.00025899202,0.092324756,0.00020713378],"about_ca_topic_score_codex":0.00005023276,"about_ca_topic_score_gemma":0.000088685156,"teacher_disagreement_score":0.091718845,"about_ca_system_score_codex":0.00013692651,"about_ca_system_score_gemma":0.00049596466,"threshold_uncertainty_score":0.9999675},"labels":[],"label_agreement":null},{"id":"W2899795015","doi":"10.1093/neuonc/noz126.359","title":"P14.124 EORTC 1709/CCTG CE.8: A phase III trial of marizomib in combination with standard temozolomide-based radiochemotherapy versus standard temozolomide-based radiochemotherapy alone in patients with newly diagnosed glioblastoma","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Temozolomide; Medicine; Oncology; Internal medicine; Population; Dacarbazine; Radiation therapy; Randomized controlled trial; Glioma; Phases of clinical research; Quality of life (healthcare); Performance status; Cancer; Clinical trial; Chemotherapy; Surgery; Cancer research","score_opus":0.009241219352810219,"score_gpt":0.2747187578403678,"score_spread":0.2654775384875576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899795015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98919934,0.00012019615,0.0001840249,0.001992637,0.0006020943,0.0074125696,0.00015441628,0.00010043067,0.00023429417],"genre_scores_gemma":[0.9964306,0.00007169665,0.001333514,0.001106466,0.00008193123,0.0005378691,0.00026851328,0.00016115855,0.000008286793],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9950947,0.0005608691,0.0012524505,0.0011098929,0.0011321408,0.0008499507],"domain_scores_gemma":[0.99589115,0.0015552394,0.00086146255,0.00094600633,0.00041689555,0.0003292595],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006466386,0.000750884,0.0022993872,0.0010876199,0.00007455932,0.00003722499,0.00028533398,0.00047125944,0.00028016896],"category_scores_gemma":[0.0002062204,0.00060497195,0.00021623659,0.0011833316,0.00033921373,0.00016993292,0.00003098116,0.00058475643,0.000010108197],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.80971926,0.013649286,0.13779812,0.000108096945,0.00031189676,0.0007060996,0.0003929297,0.0005447988,0.013395412,0.000036218087,0.0006251762,0.02271267],"study_design_scores_gemma":[0.72962075,0.1744007,0.010410637,0.00026195263,0.00021206199,0.000009362585,0.00009441662,0.00045102215,0.081300944,0.000015931531,0.002779796,0.00044238617],"about_ca_topic_score_codex":0.00023193638,"about_ca_topic_score_gemma":0.0006683948,"teacher_disagreement_score":0.16075142,"about_ca_system_score_codex":0.002179155,"about_ca_system_score_gemma":0.0018992539,"threshold_uncertainty_score":0.99964017},"labels":[],"label_agreement":null},{"id":"W2899817298","doi":"10.1093/neuonc/noy148.681","title":"PATH-25. SURVIVAL STRATIFICATION OF IDH MUTANT GLIOMA USING METHYLATION AND mRNA ANALYSIS OF HOX GENES","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Food Quality and Safety Studies","field":"Agricultural and Biological Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Western Hospital; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Hox gene; Biology; Methylation; Glioma; Gene; Hazard ratio; Cancer research; Genetics; Molecular biology; Oncology; Gene expression; Internal medicine; Medicine; Confidence interval","score_opus":0.08373638907665247,"score_gpt":0.3234200550005184,"score_spread":0.23968366592386592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899817298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985154,0.00014716428,0.000040527593,0.0007488535,0.00012162671,0.00008849492,0.000043223616,0.000010511723,0.000284198],"genre_scores_gemma":[0.9995625,0.000106145264,0.00017829021,0.000041835294,0.000090957285,0.0000014502848,0.000016799184,5.040775e-7,0.0000015220811],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989085,0.0003116472,0.00033211277,0.00020250354,0.00013186972,0.000113317314],"domain_scores_gemma":[0.9989546,0.00052473525,0.00026823673,0.00005176534,0.0001698661,0.000030798066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003921525,0.00007829253,0.00033480753,0.000038998078,0.000117891206,0.0000063685443,0.000084349565,0.00009177712,0.000046869896],"category_scores_gemma":[0.00011734591,0.000035244688,0.00007457582,0.00066564296,0.00024971846,0.000057660534,0.000048122936,0.000044173798,8.637396e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053004573,0.00005807031,0.0064063887,0.0000065700206,0.00010088068,0.0000011406519,0.0003268896,0.000010975862,0.9585867,0.0006208738,0.0000035765738,0.033824958],"study_design_scores_gemma":[0.00026887114,0.002784402,0.4704621,0.000007754978,0.00066120236,0.0000070718816,0.0025306062,0.003927659,0.5152316,0.0007940688,0.0031269619,0.00019763959],"about_ca_topic_score_codex":0.00038828352,"about_ca_topic_score_gemma":0.0020892639,"teacher_disagreement_score":0.46405575,"about_ca_system_score_codex":0.000013690989,"about_ca_system_score_gemma":0.000011616566,"threshold_uncertainty_score":0.14372367},"labels":[],"label_agreement":null},{"id":"W2899848229","doi":"10.1093/neuonc/noy148.447","title":"GENE-21. A COMMON FETAL DEVELOPMENTAL ORIGIN FOR PFA EPENDYMOMA, PFB EPENDYMOMA, AND CEREBELLAR PILOCYTIC ASTROCYTOMAS?","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Phytoplasmas and Hemiptera pathogens","field":"Agricultural and Biological Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Calgary; McGill University; Hospital for Sick Children; Montreal Children's Hospital; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Biology; Progenitor cell; Ependymoma; Population; Stem cell; Progenitor; Cerebellum; Neuroscience; Cell biology; Pathology","score_opus":0.035206359652087675,"score_gpt":0.26987416264269637,"score_spread":0.2346678029906087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899848229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994279,0.00008080413,0.000015867,0.0008838664,0.00052568095,0.0005156183,0.00015642337,0.000086249536,0.0034564445],"genre_scores_gemma":[0.9951887,0.00002465079,0.0023381268,0.0012475685,0.0009044796,0.00007759797,0.000082237864,0.000005098463,0.0001315432],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99807405,0.00011346836,0.00036971315,0.000621549,0.00017951128,0.0006417017],"domain_scores_gemma":[0.9989506,0.00046657713,0.0001549017,0.00008347587,0.00008705911,0.0002573687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021987074,0.000292298,0.0004524821,0.000027850754,0.0005239091,0.0000661946,0.00031374217,0.00023159977,0.00033558116],"category_scores_gemma":[0.000052772906,0.0001419439,0.00011263791,0.00017637877,0.00024081932,0.00012648612,0.00021317427,0.00019627051,0.00013279059],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037406888,0.00018485269,0.02279546,0.000012762646,0.000031195425,0.00025069472,0.00016370289,3.6613594e-7,0.85777897,0.00021938412,0.0030995824,0.115088984],"study_design_scores_gemma":[0.00189302,0.0059666196,0.045316674,0.000015860087,0.00007255819,0.00341317,0.00027695525,0.0003546964,0.25778896,0.0007683673,0.68349624,0.0006368958],"about_ca_topic_score_codex":0.000035021418,"about_ca_topic_score_gemma":0.0020677946,"teacher_disagreement_score":0.6803967,"about_ca_system_score_codex":0.00011644962,"about_ca_system_score_gemma":0.00008229567,"threshold_uncertainty_score":0.5788304},"labels":[],"label_agreement":null},{"id":"W2899858004","doi":"10.1093/neuonc/noy148.444","title":"GENE-18. DIVERGENT CLONAL EVOLUTION OF MELANOMA BRAIN METASTASES DURING TREATMENT WITH IMMUNOTHERAPY","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Toronto Western Hospital; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Immunotherapy; Melanoma; CD8; Cancer research; CDKN2A; Immune checkpoint; Tumor microenvironment; Biology; Exome sequencing; Somatic evolution in cancer; Immune system; Medicine; Immunology; Cancer; Gene; Mutation; Internal medicine; Genetics","score_opus":0.024871509586972984,"score_gpt":0.30064076716428056,"score_spread":0.2757692575773076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899858004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952475,0.0009924421,0.00025686662,0.0016598522,0.0002612055,0.0006422272,0.00009456233,0.0000487825,0.00079660496],"genre_scores_gemma":[0.99391776,0.0002324812,0.0046866136,0.0004851781,0.00029032226,0.00008759712,0.000052654515,0.000036976402,0.0002104423],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99842787,0.0002451507,0.00034283916,0.00039498284,0.00024881327,0.00034034517],"domain_scores_gemma":[0.99894565,0.00018048822,0.00020266035,0.00040152826,0.00012402785,0.0001456402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015135555,0.00025444594,0.0005735382,0.0001508126,0.0001244749,0.0000055749065,0.00007894291,0.00008941487,0.00084386044],"category_scores_gemma":[0.00002784615,0.0001722057,0.00016894347,0.00018771878,0.00026647205,0.00004764977,0.000039660517,0.00009156331,0.000042780714],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0065338127,0.0033026165,0.03709111,0.000043162745,0.001592455,0.0011201326,0.0006927807,0.00001822986,0.9049938,0.00042081423,0.0010405364,0.043150574],"study_design_scores_gemma":[0.023552965,0.07050156,0.090192914,0.000043712553,0.0009903399,0.0025668156,0.0002773254,0.00007369847,0.6200261,0.000118606906,0.19133341,0.00032253793],"about_ca_topic_score_codex":0.0002925578,"about_ca_topic_score_gemma":0.00010221223,"teacher_disagreement_score":0.28496766,"about_ca_system_score_codex":0.0006595341,"about_ca_system_score_gemma":0.00034280863,"threshold_uncertainty_score":0.923968},"labels":[],"label_agreement":null},{"id":"W2899864286","doi":"10.1093/neuonc/noy148.869","title":"PDTM-28. THE CONTRIBUTION OF PAX GENES AS NOVEL TUMOR SUPPRESSORS IN GROUP 3 MEDULLOBLASTOMA","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Ottawa Hospital; University of Manitoba","funders":"","keywords":"Gene silencing; Biology; H3K4me3; Transcription factor; Psychological repression; Gene; Gene knockdown; Cancer research; Medulloblastoma; Tumor progression; Histone; PAX6; Gene expression; Genetics; Promoter","score_opus":0.007132682933297351,"score_gpt":0.2599134212055321,"score_spread":0.2527807382722348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899864286","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99510986,0.00053634134,0.00013466636,0.0011460859,0.00069541665,0.00023221836,0.000013619146,0.000008702572,0.0021230937],"genre_scores_gemma":[0.99775654,0.0003418545,0.000048362337,0.0013770619,0.00034831674,0.000033614593,0.000028614044,0.000014915306,0.00005071686],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988907,0.00014628161,0.0002762846,0.000294692,0.00011167103,0.00028038942],"domain_scores_gemma":[0.99936056,0.00006486821,0.00015766281,0.0002458166,0.00011272248,0.000058344547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019772364,0.00013405898,0.00020673065,0.000044817294,0.000064780215,0.000005771755,0.00025338138,0.00023572562,0.000036296075],"category_scores_gemma":[0.0001702493,0.00009267225,0.00008493746,0.00013846974,0.0004153618,0.0000035062244,0.00011651398,0.00017215156,0.000020859543],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048074804,0.000099999386,0.00083505106,0.0000051707843,0.000034753237,0.000015739803,0.00006506392,0.000051017578,0.99419105,0.00035394647,0.0013323083,0.002535132],"study_design_scores_gemma":[0.0011901851,0.001947928,0.0012285663,0.0000090598,0.000020725014,0.0001412022,0.00006514315,0.000090585425,0.7369777,0.00008396785,0.25814992,0.0000950234],"about_ca_topic_score_codex":0.00010237631,"about_ca_topic_score_gemma":0.00033223105,"teacher_disagreement_score":0.25721338,"about_ca_system_score_codex":0.000038886465,"about_ca_system_score_gemma":0.00016150017,"threshold_uncertainty_score":0.37790647},"labels":[],"label_agreement":null},{"id":"W2899874060","doi":"10.1093/neuonc/noy148.452","title":"GENE-26. MOLECULAR CHARACTERIZATION OF BENIGN AND MALIGNANT PERIPHERAL NERVE SHEATH TUMORS THAT OCCUR IN SPORADIC AND SYNDROMIC SETTINGS","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Western Hospital; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"CDKN2A; Neurofibromatosis; Pathology; Neurofibroma; Malignant peripheral nerve sheath tumor; Biology; Plexiform neurofibroma; Cancer research; Medicine; Gene; Genetics","score_opus":0.013398232685898478,"score_gpt":0.26039333330421094,"score_spread":0.24699510061831245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899874060","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976815,0.00021114055,0.000007665373,0.0014291944,0.000112321766,0.0004363971,0.000014113554,0.000022952812,0.00008469739],"genre_scores_gemma":[0.99853265,0.00012230797,0.00021352519,0.0009897358,0.000049385588,0.000032658427,0.000029290155,0.000027107444,0.0000033349938],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9989722,0.000083300394,0.00026034558,0.0003505624,0.00011054109,0.00022306124],"domain_scores_gemma":[0.99949175,0.000044633853,0.0001381603,0.00016922645,0.000042229167,0.00011402808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001229804,0.00015701403,0.00044291862,0.00014436986,0.000035968398,0.000009880211,0.000041996424,0.000111494825,0.000033755783],"category_scores_gemma":[0.00003146186,0.00013495283,0.000037991333,0.00011843697,0.0001654243,0.00005669784,0.000049968592,0.00009606672,0.0000029179462],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011941319,0.00020101554,0.17925708,0.000039955787,0.000022360657,0.0015383426,0.0005223731,4.4788197e-7,0.8148227,0.000056562796,0.000028928383,0.0033908475],"study_design_scores_gemma":[0.003594966,0.0030512165,0.5477879,0.00010443578,0.00012549126,0.0018627966,0.00009671192,0.0003663875,0.4415298,0.000039074996,0.0013046801,0.00013648854],"about_ca_topic_score_codex":0.000057419624,"about_ca_topic_score_gemma":0.000013797667,"teacher_disagreement_score":0.37329286,"about_ca_system_score_codex":0.000078587786,"about_ca_system_score_gemma":0.00008039153,"threshold_uncertainty_score":0.5503217},"labels":[],"label_agreement":null},{"id":"W2899883991","doi":"10.1093/neuonc/noy148.844","title":"PDTM-02. STRESS GRANULES ARE INDUCED BY OXIDATIVE STRESS IN PEDIATRIC BRAIN TUMORS AND PREDICT POOR OUTCOME","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Thermal Regulation in Medicine","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; University of British Columbia","funders":"","keywords":"Oxidative stress; Immunohistochemistry; Stress granule; RNA-binding protein; Tissue microarray; Cancer research; Biology; Medicine; Pediatric cancer; Pathology; Internal medicine; Cancer; Messenger RNA; Translation (biology); Gene","score_opus":0.024155818613867112,"score_gpt":0.321844854003722,"score_spread":0.29768903538985486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899883991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865633,0.00020066963,0.000026446436,0.0108825,0.00056565483,0.00075634563,0.00009480596,0.00014655355,0.00076370116],"genre_scores_gemma":[0.9947458,0.000048591137,0.00010519036,0.0037854142,0.0010001834,0.000055367647,0.000055329616,0.0000664632,0.00013765546],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997489,0.00040005025,0.000668365,0.0005695377,0.00039668957,0.00047639414],"domain_scores_gemma":[0.99783194,0.000985037,0.00036098596,0.00033491288,0.00016840316,0.00031873022],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039675317,0.00029263453,0.0007453894,0.00039355364,0.00007017877,0.000012283271,0.00019084795,0.00030297675,0.00014300444],"category_scores_gemma":[0.0019384659,0.00024947236,0.000050247498,0.0004525475,0.00038158172,0.000116076546,0.00012753502,0.00063295645,0.000026062497],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000554519,0.00045447852,0.853879,0.00015576536,0.00002482172,0.00032182492,0.0013130096,0.0000028388827,0.13047223,0.000056666264,0.0065613943,0.006203504],"study_design_scores_gemma":[0.007870964,0.0044587124,0.9525336,0.00012865906,0.00014886224,0.0001472523,0.0012675211,0.00025608513,0.025110295,0.00008050101,0.007709263,0.0002882536],"about_ca_topic_score_codex":0.000080859725,"about_ca_topic_score_gemma":0.00023578685,"teacher_disagreement_score":0.10536193,"about_ca_system_score_codex":0.00016936401,"about_ca_system_score_gemma":0.00017101121,"threshold_uncertainty_score":0.99999577},"labels":[],"label_agreement":null},{"id":"W2899925807","doi":"10.1093/neuonc/noy148.421","title":"EXTH-74. MOLECULAR MECHANISMS OF ANTI-TUMOR ACTION OF TTFIELDS DETERMINED BY MEASUREMENTS AND MODELING OF ELECTRO-CONDUCTIVE PROPERTIES OF MICROTUBULES","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neuroscience and Neural Engineering","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MacEwan University; University of Alberta","funders":"","keywords":"Microtubule; Tubulin; Materials science; Mitosis; Electrical conductor; Actin; Biophysics; Chemistry; Biology; Cell biology; Composite material","score_opus":0.08775125009070173,"score_gpt":0.2989265778698019,"score_spread":0.2111753277791002,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899925807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99567115,0.000043511292,0.0035921342,0.000060101982,0.0002476863,0.00028504178,0.0000071779777,0.000017137741,0.000076072305],"genre_scores_gemma":[0.99944955,0.000044483444,0.000257921,0.0002055028,0.00001050119,0.000010625576,1.9596752e-7,0.000017948225,0.0000032974879],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985202,0.00014709319,0.0004476875,0.00036763572,0.00027504444,0.00024232657],"domain_scores_gemma":[0.99921703,0.00007339492,0.00031697328,0.00020316581,0.00014117814,0.000048243113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016263928,0.00015497816,0.000414632,0.00016428769,0.000044408283,0.000004631343,0.00024111435,0.00008120767,0.0000042984334],"category_scores_gemma":[0.00038650638,0.00013834155,0.000058830818,0.00023587434,0.00034909428,0.00018940888,0.000091510745,0.00014109041,3.883494e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013331877,0.00011987204,0.00001745548,0.0000845649,0.0000045561333,0.0000050951503,0.00014883821,0.0001708356,0.9987902,0.00010547738,0.000004776951,0.00041497697],"study_design_scores_gemma":[0.00042256777,0.0019484784,0.0000067091337,0.00003267332,0.000023752018,0.00005134761,0.000049569877,0.015801745,0.9813852,0.00016375838,0.000020208823,0.000093991315],"about_ca_topic_score_codex":0.000026225302,"about_ca_topic_score_gemma":0.000002006969,"teacher_disagreement_score":0.017405033,"about_ca_system_score_codex":0.00001983942,"about_ca_system_score_gemma":0.00007834215,"threshold_uncertainty_score":0.5641405},"labels":[],"label_agreement":null},{"id":"W2899929689","doi":"10.1093/neuonc/noy148.854","title":"PDTM-12. DLX2 TRANSCRIPTIONAL REGULATION OF CENTRAL NERVOUS SYSTEM CELL FATE RELEVANCE TO PEDIATRIC DIFFUSE MIDLINE GLIOMAS WITH HISTONE 3 MUTATIONS","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Biology; Chromatin immunoprecipitation; OLIG2; Histone H3; Cancer research; Histone; Genetics; Promoter; Molecular biology; Gene expression; Gene; Myelin; Oligodendrocyte","score_opus":0.015535951224219677,"score_gpt":0.26876989937306767,"score_spread":0.253233948148848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899929689","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994535,0.00020888682,0.0004888646,0.0020438405,0.00057939003,0.0008177988,0.00005269089,0.000086621934,0.0011868707],"genre_scores_gemma":[0.99659204,0.00003212999,0.0021936856,0.00031324624,0.0005452728,0.00010822865,0.000080062724,0.000037780366,0.000097521835],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99834526,0.00010679932,0.00046181216,0.00040943985,0.00032370878,0.00035298505],"domain_scores_gemma":[0.99868596,0.00021612573,0.0002287057,0.00031236303,0.00029826615,0.00025856722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000081076025,0.00020616114,0.00045190347,0.0002996219,0.00010503201,0.0000074573136,0.00008723134,0.00012462593,0.00006730451],"category_scores_gemma":[0.000060225564,0.00016901417,0.000096505595,0.00044775003,0.00012714246,0.00006650204,0.000018047234,0.00012295271,0.00005863189],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017347438,0.0031920886,0.021719597,0.00031511972,0.000076635166,0.0006511084,0.0014284691,0.000496922,0.9636133,0.00068209285,0.0030774132,0.003012566],"study_design_scores_gemma":[0.019111173,0.015565091,0.69197476,0.00012995848,0.0017097096,0.00090821536,0.00030173114,0.0015980204,0.23863739,0.000045995996,0.029571826,0.0004461485],"about_ca_topic_score_codex":0.00005946834,"about_ca_topic_score_gemma":0.000150663,"teacher_disagreement_score":0.7249759,"about_ca_system_score_codex":0.00041502868,"about_ca_system_score_gemma":0.00022857409,"threshold_uncertainty_score":0.6892198},"labels":[],"label_agreement":null},{"id":"W2899933904","doi":"10.1093/neuonc/noy148.261","title":"COMP-06. GLIOBLASTOMA DEVELOPMENT MIRRORS THE DEVELOPING BRAIN","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital; McGill University","funders":"","keywords":"Progenitor cell; Biology; Cancer research; Population; Cell; Progenitor; Lineage (genetic); Cancer stem cell; Glioma; Stem cell; Mesenchymal stem cell; Neuroscience; Cell biology; Genetics; Gene; Medicine","score_opus":0.026337220604852916,"score_gpt":0.3245071122679938,"score_spread":0.29816989166314084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899933904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9096573,0.00051062694,0.05655018,0.020441946,0.0017842806,0.0012997355,0.000013066242,0.00011559103,0.0096272845],"genre_scores_gemma":[0.97613823,0.000094697105,0.007112381,0.01489564,0.00069983525,0.00018186645,0.000052560466,0.0000991417,0.0007256718],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99775743,0.00036675573,0.00033752166,0.00060219696,0.00030252783,0.00063355296],"domain_scores_gemma":[0.99883753,0.000110414745,0.00011982902,0.000538248,0.00024911962,0.00014482853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051169517,0.00023934442,0.00021801062,0.00010270675,0.00038090924,0.000034373406,0.0006304131,0.00033687826,0.000108700406],"category_scores_gemma":[0.00038583958,0.00019938979,0.00008628373,0.0002961879,0.00036369747,0.000004063941,0.00060522836,0.00038429463,0.00035407266],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020705865,0.000043721557,0.000022240063,0.000008100828,0.0000628076,0.000039273873,0.00022509946,0.000009156028,0.95561165,0.00032971826,0.023879236,0.01956197],"study_design_scores_gemma":[0.00044674825,0.00070387,0.00015158541,0.000005611099,0.000005349202,0.00012106245,0.000053830565,0.00005235688,0.4639988,0.00004254646,0.53428394,0.00013432722],"about_ca_topic_score_codex":0.000018408795,"about_ca_topic_score_gemma":0.00064712594,"teacher_disagreement_score":0.51040465,"about_ca_system_score_codex":0.00018496344,"about_ca_system_score_gemma":0.0013386611,"threshold_uncertainty_score":0.81308794},"labels":[],"label_agreement":null},{"id":"W2899936404","doi":"10.1093/neuonc/noy148.1177","title":"CADD-49. IDENTIFICATION AND VALIDATION OF AZOLES AS HK2 INHIBITORS IN GLIOBLASTOMA <i>IN VITRO</i> AND <i>IN VIVO</i>","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Eicosanoids and Hypertension Pharmacology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Glioma; Ketoconazole; In vivo; Glycolysis; Apoptosis; Gene knockdown; Chemistry; Cancer research; In vitro; Angiogenesis; Biology; Pharmacology; Biochemistry; Metabolism","score_opus":0.009128024869980739,"score_gpt":0.27746871025280667,"score_spread":0.26834068538282596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899936404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977135,0.0003054211,0.000006164625,0.000904709,0.0002443796,0.00023439623,0.000011440647,0.000005146971,0.00057485787],"genre_scores_gemma":[0.9981631,0.00050786085,0.00005012772,0.0010780109,0.00011695373,0.00002702466,0.000012088525,0.000014644677,0.000030207773],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99869466,0.00022579389,0.00039708853,0.00039950214,0.000071870236,0.00021111112],"domain_scores_gemma":[0.999517,0.000068346446,0.00013609268,0.00014513088,0.00006582483,0.000067606714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030921903,0.00012646662,0.00024808676,0.00019975065,0.000029030565,0.000008422854,0.00008730536,0.0002489111,0.000017877217],"category_scores_gemma":[0.00014679495,0.0001314787,0.00002307865,0.00016739403,0.0002472954,0.00001104532,0.00011769583,0.00014023067,0.000003657904],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064215856,0.00013623512,0.0051042424,0.000015442485,0.000004548775,0.000018568722,0.00013632805,0.000006336617,0.9903115,0.000026013688,0.0010404495,0.0025581815],"study_design_scores_gemma":[0.0015423305,0.00078018376,0.0019167672,0.000008519537,0.00001002304,0.000071448805,0.00008342668,0.00009134624,0.9637633,0.00009760529,0.031528745,0.00010631064],"about_ca_topic_score_codex":0.00007098747,"about_ca_topic_score_gemma":0.0005247286,"teacher_disagreement_score":0.030488294,"about_ca_system_score_codex":0.000022104325,"about_ca_system_score_gemma":0.0000968572,"threshold_uncertainty_score":0.53615457},"labels":[],"label_agreement":null},{"id":"W2899936890","doi":"10.1093/neuonc/noy148.599","title":"INNV-28. EXTENT OF RESECTION IN NEWLY DIAGNOSED GLIOBLASTOMA: INCORPORATING CLINICAL AND MOLECULAR DATA TO PREDICT OUTCOME","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; Shared Health; University of Manitoba","funders":"","keywords":"Glioblastoma; Medicine; Oncology; Proportional hazards model; Internal medicine; Overall survival; IDH1; Retrospective cohort study; Surgical resection; Surgery; Mutant; Cancer research; Gene; Biology","score_opus":0.07195302820360715,"score_gpt":0.38967579637823563,"score_spread":0.31772276817462847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899936890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99425817,0.000098379656,0.00006739224,0.003907932,0.0005042776,0.00076581194,0.00002210374,0.000031191874,0.0003447584],"genre_scores_gemma":[0.9960467,0.000043340224,0.0016065581,0.001939091,0.00025474228,0.00006138517,0.000022073777,0.000023669174,0.0000024317287],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99781984,0.00030351587,0.00081612525,0.00059352175,0.00022085545,0.00024613028],"domain_scores_gemma":[0.9980909,0.0006401185,0.00021971937,0.0007005517,0.0001234141,0.00022528777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007048298,0.00016037172,0.0005984627,0.00026518546,0.00003966382,0.000009300634,0.00017037347,0.00018897696,0.000020930594],"category_scores_gemma":[0.0021939806,0.00013772237,0.00005220434,0.00038792775,0.0002319671,0.00007690193,0.00043419117,0.0002633814,0.000019573652],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009915284,0.0013883932,0.85958445,0.00003671476,0.000052175918,0.0015498132,0.00013967963,0.0000075321295,0.10977022,0.00010437369,0.0025062326,0.023868876],"study_design_scores_gemma":[0.01677747,0.032251447,0.8962302,0.00017197312,0.00028496943,0.00028854472,0.00019905821,0.0019286426,0.034709793,0.00016451228,0.016756395,0.00023696743],"about_ca_topic_score_codex":0.00014792012,"about_ca_topic_score_gemma":0.0009045219,"teacher_disagreement_score":0.07506043,"about_ca_system_score_codex":0.000082324426,"about_ca_system_score_gemma":0.00015511023,"threshold_uncertainty_score":0.5616155},"labels":[],"label_agreement":null},{"id":"W2899994584","doi":"10.1093/neuonc/noy148.543","title":"IMMU-40. SINGLE-CELL LEVEL COMPARISON OF HISTOPATHOLOGY AND SINGLE-CELL RNA-SEQ DATABASES BETWEEN IDH-MUT AND –WT GLIOBLASTOMAS REVEALS DISTINCT INNATE IMMUNE MICROENVIRONMENTS THAT CAN BE EXPLOITED FOR THERAPEUTIC GAIN","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Flow cytometry; Immune system; CD163; Biology; Glioma; Innate immune system; Cell; Microglia; Immunotherapy; CD68; Cancer research; Inflammation; Molecular biology; Phenotype; Immunology; Immunohistochemistry; Gene; Genetics","score_opus":0.08957499304302995,"score_gpt":0.29645322495828164,"score_spread":0.20687823191525168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899994584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99118817,0.0021914884,0.004239115,0.00039713792,0.00043090337,0.0006466919,0.00062825927,0.000025176494,0.00025308185],"genre_scores_gemma":[0.99578065,0.00027752336,0.0020867842,0.00076960097,0.00023069048,0.00004328412,0.00057740835,0.000092704955,0.0001413398],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972245,0.00038743892,0.00073922065,0.0008814529,0.00015844956,0.0006089566],"domain_scores_gemma":[0.99828345,0.0003302612,0.0005446238,0.00056101487,0.00010306606,0.00017760655],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003278225,0.0004581433,0.0008486688,0.00013782969,0.00022893585,0.00002519124,0.00033919123,0.0003913128,0.000012560539],"category_scores_gemma":[0.000090034875,0.00046353752,0.0001269408,0.00010101248,0.001051391,0.00001605491,0.0002936803,0.00026130918,0.0000020400198],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008611339,0.00069619424,0.03905241,0.00012703086,0.00004527562,0.0000103307275,0.00045309216,0.0000018614559,0.9509389,0.000005426953,0.0003133627,0.0074949795],"study_design_scores_gemma":[0.0032643354,0.0059564407,0.004787001,0.000027310776,0.00020702787,0.00004724223,0.00023744882,0.000048425958,0.94240195,0.00003885761,0.042568885,0.0004150606],"about_ca_topic_score_codex":0.00015300748,"about_ca_topic_score_gemma":0.0002891626,"teacher_disagreement_score":0.042255525,"about_ca_system_score_codex":0.00009376198,"about_ca_system_score_gemma":0.000084129926,"threshold_uncertainty_score":0.9997816},"labels":[],"label_agreement":null},{"id":"W2899995714","doi":"10.1093/neuonc/noy148.039","title":"ACTR-02. NRG ONCOLOGY/RTOG 0424: LONG-TERM RESULTS OF A PHASE II STUDY OF TEMOZOLOMIDE-BASED CHEMORADIOTHERAPY REGIMEN FOR HIGH-RISK LOW-GRADE GLIOMAS","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario","funders":"","keywords":"Temozolomide; Medicine; Internal medicine; Oncology; Chemoradiotherapy; Hazard ratio; Regimen; Population; Glioma; Clinical endpoint; Radiation therapy; Phases of clinical research; Chemotherapy; Confidence interval; Clinical trial","score_opus":0.030644769724216588,"score_gpt":0.35519731503702423,"score_spread":0.32455254531280764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899995714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99056,0.00022466942,0.00004485474,0.0038936392,0.000736094,0.0039347857,0.00022428494,0.0000911309,0.00029054462],"genre_scores_gemma":[0.9966953,0.00011239532,0.0009901989,0.00087979337,0.00053166377,0.0005620263,0.00010652543,0.00008856447,0.000033552897],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9963058,0.00046007702,0.0012730358,0.0009210659,0.0004061385,0.0006338686],"domain_scores_gemma":[0.9951039,0.0016678586,0.0013015593,0.0011351061,0.00048920856,0.00030234712],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006672163,0.00046988227,0.0018610954,0.0005154273,0.000201064,0.00000918186,0.00034526974,0.0004463643,0.00009133554],"category_scores_gemma":[0.00060060865,0.00038752533,0.00029608622,0.00055897835,0.0005288103,0.00007133173,0.00009875886,0.00031388074,0.000011815133],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.040859427,0.07960436,0.030703759,0.00020145324,0.0012456184,0.0013527514,0.0033294137,0.000012358949,0.743322,0.00004809971,0.01088277,0.08843795],"study_design_scores_gemma":[0.15648356,0.21038403,0.016588824,0.00009034807,0.0012385391,0.000103749335,0.0002247717,0.00014186844,0.6051129,0.000045438734,0.009314826,0.00027113073],"about_ca_topic_score_codex":0.00028712858,"about_ca_topic_score_gemma":0.00045861438,"teacher_disagreement_score":0.13820913,"about_ca_system_score_codex":0.00048911193,"about_ca_system_score_gemma":0.0007003964,"threshold_uncertainty_score":0.99985766},"labels":[],"label_agreement":null},{"id":"W2900003524","doi":"10.1093/neuonc/noy148.311","title":"DRES-04. CHARACTERIZATION OF A MODEL OF TEMOZOLOMIDE RESISTANCE IN GLIOBLASTOMA","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Temozolomide; MSH6; MLH1; MSH2; Cancer research; Methyltransferase; Downregulation and upregulation; DNA repair; Homologous recombination; Biology; DNA mismatch repair; O-6-methylguanine-DNA methyltransferase; Thiostrepton; Glioblastoma; Gene; Genetics; Methylation","score_opus":0.023196527109781984,"score_gpt":0.29343457948954754,"score_spread":0.27023805237976556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900003524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961397,0.00003732421,0.000049839324,0.0014075513,0.000105717016,0.00031343166,0.000021162003,0.0000145179565,0.0019107648],"genre_scores_gemma":[0.99894625,0.000052330328,0.0004378186,0.00041577633,0.000057330395,0.00003612451,0.000007656628,0.00001464775,0.00003205048],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990746,0.00006656483,0.0003659806,0.00020616544,0.00012700954,0.00015967264],"domain_scores_gemma":[0.99925417,0.000109175366,0.00021216979,0.00023915847,0.00013133911,0.000054016757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000098290046,0.00009747791,0.00040342074,0.00018837531,0.00001570842,0.0000014821262,0.00006424087,0.00011263616,0.000038658225],"category_scores_gemma":[0.0001276388,0.00008575876,0.000054040647,0.00023908254,0.00014043512,0.000039415365,0.00003272549,0.00008038368,0.000009644786],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00098335,0.000699684,0.014131276,0.0000465162,0.00001877209,0.00006117215,0.00045628488,0.000007842468,0.9810469,0.00046975425,0.00027595944,0.0018024474],"study_design_scores_gemma":[0.0038053782,0.0029361183,0.0523619,0.000097850796,0.00007049479,0.000018808947,0.000023978153,0.0021951476,0.9337908,0.00020385972,0.0044207023,0.000074932046],"about_ca_topic_score_codex":0.000013393815,"about_ca_topic_score_gemma":0.00028879967,"teacher_disagreement_score":0.047256112,"about_ca_system_score_codex":0.00008969522,"about_ca_system_score_gemma":0.00014957371,"threshold_uncertainty_score":0.34971407},"labels":[],"label_agreement":null},{"id":"W2900009291","doi":"10.1093/neuonc/noy148.1136","title":"TMOD-24. PATIENT-DERIVED BRAIN TUMOUR IPSCS: MODELS FOR INVESTIGATING GLIOMA STEMNESS AND DRUG DISCOVERY","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Induced pluripotent stem cell; Glioma; Biology; SOX2; Cancer research; Neural stem cell; Organoid; Cancer stem cell; Cellular differentiation; Stem cell; Cell biology; Embryonic stem cell; Gene; Genetics","score_opus":0.034616086691377314,"score_gpt":0.29531819122035763,"score_spread":0.2607021045289803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900009291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875407,0.00022473867,0.00026668372,0.009505585,0.0006103006,0.0011796266,0.00004243677,0.0000776117,0.0005522823],"genre_scores_gemma":[0.9928705,0.000014525493,0.0015880736,0.0047787093,0.00037193878,0.0002717405,0.000032887485,0.00005273626,0.00001888638],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99829495,0.00015791373,0.00038914615,0.00054177793,0.00018452927,0.00043165803],"domain_scores_gemma":[0.99816996,0.00093354913,0.00020199058,0.0002777134,0.00015167818,0.00026508665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016590966,0.00025382888,0.00053372374,0.00014174878,0.00019977296,0.00004829671,0.00008991916,0.0001319827,0.000013783776],"category_scores_gemma":[0.00040782292,0.00020838238,0.00010123678,0.00016798801,0.00028915133,0.00024370496,0.00013144559,0.00014713357,0.00001019272],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028891777,0.00056761736,0.0033705938,0.00010175202,0.00009505108,0.00035733526,0.0024050486,0.000026280619,0.9644786,0.0011738123,0.010576962,0.016557995],"study_design_scores_gemma":[0.015203853,0.010102936,0.0037531457,0.00024918967,0.0004809484,0.00100617,0.0018253215,0.010428094,0.92959285,0.006309184,0.020489112,0.00055918976],"about_ca_topic_score_codex":0.000059866685,"about_ca_topic_score_gemma":0.00009063931,"teacher_disagreement_score":0.03488578,"about_ca_system_score_codex":0.0001278185,"about_ca_system_score_gemma":0.0001966081,"threshold_uncertainty_score":0.8497587},"labels":[],"label_agreement":null},{"id":"W2900131948","doi":"10.1093/neuonc/noy148.916","title":"QOLP-30. SURVIVAL, LOCAL CONTROL, AND HEALTH RELATED QUALITY OF LIFE IN OLIGOMETASTATIC AND POLYMETASTATIC SPINAL TUMORS: A MULTICENTER, INTERNATIONAL STUDY","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; Toronto Western Hospital; McGill University; Montreal General Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Quality of life (healthcare); Spinal cord compression; Disease; Internal medicine; Spinal disease; Oncology; Performance status; Physical therapy; Spinal cord; Cancer; Surgery; Lumbar","score_opus":0.06468878878732995,"score_gpt":0.39163280597127836,"score_spread":0.3269440171839484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900131948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888848,0.0004205063,0.0009353534,0.0074274573,0.00033752955,0.0015223392,0.00003410893,0.00003252903,0.0004053812],"genre_scores_gemma":[0.99559134,0.000060726,0.0007375659,0.0034648736,0.00004325736,0.00004356094,0.0000140726825,0.000025184756,0.000019436799],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99588025,0.001332774,0.0014142493,0.0005221999,0.00049095496,0.00035954962],"domain_scores_gemma":[0.9980252,0.0005361718,0.0006033605,0.00030427054,0.00014563593,0.00038539534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025073052,0.0002328131,0.0011833333,0.0004131288,0.000048853457,0.000016247144,0.00013672876,0.000048541417,0.0002149114],"category_scores_gemma":[0.0014436863,0.00021499337,0.000055974157,0.00025267177,0.00053655106,0.00009925814,0.00015428377,0.00027668203,0.000015229981],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017641902,0.014573723,0.88541794,0.0018485857,0.0014432436,0.0012696921,0.006461731,0.000013139461,0.005350707,0.002035978,0.00088642753,0.06305693],"study_design_scores_gemma":[0.043420464,0.0126277935,0.92851776,0.00014319512,0.0003137809,0.000053813026,0.007731995,0.00627708,0.000022970455,0.00020355798,0.00047490382,0.00021269693],"about_ca_topic_score_codex":0.0012315265,"about_ca_topic_score_gemma":0.00042589047,"teacher_disagreement_score":0.06284423,"about_ca_system_score_codex":0.00012332405,"about_ca_system_score_gemma":0.00035888533,"threshold_uncertainty_score":0.8767175},"labels":[],"label_agreement":null},{"id":"W2900133207","doi":"10.1093/neuonc/noy148.1135","title":"TMOD-23. DYNAMIC PATTERNS OF GLIOBLASTOMA CLONAL EVOLUTION IN RESPONSE TO CHEMORADIOTHERAPY","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University","funders":"","keywords":"Temozolomide; Chemoradiotherapy; Radiation therapy; Somatic evolution in cancer; Oncology; Glioblastoma; Medicine; Stem cell; Biology; Cancer research; Bioinformatics; Internal medicine; Cancer; Genetics","score_opus":0.013840688834285457,"score_gpt":0.3489778122568107,"score_spread":0.3351371234225252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900133207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909335,0.000080306214,0.00016108606,0.0070485063,0.0007150686,0.00049918785,0.000022483653,0.00003543184,0.0005044553],"genre_scores_gemma":[0.9959161,0.000040359588,0.00024893397,0.003145264,0.0002862841,0.00006413458,0.000007693473,0.000024866831,0.00026633494],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99871826,0.00025000641,0.0002946285,0.0003071157,0.00013567,0.00029430116],"domain_scores_gemma":[0.99921083,0.0002865574,0.00009374998,0.0002093902,0.0000897689,0.00010972764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023184934,0.0001430991,0.0004381726,0.0003224059,0.000027548967,0.0000021645874,0.00009656152,0.00015696153,0.00056408264],"category_scores_gemma":[0.00007518852,0.00013729738,0.00006998428,0.0003043543,0.000116486735,0.000032842014,0.000037172777,0.00017926376,0.00008617152],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031756077,0.00071217935,0.029972596,0.000019531091,0.000035798035,0.00022479487,0.00086791144,0.000006713089,0.92783123,0.00003639388,0.0015057202,0.0070310673],"study_design_scores_gemma":[0.020894911,0.0618299,0.6038972,0.000070666654,0.00014737814,0.00080305897,0.00016862342,0.0010719512,0.1429121,0.00013742347,0.16776845,0.00029833618],"about_ca_topic_score_codex":0.00009783112,"about_ca_topic_score_gemma":0.0008956546,"teacher_disagreement_score":0.78491914,"about_ca_system_score_codex":0.0008482406,"about_ca_system_score_gemma":0.0003999123,"threshold_uncertainty_score":0.6176309},"labels":[],"label_agreement":null},{"id":"W2900133605","doi":"10.1093/neuonc/noy148.1115","title":"TMOD-02. DIFFUSE GLIOMATOSIS IN MOUSE MODEL OF GFAP TISSUE SPECIFIC KNOCK IN OF EGFRvIII AND KNOCK OUT OF p19 ARF","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Western Hospital; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Pathology; Immunohistochemistry; Biology; NeuN; Synaptophysin; Glioma; Nestin; Glial fibrillary acidic protein; Genetically modified mouse; Parenchyma; Leptomeninges; Cancer research; Transgene; Medicine; Neural stem cell; Stem cell; Central nervous system; Cell biology","score_opus":0.07303066409905097,"score_gpt":0.3795410821435967,"score_spread":0.30651041804454576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900133605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99260014,0.00031674246,0.000065904875,0.0008972311,0.00019464272,0.00072175224,0.000051368446,0.00001747549,0.0051347194],"genre_scores_gemma":[0.99759376,0.000782105,0.0009823131,0.00017119906,0.0001157348,0.000043119886,0.0000040869027,0.000050708877,0.00025699704],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974377,0.0002780579,0.00089977734,0.00048356433,0.00043253053,0.0004683606],"domain_scores_gemma":[0.99819034,0.00046888518,0.00024851007,0.0006624507,0.0002512901,0.00017851821],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050831534,0.00020613718,0.001029383,0.000690258,0.000018100889,0.0000040043574,0.00028123104,0.00031468156,0.0001483378],"category_scores_gemma":[0.0004250596,0.00019904735,0.00006174883,0.0005069614,0.0007082739,0.00006736335,0.00026277817,0.00044798892,0.000022772656],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010022864,0.0010872683,0.028911171,0.00038442973,0.000019636085,0.00007119395,0.0025216632,0.000054782802,0.9557093,0.00018278396,0.0015082192,0.008547288],"study_design_scores_gemma":[0.008220419,0.0052865194,0.0062401188,0.00020314743,0.00003387749,0.000047349196,0.00039116884,0.006507268,0.96014535,0.00034672164,0.012376249,0.0002017855],"about_ca_topic_score_codex":0.00043983263,"about_ca_topic_score_gemma":0.001006353,"teacher_disagreement_score":0.022671053,"about_ca_system_score_codex":0.00022317166,"about_ca_system_score_gemma":0.00046920485,"threshold_uncertainty_score":0.8116916},"labels":[],"label_agreement":null},{"id":"W2900138717","doi":"10.1093/neuonc/noy148.125","title":"CBMT-06. LOWER GRADE ISOCITRATE DEHYDROGENASE (IDH) MUTANT GLIOMAS METABOLICALLY MIMICKING GLIOBLASTOMA (GBM) EXPRESS HIGHER R:S 2-HYDROXYGLUTARATE RATIOS RELATIVE TO NON-GBM-MIMICKING IDH MUTANT GLIOMAS","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Toronto Western Hospital; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Isocitrate dehydrogenase; IDH1; Glioma; Cancer research; Mutant; Wild type; Carcinogenesis; Metabolic pathway; Biology; Chemistry; Metabolism; Internal medicine; Medicine; Enzyme; Cancer; Biochemistry; Gene","score_opus":0.014793151684431263,"score_gpt":0.2784057015416299,"score_spread":0.2636125498571987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900138717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9838131,0.0013509063,0.0025735435,0.0016571962,0.006780203,0.0013920746,0.00017025755,0.00015550757,0.0021071925],"genre_scores_gemma":[0.98216116,0.0003722025,0.0025713088,0.007123977,0.006670192,0.00032836478,0.00008041704,0.00025431684,0.00043806384],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99367195,0.0007017226,0.0012497084,0.002060871,0.0006017759,0.0017139566],"domain_scores_gemma":[0.9964603,0.0001722089,0.0006759927,0.0013116627,0.0005498233,0.0008299652],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00054590264,0.0010325145,0.0012641291,0.00045498167,0.00057393085,0.0001507084,0.0010076795,0.0010047258,0.00022012001],"category_scores_gemma":[0.00034884826,0.0010219992,0.0005814189,0.0010217734,0.00070603995,0.00007474681,0.0007283748,0.0007571652,0.00031974894],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014862559,0.00039304447,0.0000693229,0.000029238261,0.000331542,0.00033140785,0.0011614546,0.00023122496,0.9889114,0.00035711986,0.004907837,0.00179016],"study_design_scores_gemma":[0.002165933,0.0017453359,0.00015141793,0.000026444395,0.00021788495,0.00028819888,0.00008301721,0.00025243257,0.571703,0.00017661827,0.42249194,0.00069778727],"about_ca_topic_score_codex":0.00010109711,"about_ca_topic_score_gemma":0.0004202548,"teacher_disagreement_score":0.4175841,"about_ca_system_score_codex":0.0002057449,"about_ca_system_score_gemma":0.0007165117,"threshold_uncertainty_score":0.99922305},"labels":[],"label_agreement":null},{"id":"W2900142401","doi":"10.1093/neuonc/noy148.1067","title":"TMIC-07. HYPOXIC MICROENVIRONMENT CONFERS SPECIFIC ALTERATIONS IN DNA METHYLATION PROFILES IN GLIOBLASTOMA","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Western Hospital; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"DNA methylation; Biology; Laser capture microdissection; Epigenetics; Cancer research; Glioma; Methylation; HIF1A; microRNA; Tumor microenvironment; CpG site; Angiogenesis; Hypoxia (environmental); Wnt signaling pathway; Epigenomics; Microdissection; Pathology; Gene expression; Gene; Medicine; Genetics; Chemistry","score_opus":0.016941690571771587,"score_gpt":0.27359170109626674,"score_spread":0.25665001052449515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900142401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953453,0.00027117474,0.0006913561,0.001155772,0.00027976595,0.000357154,0.0000143040925,0.000008106797,0.001877086],"genre_scores_gemma":[0.9978275,0.00047204323,0.0004994919,0.00060338207,0.00028687005,0.00014217818,0.00003911755,0.00001900682,0.00011042352],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987837,0.00017960934,0.00030191068,0.00041389326,0.000080193524,0.00024071052],"domain_scores_gemma":[0.9994874,0.000026784264,0.00009336108,0.00030657955,0.000034621113,0.000051238723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016969394,0.00012975067,0.00015136189,0.00011987479,0.000060241127,0.000017116863,0.00015563313,0.00016819275,0.00016127729],"category_scores_gemma":[0.000033599234,0.00013695235,0.000040306295,0.00012771167,0.00017139762,0.0000073600463,0.0000621159,0.000120692916,0.00010614443],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013923051,0.00013915352,0.00092096627,0.0000029143116,0.000005508759,0.000006634376,0.00012923715,0.00008986227,0.9884255,0.00015553455,0.0020085415,0.007976952],"study_design_scores_gemma":[0.0007402879,0.00079324696,0.0072054532,0.0000047334797,0.000004225349,0.000012489983,0.000099957455,0.00014907161,0.68261975,0.000065434666,0.30818072,0.00012460692],"about_ca_topic_score_codex":0.000016263539,"about_ca_topic_score_gemma":0.00038473742,"teacher_disagreement_score":0.3061722,"about_ca_system_score_codex":0.00012547021,"about_ca_system_score_gemma":0.000115017094,"threshold_uncertainty_score":0.5584755},"labels":[],"label_agreement":null},{"id":"W2900174653","doi":"10.1093/neuonc/noy148.1174","title":"CADD-35. THE DEVELOPMENT OF PERSONALIZED CAM AVATAR MODEL TO PREDICT CHEMOTHERAPEUTIC DRUG SENSITIVITY/RESISTANCE OF GLIOMAS","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cell Image Analysis Techniques","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke","funders":"","keywords":"In ovo; Medicine; Glioma; Ex vivo; Temozolomide; In vivo; Oncology; Chorioallantoic membrane; Drug; Precision medicine; Personalized medicine; Cancer research; Internal medicine; Pathology; Bioinformatics; Pharmacology; Biology; Embryo; Angiogenesis","score_opus":0.014827514702109407,"score_gpt":0.288236127921865,"score_spread":0.27340861321975557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900174653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9784947,0.00018320089,0.016154792,0.0004988412,0.000039438393,0.00035716023,0.000012870822,0.000023701516,0.0042352644],"genre_scores_gemma":[0.9854982,0.00004808892,0.011997981,0.001783687,0.000097210905,0.000033750162,0.00001954995,0.000028546026,0.0004929893],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985627,0.0002016317,0.00039961713,0.00039479017,0.00019498762,0.00024628505],"domain_scores_gemma":[0.99882084,0.000075660624,0.00022167747,0.00054424535,0.0002708631,0.00006673668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051082595,0.00017487844,0.00033319544,0.00008160726,0.00007978271,0.0000056178656,0.00028835985,0.00013477172,0.000021505572],"category_scores_gemma":[0.00012834078,0.00014474169,0.000117226715,0.00019992907,0.00037325307,0.000003978765,0.00020898151,0.000101888625,0.0000053199296],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026155997,0.0001074753,0.00014164492,0.000020319352,0.00009284299,0.0000030752876,0.0012546274,0.000020940208,0.98935753,0.000022812299,0.0067113345,0.0020058376],"study_design_scores_gemma":[0.0003326973,0.00020915392,0.00009030159,0.000009722348,0.00005425827,0.000010227702,0.00010790018,0.00070678117,0.8985584,0.000027031658,0.09977687,0.0001166495],"about_ca_topic_score_codex":0.000017738432,"about_ca_topic_score_gemma":0.0010710428,"teacher_disagreement_score":0.09306553,"about_ca_system_score_codex":0.00004499597,"about_ca_system_score_gemma":0.000364229,"threshold_uncertainty_score":0.59023947},"labels":[],"label_agreement":null},{"id":"W2900191363","doi":"10.1093/neuonc/noy148.939","title":"RTHP-07. TRANSCRIPTION FACTOR NETWORKS OF OLIGODENDROGLIOMAS (IDH-MUTANT AND 1p/19q CODELETED) TREATED WITH ADJUVANT RADIOTHERAPY OR OBSERVATION INFORMS PROGNOSIS","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Oncology; Cohort; Medicine; Internal medicine; Transcription factor; Gene signature; Radiation therapy; Adjuvant; Cancer research; Gene; Biology; Gene expression; Genetics","score_opus":0.03312960050686395,"score_gpt":0.2854135150547225,"score_spread":0.2522839145478586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900191363","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958641,0.00045641934,0.0004212507,0.0013901347,0.000176481,0.0013756079,0.000033236884,0.000101131416,0.00018162961],"genre_scores_gemma":[0.9964292,0.001169038,0.0009305642,0.00094614964,0.00018748608,0.00019945492,0.000071423456,0.000049491002,0.000017204024],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99833274,0.000091989845,0.0005176798,0.00041382585,0.00025856125,0.00038520366],"domain_scores_gemma":[0.9987896,0.00019117724,0.00028028744,0.00027083207,0.0002650602,0.00020305427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009939724,0.00031117158,0.00073702674,0.00021174361,0.00009857176,0.000020013636,0.000080951286,0.00028475103,0.00018262494],"category_scores_gemma":[0.00003937212,0.00019274814,0.000089330126,0.0004649617,0.00028808505,0.00016904224,0.000015725858,0.0001850053,0.000005700576],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057528457,0.0014531268,0.257731,0.00010775299,0.0005064819,0.0003643174,0.001357066,0.000052778218,0.6123344,0.00012554499,0.00038571932,0.11982899],"study_design_scores_gemma":[0.03177672,0.06346953,0.38923275,0.00037597184,0.0011821582,0.0015129696,0.00030232442,0.020543221,0.43448347,0.000015399333,0.05648105,0.0006244272],"about_ca_topic_score_codex":0.00012382305,"about_ca_topic_score_gemma":0.00033316054,"teacher_disagreement_score":0.1778509,"about_ca_system_score_codex":0.00014528928,"about_ca_system_score_gemma":0.00016983651,"threshold_uncertainty_score":0.78600407},"labels":[],"label_agreement":null},{"id":"W2900192395","doi":"10.1093/neuonc/noy148.168","title":"CSIG-02. VAL-083 INHIBITS PROLIFERATION OF A PANEL OF EIGHT GLIOBLASTOMA STEM CELL LINES: DOWNREGULATION OF BDR4 AS A NOVEL ANTI-NEOPLASTIC MECHANISM","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Delmar (Canada)","funders":"","keywords":"Neurosphere; Cancer research; Stem cell; OLIG2; Cell growth; Downregulation and upregulation; Biology; Cyclin D1; Stem cell marker; Nestin; Cell cycle; Chemistry; Neural stem cell; Cell biology; Cellular differentiation; Cell; Oligodendrocyte; Biochemistry; Gene","score_opus":0.01570420584508861,"score_gpt":0.2522941678922644,"score_spread":0.23658996204717578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900192395","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99204254,0.00006491922,0.0061695785,0.00012737139,0.00036888034,0.00060997455,0.000046941852,0.000014001022,0.0005558137],"genre_scores_gemma":[0.9983721,0.000041481042,0.0009028025,0.00015682042,0.00031136582,0.000038135597,0.00004950445,0.000027441118,0.00010037973],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983292,0.00015317438,0.000687455,0.00038682803,0.00023213658,0.00021116082],"domain_scores_gemma":[0.9983153,0.00006569418,0.000645979,0.00033898235,0.00055879576,0.00007526334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021165617,0.00020044802,0.00038165163,0.00016715699,0.00004949103,0.0000064608753,0.00017863401,0.00036797696,0.00003135586],"category_scores_gemma":[0.00016293876,0.00018944367,0.0001095631,0.00024090392,0.00020398531,0.000015146419,0.00012095061,0.000102739934,0.000010917194],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005113866,0.00046569665,0.00009660392,0.00013256018,0.00002426773,0.0000014814135,0.00021006673,0.000033910732,0.996409,0.00055462524,0.0002821796,0.0012782105],"study_design_scores_gemma":[0.0016615726,0.0067240903,0.0001609914,0.000038786493,0.000040252646,0.000041712432,0.000076862336,0.00083120004,0.9856662,0.00010533788,0.0045059677,0.00014702888],"about_ca_topic_score_codex":0.000011472592,"about_ca_topic_score_gemma":0.000023576462,"teacher_disagreement_score":0.010742813,"about_ca_system_score_codex":0.000022707463,"about_ca_system_score_gemma":0.00033716427,"threshold_uncertainty_score":0.7725288},"labels":[],"label_agreement":null},{"id":"W2900244736","doi":"10.1093/neuonc/noy148.343","title":"EPID-16. CONSIDERATIONS FOR A SURGICAL RCT IN LOW-GRADE GLIOMAS: A SURVEY","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Randomized controlled trial; Medicine; Observational study; Randomization; Clinical equipoise; Clinical endpoint; Specialty; Oncology; Internal medicine; Family medicine","score_opus":0.0687747390986135,"score_gpt":0.3640701691860082,"score_spread":0.29529543008739473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900244736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98332995,0.00016384723,0.000026731617,0.01257828,0.00052469526,0.0011000742,0.00006573381,0.000052748044,0.0021579661],"genre_scores_gemma":[0.9959863,0.000037308735,0.0003515025,0.002800888,0.00032513577,0.00039591818,0.00005745525,0.00002614473,0.00001935355],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99832183,0.00035984957,0.00039119707,0.0004096274,0.00012726588,0.0003902115],"domain_scores_gemma":[0.995076,0.004196248,0.00008935639,0.0002748857,0.0001782582,0.00018527632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044203177,0.00017109931,0.0005270165,0.00022675225,0.00010126558,0.000015581485,0.000053017422,0.0001899812,0.00034474285],"category_scores_gemma":[0.0016067413,0.00014287254,0.00011772431,0.0002869529,0.00020144509,0.000039410246,0.00003957527,0.00015246407,0.00009322754],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036475249,0.014927868,0.7368608,0.00015492743,0.0004465358,0.011994329,0.0016080084,0.000019750049,0.05478497,0.007597055,0.15017955,0.017778661],"study_design_scores_gemma":[0.06000048,0.016985323,0.37163684,0.00013511813,0.00036248384,0.0033810553,0.00016425461,0.0008843699,0.09515281,0.003677059,0.44701916,0.0006010751],"about_ca_topic_score_codex":0.00028475188,"about_ca_topic_score_gemma":0.0055531687,"teacher_disagreement_score":0.365224,"about_ca_system_score_codex":0.00025344844,"about_ca_system_score_gemma":0.0003564678,"threshold_uncertainty_score":0.58261734},"labels":[],"label_agreement":null},{"id":"W2900256197","doi":"10.1093/neuonc/noy148.060","title":"ACTR-27. PHASE 2 STUDY OF DIANHYDROGALACTITOL (VAL-083) IN PATIENTS WITH MGMT-UNMETHYLATED, BEVACIZUMAB-NAÏVE RECURRENT GLIOBLASTOMA","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Delmar (Canada)","funders":"","keywords":"Temozolomide; Bevacizumab; Medicine; Oncology; Internal medicine; Phases of clinical research; Radiation therapy; Clinical trial; Cancer research; Chemotherapy","score_opus":0.015300275342520006,"score_gpt":0.31782206039973687,"score_spread":0.3025217850572169,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900256197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99568325,0.000038914248,0.000001581609,0.0005234314,0.0007290265,0.0020301857,0.000020929576,0.000049669758,0.00092301524],"genre_scores_gemma":[0.99932957,0.000027272114,0.00006375868,0.00021626246,0.00013361311,0.00015181949,0.000022283413,0.00004785703,0.000007556672],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99754125,0.00029151325,0.0005969501,0.0006188201,0.00046806422,0.0004834302],"domain_scores_gemma":[0.99824065,0.00031374206,0.00034261862,0.00057762023,0.00027654856,0.00024880396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015966743,0.00033225812,0.0008316757,0.00049973227,0.00006920886,0.000010767414,0.0001535211,0.00017927999,0.00019955913],"category_scores_gemma":[0.0001881109,0.00023032707,0.00008825377,0.00066509086,0.00017636993,0.0001068966,0.000101265236,0.00034872672,0.000106370295],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02144015,0.082934886,0.7453447,0.00006148646,0.00050917524,0.0016191865,0.004225974,0.000008507459,0.012898248,0.000013165331,0.0021551459,0.12878937],"study_design_scores_gemma":[0.15073547,0.40336317,0.32982892,0.00019331867,0.0010449688,0.00008911058,0.0010589965,0.00013588626,0.08096338,0.00001986306,0.03203008,0.0005368608],"about_ca_topic_score_codex":0.00010733072,"about_ca_topic_score_gemma":0.00084534904,"teacher_disagreement_score":0.4155158,"about_ca_system_score_codex":0.00038274608,"about_ca_system_score_gemma":0.00019439404,"threshold_uncertainty_score":0.9392466},"labels":[],"label_agreement":null},{"id":"W2900303949","doi":"10.1093/neuonc/noy148.019","title":"ATIM-24. INTERIM RESULTS OF A PHASE II MULTICENTER STUDY OF THE CONDITIONALLY REPLICATIVE ONCOLYTIC ADENOVIRUS DNX-2401 WITH PEMBROLIZUMAB (KEYTRUDA) FOR RECURRENT GLIOBLASTOMA; CAPTIVE STUDY (KEYNOTE-192)","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto; University Health Network","funders":"","keywords":"Oncolytic virus; Pembrolizumab; Interim; Medicine; Oncolytic adenovirus; Glioblastoma; Oncology; Internal medicine; Phases of clinical research; Virology; Cancer research; Clinical trial; Cancer; Immunotherapy; Geography","score_opus":0.042373530892576235,"score_gpt":0.36793823247529517,"score_spread":0.32556470158271894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900303949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98877984,0.000030101668,0.000018937024,0.0014928442,0.00045498868,0.008266472,0.0003925719,0.00003635956,0.00052785355],"genre_scores_gemma":[0.99770796,0.0000058197793,0.00018289697,0.00040803858,0.00016732074,0.0014147769,0.000025165864,0.000049714872,0.000038300455],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99675024,0.00045219212,0.0009981802,0.0008349916,0.00055339787,0.00041102327],"domain_scores_gemma":[0.995612,0.0011155776,0.0010598117,0.00096416846,0.0010363162,0.00021211206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003503953,0.0003707458,0.0010096077,0.00023356693,0.00021981787,0.000009001273,0.0003189879,0.00011998797,0.000060600578],"category_scores_gemma":[0.001059771,0.00022098556,0.00018802079,0.00042750614,0.00053045613,0.00007108239,0.00027541383,0.00030031684,0.000009579469],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.36183777,0.33182424,0.020242067,0.00021938393,0.0046811327,0.0006778113,0.100777194,0.00003918417,0.13812022,0.00017533934,0.014480745,0.026924921],"study_design_scores_gemma":[0.1651219,0.70330495,0.030482456,0.0002709714,0.0022723998,0.00011764935,0.0127882045,0.00038699122,0.07815958,0.000030231693,0.0067694453,0.00029521118],"about_ca_topic_score_codex":0.00012246011,"about_ca_topic_score_gemma":0.0018589245,"teacher_disagreement_score":0.37148073,"about_ca_system_score_codex":0.00047329027,"about_ca_system_score_gemma":0.00057954725,"threshold_uncertainty_score":0.90115297},"labels":[],"label_agreement":null},{"id":"W2900305229","doi":"10.1093/neuonc/noy148.316","title":"DRES-09. IN VIVO FUNCTIONAL GENOMICS IDENTIFIES DRIVERS OF CHEMORESISTANCE IN MEDULLOBLASTOMA","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Chemotherapy; Biology; Cancer research; Sonic hedgehog; Metastasis; Oncology; Cancer; Medicine; Internal medicine; Gene; Genetics","score_opus":0.02764333757226746,"score_gpt":0.31228911194245046,"score_spread":0.284645774370183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900305229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910953,0.000055153716,0.000013584543,0.0006756924,0.00031077146,0.00035205157,0.000017074775,0.000016710897,0.0074636606],"genre_scores_gemma":[0.998769,0.0000944822,0.00031128197,0.00023823026,0.00014250458,0.000037632202,0.000008386081,0.000016866636,0.00038162677],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986362,0.00010763714,0.00032667202,0.0003150598,0.00026407378,0.0003503878],"domain_scores_gemma":[0.99914527,0.0002787689,0.00009435897,0.00023277651,0.00012247283,0.00012634683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018076538,0.0001268516,0.00036911128,0.00031458648,0.00003500318,0.000005521341,0.000109326815,0.0001276963,0.00064698316],"category_scores_gemma":[0.00036903718,0.00011970757,0.00006268943,0.0002827439,0.00037232367,0.00006771964,0.00007917375,0.00021989773,0.00007459695],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028873798,0.000523256,0.1551484,0.000051170427,0.000048282975,0.0008373522,0.00048448102,0.000009144404,0.8320602,0.000083289415,0.0039602616,0.0039067506],"study_design_scores_gemma":[0.011594258,0.0022732595,0.460861,0.00006228533,0.00003485731,0.00014293505,0.0004939385,0.0006124521,0.49260923,0.00020573717,0.030959358,0.00015067407],"about_ca_topic_score_codex":0.00017297026,"about_ca_topic_score_gemma":0.0035947107,"teacher_disagreement_score":0.339451,"about_ca_system_score_codex":0.00046245998,"about_ca_system_score_gemma":0.00042000046,"threshold_uncertainty_score":0.70840114},"labels":[],"label_agreement":null},{"id":"W2900310694","doi":"10.1093/neuonc/noy148.096","title":"ACTR-66. BEVACIZUMAB THERAPY FOR THE TREATMENT OF ADULT GLIOBLASTOMA: SYSTEMATIC REVIEW &amp; META-ANALYSIS","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Bevacizumab; Medicine; Oncology; Internal medicine; Hazard ratio; Glioblastoma; Meta-analysis; Progression-free survival; Randomized controlled trial; Population; Chemotherapy; Confidence interval; Cancer research","score_opus":0.07408253091990977,"score_gpt":0.36904526070823557,"score_spread":0.29496272978832583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900310694","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.30558482,0.5629763,0.0005979437,0.08939063,0.0011442293,0.038030438,0.00039467413,0.00025865965,0.0016223191],"genre_scores_gemma":[0.9220828,0.059572387,0.0006230532,0.00925017,0.00025783002,0.007898075,0.00005058126,0.00006296725,0.00020218421],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99787474,0.0003404305,0.0007865492,0.0004179074,0.00028238675,0.00029801522],"domain_scores_gemma":[0.99571794,0.002027854,0.00053190347,0.0010980947,0.000508499,0.000115693816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027149738,0.00031270593,0.0029919797,0.00017832725,0.00012226838,0.000010249779,0.00017495763,0.00011105252,0.0005079401],"category_scores_gemma":[0.00032230205,0.00014358273,0.0022587162,0.0005793725,0.00014824273,0.000027647822,0.000018334375,0.000060840197,0.000082210936],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033400862,0.019831983,0.00075059995,0.041049153,0.87423927,0.0002455923,0.0032070132,0.00001562475,0.021846134,0.0011702585,0.018607507,0.015696796],"study_design_scores_gemma":[0.006519356,0.02381,0.00013151935,0.00051622704,0.8459262,0.00014931777,0.00008631316,0.000104627325,0.024441369,0.000044107175,0.09807354,0.00019741194],"about_ca_topic_score_codex":0.000052720537,"about_ca_topic_score_gemma":0.00040554715,"teacher_disagreement_score":0.61649793,"about_ca_system_score_codex":0.00019955897,"about_ca_system_score_gemma":0.00011303638,"threshold_uncertainty_score":0.58551335},"labels":[],"label_agreement":null},{"id":"W2900342617","doi":"10.1093/neuonc/noy148.313","title":"DRES-06. PREVENTING THE EMERGENCE OF TEMOZOLOMIDE RESISTANCE IN GLIOBLASTOMA BY PARP-1 INHIBITION","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Temozolomide; MSH6; Cancer research; Biology; PARP inhibitor; DNA repair; Synthetic lethality; MSH2; Methyltransferase; Poly ADP ribose polymerase; MLH1; DNA mismatch repair; Molecular biology; Gene; Genetics; Methylation; Polymerase; Glioblastoma","score_opus":0.01949112033093168,"score_gpt":0.3336514222823488,"score_spread":0.3141603019514171,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900342617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98302203,0.00072889274,0.000017016639,0.005749325,0.00046112452,0.0005276487,0.000013343259,0.000029840321,0.009450795],"genre_scores_gemma":[0.9969975,0.00025355618,0.00011332893,0.0015894425,0.00029945458,0.00008231608,0.000008659195,0.00001664334,0.0006391526],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99864405,0.00025171653,0.0003967323,0.00028320582,0.00013712523,0.0002871388],"domain_scores_gemma":[0.9990931,0.00033359264,0.00021490757,0.00021456732,0.00008312366,0.000060665927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027985938,0.00012883391,0.00031992394,0.000087109926,0.00007347999,0.000002908306,0.00009745124,0.00011685806,0.00052186585],"category_scores_gemma":[0.00013624487,0.00009895449,0.000067669345,0.00033916553,0.0003103439,0.000051602998,0.000058762413,0.00023732145,0.000045601206],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015336872,0.00047476575,0.009925197,0.000048880796,0.00003264681,0.00009291245,0.00091887714,0.0000010438748,0.83666056,0.00011542588,0.14731033,0.002885659],"study_design_scores_gemma":[0.004579785,0.0047862814,0.0076568876,0.00008872852,0.00015907486,0.00008525081,0.00024664085,0.00006501972,0.600489,0.00045191997,0.3812474,0.000144025],"about_ca_topic_score_codex":0.00006429793,"about_ca_topic_score_gemma":0.0016209366,"teacher_disagreement_score":0.23617159,"about_ca_system_score_codex":0.0001053098,"about_ca_system_score_gemma":0.0001641984,"threshold_uncertainty_score":0.57140654},"labels":[],"label_agreement":null},{"id":"W2900363699","doi":"10.1093/neuonc/noy148.964","title":"RTHP-34. CRANIOSPINAL IRRADIATION (CSI) AS PART OF RE-IRRADIATION (RT2) FOR CHILDREN WITH RECURRENT INTRACRANIAL EPENDYMOMA","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Ependymoma; Medicine; Radiation therapy; Overall survival; Nuclear medicine; Log-rank test; Surgery","score_opus":0.020900944284560557,"score_gpt":0.30734559449112686,"score_spread":0.2864446502065663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900363699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917213,0.00011920436,0.000087061,0.004346477,0.00075774704,0.0015978334,0.000054839526,0.000055811306,0.0012597429],"genre_scores_gemma":[0.9964179,0.0000766139,0.00096745056,0.0008995321,0.0011566456,0.00025401678,0.00017935206,0.00003870852,0.000009820996],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9983963,0.00010614285,0.0004387755,0.00044889408,0.00026837995,0.00034151017],"domain_scores_gemma":[0.99866265,0.00022728725,0.00034787858,0.0003157222,0.00026976786,0.00017667576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001865952,0.00022355422,0.0004920453,0.00016848929,0.000118708616,0.000012575531,0.00009749258,0.00019363587,0.00023861417],"category_scores_gemma":[0.0002622433,0.00018145704,0.00011906702,0.00021642099,0.00015014358,0.00009302441,0.00002440614,0.00015882455,0.000066101304],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013407699,0.008066153,0.25454062,0.00018668856,0.0011819651,0.00041370024,0.002122336,0.000037809677,0.099354066,0.0043868353,0.026516132,0.589786],"study_design_scores_gemma":[0.017100932,0.050610974,0.85409766,0.00008970304,0.0008267486,0.0009846899,0.000081080696,0.00053541036,0.0186422,0.00045274053,0.056274008,0.0003038548],"about_ca_topic_score_codex":0.00007113698,"about_ca_topic_score_gemma":0.00022862118,"teacher_disagreement_score":0.59955704,"about_ca_system_score_codex":0.00023725763,"about_ca_system_score_gemma":0.00030747705,"threshold_uncertainty_score":0.7399603},"labels":[],"label_agreement":null},{"id":"W2900387472","doi":"10.1093/neuonc/noy148.172","title":"CSIG-06. THE MOLECULAR SUBTYPE OF PRIMARY GLIOBLASTOMA CELLS CORRELATES WITH RESPONSE TO THERAPEUTIC AGENTS THAT INDUCE APOPTOSIS OR SENESCENCE","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Senescence; Glioblastoma; Apoptosis; Cancer research; Primary (astronomy); Cellular senescence; Biology; Cell biology; Genetics; Gene; Phenotype; Physics","score_opus":0.022051754566907732,"score_gpt":0.279633525026118,"score_spread":0.25758177045921027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900387472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99598724,0.00031546335,0.0008094556,0.001499089,0.000374548,0.0004925956,0.00001455086,0.000014590301,0.0004924456],"genre_scores_gemma":[0.9905996,0.00013466533,0.00020372792,0.008523514,0.00016962804,0.00004961046,0.000006229108,0.000047449,0.0002656239],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99827474,0.00042990962,0.00024612658,0.0004800079,0.00021734205,0.00035187154],"domain_scores_gemma":[0.99871194,0.00017229888,0.00019718044,0.00061587914,0.0001939192,0.00010876401],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035406003,0.00023325978,0.00028745257,0.00006413091,0.00011252454,0.000016939288,0.00045074822,0.0002463032,0.000060336555],"category_scores_gemma":[0.0000788406,0.00014776945,0.000099485645,0.00027801658,0.00035667277,0.000005300942,0.00017871612,0.00012390342,0.00004083231],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008018049,0.00010175366,0.0023653654,0.00001178862,0.00008699619,0.000023105678,0.00018414753,0.00004009478,0.981319,0.000011834668,0.004796993,0.0030408348],"study_design_scores_gemma":[0.00051910686,0.005415079,0.0024939864,0.000016225515,0.000058833248,0.00006281597,0.00008980825,0.000012190518,0.83349,0.0000042487345,0.1576677,0.00016997944],"about_ca_topic_score_codex":0.00001805239,"about_ca_topic_score_gemma":0.000027194385,"teacher_disagreement_score":0.15287071,"about_ca_system_score_codex":0.000051596468,"about_ca_system_score_gemma":0.00047473752,"threshold_uncertainty_score":0.60258627},"labels":[],"label_agreement":null},{"id":"W2900423557","doi":"10.1093/neuonc/noy148.777","title":"NIMG-51. THE IMPACT OF FUNCTIONAL MAGNETIC RESONANCE IMAGING ON CLINICAL OUTCOMES IN A PROPENSITY-MATCHED LOW GRADE GLIOMA COHORT","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Functional magnetic resonance imaging; Propensity score matching; Magnetic resonance imaging; Cohort; Retrospective cohort study; Glioma; Cohort study; Surgery; Internal medicine; Radiology","score_opus":0.04926363825930713,"score_gpt":0.36658623593270584,"score_spread":0.3173225976733987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900423557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99042225,0.000218788,0.0000015422569,0.006833661,0.00046625728,0.0008851328,0.000010010988,0.000027247632,0.0011351096],"genre_scores_gemma":[0.99764585,0.000044704288,0.00004633873,0.0019096859,0.00021977458,0.000078588455,0.0000075920916,0.000023310466,0.000024141054],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99807984,0.00034155505,0.0005683164,0.00041457787,0.000267294,0.00032839153],"domain_scores_gemma":[0.99796295,0.0011462166,0.00017636505,0.00046006116,0.0001349467,0.0001194833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048466388,0.00020203461,0.000740927,0.00015534241,0.000060386254,0.000009571346,0.00012420413,0.00011283603,0.00022874102],"category_scores_gemma":[0.00061533734,0.000114542796,0.00026562402,0.00028631568,0.00044107184,0.000036236164,0.00007936212,0.00033719552,0.00011752145],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008488051,0.0024939235,0.95925325,0.0000058285127,0.000056579323,0.0007026466,0.00008805264,0.0000055286137,0.021096746,0.00004581703,0.0052190917,0.010183713],"study_design_scores_gemma":[0.004930209,0.006393782,0.9824152,0.000035878715,0.00009820017,0.00026216535,0.000022554488,0.00024722694,0.0027850538,0.0000791258,0.0026455072,0.000085096945],"about_ca_topic_score_codex":0.00021734645,"about_ca_topic_score_gemma":0.00010878347,"teacher_disagreement_score":0.023161931,"about_ca_system_score_codex":0.00020474885,"about_ca_system_score_gemma":0.0002909814,"threshold_uncertainty_score":0.46709198},"labels":[],"label_agreement":null},{"id":"W2908578072","doi":"10.1093/neuonc/noy143","title":"Imaging and diagnostic advances for intracranial meningiomas","year":2018,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":189,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"Canadian Institutes of Health Research; National Center for Advancing Translational Sciences; National Institute of Neurological Disorders and Stroke; Brain Tumour Charity","keywords":"Meningioma; Medicine; Radiology; Medical imaging; Radiological imaging; Asymptomatic; Radiological weapon; Magnetic resonance imaging; Medical physics; Pathology","score_opus":0.040986541535662974,"score_gpt":0.3667433045078545,"score_spread":0.32575676297219147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908578072","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011805435,0.9908572,0.0004929631,0.00049467804,0.0017478493,0.0024951177,0.000023116812,0.00009721584,0.0036738254],"genre_scores_gemma":[0.000050912302,0.9923633,0.004493749,0.000289777,0.0018084354,0.00067456556,0.00008920383,0.00009577619,0.00013428452],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976714,0.00018757339,0.00069845223,0.0007615505,0.00017917472,0.0005018194],"domain_scores_gemma":[0.99606967,0.0028446768,0.00040646052,0.00036717355,0.000091427406,0.00022056644],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00041031739,0.0004466137,0.0019531252,0.00030689337,0.00014332822,0.00003668504,0.00018699068,0.0002455364,0.00006533803],"category_scores_gemma":[0.0014484897,0.000359868,0.00032338165,0.00018418365,0.0002153555,0.00008805076,0.0001875226,0.00033407166,0.00006042049],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006537059,0.0000689712,0.000019584097,0.009491698,0.000113703296,0.0031423673,0.000056881272,3.0398986e-8,0.000023221475,0.00021477348,0.008454224,0.97834915],"study_design_scores_gemma":[0.0010598571,0.0014446944,0.000004609425,0.0020336094,0.0024613827,0.005559061,0.000022032791,0.000050358147,0.0000035326775,0.0001376688,0.98695266,0.0002705245],"about_ca_topic_score_codex":0.0000024957283,"about_ca_topic_score_gemma":0.0000019966856,"teacher_disagreement_score":0.97849846,"about_ca_system_score_codex":0.00015735666,"about_ca_system_score_gemma":0.00028990576,"threshold_uncertainty_score":0.9998853},"labels":[],"label_agreement":null},{"id":"W2908805387","doi":"10.1093/neuonc/noy136","title":"Advances in multidisciplinary therapy for meningiomas","year":2018,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":165,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"Canadian Institutes of Health Research; National Center for Advancing Translational Sciences; National Institute of Neurological Disorders and Stroke; Brain Tumour Charity","keywords":"Medicine; Meningioma; Radiation therapy; Adjuvant radiotherapy; Retrospective cohort study; Adjuvant therapy; Systemic therapy; Surgery; Oncology; Internal medicine; Cancer; Chemotherapy; Breast cancer","score_opus":0.08942907686859627,"score_gpt":0.423043469464102,"score_spread":0.33361439259550574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2908805387","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001851746,0.98170966,0.000092061484,0.0002824286,0.001349236,0.004041253,0.000014590358,0.0000841659,0.012241427],"genre_scores_gemma":[0.000033919394,0.9942019,0.0026487084,0.0001227721,0.0008395429,0.0015407654,0.00014285553,0.00010683808,0.00036268568],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971648,0.0002996562,0.0009138278,0.0008486152,0.00020922995,0.0005639041],"domain_scores_gemma":[0.9978723,0.00087150116,0.0004619417,0.00056134124,0.00007612657,0.00015681611],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005756982,0.0004982097,0.002426612,0.00056021445,0.00009430492,0.000014448662,0.0003146165,0.0004877863,0.00009235722],"category_scores_gemma":[0.0001773272,0.00037643552,0.00057494926,0.00039753126,0.00014066546,0.00009006986,0.00017798725,0.000421118,0.00010661623],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032273645,0.00030010342,0.000018234083,0.0058582383,0.00008086595,0.0018006167,0.00015360602,2.624097e-7,0.000046096196,0.00017522048,0.0035919475,0.98765206],"study_design_scores_gemma":[0.0021716305,0.0042814873,0.000007241381,0.0020766947,0.0003682848,0.00082905916,0.000032093463,0.000030491561,0.000010582703,0.00013043254,0.98977476,0.00028722506],"about_ca_topic_score_codex":0.0000023114976,"about_ca_topic_score_gemma":0.0000059553686,"teacher_disagreement_score":0.9873648,"about_ca_system_score_codex":0.00031134445,"about_ca_system_score_gemma":0.0004890081,"threshold_uncertainty_score":0.99986875},"labels":[],"label_agreement":null},{"id":"W2909042567","doi":"10.1093/neuonc/noy195","title":"Malignant primary brain and other central nervous system tumors diagnosed in Canada from 2009 to 2013","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ministry of Health and Social Services; CancerCare Manitoba; Alberta Hospital Edmonton; Alberta Health Services; Cancer Care Ontario; Public Health Agency of Canada; BC Cancer Agency; Brain Tumour Foundation of Canada; University of Alberta","funders":"BC Cancer Agency; Health Canada; University of Alberta; Brain Tumour Foundation of Canada; Fondation Brain Canada; McGill University","keywords":"Medicine; Population; Incidence (geometry); Cancer registry; Brain tumor; Confidence interval; Histology; Cancer; Pediatrics; Internal medicine; Pathology","score_opus":0.011462942562967997,"score_gpt":0.2424730851837808,"score_spread":0.2310101426208128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909042567","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98681056,0.00032163516,0.000002443853,0.010137121,0.00058935094,0.00072084746,0.00009543883,0.000029375813,0.0012932383],"genre_scores_gemma":[0.98063505,0.000018023624,0.0001417435,0.018746937,0.00029423926,0.00010356594,0.000015218875,0.000030469548,0.000014776797],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984527,0.00015018744,0.00031700617,0.0004213605,0.00017514297,0.00048357586],"domain_scores_gemma":[0.9987964,0.0004529998,0.000080501515,0.00026730055,0.000036721463,0.000366079],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008131432,0.00018948203,0.0005129483,0.00010092323,0.00004309562,0.000010419118,0.000085026986,0.000085966756,0.00012645796],"category_scores_gemma":[0.0000776057,0.00015379558,0.000033900127,0.0001488152,0.000052393458,0.000024036495,0.000064895234,0.00012194212,0.000049164886],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045106915,0.0005483713,0.7034084,0.00006595799,0.00008549958,0.015363887,0.00089113874,0.000017536882,0.08697462,0.000101755315,0.16404524,0.028046472],"study_design_scores_gemma":[0.0039172354,0.0013993509,0.8337101,0.00015150054,0.000066302986,0.000239934,0.00038000208,0.00012532911,0.0068688095,0.000006768089,0.15296286,0.0001717996],"about_ca_topic_score_codex":0.7811757,"about_ca_topic_score_gemma":0.86258435,"teacher_disagreement_score":0.13030167,"about_ca_system_score_codex":0.0012203667,"about_ca_system_score_gemma":0.00095109775,"threshold_uncertainty_score":0.6271602},"labels":[],"label_agreement":null},{"id":"W2909734970","doi":"10.1093/neuonc/noy152","title":"Life after surgical resection of a meningioma: a prospective cross-sectional study evaluating health-related quality of life","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Alberta; Princess Margaret Cancer Centre; University Health Network","funders":"Canadian Institutes of Health Research; National Center for Advancing Translational Sciences; National Institute of Neurological Disorders and Stroke; Brain Tumour Charity","keywords":"Medicine; Quality of life (healthcare); Meningioma; Confidence interval; Prospective cohort study; Population; Cohort; Cohort study; Cross-sectional study; Health related quality of life; Surgery; Internal medicine; Disease; Pathology","score_opus":0.11215384200841856,"score_gpt":0.44048188621134854,"score_spread":0.32832804420293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909734970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921149,0.00013424677,0.000035113968,0.0006312239,0.00072203187,0.0017315653,0.00000778669,0.00006314628,0.0045600086],"genre_scores_gemma":[0.9987988,0.0000013752161,0.00035605446,0.00015564455,0.0003422818,0.0001826598,0.000007743756,0.000022409658,0.00013302431],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952047,0.0013236589,0.001736572,0.00058894494,0.0007905133,0.00035562026],"domain_scores_gemma":[0.99709094,0.0005699369,0.0008903293,0.0003907736,0.0007346058,0.00032341888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003917222,0.00019290892,0.00091348746,0.00029423845,0.00015175846,0.000012230774,0.00011455799,0.00018654826,0.0005018846],"category_scores_gemma":[0.00303097,0.00017278126,0.00017629334,0.00056994194,0.0003576523,0.0000830011,0.00017003359,0.0003688884,0.000024441399],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018148193,0.0019719347,0.95560294,0.00018498542,0.00037325124,0.0002718944,0.0034059598,0.0000156594,0.018961146,0.00041277296,0.00030914013,0.00034213768],"study_design_scores_gemma":[0.009610853,0.03632245,0.9514984,0.000027392207,0.000078061414,0.00025515913,0.000523586,0.0004331741,0.00071740564,0.00012830032,0.00028319913,0.0001220521],"about_ca_topic_score_codex":0.00044249962,"about_ca_topic_score_gemma":0.00006151227,"teacher_disagreement_score":0.034350514,"about_ca_system_score_codex":0.00028669287,"about_ca_system_score_gemma":0.0009154372,"threshold_uncertainty_score":0.70458156},"labels":[],"label_agreement":null},{"id":"W2910801868","doi":"10.1093/neuonc/noy178","title":"Molecular and translational advances in meningiomas","year":2018,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":140,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research; National Center for Advancing Translational Sciences; National Institute of Neurological Disorders and Stroke; Brain Tumour Charity","keywords":"Meningioma; Epigenomics; Medicine; Clinical trial; Disease; Bioinformatics; Pathology; Biology","score_opus":0.04450437069654302,"score_gpt":0.3673298499988644,"score_spread":0.3228254793023214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910801868","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00031130834,0.9729691,0.0000770145,0.0002726041,0.00033072705,0.0009151625,0.0000063306675,0.000035702942,0.025082063],"genre_scores_gemma":[0.00016079511,0.99800336,0.0011096766,0.00016089393,0.00020726629,0.00014492487,0.00006860672,0.000047343572,0.00009710927],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99808,0.0002614158,0.0005877968,0.0005553893,0.00021639532,0.00029901674],"domain_scores_gemma":[0.9991098,0.0002718963,0.0002024481,0.0002508612,0.000034357625,0.00013065699],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00029008905,0.00030949857,0.0014285932,0.00035126417,0.000045504352,0.000015115998,0.0001203457,0.00031339604,0.00010304701],"category_scores_gemma":[0.00008364139,0.00026006662,0.00019849426,0.00029124296,0.00013322417,0.00006585074,0.00006964733,0.00036804838,0.000040400944],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005341158,0.00009001215,0.000026606405,0.0055143367,0.00007937145,0.006742907,0.00008497813,5.954102e-7,0.000058546713,0.0009138301,0.00078693393,0.98564845],"study_design_scores_gemma":[0.00075200363,0.00067627145,0.000008655879,0.0013396776,0.000543311,0.002061036,0.000007778808,0.000018473364,0.0000080421605,0.00016135343,0.9942432,0.00018019],"about_ca_topic_score_codex":0.0000028985216,"about_ca_topic_score_gemma":0.0000046558125,"teacher_disagreement_score":0.99345624,"about_ca_system_score_codex":0.00006943736,"about_ca_system_score_gemma":0.0002714589,"threshold_uncertainty_score":0.99998516},"labels":[],"label_agreement":null},{"id":"W2910893602","doi":"10.1093/neuonc/noy181","title":"Challenges and opportunities in meningiomas: recommendations from the International Consortium on Meningiomas","year":2018,"lang":"en","type":"editorial","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Brain Tumour Charity","keywords":"Meningioma; Medicine; Radiology","score_opus":0.10621162622252624,"score_gpt":0.3454834786583993,"score_spread":0.23927185243587307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910893602","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013543005,0.002464067,0.000009726969,0.089102626,0.7577191,0.0009779843,0.00024196843,0.00014070068,0.13580084],"genre_scores_gemma":[0.021322735,0.0148703335,0.0010898274,0.0038150914,0.9494851,0.000717628,0.0034097712,0.00023379369,0.0050557074],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99696404,0.0004645172,0.00069766515,0.00082163524,0.00066881493,0.00038330027],"domain_scores_gemma":[0.99414,0.004484287,0.00042513225,0.0005847605,0.00020473971,0.00016103135],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009522277,0.00040762688,0.00074230303,0.0003538498,0.00017347475,0.00007991631,0.00045907678,0.0006713751,0.00044071965],"category_scores_gemma":[0.0013699641,0.00032145513,0.00011578231,0.00007847885,0.00030738747,0.00008726603,0.00040011204,0.0010221871,0.00004888537],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000513856,0.00016668465,0.000025546742,0.000027776134,0.00027112858,0.0020062742,0.0015233867,2.686716e-7,0.00042594687,0.0008888673,0.968085,0.02606528],"study_design_scores_gemma":[0.0021328914,0.0015601726,0.00021162779,0.00024298903,0.0002231544,0.00010430289,0.0013366597,0.00005059684,0.00009163847,0.00045970533,0.9933477,0.00023855567],"about_ca_topic_score_codex":0.000117427844,"about_ca_topic_score_gemma":0.00021927115,"teacher_disagreement_score":0.19176602,"about_ca_system_score_codex":0.00034689074,"about_ca_system_score_gemma":0.00043716244,"threshold_uncertainty_score":0.99992377},"labels":[],"label_agreement":null},{"id":"W2911536283","doi":"10.1093/neuonc/noz021","title":"Identification of genes functionally involved in the detrimental effects of mutant histone H3.3-K27M in Drosophila melanogaster","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Jewish General Hospital; McGill University","funders":"Canadian Institutes of Health Research; National Cancer Institute; National Institutes of Health; American University of Beirut; Deutsche Forschungsgemeinschaft; Natural Sciences and Engineering Research Council of Canada","keywords":"Biology; Drosophila melanogaster; Mutant; Histone; Histone H3; Gene; Gene knockdown; Genetics; Chromatin; RNA interference; Chromatin immunoprecipitation; Model organism; Phenotype; Mutation; Epigenetics; Genetic screen; Cell biology; Gene expression; RNA; Promoter","score_opus":0.01451104366238806,"score_gpt":0.28491693362805803,"score_spread":0.27040588996567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911536283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969172,0.00058456825,0.0000021567855,0.00092207844,0.0004178647,0.0008605685,0.0000044170074,0.0000053452313,0.0002857932],"genre_scores_gemma":[0.9992163,0.000059510312,0.000019138633,0.0005447369,0.00003147707,0.00009338298,0.000017593611,0.000010168048,0.000007687627],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988477,0.00017739834,0.0004233963,0.00021126475,0.0002089172,0.0001312857],"domain_scores_gemma":[0.99888927,0.0005809142,0.0002026066,0.00024667685,0.00005292063,0.000027605856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023006053,0.00010067332,0.0003450483,0.0002327543,0.000011084128,0.0000024786805,0.000086033135,0.000091949514,0.000035305737],"category_scores_gemma":[0.00009151853,0.000072189425,0.00006417894,0.0002876127,0.000063906016,0.000036740574,0.000030598254,0.00011321784,0.000024746618],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020944641,0.0012710885,0.22533058,0.000075104756,0.00002301925,0.00011841455,0.00033777265,0.000016013406,0.7712832,0.00017968657,0.00006951691,0.0010861672],"study_design_scores_gemma":[0.0052936953,0.0017195783,0.41593063,0.0000462986,0.00008257031,0.000044957098,0.00016431916,0.000086686305,0.57541794,0.00007535135,0.0010887303,0.000049250306],"about_ca_topic_score_codex":0.00006235596,"about_ca_topic_score_gemma":0.00011424906,"teacher_disagreement_score":0.19586527,"about_ca_system_score_codex":0.0001801251,"about_ca_system_score_gemma":0.000101188074,"threshold_uncertainty_score":0.29437992},"labels":[],"label_agreement":null},{"id":"W2939794316","doi":"10.1093/neuonc/noz066","title":"Prognostic significance of human telomerase reverse transcriptase promoter region mutations C228T and C250T for overall survival in spinal chordomas","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Bone Tumor Diagnosis and Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health; Sunnybrook Health Science Centre; Health Sciences Centre; University of British Columbia","funders":"National Cancer Institute; AOSpine; AO Foundation","keywords":"Telomerase reverse transcriptase; Chordoma; Chondrosarcoma; Medicine; Telomerase; Mutation; Sarcoma; Cancer research; Internal medicine; Oncology; Pathology; Biology; Gene; Genetics","score_opus":0.038795111187250424,"score_gpt":0.32358151874992513,"score_spread":0.2847864075626747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2939794316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99466926,0.00011408972,0.0000135101845,0.0021270553,0.00020233724,0.0023696215,0.000024073663,0.000019632169,0.00046040711],"genre_scores_gemma":[0.9986714,0.000039601793,0.00037152873,0.0003673884,0.00004416783,0.00031285195,0.000048548973,0.000024533927,0.00011994385],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988371,0.00010665004,0.00034487154,0.00035832747,0.000114708804,0.00023832767],"domain_scores_gemma":[0.9992835,0.00021980933,0.00013326021,0.00019154513,0.000071065886,0.00010084997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012969355,0.00015283721,0.0004712779,0.00013104586,0.000038467373,0.000005575281,0.000048378817,0.000093321236,0.000033063316],"category_scores_gemma":[0.000113164955,0.0001376967,0.000078861754,0.000112555295,0.0001069908,0.00007340963,0.000013341073,0.00015988665,0.000006840502],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019001771,0.00291191,0.57302016,0.0005975646,0.00007719615,0.00092675525,0.0006649892,0.000004222958,0.40849948,0.0010820585,0.0005225065,0.009792945],"study_design_scores_gemma":[0.0313243,0.027703673,0.89845777,0.00042304973,0.0006284241,0.00040497156,0.00027923597,0.00016087954,0.022249525,0.0009721492,0.01701095,0.0003850645],"about_ca_topic_score_codex":0.00013289691,"about_ca_topic_score_gemma":0.000087719294,"teacher_disagreement_score":0.38624996,"about_ca_system_score_codex":0.00008705691,"about_ca_system_score_gemma":0.0001323397,"threshold_uncertainty_score":0.5615108},"labels":[],"label_agreement":null},{"id":"W2940897955","doi":"10.1093/neuonc/noz036.200","title":"MEDU-42. ELUCIDATING THE ROLE OF STRESS GRANULE FORMATION IN MEDULLOBLASTOMA","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medulloblastoma; Stress granule; Cancer research; Apoptosis; Vincristine; Malignancy; Kinase; Cell growth; Integrated stress response; Biology; Translation (biology); Medicine; Cell biology; Internal medicine; Gene; Chemotherapy; Genetics","score_opus":0.007395292899446653,"score_gpt":0.2691838098082964,"score_spread":0.2617885169088498,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2940897955","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99346244,0.00020139402,0.00006448483,0.00034102885,0.00009392976,0.00027057063,0.0000075886865,0.0000051423026,0.005553447],"genre_scores_gemma":[0.9994085,0.00008008913,0.00008649893,0.0002238247,0.000065332184,0.000024906523,0.000029397712,0.000011333503,0.00007015122],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99897105,0.00019756184,0.00023898866,0.00018892834,0.00014071839,0.00026277135],"domain_scores_gemma":[0.999415,0.00009451166,0.00011302566,0.00027278712,0.000058648016,0.00004607684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002743926,0.00008678342,0.00015130633,0.00005751204,0.0000388561,0.0000085974325,0.00025608562,0.00012108436,0.000030386233],"category_scores_gemma":[0.00018208988,0.00006595507,0.0000506339,0.00010815581,0.000059135786,0.000008134656,0.00013958616,0.00017251296,0.000020532423],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000112439484,0.000044455217,0.0068118577,0.00001554562,0.0000067658902,0.0000037604668,0.00013446956,0.00014374749,0.9749759,0.00012599427,0.00012946226,0.017495604],"study_design_scores_gemma":[0.00064833235,0.0007424279,0.0015577237,0.000011334136,0.0000035565147,0.000030055302,0.0007001073,0.001956816,0.96905506,0.00008211263,0.025142841,0.000069663336],"about_ca_topic_score_codex":0.00006636578,"about_ca_topic_score_gemma":0.00037371216,"teacher_disagreement_score":0.02501338,"about_ca_system_score_codex":0.000024745263,"about_ca_system_score_gemma":0.00008142558,"threshold_uncertainty_score":0.268957},"labels":[],"label_agreement":null},{"id":"W2941020419","doi":"10.1093/neuonc/noz036.008","title":"ATRT-09. INTEGRATIVE ANALYSES OF GENE REGULATORY LANDSCAPES REVEAL RHABDOID TUMOR SUBGROUPS WITH POSSIBLE IMMUNE MODULATION THROUGH EPIGENETIC DYSREGULATION","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Tumors and Oncological Cases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre","funders":"","keywords":"Epigenetics; Immune system; Gene; Immune dysregulation; Biology; Epigenesis; Psychology; DNA methylation; Neuroscience; Genetics; Gene expression","score_opus":0.028439028686886105,"score_gpt":0.31530838113756016,"score_spread":0.2868693524506741,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2941020419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99324375,0.0007242989,0.0006617115,0.00055726577,0.00023639252,0.00081829494,0.000015774076,0.00007380382,0.003668692],"genre_scores_gemma":[0.99397075,0.000056005727,0.0049180593,0.00042137492,0.00022817278,0.00003428637,0.00009548149,0.00003639083,0.00023946154],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99784905,0.00028275084,0.0006583276,0.0005116417,0.00036340408,0.0003348055],"domain_scores_gemma":[0.99806714,0.000517829,0.0005292576,0.00046904333,0.00030513486,0.00011161007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002285499,0.00028815982,0.0009782141,0.00016324587,0.000076059565,0.000011337425,0.00013293604,0.00019527992,0.0002868202],"category_scores_gemma":[0.00018828113,0.0001923269,0.00017675005,0.00046065208,0.00019021641,0.00016327814,0.000054706114,0.00030941938,0.00003487327],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020401601,0.00038067042,0.05492149,0.00007872277,0.000053806227,0.00021383239,0.00044758804,0.0012955917,0.9325387,0.0003126672,0.0001761309,0.007540666],"study_design_scores_gemma":[0.0032804138,0.010080887,0.61553633,0.00010438645,0.00029918083,0.00056323886,0.00046368848,0.0023652478,0.36536765,0.00040937797,0.0012896565,0.0002399627],"about_ca_topic_score_codex":0.00011090482,"about_ca_topic_score_gemma":0.00006185203,"teacher_disagreement_score":0.56717104,"about_ca_system_score_codex":0.00020315364,"about_ca_system_score_gemma":0.00029073443,"threshold_uncertainty_score":0.7842864},"labels":[],"label_agreement":null},{"id":"W2941112345","doi":"10.1093/neuonc/noz036.159","title":"LGG-16. PREDICTORS OF OUTCOME IN BRAF-V600E PEDIATRIC GLIOMAS TREATED WITH BRAF INHIBITORS: A REPORT FROM THE PLGG TASKFORCE","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Université Laval; Stollery Children's Hospital; Hospital for Sick Children","funders":"","keywords":"Medicine; Oncology; Internal medicine; Cohort; Clinical trial; Chemotherapy; V600E; Mutation; Gene","score_opus":0.015121974236586842,"score_gpt":0.27326831815945585,"score_spread":0.258146343922869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2941112345","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929451,0.00032058076,0.000001299403,0.0021914097,0.0005388124,0.0013542323,0.00004356863,0.00007902943,0.0025260134],"genre_scores_gemma":[0.9983749,0.00006019739,0.000052300722,0.00073167897,0.0004035985,0.00012225356,0.00011545209,0.00005407177,0.00008556675],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974566,0.0002019683,0.0008773994,0.0006195455,0.00042532716,0.00041912246],"domain_scores_gemma":[0.9973502,0.0010384754,0.0005187164,0.0008044946,0.00011564898,0.00017242643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024619477,0.00032254952,0.00090968685,0.0002914733,0.000041048646,0.000012691918,0.00018791652,0.00026995063,0.00021469923],"category_scores_gemma":[0.0002960653,0.00019412767,0.00017050361,0.00080189714,0.00011854544,0.00008262562,0.00010546087,0.00038361407,0.00007171522],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005262838,0.0010536987,0.9730674,0.00003338845,0.00012871636,0.004169328,0.0004075307,0.00002186322,0.016080812,0.000015794338,0.003963519,0.00053163373],"study_design_scores_gemma":[0.01193216,0.004594815,0.94289213,0.00006978867,0.000768796,0.0010491948,0.0003339335,0.00003533778,0.020774754,0.00002039614,0.01729027,0.00023842278],"about_ca_topic_score_codex":0.0014212495,"about_ca_topic_score_gemma":0.0005162675,"teacher_disagreement_score":0.0301753,"about_ca_system_score_codex":0.00030961705,"about_ca_system_score_gemma":0.00029015902,"threshold_uncertainty_score":0.7916297},"labels":[],"label_agreement":null},{"id":"W2941193626","doi":"10.1093/neuonc/noz036.170","title":"MEDU-11. MOLECULAR CHARACTERIZATION OF ETMRs REVEALS A ROLE FOR R-LOOP MEDIATED CHROMOSOMAL INSTABILITY","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Somatic cell; Biology; Genome instability; Germline; Chromosome instability; Missense mutation; Gene; Genetics; Allele; Chromosome; Cancer research; DNA; Mutation; DNA damage","score_opus":0.00781702785624331,"score_gpt":0.2546241547081392,"score_spread":0.2468071268518959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2941193626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99727094,0.00009692408,0.00056290545,0.00030430368,0.00028158855,0.0010560532,0.00015816391,0.000020430767,0.00024868877],"genre_scores_gemma":[0.9976505,0.000025234523,0.00030302003,0.0005006909,0.000102298305,0.00010388441,0.001248031,0.0000372197,0.000029138031],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99850315,0.00021985677,0.00041434204,0.00046983457,0.00013235418,0.00026044954],"domain_scores_gemma":[0.99882376,0.00007088185,0.00031370908,0.0004686171,0.00022587404,0.000097132644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002391029,0.00017138288,0.00031380923,0.000060647664,0.000029805356,0.0000068669187,0.00020240617,0.00033888975,0.000078334204],"category_scores_gemma":[0.0003798508,0.0001813066,0.00013615248,0.0001200963,0.000088741945,0.000008639543,0.00010535329,0.000072356976,0.000014787027],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000268642,0.00016750142,0.007307981,0.00008161265,0.000033779314,0.00000223804,0.000037202455,0.000023956001,0.9907733,0.00009076479,0.00007663567,0.0011363607],"study_design_scores_gemma":[0.0012893691,0.00076074176,0.01349832,0.000009095094,0.00003888949,0.000012287913,0.000016790511,0.0004138422,0.9443156,0.00006919676,0.039413672,0.00016216036],"about_ca_topic_score_codex":0.000005083829,"about_ca_topic_score_gemma":0.00000771307,"teacher_disagreement_score":0.04645769,"about_ca_system_score_codex":0.000054575947,"about_ca_system_score_gemma":0.00026441718,"threshold_uncertainty_score":0.73934686},"labels":[],"label_agreement":null},{"id":"W2941439192","doi":"10.1093/neuonc/noz036.112","title":"HGG-18. ALTERNATIVE SPLICING OF NEUROFIBROMIN 1 IS ASSOCIATED WITH ELEVATED MAPK ACTIVITY AND POOR PROGNOSIS IN HIGH-GRADE GLIOMA","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Neurofibromin 1; MAPK/ERK pathway; Glioma; Cancer research; PI3K/AKT/mTOR pathway; Biology; Alternative splicing; RNA splicing; Carcinogenesis; Mutation; Signal transduction; Neurofibromatosis; Medicine; Genetics; Gene; RNA; Messenger RNA","score_opus":0.016597045529105105,"score_gpt":0.28580200456537247,"score_spread":0.26920495903626734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2941439192","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983554,0.000034711476,0.000017652328,0.0007042686,0.00007380286,0.0005314047,0.00002730683,0.0000117588215,0.00024371322],"genre_scores_gemma":[0.99929476,0.00007510099,0.000097033706,0.00029606474,0.00003578256,0.000032777338,0.000023100969,0.00003169077,0.000113664384],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982896,0.0003245011,0.00023832089,0.0005295011,0.00019628572,0.00042180534],"domain_scores_gemma":[0.9992046,0.00016817928,0.00021413284,0.00020608779,0.00009793091,0.0001091025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024765983,0.00019323682,0.0004085847,0.00015661653,0.000037429712,0.000015019605,0.00017323409,0.00021594518,0.0000255156],"category_scores_gemma":[0.00019901156,0.00017088008,0.000048616803,0.000282052,0.00012150055,0.000011876845,0.00017942896,0.00027513248,0.0000042522825],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006544466,0.00021442074,0.043441847,0.00002644884,0.00006780376,0.000103008904,0.00007485209,0.00002587459,0.9541429,0.000012309413,0.00019814249,0.0010379034],"study_design_scores_gemma":[0.002679594,0.0037280952,0.03713586,0.000032839176,0.000015677002,0.000052833504,0.000050275514,0.00094971526,0.9548295,0.000014416046,0.00035377496,0.00015739894],"about_ca_topic_score_codex":0.00047098487,"about_ca_topic_score_gemma":0.00025219185,"teacher_disagreement_score":0.006305988,"about_ca_system_score_codex":0.00005566686,"about_ca_system_score_gemma":0.00014941022,"threshold_uncertainty_score":0.6968287},"labels":[],"label_agreement":null},{"id":"W2941510530","doi":"10.1093/neuonc/noz036.057","title":"DIPG-36. CLINICAL, RADIOLOGICAL, AND HISTO-MOLECULAR CHARACTERISTICS OF DIFFUSE INTRINSIC PONTINE GLIOMA IN PATIENTS WHO SURVIVE LESS THAN 3 MONTHS FROM DIAGNOSIS: A REPORT FROM THE INTERNATIONAL DIPG REGISTRY","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Glioma; Stereotactic biopsy; Biopsy; Radiation therapy; Chemotherapy; Radiology; Surgery; Internal medicine","score_opus":0.022778514090043785,"score_gpt":0.29302628062065617,"score_spread":0.2702477665306124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2941510530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932201,0.00051938486,0.0000031687468,0.0034820202,0.0013865976,0.00084661774,0.00027339024,0.000024889616,0.00024386225],"genre_scores_gemma":[0.99682266,0.000896504,0.00008280286,0.001255204,0.00023114604,0.00014588328,0.00052685285,0.000030466637,0.000008461347],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971684,0.0003902235,0.0010982266,0.0007306417,0.00034477204,0.00026773603],"domain_scores_gemma":[0.9956782,0.0024042844,0.00081723643,0.0007560584,0.00018594043,0.0001582775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003195085,0.0002786203,0.0010846858,0.00010287616,0.00003783841,0.000024953562,0.00030818672,0.0003200905,0.00008376222],"category_scores_gemma":[0.002107234,0.00019426206,0.00018547116,0.00014631294,0.00028258617,0.000057334877,0.00031270646,0.0004395561,0.000012174344],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010598907,0.0032606006,0.9705951,0.000009292805,0.00026079442,0.00332459,0.00020911949,4.6311473e-7,0.0055942424,0.000026303054,0.0011716987,0.014487865],"study_design_scores_gemma":[0.008377134,0.0014669236,0.97401935,0.00011477116,0.00022012404,0.00004826564,0.00011380903,0.000027836582,0.00092795235,0.00006035265,0.014473503,0.00014998659],"about_ca_topic_score_codex":0.0012038252,"about_ca_topic_score_gemma":0.00020790481,"teacher_disagreement_score":0.014337879,"about_ca_system_score_codex":0.00017578666,"about_ca_system_score_gemma":0.0001178708,"threshold_uncertainty_score":0.7921777},"labels":[],"label_agreement":null},{"id":"W2941757790","doi":"10.1093/neuonc/noz036.059","title":"DIPG-38. DIANHYDROGALACTITOL (VAL-083) WITH AZD1775 INCREASES SURVIVAL IN DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG), IN VIVO","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Delmar (Canada)","funders":"","keywords":"In vivo; Cancer research; Wee1; DNA damage; Cell cycle checkpoint; Cancer; IC50; Cell cycle; Chemistry; Medicine; Pharmacology; In vitro; Internal medicine; Biology; DNA; Cyclin-dependent kinase 1; Biochemistry; Genetics","score_opus":0.013355405510796867,"score_gpt":0.29550850844423965,"score_spread":0.28215310293344276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2941757790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97872436,0.00026838083,0.0000012313824,0.0033256651,0.0010758742,0.001259112,0.000021829861,0.00009932944,0.01522421],"genre_scores_gemma":[0.99690694,0.00024640726,0.000052661046,0.0015246628,0.00043232317,0.00018078144,0.00003337514,0.00006928524,0.00055359304],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997346,0.00041446922,0.00052478124,0.0007041412,0.00029103056,0.00071960874],"domain_scores_gemma":[0.99801874,0.00095923,0.00019520667,0.0004409693,0.0000676413,0.0003182068],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002534345,0.00039310163,0.0011018512,0.0006422392,0.000039381914,0.000015762756,0.00019321474,0.00028751066,0.0018075292],"category_scores_gemma":[0.0001560468,0.00032941185,0.000107219115,0.0008087737,0.00016838106,0.00016433741,0.00013700857,0.0006680996,0.00019020854],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009323054,0.006189939,0.69887197,0.000104199535,0.00013205277,0.008440358,0.0005799248,0.0000218719,0.2695731,0.00010652776,0.002386863,0.0042701294],"study_design_scores_gemma":[0.13448007,0.025157304,0.41179362,0.00026350538,0.00066195655,0.003090593,0.0006501415,0.0003211237,0.05867853,0.000102540376,0.36363065,0.00116993],"about_ca_topic_score_codex":0.0021618751,"about_ca_topic_score_gemma":0.0067015844,"teacher_disagreement_score":0.3612438,"about_ca_system_score_codex":0.0006207963,"about_ca_system_score_gemma":0.0006757013,"threshold_uncertainty_score":0.9999158},"labels":[],"label_agreement":null},{"id":"W2941875587","doi":"10.1093/neuonc/noz036.247","title":"TMOD-09. TUMOR ASSOCIATED MACROPHAGE DYNAMICS IN PEDIATRIC HIGH-GRADE GLIOMAS","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Peptidase Inhibition and Analysis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Dynamics (music); Macrophage; Glioma; Medicine; Cancer research; Biology; Psychology; Genetics","score_opus":0.010146963247358715,"score_gpt":0.27176422639003867,"score_spread":0.26161726314267997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2941875587","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98688674,0.000049227398,0.000013303781,0.0036882334,0.0002642992,0.0003285107,0.000036956164,0.00012057199,0.008612165],"genre_scores_gemma":[0.9949233,0.000054959328,0.000111002104,0.0037459997,0.00022258882,0.000021500928,0.0001454546,0.000038231432,0.00073695893],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980915,0.00025738802,0.00046629374,0.00044372582,0.00028477417,0.00045626974],"domain_scores_gemma":[0.9988971,0.00029471936,0.00021625852,0.00031127734,0.0000826447,0.00019801542],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00026181713,0.0002052631,0.0006400734,0.0005482668,0.00004174752,0.000013727761,0.00012794287,0.00024661043,0.00075367175],"category_scores_gemma":[0.00034117108,0.00019736913,0.00017582717,0.0010772345,0.000052472926,0.00006775711,0.00007574839,0.0006106494,0.0008398993],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048770744,0.0035353794,0.59367347,0.0002124045,0.00013436626,0.011863696,0.00026331595,0.00016025965,0.37635872,0.0017812692,0.007924253,0.0036051886],"study_design_scores_gemma":[0.06190508,0.010217848,0.7639733,0.00036643803,0.0017613326,0.0020601326,0.0013075053,0.08677704,0.026461843,0.0015653664,0.041293126,0.0023109913],"about_ca_topic_score_codex":0.00013089013,"about_ca_topic_score_gemma":0.00046132033,"teacher_disagreement_score":0.34989685,"about_ca_system_score_codex":0.0008771343,"about_ca_system_score_gemma":0.00025548512,"threshold_uncertainty_score":0.9999381},"labels":[],"label_agreement":null},{"id":"W2941922482","doi":"10.1093/neuonc/noz036.204","title":"MEDU-46. SONIC HEDGEHOG SPEEDS UP DNA REPLICATION AND CAUSES CANCER-INITIATING MUTATIONS","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McGill University; Université de Montréal; Montreal Clinical Research Institute","funders":"","keywords":"Sonic hedgehog; Biology; DNA damage; Cancer research; Genome instability; DNA repair; DNA replication; PTCH1; Genetics; DNA; Cell biology; Gene","score_opus":0.03350962826161385,"score_gpt":0.329669469553169,"score_spread":0.29615984129155515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2941922482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932531,0.0011654905,0.00008786391,0.0012496549,0.0007229987,0.00035763477,0.00003160306,0.000042132724,0.0030895355],"genre_scores_gemma":[0.99683386,0.0006060849,0.00023508849,0.0014718946,0.00034849482,0.00010163721,0.000072946066,0.000036299512,0.00029366923],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985064,0.00015676024,0.00029016277,0.00062981056,0.00010575087,0.00031111814],"domain_scores_gemma":[0.9989526,0.00016185001,0.00018091948,0.00047353623,0.00014241812,0.000088637345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023435625,0.00018217327,0.00025971027,0.00006394603,0.00015263619,0.000020558433,0.00015342717,0.00020210125,0.00004636808],"category_scores_gemma":[0.0004992945,0.00018623527,0.00005893525,0.00011993739,0.00013951832,0.000007064426,0.00016971583,0.00016342604,0.000048841546],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003168776,0.000031751202,0.0092066685,0.000028425888,0.000055146465,0.0000061061114,0.00038053957,0.000057546207,0.9766106,0.00009926629,0.00094284967,0.012549392],"study_design_scores_gemma":[0.0010535406,0.0009471628,0.0070112394,0.000021336777,0.00008210899,0.000091939466,0.0006201572,0.00019294562,0.7604101,0.00011194223,0.2291319,0.00032562716],"about_ca_topic_score_codex":0.00005099469,"about_ca_topic_score_gemma":0.00020137943,"teacher_disagreement_score":0.22818907,"about_ca_system_score_codex":0.000058148733,"about_ca_system_score_gemma":0.00025325498,"threshold_uncertainty_score":0.75944537},"labels":[],"label_agreement":null},{"id":"W2942009355","doi":"10.1093/neuonc/noz036.124","title":"IMMU-03. TUMOR NECROSIS FACTOR OVERCOMES IMMUNE EVASION IN P53-MUTANT MEDULLOBLASTOMA","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Hospital for Sick Children","funders":"","keywords":"Evasion (ethics); Mutant; Medulloblastoma; Immune system; Tumor necrosis factor alpha; Cancer research; Biology; Immunology; Gene; Genetics","score_opus":0.010968401386089874,"score_gpt":0.26282367724237293,"score_spread":0.25185527585628303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2942009355","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953105,0.00037469403,0.0000125934175,0.00041302407,0.0011196022,0.0003518378,0.000029273244,0.000021848746,0.0023666685],"genre_scores_gemma":[0.9972143,0.00039957475,0.00007438882,0.001799298,0.00011200654,0.000037050613,0.000048425907,0.000036975973,0.00027798215],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981322,0.00018388333,0.00044030315,0.0006088917,0.00015855381,0.00047615016],"domain_scores_gemma":[0.9990333,0.00007531915,0.00016419057,0.0005422884,0.000085854284,0.000099082004],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014832044,0.00026858886,0.0004207364,0.00012446754,0.000046081077,0.00002397259,0.00040818,0.00029581998,0.00037624149],"category_scores_gemma":[0.00013061795,0.00024838134,0.00017523007,0.00014901887,0.000079487676,0.000012112238,0.00030524618,0.00028514632,0.0005369848],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044260375,0.00015384864,0.010463943,0.000015101667,0.000027085369,0.000061162784,0.00011433017,0.000025581874,0.9841694,0.000015532409,0.0006723768,0.003838992],"study_design_scores_gemma":[0.0015347558,0.002866686,0.025757916,0.00002520912,0.00001295562,0.00012569115,0.00015398063,0.000105920706,0.8792699,0.000035703277,0.08980579,0.00030550777],"about_ca_topic_score_codex":0.00010068935,"about_ca_topic_score_gemma":0.0001287633,"teacher_disagreement_score":0.104899555,"about_ca_system_score_codex":0.00008844888,"about_ca_system_score_gemma":0.00020892703,"threshold_uncertainty_score":0.99999684},"labels":[],"label_agreement":null},{"id":"W2942071564","doi":"10.1093/neuonc/noz036.043","title":"DIPG-22. GENETIC MODELING IMPLICATES RAS AND MYC AS KEY EPIGENETICALLY ACTIVATED TRANSCRIPTIONAL TARGETS OF H3K27M-DRIVEN CANCER","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Cancer research; Carcinogenesis; Biology; Epigenetics; Downregulation and upregulation; Astrocyte; DNA methylation; Transcriptome; Cancer; Gene expression; Gene; Genetics; Neuroscience; Central nervous system","score_opus":0.019812996240092036,"score_gpt":0.3001464937425,"score_spread":0.280333497502408,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2942071564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927165,0.0012726745,0.000055927158,0.004369395,0.00017234359,0.00067122123,0.000029736766,0.000030571777,0.0006816206],"genre_scores_gemma":[0.99719656,0.00080313813,0.00069041376,0.0010175064,0.00009095961,0.00013204117,0.000022105663,0.00003244448,0.000014846539],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998661,0.00007515041,0.0003437806,0.00042769697,0.00019096851,0.00030142462],"domain_scores_gemma":[0.9991464,0.00019758233,0.00009179467,0.00022645092,0.00014227137,0.00019550826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000048756814,0.00019245232,0.0005013843,0.00010743758,0.00004197384,0.000007021295,0.00008174915,0.00017388198,0.0005785],"category_scores_gemma":[0.000036209003,0.00016093794,0.00009879508,0.000110038316,0.00008893805,0.000034223227,0.00004183659,0.00016906505,0.000037251917],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026957027,0.00048681998,0.055055037,0.0000516178,0.00013722679,0.00007633562,0.00023306142,0.0016243764,0.93662924,0.0001926663,0.00011732401,0.0051267426],"study_design_scores_gemma":[0.015213838,0.007385947,0.31136853,0.00019057665,0.0008964672,0.000543845,0.00016216002,0.027553346,0.61228424,0.0012923196,0.022561474,0.000547281],"about_ca_topic_score_codex":0.00017482016,"about_ca_topic_score_gemma":0.000027655045,"teacher_disagreement_score":0.324345,"about_ca_system_score_codex":0.000096702555,"about_ca_system_score_gemma":0.00023462003,"threshold_uncertainty_score":0.6562859},"labels":[],"label_agreement":null},{"id":"W2942081042","doi":"10.1093/neuonc/noz036.017","title":"BIOL-04. DISTAL-LESS/DLX2 HOMEOBOX GENE REGULATION OF CHEMOKINE RECEPTOR CXCR4 - ROLE IN MIGRATION IN FOREBRAIN DEVELOPMENT AND CNS TUMORS","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Circular RNAs in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Biology; Chromatin immunoprecipitation; Homeobox; Chemokine receptor; Promoter; DLX5; Homeobox A1; Transcription factor; Ganglionic eminence; Gene knockdown; Cell biology; Progenitor cell; Genetics; Gene; Gene expression; Receptor; Stem cell; Chemokine","score_opus":0.007720562370815912,"score_gpt":0.2359173302880664,"score_spread":0.2281967679172505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2942081042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99843854,0.00039354918,0.00006359769,0.0002368503,0.00011952292,0.0004050884,0.000017783186,0.000008020439,0.00031706443],"genre_scores_gemma":[0.99828035,0.00009220515,0.0009195988,0.00015649613,0.00006114234,0.000046679215,0.00038056463,0.000023143843,0.000039830837],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987213,0.000124206,0.00039799773,0.00042129008,0.00011290894,0.00022228922],"domain_scores_gemma":[0.9994137,0.000041122672,0.0001661175,0.00027253848,0.000045438836,0.00006108207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020830789,0.00015568404,0.00027583662,0.00013809855,0.000019963105,0.000008121416,0.00013373766,0.00019686013,0.000027097547],"category_scores_gemma":[0.00016688836,0.00016574039,0.000043218566,0.0001667848,0.000078984296,0.000009215875,0.00012700795,0.00009548311,0.000005981452],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016522381,0.00014963359,0.11537815,0.000033058845,0.000010340679,0.000004180006,0.00018756665,0.000114877264,0.8753021,0.0000545022,0.00014879402,0.008451611],"study_design_scores_gemma":[0.0014209535,0.00031860423,0.16778041,0.000022851724,0.0000068568984,0.000014476911,0.00018020644,0.0002669356,0.8042353,0.000079370395,0.025499688,0.0001743454],"about_ca_topic_score_codex":0.00004790544,"about_ca_topic_score_gemma":0.0006189012,"teacher_disagreement_score":0.07106676,"about_ca_system_score_codex":0.00009545141,"about_ca_system_score_gemma":0.00020561367,"threshold_uncertainty_score":0.6758697},"labels":[],"label_agreement":null},{"id":"W2942259759","doi":"10.1093/neuonc/noz036.169","title":"MEDU-10. THERAPEUTIC TARGETING OF STEM CELL SELF-RENEWAL IN CHILDHOOD MEDULLOBLASTOMA: STRATEGIES FOR BLOCKING RECURRENCE","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medulloblastoma; BMI1; Wnt signaling pathway; Cancer research; Neural stem cell; Stem cell; Carcinogenesis; Biology; Medicine; Signal transduction; Internal medicine; Cancer; Cell biology","score_opus":0.011233738385092562,"score_gpt":0.2671099982123849,"score_spread":0.25587625982729234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2942259759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99383235,0.0022093703,0.0004252244,0.0000824907,0.00042348795,0.00050748617,0.000011220926,0.000014023019,0.0024943352],"genre_scores_gemma":[0.9981455,0.0003270598,0.0011579404,0.00009776187,0.00012705706,0.00004333802,0.00003812347,0.000028734175,0.000034484598],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99855286,0.00018363807,0.0004052541,0.00042450632,0.000117218835,0.00031650692],"domain_scores_gemma":[0.99914825,0.00017283452,0.00026237036,0.0002463159,0.00011765762,0.000052565232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003690444,0.00017690621,0.0002878564,0.00007876468,0.000039104096,0.000014088685,0.00022312543,0.00026175423,0.000020799616],"category_scores_gemma":[0.000029369206,0.00017611965,0.0000945178,0.00011802231,0.000040811152,0.0000066024077,0.00008484013,0.00013476038,0.0000060713987],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010147519,0.00020247027,0.0045010746,0.00005723068,0.000020130263,0.0000014212759,0.00042690997,0.0007665138,0.985845,0.00010810924,0.00004223033,0.00792743],"study_design_scores_gemma":[0.0017450221,0.002613324,0.001177013,0.000016166143,0.00003104902,0.0000035708515,0.0006917158,0.00047882568,0.96073484,0.0005835403,0.031684376,0.00024052664],"about_ca_topic_score_codex":0.000009404471,"about_ca_topic_score_gemma":0.000037636033,"teacher_disagreement_score":0.031642146,"about_ca_system_score_codex":0.000030399571,"about_ca_system_score_gemma":0.00036941268,"threshold_uncertainty_score":0.7181951},"labels":[],"label_agreement":null},{"id":"W2942259789","doi":"10.1093/neuonc/noz036.164","title":"MEDU-04. AN OTX2-PAX GENE NETWORK REGULATES GROUP 3 MEDULLOBLASTOMA DIFFERENTIATION AND TUMOR GROWTH","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Hospital for Sick Children; Ottawa Hospital; University of Manitoba","funders":"","keywords":"Biology; Gene silencing; Cancer research; SOX2; PAX6; Transcription factor; Gene; Genetics","score_opus":0.004464760759300378,"score_gpt":0.21914764425750355,"score_spread":0.21468288349820316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2942259789","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962284,0.00087436126,0.000119833196,0.0004099871,0.0010173165,0.00027059397,0.000006262322,0.000031280764,0.0010419803],"genre_scores_gemma":[0.996323,0.00070210715,0.00041600378,0.0014986596,0.000667922,0.000027288717,0.00017193395,0.000038295686,0.00015482945],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984855,0.00020218344,0.0002519577,0.00055594044,0.00012407183,0.0003803601],"domain_scores_gemma":[0.9992902,0.00004014012,0.0001568282,0.00028036183,0.00006211415,0.00017035498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013513501,0.00021567447,0.00027306486,0.000045316327,0.000094644274,0.000019863695,0.00017149781,0.0003177743,0.000048229525],"category_scores_gemma":[0.000031798678,0.00018246187,0.00007590985,0.00010656299,0.00011796598,0.000010384532,0.0001288339,0.00020492868,0.000024539448],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030853556,0.000067513974,0.005185544,0.000020691574,0.00006678682,0.000020314632,0.000041012307,0.00016993204,0.9873027,0.00026608483,0.0018062883,0.0047445702],"study_design_scores_gemma":[0.0038752223,0.008177632,0.034515817,0.000037601807,0.00016967811,0.0007247184,0.00008714717,0.0018901643,0.7973574,0.001089131,0.15127377,0.00080173044],"about_ca_topic_score_codex":0.000024494073,"about_ca_topic_score_gemma":0.000043688626,"teacher_disagreement_score":0.18994534,"about_ca_system_score_codex":0.000036768473,"about_ca_system_score_gemma":0.00007886611,"threshold_uncertainty_score":0.7440579},"labels":[],"label_agreement":null},{"id":"W2942462405","doi":"10.1093/neuonc/noz036.126","title":"IMMU-05. COMBINATIONAL CAR T-CELL AND EPIGENETIC MODIFIER THERAPY TO TARGET POSTERIOR FOSSA TUMORS","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Medicine; Oncology; Internal medicine; Ependymoma; Cancer research; Gastroenterology; Surgery","score_opus":0.02445736219046114,"score_gpt":0.31455335705601534,"score_spread":0.2900959948655542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2942462405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9771778,0.0004583807,0.000013850197,0.00688201,0.0005286495,0.0014992907,0.000014572875,0.000043426775,0.013382027],"genre_scores_gemma":[0.984466,0.00021210586,0.00036412064,0.0082137985,0.00016588619,0.00008960045,0.000025635596,0.00006479542,0.006398029],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980744,0.00023593564,0.00030194258,0.0005103583,0.00039930482,0.00047802704],"domain_scores_gemma":[0.9985471,0.00041128322,0.00006970524,0.00042238308,0.00017262613,0.0003769284],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003143308,0.00021116657,0.00049456826,0.0002294068,0.000065178014,0.000024081286,0.00018395852,0.00017242796,0.004449735],"category_scores_gemma":[0.0000814566,0.00019147339,0.00009180514,0.00020608043,0.00011930407,0.000045401608,0.00013484464,0.00040376547,0.00037994154],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089355535,0.00029805375,0.006370114,0.000029354294,0.000030190506,0.00025928894,0.0005782441,0.000021574184,0.9623919,0.00005406823,0.001584224,0.027489416],"study_design_scores_gemma":[0.014080702,0.015698384,0.051813487,0.000024888483,0.000029682542,0.0013402819,0.00025335155,0.0007048985,0.2668497,0.0003525288,0.64844084,0.0004112784],"about_ca_topic_score_codex":0.000042490385,"about_ca_topic_score_gemma":0.000003959637,"teacher_disagreement_score":0.6955422,"about_ca_system_score_codex":0.00017870526,"about_ca_system_score_gemma":0.0004547174,"threshold_uncertainty_score":0.9964603},"labels":[],"label_agreement":null},{"id":"W2944107502","doi":"10.1093/neuonc/noz084","title":"Proteomic analysis of meningiomas reveals clinically distinct molecular patterns","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Meningioma; Biology; Proteomics; Tandem mass tag; Pathology; Pathological; Cancer research; Bioinformatics; Computational biology; Quantitative proteomics; Medicine; Genetics; Gene","score_opus":0.023233692775150305,"score_gpt":0.32552197172673886,"score_spread":0.30228827895158855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944107502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98415035,0.000018277893,0.0008098531,0.0011494193,0.00036620666,0.001029937,0.000012938367,0.000053129002,0.012409903],"genre_scores_gemma":[0.99737287,0.0000036796412,0.0013168982,0.0005910446,0.000054696906,0.000056550933,0.000056024597,0.000028375798,0.0005198927],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99760413,0.0002879039,0.0008905621,0.0005351865,0.0003454583,0.00033676391],"domain_scores_gemma":[0.99824965,0.00027468606,0.0004458041,0.0007409723,0.000118910524,0.00016999088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006684431,0.00019442047,0.0010680862,0.00045254026,0.000026336413,0.000009134171,0.00022051067,0.00016794141,0.0007799711],"category_scores_gemma":[0.00030442738,0.00016953627,0.00043220117,0.00063372066,0.000063287865,0.00003627767,0.00017471371,0.00025369128,0.00011350562],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003945308,0.00023083382,0.37503186,0.00010349626,0.0009928098,0.0016083319,0.0001491233,0.00004298842,0.6196821,0.00030460136,0.00034631498,0.0011130258],"study_design_scores_gemma":[0.0068000224,0.012004382,0.90082544,0.0001311501,0.010027574,0.0004038306,0.00017045045,0.004752756,0.05024625,0.00026104698,0.013766046,0.00061102613],"about_ca_topic_score_codex":0.000025157047,"about_ca_topic_score_gemma":0.000002206048,"teacher_disagreement_score":0.56943583,"about_ca_system_score_codex":0.00008902745,"about_ca_system_score_gemma":0.00010560095,"threshold_uncertainty_score":0.8540136},"labels":[],"label_agreement":null},{"id":"W2945334907","doi":"10.1093/neuonc/noz088","title":"A genome-wide association study identifies susceptibility loci for primary central nervous system lymphoma at 6p25.3 and 3p22.1: a LOC Network study","year":2019,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Institute of Cancer Research","funders":"Blood Cancer UK; Cancer Research UK","keywords":"Primary central nervous system lymphoma; Genome-wide association study; Single-nucleotide polymorphism; Biology; Genetic association; Carcinogenesis; Germline; Genetics; Genetic predisposition; Lymphoma; Diffuse large B-cell lymphoma; Gene; Genotype; Immunology","score_opus":0.03826111693814501,"score_gpt":0.32475077663734314,"score_spread":0.28648965969919815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945334907","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.30039197,0.67545706,0.000003871222,0.00012221775,0.0019016606,0.021563206,0.0001422448,0.00016985327,0.00024790328],"genre_scores_gemma":[0.086655825,0.9040994,0.00005368046,0.000537906,0.0016268892,0.005088375,0.00090047094,0.00028533262,0.00075211196],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.993241,0.0015786723,0.0016960144,0.0017190748,0.00063402916,0.001131226],"domain_scores_gemma":[0.99207616,0.0046980274,0.0014764916,0.0011284187,0.0002625338,0.00035834324],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013360892,0.00093826966,0.0053886417,0.00021788434,0.0003457833,0.00010049387,0.00028818045,0.0007298722,0.000031312444],"category_scores_gemma":[0.000540301,0.0007629363,0.00086581055,0.00037096362,0.000077401855,0.00008009136,0.0005586954,0.0003130358,0.000112722],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005978815,0.008490511,0.3963128,0.018547952,0.0033756078,0.0012936486,0.0009349859,0.0000058129917,0.000006058285,0.0000040688456,0.005332031,0.56509864],"study_design_scores_gemma":[0.0072252094,0.0077950293,0.39976457,0.0008244602,0.0128118945,0.00023102194,0.00064829376,0.0000047002336,5.186655e-7,0.0000022597947,0.570264,0.00042809366],"about_ca_topic_score_codex":0.00015999285,"about_ca_topic_score_gemma":0.00081975135,"teacher_disagreement_score":0.5649319,"about_ca_system_score_codex":0.014756394,"about_ca_system_score_gemma":0.0013796692,"threshold_uncertainty_score":0.99948215},"labels":[],"label_agreement":null},{"id":"W2947364881","doi":"10.1093/neuonc/noz126.006","title":"PL3.3 Second interim and first molecular analysis of the EORTC randomized phase III intergroup CATNON trial on concurrent and adjuvant temozolomide in anaplastic glioma without 1p/19q codeletion","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Temozolomide; Glioma; Isocitrate dehydrogenase; Medicine; Internal medicine; Interim analysis; Hazard ratio; Oncology; IDH1; Univariate analysis; Randomized controlled trial; Confidence interval; Radiation therapy; Cancer research; Biology; Multivariate analysis","score_opus":0.014003937425835864,"score_gpt":0.30957072835750776,"score_spread":0.2955667909316719,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947364881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957011,0.00047841892,0.000031979325,0.00079446496,0.0004960038,0.0022335066,0.000025787227,0.000013087443,0.00022569261],"genre_scores_gemma":[0.99918073,0.00010720019,0.000013025419,0.00042378792,0.000025565534,0.00018766912,0.00003580721,0.00001824118,0.000007975353],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9979772,0.0004664379,0.00067336555,0.0004693399,0.00019109789,0.00022259024],"domain_scores_gemma":[0.99804735,0.0011049494,0.00036762492,0.00031019602,0.00005624149,0.000113643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038394507,0.00024513568,0.0016101329,0.0004909555,0.00003680887,0.000011658262,0.00008276147,0.00014434305,0.0001518376],"category_scores_gemma":[0.00030782467,0.00015946684,0.00025375682,0.00038576272,0.0002645053,0.000038406914,0.00009825311,0.0002354372,0.00000336537],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7527001,0.00407101,0.026252773,0.00015190872,0.0025860278,0.00061951025,0.0016480729,0.00021206948,0.20385802,0.0004940125,0.0002550852,0.007151439],"study_design_scores_gemma":[0.9466093,0.008951064,0.0056457557,0.00019320042,0.003397206,0.0000938489,0.0001505152,0.009928473,0.024090499,0.000026443846,0.00073472585,0.00017896273],"about_ca_topic_score_codex":0.00008485486,"about_ca_topic_score_gemma":0.0007746057,"teacher_disagreement_score":0.19390923,"about_ca_system_score_codex":0.00014393806,"about_ca_system_score_gemma":0.00006974407,"threshold_uncertainty_score":0.6502869},"labels":[],"label_agreement":null},{"id":"W2948500453","doi":"10.1093/neuonc/noz061","title":"DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":274,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; Public Health Ontario; University of Toronto","funders":"National Cancer Institute; National Center for Advancing Translational Sciences; Brain Tumour Charity","keywords":"Nomogram; Oncology; DNA methylation; Hazard ratio; Medicine; Internal medicine; Proportional hazards model; Meningioma; Bioinformatics; Surgery; Confidence interval; Biology; Genetics; Gene","score_opus":0.043418339530454805,"score_gpt":0.348758398496677,"score_spread":0.3053400589662222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2948500453","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883582,0.000024282936,0.0033112073,0.0005754089,0.0004580273,0.0025343914,0.0000023463565,0.00003733328,0.004698822],"genre_scores_gemma":[0.88128626,0.000014977429,0.11822298,0.00016086343,0.00003971713,0.00016514471,0.00001859357,0.000013832455,0.000077647754],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9977397,0.00029186686,0.00085184094,0.00055516063,0.000287445,0.0002739974],"domain_scores_gemma":[0.9989127,0.00029029098,0.00023376754,0.00029282016,0.000079595135,0.00019084591],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017556067,0.00015928215,0.0004948998,0.00045572352,0.00003440072,0.000012194903,0.000115020295,0.000110773595,0.000027127897],"category_scores_gemma":[0.0003231748,0.00015202543,0.000050714745,0.000458009,0.00002595313,0.000064782966,0.0002406166,0.00020446297,0.000047241218],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034184465,0.0011157995,0.43982047,0.0005735295,0.00028832097,0.00070823677,0.004012058,0.0024793684,0.04601048,0.0009381143,0.00080802664,0.49982715],"study_design_scores_gemma":[0.019799663,0.018137455,0.6735188,0.00083556,0.0007847864,0.000209169,0.0019984178,0.010037192,0.15628955,0.0002496037,0.11707615,0.0010636786],"about_ca_topic_score_codex":0.0000070909505,"about_ca_topic_score_gemma":0.0000026606604,"teacher_disagreement_score":0.49876347,"about_ca_system_score_codex":0.0001428939,"about_ca_system_score_gemma":0.000090415684,"threshold_uncertainty_score":0.6199417},"labels":[],"label_agreement":null},{"id":"W2950177304","doi":"10.1093/neuonc/noz014","title":"Updates in the management of intradural spinal cord tumors: a radiation oncology focus","year":2019,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre; St. Michael's Hospital","funders":"","keywords":"Medicine; Radiosurgery; Spinal cord; Radiation therapy; Adjuvant radiotherapy; Radiation treatment planning; Neuroimaging; Radiation oncology; Radiology","score_opus":0.06083292035226089,"score_gpt":0.38982472479798425,"score_spread":0.32899180444572335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950177304","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020734132,0.98550993,0.000001969956,0.0026888591,0.00073892984,0.003780557,0.000027972652,0.000024790457,0.0051535657],"genre_scores_gemma":[0.0069289757,0.9910364,0.00017542143,0.00061984756,0.00022390467,0.0007978157,0.00016252704,0.000044249184,0.000010854463],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99709845,0.0006790403,0.0010003578,0.0005357224,0.00027637483,0.0004100452],"domain_scores_gemma":[0.9978931,0.0006493089,0.00073563826,0.0005917908,0.000047227757,0.00008294249],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004247556,0.00041085487,0.0024429401,0.00039785722,0.000032797514,0.000011183457,0.0003467567,0.0003954378,0.00009329886],"category_scores_gemma":[0.000049799517,0.00025788604,0.00042711236,0.00048266313,0.000115933864,0.00003695632,0.000121383906,0.000595283,0.0001679149],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002704442,0.0012345817,0.00010757712,0.0054582465,0.0003430198,0.0029445887,0.00006365298,4.6209522e-7,0.000013466247,0.0013621869,0.00213541,0.98606634],"study_design_scores_gemma":[0.002680249,0.009687686,0.0006300552,0.0028306064,0.0028783968,0.001127773,0.00010440056,0.0000044434164,0.000022669514,0.0000572253,0.9798138,0.00016266145],"about_ca_topic_score_codex":0.000049291917,"about_ca_topic_score_gemma":0.000028227892,"teacher_disagreement_score":0.9859037,"about_ca_system_score_codex":0.0007770699,"about_ca_system_score_gemma":0.0005261191,"threshold_uncertainty_score":0.99998736},"labels":[],"label_agreement":null},{"id":"W2954113326","doi":"10.1093/neuonc/noz036.185","title":"MEDU-26. LATENT SOX9-POSITIVE CELLS RESPONSIBLE FOR MYC-DRIVEN MEDULLOBLASTOMA RECURRENCE","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Cancer research; SOX9; Medicine; Biology; Oncology; Internal medicine; Pathology; Transcription factor","score_opus":0.02444233564010413,"score_gpt":0.3118399544628589,"score_spread":0.2873976188227548,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954113326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95846534,0.0006777796,0.00057446834,0.014506538,0.006425106,0.0039232434,0.00021554393,0.00023908688,0.014972902],"genre_scores_gemma":[0.97314435,0.001008154,0.010151585,0.010701732,0.00082234415,0.000371917,0.00006099641,0.00016473801,0.003574181],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.997865,0.00019615114,0.00041379605,0.00065784354,0.00027973866,0.00058747904],"domain_scores_gemma":[0.99784005,0.00091893086,0.00020884856,0.00047821883,0.000246909,0.0003070634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034053315,0.00025967558,0.0007179323,0.00019018738,0.000079757025,0.00001540638,0.00019020037,0.00023101119,0.0005515827],"category_scores_gemma":[0.00017906316,0.00023231504,0.0002518011,0.00026663762,0.00012535423,0.000076271404,0.000114813236,0.00038946836,0.0006665335],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003526315,0.00033691022,0.00068133726,0.00012470719,0.000092986484,0.00015982505,0.0005048476,0.000046274312,0.92461574,0.00045208872,0.027761744,0.041697215],"study_design_scores_gemma":[0.0039431467,0.005634492,0.00080992817,0.000077066,0.00022918858,0.00018418134,0.00012124682,0.0002896414,0.39475405,0.00010042887,0.5936483,0.00020831125],"about_ca_topic_score_codex":0.00004498777,"about_ca_topic_score_gemma":0.000076520475,"teacher_disagreement_score":0.56588656,"about_ca_system_score_codex":0.00032355884,"about_ca_system_score_gemma":0.0011330427,"threshold_uncertainty_score":0.94735324},"labels":[],"label_agreement":null},{"id":"W2965868302","doi":"10.1093/neuonc/noz104","title":"Barriers to accrual and enrollment in brain tumor trials","year":2019,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Institute of Neurological Disorders and Stroke; National Cancer Institute; National Institutes of Health","keywords":"Accrual; Clinical trial; Medicine; Clinical Oncology; Oncology; Internal medicine; Brain tumor; Cancer; Intensive care medicine; Pathology; Finance","score_opus":0.6162676222829154,"score_gpt":0.6451334011564825,"score_spread":0.028865778873567116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2965868302","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00034424965,0.96627253,0.000004098505,0.018603696,0.0016923944,0.006591149,0.00006325008,0.00004108527,0.0063875327],"genre_scores_gemma":[0.000040989464,0.9795192,0.00023860195,0.017954372,0.0006402744,0.00047440326,0.00001906911,0.000093594004,0.0010194964],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99041796,0.004571201,0.0022684126,0.0011796781,0.0008357286,0.000727035],"domain_scores_gemma":[0.85489,0.14210318,0.0005570424,0.000980883,0.00017363457,0.0012952581],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.020304572,0.00043734015,0.0061078114,0.0006474849,0.000047208392,0.00002998599,0.0004984854,0.0015750284,0.0007360759],"category_scores_gemma":[0.30879372,0.0003301095,0.00050916197,0.00050293014,0.00026821933,0.000029322564,0.0007453011,0.00562763,0.0005370211],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046053788,0.00012246083,0.00008951013,0.013689728,0.00012543936,0.0014155786,0.00018101111,3.346027e-7,0.00018322431,0.0006842864,0.010721324,0.9723266],"study_design_scores_gemma":[0.002266462,0.00357039,0.000013143223,0.004274721,0.0003689746,0.00024207823,0.000059557915,0.0000016491473,0.000008120027,0.00030275751,0.98867637,0.0002158043],"about_ca_topic_score_codex":0.00002659115,"about_ca_topic_score_gemma":0.00012717798,"teacher_disagreement_score":0.97795504,"about_ca_system_score_codex":0.00074256636,"about_ca_system_score_gemma":0.009741204,"threshold_uncertainty_score":0.9999151},"labels":[],"label_agreement":null},{"id":"W2966974286","doi":"10.1093/neuonc/noz144","title":"Predictors of leptomeningeal disease following hypofractionated stereotactic radiotherapy for intact and resected brain metastases","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"National Center for Advancing Translational Sciences","keywords":"Medicine; Radiosurgery; Radiation therapy; Stereotactic radiotherapy; Odds ratio; Radiology; Retrospective cohort study; Internal medicine","score_opus":0.020314546432880082,"score_gpt":0.32420640377673066,"score_spread":0.3038918573438506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2966974286","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923299,0.00066454033,0.00012885578,0.0044785026,0.0006405058,0.0014653112,0.0001149168,0.00005663413,0.00012081805],"genre_scores_gemma":[0.996092,0.00008047844,0.0016850267,0.0016206845,0.00011416862,0.00010240482,0.00014291263,0.00004322898,0.00011905257],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985138,0.000286178,0.00033805298,0.00038449038,0.0002051811,0.0002722842],"domain_scores_gemma":[0.99718434,0.0020357755,0.00018762324,0.0002768673,0.00007330688,0.00024211282],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032548665,0.00019274588,0.000592149,0.00019685061,0.00005600231,0.000010684025,0.000059653878,0.00008600763,0.00016314485],"category_scores_gemma":[0.0005399585,0.00015760245,0.00020074398,0.00017603411,0.000062896666,0.00013896362,0.000030615032,0.00016949317,0.000004000419],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013108564,0.0017960587,0.23050585,0.00044274755,0.0030923092,0.0006933035,0.00052087917,0.000039685914,0.7106957,0.0004032711,0.0068911016,0.03181055],"study_design_scores_gemma":[0.055844743,0.03368056,0.22979091,0.00019429797,0.0036289422,0.0005531462,0.0005725618,0.0022441556,0.028241739,0.00022306676,0.64438397,0.0006419176],"about_ca_topic_score_codex":0.000028388726,"about_ca_topic_score_gemma":0.0000046888,"teacher_disagreement_score":0.68245393,"about_ca_system_score_codex":0.00016425872,"about_ca_system_score_gemma":0.00026920045,"threshold_uncertainty_score":0.6426841},"labels":[],"label_agreement":null},{"id":"W2967570386","doi":"10.1093/neuonc/noz140","title":"Targeting reduced mitochondrial DNA quantity as a therapeutic approach in pediatric high-grade gliomas","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Mitochondrial Function and Pathology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Garron Family Cancer Centre; National Health and Medical Research Council; Medical Research Council; Canadian Cancer Society Research Institute; Brain Tumour Research","keywords":"Mitochondrial DNA; Cancer research; Metformin; Biology; Glycolysis; Carcinogenesis; Mitochondrion; In vivo; Apoptosis; Pharmacology; Biochemistry; Molecular biology; Cancer; Endocrinology; Metabolism; Genetics; Insulin; Gene","score_opus":0.01721324516394191,"score_gpt":0.27195604361080006,"score_spread":0.25474279844685815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2967570386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881748,0.00044090205,0.00054298155,0.00044947088,0.0054313596,0.000746493,0.00000914143,0.00004453435,0.004160329],"genre_scores_gemma":[0.9935204,0.0003476494,0.001695481,0.0016879875,0.00211827,0.00009440186,0.00017488211,0.000055725417,0.00030522543],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99716586,0.0007238182,0.00048218094,0.0009039209,0.0001799201,0.00054428255],"domain_scores_gemma":[0.9989597,0.000119217766,0.00021332562,0.0005044858,0.00006990285,0.00013336792],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00027797732,0.00029136447,0.00044638544,0.00021840716,0.000075112344,0.000023458595,0.00034860574,0.00067159213,0.00017878434],"category_scores_gemma":[0.0002673866,0.00028648778,0.00014723818,0.00036641845,0.00007694786,0.000009433889,0.00016607733,0.00045243767,0.00030555928],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007667144,0.0003094397,0.0062454287,0.000024571118,0.000018597924,0.000039602637,0.00009635132,0.00017499577,0.98863745,0.0005996844,0.0026528852,0.00043427545],"study_design_scores_gemma":[0.01753911,0.0095507195,0.0076720407,0.000009860047,0.00019299066,0.00084645074,0.0004618922,0.00062315416,0.45070118,0.0007812827,0.50996614,0.0016551758],"about_ca_topic_score_codex":0.00006165407,"about_ca_topic_score_gemma":0.000035595942,"teacher_disagreement_score":0.5379363,"about_ca_system_score_codex":0.000055403296,"about_ca_system_score_gemma":0.0003354324,"threshold_uncertainty_score":0.99995875},"labels":[],"label_agreement":null},{"id":"W2969765955","doi":"10.1093/neuonc/noz158","title":"Molecular correlates of cerebellar mutism syndrome in medulloblastoma","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"Canadian Institutes of Health Research; National Institutes of Health; Brain Tumour Charity; Pediatric Brain Tumor Foundation; American Brain Tumor Association","keywords":"Medulloblastoma; Medicine; Cohort; Odds ratio; Oncology; Subgroup analysis; Internal medicine; Posterior fossa; Pediatrics; Surgery; Pathology; Confidence interval","score_opus":0.008709402895213554,"score_gpt":0.2603287975178987,"score_spread":0.2516193946226852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969765955","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920764,0.00047792034,0.0000017792046,0.001722852,0.00041709124,0.0005660831,0.0000045491684,0.000026225824,0.00470708],"genre_scores_gemma":[0.9991286,0.00007293985,0.00008629589,0.0006132104,0.000009645951,0.000034359527,0.000009526953,0.000025307318,0.000020119129],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988476,0.00009169558,0.0003209836,0.00029900964,0.0001771357,0.00026356056],"domain_scores_gemma":[0.99914885,0.000265142,0.000114855735,0.00032255438,0.000042826014,0.000105784486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000094232004,0.00014837843,0.00054902607,0.00020614505,0.000010916647,0.000002655191,0.00008609427,0.00019257447,0.0003061229],"category_scores_gemma":[0.00007510708,0.00012954381,0.000106996406,0.00023337777,0.00006232642,0.00002711758,0.000061272855,0.00020487532,0.00027724524],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014267156,0.0012146241,0.4215364,0.00006904451,0.000092532304,0.0071332394,0.00016619317,0.00014198486,0.5638785,0.0011999488,0.00025986007,0.0041650617],"study_design_scores_gemma":[0.018658271,0.014449491,0.57161933,0.00029279976,0.0004037,0.005354538,0.00022105138,0.0010983284,0.3582621,0.0005618488,0.02869139,0.0003871607],"about_ca_topic_score_codex":0.000041917574,"about_ca_topic_score_gemma":0.000018043747,"teacher_disagreement_score":0.20561637,"about_ca_system_score_codex":0.00012540529,"about_ca_system_score_gemma":0.00012021817,"threshold_uncertainty_score":0.52826434},"labels":[],"label_agreement":null},{"id":"W2969951593","doi":"10.1093/neuonc/noz137","title":"Patient-derived xenografts of central nervous system metastasis reveal expansion of aggressive minor clones","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"Flinn Foundation","keywords":"Biology; Somatic cell; Cancer research; Metastasis; Nonsynonymous substitution; Phenotype; Pathology; Cancer; Gene; Genome; Genetics; Medicine","score_opus":0.012034795196554841,"score_gpt":0.2756917279217693,"score_spread":0.2636569327252145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969951593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99729544,0.0010531765,0.000014687406,0.00006742072,0.00043186758,0.0004903699,0.0001411314,0.000008213019,0.00049767544],"genre_scores_gemma":[0.9991968,0.00022442972,0.00024725264,0.00007518917,0.0000758456,0.000037395414,0.00010254379,0.00002001813,0.000020478497],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985478,0.0002341264,0.00032970455,0.0003414401,0.00019358557,0.00035333206],"domain_scores_gemma":[0.9988073,0.000045657165,0.0005022661,0.00037079342,0.00014892431,0.00012502306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006124268,0.00015452516,0.0003792099,0.00006895697,0.000029983285,0.000004185653,0.00015707224,0.00015038448,0.00003208781],"category_scores_gemma":[0.00008288543,0.00013271606,0.00015739359,0.000095904725,0.000105357765,0.0000056613544,0.00016066073,0.00008606948,0.000010624629],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096350984,0.00016988459,0.0046249144,0.00013504292,0.00014498144,0.00007694796,0.00012929346,0.000026507438,0.96855617,0.000012764215,0.00095988356,0.024200127],"study_design_scores_gemma":[0.0016719325,0.0046525244,0.0032939482,0.000039097118,0.000055057662,0.000084960375,0.00028679153,0.000009557308,0.98093295,0.000003571307,0.008866381,0.00010324405],"about_ca_topic_score_codex":0.0002923864,"about_ca_topic_score_gemma":0.00007916708,"teacher_disagreement_score":0.024096884,"about_ca_system_score_codex":0.00005565408,"about_ca_system_score_gemma":0.0002444407,"threshold_uncertainty_score":0.5412004},"labels":[],"label_agreement":null},{"id":"W2971408290","doi":"10.1093/neuonc/noz126.327","title":"P14.92 Study of Glutaminergic and Glutamatergic Metabolism in 1H-MRS Monovoxel in the Most Aggressive Part of 62 Glioblastoma Before and After 18 months Treatment","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut interdisciplinaire d'innovation technologique; Université de Sherbrooke","funders":"","keywords":"T-cell receptor; Glioblastoma; Radiation therapy; Glutamine; Medicine; Internal medicine; Glutamatergic; Glutamate receptor; Oncology; Gastroenterology; Biology; Cancer research; T cell; Amino acid; Immunology; Receptor; Biochemistry; Immune system","score_opus":0.013594801122954032,"score_gpt":0.3035628431579576,"score_spread":0.2899680420350036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971408290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952967,0.00033618926,0.0000018098456,0.0025341955,0.00005085876,0.0015074357,0.000014344771,0.000016411686,0.00024205225],"genre_scores_gemma":[0.99849755,0.00029838775,0.00017334499,0.00050182565,0.0000343391,0.00044550025,0.00000396152,0.000015020132,0.000030078487],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99874264,0.00015742652,0.00043266074,0.00030678016,0.00016326216,0.00019722604],"domain_scores_gemma":[0.9991002,0.00020596458,0.00022042722,0.0003576307,0.000040907125,0.000074859134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018807982,0.00016210733,0.00058001623,0.00016431691,0.000015952148,0.000004956358,0.00010380762,0.00010428394,0.000038894017],"category_scores_gemma":[0.00006596151,0.00010175512,0.000032280688,0.00025999086,0.00018662856,0.00003572877,0.0000847213,0.000197052,0.0000017414433],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026603118,0.009332885,0.78245527,0.00031446165,0.00016751692,0.0015722287,0.022244936,0.000023370161,0.1109748,0.00062634,0.0013027746,0.06832508],"study_design_scores_gemma":[0.021150146,0.023117485,0.8997285,0.00036018406,0.00057230017,0.0005876888,0.0054262225,0.0030891672,0.013216543,0.0007425594,0.031651344,0.00035786937],"about_ca_topic_score_codex":0.0002756982,"about_ca_topic_score_gemma":0.0005088308,"teacher_disagreement_score":0.117273204,"about_ca_system_score_codex":0.00004034835,"about_ca_system_score_gemma":0.00006236915,"threshold_uncertainty_score":0.4149453},"labels":[],"label_agreement":null},{"id":"W2971458410","doi":"10.1093/neuonc/noz126.271","title":"P14.36 Treatment patterns by O6-methylguanine DNA methyltransferase promoter (MGMT) status in newly-diagnosed glioblastoma multiforme (GBM): a multi-country chart review study","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Temozolomide; Medicine; Procarbazine; Lomustine; Internal medicine; Radiation therapy; Glioblastoma; Oncology; Surgery; Vincristine; Chemotherapy; Cancer research","score_opus":0.01997145928084013,"score_gpt":0.31810502807559654,"score_spread":0.2981335687947564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971458410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98050815,0.004736386,0.0000109098955,0.0035171288,0.00061245926,0.009977056,0.0003168799,0.00015297932,0.00016805429],"genre_scores_gemma":[0.97781205,0.012860933,0.00022547701,0.0059238626,0.00012606608,0.0025068368,0.00030085634,0.00014678093,0.00009712359],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949843,0.0007185736,0.0011863627,0.001354482,0.0005521535,0.0012040789],"domain_scores_gemma":[0.99715704,0.00077368564,0.00027621235,0.0010554504,0.00014822454,0.00058941694],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00044409785,0.00084091997,0.0020829742,0.00040218545,0.000085525775,0.000033525794,0.0002288054,0.00031350058,0.0010344777],"category_scores_gemma":[0.00021967552,0.0006430799,0.000333852,0.0006089794,0.000074033276,0.00017347193,0.000096617456,0.0005341226,0.0005229932],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019994471,0.049860597,0.64803374,0.0009797114,0.00096231204,0.010386524,0.0029394582,0.000010709258,0.1963285,0.0000049508385,0.0035381934,0.084955834],"study_design_scores_gemma":[0.18176176,0.095133916,0.28925243,0.0024050307,0.0035612006,0.0006892203,0.0019457428,0.0006288453,0.10949602,0.000005041452,0.31331208,0.0018087083],"about_ca_topic_score_codex":0.001462207,"about_ca_topic_score_gemma":0.0041692783,"teacher_disagreement_score":0.3587813,"about_ca_system_score_codex":0.0013055209,"about_ca_system_score_gemma":0.00040966948,"threshold_uncertainty_score":0.9998787},"labels":[],"label_agreement":null},{"id":"W2971480381","doi":"10.1093/neuonc/noz126.265","title":"P14.30 Treatment outcomes of newly-diagnosed glioblastoma multiforme (GBM) by O6-methylguanine DNA methyltransferase promoter (MGMT) status: a multi-country study","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Life expectancy; Temozolomide; Glioblastoma; Internal medicine; Radiation therapy; Surgery","score_opus":0.018700778715185752,"score_gpt":0.31456889053716497,"score_spread":0.2958681118219792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971480381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909317,0.00042228974,0.000019766861,0.0013431372,0.0006667155,0.0058092945,0.00034144812,0.0001611357,0.0003045359],"genre_scores_gemma":[0.99631184,0.00032245298,0.0007912402,0.0012789326,0.00007601418,0.00082548516,0.0001225151,0.00012830808,0.00014321024],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9957754,0.0004568902,0.0010964132,0.0010888736,0.00060166273,0.0009807753],"domain_scores_gemma":[0.9965524,0.0013110983,0.00034432244,0.0010362453,0.0002221416,0.00053378846],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00028816273,0.00077839935,0.0020716104,0.00040793922,0.00009822749,0.000027531143,0.00022691546,0.0003491508,0.0009293832],"category_scores_gemma":[0.000266676,0.0005614041,0.00041493014,0.0004447834,0.00015191243,0.00014579395,0.00009670635,0.0003672125,0.00034541392],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012868211,0.03491468,0.54272467,0.0000841019,0.0015954928,0.001728651,0.0030319165,0.000021012116,0.39486313,0.000010698223,0.0009277086,0.01881112],"study_design_scores_gemma":[0.14982878,0.09523699,0.28103918,0.00010292333,0.0033735742,0.00017560922,0.0038082418,0.00059831515,0.39205766,0.000010304507,0.07276411,0.001004331],"about_ca_topic_score_codex":0.0009356956,"about_ca_topic_score_gemma":0.0008662879,"teacher_disagreement_score":0.26168552,"about_ca_system_score_codex":0.00080602115,"about_ca_system_score_gemma":0.00044378114,"threshold_uncertainty_score":0.9999839},"labels":[],"label_agreement":null},{"id":"W2971565273","doi":"10.1093/neuonc/noz126.346","title":"P14.111 Successful treatment of extensive metastatic disease with successive use of two different EGF receptor antagonists: case report and review of the literature","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Lesion; Progressive disease; Adenocarcinoma; Biopsy; Pathology; Radiology; Oncology; Internal medicine; Cancer; Disease","score_opus":0.019081788891445513,"score_gpt":0.3480427698820698,"score_spread":0.32896098099062426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971565273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98336375,0.011730088,0.0000056953468,0.0023530442,0.0002172585,0.0018712322,0.0003518225,0.0000079636775,0.00009912991],"genre_scores_gemma":[0.99024457,0.008263867,0.000309593,0.000684712,0.000028048658,0.000107145104,0.00012426944,0.000021982287,0.00021583657],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9986616,0.00019194075,0.0004873548,0.00031874867,0.00019691026,0.00014347608],"domain_scores_gemma":[0.99776804,0.0004036861,0.0006801049,0.000557498,0.00045332103,0.00013734573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000045249548,0.00020385042,0.0008217362,0.00006473091,0.000037739388,0.000006628522,0.00004960513,0.000031600524,0.000085031694],"category_scores_gemma":[0.00017289273,0.00010107279,0.00013499636,0.00020962994,0.00020030835,0.000080997845,0.00003528681,0.00008842063,8.018536e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00818899,0.010620672,0.6748782,0.029383082,0.00476591,0.16164802,0.008829176,0.00004645057,0.07251142,0.0011049829,0.0025727162,0.02545039],"study_design_scores_gemma":[0.0934143,0.091674395,0.19293138,0.05934383,0.06653708,0.21042587,0.0042646783,0.0002690426,0.14168046,0.00034926343,0.1371538,0.0019558868],"about_ca_topic_score_codex":0.00020685211,"about_ca_topic_score_gemma":0.00005990834,"teacher_disagreement_score":0.48194683,"about_ca_system_score_codex":0.00016469383,"about_ca_system_score_gemma":0.0005007691,"threshold_uncertainty_score":0.41216287},"labels":[],"label_agreement":null},{"id":"W2971939959","doi":"10.1093/neuonc/noz126.115","title":"P05.01 the efficacy of donepezil on cognitive function in postoperative brain tumor patients","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Donepezil; Cognition; Medicine; Montreal Cognitive Assessment; Verbal fluency test; Brain tumor; Verbal memory; Cognitive decline; Dementia; Psychology; Internal medicine; Psychiatry; Neuropsychology; Cognitive impairment; Disease","score_opus":0.015094329918717874,"score_gpt":0.29535394261686615,"score_spread":0.28025961269814825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971939959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9793753,0.00005864097,0.000006154961,0.006278852,0.0008903956,0.0020769292,0.000025415868,0.000030117933,0.011258171],"genre_scores_gemma":[0.9842517,0.00002381229,0.000005265323,0.015369677,0.0000836459,0.00008964082,0.000028144399,0.000025961986,0.00012217055],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984202,0.00030930492,0.00035994398,0.00037006324,0.00026405315,0.00027642865],"domain_scores_gemma":[0.9970776,0.0022282419,0.00019853994,0.00016781766,0.00027081356,0.000057001904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019734644,0.00019554183,0.00046312853,0.00017694882,0.00006202319,0.0000043122527,0.00006972791,0.000100708196,0.00022752864],"category_scores_gemma":[0.0014057079,0.00013824397,0.00009085632,0.00032910574,0.0002142061,0.00005595643,0.00007995699,0.00054343994,0.00025474222],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.099363536,0.012625157,0.51732534,0.0002918895,0.0012003107,0.00042352086,0.017487265,0.00029790474,0.17560217,0.0009186784,0.015751438,0.15871282],"study_design_scores_gemma":[0.034481943,0.03086188,0.91218156,0.00039612036,0.00025158326,0.000032266173,0.0015564047,0.000032970616,0.010179753,0.00007890966,0.009748233,0.00019837257],"about_ca_topic_score_codex":0.00005446757,"about_ca_topic_score_gemma":0.000076530116,"teacher_disagreement_score":0.39485624,"about_ca_system_score_codex":0.00033812335,"about_ca_system_score_gemma":0.00026425582,"threshold_uncertainty_score":0.5637425},"labels":[],"label_agreement":null},{"id":"W2972016058","doi":"10.1093/neuonc/noz126.167","title":"P11.21 Treating numerous secondary tumors in the brain with tumor treating fields: Simulation study to identify optimal transducer array layout","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Transducer; Brain tumor; Melanoma; Biomedical engineering; Pathology; Physics; Cancer research; Acoustics","score_opus":0.019306224455466692,"score_gpt":0.32949968572035016,"score_spread":0.31019346126488345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972016058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901204,0.000033847296,0.00006405264,0.004350439,0.00014114,0.0024320509,0.0000072263265,0.000050928036,0.0027999168],"genre_scores_gemma":[0.9954569,8.5239185e-7,0.00028576257,0.0037828826,0.00013269263,0.00024555836,0.000017509965,0.00004181413,0.000036035282],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978917,0.0004098334,0.00045189259,0.0005460149,0.00030420304,0.00039631082],"domain_scores_gemma":[0.9977376,0.0015489149,0.00014765156,0.00040340505,0.00005094632,0.00011150991],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039389005,0.00027056024,0.0005825092,0.00020411755,0.00010266202,0.000043467146,0.00014603543,0.000075378295,0.00025046465],"category_scores_gemma":[0.00015651812,0.00017667936,0.00009419918,0.00037359115,0.000028114928,0.00010585552,0.000025331725,0.0004078759,0.00007682292],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015437608,0.0061006774,0.805669,0.00007945235,0.00021341837,0.0045937253,0.054471254,0.040757786,0.06012117,0.0000220498,0.00029087762,0.026136816],"study_design_scores_gemma":[0.028130177,0.03621517,0.87364656,0.00026844887,0.0006291025,0.0009017057,0.03993614,0.0047393497,0.011582916,0.000021146941,0.0032769886,0.0006523151],"about_ca_topic_score_codex":0.00028408552,"about_ca_topic_score_gemma":0.0006432273,"teacher_disagreement_score":0.06797753,"about_ca_system_score_codex":0.0001740183,"about_ca_system_score_gemma":0.0001616633,"threshold_uncertainty_score":0.7204775},"labels":[],"label_agreement":null},{"id":"W2972108419","doi":"10.1093/neuonc/noz126.164","title":"P11.18 Tumor treating fields (TTFields) treatment of spinal cord metastases","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Advanced Radiotherapy Techniques","field":"Physics and Astronomy","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Spinal cord; Cancer; Lung cancer; Radiology; Pathology; Internal medicine","score_opus":0.024096254416006397,"score_gpt":0.3437658164713789,"score_spread":0.3196695620553725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972108419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94280195,0.00022088234,0.02137568,0.00033228195,0.00043300338,0.00073501415,0.00005085225,0.00011408547,0.033936225],"genre_scores_gemma":[0.98789597,0.000029167048,0.011313559,0.00024090243,0.00021482585,0.00007081256,0.00001173948,0.00002449402,0.00019852167],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990418,0.000092542294,0.00027429126,0.00027236447,0.00008213926,0.00023686174],"domain_scores_gemma":[0.9991359,0.000251497,0.00021885517,0.0003008903,0.000038929527,0.000053902924],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000044357635,0.00018003224,0.0004428728,0.00006466929,0.000039415703,0.0000072618996,0.00013050456,0.00005540735,0.0016846763],"category_scores_gemma":[0.000006793533,0.00015240823,0.00014027297,0.000091546994,0.000051507523,0.00007324875,0.00002680187,0.00011905817,0.000014082906],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077883346,0.0008532121,0.038937826,0.000022164508,0.0001692379,0.000044341836,0.00021328857,0.00009382825,0.32514042,0.0067237415,0.0009846216,0.6260385],"study_design_scores_gemma":[0.003062499,0.032649685,0.00082171574,0.000027765942,0.0001209262,0.000036826805,0.00031858622,0.000412458,0.56817573,0.002134071,0.39184415,0.0003955961],"about_ca_topic_score_codex":0.00017544969,"about_ca_topic_score_gemma":0.000004556812,"teacher_disagreement_score":0.6256429,"about_ca_system_score_codex":0.0000689024,"about_ca_system_score_gemma":0.00008764604,"threshold_uncertainty_score":0.99922794},"labels":[],"label_agreement":null},{"id":"W2972153599","doi":"10.1093/neuonc/noz126.131","title":"P08.05 Cognitive impairment in patients with newly-diagnosed high-grade gliomas","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dysexecutive syndrome; Cognition; Logistic regression; Montreal Cognitive Assessment; Medicine; Executive dysfunction; Stepwise regression; Internal medicine; Executive functions; Effects of sleep deprivation on cognitive performance; Psychology; Oncology; Audiology; Psychiatry; Cognitive impairment; Neuropsychology","score_opus":0.0107031853448566,"score_gpt":0.27408779660997407,"score_spread":0.2633846112651175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972153599","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885439,0.00009122859,0.000011215643,0.0031982723,0.0010443935,0.0033814001,0.000047367586,0.00012397552,0.0035582175],"genre_scores_gemma":[0.9935928,0.00008241688,0.00011913065,0.005446737,0.00016461899,0.00028406782,0.000092558184,0.00006923157,0.0001484329],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973861,0.00022730965,0.0004707945,0.0007176302,0.0004889023,0.0007092929],"domain_scores_gemma":[0.9980916,0.00084879424,0.00024107868,0.00028544877,0.0003119398,0.00022116791],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015706189,0.00038583807,0.00084175315,0.0004208813,0.000072442235,0.000012060297,0.000112829155,0.00023139744,0.0004625037],"category_scores_gemma":[0.00025544516,0.00032129517,0.000098491466,0.00064088445,0.00022194347,0.00012836863,0.00014969692,0.00064322155,0.00046016325],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008517769,0.003892725,0.9645072,0.00009271393,0.0003573497,0.0012369577,0.0011987007,0.000028337687,0.0022942207,0.000037335452,0.0053106984,0.0125259645],"study_design_scores_gemma":[0.059706103,0.024682326,0.90105426,0.0002888755,0.00031627773,0.00006484372,0.00073044567,0.00002649276,0.0018296022,0.000034493358,0.010912117,0.00035414234],"about_ca_topic_score_codex":0.00018919325,"about_ca_topic_score_gemma":0.00021186526,"teacher_disagreement_score":0.063452944,"about_ca_system_score_codex":0.00080776773,"about_ca_system_score_gemma":0.0003830066,"threshold_uncertainty_score":0.9999239},"labels":[],"label_agreement":null},{"id":"W2972232735","doi":"10.1093/neuonc/noz126.171","title":"P11.25 Assessing electrical properties of cells as predictive marker for patient-specific TTFields response and optimal frequency","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Microfluidic and Bio-sensing Technologies","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dielectrophoresis; Materials science; Capacitance; Permittivity; Electric field; Biomedical engineering; Optoelectronics; Nanotechnology; Dielectric; Chemistry; Medicine; Physics; Microfluidics; Electrode","score_opus":0.013484104507266,"score_gpt":0.2289120334157998,"score_spread":0.2154279289085338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972232735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948539,0.0015701207,0.0013251402,0.0002459463,0.00049470837,0.00046908317,0.000009727925,0.00025266534,0.00077870226],"genre_scores_gemma":[0.9963079,0.0004423158,0.0030526952,0.000090289315,0.000031624204,0.00002035971,0.0000017149066,0.000029246134,0.000023858738],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998975,0.000086052394,0.00028106463,0.0002628539,0.00009532151,0.0002997071],"domain_scores_gemma":[0.999173,0.00041809372,0.00006826881,0.00021130168,0.00008944647,0.00003990583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017666564,0.00016369425,0.00030986557,0.00013774037,0.000046023877,0.000021328135,0.00012425405,0.0003494881,0.000018233653],"category_scores_gemma":[0.00019763845,0.00013931708,0.000048011312,0.0001496335,0.00013717722,0.00009707361,0.000072113515,0.0002906191,0.000010412595],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006765707,0.000039410657,0.00029386295,0.00004169949,0.000019796029,0.00001546004,0.00022550108,0.00004242393,0.9801818,0.00008015918,0.0033444809,0.015038793],"study_design_scores_gemma":[0.0005716849,0.0027091526,0.00054037094,0.00003233377,0.000019731335,0.000063586485,0.00033990672,0.0035031235,0.9594494,0.00008444637,0.03251602,0.00017023357],"about_ca_topic_score_codex":0.000004487087,"about_ca_topic_score_gemma":3.4625853e-7,"teacher_disagreement_score":0.029171541,"about_ca_system_score_codex":0.00009339779,"about_ca_system_score_gemma":0.000095093106,"threshold_uncertainty_score":0.5681186},"labels":[],"label_agreement":null},{"id":"W2972253681","doi":"10.1093/neuonc/noz126.319","title":"P14.84 Intraarterial chemotherapy and osmotic blood-brain barrier modification in the treatment of primary CNS lymphoma","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Medicine; Chemotherapy; Methotrexate; Central nervous system; Primary central nervous system lymphoma; Mannitol; Blood–brain barrier; Institutional review board; Anesthesia; Internal medicine; Oncology; Surgery","score_opus":0.017407822594991833,"score_gpt":0.27657405770059484,"score_spread":0.259166235105603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972253681","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98883295,0.00027809845,0.0000014457456,0.008524675,0.00020069312,0.0010424552,0.000008852587,0.0000132618925,0.0010975442],"genre_scores_gemma":[0.996669,0.0005344767,0.000089992944,0.0024016276,0.000108945605,0.00013387323,0.00002757132,0.000016587312,0.000017960752],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99900174,0.00015951393,0.0002579753,0.00027224142,0.00012664312,0.00018185542],"domain_scores_gemma":[0.999045,0.00044757617,0.00009797986,0.00032414944,0.000025585026,0.000059674472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011685767,0.00014718153,0.00041030764,0.000098094126,0.000024161542,0.00000863585,0.00006355019,0.00011413717,0.000085672975],"category_scores_gemma":[0.000025612893,0.000094568226,0.00006596341,0.00011387243,0.00007992107,0.00003103311,0.000009369493,0.000043130596,0.000014606057],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006527659,0.0056972676,0.0629183,0.000041888205,0.00012094105,0.00017968264,0.0034043062,0.000004141497,0.7911641,0.00031945636,0.00044455245,0.1350526],"study_design_scores_gemma":[0.04450628,0.019333458,0.7358563,0.00003448842,0.0004096976,0.00046429865,0.0003741987,0.00021606269,0.11590444,0.00022434499,0.082484365,0.00019205235],"about_ca_topic_score_codex":0.000054803837,"about_ca_topic_score_gemma":0.000019322411,"teacher_disagreement_score":0.67525965,"about_ca_system_score_codex":0.00016908879,"about_ca_system_score_gemma":0.00012905864,"threshold_uncertainty_score":0.38563803},"labels":[],"label_agreement":null},{"id":"W2972294464","doi":"10.1093/neuonc/noz126.186","title":"P11.40 Development of an implantable multifunctional biodevice (GlioGel) in the treatment of recurrent glioblastoma","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; Université de Sherbrooke","funders":"","keywords":"In vivo; Temozolomide; Chemokine; Glioma; In vitro; Doxorubicin; Cancer research; Adjuvant; Brain tumor; Glioblastoma; Chemotherapy; Chemotaxis; Medicine; Pathology; Biology; Immunology; Internal medicine; Inflammation","score_opus":0.025962242766585288,"score_gpt":0.3058512753699586,"score_spread":0.27988903260337333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972294464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99673045,0.00024798248,0.0000017798487,0.000397028,0.0003932517,0.0008765152,0.000026696662,0.000013222394,0.0013130644],"genre_scores_gemma":[0.9986701,0.00011488352,0.00069518964,0.00022691781,0.00004821976,0.00016144682,0.000058207715,0.000013719161,0.000011322102],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998545,0.000145648,0.0004898568,0.00030880544,0.00026112172,0.00024956808],"domain_scores_gemma":[0.99891627,0.00039576474,0.00019379718,0.0003292776,0.0000853191,0.00007959019],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017287474,0.00018332571,0.000522385,0.00022977253,0.000035953115,0.0000040458453,0.00010404127,0.00010501144,0.00012942986],"category_scores_gemma":[0.000019923009,0.00010398227,0.000096949574,0.00027915664,0.000048530223,0.000043660737,0.000022700608,0.00008775248,0.000058821548],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066724475,0.032321084,0.16168961,0.0001832994,0.00038961627,0.00032332697,0.009607755,0.000114948285,0.4203783,0.00021254267,0.0013072421,0.36679983],"study_design_scores_gemma":[0.01589641,0.038356397,0.18252914,0.00009706437,0.00025686453,0.000543097,0.0016712443,0.00043215556,0.39806458,0.000024141707,0.36190978,0.00021910928],"about_ca_topic_score_codex":0.00008984892,"about_ca_topic_score_gemma":0.0005517539,"teacher_disagreement_score":0.36658072,"about_ca_system_score_codex":0.0002885807,"about_ca_system_score_gemma":0.00031848453,"threshold_uncertainty_score":0.42402735},"labels":[],"label_agreement":null},{"id":"W2977486434","doi":"10.1093/neuonc/noz174","title":"Finding a four-leaf clover—identifying long-term survivors in IDH-wildtype glioblastoma","year":2019,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Term (time); Glioblastoma; Wild type; Biology; Type (biology); Genetics; Oncology; Medicine; Cancer research; Gene; Ecology; Physics; Astronomy","score_opus":0.0451457835727409,"score_gpt":0.3194752112077933,"score_spread":0.2743294276350524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2977486434","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.69200563,0.0006332829,0.000008410075,0.29478398,0.006128884,0.0020372525,0.000079004654,0.00016023968,0.0041633137],"genre_scores_gemma":[0.41016376,0.00072699453,0.00013298835,0.5809031,0.0055344207,0.00037286885,0.0006901349,0.00040084642,0.0010748392],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952482,0.00047626693,0.0009905234,0.00134812,0.0006544128,0.0012824896],"domain_scores_gemma":[0.99607253,0.0019945311,0.00061230117,0.0010424765,0.00011853009,0.0001596261],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00039232298,0.00075389445,0.0017674171,0.0011629935,0.00009968579,0.000074115494,0.00039480216,0.0018540667,0.00040536994],"category_scores_gemma":[0.00043584872,0.00070175325,0.00048037426,0.0005482302,0.00012263618,0.00011700113,0.00033106192,0.0029413758,0.0012636102],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000610992,0.00070712663,0.2147957,0.0007770616,0.00037809034,0.09901618,0.00034753696,0.000013601627,0.008618335,0.000009666302,0.6669719,0.007753798],"study_design_scores_gemma":[0.010069957,0.0038030422,0.053274117,0.0008751672,0.0007542647,0.0025601997,0.000031453135,0.000047111662,0.0029541056,0.000024264684,0.92484075,0.00076554733],"about_ca_topic_score_codex":0.0002489546,"about_ca_topic_score_gemma":0.0014766784,"teacher_disagreement_score":0.28611916,"about_ca_system_score_codex":0.0012071306,"about_ca_system_score_gemma":0.00051605806,"threshold_uncertainty_score":0.99954337},"labels":[],"label_agreement":null},{"id":"W2978500253","doi":"10.1093/neuonc/noz126.185","title":"P11.39 Chloroquine as an anti-glioblastoma therapeutic: repurposing of an old drug","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Medicine; Drug; Pharmacology; Cerebrospinal fluid; Blood–brain barrier; Brain tumor; Internal medicine; Pathology; Central nervous system","score_opus":0.015730661209330678,"score_gpt":0.3067880532282295,"score_spread":0.2910573920188988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2978500253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923786,0.0002973692,0.0000012128334,0.0022018014,0.0006433389,0.00078230613,0.000008407303,0.00010044533,0.0035865044],"genre_scores_gemma":[0.9956564,0.0001072556,0.00022112827,0.0035882,0.00021434278,0.000036329846,0.000024930207,0.00005699602,0.000094430565],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99814886,0.00020111019,0.00042182277,0.00055838283,0.0002813432,0.00038848261],"domain_scores_gemma":[0.99832416,0.00024516185,0.00023111168,0.0008185196,0.00012677601,0.00025428916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021977436,0.0002480218,0.00074385776,0.00022000955,0.000058445352,0.000016793294,0.0001764261,0.00017836581,0.0005126309],"category_scores_gemma":[0.000048191694,0.00020241326,0.00013676977,0.00022246933,0.00010297752,0.00016393064,0.00006599325,0.0002409436,0.00017060382],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077219086,0.0029669274,0.046830192,0.00004789839,0.000121527475,0.0007903089,0.0008549061,0.000022077744,0.89732194,0.00076363364,0.0003040067,0.049204364],"study_design_scores_gemma":[0.010274327,0.025715781,0.074699186,0.00008614866,0.0004570286,0.0011003448,0.0005489782,0.0007076609,0.7842256,0.0002660219,0.10159941,0.00031951768],"about_ca_topic_score_codex":0.0001359427,"about_ca_topic_score_gemma":0.00006566306,"teacher_disagreement_score":0.11309637,"about_ca_system_score_codex":0.00011755687,"about_ca_system_score_gemma":0.00017038068,"threshold_uncertainty_score":0.8254173},"labels":[],"label_agreement":null},{"id":"W2981017557","doi":"10.1093/neuonc/noz175.323","title":"EPID-23. PURSUIT OF AN INTERNATIONAL LANGUAGE OF GLIOMA RESEARCH: COMMON DATA ELEMENTS FOR THE LONGITUDINAL STUDY OF ADULT MALIGNANT GLIOMA","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Bioinformatics and Genomic Networks","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Glioma; Computer science; Electronic data capture; Medical physics; Medicine; Clinical trial; Translational research; Data science; Data mining; Pathology","score_opus":0.07409258431600414,"score_gpt":0.39058704126985927,"score_spread":0.31649445695385514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981017557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977014,0.00009621961,0.00012464932,0.00020449313,0.00037837037,0.0008370394,0.00029571788,0.000002386931,0.00035970114],"genre_scores_gemma":[0.99884343,0.000040904004,0.00048026262,0.000086005,0.00013748519,0.000026781618,0.00034851176,0.00001425824,0.000022332555],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99848974,0.00017308345,0.000545675,0.00028114143,0.00028445444,0.00022588881],"domain_scores_gemma":[0.99804586,0.00021393829,0.0003622952,0.0010419777,0.00029235866,0.000043584307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010939849,0.00010496203,0.0002626209,0.00008710998,0.00004172719,0.000010096251,0.0014524856,0.00012148437,0.000026340673],"category_scores_gemma":[0.00016056882,0.00007927409,0.000053167056,0.00011554679,0.00013854512,0.000011186399,0.00090103236,0.00012883429,0.000002482682],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009849701,0.0008701565,0.010408847,0.000058752168,0.00023336754,0.00001097365,0.0006098653,0.00007645791,0.96798193,0.00027979873,0.0021813428,0.016303545],"study_design_scores_gemma":[0.012804149,0.034447107,0.01752386,0.00006303951,0.00024179668,0.0001806026,0.013982236,0.015645448,0.866325,0.0003430542,0.03797646,0.0004672026],"about_ca_topic_score_codex":0.00013983897,"about_ca_topic_score_gemma":0.0005366843,"teacher_disagreement_score":0.101656884,"about_ca_system_score_codex":0.000014330746,"about_ca_system_score_gemma":0.000092911745,"threshold_uncertainty_score":0.32327035},"labels":[],"label_agreement":null},{"id":"W2982733458","doi":"10.1093/neuonc/noz175.1132","title":"TMOD-33. AN INTEGRATED APPROACH COMBINING MATHEMATICAL AND GENOMIC METHODS TO REVEAL THE OPTIMAL TIMING OF THERAPEUTIC INTERVENTION IN WHO GRADE II DIFFUSE GLIOMA","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Glioma; Radiation therapy; Oncology; Somatic cell; Fluid-attenuated inversion recovery; Pathological; Temozolomide; Medicine; Germline mutation; Internal medicine; Proportional hazards model; Mutation; Pathology; Biology; Cancer research; Magnetic resonance imaging; Radiology; Genetics; Gene","score_opus":0.05572562521701402,"score_gpt":0.36968547767997,"score_spread":0.313959852462956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982733458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960373,0.00017448401,0.0013491005,0.0010772791,0.00010118936,0.00096299377,0.0000035007013,0.000022260614,0.0002718599],"genre_scores_gemma":[0.98029536,0.000011179241,0.019124039,0.0003902016,0.000021765925,0.00010805307,0.000011497556,0.000027385344,0.000010492453],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982654,0.00060236576,0.00043601048,0.0003360291,0.00011696285,0.00024326525],"domain_scores_gemma":[0.9988821,0.000518049,0.00013459963,0.00031730128,0.000039887025,0.00010805049],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058988656,0.00017416738,0.000594915,0.00020657358,0.000049773884,0.000014321223,0.00013038657,0.00012801665,0.000039243034],"category_scores_gemma":[0.000100791956,0.00011432546,0.00009090618,0.00024586904,0.000087230386,0.00005165322,0.00014371505,0.0002705873,0.000005967122],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004807395,0.003897879,0.0083816415,0.00010990381,0.000117767675,0.000070008165,0.005901028,0.00010281404,0.9163943,0.0016828068,0.000053711407,0.062807396],"study_design_scores_gemma":[0.059633106,0.056183714,0.30737528,0.0011896614,0.0021260674,0.0038640953,0.018776456,0.25080293,0.28717303,0.003795481,0.007816473,0.0012637207],"about_ca_topic_score_codex":0.000046752717,"about_ca_topic_score_gemma":0.000007842476,"teacher_disagreement_score":0.62922126,"about_ca_system_score_codex":0.00012419136,"about_ca_system_score_gemma":0.000043271062,"threshold_uncertainty_score":0.46620572},"labels":[],"label_agreement":null},{"id":"W2982734891","doi":"10.1093/neuonc/noz175.442","title":"GENE-40. CHARACTERIZING EPIGENETIC INTRATUMORAL HETEROGENEITY IN GLIOMA USING SINGLE-CELL BISULFITE SEQUENCING","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Epigenetics; Biology; Glioma; Epigenomics; DNA methylation; Genetics; Bisulfite sequencing; Epigenome; Computational biology; Cancer research; Gene; Gene expression","score_opus":0.048467219867310105,"score_gpt":0.297158030611291,"score_spread":0.24869081074398086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982734891","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99670565,0.00040983732,0.000010124461,0.00051502645,0.0008651932,0.0007897681,0.000009383421,0.00006418884,0.00063085457],"genre_scores_gemma":[0.9967927,0.000045834906,0.0013128852,0.0015214643,0.00019448051,0.00003786104,0.000027475648,0.000061603285,0.000005740564],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997695,0.00022829254,0.00054984586,0.0006496645,0.00022760003,0.00064957066],"domain_scores_gemma":[0.9988105,0.00020343754,0.00022779356,0.0004574385,0.00007178911,0.00022903348],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020628242,0.00031404992,0.0007268307,0.00039098386,0.000062979525,0.000033687997,0.00013103962,0.0002338177,0.000088527464],"category_scores_gemma":[0.000059806534,0.00029702054,0.00015363391,0.00043491842,0.00006687244,0.00010790525,0.00011872759,0.00033146667,0.00013785821],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001460682,0.0005945526,0.15522276,0.00005065352,0.000024364514,0.0028703795,0.00018115898,0.00008209777,0.8377531,0.000004062839,0.000013867559,0.003056901],"study_design_scores_gemma":[0.004014435,0.0018546849,0.038874466,0.000078107456,0.00010844169,0.0012877041,0.00007059719,0.00090133946,0.9505302,0.000011092632,0.0020304646,0.00023847003],"about_ca_topic_score_codex":0.000098910394,"about_ca_topic_score_gemma":0.00005873595,"teacher_disagreement_score":0.11634829,"about_ca_system_score_codex":0.0009917498,"about_ca_system_score_gemma":0.0003139295,"threshold_uncertainty_score":0.9999482},"labels":[],"label_agreement":null},{"id":"W2982750119","doi":"10.1093/neuonc/noz175.433","title":"GENE-31. IDENTIFICATION OF CORE AND CONTEXT-SPECIFIC FITNESS GENES IN GLIOBLASTOMA STEM CELLS VIA GENOME-WIDE CRISPR-Cas9 SCREENS","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Brain Institute; SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Biology; Context (archaeology); Stem cell; CRISPR; Computational biology; Gene; Genetics; SOX2; Epigenetics; Embryonic stem cell","score_opus":0.012980330572009778,"score_gpt":0.2735275995119839,"score_spread":0.26054726893997415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982750119","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908746,0.0036733267,0.004345165,0.00009032684,0.00046533855,0.00043214904,0.000029705123,0.000013170854,0.00007620381],"genre_scores_gemma":[0.998015,0.0013840355,0.00012917498,0.00017777349,0.00010320029,0.000025495003,0.000018853249,0.0000343854,0.000112109454],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998557,0.00006956642,0.00047281486,0.00050675997,0.00010982729,0.00028406008],"domain_scores_gemma":[0.9991424,0.00008035371,0.00016105437,0.00042598302,0.00010491879,0.000085281994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019553133,0.00019780667,0.000328212,0.00012299886,0.00003327032,0.000013116706,0.00021220888,0.00024887788,0.000018991792],"category_scores_gemma":[0.000015623045,0.00021461195,0.0000693645,0.00013046412,0.00010172679,0.0000059898853,0.00014511509,0.0001336187,0.000021722824],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015434965,0.00005930882,0.007114331,0.00004869629,0.000018513712,0.000015863616,0.00012034918,0.0012613031,0.97567683,0.000014901149,0.00021322722,0.0153022995],"study_design_scores_gemma":[0.0009142208,0.0006678386,0.008945319,0.0000064430233,0.00001408895,0.000052275514,0.00020937248,0.0005179251,0.9432685,0.000011774874,0.04519975,0.00019250697],"about_ca_topic_score_codex":0.000014826539,"about_ca_topic_score_gemma":0.00009594545,"teacher_disagreement_score":0.044986524,"about_ca_system_score_codex":0.00003084788,"about_ca_system_score_gemma":0.00006954532,"threshold_uncertainty_score":0.8751622},"labels":[],"label_agreement":null},{"id":"W2983101271","doi":"10.1093/neuonc/noz175.328","title":"EPID-28. WHAT DO PATTERNS OF “UNCLASSIFIED” BRAIN TUMORS TELL US ABOUT INCIDENCE RATES OF NON-MALIGNANT BRAIN TUMORS IN CANADA?","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; University of Alberta","funders":"","keywords":"Incidence (geometry); Medicine; Population; Demography; Epidemiology; Disease; Pathology; Environmental health","score_opus":0.010641020316094056,"score_gpt":0.29376110912570885,"score_spread":0.2831200888096148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983101271","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98345244,0.00031979984,0.00010583772,0.014009369,0.0008114523,0.0005645053,0.000010990632,0.000014960391,0.0007106219],"genre_scores_gemma":[0.9863545,0.0002873526,0.0002034482,0.012848811,0.00010734164,0.000017577244,0.000015862584,0.000047728492,0.00011741286],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969822,0.0003860034,0.0010020084,0.0005416908,0.00049680047,0.00059128966],"domain_scores_gemma":[0.99604905,0.002487939,0.00055354397,0.0005089506,0.00011771507,0.00028279726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010137196,0.00027566202,0.0011694187,0.0002786235,0.000031359126,0.0000162322,0.00038123757,0.0001450965,0.0002755262],"category_scores_gemma":[0.0021238842,0.00023938803,0.000114575916,0.0003206004,0.00018921492,0.00015153777,0.00017141677,0.00092168985,0.000014635616],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016204438,0.00012866955,0.70813,0.00032699195,0.00002332201,0.0011697034,0.00061933894,0.0005069587,0.26573685,0.000058722224,0.0020871358,0.02105029],"study_design_scores_gemma":[0.0052087526,0.0021589447,0.8986819,0.0026149272,0.00006249823,0.00075093313,0.0022045472,0.019457357,0.046606243,0.000079061174,0.02171879,0.00045604468],"about_ca_topic_score_codex":0.2422176,"about_ca_topic_score_gemma":0.093245745,"teacher_disagreement_score":0.2191306,"about_ca_system_score_codex":0.000502889,"about_ca_system_score_gemma":0.002956314,"threshold_uncertainty_score":0.976196},"labels":[],"label_agreement":null},{"id":"W2983242644","doi":"10.1093/neuonc/noz175.055","title":"ACTR-12. PHASE 2 STUDY OF DIANHYDROGALACTITOL (VAL-083) IN PATIENTS WITH MGMT-UNMETHYLATED, BEVACIZUMAB-NAÏVE GLIOBLASTOMA IN THE RECURRENT AND ADJUVANT SETTING","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Delmar (Canada)","funders":"","keywords":"Temozolomide; Bevacizumab; Medicine; Internal medicine; Oncology; Phases of clinical research; Adverse effect; Adjuvant; Methyltransferase; Radiation therapy; Clinical endpoint; Adjuvant therapy; Clinical trial; Cancer; Chemotherapy; Biology; DNA","score_opus":0.010454612080597522,"score_gpt":0.2936011169252499,"score_spread":0.2831465048446524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983242644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959709,0.0000968435,1.9400738e-7,0.0006735627,0.00020260725,0.0026088988,0.000009921977,0.000015191731,0.00042185705],"genre_scores_gemma":[0.99948573,0.000039333234,0.000022379998,0.00023870217,0.00002615618,0.0001469894,0.000014032855,0.00002506987,0.0000016274402],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979492,0.00041807146,0.00047114555,0.00045909148,0.000354097,0.0003484048],"domain_scores_gemma":[0.99854475,0.0006491253,0.0002524848,0.0003942899,0.00006475135,0.000094616524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029734662,0.00024006341,0.00064070517,0.00033945704,0.000037148802,0.000011721669,0.00011758648,0.000112441776,0.000033319517],"category_scores_gemma":[0.00012894941,0.00015199005,0.000045346158,0.00037107174,0.000057719637,0.00008923382,0.00007724452,0.00040639818,0.000013790998],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032791416,0.015656184,0.9215694,0.000041988347,0.00007996482,0.00064031745,0.005533687,0.000019221128,0.0033448746,0.0000056089452,0.00009059717,0.04973903],"study_design_scores_gemma":[0.07500828,0.06559096,0.8492582,0.00016298698,0.00026819788,0.000065253495,0.0030703854,0.00018032415,0.0038269723,0.0000076165534,0.0023534086,0.00020745563],"about_ca_topic_score_codex":0.0001196401,"about_ca_topic_score_gemma":0.00081245735,"teacher_disagreement_score":0.07231123,"about_ca_system_score_codex":0.00018518492,"about_ca_system_score_gemma":0.00011312652,"threshold_uncertainty_score":0.6197974},"labels":[],"label_agreement":null},{"id":"W2983438087","doi":"10.1093/neuonc/noz175.196","title":"CSIG-26. IS INTRINSIC APOPTOSIS THE SIGNALING PATHWAY ACTIVATED BY TUMOR-TREATING FIELDS FOR GLIOBLASTOMA?","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Apoptosis; Microtubule; Dexamethasone; Cell cycle; Chemistry; Glioma; Cancer research; Cell cycle checkpoint; Cell biology; Medicine; Internal medicine; Biology; Biochemistry","score_opus":0.008785879074293387,"score_gpt":0.22723520900923871,"score_spread":0.2184493299349453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983438087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992888,0.00016286495,0.0022790616,0.00041102376,0.0016148662,0.000820366,0.000049710925,0.00047756915,0.0012965449],"genre_scores_gemma":[0.9973763,0.000026341888,0.0003281085,0.0017096066,0.0002365333,0.00013275415,0.000007784664,0.00012683313,0.000055691817],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99861264,0.0000381639,0.00036304982,0.00030473832,0.00016049214,0.00052091124],"domain_scores_gemma":[0.99810773,0.0012706845,0.00011108466,0.00036032134,0.00006699055,0.00008321285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015481694,0.0002757861,0.00038258318,0.0000870105,0.00012247803,0.000041720035,0.0003367193,0.00022589196,0.00015547869],"category_scores_gemma":[0.00010214016,0.00022438036,0.00013406597,0.0002719588,0.000041679596,0.00015120303,0.00006256558,0.00046600815,0.00010009415],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012399573,0.000025227451,0.00011046686,0.00006234289,0.00007064166,0.0000041078392,0.0006029862,0.0020052402,0.9691857,0.000049502432,0.0055787833,0.022180988],"study_design_scores_gemma":[0.0010117723,0.0007443915,0.000004255695,0.000020647685,0.00003428433,0.000015654849,0.00016310367,0.003780818,0.8641063,0.00018094406,0.12971494,0.00022287534],"about_ca_topic_score_codex":0.000017328335,"about_ca_topic_score_gemma":0.00001209688,"teacher_disagreement_score":0.12413616,"about_ca_system_score_codex":0.00024256355,"about_ca_system_score_gemma":0.00007910528,"threshold_uncertainty_score":0.9149965},"labels":[],"label_agreement":null},{"id":"W2983439350","doi":"10.1093/neuonc/noz175.231","title":"CMET-30. COMPREHENSIVE METHYLOME ANALYSIS OF EGFR-MUTANT PRIMARY LUNG ADENOCARCINOMA AND MATCHED BRAIN METASTASIS","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"DNA methylation; Adenocarcinoma; Methylation; Biology; Cancer research; Lung cancer; Epigenetics; Metastasis; Lung; Brain metastasis; Pathology; Gene; Medicine; Cancer; Genetics; Internal medicine; Gene expression","score_opus":0.01898871956096887,"score_gpt":0.3415605696622252,"score_spread":0.32257185010125633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983439350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893088,0.0022363677,0.00010000159,0.003699536,0.00020714283,0.0007564104,0.000104791114,0.000039045677,0.0035479378],"genre_scores_gemma":[0.9935544,0.00020527754,0.001459353,0.004362769,0.000039229435,0.000043672804,0.0001364742,0.000028655499,0.00017014303],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984148,0.00020812271,0.00043585795,0.0004487334,0.00022636012,0.0002661365],"domain_scores_gemma":[0.9981966,0.00082333706,0.00024081721,0.00040520602,0.0001722874,0.00016175507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013725308,0.00020363044,0.0011731291,0.00047770012,0.000045302208,0.000009095882,0.000086244,0.0001285035,0.0006156744],"category_scores_gemma":[0.000060509203,0.00016701179,0.00022210425,0.00069575704,0.00011752679,0.0000658822,0.00009060877,0.00018720904,0.000028313701],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005049673,0.00049648236,0.12871952,0.00032070477,0.010033061,0.0003750552,0.0026903078,0.00011769548,0.8391788,0.00044231402,0.0016654363,0.015455648],"study_design_scores_gemma":[0.011149828,0.004551035,0.8622939,0.00004793789,0.03803926,0.00031863843,0.0023166863,0.0018465591,0.022227667,0.000121235564,0.056643587,0.0004436752],"about_ca_topic_score_codex":0.00015466264,"about_ca_topic_score_gemma":0.000020163052,"teacher_disagreement_score":0.81695116,"about_ca_system_score_codex":0.0003098628,"about_ca_system_score_gemma":0.0003219914,"threshold_uncertainty_score":0.6810543},"labels":[],"label_agreement":null},{"id":"W2983703208","doi":"10.1093/neuonc/noz175.012","title":"ATIM-12. AVELUMAB IN NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME-THE SEJ STUDY","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital; Clinique Neuro-Outaouais","funders":"","keywords":"Avelumab; Temozolomide; Medicine; Radiation therapy; Oncology; Internal medicine; Glioblastoma; Interim analysis; Immunotherapy; Clinical trial; Nivolumab; Cancer research; Cancer","score_opus":0.01701592231573077,"score_gpt":0.2967068258603395,"score_spread":0.2796909035446087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983703208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887265,0.000089231675,0.0000012413524,0.004171799,0.000709145,0.0026873548,0.000005842389,0.00007029208,0.0035386237],"genre_scores_gemma":[0.99662304,0.0000422784,0.00006652026,0.0025655392,0.00013454458,0.00041840458,0.000007887628,0.00004320837,0.000098585835],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99796396,0.0002715063,0.0004560327,0.0005189821,0.00030880506,0.0004807015],"domain_scores_gemma":[0.9978461,0.0011497564,0.0001467148,0.00063420966,0.00006670994,0.00015649742],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00026472873,0.00026552018,0.00063112925,0.00021839577,0.00007363477,0.000020590838,0.00019764445,0.00016243345,0.00043112398],"category_scores_gemma":[0.00025960026,0.00017938922,0.00012950346,0.000326789,0.00007025696,0.00007136842,0.00013352263,0.00040252047,0.00092198397],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008275913,0.007908975,0.9075212,0.000026850677,0.00014095852,0.003989826,0.00350192,0.00010229635,0.02811487,0.00006739358,0.004655274,0.043142863],"study_design_scores_gemma":[0.03801834,0.018016648,0.8269322,0.00004962904,0.00024210381,0.00030789376,0.0025297548,0.00094180973,0.006368261,0.000034983277,0.106277265,0.00028113188],"about_ca_topic_score_codex":0.000302029,"about_ca_topic_score_gemma":0.0024966171,"teacher_disagreement_score":0.10162199,"about_ca_system_score_codex":0.00034231326,"about_ca_system_score_gemma":0.00020861159,"threshold_uncertainty_score":0.99985594},"labels":[],"label_agreement":null},{"id":"W2983720088","doi":"10.1093/neuonc/noz175.479","title":"HOUT-14. PROGNOSTIC IMPACT OF FIRST PSEUDOPROGRESSION ON MRI IN GLIOBLASTOMA, AN 11 YEARS EXPERIENCE FROM A CANADIAN UNIVERSITY CENTER","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"École de Technologie Supérieure; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Glioblastoma; Cohort; Incidence (geometry); Radiation therapy; Internal medicine; Tumor progression; Oncology; Nuclear medicine; Cancer","score_opus":0.012044571287049001,"score_gpt":0.28043768035370686,"score_spread":0.26839310906665786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983720088","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99807996,0.000016580889,1.4737394e-7,0.00064491725,0.00020439041,0.0005612099,0.000060840357,0.000018042441,0.0004138874],"genre_scores_gemma":[0.99967146,0.000023480288,0.00004297783,0.00018024718,0.000028822704,0.0000092662685,0.000022992672,0.000015244664,0.000005504819],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989781,0.000091091526,0.00014921828,0.000340659,0.0001381301,0.0003028215],"domain_scores_gemma":[0.9990889,0.00016536163,0.00008243547,0.0003049155,0.00004062645,0.00031778112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004099212,0.00013751401,0.0003235721,0.0002845965,0.000029402468,0.000005452049,0.000115516516,0.00013824277,0.00034112905],"category_scores_gemma":[0.000043681306,0.00011759947,0.00008728913,0.00022057323,0.00006337362,0.000068340916,0.000036191122,0.00014613557,0.000062108316],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043197328,0.0010262674,0.98707014,0.000006188645,0.000020583098,0.0016873989,0.0012722976,0.00003497333,0.00617652,0.000009337216,0.0004980341,0.0017662721],"study_design_scores_gemma":[0.004386709,0.005980535,0.977551,0.00011935208,0.000032993943,0.00003374238,0.00036088284,0.00024274808,0.0021365585,0.0000025983884,0.00905484,0.00009803301],"about_ca_topic_score_codex":0.049261462,"about_ca_topic_score_gemma":0.16076823,"teacher_disagreement_score":0.11150675,"about_ca_system_score_codex":0.0006584086,"about_ca_system_score_gemma":0.00033346727,"threshold_uncertainty_score":0.9570696},"labels":[],"label_agreement":null},{"id":"W2983746712","doi":"10.1093/neuonc/noz175.804","title":"PDTM-28. AN OTX2-PAX3 SIGNALLING AXIS REGULATES GROUP 3 MEDULLOBLASTOMA CELL FATE","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Toronto; Ottawa Hospital; University of Manitoba","funders":"","keywords":"Biology; PAX6; Cancer research; In vivo; Chromatin; Cell fate determination; Transcription factor; Gene; Genetics","score_opus":0.00807951501155157,"score_gpt":0.23966385841881335,"score_spread":0.23158434340726178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983746712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931228,0.00067039754,0.00035651482,0.0003478409,0.0011401981,0.00035911158,0.00004167552,0.000035904097,0.0039255596],"genre_scores_gemma":[0.99412346,0.00080503855,0.0012314408,0.0025753714,0.0007036072,0.000033106553,0.0001765702,0.00007244695,0.00027897628],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981004,0.00014402642,0.0003531487,0.00074780773,0.00014300401,0.0005115854],"domain_scores_gemma":[0.99876446,0.00014574738,0.00018531767,0.0005794334,0.00009712464,0.00022791761],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021065843,0.00027950568,0.0003398487,0.00007366539,0.000091723494,0.00003642,0.0003729768,0.00039193965,0.00017410841],"category_scores_gemma":[0.000079477184,0.00029363544,0.00014163695,0.00010467802,0.00010195813,0.000008524265,0.00024330031,0.00022886746,0.00017545902],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002479617,0.00018879381,0.0013389369,0.000022822362,0.000025199213,0.000033594737,0.00008450272,0.00097360957,0.98802567,0.00018208587,0.002715773,0.006161074],"study_design_scores_gemma":[0.0011576012,0.0035310301,0.000487104,0.0000059183694,0.00003207228,0.000046781915,0.00007450328,0.00059015903,0.5445418,0.00012907093,0.44909176,0.0003122141],"about_ca_topic_score_codex":0.000055399858,"about_ca_topic_score_gemma":0.00016816157,"teacher_disagreement_score":0.446376,"about_ca_system_score_codex":0.0000705665,"about_ca_system_score_gemma":0.00021517326,"threshold_uncertainty_score":0.9999516},"labels":[],"label_agreement":null},{"id":"W2983802169","doi":"10.1093/neuonc/noz175.381","title":"EXTH-50. THIOREDOXIN REDUCTASE1 AND MGMT SYNTHETIC LETHALITY ENHANCES CYTOTOXICITY OF PRIMA-1MET(APR-246) AND AURANOFIN IN GLIOBLASTOMA","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Redox biology and oxidative stress","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Auranofin; Temozolomide; Cancer research; DNA damage; Reactive oxygen species; Thioredoxin reductase; Thioredoxin; Cytotoxicity; Cell culture; Chemistry; Oxidative stress; Biology; Glioma; Immunology; Biochemistry; In vitro","score_opus":0.00810914141307381,"score_gpt":0.27170703475949987,"score_spread":0.2635978933464261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983802169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99556303,0.0011742462,0.00003841464,0.00041334817,0.00019196694,0.00041366374,0.000040268424,0.000010822131,0.0021542371],"genre_scores_gemma":[0.9984787,0.00073345116,0.00024629134,0.00035088632,0.00007034191,0.000028805933,0.00001889531,0.000017048096,0.000055577337],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978974,0.00058810745,0.00039469704,0.0006963602,0.00008452764,0.0003389148],"domain_scores_gemma":[0.9990418,0.00021344308,0.00021876268,0.00036790108,0.00006500927,0.00009310324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004226067,0.00024199768,0.0004967383,0.00009658192,0.000050445225,0.000009668393,0.0002114801,0.0004615178,0.000029719116],"category_scores_gemma":[0.0002571395,0.00021755524,0.00006441087,0.00011172551,0.00066092535,0.000011911647,0.00024929433,0.0002656002,0.0000060383727],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007666019,0.00013607659,0.01647661,0.0000708543,0.000030063495,0.000017037744,0.00013063417,0.0000036654212,0.9791378,0.00021435645,0.00012422344,0.0028920963],"study_design_scores_gemma":[0.0010757841,0.0023151413,0.026163282,0.000024072688,0.000018951736,0.00011711097,0.00017028773,0.000018711977,0.9612788,0.00031169967,0.008297207,0.00020897796],"about_ca_topic_score_codex":0.000040413517,"about_ca_topic_score_gemma":0.00013786007,"teacher_disagreement_score":0.017859008,"about_ca_system_score_codex":0.000022264,"about_ca_system_score_gemma":0.000116823954,"threshold_uncertainty_score":0.88716453},"labels":[],"label_agreement":null},{"id":"W2983816200","doi":"10.1093/neuonc/noz175.183","title":"CSIG-12. PREX1 LINKS ABERRANT PI 3-KINASE PATHWAY SIGNALING TO MAINTENANCE OF THE NEURAL STEM CELL-LIKE PHENOTYPE OF GLIOBLASTOMA CELLS","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"14-3-3 protein interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Ottawa Hospital","funders":"","keywords":"Neural stem cell; Biology; Cell biology; Stem cell; Progenitor cell; Cancer research; Signal transduction","score_opus":0.009186315090915359,"score_gpt":0.23520399384489846,"score_spread":0.2260176787539831,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983816200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99449414,0.00011807221,0.00023414262,0.00039808743,0.001814152,0.00085073186,0.000054749486,0.000015168193,0.002020742],"genre_scores_gemma":[0.99716824,0.00001644592,0.00031738356,0.0012689509,0.00014569155,0.00005297674,0.0000052028836,0.00004563508,0.0009794744],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981068,0.0003022293,0.0005081422,0.00050726027,0.00019305405,0.00038254503],"domain_scores_gemma":[0.9983312,0.00014114812,0.00039900755,0.00079246296,0.00022915743,0.000107006315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019205941,0.00023370507,0.00036498043,0.00006916413,0.0000577808,0.000009686373,0.00056681375,0.00036277933,0.000077856545],"category_scores_gemma":[0.0000677935,0.00018865748,0.00021619438,0.00016476263,0.00012136231,0.000007566169,0.00037196334,0.00044571212,0.00004846971],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005500478,0.00019024074,0.0003590492,0.0000626437,0.000026733655,0.000010025332,0.0002629084,0.002185787,0.9923591,0.000027199663,0.0017072808,0.002258991],"study_design_scores_gemma":[0.0006939635,0.0026594184,0.00013716244,0.00003326265,0.000024307246,0.000026193571,0.00013833262,0.00023217178,0.9165265,0.000010995471,0.079357296,0.00016040406],"about_ca_topic_score_codex":0.000036185942,"about_ca_topic_score_gemma":0.00007986309,"teacher_disagreement_score":0.07765002,"about_ca_system_score_codex":0.000048534068,"about_ca_system_score_gemma":0.00023516554,"threshold_uncertainty_score":0.7693229},"labels":[],"label_agreement":null},{"id":"W2983854420","doi":"10.1093/neuonc/noz175.315","title":"EPID-15. GUIDELINES FOR THE OPTIMAL USE OF SOCIAL MEDIA FOR NEURO-ONCOLOGISTS","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Social Media in Health Education","field":"Social Sciences","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Theme (computing); Social media; Empowerment; Psychology; Medicine; Computer science; World Wide Web; Political science","score_opus":0.34678932329809453,"score_gpt":0.49278081519979755,"score_spread":0.14599149190170302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983854420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.61034364,0.00028590806,0.0017099022,0.305604,0.06710407,0.013540731,0.00018623905,0.00021499301,0.0010105093],"genre_scores_gemma":[0.8669207,0.0011725063,0.03841436,0.044463456,0.034111936,0.0142616695,0.00011310603,0.0002321205,0.00031013202],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99702734,0.0007053955,0.0007622454,0.00042037718,0.00039527155,0.0006893884],"domain_scores_gemma":[0.9168429,0.0809125,0.0006121016,0.00025355272,0.0012297926,0.00014917989],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0021314227,0.00017840366,0.00052844593,0.00009817932,0.00066740956,0.00003781328,0.00059019745,0.0004602018,0.00015681921],"category_scores_gemma":[0.087978885,0.0001511097,0.00023199918,0.0003467794,0.0007057958,0.0002018804,0.0000769966,0.00026025542,0.00003076891],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013214669,0.00056193245,0.011147422,0.00022259394,0.00008616522,0.0000040825153,0.10027305,0.0003314535,0.015592654,0.046154015,0.48694158,0.33736357],"study_design_scores_gemma":[0.00088786415,0.00055055215,0.0035113136,0.00000481577,0.00006690241,0.0000014295659,0.004744154,0.00035215702,0.00038478323,0.00058332604,0.9887757,0.00013703307],"about_ca_topic_score_codex":0.0007195627,"about_ca_topic_score_gemma":0.0021728408,"teacher_disagreement_score":0.5018341,"about_ca_system_score_codex":0.0003659221,"about_ca_system_score_gemma":0.0022705698,"threshold_uncertainty_score":0.9197035},"labels":[],"label_agreement":null},{"id":"W2983979515","doi":"10.1093/neuonc/noz175.220","title":"CMET-19. QUESTIONING THE PARADIGM: DO CSF CYTOLOGY AND MRI SCANNING IDENTIFY THE SAME DISEASE IN PATIENTS WITH NEOPLASTIC MENINGITIS (NM) – DATA FROM AN INTERNATIONAL NM REGISTRY AND A META-ANALYSIS","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Gold standard (test); Medicine; Cytology; Meta-analysis; Radiology; Internal medicine; Pathology; Nuclear medicine","score_opus":0.042225743716117266,"score_gpt":0.34200391848477646,"score_spread":0.2997781747686592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2983979515","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842167,0.0008341222,0.00035997815,0.013449241,0.00015496211,0.0005212946,0.00038209747,0.000017440858,0.000064188534],"genre_scores_gemma":[0.99623924,0.00006708504,0.00063233427,0.0021499817,0.000055200024,0.0000427999,0.00076678395,0.000017918457,0.000028641436],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980234,0.00051137636,0.00030508373,0.00067268644,0.00026812585,0.00021936069],"domain_scores_gemma":[0.99743885,0.0012178881,0.00023768541,0.0008802025,0.000051545547,0.0001738476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037418513,0.00019775162,0.0006566192,0.00013993244,0.000119813114,0.00009236691,0.00028804207,0.000068908594,0.00025485028],"category_scores_gemma":[0.00033359518,0.00010733279,0.00008547991,0.00021703774,0.00022696322,0.0002086846,0.00026381237,0.00029480646,0.000007040184],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096326065,0.0002555062,0.9826159,0.000011493317,0.012794434,0.00038928998,0.00064244884,0.0007909714,0.00003857623,0.00027692315,0.00026971742,0.0009515166],"study_design_scores_gemma":[0.003097487,0.0007629651,0.92510283,0.000009167453,0.05830866,0.000075649055,0.00021456252,0.005452199,0.0000035234245,0.0002460606,0.0065919776,0.00013493435],"about_ca_topic_score_codex":0.00095740723,"about_ca_topic_score_gemma":0.0006382056,"teacher_disagreement_score":0.057513047,"about_ca_system_score_codex":0.00006992288,"about_ca_system_score_gemma":0.00012784956,"threshold_uncertainty_score":0.4376904},"labels":[],"label_agreement":null},{"id":"W2984113977","doi":"10.1093/neuonc/noz175.1000","title":"STEM-27. LEVERAGING FUNCTIONAL GENETIC DEPENDENCIES IN TREATMENT-REFRACTORY GLIOBLASTOMA","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University","funders":"","keywords":"CRISPR; Context (archaeology); Genome editing; Biology; Temozolomide; Gene knockout; Stem cell; Cancer research; Gene; Computational biology; Bioinformatics; Genetics; Glioblastoma","score_opus":0.027881022889461534,"score_gpt":0.27395388702221923,"score_spread":0.2460728641327577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984113977","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99253696,0.0007116954,0.000005598932,0.0011430522,0.0010331342,0.00060433464,0.000005407491,0.000058173842,0.0039016262],"genre_scores_gemma":[0.9981215,0.00017528105,0.00009352591,0.0009784343,0.00015036241,0.00010894922,0.000010704332,0.0000315598,0.00032970216],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985286,0.00011881744,0.00030173155,0.00045559957,0.0002267803,0.00036847597],"domain_scores_gemma":[0.9989866,0.00041498186,0.00009653599,0.00030888183,0.000050579943,0.0001424424],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00006631925,0.00022618765,0.00046605224,0.00028141122,0.000042658932,0.000012652846,0.00006290714,0.00015666665,0.0007991764],"category_scores_gemma":[0.000019457948,0.00018434145,0.00012492407,0.00018541158,0.000044775905,0.00006703473,0.000043712742,0.00018336602,0.0008271572],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000611468,0.0021742645,0.6681434,0.000029512074,0.00013290608,0.0024181048,0.00042845475,0.00026799535,0.2607944,0.00007112515,0.0012882454,0.0636401],"study_design_scores_gemma":[0.019740017,0.014118458,0.6535425,0.000064821594,0.00028051707,0.0015211763,0.0006170159,0.0005425244,0.054987323,0.00006671112,0.25416246,0.00035644765],"about_ca_topic_score_codex":0.000075328855,"about_ca_topic_score_gemma":0.00020068056,"teacher_disagreement_score":0.25287423,"about_ca_system_score_codex":0.0008088309,"about_ca_system_score_gemma":0.0003366544,"threshold_uncertainty_score":0.9999508},"labels":[],"label_agreement":null},{"id":"W2984194917","doi":"10.1093/neuonc/noz175.447","title":"GENE-45. DISSECTING THE DRIVERS OF ADULT H3K27M-GLIOMAS AT THE SINGLE-CELL LEVEL","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Context (archaeology); Glioma; Carcinogenesis; Biology; Transcriptome; Cancer research; Cancer; Gene; Gene expression; Genetics","score_opus":0.03252501835138273,"score_gpt":0.2781104484428717,"score_spread":0.24558543009148898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984194917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9819741,0.00020606461,0.000002575901,0.0064408486,0.0008809061,0.00070834486,0.000015348729,0.000028268083,0.009743508],"genre_scores_gemma":[0.99750733,0.000053264575,0.000100113284,0.0018505778,0.000119229735,0.000042390733,0.0000116526535,0.000029336778,0.00028612872],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986437,0.00016355413,0.0002992531,0.0003262163,0.00025371462,0.0003135631],"domain_scores_gemma":[0.9977473,0.0011951479,0.00022467149,0.0005633213,0.00018004532,0.00008952479],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014854361,0.00018039509,0.0003647192,0.00007011472,0.00014387342,0.0000089912755,0.00018839599,0.00012929506,0.0003008827],"category_scores_gemma":[0.00024808146,0.00009593387,0.00018362864,0.00021449504,0.00016901227,0.000030044006,0.00015966834,0.000229532,0.0002212217],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001489411,0.0006530169,0.08355744,0.000028490102,0.000081204074,0.0001639546,0.0010545629,0.000040677885,0.90354884,0.000092278,0.004190087,0.006440526],"study_design_scores_gemma":[0.0043523833,0.0024431946,0.03027556,0.000028027946,0.00031700998,0.00032418844,0.0010821031,0.00011274855,0.92023355,0.00002944227,0.040674765,0.00012704002],"about_ca_topic_score_codex":0.00007850034,"about_ca_topic_score_gemma":0.00016850815,"teacher_disagreement_score":0.053281877,"about_ca_system_score_codex":0.00021458964,"about_ca_system_score_gemma":0.00009950904,"threshold_uncertainty_score":0.39120695},"labels":[],"label_agreement":null},{"id":"W2984488881","doi":"10.1093/neuonc/noz175.838","title":"QOLP-18. A TIME-BASED MODEL OF EARLY PALLIATIVE CARE INTERVENTION IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA, A SINGLE INSTITUTION FEASIBILITY STUDY","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Specialty; Quality of life (healthcare); Intervention (counseling); Palliative care; Physical therapy; Distress; Population; Patient satisfaction; Internal medicine; Family medicine; Surgery; Nursing","score_opus":0.08835455645446269,"score_gpt":0.3811224056015717,"score_spread":0.29276784914710896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984488881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967252,0.00006580152,0.00034839797,0.00003741585,0.00011591469,0.0020067098,0.00003968931,0.000028972168,0.0006318978],"genre_scores_gemma":[0.99924386,0.0000033942895,0.000511801,0.000103137856,0.000015763737,0.000053099833,0.000039390914,0.000018407402,0.000011150346],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983119,0.0002779332,0.0004917807,0.00039154524,0.00032072776,0.00020611133],"domain_scores_gemma":[0.9985044,0.00027636616,0.0003395879,0.000320429,0.00048307312,0.00007611993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014966204,0.0001888492,0.0006571538,0.00023393049,0.000019060248,0.0000041289995,0.000105732084,0.0001353834,0.000044021137],"category_scores_gemma":[0.00034433568,0.00015902986,0.00010858337,0.00032309082,0.00012229763,0.00011112726,0.00004924593,0.00022960613,0.000015279513],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007695213,0.0052469885,0.9671045,0.00020041139,0.000047600228,0.000026165892,0.0060583246,0.002126016,0.009141394,0.0000058801184,0.000020303056,0.0023271812],"study_design_scores_gemma":[0.03801324,0.06286489,0.88050175,0.0008913462,0.0001885632,3.3278235e-7,0.0022141063,0.0044281315,0.010549036,0.000015993382,0.00012138735,0.00021124077],"about_ca_topic_score_codex":0.0002638368,"about_ca_topic_score_gemma":0.0007808133,"teacher_disagreement_score":0.08660279,"about_ca_system_score_codex":0.00049380143,"about_ca_system_score_gemma":0.00031041872,"threshold_uncertainty_score":0.648505},"labels":[],"label_agreement":null},{"id":"W2984561122","doi":"10.1093/neuonc/noz175.298","title":"DRES-10. TEMOZOLOMIDE-ASSOCIATED HYPERMUTATION DETECTED WITH A GENE PANEL SIGNATURE IMPROVES IMMUNE RESPONSE IN GLIOBLASTOMA","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Somatic hypermutation; Temozolomide; Microsatellite instability; Cancer research; Gene signature; Biology; Gene; Concordance; Medicine; Glioblastoma; Oncology; Genetics; Gene expression; Antibody","score_opus":0.006310535102696933,"score_gpt":0.23013754111851575,"score_spread":0.2238270060158188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984561122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99802464,0.0004388529,0.000028052067,0.00039861494,0.0002882769,0.0005260765,0.000049583214,0.00002671926,0.0002192003],"genre_scores_gemma":[0.9983992,0.00012901625,0.00017761554,0.00077562366,0.00008774913,0.00006182753,0.0001037518,0.000053100233,0.00021211192],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983172,0.00030066125,0.00032969174,0.00053336646,0.00012379652,0.00039527885],"domain_scores_gemma":[0.9988273,0.00032929916,0.00021928232,0.00038521836,0.00015213921,0.000086792024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028503034,0.00023443191,0.00032979102,0.00012757216,0.000050450297,0.000023322118,0.0002181894,0.00046821233,0.000038850216],"category_scores_gemma":[0.0007178493,0.00022374763,0.00007621555,0.0002460756,0.000081333324,0.000006190551,0.00012668192,0.0002840648,0.00003971915],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011370066,0.00015547876,0.0010206162,0.000007787948,0.00004270926,0.00010323472,0.00009897891,0.00061575696,0.98400843,0.0000041337184,0.00036417024,0.0022086087],"study_design_scores_gemma":[0.00577562,0.013971818,0.047812417,0.00001750568,0.00004495348,0.00013722587,0.00013560863,0.0005792917,0.90564096,0.000030569725,0.025428671,0.0004253482],"about_ca_topic_score_codex":0.00005939273,"about_ca_topic_score_gemma":0.00040464549,"teacher_disagreement_score":0.07836749,"about_ca_system_score_codex":0.00018229659,"about_ca_system_score_gemma":0.00056365394,"threshold_uncertainty_score":0.91241634},"labels":[],"label_agreement":null},{"id":"W2984664109","doi":"10.1093/neuonc/noz175.429","title":"GENE-27. MENINGIOMA RECURRENCE: ROLE OF M1/M2 TUMOUR-ASSOCIATED MACROPHAGE INFILTRATION","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Meningioma; Immunohistochemistry; Phenotype; Infiltration (HVAC); Pathology; Immune system; Medicine; Cancer research; Biology; Immunology; Gene","score_opus":0.008211731318695712,"score_gpt":0.2320693349143049,"score_spread":0.2238576035956092,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984664109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893917,0.00045635505,0.0001068,0.000032190983,0.0020321235,0.00033608117,0.000045765515,0.00020818038,0.0073908484],"genre_scores_gemma":[0.9992352,0.00013977913,0.00031212013,0.00008306064,0.000090197405,0.000016292339,0.000039144463,0.000048563703,0.000035637164],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99876505,0.000048866317,0.0004117394,0.00021456266,0.0002009026,0.00035886458],"domain_scores_gemma":[0.99921525,0.0002195475,0.00015323836,0.00024782622,0.0000831036,0.000081056416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015906931,0.00019375821,0.00037193816,0.00012706703,0.000030492909,0.000013316268,0.0002300158,0.00025550745,0.0001765434],"category_scores_gemma":[0.00009291212,0.00020798524,0.00008519544,0.00030851297,0.000041720003,0.00015318696,0.000040667906,0.00031419983,0.00018949361],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000040697363,0.00004152137,0.0021587326,0.000029480674,0.00004259496,0.000018561052,0.0005650387,0.0020280043,0.98508507,0.00008453819,0.0005130077,0.00939278],"study_design_scores_gemma":[0.001183172,0.00071815087,0.001070561,0.000020882208,0.00004086885,0.000036695128,0.00006734663,0.0092767505,0.9533347,0.00048437002,0.033530913,0.00023557358],"about_ca_topic_score_codex":0.000015646807,"about_ca_topic_score_gemma":0.000023018396,"teacher_disagreement_score":0.033017907,"about_ca_system_score_codex":0.0002880309,"about_ca_system_score_gemma":0.00010553785,"threshold_uncertainty_score":0.8481392},"labels":[],"label_agreement":null},{"id":"W2984683685","doi":"10.1093/neuonc/noz175.331","title":"EPID-31. EFFICIENT STUDY OF SURGICALLY TREATED MENINGIOMA THROUGH CLINICAL DATA STANDARDIZATION","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Alberta","funders":"","keywords":"Electronic data capture; Medicine; Medical physics; Standardization; Terminology; Scope (computer science); Consistency (knowledge bases); Data science; Computer science; Clinical trial; Pathology; Artificial intelligence","score_opus":0.10661931371964042,"score_gpt":0.40976584459933685,"score_spread":0.30314653087969645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984683685","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97431517,0.00005189099,0.0007211886,0.00074925006,0.000776616,0.0018147569,0.000026541135,0.000087406755,0.021457203],"genre_scores_gemma":[0.99839395,0.000014219398,0.0007759796,0.00024755578,0.00012854855,0.000018369188,0.00016934118,0.000026420419,0.00022561241],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99667007,0.00061509456,0.0010795036,0.00078785524,0.00052259024,0.0003248799],"domain_scores_gemma":[0.9971527,0.0007299889,0.00039228034,0.0013939311,0.00019433249,0.00013676732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014211779,0.00020561811,0.0009517933,0.00013372862,0.000057800495,0.000013140434,0.0003789411,0.00017295577,0.00029398588],"category_scores_gemma":[0.00047124468,0.00016671032,0.00010701878,0.0004098239,0.00009385399,0.00007839218,0.0004850838,0.00027439714,0.00010170051],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016226372,0.028144507,0.73259,0.00046536277,0.0022580216,0.016840832,0.00604746,0.0031694649,0.092010275,0.002275029,0.059175104,0.040797573],"study_design_scores_gemma":[0.05357944,0.07045854,0.13071086,0.00014426136,0.0023932199,0.001042271,0.0035529626,0.02094804,0.0032756515,0.00006217214,0.7130179,0.00081469805],"about_ca_topic_score_codex":0.000040608058,"about_ca_topic_score_gemma":0.000006642971,"teacher_disagreement_score":0.6538428,"about_ca_system_score_codex":0.00010160112,"about_ca_system_score_gemma":0.00022179235,"threshold_uncertainty_score":0.67982495},"labels":[],"label_agreement":null},{"id":"W2984737845","doi":"10.1093/neuonc/noz175.436","title":"GENE-34. THERAPEUTICALLY TARGETING EPIGENOMIC AND TRANSCRIPTIONAL DYSFUNCTION IN ATRX-DEFICIENT GLIOMA","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"ATRX; SIRT2; Epigenomics; Biology; Chromatin; Death-associated protein 6; Epigenetics; Genetics; Histone; Gene; Cancer research; Mutation; DNA methylation; Gene expression; Sirtuin; Nuclear protein; Transcription factor; Acetylation","score_opus":0.019044234620464458,"score_gpt":0.2720036081499647,"score_spread":0.25295937352950026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984737845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99260134,0.0013656137,0.000023302968,0.0035254906,0.0005392478,0.00055356236,0.0000068363843,0.000032569314,0.0013520599],"genre_scores_gemma":[0.9976733,0.00017423069,0.00029506677,0.0016503794,0.00009753947,0.000048532926,0.000028730285,0.000021575339,0.000010662373],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99879926,0.00010076076,0.00028631932,0.00037750026,0.00015122912,0.000284932],"domain_scores_gemma":[0.9994726,0.0001772928,0.000059319114,0.00014493514,0.000041993986,0.00010382265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018608653,0.00014798678,0.00031700352,0.0001742835,0.000045668447,0.000011140782,0.000042979867,0.00013851703,0.0002626009],"category_scores_gemma":[0.000024864505,0.00012469666,0.000075117765,0.00014444457,0.000050531366,0.000040664843,0.00002265178,0.00018497494,0.0001263996],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003069736,0.00054604013,0.07266572,0.000016660642,0.000033925156,0.00019279507,0.0002836157,0.000047397854,0.91391474,0.0006754425,0.0000828465,0.011233821],"study_design_scores_gemma":[0.02122851,0.007320283,0.6809859,0.000053201253,0.00032416353,0.0011501188,0.00058975845,0.0017092417,0.17289606,0.0004206922,0.112885505,0.00043652212],"about_ca_topic_score_codex":0.000031901924,"about_ca_topic_score_gemma":0.00003085192,"teacher_disagreement_score":0.7410187,"about_ca_system_score_codex":0.000261521,"about_ca_system_score_gemma":0.00011031594,"threshold_uncertainty_score":0.5084982},"labels":[],"label_agreement":null},{"id":"W2985015496","doi":"10.1093/neuonc/noz175.663","title":"NCOG-01. NEUROCOGNITIVE FUNCTION (NCF) AND QUALITY OF LIFE (QOL) RESULTS FROM A PHASE II STUDY OF TEMOZOLOMIDE-BASED CHEMORADIOTHERAPY REGIMEN FOR HIGH RISK LOW-GRADE GLIOMAS","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Temozolomide; Internal medicine; Quality of life (healthcare); Verbal learning; Neurocognitive; Chemoradiotherapy; Oncology; Radiation therapy; Cognition","score_opus":0.03699080372732048,"score_gpt":0.3344651818423563,"score_spread":0.2974743781150358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985015496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935758,0.00021205224,0.000042889005,0.0013120283,0.00039055926,0.003635483,0.0007026932,0.000047400663,0.00008106605],"genre_scores_gemma":[0.9981102,0.00007354881,0.00027800674,0.00089736097,0.0001456753,0.0002592951,0.00018194407,0.000045065302,0.000008923583],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99720514,0.00053123786,0.00093878305,0.00074610184,0.00030054388,0.0002781945],"domain_scores_gemma":[0.99507076,0.0029087088,0.0010141843,0.00056363404,0.00024819773,0.00019454533],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00045268188,0.00029527105,0.0013239381,0.00022849068,0.00008848345,0.000007244673,0.000097691176,0.00020789208,0.000047616548],"category_scores_gemma":[0.0008564509,0.00024907224,0.00015974097,0.00027188053,0.0001313522,0.000063160514,0.000049490147,0.00021248445,0.0000038039616],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.087985456,0.03531989,0.09216016,0.00019303433,0.0011177645,0.00009229991,0.0022498965,0.00005455298,0.7488571,0.000045300167,0.001144447,0.030780146],"study_design_scores_gemma":[0.3396828,0.1495599,0.21508905,0.00009977094,0.0016802279,0.000010187256,0.0015612129,0.0006315809,0.2877014,0.00019250876,0.0034029218,0.00038844475],"about_ca_topic_score_codex":0.0015143689,"about_ca_topic_score_gemma":0.00019195679,"teacher_disagreement_score":0.46115565,"about_ca_system_score_codex":0.00009557138,"about_ca_system_score_gemma":0.00023075259,"threshold_uncertainty_score":0.9999961},"labels":[],"label_agreement":null},{"id":"W2985130805","doi":"10.1093/neuonc/noz175.994","title":"STEM-21. INVESTIGATING DOT1L AS AN EPIGENETIC VULNERABILITY IN BRAIN TUMOR STEM CELLS","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Calgary; University of Toronto; SickKids Foundation; Ontario Brain Institute","funders":"","keywords":"Stem cell; Biology; Cancer research; Epigenetics; Neural stem cell; Embryonic stem cell; Methyltransferase; Cancer stem cell; Cell biology; Genetics; Methylation; Gene","score_opus":0.02122578722057692,"score_gpt":0.29567190841531643,"score_spread":0.2744461211947395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985130805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99525976,0.00041975995,0.000104368664,0.00043866964,0.00065783557,0.0006412568,0.000012095817,0.000024445342,0.0024417778],"genre_scores_gemma":[0.99678695,0.00006914741,0.0005749187,0.0019129467,0.00020379246,0.000049501254,0.00003739984,0.00005050907,0.00031483246],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968738,0.0010092153,0.000569047,0.000875235,0.00019225098,0.00048046012],"domain_scores_gemma":[0.9984709,0.00024454095,0.0002378634,0.00071886106,0.00009737848,0.00023044161],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009091103,0.00026793417,0.0003784946,0.00009731557,0.00007368523,0.000033243563,0.00033728106,0.00033844102,0.00006310506],"category_scores_gemma":[0.000120130455,0.00027958676,0.00009110748,0.00018841952,0.00012802704,0.000010339158,0.00019077868,0.00034182466,0.00010926405],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006236258,0.00014147014,0.034034155,0.000032249358,0.00000831685,0.000017121245,0.00017209622,0.0011363104,0.94893205,0.00007622663,0.000068257534,0.015319355],"study_design_scores_gemma":[0.0011074449,0.0025910481,0.0054037347,0.000010206113,0.000010438433,0.000013538599,0.00019473833,0.0006692207,0.9356463,0.0005075008,0.0535353,0.00031052652],"about_ca_topic_score_codex":0.00009098822,"about_ca_topic_score_gemma":0.0002696665,"teacher_disagreement_score":0.053467043,"about_ca_system_score_codex":0.000084218176,"about_ca_system_score_gemma":0.0003745281,"threshold_uncertainty_score":0.9999656},"labels":[],"label_agreement":null},{"id":"W2985230452","doi":"10.1093/neuonc/noab196.861","title":"TAMI-79. THERAPEUTIC REVERSAL OF PRENATAL PONTINE ID1 SIGNALING IN DIPG","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"","keywords":"Cancer research; Epigenetics; Biology; Mutation; Histone; Transcriptome; GATA2; Gene; Gene expression; Genetics","score_opus":0.023194236798508114,"score_gpt":0.30199445227612004,"score_spread":0.2788002154776119,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985230452","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991523,0.0012744109,0.000010201621,0.0044586374,0.00029433187,0.00025072842,0.000008991497,0.000022879298,0.0021567815],"genre_scores_gemma":[0.9979402,0.00013815373,0.0002987192,0.0014103425,0.000093698654,0.000034519973,0.000027753564,0.000019839725,0.000036795445],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988361,0.00014780201,0.00032526054,0.00029012753,0.0001599105,0.00024082087],"domain_scores_gemma":[0.99907464,0.00041074364,0.000102894526,0.00024322109,0.000088155226,0.00008033191],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012250159,0.00012935612,0.00045908228,0.00011322419,0.000021376361,0.000004748743,0.00006233443,0.00012395198,0.0002797797],"category_scores_gemma":[0.00016967086,0.00011142803,0.0001056551,0.00026253777,0.000058036854,0.000034132,0.000061956474,0.00020415458,0.00001807478],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022018523,0.0015120899,0.06864407,0.00006775216,0.00009881697,0.004303176,0.00033930657,0.000028723336,0.90238076,0.00032160294,0.00038651307,0.021696985],"study_design_scores_gemma":[0.008018507,0.0018307307,0.043518644,0.00013332628,0.00027223802,0.00057929876,0.00024273082,0.00014746831,0.91505355,0.00015238971,0.029912978,0.00013814785],"about_ca_topic_score_codex":0.000039836515,"about_ca_topic_score_gemma":0.00007516127,"teacher_disagreement_score":0.029526467,"about_ca_system_score_codex":0.00011002528,"about_ca_system_score_gemma":0.0002390189,"threshold_uncertainty_score":0.45439035},"labels":[],"label_agreement":null},{"id":"W2985346758","doi":"10.1093/neuonc/noz175.232","title":"CMET-31. WHOLE BRAIN RADIOTHERAPY VERSUS STEREOTACTIC RADIOSURGERY IN POOR-PROGNOSIS PATIENTS WITH 1 – 10 BRAIN METASTASES: A RANDOMIZED FEASIBILITY STUDY","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Positive Living North; Spinal Cord Injury BC; Kelowna General Hospital","funders":"","keywords":"Medicine; Radiosurgery; Clinical endpoint; Radiation therapy; Randomized controlled trial; Brain metastasis; Population; Cumulative incidence; Internal medicine; Clinical trial; Surgery; Cancer; Cohort; Metastasis","score_opus":0.026386777972574122,"score_gpt":0.31609834216350036,"score_spread":0.28971156419092625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985346758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98038423,0.00021099485,0.000021589029,0.008644483,0.00076585653,0.009275525,0.00007646086,0.00009225437,0.0005285957],"genre_scores_gemma":[0.99350625,0.000019626597,0.0010223346,0.004179038,0.00009016389,0.0006572675,0.00017094678,0.00009133064,0.0002630241],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9928257,0.0037310682,0.00095924496,0.0011277747,0.0006372971,0.00071891723],"domain_scores_gemma":[0.98935735,0.008828897,0.00045330395,0.0008599407,0.00017288365,0.00032760322],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00280232,0.00056221284,0.002562242,0.000369205,0.000080226564,0.000044803695,0.00020727902,0.00018445274,0.0012926294],"category_scores_gemma":[0.0016912831,0.0004014321,0.00042541436,0.00066923053,0.00023074477,0.0001999676,0.00008266904,0.00053004426,0.0001684407],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.40539694,0.013888242,0.55441284,0.000097293756,0.0020802007,0.0010961347,0.0011122357,0.000023526749,0.0013128223,0.000024643474,0.00915172,0.011403406],"study_design_scores_gemma":[0.84578556,0.027075382,0.086994775,0.000059662696,0.0012141304,0.00008971485,0.0008551034,0.00014690572,0.00020439581,0.000016710368,0.03705083,0.0005068462],"about_ca_topic_score_codex":0.00022245383,"about_ca_topic_score_gemma":0.00015906086,"teacher_disagreement_score":0.46741804,"about_ca_system_score_codex":0.0008390598,"about_ca_system_score_gemma":0.0005594153,"threshold_uncertainty_score":0.9998438},"labels":[],"label_agreement":null},{"id":"W2985386174","doi":"10.1093/neuonc/noz175.1101","title":"TMOD-02. A MODEL OF THE INITIATION AND GENOMIC LANDSCAPE OF GLIOBLASTOMA (GBM)","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of Calgary","funders":"Narodowe Centrum Badań i Rozwoju; Instytut Biologii Doswiadczalnej im. M. Nenckiego PAN","keywords":"Subventricular zone; Biology; Comparative genomic hybridization; Cancer research; Gene; Neural stem cell; Stem cell; Cell biology; Genetics; Genome","score_opus":0.009558195283931996,"score_gpt":0.23899709456751525,"score_spread":0.22943889928358324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985386174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99581724,0.000734971,0.000080576414,0.00013792346,0.00059609266,0.0001978937,0.000029478915,0.0000035329028,0.0024022958],"genre_scores_gemma":[0.99850136,0.00056091946,0.00011252823,0.00048659192,0.00021302477,0.000009122468,0.000006232269,0.000013280781,0.0000969491],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99933875,0.000071090886,0.00018869343,0.00020459101,0.00007074317,0.00012614927],"domain_scores_gemma":[0.999444,0.000025418862,0.00016128425,0.0002727316,0.00006338082,0.00003314722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009622242,0.00008746743,0.00019847702,0.000033673718,0.00002028035,0.0000027421725,0.00013596428,0.00014834055,0.000014765092],"category_scores_gemma":[0.00004616298,0.000070594215,0.000067864516,0.000054820383,0.000077958444,0.0000030861634,0.00013544635,0.00008004603,0.0000025166598],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018646645,0.000037572077,0.0015195446,0.000021439488,0.000015056034,1.4156764e-7,0.00012221739,0.00058617734,0.9942043,0.00015975711,0.00075363746,0.0023936806],"study_design_scores_gemma":[0.0024131583,0.0012216892,0.0071013025,0.000009353478,0.00006944662,0.00004649924,0.000090720605,0.004069468,0.87577295,0.0002447764,0.108797245,0.00016339008],"about_ca_topic_score_codex":0.000007739328,"about_ca_topic_score_gemma":0.000040468032,"teacher_disagreement_score":0.11843136,"about_ca_system_score_codex":0.000007708351,"about_ca_system_score_gemma":0.00019252523,"threshold_uncertainty_score":0.28787488},"labels":[],"label_agreement":null},{"id":"W2985498522","doi":"10.1093/neuonc/noz175.617","title":"PATH-21. CLINICAL UTILITY OF DNA METHYLATION PROFILING FOR DIAGNOSIS OF CHALLENGING CENTRAL NERVOUS SYSTEM TUMORS: THE TORONTO EXPERIENCE","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Subtyping; Ependymoma; Medical diagnosis; DNA methylation; Glioma; Medulloblastoma; Medicine; Pathology; Brain tumor; Oncology; Internal medicine; Biology; Cancer research; Gene; Gene expression; Genetics","score_opus":0.05041236766600137,"score_gpt":0.3550329904914273,"score_spread":0.3046206228254259,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985498522","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951537,0.0010149344,0.00006321468,0.00053874427,0.0007751024,0.0018446601,0.00001906256,0.000030983214,0.0005595447],"genre_scores_gemma":[0.99877,0.00019764392,0.00029214323,0.00010543542,0.00014692279,0.0004577127,0.000010956488,0.000017465607,0.0000017169004],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981338,0.00026799118,0.00075486576,0.00035102284,0.00020296316,0.00028936614],"domain_scores_gemma":[0.99702024,0.0019098151,0.00039887044,0.00041883925,0.00015448457,0.0000977185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005471614,0.00014393711,0.0006773806,0.000028197943,0.000048542875,0.0000039579454,0.00012700396,0.00014163798,0.000045349803],"category_scores_gemma":[0.00042672598,0.00009699342,0.00024947035,0.000072158,0.00009558882,0.00006542557,0.00005651235,0.00011466916,0.0000026324024],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006693929,0.0017118135,0.9080298,0.0008191685,0.00014542317,0.000044853557,0.002874456,0.00003598646,0.042178478,0.001965205,0.00013575531,0.041389696],"study_design_scores_gemma":[0.007417787,0.007803341,0.5606101,0.00047412328,0.00054751616,0.000070874834,0.012546529,0.014011628,0.39184234,0.00004275175,0.0043927967,0.00024019885],"about_ca_topic_score_codex":0.00013484279,"about_ca_topic_score_gemma":0.000039189734,"teacher_disagreement_score":0.34966385,"about_ca_system_score_codex":0.00016666425,"about_ca_system_score_gemma":0.00013131012,"threshold_uncertainty_score":0.3955277},"labels":[],"label_agreement":null},{"id":"W2985655825","doi":"10.1093/neuonc/noz175.696","title":"NIMG-25. LESION-NETWORK ANALYSIS TO IDENTIFY PREFERENTIALLY-ENGAGED NETWORKS IN EPILEPTOGENIC TUMORS","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Functional Brain Connectivity Studies","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto; University Health Network","funders":"","keywords":"Voxel; Parahippocampal gyrus; Lesion; Epilepsy; Neuroscience; Medicine; Psychology; Radiology; Pathology; Temporal lobe","score_opus":0.05170857288066104,"score_gpt":0.3224845097373746,"score_spread":0.27077593685671353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985655825","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852273,0.00005507632,0.0013437276,0.0036310672,0.0030772109,0.0010045122,0.000010575543,0.00018274011,0.005467824],"genre_scores_gemma":[0.9873286,0.00006566531,0.0001525199,0.011472918,0.00042692779,0.00012290776,0.0000078757275,0.00005013649,0.00037246896],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9927572,0.0036868933,0.00066771114,0.0014763732,0.0004843933,0.00092743937],"domain_scores_gemma":[0.97639847,0.022348087,0.00025258216,0.00071494887,0.00008251853,0.00020338602],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017221138,0.00036499844,0.00091405027,0.0006315063,0.00043778215,0.00006685579,0.00066017493,0.00025051297,0.0006362896],"category_scores_gemma":[0.010473955,0.00037149273,0.00032222844,0.0032908488,0.00012600914,0.00020786675,0.00069277623,0.0016313022,0.0010494961],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007422511,0.00054073153,0.14530344,0.000023015633,0.00025659296,0.00023777485,0.000777257,0.31666702,0.5019859,0.0012506123,0.027490014,0.0047253477],"study_design_scores_gemma":[0.0045917965,0.0036128727,0.75405407,0.0000787752,0.0007935494,0.000103958824,0.00061385595,0.026809344,0.03096684,0.001734786,0.17473103,0.0019091513],"about_ca_topic_score_codex":0.000057457222,"about_ca_topic_score_gemma":0.00096467993,"teacher_disagreement_score":0.6087506,"about_ca_system_score_codex":0.00034207638,"about_ca_system_score_gemma":0.00016541015,"threshold_uncertainty_score":0.9998737},"labels":[],"label_agreement":null},{"id":"W2985913611","doi":"10.1093/neuonc/noz175.1151","title":"SCIDOT-15. DISRUPTING THE BLOOD-BRAIN BARRIER IN NEURO-ONCOLOGY: INNOVATIONS, ACHIEVEMENTS, AND LESSONS LEARNED FROM CLINICAL TRIALS","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Lanthanide and Transition Metal Complexes","field":"Materials Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Medicine; Tolerability; Blood–brain barrier; Clinical trial; Oncology; Internal medicine; Adverse effect","score_opus":0.16020268465407844,"score_gpt":0.42240610877113366,"score_spread":0.2622034241170552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985913611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95714545,0.00011804783,0.00010900882,0.038674757,0.0019374792,0.00080508593,0.00015111956,0.00008007326,0.000978987],"genre_scores_gemma":[0.9809658,0.00019739017,0.0009323328,0.017235551,0.00043910393,0.00007618993,0.000048106744,0.000035671565,0.00006988],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99053717,0.006134426,0.0016020219,0.0008929463,0.00031049742,0.00052293215],"domain_scores_gemma":[0.98424757,0.014337017,0.00061706855,0.0005582896,0.00009396998,0.00014607639],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.009002908,0.00027779702,0.0010844175,0.00017562353,0.00027668246,0.00013463228,0.0005253531,0.00031643253,0.001218326],"category_scores_gemma":[0.0053729913,0.00019824399,0.00014844262,0.00043157866,0.00041548573,0.00029398128,0.00033262238,0.00081087253,0.0003221068],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031914937,0.0002572485,0.016768882,0.000010778187,0.000032729044,0.00008984076,0.000415487,0.000016499669,0.96477914,0.0034301544,0.0008619235,0.013018179],"study_design_scores_gemma":[0.023988362,0.0052074012,0.07834474,0.000100333076,0.0006506131,0.00023540629,0.0021902153,0.0009819195,0.16533634,0.024120364,0.6975304,0.0013139148],"about_ca_topic_score_codex":0.00019051964,"about_ca_topic_score_gemma":0.00038665519,"teacher_disagreement_score":0.79944277,"about_ca_system_score_codex":0.000048353035,"about_ca_system_score_gemma":0.00037093135,"threshold_uncertainty_score":0.9996947},"labels":[],"label_agreement":null},{"id":"W2986141571","doi":"10.1093/neuonc/noz175.226","title":"CMET-25. COMPARATIVE EFFICACY OF TREATMENT PARADIGMS FOR BRAIN METASTASES – A SYSTEMATIC REVIEW","year":2019,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; McMaster University; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Temozolomide; Oncology; Randomized controlled trial; Lung cancer; Progression-free survival; Incidence (geometry); Meta-analysis; Melanoma; Adverse effect; Brain metastasis; Cancer; Overall survival; Radiation therapy; Metastasis","score_opus":0.18117725682860739,"score_gpt":0.4508045744584285,"score_spread":0.26962731762982106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986141571","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000003378791,0.9685773,0.00006117647,0.0005705969,0.0004722507,0.02842037,0.0012198654,0.00004729772,0.00062772084],"genre_scores_gemma":[0.000009955289,0.9902148,0.0012168217,0.0012975825,0.00016167795,0.004885482,0.0017526917,0.000105194784,0.0003557526],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99339724,0.0025281503,0.0023053403,0.00092828163,0.00030342213,0.0005375601],"domain_scores_gemma":[0.9843775,0.011689324,0.0021620959,0.0013308373,0.00016942319,0.0002708254],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.00095732696,0.0009956913,0.015467759,0.00030634977,0.00006466489,0.000012835043,0.00028981836,0.00034076525,0.00016079587],"category_scores_gemma":[0.0010756599,0.0005959066,0.002925861,0.00040427886,0.00015421644,0.000037121725,0.0000732413,0.0002999483,0.00023742454],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011274014,0.0015333702,2.9288574e-7,0.8575621,0.0048070448,0.00017164901,0.00008382231,7.514454e-7,0.0000062842296,0.0007429307,0.01069609,0.1242829],"study_design_scores_gemma":[0.003116775,0.011011082,1.6245035e-7,0.19158253,0.060414623,0.000789015,0.000017446677,0.000004183707,0.000009990555,0.0000054486904,0.7327995,0.00024927797],"about_ca_topic_score_codex":0.000026208,"about_ca_topic_score_gemma":0.000010166351,"teacher_disagreement_score":0.72210336,"about_ca_system_score_codex":0.0010630925,"about_ca_system_score_gemma":0.0019184562,"threshold_uncertainty_score":0.9996492},"labels":[],"label_agreement":null},{"id":"W2986281301","doi":"10.1093/neuonc/noz175.1140","title":"TMOD-41. ORTHOTOPIC PATIENT-DERIVED XENOGRAFT MODELS OF BRAIN METASTASIS: PLATFORMS FOR PRECISION ONCOLOGY AND UNDERSTANDING TUMOR BIOLOGY","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital; Princess Margaret Cancer Centre; Occupational Cancer Research Centre","funders":"","keywords":"Medicine; Cancer research; Cancer; Targeted therapy; Metastasis; Immunohistochemistry; Breast cancer; Pathology; Oncology; Internal medicine","score_opus":0.0700968200232243,"score_gpt":0.3308375232073462,"score_spread":0.2607407031841219,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986281301","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9830652,0.0005187299,0.009413081,0.0023743543,0.0005955457,0.0026346035,0.0001314459,0.000052446307,0.0012146241],"genre_scores_gemma":[0.98788756,0.00015624621,0.009154854,0.0023923968,0.000060001457,0.00017772747,0.00010342345,0.00004555167,0.000022208776],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977956,0.00020464737,0.00068150775,0.00062900304,0.0001680227,0.0005212241],"domain_scores_gemma":[0.9969443,0.0018981978,0.0004158653,0.00041412175,0.00011059464,0.00021693463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004977834,0.0003028894,0.0011676117,0.00027221706,0.00009401282,0.000008585521,0.000115923845,0.00027373663,0.0001224579],"category_scores_gemma":[0.00024247819,0.00022779353,0.00022434772,0.0001750159,0.00021812349,0.00012323669,0.00014796566,0.00026456756,0.000009146005],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008118259,0.002344105,0.007488986,0.00062672293,0.00130522,0.00038985047,0.0030671018,0.00033363968,0.6638473,0.049666245,0.0019480783,0.2608645],"study_design_scores_gemma":[0.0859609,0.21423504,0.0024314271,0.00041108,0.0034857208,0.0039621745,0.012181375,0.021394806,0.13260691,0.14565288,0.37590012,0.0017775503],"about_ca_topic_score_codex":0.000033264085,"about_ca_topic_score_gemma":0.000053866388,"teacher_disagreement_score":0.5312404,"about_ca_system_score_codex":0.00036078566,"about_ca_system_score_gemma":0.00034525906,"threshold_uncertainty_score":0.928915},"labels":[],"label_agreement":null},{"id":"W2986352314","doi":"10.1093/neuonc/noz175.914","title":"RBTT-02. RADIOSURGERY FOLLOWED BY TUMOR TREATING FIELDS FOR BRAIN METASTASES (1–10) FROM NSCLC IN THE PHASE 3 METIS TRIAL","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Radiosurgery; Clinical endpoint; Lung cancer; Adverse effect; Oncology; Internal medicine; Radiology; Randomized controlled trial; Radiation therapy","score_opus":0.030637920352280915,"score_gpt":0.33799543508606666,"score_spread":0.30735751473378575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986352314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9816946,0.00057092134,0.000033463097,0.012739769,0.00087723066,0.0025644663,0.00025854656,0.000038384096,0.0012226511],"genre_scores_gemma":[0.99024004,0.000026038391,0.00033997977,0.0076286835,0.00037271294,0.0009038918,0.00035872596,0.000035127432,0.00009481823],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978415,0.0005342687,0.0005161661,0.00048280452,0.00022488969,0.00040040805],"domain_scores_gemma":[0.99000084,0.009215348,0.00020827532,0.00042508685,0.00004152603,0.000108918444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006130754,0.00024914677,0.00086057215,0.00014335063,0.00007116917,0.000028336533,0.00015262657,0.00014684793,0.00069586106],"category_scores_gemma":[0.0013778143,0.00016715635,0.00033600852,0.00021712897,0.000044587272,0.000065539876,0.000031722924,0.00021725969,0.000051580377],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04232571,0.008661384,0.0069445926,0.000045562356,0.000534034,0.0022478993,0.0011599838,0.000008793425,0.30235595,0.00015463505,0.55355054,0.082010895],"study_design_scores_gemma":[0.28416994,0.017683087,0.00051070884,0.000057131027,0.0009104785,0.00012795842,0.00054911315,0.00039429218,0.05273984,0.00011548139,0.6424348,0.00030723508],"about_ca_topic_score_codex":0.0002626718,"about_ca_topic_score_gemma":0.00010611352,"teacher_disagreement_score":0.24961612,"about_ca_system_score_codex":0.00012971343,"about_ca_system_score_gemma":0.000193402,"threshold_uncertainty_score":0.7619191},"labels":[],"label_agreement":null},{"id":"W2986411077","doi":"10.1093/neuonc/noaa004","title":"SWI/SNF complex heterogeneity is related to polyphenotypic differentiation, prognosis, and immune response in rhabdoid tumors","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Institute of Neurological Disorders and Stroke","keywords":"Immune system; Biology; Cancer research; Immunology; Medicine","score_opus":0.021321787892530735,"score_gpt":0.2893955586368539,"score_spread":0.26807377074432315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986411077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99080026,0.00043339422,0.00015947789,0.008029104,0.000100834695,0.0003192957,0.000019973557,0.00002834259,0.000109299704],"genre_scores_gemma":[0.9935186,0.00008907419,0.00036498727,0.005836052,0.00006114022,0.000040935145,0.000046708818,0.000027314625,0.000015202943],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99845797,0.00030706887,0.0003772596,0.0005021185,0.00009566877,0.00025991254],"domain_scores_gemma":[0.99942213,0.00004705887,0.00010111136,0.00021825949,0.00005262373,0.0001587892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001661611,0.00017245104,0.00027536548,0.00005010455,0.000066300905,0.000016379958,0.0001623549,0.00018384118,0.000039129824],"category_scores_gemma":[0.0002334007,0.00017643315,0.00006195901,0.00016627822,0.00006150478,0.0000034465552,0.00019232367,0.00016620418,0.000017165094],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013013623,0.000071636176,0.006552789,0.000017449547,0.000020622296,0.00001147305,0.00046323566,0.00013167507,0.98745,0.000009141694,0.00088114553,0.003089479],"study_design_scores_gemma":[0.0029006049,0.0036743735,0.21183698,0.000024916233,0.00003540213,0.00007823009,0.00015494182,0.0038631212,0.7465839,0.00007863432,0.030318685,0.00045025238],"about_ca_topic_score_codex":0.000025036334,"about_ca_topic_score_gemma":0.000022441576,"teacher_disagreement_score":0.24086614,"about_ca_system_score_codex":0.000041362848,"about_ca_system_score_gemma":0.00012559639,"threshold_uncertainty_score":0.71947354},"labels":[],"label_agreement":null},{"id":"W2986474427","doi":"10.1093/neuonc/noz175.575","title":"INNV-34. PATTERNS OF FAILURE AND DEVELOPMENT OF A NOVEL PROGNOSTIC SCORING SYSTEM IN ELDERLY PATIENTS WITH GLIOBLASTOMA – FOLLOW UP ON 10 YEAR ANALYSIS OF THE BC CANCER AGENCY POPULATION","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of Victoria","funders":"","keywords":"Medicine; Univariate analysis; Internal medicine; Glioblastoma; Performance status; Cancer; Population; Surgery; Multivariate analysis","score_opus":0.014867253305721957,"score_gpt":0.2604247628973116,"score_spread":0.24555750959158965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986474427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990545,0.000013677678,0.000007132904,0.000049848546,0.00009858578,0.0007251667,0.000017364271,0.000004696989,0.00002901321],"genre_scores_gemma":[0.99976164,0.000002162984,0.00012613538,0.000015318363,0.000005487072,0.000062213,0.000013403985,0.000010286137,0.000003362685],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990668,0.000045603312,0.00034595435,0.00019878616,0.0002274115,0.000115410585],"domain_scores_gemma":[0.9992659,0.00010508532,0.0003124462,0.00017615451,0.00010831746,0.00003209523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006124684,0.000105011815,0.00045426143,0.00027725034,0.000015116822,0.0000018953729,0.00004994462,0.000064165535,0.000023126891],"category_scores_gemma":[0.000033758613,0.00006709165,0.00004954604,0.0004053494,0.00001591664,0.00002296404,0.00003325006,0.00006559042,8.026076e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029784167,0.000576861,0.9878625,0.00021125822,0.00029952909,0.0000051034863,0.00064793584,0.00028132874,0.005763717,0.000021871421,0.000002512046,0.004029513],"study_design_scores_gemma":[0.0042351037,0.0017916806,0.98732406,0.00044265555,0.00046682372,0.0000012073067,0.00018190665,0.00020452557,0.0052690306,2.1332839e-7,0.00003395701,0.00004883627],"about_ca_topic_score_codex":0.00036807448,"about_ca_topic_score_gemma":0.0027004352,"teacher_disagreement_score":0.0039806766,"about_ca_system_score_codex":0.00016747873,"about_ca_system_score_gemma":0.00010647575,"threshold_uncertainty_score":0.27359182},"labels":[],"label_agreement":null},{"id":"W2986598134","doi":"10.1093/neuonc/noz175.798","title":"PDTM-22. A C19MC-LIN28A-MYCN ONCOGENIC CIRCUIT DRIVEN BY HIJACKED SUPER-ENHANCERS IS A DISTINCT THERAPEUTIC VULNERABILITY IN ETMRS – A LETHAL BRAIN TUMOR","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Cancer research; Biology; Enhancer; Embryonic stem cell; Neural stem cell; Chromatin; Lineage (genetic); Cell; Gene; Cell biology; Stem cell; Transcription factor; Genetics","score_opus":0.015146781668642926,"score_gpt":0.2805255523321021,"score_spread":0.26537877066345916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986598134","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902477,0.00041244653,0.00021034644,0.003096275,0.00067330064,0.0010401976,0.00008266508,0.000046170047,0.0041908785],"genre_scores_gemma":[0.9916691,0.000049002792,0.00006169087,0.0067402287,0.00021828507,0.00019259834,0.00019069822,0.00005960882,0.0008187677],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9966903,0.00074455235,0.0005997785,0.0010624889,0.00026215057,0.0006407482],"domain_scores_gemma":[0.9985507,0.00020591961,0.00021784152,0.000739115,0.00008941519,0.0001969703],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005083416,0.0003783628,0.00052843726,0.000107116415,0.0000897429,0.000033657758,0.00049159967,0.0004339144,0.0009870023],"category_scores_gemma":[0.00036668582,0.0003748464,0.00024047843,0.00025302908,0.0002549085,0.000018079936,0.00019270566,0.00056204223,0.00020733275],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028489984,0.00029530062,0.011239947,0.000028554126,0.00004167259,0.000019681649,0.00021948975,0.000009111138,0.96639913,0.000039759536,0.015230856,0.006191604],"study_design_scores_gemma":[0.0033214486,0.002170503,0.002394028,0.000014921175,0.000026094895,0.000092602575,0.00015632455,0.00031123852,0.52944195,0.00022260728,0.4613295,0.00051881076],"about_ca_topic_score_codex":0.00011989605,"about_ca_topic_score_gemma":0.00016207984,"teacher_disagreement_score":0.44609863,"about_ca_system_score_codex":0.00026362468,"about_ca_system_score_gemma":0.00057125394,"threshold_uncertainty_score":0.9999262},"labels":[],"label_agreement":null},{"id":"W2986682168","doi":"10.1093/neuonc/noz175.488","title":"HOUT-23. ADULT MEDULLOBLASTOMA TREATMENT IMPACT SINCE 2006: A CANADIAN UNIVERSITY CENTER EXPERIENCE","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Lomustine; Medulloblastoma; Radiation therapy; Etoposide; Chemotherapy; Vincristine; Cohort; Concomitant; Internal medicine; Oncology; Surgery; Cyclophosphamide","score_opus":0.01222054368330804,"score_gpt":0.2754624270305985,"score_spread":0.26324188334729043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986682168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98354816,0.000057971996,0.0000010402093,0.0046224804,0.00044486194,0.0007412072,0.000118244054,0.000051472634,0.010414538],"genre_scores_gemma":[0.9974618,0.0001227937,0.000074543656,0.0018679273,0.00007146765,0.000019425357,0.000050064988,0.000022572865,0.00030943367],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985569,0.000092495226,0.00016476991,0.00046427915,0.0001588614,0.0005626567],"domain_scores_gemma":[0.9985669,0.00013209273,0.00008055643,0.00042546153,0.00010728766,0.00068765803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000030307934,0.00025070293,0.00044161078,0.00022106119,0.0000966828,0.000012271986,0.00012393067,0.00016148992,0.00072757335],"category_scores_gemma":[0.000037844384,0.00019877007,0.00018823122,0.0002218932,0.000086735636,0.00008258941,0.000037411468,0.00012833273,0.0006713598],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007941841,0.002147916,0.9127153,0.000014124877,0.00026500833,0.007883499,0.002345838,0.000026116923,0.048053533,0.00027516656,0.008790176,0.016689096],"study_design_scores_gemma":[0.015080071,0.011642036,0.2045055,0.00006032516,0.00024245624,0.0010728405,0.0012803007,0.00022789251,0.020531751,0.0000061144106,0.7449765,0.00037419243],"about_ca_topic_score_codex":0.03734553,"about_ca_topic_score_gemma":0.07415738,"teacher_disagreement_score":0.7361863,"about_ca_system_score_codex":0.0026525962,"about_ca_system_score_gemma":0.0009925447,"threshold_uncertainty_score":0.9690649},"labels":[],"label_agreement":null},{"id":"W2986909789","doi":"10.1093/neuonc/noz175.192","title":"CSIG-22. REGULATION OF GLIOMA STEM CELL SELF-RENEWAL AND TUMORIGENESIS BY CARBOHYDRATE BINDING PROTEINS","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Galectins and Cancer Biology","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Gene knockdown; Carcinogenesis; Biology; Cancer research; Stem cell; STAT3; Glioma; Molecular biology; Cell biology; Cell culture; Signal transduction; Genetics; Gene","score_opus":0.0071015434597486125,"score_gpt":0.21794300702146824,"score_spread":0.21084146356171962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986909789","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935151,0.0012194773,0.000011922028,0.00017580712,0.0013383239,0.00058455276,0.000042607957,0.000078477286,0.0030337414],"genre_scores_gemma":[0.99890727,0.00012664881,0.0000665157,0.0001103889,0.000041281422,0.000053442644,0.000050698825,0.000027147735,0.0006166167],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981757,0.00046824338,0.00040590012,0.0004982258,0.00003838496,0.0004135942],"domain_scores_gemma":[0.9990486,0.00021872183,0.00033314322,0.00028270914,0.00007858605,0.00003823226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021694045,0.00022028801,0.0005117071,0.00017330208,0.00010705423,0.0000073405713,0.00018566163,0.00048778128,0.000269373],"category_scores_gemma":[0.000011477454,0.00020295242,0.00007160771,0.00022845635,0.00014925115,0.000059840917,0.00011537433,0.0002514528,0.00012657378],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021240285,0.00014545316,0.008180061,0.00004975821,0.00006123956,0.0000068286554,0.000334181,0.0000038170087,0.9867376,0.00015602857,0.00092917477,0.0031834499],"study_design_scores_gemma":[0.0017905502,0.0021381008,0.0015682736,0.000008661981,0.00006135376,0.00013564252,0.00016040682,0.000009389541,0.93256515,0.00004360372,0.06132836,0.00019050426],"about_ca_topic_score_codex":0.00015545935,"about_ca_topic_score_gemma":0.000037839665,"teacher_disagreement_score":0.060399186,"about_ca_system_score_codex":0.00009882149,"about_ca_system_score_gemma":0.00018164249,"threshold_uncertainty_score":0.8276159},"labels":[],"label_agreement":null},{"id":"W2986952922","doi":"10.1093/neuonc/noz175.092","title":"ACTR-50. PRESERVATION OF NEUROCOGNITIVE FUNCTION &amp; PATIENT-REPORTED SYMPTOMS WITH HIPPOCAMPAL AVOIDANCE (HA) DURING WHOLE-BRAIN RADIOTHERAPY (WBRT) FOR BRAIN METASTASES: LONG-TERM RESULTS OF NRG ONCOLOGY CC001","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Neurocognitive; Internal medicine; Oncology; Clinical endpoint; Cumulative incidence; Radiosurgery; Radiation therapy; Randomized controlled trial; Cognition; Cohort","score_opus":0.0244943871227393,"score_gpt":0.3090803672934381,"score_spread":0.28458598017069875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986952922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857396,0.00023262594,0.003150463,0.005365169,0.0005185939,0.004269299,0.00036745172,0.00007668,0.0002801164],"genre_scores_gemma":[0.99269986,0.0000598441,0.0026097023,0.002537554,0.000178546,0.000431731,0.0010366825,0.00009957108,0.0003465117],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.995946,0.00087755034,0.0012287763,0.0009050226,0.00047458633,0.0005680767],"domain_scores_gemma":[0.9940633,0.0027963535,0.0016231926,0.00074708014,0.00056447135,0.00020556586],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007573194,0.00043735118,0.0013082968,0.00035285062,0.00009550122,0.000012318269,0.00016020815,0.00025768884,0.00009955911],"category_scores_gemma":[0.0009634746,0.0003583285,0.0002796264,0.00044971865,0.00024218687,0.0002637361,0.00006926671,0.00040147555,0.000010636127],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07009519,0.0039856755,0.04054609,0.0007764688,0.0019258276,0.00041255818,0.001574452,0.0004724786,0.80651873,0.00007982017,0.0029667083,0.07064601],"study_design_scores_gemma":[0.14977922,0.16278766,0.2739218,0.0006994039,0.0033777605,0.0024929289,0.0008038334,0.0005226176,0.12619773,0.00017091224,0.278114,0.0011321701],"about_ca_topic_score_codex":0.00007205704,"about_ca_topic_score_gemma":0.0001544402,"teacher_disagreement_score":0.680321,"about_ca_system_score_codex":0.00037090597,"about_ca_system_score_gemma":0.0005993133,"threshold_uncertainty_score":0.9998869},"labels":[],"label_agreement":null},{"id":"W2986955991","doi":"10.1093/neuonc/noz175.1137","title":"TMOD-38. PRODUCTION OF D-2-HYDROXYGLUTARATE IN SACCHAROMYCES CEREVISIAE LEADS TO GROWTH IMPAIRMENT AND DECREASED SURVIVAL","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; Montreal Neurological Institute and Hospital; McGill University","funders":"","keywords":"Saccharomyces cerevisiae; Biology; Mitochondrion; Carcinogenesis; Respiratory chain; Genetics; Knockout mouse; Biochemistry; Gene; Cell biology; Molecular biology","score_opus":0.009316071521989282,"score_gpt":0.2594382541529083,"score_spread":0.250122182630919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2986955991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951317,0.0007539293,0.000017153217,0.0008005471,0.0019557416,0.0005957577,0.00000936226,0.000009907425,0.0007259117],"genre_scores_gemma":[0.9972118,0.0012857541,0.00020714698,0.0004304817,0.0006397402,0.000046158984,0.000019622437,0.000023314813,0.00013599129],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99857223,0.00018362199,0.00029866383,0.00053834356,0.00011907901,0.00028804326],"domain_scores_gemma":[0.9993531,0.000029863673,0.000120188946,0.00030082665,0.00007207462,0.00012392033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030701028,0.00017425351,0.00037610778,0.00010634252,0.000024560679,0.000008301785,0.00014102485,0.00016487134,0.000030505766],"category_scores_gemma":[0.00013213855,0.00017040258,0.00006328142,0.00015706196,0.00006731461,0.000007684042,0.00012153386,0.00011905255,0.0000131050565],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038330173,0.00013615553,0.02123852,0.000050866027,0.000019026573,0.0000017700817,0.00013920081,0.00006305087,0.97338665,0.000059657854,0.0011278562,0.0033939304],"study_design_scores_gemma":[0.0025129956,0.0026476695,0.05775272,0.00002503929,0.00004608805,0.00006113145,0.00014130876,0.000027343862,0.64199096,0.000072193994,0.29438335,0.00033924213],"about_ca_topic_score_codex":0.0001075476,"about_ca_topic_score_gemma":0.00015373151,"teacher_disagreement_score":0.33139575,"about_ca_system_score_codex":0.00003489524,"about_ca_system_score_gemma":0.00017159918,"threshold_uncertainty_score":0.69488156},"labels":[],"label_agreement":null},{"id":"W2987001203","doi":"10.1093/neuonc/noz175.056","title":"ACTR-13. FINAL RESULTS WITH CHEMORADIOTHERAPY FOR ANAPLASTIC OLIGODENDROGLIAL TUMORS FROM NRG ONCOLOGY/RTOG 9402","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Hamilton Health Sciences; Juravinski Cancer Centre; Cancer Care Ontario; Centre Hospitalier de l’Université de Montréal; McGill University; University of Calgary","funders":"","keywords":"Procarbazine; Medicine; Lomustine; Oligodendroglial Tumor; Internal medicine; Hazard ratio; Oncology; Anaplastic astrocytoma; Oligodendroglioma; Vincristine; Progression-free survival; Chemoradiotherapy; Proportional hazards model; Nuclear medicine; Glioma; Radiation therapy; Astrocytoma; Overall survival; Chemotherapy; Confidence interval; Cancer research","score_opus":0.0254265101341337,"score_gpt":0.30211824224713424,"score_spread":0.2766917321130005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987001203","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843339,0.00018173613,0.000051486786,0.007961122,0.001037895,0.0016852082,0.00023337807,0.00011341151,0.0044019166],"genre_scores_gemma":[0.99169314,0.00010360833,0.0028845686,0.003619944,0.0008405452,0.00035184884,0.00024469013,0.00008488552,0.00017678589],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975676,0.00012625373,0.0005178399,0.00085559126,0.0002905584,0.0006421713],"domain_scores_gemma":[0.99690884,0.0017468898,0.00031934778,0.00056770636,0.00014597368,0.0003112395],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016961171,0.00039052303,0.0011489036,0.00018068442,0.00009746518,0.000022356227,0.0002004688,0.0003469757,0.0003094846],"category_scores_gemma":[0.00020912931,0.0002976328,0.00019290426,0.00021694842,0.0001562503,0.00007907391,0.00004624166,0.00038076637,0.00024098388],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09294095,0.009279352,0.069305226,0.00019176045,0.0015766049,0.009072602,0.00234538,0.00042165833,0.6451947,0.0005233375,0.06465419,0.10449423],"study_design_scores_gemma":[0.112092696,0.07293115,0.04567971,0.00018490685,0.0009934359,0.0014093845,0.00032581924,0.0019593535,0.1316253,0.00018327622,0.6318875,0.0007274966],"about_ca_topic_score_codex":0.00016322859,"about_ca_topic_score_gemma":0.00040189904,"teacher_disagreement_score":0.56723326,"about_ca_system_score_codex":0.0005920197,"about_ca_system_score_gemma":0.0007709043,"threshold_uncertainty_score":0.9999476},"labels":[],"label_agreement":null},{"id":"W2987430440","doi":"10.1093/neuonc/noz175.287","title":"DDIS-36. BTP-7, A NOVEL PEPTIDE FOR THERAPEUTIC TARGETING OF MALIGNANT BRAIN TUMORS","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Glioma; Peptide; Cancer research; Peptide library; Gene isoform; Biology; Brain tumor; Molecular biology; Biochemistry; Medicine; Peptide sequence; Pathology; Gene","score_opus":0.020164067049152558,"score_gpt":0.2779066520696116,"score_spread":0.25774258502045905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987430440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98901564,0.00034732628,0.0024256716,0.0015929218,0.00050008786,0.0010477134,0.00010048141,0.000024592306,0.0049455934],"genre_scores_gemma":[0.993446,0.00004227677,0.0022881324,0.0032365238,0.0002836513,0.000109696615,0.00009975078,0.000050707276,0.00044325794],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985474,0.000120084165,0.00036234772,0.00045856947,0.00010718889,0.00040442936],"domain_scores_gemma":[0.9990364,0.00020186535,0.00023762265,0.00033344657,0.000107256084,0.00008341756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004044449,0.00019530131,0.00033533154,0.000052963474,0.000054085634,0.0000088904635,0.0002782265,0.00023253908,0.00007640455],"category_scores_gemma":[0.000227238,0.0001802547,0.0001801645,0.00007757256,0.0000869632,0.000003905943,0.0001287837,0.00013838337,0.000025730988],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035744405,0.00012612011,0.0010133412,0.000074741954,0.0000365191,0.0000038608555,0.00011749975,0.000033356235,0.9917573,0.00068807043,0.002603805,0.0031879824],"study_design_scores_gemma":[0.0011780687,0.0020099292,0.00029338148,0.00001244458,0.000014951175,0.000040593324,0.00011391068,0.00017276553,0.67589146,0.0001341702,0.31997764,0.00016069187],"about_ca_topic_score_codex":0.0000110572255,"about_ca_topic_score_gemma":0.0000070229726,"teacher_disagreement_score":0.3173738,"about_ca_system_score_codex":0.000022770517,"about_ca_system_score_gemma":0.00023551637,"threshold_uncertainty_score":0.73505735},"labels":[],"label_agreement":null},{"id":"W2987493194","doi":"10.1093/neuonc/noz175.771","title":"PDCT-08. SUPERIOR OUTCOME FOR BRAF V600E PEDIATRIC GLIOMAS TREATED WITH TARGETED BRAF INHIBITION","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; SickKids Foundation; University of Alberta; Université Laval; Stollery Children's Hospital; Hospital for Sick Children","funders":"","keywords":"Medicine; Internal medicine; Oncology; CDKN2A; Glioma; Concomitant; Cohort; Discontinuation; V600E; Mutation; Cancer research; Cancer; Gene","score_opus":0.018998637659840747,"score_gpt":0.2863293868600879,"score_spread":0.2673307492002472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987493194","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924037,0.00019950101,0.000014684771,0.0031247097,0.00043598478,0.0023247213,0.00006781941,0.000192067,0.0012368462],"genre_scores_gemma":[0.9963499,0.00004702379,0.00041101864,0.0019174637,0.00035457942,0.00044049145,0.0002464342,0.00008236755,0.00015074544],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99795204,0.00010029965,0.0004873113,0.0006429552,0.00026124634,0.00055614125],"domain_scores_gemma":[0.99843496,0.00049552665,0.00019213073,0.00042300107,0.00019189806,0.0002625011],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012977539,0.00034798376,0.0008086145,0.00039638288,0.000098066375,0.000024436127,0.0000839465,0.0002930388,0.00046635687],"category_scores_gemma":[0.00012525672,0.0002586959,0.0002085163,0.0005330281,0.0000634546,0.00011779751,0.00004563431,0.0002278281,0.00041293693],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013974603,0.0016115389,0.72683316,0.0001554633,0.0001324908,0.0012497966,0.00017110542,0.000015267518,0.26270658,0.00014383426,0.0034298697,0.0021534448],"study_design_scores_gemma":[0.078843474,0.044704046,0.44102588,0.000077843935,0.0029972862,0.0024210548,0.00036011738,0.0004569317,0.3011786,0.00009034125,0.1267195,0.0011249408],"about_ca_topic_score_codex":0.000048219525,"about_ca_topic_score_gemma":0.000049306447,"teacher_disagreement_score":0.28580728,"about_ca_system_score_codex":0.00028210419,"about_ca_system_score_gemma":0.0002260741,"threshold_uncertainty_score":0.9999865},"labels":[],"label_agreement":null},{"id":"W2987562677","doi":"10.1093/neuonc/noz175.309","title":"EPID-09. PROGNOSTIC FACTORS IN ADULT PATIENTS WITH PRIMARY INTRACRANIAL EPENDYMOMAS: A POPULATION-BASED STUDY","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Medicine; Ependymoma; Cohort; Proportional hazards model; Radiation therapy; Epidemiology; Cancer registry; Surveillance, Epidemiology, and End Results; Brain tumor; Internal medicine; Cohort study; Chemotherapy; Survival analysis; Population; Relative survival; Oncology; Surgery; Pathology","score_opus":0.010594942822823937,"score_gpt":0.26224893281382433,"score_spread":0.2516539899910004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987562677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99519527,0.000008107519,0.0000019468864,0.00055185356,0.00033687177,0.0035135674,0.000016256641,0.000056275283,0.00031983835],"genre_scores_gemma":[0.9983825,9.976301e-7,0.00012697306,0.0009640061,0.000045356042,0.0002249783,0.00021286137,0.00003872865,0.0000036093936],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982372,0.00019841998,0.0003903487,0.00048402025,0.0003505938,0.00033942796],"domain_scores_gemma":[0.99855137,0.0006952676,0.00016399064,0.00031647336,0.0001307843,0.00014210762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008224714,0.00024621256,0.0005928751,0.00023796251,0.00004107657,0.000011760016,0.00008529365,0.00012668327,0.00013503237],"category_scores_gemma":[0.0002496057,0.00017491433,0.00006288885,0.00027448547,0.000022633374,0.00007071153,0.000033194017,0.00025264284,0.000066394176],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007809971,0.009097402,0.983601,0.00004090079,0.000054558663,0.0006637813,0.00027158178,0.000060782022,0.00048496842,0.000007801857,0.000034995268,0.0049012834],"study_design_scores_gemma":[0.01831756,0.010412846,0.97036064,0.00004759881,0.00016376529,0.000008677299,0.000109091896,0.000074237934,0.0001988124,0.000004847527,0.00015777514,0.0001441587],"about_ca_topic_score_codex":0.00030928274,"about_ca_topic_score_gemma":0.00061382435,"teacher_disagreement_score":0.017536562,"about_ca_system_score_codex":0.00041363976,"about_ca_system_score_gemma":0.00022699173,"threshold_uncertainty_score":0.71327996},"labels":[],"label_agreement":null},{"id":"W2987705555","doi":"10.1093/neuonc/noz175.233","title":"CMET-32. DNA METHYLATION ALTERATIONS IN LUNG ADENOCARCINOMAS THAT DEVELOP BRAIN METASTASES","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Brain metastasis; DNA methylation; Oncology; Medicine; Methylation; Metastasis; Lung cancer; Cohort; Internal medicine; Proportional hazards model; Adenocarcinoma; Receiver operating characteristic; Bisulfite sequencing; Cancer; Univariate analysis; Multivariate analysis; Biology; DNA; Gene","score_opus":0.02379090645040036,"score_gpt":0.29992634526114065,"score_spread":0.27613543881074026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987705555","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98902303,0.0010004183,0.002044691,0.002497658,0.00043500544,0.0004418208,0.000030437344,0.00001689609,0.0045100204],"genre_scores_gemma":[0.99578714,0.0001534274,0.0010669453,0.0019372494,0.00012816564,0.00011745956,0.00027348025,0.000024215788,0.00051193556],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99862415,0.0003087121,0.0002668749,0.00044162487,0.00010728698,0.00025132715],"domain_scores_gemma":[0.9992372,0.000111472364,0.00012061666,0.00037760867,0.00008942887,0.000063667845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029864296,0.00015088508,0.0002052601,0.000121109304,0.00006517875,0.000025374227,0.00018573497,0.00018040485,0.00015075163],"category_scores_gemma":[0.00016107474,0.00015036065,0.000061044586,0.00022852393,0.000046802503,0.000013806418,0.00008356722,0.00014563883,0.000055533143],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057630084,0.000068471076,0.0065969294,0.000010168369,0.000024302499,0.0000062378504,0.00013709455,0.00029344112,0.97960865,0.00055225857,0.006716239,0.0059285457],"study_design_scores_gemma":[0.00117209,0.0004364545,0.020336302,0.000006342735,0.000029770992,0.000037041576,0.00018865864,0.00055347785,0.4576266,0.00009224158,0.51925826,0.0002627873],"about_ca_topic_score_codex":0.000034713965,"about_ca_topic_score_gemma":0.00020345667,"teacher_disagreement_score":0.5219821,"about_ca_system_score_codex":0.00008432597,"about_ca_system_score_gemma":0.00032822284,"threshold_uncertainty_score":0.6131529},"labels":[],"label_agreement":null},{"id":"W2987742329","doi":"10.1093/neuonc/noz175.774","title":"PDCT-13. ENTRECTINIB IN CHILDREN AND ADOLESCENTS WITH RECURRENT OR REFRACTORY SOLID TUMORS INCLUDING PRIMARY CNS TUMORS","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; ROS1; Internal medicine; Response Evaluation Criteria in Solid Tumors; Refractory (planetary science); Oncology; Population; Phases of clinical research; Gastroenterology; Clinical trial; Cancer; Adenocarcinoma","score_opus":0.019675176996520223,"score_gpt":0.3154177275162873,"score_spread":0.2957425505197671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987742329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99553525,0.00009388446,8.868569e-7,0.00044882277,0.00019509581,0.0014940026,0.000012176836,0.00007145005,0.0021484052],"genre_scores_gemma":[0.9982596,0.00024037116,0.00007698708,0.0010157151,0.000112905174,0.000051912233,0.000030137951,0.00005841149,0.0001539346],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975242,0.00027864194,0.00038834623,0.00070911227,0.00040457858,0.0006951427],"domain_scores_gemma":[0.9988042,0.00020733083,0.00017450255,0.00035589837,0.00006204536,0.00039599134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017537613,0.0003079646,0.00070989213,0.0003723133,0.000075394404,0.000019165915,0.00014477583,0.0001231218,0.00010637026],"category_scores_gemma":[0.00018567401,0.00022248561,0.000055903125,0.00033776846,0.0001419812,0.00013693451,0.00024576008,0.0008592714,0.00014002374],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008615588,0.0018914534,0.8962535,0.00018089484,0.00007844369,0.0031696835,0.00033608513,0.0000035606247,0.059738353,0.0000031692477,0.00055467524,0.029174542],"study_design_scores_gemma":[0.013304022,0.013921597,0.9621211,0.00063286535,0.000060726306,0.0030126763,0.00009339127,0.000035160814,0.004559224,0.000006786445,0.0020143515,0.0002380419],"about_ca_topic_score_codex":0.000059238795,"about_ca_topic_score_gemma":0.00010040854,"teacher_disagreement_score":0.0658676,"about_ca_system_score_codex":0.00046438526,"about_ca_system_score_gemma":0.00066602114,"threshold_uncertainty_score":0.90727},"labels":[],"label_agreement":null},{"id":"W2987847528","doi":"10.1093/neuonc/noz175.493","title":"HOUT-28. FIRST-LINE TEMOZOLOMIDE VS PCV FOR LOW GRADE GLIOMAS: A 11 YEARS REAL-WORLD DATA FROM CHUM, UNIVERSITY CENTER","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"École de Technologie Supérieure; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Temozolomide; Lomustine; Procarbazine; Medicine; Dacarbazine; Internal medicine; Glioma; Progression-free survival; Vincristine; Regimen; Karnofsky Performance Status; Radiation therapy; Oncology; Chemotherapy; Cyclophosphamide","score_opus":0.046498865829104286,"score_gpt":0.3088564711884389,"score_spread":0.2623576053593346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987847528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855848,0.00005887015,0.000014247279,0.01005904,0.0008754713,0.0012310112,0.001066952,0.00010790854,0.0010017094],"genre_scores_gemma":[0.99481326,0.00032762595,0.0007391473,0.0019692082,0.00037437197,0.0000196178,0.0014121565,0.000053994736,0.0002905996],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981389,0.00010773176,0.00029080382,0.0008073072,0.00019858488,0.00045664268],"domain_scores_gemma":[0.9974551,0.0008633747,0.00019946971,0.0011774537,0.00006285783,0.00024175148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013498285,0.00024917052,0.00070544385,0.0002547271,0.00007886728,0.000016048369,0.00042094407,0.00015483334,0.00028550855],"category_scores_gemma":[0.00009834935,0.0002344658,0.00015993962,0.0003051908,0.00010842937,0.00012164806,0.00035524517,0.00020627723,0.0003216621],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031680379,0.0043673404,0.8312262,0.000121085184,0.00051983586,0.0038624012,0.00034604358,0.000026648057,0.02608755,0.0003124041,0.12226598,0.0076964493],"study_design_scores_gemma":[0.014541122,0.0019209279,0.16277747,0.00006736249,0.00041873226,0.00004599077,0.000082463004,0.0006886625,0.0032472285,0.000049744194,0.81594497,0.00021533437],"about_ca_topic_score_codex":0.0014364334,"about_ca_topic_score_gemma":0.009410857,"teacher_disagreement_score":0.693679,"about_ca_system_score_codex":0.0003479626,"about_ca_system_score_gemma":0.00016102105,"threshold_uncertainty_score":0.95612377},"labels":[],"label_agreement":null},{"id":"W2987946496","doi":"10.1093/neuonc/noz175.073","title":"ACTR-30. UPDATED EFFICACY AND SAFETY OF DABRAFENIB PLUS TRAMETINIB IN PATIENTS WITH RECURRENT/REFRACTORY BRAF V600E–MUTATED HIGH-GRADE GLIOMA (HGG) AND LOW-GRADE GLIOMA (LGG)","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Trametinib; Medicine; Dabrafenib; Internal medicine; Oncology; Glioma; Progression-free survival; Discontinuation; Interim analysis; Clinical endpoint; MEK inhibitor; Clinical trial; Chemotherapy; Cancer; Cancer research; MAPK/ERK pathway; Vemurafenib; Metastatic melanoma","score_opus":0.011397720992406346,"score_gpt":0.2691038434296475,"score_spread":0.25770612243724117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987946496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958153,0.000318632,0.000005213864,0.0010555338,0.000365533,0.0020675082,0.00014073834,0.00006977328,0.0001618119],"genre_scores_gemma":[0.99840325,0.00012176886,0.00047067582,0.0003990704,0.0000475022,0.000030419456,0.000442539,0.00007084013,0.000013944743],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9969161,0.00050444645,0.0007528417,0.0008413763,0.00040398777,0.00058125163],"domain_scores_gemma":[0.9977912,0.00079425634,0.0004225833,0.0005240886,0.00012103476,0.00034687252],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00028488418,0.0004622487,0.0012353286,0.00044530837,0.00006411782,0.000018639006,0.00014546872,0.0003147137,0.0002754702],"category_scores_gemma":[0.00016365015,0.00035686453,0.00007958406,0.0006280519,0.00032751655,0.000136466,0.00012285118,0.0005703884,0.000026573925],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.082941316,0.03350361,0.30221593,0.0014373648,0.0023980623,0.0064170915,0.004515581,0.00017604396,0.35638008,0.0007254829,0.0027858277,0.20650361],"study_design_scores_gemma":[0.120970264,0.025185522,0.8251094,0.0002985558,0.00070823426,0.00043591313,0.00020656631,0.0002603084,0.013739291,0.000046786958,0.012453293,0.000585812],"about_ca_topic_score_codex":0.00012968451,"about_ca_topic_score_gemma":0.000045171368,"teacher_disagreement_score":0.52289355,"about_ca_system_score_codex":0.00023280144,"about_ca_system_score_gemma":0.00028030077,"threshold_uncertainty_score":0.99988836},"labels":[],"label_agreement":null},{"id":"W2987989330","doi":"10.1093/neuonc/noz175.968","title":"RARE-45. ACTIVITY OF LAROTRECTINIB IN TRK FUSION CANCER PATIENTS WITH PRIMARY CENTRAL NERVOUS SYSTEM TUMORS","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Trk receptor; Medicine; Internal medicine; Oncology; Cancer; Neurotrophin; Gastroenterology; Surgery; Receptor","score_opus":0.009831218568027171,"score_gpt":0.25399045314443164,"score_spread":0.24415923457640445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2987989330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955773,0.0000629122,5.58436e-7,0.0003543389,0.0005099781,0.0012460953,0.000024822471,0.00003460606,0.002189418],"genre_scores_gemma":[0.99946195,0.000023545866,0.00003242109,0.00026056002,0.00004994553,0.00011201819,0.00002104005,0.000025589688,0.000012922237],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986728,0.000157491,0.00025581723,0.00034036796,0.00024138184,0.00033216891],"domain_scores_gemma":[0.9991528,0.00018739712,0.0002164062,0.00024435265,0.0000762466,0.00012284411],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007136383,0.00017172664,0.00063097716,0.00013407491,0.000024059502,0.0000036589333,0.00006615547,0.000121589204,0.000075502976],"category_scores_gemma":[0.00002468568,0.00012421979,0.00006879981,0.00021651736,0.00003842179,0.000056633744,0.000051767813,0.00021113313,0.000014577168],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014802206,0.0018994908,0.9065004,0.0002307746,0.000038939754,0.00030505136,0.00022302786,0.00006164877,0.06881939,0.000012499074,0.00015378097,0.020274755],"study_design_scores_gemma":[0.008218043,0.0031668183,0.9590152,0.00023756243,0.00008772073,0.000035310735,0.000051727966,0.000047832214,0.027750896,6.269845e-7,0.0012927086,0.000095540556],"about_ca_topic_score_codex":0.0006219437,"about_ca_topic_score_gemma":0.00023781756,"teacher_disagreement_score":0.05251479,"about_ca_system_score_codex":0.0006666613,"about_ca_system_score_gemma":0.00030599354,"threshold_uncertainty_score":0.5065536},"labels":[],"label_agreement":null},{"id":"W2988060405","doi":"10.1093/neuonc/noz175.383","title":"EXTH-52. CO-TARGETING ONCOSTATIN M RECEPTOR USING MONOCLONAL ANTIBODIES IN COMBINATION WITH PRESENT STANDARDS OF CARE FOR GLIOBLASTOMA","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Oncostatin M; Monoclonal antibody; Cancer research; Temozolomide; Signal transduction; Medicine; STAT3; Biology; Cytokine; Immunology; Antibody; Pharmacology; Glioma; Interleukin 6; Cell biology","score_opus":0.010732321429492837,"score_gpt":0.3069892383573241,"score_spread":0.2962569169278313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988060405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953821,0.0015470611,0.00057326845,0.00008989911,0.0008816639,0.00072594755,0.00025032522,0.000008441528,0.0005413165],"genre_scores_gemma":[0.99507517,0.00039458327,0.0036648472,0.00012292055,0.0004413982,0.00004624001,0.00017543175,0.000037234477,0.000042155956],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987552,0.00012825998,0.00029606855,0.0003585626,0.00018912724,0.0002727852],"domain_scores_gemma":[0.9991006,0.00007944561,0.00022005761,0.00017862774,0.00036946067,0.000051777846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022815375,0.00015707946,0.00035616432,0.00009093788,0.000049725357,0.000009729695,0.00011966033,0.00016538503,0.000022811795],"category_scores_gemma":[0.00011847449,0.00014940048,0.00007164248,0.00008918979,0.00008891097,0.000008993659,0.00005860474,0.000114262024,0.0000010275329],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002210324,0.00010114555,0.004241144,0.00013437158,0.000025688445,0.0000015069461,0.0006222895,0.00077265763,0.98140967,0.000040592484,0.0018153889,0.008625224],"study_design_scores_gemma":[0.0031694411,0.003266888,0.00045407916,0.000027488331,0.000021215434,0.000009851771,0.00091700617,0.00027727266,0.50584406,0.000010902779,0.48585287,0.00014892482],"about_ca_topic_score_codex":0.00004871884,"about_ca_topic_score_gemma":0.00020219866,"teacher_disagreement_score":0.4840375,"about_ca_system_score_codex":0.00010744598,"about_ca_system_score_gemma":0.0005578356,"threshold_uncertainty_score":0.6092375},"labels":[],"label_agreement":null},{"id":"W2988067761","doi":"10.1093/neuonc/noz217","title":"Targeting MEK/MELK in atypical teratoid rhabdoid tumor: a treatment approach aimed at exploiting blood–brain barrier deficiencies","year":2019,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; Hospital for Sick Children; Occupational Cancer Research Centre","funders":"","keywords":"Blood–brain barrier; Medicine; Cancer research; Neuroscience; Psychology; Central nervous system","score_opus":0.018329565370066844,"score_gpt":0.25998527766261487,"score_spread":0.241655712292548,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988067761","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9564079,0.0028067357,0.0002186254,0.034245443,0.0010595266,0.0011929829,0.00015717754,0.00008756861,0.003824037],"genre_scores_gemma":[0.34941217,0.0009007639,0.0043177633,0.62738854,0.009040149,0.0012071435,0.004222659,0.000497017,0.003013779],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956814,0.0006382231,0.00080041075,0.001502038,0.0003373781,0.0010405161],"domain_scores_gemma":[0.99835175,0.00031472754,0.00039977266,0.00073668966,0.00008830328,0.00010877899],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0003696143,0.000702133,0.00095304154,0.00016801352,0.00017816649,0.000048461956,0.00048746538,0.0013574766,0.000060503484],"category_scores_gemma":[0.000418553,0.0006381558,0.00034635482,0.00015470649,0.00020102614,0.0000068167137,0.00040590152,0.0011182743,0.000049766044],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016575816,0.00016695845,0.00056726724,0.000113417365,0.000076080454,0.00038803258,0.00028394122,0.0007232081,0.815352,0.0000015468777,0.18126212,0.0008996314],"study_design_scores_gemma":[0.0021623776,0.0014550195,0.0000121563235,0.000040156992,0.00009400534,0.0005452482,0.00017505717,0.0019236733,0.11860064,0.0000085551355,0.8742984,0.0006846962],"about_ca_topic_score_codex":0.000045991394,"about_ca_topic_score_gemma":0.000027427974,"teacher_disagreement_score":0.6967514,"about_ca_system_score_codex":0.00048923696,"about_ca_system_score_gemma":0.0007050841,"threshold_uncertainty_score":0.99993896},"labels":[],"label_agreement":null},{"id":"W2988133706","doi":"10.1093/neuonc/noz175.862","title":"RDNA-01. TUBULIN AND MICROTUBULES AS MOLECULAR TARGETS FOR TTFIELD THERAPY","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Microtubule; Tubulin; Biophysics; Cytoskeleton; Dipole; Intracellular; Materials science; Chemistry; Cell; Cell biology; Biology; Biochemistry; Organic chemistry","score_opus":0.00797132998518724,"score_gpt":0.26395436614406814,"score_spread":0.2559830361588809,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988133706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990941,0.002814413,0.0009626474,0.00133229,0.000513829,0.00093570136,0.000029999703,0.000022890119,0.0024472498],"genre_scores_gemma":[0.9817888,0.003056056,0.0022855496,0.011662429,0.00028928812,0.00014402419,0.00017139303,0.0000765906,0.00052586966],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99857956,0.00009634181,0.00025127534,0.0006037302,0.0000762035,0.00039289272],"domain_scores_gemma":[0.9992185,0.00008161475,0.00010637265,0.0004022962,0.000077476216,0.00011373869],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015372575,0.0002447131,0.00030565905,0.000054342287,0.00006865807,0.000024938377,0.0002383115,0.00043128198,0.00007566676],"category_scores_gemma":[0.000084040075,0.00023620247,0.00014156789,0.000049104674,0.0000863351,0.0000049904133,0.0001401971,0.00016603089,0.000049820836],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036241926,0.00010137188,0.0006153591,0.000022130489,0.000059169935,0.000013484356,0.00006350078,0.000011649946,0.98288834,0.00035577867,0.0038343777,0.011672416],"study_design_scores_gemma":[0.0012353988,0.0016202194,0.000066190114,0.0000029947942,0.000012009154,0.00006832956,0.000032108546,0.000042295258,0.5232011,0.00017303533,0.47338244,0.00016388595],"about_ca_topic_score_codex":0.000019133968,"about_ca_topic_score_gemma":0.000021829039,"teacher_disagreement_score":0.46954808,"about_ca_system_score_codex":0.000017799997,"about_ca_system_score_gemma":0.00015117791,"threshold_uncertainty_score":0.9632057},"labels":[],"label_agreement":null},{"id":"W2988677670","doi":"10.1093/neuonc/noz175.644","title":"PATH-48. THE DNA METHYLATION LANDSCAPE OF CORE AND PERIPHERAL DIFFUSE GLIOMA REGIONS SHOWS LITTLE SPATIAL SUBTYPE HETEROGENEITY AFTER CONSIDERING TUMOR PURITY","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Glioma; DNA methylation; Methylation; Epigenetics; DNA; Biology; Brain tumor; Pathology; Molecular biology; Cancer research; Gene; Genetics; Medicine; Gene expression","score_opus":0.01777987691746194,"score_gpt":0.28961814237103917,"score_spread":0.27183826545357725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988677670","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943691,0.00032740485,0.00028370475,0.003614167,0.0005332434,0.00036308682,0.0000064942747,0.000034458415,0.000468361],"genre_scores_gemma":[0.9975558,0.000048713635,0.00038551606,0.0017247803,0.0002068166,0.000019556332,0.000009674022,0.000023440913,0.000025699323],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99883777,0.00019532035,0.0002809138,0.00028181987,0.0001785818,0.00022559831],"domain_scores_gemma":[0.9989441,0.00041400094,0.00015472676,0.00029606797,0.000063146304,0.00012792806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027435922,0.00013985379,0.00039087207,0.00006272063,0.000067333014,0.000015687776,0.00008454767,0.00009898555,0.00019668204],"category_scores_gemma":[0.00050195935,0.00009895186,0.0000835582,0.000087275635,0.000219218,0.000046759735,0.000104078325,0.00046546926,0.00000806287],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064199703,0.00020094194,0.42108116,0.00013562385,0.000056309244,0.0003863734,0.0010616925,0.000020477037,0.56660324,0.00016545373,0.00078715663,0.00885961],"study_design_scores_gemma":[0.016073797,0.0039842995,0.7287223,0.00022503811,0.00065931125,0.0052181,0.00082392944,0.1052749,0.03741039,0.0009319356,0.09994979,0.0007262286],"about_ca_topic_score_codex":0.000086030785,"about_ca_topic_score_gemma":0.00006335083,"teacher_disagreement_score":0.5291928,"about_ca_system_score_codex":0.000038678103,"about_ca_system_score_gemma":0.0001127679,"threshold_uncertainty_score":0.40351397},"labels":[],"label_agreement":null},{"id":"W2988779892","doi":"10.1093/neuonc/noz213","title":"Less treatment for Wing less medulloblastoma: germline data re-emphasize this","year":2019,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medulloblastoma; Germline; Wing; Biology; Genetics; Engineering; Aerospace engineering","score_opus":0.10624419864360987,"score_gpt":0.3604692555815921,"score_spread":0.25422505693798225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988779892","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.039165802,0.0016505024,0.000029771001,0.9417824,0.0050375015,0.0052379337,0.0021137944,0.00025110127,0.0047311857],"genre_scores_gemma":[0.015036397,0.0016093709,0.0017207616,0.9396163,0.016460055,0.0022271227,0.018093942,0.0005981019,0.0046379226],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952543,0.00030076262,0.0008917429,0.0019475053,0.0005282241,0.0010774682],"domain_scores_gemma":[0.992751,0.0033093852,0.00059914956,0.0029263496,0.00021217865,0.00020190685],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00027989785,0.00094879116,0.00232509,0.00038090564,0.00017453554,0.000053948526,0.0007618939,0.0016882168,0.000375051],"category_scores_gemma":[0.0003448676,0.00073878,0.0005298626,0.00019669948,0.00017168552,0.00011828971,0.0004154546,0.0011168965,0.00026767972],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043321375,0.0013370152,0.0007118607,0.00034773065,0.00092042336,0.007505555,0.000121672114,0.0000034049701,0.0062779807,0.000010236804,0.92014444,0.062186476],"study_design_scores_gemma":[0.013198041,0.0058327084,0.00013821946,0.00019462181,0.0027461438,0.0007476748,0.00007864358,0.00020198466,0.002823703,0.000015340795,0.9735409,0.00048199916],"about_ca_topic_score_codex":0.00022246045,"about_ca_topic_score_gemma":0.00019681606,"teacher_disagreement_score":0.061704475,"about_ca_system_score_codex":0.0013249427,"about_ca_system_score_gemma":0.0011204253,"threshold_uncertainty_score":0.9996078},"labels":[],"label_agreement":null},{"id":"W2988963154","doi":"10.1093/neuonc/noz175.809","title":"PDTM-33. EUROPEAN GENETIC ANCESTRY ASSOCIATED WITH RISK OF CHILDHOOD EPENDYMOMA","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Ependymoma; Genome-wide association study; Demography; Incidence (geometry); Odds ratio; Ethnic group; Medicine; Genetics; Biology; Genotype; Pathology; Single-nucleotide polymorphism","score_opus":0.013697712664484746,"score_gpt":0.25801340542607026,"score_spread":0.24431569276158552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988963154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97837675,0.0002269675,0.0000025525108,0.00045878856,0.00023030798,0.00052963226,0.000038337606,0.00005527279,0.02008138],"genre_scores_gemma":[0.9988269,0.00011851471,0.00022998595,0.000608604,0.00008456188,0.000017893371,0.000028320215,0.00004554138,0.00003966282],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99849516,0.00033361872,0.00029642912,0.00036397218,0.00021843746,0.0002923917],"domain_scores_gemma":[0.9987048,0.00033625035,0.00032668601,0.00039740797,0.00009469242,0.00014018547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014994804,0.00018667172,0.00051192276,0.000094037896,0.000040449602,0.00000614423,0.00011279831,0.000104347935,0.00022424303],"category_scores_gemma":[0.00018322586,0.00013733207,0.00010049558,0.00020853893,0.000079325,0.00002889947,0.00005482211,0.00026620954,0.00023267938],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015453457,0.002341271,0.9460925,0.000021029333,0.00038447112,0.002264653,0.00026657444,0.00007849806,0.029599985,0.00002653279,0.0009841612,0.017785802],"study_design_scores_gemma":[0.0068279,0.005872326,0.9693988,0.00006525,0.00043935305,0.0003883523,0.000053155207,0.0000382866,0.009862996,0.0000162573,0.0069195507,0.00011775409],"about_ca_topic_score_codex":0.000028229066,"about_ca_topic_score_gemma":0.000033478856,"teacher_disagreement_score":0.023306333,"about_ca_system_score_codex":0.00009044903,"about_ca_system_score_gemma":0.00015846115,"threshold_uncertainty_score":0.56002396},"labels":[],"label_agreement":null},{"id":"W2989038942","doi":"10.1093/neuonc/noz175.070","title":"ACTR-27. EVOLUTION OF THE NEUROSURGEON’S ROLE IN CLINICAL TRIALS FOR GBM: A SYSTEMATIC OVERVIEW OF THE CLINICALTRIALS.GOV DATABASE","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Clinical trial; Tolerability; Neurosurgery; Demographics; Psychological intervention; Randomized controlled trial; Internal medicine; Oncology; Surgery; Adverse effect; Demography","score_opus":0.19921297757867987,"score_gpt":0.4562506505405482,"score_spread":0.2570376729618683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989038942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98337555,0.0014897637,0.000006031559,0.00459094,0.003209984,0.0070348047,0.000111573216,0.000011332721,0.00017003337],"genre_scores_gemma":[0.9979506,0.0003970281,0.000046641384,0.0011260892,0.0001545802,0.00027090445,0.000007399988,0.000022863032,0.000023883456],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99070776,0.005283185,0.003016214,0.0003999418,0.00033352766,0.00025937456],"domain_scores_gemma":[0.9758698,0.020639053,0.0020243428,0.0012236849,0.00015304323,0.00009009384],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.008696025,0.00018287271,0.0023289316,0.00009010249,0.000032895787,0.00000497809,0.0003279557,0.00025131958,0.000053065658],"category_scores_gemma":[0.028423116,0.00009152812,0.0009946676,0.0003416288,0.00013561668,0.00004243519,0.00019285183,0.00031856974,0.000018546038],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038928052,0.007463074,0.71643686,0.012150222,0.00046285236,0.000031211177,0.00019446574,0.000056162004,0.24559772,0.0042870217,0.006297054,0.0031305577],"study_design_scores_gemma":[0.10697443,0.018160293,0.7159152,0.017119857,0.009688133,0.00028796156,0.0008353508,0.004104264,0.06351881,0.0017395855,0.060982663,0.00067347166],"about_ca_topic_score_codex":0.00008546839,"about_ca_topic_score_gemma":0.00011637073,"teacher_disagreement_score":0.18207891,"about_ca_system_score_codex":0.00015446042,"about_ca_system_score_gemma":0.0006496115,"threshold_uncertainty_score":0.9797609},"labels":[],"label_agreement":null},{"id":"W2989078280","doi":"10.1093/neuonc/noz175.1023","title":"SURG-23. INTRAPARENCHYMAL MUCOSA-ASSOCIATED LYMPHOID TISSUE (MALT) LYMPHOMA: A NOVEL DISEASE PRESENTATION","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Medicine; Lymphatic system; MALT lymphoma; Lymphoma; Lesion; Pathology; Presentation (obstetrics); Mucosa-associated lymphoid tissue; Meningioma; Parenchyma; Radiology","score_opus":0.019532676623506544,"score_gpt":0.30165019316692226,"score_spread":0.2821175165434157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989078280","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98905295,0.0003871894,0.000020864867,0.0036088629,0.0012540236,0.0014149633,0.00010552416,0.00018446022,0.003971176],"genre_scores_gemma":[0.9953999,0.00019784847,0.00015239415,0.0025012274,0.0003082746,0.00027159057,0.00057402503,0.00006507631,0.00052966224],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99753636,0.00017437448,0.00052378053,0.00072063936,0.0004400767,0.00060477963],"domain_scores_gemma":[0.9978252,0.0006610102,0.0002639543,0.0005400682,0.00018147926,0.0005282692],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018143219,0.00034906334,0.0007188088,0.00020789672,0.000105697065,0.00003565641,0.0001563865,0.00024736585,0.0006003631],"category_scores_gemma":[0.00040610414,0.0003166242,0.0002032372,0.00037087625,0.00010269412,0.00013909591,0.00011515659,0.000117567295,0.0008972806],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002139968,0.012386057,0.6564447,0.0001342551,0.0004693674,0.0024389732,0.0006253307,0.0000579973,0.18047915,0.0007849936,0.018512987,0.1255262],"study_design_scores_gemma":[0.025656128,0.0032206718,0.77416795,0.000081899576,0.00069283805,0.00055203284,0.00014827072,0.001017939,0.01825077,0.00007061992,0.17571467,0.00042618028],"about_ca_topic_score_codex":0.00031023662,"about_ca_topic_score_gemma":0.0000972586,"teacher_disagreement_score":0.16222839,"about_ca_system_score_codex":0.0012517679,"about_ca_system_score_gemma":0.0011432813,"threshold_uncertainty_score":0.9999286},"labels":[],"label_agreement":null},{"id":"W2989460017","doi":"10.1093/neuonc/noz175.071","title":"ACTR-28. A CALL FOR INCREASED ROLE OF NEUROSURGEONS IN SURGICAL TRIALS FOR NON-GLIOMATOUS PRIMARY CNS TUMORS: A SYSTEMATIC REVIEW OF THE CLINICALTRIALS.GOV DATABASE","year":2019,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Clinical trial; Randomized controlled trial; Surgery; Oncology; Internal medicine","score_opus":0.1255841497779495,"score_gpt":0.4245200108524419,"score_spread":0.29893586107449244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989460017","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005201636,0.95148474,0.000002901747,0.00045848754,0.0007091781,0.04408056,0.0025826741,0.000022278407,0.00013902453],"genre_scores_gemma":[0.0002790213,0.98751086,0.00014217272,0.000932884,0.00024388346,0.0099989185,0.000752456,0.00012874974,0.000011059308],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9855968,0.0052167284,0.007152957,0.0009272423,0.0005185741,0.00058771],"domain_scores_gemma":[0.93607414,0.055390358,0.006069924,0.0018835628,0.0003278156,0.0002542174],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.008561419,0.00073702814,0.019598154,0.0004520147,0.000047282567,0.000010630426,0.0006610573,0.00064199185,0.00002815973],"category_scores_gemma":[0.03445601,0.00041580372,0.0043104347,0.0007465959,0.00016111537,0.000044918917,0.000278443,0.0005187302,0.00001148622],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007221836,0.0026851685,0.00004249698,0.9764875,0.00060505304,0.00025588318,0.000013461176,1.5720967e-7,0.00050549896,0.00006621267,0.0026599076,0.015956452],"study_design_scores_gemma":[0.010152967,0.0024655706,0.000011180684,0.52286243,0.022018807,0.00074539473,0.0000066403063,0.000015465688,0.00015505779,0.0000100017805,0.4412882,0.00026827012],"about_ca_topic_score_codex":0.000061634506,"about_ca_topic_score_gemma":0.000018233837,"teacher_disagreement_score":0.45362508,"about_ca_system_score_codex":0.0003533386,"about_ca_system_score_gemma":0.0037160025,"threshold_uncertainty_score":0.99982935},"labels":[],"label_agreement":null},{"id":"W2989513644","doi":"10.1093/neuonc/noz175.050","title":"ACTR-06. CLINICAL TRIAL OF VAL-083 IN NEWLY DIAGNOSED MGMT-UNMETHYLATED GBM: HALF-WAY REPORT","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Delmar (Canada)","funders":"","keywords":"Temozolomide; Tolerability; Medicine; Radiation therapy; O-6-methylguanine-DNA methyltransferase; Oncology; Internal medicine; Methyltransferase; Guanine; Stage (stratigraphy); Phases of clinical research; Clinical trial; Nuclear medicine; Cancer research; Biology; DNA; Gene; Adverse effect","score_opus":0.05515892660588789,"score_gpt":0.3857798892029587,"score_spread":0.3306209625970708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989513644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9835017,0.00012390413,0.0000026242274,0.005706439,0.00239331,0.0020470195,0.000005285985,0.000063529114,0.0061562434],"genre_scores_gemma":[0.997289,0.00035859563,0.00030880974,0.0012541142,0.0003861924,0.00014253522,0.000060585564,0.000047311412,0.0001528498],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99614656,0.00060878566,0.0016406229,0.00074790866,0.0003796002,0.0004765317],"domain_scores_gemma":[0.99490213,0.003141995,0.0006523019,0.0008882953,0.0001462738,0.00026900286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001158653,0.00028252625,0.0014899477,0.00028741322,0.000027149385,0.00000916284,0.00017216276,0.0005544757,0.0003545466],"category_scores_gemma":[0.002571572,0.00023171473,0.00040387103,0.00041654194,0.0001425483,0.000067758185,0.000116505726,0.00060800527,0.00027895326],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026516734,0.014297711,0.73104566,0.000076506345,0.00039264755,0.026127415,0.0003130241,0.000028285342,0.14369291,0.0001904902,0.012070045,0.04524855],"study_design_scores_gemma":[0.3387372,0.025074778,0.33326733,0.00012000269,0.0006056585,0.000777494,0.000113780006,0.000116145806,0.035152454,0.00016685085,0.2654842,0.00038409655],"about_ca_topic_score_codex":0.0002362642,"about_ca_topic_score_gemma":0.0001112964,"teacher_disagreement_score":0.39777836,"about_ca_system_score_codex":0.00020442726,"about_ca_system_score_gemma":0.0005755536,"threshold_uncertainty_score":0.9449053},"labels":[],"label_agreement":null},{"id":"W2989904783","doi":"10.1093/neuonc/noz219.1199","title":"LTBK-08. TOCA 511 &amp; TOCA FC VERSUS STANDARD OF CARE IN PATIENTS WITH RECURRENT HIGH GRADE GLIOMA","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; University of Alberta; Montreal Neurological Institute and Hospital; University Health Network; CancerCare Manitoba; Sunnybrook Hospital; Ottawa Regional Cancer Foundation; Princess Margaret Cancer Centre","funders":"","keywords":"Temozolomide; Medicine; Clinical endpoint; Internal medicine; Interim analysis; Oncology; Adverse effect; Bevacizumab; Progression-free survival; Glioma; Lomustine; Gastroenterology; Surgery; Randomized controlled trial; Chemotherapy; Cyclophosphamide; Cancer research; Vincristine","score_opus":0.016201114525663706,"score_gpt":0.28850317837808576,"score_spread":0.27230206385242206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989904783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949501,0.00027022423,3.009719e-7,0.00091995817,0.001188697,0.0014190067,0.00010767137,0.000031788833,0.0011122106],"genre_scores_gemma":[0.999148,0.00003741175,0.00026595755,0.00016927179,0.000054633656,0.00010596057,0.00017998762,0.00003393617,0.000004840215],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99828976,0.00012292276,0.00036871678,0.00044270183,0.00041288242,0.00036298332],"domain_scores_gemma":[0.9987175,0.00026350966,0.00018706814,0.00047208133,0.00020784313,0.0001519927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006350819,0.00023787908,0.00072748086,0.00024427837,0.000028837381,0.0000067458077,0.00011239126,0.000162534,0.0002191951],"category_scores_gemma":[0.00008060196,0.00018217457,0.00009288764,0.00033212735,0.00007052766,0.000051139286,0.00007582897,0.00023755924,0.000096431584],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5719398,0.0048205038,0.35941258,0.0003447164,0.00031888796,0.00072116486,0.002130708,0.0000750429,0.0030272568,0.00051936065,0.004114921,0.052575048],"study_design_scores_gemma":[0.06556551,0.6585858,0.1533025,0.00022086702,0.00033678787,0.000022770135,0.00034635124,0.000004355741,0.014006174,0.000023123577,0.10728177,0.00030397254],"about_ca_topic_score_codex":0.000032138378,"about_ca_topic_score_gemma":0.004702723,"teacher_disagreement_score":0.6537653,"about_ca_system_score_codex":0.0005532212,"about_ca_system_score_gemma":0.00023520853,"threshold_uncertainty_score":0.7428863},"labels":[],"label_agreement":null},{"id":"W2992048139","doi":"10.1093/neuonc/noz203","title":"Glioblastoma incidence rate trends in Canada and the United States compared with England, 1995–2015","year":2019,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Brain Tumour Foundation of Canada; University of Alberta","funders":"Uncle Kory Foundation; Fondation Brain Canada; Musella Foundation For Brain Tumor Research and Information; Children's Brain Tumor Foundation; National Brain Tumor Society","keywords":"Glioblastoma; Incidence (geometry); Demography; New england; Medicine; Geography; History; Gerontology; Political science; Sociology; Cancer research; Law; Physics","score_opus":0.014309428696533363,"score_gpt":0.26034038086706407,"score_spread":0.2460309521705307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992048139","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5925917,0.00018908849,3.0523006e-7,0.4061752,0.00029243642,0.00046233003,0.00007032647,0.000016236254,0.0002023884],"genre_scores_gemma":[0.5284986,0.00023967228,0.000012654864,0.4698427,0.00033992552,0.00016181248,0.0007596064,0.000051663472,0.00009337261],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976221,0.00064499874,0.00039137897,0.00052393606,0.00032522157,0.0004924048],"domain_scores_gemma":[0.9963679,0.0026623416,0.00028109716,0.00048218525,0.000107477565,0.00009899992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001952034,0.00040429944,0.0011062737,0.00046674066,0.000054949705,0.00002362808,0.00017995454,0.0002831666,0.000089273446],"category_scores_gemma":[0.000075162454,0.00022994945,0.000053378975,0.0005397338,0.00023932457,0.000029278162,0.00009084558,0.0013235767,0.000011619405],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024751273,0.00010503066,0.048926044,0.0000803496,0.00022368826,0.022095295,0.00052961754,0.00020354119,0.00012435591,0.00000491171,0.9231538,0.0020782175],"study_design_scores_gemma":[0.019757444,0.0016644453,0.013937624,0.00010609156,0.00033220716,0.00089374103,0.00010069674,0.0008260962,0.00016146811,0.000008686319,0.9619849,0.00022663626],"about_ca_topic_score_codex":0.7127163,"about_ca_topic_score_gemma":0.9257521,"teacher_disagreement_score":0.21303587,"about_ca_system_score_codex":0.0008238239,"about_ca_system_score_gemma":0.0011966306,"threshold_uncertainty_score":0.93770665},"labels":[],"label_agreement":null},{"id":"W2994157979","doi":"10.1093/neuonc/noz225","title":"Stereotactic radiosurgery for non-functioning pituitary adenomas: meta-analysis and International Stereotactic Radiosurgery Society practice opinion","year":2019,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Radiosurgery; Medicine; Pituitary adenoma; Stereotactic radiotherapy; Hypopituitarism; Randomized controlled trial; MEDLINE; Radiation therapy; Nuclear medicine; Radiology; Adenoma; Surgery; Internal medicine","score_opus":0.12615381411686147,"score_gpt":0.39132124303505517,"score_spread":0.26516742891819367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994157979","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006627018,0.9893294,0.0005232201,0.0019830766,0.00366545,0.002660797,0.0002487246,0.000079842626,0.0014431921],"genre_scores_gemma":[0.00040923676,0.991522,0.0013332003,0.0025549717,0.0007305892,0.0007915876,0.0018347659,0.00013442169,0.00068919215],"study_design_codex":"meta_analysis","study_design_gemma":"not_applicable","domain_scores_codex":[0.99555457,0.0005851337,0.0013922048,0.0013897541,0.00044976163,0.0006285914],"domain_scores_gemma":[0.9893511,0.0077577885,0.0014981951,0.0007981495,0.00027344664,0.00032129695],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009372057,0.0008793651,0.006197554,0.00076075085,0.00022072317,0.00010027703,0.00023593676,0.0007226559,0.00030683738],"category_scores_gemma":[0.00078726554,0.00067418214,0.0053879544,0.0006469735,0.00011297868,0.0005604733,0.00017205402,0.0008638636,0.000053266416],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000801257,0.0016803908,0.0014891608,0.009236529,0.57777417,0.0005744725,0.00029239737,0.0000070421083,0.000005859292,0.00003030941,0.018718211,0.38939023],"study_design_scores_gemma":[0.0015850579,0.0006481704,0.0000683345,0.00014831276,0.33084717,0.0016607718,0.000076482786,0.00011413048,2.8970578e-7,0.00001149265,0.6645117,0.00032810797],"about_ca_topic_score_codex":0.000047977846,"about_ca_topic_score_gemma":0.000005727544,"teacher_disagreement_score":0.64579344,"about_ca_system_score_codex":0.0005795626,"about_ca_system_score_gemma":0.0011231705,"threshold_uncertainty_score":0.99957097},"labels":[],"label_agreement":null},{"id":"W2995532498","doi":"10.1093/neuonc/noz232","title":"A randomized controlled phase III study of VB-111 combined with bevacizumab vs bevacizumab monotherapy in patients with recurrent glioblastoma (GLOBE)","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Ottawa Hospital; London Health Sciences Centre","funders":"National Cancer Institute; Deciphera Pharmaceuticals; Five Prime Therapeutics; American Society of Clinical Oncology; Sanofi; Celldex Therapeutics; AstraZeneca; Eli Lilly and Company","keywords":"Bevacizumab; Medicine; Concomitant; Clinical endpoint; Combination therapy; Internal medicine; Phases of clinical research; Hazard ratio; Adverse effect; Oncology; Randomized controlled trial; Progression-free survival; Surgery; Overall survival; Clinical trial; Chemotherapy; Confidence interval","score_opus":0.008743713209318665,"score_gpt":0.280442104597949,"score_spread":0.27169839138863033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995532498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9822642,0.00010267431,0.0000040423038,0.00062710897,0.00029192521,0.01622521,0.000013638962,0.000055011442,0.00041617666],"genre_scores_gemma":[0.99775165,0.000040913706,0.0000608322,0.00035271587,0.000030028956,0.0016499852,0.00003088067,0.00006306884,0.00001990739],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9962222,0.0008476027,0.0011259906,0.00069143274,0.0006376471,0.0004751454],"domain_scores_gemma":[0.9968959,0.0011436243,0.00076956017,0.00064865843,0.00034092768,0.00020132198],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00043171702,0.00049741345,0.0039984514,0.00048906193,0.000051979005,0.00001529188,0.00016859807,0.00015746779,0.00020223025],"category_scores_gemma":[0.00012658427,0.00027129622,0.00024583962,0.0004597474,0.0001424404,0.00008392552,0.00005203852,0.00032984017,0.000021293372],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.89573234,0.039913572,0.055863135,0.000033436885,0.0011837169,0.00034738734,0.0015451782,0.000044330307,0.00077714503,0.000050256975,0.00007864328,0.004430878],"study_design_scores_gemma":[0.8073834,0.1833061,0.0062995553,0.00010601611,0.0008703977,0.000020099502,0.00030213012,0.00032891813,0.000780607,0.000008405428,0.00039087882,0.00020348579],"about_ca_topic_score_codex":0.000085033374,"about_ca_topic_score_gemma":0.00041787114,"teacher_disagreement_score":0.14339253,"about_ca_system_score_codex":0.00033343222,"about_ca_system_score_gemma":0.0002946401,"threshold_uncertainty_score":0.9999739},"labels":[],"label_agreement":null},{"id":"W2996978679","doi":"10.1093/neuonc/noz175.159","title":"CBMT-37. OSMR CONTROLS CELLULAR RESPIRATION AND RESISTANCE TO THERAPY","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Biology; Cell biology; Signal transduction; Cancer research; Cell growth; Receptor; Biochemistry","score_opus":0.014294468822460346,"score_gpt":0.26118228914964847,"score_spread":0.24688782032718812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996978679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96275073,0.010081397,0.00010757461,0.0038429012,0.0035578525,0.0010417247,0.000012832409,0.000092017224,0.018512974],"genre_scores_gemma":[0.983516,0.000583988,0.00022615585,0.0100636715,0.00010420864,0.00010349318,0.000023076374,0.0000407401,0.0053387186],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981183,0.0005311008,0.00035039894,0.0005244035,0.000044338336,0.0004314602],"domain_scores_gemma":[0.9986466,0.00057043694,0.00015514789,0.0005039807,0.00009001532,0.000033808763],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00037566767,0.00020764557,0.00044447544,0.00009054445,0.00012505954,0.00001688136,0.00026083196,0.00040595836,0.00090197887],"category_scores_gemma":[0.000119790086,0.00019447046,0.00006064415,0.00013531272,0.0001688089,0.00008128345,0.00010203342,0.00041916638,0.0018306841],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012650149,0.00006315791,0.00094010937,0.000009577835,0.00004278679,0.000014748822,0.0004930336,0.0000064403057,0.97199994,0.0010481419,0.013327191,0.010789828],"study_design_scores_gemma":[0.0023564587,0.00089447846,0.0007614069,0.0000074368413,0.000009496693,0.000016217311,0.000047417238,0.00000107526,0.33837354,0.000163775,0.65723586,0.00013283924],"about_ca_topic_score_codex":0.00002086404,"about_ca_topic_score_gemma":0.00003593702,"teacher_disagreement_score":0.6439087,"about_ca_system_score_codex":0.000118826356,"about_ca_system_score_gemma":0.00014022975,"threshold_uncertainty_score":0.9989465},"labels":[],"label_agreement":null},{"id":"W2997037042","doi":"10.1093/neuonc/noz175.664","title":"NCOG-03. COGNITIVE CONCERNS AND PERFORMANCE IN PATIENTS WITH METASTATIC NON-SMALL CELL LUNG CANCER (mNSCLC)","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Cognition; Neuropsychology; Effects of sleep deprivation on cognitive performance; Boston Naming Test; Internal medicine; Depression (economics); Lung cancer; Multivariate analysis; Oncology; Clinical psychology; Psychiatry","score_opus":0.014832760062012474,"score_gpt":0.28134491353216967,"score_spread":0.2665121534701572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2997037042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99453366,0.00029816586,0.000013682844,0.00025460136,0.00021102365,0.0015335372,0.00005242479,0.000015872889,0.0030870591],"genre_scores_gemma":[0.99741715,0.00021221706,0.00043423052,0.0015618184,0.000044966073,0.00013396298,0.000047049998,0.000031751908,0.00011683905],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99878746,0.0001045487,0.0002256205,0.00039207807,0.00015820329,0.000332103],"domain_scores_gemma":[0.99918,0.00028668513,0.00013170882,0.00015940866,0.00010643078,0.00013576332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000108847016,0.00020679194,0.00050280534,0.00009931585,0.000036358877,0.000008320138,0.000049520684,0.00006434732,0.00023222165],"category_scores_gemma":[0.000020983762,0.00015105732,0.00003511435,0.000152413,0.00008605921,0.0000700047,0.00004989817,0.0002676461,0.000050588053],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013949071,0.0005888352,0.9837999,0.0002263772,0.00010802797,0.00015983358,0.00064083864,0.000021433618,0.00045923764,0.000006025054,0.00011219932,0.012482423],"study_design_scores_gemma":[0.03001212,0.0091144405,0.9522218,0.00022860491,0.0007344117,0.000030573396,0.00035858338,0.0010005683,0.0020323806,0.0000025139561,0.0040214555,0.00024252338],"about_ca_topic_score_codex":0.0001239551,"about_ca_topic_score_gemma":0.00013177756,"teacher_disagreement_score":0.031578038,"about_ca_system_score_codex":0.00015967056,"about_ca_system_score_gemma":0.00028947354,"threshold_uncertainty_score":0.61599386},"labels":[],"label_agreement":null},{"id":"W2997049714","doi":"10.1093/neuonc/noz243","title":"Connexin43 peptide, TAT-Cx43266–283, selectively targets glioma cells, impairs malignant growth, and enhances survival in mouse models in vivo","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Connexins and lens biology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research; Junta de Castilla y León; Ministerio de Economía y Competitividad; Canada Research Chairs; Fundación Ramón Areces","keywords":"Glioma; SOX2; Cancer research; In vivo; Stem cell; Nestin; Biology; Cell culture; Pathology; Neural stem cell; Transcription factor; Medicine; Cell biology; Gene","score_opus":0.00992218349736684,"score_gpt":0.24099141525660725,"score_spread":0.2310692317592404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2997049714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99417585,0.0007097411,0.00008433749,0.00035074144,0.000493923,0.0005435277,0.00005678268,0.00002324337,0.003561867],"genre_scores_gemma":[0.99754936,0.0009915922,0.00022632706,0.0007824063,0.00012934714,0.00006561825,0.000029316898,0.000045696823,0.00018036303],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971309,0.0005584662,0.0004991575,0.0009830706,0.00011622463,0.00071220804],"domain_scores_gemma":[0.99904764,0.00019679808,0.00017278193,0.00032734757,0.0000883673,0.00016704373],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004257391,0.00035919782,0.00060664245,0.00024342332,0.000051567586,0.000019583913,0.0002981609,0.0005295337,0.00007419455],"category_scores_gemma":[0.00012690347,0.00034520088,0.00009621181,0.00023387469,0.0001988795,0.000018902903,0.0002742585,0.00033847836,0.00001660939],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006496574,0.00022870413,0.007622611,0.00003428329,0.0000283985,0.00013391141,0.00025805857,0.00016218776,0.98944366,0.0006162812,0.0003607712,0.00046149583],"study_design_scores_gemma":[0.002781557,0.0028755607,0.0012844099,0.000011148684,0.000011381375,0.00011689956,0.0004413551,0.0007364938,0.9750725,0.00043331695,0.015760334,0.00047502035],"about_ca_topic_score_codex":0.0003810059,"about_ca_topic_score_gemma":0.0020832792,"teacher_disagreement_score":0.015399563,"about_ca_system_score_codex":0.000060680908,"about_ca_system_score_gemma":0.0002886297,"threshold_uncertainty_score":0.9999},"labels":[],"label_agreement":null},{"id":"W2997503641","doi":"10.1093/neuonc/noz175.767","title":"PDCT-03. CHEMOTHERAPY STRATEGIES FOR YOUNG CHILDREN NEWLY DIAGNOSED WITH MEDULLOBLASTOMA UP TO THE ERA OF MOLECULAR PROFILING – A COMPARATIVE OUTCOMES ANALYSIS","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Medulloblastoma; Medicine; Chemotherapy; Methotrexate; Oncology; Internal medicine; Clinical trial; Radiation therapy; Surgery; Pathology","score_opus":0.015548650979009218,"score_gpt":0.31137848314307853,"score_spread":0.29582983216406933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2997503641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910782,0.00011875713,0.00037949078,0.0046856203,0.00013283087,0.0029818597,0.00004536264,0.000035363773,0.00054252247],"genre_scores_gemma":[0.9954359,0.000017378523,0.0018014027,0.002072739,0.00003716056,0.00053325336,0.000059328628,0.000028769831,0.000014085064],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985431,0.00011033164,0.000335594,0.00043286293,0.0002622127,0.000315928],"domain_scores_gemma":[0.9984675,0.0005318055,0.0002172588,0.00046597506,0.0002010734,0.00011635606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013002992,0.00026232103,0.001004105,0.00017741788,0.000061279614,0.000024845405,0.00017239763,0.00009440923,0.00005939313],"category_scores_gemma":[0.00003930746,0.00015203815,0.0002813004,0.00058980135,0.00008169325,0.000053816275,0.000034519337,0.0001904823,0.000020634792],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016300787,0.0009825645,0.83380115,0.000036226917,0.0052644797,0.00008201373,0.004950747,0.0035668632,0.14507839,0.0011376736,0.0007493404,0.002720461],"study_design_scores_gemma":[0.02002854,0.01207025,0.72639775,0.000053125772,0.0037373877,0.00008042924,0.0048025157,0.0010200443,0.22907405,0.00006909227,0.002289587,0.0003772064],"about_ca_topic_score_codex":0.00017573533,"about_ca_topic_score_gemma":0.00046411005,"teacher_disagreement_score":0.10740339,"about_ca_system_score_codex":0.000086673506,"about_ca_system_score_gemma":0.00029094773,"threshold_uncertainty_score":0.61999357},"labels":[],"label_agreement":null},{"id":"W2998197281","doi":"10.1093/neuonc/noz235","title":"Molecular subgrouping of atypical teratoid/rhabdoid tumors—a reinvestigation and current consensus","year":2019,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":229,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; SickKids Foundation; Hospital for Sick Children","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Brain Tumour Charity; Deutsche Forschungsgemeinschaft; Cancer Research UK","keywords":"Consensus conference; Atypical teratoid rhabdoid tumor; Current (fluid); Medicine; Pathology; Internal medicine; Immunohistochemistry; Geology","score_opus":0.04495351810615278,"score_gpt":0.3486779024792435,"score_spread":0.30372438437309074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2998197281","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.024911158,0.97345513,0.0001575964,0.000051248968,0.0005615169,0.0005548073,0.00003841813,0.0000155478,0.00025454664],"genre_scores_gemma":[0.005377578,0.99343055,0.00038867624,0.00017578702,0.00026359942,0.000049402428,0.0002380744,0.00006380938,0.000012522456],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978026,0.00041617156,0.0006971248,0.0006644572,0.00014668691,0.00027297222],"domain_scores_gemma":[0.9986647,0.00011766638,0.00052142807,0.00047256838,0.000102923215,0.00012072671],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021260281,0.00035997014,0.0011653242,0.0000879346,0.000040895102,0.000014080972,0.00020560884,0.00053277623,0.000006575052],"category_scores_gemma":[0.0002593664,0.00033089076,0.00027984093,0.000108205604,0.00022215043,0.0000016229834,0.00020200314,0.0004118293,0.000010671977],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048938506,0.000060791965,0.000016721397,0.0067857057,0.000080814534,0.000025152038,0.000021440861,0.000030083382,0.10664581,0.00013730995,0.00093279005,0.88521445],"study_design_scores_gemma":[0.00042830277,0.0005511853,0.0000027202766,0.0016634496,0.00029933336,0.00033918986,0.0000060092957,0.0001302978,0.005384599,0.00003890418,0.9908423,0.00031374197],"about_ca_topic_score_codex":0.0000056718036,"about_ca_topic_score_gemma":0.0000032532266,"teacher_disagreement_score":0.98990947,"about_ca_system_score_codex":0.000062042345,"about_ca_system_score_gemma":0.00086509803,"threshold_uncertainty_score":0.9999143},"labels":[],"label_agreement":null},{"id":"W2998325113","doi":"10.1093/neuonc/noz175.032","title":"ATIM-33. INTERIM RESULTS OF A PHASE II MULTI-CENTER STUDY OF ONCOLYTIC ADENOVIRUS DNX-2401 WITH PEMBROLIZUMAB FOR RECURRENT GLIOBLASTOMA; CAPTIVE STUDY (KEYNOTE-192)","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Pembrolizumab; Medicine; Adverse effect; Oncology; Internal medicine; Oncolytic adenovirus; Oncolytic virus; Phases of clinical research; Cohort; Toxicity; Surgery; Immunotherapy; Cancer","score_opus":0.04000655458309873,"score_gpt":0.37554350045798796,"score_spread":0.33553694587488925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2998325113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936802,0.000081191094,0.000087674125,0.00010519281,0.0003350824,0.005160156,0.00036552377,0.000019311054,0.00016569225],"genre_scores_gemma":[0.99882007,0.00003249596,0.00016885072,0.00014646322,0.000114424685,0.00040658453,0.000058834532,0.00008365407,0.0001686402],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99629384,0.0007388097,0.00087952794,0.0010255738,0.00043728767,0.0006249317],"domain_scores_gemma":[0.99739283,0.00021324572,0.0005938686,0.0010206772,0.00056285853,0.0002165382],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006513337,0.0004073547,0.00085092126,0.00025680813,0.0000978858,0.00001183306,0.00064613303,0.00022811277,0.0000321742],"category_scores_gemma":[0.00036943352,0.00032712752,0.00016740657,0.00028871556,0.0002125708,0.000011685515,0.00047936273,0.00035392382,0.000012401552],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24645124,0.033724982,0.00079573656,0.00005986176,0.0004666857,0.000039832412,0.003929823,0.00015199567,0.7025655,8.0702927e-7,0.000553618,0.01125993],"study_design_scores_gemma":[0.09492349,0.63571686,0.00021537398,0.000031437015,0.000117150346,0.000029689403,0.003147412,0.00046988972,0.25893196,0.0000016388067,0.00611684,0.0002982801],"about_ca_topic_score_codex":0.00007927819,"about_ca_topic_score_gemma":0.0031648667,"teacher_disagreement_score":0.60199183,"about_ca_system_score_codex":0.00016680261,"about_ca_system_score_gemma":0.00074835785,"threshold_uncertainty_score":0.9999181},"labels":[],"label_agreement":null},{"id":"W2998443374","doi":"10.1093/neuonc/noz237","title":"How should we manage incidental meningiomas?","year":2019,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"Brain Tumour Charity","keywords":"Meningioma; Computer science; Business; Medicine; Radiology","score_opus":0.055227328889227115,"score_gpt":0.30446917191344736,"score_spread":0.24924184302422026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2998443374","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012877055,0.00052722165,0.00011308257,0.90629053,0.004663417,0.0018231717,0.000027505392,0.00030084638,0.07337715],"genre_scores_gemma":[0.023296818,0.00010843871,0.0011195221,0.88585764,0.009716752,0.00024212418,0.00081372575,0.0003454149,0.07849957],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99558187,0.0003907646,0.00062410574,0.0013112901,0.001012427,0.001079565],"domain_scores_gemma":[0.9973283,0.00054622366,0.00051383936,0.0013244946,0.00010404697,0.00018312965],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00033379716,0.00078089064,0.0016206164,0.0008366218,0.000120279736,0.00014584212,0.0006417144,0.001838633,0.00058120117],"category_scores_gemma":[0.00018146704,0.000702302,0.000546004,0.00034609594,0.00017999239,0.00016325538,0.000636112,0.0035481886,0.0011320577],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001361589,0.00007693139,0.00020670796,0.0005820174,0.0002864109,0.11644036,0.00017256332,7.279576e-7,0.01073123,0.00007667451,0.86754376,0.003746454],"study_design_scores_gemma":[0.0021192401,0.0020422805,0.00011621549,0.00011955116,0.0007682398,0.005941212,0.00011242429,0.00007640539,0.0006058043,0.00008009755,0.9874854,0.00053313165],"about_ca_topic_score_codex":0.000022593274,"about_ca_topic_score_gemma":0.0000042278475,"teacher_disagreement_score":0.11994164,"about_ca_system_score_codex":0.00064791203,"about_ca_system_score_gemma":0.00024211546,"threshold_uncertainty_score":0.99964565},"labels":[],"label_agreement":null},{"id":"W3000663133","doi":"10.1093/neuonc/noaa003","title":"Modeling DIPG in the mouse brainstem","year":2020,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Brainstem; Neuroscience; Biology; Medicine; Computer science","score_opus":0.034001795677342864,"score_gpt":0.25877142649666307,"score_spread":0.22476963081932022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3000663133","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09733584,0.0006033972,0.0016673584,0.8916115,0.001504906,0.00087574945,0.00009685927,0.000061878614,0.006242469],"genre_scores_gemma":[0.1051462,0.00034203558,0.00014483769,0.88890386,0.0044796057,0.000063970074,0.00067972526,0.00009220924,0.00014756044],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99768907,0.0005190936,0.0004182355,0.00070277596,0.00020550471,0.0004652933],"domain_scores_gemma":[0.9991654,0.000096977135,0.00010148822,0.0005353574,0.000046830286,0.000053948563],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001600689,0.00035543207,0.00043565786,0.00006755864,0.0000820648,0.000040208408,0.00079723046,0.0011699359,0.000012021887],"category_scores_gemma":[0.00012270123,0.00028841777,0.00021603702,0.00011311283,0.00010007598,0.000002752081,0.00012416071,0.0018684216,0.000029167666],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008595531,0.00006210839,0.000040814157,0.000057031823,0.00003114639,0.0007721666,0.00024256622,0.00053412083,0.501005,0.000007255372,0.49575034,0.0014115073],"study_design_scores_gemma":[0.0006571475,0.0006279853,0.0000011436474,0.0000070096153,0.000034653298,0.00008952359,0.00005131653,0.0028459916,0.0075603607,0.000035350266,0.9877963,0.00029319833],"about_ca_topic_score_codex":0.000065414584,"about_ca_topic_score_gemma":0.00013712226,"teacher_disagreement_score":0.49344462,"about_ca_system_score_codex":0.000053791697,"about_ca_system_score_gemma":0.00025189912,"threshold_uncertainty_score":0.9999568},"labels":[],"label_agreement":null},{"id":"W3001828378","doi":"10.1093/neuonc/noaa007","title":"Use of radiomics for the prediction of local control of brain metastases after stereotactic radiosurgery","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"Natural Sciences and Engineering Research Council of Canada; Sunnybrook Research Institute","keywords":"Radiosurgery; Radiomics; Medicine; Stereotactic radiotherapy; Medical physics; Radiology; Radiation therapy","score_opus":0.032448662517219236,"score_gpt":0.29534824347099187,"score_spread":0.26289958095377264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3001828378","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6881218,0.00074931624,0.26459876,0.044229858,0.0007709688,0.0011875792,0.0002611417,0.00003556202,0.000044986722],"genre_scores_gemma":[0.9907152,0.00010583482,0.0011723982,0.007732025,0.00019454907,0.000034895158,0.0000135765285,0.000025366237,0.0000061317974],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99858767,0.0002510982,0.000593883,0.00019583399,0.00019414748,0.00017739792],"domain_scores_gemma":[0.9938409,0.005329205,0.00036333993,0.00021385754,0.00012884058,0.00012389949],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004586755,0.00011791483,0.0006844525,0.00008127092,0.000022988375,0.000003912221,0.00009691118,0.00009035435,0.000040838648],"category_scores_gemma":[0.003213594,0.0000830361,0.00021991269,0.00014651967,0.00041038354,0.00006121845,0.000030283907,0.00030745732,5.7147616e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011110544,0.00059771544,0.036494315,0.0010000777,0.0010424001,0.00016197508,0.001252867,0.0029435828,0.75907826,0.00044934909,0.020645624,0.16522332],"study_design_scores_gemma":[0.014574604,0.0083149895,0.01658322,0.00014838643,0.0026352885,0.00051522726,0.00041699247,0.49029627,0.04746094,0.00005574583,0.41879377,0.00020456975],"about_ca_topic_score_codex":0.00002799596,"about_ca_topic_score_gemma":0.0000011336717,"teacher_disagreement_score":0.7116173,"about_ca_system_score_codex":0.000034544664,"about_ca_system_score_gemma":0.0002109722,"threshold_uncertainty_score":0.38472044},"labels":[],"label_agreement":null},{"id":"W3003700434","doi":"10.1093/neuonc/noaa019","title":"A phase I/II trial of 5-fraction stereotactic radiosurgery with 5-mm margins with concurrent temozolomide in newly diagnosed glioblastoma: primary outcomes","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Temozolomide; Radiosurgery; Glioblastoma; Medicine; Oncology; Recursive partitioning; Internal medicine; Nuclear medicine; Radiation therapy; Cancer research","score_opus":0.026057030864722736,"score_gpt":0.30346848838304247,"score_spread":0.27741145751831975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3003700434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878459,0.00012410845,0.000031404543,0.009186649,0.00038655213,0.0019281091,0.000023220244,0.000067823894,0.0004062314],"genre_scores_gemma":[0.9963432,0.00010537349,0.00016982782,0.0027799555,0.00017433196,0.00033905997,0.000034692825,0.00004911272,0.000004426203],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99777216,0.00025324547,0.0006507094,0.00054843345,0.00038606543,0.00038938728],"domain_scores_gemma":[0.9974832,0.0013264162,0.0004757787,0.0003104381,0.00009405599,0.0003101069],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015053069,0.00034220825,0.0013676948,0.00027197768,0.00005742617,0.000011574192,0.00009577629,0.00015095159,0.00007122356],"category_scores_gemma":[0.0003189525,0.00023677746,0.00015613867,0.00048599328,0.00015033098,0.00014530057,0.000059793307,0.00040836286,0.000012290329],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3751002,0.061536964,0.28669104,0.00047991978,0.0012514555,0.025113868,0.0020667484,0.00007725473,0.113791734,0.00008058668,0.0058926446,0.1279176],"study_design_scores_gemma":[0.7061251,0.18102364,0.060051683,0.00018831172,0.0011333689,0.00058101775,0.0003610397,0.00020852989,0.016900588,0.000005252406,0.032983534,0.0004379606],"about_ca_topic_score_codex":0.00006713982,"about_ca_topic_score_gemma":0.00013887844,"teacher_disagreement_score":0.3310249,"about_ca_system_score_codex":0.00040013075,"about_ca_system_score_gemma":0.0006374603,"threshold_uncertainty_score":0.9655504},"labels":[],"label_agreement":null},{"id":"W3005433336","doi":"10.1093/neuonc/noaa025","title":"Estrogen/progesterone receptor and HER2 discordance between primary tumor and brain metastases in breast cancer and its effect on treatment and survival","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; University of Toronto; Sunnybrook Health Science Centre","funders":"National Cancer Institute; Masonic Cancer Center, University of Minnesota; National Institutes of Health; National Center for Advancing Translational Sciences; University of Minnesota","keywords":"Breast cancer; Estrogen; Oncology; Internal medicine; Medicine; Progesterone receptor; Estrogen receptor; Cancer; Primary tumor; Metastasis","score_opus":0.02705868606800896,"score_gpt":0.3086234255814649,"score_spread":0.2815647395134559,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005433336","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96592176,0.004278644,0.0000017584645,0.028249025,0.000071390794,0.0009878669,0.00042376225,0.00002830286,0.000037467868],"genre_scores_gemma":[0.99493694,0.0014584167,0.00020616846,0.0029452154,0.00018114914,0.00016575833,0.000056673944,0.000037060818,0.0000126112545],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99825114,0.0004132348,0.0002563413,0.0006526478,0.00012017587,0.00030645743],"domain_scores_gemma":[0.9983626,0.0010160536,0.000097046184,0.00012933968,0.000016063428,0.00037891266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002026998,0.00033142391,0.00090895226,0.00006648755,0.00006562083,0.000022444054,0.00003394316,0.00006835699,0.0000186471],"category_scores_gemma":[0.000062873456,0.00023466314,0.000039271345,0.000113525,0.0001454626,0.00007145301,0.00009123133,0.00018926401,0.0000025201318],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003009081,0.00042855195,0.67288727,0.00038837123,0.0003533143,0.0010339649,0.000432643,0.0000013088421,0.056251965,0.00012941298,0.00022649963,0.2648576],"study_design_scores_gemma":[0.025879964,0.03669768,0.8882241,0.00019595085,0.0011339053,0.0011751571,0.00016314234,0.000046860314,0.019723134,0.000014522141,0.026279122,0.00046642622],"about_ca_topic_score_codex":0.00016532304,"about_ca_topic_score_gemma":0.000074954725,"teacher_disagreement_score":0.26439118,"about_ca_system_score_codex":0.00014920914,"about_ca_system_score_gemma":0.00010122249,"threshold_uncertainty_score":0.9569285},"labels":[],"label_agreement":null},{"id":"W3006409908","doi":"10.1093/neuonc/noaa036","title":"Implications of new understandings of gliomas in children and adults with NF1: report of a consensus conference","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Gilbert Family Foundation","keywords":"Neurofibromatosis; Glioma; Medicine; Consensus conference; Oncology; Internal medicine; Pathology; Cancer research","score_opus":0.04169166591255971,"score_gpt":0.2939665582084656,"score_spread":0.25227489229590594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006409908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901771,0.00006465314,0.000037230682,0.007970151,0.000013162931,0.0003864325,0.00002686646,0.000012227144,0.0013121916],"genre_scores_gemma":[0.99902695,0.000030341822,0.00062088616,0.0002800613,0.000014471032,0.0000037268082,0.000008954838,0.000010463985,0.000004151655],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9990359,0.000043709613,0.00045894698,0.00024428175,0.000108048174,0.00010914675],"domain_scores_gemma":[0.99902785,0.00019133044,0.00035842485,0.00018767381,0.000105248975,0.00012947213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000055881446,0.00009128774,0.00048965256,0.00009307626,0.000010684158,0.0000017400973,0.000054222357,0.00006655306,0.000021571635],"category_scores_gemma":[0.0002462506,0.00007652702,0.00003397919,0.0002732575,0.00028883584,0.000017584682,0.000041796993,0.000111577785,3.2035467e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015745455,0.00018456424,0.3686041,0.000140992,0.00004451965,0.00059384195,0.0010648384,0.000001802553,0.6231666,0.0021208082,0.0014561161,0.001047268],"study_design_scores_gemma":[0.008483855,0.010771779,0.7707766,0.0002139564,0.00020279609,0.01642243,0.00083483866,0.000059619106,0.19114101,0.00031892923,0.00061706966,0.00015711572],"about_ca_topic_score_codex":0.00016150181,"about_ca_topic_score_gemma":0.000034464334,"teacher_disagreement_score":0.4320256,"about_ca_system_score_codex":0.000015353422,"about_ca_system_score_gemma":0.00044225878,"threshold_uncertainty_score":0.31206813},"labels":[],"label_agreement":null},{"id":"W3007390653","doi":"10.1093/neuonc/noaa043","title":"The Society for Neuro-Oncology: 20/20 vision for the future","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Advances in Oncology and Radiotherapy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.02130765648942999,"score_gpt":0.3771883343025872,"score_spread":0.3558806778131572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007390653","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0032733965,0.009115268,0.035176985,0.9321658,0.011958074,0.0055892305,0.000112624264,0.00028901582,0.0023196305],"genre_scores_gemma":[0.028815143,0.029219141,0.041356955,0.84448624,0.050307877,0.0035741078,0.00018858507,0.0004217439,0.0016301791],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99765396,0.0002488412,0.0005253507,0.0006645573,0.00020859782,0.00069872086],"domain_scores_gemma":[0.98653096,0.012170138,0.0003331546,0.0005170804,0.00021018338,0.0002384902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006794678,0.00033192872,0.00071171805,0.00002572554,0.0011907998,0.000022790611,0.00058128487,0.0006809131,0.000062626415],"category_scores_gemma":[0.0008764638,0.00018304422,0.0008325072,0.00025185605,0.000832892,0.000094317926,0.00012114935,0.0010541397,0.000025333493],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004694263,0.00022902296,0.00020261478,0.00006422073,0.00028052012,0.000039312472,0.0012296186,0.00007581751,0.11647077,0.0019356186,0.6412934,0.23348483],"study_design_scores_gemma":[0.0061763455,0.011439897,0.000106859894,0.0000057972957,0.00034573913,0.00021560215,0.000933295,0.0051908935,0.001059421,0.0008694358,0.9734865,0.00017024958],"about_ca_topic_score_codex":7.9648515e-7,"about_ca_topic_score_gemma":0.00003443946,"teacher_disagreement_score":0.33219308,"about_ca_system_score_codex":0.00028060694,"about_ca_system_score_gemma":0.0007683056,"threshold_uncertainty_score":0.9158789},"labels":[],"label_agreement":null},{"id":"W3008330096","doi":"10.1093/neuonc/noaa044","title":"Resting-state fMRI detects alterations in whole brain connectivity related to tumor biology in glioma patients","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Functional Brain Connectivity Studies","field":"Neuroscience","cited_by":132,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Institute on Deafness and Other Communication Disorders; National Institutes of Health; National Institute of Neurological Disorders and Stroke; National Institute of Mental Health; Beijing Municipal Science and Technology Commission; National Institute on Drug Abuse; National Natural Science Foundation of China","keywords":"Glioma; Resting state fMRI; Neuroscience; Functional connectivity; Biology; Psychology; Cancer research","score_opus":0.03703399342944552,"score_gpt":0.30116702731075506,"score_spread":0.26413303388130954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008330096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89701664,0.0000065347917,0.00005647496,0.100526124,0.0006786952,0.00080546044,0.00004879491,0.00013871156,0.00072255847],"genre_scores_gemma":[0.958408,0.0000011617825,0.000103364386,0.04120736,0.000047852816,0.00017429818,0.0000049792015,0.00003256695,0.000020397454],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9958606,0.0016588414,0.0005530622,0.0011498985,0.00018642885,0.0005911851],"domain_scores_gemma":[0.9838416,0.015459449,0.00017594095,0.00024989186,0.00008069731,0.00019239669],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00041198888,0.0002611369,0.0004983415,0.00041758333,0.00018428863,0.00002711794,0.00030477653,0.00012557635,0.000023916977],"category_scores_gemma":[0.08422175,0.00025713435,0.000058398127,0.0017871785,0.000189792,0.00020696624,0.00041493005,0.0006587175,0.00024074085],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042851202,0.00032317216,0.03457297,0.000011221705,0.000004112262,0.000516384,0.0019959414,0.0015528663,0.9519063,0.0003282329,0.0036242506,0.004736014],"study_design_scores_gemma":[0.012879886,0.01606041,0.20950684,0.00007320846,0.000019419602,0.00023325226,0.00031906954,0.011933924,0.56153965,0.008668609,0.17727703,0.0014886986],"about_ca_topic_score_codex":0.00011150971,"about_ca_topic_score_gemma":0.0013429316,"teacher_disagreement_score":0.39036667,"about_ca_system_score_codex":0.00031265325,"about_ca_system_score_gemma":0.00021270654,"threshold_uncertainty_score":0.9999881},"labels":[],"label_agreement":null},{"id":"W3009065698","doi":"10.1093/neuonc/noaa046","title":"Advancing biology-based therapeutic approaches for atypical teratoid rhabdoid tumors","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; University of Calgary; Alberta Children's Hospital; University of Toronto; SickKids Foundation; Hospital for Sick Children","funders":"Canadian Cancer Society Research Institute","keywords":"Atypical teratoid rhabdoid tumor; SMARCB1; Epigenomics; Transcriptome; Epigenetics; Carcinogenesis; Biology; DNA methylation; Cancer; Bioinformatics; Cancer research; Medicine; Genetics; Gene; Gene expression","score_opus":0.03959391944520126,"score_gpt":0.2977486473901111,"score_spread":0.25815472794490985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009065698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86150336,0.0014527295,0.12235094,0.011879998,0.0005476196,0.0008935146,0.00006732045,0.00012530306,0.0011792338],"genre_scores_gemma":[0.9803174,0.00003646292,0.0050862087,0.013615799,0.00063127844,0.00013033069,0.00012995448,0.000042518197,0.000010043146],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99861974,0.00013197376,0.00026893907,0.0005507138,0.000060736238,0.00036790673],"domain_scores_gemma":[0.99936163,0.00009903972,0.00010528883,0.00023356569,0.000051965068,0.00014852057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013672035,0.00019802192,0.0002838009,0.000024991035,0.00009722149,0.000012473361,0.00022585285,0.00025741552,0.000019686027],"category_scores_gemma":[0.00019616558,0.0001804287,0.00015938011,0.00007732186,0.000115131894,0.000002618997,0.000067635534,0.00017287694,0.000010092025],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000615408,0.00007034576,0.0005264161,0.000040055398,0.000026832802,0.000003514611,0.00005805623,0.0013769186,0.96507156,0.00016050329,0.0017021636,0.030348226],"study_design_scores_gemma":[0.002243602,0.0035817996,0.0000975676,0.0000090075855,0.000042828306,0.00002771083,0.00010421402,0.03326537,0.45335907,0.0002726116,0.5066548,0.00034141066],"about_ca_topic_score_codex":0.0000019357253,"about_ca_topic_score_gemma":0.000005154037,"teacher_disagreement_score":0.5117125,"about_ca_system_score_codex":0.000034601195,"about_ca_system_score_gemma":0.00033556018,"threshold_uncertainty_score":0.7357669},"labels":[],"label_agreement":null},{"id":"W3010939994","doi":"10.1093/neuonc/noaa045","title":"AI-based prognostic imaging biomarkers for precision neuro-oncology: the ReSPOND consortium","year":2020,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Institute of Neurological Disorders and Stroke; National Institutes of Health; National Cancer Institute; Abramson Cancer Center; Penn Center for Precision Medicine, University of Pennsylvania; Wellcome Trust","keywords":"Precision oncology; Medicine; Medical physics; Precision medicine; Neuroimaging; Oncology; Internal medicine; Pathology","score_opus":0.030748780861377518,"score_gpt":0.3208276696118267,"score_spread":0.2900788887504492,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010939994","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0036447728,0.00084435067,0.00019896771,0.98287016,0.0034727945,0.006990382,0.0003013234,0.00028526955,0.0013919899],"genre_scores_gemma":[0.021637594,0.00008083698,0.0008066674,0.9699326,0.0033438383,0.0029384845,0.00093194237,0.0002774856,0.0000505169],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99400234,0.0013287376,0.0011329739,0.0016822858,0.0006733683,0.0011802624],"domain_scores_gemma":[0.9796535,0.017657485,0.0007923077,0.0011370719,0.00041991676,0.0003397432],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00053140346,0.000908019,0.0017335607,0.0005489,0.00038844586,0.0000977728,0.00062358397,0.001087723,0.00021858005],"category_scores_gemma":[0.004499381,0.0006373388,0.00079456234,0.0005617851,0.00067783927,0.00007555773,0.00024676792,0.0026904412,0.00017389448],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021712554,0.0005531389,0.0030402308,0.00025078404,0.000358755,0.018834159,0.00009957629,0.000006692516,0.03514781,0.0000087116,0.9085071,0.031021751],"study_design_scores_gemma":[0.008018434,0.0059607825,0.0005319848,0.00014893348,0.002350907,0.00091074675,0.00004042393,0.0013435354,0.006136828,0.00013980696,0.9739731,0.000444535],"about_ca_topic_score_codex":0.000020560967,"about_ca_topic_score_gemma":0.000014169064,"teacher_disagreement_score":0.06546594,"about_ca_system_score_codex":0.0007652419,"about_ca_system_score_gemma":0.002374138,"threshold_uncertainty_score":0.99961036},"labels":[],"label_agreement":null},{"id":"W3012355718","doi":"10.1093/neuonc/noaa059","title":"MGMT promoter methylation level in newly diagnosed low-grade glioma is a predictor of hypermutation at recurrence","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute; University of California, San Francisco; National Institutes of Health; National Institute of General Medical Sciences; University of Oklahoma","keywords":"Somatic hypermutation; Methyltransferase; Biology; Temozolomide; Methylation; Cancer research; Glioma; O-6-methylguanine-DNA methyltransferase; DNA methylation; Bisulfite sequencing; Oncology; Medicine; Genetics; Gene; Gene expression","score_opus":0.0566727774134514,"score_gpt":0.3176718136678781,"score_spread":0.2609990362544267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3012355718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98332995,0.00020825582,0.000044436703,0.0148990145,0.00020642164,0.0009537436,0.000059774888,0.000038032835,0.00026036848],"genre_scores_gemma":[0.99709624,0.000077703124,0.00053587835,0.0019228194,0.00011130287,0.00016142544,0.00006718521,0.000023134597,0.0000043374184],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984546,0.00017315532,0.00046304398,0.00041977892,0.00025557022,0.00023386182],"domain_scores_gemma":[0.99886364,0.00045103068,0.00021405632,0.00019281567,0.00010348156,0.00017498546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010422001,0.00017502664,0.00047375733,0.00017005471,0.000030229854,0.0000061844676,0.00008095909,0.00017362785,0.00014237655],"category_scores_gemma":[0.0005953247,0.0001538714,0.00009898838,0.00046532715,0.00006959725,0.000090205125,0.00006296964,0.00017701452,0.000051576902],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004814726,0.0012301172,0.11610707,0.00013342073,0.00005244653,0.0010148783,0.003754119,0.000031235824,0.8523317,0.000039745297,0.0024045464,0.022419227],"study_design_scores_gemma":[0.013246893,0.0047586653,0.3160374,0.00011879048,0.00021973609,0.000112903705,0.00011325069,0.0030676022,0.65306723,0.00012522857,0.008943897,0.00018839439],"about_ca_topic_score_codex":0.00005912988,"about_ca_topic_score_gemma":0.00006909913,"teacher_disagreement_score":0.19993031,"about_ca_system_score_codex":0.00023042661,"about_ca_system_score_gemma":0.00016752571,"threshold_uncertainty_score":0.62746936},"labels":[],"label_agreement":null},{"id":"W3014007830","doi":"10.1093/neuonc/noaa079","title":"Neuro-oncology in adolescents and young adults—an unmet need","year":2020,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Oncology; Psychology; Internal medicine","score_opus":0.020852614834897733,"score_gpt":0.28715578511135176,"score_spread":0.266303170276454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014007830","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23918077,0.0006517755,0.0000025726831,0.7516768,0.0035895505,0.0022984555,0.00009229354,0.00020649379,0.002301297],"genre_scores_gemma":[0.26402903,0.00073115324,0.00014584465,0.73058814,0.0034186742,0.00037015503,0.00048437226,0.00020330086,0.000029328876],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948608,0.0009511386,0.0010133816,0.001649067,0.00048551586,0.001040046],"domain_scores_gemma":[0.99752754,0.0005653574,0.0004947889,0.0007636095,0.00013494203,0.00051374116],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00015623069,0.00083535037,0.0020949703,0.00065991085,0.00010247456,0.000035601333,0.00036124574,0.001810248,0.00015254054],"category_scores_gemma":[0.00052159955,0.0007749358,0.00026037556,0.00048448468,0.0002924969,0.00010924391,0.00032591983,0.0037822567,0.00016707786],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012894936,0.0019271065,0.09944109,0.00062266656,0.00017124729,0.08234381,0.00083555107,0.0000017607638,0.02016262,0.0000122983465,0.77362126,0.019571116],"study_design_scores_gemma":[0.012802077,0.009326312,0.01448266,0.00029462564,0.00064502464,0.0020160163,0.00015009347,0.00017109938,0.0007323069,0.00004747195,0.9587887,0.00054361764],"about_ca_topic_score_codex":0.00034801138,"about_ca_topic_score_gemma":0.00043725246,"teacher_disagreement_score":0.18516745,"about_ca_system_score_codex":0.0007110565,"about_ca_system_score_gemma":0.00060095114,"threshold_uncertainty_score":0.9994856},"labels":[],"label_agreement":null},{"id":"W3015188401","doi":"10.1093/neuonc/noaa077","title":"Clinical impact of combined epigenetic and molecular analysis of pediatric low-grade gliomas","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; SickKids Foundation; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Methylation; Epigenetics; DNA methylation; Glioma; Pathological; Oncology; Pathology; Univariate analysis; Multivariate analysis; Medicine; Biology; Internal medicine; Cancer research; Gene; Genetics; Gene expression","score_opus":0.03388530004287449,"score_gpt":0.3629684025690152,"score_spread":0.3290831025261407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015188401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966926,0.000997906,0.000021401389,0.0017730088,0.000059940154,0.00029555341,0.000024111316,0.000015332233,0.00012016465],"genre_scores_gemma":[0.9984626,0.00064466597,0.00018079778,0.0006007061,0.00006347626,0.000011030166,0.000021026877,0.000015302507,3.706967e-7],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99849606,0.00021180684,0.0006155479,0.000322981,0.00017077426,0.00018282639],"domain_scores_gemma":[0.9984684,0.0006008864,0.00028185805,0.00025296464,0.00009108947,0.00030480395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012577174,0.00014731141,0.0010639186,0.00030863812,0.000014229927,0.000002693566,0.000077063625,0.0001483489,0.000085745865],"category_scores_gemma":[0.00038508655,0.00011590353,0.0005238887,0.001101347,0.00011788731,0.000013187673,0.000068081674,0.00014003212,0.000004379919],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033245765,0.0014055371,0.835916,0.000049436083,0.0016625663,0.00062326854,0.000113223185,0.00012602932,0.15706883,0.000029762532,0.00029466205,0.0023782605],"study_design_scores_gemma":[0.0066364566,0.014419871,0.93934757,0.000005208005,0.010078984,0.000016075359,0.0000217806,0.0020561786,0.027080799,0.000023565257,0.00020863704,0.00010486398],"about_ca_topic_score_codex":0.000040022733,"about_ca_topic_score_gemma":0.0000054807215,"teacher_disagreement_score":0.12998804,"about_ca_system_score_codex":0.00003433887,"about_ca_system_score_gemma":0.00017190709,"threshold_uncertainty_score":0.47264087},"labels":[],"label_agreement":null},{"id":"W3016851479","doi":"10.1093/neuonc/noaa102","title":"Excellent outcome of young children with nodular desmoplastic medulloblastoma treated on “Head Start” III: a multi-institutional, prospective clinical trial","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital","funders":"National Cancer Institute; National Institutes of Health; Alex's Lemonade Stand Foundation for Childhood Cancer","keywords":"Medulloblastoma; Medicine; Internal medicine; ThioTEPA; Regimen; Carboplatin; Induction chemotherapy; Prospective cohort study; Chemotherapy; Oncology; Clinical trial; Surgery; Pathology","score_opus":0.0810362073673501,"score_gpt":0.36345624048938907,"score_spread":0.282420033122039,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016851479","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942873,0.00005379626,0.0001194814,0.002080729,0.00040554637,0.0026046245,0.000051372175,0.000094507755,0.00030260737],"genre_scores_gemma":[0.99745244,0.00003568129,0.0005252837,0.0013541073,0.00030723662,0.0002311506,0.000049196897,0.000036586585,0.000008346619],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975119,0.00022240118,0.00082887436,0.0007100231,0.00039271664,0.0003340803],"domain_scores_gemma":[0.99833107,0.0005192667,0.00030487322,0.00030790165,0.00015471717,0.00038219895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001471745,0.0003395125,0.0011301097,0.00011747227,0.00009888956,0.000008642203,0.00011844384,0.00022479777,0.00009775881],"category_scores_gemma":[0.0005526966,0.00022576175,0.0002693209,0.0002715095,0.00033969275,0.00004171688,0.00006171453,0.00043449263,0.000077242206],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05657624,0.0074664564,0.92796713,0.000020508149,0.00065009494,0.0012018961,0.0002276081,0.00012908748,0.0041997298,0.00014222534,0.0004189331,0.0010000993],"study_design_scores_gemma":[0.21935757,0.05757035,0.7102615,0.00005899091,0.0009753133,0.00015202053,0.00004854916,0.0005632577,0.009082362,0.0000034166228,0.0017060112,0.00022061857],"about_ca_topic_score_codex":0.000110690096,"about_ca_topic_score_gemma":0.00020498522,"teacher_disagreement_score":0.21770558,"about_ca_system_score_codex":0.00024928828,"about_ca_system_score_gemma":0.00034380937,"threshold_uncertainty_score":0.9206297},"labels":[],"label_agreement":null},{"id":"W3016855810","doi":"10.1093/neuonc/noaa093","title":"In vitro modeling of glioblastoma initiation using PDGF-AA and p53-null neural progenitors","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; Hospital for Sick Children; University of British Columbia; Hotchkiss Brain Institute; University of Calgary","funders":"Alberta Innovates; Alberta Cancer Foundation; Genome Canada","keywords":"Glioblastoma; Platelet-derived growth factor receptor; Neural stem cell; In vitro; Null (SQL); Progenitor cell; Progenitor; Cancer research; Biology; Neuroscience; Cell biology; Computer science; Data mining; Stem cell; Growth factor; Genetics; Receptor","score_opus":0.045737084991053854,"score_gpt":0.31404902323501815,"score_spread":0.2683119382439643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016855810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952597,0.00020890213,0.000034709556,0.00381678,0.00015183166,0.00038595832,0.000005730679,0.000022662414,0.00011370602],"genre_scores_gemma":[0.99752206,0.000028031216,0.00051947864,0.0017314301,0.00015176374,0.000022870596,0.0000052136534,0.000018977335,1.9011632e-7],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9990492,0.00008757516,0.00030618702,0.0002507296,0.00012188738,0.0001844456],"domain_scores_gemma":[0.99951327,0.000112934584,0.00009996557,0.00008996464,0.000058161542,0.00012571337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000055833414,0.00012176863,0.00036109463,0.00013042969,0.000027303502,0.0000057128736,0.000036468286,0.00010087155,0.0000134779775],"category_scores_gemma":[0.00013936668,0.00011190142,0.000051642175,0.00021622574,0.000040511346,0.00008198301,0.00005106658,0.0001542128,0.000003034382],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084699685,0.0003136816,0.011083976,0.000058971753,0.000024500838,0.0006152031,0.0007434966,0.0017107136,0.9799392,0.000016598853,0.000039703646,0.0046069575],"study_design_scores_gemma":[0.005566308,0.002827139,0.0010715064,0.000027191152,0.00018638902,0.0003033902,0.0002575117,0.55224425,0.4367695,0.000038079026,0.0005826509,0.00012609163],"about_ca_topic_score_codex":0.000038910148,"about_ca_topic_score_gemma":0.000010098612,"teacher_disagreement_score":0.55053353,"about_ca_system_score_codex":0.00008358139,"about_ca_system_score_gemma":0.00009461613,"threshold_uncertainty_score":0.45632076},"labels":[],"label_agreement":null},{"id":"W3019927786","doi":"10.1093/neuonc/nou206.58","title":"EPIGENOME ALTERATIONS DEFINE LETHAL CIMP POSITIVE EPENDYMOMAS OF INFANCY","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Epigenetics; Biology; Epigenome; Atypical teratoid rhabdoid tumor; DNA methylation; CpG site; Genetics; Cancer research; Exome sequencing; Mutation; Medulloblastoma; Gene; Gene expression","score_opus":0.012154956617595492,"score_gpt":0.28100684654907465,"score_spread":0.2688518899314792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3019927786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96356374,0.0005346262,0.010109907,0.00056740094,0.00035448725,0.00020228374,0.000034018944,0.000010865667,0.024622692],"genre_scores_gemma":[0.9970745,0.00016985237,0.0017127955,0.00042352505,0.0003220663,0.000020946594,0.00017741235,0.000023031436,0.00007587264],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987545,0.00026240203,0.00033038293,0.00032240065,0.000103963626,0.00022636662],"domain_scores_gemma":[0.9991309,0.00012419545,0.00018012468,0.0003214924,0.00015480063,0.00008848341],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002510248,0.00014197319,0.00022799242,0.00006838148,0.00007736598,0.000008936547,0.00015061746,0.00021706478,0.00003914422],"category_scores_gemma":[0.00030620414,0.00014523168,0.00009145114,0.00009088013,0.00010073888,0.0000039403008,0.000103746956,0.000121266596,0.000019034576],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005299691,0.00009695472,0.0035742822,0.000007268082,0.00002127699,0.0000050801495,0.000100896774,0.00017947622,0.9856957,0.001688893,0.00012464495,0.008452483],"study_design_scores_gemma":[0.00071478874,0.0020084295,0.011745717,0.0000039266383,0.000028577437,0.000014600703,0.0000148929985,0.0001251923,0.840322,0.00068876473,0.14416973,0.00016336692],"about_ca_topic_score_codex":0.000031103395,"about_ca_topic_score_gemma":0.00008237631,"teacher_disagreement_score":0.14537373,"about_ca_system_score_codex":0.000011750042,"about_ca_system_score_gemma":0.000121206685,"threshold_uncertainty_score":0.5922376},"labels":[],"label_agreement":null},{"id":"W3020099303","doi":"10.1093/neuonc/noaa106","title":"Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions","year":2020,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1137,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Center for Advancing Translational Sciences; National Institute of Neurological Disorders and Stroke; National Cancer Institute","keywords":"Glioblastoma; Medicine; Oncology; Current (fluid); Internal medicine; Clinical Oncology; Cancer research; Cancer; Engineering","score_opus":0.034191579583664235,"score_gpt":0.34282959343282104,"score_spread":0.3086380138491568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3020099303","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00034978555,0.9690173,0.0000051866027,0.018080834,0.0019582594,0.008700471,0.00040708226,0.00014664272,0.0013344034],"genre_scores_gemma":[0.000048619044,0.9866784,0.0009910145,0.009081207,0.0010210548,0.001749316,0.00019664555,0.00022408096,0.000009618403],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.992488,0.0017781798,0.002233408,0.002140554,0.00040749187,0.00095236686],"domain_scores_gemma":[0.99274164,0.0040094946,0.0015680864,0.0008299791,0.0002463868,0.00060438586],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0008181101,0.0012944803,0.005759718,0.00037475044,0.0002332295,0.000025380845,0.00035780817,0.0007819682,0.00004553648],"category_scores_gemma":[0.0004218772,0.0010726649,0.0019576945,0.0010355732,0.0006073045,0.000049229027,0.000618657,0.0018458901,0.00002945825],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042726117,0.00197291,0.000044543674,0.05170051,0.0006879887,0.0013256898,0.00043721354,3.5763725e-7,0.00008271734,0.00017935845,0.08328978,0.85985166],"study_design_scores_gemma":[0.007983789,0.011361701,0.00008367259,0.012610343,0.0058570453,0.0019423356,0.00023647194,0.00004323691,0.000012371513,0.00001344718,0.95929885,0.00055670814],"about_ca_topic_score_codex":0.000009790974,"about_ca_topic_score_gemma":0.000045568646,"teacher_disagreement_score":0.8760091,"about_ca_system_score_codex":0.0009860382,"about_ca_system_score_gemma":0.00085317856,"threshold_uncertainty_score":0.9999807},"labels":[],"label_agreement":null},{"id":"W3021575924","doi":"10.1093/neuonc/noaa113","title":"Neuro-oncology management during the COVID-19 pandemic with a focus on WHO grades III and IV gliomas","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Pandemic; Medicine; Coronavirus disease 2019 (COVID-19); Radiation oncology; Intensive care medicine; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Disease; Medical physicist; Radiation therapy; Internal medicine; Medical physics; Infectious disease (medical specialty)","score_opus":0.07763169866407814,"score_gpt":0.37186556768401996,"score_spread":0.2942338690199418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3021575924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.69071656,0.0002694282,0.00011162891,0.303796,0.00024232066,0.0015561223,0.0000098297105,0.00025238248,0.0030457322],"genre_scores_gemma":[0.82217073,0.0009412575,0.000067995556,0.1761219,0.00045655054,0.00011728288,0.0000042994848,0.000055071312,0.00006492847],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969636,0.00053081324,0.0004917363,0.00084745453,0.00039856104,0.0007678381],"domain_scores_gemma":[0.99605274,0.0019981486,0.00024859124,0.00049878604,0.00006354529,0.001138196],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00038021448,0.0003788395,0.00082412036,0.00024974,0.00038684774,0.000032431057,0.0002641963,0.00027486694,0.000088233006],"category_scores_gemma":[0.00087133225,0.00025688417,0.00009712272,0.0005481477,0.0003767879,0.0000719234,0.00027257076,0.0010143928,0.000039572133],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.055508975,0.0016806481,0.30594224,0.0053227292,0.0009994772,0.06595801,0.032953873,0.00039971797,0.3057807,0.0078534875,0.063349925,0.15425022],"study_design_scores_gemma":[0.016709683,0.018819503,0.05008605,0.000064873544,0.00042111153,0.005222793,0.0011961451,0.00027745127,0.0010777286,0.0003759881,0.9053538,0.00039489585],"about_ca_topic_score_codex":0.00023727978,"about_ca_topic_score_gemma":0.00056561,"teacher_disagreement_score":0.8420038,"about_ca_system_score_codex":0.00076041627,"about_ca_system_score_gemma":0.0009713405,"threshold_uncertainty_score":0.9999883},"labels":[],"label_agreement":null},{"id":"W3027128667","doi":"10.1093/neuonc/noaa122","title":"Bridging the treatment gap in infant medulloblastoma: molecularly informed outcomes of a globally feasible regimen","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; SickKids Foundation; Hospital for Sick Children","funders":"Garron Family Cancer Centre; C.R. Younger Foundation; Canadian Institutes of Health Research; Government of Ontario; Princess Margaret Cancer Foundation","keywords":"Medulloblastoma; Medicine; Neurocognitive; Regimen; Cohort; Hazard ratio; Oncology; Pediatrics; Sonic hedgehog; Internal medicine; Retrospective cohort study; Pathology; Psychiatry; Confidence interval","score_opus":0.03309177039895234,"score_gpt":0.3156633087290038,"score_spread":0.28257153833005144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027128667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9469207,0.00033931868,0.000013816787,0.04727243,0.00012392543,0.0010297833,0.000011875263,0.00004581589,0.0042423345],"genre_scores_gemma":[0.99154514,0.00024942518,0.00026560653,0.0076609775,0.0000552661,0.00018046024,0.000011467861,0.000021364807,0.000010298339],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984696,0.000116230396,0.0004692027,0.00030800694,0.00028841334,0.0003485848],"domain_scores_gemma":[0.9988442,0.00036609895,0.0001943686,0.00033626266,0.000062707106,0.00019635545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009608458,0.00023384413,0.00070603035,0.00011062033,0.000042796662,0.000014117216,0.00016305897,0.000109101515,0.00004142117],"category_scores_gemma":[0.0003268722,0.00014402636,0.00020083932,0.000379843,0.00010091439,0.000053658856,0.00007933002,0.00015333568,0.000033230215],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017029081,0.0042465697,0.78561324,0.00011365564,0.0009377972,0.004733593,0.0071185688,0.00028733638,0.12979212,0.0011828841,0.0054872264,0.058784124],"study_design_scores_gemma":[0.044517126,0.029535592,0.5600175,0.00014942203,0.0012515507,0.00056850485,0.0013384293,0.0023644755,0.13113245,0.00011117103,0.228467,0.0005467136],"about_ca_topic_score_codex":0.00027346783,"about_ca_topic_score_gemma":0.00036111678,"teacher_disagreement_score":0.22559567,"about_ca_system_score_codex":0.00041533192,"about_ca_system_score_gemma":0.00049765117,"threshold_uncertainty_score":0.5873225},"labels":[],"label_agreement":null},{"id":"W3030232989","doi":"10.1093/neuonc/noaa129","title":"SNO 25th anniversary history series: Investing in the membership of the Society for Neuro-Oncology","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Series (stratigraphy); Oncology; Medicine; Internal medicine; Biology","score_opus":0.0753301635316908,"score_gpt":0.2959662792448666,"score_spread":0.22063611571317582,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3030232989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82445645,0.0010261806,0.000008567922,0.15989807,0.0011078404,0.0021046475,0.000025997895,0.00006797199,0.011304273],"genre_scores_gemma":[0.92893285,0.000117313066,0.0006271308,0.06971712,0.00033085785,0.00020422797,0.000012489472,0.000037072812,0.000020965366],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99821407,0.00040221727,0.00040951787,0.00040557646,0.00021169352,0.00035692976],"domain_scores_gemma":[0.9974107,0.0017234898,0.00029002197,0.00035510774,0.000090624984,0.00013002682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035205076,0.0002074102,0.0005492432,0.00004703003,0.000097511715,0.0000044875637,0.00032117404,0.00022063266,0.00007849221],"category_scores_gemma":[0.0010324293,0.00013255342,0.00046260128,0.0002980248,0.00038876067,0.00007055346,0.00013242943,0.0004758798,0.000006736209],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013752494,0.0019023869,0.054621473,0.00048741561,0.00036136442,0.0010191182,0.0505321,0.00015206536,0.43705428,0.0037975311,0.4416812,0.0070158127],"study_design_scores_gemma":[0.0057760742,0.0050298097,0.0068082055,0.000030730316,0.00049133966,0.00027000628,0.0045866626,0.0007530876,0.0076653506,0.00014409386,0.9682947,0.0001499609],"about_ca_topic_score_codex":0.00006172661,"about_ca_topic_score_gemma":0.00009865381,"teacher_disagreement_score":0.5266135,"about_ca_system_score_codex":0.0005529411,"about_ca_system_score_gemma":0.0007955207,"threshold_uncertainty_score":0.5405372},"labels":[],"label_agreement":null},{"id":"W3033204265","doi":"10.1093/neuonc/noaa130","title":"European genetic ancestry associated with risk of childhood ependymoma","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"National Cancer Institute; Centers for Disease Control and Prevention; University of Southern California; Cancer Registry of Greater California; National Institutes of Health; National Center for Chronic Disease Prevention and Health Promotion; Novocure; Pediatric Brain Tumor Foundation; California Department of Public Health; Musella Foundation For Brain Tumor Research and Information; Cancer Prevention and Research Institute of Texas; Sontag Foundation; American Brain Tumor Association; Alex's Lemonade Stand Foundation for Childhood Cancer","keywords":"Ependymoma; Incidence (geometry); Demography; Population; Odds ratio; Genetic genealogy; Ethnic group; Medicine; Odds; Pathology; Logistic regression; Internal medicine","score_opus":0.02370578433672586,"score_gpt":0.26475672654973204,"score_spread":0.2410509422130062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033204265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98842436,0.00026017716,0.000009686827,0.002932288,0.00007886521,0.00031924693,0.000030716965,0.00006442658,0.007880239],"genre_scores_gemma":[0.9971868,0.0001119254,0.00031684345,0.0021832436,0.00012771325,0.000013911738,0.000020596868,0.000035656056,0.000003357962],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876577,0.0002883368,0.00025429428,0.000304947,0.0001723774,0.00021425914],"domain_scores_gemma":[0.99904746,0.00022804027,0.0002497537,0.00019883749,0.000069052054,0.00020685994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007599319,0.00015011714,0.00041895578,0.000042177246,0.000042160846,0.0000047489534,0.00009212071,0.00007093738,0.000102088576],"category_scores_gemma":[0.00037621235,0.00011172629,0.0000821181,0.00022034433,0.00008174733,0.00001963614,0.000048416536,0.0002345376,0.00006145824],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035327012,0.0030834659,0.877099,0.00003631891,0.00070312765,0.01092241,0.0011940047,0.00014653472,0.05512344,0.000029681121,0.00392532,0.047383435],"study_design_scores_gemma":[0.0061336253,0.007457385,0.96316004,0.00003532497,0.0005824309,0.0002489924,0.00006457577,0.00007855585,0.014734383,0.000009305496,0.0073911888,0.000104221435],"about_ca_topic_score_codex":0.000012301717,"about_ca_topic_score_gemma":0.000015064575,"teacher_disagreement_score":0.086061016,"about_ca_system_score_codex":0.000047366284,"about_ca_system_score_gemma":0.0001293511,"threshold_uncertainty_score":0.45560658},"labels":[],"label_agreement":null},{"id":"W3043701315","doi":"10.1093/neuonc/noaa168","title":"CODEL: phase III study of RT, RT + TMZ, or TMZ for newly diagnosed 1p/19q codeleted oligodendroglioma. Analysis from the initial study design","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Cancer Institute; ECOG-ACRIN Cancer Research Group; National Institutes of Health; American College of Radiology Imaging Network; Alliance for Clinical Trials in Oncology Foundation","keywords":"Oligodendroglioma; Medicine; Oncology; Phases of clinical research; Internal medicine; Nuclear medicine; Glioma; Cancer research; Chemotherapy; Astrocytoma","score_opus":0.10551957367800514,"score_gpt":0.3849784594191705,"score_spread":0.2794588857411654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043701315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98614925,0.00015867481,0.002126266,0.0033772916,0.0002978569,0.0073982175,0.0002993689,0.0001240147,0.00006906631],"genre_scores_gemma":[0.99353796,0.000048379734,0.0005012117,0.0035680996,0.00041736139,0.0016926641,0.00015409691,0.000074898235,0.0000053157955],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9957713,0.0010249945,0.0011244034,0.0009790149,0.0005747715,0.0005255245],"domain_scores_gemma":[0.99248,0.0054851365,0.00049995526,0.0008186844,0.0003243344,0.0003919326],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040331818,0.00047800326,0.001890144,0.00029938194,0.00022868994,0.000037532667,0.00045128315,0.00019929424,0.00033959706],"category_scores_gemma":[0.0009866339,0.00031369462,0.00041158515,0.0015890796,0.00013650175,0.000080214544,0.00018641826,0.00034071135,0.000019604346],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.098281465,0.2317836,0.2224895,0.00011694318,0.04773564,0.039747417,0.07777256,0.008016547,0.15023193,0.00006022982,0.062168606,0.061595567],"study_design_scores_gemma":[0.46921384,0.26578283,0.038455594,0.000054894314,0.07500599,0.00012019222,0.039816007,0.05219236,0.044613253,0.000054859185,0.013456879,0.001233314],"about_ca_topic_score_codex":0.00096687145,"about_ca_topic_score_gemma":0.0019432699,"teacher_disagreement_score":0.37093237,"about_ca_system_score_codex":0.00014434925,"about_ca_system_score_gemma":0.0004111606,"threshold_uncertainty_score":0.9999315},"labels":[],"label_agreement":null},{"id":"W3048948367","doi":"10.1093/neuonc/noaa192","title":"Executive summary from American Radium Society’s appropriate use criteria on neurocognition after stereotactic radiosurgery for multiple brain metastases","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"National Center for Advancing Translational Sciences","keywords":"Radiosurgery; Medicine; Neurocognitive; Appropriate Use Criteria; Asymptomatic; Stereotactic biopsy; Whole brain radiotherapy; Appropriateness criteria; Radiation therapy; Medical physics; Oncology; Brain metastasis; Internal medicine; Radiology; Cancer; Cognition; Biopsy; Metastasis; Psychiatry","score_opus":0.05265641195152338,"score_gpt":0.31557431487638454,"score_spread":0.26291790292486117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048948367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9591846,0.0002755542,0.0014885063,0.032974094,0.00080703665,0.0024920895,0.002468449,0.00020879813,0.000100870275],"genre_scores_gemma":[0.8884988,0.00015097362,0.009192864,0.099399574,0.0007908513,0.00074275833,0.0010566404,0.00012063503,0.000046950263],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99715626,0.0006791739,0.00049122085,0.0008975889,0.0002538428,0.0005219167],"domain_scores_gemma":[0.9940923,0.004755621,0.00024562242,0.00036149213,0.000114560484,0.00043041026],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019807581,0.00041734206,0.0009846672,0.000084731175,0.00011010292,0.00005523941,0.00009931665,0.00012185721,0.00012523858],"category_scores_gemma":[0.0012453634,0.00036057495,0.00055102137,0.00023869773,0.0002272375,0.0001821596,0.00008036261,0.00038118128,0.000042492476],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05576785,0.0052267145,0.012863265,0.00040933673,0.0028489132,0.007235903,0.004716874,0.000034972298,0.36351764,0.000060821978,0.34200233,0.20531538],"study_design_scores_gemma":[0.02169553,0.0207849,0.018391352,0.00012301914,0.0026403524,0.00024465937,0.0011084054,0.0047047595,0.032912027,0.00014474364,0.8963839,0.0008663741],"about_ca_topic_score_codex":0.00015603243,"about_ca_topic_score_gemma":0.00002007947,"teacher_disagreement_score":0.55438155,"about_ca_system_score_codex":0.00016691072,"about_ca_system_score_gemma":0.00019192438,"threshold_uncertainty_score":0.9998846},"labels":[],"label_agreement":null},{"id":"W3094720086","doi":"10.1093/neuonc/noaa251","title":"A subset of pediatric-type thalamic gliomas share a distinct DNA methylation profile, H3K27me3 loss and frequent alteration of <i>EGFR</i>","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":126,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Brain Tumour Charity; Cancer Research UK","keywords":"Missense mutation; Epidermal growth factor receptor; Biology; Cancer research; Glioma; DNA methylation; Methylation; Mutation; Pathology; Gene; Genetics; Medicine; Cancer; Gene expression","score_opus":0.032568848816974416,"score_gpt":0.29872848756955706,"score_spread":0.26615963875258264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094720086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99455994,0.0005711241,0.000027680253,0.0034203196,0.00015962636,0.0007386816,0.000100454665,0.000030156001,0.0003920319],"genre_scores_gemma":[0.99866015,0.00018128433,0.00026700486,0.00042450582,0.00019653325,0.00004919021,0.00019908154,0.000020198446,0.0000020666478],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99871373,0.00013612203,0.0004429348,0.0003303199,0.00020881816,0.0001680826],"domain_scores_gemma":[0.99890834,0.00028397734,0.00030119953,0.00017783881,0.00019205276,0.00013660779],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000103890816,0.0001616397,0.0004914442,0.00011472441,0.00003298063,0.0000062527315,0.0000601976,0.0001229256,0.00012223165],"category_scores_gemma":[0.00035060875,0.00013524493,0.00007735473,0.00037611427,0.00006457052,0.00006505945,0.000056086148,0.00012606668,0.000011698312],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057232124,0.000721768,0.24224065,0.00040643325,0.000091869944,0.00035555597,0.0009515948,0.000012906756,0.7474998,0.00027213665,0.0018399594,0.0050349752],"study_design_scores_gemma":[0.008352542,0.010377405,0.30868042,0.00005054959,0.0011393841,0.0001819817,0.00012645734,0.0014035912,0.66459256,0.00017203414,0.0046673333,0.00025575043],"about_ca_topic_score_codex":0.000031005224,"about_ca_topic_score_gemma":0.000020038146,"teacher_disagreement_score":0.08290728,"about_ca_system_score_codex":0.00006486892,"about_ca_system_score_gemma":0.00015534209,"threshold_uncertainty_score":0.55151284},"labels":[],"label_agreement":null},{"id":"W3095696354","doi":"10.1093/neuonc/noaa248","title":"Functional analysis of low-grade glioma genetic variants predicts key target genes and transcription factors","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University","funders":"National Institute of General Medical Sciences; National Cancer Institute; National Institutes of Health; National Institute of Neurological Disorders and Stroke; National Brain Tumor Society","keywords":"Genome-wide association study; Biology; Single-nucleotide polymorphism; Genetics; Computational biology; Linkage disequilibrium; Epigenomics; 1000 Genomes Project; Genetic association; Gene; DNA methylation; Gene expression; Genotype","score_opus":0.03183574458150139,"score_gpt":0.2637381451802909,"score_spread":0.23190240059878947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095696354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951847,0.00073782285,0.00030233056,0.0030444863,0.00022260936,0.0002857475,0.00008400575,0.000038139427,0.00010010933],"genre_scores_gemma":[0.9983825,0.0001874473,0.00038655242,0.00075782154,0.00011182146,0.00002709686,0.00012841121,0.000016411082,0.0000019569052],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99879056,0.00010373611,0.00032304748,0.00036842306,0.00022397406,0.00019028006],"domain_scores_gemma":[0.99926883,0.00016479603,0.0001146199,0.00014223419,0.00006103101,0.00024851857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004320571,0.00016469225,0.00055871566,0.00027044048,0.00004682392,0.000007148681,0.00004743308,0.0001380168,0.00033252238],"category_scores_gemma":[0.00007064259,0.00013574708,0.000176073,0.00060756045,0.00008311557,0.000041175077,0.000022323642,0.00010285028,0.0000058642063],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019290627,0.00054319383,0.25592104,0.000045653516,0.00097561366,0.00026690672,0.0005379926,0.00043246674,0.7391775,0.00003282443,0.00053232175,0.0013415683],"study_design_scores_gemma":[0.0030304021,0.0019544405,0.874549,0.0000075486723,0.0031386998,0.00004883463,0.000097040625,0.004190279,0.10966761,0.000019484949,0.0031999624,0.00009675441],"about_ca_topic_score_codex":0.00002828257,"about_ca_topic_score_gemma":0.000016576902,"teacher_disagreement_score":0.6295099,"about_ca_system_score_codex":0.000047477286,"about_ca_system_score_gemma":0.0000874206,"threshold_uncertainty_score":0.55356055},"labels":[],"label_agreement":null},{"id":"W3096194200","doi":"10.1093/neuonc/noaa217","title":"Intellectual changes after radiation for children with brain tumors: which brain structures are most important?","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; Princess Margaret Cancer Centre; Hospital for Sick Children; University Health Network","funders":"Princess Margaret Cancer Foundation","keywords":"Neurocognitive; Neuropsychology; Intelligence quotient; Temporal lobe; Medicine; Cognition; Nuclear medicine; Pediatrics; Psychology; Audiology; Psychiatry; Epilepsy","score_opus":0.01621154194445419,"score_gpt":0.27352011426073003,"score_spread":0.25730857231627585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096194200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86250764,0.00040618965,0.000058192007,0.13538937,0.00009132975,0.0012829127,0.00011388759,0.000077966666,0.00007249831],"genre_scores_gemma":[0.96470165,0.000047020814,0.00023835366,0.033801943,0.00055670424,0.0003839417,0.00021321051,0.000050523035,0.000006653073],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99868685,0.000100951125,0.00024728192,0.00047409246,0.0001670328,0.00032377426],"domain_scores_gemma":[0.99849313,0.0008026299,0.0001772736,0.00019157238,0.00010294296,0.00023245715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009235952,0.0002382039,0.0004742387,0.000107253225,0.000067387686,0.000021521144,0.00008312076,0.00014416309,0.0002107041],"category_scores_gemma":[0.0014474572,0.00017654114,0.00006095634,0.00031965857,0.000071008675,0.000042155447,0.00004043225,0.0001990203,0.0000124796825],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059334002,0.0009619457,0.5521827,0.00018427691,0.00084791577,0.0012097768,0.007375342,0.000052740783,0.08763817,0.00033018773,0.24978837,0.09349521],"study_design_scores_gemma":[0.019156747,0.024034716,0.6475092,0.000094831405,0.00071376975,0.0010929655,0.0007956089,0.0007341144,0.09311709,0.00015800352,0.21192878,0.00066414766],"about_ca_topic_score_codex":0.000016367632,"about_ca_topic_score_gemma":0.00038523268,"teacher_disagreement_score":0.102194,"about_ca_system_score_codex":0.0000966286,"about_ca_system_score_gemma":0.00019193726,"threshold_uncertainty_score":0.7199139},"labels":[],"label_agreement":null},{"id":"W3110384303","doi":"10.1093/neuonc/noaa267","title":"The genetic landscape of choroid plexus tumors in children and adults","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill Genome Centre","funders":"Deutsche Forschungsgemeinschaft; Canada Foundation for Innovation","keywords":"Choroid plexus; Medicine; Anatomy; Biology; Neuroscience; Central nervous system","score_opus":0.009779667837681867,"score_gpt":0.25099615971349176,"score_spread":0.2412164918758099,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110384303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99126077,0.0014338554,2.7922007e-7,0.0063850605,0.000040371015,0.00038536737,0.000006690166,0.000012268123,0.00047534987],"genre_scores_gemma":[0.99804455,0.00053072564,0.000048653576,0.0012500465,0.00007709363,0.00003096008,0.000006309059,0.000010489427,0.0000011546066],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99931085,0.00006070718,0.00019749448,0.0001948331,0.000084001054,0.00015210855],"domain_scores_gemma":[0.9994913,0.00019726544,0.00006474063,0.00012234121,0.000020347687,0.0001040272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000041612606,0.00008545296,0.00024761478,0.000035856767,0.000027329723,0.000004096222,0.00005865218,0.00005159348,0.000023238488],"category_scores_gemma":[0.00012579415,0.000055477245,0.000033554395,0.00011891139,0.00006582543,0.000009965491,0.00004857529,0.000115512776,0.000008779755],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029372086,0.0002184773,0.94378924,0.00001278582,0.000036231173,0.00021575383,0.00041798764,0.000009395777,0.014059107,0.000038917977,0.0013199893,0.039588407],"study_design_scores_gemma":[0.004299078,0.0020626325,0.9849932,0.000012941995,0.000046881392,0.00017963928,0.00007433784,0.00019052839,0.0050170613,0.000014989176,0.003065004,0.00004370818],"about_ca_topic_score_codex":0.00004586458,"about_ca_topic_score_gemma":0.00005766321,"teacher_disagreement_score":0.041203972,"about_ca_system_score_codex":0.000017036395,"about_ca_system_score_gemma":0.00005680114,"threshold_uncertainty_score":0.22622964},"labels":[],"label_agreement":null},{"id":"W3110657713","doi":"10.1093/neuonc/noaa222.260","title":"GCT-42. CLINICAL CHARACTERISTICS OF LOCALIZED CENTRAL NERVOUS SYSTEM NON-GERMINOMATOUS GERM CELL TUMORS (NGGCT) PATIENTS ENROLLED ON ACNS1123 WITH RELAPSE: A CHILDREN’S ONCOLOGY GROUP (COG) STUDY","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Germ cell tumors; Cog; Internal medicine; Radiation therapy; Oncology; Cohort; Chemotherapy; Gastroenterology; Surgery","score_opus":0.018251379089733247,"score_gpt":0.28532887929849005,"score_spread":0.2670775002087568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110657713","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99228185,0.00004499547,0.000016010737,0.0007405938,0.0009300521,0.0047505666,0.000099141515,0.00015671451,0.0009800611],"genre_scores_gemma":[0.9962111,0.000041014344,0.00016755932,0.0024203858,0.00046102543,0.0004060929,0.00016670341,0.00011866836,0.000007432426],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99417514,0.0012470235,0.0019468983,0.0011674218,0.0006216196,0.00084192],"domain_scores_gemma":[0.995603,0.0011714525,0.0013663118,0.0007183372,0.0002554606,0.00088544],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039794113,0.0006383893,0.0028319294,0.00019955267,0.0001329099,0.000020841466,0.00034320104,0.00048200984,0.000057537043],"category_scores_gemma":[0.0003681829,0.00047996987,0.00038832196,0.0003932267,0.0002537219,0.000055201737,0.00021022126,0.0008735504,0.00012341572],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010369441,0.02612913,0.9328177,0.00023087297,0.0006736137,0.0091344565,0.0014705674,0.000016486192,0.001628649,0.00002448903,0.0014534727,0.01605112],"study_design_scores_gemma":[0.04898993,0.09550632,0.8486338,0.00012015069,0.0017531554,0.0003001304,0.00047482067,0.00036893037,0.0010151691,7.2362025e-7,0.0024763902,0.00036043083],"about_ca_topic_score_codex":0.00008898887,"about_ca_topic_score_gemma":0.00002903603,"teacher_disagreement_score":0.08418385,"about_ca_system_score_codex":0.00050685415,"about_ca_system_score_gemma":0.0006737512,"threshold_uncertainty_score":0.9997652},"labels":[],"label_agreement":null},{"id":"W3110717943","doi":"10.1093/neuonc/noaa222.720","title":"RARE-09. PRESERVATION OF ENDOCRINE FUNCTION AFTER OMMAYA RESERVOIR INSERTION IN CHILDREN WITH CYSTIC CRANIOPHARYNGIOMA","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Endocrine system; Medicine; Craniopharyngioma; Surgery; Neurocognitive; Ommaya reservoir; Hormone; Internal medicine; Chemotherapy; Cognition","score_opus":0.016895088617275105,"score_gpt":0.2588533310370583,"score_spread":0.24195824241978323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110717943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942602,0.00027697269,0.00012420196,0.0036068314,0.000066860346,0.0007049489,0.00001456311,0.000043313954,0.00090211397],"genre_scores_gemma":[0.9977763,0.00006040467,0.00016339835,0.0016114096,0.00009310223,0.00009728231,0.00015825481,0.000020659923,0.000019149607],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989309,0.000108446126,0.00028643318,0.00029579227,0.00018021296,0.0001982207],"domain_scores_gemma":[0.99947536,0.00006965951,0.000098854514,0.00017972432,0.000064176325,0.000112196736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000047766553,0.00014474662,0.0003348266,0.00011700706,0.000024714309,0.000004079962,0.00006092138,0.000081036684,0.000112712594],"category_scores_gemma":[0.00011625055,0.00011286591,0.0000495059,0.00032760683,0.00004299776,0.00018532532,0.00004143964,0.00016899026,0.000021988455],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010818412,0.00060746865,0.9589462,0.00006148985,0.00008360648,0.000329119,0.00021068187,0.000090487745,0.025900919,0.000022906597,0.00035662297,0.002572048],"study_design_scores_gemma":[0.009990917,0.007183708,0.9784076,0.000027792303,0.00017778973,0.00014476376,0.000028988434,0.00040389286,0.0014148797,0.00012630007,0.002003327,0.00009002024],"about_ca_topic_score_codex":0.00018230613,"about_ca_topic_score_gemma":0.00013035708,"teacher_disagreement_score":0.024486039,"about_ca_system_score_codex":0.00005780945,"about_ca_system_score_gemma":0.00011262144,"threshold_uncertainty_score":0.46025383},"labels":[],"label_agreement":null},{"id":"W3110733681","doi":"10.1093/neuonc/noaa222.220","title":"ETMR-17. SINGLE-CELL TRANSCRIPTOME ANALYSIS OF ETMR PATIENT SAMPLES","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; McGill University; University of Toronto; Montreal Children's Hospital","funders":"","keywords":"Biology; Phenotype; Transcriptome; Genetic heterogeneity; Cell; Computational biology; Single-cell analysis; Brain tumor; Cell type; Population; Bioinformatics; Cancer research; Neuroscience; Genetics; Gene; Pathology; Gene expression; Medicine","score_opus":0.034501752884138565,"score_gpt":0.25017401069717216,"score_spread":0.2156722578130336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110733681","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98949444,0.00053593714,0.0039970907,0.0010820911,0.00035653825,0.00024797305,0.00016235322,0.00003648893,0.0040870802],"genre_scores_gemma":[0.9928575,0.00017810085,0.000953032,0.005502235,0.00017250911,0.000015341635,0.0002506032,0.000040717834,0.000029940124],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980062,0.000210804,0.00057278556,0.0006321649,0.00020367677,0.00037435864],"domain_scores_gemma":[0.9989802,0.00009062102,0.00021769082,0.0003511569,0.00012894279,0.00023136572],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00009698075,0.00027143897,0.00062227703,0.00013845484,0.000063902095,0.000015464328,0.00033983224,0.00034492888,0.00014503083],"category_scores_gemma":[0.00010741695,0.00027130506,0.00045292996,0.00053434575,0.0001713703,0.000005570412,0.00007213101,0.00022268792,0.00000877671],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005107835,0.0004987443,0.002560723,0.000034127337,0.00032193094,0.000020663989,0.0008017131,0.00071963354,0.9870629,0.00003022943,0.0020988125,0.0053397766],"study_design_scores_gemma":[0.0009588713,0.0036053653,0.00038487746,0.0000028788165,0.00059589214,0.0000056047897,0.00017132648,0.0005176209,0.71023846,0.0000071488025,0.2832628,0.00024920204],"about_ca_topic_score_codex":0.00005031709,"about_ca_topic_score_gemma":0.00010655355,"teacher_disagreement_score":0.28116396,"about_ca_system_score_codex":0.000034267214,"about_ca_system_score_gemma":0.0001387053,"threshold_uncertainty_score":0.9999739},"labels":[],"label_agreement":null},{"id":"W3110760136","doi":"10.1093/neuonc/noaa222.225","title":"ETMR-22. TITLE: DEFINING THE CLINICAL AND PROGNOSTIC LANDSCAPE OF EMBRYONAL TUMORS WITH MULTI-LAYERED ROSETTES (ETMRs), A RARE BRAIN TUMOR REGISTRY (RBTC) STUDY","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; Alberta Children's Hospital; Children's Hospital of Eastern Ontario; University of Toronto; SickKids Foundation; University of British Columbia; Hospital for Sick Children; Occupational Cancer Research Centre","funders":"","keywords":"Medicine; Disease; Internal medicine; Cohort; Oncology; Multivariate analysis; Cerebrum; Radiation therapy; Pediatrics; Pathology; Gastroenterology; Central nervous system","score_opus":0.04325438688759634,"score_gpt":0.3404604411401131,"score_spread":0.2972060542525167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110760136","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98517925,0.0005369293,0.000034488665,0.012041399,0.00010548728,0.0008973827,0.00004762098,0.000045581975,0.0011118747],"genre_scores_gemma":[0.9942578,0.000012196982,0.0012654945,0.0042064334,0.000120091434,0.000042496224,0.000020833397,0.000024172134,0.000050453924],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987374,0.0002967811,0.00031816054,0.0003169262,0.00015965686,0.00017110925],"domain_scores_gemma":[0.9983086,0.0011316392,0.00015875982,0.00020863726,0.00004934453,0.00014304016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002631524,0.00014218912,0.00044054232,0.000026582153,0.0000520967,0.000009718875,0.00008782322,0.000054615404,0.00013198132],"category_scores_gemma":[0.00092083664,0.00008375877,0.000060739003,0.00013096593,0.00018300173,0.000016484393,0.000075738295,0.0003368912,0.000030319485],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011721222,0.0015030598,0.9580848,0.00010652659,0.00030528675,0.0030073633,0.00077182014,0.000008682717,0.00067030784,0.00027283776,0.023811705,0.0102854865],"study_design_scores_gemma":[0.03603892,0.045419358,0.82371217,0.0002225442,0.0016863205,0.0031625547,0.006660136,0.0037083207,0.0005728854,0.00005396008,0.07822278,0.0005400702],"about_ca_topic_score_codex":0.000008696583,"about_ca_topic_score_gemma":0.000016292348,"teacher_disagreement_score":0.13437265,"about_ca_system_score_codex":0.000009915725,"about_ca_system_score_gemma":0.00027088952,"threshold_uncertainty_score":0.34155837},"labels":[],"label_agreement":null},{"id":"W3110770353","doi":"10.1093/neuonc/noaa222.374","title":"IMMU-18. FAVORABLE OUTCOME IN REPLICATION REPAIR DEFICIENT HYPERMUTANT BRAIN TUMORS TO IMMUNE CHECKPOINT INHIBITION: AN INTERNATIONAL RRD CONSORTIUM REGISTRY STUDY","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; CancerCare Manitoba; Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"Medicine; Immune system; Oncology; Internal medicine; Immunotherapy; Brain tumor; Immune checkpoint; Cancer research; Immunology; Pathology","score_opus":0.05623190931796352,"score_gpt":0.3499459876646465,"score_spread":0.293714078346683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110770353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9447495,0.000051653467,0.000017832197,0.051190123,0.00031380443,0.0015928552,0.000022799131,0.00017724968,0.0018841826],"genre_scores_gemma":[0.9905207,0.000011211877,0.0003608555,0.008357273,0.00015287325,0.00043639494,0.00009926423,0.000035143235,0.000026248814],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9971541,0.00023205369,0.0010039156,0.000937287,0.00034735436,0.00032525364],"domain_scores_gemma":[0.9982362,0.00018553044,0.0002701492,0.00084541977,0.0001484786,0.0003142315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053875975,0.00023785289,0.00060387165,0.00020640895,0.00007497739,0.000027024827,0.0001762892,0.00011485681,0.0002034708],"category_scores_gemma":[0.0014041653,0.00022092016,0.00014909371,0.00045744702,0.000062935556,0.00010968114,0.00017800521,0.0003450269,0.000110011526],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008222891,0.0053343894,0.428067,0.000030515124,0.00007124043,0.0037239688,0.0017719846,0.0002000488,0.5564278,0.00023721496,0.0012833487,0.0020302448],"study_design_scores_gemma":[0.013159877,0.014255595,0.8345625,0.00008684883,0.00018634555,0.0010024084,0.0046046083,0.0015803538,0.08129902,0.000043062108,0.048751846,0.0004675247],"about_ca_topic_score_codex":0.00016980676,"about_ca_topic_score_gemma":0.00006851272,"teacher_disagreement_score":0.47512874,"about_ca_system_score_codex":0.00059227634,"about_ca_system_score_gemma":0.00022329847,"threshold_uncertainty_score":0.90088624},"labels":[],"label_agreement":null},{"id":"W3110825381","doi":"10.1093/neuonc/noaa222.842","title":"TBIO-15. MODELING DEVELOPMENTAL GENE EXPRESSION DYNAMICS AT CELLULAR RESOLUTION TO INTERPRET PEDIATRIC BRAIN TUMOR TRANSCRIPTIONAL PROGRAMS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Hospital for Sick Children; McGill University; Jewish General Hospital","funders":"","keywords":"Carcinogenesis; Biology; Gene; Transcriptome; Gene expression; Forebrain; Transcription factor; Gene regulatory network; Computational biology; Developmental biology; PAX6; Neuroscience; Genetics; Central nervous system","score_opus":0.02414728527735468,"score_gpt":0.24033658465005223,"score_spread":0.21618929937269754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110825381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91958445,0.000258504,0.0770094,0.0018049756,0.00048630283,0.00045192082,0.000051729945,0.00005710293,0.00029562216],"genre_scores_gemma":[0.98358107,0.00006092721,0.010295643,0.004594497,0.0006326622,0.0000642832,0.000682039,0.000055371846,0.000033533528],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998073,0.00016188086,0.00042829465,0.00070909294,0.00020364563,0.0004240979],"domain_scores_gemma":[0.9993587,0.00002721646,0.00006478915,0.00016534279,0.00007858721,0.00030534642],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014189018,0.0002675069,0.00026021982,0.00006238223,0.00016788876,0.000025620535,0.00030508311,0.00026501023,0.000033501634],"category_scores_gemma":[0.00012006763,0.0002800191,0.00014179858,0.0001616586,0.000049565464,0.000009830932,0.00018596987,0.00023656862,0.00003815893],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075480924,0.0001535905,0.0017903398,0.000028619233,0.00001365583,0.000039346785,0.00048041038,0.0017650148,0.99154806,0.000013209366,0.0012854602,0.0021274895],"study_design_scores_gemma":[0.0020940227,0.0028732354,0.00007834232,0.000015912812,0.00005755802,0.0001268109,0.00022912963,0.07407409,0.86438274,0.000027549775,0.055384178,0.00065640034],"about_ca_topic_score_codex":0.0000131338575,"about_ca_topic_score_gemma":0.00008091944,"teacher_disagreement_score":0.12716529,"about_ca_system_score_codex":0.0002064076,"about_ca_system_score_gemma":0.00022043454,"threshold_uncertainty_score":0.9999652},"labels":[],"label_agreement":null},{"id":"W3110829851","doi":"10.1093/neuonc/noaa215.893","title":"TAMI-04. TUMOR TREATING FIELDS (TTFIELDS) HINDER GLIOMA CELL MOTILITY THROUGH REGULATION OF MICROTUBULE AND ACTIN DYNAMICS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neuroscience and Neural Engineering","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Motility; Glioma; Microtubule; Cancer research; Medicine; Biology; Cell biology","score_opus":0.032807958249309786,"score_gpt":0.27625128274327443,"score_spread":0.24344332449396464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110829851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928242,0.000016535285,0.001070329,0.0027340227,0.00037896837,0.00026957004,0.000012769654,0.00009931304,0.0025942824],"genre_scores_gemma":[0.9959615,0.000029387546,0.0002935788,0.0035776708,0.000075966636,0.0000092089995,0.0000013218063,0.000022136646,0.00002923145],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983351,0.00016482186,0.00036455796,0.0006106742,0.00019792728,0.00032686934],"domain_scores_gemma":[0.9987085,0.0007165491,0.0002027726,0.00022612694,0.000026987575,0.00011910425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008680133,0.00019413904,0.00032739333,0.00005907416,0.00013034458,0.000028760329,0.00026216253,0.00013291964,0.000041634707],"category_scores_gemma":[0.0007725456,0.00018937998,0.00006698595,0.0004167161,0.0001702242,0.00031261324,0.00017389897,0.0003996215,0.000009838659],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057530604,0.0000616468,0.00039582892,0.00006181073,8.254207e-7,0.00009177711,0.0005096832,0.00034576256,0.99617636,0.00022499371,0.00015057545,0.0019232216],"study_design_scores_gemma":[0.0005961768,0.0005684297,0.00072279904,0.000005905571,0.000011736288,0.00012199169,0.00008327542,0.04517023,0.95116675,0.0001330587,0.001292652,0.00012699637],"about_ca_topic_score_codex":0.00002487556,"about_ca_topic_score_gemma":0.000008700595,"teacher_disagreement_score":0.045009594,"about_ca_system_score_codex":0.000043753287,"about_ca_system_score_gemma":0.00005897969,"threshold_uncertainty_score":0.7722691},"labels":[],"label_agreement":null},{"id":"W3110837854","doi":"10.1093/neuonc/noaa222.698","title":"QOL-40. THE IMPACT OF TASK COMPLEXITY ON INFORMATION PROCESSING SPEED AND NEURAL COMMUNICATION IN PAEDIATRIC BRAIN TUMOUR SURVIVORS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cerebral Palsy and Movement Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Magnetoencephalography; Cognition; Audiology; Task (project management); Neuroimaging; Neuroscience; Medicine; Electroencephalography; Psychology","score_opus":0.03996061775644011,"score_gpt":0.3214333546548075,"score_spread":0.2814727368983674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110837854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96932644,0.00009975974,0.00001580065,0.02806154,0.000026515194,0.00051321654,0.000008624472,0.000022543052,0.0019255704],"genre_scores_gemma":[0.9918747,0.00007566057,0.000028571287,0.007921836,0.000032276403,0.0000053934073,0.000053193777,0.0000068719346,0.0000014983818],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990417,0.0002526491,0.00032521127,0.00010723162,0.00012376231,0.00014946065],"domain_scores_gemma":[0.9992005,0.0003372637,0.00020695486,0.00013593554,0.00004792998,0.00007136914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026801333,0.000105537154,0.000259123,0.00009198283,0.00006089421,0.000012335049,0.00010774539,0.000066740795,0.000029909788],"category_scores_gemma":[0.00038535244,0.000074023155,0.00005377965,0.00032018384,0.00013711564,0.00016471167,0.0000730994,0.00033350175,0.000004122109],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007044248,0.0011617343,0.54120165,0.0008440872,0.0000880841,0.00003070319,0.038772907,0.0036801847,0.14837763,0.00086882635,0.012491931,0.24543801],"study_design_scores_gemma":[0.006106671,0.0042913184,0.91151756,0.000037092374,0.0000550718,0.00002752059,0.002593747,0.07025979,0.00077916397,0.00038974202,0.0037650496,0.00017726532],"about_ca_topic_score_codex":0.00061919395,"about_ca_topic_score_gemma":0.00028046567,"teacher_disagreement_score":0.3703159,"about_ca_system_score_codex":0.000055323806,"about_ca_system_score_gemma":0.00011774798,"threshold_uncertainty_score":0.30185768},"labels":[],"label_agreement":null},{"id":"W3110859485","doi":"10.1093/neuonc/noaa215.897","title":"TAMI-08. A TALE OF TWO TELOMERE MAINTENANCE MECHANISMS: TERT EXPRESSION AND THE ALT PATHWAY INDUCE UNIQUE MRS-DETECTABLE METABOLIC REPROGRAMMING IN LOW-GRADE GLIOMAS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Telomere; Biology; Cancer research; Glutaminase; Alanine; Enzyme; Glutamine; Cell biology; Biochemistry; Amino acid; DNA","score_opus":0.015243252125043946,"score_gpt":0.2864258164013784,"score_spread":0.2711825642763344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110859485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944005,0.0022749421,0.00059688184,0.0014044619,0.00007806215,0.00075709797,0.000026565267,0.000017107222,0.000444385],"genre_scores_gemma":[0.99725544,0.0008312765,0.000747199,0.0007964076,0.000073675496,0.000231557,0.000016750306,0.000026626256,0.000021092002],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982763,0.00038023407,0.000280383,0.00052209717,0.00014686557,0.00039411217],"domain_scores_gemma":[0.9992446,0.00007679317,0.00014781466,0.00033546676,0.000051345927,0.00014401319],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026339365,0.00017948684,0.00035651895,0.000058884787,0.00006836533,0.000017647699,0.00024481458,0.00014888594,0.000010958072],"category_scores_gemma":[0.00023713852,0.00012880689,0.000082968174,0.00025073942,0.0002215048,0.000009207539,0.00033977925,0.00025253397,0.0000027447454],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007209367,0.00011478829,0.00044931922,0.000031185027,0.000033604367,0.00011988476,0.00026430274,0.000012788908,0.98439234,0.00034940682,0.00008092406,0.013430539],"study_design_scores_gemma":[0.004995326,0.00090726075,0.000114032926,0.00002550403,0.000014959589,0.00007021207,0.0001723881,0.0001090415,0.96947336,0.00042536712,0.023578532,0.00011400164],"about_ca_topic_score_codex":0.00036111256,"about_ca_topic_score_gemma":0.00034922324,"teacher_disagreement_score":0.023497608,"about_ca_system_score_codex":0.000026836553,"about_ca_system_score_gemma":0.00020482218,"threshold_uncertainty_score":0.52525926},"labels":[],"label_agreement":null},{"id":"W3110870249","doi":"10.1093/neuonc/noaa215.556","title":"NCOG-17. PREDICTORS OF SURVIVAL IN ELDERLY PATIENTS UNDERGOING SURGERY FOR GBM","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Proportional hazards model; Survival analysis; Pathological; Surgery; Complication; Internal medicine","score_opus":0.04135882310759069,"score_gpt":0.29462501824749154,"score_spread":0.25326619513990084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110870249","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920291,0.000077194665,0.00016888075,0.005089415,0.000733611,0.0007477102,0.000059917198,0.000034854256,0.0010593376],"genre_scores_gemma":[0.9970443,0.00007125259,0.0004802505,0.0020394064,0.00017428899,0.00005050046,0.00009576826,0.000027302358,0.00001688167],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99866796,0.00016206347,0.0004366034,0.00029408452,0.00017082291,0.0002684694],"domain_scores_gemma":[0.9967967,0.0026585197,0.00015961438,0.00014699146,0.00007371846,0.00016441637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020260394,0.00013960789,0.0006165708,0.00009648248,0.000024797853,0.0000032341204,0.00005773868,0.0001090941,0.00006296262],"category_scores_gemma":[0.0012548518,0.00012209702,0.00016221528,0.00018775617,0.00005299696,0.000036511145,0.000039445902,0.00014090734,0.0000063556886],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019218333,0.0013869326,0.9412239,0.00039322898,0.00017739525,0.00025963283,0.00064555556,0.000041622436,0.003334878,0.00013772429,0.017696224,0.032781042],"study_design_scores_gemma":[0.045224197,0.05251297,0.47503382,0.00029125906,0.0010576394,0.00006049125,0.0010937518,0.00076118874,0.011064418,0.00031746755,0.41191015,0.00067265175],"about_ca_topic_score_codex":0.000023807925,"about_ca_topic_score_gemma":0.00013122719,"teacher_disagreement_score":0.4661901,"about_ca_system_score_codex":0.000093499,"about_ca_system_score_gemma":0.00042548706,"threshold_uncertainty_score":0.49789715},"labels":[],"label_agreement":null},{"id":"W3110871843","doi":"10.1093/neuonc/noaa215.933","title":"TAMI-46. TNFα SECRETED BY GLIOMA ASSOCIATED MACROPHAGES PROMOTES ENDOTHELIAL ACTIVATION AND RESISTANCE AGAINST ANTI-ANGIOGENIC THERAPY","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Glioma; Tumor necrosis factor alpha; Cancer research; In vivo; Bone marrow; Downregulation and upregulation; Tumor microenvironment; Secretion; Immunology; Population; Medicine; Angiogenesis; Macrophage; Biology; In vitro; Internal medicine; Tumor cells","score_opus":0.015041356225327323,"score_gpt":0.24827636085161295,"score_spread":0.23323500462628563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110871843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847971,0.006782298,0.00004315431,0.004700179,0.000970161,0.0006529611,0.00017955486,0.00023936805,0.0016352297],"genre_scores_gemma":[0.9929893,0.0014568245,0.00006753858,0.00467315,0.00010045984,0.00006356328,0.00026238526,0.00006583466,0.00032093277],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99743843,0.00084135454,0.00043717847,0.0006542492,0.00007135391,0.00055741746],"domain_scores_gemma":[0.99856323,0.0006249407,0.00037544756,0.0002700077,0.00011487983,0.000051509727],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021192608,0.00033071527,0.0005769178,0.00008875246,0.00026664365,0.000027370234,0.00033444448,0.0006265775,0.00031947315],"category_scores_gemma":[0.0004788337,0.00032099444,0.0001161991,0.0003476055,0.00040368983,0.00012759335,0.00013141487,0.0005962086,0.00012668963],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006861874,0.00012774189,0.0005183145,0.00001587995,0.00024093542,0.000049174538,0.0008109925,0.0000013241379,0.96799946,0.000028680417,0.022398653,0.007122663],"study_design_scores_gemma":[0.0034290205,0.0006400705,0.000736401,0.000011980581,0.000028580085,0.000017633894,0.000066663524,0.0000061152277,0.73793554,0.000032530665,0.2568729,0.00022256756],"about_ca_topic_score_codex":0.0000220606,"about_ca_topic_score_gemma":0.000009828228,"teacher_disagreement_score":0.23447424,"about_ca_system_score_codex":0.00015607018,"about_ca_system_score_gemma":0.00017979425,"threshold_uncertainty_score":0.9999242},"labels":[],"label_agreement":null},{"id":"W3110887690","doi":"10.1093/neuonc/noaa222.659","title":"PATH-24. MOLECULAR CLASSIFICATION OF HIGH RISK INFANT EMBRYONAL BRAIN TUMORS ENROLLED IN THE ACNS0334 TRIAL: A REPORT FROM THE CHILDREN’S ONCOLOGY GROUP","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Brain tumor; CDKN2A; Atypical teratoid rhabdoid tumor; Germline; PTCH1; Oncology; Internal medicine; Glioma; Astrocytoma; Medicine; Biology; Cancer research; Pathology; Bioinformatics; Cancer; Sonic hedgehog; Genetics; Gene","score_opus":0.02333542339404392,"score_gpt":0.29091927068363543,"score_spread":0.2675838472895915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110887690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91389656,0.00026313655,0.000037106976,0.08250519,0.0003784282,0.002309592,0.00006331651,0.000038973983,0.000507705],"genre_scores_gemma":[0.9849539,0.00012735573,0.00021483298,0.013355107,0.00040066338,0.00064867246,0.00026455626,0.0000332351,0.0000017115228],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9959055,0.0017174109,0.0010012593,0.0006272544,0.00042555502,0.00032301483],"domain_scores_gemma":[0.9951633,0.0031087196,0.00082092104,0.00068688835,0.00007814714,0.00014198596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086876407,0.00026388405,0.000905383,0.000089606634,0.00008769516,0.000014835696,0.00034151267,0.00026785416,0.000098311015],"category_scores_gemma":[0.0027278746,0.00015437944,0.0002690553,0.00042648715,0.00020239915,0.00003763875,0.00011089989,0.00069478893,0.000022232885],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.039476015,0.00981207,0.36956546,0.000038479124,0.0011041448,0.019792162,0.008071491,0.00009757544,0.4574607,0.0034184114,0.049768306,0.04139518],"study_design_scores_gemma":[0.07048991,0.009679346,0.87957877,0.000030415576,0.0006966727,0.0007088261,0.0006259721,0.0002876411,0.004561547,0.0005638728,0.0325807,0.00019630506],"about_ca_topic_score_codex":0.0013443485,"about_ca_topic_score_gemma":0.0003149356,"teacher_disagreement_score":0.51001334,"about_ca_system_score_codex":0.00019106743,"about_ca_system_score_gemma":0.00046772353,"threshold_uncertainty_score":0.6295411},"labels":[],"label_agreement":null},{"id":"W3110910606","doi":"10.1093/neuonc/noaa222.222","title":"ETMR-19. SINGLE CELL ANALYSES OF ETMRs REVEAL THAT C19MC+ POPULATION DRIVES CELL CYCLE PROGRESSION AND STEM CELL MAINTENANCE","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Stem cell; Population; Wnt signaling pathway; Biology; Cell; Cell cycle; Cell biology; Cancer research; Cell growth; Signal transduction; Genetics; Medicine","score_opus":0.028804015157162677,"score_gpt":0.30006083684240664,"score_spread":0.27125682168524395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110910606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959522,0.0013697755,0.00041538334,0.000462189,0.00011880909,0.000368207,0.000027567117,0.000024893521,0.0012609598],"genre_scores_gemma":[0.9977683,0.00017474181,0.0011817735,0.0005158759,0.00012889353,0.000014900182,0.00012581372,0.000033544104,0.00005615393],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984584,0.0002655283,0.00033684727,0.000532367,0.00015246347,0.00025439548],"domain_scores_gemma":[0.9990059,0.0000513483,0.00041077353,0.00026641416,0.00007587023,0.00018966732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009997506,0.00020092523,0.00029409907,0.00005148366,0.000069355,0.000016063523,0.0001640826,0.0002547814,0.000013883437],"category_scores_gemma":[0.000040182516,0.00018933692,0.00010131339,0.00012456771,0.000115482835,0.000012113708,0.00017655804,0.0001230794,0.000004908232],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002659651,0.00018206052,0.007404562,0.00017264452,0.000010082818,0.000013815329,0.00014657972,0.00037572547,0.98643094,0.0000033591314,0.001781265,0.0032129763],"study_design_scores_gemma":[0.00095872546,0.0012057225,0.00620322,0.000014018947,0.000065584194,0.000009532063,0.00013425032,0.00049148465,0.9808985,0.00002264319,0.009816567,0.00017976818],"about_ca_topic_score_codex":0.000013018949,"about_ca_topic_score_gemma":0.000007051718,"teacher_disagreement_score":0.008035302,"about_ca_system_score_codex":0.000039785882,"about_ca_system_score_gemma":0.00008478497,"threshold_uncertainty_score":0.77209353},"labels":[],"label_agreement":null},{"id":"W3110913480","doi":"10.1093/neuonc/noaa215.242","title":"CTNI-76. PHASE 2 CLINICAL TRIAL OF VAL-083 IN NEWLY DIAGNOSED MGMT-UNMETHYLATED GBM","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Delmar (Canada)","funders":"","keywords":"Temozolomide; Tolerability; Medicine; Methyltransferase; Phases of clinical research; O-6-methylguanine-DNA methyltransferase; Internal medicine; Radiation therapy; In vivo; Oncology; Nuclear medicine; Gastroenterology; Clinical trial; Adverse effect; Biology; DNA; Methylation","score_opus":0.09570379679146818,"score_gpt":0.41866782647270745,"score_spread":0.3229640296812393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110913480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9753612,0.00019542391,0.000011923526,0.020398462,0.0010018924,0.0014883752,0.000017803683,0.00006864639,0.0014562262],"genre_scores_gemma":[0.9922745,0.00046432466,0.0003395857,0.0060748355,0.0006314604,0.0001318854,0.0000383163,0.000038154925,0.0000069353264],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99691844,0.00063144584,0.0012075792,0.00058792887,0.00027361908,0.00038098],"domain_scores_gemma":[0.9962637,0.0025046363,0.00033723094,0.00037326562,0.000092226575,0.000428934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004394957,0.00024402069,0.0012508812,0.00015990311,0.000029255845,0.000007472662,0.00016116716,0.00037224876,0.00029290433],"category_scores_gemma":[0.0030447098,0.00020605119,0.00033421535,0.0004972834,0.00016544704,0.00004825315,0.00009833496,0.00053665147,0.000107510714],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14990282,0.043602474,0.104184024,0.00013332824,0.00058113626,0.020402312,0.0015832235,0.000050883747,0.33595574,0.0002494409,0.038063727,0.3052909],"study_design_scores_gemma":[0.69511116,0.05993675,0.016911142,0.000052805743,0.0006547693,0.000054019936,0.00013579769,0.0005877503,0.042451113,0.000081297,0.18374363,0.00027978985],"about_ca_topic_score_codex":0.000069124515,"about_ca_topic_score_gemma":0.000035312016,"teacher_disagreement_score":0.54520833,"about_ca_system_score_codex":0.00010532304,"about_ca_system_score_gemma":0.00042099427,"threshold_uncertainty_score":0.84025234},"labels":[],"label_agreement":null},{"id":"W3110925972","doi":"10.1093/neuonc/noaa222.370","title":"IMMU-14. IMMUNE CHECKPOINT INHIBITOR THERAPY FOR TREATMENT OF SYNCHRONOUS CANCERS IN PAEDIATRIC PATIENTS WITH CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Microsatellite instability; DNA mismatch repair; Medicine; Cancer; Oncology; Germline; Internal medicine; Cancer research; Biology; Colorectal cancer; Gene; Allele; Microsatellite; Genetics","score_opus":0.01901834200951528,"score_gpt":0.27254156985053835,"score_spread":0.25352322784102305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110925972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934775,0.0018282667,0.0000884203,0.001253915,0.00060632924,0.002093692,0.000060865885,0.00005179864,0.000539196],"genre_scores_gemma":[0.99661654,0.0004341257,0.0017153282,0.0006224052,0.0001743672,0.0003691991,0.000038892205,0.000024195015,0.000004964385],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983952,0.00007321819,0.0005290998,0.00043294558,0.00024463146,0.0003249286],"domain_scores_gemma":[0.9989547,0.0002832049,0.00022409047,0.00020314864,0.00020012535,0.00013470418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000082432336,0.0002234062,0.00062033976,0.00010518485,0.000045683908,0.0000030071083,0.00008751057,0.00015127324,0.00009284678],"category_scores_gemma":[0.00017007673,0.00017093489,0.00016559834,0.00032753675,0.00038326808,0.000028532535,0.000026518228,0.0001171191,0.000005020651],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026088463,0.00481597,0.62543,0.00044038656,0.0002865195,0.00018197356,0.005539647,0.0020552396,0.27929097,0.00012841907,0.0014145385,0.054327887],"study_design_scores_gemma":[0.09880382,0.21071057,0.30975035,0.00013656577,0.0005141942,0.00012741475,0.0007637957,0.0016111853,0.27271387,0.000067110064,0.103809215,0.0009919102],"about_ca_topic_score_codex":0.00010473103,"about_ca_topic_score_gemma":0.000041783493,"teacher_disagreement_score":0.31567964,"about_ca_system_score_codex":0.001315362,"about_ca_system_score_gemma":0.0022112043,"threshold_uncertainty_score":0.69705224},"labels":[],"label_agreement":null},{"id":"W3110928912","doi":"10.1093/neuonc/noaa222.536","title":"MBRS-20. CSF-DERIVED CIRCULATING TUMOR DNA AS A BIOMARKER FOR DISEASE PROGRESSION AND TUMOR EVOLUTION IN MEDULLOBLASTOMA","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Medicine; Copy-number variation; Oncology; Biomarker; Cell-free fetal DNA; Internal medicine; Prospective cohort study; Pathology; Genome; Biology; Gene; Genetics","score_opus":0.015135786449551557,"score_gpt":0.28604767331919306,"score_spread":0.2709118868696415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110928912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944269,0.0007712115,0.0006113893,0.0028725027,0.00023393106,0.000726416,0.0000658847,0.000020315958,0.00027141543],"genre_scores_gemma":[0.99506396,0.000055044424,0.00061740505,0.0036448066,0.0002948555,0.0001970955,0.00008706996,0.000036228124,0.000003544785],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986757,0.000090667716,0.00028002597,0.0005519864,0.000087301654,0.00031432556],"domain_scores_gemma":[0.999219,0.00011735591,0.00014659236,0.00017015554,0.00007042309,0.00027645315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011068619,0.00018043682,0.00022827947,0.00004703282,0.00008187916,0.000024695413,0.000120372955,0.00010062518,0.000010178396],"category_scores_gemma":[0.0010175114,0.00018690452,0.000076477845,0.00010377638,0.00010588636,0.0000061554256,0.00018894569,0.000099972094,0.000004674604],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011637694,0.000093924595,0.0053583174,0.000062708306,0.000013513889,0.0001355812,0.00007607826,0.00004148729,0.9852782,0.00008246754,0.0010474531,0.006646483],"study_design_scores_gemma":[0.017052725,0.011594106,0.08467854,0.0001785023,0.0002800911,0.00050190993,0.0006359764,0.04959811,0.40115318,0.0019397937,0.43064353,0.0017435568],"about_ca_topic_score_codex":0.000011222109,"about_ca_topic_score_gemma":0.000056721085,"teacher_disagreement_score":0.58412504,"about_ca_system_score_codex":0.00007100318,"about_ca_system_score_gemma":0.0004387402,"threshold_uncertainty_score":0.76217455},"labels":[],"label_agreement":null},{"id":"W3110935379","doi":"10.1093/neuonc/noaa222.649","title":"PATH-14. GENETIC SUSCEPTIBILITY AND OUTCOMES OF PEDIATRIC, ADOLESCENT AND YOUNG ADULT IDH-MUTANT ASTROCYTOMAS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"ATRX; Medicine; Oncology; Internal medicine; Germline; IDH1; Mutation; Cancer; Young adult; Cancer research; Gene; Biology; Genetics","score_opus":0.019508112615464698,"score_gpt":0.2788905089600257,"score_spread":0.259382396344561,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110935379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99290454,0.00074639625,0.000014288039,0.00542646,0.00017652987,0.0005587781,0.00002736307,0.000037212438,0.00010844632],"genre_scores_gemma":[0.9963004,0.0009952371,0.0005171487,0.001977297,0.00015708296,0.00002634551,0.0000053611166,0.000019667003,0.0000014566482],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986098,0.0001059401,0.00038792667,0.00045355986,0.00019234425,0.00025046043],"domain_scores_gemma":[0.9990277,0.00018169441,0.00014761907,0.00020625613,0.00011607661,0.0003206117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006572271,0.00019836606,0.00061012304,0.000058866728,0.00004293713,0.000008179838,0.000055595465,0.00012634702,0.000033774468],"category_scores_gemma":[0.00032913103,0.00015501573,0.0000823215,0.0001132733,0.00011659909,0.000026346608,0.00011669951,0.00019233656,0.000007731251],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021232157,0.0005291256,0.9245804,0.00018016492,0.000048317776,0.00048534392,0.0004465092,7.926907e-7,0.067232154,0.000026246518,0.00047435737,0.0057842573],"study_design_scores_gemma":[0.0050193714,0.003479294,0.97970986,0.000010400968,0.0004534892,0.00014809803,0.00019084846,0.00011882342,0.009984011,0.000014076416,0.00076265633,0.0001090705],"about_ca_topic_score_codex":0.000034061733,"about_ca_topic_score_gemma":0.000050457813,"teacher_disagreement_score":0.057248145,"about_ca_system_score_codex":0.000061445404,"about_ca_system_score_gemma":0.000102505626,"threshold_uncertainty_score":0.6321358},"labels":[],"label_agreement":null},{"id":"W3110936563","doi":"10.1093/neuonc/noaa222.133","title":"EPCT-09. CLR 131 IN PATIENTS WITH RELAPSED OR REFRACTORY PEDIATRIC MALIGNANCIES","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Tolerability; Refractory (planetary science); Medulloblastoma; Adverse effect; Population; Internal medicine; Oncology; Nuclear medicine; Pathology","score_opus":0.02203706713411252,"score_gpt":0.26577358251702043,"score_spread":0.24373651538290791,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110936563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99230134,0.00017686022,0.0000017862484,0.0052407803,0.00023504796,0.0006724453,0.000013675807,0.000067044064,0.0012910294],"genre_scores_gemma":[0.99396986,0.00016541881,0.00022523146,0.0052340887,0.00021437508,0.00009934351,0.00003280164,0.000037374404,0.000021533982],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99855036,0.00011578975,0.00032439208,0.00042356653,0.00025141507,0.00033446646],"domain_scores_gemma":[0.998958,0.00033741904,0.00014604277,0.00023153554,0.000084307874,0.00024271249],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000060039885,0.00020285512,0.00049170695,0.00014628652,0.000041726722,0.000008106818,0.00009219541,0.00015869908,0.00022038785],"category_scores_gemma":[0.00033043875,0.0001359905,0.00005927902,0.000459197,0.00005172585,0.00006686864,0.000059083457,0.0002964072,0.00015964461],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023675272,0.001970629,0.9725805,0.00006141961,0.000031669337,0.002375551,0.0005169557,0.0000080807495,0.0026151966,0.000025505598,0.010557592,0.0068893903],"study_design_scores_gemma":[0.019102933,0.018712016,0.8305171,0.000025075262,0.0002689138,0.000028460854,0.00009987028,0.000018725459,0.0014985506,0.0000069674,0.12951626,0.00020513879],"about_ca_topic_score_codex":0.000017544056,"about_ca_topic_score_gemma":0.000039611405,"teacher_disagreement_score":0.1420634,"about_ca_system_score_codex":0.00018513323,"about_ca_system_score_gemma":0.00030898876,"threshold_uncertainty_score":0.5545532},"labels":[],"label_agreement":null},{"id":"W3110946424","doi":"10.1093/neuonc/noaa222.433","title":"LGG-55. OUTCOME OF BRAF V600E PEDIATRIC GLIOMAS TREATED WITH TARGETED BRAF INHIBITION","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Stollery Children's Hospital; Hospital for Sick Children","funders":"","keywords":"Medicine; Internal medicine; Oncology; Glioma; CDKN2A; Discontinuation; V600E; Concomitant; Cancer; Cancer research; Mutation","score_opus":0.0283945740418875,"score_gpt":0.2858317490018318,"score_spread":0.2574371749599443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110946424","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988064,0.00024698034,0.000014455261,0.008945323,0.00012494005,0.0007045784,0.000037914975,0.00015307649,0.0017087576],"genre_scores_gemma":[0.9959236,0.00007279178,0.00027998106,0.0031915554,0.00029339944,0.000073870026,0.00010365903,0.000049344955,0.000011847368],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99822485,0.00013598608,0.0005303044,0.00047152277,0.000296569,0.0003407804],"domain_scores_gemma":[0.99868757,0.00027694565,0.00028357815,0.00026305974,0.00015824757,0.00033062167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007318823,0.00027112887,0.00076279184,0.00025074606,0.000054985583,0.000008846581,0.00007732421,0.00020754428,0.00031182662],"category_scores_gemma":[0.00020103468,0.00020391731,0.00015128993,0.00085951295,0.000091862545,0.000072424154,0.000056096414,0.00025381942,0.00014591854],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010672238,0.0016101354,0.6886138,0.00015792678,0.00013923473,0.0044597215,0.0003745022,0.00002595085,0.29470462,0.000118703014,0.006604401,0.0021238425],"study_design_scores_gemma":[0.03724096,0.02750939,0.35703257,0.00005228214,0.0027738195,0.0011455375,0.00030574904,0.00037136537,0.5446752,0.000046388173,0.028184714,0.0006620523],"about_ca_topic_score_codex":0.00006587612,"about_ca_topic_score_gemma":0.000029425013,"teacher_disagreement_score":0.33158118,"about_ca_system_score_codex":0.00012493946,"about_ca_system_score_gemma":0.0001630353,"threshold_uncertainty_score":0.8315507},"labels":[],"label_agreement":null},{"id":"W3110951180","doi":"10.1093/neuonc/noaa222.736","title":"RARE-25. RETINAL ASTROCYTOMA mTOR INHIBITOR THERAPY IN TUBEROUS SCLEROSIS MOSAICISM","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Tuberous Sclerosis Complex Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Vancouver General Hospital; Children's & Women's Health Centre of British Columbia","funders":"","keywords":"Tuberous sclerosis; Medicine; Retinal; Everolimus; Retina; mTORC1; Enucleation; Ophthalmology; Pathology; PI3K/AKT/mTOR pathway; Internal medicine; Surgery; Neuroscience; Psychology; Biology","score_opus":0.08722362094705445,"score_gpt":0.3218538980837035,"score_spread":0.23463027713664908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110951180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9581716,0.0003369017,0.000038655027,0.03661888,0.00038389384,0.0011731279,0.000018939287,0.00025107397,0.0030069447],"genre_scores_gemma":[0.98159456,0.0002563279,0.0013186932,0.015364658,0.0011066266,0.00017620985,0.000026009742,0.00010943097,0.000047471804],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99594295,0.0006196026,0.00073683757,0.0009474345,0.00074657245,0.0010066145],"domain_scores_gemma":[0.99778104,0.0006380372,0.00015077204,0.0005505235,0.00019355149,0.00068607874],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00038206394,0.00038598664,0.0009512893,0.00027485343,0.0001211546,0.000045049645,0.00044757425,0.0003645776,0.0008259917],"category_scores_gemma":[0.00060799764,0.0003633698,0.00019980295,0.0008483181,0.00030380645,0.00013256031,0.00030800488,0.0011636426,0.0005646353],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037395214,0.000554623,0.023210125,0.000042483374,0.00003308941,0.0009596249,0.0010111121,0.000011098435,0.8913919,0.00008793718,0.02094876,0.058009744],"study_design_scores_gemma":[0.036794122,0.054437257,0.2849842,0.00027025712,0.00009718378,0.0018437825,0.00089390244,0.0019632005,0.2840223,0.00008871941,0.33352205,0.0010830051],"about_ca_topic_score_codex":0.0001076018,"about_ca_topic_score_gemma":0.00007907229,"teacher_disagreement_score":0.6073696,"about_ca_system_score_codex":0.00049482385,"about_ca_system_score_gemma":0.0005789774,"threshold_uncertainty_score":0.9998818},"labels":[],"label_agreement":null},{"id":"W3110951411","doi":"10.1093/neuonc/noaa215.344","title":"EPID-26. CLINICAL AND HISTOLOGICAL CHARACTERIZATION OF PRIMARY CENTRAL NERVOUS SYSTEM SARCOMA IN PEDIATRICS. A SINGLE INSTITUTION EXPERIENCE IN A MIDDLE-INCOME COUNTRY","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Sarcoma; Vomiting; Radiation therapy; Central nervous system; Surgery; Pathology; Internal medicine","score_opus":0.07430441565403519,"score_gpt":0.3303386264161332,"score_spread":0.25603421076209804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110951411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975302,0.00009200937,0.00004508051,0.0010300006,0.00023501729,0.00064630253,0.000011365915,0.00005312603,0.00035686887],"genre_scores_gemma":[0.9984672,0.00018243383,0.00014364636,0.0010013742,0.00012696358,0.000039537466,0.000022312612,0.000014296134,0.0000022393174],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99791145,0.00041956507,0.00066934025,0.00042213485,0.0002276261,0.00034990342],"domain_scores_gemma":[0.9990658,0.0002888101,0.00017843196,0.00013846575,0.00004395606,0.00028453098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016431966,0.00014064346,0.0006232171,0.00014832635,0.00002802637,0.0000071874683,0.000096288655,0.00019705812,0.0000081779845],"category_scores_gemma":[0.00065206544,0.00012438602,0.000047969123,0.00038986976,0.00028158762,0.00011216109,0.000113545044,0.00039708614,0.000008136625],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031432447,0.0012955524,0.784315,0.00055365084,0.000008395368,0.0059974147,0.0006630298,0.0000023758464,0.19466177,0.00011371465,0.00001070325,0.009235166],"study_design_scores_gemma":[0.005486212,0.004751757,0.9856802,0.00008478513,0.000027026925,0.0004510317,0.000083372346,0.0005194659,0.0015836001,0.0000031651568,0.0012368688,0.000092518334],"about_ca_topic_score_codex":0.000039791263,"about_ca_topic_score_gemma":0.00003012515,"teacher_disagreement_score":0.2013652,"about_ca_system_score_codex":0.00038965474,"about_ca_system_score_gemma":0.00037671573,"threshold_uncertainty_score":0.5072315},"labels":[],"label_agreement":null},{"id":"W3111018425","doi":"10.1093/neuonc/noaa215.240","title":"CTNI-74. PHASE 3 TRIDENT TRIAL: CONCOMITANT RADIATION THERAPY (RT) AND TEMOZOLOMIDE +/- TUMOR TREATING FIELDS (TTFIELDS) IN NEWLY DIAGNOSED GLIOBLASTOMA","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Temozolomide; Medicine; Concomitant; Oncology; Internal medicine; Clinical endpoint; Radiation therapy; Clinical trial; Surgery","score_opus":0.030551676510782676,"score_gpt":0.32373109012069323,"score_spread":0.29317941360991057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111018425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97238475,0.001094742,0.000017901382,0.023605553,0.00037387834,0.0019126417,0.000011698671,0.000090046,0.0005087877],"genre_scores_gemma":[0.9852097,0.001176974,0.000094842915,0.012630534,0.0004626099,0.00036696967,0.000016724836,0.000036490605,0.0000051383195],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9978954,0.00030874816,0.0006640609,0.00055413373,0.00020437005,0.00037326265],"domain_scores_gemma":[0.9974125,0.0017211605,0.00025752676,0.00023427348,0.00004545299,0.00032909814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002069965,0.00028748164,0.0008343378,0.00017843363,0.0000780698,0.000033848002,0.00009764042,0.00022266018,0.00014541544],"category_scores_gemma":[0.00089679984,0.00024076861,0.00014184983,0.00028841454,0.00006854958,0.00009456774,0.00004759475,0.00037985042,0.000021127056],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08984927,0.0057364623,0.041991707,0.00008141987,0.0002695068,0.014134311,0.004885216,0.000064056156,0.22269179,0.00017072834,0.013048627,0.6070769],"study_design_scores_gemma":[0.67803466,0.070115775,0.010765765,0.000084119674,0.00032164942,0.00035878754,0.0009134499,0.004031603,0.1426943,0.000092733615,0.092055686,0.00053148466],"about_ca_topic_score_codex":0.00018512056,"about_ca_topic_score_gemma":0.00018058326,"teacher_disagreement_score":0.6065454,"about_ca_system_score_codex":0.00018989985,"about_ca_system_score_gemma":0.00022954728,"threshold_uncertainty_score":0.9818259},"labels":[],"label_agreement":null},{"id":"W3111018487","doi":"10.1093/neuonc/noaa215.283","title":"EPCO-04. GENOMIC AND EPIGENOMIC HALLMARKS OF SCHWANNOMATOSIS SCHWANNOMAS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Epigenomics; Biology; Epigenetics; Genetics; Loss of heterozygosity; SMARCB1; DNA methylation; Germline mutation; Germline; Gene; Mutation; Computational biology; Allele; Gene expression","score_opus":0.031506055309047154,"score_gpt":0.2780110550293171,"score_spread":0.24650499972026996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111018487","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9806112,0.0013127038,0.00004513612,0.0100572985,0.00026197836,0.000621822,0.000052205185,0.00013448422,0.0069031725],"genre_scores_gemma":[0.99285924,0.00031236312,0.0017420246,0.004651984,0.0002769118,0.000029549275,0.00001889025,0.00008101068,0.00002804513],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974392,0.00023014919,0.0008470708,0.0007474418,0.00024846356,0.00048765916],"domain_scores_gemma":[0.99805427,0.00043391867,0.00035205777,0.0004552414,0.000117418414,0.0005871025],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020732296,0.0003514211,0.0011490455,0.00020039262,0.0001191168,0.000026251113,0.00023051097,0.00026908892,0.0002614436],"category_scores_gemma":[0.00040132648,0.00033477021,0.00022688479,0.00030142642,0.00036716368,0.00011484858,0.00029614268,0.00048299198,0.00012180047],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079099805,0.00019185597,0.0210815,0.00020968693,0.00008711928,0.0011262599,0.00048609896,0.000004602661,0.96255016,0.0006549852,0.0031923247,0.009624414],"study_design_scores_gemma":[0.009276572,0.013714883,0.12644362,0.00011854171,0.0007031555,0.006114621,0.00076225336,0.0012431875,0.3732014,0.00019229327,0.46733683,0.00089264335],"about_ca_topic_score_codex":0.00002743879,"about_ca_topic_score_gemma":0.000002614496,"teacher_disagreement_score":0.58934873,"about_ca_system_score_codex":0.00008347702,"about_ca_system_score_gemma":0.00046374416,"threshold_uncertainty_score":0.9999104},"labels":[],"label_agreement":null},{"id":"W3111041338","doi":"10.1093/neuonc/noaa222.528","title":"MBRS-10. QUIESCENT SOX9-POSITIVE CELLS BEHIND MYC DRIVEN MEDULLOBLASTOMA RECURRENCE","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Retinoblastoma; Cancer research; Medicine; Doxycycline; Primary tumor; Oncology; Metastasis; Biology; Cancer; Internal medicine; Gene","score_opus":0.017397230178970286,"score_gpt":0.26104375845985306,"score_spread":0.24364652828088276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111041338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9518835,0.009039231,0.00043322687,0.018888768,0.0070401537,0.001588284,0.00026130112,0.0005380086,0.010327506],"genre_scores_gemma":[0.98683673,0.0011205947,0.0001485971,0.009991965,0.00019602214,0.00007615083,0.00011535112,0.00007262715,0.0014419432],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99629194,0.0014501088,0.0006152732,0.0007437566,0.0000829415,0.0008159563],"domain_scores_gemma":[0.9979222,0.0010885958,0.0003257716,0.0004283436,0.00014105541,0.000094074385],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00022164016,0.0004328663,0.000738752,0.00012880523,0.00036553573,0.000029171268,0.0007025231,0.0006217482,0.0033332936],"category_scores_gemma":[0.00034190595,0.00041226234,0.00024889625,0.00022414782,0.00067065645,0.00016742044,0.0002996033,0.0010199067,0.0056054974],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003747151,0.0003102755,0.00009445343,0.00001616116,0.00019445691,0.00012470821,0.0036918938,0.000011978082,0.9205746,0.00012222555,0.037221022,0.033891097],"study_design_scores_gemma":[0.001731336,0.0030215173,0.00038904784,0.0000192833,0.00004667868,0.00014845836,0.00029524972,0.000012756767,0.4897094,0.000010828216,0.5043692,0.000246262],"about_ca_topic_score_codex":0.000036371486,"about_ca_topic_score_gemma":0.000013542405,"teacher_disagreement_score":0.46714815,"about_ca_system_score_codex":0.00015447661,"about_ca_system_score_gemma":0.0005074761,"threshold_uncertainty_score":0.9998329},"labels":[],"label_agreement":null},{"id":"W3111049071","doi":"10.1093/neuonc/noaa215.585","title":"NCOG-47. CAN YOUNG CHILDREN WITH RELAPSED MEDULLOBLASTOMA BE SALVAGED AFTER INITIAL IRRADIATION-SPARING APPROACHES?","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Université Laval; University of Alberta; University of British Columbia; Centre Hospitalier Universitaire Sainte-Justine; University of Toronto; Dalhousie University","funders":"","keywords":"Medicine; Medulloblastoma; Chemotherapy; Neurocognitive; Surgery; Radiation therapy; Retrospective cohort study; Pathology","score_opus":0.03528585428673552,"score_gpt":0.2649763907668616,"score_spread":0.22969053648012605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111049071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97166634,0.00011431315,0.00002282654,0.023788977,0.00021754943,0.00091248815,0.00003237195,0.00015129431,0.0030938704],"genre_scores_gemma":[0.98843503,0.000022058779,0.0006187255,0.009814485,0.0005370016,0.00037782383,0.000119467426,0.0000685014,0.0000069196562],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981259,0.00016986052,0.00033913064,0.00061090465,0.00032039368,0.00043377536],"domain_scores_gemma":[0.9988686,0.00017405099,0.00016085515,0.00030559045,0.000056120163,0.0004348151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008865452,0.00029959474,0.00056128134,0.00012136587,0.00010852408,0.00002850439,0.00012060528,0.00020346873,0.00017503623],"category_scores_gemma":[0.00015955027,0.00024393822,0.000114640185,0.00031134076,0.00011916001,0.00007696143,0.00008016766,0.0004660209,0.000052530562],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002652692,0.0015003348,0.9485108,0.00005604586,0.00077950617,0.0034881134,0.0048221312,0.00014430415,0.016640572,0.00018749408,0.0043076337,0.016910352],"study_design_scores_gemma":[0.016115433,0.008053681,0.9435407,0.000045130542,0.0010106274,0.001207298,0.00030976042,0.000580076,0.017685775,0.00001349862,0.0109814,0.00045662018],"about_ca_topic_score_codex":0.00009820941,"about_ca_topic_score_gemma":0.00045100873,"teacher_disagreement_score":0.016768707,"about_ca_system_score_codex":0.00022411621,"about_ca_system_score_gemma":0.00028916405,"threshold_uncertainty_score":0.99475116},"labels":[],"label_agreement":null},{"id":"W3111053470","doi":"10.1093/neuonc/noaa215.852","title":"SURG-05. IDEAL TREATMENT REGIMEN FOR PATIENTS WITH ≥1 BRAIN METASTASIS FROM PRIMARY NON-SMALL-CELL LUNG CANCER – A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS","year":2020,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Lung cancer; Meta-analysis; Randomized controlled trial; Oncology; Brain metastasis; non-small cell lung cancer (NSCLC); Regimen; Cancer; Metastasis","score_opus":0.061050671977176375,"score_gpt":0.34625990714207094,"score_spread":0.28520923516489455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111053470","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000007405809,0.97459817,0.0002163043,0.0020380835,0.00013989917,0.020341061,0.0025107006,0.00005061093,0.00009776758],"genre_scores_gemma":[0.0000052896944,0.9719664,0.0045067235,0.0063325185,0.0002169924,0.013132413,0.0034750428,0.00017464464,0.00018999306],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9933714,0.0019931358,0.0019007144,0.0016146816,0.0004287663,0.0006912641],"domain_scores_gemma":[0.9915091,0.0044349995,0.002141764,0.001173897,0.00020650717,0.00053372665],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0007014719,0.0013211392,0.022567265,0.00024372683,0.0001457673,0.000043582662,0.00026121936,0.0003490215,0.00023609314],"category_scores_gemma":[0.00015160348,0.00073284184,0.0042282618,0.0009720031,0.00008318805,0.00005083592,0.00015118335,0.00038651502,0.000012452435],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015468744,0.0007446671,0.00006189641,0.51189315,0.4298594,0.00056339294,0.000061758816,0.0000043255136,1.7066236e-7,0.000006782275,0.010928465,0.045721333],"study_design_scores_gemma":[0.0018477725,0.0021359166,0.0000034959683,0.008645532,0.5928252,0.00003188214,0.0000040682144,0.000009785044,2.2469905e-7,0.0000016417658,0.39419982,0.00029469823],"about_ca_topic_score_codex":0.00030090736,"about_ca_topic_score_gemma":0.00018502085,"teacher_disagreement_score":0.5032476,"about_ca_system_score_codex":0.0010757559,"about_ca_system_score_gemma":0.0013069068,"threshold_uncertainty_score":0.999954},"labels":[],"label_agreement":null},{"id":"W3111053964","doi":"10.1093/neuonc/noaa222.722","title":"RARE-11. QUANTITATIVE MR IMAGING FEATURES ASSOCIATED WITH UNIQUE TRANSCRIPTIONAL CHARACTERISTICS IN PEDIATRIC ADAMANTINOMATOUS CRANIOPHARYNGIOMA: A POTENTIAL GUIDE FOR THERAPY","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Craniopharyngioma; Wnt signaling pathway; Cyst; Biology; Computational biology; Medicine; Bioinformatics; Gene; Pathology; Genetics; Endocrinology","score_opus":0.021370407560067087,"score_gpt":0.2878212856003791,"score_spread":0.26645087804031203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111053964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98823464,0.00084747275,0.00072079425,0.008411302,0.00019280583,0.0009988013,0.00016693785,0.000085230684,0.00034199536],"genre_scores_gemma":[0.99333966,0.00041621012,0.00094385684,0.0045108786,0.00018363063,0.00010340325,0.0004372819,0.000042381147,0.000022713799],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99860895,0.00013321989,0.00034502693,0.00039200956,0.00017656249,0.00034422334],"domain_scores_gemma":[0.9991915,0.00026368944,0.00016122263,0.00009610873,0.00013586797,0.00015157984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000094512645,0.00023571901,0.0005428234,0.00013501295,0.00008796641,0.000015974674,0.00009305148,0.00011927129,0.000030464698],"category_scores_gemma":[0.00017787532,0.00018805136,0.00012380544,0.00025723228,0.00005783404,0.000096654934,0.000014417176,0.00021174102,0.000004460992],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011320468,0.0026226325,0.87736565,0.00012472141,0.00028447597,0.008023341,0.0021830476,0.000025519741,0.086900994,0.00056483556,0.007518832,0.003065483],"study_design_scores_gemma":[0.02660081,0.004746331,0.9594772,0.000025954909,0.0003524293,0.00033057536,0.00019977316,0.0012513874,0.00040218487,0.00013783472,0.0061886315,0.0002869005],"about_ca_topic_score_codex":0.000046558704,"about_ca_topic_score_gemma":0.0000865373,"teacher_disagreement_score":0.08649881,"about_ca_system_score_codex":0.000077608136,"about_ca_system_score_gemma":0.00039082862,"threshold_uncertainty_score":0.7668512},"labels":[],"label_agreement":null},{"id":"W3111083929","doi":"10.1093/neuonc/noaa215.225","title":"CTNI-59. FIRST SAFETY ANALYSIS OF ANAPLASTIC MENINGIOMA PATIENTS TREATED WITH TUMOR TREATING FIELDS (TTFIELDS)","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute","keywords":"Medicine; Meningioma; Adverse effect; Oncology; Internal medicine; Lung cancer; Cancer; Surgery","score_opus":0.015087921792601372,"score_gpt":0.2582071799256962,"score_spread":0.24311925813309482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111083929","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99299854,0.00004167536,0.000060795053,0.0028183574,0.00005245159,0.00041064573,0.00005134389,0.000059397677,0.0035067783],"genre_scores_gemma":[0.99799764,0.000020277399,0.00023691531,0.0014735175,0.000052269846,0.00004847587,0.00014336215,0.000020887694,0.000006674339],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99848515,0.00008877386,0.00046567465,0.00043405863,0.00024155635,0.00028480915],"domain_scores_gemma":[0.9983335,0.00075380615,0.00026482958,0.0002542182,0.00014219344,0.00025142246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000045682118,0.0002328021,0.0009042954,0.00025154065,0.000087643115,0.000008253814,0.0000927612,0.0001299065,0.00037585385],"category_scores_gemma":[0.00030456175,0.00017099928,0.00021248226,0.0011242403,0.00006725638,0.000041631487,0.00004993858,0.00017745633,0.000012226949],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022155112,0.0012217589,0.981088,0.00006269009,0.0020948597,0.0012014555,0.00089341856,0.0008543765,0.0040892675,0.000041574298,0.0009853449,0.005251762],"study_design_scores_gemma":[0.025538474,0.048341263,0.830473,0.00013552424,0.019080412,0.000086741406,0.00043464176,0.01739034,0.037356716,0.000004410646,0.020589463,0.0005689907],"about_ca_topic_score_codex":0.00014973641,"about_ca_topic_score_gemma":0.00036999103,"teacher_disagreement_score":0.15061496,"about_ca_system_score_codex":0.000109987006,"about_ca_system_score_gemma":0.00008543643,"threshold_uncertainty_score":0.6973148},"labels":[],"label_agreement":null},{"id":"W3111092241","doi":"10.1093/neuonc/noaa222.192","title":"EPID-06. DIAGNOSTIC INTERVAL TIME OF PEDIATRIC CNS TUMORS: A REPORT OF THE CANCER IN YOUNG PEOPLE IN CANADA (CYP-C) DATABASE","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; C17 Council; BC Children's Hospital; Izaak Walton Killam Health Centre; Centre hospitalier universitaire de Québec; Alberta Children's Hospital","funders":"","keywords":"Medicine; Medulloblastoma; Demographics; Cohort; Atypical teratoid rhabdoid tumor; Pediatrics; Confidence interval; Cancer; Database; Internal medicine; Pathology; Demography","score_opus":0.019209281843366066,"score_gpt":0.2803934093081584,"score_spread":0.26118412746479236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111092241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98773724,0.00033061634,9.56347e-7,0.010664969,0.00025783,0.0005786864,0.00013145788,0.0000065801787,0.00029165813],"genre_scores_gemma":[0.9985668,0.00019345198,0.000021805787,0.00091862824,0.0001228499,0.00012755183,0.000026089154,0.00001826576,0.0000045327233],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983231,0.00016896338,0.0006759475,0.0003368154,0.00024215644,0.00025301627],"domain_scores_gemma":[0.9980965,0.0010347029,0.00032645446,0.00035145727,0.00006223047,0.00012862023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015037479,0.00014484735,0.00064371206,0.000100926256,0.000013842099,0.0000017761085,0.00017152705,0.000052871703,0.00019871016],"category_scores_gemma":[0.0023846626,0.00010829423,0.00007663861,0.00063349516,0.00004005537,0.000033791766,0.0001771031,0.0002534319,0.0000051749007],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007570285,0.0004302656,0.9775587,0.00010984278,0.00002216759,0.0037443098,0.0006055797,0.00011939427,0.0109517,0.000004185786,0.0061035603,0.00027463806],"study_design_scores_gemma":[0.0026058315,0.0004922869,0.9834852,0.00009532415,0.00020100115,0.00028168282,0.0002108145,0.00042191675,0.011375134,0.0000033365066,0.00073492393,0.000092541704],"about_ca_topic_score_codex":0.6299733,"about_ca_topic_score_gemma":0.9091761,"teacher_disagreement_score":0.27920285,"about_ca_system_score_codex":0.0005586546,"about_ca_system_score_gemma":0.002827398,"threshold_uncertainty_score":0.50156826},"labels":[],"label_agreement":null},{"id":"W3111131691","doi":"10.1093/neuonc/noaa215.543","title":"NCOG-04. PRETREATMENT VOLUME OF MR-DETERMINED WHITE MATTER INJURY (WMI) PREDICTS NEUROCOGNITIVE DECLINE AFTER HIPPOCAMPAL AVOIDANT (HA) WBRT+MEMANTINE FOR BRAIN METASTASES: SECONDARY ANALYSIS OF NRG ONCOLOGYCC001","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Montréal; University of Saskatchewan","funders":"","keywords":"Memantine; Medicine; Neurocognitive; Boston Naming Test; Cohort; Post-hoc analysis; Trail Making Test; Internal medicine; Oncology; Nuclear medicine; Dementia; Cognition; Psychiatry; Cognitive impairment","score_opus":0.01886071845245987,"score_gpt":0.308536920879403,"score_spread":0.28967620242694314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111131691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9649042,0.00034648625,0.001025636,0.024125388,0.0005156485,0.0038380853,0.004053924,0.00011286614,0.0010777954],"genre_scores_gemma":[0.96968997,0.00013634546,0.0011665049,0.02673926,0.00035459505,0.0010211498,0.0005543023,0.00010936441,0.00022852821],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99502885,0.0007229951,0.0017236532,0.0011883237,0.00053243624,0.00080372154],"domain_scores_gemma":[0.9949009,0.0019835692,0.0011260825,0.0005071143,0.0010546139,0.0004277493],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005528499,0.00067652296,0.0028536187,0.0006698077,0.00010276013,0.000012665362,0.0002620852,0.00032254276,0.0021534015],"category_scores_gemma":[0.0018031887,0.00061393686,0.00086937397,0.0015665991,0.0006954827,0.00016676624,0.00048849976,0.00066396507,0.00005694254],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.063513376,0.0050864588,0.6373651,0.001853335,0.020596629,0.0019124877,0.0057889353,0.00013434544,0.1554224,0.0000060854277,0.07123024,0.037090603],"study_design_scores_gemma":[0.04080089,0.08131091,0.68838876,0.00036653972,0.05403835,0.00033991327,0.0018414289,0.006546663,0.052203342,0.0000655202,0.07282798,0.001269676],"about_ca_topic_score_codex":0.00003676341,"about_ca_topic_score_gemma":0.00015788633,"teacher_disagreement_score":0.10321906,"about_ca_system_score_codex":0.0002891493,"about_ca_system_score_gemma":0.0006744467,"threshold_uncertainty_score":0.9996312},"labels":[],"label_agreement":null},{"id":"W3111132783","doi":"10.1093/neuonc/noaa215.816","title":"RTID-11. GBM AGILE: A GLOBAL, PHASE 2/3 ADAPTIVE PLATFORM TRIAL TO EVALUATE MULTIPLE REGIMENS IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Clinical trial; Medicine; Clinical endpoint; Agile software development; Glioblastoma; Medical physics; Oncology; Internal medicine; Computer science; Cancer research","score_opus":0.4516531105571223,"score_gpt":0.5440306338959288,"score_spread":0.09237752333880644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111132783","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96233255,0.000049396614,0.015066836,0.012701353,0.002765991,0.0055710217,0.0004712291,0.00024331079,0.0007983326],"genre_scores_gemma":[0.4799692,0.00011053015,0.50686294,0.010186379,0.0017357712,0.0009929492,0.000005575066,0.00012353914,0.000013111105],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99409485,0.0020919298,0.0015872179,0.0010330636,0.0005075565,0.00068540644],"domain_scores_gemma":[0.93069863,0.06748339,0.0004811092,0.0004347524,0.00014889019,0.000753227],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022601513,0.00041014882,0.0015153994,0.000100645026,0.00008122533,0.000040411207,0.0003960345,0.0003985321,0.0001964707],"category_scores_gemma":[0.22669858,0.00034522172,0.00016380384,0.00064944074,0.0002332761,0.000094964824,0.0004451046,0.00063826924,0.00009715957],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.40990913,0.005863876,0.0004384857,0.00021455788,0.00020596244,0.002954117,0.0036931224,0.00006564762,0.010971334,0.024859602,0.06730066,0.4735235],"study_design_scores_gemma":[0.4948066,0.1183823,0.00031279403,0.00023135,0.0006562386,0.00008851945,0.0008335751,0.018203383,0.00445736,0.27071083,0.08991572,0.0014013338],"about_ca_topic_score_codex":0.000030293493,"about_ca_topic_score_gemma":0.0004400103,"teacher_disagreement_score":0.4917961,"about_ca_system_score_codex":0.0003599348,"about_ca_system_score_gemma":0.0003411357,"threshold_uncertainty_score":0.9999},"labels":[],"label_agreement":null},{"id":"W3111168043","doi":"10.1093/neuonc/noaa215.649","title":"NIMG-36. AUTOMATIC STRATIFICATION OF ENHANCING AND NON-ENHANCING GLIOMAS INTO GENETIC SUBTYPES USING DEEP NEURAL NETWORKS AND DIFFUSION-WEIGHTED IMAGING","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Fluid-attenuated inversion recovery; Nuclear medicine; Medicine; Wild type; Magnetic resonance imaging; Mutant; Radiology; Biology; Genetics; Gene","score_opus":0.008937830575716326,"score_gpt":0.2789556554477138,"score_spread":0.27001782487199744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111168043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91720057,0.0010819534,0.077513985,0.003490651,0.00024302455,0.00032050096,3.6182695e-7,0.000067237626,0.000081724866],"genre_scores_gemma":[0.98334014,0.00013350669,0.0142611535,0.0019099086,0.00030059332,0.0000057469388,0.0000071565673,0.00004055783,0.000001246965],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9982888,0.00016815754,0.0005884912,0.00044838432,0.00019579299,0.0003103667],"domain_scores_gemma":[0.9986883,0.00044911954,0.00029352252,0.000179458,0.00008266947,0.00030697562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024601063,0.00020948757,0.00054957997,0.00014447216,0.00015524769,0.00003619641,0.00009609967,0.00011429108,0.000025717649],"category_scores_gemma":[0.0005299102,0.00019311302,0.000050633127,0.0002880039,0.00023514699,0.000098920194,0.000128799,0.000526673,0.0000011654182],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008147755,0.000040891893,0.01772679,0.00025614942,0.000022579703,0.00015589267,0.0018504017,0.00062279234,0.8486714,0.000011389452,0.00001656281,0.13054371],"study_design_scores_gemma":[0.0012652903,0.00035853471,0.015360616,0.00008776761,0.00017974319,0.00040628517,0.00038693307,0.9748754,0.0067577674,0.000060845832,0.00011611231,0.00014470541],"about_ca_topic_score_codex":0.00010043285,"about_ca_topic_score_gemma":0.000025538948,"teacher_disagreement_score":0.9742526,"about_ca_system_score_codex":0.00006262868,"about_ca_system_score_gemma":0.000102277074,"threshold_uncertainty_score":0.7874921},"labels":[],"label_agreement":null},{"id":"W3111212852","doi":"10.1093/neuonc/noaa222.445","title":"LINC-10. SIOP PODC ADAPTED TREATMENT GUIDELINES FOR CRANIOPHARYNGIOMA IN LOW- AND MIDDLE-INCOME SETTINGS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Craniopharyngioma; Guideline; Medicine; Radiation therapy; Multidisciplinary approach; Intensive care medicine; Pediatrics; Family medicine; Internal medicine; Surgery; Pathology","score_opus":0.07080230233917652,"score_gpt":0.33857971891781224,"score_spread":0.26777741657863574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111212852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9506358,0.0013856939,0.000031327745,0.04524101,0.00017254268,0.0012217973,0.00007265358,0.00009074214,0.0011484378],"genre_scores_gemma":[0.98020405,0.0005207401,0.002501071,0.015799934,0.000346254,0.00018911202,0.0001578064,0.000048769012,0.00023229625],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985057,0.000055457363,0.0004690049,0.00049840915,0.00011492244,0.00035652224],"domain_scores_gemma":[0.99900466,0.00030125788,0.00010290976,0.00017050651,0.00012607686,0.00029458394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000073267576,0.00026418734,0.00064836745,0.00010260464,0.000068295405,0.000009601754,0.000070448295,0.00016509046,0.000104146995],"category_scores_gemma":[0.00043263996,0.00020335487,0.00012190754,0.00017302672,0.000050471554,0.000060255294,0.000050847037,0.000098783225,0.000040230454],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05247043,0.01428794,0.40355632,0.0041160625,0.0021414266,0.027724585,0.010004024,0.0002383711,0.16220026,0.0005667851,0.046105117,0.27658868],"study_design_scores_gemma":[0.1420738,0.06339251,0.060958937,0.0007344868,0.0014342909,0.001088613,0.0012214471,0.023844669,0.008811823,0.00090781524,0.6943341,0.0011975365],"about_ca_topic_score_codex":0.00008034732,"about_ca_topic_score_gemma":0.000070878705,"teacher_disagreement_score":0.64822894,"about_ca_system_score_codex":0.00011166542,"about_ca_system_score_gemma":0.00018038014,"threshold_uncertainty_score":0.8292571},"labels":[],"label_agreement":null},{"id":"W3111229185","doi":"10.1093/neuonc/noaa222.405","title":"LGG-23. EXCELLENT CLINICAL / RADIOLOGICAL RESPONSE TO BRAF INHIBITION IN A YOUNG CHILD WITH IN-OPERABLE SUPRA-SELLAR PILOCYTIC ASTROCYTOMA","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Medicine; Trametinib; Pilocytic astrocytoma; Temozolomide; Oncology; Regimen; Internal medicine; Population; Lomustine; Vincristine; Dabrafenib; Chemotherapy; Vemurafenib; Glioma; Radiology; Astrocytoma; Cancer research; Cancer; Cyclophosphamide","score_opus":0.036983869973123945,"score_gpt":0.31999092182742633,"score_spread":0.2830070518543024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111229185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.962408,0.0001544875,0.000023769797,0.035080448,0.00015781673,0.0011727432,0.000007004685,0.000065025786,0.0009306856],"genre_scores_gemma":[0.98889214,0.00013886156,0.00054200465,0.009937519,0.0002157561,0.0002091217,0.000023704066,0.00003288945,0.000008023048],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996804,0.00097125635,0.0007055796,0.0007652169,0.00024345088,0.00051050435],"domain_scores_gemma":[0.99816626,0.0009179004,0.000102123544,0.00028218376,0.00005384202,0.0004776602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000622184,0.00026680276,0.0008729157,0.000218452,0.00006494465,0.000016276132,0.00008965418,0.0002705445,0.00012189742],"category_scores_gemma":[0.00093470427,0.00020269936,0.00010996121,0.0005448888,0.00011244831,0.000053337804,0.00010642008,0.00071300194,0.000226051],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08567221,0.0072108125,0.69683343,0.0000733611,0.00012254887,0.06369607,0.0026040024,0.0008631104,0.13115564,0.000103826875,0.0049347756,0.0067301947],"study_design_scores_gemma":[0.05719267,0.113033585,0.73241323,0.0003290555,0.0002476587,0.005672177,0.0009237268,0.0013368566,0.02407493,0.000018877654,0.06414007,0.000617176],"about_ca_topic_score_codex":0.000036789897,"about_ca_topic_score_gemma":0.00031192356,"teacher_disagreement_score":0.10708071,"about_ca_system_score_codex":0.00043654893,"about_ca_system_score_gemma":0.00031306932,"threshold_uncertainty_score":0.826584},"labels":[],"label_agreement":null},{"id":"W3111237371","doi":"10.1093/neuonc/noaa222.200","title":"EPID-14. GABRIELLA MILLER KIDS FIRST DATA RESOURCE CENTER: COLLABORATIVE PLATFORMS FOR ACCELERATING RESEARCH IN PEDIATRIC CANCERS &amp; STRUCTURAL BIRTH DEFECTS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Institute of Cancer Research; Ontario Institute for Cancer Research","funders":"","keywords":"Interoperability; Computer science; Workflow; Cloud computing; Download; Data science; Resource (disambiguation); World Wide Web; Database","score_opus":0.5799484253499697,"score_gpt":0.5626859255386454,"score_spread":0.017262499811324328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111237371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93123865,0.0005263525,0.00006311223,0.05616759,0.0005941896,0.0030208044,0.0004613428,0.00009334799,0.007834608],"genre_scores_gemma":[0.9827939,0.0018025679,0.0031082386,0.009540231,0.0018371159,0.00020626608,0.000377756,0.00010766687,0.00022622538],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99436855,0.0005807172,0.0010169946,0.0014499937,0.0013244329,0.0012592832],"domain_scores_gemma":[0.95440906,0.042201024,0.0002587861,0.0012341314,0.0010669668,0.0008300156],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.004670206,0.00029478138,0.00082780776,0.00037217364,0.00038197121,0.00007383701,0.0012332388,0.0007791587,0.00017917842],"category_scores_gemma":[0.06595064,0.00025476955,0.00009884077,0.00202482,0.00059424486,0.00019168611,0.0015767975,0.004890172,0.00006307965],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02500086,0.0008902115,0.50644994,0.006122903,0.00027029015,0.0019868906,0.019302104,0.0012575609,0.034505025,0.0030056185,0.37886354,0.02234506],"study_design_scores_gemma":[0.015218053,0.0099469,0.0068358704,0.0001930562,0.00007998312,0.000071639035,0.0024195805,0.0049489047,0.0020108954,0.0022756557,0.95542115,0.0005783391],"about_ca_topic_score_codex":0.0001832157,"about_ca_topic_score_gemma":0.009728909,"teacher_disagreement_score":0.5765576,"about_ca_system_score_codex":0.0009913266,"about_ca_system_score_gemma":0.0043336237,"threshold_uncertainty_score":0.99999046},"labels":[],"label_agreement":null},{"id":"W3111276509","doi":"10.1093/neuonc/noaa215.845","title":"STEM-28. NANOPARTICLES ENCAPSULATING A CONNEXIN43 MIMETIC PEPTIDE LIMIT GLIOMA STEM CELL SURVIVAL AND GLIOBLASTOMA PROGRESSION","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Temozolomide; Glioma; Cancer research; Stem cell; Microtubule; Neurosphere; Population; Brain tumor; In vivo; In vitro; Peptide; Biology; Chemistry; Medicine; Cell biology; Pathology; Biochemistry; Adult stem cell","score_opus":0.022188707121968018,"score_gpt":0.24620447627864195,"score_spread":0.22401576915667393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111276509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953796,0.0010078057,0.00026305826,0.00035495055,0.00075434556,0.0004908049,0.000017124943,0.0005715003,0.0011608112],"genre_scores_gemma":[0.99862087,0.00007447182,0.00066463323,0.0002471585,0.00022256923,0.00004560233,0.0000024586338,0.000111653295,0.000010565595],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980614,0.00011298558,0.00052334706,0.0004406852,0.00027175905,0.00058979617],"domain_scores_gemma":[0.9986545,0.00056017004,0.00013397471,0.00024362793,0.00005623622,0.00035152189],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016344804,0.0003429441,0.0005167011,0.00010179243,0.000121208024,0.00006314282,0.00024019778,0.00022065295,0.000034450986],"category_scores_gemma":[0.000036082576,0.00033522063,0.00007948113,0.00038965407,0.000114869006,0.0002054325,0.00015632065,0.00038879356,0.000083213185],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021663442,0.00004294224,0.00064223347,0.00020866164,0.00003075162,0.00031871191,0.0013365975,0.0011804472,0.96309274,0.00008347484,0.00024637466,0.032600407],"study_design_scores_gemma":[0.0022528535,0.0025244697,0.000157128,0.000051754196,0.000085045285,0.00012502092,0.00085880334,0.034205236,0.9407601,0.000055994944,0.018481353,0.00044228815],"about_ca_topic_score_codex":0.000003285137,"about_ca_topic_score_gemma":0.000015972782,"teacher_disagreement_score":0.033024788,"about_ca_system_score_codex":0.00014232227,"about_ca_system_score_gemma":0.00008528534,"threshold_uncertainty_score":0.99991},"labels":[],"label_agreement":null},{"id":"W3111280014","doi":"10.1093/neuonc/noaa215.566","title":"NCOG-28. SURGERY FOR RECURRENT GBM IMPROVES SURVIVAL INDEPENDENT OF PROGNOSTIC FACTORS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Cohort; Proportional hazards model; Internal medicine; Overall survival; Oncology; Surgery; Survival analysis","score_opus":0.060201753995783744,"score_gpt":0.3158303975689967,"score_spread":0.25562864357321297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111280014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99006766,0.0002927006,0.000038520182,0.006640938,0.0012603067,0.0012953595,0.00006627394,0.00006190471,0.00027635263],"genre_scores_gemma":[0.99848086,0.000096289696,0.00010757754,0.00073890603,0.0002461449,0.0002008476,0.0000895521,0.000036054935,0.0000037723987],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983596,0.00011465618,0.00049664086,0.00042589704,0.00025623292,0.00034695643],"domain_scores_gemma":[0.99675035,0.002355246,0.00025004402,0.00019944513,0.00014686158,0.00029806176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015683672,0.00022110071,0.0008095608,0.00011130633,0.000044437515,0.000008181194,0.00009150459,0.00016291517,0.0000657298],"category_scores_gemma":[0.0015045869,0.00017331858,0.0003035716,0.0001848039,0.0000730004,0.00003896051,0.00007121468,0.00018966818,0.000013893398],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00170085,0.00317358,0.59359187,0.00056786503,0.00039541456,0.0004077311,0.00092384045,0.000005844716,0.3218088,0.00027108478,0.011522271,0.06563089],"study_design_scores_gemma":[0.0111719165,0.026179079,0.43377993,0.00014223416,0.0015707631,0.00008746118,0.00092956005,0.00048336587,0.3546674,0.00014910765,0.17024486,0.0005943308],"about_ca_topic_score_codex":0.000019381288,"about_ca_topic_score_gemma":0.000027212662,"teacher_disagreement_score":0.15981193,"about_ca_system_score_codex":0.000104792685,"about_ca_system_score_gemma":0.00036046503,"threshold_uncertainty_score":0.7067726},"labels":[],"label_agreement":null},{"id":"W3111311155","doi":"10.1093/neuonc/noaa222.090","title":"DIPG-43. CAN WE REPROGRAM DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)? EXPLORING THE ROLE OF DISTALLESS/DLX HOMEOBOX GENE REGULATION OF OLIGODENDROGLIAL PROGENITOR CELLS (OPC) IN THE DEVELOPING VERTEBRATE NERVOUS SYSTEM","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Biology; OLIG2; Progenitor cell; Cellular differentiation; Neurosphere; Cell biology; Neural stem cell; Cancer research; Stem cell; Oligodendrocyte; Genetics; Gene; Myelin; Adult stem cell; Neuroscience; Central nervous system","score_opus":0.03152641859133665,"score_gpt":0.2560911470825856,"score_spread":0.22456472849124898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111311155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909696,0.000650414,0.000015460328,0.0063138586,0.00037607545,0.001493666,0.000021235119,0.00006390711,0.000095761156],"genre_scores_gemma":[0.99844164,0.00014377825,0.00030214645,0.00020472104,0.00034830955,0.00049129635,0.000023353843,0.000043450218,0.0000013030362],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975577,0.00040431286,0.00078681036,0.00046972276,0.00039615433,0.00038531868],"domain_scores_gemma":[0.99844253,0.00034750515,0.00042089174,0.0005207629,0.00014431133,0.00012399592],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002776076,0.00027131158,0.0007230779,0.00015345031,0.000097742995,0.0000240588,0.00029771685,0.000119242526,0.0000047516714],"category_scores_gemma":[0.00014384421,0.0001724164,0.00016498986,0.0007423068,0.00013271395,0.00006988129,0.0001615546,0.00025811713,0.000006012541],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006534757,0.0009633301,0.01772029,0.00032313747,0.00018004289,0.0008800427,0.005931416,0.00009483615,0.9071891,0.0010041469,0.00006394523,0.06499624],"study_design_scores_gemma":[0.0048388066,0.0019740288,0.029670287,0.00017640254,0.00035969308,0.00030066218,0.0032540716,0.0010939266,0.95265144,0.000045274857,0.005435246,0.00020014595],"about_ca_topic_score_codex":0.00020620688,"about_ca_topic_score_gemma":0.00016618692,"teacher_disagreement_score":0.0647961,"about_ca_system_score_codex":0.00023317784,"about_ca_system_score_gemma":0.00023372527,"threshold_uncertainty_score":0.70309365},"labels":[],"label_agreement":null},{"id":"W3111313584","doi":"10.1093/neuonc/noaa222.212","title":"ETMR-08. INTERNATIONAL CONSENSUS PROTOCOL FOR EMBRYONAL TUMOR WITH MULTILAYER ROSETTES","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Chemotherapy; Clinical trial; Radiation therapy; Oncology; Topotecan; Protocol (science); Induction chemotherapy; Internal medicine; Surgery; Pathology; Alternative medicine","score_opus":0.049436311953836465,"score_gpt":0.3539403094111172,"score_spread":0.30450399745728074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111313584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.49686196,0.000017099113,0.00015308592,0.24824376,0.00063183304,0.24522278,0.00023006575,0.0003252932,0.008314114],"genre_scores_gemma":[0.60376894,9.70116e-7,0.007722793,0.03461445,0.0008726422,0.3528357,0.00006309873,0.00007214405,0.00004924679],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99887884,0.000045282468,0.00025318406,0.00038082642,0.00019786063,0.00024401744],"domain_scores_gemma":[0.9989088,0.00044551137,0.00013168332,0.00013174614,0.0001688307,0.00021341635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005431852,0.00017675007,0.00033806654,0.000056312023,0.000054800115,0.000015575413,0.000093092,0.000060897946,0.00032098845],"category_scores_gemma":[0.00027648394,0.0001261851,0.00009505339,0.00008417947,0.00009235179,0.000023791354,0.000045993223,0.00016487476,0.00007094562],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01674105,0.0043436135,0.10144226,0.0002901478,0.0006832267,0.0075810924,0.00063044875,0.00015212828,0.58952177,0.0010463707,0.26064724,0.016920665],"study_design_scores_gemma":[0.023982733,0.0067559676,0.006502477,0.0000343945,0.00011932716,0.00068385695,0.00007868713,0.0022054878,0.070020355,0.000027290653,0.8894342,0.00015520025],"about_ca_topic_score_codex":0.0000056912845,"about_ca_topic_score_gemma":0.000011384455,"teacher_disagreement_score":0.628787,"about_ca_system_score_codex":0.000097138734,"about_ca_system_score_gemma":0.00026653585,"threshold_uncertainty_score":0.5145679},"labels":[],"label_agreement":null},{"id":"W3111326672","doi":"10.1093/neuonc/noaa215.092","title":"COVD-08. THE DIVIDED PRINCIPLE OF JUSTICE: ETHICAL DECISION-MAKING IN CANCER CARE DURING THE COVID-19 PANDEMIC","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pandemic; Coronavirus disease 2019 (COVID-19); Economic Justice; 2019-20 coronavirus outbreak; Ethical decision; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Political science; Sociology; Psychology; Medicine; Virology; Law; Pathology; Infectious disease (medical specialty); Outbreak","score_opus":0.14059576891632775,"score_gpt":0.4900574272838087,"score_spread":0.34946165836748094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111326672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8337189,0.0009291425,0.00019108203,0.1636126,0.00043038095,0.00085399044,0.000024470146,0.00006210752,0.00017731413],"genre_scores_gemma":[0.8419556,0.0005453256,0.000052279793,0.15695345,0.00040360715,0.00006055821,0.00000219754,0.000023319317,0.0000036394797],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99758,0.00054937595,0.0005778642,0.00040294882,0.0004356319,0.00045416804],"domain_scores_gemma":[0.99035484,0.008466909,0.00023040043,0.00041999432,0.00014324253,0.0003846459],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0006398807,0.00018064074,0.00053771253,0.00009125319,0.0002522571,0.000011366479,0.00034386222,0.00041254394,0.00019198739],"category_scores_gemma":[0.016358048,0.0001089027,0.00010888047,0.0004950354,0.00024647155,0.00003207045,0.00029540772,0.001960787,0.00001375427],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064051873,0.00017243171,0.7921445,0.004126179,0.00007889306,0.0015465042,0.067318015,0.0044895415,0.07338629,0.0007132498,0.004068118,0.04555113],"study_design_scores_gemma":[0.007078878,0.0019280236,0.35319793,0.00035369885,0.0004306261,0.0005006994,0.004954696,0.0012610554,0.0007752698,0.00031200482,0.6289115,0.0002956325],"about_ca_topic_score_codex":0.0005062221,"about_ca_topic_score_gemma":0.0035499271,"teacher_disagreement_score":0.62484336,"about_ca_system_score_codex":0.001053971,"about_ca_system_score_gemma":0.0038478265,"threshold_uncertainty_score":0.99192756},"labels":[],"label_agreement":null},{"id":"W3111343982","doi":"10.1093/neuonc/noab195.011","title":"Chemotherapy strategies for young children newly diagnosed with desmoplastic/extensive nodular medulloblastoma up to the era of molecular profiling – a comparative outcomes analysis of prospective multi-center European and North American trials.","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Medulloblastoma; Medicine; Oncology; Induction chemotherapy; Chemotherapy; Internal medicine; Clinical trial; Surgery; Pathology","score_opus":0.027636611289669263,"score_gpt":0.32327387925239115,"score_spread":0.2956372679627219,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111343982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946421,0.00013512929,0.0015349798,0.0011971274,0.000062376515,0.0021719441,0.00020460872,0.000017588203,0.000034154862],"genre_scores_gemma":[0.9939409,0.0000509596,0.0046280297,0.0009882341,0.000025319381,0.00023410951,0.00009937506,0.00003143082,0.0000016260605],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980584,0.0004732737,0.00051664986,0.0004928419,0.00020975772,0.00024912413],"domain_scores_gemma":[0.99747944,0.0009760034,0.0004875282,0.00032082677,0.0006161174,0.000120087694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020514085,0.0002691591,0.0016349243,0.00014707774,0.000067954614,0.000021378506,0.00009369761,0.0000338332,0.000005113415],"category_scores_gemma":[0.0003851917,0.00016302761,0.00027278787,0.0007777266,0.0002603603,0.000039061248,0.000053103857,0.00016866851,7.4777654e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017126857,0.0015544647,0.93000567,0.000021635655,0.0071724197,0.00027140987,0.00601241,0.0009805507,0.0497825,0.00008072779,0.000052826836,0.0023526833],"study_design_scores_gemma":[0.0137748225,0.003792876,0.9185714,0.000027377746,0.0033155605,0.000051105715,0.0033071402,0.0004086827,0.056558467,0.0000021478484,0.000058254827,0.00013214973],"about_ca_topic_score_codex":0.00011539986,"about_ca_topic_score_gemma":0.0018745261,"teacher_disagreement_score":0.012062136,"about_ca_system_score_codex":0.00006161454,"about_ca_system_score_gemma":0.00023706854,"threshold_uncertainty_score":0.6648073},"labels":[],"label_agreement":null},{"id":"W3111351219","doi":"10.1093/neuonc/noaa222.241","title":"GCT-21. CENTRAL NERVOUS SYSTEM GERMINOMA - PONDERING THE NEXT STEPS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Germinoma; Medicine; Clinical trial; Intensive care medicine; Germ cell tumors; Radiation therapy; Neuroscience; Pathology; Chemotherapy; Surgery; Psychology","score_opus":0.047953098766740296,"score_gpt":0.2819145050478508,"score_spread":0.2339614062811105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111351219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95527244,0.000601344,0.000023299668,0.03477399,0.00081589934,0.0007266734,0.000008087393,0.00018561224,0.0075926743],"genre_scores_gemma":[0.9906365,0.000046271245,0.00007502794,0.008421058,0.0006723748,0.000086065964,0.000009786582,0.000036644975,0.000016264505],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99846464,0.00015410446,0.00031353594,0.0003826352,0.00020650854,0.00047859323],"domain_scores_gemma":[0.9988361,0.0003347104,0.00011649194,0.00032301576,0.000043422828,0.00034623774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007202655,0.00020691109,0.00045419176,0.00004353673,0.00014413535,0.000034537417,0.00016645427,0.00013043698,0.00010489366],"category_scores_gemma":[0.00009525654,0.00013706263,0.00015990018,0.00018882529,0.00007689296,0.00006694963,0.0001129688,0.0002901705,0.00023602368],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010506674,0.0014026167,0.05404397,0.0005666781,0.0006018095,0.030472375,0.006414834,0.00024922658,0.68143845,0.00575029,0.041955277,0.17605379],"study_design_scores_gemma":[0.009356514,0.0061168154,0.092156775,0.0001030493,0.0010215332,0.004456932,0.0037808805,0.0054108594,0.038420666,0.000020856158,0.8387065,0.0004486105],"about_ca_topic_score_codex":0.00004055305,"about_ca_topic_score_gemma":0.000011493482,"teacher_disagreement_score":0.7967512,"about_ca_system_score_codex":0.00025020927,"about_ca_system_score_gemma":0.00017354777,"threshold_uncertainty_score":0.55892515},"labels":[],"label_agreement":null},{"id":"W3111413047","doi":"10.1093/neuonc/noaa222.453","title":"LINC-18. FOLLOW-UP EVALUATION OF A WEB-BASED PEDIATRIC BRAIN TUMOR BOARD IN LATIN AMERICA","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Advances in Oncology and Radiotherapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Latin Americans; Psychological intervention; Family medicine; Institutional review board; Presentation (obstetrics); Modalities; MEDLINE; Medical physics; Medical education; Nursing; Surgery; Political science","score_opus":0.043407517764554086,"score_gpt":0.3839605859701843,"score_spread":0.3405530682056302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111413047","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95962477,0.0007493488,0.0007983437,0.031525042,0.001141994,0.0010935906,0.000012730091,0.00009128814,0.0049629216],"genre_scores_gemma":[0.953211,0.00018281261,0.004880283,0.04059845,0.00091557356,0.000116831055,0.000020646634,0.000039496525,0.000034916357],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99766564,0.0007460673,0.0005311405,0.0004048393,0.00036500636,0.00028730815],"domain_scores_gemma":[0.99761975,0.0015137814,0.00032994902,0.00023105428,0.00015454773,0.00015089789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005581027,0.00017615376,0.00067727134,0.00020521309,0.000038529382,0.0000021854507,0.00014699089,0.00020538578,0.0007414872],"category_scores_gemma":[0.002706051,0.00016211269,0.00012082589,0.0006907779,0.00019235066,0.000048619906,0.000031234,0.0005135141,0.000041863692],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009804778,0.0017682125,0.2978125,0.00034217868,0.00010284365,0.0010602683,0.0028609708,0.005120995,0.38869175,0.00010111947,0.07436463,0.21796976],"study_design_scores_gemma":[0.07056484,0.022753375,0.051329415,0.000047885973,0.0008086701,0.00010966394,0.00043559674,0.14293672,0.006673404,0.00037454467,0.70339215,0.00057373464],"about_ca_topic_score_codex":0.000010714499,"about_ca_topic_score_gemma":0.000031857602,"teacher_disagreement_score":0.6290275,"about_ca_system_score_codex":0.00027916327,"about_ca_system_score_gemma":0.0016704953,"threshold_uncertainty_score":0.81187654},"labels":[],"label_agreement":null},{"id":"W3111419497","doi":"10.1093/neuonc/noaa222.522","title":"MBRS-01. DISSECTING REGULATORS OF THE ABERRANT POST-TRANSCRIPTIONAL LANDSCAPE IN MYC-AMPLIFIED GROUP 3 MEDULLOBLASTOMA","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University","funders":"","keywords":"Medulloblastoma; Cancer research; Oncogene; Biology; Context (archaeology); Mediator; Gene; Computational biology; Genetics; Cell biology; Cell cycle","score_opus":0.015873070933057943,"score_gpt":0.2675625135859207,"score_spread":0.25168944265286275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111419497","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948197,0.00017284788,0.00008703888,0.0036312486,0.00025500456,0.00023827571,0.000016954467,0.000010516586,0.00076844095],"genre_scores_gemma":[0.9976959,0.00004176587,0.0000959741,0.0018290303,0.00022692603,0.000019171248,0.000029630308,0.000021087706,0.00004052071],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985613,0.00023325782,0.00030854438,0.0003602501,0.00020456254,0.0003320401],"domain_scores_gemma":[0.99935716,0.00008089331,0.00010145895,0.00023381122,0.00009514289,0.00013150112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002108444,0.00013813694,0.0002253723,0.000044463122,0.000074693344,0.000010663443,0.00033769838,0.00018146765,0.000045478657],"category_scores_gemma":[0.00060310017,0.00010693202,0.00013128595,0.00020566426,0.000118369964,0.0000058064975,0.00015163416,0.00029429005,0.000004885555],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005191091,0.00006968706,0.0128826285,0.000026438665,0.00002013664,0.000016255097,0.00021608562,0.0000889799,0.9838032,0.00016740435,0.00079706777,0.0013929912],"study_design_scores_gemma":[0.004143515,0.004157145,0.15972677,0.00004351584,0.00003366162,0.00015237315,0.0013476486,0.0015156813,0.7568884,0.000091855945,0.07147165,0.0004277999],"about_ca_topic_score_codex":0.0000501844,"about_ca_topic_score_gemma":0.00039064302,"teacher_disagreement_score":0.22691482,"about_ca_system_score_codex":0.000021659696,"about_ca_system_score_gemma":0.00016735157,"threshold_uncertainty_score":0.43605614},"labels":[],"label_agreement":null},{"id":"W3111439303","doi":"10.1093/neuonc/noaa215.739","title":"QOLP-14. FROM SYMPTOMS TO RADIOTHERAPY: A QUALITATIVE ASSESSMENT OF PATIENT EXPERIENCE IN NEWLY DIAGNOSED HIGH-GRADE GLIOMA","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Thematic analysis; Empathy; Anxiety; Grounded theory; Medicine; Qualitative research; Perception; Patient experience; Focus group; Health care; Psychology; Psychiatry","score_opus":0.11904557650495172,"score_gpt":0.46804479647526936,"score_spread":0.34899921997031763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111439303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903332,0.00058635446,0.00079249847,0.006960509,0.00033324718,0.00060533773,0.000055007138,0.000033238095,0.00030059775],"genre_scores_gemma":[0.98143995,0.0002567145,0.011139335,0.0068406994,0.00013148597,0.00014130108,0.00002300955,0.000025224155,0.0000022548768],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978243,0.0005132654,0.00061569293,0.00043640632,0.00034457972,0.00026572414],"domain_scores_gemma":[0.99726325,0.001871739,0.00024921712,0.00024471516,0.00012067894,0.0002504058],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010984454,0.0001996178,0.00087636226,0.00015362477,0.00001744011,0.000004149435,0.0001724058,0.00013253056,0.0001510187],"category_scores_gemma":[0.00079802744,0.00017906316,0.00009842933,0.0005148031,0.00014679367,0.000057927617,0.00007275228,0.00023453857,0.00000648065],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006927426,0.0005821763,0.04001006,0.000046801866,0.00009185461,0.0006232595,0.25922406,0.00010071491,0.6878554,0.00025455217,0.0013814229,0.009136917],"study_design_scores_gemma":[0.023073632,0.03574383,0.07376705,0.0008238936,0.00017853458,0.0000176868,0.089302436,0.0012297662,0.5578309,0.00027647222,0.2169955,0.0007602689],"about_ca_topic_score_codex":0.0008764598,"about_ca_topic_score_gemma":0.00007337436,"teacher_disagreement_score":0.21561407,"about_ca_system_score_codex":0.00023644639,"about_ca_system_score_gemma":0.00026520583,"threshold_uncertainty_score":0.7301984},"labels":[],"label_agreement":null},{"id":"W3111439742","doi":"10.1093/neuonc/noaa222.560","title":"MBRS-54. POOR SURVIVAL IN REPLICATION REPAIR DEFICIENT HYPERMUTANT MEDULLOBLASTOMA AND CNS EMBRYONAL TUMORS: A REPORT FROM THE INTERNATIONAL RRD CONSORTIUM","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Cancer research; Germline mutation; Atypical teratoid rhabdoid tumor; Biology; Medicine; Mutation; Internal medicine; Oncology; Genetics; Gene","score_opus":0.03209832332616528,"score_gpt":0.29668872118507766,"score_spread":0.26459039785891236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111439742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9203682,0.00021229354,0.0000111762765,0.076803535,0.00041081582,0.0005174269,0.00004839744,0.00008781168,0.0015403528],"genre_scores_gemma":[0.9899591,0.00006594762,0.00024335162,0.009149349,0.0002948334,0.00014379082,0.000112030546,0.000021615784,0.000009986788],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979861,0.00015041383,0.0005693877,0.000723126,0.00034551247,0.00022545585],"domain_scores_gemma":[0.9983061,0.00074734725,0.00023185069,0.00042714988,0.0001071182,0.00018041987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003201515,0.0001743167,0.00039778606,0.000063436055,0.000061925064,0.000020248817,0.00013978923,0.000102699036,0.00012225725],"category_scores_gemma":[0.0016003205,0.00012622341,0.000108682405,0.00018742174,0.00013575863,0.00004353455,0.00015776388,0.00026863575,0.000032214077],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00104303,0.001198263,0.62302697,0.00001667575,0.00019376456,0.011378472,0.0011393435,0.000024488409,0.34173554,0.0007747388,0.013941812,0.005526889],"study_design_scores_gemma":[0.0054147453,0.0015654337,0.78949004,0.00006153577,0.00023485061,0.0034041079,0.0007265287,0.0039244415,0.018187903,0.00011700944,0.17665556,0.00021786561],"about_ca_topic_score_codex":0.00026272665,"about_ca_topic_score_gemma":0.00025173047,"teacher_disagreement_score":0.32354766,"about_ca_system_score_codex":0.00019710073,"about_ca_system_score_gemma":0.00030135273,"threshold_uncertainty_score":0.51472414},"labels":[],"label_agreement":null},{"id":"W3111444730","doi":"10.1093/neuonc/noaa222.348","title":"IMG-13. MRI-BASED RADIOMICS PROGNOSTIC MARKERS OF POSTERIOR FOSSA EPENDYMOMA","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Hospital for Sick Children","funders":"","keywords":"Ependymoma; Medicine; Concordance; Radiomics; Magnetic resonance imaging; Radiology; Artificial intelligence; Internal medicine; Computer science","score_opus":0.016532222824277673,"score_gpt":0.29395882249949284,"score_spread":0.27742659967521516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111444730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9129671,0.0001863497,0.0024133709,0.07870369,0.00069162244,0.0007477931,0.000012153218,0.00014527007,0.004132653],"genre_scores_gemma":[0.96765524,0.000034122928,0.0062850337,0.025509514,0.00036941684,0.000024852157,0.00003267199,0.000064220214,0.000024910136],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980896,0.00023465346,0.0005339859,0.0004437665,0.00029647793,0.0004014991],"domain_scores_gemma":[0.99825096,0.00063930015,0.0002550482,0.0002825524,0.00010045021,0.00047165935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003195035,0.00021950297,0.00070457475,0.0001247567,0.000058246285,0.000013638641,0.00023603356,0.00018385882,0.00024931444],"category_scores_gemma":[0.002495455,0.00019962653,0.00018375838,0.00028039556,0.00029098507,0.000043697553,0.00009501067,0.00076300616,0.000042588355],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043224604,0.0006149198,0.06284988,0.0007899535,0.00020006421,0.0073314775,0.0008773867,0.00048095436,0.6855777,0.00012328055,0.018849133,0.21798278],"study_design_scores_gemma":[0.027072275,0.024375776,0.058622498,0.00037702578,0.001310727,0.0062137605,0.00047525324,0.3631127,0.035148486,0.000116439,0.48217797,0.0009971022],"about_ca_topic_score_codex":0.000033867756,"about_ca_topic_score_gemma":0.0000029038622,"teacher_disagreement_score":0.65042925,"about_ca_system_score_codex":0.000092645234,"about_ca_system_score_gemma":0.00056097313,"threshold_uncertainty_score":0.81405336},"labels":[],"label_agreement":null},{"id":"W3111452451","doi":"10.1093/neuonc/noaa215.428","title":"EXTH-74. IND-ENABLING CHARACTERIZATION OF DUAL DRD2- AND ClpP-TARGETING AGENT ONC206 AS THE NEXT IMIPRIDONE FOR CLINICAL NEURO-ONCOLOGY","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Agonist; Pharmacology; Cell culture; Antagonist; Endocrinology; Internal medicine; Receptor; Chemistry; Medicine; Biology","score_opus":0.08203127632265171,"score_gpt":0.3619152169515216,"score_spread":0.2798839406288699,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111452451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9548539,0.00101971,0.0002787061,0.040624075,0.0014683736,0.0014230305,0.000019310193,0.00007970121,0.00023323174],"genre_scores_gemma":[0.9474534,0.010379247,0.00037142533,0.036480144,0.0048160823,0.00017404203,0.00014478437,0.000110025896,0.000070881084],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99635845,0.0009593119,0.0012279726,0.00067483285,0.0002653546,0.00051405095],"domain_scores_gemma":[0.9947984,0.0036119632,0.000714153,0.0003609528,0.00021729885,0.00029718445],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010334976,0.00030581304,0.0011236718,0.00012066601,0.00021269485,0.000033688866,0.00021960917,0.00042506857,0.00010196458],"category_scores_gemma":[0.0038823562,0.00024668928,0.00027851833,0.00025999037,0.00048143405,0.00013866794,0.00019525473,0.0007848799,0.000030082112],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011099838,0.00040310985,0.0038904783,0.00018218391,0.00011575004,0.00027497066,0.0024431178,0.000006872549,0.86849123,0.00014072948,0.0032087741,0.10974294],"study_design_scores_gemma":[0.0062289913,0.011468697,0.010611449,0.000043471853,0.0004055022,0.0004871548,0.0007944331,0.001271523,0.018464519,0.000025366591,0.949968,0.00023089998],"about_ca_topic_score_codex":0.000024809035,"about_ca_topic_score_gemma":0.0000056838903,"teacher_disagreement_score":0.9467592,"about_ca_system_score_codex":0.00010802206,"about_ca_system_score_gemma":0.00091030664,"threshold_uncertainty_score":0.9999985},"labels":[],"label_agreement":null},{"id":"W3111457091","doi":"10.1093/neuonc/noaa215.363","title":"EXTH-09. NEO-ADJUVANT TEMOZOLOMIDE INCREASES THE EFFICACY OF SUBSEQUENT CONCURRENT CHEMORADIATION IN A TRANSGLUTAMINASE-2 DEPENDENT MANNER","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Temozolomide; Radioresistance; In vivo; Cancer research; Dacarbazine; Downregulation and upregulation; Oncology; Medicine; Radiation therapy; Glioma; Internal medicine; Biology; Melanoma","score_opus":0.03405436361435305,"score_gpt":0.30221516278141913,"score_spread":0.2681607991670661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111457091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96715546,0.000954462,0.00004008329,0.029515654,0.00022892794,0.0009939298,0.000022412343,0.0000529303,0.0010361146],"genre_scores_gemma":[0.9957582,0.00057717453,0.00012849765,0.0031349019,0.00021646798,0.00008117818,0.000052904725,0.000029034856,0.000021636124],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980965,0.00029060213,0.0005785839,0.00041635626,0.00029088516,0.0003270564],"domain_scores_gemma":[0.99862224,0.0006314032,0.0001965832,0.00026742838,0.00005942333,0.00022293942],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002028903,0.00023755508,0.0006442696,0.000076430835,0.00005017358,0.000007461974,0.0001586346,0.00014998275,0.00018065867],"category_scores_gemma":[0.00036068712,0.00016387255,0.00016393376,0.00023574338,0.00020757866,0.000037749334,0.000053595388,0.00039085533,0.00004955011],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037025847,0.0057446966,0.049744632,0.00050617784,0.00021622887,0.003951486,0.007685953,0.0004405903,0.70919216,0.0009408573,0.0055800267,0.2122946],"study_design_scores_gemma":[0.072820984,0.020076176,0.1881616,0.00042235313,0.001700706,0.0019387291,0.005264377,0.0049673766,0.5130886,0.000089560366,0.19044104,0.0010285175],"about_ca_topic_score_codex":0.00021555914,"about_ca_topic_score_gemma":0.000107323685,"teacher_disagreement_score":0.21126607,"about_ca_system_score_codex":0.00027810203,"about_ca_system_score_gemma":0.00032585335,"threshold_uncertainty_score":0.6682529},"labels":[],"label_agreement":null},{"id":"W3111517195","doi":"10.1093/neuonc/noaa222.345","title":"IMG-09. RESPONSE ASSESSMENT IN DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG): RECOMMENDATIONS FROM THE RESPONSE ASSESSMENT IN PEDIATRIC NEURO-ONCOLOGY COMMITTEE","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Drug response; Clinical trial; Medical physics; Oncology; Internal medicine; Drug","score_opus":0.0321352473590854,"score_gpt":0.34132871324827635,"score_spread":0.30919346588919094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111517195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6638851,0.00022404797,0.000024825727,0.33297843,0.00073671364,0.0015392078,0.00010256316,0.00010311674,0.00040597055],"genre_scores_gemma":[0.97408307,0.0007073276,0.0014792521,0.022022324,0.0005839487,0.0008659227,0.00014750917,0.00010090689,0.000009752956],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9878142,0.007802912,0.00160194,0.0012606352,0.0005695381,0.0009508153],"domain_scores_gemma":[0.97812665,0.019574728,0.0005514756,0.0010479438,0.00016629398,0.0005329351],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002402398,0.0006203635,0.0014216597,0.00078477495,0.00022787317,0.00007406197,0.00060188357,0.00046906478,0.00041565354],"category_scores_gemma":[0.0035834112,0.0005019721,0.00027775115,0.0019957647,0.00019942514,0.0001763879,0.0006171394,0.0021910702,0.00012659794],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028731536,0.014284821,0.5522798,0.000043230262,0.0002117432,0.020419136,0.0034161494,0.00007183581,0.3068665,0.00039859128,0.044908807,0.028367866],"study_design_scores_gemma":[0.023738528,0.0077511445,0.74652565,0.000031853775,0.00035545803,0.00021843889,0.0009057155,0.00055329903,0.0010898871,0.000093163,0.21839966,0.0003372405],"about_ca_topic_score_codex":0.00040045264,"about_ca_topic_score_gemma":0.0011389939,"teacher_disagreement_score":0.3109561,"about_ca_system_score_codex":0.001861621,"about_ca_system_score_gemma":0.0022885303,"threshold_uncertainty_score":0.99974316},"labels":[],"label_agreement":null},{"id":"W3111542780","doi":"10.1093/neuonc/noaa222.070","title":"DIPG-20. DETERMINATION AND MANAGEMENT OF HYDROCEPHALUS IN PATIENTS WITH DIPG, AN INSTITUTIONAL EXPERIENCE","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Hydrocephalus; Univariate analysis; External ventricular drain; Cerebrospinal fluid; Surgery; Hazard ratio; Population; Multivariate analysis; Internal medicine","score_opus":0.01954453598674619,"score_gpt":0.28644167671736576,"score_spread":0.26689714073061954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111542780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99795747,0.00003345288,0.00001774123,0.0007468368,0.000043723827,0.00039855103,0.0000046543732,0.0000116085,0.0007859518],"genre_scores_gemma":[0.9986049,0.000035373283,0.00055028964,0.00068871584,0.000016116128,0.00007202041,0.000025417832,0.00000635193,8.442885e-7],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993283,0.000030604187,0.00015739014,0.00022534025,0.00015309398,0.000105230436],"domain_scores_gemma":[0.9996897,0.00002922111,0.00006139088,0.000086551256,0.000034230667,0.00009887933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00002389367,0.00008348553,0.00018114543,0.000055930483,0.00002634207,0.000003571416,0.000040035593,0.000039448292,0.000017530061],"category_scores_gemma":[0.00001590152,0.000065936605,0.000013566488,0.00012693022,0.00008883435,0.00008448142,0.000040850762,0.000054747277,0.0000021725086],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060027314,0.0016469957,0.9309528,0.0000933365,0.000026073774,0.0006411282,0.001539379,0.000041274227,0.005570897,0.0003311895,0.000024222796,0.05853242],"study_design_scores_gemma":[0.0076078433,0.0046810107,0.97888434,0.000043019598,0.00006584667,0.00001687361,0.00015890371,0.000885159,0.004463949,0.000010464074,0.003106724,0.00007585006],"about_ca_topic_score_codex":0.000007251552,"about_ca_topic_score_gemma":0.00001560228,"teacher_disagreement_score":0.05845657,"about_ca_system_score_codex":0.00006717462,"about_ca_system_score_gemma":0.00003145118,"threshold_uncertainty_score":0.26888168},"labels":[],"label_agreement":null},{"id":"W3111544385","doi":"10.1093/neuonc/noaa215.112","title":"COVD-31. THE STATE OF NEURO-ONCOLOGY DURING THE COVID-19 PANDEMIC: A WORLDWIDE ASSESSMENT","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Pandemic; Salary; Psychosocial; Medicine; Coronavirus disease 2019 (COVID-19); Family medicine; Telemedicine; Clinical trial; Nursing; Psychology; Health care; Internal medicine; Political science; Psychiatry","score_opus":0.11191427915913023,"score_gpt":0.4299457917972057,"score_spread":0.3180315126380755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111544385","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5592837,0.00027558836,0.0003513201,0.43568075,0.00069800316,0.001674328,0.000046449495,0.00018615439,0.0018037072],"genre_scores_gemma":[0.70536256,0.00075015996,0.000107876775,0.29304877,0.00048396792,0.000104484476,0.000009802528,0.000048268983,0.00008412516],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955391,0.001363485,0.0009963681,0.00068667956,0.000547049,0.00086727535],"domain_scores_gemma":[0.98874056,0.008638049,0.00061578787,0.0007816969,0.00019822118,0.0010256813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011673089,0.000366967,0.0010399902,0.0001593933,0.00038294803,0.00002465467,0.00058765296,0.000238964,0.00022632544],"category_scores_gemma":[0.005550291,0.0002273706,0.00024928275,0.0006938395,0.00057443604,0.00007988742,0.00043111644,0.001791536,0.000057463665],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060880044,0.00072218105,0.14491075,0.0014184056,0.00030079874,0.0036439034,0.017099548,0.001247376,0.7121224,0.0004483171,0.05585094,0.056147408],"study_design_scores_gemma":[0.004851468,0.0045082527,0.036069095,0.000018896691,0.00020956957,0.0012648463,0.0006578969,0.0006688288,0.0014769646,0.00024518394,0.9498298,0.00019920716],"about_ca_topic_score_codex":0.00056969846,"about_ca_topic_score_gemma":0.0008338986,"teacher_disagreement_score":0.89397883,"about_ca_system_score_codex":0.00135372,"about_ca_system_score_gemma":0.0073094703,"threshold_uncertainty_score":0.99831814},"labels":[],"label_agreement":null},{"id":"W3111581706","doi":"10.1093/neuonc/noaa222.171","title":"EPEN-36. THE TREATMENT OUTCOME OF PAEDIATRIC SUPRATENTORIAL C11ORF95-RELA FUSED EPENDYMOMA: A COMBINED REPORT FROM E-HIT SERIES AND AUSTRALIAN NEW ZEALAND CHILDREN’S HAEMATOLOGY/ONCOLOGY GROUP","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Ependymoma; Medicine; Internal medicine; Cohort; Oncology; Chemotherapy; Radiation therapy; Progression-free survival; Surgery","score_opus":0.03088575724016148,"score_gpt":0.291910606719114,"score_spread":0.26102484947895255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111581706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9139644,0.00042131587,0.0000025085603,0.08204978,0.0015643094,0.0016115417,0.0001047735,0.0000979563,0.00018344464],"genre_scores_gemma":[0.9958163,0.00045487043,0.0003629753,0.0014348028,0.0011015586,0.00020890802,0.0003707591,0.000058135338,0.00019167799],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966413,0.00045332365,0.0011613228,0.0008673557,0.00031237846,0.00056434184],"domain_scores_gemma":[0.99702275,0.0010153601,0.0006925367,0.0005807841,0.00009308265,0.0005954963],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001975266,0.00050538033,0.0018169563,0.00013735952,0.00014854725,0.000028444492,0.00021698957,0.0005299068,0.00028268396],"category_scores_gemma":[0.0003919811,0.00033596787,0.0003045155,0.00032619087,0.0003282039,0.00009456882,0.00014648052,0.00041647957,0.00004883763],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005303647,0.0028404123,0.90531343,0.00003235075,0.001118874,0.022400761,0.0021828208,0.000005505093,0.0136599885,0.00030423954,0.042302653,0.0045353374],"study_design_scores_gemma":[0.05404215,0.04315115,0.5724621,0.00002410572,0.0045186197,0.011637792,0.0005255286,0.000025042846,0.012315685,0.00047505277,0.3002575,0.000565295],"about_ca_topic_score_codex":0.0020822517,"about_ca_topic_score_gemma":0.00092169,"teacher_disagreement_score":0.33285132,"about_ca_system_score_codex":0.00029463816,"about_ca_system_score_gemma":0.00043831265,"threshold_uncertainty_score":0.9999092},"labels":[],"label_agreement":null},{"id":"W3111586173","doi":"10.1093/neuonc/noaa222.714","title":"RARE-02.RE-IRRADIATION FOR RECURRENT CRANIOPHARYNGIOMA","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; Hospital for Sick Children; Princess Margaret Cancer Centre","funders":"","keywords":"Craniopharyngioma; Medicine; Radiation therapy; Neurocognitive; Cumulative dose; Surgery; Optic chiasm; Nuclear medicine; Ophthalmology; Optic nerve; Cognition","score_opus":0.04199124678458554,"score_gpt":0.31875104485479694,"score_spread":0.2767597980702114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111586173","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90363723,0.0021820492,0.0008151434,0.07182528,0.0017214223,0.0025062845,0.00012564023,0.0002681319,0.01691879],"genre_scores_gemma":[0.9868709,0.00017195423,0.00054834713,0.011638111,0.00040211913,0.00011533705,0.00019344268,0.000023893386,0.000035903922],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990941,0.0000470344,0.00021014504,0.00030650682,0.000107322674,0.00023487608],"domain_scores_gemma":[0.9993393,0.0001782516,0.00007239822,0.00012785426,0.00004839158,0.000233829],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004305234,0.00013724224,0.00032409,0.000047695103,0.00006896387,0.000006613374,0.00006247085,0.00010576469,0.00017295236],"category_scores_gemma":[0.00019865374,0.00011639319,0.0001273786,0.00011887364,0.000026081932,0.000056220313,0.000023577224,0.000111847214,0.00011899919],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015519113,0.0034888564,0.06814665,0.00051930844,0.0004901002,0.002078563,0.0033785813,0.000037648737,0.11258063,0.0012555742,0.33155867,0.4609463],"study_design_scores_gemma":[0.020632628,0.020950887,0.02578048,0.000017768898,0.0004580705,0.00013456425,0.000142085,0.0029208625,0.002661004,0.0007032633,0.92533946,0.00025893442],"about_ca_topic_score_codex":0.000007356546,"about_ca_topic_score_gemma":0.00001105723,"teacher_disagreement_score":0.59378076,"about_ca_system_score_codex":0.00006827844,"about_ca_system_score_gemma":0.00014762612,"threshold_uncertainty_score":0.47463766},"labels":[],"label_agreement":null},{"id":"W3111592258","doi":"10.1093/neuonc/noaa222.015","title":"ATRT-16. MODELLING ATRT THROUGH SWI/SNF COMPLEX DEFICIENCY IN GENETICALLY-ENGINEERED MOUSE MODELS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"SMARCB1; Atypical teratoid rhabdoid tumor; Biology; Embryonic stem cell; Stem cell; Cancer research; Progenitor cell; Neural stem cell; Cell biology; Genetics; Medulloblastoma; Gene; Gene expression","score_opus":0.058963389022737185,"score_gpt":0.2888073450202462,"score_spread":0.229843955997509,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111592258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7387366,0.0011703599,0.25211865,0.0016212737,0.00017341638,0.00030530358,0.000028632647,0.000068851215,0.005776866],"genre_scores_gemma":[0.9810529,0.0009907873,0.012706373,0.004683869,0.0003374585,0.000035388024,0.00009290011,0.000063686675,0.000036683112],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99786645,0.00014487158,0.00051045883,0.0007491704,0.00019903386,0.00052999513],"domain_scores_gemma":[0.9991806,0.00005903239,0.00010212308,0.00039032582,0.00009101638,0.00017691316],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013170084,0.00028857953,0.00039649842,0.00003823181,0.000079956204,0.00002191905,0.0003907652,0.0003531971,0.00004695598],"category_scores_gemma":[0.00008449756,0.0003024979,0.00014933143,0.0001930912,0.000104535415,0.000009722271,0.00021011468,0.00034477783,0.000028132514],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009762347,0.00007129218,0.000025729072,0.000025475214,0.000009837899,0.000013252821,0.00022083812,0.44514644,0.5511594,0.00020668833,0.0015268989,0.0014965378],"study_design_scores_gemma":[0.001712086,0.0009824872,0.000008121394,0.000009122324,0.000031997773,0.00004545263,0.00013637275,0.85129184,0.08743278,0.00084063667,0.057060182,0.00044894766],"about_ca_topic_score_codex":0.00006243645,"about_ca_topic_score_gemma":0.000044612534,"teacher_disagreement_score":0.4637266,"about_ca_system_score_codex":0.00009046272,"about_ca_system_score_gemma":0.00025519228,"threshold_uncertainty_score":0.9999427},"labels":[],"label_agreement":null},{"id":"W3111604562","doi":"10.1093/neuonc/noaa222.276","title":"GCT-59. EPIDEMIOLOGY OF PEDIATRIC INTRA-CRANIAL GERM CELL TUMORS: COMPARING THE INCIDENCE OF INTRA-CRANIAL GERM CELL TUMORS IN THE NATIVE JAPANESE POPULATION AND IMMIGRANT JAPANESE POPULATIONS ABROAD","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Children's Hospital","funders":"","keywords":"Incidence (geometry); Medulloblastoma; Demography; Population; Epidemiology; Medicine; Immigration; Germ cell tumors; Pediatrics; Pathology; Internal medicine; Geography; Environmental health","score_opus":0.040109853985057835,"score_gpt":0.3211728424116079,"score_spread":0.28106298842655003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111604562","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99212915,0.0006723254,0.0000071085265,0.0051877475,0.0002478143,0.0013500119,0.000030588755,0.000027286804,0.0003479703],"genre_scores_gemma":[0.997545,0.00017217228,0.00015251085,0.0015018933,0.00042840012,0.00011092324,0.00005663774,0.00003062136,0.0000018404448],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99579585,0.0014364411,0.0013913922,0.0005686368,0.0003442734,0.00046343758],"domain_scores_gemma":[0.99463576,0.0036368181,0.0010070708,0.00038796998,0.00014867359,0.000183714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009881159,0.0003557148,0.0012728692,0.00026022532,0.00014625407,0.000009035185,0.0003245054,0.00021218571,0.000038340244],"category_scores_gemma":[0.0016463728,0.00022994293,0.0001916494,0.0007640769,0.00031678716,0.000107063985,0.00013106313,0.0006515526,0.000008181968],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007141899,0.0010341582,0.9441856,0.00022805769,0.000031571446,0.00031567228,0.025834696,0.00072682067,0.0257806,0.00026926195,0.00030044376,0.0005788917],"study_design_scores_gemma":[0.0044358,0.0021998063,0.9827575,0.000039518352,0.0004239392,0.00022110557,0.0034094537,0.0037911127,0.0021761742,0.0002621381,0.00007315296,0.00021026267],"about_ca_topic_score_codex":0.004660104,"about_ca_topic_score_gemma":0.00095998996,"teacher_disagreement_score":0.038571898,"about_ca_system_score_codex":0.0001321721,"about_ca_system_score_gemma":0.00017113586,"threshold_uncertainty_score":0.93768007},"labels":[],"label_agreement":null},{"id":"W3111626448","doi":"10.1093/neuonc/noaa222.183","title":"EPEN-50. THE MANAGEMENT AND TREATMENT OF PEDIATRIC SPINAL CORD EPENDYMOMA: RESULTS FROM A COLLABORATIVE INTERNATIONAL MULTI-INSTITUTIONAL REVIEW","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Ependymoma; Cohort; Spinal cord; Hazard ratio; Radiation therapy; Internal medicine; Oncology; Surgery; Confidence interval","score_opus":0.057383780453172085,"score_gpt":0.344314526923004,"score_spread":0.2869307464698319,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111626448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7675576,0.053149298,0.000107629254,0.16312844,0.0013163355,0.005064598,0.0013629916,0.00008410908,0.008228978],"genre_scores_gemma":[0.9251257,0.06494631,0.0033735738,0.005380806,0.0005387265,0.00032134377,0.0002704633,0.000016320773,0.000026756647],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987026,0.00010922056,0.00041719727,0.00039214944,0.00023996044,0.00013890122],"domain_scores_gemma":[0.9990839,0.00024271227,0.00022902156,0.00018578467,0.00012388581,0.00013473924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007450239,0.00018416467,0.0004462109,0.000056210913,0.00007339178,0.000008933777,0.000102086924,0.000055735774,0.00008093324],"category_scores_gemma":[0.00013469187,0.00011096593,0.00009189877,0.00022474343,0.00010665445,0.000038075264,0.00008382906,0.00008481391,0.000035881552],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033211306,0.017248552,0.045935225,0.001034405,0.005626552,0.024307026,0.0029307886,0.00006134242,0.010484625,0.006173451,0.07165772,0.78132904],"study_design_scores_gemma":[0.028411642,0.014409452,0.09832129,0.00021747817,0.0025034156,0.00021830614,0.00025892348,0.00027095515,0.0016918048,0.000031291926,0.8534636,0.00020183153],"about_ca_topic_score_codex":0.000055852346,"about_ca_topic_score_gemma":0.000029414738,"teacher_disagreement_score":0.7818059,"about_ca_system_score_codex":0.0001755559,"about_ca_system_score_gemma":0.00016032338,"threshold_uncertainty_score":0.45250592},"labels":[],"label_agreement":null},{"id":"W3111628160","doi":"10.1093/neuonc/noaa215.223","title":"CTNI-57. LOW-RISK MENINGIOMA: OUTCOMES FROM NRG ONCOLOGY/RTOG 0539","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Hazard ratio; Meningioma; Gastroenterology; Surgery; Confidence interval","score_opus":0.04227633261742913,"score_gpt":0.3063355793747301,"score_spread":0.26405924675730097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111628160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8995321,0.00030624506,0.00048011894,0.040597823,0.0017243301,0.0009966537,0.000049706265,0.00043862744,0.055874415],"genre_scores_gemma":[0.9795045,0.000050992425,0.0042757755,0.014450766,0.0010093745,0.000116051335,0.00009735319,0.00008103435,0.00041413918],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962134,0.00054616743,0.00089015556,0.0010601276,0.0005149727,0.00077517884],"domain_scores_gemma":[0.9969158,0.0010992662,0.00044227927,0.00069408753,0.00011885694,0.00072970276],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00040867738,0.000481068,0.0013968662,0.00020780122,0.00020311968,0.000036342997,0.00045702583,0.00046174877,0.0016969244],"category_scores_gemma":[0.0011161863,0.00041926996,0.0003718634,0.0004259637,0.00020391279,0.00012491956,0.00046609403,0.000965572,0.0015665955],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047471123,0.002142565,0.19328064,0.00026755178,0.0018558858,0.06507231,0.009408979,0.00009879855,0.35816172,0.0018977537,0.27900502,0.08406165],"study_design_scores_gemma":[0.011538352,0.007145463,0.038930226,0.000038121845,0.0011924681,0.00044126005,0.0009281711,0.0017517399,0.007247837,0.000355249,0.9298275,0.00060360035],"about_ca_topic_score_codex":0.00014564245,"about_ca_topic_score_gemma":0.00002459231,"teacher_disagreement_score":0.65082246,"about_ca_system_score_codex":0.0003569626,"about_ca_system_score_gemma":0.00038809935,"threshold_uncertainty_score":0.9998259},"labels":[],"label_agreement":null},{"id":"W3111632648","doi":"10.1093/neuonc/noaa215.280","title":"EPCO-01. LUNG ADENOCARCINOMA BRAIN METASTASIS PREDICTION, PREVENTION, AND NON-INVASIVE DIAGNOSIS USING METHYLATION SIGNATURES WITHIN TISSUE AND CIRCULATING TUMOUR DNA","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"DNA methylation; Methylation; Adenocarcinoma; Brain metastasis; Lung cancer; Oncology; Metastasis; Differentially methylated regions; Cancer research; Biology; Stage (stratigraphy); Cohort; Cancer; Pathology; Internal medicine; Medicine; DNA; Gene; Genetics; Gene expression","score_opus":0.02521400779802102,"score_gpt":0.29755169153881117,"score_spread":0.27233768374079015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111632648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848452,0.0031824773,0.008687725,0.0025461728,0.00015177848,0.000448607,0.00004477865,0.000020396597,0.00007285813],"genre_scores_gemma":[0.99582744,0.0003891021,0.001963381,0.0012636733,0.0003419407,0.00009164755,0.00008146326,0.000029982202,0.0000113741025],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985553,0.00025845572,0.00032681212,0.00055939314,0.00011086167,0.00018915994],"domain_scores_gemma":[0.9992448,0.00011609187,0.00022849329,0.00016442813,0.00010376812,0.00014240727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020964531,0.00017907731,0.00023319077,0.00005705034,0.00020701828,0.000040358762,0.000095265306,0.00021239936,0.000020374087],"category_scores_gemma":[0.0004627846,0.00018620654,0.000048943297,0.00015388045,0.000101409256,0.000020552017,0.00010908912,0.00016717953,9.835885e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003918528,0.00002971972,0.014915453,0.000048817135,0.00006939287,0.000009412926,0.0004828072,0.0009316234,0.9773582,0.000038840426,0.0013143546,0.0047621815],"study_design_scores_gemma":[0.0013359713,0.0013700147,0.029808303,0.00002843591,0.00030900582,0.00011289879,0.0005241038,0.007629527,0.94754815,0.0001679056,0.010823858,0.00034183255],"about_ca_topic_score_codex":0.00002336333,"about_ca_topic_score_gemma":0.00003343404,"teacher_disagreement_score":0.02981007,"about_ca_system_score_codex":0.000037210422,"about_ca_system_score_gemma":0.00018107984,"threshold_uncertainty_score":0.75932825},"labels":[],"label_agreement":null},{"id":"W3111637277","doi":"10.1093/neuonc/noaa222.728","title":"RARE-17. SURVIVAL BENEFIT FOR INDIVIDUALS WITH CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY SYNDROME AND BRAIN TUMORS WHO UNDERGO SURVEILLANCE PROTOCOL. A REPORT FROM THE INTERNATIONAL REPLICATION REPAIR CONSORTIUM","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; University of Manitoba; Research Institute in Oncology and Hematology; Centre hospitalier universitaire de Québec; University of Ottawa; McGill University Health Centre; McGill University; Children's Hospital of Eastern Ontario; London Health Sciences Centre; SickKids Foundation; University of Toronto; Western University; CancerCare Manitoba; Mount Sinai Hospital; Hospital for Sick Children","funders":"","keywords":"Medicine; Asymptomatic; Oncology; Cancer; Internal medicine","score_opus":0.03344212194068255,"score_gpt":0.31196797052240743,"score_spread":0.2785258485817249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111637277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9009977,0.000072279676,0.001050372,0.059954304,0.0004994031,0.032999713,0.00035174933,0.00039372352,0.0036807756],"genre_scores_gemma":[0.95231754,0.000009913805,0.006570717,0.012296723,0.00038177884,0.027911156,0.0002874982,0.00004791173,0.000176755],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971865,0.00016190326,0.00071115396,0.0010686464,0.00055869593,0.00031310914],"domain_scores_gemma":[0.99614,0.0021791027,0.00048486056,0.0006260232,0.00036995273,0.0002000509],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008386825,0.0002575179,0.0005459255,0.000052286785,0.00017532219,0.00003222072,0.00026151765,0.00018247827,0.0001525393],"category_scores_gemma":[0.0038146644,0.0001935927,0.00013188264,0.00023953868,0.0007881118,0.00007132007,0.00016933463,0.00035168673,0.0000051645725],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021803933,0.00019277015,0.92944,0.00010799762,0.00020352511,0.000692662,0.00043884083,0.00012061227,0.009393546,0.0018415086,0.054870293,0.0005178372],"study_design_scores_gemma":[0.0061060414,0.0042937277,0.41403976,0.00010266738,0.000118840384,0.0066117607,0.00027633295,0.0012250431,0.0016057704,0.0006978194,0.564526,0.00039623294],"about_ca_topic_score_codex":0.000053752916,"about_ca_topic_score_gemma":0.0001585989,"teacher_disagreement_score":0.51540023,"about_ca_system_score_codex":0.00024686477,"about_ca_system_score_gemma":0.0014000352,"threshold_uncertainty_score":0.7894481},"labels":[],"label_agreement":null},{"id":"W3111646813","doi":"10.1093/neuonc/noaa222.416","title":"LGG-34. CLINICAL AND MOLECULAR CHARACTERIZATION OF A MULTI-INSTITUTIONAL COHORT OF PEDIATRIC SPINAL CORD LOW-GRADE GLIOMAS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"CDKN2A; Medicine; Cohort; Oncology; Fusion gene; STK11; Internal medicine; IDH1; KRAS; Pathology; Cancer; Mutation; Gene; Biology; Genetics; Colorectal cancer","score_opus":0.046681860737357674,"score_gpt":0.3480639976226735,"score_spread":0.3013821368853158,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111646813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959805,0.00024350137,0.00022210702,0.0026583278,0.00022745255,0.00051978434,0.000032127387,0.000021190663,0.00009499014],"genre_scores_gemma":[0.9973749,0.00048823812,0.00055292924,0.0012703578,0.00021098061,0.000029923405,0.00005879491,0.000013173353,7.0426256e-7],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99867886,0.00011663749,0.0005497875,0.00031658917,0.00019529728,0.00014282257],"domain_scores_gemma":[0.9991834,0.00010892502,0.0002544235,0.00013740623,0.00011695672,0.00019885496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000114163275,0.0001371346,0.00056202954,0.00010629094,0.000026869528,0.0000031047707,0.000059100257,0.0001521134,0.000028465734],"category_scores_gemma":[0.00032957274,0.00011565942,0.00012524973,0.000254085,0.0002107034,0.00003527911,0.000061497965,0.00015498602,0.000008010632],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007410494,0.001237643,0.45051485,0.00010423205,0.00008392928,0.0006439232,0.000025106021,0.0000016195844,0.54139566,0.00042131735,0.00005497027,0.004775725],"study_design_scores_gemma":[0.0070302207,0.008246906,0.9068386,0.000022869812,0.0006529743,0.00014692098,0.000010334838,0.00060881255,0.07142778,0.00000695421,0.0049032285,0.00010442397],"about_ca_topic_score_codex":0.000009697181,"about_ca_topic_score_gemma":0.0000017150388,"teacher_disagreement_score":0.46996787,"about_ca_system_score_codex":0.00003081041,"about_ca_system_score_gemma":0.00024360607,"threshold_uncertainty_score":0.4716454},"labels":[],"label_agreement":null},{"id":"W3111654317","doi":"10.1093/neuonc/noaa222.765","title":"RARE-55. CHALLENGES AND SPECIFIC STRATEGIES FOR CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY SYNDROME IN LOW RESOURCE SETTINGS. ON BEHALF OF THE INTERNATIONAL RRD CONSORTIUM IN LOW RESOURCE SETTINGS PANEL","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"PMS2; MSH6; Medicine; MSH2; Lynch syndrome; Oncology; Intensive care medicine; DNA mismatch repair; Colorectal cancer; Internal medicine; Cancer","score_opus":0.04496372023528123,"score_gpt":0.27933028000355986,"score_spread":0.23436655976827864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111654317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9580954,0.0009208857,0.00001130369,0.031501725,0.00035801315,0.00092133135,0.000056464996,0.000050861192,0.008084059],"genre_scores_gemma":[0.99501836,0.00016535335,0.00041813924,0.004138159,0.00011124629,0.00008617636,0.000016009519,0.000022365888,0.000024171222],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99788326,0.00018413612,0.00060359517,0.0006099051,0.00038785764,0.00033126504],"domain_scores_gemma":[0.99822265,0.0010662453,0.00025896562,0.00025032792,0.000097068376,0.00010476327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004303856,0.0002193951,0.0004850038,0.00014633345,0.000057125388,0.000013908653,0.00028379305,0.00023007898,0.000054975804],"category_scores_gemma":[0.0008801249,0.00018650957,0.00010750263,0.00019638755,0.0008354471,0.000046362125,0.00016557836,0.00054990826,0.000004520211],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020175306,0.004674078,0.104680344,0.005412336,0.00033572188,0.0042469413,0.056513883,0.01177505,0.6237482,0.062430765,0.07447396,0.03153341],"study_design_scores_gemma":[0.021278622,0.012199421,0.21502565,0.0025744736,0.000190646,0.003776007,0.028577184,0.0054240753,0.041798722,0.0016622468,0.6662023,0.001290655],"about_ca_topic_score_codex":0.0000063707184,"about_ca_topic_score_gemma":0.00003685028,"teacher_disagreement_score":0.5917283,"about_ca_system_score_codex":0.00023618557,"about_ca_system_score_gemma":0.00056398887,"threshold_uncertainty_score":0.7605639},"labels":[],"label_agreement":null},{"id":"W3111693169","doi":"10.1093/neuonc/noaa215.859","title":"SURG-12. PREDICTORS OF SURVIVAL AND UTILITY OF INTRAOPERATIVE MRI FOR RESECTION OF GRADE II ASTROCYTOMAS AND OLIGODENDROGLIOMAS: A MULTICENTER ANALYSIS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Astrocytoma; Progression-free survival; Glioma; Internal medicine; Retrospective cohort study; Overall survival; Resection; Magnetic resonance imaging; Gastroenterology; Surgery; Oncology; Radiology","score_opus":0.0341941944633523,"score_gpt":0.3098234883462424,"score_spread":0.2756292938828901,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111693169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99741894,0.00017225355,0.00013371982,0.0013244705,0.000088460045,0.0006123701,0.00013006311,0.00001086501,0.00010887603],"genre_scores_gemma":[0.9992785,0.00012987076,0.000409097,0.0000558193,0.00004840433,0.000040074512,0.000026843387,0.000009767598,0.0000016527686],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987954,0.00016504365,0.00043754865,0.00030579095,0.000150891,0.00014532641],"domain_scores_gemma":[0.99871814,0.0006059628,0.00022879563,0.00014001995,0.00017029897,0.00013680181],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016186784,0.00012978632,0.0007980666,0.00018984416,0.000037449783,0.0000024779458,0.000039684608,0.000102994745,0.000023624287],"category_scores_gemma":[0.00035682888,0.00010587005,0.00013905675,0.0003045707,0.00021036738,0.00004177891,0.0000723363,0.00008889196,8.4827924e-8],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028045813,0.0011116045,0.7027201,0.00025810095,0.001491327,0.00003332312,0.0026179703,0.000022577384,0.28745058,0.000055656063,0.00021512601,0.001219066],"study_design_scores_gemma":[0.010989187,0.015021525,0.30462462,0.00003101363,0.0033198416,0.000015625785,0.0009999085,0.00905204,0.6543326,0.0000102721615,0.0015066799,0.000096689524],"about_ca_topic_score_codex":0.00008889174,"about_ca_topic_score_gemma":0.00030910078,"teacher_disagreement_score":0.39809546,"about_ca_system_score_codex":0.000024738556,"about_ca_system_score_gemma":0.0000610826,"threshold_uncertainty_score":0.43172553},"labels":[],"label_agreement":null},{"id":"W3111695551","doi":"10.1093/neuonc/noaa222.825","title":"SWK-08. DELAYED DIAGNOSIS OF CENTRAL NERVOUS SYSTEM (CNS) TUMORS IN CHILDREN: PERSPECTIVE FROM THE FRONTLINE","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vancouver Infectious Diseases Centre; University of British Columbia","funders":"","keywords":"Medicine; Medical diagnosis; Vomiting; Family medicine; Pediatrics; Clinical Practice; Brain tumor; Psychiatry; Pathology; Internal medicine","score_opus":0.015062690241028395,"score_gpt":0.26126742577581,"score_spread":0.24620473553478162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111695551","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97249824,0.0015757434,0.000008828143,0.023824213,0.00022927212,0.0010418494,0.00017534207,0.00006548351,0.00058104726],"genre_scores_gemma":[0.9955613,0.00017204374,0.0001183074,0.003438142,0.00043464664,0.00018316883,0.000056900288,0.000034605415,8.776865e-7],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981285,0.00028634557,0.0004764726,0.0004936889,0.00023310255,0.00038193236],"domain_scores_gemma":[0.99846333,0.00068277505,0.000209429,0.00032375436,0.00009110263,0.00022961991],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008234724,0.00023652747,0.0007482617,0.00006552414,0.000053881016,0.000009201154,0.00020129816,0.00014371691,0.000121994606],"category_scores_gemma":[0.0003349531,0.00016357063,0.0001921543,0.00030329818,0.000111399415,0.000037584763,0.00010295588,0.00034969838,0.000046029465],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007450353,0.0012543495,0.9718988,0.000019888552,0.00039198727,0.0012866389,0.0036910896,0.00018617472,0.00995227,0.00058564043,0.006024005,0.003964148],"study_design_scores_gemma":[0.008273384,0.003367902,0.9626613,0.00009341619,0.0005992847,0.00015716604,0.0041114576,0.0008730375,0.017139584,0.000032285458,0.0025080023,0.00018314351],"about_ca_topic_score_codex":0.0032773952,"about_ca_topic_score_gemma":0.00040244483,"teacher_disagreement_score":0.023063088,"about_ca_system_score_codex":0.0004879128,"about_ca_system_score_gemma":0.00020237955,"threshold_uncertainty_score":0.6670217},"labels":[],"label_agreement":null},{"id":"W3111710464","doi":"10.1093/neuonc/noaa222.259","title":"GCT-41. RESPONSE-BASED RADIATION THERAPY IN PATIENTS WITH NEWLY DIAGNOSED CENTRAL NERVOUS SYSTEM LOCALIZED GERMINOMA: A CHILDREN’S ONCOLOGY GROUP (COG) PROSPECTIVE PHASE 2 CLINICAL TRIAL","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Cog; Carboplatin; Etoposide; Germinoma; Chemotherapy; Radiation therapy; Phases of clinical research; Internal medicine; Central nervous system; Surgery; Oncology; Gastroenterology; Cisplatin","score_opus":0.029779315413367126,"score_gpt":0.3299005253535205,"score_spread":0.30012120994015334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111710464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98537683,0.00016043025,0.000063017964,0.0046593295,0.0008589062,0.0085482355,0.00006724475,0.00018403647,0.00008198413],"genre_scores_gemma":[0.9922819,0.000047308647,0.00026399008,0.005066377,0.00072055846,0.0013013572,0.00023851838,0.00007898652,9.766316e-7],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9941245,0.0024180976,0.0012218945,0.0010743875,0.0004375882,0.0007235398],"domain_scores_gemma":[0.9958094,0.0023388283,0.00063223834,0.0004268099,0.00015872328,0.00063404994],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00053941325,0.000467875,0.001584826,0.0002457216,0.00010782619,0.000028132945,0.00019363932,0.0005266562,0.000062481304],"category_scores_gemma":[0.000916854,0.00036072457,0.0003064778,0.0005350093,0.00022533585,0.00009504727,0.000045645145,0.0006655779,0.000036462094],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4674889,0.016237188,0.44192177,0.000018631601,0.00024076062,0.0025650722,0.00048165667,0.000053477375,0.00064916286,0.00002885245,0.00076718145,0.069547325],"study_design_scores_gemma":[0.41375324,0.10447957,0.4749946,0.000026565573,0.00025707376,0.000025734787,0.00004355528,0.00055935036,0.00044758274,0.0000015687788,0.0052201673,0.0001909673],"about_ca_topic_score_codex":0.00011884121,"about_ca_topic_score_gemma":0.00007290875,"teacher_disagreement_score":0.08824238,"about_ca_system_score_codex":0.0013634095,"about_ca_system_score_gemma":0.0013051179,"threshold_uncertainty_score":0.9998845},"labels":[],"label_agreement":null},{"id":"W3111753833","doi":"10.1093/neuonc/noaa222.088","title":"DIPG-41. DISSECTING THE MECHANISTIC BASIS FOR <i>ACVR1</i> AND <i>PIK3CA</i> MUTATION CO-OCCURRENCE IN DIFFUSE MIDLINE GLIOMAS USING GENETICALLY ENGINEERED MOUSE MODELS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"OLIG2; Biology; Forebrain; Gene; Carcinogenesis; Epigenetics; Transcription factor; Cancer research; Histone; Transcriptome; Mutation; Oligodendrocyte; Genetics; Neuroscience; Gene expression; Myelin; Central nervous system","score_opus":0.0500216919919357,"score_gpt":0.3121620055092161,"score_spread":0.2621403135172804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111753833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98418576,0.00027919072,0.009317134,0.0046089925,0.00016234258,0.0011947112,0.00015450378,0.000059448077,0.00003791075],"genre_scores_gemma":[0.9942011,0.00009289442,0.0027424279,0.0025176741,0.00014538162,0.00019329283,0.000071685725,0.00003470015,7.980582e-7],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9984975,0.00011342083,0.00040274666,0.00046117345,0.00017611231,0.00034903578],"domain_scores_gemma":[0.9980997,0.0012579795,0.00011859614,0.00019244995,0.00011206019,0.00021922604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015791735,0.00023141196,0.00045076857,0.00009604219,0.00011604049,0.000030366255,0.000098230754,0.00012783491,0.00000816104],"category_scores_gemma":[0.00095855957,0.00017684606,0.00008246775,0.00026844625,0.00007120683,0.00006388749,0.00005851336,0.00021356103,0.000002243679],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004892704,0.00089025515,0.0011995649,0.00015203704,0.00006653724,0.00046971653,0.0013790895,0.0035391496,0.98609793,0.00043947698,0.000275228,0.005001718],"study_design_scores_gemma":[0.0135561135,0.003413255,0.00064912654,0.000082787636,0.0007387723,0.00037595152,0.00051020127,0.70082736,0.27690774,0.0005556207,0.0019852507,0.00039783336],"about_ca_topic_score_codex":0.000022922353,"about_ca_topic_score_gemma":0.00003028659,"teacher_disagreement_score":0.70919025,"about_ca_system_score_codex":0.00011384343,"about_ca_system_score_gemma":0.00011716475,"threshold_uncertainty_score":0.7211573},"labels":[],"label_agreement":null},{"id":"W3111755010","doi":"10.1093/neuonc/noaa222.036","title":"DDEL-01. ENHANCING DRUG DELIVERY WITH MRgFUS FOR DIFFUSE INTRINSIC PONTINE GLIOMA MODEL","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Hospital for Sick Children","funders":"","keywords":"Medicine; Doxorubicin; Brainstem; In vivo; Glioma; Microbubbles; Drug; Blood–brain barrier; Pharmacology; Pathology; Cancer research; Chemotherapy; Central nervous system; Internal medicine; Ultrasound; Biology; Radiology","score_opus":0.021727403911953814,"score_gpt":0.2687987008879853,"score_spread":0.24707129697603147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111755010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97497296,0.00026887128,0.0006769726,0.02197112,0.00017745489,0.0010727984,0.000026113068,0.00015056152,0.0006831161],"genre_scores_gemma":[0.9871613,0.00007745578,0.0028179407,0.00916063,0.0003633104,0.0002906448,0.00004147034,0.000067331726,0.000019945815],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983007,0.000055859487,0.0003651339,0.00056727923,0.00021276373,0.00049830903],"domain_scores_gemma":[0.99856544,0.0004296564,0.00015241768,0.000292022,0.00015092589,0.00040956092],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009336778,0.00028264854,0.000657375,0.00013048737,0.00010421251,0.000018856279,0.00012237007,0.00012620664,0.00004175684],"category_scores_gemma":[0.00017941617,0.00021735259,0.00015189768,0.00026170947,0.0000728278,0.0000779434,0.000093421215,0.0002322913,0.00004540095],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004204297,0.0024669413,0.004696616,0.0001827167,0.00032242996,0.003703498,0.001836913,0.00037973252,0.92819095,0.000404853,0.02086644,0.032744613],"study_design_scores_gemma":[0.064834945,0.021379186,0.0026721316,0.0001678607,0.002313113,0.0012281816,0.00068415503,0.05607715,0.7485929,0.00023998332,0.10084451,0.00096587755],"about_ca_topic_score_codex":0.000032749776,"about_ca_topic_score_gemma":0.00015245393,"teacher_disagreement_score":0.17959805,"about_ca_system_score_codex":0.00016327412,"about_ca_system_score_gemma":0.00031557938,"threshold_uncertainty_score":0.8863381},"labels":[],"label_agreement":null},{"id":"W3111760764","doi":"10.1093/neuonc/noaa215.059","title":"BIOM-62 SENSITIVE DETECTION AND DISCRIMINATION OF INTRACRANIAL TUMORS BY BLOOD","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Biomarker; DNA methylation; Methylation; Glioma; Brain tumor; Medicine; Oncology; Internal medicine; Differential diagnosis; Cancer; Pathology; Cancer research; Biology; DNA; Gene; Gene expression","score_opus":0.010071678059508772,"score_gpt":0.2656741941715288,"score_spread":0.25560251611202006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111760764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97767156,0.0002400948,0.019613804,0.0014791487,0.00014839241,0.00033267148,0.000049183396,0.000017622622,0.00044748856],"genre_scores_gemma":[0.9985486,0.00027560987,0.00020704984,0.00071150495,0.00015869451,0.000016100605,0.00004923985,0.000024393219,0.000008807281],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99889797,0.00019067134,0.00019605152,0.00038242232,0.00013632073,0.00019658571],"domain_scores_gemma":[0.99951106,0.00003240707,0.0001020441,0.00012445098,0.00010790208,0.00012212322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000104122075,0.00012217562,0.00017837509,0.000047184563,0.000049104572,0.000009064699,0.00008661425,0.00022642266,0.000008727263],"category_scores_gemma":[0.00029230065,0.00013062444,0.000049989427,0.00013152808,0.0001291589,0.000004337924,0.00013208966,0.00019215142,0.0000034529496],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034390387,0.000062664316,0.0000068635422,0.000026500515,0.000036891222,0.000043144762,0.00013896613,0.00001092218,0.97712946,0.000021400907,0.00025739474,0.021921862],"study_design_scores_gemma":[0.00107327,0.0031418325,0.00006848156,0.0000049163386,0.00004661951,0.00013838841,0.00012039893,0.00071389513,0.9857427,0.000019473238,0.008821167,0.00010886114],"about_ca_topic_score_codex":0.000034384357,"about_ca_topic_score_gemma":0.000052954667,"teacher_disagreement_score":0.021813,"about_ca_system_score_codex":0.000021744183,"about_ca_system_score_gemma":0.000104716884,"threshold_uncertainty_score":0.532671},"labels":[],"label_agreement":null},{"id":"W3111796351","doi":"10.1093/neuonc/noaa222.501","title":"MBCL-25. PILOT STUDY OF A SURGERY AND CHEMOTHERAPY-ONLY APPROACH IN THE UPFRONT THERAPY OF CHILDREN WITH WNT-POSITIVE STANDARD RISK MEDULLOBLASTOMA: UPDATED OUTCOMES","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Medulloblastoma; Chemotherapy; Regimen; Vincristine; Radiation therapy; Chemotherapy regimen; Surgery; Cyclophosphamide; Oncology","score_opus":0.028819902447269136,"score_gpt":0.2799672016497182,"score_spread":0.2511472992024491,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111796351","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993888,0.00028591944,0.000009815253,0.003535667,0.000027755374,0.0020079962,0.00005494775,0.000022670163,0.00016721575],"genre_scores_gemma":[0.99765325,0.00034368705,0.000102255384,0.0017132208,0.000027907721,0.000103805265,0.000024916897,0.00003047794,4.9160917e-7],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99803734,0.0005461302,0.0004505439,0.00039805655,0.00034212918,0.00022581543],"domain_scores_gemma":[0.99855864,0.0006460207,0.00033535625,0.0002676188,0.00009491125,0.00009743382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031950945,0.00024847843,0.0010505903,0.0001302196,0.000045789693,0.000007752001,0.000120043485,0.00006288998,0.000019525223],"category_scores_gemma":[0.00006340084,0.00013675631,0.00007246734,0.00035075817,0.00016686156,0.000037381236,0.00003600765,0.00025554845,7.4811203e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050435434,0.008261011,0.9674297,0.000011714247,0.00077877374,0.00011173641,0.0054813763,0.000011506653,0.0021627184,0.000013840205,0.00042745032,0.010266616],"study_design_scores_gemma":[0.015863582,0.037638575,0.94097656,0.0000125143,0.00021494912,0.000095901334,0.001850644,0.000021507987,0.0030630305,0.000004702338,0.00015469026,0.000103369915],"about_ca_topic_score_codex":0.0003117805,"about_ca_topic_score_gemma":0.00015240225,"teacher_disagreement_score":0.029377563,"about_ca_system_score_codex":0.00005246713,"about_ca_system_score_gemma":0.0001937948,"threshold_uncertainty_score":0.5576761},"labels":[],"label_agreement":null},{"id":"W3111800309","doi":"10.1093/neuonc/noaa222.828","title":"SWK-11. ASSESSMENT OF THE INDIRECT COSTS ASSOCIATED WITH PROTON THERAPY TREATMENT FOR ALBERTA PATIENTS REFERRED OUT OF COUNTRY","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiation Therapy and Dosimetry","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; Stollery Children's Hospital","funders":"","keywords":"Guardian; Medicine; Referral; Proton therapy; Family medicine; Indirect costs; Demography; Business; Political science; Surgery; Radiation therapy","score_opus":0.04210654748746865,"score_gpt":0.3365403763682218,"score_spread":0.29443382888075315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111800309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99190944,0.00003388634,0.0000150789365,0.0025601634,0.0002550598,0.0034847101,0.00007236811,0.000019347366,0.0016499317],"genre_scores_gemma":[0.9965608,0.00006139193,0.000072530274,0.0027616597,0.00005448915,0.00031512498,0.00008891827,0.00002614796,0.000058907724],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987973,0.00022942116,0.0003447801,0.00022342743,0.00024023325,0.00016483874],"domain_scores_gemma":[0.99827695,0.00078856084,0.00047339394,0.00021527908,0.00016569403,0.00008009994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011174614,0.00014951148,0.0005131352,0.000041649953,0.0000472658,0.000003433032,0.0001041668,0.0001429561,0.000042595653],"category_scores_gemma":[0.00032273665,0.00008763917,0.00010033629,0.00020135002,0.000076673125,0.00003127244,0.000013654252,0.0001101691,8.2494955e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036608984,0.0024600693,0.91880363,0.000053012853,0.0005203858,0.0000037457187,0.0018239901,0.000021681226,0.059745688,0.000052575528,0.0013253506,0.011528966],"study_design_scores_gemma":[0.03630585,0.042788677,0.57325625,0.0000816988,0.0003288466,0.0000032810951,0.00012085687,0.0008116742,0.18002374,0.000012756362,0.16606423,0.00020214365],"about_ca_topic_score_codex":0.000056417863,"about_ca_topic_score_gemma":0.00012800857,"teacher_disagreement_score":0.3455474,"about_ca_system_score_codex":0.00033494283,"about_ca_system_score_gemma":0.00047913886,"threshold_uncertainty_score":0.35738218},"labels":[],"label_agreement":null},{"id":"W3111804892","doi":"10.1093/neuonc/noaa222.346","title":"IMG-10. MRI-BASED RADIOMIC PROGNOSTIC MARKERS OF DIFFUSE MIDLINE GLIOMA","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Radiomics; Gray level; Proportional hazards model; Concordance; Artificial intelligence; Radiology; Nuclear medicine; Internal medicine; Computer science; Image (mathematics)","score_opus":0.016125506266176086,"score_gpt":0.2940524861700402,"score_spread":0.2779269799038641,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111804892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9182127,0.000244194,0.002165398,0.07544785,0.00047572804,0.00063419767,0.000009432986,0.00017215202,0.0026383223],"genre_scores_gemma":[0.97946495,0.000045868903,0.004709174,0.015130796,0.0004667191,0.000027098506,0.000046000543,0.000066517074,0.000042864936],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980567,0.00024852031,0.00053933664,0.00045232478,0.0003073255,0.00039578107],"domain_scores_gemma":[0.99794996,0.00091448677,0.00024156192,0.00029503476,0.00010163839,0.00049730367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029653092,0.00022422014,0.0007151018,0.00016885888,0.00005273964,0.000010146985,0.00023040839,0.0001712275,0.00057914597],"category_scores_gemma":[0.003461128,0.00019684432,0.00018528421,0.00039964577,0.00032494793,0.000035731566,0.00007636368,0.0006901801,0.0000744994],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026834665,0.00072580087,0.019699119,0.000390426,0.000106963016,0.0023774123,0.0002672347,0.0002854526,0.909974,0.00006898255,0.036088046,0.027333096],"study_design_scores_gemma":[0.025106644,0.011835382,0.012170218,0.00018820904,0.00079487544,0.0009832118,0.00013743396,0.32684076,0.034676846,0.000052834184,0.5866872,0.00052638294],"about_ca_topic_score_codex":0.000018998855,"about_ca_topic_score_gemma":0.0000012445669,"teacher_disagreement_score":0.8752971,"about_ca_system_score_codex":0.00009034302,"about_ca_system_score_gemma":0.0004432423,"threshold_uncertainty_score":0.80270785},"labels":[],"label_agreement":null},{"id":"W3111829628","doi":"10.1093/neuonc/noaa215.281","title":"EPCO-02. MOLECULAR CHARACTERIZATION OF TWO NOVEL MPNST SUBGROUPS IDENTIFIES THERAPEUTIC OPPORTUNITIES","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Cancer research; Wnt signaling pathway; Biology; Targeted therapy; Transcriptome; Medicine; Internal medicine; Signal transduction; Cancer; Genetics; Gene expression; Gene","score_opus":0.07732098688833675,"score_gpt":0.30785285782687166,"score_spread":0.23053187093853492,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111829628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98652273,0.000121221696,0.0008454743,0.009957275,0.0003680928,0.00036440874,0.00004661466,0.000095799645,0.0016783903],"genre_scores_gemma":[0.9873835,0.0001377496,0.00012746426,0.0119692115,0.00016735154,0.000024436757,0.000098048265,0.00004529524,0.00004695734],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99852407,0.00014215536,0.00049396005,0.00033955232,0.0002589065,0.0002413447],"domain_scores_gemma":[0.9989831,0.00015390688,0.0002599055,0.0002676541,0.00014341417,0.00019203853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010177485,0.0001955483,0.00055249134,0.00011202629,0.000054671218,0.000022325,0.00014066498,0.00010603994,0.00018394401],"category_scores_gemma":[0.00011456379,0.00018210828,0.00014204213,0.00020144321,0.0001762038,0.00012709132,0.000085659594,0.00021581519,0.000026471225],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024032794,0.00020789358,0.0012555709,0.00012123694,0.000048004094,0.0007031484,0.00039887318,0.0000016197206,0.9903757,0.0024771355,0.00017051994,0.0039999927],"study_design_scores_gemma":[0.0023833206,0.0024793616,0.0073206457,0.00003710364,0.0002267882,0.0006456156,0.000268517,0.0004322351,0.94494826,0.000059565456,0.04100097,0.00019760273],"about_ca_topic_score_codex":0.00000814374,"about_ca_topic_score_gemma":0.0000011877413,"teacher_disagreement_score":0.045427404,"about_ca_system_score_codex":0.000027230411,"about_ca_system_score_gemma":0.00020786404,"threshold_uncertainty_score":0.742616},"labels":[],"label_agreement":null},{"id":"W3111832741","doi":"10.1093/neuonc/noaa222.115","title":"DIPG-73. SENESCENCE ASSOCIATED SECRETORY PHENOTYPE AS A MECHANISM OF RESISTANCE AND THERAPEUTIC VULNERABILITY IN BMI1 INHIBITOR TREATED DIPG","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"BMI1; Cancer research; In vivo; Senescence; Apoptosis; Phenotype; Biology; Histone H3; Synthetic lethality; Cell culture; Epigenetics; Cell biology; Gene; Genetics; DNA repair","score_opus":0.027446583687917404,"score_gpt":0.29119980426584985,"score_spread":0.26375322057793243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111832741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912597,0.00066521915,0.0000075796524,0.006286506,0.00012239632,0.0006763061,0.000022437047,0.000065103646,0.00089476793],"genre_scores_gemma":[0.9970977,0.00013410578,0.0000597582,0.002517838,0.000059174567,0.00007263311,0.000016729973,0.00002752619,0.000014591272],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981141,0.0004289996,0.0004281644,0.0005145018,0.00022230257,0.0002918939],"domain_scores_gemma":[0.9986481,0.0005905381,0.00019860647,0.00024139749,0.00011731164,0.00020405445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021560515,0.00022024363,0.0006968678,0.00008354873,0.00005070047,0.0000071252693,0.00008154877,0.00022955792,0.00007965118],"category_scores_gemma":[0.0006557253,0.00018892402,0.000078920624,0.00040234582,0.00013853963,0.00003717934,0.00006242832,0.0002996022,0.000011700653],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011728945,0.0012528436,0.07217819,0.000103557635,0.00010778857,0.00064353546,0.0013336693,0.00000266972,0.9190631,0.00080717023,0.00019195749,0.0031426335],"study_design_scores_gemma":[0.023205332,0.010972115,0.33499652,0.00029937644,0.00082935323,0.000058347632,0.00067403616,0.0010975488,0.6162381,0.0025082394,0.008508662,0.0006123565],"about_ca_topic_score_codex":0.000102719794,"about_ca_topic_score_gemma":0.00026821828,"teacher_disagreement_score":0.30282497,"about_ca_system_score_codex":0.00025428322,"about_ca_system_score_gemma":0.00021361091,"threshold_uncertainty_score":0.7704098},"labels":[],"label_agreement":null},{"id":"W3111879451","doi":"10.1093/neuonc/noaa215.772","title":"RADT-19. EFFECTS OF RADIATION DOSE-RATE AND TUMOR CHARACTERISTICS ON LOCAL CONTROL AND TOXICITY AFTER RADIOSURGERY FOR ACOUSTIC NEUROMAS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; St. Michael's Hospital; Toronto Western Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Radiosurgery; Acoustic neuroma; Nuclear medicine; Hazard ratio; Schwannoma; Cumulative incidence; Lesion; Radiation therapy; Radiology; Surgery; Confidence interval; Internal medicine; Cohort","score_opus":0.01328803839082017,"score_gpt":0.2524608727621117,"score_spread":0.23917283437129155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111879451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98897445,0.00013416875,0.0050916336,0.004059516,0.00040416615,0.0012055429,0.00002213056,0.00003787723,0.00007049774],"genre_scores_gemma":[0.99006194,0.00003119,0.0000918998,0.009412543,0.0002469708,0.00011033372,0.000011069165,0.000025601566,0.000008471536],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987467,0.00020659699,0.0003386113,0.0003581067,0.000117504904,0.00023251223],"domain_scores_gemma":[0.9977751,0.0016071938,0.00017866009,0.00013667549,0.00003788288,0.00026448074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020869612,0.00017558761,0.000601165,0.00009263674,0.00004545343,0.000012747373,0.000041287658,0.000087106404,0.000009417839],"category_scores_gemma":[0.0010872828,0.00015776827,0.000063943284,0.00008563702,0.00012042178,0.00004220653,0.00003585307,0.00016198916,0.000003220283],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010491345,0.00030223487,0.010169559,0.0019172148,0.00012405548,0.0056597097,0.000482486,0.000028204133,0.9334503,0.00016486351,0.0028409862,0.03436909],"study_design_scores_gemma":[0.03594334,0.038927004,0.74066734,0.00018591221,0.002041565,0.00096711057,0.00008950722,0.08372371,0.061155137,0.00012620201,0.035462987,0.00071020273],"about_ca_topic_score_codex":0.0000018966754,"about_ca_topic_score_gemma":2.778653e-7,"teacher_disagreement_score":0.87229514,"about_ca_system_score_codex":0.00004608776,"about_ca_system_score_gemma":0.000071235125,"threshold_uncertainty_score":0.6433603},"labels":[],"label_agreement":null},{"id":"W3111884990","doi":"10.1093/neuonc/noaa215.306","title":"EPCO-27. GLIOMA SINGLE CELL MULTI-OMIC ANALYSES REVEALS REGULATORS OF PLASTICITY AND ADAPTIVE STRESS RESPONSE","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Epigenetics; Biology; DNA methylation; Transcriptome; Glioma; Stem cell; Histone; Carcinogenesis; Transcription factor; Genetics; Cancer research; Gene; Gene expression","score_opus":0.053678361106581786,"score_gpt":0.318715153809698,"score_spread":0.2650367927031162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111884990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955818,0.00096958724,0.0025206795,0.00036455697,0.00011273406,0.00019042887,0.00007630722,0.000011146345,0.00017273666],"genre_scores_gemma":[0.9972701,0.00014677722,0.002142324,0.00025927371,0.00010785876,0.0000058346714,0.000021842934,0.000024311375,0.000021680047],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99838877,0.0004972486,0.0003464013,0.00044911564,0.000109508,0.00020894858],"domain_scores_gemma":[0.9990013,0.00027240708,0.00025702274,0.0001867929,0.00011832944,0.0001641126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017114547,0.00017256809,0.00031592033,0.00006854293,0.00005036466,0.000009706094,0.00014006508,0.00025001087,0.000011630593],"category_scores_gemma":[0.0006844816,0.00017135977,0.00007972211,0.00014536132,0.00016981746,0.0000041837534,0.00016143595,0.000115661605,0.0000035182065],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016419431,0.00014777748,0.0024352984,0.000020747013,0.000029673702,0.000020557976,0.00020608118,0.0006033073,0.99387705,0.0000069484386,0.00019583204,0.0008147512],"study_design_scores_gemma":[0.0010610627,0.0033299122,0.006602334,0.0000059153485,0.000055534223,0.000004608145,0.00010753093,0.00071801397,0.9830884,0.000021751352,0.004855507,0.00014945495],"about_ca_topic_score_codex":0.000016426713,"about_ca_topic_score_gemma":0.000022928558,"teacher_disagreement_score":0.010788707,"about_ca_system_score_codex":0.000021386904,"about_ca_system_score_gemma":0.000108184795,"threshold_uncertainty_score":0.6987849},"labels":[],"label_agreement":null},{"id":"W3111907072","doi":"10.1093/neuonc/noaa222.831","title":"TBIO-02. IMMUNE PROFILING OF RARE EMBRYONAL BRAIN TUMORS REVEAL EVIDENCE OF DYSREGULATED INTERFERON SIGNALLING AS A POTENTIAL DETERMINANT OF IMMUNOLOGICAL HETEROGENEITY","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Biology; In silico; Immune system; Glioma; Epigenomics; Transcriptome; Immunotherapy; Tumor microenvironment; Computational biology; Cancer research; Immunology; DNA methylation; Genetics; Gene; Gene expression","score_opus":0.033377809654690664,"score_gpt":0.2987804849533806,"score_spread":0.26540267529868994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111907072","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99143934,0.0059173563,0.00030839184,0.0010402522,0.0005712343,0.0005331649,0.000044310036,0.00005749653,0.00008846058],"genre_scores_gemma":[0.9989848,0.00015431193,0.00028126355,0.0003994935,0.000032819386,0.000020490761,0.00003971756,0.000033790322,0.00005329182],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9951515,0.0018731125,0.0017021362,0.0005958264,0.00011647113,0.00056092476],"domain_scores_gemma":[0.9968415,0.0012420637,0.0011184528,0.00039722244,0.00034553665,0.000055242785],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006360544,0.0003805581,0.0014079628,0.00020178803,0.000100880476,0.0000069382713,0.0008045011,0.0006226457,0.00042457628],"category_scores_gemma":[0.0018129824,0.0003329063,0.00045248854,0.0002847071,0.0010305026,0.00013646646,0.0006033653,0.0008163741,0.00005473483],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018480405,0.00033920698,0.00031027698,0.00023209222,0.00024705983,0.0001214977,0.0007499763,0.000057905272,0.97280383,0.00009221193,0.00008756559,0.0064779525],"study_design_scores_gemma":[0.0018781808,0.015818147,0.0015608468,0.00038391814,0.000099823985,0.00064934057,0.00052210863,0.0001348987,0.978303,0.000021479724,0.00038880834,0.00023944334],"about_ca_topic_score_codex":0.00008154642,"about_ca_topic_score_gemma":0.000003940891,"teacher_disagreement_score":0.016602226,"about_ca_system_score_codex":0.000078270925,"about_ca_system_score_gemma":0.0004523856,"threshold_uncertainty_score":0.9999123},"labels":[],"label_agreement":null},{"id":"W3111914727","doi":"10.1093/neuonc/noaa222.668","title":"QOL-02. PERCEPTIONS OF LATE EFFECTS CARE NEEDS AMONG SURVIVORS OF PEDIATRIC BRAIN TUMOURS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Worry; Quality of life (healthcare); Medulloblastoma; Radiation therapy; Cancer; Pediatric cancer; Family medicine; Physical therapy; Anxiety; Internal medicine; Psychiatry; Nursing","score_opus":0.019186850732725517,"score_gpt":0.3054117004378184,"score_spread":0.2862248497050929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111914727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98304623,0.0004146902,0.000076441735,0.012428421,0.0007308912,0.0007544301,0.000048404803,0.00012383334,0.0023766456],"genre_scores_gemma":[0.99267226,0.00013894709,0.00022637744,0.0059111775,0.0008867593,0.000027190516,0.000041249245,0.00006251524,0.000033521916],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972446,0.00070064585,0.0007686827,0.0004210343,0.0004735661,0.00039145572],"domain_scores_gemma":[0.9967882,0.0016731529,0.00044364866,0.00042846525,0.00025020706,0.0004163099],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033463718,0.00027155055,0.0010959655,0.0003235343,0.000060120932,0.000005456052,0.00026779287,0.00027746896,0.00015948445],"category_scores_gemma":[0.0016078671,0.0002788998,0.0003043652,0.0009643851,0.00028065548,0.00008205928,0.00015774897,0.0005929791,0.000041193813],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048164086,0.00039828313,0.83007485,0.0024367138,0.00010043096,0.00015654735,0.05292522,0.00012479642,0.10031956,0.00009039603,0.010293326,0.0025982172],"study_design_scores_gemma":[0.006264575,0.009456179,0.9500571,0.00011102282,0.00091877073,0.00004631213,0.011442912,0.00015022568,0.014137895,0.000037246587,0.006918335,0.00045940912],"about_ca_topic_score_codex":0.00075165165,"about_ca_topic_score_gemma":0.0005537598,"teacher_disagreement_score":0.11998225,"about_ca_system_score_codex":0.00011294975,"about_ca_system_score_gemma":0.00052773964,"threshold_uncertainty_score":0.9999663},"labels":[],"label_agreement":null},{"id":"W3111923710","doi":"10.1093/neuonc/noaa222.613","title":"NFB-09. ENROLLMENT AND CLINICAL CHARACTERISTICS OF NEWLY DIAGNOSED, NEUROFIBROMATOSIS TYPE 1 ASSOCIATED OPTIC PATHWAY GLIOMA (NF1-OPG): PRELIMINARY RESULTS FROM AN INTERNATIONAL MULTI-CENTER NATURAL HISTORY STUDY","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Neurofibromatosis; Natural history; Natural history study; Pediatrics; Internal medicine; Radiology","score_opus":0.05540380640046057,"score_gpt":0.3285610388089389,"score_spread":0.27315723240847833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111923710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932254,0.00014382166,0.0000021025828,0.0020450107,0.0030239697,0.0008883994,0.00038876926,0.00012846432,0.00015407291],"genre_scores_gemma":[0.99594873,0.0001182866,0.00046475529,0.0025118985,0.00042501447,0.000024040792,0.00041794011,0.00006751499,0.00002182647],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958656,0.0009061813,0.0014501456,0.0009705066,0.00047029977,0.00033725746],"domain_scores_gemma":[0.99649125,0.001529097,0.00074966275,0.00048477607,0.00027383195,0.00047135886],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003203614,0.00036215576,0.0010719879,0.00014331943,0.00006378484,0.000026302156,0.00032741195,0.0002622128,0.000058731715],"category_scores_gemma":[0.00276791,0.00033543125,0.00018940677,0.00016802995,0.00020925612,0.0001978632,0.00036280777,0.0006813994,0.000025217607],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03466816,0.022117067,0.6070362,0.00008144805,0.000924485,0.02151619,0.004441338,0.0000027466424,0.2910357,0.000017259274,0.0063596917,0.011799747],"study_design_scores_gemma":[0.026162267,0.038672063,0.9199185,0.00007293373,0.0004595082,0.0003235279,0.0003625428,0.0029393088,0.0016541108,0.0000014433731,0.009100709,0.00033313304],"about_ca_topic_score_codex":0.000081404025,"about_ca_topic_score_gemma":0.000013843951,"teacher_disagreement_score":0.3128823,"about_ca_system_score_codex":0.00020331927,"about_ca_system_score_gemma":0.00031773167,"threshold_uncertainty_score":0.99990976},"labels":[],"label_agreement":null},{"id":"W3111926312","doi":"10.1093/neuonc/noaa222.132","title":"EPCT-08. ACTIVITY OF LAROTRECTINIB IN PEDIATRIC TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION CANCER PATIENTS WITH PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Trk receptor; Medicine; Internal medicine; Adverse effect; Tropomyosin receptor kinase A; Fusion gene; Oncology; Cancer; Gastroenterology; Receptor; Neurotrophin; Gene; Biology","score_opus":0.013157519264743537,"score_gpt":0.2512920259977259,"score_spread":0.23813450673298234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111926312","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954735,0.0001734444,0.000002459616,0.0020492997,0.0004220477,0.0012579967,0.0000665618,0.00006559164,0.00048910116],"genre_scores_gemma":[0.99859935,0.0001567421,0.00011198875,0.0005961552,0.0002711463,0.00017558706,0.000043639146,0.000042027557,0.0000033392987],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99802893,0.00027628618,0.00040085573,0.0005142563,0.00033552537,0.00044414072],"domain_scores_gemma":[0.9988156,0.00021202026,0.00033311587,0.00021405969,0.0001097143,0.00031551486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007116939,0.00026145155,0.0007880586,0.00016475757,0.000049829592,0.0000066010602,0.00010199151,0.00015521602,0.0000952979],"category_scores_gemma":[0.00009575332,0.00020216529,0.00010409488,0.0005630124,0.000055947905,0.000073658666,0.00008230272,0.00033418788,0.000017933795],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003004402,0.0029435356,0.9086855,0.00050798873,0.000044749322,0.0006400262,0.0005190814,0.0000705665,0.059522253,0.000009115758,0.0012813663,0.022771383],"study_design_scores_gemma":[0.0107432455,0.00588527,0.95062965,0.00011193353,0.00028238527,0.00001859618,0.00008728039,0.00008750264,0.029477598,3.865725e-7,0.0024942858,0.00018183546],"about_ca_topic_score_codex":0.00043050246,"about_ca_topic_score_gemma":0.0001349227,"teacher_disagreement_score":0.04194415,"about_ca_system_score_codex":0.0007598662,"about_ca_system_score_gemma":0.0004738787,"threshold_uncertainty_score":0.82440615},"labels":[],"label_agreement":null},{"id":"W3111979438","doi":"10.1093/neuonc/noaa222.776","title":"RONC-03. NEUROCOGNITIVE CHANGES AFTER RADIATION FOR PEDIATRIC BRAIN TUMOURS: WHICH BRAIN SUBSTRUCTURES ARE MOST IMPORTANT?","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Princess Margaret Cancer Centre","funders":"","keywords":"Neurocognitive; Medicine; Hippocampus; Intelligence quotient; Neuropsychology; Pediatrics; Cognition; Wechsler Adult Intelligence Scale; Nuclear medicine; Psychology; Internal medicine; Audiology; Psychiatry","score_opus":0.019224484503398254,"score_gpt":0.2890138421141553,"score_spread":0.26978935761075706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111979438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8157594,0.0011101858,0.000021173708,0.18040007,0.0004123292,0.0017213163,0.00025145087,0.000115957264,0.0002080791],"genre_scores_gemma":[0.94612914,0.00026898712,0.000117586045,0.05078034,0.0016230177,0.0007819002,0.0002174031,0.000073101175,0.0000085361025],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979908,0.00020208026,0.00039121698,0.00068539823,0.00023869306,0.00049183884],"domain_scores_gemma":[0.9974458,0.0013960621,0.0003324743,0.00020923726,0.00023818391,0.00037820783],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015105311,0.00033115502,0.0006155357,0.0001922316,0.00009889875,0.00003008807,0.00010965977,0.0002405107,0.00015735939],"category_scores_gemma":[0.0023751846,0.00029004805,0.00013031336,0.0005599336,0.00005656897,0.000077764365,0.00006012533,0.00029524663,0.00003991929],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033005911,0.0011096414,0.6968385,0.00043993638,0.00024594628,0.0041196723,0.002933885,0.000030202867,0.087298684,0.000209094,0.15901726,0.044456575],"study_design_scores_gemma":[0.015722744,0.009158281,0.757048,0.00003492926,0.0012964142,0.00037620167,0.0006097862,0.0007237429,0.040487044,0.00021651773,0.17368622,0.00064013177],"about_ca_topic_score_codex":0.000010494311,"about_ca_topic_score_gemma":0.00022444535,"teacher_disagreement_score":0.1303697,"about_ca_system_score_codex":0.000121282406,"about_ca_system_score_gemma":0.00024711847,"threshold_uncertainty_score":0.9999552},"labels":[],"label_agreement":null},{"id":"W3111985146","doi":"10.1093/neuonc/noaa222.484","title":"MBCL-08. INTEGRATIVE MOLECULAR ANALYSIS OF PATIENT-MATCHED DIAGNOSTIC AND RELAPSED MEDULLOBLASTOMAS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Oncology; Internal medicine; Copy-number variation; Exome; Cohort; Biology; Exome sequencing; Gene; Medicine; Bioinformatics; Cancer research; Genome; Genetics; Mutation","score_opus":0.007042168819649711,"score_gpt":0.24567298345416375,"score_spread":0.23863081463451402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111985146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99468493,0.0009538243,0.0013108178,0.0017031492,0.00015843086,0.00026596666,0.00010495843,0.000012356899,0.00080554094],"genre_scores_gemma":[0.994096,0.00077591307,0.0006611418,0.004215043,0.00006597043,0.00003489459,0.00012167231,0.000025415377,0.000003975175],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986388,0.00014687418,0.0003714623,0.00049428997,0.000119686025,0.00022888473],"domain_scores_gemma":[0.9987219,0.0004425482,0.00022324335,0.00027591054,0.0001297111,0.0002066738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000068757516,0.00020595474,0.00050425995,0.00009995882,0.00003836485,0.0000120474815,0.00017165358,0.00020768205,0.000035886078],"category_scores_gemma":[0.002058695,0.00019693842,0.0001760794,0.00038601086,0.00018461372,0.000003228843,0.00023555079,0.000157692,0.000005625069],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026870047,0.000118838754,0.002658433,0.000016067246,0.0005590701,0.00007553681,0.00086563267,0.0009745191,0.9864164,0.0003302971,0.0015534465,0.006163086],"study_design_scores_gemma":[0.0021191114,0.0069287126,0.0016348999,0.000011466438,0.0015328297,0.000021259128,0.000967126,0.0015752693,0.874575,0.0001614417,0.11002279,0.00045007662],"about_ca_topic_score_codex":0.00003297375,"about_ca_topic_score_gemma":0.000112944734,"teacher_disagreement_score":0.11184136,"about_ca_system_score_codex":0.000028597364,"about_ca_system_score_gemma":0.00017449955,"threshold_uncertainty_score":0.8030916},"labels":[],"label_agreement":null},{"id":"W3111988047","doi":"10.1093/neuonc/noaa215.494","title":"INNV-11. GLIOBLASTOMA IN THE OLDER PERSON – HOW DO WE DECIDE ON TREATMENT?","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Glioblastoma; Population; Cohort; Incidence (geometry); Test (biology); Gerontology; Family medicine; Internal medicine; Environmental health","score_opus":0.03826035598309131,"score_gpt":0.2994631702256527,"score_spread":0.2612028142425614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111988047","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.76596534,0.0003655293,0.0000013935185,0.23106326,0.0001605336,0.00063997897,0.000007852009,0.00004308907,0.0017530029],"genre_scores_gemma":[0.98473006,0.00035029996,0.000045944125,0.014262331,0.00030470404,0.00024312563,0.000008178276,0.000030459702,0.000024863386],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99857825,0.00023588471,0.00016703292,0.000450629,0.00022645298,0.0003417305],"domain_scores_gemma":[0.9986753,0.0007219532,0.000081445054,0.00031534402,0.00002921033,0.00017673746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007036826,0.00025667786,0.0004647414,0.00013057972,0.00006525518,0.000028995308,0.00013061061,0.00014997413,0.00016630821],"category_scores_gemma":[0.00013691092,0.00014978721,0.00015748078,0.00034926413,0.00006536262,0.00003974785,0.000025276762,0.00021783561,0.00021647707],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035485267,0.011836861,0.16500129,0.00010265442,0.00043707952,0.040619794,0.03172225,0.000049818562,0.16871047,0.0015683016,0.18507369,0.39132926],"study_design_scores_gemma":[0.016484024,0.029619532,0.054226648,0.00007727132,0.00037094555,0.0005967866,0.004341546,0.00014878405,0.044375315,0.000031311756,0.8494745,0.00025335938],"about_ca_topic_score_codex":0.000030542742,"about_ca_topic_score_gemma":0.00019206064,"teacher_disagreement_score":0.66440076,"about_ca_system_score_codex":0.00029963144,"about_ca_system_score_gemma":0.00011332835,"threshold_uncertainty_score":0.6108145},"labels":[],"label_agreement":null},{"id":"W3111988545","doi":"10.1093/neuonc/noaa222.357","title":"IMG-22. A DEEP LEARNING MODEL FOR AUTOMATIC POSTERIOR FOSSA PEDIATRIC BRAIN TUMOR SEGMENTATION: A MULTI-INSTITUTIONAL STUDY","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Segmentation; Deep learning; Computer science; Ground truth; Artificial intelligence; Medulloblastoma; Ependymoma; Pilocytic astrocytoma; Convolutional neural network; Neuroradiologist; Medicine; Magnetic resonance imaging; Radiology; Astrocytoma; Glioma; Pathology","score_opus":0.04452866306211238,"score_gpt":0.33331009159362346,"score_spread":0.28878142853151106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111988545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842447,0.00016525363,0.0041549997,0.008364384,0.00020251612,0.0026084953,0.000018843395,0.00017411383,0.00006668108],"genre_scores_gemma":[0.983816,0.000008505587,0.008604449,0.00611943,0.00030069327,0.0010477307,0.000050032893,0.000035530717,0.000017585493],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99841344,0.00014398772,0.00042604937,0.0004723063,0.00023454378,0.0003096818],"domain_scores_gemma":[0.9987933,0.00051208975,0.00017948433,0.00013994749,0.00011154977,0.000263607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014325134,0.00023428955,0.000502677,0.00012769684,0.00021376264,0.000025754063,0.00009348274,0.00007451185,0.0000885062],"category_scores_gemma":[0.0006639591,0.00019641515,0.0001550804,0.00023276801,0.000041307005,0.000084843676,0.000079960046,0.00021454242,0.00006510839],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025609455,0.020784583,0.5091667,0.001168273,0.000934499,0.008291668,0.03605948,0.026227584,0.25135222,0.0002222894,0.007435139,0.13579658],"study_design_scores_gemma":[0.02717924,0.0108443145,0.026506217,0.000014051284,0.00096074527,0.0004067539,0.0015081811,0.92960745,0.00096922886,0.000015197983,0.0017201978,0.00026844948],"about_ca_topic_score_codex":0.0000080335285,"about_ca_topic_score_gemma":0.000028610022,"teacher_disagreement_score":0.90337986,"about_ca_system_score_codex":0.00022066079,"about_ca_system_score_gemma":0.00037239664,"threshold_uncertainty_score":0.8009577},"labels":[],"label_agreement":null},{"id":"W3111996078","doi":"10.1093/neuonc/noaa222.667","title":"QOL-01. LONGITUDINAL COMPARISON OF NEUROCOGNITIVE TRAJECTORIES IN PEDIATRIC MEDULLOBLASTOMA PATIENTS TREATED WITH PROTON VERSUS PHOTON RADIOTHERAPY","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"Neurocognitive; Medicine; Medulloblastoma; Radiation therapy; Pediatrics; Cognition; Internal medicine; Psychiatry; Pathology","score_opus":0.034038019124207126,"score_gpt":0.3137440631071398,"score_spread":0.2797060439829327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111996078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959698,0.00016322566,0.0000037193965,0.00077741605,0.00015573234,0.0023667912,0.000020491318,0.0000557369,0.00048709713],"genre_scores_gemma":[0.99884564,0.00013247559,0.000095335185,0.0003069759,0.00012318068,0.0004105953,0.000044012104,0.000041086223,6.807374e-7],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998261,0.00017661703,0.00044303434,0.00048777324,0.0003101595,0.00032144744],"domain_scores_gemma":[0.9987847,0.00043221997,0.0002672204,0.00015491192,0.00015440246,0.00020649575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004171383,0.000279171,0.0008368322,0.00019732065,0.000039764465,0.000007530406,0.00008988249,0.00013811665,0.000070560054],"category_scores_gemma":[0.00014869362,0.00021755238,0.000092209375,0.00066914695,0.000109978064,0.000063411106,0.000026079591,0.00028590966,0.0000084287185],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01517003,0.0033279643,0.9668244,0.0001095431,0.000107029555,0.0004734949,0.0014247544,0.000015834523,0.009137862,0.0000043632094,0.00021847377,0.0031862082],"study_design_scores_gemma":[0.038699813,0.057395108,0.7649029,0.00003310313,0.00046466454,0.000019438346,0.00022377752,0.00025937153,0.13562343,0.0000010504332,0.0021688694,0.00020852087],"about_ca_topic_score_codex":0.00006980426,"about_ca_topic_score_gemma":0.0001075893,"teacher_disagreement_score":0.20192158,"about_ca_system_score_codex":0.00018849064,"about_ca_system_score_gemma":0.00018486619,"threshold_uncertainty_score":0.88715285},"labels":[],"label_agreement":null},{"id":"W3112001372","doi":"10.1093/neuonc/noaa215.233","title":"CTNI-67. EFFICACY AND SAFETY OF LAROTRECTINIB IN PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS: AN EXPANDED DATASET","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Trk receptor; Medicine; Internal medicine; Oncology; Surgery; Receptor; Neurotrophin","score_opus":0.014923764730465115,"score_gpt":0.25709316747128363,"score_spread":0.24216940274081852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112001372","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99661714,0.000096104486,0.0000026792186,0.0008992903,0.0001569663,0.0014295776,0.0006286018,0.000049772585,0.0001198611],"genre_scores_gemma":[0.9959778,0.00004187268,0.0003573657,0.00091170997,0.00011727394,0.000053244843,0.0025048156,0.00003522361,6.6080344e-7],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99801815,0.00034653986,0.000483066,0.0004929844,0.0002604468,0.00039883397],"domain_scores_gemma":[0.9987444,0.00021930019,0.00022729023,0.00031474282,0.00005734157,0.0004369098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010875438,0.00024915795,0.0007276162,0.000111334855,0.00005711126,0.0000096936255,0.000097069176,0.00012863708,0.000047259706],"category_scores_gemma":[0.00012027943,0.00018968781,0.000041196152,0.0002506366,0.000091109236,0.00011505237,0.00010213817,0.00023714699,0.000008247368],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017456917,0.0073987003,0.86056346,0.0004890549,0.000103440594,0.0008597462,0.0015992514,0.000030224746,0.06838826,0.000040299594,0.0043720836,0.038698558],"study_design_scores_gemma":[0.03007121,0.014082392,0.9332337,0.00025430834,0.00019885197,0.000064347616,0.00040501566,0.00006355526,0.010469602,3.7126867e-7,0.010946456,0.00021018866],"about_ca_topic_score_codex":0.000117259275,"about_ca_topic_score_gemma":0.000035183184,"teacher_disagreement_score":0.072670236,"about_ca_system_score_codex":0.00027880206,"about_ca_system_score_gemma":0.00015668912,"threshold_uncertainty_score":0.7735244},"labels":[],"label_agreement":null},{"id":"W3112008511","doi":"10.1093/neuonc/noaa222.092","title":"DIPG-46. NON-DIPG PATIENTS ENROLLED IN THE INTERNATIONAL DIPG REGISTRY: HISTOPATHOLOGIC EVALUATION OF CENTRAL NEURO-IMAGING REVIEW","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; BC Children's Hospital; Hospital for Sick Children","funders":"","keywords":"Histopathology; Medicine; Medical diagnosis; Neuroimaging; Biopsy; Pilocytic astrocytoma; Radiology; Pathology; Astrocytoma; Glioma","score_opus":0.044146907517437176,"score_gpt":0.3297210212274241,"score_spread":0.2855741137099869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112008511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9235207,0.0023012892,0.000007672519,0.06505222,0.000779771,0.0019049238,0.000020169367,0.000026197258,0.0063870433],"genre_scores_gemma":[0.974176,0.0012871887,0.000059969283,0.023988571,0.00014498521,0.00021574272,0.00010822014,0.000016694199,0.0000026316052],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975671,0.0005356869,0.0005547468,0.00041304514,0.0006686901,0.0002606945],"domain_scores_gemma":[0.9985829,0.00038043523,0.00035955722,0.0003213955,0.00025235373,0.00010337894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058127556,0.00018525575,0.00051379733,0.00008380733,0.000039858634,0.000010081431,0.0002832214,0.00006735358,0.00018954264],"category_scores_gemma":[0.0025031734,0.00012990298,0.00015136029,0.00026724272,0.00007932081,0.000060790717,0.000096312935,0.00028350874,0.000023429553],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047117632,0.0030308242,0.83244026,0.00033352931,0.00006591992,0.001201651,0.0012705469,0.000064113985,0.035554323,0.00010110439,0.039665543,0.085801035],"study_design_scores_gemma":[0.01910558,0.002536893,0.81800467,0.00048804775,0.0011722328,0.00020234015,0.00017830373,0.0048897965,0.001799709,0.00008936565,0.15127245,0.00026063315],"about_ca_topic_score_codex":0.000020903817,"about_ca_topic_score_gemma":0.000010428865,"teacher_disagreement_score":0.111606896,"about_ca_system_score_codex":0.00031552173,"about_ca_system_score_gemma":0.00022272521,"threshold_uncertainty_score":0.529729},"labels":[],"label_agreement":null},{"id":"W3112019368","doi":"10.1093/neuonc/noaa215.047","title":"BIOM-50. GENETIC PREDISPOSITION TO LONGER TELOMERE LENGTH AND RISK OF CHILDHOOD, ADOLESCENT AND ADULT-ONSET EPENDYMOMA","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"SickKids Foundation; University of Toronto","funders":"","keywords":"Ependymoma; Telomere; Medicine; Population; Oncology; Genome-wide association study; Internal medicine; Pediatrics; Single-nucleotide polymorphism; Biology; Pathology; Genetics; Genotype","score_opus":0.011171728224493091,"score_gpt":0.25612428980165475,"score_spread":0.24495256157716166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112019368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914616,0.000918769,0.000016535594,0.0064663645,0.000087332206,0.00077188626,0.00010713776,0.000032033597,0.0001383651],"genre_scores_gemma":[0.99491376,0.0011711225,0.0006990429,0.0029970426,0.00012373063,0.000049230282,0.000021819407,0.000023119495,0.0000011301903],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99887204,0.00011433482,0.00026731068,0.00040233377,0.00013899586,0.00020498408],"domain_scores_gemma":[0.9991643,0.00012433784,0.0001124114,0.00017451582,0.00006656645,0.00035791332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000044569835,0.00017071197,0.0003987058,0.00009529142,0.000050357747,0.000008685073,0.000047526264,0.00011479502,0.00004208633],"category_scores_gemma":[0.00016940376,0.00014215638,0.000053778538,0.0001429549,0.00007940571,0.000026380589,0.00009035288,0.00015471502,0.000021458129],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008870402,0.0017030751,0.74277973,0.00020352223,0.00026683725,0.0010264907,0.0020594615,0.000010565362,0.10949489,0.0000357914,0.006804596,0.13472801],"study_design_scores_gemma":[0.004065752,0.0054592052,0.9514008,0.000057371002,0.0005301781,0.00055605074,0.00014183822,0.00011354536,0.03240678,0.00001508001,0.005132323,0.00012105216],"about_ca_topic_score_codex":0.000039366947,"about_ca_topic_score_gemma":0.000028020493,"teacher_disagreement_score":0.2086211,"about_ca_system_score_codex":0.000038372822,"about_ca_system_score_gemma":0.00005425442,"threshold_uncertainty_score":0.5796969},"labels":[],"label_agreement":null},{"id":"W3112027773","doi":"10.1093/neuonc/noaa215.989","title":"LTBK-04. PHASE 2 MULTICENTER STUDY OF THE ONCOLYTIC ADENOVIRUS DNX-2401 (TASADENOTUREV) IN COMBINATION WITH PEMBROLIZUMAB FOR RECURRENT GLIOBLASTOMA; CAPTIVE STUDY (KEYNOTE-192)","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto; University Health Network","funders":"","keywords":"Pembrolizumab; Temozolomide; Medicine; Phases of clinical research; Regimen; Internal medicine; Adverse effect; Surgery; Oncology; Chemotherapy; Cancer; Immunotherapy","score_opus":0.03219008510426249,"score_gpt":0.34872699407953633,"score_spread":0.31653690897527387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112027773","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99253774,0.000140824,0.000077500554,0.0014056746,0.00022819969,0.0054815235,0.000053333235,0.000017018318,0.000058181817],"genre_scores_gemma":[0.99803734,0.000024178784,0.000035439156,0.0010474499,0.00015459154,0.00059856987,0.000020046744,0.00006301658,0.000019378167],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9966696,0.0010534705,0.0005441887,0.0007914545,0.00043774507,0.00050354155],"domain_scores_gemma":[0.9984484,0.00019194985,0.00031404194,0.00056197774,0.00028806386,0.00019557259],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041364902,0.0003195821,0.00050797715,0.00012408548,0.00012316901,0.000020361014,0.00064533803,0.00018683575,0.00002190475],"category_scores_gemma":[0.0005164247,0.00022779669,0.00011476378,0.00043906464,0.0001664632,0.00001071976,0.00029559762,0.0004761806,0.000006503692],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16470633,0.021294693,0.0055797743,0.00007599595,0.00033872438,0.00010371032,0.0094188005,0.0008843142,0.77832985,0.000005486543,0.0011843026,0.018077996],"study_design_scores_gemma":[0.08996191,0.5811447,0.0029470583,0.000027455597,0.00022970485,0.00001907359,0.007282691,0.002152778,0.30583322,0.000013717256,0.00988239,0.0005053266],"about_ca_topic_score_codex":0.000049035792,"about_ca_topic_score_gemma":0.0035446892,"teacher_disagreement_score":0.55985,"about_ca_system_score_codex":0.00019157832,"about_ca_system_score_gemma":0.00056226534,"threshold_uncertainty_score":0.92892796},"labels":[],"label_agreement":null},{"id":"W3112033076","doi":"10.1093/neuonc/noaa222.428","title":"LGG-50. INTEGRATED MOLECULAR AND CLINICAL ANALYSIS OF 1,000 PEDIATRIC LOW-GRADE GLIOMAS UNCOVERS NOVEL SUBGROUPS FOR CLINICAL RISK STRATIFICATION","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"IDH1; Risk stratification; Medicine; Internal medicine; Cohort; Oncology; Histology; Gastroenterology; Pathology; Mutation; Biology; Gene; Genetics","score_opus":0.06929710980612228,"score_gpt":0.40745634062080505,"score_spread":0.3381592308146828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112033076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927998,0.00013489292,0.0031896248,0.0023128677,0.00017815176,0.0009478744,0.00027405896,0.00005176994,0.0001109447],"genre_scores_gemma":[0.9957564,0.001202241,0.0015664025,0.0010100546,0.00018982579,0.0000400077,0.00019634569,0.00003237585,0.000006339528],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99693525,0.0005519236,0.0010913798,0.0007593971,0.00031861113,0.00034342738],"domain_scores_gemma":[0.995834,0.0024942937,0.00047065294,0.00036235357,0.00024522073,0.0005935056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005775184,0.00022016754,0.0010278999,0.00034806234,0.00005820063,0.000015723766,0.00015753495,0.0003076202,0.00003784574],"category_scores_gemma":[0.003289745,0.00018561243,0.00051048736,0.001316881,0.000263255,0.00006169563,0.00007067721,0.0006233731,0.000010893773],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0075186538,0.0047183433,0.84737176,0.00016305351,0.0034441862,0.0005785646,0.00012081467,0.00009240015,0.11278166,0.00019236557,0.00222895,0.020789253],"study_design_scores_gemma":[0.039794944,0.05841537,0.7867533,0.000023023431,0.026603619,0.00009040982,0.00029939684,0.042391676,0.022266386,0.00014239653,0.02259465,0.0006248584],"about_ca_topic_score_codex":0.0000565005,"about_ca_topic_score_gemma":0.000056788474,"teacher_disagreement_score":0.09051527,"about_ca_system_score_codex":0.00006263621,"about_ca_system_score_gemma":0.0004374833,"threshold_uncertainty_score":0.75690556},"labels":[],"label_agreement":null},{"id":"W3112040438","doi":"10.1093/neuonc/noaa222.270","title":"GCT-52. TRANSCRIPTOME OF CENTRAL NERVOUS SYSTEM GERM CELL TUMOR REVEALS ITS PATHOGENESIS AND CONTRASTS WITH TESTICULAR COUNTERPARTS IN INTEGRATED OMICS ANALYSIS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Biology; Transcriptome; Atypical teratoid rhabdoid tumor; Germinoma; Germ cell tumors; DNA methylation; Germ cell; Embryonic stem cell; Epigenetics; Cancer research; Genetics; Gene; Gene expression","score_opus":0.012245279618759831,"score_gpt":0.24196034727371973,"score_spread":0.22971506765495991,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112040438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964647,0.0015451269,0.00036869195,0.00038677562,0.00006284926,0.00078513805,0.00023234935,0.00006174946,0.000092596834],"genre_scores_gemma":[0.9985547,0.000061128274,0.00032702804,0.0008616575,0.000034653174,0.00004443481,0.00007832909,0.000034359957,0.0000036997892],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981739,0.00022249344,0.00051429146,0.0004873789,0.00022286129,0.00037905673],"domain_scores_gemma":[0.998645,0.00020981417,0.00032988144,0.00020804215,0.00016068804,0.0004465497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000085818894,0.00027209445,0.0010852292,0.00017136984,0.000032239695,0.0000135230885,0.00008361849,0.00010634709,0.0000155954],"category_scores_gemma":[0.00019469504,0.00020763063,0.00015531541,0.00070224906,0.000115557654,0.00004670789,0.000021148355,0.00016722127,0.000004147741],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016441108,0.0007925226,0.634609,0.0007860117,0.00062042946,0.010631228,0.0005336511,0.00054225104,0.34840277,0.000030079851,0.000028862158,0.0013791086],"study_design_scores_gemma":[0.012027698,0.0055717463,0.9361282,0.00025969805,0.010453063,0.00067461765,0.000752553,0.021454388,0.011729776,0.0000025866048,0.000565375,0.00038032176],"about_ca_topic_score_codex":0.00006482274,"about_ca_topic_score_gemma":0.00004247042,"teacher_disagreement_score":0.336673,"about_ca_system_score_codex":0.0001723756,"about_ca_system_score_gemma":0.0003329323,"threshold_uncertainty_score":0.8466931},"labels":[],"label_agreement":null},{"id":"W3112051513","doi":"10.1093/neuonc/noaa222.243","title":"GCT-23. MULTI-INSTITUTIONAL ANALYSIS OF TREATMENT MODALITIES IN BASAL GANGLIA AND THALAMIC GERMINOMA","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; University of British Columbia; Hospital for Sick Children","funders":"","keywords":"Medicine; Chemotherapy; Basal ganglia; Nuclear medicine; Germinoma; Basal (medicine); Radiation therapy; Central nervous system; Radiology; Internal medicine","score_opus":0.046845077412024906,"score_gpt":0.3140051202842474,"score_spread":0.26716004287222245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112051513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937454,0.00039769156,0.000015519336,0.004757886,0.00007082254,0.0003093607,0.000063117775,0.000020257236,0.00061994814],"genre_scores_gemma":[0.99768776,0.00019140432,0.0003351224,0.0015801494,0.0000470168,0.00007001257,0.0000673017,0.000009543919,0.000011674489],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99901,0.00008201581,0.00029913057,0.0003183727,0.00010780168,0.00018263164],"domain_scores_gemma":[0.99935776,0.00023485217,0.00008600909,0.00014139415,0.000040078725,0.00013988215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004506847,0.00016611247,0.0006794623,0.00027023206,0.000031941832,0.0000050310364,0.000041907846,0.00009755876,0.00010227073],"category_scores_gemma":[0.000074429845,0.00012502634,0.00015337662,0.00038565078,0.00014120144,0.000035991747,0.0000366688,0.00007842185,0.000008375273],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031739747,0.0017062647,0.9050814,0.000041749547,0.0010867809,0.002664554,0.0019476482,0.00060766906,0.079295985,0.00076780695,0.00020182956,0.0062809056],"study_design_scores_gemma":[0.013032937,0.0050676265,0.9169485,0.000020654701,0.0032756417,0.000062140294,0.000589546,0.027903931,0.028826354,0.00007163797,0.0040007504,0.00020030446],"about_ca_topic_score_codex":0.00024018947,"about_ca_topic_score_gemma":0.00034364656,"teacher_disagreement_score":0.05046963,"about_ca_system_score_codex":0.0002626655,"about_ca_system_score_gemma":0.0002161765,"threshold_uncertainty_score":0.50984263},"labels":[],"label_agreement":null},{"id":"W3112056129","doi":"10.1093/neuonc/noaa222.570","title":"MBRS-66. COST-EFFECTIVE METHOD TO INCORPORATE MOLECULAR CLASSIFICATION OF MEDULLOBLASTOMA INTO A LATIN-AMERICAN CLINICAL TRIAL","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Wnt signaling pathway; Monosomy; Immunohistochemistry; Internal medicine; Fluorescence in situ hybridization; Oncology; Cancer research; Histogenesis; Medicine; Biology; Pathology; Bioinformatics; Gene; Genetics; Karyotype","score_opus":0.04892589931349365,"score_gpt":0.3908982649223801,"score_spread":0.34197236560888644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112056129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9287774,0.00006195374,0.062490027,0.005070617,0.00054368016,0.0022201317,0.000048000074,0.000020991636,0.0007671902],"genre_scores_gemma":[0.96804774,0.00008682117,0.020868717,0.00971831,0.00070248154,0.00045620665,0.00006883704,0.000045908793,0.0000049905134],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99749357,0.000738832,0.0006656819,0.0006993749,0.00014719319,0.0002553252],"domain_scores_gemma":[0.9980126,0.0005303087,0.00050811033,0.00038752044,0.00021425706,0.00034721056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049495767,0.00021097365,0.00056334457,0.000060058006,0.000042922784,0.000013489647,0.00031529946,0.00024258315,0.000009931513],"category_scores_gemma":[0.0021964652,0.0002217057,0.00020249623,0.00031771086,0.00021525196,0.0000029555829,0.0002917579,0.00024890015,0.000025417456],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011704138,0.00018900239,0.0007534442,0.000010567437,0.00006497579,0.00002171991,0.00014159242,0.00027773433,0.8145744,0.00030664232,0.002200995,0.16975477],"study_design_scores_gemma":[0.014908845,0.028182501,0.0028064952,0.0000062387785,0.00012749391,0.000009779414,0.00018033666,0.0011596223,0.43771625,0.00023001648,0.51430905,0.00036340856],"about_ca_topic_score_codex":0.00006128171,"about_ca_topic_score_gemma":0.00009135923,"teacher_disagreement_score":0.512108,"about_ca_system_score_codex":0.00006520777,"about_ca_system_score_gemma":0.0004836997,"threshold_uncertainty_score":0.9040896},"labels":[],"label_agreement":null},{"id":"W3112068339","doi":"10.1093/neuonc/noaa222.733","title":"RARE-22. GERMLINE PATHOGENIC VARIANT c.1552G&amp;gt;A;p.E518K IN DGCR8 CONFERS SUSCEPTIBILITY FOR SCHWANNOMATOSIS AND THYROID TUMORS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; University of Toronto; Jewish General Hospital; University Health Network; McGill University","funders":"","keywords":"Germline; Germline mutation; Schwannoma; Biology; Cancer research; Thyroid cancer; Somatic cell; Wilms' tumor; SMARCB1; Thyroid; Pathology; Medicine; Mutation; Genetics; Gene","score_opus":0.04108704870604132,"score_gpt":0.32339168569279486,"score_spread":0.28230463698675357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112068339","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98514867,0.00018503958,0.00012805285,0.010999312,0.0001443468,0.0019635702,0.00015705607,0.00011740524,0.0011565674],"genre_scores_gemma":[0.99419343,0.00014154614,0.0012876418,0.003778553,0.00017470197,0.00021542382,0.00009591703,0.00006147664,0.00005129532],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9971029,0.00035535332,0.00057838456,0.00091525813,0.00029377732,0.00075430545],"domain_scores_gemma":[0.9977413,0.0007882314,0.00014011505,0.00041645978,0.0001474282,0.00076648284],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033310993,0.00032908385,0.0008468984,0.00019418231,0.00010704445,0.000029203085,0.00017390514,0.00020256024,0.00024052718],"category_scores_gemma":[0.001570852,0.00029064715,0.0001716426,0.00036922126,0.00026202793,0.000108123575,0.00019117382,0.0005252209,0.00008570762],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004718544,0.0009650805,0.02603328,0.0002627604,0.00008550003,0.0043241098,0.00044662112,0.000005576741,0.95220584,0.00024974102,0.003189028,0.0075139324],"study_design_scores_gemma":[0.14957455,0.12227572,0.3237068,0.00042600255,0.0013905801,0.01149199,0.0011485828,0.008261603,0.11680991,0.0023699678,0.25972882,0.002815477],"about_ca_topic_score_codex":0.000031164025,"about_ca_topic_score_gemma":0.00009892003,"teacher_disagreement_score":0.83539593,"about_ca_system_score_codex":0.0001962269,"about_ca_system_score_gemma":0.0006481281,"threshold_uncertainty_score":0.9999546},"labels":[],"label_agreement":null},{"id":"W3112100083","doi":"10.1093/neuonc/noaa215.007","title":"BIOM-07. EXPRESSION OF ANDROGEN RECEPTOR AND PROGRAMMED DEATH-LIGAND 1 IN BREAST-TO-BRAIN-METASTASES.","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Immunohistochemistry; Androgen receptor; Breast cancer; Tissue microarray; Programmed cell death; Cancer research; Cancer; Medicine; Oncology; Apoptosis; Internal medicine; Pathology; Biology; Prostate cancer","score_opus":0.03126967492989289,"score_gpt":0.30773491660322516,"score_spread":0.27646524167333225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112100083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.959201,0.00045428777,0.00006762852,0.038636245,0.00010820598,0.0011276836,0.0001224812,0.000046326415,0.0002361667],"genre_scores_gemma":[0.9861587,0.00010418549,0.006686229,0.0067107608,0.00011475338,0.00010392455,0.0000749465,0.000034435896,0.00001204188],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99835527,0.00024235577,0.00039844512,0.00048180367,0.00019108245,0.00033103602],"domain_scores_gemma":[0.99878913,0.00033897132,0.00012302841,0.000222579,0.00005973198,0.00046652905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024268171,0.0002081125,0.00064096786,0.00013579616,0.000033938533,0.000009099676,0.00008331138,0.00012905443,0.0001334623],"category_scores_gemma":[0.00029964518,0.00016458848,0.000084338775,0.0003215148,0.00009447789,0.000044580123,0.00013057824,0.00019466189,0.000040470135],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002121102,0.0009191547,0.034961764,0.00015679047,0.00007079147,0.0007740559,0.00097601523,0.0000039301517,0.8243122,0.0000756994,0.009923422,0.12570508],"study_design_scores_gemma":[0.0146341575,0.011237086,0.012099329,0.00014940558,0.00027888856,0.00092701724,0.0005474577,0.00009181962,0.41183066,0.000054501932,0.5478278,0.00032189762],"about_ca_topic_score_codex":0.0000496563,"about_ca_topic_score_gemma":0.000008454049,"teacher_disagreement_score":0.5379043,"about_ca_system_score_codex":0.000061348655,"about_ca_system_score_gemma":0.00018903127,"threshold_uncertainty_score":0.6711723},"labels":[],"label_agreement":null},{"id":"W3112144762","doi":"10.1093/neuonc/noaa215.211","title":"CTNI-45. A PHASE 1B/2 CLINICAL STUDY OF NAPABUCASIN IN COMBINATION WITH TEMOZOLOMIDE FOR ADULT PATIENTS WITH RECURRENT OR PROGRESSED GLIOBLASTOMA MULTIFORME (GBM)","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Bioactive Compounds and Antitumor Agents","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Calgary","funders":"","keywords":"Temozolomide; Medicine; Internal medicine; Tolerability; Phases of clinical research; Adverse effect; Oncology; Surgery; Gastroenterology; Clinical trial; Chemotherapy","score_opus":0.1544762611913571,"score_gpt":0.4754712240521156,"score_spread":0.3209949628607585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112144762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993385,0.000016720514,0.0000655335,0.0015101131,0.0006732818,0.0040612174,0.00012888775,0.000060726165,0.000098529694],"genre_scores_gemma":[0.99655575,0.000027769682,0.0003746501,0.0025358603,0.00011741186,0.00028717128,0.000049396305,0.00004421376,0.000007755885],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9967068,0.0010032775,0.00089588406,0.0006748632,0.00024118776,0.0004780054],"domain_scores_gemma":[0.9971283,0.001110559,0.0006513871,0.00018309717,0.0006278208,0.00029880495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004223723,0.0003340485,0.0007970065,0.00014304723,0.0001439975,0.000014323874,0.00032304108,0.00030721398,0.000076693526],"category_scores_gemma":[0.00054360053,0.00023919054,0.000079205674,0.00049765594,0.0003395119,0.00014209059,0.000102478094,0.0008635406,0.000009115875],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18932287,0.104536965,0.57284695,0.00026240578,0.0004900942,0.00045927608,0.0036509966,0.000052322455,0.007859595,0.00007666925,0.003154514,0.11728735],"study_design_scores_gemma":[0.38193816,0.42721942,0.073066704,0.00012141154,0.0008463511,0.000046045152,0.0031172426,0.019342294,0.011908315,0.000023825602,0.08135502,0.0010152267],"about_ca_topic_score_codex":0.00000893656,"about_ca_topic_score_gemma":0.0003648985,"teacher_disagreement_score":0.49978024,"about_ca_system_score_codex":0.00010643694,"about_ca_system_score_gemma":0.00030584287,"threshold_uncertainty_score":0.97539073},"labels":[],"label_agreement":null},{"id":"W3112159644","doi":"10.1093/neuonc/noaa222.702","title":"QOL-46. LATE EFFECTS CARE FOR CHILDHOOD BRAIN TUMOUR SURVIVORS: A QUALITY IMPROVEMENT PROJECT","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Health care; Family medicine","score_opus":0.03513154014876986,"score_gpt":0.3554632314070621,"score_spread":0.32033169125829225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112159644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8979021,0.00059766375,0.0006009194,0.08926598,0.0015608652,0.0070794728,0.0002105655,0.0005748524,0.0022075837],"genre_scores_gemma":[0.898149,0.00005357217,0.0013636474,0.09708854,0.002161973,0.00076202664,0.00020452526,0.00015469488,0.00006201529],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99515486,0.0009811721,0.0010819912,0.0012527166,0.00063490326,0.00089437],"domain_scores_gemma":[0.99535465,0.0026330284,0.00050201174,0.00065774744,0.00028551527,0.00056703924],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010007367,0.00054058025,0.0015697014,0.00014670158,0.00020406133,0.000040549203,0.00039190485,0.00036891917,0.00004698513],"category_scores_gemma":[0.0042988546,0.00052139274,0.00050103717,0.00044948392,0.00014341745,0.00012044372,0.00027062037,0.0008016839,0.000070238864],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005007772,0.002253736,0.00801027,0.009471829,0.00072781375,0.00050447066,0.09239953,0.000024679171,0.7151345,0.0006115705,0.051114645,0.11473916],"study_design_scores_gemma":[0.03267636,0.042025577,0.0382922,0.00035436076,0.00073588017,0.00012343438,0.008500515,0.00023810721,0.12875524,0.0003112055,0.74645764,0.0015294909],"about_ca_topic_score_codex":0.0012458374,"about_ca_topic_score_gemma":0.0014969042,"teacher_disagreement_score":0.695343,"about_ca_system_score_codex":0.00040526924,"about_ca_system_score_gemma":0.001454299,"threshold_uncertainty_score":0.9997238},"labels":[],"label_agreement":null},{"id":"W3112164247","doi":"10.1093/neuonc/noaa215.251","title":"DDRE-06. CELLULAR STRESS RESPONSE IN DIPG THERAPY","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Cancer research; Bystander effect; Integrated stress response; Glioma; Oncology; Biology; Immunology; Genetics; Gene","score_opus":0.03885441262013729,"score_gpt":0.31000083798625916,"score_spread":0.2711464253661219,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112164247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9529566,0.0008156403,0.0000054626507,0.04455432,0.0001558424,0.00049027137,0.000011910594,0.000058630172,0.00095128873],"genre_scores_gemma":[0.9883892,0.00031988995,0.000078456746,0.010893856,0.00016877962,0.0000875131,0.000019777837,0.000028642622,0.0000139059985],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99859554,0.00034758708,0.00025432053,0.00036356304,0.0001584417,0.00028054026],"domain_scores_gemma":[0.9988719,0.00055926555,0.00006680269,0.00024425474,0.000034766206,0.00022296858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013566414,0.00016107528,0.00040994782,0.00010272567,0.000032368836,0.000008796508,0.000099493016,0.0001431957,0.00024310463],"category_scores_gemma":[0.00025577695,0.00013116784,0.000092256145,0.00025150634,0.000056727036,0.000029652483,0.000048564336,0.0002544735,0.0001869727],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047105593,0.0013061963,0.07590109,0.000015495192,0.000046982528,0.007558513,0.0011864038,0.000027503327,0.8937222,0.000066176915,0.0043258015,0.011133117],"study_design_scores_gemma":[0.012930924,0.008973988,0.08401793,0.00002710218,0.00006183653,0.00006807823,0.00026224766,0.00024427628,0.42545646,0.000034160264,0.46774167,0.00018133264],"about_ca_topic_score_codex":0.00002304849,"about_ca_topic_score_gemma":0.000012645643,"teacher_disagreement_score":0.46826568,"about_ca_system_score_codex":0.00011948062,"about_ca_system_score_gemma":0.00017351584,"threshold_uncertainty_score":0.5348869},"labels":[],"label_agreement":null},{"id":"W3112175108","doi":"10.1093/neuonc/noaa215.168","title":"CTNI-01. EFFECT OF STEREOTACTIC RADIOSURGERY COMPARED TO WHOLE-BRAIN RADIOTHERAPY FOR LIMITED BRAIN METASTASIS ON LONG TERM COGNITION AND QUALITY OF LIFE: A POOLED ANALYSIS OF RANDOMIZED CLINICAL TRIALS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Radiosurgery; Quality of life (healthcare); Randomized controlled trial; Clinical endpoint; Internal medicine; Nuclear medicine; Radiation therapy; Urology","score_opus":0.14483321113072276,"score_gpt":0.44853757322026333,"score_spread":0.30370436208954055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112175108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97337145,0.0004965626,0.00083160284,0.020451121,0.00014225104,0.004372326,0.00029888528,0.000022361755,0.000013466129],"genre_scores_gemma":[0.9936307,0.00010000855,0.00034070908,0.0052433168,0.000098532626,0.0003535676,0.00020467794,0.000027210537,0.0000012569839],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.98421645,0.011941177,0.002803519,0.0005138575,0.00030509243,0.00021987822],"domain_scores_gemma":[0.88968146,0.107768215,0.0017097015,0.00031589268,0.00018339186,0.0003413233],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.010927361,0.00027957404,0.007856348,0.0005882144,0.00003164675,0.000009102262,0.00008594555,0.00019533218,0.0000634179],"category_scores_gemma":[0.050092332,0.00020144925,0.0017549576,0.0007517298,0.00021667735,0.00003489129,0.000029223163,0.00015739497,8.734081e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.45048845,0.0019587337,0.07110286,0.00051140384,0.02426507,0.000039305538,0.00044954984,0.000043985186,0.42068332,0.00002100161,0.0012464726,0.029189859],"study_design_scores_gemma":[0.6812648,0.02248422,0.1302442,0.00017951443,0.048258267,0.000009612406,0.00006974318,0.0023480651,0.11424891,0.0000070488472,0.0006027576,0.0002828286],"about_ca_topic_score_codex":0.000028577855,"about_ca_topic_score_gemma":0.00002388518,"teacher_disagreement_score":0.30643442,"about_ca_system_score_codex":0.000051544066,"about_ca_system_score_gemma":0.000117631746,"threshold_uncertainty_score":0.95790917},"labels":[],"label_agreement":null},{"id":"W3112196266","doi":"10.1093/neuonc/noaa222.624","title":"NURS-04. COMBINATION OF NEURO-ONCOLOGY AND DERMATOLOGY CLINICS IMPROVE THE MANAGEMENT AND KNOWLEDGE OF SKIN-RELATED TOXICITIES WITH MEK AND BRAF TARGETED THERAPY","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Dermatology; Oncology nursing; Oncology; Internal medicine; Nursing; Nurse education","score_opus":0.012253833091315423,"score_gpt":0.2562277906902607,"score_spread":0.24397395759894527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112196266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924767,0.002629631,0.00013947886,0.0020274064,0.00022972684,0.000586828,0.000020330246,0.000014032062,0.0018758613],"genre_scores_gemma":[0.99477696,0.0033153968,0.00024349184,0.0015026353,0.00004783714,0.00003550972,0.000029489795,0.000025474785,0.000023228491],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984495,0.00039487923,0.00042395064,0.00043392618,0.000071553324,0.00022616315],"domain_scores_gemma":[0.99900585,0.000254595,0.0003149624,0.00021687233,0.000107361346,0.00010035336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016305476,0.00020930792,0.00045368093,0.000058041096,0.00007731674,0.000008111208,0.00016168524,0.00030438814,0.0000066058383],"category_scores_gemma":[0.00006847736,0.0001558867,0.000044194465,0.00011172165,0.00064152014,0.0000078054145,0.0002159915,0.0002014094,7.482792e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008928448,0.00022618881,0.0032368342,0.00013416086,0.0001976689,0.000035731675,0.0020014253,0.0000037092864,0.9391699,0.0023465608,0.0006453668,0.051109653],"study_design_scores_gemma":[0.01290115,0.025219094,0.013002836,0.000019991769,0.00029294295,0.0007566826,0.0026006715,0.0009727214,0.7636066,0.001033471,0.1791149,0.00047896538],"about_ca_topic_score_codex":0.0000068954223,"about_ca_topic_score_gemma":0.000023538361,"teacher_disagreement_score":0.17846952,"about_ca_system_score_codex":0.000008599096,"about_ca_system_score_gemma":0.00011880223,"threshold_uncertainty_score":0.6356875},"labels":[],"label_agreement":null},{"id":"W3112205496","doi":"10.1093/neuonc/noaa222.340","title":"IMG-04. RESPONSE ASSESSMENT IN PEDIATRIC HIGH-GRADE GLIOMA: RECOMMENDATIONS FROM THE RESPONSE ASSESSMENT IN PEDIATRIC NEURO-ONCOLOGY WORKING GROUP","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Medicine; Clinical trial; Disease; Progressive disease; Oncology; Internal medicine; Medical physics","score_opus":0.041003994562401946,"score_gpt":0.3428109529851919,"score_spread":0.30180695842278993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112205496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7624696,0.0005141028,0.000050328214,0.233409,0.0013808388,0.001674455,0.000059433678,0.00013159447,0.00031065047],"genre_scores_gemma":[0.9802333,0.0017390212,0.0027842377,0.012588716,0.0013428511,0.0010516775,0.00014247921,0.00011285137,0.000004845982],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9873886,0.0077540567,0.0016238119,0.0014850417,0.0006648558,0.0010835998],"domain_scores_gemma":[0.97619754,0.021636073,0.0006453733,0.0008775374,0.000107613014,0.00053583266],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0026893085,0.00064794585,0.0013498848,0.0010067857,0.00027110908,0.000083739586,0.00060535496,0.00056080316,0.0002922279],"category_scores_gemma":[0.0024121027,0.00053872244,0.000289822,0.002945347,0.00013345,0.00017731458,0.0005262151,0.0023097245,0.000095128424],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0136047825,0.0077533037,0.8140813,0.000049638882,0.00012946452,0.016297543,0.0024193798,0.0002695786,0.115760446,0.00057091616,0.018834624,0.010229016],"study_design_scores_gemma":[0.01586962,0.0063238726,0.88337773,0.000027436581,0.0006185588,0.00016232594,0.0007072501,0.0006228149,0.00041047178,0.00016391932,0.09130634,0.0004096563],"about_ca_topic_score_codex":0.00035494997,"about_ca_topic_score_gemma":0.0010236094,"teacher_disagreement_score":0.2208203,"about_ca_system_score_codex":0.0021971231,"about_ca_system_score_gemma":0.0022504348,"threshold_uncertainty_score":0.999992},"labels":[],"label_agreement":null},{"id":"W3112223097","doi":"10.1093/neuonc/noaa215.119","title":"CSIG-07. c-Src PHOSPHORYLATES AND INACTIVATES THE CIC TUMOR SUPPRESSOR PROTEIN IN GLIOBLASTOMA","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"14-3-3 protein interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Proto-oncogene tyrosine-protein kinase Src; Dasatinib; Phosphorylation; Cancer research; MAPK/ERK pathway; Tyrosine kinase; Tyrosine phosphorylation; Receptor tyrosine kinase; Tyrosine; Chemistry; Cell biology; Signal transduction; Molecular biology; Biology; Biochemistry","score_opus":0.011188640438070925,"score_gpt":0.259227402604683,"score_spread":0.2480387621666121,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112223097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874817,0.00040015546,0.000031774784,0.010243099,0.0001597426,0.000758315,0.00001473498,0.000029937795,0.000880542],"genre_scores_gemma":[0.9959169,0.00004155332,0.00018692862,0.003206757,0.00023434364,0.00031906227,0.0000071326212,0.00003652968,0.000050800485],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985473,0.0002603699,0.00026929146,0.0005033024,0.0000966393,0.0003231015],"domain_scores_gemma":[0.99928766,0.00013206153,0.00012589355,0.00028176737,0.000057189147,0.000115400326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012338838,0.00020540673,0.00023388377,0.000042186333,0.00010132613,0.000036279886,0.0002895172,0.00016949371,0.000097965116],"category_scores_gemma":[0.0008282653,0.00016616799,0.000062333915,0.00015364395,0.00019684347,0.000012038295,0.00030379897,0.00042180484,0.000051008617],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000541758,0.00007970874,0.0007586727,0.00001725057,0.00002210274,0.00006403086,0.0002349676,0.000015592606,0.99410033,0.0000598571,0.0026799324,0.0014258212],"study_design_scores_gemma":[0.0006277323,0.0016239191,0.0004815937,0.00000900712,0.000010138556,0.00010087668,0.00021529621,0.000111476205,0.7961614,0.00008587446,0.20043288,0.00013981418],"about_ca_topic_score_codex":0.00004903447,"about_ca_topic_score_gemma":0.000106986714,"teacher_disagreement_score":0.19793892,"about_ca_system_score_codex":0.000037093523,"about_ca_system_score_gemma":0.00012645207,"threshold_uncertainty_score":0.6776134},"labels":[],"label_agreement":null},{"id":"W3112252398","doi":"10.1093/neuonc/noaa215.976","title":"TMOD-26. ESTABLISHING A PATIENT-DERIVED, IN-VITRO ORGANOTYPIC SLICE CULTURE MODEL OF GBM","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Atlantic Cancer Research Institute; Dalhousie University","funders":"","keywords":"Flow cytometry; Cell culture; Viral vector; Western blot; Transduction (biophysics); Glioblastoma; Cancer research; Lentivirus; U87; Confocal microscopy; Confocal; In vitro; Biology; Cell biology; Pathology; Molecular biology; Medicine; Immunology; Human immunodeficiency virus (HIV); Biophysics; Genetics; Gene; Physics","score_opus":0.015090551830159631,"score_gpt":0.2481827822920996,"score_spread":0.23309223046193997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112252398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945565,0.0007201901,0.0018568808,0.00091047207,0.00012643571,0.00029513796,0.00005005008,0.00003657265,0.0014477458],"genre_scores_gemma":[0.9915381,0.00011696537,0.003562436,0.0044667036,0.0001551675,0.000024427374,0.000063892665,0.000058184163,0.000014145473],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983621,0.00019537663,0.0003917408,0.00055089185,0.00015882864,0.00034101412],"domain_scores_gemma":[0.9990662,0.000041785184,0.00020035959,0.00037481147,0.00010461168,0.00021223693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000865738,0.00021158314,0.00030911298,0.00004317178,0.000042003358,0.000015469737,0.00040797665,0.00033053994,0.000018662706],"category_scores_gemma":[0.00067729835,0.00021953587,0.000113388574,0.00019898024,0.000120954646,0.0000136402805,0.00035975367,0.00031778918,0.000014895839],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005793942,0.00018322036,0.00027750302,0.000044239765,0.000018881072,0.000057824927,0.0008338044,0.0019420006,0.98952883,0.00003798425,0.0022430376,0.004253304],"study_design_scores_gemma":[0.001025812,0.0005689165,0.000036615384,0.0000054685534,0.000030196708,0.000015764317,0.00026832815,0.0051393537,0.97076124,0.000090569134,0.021856338,0.00020138483],"about_ca_topic_score_codex":0.000009141186,"about_ca_topic_score_gemma":0.000010622513,"teacher_disagreement_score":0.019613301,"about_ca_system_score_codex":0.000038988095,"about_ca_system_score_gemma":0.00029194885,"threshold_uncertainty_score":0.8952413},"labels":[],"label_agreement":null},{"id":"W3112261995","doi":"10.1093/neuonc/noaa222.502","title":"MBCL-26. FACTORS ASSOCIATED WITH LONGER SURVIVAL AFTER FIRST RECURRENCE IN MEDULLOBLASTOMA BY MOLECULAR SUBGROUP AFTER RISK-BASED INITIAL THERAPY","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Medicine; Internal medicine; Oncology; Radiation therapy; Anaplasia; Survival analysis; Pathology","score_opus":0.02388990840599439,"score_gpt":0.2766337158713896,"score_spread":0.2527438074653952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112261995","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99306214,0.00053768314,0.000034000735,0.0049300124,0.00027220932,0.0008017416,0.00013019731,0.00011260494,0.000119430435],"genre_scores_gemma":[0.9944824,0.00009068748,0.00003298494,0.0046978714,0.00007031613,0.0004585995,0.00008403864,0.000081891456,0.000001234081],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974829,0.00049835717,0.00039785984,0.0006753713,0.00041695105,0.0005285788],"domain_scores_gemma":[0.9983176,0.00073850143,0.00020931537,0.00028311106,0.0001037627,0.00034772305],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014247309,0.00040042988,0.00072936097,0.00013090974,0.000051320418,0.000024348643,0.00013529592,0.00029135004,0.00041129408],"category_scores_gemma":[0.00036356229,0.00030162465,0.00015586412,0.00048387065,0.00016273948,0.000069652975,0.000044820514,0.00053253287,0.000043181422],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040249913,0.002133225,0.97471464,0.000020337346,0.00017202193,0.0055101393,0.0008675268,0.000025729414,0.010006534,0.0000021555848,0.0008596469,0.001663068],"study_design_scores_gemma":[0.022216754,0.012617345,0.87877524,0.0001423468,0.00032814321,0.000016047317,0.00012287326,0.0002745665,0.06776474,0.000008551258,0.017157057,0.00057631155],"about_ca_topic_score_codex":0.000081940416,"about_ca_topic_score_gemma":0.00072954415,"teacher_disagreement_score":0.09593936,"about_ca_system_score_codex":0.0002696777,"about_ca_system_score_gemma":0.00022286025,"threshold_uncertainty_score":0.9999436},"labels":[],"label_agreement":null},{"id":"W3112266738","doi":"10.1093/neuonc/noaa222.293","title":"HGG-01. ENTRECTINIB IN RECURRENT OR REFRACTORY SOLID TUMORS INCLUDING PRIMARY CNS TUMORS: UPDATED DATA IN CHILDREN AND ADOLESCENTS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; ROS1; Internal medicine; Refractory (planetary science); Response Evaluation Criteria in Solid Tumors; Oncology; Adverse effect; Fusion gene; Progressive disease; Disease; Cancer; Adenocarcinoma; Biology; Gene","score_opus":0.05858310600731239,"score_gpt":0.35919888882075207,"score_spread":0.3006157828134397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112266738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949171,0.00014200625,0.0000015089967,0.0029569818,0.00013491664,0.0012101576,0.00010491915,0.00008161642,0.00045079057],"genre_scores_gemma":[0.99554366,0.0004567072,0.00010938239,0.0031271558,0.0001833453,0.00003118221,0.00048491443,0.000051544313,0.000012085669],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968965,0.00047828266,0.0005952147,0.0009831305,0.00036513372,0.00068173005],"domain_scores_gemma":[0.99852425,0.0002278425,0.00016986688,0.00052219187,0.000036177196,0.0005196499],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002507153,0.00029903025,0.00075913046,0.00033254278,0.00006373157,0.000022381151,0.00037337968,0.00013612809,0.000101142934],"category_scores_gemma":[0.0009906238,0.00025380275,0.000038928014,0.00058549305,0.00013320938,0.00022698933,0.001047243,0.001130911,0.00006944135],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012308939,0.003897051,0.7657794,0.0002728302,0.00011216343,0.0150458235,0.0008940956,0.000003225364,0.10723655,0.0000030727736,0.008015548,0.086431354],"study_design_scores_gemma":[0.017629143,0.00884789,0.95890826,0.00049386476,0.00007396301,0.0013263029,0.00014779491,0.0004892742,0.0044975574,0.000009442361,0.0072455243,0.00033098285],"about_ca_topic_score_codex":0.00009524444,"about_ca_topic_score_gemma":0.00021559455,"teacher_disagreement_score":0.19312891,"about_ca_system_score_codex":0.0003742702,"about_ca_system_score_gemma":0.0006927762,"threshold_uncertainty_score":0.9999914},"labels":[],"label_agreement":null},{"id":"W3112270188","doi":"10.1093/neuonc/noaa222.224","title":"ETMR-21. META-ANALYSIS OF PINEAL REGION TUMOURS DEMONSTRATES MOLECULAR SUBGROUPS WITH DISTINCT CLINICO-PATHOLOGICAL FEATURES: A CONSENSUS STUDY","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Drosha; microRNA; Pinealoma; Pathological; Internal medicine; Metastasis; Oncology; Medicine; Biology; Cancer; Pathology; Gene; Genetics","score_opus":0.09120658281862033,"score_gpt":0.34775629893601884,"score_spread":0.2565497161173985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112270188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9814784,0.00078671274,0.000060581802,0.015945902,0.000044860633,0.0010660065,0.000037004895,0.00007542979,0.0005051111],"genre_scores_gemma":[0.99644077,0.000025736535,0.0004941149,0.0027566773,0.00004364374,0.00015411382,0.000050950843,0.000029228722,0.0000047518956],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9970299,0.000773094,0.00066625315,0.00080652884,0.00038333854,0.00034086878],"domain_scores_gemma":[0.997436,0.0011123457,0.00042462343,0.00048489124,0.00020165568,0.00034047305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025443616,0.00035553414,0.0023927828,0.00021101005,0.00006647906,0.0000146772245,0.00015623365,0.00019365962,0.00010676106],"category_scores_gemma":[0.0005899986,0.00021979808,0.0009106575,0.0009792943,0.00032531633,0.000017786902,0.00008074529,0.000418719,0.000009114325],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034030676,0.008244319,0.8199654,0.000045942346,0.07153911,0.059918985,0.0008846798,0.00025080366,0.033325877,0.0003804474,0.0011237381,0.00091763167],"study_design_scores_gemma":[0.009114942,0.036270007,0.43372566,0.000006566254,0.50645715,0.00097267254,0.0018505254,0.0002704948,0.010090132,0.000030467154,0.0008347834,0.00037660697],"about_ca_topic_score_codex":0.00005230584,"about_ca_topic_score_gemma":0.00017120253,"teacher_disagreement_score":0.43491802,"about_ca_system_score_codex":0.00005408163,"about_ca_system_score_gemma":0.00017586311,"threshold_uncertainty_score":0.8963105},"labels":[],"label_agreement":null},{"id":"W3112275523","doi":"10.1093/neuonc/noaa215.763","title":"RADT-09. TYPE AND TIMING OF SYSTEMIC THERAPY USE PREDICT SURVIVAL IN PATIENTS WITH BRAIN METASTASES TREATED WITH RADIATION THERAPY","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Internal medicine; Systemic therapy; Radiation therapy; Cohort; Nomogram; Multivariate analysis; Oncology; Survival analysis; Population; Pharmacy; Chemotherapy; Cancer; Surgery; Breast cancer","score_opus":0.03976402430096057,"score_gpt":0.27926717526547296,"score_spread":0.23950315096451238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112275523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99723727,0.000524742,0.000029075743,0.0009409703,0.000045767483,0.0010868652,0.000052950705,0.000034210934,0.00004816393],"genre_scores_gemma":[0.9977392,0.00059371616,0.00032714847,0.0010973044,0.000036365473,0.000026160733,0.0001419998,0.000033528693,0.0000046085556],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99859643,0.00042790218,0.00026842824,0.00031608707,0.00020555833,0.00018559277],"domain_scores_gemma":[0.998918,0.00049709145,0.00017687229,0.00017048809,0.00011542407,0.00012211595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001475525,0.00019141483,0.0005630344,0.00009665432,0.00002825268,0.000009605877,0.000044612436,0.00007140689,0.000035132798],"category_scores_gemma":[0.00011693091,0.00011921631,0.000029114073,0.00036269944,0.0000805977,0.00008794485,0.000013126975,0.00013705046,0.0000017687337],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013687966,0.00073251326,0.91426367,0.000050228926,0.00037621913,0.00020892762,0.0010351995,0.00006656023,0.010354458,0.000015972064,0.00027407103,0.05893423],"study_design_scores_gemma":[0.060563546,0.064606436,0.85691047,0.00014043764,0.00033412935,0.000113649345,0.0003706235,0.00048430503,0.007060511,0.000002373965,0.009129357,0.0002841801],"about_ca_topic_score_codex":0.00012212146,"about_ca_topic_score_gemma":0.000015794381,"teacher_disagreement_score":0.063873924,"about_ca_system_score_codex":0.000062414016,"about_ca_system_score_gemma":0.00016198229,"threshold_uncertainty_score":0.48615},"labels":[],"label_agreement":null},{"id":"W3112280284","doi":"10.1093/neuonc/noaa222.665","title":"PATH-30. EXOSOMES AS A SOURCE OF PLASMA ctDNA TO IDENTIFY POINT MUTATIONS IN PEDIATRIC GLIOMA PATIENTS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Liquid biopsy; Glioma; Microvesicles; Exosome; DNA sequencing; Point mutation; DNA; Cell-free fetal DNA; Medicine; Biopsy; Mutation; Cancer research; Internal medicine; Oncology; Pathology; Cancer; Gene; Biology; microRNA; Genetics","score_opus":0.011419155511925018,"score_gpt":0.2820337321736703,"score_spread":0.27061457666174527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112280284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972077,0.00012730353,0.0002360676,0.0011908857,0.0001912746,0.00041754008,0.000026912845,0.000019715026,0.00058260205],"genre_scores_gemma":[0.99731326,0.000041605635,0.00042329295,0.0018527358,0.00018059701,0.00005457409,0.00007717184,0.000037711012,0.000019063706],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983601,0.00022314473,0.0004432578,0.0004980886,0.00018315869,0.00029224757],"domain_scores_gemma":[0.9990661,0.000086286855,0.0001769077,0.00029368818,0.00010451939,0.00027249986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009980868,0.00017417851,0.0002471322,0.00012253258,0.00003749365,0.000011423334,0.00032949934,0.00019327381,0.00006471721],"category_scores_gemma":[0.001187985,0.0001781941,0.00010837301,0.00034014962,0.00006924074,0.0000067304786,0.0003116541,0.00015514315,0.0001516954],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002617127,0.00042109189,0.037377432,0.00005271376,0.000014891087,0.00013654088,0.0006034283,0.00026804872,0.95362926,0.000016522981,0.002755056,0.0044633243],"study_design_scores_gemma":[0.0045233374,0.0047039497,0.041029535,0.0000119253555,0.000115158895,0.000040304065,0.00044455944,0.00027754155,0.903398,0.00019436004,0.044735964,0.00052539946],"about_ca_topic_score_codex":0.000013398083,"about_ca_topic_score_gemma":0.000012925876,"teacher_disagreement_score":0.050231274,"about_ca_system_score_codex":0.000033656426,"about_ca_system_score_gemma":0.00020707793,"threshold_uncertainty_score":0.7266544},"labels":[],"label_agreement":null},{"id":"W3112290402","doi":"10.1093/neuonc/noaa215.389","title":"EXTH-35. SYNERGISTIC EFFECT OF TARGETING THIOREDOXIN REDUCTASE (TRX1) AND DEPLETION OF GLUTATHIONE SYSTEM (GSH) IN GLIOBLASTOMA STEM CELLS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Redox biology and oxidative stress","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Auranofin; Gene knockdown; Cancer research; Reactive oxygen species; Glutathione; Thioredoxin; Stem cell; Cytotoxic T cell; Apoptosis; Chemistry; Temozolomide; Thioredoxin reductase; Biology; Pharmacology; Oxidative stress; Glioma; Immunology; In vitro; Cell biology; Biochemistry; Enzyme","score_opus":0.007555543761766764,"score_gpt":0.24497172367207287,"score_spread":0.2374161799103061,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112290402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99776804,0.00089254434,0.00034658803,0.00014255312,0.00023937022,0.00035702524,0.000056534405,0.000015224956,0.00018210262],"genre_scores_gemma":[0.99939924,0.00017667045,0.00012375962,0.00009908717,0.00012710999,0.000025718378,0.000022264208,0.000020913814,0.000005208692],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99772495,0.0009382908,0.0005080154,0.00048477546,0.000094651085,0.000249325],"domain_scores_gemma":[0.9990408,0.0002625647,0.0003359912,0.00019067898,0.00006600714,0.00010397867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000376317,0.00021083152,0.0005373404,0.00007052403,0.00004083668,0.000003925927,0.0001781711,0.00035810572,0.000005982672],"category_scores_gemma":[0.00024885486,0.00018702378,0.00008089593,0.00015981309,0.0002658976,0.0000054263223,0.00016559688,0.00021478914,0.000003368592],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016754032,0.000049599883,0.0031682935,0.00039397797,0.000034849563,0.00007349928,0.00016522054,0.00012604613,0.9916622,0.000091521186,0.00020005798,0.0023592985],"study_design_scores_gemma":[0.0013677091,0.0056766123,0.00029645202,0.00005098782,0.000036586418,0.000036179135,0.0002863598,0.00026816063,0.9905841,0.000004145242,0.0012548506,0.00013789334],"about_ca_topic_score_codex":0.000014400655,"about_ca_topic_score_gemma":0.000011016598,"teacher_disagreement_score":0.005627013,"about_ca_system_score_codex":0.000025348929,"about_ca_system_score_gemma":0.0000746883,"threshold_uncertainty_score":0.7626608},"labels":[],"label_agreement":null},{"id":"W3112295718","doi":"10.1093/neuonc/noaa222.322","title":"HGG-41. STRUCTURAL VARIANT DRIVERS IN PEDIATRIC HIGH-GRADE GLIOMA","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Biology; PDGFRA; Genetics; HRAS; Computational biology; Amplicon; Genome; Glioma; Breakpoint; KRAS; Cancer research; Gene; Polymerase chain reaction; Mutation","score_opus":0.020007901364057588,"score_gpt":0.27824953311632783,"score_spread":0.2582416317522702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112295718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9694244,0.00018723302,0.000004137879,0.028537018,0.00062169426,0.0004592681,0.000013596725,0.00008169392,0.00067095744],"genre_scores_gemma":[0.9945894,0.00014053292,0.00043056367,0.004164758,0.00057298655,0.000043443175,0.000027326278,0.000028544142,0.0000024412143],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984622,0.00013164475,0.00032854048,0.00047098563,0.00021627375,0.00039033665],"domain_scores_gemma":[0.99903804,0.00027265173,0.00010952362,0.00021141792,0.000038025562,0.00033036355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000055148193,0.00021303866,0.0005090088,0.00020997954,0.00005010687,0.000012287,0.00012869287,0.00017762132,0.0002645896],"category_scores_gemma":[0.00018218812,0.00017858106,0.00010677402,0.00057323475,0.00005409218,0.000058240355,0.0000905385,0.00032602076,0.00014603729],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078468793,0.0014261232,0.5210235,0.00015623956,0.00017322181,0.0750696,0.0022946799,0.00024589218,0.35962382,0.0030839632,0.022039084,0.01407916],"study_design_scores_gemma":[0.03481852,0.009562944,0.8489827,0.000021273656,0.0010447963,0.0020546059,0.00034903883,0.0016123285,0.04247327,0.0005358615,0.057899166,0.00064551126],"about_ca_topic_score_codex":0.00009136833,"about_ca_topic_score_gemma":0.0000505017,"teacher_disagreement_score":0.32795915,"about_ca_system_score_codex":0.00021055117,"about_ca_system_score_gemma":0.00019763665,"threshold_uncertainty_score":0.72823244},"labels":[],"label_agreement":null},{"id":"W3112296607","doi":"10.1093/neuonc/noaa215.962","title":"TMOD-11. APPLICATION OF A NOVEL TRANSGENIC AND SYNGENEIC MOUSE MODELS OF HUMAN CLASSICAL GLIOBLASTOMA FOR DRUG SCREENING AND PRE-CLINICAL TRIALS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Cancer research; CDKN2A; Biology; Genetically modified mouse; Epigenetics; Transgene; Pathology; Medicine; Cancer; Gene; Genetics","score_opus":0.1445148284966045,"score_gpt":0.41371513791106423,"score_spread":0.2692003094144597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112296607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98081136,0.0002307306,0.0122502,0.00491729,0.000028971577,0.0016392816,0.000071595874,0.000025200885,0.000025400574],"genre_scores_gemma":[0.99644303,0.00009312549,0.0025375132,0.00052228704,0.00013038916,0.00022937339,0.000015866364,0.000025476937,0.000002943959],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981796,0.00021111764,0.00089937483,0.00041430286,0.00013355039,0.00016203347],"domain_scores_gemma":[0.99736536,0.0017892682,0.00036005722,0.00017532954,0.00008454851,0.00022543044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005971544,0.0001503512,0.0010918588,0.00007061964,0.000039991333,0.000004637368,0.00006561774,0.00017665111,0.0000054675315],"category_scores_gemma":[0.00039187478,0.00012429623,0.00019981185,0.0000949856,0.00018349427,0.00004119071,0.0000423678,0.00012957516,2.575124e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023394711,0.0014966241,0.0039334344,0.00022075445,0.00020150434,0.000006295066,0.0006108391,0.000100225065,0.9610415,0.0011560644,0.0004176667,0.028475618],"study_design_scores_gemma":[0.0809846,0.03332946,0.01305435,0.00012370903,0.003892127,0.00009291066,0.00033286677,0.21761109,0.6410215,0.00050545105,0.008602478,0.00044945086],"about_ca_topic_score_codex":0.000020228663,"about_ca_topic_score_gemma":0.000061507446,"teacher_disagreement_score":0.32002,"about_ca_system_score_codex":0.0000171056,"about_ca_system_score_gemma":0.0000727631,"threshold_uncertainty_score":0.5068653},"labels":[],"label_agreement":null},{"id":"W3112297166","doi":"10.1093/neuonc/noaa222.510","title":"MBCL-34. EFFICACY OF METHOTREXATE (MTX) ACCORDING TO MOLECULAR SUB-TYPE IN YOUNG CHILDREN WITH MEDULLOBLASTOMA (MB): A REPORT FROM CHILDREN’S ONCOLOGY GROUP PHASE III TRIAL ACNS0334","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medicine; Internal medicine; Medulloblastoma; Oncology; ThioTEPA; Vincristine; Etoposide; Cyclophosphamide; Chemotherapy; Cancer research","score_opus":0.021962437252536503,"score_gpt":0.3248733294773049,"score_spread":0.3029108922247684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112297166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889502,0.00021621132,0.00014397115,0.005853163,0.00059402105,0.003545296,0.000047425397,0.000119810975,0.0005298908],"genre_scores_gemma":[0.9937827,0.000068481386,0.0021006297,0.0028521344,0.00049840397,0.00027322533,0.00032030675,0.000102243444,0.0000018758133],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9956693,0.0006083638,0.0012409672,0.0012817833,0.0005066583,0.00069291546],"domain_scores_gemma":[0.9970601,0.00074881455,0.00068153354,0.000704131,0.00015479075,0.0006506196],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042096758,0.00053354225,0.0019634627,0.0004012487,0.0000735679,0.000020111664,0.00032401487,0.00040393564,0.0001017677],"category_scores_gemma":[0.0013081529,0.00045164538,0.00028133002,0.0010392045,0.00015042225,0.0000912539,0.0002598695,0.00065973145,0.000038161823],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10705836,0.00793128,0.1480254,0.000016528022,0.0012936079,0.016523292,0.0011174573,0.000121036785,0.69283444,0.000049405335,0.0013539752,0.023675216],"study_design_scores_gemma":[0.44430295,0.06915829,0.20998864,0.00015780043,0.0026145442,0.0043854443,0.00033395085,0.00014056829,0.26466694,0.000030608524,0.0034088236,0.0008114047],"about_ca_topic_score_codex":0.0009700555,"about_ca_topic_score_gemma":0.0005511505,"teacher_disagreement_score":0.4281675,"about_ca_system_score_codex":0.00049591664,"about_ca_system_score_gemma":0.0006348204,"threshold_uncertainty_score":0.9997935},"labels":[],"label_agreement":null},{"id":"W3112302730","doi":"10.1093/neuonc/noaa215.711","title":"PATH-30. CLINICAL AND GENETIC CHARACTERISTICS OF HISTONE H3 K27M-MUTANT DIFFUSE MIDLINE GLIOMAS IN ADULTS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"ATRX; Histone H3; Glioma; Astrocytoma; Biology; Histone; Pathology; Epigenetics; Mutation; Medicine; Cancer research; Gene; Genetics","score_opus":0.030555003995752877,"score_gpt":0.3364346872338789,"score_spread":0.30587968323812603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112302730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99056995,0.0005596843,0.0000057544626,0.007906842,0.0002878697,0.00049556204,0.00003980077,0.00003191848,0.00010259258],"genre_scores_gemma":[0.9949457,0.0013561512,0.00039165694,0.0029621525,0.00025246327,0.000037350794,0.000024109959,0.000028577035,0.0000018621387],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998128,0.00017065092,0.00083909294,0.00044865021,0.00016118282,0.000252423],"domain_scores_gemma":[0.9986486,0.00044784395,0.0002387655,0.00024691643,0.000093135764,0.00032474395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009696605,0.00019047172,0.000870029,0.00009587641,0.000021291984,0.000004145037,0.000080769234,0.00020632752,0.00009344601],"category_scores_gemma":[0.00079002447,0.00016143204,0.00009019569,0.00021931437,0.00021962021,0.00001843564,0.00010139296,0.0002815193,0.000030004734],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018055167,0.004355056,0.7197736,0.0002645673,0.000078032965,0.011977397,0.0007825602,6.205609e-7,0.20524907,0.000052319778,0.000887864,0.054773387],"study_design_scores_gemma":[0.017930528,0.008119022,0.9480166,0.000112140326,0.00026521712,0.00032105055,0.00005750026,0.00093224295,0.006731853,0.000016671956,0.017329242,0.00016797395],"about_ca_topic_score_codex":0.000028985367,"about_ca_topic_score_gemma":0.00002125169,"teacher_disagreement_score":0.22824295,"about_ca_system_score_codex":0.00006287434,"about_ca_system_score_gemma":0.00014905729,"threshold_uncertainty_score":0.65830076},"labels":[],"label_agreement":null},{"id":"W3112303343","doi":"10.1093/neuonc/noaa215.172","title":"CTNI-05. NRG ONCOLOGY / RTOG 1119: PHASE II RANDOMIZED STUDY OF WHOLE BRAIN RADIOTHERAPY / STEREOTACTIC RADIOSURGERY WITH CONCURRENT LAPATINIB IN PATIENTS WITH BRAIN METASTASES FROM HER2-POSITIVE BREAST CANCER","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Lapatinib; Radiosurgery; Internal medicine; Clinical endpoint; Breast cancer; Oncology; Pertuzumab; Adjuvant; Radiation therapy; Cancer; Trastuzumab; Randomized controlled trial","score_opus":0.01945880982942613,"score_gpt":0.31803899461758994,"score_spread":0.29858018478816384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112303343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.960498,0.00041341654,0.0001410805,0.031181423,0.00032683424,0.00533057,0.0020023673,0.000060699433,0.000045634642],"genre_scores_gemma":[0.98631775,0.000056190343,0.00049384235,0.011607662,0.00020540149,0.0006904291,0.0005076302,0.000104643455,0.000016451453],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.992932,0.0036339585,0.0011619553,0.0010465012,0.0006114478,0.00061411544],"domain_scores_gemma":[0.99313927,0.004666909,0.00095469377,0.00046657288,0.0002838864,0.000488666],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006848774,0.00064721925,0.0033939462,0.0002601435,0.00011732618,0.000019532441,0.00019980219,0.00017606342,0.00059118005],"category_scores_gemma":[0.00035976642,0.00044185604,0.00024359793,0.00058468827,0.00047211666,0.0001623692,0.00009737729,0.0006464931,0.000004624929],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6661256,0.057214767,0.0952864,0.00014049956,0.0070033753,0.005099023,0.019284952,0.000253391,0.008392515,0.000028539594,0.009728578,0.13144235],"study_design_scores_gemma":[0.8487153,0.10504467,0.021251727,0.00022303074,0.0021444457,0.00017837435,0.0018117555,0.00041416797,0.0010136751,0.0000038348217,0.018667178,0.000531826],"about_ca_topic_score_codex":0.0014962865,"about_ca_topic_score_gemma":0.00083913124,"teacher_disagreement_score":0.18258971,"about_ca_system_score_codex":0.0005623574,"about_ca_system_score_gemma":0.0009742967,"threshold_uncertainty_score":0.9998033},"labels":[],"label_agreement":null},{"id":"W3112353403","doi":"10.1093/neuonc/noaa215.587","title":"NCOG-49. COMBINED NECROSIS AND BRAIN INVASION PREDICT RADIO-RESISTANCE AND TUMOR RECURRENCE IN ATYPICAL MENINGIOMA","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Necrosis; Meningioma; Grading (engineering); Univariate analysis; Cohort; Proportional hazards model; Radiation therapy; Internal medicine; Concomitant; Adjuvant therapy; Surgery; Gastroenterology; Cancer; Multivariate analysis","score_opus":0.02975072618798996,"score_gpt":0.2769766309139448,"score_spread":0.24722590472595485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112353403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9598235,0.00051578326,0.000069132824,0.03639063,0.00018070012,0.0006972595,0.0000065106997,0.00007406805,0.0022424352],"genre_scores_gemma":[0.99481523,0.000050131406,0.0012073547,0.0036627236,0.000097023825,0.000054342338,0.0000149502575,0.000020177406,0.000078051635],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9981568,0.00025275242,0.00042076933,0.0006106974,0.00021625732,0.00034274798],"domain_scores_gemma":[0.9987701,0.00050841685,0.00012050094,0.00020264875,0.00003403116,0.000364293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032001422,0.00020722188,0.00055552844,0.00013037596,0.000081008875,0.000027521688,0.00011881967,0.000116372066,0.00003923741],"category_scores_gemma":[0.00090643635,0.0001942477,0.000043393404,0.00033803895,0.00019379528,0.00009203485,0.00021466718,0.0003684032,0.000013009649],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013800985,0.0006003428,0.16799903,0.0009403471,0.000106683015,0.020458259,0.004879297,0.0000062579447,0.6809365,0.002250506,0.090353005,0.017668748],"study_design_scores_gemma":[0.035597797,0.020652771,0.47932142,0.0006440475,0.0004223278,0.002606412,0.00083154056,0.009471362,0.019517807,0.001214014,0.42858708,0.0011334078],"about_ca_topic_score_codex":0.000009504009,"about_ca_topic_score_gemma":0.000017541313,"teacher_disagreement_score":0.66141874,"about_ca_system_score_codex":0.000075910146,"about_ca_system_score_gemma":0.00009984005,"threshold_uncertainty_score":0.79211915},"labels":[],"label_agreement":null},{"id":"W3112381783","doi":"10.1093/neuonc/noaa215.640","title":"NIMG-27. THRESHOLD VALUES OF EARLY METABOLIC CHANGES IN 1H MRSI METABOLIC METRICS PREDICTIVE FOR SURVIVAL IN PATIENTS WITH NEWLY DIAGNOSED HIGH-GRADE GLIOMA","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Choline; Medicine; Creatine; Glioma; Internal medicine; Magnetic resonance imaging; Proportional hazards model; Gastroenterology; Nuclear medicine; Urology; Radiology","score_opus":0.028935673253662003,"score_gpt":0.27893070911435985,"score_spread":0.24999503586069785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112381783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99130946,0.0014638797,0.000021314629,0.00390425,0.0004552584,0.0024855349,0.0001919653,0.000052737254,0.00011558016],"genre_scores_gemma":[0.99727505,0.00035164112,0.0006119736,0.0009736597,0.00019426871,0.00043909554,0.00008274999,0.000069821144,0.0000017064871],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974062,0.0002546807,0.00057079457,0.00067749,0.000521471,0.0005693645],"domain_scores_gemma":[0.997693,0.0011352908,0.000322066,0.0003289151,0.00023453693,0.0002862021],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023862351,0.00037610135,0.0015237656,0.00083777704,0.000035661007,0.0000138949135,0.0002159632,0.00024138273,0.000026037886],"category_scores_gemma":[0.00068113796,0.00029556622,0.0001446799,0.0018393497,0.00013873314,0.00012042301,0.00010616614,0.000313995,0.000006652621],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030985433,0.0039004239,0.9739269,0.00007439348,0.0003613313,0.00042613377,0.0017463602,0.00012536005,0.011037326,0.00077571697,0.0004277853,0.0040997006],"study_design_scores_gemma":[0.03255414,0.012802504,0.90809226,0.000042649604,0.00073166075,0.0000036352212,0.00023711789,0.00019816193,0.04141493,0.000107890075,0.0035871062,0.00022793667],"about_ca_topic_score_codex":0.00034740308,"about_ca_topic_score_gemma":0.0005418374,"teacher_disagreement_score":0.06583466,"about_ca_system_score_codex":0.0001152107,"about_ca_system_score_gemma":0.00020335619,"threshold_uncertainty_score":0.99994963},"labels":[],"label_agreement":null},{"id":"W3112395311","doi":"10.1093/neuonc/noaa215.892","title":"TAMI-03. IDENTIFICATION OF NOVEL DRIVERS OF LUNG-TO-BRAIN METASTASIS THROUGH IN VIVO FUNCTIONAL GENOMICS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"CRISPR; Brain metastasis; Metastasis; Primary tumor; Lung cancer; In vivo; Cancer research; Functional genomics; Cancer; Medicine; Cas9; Biology; Genome; Computational biology; Gene; Genomics; Oncology; Internal medicine; Genetics","score_opus":0.02125884097446389,"score_gpt":0.3050911775633286,"score_spread":0.2838323365888647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112395311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.902602,0.000118140444,0.094917275,0.0014236785,0.00026418013,0.00021887622,0.00008627494,0.0000069620323,0.0003626127],"genre_scores_gemma":[0.9963106,0.00006914665,0.0025208085,0.0009227376,0.00009695801,0.000014199861,0.00003338381,0.000016332324,0.000015868565],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991111,0.000038728616,0.00034435635,0.00027955463,0.000087991866,0.00013823136],"domain_scores_gemma":[0.9995428,0.00004413623,0.00011242909,0.00017281175,0.00007172091,0.000056120294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011228099,0.00010068172,0.0002016905,0.0000489372,0.00001394553,0.000003016022,0.00014301036,0.000114387505,0.000027997681],"category_scores_gemma":[0.00022184697,0.000115039154,0.00007107638,0.00016997982,0.000050121747,0.0000037612583,0.00009815467,0.00008037642,0.0000029841726],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009656726,0.00007721278,0.00055220514,0.000031673528,0.000031565247,0.0000018032426,0.00035006445,0.019591032,0.97589445,0.00012306085,0.0026114117,0.0006389261],"study_design_scores_gemma":[0.0007440965,0.00048372603,0.0013929798,0.000002353131,0.000024908739,0.0000067027822,0.0001394672,0.0016785874,0.93608046,0.000008223813,0.05934633,0.00009215597],"about_ca_topic_score_codex":0.000011369742,"about_ca_topic_score_gemma":0.00002201036,"teacher_disagreement_score":0.09370857,"about_ca_system_score_codex":0.000026631324,"about_ca_system_score_gemma":0.00009956762,"threshold_uncertainty_score":0.46911606},"labels":[],"label_agreement":null},{"id":"W3112397639","doi":"10.1093/neuonc/noaa215.196","title":"CTNI-29. CODEL: PHASE III TRIAL OF RT ALONE, RT PLUS TMZ, OR TMZ ALONE FOR NEWLY-DIAGNOSED, 1p/19q CODELETED ANAPLASTIC OLIGODENDROGLIOMA. ANALYSIS FROM THE INITIAL STUDY DESIGN. (NCCTG N0577, ALLIANCE)","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Medicine; Temozolomide; Concomitant; Internal medicine; Clinical endpoint; Progression-free survival; Oligodendroglioma; Oncology; Glioma; Surgery; Gastroenterology; Randomized controlled trial; Radiation therapy; Chemotherapy; Astrocytoma","score_opus":0.08930946883976972,"score_gpt":0.3700152749557415,"score_spread":0.2807058061159718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112397639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9739004,0.0004941833,0.0072258688,0.0072240224,0.0010048896,0.008995762,0.00089361554,0.00018035466,0.00008092729],"genre_scores_gemma":[0.99121064,0.00027380572,0.0012511702,0.0034311633,0.0012926486,0.0018636638,0.0005467087,0.00011759752,0.000012626057],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9943431,0.00094604085,0.0016790741,0.0013486759,0.00082610175,0.00085700414],"domain_scores_gemma":[0.9892818,0.007868883,0.0008064019,0.0009816773,0.00042510533,0.00063618226],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004631023,0.00072563527,0.002995083,0.0003303214,0.00028703097,0.000058949674,0.00061743386,0.00040920737,0.00049438776],"category_scores_gemma":[0.0019570265,0.0005123834,0.00076176756,0.0019903446,0.00031123374,0.00013670752,0.00021736177,0.00053791155,0.000050810322],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7627984,0.03865053,0.005531255,0.0001359881,0.021096777,0.022499131,0.007921506,0.011363059,0.04932973,0.00006271182,0.060728535,0.019882372],"study_design_scores_gemma":[0.78078073,0.09638043,0.001598276,0.000068170935,0.029972577,0.00013315554,0.001718574,0.053904805,0.020918159,0.0000536369,0.01366159,0.00080990925],"about_ca_topic_score_codex":0.00085576,"about_ca_topic_score_gemma":0.0032086521,"teacher_disagreement_score":0.057729896,"about_ca_system_score_codex":0.00032783402,"about_ca_system_score_gemma":0.0010994863,"threshold_uncertainty_score":0.9997328},"labels":[],"label_agreement":null},{"id":"W3112416841","doi":"10.1093/neuonc/noaa222.307","title":"HGG-20. DIAGNOSTIC AND BIOLOGICAL ROLE OF METHYLATION PATTERNS IN REPLICATION REPAIR DEFICIENT HIGH GRADE GLIOMAS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Princess Margaret Cancer Centre; Dalhousie University; Université Laval; Hospital for Sick Children","funders":"","keywords":"Epigenetics; DNA methylation; Methylation; Biology; Genetics; Context (archaeology); Gene; Cancer research; Gene expression","score_opus":0.024799563310060214,"score_gpt":0.2849263233552051,"score_spread":0.2601267600451449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112416841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99581903,0.0018405513,0.00083359797,0.0009797483,0.00007311584,0.00028055438,0.000021226339,0.000018598817,0.00013359016],"genre_scores_gemma":[0.99751747,0.0011792588,0.000623201,0.0003715744,0.00010331251,0.00003738369,0.00015371831,0.000012737528,0.0000013442183],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99863523,0.000264411,0.00034676457,0.00050640234,0.00008625701,0.00016094746],"domain_scores_gemma":[0.99919575,0.00023098626,0.00016647429,0.00026812573,0.00005662448,0.000082034356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002488949,0.00011789317,0.00020483776,0.000054706794,0.00002949574,0.000005382105,0.00009654075,0.00023140197,0.000007632504],"category_scores_gemma":[0.0011927503,0.000111771544,0.000054968656,0.00014697021,0.00006579626,0.0000035359626,0.00011704452,0.00010765138,0.000002159139],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060285674,0.000084747946,0.10802294,0.000011913502,0.0000071487625,0.000005003522,0.00011803673,0.00023715664,0.88259953,0.00019157243,0.000018459397,0.0086432],"study_design_scores_gemma":[0.00071815203,0.002063579,0.14559367,0.0000052646037,0.000019147981,0.0000057829125,0.00008973628,0.0009903294,0.82645977,0.00056747993,0.02334297,0.00014414373],"about_ca_topic_score_codex":0.00004350588,"about_ca_topic_score_gemma":0.000050403756,"teacher_disagreement_score":0.056139793,"about_ca_system_score_codex":0.000019201074,"about_ca_system_score_gemma":0.00004179776,"threshold_uncertainty_score":0.45579112},"labels":[],"label_agreement":null},{"id":"W3112428041","doi":"10.1093/neuonc/noaa215.094","title":"COVD-11. THE BRAIN TUMOR AND NOT FOR PROFIT AND CHARITY EXPERIENCE OF COVID 19: REACTING AND ADJUSTING TO AN UNPRECEDENTED GLOBAL PANDEMIC IN THE 21ST CENTURY","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Alliance; Pandemic; Coronavirus disease 2019 (COVID-19); Descriptive statistics; Business; Public relations; Profit (economics); Health care; Political science; Marketing; Economic growth; Economics; Disease; Medicine; Infectious disease (medical specialty); Pathology","score_opus":0.13912187874939436,"score_gpt":0.4404631463481133,"score_spread":0.30134126759871893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112428041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8885087,0.00017851508,0.00003689482,0.109817505,0.00006950806,0.0012710815,0.000027343349,0.000025645573,0.00006483698],"genre_scores_gemma":[0.89236677,0.00014098319,0.00010758952,0.107184626,0.00012752246,0.000059831687,0.0000038271687,0.000008134898,7.0679715e-7],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99858975,0.00029056004,0.00030648385,0.00036517755,0.00015130187,0.00029673995],"domain_scores_gemma":[0.9972313,0.0020320266,0.0001383334,0.00015751096,0.000056400593,0.0003844475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077246415,0.00012718143,0.0003314856,0.000034293702,0.00015494769,0.00001830168,0.00011589124,0.00009028935,0.0000045781035],"category_scores_gemma":[0.0068643508,0.00008458571,0.000019843317,0.00021536843,0.00017091662,0.000068897476,0.000112043745,0.00027852654,2.5085865e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018385849,0.00003530357,0.7403933,0.00069339806,0.00000764465,0.000086551976,0.05717736,0.0000027823212,0.16214965,0.0004564983,0.0002932444,0.036865715],"study_design_scores_gemma":[0.006972654,0.0068061748,0.81773484,0.00014490612,0.00010629798,0.0017441618,0.093348734,0.0019126642,0.002260368,0.0000901717,0.06858911,0.00028993713],"about_ca_topic_score_codex":0.0010332288,"about_ca_topic_score_gemma":0.0018523188,"teacher_disagreement_score":0.15988928,"about_ca_system_score_codex":0.0001097868,"about_ca_system_score_gemma":0.0004747557,"threshold_uncertainty_score":0.8217765},"labels":[],"label_agreement":null},{"id":"W3112457373","doi":"10.1093/neuonc/noaa215.611","title":"NCOG-73. EFFECT OF TIME TO DIAGNOSIS IN CHILDREN WITH MALIGNANT CENTRAL NERVOUS SYSTEM TUMORS ON SURVIVAL OUTCOMES AND DISEASE-ASSOCIATED MORBIDITY: AN INSTITUTIONAL COHORT STUDY","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Children's Hospital","funders":"","keywords":"Medicine; Medulloblastoma; Ependymoma; Cohort; Pediatrics; Proportional hazards model; Retrospective cohort study; Disease; Glioma; Internal medicine; Surgery; Pathology","score_opus":0.01413229069521295,"score_gpt":0.26788582985182974,"score_spread":0.2537535391566168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112457373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947854,0.000023185523,5.455293e-7,0.0017866939,0.0000881782,0.0030410916,0.00012034932,0.0000664391,0.00008807171],"genre_scores_gemma":[0.99874014,0.0000066560915,0.000007643348,0.0006162237,0.000052870248,0.00046328356,0.00008457789,0.000027134633,0.0000014688337],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978396,0.0005453796,0.00034694004,0.0005448143,0.00039398685,0.00032922212],"domain_scores_gemma":[0.998556,0.00041394524,0.00012693224,0.0002143149,0.000046473575,0.0006423383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022780617,0.00027010508,0.0010175493,0.0001346092,0.00006325734,0.00001241323,0.00009405887,0.00007130301,0.000025940204],"category_scores_gemma":[0.00042205516,0.00018629833,0.000072410614,0.00027891746,0.00007097213,0.000045586003,0.00006951641,0.00016120855,0.000022562213],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011516853,0.0030382937,0.99115574,0.000039411494,0.0003588285,0.0023855064,0.000173321,0.00033636088,0.00044530656,0.000020637037,0.00013640783,0.0007584788],"study_design_scores_gemma":[0.007436415,0.017140012,0.9738061,0.00008665703,0.000618167,0.000038060218,0.00004087981,0.00017396435,0.0004898627,4.2349203e-7,0.000031322536,0.00013818168],"about_ca_topic_score_codex":0.0004401692,"about_ca_topic_score_gemma":0.0001641526,"teacher_disagreement_score":0.017349709,"about_ca_system_score_codex":0.00033455933,"about_ca_system_score_gemma":0.00020550952,"threshold_uncertainty_score":0.75970256},"labels":[],"label_agreement":null},{"id":"W3112465741","doi":"10.1093/neuonc/noaa222.111","title":"DIPG-68. ALPHA-THALASSEMIA X-LINKED MENTAL RETARDATION PROTEIN (ATRX) LOSS-OF-FUNCTION IN A MOUSE MODEL OF DIFFUSE INTRINSIC PONTINE GLIOMA","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"ATRX; Biology; Cancer research; Nestin; Glioma; Carcinogenesis; Mutation; Genetics; Gene; Stem cell; Neural stem cell","score_opus":0.029422406604801207,"score_gpt":0.2812602307276711,"score_spread":0.25183782412286987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112465741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992163,0.00009619828,0.00008938029,0.0058417018,0.0001163546,0.0013927957,0.000041247018,0.000053168224,0.00020616899],"genre_scores_gemma":[0.9984855,0.000058649788,0.0005182936,0.0005292366,0.000089719084,0.00016841054,0.00010217478,0.000035879868,0.000012135928],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99823284,0.00013774293,0.00066629145,0.00041938177,0.0002896897,0.00025407987],"domain_scores_gemma":[0.99899226,0.00010989722,0.00034181934,0.0002781959,0.00011478322,0.00016303893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001318711,0.00022014395,0.0006701195,0.00025021876,0.00002731529,0.0000055144606,0.000100972,0.00020377815,0.00005688794],"category_scores_gemma":[0.00028798205,0.00019716413,0.00013924151,0.00039407102,0.000095008276,0.00010712251,0.000094813855,0.00025562066,0.00001811567],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021564085,0.0021362135,0.023875665,0.00010784313,0.0000847165,0.00020749848,0.0005351574,0.0001280971,0.9650474,0.00019444898,0.00036471273,0.0051618465],"study_design_scores_gemma":[0.0173622,0.006886744,0.009647793,0.000073863834,0.00026155426,0.000052473453,0.00012224902,0.01307232,0.9510195,0.00009309553,0.0012245132,0.0001836583],"about_ca_topic_score_codex":0.000071744005,"about_ca_topic_score_gemma":0.000040040784,"teacher_disagreement_score":0.015205791,"about_ca_system_score_codex":0.00020501198,"about_ca_system_score_gemma":0.00017706567,"threshold_uncertainty_score":0.804012},"labels":[],"label_agreement":null},{"id":"W3112468799","doi":"10.1093/neuonc/noaa222.833","title":"TBIO-05. GENOME-SCALE NUCLEOTIDE-SPECIFIC CHARACTERIZATION OF 5-HYDROXYMETHYLCYTOSINE IN PEDIATRIC CENTRAL NERVOUS SYSTEM TUMORS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network","funders":"","keywords":"CpG site; DNA methylation; Biology; 5-Hydroxymethylcytosine; Cancer research; Genome; Gene; Glioma; Genetics; Molecular biology; Gene expression","score_opus":0.013092659836523583,"score_gpt":0.23005758969776058,"score_spread":0.216964929861237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112468799","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99617314,0.00043606927,0.0015113765,0.00048843987,0.0003912581,0.00035781754,0.000044969885,0.000024901314,0.0005720109],"genre_scores_gemma":[0.9971172,0.0011138081,0.0004015993,0.00024595033,0.0008129744,0.000016167714,0.00024217732,0.00004134501,0.000008783294],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981572,0.0002582046,0.00059437077,0.000492923,0.00014755917,0.00034975904],"domain_scores_gemma":[0.9991417,0.000032573644,0.0003223074,0.0002521349,0.000086388114,0.00016488032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018009129,0.00019487836,0.00036449917,0.00010160157,0.000042380878,0.000012848837,0.0002239177,0.00024586244,0.000017305996],"category_scores_gemma":[0.00006866253,0.00020888938,0.000096521224,0.0003316999,0.000055343284,0.0000069476782,0.00012054179,0.00017201864,0.000013482917],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013922907,0.00008984498,0.014328728,0.00008407345,0.0000064787105,0.000028628965,0.00021482735,0.0008110059,0.98169076,0.000025778403,0.00003630724,0.0025443223],"study_design_scores_gemma":[0.0014016172,0.0018481481,0.15577179,0.000008959183,0.000036155157,0.00001404088,0.00010856124,0.0014472537,0.78502476,0.000005214244,0.05400788,0.0003255994],"about_ca_topic_score_codex":0.000009757867,"about_ca_topic_score_gemma":0.000009180925,"teacher_disagreement_score":0.19666599,"about_ca_system_score_codex":0.00005927383,"about_ca_system_score_gemma":0.00012914799,"threshold_uncertainty_score":0.85182613},"labels":[],"label_agreement":null},{"id":"W3112476639","doi":"10.1093/neuonc/noaa215.917","title":"TAMI-29. MULTIFACTORIAL UPREGULATION OF ID1 DRIVES DIPG INVASIVENESS AND IS THERAPEUTICALLY TARGETABLE","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Gene knockdown; Cancer research; Downregulation and upregulation; Small hairpin RNA; Biology; Carcinogenesis; Cancer; Cell culture; Gene; Genetics","score_opus":0.02301430700370621,"score_gpt":0.2961122783630555,"score_spread":0.27309797135934927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112476639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9619106,0.0012135803,0.03001398,0.0039992677,0.0007654705,0.0008584079,0.0000635159,0.00003556054,0.0011396017],"genre_scores_gemma":[0.99634475,0.00053965865,0.0007549577,0.0018210679,0.0003923887,0.000027165655,0.0000498772,0.00003692469,0.00003322769],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985182,0.00022949267,0.00026703565,0.00049577514,0.00020642113,0.00028307375],"domain_scores_gemma":[0.9992305,0.00007164975,0.00011780716,0.00025072804,0.00016153538,0.00016775624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012010593,0.00016847107,0.00027774548,0.000042357467,0.00006079986,0.000016168271,0.00020929531,0.0003555443,0.000096351745],"category_scores_gemma":[0.00025175046,0.00016910982,0.00008460386,0.00013409114,0.00016982917,0.0000075783737,0.00024766696,0.00021997966,0.000007911217],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054354774,0.00006266299,0.00023388954,0.00003317901,0.000070782335,0.000010393119,0.0002557266,0.00013617334,0.99012667,0.0002183419,0.00039040734,0.007918203],"study_design_scores_gemma":[0.0014305885,0.0014868798,0.00038537188,0.000004893064,0.000030993375,0.0000116943465,0.000043130527,0.00094191224,0.8886606,0.000113876595,0.10675137,0.00013868503],"about_ca_topic_score_codex":0.000020319467,"about_ca_topic_score_gemma":0.00001586875,"teacher_disagreement_score":0.106360964,"about_ca_system_score_codex":0.00002693772,"about_ca_system_score_gemma":0.00028286054,"threshold_uncertainty_score":0.6896098},"labels":[],"label_agreement":null},{"id":"W3112477812","doi":"10.1093/neuonc/noaa222.100","title":"DIPG-55. PATTERNS OF CEREBROSPINAL FLUID DIVERSION AND SURVIVAL IN CHILDREN WITH DIFFUSE INTRINSIC PONTINE GLIOMA: A REPORT FROM THE INTERNATIONAL DIPG REGISTRY","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Hydrocephalus; Cohort; Surgery; Survival analysis; Glioma; Medical record; Incidence (geometry); Cohort study; Internal medicine","score_opus":0.015168859743813176,"score_gpt":0.25422076407299565,"score_spread":0.23905190432918247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112477812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9817392,0.00011736223,0.0000115402645,0.01731147,0.0001772456,0.00035642384,0.00007606296,0.00002146718,0.00018919914],"genre_scores_gemma":[0.9985094,0.000106124324,0.0000635566,0.0008875129,0.00024444953,0.000021517126,0.00014726342,0.000016185535,0.000003956531],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987841,0.00007470981,0.00031163648,0.00039199754,0.00027804327,0.00015947287],"domain_scores_gemma":[0.9991371,0.00021046284,0.0002130571,0.00025630364,0.000063494095,0.00011958743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000084611915,0.0001572306,0.0003828941,0.000058667963,0.000038279893,0.000013559985,0.00015048838,0.0000854873,0.000071301],"category_scores_gemma":[0.00021907115,0.00010135664,0.000056979014,0.00013629963,0.000095903844,0.000046351302,0.00022942408,0.00021750467,0.000004503115],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000764446,0.00063713815,0.9488686,0.0000075288667,0.000163836,0.0027635945,0.0002270368,0.0000014591517,0.043542787,0.000027018228,0.00077067094,0.0022259082],"study_design_scores_gemma":[0.0082192,0.0012122343,0.98090816,0.00004184813,0.00017313707,0.0008851278,0.00013682377,0.000028525346,0.0060288394,0.0000071899703,0.002276671,0.000082263585],"about_ca_topic_score_codex":0.000978645,"about_ca_topic_score_gemma":0.00021889071,"teacher_disagreement_score":0.03751395,"about_ca_system_score_codex":0.00007302097,"about_ca_system_score_gemma":0.00008276804,"threshold_uncertainty_score":0.4133204},"labels":[],"label_agreement":null},{"id":"W3112499229","doi":"10.1093/neuonc/noaa222.291","title":"GCT-75. ISOLATED PITUITARY STALK THICKENING","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Pituitary stalk; Diabetes insipidus; Cohort; Malignancy; Germinoma; Germ cell tumors; Magnetic resonance imaging; Internal medicine; Radiology; Pediatrics; Gastroenterology; Pathology; Pituitary gland; Hormone","score_opus":0.02896208801568675,"score_gpt":0.29191436498490303,"score_spread":0.2629522769692163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112499229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93105054,0.001011228,0.00026691912,0.027413944,0.0004932516,0.00056878844,0.000024212917,0.00031181498,0.038859293],"genre_scores_gemma":[0.9752052,0.00019208949,0.0004193821,0.023733666,0.00023079607,0.000019972667,0.00008466568,0.000034182063,0.00008005951],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986786,0.00009381723,0.00027353078,0.00041073433,0.00017350899,0.00036979132],"domain_scores_gemma":[0.9991468,0.00015099713,0.000076482356,0.00020923505,0.000050140818,0.00036632473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000055246626,0.00020553073,0.00046035412,0.00006275786,0.00010259328,0.000008861647,0.00010213838,0.00018561176,0.0004934729],"category_scores_gemma":[0.00014447131,0.0001701576,0.00011875165,0.00021258109,0.000070319744,0.00008470117,0.000086008455,0.00039330762,0.00043936243],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009595814,0.0035137916,0.3223712,0.00031679572,0.0012036576,0.031506788,0.010866366,0.000105479136,0.34665358,0.0006775375,0.13042276,0.14276621],"study_design_scores_gemma":[0.025344882,0.025226386,0.027542884,0.00005642688,0.000900963,0.0012392619,0.0014832936,0.0052287574,0.0039325454,0.00077707734,0.90754664,0.0007208727],"about_ca_topic_score_codex":0.000052600248,"about_ca_topic_score_gemma":0.0000127683315,"teacher_disagreement_score":0.7771239,"about_ca_system_score_codex":0.00006503297,"about_ca_system_score_gemma":0.00020337908,"threshold_uncertainty_score":0.6938826},"labels":[],"label_agreement":null},{"id":"W3112505324","doi":"10.1093/neuonc/noaa222.427","title":"LGG-49. SAFETY AND EFFICACY OF TRAMETINIB (T) MONOTHERAPY AND DABRAFENIB + TRAMETINIB (D+T) COMBINATION THERAPY IN PEDIATRIC PATIENTS WITH <i>BRAF</i> V600-MUTANT LOW-GRADE GLIOMA (LGG)","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Trametinib; Combination therapy; Dabrafenib; Internal medicine; Adverse effect; Interim analysis; Refractory (planetary science); Oncology; Phases of clinical research; Clinical trial; Gastroenterology; Cancer; MAPK/ERK pathway; Kinase","score_opus":0.014611663211555761,"score_gpt":0.26312724526150627,"score_spread":0.2485155820499505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112505324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99124724,0.00062991056,0.000009292847,0.0060323477,0.00009407147,0.0017481495,0.000030243515,0.000050996103,0.00015773758],"genre_scores_gemma":[0.99595046,0.0018304256,0.00023465104,0.0017447304,0.0000742958,0.000062766354,0.000046664463,0.00005520841,7.690571e-7],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978278,0.00026274708,0.00062206347,0.0006238378,0.0003199626,0.00034354007],"domain_scores_gemma":[0.9981884,0.0008797232,0.00031575587,0.00023733529,0.00010063195,0.0002781689],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016637065,0.0003341824,0.0008605674,0.00026218148,0.000061195235,0.000018562994,0.00010260705,0.00020907643,0.000029205305],"category_scores_gemma":[0.0001610941,0.00025548445,0.00008302087,0.0006648783,0.00017255367,0.000088107656,0.00003640205,0.00029896025,0.0000033797883],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01267828,0.013853042,0.72130775,0.00018867408,0.00020513446,0.0005238262,0.0035913733,0.00004280824,0.07808691,0.00023041878,0.00014314303,0.16914864],"study_design_scores_gemma":[0.10484785,0.024428407,0.83352774,0.000046711884,0.00023713613,0.000055704666,0.00010527595,0.00022019069,0.030385526,0.000042225303,0.0057818783,0.00032133138],"about_ca_topic_score_codex":0.000021938455,"about_ca_topic_score_gemma":0.000014097987,"teacher_disagreement_score":0.16882731,"about_ca_system_score_codex":0.00007704128,"about_ca_system_score_gemma":0.00013337242,"threshold_uncertainty_score":0.99998975},"labels":[],"label_agreement":null},{"id":"W3112565522","doi":"10.1093/neuonc/noaa215.090","title":"COVD-06. BRAIN TUMOURS AND COVID-19: THE PATIENT AND CAREGIVER EXPERIENCE","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Princess Margaret Cancer Centre","funders":"","keywords":"Pandemic; Coronavirus disease 2019 (COVID-19); Medicine; Anxiety; Telehealth; Population; Isolation (microbiology); Quality of life (healthcare); Health care; Family medicine; Telemedicine; Psychiatry; Internal medicine; Nursing; Disease; Environmental health; Bioinformatics","score_opus":0.07347576339368843,"score_gpt":0.39013368972249934,"score_spread":0.3166579263288109,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112565522","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6192678,0.00048810916,0.0000920024,0.37909776,0.00011752567,0.00044941058,0.000009345957,0.000050543407,0.0004274875],"genre_scores_gemma":[0.68747497,0.00018239248,0.000024836772,0.31213713,0.00012872567,0.000023027833,0.0000031604839,0.000011720246,0.000014050691],"study_design_codex":"qualitative","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986606,0.00022594072,0.00021881828,0.00039215398,0.00018797311,0.0003144632],"domain_scores_gemma":[0.9972814,0.0013724649,0.00009171702,0.00020162232,0.000051420855,0.0010014225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013507021,0.00014918658,0.00032153176,0.00004568309,0.00019114693,0.000018181434,0.00008561327,0.00011683439,0.00007904132],"category_scores_gemma":[0.0032586968,0.00010560082,0.000034809123,0.00015360974,0.00036910205,0.000051687824,0.00014414922,0.00035505736,0.000013847866],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025415113,0.00025424027,0.16705768,0.00087693485,0.000053092248,0.0054622428,0.34411082,0.000033042168,0.08566676,0.0013534701,0.30222955,0.09036064],"study_design_scores_gemma":[0.0019456361,0.003467311,0.020206746,0.000012021534,0.000038525104,0.0005952124,0.0062015145,0.0003162305,0.000766092,0.00005523449,0.96627206,0.00012340602],"about_ca_topic_score_codex":0.00039800289,"about_ca_topic_score_gemma":0.00013045948,"teacher_disagreement_score":0.66404253,"about_ca_system_score_codex":0.00016604582,"about_ca_system_score_gemma":0.0010261962,"threshold_uncertainty_score":0.43062764},"labels":[],"label_agreement":null},{"id":"W3112598367","doi":"10.1093/neuonc/noaa222.446","title":"LINC-11. NEUROPATHOLOGY REVIEW OF LATIN AMERICAN CHILDHOOD AND ADOLESCENT BRAIN TUMOR PATIENTS: A MULTI-NATIONAL, MULTI-DISCIPLINARY PEDIATRIC NEURO-ONCOLOGY TELECONFERENCE EXPERIENCE","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Advances in Oncology and Radiotherapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Subspecialty; Medicine; Neuropathology; Atypical teratoid rhabdoid tumor; Medulloblastoma; Latin Americans; Family medicine; Pediatrics; Pathology; Disease; Political science","score_opus":0.038639359100607076,"score_gpt":0.3747304223493535,"score_spread":0.33609106324874644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112598367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9269094,0.008345789,0.003459761,0.055808384,0.0014767091,0.0032870832,0.00012633658,0.00025058797,0.00033596708],"genre_scores_gemma":[0.699616,0.03628747,0.026038297,0.23641548,0.001063099,0.00032957178,0.000095270145,0.00013529831,0.000019525496],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99575937,0.0009502299,0.0011888044,0.0011357309,0.00036604155,0.000599851],"domain_scores_gemma":[0.996057,0.0015352012,0.0010875666,0.00038527066,0.00045643523,0.0004785325],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000332603,0.0004752647,0.0015721334,0.0002185829,0.0001733997,0.0000064108103,0.00041696767,0.00024721335,0.000104474675],"category_scores_gemma":[0.00537986,0.00042962396,0.00018010374,0.0007116942,0.0012982493,0.00014005296,0.00034501308,0.001049109,0.000029856448],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023653372,0.013746432,0.7998216,0.0050414517,0.00010585152,0.003318492,0.009808284,0.00012782453,0.07633608,0.0002513003,0.01153807,0.07753924],"study_design_scores_gemma":[0.021841597,0.032526694,0.74163,0.0007011536,0.00041338813,0.0019480212,0.0006574216,0.0018131918,0.00095993007,0.00005409097,0.19642128,0.0010331947],"about_ca_topic_score_codex":0.000005198534,"about_ca_topic_score_gemma":0.0000127811445,"teacher_disagreement_score":0.22729339,"about_ca_system_score_codex":0.00028976725,"about_ca_system_score_gemma":0.0014106245,"threshold_uncertainty_score":0.9998156},"labels":[],"label_agreement":null},{"id":"W3112623271","doi":"10.1093/neuonc/noaa215.818","title":"STEM-01. TARGETING BRAIN METASTASIS-INITIATING CELLS: A PREVENTATIVE APPROACH","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Brain metastasis; Medicine; Melanoma; Metastasis; Primary tumor; Breast cancer; In vivo; Cancer research; Population; Oncology; Pathology; Cancer; Internal medicine; Biology","score_opus":0.06523996043810575,"score_gpt":0.3271838431786136,"score_spread":0.26194388274050784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112623271","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7216983,0.004267905,0.03631016,0.13919082,0.0019194363,0.009137311,0.0005509395,0.0012816446,0.08564346],"genre_scores_gemma":[0.9071379,0.00006991557,0.05710926,0.034516945,0.00061236793,0.00020820169,0.00016177652,0.0000938522,0.00008982567],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99720144,0.00087473076,0.00051799044,0.0006475569,0.00028338793,0.0004748695],"domain_scores_gemma":[0.99804384,0.0009994269,0.00027828125,0.00022026153,0.00006971269,0.00038850028],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004893492,0.00029271477,0.00074793736,0.0000714123,0.00013661214,0.000021306976,0.00013263841,0.00012377244,0.00027455098],"category_scores_gemma":[0.00032978243,0.00024578293,0.00023319885,0.00031969344,0.00009516538,0.00008845496,0.00013703838,0.000500205,0.00012287874],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018713947,0.0030942394,0.0019632622,0.00096643163,0.0017249228,0.005194376,0.01890151,0.00044618978,0.65267634,0.0017155429,0.08799605,0.22344972],"study_design_scores_gemma":[0.01962656,0.019156441,0.00044744997,0.00008398482,0.0023906066,0.0009893541,0.020895973,0.009559493,0.1930603,0.00018144633,0.7326206,0.0009878045],"about_ca_topic_score_codex":0.000018207977,"about_ca_topic_score_gemma":0.0000019803108,"teacher_disagreement_score":0.64462453,"about_ca_system_score_codex":0.00014243275,"about_ca_system_score_gemma":0.00026595176,"threshold_uncertainty_score":0.99999946},"labels":[],"label_agreement":null},{"id":"W3112642730","doi":"10.1093/neuonc/noaa215.349","title":"EPID-31. CONTEMPORARY MANAGEMENT OF GRADE 2 AND 3 GLIOMA IN ALBERTA AND MANITOBA, 2012–2016: COMPARISON OF TOLERABILITY AND OUTCOMES ACROSS CHEMOTHERAPY REGIMENS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Research Institute in Oncology and Hematology; CancerCare Manitoba; University of Alberta","funders":"","keywords":"Temozolomide; Medicine; Tolerability; Internal medicine; Procarbazine; Adverse effect; Rash; Nausea; Glioma; Oncology; Lomustine; Clinical trial; Vincristine; Chemotherapy; Surgery; Cyclophosphamide","score_opus":0.05325933579988171,"score_gpt":0.34830389388112576,"score_spread":0.2950445580812441,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112642730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9738228,0.0016637284,0.0000022150039,0.023159666,0.000059267004,0.0007608958,0.000014128727,0.000010247865,0.0005070982],"genre_scores_gemma":[0.9981626,0.0003905706,0.00021804021,0.0011503086,0.000015132414,0.000034249137,0.0000067390865,0.000014352167,0.000008008682],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987222,0.00009625836,0.0005023388,0.00037488336,0.00011570922,0.00018859288],"domain_scores_gemma":[0.99893814,0.00046581394,0.00021004966,0.00020656799,0.000028962373,0.00015048771],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013754528,0.00017749376,0.0009302437,0.00005672482,0.000028375805,0.0000060018624,0.000054377906,0.000106210784,0.000009143851],"category_scores_gemma":[0.000041082345,0.00014388429,0.000049157206,0.00011943995,0.00025877202,0.000054619606,0.000113362505,0.0001186185,0.0000010428339],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005648089,0.0011709558,0.96281374,0.00036114038,0.00017014121,0.0002109923,0.0022182027,0.0000011345829,0.01793446,0.0001236591,0.0018702598,0.012560516],"study_design_scores_gemma":[0.012558572,0.0026762285,0.9434209,0.000072777475,0.00010573879,0.0000369686,0.0015194237,0.00012872096,0.028233113,0.000088934066,0.011029557,0.00012909494],"about_ca_topic_score_codex":0.0006011432,"about_ca_topic_score_gemma":0.00042695066,"teacher_disagreement_score":0.024339847,"about_ca_system_score_codex":0.000037570004,"about_ca_system_score_gemma":0.000030024055,"threshold_uncertainty_score":0.5867431},"labels":[],"label_agreement":null},{"id":"W3112650211","doi":"10.1093/neuonc/noaa215.593","title":"NCOG-55. HARMONIZING LANGUAGE TO MAXIMIZE IMPACT: AN UPDATE ON COMMON DATA ELEMENTS FOR MENINGIOMA AND REVIEW OF CLINICAL TRIALS IN MENINGIOMA","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Alberta; University Health Network; University of Toronto","funders":"","keywords":"Medicine; Meningioma; Clinical trial; Medical physics; Oncology; Internal medicine; Surgery","score_opus":0.4427761434981502,"score_gpt":0.535081993609911,"score_spread":0.09230585011176085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112650211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9631581,0.002688699,0.0002459947,0.028422963,0.00034662895,0.00379785,0.0002035861,0.00006443488,0.0010717894],"genre_scores_gemma":[0.9639096,0.0008705783,0.013804272,0.020055452,0.00047940365,0.00015514236,0.000651481,0.000056540095,0.000017511715],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9944589,0.0015696769,0.0023725734,0.0008485068,0.00033102185,0.00041932045],"domain_scores_gemma":[0.99585867,0.0017787953,0.0007775106,0.0008794082,0.000071192815,0.00063439645],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.009035963,0.00027862977,0.0022482567,0.00020779484,0.000047941983,0.00002115407,0.00046605733,0.00012909486,0.00014337194],"category_scores_gemma":[0.009242052,0.00022954427,0.00021687215,0.00033407213,0.000052941872,0.0001311296,0.00049378583,0.0003184365,0.000021777607],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02935387,0.0019107307,0.03544144,0.007996223,0.00092723157,0.010909566,0.0026410725,0.00001991634,0.17491347,0.0009628816,0.19026065,0.54466295],"study_design_scores_gemma":[0.051421314,0.049666945,0.029464174,0.0072590047,0.003975332,0.00061070477,0.0012702981,0.019917075,0.009770034,0.00022698128,0.8248578,0.0015603626],"about_ca_topic_score_codex":0.00002683649,"about_ca_topic_score_gemma":0.00000920213,"teacher_disagreement_score":0.6345971,"about_ca_system_score_codex":0.00006908518,"about_ca_system_score_gemma":0.0001859221,"threshold_uncertainty_score":0.99910355},"labels":[],"label_agreement":null},{"id":"W3112653889","doi":"10.1093/neuonc/noaa222.598","title":"MODL-25. REPLICATION REPAIR DEFICIENT MOUSE MODELS PROVIDE INSIGHT ON HYPERMUTANT BRAIN TUMOURS, MECHANISMS OF IMMUNE EVASION, AND COMBINATORIAL IMMUNOTHERAPY","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Immunoediting; Cancer research; Biology; Nestin; OLIG2; Immune system; Immunotherapy; Conditional gene knockout; Medulloblastoma; Immunology; Gene; Central nervous system; Oligodendrocyte; Phenotype; Stem cell; Neuroscience; Neural stem cell; Myelin; Genetics","score_opus":0.021103152419640638,"score_gpt":0.26502564869597356,"score_spread":0.24392249627633292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112653889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98350024,0.0010207721,0.008326963,0.005356053,0.00027602576,0.0006949702,0.00003890416,0.00005150587,0.000734594],"genre_scores_gemma":[0.9956574,0.0007041355,0.0005572155,0.0027386157,0.000100729965,0.00010709996,0.0000655526,0.000035699843,0.00003354474],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984502,0.00018674895,0.00041074268,0.0006115298,0.0001542491,0.0001865139],"domain_scores_gemma":[0.99881846,0.000047293932,0.00024236449,0.0006662607,0.00013503377,0.000090564194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023860336,0.00016962437,0.00026651483,0.000043903907,0.00009367744,0.000011333513,0.00020958376,0.00020205934,0.000007510557],"category_scores_gemma":[0.00017858917,0.00015832293,0.00010537,0.0001137295,0.00009330445,0.000008320436,0.0000973633,0.00014946992,0.0000026345654],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060989213,0.00021272588,0.000017629736,0.000014594427,0.00002424603,0.0000031065506,0.00021593743,0.0006237744,0.9802113,0.013284148,0.00095232215,0.0038303088],"study_design_scores_gemma":[0.0017358516,0.0034728064,0.00013969956,0.000006551613,0.000020020654,0.000020663148,0.00007068683,0.0045628333,0.92957634,0.0016052545,0.05860893,0.00018034138],"about_ca_topic_score_codex":0.000024770285,"about_ca_topic_score_gemma":0.000002986493,"teacher_disagreement_score":0.05765661,"about_ca_system_score_codex":0.00004657644,"about_ca_system_score_gemma":0.0001935085,"threshold_uncertainty_score":0.6456222},"labels":[],"label_agreement":null},{"id":"W3112666175","doi":"10.1093/neuonc/noaa222.615","title":"NFB-12. TRAMETINIB THERAPY FOR PEDIATRIC PATIENTS WITH REFRACTORY LOW GRADE GLIOMA OR EXTENSIVE SYMPTOMATIC PLEXIFORM NEUROFIBROMA","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Trametinib; Clinical trial; Refractory (planetary science); Internal medicine; Oncology","score_opus":0.03686654401893162,"score_gpt":0.314632845416433,"score_spread":0.27776630139750136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112666175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99198896,0.00006352255,0.00003604432,0.0037141305,0.0002381782,0.0033173217,0.000107372434,0.0002029525,0.00033152843],"genre_scores_gemma":[0.99153984,0.00014592904,0.0006822314,0.0066154054,0.00044937045,0.00023497883,0.00011836985,0.00014520956,0.00006866845],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9971569,0.00018330754,0.0004866873,0.00079221855,0.0005896945,0.00079117075],"domain_scores_gemma":[0.99685717,0.0013713356,0.00027907957,0.00042326795,0.00029806077,0.0007710887],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00006711691,0.0004274624,0.0007819627,0.00025373287,0.00013148253,0.000041379088,0.00024304674,0.00018807278,0.00015466157],"category_scores_gemma":[0.00088967214,0.00028310562,0.00019153807,0.0005396135,0.00014976012,0.00019513484,0.000074956064,0.0004647632,0.00016700706],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2111069,0.028005937,0.1968545,0.0030382744,0.001655177,0.025040045,0.004235186,0.000024943747,0.29735893,0.00009120927,0.067677714,0.16491117],"study_design_scores_gemma":[0.14470957,0.40796396,0.29020697,0.00012786628,0.0009681125,0.0012695562,0.00032196706,0.0010378943,0.03654117,0.00014691395,0.1153243,0.0013816867],"about_ca_topic_score_codex":0.0000035160626,"about_ca_topic_score_gemma":0.0000036130998,"teacher_disagreement_score":0.37995803,"about_ca_system_score_codex":0.00013644497,"about_ca_system_score_gemma":0.0006380071,"threshold_uncertainty_score":0.9999621},"labels":[],"label_agreement":null},{"id":"W3112670293","doi":"10.1093/neuonc/noaa215.191","title":"CTNI-24. A PHASE 2 STUDY OF TRAMETINIB FOR PATIENTS WITH PEDIATRIC GLIOMA WITH ACTIVATION OF THE MAPK/ERK PATHWAY. TRAM-01","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Dalhousie University; University of Toronto; University of British Columbia; Hospital for Sick Children; McGill University Health Centre; Centre hospitalier universitaire de Québec; Université du Québec à Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Trametinib; Tolerability; Internal medicine; Adverse effect; MAPK/ERK pathway; Progressive disease; Oncology; Gastroenterology; Progression-free survival; Surgery; Disease; Overall survival; Kinase; Biology","score_opus":0.026646744472562996,"score_gpt":0.2899561925069944,"score_spread":0.2633094480344314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112670293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950439,0.000014647329,0.00002287052,0.0014251036,0.00009330331,0.0032506872,0.00004374877,0.000021900381,0.00008388567],"genre_scores_gemma":[0.9989173,0.0000031814507,0.00025761605,0.00036480022,0.00009366448,0.00030926074,0.000021847723,0.00003119019,0.000001176719],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99870193,0.00011282907,0.0003575764,0.00032102957,0.00031508782,0.00019155256],"domain_scores_gemma":[0.9986392,0.0003909958,0.0003950382,0.00025971088,0.00020197022,0.000113037626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000063298954,0.00017832845,0.0005083651,0.00009503401,0.00005065839,0.0000041898043,0.00010876423,0.00007764679,0.000018672648],"category_scores_gemma":[0.00019617197,0.000099899386,0.000084598214,0.0005495091,0.000056455458,0.00004547886,0.000028082208,0.00013393,8.917667e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021972362,0.0768401,0.73415065,0.00045259655,0.00060615933,0.00019275676,0.00808769,0.00009031617,0.115658745,0.000079390156,0.0015170976,0.040352132],"study_design_scores_gemma":[0.1619214,0.32759058,0.2568634,0.000063512176,0.002563799,0.00003189687,0.0022088988,0.00015285665,0.24244742,0.000018520363,0.0058181123,0.0003196405],"about_ca_topic_score_codex":0.000013537191,"about_ca_topic_score_gemma":0.000013225904,"teacher_disagreement_score":0.47728726,"about_ca_system_score_codex":0.000048880138,"about_ca_system_score_gemma":0.00020219559,"threshold_uncertainty_score":0.40737787},"labels":[],"label_agreement":null},{"id":"W3112694400","doi":"10.1093/neuonc/noaa222.316","title":"HGG-35. PEDIATRIC PLEOMORPHIC XANTHOASTROCYTOMA WITH ANAPLASIA TREATED WITH SURGERY AND ADJUVANT CHEMOTHERAPY: A CASE SERIES OF 3 LONG-TERM SURVIVORS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; BC Children's Hospital","funders":"","keywords":"Anaplasia; Pleomorphic xanthoastrocytoma; Medicine; Lomustine; Oncology; Chemotherapy; Radiation therapy; Internal medicine; Pathology; Astrocytoma; Vincristine; Glioma; Cancer research","score_opus":0.022055614471710335,"score_gpt":0.25420221221721734,"score_spread":0.232146597745507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112694400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99574226,0.0004508459,0.000011154643,0.0029484988,0.000045137003,0.0006123674,0.000038755617,0.0000839062,0.00006705644],"genre_scores_gemma":[0.9982053,0.0006333424,0.00016842692,0.0006891335,0.00012818832,0.00007054641,0.000041235446,0.000059102455,0.00000470858],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984603,0.00013355988,0.00035679736,0.00049233023,0.00021006343,0.00034697485],"domain_scores_gemma":[0.9985523,0.00047093953,0.00026597455,0.00024400755,0.000113248156,0.00035351285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007955294,0.00032166168,0.0010118732,0.00018764239,0.00007134192,0.000013351695,0.000050903836,0.00013078852,0.00008631563],"category_scores_gemma":[0.000051593048,0.00021783565,0.00007926105,0.0005185937,0.00021935413,0.000082913495,0.000034664074,0.00018737963,0.000004341243],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042040306,0.000572006,0.8975683,0.00018512589,0.00020995316,0.08479614,0.00038961924,0.000004333304,0.0068907635,0.0000039167717,0.0002712019,0.004904613],"study_design_scores_gemma":[0.015985254,0.02894983,0.7955703,0.000109326276,0.0017962509,0.09514257,0.00045837168,0.00007648161,0.06056149,0.0000011633136,0.0008744823,0.00047445638],"about_ca_topic_score_codex":0.00013543962,"about_ca_topic_score_gemma":0.0011419331,"teacher_disagreement_score":0.10199798,"about_ca_system_score_codex":0.000054410604,"about_ca_system_score_gemma":0.0002950399,"threshold_uncertainty_score":0.888308},"labels":[],"label_agreement":null},{"id":"W3112706733","doi":"10.1093/neuonc/noaa222.031","title":"ATRT-33. ENABLING RAPID CLASSIFICATION OF ATRT WITH NANOSTRING NCOUNTER PLATFORM","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Subtyping; DNA methylation; Transcriptome; Epigenetics; Computational biology; Workflow; Gene expression; Gene; Bioinformatics; Biology; Computer science; Database; Genetics","score_opus":0.0325335385647089,"score_gpt":0.274933744672727,"score_spread":0.24240020610801813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112706733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925263,0.00038310685,0.0021924875,0.00097281305,0.00018267731,0.00016969194,0.000015320542,0.000026745705,0.0035308625],"genre_scores_gemma":[0.9970588,0.00031961087,0.0007267527,0.0014012421,0.00037795617,0.000015228665,0.000050717168,0.000027485446,0.000022186949],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989903,0.000040128547,0.00027556135,0.0003620662,0.00012806575,0.00020389444],"domain_scores_gemma":[0.99935496,0.000039041857,0.0001830787,0.00023202508,0.00010301424,0.000087902605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009807839,0.00013911958,0.00021305916,0.000028110257,0.000051601222,0.000009731527,0.00017365202,0.00018360619,0.000030876614],"category_scores_gemma":[0.00009828194,0.000122138,0.000072084236,0.00010733556,0.000078220044,0.0000060334287,0.00007410087,0.00014971518,0.000009256388],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033527752,0.000031364012,0.00054427795,0.00003935318,0.00003075695,0.0000059580802,0.00018706784,0.00036740152,0.97654957,0.000023970595,0.0012831215,0.020601902],"study_design_scores_gemma":[0.0013381018,0.0021139877,0.00023982365,0.000020203559,0.000041735617,0.000050267812,0.0003540194,0.0025678528,0.7031144,0.000011205696,0.28995618,0.00019222363],"about_ca_topic_score_codex":0.00000995772,"about_ca_topic_score_gemma":0.00001766072,"teacher_disagreement_score":0.28867307,"about_ca_system_score_codex":0.00003380088,"about_ca_system_score_gemma":0.00023250387,"threshold_uncertainty_score":0.49806428},"labels":[],"label_agreement":null},{"id":"W3112725910","doi":"10.1093/neuonc/noaa215.002","title":"BIOM-02. IDENTIFYING MGMT ALTERATIONS AS BIOMARKERS OF SURVIVAL IN LUNG ADENOCARCINOMA WITH BRAIN METASTASES","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Queen's University; University Health Network","funders":"","keywords":"Oncology; Adenocarcinoma; Lung cancer; Methylation; Medicine; DNA methylation; Internal medicine; Proportional hazards model; Cohort; Survival analysis; Cancer; Confounding; Cancer research; Biology; Gene; Genetics; Gene expression","score_opus":0.030526273214919783,"score_gpt":0.3125680782667459,"score_spread":0.2820418050518261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112725910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901881,0.0015010377,0.003983998,0.0026965295,0.00017527059,0.00028703228,0.000038122093,0.000011447246,0.001118426],"genre_scores_gemma":[0.99748594,0.00017065732,0.0012934487,0.0007219835,0.00011809515,0.000021713191,0.00014926217,0.000026027328,0.000012858943],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984996,0.00036418388,0.00035194302,0.0004174561,0.00014162745,0.00022524274],"domain_scores_gemma":[0.9992721,0.00013836364,0.00016945573,0.0002199371,0.00008600093,0.000114113005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025890654,0.00015652002,0.00026718294,0.00009934149,0.00005089446,0.000018499382,0.00016920586,0.00014328063,0.000031753847],"category_scores_gemma":[0.0003716741,0.00015054618,0.000069525566,0.0002820751,0.00010876499,0.000007767065,0.00010688121,0.000112921,0.0000056040635],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023803157,0.00006792243,0.029758234,0.000033690092,0.000062520645,0.00003727766,0.00019740476,0.00024178899,0.9673323,0.00012007126,0.00037035896,0.001540421],"study_design_scores_gemma":[0.0016042999,0.002139959,0.011476422,0.000010707392,0.00005927456,0.000012626887,0.00026761572,0.00062170613,0.9617665,0.0000631997,0.021759426,0.00021828701],"about_ca_topic_score_codex":0.00007836641,"about_ca_topic_score_gemma":0.0003140085,"teacher_disagreement_score":0.021389067,"about_ca_system_score_codex":0.000022100683,"about_ca_system_score_gemma":0.00022670727,"threshold_uncertainty_score":0.61390954},"labels":[],"label_agreement":null},{"id":"W3112734515","doi":"10.1093/neuonc/noaa222.395","title":"LGG-13. THE CLINICAL AND MOLECULAR LANDSCAPE OF GLIOMAS IN ADOLESCENTS AND YOUNG ADULTS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University Health Network; Sunnybrook Health Science Centre; Hospital for Sick Children","funders":"","keywords":"Medicine; Glioma; Cohort; Young adult; Oncology; Internal medicine; Cancer research","score_opus":0.023505155555610148,"score_gpt":0.31369301472764355,"score_spread":0.2901878591720334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112734515","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891075,0.0010820136,0.0000019714644,0.008939684,0.00011685201,0.00036577828,0.0000035779087,0.000011470115,0.00037113554],"genre_scores_gemma":[0.99598,0.00039166433,0.00004334563,0.00349216,0.0000614888,0.000016982773,0.0000025985637,0.000011290708,4.4874767e-7],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99904364,0.00015500557,0.00032136345,0.00023225651,0.00010525778,0.00014249617],"domain_scores_gemma":[0.9994748,0.00012866607,0.00008498934,0.00013592662,0.000031932403,0.00014363926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012392782,0.000100494515,0.00035759344,0.000047167367,0.00001835617,0.0000048116317,0.00005206249,0.000107308166,0.000009446561],"category_scores_gemma":[0.00024630193,0.00006694596,0.000049202434,0.00014347794,0.0001357121,0.000015967393,0.00008780684,0.00019531728,0.000004353518],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005878891,0.0004250234,0.96613187,0.000059879283,0.000031621224,0.0009861884,0.000513655,8.436548e-7,0.017151518,0.000038686532,0.0005226302,0.013550174],"study_design_scores_gemma":[0.012556528,0.003272521,0.97256637,0.0001057038,0.00016115047,0.00022532046,0.00037865515,0.00057596527,0.0056945826,0.00002420031,0.00435534,0.00008369178],"about_ca_topic_score_codex":0.000033360535,"about_ca_topic_score_gemma":0.00007404142,"teacher_disagreement_score":0.013466482,"about_ca_system_score_codex":0.00000884169,"about_ca_system_score_gemma":0.000047375812,"threshold_uncertainty_score":0.2729977},"labels":[],"label_agreement":null},{"id":"W3112753901","doi":"10.1093/neuonc/noaa222.417","title":"LGG-35. FUNCTIONAL GENOMIC APPROACHES TO IDENTIFY THERAPEUTIC TARGETS IN <i>MYB</i> AND <i>MYBL1</i> EXPRESSING PEDIATRIC LOW-GRADE GLIOMAS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; Jewish General Hospital","funders":"","keywords":"MYB; Biology; Cell cycle; Long non-coding RNA; Neural stem cell; Glioma; Gene; Transcription factor; Cancer research; Genetics; Computational biology; RNA; Stem cell","score_opus":0.09870630516554331,"score_gpt":0.2981041554665014,"score_spread":0.19939785030095808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112753901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9774064,0.0052906335,0.00010689633,0.015201102,0.00039793176,0.0008176612,0.0000127018775,0.00008693175,0.0006797474],"genre_scores_gemma":[0.9874857,0.000306475,0.00039843883,0.010891693,0.00063860824,0.00019274326,0.000028566496,0.000052292566,0.0000054776183],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99799633,0.00017262949,0.0004237139,0.00070565677,0.00024936686,0.0004522853],"domain_scores_gemma":[0.99888515,0.0003336514,0.00011876846,0.00022650033,0.000026149864,0.0004098006],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014075114,0.00028714002,0.000558822,0.0002706358,0.00010024489,0.00004122514,0.00011185635,0.00018474968,0.000079256235],"category_scores_gemma":[0.00007518416,0.0002583611,0.00011094694,0.00047263745,0.00006834293,0.000093337374,0.0001544545,0.00033529347,0.000098160446],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060649484,0.001317015,0.19990733,0.00015092311,0.000095638396,0.0013381233,0.0015647736,0.0002255188,0.7758826,0.00016349844,0.005790763,0.012957323],"study_design_scores_gemma":[0.026957111,0.0060794167,0.6865644,0.00008566462,0.0013794829,0.0013057325,0.00086170685,0.0019107212,0.115602426,0.0006010436,0.15739428,0.0012580492],"about_ca_topic_score_codex":0.000013421499,"about_ca_topic_score_gemma":0.000016885517,"teacher_disagreement_score":0.66028017,"about_ca_system_score_codex":0.00016504609,"about_ca_system_score_gemma":0.00017655887,"threshold_uncertainty_score":0.9999869},"labels":[],"label_agreement":null},{"id":"W3112757605","doi":"10.1093/neuonc/noaa222.223","title":"ETMR-20. IMPACT OF HIGH DOSE CHEMOTHERAPY WITH AND WITHOUT METHOTREXATE (MTX) ON OUTCOME OF PATIENTS WITH EMBRYONAL TUMORS WITH MULTI-LAYERED ROSETTES (ETMRs): A REPORT FROM CHILDREN’S ONCOLOGY GROUP PHASE III TRIAL ACNS0334","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Medulloblastoma; Chemotherapy; Methotrexate; Regimen; Oncology; Internal medicine; Radiation therapy; Surgery; Pathology","score_opus":0.030537965874463335,"score_gpt":0.3423896198946818,"score_spread":0.31185165402021847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112757605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99444777,0.00005110048,0.0000706506,0.0018404826,0.00010431449,0.0029518765,0.00041357812,0.00006322052,0.00005703299],"genre_scores_gemma":[0.9930302,0.000024500749,0.0044442704,0.0015044871,0.00016042884,0.00019770504,0.0005283651,0.00010537162,0.000004664812],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99657226,0.00034751536,0.001042546,0.0009960594,0.0005595747,0.00048202433],"domain_scores_gemma":[0.99671745,0.00057542534,0.0014273972,0.000554488,0.00023813895,0.0004870716],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020885645,0.00062060193,0.0023594105,0.00020980056,0.00007266432,0.000013716098,0.00016692605,0.00026385635,0.000107483545],"category_scores_gemma":[0.00018071555,0.00036454684,0.00020619393,0.00035442182,0.00042262286,0.000100515834,0.000065508524,0.00048405846,0.0000024954156],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.27536598,0.009981086,0.68419033,0.000026871363,0.0016379328,0.001329008,0.00061160576,0.00006636905,0.021411246,0.0000074733316,0.00015805136,0.0052140243],"study_design_scores_gemma":[0.35727906,0.10348096,0.52768433,0.00006965119,0.00085347047,0.00023433185,0.000047967133,0.00009595486,0.009814233,0.000004870688,0.00016157037,0.0002736002],"about_ca_topic_score_codex":0.00093347573,"about_ca_topic_score_gemma":0.00020619006,"teacher_disagreement_score":0.15650603,"about_ca_system_score_codex":0.00026439782,"about_ca_system_score_gemma":0.00050900324,"threshold_uncertainty_score":0.9998807},"labels":[],"label_agreement":null},{"id":"W3112819026","doi":"10.1093/neuonc/noaa215.285","title":"EPCO-06. MOLECULAR DETERMINANTS OF EVOLUTION AND PROGNOSIS AMONG DIFFUSE LOWER GRADE ASTROCYTOMAS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Biology; Glioma; Isocitrate dehydrogenase; Oligodendroglioma; Cancer research; Mutant; Methylation; Reprogramming; Gene; Astrocytoma; Genetics; Enzyme","score_opus":0.020592227490768028,"score_gpt":0.2814678186736482,"score_spread":0.2608755911828802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112819026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99628943,0.00032846592,0.000042425807,0.0024907005,0.00009539076,0.0005696579,0.000009141887,0.00004357247,0.00013118912],"genre_scores_gemma":[0.998709,0.00006061978,0.000296668,0.00074702606,0.00005976239,0.00009313312,0.000006857797,0.000024832383,0.000002062707],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99886143,0.00007793704,0.0002902161,0.00035135486,0.00017433066,0.0002447289],"domain_scores_gemma":[0.9992681,0.00010614676,0.00014827179,0.00016521632,0.000058164416,0.00025409242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000045539444,0.00016751807,0.00046757248,0.00008066777,0.0000365926,0.0000065469153,0.0000624714,0.00013569537,0.000021136437],"category_scores_gemma":[0.00017360917,0.00014224985,0.000102081445,0.00016586235,0.0001525854,0.00004956532,0.00007997958,0.00014342686,0.000013151733],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014139975,0.00093795406,0.579599,0.000054530236,0.00004594573,0.0010776329,0.00014001563,0.0000020326775,0.41358906,0.000035617464,0.00038120375,0.003995596],"study_design_scores_gemma":[0.0073052538,0.007162842,0.5439563,0.00005956672,0.000517108,0.0001889729,0.00008689226,0.00074765127,0.434879,0.000034065426,0.0049033575,0.00015896832],"about_ca_topic_score_codex":0.000022532397,"about_ca_topic_score_gemma":0.00001647746,"teacher_disagreement_score":0.035642702,"about_ca_system_score_codex":0.0000773264,"about_ca_system_score_gemma":0.00007288595,"threshold_uncertainty_score":0.580078},"labels":[],"label_agreement":null},{"id":"W3112835023","doi":"10.1093/neuonc/noaa222.655","title":"PATH-20. METHYLATION ARRAY PROFILING OF PEDIATRIC BRAIN TUMORS; SINGLE CENTRE EXPERIENCE","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Methylation; DNA methylation; Medulloblastoma; Glioma; Medicine; Histopathology; Ependymoma; Oncology; Pathology; Internal medicine; Bioinformatics; Biology; Cancer research; Gene; Genetics; Gene expression","score_opus":0.1507867397177991,"score_gpt":0.4039198196266042,"score_spread":0.2531330799088051,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112835023","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9695889,0.00015788294,0.0015211784,0.026681378,0.0006058607,0.0004616831,0.0000035939474,0.00006089153,0.0009186649],"genre_scores_gemma":[0.99267775,0.000031867254,0.0017815827,0.0042627547,0.0011695093,0.000019618818,0.000022405295,0.000017229817,0.000017300306],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998582,0.0001699718,0.00051868526,0.00030139516,0.00018459697,0.00024333029],"domain_scores_gemma":[0.9986442,0.0005770448,0.00023071699,0.00015587098,0.00018891059,0.00020330196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017086942,0.000106628235,0.00028682555,0.000074497126,0.000060169798,0.0000055747582,0.00008411644,0.00013005074,0.0001361894],"category_scores_gemma":[0.0020044432,0.00010281529,0.00006066787,0.00040146706,0.000063898624,0.00008217632,0.000021352107,0.0002488824,0.000038937782],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015641672,0.00019033544,0.036806673,0.00014425708,0.0000037094733,0.00002492253,0.015399688,0.000031094187,0.928647,0.00007949122,0.00090308784,0.017613325],"study_design_scores_gemma":[0.00011784557,0.0018097928,0.00045647117,0.000016544558,0.000041365518,0.000018374854,0.007579736,0.0012963698,0.9794986,0.00016445878,0.008890724,0.00010971855],"about_ca_topic_score_codex":0.000045468645,"about_ca_topic_score_gemma":0.000009731009,"teacher_disagreement_score":0.050851602,"about_ca_system_score_codex":0.00010388006,"about_ca_system_score_gemma":0.0004378581,"threshold_uncertainty_score":0.41926858},"labels":[],"label_agreement":null},{"id":"W3112840818","doi":"10.1093/neuonc/noaa222.210","title":"ETMR-06. DISSECTING THE MOLECULAR AND DEVELOPMENTAL BASIS OF PINEOBLASTOMA THROUGH GENOMICS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Pinealocyte; Biology; Genomics; microRNA; Cancer research; Gene; Computational biology; Pineal gland; Genetics; Genome; Neuroscience","score_opus":0.021361198202763644,"score_gpt":0.24734882591578292,"score_spread":0.22598762771301928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112840818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99340934,0.0003900006,0.002353742,0.0018641689,0.00016657719,0.00017856961,0.000011850506,0.000012621707,0.0016131143],"genre_scores_gemma":[0.9922395,0.00019572554,0.0027006867,0.0046332222,0.0001654878,0.000009844992,0.00001957826,0.000028036482,0.000007962991],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990342,0.00010489608,0.00025630332,0.000321084,0.00008178271,0.00020171786],"domain_scores_gemma":[0.99956906,0.00006831506,0.00009696465,0.00013436413,0.000057631492,0.00007364544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008528339,0.00015255298,0.00020784602,0.000012746022,0.00008921148,0.00001223638,0.0002060621,0.00015609869,0.000012121869],"category_scores_gemma":[0.00022971803,0.00012694711,0.00007426257,0.00008527682,0.00015973496,0.0000038762587,0.00014944431,0.00016538595,0.0000047406957],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000127664,0.000041687475,0.001495101,0.000022251608,0.000043711258,0.000015238942,0.00087744027,0.000042456195,0.99245137,0.00009948572,0.0005161425,0.0042674383],"study_design_scores_gemma":[0.00060408906,0.0006935597,0.00026609696,0.0000034862435,0.000028847731,0.00006818719,0.00047958508,0.00015892432,0.87145865,0.00003399731,0.1260706,0.00013397797],"about_ca_topic_score_codex":0.000018507915,"about_ca_topic_score_gemma":0.000024405661,"teacher_disagreement_score":0.12555446,"about_ca_system_score_codex":0.000021618833,"about_ca_system_score_gemma":0.00014130177,"threshold_uncertainty_score":0.5176753},"labels":[],"label_agreement":null},{"id":"W3112851454","doi":"10.1093/neuonc/noaa222.401","title":"LGG-19. SPINAL LOW-GRADE GLIOMAS IN CANADIAN CHILDREN: A MULTI-CENTRE RETROSPECTIVE REVIEW","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; BC Children's Hospital; Stollery Children's Hospital; Hospital for Sick Children; Agricultural Research Institute of Ontario","funders":"","keywords":"Medicine; Retrospective cohort study; Pathological; Pilocytic astrocytoma; Surgery; Radiation therapy; Chemotherapy; Pediatrics; Astrocytoma; Internal medicine; Glioma","score_opus":0.026844336057462788,"score_gpt":0.30989366830199216,"score_spread":0.2830493322445294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112851454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.78489643,0.020399507,0.000001609339,0.19011155,0.00032677062,0.0023829322,0.00006972924,0.00009825714,0.0017132299],"genre_scores_gemma":[0.9532717,0.0036871003,0.0001651382,0.042489726,0.00020795068,0.000082941,0.000053373158,0.000036144585,0.000005956968],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99801385,0.00017497531,0.00038904004,0.00060275866,0.00019805398,0.0006213372],"domain_scores_gemma":[0.9983948,0.00005848941,0.000116676594,0.0002854303,0.00006858315,0.0010760099],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000119784076,0.00025989374,0.0007609142,0.00019907633,0.00006594481,0.000010049423,0.00013786295,0.00016895158,0.0003975057],"category_scores_gemma":[0.0007021041,0.00023166079,0.00016376426,0.0006762429,0.00007524358,0.000042829182,0.00005241411,0.00044403426,0.00025919493],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001877814,0.0016258009,0.9373285,0.0003542791,0.00014358362,0.01389566,0.00044767206,0.0000035396602,0.006873545,0.00033060284,0.027575841,0.011233152],"study_design_scores_gemma":[0.012841367,0.0035629708,0.73987186,0.0008795997,0.0004253346,0.00090437755,0.000066390225,0.00019048293,0.0027868242,0.000018049042,0.23806955,0.00038320653],"about_ca_topic_score_codex":0.027589146,"about_ca_topic_score_gemma":0.10255475,"teacher_disagreement_score":0.21049371,"about_ca_system_score_codex":0.0010964986,"about_ca_system_score_gemma":0.0008718199,"threshold_uncertainty_score":0.97888625},"labels":[],"label_agreement":null},{"id":"W3112871129","doi":"10.1093/neuonc/noaa222.456","title":"LINC-21. SURVEY ON THE RESOURCES AVAILABLE FOR PEDIATRIC NEURO-ONCOLOGY IN CHILE, SOUTH AMERICA","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Pediatric oncology; Medicine; Pediatric cancer; Gemcitabine; Childhood cancer; Topotecan; Radiation oncology; Radiation therapy; Oncology; Cancer; Pediatrics; Internal medicine; Chemotherapy","score_opus":0.052167992404418995,"score_gpt":0.29528332948063585,"score_spread":0.24311533707621685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112871129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9408563,0.0003992613,0.000009655656,0.049824324,0.00067509915,0.0019715098,0.00014761252,0.0001110761,0.0060051754],"genre_scores_gemma":[0.9605931,0.0004779134,0.00014873888,0.036899615,0.0010779096,0.00056249794,0.00008893081,0.00008615089,0.000065111606],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967451,0.00086607086,0.00062437385,0.0008285833,0.00026915228,0.0006667312],"domain_scores_gemma":[0.99214387,0.0065861912,0.00034297057,0.0004760888,0.000120761375,0.0003301321],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004824745,0.00035099557,0.0009098514,0.00022659448,0.00016694133,0.000021801014,0.0003146387,0.00027501205,0.0005066519],"category_scores_gemma":[0.0035117369,0.0002453115,0.00021034274,0.00082781294,0.00015595944,0.000035663496,0.00015605032,0.0006609526,0.0006546326],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038937065,0.0031104435,0.56619686,0.00008751928,0.00013172257,0.0010521979,0.003528787,0.00018336871,0.014599031,0.00010827341,0.39930996,0.007798103],"study_design_scores_gemma":[0.0074888975,0.015254471,0.15567307,0.000010861965,0.00028695757,0.000039714614,0.00027853693,0.000684518,0.0020378053,0.000023998264,0.81794935,0.00027180294],"about_ca_topic_score_codex":0.00018908596,"about_ca_topic_score_gemma":0.00016038837,"teacher_disagreement_score":0.4186394,"about_ca_system_score_codex":0.00019426773,"about_ca_system_score_gemma":0.00039926183,"threshold_uncertainty_score":0.99999994},"labels":[],"label_agreement":null},{"id":"W3112899297","doi":"10.1093/neuonc/noaa222.194","title":"EPID-08. FINDING THE NEEDLE IN THE HAY STACK – POPULATION-BASED STUDY OF PREDIAGNOSTIC SYMPTOMATIC INTERVAL IN CHILDREN WITH CNS TUMORS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Pediatrics; Medical record; Population; Paresis; Confidence interval; Diagnosis code; Ataxia; Health care; Retrospective cohort study; Surgery; Internal medicine","score_opus":0.026589189848266106,"score_gpt":0.29513332224347677,"score_spread":0.2685441323952107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112899297","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885779,0.00003331047,0.000004143366,0.008997015,0.0000502947,0.0022240197,0.000008082968,0.000020256277,0.000084968386],"genre_scores_gemma":[0.9970334,0.0000028729519,0.000026798944,0.002542176,0.000053743952,0.00029839808,0.000022316524,0.000019812187,4.3817136e-7],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99832255,0.00048336247,0.00043920873,0.00027095762,0.00025459006,0.00022932158],"domain_scores_gemma":[0.99763536,0.0018031212,0.00018220904,0.0002885316,0.000026031847,0.00006472815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023824042,0.00016701044,0.0004613099,0.00013771467,0.000048862657,0.000012149839,0.00019676909,0.000052279218,0.000034810128],"category_scores_gemma":[0.0005987299,0.00008933318,0.000053428514,0.0005298342,0.00004574764,0.000035636793,0.00004528971,0.00028316688,0.000008102788],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014006114,0.0021802303,0.98861825,0.000022866192,0.000056762834,0.00023068054,0.005188368,0.0025065313,0.0002134586,0.000017148428,0.00015369663,0.00067191484],"study_design_scores_gemma":[0.0060851504,0.0063571287,0.98284346,0.00007917515,0.00018763891,0.00004021679,0.0024280464,0.0015827802,0.00029544797,0.0000098878245,0.000021835405,0.00006926083],"about_ca_topic_score_codex":0.0004609371,"about_ca_topic_score_gemma":0.00063966715,"teacher_disagreement_score":0.0084555335,"about_ca_system_score_codex":0.000119496384,"about_ca_system_score_gemma":0.00012108078,"threshold_uncertainty_score":0.36429015},"labels":[],"label_agreement":null},{"id":"W3112901064","doi":"10.1093/neuonc/noaa222.673","title":"QOL-09. WHOLE-BRAIN WHITE MATTER NETWORK CONNECTIVITY IS DISRUPTED BY PEDIATRIC BRAIN TUMOR TREATMENT","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Advanced Neuroimaging Techniques and Applications","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"White matter; Magnetic resonance imaging; Medicine; Psychology; Neuroscience; Nuclear medicine; Audiology; Radiology","score_opus":0.04164659635995809,"score_gpt":0.3417017554282418,"score_spread":0.3000551590682837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112901064","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.26578695,0.00016952986,0.010421563,0.7182804,0.00017601745,0.0015917604,0.0001963718,0.00067132176,0.0027061452],"genre_scores_gemma":[0.6742212,0.00009495539,0.005688757,0.3164664,0.0016199778,0.000572025,0.00016168496,0.00014874432,0.0010262564],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99807596,0.00017381879,0.00036120004,0.0007477869,0.00015304348,0.00048820456],"domain_scores_gemma":[0.9982848,0.0006545725,0.0001970988,0.00046744902,0.00005018968,0.00034585863],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00008800235,0.00030338648,0.00057050353,0.00005552332,0.00014296113,0.000017813501,0.0001634631,0.000118088676,0.0002944511],"category_scores_gemma":[0.00014669307,0.0002735625,0.0001478824,0.00047758897,0.00010128941,0.000070973394,0.00011790905,0.0004190338,0.00029533287],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019206443,0.00036465982,0.087628,0.000028371147,0.000017892977,0.00023398451,0.00022896857,0.000020665108,0.058080606,0.00006557679,0.84929806,0.003841163],"study_design_scores_gemma":[0.0020645317,0.0024145665,0.010650282,0.0000059093513,0.00013975966,0.00022190892,0.000023503804,0.00071287097,0.003178028,0.00027957608,0.9800674,0.0002417201],"about_ca_topic_score_codex":0.000011788787,"about_ca_topic_score_gemma":0.0000034724321,"teacher_disagreement_score":0.40843427,"about_ca_system_score_codex":0.0001733012,"about_ca_system_score_gemma":0.00012456742,"threshold_uncertainty_score":0.9999716},"labels":[],"label_agreement":null},{"id":"W3112979975","doi":"10.1093/neuonc/noaa215.654","title":"NIMG-41. VARIATION IN PERFUSION AND PERMEABILITY MRI DEPENDING ON VASCULAR INPUT FUNCTION SELECTION","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"MRI in cancer diagnosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Institute in Oncology and Hematology; Health Sciences Centre; CancerCare Manitoba","funders":"","keywords":"SSS*; Medicine; Nuclear medicine; Perfusion; Dynamic contrast-enhanced MRI; Radiology; Magnetic resonance imaging; Internal medicine","score_opus":0.02509115661679715,"score_gpt":0.29041493022263565,"score_spread":0.2653237736058385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112979975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97403073,0.0000628197,0.0011172568,0.022099754,0.0005465663,0.0006811363,0.0000018746113,0.00010113911,0.001358749],"genre_scores_gemma":[0.99231744,0.00070054794,0.00035798864,0.0060695005,0.0004502029,0.000063982035,0.000010791793,0.000025009205,0.0000045492498],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9983623,0.0003201812,0.0002941048,0.0005669517,0.00023728363,0.00021918466],"domain_scores_gemma":[0.9991483,0.00037806644,0.00009865966,0.00015778707,0.00007017994,0.00014696858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003748022,0.00014988895,0.0003271452,0.00015038704,0.00007676451,0.0000127396115,0.000046791043,0.00024176037,0.0003113217],"category_scores_gemma":[0.0004392551,0.00015077715,0.000057224628,0.00037070803,0.00003821961,0.000105474035,0.000051615956,0.0005060532,0.000046077534],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015501359,0.00044604487,0.35646713,0.0001636605,0.000025883079,0.000056799836,0.002154732,0.00096799387,0.59071183,0.00019024499,0.0035510333,0.043714475],"study_design_scores_gemma":[0.0054739146,0.009139435,0.8124452,0.00006908577,0.00024296549,0.00009366628,0.00018002313,0.024249136,0.012467231,0.00016039451,0.13521336,0.00026554495],"about_ca_topic_score_codex":0.000112386006,"about_ca_topic_score_gemma":0.00016084667,"teacher_disagreement_score":0.5782446,"about_ca_system_score_codex":0.00059929135,"about_ca_system_score_gemma":0.00015807476,"threshold_uncertainty_score":0.6148514},"labels":[],"label_agreement":null},{"id":"W3112995881","doi":"10.1093/neuonc/noaa222.684","title":"QOL-22. MACHINE-LEARNING INFERENCE MAY PREDICT QUALITY OF LIFE SUBGROUPS OF ADAMANTINOMATOUS CRANIOPHARYNGIOMA","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Craniopharyngioma; Medicine; Quality of life (healthcare); Categorical variable; Artificial intelligence; Machine learning; Pediatrics; Surgery; Computer science","score_opus":0.04000410185333333,"score_gpt":0.31708878211197117,"score_spread":0.27708468025863786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112995881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893082,0.0007666843,0.00012958191,0.0018919607,0.00014066225,0.0003528821,0.0000567859,0.00008024101,0.007273003],"genre_scores_gemma":[0.99786127,0.00023239924,0.0002657417,0.001431837,0.000077104705,0.0000124082,0.00007129421,0.000023543695,0.00002440377],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981701,0.00028924335,0.0006664605,0.00034019668,0.00027194916,0.0002620929],"domain_scores_gemma":[0.99848354,0.00051529886,0.0003701797,0.00022889288,0.00010210539,0.00029998686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015349075,0.0001991179,0.00088051474,0.000080834594,0.000047223377,0.0000034938416,0.00014962957,0.00015267734,0.00030143707],"category_scores_gemma":[0.0011300393,0.0001671373,0.00017133921,0.0002323705,0.0001314585,0.000065202796,0.00011020437,0.0002974144,0.00002668338],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018420974,0.0007397424,0.93447214,0.00035243444,0.00015537972,0.00028434466,0.0005707919,0.000028425307,0.05712379,0.00033209092,0.0004860171,0.0036127623],"study_design_scores_gemma":[0.020222224,0.01261431,0.9330373,0.00007042564,0.00045478597,0.000131004,0.0004014069,0.003505001,0.00824328,0.00016876927,0.020797737,0.0003537995],"about_ca_topic_score_codex":0.0003421839,"about_ca_topic_score_gemma":0.000026653977,"teacher_disagreement_score":0.04888051,"about_ca_system_score_codex":0.00002282154,"about_ca_system_score_gemma":0.00030849123,"threshold_uncertainty_score":0.6815661},"labels":[],"label_agreement":null},{"id":"W3113000665","doi":"10.1093/neuonc/noaa215.846","title":"STEM-29. THE HISTONE VARIANT macroH2A2 ORCHESTRATES AN ACTIONABLE CHROMATIN PROGRAM OF STEMNESS IN GLIOBLASTOMA","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Calgary","funders":"","keywords":"Chromatin; Epigenetics; Biology; Histone; Epigenomics; Reprogramming; Cancer research; Transcription factor; Glioblastoma; Transcriptome; Stem cell; Computational biology; Cell biology; Cell; Genetics; DNA methylation; Gene expression; Gene","score_opus":0.01906152914665282,"score_gpt":0.2949411824889666,"score_spread":0.2758796533423138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113000665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956436,0.00038116623,0.00012422704,0.0019416587,0.00021443854,0.00052590424,0.00003838231,0.00001969928,0.0011109065],"genre_scores_gemma":[0.9979662,0.00017001922,0.00037451935,0.0010369088,0.0002402346,0.00012564067,0.000027505681,0.000027035368,0.000031982552],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988058,0.00016723979,0.00032710127,0.00035500698,0.000097155775,0.00024769886],"domain_scores_gemma":[0.99925274,0.000105236846,0.00017119768,0.0002894686,0.00007387665,0.00010745765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015508919,0.0001481185,0.00024848297,0.00003033491,0.000054154356,0.000018554378,0.00029597792,0.00017673487,0.000041060783],"category_scores_gemma":[0.00008793082,0.00012642577,0.000058946163,0.00017570646,0.00014767292,0.00000554227,0.00013480762,0.00018230638,0.000010013648],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044445955,0.00039752698,0.00031715425,0.000045677556,0.000022898603,0.00006412719,0.00032952474,0.0007609422,0.9651608,0.00020943688,0.0019418506,0.030305607],"study_design_scores_gemma":[0.0017127319,0.008610664,0.0014718615,0.0000104195815,0.000040641964,0.00013602985,0.0006947529,0.0022811585,0.5215537,0.000081037804,0.4631412,0.0002658047],"about_ca_topic_score_codex":0.00009025142,"about_ca_topic_score_gemma":0.0004420154,"teacher_disagreement_score":0.46119937,"about_ca_system_score_codex":0.000054355838,"about_ca_system_score_gemma":0.0004025977,"threshold_uncertainty_score":0.51554936},"labels":[],"label_agreement":null},{"id":"W3113002109","doi":"10.1093/neuonc/noaa215.190","title":"CTNI-23. IDH1/2wt ANAPLASTIC GLIOMAS OF THE EORTC RANDOMIZED PHASE III INTERGROUP CATNON TRIAL: OVERALL SURVIVAL RELATED TO TREATMENT, MGMT STATUS AND MOLECULAR FEATURES OF GLIOBLASTOMA","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"IDH1; Anaplastic astrocytoma; Internal medicine; Glioma; Medicine; Oncology; Astrocytoma; Adjuvant therapy; Isocitrate dehydrogenase; Methylation; Cancer research; Biology; Chemotherapy; Mutation; Genetics; Gene","score_opus":0.015174105669922675,"score_gpt":0.3051012183696928,"score_spread":0.2899271126997701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113002109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901946,0.00082669745,0.00001794056,0.004405347,0.0006973768,0.003164612,0.000055003395,0.000048353344,0.0005900663],"genre_scores_gemma":[0.9985113,0.00021858625,0.000067701156,0.0008537097,0.000058697187,0.0001989637,0.000030005698,0.00004716883,0.0000138354735],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99717045,0.0007256462,0.0008458114,0.0005470589,0.00031827844,0.00039274793],"domain_scores_gemma":[0.9972716,0.0013145482,0.00046372035,0.00042265526,0.00012699816,0.00040049115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020354433,0.00037291663,0.0018161738,0.00021648374,0.000055646495,0.000010110976,0.00014268271,0.00021015352,0.00005369008],"category_scores_gemma":[0.0010785726,0.00023740275,0.00043880858,0.00050775,0.00027101763,0.000042017127,0.00014403934,0.00021856834,0.000005612687],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.54982775,0.002315676,0.0010329495,0.00005406636,0.00097542634,0.00077721477,0.001522789,0.00004101592,0.43916184,0.00074594055,0.0005499291,0.0029954002],"study_design_scores_gemma":[0.75766474,0.029972974,0.0008866219,0.00006347063,0.0015961485,0.00008775894,0.00013231357,0.00014740526,0.20603713,0.00010238153,0.0031452668,0.00016380208],"about_ca_topic_score_codex":0.00020413983,"about_ca_topic_score_gemma":0.00016286323,"teacher_disagreement_score":0.2331247,"about_ca_system_score_codex":0.00016957382,"about_ca_system_score_gemma":0.00023746493,"threshold_uncertainty_score":0.9681003},"labels":[],"label_agreement":null},{"id":"W3113025753","doi":"10.1093/neuonc/noaa222.116","title":"DIPG-74. RE-IRRADIATION OF DIPG: DATA FROM THE INTERNATIONAL DIPG REGISTRY","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; SickKids Foundation; Centre Hospitalier Universitaire Sainte-Justine; BC Children's Hospital; University of Calgary","funders":"","keywords":"Medicine; Cohort; Radiation therapy; Clinical trial; Internal medicine; Surgery","score_opus":0.10722863328306377,"score_gpt":0.3827924553330714,"score_spread":0.2755638220500076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113025753","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11652654,0.00016522389,0.007349735,0.8568569,0.00057041994,0.0007309728,0.00045907596,0.00025796352,0.017083216],"genre_scores_gemma":[0.95447356,0.00031460272,0.007102331,0.035633758,0.0012856538,0.000048778613,0.0010486037,0.000022955126,0.00006975114],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988659,0.00007288197,0.0003247035,0.00034956943,0.00026409657,0.00012287228],"domain_scores_gemma":[0.9981703,0.0006271244,0.0002006855,0.0007990765,0.00006488701,0.00013789587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019027601,0.00009207925,0.00022961422,0.000019598338,0.000043735698,0.0000110779365,0.00075935083,0.00010420148,0.0005127078],"category_scores_gemma":[0.0015872045,0.00006725814,0.00004634262,0.0001221679,0.00017686386,0.000059659436,0.0003776135,0.00039652924,0.00004913151],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000113331655,0.00018003581,0.006980612,0.000016799,0.0000491863,0.00004068695,0.00022841059,0.0000011423048,0.29058325,0.0014585676,0.6859479,0.014400091],"study_design_scores_gemma":[0.00067522575,0.00020061768,0.0052205278,0.000021125645,0.00009723246,0.000020601232,0.000081902916,0.0079128025,0.0040035783,0.0004610989,0.9812445,0.000060788472],"about_ca_topic_score_codex":0.00012548793,"about_ca_topic_score_gemma":0.000014005027,"teacher_disagreement_score":0.837947,"about_ca_system_score_codex":0.00004512033,"about_ca_system_score_gemma":0.00017742948,"threshold_uncertainty_score":0.5613791},"labels":[],"label_agreement":null},{"id":"W3113039004","doi":"10.1093/neuonc/noaa222.252","title":"GCT-33. A PHASE 2 TRIAL OF RESPONSE-BASED RADIATION THERAPY FOR PATIENTS WITH LOCALIZED CENTRAL NERVOUS SYSTEM GERM CELL TUMORS: A CHILDREN’S ONCOLOGY GROUP (COG) STUDY. IMPACT OF RAPID CENTRAL RADIOTHERAPY REVIEW ON RADIOTHERAPY QUALITY AND PATTERN OF FAILURE FOR NON-GERMINOMATOUS GERM CELL TUMORS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Contouring; Radiation therapy; Cog; Germ cell tumors; Clinical trial; Central nervous system; Internal medicine; Chemotherapy; Oncology; Nuclear medicine","score_opus":0.02208761623045421,"score_gpt":0.32952917548143207,"score_spread":0.3074415592509779,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113039004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97443074,0.0019751021,0.00041745228,0.0009286614,0.00017532776,0.021088663,0.00093366625,0.00004632317,0.0000040654395],"genre_scores_gemma":[0.9952059,0.0009331795,0.0005218158,0.0014195632,0.00022049664,0.0013068126,0.00027582556,0.0001160194,4.1278207e-7],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99423057,0.00187539,0.0018580661,0.00085283606,0.00048245408,0.00070069777],"domain_scores_gemma":[0.99388397,0.0023412425,0.0024715243,0.0005679034,0.0002808575,0.00045452992],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008306337,0.0006452117,0.003182617,0.00026455693,0.000081312035,0.000013455184,0.00023207333,0.0002633637,0.000038227416],"category_scores_gemma":[0.00018618784,0.00046171082,0.00075941725,0.00033956213,0.00019049548,0.000071925104,0.000017004482,0.0002354791,2.9124269e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6447615,0.039956395,0.15865378,0.0034012983,0.0012886378,0.00015063777,0.0026886933,0.00010434032,0.06651481,0.0000026608063,0.0010105694,0.08146668],"study_design_scores_gemma":[0.48636281,0.3439705,0.1451725,0.00047182298,0.0008637552,0.000028902203,0.00013904976,0.00092741207,0.0207562,5.8928435e-7,0.0009249893,0.00038143017],"about_ca_topic_score_codex":0.00020750331,"about_ca_topic_score_gemma":0.000010851178,"teacher_disagreement_score":0.30401412,"about_ca_system_score_codex":0.000687519,"about_ca_system_score_gemma":0.001130162,"threshold_uncertainty_score":0.99978346},"labels":[],"label_agreement":null},{"id":"W3113041355","doi":"10.1093/neuonc/noaa215.581","title":"NCOG-43. NEUROCOGNITIVE IMPAIRMENT AND FRAILTY IN GERIATRIC PATIENTS WITH HIGH GRADE GLIOMA AND THORACIC MALIGNANCY","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Frailty in Older Adults","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Neurocognitive; Malignancy; Glioma; Internal medicine; Cohort; Geriatric oncology; Incidence (geometry); Cancer; Physical therapy; Oncology; Cognition","score_opus":0.02019640096826152,"score_gpt":0.2865715662885672,"score_spread":0.2663751653203057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113041355","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98775387,0.00017823068,0.000019051506,0.009945633,0.00018367877,0.0014148656,0.000041962383,0.000083454564,0.0003792718],"genre_scores_gemma":[0.9930456,0.000120725075,0.00062602817,0.0058789346,0.00014454428,0.00008624309,0.000035043988,0.00005093053,0.000011946682],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99798644,0.00024117265,0.00037309714,0.0006933875,0.0002763001,0.0004296006],"domain_scores_gemma":[0.9988126,0.00035080817,0.00015742345,0.00018777378,0.000107597465,0.00038378645],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00008177143,0.0002942684,0.0005780515,0.00019827248,0.000060911076,0.000019452651,0.00009056193,0.0001782678,0.00004969089],"category_scores_gemma":[0.00031564658,0.00024715197,0.000034025805,0.0005282828,0.0001815931,0.00013140205,0.00016818057,0.00048649276,0.000020825275],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052461945,0.0019517007,0.8454054,0.00059648324,0.0001088603,0.0068655186,0.004824698,0.0000072374573,0.04395419,0.00005358158,0.0025074247,0.08847874],"study_design_scores_gemma":[0.013788696,0.015470801,0.9590722,0.00009671291,0.00019122884,0.00045589168,0.00020336754,0.00010811619,0.004648665,0.00009224517,0.0055504697,0.00032161718],"about_ca_topic_score_codex":0.000057339927,"about_ca_topic_score_gemma":0.000046539193,"teacher_disagreement_score":0.11366682,"about_ca_system_score_codex":0.000088180495,"about_ca_system_score_gemma":0.00014559919,"threshold_uncertainty_score":0.9999981},"labels":[],"label_agreement":null},{"id":"W3113060413","doi":"10.1093/neuonc/noaa222.732","title":"RARE-21. CANCER SPECTRUM IN GERMLINE SUFU MUTATION CARRIERS: A COLLABORATIVE PROJECT OF THE SIOPE HOST GENOME WORKING GROUP","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital","funders":"","keywords":"Germline; Medicine; Cohort; Cancer; Germline mutation; Medulloblastoma; Internal medicine; Oncology; Gastroenterology; Mutation; Pathology; Biology; Genetics","score_opus":0.026693588313672197,"score_gpt":0.2919195217558639,"score_spread":0.2652259334421917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113060413","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929143,0.0015581781,0.00008389417,0.003736111,0.00033778223,0.000706692,0.00007056619,0.000014244623,0.0005782122],"genre_scores_gemma":[0.99712414,0.00033926405,0.00013087531,0.0018406436,0.00038077802,0.00011381081,0.000027190401,0.000028562501,0.000014731439],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984373,0.00035655015,0.00034769918,0.000441696,0.00013340854,0.0002833714],"domain_scores_gemma":[0.9993272,0.00007852163,0.00023842035,0.00020546977,0.00009685736,0.00005353371],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016460288,0.00018272815,0.00032998613,0.0000517907,0.00008125866,0.000010074529,0.00025761485,0.00017201259,0.000011041206],"category_scores_gemma":[0.00042201375,0.00014943331,0.00007681962,0.0005759781,0.00018869495,0.0000041815256,0.00023117014,0.00022723604,0.0000019937847],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029219294,0.000050037448,0.007554916,0.000027245855,0.00004987925,0.000049069702,0.0030807909,0.0003388485,0.9876248,0.0000231883,0.0002736299,0.0006353863],"study_design_scores_gemma":[0.002585563,0.0026878098,0.013007154,0.00004134895,0.00007435067,0.000023242279,0.0024711236,0.00023791539,0.7977992,0.000028487231,0.18065035,0.00039340372],"about_ca_topic_score_codex":0.00011705082,"about_ca_topic_score_gemma":0.0014277748,"teacher_disagreement_score":0.18982558,"about_ca_system_score_codex":0.00008596695,"about_ca_system_score_gemma":0.0005718654,"threshold_uncertainty_score":0.60937136},"labels":[],"label_agreement":null},{"id":"W3113076192","doi":"10.1093/neuonc/noaa222.114","title":"DIPG-72. LONG-TERM SURVIVAL OF A CLASSIC DIFFUSE INTRINSIC PONTINE GLIOMA TREATED WITH NIMOTUZUMAB","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Nimotuzumab; Medicine; Radiation therapy; Concomitant; Glioma; Oncology; Biopsy; Neuroimaging; Dysarthria; Brain biopsy; Neurooncology; Internal medicine; Surgery; Radiology; Cancer; Cancer research","score_opus":0.02626182079625786,"score_gpt":0.2798786969207702,"score_spread":0.25361687612451234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113076192","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98811334,0.00022533123,0.000016184535,0.00921269,0.00016608625,0.00070815143,0.00002536394,0.00013223507,0.0014006415],"genre_scores_gemma":[0.9980792,0.00008124457,0.000085245636,0.0013011127,0.00022587716,0.00007835301,0.00006850512,0.000060758044,0.000019718038],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980462,0.00016618306,0.00046548058,0.0005505551,0.00031760318,0.00045396318],"domain_scores_gemma":[0.9984309,0.0003529582,0.00025686738,0.00040294434,0.00015942569,0.00039692473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000068531815,0.00032706757,0.0009971923,0.00018406482,0.000056885434,0.000013512936,0.00014883727,0.00018378596,0.00020102628],"category_scores_gemma":[0.00016946439,0.00023490582,0.00016182824,0.0006137839,0.00019966331,0.000058420566,0.00011430485,0.00027932564,0.00006529103],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037033681,0.003705683,0.5705071,0.00012852337,0.00047396356,0.013112623,0.00037509113,0.0000028344023,0.3841702,0.00014672373,0.0012651467,0.02240875],"study_design_scores_gemma":[0.04106961,0.029579373,0.7469881,0.00010916731,0.001540089,0.00120578,0.000103436076,0.000083342,0.16899112,0.000008248704,0.009921785,0.00039993654],"about_ca_topic_score_codex":0.000044859884,"about_ca_topic_score_gemma":0.00010150471,"teacher_disagreement_score":0.21517909,"about_ca_system_score_codex":0.00016265888,"about_ca_system_score_gemma":0.00023253374,"threshold_uncertainty_score":0.9579181},"labels":[],"label_agreement":null},{"id":"W3113085829","doi":"10.1093/neuonc/noaa215.550","title":"NCOG-11. POST-RADIOSURGICAL OUTCOMES OF CYSTIC VESTIBULAR SCHWANNOMAS, A SYSTEMATIC REVIEW AND META-ANALYSIS","year":2020,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Meta-analysis; Radiosurgery; Systematic review; Cochrane Library; Vestibular Schwannomas; Observational study; MEDLINE; Surgery; Radiology; Internal medicine; Vestibular system","score_opus":0.08059136450558868,"score_gpt":0.3652479284145198,"score_spread":0.2846565639089311,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113085829","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000010332689,0.98909986,0.00006498296,0.0038948627,0.00010551507,0.0059633846,0.00012557764,0.000082853396,0.0006526336],"genre_scores_gemma":[0.00010608299,0.9951458,0.0010509243,0.0021231377,0.000049573617,0.00087949645,0.00020573543,0.00009706475,0.0003422158],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9921434,0.0024228445,0.003143388,0.0011357196,0.0006812645,0.0004733872],"domain_scores_gemma":[0.9937671,0.0021224816,0.001966026,0.0013819244,0.00024055543,0.0005219139],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0013984689,0.0009442096,0.028329104,0.0007908688,0.00006971832,0.0000304777,0.0005046287,0.00046811183,0.0004944155],"category_scores_gemma":[0.0029097842,0.0005882976,0.004016272,0.0015165489,0.00019820475,0.00005724522,0.0003801327,0.00070570805,0.00011286953],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012447715,0.0001451263,0.0000048932948,0.824638,0.16298492,0.01000529,0.00003120122,4.1877615e-7,0.0000039755796,0.0004378877,0.0005543776,0.001181454],"study_design_scores_gemma":[0.00023251642,0.00074487505,0.0000028099196,0.0055330778,0.62067646,0.002594899,0.000007478575,0.0000095561845,1.5331052e-7,0.000003885137,0.36995757,0.00023672642],"about_ca_topic_score_codex":0.000015118642,"about_ca_topic_score_gemma":0.0000029437886,"teacher_disagreement_score":0.8191049,"about_ca_system_score_codex":0.00017507789,"about_ca_system_score_gemma":0.0005089957,"threshold_uncertainty_score":0.99965686},"labels":[],"label_agreement":null},{"id":"W3113133978","doi":"10.1093/neuonc/noaa215.946","title":"TAMI-59. METABOLIC REGULATION OF THE EPIGENOME DRIVES LETHAL INFANTILE EPENDYMOMA","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"","keywords":"Biology; Epigenome; Epigenetics; Hypoxia (environmental); Ependymoma; Medulloblastoma; Histone methylation; Histone; Cancer research; Cell biology; Genetics; DNA methylation; Chemistry; Pathology; Medicine; Gene expression; Oxygen","score_opus":0.01314354954261283,"score_gpt":0.2558142341550323,"score_spread":0.24267068461241947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113133978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98835194,0.0027870822,0.00021077096,0.0024788016,0.0019298176,0.00034521168,0.00004697845,0.000019405548,0.003829973],"genre_scores_gemma":[0.99439514,0.0006450519,0.00022320432,0.0024603512,0.0020383468,0.000025077114,0.000033138447,0.00002949071,0.00015019147],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99862176,0.00024279473,0.00032278086,0.0003927034,0.00015655585,0.0002633929],"domain_scores_gemma":[0.9991214,0.000038732083,0.00023561138,0.00040415165,0.000088849025,0.00011124199],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012467068,0.0001704593,0.00034032392,0.000033870812,0.00008170524,0.000008904712,0.0003622089,0.00022540841,0.000086837266],"category_scores_gemma":[0.00023987507,0.00013952446,0.00019603103,0.00018752567,0.00020410017,0.0000065109193,0.00025168888,0.00018128022,0.00001502159],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011370256,0.000042278334,0.00062910747,0.000012281619,0.000033920733,0.00000249295,0.00029399022,0.000103433566,0.9845378,0.0004249373,0.0039359224,0.009870133],"study_design_scores_gemma":[0.0005202369,0.0002085629,0.0154143665,0.0000014860999,0.000044312343,0.00003110591,0.000035104833,0.000029664438,0.38529283,0.00004783534,0.598283,0.00009152396],"about_ca_topic_score_codex":0.000025279956,"about_ca_topic_score_gemma":0.000039574323,"teacher_disagreement_score":0.599245,"about_ca_system_score_codex":0.000009580108,"about_ca_system_score_gemma":0.00025807417,"threshold_uncertainty_score":0.56896424},"labels":[],"label_agreement":null},{"id":"W3113153326","doi":"10.1093/neuonc/noaa222.608","title":"NFB-04. EXAMINING DIFFUSION, ARTERIAL SPIN-LABELED PERFUSION, AND VOLUMETRIC CHANGES IN THE NEUROFIBROMATOSIS TYPE 1 BRAIN USING AN ATLAS-BASED, MULTI-PARAMETRIC APPROACH","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Adrenal and Paraganglionic Tumors","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Brain atlas; Cerebral blood flow; Putamen; White matter; Magnetic resonance imaging; Diffusion MRI; Effective diffusion coefficient; Globus pallidus; Thalamus; Caudate nucleus; Cardiology; Nuclear medicine; Basal ganglia; Neuroscience; Internal medicine; Psychology; Radiology; Central nervous system","score_opus":0.0896814171976663,"score_gpt":0.3218216275368122,"score_spread":0.2321402103391459,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113153326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937806,0.00023335377,0.00031162775,0.004342431,0.00034392244,0.000762729,0.0000062399768,0.000081548234,0.00013756403],"genre_scores_gemma":[0.9856608,0.000023484938,0.0024364311,0.011265602,0.0004771647,0.000028334109,0.00004652028,0.000049880204,0.0000117971795],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9973171,0.0007603547,0.00042114794,0.0006954352,0.000329809,0.00047617432],"domain_scores_gemma":[0.9982523,0.00082198787,0.00020490769,0.0003248394,0.00008621822,0.00030977346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004179797,0.00030818087,0.0006452234,0.0005469486,0.00018768197,0.00004372156,0.00025244287,0.00023407067,0.00006129127],"category_scores_gemma":[0.0015885924,0.00022729395,0.000052067364,0.0026097905,0.00016775374,0.000082336206,0.00014143452,0.00058350683,0.000017112652],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038558303,0.0032712277,0.06382125,0.00040572355,0.000043512875,0.00807639,0.007347467,0.0005573382,0.8795888,0.00004658049,0.0021024747,0.030883417],"study_design_scores_gemma":[0.02969662,0.029290624,0.30648446,0.00014182912,0.00060768105,0.013755086,0.003892277,0.5903571,0.009067013,0.000018624454,0.015361512,0.0013271739],"about_ca_topic_score_codex":0.00010199548,"about_ca_topic_score_gemma":0.00003209573,"teacher_disagreement_score":0.8705218,"about_ca_system_score_codex":0.0000657357,"about_ca_system_score_gemma":0.00020966976,"threshold_uncertainty_score":0.9268778},"labels":[],"label_agreement":null},{"id":"W3113178349","doi":"10.1093/neuonc/noaa215.463","title":"IMMU-33. MULTI-ANTIGEN RECOGNITION CIRCUITS OVERCOME CHALLENGES OF SPECIFICITY, HETEROGENEITY, AND DURABILITY IN T-CELL THERAPY FOR GLIOBLASTOMA","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Chimeric antigen receptor; Antigen; Epidermal growth factor receptor; Cancer research; Glioma; Tumor antigen; Brain tumor; Immunotherapy; Receptor; Priming (agriculture); Biology; Immunology; Medicine; Immune system; Pathology; Internal medicine","score_opus":0.12878803851665777,"score_gpt":0.35772822192127884,"score_spread":0.22894018340462108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113178349","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99087137,0.0014309443,0.000051572126,0.0046642553,0.00014784135,0.0019044622,0.000062102765,0.00004506772,0.0008223971],"genre_scores_gemma":[0.990192,0.008348877,0.00023656596,0.0008580919,0.00019204267,0.00010067662,0.000013634342,0.000048909795,0.000009225365],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99783975,0.0003858685,0.0005045367,0.0006240518,0.00025429198,0.00039150915],"domain_scores_gemma":[0.9983661,0.0007836259,0.00014953529,0.00030303278,0.00018424536,0.00021341603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005367792,0.00021335011,0.00071448524,0.0001740678,0.000039793365,0.000009428262,0.00015806712,0.00026117952,0.00023716832],"category_scores_gemma":[0.00029640537,0.00020738652,0.00015325478,0.00022206405,0.00020322955,0.00006764354,0.00011180154,0.0003992185,0.000014603156],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026231613,0.0008713505,0.015743865,0.00025103448,0.000033555087,0.00006188644,0.00091351813,0.0000015857572,0.8183231,0.0000066402895,0.000048100108,0.16112223],"study_design_scores_gemma":[0.016031343,0.014489723,0.089459695,0.000035299632,0.00002700804,0.00011457157,0.0003988495,0.00059880974,0.85658437,0.00018934069,0.021816852,0.00025411742],"about_ca_topic_score_codex":0.00003247153,"about_ca_topic_score_gemma":0.00022886592,"teacher_disagreement_score":0.16086811,"about_ca_system_score_codex":0.00012693211,"about_ca_system_score_gemma":0.00016251355,"threshold_uncertainty_score":0.8456977},"labels":[],"label_agreement":null},{"id":"W3113204569","doi":"10.1093/neuonc/noaa215.003","title":"BIOM-03. INVASIVE HISTOPATHOLOGY DRIVES POOR OUTCOMES IN SURGICALLY RESECTED BRAIN METASTASES","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Université de Montréal; McGill University","funders":"","keywords":"Medicine; Brain metastasis; Metastasis; Immunohistochemistry; Histopathology; Cancer; Cell; Cancer research; Pathology; Oncology; Internal medicine; Biology","score_opus":0.04225631736646311,"score_gpt":0.3231833320711179,"score_spread":0.28092701470465475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113204569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8276024,0.00039093406,0.000042723153,0.16843699,0.00033104446,0.0008568653,0.000107308275,0.00013657697,0.0020951887],"genre_scores_gemma":[0.9515759,0.0001545343,0.0027672949,0.04488955,0.00014995581,0.000120460085,0.00016468807,0.000052746927,0.00012491054],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.996633,0.001163508,0.0006413367,0.00074921414,0.00025664511,0.0005563145],"domain_scores_gemma":[0.99635893,0.0025638945,0.00020337813,0.0003562247,0.00010331872,0.00041424585],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036266184,0.00034029284,0.0012453025,0.0002742061,0.00006759425,0.000012658667,0.00019629278,0.00023210638,0.00063893734],"category_scores_gemma":[0.0037266626,0.00026718227,0.0002481341,0.0005186504,0.00028466812,0.00006981776,0.00018492858,0.00050311355,0.00024259093],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034328415,0.0030614017,0.15464096,0.00017533246,0.00040787342,0.06824342,0.0021127095,0.00003139876,0.71075445,0.00232047,0.039267994,0.015551159],"study_design_scores_gemma":[0.02377516,0.019273737,0.16356787,0.000044944794,0.0006779658,0.0022473652,0.0007964371,0.00012435293,0.024488885,0.00033444556,0.76403874,0.00063012535],"about_ca_topic_score_codex":0.00013317974,"about_ca_topic_score_gemma":0.0005063048,"teacher_disagreement_score":0.7247707,"about_ca_system_score_codex":0.00022594149,"about_ca_system_score_gemma":0.00053765415,"threshold_uncertainty_score":0.99997807},"labels":[],"label_agreement":null},{"id":"W3113212222","doi":"10.1093/neuonc/noaa222.748","title":"RARE-38. CLINICAL PRESENTATION OF MGA-NUTM1 FUSION TRANSCRIPT SARCOMA","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; CD99; Solitary fibrous tumor; Sarcoma; Magnetic resonance imaging; Ewing's sarcoma; Desmin; Ifosfamide; Cerebellar hemisphere; Etoposide; Radiology; Pathology; CD34; Chemotherapy; Surgery; Biology; Immunohistochemistry; Vimentin","score_opus":0.08564949981405803,"score_gpt":0.3791303695257698,"score_spread":0.2934808697117117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113212222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9558135,0.00061458466,0.00007076885,0.03770356,0.0005329637,0.0006671659,0.0000143769885,0.000066406676,0.0045166602],"genre_scores_gemma":[0.9905557,0.00064067706,0.0006919439,0.007612556,0.00037043513,0.000045070818,0.00004116209,0.000024121675,0.000018322367],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982806,0.00029903292,0.0006073802,0.0003737243,0.00023252367,0.00020677736],"domain_scores_gemma":[0.99859273,0.000676167,0.00016325421,0.00022946455,0.0000826155,0.00025575134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014135549,0.00014575946,0.00058941334,0.000057321187,0.00003717505,0.0000046840505,0.00009936854,0.000183715,0.0004661081],"category_scores_gemma":[0.00033467493,0.000120630364,0.00024300974,0.00017615338,0.00011403956,0.0000469909,0.000044536486,0.00026569265,0.000083155544],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021830024,0.003739405,0.44680303,0.00012905504,0.00015442973,0.001532868,0.0013780383,0.000005869513,0.34637943,0.00035313756,0.034715574,0.16262616],"study_design_scores_gemma":[0.017704537,0.012845701,0.36984766,0.000053388296,0.0006741808,0.00025219025,0.00040906973,0.00068907335,0.09752332,0.00012731884,0.4996684,0.00020516402],"about_ca_topic_score_codex":0.000021539503,"about_ca_topic_score_gemma":0.000011396891,"teacher_disagreement_score":0.46495283,"about_ca_system_score_codex":0.0000485318,"about_ca_system_score_gemma":0.00016575941,"threshold_uncertainty_score":0.51035565},"labels":[],"label_agreement":null},{"id":"W3113231955","doi":"10.1093/neuonc/noaa222.356","title":"IMG-21. PROSPECTIVE PREOPERATIVE DETERMINATION OF ISOCITRATE DEHYDROGENASE MUTATION IN GLIOMAS USING SPECTRAL EDITING MAGNETIC RESONANCE SPECTROSCOPY","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Advanced MRI Techniques and Applications","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Ottawa; Ottawa Hospital","funders":"","keywords":"Isocitrate dehydrogenase; Glioma; Magnetic resonance imaging; IDH1; Proton magnetic resonance; In vivo magnetic resonance spectroscopy; Medicine; Brain tumor; Magnetic resonance spectroscopic imaging; Nuclear medicine; Radiology; Oncology; Pathology; Mutant; Nuclear magnetic resonance; Cancer research; Biology; Genetics; Enzyme; Gene","score_opus":0.024658556178598107,"score_gpt":0.3421544068164735,"score_spread":0.31749585063787544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113231955","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.960375,0.00024321127,0.03434454,0.0021995732,0.000051705938,0.0014218794,0.000017159693,0.000094183655,0.0012527591],"genre_scores_gemma":[0.9002481,0.000048829817,0.09879807,0.0005323184,0.00021317306,0.00011686344,0.000011042548,0.000026284177,0.000005319118],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987517,0.000083856525,0.00040132974,0.00038183143,0.00014027146,0.00024099843],"domain_scores_gemma":[0.9993334,0.00010935243,0.00020752494,0.00013119045,0.00012830348,0.00009027172],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009173635,0.0001490704,0.00034231707,0.00010050917,0.000059060825,0.000006638931,0.00007402908,0.000111466965,0.000032605018],"category_scores_gemma":[0.00021397768,0.00015489785,0.000056521632,0.0005228584,0.00012729992,0.00012541769,0.00003467234,0.00031417795,0.000004165888],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002451018,0.00015217054,0.003024701,0.000030721905,0.000001812792,0.00020405557,0.0017258867,0.0001990345,0.9890246,0.0006788983,0.000024202838,0.004688845],"study_design_scores_gemma":[0.0015360479,0.0029177153,0.0037857543,0.00004636042,0.000048030044,0.00017723307,0.00041355813,0.05404951,0.93517345,0.0011109794,0.00061360485,0.00012774898],"about_ca_topic_score_codex":0.000021050935,"about_ca_topic_score_gemma":0.000035313522,"teacher_disagreement_score":0.06445353,"about_ca_system_score_codex":0.0003087358,"about_ca_system_score_gemma":0.00017333664,"threshold_uncertainty_score":0.6316551},"labels":[],"label_agreement":null},{"id":"W3113238513","doi":"10.1093/neuonc/noaa222.035","title":"COVD-04. CHARACTERISTICS OF SARS-COV-2 IN 64 CHILDREN WITH CNS TUMORS: A REPORT FROM THE SIOP/ST. JUDE CHILDREN’S RESEARCH HOSPITAL (SJCRH) GLOBAL COVID-19 CHILDHOOD CANCER REGISTRY","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Asymptomatic; Cancer; Radiation therapy; Cancer registry; Internal medicine; Pediatrics; Chemotherapy; Pediatric cancer; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Coronavirus disease 2019 (COVID-19); Disease","score_opus":0.09024475866289997,"score_gpt":0.42864073413368947,"score_spread":0.3383959754707895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113238513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8554076,0.0003610575,0.000024415845,0.14009875,0.00024579334,0.0020089983,0.0015030509,0.000104423365,0.00024590566],"genre_scores_gemma":[0.9473761,0.00036762902,0.00009841984,0.05009377,0.0014123332,0.000115019866,0.00046353426,0.00006779077,0.0000054492766],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99497265,0.0006795197,0.0011266563,0.001154724,0.0010436062,0.001022869],"domain_scores_gemma":[0.9959935,0.0010253399,0.0007296842,0.0011097516,0.000345875,0.0007958618],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008467546,0.0004352247,0.0012685267,0.00013523857,0.00022866236,0.00004188332,0.0006667519,0.00043556222,0.00010637611],"category_scores_gemma":[0.00813711,0.0003263451,0.0001640489,0.0010952449,0.0007213359,0.000103966966,0.00038237317,0.0019923209,0.000024499683],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017082983,0.0007577293,0.94775283,0.000108528715,0.00016788494,0.0033471398,0.0032839496,0.0000062489253,0.00865079,0.000039986,0.03131966,0.002856929],"study_design_scores_gemma":[0.0045967316,0.004035169,0.96789134,0.00018700106,0.00014490799,0.0014386431,0.00028430833,0.000019487728,0.0014718424,0.00008288032,0.019564157,0.0002835353],"about_ca_topic_score_codex":0.03447847,"about_ca_topic_score_gemma":0.006387364,"teacher_disagreement_score":0.091968454,"about_ca_system_score_codex":0.0016358694,"about_ca_system_score_gemma":0.011966347,"threshold_uncertainty_score":0.9999189},"labels":[],"label_agreement":null},{"id":"W3113245969","doi":"10.1093/neuonc/noaa222.760","title":"RARE-50. TREATMENT RESPONSE OF CNS HIGH-GRADE NEUROEPITHELIAL TUMORS WITH MN1 ALTERATION","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medicine; Radiation therapy; Ependymoma; Radiological weapon; Chemotherapy; Radiology; Oncology; Surgery","score_opus":0.02757787070712044,"score_gpt":0.2874370897305876,"score_spread":0.2598592190234672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113245969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96491385,0.00007440221,0.000026982714,0.033761736,0.0001709756,0.00076015317,0.000044331664,0.00007222189,0.00017537661],"genre_scores_gemma":[0.9953857,0.00007611596,0.0005145322,0.0035676735,0.00022267751,0.00013324227,0.00004604396,0.00003887126,0.0000151109725],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99837524,0.00035431652,0.0003535815,0.00042890108,0.00022540099,0.0002625355],"domain_scores_gemma":[0.99867606,0.0005130731,0.0001828422,0.0002875335,0.00007192778,0.00026856686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007141236,0.00023921554,0.0006040642,0.00011244901,0.000059981176,0.00001012542,0.000073831194,0.00008729534,0.00010303433],"category_scores_gemma":[0.00016306687,0.00016715072,0.00011287342,0.0002190941,0.00010193041,0.000049954153,0.000031085263,0.00013348013,0.000048229533],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012417985,0.001998175,0.018283932,0.000029193878,0.00013723354,0.0040613585,0.0010654795,0.00019574394,0.95515954,0.00019153712,0.0014692927,0.0049905395],"study_design_scores_gemma":[0.018303053,0.065812916,0.07537118,0.0000407888,0.0006064553,0.0005878828,0.00013530163,0.00034329918,0.76247966,0.000018223223,0.07609024,0.00021097837],"about_ca_topic_score_codex":0.00007904996,"about_ca_topic_score_gemma":0.000024477504,"teacher_disagreement_score":0.19267984,"about_ca_system_score_codex":0.00019102887,"about_ca_system_score_gemma":0.00034483217,"threshold_uncertainty_score":0.68162084},"labels":[],"label_agreement":null},{"id":"W3113287358","doi":"10.1093/neuonc/noaa215.693","title":"PATH-11. PROGNOSTIC SIGNIFICANCE OF EPIGENETIC SUBTYPES AND CpGs ASSOCIATED WITH PROGRESSION TO G-CIMP LOW IN THE EORTC RANDOMIZED PHASE III INTERGROUP CATNON","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Epigenetics; IDH1; Glioma; Oncology; Medicine; Internal medicine; Methylation; Bioinformatics; Cancer research; Biology; Genetics","score_opus":0.016621812179875826,"score_gpt":0.30101493431987436,"score_spread":0.2843931221399985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113287358","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895519,0.000317729,0.000047733924,0.0064559663,0.00005946314,0.0034201024,0.0000071556774,0.000024207051,0.00011573216],"genre_scores_gemma":[0.9973528,0.00004988693,0.00012571002,0.0015609615,0.00003439767,0.0008322211,0.000022214253,0.000019357043,0.0000024922458],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9982919,0.00049192074,0.00040258022,0.0003550047,0.00021458388,0.00024399179],"domain_scores_gemma":[0.99796975,0.0014095049,0.00021876181,0.00016599783,0.00008125886,0.00015474715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034854902,0.00018386588,0.00081881677,0.00007759352,0.000035473702,0.000008713033,0.00009804843,0.00009436127,0.000026191088],"category_scores_gemma":[0.0009328543,0.000104015584,0.00006687145,0.0003060838,0.00016480693,0.000024467654,0.000043985976,0.00018163222,0.0000032013427],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11454481,0.00885201,0.52882427,0.00026110606,0.0003461136,0.003711868,0.019755952,0.000035578123,0.29952675,0.000075480675,0.0008087473,0.02325731],"study_design_scores_gemma":[0.7056325,0.036076073,0.14143719,0.0010795407,0.0015879712,0.00014263278,0.00094529823,0.0010187188,0.10967835,0.000064524436,0.0018899568,0.0004472142],"about_ca_topic_score_codex":0.0001670757,"about_ca_topic_score_gemma":0.0010334295,"teacher_disagreement_score":0.5910877,"about_ca_system_score_codex":0.00008634023,"about_ca_system_score_gemma":0.00018628493,"threshold_uncertainty_score":0.42416322},"labels":[],"label_agreement":null},{"id":"W3113354958","doi":"10.1093/neuonc/noaa222.104","title":"DIPG-59. UPREGULATION OF PRENATAL PONTINE ID1 SIGNALING IN DIPG","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Gene knockdown; Cancer research; Chromatin immunoprecipitation; Biology; Downregulation and upregulation; Medicine; Gene expression; Gene; Genetics; Promoter","score_opus":0.0262905072779288,"score_gpt":0.29283221384761327,"score_spread":0.26654170656968446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113354958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890884,0.00022570032,0.000025238822,0.008819264,0.0001299921,0.0003918983,0.000008494133,0.000034501685,0.0012765082],"genre_scores_gemma":[0.99827445,0.000024215902,0.000321314,0.0011369447,0.00014971383,0.00003513909,0.000036308837,0.000017414193,0.000004503027],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99898344,0.00008247995,0.000338746,0.000260091,0.00015317976,0.00018206246],"domain_scores_gemma":[0.99932355,0.00024591255,0.00012553643,0.00013912849,0.000049602502,0.00011626635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007908573,0.00011722532,0.0003958617,0.00009083367,0.000018156312,0.000003884942,0.000060199713,0.00010584522,0.00014395807],"category_scores_gemma":[0.00023668753,0.000101768324,0.000078139135,0.000229708,0.000043584187,0.000046965433,0.00005430232,0.00014568644,0.000019583427],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046367833,0.00073301553,0.10896854,0.00008945133,0.000047723166,0.00068151654,0.0007615791,0.00031980424,0.8662269,0.00027071964,0.0006324479,0.020804595],"study_design_scores_gemma":[0.010128527,0.004221146,0.12908068,0.00011506996,0.0002301717,0.000099741024,0.00014401684,0.0027254322,0.83494496,0.00010607007,0.018034516,0.00016968336],"about_ca_topic_score_codex":0.000030512589,"about_ca_topic_score_gemma":0.000021041667,"teacher_disagreement_score":0.03128199,"about_ca_system_score_codex":0.00007028508,"about_ca_system_score_gemma":0.00008036536,"threshold_uncertainty_score":0.4149992},"labels":[],"label_agreement":null},{"id":"W3115366055","doi":"10.1093/neuonc/noaa300","title":"Transcription factor networks of oligodendrogliomas treated with adjuvant radiotherapy or observation inform prognosis","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston General Hospital; Queen's University; Toronto Western Hospital; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Cohort; Oncology; Radiation therapy; Internal medicine; Adjuvant; Oligodendroglioma; Adjuvant therapy; Gene signature; Overall survival; Transcription factor; Adjuvant radiotherapy; Glioma; Cancer; Cancer research; Gene expression; Gene; Biology; Astrocytoma; Genetics","score_opus":0.05016786983759589,"score_gpt":0.2905154291076138,"score_spread":0.2403475592700179,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3115366055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923056,0.00034679272,0.00038404716,0.005354935,0.00009315349,0.0011644594,0.000019275933,0.00011428665,0.0002174767],"genre_scores_gemma":[0.99544185,0.0005573216,0.00088686147,0.0026714024,0.00014198292,0.00017784748,0.00007677442,0.000038293456,0.000007683526],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99874973,0.000065601234,0.00040409563,0.00029979166,0.00022220459,0.00025858954],"domain_scores_gemma":[0.99914205,0.00014270877,0.00020498807,0.000166433,0.00013571912,0.0002080969],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004076593,0.0002222182,0.0006145558,0.00010357571,0.000041950276,0.000010336906,0.0000752544,0.00018389703,0.00017815449],"category_scores_gemma":[0.000040177838,0.0001436877,0.00011124721,0.0005236637,0.00007424308,0.00011528949,0.000009240041,0.00016456665,0.000004771727],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006560052,0.0014174895,0.23313852,0.00013761657,0.00046887656,0.000716613,0.0016433535,0.00039652403,0.635236,0.00007288013,0.0009863075,0.119225726],"study_design_scores_gemma":[0.030493319,0.052164957,0.36137187,0.00017532514,0.0011062755,0.00043640006,0.00027236866,0.020255495,0.43399885,0.0000035304797,0.099250175,0.00047144698],"about_ca_topic_score_codex":0.000045238234,"about_ca_topic_score_gemma":0.000052410654,"teacher_disagreement_score":0.2012372,"about_ca_system_score_codex":0.00014710613,"about_ca_system_score_gemma":0.00015716918,"threshold_uncertainty_score":0.5859415},"labels":[],"label_agreement":null},{"id":"W3115713778","doi":"10.1093/neuonc/noaa306","title":"Modeling human brain tumors in flies, worms, and zebrafish: From proof of principle to novel therapeutic targets","year":2020,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Zebrafish; Biology; Danio; Model organism; Caenorhabditis elegans; Computational biology; Drosophila melanogaster; Genome; RNA interference; Neuroscience; Genetics; RNA; Gene","score_opus":0.03541518766050802,"score_gpt":0.3599964333821772,"score_spread":0.3245812457216692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3115713778","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0044150646,0.9875484,0.006437984,0.00017123317,0.00022837348,0.0009675331,0.00010208294,0.000015716245,0.0001135982],"genre_scores_gemma":[0.035452172,0.9589878,0.002569467,0.0011634137,0.0006469195,0.0002926111,0.0006309541,0.00021269314,0.000043986773],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99814135,0.000104287654,0.0006494624,0.0006828668,0.00010704374,0.000315009],"domain_scores_gemma":[0.99926096,0.00007279505,0.00013700855,0.0003544651,0.000032952135,0.00014182179],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015870936,0.00036934696,0.0012121168,0.00012523237,0.00003103917,0.000011724925,0.00031931465,0.00041532685,0.0000109874345],"category_scores_gemma":[0.00014519556,0.00035250405,0.00015238897,0.00016476608,0.00004369915,0.000002408918,0.00036307183,0.00036487795,0.0000024258984],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057970203,0.00023016556,0.00001977365,0.0024057874,0.00018294266,0.000054950553,0.0003676112,0.0026856249,0.45094636,0.000071791605,0.00026873048,0.5427083],"study_design_scores_gemma":[0.00051570946,0.0005989404,0.0000069265957,0.00041005033,0.00009079033,0.000031125965,0.000020733192,0.00078852486,0.004352255,0.000020221267,0.99283683,0.00032789164],"about_ca_topic_score_codex":0.00003620934,"about_ca_topic_score_gemma":0.00019360971,"teacher_disagreement_score":0.9925681,"about_ca_system_score_codex":0.00004774167,"about_ca_system_score_gemma":0.00026702468,"threshold_uncertainty_score":0.9998927},"labels":[],"label_agreement":null},{"id":"W3116476506","doi":"10.1093/neuonc/noaa285","title":"The incidence of brain metastases among patients with metastatic breast cancer: a systematic review and meta-analysis","year":2020,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":261,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Sunnybrook Health Science Centre; University of Toronto; McMaster University Medical Centre; Canadian Centre for Applied Research in Cancer Control; Health Sciences Centre; Queen's University","funders":"","keywords":"Incidence (geometry); Medicine; Breast cancer; Oncology; Meta-analysis; Metastatic breast cancer; Internal medicine; Cancer","score_opus":0.05164096575749747,"score_gpt":0.35873308155939376,"score_spread":0.30709211580189627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3116476506","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000006379096,0.9873217,0.000024068371,0.0033307958,0.000036252426,0.007380651,0.0018526675,0.000024788145,0.000022724038],"genre_scores_gemma":[0.00009327959,0.99415886,0.00035086146,0.0024722987,0.000015949712,0.0025960184,0.0001995346,0.00007085217,0.000042327476],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9926096,0.0036116892,0.0019045144,0.0008210174,0.00066231535,0.0003908259],"domain_scores_gemma":[0.99097735,0.004674501,0.0026323337,0.0010469329,0.0003388419,0.00033003473],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0012333762,0.0007945048,0.016419066,0.00024814773,0.0001323055,0.000031891876,0.00035746663,0.00011684473,0.00022002507],"category_scores_gemma":[0.00094267604,0.0003439962,0.0024769767,0.0015565461,0.00040382188,0.00007489248,0.0001914861,0.0005120312,0.000010288468],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042347758,0.0002880134,0.000047924827,0.6200994,0.35203484,0.00038309794,0.000032822227,8.93657e-7,9.384969e-8,0.00004726025,0.0006742605,0.026348997],"study_design_scores_gemma":[0.00052947877,0.0008938361,0.000026160575,0.011423321,0.8712938,0.00037877684,0.000016741293,0.0000030409012,2.3742895e-7,0.0000027018668,0.11522531,0.0002066369],"about_ca_topic_score_codex":0.00018128374,"about_ca_topic_score_gemma":0.0002589321,"teacher_disagreement_score":0.60867614,"about_ca_system_score_codex":0.0002106619,"about_ca_system_score_gemma":0.0007595121,"threshold_uncertainty_score":0.9999012},"labels":[],"label_agreement":null},{"id":"W3118298499","doi":"10.1093/neuonc/noab002","title":"Invasive growth associated with cold-inducible RNA-binding protein expression drives recurrence of surgically resected brain metastases","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Montreal Neurological Institute and Hospital; McGill Genome Centre; Centre Hospitalier de l’Université de Montréal; McGill University; McGill University Health Centre","funders":"Terry Fox Foundation","keywords":"RNA-binding protein; RNA; Protein expression; Cancer research; Medicine; Pathology; Biology; Gene; Biochemistry","score_opus":0.032851372766128005,"score_gpt":0.29790296445135717,"score_spread":0.2650515916852292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3118298499","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941011,0.00019681519,0.0000067581946,0.0033704797,0.000106861764,0.0008365208,0.000060630224,0.000057953308,0.0012628541],"genre_scores_gemma":[0.9983072,0.00008505853,0.00080179854,0.00029991963,0.000036379355,0.00023147064,0.00014055522,0.0000304826,0.00006711565],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99744236,0.0008167347,0.0004165868,0.00055550784,0.0003973968,0.0003714357],"domain_scores_gemma":[0.99620026,0.0022968908,0.00038281857,0.00033301796,0.0005854589,0.00020152329],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003062207,0.00022721445,0.00074278057,0.00018644675,0.000105672516,0.000017277453,0.00011210087,0.00018823952,0.00017813442],"category_scores_gemma":[0.0051480546,0.00017118879,0.00011377475,0.0007574606,0.00013926608,0.00009285532,0.00012051492,0.00031913418,0.000008879017],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003367972,0.0018354813,0.013978286,0.0000613533,0.00018716922,0.004474566,0.00020692122,0.0000027099209,0.9758692,0.00029497273,0.002178699,0.000573851],"study_design_scores_gemma":[0.0052375826,0.0034703985,0.005185657,0.0007080005,0.00018536951,0.00012027677,0.00020405914,0.000004959556,0.98307246,0.000042041946,0.0016299876,0.0001392165],"about_ca_topic_score_codex":0.000027874043,"about_ca_topic_score_gemma":0.00015973668,"teacher_disagreement_score":0.0087926285,"about_ca_system_score_codex":0.00019615165,"about_ca_system_score_gemma":0.0009424573,"threshold_uncertainty_score":0.69808763},"labels":[],"label_agreement":null},{"id":"W3121286955","doi":"10.1093/neuonc/noab010","title":"De-coding Group 3 medulloblastoma biology with noncoding RNA","year":2021,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medulloblastoma; Long non-coding RNA; Non-coding RNA; Computational biology; Biology; Coding (social sciences); RNA; Genetics; Mathematics; Gene; Statistics","score_opus":0.017175688637500994,"score_gpt":0.2881248394257934,"score_spread":0.2709491507882924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3121286955","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022685906,0.007992718,0.20001021,0.69427,0.009465868,0.0043531475,0.00055755343,0.0005265674,0.060138006],"genre_scores_gemma":[0.03655054,0.0030536104,0.0068382295,0.93139285,0.014881412,0.0007721977,0.0040103025,0.00077063893,0.0017302152],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9947086,0.0011063425,0.00053248805,0.0017076926,0.0004138796,0.0015309815],"domain_scores_gemma":[0.99772143,0.00024140615,0.00037318032,0.0011195885,0.0002967385,0.00024764828],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00045438905,0.0007064211,0.0008815094,0.00032123944,0.00021493727,0.000093340146,0.00090292114,0.0034367014,0.00028696225],"category_scores_gemma":[0.00040215935,0.00070150784,0.00033722483,0.0003693866,0.0003713689,0.0000061746896,0.00075366994,0.0034723843,0.000049951203],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018455437,0.000048686506,0.000007977243,0.000077662524,0.00024282205,0.0031284583,0.000029744519,0.000030214022,0.726858,0.00006628191,0.26211667,0.007208915],"study_design_scores_gemma":[0.0010481974,0.0025206835,0.0000018961318,0.000056309436,0.00010178038,0.0015508668,0.000028908504,0.0000637276,0.26034108,0.000045142697,0.73373085,0.0005105867],"about_ca_topic_score_codex":0.00006508382,"about_ca_topic_score_gemma":0.00013446684,"teacher_disagreement_score":0.47161415,"about_ca_system_score_codex":0.0005071966,"about_ca_system_score_gemma":0.001825245,"threshold_uncertainty_score":0.9995436},"labels":[],"label_agreement":null},{"id":"W3121678103","doi":"10.1093/neuonc/noaa305","title":"Role of surgery for glioblastoma: response to letters from Dr. Gerritsen and his colleagues and Dr. Vargas Lopez","year":2020,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Glioblastoma; Medicine; Psychology; Psychoanalysis; Cancer research","score_opus":0.025224053839641797,"score_gpt":0.27770968523758177,"score_spread":0.25248563139794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3121678103","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.438306,0.0007057902,0.0000032408682,0.5592279,0.00030222684,0.00091258954,0.00046598195,0.000036864945,0.000039402526],"genre_scores_gemma":[0.07113674,0.0004323896,0.0005841713,0.92421895,0.002349871,0.0006318443,0.00035265228,0.00018676737,0.0001066003],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99735916,0.0004168839,0.00059540727,0.00089424086,0.00027020506,0.0004641309],"domain_scores_gemma":[0.9914516,0.007460765,0.00030526082,0.00038898175,0.00010874975,0.00028459934],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020884087,0.00044465734,0.0016658995,0.00043947442,0.000082917264,0.000025542422,0.000114670234,0.00056979666,0.000055778706],"category_scores_gemma":[0.00090875564,0.00040127122,0.0002293303,0.00020636662,0.00019475601,0.000038506812,0.00016627161,0.00055197853,0.000017168357],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038904774,0.00014105743,0.0025590383,0.00010676447,0.00026293012,0.0043457127,0.00027476554,3.9631297e-7,0.23286897,0.0000013841764,0.7534089,0.0021395977],"study_design_scores_gemma":[0.0030322054,0.0029136264,0.005292322,0.00013106874,0.0007151633,0.0001893613,0.00005163639,0.000015086803,0.018091401,0.00004147881,0.9692562,0.0002704038],"about_ca_topic_score_codex":0.00014453544,"about_ca_topic_score_gemma":0.000049577597,"teacher_disagreement_score":0.36716926,"about_ca_system_score_codex":0.0001865605,"about_ca_system_score_gemma":0.000309792,"threshold_uncertainty_score":0.9998439},"labels":[],"label_agreement":null},{"id":"W3127159106","doi":"10.1093/neuonc/noab034","title":"Ultra high-risk PFA ependymoma is characterized by loss of chromosome 6q","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; SickKids Foundation; Hospital for Sick Children","funders":"National Institute of Neurological Disorders and Stroke; National Cancer Institute; National Institutes of Health","keywords":"Loss function; Internal medicine; Ependymoma; Cytogenetics; Biology; Weight loss; Oncology; Risk stratification; Chromosome; Methylation; Gastroenterology; Medicine; Genetics; Pathology; Gene; Phenotype","score_opus":0.013728333183979573,"score_gpt":0.27480754030278215,"score_spread":0.26107920711880256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127159106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98925686,0.00065950234,0.000007013114,0.007551761,0.0005466857,0.00040375933,0.00030475555,0.00004762443,0.0012220552],"genre_scores_gemma":[0.9945873,0.0012272602,0.0001664243,0.003336079,0.00021656882,0.000122033925,0.00020027178,0.000038463284,0.000105616964],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982858,0.00019713902,0.0004393449,0.00048230315,0.00024657694,0.0003488779],"domain_scores_gemma":[0.9984602,0.0004267722,0.00026560054,0.00047958374,0.00015865856,0.00020921545],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00009224994,0.00022227569,0.00081346126,0.00008265003,0.00005843996,0.0000100700945,0.00010332222,0.00022344143,0.0018521978],"category_scores_gemma":[0.00014501649,0.0001923374,0.00019472951,0.00024211936,0.00011804217,0.00005251332,0.00005614228,0.00026530676,0.00018490282],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020674111,0.0020678795,0.02529386,0.00006161965,0.0002273375,0.0060387426,0.00017716353,2.3371082e-7,0.9383633,0.00008594064,0.0076450002,0.019832171],"study_design_scores_gemma":[0.006802598,0.0017124003,0.021201218,0.00002711537,0.000345919,0.0011986461,0.000035971512,0.000004301704,0.7716885,0.00004908298,0.19681194,0.0001222916],"about_ca_topic_score_codex":0.00008144866,"about_ca_topic_score_gemma":0.000012582695,"teacher_disagreement_score":0.18916695,"about_ca_system_score_codex":0.0001246743,"about_ca_system_score_gemma":0.00024296173,"threshold_uncertainty_score":0.9990603},"labels":[],"label_agreement":null},{"id":"W3127414577","doi":"10.1093/neuonc/noab017","title":"Longitudinal change in fine motor skills after brain radiotherapy and in vivo imaging biomarkers associated with decline","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Advanced Neuroimaging Techniques and Applications","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; National Institute of Neurological Disorders and Stroke; University of California, San Diego; National Cancer Institute; National Institutes of Health; Centre Technologique des Résidus Industriels; American Cancer Society; U.S. Department of Veterans Affairs; Moores Cancer Center, UC San Diego Health; Georgia Clinical and Translational Science Alliance","keywords":"Fractional anisotropy; Diffusion MRI; White matter; Medicine; Nuclear medicine; Motor cortex; Precentral gyrus; Magnetic resonance imaging; Internal medicine; Radiology","score_opus":0.03285513162950509,"score_gpt":0.3542082188403241,"score_spread":0.321353087210819,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3127414577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9547143,0.0006281168,0.00063915784,0.043103322,0.00004550822,0.0005938971,0.000021310861,0.00009089307,0.00016349788],"genre_scores_gemma":[0.9774553,0.00043227946,0.007403956,0.014159629,0.000080142956,0.0003511695,0.000017528748,0.000044502875,0.00005549321],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99883014,0.00010840979,0.00024304366,0.0004342191,0.00010121029,0.00028295282],"domain_scores_gemma":[0.99913615,0.00041693947,0.000082505045,0.00022550893,0.00005335452,0.00008556458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015964815,0.00015362767,0.00035439656,0.000184538,0.000025848713,0.000009821026,0.00005722018,0.00007487006,0.00008026465],"category_scores_gemma":[0.00023404579,0.00014186383,0.000032110416,0.00046443325,0.000120378514,0.00007414561,0.000067058325,0.00028370583,7.661225e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044129646,0.00052864774,0.72969854,0.000016031601,0.000015710017,0.0032330675,0.00016000832,0.000001425049,0.2459522,0.000018338487,0.0004971152,0.019437637],"study_design_scores_gemma":[0.0052696653,0.00060869934,0.9390067,0.00016837394,0.00003248292,0.0009075764,0.000022574892,0.0015823018,0.009026295,0.00015877638,0.042995088,0.0002214666],"about_ca_topic_score_codex":0.00004188868,"about_ca_topic_score_gemma":0.0007949565,"teacher_disagreement_score":0.23692591,"about_ca_system_score_codex":0.00020112064,"about_ca_system_score_gemma":0.000090786794,"threshold_uncertainty_score":0.5785039},"labels":[],"label_agreement":null},{"id":"W3128294753","doi":"10.1093/neuonc/noab004","title":"In the beginning: PDGFA and the genesis of GBM","year":2021,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Alberta Innovates; Alberta Cancer Foundation; Genome Canada","keywords":"Computer science; Psychology","score_opus":0.02962222994486428,"score_gpt":0.2972527079075465,"score_spread":0.2676304779626822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3128294753","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12655208,0.0032675096,5.033762e-7,0.8664572,0.0004037984,0.00056910154,0.000009675729,0.0000067180827,0.0027333992],"genre_scores_gemma":[0.06505885,0.0014277983,0.000047917056,0.9316856,0.0013385209,0.00027956764,0.000051631396,0.00003355347,0.00007655742],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99825084,0.0006219813,0.0003154801,0.00032749868,0.00024266554,0.00024156008],"domain_scores_gemma":[0.99669415,0.0025362712,0.0001859124,0.00049878476,0.000058397232,0.000026486106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027470902,0.00020579336,0.0007621162,0.000120916,0.00004489897,0.000012437185,0.00016859602,0.00042992964,0.00010625952],"category_scores_gemma":[0.00021996904,0.00010273406,0.00016157886,0.00019672942,0.00034238346,0.000013958438,0.000091848495,0.0009057129,0.000008141468],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008780043,0.0002188018,0.0037562067,0.00009735636,0.00013689985,0.0108814845,0.0012545214,7.74851e-7,0.0019527384,0.00014167228,0.9784805,0.0029912046],"study_design_scores_gemma":[0.0040178234,0.00045471842,0.003484151,0.000043566957,0.0005263693,0.0010373897,0.0002459377,0.0000070852534,0.0007251062,0.000087320164,0.98929596,0.00007456436],"about_ca_topic_score_codex":0.00022649934,"about_ca_topic_score_gemma":0.000029726873,"teacher_disagreement_score":0.065228395,"about_ca_system_score_codex":0.000060510105,"about_ca_system_score_gemma":0.0001837793,"threshold_uncertainty_score":0.41893733},"labels":[],"label_agreement":null},{"id":"W3134763185","doi":"10.1093/neuonc/noab057","title":"MR-guided focused ultrasound liquid biopsy enriches circulating biomarkers in patients with brain tumors","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Ultrasound and Hyperthermia Applications","field":"Engineering","cited_by":163,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Sunnybrook Hospital; University of Toronto","funders":"Focused Ultrasound Foundation","keywords":"Medicine; Liquid biopsy; Biomarker; Temozolomide; Biopsy; Brain biopsy; Pathology; Brain tumor; Oncology; Cancer; Glioma; Internal medicine; Cancer research; Biology","score_opus":0.012342447963754749,"score_gpt":0.233070411040181,"score_spread":0.22072796307642625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134763185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942451,0.00006325542,0.00035770377,0.00047663102,0.00016562674,0.00027253176,0.000016463988,0.00022162378,0.0041810656],"genre_scores_gemma":[0.9976773,0.000012240977,0.0015244215,0.00049696665,0.00006331115,0.00008073324,0.00006930155,0.00006598405,0.000009722022],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99863243,0.00010660264,0.0003569046,0.0003588994,0.00015022389,0.00039491552],"domain_scores_gemma":[0.99860865,0.00082758366,0.000064402404,0.00031917501,0.000072656025,0.00010751064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011081702,0.00021484379,0.00031094294,0.00013360739,0.00008261788,0.000031229818,0.0001588566,0.00015029432,0.00009318374],"category_scores_gemma":[0.00025794966,0.00021275069,0.000055901994,0.00062810595,0.00007532841,0.00009950463,0.000027007012,0.0002617821,0.000035366702],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049961287,0.00021620897,0.063487716,0.000037053836,0.000089492176,0.00010982527,0.0006532649,0.0017278149,0.93003,0.0001639375,0.0006745004,0.0027602445],"study_design_scores_gemma":[0.019145941,0.0024953138,0.6812533,0.00024287724,0.0002753184,0.0014775598,0.001810565,0.0041511133,0.15525721,0.0006509457,0.12995249,0.003287334],"about_ca_topic_score_codex":0.00002429333,"about_ca_topic_score_gemma":0.00007863195,"teacher_disagreement_score":0.77477276,"about_ca_system_score_codex":0.00018849618,"about_ca_system_score_gemma":0.00012900644,"threshold_uncertainty_score":0.8675721},"labels":[],"label_agreement":null},{"id":"W3135188269","doi":"10.1093/neuonc/noab064","title":"Brainstem gliomas … the devil is in the details","year":2021,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Brainstem; Medicine; Internal medicine","score_opus":0.041073676061902265,"score_gpt":0.30537390633386935,"score_spread":0.2643002302719671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135188269","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.050831374,0.0021729728,8.45658e-7,0.9331199,0.0009772589,0.0011123152,0.000025504209,0.000033447563,0.011726388],"genre_scores_gemma":[0.040470388,0.00035436734,0.00002781762,0.9556932,0.002549715,0.00052858185,0.00014042914,0.000064712076,0.00017082017],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967385,0.0009948333,0.0005058814,0.0006533891,0.00051393063,0.0005934711],"domain_scores_gemma":[0.99577755,0.0026972806,0.00022743376,0.0011339678,0.00010123231,0.00006252987],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00036274604,0.00041417315,0.00087024213,0.000202036,0.00012863637,0.0000594506,0.000472644,0.0009058507,0.00043450357],"category_scores_gemma":[0.00026945877,0.00021349522,0.00037571782,0.0005416101,0.0001803331,0.000028727443,0.00014426692,0.002333969,0.0002244081],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021826447,0.0002936593,0.001973596,0.00007102526,0.00015040698,0.044575777,0.00078832946,4.379182e-7,0.0017781606,0.00004314487,0.94076574,0.009537893],"study_design_scores_gemma":[0.0018640572,0.00063218735,0.00194238,0.00007934036,0.0004446435,0.002841446,0.00023636938,0.0000071344166,0.0015649832,0.00005062269,0.99017733,0.00015948866],"about_ca_topic_score_codex":0.00007219233,"about_ca_topic_score_gemma":0.00023013564,"teacher_disagreement_score":0.049411602,"about_ca_system_score_codex":0.0002976708,"about_ca_system_score_gemma":0.0005460633,"threshold_uncertainty_score":0.9999677},"labels":[],"label_agreement":null},{"id":"W3137367749","doi":"10.1093/neuonc/noab027","title":"Medulloblastoma (cross)talk through extracellular vesicles","year":2021,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Extracellular vesicles; Vesicle; Chemistry; Medicine; Cell biology; Biology; Cancer research; Biochemistry; Membrane","score_opus":0.019007131321207345,"score_gpt":0.2877132220485177,"score_spread":0.26870609072731033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3137367749","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.37151068,0.07269596,0.0026079416,0.5078869,0.012571915,0.0027277248,0.0010149779,0.0005223776,0.028461508],"genre_scores_gemma":[0.03022351,0.002521744,0.004613155,0.9225227,0.022283396,0.00039244644,0.0067665223,0.0008039866,0.009872523],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99416935,0.000997608,0.0009363235,0.0020575672,0.00059577153,0.0012433799],"domain_scores_gemma":[0.9965205,0.0002410646,0.0005999625,0.0020957587,0.0003038551,0.00023883951],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0002952995,0.0009248571,0.0009389308,0.00010396183,0.0002336034,0.00014323802,0.0013064807,0.0035488217,0.0005948296],"category_scores_gemma":[0.0006190913,0.001027708,0.000734062,0.00023061455,0.00078129256,0.000015560385,0.0009247648,0.0024486303,0.00028072507],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000753293,0.00013822777,0.000059793434,0.00010414428,0.0001246299,0.008284734,0.000031986445,0.00001600395,0.51950294,0.000020690613,0.47002825,0.0016132542],"study_design_scores_gemma":[0.0007665095,0.00056893734,0.000017933939,0.000026611135,0.00013620351,0.00087118265,0.000026530177,0.000010974653,0.30581123,0.00018076188,0.69093996,0.00064315734],"about_ca_topic_score_codex":0.000018950934,"about_ca_topic_score_gemma":0.000023291565,"teacher_disagreement_score":0.41463584,"about_ca_system_score_codex":0.00017181273,"about_ca_system_score_gemma":0.0011293835,"threshold_uncertainty_score":0.9998528},"labels":[],"label_agreement":null},{"id":"W3139439448","doi":"10.1093/neuonc/noab067","title":"The histology of brain tumors for 67 331 children and 671 085 adults diagnosed in 60 countries during 2000-2014: a global, population-based study (CONCORD-3)","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Instituto Nacional do Câncer, Ministério da Saúde; CHILDREN with CANCER UK; Saskatchewan Cancer Agency; Susan G. Komen","keywords":"Histology; Medicine; Population; Brain tumor; Pediatrics; Pathology; Environmental health","score_opus":0.009281192311493845,"score_gpt":0.2858275920494354,"score_spread":0.2765463997379416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3139439448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98926234,0.0013175916,0.0000024638923,0.0073631397,0.00023787905,0.0016700774,0.00007972611,0.000026909798,0.00003984245],"genre_scores_gemma":[0.9982735,0.000086536435,0.000074148564,0.0010312063,0.00006780311,0.00036770193,0.000070820555,0.000020831301,0.0000074539294],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99824005,0.00028481116,0.0005205845,0.00045434217,0.00016211609,0.00033809134],"domain_scores_gemma":[0.997174,0.002019438,0.00022933967,0.00033280445,0.00014348463,0.000100902216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020581738,0.00020005717,0.00062845176,0.00009515305,0.00014729895,0.000013497079,0.00009286816,0.00012142025,0.00003158236],"category_scores_gemma":[0.00093021523,0.00015656145,0.000089728324,0.00018798102,0.00011593048,0.000032967273,0.00005872951,0.0001297517,0.000003431596],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010244129,0.0014573286,0.9913609,0.000046515008,0.000084470674,0.0009713201,0.0003316209,0.000036726655,0.0009463377,0.000092645205,0.0008929864,0.002754758],"study_design_scores_gemma":[0.015957622,0.0023314198,0.97835255,0.000047997557,0.00014150198,0.00013496386,0.00031225802,0.0000922485,0.0011513184,0.000048589005,0.0013227826,0.00010673822],"about_ca_topic_score_codex":0.0011593763,"about_ca_topic_score_gemma":0.010700839,"teacher_disagreement_score":0.014933209,"about_ca_system_score_codex":0.00040524692,"about_ca_system_score_gemma":0.00047596675,"threshold_uncertainty_score":0.63843906},"labels":[],"label_agreement":null},{"id":"W3141953003","doi":"10.1093/neuonc/noab035","title":"The relevance of surgical status in nodular leptomeningeal metastasis patient outcomes","year":2021,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Occupational Cancer Research Centre","funders":"","keywords":"Medicine; Relevance (law); Metastasis; Clinical significance; Radiology; Pathology; Internal medicine; Cancer","score_opus":0.026879895231642456,"score_gpt":0.3114301502874609,"score_spread":0.28455025505581844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3141953003","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09236363,0.005433028,0.000006218648,0.8971715,0.0017496089,0.0011492084,0.0002600118,0.000039960567,0.0018268283],"genre_scores_gemma":[0.049922477,0.013602387,0.0039968044,0.92721534,0.0015312511,0.0007112055,0.0016031959,0.00030838492,0.0011089596],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958597,0.0011151693,0.00092997804,0.0006651868,0.0006432937,0.0007866956],"domain_scores_gemma":[0.9943945,0.00402824,0.00046840904,0.0008235099,0.00015856813,0.00012677345],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036358114,0.00042454735,0.0016158576,0.00018388545,0.000076870165,0.000016085061,0.00018018649,0.0005507212,0.00021191999],"category_scores_gemma":[0.00046688542,0.00026936058,0.00047780533,0.0003122079,0.00026692997,0.000027193577,0.00019355072,0.0019798146,0.000020826881],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005866011,0.00087311165,0.010280127,0.00025422158,0.0010753629,0.07997925,0.0003935547,0.00001929794,0.00048318718,0.00009544405,0.7624613,0.14349855],"study_design_scores_gemma":[0.003068293,0.0020571486,0.0007542318,0.000056120127,0.0004226513,0.00056114304,0.000105567415,0.000008104595,0.00067806605,0.000028945007,0.9920893,0.00017046313],"about_ca_topic_score_codex":0.0001386229,"about_ca_topic_score_gemma":0.00007569092,"teacher_disagreement_score":0.22962798,"about_ca_system_score_codex":0.00045426103,"about_ca_system_score_gemma":0.0006546312,"threshold_uncertainty_score":0.99997586},"labels":[],"label_agreement":null},{"id":"W3143439380","doi":"10.1093/neuonc/noab082","title":"Report of National Brain Tumor Society roundtable workshop on innovating brain tumor clinical trials: building on lessons learned from COVID-19 experience","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; National Brain Tumor Society","keywords":"Clinical trial; Coronavirus disease 2019 (COVID-19); Food and drug administration; Brain tumor; Medicine; Medical education; Internal medicine; Psychiatry; Pharmacology","score_opus":0.5043035813782832,"score_gpt":0.5875728022539016,"score_spread":0.08326922087561839,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3143439380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.62540895,0.00007981078,0.0015179449,0.36991984,0.0015196846,0.0005280943,0.00005390275,0.00009458224,0.0008771925],"genre_scores_gemma":[0.66343164,0.00006995425,0.0035228638,0.33004516,0.0017297462,0.00008285856,0.00011090148,0.000057818375,0.0009490247],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9929313,0.0021508993,0.0023343952,0.0011187607,0.00087225373,0.0005923894],"domain_scores_gemma":[0.9376546,0.05857164,0.0016686594,0.0007417523,0.000674113,0.00068919663],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.009431467,0.00029754962,0.0015632317,0.00017823366,0.00027636375,0.000055678713,0.0002124352,0.00036880022,0.00034113388],"category_scores_gemma":[0.28984925,0.00028274208,0.0004414107,0.00093055144,0.00022481428,0.00016319405,0.0001847591,0.0015079293,0.000014567951],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005880044,0.003059981,0.0228002,0.00046475773,0.00034367086,0.015128237,0.0064265453,0.0006463541,0.5886319,0.00765684,0.26849377,0.0804677],"study_design_scores_gemma":[0.010535917,0.0028006237,0.006838053,0.0004768511,0.000087825545,0.0015067246,0.0032113213,0.0013461544,0.013728357,0.002955543,0.95605797,0.00045467986],"about_ca_topic_score_codex":0.00042209035,"about_ca_topic_score_gemma":0.00015416658,"teacher_disagreement_score":0.6875642,"about_ca_system_score_codex":0.0017157494,"about_ca_system_score_gemma":0.01511623,"threshold_uncertainty_score":0.99996245},"labels":[],"label_agreement":null},{"id":"W3153000652","doi":"10.1093/neuonc/noab093","title":"Metabolic imaging detects elevated glucose flux through the pentose phosphate pathway associated with TERT expression in low-grade gliomas","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Institute of Biomedical Imaging and Bioengineering; National Institute of Neurological Disorders and Stroke; National Cancer Institute; National Institutes of Health; American Cancer Society; U.S. Department of Defense","keywords":"Pentose phosphate pathway; Flux (metallurgy); Glycolysis; Glioma; Chemistry; Phosphate; Biochemistry; Carbohydrate metabolism; Metabolism; Cell biology; Cancer research; Biology","score_opus":0.017358623992627366,"score_gpt":0.27437140621611095,"score_spread":0.25701278222348356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3153000652","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990143,0.0045281895,0.000061915176,0.003056892,0.00055131107,0.0006306277,0.000012055731,0.00018663566,0.00082935445],"genre_scores_gemma":[0.9925981,0.0006157077,0.00029457858,0.005903579,0.00014244439,0.00008987416,0.00007533588,0.000074422154,0.0002059312],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9966475,0.0007537587,0.0005579256,0.0007426096,0.00048718287,0.00081106456],"domain_scores_gemma":[0.99789774,0.0007263178,0.0002807944,0.00067004736,0.0002272513,0.00019786392],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033685868,0.00038256354,0.00080237637,0.00015516399,0.00019551362,0.000045010158,0.00027556246,0.00020886453,0.0002357643],"category_scores_gemma":[0.0010514185,0.00025996473,0.00012913208,0.0012812072,0.00023344722,0.00022092035,0.00016995281,0.0008180093,0.000043881093],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044462882,0.0007394939,0.014235668,0.00003345965,0.00005233347,0.0073037283,0.0019284267,0.000015838823,0.96217275,0.000030332663,0.0003398481,0.01270347],"study_design_scores_gemma":[0.005315114,0.00035337606,0.038281947,0.00025149225,0.00011524002,0.0006694847,0.00068748253,0.00036133957,0.91248167,0.000065372005,0.04114736,0.0002701062],"about_ca_topic_score_codex":0.00011400568,"about_ca_topic_score_gemma":0.0004223642,"teacher_disagreement_score":0.04969109,"about_ca_system_score_codex":0.00020047452,"about_ca_system_score_gemma":0.0006931321,"threshold_uncertainty_score":0.9999853},"labels":[],"label_agreement":null},{"id":"W3155618875","doi":"10.1093/neuonc/noab189","title":"COVID-19 in pediatric cancer: Where are the brain tumors?","year":2021,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; BC Children's Hospital","funders":"","keywords":"Medicine; Pediatric oncology; Pediatric cancer; Pandemic; Immunosuppression; Cancer; Coronavirus disease 2019 (COVID-19); Disease; Pediatrics; Oncology; Internal medicine; Intensive care medicine; Infectious disease (medical specialty)","score_opus":0.0711742864164797,"score_gpt":0.39886004312712403,"score_spread":0.3276857567106443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3155618875","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006240462,0.006000196,0.0000057430398,0.98292285,0.0022096427,0.0013097022,0.00012845891,0.00012861837,0.0010543093],"genre_scores_gemma":[0.004094744,0.009782252,0.000015572557,0.9682223,0.016105346,0.00029565362,0.00015673132,0.00012220327,0.0012051994],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9951194,0.0013383504,0.00080107234,0.0010141169,0.0006139561,0.001113097],"domain_scores_gemma":[0.99185365,0.005723596,0.0005971425,0.0009904741,0.00018384383,0.0006513019],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0006198944,0.00053128944,0.001478399,0.0005299915,0.00017588974,0.000037695634,0.00046785825,0.0017261093,0.0013046851],"category_scores_gemma":[0.0051418897,0.00040941848,0.00028364742,0.0009250819,0.00016957056,0.00004811921,0.00023662986,0.0066828695,0.000096966454],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013786355,0.0000782831,0.056923825,0.0028395143,0.000024678211,0.035041198,0.0006509087,0.000010501915,0.0001493086,0.000004968477,0.9019861,0.00215284],"study_design_scores_gemma":[0.0021439604,0.00065104885,0.0137096895,0.00015620523,0.00019855173,0.0010707134,0.00019968789,0.000010722045,0.000010039477,0.00004640844,0.98149896,0.00030402397],"about_ca_topic_score_codex":0.004253237,"about_ca_topic_score_gemma":0.010446184,"teacher_disagreement_score":0.07951284,"about_ca_system_score_codex":0.0036870483,"about_ca_system_score_gemma":0.026183268,"threshold_uncertainty_score":0.9998358},"labels":[],"label_agreement":null},{"id":"W3158444240","doi":"10.1093/neuonc/noab088","title":"Prognostic significance of genome-wide DNA methylation profiles within the randomized, phase 3, EORTC CATNON trial on non-1p/19q deleted anaplastic glioma","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Health and Medical Research Council; Medical Research Council; Brain Tumour Charity; National Cancer Institute; Cancer Research UK; Cancer Australia; KWF Kankerbestrijding; NRG Oncology; U.S. Department of Defense","keywords":"Temozolomide; Anaplastic astrocytoma; Glioma; Oncology; IDH1; Internal medicine; Medicine; Hazard ratio; CDKN2A; DNA methylation; Cancer research; Biology; Astrocytoma; Cancer; Genetics; Mutation","score_opus":0.024297912445691607,"score_gpt":0.30847900653563326,"score_spread":0.28418109408994163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3158444240","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98955196,0.00036139737,0.00035077697,0.0032540318,0.0008465348,0.0049075605,0.00003366331,0.000046523102,0.00064757874],"genre_scores_gemma":[0.9969813,0.000059066035,0.0003314999,0.000737339,0.00028673594,0.0014008104,0.00014869521,0.000040640345,0.000013870324],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9967901,0.0010311034,0.0008690853,0.00054944085,0.00043064196,0.00032960728],"domain_scores_gemma":[0.99127924,0.0071839443,0.0005913184,0.00048080168,0.00030730572,0.00015739343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074649067,0.00029655997,0.0011845264,0.00020611771,0.0001207363,0.000021839809,0.0001411436,0.00018931708,0.00012274634],"category_scores_gemma":[0.0051773167,0.00019222815,0.00029286882,0.0005811697,0.00027457063,0.000045960223,0.000052128544,0.0003132662,0.000031897536],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.34335747,0.0043167556,0.00055222603,0.00009034454,0.000484915,0.0020193907,0.00057133526,0.0004293377,0.6437551,0.0002644448,0.00046272532,0.0036959562],"study_design_scores_gemma":[0.55716866,0.009210458,0.0009802328,0.000067354194,0.0013975882,0.00012750294,0.0001678451,0.001593734,0.42788702,0.00013264378,0.0011014754,0.0001654914],"about_ca_topic_score_codex":0.000030995874,"about_ca_topic_score_gemma":0.000060217397,"teacher_disagreement_score":0.21586807,"about_ca_system_score_codex":0.00015308351,"about_ca_system_score_gemma":0.000779386,"threshold_uncertainty_score":0.7838837},"labels":[],"label_agreement":null},{"id":"W3161379071","doi":"10.1093/neuonc/noab078","title":"Reply to letter by Schwartz et al.","year":2021,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Health Sciences Centre; Queen's University","funders":"","keywords":"Philosophy; Psychology; Psychoanalysis","score_opus":0.030072708552614888,"score_gpt":0.31823177536103386,"score_spread":0.28815906680841896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3161379071","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00073569705,0.00058408384,0.00009488191,0.9892348,0.001998878,0.0008370239,0.00020206721,0.000109249355,0.006203302],"genre_scores_gemma":[0.000048993,0.00018318657,0.002225856,0.98792034,0.0025518062,0.00023168615,0.0018116059,0.00014080007,0.004885728],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965639,0.0006706143,0.00049124076,0.0011339638,0.00047085833,0.00066943554],"domain_scores_gemma":[0.99766904,0.00068919535,0.00018333693,0.0010893325,0.00012982573,0.00023925894],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00028527106,0.00048425817,0.0011409393,0.00018151128,0.00006480197,0.00003764188,0.00019100089,0.0006033978,0.0017539577],"category_scores_gemma":[0.00032567052,0.00041477502,0.00033792274,0.00021233359,0.00008222313,0.000034938,0.00020300463,0.0026124592,0.00088809105],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000081939215,0.00021458037,0.00004929349,0.00005441492,0.00023363656,0.03476845,0.000060125032,5.169976e-7,0.0103564635,0.0000055047617,0.9471688,0.0070062685],"study_design_scores_gemma":[0.0016997192,0.002358163,0.000023604704,0.000061401406,0.00036997008,0.0018177385,0.000008332039,0.0000012776521,0.0018291181,0.000008609754,0.99154365,0.00027839496],"about_ca_topic_score_codex":0.00009970137,"about_ca_topic_score_gemma":0.000008405191,"teacher_disagreement_score":0.044374865,"about_ca_system_score_codex":0.0003211606,"about_ca_system_score_gemma":0.0005002044,"threshold_uncertainty_score":0.99988985},"labels":[],"label_agreement":null},{"id":"W3162066709","doi":"10.1093/neuonc/noab036","title":"Loss of H3K27me3 in meningiomas","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University of British Columbia; University Health Network","funders":"Canadian Institutes of Health Research; Brain Tumour Charity","keywords":"Meningioma; Medicine; Radiology","score_opus":0.03115777824416481,"score_gpt":0.31288817980757083,"score_spread":0.281730401563406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3162066709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9185563,0.00022025354,0.000065426226,0.003310037,0.0003604843,0.0001867431,0.0000016676107,0.000027374937,0.07727177],"genre_scores_gemma":[0.9970817,0.000017180686,0.0014039985,0.00057087553,0.000079381716,0.000019021436,0.000011637108,0.000016111197,0.00080010603],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99874175,0.00014641184,0.00038166877,0.00029172195,0.00018590232,0.00025253723],"domain_scores_gemma":[0.9992247,0.00018519504,0.00009379604,0.00031830004,0.000084162006,0.000093809795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022842962,0.00010723983,0.00043312475,0.00014189674,0.000023776574,0.000005264915,0.00008309806,0.000108335866,0.00045675662],"category_scores_gemma":[0.00025780604,0.000104231985,0.00008683591,0.00037339222,0.00007027173,0.000033686098,0.00012163966,0.00019466608,0.000036866477],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004935835,0.00086182833,0.0460422,0.00020990358,0.000090731504,0.071123704,0.000981682,0.000027351098,0.85346204,0.004052946,0.009913345,0.012740693],"study_design_scores_gemma":[0.011505669,0.004037889,0.06753718,0.00015437753,0.0002939496,0.008920982,0.0011301577,0.0006799042,0.31425515,0.0014105706,0.5896572,0.00041700774],"about_ca_topic_score_codex":0.000026370524,"about_ca_topic_score_gemma":0.000020024654,"teacher_disagreement_score":0.5797438,"about_ca_system_score_codex":0.000090228765,"about_ca_system_score_gemma":0.00022565965,"threshold_uncertainty_score":0.50011647},"labels":[],"label_agreement":null},{"id":"W3163074318","doi":"","title":"The Canadian paediatric brain tumour consortium (CPBTC): A model of cooperation using teleconferencing services","year":2007,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Healthcare Systems and Technology","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Teleconference; Telecommunications; Computer science","score_opus":0.03294521497880057,"score_gpt":0.2784333733223388,"score_spread":0.24548815834353824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3163074318","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9816157,0.0001276633,0.00090992165,0.007805782,0.0008055568,0.00044628527,0.0000040198297,0.00008716479,0.008197867],"genre_scores_gemma":[0.99393314,0.0000093290555,0.00015900469,0.0052584233,0.00058300904,0.000009424719,0.000006645526,0.000023844697,0.000017163407],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984387,0.000044070515,0.0005666375,0.0002546487,0.00013936734,0.0005565892],"domain_scores_gemma":[0.99872506,0.00025376683,0.0003922653,0.00021853425,0.0003678951,0.000042498996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001240983,0.00014776419,0.00028077717,0.00044495868,0.0005441163,0.0000866798,0.0002831967,0.00027871985,0.000015621665],"category_scores_gemma":[0.00026741298,0.00012147424,0.000047431702,0.00050923537,0.000087714034,0.0002442615,0.000087077904,0.0003051414,0.000026421883],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016500153,0.00014560428,0.053840976,0.0009193101,0.000073904404,0.0002265397,0.0006886769,0.0049638795,0.50303924,0.26566494,0.003994355,0.16627757],"study_design_scores_gemma":[0.0013450648,0.00016062894,0.0033248519,0.00004592705,0.00008330276,0.000088786925,0.0014990929,0.45795476,0.0025046796,0.0028549526,0.5296319,0.0005060485],"about_ca_topic_score_codex":0.24366081,"about_ca_topic_score_gemma":0.863748,"teacher_disagreement_score":0.6200872,"about_ca_system_score_codex":0.00022480066,"about_ca_system_score_gemma":0.0008342218,"threshold_uncertainty_score":0.7613757},"labels":[],"label_agreement":null},{"id":"W3164180016","doi":"10.1093/neuonc/noab131","title":"Metformin effects on brain development following cranial irradiation in a mouse model","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Occupational Cancer Research Centre; Health Sciences Centre; Sunnybrook Health Science Centre; Hospital for Sick Children; University of Toronto","funders":"Canadian Institutes of Health Research; Government of Ontario; Ontario Institute for Cancer Research","keywords":"Metformin; Medicine; Neuroscience; Biology; Endocrinology; Diabetes mellitus","score_opus":0.012720500676021233,"score_gpt":0.2740832325343112,"score_spread":0.26136273185829,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164180016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912533,0.0062825107,0.00047315512,0.00023193563,0.00060914364,0.00020228144,0.000004920816,0.0000141082555,0.0009286075],"genre_scores_gemma":[0.97571105,0.0025832418,0.0033015164,0.017027745,0.00050748844,0.00023363417,0.00014643859,0.000058440794,0.00043047065],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99863756,0.00021513918,0.00025092982,0.00043371122,0.00013835872,0.00032430666],"domain_scores_gemma":[0.99945813,0.000120156445,0.00006757408,0.00023227667,0.00003578079,0.00008607355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025803593,0.00016429256,0.00026956602,0.00006934703,0.00005517384,0.000013961245,0.00012263146,0.00023894904,0.000011535991],"category_scores_gemma":[0.00048527247,0.00017230863,0.0000965571,0.00010642635,0.000016066859,0.000005693357,0.00007690419,0.00016000446,0.000016695898],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007430591,0.000102176506,0.00014448162,0.000015821088,0.000024760933,0.00005173792,0.0001838548,0.00056783616,0.7893236,0.00005935664,0.0013589427,0.2080931],"study_design_scores_gemma":[0.0014638595,0.00020489247,0.00017119705,0.000005957643,0.00001124306,0.000004891894,0.000018356233,0.00052304374,0.67638224,0.00006325201,0.321006,0.00014508222],"about_ca_topic_score_codex":0.000004379528,"about_ca_topic_score_gemma":0.00016006181,"teacher_disagreement_score":0.31964707,"about_ca_system_score_codex":0.00009694692,"about_ca_system_score_gemma":0.0006182892,"threshold_uncertainty_score":0.7026542},"labels":[],"label_agreement":null},{"id":"W3164773505","doi":"10.1093/neuonc/noab136","title":"Therapeutic implications of improved molecular diagnostics for rare CNS embryonal tumor entities: results of an international, retrospective study","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Medical Research Council; Deutsche Kinderkrebsstiftung; Brain Tumour Charity","keywords":"DNA methylation; Atypical teratoid rhabdoid tumor; Methylation; Medicine; Glioma; Neuroblastoma; Retrospective cohort study; Oncology; Pathology; Internal medicine; Biology; Immunohistochemistry; Cancer research; DNA; Gene; Genetics; Cell culture; Gene expression","score_opus":0.029479160069184145,"score_gpt":0.3651712102795587,"score_spread":0.3356920502103745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164773505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994713,0.0000597165,0.00018651718,0.0014147938,0.00022368047,0.001256537,0.0006366896,0.000022119888,0.0014869211],"genre_scores_gemma":[0.99831074,0.00007325186,0.0006341232,0.00043742795,0.0000597257,0.00022955485,0.00015422975,0.000025089448,0.00007584993],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986266,0.00016196376,0.00039387634,0.00037650508,0.00023311081,0.0002079606],"domain_scores_gemma":[0.9978147,0.0005908947,0.00019885757,0.00044019814,0.0008361568,0.000119154094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011601902,0.000121300945,0.00036712948,0.000125117,0.000044634548,0.000008481651,0.000161494,0.000051578005,0.00004363358],"category_scores_gemma":[0.0014996112,0.00011247044,0.00011481525,0.00019285396,0.00011098226,0.00006152254,0.000088364686,0.00016463986,0.0000023346176],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021359765,0.006584098,0.018496605,0.000046359717,0.00048370054,0.000628991,0.00047375652,0.000005136906,0.9672169,0.0008245807,0.00028819172,0.0028157055],"study_design_scores_gemma":[0.023375405,0.034454357,0.36695862,0.00004062845,0.000522748,0.0003893969,0.0014942588,0.0003568949,0.56455946,0.0019118384,0.0057519823,0.00018442333],"about_ca_topic_score_codex":0.000024005654,"about_ca_topic_score_gemma":0.00007322331,"teacher_disagreement_score":0.40265745,"about_ca_system_score_codex":0.00014331237,"about_ca_system_score_gemma":0.0005612121,"threshold_uncertainty_score":0.45864117},"labels":[],"label_agreement":null},{"id":"W3165056209","doi":"10.1093/neuonc/noab134","title":"Spatial concordance of DNA methylation classification in diffuse glioma","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital; Hospital for Sick Children","funders":"National Institute of Neurological Disorders and Stroke; National Cancer Institute; U.S. Department of Defense","keywords":"Concordance; DNA methylation; Glioma; Biology; Methylation; Computational biology; DNA; Genetics; Gene","score_opus":0.03552386051443346,"score_gpt":0.319901244927632,"score_spread":0.28437738441319854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165056209","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927883,0.00023401414,0.00009965404,0.0043228567,0.00031088185,0.00025511443,0.0000063556154,0.000018725736,0.0019640536],"genre_scores_gemma":[0.99897355,0.000103809216,0.00032128178,0.000395684,0.000079085745,0.000061381485,0.000046185844,0.000012378622,0.0000066474936],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998945,0.00017418899,0.0003378661,0.0002577188,0.00014237035,0.00014283492],"domain_scores_gemma":[0.99903864,0.00037011385,0.00015460367,0.0002446379,0.00012748335,0.00006454162],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000816547,0.00009409478,0.00034348067,0.00012795966,0.000018431352,0.0000038990506,0.000039944738,0.00011659841,0.00008504924],"category_scores_gemma":[0.0003532028,0.000087568194,0.00006484232,0.00030575093,0.000056192355,0.000036687146,0.000027974864,0.00011677514,0.0000182647],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012345222,0.0016172619,0.048371866,0.000021274973,0.000019598241,0.00064061175,0.00014726531,0.000003495066,0.9015782,0.00059047254,0.00019504472,0.046691462],"study_design_scores_gemma":[0.005742636,0.0006260181,0.32281336,0.00002250109,0.000068506524,0.00010084676,0.0000887023,0.00051497924,0.65934545,0.00012456675,0.010496595,0.000055837234],"about_ca_topic_score_codex":0.000070195725,"about_ca_topic_score_gemma":0.00033005697,"teacher_disagreement_score":0.2744415,"about_ca_system_score_codex":0.00016753862,"about_ca_system_score_gemma":0.00022384485,"threshold_uncertainty_score":0.3570927},"labels":[],"label_agreement":null},{"id":"W3166172363","doi":"10.1093/neuonc/noab090.198","title":"EPCT-12. NATIONAL MULTICENTERED RETROSPECTIVE REVIEW OF DEMOGRAPHIC, TUMOUR AND INTRAOPERATIVE FEATURES ASSOCIATED WITH THE DEVELOPMENT OF CEREBELLAR MUTISM AFTER PEDIATRIC POSTERIOR FOSSA TUMOUR RESECTION","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University; University of Calgary; University of Alberta; McMaster University","funders":"","keywords":"Medicine; Ependymoma; Medulloblastoma; Astrocytoma; Surgery; Pilocytic astrocytoma; Retrospective cohort study; Hydrocephalus; Glioma","score_opus":0.014250421261590885,"score_gpt":0.2784480752848482,"score_spread":0.26419765402325734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3166172363","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98650265,0.007894834,0.0000024137548,0.0043645115,0.00010242317,0.00072111096,0.000040120885,0.000011290296,0.00036062382],"genre_scores_gemma":[0.99592817,0.00247594,0.00034593663,0.0009816758,0.00005440159,0.00014049542,0.000044158704,0.000017153397,0.000012053627],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99836075,0.00034516733,0.00040146292,0.0003281937,0.00038857534,0.00017582702],"domain_scores_gemma":[0.9982075,0.00039670718,0.00033731182,0.00012448053,0.00085955835,0.000074424526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028122863,0.00017761928,0.000532844,0.00013138425,0.000093613475,0.000008896653,0.000052720756,0.000106842606,0.00004919588],"category_scores_gemma":[0.0006560158,0.00011473567,0.00008291088,0.00040561013,0.00010797137,0.000045880824,0.000072494426,0.00024877655,0.0000011350373],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019094512,0.0035766566,0.55336785,0.0019948985,0.0014345924,0.0010486471,0.0046895724,0.0000030652923,0.42461708,0.00014019822,0.0037208314,0.0034971493],"study_design_scores_gemma":[0.003207306,0.0013482913,0.93345994,0.0007357905,0.00048559028,0.0002213246,0.00019165818,0.0000066821017,0.05984549,0.000013621997,0.00038472845,0.000099600205],"about_ca_topic_score_codex":0.000008008062,"about_ca_topic_score_gemma":0.0006786787,"teacher_disagreement_score":0.38009205,"about_ca_system_score_codex":0.00023404186,"about_ca_system_score_gemma":0.0005352639,"threshold_uncertainty_score":0.46787846},"labels":[],"label_agreement":null},{"id":"W3166680572","doi":"10.1093/neuonc/noab090.103","title":"HGG-39. ALTERNATIVE SPLICING OF <i>NEUROFIBROMIN 1</i> IS ASSOCIATED WITH ELEVATED MAPK ACTIVITY AND POOR PROGNOSIS IN HIGH-GRADE GLIOMA","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Hospital for Sick Children","funders":"","keywords":"Neurofibromin 1; RNA splicing; MAPK/ERK pathway; Biology; Cancer research; Spliceosome; Carcinogenesis; Alternative splicing; Genetics; Gene; Signal transduction; RNA; Messenger RNA","score_opus":0.020466211873663907,"score_gpt":0.2823634488948709,"score_spread":0.261897237021207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3166680572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99148667,0.00010225711,0.000002885092,0.0073702224,0.00012022458,0.0006037992,0.000051091938,0.000039651142,0.00022321184],"genre_scores_gemma":[0.99853873,0.00011213733,0.00018205795,0.00094757514,0.000034882934,0.00010492788,0.000028771474,0.000039376093,0.000011539171],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99811447,0.00032164768,0.0003450449,0.00057534,0.00027493364,0.00036854183],"domain_scores_gemma":[0.99842453,0.00075335486,0.00029314277,0.00020564711,0.00017476773,0.0001485529],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013913853,0.00025354652,0.00084804796,0.00023171994,0.00004663923,0.000014013054,0.00006320411,0.00017767414,0.000043890886],"category_scores_gemma":[0.00026057934,0.00021183447,0.00007567446,0.0007195197,0.00012318927,0.00007918954,0.0000998311,0.00029705768,0.0000038224507],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037771667,0.0023487734,0.13334653,0.0000450236,0.00022965763,0.0064072567,0.00037339723,0.000005170557,0.8545914,0.000044260367,0.0002541819,0.0019766293],"study_design_scores_gemma":[0.007586934,0.0025081856,0.18422464,0.00014484562,0.0002427179,0.0003928459,0.000082361104,0.00018900569,0.8042073,0.000032338543,0.00026372456,0.00012506514],"about_ca_topic_score_codex":0.00044800932,"about_ca_topic_score_gemma":0.00037653887,"teacher_disagreement_score":0.05087811,"about_ca_system_score_codex":0.00022587141,"about_ca_system_score_gemma":0.00022960674,"threshold_uncertainty_score":0.86383593},"labels":[],"label_agreement":null},{"id":"W3166940707","doi":"10.1093/neuonc/noab090.168","title":"RARE-07. EFFICACY AND SAFETY OF LAROTRECTINIB IN PEDIATRIC PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION-POSITIVE PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Trk receptor; Medicine; Internal medicine; Glioma; Oncology; Neuroblastoma; Gastroenterology; Cancer research; Receptor; Neurotrophin; Biology","score_opus":0.006823661440236482,"score_gpt":0.23211809392366775,"score_spread":0.22529443248343126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3166940707","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963773,0.00043517858,0.0000027946735,0.0006329687,0.00033768063,0.0011461467,0.00007482648,0.00003913944,0.00095398776],"genre_scores_gemma":[0.99867564,0.00023365873,0.00032757694,0.00033290114,0.00012783783,0.000067418565,0.00018880429,0.00003697965,0.000009156061],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978628,0.00039751932,0.0005135666,0.0005308508,0.0002805391,0.00041469047],"domain_scores_gemma":[0.99840546,0.00062618864,0.00025103352,0.0002682939,0.00019972018,0.00024932402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000984883,0.00025542526,0.0007853094,0.00019311772,0.000072498,0.000009725187,0.00006409884,0.00015262168,0.00006853217],"category_scores_gemma":[0.00017255303,0.00020326978,0.000080504295,0.00046471256,0.00008111049,0.000055422322,0.000102928774,0.00027679873,0.000011774739],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003943051,0.004893821,0.95253694,0.00035696907,0.00007968961,0.0035163625,0.00079664856,0.00002656259,0.014988828,0.00006542556,0.00045978013,0.018335909],"study_design_scores_gemma":[0.017160024,0.0038036075,0.9663305,0.00021646921,0.00030369687,0.00016038517,0.0002449598,0.0000108663135,0.010798973,9.1242384e-7,0.0008107424,0.00015882916],"about_ca_topic_score_codex":0.00006351485,"about_ca_topic_score_gemma":0.000044471948,"teacher_disagreement_score":0.018177079,"about_ca_system_score_codex":0.0005137916,"about_ca_system_score_gemma":0.00046097237,"threshold_uncertainty_score":0.8289101},"labels":[],"label_agreement":null},{"id":"W3167505290","doi":"10.1093/neuonc/noab090.176","title":"RARE-15. THE MOLECULAR PROFILE OF SECONDARY MENINGIOMAS IN SURVIVORS OF CHILDHOOD NON-CENTRAL NERVOUS SYSTEM CANCERS","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Alberta","funders":"","keywords":"Medicine; Cohort; Meningioma; Radiation therapy; Exome sequencing; Oncology; Cancer; Internal medicine; Surgery; Biology; Mutation; Genetics; Gene","score_opus":0.01019744195147335,"score_gpt":0.24849548749599237,"score_spread":0.23829804554451903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3167505290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9703401,0.00063318276,0.0000779868,0.00089622044,0.0006578785,0.0007517442,0.00001685151,0.000026135393,0.026599918],"genre_scores_gemma":[0.9990141,0.000010173253,0.0004403201,0.0002510294,0.00006667056,0.00006845013,0.00002907643,0.000029463776,0.00009071454],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979276,0.0003571712,0.00063133275,0.00036519847,0.0003091739,0.00040951118],"domain_scores_gemma":[0.99881184,0.00017591869,0.00027984974,0.00050096406,0.00011973063,0.000111716385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003442536,0.00018248662,0.0006840049,0.00015794559,0.000040463805,0.000006348825,0.00020319843,0.0001311705,0.00016724756],"category_scores_gemma":[0.00011279635,0.00014622256,0.00016441528,0.0005037523,0.00011865429,0.000038552636,0.0001586961,0.00032924046,0.000006071295],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006026097,0.0006729839,0.022431888,0.0015235625,0.00044077486,0.025654081,0.0059196195,0.00071560976,0.9235459,0.0029940524,0.0028664244,0.012632509],"study_design_scores_gemma":[0.012174772,0.0045450875,0.26346567,0.0007260778,0.00081403676,0.0051396755,0.011378616,0.003295453,0.6769255,0.00006885434,0.02085527,0.000611022],"about_ca_topic_score_codex":0.00038336046,"about_ca_topic_score_gemma":0.00012924038,"teacher_disagreement_score":0.24662042,"about_ca_system_score_codex":0.00026050638,"about_ca_system_score_gemma":0.0010477365,"threshold_uncertainty_score":0.5962783},"labels":[],"label_agreement":null},{"id":"W3168486234","doi":"10.1093/neuonc/noab090.197","title":"EPCT-11. RURALITY INDEX SCORE AND PEDIATRIC NEURO-ONCOLOGICAL OUTCOME IN ONTARIO","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Global Health Workforce Issues","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Rurality; Medicine; Index (typography); Demography; Cohort; Rural area; Pediatrics; Population; Environmental health; Internal medicine; Pathology","score_opus":0.10717405221317859,"score_gpt":0.43370736578740066,"score_spread":0.32653331357422205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3168486234","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9697961,0.00031255453,0.000011540164,0.013150347,0.0033312298,0.001212744,0.000012604307,0.00017577088,0.011997094],"genre_scores_gemma":[0.9714525,0.00033335542,0.0003574741,0.026081473,0.0005573738,0.00020891897,0.000029899255,0.000044561762,0.0009344734],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99238384,0.0030187753,0.0016506023,0.0010163956,0.00039380684,0.0015365748],"domain_scores_gemma":[0.9935633,0.004477868,0.0004843886,0.0006193933,0.00025042382,0.00060463167],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010970437,0.00040509913,0.0011770409,0.00021445483,0.00055521174,0.000018239558,0.00036214234,0.0011138167,0.0020825206],"category_scores_gemma":[0.002135223,0.0003768592,0.00011314156,0.00073144486,0.0001812427,0.0001701915,0.00084489514,0.0033388576,0.00033416436],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019413543,0.00026641827,0.9873781,0.00015848923,0.0000042256133,0.001543972,0.0013988694,0.000016286194,0.00032806862,0.0008559845,0.0068380656,0.0010173589],"study_design_scores_gemma":[0.0020954008,0.00040328642,0.7073498,0.000028346567,0.000029474713,0.00009054919,0.00075870566,0.00003153238,0.000009597032,0.00063018844,0.2883547,0.0002184349],"about_ca_topic_score_codex":0.019217594,"about_ca_topic_score_gemma":0.44337416,"teacher_disagreement_score":0.42415655,"about_ca_system_score_codex":0.00189555,"about_ca_system_score_gemma":0.0031152344,"threshold_uncertainty_score":0.99986833},"labels":[],"label_agreement":null},{"id":"W3168961686","doi":"10.1093/neuonc/noab090.038","title":"EMBR-20. ELONGATION CONTROL OF MRNA TRANSLATION DRIVES GROUP 3 MEDULLOBLASTOMA","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre","funders":"","keywords":"microRNA; Biology; Untranslated region; Messenger RNA; Three prime untranslated region; Translation (biology); Medulloblastoma; Translational regulation; Cancer research; Molecular biology; Genetics; Gene","score_opus":0.011302065578731415,"score_gpt":0.28199158325182067,"score_spread":0.27068951767308924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3168961686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6905317,0.0040185475,0.28870487,0.0046621603,0.0015921551,0.0012398349,0.00013595527,0.00007317556,0.009041619],"genre_scores_gemma":[0.99702734,0.00041712992,0.001249136,0.0006915522,0.00021582819,0.00005467917,0.00022658585,0.000038497627,0.00007925898],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981654,0.00045650135,0.00034466252,0.00047128022,0.00025508789,0.0003070578],"domain_scores_gemma":[0.9990213,0.000094006384,0.00014856196,0.00036906477,0.00025758025,0.00010950376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022390542,0.0001607069,0.0002733592,0.00008350249,0.00006534328,0.00001261678,0.00018005831,0.00038122665,0.0001081647],"category_scores_gemma":[0.00024081822,0.0001788237,0.00015606509,0.00020942838,0.00011648854,0.0000065680106,0.0000676506,0.00023918411,0.000013048068],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034801845,0.0001387469,0.000038190392,0.000022499637,0.000076992656,0.000055767123,0.00006806314,0.00043758543,0.9660396,0.00026829747,0.00041186996,0.032094344],"study_design_scores_gemma":[0.0022693349,0.0012696541,0.00012963683,0.000008881458,0.00004263381,0.00010960296,0.000060766422,0.0010196179,0.87744385,0.00013467667,0.11737644,0.00013492916],"about_ca_topic_score_codex":0.00000957285,"about_ca_topic_score_gemma":0.00019888839,"teacher_disagreement_score":0.30649564,"about_ca_system_score_codex":0.000053980217,"about_ca_system_score_gemma":0.00042121703,"threshold_uncertainty_score":0.7292219},"labels":[],"label_agreement":null},{"id":"W3169246075","doi":"10.1093/neuonc/noab090.008","title":"ATRT-09. IDENTIFICATION OF POTENTIAL GENETIC DRIVERS OF METHOTREXATE (MTX) RESISTANCE IN ATYPICAL TERATOID RHABDOID TUMOURS (ATRT) THROUGH A GENOME-WIDE RNAI SCREEN","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Biology; Transfection; RNA interference; Cancer research; Small hairpin RNA; Gene; Blot; Cell culture; Molecular biology; Genetics; RNA","score_opus":0.01721175098722627,"score_gpt":0.2911656772268459,"score_spread":0.2739539262396196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3169246075","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920346,0.0017501535,0.00043794684,0.0041564205,0.00026393204,0.00050625554,0.00005050612,0.000020939455,0.00077922986],"genre_scores_gemma":[0.9917577,0.00099529,0.0064881365,0.00048030016,0.000078332916,0.000050008475,0.00007088682,0.000031333115,0.000048012924],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9974675,0.000442106,0.0008716626,0.0005538034,0.0003337781,0.00033111847],"domain_scores_gemma":[0.99827904,0.0004028287,0.0004255457,0.00051893794,0.0002577563,0.00011589466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021403813,0.00020902023,0.0007444418,0.00017954028,0.000048192873,0.000010414568,0.00016022129,0.00018827103,0.000109665714],"category_scores_gemma":[0.00039504078,0.00020424582,0.00021594155,0.0005019212,0.00020804183,0.00007344048,0.00010258762,0.0002428283,0.000020023446],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064819126,0.0011295503,0.08406093,0.00009940377,0.00012001808,0.0023309067,0.00060171477,0.00017083838,0.90762454,0.00023399481,0.0005252992,0.0024545847],"study_design_scores_gemma":[0.004215231,0.000585347,0.56902915,0.00006633875,0.00034224696,0.000115611205,0.00021872118,0.000058877602,0.41840526,0.0004937762,0.0063308515,0.00013861174],"about_ca_topic_score_codex":0.00006062388,"about_ca_topic_score_gemma":0.00029141066,"teacher_disagreement_score":0.4892193,"about_ca_system_score_codex":0.00022118363,"about_ca_system_score_gemma":0.0003825087,"threshold_uncertainty_score":0.8328903},"labels":[],"label_agreement":null},{"id":"W3169764605","doi":"10.1093/neuonc/noab090.193","title":"EPCT-07. ID1 IS A KEY TRANSCRIPTIONAL REGULATOR OF DIPG INVASION AND IS TARGETABLE WITH CANNABIDIOL","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Gene knockdown; Cancer research; Biology; Carcinogenesis; Small hairpin RNA; Exome sequencing; Cancer; Mutation; Gene; Genetics","score_opus":0.01345260532825223,"score_gpt":0.265789012475972,"score_spread":0.25233640714771977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3169764605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97986853,0.0050444934,0.0041940715,0.0068855034,0.00031353784,0.0005427911,0.00017667659,0.000019837233,0.002954538],"genre_scores_gemma":[0.9911414,0.0014702501,0.001866552,0.0038564557,0.00016180689,0.0000676231,0.00012184904,0.000059289454,0.0012548147],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983465,0.00017499465,0.000249568,0.00060533546,0.00027723965,0.00034636978],"domain_scores_gemma":[0.9990092,0.000023018023,0.00009246773,0.000405647,0.00030363273,0.00016606232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014665599,0.00018341799,0.0002981137,0.00006578226,0.00007722035,0.00001554419,0.00015389982,0.00033026852,0.00037165132],"category_scores_gemma":[0.000085635824,0.00017624594,0.00009270271,0.00018516317,0.0001753408,0.000007004433,0.00014480336,0.00024247344,0.000009612383],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039470877,0.00011008678,0.00011428437,0.00004803411,0.00009076327,0.00008829845,0.00018691017,0.000028122175,0.98795384,0.00026836808,0.008959491,0.001757081],"study_design_scores_gemma":[0.0011434888,0.0010324821,0.00019957926,0.00001285658,0.00003304307,0.00023245964,0.000053988057,0.000054171778,0.69991016,0.000116905765,0.29708683,0.0001240512],"about_ca_topic_score_codex":0.00006458149,"about_ca_topic_score_gemma":0.00013828707,"teacher_disagreement_score":0.28812733,"about_ca_system_score_codex":0.000050340674,"about_ca_system_score_gemma":0.00094720884,"threshold_uncertainty_score":0.7187101},"labels":[],"label_agreement":null},{"id":"W3170014096","doi":"10.1093/neuonc/noab090.147","title":"TMOD-06. LOSS OF DICER COOPERATES WITH TUMOR SUPPRESSORS TO INITIATE METASTATIC MEDULLOBLASTOMA","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Dicer; Biology; PTEN; Medulloblastoma; Cancer research; Carcinogenesis; Glioma; microRNA; Tumor progression; Tumor initiation; Cancer; Genetics; Small interfering RNA; PI3K/AKT/mTOR pathway; Gene; RNA","score_opus":0.014979936731803605,"score_gpt":0.30108288245367376,"score_spread":0.28610294572187017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170014096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9825596,0.000595106,0.012142633,0.001327311,0.000289609,0.0006145396,0.0001313769,0.000027983766,0.0023118367],"genre_scores_gemma":[0.9943165,0.00015004675,0.0020869377,0.0027845975,0.000099537305,0.00013759967,0.00012730758,0.00007778148,0.00021967573],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997668,0.0004479653,0.00035374126,0.0006737014,0.00033056966,0.0005259652],"domain_scores_gemma":[0.99838114,0.00010196545,0.00012279427,0.0005794217,0.00054944825,0.00026523168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020605966,0.00025226595,0.00043569502,0.00011273164,0.00006875539,0.000023997674,0.00032455428,0.0001522109,0.00024127813],"category_scores_gemma":[0.00048226243,0.0002331362,0.00010241898,0.0004336815,0.00019375642,0.0000065120435,0.00038420505,0.00029300142,0.00005574694],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000646324,0.00021854261,0.00005172328,0.000046633868,0.00017732149,0.0011437103,0.00010679422,0.0014341818,0.992917,0.00016963416,0.002124909,0.0009632346],"study_design_scores_gemma":[0.0014881458,0.0027830955,0.00004386917,0.000022883347,0.00006989292,0.00073151314,0.00011603514,0.00009231606,0.897075,0.00005274854,0.09730776,0.00021673147],"about_ca_topic_score_codex":0.00004207634,"about_ca_topic_score_gemma":0.0003395815,"teacher_disagreement_score":0.095841974,"about_ca_system_score_codex":0.00005833453,"about_ca_system_score_gemma":0.0010460265,"threshold_uncertainty_score":0.95070183},"labels":[],"label_agreement":null},{"id":"W3170458266","doi":"10.1093/neuonc/noab090.040","title":"EMBR-22. RATIONAL DEVELOPMENT OF SYNERGISTIC THERAPIES ALONGSIDE BMI1 INHIBITION FOR GROUP 3 MEDULLOBLASTOMA","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University","funders":"","keywords":"Medulloblastoma; Context (archaeology); BMI1; Biology; CRISPR; Cancer research; PI3K/AKT/mTOR pathway; Cancer; Gene; Signal transduction; Genetics","score_opus":0.022094467575562583,"score_gpt":0.2825927927255436,"score_spread":0.260498325149981,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170458266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97593826,0.0008972147,0.021339837,0.0005032597,0.0004544343,0.00025094737,0.00003219112,0.000018766705,0.00056506786],"genre_scores_gemma":[0.98779,0.000038553735,0.010667855,0.00067346386,0.00022513123,0.00017430134,0.00032129243,0.000026747039,0.00008266189],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986417,0.00016967158,0.00043297152,0.00038441943,0.0001352301,0.00023596291],"domain_scores_gemma":[0.9991017,0.00019152174,0.00017243582,0.00018232851,0.00030499822,0.000047025587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002706315,0.0001613013,0.0002773573,0.00004653235,0.00014415882,0.000009089864,0.00008987634,0.00017421774,0.00002885157],"category_scores_gemma":[0.0005821106,0.00016283017,0.00009691405,0.00008598208,0.00012834645,0.000003626861,0.0001188765,0.000075322445,0.000006053055],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011253198,0.00016379247,0.00015762585,0.00004575074,0.000121858924,0.000028147499,0.0003355692,0.000044310164,0.9885825,0.0004763771,0.0015100873,0.008421475],"study_design_scores_gemma":[0.000839321,0.0005146856,0.00072306267,0.000014104162,0.000027977312,0.00004626439,0.00024033911,0.00002391815,0.8636292,0.0002033139,0.1335935,0.00014431078],"about_ca_topic_score_codex":0.0000016707966,"about_ca_topic_score_gemma":0.00009618313,"teacher_disagreement_score":0.1320834,"about_ca_system_score_codex":0.00004294419,"about_ca_system_score_gemma":0.0005527424,"threshold_uncertainty_score":0.6640021},"labels":[],"label_agreement":null},{"id":"W3170650872","doi":"10.1093/neuonc/noab132","title":"An international multicenter matched cohort analysis of incidental meningioma progression during active surveillance or after stereotactic radiosurgery: the IMPASSE study","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Alberta; Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke","funders":"National Institute for Health and Care Research","keywords":"Medicine; Asymptomatic; Radiosurgery; Meningioma; Cohort; Propensity score matching; Watchful waiting; Surgery; Radiology; Internal medicine; Radiation therapy; Cancer","score_opus":0.018594191007778794,"score_gpt":0.34521713418771127,"score_spread":0.32662294317993246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170650872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975179,0.000026385536,0.000020562613,0.0007050161,0.0005418342,0.0008387057,0.000015889787,0.000038931033,0.000294819],"genre_scores_gemma":[0.99921346,0.000008984124,0.00016644076,0.00014370054,0.000108881955,0.00020014774,0.000061011397,0.00002184872,0.00007553683],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974364,0.0006904295,0.00055335934,0.0005206479,0.0005258358,0.00027332603],"domain_scores_gemma":[0.99834913,0.00036419102,0.00033681825,0.00058616546,0.00023615126,0.0001275568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005202682,0.00019730473,0.0006883691,0.00034348282,0.00008314724,0.000040833398,0.0002074356,0.00007694393,0.00052628655],"category_scores_gemma":[0.0002455734,0.00013141516,0.00019820301,0.0006951572,0.0000750689,0.0001848578,0.00023307597,0.00023252249,0.000006166776],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048793573,0.0015939985,0.893011,0.000023106963,0.003044174,0.013404853,0.0023851427,0.000017071558,0.08038343,0.0000026419914,0.000023684466,0.0012315771],"study_design_scores_gemma":[0.0024156827,0.0009216343,0.983644,0.00001841415,0.0013742712,0.000542224,0.002408398,0.0012598451,0.006993202,7.806504e-7,0.0003060863,0.00011544066],"about_ca_topic_score_codex":0.00003233574,"about_ca_topic_score_gemma":0.00014438531,"teacher_disagreement_score":0.09063306,"about_ca_system_score_codex":0.00026095085,"about_ca_system_score_gemma":0.00012944819,"threshold_uncertainty_score":0.57624686},"labels":[],"label_agreement":null},{"id":"W3170737052","doi":"10.1093/neuonc/noab090.054","title":"EPEN-04. SIOP EPENDYMOMA I: FINAL RESULTS, LONG TERM FOLLOW-UP AND MOLECULAR ANALYSIS OF THE TRIAL COHORT: A BIOMECA CONSORTIUM STUDY","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Ependymoma; Radiation therapy; Oncology; Internal medicine; Context (archaeology); Hazard ratio; Cohort; Lomustine; Population; Surgery; Vincristine; Chemotherapy; Confidence interval; Cyclophosphamide","score_opus":0.0323953465718085,"score_gpt":0.3235388786236317,"score_spread":0.2911435320518232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170737052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941929,0.00043560853,0.000004186363,0.0025369008,0.0006230297,0.0014358697,0.00007140725,0.000020623003,0.00067948375],"genre_scores_gemma":[0.99891526,0.000056886915,0.000036618254,0.00064593623,0.00006172656,0.00013450877,0.0000631796,0.000019705056,0.000066154826],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973561,0.0006156133,0.00068694673,0.0006465045,0.00040040514,0.00029439517],"domain_scores_gemma":[0.99784374,0.0006949111,0.00032634856,0.00077854533,0.00019704748,0.00015939059],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035787257,0.00022870691,0.0010406112,0.00028323414,0.000102514205,0.000021986625,0.00014015459,0.00015516314,0.00012987507],"category_scores_gemma":[0.0008580639,0.00015951195,0.000389391,0.0011156661,0.0001668798,0.0000287962,0.00022466031,0.00021826675,0.000005434507],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019958027,0.008839214,0.68664485,0.000038616403,0.007883643,0.025691401,0.0008862679,0.000013163077,0.23563722,0.00009136509,0.0010778239,0.013238416],"study_design_scores_gemma":[0.11927756,0.0061217537,0.782065,0.000025755851,0.015886512,0.00041241676,0.00033900508,0.00007544467,0.07382664,0.000013504826,0.0017765373,0.00017991736],"about_ca_topic_score_codex":0.00008333093,"about_ca_topic_score_gemma":0.00056095666,"teacher_disagreement_score":0.16181059,"about_ca_system_score_codex":0.00009348055,"about_ca_system_score_gemma":0.00035556237,"threshold_uncertainty_score":0.65047085},"labels":[],"label_agreement":null},{"id":"W3170891449","doi":"10.1093/neuonc/noab090.121","title":"IMMU-14. COMPUTATIONAL DECONVOLUTION OF TUMOR-INFILTRATING IMMUNE COMPONENTS IN PEDIATRIC NERVOUS SYSTEM TUMORS","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Immunotherapy; Immune system; Tumor microenvironment; Cancer research; CD8; Medicine; T cell; Immune checkpoint; Immunology; Biology","score_opus":0.033518168114641644,"score_gpt":0.3120968245030121,"score_spread":0.2785786563883705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170891449","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99242234,0.00049527944,0.00009839322,0.0006327076,0.0005257279,0.00047463097,0.000009493418,0.000056611836,0.005284828],"genre_scores_gemma":[0.9983754,0.00005019474,0.0008400206,0.00022854333,0.00024382245,0.000034151366,0.00009270165,0.000035461286,0.000099687975],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9973104,0.00057012367,0.0008559056,0.00038817836,0.00046890092,0.00040650458],"domain_scores_gemma":[0.9980715,0.0008692611,0.00028348184,0.00029271777,0.0003515807,0.0001314514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005396122,0.00017073037,0.0006959324,0.0003478425,0.00006436575,0.000012162881,0.00014451791,0.00012901111,0.00034443714],"category_scores_gemma":[0.00033671112,0.0001832867,0.0001424473,0.000698209,0.000099594385,0.00006606847,0.00012409796,0.00057287375,0.000046749243],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053760345,0.0005027125,0.07294712,0.00048417208,0.000036141133,0.0024978686,0.00040210484,0.0018832503,0.9158647,0.0003156852,0.00015831183,0.0043703425],"study_design_scores_gemma":[0.015910653,0.002996121,0.8390509,0.00031667112,0.00018611732,0.009882054,0.0024525255,0.046837095,0.07794656,0.000167985,0.0037467587,0.00050659885],"about_ca_topic_score_codex":0.00014499668,"about_ca_topic_score_gemma":0.000031371,"teacher_disagreement_score":0.8379181,"about_ca_system_score_codex":0.00058857375,"about_ca_system_score_gemma":0.0010084935,"threshold_uncertainty_score":0.74742144},"labels":[],"label_agreement":null},{"id":"W3171058716","doi":"10.1093/neuonc/noab090.049","title":"EMBR-32. INTEGRATED STRESS RESPONSE PLAYS A PRO-SURVIVAL ROLE IN MYC-DRIVEN MEDULLOBLASTOMA","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of British Columbia Hospital","funders":"","keywords":"Integrated stress response; Unfolded protein response; Gene knockdown; Apoptosis; Translation (biology); Cancer research; Programmed cell death; Initiation factor; Cell biology; Endoplasmic reticulum; Messenger RNA; Biology; Chemistry; Biochemistry; Gene","score_opus":0.015271436749753153,"score_gpt":0.31087881378433646,"score_spread":0.2956073770345833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3171058716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948863,0.0004902217,0.000027908216,0.0009982617,0.0002559572,0.00032177384,0.00015822132,0.000022386253,0.0028390097],"genre_scores_gemma":[0.99807405,0.00024125088,0.00022866843,0.000419209,0.00013810849,0.00017578612,0.0002862118,0.00003770625,0.00039900612],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974723,0.00086798944,0.00027442275,0.0006406327,0.00020727629,0.00053741917],"domain_scores_gemma":[0.998987,0.0001384814,0.00007692097,0.0004381323,0.00015459908,0.00020483068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020553837,0.00021946339,0.00031230669,0.00010478143,0.000067563196,0.00002995486,0.00025320626,0.00028046317,0.00010720396],"category_scores_gemma":[0.00060651713,0.0002117758,0.00010388129,0.0002920478,0.00012043024,0.000006450756,0.00028664275,0.0003272386,0.00005098463],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005077487,0.0005672693,0.010719285,0.000012064645,0.00007971581,0.0016050265,0.00014808081,0.000079557765,0.9735521,0.00002454116,0.0012319521,0.006902922],"study_design_scores_gemma":[0.0039664893,0.002770309,0.006860506,0.000023724393,0.000019629331,0.00021126388,0.0005014331,0.00017511539,0.7497521,0.00004317647,0.23543984,0.00023642789],"about_ca_topic_score_codex":0.00019986568,"about_ca_topic_score_gemma":0.006528083,"teacher_disagreement_score":0.23420788,"about_ca_system_score_codex":0.000182838,"about_ca_system_score_gemma":0.0013925262,"threshold_uncertainty_score":0.8635966},"labels":[],"label_agreement":null},{"id":"W3171192879","doi":"10.1093/neuonc/noab090.021","title":"EMBR-03. PINEOBLASTOMA: A POOLED OUTCOME STUDY OF NORTH AMERICAN AND AUSTRALIAN THERAPEUTIC DATA","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medulloblastoma; Medicine; Proportional hazards model; Oncology; Cohort; Clinical trial; Survival analysis; Log-rank test; Wilcoxon signed-rank test; Internal medicine; Pediatrics; Mann–Whitney U test; Pathology","score_opus":0.031917764932091065,"score_gpt":0.322704676709906,"score_spread":0.2907869117778149,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3171192879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99818295,0.00021828289,0.0000130609305,0.0008649824,0.00020980655,0.00017075292,0.000030587125,0.0000095352,0.00030006777],"genre_scores_gemma":[0.9982663,0.00031864198,0.00008234192,0.0009509104,0.000096876036,0.000010547488,0.00008148877,0.000018283728,0.0001746093],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9986748,0.00020904929,0.000294835,0.0004990717,0.00010407936,0.00021816196],"domain_scores_gemma":[0.99902385,0.000033603483,0.00016317556,0.0006137472,0.000071470946,0.00009413114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000784555,0.00014926755,0.00032418346,0.000035717167,0.00004713878,0.000008993399,0.0002845819,0.00008524972,0.000009857773],"category_scores_gemma":[0.000060223476,0.00012516216,0.00004120485,0.0002051663,0.00017199422,0.0000038028425,0.00033829137,0.00019576782,0.0000047795],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029960944,0.00089774694,0.13861173,0.000033937024,0.00046258912,0.0002643883,0.0002147487,0.00010712037,0.80245477,0.000004320633,0.0015210256,0.05512803],"study_design_scores_gemma":[0.0072879745,0.016796736,0.571036,0.000013673484,0.0007985003,0.00079191354,0.002256379,0.00019374053,0.09281096,0.000014763503,0.3072479,0.00075146015],"about_ca_topic_score_codex":0.000111042384,"about_ca_topic_score_gemma":0.0016750402,"teacher_disagreement_score":0.7096438,"about_ca_system_score_codex":0.000017052162,"about_ca_system_score_gemma":0.00016235095,"threshold_uncertainty_score":0.5103964},"labels":[],"label_agreement":null},{"id":"W3171268121","doi":"10.1093/neuonc/noab090.039","title":"EMBR-21. CLINICALLY TRACTABLE OUTCOME PREDICTION OF GROUP 3/4 MEDULLOBLASTOMA BASED ON TPD52 IMMUNOHISTOCHEMISTRY: A MULTICOHORT STUDY","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital","funders":"","keywords":"Medulloblastoma; Oncology; Internal medicine; Biomarker; Immunohistochemistry; Risk stratification; Receiver operating characteristic; Multivariate analysis; Medicine; Bioinformatics; Biology; Pathology; Genetics","score_opus":0.02222417297214018,"score_gpt":0.3545420029800312,"score_spread":0.332317830007891,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3171268121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98563176,0.000059198093,0.0008712528,0.0031855437,0.0011734427,0.0006394009,0.000013059723,0.00012530271,0.008301037],"genre_scores_gemma":[0.9928887,0.000023863684,0.002594737,0.0037733552,0.00027079514,0.00006771812,0.00006545661,0.000052328105,0.00026307054],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9969647,0.00038700015,0.0011134727,0.00062607095,0.00053781935,0.00037093676],"domain_scores_gemma":[0.997313,0.0011935404,0.0003370665,0.00067420834,0.00020731021,0.0002748812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010622882,0.00024180682,0.0009039628,0.000121499506,0.00009687172,0.0000140020975,0.00019033352,0.00025275422,0.00028942284],"category_scores_gemma":[0.004680029,0.0002229722,0.0002352999,0.0002686641,0.00019187224,0.000040578772,0.00008340419,0.0012932888,0.000018687368],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012625789,0.0058643357,0.2226166,0.00013167334,0.00012609472,0.001384769,0.00031951535,0.00028065374,0.7493796,0.000012800399,0.0013394958,0.017281892],"study_design_scores_gemma":[0.05919516,0.044168286,0.46677193,0.00059817755,0.0025975124,0.0018566449,0.0029093083,0.243283,0.03272727,0.000059045753,0.14480084,0.0010328302],"about_ca_topic_score_codex":0.000042976353,"about_ca_topic_score_gemma":0.0000031920677,"teacher_disagreement_score":0.71665233,"about_ca_system_score_codex":0.00023912969,"about_ca_system_score_gemma":0.00052311335,"threshold_uncertainty_score":0.90925425},"labels":[],"label_agreement":null},{"id":"W3171734833","doi":"10.1093/neuonc/noab090.003","title":"ATRT-04. CORRELATION OF CLINICOPATHOLOGIC FEATURES AND CUMULATIVE INCIDENCE OF RELAPSE FOR PATIENTS WITH ATYPICAL TERATOID RHABDOID TUMOR ON ACNS0333: A REPORT FROM THE CHILDREN’S ONCOLOGY GROUP","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Hospital for Sick Children","funders":"","keywords":"Atypical teratoid rhabdoid tumor; Medicine; Cumulative incidence; Internal medicine; Incidence (geometry); Relapse prevention; Chemotherapy; Cohort; Oncology; Radiation therapy; Immunohistochemistry","score_opus":0.0104755144788739,"score_gpt":0.2859926181670484,"score_spread":0.2755171036881745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3171734833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99755853,0.0004646496,0.0006606712,0.00030885576,0.00029100914,0.0004532482,0.00010598546,0.00000828968,0.00014875042],"genre_scores_gemma":[0.99559504,0.00014089895,0.002634661,0.0009966224,0.00015106046,0.000049756552,0.00039520115,0.0000196485,0.000017114859],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983357,0.00032826368,0.0004898513,0.0005269154,0.00014631131,0.00017293871],"domain_scores_gemma":[0.9979828,0.0007294784,0.0005706097,0.00038808904,0.00027727586,0.00005172744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025366605,0.0001699079,0.00038931586,0.000022594526,0.00008051337,0.0000062956033,0.00013880714,0.00027761867,0.0000082373335],"category_scores_gemma":[0.0013723711,0.00011928784,0.00009676369,0.000077793935,0.00026336015,0.0000059334125,0.00013096065,0.00024634498,6.1455836e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008872775,0.0013098967,0.51508164,0.000042384814,0.00018208494,0.00014821476,0.00068296475,0.0010576588,0.44640997,0.00017146481,0.0034244834,0.022616468],"study_design_scores_gemma":[0.0076791476,0.018599443,0.875472,0.00013116981,0.00027214785,0.0008692719,0.00023923468,0.0006396611,0.08466193,0.0006578311,0.010359254,0.0004189124],"about_ca_topic_score_codex":0.000028078097,"about_ca_topic_score_gemma":0.00012579677,"teacher_disagreement_score":0.36174804,"about_ca_system_score_codex":0.000042934003,"about_ca_system_score_gemma":0.00030834918,"threshold_uncertainty_score":0.4864417},"labels":[],"label_agreement":null},{"id":"W3171770674","doi":"10.1093/neuonc/noab090.162","title":"RARE-01. ASSESSING THE SYMPTOM DIAGNOSTIC INTERVAL FOR CHILDREN WITH CENTRAL NERVOUS SYSTEM TUMOURS","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Janeway Children's Health and Rehabilitation Centre; Memorial University of Newfoundland; Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Medicine; Medulloblastoma; Ependymoma; Vomiting; Nausea; Glioma; Retrospective cohort study; Pediatrics; Internal medicine; Surgery; Pathology","score_opus":0.015588288604384312,"score_gpt":0.28959555575805573,"score_spread":0.2740072671536714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3171770674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98773795,0.0006308393,0.00018314802,0.008747724,0.00077856943,0.0010819166,0.00002793569,0.00010182914,0.0007100769],"genre_scores_gemma":[0.99680054,0.00003768645,0.00036230602,0.0018116501,0.00048892776,0.00033633207,0.00010033933,0.000049532933,0.0000126799005],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983314,0.00022459647,0.00029357112,0.00043724527,0.00020162166,0.000511547],"domain_scores_gemma":[0.9972209,0.0019242825,0.0001501362,0.0003814278,0.0001306096,0.00019265371],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012140748,0.0002292087,0.00051854405,0.000055630757,0.00019159743,0.000073068884,0.00012698029,0.000112514965,0.000031627656],"category_scores_gemma":[0.00045380014,0.00014012911,0.00017309544,0.00018243896,0.00009993483,0.00006376845,0.00007494477,0.00023915897,0.000015687032],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020187728,0.0014975494,0.94119,0.00015391836,0.0005447546,0.0054038027,0.00054874364,0.00014836044,0.013095667,0.0010447975,0.008382263,0.027788255],"study_design_scores_gemma":[0.006492184,0.002374678,0.9528282,0.00030781596,0.001397355,0.007325088,0.0008863626,0.00030849304,0.020580765,0.000014234742,0.0072804075,0.00020439601],"about_ca_topic_score_codex":0.000034330616,"about_ca_topic_score_gemma":0.00006409684,"teacher_disagreement_score":0.02758386,"about_ca_system_score_codex":0.0003400932,"about_ca_system_score_gemma":0.00045842392,"threshold_uncertainty_score":0.5714299},"labels":[],"label_agreement":null},{"id":"W3174246647","doi":"10.1093/neuonc/noab106","title":"The 2021 WHO Classification of Tumors of the Central Nervous System: a summary","year":2021,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":11779,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Brain Tumour Charity; World Health Organization","keywords":"Grading (engineering); Nomenclature; Central nervous system; Medical diagnosis; Brain tumor; Classification scheme; Pathology; Biology; Taxonomy (biology); Computer science; Medicine; Neuroscience; Bioinformatics; Information retrieval; Zoology","score_opus":0.04515445518274325,"score_gpt":0.3309438238166508,"score_spread":0.2857893686339075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3174246647","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00065958354,0.99242425,6.83032e-7,0.0010511685,0.0012310356,0.0014741215,0.000056909103,0.0000107248225,0.003091531],"genre_scores_gemma":[0.0034180381,0.9957931,0.000010380448,0.000066722896,0.00023421625,0.0002815328,0.00007012052,0.000039992337,0.00008589676],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970996,0.0009792167,0.0009525342,0.00036209793,0.00030304177,0.000303538],"domain_scores_gemma":[0.9965645,0.0011933431,0.0010443301,0.0009295173,0.00017322549,0.00009509571],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024349324,0.00027973732,0.002052327,0.00007969109,0.000094153045,0.000009787337,0.00030815043,0.00030076018,0.000026856824],"category_scores_gemma":[0.00031533517,0.0001378261,0.000820763,0.00044651088,0.00021147342,0.000013629478,0.00014607457,0.00038573533,0.000008728378],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021313801,0.0004982358,0.00046665457,0.008321156,0.0004244286,0.00034674915,0.00006777465,6.138192e-7,0.0004090999,0.002305397,0.010787255,0.9763513],"study_design_scores_gemma":[0.00048139808,0.00033843718,0.0013772948,0.008822999,0.0024832825,0.0005095761,0.00015491659,0.000008763671,0.00015714047,0.0000020774703,0.98558277,0.000081370235],"about_ca_topic_score_codex":0.000047417325,"about_ca_topic_score_gemma":0.000041625208,"teacher_disagreement_score":0.97626996,"about_ca_system_score_codex":0.00042840562,"about_ca_system_score_gemma":0.0015036088,"threshold_uncertainty_score":0.5620385},"labels":[],"label_agreement":null},{"id":"W3176243936","doi":"10.1093/neuonc/noab159","title":"The PI3K/Akt/mTOR pathway as a preventive target in melanoma brain metastasis","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; Deutsche Forschungsgemeinschaft; Wellcome Trust; Francis Crick Institute; Fonds de recherche du Québec; Deutsche Krebshilfe; Cancer Research UK","keywords":"PI3K/AKT/mTOR pathway; Protein kinase B; Brain metastasis; Melanoma; Metastasis; Cancer research; Medicine; Neuroscience; Internal medicine; Psychology; Cancer; Biology; Signal transduction; Cell biology","score_opus":0.019167413576155305,"score_gpt":0.30761217040208505,"score_spread":0.28844475682592974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3176243936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88093466,0.0043027103,0.00012165627,0.091529176,0.0012836304,0.0014989879,0.000120389675,0.0000914015,0.020117417],"genre_scores_gemma":[0.9740746,0.00041754192,0.004495469,0.015739303,0.00035937777,0.0004331599,0.00015193087,0.00008031394,0.0042483136],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99715346,0.0011379364,0.0004292755,0.00051848893,0.00026587647,0.00049496314],"domain_scores_gemma":[0.9971966,0.0018396376,0.00014216942,0.00051841745,0.00011092901,0.00019222756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066095137,0.00023569366,0.0005839351,0.00008762906,0.00013635145,0.000025824089,0.0001373743,0.00013976332,0.0007471823],"category_scores_gemma":[0.0013026507,0.00016169541,0.00023667989,0.00037972536,0.0001301774,0.000051595172,0.0001470757,0.00041709788,0.00020514417],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002914646,0.006546313,0.0125099225,0.00015987096,0.0019773636,0.06403693,0.003814197,0.00003294396,0.24042952,0.020241631,0.07002945,0.5773072],"study_design_scores_gemma":[0.0042655063,0.0030709403,0.0034197427,0.000025332929,0.00019133123,0.0013952802,0.0008778256,0.000036970334,0.055363905,0.0020161667,0.9291853,0.00015173401],"about_ca_topic_score_codex":0.00007632202,"about_ca_topic_score_gemma":0.000326525,"teacher_disagreement_score":0.85915583,"about_ca_system_score_codex":0.0002506954,"about_ca_system_score_gemma":0.00090732536,"threshold_uncertainty_score":0.8181122},"labels":[],"label_agreement":null},{"id":"W31786602","doi":"10.1093/neuonc/noz203","title":"Salvation in the Tribulation: Revisited","year":2009,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Historical and Linguistic Studies","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Uncle Kory Foundation; Fondation Brain Canada; Musella Foundation For Brain Tumor Research and Information; National Brain Tumor Society","keywords":"Computer science","score_opus":0.04593678078568604,"score_gpt":0.3614538914035087,"score_spread":0.31551711061782267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W31786602","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.053260196,0.00042849922,0.00018412864,0.13143012,0.0012872439,0.00046199275,0.0000014747842,0.00009138001,0.81285495],"genre_scores_gemma":[0.99263895,0.00008786404,0.00007783635,0.00624496,0.00080756383,0.000006754829,0.0000018305396,0.0000014049032,0.00013283434],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99910444,0.00036925293,0.00013774862,0.00010242277,0.00015004644,0.00013609261],"domain_scores_gemma":[0.999114,0.00069808034,0.000047763602,0.00006652193,0.00005186764,0.000021796535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005385619,0.000039189177,0.00010281715,0.00003448491,0.0002599639,0.000009736973,0.00011864344,0.00006129532,0.000056455487],"category_scores_gemma":[0.0025478778,0.000028221306,0.000022189202,0.00037885565,0.000069397494,0.000022113405,0.000006056121,0.00011462268,0.00003341963],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000079750214,0.0003517989,0.008028686,0.000004256181,0.0000055210153,0.00013890362,0.09401246,0.000017048058,0.0018566917,0.516295,0.13418567,0.24502419],"study_design_scores_gemma":[0.0001424028,0.00013273602,0.017729802,0.00000156094,0.000004482629,8.484083e-7,0.00057069137,0.000011432548,0.0000030835402,0.0046828873,0.9766879,0.000032184427],"about_ca_topic_score_codex":0.00014047565,"about_ca_topic_score_gemma":0.00023648821,"teacher_disagreement_score":0.93937874,"about_ca_system_score_codex":0.00014439675,"about_ca_system_score_gemma":0.00006663685,"threshold_uncertainty_score":0.30502316},"labels":[],"label_agreement":null},{"id":"W3182039670","doi":"10.1093/neuonc/noab178","title":"Emergence and maintenance of actionable genetic drivers at medulloblastoma relapse","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Medical Research Council; Brain Tumour Charity; CHILDREN with CANCER UK; Canadian Institutes of Health Research; National Institute for Health and Care Research; Action Medical Research; Cancer Research UK; C.R. Younger Foundation; Academy of Medical Sciences; JGW Patterson Foundation","keywords":"Medulloblastoma; Biology; Oncology; Wnt signaling pathway; Disease; Mutation; Genetic divergence; Internal medicine; Gene; Cohort; Genetics; Bioinformatics; Medicine; Genetic diversity","score_opus":0.013510534655763868,"score_gpt":0.2713937264407502,"score_spread":0.25788319178498637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3182039670","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917773,0.00067736715,0.000009946554,0.0039415797,0.00037494634,0.00015244778,0.000006657242,0.000016801348,0.0030429557],"genre_scores_gemma":[0.9960876,0.0016798506,0.0010813436,0.0007730833,0.000039542298,0.000031533786,0.0000060256943,0.000012828432,0.00028817993],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9991632,0.000057767214,0.00018884648,0.00027873614,0.00012500989,0.00018642709],"domain_scores_gemma":[0.99931234,0.00015713477,0.000086437154,0.00020466586,0.00011484608,0.00012459407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000036381578,0.000096565556,0.00027108577,0.00004984693,0.000052247502,0.0000021368326,0.000035244655,0.000083894185,0.00068728044],"category_scores_gemma":[0.00015061909,0.00008543888,0.000059887938,0.00014736234,0.00010781185,0.000023516774,0.00008554052,0.000088299144,0.00003514924],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018414052,0.0004985911,0.09788868,0.00004894682,0.00008657413,0.0026659248,0.00020934791,0.00002219611,0.8655448,0.00026415213,0.020948932,0.011637723],"study_design_scores_gemma":[0.005273307,0.0026902051,0.182387,0.00006179241,0.0003373483,0.0030815185,0.00051982974,0.00025040846,0.51260406,0.0001607263,0.2924712,0.00016260202],"about_ca_topic_score_codex":0.000016937865,"about_ca_topic_score_gemma":0.000089609945,"teacher_disagreement_score":0.35294074,"about_ca_system_score_codex":0.00009695316,"about_ca_system_score_gemma":0.00014538312,"threshold_uncertainty_score":0.75252384},"labels":[],"label_agreement":null},{"id":"W3182741432","doi":"10.1093/neuonc/noab164","title":"Selumetinib for optic pathway glioma: Seeing through the fog, (not yet) the end of the tunnel?","year":2021,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Glioma; Selumetinib; Medicine; Internal medicine; Cancer research; Cancer","score_opus":0.041005595553394725,"score_gpt":0.2994889941255563,"score_spread":0.25848339857216157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3182741432","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08784483,0.0017598366,0.0000118568405,0.9002301,0.0033593818,0.0029159647,0.00018201588,0.000045110635,0.0036508802],"genre_scores_gemma":[0.29109818,0.00021030345,0.0003803826,0.7019056,0.0041469783,0.001422372,0.00019807855,0.0001865933,0.00045153793],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965785,0.0007795328,0.0006997907,0.00070969114,0.00056355394,0.00066892826],"domain_scores_gemma":[0.99094355,0.0066033853,0.0006331325,0.001502509,0.00026324578,0.000054204418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004031004,0.0005052499,0.0010950369,0.000077960256,0.00036583655,0.000042112206,0.000690168,0.00079174194,0.00019786973],"category_scores_gemma":[0.0009233904,0.00022729312,0.0008555347,0.0004111697,0.0005516625,0.000036199734,0.00036012844,0.0017012357,0.000023228717],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012010753,0.00047359502,0.00016661153,0.00029593369,0.00076622656,0.0032567969,0.0015138341,0.000016135864,0.043879572,0.0006650089,0.94387215,0.004974],"study_design_scores_gemma":[0.002522119,0.0010115099,0.00038463448,0.00014255136,0.0013528597,0.0013569879,0.0003263262,0.00002883179,0.04147142,0.00027520917,0.95094573,0.00018182727],"about_ca_topic_score_codex":0.00008086024,"about_ca_topic_score_gemma":0.00004886583,"teacher_disagreement_score":0.20325334,"about_ca_system_score_codex":0.00024387674,"about_ca_system_score_gemma":0.0008361203,"threshold_uncertainty_score":0.92687446},"labels":[],"label_agreement":null},{"id":"W3186420077","doi":"10.1093/neuonc/noab172","title":"SNO 2020 diversity survey: defining demographics, racial biases, career success metrics and a path forward for the field of neuro-oncology","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Diversity and Career in Medicine","field":"Social Sciences","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"National Institute of Neurological Disorders and Stroke; National Institutes of Health","keywords":"Mentorship; Diversity (politics); Ethnic group; Oncology; Clinical Oncology; Medicine; Internal medicine; Medical education; Psychology; Political science; Cancer","score_opus":0.062953334179413,"score_gpt":0.34059270574443024,"score_spread":0.2776393715650172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3186420077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9437774,0.0035008562,0.0018647504,0.03614984,0.0068075396,0.0010258931,0.00048897037,0.000091206,0.0062935646],"genre_scores_gemma":[0.9849141,0.0031925337,0.00028841328,0.011167884,0.00033310088,0.000014136652,0.000042474498,0.000012257712,0.000035082303],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99685246,0.0013040175,0.0003052255,0.00044030655,0.000621504,0.00047647208],"domain_scores_gemma":[0.9744052,0.02426792,0.0002485267,0.00023829986,0.0006337645,0.00020624224],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0029876977,0.00015982153,0.00052422035,0.00014588573,0.0012063724,0.000048675684,0.00073129847,0.00039027416,0.00011487644],"category_scores_gemma":[0.016464386,0.00014424497,0.00017205431,0.0011224742,0.0008208271,0.00013854966,0.0009645001,0.0004716003,0.0000025146005],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005662527,0.0002437001,0.82624286,0.000056640292,0.00016555825,0.00043121248,0.013623882,0.000020129366,0.0005167936,0.004141026,0.07455374,0.07943821],"study_design_scores_gemma":[0.003297558,0.0027655968,0.059671987,0.000023485194,0.0007443558,0.00003233134,0.027220946,0.0001961033,0.0004955696,0.0007049145,0.90447134,0.0003758288],"about_ca_topic_score_codex":0.0036282698,"about_ca_topic_score_gemma":0.025812462,"teacher_disagreement_score":0.8299176,"about_ca_system_score_codex":0.00009506483,"about_ca_system_score_gemma":0.0008110044,"threshold_uncertainty_score":0.9919639},"labels":[],"label_agreement":null},{"id":"W3197841440","doi":"10.1093/neuonc/noab205","title":"Single-cell transcriptome and genome analysis: A much-needed tool for pituitary neuroendocrine tumor studies","year":2021,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Transcriptome; Computational biology; Genome; Pituitary tumors; Biology; Bioinformatics; Genetics; Gene; Endocrinology; Gene expression","score_opus":0.04060059740498982,"score_gpt":0.296075306838956,"score_spread":0.25547470943396616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3197841440","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3729891,0.028953537,0.00007482772,0.5908934,0.0016063392,0.0030122672,0.0007612273,0.00022073078,0.0014885677],"genre_scores_gemma":[0.091897875,0.0030893444,0.0009084565,0.89601237,0.0020945002,0.00077717466,0.0032082137,0.00019622377,0.0018158695],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964092,0.00026254426,0.00077666965,0.0013042201,0.00034456793,0.0009027905],"domain_scores_gemma":[0.99780095,0.00084592873,0.00028310218,0.00064711913,0.0002379588,0.00018493421],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00009195844,0.00075906405,0.0025613639,0.0006718113,0.00018401041,0.000036660433,0.00018570585,0.0002595796,0.00011142519],"category_scores_gemma":[0.00018646364,0.0006460904,0.00078525185,0.00052317,0.0002240989,0.00008707868,0.00011998947,0.0011023517,0.000013099248],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017359344,0.00280332,0.002842818,0.0031557896,0.013636938,0.13456574,0.0009898989,0.0000098475375,0.07965522,0.000007463709,0.7582045,0.0023925172],"study_design_scores_gemma":[0.010252209,0.006001529,0.0005742829,0.00004341512,0.016453596,0.0022805799,0.00051971304,0.000035283236,0.00061203405,0.00011948768,0.9625472,0.0005606764],"about_ca_topic_score_codex":0.00004767399,"about_ca_topic_score_gemma":0.00005577322,"teacher_disagreement_score":0.30511895,"about_ca_system_score_codex":0.0002231324,"about_ca_system_score_gemma":0.0003102569,"threshold_uncertainty_score":0.99959904},"labels":[],"label_agreement":null},{"id":"W3198752233","doi":"10.1093/neuonc/noab210","title":"The benefit of early surgery on overall survival in incidental low-grade glioma patients: A multicenter study","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Glioma; Multivariate analysis; Univariate analysis; Surgery; Surgical resection; Radiological weapon; Multicenter study; Radiology; Internal medicine; Randomized controlled trial","score_opus":0.02317050830082183,"score_gpt":0.2951102802211432,"score_spread":0.27193977192032137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3198752233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968244,0.00007713005,7.0586026e-8,0.0012717218,0.00090620475,0.000655415,0.000014869998,0.000014748428,0.00023546787],"genre_scores_gemma":[0.999198,0.000053524403,0.000006183021,0.00052712305,0.00006425415,0.000095946,0.000021328648,0.000023634782,0.000009986701],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981535,0.0003173963,0.0005012837,0.00034862684,0.00036968803,0.00030950684],"domain_scores_gemma":[0.9972819,0.0019490652,0.00016203952,0.0003658244,0.0001397792,0.00010137239],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020717211,0.00017327575,0.00053175335,0.00015316323,0.000060110302,0.000015583173,0.00008760021,0.00009014452,0.000043134598],"category_scores_gemma":[0.00043799612,0.00011187417,0.00016091272,0.00025520034,0.00005943296,0.000043438926,0.00011422932,0.00021406925,0.000024431703],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007970074,0.013858946,0.96384186,0.000012695211,0.00010657072,0.00313928,0.0005772343,0.000004960149,0.010342174,0.000035270794,0.0003077179,0.006976272],"study_design_scores_gemma":[0.00831164,0.0027533842,0.97139347,0.000047728507,0.00007795696,0.000017217015,0.00039494009,0.000011907778,0.015682878,0.000015419224,0.0012108604,0.00008259318],"about_ca_topic_score_codex":0.00030162625,"about_ca_topic_score_gemma":0.0013446329,"teacher_disagreement_score":0.011105562,"about_ca_system_score_codex":0.00023192981,"about_ca_system_score_gemma":0.00012869394,"threshold_uncertainty_score":0.45620963},"labels":[],"label_agreement":null},{"id":"W3199027842","doi":"10.1093/neuonc/noab180.043","title":"OS10.5.A BrainWear: Longitudinal, objective assessment of physical activity in 42 HGG patients","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Stroke Rehabilitation and Recovery","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biobank; Medicine; Accelerometer; Physical activity; Longitudinal study; Quality of life (healthcare); Physical therapy; Physical medicine and rehabilitation; Computer science; Pathology; Bioinformatics","score_opus":0.023590876452461048,"score_gpt":0.36074223704773156,"score_spread":0.3371513605952705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3199027842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845735,0.000015144464,0.000049745373,0.0012311572,0.0004905996,0.00033783918,0.000011365689,0.000018001238,0.01327266],"genre_scores_gemma":[0.99902314,0.000024242267,0.0003572578,0.00035528748,0.000106142,0.00003077234,0.000010924059,0.00001405706,0.00007819872],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986436,0.00036083817,0.0002055675,0.00034074852,0.00024598776,0.00020330712],"domain_scores_gemma":[0.9979357,0.0014100441,0.00012156085,0.00022218241,0.00022229509,0.00008818829],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001259501,0.000119991746,0.0005263162,0.00013314585,0.000024972636,0.000003981413,0.00004823782,0.00011799616,0.00009625985],"category_scores_gemma":[0.0007955008,0.00010735,0.00017227793,0.00030636336,0.000120028584,0.00006702695,0.00007229244,0.00038269034,0.000013093129],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002534285,0.0049124938,0.73175246,0.00010177505,0.000054320015,0.0001742221,0.00056821224,0.00003004811,0.23519018,0.00020735686,0.0004209254,0.026334563],"study_design_scores_gemma":[0.002921218,0.0026547227,0.97224927,0.000034162415,0.000041040457,0.000027927337,0.00020299735,0.00037585222,0.01755871,0.000054320753,0.0038018178,0.00007795365],"about_ca_topic_score_codex":0.000025962845,"about_ca_topic_score_gemma":0.000032816162,"teacher_disagreement_score":0.24049681,"about_ca_system_score_codex":0.00035407394,"about_ca_system_score_gemma":0.0006584866,"threshold_uncertainty_score":0.43776062},"labels":[],"label_agreement":null},{"id":"W3199163722","doi":"10.1093/neuonc/noab214","title":"Recent advances and new discoveries in the pipeline of the treatment of primary spinal tumors and spinal metastases: a scoping review of registered clinical studies from 2000 to 2020","year":2021,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Toronto Western Hospital; St. Michael's Hospital; Sunnybrook Health Science Centre; Toronto Rehabilitation Institute; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Pipeline (software); Computer science","score_opus":0.21680980812596296,"score_gpt":0.48633851246172133,"score_spread":0.2695287043357584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3199163722","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00048057977,0.99097484,0.000008118141,0.0041314047,0.00020896063,0.003941469,0.00013608474,0.000003462662,0.000115058785],"genre_scores_gemma":[0.0000055060045,0.99664676,0.0010127969,0.001971247,0.00010907178,0.00014524534,0.00005880895,0.000019968844,0.000030602227],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9947515,0.0018616382,0.0022156483,0.0005823296,0.00039812186,0.00019076656],"domain_scores_gemma":[0.99616367,0.0013119169,0.0015312771,0.0007611519,0.000112436406,0.000119544886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000978238,0.0003721026,0.00496486,0.000093567345,0.00002508202,0.0000063225775,0.00022847639,0.0000682463,0.000056653258],"category_scores_gemma":[0.0026134711,0.00019427815,0.00040433204,0.00043895934,0.00046128465,0.000046824738,0.00026956396,0.00021739736,5.305543e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005020052,0.0005844422,0.0000820963,0.15211734,0.00027294,0.00020131597,0.00017915315,1.2080662e-7,0.0000018438177,0.000010771092,0.0017505143,0.84429747],"study_design_scores_gemma":[0.0013601591,0.0042148326,0.00020179157,0.25546318,0.0057298397,0.000054194123,0.0003765241,2.3535972e-7,0.0000029559728,0.000013741605,0.7324804,0.00010216603],"about_ca_topic_score_codex":0.000036788653,"about_ca_topic_score_gemma":0.00010331542,"teacher_disagreement_score":0.8441953,"about_ca_system_score_codex":0.00012752946,"about_ca_system_score_gemma":0.0017751429,"threshold_uncertainty_score":0.7922433},"labels":[],"label_agreement":null},{"id":"W3200062275","doi":"10.1093/neuonc/noab180.013","title":"JS01.4.A The neurocognitive function changes with awake craniotomy for low-grade glioma in the left hemispheric eloquent regions","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Neurocognitive; Medicine; Perioperative; Cognition; Craniotomy; Glioma; Awake craniotomy; Effects of sleep deprivation on cognitive performance; Brain tumor; Anesthesia; Psychiatry","score_opus":0.02718965427623115,"score_gpt":0.2911649513503074,"score_spread":0.26397529707407624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200062275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8991417,0.00061777973,0.00013540307,0.095125854,0.000442561,0.002227668,0.000015772095,0.000050770715,0.00224244],"genre_scores_gemma":[0.9845536,0.00018085506,0.000082468425,0.0132184345,0.00029640307,0.001522835,0.000049575254,0.00003690579,0.000058966678],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984505,0.00031267156,0.00019372217,0.00044455103,0.00022415788,0.00037439645],"domain_scores_gemma":[0.9980994,0.0011376765,0.00012089157,0.00039904876,0.0001591767,0.00008379674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017630919,0.00021672751,0.0003540586,0.0000701966,0.00018557308,0.000028403016,0.000108293534,0.00011517425,0.00007892186],"category_scores_gemma":[0.00017806515,0.000116600524,0.00011903179,0.00044262063,0.00013089972,0.00003157364,0.000041384857,0.00029026702,0.000014593846],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031430717,0.013404991,0.037077498,0.0003776465,0.0010386017,0.023731038,0.010095848,0.00008909763,0.77655077,0.004560753,0.06076673,0.069163956],"study_design_scores_gemma":[0.021376666,0.009779876,0.1440301,0.00020858548,0.0016326748,0.008159273,0.0103799105,0.00019457626,0.10031013,0.00049203954,0.70300496,0.00043123963],"about_ca_topic_score_codex":0.000026856478,"about_ca_topic_score_gemma":0.00071434473,"teacher_disagreement_score":0.6762406,"about_ca_system_score_codex":0.00010755387,"about_ca_system_score_gemma":0.00023233701,"threshold_uncertainty_score":0.47548312},"labels":[],"label_agreement":null},{"id":"W3200402883","doi":"10.1093/neuonc/noab227","title":"Impact of the methylation classifier and ancillary methods on CNS tumor diagnostics","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute; National Institutes of Health; Center for Cancer Research","keywords":"Classifier (UML); Confidence interval; Medicine; Methylation; Oncology; DNA methylation; Brain tumor; Artificial intelligence; Internal medicine; Pathology; Computer science; Biology","score_opus":0.04601508791301511,"score_gpt":0.3890986404856309,"score_spread":0.3430835525726158,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200402883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99215055,0.0008532489,0.000035143647,0.0035778566,0.00035786995,0.00026736606,0.000016356837,0.000012949895,0.0027286916],"genre_scores_gemma":[0.99607486,0.00046635896,0.0016766088,0.0016315337,0.00008687771,0.000027314542,0.000008278853,0.000016017995,0.000012147682],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988429,0.000436612,0.00020804169,0.00022274206,0.00013150464,0.00015819237],"domain_scores_gemma":[0.9972341,0.0021274681,0.00011912795,0.00030456687,0.00011896654,0.00009577816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018069513,0.00011925495,0.00034629487,0.000054594646,0.000050409693,0.000005845631,0.00004017899,0.00009343735,0.00007807944],"category_scores_gemma":[0.0017545577,0.00007184059,0.00014955281,0.00020636157,0.0000839551,0.000019265124,0.000065835964,0.00018183488,0.0000044949734],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000120347504,0.0010636742,0.3045522,0.00002606433,0.00017685516,0.00061716425,0.00020366027,0.000037227142,0.6048072,0.00048209113,0.0040739304,0.083839566],"study_design_scores_gemma":[0.0018084372,0.0019632897,0.7426012,0.000028399638,0.00029246957,0.00030517147,0.000047322712,0.00016607947,0.22975866,0.00022291263,0.022742251,0.000063760126],"about_ca_topic_score_codex":0.000016491706,"about_ca_topic_score_gemma":0.000014818632,"teacher_disagreement_score":0.43804902,"about_ca_system_score_codex":0.0001510698,"about_ca_system_score_gemma":0.00032184212,"threshold_uncertainty_score":0.29295745},"labels":[],"label_agreement":null},{"id":"W3200623012","doi":"10.1093/neuonc/noab180.181","title":"P14.76 Bevacizumab (BEV) alone or in combination with chemotherapy in recurrent Glioblastoma Multiforme (GBM): A real world experience","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Saskatchewan Cancer Agency","funders":"","keywords":"Medicine; Bevacizumab; Chemotherapy; Internal medicine; Cohort; Glioblastoma; Oncology; Retrospective cohort study; Surgery; Population","score_opus":0.022970938212678243,"score_gpt":0.3236547406914029,"score_spread":0.3006838024787246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200623012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891841,0.000098839606,0.0000048772295,0.008720185,0.00024082772,0.0007322168,0.0000037951572,0.00004645558,0.0009687014],"genre_scores_gemma":[0.9967285,0.0004769866,0.0005936956,0.0015411063,0.00005145422,0.00047113225,0.000028546157,0.0000328393,0.00007577829],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9981691,0.000166496,0.0004484641,0.0005353489,0.00027729277,0.00040329507],"domain_scores_gemma":[0.99893934,0.0003493676,0.00013876545,0.00032253118,0.000108407134,0.00014161432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012001655,0.000231687,0.00059066864,0.00036169295,0.0000428109,0.000016404774,0.00008779432,0.00012442238,0.00025304168],"category_scores_gemma":[0.00013992561,0.00016228852,0.000056796867,0.0010081765,0.00009398806,0.00009212957,0.00004886685,0.0003038065,0.000022289147],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025910746,0.025065564,0.369979,0.00015848337,0.00013290804,0.03409362,0.014822295,0.000050714865,0.14461131,0.0004912787,0.0018178171,0.38286626],"study_design_scores_gemma":[0.09673094,0.025247712,0.5300441,0.0006306318,0.00011068033,0.0016289806,0.0027642858,0.0018544556,0.2640517,0.00009636937,0.07619861,0.0006415897],"about_ca_topic_score_codex":0.0001847264,"about_ca_topic_score_gemma":0.022705866,"teacher_disagreement_score":0.38222468,"about_ca_system_score_codex":0.00077050814,"about_ca_system_score_gemma":0.00040516944,"threshold_uncertainty_score":0.9951272},"labels":[],"label_agreement":null},{"id":"W3200626583","doi":"10.1093/neuonc/noab213","title":"A molecularly integrated grade for meningioma","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":223,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute of General Medical Sciences; National Cancer Institute; Brain Tumour Charity; Brain Science Foundation","keywords":"Meningioma; Grading (engineering); Medicine; CDKN2A; Cohort; Proportional hazards model; Oncology; Radiosurgery; Radiology; Internal medicine; Radiation therapy; Cancer; Biology","score_opus":0.039975119889256755,"score_gpt":0.32312395743146904,"score_spread":0.2831488375422123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200626583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92383283,0.00050315,0.018943608,0.019158708,0.0012838095,0.0011826371,0.000015275571,0.0002445752,0.0348354],"genre_scores_gemma":[0.9679569,0.000010824269,0.025363829,0.0040794727,0.00024548633,0.00025879708,0.00015870928,0.000049811588,0.0018761404],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985424,0.00014082828,0.0003181282,0.00044371182,0.000182597,0.00037228962],"domain_scores_gemma":[0.99894655,0.00022416924,0.00008771648,0.00035513932,0.0002057494,0.00018065627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019524388,0.00017124605,0.00042478862,0.00013821045,0.000081537066,0.000026123224,0.00010456796,0.000147445,0.00018883961],"category_scores_gemma":[0.0004718028,0.00015715983,0.00018617671,0.0003398137,0.000052516963,0.00004386085,0.00008506422,0.00021680529,0.000050970917],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032292414,0.00032184587,0.0003258742,0.00006857516,0.00014596373,0.015438227,0.0002744354,0.0000035112344,0.94572854,0.0055409423,0.020530734,0.011298416],"study_design_scores_gemma":[0.0037446446,0.0022342554,0.0004815096,0.000026196256,0.00028028892,0.0034978935,0.00031826663,0.0011514626,0.14079535,0.00055503065,0.846741,0.00017407023],"about_ca_topic_score_codex":0.00000820501,"about_ca_topic_score_gemma":0.000005049108,"teacher_disagreement_score":0.8262103,"about_ca_system_score_codex":0.00013214872,"about_ca_system_score_gemma":0.0003497038,"threshold_uncertainty_score":0.64087915},"labels":[],"label_agreement":null},{"id":"W3202924187","doi":"10.1093/neuonc/noab235","title":"DNA methylation-based prognostic subtypes of chordoma tumors in tissue and plasma","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Bone Tumor Diagnosis and Treatments","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research; Beijing Municipal Science and Technology Commission; Canada Research Chairs; Terry Fox Research Institute; Canadian Cancer Society; National Institutes of Health; Ontario Institute for Cancer Research; Natural Sciences and Engineering Research Council of Canada; Princess Margaret Cancer Foundation","keywords":"DNA methylation; Chordoma; Methylation; Cancer research; DNA; Biology; Pathology; Medicine; Genetics; Gene; Gene expression","score_opus":0.01921135623655127,"score_gpt":0.30150047928464474,"score_spread":0.28228912304809345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3202924187","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99480003,0.0004677668,0.0000038289304,0.0025957332,0.00011371883,0.00033339733,0.0000073986334,0.000018830846,0.0016592857],"genre_scores_gemma":[0.99874246,0.000055196393,0.00061110564,0.00040873053,0.00003070204,0.00005823843,0.000027977963,0.000016577776,0.00004899757],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990425,0.00013617349,0.0002766994,0.00026176657,0.00011440821,0.00016843838],"domain_scores_gemma":[0.9986635,0.00092293706,0.000094872725,0.00015579518,0.0000751504,0.000087729866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009235634,0.000111466245,0.0004194348,0.00011021435,0.000021358539,0.0000043996283,0.000030625477,0.00008177503,0.00014414315],"category_scores_gemma":[0.00057423924,0.00010069559,0.00003448195,0.000226062,0.00007955777,0.000026211414,0.000026176023,0.00013358776,0.000018113278],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021946066,0.0012512065,0.7739235,0.000111627116,0.000033577282,0.003456532,0.00015003422,0.000018832592,0.1861076,0.0001952723,0.0002012779,0.03433104],"study_design_scores_gemma":[0.0048711845,0.0019359387,0.6259036,0.00008238234,0.00013601707,0.0002496263,0.000057163215,0.00030329954,0.35579836,0.00009739566,0.0104740225,0.000091016256],"about_ca_topic_score_codex":0.00004821136,"about_ca_topic_score_gemma":0.0002147056,"teacher_disagreement_score":0.16969077,"about_ca_system_score_codex":0.000059039055,"about_ca_system_score_gemma":0.00032782982,"threshold_uncertainty_score":0.4106247},"labels":[],"label_agreement":null},{"id":"W3206367283","doi":"10.1093/neuonc/noab245","title":"Accuracy of central neuro-imaging review of DIPG compared with histopathology in the International DIPG Registry","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; BC Children's Hospital; University of British Columbia; Hospital for Sick Children","funders":"National Cancer Institute; Agency for Healthcare Research and Quality; Isabella and Marcus Foundation; Robert Connor Dawes Foundation; Cure Brain Cancer Foundation; Brooke Healey Foundation; Reflections of Grace Foundation; Jeffrey Thomas Hayden Foundation; Cure Starts Now Foundation; Musella Foundation For Brain Tumor Research and Information","keywords":"Medical diagnosis; Histopathology; Medicine; Radiology; Biopsy; Stereotactic biopsy; Medical imaging; Magnetic resonance imaging; Pathology","score_opus":0.02741761961563569,"score_gpt":0.31952144682370054,"score_spread":0.2921038272080648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3206367283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9171799,0.012982002,0.000014307429,0.060351204,0.00056834467,0.00055336516,0.000026708478,0.000016265954,0.008307929],"genre_scores_gemma":[0.9841112,0.0052742297,0.00023282428,0.010189165,0.00006384516,0.000047671336,0.000061059494,0.000012588854,0.0000074186146],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985775,0.00027228263,0.00044344616,0.00027070873,0.00023522756,0.00020084373],"domain_scores_gemma":[0.99817973,0.00084792357,0.00033459713,0.00041070007,0.00017531986,0.00005171683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017243063,0.00012492925,0.0005347837,0.00007089108,0.000018882509,0.000004006528,0.00020047069,0.000042047126,0.00013798501],"category_scores_gemma":[0.000923207,0.00008426961,0.00009805495,0.00021464274,0.00015482356,0.000036434398,0.000076469405,0.0002272342,0.000002703109],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046014457,0.003573889,0.72106713,0.0014073815,0.000082862505,0.016260013,0.000743244,0.000014688516,0.21297841,0.0014933263,0.017040199,0.024878712],"study_design_scores_gemma":[0.00800035,0.001122811,0.5046667,0.0023466402,0.0005315076,0.007455513,0.00047605674,0.00013020469,0.022073003,0.000072713185,0.45294163,0.00018290729],"about_ca_topic_score_codex":0.00003753503,"about_ca_topic_score_gemma":0.000057579684,"teacher_disagreement_score":0.43590143,"about_ca_system_score_codex":0.000113655,"about_ca_system_score_gemma":0.0003344185,"threshold_uncertainty_score":0.3436415},"labels":[],"label_agreement":null},{"id":"W3207478520","doi":"10.1093/neuonc/noab238","title":"Improving the noninvasive classification of glioma genetic subtype with deep learning and diffusion-weighted imaging","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute of General Medical Sciences; National Cancer Institute","keywords":"Convolutional neural network; Radiogenomics; Diffusion MRI; Glioma; Magnetic resonance imaging; Artificial intelligence; Medicine; Computer science; Machine learning; Radiology; Nuclear medicine; Radiomics; Cancer research","score_opus":0.011456615099725105,"score_gpt":0.2578165132133335,"score_spread":0.2463598981136084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3207478520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994684,0.0014532723,0.0001691848,0.0027735485,0.00008238938,0.00025015062,9.469296e-7,0.000022531505,0.00056399923],"genre_scores_gemma":[0.9984974,0.00022588552,0.00085749367,0.00028411407,0.00005496892,0.000041267314,0.000011549879,0.000019580742,0.000007693549],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99908036,0.00014644254,0.0001892222,0.00027835698,0.00013642936,0.00016919768],"domain_scores_gemma":[0.99887925,0.0004977722,0.00017431032,0.00018900773,0.00018721652,0.000072468574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006428301,0.00011246194,0.0002421834,0.000071876544,0.00011993397,0.000013926577,0.00004070564,0.000054386997,0.000044692413],"category_scores_gemma":[0.00017591073,0.00007101684,0.00003807354,0.0002286918,0.00012389806,0.000025417961,0.00006244517,0.00017684017,0.0000041520548],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008379892,0.0001884778,0.18485445,0.000023843491,0.00003452561,0.0010932271,0.00031699057,0.0000028587717,0.7375219,0.000068663845,0.000016485566,0.07579478],"study_design_scores_gemma":[0.0066079213,0.0019338074,0.60312605,0.000083555155,0.0007139099,0.0048534065,0.002271571,0.011291432,0.3625422,0.000050046445,0.00634256,0.00018350828],"about_ca_topic_score_codex":0.00003237373,"about_ca_topic_score_gemma":0.000061493636,"teacher_disagreement_score":0.4182716,"about_ca_system_score_codex":0.000060540086,"about_ca_system_score_gemma":0.00017352517,"threshold_uncertainty_score":0.28959826},"labels":[],"label_agreement":null},{"id":"W3208793479","doi":"10.1093/neuonc/noab249","title":"The data behind the image—Deep learning and its potential impact in neuro-oncological imaging","year":2021,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mental Health Research Canada; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Deep learning; Artificial intelligence; Computer science; Data science","score_opus":0.02253871348312259,"score_gpt":0.34445580765706363,"score_spread":0.32191709417394104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3208793479","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017442571,0.0060721436,0.00018439855,0.97078097,0.0022166662,0.0008945987,0.000024117937,0.00011342121,0.0022710892],"genre_scores_gemma":[0.074516386,0.009648745,0.0006091896,0.89935803,0.013458518,0.00011015532,0.0012754296,0.00033343642,0.0006901094],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9932318,0.0024822918,0.0008749947,0.0014168749,0.0007394019,0.0012546751],"domain_scores_gemma":[0.99198353,0.0059474,0.00051179185,0.0011327782,0.00016927505,0.00025524007],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0021537188,0.00062990387,0.0011961183,0.00021620521,0.0006864559,0.0003554401,0.0012680267,0.0007478135,0.00025689186],"category_scores_gemma":[0.009365461,0.00036412344,0.00025995463,0.0002946285,0.00082630315,0.00017949588,0.0019131933,0.015324366,0.000036421727],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027888457,0.00014906119,0.0047675543,0.0001380755,0.00019801641,0.05711928,0.00041656915,0.0000903451,0.027587667,0.000012943706,0.7461228,0.16311882],"study_design_scores_gemma":[0.0018140187,0.00048120823,0.0024570513,0.00007217691,0.00035482773,0.009300169,0.0001913734,0.07071426,0.000021499323,0.00005085688,0.9142346,0.0003079569],"about_ca_topic_score_codex":0.00009772302,"about_ca_topic_score_gemma":0.000026285705,"teacher_disagreement_score":0.16811183,"about_ca_system_score_codex":0.00030146205,"about_ca_system_score_gemma":0.00078174094,"threshold_uncertainty_score":0.9998811},"labels":[],"label_agreement":null},{"id":"W3211085456","doi":"10.1093/neuonc/noab252","title":"EANO, SNO and Euracan consensus review on the current management and future development of intracranial germ cell tumors in adolescents and young adults","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":148,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute","keywords":"Medicine; Radiation therapy; Germ cell tumors; Germinoma; Chemotherapy; Biopsy; Population; Chemoradiotherapy; Disease; Surgery; Incidence (geometry); Oncology; Internal medicine","score_opus":0.014894473166292426,"score_gpt":0.2745480269951017,"score_spread":0.2596535538288093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211085456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9695516,0.02350607,2.3257672e-7,0.0053894273,0.00025811951,0.000799746,0.0000053713843,0.0000069707917,0.00048241415],"genre_scores_gemma":[0.9621169,0.036149647,0.00016755548,0.0014251075,0.00006031449,0.00005800778,0.000007392681,0.000011790511,0.0000033120596],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9987855,0.00016969482,0.00036381301,0.0003385056,0.00015661078,0.00018587222],"domain_scores_gemma":[0.99944276,0.00010513268,0.00013470645,0.00016316526,0.00005137539,0.00010288629],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016999128,0.00016731105,0.00040878518,0.000065989356,0.000052447715,0.0000072375105,0.000036753565,0.000045824665,0.000014898037],"category_scores_gemma":[0.00004568575,0.0001137377,0.000027389095,0.00012507931,0.00007727231,0.000009789935,0.000105038685,0.0002197974,0.000002323912],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034378734,0.0014697664,0.12636618,0.0037423293,0.00005434098,0.0029763023,0.00085712527,1.3978779e-7,0.0024909775,0.00013678368,0.0012620882,0.8603002],"study_design_scores_gemma":[0.00781839,0.000797967,0.8964119,0.00509267,0.00028080036,0.00060168485,0.0006203102,0.000023636108,0.0050220573,0.000019063124,0.083112255,0.00019928034],"about_ca_topic_score_codex":0.0000048933516,"about_ca_topic_score_gemma":0.00008525747,"teacher_disagreement_score":0.8601009,"about_ca_system_score_codex":0.00006523705,"about_ca_system_score_gemma":0.00009895231,"threshold_uncertainty_score":0.46380886},"labels":[],"label_agreement":null},{"id":"W3211524163","doi":"10.1093/neuonc/noab196.080","title":"STEM-04. PD-1 INDEPENDENT OF PD-L1 LIGATION PROMOTES GLIOBLASTOMA GROWTH THROUGH THE NFkB PATHWAY","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Glioblastoma; Cancer research; PD-L1; Immune system; Stem cell; Biology; Cell biology; Immunology; Immunotherapy","score_opus":0.017812823253044455,"score_gpt":0.2927611497394863,"score_spread":0.27494832648644185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211524163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99273634,0.0010021343,0.000115557996,0.0017807601,0.0002745549,0.00038096283,0.00005684506,0.000013298086,0.0036395236],"genre_scores_gemma":[0.9982596,0.0004618979,0.00008427929,0.00056969136,0.00018979596,0.0000954263,0.0000661115,0.00002303886,0.00025016567],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984721,0.00030377318,0.0002546721,0.00041363487,0.00024491813,0.00031091584],"domain_scores_gemma":[0.99904305,0.00010077083,0.00014150185,0.00040548257,0.00023098559,0.000078187935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012709398,0.00015566485,0.00021487949,0.000027474423,0.00010055352,0.000020429272,0.00022818317,0.00018844538,0.000051185812],"category_scores_gemma":[0.00016209789,0.00011842153,0.00012193868,0.00016739011,0.00015072258,0.000008044834,0.0002574212,0.00018663747,0.000019999134],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037730517,0.00033942863,0.0015064824,0.000031298707,0.000115046605,0.00014774363,0.00023813822,0.0000078533585,0.98590446,0.00031072547,0.0017122207,0.009309307],"study_design_scores_gemma":[0.0010953973,0.0022877373,0.0009431671,0.00000874832,0.000023042327,0.00015319558,0.0001652414,0.000008626739,0.9311801,0.00038392877,0.063656844,0.000093962044],"about_ca_topic_score_codex":0.00011947023,"about_ca_topic_score_gemma":0.000720352,"teacher_disagreement_score":0.061944623,"about_ca_system_score_codex":0.00006425462,"about_ca_system_score_gemma":0.00060335966,"threshold_uncertainty_score":0.482909},"labels":[],"label_agreement":null},{"id":"W3212593103","doi":"10.1093/neuonc/noab259","title":"Consensus core clinical data elements for meningiomas (v2021.1)","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research; Brain Tumour Charity","keywords":"Medicine; Data sharing; Medical physics; Core (optical fiber); Meningioma; Process (computing); Computer science; Pathology; Alternative medicine","score_opus":0.2623891071117285,"score_gpt":0.45603660722943723,"score_spread":0.1936475001177087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212593103","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94980127,0.0004611676,0.0009243956,0.017418059,0.0037367393,0.0014870353,0.0001554245,0.00016299651,0.02585293],"genre_scores_gemma":[0.8929411,0.00010761663,0.08470204,0.011856597,0.0022644382,0.00020559918,0.0025560984,0.00014154565,0.0052249394],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971648,0.00024330597,0.0009262198,0.000901262,0.00027773238,0.0004867066],"domain_scores_gemma":[0.99663556,0.0012767941,0.00025029163,0.0013193991,0.0002324356,0.00028551402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011244453,0.00020328148,0.00068997627,0.00008940666,0.00012205572,0.000022552073,0.0003324133,0.00020904884,0.00041416587],"category_scores_gemma":[0.0023790763,0.00019411248,0.00016720865,0.00021346164,0.00013621738,0.000039664003,0.0006582371,0.00031804747,0.000110280336],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001299211,0.0013826897,0.04308967,0.00021464718,0.0007145476,0.032705024,0.00014614055,0.0000023670414,0.11260153,0.0032055494,0.7411621,0.06347647],"study_design_scores_gemma":[0.006168755,0.0021409048,0.0032407977,0.000025279478,0.00051596586,0.0020502273,0.00022007557,0.0027926816,0.0017179251,0.000251603,0.9806961,0.0001797305],"about_ca_topic_score_codex":0.000004024461,"about_ca_topic_score_gemma":0.000009563093,"teacher_disagreement_score":0.23953392,"about_ca_system_score_codex":0.00008171657,"about_ca_system_score_gemma":0.0006302019,"threshold_uncertainty_score":0.79156774},"labels":[],"label_agreement":null},{"id":"W3213185511","doi":"10.1093/neuonc/noab196.005","title":"EPCO-06. AGE- AND REGION-SPECIFIC MULTI-OMIC CHARACTERIZATION OF H3-K27M MUTANT DIFFUSE MIDLINE GLIOMA","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Biology; Histone H3; Glioma; Cell; Chromatin; Pathology; Cancer research; Genetics; Medicine; Gene","score_opus":0.03576736390376401,"score_gpt":0.2876001096597463,"score_spread":0.2518327457559823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213185511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923629,0.0005749905,0.00009027155,0.0059937024,0.00038079312,0.0004035488,0.000026642118,0.000049101538,0.000118025164],"genre_scores_gemma":[0.99565816,0.0024101455,0.0003719268,0.0010335457,0.00016799541,0.00005127289,0.00022683627,0.00003524199,0.00004488033],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985866,0.00014369906,0.00042228092,0.00044745186,0.00015215507,0.00024779557],"domain_scores_gemma":[0.99883926,0.00022229829,0.00020401341,0.0003808981,0.00018392105,0.00016958585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006773202,0.00019534581,0.0005764741,0.00016582973,0.000058285455,0.000014517403,0.000060219358,0.0001756171,0.00008003974],"category_scores_gemma":[0.00014450269,0.00016992296,0.000091142574,0.0003301496,0.00013325112,0.000052477422,0.000081437625,0.00015721685,0.000026398327],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015758732,0.0021341555,0.011671385,0.000047209425,0.00006285641,0.0118832495,0.0003150165,5.5865854e-7,0.96036196,0.00015885549,0.00047824622,0.01272893],"study_design_scores_gemma":[0.011808737,0.0011204914,0.2055403,0.00007970856,0.00021923872,0.0024445252,0.00009683487,0.00020587961,0.648416,0.000022755365,0.12986687,0.00017864196],"about_ca_topic_score_codex":0.000009227744,"about_ca_topic_score_gemma":0.00001924978,"teacher_disagreement_score":0.31194595,"about_ca_system_score_codex":0.00010397442,"about_ca_system_score_gemma":0.00012071358,"threshold_uncertainty_score":0.69292575},"labels":[],"label_agreement":null},{"id":"W3213465860","doi":"10.1093/neuonc/noab196.468","title":"PATH-16. EVALUATION OF SEX-BASED DIFFERENCES IN CLINICAL OUTCOMES AND TUMOR GENOMICS IN PATIENTS WITH NEWLY DIAGNOSED IDH-WILDTYPE GLIOBLASTOMA RECEIVING CHEMORADIATION","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"CDKN2A; Hazard ratio; CDKN2B; Medicine; Internal medicine; Oncology; Cancer; Exome sequencing; Confidence interval; Biology; Gene; Mutation; Genetics","score_opus":0.037335554312836715,"score_gpt":0.3130729328709455,"score_spread":0.2757373785581088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213465860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99835134,0.000091517024,0.0000068642607,0.0004146071,0.00016401208,0.0008048892,0.0000056339095,0.000011550399,0.00014958504],"genre_scores_gemma":[0.99877286,0.000030492574,0.0005104496,0.00052859384,0.00003236275,0.00006374895,0.000038617247,0.000019527293,0.0000033727617],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976915,0.0006880618,0.0006353517,0.00040972317,0.0003745438,0.00020082969],"domain_scores_gemma":[0.997982,0.0011672407,0.00028863142,0.00024123353,0.00022530573,0.00009556011],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061894045,0.00016619946,0.00068148697,0.00016993935,0.00001957128,0.000007990659,0.000052245923,0.00012769041,0.000031575702],"category_scores_gemma":[0.0012556862,0.00013515036,0.0000563989,0.00024404716,0.00008305607,0.000050835864,0.00003581344,0.00024157055,0.0000023958378],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009045382,0.0010557891,0.965107,0.00004452365,0.000024206136,0.00018768554,0.00027176389,0.0000735938,0.0017781394,0.0000016632384,0.000010403042,0.030540653],"study_design_scores_gemma":[0.01753075,0.0038349857,0.97249293,0.000055387532,0.00014383323,0.000009981958,0.00012347296,0.0020579651,0.0035998248,0.0000199433,0.000032746106,0.000098185075],"about_ca_topic_score_codex":0.00007735224,"about_ca_topic_score_gemma":0.0008838712,"teacher_disagreement_score":0.030442467,"about_ca_system_score_codex":0.0005671896,"about_ca_system_score_gemma":0.0008730799,"threshold_uncertainty_score":0.5511272},"labels":[],"label_agreement":null},{"id":"W3214849846","doi":"10.1093/neuonc/noab196.548","title":"NIMG-50. DEUTERIUM METABOLIC IMAGING OF THE ALTERNATIVE LENGTHENING OF TELOMERES PATHWAY REPORTS ON TUMOR BURDEN AND PSEUDOPROGRESSION IN LOW-GRADE GLIOMAS","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Mitochondrial Function and Pathology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotchkiss Brain Institute; Ontario Brain Institute","funders":"","keywords":"Telomere; Glioma; Glycolysis; Cancer research; Neurosphere; Flux (metallurgy); In vivo; Magnetic resonance imaging; Chemistry; Biology; Medicine; Enzyme; Biochemistry; In vitro; DNA; Endothelial stem cell; Radiology","score_opus":0.011982725583524596,"score_gpt":0.2696421688163785,"score_spread":0.2576594432328539,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214849846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99584836,0.0013312709,0.00004311513,0.00056912814,0.0011316547,0.00017649597,0.000009882945,0.000005624036,0.000884471],"genre_scores_gemma":[0.99856275,0.00021067567,0.0003986565,0.00045937605,0.00027911682,0.000017392034,0.000012284454,0.000018043824,0.000041689753],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983995,0.00046416942,0.00040922116,0.00041693816,0.00011901989,0.0001911713],"domain_scores_gemma":[0.9990571,0.00008689775,0.00035138207,0.00036276452,0.000094256386,0.000047573336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020101102,0.00014352481,0.0003189379,0.000084806714,0.000039924274,0.0000060854372,0.00011813879,0.00010918057,0.00002152207],"category_scores_gemma":[0.00043863783,0.00011102256,0.00009109924,0.00015034195,0.00017360716,0.000004648407,0.00023195204,0.0001840858,8.2285356e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015573784,0.00007430346,0.008724927,0.0000208968,0.000017504657,0.0003519127,0.0002409468,0.000071345916,0.98450476,0.00011270856,0.000074479765,0.0056504495],"study_design_scores_gemma":[0.0006379368,0.00029080562,0.0034148055,0.000039644736,0.000016206983,0.0009430496,0.00016897345,0.000049220973,0.9444091,0.00011142491,0.049826484,0.00009237426],"about_ca_topic_score_codex":0.00003525489,"about_ca_topic_score_gemma":0.0000355309,"teacher_disagreement_score":0.049752004,"about_ca_system_score_codex":0.000010896334,"about_ca_system_score_gemma":0.00015281643,"threshold_uncertainty_score":0.45273682},"labels":[],"label_agreement":null},{"id":"W3214977940","doi":"10.1093/neuonc/noab270","title":"Phase II trial of response-based radiation therapy for patients with localized germinoma: a Children’s Oncology Group study","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute; St. Baldrick's Foundation","keywords":"Germinoma; Radiation oncology; Medicine; Radiation therapy; Oncology; Internal medicine","score_opus":0.02193581011029141,"score_gpt":0.33252448757492686,"score_spread":0.3105886774646355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214977940","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99164873,0.00013450444,0.000043171964,0.0019931335,0.00045368777,0.005574995,0.00006885479,0.00003754714,0.00004537961],"genre_scores_gemma":[0.99634105,0.000029445773,0.00044404765,0.0013439484,0.00015244116,0.0013605426,0.0002835763,0.00003938574,0.0000055832543],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9975554,0.0008499202,0.00053263316,0.0005030661,0.00026737133,0.000291607],"domain_scores_gemma":[0.9972263,0.0015878421,0.00036411465,0.000401901,0.0002758613,0.00014396611],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003571888,0.0002296559,0.0008663994,0.00019737119,0.000121030724,0.000006850922,0.000080873346,0.0001872284,0.00008054549],"category_scores_gemma":[0.00046803232,0.00017454335,0.0001764346,0.00026441304,0.0000919575,0.000037410056,0.00003090662,0.00014358177,0.0000026676933],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.58681494,0.18026127,0.06664146,0.000012088814,0.0004450173,0.00043885724,0.0005714908,0.000006978735,0.020633401,0.00001831685,0.00090046413,0.14325571],"study_design_scores_gemma":[0.5851947,0.32574135,0.04671399,0.00000833585,0.00040984873,0.000020259702,0.000055359826,0.00004564798,0.011646414,0.000006364139,0.030049039,0.00010866977],"about_ca_topic_score_codex":0.0000213222,"about_ca_topic_score_gemma":0.00003752508,"teacher_disagreement_score":0.14548007,"about_ca_system_score_codex":0.0003344129,"about_ca_system_score_gemma":0.0009971805,"threshold_uncertainty_score":0.71176714},"labels":[],"label_agreement":null},{"id":"W3215083260","doi":"10.1093/neuonc/noab196.911","title":"IOTG-02. Glioma Supra Marginal Incision Trial (G-SUMIT): a phase II pilot randomized control trial to assess the feasibility of “supra-marginal” surgical resection of malignant glioma","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Randomized controlled trial; Glioma; Surgery; Resection; Radiation therapy","score_opus":0.07907108385133853,"score_gpt":0.38999143415155435,"score_spread":0.3109203503002158,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215083260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9802318,0.00034743408,0.000077083365,0.00876496,0.0022599872,0.007557911,0.0001186503,0.000046632733,0.0005954913],"genre_scores_gemma":[0.99755883,0.000085980224,0.00013689372,0.00030160227,0.0008531804,0.00093584985,0.00006068956,0.0000446694,0.000022321072],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9907684,0.004660438,0.0019399516,0.00095398404,0.0010625444,0.0006147038],"domain_scores_gemma":[0.98816395,0.008655866,0.00083075877,0.0010451702,0.0009098309,0.00039445137],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0040853033,0.0004594295,0.0029350207,0.00044740984,0.00023889459,0.000033775996,0.00029110082,0.00036061212,0.00056916644],"category_scores_gemma":[0.0067201043,0.0002984996,0.00092956965,0.0011300565,0.00044105467,0.00010073099,0.00025452062,0.00051585364,0.000013645102],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.61969113,0.012838544,0.00021105162,0.00004651757,0.00029138598,0.0031140973,0.000110290304,0.000010119245,0.36084983,0.00043833742,0.0007898077,0.0016088973],"study_design_scores_gemma":[0.74639994,0.06818459,0.00016686921,0.00007206465,0.0011219498,0.0010611133,0.0000918499,0.00015014036,0.17725037,0.00010606576,0.005233288,0.0001617432],"about_ca_topic_score_codex":0.00016172694,"about_ca_topic_score_gemma":0.00010139175,"teacher_disagreement_score":0.18359947,"about_ca_system_score_codex":0.00039233026,"about_ca_system_score_gemma":0.0011996743,"threshold_uncertainty_score":0.9999467},"labels":[],"label_agreement":null},{"id":"W3215114010","doi":"10.1093/neuonc/noab196.231","title":"CTNI-06. TRAM-01: A PHASE 2 STUDY OF TRAMETINIB FOR PATIENTS WITH PEDIATRIC GLIOMA WITH ACTIVATION OF THE MAPK/ERK PATHWAY","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; McGill University; Hospital for Sick Children; Centre Hospitalier Universitaire de Sherbrooke; Izaak Walton Killam Health Centre; Centre hospitalier universitaire de Québec; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Trametinib; Tolerability; Internal medicine; MAPK/ERK pathway; Progressive disease; Oncology; Progression-free survival; Adverse effect; Gastroenterology; Surgery; Disease; Overall survival; Biology; Kinase","score_opus":0.019691603867848895,"score_gpt":0.29284752650206736,"score_spread":0.27315592263421845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215114010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996934,0.000028144867,0.000016305117,0.00051067024,0.000109428096,0.0022151512,0.000050501058,0.000014817568,0.00012100299],"genre_scores_gemma":[0.99909574,0.00000533795,0.0002927286,0.00014623128,0.000066305205,0.00031767445,0.000041780437,0.00002914769,0.0000050436947],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986267,0.00015279849,0.00035855637,0.00033176254,0.00032394528,0.000206227],"domain_scores_gemma":[0.99820155,0.0006167473,0.0003633448,0.000378501,0.00036005038,0.00007979667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008586635,0.0001726419,0.0005049823,0.00012101556,0.00005904735,0.000005015479,0.00008467491,0.000085803826,0.00002707331],"category_scores_gemma":[0.00026051493,0.000099041594,0.00009240284,0.0005925956,0.000055479493,0.000040998297,0.000030227702,0.00012404709,8.1343165e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066704694,0.092172116,0.7358023,0.0002762867,0.00052486523,0.00033165675,0.0030746055,0.000048406455,0.13423274,0.000084180814,0.0006648698,0.026117515],"study_design_scores_gemma":[0.10330152,0.09793004,0.38851756,0.0000699124,0.0018661517,0.000073639625,0.0018262949,0.000033626413,0.40276304,0.00002465141,0.003374727,0.00021882549],"about_ca_topic_score_codex":0.000014611136,"about_ca_topic_score_gemma":0.000036635793,"teacher_disagreement_score":0.3472847,"about_ca_system_score_codex":0.000069245805,"about_ca_system_score_gemma":0.00035697623,"threshold_uncertainty_score":0.4038799},"labels":[],"label_agreement":null},{"id":"W3215163439","doi":"10.1093/neuonc/noab196.001","title":"EPCO-02. GERMLINE SINGLE NUCLEOTIDE POLYMORPHISM rs55705857 AT 8q24 INTERACTS WITH SOMATIC IDH1 MUTATION TO ENHANCE HUMAN GLIOMA FORMATION","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"","keywords":"Isocitrate dehydrogenase; Single-nucleotide polymorphism; Glioma; Biology; IDH1; Germline; Locus (genetics); Genetics; Molecular biology; Germline mutation; Cancer research; Genotype; Mutant; Gene; Mutation","score_opus":0.01959444430569937,"score_gpt":0.31207794412746254,"score_spread":0.29248349982176314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215163439","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858918,0.00016771878,0.00015971609,0.010088705,0.000402123,0.0006517055,0.000010430565,0.000107339096,0.0025204418],"genre_scores_gemma":[0.9943486,0.000013539191,0.0013000319,0.0036475637,0.00021223025,0.00013060021,0.00019961577,0.000050089926,0.000097772965],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99819374,0.00014967468,0.00050713733,0.00045780258,0.0003039248,0.00038773115],"domain_scores_gemma":[0.99853724,0.00028725216,0.00025852668,0.00041666502,0.00023502155,0.00026526523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009619621,0.00025692227,0.0005021363,0.00024220055,0.00016977346,0.00003912449,0.000084904605,0.000119577904,0.00036664444],"category_scores_gemma":[0.00018902963,0.0002198152,0.00009664577,0.00041521428,0.00005230047,0.00020790406,0.000107525375,0.00016725645,0.0003938099],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021343179,0.0013153545,0.00076869415,0.00007894876,0.00006978781,0.0050325184,0.0012640555,0.000036538404,0.97600055,0.00006152196,0.002137351,0.013021251],"study_design_scores_gemma":[0.0027246121,0.003723871,0.0061752754,0.00019043144,0.00023761936,0.0029249182,0.00020633148,0.00018427939,0.9701181,0.00006521754,0.013253967,0.00019535163],"about_ca_topic_score_codex":0.000031333635,"about_ca_topic_score_gemma":0.0005304404,"teacher_disagreement_score":0.0128259,"about_ca_system_score_codex":0.00068990997,"about_ca_system_score_gemma":0.00012180417,"threshold_uncertainty_score":0.89638036},"labels":[],"label_agreement":null},{"id":"W3215197047","doi":"10.1093/neuonc/noab274","title":"Efficacy and safety of larotrectinib in TRK fusion-positive primary central nervous system tumors","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":170,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"National Cancer Institute; National Institute for Health and Care Research","keywords":"Trk receptor; Central nervous system; Medicine; Fusion; Primary (astronomy); Neuroscience; Cancer research; Internal medicine; Biology; Neurotrophin; Receptor","score_opus":0.011731057816536357,"score_gpt":0.2667124807461399,"score_spread":0.2549814229296035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215197047","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99079996,0.0005504932,0.000003037515,0.001710901,0.0002886102,0.000578648,0.000020859072,0.000029573832,0.006017928],"genre_scores_gemma":[0.99888337,0.00017876984,0.00017091421,0.0005853064,0.00007623921,0.00003503346,0.0000410884,0.000017840435,0.00001142739],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99859947,0.00025967445,0.0003773797,0.00033848992,0.00014143679,0.00028355565],"domain_scores_gemma":[0.9987814,0.0006802942,0.00011774996,0.00019547025,0.00007431873,0.00015075738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010483407,0.00014571006,0.00061709713,0.00010071927,0.00004194124,0.000005075066,0.00004005681,0.00011881904,0.00003590903],"category_scores_gemma":[0.00014607554,0.00012533089,0.00007452884,0.00024013195,0.00006638396,0.000025149891,0.00008531632,0.00019622222,0.0000058907985],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003383899,0.0047798613,0.21482868,0.0005282366,0.00022386832,0.028348953,0.0021249503,0.0000700666,0.6021234,0.0010504028,0.00072121643,0.14181647],"study_design_scores_gemma":[0.010064299,0.0015746445,0.91752696,0.0003063313,0.00016804942,0.0017995677,0.00046856282,0.000046866448,0.064344324,0.0000054080656,0.00359344,0.000101568345],"about_ca_topic_score_codex":0.00007548876,"about_ca_topic_score_gemma":0.000054747226,"teacher_disagreement_score":0.70269823,"about_ca_system_score_codex":0.00031842795,"about_ca_system_score_gemma":0.0003169195,"threshold_uncertainty_score":0.51108456},"labels":[],"label_agreement":null},{"id":"W3215248537","doi":"10.1093/neuonc/noab196.879","title":"TMOD-18. DIRECT IN VIVO CRISPR SCREEN IDENTIFIES COOPERATING TUMOR SUPPRESSORS THAT DRIVE PROGRESSION OF IDH1-MUTANT LOW-GRADE GLIOMA TO AGGRESSIVE GLIOBLASTOMA","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Princess Margaret Cancer Centre; McGill University; Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"","keywords":"ATRX; IDH1; Cancer research; Glioma; Mutant; Biology; PTEN; CRISPR; Mutation; PI3K/AKT/mTOR pathway; Gene; Genetics; Signal transduction","score_opus":0.021574559586447196,"score_gpt":0.3262766865455839,"score_spread":0.3047021269591367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215248537","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99355215,0.00082895195,0.0000064817705,0.0027719608,0.00055694213,0.0012063672,0.00009440332,0.00008033607,0.0009024034],"genre_scores_gemma":[0.99812543,0.00009747576,0.00039604687,0.0007917132,0.00013983839,0.0003430133,0.000025456991,0.000064815315,0.000016233449],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967307,0.00048176866,0.00072101725,0.00086391164,0.0005581297,0.00064447254],"domain_scores_gemma":[0.99747705,0.0007921537,0.00047820972,0.0005709099,0.00034274804,0.0003389152],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022042546,0.00039941393,0.0011496508,0.00046696528,0.00013133105,0.000048953847,0.00020911774,0.00017937511,0.0003912465],"category_scores_gemma":[0.0012443037,0.0003325321,0.00021012651,0.0009194979,0.0001763722,0.00014015264,0.0003562399,0.00034432,0.00003026405],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006701968,0.0018750181,0.029035684,0.000117868185,0.00011783954,0.03024147,0.001219713,0.00011672593,0.9303996,0.000036839545,0.003306529,0.0028625065],"study_design_scores_gemma":[0.00446394,0.0025956829,0.006556833,0.0010316095,0.00018800463,0.0011592149,0.001029003,0.00022879604,0.9799975,0.000016996559,0.0024872674,0.00024511278],"about_ca_topic_score_codex":0.00011672041,"about_ca_topic_score_gemma":0.00077788776,"teacher_disagreement_score":0.04959793,"about_ca_system_score_codex":0.0002693102,"about_ca_system_score_gemma":0.0003878289,"threshold_uncertainty_score":0.9999127},"labels":[],"label_agreement":null},{"id":"W3215364878","doi":"10.1093/neuonc/noab196.594","title":"NCOG-01. RADIATION THERAPY MANAGEMENT FOR METASTATIC DISEASE TO THE BRAIN IN NSCLC PATIENTS – SURVIVAL OUTCOMES OF THE BRITISH COLUMBIA POPULATION 1996-2016","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Internal medicine; Radiosurgery; Lung cancer; Radiation therapy; Proportional hazards model; Oncology; Performance status; Brain metastasis; Cancer; Population; Surgery; Metastasis","score_opus":0.021310284801281002,"score_gpt":0.303587966725419,"score_spread":0.282277681924138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215364878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9792791,0.00021573022,0.00009904288,0.016558064,0.0008071376,0.002689703,0.00018337808,0.0000128575475,0.00015498212],"genre_scores_gemma":[0.99055266,0.00011134727,0.0005637875,0.0076595536,0.000047898608,0.0003733633,0.00024254217,0.000024465682,0.00042435018],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983381,0.00054132065,0.00036321217,0.00029025108,0.00025798046,0.00020916201],"domain_scores_gemma":[0.99870366,0.00063256716,0.00014630792,0.0003545615,0.00007457096,0.00008833399],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003653004,0.000103271035,0.00035862735,0.00003433134,0.00014059353,0.000048004367,0.0001033529,0.000029237162,0.000060246348],"category_scores_gemma":[0.00048804533,0.000082870705,0.00016721484,0.00025186222,0.000030572923,0.00003690691,0.00006421528,0.00008065585,0.000003366718],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002740482,0.0011638085,0.6770722,0.000049636998,0.0001708959,0.00009841151,0.00010497631,0.000059646387,0.00010490277,0.000099893536,0.008110337,0.3126912],"study_design_scores_gemma":[0.0058565713,0.0004725491,0.9368622,0.000028572853,0.00017756927,0.00000560941,0.00007838255,0.000057972866,0.00002838863,0.00030456245,0.05606251,0.00006515045],"about_ca_topic_score_codex":0.0022244204,"about_ca_topic_score_gemma":0.018793864,"teacher_disagreement_score":0.31262606,"about_ca_system_score_codex":0.00014946557,"about_ca_system_score_gemma":0.00011315997,"threshold_uncertainty_score":0.9991106},"labels":[],"label_agreement":null},{"id":"W3215366287","doi":"10.1093/neuonc/noab196.061","title":"BIOM-30. BLOOD COUNTS THROUGH TREATMENT COURSE IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS RECEIVING CHEMORADIATION","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Neutropenia; Temozolomide; Internal medicine; Gastroenterology; Glioblastoma; Lymphocyte; Radiation therapy; Proportional hazards model; Chemotherapy; Oncology; Cancer research","score_opus":0.01769910270985805,"score_gpt":0.29522945524976657,"score_spread":0.27753035253990854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215366287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900537,0.0005070323,0.0000014542318,0.002154589,0.00060834276,0.00042575586,0.000019428468,0.000046750916,0.006182913],"genre_scores_gemma":[0.99727917,0.0007645472,0.00021168299,0.0012855006,0.00014812377,0.00014046325,0.000096643365,0.000029274883,0.000044609173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998787,0.00010466201,0.0002759138,0.0003744083,0.0001779512,0.000280102],"domain_scores_gemma":[0.9991345,0.00028548925,0.00010924387,0.0002637921,0.00010430478,0.00010268358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000046331366,0.00018201546,0.00039531873,0.00007480638,0.000044996817,0.00001394882,0.000044920034,0.00015487758,0.0004972382],"category_scores_gemma":[0.0001740522,0.00016160395,0.00008681591,0.00028598213,0.000037018854,0.000057343987,0.000028877048,0.000106455846,0.0002774723],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027608353,0.02226087,0.6978606,0.000051147417,0.0003632829,0.0109046595,0.0015192876,0.00003137049,0.04356827,0.00017097974,0.013788223,0.20920521],"study_design_scores_gemma":[0.04793729,0.009129563,0.47229666,0.00014124671,0.0010017859,0.00027415014,0.00024305616,0.00018202316,0.17316423,0.00011320784,0.29509848,0.00041832257],"about_ca_topic_score_codex":0.00005748914,"about_ca_topic_score_gemma":0.00019386304,"teacher_disagreement_score":0.28131026,"about_ca_system_score_codex":0.0004348622,"about_ca_system_score_gemma":0.00032612242,"threshold_uncertainty_score":0.65900177},"labels":[],"label_agreement":null},{"id":"W3215398375","doi":"10.1093/neuonc/noab196.021","title":"EPCO-22. INHERITED POLYMORPHISM IN CHROMOSOME 8Q24 COOPERATES WITH MUTANT IDH1, Trp53 AND ATRX LOSS TO INDUCE LOW-GRADE GLIOMA","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children; Princess Margaret Cancer Centre; Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"ATRX; Biology; Allele; Genetics; CDKN2A; Locus (genetics); Glioma; Cancer research; Penetrance; Gene; Single-nucleotide polymorphism; Genotype; Mutant; IDH1; Carcinogenesis; Mutation; Phenotype","score_opus":0.018053797502934458,"score_gpt":0.2826563719139711,"score_spread":0.26460257441103663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215398375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9790171,0.0011128027,0.0000018662801,0.018503474,0.00026782625,0.0006817083,0.000028394334,0.00006312439,0.00032371577],"genre_scores_gemma":[0.9940501,0.00021799353,0.00026037238,0.0050052125,0.0001588451,0.00018637007,0.00004329966,0.000057827572,0.000019998071],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99787885,0.00020226583,0.00040841225,0.00072799285,0.0002470456,0.00053541927],"domain_scores_gemma":[0.99863726,0.00030999925,0.00008976101,0.00039756155,0.00014623391,0.00041917936],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00010490048,0.0003320933,0.0007793859,0.00030667146,0.0000803189,0.000039405866,0.00009699398,0.00024115366,0.00021932002],"category_scores_gemma":[0.0001977024,0.00026636999,0.000059083908,0.001102836,0.00015125137,0.000079567704,0.00013582305,0.00035242314,0.00005802818],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038297276,0.0016872943,0.037593164,0.00004363995,0.0000929936,0.047391225,0.00061729556,0.000011665748,0.9077097,0.00013325781,0.0004554425,0.0038813388],"study_design_scores_gemma":[0.014157746,0.0054974672,0.10436209,0.0002572728,0.00022359757,0.010780915,0.00036378167,0.00006733235,0.8404843,0.000036947902,0.023355355,0.00041319086],"about_ca_topic_score_codex":0.00013187862,"about_ca_topic_score_gemma":0.0004986739,"teacher_disagreement_score":0.06722541,"about_ca_system_score_codex":0.00024798277,"about_ca_system_score_gemma":0.00046516728,"threshold_uncertainty_score":0.99997884},"labels":[],"label_agreement":null},{"id":"W3215432528","doi":"10.1093/neuonc/noab196.453","title":"INNV-43. MORE THAN WHAT MEETS THE EYE: ETMR AN UNDER RECOGNISED ATYPICAL BRAINSTEM PRIMARY. A RARE BRAIN TUMOR CONSORTIUM (RBTC) STUDY","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Hospital for Sick Children","funders":"","keywords":"Medicine; Brainstem; Radiation therapy; Chemotherapy; Biopsy; Brain tumor; Pediatrics; Radiology; Surgery; Pathology; Internal medicine","score_opus":0.03640527548951738,"score_gpt":0.332351303696803,"score_spread":0.2959460282072856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215432528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8942709,0.00075558934,0.0000039420506,0.101016246,0.0009045916,0.001781548,0.000017458935,0.00013381724,0.0011159272],"genre_scores_gemma":[0.95183104,0.00011591906,0.00012361987,0.046860818,0.0003331497,0.0003955425,0.00011978652,0.00007630833,0.00014379203],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99597555,0.0013341827,0.0006144697,0.0009672552,0.0004982726,0.0006102709],"domain_scores_gemma":[0.9965316,0.0015302454,0.00022384032,0.0010297272,0.0002791205,0.0004054601],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004450678,0.00041034885,0.0009319375,0.00012819492,0.00026115667,0.00013007065,0.0002645162,0.00022971412,0.00030838687],"category_scores_gemma":[0.00057382556,0.0002844466,0.0002293913,0.0004777078,0.0002631121,0.00023243553,0.00025917706,0.00061264844,0.00009085828],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005221666,0.04191572,0.36894333,0.00024467762,0.0020928022,0.07226696,0.01238265,0.000056502715,0.31599957,0.0010937689,0.041984867,0.1377975],"study_design_scores_gemma":[0.023608828,0.009682192,0.7658788,0.00016631909,0.0010924423,0.0027258855,0.01944819,0.00014578884,0.017332252,0.00012803913,0.15919858,0.0005926949],"about_ca_topic_score_codex":0.00002615394,"about_ca_topic_score_gemma":0.0004957037,"teacher_disagreement_score":0.39693546,"about_ca_system_score_codex":0.000358156,"about_ca_system_score_gemma":0.0009627473,"threshold_uncertainty_score":0.9999608},"labels":[],"label_agreement":null},{"id":"W3215441874","doi":"10.1093/neuonc/noab196.031","title":"EPCO-32. IDENTIFICATION OF PROGNOSTIC CHORDOMA SUBGROUPS USING DNA METHYLATION SIGNATURES IN TISSUE AND PLASMA","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Bone Tumor Diagnosis and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Chordoma; DNA methylation; Differentially methylated regions; Proportional hazards model; Biology; Epigenetics; Methylation; Cancer research; Oncology; Bioinformatics; Internal medicine; Pathology; Medicine; Gene; Genetics; Gene expression","score_opus":0.026749080330018046,"score_gpt":0.3248480902901534,"score_spread":0.29809900996013533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215441874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971981,0.0010732677,0.000030444598,0.00072500214,0.00020996,0.0004119189,0.0000072700304,0.00001633015,0.00032771265],"genre_scores_gemma":[0.9989685,0.00016423193,0.0005757121,0.000119488905,0.000048001355,0.00003390754,0.00003610219,0.000016734073,0.00003736223],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988799,0.00017459349,0.0003681558,0.00029253142,0.0001336138,0.00015120268],"domain_scores_gemma":[0.9990462,0.0004594509,0.00017231237,0.00016003891,0.00010056308,0.000061456434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001513589,0.000108485685,0.00034191197,0.0001346007,0.00003287469,0.000009796683,0.00003139623,0.00013118,0.00005550854],"category_scores_gemma":[0.00048024635,0.000103972234,0.000031631276,0.00025321747,0.000062178944,0.00007011662,0.000034880108,0.00015713101,0.0000059084377],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009377618,0.0005576334,0.09992174,0.00006818743,0.000026620795,0.0005590397,0.00022101474,0.000041235104,0.8746063,0.00017544093,0.00005240417,0.023676563],"study_design_scores_gemma":[0.0024303752,0.0006303375,0.44713867,0.000057783964,0.00020752139,0.0002167203,0.000085664185,0.0013435482,0.5453359,0.00018699434,0.0022833159,0.00008321487],"about_ca_topic_score_codex":0.00003628372,"about_ca_topic_score_gemma":0.000097867145,"teacher_disagreement_score":0.34721693,"about_ca_system_score_codex":0.0000960872,"about_ca_system_score_gemma":0.0001327128,"threshold_uncertainty_score":0.42398646},"labels":[],"label_agreement":null},{"id":"W3215445514","doi":"10.1093/neuonc/noab196.915","title":"ITVT-03. Use of Functional MRI and DTI for Surgical Planning of Maximal Extent of Resection of CNS Tumors - A Single Neurosurgical Center’s Experience","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Advanced Neuroimaging Techniques and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Magnetic resonance imaging; Diffusion MRI; Neuronavigation; Surgical planning; Functional imaging; Functional magnetic resonance imaging; Neuroimaging; Radiology; Nuclear medicine","score_opus":0.1644279284472633,"score_gpt":0.3897089641072013,"score_spread":0.22528103565993798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215445514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912463,0.000063449916,0.007312845,0.0006481608,0.00009859362,0.0003289156,0.000053266485,0.00002475382,0.00022371855],"genre_scores_gemma":[0.9936599,0.00007590811,0.0059967986,0.00011207211,0.00004141207,0.000052005966,0.000022070986,0.000016189375,0.000023619163],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987921,0.00006668541,0.0005137827,0.00030483922,0.00017106826,0.0001515391],"domain_scores_gemma":[0.9985088,0.00063135626,0.0003026641,0.00022693643,0.00025938073,0.00007086027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008188101,0.00010104797,0.00043383654,0.000094843,0.000033034547,0.0000023878897,0.00005223807,0.00007361108,0.000028452183],"category_scores_gemma":[0.00030429097,0.00009706113,0.00010432563,0.00019657217,0.0003208129,0.000060665527,0.00009378244,0.0001549719,1.0656892e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016779484,0.00097353273,0.019543758,0.00013923626,0.000010497567,0.00011184819,0.00015003067,0.00018222006,0.9748523,0.00094477343,0.00027587017,0.0011379648],"study_design_scores_gemma":[0.0045872387,0.006720268,0.036259927,0.00020290737,0.00008905797,0.003146359,0.00025156475,0.0023350434,0.8814802,0.000287969,0.06449194,0.00014749025],"about_ca_topic_score_codex":0.000008002882,"about_ca_topic_score_gemma":0.000001120156,"teacher_disagreement_score":0.09337209,"about_ca_system_score_codex":0.000026403784,"about_ca_system_score_gemma":0.00009427395,"threshold_uncertainty_score":0.3958038},"labels":[],"label_agreement":null},{"id":"W3215503905","doi":"10.1093/neuonc/noab196.612","title":"NCOG-21. PREDICTORS OF SURVIVAL IN ELDERLY PATIENTS UNDERGOING SURGERY FOR GBM","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Vascular Malformations and Hemangiomas","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Complication; Medical record; Retrospective cohort study; Surgery; Comorbidity; Survival analysis; Proportional hazards model; Internal medicine","score_opus":0.02611137550732264,"score_gpt":0.28274584972044947,"score_spread":0.25663447421312685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215503905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945235,0.00011675648,0.0002958317,0.0009925875,0.0009458787,0.00035104444,0.000015264211,0.000024657154,0.0027344767],"genre_scores_gemma":[0.99862015,0.00012126139,0.0005220566,0.00035901353,0.00012320324,0.000039788396,0.00013063532,0.000021727445,0.00006218957],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988182,0.00011133303,0.00045888097,0.00019791121,0.00017087212,0.0002428108],"domain_scores_gemma":[0.99807096,0.0012923311,0.0001308301,0.00021675877,0.00021150721,0.000077640325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026309682,0.00010093415,0.00047845332,0.00019425391,0.000037375572,0.0000048322017,0.00004762853,0.00014149412,0.00006154829],"category_scores_gemma":[0.0011797833,0.00009877604,0.000201202,0.00026225453,0.000039073504,0.00007141647,0.00004335573,0.0001249174,0.000007115813],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035860692,0.0014325298,0.9532776,0.00075908157,0.00015609764,0.00019796056,0.000884418,0.000040015802,0.013601463,0.00079810515,0.0075340974,0.020960057],"study_design_scores_gemma":[0.016044982,0.0046779136,0.71221614,0.00036003895,0.00043498955,0.00020684453,0.0013499055,0.0006121224,0.022129329,0.0004981518,0.24103276,0.0004367996],"about_ca_topic_score_codex":0.000012465136,"about_ca_topic_score_gemma":0.0003656644,"teacher_disagreement_score":0.24106142,"about_ca_system_score_codex":0.00009749378,"about_ca_system_score_gemma":0.00074817083,"threshold_uncertainty_score":0.402797},"labels":[],"label_agreement":null},{"id":"W3215508843","doi":"10.1093/neuonc/noab196.242","title":"CTNI-17. A PHASE 1 WITH DOSE EXPANSION/PHASE 2 STUDY OF SELINEXOR IN COMBINATION WITH STANDARD OF CARE THERAPY FOR NEWLY DIAGNOSED OR RECURRENT GLIOBLASTOMA","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Nuclear Structure and Function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Temozolomide; Clinical endpoint; Medicine; Oncology; Bevacizumab; Phases of clinical research; Internal medicine; Radiation therapy; Clinical trial; Cancer research; Chemotherapy","score_opus":0.01334965007866061,"score_gpt":0.3127865269656032,"score_spread":0.2994368768869426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215508843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979785,0.00018651187,0.00044706225,0.00013467747,0.00016297204,0.0009805205,0.00006985402,0.000007837951,0.000032072323],"genre_scores_gemma":[0.99851733,0.00013159095,0.0008391736,0.00017455145,0.00006545782,0.00010917997,0.00012132532,0.00002753359,0.000013860523],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988918,0.00015239952,0.00029195388,0.0003638039,0.0001455507,0.00015451579],"domain_scores_gemma":[0.99893874,0.00007553933,0.00020515485,0.00027734134,0.0004545198,0.000048684513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008166507,0.00015447834,0.0003517526,0.00007685934,0.000037526253,0.0000060120224,0.00008739556,0.00012421956,0.000024805406],"category_scores_gemma":[0.00008492659,0.00010171957,0.000044211545,0.00021586307,0.00005794425,0.00000642421,0.00003134146,0.00010158645,1.4215891e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12685561,0.004699023,0.00078666897,0.00006500915,0.00009172052,0.00015225717,0.0028713804,0.0001767161,0.71961856,0.000009545147,0.0008310379,0.14384247],"study_design_scores_gemma":[0.09487385,0.39112008,0.0006328103,0.000040574356,0.000092296745,0.00006917606,0.008261406,0.00009687859,0.4436093,0.00001046885,0.06096675,0.00022639954],"about_ca_topic_score_codex":0.000011554597,"about_ca_topic_score_gemma":0.001581079,"teacher_disagreement_score":0.38642105,"about_ca_system_score_codex":0.000039635215,"about_ca_system_score_gemma":0.00040752045,"threshold_uncertainty_score":0.41480035},"labels":[],"label_agreement":null},{"id":"W3215519365","doi":"10.1093/neuonc/noab196.669","title":"EXTH-30. HARNESSING CELLULAR STRESS FOR IMMUNE TARGETING OF DIPGS","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Context (archaeology); Immune system; Cancer research; In vivo; Ex vivo; Glioma; Pharmacology; Immunology; Biology; Genetics","score_opus":0.01776142761993329,"score_gpt":0.3139705883554132,"score_spread":0.2962091607354799,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215519365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99183524,0.004288684,0.0016365274,0.00045131243,0.00034436863,0.00027096033,0.00009680843,0.000009927855,0.0010661575],"genre_scores_gemma":[0.9974825,0.0004361832,0.0011163049,0.00012222173,0.00025376104,0.00007185862,0.0003384526,0.000027263104,0.00015149583],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99886084,0.00015662904,0.00023205215,0.0003427794,0.000098455464,0.00030922654],"domain_scores_gemma":[0.9993106,0.000098539356,0.000099936464,0.00025685516,0.00015573218,0.00007830483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013504805,0.000118508906,0.00023029599,0.000028635053,0.00007757254,0.000013068614,0.0001400674,0.00014722254,0.00008104389],"category_scores_gemma":[0.00031514827,0.00011808537,0.00012964969,0.00006901308,0.00007056236,0.0000034201628,0.00016952882,0.00010090493,0.000005213287],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001633057,0.00019803226,0.0012943972,0.00005825214,0.000068772366,0.00007895743,0.00005200422,0.000026405609,0.9829352,0.0000329239,0.0007315547,0.014360208],"study_design_scores_gemma":[0.0012127308,0.00060732086,0.00020472826,0.000010142838,0.00002306918,0.000013578568,0.00010583416,0.000041376963,0.8754574,0.000050322833,0.12218969,0.00008379418],"about_ca_topic_score_codex":0.000039486396,"about_ca_topic_score_gemma":0.000039045422,"teacher_disagreement_score":0.121458136,"about_ca_system_score_codex":0.000040574076,"about_ca_system_score_gemma":0.00035159983,"threshold_uncertainty_score":0.48153818},"labels":[],"label_agreement":null},{"id":"W3215530196","doi":"10.1093/neuonc/noab196.353","title":"EPID-20. THE RISING INCIDENCE AND PREVALENCE OF BRAIN TUMOURS: A CANADIAN EPIDEMIOLOGICAL STUDY","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Incidence (geometry); Medicine; Epidemiology; Demography; Cancer registry; Standardized rate; Pediatrics; Pathology","score_opus":0.048383281597215534,"score_gpt":0.3541804403768442,"score_spread":0.30579715877962865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215530196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94731677,0.0014866868,0.000032990818,0.049648866,0.00014031921,0.00058982073,0.000022421751,0.000013554056,0.000748603],"genre_scores_gemma":[0.98853713,0.00018321216,0.00071843027,0.010355492,0.00008036317,0.000035606125,0.000004638881,0.0000098322525,0.00007528828],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974509,0.001375644,0.00034050242,0.00038440505,0.00013894685,0.00030963696],"domain_scores_gemma":[0.9958609,0.0032937552,0.00012460946,0.00037137954,0.0000958787,0.00025351337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012293948,0.00014079394,0.0005027543,0.000052797106,0.00011714074,0.000007150599,0.000104882994,0.000086696404,0.00016204095],"category_scores_gemma":[0.004262311,0.000087215325,0.000073491785,0.00018320592,0.0002294692,0.000029419578,0.000104507155,0.00030539074,0.000007660137],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015318728,0.000824159,0.9388446,0.000103738654,0.00012557351,0.006791294,0.0014625998,0.000023228476,0.011402032,0.00046892033,0.00477563,0.03502503],"study_design_scores_gemma":[0.0024405972,0.005735039,0.9556482,0.00007343068,0.0005120444,0.00314312,0.0018298692,0.00017487776,0.0015888779,0.00048450936,0.028227748,0.00014169286],"about_ca_topic_score_codex":0.005949235,"about_ca_topic_score_gemma":0.022650115,"teacher_disagreement_score":0.0412204,"about_ca_system_score_codex":0.0001314137,"about_ca_system_score_gemma":0.0007111315,"threshold_uncertainty_score":0.99518394},"labels":[],"label_agreement":null},{"id":"W3215679919","doi":"10.1093/neuonc/noaa222.407","title":"LGG-25. A PHASE 2 STUDY OF TRAMETINIB FOR PATIENTS WITH PEDIATRIC GLIOMA WITH ACTIVATION OF THE MAPK/ERK PATHWAY. TRAM-01","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval; BC Children's Hospital; Izaak Walton Killam Health Centre; Alberta Children's Hospital; University of Calgary; McGill University; University of British Columbia; Hospital for Sick Children; Université de Montréal; Montreal Children's Hospital; Centre hospitalier universitaire de Québec; Dalhousie University; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Trametinib; Medicine; Tolerability; Adverse effect; Internal medicine; MAPK/ERK pathway; Oncology; Refractory (planetary science); Gastroenterology; Surgery; Biology","score_opus":0.025199194936663446,"score_gpt":0.2910351558811074,"score_spread":0.26583596094444395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215679919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953276,0.000014064255,0.000025377978,0.0012791639,0.0000763705,0.0030985312,0.000055844783,0.000021441794,0.00010162684],"genre_scores_gemma":[0.9989661,0.0000032422784,0.0002385462,0.00035617265,0.000089013694,0.00029340133,0.000021993408,0.000030557716,9.551595e-7],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99871856,0.000111649366,0.0003530271,0.00031743117,0.00030999957,0.00018931419],"domain_scores_gemma":[0.99864185,0.0003957949,0.00039494652,0.00025862904,0.00019753902,0.0001112359],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000063370106,0.00017627186,0.00050188176,0.00009612233,0.00005142152,0.000004022168,0.00010863422,0.00007814178,0.000020391026],"category_scores_gemma":[0.00018280074,0.000098777535,0.0000838666,0.00054156774,0.000056635334,0.00004121034,0.000027373046,0.00013101519,0.0000010219038],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019024868,0.07057668,0.76442146,0.00042160324,0.00057990913,0.00018327528,0.0076567405,0.00008392464,0.097396165,0.00008195867,0.0011502261,0.038423203],"study_design_scores_gemma":[0.15309471,0.31154394,0.3315,0.00006520461,0.0025349094,0.00002934781,0.002141851,0.0001456696,0.19365297,0.00001809132,0.0049647656,0.00030853666],"about_ca_topic_score_codex":0.000015550228,"about_ca_topic_score_gemma":0.000013412533,"teacher_disagreement_score":0.43292144,"about_ca_system_score_codex":0.000048513826,"about_ca_system_score_gemma":0.00019479265,"threshold_uncertainty_score":0.4028031},"labels":[],"label_agreement":null},{"id":"W3215696868","doi":"10.1093/neuonc/noab196.498","title":"PATH-46. DIAGNOSTIC IMPACT OF THE CNS TUMOR METHYLATION PROFILING IN A NEUROPATHOLOGY CONSULT PRACTICE","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Neuropathology; Classifier (UML); Brain tumor; Medulloblastoma; Methylation; Medicine; DNA methylation; Profiling (computer programming); Oncology; Pathology; Internal medicine; Artificial intelligence; Computer science; Biology; Disease","score_opus":0.015847717853677324,"score_gpt":0.35420435867283906,"score_spread":0.3383566408191617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215696868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9796624,0.00039862143,0.00030276747,0.013826767,0.00070718356,0.00042543572,0.00000511089,0.000029212479,0.00464249],"genre_scores_gemma":[0.9918909,0.00015265867,0.002295562,0.0054314667,0.00013973807,0.000025822204,0.000009027943,0.00003196758,0.000022873064],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99730664,0.0013726706,0.0004734176,0.0003431678,0.00020734934,0.0002967638],"domain_scores_gemma":[0.9938975,0.0050659487,0.0003293466,0.00035918562,0.00023640618,0.00011160764],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.00080007745,0.00014156707,0.0004690201,0.00010030824,0.00004522793,0.0000091456,0.0001206799,0.00010657642,0.000063475454],"category_scores_gemma":[0.070774876,0.00010132762,0.0001430219,0.00045650086,0.00020429125,0.000066404114,0.00012543192,0.0011076225,0.000013665785],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023609838,0.00055647723,0.11291507,0.00008480055,0.000036441856,0.005809446,0.00070750393,0.0005523976,0.8654527,0.00033189153,0.00050088577,0.012816262],"study_design_scores_gemma":[0.019980002,0.0069917655,0.69912827,0.00061031844,0.0013496715,0.04594821,0.0017142304,0.04933231,0.104126565,0.0013164387,0.06874484,0.00075740064],"about_ca_topic_score_codex":0.00008273402,"about_ca_topic_score_gemma":0.0000065813906,"teacher_disagreement_score":0.7613262,"about_ca_system_score_codex":0.0001525099,"about_ca_system_score_gemma":0.0009521292,"threshold_uncertainty_score":0.93705237},"labels":[],"label_agreement":null},{"id":"W3215705432","doi":"10.1093/neuonc/noab196.100","title":"STEM-26. BLOOD-TUMOR BARRIER IS COMPOSED OF MECHANOSENSING TUMOR CELLS THAT MASK THERAPEUTIC VULNERABILITY","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto; Hospital for Sick Children","funders":"","keywords":"Cell biology; Biology; Wnt signaling pathway; Stem cell; Signal transduction; Cancer research; Neuroscience","score_opus":0.04135974310705605,"score_gpt":0.2928577645974006,"score_spread":0.25149802149034456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215705432","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917741,0.0002685447,0.00012384428,0.0023699356,0.002225542,0.00045416172,0.000036106467,0.00013632709,0.0026114485],"genre_scores_gemma":[0.9679678,0.000087102984,0.00075538334,0.030484108,0.00026006548,0.00001407897,0.000017013115,0.00006159173,0.00035286226],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971155,0.0009064515,0.00057636964,0.00067990465,0.00027991156,0.0004418816],"domain_scores_gemma":[0.99758303,0.00083782827,0.0003039709,0.0007255001,0.0003136937,0.00023596564],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00030392627,0.00028895747,0.0010390158,0.00012589707,0.000115143725,0.000009415977,0.00011758233,0.00022669257,0.0014171357],"category_scores_gemma":[0.000098659584,0.00025884685,0.00026442925,0.00033265894,0.0002662278,0.000051169645,0.00011575289,0.0006317974,0.00010785852],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006066204,0.00059755106,0.002112781,0.00015474168,0.00012275744,0.0012293259,0.0004337316,0.000008861703,0.9897305,0.0000928963,0.0011437499,0.003766534],"study_design_scores_gemma":[0.0032537694,0.0019847136,0.0016836822,0.00003143016,0.0003705933,0.0013518699,0.00050328416,0.0003061599,0.93019605,0.00020782446,0.05992082,0.00018982141],"about_ca_topic_score_codex":0.000017377459,"about_ca_topic_score_gemma":0.000016735934,"teacher_disagreement_score":0.05953442,"about_ca_system_score_codex":0.00009615868,"about_ca_system_score_gemma":0.0007199484,"threshold_uncertainty_score":0.99998635},"labels":[],"label_agreement":null},{"id":"W3215705870","doi":"10.1093/neuonc/noab196.123","title":"CBIO-24. NF2 LOSS-OF-FUNCTION COOPERATES WITH HYPOXIA TO DRIVE RADIATION RESISTANCE IN GRADE 2 MENINGIOMAS","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Radioresistance; Necrosis; Cancer research; Downregulation and upregulation; Gene knockdown; Biology; Clonogenic assay; DNA damage; Programmed cell death; Radiation therapy; Hypoxia (environmental); Pathology; In vitro; Cell culture; Medicine; Apoptosis; Internal medicine; Gene; Chemistry; Genetics; DNA","score_opus":0.02078153122316179,"score_gpt":0.3060761352444582,"score_spread":0.2852946040212964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215705870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99177265,0.00025501798,0.000066758956,0.004792794,0.00021168473,0.0005109724,0.0000095067135,0.000036384932,0.0023442227],"genre_scores_gemma":[0.9971082,0.00010589279,0.0011354003,0.0009105398,0.00007453977,0.00008088065,0.000041842828,0.000027487922,0.0005151896],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99850583,0.00022493942,0.00025826326,0.00041267756,0.0002689964,0.00032928685],"domain_scores_gemma":[0.99895734,0.00030571147,0.00008005935,0.00026119815,0.00019422572,0.00020149683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009081031,0.00014757835,0.00036122507,0.00021209879,0.00004986746,0.000011196814,0.00006274911,0.00009208874,0.00006808986],"category_scores_gemma":[0.00034078732,0.00012527412,0.000042422394,0.00074962236,0.000082864826,0.000076685006,0.000044326134,0.00024082873,0.000056001692],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004880941,0.001079687,0.03347432,0.00007008009,0.00011012082,0.008013307,0.00045184072,0.000081973914,0.94332314,0.00054011133,0.0033442013,0.004630286],"study_design_scores_gemma":[0.012948712,0.013113776,0.19011022,0.00015767537,0.0001670063,0.00071020523,0.00020708318,0.00008976152,0.66754997,0.00026159026,0.1144155,0.00026851724],"about_ca_topic_score_codex":0.000025005693,"about_ca_topic_score_gemma":0.0006743771,"teacher_disagreement_score":0.27577317,"about_ca_system_score_codex":0.0002281104,"about_ca_system_score_gemma":0.0005172768,"threshold_uncertainty_score":0.51085305},"labels":[],"label_agreement":null},{"id":"W3215884701","doi":"10.1093/neuonc/noab196.863","title":"TMOD-01. AN IN VIVO FUNCTIONAL GENOMICS SCREEN TO IDENTIFY NOVEL DRIVERS OF LUNG-TO-BRAIN METASTASIS","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Chemical Reactions and Isotopes","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"In vivo; Lung cancer; Brain metastasis; Metastasis; CRISPR; Lung; Cancer; Primary tumor; Medicine; Brain tumor; Cancer research; Biology; Computational biology; Bioinformatics; Neuroscience; Pathology; Gene; Internal medicine; Genetics","score_opus":0.12586533757090496,"score_gpt":0.4465192405110154,"score_spread":0.3206539029401104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215884701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855178,0.000056578465,0.0012076296,0.006656124,0.0013626297,0.00041958434,0.00032367368,0.000040848947,0.0044151023],"genre_scores_gemma":[0.9757429,0.00009562273,0.0029277538,0.020331066,0.0003478619,0.00009405949,0.00007944048,0.00004329696,0.00033804163],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978942,0.00039250316,0.00051726046,0.0005673767,0.00017019028,0.00045843294],"domain_scores_gemma":[0.99781454,0.0011276666,0.00012780074,0.00029076106,0.00019512908,0.0004440844],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005157938,0.00021663665,0.00047623634,0.0002584374,0.00010764567,0.000016161728,0.00028753735,0.00038053482,0.0034277819],"category_scores_gemma":[0.00060007535,0.00024218771,0.00013918553,0.0006253352,0.00012783257,0.00014310256,0.00026534588,0.00075122574,0.000097531985],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005048307,0.00094359805,0.0027241341,0.000015532387,0.00010853825,0.00010048125,0.00044409564,0.0022589362,0.9602725,0.0009403287,0.022981683,0.008705345],"study_design_scores_gemma":[0.0014183524,0.00035286832,0.0032412938,0.000004177138,0.00009565877,0.00006539362,0.00022160349,0.0006529057,0.41653258,0.00008597515,0.5771602,0.0001690172],"about_ca_topic_score_codex":0.0000790177,"about_ca_topic_score_gemma":0.00047718055,"teacher_disagreement_score":0.5541785,"about_ca_system_score_codex":0.0003574349,"about_ca_system_score_gemma":0.00042921465,"threshold_uncertainty_score":0.9974832},"labels":[],"label_agreement":null},{"id":"W3215896415","doi":"10.1093/neuonc/noab196.015","title":"EPCO-16. ONCOHISTONE INTERACTOME PROFILING UNCOVERS MECHANISMS OF CHROMATIN DISRUPTION AND IDENTIFIES POTENTIAL THERAPEUTIC TARGETS IN PEDIATRIC HIGH-GRADE GLIOMA","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Hospital for Sick Children","funders":"","keywords":"Methyltransferase; Chromatin; Epigenetics; Histone; Methylation; PRC2; DNA methylation; Biology; Mutant; EZH2; Transcription factor; Histone methylation; Histone H3; Genetics; Cell biology; DNA; Gene; Gene expression","score_opus":0.011220755896348404,"score_gpt":0.28270145925320606,"score_spread":0.27148070335685764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215896415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874637,0.0031042004,0.008173661,0.00019835793,0.00072947325,0.00019205298,0.0000147458095,0.00000901681,0.00011476937],"genre_scores_gemma":[0.9966174,0.0015271662,0.0013715168,0.000098861434,0.00015592099,0.000019383198,0.00016451918,0.000023210916,0.000022069615],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985712,0.00027194584,0.0003933494,0.0004044983,0.00014470443,0.0002142668],"domain_scores_gemma":[0.99934494,0.000067611094,0.00022502319,0.00020736166,0.000097589385,0.000057440535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020348461,0.00015463804,0.00026278343,0.00013628033,0.000048065613,0.000018091292,0.000098259494,0.00023428077,0.000023044702],"category_scores_gemma":[0.00013894723,0.00016290127,0.00006881357,0.00019000267,0.00006163235,0.0000105182135,0.00013518437,0.0001453335,0.0000023943212],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008505349,0.0001626549,0.0015003561,0.000054221222,0.000019401556,0.000056435667,0.000093229675,0.00017177135,0.9945106,0.0002217276,0.000013560163,0.0031109988],"study_design_scores_gemma":[0.0010235034,0.00060286594,0.0046224343,0.0000057297984,0.00005121255,0.00003240182,0.0001427859,0.00014206582,0.9899676,0.0027304157,0.00053407496,0.00014490288],"about_ca_topic_score_codex":0.000031533174,"about_ca_topic_score_gemma":0.00012809796,"teacher_disagreement_score":0.00915363,"about_ca_system_score_codex":0.00006242927,"about_ca_system_score_gemma":0.00015380963,"threshold_uncertainty_score":0.6642921},"labels":[],"label_agreement":null},{"id":"W3215935280","doi":"10.1093/neuonc/noab196.876","title":"TMOD-15. CHARACTERIZATION OF THE MINIMAL RESIDUAL DISEASE STATE REVEALS DISTINCT EVOLUTIONARY TRAJECTORIES OF HUMAN GLIOBLASTOMA","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University","funders":"","keywords":"Minimal residual disease; Glioblastoma; Disease; Brain tumor; Transcriptome; Cancer research; Oncology; Biology; Cancer; Medicine; Gene; Internal medicine; Pathology; Genetics; Gene expression","score_opus":0.009684409550831444,"score_gpt":0.2567727922615968,"score_spread":0.2470883827107654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215935280","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978762,0.0002408077,0.000044707253,0.00046325952,0.00038988778,0.00014962476,0.0006369915,0.000004435613,0.00019407657],"genre_scores_gemma":[0.99889904,0.0001449226,0.00005301753,0.00026142134,0.00025314576,0.000017683407,0.00023307861,0.000017913557,0.00011978709],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99893844,0.00017550641,0.00033431218,0.0002709816,0.00011988822,0.00016088014],"domain_scores_gemma":[0.99904263,0.00007738893,0.00025006357,0.0003561552,0.00020269911,0.00007105719],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007548392,0.00011450565,0.0002037758,0.000024024694,0.000075373166,0.00000595221,0.00016429681,0.0000888179,0.000029988685],"category_scores_gemma":[0.00040040785,0.00010459986,0.000100197394,0.00011106326,0.00020649222,0.0000035460282,0.0002110041,0.00007849276,9.403694e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034992964,0.00016620016,0.020033713,0.000040900835,0.000023136561,0.000021096133,0.000069771835,0.000023688312,0.97752786,0.00018287096,0.0010324687,0.00052837655],"study_design_scores_gemma":[0.0005380462,0.0008139271,0.31193602,0.000014636734,0.000050435596,0.000018710196,0.000029162726,0.00001150992,0.6674626,0.0002361891,0.01877889,0.00010986554],"about_ca_topic_score_codex":0.000010067974,"about_ca_topic_score_gemma":0.00010635392,"teacher_disagreement_score":0.31006524,"about_ca_system_score_codex":0.00003244556,"about_ca_system_score_gemma":0.0005598459,"threshold_uncertainty_score":0.42654583},"labels":[],"label_agreement":null},{"id":"W3215974396","doi":"10.1093/neuonc/noab196.615","title":"NCOG-24. REAL-WORLD ANALYSIS OF OUTCOMES OF PATIENTS RECEIVING BEVACIZUMAB FOR RECURRENT GLIOBLASTOMA IN BRITISH COLUMBIA","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Bevacizumab; Temozolomide; Demographics; Chemotherapy; Internal medicine; Glioblastoma; Oncology; Proportional hazards model; Retrospective cohort study; Overall survival; Surgery","score_opus":0.019325454212087124,"score_gpt":0.30946887311374577,"score_spread":0.2901434189016586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215974396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99762404,0.0001251715,0.0000022786842,0.000542115,0.00039795425,0.000591652,0.00019187914,0.000016539314,0.00050838146],"genre_scores_gemma":[0.99869275,0.00025307733,0.00039093825,0.00022627272,0.000022579543,0.00015297039,0.00015983428,0.000022532158,0.000079072845],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981193,0.00015941341,0.0007700678,0.00042134093,0.0002459119,0.0002839937],"domain_scores_gemma":[0.9978764,0.0009301425,0.00035964279,0.00033320044,0.00039304103,0.000107549364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015263315,0.000123328,0.001250386,0.00036367596,0.000035310975,0.000015351212,0.000085180276,0.00011525996,0.00021973571],"category_scores_gemma":[0.0007522507,0.00015162883,0.00038788424,0.0013239592,0.000061934195,0.000037999525,0.00008105458,0.0001296651,0.0000014312357],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000242179,0.0031965931,0.908711,0.000081362705,0.0007241633,0.00022974674,0.00013708588,0.000019134315,0.0014104489,0.000007969811,0.0018490725,0.08339125],"study_design_scores_gemma":[0.0061930604,0.003133805,0.9785486,0.00008462721,0.001793802,0.0000075043095,0.00009108729,0.00015841883,0.0032904597,0.000029696115,0.006567744,0.00010119984],"about_ca_topic_score_codex":0.0027020818,"about_ca_topic_score_gemma":0.5057407,"teacher_disagreement_score":0.50303864,"about_ca_system_score_codex":0.00029992513,"about_ca_system_score_gemma":0.0002133373,"threshold_uncertainty_score":0.6183244},"labels":[],"label_agreement":null},{"id":"W3216064554","doi":"10.1093/neuonc/noab196.886","title":"TMOD-25. LATENT SOX9-POSITIVE CELLS BEHIND MYC-DRIVEN MEDULLOBLASTOMA RELAPSE","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medulloblastoma; Cancer research; Metastasis; Medicine; SOX9; Doxycycline; Immune system; Biology; Gene; Transcription factor; Cancer; Internal medicine; Immunology; Genetics","score_opus":0.016248565749370232,"score_gpt":0.2784242439363501,"score_spread":0.2621756781869799,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216064554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9720017,0.00047930412,0.000017800498,0.015064869,0.0013104883,0.0005784504,0.000050341598,0.00010050817,0.010396556],"genre_scores_gemma":[0.9925593,0.0003655346,0.00086372165,0.005280227,0.0003151476,0.00012034547,0.00008937568,0.000058229467,0.00034812273],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99783224,0.00026237135,0.00040218869,0.0006699632,0.0003170141,0.00051624334],"domain_scores_gemma":[0.9982087,0.00052729005,0.00015442574,0.00048996136,0.00023572317,0.0003838716],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000095721734,0.00029370416,0.00066679704,0.00012729206,0.00012623216,0.00002351167,0.000114056595,0.00029748958,0.0006781324],"category_scores_gemma":[0.00013346603,0.00025886184,0.00025945972,0.00019945188,0.00012801669,0.00006341925,0.00017610611,0.0004241935,0.000701907],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027766183,0.0031534266,0.012023219,0.000034676574,0.00035874144,0.026416618,0.00097021164,0.0000665302,0.9203042,0.0005324595,0.022169191,0.013693057],"study_design_scores_gemma":[0.008300319,0.004201629,0.031740434,0.00009505588,0.00080379937,0.0020253642,0.00022875404,0.00028790502,0.76729405,0.00011976851,0.18458574,0.0003172073],"about_ca_topic_score_codex":0.00003796416,"about_ca_topic_score_gemma":0.00012786196,"teacher_disagreement_score":0.16241653,"about_ca_system_score_codex":0.00039502408,"about_ca_system_score_gemma":0.0005046855,"threshold_uncertainty_score":0.99998635},"labels":[],"label_agreement":null},{"id":"W3216078554","doi":"10.1093/neuonc/noab196.373","title":"IMMU-14. REVEALING THE MANY MYELOID STATES IN HUMAN BRAIN TUMORS AND WAYS TO PERTURB THEM","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"","keywords":"Tumor microenvironment; Reprogramming; Immunotherapy; Myeloid; Immune system; Brain tumor; Cancer research; Biology; Myeloid cells; Cancer immunotherapy; Medicine; Cell; Immunology; Pathology","score_opus":0.022148403595210354,"score_gpt":0.27306192061723394,"score_spread":0.2509135170220236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216078554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9707441,0.0037264456,0.0000663519,0.016694343,0.001593573,0.00039619472,0.000017612918,0.00006491127,0.0066964664],"genre_scores_gemma":[0.9803258,0.00044986798,0.0001753913,0.017160427,0.00009039911,0.000097136304,0.000055360328,0.000049748676,0.0015958542],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99769115,0.0006475473,0.0004621444,0.0005535643,0.000043540975,0.00060204306],"domain_scores_gemma":[0.99777347,0.00148371,0.00012355474,0.0005057556,0.000080802456,0.00003271773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058529305,0.00023319032,0.0004687693,0.00009277916,0.00031020973,0.000025087162,0.00038593385,0.00029919067,0.00069848],"category_scores_gemma":[0.00044368333,0.00019291652,0.00007239536,0.00024953627,0.00034597094,0.000054872595,0.0004759476,0.0008822232,0.00024896322],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010827006,0.000081563405,0.00077312154,0.000017735745,0.000038626295,0.00020189211,0.0033997162,0.000030094086,0.96807253,0.0021561638,0.015505056,0.009615217],"study_design_scores_gemma":[0.0017668662,0.00046496175,0.0044485424,0.000047051133,0.00002765855,0.00094296073,0.0018629216,0.000007429566,0.37989855,0.0017167813,0.6085177,0.0002985551],"about_ca_topic_score_codex":0.00013344309,"about_ca_topic_score_gemma":0.00021069733,"teacher_disagreement_score":0.5930127,"about_ca_system_score_codex":0.0001720715,"about_ca_system_score_gemma":0.00019260358,"threshold_uncertainty_score":0.7866907},"labels":[],"label_agreement":null},{"id":"W3216104460","doi":"10.1093/neuonc/noab196.603","title":"NCOG-12. COGNITIVE FUNCTION (CF) &amp; QUALITY OF LIFE (QOL) IN PATIENTS TREATED WITH PROCARBAZINE, CCNU, &amp; VINCRISTINE (PCV) + RADIOTHERAPY (RT) VS. RT FOR ANAPLASTIC OLIGODENDROGLIOMA (AO) ON NRG RTOG TRIAL 9402","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; London Health Sciences Centre; University of Calgary; Victoria Hospital; Centre Hospitalier de l’Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Procarbazine; Quality of life (healthcare); Internal medicine; Oncology; Vincristine; Physical therapy; Chemotherapy","score_opus":0.04271951688715805,"score_gpt":0.32815808853094314,"score_spread":0.2854385716437851,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216104460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941446,0.00018013579,0.00023673513,0.0007924222,0.0005777342,0.003281085,0.00021561781,0.00007851212,0.0004931186],"genre_scores_gemma":[0.99543,0.00008606338,0.00047005803,0.001575483,0.00031364037,0.00090532604,0.0010609672,0.00008534411,0.0000731135],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99639255,0.00064889144,0.0010271865,0.0008955979,0.0005041288,0.0005316746],"domain_scores_gemma":[0.9958429,0.0021640745,0.00057455583,0.0004458003,0.0006770309,0.00029569425],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003134759,0.00046713775,0.0014888103,0.00040884383,0.000095553194,0.000018699513,0.00009532623,0.0003340589,0.00017597279],"category_scores_gemma":[0.002363243,0.0003787423,0.000242732,0.00067383953,0.00016068108,0.00007479926,0.00003720211,0.00032393617,0.000026667207],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5540074,0.02281225,0.37999707,0.00032882678,0.0012900383,0.00030355557,0.00051123096,0.000059023678,0.024895387,0.00010065024,0.0040821875,0.011612369],"study_design_scores_gemma":[0.45131785,0.070484474,0.4411789,0.00032810884,0.0013659294,0.000074043615,0.00011025973,0.00011727105,0.014160817,0.000031818698,0.020251008,0.0005795276],"about_ca_topic_score_codex":0.00022894423,"about_ca_topic_score_gemma":0.0029095137,"teacher_disagreement_score":0.10268958,"about_ca_system_score_codex":0.0004517812,"about_ca_system_score_gemma":0.00064869015,"threshold_uncertainty_score":0.9998664},"labels":[],"label_agreement":null},{"id":"W3216145966","doi":"10.1093/neuonc/noab267","title":"Low and steady wins the race: For melanoma brain metastases, is prevention better than a cure?","year":2021,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Race (biology); Melanoma; Medicine; Internal medicine; Oncology; Cancer research; Sociology; Gender studies","score_opus":0.03220070741561534,"score_gpt":0.3175659699784853,"score_spread":0.28536526256287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216145966","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010077446,0.001800584,0.00040520253,0.9825391,0.001068422,0.002887571,0.000852592,0.00005028019,0.00031878933],"genre_scores_gemma":[0.0009871799,0.00034734487,0.0022557587,0.984139,0.004128517,0.0008564711,0.0028089094,0.000143233,0.004333564],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.996429,0.0010861825,0.00054397626,0.00094721845,0.0003758238,0.0006177758],"domain_scores_gemma":[0.9963868,0.0021205335,0.00038913178,0.0008355275,0.00013826512,0.00012973526],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00060087803,0.0005382136,0.0012122171,0.0001523765,0.00018844038,0.00006551895,0.00019562837,0.0010227191,0.00050196325],"category_scores_gemma":[0.00024761274,0.00036241263,0.00054020854,0.00016462024,0.00020029025,0.00006219606,0.00016732125,0.0019407365,0.000030794487],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019320022,0.0003234569,0.0001590812,0.00042788996,0.00096227985,0.0028918479,0.00026234312,2.635707e-7,0.0013669364,0.00003697318,0.9650553,0.028320462],"study_design_scores_gemma":[0.0043990053,0.003762713,0.00021371557,0.00013087415,0.0024318732,0.0016834592,0.000084285675,0.000025689005,0.0014177889,0.00032549107,0.9852613,0.00026381144],"about_ca_topic_score_codex":0.000040655676,"about_ca_topic_score_gemma":0.000088092325,"teacher_disagreement_score":0.02805665,"about_ca_system_score_codex":0.00018591824,"about_ca_system_score_gemma":0.0004944533,"threshold_uncertainty_score":0.99988276},"labels":[],"label_agreement":null},{"id":"W3216151293","doi":"10.1093/neuonc/noab196.692","title":"EXTH-53. ANTI-ROBO1 CAR T CELLS EFFECTIVELY TARGET MALIGNANT BRAIN CANCER","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Canada; McMaster University","funders":"","keywords":"Downregulation and upregulation; Cancer research; Chimeric antigen receptor; Glioma; Cancer; Degranulation; Medicine; Antigen; Antibody; Brain tumor; Cancer cell; Immunology; Immunotherapy; Biology; Receptor; Pathology; Internal medicine; Gene","score_opus":0.02928900314783732,"score_gpt":0.3489784364317776,"score_spread":0.3196894332839403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216151293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95955694,0.0012991823,0.00016368656,0.018285496,0.0021143008,0.0011853478,0.00006236365,0.00014942928,0.017183261],"genre_scores_gemma":[0.9454763,0.002310294,0.0012705927,0.026353061,0.0023333433,0.0004568011,0.00008867054,0.00028003316,0.02143092],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99663746,0.00087238493,0.00037264943,0.00081407157,0.00047923517,0.00082422275],"domain_scores_gemma":[0.9973201,0.0012473279,0.0001077857,0.00060663465,0.0003390229,0.00037912937],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000501403,0.00029445832,0.0008514581,0.00017904499,0.0001133887,0.000026985506,0.00021164257,0.00033913276,0.00978759],"category_scores_gemma":[0.00042307735,0.00027063492,0.00023556406,0.0005319142,0.00022055344,0.00006121981,0.00021566873,0.0008642348,0.00030789926],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043376393,0.00037099875,0.0037287578,0.00011609287,0.00012864642,0.0057469117,0.00042967655,0.000051788862,0.9349581,0.00005605667,0.031223169,0.02275605],"study_design_scores_gemma":[0.00219098,0.00091694435,0.0029251415,0.000034265642,0.00004437256,0.00041812193,0.00007024702,0.00010404517,0.5603808,0.00003592755,0.4327377,0.00014145183],"about_ca_topic_score_codex":0.00022015955,"about_ca_topic_score_gemma":0.00012293221,"teacher_disagreement_score":0.40151453,"about_ca_system_score_codex":0.000593876,"about_ca_system_score_gemma":0.0016016575,"threshold_uncertainty_score":0.9999746},"labels":[],"label_agreement":null},{"id":"W3216334861","doi":"10.1093/neuonc/noab196.032","title":"EPCO-33. CELL-TYPE PROPORTION DECONVOLUTION OF PEDIATRIC CENTRAL NERVOUS SYSTEM TUMORS FROM SINGLE NUCLEI RNA-seq UNCOVERS UNDERLYING TRANSCRIPTOMIC CHANGES FROM BULK TUMOR RNA-seq COMPARED TO NORMAL BRAIN","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Biology; Transcriptome; Gene; RNA; Cell type; RNA-Seq; Gene expression; Brain tumor; Cell; Molecular biology; Cancer research; Genetics; Pathology; Medicine","score_opus":0.037818530060769,"score_gpt":0.27279361741492497,"score_spread":0.23497508735415598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216334861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99208075,0.0007838172,0.00013950178,0.002861729,0.0022392422,0.0009924123,0.00030890838,0.0001467275,0.00044694287],"genre_scores_gemma":[0.99675107,0.0000679884,0.00074473344,0.0011935135,0.00059560547,0.00006748606,0.00049069856,0.00007213367,0.00001677041],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969774,0.00032976587,0.0007820772,0.0007776042,0.00044989376,0.0006832906],"domain_scores_gemma":[0.99797374,0.00042395882,0.00046906152,0.0004431792,0.00025329992,0.00043678994],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014187131,0.00038596525,0.0010201134,0.00027171982,0.0001384229,0.00003555975,0.0001673814,0.00021581457,0.00022000472],"category_scores_gemma":[0.00015221999,0.00038372824,0.00021696242,0.0005709299,0.00006992946,0.00011235718,0.000072344825,0.00029912978,0.00006589447],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088248035,0.0015538781,0.037020802,0.00021140993,0.00015307688,0.002447511,0.00132439,0.00078737637,0.94963557,0.000032509313,0.002691943,0.0032590607],"study_design_scores_gemma":[0.015358334,0.006312503,0.17068948,0.00033674896,0.0023240321,0.00036990817,0.004972267,0.003045616,0.7881691,0.000057896847,0.0075405897,0.0008235552],"about_ca_topic_score_codex":0.0024211567,"about_ca_topic_score_gemma":0.0016919136,"teacher_disagreement_score":0.1614665,"about_ca_system_score_codex":0.0011994852,"about_ca_system_score_gemma":0.0007151123,"threshold_uncertainty_score":0.9998615},"labels":[],"label_agreement":null},{"id":"W3216361204","doi":"10.1093/neuonc/noab196.741","title":"QOLP-20. DIETARY, ACTIVITY, AND QUALITY OF LIFE METRICS IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA IMPLEMENTING A KETOGENIC DIET: RESULTS OF A PHASE 1 CLINICAL TRIAL","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Diet and metabolism studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ketogenic diet; Medicine; Ketosis; Ketone bodies; Quality of life (healthcare); Internal medicine; Clinical trial; Endocrinology; Diabetes mellitus; Metabolism; Epilepsy","score_opus":0.10290699529354985,"score_gpt":0.41716605604836166,"score_spread":0.3142590607548118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216361204","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971051,0.00029809045,0.0000069635335,0.00056528044,0.00055447506,0.00081840093,0.00012164561,0.000015978942,0.00051401526],"genre_scores_gemma":[0.99836534,0.00062280224,0.00039843115,0.00033136492,0.00019419406,0.000031501044,0.00002612792,0.000020363901,0.000009892681],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99646646,0.0008259928,0.001413022,0.00050927285,0.0004096639,0.00037558502],"domain_scores_gemma":[0.9951582,0.0031136281,0.00083198526,0.0003523733,0.00034871305,0.00019512308],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0014595743,0.00020485366,0.0016090982,0.00022435737,0.000043417265,0.0000056675804,0.000089176036,0.0001624889,0.000013879074],"category_scores_gemma":[0.010257458,0.00016855057,0.00018687926,0.00073131314,0.00024063732,0.000074685755,0.00032111598,0.00036028985,7.74349e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.34803337,0.00897065,0.5574412,0.00016961488,0.0003479064,0.00009073899,0.0008010277,6.768437e-7,0.014859106,0.000017543256,0.00048395694,0.06878424],"study_design_scores_gemma":[0.32194886,0.029298285,0.639423,0.000037131686,0.0003730687,0.0000013434399,0.0003046638,0.000015617794,0.0020639924,0.000011098395,0.006382603,0.00014033016],"about_ca_topic_score_codex":0.00014880826,"about_ca_topic_score_gemma":0.0013237315,"teacher_disagreement_score":0.081981845,"about_ca_system_score_codex":0.00003566158,"about_ca_system_score_gemma":0.00054431596,"threshold_uncertainty_score":0.99807954},"labels":[],"label_agreement":null},{"id":"W3216384050","doi":"10.1093/neuonc/noab196.855","title":"TAMI-73. GLIOBLASTOMA CELL POPULATIONS WITH DISTINCT ONCOGENIC PROGRAMS RELEASE PODOPLANIN AS PROCOAGULANT EXTRACELLULAR VESICLES","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital; McGill University; McGill University Health Centre","funders":"","keywords":"Podoplanin; Cancer research; Microvesicles; Biology; Chemistry; Immunology; microRNA; Gene; Biochemistry","score_opus":0.015314858277603633,"score_gpt":0.266599253932278,"score_spread":0.25128439565467436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216384050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99186766,0.0028360952,0.0011686237,0.00047455492,0.0002940118,0.00075294805,0.00005027771,0.00011143162,0.0024444093],"genre_scores_gemma":[0.9923387,0.00009083018,0.0044246097,0.00051114045,0.00041712317,0.00018989742,0.00074811885,0.00012841549,0.0011511719],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968201,0.00046859568,0.00054251467,0.0011064588,0.00035162494,0.0007107417],"domain_scores_gemma":[0.9978923,0.00006469459,0.00031264816,0.0010007459,0.00025854455,0.00047106063],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001942291,0.00044490176,0.00041480843,0.00007610922,0.0002447423,0.00007357967,0.00042250805,0.0003938116,0.000114200804],"category_scores_gemma":[0.00027908297,0.00043072773,0.0002167461,0.0003536117,0.000295283,0.000015365924,0.0002992038,0.00039093778,0.00014764965],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006920523,0.0013242783,0.0062168357,0.00006793896,0.00005754411,0.0033010002,0.00007793131,0.00012878662,0.97545266,0.00026678728,0.0012943483,0.011119846],"study_design_scores_gemma":[0.0019676834,0.0029256647,0.0012636045,0.000027645434,0.00020478563,0.0016776228,0.00023366623,0.00020486374,0.7773298,0.00020625959,0.21338959,0.0005688043],"about_ca_topic_score_codex":0.000022777276,"about_ca_topic_score_gemma":0.00031847155,"teacher_disagreement_score":0.21209523,"about_ca_system_score_codex":0.000097134565,"about_ca_system_score_gemma":0.0010360423,"threshold_uncertainty_score":0.99981445},"labels":[],"label_agreement":null},{"id":"W3216564407","doi":"10.1093/neuonc/noab196.092","title":"STEM-18. STROMAL EXTRACELLULAR VESICLES DRIVE GLIOMA STEM CELL REPROGRAMMING","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Reprogramming; Stromal cell; Cell biology; Biology; Stem cell; Mesenchymal stem cell; Glioma; Cancer stem cell; Phenotype; Extracellular vesicle; Microvesicles; Cell; Cancer research; microRNA; Genetics; Gene","score_opus":0.018250900688940707,"score_gpt":0.2700543197270724,"score_spread":0.2518034190381317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216564407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98277515,0.010263585,0.0012675825,0.00033272628,0.00076337566,0.00038106018,0.000044305547,0.00009316305,0.0040790313],"genre_scores_gemma":[0.99410194,0.00022022899,0.0029374855,0.0005028921,0.00059391354,0.00007791354,0.000167005,0.000114040115,0.0012845678],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9962997,0.0006749583,0.000624601,0.0013093194,0.00031359371,0.00077783637],"domain_scores_gemma":[0.9976506,0.00013180987,0.0003110088,0.0012850254,0.00022360368,0.00039794692],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003479094,0.00040518088,0.0004396114,0.000082058556,0.00019793115,0.000079645346,0.00053153577,0.0005264886,0.0001397267],"category_scores_gemma":[0.000075324955,0.00046067504,0.00032172218,0.0002819873,0.00025822892,0.000013874672,0.0005636401,0.00040069045,0.00011541408],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001714265,0.00057961745,0.0017051455,0.00005817279,0.00006209508,0.0036938286,0.00010423222,0.00005287875,0.9500063,0.00018030588,0.0032320232,0.040153958],"study_design_scores_gemma":[0.001066746,0.00073532556,0.00015946575,0.000009155966,0.00007990309,0.0004582367,0.00058300566,0.00007722152,0.74634945,0.000045163404,0.25010252,0.00033377044],"about_ca_topic_score_codex":0.000005651657,"about_ca_topic_score_gemma":0.000017780534,"teacher_disagreement_score":0.2468705,"about_ca_system_score_codex":0.000091651535,"about_ca_system_score_gemma":0.0006342929,"threshold_uncertainty_score":0.99978447},"labels":[],"label_agreement":null},{"id":"W3216894132","doi":"10.1093/neuonc/noab196.081","title":"STEM-05. FUNCTIONAL MAPPING REVEALS WIDESPREAD REMODELLING AND UNRECOGNIZED PATHWAY DEPENDENCIES IN RECURRENT GLIOBLASTOMA","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"ATP Synthase and ATPases Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Canada; University Health Network; University of Toronto; McMaster University","funders":"","keywords":"PTEN; Cancer research; Biology; Signal transduction; Synthetic lethality; Genetics; PI3K/AKT/mTOR pathway; DNA repair; Gene","score_opus":0.04605082114340747,"score_gpt":0.2971969502306166,"score_spread":0.2511461290872091,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216894132","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994257,0.0018509607,0.0015148458,0.00074509846,0.0004298779,0.00019641929,0.000023371864,0.000016408803,0.0009660332],"genre_scores_gemma":[0.9961894,0.0015257422,0.000709147,0.0006975376,0.00026991242,0.000048204758,0.00006444172,0.000029246981,0.00046633283],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979957,0.00043588877,0.0003480726,0.0006235296,0.00019229673,0.0004045322],"domain_scores_gemma":[0.9990815,0.00027548312,0.00009174368,0.0002606891,0.00015559421,0.00013502069],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038879106,0.00017977796,0.00028988242,0.0001040231,0.00010348308,0.000030508976,0.00011994419,0.0002588097,0.000060385344],"category_scores_gemma":[0.0003241025,0.0001677786,0.000080740436,0.00019551547,0.000098349454,0.000009516498,0.00028431465,0.0003082586,0.00001691239],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041052655,0.000105784835,0.0011250888,0.00003312747,0.000023924122,0.00036647334,0.000066684974,0.0000708199,0.9275089,0.000035733323,0.00092954986,0.06932337],"study_design_scores_gemma":[0.0018231253,0.0012495152,0.00050862436,0.000073100266,0.00001408059,0.00039257194,0.00060955447,0.0009570761,0.82863,0.00026134087,0.16517511,0.00030595658],"about_ca_topic_score_codex":0.00000956916,"about_ca_topic_score_gemma":0.00024680007,"teacher_disagreement_score":0.16424556,"about_ca_system_score_codex":0.00005714306,"about_ca_system_score_gemma":0.0004326562,"threshold_uncertainty_score":0.6841813},"labels":[],"label_agreement":null},{"id":"W3216935060","doi":"10.1093/neuonc/noab196.524","title":"NIMG-24. RANO CRITERIA DETECTS EARLY PROGRESSION SOONER THAN MODIFIED RANO CRITERIA IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Glioblastoma; Medicine; Progression-free survival; Tumor progression; Retrospective cohort study; Radiation therapy; Oncology; Surgery; Internal medicine; Overall survival; Radiology; Medical physics; Cancer; Cancer research","score_opus":0.01651467078057148,"score_gpt":0.2938790076198118,"score_spread":0.2773643368392403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216935060","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99453425,0.00020815624,0.000011628118,0.0018764113,0.0009625406,0.0014102503,0.000026010377,0.00012032412,0.0008504473],"genre_scores_gemma":[0.9968363,0.000040385592,0.000872371,0.0014449583,0.0001846278,0.00042096686,0.00007880139,0.00009229779,0.000029313092],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968074,0.00054175215,0.0005654868,0.00087498873,0.00048295848,0.0007274106],"domain_scores_gemma":[0.99808365,0.00041752847,0.0002080673,0.00061972166,0.00030551382,0.00036550235],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015655361,0.0004451151,0.0009327472,0.00030642666,0.00010946773,0.000068779875,0.0001547799,0.00033947147,0.00038614488],"category_scores_gemma":[0.00028588736,0.0003429325,0.00015088488,0.0005657225,0.00013404903,0.00017434746,0.00014875406,0.00039285122,0.000078760226],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01291463,0.010658287,0.5818412,0.00017540269,0.00022875878,0.019269668,0.0017333971,0.000016843425,0.31761134,0.000052653162,0.0041068997,0.051390942],"study_design_scores_gemma":[0.061042007,0.016034642,0.76434696,0.00044618742,0.0003310499,0.00018603115,0.000110922934,0.00019273366,0.14870444,0.0000621288,0.008008443,0.0005344776],"about_ca_topic_score_codex":0.00006514275,"about_ca_topic_score_gemma":0.00033199004,"teacher_disagreement_score":0.18250573,"about_ca_system_score_codex":0.000262622,"about_ca_system_score_gemma":0.00033135733,"threshold_uncertainty_score":0.99990225},"labels":[],"label_agreement":null},{"id":"W3216971193","doi":"10.1093/neuonc/noab272","title":"Radiomic signatures of posterior fossa ependymoma: Molecular subgroups and risk profiles","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children; Western University","funders":"Canadian Institutes of Health Research; National Institutes of Health; National Cancer Institute; National Institute for Health and Care Research; Cancer Research UK","keywords":"Medicine; Magnetic resonance imaging; Ependymoma; Radiology; Proportional hazards model; Oncology; Internal medicine","score_opus":0.010521962687975893,"score_gpt":0.27227363370569285,"score_spread":0.26175167101771696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216971193","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910071,0.005668529,0.0000056461495,0.0019699081,0.00021686107,0.00037107387,0.000037619637,0.00002647587,0.00069677376],"genre_scores_gemma":[0.99790883,0.0005228553,0.000732731,0.00066420605,0.00005688827,0.000050971892,0.00002941165,0.000023977638,0.000010118442],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988316,0.00019739717,0.00025583536,0.00035394946,0.00014384516,0.0002173385],"domain_scores_gemma":[0.99908835,0.00025970297,0.00014077722,0.0002772384,0.00010371701,0.00013024175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000088357556,0.00015844224,0.0004957216,0.00009413224,0.000044190358,0.0000092576765,0.00005293819,0.00017235139,0.000091375936],"category_scores_gemma":[0.00023332995,0.00013197529,0.00011148348,0.00013758922,0.00011043918,0.000028610619,0.0000892467,0.00020567884,0.000008312236],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001878848,0.0006099498,0.038217872,0.00006214362,0.0001772037,0.009145778,0.00015581356,0.000003580816,0.9268747,0.0003280409,0.00051860133,0.023718445],"study_design_scores_gemma":[0.004686924,0.001894895,0.10465114,0.00003465563,0.0005518949,0.002383379,0.000111061665,0.000052937256,0.8794392,0.0001442166,0.005933465,0.00011625624],"about_ca_topic_score_codex":0.000047897913,"about_ca_topic_score_gemma":0.000028977163,"teacher_disagreement_score":0.066433266,"about_ca_system_score_codex":0.000057102963,"about_ca_system_score_gemma":0.00017271089,"threshold_uncertainty_score":0.53817964},"labels":[],"label_agreement":null},{"id":"W3216975602","doi":"10.1093/neuonc/noab196.078","title":"STEM-02. THERAPEUTIC INTERVENTION OF LUNG-, BREAST-, AND MELANOMA-BRAIN METASTASIS","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Brain metastasis; Population; Medicine; Breast cancer; Context (archaeology); Cancer research; Metastasis; Melanoma; In vivo; Lung cancer; Cancer stem cell; Oncology; Pathology; Cancer; Internal medicine; Biology","score_opus":0.026815285374729915,"score_gpt":0.3221159003478448,"score_spread":0.2953006149731149,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216975602","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.967426,0.0072145974,0.00064211385,0.021686256,0.00045296593,0.000542446,0.000113262526,0.00004991253,0.0018724541],"genre_scores_gemma":[0.9961486,0.00020171041,0.00081058487,0.0022884605,0.00006120491,0.00003246642,0.000050214054,0.000024599516,0.00038218376],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984707,0.0004897906,0.0003513331,0.0003271464,0.00015514491,0.00020584023],"domain_scores_gemma":[0.9988747,0.00044466407,0.00014971102,0.000293491,0.00011569275,0.00012170271],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030718787,0.000154991,0.0005264882,0.000091686205,0.000037200287,0.0000093618855,0.000049960097,0.00009834184,0.0004762105],"category_scores_gemma":[0.000047351044,0.00012649286,0.00018725365,0.000174031,0.00009953965,0.000045378467,0.000079757636,0.00016437024,0.000011645015],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006203026,0.0017494049,0.014436764,0.00033820514,0.0010945778,0.001588771,0.00042009228,0.0000022465174,0.11675355,0.0025679623,0.0028369569,0.85759115],"study_design_scores_gemma":[0.037112717,0.020508999,0.1347297,0.00040911755,0.0078043453,0.032365583,0.0030406818,0.00096039835,0.22679564,0.0022014126,0.53323394,0.0008374479],"about_ca_topic_score_codex":0.000034824618,"about_ca_topic_score_gemma":0.00003493005,"teacher_disagreement_score":0.8567537,"about_ca_system_score_codex":0.00007805667,"about_ca_system_score_gemma":0.00014260843,"threshold_uncertainty_score":0.5214171},"labels":[],"label_agreement":null},{"id":"W3216996692","doi":"10.1093/neuonc/noab196.233","title":"CTNI-08. DB102-01 ENGAGE STUDY: A BIOMARKER-GUIDED, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTI-CENTER PHASE 3 CLINICAL TRIAL OF DB102 IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Temozolomide; Placebo; Internal medicine; Biomarker; Clinical endpoint; Oncology; Surrogate endpoint; Clinical trial; Phases of clinical research; Progression-free survival; Randomized controlled trial; Radiation therapy; Chemotherapy; Pathology","score_opus":0.0727596786582985,"score_gpt":0.3900084116739805,"score_spread":0.317248733015682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216996692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9789061,0.00018319652,0.000032868746,0.001084871,0.0016801577,0.017374963,0.00005472645,0.00007511582,0.000608005],"genre_scores_gemma":[0.994861,0.00012454251,0.00044929388,0.0008928638,0.0002774325,0.0031493115,0.0001204758,0.000098059114,0.000026992115],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9901058,0.004160491,0.0028978034,0.0012788788,0.0008025852,0.0007544179],"domain_scores_gemma":[0.9899603,0.0069564413,0.0010578433,0.0010033689,0.0005145203,0.0005075356],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002598598,0.0006775719,0.0044231243,0.0006017472,0.00011855,0.000042738233,0.00027189468,0.00048002318,0.00024326927],"category_scores_gemma":[0.0038059065,0.00048663275,0.000934529,0.0007491886,0.00038090648,0.00013180754,0.00023338843,0.0008665217,0.000060403887],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7767483,0.124982834,0.08225557,0.000033765726,0.0014978651,0.0055336724,0.000437985,0.000010459557,0.00046153905,0.000007986137,0.0010067959,0.0070232386],"study_design_scores_gemma":[0.9614909,0.02817339,0.004069105,0.0001076709,0.0016006677,0.000061588384,0.00039034462,0.0003059934,0.0008994371,0.000002724224,0.0025636498,0.00033450843],"about_ca_topic_score_codex":0.00012990917,"about_ca_topic_score_gemma":0.0007483978,"teacher_disagreement_score":0.18474263,"about_ca_system_score_codex":0.00028672867,"about_ca_system_score_gemma":0.0009880472,"threshold_uncertainty_score":0.99975854},"labels":[],"label_agreement":null},{"id":"W3217006037","doi":"10.1093/neuonc/noab196.466","title":"PATH-14. ALPHA CARDIAC ACTIN EXPRESSION IS OBSERVED IN AGGRESSIVE GLIOMA SUBTYPES AND GLIOBLASTOMA STEM CELLS","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Glioma; Biology; Cancer research; Actin; Western blot; Pathology; Protein subunit; Molecular biology; Cell biology; Medicine; Gene; Genetics","score_opus":0.02383724390006087,"score_gpt":0.27874561897179145,"score_spread":0.2549083750717306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217006037","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916766,0.0037413556,8.4056194e-7,0.0027186347,0.00078326225,0.00046422688,0.000039513332,0.00005021186,0.0005253294],"genre_scores_gemma":[0.9973388,0.0010163741,0.00014941301,0.0011033106,0.00014799037,0.00012978018,0.000011361629,0.00004145377,0.000061559156],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979189,0.00036586137,0.0003739637,0.00067017454,0.00025257104,0.00041852574],"domain_scores_gemma":[0.9982769,0.0006569157,0.00024206012,0.0004256019,0.00014259538,0.00025594255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012455396,0.00027389347,0.0007471272,0.00016876086,0.000078096855,0.000026954214,0.00007945794,0.00029324635,0.0001546889],"category_scores_gemma":[0.00011608842,0.00023383685,0.00015020669,0.00035385683,0.000078881574,0.00008361297,0.00018004315,0.0003007872,0.000053464195],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042998558,0.0007706252,0.034113467,0.00007420347,0.00006543274,0.016550131,0.0008823351,0.0000018321482,0.92003447,0.000015212566,0.0077425796,0.019319696],"study_design_scores_gemma":[0.0042285193,0.0013696209,0.015549484,0.00019790305,0.0001377967,0.0003967269,0.0006192924,0.000029509247,0.9417905,0.000020692947,0.035492394,0.00016755244],"about_ca_topic_score_codex":0.00003347186,"about_ca_topic_score_gemma":0.000045613055,"teacher_disagreement_score":0.027749814,"about_ca_system_score_codex":0.00017708524,"about_ca_system_score_gemma":0.00023230804,"threshold_uncertainty_score":0.953559},"labels":[],"label_agreement":null},{"id":"W3217052936","doi":"10.1093/neuonc/noab196.634","title":"NCOG-44. FEASIBILITY AND UTILITY OF THE MONTREAL COGNITIVE ASSESSMENT IN ROUTINE CLINICAL EXAMS AND TELEHEALTH VISITS IN NEURO-ONCOLOGY","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Telehealth; Montreal Cognitive Assessment; Medicine; Telemedicine; Cognition; Physical therapy; Descriptive statistics; Reliability (semiconductor); Test (biology); Family medicine; Cognitive impairment; Health care; Psychiatry","score_opus":0.06249526940776881,"score_gpt":0.41118645046855257,"score_spread":0.3486911810607838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217052936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98069024,0.00075468945,0.000015916947,0.010605395,0.00064609473,0.0018335788,0.00005361478,0.000027466513,0.005372975],"genre_scores_gemma":[0.9922863,0.002255436,0.00008381307,0.005109538,0.00012590838,0.00008283893,0.000012725536,0.000023811695,0.000019602381],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9940239,0.0028629827,0.0012657221,0.001005705,0.0002964129,0.0005452629],"domain_scores_gemma":[0.99306387,0.0056119254,0.00042224594,0.00036592275,0.00030096565,0.00023508881],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017846763,0.00030055764,0.0014138856,0.00013991082,0.00009787061,0.0000080104055,0.00010178418,0.00039427818,0.00006584199],"category_scores_gemma":[0.004461123,0.0002451,0.00012405988,0.0005690949,0.0008858759,0.00007434584,0.00057234964,0.001672459,0.0000017944105],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020522003,0.0020638884,0.8847745,0.000110513385,0.000065865206,0.000584025,0.0007325794,8.7766165e-7,0.0021057765,0.00001988218,0.0002604276,0.10722947],"study_design_scores_gemma":[0.015738461,0.0042357487,0.97478145,0.0001342377,0.00021224881,0.00038432344,0.0015134787,0.00045008096,0.0006138926,0.0002149657,0.0015765437,0.00014457582],"about_ca_topic_score_codex":0.0006469605,"about_ca_topic_score_gemma":0.011676428,"teacher_disagreement_score":0.10708489,"about_ca_system_score_codex":0.0004924858,"about_ca_system_score_gemma":0.0018497953,"threshold_uncertainty_score":0.9994888},"labels":[],"label_agreement":null},{"id":"W3217065735","doi":"10.1093/neuonc/noab196.728","title":"QOLP-07. EXPLORING CALM IN PATIENTS WITH HIGH-GRADE GLIOMA","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Distress; Randomized controlled trial; Anxiety; Depression (economics); Quality of life (healthcare); Clinical trial; Adverse effect; Cancer; Clinical psychology; Internal medicine; Physical therapy; Psychiatry; Nursing","score_opus":0.034265807147396146,"score_gpt":0.2869844000601862,"score_spread":0.2527185929127901,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217065735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913963,0.00012847886,0.000011261019,0.004652105,0.0009597044,0.00047500574,0.000011126327,0.00008057199,0.0022854153],"genre_scores_gemma":[0.9970697,0.000095275434,0.00020666332,0.0021033515,0.00020569986,0.00018377283,0.000032209256,0.000041323827,0.000062002095],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983585,0.00014315528,0.0003039091,0.00046269302,0.0002934669,0.00043828346],"domain_scores_gemma":[0.9990304,0.00028292974,0.00009441344,0.00023918824,0.00021752655,0.00013551336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007548365,0.00020463284,0.0005095523,0.00019026943,0.000070327565,0.000007533655,0.00006272081,0.000114462964,0.00021746167],"category_scores_gemma":[0.00031872818,0.00018070056,0.00005398331,0.00053192955,0.00012351752,0.00010289352,0.0001304795,0.00046911347,0.00010031543],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032720114,0.0033351658,0.8906949,0.00015115726,0.000323306,0.0092883585,0.001822705,0.000049827933,0.054534137,0.00015630144,0.0052461675,0.031125953],"study_design_scores_gemma":[0.020904595,0.005610586,0.8911899,0.000166004,0.00025235512,0.0002048009,0.00066314044,0.00001225252,0.034103483,0.000054394022,0.046533156,0.0003053768],"about_ca_topic_score_codex":0.00006624949,"about_ca_topic_score_gemma":0.00017147213,"teacher_disagreement_score":0.041286986,"about_ca_system_score_codex":0.00048690292,"about_ca_system_score_gemma":0.00028797387,"threshold_uncertainty_score":0.7368755},"labels":[],"label_agreement":null},{"id":"W3217106497","doi":"10.1093/neuonc/noab196.288","title":"DDRE-04. EFFECTIVENESS AND SAFETY OF OSIMERTINIB FOR PATIENTS WITH LEPTOMENINGEAL METASTASES FORM NON-SMALL CELL LUNG CANCER: A SYSTEMATIC REVIEW AND META-ANALYSIS","year":2021,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Osimertinib; Medicine; Common Terminology Criteria for Adverse Events; Internal medicine; Oncology; Lung cancer; Adverse effect; Meta-analysis; Hazard ratio; Epidermal growth factor receptor; Cancer; Confidence interval; Erlotinib","score_opus":0.03459315506263771,"score_gpt":0.3857840444814286,"score_spread":0.3511908894187909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217106497","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000079215,0.9856811,0.00018011624,0.00006894599,0.00005667273,0.012656964,0.0011797633,0.000012863134,0.000084364765],"genre_scores_gemma":[0.00029974504,0.9905643,0.0005853906,0.00026951512,0.000017052926,0.0075469585,0.00060103595,0.0000623867,0.000053609707],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9971375,0.0006301292,0.0010744353,0.00067700364,0.00020359627,0.00027737126],"domain_scores_gemma":[0.9957789,0.001978675,0.001244562,0.0004393161,0.00039361927,0.00016488279],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00043041565,0.00052582327,0.011231128,0.00025583126,0.00009219973,0.000014034507,0.00009681397,0.00017167091,0.000052631425],"category_scores_gemma":[0.00015112477,0.00030401294,0.0012351271,0.0006014575,0.00007754924,0.000049574668,0.000075970835,0.00019814637,4.2004334e-7],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000066991124,0.00029808687,0.00016206985,0.83523834,0.15564387,0.000023288125,0.00009969747,0.0000012488013,0.0000010124201,0.0000064535657,0.000059199945,0.008399725],"study_design_scores_gemma":[0.0020494114,0.0013425952,0.000030376601,0.024264785,0.93701494,0.000034157383,0.000015839913,0.0000045205647,0.0000069161138,4.874243e-7,0.035027564,0.00020843103],"about_ca_topic_score_codex":0.000062016974,"about_ca_topic_score_gemma":0.00004374886,"teacher_disagreement_score":0.8109736,"about_ca_system_score_codex":0.00031075653,"about_ca_system_score_gemma":0.00086601154,"threshold_uncertainty_score":0.9999412},"labels":[],"label_agreement":null},{"id":"W3217143832","doi":"10.1093/neuonc/noab196.217","title":"CTIM-25. A RANDOMIZED PHASE 3 STUDY OF NIVOLUMAB OR PLACEBO COMBINED WITH RADIOTHERAPY PLUS TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA WITH METHYLATED MGMT PROMOTER: CHECKMATE 548","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"","keywords":"Temozolomide; Medicine; Nivolumab; Internal medicine; Placebo; Oncology; Radiation therapy; Phases of clinical research; Progression-free survival; Randomized controlled trial; Gastroenterology; Cancer; Clinical trial; Overall survival; Immunotherapy; Pathology","score_opus":0.011643069760755319,"score_gpt":0.28607589327143335,"score_spread":0.27443282351067805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217143832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899723,0.00012513387,0.000040639145,0.0007574298,0.000118205055,0.008734738,0.000019561281,0.000101393896,0.00013062208],"genre_scores_gemma":[0.99648035,0.000060254977,0.0013129598,0.0004543247,0.000030264562,0.0014499375,0.000058671616,0.00011791814,0.000035323275],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99586,0.0011941985,0.0008901058,0.0008844256,0.00059242954,0.0005788803],"domain_scores_gemma":[0.9964979,0.0014110506,0.00063255196,0.00070532394,0.00047603832,0.00027708817],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003693428,0.0005761853,0.002817906,0.00041734893,0.00008630102,0.000030407275,0.00016340938,0.00019875291,0.00018479388],"category_scores_gemma":[0.00031096654,0.0003330233,0.0001222454,0.0011140798,0.0002739136,0.00012820684,0.000058271555,0.00041514743,0.0000047723156],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8632003,0.038626473,0.06489868,0.000099118915,0.0021514094,0.013743904,0.0036475486,0.00028437824,0.008301284,0.0000056241915,0.00015055493,0.0048907017],"study_design_scores_gemma":[0.84435576,0.12476582,0.010669299,0.00020962568,0.0011355316,0.00023146473,0.0007074685,0.0007223295,0.016622672,0.00000247178,0.00026322625,0.00031433094],"about_ca_topic_score_codex":0.00027511985,"about_ca_topic_score_gemma":0.0026187813,"teacher_disagreement_score":0.08613934,"about_ca_system_score_codex":0.00049611693,"about_ca_system_score_gemma":0.0010023814,"threshold_uncertainty_score":0.9999122},"labels":[],"label_agreement":null},{"id":"W3217210659","doi":"10.1093/neuonc/noab196.026","title":"EPCO-27. SINGLE-CELL ANALYSIS OF ETMR PATIENT SAMPLES LINKS TRANSCRIPTIONAL PHENOTYPES TO GENETIC DRIVER ALTERATIONS AND INFORMS NOVEL THERAPEUTIC STRATEGIES","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre","funders":"","keywords":"Biology; SOX2; Embryonic stem cell; Stem cell; Phenotype; Neural stem cell; microRNA; Population; Progenitor cell; Cell; Gene silencing; KLF4; Cancer research; Genetics; Cell biology; Gene; Medicine","score_opus":0.021333463713070627,"score_gpt":0.2644507298644257,"score_spread":0.24311726615135507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217210659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97484756,0.0017388496,0.021972386,0.00030718755,0.00015876634,0.00017972248,0.00014434804,0.000010013003,0.00064117514],"genre_scores_gemma":[0.99107444,0.00016890845,0.006693577,0.0016516179,0.0000659138,0.000021596952,0.00026463397,0.000018807943,0.000040518065],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99878955,0.00009639205,0.00036260666,0.00039265078,0.00014555265,0.00021323004],"domain_scores_gemma":[0.99916404,0.00007924005,0.000113121554,0.00032259972,0.0001910807,0.00012989737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000055408796,0.00016652324,0.00026175907,0.00012079859,0.00006691951,0.0000372818,0.00013323798,0.00022409529,0.00007904178],"category_scores_gemma":[0.00005693572,0.000165364,0.00014819398,0.00027146112,0.00014185034,0.00001012253,0.000089689376,0.00013746636,0.0000036790723],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000945463,0.0004499457,0.001538585,0.000019702828,0.00026283064,0.000011201338,0.0005805617,0.005528641,0.98432297,0.0004858726,0.000075564305,0.006629569],"study_design_scores_gemma":[0.0011991325,0.0018859457,0.02356554,0.000007831335,0.0010655251,0.000033711192,0.00093109946,0.0010632734,0.87502784,0.00028295742,0.094541356,0.00039576445],"about_ca_topic_score_codex":0.000009603684,"about_ca_topic_score_gemma":0.00018305436,"teacher_disagreement_score":0.10929512,"about_ca_system_score_codex":0.00002412882,"about_ca_system_score_gemma":0.0003169949,"threshold_uncertainty_score":0.6743348},"labels":[],"label_agreement":null},{"id":"W3217222663","doi":"10.1093/neuonc/noab196.463","title":"PATH-11. PDGFA INITIATES ABERRANT MITOSIS AND MALIGNANT TRANSFORMATION OF NEURAL PROGENITOR CELLS","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Calgary","funders":"","keywords":"Biology; Mitosis; Progenitor cell; Cell biology; Platelet-derived growth factor receptor; Growth factor; Cell cycle; Subventricular zone; Stem cell; Cancer research; Immunology; Cell; Genetics; Receptor","score_opus":0.022924073194300815,"score_gpt":0.27875670326381685,"score_spread":0.25583263006951606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217222663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99334055,0.0007283252,0.000007054982,0.004460461,0.0003818176,0.0004281364,0.0000359068,0.00002644015,0.0005912903],"genre_scores_gemma":[0.998112,0.00054051453,0.0003143292,0.00080697093,0.00008330182,0.00008206717,0.000038563197,0.00001737451,0.0000048598613],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988882,0.000121562494,0.00037356492,0.00024524768,0.00015354245,0.00021789447],"domain_scores_gemma":[0.99925447,0.00021765482,0.00010970467,0.00016645143,0.0001240549,0.00012768991],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007189921,0.00014626767,0.00041436445,0.000079487145,0.000046722977,0.0000098932205,0.000036664944,0.00012121849,0.00008000657],"category_scores_gemma":[0.000043334887,0.0001172629,0.00010719462,0.0001377826,0.00007330844,0.00006432828,0.000025821568,0.00010159446,0.000009419742],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009835149,0.0008807579,0.017296469,0.0001685874,0.000064863256,0.0009064209,0.0008888086,0.0000026901298,0.9656124,0.00009765755,0.00048281183,0.013500199],"study_design_scores_gemma":[0.00334157,0.0014006291,0.0133289015,0.000048532314,0.00033068407,0.0005792394,0.0003765867,0.00027039915,0.9667614,0.000025734,0.013440574,0.00009573638],"about_ca_topic_score_codex":0.000026525267,"about_ca_topic_score_gemma":0.00003500219,"teacher_disagreement_score":0.0134044625,"about_ca_system_score_codex":0.000044504643,"about_ca_system_score_gemma":0.00013032193,"threshold_uncertainty_score":0.47818422},"labels":[],"label_agreement":null},{"id":"W3217321524","doi":"10.1093/neuonc/noab196.246","title":"CTNI-21. PHASE 2 STUDY OF VAL-083 AND RADIOTHERAPY IN NEWLY DIAGNOSED MGMT-UNMETHYLATED GBM","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Temozolomide; Medicine; Methyltransferase; Radiation therapy; O-6-methylguanine-DNA methyltransferase; In vivo; Internal medicine; Phases of clinical research; Oncology; Stage (stratigraphy); Gastroenterology; Cancer research; Chemotherapy; Biology; DNA; Methylation","score_opus":0.025632566711072675,"score_gpt":0.34625628651452445,"score_spread":0.3206237198034518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217321524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931727,0.002053558,0.0000052235073,0.0031780316,0.0002791774,0.00090363866,0.0000069298744,0.00003219895,0.00036853683],"genre_scores_gemma":[0.9970774,0.0011648639,0.00027538528,0.0012154033,0.0000793652,0.00012129052,0.000014707267,0.000031911313,0.000019641091],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982034,0.0003972617,0.00045860896,0.00046796328,0.00019076419,0.00028202165],"domain_scores_gemma":[0.9983594,0.00086965883,0.00013686874,0.0003709072,0.00009745163,0.00016570404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017253857,0.00020276253,0.0007859148,0.00021531011,0.00003820603,0.000010026987,0.00006562894,0.00015100764,0.00018716033],"category_scores_gemma":[0.00027091804,0.0001761661,0.00007537416,0.00044716027,0.00007497346,0.00004207187,0.00005245038,0.00023117964,0.000005267114],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007774174,0.02313192,0.2786346,0.000035570683,0.00027413608,0.014788906,0.0029359828,0.000023522474,0.6035366,0.000029175311,0.0012326922,0.07459947],"study_design_scores_gemma":[0.21717164,0.038182132,0.46812266,0.000103599166,0.00077689206,0.00072405365,0.0031732249,0.0004438243,0.21975791,0.00009221585,0.05100527,0.00044655832],"about_ca_topic_score_codex":0.00015618453,"about_ca_topic_score_gemma":0.00029911436,"teacher_disagreement_score":0.3837787,"about_ca_system_score_codex":0.00014139929,"about_ca_system_score_gemma":0.00020762825,"threshold_uncertainty_score":0.7183845},"labels":[],"label_agreement":null},{"id":"W3217334326","doi":"10.1093/neuonc/noab196.588","title":"NCMP-17. BEWARE: ALL POSTERIOR FOSSA MASSES IN CHILDREN ARE NOT BRAIN TUMORS","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Medicine; Lumbar puncture; Papilledema; Headaches; Bone marrow; Radiology; Pathology; Surgery; Cerebrospinal fluid","score_opus":0.022379855995034646,"score_gpt":0.30217476056253645,"score_spread":0.2797949045675018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217334326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93820786,0.00037007438,7.9894284e-7,0.058982845,0.00026487574,0.00048743942,0.00004389127,0.000062882835,0.0015793482],"genre_scores_gemma":[0.9715246,0.00010145438,0.00024466385,0.027542975,0.00019142903,0.00012653101,0.00012161537,0.000040948184,0.0001057962],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981821,0.00020693378,0.00038622564,0.0005599129,0.00021189061,0.00045289614],"domain_scores_gemma":[0.99868613,0.00046670495,0.00013918192,0.00041571015,0.000083577776,0.00020869785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011633552,0.00024089888,0.0006446162,0.0001655421,0.00004713779,0.000023169801,0.00011126214,0.00018833888,0.00048559986],"category_scores_gemma":[0.00046268068,0.00021775712,0.00014494565,0.00027586517,0.000067613815,0.0000550632,0.00015451555,0.00030828832,0.00010265949],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001909576,0.0019745878,0.74344987,0.00002914948,0.00013681919,0.014734198,0.00026796616,0.000008533452,0.20354196,0.000057371817,0.020777088,0.014831515],"study_design_scores_gemma":[0.006142807,0.00132147,0.82904136,0.000074337484,0.00014528992,0.003329262,0.00014857786,0.000012215872,0.07496112,0.000033983146,0.084591836,0.00019773148],"about_ca_topic_score_codex":0.0000830744,"about_ca_topic_score_gemma":0.00033329608,"teacher_disagreement_score":0.12858084,"about_ca_system_score_codex":0.0002502856,"about_ca_system_score_gemma":0.0003151575,"threshold_uncertainty_score":0.88798773},"labels":[],"label_agreement":null},{"id":"W3217336123","doi":"10.1093/neuonc/noab196.234","title":"CTNI-09. TRIDENT PHASE 3 TRIAL (EF-32): FIRST-LINE TUMOR TREATING FIELDS (TTFields; 200 KHZ) CONCOMITANT WITH CHEMO-RADIATION, FOLLOWED BY MAINTENANCE TTFIELDS/TEMOZOLOMIDE IN NEWLY-DIAGNOSED GLIOBLASTOMA","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Temozolomide; Medicine; Concomitant; Radiation therapy; Clinical endpoint; Oncology; Internal medicine; Phases of clinical research; Surgery; Clinical trial","score_opus":0.013821871884512433,"score_gpt":0.29384194120033774,"score_spread":0.2800200693158253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217336123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97366774,0.0009676875,0.00015286996,0.020417273,0.0009874216,0.0020021745,0.00006743729,0.000116669224,0.0016207465],"genre_scores_gemma":[0.9908971,0.0006391098,0.00034138619,0.0064170645,0.0005644542,0.0006164591,0.0001385664,0.00007584256,0.000310009],"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9961937,0.00030600335,0.0011713298,0.0010264098,0.00044224545,0.0008603066],"domain_scores_gemma":[0.995772,0.0023641326,0.0004983326,0.00069460814,0.00024746897,0.00042342872],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032207562,0.00055016536,0.0014404298,0.00024672554,0.00017171528,0.000060806095,0.00021362142,0.00045941953,0.00058552966],"category_scores_gemma":[0.0018582538,0.00046212363,0.0003026639,0.0007377467,0.000117738,0.0001476375,0.00009622299,0.00074265647,0.000047732927],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18306765,0.030852074,0.045508858,0.00036089393,0.0012040253,0.11815308,0.0033080466,0.00080286496,0.18106079,0.00027438652,0.32326296,0.11214439],"study_design_scores_gemma":[0.56339216,0.03179615,0.000950556,0.00036892432,0.00075910427,0.0014639089,0.000970898,0.0017692059,0.28036532,0.00008190694,0.11724738,0.0008344638],"about_ca_topic_score_codex":0.00044403112,"about_ca_topic_score_gemma":0.0036941816,"teacher_disagreement_score":0.38032454,"about_ca_system_score_codex":0.00062338635,"about_ca_system_score_gemma":0.00091108924,"threshold_uncertainty_score":0.99978304},"labels":[],"label_agreement":null},{"id":"W3217378019","doi":"10.1093/neuonc/noab196.020","title":"EPCO-21. CORE REGULATORY CIRCUIT TRANSCRIPTION FACTORS DRIVE EXPRESSION FROM HIGH LEVEL AMPLICONS IN PEDIATRIC HIGH-GRADE GLIOMAS","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Circular RNAs in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Oncogene; Enhancer; Amplicon; Biology; Transcription factor; Cancer research; Oncogene Proteins; Genetics; Gene; Regulation of gene expression; Cell cycle; Polymerase chain reaction","score_opus":0.04037904642475229,"score_gpt":0.27600996968007707,"score_spread":0.23563092325532478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217378019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99540836,0.0018223835,0.0004252408,0.00022650526,0.0012760523,0.00028286473,0.00035700528,0.000046120327,0.00015546754],"genre_scores_gemma":[0.99648535,0.00058698864,0.00023918063,0.0005701484,0.00063807453,0.00006027725,0.0013125907,0.000064975575,0.000042383203],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974424,0.0003840448,0.00046121248,0.0009906742,0.00026131383,0.00046031983],"domain_scores_gemma":[0.9985476,0.00015796909,0.00019168551,0.0007710063,0.0001087254,0.00022298946],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000093905124,0.00032903248,0.0004243016,0.00015819859,0.00010473999,0.000026537964,0.00034890138,0.00060976256,0.0001759471],"category_scores_gemma":[0.0003340693,0.00035867246,0.00021041119,0.00028799678,0.00014323572,0.000013894437,0.00017750377,0.00033570337,0.000019492818],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000071124734,0.00039679016,0.06360866,0.000020307187,0.000029464354,0.00027144235,0.00014711922,0.00007214901,0.9327108,0.00017135561,0.001517754,0.0009829911],"study_design_scores_gemma":[0.0017548362,0.00022481008,0.3523907,0.000011782096,0.000094045536,0.000035892674,0.00016216269,0.0000052084456,0.6340778,0.00087352406,0.010045715,0.00032355124],"about_ca_topic_score_codex":0.00015546086,"about_ca_topic_score_gemma":0.00040612268,"teacher_disagreement_score":0.29863307,"about_ca_system_score_codex":0.00014659592,"about_ca_system_score_gemma":0.00050354435,"threshold_uncertainty_score":0.9998865},"labels":[],"label_agreement":null},{"id":"W3217659434","doi":"10.1093/neuonc/noab196.571","title":"NIMG-74. RESPONSE ASSESSMENT AFTER DOSE-ESCALATED RADIOTHERAPY: IMAGING PROTOCOL OF A MULTICENTER PHASE III TRIAL ON INTRAOPERATIVE RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA (INTRAGO-II;ARO2016-1;AG-NRO-03)","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"","keywords":"Medicine; Neuroradiology; Radiation therapy; Radiology; Radiological weapon; Nuclear medicine; Glioblastoma; Neurology","score_opus":0.015423539568487252,"score_gpt":0.3625809745348222,"score_spread":0.34715743496633494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217659434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93487316,0.00015349682,0.0000624708,0.008325105,0.0005785552,0.055682518,0.000042956974,0.00008510739,0.00019663248],"genre_scores_gemma":[0.91762394,0.00011636133,0.0019714332,0.0054735006,0.00041733618,0.074197836,0.000025092211,0.00012484909,0.000049676226],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.994233,0.0020721422,0.0013169885,0.0010767407,0.000540237,0.00076084986],"domain_scores_gemma":[0.99658436,0.0016304468,0.00042306524,0.0007699666,0.00023781003,0.00035437415],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00071526924,0.00062294025,0.0015552817,0.000597156,0.000116398194,0.00005476153,0.00019495806,0.0003184048,0.0015786331],"category_scores_gemma":[0.00032546095,0.0005141578,0.0003733058,0.0006435113,0.00025148806,0.00016738045,0.00008587038,0.00073685497,0.00001311185],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.40804392,0.01810786,0.0034316909,0.000040472085,0.00031699357,0.011118392,0.0018715094,0.00003812444,0.52422535,0.000017315502,0.0014028725,0.0313855],"study_design_scores_gemma":[0.64846385,0.052356124,0.013415814,0.00039664962,0.00021519486,0.00030181147,0.00031503895,0.0034202053,0.20885433,0.0000077688255,0.071749285,0.00050393044],"about_ca_topic_score_codex":0.000062537976,"about_ca_topic_score_gemma":0.00012396429,"teacher_disagreement_score":0.315371,"about_ca_system_score_codex":0.001418559,"about_ca_system_score_gemma":0.0012683594,"threshold_uncertainty_score":0.999731},"labels":[],"label_agreement":null},{"id":"W3217762824","doi":"10.1093/neuonc/noab196.450","title":"INNV-40. REAL WORLD INTEGRATION OF THE NEUROLOGIC ASSESSMENT IN NEURO-ONCOLOGY (NANO) SCALE IN CLINICAL PRACTICE IN PATIENTS WITH IDH-WT GBM","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Internal medicine; Clinical trial; Oncology; Physical therapy","score_opus":0.030635473931922053,"score_gpt":0.3790991979070396,"score_spread":0.34846372397511755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217762824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97157556,0.000050946623,0.000019025189,0.019283783,0.00088949903,0.0012935683,0.000013296682,0.000021402973,0.0068528918],"genre_scores_gemma":[0.9851022,0.00021779393,0.0032159227,0.011117244,0.00008740307,0.00013452361,0.000058001875,0.000035447858,0.000031470114],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99305403,0.0038884338,0.0013773917,0.00077535544,0.0004269881,0.00047777293],"domain_scores_gemma":[0.99460673,0.0037085742,0.0006344431,0.0006611953,0.00025758092,0.00013145711],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013098347,0.0002923395,0.0010436586,0.00032168275,0.000043409058,0.000012114007,0.0002100347,0.00030016023,0.000074394775],"category_scores_gemma":[0.0024431718,0.0001986993,0.00014162218,0.0013118008,0.0002750996,0.00014848524,0.00024931307,0.0016646254,0.000007775121],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034308375,0.008491033,0.9293483,0.000027473918,0.000036096746,0.0018293043,0.00032597777,0.00012668355,0.0036338954,0.0003562919,0.00036744805,0.052026644],"study_design_scores_gemma":[0.012413096,0.008856934,0.9542046,0.000052740066,0.00016929083,0.0001295389,0.00030546344,0.00019921892,0.0005723013,0.00010269856,0.022859022,0.00013507696],"about_ca_topic_score_codex":0.0004008816,"about_ca_topic_score_gemma":0.013098745,"teacher_disagreement_score":0.05189157,"about_ca_system_score_codex":0.0005358905,"about_ca_system_score_gemma":0.0014808561,"threshold_uncertainty_score":0.8102722},"labels":[],"label_agreement":null},{"id":"W3217776441","doi":"10.1093/neuonc/noab196.072","title":"BIOM-41. LIVE-CELL IMAGING SHOWS UNEVEN SEGREGATION OF EXTRACHROMOSOMAL DNA ELEMENTS AND TRANSCRIPTIONALLY ACTIVE EXTRACHROMOSOMAL DNA CLUSTERS IN CANCER","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Extrachromosomal DNA; Biology; Mitosis; DNA; Carcinogenesis; Cell biology; Genetics; Cell; Cancer","score_opus":0.012188513807999044,"score_gpt":0.27023144227397505,"score_spread":0.258042928465976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217776441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99579716,0.0015791814,0.00016037829,0.0007381079,0.0003854698,0.00026786735,0.00026657002,0.0000066278135,0.000798619],"genre_scores_gemma":[0.99656814,0.0012188142,0.00071793346,0.0009219904,0.00019347794,0.00006313679,0.00022195437,0.00003189101,0.000062670726],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984566,0.00015478815,0.00040707493,0.00053382496,0.00013521563,0.00031248073],"domain_scores_gemma":[0.9992524,0.0001006935,0.00019666644,0.00020754483,0.00014024459,0.000102490594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000113909766,0.00020109776,0.00027724102,0.000072259056,0.000057173445,0.000019165978,0.0001381456,0.00017988638,0.00011920092],"category_scores_gemma":[0.00007335714,0.0002359359,0.000084984575,0.00011470912,0.00014073263,0.000015318123,0.00012091505,0.00016666541,0.0000019820513],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022456016,0.00031607237,0.008652155,0.000048808957,0.000033691922,0.000095589225,0.00029176433,0.00014614365,0.9696734,0.000046994643,0.0003010964,0.020169752],"study_design_scores_gemma":[0.0031922022,0.0006737303,0.014789113,0.00003814006,0.00007531258,0.00010290736,0.00051113043,0.0007824499,0.95233846,0.00008992544,0.027089637,0.00031701295],"about_ca_topic_score_codex":0.0001235081,"about_ca_topic_score_gemma":0.0021835158,"teacher_disagreement_score":0.02678854,"about_ca_system_score_codex":0.00012485152,"about_ca_system_score_gemma":0.0006175789,"threshold_uncertainty_score":0.9621187},"labels":[],"label_agreement":null},{"id":"W3217784408","doi":"10.1093/neuonc/noab196.798","title":"TAMI-14. REDUCTION IN S. CEREVISIAE GROWTH AND CELL VIABILITY IN RESPONSE TO D-2-HYDROXYGLUTARATE ACCUMULATION IS DAMPENED BY GROWTH CONDITIONS PERMISSIVE OF OXIDATIVE PHOSPHORYLATION","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal","funders":"","keywords":"Viability assay; Biology; Yeast; Biochemistry; Oxidative phosphorylation; Cell growth; Saccharomyces cerevisiae; Mitochondrion; Isocitrate dehydrogenase; Glycolysis; Cell; Cell biology; Metabolism","score_opus":0.012715252238251517,"score_gpt":0.29339647857306966,"score_spread":0.2806812263348181,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217784408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99651504,0.00065333204,0.0001560134,0.0013560413,0.0003449103,0.0004657793,0.00015574017,0.000006546571,0.00034658302],"genre_scores_gemma":[0.9976248,0.00092854147,0.00033355053,0.00055726926,0.000115742856,0.00006709459,0.00027576985,0.000018066861,0.00007914757],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980364,0.00065685686,0.00040723334,0.00057223975,0.000110385256,0.00021690119],"domain_scores_gemma":[0.99914265,0.00012289156,0.00017936346,0.00023707251,0.00021981078,0.00009820303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033828008,0.00016525897,0.00032736082,0.00012814168,0.000048935522,0.000011663889,0.00008587449,0.0002514203,0.000053122032],"category_scores_gemma":[0.00064101495,0.00019257824,0.000056114266,0.00035688758,0.00010661546,0.00002215968,0.00009197882,0.00016643514,0.000003287207],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010802705,0.0001950992,0.0020025726,0.000028670947,0.000008895332,0.0000037370128,0.00078643404,0.00011816772,0.9935273,0.000030125788,0.0015492433,0.00066951814],"study_design_scores_gemma":[0.0017162733,0.0004664839,0.028487412,0.00001015174,0.0000221079,0.00002024749,0.0002571414,0.00007417131,0.9487062,0.00026622933,0.01980736,0.00016619879],"about_ca_topic_score_codex":0.00013036898,"about_ca_topic_score_gemma":0.00009351983,"teacher_disagreement_score":0.044821043,"about_ca_system_score_codex":0.00008593736,"about_ca_system_score_gemma":0.00034708768,"threshold_uncertainty_score":0.7853113},"labels":[],"label_agreement":null},{"id":"W3217795007","doi":"10.1093/neuonc/noab196.719","title":"EXTH-80. PBI-200: IN VIVO EFFICACY OF A NOVEL, HIGHLY CNS-PENETRANT NEXT GENERATION TRK INHIBITOR","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Mechanisms and Therapy","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Paraza Pharma (Canada)","funders":"","keywords":"Trk receptor; In vivo; Pharmacology; Medicine; Potency; Cancer research; In vitro; Biology; Internal medicine; Receptor; Neurotrophin; Biochemistry; Genetics","score_opus":0.05111894012264943,"score_gpt":0.31172980431160974,"score_spread":0.2606108641889603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217795007","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99185216,0.00072817446,0.00067715545,0.0033594167,0.0017844797,0.00043855357,0.000016200906,0.000035958667,0.0011078847],"genre_scores_gemma":[0.99236244,0.0004977783,0.0019528599,0.0038817408,0.0010407676,0.00004535413,0.00002551397,0.000040011502,0.00015352674],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984481,0.00011540801,0.0004965207,0.00042418594,0.00022558676,0.00029021208],"domain_scores_gemma":[0.99908715,0.00018635367,0.0001374385,0.0003349597,0.00013275442,0.00012132274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017292908,0.0001740595,0.0005579364,0.0001546316,0.00003689469,0.000012862699,0.00008099587,0.0002200753,0.0006800047],"category_scores_gemma":[0.00012321802,0.00016743659,0.000119576114,0.00037291352,0.00005322064,0.00006820999,0.000040425042,0.00029100405,0.000011822692],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005812997,0.0010310125,0.0001491833,0.000031010335,0.000025746676,0.00038732693,0.00048142023,0.000059939586,0.9777113,0.0011192721,0.0015248586,0.016897615],"study_design_scores_gemma":[0.01061468,0.0021311783,0.00089177035,0.00004737537,0.000055671375,0.00026208855,0.000101882535,0.0010541998,0.8312049,0.000043429663,0.15344812,0.00014470507],"about_ca_topic_score_codex":0.000122059115,"about_ca_topic_score_gemma":0.0006438163,"teacher_disagreement_score":0.15192327,"about_ca_system_score_codex":0.00020417548,"about_ca_system_score_gemma":0.0006885706,"threshold_uncertainty_score":0.74455744},"labels":[],"label_agreement":null},{"id":"W3612970","doi":"10.1093/neuonc/nor150","title":"IMMUNOLOGY RESEARCH","year":2011,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brucella: diagnosis, epidemiology, treatment","field":"Veterinary","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal University Hospital","funders":"","keywords":"Engineering ethics; Engineering","score_opus":0.34669180482299566,"score_gpt":0.4549594897990909,"score_spread":0.10826768497609524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3612970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83538395,0.0011319561,0.000021915184,0.0052536437,0.0023247174,0.000765691,0.000016332846,0.00032426356,0.15477756],"genre_scores_gemma":[0.9926738,0.0009594426,0.002372012,0.0027781175,0.00034243742,0.0005989177,0.000015133523,0.000082350096,0.00017777638],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99285555,0.004051552,0.00066488195,0.00093370426,0.00021071073,0.0012835938],"domain_scores_gemma":[0.99379426,0.004467803,0.00019714297,0.0011115844,0.0002074485,0.00022174319],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0018532708,0.0003122424,0.00072008936,0.00038346054,0.00026720346,0.00000947745,0.0007707726,0.0007530088,0.0034290252],"category_scores_gemma":[0.0016606988,0.0002893241,0.00017231461,0.00035455872,0.00092500134,0.00009796985,0.000663268,0.001289437,0.0084238285],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043651126,0.00447409,0.066966236,0.000047289723,0.000563874,0.015613815,0.005368251,0.0000025191025,0.5335732,0.026002588,0.2623244,0.08069864],"study_design_scores_gemma":[0.0021144385,0.017899828,0.086067945,0.000013774332,0.000064327236,0.0027682285,0.00056410505,0.000030991127,0.012545972,0.007763958,0.8697775,0.00038889886],"about_ca_topic_score_codex":0.0009018643,"about_ca_topic_score_gemma":0.00016321724,"teacher_disagreement_score":0.6074531,"about_ca_system_score_codex":0.000563293,"about_ca_system_score_gemma":0.00027004498,"threshold_uncertainty_score":0.9999559},"labels":[],"label_agreement":null},{"id":"W4200001411","doi":"10.1093/neuonc/noab279","title":"Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Lomustine; Procarbazine; Medicine; Temozolomide; Oncology; Internal medicine; Oligodendroglioma; Oligodendroglial Tumor; Bevacizumab; Glioma; Vincristine; Astrocytoma; Radiation therapy; Chemotherapy; Cancer research; Cyclophosphamide","score_opus":0.01947085525348784,"score_gpt":0.31188992917641567,"score_spread":0.2924190739229278,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200001411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903455,0.0011316213,0.000025786007,0.00712933,0.0003324346,0.0006257753,0.000022248107,0.000032551423,0.00035477942],"genre_scores_gemma":[0.99237067,0.0009022314,0.0014702753,0.0045707016,0.0002883979,0.000274937,0.00007204354,0.000033107623,0.000017644432],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986562,0.0000837788,0.00040447005,0.000416807,0.00011980956,0.00031891148],"domain_scores_gemma":[0.9988488,0.0005645158,0.00008179438,0.00023369287,0.000119335906,0.0001518787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010512022,0.0001759316,0.0004939155,0.00010898912,0.000041272306,0.000014424608,0.000052128576,0.00012081896,0.00007793602],"category_scores_gemma":[0.00045456924,0.0001469686,0.00009491424,0.00014120695,0.00005776694,0.000043303833,0.000046103516,0.00015064573,0.000009739814],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006301409,0.011019011,0.1289188,0.00021185656,0.0003023378,0.013115501,0.0016861992,0.000038988597,0.4956783,0.00088922994,0.018753717,0.32308465],"study_design_scores_gemma":[0.14534937,0.01631301,0.07228401,0.0003283983,0.00025339128,0.0026787943,0.0014587308,0.0025463465,0.25145793,0.00043971147,0.5063101,0.00058019103],"about_ca_topic_score_codex":0.00004110876,"about_ca_topic_score_gemma":0.00019374525,"teacher_disagreement_score":0.4875564,"about_ca_system_score_codex":0.00015268703,"about_ca_system_score_gemma":0.0002791032,"threshold_uncertainty_score":0.59932053},"labels":[],"label_agreement":null},{"id":"W4200003507","doi":"10.1093/neuonc/noab196.283","title":"CTNI-58. EFFICACY AND SAFETY OF LAROTRECTINIB IN ADULT AND PEDIATRIC PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION-POSITIVE PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Trk receptor; Medicine; Internal medicine; Oncology; Gastroenterology; Receptor; Neurotrophin","score_opus":0.005435077052758422,"score_gpt":0.22623551095783923,"score_spread":0.2208004339050808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200003507","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969968,0.00041752544,0.0000017488312,0.00067141093,0.00022472041,0.0010440944,0.00007612764,0.000029528366,0.00053800124],"genre_scores_gemma":[0.9986101,0.0003841267,0.00035008776,0.00034178444,0.0000995957,0.0000564471,0.00012002589,0.0000309646,0.000006910199],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998142,0.0003142525,0.00044579073,0.0005088828,0.00023088566,0.00035819496],"domain_scores_gemma":[0.9985601,0.0005513953,0.00021571944,0.00020927117,0.00021985223,0.00024369631],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007813265,0.00023772274,0.00070640317,0.00016976183,0.0000714319,0.000010302994,0.000044606208,0.00014060056,0.000029564011],"category_scores_gemma":[0.00018334817,0.00018762688,0.000052189087,0.00037409534,0.00009267023,0.00005270443,0.00009683322,0.00024132333,0.0000031699067],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033948636,0.0033405456,0.95012885,0.00039551905,0.00007619892,0.0021118969,0.00079212064,0.000009414708,0.014153191,0.00009439908,0.0002849308,0.025218075],"study_design_scores_gemma":[0.01817382,0.0038491532,0.96941185,0.00023689248,0.00029926628,0.00018657173,0.0003266946,0.00001775647,0.0068942066,0.000001045984,0.0004513505,0.00015136684],"about_ca_topic_score_codex":0.00010205984,"about_ca_topic_score_gemma":0.000070643146,"teacher_disagreement_score":0.025066707,"about_ca_system_score_codex":0.00032344947,"about_ca_system_score_gemma":0.00029128918,"threshold_uncertainty_score":0.7651202},"labels":[],"label_agreement":null},{"id":"W4200005408","doi":"10.1093/neuonc/noab196.251","title":"CTNI-26. PHASE 2 STUDY OF DIANHYDROGALACTITOL (VAL-083) IN PATIENTS WITH MGMT-UNMETHYLATED, BEVACIZUMAB-NAÏVE GLIOBLASTOMA IN THE RECURRENT AND ADJUVANT SETTING","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Temozolomide; Medicine; Bevacizumab; Oncology; Internal medicine; Adjuvant; Radiation therapy; Methyltransferase; Chemoradiotherapy; O-6-methylguanine-DNA methyltransferase; Chemotherapy; DNA; Biology; Methylation","score_opus":0.012645587143556502,"score_gpt":0.30346787384469015,"score_spread":0.29082228670113364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200005408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99663067,0.00028433377,4.877432e-7,0.0012586168,0.00018327349,0.0014047745,0.000010849957,0.000019151626,0.00020783034],"genre_scores_gemma":[0.999316,0.0000708319,0.000045898356,0.0003199715,0.000034187597,0.00016725887,0.00001588323,0.00002890949,0.0000010973514],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977507,0.0005755609,0.00050058163,0.00048572128,0.0003535501,0.0003339022],"domain_scores_gemma":[0.99861205,0.00057576236,0.00021282934,0.00037783675,0.00011791806,0.000103624494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026141468,0.00022984028,0.00062856777,0.000263872,0.000054012038,0.000013952896,0.00009152625,0.000106350715,0.000027998944],"category_scores_gemma":[0.0002727174,0.00015381537,0.000049436276,0.00060734566,0.00007099595,0.000069018046,0.00009253479,0.00040217058,0.0000058472],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023543334,0.026648778,0.86213535,0.000051272757,0.00012391452,0.0049277144,0.0068171765,0.00002357618,0.004904431,0.000008917584,0.00017554489,0.09182898],"study_design_scores_gemma":[0.0858024,0.04688989,0.84279466,0.00022958031,0.0004984984,0.00022928775,0.0064911805,0.00020563809,0.013467098,0.00001851316,0.0031019154,0.0002713178],"about_ca_topic_score_codex":0.000092834336,"about_ca_topic_score_gemma":0.0014690143,"teacher_disagreement_score":0.09155766,"about_ca_system_score_codex":0.0001808862,"about_ca_system_score_gemma":0.00016459882,"threshold_uncertainty_score":0.6272409},"labels":[],"label_agreement":null},{"id":"W4200240386","doi":"10.1093/neuonc/noab196.525","title":"NIMG-25. IMPROVING THE NONINVASIVE CLASSIFICATION OF GLIOMA GENETIC SUBTYPE WITH DEEP LEARNING AND DIFFUSION-WEIGHTED IMAGING","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Glioma; Fluid-attenuated inversion recovery; Nuclear medicine; Artificial intelligence; Radiology; Computer science; Magnetic resonance imaging; Cancer research","score_opus":0.008333367874437536,"score_gpt":0.2677057116391958,"score_spread":0.25937234376475826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200240386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98439705,0.0011881563,0.004634507,0.0074436297,0.00018917891,0.00022369513,5.112154e-7,0.000046114685,0.0018771493],"genre_scores_gemma":[0.9941371,0.0003045538,0.0042267856,0.0010428774,0.0001689179,0.000012926356,0.000012217882,0.000037141766,0.000057489877],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9985442,0.00028528302,0.00030059236,0.0003739682,0.00023117015,0.0002647825],"domain_scores_gemma":[0.99840665,0.00075123936,0.00025828785,0.00023706858,0.00021343512,0.00013332079],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024388403,0.00014850486,0.00033973862,0.00010091802,0.00017881309,0.000025767245,0.00009438023,0.00008104667,0.00006119392],"category_scores_gemma":[0.0009356184,0.00010075276,0.00004952346,0.0002971932,0.00031805818,0.000040368217,0.00011148067,0.00073162693,0.000004639168],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010231023,0.00007696174,0.085591905,0.00005702311,0.000028088929,0.0008112301,0.00057591306,0.000013601239,0.7398256,0.0001215874,0.00004637154,0.17274943],"study_design_scores_gemma":[0.010135545,0.0024743094,0.4177682,0.00031982124,0.0009954319,0.020009395,0.005192716,0.42536336,0.05045391,0.00025399635,0.06645593,0.0005773711],"about_ca_topic_score_codex":0.000041772564,"about_ca_topic_score_gemma":0.000016181502,"teacher_disagreement_score":0.68937165,"about_ca_system_score_codex":0.0000620281,"about_ca_system_score_gemma":0.00029921017,"threshold_uncertainty_score":0.41085783},"labels":[],"label_agreement":null},{"id":"W4200335423","doi":"10.1093/neuonc/noab262","title":"Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Radiosurgery; Asymptomatic; Guideline; Systemic therapy; Radiation therapy; Lung cancer; Brain metastasis; Cancer; Oncology; Surgery; Radiology; Breast cancer; Internal medicine; Metastasis; Pathology","score_opus":0.048119475896673536,"score_gpt":0.37346465163376297,"score_spread":0.32534517573708943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200335423","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.33747336,0.009834489,0.041566744,0.5656382,0.0057476484,0.009934247,0.0033097563,0.0008409256,0.025654627],"genre_scores_gemma":[0.37526765,0.001760072,0.4635862,0.132162,0.0045394674,0.0031069156,0.008466701,0.00048667064,0.010624291],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99766177,0.00034115626,0.0006031552,0.00066017633,0.00020409244,0.0005296307],"domain_scores_gemma":[0.9975703,0.001087845,0.00015599462,0.00060899975,0.00025350775,0.00032338753],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032656474,0.00032468673,0.0008613256,0.00010200761,0.00011923209,0.0000200084,0.0000815763,0.00014292652,0.00084589486],"category_scores_gemma":[0.0006974987,0.00025268612,0.00045106304,0.00020527461,0.00007880601,0.00004646648,0.000064991385,0.00014590983,0.000099160614],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019604086,0.005798929,0.0009726866,0.00012292515,0.0016445069,0.009971503,0.00036603838,0.00008654047,0.21099928,0.0034573358,0.2602904,0.50432944],"study_design_scores_gemma":[0.0119594345,0.009053567,0.0001211984,0.000012833164,0.00074282783,0.0018996858,0.00029974795,0.00025764373,0.040778667,0.00016504989,0.93455756,0.00015176556],"about_ca_topic_score_codex":0.00004378267,"about_ca_topic_score_gemma":0.00010234543,"teacher_disagreement_score":0.6742672,"about_ca_system_score_codex":0.00045461598,"about_ca_system_score_gemma":0.0009644098,"threshold_uncertainty_score":0.99999255},"labels":[],"label_agreement":null},{"id":"W4200411804","doi":"10.1093/neuonc/noab196.066","title":"BIOM-35. CLINICALLY TRACTABLE OUTCOME PREDICTION OF GROUP 3/4 MEDULLOBLASTOMA BASED ON TPD52 IMMUNOHISTOCHEMISTRY: A MULTICOHORT STUDY","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; BC Children's Hospital","funders":"","keywords":"Medulloblastoma; Oncology; Internal medicine; Immunohistochemistry; Biomarker; Risk stratification; Receiver operating characteristic; Multivariate analysis; Medicine; Bioinformatics; Biology; Pathology; Genetics","score_opus":0.03312051520766966,"score_gpt":0.34972324853284326,"score_spread":0.3166027333251736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200411804","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99401325,0.000096101285,0.000026484377,0.00131927,0.000703266,0.0009419856,0.00005695465,0.00008666771,0.002755997],"genre_scores_gemma":[0.997635,0.000027607108,0.000582642,0.0011919884,0.000119835786,0.0002603642,0.000103011385,0.00003952865,0.00004003346],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99737155,0.0002495207,0.0009953022,0.00062885444,0.0004286816,0.00032608627],"domain_scores_gemma":[0.99756974,0.00097655266,0.00030205632,0.0007349392,0.0002068047,0.00020990519],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038061893,0.0002600227,0.0008754502,0.00013360179,0.00007702256,0.000010502048,0.00012075743,0.00025999264,0.00030763587],"category_scores_gemma":[0.00092914107,0.0002277475,0.00027311948,0.0003077609,0.000109792054,0.0000364736,0.00006443621,0.00037550594,0.000030922023],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009470229,0.018108295,0.36699742,0.000051238225,0.00018399676,0.0015664529,0.000104894796,0.000029613633,0.60637885,0.0000066198413,0.0005998131,0.0050257836],"study_design_scores_gemma":[0.04183802,0.041839838,0.65949726,0.0002033056,0.0021559563,0.00040940053,0.0009282359,0.0033009385,0.22769104,0.000012498556,0.021719832,0.00040369673],"about_ca_topic_score_codex":0.00004718901,"about_ca_topic_score_gemma":0.000017163735,"teacher_disagreement_score":0.3786878,"about_ca_system_score_codex":0.00033817935,"about_ca_system_score_gemma":0.0003695268,"threshold_uncertainty_score":0.9287274},"labels":[],"label_agreement":null},{"id":"W4200508878","doi":"10.1093/neuonc/noab282","title":"Clinical utility of targeted next-generation sequencing assay in IDH-wildtype glioblastoma for therapy decision-making","year":2021,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"National Institute of Neurological Disorders and Stroke; National Cancer Institute; National Institutes of Health; Conquer Cancer Foundation","keywords":"Medicine; Clinical trial; Oncology; Targeted therapy; Internal medicine; Clinical research; Precision medicine; Bioinformatics; Cancer; Pathology","score_opus":0.1129376079302941,"score_gpt":0.39541470149860886,"score_spread":0.28247709356831474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200508878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955701,0.0008488939,0.0007409355,0.0010998494,0.0008118574,0.0006034534,0.000011717114,0.000025053507,0.00028809544],"genre_scores_gemma":[0.9920685,0.00030851355,0.005638925,0.0016076192,0.0002438787,0.000081888895,0.000026714568,0.00002188459,0.0000020210982],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979336,0.00041343778,0.00073819084,0.00045619588,0.000185105,0.00027344545],"domain_scores_gemma":[0.99614936,0.002937795,0.00020440898,0.0003351115,0.00028454186,0.000088809626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086269015,0.00014752254,0.0006200478,0.00012698153,0.000056108056,0.000011238208,0.000069884096,0.00025795362,0.0001949196],"category_scores_gemma":[0.002598418,0.00012635528,0.0002068976,0.00030925812,0.00006200195,0.00006397025,0.00004706377,0.00021921792,0.000006133422],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009278252,0.0012199666,0.09414968,0.00001831348,0.00006679283,0.00054084125,0.00014843683,0.000042270014,0.5080076,0.00008577328,0.0014961838,0.3932963],"study_design_scores_gemma":[0.023382215,0.011547207,0.20533744,0.00031179143,0.00027681538,0.00039026284,0.00045143525,0.047799204,0.6561106,0.0016135873,0.0523641,0.00041533748],"about_ca_topic_score_codex":0.000014076099,"about_ca_topic_score_gemma":0.00040307085,"teacher_disagreement_score":0.39288098,"about_ca_system_score_codex":0.00017761288,"about_ca_system_score_gemma":0.0006938489,"threshold_uncertainty_score":0.5152619},"labels":[],"label_agreement":null},{"id":"W4205312646","doi":"10.1093/neuonc/noac013","title":"Risk factors for treatment-refractory and relapsed optic pathway glioma in children with neurofibromatosis type 1","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Neurofibromatosis; Optic nerve; Glioma; Neurofibromatoses; Radiation therapy","score_opus":0.019629401950657453,"score_gpt":0.26554555802627605,"score_spread":0.2459161560756186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205312646","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972065,0.00023670596,0.0000018621703,0.00036488808,0.00027283904,0.0013752191,0.00015935715,0.000105282714,0.00027731454],"genre_scores_gemma":[0.99876666,0.00008325461,0.00030805208,0.0002962529,0.000062507286,0.00025641502,0.00009789434,0.00008283705,0.000046136833],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979713,0.00036629522,0.0003687169,0.0006489909,0.00021796752,0.00042674976],"domain_scores_gemma":[0.9982889,0.0008488056,0.00022544498,0.00038436655,0.000041588417,0.00021087554],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001258875,0.00031407684,0.000682678,0.00032536057,0.00027359687,0.00001988592,0.00011238371,0.00010726572,0.0000799969],"category_scores_gemma":[0.00020668087,0.00024636,0.00010884688,0.00041626114,0.000110697205,0.00008637064,0.000105012565,0.0002919342,0.0000051707993],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031389727,0.0013449208,0.7066595,0.000029944365,0.00015936917,0.0012346007,0.00057050196,0.000046994377,0.28228796,0.00010826151,0.0006485554,0.0037704108],"study_design_scores_gemma":[0.024537208,0.11870828,0.7384157,0.00002783113,0.00077451806,0.012582185,0.0008836467,0.00032269245,0.05697776,0.00007572413,0.04593675,0.0007576822],"about_ca_topic_score_codex":0.00013904665,"about_ca_topic_score_gemma":0.000015744237,"teacher_disagreement_score":0.22531019,"about_ca_system_score_codex":0.00022536336,"about_ca_system_score_gemma":0.0003259333,"threshold_uncertainty_score":0.99999887},"labels":[],"label_agreement":null},{"id":"W4206467252","doi":"10.1093/neuonc/noac012","title":"SIOP Ependymoma I: Final results, long-term follow-up, and molecular analysis of the trial cohort—A BIOMECA Consortium Study","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"NIHR Great Ormond Street Hospital Biomedical Research Centre; Associazione Bianca Garavaglia; Brain Tumour Charity; CHILDREN with CANCER UK; James Tudor Foundation; National Institute for Health and Care Research; Cancer Research UK","keywords":"Ependymoma; Cohort; Medicine; Term (time); Oncology; Internal medicine; Surgery; Physics","score_opus":0.03388866853965134,"score_gpt":0.32307463042945755,"score_spread":0.2891859618898062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206467252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941032,0.00023496401,0.0000018458678,0.0023532622,0.00075073057,0.0019990082,0.0001234646,0.000022285469,0.00041125168],"genre_scores_gemma":[0.99875826,0.000020888268,0.000011196113,0.0006723387,0.00004257187,0.00036449434,0.00006666315,0.000018649653,0.000044926473],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974045,0.00069580664,0.00060544687,0.0005428759,0.00048881484,0.00026255843],"domain_scores_gemma":[0.9982597,0.0005256397,0.00035482348,0.00065579073,0.00008209116,0.00012195746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045164424,0.00019472816,0.000853213,0.00038494336,0.00019593464,0.000011462438,0.00019042929,0.00007603945,0.00022237567],"category_scores_gemma":[0.00031600153,0.00013987783,0.0003391181,0.0010869937,0.0001468087,0.000019488587,0.0003631314,0.0002631018,0.0000025438085],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.035554778,0.008867627,0.8505396,0.000018500034,0.0058325753,0.008560659,0.0008013209,0.00008740615,0.08222947,0.00007918595,0.0016522252,0.0057766307],"study_design_scores_gemma":[0.13998435,0.01764147,0.8103783,0.0000067290443,0.01522393,0.00030811576,0.00042762313,0.00015037466,0.012083237,0.000011730504,0.0035962318,0.00018790313],"about_ca_topic_score_codex":0.00012933141,"about_ca_topic_score_gemma":0.00018279796,"teacher_disagreement_score":0.10442958,"about_ca_system_score_codex":0.00014843038,"about_ca_system_score_gemma":0.00021938696,"threshold_uncertainty_score":0.57040524},"labels":[],"label_agreement":null},{"id":"W4206962479","doi":"10.1093/neuonc/noac021","title":"Transcriptome and methylome analysis of CNS germ cell tumor finds its cell-of-origin in embryogenesis and reveals shared similarities with testicular counterparts","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Thompson Rivers University; University Health Network","funders":"Japan Society for the Promotion of Science; Japan Agency for Medical Research and Development","keywords":"Biology; Transcriptome; Seminoma; Germ cell tumors; Phenotype; Tumor microenvironment; Germ cell; Atypical teratoid rhabdoid tumor; Embryonic stem cell; Germinoma; Cancer research; Pathology; Immune system; Immunology; Genetics; Gene expression; Immunohistochemistry; Gene; Medicine; Chemotherapy","score_opus":0.021433863403657823,"score_gpt":0.27887818517481566,"score_spread":0.25744432177115784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206962479","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955261,0.002828992,0.0000033190777,0.00050421036,0.000052431107,0.00046025307,0.00029607693,0.000012441405,0.00031621152],"genre_scores_gemma":[0.9987431,0.0002108849,0.00022788168,0.00052353257,0.000008562009,0.00018864145,0.00004418498,0.000022228849,0.00003094682],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9983952,0.00023458914,0.0004607922,0.00039413894,0.00027080823,0.00024449598],"domain_scores_gemma":[0.998656,0.00068023655,0.0002344049,0.00022430245,0.0000860857,0.000119008844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027271349,0.00019719003,0.0010505283,0.0006728334,0.000059899154,0.00000771292,0.00007616759,0.000060662504,0.00019086036],"category_scores_gemma":[0.000056810815,0.00016800378,0.00010745341,0.0008090372,0.00011326008,0.00004268262,0.00005860408,0.00016118733,3.595585e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002818035,0.0010603563,0.3833794,0.0002384706,0.00032247324,0.001236991,0.001027632,0.0003696493,0.61174875,0.00002113177,0.00013293231,0.00018040025],"study_design_scores_gemma":[0.010681049,0.008844869,0.7610638,0.00008010991,0.008254636,0.00023921017,0.0015481317,0.0014751876,0.2022119,0.000022218685,0.0051980484,0.00038081242],"about_ca_topic_score_codex":0.00008871597,"about_ca_topic_score_gemma":0.000072705014,"teacher_disagreement_score":0.40953687,"about_ca_system_score_codex":0.00009895666,"about_ca_system_score_gemma":0.00015070691,"threshold_uncertainty_score":0.68509954},"labels":[],"label_agreement":null},{"id":"W4206992752","doi":"10.1093/neuonc/noac022","title":"Deuterium magnetic resonance spectroscopy enables noninvasive metabolic imaging of tumor burden and response to therapy in low-grade gliomas","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Institute of Neurological Disorders and Stroke; National Cancer Institute; National Institutes of Health; U.S. Department of Defense","keywords":"In vivo; Glycolysis; Astrocytoma; Cancer research; In vivo magnetic resonance spectroscopy; Phosphofructokinase; Ex vivo; Glioma; Chemistry; Magnetic resonance spectroscopic imaging; Magnetic resonance imaging; Pathology; Biology; Medicine; Enzyme; Biochemistry","score_opus":0.012451803179203974,"score_gpt":0.2827565351614721,"score_spread":0.2703047319822681,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206992752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9715865,0.014954535,0.0000013080958,0.012226034,0.00019975223,0.0008158663,0.000028657609,0.000025012074,0.00016232257],"genre_scores_gemma":[0.99537814,0.00079019216,0.0006720254,0.0025666307,0.00009241811,0.0004454078,0.000004281594,0.000035056855,0.000015840385],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980456,0.0005590648,0.00033589298,0.00044979004,0.00023062741,0.00037902346],"domain_scores_gemma":[0.99881005,0.0005718244,0.00010663836,0.00032354103,0.000046451423,0.00014151885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035305723,0.00019272954,0.000576316,0.0004695111,0.000080295344,0.000010732149,0.00013098419,0.000030855077,0.00015671004],"category_scores_gemma":[0.0001680376,0.0001775768,0.000069941714,0.00055214646,0.00010149366,0.0000361769,0.00017319743,0.000210461,0.0000056640197],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036723192,0.0004976766,0.034809306,0.000014699576,0.000016849433,0.0054984996,0.0017181638,0.000028068807,0.9410852,0.00006449611,0.00035545076,0.012239242],"study_design_scores_gemma":[0.009015611,0.0075018764,0.19317757,0.000042386135,0.00007116726,0.0014588815,0.00081732124,0.00010490561,0.59916323,0.000094599876,0.18836354,0.00018887795],"about_ca_topic_score_codex":0.00020526224,"about_ca_topic_score_gemma":0.00003780525,"teacher_disagreement_score":0.34192196,"about_ca_system_score_codex":0.00019454624,"about_ca_system_score_gemma":0.00027464327,"threshold_uncertainty_score":0.7241372},"labels":[],"label_agreement":null},{"id":"W4210724732","doi":"10.1093/neuonc/noac032","title":"The impact of brain invasion criteria on the incidence and distribution of WHO grade 1, 2, and 3 meningiomas","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Incidence (geometry); Distribution (mathematics); Meningioma; Medicine; Mathematics; Surgery; Mathematical analysis","score_opus":0.034708535235699375,"score_gpt":0.3300618490305295,"score_spread":0.2953533137948301,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210724732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884954,0.00017542244,0.000019141064,0.010311392,0.00008952801,0.00036531215,0.000017070277,0.000008100432,0.0005186317],"genre_scores_gemma":[0.9996373,0.000029382543,0.000013822313,0.00020892564,0.000023353681,0.00003185773,0.000010633574,0.000006832097,0.000037861704],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988519,0.0004114234,0.00023208444,0.00016725672,0.00019388321,0.00014343893],"domain_scores_gemma":[0.99840784,0.0011171312,0.00016714194,0.0002253248,0.000032566888,0.00004996926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007723537,0.00008770066,0.00022188226,0.000047966183,0.00022925813,0.00000890461,0.00010284178,0.000031279014,0.000041988103],"category_scores_gemma":[0.0004973047,0.000049343093,0.00005176928,0.00016004081,0.0001913688,0.000026553182,0.00025616895,0.00017839592,4.0820822e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015087461,0.00019988157,0.017751474,0.000059351627,0.000100781646,0.00040771824,0.0018604193,0.000026176349,0.92233473,0.008859712,0.039038025,0.007852976],"study_design_scores_gemma":[0.005221487,0.035177074,0.8363638,0.00011831566,0.000289298,0.0033342452,0.0026132818,0.0067236503,0.044742964,0.004309139,0.060791075,0.00031568596],"about_ca_topic_score_codex":0.00007560181,"about_ca_topic_score_gemma":0.000002954706,"teacher_disagreement_score":0.8775918,"about_ca_system_score_codex":0.00008047563,"about_ca_system_score_gemma":0.00006604834,"threshold_uncertainty_score":0.20121528},"labels":[],"label_agreement":null},{"id":"W4212899626","doi":"10.1093/neuonc/nou174.292","title":"P15.13 * THE NEUROLOGIC ASSESSMENT IN NEURO-ONCOLOGY (NANO) SCALE: A TOOL TO ASSESS NEUROLOGIC FUNCTION FOR INTEGRATION IN THE RADIOLOGIC ASSESSMENT IN NEURO-ONCOLOGY (RANO) CRITERIA","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario","funders":"","keywords":"Medicine; Metric (unit); Clinical trial; Intensive care medicine; Psychological intervention; Medical physics; Physical therapy; Internal medicine","score_opus":0.04391201782448898,"score_gpt":0.3599111750061347,"score_spread":0.3159991571816457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212899626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8840349,0.00010375416,0.0019339806,0.0995383,0.003577228,0.007803681,0.00003038241,0.00016286281,0.002814919],"genre_scores_gemma":[0.90904313,0.00021249383,0.0013013972,0.080867246,0.00059541,0.007725736,0.00014328076,0.000103475126,0.000007839917],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9846082,0.008486337,0.002220511,0.0021960968,0.0006899917,0.0017988698],"domain_scores_gemma":[0.9842812,0.0128267715,0.0008122891,0.0014810715,0.00029387348,0.00030478847],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.005089613,0.0010614241,0.0022611222,0.0011928238,0.00037002304,0.00015150355,0.0011479664,0.0011215928,0.00015909289],"category_scores_gemma":[0.0031848676,0.00068378286,0.0004470655,0.001803178,0.0004441682,0.00029242542,0.0004509798,0.0029537599,0.000048057544],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006283565,0.010838484,0.28686976,0.00014665695,0.00008757705,0.0033499624,0.0016009986,0.0038167054,0.5393594,0.0046727518,0.009689564,0.13328458],"study_design_scores_gemma":[0.016566982,0.054726243,0.75512844,0.00004103627,0.00047476403,0.0014983189,0.0009384652,0.018761365,0.0010609054,0.0020764763,0.14802794,0.00069903967],"about_ca_topic_score_codex":0.00021948232,"about_ca_topic_score_gemma":0.0032209042,"teacher_disagreement_score":0.5382985,"about_ca_system_score_codex":0.0015090217,"about_ca_system_score_gemma":0.0011063981,"threshold_uncertainty_score":0.9995613},"labels":[],"label_agreement":null},{"id":"W4212979581","doi":"10.1093/neuonc/nov061.111","title":"MB-35 * VERY ENCOURAGING LONG-TERM SURVIVAL AND NEUROCOGNITIVE OUTCOME OF YOUNG CHILDREN TREATED FOR MEDULLOBLASTOMA WITH SEQUENTIAL HIGH DOSE CHEMOTHERAPY","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Alberta Children's Hospital","funders":"","keywords":"Medulloblastoma; Neurocognitive; Term (time); Chemotherapy; Outcome (game theory); Medicine; Pediatrics; Oncology; Internal medicine; Cognition; Mathematics; Physics; Psychiatry; Pathology","score_opus":0.031007402473552003,"score_gpt":0.312244952060734,"score_spread":0.281237549587182,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212979581","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99673,0.00009791524,0.000053332817,0.0010465817,0.00029410078,0.001339827,0.000058284255,0.0000623182,0.00031760117],"genre_scores_gemma":[0.99872506,0.000057670346,0.00022541973,0.0004946191,0.00018659771,0.0001424713,0.000095462005,0.00005762649,0.000015083536],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99846774,0.00012167821,0.0003558398,0.0004594265,0.0002447385,0.00035059472],"domain_scores_gemma":[0.9987559,0.00031662523,0.00022364088,0.00022221598,0.0002211136,0.0002605383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014798052,0.00028537167,0.00074065157,0.00016930353,0.00005825506,0.000016273474,0.000081488164,0.00013700062,0.000021696796],"category_scores_gemma":[0.00009259301,0.00021537887,0.0001006241,0.00015795707,0.0001931695,0.00008120804,0.000046421952,0.00015996091,0.0000036008685],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032414044,0.0009362251,0.9494162,0.00003637555,0.00039336417,0.00063399953,0.00029580528,0.000005062684,0.035007566,0.000036610963,0.00010326242,0.00989409],"study_design_scores_gemma":[0.030654978,0.008728002,0.8920134,0.000054133186,0.000769876,0.0010748977,0.00009890397,0.000037511967,0.06620192,0.000020150139,0.00013549546,0.00021076962],"about_ca_topic_score_codex":0.00015862935,"about_ca_topic_score_gemma":0.00014715172,"teacher_disagreement_score":0.057402868,"about_ca_system_score_codex":0.00013359984,"about_ca_system_score_gemma":0.000166792,"threshold_uncertainty_score":0.8782895},"labels":[],"label_agreement":null},{"id":"W4213298430","doi":"10.1093/neuonc/nox036.312","title":"P09.57 Clinical trials of VAL-083 in patients with chemoresistant glioblastoma","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Delmar (Canada)","funders":"","keywords":"Temozolomide; Medicine; Bevacizumab; Clinical trial; Oncology; Internal medicine; Glioma; Phases of clinical research; Chemotherapy; Cancer research","score_opus":0.07139444316969258,"score_gpt":0.4071667440077629,"score_spread":0.33577230083807036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213298430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941244,0.000047560858,0.0000011458396,0.002531378,0.00044929696,0.0008125301,0.000025508438,0.000015735015,0.0019924606],"genre_scores_gemma":[0.99901736,0.00005536823,0.00021000998,0.00047504736,0.00013665493,0.000057944253,0.000010438073,0.000023610699,0.000013558967],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99761194,0.00043714882,0.0010352484,0.00037911173,0.00026579422,0.00027072884],"domain_scores_gemma":[0.99684805,0.0012307152,0.0008894891,0.00071132724,0.00014273834,0.00017770349],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011968096,0.00017642915,0.0013538885,0.0001307011,0.0000675158,0.0000127874655,0.00017290642,0.00020570059,0.00010940489],"category_scores_gemma":[0.0036137097,0.000117014235,0.00020633356,0.000073847936,0.0002503555,0.000052367308,0.00009574647,0.00023361016,0.000027225875],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006166751,0.0046064137,0.9409139,0.000033365006,0.00013824525,0.0006570038,0.000070694434,0.0000013786517,0.004316687,0.000083392464,0.0023862785,0.040625844],"study_design_scores_gemma":[0.028965598,0.01073814,0.92912084,0.00008499856,0.00029099765,0.00001275091,0.000018477278,0.00001366561,0.014581515,0.000036100755,0.016036844,0.00010008454],"about_ca_topic_score_codex":0.000041768883,"about_ca_topic_score_gemma":0.00014785337,"teacher_disagreement_score":0.04052576,"about_ca_system_score_codex":0.00010292951,"about_ca_system_score_gemma":0.00024007139,"threshold_uncertainty_score":0.4771702},"labels":[],"label_agreement":null},{"id":"W4213432989","doi":"10.1093/neuonc/noac057","title":"Pattern of treatment failures in patients with central nervous system non-germinomatous germ cell tumors (CNS-NGGCT): A pooled analysis of clinical trials","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Radiation therapy; Cohort; Germ cell tumors; Cog; Clinical trial; Central nervous system; Disease; Oncology; Cohort study; Chemotherapy; Surgery","score_opus":0.03128564086027897,"score_gpt":0.3422894081930291,"score_spread":0.31100376733275015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213432989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99758446,0.00012971234,0.000015010393,0.000074757954,0.00021035259,0.0014484844,0.00038544188,0.000026888709,0.00012489106],"genre_scores_gemma":[0.9992909,0.0000084595285,0.000070277136,0.00012904535,0.00003989582,0.000176616,0.00024244153,0.00003105054,0.000011318323],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956571,0.001405812,0.0016838422,0.00049826776,0.0003891872,0.0003658221],"domain_scores_gemma":[0.9967554,0.0009999773,0.0013979829,0.0004887015,0.00009591472,0.00026198724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004664961,0.0002647806,0.0025412412,0.0004306143,0.000046831334,0.000004635069,0.00013204856,0.00009758319,0.00011213909],"category_scores_gemma":[0.00020209573,0.00018894435,0.0007058622,0.00059940096,0.000082780614,0.000024209738,0.00008706912,0.00017720266,0.0000028379452],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029852306,0.007025946,0.9624014,0.0001358668,0.0021448892,0.0015165942,0.00031556017,0.0010276441,0.00041377702,0.0000026268867,0.000034269793,0.021996232],"study_design_scores_gemma":[0.01865767,0.015183441,0.9519844,0.000034302648,0.011267533,0.000026566673,0.00038748793,0.0018338675,0.0003143489,6.576577e-7,0.0001845064,0.00012521227],"about_ca_topic_score_codex":0.0013557123,"about_ca_topic_score_gemma":0.00014085416,"teacher_disagreement_score":0.02187102,"about_ca_system_score_codex":0.00054774137,"about_ca_system_score_gemma":0.0007514819,"threshold_uncertainty_score":0.7704927},"labels":[],"label_agreement":null},{"id":"W4214581307","doi":"10.1093/neuonc/noy059.587","title":"QOL-05. E-SURVEY OF CURRENT INTERNATIONAL PHYSIOTHERAPY PRACTICE FOR CHILDREN WITH ATAXIA FOLLOWING SURGICAL RESECTION OF POSTERIOR FOSSA TUMOUR","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Psychological intervention; Physical therapy; Intervention (counseling); Psychosocial; Rehabilitation; Gait training; Physical medicine and rehabilitation; Nursing","score_opus":0.035935525871608025,"score_gpt":0.38884707824862325,"score_spread":0.3529115523770152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214581307","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966234,0.0001902794,0.000065248634,0.0012482229,0.0008349621,0.00070471736,0.000063211715,0.000015308357,0.0002546357],"genre_scores_gemma":[0.9987308,0.00006945731,0.00050981104,0.00018830592,0.00030472345,0.00006817296,0.00010033107,0.0000224762,0.0000059232348],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99881923,0.00017590793,0.0003128111,0.0002757687,0.0002497296,0.00016655028],"domain_scores_gemma":[0.99827445,0.00069518853,0.0003212028,0.00018336652,0.00045825244,0.00006755278],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029464558,0.00012805613,0.0003945552,0.000111802496,0.000043919157,0.000006702792,0.00009260844,0.000070765076,0.000035958128],"category_scores_gemma":[0.00037704842,0.00009598639,0.0001167338,0.00015504149,0.000092970055,0.00009101629,0.000037082384,0.000105067855,0.000003771701],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018987022,0.0067090006,0.44306487,0.0000652866,0.0013143915,0.00013814465,0.00045253095,0.000006394393,0.45939723,0.00013333024,0.0051624174,0.0645694],"study_design_scores_gemma":[0.020522438,0.031006211,0.72230047,0.00014781942,0.0004087348,0.0007326476,0.000054560736,0.00010653511,0.17771357,0.000015777085,0.046828132,0.00016310824],"about_ca_topic_score_codex":0.00021430278,"about_ca_topic_score_gemma":0.0001949008,"teacher_disagreement_score":0.28168362,"about_ca_system_score_codex":0.000095115356,"about_ca_system_score_gemma":0.00016687464,"threshold_uncertainty_score":0.39142114},"labels":[],"label_agreement":null},{"id":"W4214703099","doi":"10.1093/neuonc/noaa215.807","title":"RTID-01. RADIOSURGERY FOLLOWED BY TUMOR TREATING FIELDS FOR BRAIN METASTASES (1-10) FROM NSCLC IN THE PHASE 3 METIS TRIAL","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Radiosurgery; Clinical endpoint; Lung cancer; Oncology; Adverse effect; Neurocognitive; Internal medicine; Randomized controlled trial; Radiation therapy","score_opus":0.048985329043387336,"score_gpt":0.3436906354942629,"score_spread":0.29470530645087556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214703099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9273637,0.0006323019,0.00011532132,0.06857843,0.00041496867,0.0019614636,0.0003292255,0.000052997835,0.0005515741],"genre_scores_gemma":[0.97102183,0.00002899423,0.00046952144,0.026496556,0.00062337343,0.0009557101,0.00035569246,0.000034304878,0.000013990274],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978627,0.0005477895,0.00053485844,0.00048152657,0.00021027004,0.00036283396],"domain_scores_gemma":[0.9919934,0.0073334207,0.00019220954,0.0002728207,0.000030768766,0.00017734738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039387748,0.00024230785,0.0008226626,0.000082895094,0.00008919572,0.00002778357,0.0001504135,0.00012394726,0.0004551956],"category_scores_gemma":[0.0027787795,0.00016634684,0.00033153716,0.000267699,0.000053444746,0.000055322067,0.00003516883,0.00022504017,0.000020555632],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.035685074,0.0042367517,0.0014430204,0.000029988229,0.000348994,0.0031134677,0.001469698,0.0000064274404,0.20855168,0.000059883823,0.6946249,0.05043009],"study_design_scores_gemma":[0.2336809,0.017695682,0.00020508602,0.000031503187,0.001058029,0.00007270288,0.00060133444,0.0006651442,0.06869905,0.00006531687,0.6769604,0.000264875],"about_ca_topic_score_codex":0.00018416594,"about_ca_topic_score_gemma":0.00007993648,"teacher_disagreement_score":0.19799583,"about_ca_system_score_codex":0.000091058144,"about_ca_system_score_gemma":0.00018314995,"threshold_uncertainty_score":0.67834276},"labels":[],"label_agreement":null},{"id":"W4214740171","doi":"10.1093/neuonc/nou265.2","title":"NT-02 * EARLY TREATMENT OF HER2-AMPLIFIED BRAIN TUMOURS WITH TARGETED NK-92 CELLS AND FOCUSED ULTRASOUND IMPROVES SURVIVAL","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Brain metastasis; Cancer research; Microbubbles; Breast cancer; Radiation therapy; Metastasis; Pathology; Cancer; Internal medicine; Ultrasound","score_opus":0.01303862848947757,"score_gpt":0.23979880754532307,"score_spread":0.2267601790558455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214740171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99733204,0.000049943646,0.00019262843,0.0007414007,0.00063157314,0.00052247144,0.00004245512,0.000108643304,0.00037885318],"genre_scores_gemma":[0.99775684,0.000021885808,0.0015399251,0.00037979358,0.00012459468,0.000047948262,0.0000047456783,0.00004642133,0.00007781731],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973718,0.00070829754,0.0004303448,0.0006382437,0.00028454058,0.0005667526],"domain_scores_gemma":[0.9964796,0.0024002087,0.00029710415,0.00047785282,0.00011188222,0.00023339782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004568208,0.00030252815,0.00063594506,0.00010468351,0.000110385314,0.000058363963,0.00023330913,0.00014589533,0.00010014925],"category_scores_gemma":[0.0002087106,0.00023919441,0.00006425626,0.0001882341,0.0004558557,0.00015446718,0.00005450124,0.00010578622,0.0000675885],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007038742,0.00044011566,0.00348866,0.000022005768,0.00001548418,0.000036515998,0.00067349017,0.000059024846,0.99195516,0.0001277801,0.0002726333,0.00220527],"study_design_scores_gemma":[0.0036474776,0.009079326,0.007906166,0.000008297441,0.0000691321,0.000031608757,0.00010909081,0.000075282755,0.9750277,0.00011978542,0.0036853277,0.00024079891],"about_ca_topic_score_codex":0.0005446068,"about_ca_topic_score_gemma":0.00023777237,"teacher_disagreement_score":0.016927438,"about_ca_system_score_codex":0.00012785291,"about_ca_system_score_gemma":0.0002132031,"threshold_uncertainty_score":0.9754065},"labels":[],"label_agreement":null},{"id":"W4220732082","doi":"10.1093/neuonc/noac072","title":"Effectiveness and safety of pneumocystis pneumonia prophylaxis for patients receiving temozolomide chemoradiotherapy","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Western University","funders":"Ontario Ministry of Health and Long-Term Care; Canadian Cancer Society; Canadian Centre for Applied Research in Cancer Control","keywords":"Medicine; Temozolomide; Chemoradiotherapy; Internal medicine; Population; Cohort; Retrospective cohort study; Neutropenia; Oncology; Surgery; Cancer; Radiation therapy; Chemotherapy","score_opus":0.014494316526808593,"score_gpt":0.32554737051981536,"score_spread":0.31105305399300676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220732082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946207,0.00043132174,0.000041749965,0.0012740633,0.00043198717,0.0025533072,0.00007486929,0.00004054292,0.00053145754],"genre_scores_gemma":[0.9979724,0.00033721887,0.0003685886,0.0002650807,0.000075729055,0.0008928405,0.00001292644,0.00004093001,0.000034249842],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982218,0.0004148491,0.000300068,0.00041716167,0.00031377177,0.00033235986],"domain_scores_gemma":[0.9976245,0.0017006835,0.0001596521,0.0002476503,0.00018283742,0.00008463779],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005778459,0.00015688677,0.00068291376,0.00014022522,0.00024564183,0.0000048681436,0.00013166277,0.00006588533,0.00003306655],"category_scores_gemma":[0.00094719103,0.0001419842,0.00008646418,0.00024565883,0.00019815395,0.00004188409,0.00022982279,0.00033989726,8.6660515e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0084299445,0.00057369313,0.13853185,0.0010385639,0.00018060708,0.000050555576,0.0007811197,0.00001947861,0.6968829,0.000049165767,0.0006629231,0.15279922],"study_design_scores_gemma":[0.02271647,0.056860138,0.6981022,0.000108882254,0.00015511492,0.00022561726,0.0002736261,0.0002080031,0.050520245,0.00024942518,0.17022125,0.00035904054],"about_ca_topic_score_codex":0.000039425595,"about_ca_topic_score_gemma":0.0000076286897,"teacher_disagreement_score":0.64636266,"about_ca_system_score_codex":0.0007554662,"about_ca_system_score_gemma":0.00029275598,"threshold_uncertainty_score":0.57899475},"labels":[],"label_agreement":null},{"id":"W4220994793","doi":"10.1093/neuonc/noac062","title":"Opportunities and challenges for the development of “core outcome sets” in neuro-oncology","year":2022,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Delphi Technique in Research","field":"Social Sciences","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Marie Curie; National Institute for Health and Care Research","keywords":"Delphi method; Intervention (counseling); Scope (computer science); Medicine; Brain tumor; Glioma; Oncology; Clinical trial; Precision oncology; Delphi; Medical physics; Internal medicine; Psychology; Intensive care medicine; Pathology; Cancer research; Computer science; Psychiatry; Cancer; Artificial intelligence","score_opus":0.7326601777933447,"score_gpt":0.5548178042793237,"score_spread":0.177842373514021,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220994793","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003793941,0.9673774,0.000013466117,0.012297799,0.0012685215,0.004285805,0.000062971456,0.00009884169,0.01455722],"genre_scores_gemma":[0.000038728245,0.9945245,0.00094874203,0.00041564874,0.0001616152,0.0036985544,0.000020951042,0.00007087389,0.00012040375],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9937666,0.0026351023,0.0014412496,0.0006943863,0.00064865896,0.00081398344],"domain_scores_gemma":[0.9752282,0.023199545,0.0007929614,0.0004837204,0.00012280614,0.00017279545],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0066559603,0.0003922872,0.0020218377,0.00060830486,0.0005873314,0.000028503793,0.0016053339,0.00073401467,0.00026898528],"category_scores_gemma":[0.003464123,0.00031169865,0.0002732193,0.00044109183,0.0011180467,0.00007883643,0.0010374286,0.0013133101,0.000005506496],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002969374,0.00012070554,0.000016197218,0.0024563244,0.00004347475,0.00012449744,0.0056151655,2.489195e-7,0.0000035255705,0.005734172,0.0012502467,0.9846057],"study_design_scores_gemma":[0.00024679664,0.00053238333,0.000012541147,0.00014252264,0.00010440649,0.000047902926,0.0082114,0.0000036365302,0.0000010302803,0.00035341366,0.99010634,0.00023762963],"about_ca_topic_score_codex":0.00012490909,"about_ca_topic_score_gemma":0.0036010009,"teacher_disagreement_score":0.9888561,"about_ca_system_score_codex":0.0010188922,"about_ca_system_score_gemma":0.006129891,"threshold_uncertainty_score":0.9999335},"labels":[],"label_agreement":null},{"id":"W4221089132","doi":"10.1093/neuonc/noac081","title":"Identifying risk factors for recurrence/relapse in NF1 optic pathway gliomas: Moving forward by looking back","year":2022,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institute of Neurological Disorders and Stroke; National Cancer Institute; National Institutes of Health; National Cancer Center","keywords":"Medicine; Internal medicine; Oncology; Radiology","score_opus":0.03636947294559108,"score_gpt":0.2981983915010021,"score_spread":0.261828918555411,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221089132","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9211021,0.0015062641,0.00015955858,0.063260905,0.007286134,0.0035638846,0.001311468,0.0002412911,0.0015683926],"genre_scores_gemma":[0.2971378,0.0022550798,0.005891762,0.662971,0.011442198,0.004419422,0.010158353,0.0022646147,0.0034597442],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.994261,0.000845947,0.001356997,0.0015785977,0.0006991697,0.0012582628],"domain_scores_gemma":[0.99387634,0.003907051,0.0010297082,0.00084717514,0.000109941575,0.00022976343],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0006024263,0.00080923236,0.0018601246,0.0009205007,0.0003409752,0.00010817633,0.00057541294,0.0011674908,0.00090470904],"category_scores_gemma":[0.0015627609,0.0007949906,0.00067518884,0.00061630586,0.00016135284,0.00020766834,0.0004488098,0.004710412,0.000061117884],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034744022,0.000276482,0.0066196653,0.0010728141,0.0001397659,0.011775278,0.00072091585,0.000014643735,0.03581781,0.000016149777,0.93971276,0.0034862875],"study_design_scores_gemma":[0.0029063877,0.0037409088,0.00016548444,0.0002742593,0.00036733385,0.0012850587,0.00046842382,0.00021863739,0.005594708,0.00010829325,0.9841923,0.00067818986],"about_ca_topic_score_codex":0.00016727393,"about_ca_topic_score_gemma":0.000021061105,"teacher_disagreement_score":0.6239643,"about_ca_system_score_codex":0.0007944232,"about_ca_system_score_gemma":0.00060391927,"threshold_uncertainty_score":0.9994501},"labels":[],"label_agreement":null},{"id":"W4223537410","doi":"10.1093/neuonc/noac087","title":"Entrectinib in children and young adults with solid or primary CNS tumors harboring <i>NTRK</i>, <i>ROS1</i>, or <i>ALK</i> aberrations (STARTRK-NG)","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":138,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"National Cancer Institute; F. Hoffmann-La Roche; Cancer Research Foundation","keywords":"ROS1; Medicine; Internal medicine; Oncology; Cancer; Adenocarcinoma","score_opus":0.009531803600998194,"score_gpt":0.2932586197177411,"score_spread":0.2837268161167429,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223537410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861156,0.00029978057,0.00001906059,0.0029078883,0.00051408506,0.0018493019,0.00016475978,0.00014277057,0.007986779],"genre_scores_gemma":[0.99093795,0.00026435425,0.00083172315,0.0055378033,0.00021956458,0.00082155043,0.00028772771,0.00007102674,0.001028285],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99806094,0.00015787387,0.0004176745,0.0006010506,0.00029226215,0.00047018353],"domain_scores_gemma":[0.9990293,0.00021413865,0.00017809973,0.0003089318,0.00006281179,0.00020675668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012984002,0.00026544512,0.00052648666,0.0002121684,0.00038910488,0.000027630454,0.00011262386,0.000072441624,0.0003656389],"category_scores_gemma":[0.00007456028,0.00019749894,0.00005199666,0.0005293145,0.00011586646,0.00015287893,0.00014459029,0.0005433664,0.000008516683],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018521685,0.0052442946,0.8448593,0.00022557734,0.0008644736,0.0067204195,0.024516955,0.000792407,0.03524299,0.0002119044,0.023683565,0.03911641],"study_design_scores_gemma":[0.066019535,0.029082421,0.61091673,0.00033120342,0.0020487425,0.023999505,0.0070267306,0.00044855397,0.0040828,0.000052575106,0.25459972,0.0013914516],"about_ca_topic_score_codex":0.0005082156,"about_ca_topic_score_gemma":0.0016545267,"teacher_disagreement_score":0.23394257,"about_ca_system_score_codex":0.0005760555,"about_ca_system_score_gemma":0.0013787049,"threshold_uncertainty_score":0.8053773},"labels":[],"label_agreement":null},{"id":"W4223566665","doi":"10.1093/neuonc/noac085","title":"Glioblastoma scRNA-seq shows treatment-induced, immune-dependent increase in mesenchymal cancer cells and structural variants in distal neural stem cells","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University and Génome Québec Innovation Centre; McGill University; McGill Genome Centre; Montreal Neurological Institute and Hospital","funders":"National Institute of Neurological Disorders and Stroke; Cancer Research Society; Canadian Institutes of Health Research; KWF Kankerbestrijding; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Brain Tumour Foundation of Canada","keywords":"Subventricular zone; Biology; Mesenchymal stem cell; Neural stem cell; Cancer research; Progenitor cell; Immune system; Cancer; Tumor microenvironment; Cancer stem cell; Cancer cell; Stem cell; Immunology; Cell biology; Genetics","score_opus":0.018218892729097155,"score_gpt":0.2827486938397232,"score_spread":0.264529801110626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223566665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99538857,0.0006820875,1.732463e-7,0.0010990683,0.0010869304,0.001223158,0.00025178917,0.0000428271,0.0002254063],"genre_scores_gemma":[0.99844295,0.0001340362,0.000019732764,0.0005189797,0.00010787377,0.0006460998,0.0000198673,0.000052893283,0.000057559766],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99702483,0.0005607789,0.0006051991,0.0007671545,0.00036038455,0.0006816531],"domain_scores_gemma":[0.99877226,0.00032919273,0.00020077333,0.0003711306,0.0000321632,0.0002945011],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000178662,0.00041185552,0.0008590675,0.00040963027,0.00016741613,0.000030699488,0.00016253727,0.00014649854,0.0005667778],"category_scores_gemma":[0.000015445352,0.00035627955,0.00012891916,0.0003731445,0.00008179453,0.000115844836,0.00031627814,0.00052340317,0.000009988044],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019484842,0.0015230589,0.084137544,0.000027758655,0.000096722535,0.015899505,0.0010958387,0.0005636814,0.8601166,0.0000325353,0.000105166815,0.034453083],"study_design_scores_gemma":[0.053014938,0.020845104,0.24093956,0.00006646629,0.0006275046,0.0033866453,0.0034817548,0.010185927,0.66263217,0.000056915014,0.0037461016,0.0010169348],"about_ca_topic_score_codex":0.005271202,"about_ca_topic_score_gemma":0.006062031,"teacher_disagreement_score":0.19748446,"about_ca_system_score_codex":0.001673843,"about_ca_system_score_gemma":0.00040128484,"threshold_uncertainty_score":0.9998889},"labels":[],"label_agreement":null},{"id":"W4224981127","doi":"10.1093/neuonc/noac106","title":"Factors correlating with survival following adjuvant or definitive radiosurgery for large brain metastases","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Radiosurgery; Internal medicine; Adjuvant; Propensity score matching; Multivariate analysis; Urology; Incidence (geometry); Univariate analysis; Cumulative incidence; Oncology; Prospective cohort study; Gastroenterology; Nuclear medicine; Surgery; Cohort; Radiation therapy","score_opus":0.07140361507150825,"score_gpt":0.3339277149654085,"score_spread":0.26252409989390024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224981127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892062,0.00040704993,0.0017982285,0.0030318224,0.0020650101,0.001587065,0.0009430586,0.0001415742,0.0008199751],"genre_scores_gemma":[0.99214226,0.000010826792,0.00235172,0.003984943,0.00013373091,0.0004872779,0.00062534533,0.00008581728,0.00017805939],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99731416,0.0007170979,0.00041055164,0.0005431621,0.00038068197,0.00063433504],"domain_scores_gemma":[0.9919327,0.007274024,0.0002501746,0.00027816076,0.000053858686,0.00021108208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009882213,0.00031289094,0.0009716912,0.00017150427,0.00053411926,0.000014695074,0.000098029515,0.000068830384,0.00053653336],"category_scores_gemma":[0.0012747055,0.00021266544,0.0003774904,0.00033228146,0.00004887504,0.00007131423,0.00013146024,0.00041617974,0.000005317641],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.043419372,0.01666464,0.5226925,0.00067228364,0.012218071,0.06290614,0.012447883,0.0013190479,0.03180446,0.022374952,0.08270041,0.19078027],"study_design_scores_gemma":[0.028399816,0.030625088,0.013024886,0.0000616086,0.0028321506,0.0012299482,0.015487064,0.0008107156,0.002171305,0.00014556032,0.90447205,0.00073980633],"about_ca_topic_score_codex":0.000037028956,"about_ca_topic_score_gemma":0.00008386564,"teacher_disagreement_score":0.8217716,"about_ca_system_score_codex":0.00032755514,"about_ca_system_score_gemma":0.00065623195,"threshold_uncertainty_score":0.8672245},"labels":[],"label_agreement":null},{"id":"W4225630787","doi":"10.1093/neuonc/noac116","title":"Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated <i>MGMT</i> promoter","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":501,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"National Cancer Institute; National Center for Advancing Translational Sciences; National Institute of Neurological Disorders and Stroke; Ono Pharmaceutical; Bristol-Myers Squibb","keywords":"Temozolomide; Medicine; Internal medicine; Nivolumab; Placebo; Regimen; Dacarbazine; Chemoradiotherapy; Gastroenterology; Radiation therapy; Progression-free survival; Randomized controlled trial; Clinical endpoint; Chemotherapy; Oncology; Cancer; Immunotherapy; Pathology","score_opus":0.02156685144926639,"score_gpt":0.3125214745721496,"score_spread":0.2909546231228832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225630787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886506,0.0001229401,0.00015655872,0.0033377747,0.0003443368,0.0068556606,0.00009760176,0.00011255819,0.00032196447],"genre_scores_gemma":[0.9908264,0.00004177828,0.0021299971,0.0019322218,0.00023603305,0.0045012343,0.00007587551,0.00012322604,0.00013322962],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9975713,0.00026692607,0.0005672855,0.0006549466,0.00043108052,0.00050845067],"domain_scores_gemma":[0.9975022,0.001109173,0.00047760943,0.00051432435,0.00017118109,0.00022550258],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003058496,0.00037530338,0.0013618835,0.00025414478,0.00019484942,0.000014846976,0.0001935784,0.00014262539,0.00037852253],"category_scores_gemma":[0.0001237619,0.000248095,0.00017740398,0.0005570769,0.00018480913,0.000070927905,0.00006135564,0.0003367811,0.0000028057623],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8094104,0.011105097,0.00016076106,0.000074043026,0.00070136983,0.0032853896,0.0008726465,0.00017209032,0.14464012,0.000024237539,0.006758519,0.022795347],"study_design_scores_gemma":[0.62295896,0.19232073,0.00001685218,0.0000261929,0.00061444077,0.0008605435,0.0002508545,0.0006054447,0.119194634,0.000008517837,0.06292647,0.00021635919],"about_ca_topic_score_codex":0.000085112646,"about_ca_topic_score_gemma":0.00023128705,"teacher_disagreement_score":0.18645142,"about_ca_system_score_codex":0.00055412465,"about_ca_system_score_gemma":0.001224123,"threshold_uncertainty_score":0.99999714},"labels":[],"label_agreement":null},{"id":"W4226297738","doi":"10.1093/neuonc/noac088","title":"Comprehensive profiling of myxopapillary ependymomas identifies a distinct molecular subtype with relapsing disease","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Fördergemeinschaft Kinderkrebs-Zentrum Hamburg; Friedberg Charitable Foundation; Deutsche Forschungsgemeinschaft; Making Headway Foundation; Gert und Susanna Mayer Stiftung","keywords":"DNA methylation; Ependymoma; Histopathology; Biology; Methylation; Pathological; Pathology; Disease; Oncology; Medicine; Gene; Genetics; Gene expression","score_opus":0.02063884002091162,"score_gpt":0.2846931370558588,"score_spread":0.2640542970349472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4226297738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99446744,0.0018103357,0.000024963707,0.0016439185,0.00030478172,0.0007138214,0.000036867714,0.000053508847,0.0009443815],"genre_scores_gemma":[0.99850845,0.000034090786,0.00036985328,0.00070708425,0.000035429915,0.00019439467,0.00009862474,0.00003851342,0.000013564526],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99846464,0.0002352167,0.0002923387,0.00038652815,0.00036287788,0.00025840133],"domain_scores_gemma":[0.99882954,0.00029129416,0.00020622826,0.00036228535,0.00013056837,0.00018009031],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000823145,0.00017880525,0.00045046114,0.00014686986,0.0001710665,0.000008344208,0.00009832861,0.000031684565,0.00015083345],"category_scores_gemma":[0.000105857696,0.00015029624,0.00011802304,0.00027524293,0.0001390306,0.00003652609,0.00019472602,0.00025600623,0.000008022953],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022590968,0.0015801722,0.110233426,0.00020979901,0.00024215564,0.027767554,0.000283707,0.00050372543,0.85386515,0.0006720659,0.00054384104,0.0018393324],"study_design_scores_gemma":[0.022571811,0.01602954,0.18744278,0.00031822757,0.003453063,0.0047503468,0.0030108655,0.0015824065,0.69228953,0.0009974723,0.06660791,0.0009460822],"about_ca_topic_score_codex":0.00003319931,"about_ca_topic_score_gemma":0.0000062827203,"teacher_disagreement_score":0.16157562,"about_ca_system_score_codex":0.00017198022,"about_ca_system_score_gemma":0.00034493092,"threshold_uncertainty_score":0.61289024},"labels":[],"label_agreement":null},{"id":"W4229781797","doi":"10.1093/neuonc/nov237.13","title":"TMOD-13GENETICALLY ENGINEERED MOUSE MODELS OF CHOROID PLEXUS TUMORS","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Mathematical Biology Tumor Growth","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Choroid plexus; Anatomy; Pathology; Biology; Medicine; Neuroscience","score_opus":0.07750652243336452,"score_gpt":0.3173663730650181,"score_spread":0.23985985063165355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229781797","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93554837,0.00007331547,0.015606238,0.00093369355,0.00036514312,0.000819864,0.000044666704,0.000329066,0.046279673],"genre_scores_gemma":[0.95640224,0.000011935597,0.04255856,0.00048708284,0.00013873592,0.00008137353,0.000008570536,0.00008176485,0.00022971246],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9973543,0.00036337107,0.0008945587,0.00045507582,0.0003625988,0.00057004247],"domain_scores_gemma":[0.99655706,0.0017474147,0.0002932475,0.0007272429,0.00025868704,0.00041636123],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00072346197,0.0003214324,0.0009525884,0.00015168836,0.000033529184,0.000009541378,0.0005821039,0.00034270188,0.00013240427],"category_scores_gemma":[0.0031385676,0.00027852907,0.00014751396,0.00022289828,0.0003241337,0.00008115697,0.0002599359,0.00043220175,0.000110414585],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029658485,0.0013290928,0.0001605349,0.00026670608,0.00009919402,0.00022071377,0.0016481479,0.00045529832,0.364205,0.6155162,0.014745721,0.001056827],"study_design_scores_gemma":[0.0032356356,0.0029262255,0.00004340668,0.000031978525,0.00014898139,0.00044635538,0.0002729043,0.022036448,0.13650797,0.8281666,0.005596658,0.0005868308],"about_ca_topic_score_codex":0.00000837339,"about_ca_topic_score_gemma":0.000007313976,"teacher_disagreement_score":0.22769701,"about_ca_system_score_codex":0.00014316072,"about_ca_system_score_gemma":0.00033773316,"threshold_uncertainty_score":0.9999667},"labels":[],"label_agreement":null},{"id":"W4230245164","doi":"10.1093/neuonc/nov061.79","title":"MB-03 * FUNCTIONAL CHARACTERIZATION OF NOVEL BIOMARKERS IN SELECTING FOR SUBTYPE SPECIFIC MEDULLOBLASTOMA PHENOTYPES","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Manitoba","funders":"","keywords":"Medulloblastoma; Phenotype; Computational biology; Cancer research; Biology; Medicine; Genetics; Gene","score_opus":0.055424394973749826,"score_gpt":0.2966071030809768,"score_spread":0.241182708107227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230245164","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99565834,0.00006845402,0.00038892488,0.001776039,0.0007313605,0.0005577815,0.000018537283,0.000027414602,0.00077312376],"genre_scores_gemma":[0.99825716,0.000018189248,0.00093000283,0.0003295063,0.00020651905,0.00009609494,0.00013024206,0.000022527027,0.000009768838],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990552,0.00004374322,0.0002995617,0.0002521299,0.00014793761,0.00020141798],"domain_scores_gemma":[0.99913955,0.00027454953,0.00016371375,0.00012096705,0.00019985501,0.00010136353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020246001,0.00011744066,0.00031126506,0.00021047665,0.000027485754,0.0000050983076,0.000040844807,0.00011473385,0.000042988657],"category_scores_gemma":[0.00025435278,0.00010578292,0.000060591112,0.0002933573,0.000046132423,0.000052054813,0.000020896443,0.00008336188,0.000014131609],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012374101,0.0011545494,0.043572344,0.000025015552,0.00007388768,0.000024501453,0.00019215711,0.00002010187,0.9437821,0.00028397245,0.001009943,0.008624044],"study_design_scores_gemma":[0.028271906,0.0070617083,0.36338702,0.000091764494,0.00024429278,0.0003174375,0.00036464588,0.0027464023,0.45135558,0.000113974005,0.1457347,0.00031056357],"about_ca_topic_score_codex":0.000017060163,"about_ca_topic_score_gemma":0.000042048283,"teacher_disagreement_score":0.49242648,"about_ca_system_score_codex":0.00022655017,"about_ca_system_score_gemma":0.00025732513,"threshold_uncertainty_score":0.43137023},"labels":[],"label_agreement":null},{"id":"W4230473682","doi":"10.1093/neuonc/noy059.162","title":"DIPG-69. CHARACTERISTICS OF PATIENTS ≥ 10 YEARS OF AGE WITH DIFFUSE INTRINSIC PONTINE GLIOMA: A REPORT FROM THE INTERNATIONAL DIPG REGISTRY","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cardiac tumors and thrombi","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Radiological weapon; Pathological; Population; Pediatrics; Overall survival; Retrospective cohort study; Internal medicine; Surgery","score_opus":0.011178961558542713,"score_gpt":0.2636494803249901,"score_spread":0.2524705187664474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230473682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940405,0.000014366727,0.000010249943,0.000629466,0.0010020663,0.00023551466,0.00012308345,0.000018485884,0.0039262557],"genre_scores_gemma":[0.99840724,0.000015479432,0.00013746349,0.0003887943,0.00067193754,0.000009667085,0.00019873302,0.00002297301,0.00014769507],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987511,0.00005549901,0.0004602972,0.00025667762,0.00032567143,0.00015076408],"domain_scores_gemma":[0.9982765,0.00026499436,0.0005467987,0.00052284065,0.00031845976,0.000070419715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013576896,0.00011754135,0.0004873874,0.00006287992,0.00002374632,0.0000072918633,0.0001778891,0.00009248427,0.00019476701],"category_scores_gemma":[0.00084100454,0.00008473728,0.000098969,0.00014069554,0.00041324104,0.000031100826,0.00013024741,0.00019567269,0.000013980671],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004240978,0.0020954877,0.76406306,0.000038694754,0.00041518954,0.0073511763,0.0010973082,8.9660276e-8,0.178102,0.00013164981,0.01764563,0.024818707],"study_design_scores_gemma":[0.0029772306,0.0015475535,0.89351034,0.000039962215,0.0001662386,0.00031355224,0.000047181347,0.0000034098648,0.0035859973,0.000022906113,0.09771402,0.00007157368],"about_ca_topic_score_codex":0.00017700475,"about_ca_topic_score_gemma":0.000044001863,"teacher_disagreement_score":0.174516,"about_ca_system_score_codex":0.000058096135,"about_ca_system_score_gemma":0.0001524347,"threshold_uncertainty_score":0.3455486},"labels":[],"label_agreement":null},{"id":"W4232086884","doi":"10.1093/neuonc/now212.452","title":"MPTH-14. MOLECULAR CLASSIFICATION AND CLINICAL CHARACTERISTICS OF MEDULLOBLASTOMAS IN JAPAN","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Wnt signaling pathway; Medulloblastoma; Cytogenetics; Immunohistochemistry; Molecular genetics; Oncology; Biology; Phenotype; Internal medicine; Molecular cytogenetics; Gene; Cancer research; Pathology; Bioinformatics; Medicine; Genetics; Chromosome","score_opus":0.0338789855703825,"score_gpt":0.3417916033240748,"score_spread":0.30791261775369233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232086884","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914081,0.000059507027,0.000019794079,0.0073407823,0.00021193478,0.00027080075,0.00000838634,0.000015068101,0.00066561747],"genre_scores_gemma":[0.99869496,0.00039985866,0.00017166787,0.0006186965,0.000055557255,0.000031808333,0.0000060820557,0.000013611552,0.000007786079],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99885976,0.00014391847,0.00046174746,0.0002690804,0.00010896745,0.0001564968],"domain_scores_gemma":[0.9988411,0.0005659775,0.0001725861,0.0002315758,0.00006855844,0.00012018779],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019922655,0.00009910365,0.00041369474,0.0001059278,0.000011754619,0.0000024219837,0.00004676598,0.00016707926,0.00004064527],"category_scores_gemma":[0.0005634356,0.00006701694,0.00006241564,0.00008667094,0.000168684,0.000023986153,0.000037671754,0.00010806992,0.000022259806],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013359202,0.000632111,0.49321222,0.000010732103,0.000024216633,0.00015239057,0.000029556413,1.6329016e-8,0.39032602,0.0005408257,0.00015893532,0.1147794],"study_design_scores_gemma":[0.003987799,0.0020445157,0.96019715,0.000049525424,0.00010390429,0.00007093111,0.000022520568,0.000031084397,0.019438654,0.00006482243,0.013928813,0.00006026454],"about_ca_topic_score_codex":0.000006762992,"about_ca_topic_score_gemma":0.000017774071,"teacher_disagreement_score":0.46698496,"about_ca_system_score_codex":0.00007552654,"about_ca_system_score_gemma":0.00009876019,"threshold_uncertainty_score":0.27328715},"labels":[],"label_agreement":null},{"id":"W4232542154","doi":"10.1093/neuonc/noaa087","title":"Erratum to ‘Connexin43 peptide, TAT-Cx43266–283, selectively targets glioma cells, impairs malignant growth, and enhances survival in mouse models in vivo’","year":2020,"lang":"en","type":"erratum","venue":"Neuro-Oncology","topic":"Connexins and lens biology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Junta de Castilla y León; Ministerio de Economía y Competitividad; Fundación Ramón Areces","keywords":"In vivo; Glioma; Cancer research; Peptide; Biology; Chemistry; Cell biology; Biochemistry; Genetics","score_opus":0.013340792271496548,"score_gpt":0.2509124046445097,"score_spread":0.23757161237301316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232542154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9028946,0.008536645,0.00047437244,0.006580538,0.027623422,0.003652782,0.0011520986,0.00017918991,0.04890632],"genre_scores_gemma":[0.96982586,0.009137831,0.000783624,0.0067025987,0.003170927,0.00057080964,0.00077651517,0.00037154864,0.008660259],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99400836,0.0010727204,0.0010409663,0.0023070201,0.0002604781,0.001310477],"domain_scores_gemma":[0.99809,0.00019064287,0.00040581133,0.0005801427,0.00018745853,0.0005459144],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0004925357,0.0009848715,0.0016005362,0.00060311035,0.000112448244,0.0000547892,0.0007899138,0.0021907329,0.00005044195],"category_scores_gemma":[0.0005112489,0.0010018685,0.00024388693,0.00059887214,0.00030133437,0.000020163765,0.00086031883,0.0016408837,0.000019417452],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085868174,0.0002380962,0.0001582939,0.00011904876,0.000074687625,0.00067662797,0.00043971214,0.000074184514,0.79011244,0.00013160339,0.2067426,0.0003740547],"study_design_scores_gemma":[0.0023845944,0.006635816,0.0002087603,0.000068895446,0.0000588342,0.00018875497,0.0005331791,0.00046083672,0.3766338,0.0005302978,0.6107752,0.0015210835],"about_ca_topic_score_codex":0.0006102147,"about_ca_topic_score_gemma":0.007644601,"teacher_disagreement_score":0.4134786,"about_ca_system_score_codex":0.0001651532,"about_ca_system_score_gemma":0.0012929196,"threshold_uncertainty_score":0.9992432},"labels":[],"label_agreement":null},{"id":"W4232613062","doi":"10.1093/neuonc/nox168.810","title":"PDTM-48. PEROXIREDOXIN1 IS A THERAPEUTIC TARGET IN GROUP-3 MEDULLOBLASTOMA","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Mitochondrial Function and Pathology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Medulloblastoma; Cancer research; Gene silencing; Apoptosis; Radiation therapy; Chemotherapy; Medicine; Biology; Oncology; Internal medicine; Gene; Genetics","score_opus":0.01978901821219837,"score_gpt":0.2912706027479169,"score_spread":0.2714815845357185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232613062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9518829,0.0006191879,0.0014319668,0.006942705,0.005603878,0.0006047562,0.00003717038,0.000049860468,0.032827586],"genre_scores_gemma":[0.9863864,0.0002751424,0.0009718755,0.010309991,0.0008449036,0.000091596215,0.000045635454,0.000046399382,0.0010280629],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.998189,0.0002911622,0.0003130762,0.00064082845,0.00011941936,0.00044654592],"domain_scores_gemma":[0.9986797,0.000045842964,0.00020935299,0.0008743495,0.000055792178,0.00013496088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002467328,0.00023599599,0.0003345917,0.00008720013,0.0002343299,0.000040796578,0.00053768646,0.0005109485,0.000494856],"category_scores_gemma":[0.00027114482,0.00022812934,0.00013873451,0.00005340909,0.00025650603,0.000009213775,0.00024227485,0.00030527555,0.00023494956],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004367268,0.00015836266,0.0066565676,0.0000072069597,0.000023311988,0.00011030982,0.00015415106,0.0000043084233,0.9705056,0.0003031667,0.013197269,0.008442997],"study_design_scores_gemma":[0.0019265309,0.0014145584,0.0041866433,0.000004469954,0.00001650493,0.0002265921,0.00006451504,0.000078840356,0.12813017,0.00039348897,0.86331147,0.00024624047],"about_ca_topic_score_codex":0.000043332613,"about_ca_topic_score_gemma":0.00036181195,"teacher_disagreement_score":0.85011417,"about_ca_system_score_codex":0.000039755203,"about_ca_system_score_gemma":0.00015240764,"threshold_uncertainty_score":0.93028444},"labels":[],"label_agreement":null},{"id":"W4232645866","doi":"10.1093/neuonc/noaa222.495","title":"MBCL-19. CHEMOTHERAPY STRATEGIES FOR YOUNG CHILDREN NEWLY DIAGNOSED WITH DESMOPLASTIC/EXTENSIVE NODULAR MEDULLOBLASTOMA UP TO THE ERA OF MOLECULAR PROFILING – A COMPARATIVE OUTCOMES ANALYSIS OF PROSPECTIVE MULTI-CENTER EUROPEAN AND NORTH AMERICAN TRIALS","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital","funders":"","keywords":"Medulloblastoma; Medicine; Induction chemotherapy; Chemotherapy; Oncology; Clinical trial; Internal medicine; Methotrexate; Cytarabine; Surgery; Pathology","score_opus":0.03707217594381081,"score_gpt":0.32851647301048736,"score_spread":0.29144429706667657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4232645866","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99070305,0.0000900625,0.0024050162,0.0030499692,0.000042098305,0.0033992436,0.00026001953,0.00002666609,0.000023891655],"genre_scores_gemma":[0.9931371,0.000036794994,0.0036970156,0.0027186826,0.000035914694,0.0002652271,0.000073078554,0.000035645968,5.431704e-7],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979642,0.00044912347,0.0005784763,0.0005237014,0.00022506781,0.00025944223],"domain_scores_gemma":[0.9975472,0.0010126614,0.00059644255,0.0002559984,0.00038205608,0.00020563726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020290371,0.00030213734,0.0018049938,0.00013805395,0.0000695175,0.00002037471,0.00012896376,0.00003501985,0.000004419313],"category_scores_gemma":[0.00052701985,0.00017969061,0.0002753974,0.00077019294,0.0002896893,0.00004381126,0.000054608463,0.00018236443,0.0000011499121],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033983365,0.001064109,0.9313225,0.000030337244,0.006833496,0.00014716711,0.012001566,0.0016216765,0.041752744,0.00006030518,0.00011469192,0.0016530709],"study_design_scores_gemma":[0.017833497,0.008188043,0.9375704,0.000021527823,0.0036576355,0.000022640506,0.0036240814,0.0009923688,0.02783289,0.0000016437414,0.000090483256,0.00016482428],"about_ca_topic_score_codex":0.00013634501,"about_ca_topic_score_gemma":0.00071258924,"teacher_disagreement_score":0.014435162,"about_ca_system_score_codex":0.00005535822,"about_ca_system_score_gemma":0.00017937357,"threshold_uncertainty_score":0.73275703},"labels":[],"label_agreement":null},{"id":"W4233683996","doi":"10.1093/neuonc/noaa222.339","title":"IMG-03. RESPONSE ASSESSMENT IN PEDIATRIC LOW-GRADE GLIOMA: RECOMMENDATIONS FROM THE RESPONSE ASSESSMENT IN PEDIATRIC NEURO-ONCOLOGY (RAPNO) WORKING GROUP","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Medical physics; Clinical trial; MEDLINE; Consensus conference; Pathology; Internal medicine","score_opus":0.04050351392236156,"score_gpt":0.3450257419854616,"score_spread":0.30452222806310003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233683996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79613054,0.0006220994,0.000044327073,0.19930036,0.0013410649,0.0018834963,0.000058425307,0.00013951735,0.00048018727],"genre_scores_gemma":[0.9797704,0.0020327382,0.0020244422,0.013549658,0.001279145,0.00109013,0.00012998338,0.00011866815,0.000004785746],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98716456,0.007751171,0.0017035638,0.0015421208,0.00069139944,0.0011471999],"domain_scores_gemma":[0.97685504,0.020874647,0.00066492904,0.00091430405,0.00011967235,0.00057141605],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0028615564,0.0006822116,0.0013744832,0.0010802991,0.0002814997,0.00008758191,0.0006379317,0.00058492826,0.0003004905],"category_scores_gemma":[0.0025997697,0.0005710131,0.0003352394,0.0032712938,0.00014626294,0.00018595617,0.00053473347,0.0024217183,0.00012499758],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01302855,0.0076212795,0.82568806,0.00005948132,0.00011961467,0.015300087,0.002849602,0.00019753574,0.11116778,0.00029021953,0.015060374,0.008617387],"study_design_scores_gemma":[0.015810046,0.0062379073,0.8852918,0.00003900791,0.00060327555,0.00019303721,0.0010430913,0.00091467117,0.00045739577,0.00011404624,0.088840574,0.0004551259],"about_ca_topic_score_codex":0.00021708818,"about_ca_topic_score_gemma":0.00070821954,"teacher_disagreement_score":0.18575071,"about_ca_system_score_codex":0.0020823204,"about_ca_system_score_gemma":0.0024555475,"threshold_uncertainty_score":0.9998797},"labels":[],"label_agreement":null},{"id":"W4234183193","doi":"10.1093/neuonc/noaa215.644","title":"NIMG-31. NON-DIPG PATIENTS ENROLLED IN THE INTERNATIONAL DIPG REGISTRY: HISTOPATHOLOGIC EVALUATION OF CENTRAL NEURO-IMAGING REVIEW","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; BC Children's Hospital; University of Toronto; Hospital for Sick Children","funders":"","keywords":"Histopathology; Medicine; Pilocytic astrocytoma; Medical diagnosis; Biopsy; Pathology; Radiology; Astrocytoma; Stereotactic biopsy; Glioma; Medulloblastoma; Ganglioglioma; Epilepsy","score_opus":0.044511088822360594,"score_gpt":0.32953472570027104,"score_spread":0.28502363687791044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4234183193","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92424554,0.0019007412,0.0000056748604,0.06461567,0.00065670174,0.0016789789,0.000015559383,0.000021240863,0.0068598883],"genre_scores_gemma":[0.9725515,0.0011004311,0.000058110232,0.025895707,0.00012643865,0.00015687216,0.00009437039,0.000013861927,0.000002689812],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99786097,0.000432975,0.0005062636,0.00036920418,0.0005982523,0.00023232009],"domain_scores_gemma":[0.9987318,0.00033166428,0.0003246367,0.00028488322,0.0002360662,0.00009097231],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005441542,0.00016323842,0.00046172598,0.00007610044,0.00003201922,0.00000820662,0.00025530005,0.000060330112,0.00014396539],"category_scores_gemma":[0.0022450353,0.00011428337,0.0001350083,0.00024422086,0.000068990696,0.00005284539,0.00008196716,0.00025606542,0.000024188317],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046235436,0.0028253698,0.81977755,0.00031485627,0.000058092508,0.0011071129,0.001218889,0.00004529109,0.050476547,0.000071720446,0.056938518,0.06670372],"study_design_scores_gemma":[0.019014953,0.002507375,0.80440986,0.00045518138,0.0010763564,0.00019391239,0.0001835683,0.0042497064,0.002218502,0.00007882672,0.16537483,0.0002369246],"about_ca_topic_score_codex":0.000016970806,"about_ca_topic_score_gemma":0.000008204467,"teacher_disagreement_score":0.10843631,"about_ca_system_score_codex":0.00030582465,"about_ca_system_score_gemma":0.00024068198,"threshold_uncertainty_score":0.46603408},"labels":[],"label_agreement":null},{"id":"W4236152653","doi":"10.1093/neuonc/noy148.863","title":"PDTM-21. MATCHING OF SINGLE CELL TRANSCRIPTOMICS FROM CEREBELLAR DEVELOPMENT IDENTIFIES PUTATIVE SUBGROUP SPECIFIC CELLS OF ORIGIN FOR MEDULLOBLASTOMA","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Calgary; McGill University; Hospital for Sick Children; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Biology; Medulloblastoma; Population; Cerebellum; Lineage markers; Single-cell analysis; Progenitor cell; Stem cell; Genetics; Cell; Neuroscience","score_opus":0.041318687902551686,"score_gpt":0.3141205460476487,"score_spread":0.27280185814509705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4236152653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860697,0.00018991347,0.009387184,0.00029623313,0.0008013526,0.0010067873,0.00007681944,0.00003558736,0.0021364368],"genre_scores_gemma":[0.96737456,0.00010351776,0.031527612,0.00024472832,0.00022495593,0.000039161998,0.00006555948,0.00007747593,0.00034244056],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973515,0.00021665938,0.00086068537,0.000572389,0.0005152363,0.00048348677],"domain_scores_gemma":[0.99745005,0.0011012268,0.0003490717,0.0003911681,0.0005065222,0.00020193894],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000395258,0.0002587615,0.00079324166,0.00030457825,0.00009437055,0.0000147076125,0.00031053196,0.00024022607,0.00040073277],"category_scores_gemma":[0.000093588314,0.00024859337,0.00018239798,0.00028945497,0.00047579635,0.00006327748,0.00011553669,0.0002948281,0.000092227485],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016020618,0.0007395792,0.00026502466,0.00024241109,0.00007223764,0.00006474727,0.005599241,0.000010699137,0.9832748,0.000042706513,0.002570572,0.005515892],"study_design_scores_gemma":[0.0025402268,0.0024652095,0.0004613251,0.00004813174,0.00006751149,0.000014497491,0.0011233401,0.00010323279,0.8847625,0.00034021496,0.10792305,0.0001507308],"about_ca_topic_score_codex":0.00006988358,"about_ca_topic_score_gemma":0.00009397774,"teacher_disagreement_score":0.105352476,"about_ca_system_score_codex":0.00030176435,"about_ca_system_score_gemma":0.0005678311,"threshold_uncertainty_score":0.9999966},"labels":[],"label_agreement":null},{"id":"W4236267368","doi":"10.1093/neuonc/noz175.452","title":"GENE-50. SWI/SNF COMPLEX HETEROGENEITY RELATES WITH POLYPHENOTYPIC DIFFERENTIATION, PROGNOSIS AND IMMUNE RESPONSE IN RHABDOID TUMORS","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"SMARCB1; Biology; DNA methylation; SWI/SNF; SMARCA4; Epigenetics; Cancer research; Immunohistochemistry; Methylation; Cellular differentiation; Gene; Gene expression; Immunology; Genetics; Chromatin remodeling","score_opus":0.012317014728936607,"score_gpt":0.25798695469413613,"score_spread":0.24566993996519954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4236267368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99802893,0.0006880148,0.00010850921,0.0005043658,0.00011702634,0.00035836085,0.000011277116,0.000022450224,0.00016106109],"genre_scores_gemma":[0.9985278,0.00015312136,0.00060342404,0.00047275616,0.000056633766,0.00004691039,0.00006547167,0.000033196244,0.000040654042],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99851227,0.00029965935,0.00030691482,0.0004877395,0.0001055097,0.00028791852],"domain_scores_gemma":[0.9993261,0.00007465498,0.00014347056,0.00032380474,0.00005782603,0.000074158095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021746813,0.00019479568,0.00029527553,0.00006886653,0.000063446816,0.000018422863,0.00014583964,0.0001922066,0.00002804157],"category_scores_gemma":[0.000062265564,0.00017143747,0.00005284454,0.00009707657,0.00009571065,0.000005568485,0.00012318813,0.00016940027,0.000012047084],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019198844,0.00010210115,0.059395216,0.000021558131,0.000029554143,0.000008280332,0.000094189796,0.00028397478,0.9362943,0.0000084508065,0.000055398476,0.0017870917],"study_design_scores_gemma":[0.003117961,0.0032871773,0.42213604,0.00003313895,0.0000362219,0.00018980012,0.00009587465,0.0018195864,0.5641814,0.000053184027,0.0046835663,0.0003660495],"about_ca_topic_score_codex":0.000050162176,"about_ca_topic_score_gemma":0.00007493559,"teacher_disagreement_score":0.3721129,"about_ca_system_score_codex":0.00005295597,"about_ca_system_score_gemma":0.0001483972,"threshold_uncertainty_score":0.6991017},"labels":[],"label_agreement":null},{"id":"W4236954344","doi":"10.1093/neuonc/now075.26","title":"LG-26GERMLINE AND SOMATIC FGFR1 ABNORMALITIES IN DYSEMBRYOPLASTIC NEUROEPITHELIAL TUMORS","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; McGill University","funders":"","keywords":"Somatic cell; Psychology; Biology; Genetics","score_opus":0.01605979703592154,"score_gpt":0.2763636554146519,"score_spread":0.2603038583787304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4236954344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98921084,0.00015893679,0.000012749055,0.008564148,0.00040427598,0.00039168145,0.000015751191,0.00006184764,0.0011797381],"genre_scores_gemma":[0.9977923,0.00022710898,0.000090705515,0.0014986586,0.00017624843,0.00010153728,0.0000043389437,0.000030309388,0.00007879432],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99851733,0.00016601407,0.0004045834,0.00035628682,0.00016309082,0.0003927025],"domain_scores_gemma":[0.99819314,0.0012282778,0.000106625084,0.00023787927,0.000040113093,0.00019395846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013145113,0.00021082387,0.0005235405,0.00023577306,0.000047017187,0.0000112615035,0.00006827808,0.00010403165,0.0001554419],"category_scores_gemma":[0.00049221487,0.00013465181,0.000064764354,0.00013498089,0.00016242905,0.00008078704,0.00007624421,0.0001494637,0.0000995763],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006198463,0.0014820058,0.34174743,0.00017066473,0.0000585131,0.0079615535,0.00055147556,0.000007439392,0.60457146,0.001143392,0.0017358707,0.03995032],"study_design_scores_gemma":[0.03010804,0.009047145,0.8194771,0.00059531914,0.0004201334,0.0051665935,0.00033627098,0.00040259215,0.084929176,0.001154296,0.047774766,0.00058859587],"about_ca_topic_score_codex":0.00003785229,"about_ca_topic_score_gemma":0.00007277071,"teacher_disagreement_score":0.5196423,"about_ca_system_score_codex":0.00012765876,"about_ca_system_score_gemma":0.00014655222,"threshold_uncertainty_score":0.54909414},"labels":[],"label_agreement":null},{"id":"W4237365222","doi":"10.1093/neuonc/nox168.1130","title":"SCDT-51. INITIAL EXPERIENCE OF BLOOD-BRAIN BARRIER OPENING FOR CHEMOTHERAPEUTIC-DRUG DELIVERY TO BRAIN TUMOURS BY MR-GUIDED FOCUSED ULTRASOUND","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Ultrasound and Hyperthermia Applications","field":"Engineering","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Scottish Cot Death Trust","keywords":"Medicine; Microbubbles; Blood–brain barrier; Extravasation; Magnetic resonance imaging; Glioma; Focused ultrasound; Drug delivery; Ultrasound; Radiology; Pathology; Internal medicine; Central nervous system; Cancer research","score_opus":0.027136394705324644,"score_gpt":0.3085902262507642,"score_spread":0.28145383154543957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237365222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914608,0.00008892723,0.0020712167,0.002276461,0.00038150448,0.0007910849,0.00014043268,0.00014777218,0.0026418057],"genre_scores_gemma":[0.99298257,0.000027399183,0.0029217957,0.0031309014,0.00022174275,0.000429671,0.00001973601,0.00008938583,0.0001768076],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998465,0.000057768484,0.00041980948,0.00040346986,0.00015175791,0.00050219096],"domain_scores_gemma":[0.99748474,0.0014092928,0.0001441044,0.00065232615,0.000093716546,0.00021580514],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024285004,0.00024189973,0.00043176627,0.000075702934,0.0003823206,0.00011872156,0.00076838763,0.00016414726,0.0001486203],"category_scores_gemma":[0.00056903024,0.00027654832,0.00011835666,0.000095180614,0.00020623552,0.0002161864,0.00006774138,0.00021563201,0.000020589305],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003506201,0.000069803355,0.0007025545,0.000022210083,0.000044312597,0.000004089766,0.0024573193,0.00011173547,0.97349364,0.00009759358,0.017656635,0.005305038],"study_design_scores_gemma":[0.0021933594,0.00029526048,0.00054411974,0.000021656992,0.00007740334,0.000065226486,0.0003945534,0.0005585321,0.7097881,0.00020788086,0.28544834,0.00040558522],"about_ca_topic_score_codex":0.00017034092,"about_ca_topic_score_gemma":0.0002692111,"teacher_disagreement_score":0.26779172,"about_ca_system_score_codex":0.00006153201,"about_ca_system_score_gemma":0.00011408621,"threshold_uncertainty_score":0.99996865},"labels":[],"label_agreement":null},{"id":"W4237835182","doi":"10.1093/neuonc/now212.640","title":"PDTB-21. CD271 (p75NTR) AS A NOVEL DIAGNOSTIC MARKER AND THERAPEUTIC TARGET FOR SHH MEDULLOBLASTOMA","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; Hospital for Sick Children; SickKids Foundation; University of Manitoba","funders":"","keywords":"Medulloblastoma; Cancer research; Gene knockdown; Flow cytometry; Immunohistochemistry; Low-affinity nerve growth factor receptor; Wnt signaling pathway; Progenitor cell; Biology; Sonic hedgehog; Phenotype; Stem cell; Cell culture; Molecular biology; Cell biology; Immunology; Signal transduction; Gene; Receptor; Genetics; Neurotrophin","score_opus":0.011433614078062175,"score_gpt":0.26667647280408446,"score_spread":0.2552428587260223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237835182","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9646334,0.0012582735,0.012263386,0.015450278,0.0013009337,0.0014277922,0.0001226678,0.000068036315,0.0034752046],"genre_scores_gemma":[0.99099284,0.0003576359,0.0014833254,0.005379829,0.000485154,0.00030679884,0.00003276376,0.00004944937,0.00091219874],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986804,0.00010855815,0.000253746,0.0004973295,0.00010417963,0.0003557943],"domain_scores_gemma":[0.99887514,0.0004708981,0.00011971809,0.00028948,0.000093259914,0.00015150872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020212708,0.00020617327,0.00022221074,0.000056127035,0.00009522197,0.000017422579,0.00017889812,0.00028481256,0.000114074894],"category_scores_gemma":[0.0012826741,0.00015206407,0.000091806665,0.00005860621,0.00019252849,0.0000064755463,0.00012249233,0.00008531128,0.000039261362],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003175615,0.000112673115,0.000867826,0.000011207527,0.000039204322,0.0000063591765,0.000019313482,7.8483976e-7,0.95454526,0.0005910703,0.008317906,0.03517081],"study_design_scores_gemma":[0.0017817667,0.0018604161,0.0006951948,0.000009112674,0.000020707535,0.000088803165,0.000014564857,0.000025743268,0.34580973,0.00050727435,0.64902157,0.00016513973],"about_ca_topic_score_codex":0.0000047800095,"about_ca_topic_score_gemma":0.000016834138,"teacher_disagreement_score":0.6407036,"about_ca_system_score_codex":0.00003213734,"about_ca_system_score_gemma":0.0001787253,"threshold_uncertainty_score":0.62009925},"labels":[],"label_agreement":null},{"id":"W4237937188","doi":"10.1093/neuonc/5.1.23","title":"Tenth International Symposium on Pediatric Neuro-Oncology","year":2003,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Pediatric oncology; Medicine; Medical physics; Internal medicine; Cancer","score_opus":0.020291391596054375,"score_gpt":0.30031013466099443,"score_spread":0.28001874306494007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237937188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84584403,0.0002037968,0.000012976789,0.030913984,0.0057858513,0.0008223327,0.000021526801,0.00015809515,0.11623743],"genre_scores_gemma":[0.9827819,0.00092404266,0.0003246544,0.01465312,0.0008977755,0.00020552851,0.000042740594,0.0000592437,0.00011100331],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99765927,0.0003268599,0.0004688081,0.0006684861,0.00036665445,0.00050989917],"domain_scores_gemma":[0.9978047,0.0010718291,0.0002181592,0.0004267997,0.00014997882,0.0003285058],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021084957,0.0003065993,0.00056741765,0.00029911095,0.000106420375,0.000020424699,0.00019506371,0.00029870574,0.00075426226],"category_scores_gemma":[0.00063938415,0.00025846425,0.00020880505,0.00030071646,0.00008949403,0.000061799205,0.000074849115,0.0004845589,0.00071124954],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014839451,0.016728174,0.33931053,0.00007847211,0.0004779845,0.016542803,0.00077493535,0.00025470427,0.41160595,0.011390292,0.16139229,0.03995992],"study_design_scores_gemma":[0.0076688235,0.007098398,0.009926094,0.000008165629,0.00037278316,0.0013292243,0.000077618184,0.00007330818,0.020427926,0.00010474949,0.95269585,0.00021704889],"about_ca_topic_score_codex":0.000012300703,"about_ca_topic_score_gemma":0.0000133875255,"teacher_disagreement_score":0.7913036,"about_ca_system_score_codex":0.0005759827,"about_ca_system_score_gemma":0.00037652295,"threshold_uncertainty_score":0.99998677},"labels":[],"label_agreement":null},{"id":"W4239674161","doi":"10.1093/neuonc/noq116.s8","title":"-Omics and Prognostic Markers","year":2010,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Nutrition, Genetics, and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Computational biology; Omics; Biology; Medicine; Data science; Computer science; Bioinformatics","score_opus":0.0072056197055349646,"score_gpt":0.2531591448037866,"score_spread":0.24595352509825164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239674161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947245,0.00031664362,0.00006838232,0.0007591822,0.0007000586,0.0002207593,0.000025379975,0.000018208802,0.003166869],"genre_scores_gemma":[0.9956279,0.00047958276,0.0011978032,0.001954756,0.00053114706,0.000034720182,0.00007578624,0.000023763832,0.0000745588],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99916184,0.000064747175,0.00014618058,0.00034133287,0.000060552444,0.00022533888],"domain_scores_gemma":[0.9993853,0.000049867722,0.000053062842,0.0002545604,0.00006489576,0.0001923202],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009797864,0.00012305033,0.00012163127,0.00003529924,0.00007263781,0.00001758716,0.00011928469,0.00022499508,0.000034900604],"category_scores_gemma":[0.00032842654,0.00012821889,0.000047841982,0.000037920076,0.0002047517,0.000002206337,0.00009940041,0.000153168,0.000012311721],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018429186,0.00012223772,0.018219246,0.000015285303,0.000011889612,0.000020023519,0.000017071261,0.0000011230072,0.9669837,0.00010449384,0.006758707,0.007561952],"study_design_scores_gemma":[0.0019070193,0.0013684145,0.020076457,0.0000026957396,0.000060613755,0.00021790076,0.0000684143,0.000060737937,0.1439677,0.0006585417,0.8313342,0.00027734388],"about_ca_topic_score_codex":0.000004204275,"about_ca_topic_score_gemma":0.00005375342,"teacher_disagreement_score":0.8245754,"about_ca_system_score_codex":0.000006212173,"about_ca_system_score_gemma":0.00015244815,"threshold_uncertainty_score":0.5228615},"labels":[],"label_agreement":null},{"id":"W4239860724","doi":"10.1093/neuonc/nox168.1042","title":"TMOD-03. GENES PRESERVING STEM CELL STATE IN GROUP 3 MB BTICS CONTRIBUTE TO THERAPY EVASION AND RELAPSE","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Biology; Stem cell; Population; Downregulation and upregulation; Medulloblastoma; Gene; Cancer research; Oncology; Internal medicine; Medicine; Genetics","score_opus":0.02712140931057723,"score_gpt":0.32212241250258006,"score_spread":0.29500100319200284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239860724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954863,0.0022921013,0.00009077154,0.0006994101,0.00020696789,0.0005198794,0.000046696743,0.000008116075,0.00064971147],"genre_scores_gemma":[0.99044704,0.008444997,0.00014662807,0.0004525166,0.000107438565,0.000090857175,0.000027535409,0.000025021858,0.00025795712],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987064,0.0001631609,0.00017671472,0.000437435,0.00012183852,0.00039442178],"domain_scores_gemma":[0.99905735,0.000051822997,0.00009781155,0.0005400412,0.00006324897,0.00018971025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020690743,0.00015335824,0.00021373607,0.000051907653,0.0001713763,0.00006293545,0.00030701293,0.00013909678,0.0000082515035],"category_scores_gemma":[0.000065377324,0.00013740572,0.00004169112,0.000036788442,0.00007747083,0.000010318786,0.00042889445,0.00013759802,0.000011770811],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009713725,0.00016831083,0.023112666,0.000015798978,0.00002678059,0.00015637088,0.00010973092,0.00003079865,0.917502,0.000005416471,0.0012783158,0.056622464],"study_design_scores_gemma":[0.0067997943,0.0048660603,0.020363659,0.00001751367,0.000012260329,0.000035407927,0.000042207455,0.0001404668,0.5814676,0.00017456082,0.38582516,0.00025527805],"about_ca_topic_score_codex":0.0004886654,"about_ca_topic_score_gemma":0.0023139212,"teacher_disagreement_score":0.38454685,"about_ca_system_score_codex":0.00006314921,"about_ca_system_score_gemma":0.00011409264,"threshold_uncertainty_score":0.56032425},"labels":[],"label_agreement":null},{"id":"W4240082975","doi":"10.1093/neuonc/noy148.977","title":"RBTT-08. EORTC 1709/CCTG CE.8: A PHASE III TRIAL OF MARIZOMIB IN COMBINATION WITH STANDARD TEMOZOLOMIDE-BASED RADIOCHEMOTHERAPY VERSUS STANDARD TEMOZOLOMIDE-BASED RADIOCHEMOTHERAPY ALONE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Temozolomide; Medicine; Oncology; Dacarbazine; Internal medicine; Radiation therapy; Population; Chemotherapy; Quality of life (healthcare); Phases of clinical research; Randomized controlled trial; Clinical trial","score_opus":0.011390608306242824,"score_gpt":0.28608055039673225,"score_spread":0.2746899420904894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240082975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904502,0.00009527503,0.00043742615,0.002238601,0.00059101905,0.0056935926,0.0001549447,0.00011091068,0.00022801135],"genre_scores_gemma":[0.9954353,0.000061198654,0.0021005007,0.0012921698,0.0001768921,0.0005546913,0.00021693595,0.0001572378,0.000005048559],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9950507,0.000591028,0.0012744587,0.0010997157,0.001093564,0.0008905226],"domain_scores_gemma":[0.9959255,0.0013337408,0.0008666729,0.00091214327,0.0005957785,0.00036616967],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006880939,0.00075231417,0.0021247577,0.0011046927,0.00012381804,0.00003903361,0.00029395922,0.0004681017,0.00025272355],"category_scores_gemma":[0.0003043041,0.00060589693,0.00021802587,0.0013185167,0.0007229343,0.00016413679,0.000032526685,0.00051411946,0.000007861019],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8688376,0.014637621,0.06785342,0.00007012128,0.00032282204,0.0008208403,0.00057178765,0.00012961583,0.009899014,0.000032561737,0.0012139817,0.035610635],"study_design_scores_gemma":[0.67569214,0.1904742,0.0075799595,0.00021991805,0.00022540908,0.000010490625,0.00008493753,0.0003601859,0.121331714,0.000019796855,0.0035926027,0.00040866534],"about_ca_topic_score_codex":0.0002423119,"about_ca_topic_score_gemma":0.0013762744,"teacher_disagreement_score":0.19314547,"about_ca_system_score_codex":0.002095678,"about_ca_system_score_gemma":0.0019545865,"threshold_uncertainty_score":0.9996392},"labels":[],"label_agreement":null},{"id":"W4240141338","doi":"10.1093/neuonc/nox036.229","title":"P08.40 The prognostic and predictive value of an explant assay of gliomas in response to temozolomide","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Temozolomide; Glioma; Explant culture; Cancer research; Medicine; Apoptosis; Methylation; In vivo; Pathological; Pathology; Oncology; Biology; In vitro","score_opus":0.02449150331396757,"score_gpt":0.3203009703170735,"score_spread":0.29580946700310595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240141338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921383,0.00009033493,0.000004596062,0.0060319,0.00015151034,0.0009872864,0.00003130118,0.000009595924,0.00055517326],"genre_scores_gemma":[0.9992412,0.000030258272,0.00019765155,0.00031721598,0.00004033929,0.0001496679,0.0000043857067,0.000013938434,0.0000053574295],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985324,0.0005211643,0.0003051985,0.00027229165,0.0001693636,0.00019954755],"domain_scores_gemma":[0.9971933,0.0018200374,0.00022350176,0.00055271643,0.000079329315,0.00013110948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007553174,0.00012643168,0.00044176012,0.00017197416,0.00007641207,0.000008914462,0.00016653747,0.000106089385,0.000010755256],"category_scores_gemma":[0.002876733,0.00008170107,0.000044592285,0.0000907822,0.00023005708,0.00005549221,0.00012685407,0.00013611051,0.0000041768094],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009931041,0.0014514283,0.33089453,0.000037716163,0.00008041867,0.0015156888,0.002060593,0.00003915479,0.6426491,0.0001691915,0.00031215508,0.010858954],"study_design_scores_gemma":[0.0033732546,0.00851574,0.8942682,0.00008099005,0.00014801328,0.0002563977,0.00029592044,0.0003349076,0.09065022,0.00009845137,0.0019188271,0.000059036436],"about_ca_topic_score_codex":0.00013593983,"about_ca_topic_score_gemma":0.00014026991,"teacher_disagreement_score":0.56337374,"about_ca_system_score_codex":0.00006784356,"about_ca_system_score_gemma":0.00017166334,"threshold_uncertainty_score":0.3443926},"labels":[],"label_agreement":null},{"id":"W4240277013","doi":"10.1093/neuonc/now212.887","title":"TMOD-17. CONVERGENCE OF BMI1 AND CHD7 ON ERK SIGNALLING IN MEDULLOBLASTOMA","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"BMI1; Medulloblastoma; Biology; Cancer research; Polycomb-group proteins; Wnt signaling pathway; Gene knockdown; Cell biology; Stem cell; Signal transduction; Genetics; Repressor; Transcription factor; Cell culture","score_opus":0.01459587306335238,"score_gpt":0.277045863754923,"score_spread":0.26244999069157066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240277013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964032,0.00040288825,0.00090864237,0.0004913491,0.00019250961,0.000126088,0.000007519904,0.000004970256,0.0014628231],"genre_scores_gemma":[0.9983007,0.0009849885,0.00026901584,0.00025840502,0.00008758765,0.000012128179,0.0000044151434,0.000013381873,0.00006938419],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990589,0.000121919074,0.0002429709,0.0003087876,0.00008582438,0.00018157385],"domain_scores_gemma":[0.9994573,0.00014374634,0.00011261769,0.00017106619,0.00005099502,0.00006429306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020462612,0.000108427506,0.0001746069,0.000060154835,0.000021991349,0.0000029215903,0.00010378197,0.00018498505,0.0000325468],"category_scores_gemma":[0.00019903066,0.00008590432,0.00003594435,0.00006286652,0.0001112641,0.0000025553074,0.00007000579,0.0000683321,0.0000057807956],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001473917,0.00005878924,0.009412503,0.0000070683504,0.000007189367,0.0000073801148,0.00003513009,0.000062082654,0.9753523,0.00014839046,0.000102355,0.014659456],"study_design_scores_gemma":[0.00087030826,0.0016990713,0.005788221,0.000016672773,0.000006437715,0.000004277821,0.000013639629,0.00006708137,0.9569452,0.00034378277,0.034139287,0.00010603903],"about_ca_topic_score_codex":0.000009335564,"about_ca_topic_score_gemma":0.00006212441,"teacher_disagreement_score":0.03403693,"about_ca_system_score_codex":0.00001821638,"about_ca_system_score_gemma":0.00007622712,"threshold_uncertainty_score":0.35030764},"labels":[],"label_agreement":null},{"id":"W4240779700","doi":"10.1215/s152285170100031x","title":"Immunotherapy Task Force For Malignant Brain Tumors April 21, 2001, Toronto, Ontario","year":2001,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Task force; Immunotherapy; Task (project management); Conjunction (astronomy); Medicine; Internal medicine; Management; Political science; Cancer","score_opus":0.025623962175538063,"score_gpt":0.3056082259843714,"score_spread":0.2799842638088333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240779700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9381971,0.002463384,0.0023885758,0.025113737,0.0016296199,0.0036280649,0.00007749405,0.00021559035,0.026286442],"genre_scores_gemma":[0.86373544,0.001606335,0.018441208,0.07699695,0.0015946255,0.001382732,0.00046733723,0.00030263542,0.035472732],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979264,0.00017773012,0.00045837022,0.00052736764,0.00020578915,0.0007043105],"domain_scores_gemma":[0.99834234,0.00063003146,0.00017168626,0.0005159739,0.00008771654,0.00025224124],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004656244,0.00030566176,0.0006964651,0.000058014914,0.00015984353,0.000016855995,0.00015392328,0.00018387442,0.002504253],"category_scores_gemma":[0.00013268576,0.00024773797,0.00029269553,0.000085744236,0.000095990166,0.000087485685,0.000043419885,0.00024336283,0.000060649138],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0094121415,0.0037707675,0.020686336,0.00010525609,0.000918479,0.0046882182,0.0032991832,0.000037049405,0.4192603,0.003335328,0.23943563,0.2950513],"study_design_scores_gemma":[0.008762201,0.0075422833,0.0062661497,0.000025052464,0.00015411354,0.001531716,0.00020133419,0.000095932475,0.0027341933,0.00038450726,0.9720879,0.00021457316],"about_ca_topic_score_codex":0.011701053,"about_ca_topic_score_gemma":0.051180705,"teacher_disagreement_score":0.7326523,"about_ca_system_score_codex":0.001271917,"about_ca_system_score_gemma":0.00066251296,"threshold_uncertainty_score":0.9999975},"labels":[],"label_agreement":null},{"id":"W4240905434","doi":"10.1215/s1522851799000541","title":"Myeloablative chemotherapy for recurrent aggressive oligodendroglioma","year":2000,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Western University","funders":"York University; Memorial Sloan-Kettering Cancer Center; Massachusetts General Hospital","keywords":"Oligodendroglioma; Chemotherapy; Medicine; Oncology; Internal medicine; Glioma; Cancer research; Astrocytoma","score_opus":0.023512595755182723,"score_gpt":0.3268441634979715,"score_spread":0.3033315677427888,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240905434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97081923,0.00097600877,0.000017312494,0.012860994,0.00045657542,0.0014819558,0.000041526615,0.000098742225,0.013247645],"genre_scores_gemma":[0.9886987,0.0013887503,0.0013112725,0.0068092407,0.00055888266,0.0008401858,0.000070960996,0.00006592165,0.00025607416],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987012,0.0000713788,0.0002753991,0.0004201575,0.00015296473,0.000378881],"domain_scores_gemma":[0.9988443,0.00042720934,0.00016124375,0.00027147567,0.000103980965,0.00019174343],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0000765685,0.00021592407,0.00048659346,0.00011460618,0.000094201256,0.00001099301,0.000087709595,0.00016397769,0.0014216845],"category_scores_gemma":[0.00009789717,0.0001742149,0.00019567194,0.00018241414,0.000092878116,0.000043299526,0.000015220266,0.00015088671,0.00018770726],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022901392,0.0018764641,0.0016498072,0.000029915253,0.00023296975,0.00094318454,0.00077623414,0.000009237335,0.040835362,0.00032876656,0.027761571,0.92326635],"study_design_scores_gemma":[0.01287536,0.0093672965,0.004722126,0.00006578631,0.00023433262,0.00063023134,0.00006678984,0.0003361905,0.12551747,0.0004536804,0.8455215,0.00020923106],"about_ca_topic_score_codex":0.00000779844,"about_ca_topic_score_gemma":0.00001297578,"teacher_disagreement_score":0.92305714,"about_ca_system_score_codex":0.00021867645,"about_ca_system_score_gemma":0.00014718507,"threshold_uncertainty_score":0.99949116},"labels":[],"label_agreement":null},{"id":"W4240962932","doi":"10.1093/neuonc/nox036.076","title":"OS11.5 ACT IV: An international, double-blind, phase 3 trial of rindopepimut in newly diagnosed, EGFRvIII-expressing glioblastoma","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Temozolomide; Interim analysis; Hazard ratio; Internal medicine; Oncology; Cohort; Clinical endpoint; Confidence interval; Randomized controlled trial; Chemotherapy","score_opus":0.0690954306968465,"score_gpt":0.4028926386686069,"score_spread":0.33379720797176043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240962932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98671955,0.000056673776,0.0000050691565,0.0028746556,0.0017919224,0.0013287951,0.000020187223,0.000039885083,0.007163269],"genre_scores_gemma":[0.9982037,0.00018680033,0.00020795916,0.00040105358,0.0006327012,0.00027532698,0.00003374898,0.00004053693,0.000018157623],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9979144,0.00015602699,0.00064282323,0.00054963265,0.00035858556,0.00037853656],"domain_scores_gemma":[0.99763525,0.0004270755,0.000590024,0.00095073204,0.00014442537,0.00025250678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031576087,0.00026430128,0.0007497772,0.00038757108,0.00015243154,0.0000819995,0.0004953648,0.00024962283,0.00021159874],"category_scores_gemma":[0.000542087,0.00023236951,0.00018135754,0.00010583729,0.00020512188,0.00042020585,0.00019677682,0.0003412491,0.000039456387],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.46411246,0.026427109,0.070267364,0.00004853947,0.00028903867,0.008534227,0.0009347453,0.00008462077,0.24766326,0.00042247245,0.0012899289,0.17992623],"study_design_scores_gemma":[0.8263351,0.015710698,0.0163005,0.00012773494,0.00022383657,0.00017809038,0.000109163455,0.000354338,0.0941981,0.000054894357,0.046166737,0.00024085146],"about_ca_topic_score_codex":0.00035779222,"about_ca_topic_score_gemma":0.0005959959,"teacher_disagreement_score":0.36222258,"about_ca_system_score_codex":0.00021938593,"about_ca_system_score_gemma":0.00030545157,"threshold_uncertainty_score":0.94757533},"labels":[],"label_agreement":null},{"id":"W4241427629","doi":"10.1093/neuonc/nov061.132","title":"PM-10 * GENETICALLY ENGINEERED MOUSE MODELS OF CHOROID PLEXUS TUMORS","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Mathematical Biology Tumor Growth","field":"Mathematics","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Choroid plexus; Genetically engineered; Genetically modified organism; Biology; Computational biology; Genetics; Neuroscience; Gene","score_opus":0.0719459831229457,"score_gpt":0.312822113114756,"score_spread":0.2408761299918103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241427629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9217924,0.00008492103,0.010976954,0.00096444396,0.0003519318,0.0008754022,0.000052628475,0.00036083724,0.06454051],"genre_scores_gemma":[0.9481169,0.000013493134,0.050252616,0.0005239617,0.00019400788,0.0000978098,0.000012737567,0.00010148286,0.0006870111],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99736285,0.0003575768,0.00089801464,0.0004552092,0.000355171,0.00057119405],"domain_scores_gemma":[0.9965404,0.0017431816,0.00029670718,0.00073096115,0.00027927474,0.00040947276],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007002112,0.00032297877,0.000943741,0.0001552836,0.00003350401,0.000009970393,0.000582802,0.00035167468,0.0003303907],"category_scores_gemma":[0.0033787661,0.00027985917,0.0001469713,0.00021304395,0.000325702,0.00007711014,0.00026563634,0.0004106915,0.00019250045],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046285262,0.0017338315,0.000111375666,0.00035528294,0.00013446,0.00032279227,0.0018329337,0.0004998284,0.43388948,0.5175975,0.04153377,0.0015259143],"study_design_scores_gemma":[0.004143388,0.0040384308,0.000037548405,0.00003650393,0.00019909994,0.00057379395,0.00028331048,0.02823569,0.16512907,0.78259546,0.013975476,0.00075226126],"about_ca_topic_score_codex":0.0000065234485,"about_ca_topic_score_gemma":0.0000059999024,"teacher_disagreement_score":0.2687604,"about_ca_system_score_codex":0.00013577357,"about_ca_system_score_gemma":0.000329432,"threshold_uncertainty_score":0.99996537},"labels":[],"label_agreement":null},{"id":"W4242213985","doi":"10.1093/neuonc/noy059.223","title":"EPEN-23. MOLECULAR HETEROGENEITY AMONG PEDIATRIC POSTERIOR FOSSA EPENDYMOMA","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Vascular Malformations and Hemangiomas","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Ependymoma; Histogenesis; Biology; Genetic heterogeneity; Oncology; Gene; Pathology; Genetics; Bioinformatics; Internal medicine; Immunohistochemistry; Medicine; Immunology; Phenotype","score_opus":0.018585694410918754,"score_gpt":0.29883193160052446,"score_spread":0.28024623718960573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242213985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98753643,0.00023365955,0.00040114904,0.0012909742,0.00058008294,0.000557883,0.000007779202,0.00012736584,0.009264688],"genre_scores_gemma":[0.9951526,0.000026740163,0.0011528984,0.0027144742,0.0007490189,0.0000497545,0.000032428008,0.00004322986,0.00007887344],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9983232,0.00014115234,0.00041520564,0.00039097908,0.0002706238,0.00045883225],"domain_scores_gemma":[0.9987187,0.00005570629,0.00015903855,0.0005819751,0.00021421986,0.00027037546],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00024431766,0.00021633833,0.00044322055,0.0002541997,0.00016494204,0.000025010362,0.0001819039,0.00026270997,0.0003524862],"category_scores_gemma":[0.00015385446,0.00019803195,0.00025432382,0.0003275985,0.00017287991,0.00013951448,0.00017692396,0.00026249822,0.0009082871],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008734288,0.0016442316,0.19431101,0.00040645024,0.00044297488,0.01135777,0.0017281735,0.000009590892,0.7206626,0.0010567872,0.015046619,0.05246038],"study_design_scores_gemma":[0.010650828,0.011893764,0.5355332,0.000041524247,0.0015396568,0.013613599,0.00021246263,0.0010812442,0.21230176,0.00026422655,0.21186775,0.0009999741],"about_ca_topic_score_codex":0.00002425904,"about_ca_topic_score_gemma":0.000068035384,"teacher_disagreement_score":0.5083608,"about_ca_system_score_codex":0.00011165835,"about_ca_system_score_gemma":0.00020080601,"threshold_uncertainty_score":0.99986964},"labels":[],"label_agreement":null},{"id":"W4242737299","doi":"10.1093/neuonc/noy059.495","title":"MBRS-50. PEROXIREDOXIN1 IS A THERAPEUTIC TARGET IN GROUP-3 MEDULLOBLASTOMA","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"bioluminescence and chemiluminescence research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; Hospital for Sick Children; University of Toronto; University of Manitoba; Research Institute in Oncology and Hematology","funders":"","keywords":"Gene knockdown; Cancer research; Apoptosis; Gene silencing; DNA damage; Biology; RNA interference; Sensitization; Immunology; Gene; DNA; RNA; Biochemistry","score_opus":0.018185790717808764,"score_gpt":0.30778094548731333,"score_spread":0.2895951547695046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242737299","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891127,0.0007478354,0.00021881747,0.003068685,0.00043646526,0.00035727702,0.000014038897,0.00003309182,0.006011142],"genre_scores_gemma":[0.99253523,0.00044567927,0.00043313965,0.005270142,0.00086950813,0.00008178198,0.000045746056,0.00004300653,0.00027578566],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977694,0.00018509224,0.00033447874,0.0007305709,0.00023432156,0.0007461473],"domain_scores_gemma":[0.9990093,0.00004824814,0.000090455316,0.00053158385,0.00014185929,0.0001785356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003081334,0.00026136695,0.00030508926,0.000115693045,0.00010448542,0.000023747389,0.00053972186,0.000490475,0.00028341814],"category_scores_gemma":[0.00011934218,0.00024341467,0.00011738434,0.00030845057,0.00059005583,0.000012110898,0.00025425456,0.00031807885,0.0001850454],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002991012,0.00025406491,0.009295673,0.000016120224,0.000021143835,0.000035421224,0.0001730703,1.852723e-7,0.97116804,0.000039678704,0.007338231,0.011359263],"study_design_scores_gemma":[0.00076469046,0.0019421488,0.0014196045,0.000009572041,0.000007180063,0.00009069501,0.00016856693,0.00007049995,0.59326786,0.000086548105,0.40196255,0.00021007904],"about_ca_topic_score_codex":0.000054274464,"about_ca_topic_score_gemma":0.00021878691,"teacher_disagreement_score":0.39462432,"about_ca_system_score_codex":0.00007015825,"about_ca_system_score_gemma":0.00026313085,"threshold_uncertainty_score":0.99261624},"labels":[],"label_agreement":null},{"id":"W4243036438","doi":"10.1093/neuonc/noaa222.500","title":"MBCL-24. CAN YOUNG CHILDREN WITH RELAPSED MEDULLOBLASTOMA BE SALVAGED AFTER INITIAL IRRADIATION-SPARING APPROACHES?","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Izaak Walton Killam Health Centre; Stollery Children's Hospital; Alberta Children's Hospital; University of Calgary; University of British Columbia; University of Alberta; BC Children's Hospital; Université Laval; Hospital for Sick Children; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; Dalhousie University","funders":"","keywords":"Medulloblastoma; Medicine; Radiation therapy; Chemotherapy; Neurocognitive; Retrospective cohort study; Young adult; Salvage therapy; Surgery; Oncology; Internal medicine; Pathology","score_opus":0.037378132802897916,"score_gpt":0.26372608050898283,"score_spread":0.2263479477060849,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243036438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97073257,0.00012484861,0.000020311752,0.0251063,0.00026598934,0.000925956,0.000030952517,0.00015494712,0.0026381556],"genre_scores_gemma":[0.9888421,0.000022829652,0.0006024318,0.009398199,0.0005519576,0.00038902945,0.00011700096,0.00006843269,0.000007961306],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99814683,0.00017174373,0.00033821192,0.00060073484,0.000315097,0.00042740803],"domain_scores_gemma":[0.9988903,0.00016671645,0.00015962558,0.0003048344,0.00005227801,0.00042624652],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000861752,0.00029451752,0.000555771,0.00011756026,0.00010591766,0.000028873612,0.00011872359,0.00019963132,0.0001584657],"category_scores_gemma":[0.00014761816,0.00023770967,0.00011196115,0.00030359256,0.00011280111,0.00007563392,0.00007722322,0.00046537234,0.000050344046],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002576722,0.0015616753,0.95060784,0.000059430655,0.0007740301,0.0033640063,0.0048332107,0.00013400879,0.015752507,0.00019922701,0.0057436186,0.014393744],"study_design_scores_gemma":[0.01798323,0.008685436,0.9364061,0.000050500406,0.0010680463,0.0013110178,0.0003456671,0.0006144465,0.01838432,0.0000130413055,0.014643333,0.00049491384],"about_ca_topic_score_codex":0.00008514364,"about_ca_topic_score_gemma":0.00040906278,"teacher_disagreement_score":0.018109618,"about_ca_system_score_codex":0.00022121223,"about_ca_system_score_gemma":0.0002737248,"threshold_uncertainty_score":0.9693519},"labels":[],"label_agreement":null},{"id":"W4243210036","doi":"10.1093/neuonc/nox083.123","title":"IMMU-13. LARGE SCALE TUMOR MUTATIONAL BURDEN ANALYSIS OF PEDIATRIC TUMORS PROVIDES A DIAGNOSTIC TOOL FOR GERMLINE PREDISPOSITION AND REVEALS NOVEL CANDIDATES FOR IMMUNE CHECKPOINT INHIBITION","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer therapeutics and mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"Somatic hypermutation; Germline; Germline mutation; Mutation; Exome sequencing; Cancer research; Cancer; DNA mismatch repair; Biology; Deep sequencing; Genetics; Medicine; Gene; DNA repair; Genome; Antibody","score_opus":0.011569161597073947,"score_gpt":0.2890082230358321,"score_spread":0.2774390614387582,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243210036","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9814288,0.00034381397,0.015119841,0.00051914353,0.00016428097,0.0009973656,0.0014041074,0.000007344553,0.000015312413],"genre_scores_gemma":[0.9957599,0.00019617222,0.0017249441,0.00022110852,0.00046222712,0.0005586824,0.0010202925,0.000023995153,0.000032687563],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99884856,0.000031959888,0.00041109658,0.00037831638,0.00008841843,0.00024164683],"domain_scores_gemma":[0.99873203,0.00020027446,0.0005080567,0.00027800546,0.00022688968,0.000054727687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035120596,0.00015124599,0.00035625056,0.00011872384,0.0002190508,0.000033965847,0.00012276924,0.000123802,0.0000069412536],"category_scores_gemma":[0.00052665645,0.00015136965,0.0001935335,0.00007109908,0.000073439674,0.00001284799,0.00009692202,0.00005758509,2.912226e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005307688,0.00015770354,0.0013069552,0.00009821866,0.00018347322,0.0000026347943,0.000108187975,0.00009890235,0.99617517,0.00015439597,0.000050064536,0.0011335342],"study_design_scores_gemma":[0.0065515772,0.003767289,0.03708554,0.000029724462,0.0024016516,0.00004869168,0.00011570691,0.008205936,0.9356648,0.0010899913,0.0046350854,0.00040404877],"about_ca_topic_score_codex":0.000047501104,"about_ca_topic_score_gemma":0.00016053213,"teacher_disagreement_score":0.060510404,"about_ca_system_score_codex":0.00003405182,"about_ca_system_score_gemma":0.00015922835,"threshold_uncertainty_score":0.6172675},"labels":[],"label_agreement":null},{"id":"W4243655222","doi":"10.1093/neuonc/noz175.800","title":"PDTM-24. PINEOBLASTOMA SEGREGATES INTO MOLECULAR SUBTYPES WITH DISTINCT CLINICOPATHOLOGIC FEATURES: REPORT FROM THE RARE BRAIN TUMOUR CONSORTIUM","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Social Innovation; Hospital for Sick Children","funders":"","keywords":"Drosha; Medulloblastoma; Germline; Oncology; Epigenetics; Brain tumor; Internal medicine; DNA methylation; Methylation; Medicine; Biology; Bioinformatics; Pathology; Genetics; Gene","score_opus":0.012099061686657244,"score_gpt":0.283983785275169,"score_spread":0.27188472358851173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243655222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9655842,0.00106896,0.000017294604,0.029034216,0.00063769764,0.0011191464,0.000027373502,0.00014063992,0.0023704455],"genre_scores_gemma":[0.9897551,0.000050163184,0.0007212518,0.008747031,0.00021811173,0.00015372859,0.0001761588,0.000056547447,0.0001219041],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99754757,0.00039356572,0.0005087023,0.00080484105,0.0003268197,0.0004185281],"domain_scores_gemma":[0.99628377,0.0020733543,0.00039097358,0.00089724106,0.00016156858,0.00019310594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030384294,0.00036521326,0.0007896424,0.00007526218,0.000114942,0.00003694163,0.00023534242,0.00025571464,0.00026382398],"category_scores_gemma":[0.001138756,0.00020466125,0.0001930752,0.0002396514,0.00026707246,0.000051855688,0.00014518548,0.0005540843,0.0002463718],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012406658,0.0009819545,0.6603725,0.000043807944,0.00024453003,0.050709363,0.0004999083,0.000019175694,0.25410825,0.0001926967,0.025434026,0.006153164],"study_design_scores_gemma":[0.010797718,0.010564172,0.7214972,0.00023244052,0.0009115261,0.012470255,0.00086511497,0.00006718291,0.09395676,0.0007978022,0.14727324,0.0005666042],"about_ca_topic_score_codex":0.00018283544,"about_ca_topic_score_gemma":0.00035068244,"teacher_disagreement_score":0.16015147,"about_ca_system_score_codex":0.00013050638,"about_ca_system_score_gemma":0.00036950625,"threshold_uncertainty_score":0.83458436},"labels":[],"label_agreement":null},{"id":"W4243908687","doi":"10.1093/neuonc/noy148.988","title":"RARE-11. EFFICACY AND SAFETY OF DABRAFENIB + TRAMETINIB IN PATIENTS WITH RECURRENT/REFRACTORY BRAF V600E–MUTATED LOW-GRADE GLIOMA (LGG)","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Dabrafenib; Medicine; Trametinib; Internal medicine; Adverse effect; Progression-free survival; Oncology; Clinical endpoint; Refractory (planetary science); Nausea; Melanoma; Glioma; MEK inhibitor; Gastroenterology; Surgery; Clinical trial; Cancer; Vemurafenib; Chemotherapy; Cancer research; Metastatic melanoma","score_opus":0.015409064341804737,"score_gpt":0.288089727165392,"score_spread":0.27268066282358727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243908687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969933,0.00013858991,0.000015376505,0.000858716,0.0003331072,0.001113548,0.00006547962,0.00004454919,0.0004373065],"genre_scores_gemma":[0.9982812,0.000057292593,0.0008068348,0.00053857424,0.00010586452,0.000024491994,0.00013240588,0.000042751777,0.000010575296],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99784344,0.00037835154,0.0005537139,0.0005347405,0.0002826418,0.00040709917],"domain_scores_gemma":[0.9981689,0.0007696017,0.00027759784,0.00039561265,0.00015392608,0.00023434852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023254238,0.00028148142,0.0007408123,0.00026306728,0.000061493214,0.000007744282,0.00010739975,0.00018497706,0.00018317398],"category_scores_gemma":[0.00034915635,0.00021092253,0.00006779826,0.00044086797,0.00046323065,0.000076330565,0.00006975915,0.0003011586,0.000018299468],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.048968516,0.029787447,0.54375595,0.0005543642,0.0006994616,0.0024928297,0.004308493,0.0000137334555,0.06088496,0.00028440278,0.003499315,0.30475053],"study_design_scores_gemma":[0.065714516,0.032990232,0.85146123,0.0002683327,0.0004322803,0.00020265495,0.00013500618,0.000051810075,0.011797344,0.000029941883,0.036575284,0.00034135478],"about_ca_topic_score_codex":0.000049514834,"about_ca_topic_score_gemma":0.00015223744,"teacher_disagreement_score":0.3077053,"about_ca_system_score_codex":0.00013623496,"about_ca_system_score_gemma":0.00025382548,"threshold_uncertainty_score":0.8601171},"labels":[],"label_agreement":null},{"id":"W4244695146","doi":"10.1093/neuonc/nox074","title":"Highlights from the Literature","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Vagus Nerve Stimulation Research","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.07111079299926222,"score_gpt":0.3750462248450668,"score_spread":0.30393543184580457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244695146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81348944,0.000105439125,0.000045037006,0.12314304,0.0027922045,0.00056728645,0.00009736389,0.00015342304,0.059606746],"genre_scores_gemma":[0.9916747,0.00006482796,0.00007845376,0.0068447175,0.00063888734,0.000026888923,0.0000043087853,0.000020958361,0.0006462476],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979662,0.0006017023,0.0001863049,0.00052759465,0.0003576892,0.00036053263],"domain_scores_gemma":[0.9958411,0.0025383965,0.00017335835,0.0012588487,0.000070467104,0.00011782758],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019389471,0.00013991231,0.0001818884,0.000046676603,0.0011409944,0.00039616873,0.0015288305,0.00016695354,0.00037796982],"category_scores_gemma":[0.0043233633,0.00008917842,0.00007737768,0.00012035459,0.00038100945,0.00025844635,0.00045891793,0.0005964092,0.0007894728],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007843581,0.00006346251,0.0014743361,0.0000026235184,0.0000028520656,0.0004973894,0.00054661435,0.000019245172,0.96423286,0.00735848,0.017696321,0.008027403],"study_design_scores_gemma":[0.0008672948,0.0002361047,0.021886604,0.000009534364,0.000008108007,0.00005052323,0.000010753355,0.00076852186,0.20358253,0.0031649584,0.76928484,0.000130218],"about_ca_topic_score_codex":0.00006248902,"about_ca_topic_score_gemma":0.0000648881,"teacher_disagreement_score":0.76065034,"about_ca_system_score_codex":0.000053581745,"about_ca_system_score_gemma":0.000121643185,"threshold_uncertainty_score":0.99998856},"labels":[],"label_agreement":null},{"id":"W4244728752","doi":"10.1093/neuonc/noaa215.238","title":"CTNI-72. PHASE 2 STUDY OF DIANHYDROGALACTITOL (VAL-083) IN PATIENTS WITH MGMT-UNMETHYLATED, BEVACIZUMAB-NAÏVE GLIOBLASTOMA IN THE RECURRENT AND ADJUVANT SETTING","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Delmar (Canada)","funders":"","keywords":"Temozolomide; Bevacizumab; Medicine; Internal medicine; Oncology; Adjuvant; Radiation therapy; Adjuvant therapy; Cancer; Chemotherapy","score_opus":0.016191380885355787,"score_gpt":0.2998533169003955,"score_spread":0.28366193601503975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244728752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945791,0.00015499596,8.749985e-7,0.0029346403,0.00010966516,0.002025311,0.000013851385,0.00002013336,0.00016144181],"genre_scores_gemma":[0.99893564,0.000039661285,0.000038956405,0.00074152515,0.000045238794,0.00015966654,0.000014182518,0.000024813018,3.052326e-7],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99789816,0.00044116462,0.0005008059,0.00047288742,0.0003444151,0.00034257295],"domain_scores_gemma":[0.99875885,0.0005285083,0.00023148903,0.00026406368,0.00006864585,0.00014845574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022113664,0.00023825381,0.0006334874,0.00021722414,0.00005069642,0.00001177037,0.00011772295,0.00009691563,0.000020548458],"category_scores_gemma":[0.00026080816,0.00015466729,0.000045154615,0.0005653807,0.00007302398,0.00007266868,0.00009387849,0.0004222084,0.0000068984805],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050131045,0.016422072,0.8730756,0.0000641526,0.000112053094,0.002142624,0.014912363,0.000035272882,0.0036520334,0.000006125832,0.0002864751,0.084278144],"study_design_scores_gemma":[0.11482465,0.12272357,0.7430282,0.00018769424,0.00058172835,0.000083662504,0.0069626565,0.0008664689,0.0062391777,0.000011079569,0.0041450253,0.00034603997],"about_ca_topic_score_codex":0.00008561941,"about_ca_topic_score_gemma":0.0004403866,"teacher_disagreement_score":0.13004734,"about_ca_system_score_codex":0.00012801231,"about_ca_system_score_gemma":0.00009420128,"threshold_uncertainty_score":0.6307149},"labels":[],"label_agreement":null},{"id":"W4244757840","doi":"10.1093/neuonc/noz036.192","title":"MEDU-34. PILOT STUDY OF A SURGERY AND CHEMOTHERAPY-ONLY APPROACH IN THE UPFRONT THERAPY OF CHILDREN WITH WNT-POSITIVE STANDARD RISK MEDULLOBLASTOMA","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Medulloblastoma; Radiation therapy; Oncology; Vincristine; Chemotherapy; Internal medicine; Surgery; Adjuvant therapy; Cyclophosphamide; Pathology","score_opus":0.01923915387060987,"score_gpt":0.269810175691131,"score_spread":0.25057102182052116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244757840","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958394,0.00043850185,0.0000031556538,0.00060441083,0.000050805113,0.0025304283,0.000028748544,0.000012891728,0.0004916544],"genre_scores_gemma":[0.99870193,0.00052623457,0.00008674883,0.0004928113,0.000030230325,0.00011992266,0.00001120173,0.000029398538,0.0000015382169],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99812025,0.0005089211,0.00038471867,0.00038329692,0.00036443502,0.00023840346],"domain_scores_gemma":[0.99828196,0.0008624948,0.00032295234,0.00036922304,0.00009778315,0.000065583336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004997705,0.00022282786,0.0008915138,0.00018544501,0.000034424407,0.000006553054,0.000111017784,0.00006709687,0.000028763745],"category_scores_gemma":[0.00003495341,0.00012537366,0.00006280935,0.00027510573,0.00015423277,0.000037577276,0.000028975155,0.00023600992,0.0000013744061],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005890666,0.011096182,0.95022434,0.000014971105,0.00052483904,0.000054176937,0.0038989668,0.000011511128,0.005653147,0.00002425987,0.00015584892,0.022451099],"study_design_scores_gemma":[0.013891966,0.05063355,0.9268721,0.000030312287,0.00014437849,0.00022913647,0.0020370847,0.00001330907,0.005902648,0.000009688683,0.00013707741,0.00009875849],"about_ca_topic_score_codex":0.00048569564,"about_ca_topic_score_gemma":0.00023257504,"teacher_disagreement_score":0.03953737,"about_ca_system_score_codex":0.0000810744,"about_ca_system_score_gemma":0.00023192058,"threshold_uncertainty_score":0.5112589},"labels":[],"label_agreement":null},{"id":"W4244793041","doi":"10.1093/neuonc/noy148.975","title":"RBTT-05. TUMOR TREATING FIELDS AND RADIOSURGERY FOR SUPRA- AND/OR INFRATENTORIAL BRAIN METASTASES (1–10) FROM NSCLC IN THE PHASE 3 METIS STUDY","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Radiosurgery; Clinical endpoint; Lung cancer; Adverse effect; Oncology; Internal medicine; Clinical trial; Radiology; Radiation therapy","score_opus":0.04607792567418675,"score_gpt":0.36039493658699506,"score_spread":0.31431701091280834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244793041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992275,0.00026807713,0.000012728058,0.0050614653,0.0006355212,0.0014628492,0.00008233609,0.000023515619,0.00017851582],"genre_scores_gemma":[0.99493676,0.000034036537,0.00030981822,0.003257202,0.0009390011,0.00044724133,0.000039393926,0.000020247244,0.00001630601],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983484,0.00044488697,0.00036350297,0.00041155162,0.00014901346,0.00028260698],"domain_scores_gemma":[0.99402875,0.0054092705,0.00012248619,0.00024815794,0.00006149723,0.00012985733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055299874,0.00020094223,0.0005850929,0.00013704774,0.0001324653,0.000039376857,0.00007418792,0.000086692395,0.00020665626],"category_scores_gemma":[0.0018608279,0.00012123037,0.00006819659,0.00016672729,0.00012338838,0.00006736014,0.000051278297,0.00013711189,0.00000423427],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024039814,0.025272055,0.21492042,0.000113129485,0.0015192796,0.013152637,0.02328523,0.0000023459465,0.12130481,0.0003291038,0.21721528,0.3588459],"study_design_scores_gemma":[0.17977948,0.14335567,0.07046497,0.00015935855,0.004004829,0.0015212261,0.013002815,0.0010411225,0.040033065,0.00064212445,0.54511034,0.0008849836],"about_ca_topic_score_codex":0.0004522797,"about_ca_topic_score_gemma":0.00093823683,"teacher_disagreement_score":0.3579609,"about_ca_system_score_codex":0.000050262977,"about_ca_system_score_gemma":0.00013387794,"threshold_uncertainty_score":0.4943631},"labels":[],"label_agreement":null},{"id":"W4244948088","doi":"10.1093/neuonc/noz036.184","title":"MEDU-25. GENES PRESERVING STEM CELL STATE IN GROUP 3 MB BTICs CONTRIBUTE TO THERAPY EVASION AND RELAPSE","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Population; Gene knockdown; Biology; Medulloblastoma; Cancer research; Stem cell; Small hairpin RNA; Internal medicine; Oncology; Gene; Medicine; Genetics","score_opus":0.02205771830723043,"score_gpt":0.285522454845309,"score_spread":0.2634647365380786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244948088","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99175406,0.0026278892,0.000011143565,0.003312725,0.00043270466,0.001296437,0.000012755301,0.000034671033,0.0005176339],"genre_scores_gemma":[0.9941421,0.0031595917,0.00018409267,0.0022211128,0.00005567051,0.000101798745,0.000012411089,0.000031507563,0.00009171583],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985833,0.00018734283,0.00029930362,0.00040085262,0.00017941743,0.00034978558],"domain_scores_gemma":[0.9987548,0.00055365975,0.00009167294,0.0003307527,0.00006536284,0.00020374531],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023949644,0.00017984734,0.0004722378,0.00015970544,0.000036136127,0.00001605346,0.000091341375,0.00013006784,0.000061355175],"category_scores_gemma":[0.000032361313,0.00014104112,0.00004979434,0.00016395324,0.000025162404,0.00005730082,0.0001216161,0.00018451651,0.00007086309],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007212775,0.0009626717,0.2672151,0.00006892878,0.000043879478,0.00080805545,0.0010161605,0.00008588576,0.67409605,0.000052200958,0.0016238266,0.05330593],"study_design_scores_gemma":[0.033028416,0.015307451,0.21273093,0.00018300547,0.00014764942,0.00021117569,0.00046079324,0.0011164042,0.2549833,0.00024023744,0.48113257,0.0004580882],"about_ca_topic_score_codex":0.00011272701,"about_ca_topic_score_gemma":0.0001759032,"teacher_disagreement_score":0.47950873,"about_ca_system_score_codex":0.0001615544,"about_ca_system_score_gemma":0.000071444694,"threshold_uncertainty_score":0.575149},"labels":[],"label_agreement":null},{"id":"W4245632703","doi":"10.1093/neuonc/noz175.054","title":"ACTR-11. SECOND INTERIM AND 1ST MOLECULAR ANALYSIS OF THE EORTC RANDOMIZED PHASE III INTERGROUP CATNON TRIAL ON CONCURRENT AND ADJUVANT TEMOZOLOMIDE IN ANAPLASTIC GLIOMA WITHOUT 1p/19q CODELETION","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Temozolomide; Medicine; Internal medicine; Glioma; Interim analysis; Isocitrate dehydrogenase; Hazard ratio; Oncology; IDH1; Randomized controlled trial; Confidence interval; Radiation therapy; Cancer research; Biology","score_opus":0.014905637133393239,"score_gpt":0.31729356504368544,"score_spread":0.30238792791029223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245632703","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958469,0.00043277928,0.000035471458,0.00065509893,0.00052730826,0.0022477764,0.000027179356,0.000013627194,0.00021386065],"genre_scores_gemma":[0.9992182,0.0000811785,0.0000137718525,0.00042044348,0.000027670698,0.00016828075,0.000042227268,0.000019375188,0.000008845864],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9977687,0.00060585636,0.0006953714,0.00048776984,0.00020296471,0.00023936556],"domain_scores_gemma":[0.99805754,0.0010305358,0.0003993009,0.0003270816,0.00006127775,0.00012424367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043172904,0.00025947328,0.0016957648,0.0005272759,0.00003220483,0.000012897,0.00008880014,0.00015557233,0.00014769736],"category_scores_gemma":[0.00031065816,0.00016834715,0.00026790716,0.00039554026,0.00026758647,0.000044010172,0.00010040137,0.00023864792,0.0000030384647],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5401667,0.0033537133,0.022381235,0.000097696466,0.0020770852,0.00048939703,0.0011235263,0.000084527084,0.42047787,0.00048246112,0.00015708448,0.009108719],"study_design_scores_gemma":[0.92988425,0.008261559,0.006188432,0.0001625738,0.004224164,0.00009804367,0.0001785279,0.0072238804,0.042939372,0.00002668033,0.0006245673,0.00018794584],"about_ca_topic_score_codex":0.00008739273,"about_ca_topic_score_gemma":0.000712252,"teacher_disagreement_score":0.38971755,"about_ca_system_score_codex":0.0001350367,"about_ca_system_score_gemma":0.00008733466,"threshold_uncertainty_score":0.6864998},"labels":[],"label_agreement":null},{"id":"W4246785612","doi":"10.1093/neuonc/nov228.28","title":"PTPS-28INHIBITION OF LACTATE DEHYDROGENASE-A USING SODIUM OXAMATE LEADS TO METABOLIC CHANGES, DECREASED GROWTH AND MIGRATION IN MEDULLOBLASTOMA CELL LINES","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Supramolecular Self-Assembly in Materials","field":"Materials Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Lactate dehydrogenase; Sodium; Sodium lactate; Cell biology; Chemistry; Biology; Cancer research; Biochemistry; Enzyme","score_opus":0.030627539628955407,"score_gpt":0.2874013955255016,"score_spread":0.25677385589654617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4246785612","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99728566,0.00018981357,0.00019614688,0.00077226834,0.0007937333,0.0005568301,0.000029999534,0.00007899655,0.000096525946],"genre_scores_gemma":[0.99338645,0.000055448578,0.005388471,0.0008823921,0.00015672087,0.00006524871,0.000017898043,0.000045205838,0.000002137732],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99723786,0.00091221806,0.0005560938,0.00051567005,0.00031586894,0.00046228283],"domain_scores_gemma":[0.99869937,0.0002129131,0.0003392002,0.00027420284,0.00019894326,0.00027539744],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009440273,0.0002636328,0.00060350675,0.0003721021,0.000053432952,0.000062013634,0.00021693093,0.00020571006,0.000029544668],"category_scores_gemma":[0.0005893188,0.00026315192,0.00004083423,0.0003826933,0.000100647696,0.00021425982,0.00016880676,0.000097257966,0.000050627063],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033329552,0.00014650404,0.0010040825,0.00005350057,0.0000034299305,0.000083354564,0.00078274735,0.0001531564,0.9971824,0.000061288185,0.000092538394,0.00010367544],"study_design_scores_gemma":[0.0013600418,0.0006394365,0.00037326306,0.000025830084,0.00005627269,0.00009845485,0.00014759932,0.0005809203,0.9953992,0.00015913544,0.00093940785,0.00022046412],"about_ca_topic_score_codex":0.00074161286,"about_ca_topic_score_gemma":0.0011902743,"teacher_disagreement_score":0.005192324,"about_ca_system_score_codex":0.000103746985,"about_ca_system_score_gemma":0.00027861763,"threshold_uncertainty_score":0.99998206},"labels":[],"label_agreement":null},{"id":"W4247033514","doi":"10.1093/neuonc/noq116.s12","title":"Pediatrics Laboratory Research","year":2010,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba","funders":"","keywords":"Medicine","score_opus":0.06282275067363098,"score_gpt":0.41497756922211493,"score_spread":0.35215481854848396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247033514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93033665,0.00020353896,0.0000113476935,0.037626106,0.0031944124,0.0004717403,0.000020020329,0.00017987256,0.027956298],"genre_scores_gemma":[0.97405076,0.00023484378,0.0017678159,0.017513104,0.00594699,0.000065356515,0.000016934488,0.00007935498,0.0003248188],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971626,0.00060754124,0.00040200286,0.00048933405,0.0007530097,0.00058553915],"domain_scores_gemma":[0.9961386,0.0019813804,0.000105135994,0.0007548398,0.0005745225,0.00044557845],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0024695466,0.0001548472,0.00042590624,0.00031271923,0.00015872034,0.000019786734,0.00027733046,0.00040318782,0.0005877509],"category_scores_gemma":[0.004327744,0.00015246938,0.00008289514,0.0007624787,0.00036264115,0.00007611517,0.00018124198,0.002569452,0.00079358736],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047292866,0.0009352555,0.047122903,0.00020197028,0.000029788021,0.00083734724,0.002645764,6.871878e-7,0.60865414,0.002705884,0.32251173,0.013881623],"study_design_scores_gemma":[0.0016061849,0.0013802464,0.013308512,0.000006435367,0.000038862472,0.00014786086,0.00033309232,0.0000097516395,0.008718055,0.00028582514,0.97402734,0.00013782893],"about_ca_topic_score_codex":0.0001245324,"about_ca_topic_score_gemma":0.00051707576,"teacher_disagreement_score":0.6515156,"about_ca_system_score_codex":0.00014167294,"about_ca_system_score_gemma":0.0019621085,"threshold_uncertainty_score":0.9999844},"labels":[],"label_agreement":null},{"id":"W4248153717","doi":"10.1093/neuonc/nox083.163","title":"MEDU-12. CD271 (P75NTR) AS A NOVEL DIAGNOSTIC MARKER AND THERAPEUTIC TARGET FOR SHH MEDULLOBLASTOMA","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Hospital for Sick Children; University of Manitoba","funders":"","keywords":"Low-affinity nerve growth factor receptor; Biology; Cancer research; Wnt signaling pathway; Cell biology; Signal transduction; Neurotrophin; Receptor; Genetics","score_opus":0.03483821565849053,"score_gpt":0.33102675158198475,"score_spread":0.2961885359234942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248153717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9453147,0.0021352775,0.000111627065,0.039903175,0.001230736,0.0021903967,0.000061608465,0.00009517898,0.008957273],"genre_scores_gemma":[0.9890463,0.00049720623,0.001670794,0.0073022563,0.0003649686,0.0008201697,0.000019013392,0.00006452254,0.00021477298],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99833846,0.000071540184,0.000316485,0.00056373427,0.00020740007,0.00050238235],"domain_scores_gemma":[0.9955238,0.0031723562,0.0002281866,0.0006716583,0.000098661185,0.00030531536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022809027,0.0002962687,0.0006480606,0.000098096985,0.00036306487,0.000059049024,0.00020626257,0.00023445398,0.00023709165],"category_scores_gemma":[0.0020881777,0.00023400129,0.00016209991,0.000036021956,0.00028636729,0.00006823646,0.00013638857,0.00021532265,0.00007863035],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030357034,0.0059363465,0.5269692,0.0002192946,0.0010484087,0.0025860877,0.0008643902,0.0000037386158,0.074915886,0.0047508962,0.017347313,0.36232275],"study_design_scores_gemma":[0.011639344,0.0056070494,0.3608943,0.00007102473,0.0006897052,0.0013186918,0.0000819507,0.000316125,0.0064974753,0.0013385217,0.6112763,0.00026948098],"about_ca_topic_score_codex":0.0000699009,"about_ca_topic_score_gemma":0.000102164035,"teacher_disagreement_score":0.59392905,"about_ca_system_score_codex":0.00013188852,"about_ca_system_score_gemma":0.00025247745,"threshold_uncertainty_score":0.9542296},"labels":[],"label_agreement":null},{"id":"W4248583111","doi":"10.1093/neuonc/noz175.379","title":"EXTH-47. THERAPEUTIC REVERSAL OF PRENATAL PONTINE ID1 SIGNALING IN DIPG","year":2019,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Cancer research; Chromatin immunoprecipitation; Biology; Gene knockdown; Enhancer; Pathology; Medicine; Gene expression; Gene; Genetics; Promoter","score_opus":0.012404726114331825,"score_gpt":0.27704638113302754,"score_spread":0.26464165501869574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248583111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99517894,0.0011473382,0.00029094765,0.00019644524,0.00033916207,0.00023873441,0.000007037813,0.000006461997,0.002594957],"genre_scores_gemma":[0.9988169,0.00023276181,0.00040111438,0.00024704865,0.000115886796,0.000009842847,0.00004235653,0.00002108275,0.000113002934],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988954,0.00016916281,0.00029969265,0.00031612458,0.000104061335,0.00021556887],"domain_scores_gemma":[0.9993998,0.000081562335,0.00014178976,0.00027250915,0.0000607355,0.000043611657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002645584,0.00012225902,0.0002228462,0.00007009641,0.000016476499,0.000005428246,0.0001619151,0.00022437672,0.00006351792],"category_scores_gemma":[0.00008197323,0.00012016186,0.000071673145,0.00009888582,0.000048716287,0.0000037738791,0.000094950636,0.00014050653,0.0000143287325],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001671738,0.000086600056,0.017730922,0.000021220467,0.00001515249,0.000006509978,0.00007838306,0.0003298894,0.9725623,0.00008149421,0.000022831506,0.0088974815],"study_design_scores_gemma":[0.0011234287,0.0012029231,0.00429338,0.000010626553,0.0000138082005,0.00000611487,0.000040725037,0.00017152999,0.955551,0.00017922815,0.03727954,0.00012764716],"about_ca_topic_score_codex":0.00002098271,"about_ca_topic_score_gemma":0.000034326313,"teacher_disagreement_score":0.03725671,"about_ca_system_score_codex":0.000020890426,"about_ca_system_score_gemma":0.00010902984,"threshold_uncertainty_score":0.49000582},"labels":[],"label_agreement":null},{"id":"W4249757522","doi":"10.1093/neuonc/nov206.08","title":"ATCT-08THE IMPACT OF EXTENDED ADJUVANT TEMOZOLOMIDE IN NEWLY-DIAGNOSED GLIOBLASTOMA: A SECONDARY ANALYSIS OF EORTC AND NRG ONCOLOGY/RTOG","year":2015,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Temozolomide; Glioblastoma; Medicine; Oncology; Adjuvant; Internal medicine; Cancer research","score_opus":0.023883929749458632,"score_gpt":0.335393357412885,"score_spread":0.3115094276634264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249757522","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941459,0.0012521716,0.0000041872363,0.0011168089,0.00017941321,0.00070645113,0.00009085966,0.000032645523,0.0024715923],"genre_scores_gemma":[0.99866986,0.00031023374,0.0003107445,0.00047224242,0.000056193054,0.00009622554,0.000042929125,0.000032201395,0.00000934369],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997284,0.00044400105,0.000938223,0.00056763645,0.00029481458,0.00047132093],"domain_scores_gemma":[0.9969462,0.0012650791,0.0005504289,0.00054964767,0.0002481844,0.0004404679],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00057151326,0.000333943,0.0020700686,0.0011802526,0.000029227152,0.0000062095496,0.00015542019,0.00036840196,0.00021567092],"category_scores_gemma":[0.0006808679,0.0002570516,0.00044221964,0.0012951841,0.0003360738,0.00008466577,0.00014992704,0.00038169645,0.000011215686],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00574877,0.007240207,0.68404865,0.00008902287,0.0035057396,0.0064885635,0.003340459,0.0005850023,0.18305337,0.00009517553,0.0067922347,0.099012785],"study_design_scores_gemma":[0.029939827,0.025340736,0.9121496,0.000060256487,0.0041386876,0.0004755677,0.0010705579,0.0014441303,0.018988786,0.0001801301,0.0059264144,0.0002852762],"about_ca_topic_score_codex":0.00109477,"about_ca_topic_score_gemma":0.002933784,"teacher_disagreement_score":0.22810097,"about_ca_system_score_codex":0.00069137535,"about_ca_system_score_gemma":0.0013841931,"threshold_uncertainty_score":0.9999882},"labels":[],"label_agreement":null},{"id":"W4249946082","doi":"10.1093/neuonc/now070.30","title":"EPN-31MOLECULAR REFINEMENT OF PEDIATRIC POSTERIOR FOSSA EPENDYMOMA","year":2016,"lang":"es","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Ependymoma; Posterior fossa; Medicine; Anatomy; Radiology","score_opus":0.019718702800600736,"score_gpt":0.29749768332231424,"score_spread":0.2777789805217135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249946082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9711974,0.003737592,0.000017108789,0.018072704,0.0015031337,0.0009233117,0.00012567684,0.000049880957,0.004373184],"genre_scores_gemma":[0.9946992,0.0025181612,0.00019159287,0.0014450825,0.00083319325,0.00014525099,0.000014884471,0.00007233452,0.000080290396],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99674845,0.00037428623,0.000932552,0.00074598636,0.0004871489,0.0007115549],"domain_scores_gemma":[0.99723405,0.0007438542,0.0005797768,0.0008334761,0.00023891314,0.0003699238],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027594433,0.00044635514,0.0010572491,0.00039343486,0.00007892092,0.00001623752,0.00027193574,0.00037470058,0.0012654025],"category_scores_gemma":[0.00045244442,0.00030103285,0.00035235385,0.00034142102,0.00018055999,0.00006407851,0.00028477437,0.00019939401,0.00063655974],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005726358,0.0030010592,0.080187015,0.00022918853,0.00034254065,0.007436443,0.00014635728,6.682942e-7,0.73748404,0.00077706436,0.007722402,0.16210058],"study_design_scores_gemma":[0.024181379,0.022295432,0.17054243,0.00031177828,0.0035098174,0.0012680823,0.00008562982,0.000008615262,0.42836165,0.00012290967,0.3486888,0.0006234434],"about_ca_topic_score_codex":0.000080968755,"about_ca_topic_score_gemma":0.000014951849,"teacher_disagreement_score":0.3409664,"about_ca_system_score_codex":0.00039364307,"about_ca_system_score_gemma":0.0005559279,"threshold_uncertainty_score":0.99994415},"labels":[],"label_agreement":null},{"id":"W4250206320","doi":"10.1093/neuonc/nor156","title":"PEDIATRICS CLINICAL RESEARCH","year":2011,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Child and Adolescent Health","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital","funders":"","keywords":"Computer science","score_opus":0.458000253747527,"score_gpt":0.585007938015258,"score_spread":0.12700768426773096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250206320","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7269006,0.00018176135,0.000043405038,0.0074424203,0.008070988,0.0012667808,0.000012695401,0.00021860702,0.25586274],"genre_scores_gemma":[0.9675314,0.00199962,0.0007810909,0.022026572,0.0066612526,0.000020448158,0.000008021506,0.00005285672,0.0009187394],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99213797,0.0051708077,0.0009010984,0.00046326107,0.00030438387,0.0010224723],"domain_scores_gemma":[0.9940699,0.004468399,0.0002112893,0.0004822831,0.00029221544,0.0004759221],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.005086773,0.0001189212,0.00038152962,0.00018883702,0.00078939705,0.0000026773253,0.00036800624,0.00058126816,0.0013990124],"category_scores_gemma":[0.0023793306,0.00010137794,0.000089708774,0.0003831633,0.0002202185,0.000056054334,0.00036169105,0.0039830543,0.004727862],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043874123,0.0007547567,0.49730957,0.0001623664,0.0000061162173,0.0002011008,0.0066701435,8.4437886e-8,0.0004160217,0.009571836,0.44827557,0.03619368],"study_design_scores_gemma":[0.0014371963,0.0012038192,0.11984775,0.000023373625,0.0000124097405,0.000007963012,0.0015472033,0.000013319222,0.000017020453,0.0015913569,0.8741923,0.00010626693],"about_ca_topic_score_codex":0.00017037155,"about_ca_topic_score_gemma":0.00019537074,"teacher_disagreement_score":0.42591673,"about_ca_system_score_codex":0.00028298754,"about_ca_system_score_gemma":0.002701496,"threshold_uncertainty_score":0.99951386},"labels":[],"label_agreement":null},{"id":"W4250453028","doi":"10.1093/neuonc/not047","title":"Abstracts","year":2013,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Ginseng Biological Effects and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Computer science","score_opus":0.013816929759044626,"score_gpt":0.27775749798613386,"score_spread":0.2639405682270892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250453028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9670339,0.000075191936,0.00019911087,0.0029576095,0.00016423127,0.00031482935,0.0000047281264,0.000031076685,0.029219301],"genre_scores_gemma":[0.9943947,0.000070561815,0.0006355056,0.0042346604,0.00025502584,0.0001458652,0.000044275526,0.000011520484,0.00020786414],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99924314,0.00006468581,0.00015080477,0.00027829656,0.00004459497,0.00021850747],"domain_scores_gemma":[0.99947464,0.00006214071,0.00006018085,0.00024464435,0.000050952807,0.00010743863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007513657,0.00010110147,0.00011303433,0.000015958116,0.000063225416,0.00001501237,0.00016087246,0.00020430793,0.00017723616],"category_scores_gemma":[0.0001425213,0.0000792715,0.000055113032,0.000048354206,0.00009011634,0.0000019626873,0.000082084654,0.00011926314,0.0006187023],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007229315,0.00007644773,0.00019652987,0.000001990629,0.000006133076,0.0000029638225,0.00000473656,0.000015782865,0.9563224,0.00021630211,0.02217424,0.020975262],"study_design_scores_gemma":[0.00024116757,0.0006499183,0.006909647,7.4526974e-7,0.000004611864,0.00003130934,0.000012455222,0.000024308194,0.18812527,0.00022327807,0.8036789,0.00009843991],"about_ca_topic_score_codex":0.000028961671,"about_ca_topic_score_gemma":0.000008356472,"teacher_disagreement_score":0.78150463,"about_ca_system_score_codex":0.000010748257,"about_ca_system_score_gemma":0.00004756053,"threshold_uncertainty_score":0.7952373},"labels":[],"label_agreement":null},{"id":"W4250934049","doi":"10.1093/neuonc/nou243.11","title":"CN-11 * ORTERONEL (TAK-700) AND POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME (PRES)","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neurological Complications and Syndromes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; Western University","funders":"","keywords":"Medicine; Posterior reversible encephalopathy syndrome; Headaches; Internal medicine; Endocrinology; Urology; Surgery; Magnetic resonance imaging; Radiology","score_opus":0.02507679741692753,"score_gpt":0.2819334388349893,"score_spread":0.25685664141806175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250934049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98404354,0.000097887016,0.00014396678,0.008706461,0.00030345377,0.0004207961,0.0000067857045,0.00012080491,0.0061563244],"genre_scores_gemma":[0.9891978,0.000070139424,0.00080039445,0.009471795,0.000080225145,0.000046817233,0.00001020077,0.000024734942,0.000297891],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99837625,0.00022578248,0.00033165718,0.0005436539,0.00016456946,0.00035809836],"domain_scores_gemma":[0.9986394,0.00041697294,0.0001146145,0.0004873389,0.00007147026,0.00027021405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021851216,0.00019511169,0.0005433597,0.00013037196,0.00013377923,0.000020979098,0.00017672277,0.00019237494,0.00032492698],"category_scores_gemma":[0.0002762221,0.00016092331,0.00007598792,0.00018177567,0.00020947159,0.000078412304,0.00017677866,0.0003158673,0.00017465094],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050540187,0.00093468523,0.08813719,0.00019997705,0.000058031877,0.0027446998,0.00039317168,0.0000037342302,0.83789355,0.0025866744,0.007757081,0.0587858],"study_design_scores_gemma":[0.003381173,0.011687073,0.3808864,0.000033065313,0.00019340873,0.026724612,0.000066572975,0.00044358915,0.001877468,0.0010021508,0.5733487,0.00035578816],"about_ca_topic_score_codex":0.000017628752,"about_ca_topic_score_gemma":0.000008676312,"teacher_disagreement_score":0.83601606,"about_ca_system_score_codex":0.000040107207,"about_ca_system_score_gemma":0.0000636646,"threshold_uncertainty_score":0.6562263},"labels":[],"label_agreement":null},{"id":"W4251009049","doi":"10.1093/neuonc/noaa222.185","title":"EPEN-52. METABOLIC REGULATION OF THE EPIGENOME DRIVES LETHAL INFANTILE EPENDYMOMA","year":2020,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Epigenome; Ependymoma; Epigenetics; Biology; Cancer research; Tumor microenvironment; Acetylation; Cell biology; DNA methylation; Biochemistry; Medicine; Pathology","score_opus":0.01368834798923768,"score_gpt":0.2578224894722051,"score_spread":0.24413414148296742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4251009049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872516,0.0029234136,0.00019701518,0.002719244,0.0019425317,0.00036908494,0.000047573725,0.000019639314,0.0045299423],"genre_scores_gemma":[0.99435306,0.0006135984,0.00024292673,0.0025240788,0.0020169967,0.000026632117,0.000034512766,0.000031156378,0.0001570671],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985484,0.0002574142,0.00034126904,0.00041233117,0.00016573863,0.0002748434],"domain_scores_gemma":[0.9990664,0.00004266528,0.00024773326,0.0004267416,0.00009711012,0.00011935775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013727254,0.00017864938,0.00035779708,0.00003520993,0.00008665321,0.0000098582905,0.00039028245,0.0002338911,0.00010542643],"category_scores_gemma":[0.0002613822,0.00014628172,0.00020260634,0.0001907888,0.0002030887,0.0000073079495,0.00027192137,0.00019137321,0.000017808978],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012877108,0.000045384608,0.00056811183,0.000012586226,0.0000358428,0.000002941975,0.00030741183,0.00009199871,0.9842183,0.00048268068,0.0038205835,0.010285383],"study_design_scores_gemma":[0.0005407553,0.00020882487,0.01239486,0.000001574325,0.000044788754,0.000036055957,0.000033119326,0.000022886776,0.40224653,0.000055049266,0.58432186,0.00009368426],"about_ca_topic_score_codex":0.000026600723,"about_ca_topic_score_gemma":0.000041724947,"teacher_disagreement_score":0.58197176,"about_ca_system_score_codex":0.000009847019,"about_ca_system_score_gemma":0.00027871467,"threshold_uncertainty_score":0.59651953},"labels":[],"label_agreement":null},{"id":"W4251295856","doi":"10.1093/neuonc/noy059.033","title":"ATRT-36. META-ANALYSIS OF TREATMENT MODALITIES IN METASTATIC ATYPICAL TERATOID/RHABDOID TUMORS IN CHILDREN","year":2018,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; Children's Hospital of Eastern Ontario; Hospital for Sick Children; University of Ottawa","funders":"","keywords":"Medicine; Atypical teratoid rhabdoid tumor; Chemotherapy; Confidence interval; Univariate analysis; Oncology; Radiation therapy; Internal medicine; Multivariate analysis; Central nervous system","score_opus":0.03839222590954251,"score_gpt":0.32430352863761513,"score_spread":0.28591130272807264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4251295856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979787,0.0008666954,0.000114687515,0.00021813838,0.00005232558,0.00021748472,0.000055979825,0.000007248441,0.0004887723],"genre_scores_gemma":[0.99843585,0.00014040378,0.00065532594,0.00045022243,0.00007496115,0.00007496865,0.00008280388,0.000016819871,0.00006862091],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983558,0.00032875195,0.0005064494,0.00043850415,0.00010357009,0.00026692715],"domain_scores_gemma":[0.9992854,0.00007343771,0.0001459166,0.00037789796,0.000059255846,0.000058066664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021305315,0.00019779443,0.0008771306,0.00022332449,0.000026489139,0.0000074266413,0.00016599095,0.00012442764,0.00014228048],"category_scores_gemma":[0.00007996925,0.00015926483,0.00044750757,0.00034460187,0.00017391163,0.0000036168794,0.00006894645,0.000090989306,0.000005622039],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012492273,0.0012155699,0.04255732,0.000026869673,0.035841398,0.000047943453,0.001343238,0.011914543,0.8979992,0.00022015185,0.0004443651,0.0071401307],"study_design_scores_gemma":[0.010061197,0.017825019,0.059947405,0.000016950922,0.0809233,0.0002556747,0.00088479,0.021725165,0.781167,0.00091239956,0.02470007,0.001581033],"about_ca_topic_score_codex":0.00048963336,"about_ca_topic_score_gemma":0.0018653675,"teacher_disagreement_score":0.11683224,"about_ca_system_score_codex":0.00010664238,"about_ca_system_score_gemma":0.0002413062,"threshold_uncertainty_score":0.6494631},"labels":[],"label_agreement":null},{"id":"W4251454374","doi":"10.1093/neuonc/nou239.21","title":"BI-21 * BRAF MUTATION AND CDKN2A DELETIONS DEFINE A CLINICALLY DISTINCT SUBGROUP OF CHILDHOOD SECONDARY HIGH GRADE GLIOMA","year":2014,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"ATRX; CDKN2A; Glioma; Biology; IDH1; Cancer research; Oncology; Mutation; Somatic cell; Medicine; Genetics; Gene","score_opus":0.014558264774087393,"score_gpt":0.2870590009820569,"score_spread":0.2725007362079695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4251454374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99093866,0.00018294729,0.00010263594,0.0066159093,0.00028490528,0.00044128162,0.00004248331,0.00005909774,0.0013320702],"genre_scores_gemma":[0.99684525,0.000075382886,0.0012877266,0.0013497903,0.00018315262,0.00007865301,0.00014631268,0.0000295303,0.0000041902977],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99835926,0.0002193479,0.0005870999,0.0004056514,0.0001731495,0.00025548865],"domain_scores_gemma":[0.99785,0.0012688453,0.00026551628,0.00030676363,0.000101439204,0.0002074125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024357598,0.00019052741,0.0005873194,0.00018627637,0.00008866596,0.000010543089,0.00007457535,0.00018668741,0.00013063176],"category_scores_gemma":[0.0006653744,0.00016006971,0.00012296013,0.00022698687,0.00019528203,0.000047807647,0.00006820001,0.00025157796,0.000027682514],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008683232,0.011865551,0.29059395,0.000262459,0.0005178828,0.0024946795,0.00096347823,0.000018436589,0.27093536,0.008218743,0.0055408617,0.4077203],"study_design_scores_gemma":[0.012580466,0.0098506445,0.9393822,0.00005113873,0.00058383856,0.0016720672,0.0000449537,0.00015680837,0.011662673,0.0015341464,0.022284903,0.00019615304],"about_ca_topic_score_codex":0.00009426641,"about_ca_topic_score_gemma":0.0001556101,"teacher_disagreement_score":0.6487883,"about_ca_system_score_codex":0.000054044245,"about_ca_system_score_gemma":0.00014615338,"threshold_uncertainty_score":0.65274537},"labels":[],"label_agreement":null},{"id":"W4251991087","doi":"10.1093/neuonc/nox168.936","title":"STEM-21. CONTEXT-SPECIFIC TUMOR SUPPRESSIVE FUNCTION OF THE CANONICAL Wnt PATHWAY IN PEDIATRIC MEDULLOBLASTOMA HIGHLIGHTS A THERAPEUTIC STRATEGY FOR TREATMENT-REFRACTORY SUBGROUPS","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Wnt signaling pathway; Medulloblastoma; Cancer research; Biology; In vivo; SOX2; Beta-catenin; Context (archaeology); Signal transduction; Cell biology; Transcription factor; Gene; Genetics","score_opus":0.03219366632729257,"score_gpt":0.2797318604996017,"score_spread":0.24753819417230913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4251991087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99597645,0.0014007041,0.00003862406,0.00040733613,0.0009982521,0.0006110163,0.00005694249,0.0000071983404,0.00050345546],"genre_scores_gemma":[0.9983752,0.0005399804,0.000004562566,0.00028945602,0.00036425667,0.00017714426,0.000021756143,0.00002524842,0.00020240873],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984941,0.00021788178,0.00037484072,0.0004748241,0.000110982866,0.00032736716],"domain_scores_gemma":[0.9986305,0.00010804757,0.00041420295,0.00063803286,0.00013848384,0.00007072261],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000112878566,0.00023026374,0.0003538892,0.000057206555,0.00018377695,0.000029698442,0.00048035415,0.00025721628,0.000018284605],"category_scores_gemma":[0.00002965543,0.00015964067,0.00020642288,0.000041318475,0.0001941704,0.000012967545,0.000109248926,0.000120369594,0.000007304152],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00174761,0.0004574218,0.005384596,0.000017862187,0.000053188433,0.000028109995,0.00009760535,0.000023529183,0.9623169,0.0007920127,0.00086225633,0.028218916],"study_design_scores_gemma":[0.004639567,0.011967535,0.037532445,0.000013688256,0.00009261356,0.00005809377,0.0002605482,0.000042330186,0.742497,0.00019220325,0.20239869,0.00030528667],"about_ca_topic_score_codex":0.00008808443,"about_ca_topic_score_gemma":0.0017447626,"teacher_disagreement_score":0.21981989,"about_ca_system_score_codex":0.00008493068,"about_ca_system_score_gemma":0.0007235923,"threshold_uncertainty_score":0.65099573},"labels":[],"label_agreement":null},{"id":"W4252705843","doi":"10.1215/s1522851701000461","title":"Metastatic papillary craniopharyngioma: Case study and study of tumor angiogenesis","year":2002,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Craniopharyngioma; Medicine; Angiogenesis; Pathology; Cancer research; Radiology","score_opus":0.04011557964673074,"score_gpt":0.30816557748066736,"score_spread":0.2680499978339366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252705843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958639,0.0017414414,0.000001276609,0.00017408683,0.00012212618,0.0013770133,0.000010672953,0.00003345633,0.00067602453],"genre_scores_gemma":[0.9993131,0.00008229336,0.00008173085,0.00036308798,0.000029189338,0.00007264211,0.0000027611318,0.000022589613,0.000032578868],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987007,0.00022943446,0.00033515622,0.00034799363,0.00017040165,0.00021633018],"domain_scores_gemma":[0.99916756,0.00022959919,0.00010313957,0.00029088376,0.00004995864,0.00015884453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009678335,0.0001862351,0.0006044659,0.00016043795,0.00009232789,0.000004882018,0.00005049814,0.00003210687,0.00016137486],"category_scores_gemma":[0.000056516255,0.00014404218,0.00006918298,0.00021794278,0.00005423358,0.000050432394,0.000063748834,0.00008337675,0.00001597393],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040921202,0.032821245,0.6368262,0.00006812431,0.0008421971,0.29972804,0.006638381,0.0000029698679,0.004063254,0.0000022496747,0.0009227808,0.017675346],"study_design_scores_gemma":[0.13191858,0.20874226,0.37111762,0.00003559248,0.012009851,0.15955886,0.109328166,0.0011959518,0.0008055108,0.00010363003,0.0042600883,0.00092387456],"about_ca_topic_score_codex":0.0005602857,"about_ca_topic_score_gemma":0.00028198468,"teacher_disagreement_score":0.2657086,"about_ca_system_score_codex":0.000027948447,"about_ca_system_score_gemma":0.00002976884,"threshold_uncertainty_score":0.58738697},"labels":[],"label_agreement":null},{"id":"W4252970161","doi":"10.1215/15228517-4-3-214","title":"Canadian Neuro-oncology 10th Biennial Meeting","year":2002,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; University of Manitoba; Montreal Neurological Institute and Hospital; CancerCare Manitoba","funders":"","keywords":"Medicine; Oncology; Internal medicine; Medical physics","score_opus":0.02704887058149659,"score_gpt":0.282291522257822,"score_spread":0.2552426516763254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252970161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80309856,0.0006364154,0.0000033606404,0.06885653,0.002378244,0.0009278141,0.0000325881,0.00018559997,0.12388089],"genre_scores_gemma":[0.9760064,0.0003636394,0.00046369527,0.021941774,0.0008406258,0.00015347589,0.000026532694,0.00007460598,0.00012925798],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99717075,0.0003104365,0.00052101444,0.00070570636,0.00026347078,0.0010286511],"domain_scores_gemma":[0.9972772,0.00087973644,0.00018365894,0.00051032816,0.00013455872,0.0010145176],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00021658029,0.00034763137,0.0007719944,0.00049375446,0.0002610862,0.000026477064,0.0002134568,0.00042778632,0.0018930456],"category_scores_gemma":[0.0006937211,0.00031444905,0.00020500623,0.00043640178,0.00015507956,0.000072052484,0.000090984795,0.00055644085,0.0011378161],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028044332,0.0030450728,0.088798404,0.000058038888,0.00030145992,0.03489963,0.0019916513,0.00008667223,0.357575,0.00093318557,0.26413786,0.2478926],"study_design_scores_gemma":[0.004786089,0.0039353995,0.0036303182,0.000020076284,0.00027342062,0.0018757521,0.00012741279,0.0008871128,0.007672799,0.00003988366,0.9764992,0.00025252067],"about_ca_topic_score_codex":0.014546592,"about_ca_topic_score_gemma":0.059462823,"teacher_disagreement_score":0.71236134,"about_ca_system_score_codex":0.0013501957,"about_ca_system_score_gemma":0.00062950887,"threshold_uncertainty_score":0.99993074},"labels":[],"label_agreement":null},{"id":"W4253125386","doi":"10.1093/neuonc/now188.181","title":"P08.48 Combined alterations in MAPK pathway genes, CDKN2A/B and ATRX characterize anaplastic pilocytic astrocytoma","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Delmar (Canada); University of British Columbia","funders":"","keywords":"ATRX; Pilocytic astrocytoma; CDKN2A; Cancer research; Anaplastic astrocytoma; Astrocytoma; Gene; Biology; Medicine; Glioma; Genetics; Mutation","score_opus":0.021650308722584177,"score_gpt":0.26793796724899366,"score_spread":0.2462876585264095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253125386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920834,0.00016274616,0.000043526285,0.0062215184,0.00043620434,0.0005661029,0.000047171143,0.00005664383,0.00038272285],"genre_scores_gemma":[0.99789584,0.00020743613,0.00019492886,0.0012102778,0.00015105383,0.00020925494,0.000039509494,0.00002875536,0.0000629358],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99855286,0.00013610847,0.00036990046,0.0004221547,0.00014034164,0.00037864994],"domain_scores_gemma":[0.99878204,0.00054159475,0.00010982877,0.00027972308,0.00005757515,0.0002292161],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000925884,0.00021768341,0.0004886365,0.00021922315,0.00007302817,0.000018260132,0.000069684014,0.00013252131,0.00020093197],"category_scores_gemma":[0.00015312395,0.00015172185,0.000062172156,0.00015634533,0.00010565752,0.00008556033,0.00007096749,0.00013471987,0.00015151751],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011112831,0.001045532,0.054870207,0.000030958698,0.00005943125,0.0021803738,0.00012552775,0.0000010891619,0.89390004,0.00055446627,0.0008651585,0.045255948],"study_design_scores_gemma":[0.039694924,0.018551324,0.6831392,0.00023224969,0.0003121842,0.0016755424,0.00007083511,0.00040718535,0.14180653,0.00020219378,0.11341122,0.0004965934],"about_ca_topic_score_codex":0.000023180703,"about_ca_topic_score_gemma":0.0002695829,"teacher_disagreement_score":0.7520935,"about_ca_system_score_codex":0.00028699113,"about_ca_system_score_gemma":0.00022152576,"threshold_uncertainty_score":0.6187038},"labels":[],"label_agreement":null},{"id":"W4253312121","doi":"10.1093/neuonc/now073.105","title":"HG-109CONTEMPORARY SURVIVAL ENDPOINTS: AN INTERNATIONAL DIFFUSE INTRINSIC PONTINE GLIOMA REGISTRY STUDY","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Hospital for Sick Children","funders":"","keywords":"Medicine; Glioma; Oncology; Cancer research","score_opus":0.023863114997970326,"score_gpt":0.3341269492117,"score_spread":0.31026383421372966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253312121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95920694,0.00003312258,0.0004451041,0.024986988,0.0028102563,0.00040757595,0.000009096905,0.00019336081,0.0119075645],"genre_scores_gemma":[0.99455327,0.00005750186,0.00048415572,0.0027391294,0.0014494545,0.000025442896,0.00002539288,0.00005603725,0.000609607],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976193,0.00043345988,0.0005326766,0.0006096807,0.0004382588,0.00036663123],"domain_scores_gemma":[0.99809134,0.00053228077,0.00024048288,0.00061899325,0.00013153857,0.00038535078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076116534,0.00023359548,0.0005400151,0.0002476636,0.000080497084,0.00003155945,0.00041574345,0.00014568455,0.00038622212],"category_scores_gemma":[0.002330467,0.0001619214,0.00010319006,0.00016294503,0.0002241673,0.00023093242,0.00021304413,0.0006080875,0.00008307106],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015311339,0.003868346,0.34142512,0.000018928664,0.0002056334,0.008488176,0.0005891333,7.531456e-7,0.4100429,0.0005579206,0.0067228097,0.22654912],"study_design_scores_gemma":[0.034277894,0.0092761405,0.2302747,0.00012459242,0.00022089852,0.0035515495,0.00096848153,0.00053087214,0.003251464,0.00031773528,0.7166344,0.00057128916],"about_ca_topic_score_codex":0.00007945995,"about_ca_topic_score_gemma":0.000024857462,"teacher_disagreement_score":0.7099116,"about_ca_system_score_codex":0.00018922304,"about_ca_system_score_gemma":0.0002454337,"threshold_uncertainty_score":0.6602963},"labels":[],"label_agreement":null},{"id":"W4253468179","doi":"10.1093/neuonc/nox168.722","title":"PATH-32. MOLECULAR HETEROGENEITY AMONG PEDIATRIC POSTERIOR FOSSA EPENDYMOMA","year":2017,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Ependymoma; Biology; Genetic heterogeneity; Medulloblastoma; Gene; Genetics; Oncology; Bioinformatics; Pathology; Medicine","score_opus":0.023139083481306187,"score_gpt":0.31204627730103107,"score_spread":0.2889071938197249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253468179","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911997,0.00041421378,0.0000074002346,0.0030620669,0.00082281895,0.00062426226,0.000019978042,0.000074019525,0.0037755899],"genre_scores_gemma":[0.99773,0.00008422714,0.0002015896,0.0014203098,0.0003481018,0.00013681201,0.000017152472,0.000044934266,0.00001683338],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982857,0.00012559022,0.00032794307,0.00054465816,0.00025203876,0.00046403197],"domain_scores_gemma":[0.9980916,0.00010919333,0.00030872875,0.0010522546,0.00010027292,0.0003379445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013908722,0.00026414587,0.0005547848,0.00012430633,0.0002925792,0.00006638932,0.00027786935,0.00024786056,0.00011630782],"category_scores_gemma":[0.00030953225,0.00022605305,0.00024372674,0.0000648998,0.00014307846,0.00010771038,0.00026137897,0.00025034967,0.00019597271],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001801961,0.0011191654,0.75274414,0.00006348556,0.00010999322,0.027696632,0.00008787766,0.0000016830965,0.19035389,0.000058090613,0.0014458522,0.02613899],"study_design_scores_gemma":[0.0052495357,0.0025444601,0.8737304,0.000016835971,0.00055077893,0.0011248199,0.0000148628815,0.000042788415,0.10677471,0.000050634702,0.009669882,0.00023029292],"about_ca_topic_score_codex":0.00009640834,"about_ca_topic_score_gemma":0.00007566494,"teacher_disagreement_score":0.120986246,"about_ca_system_score_codex":0.00014220759,"about_ca_system_score_gemma":0.00014956077,"threshold_uncertainty_score":0.9218176},"labels":[],"label_agreement":null},{"id":"W4253874867","doi":"10.1093/neuonc/now076.77","title":"MB-81THE GD3 ACETYLATION PATHWAY AS A POTENTIAL THERAPEUTIC TARGET FOR PAEDIATRIC MEDULLOBLASTOMA","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Acetylation; Cancer research; Medicine; Chemistry; Biochemistry","score_opus":0.016139275131488908,"score_gpt":0.2848312842288182,"score_spread":0.2686920090973293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253874867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96150714,0.0009533857,0.0015456266,0.031271532,0.0013130127,0.0017155022,0.000055031218,0.00016043014,0.0014783266],"genre_scores_gemma":[0.99541795,0.00017013564,0.00061798224,0.0024819134,0.00068279065,0.00044227694,0.00002528511,0.0000482264,0.000113412396],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984828,0.00014146829,0.00031068223,0.00042304042,0.00022366583,0.00041832557],"domain_scores_gemma":[0.9985538,0.0006740026,0.00016344951,0.0002988761,0.000120464094,0.00018937846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017914211,0.0002162839,0.00040066795,0.0001729499,0.000105478204,0.0000116608635,0.000100410885,0.00022934239,0.00035032473],"category_scores_gemma":[0.00023306112,0.0001328791,0.00022870627,0.00016770535,0.000073895644,0.000069141766,0.00004458736,0.00010548346,0.00029630377],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008245232,0.0014545007,0.0047484855,0.000023130136,0.00014648918,0.0002730092,0.0001271486,0.0000058733162,0.68905634,0.000998416,0.0040907264,0.29825136],"study_design_scores_gemma":[0.026702253,0.013860631,0.009735961,0.00003089828,0.00064357166,0.0006084171,0.000084725834,0.0002888607,0.26041305,0.003514359,0.6837888,0.00032850387],"about_ca_topic_score_codex":0.0000074658633,"about_ca_topic_score_gemma":0.0000095933365,"teacher_disagreement_score":0.67969805,"about_ca_system_score_codex":0.00022275474,"about_ca_system_score_gemma":0.00026268492,"threshold_uncertainty_score":0.5418652},"labels":[],"label_agreement":null},{"id":"W4254437594","doi":"10.1215/s1152851705200406","title":"Abstracts for the Second International Symposium on Central Nervous System Germ Cell Tumors","year":2005,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre","funders":"","keywords":"Germ cell tumors; Germ cell; Central nervous system; Neuroscience; Biology; Genetics","score_opus":0.014987666798865939,"score_gpt":0.2729815386472019,"score_spread":0.257993871848336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4254437594","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9418474,0.000088147506,0.000007952589,0.023603944,0.0018215977,0.0009130526,0.00005385391,0.00006524623,0.03159884],"genre_scores_gemma":[0.99404466,0.000022591532,0.00010038723,0.0042175897,0.0010767558,0.00019966277,0.000027003049,0.00002600104,0.00028533294],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988883,0.000039787905,0.00030038078,0.00027451583,0.00017150393,0.00032547416],"domain_scores_gemma":[0.99864626,0.0007581218,0.00016016037,0.00023028222,0.00006544128,0.00013973058],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000115485585,0.00015404921,0.0002523197,0.000052518822,0.00008868239,0.000021834509,0.00013780882,0.000097768796,0.00017781879],"category_scores_gemma":[0.000039187064,0.000100911835,0.0001437419,0.00004376121,0.000039375565,0.00003487003,0.000028909344,0.00017542344,0.00012937069],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028801775,0.008970221,0.01649487,0.00053806015,0.0008007722,0.0042576473,0.0020781758,0.006729468,0.6354161,0.005906736,0.17201188,0.14391588],"study_design_scores_gemma":[0.0041921167,0.0015138455,0.026400423,0.000029355804,0.00014700636,0.00046907674,0.00016062002,0.0013202715,0.12736231,0.0000046149794,0.8382967,0.0001036295],"about_ca_topic_score_codex":0.000013139468,"about_ca_topic_score_gemma":0.000050418927,"teacher_disagreement_score":0.66628486,"about_ca_system_score_codex":0.00044784645,"about_ca_system_score_gemma":0.00010806003,"threshold_uncertainty_score":0.4115065},"labels":[],"label_agreement":null},{"id":"W4254888685","doi":"10.1093/neuonc/now212.284","title":"EXTH-40. M011L-DEFICIENT ONCOLYTIC MYXOMA VIRUS INDUCES APOPTOSIS IN BRAIN TUMOR INITIATING CELLS AND ENHANCES SURVIVAL IN A NOVEL IMMUNOCOMPETENT MOUSE MODEL OF GLIOBLASTOMA","year":2016,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Oncolytic virus; Myxoma virus; Apoptosis; Temozolomide; Glioma; Biology; Cancer research; Programmed cell death; Virus; Cell culture; Virology; Genetics","score_opus":0.028132409752156827,"score_gpt":0.30027926414700884,"score_spread":0.27214685439485203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4254888685","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982082,0.00017611358,0.00016149988,0.00049590366,0.00012790256,0.0004889252,0.000084608284,0.0000125545375,0.0002442656],"genre_scores_gemma":[0.9987022,0.00027586467,0.0002853465,0.00045386315,0.000056312303,0.00012804475,0.0000052251858,0.000045192486,0.000047921305],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973981,0.00043246592,0.00064229063,0.00066486694,0.00027087674,0.0005914176],"domain_scores_gemma":[0.99874264,0.000401694,0.0002470671,0.00039034232,0.0001030816,0.00011518874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007837551,0.0002769431,0.0004972941,0.00029684522,0.000052869345,0.000016504935,0.00038825188,0.00023071338,0.000016068463],"category_scores_gemma":[0.00030536728,0.00023545518,0.00008471448,0.00024616715,0.00028844757,0.000015163824,0.00035335572,0.00025951373,0.0000061351384],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033578828,0.00058861595,0.0002736978,0.000028710236,0.00002316188,0.000010759014,0.00036847254,0.00063938304,0.9902414,0.000024275987,0.00001921542,0.0044243946],"study_design_scores_gemma":[0.0032732745,0.0061803544,0.0001836486,0.000037929978,0.0000065715926,0.000010884947,0.00021323696,0.0011090519,0.9883466,0.00003053796,0.00036562895,0.00024230439],"about_ca_topic_score_codex":0.00009246748,"about_ca_topic_score_gemma":0.0017086074,"teacher_disagreement_score":0.0055917385,"about_ca_system_score_codex":0.00017142347,"about_ca_system_score_gemma":0.00064574933,"threshold_uncertainty_score":0.9601584},"labels":[],"label_agreement":null},{"id":"W4280638952","doi":"10.1093/neuonc/noac123","title":"Characteristics of children ≤36 months of age with DIPG: A report from the international DIPG registry","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; Dalhousie University; Hospital for Sick Children; University of Toronto","funders":"National Institute of Neurological Disorders and Stroke; Isabella and Marcus Foundation; Robert Connor Dawes Foundation; Cure Brain Cancer Foundation; Brooke Healey Foundation; Cure Starts Now Foundation; Strong; Reflections of Grace Foundation; Jeffrey Thomas Hayden Foundation; Musella Foundation For Brain Tumor Research and Information","keywords":"Medicine; Pediatrics; Population; Internal medicine","score_opus":0.014572547709080312,"score_gpt":0.2707352956366816,"score_spread":0.2561627479276013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280638952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919479,0.000081965,0.0000047196254,0.0048304102,0.0003304052,0.00032655793,0.00025437446,0.000013922063,0.0022097307],"genre_scores_gemma":[0.9983561,0.00004583335,0.0001455361,0.0007683315,0.00014525872,0.0000962062,0.00038569327,0.000015754855,0.000041270243],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989306,0.000071776056,0.00034607245,0.00022660512,0.00031566198,0.00010933704],"domain_scores_gemma":[0.9986922,0.0003171636,0.0004526392,0.0004217311,0.00006982956,0.000046401823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001130255,0.00010012668,0.00034689525,0.000042773452,0.000049420047,0.0000041492863,0.00018592436,0.00004163895,0.0002763932],"category_scores_gemma":[0.00019117228,0.00006625213,0.00007958997,0.00009253053,0.00011620416,0.000015410014,0.00016708263,0.00020760257,0.000001677927],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000805083,0.0015344055,0.92726797,0.0000069073485,0.00042345055,0.0058824657,0.00037360736,0.000008168867,0.051806003,0.00010276502,0.006709441,0.0050797635],"study_design_scores_gemma":[0.0022893772,0.0013300617,0.9473385,0.0000173242,0.00028856169,0.0012395459,0.000115311566,0.000019006231,0.006922851,0.000028013397,0.040352393,0.000059032474],"about_ca_topic_score_codex":0.0003975529,"about_ca_topic_score_gemma":0.000042948937,"teacher_disagreement_score":0.04488315,"about_ca_system_score_codex":0.00010055288,"about_ca_system_score_gemma":0.00017109806,"threshold_uncertainty_score":0.30263117},"labels":[],"label_agreement":null},{"id":"W4281382214","doi":"10.1093/neuonc/noac141","title":"Therapeutic targeting of prenatal pontine ID1 signaling in diffuse midline glioma","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"National Institute of Neurological Disorders and Stroke; Helse Sør-Øst RHF; National Cancer Institute; National Institutes of Health; Norges Forskningsråd; Universitetet i Oslo; National Human Genome Research Institute; Pediatric Brain Tumor Foundation","keywords":"Gene knockdown; Cancer research; Downregulation and upregulation; Glioma; Medicine; Biology; Cell culture; Gene; Genetics","score_opus":0.012145755985862986,"score_gpt":0.26907731042382643,"score_spread":0.25693155443796345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281382214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99687475,0.0020336094,0.00010518105,0.00020890194,0.0003100437,0.00022737077,0.00004033406,0.000023713099,0.00017610945],"genre_scores_gemma":[0.9985112,0.00001698382,0.00040600574,0.00056344597,0.00019403314,0.00008232707,0.00016054742,0.00004198168,0.000023457767],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981418,0.0004198868,0.0004642073,0.00043706037,0.00019710798,0.0003399104],"domain_scores_gemma":[0.99919635,0.00014430303,0.0002336161,0.0002965223,0.000056186273,0.00007300137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034373847,0.00017731856,0.000284601,0.00013580604,0.000101296784,0.0000070137326,0.00038523844,0.00011281202,0.00014138814],"category_scores_gemma":[0.00026052704,0.00019157346,0.000110584646,0.00022053921,0.00009681718,0.0000039483966,0.00041851858,0.00025527194,0.0000028735155],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050063216,0.0007675442,0.0044141854,0.00003158676,0.000033585766,0.00013238912,0.00016158972,0.0018730703,0.98901176,0.000020455034,0.00026583613,0.0027873775],"study_design_scores_gemma":[0.0023256426,0.0011797731,0.0004942447,0.000007913264,0.000029275996,0.00007450779,0.00020130265,0.0003208398,0.949052,0.000048212387,0.046062984,0.00020331268],"about_ca_topic_score_codex":0.000019151044,"about_ca_topic_score_gemma":0.000013989916,"teacher_disagreement_score":0.045797147,"about_ca_system_score_codex":0.00004993241,"about_ca_system_score_gemma":0.00023206811,"threshold_uncertainty_score":0.78121394},"labels":[],"label_agreement":null},{"id":"W4281609813","doi":"10.1093/neuonc/noac079.353","title":"LGG-41. The clinical and molecular landscape of gliomas in adolescents and young adults","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; University Health Network; Sunnybrook Health Science Centre; Hospital for Sick Children","funders":"","keywords":"CDKN2A; ATRX; Medicine; Glioma; Cohort; Oncology; Young adult; Internal medicine; Melanoma; Cancer research; Mutation; Cancer; Biology; Gene; Genetics","score_opus":0.018243485969278883,"score_gpt":0.3127269763470132,"score_spread":0.2944834903777343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281609813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99485755,0.0013648224,6.074666e-7,0.002715295,0.00024047027,0.0004026525,0.0000072609832,0.000009209903,0.00040214305],"genre_scores_gemma":[0.99826807,0.00023990314,0.00002747958,0.0013477654,0.000032744643,0.00006589938,0.0000046518167,0.000011639795,0.0000018664864],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988714,0.0002853213,0.00031581617,0.00022451837,0.00014823796,0.00015471825],"domain_scores_gemma":[0.99946,0.00015447443,0.000096255724,0.00018529898,0.000024270137,0.00007971669],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026702235,0.000092584116,0.0003194219,0.00009484191,0.000050465715,0.000003795315,0.0000624903,0.000061962055,0.000027712878],"category_scores_gemma":[0.00011326604,0.00006624411,0.000050909617,0.00016204624,0.00012202632,0.000012842184,0.0001854729,0.00026019692,0.0000014830713],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058367325,0.0009425153,0.97127014,0.00003127644,0.000032546766,0.0012423052,0.000381348,0.000002962738,0.010885247,0.000078286335,0.0005841501,0.013965524],"study_design_scores_gemma":[0.013292382,0.0040565063,0.96686274,0.00005261805,0.00015966392,0.0008283784,0.0008369474,0.00032904762,0.0023139727,0.00006474855,0.011110832,0.000092182796],"about_ca_topic_score_codex":0.000057654433,"about_ca_topic_score_gemma":0.000076318225,"teacher_disagreement_score":0.0138733415,"about_ca_system_score_codex":0.000024568697,"about_ca_system_score_gemma":0.000061220475,"threshold_uncertainty_score":0.2701356},"labels":[],"label_agreement":null},{"id":"W4281609890","doi":"10.1093/neuonc/noac137","title":"Low-risk meningioma: Initial outcomes from NRG Oncology/RTOG 0539","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre","funders":"National Cancer Institute","keywords":"Meningioma; Oncology; Internal medicine; Medicine; Surgery","score_opus":0.03686795975668634,"score_gpt":0.32402441550872996,"score_spread":0.2871564557520436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281609890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91285664,0.00015807227,0.00014465376,0.0085120285,0.003654756,0.00087812555,0.00010594255,0.0002817101,0.07340806],"genre_scores_gemma":[0.9906995,0.000015930696,0.0016777494,0.0054641417,0.00063762395,0.00039037378,0.00018818598,0.00006823655,0.0008582319],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.995924,0.0010214375,0.0007958526,0.00086944585,0.0006616863,0.0007275728],"domain_scores_gemma":[0.9971738,0.0012123947,0.0004371184,0.0007480799,0.000081774604,0.00034684048],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00074521214,0.00038282,0.0010868061,0.00039581014,0.0005238056,0.000025406822,0.00045780887,0.00023932719,0.005114867],"category_scores_gemma":[0.0004973154,0.00036469006,0.00032887078,0.0004094331,0.00017816648,0.000093186514,0.0009212686,0.0012356444,0.0003943377],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008608491,0.006940668,0.12943576,0.0001403386,0.002202342,0.14796875,0.009938018,0.00040008887,0.21968311,0.0034174398,0.30279055,0.16847444],"study_design_scores_gemma":[0.010675332,0.008428136,0.02169667,0.000011845413,0.00081489707,0.0015159,0.0016362508,0.00059384736,0.0035664146,0.00067709654,0.94991666,0.0004669436],"about_ca_topic_score_codex":0.00024668052,"about_ca_topic_score_gemma":0.000036377136,"teacher_disagreement_score":0.6471261,"about_ca_system_score_codex":0.0008173914,"about_ca_system_score_gemma":0.00053979846,"threshold_uncertainty_score":0.9998805},"labels":[],"label_agreement":null},{"id":"W4281616881","doi":"10.1093/neuonc/noac079.203","title":"GCT-09. Transcriptome and methylome profiles of CNS germ cell tumors and their comparison with testicular counterpart","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thompson Rivers University","funders":"","keywords":"Transcriptome; Biology; Germinoma; Seminoma; Germ cell tumors; Germ cell; Atypical teratoid rhabdoid tumor; Methylation; DNA methylation; Pathology; Immunohistochemistry; Gene expression; Genetics; Immunology; Gene; Medicine; Chemotherapy","score_opus":0.018765382108171573,"score_gpt":0.2736661221622107,"score_spread":0.2549007400540391,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281616881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99535966,0.0015342106,0.000010888721,0.0014859743,0.0000900499,0.00065507554,0.00006809407,0.000029898618,0.0007661373],"genre_scores_gemma":[0.9988769,0.00007560934,0.0001755001,0.00056909135,0.000024420262,0.00022007951,0.000022399552,0.00002550263,0.000010495107],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988136,0.00016856573,0.00028741237,0.00032917672,0.00017721517,0.00022401223],"domain_scores_gemma":[0.9990365,0.00043646613,0.00015262325,0.00019104873,0.000049094506,0.00013428637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016439424,0.00018802784,0.0006505761,0.00012660667,0.00010442569,0.00000830523,0.00006273716,0.0000488178,0.00008088433],"category_scores_gemma":[0.000026105781,0.0001305435,0.000049521732,0.00015961447,0.0001982661,0.000029253568,0.00006217932,0.0002325489,0.0000014960817],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048218496,0.0018807849,0.25029358,0.0001538306,0.000116872325,0.0005920678,0.002826362,0.00004362664,0.7396405,0.00007606239,0.0008686659,0.0030254514],"study_design_scores_gemma":[0.018550338,0.03692369,0.17956634,0.00009515653,0.0009930034,0.0027320583,0.007162369,0.0016312385,0.60713553,0.00010911469,0.14458297,0.0005181839],"about_ca_topic_score_codex":0.000035724854,"about_ca_topic_score_gemma":0.000013609533,"teacher_disagreement_score":0.1437143,"about_ca_system_score_codex":0.00007028232,"about_ca_system_score_gemma":0.00012830502,"threshold_uncertainty_score":0.53234094},"labels":[],"label_agreement":null},{"id":"W4281625178","doi":"10.1093/neuonc/noac079.251","title":"HGG-36. Elucidating the role of long non-coding RNAs in pediatric high grade gliomas","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"CRISPR; Biology; Computational biology; Genome; Cas9; Histone; RNA interference; Long non-coding RNA; Genetics; RNA; Gene","score_opus":0.010242314031833037,"score_gpt":0.27637667873465094,"score_spread":0.2661343647028179,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281625178","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98917884,0.00190241,0.0036234346,0.0009939508,0.000784757,0.00077622867,0.000027786748,0.000021020936,0.0026915725],"genre_scores_gemma":[0.9984289,0.00040285656,0.00016004447,0.0003864284,0.00030714722,0.00018093394,0.000047676396,0.000046987563,0.000039048417],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977375,0.0005298274,0.00038742862,0.00049963506,0.00035475614,0.0004908455],"domain_scores_gemma":[0.99902064,0.00013047206,0.00021377367,0.00049240096,0.00006492441,0.00007779793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006303332,0.00017375396,0.0002549174,0.00022790678,0.0002026474,0.000013657441,0.0006137552,0.00017663278,0.0000942313],"category_scores_gemma":[0.00023763799,0.00016811685,0.00011721303,0.00063303,0.000078546924,0.0000045471647,0.00092643703,0.0006799486,0.00000600641],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017209089,0.0001354133,0.0005249113,0.000015418465,0.000021374894,0.00013535147,0.00014328786,0.002046958,0.98636186,0.0001719273,0.00030101588,0.009970364],"study_design_scores_gemma":[0.0012149803,0.0012453832,0.00095537456,0.00000302722,0.00003155788,0.00018518542,0.00036042483,0.00081941154,0.9620662,0.00021907446,0.032718576,0.00018081909],"about_ca_topic_score_codex":0.0001865367,"about_ca_topic_score_gemma":0.0001573212,"teacher_disagreement_score":0.032417558,"about_ca_system_score_codex":0.00014511148,"about_ca_system_score_gemma":0.00041811343,"threshold_uncertainty_score":0.68556064},"labels":[],"label_agreement":null},{"id":"W4281627759","doi":"10.1093/neuonc/noac079.063","title":"DIPG-06. Uncovering the FACTs in Diffuse Midline Glioma (DMG)","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Epigenome; Chromatin; Epigenetics; Histone; Biology; Transcription (linguistics); Transcriptome; Genetics; Cell biology; Cancer research; DNA methylation; Gene; Gene expression","score_opus":0.015527463166217744,"score_gpt":0.2911000665546894,"score_spread":0.27557260338847167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281627759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99272394,0.0007295011,0.00075470086,0.0026741724,0.00067155284,0.0005694714,0.00003866663,0.000026716698,0.0018112742],"genre_scores_gemma":[0.9964258,0.00019111545,0.00007471119,0.0024489565,0.00021437285,0.0002668946,0.00009214853,0.00005674553,0.0002292734],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99764585,0.0005867946,0.0002986046,0.00056903006,0.00034342502,0.00055630883],"domain_scores_gemma":[0.99901724,0.00010415298,0.00010362436,0.0006149866,0.000050115304,0.00010987304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044624857,0.00019911242,0.0002271371,0.00014496186,0.00023406497,0.000023257648,0.00062394835,0.00018038637,0.0001567433],"category_scores_gemma":[0.00030771896,0.00018138955,0.000118347874,0.00041939548,0.00010338688,0.0000040283676,0.001149537,0.0007350658,0.000026432574],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027742086,0.0002700328,0.00007196007,0.000007163466,0.000027962298,0.00038494467,0.0001128542,0.003345618,0.9884545,0.0000848513,0.0032403155,0.0037223566],"study_design_scores_gemma":[0.0022218642,0.0012100484,0.00015804647,0.0000025453812,0.0000126434015,0.0003216665,0.00017808238,0.0004302363,0.3834509,0.00012620301,0.61170167,0.00018611496],"about_ca_topic_score_codex":0.00011093419,"about_ca_topic_score_gemma":0.00030350022,"teacher_disagreement_score":0.6084613,"about_ca_system_score_codex":0.0002443354,"about_ca_system_score_gemma":0.00040702164,"threshold_uncertainty_score":0.7396851},"labels":[],"label_agreement":null},{"id":"W4281630031","doi":"10.1093/neuonc/noac079.196","title":"GCT-02. Imaging response assessment for Central Nervous System Germ Cell Tumours: consensus recommendations from the European Society for Paediatric Oncology Brain Tumour Group (SIOPE-BTG) and North American Children’s Oncology Group (COG)","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Oncology; Clinical trial; Internal medicine; Germ cell tumors; Disease; Radiological weapon; Chemotherapy; Surgery","score_opus":0.016431813384265824,"score_gpt":0.28999091683955425,"score_spread":0.27355910345528844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281630031","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9101222,0.0007515295,0.00035246686,0.08014796,0.0013653643,0.0047884937,0.0019196487,0.00019668948,0.0003556537],"genre_scores_gemma":[0.9756643,0.00017699909,0.00679207,0.01244343,0.0010021317,0.002485438,0.0012680707,0.00015169277,0.000015877382],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9916963,0.004612095,0.0010293864,0.0011997126,0.00032420343,0.0011383115],"domain_scores_gemma":[0.98360324,0.014105608,0.0010878409,0.00056936184,0.00017134231,0.00046262052],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0024377315,0.00054005627,0.0012167856,0.00018024721,0.0012842634,0.00006586771,0.00040926554,0.000108977416,0.0000382949],"category_scores_gemma":[0.00045034118,0.00045050035,0.0006039724,0.0004939916,0.00041346892,0.000060187416,0.00053332426,0.0008873913,0.0000064063456],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007760179,0.008064286,0.29156712,0.00014449257,0.0010923267,0.0023195427,0.0050185253,0.00023399033,0.06551805,0.00041671674,0.34259152,0.27527323],"study_design_scores_gemma":[0.017952904,0.015939044,0.6033816,0.000019221272,0.0022307015,0.0014273563,0.007797059,0.002273643,0.00016319037,0.000024161971,0.3482882,0.00050296116],"about_ca_topic_score_codex":0.00055985316,"about_ca_topic_score_gemma":0.000746902,"teacher_disagreement_score":0.31181443,"about_ca_system_score_codex":0.0027050343,"about_ca_system_score_gemma":0.0010600603,"threshold_uncertainty_score":0.99979466},"labels":[],"label_agreement":null},{"id":"W4281631742","doi":"10.1093/neuonc/noac079.417","title":"MEDB-43. Development of a bioinformatics pipeline for identification of differential DNA methylation events associated with medulloblastoma relapse","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"DNA methylation; Cohort; Epigenetics; Oncology; Biology; Methylation; Differentially methylated regions; Internal medicine; Medulloblastoma; Bioinformatics; Genetics; Medicine; Gene; Gene expression","score_opus":0.015471338879330842,"score_gpt":0.28890613709084517,"score_spread":0.27343479821151434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281631742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.77589774,0.000053551827,0.22245266,0.00013731205,0.00031563264,0.00091594964,0.00013288778,0.000013542911,0.00008075448],"genre_scores_gemma":[0.99625874,0.000018741617,0.0023362758,0.000061615385,0.000029884784,0.00028780717,0.0008756219,0.000033712742,0.00009757591],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981064,0.0002527838,0.00069583196,0.00027376608,0.00042657915,0.00024462756],"domain_scores_gemma":[0.9985806,0.000086134416,0.00066213,0.000277181,0.0003311441,0.000062820094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000610219,0.00014258959,0.0002746582,0.00016511611,0.00013806182,0.000004393415,0.00026373815,0.00016583393,0.000038046477],"category_scores_gemma":[0.00047655258,0.00014431379,0.00009050156,0.0002547787,0.000062458785,0.00000599554,0.00023759925,0.00017675465,0.0000010907179],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083161035,0.00029554582,0.000021781943,0.000042239488,0.00013361662,0.0000013195819,0.0003222366,0.0008768875,0.9862847,0.000037344278,0.0003061174,0.010846639],"study_design_scores_gemma":[0.0022460716,0.0016795687,0.00019711445,0.000009729831,0.000069169655,0.000012170444,0.00017232438,0.007682203,0.97906125,0.000048006386,0.008689587,0.00013280164],"about_ca_topic_score_codex":0.000003145964,"about_ca_topic_score_gemma":0.00004720741,"teacher_disagreement_score":0.22036105,"about_ca_system_score_codex":0.00017825732,"about_ca_system_score_gemma":0.0006740559,"threshold_uncertainty_score":0.5884946},"labels":[],"label_agreement":null},{"id":"W4281632416","doi":"10.1093/neuonc/noac079.212","title":"GCT-18. Endoscopic third ventriculostomy (ETV) and tumor biopsy are not associated with relapse rate or patterns in primary central nervous system (CNS) germ cell tumor (GCT)","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Germinoma; Medicine; Biopsy; Internal medicine; Surgery; Radiology; Chemotherapy","score_opus":0.014933443125683411,"score_gpt":0.24143273873422172,"score_spread":0.22649929560853832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281632416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99492604,0.0002966918,0.0000011231942,0.0014293577,0.00064873125,0.001552613,0.00021001934,0.00013814487,0.0007972637],"genre_scores_gemma":[0.99601716,0.000045489323,0.000035187903,0.0028613436,0.00010593589,0.00066359906,0.00012919538,0.000070252085,0.0000718614],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99667764,0.0007768317,0.00059119245,0.0007507258,0.00040685592,0.00079677167],"domain_scores_gemma":[0.9978746,0.0007730095,0.0005887803,0.000377959,0.00007062358,0.00031498604],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031130487,0.0003989798,0.0010262688,0.00030895235,0.00021151705,0.00003079658,0.00016956415,0.00010872286,0.00016701988],"category_scores_gemma":[0.00014921432,0.00030161117,0.000108539105,0.00054424175,0.00007641658,0.000067580586,0.00023456926,0.00067902287,0.000017319937],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017564705,0.0030142197,0.8499144,0.00040572972,0.0001424951,0.11530462,0.00045450186,0.00006907529,0.026535032,0.000016377839,0.0017214172,0.00066571374],"study_design_scores_gemma":[0.016912565,0.0050737434,0.9604384,0.00025684448,0.0004579689,0.0032793852,0.0009760786,0.00017434717,0.008410244,0.0000015756864,0.003708086,0.0003108142],"about_ca_topic_score_codex":0.0001909026,"about_ca_topic_score_gemma":0.00017051827,"teacher_disagreement_score":0.11202523,"about_ca_system_score_codex":0.0018464685,"about_ca_system_score_gemma":0.00057795946,"threshold_uncertainty_score":0.9999436},"labels":[],"label_agreement":null},{"id":"W4281632793","doi":"10.1093/neuonc/noac079.226","title":"HGG-11. Clinical characteristics and clinical evolution of a large cohort of pediatric patients with primary central nervous system (CNS) tumors and tropomyosin receptor kinase (TRK) fusion.","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; London Health Sciences Centre; BC Children's Hospital; Montreal Children's Hospital; Izaak Walton Killam Health Centre; Hospital for Sick Children","funders":"","keywords":"Trk receptor; Medicine; Internal medicine; Oncology; Radiation therapy; Pathology; Gastroenterology; Neurotrophin; Receptor","score_opus":0.012495681392844935,"score_gpt":0.2829487737865249,"score_spread":0.27045309239367993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281632793","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973838,0.00024285361,0.0000070059095,0.00024297416,0.0006810385,0.001078036,0.0002873437,0.00002743679,0.000049515806],"genre_scores_gemma":[0.9987987,0.00026905895,0.00022954479,0.00021245256,0.00022790628,0.00006615751,0.00016468656,0.000027732327,0.0000037577863],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970659,0.0006850143,0.0010990469,0.00047580968,0.00035973513,0.00031448182],"domain_scores_gemma":[0.9979197,0.0006487183,0.0007136951,0.0002737041,0.00016419636,0.00028001392],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005624617,0.00018978666,0.0010247589,0.0001467249,0.00010909715,0.0000043098225,0.00007684136,0.00014563945,0.000048761332],"category_scores_gemma":[0.00027805183,0.00015252174,0.00012318269,0.0002138889,0.0001885313,0.000034586432,0.00022593101,0.00035054388,0.0000015669772],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018029431,0.005097577,0.9864771,0.00020891974,0.000094429146,0.00024069355,0.00005807081,6.3644643e-7,0.0006120972,0.00010212478,0.0008918925,0.0044135186],"study_design_scores_gemma":[0.009287571,0.010239589,0.976735,0.000031261796,0.000839513,0.00006419631,0.00012584041,0.00010203374,0.0000357547,0.0000011416033,0.0024314732,0.00010663924],"about_ca_topic_score_codex":0.00004403988,"about_ca_topic_score_gemma":0.000011818171,"teacher_disagreement_score":0.009742111,"about_ca_system_score_codex":0.00032866563,"about_ca_system_score_gemma":0.0003926219,"threshold_uncertainty_score":0.6219656},"labels":[],"label_agreement":null},{"id":"W4281638651","doi":"10.1093/neuonc/noac079.049","title":"RARE-24. The use of novel<i>in vitro</i> models to study adamantinomatous craniopharyngioma disease biology and drug response","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Children's Hospital","funders":"","keywords":"Cell culture; Biology; Population; Immunofluorescence; Cell; Molecular biology; Vimentin; Cell biology; In vitro; Transfection; Immunology; Genetics; Antibody; Immunohistochemistry; Medicine","score_opus":0.04786275865996559,"score_gpt":0.3022018912081063,"score_spread":0.2543391325481407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281638651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922475,0.00040948088,0.000027431564,0.005418308,0.00022243394,0.0014215176,0.00016990282,0.000027749547,0.000055659737],"genre_scores_gemma":[0.99529296,0.000026576701,0.000205484,0.00409953,0.00002038045,0.00026008178,0.000024470131,0.00002291644,0.0000476206],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981417,0.0006868376,0.00032530053,0.00040747237,0.00015600602,0.0002826608],"domain_scores_gemma":[0.9984343,0.00087003934,0.00008875026,0.0003916076,0.00003072763,0.00018458779],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028686845,0.00017112482,0.0004473908,0.00019754293,0.00015026519,0.0000063421344,0.00014190516,0.000033590055,0.00003293138],"category_scores_gemma":[0.00014454647,0.00012409303,0.00007078197,0.00028139882,0.00008069343,0.000058817917,0.00032270292,0.00020241199,0.0000024472881],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15650028,0.024552668,0.43023318,0.00004951885,0.00035321777,0.010700577,0.011301295,0.0023686627,0.34782362,0.00035566566,0.0040904596,0.011670864],"study_design_scores_gemma":[0.09470827,0.029890457,0.75627595,0.000031241812,0.0014908615,0.0019169333,0.004936394,0.01498981,0.003035309,0.0015339784,0.09018951,0.0010013075],"about_ca_topic_score_codex":0.0003678448,"about_ca_topic_score_gemma":0.00005251483,"teacher_disagreement_score":0.34478828,"about_ca_system_score_codex":0.0000614008,"about_ca_system_score_gemma":0.00019850538,"threshold_uncertainty_score":0.50603664},"labels":[],"label_agreement":null},{"id":"W4281640097","doi":"10.1093/neuonc/noac079.462","title":"MEDB-88. BAF60C/SMARCD3-mediated novel neurodevelopmental epigenomic program promotes metastatic dissemination in medulloblastoma","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Biology; Epigenomics; Cerebellum; Reelin; Chromatin; Transcription factor; Neuroscience; EZH2; Cancer research; Enhancer; Genetics; Gene expression; Gene; DNA methylation","score_opus":0.01391385690840411,"score_gpt":0.2983467163557028,"score_spread":0.2844328594472987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281640097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968063,0.00022313306,0.00017404086,0.0007770651,0.0005355306,0.000800464,0.000068925016,0.0000600522,0.0005544783],"genre_scores_gemma":[0.9953517,0.00007317489,0.0023255146,0.0006650382,0.000082341976,0.000763693,0.0005812038,0.0000552392,0.000102142396],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979167,0.0002885038,0.00046570838,0.00062736816,0.0002601302,0.00044157985],"domain_scores_gemma":[0.9992535,0.0001169164,0.00019535546,0.00027312335,0.00005344298,0.000107663705],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040739684,0.00023914817,0.00029715084,0.00013969753,0.00016367616,0.000019179615,0.00033350367,0.00010101206,0.0001217534],"category_scores_gemma":[0.00027869944,0.00025610448,0.00008986478,0.00029024767,0.00009464964,0.0000068406844,0.0003554835,0.0003387057,0.000012241143],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016834961,0.0007371927,0.0009793475,0.00002305155,0.000030474423,0.000048750655,0.00032902288,0.0005196803,0.9571821,0.000009308463,0.0010950658,0.038877636],"study_design_scores_gemma":[0.0076916567,0.009993724,0.012568738,0.000041239655,0.00012779386,0.0013777291,0.0017942262,0.034415536,0.38882858,0.00012415128,0.54147124,0.0015653785],"about_ca_topic_score_codex":0.000029178305,"about_ca_topic_score_gemma":0.00014075496,"teacher_disagreement_score":0.56835353,"about_ca_system_score_codex":0.00025259546,"about_ca_system_score_gemma":0.00049563835,"threshold_uncertainty_score":0.9999891},"labels":[],"label_agreement":null},{"id":"W4281642484","doi":"10.1093/neuonc/noac079.199","title":"GCT-05. Multi-institutional analysis of treatment modalities in metastatic germinoma in children","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Germinoma; Chemotherapy; Germ cell tumors; Radiation therapy; Biopsy; Primary tumor; Radiology; Progressive disease; Surgery; Metastasis; Internal medicine; Cancer","score_opus":0.03782648099807337,"score_gpt":0.3229005641374541,"score_spread":0.28507408313938076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281642484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976688,0.00037102512,0.0000052563964,0.0008149918,0.00009197152,0.0005766004,0.00015684123,0.0000131110655,0.000301411],"genre_scores_gemma":[0.998418,0.00006967262,0.00031685855,0.00038702233,0.000013539184,0.0005422727,0.00022214976,0.0000099140825,0.00002057776],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99859023,0.00025771727,0.0004299998,0.0003139305,0.00017989721,0.00022824378],"domain_scores_gemma":[0.99929696,0.0002674866,0.000121319776,0.00022178743,0.000023497645,0.000068957175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001387251,0.00016165308,0.0007726668,0.0010076949,0.0000559802,0.0000030445633,0.000073292336,0.0000373771,0.00037083824],"category_scores_gemma":[0.000047814538,0.00013209406,0.00021608584,0.0008518136,0.00008666143,0.000031034855,0.00006754612,0.0001292464,0.000004404158],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019384285,0.005971609,0.960314,0.000008325287,0.0012785632,0.0014054182,0.00094830425,0.015377874,0.0072855894,0.0006654749,0.000050243398,0.0065008043],"study_design_scores_gemma":[0.01043134,0.002920876,0.97252196,0.0000052097607,0.0019311734,0.00025432126,0.0003847038,0.006623016,0.0022972533,0.00003356759,0.002483903,0.00011268561],"about_ca_topic_score_codex":0.0018824983,"about_ca_topic_score_gemma":0.0011282907,"teacher_disagreement_score":0.012207999,"about_ca_system_score_codex":0.0012311622,"about_ca_system_score_gemma":0.00040686553,"threshold_uncertainty_score":0.538664},"labels":[],"label_agreement":null},{"id":"W4281646138","doi":"10.1093/neuonc/noac079.393","title":"MEDB-18. Elongation control of mRNA translation supports Group 3 medulloblastoma adaptation to nutrient deprivation","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Mitochondrial Function and Pathology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia","funders":"","keywords":"Gene knockdown; Translation (biology); Biology; Cell biology; Messenger RNA; Apoptosis; Biochemistry; Gene","score_opus":0.017733089707436606,"score_gpt":0.26077433357502705,"score_spread":0.24304124386759043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281646138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7626089,0.00010152386,0.23100488,0.0018176169,0.0022548179,0.001026824,0.00007217495,0.000034391207,0.0010788838],"genre_scores_gemma":[0.99500203,0.00002687981,0.0017609419,0.0020932546,0.0002506078,0.00025952683,0.0005431637,0.000022909258,0.00004070728],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99814904,0.000554146,0.00044237697,0.0004145687,0.00023182777,0.00020806532],"domain_scores_gemma":[0.9991885,0.0000957237,0.00025533832,0.00024961072,0.00011508942,0.0000957254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038771937,0.00013934216,0.00022470484,0.0001548367,0.00013984232,0.00000564172,0.0001399745,0.00016113193,0.00037866322],"category_scores_gemma":[0.00018854057,0.00015898196,0.00009405621,0.00022177048,0.000041327712,0.000007829902,0.000056813973,0.00015885408,0.000010927029],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013786845,0.00017105328,0.0007344855,0.000007652915,0.000019906724,0.0000099875115,0.00045699964,0.0038789923,0.97311085,0.00038881856,0.0021957136,0.017646847],"study_design_scores_gemma":[0.0041489857,0.0083074495,0.001520447,0.0000035118544,0.00007093087,0.00018475961,0.0005296787,0.002806503,0.2933591,0.00030004318,0.68848747,0.0002811127],"about_ca_topic_score_codex":0.000022735125,"about_ca_topic_score_gemma":0.00010550119,"teacher_disagreement_score":0.68629175,"about_ca_system_score_codex":0.00007084485,"about_ca_system_score_gemma":0.00015045119,"threshold_uncertainty_score":0.6483096},"labels":[],"label_agreement":null},{"id":"W4281648883","doi":"10.1093/neuonc/noac079.297","title":"IMMU-04. Transcriptional analysis reveals distinct microenvironmental subgroups across pediatric nervous system tumors","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Hospital for Sick Children; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Immune system; Medulloblastoma; Tumor microenvironment; Biology; Cell type; Cancer research; Myeloid; Immunotherapy; Transcriptome; Cell; Immunology; Gene; Genetics; Gene expression","score_opus":0.014127060509964354,"score_gpt":0.2691264567533607,"score_spread":0.25499939624339635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281648883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99542516,0.000767847,0.00002359329,0.0015801183,0.00054013694,0.0006244681,0.0005227777,0.00009739759,0.0004185169],"genre_scores_gemma":[0.9976589,0.000047231206,0.000097445976,0.000777099,0.00029716242,0.0005236029,0.000485847,0.000044029584,0.00006869436],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972613,0.00039213712,0.0006095858,0.000667971,0.00049936376,0.0005696475],"domain_scores_gemma":[0.99877983,0.00026345268,0.00025533652,0.00041748647,0.000027568927,0.00025630978],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032536688,0.00028813802,0.0008380311,0.00028338938,0.0004889073,0.000020235333,0.0001991483,0.00009177225,0.0008301935],"category_scores_gemma":[0.000026206753,0.00026966535,0.0005558829,0.000845414,0.00009591993,0.00004691356,0.0001686598,0.00039908141,0.00008732512],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048580952,0.0025615504,0.8128909,0.00009771465,0.0007526502,0.0061521367,0.0006586517,0.00047222045,0.17154339,0.00017616538,0.0025485212,0.0016603137],"study_design_scores_gemma":[0.0048423265,0.0023959524,0.9597363,0.0000052600226,0.0038515395,0.0021737458,0.001485528,0.00026359851,0.0012185015,0.000008466549,0.023733294,0.0002855091],"about_ca_topic_score_codex":0.00010571912,"about_ca_topic_score_gemma":0.000028954124,"teacher_disagreement_score":0.17032489,"about_ca_system_score_codex":0.0013271201,"about_ca_system_score_gemma":0.00010193923,"threshold_uncertainty_score":0.99997556},"labels":[],"label_agreement":null},{"id":"W4281654265","doi":"10.1093/neuonc/noac079.082","title":"DIPG-25. Patterns of cerebrospinal fluid diversion and survival in children with diffuse intrinsic pontine glioma: a report from the International Diffuse Intrinsic Pontine Glioma Registry","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Hydrocephalus; Glioma; Vomiting; Incidence (geometry); Cerebrospinal fluid; Surgery; Radiation therapy; Internal medicine","score_opus":0.01135986040156675,"score_gpt":0.24773150296573,"score_spread":0.23637164256416324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281654265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902252,0.00026560173,0.0000065513136,0.0077154166,0.0006028881,0.0007443196,0.0002275119,0.000045996974,0.00016654415],"genre_scores_gemma":[0.9983928,0.00011197477,0.00006622389,0.00050172216,0.00029954317,0.00012802964,0.00043729268,0.0000409453,0.00002147656],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99739677,0.00024781693,0.0006285445,0.00071342086,0.00066022715,0.00035322236],"domain_scores_gemma":[0.99816126,0.00041776814,0.00049884006,0.00065124076,0.000114952345,0.00015593164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030310077,0.00031433682,0.00068398716,0.0003047069,0.00016857943,0.000029585506,0.00035513,0.00011358398,0.00022044244],"category_scores_gemma":[0.0002651025,0.0002265608,0.00012125005,0.00041582307,0.00017072979,0.00008435824,0.00088630174,0.0005249866,0.0000033614983],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017899831,0.0032164583,0.92374766,0.000010183243,0.00032934337,0.008720481,0.0002967896,0.0000039595316,0.05660712,0.00007088898,0.0010442191,0.004162904],"study_design_scores_gemma":[0.018691843,0.0027405855,0.9623433,0.000048292542,0.0003105196,0.0060717687,0.00033632916,0.000022729211,0.0045823134,0.000023475419,0.004641867,0.00018702242],"about_ca_topic_score_codex":0.0026017702,"about_ca_topic_score_gemma":0.0005775055,"teacher_disagreement_score":0.052024804,"about_ca_system_score_codex":0.00031242182,"about_ca_system_score_gemma":0.00016491445,"threshold_uncertainty_score":0.92388815},"labels":[],"label_agreement":null},{"id":"W4281661953","doi":"10.1093/neuonc/noac079.511","title":"QOL-28. Clinico-molecular correlates of quality of survival and neurocognitive outcomes in medulloblastoma; a meta-analysis of the SIOP-UKCCSG-PNET3 and HIT-SIOP-PNET4 trials","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Neurocognitive; Survivorship curve; Quality of life (healthcare); Wechsler Adult Intelligence Scale; Internal medicine; Oncology; Randomized controlled trial; Clinical trial; Cancer; Cognition; Psychiatry","score_opus":0.13076726378010523,"score_gpt":0.4100935557205783,"score_spread":0.2793262919404731,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281661953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936928,0.0014211781,0.0000031596448,0.0030886855,0.00020872723,0.0010473402,0.0003194289,0.0000087199305,0.00020997401],"genre_scores_gemma":[0.9987886,0.0001549341,0.000044999626,0.00079516583,0.000007707791,0.00015972277,0.000018710427,0.000019877636,0.000010264387],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99280155,0.0041622883,0.0017593598,0.0005068275,0.0005366117,0.00023339265],"domain_scores_gemma":[0.98829484,0.009570241,0.0013802586,0.0004780665,0.0001697829,0.00010682625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026740402,0.0002613085,0.00428956,0.00045297126,0.000059262555,0.000004403213,0.00016467944,0.00012844932,0.0002605204],"category_scores_gemma":[0.0037446038,0.000168344,0.0012041399,0.00086030026,0.00035951647,0.000027943554,0.00039057905,0.000339354,4.3589523e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016130749,0.0031719438,0.79705346,0.00009583823,0.037572213,0.00020548991,0.0011040502,0.00028892752,0.15627879,0.00067378994,0.00005156557,0.0018908787],"study_design_scores_gemma":[0.009256929,0.0038471972,0.8370336,0.000008371231,0.121787935,0.000031226708,0.0013399627,0.00022951618,0.025590796,0.0002851809,0.00041007312,0.00017918288],"about_ca_topic_score_codex":0.00036841346,"about_ca_topic_score_gemma":0.00031156608,"teacher_disagreement_score":0.130688,"about_ca_system_score_codex":0.0000495471,"about_ca_system_score_gemma":0.00016333992,"threshold_uncertainty_score":0.6864869},"labels":[],"label_agreement":null},{"id":"W4281671975","doi":"10.1093/neuonc/noac079.094","title":"DIPG-37. Exploring the role of the epigenetic factor H2A.Z acetylation in DIPG","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Histone H3; Histone; Epigenetics; Carcinogenesis; Cancer research; Biology; Acetylation; Nucleosome; Genetics; Enhancer; Cancer; Gene; Molecular biology; Transcription factor","score_opus":0.026823172876355272,"score_gpt":0.26632675998467614,"score_spread":0.23950358710832087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281671975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961631,0.00085718447,0.000040068848,0.0011473602,0.00045019045,0.00024904494,0.00002150995,0.0000046156415,0.0010669823],"genre_scores_gemma":[0.99868196,0.00029649952,0.000019853962,0.00046811736,0.00011096643,0.0003155953,0.00001175539,0.000014232309,0.00008099983],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99900556,0.00028917825,0.00020346504,0.00022094109,0.00012046196,0.00016037014],"domain_scores_gemma":[0.9993555,0.000049606737,0.000118610136,0.00041702928,0.000036971134,0.000022286657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014003758,0.000083357976,0.000105369385,0.000024301225,0.00016119581,0.0000054991883,0.00035340048,0.00004854435,0.00007021155],"category_scores_gemma":[0.00007622063,0.00005908377,0.00007020832,0.00016659555,0.00007657817,0.0000031872814,0.00027277612,0.0001870416,0.0000021981966],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003781078,0.00006184777,0.006583069,0.0000020946036,0.000008144109,5.868218e-7,0.00029488356,0.0015629176,0.95498604,0.00015597057,0.00017120047,0.03613544],"study_design_scores_gemma":[0.00037417834,0.00034455367,0.04539554,0.0000016707164,0.000011497479,0.000010101186,0.0008418301,0.00020602185,0.41563144,0.00019081958,0.5369014,0.0000909608],"about_ca_topic_score_codex":0.000039919345,"about_ca_topic_score_gemma":0.00010688354,"teacher_disagreement_score":0.5393546,"about_ca_system_score_codex":0.00005881256,"about_ca_system_score_gemma":0.00013599357,"threshold_uncertainty_score":0.2409366},"labels":[],"label_agreement":null},{"id":"W4281673082","doi":"10.1093/neuonc/noac079.330","title":"LGG-15. Late mortality and morbidity of adult survivors of childhood glioma treated across three decades: a report from the Childhood Cancer Survivor Study","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Cumulative incidence; Incidence (geometry); Late effect; Glioma; Radiation therapy; Pediatrics; Cancer; Internal medicine; Surgery; Cohort","score_opus":0.03519455248854827,"score_gpt":0.3401039937371175,"score_spread":0.3049094412485693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281673082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945085,0.00064703287,7.5976294e-7,0.0012640599,0.00049073284,0.0019173853,0.0009495987,0.00005460818,0.00016729716],"genre_scores_gemma":[0.99868435,0.00014584108,0.000013003658,0.00035632862,0.00010554325,0.0005520215,0.00009468541,0.000043942287,0.0000043079767],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99681526,0.0005854447,0.00088931125,0.0007245169,0.0005891498,0.00039630482],"domain_scores_gemma":[0.997118,0.0008651974,0.00071246485,0.0009166464,0.00022656478,0.00016111718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057705154,0.00032245356,0.0010830353,0.000088364264,0.00027146153,0.000011491603,0.00025889825,0.00012609776,0.00023611794],"category_scores_gemma":[0.0003911466,0.00022911953,0.00020578397,0.000587964,0.0002514646,0.000049817318,0.00041795656,0.00043552968,0.0000015995732],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030994733,0.007813869,0.9690356,0.000016708316,0.0010372356,0.0021315678,0.005116003,0.000053619664,0.011352654,0.0000087627295,0.00025228912,0.002871712],"study_design_scores_gemma":[0.0067223767,0.002768965,0.97683036,0.000021101785,0.0008836948,0.00028973498,0.0019291136,0.00004058642,0.0098652495,0.00006591353,0.00043016076,0.00015275029],"about_ca_topic_score_codex":0.0776171,"about_ca_topic_score_gemma":0.080827236,"teacher_disagreement_score":0.007794721,"about_ca_system_score_codex":0.00015356787,"about_ca_system_score_gemma":0.00031849838,"threshold_uncertainty_score":0.9359453},"labels":[],"label_agreement":null},{"id":"W4281675166","doi":"10.1093/neuonc/noac079.006","title":"ATRT-07. Low-grade diffusely infiltrative tumor, SMARCB1-mutant: a clinical and histopathological distinct entity showing epigenetic similarity with ATRT-MYC","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Atypical teratoid rhabdoid tumor; SMARCB1; DNA methylation; Pathology; Lesion; Methylation; Epigenetics; Medicine; Immunohistochemistry; Cancer research; Biology; DNA; Gene; Genetics; Gene expression","score_opus":0.030702632775183147,"score_gpt":0.3043249687461088,"score_spread":0.27362233597092567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281675166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99596745,0.0007690801,0.0008273083,0.00063479674,0.00051392004,0.00037739926,0.00008966295,0.000051958687,0.0007684081],"genre_scores_gemma":[0.99643475,0.00021624692,0.0007288413,0.002007132,0.00033296927,0.00010907327,0.000077589,0.00004248057,0.00005091628],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99666655,0.0009751856,0.0005740939,0.0010121797,0.00028260308,0.0004893874],"domain_scores_gemma":[0.99869514,0.0002604858,0.00025835753,0.00047957688,0.00007610997,0.00023032702],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006234408,0.00032646276,0.00055110763,0.000048136277,0.0004599794,0.000030646555,0.00034896858,0.00022249308,0.00013887309],"category_scores_gemma":[0.00042565996,0.00028945346,0.00018336989,0.00014346733,0.0006339229,0.0000069269063,0.0006152448,0.0008014611,0.00000571151],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016611536,0.0014510258,0.15170254,0.000085421816,0.00011964652,0.0011355233,0.0005333497,0.000648182,0.8262884,0.000109675915,0.0016837489,0.014581319],"study_design_scores_gemma":[0.021730902,0.0397908,0.23693703,0.00009727381,0.0009942177,0.009013442,0.0020785108,0.008799237,0.069345035,0.0017521302,0.60549885,0.0039625564],"about_ca_topic_score_codex":0.000035110144,"about_ca_topic_score_gemma":0.00015794509,"teacher_disagreement_score":0.7569434,"about_ca_system_score_codex":0.00011662647,"about_ca_system_score_gemma":0.00042851045,"threshold_uncertainty_score":0.9999558},"labels":[],"label_agreement":null},{"id":"W4281678078","doi":"10.1093/neuonc/noac079.448","title":"MEDB-74. Serial assessment of measurable residual disease in medulloblastoma liquid biopsies","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Medicine; Minimal residual disease; Oncology; Biomarker; Liquid biopsy; Internal medicine; Cerebrospinal fluid; Prospective cohort study; Surrogate endpoint; Pathology; Cancer; Biology; Bone marrow","score_opus":0.013219359947624285,"score_gpt":0.2857020498579654,"score_spread":0.2724826899103411,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281678078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99519837,0.00042808725,0.000024032246,0.0013185478,0.000995189,0.00027465,0.00022808637,0.000009267194,0.0015237917],"genre_scores_gemma":[0.9979165,0.00030833954,0.00026170234,0.0008644235,0.00028319022,0.00016504774,0.0001301382,0.000028166785,0.00004249314],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984134,0.0002990051,0.00035947826,0.0004059206,0.00022044026,0.0003017627],"domain_scores_gemma":[0.99916565,0.000116096686,0.00016301841,0.0003590146,0.00006341395,0.00013280954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035197768,0.00015173355,0.00027215164,0.00009782687,0.00009584092,0.000008754676,0.00029398373,0.00009271931,0.00013751694],"category_scores_gemma":[0.00027525434,0.00017187999,0.00008339091,0.00013622097,0.0001169644,0.0000031830448,0.0005131169,0.00020340557,0.0000018755867],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018675762,0.00038093713,0.0072987173,0.000019552928,0.000027500178,0.00011032256,0.00006989987,0.0079973135,0.97645324,0.00033797597,0.0049151047,0.0005218846],"study_design_scores_gemma":[0.004336894,0.010700633,0.0125163,0.0000106470325,0.000085518426,0.00006701771,0.00041932086,0.0006269861,0.29994428,0.00023210491,0.6705445,0.0005157847],"about_ca_topic_score_codex":0.00011472261,"about_ca_topic_score_gemma":0.0003510886,"teacher_disagreement_score":0.67650896,"about_ca_system_score_codex":0.00015702203,"about_ca_system_score_gemma":0.0012234403,"threshold_uncertainty_score":0.7009063},"labels":[],"label_agreement":null},{"id":"W4281679010","doi":"10.1093/neuonc/noac079.474","title":"NFB-12. Effect of trametinib on leg length discrepancy in a child with NF1 related plexiform neurofibroma","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital","funders":"","keywords":"Medicine; Plexiform neurofibroma; Bone age; Neurofibroma; Trametinib; Neurofibromatosis; Radiology; Anatomy; Biology","score_opus":0.01129989077058915,"score_gpt":0.29624410415454494,"score_spread":0.2849442133839558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281679010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9708218,0.00004147613,4.84383e-7,0.0025616148,0.00016777964,0.0014458656,0.000044506243,0.00008464676,0.024831817],"genre_scores_gemma":[0.99894094,0.000030446585,0.00003699011,0.00035758398,0.000031833322,0.00026799858,0.000055313587,0.00006870841,0.00021017148],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9971563,0.00065876765,0.00043287314,0.0006008516,0.0005791321,0.0005720451],"domain_scores_gemma":[0.9981462,0.0009127176,0.0001822342,0.0004998613,0.000026671656,0.00023233198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002614936,0.00028794122,0.0007462768,0.00043640612,0.00013812263,0.000008694008,0.00019733373,0.00009496852,0.00031524943],"category_scores_gemma":[0.000341916,0.00021201912,0.0001469061,0.0006052929,0.00016674522,0.000073858086,0.00016672579,0.0012266912,0.000043117576],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18042672,0.020099591,0.18054135,0.00097269897,0.0011715203,0.12450901,0.0025456862,0.0005702917,0.25158057,0.0020861502,0.003685963,0.23181045],"study_design_scores_gemma":[0.07516144,0.6491191,0.1147777,0.00027619465,0.00040912512,0.017564867,0.0002711212,0.00065915694,0.071108975,0.00015783939,0.06986255,0.0006319703],"about_ca_topic_score_codex":0.00005605616,"about_ca_topic_score_gemma":0.000031550582,"teacher_disagreement_score":0.62901944,"about_ca_system_score_codex":0.00024766877,"about_ca_system_score_gemma":0.00023575571,"threshold_uncertainty_score":0.8645889},"labels":[],"label_agreement":null},{"id":"W4281685066","doi":"10.1093/neuonc/noac079.382","title":"MEDB-07. Long-term medical and functional outcomes of medulloblastoma survivors: a population-based, matched cohort study","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Institute for Clinical Evaluative Sciences; SickKids Foundation; Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"Medicine; Interquartile range; Medulloblastoma; Hazard ratio; Cancer registry; National Death Index; Population; Cohort; Pediatrics; Medical record; Proportional hazards model; Cancer; Internal medicine; Confidence interval","score_opus":0.020368692093338286,"score_gpt":0.3065351404884014,"score_spread":0.2861664483950631,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281685066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99287355,0.000091657006,0.000010388809,0.0051074577,0.00064728304,0.0010514237,0.000023497983,0.00005176407,0.00014298839],"genre_scores_gemma":[0.99765104,0.0000094364,0.000031642005,0.0015405507,0.00006686329,0.00053796096,0.00011814113,0.000026496467,0.000017887742],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975393,0.00037851496,0.0004877935,0.00042424107,0.0009386716,0.00023150415],"domain_scores_gemma":[0.9981452,0.0010593244,0.00018623512,0.00029611244,0.00007813751,0.00023498139],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00049441925,0.00019117005,0.0007311734,0.00020924216,0.000141607,0.0000059783033,0.00009132236,0.00009900008,0.0030543506],"category_scores_gemma":[0.00033154208,0.00015819297,0.00011400906,0.00020148486,0.00008789696,0.000027824373,0.00016349895,0.00027973508,0.000012561322],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036981792,0.0045377347,0.9903979,0.000027161643,0.0003087011,0.0013752858,0.00012210733,0.000038127455,0.00066253304,0.000041976025,0.00033355554,0.001785157],"study_design_scores_gemma":[0.0062575005,0.0029135284,0.9891094,0.000007629708,0.0003711221,0.00030253333,0.0001956831,0.00016259965,0.00016531389,0.000014502267,0.00040170303,0.00009851287],"about_ca_topic_score_codex":0.00051097857,"about_ca_topic_score_gemma":0.0010152733,"teacher_disagreement_score":0.0058876825,"about_ca_system_score_codex":0.00022801058,"about_ca_system_score_gemma":0.00031476695,"threshold_uncertainty_score":0.997857},"labels":[],"label_agreement":null},{"id":"W4281685884","doi":"10.1093/neuonc/noac079.222","title":"HGG-06. Phase 2 Study of Veliparib and Local Irradiation, Followed by Maintenance Veliparib and Temozolomide, in Patients with Newly Diagnosed High-Grade Glioma without H3 K27M or BRAF Mutations: A Report from the Children's Oncology Group ACNS1721 Study","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Children's Hospital","funders":"","keywords":"Veliparib; Temozolomide; Medicine; Internal medicine; Oncology; Radiation therapy; PARP inhibitor; Chemotherapy; Glioma; Cancer research; Poly ADP ribose polymerase; Biology","score_opus":0.01189601658187891,"score_gpt":0.2865408807553826,"score_spread":0.2746448641735037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281685884","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914392,0.00027419368,0.00001947852,0.0019096999,0.0002670682,0.00580808,0.00022179421,0.00004658465,0.0000138741225],"genre_scores_gemma":[0.99614507,0.000038105747,0.00017961343,0.0008802164,0.00005841447,0.0020453553,0.00058813026,0.00005851388,0.000006602774],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99585253,0.0010451195,0.0010328586,0.0010280794,0.0005858717,0.0004555238],"domain_scores_gemma":[0.9964601,0.0017638499,0.00075964705,0.00062996725,0.000171178,0.00021526476],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005029361,0.0004099463,0.0011894625,0.0002634539,0.00034074023,0.000027570793,0.00021675859,0.0001388163,0.000055162098],"category_scores_gemma":[0.0006394242,0.00027867325,0.00005263178,0.0008317371,0.00030829862,0.00012214395,0.00026642447,0.00052890624,0.0000017588656],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00497026,0.04007643,0.9310337,0.0000076089054,0.0005944518,0.0049046543,0.0046308357,0.000089438916,0.00095046475,0.000008887793,0.004959764,0.0077735134],"study_design_scores_gemma":[0.1039146,0.043961667,0.8409801,0.000019302415,0.00089048257,0.0003783762,0.007395523,0.00011281835,0.000079930665,0.00001806873,0.0020224368,0.00022666196],"about_ca_topic_score_codex":0.0037115195,"about_ca_topic_score_gemma":0.0045025963,"teacher_disagreement_score":0.09894434,"about_ca_system_score_codex":0.00047954527,"about_ca_system_score_gemma":0.0004090758,"threshold_uncertainty_score":0.99996656},"labels":[],"label_agreement":null},{"id":"W4281687841","doi":"10.1093/neuonc/noac079.324","title":"LGG-08. MR Imaging of pediatric low-grade gliomas: Pretherapeutic differentiation of<i>BRAF</i> V600E mutation,<i>BRAF</i>-Fused and Wild-Type tumors in patients without Neurofibromatosis-1","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Public Health Ontario; BC Children's Hospital; Dalhousie University; University of Toronto; Izaak Walton Killam Health Centre","funders":"","keywords":"V600E; Medicine; Wild type; Mutation; Magnetic resonance imaging; Cancer research; Mutant; Pathology; Nuclear medicine; Radiology; Biology; Gene; Genetics","score_opus":0.011587093337299693,"score_gpt":0.2622167037895961,"score_spread":0.2506296104522964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281687841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99720144,0.0005738026,0.0000046619234,0.0005669989,0.0004860326,0.0010294453,0.00002982276,0.000047091202,0.00006067661],"genre_scores_gemma":[0.9988562,0.00010370135,0.000086814514,0.00060604955,0.00005940873,0.00013303332,0.00009898005,0.000053670257,0.0000021717779],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99746764,0.00046927243,0.0007550891,0.00050292345,0.00046949397,0.00033561283],"domain_scores_gemma":[0.99843,0.0004136274,0.0005588689,0.0003276305,0.00014679086,0.00012305897],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017517513,0.00026711606,0.000710795,0.0006497975,0.0001008322,0.000011099804,0.00013510558,0.00007575544,0.00005455968],"category_scores_gemma":[0.00015808847,0.00025851483,0.00010862497,0.00090329756,0.000099139106,0.000113412505,0.00014479308,0.00027857214,0.000002830416],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047315162,0.0025465507,0.93117374,0.00016477615,0.000058533416,0.00012935449,0.0009289911,0.00011041312,0.061879694,0.000027604021,0.00013593177,0.0023712525],"study_design_scores_gemma":[0.014332892,0.0037676862,0.95315516,0.00004007734,0.0005464916,0.00010210345,0.00022717632,0.001184434,0.026002403,0.000106230305,0.00030831323,0.00022701452],"about_ca_topic_score_codex":0.000054595836,"about_ca_topic_score_gemma":0.000011341214,"teacher_disagreement_score":0.03587729,"about_ca_system_score_codex":0.00016329541,"about_ca_system_score_gemma":0.00019244896,"threshold_uncertainty_score":0.9999867},"labels":[],"label_agreement":null},{"id":"W4281689332","doi":"10.1093/neuonc/noac079.170","title":"EPID-02. Survival Experience in Pediatric Patients of Central Nervous System (CNS) Tumour in Canada","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Cancer registry; Choroid plexus; Astrocytoma; Central nervous system; Internal medicine; Oncology; Cancer; Pathology; Glioma","score_opus":0.018065750585793985,"score_gpt":0.2603503529750069,"score_spread":0.24228460238921293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281689332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99690896,0.00013936324,2.6458576e-7,0.00043291762,0.0013471164,0.00049273507,0.00003557218,0.000011206098,0.0006318675],"genre_scores_gemma":[0.9993666,0.00002433303,0.000010196995,0.0002814348,0.00005807033,0.00021960826,0.00002136356,0.000016188515,0.0000022026363],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980857,0.00033125546,0.0004859785,0.00030967157,0.00036431468,0.00042311987],"domain_scores_gemma":[0.9991635,0.0002944854,0.00017114877,0.00018991703,0.00004010763,0.00014080762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000113534625,0.00013654097,0.0004993787,0.00019710339,0.000041194748,0.000002097228,0.00013598196,0.00004018155,0.0000738294],"category_scores_gemma":[0.00011418425,0.00013147826,0.000048405953,0.00048146848,0.000019959696,0.000025654257,0.00012624112,0.00023940786,0.000002054993],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014384392,0.0008681539,0.9914824,0.000058662255,0.0000059048575,0.0025768084,0.0006368729,0.00047049843,0.0013100788,0.00003436132,0.0005354843,0.0018769559],"study_design_scores_gemma":[0.0040319785,0.0009859577,0.9893774,0.0000097959555,0.00003329928,0.00004395713,0.0017303205,0.00019716694,0.0016407011,0.0000012564963,0.0018558969,0.00009229726],"about_ca_topic_score_codex":0.3880241,"about_ca_topic_score_gemma":0.42721274,"teacher_disagreement_score":0.039188642,"about_ca_system_score_codex":0.0026412134,"about_ca_system_score_gemma":0.0014474776,"threshold_uncertainty_score":0.6906681},"labels":[],"label_agreement":null},{"id":"W4281690021","doi":"10.1093/neuonc/noac079.074","title":"DIPG-17. CD155 regulates cell growth and immune evasion in diffuse intrinsic pontine glioma","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Cancer research; Immune checkpoint; Biology; Immune system; CD137; IL-2 receptor; Immunotherapy; Glioma; T cell; CD86; CD44; Immunology; Cell","score_opus":0.00853908833374474,"score_gpt":0.22943345955700156,"score_spread":0.22089437122325684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281690021","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9775226,0.016700469,0.0000031698048,0.0019467906,0.0013771895,0.00046877167,0.000021388041,0.00010712651,0.0018525005],"genre_scores_gemma":[0.9964744,0.0010672098,0.00003228031,0.0011343001,0.00003242808,0.00013341715,0.00008060869,0.00005058655,0.000994757],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9962938,0.0017605857,0.00065115775,0.0005672662,0.00006994987,0.000657251],"domain_scores_gemma":[0.99816465,0.0010331463,0.00027232178,0.00045851062,0.00004067391,0.000030703446],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00057305663,0.00032908286,0.0006656224,0.0005396177,0.00050537,0.000018872943,0.00044746225,0.0003176512,0.0010597958],"category_scores_gemma":[0.00020277382,0.00032158886,0.00012838742,0.0004979155,0.0003615931,0.00013051151,0.00067981135,0.0010533727,0.00007836153],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004208964,0.0011860408,0.0009381672,0.000017565253,0.000053701555,0.00025389233,0.0012159577,0.0000036776653,0.97912574,0.00025391014,0.0017408994,0.011001476],"study_design_scores_gemma":[0.012240623,0.0038537828,0.014384373,0.000012570815,0.000042740176,0.0017470116,0.0006949549,0.000005238471,0.71879387,0.00025695108,0.24758494,0.00038291537],"about_ca_topic_score_codex":0.00020909867,"about_ca_topic_score_gemma":0.000017883018,"teacher_disagreement_score":0.26033184,"about_ca_system_score_codex":0.00014834467,"about_ca_system_score_gemma":0.00016212871,"threshold_uncertainty_score":0.99992365},"labels":[],"label_agreement":null},{"id":"W4281692082","doi":"10.1093/neuonc/noac079.155","title":"EPEN-18. Oncogenic 3D genome conformations identify novel therapeutic targets in ependymoma","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"CTCF; Biology; Carcinogenesis; Genome; Chromosome conformation capture; DNA methylation; Enhancer; Gene; Chromatin; Genetics; Cancer research; Computational biology; Gene expression","score_opus":0.04432274116930166,"score_gpt":0.33169151334022573,"score_spread":0.28736877217092405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281692082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97785044,0.001515279,0.00007943398,0.0070157223,0.0010311074,0.0013493362,0.0001049575,0.000093797695,0.010959957],"genre_scores_gemma":[0.99273235,0.00007705814,0.00017699141,0.006022792,0.00008104372,0.00063581014,0.00017354074,0.000033325105,0.00006711472],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982804,0.00015772243,0.0004847515,0.0003436659,0.00031057198,0.00042288032],"domain_scores_gemma":[0.9989608,0.0003108897,0.00016788775,0.00036030263,0.000054390606,0.00014574113],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00026577458,0.00019481154,0.00044804183,0.0003519706,0.00021809447,0.000016376714,0.00018574903,0.00009761688,0.0034916035],"category_scores_gemma":[0.00005738183,0.00018636136,0.00013854039,0.0003763583,0.00006217143,0.00008877287,0.00020510705,0.0004618797,0.00020946302],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048096615,0.007206308,0.0142343,0.0000535114,0.0003849732,0.0069970083,0.0031088288,0.00081159826,0.93212557,0.0019355526,0.0032461463,0.029415216],"study_design_scores_gemma":[0.016942602,0.0041763196,0.13913566,0.000010976206,0.0004137472,0.0055960943,0.0011144448,0.0011848571,0.0091917,0.00029061886,0.82154894,0.00039401956],"about_ca_topic_score_codex":0.00005838308,"about_ca_topic_score_gemma":0.000085269756,"teacher_disagreement_score":0.9229339,"about_ca_system_score_codex":0.00069175527,"about_ca_system_score_gemma":0.0003724628,"threshold_uncertainty_score":0.99741936},"labels":[],"label_agreement":null},{"id":"W4281702701","doi":"10.1093/neuonc/noac079.583","title":"OTHR-45. Kids First Variant WorkBench: application to germline genomic discoveries in the Children's Brain Tumor Network","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Genomics and Rare Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Python (programming language); Computer science; Genomics; Ensembl; Database; Genome; Biology; Gene; Genetics; Programming language","score_opus":0.005433572827895831,"score_gpt":0.23454205331168054,"score_spread":0.2291084804837847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281702701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877214,0.0005339876,0.00084206066,0.008999873,0.00038527435,0.0008043525,0.00013694014,0.000013361262,0.0005627564],"genre_scores_gemma":[0.9816971,0.000098365555,0.0002554666,0.016258482,0.00071426097,0.00052955345,0.00038016235,0.00003211273,0.00003452474],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984336,0.00027640286,0.00028109102,0.00051183475,0.00012061276,0.00037649774],"domain_scores_gemma":[0.999167,0.00009711934,0.00011724073,0.00050904346,0.00001923967,0.0000903043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003492428,0.00017828627,0.00019892567,0.00007332908,0.00032758387,0.00002994596,0.0005578471,0.000071235336,0.00006276132],"category_scores_gemma":[0.00007874859,0.00015472948,0.000096255746,0.0003200325,0.000070945294,0.0000031397371,0.00050113455,0.00022264221,0.000014069421],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015672087,0.0013597296,0.029848987,0.000026457263,0.00012880533,0.0004953111,0.0011951736,0.10949353,0.6594833,0.0033265618,0.1809129,0.012162033],"study_design_scores_gemma":[0.00076440483,0.0010851712,0.048319302,0.000002379862,0.00002733037,0.0004164506,0.00023054086,0.00017011965,0.00069994223,0.0003499923,0.94764066,0.00029370363],"about_ca_topic_score_codex":0.000081416605,"about_ca_topic_score_gemma":0.00032845137,"teacher_disagreement_score":0.76672775,"about_ca_system_score_codex":0.000056131812,"about_ca_system_score_gemma":0.00018738065,"threshold_uncertainty_score":0.6309685},"labels":[],"label_agreement":null},{"id":"W4281707601","doi":"10.1093/neuonc/noac079.076","title":"DIPG-19. FOXR2 is an oncogenic driver across pediatric and adult cancers","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Biology; Carcinogenesis; Epigenetics; Transcriptome; Cancer research; Epigenomics; Transcription factor; Oncogene; Cancer; Pediatric cancer; DNA methylation; Genetics; Gene; Gene expression; Cell cycle","score_opus":0.027099990667278882,"score_gpt":0.3557544753334464,"score_spread":0.32865448466616753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281707601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99463534,0.00023035154,0.0000019079,0.0030880813,0.00036206434,0.000552543,0.0001288528,0.000081128324,0.0009197527],"genre_scores_gemma":[0.98906577,0.0006555882,0.00009464475,0.009163528,0.000284178,0.00020096367,0.00003487283,0.000044909106,0.00045555877],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978527,0.00027681273,0.00022324768,0.0005938934,0.00042444418,0.00062892976],"domain_scores_gemma":[0.9986589,0.00020860946,0.00009336662,0.00035633286,0.000085546955,0.00059725315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001278174,0.00019147062,0.00035413442,0.00014054526,0.00041218076,0.000017506482,0.00016546133,0.000081629405,0.0006502131],"category_scores_gemma":[0.00013601524,0.00018005585,0.000089340494,0.00035550288,0.00014497199,0.00008981432,0.00034082917,0.0006018155,0.00006647629],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008144805,0.0035810808,0.47662044,0.0002474045,0.00043096062,0.026470369,0.010099483,0.00008265673,0.23193729,0.00014029436,0.12629746,0.11594775],"study_design_scores_gemma":[0.0315129,0.05088396,0.115095735,0.0000066846064,0.00060225214,0.006348766,0.0020931172,0.0009181682,0.012073988,0.00021443174,0.7795346,0.0007154049],"about_ca_topic_score_codex":0.0003680186,"about_ca_topic_score_gemma":0.00018506667,"teacher_disagreement_score":0.65323716,"about_ca_system_score_codex":0.00066494965,"about_ca_system_score_gemma":0.00082942005,"threshold_uncertainty_score":0.7342465},"labels":[],"label_agreement":null},{"id":"W4281711757","doi":"10.1093/neuonc/noac079.587","title":"PATH-03. Clinically Tractable Outcome Prediction of Group 3/4 Medulloblastoma Based on TPD52 Immunohistochemistry: a Multicohort Study","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; Canada's Michael Smith Genome Sciences Centre; University of British Columbia","funders":"","keywords":"Medulloblastoma; Oncology; Internal medicine; Immunohistochemistry; Biomarker; Multivariate analysis; Receiver operating characteristic; Biology; Medicine; Bioinformatics; Pathology; Genetics","score_opus":0.020240693518660563,"score_gpt":0.34173489698509263,"score_spread":0.3214942034664321,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281711757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898011,0.000035680587,0.00035527573,0.0022671693,0.0012658406,0.0010409344,0.000032984306,0.00014110979,0.0050598877],"genre_scores_gemma":[0.99440956,0.000008711634,0.0011167201,0.0037850337,0.00019235225,0.00024636555,0.000067688416,0.000054895136,0.00011867237],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9967205,0.00053982844,0.0010738405,0.000572551,0.0007250683,0.00036821084],"domain_scores_gemma":[0.9976421,0.0010374723,0.00041690154,0.0005902617,0.00008620868,0.00022702664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017249939,0.00022771583,0.0007871,0.0001714664,0.00021441361,0.000008423413,0.00028533672,0.00013085995,0.0005309752],"category_scores_gemma":[0.0021799628,0.00021623152,0.00022328495,0.00028061832,0.00016803069,0.000033225748,0.00015472606,0.0017758883,0.0000113004935],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003712958,0.010397788,0.39365977,0.00013969713,0.0001401496,0.001087071,0.0006996665,0.0015325297,0.56565624,0.00001916405,0.003195273,0.019759687],"study_design_scores_gemma":[0.049085226,0.09470899,0.26885825,0.00015594972,0.0015540054,0.0011329973,0.0033335618,0.3802975,0.0020079287,0.00004426601,0.19801418,0.00080713583],"about_ca_topic_score_codex":0.00007675265,"about_ca_topic_score_gemma":0.0000010810919,"teacher_disagreement_score":0.5636483,"about_ca_system_score_codex":0.0004284666,"about_ca_system_score_gemma":0.00034292488,"threshold_uncertainty_score":0.88176656},"labels":[],"label_agreement":null},{"id":"W4281722844","doi":"10.1093/neuonc/noac079.369","title":"LGG-58. Understanding the transcriptional heterogeneity of pediatric low-grade gliomas and its implication for tumor pathophysiology","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Hospital for Sick Children","funders":"","keywords":"Biology; Cell; Microglia; Single-cell analysis; Progenitor cell; Cell type; Genetic heterogeneity; Population; Cell cycle; Cancer research; Gene; Bioinformatics; Neuroscience; Phenotype; Medicine; Immunology; Cell biology; Genetics; Stem cell; Inflammation","score_opus":0.05608979461747214,"score_gpt":0.3139350522948154,"score_spread":0.25784525767734323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281722844","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929908,0.0011180019,0.00009515282,0.0044285753,0.00027784702,0.0009060099,0.00012097934,0.000019821855,0.000042842414],"genre_scores_gemma":[0.9979846,0.00015506265,0.000053271116,0.000965609,0.00015911489,0.0006180052,0.000045833312,0.000016790455,0.0000017325995],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9989583,0.00015931268,0.00025372507,0.0002869087,0.00013817074,0.00020361676],"domain_scores_gemma":[0.9990455,0.0005319259,0.00015345227,0.00015630669,0.00004394173,0.00006887589],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016375548,0.00011568086,0.0002850912,0.00012326309,0.00023656116,0.000003800172,0.0000815304,0.000048404992,0.000041916202],"category_scores_gemma":[0.00005403007,0.00008804,0.00011979156,0.00020056167,0.000056812347,0.000024687622,0.000054250053,0.00013663937,0.0000012799218],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003874232,0.0007941545,0.008354429,0.00007665611,0.000062818865,0.000051244406,0.00025814387,0.00006398917,0.98156476,0.0073848506,0.0005199217,0.00048163475],"study_design_scores_gemma":[0.050501324,0.04164065,0.45921913,0.00003109131,0.004430813,0.0035089164,0.0038034862,0.006875263,0.34161243,0.031130057,0.056119736,0.0011271037],"about_ca_topic_score_codex":0.000004015553,"about_ca_topic_score_gemma":0.00000484145,"teacher_disagreement_score":0.6399523,"about_ca_system_score_codex":0.00021116556,"about_ca_system_score_gemma":0.00012243472,"threshold_uncertainty_score":0.3590167},"labels":[],"label_agreement":null},{"id":"W4281724068","doi":"10.1093/neuonc/noac079.423","title":"MEDB-49. Relapsed SHH medulloblastomas in young children. Are there alternatives to full-dose craniospinal irradiation?","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; London Health Sciences Centre; BC Children's Hospital; Izaak Walton Killam Health Centre; Centre hospitalier universitaire de Québec; Alberta Children's Hospital","funders":"","keywords":"Medulloblastoma; Medicine; Radiation therapy; Salvage therapy; Chemotherapy; Neurocognitive; Surgery; Population; Cohort; Internal medicine; Pathology","score_opus":0.01458668472295697,"score_gpt":0.29203563345011685,"score_spread":0.27744894872715986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281724068","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9782629,0.00035477636,0.0000032946139,0.017047403,0.000781073,0.0010994301,0.00005543866,0.00007931487,0.0023163452],"genre_scores_gemma":[0.99570733,0.00006628983,0.00015924631,0.0030156607,0.00020045896,0.00069968525,0.000052471652,0.00004856919,0.000050296025],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977484,0.0003746108,0.0004146568,0.0005925139,0.00043572256,0.00043412557],"domain_scores_gemma":[0.99886286,0.00025286237,0.00020307218,0.00036601018,0.00006320532,0.0002520076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022175793,0.00025611077,0.000537063,0.00036601533,0.00019308207,0.000016178285,0.00022399604,0.000093092254,0.00073934457],"category_scores_gemma":[0.00023467107,0.0002367715,0.00012798132,0.0005247362,0.0000566296,0.00006341517,0.00019407828,0.000495202,0.0001265477],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014897812,0.0034156952,0.8859416,0.000017066672,0.0002109569,0.003888868,0.0026149056,0.00095553976,0.08963952,0.00038327728,0.005119042,0.006323712],"study_design_scores_gemma":[0.008034399,0.0056063607,0.9664774,0.000024555904,0.00009552012,0.0008806431,0.00078732456,0.00018744747,0.0018210445,0.00008942111,0.01578664,0.00020924499],"about_ca_topic_score_codex":0.00019421085,"about_ca_topic_score_gemma":0.00075872446,"teacher_disagreement_score":0.08781848,"about_ca_system_score_codex":0.0007294044,"about_ca_system_score_gemma":0.00020661583,"threshold_uncertainty_score":0.96552616},"labels":[],"label_agreement":null},{"id":"W4281728046","doi":"10.1093/neuonc/noac079.217","title":"HGG-01. A novel genetically engineered H3.3G34R model reveals cooperation with ATRX loss in upregulation of PRC2 target genes and promotion of the NOTCH pathway","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"ATRX; Context (archaeology); Cancer research; Biology; Mutation; Gene; Genetics","score_opus":0.019860776948453594,"score_gpt":0.2544088677058148,"score_spread":0.2345480907573612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281728046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958691,0.00013591965,0.0007567378,0.002102323,0.000058638438,0.0009781389,0.000038118727,0.000010149679,0.000050873954],"genre_scores_gemma":[0.99722826,0.00003062133,0.0023257623,0.00013715289,0.000021457257,0.00019935386,0.000033564636,0.000016965798,0.000006848881],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990057,0.000121997124,0.00031465123,0.00022057728,0.00020853081,0.00012854314],"domain_scores_gemma":[0.9993984,0.00011135599,0.00014866082,0.00019665071,0.000104987215,0.00003995537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017152769,0.00010789685,0.00029826866,0.0000878605,0.00004653833,0.0000029006515,0.000054783584,0.00006540733,0.000021449483],"category_scores_gemma":[0.000072109586,0.000075923,0.000035650457,0.00022664045,0.00006665967,0.00003162673,0.00006603296,0.000113454524,1.8926214e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024192125,0.0011010781,0.035092626,0.000047724665,0.00002635936,0.000020155243,0.000476893,0.06798675,0.89265096,0.00061447587,0.000023827322,0.0017172525],"study_design_scores_gemma":[0.0099901315,0.006557704,0.2182793,0.00007508157,0.0001892367,0.00036561774,0.00009580606,0.25480232,0.5085354,0.0002529541,0.00066957873,0.00018688099],"about_ca_topic_score_codex":0.000015966596,"about_ca_topic_score_gemma":0.000038745147,"teacher_disagreement_score":0.38411555,"about_ca_system_score_codex":0.00010197991,"about_ca_system_score_gemma":0.0001976061,"threshold_uncertainty_score":0.30960503},"labels":[],"label_agreement":null},{"id":"W4281728172","doi":"10.1093/neuonc/noac079.221","title":"HGG-05. Systematic review of diffuse hemispheric glioma, H3 G34-mutant and clinical factors influencing outcomes","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nova Scotia Health Authority; Hospital for Sick Children; Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"ATRX; Medicine; PDGFRA; Internal medicine; Oncology; IDH1; Glioma; Pediatrics; Mutation; Cancer research; Stromal cell","score_opus":0.034325994089038636,"score_gpt":0.3453557440419695,"score_spread":0.31102974995293087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281728172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987031,0.009365313,9.90836e-7,0.001334464,0.0004171248,0.0015919401,0.000019731811,0.000045335688,0.00019409155],"genre_scores_gemma":[0.9920997,0.0030482346,0.000074559975,0.0044113626,0.000027315704,0.00028570832,0.000012413951,0.000031103635,0.000009589608],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972106,0.0005861985,0.00117833,0.00039107713,0.00036632502,0.00026743015],"domain_scores_gemma":[0.9968539,0.0017928628,0.0005664622,0.00049986615,0.00007620872,0.00021069359],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000529977,0.00023706874,0.0018360247,0.00009448736,0.00010207734,0.0000063973157,0.00014473007,0.00008959033,0.00020465681],"category_scores_gemma":[0.0015415563,0.00016528272,0.00030941566,0.0003028513,0.000101410464,0.000035122728,0.00024485413,0.00032503114,0.000008309101],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017148299,0.0054797684,0.760494,0.15900384,0.0011081996,0.0042342604,0.00076573883,0.0000034447146,0.06536749,0.00013684083,0.0019344438,0.0013004798],"study_design_scores_gemma":[0.06854299,0.05097552,0.64222604,0.10245433,0.03538866,0.013597796,0.0072321533,0.00054892036,0.037196256,0.00022269014,0.038820278,0.002794358],"about_ca_topic_score_codex":0.000037381655,"about_ca_topic_score_gemma":0.000007008282,"teacher_disagreement_score":0.118267946,"about_ca_system_score_codex":0.00023711094,"about_ca_system_score_gemma":0.00017791944,"threshold_uncertainty_score":0.67400336},"labels":[],"label_agreement":null},{"id":"W4281731883","doi":"10.1093/neuonc/noac079.116","title":"DIPG-59. Blood Brain Barrier (BBB) modulation using Cadherin peptides in the treatment of Diffuse Midline Glioma of the Pons (DMG-P)","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; Research Manitoba","funders":"","keywords":"In vitro; Blood–brain barrier; Glioma; Chemistry; Tight junction; Cancer research; Permeability (electromagnetism); Brainstem; In vivo; Biophysics; Pathology; Pharmacology; Medicine; Central nervous system; Biochemistry; Biology; Internal medicine; Membrane","score_opus":0.032572868630529384,"score_gpt":0.30683182144574206,"score_spread":0.2742589528152127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281731883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933732,0.00029967786,0.0000019159488,0.0049548373,0.00021070398,0.0009245158,0.00006341804,0.0000110442625,0.00016066713],"genre_scores_gemma":[0.9989694,0.00004075946,0.0000947117,0.0005887625,0.00006658955,0.00018397204,0.000017614126,0.000022416898,0.000015801214],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982384,0.0005542599,0.0004260404,0.00025836585,0.00029848455,0.00022448126],"domain_scores_gemma":[0.99847716,0.00070992205,0.00024131505,0.00047863304,0.000040952786,0.000051989795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020293817,0.00017115929,0.0004363873,0.00016368946,0.0001312407,0.0000044692247,0.0001531411,0.00006909152,0.000110911904],"category_scores_gemma":[0.00013531776,0.00010172077,0.00020014118,0.00047174323,0.0001200137,0.000026171008,0.00008016077,0.00014442332,9.3301406e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025357935,0.007577773,0.099802405,0.000018423476,0.00012717093,0.00044611713,0.003367571,0.0014267425,0.8836079,0.00016719033,0.00014105212,0.0030640545],"study_design_scores_gemma":[0.032319285,0.018976893,0.49850908,0.000061814724,0.0016713545,0.0016921936,0.0031890597,0.006997865,0.40547168,0.00031736816,0.030467693,0.00032571223],"about_ca_topic_score_codex":0.00047903578,"about_ca_topic_score_gemma":0.00027671971,"teacher_disagreement_score":0.47813624,"about_ca_system_score_codex":0.00026636993,"about_ca_system_score_gemma":0.0001606897,"threshold_uncertainty_score":0.41480526},"labels":[],"label_agreement":null},{"id":"W4281738783","doi":"10.1093/neuonc/noac079.216","title":"GCT-22. OUTCOMES OF CHILDREN WITH LOCALIZED AND METASTATIC GERMINOMA TREATED WITH CHEMOTHERAPY FOLLOWED BY RADIATION THERAPY WITHOUT PRIMARY TUMOR BOOST","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Chemotherapy; Radiation therapy; Germinoma; Retrospective cohort study; Primary tumor; Radiology; Surgery; Internal medicine; Metastasis; Cancer","score_opus":0.010812067301997238,"score_gpt":0.26733861349501886,"score_spread":0.2565265461930216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281738783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99502933,0.0009374275,0.000010851633,0.0019561357,0.00003406074,0.0016346977,0.00006862,0.00005827187,0.00027059182],"genre_scores_gemma":[0.994179,0.0002192883,0.0004954882,0.004341807,0.000015168087,0.00044598267,0.0002006014,0.000062446685,0.00004022467],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984471,0.00023129153,0.00031505342,0.00041950223,0.0003251778,0.00026188118],"domain_scores_gemma":[0.9989874,0.00022563305,0.0003111955,0.00029329644,0.000049240785,0.00013326824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012232,0.0002843488,0.0009140397,0.00015689219,0.00011615226,0.000010383322,0.00008286682,0.000038720806,0.00017268796],"category_scores_gemma":[0.000013489986,0.00018388616,0.000078041856,0.0002639705,0.0001558271,0.0000537698,0.000028595397,0.00016832027,0.0000014365377],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036453945,0.0020424782,0.92286444,0.000013905823,0.0009242335,0.00027507808,0.00027143914,0.000008319244,0.05217074,0.000010286452,0.0014952299,0.016278453],"study_design_scores_gemma":[0.07036835,0.023552148,0.8272709,0.000014455185,0.00091644505,0.0014579457,0.00011729305,0.00009046273,0.055849925,0.0000080905,0.02002869,0.00032527695],"about_ca_topic_score_codex":0.00013032636,"about_ca_topic_score_gemma":0.000011102636,"teacher_disagreement_score":0.09559352,"about_ca_system_score_codex":0.00018469579,"about_ca_system_score_gemma":0.0002242714,"threshold_uncertainty_score":0.749866},"labels":[],"label_agreement":null},{"id":"W4281749964","doi":"10.1093/neuonc/noac079.310","title":"IMMU-17. Comprehensive immunological gene expression profiling of pediatric brain tumors","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Immune system; Immunotherapy; Glioma; Immune privilege; Cancer research; Brain tumor; Tumor microenvironment; Immune checkpoint; Gene expression profiling; Medicine; Biology; Immunology; Gene expression; Pathology; Gene","score_opus":0.03296625932492335,"score_gpt":0.3054882796986671,"score_spread":0.27252202037374373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281749964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941029,0.0015173535,0.000008524293,0.0024876157,0.00038122042,0.0006731441,0.000028739702,0.0000625361,0.000737989],"genre_scores_gemma":[0.9964864,0.00015559126,0.0012082626,0.0015671058,0.00016507921,0.00029856624,0.00007491801,0.000024491581,0.000019537423],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998257,0.00035328328,0.000419083,0.0003848917,0.00027955856,0.00030620713],"domain_scores_gemma":[0.9985006,0.00074290216,0.00024958447,0.00031679406,0.000091590446,0.00009855426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013263982,0.00017487096,0.00055709435,0.00020393082,0.0001624421,0.0000036121262,0.0001453255,0.000097750126,0.000588488],"category_scores_gemma":[0.00016115495,0.00014340012,0.00015969409,0.00031260573,0.00007955969,0.000025244488,0.00036650093,0.0004141625,0.000018011357],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043816466,0.0014491715,0.025064806,0.000023945293,0.00003940912,0.0013944084,0.00016800861,0.0001398987,0.9646688,0.00008096755,0.0043714084,0.0021610016],"study_design_scores_gemma":[0.0077960067,0.0098766135,0.045945607,0.000012065027,0.00024950394,0.0010413822,0.00082896114,0.00011252207,0.89644355,0.00009485228,0.037372883,0.00022604747],"about_ca_topic_score_codex":0.0000118454545,"about_ca_topic_score_gemma":3.0687158e-7,"teacher_disagreement_score":0.06822526,"about_ca_system_score_codex":0.00019517161,"about_ca_system_score_gemma":0.00020095443,"threshold_uncertainty_score":0.6443531},"labels":[],"label_agreement":null},{"id":"W4281753564","doi":"10.1093/neuonc/noac079.340","title":"LGG-26. Predicting MAPK inhibitor sensitivity in pediatric low-grade gliomas with novel gene expression-derived signatures","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"MAPK/ERK pathway; Gene signature; Biology; Cancer research; Gene expression; Gene; Gene expression profiling; Medicine; Bioinformatics; Pathology; Genetics; Signal transduction","score_opus":0.014743019385586031,"score_gpt":0.25972111797201575,"score_spread":0.24497809858642972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281753564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99541926,0.00046916894,0.000025259535,0.0021264572,0.00061602495,0.0009018952,0.00005879578,0.00016870703,0.00021443251],"genre_scores_gemma":[0.99674505,0.000053092157,0.0008413775,0.0012647973,0.0005759454,0.00038801206,0.000050324812,0.00007542027,0.0000059848467],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99757737,0.00031618917,0.00038875523,0.00069162936,0.00049975695,0.0005262965],"domain_scores_gemma":[0.99834836,0.0007598802,0.00023434428,0.00036305032,0.00006928745,0.00022506379],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002950927,0.0003030842,0.0005912386,0.00045221014,0.00024043165,0.000014830392,0.00010028637,0.0001736594,0.00007776655],"category_scores_gemma":[0.00017881452,0.00025110325,0.00010926588,0.00068812125,0.000071199196,0.000072730334,0.00028992546,0.00079770363,0.00000772851],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005519093,0.0025895252,0.16463137,0.00004049435,0.000032400007,0.007812999,0.00045502497,0.0008767716,0.82163626,0.0000087854005,0.0009191083,0.00044537932],"study_design_scores_gemma":[0.016266335,0.0048727863,0.24886529,0.00005485946,0.00033744512,0.00195518,0.00052346266,0.000972794,0.7206257,0.000015919857,0.0050938213,0.00041642282],"about_ca_topic_score_codex":0.00007714958,"about_ca_topic_score_gemma":0.000111736954,"teacher_disagreement_score":0.10101055,"about_ca_system_score_codex":0.00042738172,"about_ca_system_score_gemma":0.00033855616,"threshold_uncertainty_score":0.9999941},"labels":[],"label_agreement":null},{"id":"W4281755113","doi":"10.1093/neuonc/noac079.530","title":"SURG-12. Endoscopic evaluation of ventricular dissemination in primary central nervous system (CNS) germ cell tumors (GCTs)","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Germinoma; Medicine; Neurosurgery; Germ cell tumors; Endoscopic third ventriculostomy; Exact test; Internal medicine; Primary tumor; Surgery; Oncology; Pathology; Cancer; Endoscopy; Metastasis; Chemotherapy","score_opus":0.01647057869221559,"score_gpt":0.2844507484136681,"score_spread":0.2679801697214525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281755113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99376506,0.00067159283,0.0000027779702,0.00045949544,0.00059004565,0.001258461,0.000019146943,0.000032447675,0.0032009636],"genre_scores_gemma":[0.99907094,0.000020050811,0.00003176395,0.00013138569,0.00006979656,0.00047035038,0.00017224422,0.000021642109,0.00001179986],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99746907,0.00073545374,0.00047831304,0.00032598834,0.0006843206,0.00030688327],"domain_scores_gemma":[0.9988837,0.00036161463,0.0003040743,0.00025117357,0.00010292998,0.00009646901],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006971995,0.00014687632,0.00046555718,0.00028256333,0.000069407,0.000005339426,0.00009219117,0.00007058969,0.00017599041],"category_scores_gemma":[0.0001308902,0.00014031697,0.00010627002,0.0003276871,0.000030924868,0.000040355015,0.00008399967,0.00021094592,0.000007172488],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040666613,0.006168308,0.6232913,0.0006604494,0.00008675151,0.0068075927,0.0014037793,0.0037808053,0.2929113,0.00028325553,0.0026234372,0.06157638],"study_design_scores_gemma":[0.009775652,0.0025466266,0.89111495,0.000119593744,0.00069450005,0.0004825324,0.00095664663,0.004982212,0.08368431,0.000018432074,0.0054496033,0.00017493643],"about_ca_topic_score_codex":0.00007677067,"about_ca_topic_score_gemma":0.000017037948,"teacher_disagreement_score":0.26782367,"about_ca_system_score_codex":0.0021418303,"about_ca_system_score_gemma":0.00048663677,"threshold_uncertainty_score":0.572196},"labels":[],"label_agreement":null},{"id":"W4281777545","doi":"10.1093/neuonc/noac079.389","title":"MEDB-14. Clinical outcome of pediatric medulloblastoma patients with Li-Fraumeni syndrome","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Medicine; Retrospective cohort study; Chemotherapy; Radiation therapy; Internal medicine; Oncology; Missense mutation; Incidence (geometry); Pathology; Mutation; Biology","score_opus":0.02551840645439419,"score_gpt":0.3166582305985973,"score_spread":0.29113982414420314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281777545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936282,0.00014232333,0.000047662237,0.0011151799,0.0021219682,0.0009415253,0.0000621766,0.00010703933,0.0018339428],"genre_scores_gemma":[0.99653256,0.000041811363,0.00042397992,0.0024498636,0.0001807051,0.00012918841,0.00005550363,0.000084084546,0.00010229446],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99653155,0.0005208656,0.0010462576,0.0006218868,0.0008129654,0.00046648792],"domain_scores_gemma":[0.9977648,0.000510578,0.0005564222,0.0006539446,0.00019659847,0.00031765702],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005096085,0.00025958777,0.0009779208,0.00032687705,0.00011171641,0.0000040153504,0.00029895955,0.00024154827,0.00075754285],"category_scores_gemma":[0.0005647228,0.00023520448,0.0002488138,0.00068562845,0.00018247572,0.000043928918,0.00038382673,0.0012998427,0.00007200624],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002787419,0.0028085564,0.9741504,0.000103407605,0.00022843269,0.003181738,0.00023835889,0.00016908962,0.002616233,0.000064602464,0.008236542,0.005415209],"study_design_scores_gemma":[0.03301718,0.07355932,0.6473089,0.000024285295,0.0019480134,0.0031342048,0.00017302846,0.0002068132,0.0007489512,0.00005085982,0.2391174,0.000711062],"about_ca_topic_score_codex":0.000023409804,"about_ca_topic_score_gemma":0.000020964286,"teacher_disagreement_score":0.32684153,"about_ca_system_score_codex":0.00041240352,"about_ca_system_score_gemma":0.0007228579,"threshold_uncertainty_score":0.95913607},"labels":[],"label_agreement":null},{"id":"W4281779592","doi":"10.1093/neuonc/noac079.372","title":"LGG-61. Cerebrospinal fluid as a source for liquid biopsy in pediatric gliomas","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"","keywords":"Liquid biopsy; Biopsy; Medicine; Cerebrospinal fluid; Pathology; Oncology; Internal medicine; Cancer","score_opus":0.019711849833012062,"score_gpt":0.3019914259427216,"score_spread":0.28227957610970955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281779592","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98776394,0.0007602815,0.000016104705,0.007873691,0.0007371641,0.0011405363,0.00002352364,0.0000859326,0.0015988284],"genre_scores_gemma":[0.994514,0.0000799784,0.00024433236,0.0030291239,0.0004646106,0.0014739573,0.000051610714,0.0000548023,0.00008758602],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99808615,0.00016740365,0.00040390634,0.00054325256,0.00027820893,0.0005210739],"domain_scores_gemma":[0.9988285,0.0004406973,0.00014169018,0.00032804505,0.00006056515,0.00020055354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024045225,0.00022254576,0.0005085101,0.0004929616,0.00023566208,0.000014579356,0.00016545126,0.00012509625,0.0005144298],"category_scores_gemma":[0.00022727117,0.00021386755,0.00019586048,0.0006580202,0.00006071136,0.00003622967,0.00020473289,0.0003202916,0.000084680396],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013870926,0.013376866,0.17713071,0.0003480293,0.00022581416,0.012057884,0.0028781944,0.00043748767,0.70846766,0.002311064,0.04921454,0.019680837],"study_design_scores_gemma":[0.019791465,0.043056205,0.022526363,0.0000120625555,0.00056575245,0.004209333,0.00061918725,0.00036664822,0.022240076,0.0002027007,0.8859876,0.00042263803],"about_ca_topic_score_codex":0.00012049573,"about_ca_topic_score_gemma":0.000030868814,"teacher_disagreement_score":0.83677304,"about_ca_system_score_codex":0.0004839873,"about_ca_system_score_gemma":0.0005506341,"threshold_uncertainty_score":0.8721265},"labels":[],"label_agreement":null},{"id":"W4281781457","doi":"10.1093/neuonc/noac079.048","title":"RARE-23. Preservation of endocrine function after Ommaya reservoir insertion in children with cystic craniopharyngioma","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Endocrine system; Medicine; Surgery; Craniopharyngioma; Ommaya reservoir; Radiation therapy; Debulking; Retrospective cohort study; Hormone; Internal medicine; Chemotherapy; Cancer","score_opus":0.012611462153198279,"score_gpt":0.2563043907920206,"score_spread":0.24369292863882233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281781457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966619,0.0003270569,0.000044353557,0.0010856917,0.00013714508,0.00076664204,0.000027277856,0.000034930177,0.0009150138],"genre_scores_gemma":[0.99827206,0.000035924586,0.00007649952,0.00074990693,0.000048760325,0.0003600753,0.00034586113,0.000021190488,0.00008973905],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99877465,0.00019818111,0.00028019608,0.0002838101,0.00025037737,0.00021276143],"domain_scores_gemma":[0.99945253,0.00008000508,0.0001118176,0.00024148278,0.000051107825,0.00006304832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010055773,0.00013292277,0.00029775948,0.00023152606,0.00006628549,0.0000032149674,0.000072053226,0.000046940295,0.0002875989],"category_scores_gemma":[0.000056754212,0.00011127005,0.000050228256,0.0003798388,0.000038655984,0.00014598102,0.00008591693,0.0002218434,0.000008877351],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010598541,0.0012998612,0.970494,0.000030971514,0.000082378065,0.00040047133,0.00015073274,0.00034084413,0.014040123,0.00003565312,0.00046018139,0.002066268],"study_design_scores_gemma":[0.009699247,0.007889503,0.976811,0.000012585098,0.0001575347,0.00047379895,0.000048401937,0.00019876608,0.00045589128,0.00033910997,0.0038251095,0.0000890509],"about_ca_topic_score_codex":0.00031604382,"about_ca_topic_score_gemma":0.0002011739,"teacher_disagreement_score":0.013584232,"about_ca_system_score_codex":0.00015367528,"about_ca_system_score_gemma":0.00014562432,"threshold_uncertainty_score":0.45374608},"labels":[],"label_agreement":null},{"id":"W4281784147","doi":"10.1093/neuonc/noac079.038","title":"RARE-13. Clinical management and functional and survival outcomes in pediatric craniopharyngioma, a patient and family perspective","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"","keywords":"Craniopharyngioma; Medicine; Radiation therapy; Quality of life (healthcare); Pediatrics; Neurocognitive; Chemotherapy; Biopsy; Surgery; Internal medicine; Psychiatry; Cognition","score_opus":0.027259042182802503,"score_gpt":0.3087836467949135,"score_spread":0.281524604612111,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281784147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99113667,0.002070322,0.0000050929175,0.0016375626,0.0004671176,0.0005028176,0.000021331665,0.00001922434,0.004139835],"genre_scores_gemma":[0.99653184,0.0014165031,0.00009888806,0.0017126569,0.00005118673,0.00009358988,0.0000143188545,0.000011669695,0.00006933382],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99877316,0.00019562457,0.00025529094,0.0004157616,0.00017605264,0.0001841322],"domain_scores_gemma":[0.99938625,0.00030709954,0.000059589605,0.0001002228,0.00002194951,0.00012486122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014982156,0.0001356039,0.00038667442,0.0001711702,0.00011876925,0.0000066119446,0.00002548598,0.00005163661,0.000047219015],"category_scores_gemma":[0.000044640426,0.00011492895,0.00004650086,0.00012391093,0.000072370356,0.000038828366,0.00022039936,0.00022778474,0.0000025205795],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009407926,0.001044197,0.98964775,0.000019268282,0.00007595207,0.0014627106,0.00034476878,0.00000253465,0.000030883537,0.0003100456,0.00065431424,0.0054667895],"study_design_scores_gemma":[0.0095370915,0.00317015,0.98159844,0.000001363346,0.00018564597,0.0001611604,0.0017886126,0.00004668972,4.420065e-7,0.0005486961,0.002872834,0.00008885539],"about_ca_topic_score_codex":0.00009827867,"about_ca_topic_score_gemma":0.00004760006,"teacher_disagreement_score":0.008596299,"about_ca_system_score_codex":0.0000889621,"about_ca_system_score_gemma":0.00006102317,"threshold_uncertainty_score":0.46866667},"labels":[],"label_agreement":null},{"id":"W4281829220","doi":"10.1093/neuonc/noac079.301","title":"IMMU-08. Nivolumab with or without ipilimumab in pediatric patients with high-grade CNS malignancies: efficacy, safety, biomarker, and pharmacokinetic results from Checkmate 908","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Nivolumab; Ipilimumab; Internal medicine; Oncology; Cancer; Immunotherapy","score_opus":0.01715287258485537,"score_gpt":0.27390931060693846,"score_spread":0.2567564380220831,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281829220","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942411,0.0006646889,0.000007034757,0.0020239532,0.00056720636,0.0016072838,0.00038718636,0.000112594156,0.0003889114],"genre_scores_gemma":[0.9958575,0.0011302729,0.0004302714,0.0016970992,0.00014653984,0.0001751886,0.0003044022,0.00009321297,0.00016554941],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99669874,0.00041875837,0.00076533295,0.00091714785,0.000571376,0.00062865735],"domain_scores_gemma":[0.998199,0.0005867134,0.000433783,0.00050223904,0.00008394596,0.00019430596],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003573737,0.0004245378,0.00083035795,0.00038524385,0.00024124258,0.000023368595,0.00026711408,0.00013839475,0.0003464646],"category_scores_gemma":[0.00007193552,0.00031043767,0.00007273186,0.0010353648,0.00029240586,0.00009932495,0.000220695,0.00059829827,0.00000881997],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.59846896,0.004771798,0.23224972,0.00019680827,0.0005913442,0.0020961878,0.003874646,0.00011604236,0.098503664,0.0000043553428,0.006883099,0.052243363],"study_design_scores_gemma":[0.18853426,0.018202689,0.71719337,0.00009556464,0.0006756726,0.0003409809,0.00052329997,0.00029658843,0.0024177863,0.0000071154464,0.071010605,0.00070207677],"about_ca_topic_score_codex":0.0009579636,"about_ca_topic_score_gemma":0.00049552135,"teacher_disagreement_score":0.48494366,"about_ca_system_score_codex":0.000556895,"about_ca_system_score_gemma":0.00069605623,"threshold_uncertainty_score":0.9999348},"labels":[],"label_agreement":null},{"id":"W4281836521","doi":"10.1093/neuonc/noac079.275","title":"HGG-60. Structural variants shape driver combinations and outcomes in pediatric high-grade glioma","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Biology; Amplicon; CDKN2A; Genetics; Glioma; Cancer research; Computational biology; Gene","score_opus":0.01134033711379088,"score_gpt":0.28941597157509813,"score_spread":0.27807563446130723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281836521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99652904,0.0002959088,0.0001097959,0.0016223988,0.0006789835,0.0004085367,0.000062588384,0.000019601672,0.0002731334],"genre_scores_gemma":[0.9983902,0.00017610862,0.0002242795,0.0007564923,0.00009900496,0.00013723756,0.00010513309,0.000037300437,0.00007422712],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980624,0.00042866176,0.00026493645,0.0005534093,0.00027336078,0.00041726284],"domain_scores_gemma":[0.99933213,0.000084936124,0.00009798067,0.0003105774,0.000054276425,0.00012012116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020375608,0.00018270532,0.00025634424,0.00027934223,0.0002168567,0.000021432992,0.0003226231,0.00019094191,0.00022487507],"category_scores_gemma":[0.00017033305,0.00019971318,0.00006795573,0.00037541735,0.00008135949,0.0000066526395,0.00073980336,0.0004900073,0.00000692094],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010888291,0.00021449248,0.0031914744,0.000010819142,0.00003617251,0.0004239945,0.000094597286,0.0004098768,0.9911031,0.0008561894,0.0011180546,0.0024323345],"study_design_scores_gemma":[0.046478614,0.018410027,0.39462397,0.000009478934,0.0004226904,0.003589523,0.00090975966,0.013066754,0.36067745,0.008381039,0.15045485,0.0029758406],"about_ca_topic_score_codex":0.00007688597,"about_ca_topic_score_gemma":0.000114909795,"teacher_disagreement_score":0.63042563,"about_ca_system_score_codex":0.00014064272,"about_ca_system_score_gemma":0.00028052749,"threshold_uncertainty_score":0.8144067},"labels":[],"label_agreement":null},{"id":"W4281863432","doi":"10.1093/neuonc/noac079.183","title":"ETMR-05. Single-cell transcriptomics of ETMR reveals developmental cellular programs and tumor-pericyte communications in the microenvironment","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Biology; Tumor microenvironment; Wnt signaling pathway; Cell biology; Embryonic stem cell; Transcriptome; Neural stem cell; Stem cell; Progenitor cell; Neuroblast; Pericyte; Cell; Extracellular matrix; Cancer research; Signal transduction; Neurogenesis; Genetics; Endothelial stem cell","score_opus":0.04709514991579847,"score_gpt":0.27447280051935175,"score_spread":0.22737765060355328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281863432","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906056,0.0019212756,0.000018761077,0.0039381227,0.00013317954,0.0008913977,0.000025054824,0.000012032776,0.002454609],"genre_scores_gemma":[0.9918274,0.0006988068,0.003637822,0.0034614706,0.000020435542,0.00021365506,0.00005216016,0.00002230204,0.000065900655],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99853516,0.0003996421,0.00039521788,0.00024108539,0.00019507669,0.00023383599],"domain_scores_gemma":[0.99921626,0.00015758655,0.0001420076,0.00040465177,0.000013110234,0.00006639541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004447139,0.00013055463,0.000345013,0.000080482256,0.00013242333,0.000007247771,0.00028795283,0.00003886826,0.00008418422],"category_scores_gemma":[0.000013659965,0.000112593334,0.000071929026,0.00020388122,0.00025135028,0.00002258015,0.00019968697,0.00043042624,0.0000027481956],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019766521,0.0014068224,0.0030314007,0.000052967156,0.000016942597,0.00010934222,0.0044985996,0.0000043673517,0.96736467,0.00003734097,0.0005918518,0.022688018],"study_design_scores_gemma":[0.0030231997,0.002279532,0.0013824584,0.000014790872,0.00015220746,0.00066337344,0.0064563523,0.000033604352,0.091567114,0.000028331044,0.8942572,0.00014186576],"about_ca_topic_score_codex":0.00007938317,"about_ca_topic_score_gemma":0.00006814208,"teacher_disagreement_score":0.8936653,"about_ca_system_score_codex":0.00031750865,"about_ca_system_score_gemma":0.00016656931,"threshold_uncertainty_score":0.4591423},"labels":[],"label_agreement":null},{"id":"W4281863931","doi":"10.1093/neuonc/noac079.472","title":"NFB-08. TRAM-01: A Phase 2 study of trametinib for pediatric patients with neurofibromatosis type 1 and plexiform neurofibromas","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"IWK Foundation; BC Children's Hospital; Centre Hospitalier Universitaire de Sherbrooke; Hospital for Sick Children; Alberta Children's Hospital; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Neurofibromatosis; Trametinib; Adverse effect; Dysgeusia; Surgery; Internal medicine; Radiology","score_opus":0.02761007312132264,"score_gpt":0.32906746521333063,"score_spread":0.301457392092008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281863931","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99551237,0.000039633345,0.0000029898513,0.00032502806,0.00025730397,0.003357618,0.00014768893,0.000069992944,0.00028734966],"genre_scores_gemma":[0.9987449,0.000020730846,0.00021764754,0.00033045083,0.00006164716,0.00043827822,0.00007203179,0.00007915113,0.00003514252],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9974696,0.00031248044,0.00045401976,0.00064424204,0.0005843198,0.00053530926],"domain_scores_gemma":[0.9981812,0.00063732517,0.00024677458,0.00039780856,0.00018702242,0.00034987018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014469837,0.00028179193,0.0006615025,0.00037497524,0.00024834485,0.000013875067,0.00017345128,0.00006061394,0.00010612388],"category_scores_gemma":[0.00026284796,0.00023382907,0.00008031733,0.00080540776,0.00009437575,0.00008468273,0.00019381795,0.000392189,0.0000053068966],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.114857435,0.10334748,0.6224782,0.0009745242,0.00081376574,0.003358971,0.0035217155,0.00005778019,0.08487016,0.00008331234,0.008166037,0.057470646],"study_design_scores_gemma":[0.11729197,0.6675537,0.19319159,0.000009817924,0.001222568,0.00047361603,0.00082981435,0.00017909262,0.0033174013,0.0000437369,0.015474281,0.00041236982],"about_ca_topic_score_codex":0.000018734252,"about_ca_topic_score_gemma":0.000007931502,"teacher_disagreement_score":0.56420624,"about_ca_system_score_codex":0.00008504043,"about_ca_system_score_gemma":0.00035402877,"threshold_uncertainty_score":0.9535273},"labels":[],"label_agreement":null},{"id":"W4281875960","doi":"10.1093/neuonc/noac079.547","title":"OTHR-08. Pediatric Neurologic Assessment in Neuro-oncology (pNANO) Scale: A tool to assess neurologic function for Response Assessment in Neuro-oncology (RAPNO)","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Medicine; Physical medicine and rehabilitation; Physical therapy","score_opus":0.039775396692827286,"score_gpt":0.35168583339705556,"score_spread":0.31191043670422824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281875960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9212173,0.00023786518,0.0003781667,0.061775826,0.005981847,0.008480132,0.00017327054,0.00037740415,0.0013781706],"genre_scores_gemma":[0.92813545,0.00028050228,0.0022080208,0.054363452,0.0006948048,0.01385109,0.00017862428,0.00024934465,0.0000386938],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9814937,0.00841533,0.002775613,0.0034072353,0.0012627019,0.0026454225],"domain_scores_gemma":[0.9835218,0.01248256,0.0011897467,0.0016274612,0.0003622536,0.0008161831],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0046717813,0.0013349558,0.0030275383,0.0031960055,0.0006812357,0.000098089404,0.001075426,0.0010293083,0.00075871486],"category_scores_gemma":[0.0025652621,0.0013271982,0.0006850104,0.0034872964,0.00027136388,0.00031315716,0.0015295653,0.0041342163,0.00008762133],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.035939645,0.021120839,0.4852815,0.00021403452,0.00013858036,0.023643004,0.0006352126,0.010329358,0.3774538,0.0007099228,0.013558533,0.03097555],"study_design_scores_gemma":[0.023919342,0.09467115,0.53380674,0.000009225564,0.0007803418,0.002159633,0.0005092698,0.0035559519,0.0006028663,0.000383392,0.33869383,0.00090822537],"about_ca_topic_score_codex":0.000119816934,"about_ca_topic_score_gemma":0.0005473804,"teacher_disagreement_score":0.37685096,"about_ca_system_score_codex":0.004408948,"about_ca_system_score_gemma":0.0048848363,"threshold_uncertainty_score":0.99994016},"labels":[],"label_agreement":null},{"id":"W4281885836","doi":"10.1093/neuonc/noac079.042","title":"RARE-17. Multi-institutional craniopharyngioma cohort highlights need for more comprehensive data collection on comorbidities and quality of life","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital","funders":"","keywords":"Craniopharyngioma; Medicine; Cohort; Radiation therapy; Quality of life (healthcare); Surgery; Cohort study; Chemotherapy; Retrospective cohort study; Comorbidity; Internal medicine; Pediatrics","score_opus":0.09912414256084784,"score_gpt":0.35376999917756696,"score_spread":0.2546458566167191,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281885836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923228,0.0004774819,0.0001489364,0.0034041845,0.0006219344,0.0012131174,0.0010616907,0.00004308495,0.0007067636],"genre_scores_gemma":[0.9941525,0.00015980437,0.0005604096,0.0028547866,0.00007433119,0.0001763732,0.0018628531,0.000014034779,0.00014491424],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99870884,0.00016257132,0.0003317563,0.00038667512,0.00023858424,0.00017154944],"domain_scores_gemma":[0.9987371,0.0005730507,0.00015420491,0.00032183397,0.000097930155,0.00011586862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012595861,0.00015783602,0.00054617954,0.00012579291,0.00037292804,0.0000045459165,0.000116749994,0.000068366586,0.000085916945],"category_scores_gemma":[0.00015441974,0.00013233493,0.00006964117,0.00012871136,0.00019657031,0.00006654773,0.00016366868,0.00014199184,0.0000017180537],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.040578,0.013514156,0.63593,0.0007890873,0.0022730872,0.00095334684,0.0020197628,0.00067030964,0.09103083,0.007914066,0.2011442,0.003183167],"study_design_scores_gemma":[0.042382047,0.008685679,0.7224145,0.000021279831,0.00052193296,0.00035705778,0.0010633194,0.0053231725,0.001040513,0.00018440309,0.21767527,0.00033081454],"about_ca_topic_score_codex":0.00038134368,"about_ca_topic_score_gemma":0.00007709884,"teacher_disagreement_score":0.08999032,"about_ca_system_score_codex":0.00011796731,"about_ca_system_score_gemma":0.00037580417,"threshold_uncertainty_score":0.53964615},"labels":[],"label_agreement":null},{"id":"W4281887121","doi":"10.1093/neuonc/noac079.233","title":"HGG-18. Long-term efficacy and safety of larotrectinib in paediatric patients with tropomyosin receptor kinase (TRK) fusion-positive primary central nervous system (CNS) tumours","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Trk receptor; Medicine; Internal medicine; Tropomyosin receptor kinase A; Confidence interval; Clinical endpoint; Oncology; Gastroenterology; Neurotrophin; Surgery; Clinical trial; Receptor","score_opus":0.008306892474957191,"score_gpt":0.24107876995063443,"score_spread":0.23277187747567724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281887121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99574643,0.00044343685,0.0000021249048,0.0005950472,0.0005209293,0.0019885364,0.00015346022,0.00004851999,0.00050148735],"genre_scores_gemma":[0.9988036,0.000111248664,0.00010622756,0.00034261326,0.00009510668,0.0002113047,0.000277619,0.000044799828,0.000007448078],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99749064,0.00058506586,0.00051484763,0.0005429835,0.00039458834,0.0004718544],"domain_scores_gemma":[0.99847573,0.00058524415,0.0003299453,0.00027073373,0.00009390404,0.0002444228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001688481,0.00027531583,0.00075788895,0.0003250283,0.00015850854,0.000008578792,0.00011020085,0.00010295704,0.00015937892],"category_scores_gemma":[0.000073644354,0.00022756803,0.00009147632,0.00052556756,0.000103137085,0.00005154466,0.00021263731,0.00041943614,0.0000047651583],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006163828,0.005151186,0.9451659,0.00016814443,0.000083680585,0.0017894972,0.0006436789,0.00007439931,0.00738371,0.000027560853,0.00048310906,0.032865323],"study_design_scores_gemma":[0.01935322,0.008486478,0.9685464,0.00010165421,0.00029597766,0.00019350986,0.00023454803,0.000015584317,0.0020034227,5.8757007e-7,0.00059606164,0.00017254181],"about_ca_topic_score_codex":0.00010623406,"about_ca_topic_score_gemma":0.000047150734,"teacher_disagreement_score":0.032692783,"about_ca_system_score_codex":0.0010969634,"about_ca_system_score_gemma":0.00029800387,"threshold_uncertainty_score":0.9279955},"labels":[],"label_agreement":null},{"id":"W4281901111","doi":"10.1093/neuonc/noac079.198","title":"GCT-04. Pattern of Treatment Failures in Central Nervous System Non-Germinomatous Germ Cell Tumors (CNS-NGGCT): A Pooled Analysis of Clinical Trials","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Radiation therapy; Internal medicine; Cohort; Cog; Central nervous system; Germ cell tumors; Clinical trial; Oncology; Disease; Chemotherapy","score_opus":0.05428292682633083,"score_gpt":0.3703771646224035,"score_spread":0.31609423779607265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281901111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961206,0.00031097126,0.000008467346,0.00063836185,0.0005533084,0.0015050548,0.00027821874,0.00003517577,0.0005498906],"genre_scores_gemma":[0.998824,0.000067345056,0.00005344589,0.0002873301,0.00011797342,0.0004749659,0.0001233204,0.0000367577,0.000014843473],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99301845,0.00250276,0.0028866667,0.0006638699,0.00040682626,0.0005214354],"domain_scores_gemma":[0.99442476,0.0029138564,0.0016394524,0.0006539878,0.00008696167,0.00028098535],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015180171,0.00034329153,0.004002565,0.0008710945,0.00006375056,0.000007478293,0.00020901572,0.00018736886,0.00029567812],"category_scores_gemma":[0.00029289644,0.00026955997,0.0013605512,0.00093445147,0.000104590086,0.00002683532,0.00014583136,0.00029220656,0.000007665614],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017384496,0.010734452,0.8763239,0.00023132944,0.0035994325,0.0072442237,0.0015230683,0.0026217753,0.04390674,0.000027115553,0.000574322,0.05147522],"study_design_scores_gemma":[0.038177025,0.026930474,0.84225863,0.000098668934,0.024712952,0.00041184638,0.0038226517,0.012483421,0.043806363,0.0000064118976,0.0068118204,0.00047973735],"about_ca_topic_score_codex":0.0025934007,"about_ca_topic_score_gemma":0.00052795635,"teacher_disagreement_score":0.05099548,"about_ca_system_score_codex":0.0008879473,"about_ca_system_score_gemma":0.0007479714,"threshold_uncertainty_score":0.9999757},"labels":[],"label_agreement":null},{"id":"W4281904723","doi":"10.1093/neuonc/noac079.702","title":"INSP-06. Recent advances in improving neuropsychological outcomes for paediatric brain tumour patients - Are we entering a new era?","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Neuropsychology; Medicine; Medulloblastoma; Radiation therapy; Cognition; Pediatrics; Psychiatry; Surgery; Pathology","score_opus":0.029520625663199684,"score_gpt":0.3227030704319748,"score_spread":0.29318244476877514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281904723","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9606886,0.0018877238,0.000027424381,0.034370176,0.0012463799,0.0014327199,0.00004599639,0.00008059787,0.00022041568],"genre_scores_gemma":[0.9873837,0.0013291278,0.0003601526,0.009846212,0.00018338567,0.00076872465,0.000056812903,0.00004511251,0.000026719576],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99792695,0.0002445169,0.0004843688,0.00060398236,0.00025866347,0.0004815234],"domain_scores_gemma":[0.9984781,0.0007693086,0.0002702146,0.000233638,0.00004877699,0.00019995797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017213426,0.00024335574,0.0005861517,0.0003017749,0.00013961337,0.000013850939,0.00017042484,0.00008105674,0.00016211277],"category_scores_gemma":[0.0007165265,0.00020472714,0.00016161196,0.00037802485,0.000027361839,0.00008600029,0.00024580033,0.0004379167,0.000010224804],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067934033,0.0026588684,0.6869255,0.00004726046,0.000020563763,0.0007637609,0.00022671012,0.000113165916,0.008633509,0.00002295762,0.0073204,0.292588],"study_design_scores_gemma":[0.012051521,0.0055178795,0.42728916,0.000012280834,0.00006750693,0.00007113305,0.00017501677,0.00010393977,0.00028393758,0.00010259525,0.55414945,0.00017557664],"about_ca_topic_score_codex":0.000014648425,"about_ca_topic_score_gemma":0.0000562436,"teacher_disagreement_score":0.54682904,"about_ca_system_score_codex":0.00042257374,"about_ca_system_score_gemma":0.00013749392,"threshold_uncertainty_score":0.83485305},"labels":[],"label_agreement":null},{"id":"W4281909587","doi":"10.1093/neuonc/noac079.413","title":"MEDB-39. Oncogenic mechanisms underlying GLI2-amplified medulloblastoma","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"GLI2; Cancer research; Carcinogenesis; Medulloblastoma; Biology; Embryonic stem cell; MAPK/ERK pathway; Population; Cell biology; Medicine; Sonic hedgehog; Genetics; Signal transduction; Cancer","score_opus":0.04233833967915349,"score_gpt":0.30549004933970997,"score_spread":0.26315170966055645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281909587","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9833098,0.00084111665,0.0053919116,0.0019938855,0.0024620425,0.00058982085,0.00007782414,0.00014383724,0.0051897825],"genre_scores_gemma":[0.99332076,0.0000780774,0.0011297441,0.0045169033,0.00020345428,0.00030958926,0.00008520836,0.000080180456,0.00027606968],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99719495,0.0005791047,0.00042551983,0.0008148588,0.00035015206,0.0006354309],"domain_scores_gemma":[0.9988001,0.00016752598,0.00021121083,0.0005585805,0.00009094909,0.00017164976],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00054396014,0.00031028068,0.00041242648,0.000120404526,0.00061281933,0.000019054067,0.000574072,0.00021792763,0.00023087882],"category_scores_gemma":[0.00030324172,0.0003405636,0.00020831822,0.0002475372,0.00014149347,0.0000039171186,0.0010174914,0.00045995592,0.00006180705],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020544682,0.00015500397,0.00006848219,0.000010244572,0.00011379928,0.00015399748,0.00025527267,0.0003400875,0.9883847,0.0007441365,0.004400201,0.005168632],"study_design_scores_gemma":[0.001545524,0.0041164164,0.0001724799,0.000003444866,0.00007537513,0.00047586972,0.0013044791,0.0001248898,0.41747472,0.0011224212,0.57312155,0.0004628453],"about_ca_topic_score_codex":0.000020343929,"about_ca_topic_score_gemma":0.000045974193,"teacher_disagreement_score":0.57091,"about_ca_system_score_codex":0.00019915955,"about_ca_system_score_gemma":0.00048334268,"threshold_uncertainty_score":0.99990463},"labels":[],"label_agreement":null},{"id":"W4281927392","doi":"10.1093/neuonc/noac079.306","title":"IMMU-13. Dual CTLA4/ PD-1 blockade improves survival for replication-repair deficient high-grade gliomas failing single agent PD-1 inhibition: An IRRDC study","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Centre hospitalier de l'Université Laval; CancerCare Manitoba; London Health Sciences Centre; Izaak Walton Killam Health Centre; Hospital for Sick Children","funders":"","keywords":"Medicine; Pembrolizumab; Blockade; Ipilimumab; Nivolumab; Internal medicine; Oncology; Progression-free survival; Gastroenterology; Surgery; Immunotherapy; Overall survival; Cancer","score_opus":0.04748209181420845,"score_gpt":0.3231993565652041,"score_spread":0.27571726475099567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281927392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98789054,0.00032644745,0.000030755953,0.005847598,0.0015803509,0.003582342,0.00011809387,0.00037865655,0.00024520987],"genre_scores_gemma":[0.99424064,0.0000116679375,0.0005775493,0.00093875366,0.00049834413,0.0031983731,0.00040281424,0.00008937278,0.000042455846],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996043,0.0005101834,0.00081747933,0.0013493219,0.000628238,0.0006517448],"domain_scores_gemma":[0.99720836,0.0006943769,0.00036142577,0.0012123329,0.00020674423,0.0003167718],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007819439,0.0003923327,0.000754469,0.00035285775,0.0007501492,0.000046611556,0.00018039135,0.00013781147,0.00015012837],"category_scores_gemma":[0.0003049068,0.00037711076,0.00031638102,0.00057048176,0.000109211156,0.00010057906,0.0003310703,0.0003841719,0.0000210991],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093580945,0.03297105,0.00912057,0.00006070402,0.00034057928,0.002018332,0.0019783117,0.0005762137,0.94228166,0.0005819383,0.0030729407,0.0060618664],"study_design_scores_gemma":[0.0502239,0.1231638,0.09090917,0.00005001005,0.003291181,0.0027488337,0.02292483,0.0029550523,0.39662296,0.0006501015,0.30480212,0.0016580679],"about_ca_topic_score_codex":0.00026235232,"about_ca_topic_score_gemma":0.00023960782,"teacher_disagreement_score":0.54565877,"about_ca_system_score_codex":0.00090775493,"about_ca_system_score_gemma":0.000321421,"threshold_uncertainty_score":0.9998681},"labels":[],"label_agreement":null},{"id":"W4281953957","doi":"10.1093/neuonc/noac079.371","title":"LGG-60. Development and implementation of a complementary diagnostic tool to detect targetable pathways in pediatric glioma patients","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"","keywords":"Glioma; PI3K/AKT/mTOR pathway; MAPK/ERK pathway; Cancer research; Concordance; Medicine; Transcriptome; Biology; Signal transduction; Internal medicine; Gene expression; Gene; Genetics","score_opus":0.019309938076444183,"score_gpt":0.28638215054632143,"score_spread":0.2670722124698772,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281953957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973014,0.00016106592,0.000005639728,0.00061250484,0.00023223845,0.0015223457,0.00008307637,0.000018870633,0.0000628833],"genre_scores_gemma":[0.99614984,0.000046810183,0.0015652162,0.0009863285,0.00003468796,0.0010207995,0.00017438472,0.000021091326,8.7248776e-7],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982893,0.00014840369,0.00055247266,0.00035842907,0.0003155699,0.00033583734],"domain_scores_gemma":[0.9990235,0.00048212634,0.00015769352,0.00015556527,0.00005663967,0.00012445697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022060172,0.00016439444,0.0003901546,0.0004343228,0.00012122029,0.000005884554,0.00008123748,0.000033224856,0.00037149215],"category_scores_gemma":[0.00011613392,0.00014937484,0.000041865344,0.00047973578,0.00001554018,0.00004402192,0.0002867946,0.00013074663,0.000008899612],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017610194,0.0011391523,0.8664572,0.000064573454,0.000037999398,0.0005912736,0.0016619375,0.00003709322,0.014597887,0.000020134572,0.0019510811,0.11326554],"study_design_scores_gemma":[0.008960306,0.0049342862,0.91294175,0.0000070949236,0.00013079765,0.000042215273,0.00064952625,0.000010766519,0.041607093,0.000044555214,0.030509848,0.00016176912],"about_ca_topic_score_codex":0.00017565531,"about_ca_topic_score_gemma":0.00035272085,"teacher_disagreement_score":0.11310377,"about_ca_system_score_codex":0.00048731343,"about_ca_system_score_gemma":0.00026636422,"threshold_uncertainty_score":0.60913295},"labels":[],"label_agreement":null},{"id":"W4281954110","doi":"10.1093/neuonc/noac079.621","title":"LINC-22. Primary central nervous system (CNS) germ cell tumors (GCT) in Central America and the Caribbean region: an AHOPCA 20-year experience","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Headaches; Germ cell tumors; Pediatrics; Epidemiology; Germinoma; Internal medicine; Surgery; Chemotherapy","score_opus":0.012671837209737856,"score_gpt":0.2488739161612729,"score_spread":0.23620207895153505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281954110","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883899,0.0006472441,0.0000034839109,0.005079499,0.000700811,0.0010827784,0.000021747119,0.000083820436,0.00399071],"genre_scores_gemma":[0.995922,0.00016242055,0.00006788984,0.0030342578,0.00023546215,0.0004534707,0.00004921453,0.00003930046,0.00003594443],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971087,0.0007741434,0.00045435713,0.0006056515,0.00034182554,0.0007153486],"domain_scores_gemma":[0.9985238,0.00036310975,0.00022996232,0.0005122808,0.00003496244,0.00033591822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013005544,0.0002573554,0.00068411516,0.0001276344,0.0002731193,0.000028227747,0.00023807002,0.000086182095,0.000078297584],"category_scores_gemma":[0.000047460693,0.00019554923,0.00012298711,0.0003400136,0.000338875,0.00007299394,0.00025107694,0.00051853043,0.0000064927144],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011988027,0.010706262,0.64956856,0.0006806366,0.0002554075,0.0815514,0.07528711,0.0018620469,0.070871346,0.0042085005,0.031719908,0.06130078],"study_design_scores_gemma":[0.04202031,0.011530256,0.46497664,0.000111598885,0.0005908259,0.009401664,0.04838536,0.004122827,0.004722952,0.000053138556,0.4131105,0.0009739137],"about_ca_topic_score_codex":0.00053996354,"about_ca_topic_score_gemma":0.00005402277,"teacher_disagreement_score":0.3813906,"about_ca_system_score_codex":0.0008445198,"about_ca_system_score_gemma":0.00036559877,"threshold_uncertainty_score":0.79742664},"labels":[],"label_agreement":null},{"id":"W4281996388","doi":"10.1093/neuonc/noac079.339","title":"LGG-25. The first-in-class ERK inhibitor ulixertinib (BVD-523) shows activity in MAPK-driven pediatric low-grade glioma models as single agent and in combination with MEK inhibitors or senolytics","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Berlin Institute of Health; Deutschen Konsortium für Translationale Krebsforschung; Freie Universität Berlin; McGill University Health Centre; Deutsches Krebsforschungszentrum; Humboldt-Universität zu Berlin; McGill University","keywords":"MEK inhibitor; In vivo; MAPK/ERK pathway; Trametinib; Cancer research; Pharmacology; Melanoma; Biology; Kinase; Cell biology","score_opus":0.026960471800129882,"score_gpt":0.27030121092381715,"score_spread":0.24334073912368726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281996388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866223,0.00017812959,0.0000039305933,0.010798105,0.0003992279,0.0016430618,0.00002057036,0.00004138805,0.0002933315],"genre_scores_gemma":[0.9980453,0.000110878056,0.00005805603,0.0009818205,0.00012165363,0.00060014916,0.000017048278,0.000050145904,0.000014933367],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99753505,0.00040091423,0.0004907418,0.00060473353,0.00046600305,0.0005025674],"domain_scores_gemma":[0.99836075,0.00088511023,0.000244171,0.0003233154,0.000045263507,0.0001414014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003128242,0.00030742382,0.0005964664,0.0006162339,0.00016505328,0.000028797105,0.00014437317,0.00016668478,0.000046987367],"category_scores_gemma":[0.00012929391,0.00022357352,0.000067708104,0.0011162672,0.00010914964,0.00014185677,0.0002527946,0.000683732,0.0000062681193],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009062451,0.039434295,0.70262223,0.00045321844,0.00017122754,0.032651253,0.011467262,0.023296304,0.16212644,0.00045666096,0.0045712036,0.013687471],"study_design_scores_gemma":[0.14304078,0.060726497,0.42953888,0.00050340826,0.0015173272,0.0046645245,0.007995252,0.13734716,0.16964835,0.0016810213,0.040656026,0.0026807708],"about_ca_topic_score_codex":0.00024456656,"about_ca_topic_score_gemma":0.003185101,"teacher_disagreement_score":0.27308333,"about_ca_system_score_codex":0.0011002965,"about_ca_system_score_gemma":0.0003372327,"threshold_uncertainty_score":0.9117063},"labels":[],"label_agreement":null},{"id":"W4281998879","doi":"10.1093/neuonc/noac079.569","title":"OTHR-31. The molecular profile of secondary meningiomas in survivors of childhood non-central nervous system (CNS) cancers","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; University of Alberta","funders":"","keywords":"Meningioma; Cohort; Medicine; Exome sequencing; Exome; Radiation therapy; Germline mutation; Oncology; Internal medicine; Pathology; Gene; Biology; Mutation; Genetics","score_opus":0.01018043689883057,"score_gpt":0.2464159697532678,"score_spread":0.2362355328544372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281998879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.971516,0.00035548376,0.00003872111,0.00086306565,0.00079473184,0.0012909223,0.000034293334,0.000033174005,0.02507359],"genre_scores_gemma":[0.99907446,0.0000040886166,0.0001961284,0.0002780381,0.000054570744,0.00024092053,0.00002712414,0.000034310327,0.00009033872],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9976899,0.0004193206,0.000651629,0.00036761633,0.00042716012,0.0004443576],"domain_scores_gemma":[0.99883837,0.00016017715,0.0003655875,0.00048209558,0.000052761337,0.00010103112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058400806,0.0001880663,0.00064888556,0.000256577,0.00009595621,0.000004447454,0.0003331972,0.00007686638,0.00023588147],"category_scores_gemma":[0.000052153082,0.00015706448,0.00016236061,0.00055351754,0.00012404237,0.00003416507,0.0003038354,0.00048178041,0.0000037743598],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024223588,0.0018367643,0.032746006,0.002216545,0.00090256956,0.019916896,0.020092849,0.008552407,0.8700962,0.0077507985,0.0121521065,0.021314481],"study_design_scores_gemma":[0.037289854,0.033790484,0.42450157,0.0006448168,0.0020715115,0.010603032,0.060487144,0.022290904,0.23464634,0.00022591978,0.17153203,0.0019163918],"about_ca_topic_score_codex":0.0009718092,"about_ca_topic_score_gemma":0.000070520866,"teacher_disagreement_score":0.6354499,"about_ca_system_score_codex":0.00054691744,"about_ca_system_score_gemma":0.0008324432,"threshold_uncertainty_score":0.6404904},"labels":[],"label_agreement":null},{"id":"W4282002300","doi":"10.1093/neuonc/noac079.284","title":"IMG-08. Response assessment for pediatric craniopharyngioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Craniopharyngioma; Medicine; Clinical trial; Radiation therapy; Radiological weapon; Magnetic resonance imaging; Prospective cohort study; Natural history study; Radiology; Internal medicine; Oncology; Disease","score_opus":0.03229251964687891,"score_gpt":0.34545194753579966,"score_spread":0.31315942788892076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282002300","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9233676,0.0010313805,0.0004451152,0.06770511,0.0029958999,0.0029825966,0.00035171243,0.00014446602,0.00097607926],"genre_scores_gemma":[0.98133314,0.001079654,0.0036604356,0.009697236,0.0008214355,0.0027444265,0.00048370793,0.00010302798,0.00007692341],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9909382,0.0053464384,0.0010977474,0.0011257112,0.00055538584,0.0009365407],"domain_scores_gemma":[0.98084176,0.01746313,0.00051068194,0.0008003257,0.00009369476,0.00029040725],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003213836,0.0004904457,0.00094943977,0.0007234302,0.00092258217,0.000044550616,0.0005434332,0.00026132946,0.00061878376],"category_scores_gemma":[0.00092233886,0.00041715312,0.00036477062,0.0013158753,0.00008703511,0.00014311392,0.0005269745,0.0014420914,0.00002599913],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07454888,0.012894215,0.79312545,0.00006509375,0.00033260343,0.0058170236,0.0024718638,0.00029766644,0.025313305,0.0005654756,0.058341574,0.026226865],"study_design_scores_gemma":[0.021297233,0.011681751,0.6131634,0.000006918658,0.00088991993,0.00031940127,0.0013699566,0.0007591237,0.000014438432,0.0008306591,0.349279,0.00038820237],"about_ca_topic_score_codex":0.00017090689,"about_ca_topic_score_gemma":0.0002197624,"teacher_disagreement_score":0.29093742,"about_ca_system_score_codex":0.0017481705,"about_ca_system_score_gemma":0.002525368,"threshold_uncertainty_score":0.99982804},"labels":[],"label_agreement":null},{"id":"W4282023526","doi":"10.1093/neuonc/noac079.044","title":"RARE-19. Molecular characterization and treatment response of metastatic DIA/DIG","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital","funders":"","keywords":"Medicine; Vincristine; Carboplatin; Adjuvant therapy; Adjuvant; Surgery; Chemotherapy; Oncology; Internal medicine; Cisplatin; Cyclophosphamide","score_opus":0.02463289840132039,"score_gpt":0.30055116228849293,"score_spread":0.27591826388717255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282023526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99431354,0.000273255,0.000025638878,0.004429594,0.00013723978,0.00059789204,0.00007336504,0.000023710556,0.00012579479],"genre_scores_gemma":[0.99774647,0.00014901588,0.0001496245,0.001392547,0.000015072641,0.0003604102,0.00013603235,0.00001960743,0.000031244337],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99873334,0.00048677094,0.00022941495,0.00024339087,0.0001544174,0.00015267514],"domain_scores_gemma":[0.99912196,0.00039694388,0.00013107019,0.00021031837,0.000023903905,0.00011582351],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015511739,0.00012396078,0.000373317,0.00016228457,0.00007631257,0.0000045286756,0.000037507332,0.000029044377,0.00016388315],"category_scores_gemma":[0.00012280782,0.0001052449,0.000072737894,0.00016695497,0.00005237168,0.00002314118,0.00006385982,0.000071474766,0.0000039934853],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017815867,0.00130302,0.0067912475,0.000013543688,0.000113832895,0.0021947015,0.00050867215,0.000011542362,0.96380556,0.00014259655,0.000097989425,0.023235736],"study_design_scores_gemma":[0.014293904,0.025206167,0.11723842,0.000013011882,0.0010502556,0.0013640928,0.00034159352,0.00019757448,0.5450771,0.000054527278,0.29496223,0.00020112486],"about_ca_topic_score_codex":0.000019772568,"about_ca_topic_score_gemma":0.0000027987633,"teacher_disagreement_score":0.41872844,"about_ca_system_score_codex":0.00026582298,"about_ca_system_score_gemma":0.0001828157,"threshold_uncertainty_score":0.42917624},"labels":[],"label_agreement":null},{"id":"W4286615423","doi":"10.1093/neuonc/noac180","title":"Phase II study of intrathecal administration of trastuzumab in patients with HER2-positive breast cancer with leptomeningeal metastasis","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Centre Léon Bérard","keywords":"Medicine; Trastuzumab; Breast cancer; Internal medicine; Concomitant; Oncology; Metastatic breast cancer; Clinical endpoint; Brain metastasis; Cancer; Quality of life (healthcare); Metastasis; Radiation therapy; Population; Phases of clinical research; Chemotherapy; Clinical trial","score_opus":0.015089337099935058,"score_gpt":0.31592942794437523,"score_spread":0.3008400908444402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4286615423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974998,0.000020427558,0.0000135769,0.00053871446,0.000057818863,0.0012816247,0.00046976455,0.00000973889,0.0001084969],"genre_scores_gemma":[0.99921167,0.0000030894146,0.00022434836,0.00013445553,0.000019286956,0.00028755833,0.000092324124,0.000021830258,0.0000054549873],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9983438,0.00036762207,0.00036786584,0.0003175684,0.00040582317,0.00019728206],"domain_scores_gemma":[0.99921966,0.00010816385,0.00027992984,0.00018632715,0.00012395353,0.00008194372],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001670039,0.00016822264,0.00058097334,0.00015358318,0.00008421414,0.0000023100408,0.000069020854,0.000031183656,0.00025140552],"category_scores_gemma":[0.000008834896,0.00012241962,0.000041162366,0.00037169206,0.00009881541,0.000046392383,0.00005789418,0.0002501674,2.3776498e-7],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13755465,0.2564638,0.36926836,0.00011139889,0.0021540576,0.00228466,0.017086055,0.0007300369,0.007144298,0.00009399944,0.00021538591,0.20689331],"study_design_scores_gemma":[0.08252925,0.6170058,0.28566515,0.000039029903,0.0014494382,0.00037131234,0.0070554684,0.000064729604,0.005128841,0.0000036154674,0.0004843734,0.00020293439],"about_ca_topic_score_codex":0.00032575725,"about_ca_topic_score_gemma":0.00051672745,"teacher_disagreement_score":0.36054206,"about_ca_system_score_codex":0.00030287835,"about_ca_system_score_gemma":0.0005010322,"threshold_uncertainty_score":0.49921268},"labels":[],"label_agreement":null},{"id":"W4289100902","doi":"10.1093/neuonc/noac188","title":"EANO - EURACAN - SNO Guidelines on circumscribed astrocytic gliomas, glioneuronal, and neuronal tumors","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Institutes of Health; LEO Pharma; Servier; Associazione Italiana per la Ricerca sul Cancro; Sanofi; Brain Tumour Charity; Agios Pharmaceuticals; Novocure; Genentech; Y-mAbs Therapeutics; BeiGene; National Cancer Institute; Medac; European Federation of Pharmaceutical Industries and Associations; Fondazione Italiana per la Ricerca sul Cancro; Pfizer; BioClinica; AstraZeneca; American Society of Clinical Oncology","keywords":"Glioma; Medicine; Oligodendroglioma; Pathology; Astrocytoma; Cancer research","score_opus":0.04568042957002215,"score_gpt":0.3217638257064698,"score_spread":0.2760833961364476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4289100902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97330284,0.0002901886,0.000002793833,0.022901392,0.00082245417,0.00062554894,0.00006328591,0.00013426138,0.0018572372],"genre_scores_gemma":[0.98261,0.00007428526,0.00017870938,0.016310822,0.0003382925,0.00027781463,0.000074229356,0.000071020215,0.00006483471],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972152,0.00033624747,0.00057382666,0.000773004,0.00057910476,0.0005226284],"domain_scores_gemma":[0.998394,0.00049010135,0.00020924784,0.0004326348,0.00011877049,0.00035526254],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022596242,0.00034308966,0.00061396515,0.00039242592,0.0003674807,0.000025736283,0.00018090566,0.00007682153,0.000681948],"category_scores_gemma":[0.0004058997,0.00031532306,0.00015707737,0.00041135872,0.00013679729,0.000057121382,0.00029975522,0.0005636718,0.000058056256],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029293818,0.004921042,0.04574528,0.000094962525,0.00028051212,0.02397988,0.0003674945,0.0008172513,0.7328242,0.0030807368,0.13098373,0.053975496],"study_design_scores_gemma":[0.013515987,0.02524203,0.07840919,0.00004352895,0.0004942969,0.009311974,0.00036093255,0.0013263733,0.021225538,0.00023414352,0.8492962,0.00053982093],"about_ca_topic_score_codex":0.000037177117,"about_ca_topic_score_gemma":0.0000075203084,"teacher_disagreement_score":0.71831244,"about_ca_system_score_codex":0.0003275915,"about_ca_system_score_gemma":0.00035096463,"threshold_uncertainty_score":0.9999299},"labels":[],"label_agreement":null},{"id":"W4294679016","doi":"10.1093/neuonc/noac174.281","title":"P13.01.A Challenges and Solutions for Establishing a CNS Tumor Registry in Africa","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"","keywords":"Medicine; Pathological; Developing country; Incidence (geometry); Pathology; Economic growth","score_opus":0.06946607252400029,"score_gpt":0.30330116276196983,"score_spread":0.23383509023796956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294679016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90642685,0.012256289,0.0000112570215,0.06738418,0.0006158249,0.0013176562,0.00008064819,0.0000914769,0.011815837],"genre_scores_gemma":[0.9969432,0.0005672213,0.00030655984,0.00084224663,0.00010067287,0.0011680641,0.000018029672,0.000021493102,0.00003253944],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99887115,0.000112270674,0.00019007189,0.00033289907,0.00011584508,0.00037776775],"domain_scores_gemma":[0.9988653,0.0007166168,0.0000805276,0.0002084845,0.000025115263,0.00010397086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027516528,0.000108676824,0.00030376643,0.00015528816,0.00019113506,0.000009997869,0.00007398731,0.00005040784,0.00004948679],"category_scores_gemma":[0.00035722,0.0001048627,0.000057990223,0.00012660821,0.000053830467,0.000046737456,0.00017268228,0.00024501857,0.0000021370493],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030780323,0.019482307,0.03246131,0.0008559309,0.00049787475,0.01840012,0.028246252,0.0004654572,0.2963153,0.049918406,0.17608097,0.37419802],"study_design_scores_gemma":[0.006010382,0.0034780912,0.011878232,0.000022118986,0.0001414803,0.00089612155,0.0038248398,0.0004683876,0.000505782,0.0009181389,0.9717154,0.0001410626],"about_ca_topic_score_codex":0.000030798517,"about_ca_topic_score_gemma":0.00019618543,"teacher_disagreement_score":0.7956344,"about_ca_system_score_codex":0.00025428302,"about_ca_system_score_gemma":0.00016449222,"threshold_uncertainty_score":0.4276177},"labels":[],"label_agreement":null},{"id":"W4294680146","doi":"10.1093/neuonc/noac174.233","title":"P11.44.A The impact of heme biosynthesis regulation on glioma aggressiveness: correlations with most recent diagnostic molecular markers","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Glioma; Biology; Heme; Biosynthesis; Cancer research; Gene; Genetics; Biochemistry; Enzyme","score_opus":0.014628132194430687,"score_gpt":0.28485870768444616,"score_spread":0.27023057549001545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294680146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98934317,0.00037198528,0.000021824471,0.0074045574,0.00020247648,0.0010060087,0.00006634106,0.00003528014,0.00154835],"genre_scores_gemma":[0.9987282,0.00013393264,0.00005496848,0.0005104251,0.00003679819,0.0004181962,0.00007346866,0.000036549023,0.0000074173918],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99820787,0.0005415311,0.00029766845,0.00032615935,0.000373273,0.00025349105],"domain_scores_gemma":[0.995927,0.0030041959,0.00033512415,0.0004884346,0.00013608387,0.00010918936],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00022101165,0.00020174227,0.00036987042,0.00022369648,0.0002367835,0.000008690037,0.00012670587,0.00007064871,0.0010226469],"category_scores_gemma":[0.0009990332,0.00012695561,0.00013534309,0.0007804217,0.00013077323,0.000030774445,0.000077429606,0.00023099103,0.000015326323],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007772688,0.007858959,0.16229704,0.00005007521,0.0015075011,0.0059847585,0.0007210233,0.06435027,0.63945806,0.0009744032,0.021435555,0.08758968],"study_design_scores_gemma":[0.010645148,0.028856417,0.7543149,0.00024254556,0.0016681985,0.0020011547,0.00071287394,0.0034528526,0.16941099,0.00022659157,0.027989484,0.0004788611],"about_ca_topic_score_codex":0.000100098834,"about_ca_topic_score_gemma":0.000012182904,"teacher_disagreement_score":0.5920178,"about_ca_system_score_codex":0.00055593345,"about_ca_system_score_gemma":0.00038512854,"threshold_uncertainty_score":0.99989057},"labels":[],"label_agreement":null},{"id":"W4294682852","doi":"10.1093/neuonc/noac174.138","title":"P07.06.B The Impact of Using Intraoperative Ultrasound on Surgical Resection of High-Grade Glioma: A Systematic Review and Meta-Analysis","year":2022,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Meta-analysis; Systematic review; MEDLINE; Study heterogeneity; Resection; Randomized controlled trial; Surgery; Internal medicine","score_opus":0.13871388304492588,"score_gpt":0.42595199513707,"score_spread":0.2872381120921441,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294682852","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0024582362,0.99285746,8.131944e-7,0.00023454505,0.000050952738,0.0040949467,0.00020667732,0.000010678459,0.00008569062],"genre_scores_gemma":[0.011535246,0.9873049,0.000018352352,0.000087533015,0.00003420282,0.00085538195,0.0001181428,0.00003884455,0.0000073790125],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9934083,0.0038386928,0.0015323344,0.0005454564,0.00043434714,0.00024085407],"domain_scores_gemma":[0.99113667,0.0062390827,0.0015832238,0.0007981639,0.00012743546,0.00011542025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010800844,0.0005054147,0.011527175,0.00059142616,0.000108597225,0.000012644558,0.00017993794,0.00022397695,0.00067956414],"category_scores_gemma":[0.0008622698,0.00023115252,0.0037201247,0.0018094074,0.00017100356,0.000028328757,0.00008841187,0.0005564,0.0000033920282],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009626881,0.0025780369,0.00001906669,0.544821,0.44867057,0.0014854578,0.00019597262,0.00008430747,0.00016648172,0.0003041603,0.0004165444,0.0011620917],"study_design_scores_gemma":[0.00064432627,0.0031120058,0.000005644217,0.005411465,0.97654366,0.0033072631,0.00003002991,0.000007588779,0.00004188175,0.0000064300407,0.010738233,0.00015145374],"about_ca_topic_score_codex":0.00034704315,"about_ca_topic_score_gemma":0.00002463293,"teacher_disagreement_score":0.5394096,"about_ca_system_score_codex":0.00047552734,"about_ca_system_score_gemma":0.00038579124,"threshold_uncertainty_score":0.9426126},"labels":[],"label_agreement":null},{"id":"W4294683598","doi":"10.1093/neuonc/noac174.222","title":"P11.33.B Tumour Treating Fields (TTFields; 200 kHz) with chemo-radiation and maintenance TTFields/temozolomide as first-line treatment for newly-diagnosed glioblastoma: The phase 3 TRIDENT Trial (EF-32)","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Temozolomide; Medicine; Internal medicine; Oncology; Clinical endpoint; Clinical trial; Concomitant; Phases of clinical research; Cancer; Adverse effect; Progression-free survival; Radiation therapy; Surgery; Chemotherapy","score_opus":0.02202927441482746,"score_gpt":0.3144258127881759,"score_spread":0.29239653837334845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294683598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9608191,0.0005696696,0.00013732031,0.03264404,0.00070188724,0.0042768386,0.00009522016,0.00008889585,0.00066703086],"genre_scores_gemma":[0.9909105,0.0005954459,0.00016919119,0.0038761545,0.00073778845,0.0032637897,0.00009102841,0.000056574136,0.0002995749],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99755734,0.00021667001,0.000601722,0.00071637484,0.0003277473,0.00058015774],"domain_scores_gemma":[0.9962505,0.0025477451,0.0003985214,0.00046215052,0.00010102437,0.0002400225],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030379338,0.00041870086,0.00081430684,0.00017020588,0.00063570804,0.00004790735,0.00016504843,0.00019670386,0.00029830047],"category_scores_gemma":[0.0005244195,0.00027745042,0.00024772008,0.0002947505,0.000096539596,0.00007993481,0.00009664931,0.00038778683,0.00001015209],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.31879312,0.02323541,0.0044212057,0.00020071596,0.0016693639,0.008802305,0.008722461,0.0029716243,0.021111881,0.0007720655,0.072580256,0.53671956],"study_design_scores_gemma":[0.4902073,0.17474921,0.0005792002,0.00006616808,0.0017551081,0.0017370869,0.0021778601,0.004345353,0.042595934,0.00030508087,0.28090945,0.0005722396],"about_ca_topic_score_codex":0.0005822316,"about_ca_topic_score_gemma":0.0010116558,"teacher_disagreement_score":0.53614736,"about_ca_system_score_codex":0.000645601,"about_ca_system_score_gemma":0.0004366611,"threshold_uncertainty_score":0.99996775},"labels":[],"label_agreement":null},{"id":"W4294684310","doi":"10.1093/neuonc/noac174.050","title":"OS07.5.A Report from the pooled analysis of the randomized trials NORDIC, NOA-8 and CE.6 on elderly patients with glioblastoma","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Sunnybrook Hospital; University of Toronto; Queen's University","funders":"","keywords":"Temozolomide; Medicine; Concomitant; Internal medicine; Randomized controlled trial; Glioblastoma; Radiation therapy; Clinical trial; Oncology; Quality of life (healthcare); Pooled analysis; Overall survival; Confidence interval","score_opus":0.01790241735507129,"score_gpt":0.2887873855189513,"score_spread":0.27088496816387997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294684310","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989128,0.00016769613,0.0000036462025,0.007847323,0.00033588952,0.0017814608,0.0001192933,0.000017174392,0.00059953635],"genre_scores_gemma":[0.9972706,0.00003116718,0.000033165594,0.002090673,0.00005632575,0.00041640742,0.00006883703,0.000018278579,0.000014572553],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960457,0.002122317,0.0007397044,0.00039371912,0.00051578996,0.00018273215],"domain_scores_gemma":[0.99160033,0.006721806,0.000845113,0.00064248365,0.00011254191,0.000077694174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012206502,0.00018747011,0.0017479557,0.00017234808,0.00020719193,0.00001178034,0.00014569506,0.00006394647,0.00038676415],"category_scores_gemma":[0.001885226,0.00008404023,0.0004953952,0.0006590647,0.0001876172,0.000022377684,0.00013173009,0.0002568729,0.0000019731913],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.27412385,0.0058192867,0.63932836,0.000014353437,0.022308337,0.0016461705,0.0019336132,0.00054848235,0.014110467,0.00022279208,0.010066505,0.029877784],"study_design_scores_gemma":[0.41203415,0.011010139,0.4929036,0.000033072294,0.05060271,0.00011268444,0.00042835818,0.00029795658,0.0070645367,0.0001523158,0.02512291,0.00023758147],"about_ca_topic_score_codex":0.00032610283,"about_ca_topic_score_gemma":0.00030832939,"teacher_disagreement_score":0.14642479,"about_ca_system_score_codex":0.000104621286,"about_ca_system_score_gemma":0.00018339556,"threshold_uncertainty_score":0.42347962},"labels":[],"label_agreement":null},{"id":"W4294685605","doi":"10.1093/neuonc/noac174.033","title":"OS02.5.A Alzheimer-type neuropathological changes in glioblastoma-adjacent cortex","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Neuropathology; Pathology; Neuropil; Medicine; Neurology; Cerebral amyloid angiopathy; Amyloid (mycology); Neurochemistry; Internal medicine; Dementia; Central nervous system; Disease; Psychiatry","score_opus":0.042155248664756555,"score_gpt":0.3241784885956057,"score_spread":0.28202323993084916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294685605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96772826,0.0013330178,0.000003868805,0.019857168,0.0028000597,0.0012669734,0.000026550892,0.00023176169,0.006752343],"genre_scores_gemma":[0.9823996,0.00059882604,0.000041187333,0.016112374,0.00029773408,0.00034193572,0.000015002238,0.000051922114,0.00014143664],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972379,0.00063004915,0.0003907574,0.0006839695,0.00042235773,0.00063495],"domain_scores_gemma":[0.9987801,0.0004525786,0.00017586905,0.00030131056,0.00011785803,0.00017232366],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00034791356,0.0002828179,0.00067564496,0.00035274174,0.00022259058,0.000007320957,0.00018301472,0.00013117438,0.0015998029],"category_scores_gemma":[0.00045698072,0.00027234602,0.000099889614,0.0008177937,0.00024219065,0.000035405104,0.0006239069,0.0012008419,0.00014053771],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01697811,0.005472883,0.060414035,0.0000755637,0.0004297584,0.036895413,0.0029932554,0.00023938154,0.66887695,0.00026750503,0.06736277,0.1399944],"study_design_scores_gemma":[0.008477288,0.046332147,0.1163915,0.000029690857,0.00057970505,0.005109186,0.001505613,0.000356031,0.006666583,0.00009637656,0.81395674,0.0004991579],"about_ca_topic_score_codex":0.000023769508,"about_ca_topic_score_gemma":0.00015367253,"teacher_disagreement_score":0.74659395,"about_ca_system_score_codex":0.000522924,"about_ca_system_score_gemma":0.0002686294,"threshold_uncertainty_score":0.9999729},"labels":[],"label_agreement":null},{"id":"W4294686035","doi":"10.1093/neuonc/noac174.254","title":"P11.65.B GBM AGILE: A global, phase 2/3 adaptive platform trial to evaluate multiple treatment regimens in newly diagnosed and recurrent glioblastoma","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Agile software development; Medicine; Randomization; Protocol (science); Clinical trial; Biomarker; Medical physics; Oncology; Computer science; Internal medicine; Software engineering; Pathology; Alternative medicine","score_opus":0.4195986878733863,"score_gpt":0.5471289144013946,"score_spread":0.12753022652800827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294686035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9818053,0.0000820595,0.0023625537,0.002906879,0.0041042278,0.006611842,0.0010056746,0.00016480601,0.0009566334],"genre_scores_gemma":[0.622617,0.00024280397,0.3641671,0.0033426885,0.0012782865,0.008042364,0.00001935794,0.00017607641,0.000114343435],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99292237,0.0033444222,0.0014265585,0.00101246,0.0005874796,0.0007067226],"domain_scores_gemma":[0.9353366,0.063084684,0.00048695595,0.00057321537,0.00008990722,0.00042863734],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002771517,0.00042682674,0.0014475707,0.00017864963,0.00020597113,0.00003058867,0.0003485036,0.00021748689,0.00047916637],"category_scores_gemma":[0.058481935,0.00035579145,0.00019276195,0.0006037269,0.0001680183,0.00006270564,0.00055335445,0.0005712962,0.000038407583],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.29182628,0.01202008,0.00015642833,0.00003995194,0.00022491578,0.0024534718,0.0021149213,0.00013121606,0.0025174087,0.011761877,0.016158776,0.66059464],"study_design_scores_gemma":[0.42869678,0.21275645,0.00015156351,0.00006240162,0.000605855,0.00019243041,0.0011122902,0.006304479,0.0014300254,0.23502202,0.11275366,0.00091205054],"about_ca_topic_score_codex":0.00007931793,"about_ca_topic_score_gemma":0.0005384018,"teacher_disagreement_score":0.65968263,"about_ca_system_score_codex":0.0017629787,"about_ca_system_score_gemma":0.00046295245,"threshold_uncertainty_score":0.99988943},"labels":[],"label_agreement":null},{"id":"W4296781687","doi":"10.1093/neuonc/noac221","title":"Response assessment in pediatric craniopharyngioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) Working Group","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Craniopharyngioma; Medicine; Radiation therapy; Clinical trial; Magnetic resonance imaging; Progressive disease; Prospective cohort study; Oncology; Radiology; Internal medicine; Disease","score_opus":0.029395434214440536,"score_gpt":0.33596266804512376,"score_spread":0.30656723383068324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296781687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.925627,0.00092014525,0.00005526592,0.06759091,0.0021428387,0.0016681479,0.00010371018,0.00010307527,0.0017889161],"genre_scores_gemma":[0.9856153,0.0017216405,0.0011922106,0.009456838,0.00043140995,0.0012008561,0.00024958648,0.00008042374,0.0000517128],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9877389,0.008433474,0.0011785307,0.0011074585,0.0006269955,0.00091462844],"domain_scores_gemma":[0.98601663,0.012409555,0.00046402938,0.0007888458,0.000056390603,0.00026456642],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0033928324,0.00047868694,0.0009493159,0.0010710995,0.00054642756,0.000037603295,0.00054822135,0.00026847643,0.0007491625],"category_scores_gemma":[0.0007638252,0.0004160466,0.00024226223,0.0020551267,0.000087054046,0.00015348902,0.0006409669,0.0022411954,0.000036750513],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0215052,0.0069240574,0.9323062,0.000017533877,0.00007621786,0.009468879,0.001617583,0.00024114661,0.0074094203,0.0001389955,0.011712024,0.008582777],"study_design_scores_gemma":[0.015240532,0.0060715186,0.8475207,0.00000792508,0.00034512617,0.00029638095,0.0012759424,0.0005054198,0.000006664028,0.0003815302,0.1280459,0.00030233443],"about_ca_topic_score_codex":0.00045996738,"about_ca_topic_score_gemma":0.0008835661,"teacher_disagreement_score":0.11633389,"about_ca_system_score_codex":0.0021553962,"about_ca_system_score_gemma":0.0026269436,"threshold_uncertainty_score":0.9998291},"labels":[],"label_agreement":null},{"id":"W4298395292","doi":"10.1093/neuonc/noac200.023","title":"Health-Related Quality of Life in Patients With High-Grade Glioma: A Systematic Review","year":2022,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Checklist; Quality of life (healthcare); Life expectancy; Anxiety; Depression (economics); Physical therapy; Population; Health related quality of life; Mental health; Social support; Gerontology; Psychiatry; Psychology; Internal medicine; Environmental health; Disease","score_opus":0.06730882957820372,"score_gpt":0.365950299012285,"score_spread":0.29864146943408126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4298395292","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021718354,0.9861815,9.584047e-8,0.0010112717,0.00030920192,0.010089577,0.00010580273,0.000041484287,0.00008921442],"genre_scores_gemma":[0.0010184174,0.9946777,0.000029681005,0.0012208602,0.000018827131,0.0023855083,0.0005647336,0.000080393125,0.0000038287744],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9908608,0.00383664,0.003567029,0.00066696375,0.0006432039,0.00042534474],"domain_scores_gemma":[0.99345493,0.0018561634,0.0033718557,0.00093596504,0.00008900518,0.00029205627],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011420764,0.0005393111,0.011457895,0.0004844638,0.000054523538,0.0000043971313,0.00025197933,0.00028490674,0.0002349196],"category_scores_gemma":[0.0014257072,0.00035098664,0.0005582635,0.0012892837,0.00007843639,0.000028211203,0.00013801873,0.00074526406,0.000034351862],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006374865,0.0037317553,0.0007128507,0.97147185,0.00062446366,0.0003860315,0.000043092823,2.3235431e-7,2.8848666e-7,0.000098328914,0.0009268636,0.021940514],"study_design_scores_gemma":[0.011026969,0.008364817,0.0012441137,0.65444463,0.008372654,0.0002935078,0.000020373463,3.5550514e-7,4.821136e-7,0.000008067046,0.315731,0.0004930428],"about_ca_topic_score_codex":0.0003998191,"about_ca_topic_score_gemma":0.000071101094,"teacher_disagreement_score":0.3170272,"about_ca_system_score_codex":0.0012078244,"about_ca_system_score_gemma":0.0016534259,"threshold_uncertainty_score":0.9998942},"labels":[],"label_agreement":null},{"id":"W4300547400","doi":"10.1215/15228517-2008-024","title":"Abstracts from the Thirteenth International Symposium on Pediatric Neuro-Oncology","year":2008,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Calgary","funders":"US-UK Fulbright Commission; Fulbright Australia; Dana-Farber Cancer Institute","keywords":"Medicine; Pediatric oncology; Medical physics; Oncology; Internal medicine; Cancer","score_opus":0.02651239030925449,"score_gpt":0.290919689644171,"score_spread":0.26440729933491647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4300547400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9061578,0.00022122951,0.0000030815056,0.063818835,0.0035882748,0.0005872923,0.000052948093,0.00010737305,0.025463158],"genre_scores_gemma":[0.9723819,0.0021371553,0.0001203785,0.02268661,0.0023543574,0.00013070674,0.000100455916,0.00004569092,0.000042744326],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99771816,0.00025013965,0.000522396,0.0006192889,0.0004542986,0.0004356941],"domain_scores_gemma":[0.99580884,0.002984861,0.00029708561,0.0005294704,0.00013146989,0.0002482548],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00016129467,0.00030049073,0.00051325664,0.00012979124,0.00021656076,0.000018210156,0.0003506235,0.0002907218,0.00047135857],"category_scores_gemma":[0.0004492627,0.00020566637,0.00021370099,0.00021041285,0.00016814028,0.00006894628,0.00013943245,0.00066565024,0.0008418441],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002033475,0.009810636,0.4421315,0.000018551964,0.00054198375,0.024516119,0.0021452308,0.0004206055,0.15987092,0.00070545316,0.33202,0.02578553],"study_design_scores_gemma":[0.006341559,0.004077384,0.2873699,0.000010183304,0.0003806715,0.0012721558,0.00008169846,0.00009966977,0.009543196,0.0000702192,0.6905532,0.0002001878],"about_ca_topic_score_codex":0.00014999462,"about_ca_topic_score_gemma":0.000059859634,"teacher_disagreement_score":0.35853317,"about_ca_system_score_codex":0.0003885023,"about_ca_system_score_gemma":0.00038654968,"threshold_uncertainty_score":0.9999361},"labels":[],"label_agreement":null},{"id":"W4304109093","doi":"10.1093/neuonc/noac232","title":"Global survival trends for brain tumors, by histology: Analysis of individual records for 67,776 children diagnosed in 61 countries during 2000–2014 (CONCORD-3)","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Centers for Disease Control and Prevention; Susan G. Komen; Swiss Re; Maine Cancer Foundation; CHILDREN with CANCER UK; Institut National Du Cancer; Instituto Nacional do Câncer, Ministério da Saúde; American Cancer Society; Cancer Research UK; Cancer Registry of Greater California; Swiss Cancer Research Foundation; Ligue Contre le Cancer; Saskatchewan Cancer Agency","keywords":"Medicine; Medulloblastoma; Population; Cancer; Survival analysis; Demography; Oncology; Internal medicine; Pathology; Environmental health","score_opus":0.015604013290088614,"score_gpt":0.3016568838066956,"score_spread":0.286052870516607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4304109093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98566014,0.0007230572,0.00002454621,0.0068952483,0.00055720593,0.0010183885,0.004899764,0.000049141257,0.00017248937],"genre_scores_gemma":[0.9943876,0.000052228144,0.0002122687,0.0014703865,0.00011586494,0.0015316693,0.0021339585,0.000037878694,0.000058091526],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972844,0.00035370837,0.0007550456,0.00068059494,0.00034100606,0.0005852074],"domain_scores_gemma":[0.9972084,0.0017535712,0.00043188554,0.00036456416,0.000089500485,0.00015203696],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00061698386,0.0002978196,0.0013916204,0.00074234704,0.0002296293,0.000014963233,0.00028077315,0.00016986353,0.00043203216],"category_scores_gemma":[0.0004113145,0.0003013517,0.00043533448,0.0010664848,0.0001919011,0.000050451486,0.00016564959,0.00020062295,0.0000016047289],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017538394,0.0018866139,0.92203474,0.000038041933,0.0014975353,0.00020601912,0.00043550882,0.00021254251,0.0018899578,0.00021724038,0.06045301,0.009374929],"study_design_scores_gemma":[0.017901147,0.0059484015,0.8771223,0.000009471636,0.0029283864,0.00010371669,0.00024105488,0.00028354448,0.0009968507,0.000055646186,0.094125934,0.00028357707],"about_ca_topic_score_codex":0.0007715851,"about_ca_topic_score_gemma":0.0033741242,"teacher_disagreement_score":0.0449125,"about_ca_system_score_codex":0.0011151817,"about_ca_system_score_gemma":0.0004969797,"threshold_uncertainty_score":0.99994385},"labels":[],"label_agreement":null},{"id":"W4308684155","doi":"10.1093/neuonc/noac217","title":"Global survival trends for brain tumors, by histology: analysis of individual records for 556,237 adults diagnosed in 59 countries during 2000–2014 (CONCORD-3)","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Centers for Disease Control and Prevention; Swiss Cancer Research Foundation; Susan G. Komen; Ligue Contre le Cancer; Swiss Re; CHILDREN with CANCER UK; National Cancer Institute; Institut National Du Cancer; Cancer Research UK; American Cancer Society","keywords":"Medicine; Oligodendroglioma; Population; Glioma; Brain tumor; Histology; Survival analysis; Astrocytoma; Oncology; Glioblastoma; Demography; Gerontology; Internal medicine; Pathology; Environmental health; Cancer research","score_opus":0.01656716708719176,"score_gpt":0.3036107421851673,"score_spread":0.28704357509797557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308684155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863022,0.00069814536,0.000023864886,0.0066829603,0.00076902466,0.000986703,0.0042396574,0.00004973862,0.0002477302],"genre_scores_gemma":[0.9945731,0.000068387846,0.00020198029,0.0014659571,0.000105712315,0.0019483583,0.0015324801,0.000037032663,0.00006698651],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99716634,0.00036001287,0.00080597895,0.0007058038,0.00035947538,0.0006023757],"domain_scores_gemma":[0.9965938,0.002300249,0.00045576697,0.0003650203,0.00012321246,0.00016198074],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006169681,0.0003010482,0.0014396978,0.00073384447,0.00018245525,0.000010720483,0.0002676433,0.00017756909,0.00043620283],"category_scores_gemma":[0.000559135,0.00030459903,0.00043146734,0.0011399039,0.0001570088,0.000052958283,0.00015573605,0.00019712045,0.0000017653292],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062254607,0.0029727446,0.87324685,0.00013157526,0.001566214,0.00062964536,0.0010153904,0.00024793833,0.002829271,0.00029966483,0.09256409,0.018271184],"study_design_scores_gemma":[0.036092535,0.011656245,0.66941476,0.000027708604,0.0036291853,0.00011331153,0.0010290656,0.00079810503,0.0016547916,0.0000758792,0.2750719,0.0004365101],"about_ca_topic_score_codex":0.0007341254,"about_ca_topic_score_gemma":0.005767892,"teacher_disagreement_score":0.20383203,"about_ca_system_score_codex":0.0012283106,"about_ca_system_score_gemma":0.00044507688,"threshold_uncertainty_score":0.99994063},"labels":[],"label_agreement":null},{"id":"W4308976535","doi":"10.1093/neuonc/noac209.183","title":"CSIG-34. LIN28B-LET-7-PBK PATHWAY IS AN IMPORTANT REGULATOR OF GROUP 3 MEDULLOBLASTOMA PROLIFERATION","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Gene knockdown; Cell growth; Apoptosis; Small hairpin RNA; Cancer research; Downregulation and upregulation; Medulloblastoma; Metastasis; Biology; Cell cycle; Stem cell; Cell biology; Cancer; Genetics","score_opus":0.019880294588353466,"score_gpt":0.28090917801063015,"score_spread":0.2610288834222767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308976535","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911972,0.00024777572,0.0000067503474,0.006125044,0.00062510767,0.0009470701,0.00008034869,0.000080565056,0.0006901163],"genre_scores_gemma":[0.9940327,0.000041982086,0.00035294052,0.004622264,0.00023887791,0.0005001094,0.00013566451,0.000046149686,0.000029339544],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977817,0.00028033392,0.0006302377,0.0005146817,0.00046168256,0.0003313433],"domain_scores_gemma":[0.9986271,0.00015568642,0.00033953425,0.0005296873,0.00011345332,0.00023448728],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032380986,0.00021927478,0.00057336624,0.00020055039,0.0001722189,0.000009640672,0.00014177362,0.00013349536,0.0008894471],"category_scores_gemma":[0.00009683466,0.00019405986,0.00015888535,0.00029423597,0.00008278687,0.00007847434,0.00013099503,0.00029220962,0.000015787806],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009461012,0.005104343,0.069385186,0.00005909653,0.000155892,0.0016097337,0.0015823205,0.00002419006,0.8920618,0.002420519,0.009135321,0.017515471],"study_design_scores_gemma":[0.0100384895,0.033830017,0.034085844,0.000027839718,0.0004418794,0.0016029101,0.0009886896,0.0017044508,0.42931867,0.00045841234,0.4871092,0.00039358882],"about_ca_topic_score_codex":0.000043279753,"about_ca_topic_score_gemma":0.00007193539,"teacher_disagreement_score":0.4779739,"about_ca_system_score_codex":0.0003426587,"about_ca_system_score_gemma":0.0003634902,"threshold_uncertainty_score":0.97388226},"labels":[],"label_agreement":null},{"id":"W4308976543","doi":"10.1093/neuonc/noac209.442","title":"EPCO-07. NON-GENOMIC DETERMINANTS OF TUMOR CELL PHENOTYPES IN ADULT GLIOBLASTOMA","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University","funders":"","keywords":"Phenotype; Biology; Epigenetics; Cancer research; Genetics; Somatic evolution in cancer; Mesenchymal stem cell; DNA methylation; Cancer; Tumor progression; Gene; Gene expression","score_opus":0.0061046569588486125,"score_gpt":0.24327205798355153,"score_spread":0.2371674010247029,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308976543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968413,0.00026986178,0.000014930844,0.00010594953,0.00063374394,0.0002501826,0.00011326474,0.000005411206,0.0017653201],"genre_scores_gemma":[0.99768114,0.00020738978,0.00026228724,0.0014934955,0.00015717521,0.000090475776,0.000022089973,0.00003594977,0.000050019018],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986905,0.00010859782,0.0003744336,0.00040513446,0.00010423282,0.0003171074],"domain_scores_gemma":[0.99922043,0.00009078313,0.00021507007,0.0003409792,0.000057325437,0.00007542088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014041613,0.00015951127,0.00030037813,0.00009800728,0.0000722534,0.00000581731,0.00034101296,0.00008983478,0.0000999466],"category_scores_gemma":[0.000105957115,0.0001861465,0.0000905677,0.000119452576,0.00008202897,0.0000020754671,0.00049795426,0.00019473342,0.000020246618],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005786195,0.00029603197,0.009031199,0.000024860621,0.000007087028,0.0001252661,0.00012713547,0.00095434894,0.98029256,0.00002087932,0.002302837,0.006239161],"study_design_scores_gemma":[0.0027035612,0.0057650236,0.0053106253,0.00000514226,0.000029161198,0.00012958262,0.0002653595,0.0006147162,0.7885513,0.00007518693,0.19623241,0.00031797757],"about_ca_topic_score_codex":0.000119510965,"about_ca_topic_score_gemma":0.00063213427,"teacher_disagreement_score":0.19392957,"about_ca_system_score_codex":0.00010329184,"about_ca_system_score_gemma":0.00043083937,"threshold_uncertainty_score":0.7590834},"labels":[],"label_agreement":null},{"id":"W4308976590","doi":"10.1093/neuonc/noac209.303","title":"CTNI-38. UPDATE ON GBM AGILE: A GLOBAL, PHASE 2/3 ADAPTIVE PLATFORM TRIAL TO EVALUATE MULTIPLE REGIMENS IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Agile software development; Randomization; Biomarker; Clinical trial; Oncology; Glioblastoma; Protocol (science); Internal medicine; Computer science; Pathology; Cancer research; Alternative medicine; Biology; Software engineering","score_opus":0.3613912606678735,"score_gpt":0.5353546190290961,"score_spread":0.17396335836122256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308976590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9770293,0.000043271066,0.003141267,0.005117933,0.0057810564,0.0060104653,0.0011221921,0.00019549599,0.001559015],"genre_scores_gemma":[0.65526384,0.00016700335,0.32766667,0.010446857,0.001453907,0.004704456,0.000021758835,0.00020902063,0.00006646272],"study_design_codex":"randomized_trial","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99220836,0.0037718767,0.0014805313,0.0010681383,0.0007385229,0.00073257444],"domain_scores_gemma":[0.9330764,0.065235905,0.0005443251,0.00062591775,0.00009990834,0.00041756273],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0043540373,0.0004105273,0.0013575461,0.0002165588,0.00020829466,0.000034428263,0.00047868618,0.00024020353,0.0006218968],"category_scores_gemma":[0.09804448,0.00036233637,0.0001646336,0.0007051951,0.00018800999,0.000068213616,0.0007528257,0.0010482981,0.00007708651],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.46607643,0.009493909,0.000078608005,0.0000623623,0.000168896,0.0026023432,0.0013566519,0.0002960309,0.0022712944,0.04264629,0.064148165,0.41079903],"study_design_scores_gemma":[0.32283664,0.12776853,0.00011767055,0.0000958827,0.00032136004,0.00013101863,0.00073989463,0.007908179,0.0012098713,0.4039788,0.13391405,0.0009781077],"about_ca_topic_score_codex":0.000024828227,"about_ca_topic_score_gemma":0.00020190647,"teacher_disagreement_score":0.4098209,"about_ca_system_score_codex":0.0008917407,"about_ca_system_score_gemma":0.00034995543,"threshold_uncertainty_score":0.9998829},"labels":[],"label_agreement":null},{"id":"W4308976659","doi":"10.1093/neuonc/noac209.010","title":"ANGI-11. RAB27 IS REQUIRED FOR REGULATING INTACT VASCULATURE IN GLIOBLASTOMA","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cellular transport and secretion","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Biology; Angiogenesis; Pathology; Vascular permeability; Glioma; Cancer research; Medicine; Endocrinology","score_opus":0.012085935201713752,"score_gpt":0.25685195754691365,"score_spread":0.2447660223451999,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308976659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956703,0.00033433168,0.0013988076,0.0010685845,0.0005254119,0.0004761854,0.000045264056,0.000022570284,0.00045852258],"genre_scores_gemma":[0.9963825,0.000038393173,0.00035504845,0.0016471873,0.00026805664,0.00015999815,0.000954086,0.00003991167,0.00015486432],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99861085,0.00014544002,0.00029551907,0.00048619465,0.00013651092,0.0003254855],"domain_scores_gemma":[0.9994269,0.000040671675,0.00011503377,0.00030913556,0.00004529114,0.000062978484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030725234,0.00015970426,0.00023612751,0.0000965327,0.00015518678,0.000009630324,0.00020238341,0.0002256097,0.0001296421],"category_scores_gemma":[0.00005785942,0.00017971553,0.00019538234,0.00017854861,0.000047080524,0.0000054388684,0.00011573767,0.00021738817,0.0000021936858],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006118493,0.00009619922,0.0027335633,0.000017734814,0.000019423034,0.000034102086,0.00029664495,0.0003007567,0.9910749,0.00010953113,0.0015288518,0.0031764486],"study_design_scores_gemma":[0.0019900198,0.0018450512,0.0009283656,0.000003789198,0.000026803886,0.000083731706,0.00019785139,0.00075722556,0.17911491,0.00014769517,0.81469405,0.00021051026],"about_ca_topic_score_codex":0.000020160744,"about_ca_topic_score_gemma":0.00026049948,"teacher_disagreement_score":0.8131652,"about_ca_system_score_codex":0.00008033532,"about_ca_system_score_gemma":0.00013153188,"threshold_uncertainty_score":0.73285866},"labels":[],"label_agreement":null},{"id":"W4308976783","doi":"10.1093/neuonc/noac209.327","title":"CTNI-62. LONG-TERM EFFICACY AND SAFETY OF LAROTRECTINIB IN PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bayer (Canada); Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Trk receptor; Medicine; Internal medicine; Confidence interval; Clinical endpoint; Glioma; Oncology; Gastroenterology; Surgery; Clinical trial; Receptor; Neurotrophin; Cancer research","score_opus":0.008525808754963329,"score_gpt":0.23888200652768363,"score_spread":0.2303561977727203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308976783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967174,0.00017040406,9.979475e-7,0.00051406067,0.00040641002,0.0017097133,0.00006356066,0.000049489383,0.00036797917],"genre_scores_gemma":[0.9991134,0.000040630308,0.000091100424,0.0002932821,0.000056027173,0.00015823239,0.00019710588,0.00004042477,0.000009824098],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978467,0.00041270902,0.00049482065,0.00047955685,0.00035592762,0.00041024658],"domain_scores_gemma":[0.9988782,0.0002808515,0.0002745883,0.0003018137,0.00006468918,0.00019988473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014924165,0.00023743752,0.0007056751,0.00022592302,0.00013249843,0.000007074326,0.00010006041,0.00008578365,0.0001454261],"category_scores_gemma":[0.000053313364,0.00019266586,0.00007007601,0.0003317305,0.000094311355,0.000044900182,0.00018537264,0.00033993204,0.0000043442074],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0073267757,0.0047176396,0.93386835,0.00022562042,0.0000646493,0.0012751035,0.0004934725,0.00005096866,0.017778145,0.00003491885,0.0002914323,0.033872925],"study_design_scores_gemma":[0.020838195,0.009014733,0.9646477,0.00015891851,0.00014686835,0.00015703401,0.0001314218,0.000012272009,0.0030312745,4.5132626e-7,0.001716814,0.00014429513],"about_ca_topic_score_codex":0.00009868675,"about_ca_topic_score_gemma":0.00003728463,"teacher_disagreement_score":0.03372863,"about_ca_system_score_codex":0.0008817572,"about_ca_system_score_gemma":0.00021644728,"threshold_uncertainty_score":0.78566855},"labels":[],"label_agreement":null},{"id":"W4308976790","doi":"10.1093/neuonc/noac209.276","title":"CTNI-10. RANDOMIZED PIVOTAL STUDY OF BLOOD-BRAIN BARRIER (BBB) DISRUPTION USING EXABLATE MODEL 4000 WITH STANDARD OF CARE (SOC) THERAPY IN NON-SMALL CELL LUNG CANCER (NSCLC) BRAIN METASTASES: LIMITLESS TRIAL","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Oncology; Lung cancer; Internal medicine; Randomized controlled trial; Clinical endpoint; non-small cell lung cancer (NSCLC); Pembrolizumab; Progression-free survival; Randomization; Immunotherapy; Cancer; Overall survival","score_opus":0.02676823639182252,"score_gpt":0.3253090690855392,"score_spread":0.2985408326937167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308976790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990037,0.001228292,0.00032455268,0.00041009416,0.00026195814,0.0069794604,0.0005252738,0.000023930002,0.00020943064],"genre_scores_gemma":[0.9970048,0.00014122273,0.0009866715,0.0004934075,0.00008610838,0.0010508398,0.0000733551,0.00008306957,0.00008050891],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9949712,0.0023109298,0.0009972473,0.0006520553,0.0006280557,0.00044046983],"domain_scores_gemma":[0.9972888,0.0012297553,0.00066932116,0.00044786948,0.00021010745,0.00015411363],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001520159,0.0004037447,0.002189802,0.00036616565,0.00014139523,0.000011652581,0.00018828262,0.0001138053,0.0004218243],"category_scores_gemma":[0.00013416872,0.00030995,0.00032965935,0.0004610724,0.00017145475,0.000071206814,0.00014802994,0.00048803166,2.9225274e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8659071,0.0053564864,0.001462298,0.0002091785,0.0012079116,0.0007831574,0.018282851,0.045253046,0.057620265,0.00002202702,0.0002458587,0.0036498515],"study_design_scores_gemma":[0.9253879,0.039104186,0.00007715187,0.00007244196,0.0028172915,0.000054492994,0.009521031,0.014489899,0.0076012607,0.000011710474,0.0005541585,0.00030846352],"about_ca_topic_score_codex":0.0010652244,"about_ca_topic_score_gemma":0.00064456376,"teacher_disagreement_score":0.05948084,"about_ca_system_score_codex":0.0005025774,"about_ca_system_score_gemma":0.0013002706,"threshold_uncertainty_score":0.99993527},"labels":[],"label_agreement":null},{"id":"W4308976883","doi":"10.1093/neuonc/noac209.135","title":"STEM-18. EPIGENETIC AND MOLECULAR COORDINATION BETWEEN HDAC2 AND SMAD3-SKI IS REQUIRED FOR GROWTH AND STEM CELL CHARACTERISTICS OF BRAIN TUMOUR STEM CELLS","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Neurosciences, Mental Health and Addiction; Government of Canada; University of Calgary","funders":"","keywords":"Epigenetics; Biology; Stem cell; Chromatin; Cancer stem cell; Neural stem cell; Cancer research; Cell growth; Cell biology; Genetics","score_opus":0.019614621106355354,"score_gpt":0.27745685641914053,"score_spread":0.25784223531278516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308976883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958999,0.0008489638,0.0005425699,0.0010682573,0.00016436585,0.00080625137,0.0005350785,0.000011402702,0.00012316841],"genre_scores_gemma":[0.99856853,0.00016730573,0.0001651742,0.00044733248,0.00010185592,0.00012431516,0.000090776215,0.000057343048,0.00027737746],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977798,0.00050539564,0.00046022775,0.0006574235,0.00022876968,0.00036840964],"domain_scores_gemma":[0.9988391,0.00029705605,0.00028138713,0.0002704901,0.00013396946,0.00017803884],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00047983014,0.00022941323,0.00045130504,0.00014153989,0.00020080677,0.000026415652,0.00019158813,0.00021811856,0.000008173277],"category_scores_gemma":[0.000033826236,0.00026496392,0.000067255525,0.00013009695,0.00024518662,0.000007465475,0.00047504497,0.00023006756,9.071299e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018450292,0.000087767745,0.0011297811,0.00022454362,0.000031586947,0.000029061839,0.00026480385,0.0000017143894,0.985424,0.000029424886,0.0026712494,0.009921561],"study_design_scores_gemma":[0.0016404684,0.0041042054,0.00040391381,0.000006682636,0.00005610779,0.000046288143,0.0002534702,0.000119173776,0.9571116,0.000025971274,0.036005795,0.00022631887],"about_ca_topic_score_codex":0.000014451184,"about_ca_topic_score_gemma":0.0000026295818,"teacher_disagreement_score":0.033334546,"about_ca_system_score_codex":0.000059000773,"about_ca_system_score_gemma":0.00018845595,"threshold_uncertainty_score":0.9999803},"labels":[],"label_agreement":null},{"id":"W4308976884","doi":"10.1093/neuonc/noac209.400","title":"DDDR-35. TARGETING GBM INVASION BY INHIBITING KCNA1 WITH 4-AMINOPYRIDINE: AN FDA APPROVED DRUG THAT EASILY PASS THROUGH THE BBB","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of California, San Francisco; Associazione Italiana per la Ricerca sul Cancro; Hospital for Sick Children; Lazio Innova","keywords":"Medicine; Drug; Glioblastoma; Cancer research; 4-Aminopyridine; Oncology; Pharmacology; Pathology; Internal medicine","score_opus":0.026420053005179685,"score_gpt":0.2749201693302587,"score_spread":0.248500116325079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308976884","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9746269,0.0006522351,0.000018533292,0.018780109,0.0004468825,0.0011602137,0.000035891877,0.00015315486,0.0041260826],"genre_scores_gemma":[0.990551,0.00010585167,0.000450183,0.007592862,0.00027763282,0.00063488184,0.00024033821,0.00008229456,0.000064973676],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99706084,0.0006286176,0.00039099425,0.0007454314,0.00056546874,0.00060867675],"domain_scores_gemma":[0.9982046,0.0007135234,0.0003486327,0.0004740725,0.00007719188,0.00018199503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045776358,0.0003497432,0.0005567261,0.00008182716,0.0007934239,0.0000418722,0.00026995546,0.000098253055,0.00017881709],"category_scores_gemma":[0.00016017973,0.00022985085,0.00012129263,0.00037821464,0.00015666414,0.0001774969,0.0003456024,0.00076216203,0.000017450962],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088574603,0.0030109093,0.05789592,0.00006980155,0.00018124709,0.0018034609,0.0058050235,0.0002325316,0.806488,0.00040146284,0.10721511,0.016010795],"study_design_scores_gemma":[0.010686287,0.006632651,0.0030838605,0.000063487096,0.00053535757,0.0013115662,0.014060672,0.0007498216,0.3161396,0.00014222022,0.6460403,0.0005541628],"about_ca_topic_score_codex":0.00042672094,"about_ca_topic_score_gemma":0.00011394231,"teacher_disagreement_score":0.5388252,"about_ca_system_score_codex":0.00037981998,"about_ca_system_score_gemma":0.0002506602,"threshold_uncertainty_score":0.93730456},"labels":[],"label_agreement":null},{"id":"W4308976889","doi":"10.1093/neuonc/noac209.057","title":"BIOM-47. PREDICTORS OF SEIZURE AT ONSET USING A FUNCTIONAL VARIANT ANALYSIS OF TARGETED NEXT GENERATION SEQUENCING IN GBM","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Univariate analysis; Exome sequencing; Multivariate analysis; Internal medicine; Oncology; Logistic regression; Exome; Univariate; Medicine; Biology; Bioinformatics; Gene; Genetics; Multivariate statistics; Mutation","score_opus":0.04077867267202619,"score_gpt":0.26582499817758987,"score_spread":0.2250463255055637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308976889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99784786,0.0002920239,0.0007081536,0.00008010948,0.00047689272,0.00013698108,0.00038284375,0.0000033522915,0.00007176922],"genre_scores_gemma":[0.9980221,0.0001087642,0.00040096053,0.00044509378,0.00013043729,0.000023347457,0.00084662845,0.000013698956,0.00000897663],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988367,0.00018749668,0.0003731455,0.00030561897,0.00013616645,0.00016088357],"domain_scores_gemma":[0.9993349,0.00007398609,0.00025145386,0.00022291603,0.0000780554,0.00003872286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021916819,0.00010456598,0.00027610018,0.00026720212,0.0000779765,0.000004509474,0.00010597077,0.00011472017,0.00013432682],"category_scores_gemma":[0.00013327606,0.00012032521,0.00012262799,0.0005170702,0.000061514955,0.0000031077827,0.00023689544,0.00010427862,3.0373522e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016552325,0.00006548591,0.013940037,0.0000059697873,0.0001815101,0.000022811126,0.00009455999,0.16683072,0.8177373,0.0000238902,0.0007810699,0.00015114181],"study_design_scores_gemma":[0.0023336767,0.0026402185,0.016416058,0.000005462223,0.0011238279,0.0002151949,0.00037562597,0.21789059,0.70528895,0.000029659312,0.053271096,0.0004096471],"about_ca_topic_score_codex":0.00034336915,"about_ca_topic_score_gemma":0.0006495594,"teacher_disagreement_score":0.112448335,"about_ca_system_score_codex":0.00039280482,"about_ca_system_score_gemma":0.0006874662,"threshold_uncertainty_score":0.49067196},"labels":[],"label_agreement":null},{"id":"W4308977007","doi":"10.1093/neuonc/noac209.646","title":"NIMG-28. USE OF NEUROIMAGING TECHNIQUES IN GLIOMA PATIENTS – RESULTS OF AN INTERNATIONAL SURVEY ON BEHALF OF THE EORTC BRAIN TUMOR GROUP","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Neuroimaging; Medicine; Glioma; Nuclear medicine; Magnetic resonance imaging; Diffusion MRI; Radiology; Medical physics; Psychiatry","score_opus":0.035672399757505614,"score_gpt":0.3169352618992086,"score_spread":0.281262862141703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308977007","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968019,0.000004155163,3.6093542e-7,0.0016022649,0.00033940098,0.000554155,0.0004419201,0.0000141927085,0.00024164334],"genre_scores_gemma":[0.9988121,0.000004563428,0.00010988331,0.0008396188,0.000016474653,0.00005139743,0.00014333328,0.00001886561,0.0000037882098],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978782,0.00073555525,0.00056291383,0.00028232895,0.00038071707,0.00016027389],"domain_scores_gemma":[0.9979833,0.0010099438,0.00044358664,0.0003861862,0.00012896978,0.000048017646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004939578,0.00011624274,0.00035609817,0.00032685892,0.000029459741,0.0000032776857,0.00022476078,0.000036252077,0.000026057616],"category_scores_gemma":[0.0012424467,0.000084617335,0.00008490872,0.00036331732,0.000102190286,0.0000651152,0.00022884298,0.00021885753,3.6877555e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018474292,0.005515464,0.80567884,0.00001275361,0.000028457429,0.00026427384,0.00023101784,0.00003656781,0.17453963,0.00007414266,0.0014476556,0.01032376],"study_design_scores_gemma":[0.0032356153,0.0046038236,0.8771979,0.000026888114,0.000022633096,0.0000322155,0.000022809269,0.00007812007,0.111389525,0.000016949665,0.0033253785,0.000048139274],"about_ca_topic_score_codex":0.0016205919,"about_ca_topic_score_gemma":0.0004759399,"teacher_disagreement_score":0.071519054,"about_ca_system_score_codex":0.00016281343,"about_ca_system_score_gemma":0.00008798496,"threshold_uncertainty_score":0.34505948},"labels":[],"label_agreement":null},{"id":"W4308977070","doi":"10.1093/neuonc/noac209.333","title":"CTNI-68. FIREFLY-1 (PNOC026): PHASE 2 STUDY OF PAN-RAF INHIBITOR TOVORAFENIB IN PEDIATRIC AND YOUNG ADULT PATIENTS WITH RAF-ALTERED RECURRENT OR PROGRESSIVE LOW-GRADE GLIOMA OR ADVANCED SOLID TUMORS","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; McGill University Health Centre; Université de Montréal; Centre hospitalier de l'Université Laval; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Adverse effect; Internal medicine; Gastroenterology; Response Evaluation Criteria in Solid Tumors; Phases of clinical research; Vomiting; Anemia; Oncology; Glioma; Surgery; Clinical trial; Cancer research","score_opus":0.016804126077242278,"score_gpt":0.3232962237666636,"score_spread":0.3064920976894213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308977070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936951,0.00035203897,2.5306437e-7,0.0004264119,0.00074973603,0.0045872945,0.00011085343,0.00005777347,0.000020567955],"genre_scores_gemma":[0.9971285,0.00009787548,0.0001308915,0.00018903689,0.00017609258,0.0021116238,0.000092479786,0.00006543673,0.000008080897],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99663174,0.0004397243,0.00088833814,0.00084235874,0.0006350995,0.0005627519],"domain_scores_gemma":[0.99794716,0.00037802116,0.0006743573,0.0005131291,0.00023019813,0.00025711753],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014280027,0.00042422334,0.001083512,0.0005499937,0.00017478497,0.000015882844,0.00021213802,0.000092553164,0.00011310184],"category_scores_gemma":[0.00041163128,0.00029036286,0.00007751443,0.0010619574,0.00010063025,0.00011574223,0.00035450928,0.00047092428,0.0000033711624],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.049874038,0.09480272,0.7607716,0.00042367552,0.00025983423,0.017264789,0.009069039,0.000051766412,0.008794206,0.0000034635443,0.0014970512,0.057187837],"study_design_scores_gemma":[0.2819814,0.29324907,0.3937445,0.00029988142,0.0014603062,0.0010551425,0.007491461,0.00027906563,0.017954208,0.000012572912,0.0015262547,0.0009461298],"about_ca_topic_score_codex":0.00006185366,"about_ca_topic_score_gemma":0.00026888892,"teacher_disagreement_score":0.36702707,"about_ca_system_score_codex":0.000393041,"about_ca_system_score_gemma":0.0004069887,"threshold_uncertainty_score":0.9999549},"labels":[],"label_agreement":null},{"id":"W4308977071","doi":"10.1093/neuonc/noac209.368","title":"DDDR-03. DEVELOPMENT OF NOVEL ANTI-BRAIN METASTASIS INHIBITORS","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Brain metastasis; Cancer research; Medicine; Metastasis; Cell; Population; Cell culture; Transcriptome; Pathology; Cancer; Biology; Gene; Internal medicine; Gene expression","score_opus":0.04471516655315932,"score_gpt":0.3191582260845011,"score_spread":0.2744430595313418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308977071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98433346,0.00028670146,0.0003576616,0.010635317,0.0008799047,0.000732404,0.00009616701,0.000066395856,0.0026119864],"genre_scores_gemma":[0.97256565,0.000014158868,0.022312367,0.0045378413,0.000100930614,0.00018396579,0.00010563775,0.000042760465,0.00013669375],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.998022,0.00024007706,0.00056359504,0.00040577303,0.00042147885,0.0003470466],"domain_scores_gemma":[0.998799,0.00039550857,0.00023989077,0.00033250457,0.00006880959,0.00016424606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006334559,0.00020468401,0.0006388212,0.00022895657,0.00020074217,0.000004537417,0.00013630312,0.00006474958,0.00085586193],"category_scores_gemma":[0.0001808718,0.00018157398,0.00016778638,0.0003993815,0.00009288404,0.00003269531,0.0002956201,0.00033547689,0.000028957782],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006352104,0.00697941,0.00481904,0.00013725477,0.0008324432,0.0012364459,0.0027736889,0.00022831874,0.773929,0.0014634014,0.032191135,0.17477468],"study_design_scores_gemma":[0.0054642125,0.00265457,0.0027751666,0.000010119968,0.00026104372,0.0006440732,0.00088362617,0.000065254106,0.08049063,0.000018461535,0.9065702,0.00016264246],"about_ca_topic_score_codex":0.00002745879,"about_ca_topic_score_gemma":0.000013992882,"teacher_disagreement_score":0.87437904,"about_ca_system_score_codex":0.00034656294,"about_ca_system_score_gemma":0.0007942032,"threshold_uncertainty_score":0.9371088},"labels":[],"label_agreement":null},{"id":"W4308977216","doi":"10.1093/neuonc/noac209.808","title":"EXTH-09. HSP90 INHIBITION AS A NOVEL THERAPY FOR DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Hsp90; Hsp90 inhibitor; Cancer research; Glioma; Medicine; Cancer; Cell culture; Viability assay; Biology; Heat shock protein; Internal medicine; Biochemistry; Genetics; Gene","score_opus":0.024749196199097635,"score_gpt":0.3183052436406788,"score_spread":0.29355604744158115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308977216","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914912,0.00035622943,0.0010764921,0.0036415532,0.0003872626,0.0015222677,0.00010816599,0.00004341025,0.001373419],"genre_scores_gemma":[0.9932097,0.00016106544,0.0005544418,0.0030337793,0.00057920686,0.0017231522,0.00029411906,0.00007882207,0.0003657112],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977629,0.000333586,0.00033884763,0.00068399205,0.00029520367,0.00058547757],"domain_scores_gemma":[0.9989253,0.00013074886,0.000106588865,0.0005182566,0.00015334281,0.00016572398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004993163,0.00022454538,0.00028584714,0.00018507558,0.00033763555,0.00002686307,0.00034084424,0.00022482744,0.00023487069],"category_scores_gemma":[0.00048405997,0.00023248198,0.0001621112,0.00028246667,0.00011588556,0.0000064703827,0.0005652292,0.00039470717,0.000026843092],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018284379,0.0008761177,0.000073591225,0.0000124535345,0.000038577185,0.00009206979,0.000076993,0.000018165447,0.9556506,0.0002374117,0.005141168,0.035954375],"study_design_scores_gemma":[0.00395009,0.005909804,0.00009112357,0.0000013507345,0.0000059257895,0.00031842393,0.000049451566,0.000043721884,0.49059442,0.00010909233,0.49877343,0.00015318036],"about_ca_topic_score_codex":0.000050753373,"about_ca_topic_score_gemma":0.000033533863,"teacher_disagreement_score":0.49363226,"about_ca_system_score_codex":0.00013977912,"about_ca_system_score_gemma":0.00054208376,"threshold_uncertainty_score":0.948034},"labels":[],"label_agreement":null},{"id":"W4308977228","doi":"10.1093/neuonc/noac209.462","title":"EPCO-28. DOT1L AND PRC2 REGULATE A SHARED EPIGENETIC MECHANISM IN GLIOBLASTOMA AND MIXED LINEAGE LEUKEMIA","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Neurosciences, Mental Health and Addiction; Government of Canada; University of Calgary","funders":"","keywords":"Epigenetics; PRC2; Biology; DNA methylation; Chromatin; Cancer research; Histone; Genetics; EZH2; Gene; Gene expression","score_opus":0.010823839808588141,"score_gpt":0.2540997245746737,"score_spread":0.24327588476608558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308977228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99629796,0.002054421,0.00021500155,0.0004402571,0.00032148132,0.00037596098,0.000034076216,0.000017669014,0.00024319555],"genre_scores_gemma":[0.9972392,0.0011923652,0.0006546583,0.00047322563,0.000121006124,0.00011664578,0.000051048435,0.000041780753,0.00011009913],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99813396,0.0004083092,0.00034674976,0.0006294452,0.00014459569,0.00033694124],"domain_scores_gemma":[0.9993057,0.00007443773,0.00014792224,0.00030393695,0.000039111976,0.00012883854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000408471,0.00020533327,0.00027738558,0.00013733131,0.0001598629,0.000024405079,0.00016431509,0.00021494317,0.00003896613],"category_scores_gemma":[0.00012734332,0.00022994538,0.000048747595,0.00015921179,0.00007841291,0.000004786518,0.0005301708,0.00026555554,0.0000024005392],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002453461,0.000057925954,0.00094062625,0.000014210527,0.0000143737,0.00006595612,0.00017311779,0.00032220114,0.9878319,0.00012349313,0.0001732844,0.010037556],"study_design_scores_gemma":[0.0025084517,0.0041697896,0.006558452,0.0000060614157,0.000027598424,0.00012025564,0.00019019231,0.0020053894,0.86332226,0.0013431641,0.11938803,0.0003603611],"about_ca_topic_score_codex":0.00003166996,"about_ca_topic_score_gemma":0.00021999826,"teacher_disagreement_score":0.12450965,"about_ca_system_score_codex":0.000090461916,"about_ca_system_score_gemma":0.00018310918,"threshold_uncertainty_score":0.93769},"labels":[],"label_agreement":null},{"id":"W4308977249","doi":"10.1093/neuonc/noac209.594","title":"PATH-21. INVESTIGATING CHANGES IN IDH MUTATION STATUS AT GLIOMA RECURRENCE","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"IDH2; Isocitrate dehydrogenase; IDH1; Glioma; Sanger sequencing; Immunohistochemistry; Carcinogenesis; Biology; Pathology; Mutation; Methylation; Biopsy; Cancer research; PTEN; Oncology; Medicine; Cancer; Gene; Genetics; PI3K/AKT/mTOR pathway","score_opus":0.03756683201148126,"score_gpt":0.31348693781309633,"score_spread":0.2759201058016151,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308977249","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990582,0.0005025499,9.149514e-7,0.006611696,0.00054868637,0.00052154815,0.000029678404,0.000051159772,0.001151798],"genre_scores_gemma":[0.99638754,0.00008523008,0.00025979854,0.002434976,0.00007875058,0.0006112309,0.000107359956,0.00002156393,0.000013526113],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99841386,0.00030043258,0.00024869075,0.00037047084,0.000254895,0.0004116492],"domain_scores_gemma":[0.99902457,0.0004232635,0.00015649336,0.00019591942,0.000038960283,0.00016079807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002183116,0.00013952435,0.00030066757,0.00024075777,0.00017264341,0.0000071052946,0.00006971658,0.00006296205,0.0003447253],"category_scores_gemma":[0.00036840557,0.00013653972,0.000042580737,0.0004760201,0.000066024964,0.0000345128,0.00020851102,0.00028376994,0.000032640684],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021305824,0.001093552,0.27224326,0.00006897283,0.000032303626,0.00839188,0.0038829786,0.00011554985,0.62281626,0.0003297803,0.003948089,0.086864345],"study_design_scores_gemma":[0.021224448,0.020198215,0.3229948,0.00016324504,0.0003274656,0.004518044,0.004024499,0.0032518064,0.2607367,0.0010539914,0.36075607,0.00075071235],"about_ca_topic_score_codex":0.00013742647,"about_ca_topic_score_gemma":0.0004276342,"teacher_disagreement_score":0.36207953,"about_ca_system_score_codex":0.0008678968,"about_ca_system_score_gemma":0.00019678847,"threshold_uncertainty_score":0.5567928},"labels":[],"label_agreement":null},{"id":"W4308977251","doi":"10.1093/neuonc/noac209.271","title":"CTNI-04. TRAM-01: A PHASE 2 STUDY OF TRAMETINIB FOR PEDIATRIC PATIENTS WITH NEUROFIBROMATOSIS TYPE 1 AND PLEXIFORM NEUROFIBROMAS","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; McGill University Health Centre; Centre Hospitalier Universitaire de Sherbrooke; Hospital for Sick Children; Centre hospitalier universitaire de Québec; BC Children's Hospital; SickKids Foundation; Centre hospitalier de l'Université Laval; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Trametinib; Neurofibromatosis; Adverse effect; Dysgeusia; Internal medicine; Surgery; Radiology","score_opus":0.02775016837810763,"score_gpt":0.3290209320926506,"score_spread":0.301270763714543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308977251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99541223,0.000040463754,0.0000029326068,0.00032788177,0.00025899752,0.0034526666,0.00014533689,0.00007062631,0.00028887743],"genre_scores_gemma":[0.998724,0.000019962308,0.0002210331,0.00033076073,0.00006318239,0.00045311102,0.00007145581,0.00008056959,0.000035951827],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9974526,0.00031487417,0.00045799432,0.0006486601,0.0005893084,0.00053653267],"domain_scores_gemma":[0.9981569,0.0006485652,0.00024861182,0.0004010504,0.00019266116,0.00035219846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014544444,0.00028427006,0.0006662084,0.0003773379,0.0002495912,0.000014007055,0.0001750278,0.000061179875,0.00009954266],"category_scores_gemma":[0.0002676136,0.00023592057,0.00008067173,0.0008121138,0.000095002666,0.00008556934,0.00019243074,0.0003951602,0.000004578052],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10839277,0.09912539,0.64411503,0.00092765957,0.0007743822,0.0031730733,0.003380797,0.000053365602,0.07867083,0.00008169588,0.007716608,0.053588383],"study_design_scores_gemma":[0.11517126,0.66287464,0.20010254,0.000009920939,0.0012219083,0.00046450616,0.0008429952,0.00017986358,0.0033472283,0.00004358665,0.015327153,0.00041437417],"about_ca_topic_score_codex":0.000020869888,"about_ca_topic_score_gemma":0.000008429325,"teacher_disagreement_score":0.56374925,"about_ca_system_score_codex":0.00008610475,"about_ca_system_score_gemma":0.00035691346,"threshold_uncertainty_score":0.96205616},"labels":[],"label_agreement":null},{"id":"W4308977252","doi":"10.1093/neuonc/noac209.571","title":"INNV-31. PROTECT: PROCARBAZINE, LOMUSTINE, AND VINCRISTINE VERSUS TEMOZOLAMIDE IN HIGH-RISK, LOW-GRADE GLIOMAS: A RETROSPECTIVE COHORT STUDY","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Procarbazine; Medicine; Lomustine; Oligodendroglioma; Temozolomide; Vincristine; Internal medicine; Retrospective cohort study; Glioma; Surgery; Oncology; Chemotherapy; Astrocytoma; Cyclophosphamide","score_opus":0.013487882927569972,"score_gpt":0.28114174097646943,"score_spread":0.26765385804889946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308977252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898491,0.00029175114,0.000001883053,0.0018741782,0.0006548644,0.006150907,0.000055934048,0.00014492734,0.00097648805],"genre_scores_gemma":[0.9948702,0.00006862251,0.00016011043,0.00032612536,0.00015608227,0.0042864075,0.000043170137,0.0000658918,0.00002340499],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966637,0.0005456931,0.0006147821,0.0010375429,0.0005816086,0.0005566673],"domain_scores_gemma":[0.99831235,0.0004816273,0.00032838288,0.00053659535,0.00012777976,0.00021323866],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006637104,0.0003923532,0.0010401009,0.00054593396,0.00030118294,0.000022667695,0.00017436061,0.00013172219,0.000109789726],"category_scores_gemma":[0.00112256,0.00035953216,0.00008816788,0.0011744493,0.00014046245,0.000066196655,0.00041031276,0.0010897494,0.000016259786],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025980345,0.0062861764,0.96879786,0.000042321462,0.00025313252,0.0064776144,0.00066081807,0.000040101666,0.011194704,0.00008519441,0.000977254,0.002586811],"study_design_scores_gemma":[0.02565313,0.020430122,0.9456554,0.000019172161,0.0005423893,0.0003884587,0.0009147752,0.00024224145,0.0016395804,0.000081946775,0.0041581723,0.0002746177],"about_ca_topic_score_codex":0.0019687153,"about_ca_topic_score_gemma":0.001064036,"teacher_disagreement_score":0.023142442,"about_ca_system_score_codex":0.0014940222,"about_ca_system_score_gemma":0.00035052132,"threshold_uncertainty_score":0.9998857},"labels":[],"label_agreement":null},{"id":"W4308977416","doi":"10.1093/neuonc/noac209.952","title":"QOL-25. IMPACTS OF IMPLEMENTING A PROSPECTIVE TREATMENT AND SURVEILLANCE PROTOCOL FOR THE MANAGEMENT OF NF2-ASSOCIATED VESTIBULAR SCHWANNOMAS ON TUMOR GROWTH, HEARING OUTCOMES, AND QUALITY OF LIFE","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Bevacizumab; Neurofibromatosis type 2; Quality of life (healthcare); Prospective cohort study; Hearing loss; Cohort; Pediatrics; Surgery; Internal medicine; Audiology; Schwannoma; Chemotherapy","score_opus":0.06412302229070513,"score_gpt":0.3670834514717785,"score_spread":0.30296042918107335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308977416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9436498,0.000037675152,0.000026828313,0.0010033102,0.00004614902,0.05429421,0.0000620245,0.0000212654,0.0008586893],"genre_scores_gemma":[0.9633415,0.0000035128767,0.0004281535,0.000111169706,0.0000148409645,0.03603149,0.000008837309,0.000021770944,0.00003875296],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979002,0.00033491605,0.000760456,0.00036997275,0.000308319,0.00032612003],"domain_scores_gemma":[0.99799573,0.00072951184,0.00075767894,0.00030274029,0.00012207667,0.00009224528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014806098,0.00019994954,0.00079963467,0.00013164741,0.00019765891,0.000007931661,0.00011090282,0.000033776312,0.00002157675],"category_scores_gemma":[0.00031339048,0.0001457576,0.00009221336,0.00021678617,0.00011843617,0.000030985775,0.00032198802,0.00013451691,1.4238843e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042261807,0.0016457422,0.9466246,0.0018570324,0.0015078109,0.0001404255,0.0011553961,0.00003573306,0.032307807,0.008270759,0.00020519237,0.002023349],"study_design_scores_gemma":[0.016351813,0.015080263,0.9595197,0.00006371808,0.00021481678,0.000032335418,0.0011826174,0.00027748974,0.0036345252,0.00022756282,0.0032545743,0.0001605992],"about_ca_topic_score_codex":0.00029656227,"about_ca_topic_score_gemma":0.0000348296,"teacher_disagreement_score":0.028673284,"about_ca_system_score_codex":0.0002494666,"about_ca_system_score_gemma":0.00012627615,"threshold_uncertainty_score":0.5943822},"labels":[],"label_agreement":null},{"id":"W4308977430","doi":"10.1093/neuonc/noac209.177","title":"CSIG-28. THE HEDGEHOG GENE EXPRESSION PROGRAM REGULATES LIPID FEEDBACK MECHANISMS UNDERLYING HEDGEHOG-ASSOCIATED MEDULLOBLASTOMA","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Smoothened; Hedgehog signaling pathway; Hedgehog; GLI1; Biology; Cilium; Sonic hedgehog; Cell biology; Genetics; Gene","score_opus":0.030108250192044134,"score_gpt":0.2916004519560762,"score_spread":0.2614922017640321,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308977430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98984677,0.0010423958,0.0008900821,0.002734458,0.0022293304,0.0014545136,0.0000697858,0.0002945019,0.0014381878],"genre_scores_gemma":[0.99389315,0.00014312926,0.0015159142,0.0024407282,0.00034294836,0.0009113171,0.00020984406,0.00012295022,0.00042003492],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99572974,0.001283483,0.0005887285,0.0010185969,0.00048810177,0.00089133624],"domain_scores_gemma":[0.99813044,0.00028580643,0.00041203012,0.00080934534,0.0001801001,0.00018225965],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0008929953,0.0004669584,0.0005325526,0.000108134,0.0013582513,0.000058005775,0.00090282713,0.00035647815,0.000121643716],"category_scores_gemma":[0.00055809185,0.00039391607,0.00028273006,0.00042050565,0.00030169135,0.000008809037,0.0014851536,0.0006659325,0.000026102598],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023539565,0.000467504,0.00013151122,0.000015129344,0.00013950025,0.000061861436,0.0005101752,0.00085610786,0.9779343,0.00007471427,0.010579156,0.008994666],"study_design_scores_gemma":[0.0015516035,0.004513378,0.0004683865,0.000015613723,0.000087911845,0.00019461595,0.0012747817,0.0003472477,0.7425601,0.00037400788,0.24812153,0.0004908478],"about_ca_topic_score_codex":0.000016269016,"about_ca_topic_score_gemma":0.000051954736,"teacher_disagreement_score":0.23754238,"about_ca_system_score_codex":0.00024266503,"about_ca_system_score_gemma":0.0003681266,"threshold_uncertainty_score":0.9999418},"labels":[],"label_agreement":null},{"id":"W4308977441","doi":"10.1093/neuonc/noac209.318","title":"CTNI-53. PNOC014: PHASE IB STUDY RESULTS OF DAY101(TOVORAFENIB) FOR CHILDREN WITH LOW-GRADE GLIOMAS (LGGS) AND OTHER RAS/RAF/MEK/ERK PATHWAY-ACTIVATED TUMORS","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Dosing; Body surface area; MAPK/ERK pathway; Toxicity; MEK inhibitor; Adverse effect; Internal medicine; Oncology; Nuclear medicine; Kinase; Chemistry","score_opus":0.024339299112671783,"score_gpt":0.31004749124828296,"score_spread":0.28570819213561116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308977441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99310094,0.00019239848,0.0000060133902,0.0014805725,0.00021353629,0.0038993675,0.00065089396,0.00009992862,0.0003563676],"genre_scores_gemma":[0.9974671,0.000010073443,0.00016359352,0.0008690772,0.00014229809,0.0010507379,0.0001701518,0.00009563982,0.00003135318],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99722224,0.0003713229,0.0006524679,0.0008341076,0.0004201719,0.0004996779],"domain_scores_gemma":[0.997973,0.0005903396,0.00046640265,0.00060237583,0.00011230406,0.0002555659],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036488747,0.00038986013,0.0009687417,0.00035830727,0.0002735563,0.000015977292,0.00018763011,0.00010546803,0.00010826713],"category_scores_gemma":[0.00018636919,0.00030872275,0.00013162289,0.00055688067,0.00017914017,0.00006109487,0.0001717274,0.0003478559,0.0000041982153],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024858775,0.043307282,0.13134593,0.000100599056,0.0016328102,0.0030028897,0.0049351454,0.00015526814,0.7682074,0.00017557887,0.006427178,0.015851162],"study_design_scores_gemma":[0.23922722,0.12789473,0.09744479,0.000101051155,0.0018479021,0.0023387084,0.0035755134,0.00023321487,0.45021242,0.000096578224,0.076116584,0.0009112818],"about_ca_topic_score_codex":0.00025644177,"about_ca_topic_score_gemma":0.00012049152,"teacher_disagreement_score":0.31799495,"about_ca_system_score_codex":0.00019774796,"about_ca_system_score_gemma":0.00029101642,"threshold_uncertainty_score":0.99993646},"labels":[],"label_agreement":null},{"id":"W4308977714","doi":"10.1093/neuonc/noac209.144","title":"STEM-27. MECHANOSENSITIVE BRAIN TUMOR CELLS CONSTRUCT BLOOD-TUMOR BARRIER TO MASK CHEMOSENSITIVITY","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"","keywords":"Mechanosensitive channels; SOX2; Biology; Cancer cell; Cell biology; Wnt signaling pathway; Brain tumor; Cancer research; Cancer; Ion channel; Pathology; Medicine; Signal transduction","score_opus":0.01639442208434566,"score_gpt":0.26171038339733105,"score_spread":0.2453159613129854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308977714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9774138,0.000029838682,0.0000856451,0.008664753,0.0043426836,0.0011246634,0.00024617862,0.00021741044,0.007875056],"genre_scores_gemma":[0.8727351,0.000007504252,0.0007928191,0.12404765,0.00056244474,0.0001116915,0.000053030486,0.00007665516,0.0016131233],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99635464,0.0011788578,0.0004978877,0.0009123235,0.00037942614,0.0006768678],"domain_scores_gemma":[0.99731463,0.0011929885,0.00024217374,0.0005570215,0.0001743504,0.00051882485],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005142273,0.00036209225,0.0009930565,0.00029094119,0.000324585,0.000010944523,0.00015056925,0.00013697369,0.0019406334],"category_scores_gemma":[0.00028702384,0.00037231852,0.0002388102,0.00051189953,0.00022769891,0.000049115188,0.00044249493,0.0010433361,0.0004489052],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015249511,0.00035380616,0.00020535718,0.000032826432,0.00008300001,0.007822819,0.0005890751,0.000045101573,0.9550498,0.0003350978,0.030899612,0.0030585686],"study_design_scores_gemma":[0.0039417623,0.007158946,0.00040305423,0.000011059217,0.00021903765,0.010330219,0.0018669679,0.00018907519,0.5450453,0.00009543872,0.43037122,0.00036792867],"about_ca_topic_score_codex":0.000033109758,"about_ca_topic_score_gemma":0.000023724619,"teacher_disagreement_score":0.4100045,"about_ca_system_score_codex":0.0003154257,"about_ca_system_score_gemma":0.0007706187,"threshold_uncertainty_score":0.99987286},"labels":[],"label_agreement":null},{"id":"W4308977734","doi":"10.1093/neuonc/noac209.296","title":"CTNI-31. COG ACNS1721: PHASE 2 STUDY OF VELIPARIB AND LOCAL IRRADIATION, FOLLOWED BY MAINTENANCE VELIPARIB AND TEMOZOLOMIDE, IN PATIENTS WITH NEWLY DIAGNOSED HIGH-GRADE GLIOMA WITHOUT H3 K27M OR BRAF MUTATIONS","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Veliparib; Temozolomide; Medicine; Internal medicine; PARP inhibitor; Oncology; Radiation therapy; Glioma; Interim analysis; Clinical trial; Cancer research; Poly ADP ribose polymerase; Biology","score_opus":0.012898713778758715,"score_gpt":0.2864777575381292,"score_spread":0.2735790437593705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308977734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995131,0.00020199336,0.000024010309,0.0015800224,0.00021707463,0.0025757544,0.00019594934,0.000041185227,0.00003301461],"genre_scores_gemma":[0.9977482,0.000039199258,0.00020171197,0.0007287914,0.000025816193,0.0009494398,0.00024467465,0.000047265472,0.000014930984],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975327,0.00033895508,0.0006271618,0.0006718349,0.0004187861,0.0004105163],"domain_scores_gemma":[0.9981481,0.0007622136,0.00035762053,0.00033447103,0.00015548662,0.00024213594],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019199698,0.00031338178,0.00084703654,0.00033702358,0.00022175965,0.0000192024,0.000120267956,0.00010568809,0.00005756033],"category_scores_gemma":[0.00029953753,0.0002488294,0.000037224603,0.00076795364,0.00023162074,0.000111901114,0.00013749993,0.0003270036,0.0000021260485],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007099434,0.027694492,0.9278794,0.000052447336,0.00037900888,0.002123498,0.0032910157,0.00034155918,0.008147517,0.000054133194,0.009985754,0.012951725],"study_design_scores_gemma":[0.1860263,0.049993668,0.74896604,0.000048120422,0.00093856815,0.00020223764,0.0040289243,0.00082909607,0.0013718066,0.000027864826,0.007162862,0.00040449467],"about_ca_topic_score_codex":0.00062376435,"about_ca_topic_score_gemma":0.0009722489,"teacher_disagreement_score":0.17892687,"about_ca_system_score_codex":0.00029655066,"about_ca_system_score_gemma":0.0003223894,"threshold_uncertainty_score":0.9999964},"labels":[],"label_agreement":null},{"id":"W4308977735","doi":"10.1093/neuonc/noac209.019","title":"BIOM-09. GUIDING PRECISION THERAPEUTICS THROUGH INTERROGATING ONCOGENIC PATHWAY ACTIVATION","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"PI3K/AKT/mTOR pathway; MAPK/ERK pathway; Cancer research; Protein kinase B; Medicine; Signal transduction; Biology; Genetics","score_opus":0.08886516930571865,"score_gpt":0.35031463791012984,"score_spread":0.2614494686044112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308977735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876709,0.0002533057,0.00014297647,0.0061859917,0.0008451462,0.0006102007,0.0000111430145,0.000106792984,0.0041735386],"genre_scores_gemma":[0.99414605,0.00007691135,0.00088078453,0.00436951,0.00017608603,0.000233857,0.0000535316,0.0000388537,0.000024425253],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99838287,0.00027725758,0.00036199993,0.0003837329,0.00031075277,0.000283369],"domain_scores_gemma":[0.9987369,0.00060483796,0.00021966807,0.0003060191,0.00006648736,0.00006604913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023664263,0.00017165864,0.00032642027,0.00012453973,0.000304189,0.000014836083,0.00012601455,0.000095065196,0.00035009248],"category_scores_gemma":[0.00013372251,0.00015014272,0.00014012564,0.0003243244,0.000039225604,0.000084860825,0.0002298499,0.00026176637,0.000032923934],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019149839,0.0008030706,0.0019250667,0.000008912275,0.00008999154,0.00018162552,0.0020725268,0.00005367037,0.8328864,0.00023349973,0.0007777304,0.160776],"study_design_scores_gemma":[0.0032484615,0.004140161,0.00071127625,0.000028596982,0.00014888747,0.0003120038,0.0018156394,0.00067727506,0.5187286,0.00032452308,0.46972197,0.00014260216],"about_ca_topic_score_codex":0.000027506772,"about_ca_topic_score_gemma":0.000009135311,"teacher_disagreement_score":0.46894425,"about_ca_system_score_codex":0.00072190026,"about_ca_system_score_gemma":0.00020313602,"threshold_uncertainty_score":0.6122642},"labels":[],"label_agreement":null},{"id":"W4308977915","doi":"10.1093/neuonc/noac209.200","title":"RADT-10. THE LOST METASTASES: DEEP LEARNING’S POTENTIAL IN RADIOSURGERY QUALITY ASSURANCE","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital; Centre Hospitalier de l’Université de Montréal; Centre intégré de santé et de services sociaux de la Montérégie-Centre; Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Centre Intégré de Santé et de Services Sociaux des Laurentides; GDI Integrated Facility Services (Canada)","funders":"","keywords":"Medicine; Radiosurgery; False positive paradox; Radiology; Quality assurance; Medical physics; Radiation therapy; Nuclear medicine; Artificial intelligence; Computer science; Pathology","score_opus":0.017400297816076417,"score_gpt":0.32343560148428885,"score_spread":0.3060353036682124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308977915","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92401254,0.0015428478,0.0011619241,0.05999844,0.0026410974,0.0007017691,0.00001243497,0.00013927571,0.009789665],"genre_scores_gemma":[0.98782957,0.00019988773,0.000379231,0.0103388,0.00038468928,0.000083157036,0.00004661883,0.000045796547,0.00069225684],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99514014,0.0027061263,0.0006046043,0.00048442467,0.0005495736,0.0005151223],"domain_scores_gemma":[0.9971725,0.0019319394,0.00028047658,0.0003886655,0.000052556014,0.00017389334],"candidate_categories":["research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0030466905,0.00020063439,0.0006539385,0.00018685551,0.0003505396,0.000023500737,0.0003096042,0.00008356578,0.0024434868],"category_scores_gemma":[0.003250208,0.00015920655,0.0002100179,0.000469237,0.0002606901,0.000057125915,0.0002561301,0.0024628257,0.00007559815],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00393953,0.0024351054,0.13344826,0.0002568798,0.00039507702,0.013515029,0.0035803816,0.044690315,0.18315704,0.0011447042,0.10474672,0.50869095],"study_design_scores_gemma":[0.0031631398,0.0007976694,0.022527525,0.000010553175,0.000107583546,0.0014519487,0.0007433897,0.015413967,0.0001820708,0.000100244455,0.9553032,0.0001987194],"about_ca_topic_score_codex":0.00021437622,"about_ca_topic_score_gemma":0.00002579145,"teacher_disagreement_score":0.8505565,"about_ca_system_score_codex":0.00030365438,"about_ca_system_score_gemma":0.0003716488,"threshold_uncertainty_score":0.99983853},"labels":[],"label_agreement":null},{"id":"W4308977924","doi":"10.1093/neuonc/noac209.120","title":"STEM-03. MOLECULAR PROFILING OF PRIMARY VERSUS RECURRENT GLIOBLASTOMA BRAIN TUMOR STEM CELLS UNCOVERS SIGNALING MECHANISMS THAT PROMOTE THE AGGRESSIVENESS OF RECURRENT GLIOBLASTOMA","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Neurosciences, Mental Health and Addiction; Government of Canada; University of Calgary","funders":"","keywords":"Stem cell; Temozolomide; Cancer research; Brain tumor; Population; Cancer stem cell; Primary tumor; Medicine; Biology; Oncology; Cancer; Pathology; Internal medicine; Glioblastoma; Metastasis; Genetics","score_opus":0.024638354563905875,"score_gpt":0.2747157493756938,"score_spread":0.2500773948117879,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308977924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991922,0.0011925874,0.000081841084,0.0015295659,0.0024341503,0.0024667515,0.00016159656,0.00006752761,0.00014394439],"genre_scores_gemma":[0.9982134,0.00006466705,0.00041116725,0.0005218129,0.00006238128,0.00061191333,0.000021208365,0.00008453717,0.000008924038],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9957128,0.0009997549,0.000847209,0.00076771586,0.0010789917,0.0005935107],"domain_scores_gemma":[0.9965316,0.0011182013,0.0011998257,0.00071284815,0.00023229425,0.0002052263],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00076542736,0.0004507329,0.0011113043,0.00033615544,0.00023407143,0.00001573761,0.00045706826,0.00012466121,0.000095622316],"category_scores_gemma":[0.00006567514,0.0003030582,0.00042003137,0.00070288253,0.0001817353,0.000069824564,0.0005522271,0.0006295917,0.000008556776],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0117637655,0.002116518,0.00019164753,0.00044264132,0.0003779483,0.0021442464,0.00066887366,0.0014538608,0.93020386,0.00041409401,0.00036046735,0.049862064],"study_design_scores_gemma":[0.007355373,0.03103557,0.00003648763,0.00025669122,0.00052823464,0.00025433555,0.0013781564,0.00041054285,0.951943,0.00007461558,0.0064813127,0.00024568054],"about_ca_topic_score_codex":0.00001264456,"about_ca_topic_score_gemma":0.000013053453,"teacher_disagreement_score":0.049616385,"about_ca_system_score_codex":0.0008665913,"about_ca_system_score_gemma":0.0007856036,"threshold_uncertainty_score":0.9999421},"labels":[],"label_agreement":null},{"id":"W4308977947","doi":"10.1093/neuonc/noac209.109","title":"CNSC-28. IDENTIFICATION OF EAG2-KVß2 POTASSIUM CHANNEL COMPLEX IN NEURON-GBM COMMUNICATIONS REVEALS GBM VULNERABILITY TO DESIGNER INTERFERENCE PEPTIDE","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cellular Mechanics and Interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Cancer research; Cell growth; RNA interference; Biology; Potassium channel; Regulator; Cell; Neuroscience; Cell biology; Endocrinology; Gene; RNA; Biochemistry","score_opus":0.052973766892466204,"score_gpt":0.32683669675710086,"score_spread":0.2738629298646347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308977947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9780504,0.00015680295,0.00985479,0.0068789986,0.001085195,0.00107099,0.0002472051,0.000029934803,0.0026256961],"genre_scores_gemma":[0.99693745,0.00009059148,0.0004286631,0.0015680696,0.00006110644,0.00033926676,0.0003096985,0.000028276416,0.00023685257],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.997323,0.0010028125,0.0007104528,0.0005338511,0.0001490322,0.000280849],"domain_scores_gemma":[0.9980135,0.00016393716,0.0003119761,0.0012426119,0.00016505487,0.00010294825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007231405,0.00017180454,0.00029623456,0.00017144538,0.00022193673,0.00001778279,0.00085706095,0.000108029766,0.00014726704],"category_scores_gemma":[0.00044177115,0.00020093218,0.00011750556,0.00031106416,0.000097276796,0.000010007876,0.001023456,0.00043630283,0.000018573965],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001396062,0.00052850833,0.0002852544,0.000012107724,0.000013898277,0.0000040376794,0.00022052845,0.0005517595,0.9910759,0.00047150734,0.005089401,0.0016075309],"study_design_scores_gemma":[0.001559751,0.00471238,0.008944678,0.000017945516,0.000069588335,0.00017239251,0.0013079131,0.010675095,0.48187065,0.0012115788,0.48880512,0.00065291167],"about_ca_topic_score_codex":0.00012867077,"about_ca_topic_score_gemma":0.00024845844,"teacher_disagreement_score":0.5092052,"about_ca_system_score_codex":0.00014411542,"about_ca_system_score_gemma":0.00018659694,"threshold_uncertainty_score":0.81937766},"labels":[],"label_agreement":null},{"id":"W4308977979","doi":"10.1093/neuonc/noac209.1140","title":"MODL-12. A NOVEL GENETICALLY ENGINEERED H3.3G34R MODEL REVEALS COOPERATION WITH ATRX LOSS IN UPREGULATION OF HOXA CLUSTER GENES AND PROMOTION OF NEURONAL LINEAGE","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"ATRX; Context (archaeology); Biology; Gene; Cancer research; Genetics; Mutation","score_opus":0.0237888244673174,"score_gpt":0.26931468147261517,"score_spread":0.24552585700529778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308977979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945509,0.000093486386,0.0028539323,0.0015085475,0.000051891428,0.00083365664,0.000038169223,0.000012398377,0.00005702458],"genre_scores_gemma":[0.99588525,0.000040517625,0.0035443073,0.00023666567,0.000032553104,0.00016024786,0.00006814967,0.000021503141,0.000010782586],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9988648,0.00011552653,0.0003850031,0.00027303846,0.000216574,0.00014500736],"domain_scores_gemma":[0.99938333,0.00013107156,0.00014560962,0.00016826512,0.00011199358,0.000059731785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016082583,0.00012776771,0.00036302028,0.00016166523,0.00003473729,0.0000036044564,0.000044915898,0.00007342973,0.000022472583],"category_scores_gemma":[0.000049061826,0.00011036289,0.00003634755,0.00016151459,0.000065045206,0.00004566434,0.00006749187,0.00013011266,2.7371522e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007305922,0.0016260511,0.020155763,0.000082122606,0.000033341174,0.000046174035,0.00038239002,0.2270111,0.7470136,0.00028378097,0.00003768841,0.0025973779],"study_design_scores_gemma":[0.012097347,0.009074111,0.10841284,0.00004716227,0.00024062919,0.00030236045,0.000042613945,0.7758365,0.09349841,0.000049059527,0.00023568503,0.00016325912],"about_ca_topic_score_codex":0.000013361001,"about_ca_topic_score_gemma":0.000040199433,"teacher_disagreement_score":0.6535152,"about_ca_system_score_codex":0.000085585285,"about_ca_system_score_gemma":0.0001395852,"threshold_uncertainty_score":0.45004678},"labels":[],"label_agreement":null},{"id":"W4308978003","doi":"10.1093/neuonc/noac209.916","title":"QLTI-14. PEDIATRIC CENTRAL NERVOUS SYSTEM TUMOR SURVIVOR AND CAREGIVER EXPERIENCES WITH MULTIDISCIPLINARY TELEMEDICINE","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Telemedicine and Telehealth Implementation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Telemedicine; Telehealth; Medicine; Pediatric oncology; Survivorship curve; Pediatric cancer; Multidisciplinary approach; Demographics; Family medicine; Medical emergency; Health care; Cancer; Internal medicine","score_opus":0.020120244840176594,"score_gpt":0.30895029268460766,"score_spread":0.28883004784443106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308978003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921328,0.00052911945,0.00009265423,0.0038273318,0.0012515497,0.001208922,0.000024601037,0.00016620598,0.0007668132],"genre_scores_gemma":[0.9959212,0.000054992717,0.00034023117,0.0020304604,0.0009215653,0.0005558188,0.000075972705,0.00004135258,0.00005838267],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.9973373,0.00031940738,0.00054441486,0.0005594654,0.00057748123,0.0006619297],"domain_scores_gemma":[0.9985552,0.00034509884,0.00030364786,0.00026886407,0.00009986123,0.00042737304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003683826,0.00024824587,0.00059726625,0.00027458355,0.00046248705,0.000008293097,0.00013561698,0.00005542215,0.0003464807],"category_scores_gemma":[0.000071480106,0.00019308917,0.000044269804,0.00049038796,0.00016616982,0.00008650445,0.00019206571,0.00050825794,0.0000052238497],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040770974,0.00089162914,0.8104665,0.0014497237,0.00010771565,0.013217423,0.1030996,0.000055604432,0.0050386614,0.00021186756,0.026284581,0.03509957],"study_design_scores_gemma":[0.021185476,0.038624562,0.310254,0.000048247053,0.0007806094,0.016385466,0.4831483,0.0013828172,0.0006579371,0.0000050469166,0.12692334,0.0006041778],"about_ca_topic_score_codex":0.00037234277,"about_ca_topic_score_gemma":0.00013784948,"teacher_disagreement_score":0.50021255,"about_ca_system_score_codex":0.00038846183,"about_ca_system_score_gemma":0.0006625227,"threshold_uncertainty_score":0.7873948},"labels":[],"label_agreement":null},{"id":"W4309013902","doi":"10.1093/neuonc/noac209.397","title":"DDDR-32. A NEW IMMUNOMODULATORY FUNCTION OF PYRIDO-PYRIMIDINE DERIVATIVES TO IMPAIR METASTATIC GROUP 3 MEDULLOBLASTOMA IN VIVO","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of California, San Francisco; Associazione Italiana per la Ricerca sul Cancro; Hospital for Sick Children; Lazio Innova","keywords":"Medulloblastoma; In vivo; Cancer research; Epithelial–mesenchymal transition; Vincristine; Medicine; Pharmacology; Biology; Oncology; Metastasis; Chemotherapy; Internal medicine; Chemistry; Cancer; Cyclophosphamide","score_opus":0.022728537731646185,"score_gpt":0.28986979557692005,"score_spread":0.26714125784527387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309013902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933229,0.0005092373,0.000067449415,0.0038762782,0.00062047935,0.0009625482,0.000024083385,0.000056137822,0.0005608625],"genre_scores_gemma":[0.9958632,0.000025873696,0.0006036556,0.002922082,0.000075876356,0.00041043325,0.00002103443,0.0000407908,0.00003703143],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99799186,0.00032298194,0.00056544703,0.00043971615,0.00032403713,0.00035592986],"domain_scores_gemma":[0.99867874,0.00041993317,0.0002160117,0.00036548974,0.000056072986,0.0002637537],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002847489,0.00023043869,0.0007231762,0.00053032994,0.00008521698,0.000005586099,0.00013473078,0.00005590044,0.0014638993],"category_scores_gemma":[0.00025384635,0.00021434165,0.00016218054,0.0006952452,0.00006294916,0.00006964722,0.00020814882,0.0002843717,0.00002108081],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020134267,0.0026997225,0.010097086,0.00005108576,0.00022721502,0.00066666683,0.001442205,0.00062185177,0.9504649,0.0004471869,0.010503714,0.020764962],"study_design_scores_gemma":[0.026358586,0.060305115,0.26521054,0.000107045,0.0009898345,0.0008630456,0.003994566,0.00067148416,0.2147827,0.00083366426,0.4252414,0.00064202375],"about_ca_topic_score_codex":0.00022563146,"about_ca_topic_score_gemma":0.00015040183,"teacher_disagreement_score":0.7356822,"about_ca_system_score_codex":0.0005469347,"about_ca_system_score_gemma":0.0004112036,"threshold_uncertainty_score":0.9994489},"labels":[],"label_agreement":null},{"id":"W4309014060","doi":"10.1093/neuonc/noac209.507","title":"IMMU-09. IMMUNOLOGICAL CHARACTERIZATION OF PEDIATRIC BRAIN TUMORS HAS CLINICAL IMPLICATIONS FOR PATIENT MANAGEMENT AND PROGNOSIS","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Inflammation; Immunotherapy; Immune system; Glioma; Medicine; Brain tumor; Tumor microenvironment; Cancer research; Biomarker; Immunology; Pathology; Biology","score_opus":0.052818894544610306,"score_gpt":0.33387839038335715,"score_spread":0.28105949583874684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309014060","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97189504,0.0001895462,0.000049337126,0.025459843,0.0002270492,0.0019279816,0.0001024683,0.000035935744,0.000112826376],"genre_scores_gemma":[0.99486357,0.0003553166,0.0005060526,0.0014382642,0.00007709738,0.0025145356,0.00021891051,0.000017394912,0.000008874824],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985895,0.00019527099,0.0005481201,0.0003581518,0.000109968954,0.0001989784],"domain_scores_gemma":[0.99884236,0.0005085313,0.0002879592,0.00021369927,0.000067414316,0.000080026795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022373763,0.0001184349,0.0003766369,0.00014990516,0.00018921572,0.000008009122,0.00007952906,0.00006828363,0.00004724908],"category_scores_gemma":[0.00012194626,0.00010331045,0.00012500511,0.00022739865,0.0000897811,0.000024815401,0.00021820217,0.00014815308,0.0000024998894],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007601526,0.007984621,0.5720405,0.00010907553,0.00025359166,0.00010571037,0.00027561476,0.000004793934,0.13062383,0.0032755793,0.0036532853,0.28091326],"study_design_scores_gemma":[0.00377315,0.0095839985,0.8869205,0.0000045452216,0.0003933406,0.00008631514,0.00009525563,0.000046600308,0.0017471166,0.00016852448,0.097080104,0.00010053562],"about_ca_topic_score_codex":0.0000029344133,"about_ca_topic_score_gemma":6.2836256e-7,"teacher_disagreement_score":0.31488,"about_ca_system_score_codex":0.00009901083,"about_ca_system_score_gemma":0.00008185629,"threshold_uncertainty_score":0.42128778},"labels":[],"label_agreement":null},{"id":"W4309014071","doi":"10.1093/neuonc/noac209.469","title":"EPCO-35. THE ZINC FINGER IN THE CEREBELLUM (ZIC1/4) LOCUS IS A CONTEXT DEPENDENT DRIVER GENE IN MEDULLOBLASTOMA","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Epigenetics; Biology; Chromatin; Medulloblastoma; Genetics; Cancer research; Gene; Phenotype; High-mobility group; Context (archaeology); Histone","score_opus":0.01804259810641576,"score_gpt":0.26511078014504835,"score_spread":0.2470681820386326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309014071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98814714,0.0020537518,0.00003978253,0.006729391,0.00058480055,0.0005722395,0.0000410769,0.00001278455,0.0018190303],"genre_scores_gemma":[0.9844688,0.00021501753,0.000027322,0.014482814,0.00019910886,0.00037002354,0.000015959686,0.000031995067,0.00018894344],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971266,0.0010765125,0.00038983795,0.0005909355,0.00031259016,0.0005035318],"domain_scores_gemma":[0.9988747,0.0002922607,0.00013214863,0.00061270554,0.0000407913,0.0000473644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084048347,0.00023678539,0.00031549702,0.00008867302,0.0002860819,0.000018140772,0.00078664755,0.00015706445,0.00014061558],"category_scores_gemma":[0.00020590879,0.00017126731,0.00013936407,0.00026007977,0.00022976578,0.0000034090658,0.00075354794,0.0006087142,0.00003247415],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002825397,0.00039961466,0.005788521,0.000008934657,0.000088430475,0.0005075054,0.005506853,0.000802369,0.9598121,0.00008661773,0.015913757,0.0108027505],"study_design_scores_gemma":[0.0019428917,0.0016010402,0.0019267378,0.0000048418383,0.00003759802,0.0003117597,0.0033713148,0.000115432485,0.13945615,0.00012657382,0.85081375,0.00029191567],"about_ca_topic_score_codex":0.00017979665,"about_ca_topic_score_gemma":0.0017951847,"teacher_disagreement_score":0.83489996,"about_ca_system_score_codex":0.00013583276,"about_ca_system_score_gemma":0.00022628611,"threshold_uncertainty_score":0.6984078},"labels":[],"label_agreement":null},{"id":"W4309014292","doi":"10.1093/neuonc/noac209.472","title":"EPCO-38. TYPE B ULTRA LONG-RANGE INTERACTIONS IN PFAS (TULIPS) ARE RECURRENT EPIGENOMIC FEATURES OF PFA EPENDYMOMA","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Princess Margaret Cancer Centre; Université de Montréal; University of Calgary; McGill University; Centre Hospitalier Universitaire Sainte-Justine; University Health Network; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Biology; Epigenomics; Epigenetics; Ependymoma; Genome; Genetics; Bisulfite sequencing; Computational biology; DNA methylation; Gene; Pathology; Medicine; Gene expression","score_opus":0.03514456935066453,"score_gpt":0.3296389742227801,"score_spread":0.2944944048721156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309014292","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98673743,0.0016157276,0.0000010922664,0.0053688134,0.0017845262,0.000635094,0.000067740286,0.000035465353,0.0037541029],"genre_scores_gemma":[0.9984427,0.00025814265,0.000048324862,0.00072389655,0.00012329302,0.00022310308,0.00007357557,0.000030983174,0.00007595549],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984242,0.00028073197,0.000393364,0.0003867304,0.00021209421,0.00030293502],"domain_scores_gemma":[0.9987512,0.00046679127,0.00024132675,0.00034608098,0.000072583665,0.00012197924],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00014724726,0.00018678975,0.0005379627,0.0003352136,0.000100248784,0.0000063121106,0.00014755905,0.00006705789,0.0013225812],"category_scores_gemma":[0.00018210452,0.00017435396,0.00014386777,0.00038904996,0.00006227264,0.000040833525,0.00010186684,0.0005827992,0.00005878353],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004005403,0.014421969,0.6251756,0.00021628042,0.00046861975,0.015571927,0.0051319827,0.00041905537,0.20405753,0.0005765781,0.054006852,0.075948216],"study_design_scores_gemma":[0.0061580106,0.005384129,0.7537619,0.00007515842,0.0002731559,0.0023265202,0.0012174859,0.00003433821,0.021397049,0.000089881294,0.20902427,0.00025812752],"about_ca_topic_score_codex":0.00016343452,"about_ca_topic_score_gemma":0.0009645703,"teacher_disagreement_score":0.18266048,"about_ca_system_score_codex":0.00058300584,"about_ca_system_score_gemma":0.00019808598,"threshold_uncertainty_score":0.99959034},"labels":[],"label_agreement":null},{"id":"W4309014302","doi":"10.1093/neuonc/noac209.435","title":"EPID-25. THE CLINICAL AND MOLECULAR LANDSCAPE OF GLIOMAS IN ADOLESCENTS AND YOUNG ADULTS","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Princess Margaret Cancer Centre; Health Sciences Centre; Sunnybrook Health Science Centre; University Health Network; SickKids Foundation; University of Toronto; Hospital for Sick Children","funders":"","keywords":"Medicine; Glioma; Cohort; Young adult; Internal medicine; Oncology; Cancer research","score_opus":0.0197734005871599,"score_gpt":0.3174353657158528,"score_spread":0.2976619651286929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309014302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99375314,0.0014528699,9.063047e-7,0.0036984219,0.0002448359,0.00041145235,0.000007369877,0.000009049977,0.00042195802],"genre_scores_gemma":[0.9979128,0.00025020906,0.000029427878,0.0016868665,0.000033992736,0.00006867108,0.0000045770203,0.000011626498,0.0000018098623],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998803,0.00032943682,0.00033420726,0.00022964372,0.00014419819,0.00015947434],"domain_scores_gemma":[0.9994082,0.00018880493,0.00010304348,0.00019280099,0.000024058278,0.00008309881],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003105403,0.00009407372,0.00033783447,0.00009678835,0.000051257597,0.0000034914744,0.00006434292,0.00006263528,0.000028689765],"category_scores_gemma":[0.00014308597,0.000067277724,0.000053358726,0.0001590146,0.00012722453,0.000012940506,0.00019035714,0.00026105705,0.0000015838365],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048641412,0.0009276413,0.97028255,0.000031992637,0.00003234982,0.0012063994,0.00034375128,0.0000028409602,0.007880198,0.000082874976,0.0006459302,0.018077053],"study_design_scores_gemma":[0.012272206,0.0037424988,0.9684055,0.000048490663,0.00014948168,0.00076477026,0.0006801074,0.00027076397,0.0021610055,0.00007165857,0.011346626,0.00008692701],"about_ca_topic_score_codex":0.000061918974,"about_ca_topic_score_gemma":0.00007574913,"teacher_disagreement_score":0.017990125,"about_ca_system_score_codex":0.000024995681,"about_ca_system_score_gemma":0.000058722817,"threshold_uncertainty_score":0.27435058},"labels":[],"label_agreement":null},{"id":"W4309014408","doi":"10.1093/neuonc/noac209.452","title":"EPCO-17. UNMASKING CLONAL EVOLUTION OF DIFFUSE INTRINSIC GLIOMA USING MULTI-MODAL GENOMIC DATA","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Biology; Epigenetics; Somatic evolution in cancer; Epigenome; DNA methylation; Transcriptome; Genetics; Glioma; Exome sequencing; Epigenomics; Exome; Genome; Phenotype; Computational biology; Gene; Gene expression","score_opus":0.06440820373949774,"score_gpt":0.3327576589872273,"score_spread":0.2683494552477296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309014408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967206,0.0007314363,0.00014861267,0.0008180834,0.00073708285,0.000503369,0.0001589624,0.00004395467,0.00013786893],"genre_scores_gemma":[0.9973025,0.000024547755,0.0018270075,0.00039255532,0.00019923602,0.000046925732,0.00016564906,0.000035918612,0.0000057168972],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9981585,0.0002476195,0.00043193164,0.0005291883,0.0002947795,0.00033793744],"domain_scores_gemma":[0.9985361,0.00029445917,0.00026234004,0.0007192251,0.000060474773,0.00012736251],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002489608,0.00018191228,0.00048744306,0.00032298433,0.00020277649,0.000007362093,0.00029609344,0.00009048096,0.00023398442],"category_scores_gemma":[0.00015363832,0.00017883435,0.000098904326,0.00035361448,0.000110524794,0.00007664864,0.00095486833,0.00032798687,0.000010746384],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041913136,0.003217892,0.07179904,0.000028643191,0.00014324355,0.0015741587,0.00025318316,0.00047055623,0.91261935,0.00024175653,0.000872201,0.008360868],"study_design_scores_gemma":[0.06283339,0.010222327,0.57170314,0.000097874276,0.0028187004,0.010553778,0.0018094676,0.09758672,0.058112074,0.00026450222,0.18296574,0.0010323012],"about_ca_topic_score_codex":0.00026439416,"about_ca_topic_score_gemma":0.000047063026,"teacher_disagreement_score":0.85450727,"about_ca_system_score_codex":0.0011346905,"about_ca_system_score_gemma":0.0005073144,"threshold_uncertainty_score":0.72926533},"labels":[],"label_agreement":null},{"id":"W4309014415","doi":"10.1093/neuonc/noac209.398","title":"DDDR-33. TARGETING TGFΒ PATHWAY DEPENDENCIES IN GROUP 3 MEDULLOBLASTOMA","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"University of California, San Francisco; Associazione Italiana per la Ricerca sul Cancro; Hospital for Sick Children; Lazio Innova","keywords":"Medulloblastoma; Cancer research; Effector; Biology; Transforming growth factor; Cell biology","score_opus":0.01805968335924277,"score_gpt":0.27305550557854463,"score_spread":0.25499582221930184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309014415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884007,0.00057241804,0.0000036024899,0.0046576792,0.00082374556,0.00051985984,0.000024536403,0.0000899091,0.00490754],"genre_scores_gemma":[0.9957099,0.000053754207,0.00026901902,0.0031863481,0.00014526636,0.00052162335,0.000047362286,0.000036168647,0.000030551204],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980064,0.0003313777,0.00038171335,0.00045333046,0.00036072658,0.00046646263],"domain_scores_gemma":[0.99893296,0.0004910046,0.00012912735,0.0002559824,0.00003673567,0.00015421692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036479684,0.00019344132,0.0004637863,0.00025911292,0.00018824091,0.000009993774,0.00015027191,0.00009643847,0.0009127482],"category_scores_gemma":[0.00025794332,0.00017880766,0.0001213641,0.00037669664,0.00006031821,0.000050508166,0.00028839876,0.0005058293,0.00006835953],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049574464,0.003498183,0.14482228,0.000043776403,0.00008376835,0.015478056,0.0018075457,0.00019126137,0.78590363,0.001416449,0.012543919,0.033715382],"study_design_scores_gemma":[0.00894041,0.007406768,0.037988488,0.000023304954,0.00011604181,0.00151771,0.0031235414,0.00044490962,0.04571221,0.00030086408,0.8940913,0.00033442423],"about_ca_topic_score_codex":0.0001226215,"about_ca_topic_score_gemma":0.0002595309,"teacher_disagreement_score":0.8815474,"about_ca_system_score_codex":0.0006136041,"about_ca_system_score_gemma":0.00022941171,"threshold_uncertainty_score":0.9993953},"labels":[],"label_agreement":null},{"id":"W4309014483","doi":"10.1093/neuonc/noac209.399","title":"DDDR-34. RECURRENT RELA FUSION-POSITIVE EPENDYMOMA TREATED WITH VAL-083 UNDER EXPANDED ACCESS: A CASE REPORT","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of California, San Francisco; Associazione Italiana per la Ricerca sul Cancro; Hospital for Sick Children; Lazio Innova","keywords":"Ependymoma; Medicine; Carboplatin; Internal medicine; Oncology; Neutropenia; Temozolomide; Chemotherapy; Gastroenterology; Surgery; Cisplatin","score_opus":0.03688535145602527,"score_gpt":0.33629641486761613,"score_spread":0.29941106341159085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309014483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845411,0.00027248415,0.000017762493,0.0069898,0.0005395806,0.0013934871,0.000063150335,0.00015507237,0.00602752],"genre_scores_gemma":[0.9960618,0.000052660725,0.000120062075,0.0021130422,0.00012517927,0.0010423657,0.0002551663,0.00006554726,0.00016416039],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9971927,0.00045079124,0.0005309464,0.0008560923,0.0004757064,0.000493777],"domain_scores_gemma":[0.99789095,0.0005928916,0.0003731714,0.00063539535,0.00017700864,0.00033061087],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002458943,0.00035926935,0.00071441877,0.0002868377,0.00044826584,0.000032210643,0.00014975393,0.00013457342,0.0010912382],"category_scores_gemma":[0.000110816574,0.0002674749,0.00017614872,0.0005747515,0.00009696702,0.00009871016,0.0003615054,0.0005690965,0.000030415164],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023525273,0.0038698153,0.013229589,0.000019469482,0.0003750959,0.9511287,0.0005861109,0.00009313939,0.009419244,0.00015742247,0.0074771377,0.01129173],"study_design_scores_gemma":[0.014713213,0.017248698,0.015942609,0.00006667871,0.0014420925,0.8939738,0.0018358292,0.00020456458,0.02132347,0.00013045699,0.03265669,0.00046184895],"about_ca_topic_score_codex":0.00047425024,"about_ca_topic_score_gemma":0.00027942943,"teacher_disagreement_score":0.057154864,"about_ca_system_score_codex":0.0010363075,"about_ca_system_score_gemma":0.0005390794,"threshold_uncertainty_score":0.99997777},"labels":[],"label_agreement":null},{"id":"W4309014865","doi":"10.1093/neuonc/noac209.401","title":"DDDR-36. VAL-083 IN PATIENTS WITH RECURRENT GLIOBLASTOMA TREATED UNDER EXPANDED ACCESS PROGRAM","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"University of Texas MD Anderson Cancer Center","keywords":"Temozolomide; Medicine; Bevacizumab; Internal medicine; Clinical trial; Dexamethasone; Oncology; Refractory (planetary science); Adverse effect; Radiosurgery; PTEN; Gastroenterology; Surgery; Radiation therapy; Chemotherapy","score_opus":0.024971132027790763,"score_gpt":0.32462487955634184,"score_spread":0.29965374752855106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309014865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99413925,0.000062669766,7.751501e-7,0.002319147,0.00038252742,0.0021002628,0.000023448763,0.00014203519,0.0008298853],"genre_scores_gemma":[0.9967445,0.000018132487,0.000058876038,0.001091982,0.00004600252,0.0018486807,0.00012519152,0.000045753273,0.00002085186],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99794954,0.0002775393,0.00034533316,0.0005471359,0.00041330652,0.00046712862],"domain_scores_gemma":[0.9990317,0.00017575888,0.00016487612,0.00034577213,0.00009307438,0.000188785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009633128,0.0002648672,0.00053204765,0.0003289648,0.00012955244,0.000024780618,0.00017487974,0.00009037661,0.0003614273],"category_scores_gemma":[0.000033048087,0.00017966561,0.00008921222,0.00070770195,0.000072346105,0.00007923548,0.00022271945,0.0003883091,0.000019353482],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009648446,0.021220746,0.80384403,0.000032216536,0.00018127057,0.0014729305,0.00037458062,0.00014892602,0.0011559798,0.000041123352,0.0037065046,0.15817326],"study_design_scores_gemma":[0.029045481,0.052182242,0.8642226,0.00004069094,0.00028497918,0.00012167634,0.0001943395,0.00013517209,0.0028258292,0.000049283404,0.050604828,0.00029287706],"about_ca_topic_score_codex":0.000056633675,"about_ca_topic_score_gemma":0.00018966556,"teacher_disagreement_score":0.15788038,"about_ca_system_score_codex":0.0007451017,"about_ca_system_score_gemma":0.0002141243,"threshold_uncertainty_score":0.7326551},"labels":[],"label_agreement":null},{"id":"W4309014874","doi":"10.1093/neuonc/noac209.410","title":"EOLP-05. POSTMORTEM TISSUE DONATION: GIVING FAMILIES THE ABILITY TO CHOOSE","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Conversation; Donation; Organ donation; Medicine; Health care; Health professionals; Psychology; Family medicine; Social psychology; Transplantation; Public relations; Political science; Surgery; Law; Communication","score_opus":0.08955006624669676,"score_gpt":0.41093308561708813,"score_spread":0.3213830193703914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309014874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9521271,0.0007480245,0.0000666628,0.030657759,0.0012033688,0.00066006376,0.000038629958,0.000078010184,0.014420354],"genre_scores_gemma":[0.9866374,0.0001456346,0.0006000305,0.011643136,0.00033525642,0.00014557323,0.000019229663,0.000021049333,0.00045267335],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984011,0.00035441885,0.00033171955,0.0003207343,0.000344738,0.00024727045],"domain_scores_gemma":[0.9981242,0.0010843658,0.000114774964,0.000414943,0.0001494375,0.00011232473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046068846,0.0001373206,0.0003763453,0.000102713304,0.00019306406,0.0000059011727,0.00023386507,0.00006273658,0.00068463676],"category_scores_gemma":[0.001007488,0.0001068218,0.00008228394,0.00037111074,0.00012383614,0.000041258456,0.00027875823,0.00039194492,0.000043454595],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000967199,0.0007382803,0.0773835,0.00019222345,0.000108229,0.00063526013,0.026049891,0.00031475045,0.5878006,0.0012822995,0.069798544,0.23472922],"study_design_scores_gemma":[0.00069194665,0.0016436705,0.034872666,0.000014968463,0.000047720234,0.00010851742,0.0034611528,0.00005274924,0.01081932,0.000099054225,0.9480955,0.000092751594],"about_ca_topic_score_codex":0.00019534733,"about_ca_topic_score_gemma":0.00007152248,"teacher_disagreement_score":0.878297,"about_ca_system_score_codex":0.00026520083,"about_ca_system_score_gemma":0.0002455001,"threshold_uncertainty_score":0.74962926},"labels":[],"label_agreement":null},{"id":"W4309014881","doi":"10.1093/neuonc/noac209.396","title":"DDDR-31. THE THERAPEUTIC POTENTIAL OF THE LONG NON-CODING RNA LNC-HLX-2-7 IN GROUP 3 MEDULLOBLASTOMAS IN CHILDREN","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of California, San Francisco; Associazione Italiana per la Ricerca sul Cancro; Hospital for Sick Children; Lazio Innova","keywords":"Biology; Chromatin immunoprecipitation; Cancer research; Medulloblastoma; RNA; Enhancer; Long non-coding RNA; Promoter; Gene; Gene expression; Genetics","score_opus":0.007836248946568576,"score_gpt":0.26234683628395244,"score_spread":0.25451058733738385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309014881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943019,0.00064778747,0.0011600553,0.0015609853,0.00059991627,0.0009736758,0.000017942017,0.000007988045,0.0007297538],"genre_scores_gemma":[0.9980743,0.00019305367,0.000025656313,0.0012798902,0.00011880024,0.00019540399,0.000023877123,0.0000408097,0.000048206723],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997479,0.00081242487,0.0003700945,0.00048046568,0.00037335264,0.00048462953],"domain_scores_gemma":[0.9990842,0.00006196923,0.00016533738,0.0005985413,0.00003865525,0.00005134228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006623528,0.00018546377,0.0002494205,0.00014412454,0.00018038905,0.000013327938,0.00091814244,0.00019586273,0.00007367215],"category_scores_gemma":[0.000088334855,0.00014407521,0.00016595967,0.0005146714,0.00018962008,0.0000042846746,0.0010490625,0.00088974583,0.000003330265],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026896578,0.00017741277,0.0010055531,0.0000061667956,0.000049004724,0.000040349823,0.00012976317,0.0032464478,0.98755044,0.00010452558,0.00026303888,0.00715832],"study_design_scores_gemma":[0.0042213798,0.0022960557,0.03219566,0.000017821361,0.000060070226,0.00060466264,0.00044809008,0.0018700203,0.94101804,0.00027911054,0.016620561,0.00036850554],"about_ca_topic_score_codex":0.00020977035,"about_ca_topic_score_gemma":0.0005068156,"teacher_disagreement_score":0.04653239,"about_ca_system_score_codex":0.00020064409,"about_ca_system_score_gemma":0.00040126644,"threshold_uncertainty_score":0.5875217},"labels":[],"label_agreement":null},{"id":"W4309015204","doi":"10.1093/neuonc/noac209.677","title":"NIMG-59. EVALUATION OF THE RESPONSE ASSESSMENT CRITERIA IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Fluid-attenuated inversion recovery; Glioblastoma; Correlation; Population; Nuclear medicine; Oncology; Internal medicine; Surgery; Radiology; Magnetic resonance imaging; Cancer research","score_opus":0.03871838840867693,"score_gpt":0.37675921570429155,"score_spread":0.33804082729561463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309015204","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98536426,0.00029698736,6.4277054e-7,0.012183436,0.00065631344,0.001079492,0.000020001318,0.000011793033,0.00038705248],"genre_scores_gemma":[0.9984129,0.000043371063,0.000072366696,0.00085613126,0.000032614218,0.00055725354,0.0000055815844,0.000013847812,0.000005933928],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99647814,0.0022288805,0.00032463568,0.00028434183,0.0005049323,0.00017904218],"domain_scores_gemma":[0.99850243,0.0008755199,0.00015973214,0.00030215562,0.00009421589,0.00006597006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001583084,0.000117385745,0.00030310015,0.00017832716,0.000087690554,0.0000065036993,0.00009100101,0.00005152227,0.00040432645],"category_scores_gemma":[0.00058541866,0.00008072048,0.000066404435,0.00031437477,0.00006962784,0.000027538288,0.00020295539,0.00024867925,0.0000021773997],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009229461,0.0059364424,0.14907962,0.000051352774,0.00010062209,0.00077880983,0.002607688,0.0003349161,0.65334296,0.00022629253,0.009890088,0.16842176],"study_design_scores_gemma":[0.0141375065,0.0107024945,0.91510016,0.00003855949,0.0003137306,0.0002220455,0.00065119605,0.0031232205,0.010441653,0.00017874688,0.044986513,0.0001041931],"about_ca_topic_score_codex":0.00003652764,"about_ca_topic_score_gemma":0.00015141806,"teacher_disagreement_score":0.76602054,"about_ca_system_score_codex":0.00067512546,"about_ca_system_score_gemma":0.00056519714,"threshold_uncertainty_score":0.4427091},"labels":[],"label_agreement":null},{"id":"W4309015237","doi":"10.1093/neuonc/noac209.133","title":"STEM-16. MACROH2A2 REPRESSES AN EPIGENETIC SELF-RENEWAL NETWORK IN GLIOBLASTOMA STEM CELLS","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; Hospital for Sick Children; Canada's Michael Smith Genome Sciences Centre; Princess Margaret Cancer Centre; McGill University; University of Calgary","funders":"","keywords":"Epigenetics; Psychological repression; Biology; Gene knockdown; Stem cell; Chromatin; Cancer research; Phenotype; Downregulation and upregulation; Histone; Repressor; Glioblastoma; IRF4; Enhancer; Cell biology; Gene expression; Gene; Genetics; Transcription factor","score_opus":0.01014786125436833,"score_gpt":0.24897101861208995,"score_spread":0.2388231573577216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309015237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941229,0.0019646967,0.00008370106,0.00024222076,0.0018096693,0.00044694723,0.000087554756,0.000040378363,0.0012018867],"genre_scores_gemma":[0.99505126,0.0011039503,0.00023248114,0.0023537031,0.0007754597,0.00022443278,0.000035547662,0.0000705683,0.00015259582],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974382,0.00050136907,0.00045349778,0.00081593276,0.00017929202,0.0006117167],"domain_scores_gemma":[0.99867994,0.00017147878,0.00020026871,0.0007062711,0.00005534176,0.00018668654],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032748072,0.00025917083,0.0003536684,0.000083786756,0.00020631753,0.000031872525,0.00051550404,0.0002053207,0.00011243999],"category_scores_gemma":[0.000015888007,0.0003091532,0.000106401654,0.0002484334,0.00007160916,0.0000042538522,0.0007255213,0.00032080928,0.000014776865],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009510394,0.0007424473,0.0061587864,0.000028336033,0.000065178596,0.00039608602,0.00031283888,0.056147583,0.8886433,0.00015106346,0.01965558,0.02674772],"study_design_scores_gemma":[0.00146019,0.0055502043,0.00018596904,0.0000037381665,0.00004288983,0.00015814243,0.00028984336,0.0003149593,0.2712361,0.00017129863,0.72019255,0.00039414558],"about_ca_topic_score_codex":0.00010541702,"about_ca_topic_score_gemma":0.001318268,"teacher_disagreement_score":0.70053697,"about_ca_system_score_codex":0.00023609189,"about_ca_system_score_gemma":0.0004908072,"threshold_uncertainty_score":0.99993604},"labels":[],"label_agreement":null},{"id":"W4309015243","doi":"10.1093/neuonc/noac209.910","title":"QLTI-08. SURVEY OF CANADIAN NEURO-ONCOLOGY CLINICIANS ABOUT THE TREATMENT OF ADULT MEDULLOBLASTOMA","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre; Western University","funders":"","keywords":"Lomustine; Medicine; Medulloblastoma; Vincristine; Regimen; Population; Oncology; Chemotherapy; Internal medicine; Chemotherapy regimen; Carboplatin; Cyclophosphamide; Cisplatin; Pathology","score_opus":0.04468450738810469,"score_gpt":0.32469772969155547,"score_spread":0.28001322230345077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309015243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97371525,0.00057951885,0.0000011863917,0.016489403,0.0016293367,0.0014065877,0.0006185686,0.000034879205,0.00552528],"genre_scores_gemma":[0.9918659,0.0014280586,0.00007877215,0.0057134633,0.00012844834,0.00053117366,0.00014714917,0.00005774101,0.000049300026],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99594605,0.0014299433,0.0009767788,0.00058282586,0.00039875545,0.00066563505],"domain_scores_gemma":[0.99457425,0.0032480606,0.000569199,0.0008298553,0.0003573691,0.00042124782],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00048108413,0.00034181878,0.0012395747,0.00066854013,0.0002793523,0.0000060101893,0.0003462637,0.0002155178,0.00088409806],"category_scores_gemma":[0.00064913195,0.0002510082,0.0003444994,0.001070981,0.00036979406,0.000026633725,0.00010614622,0.00038229924,0.000032985492],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040616235,0.020929698,0.5926148,0.00007683451,0.0016135679,0.007107347,0.0072652632,0.0006961369,0.09245256,0.0012251722,0.06931096,0.20264602],"study_design_scores_gemma":[0.009006062,0.0376987,0.2356821,0.000012199644,0.0006382697,0.00060738734,0.0008164878,0.00022809941,0.015479303,0.000024025296,0.6996056,0.00020176783],"about_ca_topic_score_codex":0.12828249,"about_ca_topic_score_gemma":0.44350174,"teacher_disagreement_score":0.6302946,"about_ca_system_score_codex":0.001139112,"about_ca_system_score_gemma":0.002465935,"threshold_uncertainty_score":0.9999942},"labels":[],"label_agreement":null},{"id":"W4309015489","doi":"10.1093/neuonc/noac209.110","title":"CNSC-29. INVESTIGATING THE INFLUENCE OF DOPAMINERGIC ACTIVITY ON THE GLIOBLASTOMA NICHE","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cholinesterase and Neurodegenerative Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Neuroscience; Dopamine; Biology; Dopaminergic; Neurotransmitter; Neurotransmitter receptor; Context (archaeology); Neural stem cell; Stem cell; Central nervous system; Receptor; Cell biology; Genetics","score_opus":0.03546660014543478,"score_gpt":0.3122072322256023,"score_spread":0.2767406320801675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309015489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98354864,0.000053792683,8.818627e-7,0.014777154,0.00019165392,0.00044825964,0.000025307865,0.000036151858,0.00091816264],"genre_scores_gemma":[0.97531253,0.000019467932,0.0000064613655,0.02423005,0.00017265172,0.0001717579,0.0000034462066,0.000021849468,0.0000617653],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979714,0.0008831671,0.00025432164,0.0003124,0.00035358666,0.00022510262],"domain_scores_gemma":[0.99700546,0.0020719748,0.00022689595,0.00051258644,0.00008687735,0.00009619154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030347015,0.00016493465,0.00029115932,0.00007083611,0.0003503564,0.000008514058,0.00027057843,0.000040472096,0.00011718744],"category_scores_gemma":[0.0012533406,0.000095964155,0.00011852318,0.00042912085,0.0003089374,0.000044917266,0.0002542348,0.00071780925,0.000011594877],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005674083,0.00038353167,0.004717576,0.0000180479,0.000023943883,0.00014599787,0.0004979143,0.0023493208,0.98569745,0.0003756077,0.003465727,0.0017574889],"study_design_scores_gemma":[0.00343459,0.01085708,0.10810478,0.000052447027,0.00030775645,0.00085906667,0.00089993177,0.0025402058,0.788307,0.00023350418,0.084070235,0.0003333682],"about_ca_topic_score_codex":0.000026292822,"about_ca_topic_score_gemma":0.000018846866,"teacher_disagreement_score":0.1973904,"about_ca_system_score_codex":0.00007825055,"about_ca_system_score_gemma":0.00033092016,"threshold_uncertainty_score":0.39133048},"labels":[],"label_agreement":null},{"id":"W4309015989","doi":"10.1093/neuonc/noac209.078","title":"BIOS-02. CLINICAL OUTCOMES OF OVER 600 PATIENTS WITH GLIOBLASTOMA TREATED AT A CANADIAN TERTIARY CENTER IN THE PAST 15 YEARS: A COMPARATIVE ANALYSIS WITH THE PIVOTAL STUPP TRIAL","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Temozolomide; Cohort; Glioblastoma; Internal medicine; Confidence interval; Radiation therapy; Regimen; Clinical trial; Concomitant; Retrospective cohort study; Medical record; Subgroup analysis; Cohort study; Pediatrics; Surgery","score_opus":0.02343917120064924,"score_gpt":0.3187141365418633,"score_spread":0.29527496534121406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309015989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948188,0.000015345076,1.4598531e-7,0.0031382553,0.000100476806,0.0014698899,0.00018692367,0.00000920922,0.00026097524],"genre_scores_gemma":[0.9965712,0.000002346442,0.000006858881,0.0029312738,0.000040831957,0.0003206832,0.00010180386,0.000013582975,0.000011438232],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997641,0.0008894812,0.00041773095,0.0003509832,0.000394846,0.00030595524],"domain_scores_gemma":[0.9983434,0.00082444365,0.0002403333,0.00039252438,0.000061328334,0.00013796026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002335765,0.00019376597,0.0007518991,0.0003314746,0.000120961005,0.000010494481,0.00018369581,0.000063728075,0.00024480157],"category_scores_gemma":[0.000028641036,0.00009198927,0.00021428653,0.00084279664,0.00021220217,0.000027833217,0.00008575654,0.0003222422,0.000006525266],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016318873,0.0034758903,0.97267836,0.0000018277105,0.0012907733,0.0008767603,0.0016131992,0.00003669567,0.000018036326,0.0000046922214,0.0034184565,0.00026645634],"study_design_scores_gemma":[0.05070779,0.013564283,0.92528826,0.000004110871,0.0011979301,0.000027295197,0.000550093,0.00003749829,0.000016793314,4.8217277e-7,0.0085237855,0.00008168233],"about_ca_topic_score_codex":0.0077150175,"about_ca_topic_score_gemma":0.21892916,"teacher_disagreement_score":0.21121414,"about_ca_system_score_codex":0.00035381728,"about_ca_system_score_gemma":0.00022853217,"threshold_uncertainty_score":0.99889266},"labels":[],"label_agreement":null},{"id":"W4309016097","doi":"10.1093/neuonc/noac209.756","title":"NCOG-03. IMPACT OF THE RATE OF RADIOGRAPHIC RESPONSE (RR) OF BRAIN METASTASES (BM) TO WHOLE BRAIN RADIATION THERAPY (WBRT) ON NEUROCOGNITIVE FUNCTION (NCF) ON NRG-CC001","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Saskatchewan Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Neurocognitive; Randomized controlled trial; Logistic regression; Whole brain radiotherapy; Clinical trial; Oncology; Cancer; Cognition; Brain metastasis","score_opus":0.0316856420480753,"score_gpt":0.35668463174787735,"score_spread":0.32499898969980207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309016097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9488648,0.000046494122,0.0003020527,0.048417855,0.00016434738,0.0015554236,0.00023612849,0.000054542998,0.00035832115],"genre_scores_gemma":[0.9818403,0.00004954548,0.00013365899,0.017448213,0.00006262712,0.00030216476,0.000049767183,0.00003305392,0.00008067361],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965396,0.0020033338,0.0005122632,0.00035519397,0.0003630018,0.00022661588],"domain_scores_gemma":[0.9954697,0.003220845,0.0004681442,0.0005504118,0.00015782971,0.0001330911],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014599689,0.0001845243,0.00050140335,0.0004988271,0.00011713048,0.000003791945,0.00023150632,0.00007612304,0.00023639975],"category_scores_gemma":[0.002017782,0.0001330762,0.0003222101,0.0013054452,0.0002135249,0.000033063607,0.000088163164,0.0004969401,0.000005298844],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009550836,0.0009846115,0.00083561323,0.000014533749,0.00008552975,0.000012320636,0.00028618323,0.00018902529,0.87877107,0.0002660615,0.0833632,0.02564102],"study_design_scores_gemma":[0.007999756,0.063243836,0.15189913,0.00009328709,0.00030063864,0.000116326104,0.00029343282,0.0008459083,0.3261422,0.0009333258,0.44784018,0.0002920087],"about_ca_topic_score_codex":0.000103266706,"about_ca_topic_score_gemma":0.000003266212,"teacher_disagreement_score":0.5526289,"about_ca_system_score_codex":0.00014076437,"about_ca_system_score_gemma":0.00040623668,"threshold_uncertainty_score":0.542669},"labels":[],"label_agreement":null},{"id":"W4309016107","doi":"10.1093/neuonc/noac209.1156","title":"MODL-29. IN SILICO MODELING TO PREDICT ONCOGENICITY AND POTENTIAL TARGETABILITY OF NOVEL FGFR VARIANTS IN PEDIATRIC LOW GRADE GLIOMA","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Mutant; Fibroblast growth factor receptor 1; Missense mutation; Mutation; In silico; Wild type; Fibroblast growth factor receptor; Cancer research; Gene; Biology; Genetics; Receptor; Fibroblast growth factor","score_opus":0.01853663400268998,"score_gpt":0.28392536243993577,"score_spread":0.2653887284372458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309016107","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975686,0.0001185368,0.0010101842,0.00031432562,0.00022381982,0.0005804384,0.0001170597,0.000009282953,0.000057739486],"genre_scores_gemma":[0.9990364,0.00003552943,0.0005134728,0.00013204734,0.00011586848,0.0000995214,0.000035931353,0.000028099723,0.0000031847865],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99754524,0.00046450619,0.00049086066,0.00070449297,0.00030677769,0.00048812182],"domain_scores_gemma":[0.9992532,0.00007872439,0.00009217296,0.00035663586,0.00006381324,0.00015542634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006594595,0.00018124786,0.0003451441,0.00032131205,0.000067040746,0.0000079490255,0.00036807262,0.00019806909,0.000026038593],"category_scores_gemma":[0.00044077923,0.0002080557,0.00007428556,0.0005262468,0.00007432962,0.000008859345,0.0010230006,0.000489647,0.0000012690457],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006784783,0.0007858334,0.030383205,0.00005473085,0.000008072043,0.000058488647,0.00013829506,0.071918234,0.8956991,0.000007765128,0.000044279128,0.00022354888],"study_design_scores_gemma":[0.0150982225,0.0107808225,0.13748512,0.000014406395,0.000069602655,0.0004929259,0.00042838047,0.41441467,0.418705,0.0003194853,0.0011288064,0.0010625938],"about_ca_topic_score_codex":0.00029539337,"about_ca_topic_score_gemma":0.00021112221,"teacher_disagreement_score":0.4769941,"about_ca_system_score_codex":0.00015321356,"about_ca_system_score_gemma":0.0004492718,"threshold_uncertainty_score":0.8484265},"labels":[],"label_agreement":null},{"id":"W4309016113","doi":"10.1093/neuonc/noac209.311","title":"CTNI-46. PIVOTAL STUDY TO EVALUATE SAFETY AND EFFICACY OF EXABLATE MODEL 4000 USING MICROBUBBLE RESONATORS TO TEMPORARILY MEDIATE BLOOD-BRAIN BARRIER DISRUPTION FOR LIQUID BIOPSY IN GLIOBLASTOMA (LIBERATE)","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Liquid biopsy; Oncology; Biomarker; Surrogate endpoint; Biopsy; Internal medicine; Cancer; Chemistry","score_opus":0.016929066958419378,"score_gpt":0.30241226127756804,"score_spread":0.28548319431914865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309016113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964447,0.00018912698,0.00042210106,0.0005783116,0.00032990408,0.0016114471,0.0003631005,0.000009684859,0.000051621082],"genre_scores_gemma":[0.9972199,0.000040687373,0.0011663919,0.0011250128,0.00011774992,0.00016914605,0.000045900328,0.0000582404,0.00005697234],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979039,0.00027780663,0.00055587845,0.0007022767,0.00016809313,0.0003920788],"domain_scores_gemma":[0.99896693,0.00020645671,0.00016980807,0.00034460242,0.000104975836,0.00020720698],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008141432,0.00023644122,0.00040700272,0.00021844832,0.0001625656,0.00001813073,0.00022681674,0.00011483167,0.000010711717],"category_scores_gemma":[0.00041534725,0.00026845763,0.000080244514,0.0002798789,0.000057872676,0.0000065469967,0.00065616483,0.00016658954,0.0000010013472],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008903035,0.0005756398,0.0005092946,0.00001370051,0.000044938697,0.000032617827,0.0012008699,0.08720384,0.90040225,0.0000293885,0.00040935245,0.0006750593],"study_design_scores_gemma":[0.035562795,0.1032323,0.0023811236,0.000052148618,0.000599754,0.00038450945,0.0028366442,0.04094824,0.6987653,0.0003475617,0.11276051,0.002129156],"about_ca_topic_score_codex":0.00009417763,"about_ca_topic_score_gemma":0.0003115545,"teacher_disagreement_score":0.201637,"about_ca_system_score_codex":0.00013533392,"about_ca_system_score_gemma":0.00049409526,"threshold_uncertainty_score":0.99997675},"labels":[],"label_agreement":null},{"id":"W4309016122","doi":"10.1093/neuonc/noac209.128","title":"STEM-11. POLYAMINE METABOLISM AND INFLAMMATORY STATE CONTROL A VIRAL MIMICRY-DRIVEN QUIESCENT PHENOTYPE IN GLIOMA STEM CELLS (GSCS)","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Biology; Epigenetics; Stem cell; Cell biology; Downregulation and upregulation; Polycomb-group proteins; Cancer research; Genetics; Gene expression; Gene; Repressor","score_opus":0.011021320147083924,"score_gpt":0.26215465227140156,"score_spread":0.25113333212431765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309016122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957055,0.0020951822,0.00003166844,0.0006454692,0.00046039102,0.0007926704,0.000148245,0.000025798872,0.000095063464],"genre_scores_gemma":[0.99736285,0.0003133115,0.00003062029,0.0016497914,0.00017166001,0.00022342111,0.000027019445,0.000067166984,0.00015413888],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9966602,0.0012477098,0.00045843335,0.0006837099,0.00029158025,0.00065836427],"domain_scores_gemma":[0.9989743,0.00010034392,0.00017902745,0.00048562334,0.00006967476,0.00019100835],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00053940027,0.00028922822,0.00046378386,0.00023294352,0.00016337122,0.000025878773,0.00043496108,0.00016032202,0.000070849695],"category_scores_gemma":[0.000013331118,0.00030616563,0.00009738202,0.00019965558,0.00020106103,0.00000851673,0.0005388557,0.0004470732,0.000015600193],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004628196,0.00022687296,0.001557031,0.00002210003,0.00007089593,0.0002879149,0.00023671411,0.0008156389,0.9760959,0.00003004495,0.0007042835,0.015324396],"study_design_scores_gemma":[0.0076388777,0.0054997285,0.0008453607,0.0000035129717,0.000035275807,0.000091507325,0.00025564292,0.00063654134,0.8263339,0.000024936926,0.15825534,0.00037939983],"about_ca_topic_score_codex":0.000054829245,"about_ca_topic_score_gemma":0.00056442205,"teacher_disagreement_score":0.15755105,"about_ca_system_score_codex":0.00014201374,"about_ca_system_score_gemma":0.0004735814,"threshold_uncertainty_score":0.999939},"labels":[],"label_agreement":null},{"id":"W4309016124","doi":"10.1093/neuonc/noac209.877","title":"EXTH-79. HIJACKING A NEURODEVELOPMENTAL EPIGENOMIC PROGRAM IN METASTATIC DISSEMINATION OF MEDULLOBLASTOMA","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Cerebellum; Biology; Reelin; Epigenomics; Chromatin; Neuroscience; Transcription factor; DAB1; EZH2; Cancer research; Gene expression; Genetics; Gene; DNA methylation; Receptor","score_opus":0.013343170313016975,"score_gpt":0.30915709065271274,"score_spread":0.2958139203396958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309016124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980484,0.00028083834,0.00014057435,0.00018360457,0.00030642294,0.0003611712,0.000018479785,0.000018591885,0.0006418801],"genre_scores_gemma":[0.9977393,0.00006390196,0.0015162352,0.00023617825,0.00003799895,0.00025659023,0.00007985607,0.000026164435,0.000043759777],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986593,0.00024184179,0.00035760808,0.00034767133,0.00015775433,0.00023579807],"domain_scores_gemma":[0.99949664,0.000064373,0.0001712065,0.00018954922,0.00003395255,0.000044300145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002602362,0.00012834353,0.00021687587,0.00009684672,0.00007593425,0.000006095845,0.00020583793,0.000051614017,0.00007860604],"category_scores_gemma":[0.00011544065,0.00014261817,0.00006902979,0.00017409679,0.00005889015,0.0000033627734,0.00023624262,0.0001766934,0.0000021609592],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013472636,0.00029837136,0.0010786694,0.00002093774,0.000015962929,0.00002765634,0.00033867866,0.001291889,0.89748275,0.000014141912,0.00045999372,0.09883621],"study_design_scores_gemma":[0.0038664294,0.008796784,0.013374459,0.000052759067,0.00010168763,0.0006893068,0.0027500386,0.0129887145,0.7376511,0.00024099673,0.21858546,0.00090225216],"about_ca_topic_score_codex":0.000020077108,"about_ca_topic_score_gemma":0.000056652723,"teacher_disagreement_score":0.21812548,"about_ca_system_score_codex":0.00013705295,"about_ca_system_score_gemma":0.00027232693,"threshold_uncertainty_score":0.58158},"labels":[],"label_agreement":null},{"id":"W4309016321","doi":"10.1093/neuonc/noac209.341","title":"DNAR-09. THE IMPACT OF MISMATCH REPAIR DEFICIENCY ON HIGH GRADE GLIOMAS IN CHILDREN, ADOLESCENTS AND YOUNG ADULTS; A REPORT FROM THE IRRDC AND THE GLIOMA TASKFORCE","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Mount Sinai Hospital; Health Sciences Centre; University Health Network; University of Toronto; Sunnybrook Health Science Centre; Hospital for Sick Children","funders":"","keywords":"Microsatellite instability; DNA mismatch repair; Lynch syndrome; Medicine; Glioma; Germline mutation; Germline; Cancer; Internal medicine; Oncology; Cancer research; Mutation; Genetics; Biology; Gene; Allele; Microsatellite; Colorectal cancer","score_opus":0.011191222141052884,"score_gpt":0.2773429234042501,"score_spread":0.2661517012631972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309016321","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927287,0.001402431,9.292453e-7,0.0034162905,0.00051192305,0.0015225986,0.000053835975,0.00003802296,0.00032527675],"genre_scores_gemma":[0.9986255,0.00013057727,0.000026092861,0.00087976834,0.00011546495,0.00016121237,0.000017773795,0.00003151868,0.000012090389],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99735504,0.00074789,0.0005339935,0.0005389174,0.00047238133,0.00035177878],"domain_scores_gemma":[0.99802583,0.00073557626,0.0003461917,0.0007562179,0.00005271435,0.00008344648],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000757224,0.00024177137,0.00048721934,0.00009886394,0.0002559162,0.000012921699,0.00032315552,0.0001099687,0.000062673804],"category_scores_gemma":[0.00067756465,0.000120955694,0.00016318221,0.0005135252,0.000630694,0.000020948215,0.00039003798,0.0007809417,0.0000014150156],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005775862,0.00050098344,0.9566839,0.00002328036,0.00011255252,0.00064600754,0.0052752187,0.00015884756,0.02464116,0.00007283033,0.0036969038,0.0024124882],"study_design_scores_gemma":[0.0065732496,0.0030644862,0.98075163,0.000045868146,0.0001434749,0.005849482,0.00089528406,0.0005040624,0.0010845627,0.00033446355,0.0006208169,0.00013263494],"about_ca_topic_score_codex":0.0069020414,"about_ca_topic_score_gemma":0.0003236963,"teacher_disagreement_score":0.02406775,"about_ca_system_score_codex":0.000287749,"about_ca_system_score_gemma":0.0002816719,"threshold_uncertainty_score":0.9997111},"labels":[],"label_agreement":null},{"id":"W4309016324","doi":"10.1093/neuonc/noac209.142","title":"STEM-25. IN VIVO FUNCTIONAL GENOMICS IDENTIFIES ESSENTIALITY OF POTASSIUM HOMEOSTASIS IN MEDULLOBLASTOMA","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Caveolin-1 and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Biology; Functional genomics; Homeostasis; Transposable element; Cell biology; Gene; Cancer research; Genomics; Genetics; Genome","score_opus":0.01375607269982954,"score_gpt":0.24859400984256114,"score_spread":0.2348379371427316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309016324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99663776,0.0008526083,0.00010813185,0.0003447721,0.00078621256,0.00017939303,0.00009193293,0.000007902296,0.0009912794],"genre_scores_gemma":[0.99884915,0.00023994464,0.000026513084,0.00038591944,0.0001148076,0.000081816164,0.00007639197,0.000021169502,0.0002042952],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983946,0.00027752254,0.00044151716,0.0004294351,0.00018631357,0.0002706113],"domain_scores_gemma":[0.99937177,0.000060824295,0.00018474773,0.00026393632,0.00006726816,0.000051464696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038748115,0.00014527039,0.0002848734,0.0001616178,0.000072235875,0.000009922946,0.00024194916,0.00014291311,0.00031105132],"category_scores_gemma":[0.000052297913,0.00017052442,0.00009820244,0.00024800975,0.0001242937,0.000006145836,0.00042117678,0.00024459363,0.0000037230866],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004091009,0.0003590075,0.00459378,0.00004518546,0.000021333344,0.00006543359,0.00013898629,0.00080304145,0.9899037,0.00006645056,0.0016996707,0.001894333],"study_design_scores_gemma":[0.0012518588,0.0005727514,0.002494749,0.0000028325142,0.000018497725,0.00011605276,0.00088872423,0.000054294556,0.82470435,0.00015588859,0.16956306,0.00017694324],"about_ca_topic_score_codex":0.0000980384,"about_ca_topic_score_gemma":0.00086398894,"teacher_disagreement_score":0.16786338,"about_ca_system_score_codex":0.00011490414,"about_ca_system_score_gemma":0.00044080685,"threshold_uncertainty_score":0.6953784},"labels":[],"label_agreement":null},{"id":"W4309016325","doi":"10.1093/neuonc/noac209.264","title":"CTIM-32. FIRST-IN-CHILDREN PHASE 1 TRIAL OF INDOXIMOD-BASED CHEMO-IMMUNOTHERAPY FOR PATIENTS WITH PEDIATRIC BRAIN TUMORS: ANALYSIS OF SAFETY, TOLERABILITY, AND 5-YEAR OUTCOME","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Temozolomide; Medulloblastoma; Regimen; Glioma; Ependymoma; Tolerability; Chemotherapy; Internal medicine; Radiation therapy; Surgery; Oncology; Adverse effect; Pathology","score_opus":0.01425346185207096,"score_gpt":0.3017858235590598,"score_spread":0.28753236170698887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309016325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99571776,0.0000646824,0.000013372387,0.0012698031,0.00007962866,0.0024620641,0.00035352932,0.00001280088,0.000026379032],"genre_scores_gemma":[0.9985913,0.000015292842,0.00023974356,0.00045501327,0.000039395884,0.00038653307,0.00024602743,0.000025101774,0.0000015633054],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981396,0.00018888045,0.00074277556,0.0003935661,0.00030801236,0.00022713735],"domain_scores_gemma":[0.9978317,0.0011888511,0.00044249767,0.00035567625,0.00010264229,0.00007864228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037458187,0.00018455941,0.0011435188,0.0006558971,0.000071494294,0.0000039779698,0.000111353576,0.00007191449,0.00015673303],"category_scores_gemma":[0.00022501909,0.00015337236,0.00023636474,0.0009021263,0.000081525024,0.000029376202,0.00006176533,0.00016223699,2.7342378e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05110534,0.011881737,0.93301547,0.00004240594,0.00046202898,0.000012632543,0.00019900475,0.0003708454,0.00044230232,0.000011965388,0.00006914572,0.002387114],"study_design_scores_gemma":[0.29690126,0.03096305,0.6688172,0.000005126107,0.001536733,0.0000034251452,0.000038359405,0.000386144,0.0006236416,0.00001478107,0.0005773345,0.00013293076],"about_ca_topic_score_codex":0.00009558778,"about_ca_topic_score_gemma":0.00005508424,"teacher_disagreement_score":0.26419824,"about_ca_system_score_codex":0.00021315564,"about_ca_system_score_gemma":0.00019154743,"threshold_uncertainty_score":0.62543434},"labels":[],"label_agreement":null},{"id":"W4309016784","doi":"10.1093/neuonc/noac209.775","title":"NCOG-22. TIGER PRO-ACTIVE STUDY: INVESTIGATING DAILY ACTIVITY, SLEEP AND NEUROCOGNITIVE FUNCTIONING IN GLIOBLASTOMA PATIENTS APPLYING TTFIELDS THERAPY IN GERMANY IN ROUTINE CLINICAL CARE","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Neurocognitive; Medicine; Quality of life (healthcare); Adverse effect; Clinical trial; Oncology; Internal medicine; Cognition; Psychiatry","score_opus":0.039854096848771774,"score_gpt":0.341000527857423,"score_spread":0.30114643100865124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309016784","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951634,0.000069648864,8.174691e-7,0.0005922602,0.00037983083,0.0031957964,0.000008829038,0.00003498012,0.0005544631],"genre_scores_gemma":[0.9959534,0.000027626673,0.000025933185,0.0016385564,0.000075235606,0.002225036,0.000012266795,0.00003959217,0.0000023957436],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966976,0.0012257134,0.0006117139,0.0007489205,0.00030913728,0.00040690028],"domain_scores_gemma":[0.99828297,0.0010362907,0.00025976347,0.0001960766,0.00008942497,0.00013546347],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004334773,0.00026292593,0.00068988284,0.00047793193,0.00015650777,0.000018574154,0.00008916744,0.00014408542,0.00004812911],"category_scores_gemma":[0.00043456856,0.00025814402,0.000068058034,0.0006697566,0.00009244819,0.00013426742,0.0003200411,0.0012617706,0.0000034866084],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014004593,0.0038703426,0.82210696,0.000014887782,0.000036223595,0.0010099397,0.0070668897,0.00006855378,0.0030552133,0.0000022890954,0.000016304095,0.16135193],"study_design_scores_gemma":[0.020738466,0.014556391,0.9552336,0.000038827005,0.000042251217,0.000030089794,0.0069709793,0.0005202445,0.0010970038,0.000015619007,0.000578915,0.00017763951],"about_ca_topic_score_codex":0.00032967597,"about_ca_topic_score_gemma":0.0010019522,"teacher_disagreement_score":0.1611743,"about_ca_system_score_codex":0.00049125415,"about_ca_system_score_gemma":0.00019920553,"threshold_uncertainty_score":0.99998707},"labels":[],"label_agreement":null},{"id":"W4309016792","doi":"10.1093/neuonc/noac209.830","title":"EXTH-32. SEQUENTIAL SUNITINIB AND AURANOFIN TREATMENT INDUCEDCYTOTOXICITY THROUGH ROS-MEDIATED MECHANISM IN GLIOBLASTOMA","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Auranofin; Sunitinib; Cancer research; Temozolomide; Pharmacology; Reactive oxygen species; Angiogenesis; DNA damage; Cytotoxic T cell; Medicine; Chemistry; Cancer; Immunology; Glioma; Internal medicine; Biochemistry; Rheumatoid arthritis","score_opus":0.03953968774424947,"score_gpt":0.31145081082842535,"score_spread":0.27191112308417587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309016792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99162334,0.00020539817,0.0000061368037,0.0041713594,0.0004416085,0.0011803425,0.00008586069,0.00010274076,0.0021832348],"genre_scores_gemma":[0.9957383,0.00018605901,0.00011630393,0.0027583926,0.00011110935,0.0009364681,0.00007939412,0.00004704807,0.000026919166],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977257,0.0004790731,0.00042747593,0.0006044573,0.0002609676,0.0005022764],"domain_scores_gemma":[0.9988282,0.0004675081,0.00015074489,0.00031219583,0.000045595403,0.0001958122],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017517467,0.00031629365,0.00068575057,0.00027091583,0.00021772338,0.000018221703,0.000101210106,0.00017755813,0.00077603094],"category_scores_gemma":[0.00008914375,0.0002852262,0.00011647581,0.00042552597,0.000095506926,0.000083500076,0.00020285483,0.00038741503,0.000029279248],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015755288,0.005229257,0.005531301,0.000028956953,0.00018206084,0.011210519,0.0023327584,0.00002769376,0.9582596,0.0030104332,0.0008674856,0.011744454],"study_design_scores_gemma":[0.042059164,0.04075803,0.009416829,0.00003697024,0.00052589533,0.0037266167,0.0019055408,0.0006051892,0.7267663,0.002602876,0.17093858,0.00065799797],"about_ca_topic_score_codex":0.0004585957,"about_ca_topic_score_gemma":0.00041860438,"teacher_disagreement_score":0.23149325,"about_ca_system_score_codex":0.0010836335,"about_ca_system_score_gemma":0.00035696357,"threshold_uncertainty_score":0.99996},"labels":[],"label_agreement":null},{"id":"W4309016801","doi":"10.1093/neuonc/noac209.757","title":"NCOG-04. RANO-BM RESPONSE CRITERIA VERIFICATION STUDY IN A SRS-TREATED COHORT","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Medicine; Radiosurgery; Cohort; False positive paradox; Predictive value; Retrospective cohort study; Oncology; Demographics; Internal medicine; Radiology; Nuclear medicine; Surgery; Radiation therapy; Machine learning","score_opus":0.03607026819700404,"score_gpt":0.3542618700671986,"score_spread":0.3181916018701946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309016801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919173,0.000120635785,0.000006894063,0.0043604434,0.00044306734,0.002077704,0.00003582591,0.000080004655,0.0009581002],"genre_scores_gemma":[0.99640864,0.000022967979,0.00015908117,0.0020048036,0.00005877974,0.0010159821,0.00007985638,0.000033782948,0.00021610991],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960487,0.002423352,0.00042864046,0.0005197205,0.00028209278,0.00029752785],"domain_scores_gemma":[0.9986285,0.0005656639,0.00012123402,0.0005148922,0.000053370888,0.00011633923],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013763515,0.00018046831,0.0005189311,0.00027952116,0.00014651913,0.000010486592,0.000119653705,0.0000674365,0.0011847371],"category_scores_gemma":[0.0003465883,0.00016977245,0.000081994105,0.00047593808,0.000054791057,0.00003727174,0.00011626544,0.00037204506,0.000062669475],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04236791,0.013377516,0.55509216,0.00002900044,0.0003259101,0.014755264,0.003971461,0.000059904334,0.33979067,0.00005619545,0.008985295,0.021188686],"study_design_scores_gemma":[0.0159712,0.01876954,0.773205,0.00000836048,0.00041304465,0.00075628393,0.002292435,0.00023632325,0.002431408,0.000025677371,0.18569452,0.00019621638],"about_ca_topic_score_codex":0.00023600878,"about_ca_topic_score_gemma":0.00007517522,"teacher_disagreement_score":0.33735928,"about_ca_system_score_codex":0.00063752325,"about_ca_system_score_gemma":0.00031042038,"threshold_uncertainty_score":0.9997283},"labels":[],"label_agreement":null},{"id":"W4309016939","doi":"10.1093/neuonc/noac209.583","title":"PATH-10. A CASE OF ADULT THALAMIC DIFFUSE MIDLINE GLIOMA, H3 K27-ALTERED WITH AN IMPRESSIVE RESPONSE TO RADIOTHERAPY AND CONCOMITANT PLUS ADJUVANT TEMOZOLOMIDE","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Temozolomide; Concomitant; Regimen; Radiation therapy; Magnetic resonance imaging; Fluid-attenuated inversion recovery; Internal medicine; Surgery; Oncology; Radiology","score_opus":0.014590420221369789,"score_gpt":0.2947048100645221,"score_spread":0.2801143898431523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309016939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99272794,0.0006079891,0.000014921854,0.004372965,0.00018545637,0.0017202433,0.0002484003,0.00006115003,0.00006094082],"genre_scores_gemma":[0.99579895,0.00008591124,0.0008305546,0.0024006695,0.000087944725,0.00066023035,0.000035799505,0.00007072595,0.000029230776],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99710953,0.00097584527,0.00051234366,0.00067962834,0.00028568145,0.00043696078],"domain_scores_gemma":[0.99727833,0.0011381413,0.00031152085,0.00065671833,0.00018596699,0.00042931555],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032390497,0.00033873066,0.0009932762,0.00034500568,0.00018917538,0.000014143157,0.00014797928,0.00010968997,0.00026165345],"category_scores_gemma":[0.00028200517,0.00025868518,0.00009983045,0.00033915782,0.00018638119,0.000060015143,0.00015413124,0.00030548617,0.000004351802],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05102218,0.002493424,0.0044101113,0.000048226386,0.00023316276,0.086063206,0.00331896,0.00007794223,0.84300125,0.000044676093,0.0009963897,0.008290456],"study_design_scores_gemma":[0.19333771,0.24468736,0.03619009,0.00025326636,0.0018126669,0.21472551,0.010481835,0.00866319,0.24292132,0.0000731959,0.045382034,0.001471833],"about_ca_topic_score_codex":0.00036332486,"about_ca_topic_score_gemma":0.00023375181,"teacher_disagreement_score":0.60007995,"about_ca_system_score_codex":0.00055956346,"about_ca_system_score_gemma":0.0004396494,"threshold_uncertainty_score":0.9999865},"labels":[],"label_agreement":null},{"id":"W4309017078","doi":"10.1093/neuonc/noac209.113","title":"CNSC-32. ACTIN SUBUNIT STRUCTURAL DIVERSITY IN SHH MEDULLOBLASTOMA: IMPLICATIONS FOR CANCER BIOLOGY AND NEURODEVELOPMENT","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital; Université de Montréal; Institute for Research in Immunology and Cancer; McGill University","funders":"","keywords":"Biology; Actin; Cell biology; Sonic hedgehog; Molecular biology; Signal transduction","score_opus":0.04385490861652398,"score_gpt":0.3440628560121906,"score_spread":0.30020794739566664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309017078","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9725419,0.00020021482,0.000005828185,0.02569884,0.00040583764,0.0007911911,0.00013556765,0.000030647552,0.00018993193],"genre_scores_gemma":[0.99618655,0.00010394232,0.00021553767,0.0025404189,0.000046167806,0.0008132085,0.000064363216,0.000014482209,0.000015309392],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989186,0.00012285048,0.00020242043,0.00038975396,0.00007098586,0.0002953986],"domain_scores_gemma":[0.9991832,0.00039225118,0.0000957256,0.0001632915,0.000051160976,0.0001144151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010320791,0.00013722754,0.00031984918,0.0001748828,0.000388637,0.000004899655,0.00010743783,0.000066755194,0.00017272285],"category_scores_gemma":[0.00007640368,0.00012755663,0.0000502475,0.0002043451,0.00007647836,0.000029251907,0.0004762368,0.00021663989,0.0000016663225],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003758915,0.00034245328,0.874589,0.000018168079,0.00006417748,0.00006818427,0.00071903825,0.000037629055,0.06541705,0.0010847114,0.0021979292,0.05508573],"study_design_scores_gemma":[0.004666088,0.0015374272,0.85301644,0.00000327097,0.0001116598,0.00021461012,0.00019788406,0.00011247792,0.0018003803,0.0005875864,0.13762149,0.00013070121],"about_ca_topic_score_codex":0.00030344617,"about_ca_topic_score_gemma":0.00065204035,"teacher_disagreement_score":0.13542357,"about_ca_system_score_codex":0.00045981203,"about_ca_system_score_gemma":0.00023365961,"threshold_uncertainty_score":0.52016085},"labels":[],"label_agreement":null},{"id":"W4309017087","doi":"10.1093/neuonc/noac209.769","title":"NCOG-16. REAL-WORLD ANALYSIS OF OUTCOMES OF PATIENTS RECEIVING BEVACIZUMAB FOR RECURRENT GLIOBLASTOMA","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Bevacizumab; Medicine; Temozolomide; Demographics; Glioblastoma; Oncology; Internal medicine; Progression-free survival; Overall survival; Surgery; Chemotherapy; Cancer research","score_opus":0.023660969356367856,"score_gpt":0.3273901123684455,"score_spread":0.30372914301207765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309017087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957534,0.00006719898,0.000007019943,0.0012853936,0.0005038964,0.0008162935,0.0002786236,0.00002630218,0.0012618756],"genre_scores_gemma":[0.99877316,0.00005384833,0.00018077236,0.0003460195,0.000023703526,0.00037954733,0.00017291603,0.000024615201,0.000045434568],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981424,0.00018912414,0.00067077356,0.00036722753,0.00036352806,0.00026694938],"domain_scores_gemma":[0.9977244,0.0010305005,0.0005355309,0.00039482283,0.00020872602,0.00010599952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021781787,0.00017488579,0.0010957114,0.00091401016,0.000092987015,0.0000027459157,0.00013798029,0.00005461918,0.0003939154],"category_scores_gemma":[0.00031030882,0.00013908489,0.00050137646,0.0011520848,0.000056731235,0.000026635646,0.0001617636,0.00015255286,0.0000018426814],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024036074,0.004735085,0.9031367,0.00007203281,0.0020616865,0.000037670925,0.00045865352,0.00020676624,0.002761403,0.00021600883,0.0032909652,0.08061946],"study_design_scores_gemma":[0.009640295,0.021139413,0.8835172,0.000018043875,0.006433758,0.000004961918,0.00024808935,0.00059372827,0.011036763,0.00006983003,0.06711325,0.00018464388],"about_ca_topic_score_codex":0.00010329407,"about_ca_topic_score_gemma":0.0013779794,"teacher_disagreement_score":0.08043482,"about_ca_system_score_codex":0.00055593665,"about_ca_system_score_gemma":0.00013456843,"threshold_uncertainty_score":0.56717175},"labels":[],"label_agreement":null},{"id":"W4309017207","doi":"10.1093/neuonc/noac209.763","title":"NCOG-10. SURGERY FOR RECURRENT GBM: A RETROSPECTIVE CASE-CONTROL STUDY","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Medicine; Cohort; Surgery; Retrospective cohort study; Multivariate analysis; Disease; Internal medicine","score_opus":0.03528777109535199,"score_gpt":0.3236461614410002,"score_spread":0.28835839034564825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309017207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878726,0.00038826282,0.000012708772,0.0052717035,0.0017609319,0.0034922985,0.00025717486,0.000098147044,0.00084617565],"genre_scores_gemma":[0.9939103,0.000013760042,0.00003982582,0.001716285,0.00028451747,0.0039064083,0.000027938328,0.000042511354,0.000058411508],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.997911,0.00043254782,0.0004006718,0.0005720032,0.00027511886,0.00040869607],"domain_scores_gemma":[0.9971507,0.0019651374,0.00019398044,0.00037014092,0.00014698687,0.00017300708],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00057527696,0.00021275599,0.0007842128,0.00022741249,0.000330739,0.000011526049,0.00007616661,0.00006605475,0.0012576327],"category_scores_gemma":[0.0006166763,0.00019001155,0.0002857961,0.0002803108,0.00004162469,0.000030127807,0.000097340235,0.00031583075,0.000030323139],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009189289,0.02906036,0.48965067,0.0000644,0.0014199899,0.09511839,0.0024473115,0.000047192996,0.0072276746,0.00028430187,0.23854995,0.12694049],"study_design_scores_gemma":[0.047490995,0.098188505,0.17839798,0.00002139493,0.0033522232,0.01942181,0.0053071487,0.00088409375,0.0014482485,0.0002982112,0.6445011,0.0006883212],"about_ca_topic_score_codex":0.000044863744,"about_ca_topic_score_gemma":0.00013909373,"teacher_disagreement_score":0.4059511,"about_ca_system_score_codex":0.0008994148,"about_ca_system_score_gemma":0.00030089353,"threshold_uncertainty_score":0.99965537},"labels":[],"label_agreement":null},{"id":"W4309017246","doi":"10.1093/neuonc/noac209.958","title":"RBIO-06. CLINICAL AND MOLECULAR PREDICTORS OF RADIATION RESPONSIVENESS IN MENINGIOMAS: A MULTICENTER RETROSPECTIVE COHORT STUDY","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Meningioma; Medicine; Oncology; Cohort; DNA methylation; Internal medicine; Propensity score matching; Malignant meningioma; Pathology; Biology; Gene expression; Gene; Genetics","score_opus":0.020174283903825002,"score_gpt":0.331057886604955,"score_spread":0.31088360270113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309017246","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960335,0.000090045454,0.000022986562,0.0005209431,0.00048058378,0.0019440575,0.000007768502,0.000028301543,0.0008718203],"genre_scores_gemma":[0.99924874,0.000009285348,0.00010887136,0.00025175163,0.000050073184,0.00024303468,0.000016328417,0.000020632544,0.000051253843],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99696165,0.001296857,0.00064347405,0.00049987744,0.0003872155,0.00021089434],"domain_scores_gemma":[0.9989709,0.00033034122,0.00022941681,0.00030320967,0.00006767582,0.00009843856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016561036,0.0001344025,0.00060433306,0.00028556722,0.00007924551,0.000006553886,0.000105126186,0.00007381795,0.00006558197],"category_scores_gemma":[0.00062934175,0.0001354811,0.000077207806,0.00034044991,0.00011119872,0.00004093456,0.00028715836,0.0003918828,0.000001929268],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020962048,0.0012113715,0.9742445,0.000017788781,0.00016488337,0.004336321,0.0013456024,0.000032939308,0.015282716,0.00006731662,0.00049337425,0.0007070181],"study_design_scores_gemma":[0.006549028,0.0073112594,0.9792883,0.000007858036,0.0002285635,0.00012846736,0.0014441722,0.0006345332,0.0006927214,0.000024509549,0.0035982768,0.000092357644],"about_ca_topic_score_codex":0.000059645412,"about_ca_topic_score_gemma":0.000007776841,"teacher_disagreement_score":0.014589994,"about_ca_system_score_codex":0.0002509254,"about_ca_system_score_gemma":0.00012544991,"threshold_uncertainty_score":0.55247587},"labels":[],"label_agreement":null},{"id":"W4309017257","doi":"10.1093/neuonc/noac209.059","title":"BIOM-49. A PILOT STUDY OF CEREBROSPINAL FLUID EXOSOMAL SMALL RNA-SEQUENCING IN PEDIATRIC MEDULLOBLASTOMA PATIENTS ON THE NEXT CONSORTIUM “HEAD START” 4 PROTOCOL","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Cerebrospinal fluid; RNA; Biology; RNA extraction; Non-coding RNA; Oncology; Bioinformatics; Medicine; Internal medicine; Gene; Cancer research; Genetics","score_opus":0.04850376539374591,"score_gpt":0.29431981969933146,"score_spread":0.24581605430558556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309017257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9753689,0.00003274663,0.000004280711,0.00015093356,0.00028237322,0.023419278,0.00003874577,0.000018770676,0.0006839279],"genre_scores_gemma":[0.9712488,0.0000065519584,0.00004349316,0.00070688117,0.00015368304,0.027739484,0.000024846997,0.000050379847,0.000025864598],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99643546,0.0012865743,0.000690596,0.0007045173,0.00039701024,0.00048581164],"domain_scores_gemma":[0.9984753,0.00016034783,0.00040621217,0.0007129165,0.00011085188,0.00013438109],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00046894737,0.00028764366,0.00032667696,0.00017125835,0.00021177062,0.000017367342,0.000692101,0.00009416472,0.00011336499],"category_scores_gemma":[0.0003947375,0.00025715306,0.00009101985,0.00036725428,0.0001517595,0.0000068350514,0.0007032655,0.00045245714,0.000012809868],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038513506,0.005377544,0.053675964,0.00004756737,0.000030956573,0.00015646702,0.00023977029,0.00071137754,0.9342904,0.00004291679,0.0007264625,0.0008491942],"study_design_scores_gemma":[0.029520277,0.30901787,0.10545478,0.000028860872,0.00025819225,0.00012153812,0.0035236313,0.0007610014,0.50725156,0.00014933883,0.042431492,0.001481496],"about_ca_topic_score_codex":0.000091721035,"about_ca_topic_score_gemma":0.00032176255,"teacher_disagreement_score":0.4270389,"about_ca_system_score_codex":0.0002520136,"about_ca_system_score_gemma":0.00075485586,"threshold_uncertainty_score":0.9999881},"labels":[],"label_agreement":null},{"id":"W4309017261","doi":"10.1093/neuonc/noac209.1133","title":"MODL-05. DISCOVERY OF DYNAMIC MINIMAL RESIDUAL DISEASE STATES IN ADULT GLIOBLASTOMA USING SINGLE CELL TECHNOLOGY","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto; McMaster University","funders":"","keywords":"Glioblastoma; Multidrug tolerance; Minimal residual disease; Disease; Residual; Computational biology; Rapid cycling; Chemoradiotherapy; Biology; Cancer research; Cancer; Medicine; Genetics; Computer science; Pathology; Neuroscience; Bacteria; Algorithm","score_opus":0.0097194999590045,"score_gpt":0.24090129072359287,"score_spread":0.23118179076458836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309017261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977518,0.0003617297,0.00032472576,0.00050122215,0.00045224957,0.0002490237,0.00020271023,0.000022071006,0.00013448877],"genre_scores_gemma":[0.99851745,0.00008329035,0.00062200386,0.00047023906,0.000059585025,0.000039557544,0.000103345716,0.000047538106,0.000056959525],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981991,0.00023244534,0.00043625187,0.00054892653,0.0001690334,0.00041424207],"domain_scores_gemma":[0.9992352,0.000058385187,0.00019147742,0.00036673687,0.00006777179,0.00008043124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000116757416,0.00021621776,0.00032616954,0.0002592875,0.00010740158,0.000011617382,0.00036113174,0.0001846181,0.00001639417],"category_scores_gemma":[0.000090925074,0.00024373711,0.00010335188,0.00030562934,0.00025274782,0.000009908045,0.00035353465,0.00031908337,0.0000012373016],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001848733,0.00094626006,0.0037219333,0.000041021765,0.000015310681,0.00019219851,0.000108014945,0.003883916,0.9877645,0.00003411132,0.00017530736,0.0012687242],"study_design_scores_gemma":[0.0038333766,0.008556376,0.0007427999,0.00001736437,0.000083934225,0.0001323067,0.0012125102,0.008771241,0.9657156,0.00036224452,0.010034087,0.0005381717],"about_ca_topic_score_codex":0.00007036206,"about_ca_topic_score_gemma":0.00024910938,"teacher_disagreement_score":0.02204888,"about_ca_system_score_codex":0.00015952878,"about_ca_system_score_gemma":0.00036681007,"threshold_uncertainty_score":0.99393106},"labels":[],"label_agreement":null},{"id":"W4309017263","doi":"10.1093/neuonc/noac209.611","title":"PATH-38. DISSEMINATED “MYXOID GLIONEURONAL TUMOR, PDGFRA P. K385-MUTANT” IN AN ADOLESCENT MANAGED WITH OBSERVATION AND WITHOUT ANY ADJUVANT THERAPY","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Hospital for Sick Children; Children's Hospital of Winnipeg; CancerCare Manitoba","funders":"","keywords":"Medicine; PDGFRA; Septum pellucidum; Pilocytic astrocytoma; Pathology; Radiology; Glioma; Cancer research; Astrocytoma; GiST","score_opus":0.02351185612717296,"score_gpt":0.2864063054543172,"score_spread":0.2628944493271443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309017263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994769,0.0005095149,0.000004157849,0.0032186124,0.00019137305,0.001092863,0.00002472344,0.00008182287,0.00010793242],"genre_scores_gemma":[0.99588686,0.0002610525,0.00013870689,0.0030877667,0.000058295307,0.00039173558,0.00011087431,0.000053568812,0.000011163922],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99787855,0.00041368746,0.00034505024,0.00061820174,0.00036005126,0.00038448413],"domain_scores_gemma":[0.9990936,0.0001259981,0.00017495935,0.0003388672,0.00006570089,0.00020089465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022897041,0.00027144098,0.0005244623,0.0002333932,0.00018537023,0.00002164438,0.00011756201,0.00006293928,0.00014024024],"category_scores_gemma":[0.000037182625,0.00021532293,0.000047675025,0.0004487397,0.00009658,0.0001090517,0.000096776435,0.0004908752,0.0000037666666],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026391079,0.0035183239,0.65061605,0.00003656636,0.000040272545,0.0049826605,0.00062290864,0.000058382702,0.32428125,0.00008341178,0.00028971775,0.012831339],"study_design_scores_gemma":[0.011500214,0.010682601,0.94846636,0.000060086953,0.00008711125,0.0010685489,0.00072162296,0.0014026576,0.011703253,0.00003022148,0.014036149,0.000241178],"about_ca_topic_score_codex":0.000049903734,"about_ca_topic_score_gemma":0.00010062975,"teacher_disagreement_score":0.312578,"about_ca_system_score_codex":0.0002850209,"about_ca_system_score_gemma":0.00015646647,"threshold_uncertainty_score":0.8780614},"labels":[],"label_agreement":null},{"id":"W4309017265","doi":"10.1093/neuonc/noac209.197","title":"RADT-07. RADIOGRAPHIC “NECROSIS\" FOLLOWING SINGLE-FRACTION SRS AND IMMUNE CHECKPOINT INHIBITION IS ASSOCIATED WITH IMPROVED SURVIVAL IN PATIENTS WITH BRAIN METASTASES: AN INTERNATIONAL MULTICENTER STUDY","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Université de Sherbrooke; Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Medicine; Radiosurgery; Hazard ratio; Internal medicine; Lung cancer; Necrosis; Renal cell carcinoma; Melanoma; Urology; Histology; Radiation therapy; Oncology; Nuclear medicine; Confidence interval; Cancer research","score_opus":0.016438307310203903,"score_gpt":0.27549046062668386,"score_spread":0.25905215331647996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309017265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963837,0.0000290103,0.000035120156,0.0012086885,0.00040885987,0.0017215685,0.00009979533,0.00005172026,0.000061513594],"genre_scores_gemma":[0.99763846,0.0000044758367,0.00034462314,0.000994528,0.00003054274,0.00025033386,0.00067962165,0.000046635814,0.000010793096],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972154,0.0009188963,0.00046356983,0.0005938242,0.0004940606,0.00031424483],"domain_scores_gemma":[0.9988505,0.00032893987,0.00032936505,0.00026201794,0.000103334496,0.00012579355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000819397,0.00026474352,0.00057752116,0.00037941523,0.00019494005,0.000038797087,0.00007781305,0.00006249664,0.00011283488],"category_scores_gemma":[0.0001843171,0.00021651495,0.00010972617,0.00042446257,0.000069281654,0.00028044896,0.000108606386,0.00045744813,0.0000011128765],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070829256,0.018122513,0.93414724,0.000012390594,0.0013165987,0.00087691867,0.0020352064,0.000045078974,0.029840369,0.0000051294633,0.00003383176,0.0064818216],"study_design_scores_gemma":[0.06250154,0.037950017,0.8916024,0.00004636593,0.00085925637,0.000051045798,0.003543956,0.0006509259,0.0014154556,0.000011628105,0.0010538338,0.00031358056],"about_ca_topic_score_codex":0.00041069367,"about_ca_topic_score_gemma":0.00043760642,"teacher_disagreement_score":0.055418614,"about_ca_system_score_codex":0.00074161135,"about_ca_system_score_gemma":0.00009703898,"threshold_uncertainty_score":0.88292235},"labels":[],"label_agreement":null},{"id":"W4309017270","doi":"10.1093/neuonc/noac209.295","title":"CTNI-30. LOGGIC/FIREFLY-2: A PHASE 3, RANDOMIZED TRIAL OF TOVORAFENIB VS. CHEMOTHERAPY IN PEDIATRIC PATIENTS WITH NEWLY DIAGNOSED LOW-GRADE GLIOMA HARBORING AN ACTIVATING RAF ALTERATION","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Tolerability; Regimen; Internal medicine; Chemotherapy regimen; Clinical endpoint; Oncology; Chemotherapy; Randomized controlled trial; Phases of clinical research; Glioma; Adverse effect; Cancer research","score_opus":0.016577567645459448,"score_gpt":0.30397161738416234,"score_spread":0.2873940497387029,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309017270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941132,0.00007055348,0.000027072358,0.0010112029,0.0005034922,0.004087873,0.00001880842,0.00006073876,0.00010706421],"genre_scores_gemma":[0.9967068,0.00007335213,0.000385439,0.00068356225,0.00035080162,0.0015986245,0.00013937992,0.000060253915,0.000001777327],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99669975,0.0009355958,0.0008551823,0.00058022933,0.0005218036,0.00040744036],"domain_scores_gemma":[0.99730027,0.0013992342,0.00064932776,0.00037218854,0.000105643696,0.00017332057],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005990618,0.00031483232,0.0012754033,0.0005402232,0.00014636353,0.000020614953,0.000150093,0.00011780867,0.00023379514],"category_scores_gemma":[0.00042815934,0.0002586118,0.00018291258,0.0006872497,0.0000738871,0.00016311149,0.00006632355,0.00038812362,0.0000024921367],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.89145494,0.02473257,0.022251766,0.000063529405,0.00014804289,0.0010357728,0.0018186009,0.00043316497,0.0418135,0.000042491087,0.00013744844,0.016068172],"study_design_scores_gemma":[0.9599651,0.01803972,0.004899719,0.000020271093,0.00025331636,0.000019386034,0.00008363232,0.0011676322,0.0148403235,0.0000267143,0.00048092043,0.00020325473],"about_ca_topic_score_codex":0.000111898495,"about_ca_topic_score_gemma":0.000018223214,"teacher_disagreement_score":0.06851017,"about_ca_system_score_codex":0.00043555195,"about_ca_system_score_gemma":0.00035550853,"threshold_uncertainty_score":0.9999866},"labels":[],"label_agreement":null},{"id":"W4309017517","doi":"10.1093/neuonc/noac209.601","title":"PATH-28. DIFFERENCES IN METHYLATION PROFILES BETWEEN LONG-TERM SURVIVORS AND SHORT-TERM SURVIVORS OF IDH WILD-TYPE GLIOBLASTOMA","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Western University; Occupational Cancer Research Centre; Princess Margaret Cancer Centre; University Health Network; University of Toronto; McMaster University","funders":"","keywords":"Isocitrate dehydrogenase; CDKN2A; Methylation; DNA methylation; CDKN2B; Biology; IDH1; Oncology; Cancer research; Internal medicine; Medicine; Genetics; Gene; Gene expression; Enzyme","score_opus":0.032745849954341134,"score_gpt":0.30335962577374065,"score_spread":0.2706137758193995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309017517","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973097,0.00052718114,0.000004310863,0.0007178104,0.00041716165,0.00077534217,0.000047592956,0.000039600705,0.00016128896],"genre_scores_gemma":[0.9992688,0.00022824024,0.000037758844,0.00010045815,0.00008466756,0.00015530559,0.000086461776,0.000029505463,0.000008821598],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977796,0.00053680985,0.0005176619,0.00047502044,0.0003692961,0.00032160673],"domain_scores_gemma":[0.9984704,0.00085475744,0.00019492346,0.00027215577,0.00007033739,0.00013737712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036152522,0.00023526551,0.00078409945,0.00037637164,0.00010410141,0.000011526904,0.00014240174,0.00013547266,0.00015806366],"category_scores_gemma":[0.000115529074,0.00020522144,0.00008422908,0.00048135963,0.00014133095,0.00006640303,0.00021876239,0.00032057904,0.0000033484905],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028606947,0.0006783115,0.92787766,0.0000835749,0.00008278185,0.0004602568,0.0005902253,0.0000041135577,0.0508745,0.0000409967,0.000039986546,0.01898154],"study_design_scores_gemma":[0.0016125047,0.0052579986,0.9748701,0.00003430218,0.00018573078,0.000064287495,0.00018061306,0.00004528096,0.017258128,0.000044612025,0.00030049743,0.00014595124],"about_ca_topic_score_codex":0.000340405,"about_ca_topic_score_gemma":0.0013731988,"teacher_disagreement_score":0.04699245,"about_ca_system_score_codex":0.00016251291,"about_ca_system_score_gemma":0.00013636731,"threshold_uncertainty_score":0.83686876},"labels":[],"label_agreement":null},{"id":"W4309017638","doi":"10.1093/neuonc/noac209.879","title":"EXTH-81. ITGA5 IS A NOVEL IMMUNOTHERAPEUTIC TARGET AGAINST TREATMENT REFRACTORY MEDULLOBLASTOMA","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto","funders":"","keywords":"Medulloblastoma; Medicine; In vivo; Radiation therapy; Cytotoxic T cell; Oncology; Chemotherapy; Wnt signaling pathway; Primitive neuroectodermal tumor; Cancer research; Internal medicine; In vitro; Biology; Signal transduction","score_opus":0.029741173404336116,"score_gpt":0.30260519332213504,"score_spread":0.2728640199177989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309017638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97477967,0.002440816,0.000014284978,0.014294703,0.0011404966,0.0011240994,0.00014016649,0.0001690308,0.005896751],"genre_scores_gemma":[0.97724944,0.00051997555,0.0005063482,0.019919006,0.0001963269,0.0011291092,0.00010476775,0.0000888707,0.00028618102],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99774545,0.00020812535,0.0004452966,0.00064624735,0.00040047037,0.0005543988],"domain_scores_gemma":[0.99845546,0.0003814214,0.0002076057,0.000660534,0.000064062144,0.0002309259],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001415328,0.00036773292,0.0007079676,0.00025910843,0.00032825407,0.000015439407,0.00017905068,0.00013683103,0.0024905214],"category_scores_gemma":[0.00003581819,0.00031052157,0.00031386505,0.00029897146,0.00010138593,0.00005599113,0.00014937705,0.00036733,0.00017877968],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010741247,0.011488329,0.006297691,0.000018935318,0.00070484774,0.0021283978,0.0019107623,0.00007050594,0.8864101,0.00013060909,0.010897302,0.07886839],"study_design_scores_gemma":[0.010220606,0.011556265,0.0037573194,0.000009585282,0.00029773713,0.0005567523,0.0003536994,0.00024210899,0.038830996,0.000037308622,0.9339126,0.00022503166],"about_ca_topic_score_codex":0.00007248151,"about_ca_topic_score_gemma":0.000017181248,"teacher_disagreement_score":0.9230153,"about_ca_system_score_codex":0.0018259801,"about_ca_system_score_gemma":0.0005368463,"threshold_uncertainty_score":0.9999347},"labels":[],"label_agreement":null},{"id":"W4309017650","doi":"10.1093/neuonc/noac209.069","title":"BIOM-59. NOVEL BIOMARKER DISCOVERY AND DIAGNOSTICS FOR INTRA-AXIAL BRAIN TUMORS, USING CSF PROTEOMICS","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Proteomics; Cerebrospinal fluid; Brain tumor; Biomarker; Biomarker discovery; Medicine; Malignancy; Brain biopsy; Liquid biopsy; Pathology; Receiver operating characteristic; Oncology; Cancer; Biopsy; Biology; Internal medicine; Gene","score_opus":0.040537385572249986,"score_gpt":0.3157343512396935,"score_spread":0.2751969656674435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309017650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98318684,0.00027909182,0.0011187284,0.011986932,0.00082704984,0.0020556706,0.0004016235,0.000045303586,0.00009878368],"genre_scores_gemma":[0.98788637,0.0000785848,0.0049761436,0.0056248493,0.000336216,0.0008477143,0.00015981164,0.0000705504,0.000019776393],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984288,0.000109394365,0.00036063298,0.0004916718,0.00019773455,0.00041174015],"domain_scores_gemma":[0.9977355,0.0016088242,0.00017588072,0.000258218,0.000058175076,0.00016339468],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002590496,0.0002312054,0.00049219,0.00019730208,0.00029083752,0.000039615134,0.00009788583,0.00010587646,0.00003924433],"category_scores_gemma":[0.0009604801,0.00021089839,0.00012352527,0.00022953768,0.0001498238,0.000089737245,0.00025375126,0.00022581154,0.0000020676418],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008924616,0.0020853772,0.016159877,0.00007367601,0.00014759187,0.0007108888,0.00022382042,0.00004319262,0.9605216,0.0012274525,0.008331844,0.009582219],"study_design_scores_gemma":[0.045051794,0.018910121,0.038880553,0.00012350318,0.0016960946,0.0066562183,0.00095494406,0.014986607,0.16751276,0.001102039,0.70291746,0.001207889],"about_ca_topic_score_codex":0.000064077125,"about_ca_topic_score_gemma":0.00002119703,"teacher_disagreement_score":0.79300886,"about_ca_system_score_codex":0.00038093736,"about_ca_system_score_gemma":0.00038108526,"threshold_uncertainty_score":0.8600187},"labels":[],"label_agreement":null},{"id":"W4309017983","doi":"10.1093/neuonc/noac209.169","title":"CSIG-20. PROTEOGENOMICS PROFILING REVEALS ENRICHED PROTEIN TRANSLATION REGULATORS AS NEW THERAPEUTIC TARGETS IN DIPG","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"","keywords":"Biology; Proteome; Histone; Epigenetics; Transcriptome; Histone H3; Proteomics; Gene knockdown; DNA methylation; Metabolome; Methylation; Translation (biology); Cell biology; Molecular biology; Cancer research; Genetics; Messenger RNA; Gene expression; Bioinformatics; Apoptosis; Metabolomics; DNA; Gene","score_opus":0.023574319208424045,"score_gpt":0.285881132570665,"score_spread":0.26230681336224093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309017983","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879818,0.002767459,0.0016654201,0.0032148731,0.00028956472,0.0022524237,0.000019258066,0.000031047177,0.0017781573],"genre_scores_gemma":[0.9951333,0.00009172564,0.0015710299,0.0012719083,0.00020652657,0.00096341013,0.00014895598,0.000044196182,0.0005689657],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983073,0.0003723126,0.00035986144,0.00050435786,0.00014952691,0.0003066428],"domain_scores_gemma":[0.9992963,0.000022757133,0.00016918624,0.00036903494,0.000039247778,0.00010344812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034339563,0.00016929585,0.00021239472,0.00008963539,0.00015483526,0.000014258321,0.00026376732,0.0001650196,0.000108853914],"category_scores_gemma":[0.0000655321,0.00018230914,0.00008295735,0.00022886657,0.000039437644,0.0000068065515,0.00008433692,0.000282402,0.000007749709],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027988772,0.00011892704,0.00046067915,0.000010039478,0.000018651524,0.000008653615,0.00021886238,0.0008424754,0.97254497,0.0005804179,0.0003627125,0.024553709],"study_design_scores_gemma":[0.0017101096,0.0015416457,0.00048401864,0.0000037231528,0.000024025168,0.000054435848,0.00022694796,0.00036833718,0.48058242,0.0022221312,0.5124562,0.00032599558],"about_ca_topic_score_codex":0.00003000933,"about_ca_topic_score_gemma":0.000034118697,"teacher_disagreement_score":0.5120935,"about_ca_system_score_codex":0.0001504507,"about_ca_system_score_gemma":0.000771266,"threshold_uncertainty_score":0.7434351},"labels":[],"label_agreement":null},{"id":"W4309017992","doi":"10.1093/neuonc/noac209.618","title":"PATH-45. INTRAEPIGLIOM - RAPID SEQUENCING-BASED DIAGNOSIS OF BRAIN TUMORS","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Nanopore sequencing; Minion; Medical diagnosis; Computer science; Brain biopsy; Classifier (UML); DNA sequencing; Medicine; Artificial intelligence; Pathology; Biopsy; Biology; Gene","score_opus":0.013739696045676588,"score_gpt":0.2567201268820625,"score_spread":0.24298043083638593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309017992","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99274343,0.00080332655,0.00028459085,0.0030401286,0.0008121685,0.00034612927,0.0003269925,0.00002053909,0.0016226688],"genre_scores_gemma":[0.98981744,0.00023965293,0.0003924284,0.0087655,0.00025317058,0.0002863295,0.00018426376,0.000042975902,0.00001821154],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983722,0.00028379096,0.00038163317,0.00045678957,0.00017275369,0.00033285262],"domain_scores_gemma":[0.99871385,0.00039582065,0.00024014154,0.00045122625,0.00007529891,0.0001236884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034189888,0.00018178424,0.00030953504,0.000109619905,0.0001369228,0.0000093529225,0.00035796248,0.0001288425,0.00034587915],"category_scores_gemma":[0.00056755554,0.00020931155,0.000157567,0.00020415559,0.0001464102,0.0000020734458,0.00033866323,0.00024656823,0.0000056856297],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025595215,0.00025822688,0.0037215329,0.000028147011,0.00003148904,0.00014125615,0.000102793456,0.0034129834,0.94218445,0.00024954093,0.038483404,0.011130229],"study_design_scores_gemma":[0.001224082,0.0039876257,0.0003129464,0.0000042567717,0.000028450993,0.00006046529,0.00015439882,0.00032934506,0.4047093,0.00011549386,0.5888582,0.0002154058],"about_ca_topic_score_codex":0.00010314451,"about_ca_topic_score_gemma":0.000055892953,"teacher_disagreement_score":0.5503748,"about_ca_system_score_codex":0.00017816923,"about_ca_system_score_gemma":0.0010910524,"threshold_uncertainty_score":0.85354775},"labels":[],"label_agreement":null},{"id":"W4309018298","doi":"10.1093/neuonc/noac209.217","title":"RADT-27. FRACTIONATED RADIOTHERAPY AS FIRST-LINE TREATMENT FOR INTRACRANIAL MENINGIOMAS","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Queen's University; University of Toronto","funders":"","keywords":"Medicine; Radiosurgery; Radiation therapy; Cohort; Meningioma; Cavernous sinus; Adverse effect; Surgery; Logistic regression; Proportional hazards model; Stage (stratigraphy); Radiology; Internal medicine","score_opus":0.036167948901926913,"score_gpt":0.3304965788096187,"score_spread":0.29432862990769176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309018298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9493264,0.0005334371,0.0027973603,0.033859175,0.0033152946,0.002862324,0.00004360874,0.00027970324,0.00698268],"genre_scores_gemma":[0.98139226,0.00013611757,0.0072372807,0.0038947249,0.0012183399,0.0016299674,0.00028615328,0.000111893554,0.004093229],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981042,0.00017946234,0.0004325604,0.0005327687,0.000318351,0.00043266427],"domain_scores_gemma":[0.9986972,0.00050644745,0.00019235916,0.00035113274,0.00006847305,0.00018437358],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002920806,0.0002565561,0.00055695476,0.00026592228,0.00045013972,0.000017471051,0.0001514981,0.00010712396,0.0025380475],"category_scores_gemma":[0.00010467492,0.00023737385,0.00023213077,0.00028559103,0.000054767705,0.00005600711,0.00007410781,0.0002530283,0.00004460317],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03072269,0.00808487,0.002919358,0.000163152,0.0023122185,0.028646877,0.0045285,0.0032964614,0.48425654,0.0055677346,0.13559064,0.29391095],"study_design_scores_gemma":[0.011308128,0.02094215,0.00025148963,0.000003919366,0.00024508845,0.0035429015,0.00017371752,0.006294757,0.0025037818,0.00028563754,0.9542604,0.00018803471],"about_ca_topic_score_codex":0.000074797135,"about_ca_topic_score_gemma":0.000009944994,"teacher_disagreement_score":0.81866974,"about_ca_system_score_codex":0.0011375541,"about_ca_system_score_gemma":0.0002821311,"threshold_uncertainty_score":0.99837375},"labels":[],"label_agreement":null},{"id":"W4309018309","doi":"10.1093/neuonc/noac209.804","title":"EXTH-05. TOWARD 100% CLINICAL EFFICACY FOR TUMOR-TREATING FIELDS","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"bioluminescence and chemiluminescence research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"In vivo; Radiation therapy; Intracellular; Cancer; Medicine; Biology; Internal medicine; Cell biology","score_opus":0.05895194278720524,"score_gpt":0.38844839722916424,"score_spread":0.329496454441959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309018309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99144924,0.0003352514,0.00051330135,0.0036153893,0.0009784647,0.0006330676,0.000039987604,0.000039378658,0.0023959384],"genre_scores_gemma":[0.9936856,0.00015886541,0.00055334123,0.0036200348,0.0010600644,0.00024982897,0.00017379284,0.00003747468,0.00046098803],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978348,0.00027658453,0.00045068265,0.0006751391,0.00020459753,0.0005581962],"domain_scores_gemma":[0.9988111,0.00033268146,0.00014577253,0.0004289271,0.00011135354,0.00017014312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006436949,0.00018901608,0.0003251133,0.000052165295,0.00027742868,0.000018529272,0.0005435575,0.0002352042,0.00015987117],"category_scores_gemma":[0.00079481595,0.00018982805,0.00026075245,0.00015234067,0.00017868771,0.0000051541315,0.00055890053,0.0004955192,0.000014927936],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066467817,0.0005150732,0.0069249375,0.00003247733,0.00003887087,0.00007837416,0.000084447776,0.000015565523,0.8976009,0.000044340493,0.04958185,0.044418488],"study_design_scores_gemma":[0.0021501933,0.0053914753,0.00052004674,0.000004799048,0.000030749976,0.00022073701,0.00047505274,0.00022843879,0.18465982,0.00004221752,0.80599093,0.00028554344],"about_ca_topic_score_codex":0.000017935738,"about_ca_topic_score_gemma":0.000013221718,"teacher_disagreement_score":0.75640905,"about_ca_system_score_codex":0.000053404394,"about_ca_system_score_gemma":0.000441695,"threshold_uncertainty_score":0.7740963},"labels":[],"label_agreement":null},{"id":"W4309018312","doi":"10.1093/neuonc/noac209.572","title":"INNV-32. COMPARING THE MONTREAL COGNITIVE ASSESSMENT (MOCA) FULL AND 5-MINUTE PROTOCOLS IN MILD COGNITIVE IMPAIRMENT SCREENING OF ADULT CNS TUMOR PATIENTS","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Montreal Cognitive Assessment; Medicine; Cognitive impairment; Cognition; Internal medicine; Physical therapy; Psychiatry","score_opus":0.032577586381566784,"score_gpt":0.33349237071671156,"score_spread":0.3009147843351448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309018312","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9801234,0.0000353197,0.000015148108,0.0010335526,0.00008112562,0.01733585,0.00011851912,0.000022154198,0.0012349584],"genre_scores_gemma":[0.9744499,0.000008950715,0.00014655251,0.001493873,0.000032341748,0.023746142,0.00009322986,0.000026603024,0.0000024462843],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977955,0.0004335027,0.0005190129,0.0004501696,0.00042755296,0.00037423256],"domain_scores_gemma":[0.9983361,0.0007849678,0.0003521755,0.00016130449,0.00023367572,0.00013179574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024631718,0.00024075198,0.00063338084,0.00020066029,0.00020228206,0.00001401264,0.00010442145,0.000051059764,0.000059267146],"category_scores_gemma":[0.00014027768,0.00018609306,0.000092104645,0.00028988995,0.0001693368,0.000053139967,0.00037112398,0.00049043464,0.0000021508415],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036180767,0.0070164376,0.9652411,0.000096688695,0.0002476984,0.0008701759,0.0026779345,0.00007727897,0.001905004,0.00008345368,0.0002924509,0.017873727],"study_design_scores_gemma":[0.03219363,0.01498995,0.94267035,0.00034727802,0.00031005227,0.00012865037,0.004180048,0.0009509581,0.0036342724,0.000044498676,0.00038057292,0.00016974445],"about_ca_topic_score_codex":0.0005132022,"about_ca_topic_score_gemma":0.00052193453,"teacher_disagreement_score":0.028575556,"about_ca_system_score_codex":0.0003931257,"about_ca_system_score_gemma":0.00028819524,"threshold_uncertainty_score":0.7588655},"labels":[],"label_agreement":null},{"id":"W4309018548","doi":"10.1093/neuonc/noac209.588","title":"PATH-15. THE PROGNOSTIC IMPLICATION OF MGMT PROMOTER METHYLATION IN IDH-MUTANT GLIOMAS","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Oligodendroglioma; CDKN2A; Astrocytoma; Glioma; Oncology; Medicine; Methylation; IDH1; Internal medicine; Univariate analysis; Cancer research; Biology; Multivariate analysis; Mutant; Cancer; Gene","score_opus":0.023086148226408986,"score_gpt":0.3059110953441583,"score_spread":0.2828249471177493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309018548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861507,0.00024157892,0.000011961898,0.011251379,0.00018615836,0.0014162004,0.0000131132865,0.000024603618,0.00070431904],"genre_scores_gemma":[0.9982267,0.000024497009,0.000081911596,0.0005934795,0.000046135876,0.00097025133,0.000036486617,0.000016968928,0.0000035712042],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.998624,0.00033939755,0.00034415073,0.0002578515,0.00022575883,0.00020880695],"domain_scores_gemma":[0.9988883,0.0005161858,0.00018832272,0.00029303806,0.00006773569,0.000046392553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003779493,0.00010670754,0.00026811674,0.000161582,0.000090239315,0.000004943261,0.000100395235,0.00005956709,0.00014084754],"category_scores_gemma":[0.00024356318,0.00007471613,0.00007105264,0.00044137638,0.00005325732,0.000032588632,0.00011258184,0.00023275311,0.000010986878],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016971542,0.0014876117,0.12408963,0.000031251067,0.00003597239,0.0002722533,0.00083132496,0.000046771373,0.8491044,0.00085013703,0.00030408637,0.02277683],"study_design_scores_gemma":[0.0064380304,0.007695265,0.69163305,0.00003176493,0.00038108262,0.0008078126,0.0005722264,0.001326458,0.2397151,0.0016420403,0.04956964,0.00018753225],"about_ca_topic_score_codex":0.00005674241,"about_ca_topic_score_gemma":0.000040950974,"teacher_disagreement_score":0.6093893,"about_ca_system_score_codex":0.00023777255,"about_ca_system_score_gemma":0.00016327537,"threshold_uncertainty_score":0.30468354},"labels":[],"label_agreement":null},{"id":"W4309018553","doi":"10.1093/neuonc/noac209.1144","title":"MODL-16. SOMATICALLY ENGINEERED MOUSE MODELS RECAPITULATING CELLULAR AND MOLECULAR FEATURES OF HUMAN GBM","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"PTEN; Biology; CDKN2A; Cancer research; PDGFRA; Context (archaeology); Phenotype; Mesenchymal stem cell; Pathology; Stromal cell; PI3K/AKT/mTOR pathway; Gene; Genetics; Medicine; Signal transduction","score_opus":0.009580931457660003,"score_gpt":0.2737601221694131,"score_spread":0.2641791907117531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309018553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9779403,0.001267377,0.01859536,0.00016443238,0.00013029126,0.00023645717,0.00002266242,0.000028268185,0.0016148427],"genre_scores_gemma":[0.9969401,0.000050417657,0.0024262539,0.00026820222,0.00006832647,0.000051177176,0.0000729643,0.000045944074,0.00007662657],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987482,0.00013054899,0.00030483777,0.00037209288,0.00016665229,0.00027765747],"domain_scores_gemma":[0.9993793,0.000039213417,0.000091199174,0.0003474306,0.000044515782,0.000098365344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018336454,0.00018514911,0.00027651145,0.00008094314,0.000115011324,0.0000095610785,0.00021094196,0.00013782672,0.000027728296],"category_scores_gemma":[0.00006329637,0.00021003926,0.000090297915,0.00008542443,0.000064241074,0.000003489999,0.0003622734,0.00024711035,4.336185e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032100197,0.000069542984,0.00003189353,0.000037412938,0.000036807593,0.000024549092,0.00017243136,0.041620042,0.95549405,0.0007908076,0.000339807,0.0013505822],"study_design_scores_gemma":[0.00073278305,0.0010518484,0.00004294848,0.0000033474353,0.000036384055,0.00007423877,0.00017784498,0.005215398,0.9878184,0.00056028663,0.0040706173,0.00021590813],"about_ca_topic_score_codex":0.000015370644,"about_ca_topic_score_gemma":0.000005476857,"teacher_disagreement_score":0.036404643,"about_ca_system_score_codex":0.000032143973,"about_ca_system_score_gemma":0.000055940196,"threshold_uncertainty_score":0.8565153},"labels":[],"label_agreement":null},{"id":"W4309018697","doi":"10.1093/neuonc/noac209.1165","title":"MODL-38. DEVELOPMENTAL EFFECTS OF MYBL1 ACTIVATION ON MURINE BRAIN AND GLIAL DEVELOPMENT","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"OLIG2; Biology; Progenitor cell; Neural stem cell; Cell biology; Stem cell; Neuroscience; Central nervous system","score_opus":0.015198184312156466,"score_gpt":0.2746167002708395,"score_spread":0.25941851595868304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309018697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994654,0.000041454747,0.000009259277,0.0030802912,0.00026943206,0.0006209272,0.0000035943315,0.000028922943,0.0012920897],"genre_scores_gemma":[0.996504,0.000012412021,0.0008023868,0.0022355071,0.000047398542,0.00030701162,0.000037186932,0.000018955034,0.000035125544],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989181,0.00012183769,0.00023789897,0.00028232104,0.0002507537,0.00018906491],"domain_scores_gemma":[0.9990672,0.00059960206,0.00011040696,0.00010205792,0.00002653896,0.00009422284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011927541,0.00014193839,0.00030858,0.00017030667,0.00013642361,0.0000035336727,0.00005126067,0.000053876312,0.00013370159],"category_scores_gemma":[0.0001615516,0.0001290478,0.00003659628,0.00014564517,0.0000403533,0.000025470606,0.00014494221,0.00017362804,0.000008805052],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088045205,0.0024782356,0.01252413,0.00010917488,0.00014481097,0.00060662633,0.0015561595,0.0000339938,0.8698556,0.00030226324,0.0047504227,0.106758155],"study_design_scores_gemma":[0.0072686765,0.004313717,0.09202814,0.00003105576,0.000043871958,0.00018799122,0.00016568035,0.000034472618,0.75672525,0.000032674754,0.13904288,0.00012556072],"about_ca_topic_score_codex":0.000011651807,"about_ca_topic_score_gemma":0.000004530514,"teacher_disagreement_score":0.13429247,"about_ca_system_score_codex":0.00048176723,"about_ca_system_score_gemma":0.00028328286,"threshold_uncertainty_score":0.52624166},"labels":[],"label_agreement":null},{"id":"W4309018743","doi":"10.1093/neuonc/noac209.1116","title":"TMIC-73. HIGH-DIMENSIONAL HISTOPATHOLOGIC EVALUATION OF THE HYPOXIC MICROENVIRONMENT IN GLIOBLASTOMA","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; Hamilton Health Sciences; Occupational Cancer Research Centre; University Health Network","funders":"","keywords":"Hypoxia (environmental); Pathology; Biology; Immunohistochemistry; Angiogenesis; Cell type; Cell; Mass cytometry; Tumor microenvironment; Cancer research; Phenotype; Medicine; Chemistry; Tumor cells","score_opus":0.023595048954478802,"score_gpt":0.2781064633221459,"score_spread":0.2545114143676671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309018743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920507,0.00047879483,3.765805e-7,0.0057695596,0.00059886544,0.00077525387,0.000016040052,0.000011100824,0.00029928703],"genre_scores_gemma":[0.997577,0.000015396408,0.00007633332,0.0018844312,0.000030886433,0.00038083084,0.000008234183,0.000013658706,0.000013231877],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9979218,0.0007168823,0.00030988504,0.0003016994,0.0005561962,0.0001935184],"domain_scores_gemma":[0.9992267,0.00017880475,0.000180691,0.00033155808,0.000035993184,0.000046251105],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00057389634,0.000120227145,0.00029493077,0.00013493354,0.00009628775,0.0000014584496,0.000114249735,0.000058519898,0.0011101725],"category_scores_gemma":[0.000119417506,0.00008839399,0.000097387165,0.00020897058,0.00010092685,0.000015041104,0.00022878234,0.00024314197,0.000019143417],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029184672,0.002388583,0.025048632,0.0000079477395,0.000019605888,0.00034863089,0.00017724905,0.0036136569,0.9532757,0.00008773222,0.0024127602,0.01232765],"study_design_scores_gemma":[0.015253711,0.007849609,0.7202582,0.000025521902,0.00065408804,0.001197768,0.00019013043,0.002134134,0.21635097,0.00054133043,0.035337962,0.00020659497],"about_ca_topic_score_codex":0.000030000047,"about_ca_topic_score_gemma":0.00003394828,"teacher_disagreement_score":0.7369247,"about_ca_system_score_codex":0.0012767215,"about_ca_system_score_gemma":0.00022790153,"threshold_uncertainty_score":0.99980295},"labels":[],"label_agreement":null},{"id":"W4309019018","doi":"10.1093/neuonc/noac209.1131","title":"MODL-03. IDH-MUTANT GLIOMA GWAS ALLELE RS55705857 ON 8Q24 IS CHANGING THE DYNAMICS OF UNPATTERNED CEREBRAL ORGANOID DEVELOPMENT","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"","keywords":"Organoid; Allele; Biology; Induced pluripotent stem cell; Embryoid body; Genetics; Molecular biology; Cancer research; Cell biology; Embryonic stem cell; Gene","score_opus":0.022057185326070924,"score_gpt":0.28007110375935945,"score_spread":0.2580139184332885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309019018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9764423,0.00012999655,0.00020198784,0.017986929,0.0010353749,0.0006530133,0.00007762702,0.000054419248,0.003418373],"genre_scores_gemma":[0.9874192,0.000046446108,0.00039145327,0.011298081,0.00017681344,0.00012920138,0.000071031485,0.000058428737,0.0004093321],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99791163,0.00019611046,0.00045348605,0.00043393637,0.00050079485,0.00050405815],"domain_scores_gemma":[0.9989164,0.00018320375,0.00024301262,0.00044945246,0.00008069233,0.00012724008],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00040881467,0.00022824375,0.00051729305,0.00027912672,0.00027194753,0.000009043102,0.00028683126,0.00008407688,0.0022255413],"category_scores_gemma":[0.000049538732,0.00017947028,0.00013565824,0.00060921797,0.000089155044,0.000026069,0.00042451912,0.0005184389,0.0000477112],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027489425,0.00197122,0.0033004098,0.00030919537,0.0005840474,0.0017052033,0.022925723,0.0007958062,0.8000253,0.0025331327,0.014250183,0.14885083],"study_design_scores_gemma":[0.0053063612,0.0037142367,0.0008887124,0.000031483727,0.00029837625,0.0011013648,0.005030097,0.003341671,0.4014186,0.00012798706,0.5783439,0.00039717552],"about_ca_topic_score_codex":0.00007382234,"about_ca_topic_score_gemma":0.00012393299,"teacher_disagreement_score":0.56409377,"about_ca_system_score_codex":0.00082077924,"about_ca_system_score_gemma":0.00063011236,"threshold_uncertainty_score":0.99868655},"labels":[],"label_agreement":null},{"id":"W4309019023","doi":"10.1093/neuonc/noac209.1014","title":"TMET-09. LOSS OF MAT2A COMPROMISES METHIONINE METABOLISM AND REPRESENTS A VULNERABILITY IN H3K27M MUTANT GLIOMAS","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Hospital for Sick Children; McGill University","funders":"","keywords":"Epigenetics; Methionine Adenosyltransferase; Methionine; Methylation; Biology; Mutant; Methyltransferase; DNA methylation; Cancer research; Cell biology; Genetics; Chemistry; Gene; Gene expression; Amino acid","score_opus":0.02042787843049634,"score_gpt":0.3095081475939314,"score_spread":0.2890802691634351,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309019023","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957956,0.0021607422,0.00014779059,0.0004927614,0.00031204397,0.00034245392,0.00005141112,0.0000084240355,0.00068876694],"genre_scores_gemma":[0.9983145,0.00039942923,0.0008743795,0.00015880872,0.00007040774,0.00008565151,0.000051072435,0.000019801391,0.000025952244],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99777585,0.000839419,0.00044763423,0.0005166813,0.00018628436,0.0002341153],"domain_scores_gemma":[0.9990701,0.0001542591,0.00020365734,0.00041682104,0.00007695383,0.00007820796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080862653,0.00015106835,0.00037103522,0.0001250087,0.00009948844,0.0000074075265,0.00019638984,0.00013881884,0.000062975974],"category_scores_gemma":[0.0004190891,0.00015427751,0.000074950614,0.00023793701,0.00016959647,0.0000040921886,0.0005022256,0.0002503073,8.9956313e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032809458,0.0002780702,0.013566855,0.000019409725,0.000026627558,0.000034284123,0.00013388351,0.00039781057,0.97948605,0.00018097539,0.000042033134,0.0055059316],"study_design_scores_gemma":[0.0021047143,0.0011131419,0.027813004,0.0000023317614,0.00003945538,0.000052911528,0.0001222692,0.0003224564,0.86719626,0.0012170628,0.09982823,0.00018816936],"about_ca_topic_score_codex":0.000119992656,"about_ca_topic_score_gemma":0.00007284743,"teacher_disagreement_score":0.11228977,"about_ca_system_score_codex":0.000033556873,"about_ca_system_score_gemma":0.000122005404,"threshold_uncertainty_score":0.6291254},"labels":[],"label_agreement":null},{"id":"W4309019064","doi":"10.1093/neuonc/noac209.1104","title":"TMIC-60. THE ROLE OF ICAM1 IN GLIOBLASTOMA TUMORIGENESIS UNDER HYPOXIC CONDITIONS","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; Occupational Cancer Research Centre; University of Toronto","funders":"","keywords":"Carcinogenesis; Tumor microenvironment; Cancer research; ICAM-1; Biology; Cell growth; Cell adhesion molecule; Tumor progression; Cell adhesion; Intracellular; Cell; Cell biology; Cancer; Tumor cells; Biochemistry","score_opus":0.00865200405683501,"score_gpt":0.2583086582321263,"score_spread":0.2496566541752913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309019064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924426,0.0024695317,0.000020085101,0.00084512535,0.0013579398,0.00027820273,0.00010969554,0.00001218854,0.0024646302],"genre_scores_gemma":[0.9966627,0.00046212322,0.000028020851,0.0018773952,0.0005356146,0.00022362258,0.00003559186,0.000026571492,0.00014837108],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985597,0.00035690347,0.00029464674,0.00034218477,0.00015344021,0.00029312196],"domain_scores_gemma":[0.99924594,0.00009342688,0.00014848045,0.00040328808,0.00004665374,0.000062209234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002164199,0.00013977662,0.00024857948,0.00009578123,0.00016123707,0.0000057301536,0.00035465017,0.00010250767,0.00024084831],"category_scores_gemma":[0.00006741265,0.00012782223,0.00012583779,0.00025119976,0.00017455287,0.0000031337192,0.00029198697,0.00022785147,0.000008542992],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017312671,0.00018337928,0.00032667772,0.0000036234214,0.00002414415,0.000007396923,0.000121389996,0.0009265913,0.9893228,0.0007300425,0.0044708485,0.0037099977],"study_design_scores_gemma":[0.0007084296,0.00068526476,0.0020990516,0.0000010160353,0.000029315093,0.00010810971,0.0007406568,0.00004100534,0.2709031,0.00065871293,0.72391266,0.000112670874],"about_ca_topic_score_codex":0.00008099953,"about_ca_topic_score_gemma":0.00039774532,"teacher_disagreement_score":0.71944183,"about_ca_system_score_codex":0.000056349443,"about_ca_system_score_gemma":0.00036667366,"threshold_uncertainty_score":0.52124393},"labels":[],"label_agreement":null},{"id":"W4310516388","doi":"10.1093/neuonc/noac264","title":"Cerebrospinal fluid methylome-based liquid biopsies for accurate malignant brain neoplasm classification","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Cancer Institute","keywords":"Cerebrospinal fluid; Pathology; Liquid biopsy; Neoplasm; Medicine; Computational biology; Biology; Cancer; Internal medicine","score_opus":0.04875382338574128,"score_gpt":0.33314255775091794,"score_spread":0.28438873436517664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310516388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9263794,0.000267593,0.00029454226,0.06961727,0.0009516533,0.0015320103,0.00014930638,0.00013001046,0.00067821826],"genre_scores_gemma":[0.9865185,0.000028658309,0.0009131752,0.009566143,0.00017074865,0.0024165364,0.0002662348,0.000049669598,0.00007032109],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980676,0.0002812376,0.00042875973,0.00053725636,0.00026414762,0.00042096415],"domain_scores_gemma":[0.9979493,0.0011383467,0.00022403455,0.00039519538,0.00012125022,0.00017184162],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037735712,0.00022577702,0.00047867995,0.00025153873,0.00033968923,0.0000187083,0.00015557368,0.00011530721,0.00031572612],"category_scores_gemma":[0.00036523084,0.00020014569,0.00021148121,0.00032859156,0.00009040105,0.000045518154,0.00008984971,0.00022606306,0.000038408773],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022120716,0.0012946159,0.0012336661,0.00005410354,0.000083913095,0.0002580966,0.00014951616,0.00019744378,0.96613073,0.0013851329,0.018130682,0.008870041],"study_design_scores_gemma":[0.008334721,0.016701914,0.0067137657,0.000014080432,0.00029172783,0.0002613169,0.00036976783,0.0035858795,0.25698876,0.00008278516,0.7064282,0.0002270902],"about_ca_topic_score_codex":0.000022977178,"about_ca_topic_score_gemma":0.000015143794,"teacher_disagreement_score":0.70914197,"about_ca_system_score_codex":0.00048424886,"about_ca_system_score_gemma":0.0005458745,"threshold_uncertainty_score":0.81617045},"labels":[],"label_agreement":null},{"id":"W4310786023","doi":"10.1093/neuonc/noac262","title":"Association of circulating markers with cognitive decline after radiation therapy for brain metastasis","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McMaster University","funders":"National Center for Advancing Translational Sciences; National Cancer Institute; National Institutes of Health","keywords":"Neurocognitive; Medicine; Internal medicine; Cognitive decline; Brain metastasis; Oncology; Radiosurgery; Radiation therapy; Apolipoprotein E; Clinical endpoint; Gastroenterology; Randomized controlled trial; Dementia; Cognition; Metastasis; Cancer; Psychiatry; Disease","score_opus":0.020128949864012893,"score_gpt":0.311917193401129,"score_spread":0.29178824353711613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310786023","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850338,0.00027348104,0.0009600567,0.011635764,0.00015793245,0.0013673531,0.0002470602,0.000024169647,0.0003003505],"genre_scores_gemma":[0.9905433,0.00003767422,0.0017685127,0.0065554953,0.00007516465,0.0007087834,0.00022438075,0.00002679879,0.000059860846],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99861443,0.0004418301,0.00025729727,0.00023627613,0.0002588802,0.00019130335],"domain_scores_gemma":[0.9974608,0.001920143,0.00033203664,0.00010469612,0.00012904636,0.000053282547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007760767,0.00011282846,0.00034792777,0.00009945823,0.00009438867,0.000004595704,0.000034336357,0.000047971782,0.00036770615],"category_scores_gemma":[0.0004248969,0.00009437865,0.00012100137,0.00019031475,0.000026107444,0.000035013836,0.000031001084,0.00014392115,0.0000014090377],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021815015,0.0019480087,0.30787548,0.00008549122,0.0023911286,0.00032365212,0.0013832441,0.00020598681,0.026790055,0.000112416805,0.0036198387,0.6334497],"study_design_scores_gemma":[0.0686824,0.054201167,0.43878144,0.00004366554,0.0031452926,0.00048672833,0.0025686896,0.0020694498,0.015526599,0.00040574392,0.41358042,0.00050839694],"about_ca_topic_score_codex":0.00002489183,"about_ca_topic_score_gemma":0.000021374186,"teacher_disagreement_score":0.6329413,"about_ca_system_score_codex":0.00034078467,"about_ca_system_score_gemma":0.00019920804,"threshold_uncertainty_score":0.40261245},"labels":[],"label_agreement":null},{"id":"W4311662637","doi":"10.1093/neuonc/noac271","title":"BI-907828, a novel potent MDM2 inhibitor, inhibits glioblastoma brain tumor stem cells in vitro and prolongs survival in orthotopic xenograft mouse models","year":2022,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Canadian Institutes of Health Research","keywords":"Mdm2; Cancer research; Temozolomide; Apoptosis; Glioma; In vivo; Stem cell; In vitro; Biology; Medicine; Cell biology","score_opus":0.01770364078331007,"score_gpt":0.24633740342756605,"score_spread":0.22863376264425597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311662637","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929475,0.0003324288,0.00011912791,0.0031148065,0.0007837083,0.0021108994,0.00010238781,0.00012689816,0.00036222697],"genre_scores_gemma":[0.9952103,0.000036026922,0.00027396338,0.0035651939,0.00011407284,0.0005485513,0.000020825837,0.000109858935,0.00012118847],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99626887,0.0005635268,0.0008190115,0.0009769925,0.00056351174,0.0008081062],"domain_scores_gemma":[0.99862075,0.0002824082,0.0002544907,0.00047898412,0.00007548124,0.00028789046],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007158993,0.00039665762,0.00090548117,0.00083705084,0.0001107377,0.000020734837,0.00020750702,0.00024639504,0.000027640477],"category_scores_gemma":[0.000087511406,0.0004371385,0.00013658855,0.0009900855,0.00015952562,0.0001172438,0.0005778186,0.0016303724,0.000009175061],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031124568,0.0011238232,0.0005018471,0.000097153825,0.000026540187,0.00352635,0.0015550522,0.0027221371,0.9815211,0.00006418503,0.00034539463,0.0054039555],"study_design_scores_gemma":[0.023740703,0.008127557,0.00043124135,0.00008935746,0.00009162244,0.0026354457,0.001190316,0.018216152,0.9130679,0.000084565276,0.031621616,0.00070353487],"about_ca_topic_score_codex":0.00028487606,"about_ca_topic_score_gemma":0.00088374724,"teacher_disagreement_score":0.068453215,"about_ca_system_score_codex":0.00097025855,"about_ca_system_score_gemma":0.00079574384,"threshold_uncertainty_score":0.999808},"labels":[],"label_agreement":null},{"id":"W4313446900","doi":"10.1093/neuonc/noac209","title":"Author Index","year":2022,"lang":"en","type":"paratext","venue":"Neuro-Oncology","topic":"","field":"","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Nuclear Safety Commission","keywords":"Index (typography); Mathematics; Computer science; World Wide Web","score_opus":0.04315502769267362,"score_gpt":0.34890001309538643,"score_spread":0.30574498540271283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313446900","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016695398,0.0011045787,0.000026800182,0.0031303738,0.04120112,0.0014129671,0.0025133227,0.000500042,0.94844127],"genre_scores_gemma":[0.016446605,0.00036843814,0.000271211,0.015063828,0.0073399246,0.0027494605,0.004838802,0.0025279638,0.9503938],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99225974,0.0027668935,0.000968547,0.0017251023,0.00093343784,0.0013462525],"domain_scores_gemma":[0.9954669,0.0013591411,0.0011101195,0.001480446,0.0001633325,0.00042005946],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.00078231504,0.0008980103,0.001734204,0.0010654397,0.00040001218,0.000064697066,0.001764743,0.001674955,0.23876111],"category_scores_gemma":[0.00059576996,0.0010121424,0.00042572085,0.0011059535,0.00038407286,0.00010504959,0.0016426038,0.0053020054,0.521022],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003814996,0.00036619487,0.00003460569,0.00005493135,0.00011140505,0.0012117389,0.00024549232,0.00047719272,0.03549209,0.00012522354,0.9554159,0.0060836924],"study_design_scores_gemma":[0.0012859588,0.0015878475,0.00005651842,0.000008675152,0.0001414914,0.00066679134,0.00008242063,0.00012144952,0.00039562225,0.00006425682,0.99483424,0.0007547438],"about_ca_topic_score_codex":0.00013866619,"about_ca_topic_score_gemma":0.00009394438,"teacher_disagreement_score":0.2822609,"about_ca_system_score_codex":0.002611336,"about_ca_system_score_gemma":0.0034272715,"threshold_uncertainty_score":0.9996211},"labels":[],"label_agreement":null},{"id":"W4321372568","doi":"10.1093/neuonc/noad031","title":"Nivolumab with or without ipilimumab in pediatric patients with high-grade CNS malignancies: Safety, efficacy, biomarker, and pharmacokinetics—CheckMate 908","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute; Sidney Kimmel Comprehensive Cancer Center; National Institutes of Health; Hospital for Sick Children; Great Ormond Street Hospital for Children; National Institute for Health and Care Research; Centre de Recherche en Cancérologie de Marseille; Brain Tumour Charity; Murdoch Children's Research Institute; Children’s Hospital of Wisconsin Research Institute; Alder Hey Children's NHS Foundation Trust; Morgan Adams Foundation; Children's Hospital Colorado; Johns Hopkins University; Memorial Sloan-Kettering Cancer Center; Bristol-Myers Squibb","keywords":"Medicine; Nivolumab; Ipilimumab; Internal medicine; Oncology; Clinical endpoint; Adverse effect; Cancer; Clinical trial; Immunotherapy","score_opus":0.021348993129385572,"score_gpt":0.29249290710806514,"score_spread":0.27114391397867954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321372568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954735,0.00016087713,0.0000033554875,0.0020668523,0.00026781976,0.0015077079,0.000047345235,0.00018611061,0.00028640137],"genre_scores_gemma":[0.9973016,0.001197946,0.00035431876,0.0005857955,0.00010347645,0.00020532642,0.00010856954,0.00008821462,0.000054777287],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99761415,0.00016209905,0.000448572,0.0007113049,0.00040190516,0.00066194485],"domain_scores_gemma":[0.9984866,0.0005483081,0.00020131309,0.00035596034,0.000114766306,0.00029306771],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015791484,0.00039229266,0.0007809394,0.00052339374,0.00010886079,0.000023280412,0.00012863327,0.00016331194,0.00006930465],"category_scores_gemma":[0.00008570742,0.00025431527,0.000050560902,0.0012362598,0.00017783842,0.00007849053,0.0001323546,0.00026575997,0.00006268968],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070671574,0.0030034739,0.96443796,0.00018497303,0.00016769637,0.0029804658,0.00049365044,0.000049213802,0.0065442366,0.000016794726,0.0036435868,0.011410798],"study_design_scores_gemma":[0.06011224,0.008599192,0.91783404,0.00009588652,0.0006974478,0.00016102771,0.000104099556,0.00030500555,0.002754491,0.0000073366114,0.008985202,0.000344048],"about_ca_topic_score_codex":0.00008885736,"about_ca_topic_score_gemma":0.00029081365,"teacher_disagreement_score":0.053045087,"about_ca_system_score_codex":0.00022044007,"about_ca_system_score_gemma":0.0002983863,"threshold_uncertainty_score":0.9999909},"labels":[],"label_agreement":null},{"id":"W4321611743","doi":"10.1093/neuonc/noad047","title":"The development of a rapid patient-derived xenograft model to predict chemotherapeutic drug sensitivity/resistance in malignant glial tumors","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"Fonds de Recherche du Québec - Santé; Natural Sciences and Engineering Research Council of Canada","keywords":"Temozolomide; Carboplatin; Medicine; Glioma; Drug; Oncology; Drug resistance; Cancer research; Internal medicine; Pharmacology; Cisplatin; Chemotherapy; Biology","score_opus":0.025114773436739412,"score_gpt":0.27943862448361007,"score_spread":0.25432385104687066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321611743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99232936,0.00010232427,0.00003943152,0.0058919494,0.00018223241,0.0009762043,0.000012186869,0.00006696638,0.00039931765],"genre_scores_gemma":[0.99752563,0.00006666694,0.0009911559,0.001037119,0.000029573785,0.00028101256,0.000012251122,0.000031829644,0.000024745701],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981929,0.00017532874,0.00052056357,0.00036255884,0.00029417817,0.00045444374],"domain_scores_gemma":[0.99879324,0.0005367538,0.00013958171,0.0003022837,0.000081838196,0.00014631425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036518715,0.00019618632,0.00045766847,0.00020064073,0.00011132,0.000008753608,0.00008911751,0.00007320476,0.00000786132],"category_scores_gemma":[0.00012451722,0.00013991498,0.00008709897,0.00048776125,0.00008932289,0.00002508526,0.000107165935,0.00014562972,0.000031347052],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010277088,0.00088145275,0.0052421927,0.000053900258,0.000109795175,0.00071343756,0.0102414545,0.0006379782,0.9252971,0.000079167345,0.0019673896,0.053748433],"study_design_scores_gemma":[0.0070940834,0.0014337044,0.047363017,0.00026310296,0.00012065141,0.000055527817,0.0015106151,0.0077860253,0.9003593,0.00016332511,0.03351949,0.0003311888],"about_ca_topic_score_codex":0.000012563313,"about_ca_topic_score_gemma":0.0008375596,"teacher_disagreement_score":0.053417243,"about_ca_system_score_codex":0.00023753716,"about_ca_system_score_gemma":0.00046163928,"threshold_uncertainty_score":0.57055676},"labels":[],"label_agreement":null},{"id":"W4323037649","doi":"10.1093/neuonc/noad053","title":"Atypical neurofibromas reveal distinct epigenetic features with proximity to benign peripheral nerve sheath tumor entities","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Friedberg Charitable Foundation; Deutsche Krebshilfe","keywords":"Malignant peripheral nerve sheath tumor; Epigenetics; CDKN2A; Pathology; Neurofibromatosis; Malignant transformation; Neurofibroma; Biology; DNA methylation; Cancer research; Medicine; Internal medicine; Cancer; Gene; Gene expression","score_opus":0.02322527932694977,"score_gpt":0.2864650449770008,"score_spread":0.263239765650051,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323037649","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868251,0.00008244069,0.000036072615,0.0076394184,0.00066709163,0.0011520019,0.000051597835,0.00048010517,0.0030661563],"genre_scores_gemma":[0.99382067,0.000011416323,0.0008501734,0.003077127,0.0005461658,0.00021508946,0.00005856803,0.00010833569,0.0013124727],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9967905,0.0003913968,0.0005049511,0.00093706115,0.00052277546,0.00085329206],"domain_scores_gemma":[0.99800646,0.00047869986,0.00013123044,0.00065029424,0.00013449075,0.0005988237],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019883392,0.00043305758,0.00087027095,0.00025088477,0.00026257877,0.00007473877,0.00026302502,0.00016396953,0.00017857362],"category_scores_gemma":[0.0004386879,0.00033682896,0.00020520274,0.0007078708,0.0002667177,0.00011571756,0.00025284602,0.00059078843,0.00017747303],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009927474,0.0009555399,0.13281497,0.0005075967,0.00013564886,0.04106841,0.0011700721,0.000106174986,0.69904464,0.0017191252,0.1062472,0.00630315],"study_design_scores_gemma":[0.003393885,0.018943863,0.8468235,0.00014275032,0.00027018084,0.01057442,0.00033667914,0.00017634763,0.035555135,0.00021803116,0.082918786,0.0006464091],"about_ca_topic_score_codex":0.000049805843,"about_ca_topic_score_gemma":0.00007656596,"teacher_disagreement_score":0.71400857,"about_ca_system_score_codex":0.00013605255,"about_ca_system_score_gemma":0.00041076235,"threshold_uncertainty_score":0.9999084},"labels":[],"label_agreement":null},{"id":"W4365442816","doi":"10.1093/neuonc/noad019","title":"Variation in postoperative outcomes of patients with intracranial tumors: insights from a prospective international cohort study during the COVID-19 pandemic","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; Royal University Hospital; Saskatoon City Hospital","funders":"Economic and Social Research Council; Vascular Society; Engineering and Physical Sciences Research Council; Association of Upper Gastrointestinal Surgery of Great Britain and Ireland; British Gynaecological Cancer Society; Prince Sultan Military Medical City; Urology Foundation; Medizinische Universität Innsbruck; University of Cape Town; King Saud University; Università di Bologna; Sapienza Università di Roma; Universität Innsbruck; King Faisal Specialist Hospital and Research Centre; NIH Clinical Center; Bowel Disease Research Foundation; Wellcome Trust; University College London; Cancer Research UK; George Washington University; University of the Philippines; National Institute for Health and Care Research; European Society of Coloproctology; Humanitas Research Hospital; Government of the United Kingdom; Yorkshire Cancer Research; Tishreen University; Queen Elizabeth Hospital Birmingham Charity; Bowel and Cancer Research; Humanitas University; Sarcoma UK; Massachusetts General Hospital","keywords":"Medicine; Pandemic; Incidence (geometry); Logistic regression; Odds ratio; Confounding; Prospective cohort study; Cohort; Cohort study; Pediatrics; Internal medicine; Coronavirus disease 2019 (COVID-19)","score_opus":0.033303256343916746,"score_gpt":0.3649152209356489,"score_spread":0.33161196459173214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365442816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912676,0.000004839925,0.00002004695,0.0056651705,0.00033151754,0.0025048438,0.000047620288,0.00007054255,0.00008778004],"genre_scores_gemma":[0.99588215,0.000011086976,0.000020132675,0.0037418113,0.000101565514,0.0001679426,0.00004519678,0.000017710596,0.000012419469],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982808,0.0003279581,0.00042181413,0.0003619793,0.00041117825,0.00019627517],"domain_scores_gemma":[0.9980863,0.0011510927,0.00020532009,0.00021046729,0.00021879787,0.00012802031],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025030278,0.00014951701,0.00046088497,0.0002721344,0.00009283814,0.000010182745,0.0001325879,0.000092296454,0.000051803992],"category_scores_gemma":[0.0019360946,0.000094283394,0.00003502154,0.00041118922,0.00007947263,0.00010164009,0.000089354384,0.00039886285,0.000011690606],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022906642,0.0006840107,0.97438866,0.000014562125,0.000123498,0.00026549722,0.019014036,0.00006929259,0.002783253,0.00003155993,0.00001970512,0.00031528194],"study_design_scores_gemma":[0.008119145,0.002134613,0.9883176,0.000014596253,0.000051454397,0.0000125659035,0.00077050994,0.000111882386,0.000030416708,0.0001263424,0.00023218861,0.000078661375],"about_ca_topic_score_codex":0.0023053666,"about_ca_topic_score_gemma":0.005679125,"teacher_disagreement_score":0.018243527,"about_ca_system_score_codex":0.001149667,"about_ca_system_score_gemma":0.0009752039,"threshold_uncertainty_score":0.3844765},"labels":[],"label_agreement":null},{"id":"W4366365187","doi":"10.1093/neuonc/noad078","title":"LOGGIC Core BioClinical Data Bank: Added clinical value of RNA-Seq in an international molecular diagnostic registry for pediatric low-grade glioma patients","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster Children's Hospital","funders":"Norgine; Deutschen Konsortium für Translationale Krebsforschung; Universität Heidelberg; Servier; Medizinische Universität Wien; National and Kapodistrian University of Athens; PharmaMar; Alexion Pharmaceuticals; University of New South Wales; Jazz Pharmaceuticals; Deutsche Kinderkrebsstiftung; McMaster University; Deutsches Krebsforschungszentrum; Univerzita Karlova v Praze; Universitätsklinikum Heidelberg; Freie Universität Berlin; Brain Tumour Charity; Sanofi; Universität Wien; Semmelweis Egyetem; Pfizer; Rigshospitalet; Amgen; Humboldt-Universität zu Berlin; Eli Lilly and Company; Pediatric Brain Tumor Foundation","keywords":"RNA; Medicine; Fusion gene; DNA methylation; RNA-Seq; Gene; Oncology; Bioinformatics; Internal medicine; Cancer research; Biology; Genetics; Transcriptome; Gene expression","score_opus":0.10939937354189294,"score_gpt":0.4281708339732458,"score_spread":0.31877146043135285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366365187","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936886,0.000065048655,0.000014239162,0.0025514804,0.0018549393,0.0010984055,0.0005852107,0.00006411292,0.00007799914],"genre_scores_gemma":[0.99450177,0.00046923087,0.0005794699,0.00088225864,0.0005388112,0.0001775919,0.0028004823,0.000046603836,0.0000037682103],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969048,0.0002765531,0.0011801883,0.00086365064,0.000378015,0.0003968165],"domain_scores_gemma":[0.9929224,0.0051618544,0.00042156142,0.0010342086,0.00019008941,0.00026984225],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0006466522,0.00022882906,0.00075340975,0.00039963293,0.000033632983,0.0000115594885,0.00062777486,0.000384979,0.00004804889],"category_scores_gemma":[0.010812346,0.00018908859,0.00020424227,0.00054453284,0.00017009597,0.00010102165,0.00040260397,0.00035464586,0.000038158505],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061465177,0.008619723,0.96183705,0.000084244406,0.00010632312,0.0021790573,0.000039129085,0.000043160344,0.0038370409,0.00019801191,0.010469544,0.011972072],"study_design_scores_gemma":[0.023860889,0.009979989,0.94888055,0.00008090838,0.0006461224,0.00005933146,0.00004777523,0.005094383,0.002979133,0.00042550193,0.0076603834,0.0002850428],"about_ca_topic_score_codex":0.000027289841,"about_ca_topic_score_gemma":0.00003303399,"teacher_disagreement_score":0.023246238,"about_ca_system_score_codex":0.000104812054,"about_ca_system_score_gemma":0.00036339156,"threshold_uncertainty_score":0.99752},"labels":[],"label_agreement":null},{"id":"W4367060277","doi":"10.1093/neuonc/noad059","title":"Epidemiology, biology, and management of venous thromboembolism in gliomas: An interdisciplinary review","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; McGill University","funders":"National Institute of Neurological Disorders and Stroke; National Heart, Lung, and Blood Institute; Northwestern University","keywords":"Medicine; Glioma; Internal medicine; Low molecular weight heparin; Oncology; Risk factor; Intensive care medicine; Thrombosis; Cancer research","score_opus":0.06284997916318107,"score_gpt":0.4287012859428215,"score_spread":0.3658513067796404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367060277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9374317,0.017793283,0.00003166152,0.02743321,0.0009699649,0.002745924,0.000021784104,0.0002345959,0.013337855],"genre_scores_gemma":[0.809831,0.17833318,0.0011632319,0.00985941,0.00015978218,0.000426,0.00013292073,0.000058025944,0.00003641646],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9973956,0.0005136964,0.0008226219,0.0006293986,0.00010028069,0.0005384434],"domain_scores_gemma":[0.99854374,0.0004369891,0.0002452738,0.0005523482,0.000046522862,0.00017512968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015697285,0.00023786217,0.001775984,0.0004197747,0.00006851279,0.000001987457,0.00022145605,0.0002002617,0.00007593036],"category_scores_gemma":[0.00014818583,0.00020729771,0.00011374659,0.0006441638,0.00033177843,0.00007034743,0.00085774285,0.00028610573,0.00006462102],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052056724,0.008856597,0.05010896,0.02214475,0.001239093,0.0058554634,0.0033422566,0.00005619013,0.024690663,0.07316423,0.08885882,0.72116244],"study_design_scores_gemma":[0.0037949905,0.010414283,0.84845114,0.0036445467,0.0010370965,0.00039771426,0.0015781217,0.0003528177,0.00033677704,0.012742724,0.1167654,0.00048439892],"about_ca_topic_score_codex":0.00006736963,"about_ca_topic_score_gemma":0.000060817005,"teacher_disagreement_score":0.79834217,"about_ca_system_score_codex":0.000101979924,"about_ca_system_score_gemma":0.000054659635,"threshold_uncertainty_score":0.84533554},"labels":[],"label_agreement":null},{"id":"W4367184303","doi":"10.1093/neuonc/noad082","title":"Mitogen-induced defective mitosis transforms neural progenitor cells","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia; University of Calgary","funders":"Alberta Children's Hospital Foundation; Alberta Cancer Foundation; Canadian Institutes of Health Research; Alberta Innovates; Cancer Research Society","keywords":"Mitosis; Biology; Progenitor cell; Cell biology; Neural stem cell; Population; Cell division; Cancer research; Genetics; Stem cell; Cell","score_opus":0.01619326943506174,"score_gpt":0.27376029121176787,"score_spread":0.25756702177670615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367184303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99502605,0.0001014961,0.00014017297,0.0005077673,0.0023237844,0.00064112106,0.000056426845,0.00010958276,0.0010935983],"genre_scores_gemma":[0.9968017,0.00038383555,0.0001355163,0.0012249214,0.0007629787,0.00019671502,0.0001616718,0.000077384364,0.00025528253],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99803185,0.00018585414,0.000328458,0.00067531446,0.00014897672,0.00062951946],"domain_scores_gemma":[0.9991213,0.00007131357,0.000103857834,0.00041675716,0.000102370504,0.00018436776],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015746472,0.00029807977,0.00031853674,0.00012418091,0.00015014842,0.000024498648,0.00034362485,0.00048407473,0.000022869948],"category_scores_gemma":[0.00007172123,0.00028287855,0.00028393036,0.0003180172,0.00009067511,0.0000072143553,0.0001472353,0.00028170514,0.00020536577],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017028447,0.00010045682,0.00046830683,0.000018301489,0.000074300966,0.000045930858,0.00018361157,0.000033130527,0.97572416,0.000014036434,0.0069745923,0.016192863],"study_design_scores_gemma":[0.00094861427,0.0012661028,0.00026029066,0.000002795715,0.000051159554,0.0000723425,0.00014782819,0.00022226326,0.85095483,0.000021180133,0.14578842,0.00026416016],"about_ca_topic_score_codex":0.000023256289,"about_ca_topic_score_gemma":0.00011133997,"teacher_disagreement_score":0.13881382,"about_ca_system_score_codex":0.000054635653,"about_ca_system_score_gemma":0.0002111432,"threshold_uncertainty_score":0.99996233},"labels":[],"label_agreement":null},{"id":"W4380302352","doi":"10.1093/neuonc/noad073.245","title":"MDB-12. TRANS-SPECIES ANALYSIS OF REPLICATION-REPAIR DEFICIENT (RRD) MEDULLOBLASTOMA AND RESPONSE TO IMMUNE-CHECKPOINT INHIBITION: AN IRRDC REPORT","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Cancer research; Biology; Sonic hedgehog; Transcriptome; Microsatellite instability; Immune checkpoint; Chromosome instability; Immune system; Immunotherapy; Genetics; Gene; Gene expression; Chromosome","score_opus":0.03871376592034477,"score_gpt":0.3327544107041853,"score_spread":0.29404064478384057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380302352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897713,0.00009296867,0.0001115667,0.0070123808,0.00034894288,0.00071701617,0.00004150451,0.000269265,0.0016350326],"genre_scores_gemma":[0.9971804,0.00007715695,0.001147868,0.00072042627,0.0000673798,0.00020008968,0.000087254346,0.0000369521,0.0004824739],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9969316,0.00036686347,0.00096375134,0.0009048333,0.0004752113,0.0003577228],"domain_scores_gemma":[0.9970931,0.0007173264,0.00027790281,0.0013050882,0.00031568194,0.00029090114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015735523,0.0002225221,0.0007928376,0.0009374277,0.00009801892,0.000010880422,0.00012412743,0.00021553358,0.00029358972],"category_scores_gemma":[0.0018759392,0.00021495082,0.00029173665,0.0019877309,0.00026591623,0.000045933124,0.00012308011,0.00024453108,0.000020601266],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003406568,0.00022505806,0.010568818,0.000039701554,0.00024370309,0.0006523514,0.002781488,0.00035127136,0.97867787,0.000033701974,0.0011840366,0.0018354078],"study_design_scores_gemma":[0.001337462,0.0065965056,0.67444754,0.000032712396,0.0011025848,0.0008744559,0.0011271117,0.00087852555,0.22054465,0.000050620747,0.0927552,0.0002526438],"about_ca_topic_score_codex":0.000058762947,"about_ca_topic_score_gemma":0.00031110385,"teacher_disagreement_score":0.75813323,"about_ca_system_score_codex":0.0003563432,"about_ca_system_score_gemma":0.00048288488,"threshold_uncertainty_score":0.876544},"labels":[],"label_agreement":null},{"id":"W4380302375","doi":"10.1093/neuonc/noad073.313","title":"TRLS-10. ROVER: A PHASE 1/2 STUDY OF AVAPRITINIB IN PEDIATRIC PATIENTS WITH SOLID TUMORS DEPENDENT ON KIT OR PDGFRA SIGNALING","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"PDGFRA; Cancer research; Glioma; Medicine; Stromal cell; GiST","score_opus":0.036139378281458495,"score_gpt":0.34302528398990506,"score_spread":0.30688590570844654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380302375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997414,0.000031548134,4.6360398e-7,0.00028543803,0.000174486,0.0015154739,0.00002336279,0.000065357286,0.0004898631],"genre_scores_gemma":[0.998882,0.000047082533,0.000027736993,0.0004945344,0.0001226864,0.00029909157,0.000039174527,0.00004335683,0.000044363118],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979047,0.00019729581,0.0005560424,0.0004899232,0.0004628741,0.0003891744],"domain_scores_gemma":[0.99827534,0.0009256999,0.00023109443,0.00031285876,0.000102290105,0.00015268808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019243,0.00023231153,0.0007111468,0.0004750515,0.000049965758,0.0000075474745,0.000112616195,0.000092548384,0.00024304134],"category_scores_gemma":[0.00028484536,0.00016452334,0.00006627576,0.0006675223,0.000030583218,0.000039312697,0.00007251422,0.00025956653,0.000111635665],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006355034,0.0360727,0.9298121,0.00006977771,0.00009536969,0.007107096,0.001297895,0.00028095138,0.0008986417,0.0000049528544,0.0010913128,0.016914189],"study_design_scores_gemma":[0.09942147,0.1146734,0.77542865,0.00011375174,0.00075746427,0.0000557648,0.0019773822,0.0001738828,0.0054413415,0.000011496154,0.0015877192,0.00035765712],"about_ca_topic_score_codex":0.000060741295,"about_ca_topic_score_gemma":0.00014305669,"teacher_disagreement_score":0.1543834,"about_ca_system_score_codex":0.00019135959,"about_ca_system_score_gemma":0.00024531633,"threshold_uncertainty_score":0.6709067},"labels":[],"label_agreement":null},{"id":"W4380302463","doi":"10.1093/neuonc/noad073.212","title":"LGG-02. DRUG-CLASS SPECIFIC GENE-BASED MAPK SENSITIVITY SCORES (MSS) PREDICT SENSITIVITY TO MAPK INHIBITORS AND IDENTIFY IMMUNE INFILTRATION AS PUTATIVE TARGET IN PEDIATRIC LOW-GRADE GLIOMAS","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"MAPK/ERK pathway; Biology; Immune system; Cancer research; Gene; Gene expression; Gene expression profiling; Gene signature; Medicine; Bioinformatics; Immunology; Genetics; Signal transduction","score_opus":0.01617576121760463,"score_gpt":0.2890989774877802,"score_spread":0.2729232162701756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380302463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98979837,0.0002642583,0.000042662843,0.0065721367,0.0010440189,0.0017417606,0.0001313511,0.00023431184,0.0001711471],"genre_scores_gemma":[0.9974716,0.00025176987,0.0002975023,0.0008119652,0.00056160707,0.00019164357,0.00032879156,0.00007049893,0.000014677928],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9960443,0.0010006671,0.00070226664,0.0009876532,0.00055075967,0.0007143972],"domain_scores_gemma":[0.9967982,0.0019249598,0.0002656285,0.0004300465,0.00018350841,0.0003976441],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000999137,0.00046165308,0.0008992548,0.0013009945,0.00017162607,0.000066800574,0.00006824477,0.0002945211,0.000023211462],"category_scores_gemma":[0.0006270102,0.0004498691,0.00017737946,0.0018181689,0.00017415472,0.00018955002,0.0001695765,0.00049630663,0.0002481593],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005530724,0.0011405421,0.20611475,0.00012300168,0.00006267938,0.016666861,0.0011673467,0.001099838,0.76711076,0.000042339438,0.0034844151,0.002434367],"study_design_scores_gemma":[0.004079772,0.0010405027,0.52047366,0.000053158692,0.00013135053,0.00030061815,0.00023644487,0.0016096783,0.4706114,0.00008808822,0.0011019409,0.0002734033],"about_ca_topic_score_codex":0.00043201196,"about_ca_topic_score_gemma":0.0005974106,"teacher_disagreement_score":0.3143589,"about_ca_system_score_codex":0.00053508655,"about_ca_system_score_gemma":0.0004060771,"threshold_uncertainty_score":0.9997953},"labels":[],"label_agreement":null},{"id":"W4380302510","doi":"10.1093/neuonc/noad073.254","title":"MDB-21. THE OTX2-REGULATED ALTERNATIVE SPLICING LANDSCAPE CONTROLS DIFFERENTIATION AND RECONSTITUTES THE DEVELOPMENTAL ORIGINS OF GROUP 3 MEDULLOBLASTOMA","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; McGill University; University of Manitoba; Hospital for Sick Children","funders":"","keywords":"Exon; RNA splicing; Exon skipping; Medulloblastoma; Biology; Alternative splicing; Morpholino; Transcriptome; Gene knockdown; Genetics; RNA; Cancer research; Gene; Molecular biology; Gene expression","score_opus":0.014854754473857519,"score_gpt":0.27505033023836506,"score_spread":0.2601955757645075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380302510","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99731296,0.00011650346,0.00015353892,0.0013381267,0.000199652,0.00033295323,0.000016042304,0.000016266304,0.0005139435],"genre_scores_gemma":[0.9988559,0.00036736313,0.000053917738,0.00034092786,0.00014055586,0.00004606354,0.000055494296,0.000012756735,0.0001270116],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989031,0.0002170926,0.0002195404,0.00025343915,0.0001403127,0.00026652034],"domain_scores_gemma":[0.9992981,0.0002980334,0.000119620374,0.00016497576,0.00006159444,0.00005766625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034089424,0.000121526675,0.00017779955,0.000059140457,0.00018841635,0.000022941465,0.00022462914,0.00009684295,0.000014542701],"category_scores_gemma":[0.000248258,0.00007271366,0.000048373127,0.00015561336,0.00022580364,0.0000064513792,0.00018944633,0.00015286982,0.000010606429],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001629015,0.000023835588,0.0060250056,0.0000073903416,0.00008535276,0.0000094654215,0.00015289146,0.000036606565,0.9823544,0.0009048249,0.00079504785,0.009442282],"study_design_scores_gemma":[0.0037817357,0.0016808826,0.056068167,0.000034452973,0.00007065044,0.00024432584,0.0013367579,0.008872347,0.8187826,0.00031921486,0.10849942,0.0003093956],"about_ca_topic_score_codex":0.000088711444,"about_ca_topic_score_gemma":0.0003274507,"teacher_disagreement_score":0.16357175,"about_ca_system_score_codex":0.000036677928,"about_ca_system_score_gemma":0.00011086212,"threshold_uncertainty_score":0.2965177},"labels":[],"label_agreement":null},{"id":"W4380354323","doi":"10.1093/neuonc/noad073.117","title":"EPEN-13. PATTERN OF RELAPSE IN POSTERIOR FOSSA EPENDYMOMA GROUP A","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Ependymoma; Neurosurgery; Radiation therapy; Surgery","score_opus":0.02625450403093505,"score_gpt":0.3063737258674627,"score_spread":0.28011922183652765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380354323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916501,0.000109369445,0.000001913432,0.005590992,0.00047961614,0.0005266241,0.000019178444,0.00007107942,0.0015511445],"genre_scores_gemma":[0.998113,0.00008022273,0.000041233598,0.0014296748,0.000076156946,0.00015330172,0.000041794323,0.000031675998,0.00003297575],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99857014,0.00013576829,0.0004130411,0.00034833568,0.00018733925,0.00034537812],"domain_scores_gemma":[0.99900293,0.00036282674,0.00012653306,0.00033980815,0.000042392025,0.00012549465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018552551,0.00016075812,0.0005346109,0.00033084734,0.000026102503,0.0000053280633,0.00010324467,0.00016792947,0.00019301723],"category_scores_gemma":[0.00014402153,0.0001378782,0.00011752503,0.00043315912,0.000065645225,0.000041774965,0.00012927697,0.00020447328,0.00029530312],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045523088,0.0020079513,0.3444954,0.00012667199,0.00008968771,0.026363406,0.0013324289,0.0000062590566,0.40516332,0.000072015886,0.004918241,0.2149694],"study_design_scores_gemma":[0.01322304,0.006668748,0.9175941,0.0001406495,0.00017231694,0.0015915658,0.0003933771,0.00021139377,0.032710142,0.0001395125,0.026943779,0.00021139949],"about_ca_topic_score_codex":0.0003745821,"about_ca_topic_score_gemma":0.0007212289,"teacher_disagreement_score":0.57309866,"about_ca_system_score_codex":0.00012288739,"about_ca_system_score_gemma":0.00008483629,"threshold_uncertainty_score":0.562251},"labels":[],"label_agreement":null},{"id":"W4380354470","doi":"10.1093/neuonc/noad073.141","title":"OUTC-04. SUBSEQUENT CNS MALIGNANCY AMONG SURVIVORS OF CHILDHOOD CANCER: A REPORT FROM THE CHILDHOOD CANCER SURVIVOR STUDY (CCSS)","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Incidence (geometry); Cumulative incidence; Confidence interval; Cancer; Internal medicine; Radiation therapy; Childhood cancer; Malignancy; Oncology; Pediatrics; Cohort","score_opus":0.028509285726435223,"score_gpt":0.31735768605780246,"score_spread":0.2888484003313672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380354470","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845942,0.0014187086,8.834457e-7,0.007774116,0.0022720136,0.0026940033,0.00033731046,0.0002020601,0.0007066563],"genre_scores_gemma":[0.99512094,0.0014445613,0.000012879728,0.00091313495,0.00054378575,0.001654562,0.00013649728,0.000097247685,0.00007640729],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99618655,0.0004913679,0.0010085566,0.00095452275,0.00066985824,0.00068911957],"domain_scores_gemma":[0.99674684,0.0009827695,0.000629763,0.0011490006,0.00022116123,0.0002704544],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00056219817,0.00045011478,0.0012013383,0.00020283052,0.00020341574,0.000023391127,0.00036524568,0.00022528801,0.00043712044],"category_scores_gemma":[0.0003911947,0.00030803698,0.0003344941,0.00092973164,0.00019817341,0.000073280054,0.0002543132,0.00046660786,0.000060128215],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008855597,0.003973663,0.9679514,0.000017841548,0.0008962665,0.004648047,0.0044200085,0.00008643013,0.005229212,0.000016473346,0.004724424,0.007947678],"study_design_scores_gemma":[0.0047315997,0.001344512,0.97742933,0.00011472913,0.0009661412,0.0000999379,0.0015439976,0.000022250832,0.0055737398,0.000043735676,0.00789584,0.00023419489],"about_ca_topic_score_codex":0.057556264,"about_ca_topic_score_gemma":0.07884839,"teacher_disagreement_score":0.02129213,"about_ca_system_score_codex":0.00033549103,"about_ca_system_score_gemma":0.00081249245,"threshold_uncertainty_score":0.9999372},"labels":[],"label_agreement":null},{"id":"W4380354507","doi":"10.1093/neuonc/noad073.037","title":"BIOL-18. NEWLY DEVELOPED REPLICATION REPAIR DEFICIENT (RRD) MOUSE MODELS PROVIDE INSIGHTS INTO MEDULLOBLASTOMA/GLIOMAGENESIS AND RESPONSE TO IMMUNOTHERAPY","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"OLIG2; Medulloblastoma; Cancer research; Nestin; Glioma; Biology; Germline; MLH1; Germline mutation; DNA mismatch repair; Mutation; Genetics; Stem cell; Gene; DNA repair; Neural stem cell; Neuroscience; Oligodendrocyte; Myelin; Central nervous system","score_opus":0.044175812476814014,"score_gpt":0.3301377840276562,"score_spread":0.2859619715508422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380354507","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98931015,0.0004171439,0.0006114736,0.0062234295,0.00049719855,0.0017302522,0.000006549139,0.00068309,0.00052071654],"genre_scores_gemma":[0.9821726,0.0004961913,0.010655195,0.005117188,0.00010078925,0.0007352946,0.00001970157,0.000107802894,0.0005952278],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969463,0.0004907204,0.0006015376,0.0010873966,0.00039075487,0.00048329233],"domain_scores_gemma":[0.9973687,0.0007460727,0.00016524787,0.0011106079,0.000284863,0.00032453178],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000764744,0.00031396523,0.00052768405,0.0006943254,0.00018327351,0.000023598095,0.00023165162,0.00030274765,0.000044773304],"category_scores_gemma":[0.0014058894,0.00028472813,0.00010580418,0.001347918,0.0001644032,0.00008332542,0.00026429066,0.00024710133,0.00013250629],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0073415823,0.00012211362,0.00054921507,0.00004218937,0.00004902031,0.00012786614,0.0043072174,0.0004767201,0.9468334,0.000033060012,0.0078229755,0.03229469],"study_design_scores_gemma":[0.0039677033,0.007906231,0.018831367,0.000052398074,0.000091005655,0.00029071452,0.00062522735,0.0070539624,0.57827795,0.00051464204,0.38183466,0.00055416295],"about_ca_topic_score_codex":0.00011861954,"about_ca_topic_score_gemma":0.00018149112,"teacher_disagreement_score":0.3740117,"about_ca_system_score_codex":0.0007801633,"about_ca_system_score_gemma":0.0011326273,"threshold_uncertainty_score":0.9999605},"labels":[],"label_agreement":null},{"id":"W4380355153","doi":"10.1093/neuonc/noad073.082","title":"DIPG-35. IDENTIFYING DRIVER-SPECIFIC VULNERABILITIES IN PAEDIATRIC HIGH GRADE GLIOMA SUBTYPES","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; Jewish General Hospital","funders":"","keywords":"Biology; Glioma; Cancer research; Transcriptome; Phenotype; Genetics; Gene; Gene expression","score_opus":0.03810334214116783,"score_gpt":0.3066112993186172,"score_spread":0.26850795717744935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380355153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901054,0.0012868313,0.0000025824554,0.0056382837,0.001522781,0.0005440466,0.000015832813,0.0002603839,0.0006238753],"genre_scores_gemma":[0.9972941,0.0013477202,0.000105317966,0.00039068333,0.00045703116,0.00023690553,0.00006541486,0.00004956722,0.000053230793],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977923,0.00025890255,0.00046808252,0.00058163615,0.00031653154,0.00058255455],"domain_scores_gemma":[0.9980425,0.0012002578,0.00011482934,0.00040600938,0.000057923262,0.0001784273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028532848,0.0002507648,0.0005961628,0.00086142676,0.00011755027,0.000031189382,0.00014922737,0.00021288136,0.00023541019],"category_scores_gemma":[0.00021584662,0.00022217988,0.00015926767,0.001342967,0.00012702002,0.00009942334,0.00014576271,0.00036736266,0.0005843205],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003395577,0.0024812722,0.55782545,0.00019264352,0.00014611486,0.022285512,0.0023453685,0.00018398436,0.33388945,0.005466412,0.0402102,0.034634035],"study_design_scores_gemma":[0.011524224,0.0026265525,0.76633614,0.00008453114,0.00023848325,0.00050325436,0.001329112,0.00017452525,0.082507916,0.0030335567,0.13114698,0.0004947052],"about_ca_topic_score_codex":0.00014088117,"about_ca_topic_score_gemma":0.00017135854,"teacher_disagreement_score":0.25138155,"about_ca_system_score_codex":0.0003663799,"about_ca_system_score_gemma":0.00012434956,"threshold_uncertainty_score":0.90602326},"labels":[],"label_agreement":null},{"id":"W4380355317","doi":"10.1093/neuonc/noad073.027","title":"BIOL-08. RADIATION DRIVES METASTASIS IN MEDULLOBLASTOMA THROUGH AN INFLAMMATORY PROCESS","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Medicine; Inflammation; Metastasis; Cancer research; Chemokine; Radiation therapy; Intravital microscopy; Brain metastasis; Pathology; Immunology; Internal medicine; Cancer","score_opus":0.0324658596702496,"score_gpt":0.3463694103499357,"score_spread":0.31390355067968606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380355317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99072737,0.00018781064,0.000012372752,0.0055787363,0.00048692364,0.00054527697,0.000010389831,0.00025348976,0.002197608],"genre_scores_gemma":[0.9957295,0.0009943248,0.0002027217,0.0023256973,0.00028685332,0.00034171063,0.000052551328,0.00004386241,0.00002276999],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99824154,0.00022769436,0.00040194285,0.00046626342,0.00025477778,0.0004077707],"domain_scores_gemma":[0.99919784,0.00015850598,0.0001398099,0.00028111224,0.00008297198,0.0001397556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029800256,0.00018831453,0.00045832168,0.00028354983,0.00006917784,0.000014884085,0.00014936956,0.00019986581,0.00018060174],"category_scores_gemma":[0.00020750027,0.0001689041,0.0000830344,0.0008410342,0.00011830017,0.00030760936,0.000052114596,0.00030351325,0.0001681012],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001217606,0.0012034851,0.21825862,0.0004934522,0.00018898949,0.0009080196,0.013258599,0.00042701836,0.35845757,0.0011367017,0.009754462,0.3946955],"study_design_scores_gemma":[0.007681052,0.0067671454,0.21883619,0.00012804307,0.00031141166,0.00019256092,0.004658858,0.0023633675,0.18831655,0.000734412,0.5693903,0.00062009756],"about_ca_topic_score_codex":0.000032712443,"about_ca_topic_score_gemma":0.00014566879,"teacher_disagreement_score":0.5596359,"about_ca_system_score_codex":0.00018136266,"about_ca_system_score_gemma":0.00039407043,"threshold_uncertainty_score":0.6887709},"labels":[],"label_agreement":null},{"id":"W4380355976","doi":"10.1093/neuonc/noad073.175","title":"HGG-26. GENOMIC AND IMMUNE ANALYSIS OF PRIMARY REPLICATION-REPAIR DEFICIENT (RRD) GLIOMAS REVEALS THREE SUBGROUPS WITH DISTINCT DRIVERS AND RESPONSE TO IMMUNOTHERAPY: AN IRRDC REPORT","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Biology; Microsatellite instability; Glioma; Genome instability; ATRX; Cancer research; Genetics; Somatic hypermutation; Mutation; Transcriptome; Chromothripsis; DNA mismatch repair; Gene; Allele; Microsatellite; DNA repair; Gene expression; Antibody","score_opus":0.023053933566318657,"score_gpt":0.30159566507537555,"score_spread":0.2785417315090569,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380355976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99636805,0.0003726387,0.00008227172,0.0015408573,0.00014604458,0.00096547283,0.00002643655,0.00020560586,0.00029261195],"genre_scores_gemma":[0.99712545,0.00010700993,0.0019410467,0.0004755589,0.00003213761,0.00012720749,0.00005493694,0.000059289247,0.000077382945],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9974755,0.00028233777,0.0006588515,0.00091462105,0.00032996913,0.00033873896],"domain_scores_gemma":[0.997108,0.00076309755,0.00035771905,0.0013531642,0.0002032329,0.00021478199],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013626252,0.00023843731,0.0008744301,0.00072615244,0.00011164362,0.000012568744,0.00015797648,0.00015471819,0.000043779626],"category_scores_gemma":[0.0005413016,0.00020597204,0.00012415172,0.0016419418,0.00033215588,0.00004259077,0.00018038116,0.00019709386,0.0000060368843],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005785409,0.00009608807,0.26281136,0.000033844586,0.00037518554,0.00042484165,0.00084019103,0.00008266297,0.7251195,0.000009125435,0.00016182754,0.00425999],"study_design_scores_gemma":[0.0013890042,0.0048475736,0.9825896,0.000017663431,0.0007717833,0.00060188485,0.00017303812,0.0002939518,0.005130935,0.00003075497,0.0039710356,0.0001827493],"about_ca_topic_score_codex":0.00017805463,"about_ca_topic_score_gemma":0.00038290568,"teacher_disagreement_score":0.7199885,"about_ca_system_score_codex":0.0004372498,"about_ca_system_score_gemma":0.00043592489,"threshold_uncertainty_score":0.83992964},"labels":[],"label_agreement":null},{"id":"W4380356855","doi":"10.1093/neuonc/noad073.248","title":"MDB-15. CLINICAL CHARACTERISTICS AND OUTCOME OF CHILDHOOD LI-FRAUMENI SYNDROME MEDULLOBLASTOMA PATIENTS","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Medicine; Retrospective cohort study; Internal medicine; Missense mutation; Chemotherapy; Oncology; Radiation therapy; Cohort; Pediatrics; Mutation; Pathology; Biology; Genetics","score_opus":0.027585985185095294,"score_gpt":0.33046548048890756,"score_spread":0.30287949530381225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380356855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99504966,0.00004633349,0.000014795639,0.0013201819,0.0019309369,0.000638871,0.000077785386,0.00016102853,0.0007604266],"genre_scores_gemma":[0.997256,0.00023416072,0.00019953176,0.0018994557,0.00014986041,0.000031593587,0.00009558075,0.000067012945,0.000066837514],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974849,0.00021658755,0.0010356659,0.00051340536,0.00033358193,0.000415835],"domain_scores_gemma":[0.99820495,0.00048678016,0.00037827215,0.00046887834,0.0001430951,0.0003180555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003729136,0.0002331867,0.0009809195,0.00024598915,0.000053327665,0.00000695542,0.0001490693,0.00043429038,0.0000996991],"category_scores_gemma":[0.0014828608,0.00022395505,0.00018385537,0.00038526888,0.00025049236,0.00004048039,0.00025364003,0.0006978092,0.00024276128],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007312281,0.0018029776,0.88756895,0.0002252035,0.00030271462,0.0030474465,0.00059661706,0.0000032948842,0.027365599,0.00011322934,0.0060538505,0.07218886],"study_design_scores_gemma":[0.0053285765,0.006712181,0.9447941,0.00006023466,0.00025009963,0.00066162075,0.00003339321,0.00012778128,0.00067551335,0.000031797885,0.0411416,0.00018308358],"about_ca_topic_score_codex":0.0000093916815,"about_ca_topic_score_gemma":0.0000091697775,"teacher_disagreement_score":0.07200578,"about_ca_system_score_codex":0.000104481245,"about_ca_system_score_gemma":0.0002452246,"threshold_uncertainty_score":0.9132622},"labels":[],"label_agreement":null},{"id":"W4380358406","doi":"10.1093/neuonc/noad073.010","title":"ATRT-10. SINGLE-CELL TRANSCRIPTOME ANALYSIS REVEALS CELLULAR HIERARCHIES AND THERAPEUTIC VULNERABILITIES OF ETMR","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre","funders":"","keywords":"Biology; Transcriptome; SOX2; Neurogenesis; Neural stem cell; Cell cycle; Gene silencing; Population; microRNA; Cell; Cancer research; Stem cell; Progenitor cell; Cell biology; Gene; Genetics; Embryonic stem cell; Gene expression; Medicine","score_opus":0.026753731136171983,"score_gpt":0.26090613472528146,"score_spread":0.23415240358910946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380358406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949374,0.0016919319,0.00051946874,0.0004150701,0.00028165558,0.00022852907,0.00006215373,0.000053277276,0.0018105027],"genre_scores_gemma":[0.9972049,0.00061323476,0.00024238619,0.00051468884,0.0001481349,0.000026727512,0.000138049,0.00004406364,0.0010678392],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979531,0.000388921,0.000493032,0.0005685444,0.00017685056,0.00041951635],"domain_scores_gemma":[0.9989401,0.0002514257,0.00014532071,0.00043463908,0.000106009065,0.00012249549],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003619861,0.00026697098,0.0005778837,0.0002984075,0.00011324663,0.00002188654,0.00025949496,0.00031835336,0.00007783303],"category_scores_gemma":[0.000081486214,0.00025678435,0.00030447333,0.0005928675,0.0004116651,0.0000057239663,0.000071637325,0.00019926444,0.000011162788],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029212167,0.00020156261,0.0034340133,0.00009715115,0.00024760835,0.000016154167,0.0006327226,0.00021187185,0.98951066,0.00005957614,0.000375949,0.0049206237],"study_design_scores_gemma":[0.0013600887,0.0031035673,0.0012461457,0.000007594953,0.0005769781,0.000012717499,0.00048486935,0.00042027916,0.90159065,0.00038289203,0.090439595,0.0003746165],"about_ca_topic_score_codex":0.00003909827,"about_ca_topic_score_gemma":0.000058560076,"teacher_disagreement_score":0.09006365,"about_ca_system_score_codex":0.000024744102,"about_ca_system_score_gemma":0.00009044262,"threshold_uncertainty_score":0.99998844},"labels":[],"label_agreement":null},{"id":"W4380358639","doi":"10.1093/neuonc/noad073.219","title":"LGG-09. CLINICAL ACTIVITY OF PAN-RAF INHIBITOR TOVORAFENIB IN THE REGISTRATIONAL PEDIATRIC LOW-GRADE GLIOMA ARM OF THE PHASE 2 FIREFLY-1 (PNOC026) STUDY","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Adverse effect; Medicine; Glioma; Clinical endpoint; Internal medicine; Phases of clinical research; Clinical trial; Oncology; Surgery; Gastroenterology; Cancer research","score_opus":0.07688933433642507,"score_gpt":0.40788209386077073,"score_spread":0.33099275952434565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380358639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905702,0.000062982115,4.9940843e-7,0.0068605994,0.00068518176,0.0014715359,0.000043986405,0.00002932773,0.00027571892],"genre_scores_gemma":[0.99890774,0.00008334156,0.000012708767,0.00029437192,0.00048657236,0.00017492323,0.000012756854,0.000018633573,0.000008966936],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971327,0.0008888087,0.0007762598,0.0004018887,0.0005251104,0.00027523062],"domain_scores_gemma":[0.9960039,0.002759409,0.00044886468,0.000615262,0.000094216855,0.00007832021],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009840872,0.00018996275,0.0006256191,0.0002026116,0.00007531895,0.000007841165,0.0002735372,0.0001796358,0.00003035681],"category_scores_gemma":[0.000942434,0.00011121527,0.0002684785,0.001162183,0.00020407684,0.000047417376,0.00012760368,0.00044901893,0.000017605264],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016047799,0.06042211,0.7867333,0.00011831889,0.00018167867,0.0022627327,0.001706267,0.00002441268,0.11867302,0.00018396301,0.011739748,0.016349658],"study_design_scores_gemma":[0.018489301,0.010486896,0.93753946,0.000023957115,0.000488433,0.000105433835,0.0006577084,0.00011771003,0.028899316,0.0001120574,0.0029539526,0.00012579642],"about_ca_topic_score_codex":0.000082046776,"about_ca_topic_score_gemma":0.00022754341,"teacher_disagreement_score":0.15080613,"about_ca_system_score_codex":0.00007936992,"about_ca_system_score_gemma":0.00043586787,"threshold_uncertainty_score":0.4535227},"labels":[],"label_agreement":null},{"id":"W4380358945","doi":"10.1093/neuonc/noad073.229","title":"LGG-20. LANDSCAPE OF FGFR ALTERATIONS IN PEDIATRIC AND AYA GLIOMAS","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Fibroblast growth factor receptor; Fibroblast growth factor receptor 1; Glioma; Cohort; Young adult; Oncology; Pediatric cancer; Internal medicine; Cancer; Fibroblast growth factor; Cancer research; Pediatrics; Receptor","score_opus":0.012426141081313003,"score_gpt":0.2752612076046285,"score_spread":0.2628350665233155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380358945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937054,0.00193545,0.00002069804,0.0005179683,0.0010367114,0.00014917659,0.000028611761,0.000016133585,0.0025898654],"genre_scores_gemma":[0.99153936,0.006137854,0.00010925462,0.00039115493,0.0014344063,0.00004239531,0.00008949506,0.000019512428,0.0002365929],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99913377,0.00009029011,0.00021680514,0.00027500986,0.00006944531,0.00021471288],"domain_scores_gemma":[0.99957293,0.000057792782,0.000074143,0.000187008,0.00004235242,0.000065745124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014765056,0.000099999874,0.00019835889,0.00017222259,0.000035120942,0.000006889748,0.00009789358,0.00016215329,0.00001733043],"category_scores_gemma":[0.00012688558,0.00010144027,0.000046583562,0.00032345558,0.00005168633,0.0000037044654,0.000107946726,0.000100175,0.0000112898],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000086383334,0.00006390427,0.010664448,0.000025667303,0.000009487935,0.000013173778,0.00016075879,0.000085378146,0.9643022,0.00010855758,0.018828401,0.0056516454],"study_design_scores_gemma":[0.002337742,0.0007845727,0.037718862,0.0000034530249,0.000055829325,0.0000783375,0.00012602772,0.00019913574,0.06318968,0.00015813582,0.8951288,0.00021946768],"about_ca_topic_score_codex":0.000019162257,"about_ca_topic_score_gemma":0.00033895017,"teacher_disagreement_score":0.9011125,"about_ca_system_score_codex":0.0000066592293,"about_ca_system_score_gemma":0.00015680835,"threshold_uncertainty_score":0.41366145},"labels":[],"label_agreement":null},{"id":"W4380359043","doi":"10.1093/neuonc/noad073.195","title":"IMMU-08. SALVAGE IMMUNOTHERAPIES FOR REPLICATION REPAIR DEFICIENT (RRD) HIGH-GRADE GLIOMA FAILING ANTI-PD1 MONOTHERAPY: AN IRRDC REPORT","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"Ipilimumab; Medicine; Nivolumab; Immunotherapy; Internal medicine; Progressive disease; Immune checkpoint; Salvage therapy; Oncology; Expanded access; Progression-free survival; Blockade; Surgery; Chemotherapy; Cancer","score_opus":0.037875624931700096,"score_gpt":0.34134928180455,"score_spread":0.3034736568728499,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380359043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856975,0.0007510719,0.00015445476,0.009428718,0.00087116146,0.001861232,0.000033817032,0.000999756,0.00020228846],"genre_scores_gemma":[0.99348426,0.00049846515,0.0024883542,0.0013598859,0.0003285309,0.0011587392,0.0004679726,0.00013026508,0.00008355198],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969566,0.00017039929,0.00081462425,0.0011365586,0.00031665913,0.0006051839],"domain_scores_gemma":[0.9970074,0.0005500659,0.000413841,0.001659326,0.00019252406,0.00017679801],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00078205194,0.00034137414,0.0007389544,0.00043965282,0.00028073895,0.000038629085,0.00018634916,0.0002778058,0.00005313663],"category_scores_gemma":[0.00033985192,0.00030031617,0.0003600236,0.00068768853,0.00012770791,0.00012250202,0.00006467878,0.00020939694,0.00007556325],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004339286,0.0014786149,0.008846705,0.000057693764,0.00026991797,0.0024345487,0.0006581105,0.00009984645,0.95569,0.00075565156,0.00446889,0.02480606],"study_design_scores_gemma":[0.012528602,0.007242819,0.14091712,0.000082780236,0.00053177663,0.0026338594,0.0007892545,0.0025968135,0.45417795,0.0008505648,0.37702683,0.000621633],"about_ca_topic_score_codex":0.00015229889,"about_ca_topic_score_gemma":0.000029725381,"teacher_disagreement_score":0.5015121,"about_ca_system_score_codex":0.00031500502,"about_ca_system_score_gemma":0.00021985284,"threshold_uncertainty_score":0.9999449},"labels":[],"label_agreement":null},{"id":"W4380359389","doi":"10.1093/neuonc/noad073.061","title":"DIPG-14. PROTEOGENOMICS PROFILING REVEALS ENRICHED NON-HISTONE PROTEIN METHYLTRANSFERASES AS NEW THERAPEUTIC TARGETS IN DIPG","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"","keywords":"Biology; Epigenetics; Histone; Proteome; Histone H3; Transcriptome; Proteomics; Proteogenomics; Methyltransferase; DNA methylation; Methylation; Genetics; Cancer research; Gene expression; DNA; Gene","score_opus":0.03884201523732462,"score_gpt":0.34493542876432387,"score_spread":0.30609341352699926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380359389","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9729298,0.0015949041,0.00032732575,0.015309384,0.0005674651,0.005805104,0.000012820151,0.00031305177,0.0031401545],"genre_scores_gemma":[0.98857886,0.00076633086,0.001792102,0.0055465475,0.00042423562,0.0018326377,0.000056660385,0.0001240706,0.0008785644],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970165,0.00033140316,0.0007270545,0.00077867944,0.00036124926,0.0007851162],"domain_scores_gemma":[0.9985873,0.00027744248,0.00016568344,0.00047378507,0.0001123893,0.00038338866],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006531423,0.00037231218,0.0009510283,0.0003910038,0.000109229666,0.000022576723,0.0002613219,0.00035797147,0.00027390957],"category_scores_gemma":[0.000545089,0.0003359748,0.00019901758,0.000999654,0.00010691568,0.00009648874,0.00008790588,0.00074731273,0.00026550933],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008531249,0.00037167754,0.0039426084,0.00020115483,0.000076986384,0.00035754227,0.0010522718,0.000024534636,0.95566756,0.000251101,0.001470611,0.03573086],"study_design_scores_gemma":[0.007666113,0.00652412,0.009344035,0.00019657248,0.00028603376,0.00014176128,0.00051110785,0.00040547378,0.8720361,0.0017182439,0.10049407,0.0006763904],"about_ca_topic_score_codex":0.00022351278,"about_ca_topic_score_gemma":0.00007249755,"teacher_disagreement_score":0.09902346,"about_ca_system_score_codex":0.00045952326,"about_ca_system_score_gemma":0.0013585262,"threshold_uncertainty_score":0.9999092},"labels":[],"label_agreement":null},{"id":"W4380361287","doi":"10.1093/neuonc/noad073.015","title":"ATRT-15. ATRTS HIJACK EPIGENETIC MECHANISMS TO PROMOTE IMMUNOSUPPRESSION AND ESCAPE FROM NK CELL THERAPY","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Chromatin; Biology; Enhancer; Chromatin remodeling; Cancer research; Epigenetics; Cell biology; Gene silencing; Histone; Transcription factor; Genetics; Gene","score_opus":0.014510554393316194,"score_gpt":0.27493065728412613,"score_spread":0.26042010289080997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380361287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994684,0.0016741217,0.0009432838,0.00093408773,0.0006953335,0.00038989776,0.000034757268,0.00007057961,0.0005739492],"genre_scores_gemma":[0.9901147,0.004371577,0.0027400658,0.0018339012,0.0003470308,0.00007723078,0.00014480439,0.00006612534,0.0003045525],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984177,0.00015091001,0.00026470533,0.00064631697,0.00014576118,0.0003746104],"domain_scores_gemma":[0.99918073,0.00005870169,0.000092921815,0.00045651838,0.000055276643,0.00015582754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015834365,0.00022720435,0.00025725862,0.00005868153,0.00011905716,0.00002603416,0.0002413557,0.00030569945,0.0000926572],"category_scores_gemma":[0.000053138505,0.000208513,0.00008574027,0.00013553257,0.00004566616,0.0000033705085,0.00027696064,0.000150372,0.00012053157],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015274911,0.000048769856,0.00006301755,0.000010985895,0.000018410397,0.000020640242,0.00020693602,0.00021204543,0.93399084,0.0000029527087,0.005983715,0.05928893],"study_design_scores_gemma":[0.0010628041,0.0013929788,0.00033927857,0.00001522728,0.000016235708,0.000015767528,0.00007390589,0.0009853881,0.8581133,0.00055606145,0.13719974,0.00022929197],"about_ca_topic_score_codex":0.00006333281,"about_ca_topic_score_gemma":0.00002944636,"teacher_disagreement_score":0.13121603,"about_ca_system_score_codex":0.00002903998,"about_ca_system_score_gemma":0.00013159098,"threshold_uncertainty_score":0.8502913},"labels":[],"label_agreement":null},{"id":"W4380362243","doi":"10.1093/neuonc/noad073.198","title":"IMMU-11. PRECLINICAL HIGH-RISK PEDIATRIC BRAIN TUMOR MODELS FOR IMMUNOTHERAPY: HURDLES AND THE WAY FORWARD","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Immunotherapy; Medicine; Brain tumor; Cancer; Cancer immunotherapy; Epigenetics; Immunology; Oncology; Bioinformatics; Immune system; Cancer research; Internal medicine; Biology; Pathology","score_opus":0.030122104084715332,"score_gpt":0.3238255471242193,"score_spread":0.29370344303950396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380362243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9575393,0.0012043291,0.00014288402,0.038396783,0.0005893569,0.0017506849,0.00006732696,0.00013892543,0.00017041138],"genre_scores_gemma":[0.99016,0.0033361898,0.00049676636,0.004212035,0.0005811219,0.0010383829,0.00003945439,0.000060776052,0.00007527198],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981694,0.00030470086,0.0004694918,0.00045780637,0.00017904358,0.00041954816],"domain_scores_gemma":[0.99241203,0.006776153,0.00020780509,0.00040139837,0.00007411655,0.00012852196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079311675,0.00022074877,0.00067730335,0.00015450643,0.0002030197,0.000023632432,0.00014407946,0.0001608608,0.000033768425],"category_scores_gemma":[0.00074770354,0.00013558542,0.0002555885,0.0002633452,0.00019718685,0.000054261658,0.00010328876,0.0002450495,0.000043648834],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020244135,0.005597948,0.21982013,0.00054182525,0.0021244003,0.0018279973,0.0062443283,0.0016511489,0.03784595,0.041125823,0.28575274,0.37722355],"study_design_scores_gemma":[0.18123887,0.020037362,0.2134163,0.00006673148,0.004169778,0.00069276046,0.0008796899,0.039642297,0.00675347,0.061748717,0.47024795,0.0011060879],"about_ca_topic_score_codex":0.00011002122,"about_ca_topic_score_gemma":0.00005130183,"teacher_disagreement_score":0.37611747,"about_ca_system_score_codex":0.00006187473,"about_ca_system_score_gemma":0.00013674708,"threshold_uncertainty_score":0.55290127},"labels":[],"label_agreement":null},{"id":"W4380362967","doi":"10.1093/neuonc/noad073.067","title":"DIPG-20. DELINEATING MEDIATORS OF ONCOGENESIS IN FOXR2-EXPRESSING DIFFUSE MIDLINE GLIOMAS","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Circular RNAs in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Carcinogenesis; Epigenetics; Biology; Transcription factor; Cancer research; Histone; Glioma; Cell biology; Genetics; Cancer; Gene","score_opus":0.01834662421488841,"score_gpt":0.30521042662217124,"score_spread":0.2868638024072828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380362967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976254,0.0007923354,0.00011217742,0.0002956469,0.00044349078,0.00021057733,0.000042577612,0.000048448528,0.00042935344],"genre_scores_gemma":[0.99817306,0.00029852614,0.0004282961,0.00039561043,0.00038846018,0.00005351017,0.00018213369,0.000056863057,0.000023549946],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980992,0.00026340326,0.0005227516,0.00050465507,0.00020309155,0.00040687606],"domain_scores_gemma":[0.9988668,0.0002240583,0.0002124565,0.0004693366,0.000094841635,0.00013253198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027725106,0.00020611404,0.00035405267,0.00022940968,0.00005655449,0.0000100743455,0.0003348278,0.00027861234,0.000018516752],"category_scores_gemma":[0.0014904325,0.00021758286,0.0001529784,0.00048951537,0.00015698474,0.0000054784077,0.00035368392,0.00013979072,0.0000145239155],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011731342,0.0002201478,0.04178763,0.00004029606,0.000026431066,0.00015835263,0.00008604647,0.0005004271,0.948452,0.000008575494,0.0011682819,0.0074344752],"study_design_scores_gemma":[0.002612906,0.00051042263,0.010964712,0.00003633801,0.000059455637,0.000048083064,0.00021429296,0.001134544,0.93751645,0.000060217946,0.046523552,0.00031902557],"about_ca_topic_score_codex":0.000033276432,"about_ca_topic_score_gemma":0.0001512418,"teacher_disagreement_score":0.045355268,"about_ca_system_score_codex":0.000049573355,"about_ca_system_score_gemma":0.00024901005,"threshold_uncertainty_score":0.8872771},"labels":[],"label_agreement":null},{"id":"W4380363071","doi":"10.1093/neuonc/noad073.114","title":"EPEN-10. SPINAL EPENDYMOMA WITH MYCN-AMPLIFICATION – A DISEASE OF CHILDHOOD AND YOUNG ADULTHOOD WITH DISMAL PROGNOSIS","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; University of British Columbia","funders":"","keywords":"Ependymoma; Medicine; Cohort; Epidemiology; Copy-number variation; Metastasis; Population; Oncology; Pathology; Internal medicine; Pediatrics; Biology; Cancer; Genetics; Genome","score_opus":0.016508631324363077,"score_gpt":0.2791648079999841,"score_spread":0.262656176675621,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380363071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99282855,0.0001354292,0.000010935555,0.005406592,0.00006413896,0.0010595632,0.00005380226,0.000078362864,0.00036265093],"genre_scores_gemma":[0.9986149,0.00008445557,0.00032505847,0.00021614347,0.00007619885,0.0005105855,0.00011839706,0.0000379561,0.000016298147],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99862623,0.000074558,0.00024884182,0.00047353754,0.00027239474,0.00030444522],"domain_scores_gemma":[0.9989919,0.00010689699,0.00017171774,0.00029771894,0.00012822753,0.0003035546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007964915,0.0002081822,0.0004088956,0.00018094023,0.00008567844,0.000014274328,0.000070291375,0.00007544317,0.00005544332],"category_scores_gemma":[0.00009744138,0.00014136595,0.000053802447,0.0004178354,0.00015051979,0.00005435339,0.000050759794,0.00013356791,0.000027602848],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004854126,0.004196544,0.9305841,0.0002533824,0.00030921903,0.004654437,0.0008873621,0.000011718145,0.013766837,0.0006608397,0.0009600349,0.038861442],"study_design_scores_gemma":[0.0065097203,0.009902436,0.9744848,0.00014776172,0.0006498875,0.0007708148,0.00027570545,0.000081048456,0.0046903864,0.000037610782,0.002299961,0.0001498789],"about_ca_topic_score_codex":0.000027358348,"about_ca_topic_score_gemma":0.000048179143,"teacher_disagreement_score":0.043900732,"about_ca_system_score_codex":0.0000546999,"about_ca_system_score_gemma":0.0002508102,"threshold_uncertainty_score":0.5764736},"labels":[],"label_agreement":null},{"id":"W4380365659","doi":"10.1093/neuonc/noad073.214","title":"LGG-04. CLINICALLY RELEVANT MODELING OF FUSION-DRIVEN PEDIATRIC LOW GRADE GLIOMAS USING DROSOPHILA MELANOGASTER","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"","keywords":"Drosophila melanogaster; Biology; Model organism; Zebrafish; Phenotype; Melanogaster; Glioma; Fusion protein; Fusion gene; Mdm2; Signal transduction; Cancer research; Gene; Computational biology; Genetics","score_opus":0.059989039324182356,"score_gpt":0.34442734460077057,"score_spread":0.2844383052765882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380365659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947663,0.00019469908,0.00005491337,0.0029813878,0.00086875306,0.00055320776,0.000019466153,0.00013131696,0.00042996902],"genre_scores_gemma":[0.99638003,0.0006829019,0.0012447786,0.0009349154,0.000616498,0.000039919352,0.00002999427,0.00006265588,0.000008287472],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9974318,0.0001888415,0.0009248943,0.00055776874,0.00040045686,0.00049623183],"domain_scores_gemma":[0.99797624,0.0008032478,0.00031078226,0.0004823317,0.00017004146,0.00025732617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032085957,0.0002570714,0.0007979542,0.00051799795,0.000101405116,0.000010543646,0.00016221261,0.00030416858,0.00006518827],"category_scores_gemma":[0.000427747,0.00021503954,0.00029335936,0.0007930678,0.00008074656,0.00006073884,0.00022443986,0.00034080312,0.00014619906],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008916282,0.00343037,0.28008997,0.0003568156,0.00026538278,0.008704083,0.0009240122,0.022348799,0.6752938,0.00023828483,0.0023910776,0.005065734],"study_design_scores_gemma":[0.029458396,0.013557554,0.03154921,0.00041995573,0.0036353876,0.0017595581,0.0005599021,0.8899988,0.017295657,0.0018017958,0.0088694375,0.0010943204],"about_ca_topic_score_codex":0.000030333296,"about_ca_topic_score_gemma":0.000009189266,"teacher_disagreement_score":0.86765003,"about_ca_system_score_codex":0.000141213,"about_ca_system_score_gemma":0.00032018602,"threshold_uncertainty_score":0.8769058},"labels":[],"label_agreement":null},{"id":"W4380366399","doi":"10.1093/neuonc/noad073.042","title":"BIOL-23. LOSS OF MICRORNAS COOPERATES WITH TUMOR SUPPRESSORS TO INITIATE MYC-DEPENDENT METASTATIC MEDULLOBLASTOMA","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"","keywords":"Dicer; Biology; Cancer research; Medulloblastoma; PTEN; Gene silencing; microRNA; Glioma; Tumor progression; Tumor initiation; Carcinogenesis; Cancer; PI3K/AKT/mTOR pathway; Small interfering RNA; Genetics; Cell culture; Transfection; Signal transduction","score_opus":0.02381797646764164,"score_gpt":0.29444827492564724,"score_spread":0.27063029845800557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380366399","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974797,0.00018376476,0.00026785422,0.0006565266,0.0003365973,0.00043961324,0.00017329126,0.000059396087,0.0004032806],"genre_scores_gemma":[0.9973241,0.00010915716,0.00060687185,0.0014407779,0.000110686706,0.00012614518,0.00009102502,0.00006306272,0.00012815838],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979555,0.0002871849,0.0004219314,0.0006012052,0.00020210656,0.0005320641],"domain_scores_gemma":[0.99880147,0.00018693965,0.00016975103,0.00040396446,0.00026684173,0.0001710575],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031885572,0.00029265686,0.00050931313,0.00017610875,0.00009757189,0.000015497404,0.00035725543,0.00010626577,0.000025882473],"category_scores_gemma":[0.000451228,0.00024524535,0.00008590404,0.00042718253,0.00026438318,0.0000047592257,0.00037088932,0.00016254101,0.00018189146],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046319896,0.00012347102,0.0013194918,0.000050697603,0.00018791176,0.0005064496,0.00042524713,0.0007282319,0.99238735,0.00002829683,0.0033969197,0.0003827463],"study_design_scores_gemma":[0.0011495037,0.00357383,0.00048011038,0.00002458218,0.00006999405,0.00019594526,0.000388559,0.00002640992,0.95124,0.000023061591,0.042565368,0.00026260622],"about_ca_topic_score_codex":0.00003112304,"about_ca_topic_score_gemma":0.0001960066,"teacher_disagreement_score":0.04114731,"about_ca_system_score_codex":0.000030921874,"about_ca_system_score_gemma":0.00029063926,"threshold_uncertainty_score":1},"labels":[],"label_agreement":null},{"id":"W4380368215","doi":"10.1093/neuonc/noad073.222","title":"LGG-12. CLINICAL AND MOLECULAR FEATURES OF DISSEMINATED PEDIATRIC LOW-GRADE GLIOMA","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"KRAS; Medicine; Glioma; Population; Oncology; Metastasis; Internal medicine; Cancer research; Cancer; Colorectal cancer","score_opus":0.022943631839554487,"score_gpt":0.3506606101613883,"score_spread":0.3277169783218338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380368215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931873,0.00072193134,0.0000011104614,0.004349131,0.00039553814,0.00037067436,0.0000138667565,0.000096574324,0.00086388626],"genre_scores_gemma":[0.9982104,0.0009062798,0.00008785971,0.0005101347,0.00015689175,0.00004403678,0.00003387467,0.000029041315,0.000021496115],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985675,0.00017067368,0.00040807555,0.00037963258,0.00019233066,0.00028176355],"domain_scores_gemma":[0.9984682,0.0008349519,0.0001355346,0.0002790731,0.00006342782,0.00021880865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020992759,0.00016461046,0.0005517968,0.0002825984,0.00003814106,0.000006734212,0.00008131218,0.00024330549,0.00003011902],"category_scores_gemma":[0.00057123613,0.00013201493,0.0001504008,0.0005148498,0.00015173777,0.000021726786,0.00010367591,0.00024633558,0.000037074366],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003060764,0.0017905331,0.395492,0.0001495879,0.00014924377,0.011638932,0.00017538348,0.000003328936,0.53520274,0.00036177292,0.037036162,0.017694222],"study_design_scores_gemma":[0.007219607,0.0038371873,0.8288543,0.000035344503,0.00073890074,0.0005804878,0.000097814285,0.000073234376,0.14583033,0.00018623941,0.01236218,0.00018435913],"about_ca_topic_score_codex":0.000013633745,"about_ca_topic_score_gemma":0.000008188715,"teacher_disagreement_score":0.43336233,"about_ca_system_score_codex":0.000026213003,"about_ca_system_score_gemma":0.00009775993,"threshold_uncertainty_score":0.5383413},"labels":[],"label_agreement":null},{"id":"W4380368915","doi":"10.1093/neuonc/noad073.060","title":"DIPG-13. NEW IMMUNOCOMPETENT GENETICALLY-ENGINEERED MOUSE MODELS OF PEDIATRIC-TYPE DIFFUSE HIGH-GRADE GLIOMAS REVEAL MECHANISMS OF TUMOR INITIATION AND PROGRESSION","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Biology; Lineage markers; OLIG2; Cancer research; KRAS; Cell of origin; Glioma; Tumor initiation; IDH1; Pathology; Mutation; Progenitor cell; Oligodendrocyte; Gene; Stem cell; Carcinogenesis; Medicine; Myelin; Genetics","score_opus":0.029249437841759048,"score_gpt":0.2896653529142814,"score_spread":0.2604159150725224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380368915","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99663836,0.000768019,0.00015613562,0.0010389539,0.00037044825,0.0008483413,0.000019332292,0.00009404628,0.00006634156],"genre_scores_gemma":[0.9952359,0.00077384076,0.00349423,0.00017023312,0.00012601419,0.00007342081,0.00006744196,0.00004063159,0.000018245786],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99847746,0.000115585135,0.0005088281,0.00032470265,0.00030211144,0.00027131892],"domain_scores_gemma":[0.9988564,0.00024222728,0.00023921266,0.0002975,0.00015345294,0.00021116734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012910953,0.00020015077,0.00056462735,0.0003551835,0.000037992664,0.0000066794782,0.00009255425,0.00014989762,0.000017737611],"category_scores_gemma":[0.00015066104,0.00016453725,0.000085329346,0.00049454666,0.00004940574,0.000053285905,0.00012861779,0.00015684505,0.00000837876],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039152024,0.0018594876,0.00276605,0.00016829812,0.000084097104,0.00031690672,0.00020860607,0.00018550377,0.98287237,0.003728071,0.0011571235,0.0062619857],"study_design_scores_gemma":[0.016993478,0.012202901,0.04392932,0.00012064211,0.0011393178,0.0002294166,0.00012761306,0.005599038,0.91193557,0.006683344,0.0006780587,0.00036130217],"about_ca_topic_score_codex":0.000048088474,"about_ca_topic_score_gemma":0.000005347889,"teacher_disagreement_score":0.070936784,"about_ca_system_score_codex":0.00006488112,"about_ca_system_score_gemma":0.00029412008,"threshold_uncertainty_score":0.67096347},"labels":[],"label_agreement":null},{"id":"W4380368985","doi":"10.1093/neuonc/noad073.240","title":"MDB-07. MYC AND TGFΒ PROMOTE GROUP 3 MEDULLOBLASTOMA TUMOR RESISTANCE THROUGH DEREGULATION OF KDM2B TARGETS","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Demethylase; Cancer research; Medulloblastoma; Biology; Effector; Epigenetics; Downregulation and upregulation; Carcinogenesis; Cancer; Gene; Cell biology; Genetics","score_opus":0.019951217120714956,"score_gpt":0.2950622195076874,"score_spread":0.27511100238697245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380368985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890035,0.0005821973,0.000014911862,0.006369588,0.00030358075,0.0006827086,0.000016908289,0.00011782678,0.0029087851],"genre_scores_gemma":[0.99754816,0.00019937375,0.001228849,0.0006516966,0.00011001569,0.00011588042,0.0000407581,0.000032902677,0.00007234658],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99861544,0.00010838601,0.0003491864,0.00039729802,0.00022435862,0.00030531158],"domain_scores_gemma":[0.99901664,0.00032299547,0.00018621344,0.00027652213,0.00008675973,0.00011083855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001483229,0.0001753209,0.00047424034,0.00011749622,0.000079179714,0.0000073438105,0.000064507,0.00011296584,0.00009395789],"category_scores_gemma":[0.00021785988,0.00014897749,0.000076310076,0.00033008307,0.00014451236,0.00007783797,0.00007178068,0.00012736583,0.00009098725],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090949185,0.0012253636,0.025452,0.00038633382,0.0001930897,0.0025843186,0.0018546886,0.000015675238,0.9236237,0.0031458251,0.028282376,0.012327134],"study_design_scores_gemma":[0.010594142,0.0061018784,0.31344026,0.000256775,0.0004726393,0.00046415697,0.00033948352,0.00054038246,0.31670246,0.0040484536,0.34667084,0.00036853354],"about_ca_topic_score_codex":0.0000218844,"about_ca_topic_score_gemma":0.00010878112,"teacher_disagreement_score":0.60692126,"about_ca_system_score_codex":0.00009534775,"about_ca_system_score_gemma":0.0000826811,"threshold_uncertainty_score":0.60751253},"labels":[],"label_agreement":null},{"id":"W4380369756","doi":"10.1093/neuonc/noad073.271","title":"MDB-39. ASSESSMENT OF MEDULLOBLASTOMA PATIENTS THROUGH MONITORING EXTRACELLULAR VESICLES VIA SURFACE-ENHANCED RAMAN SPECTROSCOPY COMBINED WITH MACHINE LEARNING","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Extracellular vesicles; Liquid biopsy; Medulloblastoma; Machine learning; Computer science; Raman spectroscopy; Extracellular vesicle; Artificial intelligence; Medicine; Bioinformatics; Biomedical engineering; Pathology; Cancer; Chemistry; Internal medicine; Biology","score_opus":0.010944685083116162,"score_gpt":0.287793572053417,"score_spread":0.27684888697030086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380369756","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99371064,0.00035840904,0.003823374,0.00013241445,0.0004972048,0.00052661076,0.000021046411,0.00011544495,0.00081487565],"genre_scores_gemma":[0.9929439,0.00029785614,0.006010848,0.00005768451,0.00015674847,0.000044908847,0.00025162578,0.00010419767,0.00013223378],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99727607,0.0004448663,0.0005311445,0.00073477393,0.00040754818,0.00060557],"domain_scores_gemma":[0.9985101,0.00013677344,0.0004218847,0.00057996705,0.00017732912,0.00017392673],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00029805873,0.00036738266,0.0004827867,0.00007559369,0.00017599111,0.00002332205,0.00041698813,0.00026010218,0.000036280606],"category_scores_gemma":[0.0001409793,0.0003573491,0.00013961381,0.00036068654,0.00024826976,0.000018383766,0.00031014092,0.0004278676,0.000025089648],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006233426,0.00047147006,0.06943035,0.00005680652,0.00009648085,0.00008182654,0.0001350059,0.0028315,0.92494774,0.000032729244,0.00013470526,0.0011580618],"study_design_scores_gemma":[0.0029061406,0.00568593,0.013948782,0.000029337341,0.00007552646,0.000009467616,0.00013308019,0.0014974868,0.97031003,0.00007251732,0.004995714,0.00033601126],"about_ca_topic_score_codex":0.000020097621,"about_ca_topic_score_gemma":0.000013533405,"teacher_disagreement_score":0.05548157,"about_ca_system_score_codex":0.00009827147,"about_ca_system_score_gemma":0.00021297786,"threshold_uncertainty_score":0.9998878},"labels":[],"label_agreement":null},{"id":"W4380371135","doi":"10.1093/neuonc/noad073.006","title":"ATRT-06. ETMR TUMORIGENESIS MIRRORS RADIAL GLIAL DEVELOPMENT","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Circular RNAs in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Biology; Wnt signaling pathway; Embryonic stem cell; Carcinogenesis; microRNA; Embryogenesis; Context (archaeology); Gene; Cancer research; Genetics; Cell biology","score_opus":0.027583391616586926,"score_gpt":0.30340009055339573,"score_spread":0.2758166989368088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380371135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99557394,0.00027394615,0.00007045204,0.00061209477,0.0014595311,0.00028584615,0.00002688738,0.000119821925,0.001577495],"genre_scores_gemma":[0.99615437,0.00019075899,0.00052439986,0.0014091498,0.0007508693,0.00013320398,0.0003685547,0.000070652946,0.00039805783],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99803615,0.00019991092,0.0003459962,0.00064258627,0.00022632847,0.0005490273],"domain_scores_gemma":[0.9990336,0.000090282345,0.000110864145,0.0004613416,0.0000742523,0.00022971156],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022552742,0.00024595004,0.0002680215,0.00012093348,0.00016771065,0.000019811601,0.00041068246,0.00028113724,0.00009420983],"category_scores_gemma":[0.0005015591,0.00026475516,0.00016594585,0.00026569987,0.00014473706,0.0000039719393,0.00034210682,0.00014462552,0.000702872],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014656485,0.00012254664,0.005527696,0.00001900618,0.00006905245,0.00030178868,0.00013436809,0.000043913584,0.9534264,0.000049334212,0.026137512,0.014021812],"study_design_scores_gemma":[0.00075791293,0.00026658401,0.009662887,0.000003396627,0.000028394888,0.00006971988,0.000055126773,0.00001895922,0.27930018,0.000033148364,0.7095555,0.0002481781],"about_ca_topic_score_codex":0.00002043866,"about_ca_topic_score_gemma":0.0001097315,"teacher_disagreement_score":0.683418,"about_ca_system_score_codex":0.00009975369,"about_ca_system_score_gemma":0.00078191236,"threshold_uncertainty_score":0.99998045},"labels":[],"label_agreement":null},{"id":"W4380372174","doi":"10.1093/neuonc/noad073.083","title":"DIPG-36. H3K27M HISTONE MUTANT GLIOMAS ARE SENSITIVE TO METHIONINE LOSS AND MAT2A INHIBITION THROUGH A NOVEL FEEDBACK MECHANISM BETWEEN AMD1 AND METTL16","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Methionine Adenosyltransferase; Methionine; Epigenetics; Methyltransferase; Methylation; Histone; Biology; Regulator; Cell biology; Cancer research; Biochemistry; Amino acid; Gene","score_opus":0.02888501305955689,"score_gpt":0.3151405217067985,"score_spread":0.28625550864724164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380372174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98593485,0.00015239739,0.0046603084,0.008085373,0.00021961753,0.0003988886,0.00020978914,0.00004754755,0.00029120012],"genre_scores_gemma":[0.9952992,0.000489667,0.0012747326,0.0022134709,0.00028698883,0.00009253611,0.00015034234,0.000040391846,0.00015266312],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99849397,0.00012637996,0.0002734324,0.0006513036,0.00013377996,0.00032116403],"domain_scores_gemma":[0.9991881,0.0000864058,0.00014558843,0.00029602504,0.00013815197,0.00014570568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023323837,0.00021658035,0.00033386747,0.000108450775,0.00017360924,0.00002551077,0.00008236309,0.0002832813,0.000009502883],"category_scores_gemma":[0.00013538242,0.0002126524,0.000054968325,0.00031171864,0.00016693042,0.000011470251,0.00025515564,0.00016655409,0.000025866086],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000121932055,0.00004584533,0.00009801199,0.000019298068,0.000049168233,0.00006291462,0.00041694666,0.00000829509,0.9941706,0.0006079641,0.0015902404,0.0028087809],"study_design_scores_gemma":[0.0014969833,0.0010730106,0.006419768,0.000022236596,0.00010007934,0.00025610207,0.00053700234,0.00006207556,0.8811094,0.0006248463,0.10796209,0.00033641493],"about_ca_topic_score_codex":0.000056948964,"about_ca_topic_score_gemma":0.00007781534,"teacher_disagreement_score":0.113061205,"about_ca_system_score_codex":0.00006831993,"about_ca_system_score_gemma":0.000079674915,"threshold_uncertainty_score":0.86717135},"labels":[],"label_agreement":null},{"id":"W4380372553","doi":"10.1093/neuonc/noad073.176","title":"HGG-27. THE IMPACT OF MISMATCH REPAIR DEFICIENCY ON GLIOMAS IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS; A REPORT FROM THE IRRDC AND THE GLIOMA TASK FORCE","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; University of Toronto; Mount Sinai Hospital; Health Sciences Centre; Sunnybrook Health Science Centre; Structural Genomics Consortium; Hospital for Sick Children","funders":"","keywords":"Medicine; Germline; Oncology; Glioma; DNA mismatch repair; Internal medicine; Cancer research; Germline mutation; Cancer; Mutation; Genetics; Biology; Gene","score_opus":0.01177961469797215,"score_gpt":0.28856862690539814,"score_spread":0.27678901220742597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380372553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933159,0.0010376516,0.0000016451373,0.0030231907,0.00047249583,0.0014349531,0.000028669121,0.00006816368,0.00061735837],"genre_scores_gemma":[0.9987322,0.000347808,0.000018822604,0.00061513204,0.00014351029,0.000072745104,0.000013325419,0.000031324278,0.00002513844],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978295,0.00041509917,0.00051636196,0.0005134435,0.00034682458,0.0003787832],"domain_scores_gemma":[0.99779195,0.0010292988,0.00026943046,0.00073802174,0.00008554765,0.00008574699],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007975241,0.00023577742,0.0004756144,0.00011508092,0.00012654507,0.000015188335,0.00025308118,0.00017053961,0.00002005949],"category_scores_gemma":[0.0014420762,0.00010995969,0.00016677068,0.000693888,0.00067199586,0.00002628002,0.00023527302,0.00051723415,0.000007434158],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035009382,0.00016433575,0.94447273,0.000032145213,0.00009105268,0.0004874508,0.0039832722,0.000042603733,0.03611656,0.000028634495,0.008134023,0.0029462636],"study_design_scores_gemma":[0.004645186,0.0016044322,0.9873702,0.00010590734,0.00011600715,0.0025131593,0.0006258993,0.00086439366,0.0014296985,0.0002884181,0.00032466292,0.000112047775],"about_ca_topic_score_codex":0.0026285627,"about_ca_topic_score_gemma":0.0004564916,"teacher_disagreement_score":0.042897467,"about_ca_system_score_codex":0.00014825797,"about_ca_system_score_gemma":0.00026786595,"threshold_uncertainty_score":0.4484026},"labels":[],"label_agreement":null},{"id":"W4381250167","doi":"10.1093/neuonc/noad073.320","title":"Author Index","year":2023,"lang":"en","type":"paratext","venue":"Neuro-Oncology","topic":"","field":"","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Nuclear Safety Commission","keywords":"Index (typography); Computer science; World Wide Web","score_opus":0.0589635921977023,"score_gpt":0.3666350457616977,"score_spread":0.3076714535639954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381250167","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019980236,0.00049722934,0.000047718004,0.0047776247,0.0603224,0.0015581724,0.0021554274,0.0015042291,0.92713916],"genre_scores_gemma":[0.0071857604,0.00035463614,0.00015668491,0.005178374,0.008249775,0.0010051067,0.0022838034,0.0025694454,0.97301644],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99349445,0.001533123,0.0010055826,0.0017057455,0.0007432776,0.0015178403],"domain_scores_gemma":[0.9949748,0.0019540496,0.0009368643,0.0014015455,0.0002588956,0.0004738694],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.0007428693,0.0009344427,0.0018168259,0.0012549025,0.00020963784,0.000081525424,0.0014295712,0.0029569387,0.016977275],"category_scores_gemma":[0.0011119768,0.0009898124,0.00040911185,0.0014684536,0.0004488702,0.00010194989,0.0009436003,0.0036166327,0.9017109],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021970068,0.00016985022,0.000022256896,0.00008391494,0.00012155475,0.0013137391,0.00018885681,0.00023211853,0.041432228,0.00008209276,0.9509366,0.0051970743],"study_design_scores_gemma":[0.0011151363,0.00089724275,0.0001582755,0.000036321613,0.00013400034,0.00026592906,0.000049496484,0.00019900785,0.00071352965,0.00012391678,0.99557745,0.00072967005],"about_ca_topic_score_codex":0.00016220346,"about_ca_topic_score_gemma":0.0003174741,"teacher_disagreement_score":0.8847336,"about_ca_system_score_codex":0.0013251716,"about_ca_system_score_gemma":0.0026383114,"threshold_uncertainty_score":0.99925524},"labels":[],"label_agreement":null},{"id":"W4382395320","doi":"10.1093/neuonc/noad114","title":"Clinical outcome of pediatric medulloblastoma patients with Li–Fraumeni syndrome","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; SickKids Foundation; Hospital for Sick Children; Princess Margaret Cancer Centre","funders":"National Cancer Institute; National Institute of Neurological Disorders and Stroke; Helse Sør-Øst RHF; University of California, San Francisco; Deutschen Konsortium für Translationale Krebsforschung; Université de Recherche Paris Sciences et Lettres; Norges Forskningsråd; Institut Gustave-Roussy; Deutsche Kinderkrebsstiftung; Universitätsklinikum Hamburg-Eppendorf; Making Headway Foundation; Universitätsklinikum Heidelberg; Université Paris-Saclay; Universitetet i Oslo; Bundesministerium für Bildung und Forschung; Hospital for Sick Children; State Government of Victoria; Brain Tumour Research; Institut National de la Santé et de la Recherche Médicale; Bundesamt für Gesundheit; Brain Tumour Charity; Deutsches Krebsforschungszentrum; Centre National de la Recherche Scientifique; Robert Connor Dawes Foundation; Cancer Australia; National Institutes of Health; Friedberg Charitable Foundation; Cancer Research UK; Eli Lilly and Company; Y-mAbs Therapeutics","keywords":"Li–Fraumeni syndrome; Medulloblastoma; Outcome (game theory); Medicine; Pediatrics; Oncology; Cancer research; Mutation; Genetics; Germline mutation; Biology","score_opus":0.03179412279404297,"score_gpt":0.33670182763302103,"score_spread":0.30490770483897806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382395320","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951214,0.000048584094,0.000038458493,0.0008387451,0.0014742669,0.00071482017,0.000028115313,0.00021876002,0.0015168325],"genre_scores_gemma":[0.99799234,0.00010485771,0.00032156784,0.0010788433,0.00022260066,0.000044821492,0.00004836272,0.000075831325,0.000110756024],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974372,0.00022019802,0.00087727146,0.00051981065,0.00048925774,0.00045626602],"domain_scores_gemma":[0.9980389,0.0005608993,0.0003605658,0.0005439696,0.00020058817,0.00029506974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036566865,0.00022364371,0.0008510568,0.0003720211,0.000042586715,0.0000040662912,0.00018611779,0.00037693692,0.00013955931],"category_scores_gemma":[0.00072601676,0.00018776949,0.00020544275,0.0009683335,0.00017701759,0.000043077587,0.00015976751,0.0006843282,0.0004865829],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009406776,0.0008106955,0.97877264,0.00011804194,0.00013411177,0.0021857885,0.000106031766,0.00004341649,0.0026351777,0.000030492645,0.006832334,0.0073905727],"study_design_scores_gemma":[0.01143966,0.017488161,0.9299516,0.000031130978,0.00066636637,0.0004062682,0.000037407972,0.00012359214,0.0005070906,0.000024366955,0.039053943,0.00027037866],"about_ca_topic_score_codex":0.000013502345,"about_ca_topic_score_gemma":0.00001815515,"teacher_disagreement_score":0.048821025,"about_ca_system_score_codex":0.00015248409,"about_ca_system_score_gemma":0.00042622385,"threshold_uncertainty_score":0.7657018},"labels":[],"label_agreement":null},{"id":"W4383481395","doi":"10.1093/neuonc/noad110","title":"Increasing growth and impact of <i>Neuro-Oncology</i>","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Library science; Web site; Gerontology; Oncology; General surgery; Internal medicine; Computer science; The Internet","score_opus":0.025357579235806855,"score_gpt":0.3266095411650331,"score_spread":0.30125196192922626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383481395","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879357,0.00022506183,0.0000016945714,0.0048249853,0.00031441907,0.0004873886,0.000027181013,0.00013904499,0.006044532],"genre_scores_gemma":[0.9972655,0.0007642127,0.000197763,0.0014784982,0.00015616376,0.000058079862,0.000031672862,0.000042942684,0.000005121142],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982198,0.00030707152,0.00040047232,0.00042789165,0.00019719475,0.00044758205],"domain_scores_gemma":[0.9970326,0.0020905242,0.00019403157,0.00029150417,0.00009613558,0.00029520702],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030525413,0.0002376476,0.0007570823,0.00035085878,0.0000822664,0.000010347783,0.00009420171,0.00023150459,0.00006823268],"category_scores_gemma":[0.00095256016,0.00018692321,0.00020302628,0.0005579199,0.00021159908,0.00006448232,0.0001588002,0.0002770064,0.00006575497],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043701127,0.0005676642,0.26454875,0.000047786765,0.00013386336,0.0019341805,0.00024821833,0.0000058273895,0.7123244,0.00014722804,0.0064497055,0.01315539],"study_design_scores_gemma":[0.017883051,0.024004089,0.7315807,0.000108583976,0.001053523,0.006419305,0.0003482919,0.00048166577,0.16399415,0.00059296715,0.05306074,0.00047296326],"about_ca_topic_score_codex":0.00028840904,"about_ca_topic_score_gemma":0.000019675821,"teacher_disagreement_score":0.54833025,"about_ca_system_score_codex":0.0001908661,"about_ca_system_score_gemma":0.00038116626,"threshold_uncertainty_score":0.7622507},"labels":[],"label_agreement":null},{"id":"W4384926001","doi":"10.1093/neuonc/noad126","title":"Integrated molecular analysis reveals hypermethylation and overexpression of HOX genes to be poor prognosticators in isocitrate dehydrogenase mutant glioma","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Queen's University; Thompson Rivers University; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Isocitrate dehydrogenase; Hox gene; Biology; DNA methylation; Glioma; Methylation; Oncology; Cancer research; IDH2; Gene; Genetics; IDH1; Mutant; Gene expression; Medicine","score_opus":0.024133731369126384,"score_gpt":0.31293716154411855,"score_spread":0.28880343017499216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384926001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99612534,0.00021167082,0.000019689247,0.002713253,0.000044222157,0.0007248285,0.00004364501,0.000049463666,0.00006787825],"genre_scores_gemma":[0.9985014,0.00011308772,0.00049202365,0.0006159067,0.000014066189,0.00014827923,0.00009177519,0.000021621257,0.0000017981383],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985281,0.00019361777,0.00041382277,0.00040283552,0.0002001205,0.0002614651],"domain_scores_gemma":[0.9989768,0.00038099306,0.00013300321,0.00022048861,0.000100457895,0.00018820229],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022797725,0.00017131792,0.00058612326,0.00090103905,0.00003298998,0.000008511673,0.00006063655,0.00015338392,0.000029249317],"category_scores_gemma":[0.0004730831,0.00013774562,0.000116582996,0.0023564175,0.000057190155,0.000035240017,0.00007101824,0.000109237684,0.0000094520865],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018309358,0.00034889605,0.061662998,0.00002972328,0.00021432724,0.0011307831,0.00025920683,0.00021448414,0.93028843,0.00006785916,0.000104992374,0.0054952246],"study_design_scores_gemma":[0.0017988161,0.0011114597,0.04563305,0.000053413754,0.0006793732,0.000039007107,0.0002099973,0.002122341,0.94745964,0.00007614044,0.0007067131,0.00011004647],"about_ca_topic_score_codex":0.00009718371,"about_ca_topic_score_gemma":0.000051259885,"teacher_disagreement_score":0.017171228,"about_ca_system_score_codex":0.00009951083,"about_ca_system_score_gemma":0.000093038456,"threshold_uncertainty_score":0.56171036},"labels":[],"label_agreement":null},{"id":"W4385330942","doi":"10.1093/neuonc/noad134","title":"Stationary-to-migratory transition in glioblastoma stem-like cells driven by a fatty acid-binding protein 7-RXR<b>α</b> neurogenic pathway","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Peroxisome Proliferator-Activated Receptors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research; Terry Fox Research Institute","keywords":"Biology; SOX2; Stem cell; Cancer research; Cell migration; Cancer stem cell; Epithelial–mesenchymal transition; Stem cell marker; Cell; Transcription factor; Cell biology; Transition (genetics); Biochemistry; Gene","score_opus":0.01022647543154151,"score_gpt":0.24481000452448196,"score_spread":0.23458352909294045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385330942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969634,0.000065598935,0.00021897913,0.0007249452,0.0006066023,0.0010196214,0.00021790592,0.00013305998,0.00004991392],"genre_scores_gemma":[0.99751055,0.000076834185,0.00016336492,0.001172754,0.00014958996,0.00054137525,0.00018181896,0.00009958802,0.00010410946],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970485,0.0005998819,0.0004946491,0.0008975982,0.0002674395,0.00069195416],"domain_scores_gemma":[0.99902326,0.000094168885,0.00016211087,0.0003656568,0.00009161011,0.00026316906],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00027363581,0.00035288805,0.00035251267,0.0003427021,0.00013251977,0.000029075916,0.00033928046,0.00047541902,0.000031716278],"category_scores_gemma":[0.000103046106,0.0003895239,0.00013063283,0.0007527678,0.00009826123,0.000020637153,0.00015772553,0.00043208135,0.00023414093],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004165618,0.00017922932,0.0005053637,0.000027002889,0.00003202079,0.000113908965,0.00038031724,0.0003910946,0.9904769,0.000003169909,0.005118552,0.0023558862],"study_design_scores_gemma":[0.0011195131,0.0018958795,0.00006647306,0.000014339454,0.000009985581,0.000030891202,0.00024966287,0.00020243149,0.9464868,0.0000044957173,0.049598478,0.00032110172],"about_ca_topic_score_codex":0.00000817725,"about_ca_topic_score_gemma":0.000087715125,"teacher_disagreement_score":0.044479925,"about_ca_system_score_codex":0.00017117475,"about_ca_system_score_gemma":0.00037668025,"threshold_uncertainty_score":0.99985564},"labels":[],"label_agreement":null},{"id":"W4385441608","doi":"10.1093/neuonc/noad141","title":"Phase I trial of panobinostat in children with diffuse intrinsic pontine glioma: A report from the Pediatric Brain Tumor Consortium (PBTC-047)","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Panobinostat; Neutropenia; Tolerability; Glioma; Population; Nausea; Toxicity; Internal medicine; Oncology; Adverse effect","score_opus":0.01781532449310919,"score_gpt":0.29939279666851515,"score_spread":0.28157747217540596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385441608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98837614,0.0001549669,0.0000011655047,0.008505602,0.00042579797,0.0021730727,0.00009442482,0.00010097125,0.00016786308],"genre_scores_gemma":[0.9977422,0.000096452066,0.0000386108,0.00092861766,0.0005891664,0.00030974668,0.00023792872,0.00004457004,0.000012759283],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99755555,0.0002940816,0.0007908204,0.00056518556,0.00035925422,0.0004351076],"domain_scores_gemma":[0.9968683,0.0017514194,0.00047864052,0.0006494192,0.00009104453,0.00016115763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038906446,0.000269501,0.0008255569,0.0003774568,0.000059582413,0.000013573502,0.00016455437,0.000121466444,0.000060830524],"category_scores_gemma":[0.001253686,0.00016948473,0.00014614826,0.0012077652,0.00016325735,0.000047807756,0.000121985395,0.0003330548,0.00004064544],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02257241,0.010109952,0.88667893,0.000014397663,0.00025764955,0.025718203,0.0003884274,0.0000038335525,0.033648893,0.000029811868,0.01602587,0.0045516384],"study_design_scores_gemma":[0.3773936,0.015158432,0.587471,0.000027902464,0.00092292286,0.0033238935,0.00015237596,0.000024578434,0.010080957,0.000051618867,0.0051499465,0.00024277491],"about_ca_topic_score_codex":0.0004947305,"about_ca_topic_score_gemma":0.00020040284,"teacher_disagreement_score":0.35482118,"about_ca_system_score_codex":0.00010501902,"about_ca_system_score_gemma":0.00048479304,"threshold_uncertainty_score":0.6911387},"labels":[],"label_agreement":null},{"id":"W4385483101","doi":"10.1093/neuonc/noad140","title":"<i>Isocitrate dehydrogenase</i> wt and IDHmut adult-type diffuse gliomas display distinct alterations in ribosome biogenesis and 2’O-methylation of ribosomal RNA","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"Institut National Du Cancer; Ligue Contre le Cancer; Direction Générale de l’offre de Soins; Advanced Remanufacturing and Technology Centre; Institut National de la Santé et de la Recherche Médicale; Brigham and Women's Hospital","keywords":"Isocitrate dehydrogenase; Ribosome biogenesis; Ribosomal RNA; Biology; Ribosome; RNA; Methylation; Glioma; Molecular biology; Cancer research; Genetics; Biochemistry; Gene; Enzyme","score_opus":0.019624136466634662,"score_gpt":0.2943896365440803,"score_spread":0.2747655000774456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385483101","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961028,0.0004949759,0.000005227379,0.0023515455,0.0001919346,0.0004994665,0.00010211059,0.00005837585,0.00019355926],"genre_scores_gemma":[0.99844205,0.00078740565,0.00011448753,0.00029970126,0.00007169699,0.000082203886,0.0001650002,0.00002884741,0.0000085932625],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985438,0.00015754785,0.00044743757,0.00039887373,0.00016166613,0.0002906622],"domain_scores_gemma":[0.99876213,0.00060153933,0.00015447858,0.00021169365,0.00009795866,0.00017221333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014452405,0.00020144801,0.00047134364,0.0003386582,0.00009503594,0.00001624117,0.000050332892,0.00015789807,0.0000139556805],"category_scores_gemma":[0.00029925618,0.00017290472,0.000063850624,0.0007224522,0.00015347685,0.00008165914,0.00007629796,0.0001240347,0.000015851127],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023505579,0.0006082846,0.21288206,0.000058883365,0.00006766373,0.0005312853,0.00046364113,0.000015528361,0.7808327,0.00039362628,0.00021464331,0.0036966382],"study_design_scores_gemma":[0.010384397,0.0027931158,0.5729714,0.00009276619,0.0004430814,0.00025888998,0.00016159356,0.0036693942,0.4064151,0.0004288749,0.0020805628,0.0003008143],"about_ca_topic_score_codex":0.00018269701,"about_ca_topic_score_gemma":0.00052058254,"teacher_disagreement_score":0.3744176,"about_ca_system_score_codex":0.00008758181,"about_ca_system_score_gemma":0.00008466994,"threshold_uncertainty_score":0.705085},"labels":[],"label_agreement":null},{"id":"W4385909599","doi":"10.1093/neuonc/noad151","title":"Prognostic value of integrative genomic approaches for IDH-mutant gliomas","year":2023,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Oncology; Library science; Internal medicine; Medicine; Gerontology; Family medicine; Computer science","score_opus":0.0617632911076632,"score_gpt":0.3083971603640845,"score_spread":0.24663386925642128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385909599","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17880476,0.00097030605,0.00013061876,0.8048052,0.002968166,0.008768807,0.00082025863,0.0002833558,0.002448534],"genre_scores_gemma":[0.31427553,0.0007553798,0.0048233015,0.6430739,0.013756899,0.015142598,0.006133354,0.0012417502,0.0007972758],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99727154,0.0002519568,0.00071218057,0.00084301515,0.0003115583,0.00060975744],"domain_scores_gemma":[0.99535334,0.0032879163,0.0005207722,0.0005335555,0.00018849567,0.00011593331],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021047064,0.0005626872,0.0016456399,0.0005360985,0.00006929296,0.000014667702,0.0002509673,0.0011186149,0.000038669696],"category_scores_gemma":[0.0008160576,0.00040357467,0.00055377604,0.00033798872,0.00026278483,0.00002616907,0.00013350468,0.001135983,0.000094030045],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041508826,0.0010945396,0.0020363643,0.0011522857,0.0014605974,0.0074586943,0.00081970927,0.000021096337,0.058193468,0.0006878355,0.9153888,0.011271508],"study_design_scores_gemma":[0.004920245,0.008933267,0.0015961985,0.000313987,0.0028394375,0.00062511227,0.00022242148,0.000545696,0.023995107,0.0009251587,0.95465904,0.0004243336],"about_ca_topic_score_codex":0.000037766702,"about_ca_topic_score_gemma":0.000023544311,"teacher_disagreement_score":0.1617313,"about_ca_system_score_codex":0.00046706924,"about_ca_system_score_gemma":0.00072927674,"threshold_uncertainty_score":0.99984163},"labels":[],"label_agreement":null},{"id":"W4386537414","doi":"10.1093/neuonc/noad137.450","title":"P22.01.A PERSON-CENTRED PRACTICE: EXPLORING FAMILY STRENGTH BY USING GENOGRAMS AND ECOMAPS","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Family and Patient Care in Intensive Care Units","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Genogram; Conversation; Intervention (counseling); Nursing; Distress; Psychology; Kinship; Presentation (obstetrics); Medicine; Developmental psychology; Psychotherapist; Sociology; Communication","score_opus":0.3113215594542156,"score_gpt":0.42121983656914835,"score_spread":0.10989827711493277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386537414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9737485,0.000643254,0.000027586348,0.003915243,0.010837057,0.00082851696,0.00012970647,0.00040781902,0.009462296],"genre_scores_gemma":[0.94586265,0.0028424535,0.0010249291,0.047752768,0.0011714095,0.00037364865,0.00039034398,0.00018680887,0.0003950123],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963745,0.0013036446,0.0005280592,0.00056433456,0.00028912092,0.0009403375],"domain_scores_gemma":[0.9902542,0.00805324,0.0003459939,0.00033696822,0.0007161647,0.00029342843],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003806329,0.00028439614,0.00046108448,0.00023561987,0.0009224142,0.000020871088,0.00020417555,0.00039372663,0.00009016119],"category_scores_gemma":[0.005051175,0.00028379992,0.000079750316,0.0005594418,0.00015188588,0.0003416248,0.00026164437,0.0012404529,0.00033758365],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069499225,0.0002565399,0.016445221,0.00033389463,0.00016893794,0.0010971338,0.06628733,0.00005052729,0.21512663,0.00042076217,0.6416059,0.057512112],"study_design_scores_gemma":[0.0014788816,0.0007103343,0.00084287854,0.0001356564,0.00008390803,0.0000357637,0.14012124,0.0010109764,0.0003650022,0.000016292885,0.8549173,0.00028178643],"about_ca_topic_score_codex":0.00038457804,"about_ca_topic_score_gemma":0.00004094718,"teacher_disagreement_score":0.21476163,"about_ca_system_score_codex":0.00033864254,"about_ca_system_score_gemma":0.0003550977,"threshold_uncertainty_score":0.99996144},"labels":[],"label_agreement":null},{"id":"W4386537420","doi":"10.1093/neuonc/noad137.391","title":"P17.01.A THE VALUE OF ETOPOSIDE FOR RECURRENT GLIOMA","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Etoposide; Medicine; Glioma; Internal medicine; Bevacizumab; Chemotherapy; Retrospective cohort study; Oligodendroglioma; Carboplatin; Surgery; Oncology; Astrocytoma; Cisplatin; Cancer research","score_opus":0.03986563303474235,"score_gpt":0.34630953173963214,"score_spread":0.3064438987048898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386537420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9689496,0.00034702526,0.000010513618,0.026847288,0.0010386348,0.0010214314,0.000031082935,0.00008034594,0.0016740488],"genre_scores_gemma":[0.9976253,0.0001935678,0.0001759378,0.0012729595,0.0002252566,0.00041731625,0.000035147565,0.000027163787,0.000027365415],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99893713,0.000099639685,0.00028048584,0.0002432323,0.0001627813,0.00027673363],"domain_scores_gemma":[0.9980884,0.0013047607,0.000116986455,0.0003228102,0.000079465986,0.00008756234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023482552,0.00012370881,0.00034946078,0.00013283112,0.000075261196,0.0000051629304,0.00011202106,0.00009940397,0.000043736312],"category_scores_gemma":[0.00037453577,0.00007814568,0.00018052688,0.00035308488,0.000090937356,0.000016886472,0.000067983754,0.00011911377,0.00007343223],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091993227,0.0013945857,0.0068505947,0.00014480037,0.00026846884,0.00075869303,0.00081930234,0.000061303326,0.7230368,0.009135826,0.1399472,0.11666249],"study_design_scores_gemma":[0.006216065,0.008375509,0.02275045,0.00005631816,0.00051835185,0.00028772405,0.00027671852,0.0009869208,0.33864996,0.0014327606,0.6203143,0.0001349042],"about_ca_topic_score_codex":0.000020132988,"about_ca_topic_score_gemma":0.000027012555,"teacher_disagreement_score":0.48036712,"about_ca_system_score_codex":0.00008284009,"about_ca_system_score_gemma":0.00013867184,"threshold_uncertainty_score":0.31866884},"labels":[],"label_agreement":null},{"id":"W4386537550","doi":"10.1093/neuonc/noad137.155","title":"P06.15.B IMMUNOTHERAPEUTIC TARGETING OF FIBROBLAST ACTIVATION PROTEIN (FAP) IN TREATMENT REFRACTORY GLIOBLASTOMA USING NOVEL CAR-T CELL THERAPY","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Fibroblast activation protein, alpha; Chimeric antigen receptor; Cancer research; Stromal cell; Medicine; Glioma; Antigen; U87; Immunology; Immunotherapy; Cancer; Internal medicine; Immune system","score_opus":0.05777059559807561,"score_gpt":0.3468138788377503,"score_spread":0.28904328323967465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386537550","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959329,0.00013853563,0.000046477806,0.00059178536,0.00010816136,0.0018547848,0.000008895874,0.00011202142,0.0012064741],"genre_scores_gemma":[0.99787134,0.00023559603,0.0005116693,0.00025622523,0.00021414093,0.00017053068,0.00002357157,0.00011471897,0.0006022144],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975449,0.0003137208,0.0006020952,0.00050664606,0.000418442,0.00061423186],"domain_scores_gemma":[0.9984264,0.0005813902,0.00028419076,0.00045309617,0.00014555076,0.00010937293],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00044971218,0.0002967861,0.0006475884,0.0006691577,0.000083800376,0.000013742121,0.00016628759,0.00029669897,0.0006174775],"category_scores_gemma":[0.00010029596,0.00026684173,0.00016942427,0.0010271702,0.0001495026,0.000111090936,0.000068980335,0.00049077254,0.000036769194],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038446554,0.0010283088,0.00079141435,0.000083053674,0.00006597051,0.00007773509,0.0016041314,0.00024523906,0.96138495,0.000005521566,0.000050938765,0.030818092],"study_design_scores_gemma":[0.007579278,0.0073850024,0.0016203418,0.0001435713,0.000014509864,0.000033598866,0.00050190825,0.0016096019,0.9446192,0.000017880553,0.036300007,0.00017511072],"about_ca_topic_score_codex":0.00045687967,"about_ca_topic_score_gemma":0.00004869459,"teacher_disagreement_score":0.036249068,"about_ca_system_score_codex":0.0011521401,"about_ca_system_score_gemma":0.0007305089,"threshold_uncertainty_score":0.99997836},"labels":[],"label_agreement":null},{"id":"W4386537575","doi":"10.1093/neuonc/noad137.004","title":"PL02.2.A RAPID, COMPREHENSIVE REPORTING OF MOLECULAR DIAGNOSTICS WITH RAPID-CNS2: A PROSPECTIVE VALIDATION COHORT","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Indel; Turnaround time; Concordance; DNA sequencing; Nanopore sequencing; Computational biology; Subtyping; Molecular diagnostics; Copy-number variation; Medical diagnosis; Whole genome sequencing; Biology; Medicine; Bioinformatics; Genetics; Computer science; Genome; Gene; Single-nucleotide polymorphism; Pathology; Genotype","score_opus":0.030956044199625266,"score_gpt":0.31722814736600796,"score_spread":0.2862721031663827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386537575","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936054,0.0002613556,0.00006807066,0.0017225767,0.00024601823,0.0016316336,0.00001454726,0.00014921658,0.0023012266],"genre_scores_gemma":[0.9977048,0.0004826442,0.0005993526,0.00058727904,0.00007774583,0.00037436179,0.00011852059,0.000047061923,0.000008246782],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99780256,0.00014813335,0.00086055434,0.0004893116,0.0003667042,0.0003327147],"domain_scores_gemma":[0.9970035,0.000925534,0.0010367505,0.00040729778,0.0004856686,0.00014126442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027066565,0.00022197656,0.00079523114,0.00024061954,0.00007222516,0.000009843946,0.000068716756,0.00014216328,0.000059427664],"category_scores_gemma":[0.0016628326,0.00017729867,0.00013027278,0.000647971,0.00015068341,0.00004422539,0.00007572548,0.00021863067,0.000040934574],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004013254,0.00093286694,0.54690087,0.0001126145,0.00055328605,0.009575114,0.00053967297,0.00027457147,0.42645586,0.00039729185,0.0030294247,0.010827126],"study_design_scores_gemma":[0.005268122,0.0059321662,0.4040607,0.000121639285,0.0008441026,0.0006752718,0.00038371657,0.00020406338,0.5724694,0.00017083134,0.009663237,0.00020674808],"about_ca_topic_score_codex":0.000038498965,"about_ca_topic_score_gemma":0.0000059216163,"teacher_disagreement_score":0.14601354,"about_ca_system_score_codex":0.00017618963,"about_ca_system_score_gemma":0.00027101015,"threshold_uncertainty_score":0.72300303},"labels":[],"label_agreement":null},{"id":"W4386537608","doi":"10.1093/neuonc/noad137.101","title":"P02.16.B COMPENSATORY CROSS-TALK BETWEEN AUTOPHAGY AND GLYCOLYSIS REGULATES SENESCENCE AND STEMNESS IN HETEROGENEOUS GLIOBLASTOMA TUMOR SUBPOPULATIONS","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Manitoba","funders":"","keywords":"Biology; Glycolysis; Cancer research; Autophagy; Stem cell; Senescence; Cancer stem cell; Downregulation and upregulation; Cell biology; Apoptosis; Biochemistry; Metabolism","score_opus":0.014845394026434023,"score_gpt":0.2903988259796543,"score_spread":0.27555343195322024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386537608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970572,0.0015917129,0.000022807923,0.00016787909,0.0006958524,0.00029136488,0.000056962137,0.000052347343,0.00006387002],"genre_scores_gemma":[0.9981663,0.00058107346,0.000058767735,0.00031899445,0.0006088057,0.00005727495,0.00006439534,0.00003795862,0.00010638395],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982504,0.00019503722,0.0003694019,0.0006391602,0.00012564957,0.00042029933],"domain_scores_gemma":[0.9991837,0.00011570094,0.0001374848,0.0003279363,0.00006743354,0.00016770697],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022610924,0.00022976412,0.0004272389,0.00017741868,0.00015618527,0.000043571014,0.00016149535,0.00024069397,0.00001332901],"category_scores_gemma":[0.00011057124,0.00024735433,0.000071599905,0.000299693,0.00030729757,0.00001166891,0.0002704092,0.00016015788,0.000007717874],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001865638,0.000045186986,0.0639298,0.00004864746,0.000038235492,0.00009182236,0.00012464444,0.00023157102,0.92298096,0.00002768504,0.00036491538,0.011929975],"study_design_scores_gemma":[0.003046716,0.0009896468,0.48122248,0.000023540995,0.00009932136,0.00071017275,0.00012331795,0.0005265525,0.33570683,0.00020117633,0.17675874,0.00059151615],"about_ca_topic_score_codex":0.00012527678,"about_ca_topic_score_gemma":0.000985595,"teacher_disagreement_score":0.58727413,"about_ca_system_score_codex":0.000042094773,"about_ca_system_score_gemma":0.00012926412,"threshold_uncertainty_score":0.99999785},"labels":[],"label_agreement":null},{"id":"W4386537623","doi":"10.1093/neuonc/noad137.220","title":"P10.22.B COMBINATION OF ARTS MIMETICS WITH AUTOPHAGY INHIBITORS AS A NOVEL THERAPEUTIC STRATEGY TO OVERCOME APOPTOSIS RESISTANCE IN GLIOBLASTOMA","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Nanoplatforms for cancer theranostics","field":"Engineering","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Manitoba","funders":"Institut National Du Cancer; European Commission","keywords":"Apoptosis; Autophagy; Programmed cell death; In vivo; Cancer research; Medicine; Downregulation and upregulation; Radiation therapy; Chemistry; Biology; Internal medicine; Biochemistry; Biotechnology","score_opus":0.016721277247648207,"score_gpt":0.26192059412356977,"score_spread":0.24519931687592156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386537623","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957797,0.00009890673,0.0006973109,0.0002051202,0.0006622393,0.0004949526,0.00002210335,0.0002811552,0.0017585253],"genre_scores_gemma":[0.9990581,0.00005553414,0.0004067733,0.00021572394,0.00004463268,0.000073826006,0.000005815172,0.00008084517,0.000058737805],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985466,0.000029568551,0.0004378179,0.0002743443,0.00028676473,0.00042493298],"domain_scores_gemma":[0.9990865,0.00034967635,0.000093751994,0.0002920695,0.0000782928,0.0000996975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016399763,0.00023398257,0.00040756198,0.00048167745,0.00003329336,0.000017758306,0.00021377068,0.00018870333,0.000023384573],"category_scores_gemma":[0.000054687305,0.0002353963,0.000050066,0.0014015554,0.000067808425,0.00013057917,0.000044290868,0.00028128215,0.000054064665],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036294135,0.00013578906,0.00023664402,0.00010942041,0.000045240715,0.000045864443,0.00087950507,0.02043313,0.9710781,0.0020338371,0.0004058995,0.004233656],"study_design_scores_gemma":[0.0040210965,0.004674991,0.0042368206,0.00013583056,0.000057986406,0.000024520079,0.00028832103,0.0047740783,0.9591562,0.002610103,0.019503979,0.00051607407],"about_ca_topic_score_codex":0.000024786315,"about_ca_topic_score_gemma":0.00040364228,"teacher_disagreement_score":0.019098079,"about_ca_system_score_codex":0.00036073654,"about_ca_system_score_gemma":0.00013344354,"threshold_uncertainty_score":0.95991826},"labels":[],"label_agreement":null},{"id":"W4386537642","doi":"10.1093/neuonc/noad137.071","title":"OS12.7.A IMPLEMENTATION OF A NATIONAL AYA MOLECULAR TUMOR BOARD: REPORT FROM THE CANADIAN AYA NEURO-ONCOLOGY NETWORK","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; Princess Margaret Cancer Centre; Hospital for Sick Children; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Interim; Population; Survivorship curve; Neurosurgery; Oncology; Young adult; Pediatrics; Family medicine; Internal medicine; Cancer; Surgery","score_opus":0.02576346696352007,"score_gpt":0.3355378453889705,"score_spread":0.30977437842545047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386537642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94584984,0.00017880452,0.0000089747455,0.045968663,0.0013970739,0.001145467,0.00015141611,0.0000894752,0.0052102795],"genre_scores_gemma":[0.98352474,0.00005597124,0.00027356847,0.014529728,0.00058353547,0.00036528817,0.000604429,0.000049419614,0.000013335827],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972238,0.0003694868,0.0007126453,0.0005525356,0.0005273729,0.00061417074],"domain_scores_gemma":[0.9971443,0.0013574654,0.00041286752,0.00045340788,0.0003079887,0.0003239683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000548036,0.00024342882,0.0005712468,0.00023124026,0.0002277534,0.000020313462,0.00020160958,0.00018377515,0.0004585072],"category_scores_gemma":[0.00056490407,0.00019647897,0.00019881925,0.00068740774,0.00015743924,0.000048428315,0.000111245514,0.00033604444,0.00013580354],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025993524,0.0005436914,0.4003819,0.000025354066,0.0006492804,0.039770156,0.0009908634,0.0008383516,0.16320701,0.0024754761,0.37087455,0.019983418],"study_design_scores_gemma":[0.004457191,0.0016499269,0.324023,0.000020952462,0.0003924421,0.0011558871,0.0004765552,0.00028907973,0.011394061,0.0012997562,0.65463364,0.00020751794],"about_ca_topic_score_codex":0.053697526,"about_ca_topic_score_gemma":0.18801734,"teacher_disagreement_score":0.2837591,"about_ca_system_score_codex":0.00077755813,"about_ca_system_score_gemma":0.0030114057,"threshold_uncertainty_score":0.952604},"labels":[],"label_agreement":null},{"id":"W4386537711","doi":"10.1093/neuonc/noad137.173","title":"P07.13.B A RANDOMIZED STUDY OF LOW-INTENSITY FOCUSED ULTRASOUND FOR BLOOD-BRAIN BARRIER DISRUPTION FOR BRAIN METASTASIS FROM NON-SMALL CELL LUNG CANCER (LIMITLESS)","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Ultrasound and Hyperthermia Applications","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Pembrolizumab; Lung cancer; Brain metastasis; Internal medicine; Microbubbles; Oncology; Randomized controlled trial; Cancer; Metastasis; Immunotherapy; Ultrasound; Radiology","score_opus":0.017863501952171585,"score_gpt":0.276954727855032,"score_spread":0.25909122590286043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386537711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97747767,0.000113278795,0.015752908,0.000639117,0.0005067839,0.0042891284,0.0008023487,0.0002633367,0.00015545491],"genre_scores_gemma":[0.9928861,0.000106579704,0.001304472,0.00044223398,0.00026923636,0.0046202736,0.0001548717,0.000110657464,0.00010555857],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9982222,0.00016671207,0.0005798285,0.00046740664,0.00013509455,0.00042880687],"domain_scores_gemma":[0.99090034,0.008309369,0.00016328084,0.00034313346,0.00016234543,0.00012155268],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00056245533,0.00029066496,0.0010213825,0.00016717165,0.00014567656,0.00002862859,0.00026457544,0.00019787194,0.000059427504],"category_scores_gemma":[0.000581174,0.00027428943,0.00032441763,0.0003109874,0.00007807506,0.00006859927,0.000038121005,0.00020680804,0.000010348357],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032307224,0.00046436652,0.00065070955,0.00018256294,0.00060479913,0.0000057962075,0.00435355,0.005817376,0.97642034,0.00004280788,0.0064850724,0.0017418741],"study_design_scores_gemma":[0.47101688,0.0023839008,0.004230918,0.00011346828,0.0073550907,0.000022745442,0.0063165366,0.17195202,0.28747112,0.0023445045,0.044779044,0.0020137664],"about_ca_topic_score_codex":0.00028873884,"about_ca_topic_score_gemma":0.0014771217,"teacher_disagreement_score":0.6889492,"about_ca_system_score_codex":0.00008114701,"about_ca_system_score_gemma":0.000093058996,"threshold_uncertainty_score":0.9999709},"labels":[],"label_agreement":null},{"id":"W4386537716","doi":"10.1093/neuonc/noad137.019","title":"JS03.6.A NEUROTOXICITY IN PATIENTS WITH CNS LYMPHOMAS TREATED WITH CAR T CELL THERAPY. A LOC NETWORK STUDY","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Neurotoxicity; Lymphoma; Encephalopathy; Internal medicine; Toxicity; Gastroenterology; Pediatrics; Oncology","score_opus":0.026686438841491265,"score_gpt":0.3005137498712934,"score_spread":0.2738273110298022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386537716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900736,0.000033450244,0.0000019046873,0.0003549006,0.00014643195,0.004600039,0.000007945984,0.0002629252,0.004518791],"genre_scores_gemma":[0.9970614,0.00009416362,0.000029461595,0.0011302371,0.00019683025,0.0004306104,0.000043440778,0.0001452883,0.0008686144],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996279,0.0007994771,0.00040802252,0.0008171566,0.0007168959,0.0009794735],"domain_scores_gemma":[0.99806863,0.0005388582,0.00014006704,0.0007525838,0.00020699324,0.00029288762],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042555388,0.00038470826,0.0008288136,0.0003847814,0.00012197252,0.000025269606,0.000268912,0.00019242376,0.0004896737],"category_scores_gemma":[0.000052390795,0.00027411574,0.00007677942,0.0021608965,0.00020114159,0.0000686087,0.00012467566,0.00068615505,0.00011212466],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016736139,0.003526752,0.9351137,0.000022338843,0.00011303954,0.0028554413,0.0010139222,0.00042697488,0.0263734,0.0000017019705,0.001443745,0.012372825],"study_design_scores_gemma":[0.04748793,0.054282676,0.8609701,0.00003165796,0.00008404736,0.0000573003,0.00038096844,0.00033150715,0.004180547,0.000006606266,0.031833604,0.00035310147],"about_ca_topic_score_codex":0.000334788,"about_ca_topic_score_gemma":0.00049985835,"teacher_disagreement_score":0.07414366,"about_ca_system_score_codex":0.00038530666,"about_ca_system_score_gemma":0.00053357985,"threshold_uncertainty_score":0.9999711},"labels":[],"label_agreement":null},{"id":"W4386537729","doi":"10.1093/neuonc/noad137.449","title":"P21.07.B THE LHSC/WESTERN BRAIN TUMOUR TISSUE BANK: A GLOBAL RESOURCE","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Tissue bank; Brain tissue; Medicine; Pathology; Tumour tissue; Internal medicine","score_opus":0.02734096135030423,"score_gpt":0.33230360508125195,"score_spread":0.3049626437309477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386537729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8394713,0.00023740815,0.0000056482486,0.14702837,0.00048717175,0.00065371057,0.0000307157,0.00025362967,0.011832043],"genre_scores_gemma":[0.98039424,0.00005241001,0.00003439945,0.018190302,0.00052340206,0.00017364332,0.000047536643,0.000038126087,0.00054592616],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982077,0.00026898063,0.0002906926,0.0004359134,0.0002881105,0.0005086156],"domain_scores_gemma":[0.99827313,0.000888082,0.00010141665,0.00048346657,0.000048770835,0.0002051373],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00027924008,0.00021603206,0.00042034822,0.00008086703,0.0001472733,0.000027708991,0.0002131064,0.00016326792,0.00020485102],"category_scores_gemma":[0.00038451582,0.00014459802,0.00011974482,0.0005279749,0.00012790154,0.00003142907,0.00019054869,0.00025083852,0.002517848],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003571294,0.0010080911,0.09147522,0.0000498718,0.00019566772,0.013028018,0.000988887,0.000053709817,0.119500175,0.0010558374,0.676587,0.0957004],"study_design_scores_gemma":[0.0025687423,0.0015035261,0.107654825,0.000021431148,0.00013927012,0.0008734881,0.00019416724,0.00005816724,0.0050555035,0.00015017646,0.88167006,0.0001106357],"about_ca_topic_score_codex":0.00008172361,"about_ca_topic_score_gemma":0.00018268454,"teacher_disagreement_score":0.20508307,"about_ca_system_score_codex":0.00022767155,"about_ca_system_score_gemma":0.00016586801,"threshold_uncertainty_score":0.9982588},"labels":[],"label_agreement":null},{"id":"W4386537738","doi":"10.1093/neuonc/noad137.263","title":"P11.29.B UPDATE ON GBM AGILE: A GLOBAL, PHASE 2/3 ADAPTIVE PLATFORM TRIAL TO EVALUATE MULTIPLE REGIMENS IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Agile software development; Medicine; Biomarker; Glioblastoma; Randomization; Clinical trial; Oncology; Internal medicine; Medical physics; Computer science; Cancer research; Biology; Software engineering","score_opus":0.05586208752735044,"score_gpt":0.3697767566920936,"score_spread":0.31391466916474314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386537738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845216,0.00011350575,0.0000026900123,0.010232784,0.0012140915,0.0030438732,0.00014397789,0.00016120423,0.00056623115],"genre_scores_gemma":[0.9952269,0.00037649224,0.00013514356,0.0028552113,0.0002817298,0.0010004768,0.000067243,0.000042127365,0.000014684246],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99729663,0.00022482197,0.0005481067,0.00082984625,0.00041638306,0.0006842008],"domain_scores_gemma":[0.9976732,0.001136094,0.00017458716,0.00043095852,0.000096788994,0.0004883494],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000397712,0.00037540862,0.00081499177,0.00042252176,0.000100140496,0.000026019954,0.00012799534,0.00022062633,0.00007495235],"category_scores_gemma":[0.0010720111,0.0002924783,0.00013425086,0.00094511197,0.00008401472,0.000078035155,0.00017187874,0.0003325561,0.0004939501],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.32791921,0.0126518905,0.006156654,0.00005491162,0.00037231803,0.020986767,0.0017359282,0.00036278943,0.017583782,0.0006674599,0.11612668,0.49538162],"study_design_scores_gemma":[0.5871817,0.14211102,0.01840485,0.0003124346,0.0005347184,0.00027301055,0.0006312646,0.0055334647,0.011347584,0.00032429636,0.23267148,0.00067419314],"about_ca_topic_score_codex":0.000095553885,"about_ca_topic_score_gemma":0.0012213868,"teacher_disagreement_score":0.4947074,"about_ca_system_score_codex":0.00070905994,"about_ca_system_score_gemma":0.00027693852,"threshold_uncertainty_score":0.99995273},"labels":[],"label_agreement":null},{"id":"W4386537774","doi":"10.1093/neuonc/noad137.297","title":"P11.63.B VALIDATING THE NEUROLOGIC ASSESSMENT IN NEURO-ONCOLOGY (NANO) SCALE IN CLINICAL PRACTICE: A MULTI-CENTER PROSPECTIVE STUDY IN PATIENTS WITH GLIOBLASTOMA","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Internal medicine; Clinical trial; Prospective cohort study; Demographics; Performance status; Oncology; Physical therapy; Cancer","score_opus":0.03686687034144451,"score_gpt":0.3955371347037637,"score_spread":0.3586702643623192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386537774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98402077,0.000016083073,0.0000026799908,0.008891601,0.0007435966,0.005592225,0.000011082553,0.00010271038,0.0006192591],"genre_scores_gemma":[0.9935353,0.000040232637,0.00037433134,0.0043045683,0.000101577745,0.0015506557,0.00002076654,0.00006817304,0.000004430789],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9928206,0.0030866622,0.0013948188,0.0012498582,0.0005624265,0.00088563253],"domain_scores_gemma":[0.9939053,0.0044795275,0.0005640109,0.00065230293,0.00021202382,0.00018682462],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018641718,0.00043819478,0.0011723444,0.0006310774,0.0001162554,0.00003676143,0.00030767426,0.00031863453,0.000027143851],"category_scores_gemma":[0.0023379643,0.00029322066,0.00012853926,0.0016705956,0.00023063063,0.0001956342,0.0004463112,0.0017957927,0.00007111566],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032361161,0.04129743,0.9383505,0.0000151445165,0.00006824056,0.0062754652,0.0015779934,0.0001736011,0.0005865903,0.000011533809,0.00022660854,0.008180757],"study_design_scores_gemma":[0.046820115,0.03495258,0.9125413,0.000033182332,0.0001422048,0.000107249936,0.0018177343,0.00090154546,0.000083721796,0.000012021488,0.0023952737,0.00019308909],"about_ca_topic_score_codex":0.00015438854,"about_ca_topic_score_gemma":0.0037800733,"teacher_disagreement_score":0.043584,"about_ca_system_score_codex":0.0007985532,"about_ca_system_score_gemma":0.00056655693,"threshold_uncertainty_score":0.999952},"labels":[],"label_agreement":null},{"id":"W4386537972","doi":"10.1093/neuonc/noad137.061","title":"OS09.4.A RANO 2.0: UPDATE TO THE RESPONSE ASSESSMENT IN NEURO-ONCOLOGY (RANO) CRITERIA FOR HIGH- AND LOW-GRADE GLIOMAS IN ADULTS","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Glioma; Cohort; Glioblastoma; Radiation therapy; Tumor progression; Medical physics; Radiology; Oncology; Surgery; Internal medicine; Cancer; Cancer research","score_opus":0.025056878561897655,"score_gpt":0.3532995330266157,"score_spread":0.32824265446471806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386537972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8571912,0.00012278726,0.00001205045,0.1385234,0.0011373853,0.002713143,0.00007512775,0.000093096416,0.00013179843],"genre_scores_gemma":[0.98546404,0.0003555638,0.0005647542,0.011087839,0.00022720188,0.0021375366,0.0000723202,0.00007177114,0.000018996428],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9958914,0.0013397485,0.00075471244,0.00090283906,0.00026743734,0.00084385637],"domain_scores_gemma":[0.99457395,0.0042971293,0.00016065523,0.00058468507,0.00009373095,0.0002898445],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015044208,0.00037183662,0.00094478513,0.00089006964,0.00012737495,0.0000343247,0.00025135058,0.00031298396,0.000075143376],"category_scores_gemma":[0.0010994275,0.00028413333,0.00011939857,0.0011325382,0.00014077073,0.00007920582,0.00026281353,0.00046699072,0.00009548869],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02983051,0.0037917634,0.04393014,0.00024527896,0.00015265045,0.01608267,0.0035554266,0.00017140838,0.81452954,0.0014009493,0.040827252,0.04548244],"study_design_scores_gemma":[0.036214005,0.012648437,0.59785295,0.00017596682,0.00019494307,0.00049827754,0.0006738435,0.001689329,0.0148419235,0.00046897726,0.3343247,0.00041665416],"about_ca_topic_score_codex":0.00018629117,"about_ca_topic_score_gemma":0.0014904772,"teacher_disagreement_score":0.79968756,"about_ca_system_score_codex":0.0005145691,"about_ca_system_score_gemma":0.00049625436,"threshold_uncertainty_score":0.9999611},"labels":[],"label_agreement":null},{"id":"W4386537973","doi":"10.1093/neuonc/noad137.006","title":"PL02.4.A SHARED DECISION-MAKING IN NEUROSURGICAL CONSULTATIONS WITH NEWLY DIAGNOSED BRAIN TUMOR PATIENTS: A THEMATIC ANALYSIS OF PATIENT INVOLVEMENT","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Patient-Provider Communication in Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Thematic analysis; Coding (social sciences); Medicine; Psychology; Qualitative research; Medical education; Nursing","score_opus":0.09808959879734741,"score_gpt":0.4129529608637065,"score_spread":0.31486336206635906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386537973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99153626,0.00006436605,0.00015128628,0.0039211796,0.0004593116,0.0030247762,0.00021480385,0.00017030729,0.00045770916],"genre_scores_gemma":[0.98911273,0.000036698402,0.002176635,0.006347942,0.00001825883,0.0019854554,0.0002656324,0.000051452695,0.0000051785123],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9931882,0.0026406606,0.0021336356,0.0006326529,0.0006714611,0.0007334106],"domain_scores_gemma":[0.96958065,0.02710618,0.0013148846,0.0010628854,0.00071914814,0.00021627275],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004775838,0.0002890909,0.0009878341,0.0015412502,0.00046740193,0.000011992023,0.00057343335,0.00021203455,0.0002825157],"category_scores_gemma":[0.008473688,0.00024953764,0.00015053304,0.00505636,0.00018711957,0.0001685366,0.00053970964,0.00089972455,0.00010596257],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012648533,0.002036886,0.84001684,0.00056913274,0.00033138605,0.00030292888,0.11586243,0.020735143,0.00057097815,0.0019339115,0.0037182218,0.01265731],"study_design_scores_gemma":[0.02035072,0.005404915,0.84292936,0.0027910355,0.000744511,0.0000058215137,0.074988894,0.034716986,0.000043949138,0.002877406,0.014213975,0.00093241106],"about_ca_topic_score_codex":0.0004256808,"about_ca_topic_score_gemma":0.00434772,"teacher_disagreement_score":0.040873535,"about_ca_system_score_codex":0.000802622,"about_ca_system_score_gemma":0.001300631,"threshold_uncertainty_score":0.9999957},"labels":[],"label_agreement":null},{"id":"W4386538594","doi":"10.1093/neuonc/noad137.403","title":"P17.13.A OUTCOME ANALYSIS OF PATIENTS WITH RECURRENT HIGH-GRADE GLIOMAS TREATED WITH ORAL ETOPOSIDE (VP16) IN ALBERTA, CANADA: A POPULATION-BASED RETROSPECTIVE STUDY","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Etoposide; Internal medicine; Proportional hazards model; Glioma; Retrospective cohort study; Population; Survival analysis; Log-rank test; Progression-free survival; Oligodendroglioma; Surgery; Overall survival; Chemotherapy; Astrocytoma","score_opus":0.01726419991707103,"score_gpt":0.2886614279773033,"score_spread":0.2713972280602323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386538594","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99705327,0.000007705685,6.9795107e-7,0.0012507216,0.00010574442,0.0013944709,0.00009729807,0.000039584676,0.000050537034],"genre_scores_gemma":[0.9987651,0.0000016715339,0.000033970347,0.00021919495,0.000012640501,0.00023978161,0.0006815071,0.000035334764,0.000010766794],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976277,0.0002506351,0.0005811177,0.0005827368,0.00057384744,0.00038396797],"domain_scores_gemma":[0.9984177,0.00044992607,0.0003236183,0.00042747482,0.0002135119,0.0001677771],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001140709,0.00029712231,0.0012260998,0.0010289081,0.0000618346,0.000007592135,0.000094493036,0.00009414454,0.0000517202],"category_scores_gemma":[0.0001591363,0.00020516953,0.00009895471,0.003647912,0.000047965328,0.000038465485,0.000031184496,0.00020675357,0.0000029845228],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012167791,0.0037513284,0.9902898,0.000013606189,0.0011858008,0.0011125796,0.00023909933,0.0015744837,0.00007458279,0.000013559526,0.00010865989,0.0004197147],"study_design_scores_gemma":[0.012470273,0.007305977,0.97650474,0.000021830787,0.0024698037,0.0000021481153,0.00015239704,0.0005808497,0.000252422,0.0000026469822,0.00007153288,0.00016535375],"about_ca_topic_score_codex":0.7184881,"about_ca_topic_score_gemma":0.9740721,"teacher_disagreement_score":0.255584,"about_ca_system_score_codex":0.0013988321,"about_ca_system_score_gemma":0.00046611208,"threshold_uncertainty_score":0.8366571},"labels":[],"label_agreement":null},{"id":"W4386538802","doi":"10.1093/neuonc/noad137.005","title":"PL02.3.A NRG ONCOLOGY STUDY BN007: RANDOMIZED PHASE II/III TRIAL OF IPILIMIUMAB (IPI) PLUS NIVOLUMAB (NIVO) VS. TEMOZOLOMIDE (TMZ) IN MGMT-UNMETHYLATED (UMGMT) NEWLY DIAGNOSED GLIOBLASTOMA (NGBM)","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Temozolomide; Medicine; Internal medicine; Hazard ratio; Clinical endpoint; Nivolumab; Oncology; Progression-free survival; Randomized controlled trial; Phases of clinical research; Dacarbazine; Surrogate endpoint; Cancer; Chemotherapy; Confidence interval; Immunotherapy","score_opus":0.027444133392864743,"score_gpt":0.3433068402133076,"score_spread":0.3158627068204429,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386538802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9764328,0.0002866918,0.000009166459,0.0052957437,0.0031144777,0.012393593,0.00006389167,0.00041210026,0.001991564],"genre_scores_gemma":[0.9939001,0.0006541621,0.000147612,0.0010633842,0.00056929066,0.003205163,0.00013414194,0.00016358793,0.00016253215],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.98949647,0.0034203322,0.0030324552,0.0016420461,0.00093075074,0.0014779326],"domain_scores_gemma":[0.98671454,0.0097232405,0.0012764294,0.0013075144,0.00036687742,0.0006113848],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0030107105,0.00095328153,0.005811523,0.001997493,0.00028684354,0.00003187557,0.0005912114,0.00097002287,0.0005129009],"category_scores_gemma":[0.0042599356,0.00082818023,0.0009537735,0.0025650507,0.0006859821,0.00017726167,0.00057735835,0.0011883866,0.00021603196],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.86354184,0.034117777,0.0009957092,0.00006468507,0.0011721206,0.016627146,0.0044002915,0.00025678362,0.04320016,0.00007020493,0.011664774,0.023888513],"study_design_scores_gemma":[0.8803274,0.089934036,0.00086351397,0.000082398365,0.0016239752,0.00018192222,0.0016131992,0.001980692,0.011919982,0.00011746085,0.010859998,0.0004954262],"about_ca_topic_score_codex":0.0011695863,"about_ca_topic_score_gemma":0.0022473664,"teacher_disagreement_score":0.05581626,"about_ca_system_score_codex":0.001776264,"about_ca_system_score_gemma":0.0020838014,"threshold_uncertainty_score":0.9994169},"labels":[],"label_agreement":null},{"id":"W4386557984","doi":"10.1093/neuonc/noad137.011","title":"KS02.6.A INDIGO: A GLOBAL, RANDOMIZED, DOUBLE-BLINDED, PHASE III STUDY OF VORASIDENIB VERSUS PLACEBO IN PATIENTS WITH RESIDUAL OR RECURRENT GRADE 2 GLIOMA WITH AN IDH1/2 MUTATION","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"","keywords":"Medicine; Internal medicine; Glioma; Interim analysis; Randomized controlled trial; Clinical endpoint; Placebo; Randomization; Hazard ratio; Surgery; Oncology; Confidence interval; Pathology","score_opus":0.0548570023581767,"score_gpt":0.3746291240748868,"score_spread":0.3197721217167101,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386557984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99195564,0.000030071918,0.0000024383367,0.0004281298,0.00039208526,0.006938688,0.000035495843,0.00010121732,0.00011624437],"genre_scores_gemma":[0.99840397,0.000015740852,0.00010982788,0.000059855953,0.00006332651,0.0010909196,0.0002134098,0.000040756117,0.0000021898063],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99684495,0.0005962216,0.00073349715,0.0006597724,0.0007085182,0.000457053],"domain_scores_gemma":[0.9977951,0.00085030904,0.00046120325,0.00044073863,0.00022134367,0.00023131096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004336623,0.00035224788,0.0012384442,0.00056087726,0.000085825624,0.000023410694,0.00014746631,0.00015463216,0.0000339944],"category_scores_gemma":[0.0002078212,0.00022568004,0.000065192115,0.0015640978,0.00017424984,0.00015600471,0.000068967296,0.00025360787,0.000014109126],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.91767365,0.019642906,0.047885302,0.000036915666,0.00047639158,0.0048763226,0.00283291,0.00015437289,0.00018631747,0.000037068,0.00023967502,0.0059581734],"study_design_scores_gemma":[0.89856505,0.07396782,0.021893077,0.00007175179,0.00092651666,0.000079379366,0.0029478264,0.00007971021,0.0011952302,0.00001480712,0.00006468331,0.00019412239],"about_ca_topic_score_codex":0.00057572074,"about_ca_topic_score_gemma":0.00528834,"teacher_disagreement_score":0.054324914,"about_ca_system_score_codex":0.0003631871,"about_ca_system_score_gemma":0.00048249602,"threshold_uncertainty_score":0.92029643},"labels":[],"label_agreement":null},{"id":"W4386558863","doi":"10.1093/neuonc/noad137.003","title":"PL02.1.A DELINEATING AND TARGETING A NOVEL METABOLISM-BASED POST-TRANSLATIONAL MECHANISM REGULATING THE ABUNDANCE OF THE ‘UNDRUGGABLE’ ONCOPROTEIN C-MYC IN MEDULLOBLASTOMA","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; CancerCare Manitoba; University of Manitoba","funders":"","keywords":"Medulloblastoma; Cancer research; Epigenetics; Biology; Mechanism (biology); Cancer; Oncogene; Regulator; Bioinformatics; Genetics; Gene","score_opus":0.01824140100343512,"score_gpt":0.28064705153394437,"score_spread":0.26240565053050924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386558863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.978956,0.00026980875,0.00017941718,0.019211818,0.00022473883,0.0009023847,0.000036353773,0.00005087304,0.0001686338],"genre_scores_gemma":[0.99546957,0.000013265452,0.002811523,0.0013667074,0.000116686424,0.00015867068,0.000022183121,0.000032043303,0.000009330727],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982543,0.00017373315,0.000537829,0.0003440552,0.00035470337,0.0003353662],"domain_scores_gemma":[0.99791294,0.0013254221,0.00027760377,0.00026374013,0.00015222089,0.00006805611],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063062244,0.00018987115,0.00042046316,0.00015552854,0.00020198325,0.00001785566,0.0001450035,0.00012410761,0.000028246792],"category_scores_gemma":[0.00090553844,0.00011789861,0.00011690858,0.00067753386,0.00013688447,0.000059288042,0.00009241931,0.00031104076,0.000005029379],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018856219,0.00029488798,0.012531352,0.00006844728,0.000049919017,0.000050128463,0.0010742551,0.0027534647,0.96759516,0.0022460595,0.00008145618,0.013066293],"study_design_scores_gemma":[0.021247046,0.0015479766,0.20149034,0.00071135105,0.00052137725,0.00031467943,0.0028746806,0.22492972,0.5279081,0.0020500147,0.01585091,0.00055379205],"about_ca_topic_score_codex":0.0001628102,"about_ca_topic_score_gemma":0.00024252971,"teacher_disagreement_score":0.43968707,"about_ca_system_score_codex":0.000067620174,"about_ca_system_score_gemma":0.00032321693,"threshold_uncertainty_score":0.48077658},"labels":[],"label_agreement":null},{"id":"W4386561105","doi":"10.1093/neuonc/noad137.362","title":"P14.11.B A MULTICENTER STUDY OF LOW-INTENSITY FOCUSED ULTRASOUND WITH SYSTEMIC MICROBUBBLE OSCILLATORS FOR BLOOD-BRAIN BARRIER DISRUPTION FOR LIQUID BIOPSY IN GLIOBLASTOMA (LIBERATE)","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"MRI in cancer diagnosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Microbubbles; Liquid biopsy; Biopsy; Brain tumor; Radiology; Ultrasound; Pathology; Oncology; Internal medicine; Cancer","score_opus":0.018799516868296146,"score_gpt":0.30101907223871116,"score_spread":0.282219555370415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386561105","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99069977,0.000031214273,0.000107783555,0.0021150426,0.00076512963,0.0059900223,0.00012975119,0.00014186186,0.000019417068],"genre_scores_gemma":[0.9967175,0.000039134604,0.0003953862,0.00080651656,0.00020077426,0.001634254,0.000029196648,0.00010438179,0.000072871495],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99739146,0.00020759879,0.0007509692,0.0007724047,0.00026031138,0.0006172421],"domain_scores_gemma":[0.99614954,0.0023824906,0.00033594324,0.0005048784,0.00043752405,0.0001896365],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006280324,0.00032760552,0.001015664,0.0004895625,0.00008913434,0.0000163283,0.00018029961,0.00026294045,0.000022011138],"category_scores_gemma":[0.0006320395,0.00028313886,0.00015332937,0.0007262203,0.0001429065,0.0000922833,0.000073740295,0.00023912273,0.000012044428],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016105544,0.0017792599,0.1491728,0.00091628224,0.00022173472,0.00026552944,0.004427373,0.00026098083,0.82161623,0.000010821875,0.0050623794,0.00016104874],"study_design_scores_gemma":[0.13284196,0.12917237,0.037897713,0.0021341231,0.002469273,0.0017972268,0.015585174,0.0030897465,0.65616345,0.000047262936,0.017310679,0.0014910062],"about_ca_topic_score_codex":0.00016061783,"about_ca_topic_score_gemma":0.0021232339,"teacher_disagreement_score":0.1654528,"about_ca_system_score_codex":0.0003572045,"about_ca_system_score_gemma":0.0003005666,"threshold_uncertainty_score":0.9999621},"labels":[],"label_agreement":null},{"id":"W4386757632","doi":"10.1093/neuonc/noad170","title":"Preclinical pediatric brain tumor models for immunotherapy: Hurdles and a way forward","year":2023,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"National Cancer Institute; Children’s Hospital of Wisconsin Research Institute; Stand Up To Cancer; Seattle Children's Research Institute; Nationwide Children's Hospital; Hospital for Sick Children; Ohio State University","keywords":"Medicine; Immunotherapy; Intensive care medicine; Brain tumor; Clinical trial; Cancer; Oncology; Internal medicine; Pathology","score_opus":0.11407454973622747,"score_gpt":0.4144428150837515,"score_spread":0.30036826534752403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386757632","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00042317394,0.9919872,0.000041191197,0.0020056919,0.0006988956,0.0042735343,0.00019257018,0.00015137586,0.00022631789],"genre_scores_gemma":[0.00004461662,0.9935784,0.0005640556,0.0013118398,0.0009557418,0.0030851818,0.000162272,0.00019411137,0.000103789396],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99708635,0.00029839302,0.0010270121,0.00086750794,0.00019797575,0.00052274176],"domain_scores_gemma":[0.9917883,0.0068968814,0.00048818733,0.00049861835,0.000079295736,0.00024867084],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00049264915,0.00053271704,0.003099637,0.00038625597,0.00009818676,0.000026311842,0.00018463087,0.0005793489,0.000031868032],"category_scores_gemma":[0.00067827804,0.00038682998,0.0008954841,0.00030646884,0.00009404665,0.00004357195,0.00013549265,0.00049033266,0.00007810474],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001424464,0.0006923103,0.00006335135,0.009387314,0.0005136659,0.00055432733,0.000067199086,0.0000014355943,0.000015760132,0.0003333482,0.01786434,0.9703645],"study_design_scores_gemma":[0.0035479413,0.0032339788,0.000024012961,0.0008270915,0.0031060404,0.0004369872,0.0000089777395,0.000088837915,0.0000027084427,0.00055535237,0.98790383,0.0002642105],"about_ca_topic_score_codex":0.000010025359,"about_ca_topic_score_gemma":0.000012432595,"teacher_disagreement_score":0.9701003,"about_ca_system_score_codex":0.000201479,"about_ca_system_score_gemma":0.0007165704,"threshold_uncertainty_score":0.9998584},"labels":[],"label_agreement":null},{"id":"W4386800568","doi":"10.1093/neuonc/noad147.094","title":"WHAT ROLE CAN A PERSONAL TRAINER PLAY IN IMPROVING QUALITY OF LIFE THROUGHOUT ONCOLOGY TREATMENT FOR PEOPLE WITH A BRAIN TUMOUR","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Trainer; Medicine; Quality of life (healthcare); Oncology; Psychology; Medical education; Nursing","score_opus":0.053694379902390635,"score_gpt":0.3754868771917523,"score_spread":0.32179249728936166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386800568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92038584,0.0002165839,0.00006096934,0.076299965,0.00058091304,0.0017504827,0.00012796253,0.00013565672,0.0004416205],"genre_scores_gemma":[0.98730016,0.000114413,0.00055236235,0.010462288,0.000539587,0.00064352364,0.00013517949,0.000082399485,0.00017008737],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99626666,0.00078760827,0.0009834078,0.0007833092,0.00042473164,0.00075428456],"domain_scores_gemma":[0.99483407,0.0037952638,0.00050282635,0.00038431372,0.00014492626,0.00033859446],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014041691,0.00036707346,0.0017514399,0.0003057794,0.000091608876,0.000019819572,0.00018174721,0.00032116516,0.000061863866],"category_scores_gemma":[0.00141389,0.00031002934,0.00026607473,0.0005814104,0.00021364543,0.00015370044,0.000084526575,0.00039246833,0.000011529552],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018009486,0.0047037695,0.08128758,0.0013699762,0.00068783236,0.0005104401,0.3051078,0.00018184997,0.5100458,0.0006650267,0.006338899,0.07109148],"study_design_scores_gemma":[0.11129738,0.09207213,0.39745647,0.0005419606,0.00082348543,0.00081532873,0.22727603,0.0048999893,0.022768514,0.00064898084,0.13953286,0.001866857],"about_ca_topic_score_codex":0.006633053,"about_ca_topic_score_gemma":0.09107395,"teacher_disagreement_score":0.48727733,"about_ca_system_score_codex":0.0010062483,"about_ca_system_score_gemma":0.0036131728,"threshold_uncertainty_score":0.9999819},"labels":[],"label_agreement":null},{"id":"W4386800574","doi":"10.1093/neuonc/noad147.025","title":"INDIGO: A GLOBAL, RANDOMIZED, DOUBLE-BLINDED, PHASE 3 STUDY OF VORASIDENIB VERSUS PLACEBO IN PATIENTS WITH RESIDUAL OR RECURRENT GRADE 2 GLIOMA WITH AN IDH1/2 MUTATION","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"","keywords":"Medicine; Placebo; Internal medicine; Adverse effect; Glioma; Gastroenterology; Randomization; Clinical endpoint; Randomized controlled trial; Hazard ratio; Surgery; Confidence interval; Pathology","score_opus":0.057691041798597194,"score_gpt":0.3784737549682509,"score_spread":0.32078271316965373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386800574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99304193,0.000024832992,0.0000018240461,0.0004490033,0.00035160387,0.0059083626,0.000034562807,0.00008758828,0.00010026789],"genre_scores_gemma":[0.9986185,0.000013121903,0.0001154014,0.0000551081,0.000056245273,0.0009195219,0.00018489758,0.000035642406,0.0000015593042],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99717075,0.00057028246,0.0006252408,0.00058890245,0.0006398579,0.00040496964],"domain_scores_gemma":[0.99800074,0.0008116353,0.0003900943,0.00039404628,0.0001995345,0.00020392264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038321898,0.0003095308,0.0010646451,0.0005063862,0.00007074862,0.000020530346,0.0001281113,0.00013489448,0.000029380555],"category_scores_gemma":[0.00022454452,0.00019581089,0.000055897744,0.0014383506,0.00015226711,0.00013766288,0.00005737294,0.00022220142,0.000014623411],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.89524585,0.019425273,0.07160588,0.00003601884,0.0004025784,0.004774545,0.0022663432,0.00014373915,0.00016017079,0.000030990035,0.00020220786,0.0057064295],"study_design_scores_gemma":[0.88319945,0.08002137,0.032023136,0.00006279968,0.00080354535,0.00007178748,0.0023627477,0.00007048051,0.0011381239,0.000014308421,0.00006217606,0.00017010246],"about_ca_topic_score_codex":0.00040871007,"about_ca_topic_score_gemma":0.00387883,"teacher_disagreement_score":0.060596097,"about_ca_system_score_codex":0.00032569014,"about_ca_system_score_gemma":0.00043302902,"threshold_uncertainty_score":0.7984936},"labels":[],"label_agreement":null},{"id":"W4386800579","doi":"10.1093/neuonc/noad174","title":"Indoximod-based chemo-immunotherapy for pediatric brain tumors: A first-in-children phase I trial","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Tryptophan and brain disorders","field":"Neuroscience","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute; Cannonball Kids' cancer Foundation; Alex's Lemonade Stand Foundation for Childhood Cancer","keywords":"Medicine; Temozolomide; Internal medicine; Immunotherapy; Oncology; Gastroenterology; Radiation therapy; Chemotherapy; Glioma; Cancer; Cancer research","score_opus":0.033341433046735265,"score_gpt":0.32507363542328427,"score_spread":0.291732202376549,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386800579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891031,0.000035273097,0.00012867551,0.0065364027,0.0008448079,0.0025673702,0.00007659638,0.0003758246,0.0003319977],"genre_scores_gemma":[0.98611873,0.00007037728,0.00010456626,0.012072742,0.0006623766,0.00077352015,0.000032826378,0.000085260814,0.00007961189],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99726874,0.00034195368,0.00052457955,0.00082364416,0.0002642379,0.0007768495],"domain_scores_gemma":[0.9953941,0.0038363102,0.00021812483,0.00040207588,0.000025030347,0.00012437283],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00044157673,0.00028988716,0.00048016538,0.0005877352,0.00019530587,0.00004798189,0.0005947848,0.00022862101,0.00011476837],"category_scores_gemma":[0.0025199591,0.00029125897,0.00022589006,0.0014131458,0.00014898818,0.000120229204,0.00007252637,0.00036340975,0.00017316882],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.046991758,0.0040866486,0.0027504915,0.000075219046,0.000015301775,0.00030462857,0.0010688727,0.00046642506,0.8640423,0.00061343337,0.043413315,0.036171623],"study_design_scores_gemma":[0.5850566,0.01587244,0.0044331723,0.00001732891,0.00003208718,0.00007510558,0.00011469328,0.007475038,0.22740604,0.0024332728,0.15585783,0.0012263719],"about_ca_topic_score_codex":0.000013985259,"about_ca_topic_score_gemma":0.000026737802,"teacher_disagreement_score":0.63663626,"about_ca_system_score_codex":0.00011396542,"about_ca_system_score_gemma":0.00044010507,"threshold_uncertainty_score":0.9999539},"labels":[],"label_agreement":null},{"id":"W4386800582","doi":"10.1093/neuonc/noad147.086","title":"TITLE THE TEENAGE AND YOUNG ADULT (TYA) POPULATION (16-24YO) BENEfiT FROM HAVING SPECIALIST NURSE INPUT","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Attendance; Medicine; Nursing; Family medicine; Nurse practitioners; Population; Outpatient clinic; Clinical nurse specialist; Health care; Internal medicine","score_opus":0.025226945666145542,"score_gpt":0.3240391236161963,"score_spread":0.2988121779500508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386800582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9299828,0.00024805233,0.00001607399,0.01701032,0.0030000044,0.0003200462,0.00003690727,0.00019797716,0.049187828],"genre_scores_gemma":[0.99232864,0.0003456104,0.00013184888,0.0032283384,0.002077007,0.000018836596,0.00013415844,0.000044152202,0.0016914002],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99901396,0.00008784519,0.00024077497,0.00025187316,0.00020477234,0.0002007462],"domain_scores_gemma":[0.9991142,0.000387715,0.00009671926,0.00027008067,0.000045504712,0.00008574223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019791945,0.000104434206,0.00022699771,0.00005631243,0.00014750531,0.000025785712,0.00008926488,0.000113727976,0.00023743302],"category_scores_gemma":[0.00037818798,0.00008595013,0.000047554797,0.00015595014,0.0000782866,0.00004089054,0.000058947153,0.00022742609,0.00036805077],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000579462,0.00024419685,0.21189971,0.00011531143,0.00016713324,0.0003998296,0.0065508354,0.000008324859,0.023982449,0.01086928,0.47529155,0.2698919],"study_design_scores_gemma":[0.0015990024,0.00027847217,0.5315337,0.00006584231,0.00011318191,0.00006622035,0.0010326864,0.00034599676,0.0005848093,0.002363233,0.46181285,0.00020396347],"about_ca_topic_score_codex":0.00209714,"about_ca_topic_score_gemma":0.005058239,"teacher_disagreement_score":0.31963402,"about_ca_system_score_codex":0.00013155778,"about_ca_system_score_gemma":0.00005503902,"threshold_uncertainty_score":0.47306708},"labels":[],"label_agreement":null},{"id":"W4386800593","doi":"10.1093/neuonc/noad147.085","title":"SHOULD CALCIUM SUPPLEMENTS BE PRESCRIBED PROPHYLACTICALLY FOR PATIENTS DIAGNOSED WITH A HIGH-GRADE GLIOMA (HGG) ON PROLONGED STEROID USE?","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Osteoporosis; Dexamethasone; Debulking; Quality of life (healthcare); Glioma; Surgery; Internal medicine; Cancer","score_opus":0.07053719159932792,"score_gpt":0.3372964755544658,"score_spread":0.26675928395513787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386800593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9803217,0.000008358535,0.0000106157795,0.012666853,0.00057958276,0.0057713785,0.0003236364,0.00024061216,0.00007723076],"genre_scores_gemma":[0.99087584,0.000015263535,0.0006083315,0.003507238,0.0001793774,0.003910924,0.00074118073,0.00011220206,0.0000496204],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99703044,0.00020577393,0.0004828804,0.0008351454,0.0006112619,0.0008344786],"domain_scores_gemma":[0.99716073,0.0014496824,0.00020442465,0.0005605461,0.0002599614,0.00036466308],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014941477,0.00041343799,0.00071817316,0.00035731023,0.00016502432,0.0000510142,0.0001678815,0.00025383692,0.00006665521],"category_scores_gemma":[0.000667119,0.00029628366,0.00015107651,0.0004904598,0.0001192299,0.00012307742,0.00010788717,0.00030774198,0.000064953114],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023197133,0.03161965,0.46966532,0.00048775418,0.0013550333,0.01082984,0.0015267677,0.000064522275,0.3016311,0.00058522756,0.14353289,0.0155048],"study_design_scores_gemma":[0.08010477,0.12627532,0.43698987,0.00015092881,0.0013803858,0.000105949126,0.00015319981,0.0002807628,0.16522183,0.00009844264,0.18848379,0.00075474416],"about_ca_topic_score_codex":0.00008273614,"about_ca_topic_score_gemma":0.00016040688,"teacher_disagreement_score":0.13640925,"about_ca_system_score_codex":0.00030833957,"about_ca_system_score_gemma":0.0002241433,"threshold_uncertainty_score":0.9999489},"labels":[],"label_agreement":null},{"id":"W4386800630","doi":"10.1093/neuonc/noad147.087","title":"THE ROLE OF A GENOMICS CLINICAL NURSE SPECIALIST IN HELPING TO BUILD A PATHWAY FOR WHOLE GENOME SEQUENCING TO BE OFFERED TO NEURO-ONCOLOGY PATIENTS","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Clinical nurse specialist; Medicine; Test (biology); Oncology nursing; Informed consent; Nursing; Whole genome sequencing; Genome; Nurse education; Pathology; Genetics; Gene; Alternative medicine; Biology","score_opus":0.030042483578097346,"score_gpt":0.31953381712593026,"score_spread":0.2894913335478329,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386800630","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98944175,0.00008528417,0.00027332196,0.005586848,0.0016067286,0.0018630404,0.0005778428,0.000020508955,0.0005446807],"genre_scores_gemma":[0.97556597,0.00031194152,0.0019168515,0.019579675,0.0015057968,0.0006517176,0.00027450916,0.00012555387,0.00006801044],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970403,0.00026184166,0.0009594966,0.0008231476,0.00015519826,0.00076006504],"domain_scores_gemma":[0.99760336,0.0008807595,0.00024530577,0.0006393292,0.00024895903,0.0003822738],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00078313,0.00027309143,0.00058741204,0.00020020935,0.00015900398,0.00003563777,0.0006461492,0.0003474339,0.000004235022],"category_scores_gemma":[0.0030730881,0.00027019708,0.00020175695,0.00042291597,0.000107948435,0.000004703574,0.00060690386,0.00024130142,0.00004142429],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012103496,0.00017942049,0.0027079629,0.000011247572,0.000029066137,0.00002334041,0.00079466583,0.0020025508,0.9486706,0.00018839873,0.004641292,0.03954107],"study_design_scores_gemma":[0.0015785032,0.005891142,0.0047480944,0.000008389588,0.000022922433,0.000007326313,0.00064302736,0.00018126507,0.052460887,0.00017248132,0.93401355,0.00027239096],"about_ca_topic_score_codex":0.00010841139,"about_ca_topic_score_gemma":0.0027099336,"teacher_disagreement_score":0.92937225,"about_ca_system_score_codex":0.00041961012,"about_ca_system_score_gemma":0.0010313488,"threshold_uncertainty_score":0.999975},"labels":[],"label_agreement":null},{"id":"W4386800653","doi":"10.1093/neuonc/noad147.048","title":"AN ANALYSIS OF THE EFFECTIVENESS OF CURRENT PROVISION OF FATIGUE MANAGEMENT STRATEGIES WITHIN A NEURO-ONCOLOGY MDT CLINIC","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Cancer-related fatigue; Psychological intervention; Rehabilitation; Quality of life (healthcare); Physical therapy; Intervention (counseling); Cancer; Internal medicine; Nursing","score_opus":0.04810793204400959,"score_gpt":0.3929343795516356,"score_spread":0.34482644750762603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386800653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994166,0.00013093132,0.0002423346,0.00023646944,0.0017107318,0.0010719327,0.00004093202,0.00005236999,0.0023483091],"genre_scores_gemma":[0.9993697,0.00022510643,0.00002957777,0.0001369269,0.00005136685,0.000104890496,0.000045975386,0.00002489103,0.000011596655],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.996166,0.0018414321,0.0008186083,0.00048175803,0.00042421915,0.00026796226],"domain_scores_gemma":[0.99659497,0.0016297955,0.0006372983,0.00078493374,0.00025771573,0.00009528201],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014386986,0.00020468452,0.0011467998,0.0005854661,0.000044689496,0.0000054418233,0.00035728567,0.00018030342,0.000060427803],"category_scores_gemma":[0.00023543353,0.00014947275,0.00039711478,0.002159358,0.00034192577,0.000070177164,0.00021008385,0.0003754463,0.000004262512],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0074443305,0.0026915974,0.1998647,0.0046155043,0.0019123496,0.00022635837,0.0069961865,0.0072887745,0.6836358,0.005721229,0.00038806233,0.07921512],"study_design_scores_gemma":[0.006911805,0.017669147,0.8516765,0.00052231783,0.008468638,0.000029880548,0.013071703,0.0057437955,0.08278775,0.0009987943,0.011705689,0.00041395877],"about_ca_topic_score_codex":0.00025296584,"about_ca_topic_score_gemma":0.0010620033,"teacher_disagreement_score":0.65181184,"about_ca_system_score_codex":0.00014105775,"about_ca_system_score_gemma":0.00055041444,"threshold_uncertainty_score":0.6095322},"labels":[],"label_agreement":null},{"id":"W4386800655","doi":"10.1093/neuonc/noad147.047","title":"PSYCHOLOGY EDUCATION WORKSHOPS ARE AN INNOVATIVE METHOD OF OFFERING PSYCHOLOGICAL INPUT TO A WIDER POPULATION","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Family Support in Illness","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Psychology; Set (abstract data type); Service (business); Medical education; Population; Medicine; Computer science","score_opus":0.10146406825778896,"score_gpt":0.47826145585896435,"score_spread":0.37679738760117537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386800655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96548843,0.000007333992,0.002361009,0.012058598,0.003732718,0.0005954152,0.000007058821,0.00022717343,0.015522246],"genre_scores_gemma":[0.9826917,0.000018951529,0.007961965,0.008603364,0.000396185,0.00015692557,0.000034386398,0.000025231713,0.00011130423],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99683714,0.0013960209,0.00048021163,0.00056391297,0.0002907513,0.0004319769],"domain_scores_gemma":[0.99806297,0.00076401787,0.0003084958,0.0003574026,0.0003421173,0.00016498391],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014303094,0.00014770025,0.0003862167,0.00044471034,0.00021200156,0.000019752137,0.00041339872,0.0004065184,0.00016221045],"category_scores_gemma":[0.0020606273,0.00015246648,0.00004768557,0.0029701851,0.00018830951,0.00021024486,0.00010478234,0.00033259712,0.00009273711],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000255467,0.00077323854,0.11223327,0.000017111202,0.000020881334,0.000042244592,0.02696874,0.00026410175,0.044306777,0.0152886305,0.019722067,0.78010744],"study_design_scores_gemma":[0.00048448035,0.00083683594,0.7865078,0.000026903717,0.0000171624,0.00002317992,0.011311638,0.000076478456,0.0003283518,0.00980945,0.19025734,0.00032038786],"about_ca_topic_score_codex":0.00048344073,"about_ca_topic_score_gemma":0.00092687184,"teacher_disagreement_score":0.77978706,"about_ca_system_score_codex":0.00018173923,"about_ca_system_score_gemma":0.00023929204,"threshold_uncertainty_score":0.6217403},"labels":[],"label_agreement":null},{"id":"W4386800658","doi":"10.1093/neuonc/noad147.089","title":"STEREOTACTIC RADIOSURGERY FOR BRAIN METASTASES FROM GASTROINTESTINAL PRIMARIES: ANALYSIS OF OUTCOMES","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Rectum; Malignancy; Radiosurgery; Gastrointestinal cancer; Colorectal cancer; Cohort; Retrospective cohort study; Cancer; Internal medicine; Radiology; Surgery; Radiation therapy","score_opus":0.04920836028553705,"score_gpt":0.3489789069499843,"score_spread":0.29977054666444725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386800658","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.984068,0.00009571935,0.0016453111,0.01177203,0.00031598413,0.0007134366,0.0010725552,0.00013219866,0.00018476282],"genre_scores_gemma":[0.97613764,0.000038273756,0.016501939,0.0049808137,0.0001396902,0.00020697365,0.0017146039,0.000059114107,0.00022095416],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980997,0.00028488805,0.0005638349,0.0004301728,0.00023732473,0.00038409917],"domain_scores_gemma":[0.98938966,0.009585553,0.00029359752,0.00044581166,0.00011539329,0.00016998508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055065646,0.00022255452,0.0013291354,0.00060169486,0.000061374594,0.000011633199,0.00009870797,0.000060100523,0.00031956736],"category_scores_gemma":[0.002362195,0.00017443062,0.0006631168,0.0009239274,0.00013062326,0.00005118784,0.00006628904,0.00013955585,0.00002485044],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027074334,0.0019383932,0.8331784,0.00019570501,0.015116357,0.0030029342,0.00050320616,0.00027972282,0.0631793,0.00081645587,0.03954673,0.039535336],"study_design_scores_gemma":[0.012498438,0.008434164,0.7920629,0.000071520626,0.030038558,0.00042486782,0.00089761347,0.004092083,0.005479495,0.00061411626,0.14493115,0.00045511383],"about_ca_topic_score_codex":0.00016174914,"about_ca_topic_score_gemma":0.00008039823,"teacher_disagreement_score":0.10538442,"about_ca_system_score_codex":0.00011745095,"about_ca_system_score_gemma":0.0002826222,"threshold_uncertainty_score":0.71130747},"labels":[],"label_agreement":null},{"id":"W4386808336","doi":"10.1093/neuonc/noad171","title":"Unraveling schwannomas","year":2023,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pediatric oncology; Medicine; Library science; Family medicine; Internal medicine","score_opus":0.05028158929375985,"score_gpt":0.31394747561683156,"score_spread":0.2636658863230717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386808336","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.024986936,0.00023905953,0.0000145222275,0.9454894,0.0055630417,0.00090759527,0.00011532248,0.00094086747,0.021743242],"genre_scores_gemma":[0.0025935634,0.00019667597,0.0004837264,0.9776901,0.013231675,0.0001417874,0.00057916366,0.00042259844,0.0046606874],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960253,0.00036638082,0.0008435099,0.0011502227,0.0006407952,0.00097375637],"domain_scores_gemma":[0.996673,0.0015071712,0.00038138562,0.0010170952,0.00018743955,0.00023389857],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00025788855,0.00061721593,0.0015061708,0.00062258006,0.00016746155,0.000058571022,0.00036236524,0.00186749,0.00040636424],"category_scores_gemma":[0.00073681195,0.00056731893,0.0005055299,0.00050884247,0.00021882396,0.000063742526,0.00028898302,0.0043745376,0.0031503981],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000083763036,0.000058106023,0.00013650475,0.00029084945,0.00008258051,0.08458042,0.000048373775,8.697828e-7,0.042436164,0.000026949296,0.86927265,0.002982773],"study_design_scores_gemma":[0.001134202,0.0020191781,0.00023157848,0.00015085736,0.00032184407,0.0072500934,0.000028060213,0.000041435098,0.004213793,0.00008270965,0.98412174,0.0004044885],"about_ca_topic_score_codex":0.00003299979,"about_ca_topic_score_gemma":0.0000027694377,"teacher_disagreement_score":0.11484911,"about_ca_system_score_codex":0.00025200058,"about_ca_system_score_gemma":0.0009591096,"threshold_uncertainty_score":0.99967784},"labels":[],"label_agreement":null},{"id":"W4386949028","doi":"10.1093/neuonc/noad125","title":"Optimizing preclinical pediatric low-grade glioma models for meaningful clinical translation","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"National Institute of Neurological Disorders and Stroke; Pediatric Brain Tumor Foundation; School of Medicine, Emory University; Array BioPharma; University of California, Los Angeles; Universitätsklinikum Heidelberg; Perelman School of Medicine, University of Pennsylvania; U.S. Department of Defense; Ian's Friends Foundation; Springworks Therapeutics; Deutsches Krebsforschungszentrum; National Cancer Institute; Alexion Pharmaceuticals; University of Toronto; Emory University; Deutschen Konsortium für Translationale Krebsforschung; Children's National Hospital; University of Pennsylvania; Hospital for Sick Children; Pfizer; Exelixis; Children's Hospital of Philadelphia; AstraZeneca; Brain Tumour Charity","keywords":"Medicine; MAPK/ERK pathway; Glioma; Microglia; Central nervous system; Stromal cell; Oncology; Brain tumor; Bioinformatics; Cancer research; Neuroscience; Internal medicine; Pathology; Signal transduction; Psychology; Biology; Inflammation","score_opus":0.14984592951819511,"score_gpt":0.4152956796911838,"score_spread":0.26544975017298866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386949028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98374563,0.00040484584,0.0013689873,0.010101723,0.0014884331,0.001565394,0.000027677388,0.00037002028,0.00092730805],"genre_scores_gemma":[0.98977,0.00080840715,0.0064297793,0.0010812617,0.0013159954,0.00040389065,0.00011034043,0.000066944645,0.000013406474],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9975355,0.00022645392,0.0008758528,0.0006352967,0.00024760625,0.00047923782],"domain_scores_gemma":[0.9950006,0.004077085,0.00019812024,0.0003255619,0.00010963157,0.0002889828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007669615,0.00021543313,0.00070616574,0.00028773444,0.00011071758,0.000016715569,0.000121958685,0.00041146195,0.000030486732],"category_scores_gemma":[0.00059924,0.00018865099,0.000449699,0.00051968615,0.00007009588,0.000094851086,0.00004826434,0.0003359739,0.00010494336],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008848934,0.021589631,0.1387123,0.0011642425,0.0014756821,0.008144844,0.0048043635,0.02682043,0.11016238,0.0044592516,0.106110945,0.567707],"study_design_scores_gemma":[0.09935198,0.03381456,0.031535406,0.00017602775,0.0063479817,0.00078660063,0.00047160353,0.6469707,0.01958126,0.007980188,0.15143482,0.0015488736],"about_ca_topic_score_codex":0.000004149336,"about_ca_topic_score_gemma":0.000009606861,"teacher_disagreement_score":0.62015027,"about_ca_system_score_codex":0.00008330228,"about_ca_system_score_gemma":0.00024993427,"threshold_uncertainty_score":0.76929635},"labels":[],"label_agreement":null},{"id":"W4387946694","doi":"10.1093/neuonc/noad208","title":"Proteometabolomics of initial and recurrent glioblastoma highlights an increased immune cell signature with altered lipid metabolism","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Deutsche Forschungsgemeinschaft","keywords":"Proteome; Tumor microenvironment; Metabolome; Lipidomics; Immune system; Omics; Proteomics; Tumor progression; Metabolomics; Reprogramming; Cancer research; Computational biology; Basigin; Cell; Biology; Bioinformatics; Cancer; Immunology; Biochemistry; Gene; Genetics","score_opus":0.01131400021762956,"score_gpt":0.2692886709685247,"score_spread":0.25797467075089514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387946694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900158,0.0033790327,0.000018368037,0.00047712386,0.0038920306,0.000972507,0.000119873745,0.00021565308,0.0009096191],"genre_scores_gemma":[0.99737185,0.0010227914,0.00035152282,0.0003389859,0.00026236838,0.00017685005,0.00019401326,0.00007923175,0.00020240799],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970009,0.00095588056,0.0006295174,0.0006708517,0.00009036563,0.0006525408],"domain_scores_gemma":[0.9981614,0.00048456847,0.00048377964,0.0006073583,0.00019312333,0.00006978707],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004260118,0.0003991231,0.00095261296,0.00042591747,0.00018581307,0.000014642205,0.0004669473,0.0007033215,0.00028680512],"category_scores_gemma":[0.0001020199,0.00029960592,0.00010094949,0.00057747716,0.000685254,0.0001709281,0.00029459753,0.00095768506,0.00012825083],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049717966,0.00035251735,0.000040044324,0.000068956964,0.00013085245,0.00005743375,0.0008471088,0.000013817797,0.9817605,0.00027278182,0.0018272365,0.009656965],"study_design_scores_gemma":[0.0047516376,0.0041476595,0.0018372933,0.000021644324,0.0001511719,0.00017558345,0.00015307944,0.000014797303,0.7512449,0.000048723785,0.2371725,0.00028099466],"about_ca_topic_score_codex":0.00007133227,"about_ca_topic_score_gemma":0.000050634106,"teacher_disagreement_score":0.23534526,"about_ca_system_score_codex":0.000060910617,"about_ca_system_score_gemma":0.00037025742,"threshold_uncertainty_score":0.9999456},"labels":[],"label_agreement":null},{"id":"W4387949117","doi":"10.1093/neuonc/noad196","title":"Time to treat the climate and nature crisis as one indivisible global health emergency","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Climate Change and Health Impacts","field":"Environmental Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Political science","score_opus":0.03938171483665656,"score_gpt":0.37404322914137833,"score_spread":0.3346615143047218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387949117","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8267158,0.00017310525,6.4453224e-7,0.15396929,0.00036264278,0.00050653314,0.0001034583,0.00011447294,0.018054057],"genre_scores_gemma":[0.80621636,0.0148983635,0.00019487593,0.17674041,0.00062105973,0.00017208802,0.00009579506,0.0000779131,0.0009831362],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99817693,0.0001743054,0.00025193836,0.000392523,0.00023872593,0.0007655642],"domain_scores_gemma":[0.99908423,0.000120232784,0.000093229755,0.00026920438,0.000006823955,0.000426269],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00047867064,0.00014813598,0.00025030374,0.000043221902,0.0003772553,0.000017105713,0.00022759626,0.00016804533,0.0047394186],"category_scores_gemma":[0.00010914159,0.000112886926,0.000035122237,0.0007194449,0.000072687246,0.0000824695,0.0004909644,0.0002757792,0.012185366],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009713327,0.00012117938,0.012110032,0.00003904148,0.000005700314,0.0000568005,0.0024362018,0.000035149267,0.0062457975,0.00008657242,0.91447383,0.06429255],"study_design_scores_gemma":[0.00090591144,0.003707513,0.2893002,0.000017912185,0.000039863695,0.00014283088,0.0010007861,0.00016877595,0.00039368751,0.0021300677,0.7018529,0.00033956007],"about_ca_topic_score_codex":0.0004164861,"about_ca_topic_score_gemma":0.0006322963,"teacher_disagreement_score":0.27719018,"about_ca_system_score_codex":0.00035115474,"about_ca_system_score_gemma":0.000048365062,"threshold_uncertainty_score":0.9961704},"labels":[],"label_agreement":null},{"id":"W4388486354","doi":"10.1093/neuonc/noad210","title":"Inhibition of ATR opposes glioblastoma invasion through disruption of cytoskeletal networks and integrin internalization via macropinocytosis","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Metropolitan University","funders":"Medical Research Council; Deutschen Konsortium für Translationale Krebsforschung; National Centre for the Replacement Refinement and Reduction of Animals in Research; Brain Tumour Charity; University of Glasgow; National Centre for the Replacement, Refinement and Reduction of Animals in Research; Cancer Research UK; University of Sheffield; Deutsches Krebsforschungszentrum","keywords":"Internalization; Intravital microscopy; Cytoskeleton; In vivo; Cancer research; Integrin; Motility; Biology; Pathology; Cell biology; Cell; Medicine","score_opus":0.025797958188337845,"score_gpt":0.3085467064945886,"score_spread":0.28274874830625074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388486354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951276,0.00016117471,0.0029270262,0.00084585405,0.00027228284,0.00038785874,0.0000090214135,0.000057351263,0.00021179876],"genre_scores_gemma":[0.99814326,0.0012681542,0.00014186314,0.00020772775,0.00009287284,0.000041420153,0.00007791824,0.000021600235,0.000005192442],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99891275,0.000119790435,0.0003750382,0.00025828346,0.00016368073,0.00017043883],"domain_scores_gemma":[0.99914855,0.00026572795,0.00025086242,0.0001602609,0.00011036096,0.00006422295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010332728,0.00014324143,0.00040323107,0.0001935767,0.00003704018,0.000005669204,0.00003939558,0.00016078416,0.00003349699],"category_scores_gemma":[0.000118360585,0.000120728626,0.00009674344,0.0003960803,0.00013381345,0.00010248389,0.0001112582,0.00012755541,0.000007739817],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007110518,0.0005562958,0.04534771,0.00019840288,0.00009172017,0.00021149467,0.00055509777,0.00046797915,0.8998226,0.00053897913,0.0011762024,0.050322466],"study_design_scores_gemma":[0.006267268,0.010167856,0.04390613,0.00055481633,0.00043339652,0.00040588615,0.00040328782,0.010295884,0.92308396,0.0005962843,0.003673777,0.00021146853],"about_ca_topic_score_codex":0.000069699396,"about_ca_topic_score_gemma":0.00008006498,"teacher_disagreement_score":0.050110996,"about_ca_system_score_codex":0.00009193943,"about_ca_system_score_gemma":0.000036652837,"threshold_uncertainty_score":0.49231705},"labels":[],"label_agreement":null},{"id":"W4388551842","doi":"10.1093/neuonc/noad195","title":"Pediatric low-grade glioma: State-of-the-art and ongoing challenges","year":2023,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Deutsches Krebsforschungszentrum; Brain Tumour Charity; Pediatric Brain Tumor Foundation","keywords":"Medicine; Glioma; Clinical trial; Quality of life (healthcare); Disease; Natural history; Epidemiology; Intensive care medicine; Pathology; Internal medicine; Cancer research","score_opus":0.0757305325320381,"score_gpt":0.3544998617690252,"score_spread":0.2787693292369871,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388551842","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005178108,0.9904993,1.756089e-7,0.0012401851,0.00094967935,0.001424009,0.000038948896,0.000078157565,0.0005914421],"genre_scores_gemma":[0.0002705583,0.99875045,0.000028072847,0.00009992249,0.00036845403,0.0003135805,0.000023126866,0.00010284131,0.00004301655],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99768674,0.00032929023,0.0007037069,0.00059871795,0.00027909828,0.00040246354],"domain_scores_gemma":[0.997087,0.0015976232,0.0005292028,0.00054303167,0.00005827232,0.00018489738],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022192902,0.00042853554,0.002199569,0.0004493371,0.00007172673,0.000009905553,0.0001920665,0.00034866465,0.000015923959],"category_scores_gemma":[0.0002958014,0.0002771348,0.00048310304,0.0005958126,0.00011077571,0.0000250179,0.0002755346,0.0005085855,0.00015376479],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011186737,0.0006347938,0.0002154918,0.02164811,0.00028469277,0.0018861656,0.0001273257,3.3606085e-7,0.000044224853,0.000071948416,0.0037030226,0.9713727],"study_design_scores_gemma":[0.0012015265,0.0008264791,0.00033005656,0.0020220203,0.0028787404,0.00082320266,0.000014752963,0.0000013555385,0.00005439241,0.00004290422,0.99161977,0.00018477936],"about_ca_topic_score_codex":0.000007670861,"about_ca_topic_score_gemma":0.000042425305,"teacher_disagreement_score":0.98791677,"about_ca_system_score_codex":0.00018782468,"about_ca_system_score_gemma":0.0005759016,"threshold_uncertainty_score":0.9999681},"labels":[],"label_agreement":null},{"id":"W4388588341","doi":"10.1093/neuonc/noad179.0959","title":"QOL-07. RESISTING DECLINES IN FUNCTIONAL FITNESS: PRELIMINARY FINDINGS FROM THE RESIST TRIAL","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Acadia University; Dalhousie University","funders":"","keywords":"Medicine; Physical therapy; Attrition; Grip strength; Circuit training; Adverse effect; Randomized controlled trial; Internal medicine","score_opus":0.06705979609911875,"score_gpt":0.3419399845171719,"score_spread":0.2748801884180532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95151687,0.00027350846,0.000009758409,0.041508194,0.0026766644,0.0010245369,0.000038374485,0.00019829185,0.0027538035],"genre_scores_gemma":[0.99098325,0.00032015864,0.00006173053,0.004733032,0.0023443012,0.00044372046,0.00012829549,0.000047536763,0.00093796354],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9978825,0.0003109271,0.00053227216,0.000510601,0.00033929117,0.0004244003],"domain_scores_gemma":[0.99320126,0.0061858734,0.00014701046,0.00026048688,0.0001292011,0.0000761918],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057608605,0.00020859901,0.00047700072,0.00019911387,0.00031541206,0.000015185101,0.00012672668,0.00020953236,0.00031884815],"category_scores_gemma":[0.0053081405,0.00016089831,0.0001299092,0.00068429275,0.000259374,0.0000629592,0.00023987121,0.0006407861,0.00036841404],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20581117,0.000823901,0.14079002,0.00008456102,0.0003755353,0.002740136,0.0022185154,0.00013276207,0.030804388,0.00010022766,0.5967856,0.019333152],"study_design_scores_gemma":[0.046347797,0.0036270842,0.821602,0.00019635269,0.00029908383,0.000061457475,0.0012922349,0.00026132405,0.00057880004,0.0004694144,0.12506127,0.00020316536],"about_ca_topic_score_codex":0.00021324462,"about_ca_topic_score_gemma":0.00047653695,"teacher_disagreement_score":0.680812,"about_ca_system_score_codex":0.00029159882,"about_ca_system_score_gemma":0.00036288888,"threshold_uncertainty_score":0.6561243},"labels":[],"label_agreement":null},{"id":"W4388588352","doi":"10.1093/neuonc/noad179.1142","title":"TMIC-77. UNVEILING THE DEPTHS: EXPLORING DIFFUSE MIDLINE GLIOMA, TUMORIGENESIS, AND RADIATION RESISTANCE","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Neuroscience; Carcinogenesis; Glioma; Resistance (ecology); Cancer; Biology; Bioinformatics; Psychology; Cancer research; Genetics; Ecology","score_opus":0.048697231723253694,"score_gpt":0.3045791695223482,"score_spread":0.2558819377990945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852075,0.0017493627,0.000007873974,0.011244703,0.0006526065,0.0005504235,0.0000074789887,0.00017011716,0.00040996232],"genre_scores_gemma":[0.9950386,0.0030334957,0.000113794216,0.0008556843,0.0004209026,0.0004199009,0.0000287406,0.000038239712,0.000050630628],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986191,0.00014118227,0.00030207416,0.0003892774,0.00020188706,0.00034650214],"domain_scores_gemma":[0.99846995,0.00087297417,0.00011297784,0.000346225,0.000055079927,0.00014277424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025264145,0.00017940851,0.00033515724,0.00019932205,0.00021481325,0.00002410904,0.00009243702,0.000084278785,0.00001954533],"category_scores_gemma":[0.00035291078,0.00012726097,0.000075290794,0.0005421209,0.0000846524,0.00007681159,0.000074054915,0.00016812733,0.0000691012],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068534364,0.0010565704,0.08863901,0.00018459794,0.00022058935,0.0052072606,0.0023915195,0.000094527095,0.80521864,0.0012161058,0.0139904125,0.081095435],"study_design_scores_gemma":[0.011584432,0.0012803494,0.32319883,0.00012893161,0.00050818024,0.00040437173,0.0012426646,0.0010448004,0.2357076,0.00040530984,0.42410994,0.00038457394],"about_ca_topic_score_codex":0.00003271408,"about_ca_topic_score_gemma":0.00014265698,"teacher_disagreement_score":0.569511,"about_ca_system_score_codex":0.00014409069,"about_ca_system_score_gemma":0.00009083044,"threshold_uncertainty_score":0.5189552},"labels":[],"label_agreement":null},{"id":"W4388588359","doi":"10.1093/neuonc/noad179.0628","title":"INNV-39. INVESTIGATING MULTI-AGENT INTRATHECAL CHEMOTHERAPY AS A TREATMENT FOR PRIMARY AND SECONDARY CENTRAL NERVOUS SYSTEM LYMPHOMA: SAFETY AND EFFICACY RESULTS FROM AN INSTITUTIONAL COHORT STUDY","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"CNS Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Rituximab; Etoposide; Ommaya reservoir; Internal medicine; Primary central nervous system lymphoma; Cytarabine; Oncology; ThioTEPA; Lymphoma; Topotecan; Diffuse large B-cell lymphoma; Chemotherapy; Surgery; Cyclophosphamide","score_opus":0.03249400732168699,"score_gpt":0.3152593963784103,"score_spread":0.28276538905672327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588359","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933126,0.0002285125,0.000016852597,0.0015658846,0.00039418196,0.0036435607,0.00039518747,0.00021549912,0.00022772551],"genre_scores_gemma":[0.9957897,0.00037012564,0.00096150814,0.0010897305,0.0003246654,0.0004951505,0.00089082465,0.00004815124,0.000030153864],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9975755,0.00022782733,0.00063371874,0.00089147704,0.00022572758,0.00044569967],"domain_scores_gemma":[0.9980514,0.0009060301,0.00018333003,0.00034512806,0.000063712134,0.00045041202],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002946858,0.00035643912,0.0008139158,0.0001286465,0.000329732,0.000043356813,0.00007528019,0.00018845388,0.0000076514625],"category_scores_gemma":[0.0001696836,0.00028815868,0.00009347966,0.0001740841,0.00021575904,0.00008729675,0.00008462876,0.00010631437,0.000011060085],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006048388,0.00767317,0.28893393,0.00009596648,0.0009569555,0.0023548603,0.0069671767,0.00007030552,0.009854382,0.00023376473,0.00023053843,0.67658055],"study_design_scores_gemma":[0.05098456,0.007196931,0.9276881,0.000057511756,0.0004105074,0.0004046785,0.0009089151,0.0021337257,0.00075979764,0.000007743592,0.009249624,0.00019785967],"about_ca_topic_score_codex":0.0010052917,"about_ca_topic_score_gemma":0.00016961124,"teacher_disagreement_score":0.67638266,"about_ca_system_score_codex":0.0014354357,"about_ca_system_score_gemma":0.00095970766,"threshold_uncertainty_score":0.9999571},"labels":[],"label_agreement":null},{"id":"W4388588361","doi":"10.1093/neuonc/noad179.1177","title":"MODL-26. A PROTOCOL TO ADAPT GLIOBLASTOMA IN VITRO CULTURE SYSTEMS INTO ORGANOID MODELS USING NEUROCULT™ NS-A PROLIFERATION MEDIUM","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"3D Printing in Biomedical Research","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stemcell Technologies","funders":"","keywords":"Organoid; Matrigel; In vitro; In vivo; Spheroid; Cell culture; Cell biology; Chemistry; Biology; Biochemistry","score_opus":0.03608982723777983,"score_gpt":0.3341194128589796,"score_spread":0.2980295856211998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588361","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.71536446,0.000079483514,0.05384631,0.0073640198,0.006792736,0.2053241,0.000047142115,0.007922994,0.003258769],"genre_scores_gemma":[0.9107097,0.000015701145,0.0039065615,0.0005463597,0.0012779474,0.083106905,0.000014833745,0.00031112015,0.000110881876],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9969157,0.0003537021,0.0006259378,0.0005652605,0.00069637055,0.00084302214],"domain_scores_gemma":[0.9987255,0.0002806419,0.00006592923,0.00038877683,0.00016782367,0.00037136654],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006578357,0.0003045773,0.00046790205,0.00063885207,0.00010749926,0.00009257243,0.0005009266,0.00042233345,0.0000147575165],"category_scores_gemma":[0.0008149237,0.00028972802,0.000056384368,0.0018765938,0.00007357663,0.00022988263,0.00034156826,0.00089576887,0.00022773366],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020658327,0.000049393293,0.000024559702,0.00029271233,0.000010301863,0.00022278726,0.0011681648,0.21909042,0.7724897,0.000034745477,0.0042746193,0.0021360044],"study_design_scores_gemma":[0.0009132393,0.0004798607,0.000031102863,0.00006238938,0.000006062821,0.00006773021,0.00012022231,0.8242692,0.12474786,0.00011526251,0.0489436,0.0002435221],"about_ca_topic_score_codex":0.000061958264,"about_ca_topic_score_gemma":0.00004786966,"teacher_disagreement_score":0.64774185,"about_ca_system_score_codex":0.0006300629,"about_ca_system_score_gemma":0.00030648624,"threshold_uncertainty_score":0.9999555},"labels":[],"label_agreement":null},{"id":"W4388588373","doi":"10.1093/neuonc/noad179.0660","title":"PATH-30. GLIOMAS WITH FGFR ONCOGENIC ALTERATIONS: CLINICO-PATHOLOGICAL FEATURES, MANAGEMENT AND OUTCOMES IN PEDIATRIC, ADOLESCENT AND YOUNG ADULT PATIENTS.","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Winnipeg; University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Medicine; Fibroblast growth factor receptor; Pathological; Astrocytoma; Pilocytic astrocytoma; Fibroblast growth factor receptor 1; Glioma; PTPN11; Internal medicine; Oncology; Pathology; Fibroblast growth factor; Cancer; Cancer research; Receptor; KRAS; Colorectal cancer","score_opus":0.01431956166184641,"score_gpt":0.2966408297902794,"score_spread":0.282321268128433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99792635,0.00022510035,0.000016994512,0.00052477553,0.00017534227,0.0006776922,0.000030479794,0.000033485994,0.0003897506],"genre_scores_gemma":[0.99605525,0.0024220631,0.0003477193,0.0006719442,0.00010372936,0.0001310687,0.00012566167,0.00003150673,0.00011105897],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99804443,0.0002843603,0.00031800952,0.0006784942,0.00022715142,0.00044752966],"domain_scores_gemma":[0.9993023,0.00009100242,0.00009219395,0.00028204205,0.000088408524,0.00014401106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022282614,0.00022298798,0.00028309406,0.0001952827,0.00009040467,0.000035996574,0.00016809584,0.00025435747,0.00000719894],"category_scores_gemma":[0.0002217577,0.00017897444,0.00004672523,0.00024325454,0.00014087906,0.000008693677,0.00045133373,0.00031812052,0.000021201473],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035065046,0.00030323726,0.9693543,0.00009805063,0.000026278121,0.0003050868,0.00009258331,0.000005281862,0.022637526,0.000075200194,0.003481984,0.003269864],"study_design_scores_gemma":[0.0032599627,0.002778598,0.9862158,0.000012324275,0.000032019605,0.0000613355,0.00009430577,0.000033314598,0.0018530013,0.0000327564,0.0053922446,0.0002343807],"about_ca_topic_score_codex":0.000010898344,"about_ca_topic_score_gemma":0.00015186708,"teacher_disagreement_score":0.020784525,"about_ca_system_score_codex":0.000042181986,"about_ca_system_score_gemma":0.00006069633,"threshold_uncertainty_score":0.7298366},"labels":[],"label_agreement":null},{"id":"W4388588374","doi":"10.1093/neuonc/noad179.0337","title":"CTNI-55. A MULTICENTER STUDY OF LOW-INTENSITY FOCUSED ULTRASOUND WITH SYSTEMIC MICROBUBBLE OSCILLATORS FOR BLOOD-BRAIN BARRIER DISRUPTION FOR LIQUID BIOPSY IN GLIOBLASTOMA (LIBERATE)","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Ultrasound and Hyperthermia Applications","field":"Engineering","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Concordance; Biopsy; Liquid biopsy; Microbubbles; Blood sampling; Radiology; Ultrasound; Internal medicine; Oncology; Cancer","score_opus":0.011266891437333922,"score_gpt":0.24814163151063656,"score_spread":0.23687474007330264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99569726,0.00002341549,0.00083893427,0.00012671179,0.00029263803,0.0025905333,0.00012976793,0.00026745783,0.000033254284],"genre_scores_gemma":[0.99825144,0.0000118934,0.00032526546,0.000094735195,0.00008912087,0.0010785987,0.000027290056,0.00008673164,0.00003493536],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99854445,0.00006475683,0.00046215678,0.00039962403,0.00010751436,0.00042150507],"domain_scores_gemma":[0.9982876,0.0010515356,0.000102837,0.00032063984,0.00014476168,0.000092631424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024155992,0.00024058705,0.0004929504,0.00024951334,0.0000946885,0.000022252892,0.00018555755,0.00017198648,0.000007309278],"category_scores_gemma":[0.00014398903,0.00021951101,0.00008696457,0.00048517899,0.00006392065,0.00008901106,0.000026903477,0.00016856284,0.000017129696],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089023664,0.00039309126,0.0036486872,0.00021304922,0.00009990248,0.000015084376,0.0028039638,0.0044713793,0.98686457,0.000025563008,0.00043603117,0.00013846978],"study_design_scores_gemma":[0.07176769,0.028554417,0.014719008,0.00069130264,0.0014281615,0.0012283066,0.02104111,0.04781282,0.780336,0.000236516,0.029020933,0.0031637268],"about_ca_topic_score_codex":0.000027173552,"about_ca_topic_score_gemma":0.0005166236,"teacher_disagreement_score":0.20652853,"about_ca_system_score_codex":0.000109691384,"about_ca_system_score_gemma":0.000057218243,"threshold_uncertainty_score":0.89513993},"labels":[],"label_agreement":null},{"id":"W4388588379","doi":"10.1093/neuonc/noad179.1183","title":"MODL-32. EGFRVIII OVEREXPRESSION AND LOSS OF MOUSE SPECIFIC CDKN2A IN GLIAL CELLS LEADS TO GLIOMAGENESIS IN A NOVEL MOUSE MODEL","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Pathology; NeuN; OLIG2; Immunohistochemistry; Glioma; Biology; Cancer research; Glial fibrillary acidic protein; Medicine; Oligodendrocyte; Central nervous system","score_opus":0.0371716245391149,"score_gpt":0.30388335912019804,"score_spread":0.26671173458108316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973504,0.00009555499,0.000033722215,0.0012237476,0.00012978874,0.00075049605,0.00010430925,0.00005175825,0.00026023336],"genre_scores_gemma":[0.99785036,0.0003741487,0.0007980967,0.000568863,0.00006308352,0.00014835362,0.000019043498,0.000049602048,0.00012843517],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99817085,0.000083119674,0.00049822865,0.0005656603,0.0002351451,0.00044698964],"domain_scores_gemma":[0.998948,0.0002852884,0.00010492031,0.0003899365,0.00005698751,0.00021489894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018609969,0.00024261976,0.00066325726,0.0007872603,0.00003190769,0.000010412921,0.00012358301,0.00022784875,0.000026714471],"category_scores_gemma":[0.000084537365,0.00022034523,0.00008055413,0.00070305134,0.00008353555,0.00006853023,0.00021604028,0.00020145635,0.00004939657],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082052144,0.0015695583,0.013228547,0.0000662338,0.0000122349875,0.0005854503,0.0008592616,0.008087065,0.97099036,0.00006560541,0.002333562,0.0013816045],"study_design_scores_gemma":[0.010004182,0.0013524995,0.00918228,0.00010779398,0.000036636065,0.000040043262,0.00013598707,0.010755752,0.96555585,0.000042070762,0.0025723912,0.00021450344],"about_ca_topic_score_codex":0.00016073005,"about_ca_topic_score_gemma":0.00018330234,"teacher_disagreement_score":0.009183661,"about_ca_system_score_codex":0.00026816694,"about_ca_system_score_gemma":0.0001591224,"threshold_uncertainty_score":0.89854175},"labels":[],"label_agreement":null},{"id":"W4388588383","doi":"10.1093/neuonc/noad179.0051","title":"BIOM-40. THERABIOME-GBM: THERAPEUTIC OUTCOMES RELATED TO GUT MICROBIOME IN GLIOBLASTOMA (GBM) PATIENTS RECEIVING CHEMO-RADIATION: A PROSPECTIVE OBSERVATIONAL STUDY","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Temozolomide; Medicine; Internal medicine; Oncology; Adjuvant; Observational study; Clinical endpoint; Prospective cohort study; Radiation therapy; Colorectal cancer; Randomized controlled trial; Cancer","score_opus":0.04321680355414979,"score_gpt":0.3412842826837754,"score_spread":0.2980674791296256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844644,0.000052230556,6.0421485e-7,0.011070498,0.0007199089,0.0030201082,0.000024919731,0.00019671253,0.00045059234],"genre_scores_gemma":[0.9964642,0.00002114191,0.00005082485,0.0023901027,0.000052459,0.0007818279,0.0000733241,0.000058399484,0.00010775673],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997585,0.00023770003,0.0006384684,0.00069533597,0.00035253007,0.0004909573],"domain_scores_gemma":[0.9984602,0.000599698,0.0001877419,0.0003903819,0.00019796607,0.00016404713],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031055493,0.0003175703,0.0006628859,0.0007805686,0.00012245774,0.000028658642,0.00016601116,0.0001954749,0.00011830814],"category_scores_gemma":[0.00031551646,0.0002646239,0.00012677826,0.0023166311,0.000056704786,0.00010151236,0.00012580582,0.00025859268,0.0004185062],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004019563,0.003872976,0.907362,0.000012648454,0.00025973908,0.00029219198,0.0031740633,0.000020553445,0.066589676,0.00004863194,0.0009776354,0.016987944],"study_design_scores_gemma":[0.009738349,0.004918644,0.9772175,0.000028819955,0.00010172342,0.0000189158,0.00038938172,0.000068707304,0.0026086005,0.00016758557,0.004540667,0.0002010843],"about_ca_topic_score_codex":0.0000491767,"about_ca_topic_score_gemma":0.00016406225,"teacher_disagreement_score":0.06985553,"about_ca_system_score_codex":0.00090634456,"about_ca_system_score_gemma":0.00019465484,"threshold_uncertainty_score":0.99998057},"labels":[],"label_agreement":null},{"id":"W4388588426","doi":"10.1093/neuonc/noad179.0992","title":"RTID-01. A RANDOMIZED STUDY OF LOW-INTENSITY FOCUSED ULTRASOUND FOR BLOOD-BRAIN BARRIER DISRUPTION FOR BRAIN METASTASIS FROM NON-SMALL CELL LUNG CANCER (LIMITLESS)","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Ultrasound and Hyperthermia Applications","field":"Engineering","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Pembrolizumab; Lung cancer; Clinical endpoint; Brain metastasis; Randomized controlled trial; Internal medicine; Oncology; Surgery; Cancer; Metastasis; Immunotherapy","score_opus":0.018234762465045854,"score_gpt":0.27840953344250785,"score_spread":0.260174770977462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97789794,0.00010820429,0.01541481,0.0006827887,0.0004835598,0.004261022,0.0007452803,0.0002650358,0.0001413607],"genre_scores_gemma":[0.9927708,0.00010277605,0.0014453449,0.00045253537,0.00026020914,0.0046134973,0.0001504592,0.00010931882,0.00009506629],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99822235,0.00016820549,0.0005840104,0.0004619448,0.00013464593,0.00042883647],"domain_scores_gemma":[0.99102485,0.008203582,0.00016383523,0.00034020434,0.00014562185,0.00012190266],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005592924,0.00028677977,0.0010053428,0.00016129018,0.00014491666,0.00002807352,0.00025872074,0.00019246574,0.00006319046],"category_scores_gemma":[0.0005964132,0.0002700591,0.00032134223,0.0003085751,0.00007757065,0.00006826377,0.000037766826,0.00020145053,0.0000102466765],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032810378,0.00044366487,0.0005611056,0.00017313907,0.00056818116,0.000005321803,0.0039596455,0.005238783,0.9780685,0.00004451454,0.0061899046,0.0014662397],"study_design_scores_gemma":[0.44099563,0.0022540768,0.00373895,0.00010578687,0.006837566,0.000019947336,0.005859467,0.15268342,0.33910328,0.0021581121,0.044365805,0.0018779445],"about_ca_topic_score_codex":0.00024661908,"about_ca_topic_score_gemma":0.0011784217,"teacher_disagreement_score":0.6389652,"about_ca_system_score_codex":0.00008338745,"about_ca_system_score_gemma":0.00009160342,"threshold_uncertainty_score":0.99997514},"labels":[],"label_agreement":null},{"id":"W4388588427","doi":"10.1093/neuonc/noad179.0976","title":"QOL-24. FINANCIAL AID REQUESTS BY BRAIN TUMOR PATIENTS IN ONTARIO THROUGH GOFUNDME","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"The Scarborough Hospital; London Health Sciences Centre; University of Toronto","funders":"","keywords":"Thematic analysis; Finance; Psychosocial; Distress; Indirect costs; Medicine; Qualitative research; Psychology; Business; Psychiatry; Clinical psychology; Accounting","score_opus":0.034898855266942516,"score_gpt":0.2582457067067476,"score_spread":0.2233468514398051,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94055116,0.00019541364,0.000072026945,0.0045738323,0.003453405,0.0004600497,0.00024685648,0.00010659144,0.05034068],"genre_scores_gemma":[0.98189616,0.0002220631,0.0002332499,0.014912348,0.0003091196,0.00013487515,0.00014277043,0.0000818724,0.002067518],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99729985,0.000040447052,0.0010182235,0.00076363055,0.00004917843,0.00082865736],"domain_scores_gemma":[0.9987568,0.00019084783,0.00049585564,0.00037501473,0.000036068206,0.00014537192],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00044251795,0.0002900999,0.0008321318,0.00026961157,0.000110201494,0.00005039669,0.00040545932,0.00031695387,0.0004888232],"category_scores_gemma":[0.0008390136,0.00037255956,0.00014567633,0.00041313717,0.00013215127,0.0005708067,0.00016297215,0.00064437045,0.0026969293],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029037966,0.0005570299,0.62534416,0.000034390414,0.0000229466,0.00018720869,0.0031112973,0.00017480226,0.00035980073,0.067742065,0.2979189,0.004257045],"study_design_scores_gemma":[0.0025287864,0.00066156284,0.1663005,0.000013216208,0.0000028380925,0.000004734616,0.000017859757,0.000028478964,0.000112986796,0.039989874,0.7900043,0.00033485278],"about_ca_topic_score_codex":0.033679694,"about_ca_topic_score_gemma":0.09811647,"teacher_disagreement_score":0.49208543,"about_ca_system_score_codex":0.0019261824,"about_ca_system_score_gemma":0.00060676096,"threshold_uncertainty_score":0.9998726},"labels":[],"label_agreement":null},{"id":"W4388588432","doi":"10.1093/neuonc/noad179.0990","title":"RBIO-10. NEUROMODULATORY EFFECT AND DOSE RESPONSE OF FUNCTIONAL RADIOSURGERY ON CORTICAL NEURONS","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Functional Brain Connectivity Studies","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Radiosurgery; Prefrontal cortex; Neuroscience; Premovement neuronal activity; Medicine; Nuclear medicine; Chemistry; Radiation therapy; Biology; Cognition; Internal medicine","score_opus":0.049419818128794195,"score_gpt":0.29943393993182027,"score_spread":0.25001412180302607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588432","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98644245,0.000016146814,0.000007149204,0.009327437,0.0024573288,0.00036214053,0.000034673485,0.00027894814,0.0010737225],"genre_scores_gemma":[0.9924359,0.000040726976,0.0000050041112,0.006965494,0.00017678206,0.000074938594,0.0000027830772,0.000044811466,0.00025356855],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99495155,0.002786152,0.00037989116,0.0009328844,0.00048311584,0.00046639226],"domain_scores_gemma":[0.90796214,0.09131467,0.00013893264,0.00037409458,0.000052844443,0.00015728583],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011171921,0.0002764884,0.00051730283,0.00044011496,0.0003251074,0.000017975039,0.00016536804,0.00015680202,0.00011892695],"category_scores_gemma":[0.055932302,0.00025933687,0.0001480084,0.00073935086,0.00070241984,0.00011340348,0.000283556,0.00054529373,0.00036568628],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00647773,0.00018015335,0.0021322907,0.000024739495,0.0000127938565,0.0006664847,0.00006311071,0.00032472564,0.95175517,0.0005447144,0.035147082,0.002671015],"study_design_scores_gemma":[0.0033347388,0.013043475,0.5863035,0.000021914395,0.00006960462,0.00087024726,0.000035039142,0.0028027422,0.24053182,0.0002872549,0.15221919,0.00048048113],"about_ca_topic_score_codex":0.0000025018853,"about_ca_topic_score_gemma":0.0000021005683,"teacher_disagreement_score":0.71122336,"about_ca_system_score_codex":0.00009128378,"about_ca_system_score_gemma":0.00019314363,"threshold_uncertainty_score":0.9999859},"labels":[],"label_agreement":null},{"id":"W4388588439","doi":"10.1093/neuonc/noad179.0111","title":"CNSC-27. LOSS OF CAPICUA IMPAIRS OLIGODENDROGENESIS IN THE DEVELOPING MOUSE BRAIN","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Biology; PDGFRA; Oligodendrocyte; Molecular biology; Transcriptome; Cell biology; Lineage markers; Cancer research; Myelin; Gene expression; Neuroscience; Gene; Genetics; Stem cell; Central nervous system; Progenitor cell","score_opus":0.03412638087190769,"score_gpt":0.3197003617921852,"score_spread":0.2855739809202775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588439","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.970327,0.00013925933,0.0000036621323,0.028140815,0.00020501329,0.00043684206,0.000010011164,0.000055962784,0.00068141095],"genre_scores_gemma":[0.9955235,0.00027425375,0.000120114324,0.0038073459,0.000068973044,0.00012238971,0.000018647603,0.000024224522,0.000040552917],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99864525,0.00021652697,0.00033632902,0.00025863928,0.00020507914,0.00033817207],"domain_scores_gemma":[0.9984457,0.001029011,0.000096495576,0.0003124929,0.00004950684,0.00006681352],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034560918,0.00014569238,0.00039878895,0.00025638327,0.00004507144,0.000005943545,0.000156049,0.00012442637,0.000047792637],"category_scores_gemma":[0.00028614333,0.00010084851,0.00010655779,0.0006687182,0.0000861599,0.000027265445,0.000073945455,0.00014445222,0.0001222767],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027715068,0.0016059013,0.46252573,0.00021252374,0.0002380026,0.0099305175,0.005373117,0.0001698302,0.43816823,0.0026879753,0.04184932,0.036961712],"study_design_scores_gemma":[0.0112180635,0.002982888,0.39749572,0.000118382915,0.00025962098,0.0014298885,0.002590981,0.00033489714,0.410421,0.00042858333,0.17230123,0.00041875322],"about_ca_topic_score_codex":0.00013312076,"about_ca_topic_score_gemma":0.0002780728,"teacher_disagreement_score":0.13045192,"about_ca_system_score_codex":0.00015351357,"about_ca_system_score_gemma":0.00023959747,"threshold_uncertainty_score":0.4112483},"labels":[],"label_agreement":null},{"id":"W4388588461","doi":"10.1093/neuonc/noad179.0296","title":"CTNI-14. NEOADJUVANT STEREOTACTIC RADIOSURGERY (NASRS) FOR LARGE BRAIN METASTASES (BRM): RESULTS OF AN INTERNATIONAL MULTICENTER PHASE II TRIAL","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University Health Network; Toronto Western Hospital; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Radiosurgery; Clinical endpoint; Radiation therapy; Surgery; Lesion; Nuclear medicine; Randomized controlled trial","score_opus":0.05529110521120137,"score_gpt":0.3893552114297121,"score_spread":0.3340641062185107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588461","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9784208,0.00006334217,0.00018261078,0.0114748655,0.0039101713,0.002354336,0.0030098378,0.00014504073,0.00043898908],"genre_scores_gemma":[0.9906403,0.000090659814,0.0016920073,0.0032175353,0.0009471184,0.0003245875,0.0025610179,0.00006071216,0.00046609694],"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970748,0.00047514163,0.00091048743,0.0006093481,0.0004015125,0.00052871084],"domain_scores_gemma":[0.9960569,0.0024967515,0.00043214072,0.0005345437,0.00021521041,0.0002644384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001509854,0.00027575679,0.00084337796,0.00040153673,0.00012606318,0.000017260665,0.00019175968,0.00016133243,0.00021818164],"category_scores_gemma":[0.0027265493,0.00022796683,0.00038061006,0.00026506395,0.00008287496,0.00019031159,0.00012793644,0.00024877454,0.000031743337],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.53838754,0.026485236,0.00032657012,0.0001778263,0.0018552063,0.0046735625,0.0012834709,0.000034709254,0.07487337,0.0007875473,0.107541546,0.24357341],"study_design_scores_gemma":[0.29439768,0.032634918,0.0003338339,0.000034395238,0.00052553567,0.00018510035,0.00021497831,0.0023912585,0.00860208,0.00003776251,0.6604672,0.00017525055],"about_ca_topic_score_codex":0.000027717811,"about_ca_topic_score_gemma":0.000043766173,"teacher_disagreement_score":0.55292565,"about_ca_system_score_codex":0.00014547032,"about_ca_system_score_gemma":0.00028730286,"threshold_uncertainty_score":0.92962176},"labels":[],"label_agreement":null},{"id":"W4388588466","doi":"10.1093/neuonc/noad179.0227","title":"RADT-38. DOSE ESCALATED RADIOTHERAPY IS ASSOCIATED WITH IMPROVED OUTCOMES FOR HIGH GRADE MENINGIOMA","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Cohort; Radiation therapy; Nuclear medicine; Cumulative dose; Internal medicine; Concomitant; Gastroenterology; Surgery; Urology","score_opus":0.03261581152657773,"score_gpt":0.31418200231484666,"score_spread":0.28156619078826894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9745,0.000049891332,0.0003214896,0.020868395,0.00077730557,0.001951403,0.00003198861,0.0006581923,0.000841318],"genre_scores_gemma":[0.99023235,0.000022111995,0.002041914,0.0032852846,0.00018349684,0.0004149386,0.00021022889,0.0001139451,0.003495745],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975914,0.00016428676,0.0005127178,0.00064845796,0.000329042,0.00075409753],"domain_scores_gemma":[0.99808127,0.0007993077,0.00027754187,0.00047272933,0.00012872605,0.00024041109],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00047677787,0.0003563297,0.00094760297,0.00039390722,0.00018151542,0.000033817814,0.00021311817,0.00028712422,0.0001729623],"category_scores_gemma":[0.00030525879,0.00027436457,0.00020723665,0.00079932273,0.00011027668,0.000078053505,0.000070515605,0.0002886706,0.000040984487],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036936519,0.0010818054,0.020499896,0.00014686983,0.002805874,0.007728558,0.0026754804,0.000034213772,0.84007215,0.0011972801,0.105366014,0.014698181],"study_design_scores_gemma":[0.113997266,0.04513919,0.30628866,0.00020994271,0.0025629746,0.0015693326,0.00095253024,0.034380175,0.06696894,0.0014970562,0.42413655,0.0022973777],"about_ca_topic_score_codex":0.0000340733,"about_ca_topic_score_gemma":0.000008828318,"teacher_disagreement_score":0.77310324,"about_ca_system_score_codex":0.00030173754,"about_ca_system_score_gemma":0.00017413755,"threshold_uncertainty_score":0.99997085},"labels":[],"label_agreement":null},{"id":"W4388588487","doi":"10.1093/neuonc/noad179.0967","title":"QOL-15. THE PIVOTAL TRIDENT STUDY OF TUMOR TREATING FIELDS (TTFIELDS) THERAPY WITH CHEMORADIATION, FOLLOWED BY MAINTENANCE TTFIELDS THERAPY/TEMOZOLOMIDE (TMZ), IN NEWLY DIAGNOSED GLIOBLASTOMA (NDGBM)","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Temozolomide; Oncology; Concomitant; Internal medicine; Clinical endpoint; Radiation therapy; Chemoradiotherapy; Hazard ratio; Progression-free survival; Clinical trial; Chemotherapy; Confidence interval","score_opus":0.016422238184064988,"score_gpt":0.28520466473494865,"score_spread":0.2687824265508837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588487","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867056,0.00042996721,0.000008385979,0.0095198,0.00032198045,0.0023795948,0.00001087413,0.00010854694,0.00051522657],"genre_scores_gemma":[0.9951137,0.00074226246,0.000025429803,0.0028847088,0.00013722434,0.0009470728,0.000016635073,0.00005565549,0.0000773522],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973093,0.00036370195,0.00071877934,0.0006126508,0.00043232873,0.0005632004],"domain_scores_gemma":[0.99677515,0.0019443446,0.00038632884,0.00062087993,0.00013399808,0.00013926912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040881662,0.00038000365,0.0008921906,0.00026947554,0.0001448665,0.000029489842,0.00028209685,0.00021083246,0.00010759056],"category_scores_gemma":[0.00032348552,0.00023705038,0.0001678829,0.0010109238,0.0001087991,0.000086197375,0.00006735852,0.00048916665,0.000019244051],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010880223,0.015180256,0.6552125,0.000057615638,0.00087333145,0.007752959,0.01580978,0.00078819995,0.14445835,0.0000630963,0.0657994,0.08312424],"study_design_scores_gemma":[0.1753264,0.10975568,0.43228722,0.0002707411,0.0004736463,0.0005195264,0.021479497,0.0019107466,0.23240215,0.00014341206,0.024292763,0.0011381971],"about_ca_topic_score_codex":0.00090960786,"about_ca_topic_score_gemma":0.0019632797,"teacher_disagreement_score":0.22292532,"about_ca_system_score_codex":0.00016256256,"about_ca_system_score_gemma":0.00023523936,"threshold_uncertainty_score":0.9666634},"labels":[],"label_agreement":null},{"id":"W4388588489","doi":"10.1093/neuonc/noad179.0615","title":"INNV-26. THE CHALLENGE OF TREATING ADULTS WITH MEDULLOBLASTOMA – THE CANON EXPERIENCE","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; Health Sciences Centre; Sunnybrook Health Science Centre; Dalhousie University; Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Medicine; Population; Young adult; Pediatrics; Brain tumor; Radiation therapy; Internal medicine; Pathology","score_opus":0.023368114692024877,"score_gpt":0.30004251576857444,"score_spread":0.27667440107654956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97055274,0.00023643012,9.39968e-7,0.023823394,0.00016826193,0.0005554763,0.000004054548,0.00008661564,0.004572084],"genre_scores_gemma":[0.99835694,0.00023673024,0.000025016,0.0008121972,0.0001083384,0.00040689233,0.000003735674,0.000026756032,0.000023385674],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99887216,0.00012789012,0.00022206118,0.00026421083,0.00024031318,0.0002733358],"domain_scores_gemma":[0.99841917,0.0008716239,0.00014192426,0.00041828013,0.00007877463,0.00007022163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013454533,0.0001428257,0.00029284175,0.00006849111,0.00013343769,0.000005845667,0.00015453434,0.00006978338,0.00006296509],"category_scores_gemma":[0.00017546843,0.00006387743,0.0000637033,0.00041632846,0.00023429948,0.000025936095,0.00007443862,0.00016921418,0.000041955478],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035295552,0.0031733674,0.17674512,0.0002529472,0.00062081555,0.0057258243,0.12128089,0.0001809922,0.16790047,0.003337214,0.011023054,0.50622976],"study_design_scores_gemma":[0.025943859,0.040219292,0.32778504,0.00079496106,0.0010196046,0.0018257432,0.046234798,0.002410391,0.26991355,0.00028330064,0.28286687,0.00070258166],"about_ca_topic_score_codex":0.00017238561,"about_ca_topic_score_gemma":0.0006736073,"teacher_disagreement_score":0.5055272,"about_ca_system_score_codex":0.0000661671,"about_ca_system_score_gemma":0.000143752,"threshold_uncertainty_score":0.2604846},"labels":[],"label_agreement":null},{"id":"W4388588499","doi":"10.1093/neuonc/noad179.0556","title":"IMMU-24. SALVAGE IMMUNOTHERAPIES FOR REPLICATION REPAIR DEFICIENT (RRD) HIGH-GRADE GLIOMA FAILING ANTI-PD1 MONOTHERAPY: A REPORT FROM THE INTERNATIONAL RRD CONSORTIUM","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"Ipilimumab; Medicine; Internal medicine; Oncology; Expanded access; Nivolumab; Immune checkpoint; Progression-free survival; Progressive disease; Salvage therapy; Immunotherapy; Surgery; Chemotherapy; Cancer","score_opus":0.037144638281678174,"score_gpt":0.325559275956624,"score_spread":0.2884146376749458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588499","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95475125,0.00086162967,0.00015327138,0.040183473,0.001852999,0.0014081072,0.000098570985,0.00047787352,0.00021281031],"genre_scores_gemma":[0.9924358,0.000574513,0.0012817797,0.003396561,0.00048932206,0.0010554814,0.00060327176,0.00007523698,0.00008801004],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99761075,0.00012460796,0.0007191232,0.00082523824,0.0003443134,0.00037597195],"domain_scores_gemma":[0.99660665,0.0015359629,0.00042802872,0.001156258,0.00019152333,0.00008160277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005909554,0.0002551687,0.0004949474,0.00019526099,0.00022289042,0.000049097303,0.00026574073,0.00018103133,0.00009318873],"category_scores_gemma":[0.00064552214,0.00018716477,0.00033572598,0.00037425113,0.00013855298,0.00006771966,0.00009727898,0.00020936187,0.00006349021],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055546645,0.0008625498,0.032795712,0.0000143039015,0.00068689516,0.001374663,0.0008600011,0.000069399524,0.915836,0.00070500426,0.032034587,0.0142054595],"study_design_scores_gemma":[0.008315979,0.0011729375,0.15301184,0.000066993314,0.00037707604,0.00079307024,0.00074642175,0.0019966739,0.21571377,0.00084474916,0.61665815,0.00030235172],"about_ca_topic_score_codex":0.00036712666,"about_ca_topic_score_gemma":0.000055877263,"teacher_disagreement_score":0.7001222,"about_ca_system_score_codex":0.0002779129,"about_ca_system_score_gemma":0.00020752355,"threshold_uncertainty_score":0.7632358},"labels":[],"label_agreement":null},{"id":"W4388588513","doi":"10.1093/neuonc/noad179.0843","title":"NCOG-30. ENVIRONMENTAL ENRICHMENT AND HEALTH OUTCOMES AFTER RADIATION","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Socioeconomic status; Montreal Cognitive Assessment; Glioma; Cohort; Physical therapy; Cognition; Gerontology; Psychology; Internal medicine; Cognitive impairment; Psychiatry; Population","score_opus":0.022718172714691176,"score_gpt":0.3295687331466246,"score_spread":0.30685056043193343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9450561,0.0008980414,0.000015849286,0.05083423,0.00081646733,0.0009354226,0.000032543543,0.00015900136,0.0012523864],"genre_scores_gemma":[0.98046607,0.0031907896,0.00003590841,0.015525636,0.00016696028,0.00019772304,0.000037357255,0.000024012326,0.00035555774],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987634,0.00009254154,0.00025867907,0.00032026437,0.00019351955,0.00037163703],"domain_scores_gemma":[0.99941194,0.00020067523,0.00009668955,0.00012853938,0.000009538867,0.00015263977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021212571,0.00015328846,0.00037028114,0.00014983506,0.0001069648,0.0000055386267,0.00002953321,0.000082336286,0.0003088773],"category_scores_gemma":[0.000058182406,0.00013629174,0.000056149227,0.00012383127,0.00011077473,0.000041855263,0.00012100469,0.0002076302,0.0004371857],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032510102,0.00031518601,0.762693,0.000058231057,0.00017394345,0.00032243176,0.0018930187,0.0000040997347,0.0053881346,0.00001660725,0.03578288,0.19302739],"study_design_scores_gemma":[0.0029096233,0.001702658,0.8364667,0.000012291004,0.00006965978,0.00005983313,0.00036378717,0.000049220427,0.00020737584,0.000028647723,0.15803696,0.000093200906],"about_ca_topic_score_codex":0.000021862174,"about_ca_topic_score_gemma":0.000013410018,"teacher_disagreement_score":0.19293419,"about_ca_system_score_codex":0.0005654657,"about_ca_system_score_gemma":0.000098704004,"threshold_uncertainty_score":0.56192833},"labels":[],"label_agreement":null},{"id":"W4388588518","doi":"10.1093/neuonc/noad179.0978","title":"QOL-26. A RANDOMIZED, DOUBLE-BLIND PHASE 3 STUDY OF VORASIDENIB VS PLACEBO IN PATIENTS WITH MUTANT <i>IDH1/2</i>DIFFUSE GLIOMA (INDIGO): ANALYSIS OF HEALTH-RELATED QUALITY OF LIFE, NEUROCOGNITION AND SEIZURES","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre; Toronto General Hospital","funders":"","keywords":"Medicine; Placebo; Clinical endpoint; Quality of life (healthcare); Randomized controlled trial; Neurocognitive; Internal medicine; Physical therapy; Cognition; Psychiatry; Pathology","score_opus":0.04818460316316055,"score_gpt":0.3572831364768596,"score_spread":0.3090985333136991,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99434984,0.00011990541,0.0000026486769,0.000498828,0.00008488552,0.0047915257,0.00007683138,0.000046007364,0.000029542021],"genre_scores_gemma":[0.99926925,0.00007990678,0.000015829499,0.00014446671,0.0000087191975,0.00031176378,0.00013472438,0.000034291686,0.0000010600105],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99503416,0.0015654707,0.0019939912,0.0005319441,0.0005509548,0.000323467],"domain_scores_gemma":[0.99568915,0.001920856,0.0014893663,0.00039860033,0.00030891653,0.00019313337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011645324,0.00027858885,0.00301163,0.0016565118,0.00005411181,0.000006832321,0.00009265897,0.00015244978,0.000025872912],"category_scores_gemma":[0.0006211687,0.00021045266,0.00021203479,0.0027491122,0.00023525582,0.00006985529,0.00007900246,0.00022063375,0.0000020332561],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.55233866,0.02313483,0.40845606,0.00021208895,0.002449915,0.00035972698,0.0037596447,0.0002131868,0.0077002505,0.000014702421,0.000037327794,0.0013236004],"study_design_scores_gemma":[0.7174297,0.010580704,0.26558384,0.000057036126,0.0026098667,0.00000921911,0.0006956772,0.0002947541,0.0026054268,0.000013779485,0.000005861922,0.00011413882],"about_ca_topic_score_codex":0.0017664047,"about_ca_topic_score_gemma":0.0011645578,"teacher_disagreement_score":0.16509102,"about_ca_system_score_codex":0.000076253375,"about_ca_system_score_gemma":0.00026157292,"threshold_uncertainty_score":0.8582011},"labels":[],"label_agreement":null},{"id":"W4388588526","doi":"10.1093/neuonc/noad179.0151","title":"CCRG-02. DEVELOPMENTALLY PARTITIONED PROLIFERATIVE COMPARTMENTS IN GLIOBLASTOMA","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Biology; Transcriptome; Progenitor cell; Cell growth; Compartment (ship); Cancer research; Neural stem cell; Cell; Pathology; Stem cell; Gene; Cell biology; Gene expression; Genetics; Medicine","score_opus":0.02535767786171686,"score_gpt":0.28661878104856214,"score_spread":0.26126110318684526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99621874,0.00003244356,0.000112138776,0.00062182953,0.00051624025,0.0003361735,0.000018695102,0.000050556828,0.0020931982],"genre_scores_gemma":[0.99754256,0.00008997721,0.00024374171,0.0015385803,0.00013315516,0.00012349119,0.00015424815,0.000025998059,0.00014825254],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986792,0.000158989,0.00029449258,0.00039067608,0.00011488995,0.000361742],"domain_scores_gemma":[0.9995903,0.00004034246,0.00006632617,0.00016207206,0.000050434028,0.00009056503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015036121,0.00016602379,0.00021956042,0.000107061336,0.00008705909,0.000016407097,0.00016310584,0.00018304815,0.000033075652],"category_scores_gemma":[0.00006287973,0.00017035764,0.000054770342,0.0002614579,0.00008826968,0.0000056561025,0.00008891061,0.00014529121,0.00015540725],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043147715,0.000251536,0.015368299,0.000010243862,0.00002661631,0.00009834286,0.00030496836,0.00016169225,0.9760643,0.000050711624,0.0049679293,0.0022638813],"study_design_scores_gemma":[0.003110531,0.0019859215,0.013253519,0.000012959109,0.000012415283,0.000050184717,0.00017988168,0.00042521994,0.7905082,0.00014433006,0.19000235,0.0003144675],"about_ca_topic_score_codex":0.00000969895,"about_ca_topic_score_gemma":0.0004374668,"teacher_disagreement_score":0.18555608,"about_ca_system_score_codex":0.00007085034,"about_ca_system_score_gemma":0.00021348035,"threshold_uncertainty_score":0.69469833},"labels":[],"label_agreement":null},{"id":"W4388588533","doi":"10.1093/neuonc/noad179.0970","title":"QOL-18. HIGHER VINCRISTINE DOSES CORRELATE WITH LONGER OVERALL SURVIVAL: A POST-HOC ANALYSIS OF PARTICIPANTS RECEIVING PCV ON RTOG 9402","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Hamilton Health Sciences; McGill University Health Centre; Juravinski Cancer Centre; Centre Hospitalier de l’Université de Montréal; University of Calgary","funders":"","keywords":"Lomustine; Procarbazine; Medicine; Vincristine; Internal medicine; Oncology; Randomization; Post-hoc analysis; Survival analysis; Randomized controlled trial; Gastroenterology; Chemotherapy","score_opus":0.06165610226933519,"score_gpt":0.3420842834167095,"score_spread":0.2804281811473743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99165106,0.00011616003,0.0000027201831,0.004063525,0.0006008227,0.00040542937,0.000054204265,0.00016202484,0.0029440394],"genre_scores_gemma":[0.99757355,0.00022494986,0.00007580258,0.0014418114,0.00010133044,0.00010553605,0.00012598395,0.000057698762,0.00029334732],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997613,0.0002614599,0.00051363657,0.0005832584,0.00042899026,0.0005996606],"domain_scores_gemma":[0.99721825,0.0014659988,0.00029037296,0.0005587728,0.00020748835,0.0002591],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00028172054,0.00029971503,0.0011247802,0.00064114237,0.000079921454,0.000014466445,0.00012051595,0.0001785032,0.0010593897],"category_scores_gemma":[0.00030377423,0.00021749224,0.00024336859,0.0014532005,0.00012441921,0.000050228762,0.00009140013,0.00026723085,0.00019877689],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0095340675,0.005397736,0.7686825,0.00016385375,0.00873723,0.011241549,0.0017143121,0.0033265096,0.15437877,0.00062005775,0.019781297,0.016422125],"study_design_scores_gemma":[0.0062562167,0.009379938,0.95942,0.00010257918,0.0056011374,0.000025564275,0.00012109052,0.0011327494,0.0036784313,0.000018299914,0.014017407,0.00024653412],"about_ca_topic_score_codex":0.0002694454,"about_ca_topic_score_gemma":0.0003681332,"teacher_disagreement_score":0.19073758,"about_ca_system_score_codex":0.00017862704,"about_ca_system_score_gemma":0.00013787835,"threshold_uncertainty_score":0.9998538},"labels":[],"label_agreement":null},{"id":"W4388588541","doi":"10.1093/neuonc/noad179.0470","title":"EPCO-05. SPATIOTEMPORAL MODELLING OF GLIOBLASTOMA FOR DRUG PREDICTION","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Tumor microenvironment; Cancer research; Downregulation and upregulation; Tumor progression; Microglia; Glioblastoma; Biology; Brain tumor; Computational biology; Neuroscience; Medicine; Immunology; Gene; Inflammation; Pathology; Tumor cells; Genetics","score_opus":0.04295914583397537,"score_gpt":0.30626219704702073,"score_spread":0.26330305121304537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588541","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99287224,0.00006694939,0.00083181274,0.004008424,0.0006981472,0.00077100634,0.0000661775,0.000145504,0.00053971325],"genre_scores_gemma":[0.99835926,0.00009459787,0.0007041007,0.0002735441,0.00021394606,0.00019875058,0.00007759101,0.000028183345,0.0000500259],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99901444,0.00004407392,0.00030830054,0.00025475188,0.00015237607,0.0002260572],"domain_scores_gemma":[0.9991066,0.00037363282,0.00012579768,0.00019189286,0.00010845036,0.00009365596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015880077,0.000114544506,0.00033583635,0.00021452334,0.00005429175,0.0000039009988,0.000049828817,0.00010743624,0.000025584224],"category_scores_gemma":[0.00007746125,0.000101129495,0.00012868489,0.00024956962,0.00004597764,0.000041425177,0.000030286285,0.00009374386,0.000033699696],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046690335,0.004429229,0.06745566,0.0008094886,0.00064805703,0.0012950778,0.0035810384,0.04343896,0.49616778,0.0027683089,0.23403396,0.1407034],"study_design_scores_gemma":[0.015136751,0.012871563,0.0075195353,0.00012864896,0.0006720844,0.00018201719,0.00043111833,0.3352134,0.4017935,0.0013827618,0.22440864,0.00025996464],"about_ca_topic_score_codex":0.000032724933,"about_ca_topic_score_gemma":0.000023847222,"teacher_disagreement_score":0.29177442,"about_ca_system_score_codex":0.00009284072,"about_ca_system_score_gemma":0.00011993387,"threshold_uncertainty_score":0.4123941},"labels":[],"label_agreement":null},{"id":"W4388588548","doi":"10.1093/neuonc/noad179.0044","title":"BIOM-33. TRNA FRAGMENTS IN PLASMA EXTRACELLULAR VESICLES FROM HIGH GRADE GLIOMA PATIENTS, POTENTIAL BIOMARKERS?","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Atlantic Cancer Research Institute; Dalhousie University","funders":"","keywords":"Transfer RNA; Biology; RNA; Translation (biology); Small RNA; Epigenetics; Extracellular vesicles; Computational biology; Cell biology; Molecular biology; Cancer research; Biochemistry; Gene; Messenger RNA","score_opus":0.013681023995712872,"score_gpt":0.25648016628450165,"score_spread":0.2427991422887888,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99680185,0.00028047067,0.000094784715,0.0010536377,0.0010861151,0.00029029933,0.00020732093,0.00004218252,0.00014333258],"genre_scores_gemma":[0.99750185,0.00044830245,0.0003361137,0.00022503965,0.0002699316,0.000099312776,0.0009847346,0.00004194679,0.00009276807],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99817574,0.00020537965,0.00038377714,0.0006351758,0.00018479583,0.00041515927],"domain_scores_gemma":[0.99907213,0.00004521571,0.00015349133,0.00055942003,0.000054732547,0.000115012015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013348364,0.00021168272,0.00023448364,0.00019038175,0.0001010143,0.000027291353,0.00042352494,0.00034213142,0.00007643853],"category_scores_gemma":[0.0000914026,0.00019844578,0.00010094442,0.00038825796,0.00012009391,0.000009218509,0.00023172614,0.00014575898,0.0001265963],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019650809,0.00031143508,0.0044901622,0.0000053120134,0.000056521134,0.00011779971,0.000047950605,0.00007981903,0.9593894,0.000021541824,0.008205963,0.027077574],"study_design_scores_gemma":[0.0043896493,0.0008163804,0.07089065,0.000010615226,0.000044677086,0.000012969822,0.00014659304,0.0006087259,0.7127094,0.0003917784,0.2095901,0.00038842205],"about_ca_topic_score_codex":0.00022312194,"about_ca_topic_score_gemma":0.00007840464,"teacher_disagreement_score":0.24667999,"about_ca_system_score_codex":0.000066374196,"about_ca_system_score_gemma":0.000114212264,"threshold_uncertainty_score":0.8092384},"labels":[],"label_agreement":null},{"id":"W4388588556","doi":"10.1093/neuonc/noad179.0479","title":"EPCO-16. DISRUPTING DOT1L EPIGENETIC ACTIVITY REPROGRAMS GLIOBLASTOMA STEM CELLS TOWARDS A DOPAMINERGIC NEURONAL-LIKE STATE","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Neurosciences, Mental Health and Addiction; Government of Canada; University of Calgary","funders":"","keywords":"Epigenetics; Biology; Chromatin; Neural stem cell; Transcription factor; Stem cell; Epigenetic regulation of neurogenesis; Epigenomics; Embryonic stem cell; Gene silencing; Regulation of gene expression; Neuroscience; Gene expression; Genetics; Cancer research; Cell biology; DNA methylation; Chromatin remodeling; Gene","score_opus":0.021296636547715606,"score_gpt":0.29542410880173037,"score_spread":0.27412747225401474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588556","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945394,0.00045350587,0.001260166,0.00051979115,0.001420325,0.00052778266,0.000045383367,0.00015404256,0.0010796099],"genre_scores_gemma":[0.99629337,0.0014750231,0.00024203477,0.00042393053,0.00040862113,0.00012262212,0.000054036223,0.00010625701,0.00087409356],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965749,0.0005670139,0.0005270103,0.0011469093,0.00034114602,0.00084304763],"domain_scores_gemma":[0.99823684,0.00017359895,0.0003396797,0.0008128214,0.00015210717,0.00028495397],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00063031766,0.00040813163,0.00044606547,0.00017329978,0.00020574772,0.00006733984,0.0003978422,0.00035378293,0.000023748687],"category_scores_gemma":[0.00011486011,0.00041389628,0.00023885172,0.0005630376,0.00017937055,0.000010514302,0.0005027874,0.00035846728,0.00012852786],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021430044,0.00012231615,0.0005869763,0.000028308648,0.00003176198,0.000085208376,0.000084784064,0.0011908484,0.7477441,0.0000047846756,0.00050977117,0.24939686],"study_design_scores_gemma":[0.00080303714,0.002671742,0.0020272008,0.0000067265273,0.000035304904,0.000021069525,0.000055564895,0.0009924517,0.76140875,0.00008917809,0.23154111,0.00034784747],"about_ca_topic_score_codex":0.00006346349,"about_ca_topic_score_gemma":0.00018889752,"teacher_disagreement_score":0.24904902,"about_ca_system_score_codex":0.00009397123,"about_ca_system_score_gemma":0.00026662723,"threshold_uncertainty_score":0.99983126},"labels":[],"label_agreement":null},{"id":"W4388588565","doi":"10.1093/neuonc/noad179.0473","title":"EPCO-09. CHARACTERIZING THE GBM CELLULAR LANDSCAPE BY LARGE-SCALE SINGLE-NUCLEUS RNA-SEQUENCING","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Biology; Computational biology; Exome sequencing; RNA; Deep sequencing; Exome; Cell type; Tumor microenvironment; Genome; Cell; Gene; Genetics; Phenotype; Cancer","score_opus":0.02119131351393815,"score_gpt":0.24084192963388285,"score_spread":0.21965061611994469,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99112177,0.00037687493,0.0007199421,0.001994256,0.0013570471,0.00025863523,0.0000926508,0.000116595074,0.003962249],"genre_scores_gemma":[0.9936317,0.00043011896,0.00016799849,0.00392227,0.0008042321,0.000040727766,0.00041220247,0.00008392694,0.0005068214],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99797124,0.0002329307,0.00035922136,0.00057837693,0.00017851578,0.00067970995],"domain_scores_gemma":[0.9990528,0.00010429591,0.00014610574,0.00049315015,0.00006556196,0.00013805459],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038927476,0.00026867268,0.00030314585,0.00006417864,0.0003025265,0.00005878765,0.00045761565,0.00036615191,0.000058806494],"category_scores_gemma":[0.00010550957,0.00022485384,0.00017088288,0.0002450746,0.00012311872,0.0000090904205,0.00019086682,0.0003524097,0.00013088612],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008150601,0.000102646336,0.0009780757,0.000016177453,0.000030117499,0.000056521803,0.00043193373,0.000022103659,0.98079693,0.000014379511,0.012834567,0.004635034],"study_design_scores_gemma":[0.00055934425,0.00041550983,0.00010397584,0.0000052996133,0.000023421522,0.000026702619,0.00024127055,0.000481727,0.5162469,0.00001355022,0.48171136,0.00017094883],"about_ca_topic_score_codex":0.000022602935,"about_ca_topic_score_gemma":0.000052750376,"teacher_disagreement_score":0.46887678,"about_ca_system_score_codex":0.000061408304,"about_ca_system_score_gemma":0.00013795226,"threshold_uncertainty_score":0.91692734},"labels":[],"label_agreement":null},{"id":"W4388588572","doi":"10.1093/neuonc/noad179.0183","title":"CSIG-27. FLUID SHEAR STRESS ACTIVATES A MECHANO-METASTATIC CASCADE TO PROMOTE MEDULLOBLASTOMA METASTASIS","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; SickKids Foundation","funders":"","keywords":"Metastasis; Cancer research; Cerebrospinal fluid; Cancer cell; Cell; Cell migration; Medulloblastoma; Chemistry; Medicine; Pathology; Cancer; Internal medicine","score_opus":0.018680038004465705,"score_gpt":0.2958610730525301,"score_spread":0.2771810350480644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98909855,0.00083330856,0.00060870586,0.0029942677,0.004099986,0.0010163793,0.0003294131,0.00016571577,0.000853647],"genre_scores_gemma":[0.9732756,0.0036306025,0.0062035476,0.007917518,0.0048051304,0.0009460258,0.00060453994,0.00035337693,0.0022636612],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99707884,0.00034078918,0.00044319758,0.0009450208,0.0003186084,0.00087353017],"domain_scores_gemma":[0.99851316,0.00010791947,0.00014697852,0.0006724778,0.00014305678,0.00041638856],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040079444,0.00040183985,0.0006083977,0.00028226295,0.00015295077,0.00004128061,0.00048005904,0.00026950962,0.00011284495],"category_scores_gemma":[0.0005527593,0.0003882033,0.00023775084,0.00065880833,0.00010782584,0.000012729483,0.00044218803,0.0002760038,0.00030856286],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003008309,0.00013794133,0.000020017349,0.00004129687,0.0001564502,0.00006380644,0.00027313133,0.00020341942,0.9231921,0.000062841864,0.039179996,0.036368176],"study_design_scores_gemma":[0.00063177594,0.0008709168,0.00008902944,0.000008470857,0.00008135455,0.00009208844,0.0001437244,0.000050624847,0.4926512,0.000049474133,0.5051143,0.00021703413],"about_ca_topic_score_codex":0.00007267138,"about_ca_topic_score_gemma":0.00020978657,"teacher_disagreement_score":0.46593434,"about_ca_system_score_codex":0.000064161846,"about_ca_system_score_gemma":0.00038617902,"threshold_uncertainty_score":0.999857},"labels":[],"label_agreement":null},{"id":"W4388588586","doi":"10.1093/neuonc/noad179.0682","title":"PATH-52. MENINGIOMA MOLECULAR GROUPS PREDICT RESPONSE TO SURGERY AND RADIOTHERAPY","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Toronto Western Hospital; Princess Margaret Cancer Centre; McMaster University; University of Toronto","funders":"","keywords":"Adjuvant; Meningioma; Medicine; Methylation; Oncology; Proportional hazards model; Internal medicine; Adjuvant therapy; Radiation therapy; Surgery; Cancer; Biology; Genetics; Gene","score_opus":0.024543917635204814,"score_gpt":0.2979852114148522,"score_spread":0.2734412937796474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588586","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9805303,0.0002847617,0.000418588,0.015796684,0.00061944034,0.0006798944,0.000006242629,0.00032885285,0.0013352075],"genre_scores_gemma":[0.99474484,0.00006652908,0.0009325411,0.0033905173,0.00019849419,0.00014908523,0.000021462534,0.00005756638,0.00043895107],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99772614,0.0005006001,0.00038903893,0.00054696505,0.00032342214,0.00051380834],"domain_scores_gemma":[0.9979605,0.0010860517,0.000086489235,0.00044152432,0.00004809098,0.00037732342],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012987473,0.00021943403,0.000561039,0.00062684255,0.00009583008,0.000026561456,0.00011311189,0.00015237997,0.00009261239],"category_scores_gemma":[0.00061718223,0.0002061735,0.00012418612,0.0006583111,0.00007776068,0.000052014595,0.00014101552,0.00019603765,0.0000952385],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00450005,0.000100651974,0.0055973176,0.0000721093,0.00012039337,0.037066005,0.0009379548,0.000014980953,0.8712587,0.00027212338,0.06435142,0.015708301],"study_design_scores_gemma":[0.004221932,0.0067557567,0.09683358,0.00010414015,0.00020347386,0.0042476915,0.0003823011,0.0016321455,0.014817875,0.00019521943,0.87009203,0.0005138353],"about_ca_topic_score_codex":0.000008162622,"about_ca_topic_score_gemma":7.2910814e-7,"teacher_disagreement_score":0.85644084,"about_ca_system_score_codex":0.00012947054,"about_ca_system_score_gemma":0.00015425352,"threshold_uncertainty_score":0.8407512},"labels":[],"label_agreement":null},{"id":"W4388588599","doi":"10.1093/neuonc/noad179.0518","title":"DISP-02. PATTERNS IN THE INCIDENCE OF BRAIN METASTASIS BY RACE AND ETHNICITY: A SYSTEMATIC REVIEW","year":2023,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Incidence (geometry); Medicine; Pacific islanders; Ethnic group; Cancer; Lung cancer; Demography; Internal medicine; Oncology; Population","score_opus":0.08173283595690423,"score_gpt":0.4092282875138548,"score_spread":0.3274954515569506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588599","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006182544,0.9886996,0.000019968498,0.004541126,0.000112442314,0.0061940257,0.00029599702,0.000026145322,0.00004884222],"genre_scores_gemma":[0.00004095082,0.9931127,0.000051363713,0.005123769,0.000036965328,0.0013593539,0.00015484606,0.00006308855,0.000056955298],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99267334,0.0043385797,0.0016207453,0.0005879073,0.00042919203,0.00035025598],"domain_scores_gemma":[0.9905335,0.007577225,0.00080823014,0.00090544036,0.000056208635,0.000119423166],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0031358171,0.0004820287,0.005919487,0.00019816362,0.00003989538,0.000012634395,0.00036180686,0.00025142616,0.000041878164],"category_scores_gemma":[0.0031272147,0.0002613649,0.00052645407,0.0007200508,0.00012684734,0.000035783516,0.00020063734,0.0007492214,0.000044707947],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00000800531,0.00021450326,0.000010458093,0.8680935,0.00041193765,0.0010975023,0.00015365251,2.7257812e-8,0.0000056911863,0.0000510339,0.006236012,0.1237177],"study_design_scores_gemma":[0.0006489607,0.0012050316,0.000011415774,0.4569015,0.01477254,0.0021712403,0.00011779977,0.0000026560692,0.0000019478284,0.000012973547,0.523943,0.00021095126],"about_ca_topic_score_codex":0.00014334334,"about_ca_topic_score_gemma":0.0001350895,"teacher_disagreement_score":0.517707,"about_ca_system_score_codex":0.00017472176,"about_ca_system_score_gemma":0.00034173566,"threshold_uncertainty_score":0.99998385},"labels":[],"label_agreement":null},{"id":"W4388588613","doi":"10.1093/neuonc/noad179.0030","title":"BIOM-19. PLASMA EXTRACELLULAR VESICLE SAMPLING FROM HIGH GRADE GLIOMA PATIENTS DEMONSTRATES A SMALL RNA SIGNATURE INDICATIVE OF DISEASE AND IDENTIFIES LNCRNA RPPH1 AS A HIGH GRADE GLIOMA BIOMARKER","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Atlantic Cancer Research Institute; Nova Scotia Health Authority; Dalhousie University","funders":"","keywords":"Glioma; Paracrine signalling; microRNA; RNA; Biomarker; Cancer research; Biology; Extracellular vesicle; Messenger RNA; Transfer RNA; Small RNA; Microvesicles; Cell biology; Gene; Biochemistry; Receptor","score_opus":0.020356099455629804,"score_gpt":0.2751730821211275,"score_spread":0.2548169826654977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588613","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994389,0.0023271423,0.00013946262,0.0007589115,0.0006149909,0.00076713564,0.0008608882,0.00011036063,0.00003212153],"genre_scores_gemma":[0.9965554,0.0003418822,0.0009244302,0.00021219355,0.00020285076,0.00011768244,0.0014944882,0.000108957334,0.000042121075],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996302,0.00055753964,0.00076177064,0.0012724535,0.00039687566,0.00070933375],"domain_scores_gemma":[0.9970225,0.00049533986,0.000873852,0.00078831223,0.00016201711,0.0006579718],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000257676,0.00053912814,0.00056383223,0.00039438278,0.00024675828,0.00007333515,0.0006574684,0.0006101613,0.000044955355],"category_scores_gemma":[0.0012314797,0.00051627983,0.00023522835,0.0007292574,0.000804639,0.000029531975,0.00063383114,0.00035585638,0.000043129156],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001046479,0.00073037605,0.009011162,0.00008566941,0.00030324692,0.0007761703,0.0002142258,0.000030832543,0.9827803,0.0001467245,0.0009365859,0.0039382456],"study_design_scores_gemma":[0.0033889737,0.00081089395,0.048451927,0.000052745225,0.00031862373,0.000029533032,0.00027859674,0.0002040162,0.94079477,0.0034822903,0.0016268201,0.00056079205],"about_ca_topic_score_codex":0.00021778463,"about_ca_topic_score_gemma":0.0000464748,"teacher_disagreement_score":0.041985493,"about_ca_system_score_codex":0.0000699071,"about_ca_system_score_gemma":0.00034363146,"threshold_uncertainty_score":0.99972886},"labels":[],"label_agreement":null},{"id":"W4388588618","doi":"10.1093/neuonc/noad179.0190","title":"RADT-01. BASELINE HIPPOCAMPAL VOLUME AS A PREDICTOR OF NEUROCOGNITIVE CHANGES AFTER WBRT OR HA-WBRT: SECONDARY ANALYSIS OF NRG ONCOLOGY CC001","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Université de Montréal","funders":"","keywords":"Medicine; Neurocognitive; Internal medicine; Correlation; Baseline (sea); Oncology; Nuclear medicine; Cognition","score_opus":0.02596337875086452,"score_gpt":0.31816516016348984,"score_spread":0.2922017814126253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98618954,0.00033047877,0.0000123438,0.008700416,0.0007053037,0.0011401355,0.0007591075,0.00013422476,0.0020284615],"genre_scores_gemma":[0.9926079,0.0006903808,0.00017161138,0.0045983363,0.0003440168,0.0006871098,0.0004832219,0.00007025078,0.00034720043],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99651957,0.00066250487,0.0008881138,0.0008158895,0.00046245367,0.00065149623],"domain_scores_gemma":[0.9958636,0.002227305,0.00053304725,0.000587902,0.00041634173,0.0003717971],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00053688267,0.00041084446,0.0019460119,0.0014956117,0.00006293002,0.000007968317,0.000204923,0.00037567312,0.0046388293],"category_scores_gemma":[0.0011450832,0.00032892436,0.00048845063,0.002242938,0.0003934114,0.00006919228,0.00024055639,0.00045002936,0.0002070027],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023139512,0.012971439,0.30319476,0.0008242038,0.012603516,0.0394671,0.0061408384,0.000116960764,0.28262365,0.00006998962,0.059187673,0.25966036],"study_design_scores_gemma":[0.023739599,0.040517606,0.54271674,0.00016625154,0.01931998,0.00079401326,0.0016626308,0.0043002474,0.04923983,0.00009281807,0.31681675,0.0006335708],"about_ca_topic_score_codex":0.00015422152,"about_ca_topic_score_gemma":0.0010375541,"teacher_disagreement_score":0.2590268,"about_ca_system_score_codex":0.0002322331,"about_ca_system_score_gemma":0.0009042434,"threshold_uncertainty_score":0.99991626},"labels":[],"label_agreement":null},{"id":"W4388588619","doi":"10.1093/neuonc/noad179.0507","title":"EPCO-45. CELLULAR HIERARCHIES OF ETMR ARE SHAPED BY ONCOGENIC MICRORNAS AND RECEPTOR-LIGAND INTERACTIONS","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre","funders":"","keywords":"Biology; microRNA; Population; Cell; Stem cell; Neural stem cell; Cancer research; Neuroscience; Genetics; Cell biology; Gene; Medicine","score_opus":0.013759409685136649,"score_gpt":0.2791785041914618,"score_spread":0.2654190945063251,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956067,0.001972615,0.00012811531,0.00085167994,0.00046635815,0.00024082795,0.00017150087,0.000045361303,0.0005167958],"genre_scores_gemma":[0.9966752,0.0010257933,0.0003107253,0.00053086464,0.00021333687,0.00003953437,0.00038680644,0.000053453332,0.00076430844],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99842525,0.0002405738,0.0003590198,0.00051935535,0.00012088674,0.00033494638],"domain_scores_gemma":[0.99897265,0.00013038599,0.00022907158,0.00040862092,0.000079653546,0.0001795844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018648921,0.00021123652,0.00029471403,0.0001143783,0.00010652553,0.000016319897,0.000261933,0.00023079221,0.000062372645],"category_scores_gemma":[0.00023694003,0.00022588774,0.00012969323,0.00020167939,0.00032988878,0.000007951425,0.00031162612,0.0002507612,0.0000637573],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020870302,0.00011691051,0.0012809482,0.000034275225,0.000064676715,0.00004264592,0.000115763825,0.0000072027206,0.9582676,0.000022284945,0.035978753,0.0038601805],"study_design_scores_gemma":[0.0005505278,0.0004109068,0.00025296572,0.000007737544,0.00003601052,0.000028088843,0.00018414312,0.000056656987,0.6644295,0.000063465566,0.33383664,0.00014337085],"about_ca_topic_score_codex":0.000011224437,"about_ca_topic_score_gemma":0.000024480838,"teacher_disagreement_score":0.2978579,"about_ca_system_score_codex":0.000037687438,"about_ca_system_score_gemma":0.00015326483,"threshold_uncertainty_score":0.9211435},"labels":[],"label_agreement":null},{"id":"W4388588622","doi":"10.1093/neuonc/noad179.0599","title":"INNV-10. GLIOMAS IN ADOLESCENTS AND YOUNG ADULTS – EXPERIENCE OF CASES PRESENTED AT NATIONAL AYA MULTI-DISCIPLINARY ROUNDS","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; BC Cancer Agency; University of Manitoba; London Health Sciences Centre; Centre Hospitalier Universitaire Sainte-Justine; Health Sciences Centre; CancerCare Manitoba; Hospital for Sick Children","funders":"","keywords":"Medicine; Glioma; PDGFRA; Oncology; Internal medicine; KRAS; Population; CDKN2A; Young adult; Cancer; Cancer research; Colorectal cancer; GiST","score_opus":0.04863606249864656,"score_gpt":0.3583593643765998,"score_spread":0.30972330187795327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978398,0.00023572413,4.879953e-7,0.0008553107,0.0002623637,0.000448978,0.000026475318,0.000044154385,0.00028667433],"genre_scores_gemma":[0.99934953,0.00010060294,0.00004787252,0.00012552133,0.000050020048,0.00017264485,0.00005167911,0.000017215409,0.00008490162],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986973,0.00008974642,0.00031770763,0.00036402463,0.00027625373,0.00025497205],"domain_scores_gemma":[0.99925923,0.00023273425,0.000107123975,0.00015712625,0.00012788767,0.00011589883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009355923,0.00014397307,0.00032020724,0.0003391641,0.00006466029,0.0000054819884,0.00007066191,0.00011528497,0.00004294627],"category_scores_gemma":[0.00041756418,0.0001270916,0.0000500402,0.00050880073,0.00014841558,0.00006936368,0.0002433641,0.00010417983,0.000030731804],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010374506,0.0016977874,0.89054877,0.000114856804,0.000026389349,0.004960223,0.0022994096,0.000018640825,0.09606379,0.000016773225,0.0016937499,0.001522142],"study_design_scores_gemma":[0.009292473,0.001452207,0.9670125,0.00022643701,0.00003331263,0.0009687541,0.00087989663,0.0023535385,0.015800819,0.000010804157,0.0018514814,0.00011776582],"about_ca_topic_score_codex":0.00017261118,"about_ca_topic_score_gemma":0.000718604,"teacher_disagreement_score":0.080262974,"about_ca_system_score_codex":0.00021924557,"about_ca_system_score_gemma":0.00009669762,"threshold_uncertainty_score":0.5182645},"labels":[],"label_agreement":null},{"id":"W4388588647","doi":"10.1093/neuonc/noad179.0619","title":"INNV-30. DEVELOPMENT AND IMPLEMENTATION OF A NOVEL, BRIEF NEUROCOGNITIVE SCREENING AND REHABILITATION SERVICE IN A CLINICAL NEURO-ONCOLOGY SETTING","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Traumatic Brain Injury Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Neurocognitive; Neurorehabilitation; Rehabilitation; Neuropsychology; Medicine; Mood; Quality of life (healthcare); Cognition; Psychology; Psychiatry; Physical medicine and rehabilitation; Physical therapy; Nursing","score_opus":0.10972876307335845,"score_gpt":0.4507277966976187,"score_spread":0.34099903362426026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97921664,0.00001663725,0.0001839091,0.018416107,0.00014792234,0.0015364013,0.000016013493,0.00007842144,0.00038795965],"genre_scores_gemma":[0.97696185,0.00005456983,0.016887976,0.0056481343,0.0001002656,0.0002381631,0.00005478133,0.00004884769,0.0000054174716],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99632794,0.0008586245,0.0013030563,0.0006675831,0.00034846255,0.00049431686],"domain_scores_gemma":[0.9881159,0.010801954,0.00035069342,0.00020446653,0.00031639592,0.00021060657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027074062,0.00020312949,0.00068275456,0.0005668137,0.00009788212,0.000015740721,0.00010613769,0.00024389323,0.00004632331],"category_scores_gemma":[0.00409848,0.00021174559,0.000047988513,0.0009083689,0.0002886629,0.00013565687,0.00034134716,0.00071250374,0.000013221345],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011425288,0.00045681576,0.237105,0.0005887092,0.00007106404,0.00028896477,0.014853972,0.000009136063,0.09349243,0.0001611632,0.00089195627,0.6509383],"study_design_scores_gemma":[0.0129198525,0.005589842,0.9442876,0.00013785186,0.00006898745,0.00033409358,0.010728103,0.0029256875,0.0016962179,0.00006260629,0.021063546,0.00018561553],"about_ca_topic_score_codex":0.00013631087,"about_ca_topic_score_gemma":0.0005380925,"teacher_disagreement_score":0.7071826,"about_ca_system_score_codex":0.00012767466,"about_ca_system_score_gemma":0.0008232682,"threshold_uncertainty_score":0.8634735},"labels":[],"label_agreement":null},{"id":"W4388588697","doi":"10.1093/neuonc/noad179.0624","title":"INNV-35. IMPLEMENTATION OF A NATIONAL ADOLESCENT AND YOUNG ADULT MOLECULAR TUMOR BOARD: REPORT FROM THE CANADIAN AYA NEURO-ONCOLOGY NETWORK","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; Dalhousie University; Princess Margaret Cancer Centre; Izaak Walton Killam Health Centre; BC Cancer Agency; Centre Hospitalier Universitaire Sainte-Justine; London Health Sciences Centre; St. Michael's Hospital; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Medulloblastoma; Population; Atypical teratoid rhabdoid tumor; Young adult; Neurosurgery; Pediatrics; Ependymoma; Oncology; Multidisciplinary approach; Family medicine; Internal medicine; Pathology; Psychiatry","score_opus":0.019401270188600363,"score_gpt":0.3170526776971318,"score_spread":0.2976514075085314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96801734,0.00020275377,0.0000065545455,0.028344072,0.0009731898,0.0009876579,0.000104627594,0.000053107146,0.0013107172],"genre_scores_gemma":[0.9856104,0.00013450792,0.00017334014,0.013092461,0.0003807341,0.00023043605,0.00033702274,0.00003586381,0.0000052378896],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99775326,0.00027922695,0.00058927614,0.00048865157,0.00040902453,0.00048055296],"domain_scores_gemma":[0.99821585,0.0005492368,0.000327016,0.00030900084,0.00031516445,0.00028373758],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003519453,0.0002119071,0.00046605797,0.00018391306,0.0001910728,0.000020211275,0.00012139966,0.00014739083,0.00010139852],"category_scores_gemma":[0.00042660985,0.00017100309,0.00010868364,0.00045849397,0.00015109206,0.00004166203,0.00010439245,0.0002966575,0.00002808853],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018273495,0.00030708103,0.78328663,0.00002770104,0.0002676527,0.014453046,0.00074461405,0.00011920422,0.06735738,0.0010529989,0.119320154,0.012880801],"study_design_scores_gemma":[0.005275709,0.0014426037,0.8296886,0.00004880626,0.00037189707,0.0016117096,0.00073312584,0.0003865357,0.00837964,0.0005535055,0.15130064,0.00020720517],"about_ca_topic_score_codex":0.054616474,"about_ca_topic_score_gemma":0.23697284,"teacher_disagreement_score":0.18235637,"about_ca_system_score_codex":0.00056531926,"about_ca_system_score_gemma":0.0016461938,"threshold_uncertainty_score":0.95167893},"labels":[],"label_agreement":null},{"id":"W4388588709","doi":"10.1093/neuonc/noad179.0513","title":"EPCO-51. FUNCTIONAL ANALYSIS OF REGULATORY MUTATIONS IN PEDIATRIC BRAIN TUMORS","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Genetics and Neurodevelopmental Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Gene; Biology; Transcription factor; Genetics; Chromatin; Enhancer; Genome; Regulatory sequence; Somatic cell; Computational biology","score_opus":0.013997817955015176,"score_gpt":0.2635607364601688,"score_spread":0.24956291850515364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977806,0.00007037289,0.000050138235,0.00065355626,0.0001997477,0.00011906515,0.000021530075,0.000014562589,0.0010904339],"genre_scores_gemma":[0.99844843,0.0002233804,0.00007044483,0.00066609826,0.000031674015,0.000033143886,0.00034928805,0.000017449565,0.00016007722],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99883246,0.000119721306,0.00032286462,0.00036004122,0.00013846043,0.00022644953],"domain_scores_gemma":[0.99947417,0.0000971832,0.00011022346,0.00020682816,0.000050789633,0.000060799026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018535854,0.000116342526,0.00021811898,0.0005522501,0.000042865657,0.000004261773,0.00012995701,0.00012840198,0.00004795694],"category_scores_gemma":[0.00016991339,0.0001297803,0.00012365723,0.0013629863,0.00007400343,0.000002314423,0.000112705435,0.00009562326,0.000021895157],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053404445,0.00011996702,0.079442814,0.0000121161565,0.000087630055,0.000020370062,0.000097691576,0.0098947305,0.90264034,0.000071279166,0.00609221,0.0014674582],"study_design_scores_gemma":[0.0005663307,0.00029189093,0.97138405,9.08733e-7,0.00010755563,0.000005381674,0.000109816545,0.0004870996,0.015971785,0.00008218452,0.010857553,0.00013547036],"about_ca_topic_score_codex":0.000009628653,"about_ca_topic_score_gemma":0.00015110886,"teacher_disagreement_score":0.8919412,"about_ca_system_score_codex":0.000021304086,"about_ca_system_score_gemma":0.00022789263,"threshold_uncertainty_score":0.5292287},"labels":[],"label_agreement":null},{"id":"W4388588713","doi":"10.1093/neuonc/noad179.0074","title":"BIOM-63. PROTEOMIC BASED PROFILING OF CSF FOR CNSL MANAGEMENT","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Cerebrospinal fluid; Primary central nervous system lymphoma; Proteomics; Medicine; Lymphoma; Shotgun proteomics; Oncology; Clinical endpoint; Bioinformatics; Internal medicine; Biology; Clinical trial","score_opus":0.020812268447916886,"score_gpt":0.2987394049311476,"score_spread":0.2779271364832307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588713","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98479766,0.00044318885,0.0040488625,0.0011585336,0.003574815,0.0025090056,0.00013346723,0.000083299725,0.003251161],"genre_scores_gemma":[0.9622002,0.0016741543,0.02326326,0.0037939444,0.0039198548,0.0026103328,0.0008113835,0.00017583555,0.0015510293],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988032,0.00007240701,0.00027075296,0.000414366,0.000099349476,0.0003398965],"domain_scores_gemma":[0.9993301,0.000038411763,0.00013514132,0.00034018446,0.000087392116,0.00006874981],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026913785,0.00014686467,0.0002520985,0.0001230737,0.00005835227,0.000007149266,0.00021177785,0.00018038871,0.000012528476],"category_scores_gemma":[0.000098446326,0.00014671891,0.00014634909,0.00018879924,0.00008358216,0.00000255036,0.00012130358,0.00007380797,0.000015596042],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029508182,0.000071316645,0.000105257015,0.00013207366,0.000040624134,0.0000041734447,0.000019248786,0.00011475525,0.9671164,0.00020006174,0.011616883,0.020284088],"study_design_scores_gemma":[0.0012204128,0.00045440343,0.00019485682,0.0000048096263,0.00003597815,0.0000038110848,0.00003215911,0.00024655522,0.53157336,0.0000679643,0.4660723,0.00009339166],"about_ca_topic_score_codex":0.000006287482,"about_ca_topic_score_gemma":0.000010117806,"teacher_disagreement_score":0.4544554,"about_ca_system_score_codex":0.000021197695,"about_ca_system_score_gemma":0.00018902626,"threshold_uncertainty_score":0.59830236},"labels":[],"label_agreement":null},{"id":"W4388588716","doi":"10.1093/neuonc/noad179.0374","title":"DNAR-08. BASE EXCISION REPAIR AS A THERAPEUTIC TARGET FOR DIFFUSE HEMISPHERIC GLIOMA, H3.3G34-MUTANT","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Global Health Research; Hospital for Sick Children","funders":"","keywords":"XRCC1; Base excision repair; DNA repair; Biology; Cancer research; Glioma; Nucleotide excision repair; Homologous recombination; ERCC1; Gene knockdown; Wild type; Mutant; Mutation; DNA mismatch repair; Molecular biology; Genetics; Apoptosis; DNA; Single-nucleotide polymorphism; Gene","score_opus":0.031622645338935725,"score_gpt":0.322488166151862,"score_spread":0.29086552081292627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853165,0.00065380835,0.000055728615,0.009589111,0.0008592091,0.0017954669,0.00003774776,0.0006562504,0.0010361831],"genre_scores_gemma":[0.99164397,0.00031079692,0.001100886,0.004829123,0.00037389956,0.0012881734,0.00013457944,0.00011266848,0.00020593492],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976168,0.00016211276,0.0004844408,0.0007383614,0.0003244488,0.00067378493],"domain_scores_gemma":[0.99744046,0.0012581014,0.00016308604,0.00067365286,0.00012577778,0.00033894897],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030611773,0.00034005745,0.0006964238,0.00022206706,0.00018057034,0.000019888004,0.00015379724,0.00026767922,0.0004600839],"category_scores_gemma":[0.0005030426,0.0002660744,0.00042204696,0.0007373989,0.00009688751,0.00005937427,0.00011402683,0.00022420852,0.0006112142],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013947466,0.0026592878,0.0039167707,0.0001091386,0.00024361201,0.00711198,0.0003621519,0.000024572537,0.92374575,0.00026201532,0.030300599,0.02986938],"study_design_scores_gemma":[0.018418923,0.011412407,0.005124363,0.00007272686,0.00059203245,0.0011909415,0.00036182962,0.0041953255,0.21033943,0.0016234466,0.7462583,0.00041024145],"about_ca_topic_score_codex":0.000032866206,"about_ca_topic_score_gemma":0.000012852503,"teacher_disagreement_score":0.71595776,"about_ca_system_score_codex":0.0002761564,"about_ca_system_score_gemma":0.00026366577,"threshold_uncertainty_score":0.99997914},"labels":[],"label_agreement":null},{"id":"W4388588719","doi":"10.1093/neuonc/noad179.0400","title":"DDDR-06. THE SMOKING CESSATION AGENT LOBELINE DELAYS HYPOXIC STRESS RECOVERY RESULTING IN GLIOBLASTOMA CELL DEATH","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Metabolomics and Mass Spectrometry Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Atlantic Cancer Research Institute; Saint John Regional Hospital; Dalhousie University","funders":"","keywords":"Hypoxia (environmental); Programmed cell death; Cell biology; Stress granule; Chemistry; Cell; Gene silencing; Cancer research; Pharmacology; Apoptosis; Biology; Translation (biology); Messenger RNA; Biochemistry","score_opus":0.02131458777356622,"score_gpt":0.2777015387823962,"score_spread":0.25638695100882997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948724,0.0006619062,0.0001411119,0.0011448496,0.00074183865,0.00026641757,0.000040388662,0.00003551421,0.0020955661],"genre_scores_gemma":[0.99499726,0.0030866463,0.00017774393,0.0007687952,0.0005467488,0.00006603096,0.00008619498,0.000034231984,0.0002363603],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99814725,0.00028110677,0.00041584455,0.00051880546,0.00016042005,0.00047658215],"domain_scores_gemma":[0.9990554,0.0002229221,0.00021796064,0.00037265453,0.00007198295,0.000059100013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006367952,0.00020843704,0.000273162,0.00018043975,0.00018359875,0.000028276787,0.00029458696,0.0002141482,0.000010303121],"category_scores_gemma":[0.00047351062,0.00017140669,0.000102225385,0.00044889073,0.000060687064,0.0000063848784,0.00038728153,0.0002800689,0.000024560546],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016580686,0.00009448179,0.0077267787,0.000019601634,0.000040325787,0.000070472,0.00015427644,0.0017861312,0.9799882,0.00006997798,0.0052769715,0.004606949],"study_design_scores_gemma":[0.0031968146,0.0023145848,0.02676044,0.00002846763,0.00010304929,0.00006050251,0.0013285802,0.002358426,0.60792756,0.0005859984,0.35474026,0.00059530104],"about_ca_topic_score_codex":0.00005002685,"about_ca_topic_score_gemma":0.0003830201,"teacher_disagreement_score":0.37206066,"about_ca_system_score_codex":0.000075040574,"about_ca_system_score_gemma":0.00011882912,"threshold_uncertainty_score":0.69897616},"labels":[],"label_agreement":null},{"id":"W4388588751","doi":"10.1093/neuonc/noad179.0508","title":"EPCO-46. CHARACTERIZING ATYPICAL TERATOID RHABDOID TUMOR SUBTYPE ENHANCER INTERACTION LANDSCAPE","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Enhancer; SMARCB1; Biology; PDGFRB; DNA methylation; Epigenetics; Genetics; Histone; Epigenomics; Chromatin immunoprecipitation; Gene; Genome; Computational biology; Cancer research; Promoter; Chromatin remodeling; Transcription factor; Gene expression","score_opus":0.01740175606500304,"score_gpt":0.30063517374927407,"score_spread":0.283233417684271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588751","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99436367,0.00016945432,0.0001380395,0.0009904195,0.0015659063,0.00014571784,0.000013767075,0.00010132243,0.0025116901],"genre_scores_gemma":[0.99556106,0.00045400526,0.00013030028,0.002137339,0.001126689,0.000061209445,0.00019740105,0.000042716765,0.00028927985],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986289,0.00012544492,0.0002851013,0.00047929207,0.00011911076,0.0003621199],"domain_scores_gemma":[0.99933237,0.000058149893,0.00013013059,0.00030548716,0.00007310472,0.000100757796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016931556,0.00018362995,0.0002340128,0.00007656932,0.00010429379,0.000029688861,0.00017704084,0.00019978329,0.00018584353],"category_scores_gemma":[0.00013753222,0.00017703467,0.00010971513,0.00016857234,0.000051302486,0.000008269128,0.00014664324,0.00025662067,0.00036032707],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034539486,0.000048945694,0.00070608285,0.000017254846,0.000021717635,0.000040111267,0.00008406746,0.000053691263,0.97038805,0.000009254025,0.013183952,0.015101497],"study_design_scores_gemma":[0.00062910165,0.0005930574,0.0015219575,0.000016621545,0.000016331322,0.00015005737,0.00009819473,0.0014721061,0.46482083,0.00001979113,0.5304559,0.00020606704],"about_ca_topic_score_codex":0.000006575405,"about_ca_topic_score_gemma":0.000025203653,"teacher_disagreement_score":0.51727194,"about_ca_system_score_codex":0.000046457822,"about_ca_system_score_gemma":0.00017082904,"threshold_uncertainty_score":0.72192645},"labels":[],"label_agreement":null},{"id":"W4388588782","doi":"10.1093/neuonc/noad179.0520","title":"DISP-05. UNDERSTANDING THE INDIVIDUAL CHALLENGES AND EXPERIENCES OF YOUNG ADULTS WITH A DIAGNOSIS OF GLIOBLASTOMA AND HIGH-GRADE ASTROCYTOMA","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; The Scarborough Hospital; University of Toronto","funders":"","keywords":"Thematic analysis; Glioma; Qualitative research; Young adult; Population; Medicine; Axial coding; Glioblastoma; Psychology; Gerontology; Grounded theory; Sociology","score_opus":0.05866666519521551,"score_gpt":0.30979447899514356,"score_spread":0.25112781379992805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895529,0.0012759181,0.000015639038,0.008336926,0.000218345,0.0004123001,0.00001760936,0.000054557167,0.00011576532],"genre_scores_gemma":[0.99733955,0.0020049263,0.00009389121,0.0003042159,0.00010690209,0.00012284877,0.00000354905,0.00002190189,0.0000022091401],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.998395,0.00022848522,0.00034548462,0.00035437717,0.00041231097,0.00026433283],"domain_scores_gemma":[0.9978591,0.0014937269,0.0002550211,0.00023227872,0.000041276853,0.00011858579],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003742516,0.00017022013,0.00054358726,0.00016710577,0.00008583994,0.000008813701,0.00013352338,0.00010630002,0.000011239681],"category_scores_gemma":[0.00023281816,0.000117008385,0.00004033403,0.00026993413,0.00074174436,0.00007642102,0.00015927716,0.00020564697,6.981067e-7],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005186643,0.00056494103,0.061185718,0.0011528677,0.00046355175,0.00037126537,0.89575374,0.000006276324,0.0027697852,0.0032049743,0.0012235136,0.028116746],"study_design_scores_gemma":[0.007922579,0.02290683,0.20935673,0.00062482635,0.0003182279,0.0006914385,0.7437945,0.000079772624,0.012956411,0.0003675523,0.000711001,0.00027013235],"about_ca_topic_score_codex":0.000096061565,"about_ca_topic_score_gemma":0.0015928162,"teacher_disagreement_score":0.15195921,"about_ca_system_score_codex":0.000045271554,"about_ca_system_score_gemma":0.00010853735,"threshold_uncertainty_score":0.47714633},"labels":[],"label_agreement":null},{"id":"W4388588799","doi":"10.1093/neuonc/noad179.0424","title":"DDDR-31. TARGETING CANCER STEM CELLS WITH A CDK2 INHIBITOR IN GLIOBLASTOMA","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Cancer research; Stem cell; CDK inhibitor; Cyclin-dependent kinase; Cancer stem cell; Biology; Cancer; Cell cycle; Cell biology; Genetics","score_opus":0.008996403821320255,"score_gpt":0.25389812578119003,"score_spread":0.24490172195986978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588799","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976423,0.00023499559,0.000052641393,0.0005685339,0.0005692202,0.00031511,0.000030463998,0.00004871772,0.0005380181],"genre_scores_gemma":[0.99650246,0.00076903455,0.00016009963,0.0013240556,0.0004942219,0.00016380474,0.000031410458,0.000061324405,0.00049359305],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99847347,0.00011757079,0.00027808506,0.00052830536,0.00010793799,0.0004946272],"domain_scores_gemma":[0.9994203,0.00004556505,0.00011618377,0.00025687108,0.000062151186,0.00009892963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016996973,0.00020788875,0.00026251515,0.0001232793,0.00006336138,0.000016141894,0.00020936652,0.0002845288,0.000016896134],"category_scores_gemma":[0.000020253741,0.00019091096,0.00006449384,0.00034083653,0.000100880374,0.0000049769965,0.00019421183,0.00024199129,0.00006079609],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027304297,0.00006907167,0.0018300273,0.000025538497,0.000021162581,0.0001492266,0.0001468811,0.0007249093,0.9737283,0.0000116859,0.018522268,0.0044979025],"study_design_scores_gemma":[0.0010036917,0.0011162262,0.00012398808,0.000017060329,0.000013801804,0.000027740478,0.00022677719,0.00036218262,0.7184154,0.0000053082817,0.27848193,0.00020593706],"about_ca_topic_score_codex":0.0000565786,"about_ca_topic_score_gemma":0.0011164525,"teacher_disagreement_score":0.25995967,"about_ca_system_score_codex":0.00007716181,"about_ca_system_score_gemma":0.00036980194,"threshold_uncertainty_score":0.7785123},"labels":[],"label_agreement":null},{"id":"W4388588801","doi":"10.1093/neuonc/noad179.0333","title":"CTNI-51. A RANDOMIZED DOUBLE-BLIND PHASE 3 STUDY OF VORASIDENIB VS PLACEBO IN PATIENTS WITH MUTANT <i>IDH1</i>/<i>2</i> DIFFUSE GLIOMA (INDIGO): EXPLORATORY ANALYSIS OF VARIANT ALLELE FREQUENCY AND PROGRESSION-FREE SURVIVAL","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre; Toronto General Hospital","funders":"","keywords":"Medicine; IDH1; Internal medicine; Glioma; Placebo; Hazard ratio; Gastroenterology; Isocitrate dehydrogenase; Mucositis; Oligodendroglioma; Oncology; Interim analysis; Progression-free survival; Randomized controlled trial; Confidence interval; Astrocytoma; Pathology; Chemotherapy; Mutant; Biology; Genetics; Cancer research","score_opus":0.02803217890194327,"score_gpt":0.32091978870986276,"score_spread":0.2928876098079195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993836,0.00011756001,0.000005311616,0.000385482,0.00016147416,0.005281678,0.000067599685,0.0000585823,0.00008632727],"genre_scores_gemma":[0.9984049,0.000070599075,0.000121731355,0.00006574879,0.000027860213,0.0011300633,0.00012920614,0.000048261816,0.0000015876877],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99595064,0.0008897233,0.0011764938,0.0007222154,0.0008090396,0.0004518835],"domain_scores_gemma":[0.9964072,0.0015081671,0.000711946,0.0008151364,0.0003020033,0.0002555276],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008977943,0.00038882013,0.0025754848,0.0015226059,0.00007367804,0.000016331234,0.00022526353,0.00018464065,0.000040222447],"category_scores_gemma":[0.00045114863,0.00026843502,0.00021397397,0.0026147002,0.00027380598,0.00012049939,0.00020802829,0.0002577907,0.0000029911434],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5137709,0.03525792,0.4140169,0.00009528509,0.0038591425,0.004753866,0.0052747936,0.00005592554,0.021766277,0.00006235658,0.00011220829,0.00097444694],"study_design_scores_gemma":[0.9337059,0.012779474,0.040057063,0.0000745247,0.005433896,0.000016853923,0.0011343497,0.00024003946,0.006256991,0.000044037944,0.000028563589,0.00022826],"about_ca_topic_score_codex":0.00027844257,"about_ca_topic_score_gemma":0.0008979776,"teacher_disagreement_score":0.41993508,"about_ca_system_score_codex":0.00011604652,"about_ca_system_score_gemma":0.0002760216,"threshold_uncertainty_score":0.9999768},"labels":[],"label_agreement":null},{"id":"W4388588806","doi":"10.1093/neuonc/noad179.0014","title":"BIOM-03. LACK OF CORRELATION OF MR-DETERMINED WHITE MATTER INJURY(WMI)WITH NEUROCOGNITIVE FUNCTION (NCF)6 MONTHS FOLLOWING WBRT+/-HIPPOCAMPAL AVOIDANCE(HA)+MEMANTINE:SECONDARY ANALYSIS OF NRG ONCOLOGY NRGCC001","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Memantine; Medicine; Neurocognitive; Post-hoc analysis; Oncology; Internal medicine; Trail Making Test; Fluid-attenuated inversion recovery; Nuclear medicine; Magnetic resonance imaging; Radiology; NMDA receptor; Cognition; Cognitive impairment; Psychiatry","score_opus":0.023750770192931453,"score_gpt":0.3130954493925948,"score_spread":0.28934467919966333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924073,0.00006998749,0.00010786913,0.0011684892,0.000677716,0.00097446487,0.00014014896,0.00007324582,0.004380752],"genre_scores_gemma":[0.99812764,0.000056858527,0.00019968809,0.0008617718,0.00008628032,0.00015556358,0.00036592103,0.000059123835,0.0000871568],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99681646,0.00043500125,0.0011561953,0.00068033376,0.00044107955,0.00047096066],"domain_scores_gemma":[0.9966842,0.0011488381,0.001067691,0.0005046883,0.0004318832,0.00016268693],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004084404,0.0003761993,0.0017827933,0.0012849213,0.00007879727,0.0000076277197,0.00014403962,0.0003194886,0.0006245587],"category_scores_gemma":[0.0002293384,0.00031740873,0.00056592625,0.0025371222,0.0002606425,0.00015037769,0.00011938377,0.00036199717,0.00011362021],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040799435,0.0013418955,0.73627406,0.00020217327,0.0027737555,0.00075239217,0.00093629304,0.00064613717,0.2302908,0.000018889608,0.0023859257,0.020297743],"study_design_scores_gemma":[0.009417726,0.013045647,0.9150797,0.0001456045,0.010104719,0.000069636255,0.0007979595,0.004116402,0.044074744,0.000038958213,0.0028066516,0.00030221726],"about_ca_topic_score_codex":0.00011925728,"about_ca_topic_score_gemma":0.0002203066,"teacher_disagreement_score":0.18621606,"about_ca_system_score_codex":0.00018328786,"about_ca_system_score_gemma":0.00037666474,"threshold_uncertainty_score":0.9999278},"labels":[],"label_agreement":null},{"id":"W4388588881","doi":"10.1093/neuonc/noad179.0815","title":"NCOG-02. MANAGEMENT OF PATIENTS WITH MELANOMA BRAIN METASTASES AND PRIOR SYSTEMIC TREATMENT EXPOSURE: A SINGLE-CENTER EXPERIENCE","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Melanoma; Single Center; Internal medicine; Oncology; Progression-free survival; Proportional hazards model; Retrospective cohort study; Adverse effect; Expanded access; Systemic therapy; Overall survival; Cancer; Cancer research","score_opus":0.027698674775487948,"score_gpt":0.2859832643915798,"score_spread":0.25828458961609185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99648976,0.00024915786,0.000028526369,0.0008544714,0.00018509847,0.0015801779,0.000116157404,0.00008027417,0.00041636993],"genre_scores_gemma":[0.99739695,0.00015271004,0.0012569302,0.00043530215,0.000029623216,0.00036678847,0.00013651169,0.00003607221,0.00018909456],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9982638,0.00020951038,0.0003927199,0.00049287867,0.0002879796,0.00035311416],"domain_scores_gemma":[0.9988847,0.00029214454,0.000193604,0.000386552,0.000071226044,0.0001717869],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001344194,0.0002677289,0.0006172073,0.00016560918,0.00006916378,0.000012205826,0.00007561062,0.00006777987,0.00005567391],"category_scores_gemma":[0.000029768744,0.00018012278,0.00008795182,0.00030116425,0.00014294506,0.000058450383,0.00009450594,0.00006888975,0.000023091812],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058840564,0.010999113,0.43912584,0.0011914906,0.002689725,0.008582053,0.0075047137,0.00002363579,0.017372373,0.0004880525,0.0025549955,0.50358397],"study_design_scores_gemma":[0.11618683,0.14692228,0.36478072,0.001232337,0.0044183102,0.0025786927,0.009925972,0.00013568463,0.024143588,0.00006079557,0.3283602,0.001254599],"about_ca_topic_score_codex":0.00002084793,"about_ca_topic_score_gemma":0.00001418433,"teacher_disagreement_score":0.50232935,"about_ca_system_score_codex":0.00022995585,"about_ca_system_score_gemma":0.000057340185,"threshold_uncertainty_score":0.73451936},"labels":[],"label_agreement":null},{"id":"W4388588920","doi":"10.1093/neuonc/noad179.1198","title":"MODL-47. A NEW MOUSE MODEL OF IDH MUTATED GLIOMAS IDENTIFIES TUMOR CELLS OF ORIGIN AND DETERMINANTS OF SENSITIVITY TO IDH INHIBITORS","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; McGill University; Hospital for Sick Children; Princess Margaret Cancer Centre","funders":"","keywords":"Biology; IDH1; Mutant; Cancer research; IDH2; Glioma; Tumor progression; Genetics; Gene","score_opus":0.035271072152317055,"score_gpt":0.3161033457505929,"score_spread":0.28083227359827584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985399,0.0000295641,0.000015970792,0.00038840988,0.00021002952,0.0005848795,0.00012214777,0.000043782555,0.00006530568],"genre_scores_gemma":[0.9993352,0.00006109952,0.00031751842,0.00013428113,0.000035914964,0.000022394057,0.000008610999,0.000030124562,0.00005480822],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984472,0.00011728374,0.00055491645,0.00035171394,0.00024865533,0.00028023668],"domain_scores_gemma":[0.9986086,0.00043056993,0.00027887858,0.00030526004,0.00015717922,0.00021953974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021545078,0.00019457599,0.000852115,0.00045074048,0.000027284277,0.000004616655,0.00006051061,0.00011090858,0.000007996214],"category_scores_gemma":[0.00022221314,0.00017128045,0.00011308892,0.00050351396,0.00014284824,0.00005518435,0.00014280214,0.00010094067,0.000013183069],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033287719,0.0004908217,0.01862941,0.00017190696,0.000056557812,0.0008767179,0.0008102857,0.0011143689,0.972924,0.000013021108,0.0018448269,0.0027352257],"study_design_scores_gemma":[0.002549824,0.0013722966,0.006866005,0.000078525,0.00019066132,0.00007792934,0.00016633094,0.007489936,0.98092157,0.000069896705,0.00011645317,0.00010055363],"about_ca_topic_score_codex":0.000454152,"about_ca_topic_score_gemma":0.00027604616,"teacher_disagreement_score":0.011763405,"about_ca_system_score_codex":0.000057558096,"about_ca_system_score_gemma":0.0002512616,"threshold_uncertainty_score":0.6984614},"labels":[],"label_agreement":null},{"id":"W4388588953","doi":"10.1093/neuonc/noad179.0677","title":"PATH-47. MOLECULAR MARKERS ASSOCIATED WITH SURVIVAL IN GRADE 3 MENINGIOMA","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto; University of British Columbia","funders":"","keywords":"CDKN2A; BAP1; Immunohistochemistry; Meningioma; Grading (engineering); Pathology; Medicine; Oncology; Biology; Internal medicine; Cancer research; Cancer","score_opus":0.028321900888070153,"score_gpt":0.29011775765510134,"score_spread":0.2617958567670312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97477627,0.000032993375,0.000043236763,0.004186249,0.00042394857,0.0005583716,0.000004342441,0.00025617806,0.019718438],"genre_scores_gemma":[0.99854016,0.000008125452,0.0002432375,0.0005563041,0.000051016097,0.000090523055,0.00007852991,0.00004637603,0.0003857491],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99775153,0.000392869,0.00035588417,0.00047664891,0.00042384202,0.0005992293],"domain_scores_gemma":[0.998921,0.00039329295,0.00012943902,0.00032413882,0.00005378922,0.00017838072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000715293,0.0002188498,0.0005264585,0.0004237993,0.00005848164,0.000015674392,0.0001514325,0.00017350138,0.00008474017],"category_scores_gemma":[0.00042365762,0.00019301752,0.00009091068,0.0011538018,0.00008667213,0.0000482828,0.000121725585,0.00035158434,0.00010880631],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00217652,0.0010933195,0.12287508,0.00016100904,0.0006190731,0.2721194,0.0013842597,0.00025108774,0.5703772,0.0037216411,0.018737106,0.006484317],"study_design_scores_gemma":[0.034711752,0.017263772,0.76107496,0.00047381953,0.0009374792,0.0021081078,0.002920878,0.010554558,0.017265752,0.001012919,0.15007724,0.0015987629],"about_ca_topic_score_codex":0.000045988185,"about_ca_topic_score_gemma":0.000034552886,"teacher_disagreement_score":0.63819987,"about_ca_system_score_codex":0.0003289039,"about_ca_system_score_gemma":0.00015649326,"threshold_uncertainty_score":0.78710264},"labels":[],"label_agreement":null},{"id":"W4388588958","doi":"10.1093/neuonc/noad179.1159","title":"MODL-08. A COMPENDIUM OF SYNGENEIC, TRANSPLANTABLE PEDIATRIC HIGH-GRADE GLIOMA MODELS REVEALS SUBTYPE-SPECIFIC THERAPEUTIC VULNERABILITIES","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; Montreal Children's Hospital; Jewish General Hospital","funders":"","keywords":"Biology; Cancer research; Histone H3; KRAS; Phenotype; Glioma; Mutation; Gene; Histone; Genetics","score_opus":0.049477504449376576,"score_gpt":0.2942189613114304,"score_spread":0.2447414568620538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912941,0.0026599076,0.0000587354,0.0028660258,0.0007289497,0.0008978496,0.00014371931,0.000218702,0.0011320118],"genre_scores_gemma":[0.99507964,0.0035316516,0.00021097354,0.0003943367,0.0002971756,0.00023672354,0.00011650721,0.00006802269,0.00006495654],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974634,0.00029785986,0.0006417305,0.0005782506,0.00039838982,0.00062037766],"domain_scores_gemma":[0.9977797,0.0011170611,0.00020236008,0.00057280046,0.000117136384,0.00021089497],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030716517,0.0003250233,0.0009826439,0.0005577554,0.000119739576,0.00001508597,0.00020984854,0.00024968287,0.00024372131],"category_scores_gemma":[0.000025893514,0.000270234,0.0002316316,0.00085479976,0.00014117364,0.000096586664,0.000055243578,0.00028784355,0.00017052863],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011942625,0.0039782664,0.027431782,0.00076909724,0.00045988287,0.003453453,0.0019761943,0.0038726183,0.925294,0.012549456,0.014438933,0.0045820917],"study_design_scores_gemma":[0.05163303,0.020368783,0.1572214,0.00028591664,0.005373469,0.0031393955,0.0019324627,0.008732063,0.6486263,0.035424456,0.06497448,0.0022882407],"about_ca_topic_score_codex":0.00010560138,"about_ca_topic_score_gemma":0.000023312748,"teacher_disagreement_score":0.27666765,"about_ca_system_score_codex":0.00017505883,"about_ca_system_score_gemma":0.00020336281,"threshold_uncertainty_score":0.99997497},"labels":[],"label_agreement":null},{"id":"W4388588967","doi":"10.1093/neuonc/noad179.0900","title":"EXTH-47. TUMOUR-TARGETED PAN-RAS INHIBITION AS A NOVEL THERAPY FOR DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Chimera (genetics); Cancer research; Viability assay; Downregulation and upregulation; Glioma; Cell; Targeted therapy; Cell culture; Biology; Cancer; Biochemistry","score_opus":0.025646377028864065,"score_gpt":0.3257621961385854,"score_spread":0.30011581910972135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954082,0.0003821399,0.00017450095,0.0021457567,0.00033928725,0.0009092363,0.00015128785,0.000078614605,0.00041099644],"genre_scores_gemma":[0.9956099,0.0008612096,0.00013225841,0.0011611761,0.00051005994,0.0005709765,0.00086919917,0.000058933718,0.00022628612],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99833745,0.00009707743,0.0002532134,0.00057061116,0.00016445617,0.00057719153],"domain_scores_gemma":[0.9991669,0.000108540014,0.00010202233,0.00031896878,0.00013553665,0.00016801656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016730532,0.00022660804,0.00026213797,0.00017074012,0.00013837143,0.000031591335,0.00016730258,0.00022304719,0.000037922804],"category_scores_gemma":[0.0002983581,0.00020783082,0.000162994,0.00032279248,0.00009937783,0.000007777783,0.00015331403,0.00014786843,0.00010549276],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016159159,0.00057508994,0.00034018292,0.000012139973,0.00009458282,0.00016737165,0.000052034262,0.0000029662745,0.9637635,0.000067045425,0.009759662,0.023549521],"study_design_scores_gemma":[0.008968648,0.005233807,0.0029000049,0.0000056527024,0.000018625353,0.00012969987,0.0000351212,0.00003097926,0.77567047,0.000245758,0.20658429,0.00017693901],"about_ca_topic_score_codex":0.00013526258,"about_ca_topic_score_gemma":0.00024621282,"teacher_disagreement_score":0.19682463,"about_ca_system_score_codex":0.00007566819,"about_ca_system_score_gemma":0.00031318373,"threshold_uncertainty_score":0.8475095},"labels":[],"label_agreement":null},{"id":"W4388588971","doi":"10.1093/neuonc/noad179.0259","title":"CTIM-19. ONCOLYTIC DNX-2401 VIROTHERAPY PLUS PEMBROLIZUMAB IN RECURRENT GLIOBLASTOMA: A PHASE 1/2 TRIAL","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Toronto Western Hospital; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Clinical endpoint; Medicine; Pembrolizumab; Oncolytic virus; Oncology; Internal medicine; Hazard ratio; Confidence interval; Phases of clinical research; Clinical trial; Immunotherapy; Cancer","score_opus":0.03965479245783439,"score_gpt":0.38643010450204035,"score_spread":0.346775312044206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993633,0.00040814318,0.000042984473,0.0018280193,0.0011462511,0.0016779075,0.000045480996,0.0001084561,0.0011097757],"genre_scores_gemma":[0.9927683,0.0019520575,0.00004819041,0.0020160528,0.0013998066,0.0009208213,0.00013805988,0.0001438262,0.0006129179],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99606985,0.0009432384,0.00060961314,0.000977405,0.0004118687,0.0009880497],"domain_scores_gemma":[0.99838984,0.00024811833,0.00017487444,0.00077433634,0.000089031804,0.00032382514],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000869583,0.000378965,0.0005772797,0.00047138514,0.00013813983,0.000037743106,0.000625386,0.0004925339,0.0002308259],"category_scores_gemma":[0.00044107594,0.0003521936,0.00023444531,0.00087337126,0.00023415715,0.000009266495,0.00026114247,0.0005908018,0.0003340234],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2640083,0.0008033522,0.000017757333,0.000016597163,0.000050218237,0.00033500255,0.00019148,0.00023247162,0.6658487,0.000009927905,0.010822133,0.05766408],"study_design_scores_gemma":[0.18561079,0.11979261,0.00003295146,0.000014782631,0.000025075455,0.00012151377,0.00013039027,0.0018523531,0.23375824,0.00013693013,0.45798543,0.0005389327],"about_ca_topic_score_codex":0.000032958807,"about_ca_topic_score_gemma":0.0012283267,"teacher_disagreement_score":0.44716328,"about_ca_system_score_codex":0.00041658388,"about_ca_system_score_gemma":0.001619058,"threshold_uncertainty_score":0.999893},"labels":[],"label_agreement":null},{"id":"W4388588988","doi":"10.1093/neuonc/noad179.0679","title":"PATH-49. COMPREHENSIVE RNA-SEQ ANALYSIS REVEALS NOVEL SUBTYPES OF MENINGIOMAS AND PREDICTS PATIENT OUTCOME.","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"","keywords":"Meningioma; Computational biology; Biology; Grading (engineering); DNA sequencing; Gene; Bioinformatics; Medicine; Genetics; Pathology","score_opus":0.053970420198538115,"score_gpt":0.3192611067677274,"score_spread":0.2652906865691893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99167156,0.00020359168,0.00016165836,0.0020012243,0.00037181177,0.00058873283,0.000035678982,0.00013100798,0.004834709],"genre_scores_gemma":[0.99778056,0.00003602394,0.0010226021,0.0007169736,0.00006868302,0.000047950572,0.00007230375,0.000028309825,0.00022656684],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9977857,0.00015349462,0.0007509111,0.0005088645,0.00040322408,0.00039781633],"domain_scores_gemma":[0.99822414,0.0005518548,0.00035571228,0.0004517142,0.00019288427,0.00022371186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029212915,0.00022977317,0.0009792668,0.00072821626,0.00008289285,0.000011881061,0.00012381788,0.00015495904,0.00005907196],"category_scores_gemma":[0.00029316102,0.00020018368,0.00021508793,0.0012463023,0.00014743756,0.000051774452,0.0002742804,0.00020635461,0.000037352052],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007240894,0.0005106115,0.21361606,0.00051989494,0.0017528223,0.0049518854,0.0028172436,0.00021662943,0.7555569,0.0012848413,0.010729303,0.007319753],"study_design_scores_gemma":[0.008823328,0.009623977,0.8487432,0.00012668701,0.00679069,0.000764137,0.0024191602,0.008579416,0.014634044,0.0004377277,0.09833334,0.00072431064],"about_ca_topic_score_codex":0.00004080449,"about_ca_topic_score_gemma":0.0000059443723,"teacher_disagreement_score":0.7409228,"about_ca_system_score_codex":0.000073078634,"about_ca_system_score_gemma":0.00006553771,"threshold_uncertainty_score":0.81632537},"labels":[],"label_agreement":null},{"id":"W4388588992","doi":"10.1093/neuonc/noad179.0672","title":"PATH-42. UNCOVERING AN ASSOCIATION BETWEEN OLIGODENDROGLIOMA AND THE HUMAN PAPILLOMAVIRUS (HPV) THROUGH MOLECULAR SUBPOPULATION ANALYSIS USING NETRAAI","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"PTEN; Biology; Glioma; Cancer research; HDAC1; Copy-number variation; Gene; Molecular biology; Histone; Genetics; Histone deacetylase; Signal transduction; PI3K/AKT/mTOR pathway","score_opus":0.04053056462054656,"score_gpt":0.34510781130023604,"score_spread":0.3045772466796895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388588992","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974579,0.00016453741,0.00009884796,0.0011580281,0.0001382922,0.00044781493,0.0000176617,0.00011819431,0.0003986979],"genre_scores_gemma":[0.9987302,0.00009893479,0.00015923652,0.0005455432,0.00018686388,0.000046729827,0.00019336576,0.0000324914,0.0000066745724],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980673,0.00041487682,0.00039467643,0.00041816398,0.00035163484,0.00035332388],"domain_scores_gemma":[0.99873805,0.00045417948,0.00028188308,0.00033428028,0.00008383367,0.00010778175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047472582,0.00019797392,0.0006394559,0.00028154888,0.00027491947,0.00005237638,0.00008275474,0.00021427774,0.00002794314],"category_scores_gemma":[0.00016881894,0.00015313424,0.00020116699,0.001216357,0.00006884257,0.00014606527,0.00007939418,0.00019935335,0.000012600323],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005789039,0.000147245,0.84333533,0.000019499055,0.0011685228,0.0005468467,0.000877857,0.0012045963,0.14785829,0.00051710464,0.000070148766,0.004196673],"study_design_scores_gemma":[0.007612112,0.0007808687,0.952735,0.000019280546,0.007471967,0.000045780984,0.00028999065,0.0064554233,0.020757433,0.0017848979,0.0017855758,0.00026168936],"about_ca_topic_score_codex":0.0009544393,"about_ca_topic_score_gemma":0.00019647679,"teacher_disagreement_score":0.12710086,"about_ca_system_score_codex":0.0004079271,"about_ca_system_score_gemma":0.000046495243,"threshold_uncertainty_score":0.6244633},"labels":[],"label_agreement":null},{"id":"W4388589009","doi":"10.1093/neuonc/noad179.1201","title":"MODL-50. CLONAL EXPANSION OF SPONTANEOUS AND INJECTED TUMORS IN SYNGENEIC MOUSE MODELS OF GLIOBLASTOMA","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Biology; Somatic cell; Transcriptome; Electroporation; Cancer research; Population; Gene; Genetics; Gene expression; Medicine","score_opus":0.02123646328589057,"score_gpt":0.28106860178831355,"score_spread":0.259832138502423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986178,0.00017258587,0.000003572378,0.00043603787,0.000082514816,0.00040226043,0.000026335507,0.0000477071,0.00021117252],"genre_scores_gemma":[0.9993295,0.00025494254,0.00014862244,0.00014226824,0.00002281258,0.000049175484,0.000016783011,0.000024918529,0.000010947527],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987651,0.00010616855,0.00040300319,0.0002874405,0.00019791312,0.00024033606],"domain_scores_gemma":[0.9990929,0.00038202674,0.0001308423,0.00021577466,0.00007232221,0.00010614193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011219577,0.00014629938,0.000567622,0.00044220395,0.00001894973,0.000002022562,0.000061031827,0.0001349383,0.00002145631],"category_scores_gemma":[0.00010786334,0.00012703516,0.0000650925,0.00041652613,0.00009972274,0.000036129895,0.00008543349,0.00013847463,0.0000069761163],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013112859,0.000754802,0.0068442835,0.000103292856,0.00004458728,0.0075491634,0.0006361862,0.0021683024,0.9726536,0.00020291802,0.00030282515,0.007428755],"study_design_scores_gemma":[0.015369781,0.019152185,0.09732217,0.0002903377,0.00030480386,0.0058946,0.00076528714,0.038251348,0.82053876,0.0008887956,0.0008504165,0.00037150038],"about_ca_topic_score_codex":0.00015182685,"about_ca_topic_score_gemma":0.00017746243,"teacher_disagreement_score":0.15211484,"about_ca_system_score_codex":0.00008944692,"about_ca_system_score_gemma":0.00015743669,"threshold_uncertainty_score":0.51803434},"labels":[],"label_agreement":null},{"id":"W4388589012","doi":"10.1093/neuonc/noad179.1204","title":"Author Index","year":2023,"lang":"en","type":"paratext","venue":"Neuro-Oncology","topic":"","field":"","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Nuclear Safety Commission","keywords":"Index (typography); Psychology; Computer science; World Wide Web","score_opus":0.0589635921977023,"score_gpt":0.3666350457616977,"score_spread":0.3076714535639954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589012","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019980236,0.00049722934,0.000047718004,0.0047776247,0.0603224,0.0015581724,0.0021554274,0.0015042291,0.92713916],"genre_scores_gemma":[0.0071857604,0.00035463614,0.00015668491,0.005178374,0.008249775,0.0010051067,0.0022838034,0.0025694454,0.97301644],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99349445,0.001533123,0.0010055826,0.0017057455,0.0007432776,0.0015178403],"domain_scores_gemma":[0.9949748,0.0019540496,0.0009368643,0.0014015455,0.0002588956,0.0004738694],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.0007428693,0.0009344427,0.0018168259,0.0012549025,0.00020963784,0.000081525424,0.0014295712,0.0029569387,0.016977275],"category_scores_gemma":[0.0011119768,0.0009898124,0.00040911185,0.0014684536,0.0004488702,0.00010194989,0.0009436003,0.0036166327,0.9017109],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021970068,0.00016985022,0.000022256896,0.00008391494,0.00012155475,0.0013137391,0.00018885681,0.00023211853,0.041432228,0.00008209276,0.9509366,0.0051970743],"study_design_scores_gemma":[0.0011151363,0.00089724275,0.0001582755,0.000036321613,0.00013400034,0.00026592906,0.000049496484,0.00019900785,0.00071352965,0.00012391678,0.99557745,0.00072967005],"about_ca_topic_score_codex":0.00016220346,"about_ca_topic_score_gemma":0.0003174741,"teacher_disagreement_score":0.8847336,"about_ca_system_score_codex":0.0013251716,"about_ca_system_score_gemma":0.0026383114,"threshold_uncertainty_score":0.99925524},"labels":[],"label_agreement":null},{"id":"W4388589017","doi":"10.1093/neuonc/noad179.1097","title":"TMIC-31. MULTI-PLATFORM GENOMIC LANDSCAPE OF INTRA-TUMORAL HYPOXIA IN GLIOBLASTOMA","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thompson Rivers University; University Health Network; University of Toronto; The Scarborough Hospital; Toronto Western Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Transcriptome; Biology; Laser capture microdissection; Epigenomics; Hypoxia (environmental); Chromatin; DNA methylation; Gene expression profiling; Cancer research; Gene expression; Computational biology; Gene; Genetics; Chemistry","score_opus":0.017071761693759208,"score_gpt":0.2731218528501231,"score_spread":0.2560500911563639,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99541575,0.0008108916,0.00003136335,0.00023346569,0.0020113378,0.00028297887,0.000048048052,0.000037038863,0.0011291375],"genre_scores_gemma":[0.99573374,0.001859187,0.00030040162,0.00062954286,0.0010512233,0.00005904608,0.00007076953,0.000046286998,0.00024979885],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99843335,0.00007808118,0.00042305904,0.00046711531,0.00011158506,0.0004868256],"domain_scores_gemma":[0.999235,0.000053840282,0.00016021379,0.00037522046,0.00005743149,0.000118303215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025145934,0.00021153355,0.00041990908,0.00022511599,0.000040742998,0.0000089167215,0.0003045185,0.00030816672,0.000043562544],"category_scores_gemma":[0.00013503336,0.00021673177,0.00013042979,0.00032967937,0.00012624006,0.0000066815655,0.00022545883,0.00022961461,0.000074597],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004128279,0.000112375084,0.0016120361,0.000023585351,0.000022439846,0.000033855053,0.00016555506,0.00015623697,0.97090673,0.000042609277,0.012452712,0.014059039],"study_design_scores_gemma":[0.0040798727,0.0013354076,0.018492592,0.0000093743165,0.00003363645,0.00014110401,0.00026149416,0.0005742289,0.30694303,0.00006614583,0.66773546,0.0003276775],"about_ca_topic_score_codex":0.000046455407,"about_ca_topic_score_gemma":0.000763345,"teacher_disagreement_score":0.6639637,"about_ca_system_score_codex":0.000039229584,"about_ca_system_score_gemma":0.00033641554,"threshold_uncertainty_score":0.8838065},"labels":[],"label_agreement":null},{"id":"W4388589038","doi":"10.1093/neuonc/noad179.0792","title":"NCMP-08. TREATMENT OF PITUITARY METASTASIS: A SINGLE CENTER EXPERIENCE AND SYSTEMATIC LITERATURE REVIEW","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Toronto Western Hospital; University of Toronto","funders":"","keywords":"Medicine; Diabetes insipidus; Retrospective cohort study; Hypopituitarism; Radiation therapy; Surgery; Radiosurgery; Internal medicine","score_opus":0.03463046874427136,"score_gpt":0.3221712558658526,"score_spread":0.28754078712158126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589038","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.71257925,0.27660272,0.00000670948,0.0041501876,0.0004748688,0.0028933259,0.00011146176,0.00015189518,0.0030295989],"genre_scores_gemma":[0.83972937,0.1567859,0.00020648405,0.0024006036,0.000055891705,0.00043638507,0.00016116239,0.00002856176,0.00019565121],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987414,0.00016017952,0.00038682134,0.0003123532,0.00015400969,0.00024522308],"domain_scores_gemma":[0.9992018,0.0001629495,0.0001259857,0.0003184034,0.000053168427,0.0001377218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007705427,0.00019978668,0.0008938068,0.00012918437,0.000046271947,0.0000070247165,0.00005560976,0.000077917604,0.000038316542],"category_scores_gemma":[0.00010364135,0.0001286071,0.00013528811,0.00034624545,0.000067391076,0.00006801663,0.000037777216,0.000061900006,0.00003911141],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028080808,0.026978675,0.1478885,0.46502125,0.0045074103,0.046209417,0.041212343,0.000005687456,0.109628305,0.0005657723,0.03616052,0.11901403],"study_design_scores_gemma":[0.09328959,0.124006905,0.032767445,0.25540876,0.017907757,0.034061357,0.008646873,0.0005668482,0.018953823,0.000934823,0.41068926,0.0027665535],"about_ca_topic_score_codex":0.000008619094,"about_ca_topic_score_gemma":0.0000066328134,"teacher_disagreement_score":0.37452874,"about_ca_system_score_codex":0.00007545473,"about_ca_system_score_gemma":0.00005233766,"threshold_uncertainty_score":0.5244445},"labels":[],"label_agreement":null},{"id":"W4388589044","doi":"10.1093/neuonc/noad179.0639","title":"PATH-09. THE IMPACT OF MISMATCH REPAIR DEFICIENCY ON GLIOMAS IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS; A MULTI-CENTRIC, COLLABORATIVE STUDY LED BY THE IRRDC AND GLIOMA TASKFORCE","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; Mount Sinai Hospital; Health Sciences Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"Microsatellite instability; Germline; DNA mismatch repair; Glioma; Germline mutation; Medicine; Somatic hypermutation; Oncology; Internal medicine; Cancer; Mutation; Cancer research; Genetics; Biology; Immunology; Allele; Microsatellite; Gene; Antibody","score_opus":0.012914611588804494,"score_gpt":0.30634772352351586,"score_spread":0.2934331119347114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589044","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99499315,0.0008844915,0.0000012495805,0.0004928783,0.0002457869,0.0031287423,0.000069369,0.00007100653,0.00011334627],"genre_scores_gemma":[0.9992715,0.00028960867,0.000019311707,0.00017149899,0.000041957435,0.00014716551,0.000009009344,0.0000340773,0.000015848957],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975821,0.00061559636,0.00045551237,0.0005573466,0.00035010886,0.00043937014],"domain_scores_gemma":[0.99860746,0.00045227946,0.00022370582,0.0004411113,0.00015442078,0.00012101727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005179194,0.00028464402,0.00051991927,0.00021273548,0.00014241759,0.000016562124,0.00020250984,0.00015763863,0.000012364898],"category_scores_gemma":[0.0007726854,0.00016276426,0.00008628383,0.0015678246,0.00033472097,0.000029643816,0.00019534642,0.00045373072,0.00000630224],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022001413,0.0014097424,0.93744195,0.000045189227,0.00008868659,0.00017470264,0.009770556,0.000036866924,0.04266242,0.0000040729074,0.0038438656,0.0023218126],"study_design_scores_gemma":[0.009774691,0.010178991,0.9700523,0.00007326692,0.00010643248,0.0003256798,0.0054861004,0.0015799606,0.0021416205,0.0000074457494,0.000113305316,0.00016022293],"about_ca_topic_score_codex":0.00086721487,"about_ca_topic_score_gemma":0.00041691493,"teacher_disagreement_score":0.0405208,"about_ca_system_score_codex":0.00026107734,"about_ca_system_score_gemma":0.00032697193,"threshold_uncertainty_score":0.6637334},"labels":[],"label_agreement":null},{"id":"W4388589064","doi":"10.1093/neuonc/noad179.0692","title":"PATH-63. NEXT GENERATION SEQUENCING FOR CNS TUMORS IN CHILDREN; DOES IT ADD VALUE IN A MIDDLE-INCOME COUNTRY SETUP?","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Trametinib; Oncology; Internal medicine; Targeted therapy; Dabrafenib; Glioma; Sarcoma; Cancer; Pathology; Cancer research; MAPK/ERK pathway; Metastatic melanoma; Kinase","score_opus":0.05613365512920913,"score_gpt":0.3043581957851118,"score_spread":0.2482245406559027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942163,0.00012985904,0.000004615798,0.003451392,0.00048040278,0.0013665584,0.0000721643,0.0000837434,0.00019496203],"genre_scores_gemma":[0.99528384,0.0001776691,0.0002983209,0.0027600285,0.00037692869,0.0007097685,0.00032912722,0.000042986434,0.00002135642],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99818486,0.00015796162,0.000492681,0.00049094396,0.00018920309,0.00048437135],"domain_scores_gemma":[0.99896735,0.00045634212,0.00012173435,0.00026282255,0.00004994129,0.0001417914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035095378,0.00021504732,0.000511293,0.00041158634,0.00007413996,0.000023242843,0.000093131464,0.00019748727,0.000063194835],"category_scores_gemma":[0.0004247225,0.00017107783,0.00009194034,0.00057816587,0.00004854933,0.00009975931,0.000057419322,0.000242529,0.000050548584],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027664672,0.0009737838,0.5309671,0.00020635854,0.00010428681,0.0030374643,0.0022267476,0.0016430266,0.45014706,0.00090608955,0.0044296617,0.0050817723],"study_design_scores_gemma":[0.04365322,0.00865432,0.71674335,0.0012677892,0.0005837067,0.0016272154,0.0028797474,0.094198264,0.10475085,0.0013738432,0.022978647,0.0012890472],"about_ca_topic_score_codex":0.0005432691,"about_ca_topic_score_gemma":0.0020683757,"teacher_disagreement_score":0.34539622,"about_ca_system_score_codex":0.00076752785,"about_ca_system_score_gemma":0.00044488505,"threshold_uncertainty_score":0.6976352},"labels":[],"label_agreement":null},{"id":"W4388589072","doi":"10.1093/neuonc/noad179.1050","title":"TMET-06. METABOLOGENOMIC CHARACTERIZATION UNCOVERS HETEROGENEITY AMONGST IDH MUTANT","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; Princess Margaret Cancer Centre; University of Toronto; Thompson Rivers University; University Health Network","funders":"","keywords":"Isocitrate dehydrogenase; Biology; Epigenetics; Glioma; IDH1; DNA methylation; Mutant; Cancer research; Genetics; Gene; Enzyme; Gene expression; Biochemistry","score_opus":0.028457859274519548,"score_gpt":0.29776820204228954,"score_spread":0.26931034276777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589072","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940548,0.00006212141,0.000014754778,0.0035008173,0.00090014306,0.0006322246,0.000078309335,0.00023507928,0.00052177225],"genre_scores_gemma":[0.99600565,0.00053132605,0.000062194515,0.0024294395,0.00018083109,0.00016807605,0.0005419241,0.000044202134,0.00003632436],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983945,0.00016526684,0.000345881,0.0004789874,0.00019129546,0.00042406956],"domain_scores_gemma":[0.99898267,0.000217044,0.00016209303,0.00036501404,0.00006922798,0.00020394026],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000184676,0.00022356227,0.0005416523,0.00025921068,0.000104962826,0.000016560316,0.000102931146,0.00019149686,0.00013130967],"category_scores_gemma":[0.00015185948,0.00019007464,0.00017458906,0.00048706602,0.00008658019,0.00006917488,0.00009826632,0.00017555998,0.0010925474],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010573362,0.00035321884,0.08129803,0.00001546265,0.00014289963,0.0011807176,0.00009201408,0.00001636516,0.9062268,0.00014898111,0.00082310656,0.009596631],"study_design_scores_gemma":[0.0035199241,0.0011389756,0.29100895,0.000010278553,0.00038667175,0.00023540558,0.000048524536,0.00019645087,0.48802602,0.000047938185,0.21520557,0.00017527872],"about_ca_topic_score_codex":0.000025111614,"about_ca_topic_score_gemma":0.000032965178,"teacher_disagreement_score":0.41820082,"about_ca_system_score_codex":0.00025629957,"about_ca_system_score_gemma":0.0001652918,"threshold_uncertainty_score":0.9996852},"labels":[],"label_agreement":null},{"id":"W4388589074","doi":"10.1093/neuonc/noad179.0671","title":"PATH-41. INTEGRATED MOLECULAR ANALYSIS REVEALS HYPERMETHYLATION AND OVEREXPRESSION OF HOX GENES TO BE POOR PROGNOSTICATORS IN IDH MUTANT GLIOMA","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto; Thompson Rivers University","funders":"","keywords":"Hox gene; Biology; DNA methylation; Glioma; Methylation; Oncology; Copy-number variation; Cancer research; Proportional hazards model; Gene; Genetics; Internal medicine; Gene expression; Genome; Medicine","score_opus":0.02175187963742699,"score_gpt":0.31188484975283143,"score_spread":0.29013297011540445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99571884,0.00020091953,0.00002740343,0.0030901597,0.000062345265,0.0007304653,0.000038470258,0.000048488735,0.000082891784],"genre_scores_gemma":[0.9985431,0.00012057106,0.00052801624,0.0005238049,0.000017404931,0.00015299814,0.00009134774,0.000020738873,0.0000020144607],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985047,0.00018773499,0.00041393217,0.00040534936,0.00021809693,0.00027016384],"domain_scores_gemma":[0.9989152,0.0004417007,0.00013286452,0.00023701122,0.00010659728,0.00016663369],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024201605,0.00016625629,0.0005998377,0.0009378502,0.000031823056,0.00000806255,0.00006298505,0.00015483967,0.00003321266],"category_scores_gemma":[0.0006489355,0.00013071201,0.00010332924,0.0022057532,0.000051544033,0.000033542252,0.00009594134,0.00010951612,0.000009493159],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016392255,0.00034385268,0.103912406,0.000034817727,0.000147273,0.0009576791,0.00025092837,0.000079450125,0.8840946,0.000077952696,0.00017353568,0.009763605],"study_design_scores_gemma":[0.0021140724,0.0015865157,0.17926371,0.000090130845,0.0007064492,0.00004238631,0.00027080867,0.0012584508,0.8129274,0.00007761386,0.0015380044,0.00012440691],"about_ca_topic_score_codex":0.00009793457,"about_ca_topic_score_gemma":0.000034836434,"teacher_disagreement_score":0.075351305,"about_ca_system_score_codex":0.00009581523,"about_ca_system_score_gemma":0.000078956735,"threshold_uncertainty_score":0.5330281},"labels":[],"label_agreement":null},{"id":"W4388589080","doi":"10.1093/neuonc/noad179.1121","title":"TMIC-55. TURNING ENEMY INTO ALLY: HIJACK BRAIN TUMOR CELLS TO BREAK DOWN THE BLOOD-TUMOR BARRIER","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Caveolin-1 and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Cancer research; Wnt signaling pathway; Blood–brain barrier; Gene knockdown; Medulloblastoma; Brain tumor; Mesenchymal stem cell; Cancer stem cell; Medicine; Cancer; Signal transduction; Cell biology; Internal medicine; Biology; Pathology; Cell culture; Central nervous system","score_opus":0.007864318550274883,"score_gpt":0.2561955975863183,"score_spread":0.24833127903604343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892674,0.000405723,0.00013955953,0.005461363,0.0008660105,0.00043732856,0.000038209244,0.00009409408,0.0032902914],"genre_scores_gemma":[0.9728545,0.00016385861,0.00023896503,0.02295892,0.0011912668,0.0001598375,0.00012633513,0.00009296141,0.0022133517],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976123,0.00028927648,0.00041653687,0.00078064704,0.00022669448,0.00067452545],"domain_scores_gemma":[0.9985214,0.00027162762,0.00016295709,0.0006366526,0.00013088566,0.00027650714],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00057386357,0.00033192814,0.00036076354,0.00011430799,0.00025834027,0.00006107404,0.0006736561,0.00021676115,0.00018949395],"category_scores_gemma":[0.0005858435,0.00027047293,0.0001929882,0.00041309124,0.00017425668,0.0000068767263,0.0006073583,0.00035578682,0.0005888548],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011507359,0.000067904446,0.00017150935,0.000035635534,0.000054110533,0.0003599664,0.0004204006,0.00019400878,0.94557065,0.00004253711,0.050098166,0.00287005],"study_design_scores_gemma":[0.00043241703,0.0004117414,0.00006595708,0.000005270389,0.000031680956,0.00021566228,0.00018806366,0.00003676184,0.5134801,0.000073280746,0.48487252,0.0001864991],"about_ca_topic_score_codex":0.000075983495,"about_ca_topic_score_gemma":0.00025265885,"teacher_disagreement_score":0.43477437,"about_ca_system_score_codex":0.00003387246,"about_ca_system_score_gemma":0.00044471724,"threshold_uncertainty_score":0.9999747},"labels":[],"label_agreement":null},{"id":"W4388589102","doi":"10.1093/neuonc/noad179.0637","title":"PATH-07. GENOMIC AND IMMUNE ANALYSIS OF PRIMARY REPLICATION-REPAIR DEFICIENT (RRD) GLIOMAS REVEALS THREE SUBGROUPS WITH DISTINCT DRIVERS AND RESPONSE TO IMMUNOTHERAPY: AN IRRDC REPORT.","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Biology; Microsatellite instability; Glioma; Cancer research; Genome instability; ATRX; PTEN; Mutation; DNA mismatch repair; Immune system; Somatic hypermutation; Genetics; Gene; DNA repair; Allele; Microsatellite; Antibody; B cell; DNA damage","score_opus":0.021332969871373814,"score_gpt":0.2952102071822529,"score_spread":0.2738772373108791,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589102","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99653214,0.00043256072,0.00009368352,0.0013780809,0.000140782,0.0009550672,0.00003816736,0.00015485188,0.00027466932],"genre_scores_gemma":[0.9971028,0.00012541727,0.0019497906,0.00046114105,0.000031152344,0.00013258833,0.000077931734,0.000049516475,0.000069694506],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9974424,0.0003067396,0.0006657172,0.0009168285,0.00032760075,0.00034071924],"domain_scores_gemma":[0.99704844,0.0007945304,0.0003765462,0.0013636439,0.00019963738,0.00021722305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013430185,0.00024007302,0.000870567,0.0006529955,0.00011143068,0.00001292116,0.00015404707,0.00015957779,0.00005542084],"category_scores_gemma":[0.0005712936,0.00020724114,0.0001253606,0.0014749782,0.00031851043,0.000041639778,0.0001794012,0.00019821225,0.000006783518],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005757672,0.0001062943,0.24423915,0.00004306842,0.0003421244,0.00050956063,0.0009706835,0.000064012405,0.7431635,0.000010294785,0.00015525504,0.0046383445],"study_design_scores_gemma":[0.0014057441,0.0051420853,0.98421407,0.000021198706,0.000737812,0.0005220251,0.00018837178,0.000333252,0.0039846487,0.000035784233,0.0032298649,0.00018514735],"about_ca_topic_score_codex":0.00016624306,"about_ca_topic_score_gemma":0.00027496857,"teacher_disagreement_score":0.7399749,"about_ca_system_score_codex":0.0004131196,"about_ca_system_score_gemma":0.00041296895,"threshold_uncertainty_score":0.8451049},"labels":[],"label_agreement":null},{"id":"W4388589111","doi":"10.1093/neuonc/noad179.0181","title":"CSIG-25. OVERCOMING RESISTANCE TO THERAPIES TARGETING THE MAPK PATHWAY IN GLIOBLASTOMA","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"14-3-3 protein interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"","keywords":"MAPK/ERK pathway; Cancer research; Psychological repression; Repressor; Transcription factor; Receptor tyrosine kinase; Context (archaeology); Signal transduction; Carcinogenesis; Kinase; Biology; Cell biology; Cancer; Gene; Gene expression; Genetics","score_opus":0.013445097062256247,"score_gpt":0.28246637455434126,"score_spread":0.269021277492085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98686165,0.00033253705,0.00021324343,0.007872699,0.0008125755,0.00045568126,0.000015859177,0.00006323272,0.003372546],"genre_scores_gemma":[0.99514765,0.00009193112,0.00046621548,0.0027564766,0.00039042602,0.00025626994,0.000011545449,0.000041312003,0.0008382061],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99845153,0.0003069915,0.00028283126,0.00042946864,0.000120696226,0.0004084961],"domain_scores_gemma":[0.99912983,0.00025602957,0.00009451354,0.0003941199,0.00006131563,0.00006417505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040410858,0.00016210505,0.00017680228,0.00011260869,0.00015965643,0.000028541412,0.00035103547,0.00016922009,0.000041120788],"category_scores_gemma":[0.00070391543,0.00013666098,0.000079540376,0.000377573,0.000072777526,0.0000065003633,0.00026806435,0.00028824862,0.00015513226],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019071435,0.00003281272,0.00046185285,0.0000067714186,0.000015138522,0.00005653176,0.0005342507,0.00012636493,0.97347236,0.00018503156,0.022281721,0.0026364394],"study_design_scores_gemma":[0.0002383873,0.00029696518,0.00058394705,0.000010540721,0.0000023023417,0.000012854972,0.00042135478,0.000019080211,0.3597259,0.00013169198,0.6384516,0.00010544667],"about_ca_topic_score_codex":0.00002303878,"about_ca_topic_score_gemma":0.0010298775,"teacher_disagreement_score":0.6161698,"about_ca_system_score_codex":0.00006776658,"about_ca_system_score_gemma":0.000113276794,"threshold_uncertainty_score":0.55728734},"labels":[],"label_agreement":null},{"id":"W4388589113","doi":"10.1093/neuonc/noad179.0794","title":"NCMP-10. DEXAMETHASONE: A TOOL AND A PROBLEM IN GLIOBLASTOMA MANAGEMENT","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Medicine; Metformin; Dexamethasone; Leukocytosis; Glycemic; Internal medicine; Diabetes mellitus; Univariate analysis; Gastroenterology; Complication; Proportional hazards model; Hazard ratio; Surgery; Multivariate analysis; Endocrinology","score_opus":0.01926542897391518,"score_gpt":0.2984501386200385,"score_spread":0.2791847096461233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855031,0.00013656712,0.0000024151257,0.0062825745,0.00012443302,0.0009531081,0.0000040113196,0.0001322078,0.0068615824],"genre_scores_gemma":[0.9960928,0.00045729787,0.0009386303,0.0014690842,0.000061566745,0.0006527865,0.000009412573,0.00003296197,0.00028544114],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987281,0.00008954298,0.00025589665,0.00040300045,0.0001603746,0.0003631041],"domain_scores_gemma":[0.9992876,0.00028856174,0.0000562214,0.00022932646,0.00002699347,0.00011130921],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002024791,0.00015754887,0.0003592819,0.0003784785,0.000039744067,0.00001324137,0.000059164868,0.00010851245,0.00015619004],"category_scores_gemma":[0.0000696614,0.00013501241,0.000053227435,0.0005974551,0.000058548245,0.000037617654,0.00014602448,0.00014765181,0.00032588816],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017635459,0.003310105,0.12833735,0.00056888495,0.0003848647,0.04187045,0.0014681628,0.00007555509,0.08836955,0.0034649398,0.07463597,0.65575063],"study_design_scores_gemma":[0.020964827,0.00848938,0.21608734,0.00019395883,0.00038972692,0.00086298585,0.000570955,0.000962383,0.012123949,0.0010525489,0.73790693,0.00039503357],"about_ca_topic_score_codex":0.000018737319,"about_ca_topic_score_gemma":0.00006736078,"teacher_disagreement_score":0.66327095,"about_ca_system_score_codex":0.00015172706,"about_ca_system_score_gemma":0.00005068447,"threshold_uncertainty_score":0.55056465},"labels":[],"label_agreement":null},{"id":"W4388589123","doi":"10.1093/neuonc/noad179.0793","title":"NCMP-09. THE CURRENT LANDSCAPE OF SPINE ONCOLOGY SURGICAL TRIALS AND FUTURE OPPORTUNITIES","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Clinical trial; Population; Internal medicine; Observational study; Oncology","score_opus":0.12787348597349069,"score_gpt":0.3933893854923453,"score_spread":0.2655158995188546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.66596204,0.00623078,0.000027296905,0.2559022,0.005541704,0.0029896733,0.00014452153,0.00030721942,0.062894545],"genre_scores_gemma":[0.89887464,0.073937595,0.0007041894,0.013063024,0.008300736,0.00074809307,0.0007595864,0.00019204254,0.0034200873],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99711066,0.0011393926,0.00075526827,0.0003176664,0.0003456934,0.00033130514],"domain_scores_gemma":[0.99729216,0.0016413482,0.00036821552,0.00037537093,0.00009305115,0.00022987173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023731939,0.00019518718,0.0011024163,0.00024602018,0.00007066893,0.000010493182,0.00015996525,0.000118838,0.0007001802],"category_scores_gemma":[0.0008595956,0.00012363234,0.0001760053,0.00028914973,0.00027898597,0.000034904613,0.00021094688,0.0003899926,0.000041805637],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00138994,0.00057833066,0.0010363676,0.00040167294,0.00020162991,0.002572,0.00068361696,0.0000031700242,0.0014121742,0.006535586,0.1398122,0.84537333],"study_design_scores_gemma":[0.0051975623,0.0017025963,0.0051958994,0.000020091304,0.0005977416,0.0001500798,0.0016813002,0.00023606443,0.00007461139,0.00025557654,0.9847931,0.00009535247],"about_ca_topic_score_codex":0.0000041344906,"about_ca_topic_score_gemma":0.0000061070245,"teacher_disagreement_score":0.84527797,"about_ca_system_score_codex":0.000038071463,"about_ca_system_score_gemma":0.00044013027,"threshold_uncertainty_score":0.76664823},"labels":[],"label_agreement":null},{"id":"W4388589141","doi":"10.1093/neuonc/noad179.1060","title":"TMET-16. ELUCIDATING MECHANISMS OF ENHANCED OXIDATIVE PHOSPHORYLATION IN MYC-AMPLIFIED MEDULLOBLASTOMA","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia","funders":"","keywords":"Gene knockdown; Oxidative phosphorylation; Cell biology; Biology; Elongation factor; Chemistry; Molecular biology; Biochemistry; Apoptosis; Gene; RNA","score_opus":0.018151320542822653,"score_gpt":0.2953032925489374,"score_spread":0.27715197200611474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9736212,0.00007117286,0.021204228,0.00030546403,0.00031722704,0.0003073005,0.000026578591,0.00003083607,0.0041159806],"genre_scores_gemma":[0.99810237,0.00019077868,0.0008533026,0.00028668824,0.00006892182,0.00013808138,0.00017480737,0.000024182898,0.00016086097],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987113,0.00015102005,0.0003531982,0.00040238508,0.00012523975,0.0002568948],"domain_scores_gemma":[0.99922645,0.00008448457,0.00021638448,0.0003113143,0.000109576,0.000051803832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002937186,0.0001344118,0.00022423553,0.00012995371,0.000053634507,0.0000069487974,0.0001873647,0.00020809937,0.0000727995],"category_scores_gemma":[0.00025819885,0.00014083264,0.000065722,0.00041356037,0.000068694324,0.0000063867838,0.000103317754,0.00012694074,0.00004551953],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012687243,0.000059407692,0.00009097556,0.000009258666,0.00001602105,0.0000031605973,0.00014752142,0.0003285204,0.9802649,0.0008623299,0.0007415941,0.017349452],"study_design_scores_gemma":[0.00073371886,0.00058637594,0.0013609335,0.000008268353,0.000009726271,0.0000041582985,0.00041600646,0.00023029925,0.9832565,0.0010159323,0.012253701,0.00012437995],"about_ca_topic_score_codex":0.000036075147,"about_ca_topic_score_gemma":0.00013019404,"teacher_disagreement_score":0.024481162,"about_ca_system_score_codex":0.00007044175,"about_ca_system_score_gemma":0.00017308291,"threshold_uncertainty_score":0.57429886},"labels":[],"label_agreement":null},{"id":"W4388589166","doi":"10.1093/neuonc/noad179.0138","title":"STEM-12. TARGETING GLIOBLASTOMA WITH A BRAIN PENETRANT DRUG THAT IMPAIRS BRAIN TUMOUR STEM CELLS","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Stem cell; Cancer research; Biology; DNA repair; Neural stem cell; Cell cycle; Cancer stem cell; Notch signaling pathway; Transcriptome; Cell; Signal transduction; Gene; Cell biology; Gene expression; Genetics","score_opus":0.014192328949022637,"score_gpt":0.256676528824476,"score_spread":0.24248419987545336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938522,0.000492884,0.0005550557,0.0029673406,0.0005480304,0.0004826247,0.000035320907,0.000105998144,0.00096057676],"genre_scores_gemma":[0.9965267,0.0002628551,0.00027972364,0.0012212907,0.00035261124,0.00006398314,0.00006958059,0.00009518645,0.0011280277],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99735177,0.00052345265,0.00039042404,0.0007768535,0.0002864477,0.0006710813],"domain_scores_gemma":[0.9986511,0.00036492935,0.00025471745,0.00041398252,0.00009629667,0.00021900129],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00080315914,0.00033503943,0.0003691448,0.00015990694,0.00018486482,0.000049224407,0.00033390912,0.00028673935,0.000025245648],"category_scores_gemma":[0.00005172267,0.0003011895,0.00014077678,0.00029329868,0.000104079234,0.000009155646,0.00021568862,0.00028099946,0.000081650316],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029601261,0.00006850207,0.001790467,0.000035526613,0.000039358503,0.0001572657,0.0003468156,0.0008489035,0.97187054,0.000018422981,0.01682211,0.0077061015],"study_design_scores_gemma":[0.0011362482,0.002098845,0.0006506133,0.000012125546,0.0000220359,0.000028052922,0.0005413024,0.00048046157,0.78443515,0.000027242893,0.21026172,0.00030619124],"about_ca_topic_score_codex":0.000026503438,"about_ca_topic_score_gemma":0.00031130694,"teacher_disagreement_score":0.19343962,"about_ca_system_score_codex":0.000054471762,"about_ca_system_score_gemma":0.00026459867,"threshold_uncertainty_score":0.99994403},"labels":[],"label_agreement":null},{"id":"W4388589183","doi":"10.1093/neuonc/noad179.1119","title":"TMIC-53. TRANSGLUTAMINASE 2 EXPRESSION IN GLIOBLASTOMA: EVIDENCE FOR A ROLE IN EFFEROCYTOSIS","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Blood properties and coagulation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; St. Michael's Hospital; Ottawa Hospital","funders":"","keywords":"Efferocytosis; Phagocytosis; Biology; CD68; Cancer research; Glioma; Cancer cell; Immunohistochemistry; Macrophage; Microglia; Cancer; Apoptosis; Immunology; Inflammation; In vitro","score_opus":0.05354532237780473,"score_gpt":0.3367665591048757,"score_spread":0.28322123672707095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948265,0.00038242157,0.00006450432,0.0034252692,0.00019394176,0.0008847068,0.0000031446912,0.000081148195,0.00013836955],"genre_scores_gemma":[0.99817216,0.00018128376,0.00018756429,0.00083533744,0.00011201393,0.00041995457,0.0000057946027,0.000025587988,0.00006031823],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987281,0.00014228717,0.0003249824,0.00034034147,0.00013584174,0.0003284775],"domain_scores_gemma":[0.9989924,0.00063705526,0.00005502631,0.00020064443,0.00003667887,0.00007822781],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029917868,0.00012649423,0.00035635522,0.00028065624,0.00003839037,0.0000066178122,0.00009507572,0.00019151147,0.000031470827],"category_scores_gemma":[0.0003997496,0.00010908118,0.000071183655,0.00046900782,0.000035059522,0.000098669356,0.0000443317,0.00022577164,0.00003972657],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034221676,0.00018082341,0.0067267884,0.00014169872,0.000003961127,0.00015328632,0.0011782224,0.00014229317,0.936664,0.000010181955,0.0007296994,0.050646868],"study_design_scores_gemma":[0.013711528,0.010197932,0.100600846,0.0010387639,0.000115702016,0.00013395207,0.0011118456,0.023140987,0.8045232,0.00033996243,0.044731304,0.00035393823],"about_ca_topic_score_codex":0.000050651528,"about_ca_topic_score_gemma":0.00030104202,"teacher_disagreement_score":0.13214077,"about_ca_system_score_codex":0.00012570327,"about_ca_system_score_gemma":0.00012449712,"threshold_uncertainty_score":0.44482014},"labels":[],"label_agreement":null},{"id":"W4388589198","doi":"10.1093/neuonc/noad179.1057","title":"TMET-13. DNA DAMAGE SIGNALING ACTIVATES GTP SYNTHESIS TO PROMOTE GLIOBLASTOMA TREATMENT RESISTANCE","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"DNA damage; Cancer research; DNA repair; Pharmacology; Signal transduction; DNA synthesis; Medicine; Biology; In vitro; DNA; Biochemistry","score_opus":0.015232352303123552,"score_gpt":0.2747155993197101,"score_spread":0.2594832470165866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947496,0.00003632232,0.00010341387,0.0022495168,0.0002814421,0.000609428,0.00003770151,0.00017625293,0.0017562952],"genre_scores_gemma":[0.99372095,0.000070133225,0.0030677961,0.0009217498,0.00026060388,0.00041210031,0.000030624833,0.00009074007,0.0014252992],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980105,0.00020827448,0.0002817317,0.0007890129,0.00018327455,0.00052719214],"domain_scores_gemma":[0.9987856,0.00017505314,0.00011371386,0.0006236272,0.00008048371,0.00022151225],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022559539,0.00029445102,0.0003753364,0.00016230879,0.00013225367,0.000029639697,0.0002839181,0.00028308175,0.000046131772],"category_scores_gemma":[0.00059599103,0.00028068523,0.00017143284,0.00038477688,0.000057690686,0.0000058838104,0.00018739582,0.000107671534,0.00017798145],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006352499,0.00016180308,0.000047733418,0.000019593703,0.00007790861,0.00029354286,0.00012443353,0.00006494212,0.9869873,0.000030184523,0.0030169215,0.008540405],"study_design_scores_gemma":[0.0003395399,0.0024226909,0.00009435794,0.000017090959,0.0000396836,0.00003290419,0.00006733144,0.000038885093,0.7496653,0.00004330378,0.2470528,0.0001860813],"about_ca_topic_score_codex":0.0000075030825,"about_ca_topic_score_gemma":0.00012894928,"teacher_disagreement_score":0.24403588,"about_ca_system_score_codex":0.0001450596,"about_ca_system_score_gemma":0.00019826676,"threshold_uncertainty_score":0.99996454},"labels":[],"label_agreement":null},{"id":"W4388589200","doi":"10.1093/neuonc/noad179.1070","title":"TMIC-04. IMMUNE PROFILING OF PEDIATRIC ONCOHISTONE GLIOMAS REVEALS DIVERSE MYELOID POPULATIONS AND TUMOR-PROMOTING BEHAVIORS","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Montreal Children's Hospital; Jewish General Hospital; Centre Hospitalier Universitaire Sainte-Justine; Université Laval; McGill University","funders":"","keywords":"Myeloid; Immune system; Cancer research; Mass cytometry; Biology; Tumor microenvironment; Glioma; Histone H3; Epigenome; Immunology; Epigenetics; Phenotype; DNA methylation; Genetics","score_opus":0.04512539116291482,"score_gpt":0.3351938413008249,"score_spread":0.2900684501379101,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99666244,0.00050226995,0.0000016711334,0.0010292459,0.00054661284,0.0007374231,0.00003105416,0.00012969782,0.0003595976],"genre_scores_gemma":[0.9984338,0.00018391453,0.00083716586,0.00011110306,0.00018936348,0.00010203131,0.00007809247,0.00003620165,0.000028307704],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99834913,0.00012253415,0.00056083174,0.0003897256,0.00022965495,0.000348145],"domain_scores_gemma":[0.99881595,0.00029164032,0.00031470734,0.00029396382,0.00011627004,0.00016747753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029632606,0.00019080342,0.00056899973,0.000501869,0.00016234764,0.000007880143,0.00008178592,0.00012272269,0.00005819012],"category_scores_gemma":[0.0003690231,0.00017703381,0.00012152162,0.00079103484,0.00009444028,0.000064443644,0.00015878308,0.00021350743,0.000050464285],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047908565,0.00040599855,0.40430117,0.0000898916,0.000025484176,0.0010980323,0.0004622921,0.000009472927,0.59001696,0.0001368378,0.00051091367,0.0028950486],"study_design_scores_gemma":[0.005794113,0.0028004476,0.881391,0.00007080826,0.0014661946,0.00056590204,0.00075937726,0.000246391,0.105326205,0.00019857047,0.0010757557,0.00030523157],"about_ca_topic_score_codex":0.00011747326,"about_ca_topic_score_gemma":0.0000195539,"teacher_disagreement_score":0.48469076,"about_ca_system_score_codex":0.00015933339,"about_ca_system_score_gemma":0.0001275614,"threshold_uncertainty_score":0.72192293},"labels":[],"label_agreement":null},{"id":"W4388589205","doi":"10.1093/neuonc/noad179.1083","title":"TMIC-17. THE ROLE OF ICAM1 IN GLIOBLASTOMA TUMORIGENESIS UNDER HYPOXIC CONDITIONS","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Western Hospital; The Scarborough Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Cancer research; Tumor microenvironment; Biology; Carcinogenesis; Cancer","score_opus":0.013335124329389958,"score_gpt":0.27282350821881635,"score_spread":0.2594883838894264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850818,0.0016260027,0.000005497464,0.0022559883,0.0022543592,0.00037782482,0.00005469523,0.00012795225,0.008215881],"genre_scores_gemma":[0.99734473,0.00030466175,0.000008237954,0.001084434,0.000051041945,0.00014515186,0.000032645756,0.000031956635,0.0009971379],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980748,0.000566436,0.00046295163,0.0003373898,0.000047713893,0.00051065255],"domain_scores_gemma":[0.99774545,0.0014971944,0.00019014062,0.0004867477,0.000062369465,0.000018082805],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0003285958,0.00018117213,0.00040055037,0.00027823285,0.00015826915,0.000004853492,0.00048716672,0.0003426653,0.0013169702],"category_scores_gemma":[0.00014323089,0.00014878466,0.00011659498,0.00067634566,0.0006366568,0.000048559952,0.0002275658,0.0004979554,0.0015519169],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001525652,0.0001339673,0.0011046681,0.000006756128,0.000057353624,0.00002959406,0.00047810256,0.0002575201,0.97578347,0.0017937769,0.016794534,0.0034076814],"study_design_scores_gemma":[0.00123539,0.00055926415,0.009539454,0.000011236389,0.000041327097,0.00016412069,0.0013624441,0.000021911437,0.58018446,0.0025469307,0.40418145,0.00015199384],"about_ca_topic_score_codex":0.000097289136,"about_ca_topic_score_gemma":0.00027613586,"teacher_disagreement_score":0.395599,"about_ca_system_score_codex":0.00014058605,"about_ca_system_score_gemma":0.00027314143,"threshold_uncertainty_score":0.99959594},"labels":[],"label_agreement":null},{"id":"W4388589206","doi":"10.1093/neuonc/noad179.1190","title":"MODL-39. ELUCIDATING THE TRANSCRIPTOMIC LANDSCAPE OF METASTATIC PEDIATRIC MEDULLOBLASTOMA","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medulloblastoma; Transcriptome; Biology; Wnt signaling pathway; Epigenetics; Gene; Disease; Cancer research; Bioinformatics; Computational biology; Genetics; Gene expression; Medicine; Internal medicine","score_opus":0.028529829108366857,"score_gpt":0.303704263540375,"score_spread":0.2751744344320081,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589206","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896785,0.0003894406,0.000017337185,0.007338645,0.0004187572,0.0005065152,0.000021834683,0.00010407854,0.0015248606],"genre_scores_gemma":[0.9981816,0.000329953,0.0001515965,0.00095494284,0.00016719932,0.00013487422,0.000025012396,0.000031497417,0.000023319137],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99857223,0.00017923965,0.00038619633,0.00027994442,0.000252514,0.00032988164],"domain_scores_gemma":[0.99803376,0.0013175444,0.00015492222,0.0003208807,0.0000645926,0.00010831069],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029792634,0.00016296312,0.00046638882,0.00024738925,0.0000815738,0.0000075401026,0.000139382,0.0000714106,0.00017186548],"category_scores_gemma":[0.0003035359,0.00010458628,0.00017185383,0.00071273075,0.00006552375,0.000034792833,0.000046161687,0.00020339247,0.00016250144],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006165508,0.0021550006,0.15028557,0.0004543145,0.0006508345,0.0026135026,0.0037417917,0.00068107026,0.7308623,0.001010626,0.056972805,0.049955633],"study_design_scores_gemma":[0.038293533,0.016866567,0.46271846,0.00013547995,0.008789711,0.002046639,0.0054042563,0.017490683,0.30819026,0.001294797,0.13775246,0.0010171587],"about_ca_topic_score_codex":0.000021268303,"about_ca_topic_score_gemma":0.000024010955,"teacher_disagreement_score":0.42267206,"about_ca_system_score_codex":0.00004746501,"about_ca_system_score_gemma":0.00017622916,"threshold_uncertainty_score":0.4264905},"labels":[],"label_agreement":null},{"id":"W4388589215","doi":"10.1093/neuonc/noad179.0267","title":"CTIM-27. PERIPHERAL BIOMARKER ANALYSIS OF T CELL-MEDIATED COLLAGEN REMODELING CORRELATES WITH TUMOR RESPONSES IN A PHASE IIA TRIAL OF VACCINE IMMUNOTHERAPEUTIC CANDIDATE (VBI-1901)","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Variation Biotechnologies (Canada)","funders":"","keywords":"Medicine; CD8; Biomarker; Immune system; Antigen; T cell; Granzyme B; Immunotherapy; Immunology; ELISPOT; Nivolumab; Internal medicine; Chemistry","score_opus":0.0409655345464307,"score_gpt":0.3630091074634387,"score_spread":0.32204357291700797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963417,0.0003608587,0.000022592481,0.00091775786,0.00019660222,0.001136225,0.00012370832,0.00006150684,0.0008390401],"genre_scores_gemma":[0.9979808,0.0009425527,0.00011753949,0.00036921384,0.00005140417,0.00007092407,0.0001339631,0.00006096037,0.0002726775],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99659246,0.00068927545,0.0010896433,0.0005198933,0.0005208957,0.0005878088],"domain_scores_gemma":[0.9970166,0.0015367153,0.00042919256,0.00054325885,0.0002892912,0.0001849261],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013259883,0.00027649896,0.0015718457,0.0020903526,0.000073749135,0.000014554985,0.00022699845,0.00022900807,0.0006586847],"category_scores_gemma":[0.00046255556,0.00022262134,0.00025774227,0.004828826,0.00017219583,0.00007375327,0.00010747376,0.0003813118,0.000024661127],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2526676,0.0010840361,0.006450001,0.00006899876,0.00077569333,0.00076307496,0.0012167661,0.00041437024,0.7310918,0.0000018842269,0.0002690142,0.005196745],"study_design_scores_gemma":[0.43102226,0.040228724,0.031010285,0.00023367813,0.005252278,0.00019349463,0.0025502574,0.33480772,0.095551625,0.000021314714,0.058247555,0.0008808104],"about_ca_topic_score_codex":0.0012065038,"about_ca_topic_score_gemma":0.0012349436,"teacher_disagreement_score":0.6355402,"about_ca_system_score_codex":0.00032996348,"about_ca_system_score_gemma":0.0014411501,"threshold_uncertainty_score":0.9078235},"labels":[],"label_agreement":null},{"id":"W4388589244","doi":"10.1093/neuonc/noad179.0780","title":"NIMG-85. EVALUATING THE PERFORMANCE OF A DEEP LEARNING GLIOMA SEGMENTATION MODEL USING COMBINED PRE- AND POST-TREATMENT MRI TRAINING DATA","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services","funders":"","keywords":"Computer science; Segmentation; Convolutional neural network; Workflow; Magnetic resonance imaging; Artificial intelligence; Glioma; Dice; Deep learning; Pattern recognition (psychology); Machine learning; Medicine; Radiology","score_opus":0.07624121402978769,"score_gpt":0.3977261482719263,"score_spread":0.32148493424213864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945354,0.000096314885,0.0012455108,0.0032363916,0.00016711552,0.0004536889,0.000004216596,0.00007658382,0.00018477745],"genre_scores_gemma":[0.9893397,0.00019815064,0.009603454,0.00053894846,0.00010628234,0.000017639104,0.000116626536,0.000034454304,0.000044716537],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9984472,0.00026354147,0.00036113092,0.00035619264,0.00027644774,0.0002954943],"domain_scores_gemma":[0.9986556,0.00061913294,0.00022697344,0.00032522733,0.000077834695,0.000095242714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010697446,0.00015002428,0.0003535167,0.00014490944,0.00023969289,0.00001914885,0.00016211423,0.00007570697,0.000010742927],"category_scores_gemma":[0.00075914804,0.00010901919,0.000038579747,0.0002609416,0.00019106276,0.0001181705,0.00020678174,0.00040669908,0.0000031059446],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031707555,0.000057087764,0.0073913676,0.000068475645,0.000062439736,0.00004224843,0.0064752074,0.09111899,0.68724626,0.000018585906,0.000017690265,0.20718455],"study_design_scores_gemma":[0.0023121152,0.003203947,0.004240988,0.00004963995,0.00023139028,0.00029888717,0.0012456109,0.9865189,0.0015697634,0.00002344538,0.00022247406,0.00008283044],"about_ca_topic_score_codex":0.0000634602,"about_ca_topic_score_gemma":0.0000071587788,"teacher_disagreement_score":0.8953999,"about_ca_system_score_codex":0.00010352774,"about_ca_system_score_gemma":0.00025122997,"threshold_uncertainty_score":0.44456732},"labels":[],"label_agreement":null},{"id":"W4388589279","doi":"10.1093/neuonc/noad179.0997","title":"RTID-06. THE PIVOTAL METIS (EF-25) STUDY OF TUMOR TREATING FIELDS (TTFIELDS) THERAPY FOR BRAIN METASTASES FROM NON-SMALL CELL LUNG CANCER (NSCLC) FOLLOWING RADIOSURGERY","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Radiosurgery; Oncology; Clinical endpoint; Lung cancer; Neurocognitive; Internal medicine; Radiation therapy; Clinical trial; Cognition","score_opus":0.031133857206822626,"score_gpt":0.3257966754217294,"score_spread":0.2946628182149068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903514,0.0012732312,0.000053866646,0.0046892604,0.0008542412,0.0023737063,0.000088201436,0.00007710689,0.00023900704],"genre_scores_gemma":[0.9952628,0.00020636237,0.00019093794,0.002319793,0.00032096467,0.0015383865,0.000053559164,0.000056869245,0.000050305498],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978827,0.00033343225,0.0005549476,0.00052003714,0.0002520179,0.0004568176],"domain_scores_gemma":[0.99268633,0.006394458,0.00027208103,0.0004556281,0.00007315089,0.00011832803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046712096,0.00029511092,0.00089916826,0.00018700793,0.00019485748,0.000022351709,0.00018267905,0.00012722284,0.000103705046],"category_scores_gemma":[0.0003179368,0.0001987127,0.0004423975,0.00040435363,0.000040712595,0.000048981543,0.00008205821,0.00024569096,0.0000061967376],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010273485,0.005784199,0.48787045,0.00012844717,0.0028405956,0.00291499,0.01429678,0.00048899243,0.3837721,0.000017132596,0.048732683,0.05212629],"study_design_scores_gemma":[0.09161982,0.03210336,0.23645775,0.0005026864,0.008584684,0.000114328766,0.025111487,0.009979002,0.5338645,0.00015226172,0.06001683,0.0014933165],"about_ca_topic_score_codex":0.001948789,"about_ca_topic_score_gemma":0.00076078606,"teacher_disagreement_score":0.2514127,"about_ca_system_score_codex":0.00009534447,"about_ca_system_score_gemma":0.00024954427,"threshold_uncertainty_score":0.81032693},"labels":[],"label_agreement":null},{"id":"W4388589457","doi":"10.1093/neuonc/noad179.0158","title":"CSIG-02. SHH PATHWAY ACTIVATION DRIVES NEURAL CREST CELL SIGNATURE IN A SUBGROUP OF MPNSTS","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; McMaster University; University of Toronto","funders":"","keywords":"Neural crest; Cancer research; Biology; Neurofibroma; Neural stem cell; Neurofibromatosis; Cell biology; Pathology; Medicine; Stem cell; Genetics","score_opus":0.02427417512274905,"score_gpt":0.31639231195074036,"score_spread":0.2921181368279913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934688,0.000035590972,0.0000037971747,0.0022342945,0.00023477327,0.00064144726,0.0000151535405,0.000099583594,0.0032665587],"genre_scores_gemma":[0.9987853,0.00007795886,0.000050850624,0.0005745294,0.00010290737,0.00006907776,0.0000622258,0.00003712323,0.00024002208],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981923,0.0002721355,0.00031197927,0.0004021365,0.00033793136,0.0004835126],"domain_scores_gemma":[0.99858147,0.00074163335,0.00011877896,0.00028303405,0.00008593119,0.00018914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001359189,0.00018587269,0.00041739436,0.00048110122,0.00004531638,0.000008458958,0.00013800415,0.00020758375,0.00007227021],"category_scores_gemma":[0.0003599727,0.00015936719,0.000095538715,0.000809578,0.00011833062,0.000115089366,0.000112149486,0.00059509085,0.000103639955],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088855636,0.0007062188,0.016406648,0.00008820281,0.000018031844,0.0025669583,0.00038285417,0.000040472605,0.9676982,0.000046381618,0.001630567,0.009526904],"study_design_scores_gemma":[0.007837288,0.0075415843,0.19989291,0.000065257715,0.000034067532,0.000121162746,0.00021208092,0.001041221,0.77071685,0.0001540854,0.012201169,0.0001823371],"about_ca_topic_score_codex":0.000047879283,"about_ca_topic_score_gemma":0.00007938355,"teacher_disagreement_score":0.19698136,"about_ca_system_score_codex":0.00012502784,"about_ca_system_score_gemma":0.00028714194,"threshold_uncertainty_score":0.6498805},"labels":[],"label_agreement":null},{"id":"W4388589461","doi":"10.1093/neuonc/noad179.0319","title":"CTNI-37. CLINICAL ACTIVITY OF RAF INHIBITOR TOVORAFENIB ACCORDING TO PRIOR MAPK INHIBITOR TREATMENT IN THE REGISTRATIONAL PEDIATRIC LOW-GRADE GLIOMA ARM OF THE PHASE 2 FIREFLY-1 (PNOC026) STUDY","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Adverse effect; Phases of clinical research; Glioma; Internal medicine; Surgery; Oncology; Cancer research; Clinical trial","score_opus":0.07453843266915541,"score_gpt":0.40596120970024585,"score_spread":0.33142277703109047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589461","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98849916,0.000058611942,8.788978e-7,0.0069632544,0.0009200871,0.0033379141,0.000059080805,0.000040676172,0.00012034851],"genre_scores_gemma":[0.9981902,0.00007898713,0.000041896514,0.0003068527,0.00078017515,0.0005428277,0.00001554409,0.00002979615,0.000013694856],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966533,0.000824286,0.00097386993,0.00058343017,0.000579159,0.00038596243],"domain_scores_gemma":[0.9959963,0.002545418,0.000473091,0.00071926817,0.000110133864,0.00015581699],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008563869,0.00029636236,0.00087249564,0.00029420218,0.0001216046,0.000015651927,0.00028094748,0.00019291548,0.000021743312],"category_scores_gemma":[0.00082625926,0.00017369172,0.00035680115,0.0014691122,0.00012952095,0.00006463742,0.00017457019,0.00033546108,0.00002371006],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030806134,0.0630899,0.60489327,0.00011049471,0.00026643224,0.002123119,0.0031677145,0.00005615513,0.28666392,0.000063725,0.0042226943,0.03226197],"study_design_scores_gemma":[0.03955859,0.035488553,0.7403458,0.000086760934,0.0010446864,0.00014656108,0.0025880872,0.00014757557,0.17497295,0.000051383777,0.005269582,0.00029950513],"about_ca_topic_score_codex":0.00012353939,"about_ca_topic_score_gemma":0.00025373005,"teacher_disagreement_score":0.1354525,"about_ca_system_score_codex":0.00029135577,"about_ca_system_score_gemma":0.0005743419,"threshold_uncertainty_score":0.7082943},"labels":[],"label_agreement":null},{"id":"W4388589463","doi":"10.1093/neuonc/noad179.0133","title":"STEM-06. OSMR INTERACTOME MAPPING REVEALS THE SIGNIFICANCE OF A CHLORIDE CHANNEL IN CYTOKINE REGULATION AND BRAIN TUMOUR STEM CELL SELF-RENEWAL","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McGill University; University of Ottawa","funders":"","keywords":"Biology; Cell biology; Signal transduction; Interactome; Cancer research; Biochemistry; Gene","score_opus":0.036617784045119,"score_gpt":0.29122844744130055,"score_spread":0.25461066339618155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98974794,0.00005566018,0.00008378798,0.007657107,0.00046586338,0.0007439904,0.000025376848,0.00011237446,0.0011078975],"genre_scores_gemma":[0.9979735,0.00008270593,0.000044422828,0.0009690172,0.00029006792,0.00009958528,0.0000228748,0.000033861947,0.0004839555],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982207,0.00025441954,0.0006284993,0.0003793035,0.00020029806,0.00031682051],"domain_scores_gemma":[0.99781895,0.0013587407,0.00033359433,0.00028024646,0.00011535129,0.000093141],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063729426,0.00018487318,0.0005008223,0.00038772324,0.000077789264,0.000015298116,0.0001275436,0.0001229619,0.000030643445],"category_scores_gemma":[0.000107741515,0.00014764388,0.00008995806,0.0006896257,0.00007128264,0.00009654902,0.000105623156,0.00043309672,0.000031190066],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025256933,0.00014131166,0.0016439158,0.00015311896,0.000024131792,0.00010794247,0.003294325,0.00022661564,0.99026275,0.00007602208,0.0025396263,0.0012776719],"study_design_scores_gemma":[0.0053508575,0.0030231304,0.049717546,0.00058641966,0.00014733047,0.00063698296,0.0053872666,0.013268626,0.83430874,0.00046763133,0.08667135,0.00043412278],"about_ca_topic_score_codex":0.00007824943,"about_ca_topic_score_gemma":0.000046450794,"teacher_disagreement_score":0.15595402,"about_ca_system_score_codex":0.00016609434,"about_ca_system_score_gemma":0.0001574174,"threshold_uncertainty_score":0.6020742},"labels":[],"label_agreement":null},{"id":"W4388589468","doi":"10.1093/neuonc/noad179.0377","title":"DNAR-11. NUCLEAR POTASSIUM GOVERNS NUCLEAR ENVELOPE INTEGRITY AND GENOMIC STRUCTURE IN MEDULLOBLASTOMA","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"RNA and protein synthesis mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Potassium channel; Cell biology; Nuclear pore; Cytosol; Nuclear localization sequence; Biology; Potassium; Cell nucleus; Chemistry; Biophysics; Nucleus; Biochemistry","score_opus":0.011813585789159382,"score_gpt":0.24613790240063863,"score_spread":0.23432431661147923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99503076,0.0000857204,0.000008605019,0.0031121166,0.00044777396,0.00026169512,0.000057267014,0.000054261614,0.000941817],"genre_scores_gemma":[0.9965041,0.00042204556,0.0006782295,0.0019667808,0.00022631638,0.000013270361,0.000035278972,0.00006864342,0.000085317806],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983053,0.00028167403,0.00027105917,0.0005928274,0.00012624906,0.00042287933],"domain_scores_gemma":[0.9992888,0.00008157524,0.00011031133,0.00035103175,0.000030007146,0.00013827179],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024986075,0.00023105068,0.00030335388,0.00009653667,0.000104146384,0.000029530765,0.00031793452,0.0005274473,0.00018549619],"category_scores_gemma":[0.00029030093,0.00022514521,0.000069167036,0.0001577144,0.00012473422,0.000006960445,0.0004039382,0.00036595392,0.000099495686],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017904729,0.00003172363,0.0008951583,0.000016327283,0.000016641012,0.00009766167,0.00019794013,0.000008253896,0.98460186,0.0004944416,0.00444748,0.009013498],"study_design_scores_gemma":[0.0008858767,0.0009268831,0.011011799,0.000010478111,0.000017951708,0.00019563708,0.00036829498,0.00012288103,0.14545445,0.000531095,0.84015155,0.0003231197],"about_ca_topic_score_codex":0.00006481971,"about_ca_topic_score_gemma":0.00034404278,"teacher_disagreement_score":0.8391474,"about_ca_system_score_codex":0.000064072556,"about_ca_system_score_gemma":0.000113159556,"threshold_uncertainty_score":0.9181155},"labels":[],"label_agreement":null},{"id":"W4388589481","doi":"10.1093/neuonc/noad179.0105","title":"CNSC-21. INVESTIGATING THE EVOLUTION OF NEURON-GLIOMA CIRCUIT DYNAMICS USING AN IN VIVO IMAGING METHOD","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Glioma; Neuroscience; Neuron; Biological neural network; Calcium imaging; Premovement neuronal activity; Biology; Synaptogenesis; In vivo; Calcium; Medicine; Cancer research; Internal medicine","score_opus":0.0497082504688876,"score_gpt":0.3465323853873724,"score_spread":0.2968241349184848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947936,0.0000883498,0.0006831258,0.0027490798,0.00039278445,0.00045134148,0.000010929462,0.00008605882,0.0007447505],"genre_scores_gemma":[0.9977838,0.000011951764,0.0013474816,0.0006555378,0.00010282036,0.00004366088,0.0000125342285,0.000039077742,0.0000031550117],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9980628,0.00052968255,0.00043287204,0.00037729103,0.00022530893,0.00037204885],"domain_scores_gemma":[0.9983852,0.00083960575,0.00021489627,0.0003768032,0.000065209206,0.00011826897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006152523,0.00016976794,0.0004020569,0.00042675828,0.00010813436,0.000013173151,0.00014107455,0.0000965664,0.000016407555],"category_scores_gemma":[0.0005183635,0.00013577876,0.000089163084,0.0011185969,0.00014369177,0.000098273966,0.00010314346,0.00028106675,0.000006986742],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017839258,0.00028910226,0.14185362,0.000031694773,0.00002108057,0.0006811422,0.0006192173,0.0014212609,0.8381248,0.001583101,0.000101108766,0.015256037],"study_design_scores_gemma":[0.004462963,0.0010798957,0.097503856,0.00013368153,0.00036623506,0.0013290753,0.0028323582,0.8260348,0.061321225,0.0036673504,0.0010089854,0.00025961708],"about_ca_topic_score_codex":0.00082349207,"about_ca_topic_score_gemma":0.00031862786,"teacher_disagreement_score":0.8246135,"about_ca_system_score_codex":0.00068555376,"about_ca_system_score_gemma":0.00031513078,"threshold_uncertainty_score":0.55368966},"labels":[],"label_agreement":null},{"id":"W4388589483","doi":"10.1093/neuonc/noad179.0187","title":"CSIG-31. JAK/STAT PATHWAY CO-OPERATES WITH CIC-FUSIONS TO DRIVE CIC- REARRANGED SARCOMAS","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; Barrie Urology Group; University of Toronto","funders":"","keywords":"STAT1; Cancer research; STAT protein; Transcription factor; JAK-STAT signaling pathway; Janus kinase 1; Fusion protein; Effector; STAT3; Janus kinase; Signal transduction; STAT4; PIM1; Biology; stat; Gene; Cell biology; Phosphorylation; Receptor tyrosine kinase; Genetics","score_opus":0.017080852392914566,"score_gpt":0.28663714626804526,"score_spread":0.2695562938751307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97770756,0.00010715089,0.00025157403,0.0064071496,0.0005143701,0.0007891594,0.00008824399,0.00014700898,0.013987806],"genre_scores_gemma":[0.9880577,0.00026691335,0.00091946754,0.006897691,0.00053378346,0.00027452683,0.0005886679,0.00007934171,0.0023819418],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.998171,0.00022976537,0.0002867073,0.0006265832,0.00019802159,0.0004879446],"domain_scores_gemma":[0.9989108,0.00008617311,0.0000939035,0.00049408723,0.00014128226,0.00027378116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022459593,0.0002520993,0.00028356677,0.00015513129,0.0002252389,0.000035904875,0.00029470678,0.0002678454,0.000116165495],"category_scores_gemma":[0.00030725522,0.00021447145,0.00008517093,0.00039483223,0.00013495304,0.000008624434,0.00020514546,0.00024007105,0.00048101152],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020079514,0.000076005555,0.0007338287,0.000006796734,0.000026314665,0.00009757412,0.0002091632,0.000043648513,0.90980387,0.000105753395,0.08271411,0.0059821107],"study_design_scores_gemma":[0.0006406525,0.0014716822,0.0004740192,0.000006860157,0.000008339098,0.0000387288,0.00017375156,0.000023953202,0.46932542,0.000018662875,0.5276428,0.00017516472],"about_ca_topic_score_codex":0.00002750417,"about_ca_topic_score_gemma":0.00018796013,"teacher_disagreement_score":0.44492865,"about_ca_system_score_codex":0.00004799564,"about_ca_system_score_gemma":0.00037128123,"threshold_uncertainty_score":0.8745892},"labels":[],"label_agreement":null},{"id":"W4388589484","doi":"10.1093/neuonc/noad179.0965","title":"QOL-13. MEASURING FEAR OF CANCER RECURRENCE IN PATIENTS WITH PRIMARY BRAIN TUMORS","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Chicoutimi","funders":"","keywords":"Discriminant validity; Exploratory factor analysis; Clinical psychology; Distress; Coping (psychology); Anxiety; Psychology; Medicine; Cronbach's alpha; Brain tumor; Internal medicine; Psychiatry; Psychometrics","score_opus":0.02496247449658845,"score_gpt":0.3009778744280461,"score_spread":0.27601539993145763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916044,0.00011597805,0.00000313069,0.0033351234,0.00041853494,0.0007711581,0.000024226127,0.000080194695,0.0036472657],"genre_scores_gemma":[0.9976318,0.00019708196,0.000042469703,0.0017385279,0.00008263587,0.00014681216,0.000020309599,0.000033416465,0.00010693683],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99845815,0.00012884455,0.0003336586,0.0003540088,0.00034869203,0.00037661992],"domain_scores_gemma":[0.99895996,0.0004023501,0.00017643523,0.00017146164,0.00020617007,0.000083626794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021931084,0.0001658153,0.0005155324,0.00029458757,0.00004534122,0.0000026312916,0.00008711031,0.000085135136,0.0000516782],"category_scores_gemma":[0.00048964465,0.00014372445,0.000045675097,0.00080877857,0.00018910477,0.000060539845,0.0001174992,0.00039072265,0.000029629608],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016795106,0.000325519,0.9515116,0.00016788862,0.000078099765,0.0001587074,0.0008464339,0.00007868348,0.0061198194,0.0000045084034,0.0062172697,0.032811962],"study_design_scores_gemma":[0.0057568266,0.0025562083,0.98464763,0.0004051975,0.00006496842,0.000008856824,0.00013471853,0.000028941673,0.0015895148,0.000013614586,0.0046650735,0.00012844449],"about_ca_topic_score_codex":0.00025712105,"about_ca_topic_score_gemma":0.00044201265,"teacher_disagreement_score":0.033136036,"about_ca_system_score_codex":0.0004978129,"about_ca_system_score_gemma":0.00044286158,"threshold_uncertainty_score":0.58609134},"labels":[],"label_agreement":null},{"id":"W4388589496","doi":"10.1093/neuonc/noad179.0306","title":"CTNI-24. CLINICAL ACTIVITY AND SAFETY OF THE RAF INHIBITOR TOVORAFENIB IN PATIENTS WITH OPTIC PATHWAY GLIOMAS IN THE REGISTRATIONAL PEDIATRIC LOW-GRADE GLIOMA ARM OF THE PHASE 2 FIREFLY-1 (PNOC026) STUDY","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Ocular Oncology and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Montreal Children's Hospital; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Adverse effect; Glioma; Internal medicine; Progressive disease; Phases of clinical research; Oncology; Gastroenterology; Surgery; Disease; Cancer research; Chemotherapy","score_opus":0.031141463253088645,"score_gpt":0.34197814888971584,"score_spread":0.3108366856366272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952084,0.000027888193,4.4508351e-7,0.0019654431,0.00046986493,0.0021350796,0.000029427096,0.00001339566,0.00015007904],"genre_scores_gemma":[0.9995616,0.000017539045,0.00001977332,0.00017601255,0.00010957521,0.000076450604,0.000010543591,0.000015678334,0.000012836794],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99690634,0.0014128003,0.0006310696,0.0003765977,0.00042351463,0.0002496555],"domain_scores_gemma":[0.9974251,0.0015111156,0.00041517083,0.000513153,0.00007725279,0.000058206457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091880566,0.00018746183,0.0005440613,0.00015257826,0.00010391013,0.00000468272,0.00023929887,0.00021505178,0.000007840614],"category_scores_gemma":[0.0006376989,0.00009321016,0.0001150442,0.0011490025,0.00039010125,0.000064252716,0.00015656205,0.0005957866,0.0000026371592],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003819422,0.01337646,0.97773486,0.000039875715,0.00007133089,0.0004494838,0.00084306655,0.000012251967,0.0015164145,0.000039449602,0.00010219181,0.0019951693],"study_design_scores_gemma":[0.025335375,0.008656719,0.96401024,0.000023843191,0.0002058458,0.00004665897,0.00023204215,0.0000421294,0.0011038093,0.000044286706,0.00022712107,0.00007194312],"about_ca_topic_score_codex":0.00003150895,"about_ca_topic_score_gemma":0.00035461065,"teacher_disagreement_score":0.021515954,"about_ca_system_score_codex":0.00009469223,"about_ca_system_score_gemma":0.0005236129,"threshold_uncertainty_score":0.38009998},"labels":[],"label_agreement":null},{"id":"W4388589521","doi":"10.1093/neuonc/noad179.0127","title":"CNSC-44. BIOLOGICAL PATTERN DISCOVERY IN GLIOBLASTOMA","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cell Image Analysis Techniques","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Structural Genomics Consortium; Ontario Brain Institute; SickKids Foundation; Centre for Global Health Research; University of Toronto; University Health Network","funders":"","keywords":"Glioblastoma; Phenotype; Pixel; Computational biology; Biology; Computer science; Gene; Pattern recognition (psychology); Neuroscience; Artificial intelligence; Genetics; Cancer research","score_opus":0.015157873181392308,"score_gpt":0.295798267752786,"score_spread":0.28064039457139367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99520046,0.000083665946,0.0007843192,0.0005899661,0.00010079154,0.00018370936,0.000007044709,0.000110685425,0.0029393665],"genre_scores_gemma":[0.9959211,0.0006343774,0.00006715256,0.0027442265,0.00022073099,0.00007830071,0.00009114079,0.000027742532,0.0002152638],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983546,0.00024512873,0.00030823582,0.0005836938,0.00010055278,0.0004078026],"domain_scores_gemma":[0.9992795,0.00009088657,0.0000897127,0.00043922703,0.000031711734,0.000068989786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002743721,0.00018428802,0.00030262893,0.00019243357,0.000039909835,0.000024635741,0.0003234492,0.0003350008,0.000040972882],"category_scores_gemma":[0.00024097432,0.00016702205,0.00014660253,0.0003919995,0.00013920349,0.0000075194303,0.0004174677,0.00022252627,0.0001258221],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007963636,0.0001035474,0.011980499,0.000004556608,0.000016777843,0.00031503776,0.000024645235,0.000013605376,0.9496587,0.000009976397,0.017087832,0.020705193],"study_design_scores_gemma":[0.00057160016,0.0017240839,0.004042387,0.000005347232,0.000014665742,0.00006657629,0.0000748127,0.00020743744,0.6848319,0.0001312337,0.30807194,0.00025801445],"about_ca_topic_score_codex":0.00003741552,"about_ca_topic_score_gemma":0.00033898442,"teacher_disagreement_score":0.29098412,"about_ca_system_score_codex":0.000042639353,"about_ca_system_score_gemma":0.00007508298,"threshold_uncertainty_score":0.68109614},"labels":[],"label_agreement":null},{"id":"W4388589533","doi":"10.1093/neuonc/noad179.0527","title":"DISP-12. BRAIN CANCER CANADA FUNDS CRITICALLY NEEDED RESEARCH AND ADVOCATES FOR PATIENTS, WITH THE AIM TO IMPROVE OUTCOMES FOR CANADIANS DIAGNOSED WITH PRIMARY MALIGNANT BRAIN TUMOURS","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ontario Brain Institute","funders":"","keywords":"Temozolomide; Medicine; Brain cancer; Cancer; Family medicine; Glioblastoma; Political science; Internal medicine; Cancer research","score_opus":0.16511492376747897,"score_gpt":0.4173282999642205,"score_spread":0.25221337619674156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589533","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.48437402,0.000072412455,0.00036425228,0.50860345,0.00046860674,0.0032892325,0.0026365481,0.000027614165,0.00016384579],"genre_scores_gemma":[0.68881005,0.000040329145,0.00094614405,0.29848698,0.00045370092,0.009024019,0.00026533272,0.00016802017,0.0018054295],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963237,0.0003221513,0.0012925855,0.0008025678,0.0001690403,0.0010899688],"domain_scores_gemma":[0.97812104,0.020180266,0.00044255648,0.0004363352,0.000354509,0.0004653035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006329139,0.00024460332,0.000940158,0.00032586904,0.0005489136,0.000093539384,0.00037533144,0.0001280031,0.000025282083],"category_scores_gemma":[0.008022589,0.00020428408,0.00005022556,0.00032757543,0.00021602627,0.00014960954,0.00008700824,0.00024537134,0.000016432656],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004118856,0.00013803721,0.26810202,0.0004970138,0.00011786283,0.000014770059,0.002949801,0.00018300502,0.000062483305,0.010090342,0.7159786,0.0014541382],"study_design_scores_gemma":[0.005746886,0.004710715,0.340219,0.00006654072,0.00002743635,0.0000043232653,0.0068433606,0.0016193073,0.00001894637,0.0018128629,0.63828427,0.0006463282],"about_ca_topic_score_codex":0.5095205,"about_ca_topic_score_gemma":0.9259592,"teacher_disagreement_score":0.41643882,"about_ca_system_score_codex":0.0016614543,"about_ca_system_score_gemma":0.003329178,"threshold_uncertainty_score":0.96043676},"labels":[],"label_agreement":null},{"id":"W4388589549","doi":"10.1093/neuonc/noad179.0499","title":"EPCO-37. DISSECTING GBM EVOLUTION FOLLOWING STANDARD-OF-CARE BY LARGE-SCALE LONGITUDINAL SINGLE NUCLEUS RNA-SEQUENCING","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Transcriptome; Phenotype; Temozolomide; Biology; Exome sequencing; RNA; Cohort; microRNA; Cancer research; Medicine; Glioblastoma; Internal medicine; Genetics; Gene; Gene expression","score_opus":0.02749759633724188,"score_gpt":0.3110289152744299,"score_spread":0.283531318937188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99361914,0.0010233861,0.00016659709,0.00089421554,0.0012607668,0.0004472861,0.000077435005,0.00023002917,0.0022811412],"genre_scores_gemma":[0.9989051,0.000051550604,0.00048242454,0.00013099152,0.00019725433,0.000058434303,0.00009757389,0.000055323108,0.000021325874],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997975,0.00012006253,0.00043602986,0.00049987464,0.00038496012,0.00058410666],"domain_scores_gemma":[0.9987142,0.00041613204,0.00018924238,0.000312334,0.0001857641,0.00018234208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026677974,0.00022859113,0.0006432066,0.00018047844,0.00023831893,0.000019569714,0.00010361877,0.00019275495,0.00006342214],"category_scores_gemma":[0.00053406507,0.0002127318,0.00027787092,0.00057740824,0.000058251684,0.000102122984,0.00011400057,0.00026547202,0.000052602587],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030340184,0.0004588483,0.13539861,0.00014063164,0.00015165722,0.0015352237,0.0020735604,0.00007897108,0.8420971,0.0001008473,0.004876647,0.012784471],"study_design_scores_gemma":[0.020132419,0.019253392,0.05424973,0.0009316226,0.001854204,0.0004260879,0.02732502,0.001723013,0.77582645,0.00030251694,0.09703161,0.00094390765],"about_ca_topic_score_codex":0.000058638878,"about_ca_topic_score_gemma":0.00016443587,"teacher_disagreement_score":0.09215496,"about_ca_system_score_codex":0.0012913671,"about_ca_system_score_gemma":0.000244945,"threshold_uncertainty_score":0.8674951},"labels":[],"label_agreement":null},{"id":"W4388589565","doi":"10.1093/neuonc/noad179.0037","title":"BIOM-26. RAPID IDENTIFICATION OF <i>IDH1</i>-R132 VARIANTS IN GLIOMA WITH LOCKED NUCLEIC ACID LOOP-MEDIATED ISOTHERMAL AMPLIFICATION (LNA-LAMP)","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Isocitrate dehydrogenase; Chemistry; Wild type; Mutant; Molecular biology; Loop-mediated isothermal amplification; IDH1; Locked nucleic acid; DNA; Oligonucleotide; Biology; Gene; Biochemistry; Enzyme","score_opus":0.02212467388148024,"score_gpt":0.2841468640563205,"score_spread":0.26202219017484024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939032,0.00014670499,0.00005267802,0.0039212946,0.00032721477,0.0010240979,0.000040036903,0.00022357806,0.00036118008],"genre_scores_gemma":[0.99856627,0.00018861699,0.000116704105,0.00046769102,0.000078130455,0.00026333364,0.00022856706,0.00007460648,0.000016085442],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99770075,0.0002239412,0.00073078537,0.0005787899,0.00034091857,0.00042478967],"domain_scores_gemma":[0.99828166,0.00038113323,0.0004261521,0.00057258847,0.0001835766,0.00015488645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038748738,0.00024820544,0.00057818834,0.00074409734,0.000064928434,0.000017760096,0.00017384398,0.0002449341,0.00014451142],"category_scores_gemma":[0.0002699736,0.00021054472,0.000087457636,0.0017867071,0.00017867742,0.000113938026,0.00005361757,0.00019976188,0.0004854043],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006140132,0.001290566,0.019652901,0.00006328455,0.00009363518,0.0006457425,0.00045881464,0.000023727624,0.9622236,0.00014604424,0.0013539605,0.013433714],"study_design_scores_gemma":[0.010267445,0.002304542,0.40960717,0.000082347375,0.00025270035,0.0002347329,0.0003490535,0.0016829302,0.5687847,0.00007446132,0.006104921,0.00025498233],"about_ca_topic_score_codex":0.0000796142,"about_ca_topic_score_gemma":0.000076350196,"teacher_disagreement_score":0.39343888,"about_ca_system_score_codex":0.00019281155,"about_ca_system_score_gemma":0.00022935883,"threshold_uncertainty_score":0.8585764},"labels":[],"label_agreement":null},{"id":"W4388589580","doi":"10.1093/neuonc/noad179.0366","title":"CTNI-85. GBM AGILE PLATFORM TRIAL FOR NEWLY DIAGNOSED AND RECURRENT GBM: RESULTS OF FIRST EXPERIMENTAL ARM, REGORAFENIB","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Regorafenib; Medicine; Clinical endpoint; Randomization; Randomized controlled trial; Internal medicine; Oncology; Hazard ratio; Confidence interval; Cancer; Colorectal cancer","score_opus":0.38453446809192626,"score_gpt":0.455586521230215,"score_spread":0.07105205313828872,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9505019,0.001019916,0.0001011453,0.033977717,0.0052451515,0.0034568382,0.0013967392,0.0001329464,0.0041676313],"genre_scores_gemma":[0.9893951,0.0009004358,0.00132046,0.004397563,0.0016760358,0.0014737002,0.0003436937,0.00009635,0.00039666035],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9944227,0.00021270147,0.003907644,0.00080787536,0.000099662895,0.00054945576],"domain_scores_gemma":[0.9911657,0.005711613,0.0023314103,0.000495485,0.00006525478,0.00023056843],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.007129747,0.00024415116,0.0013455498,0.000426683,0.00023229564,0.000039199113,0.0002920838,0.0003032582,0.00012818737],"category_scores_gemma":[0.007324341,0.00030702446,0.00018234516,0.00026124422,0.00017924866,0.00028030004,0.00013624634,0.00021525411,0.00036504326],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024708152,0.0020348497,0.0027344588,0.0009575027,0.00021436173,0.000037783222,0.015928796,0.00034022823,0.0007314987,0.043644678,0.9023474,0.0063202763],"study_design_scores_gemma":[0.07382165,0.005363597,0.0010108544,0.000053630458,0.000016671615,0.000012420699,0.0021627692,0.006070523,0.00053797395,0.004498242,0.90602577,0.00042590898],"about_ca_topic_score_codex":0.0003314913,"about_ca_topic_score_gemma":0.0004079865,"teacher_disagreement_score":0.049113497,"about_ca_system_score_codex":0.000498315,"about_ca_system_score_gemma":0.00022057172,"threshold_uncertainty_score":0.9999382},"labels":[],"label_agreement":null},{"id":"W4388589709","doi":"10.1093/neuonc/noad179.0442","title":"EPID-10. CNSONTRK STUDY: CLINICAL CHARACTERISTICS AND OUTCOME OF CENTRAL NERVOUS SYSTEM TUMORS HARBORING NTRK GENE FUSIONS","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; BC Children's Hospital; Izaak Walton Killam Health Centre; Hospital for Sick Children; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Trk receptor; Medicine; Internal medicine; Retrospective cohort study; Oncology; Central nervous system; Glioma; Gastroenterology; Pathology; Neurotrophin; Cancer research","score_opus":0.07178946823431683,"score_gpt":0.3735676617704192,"score_spread":0.3017781935361024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958173,0.000063682324,0.0000040441214,0.0014901421,0.0012789305,0.0009048385,0.00005164341,0.00015337838,0.00023601705],"genre_scores_gemma":[0.99883443,0.000107908905,0.000090034475,0.00035949625,0.00041549187,0.000091936825,0.000029136561,0.000037871036,0.00003368851],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975254,0.00030661334,0.001002813,0.00046041625,0.00023236788,0.0004723822],"domain_scores_gemma":[0.9978167,0.0010149564,0.0003067746,0.00040381958,0.0000983319,0.00035940594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047377066,0.00021616377,0.0011112483,0.00017027363,0.00010806368,0.0000119145925,0.00010564913,0.00015461595,0.00004359523],"category_scores_gemma":[0.00066736835,0.00017653525,0.0001595564,0.00027794638,0.00010884321,0.000026563388,0.00019029346,0.00026462012,0.00007846613],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018506934,0.0013898048,0.9699208,0.00010517682,0.00014351377,0.0053686146,0.00024346182,0.0000047186795,0.009773022,0.000080880796,0.0008146862,0.011970252],"study_design_scores_gemma":[0.0039817085,0.0029467654,0.9849932,0.00004967671,0.0004823682,0.0001880804,0.0004542223,0.0003358867,0.00080155383,0.0000019613854,0.0056503564,0.00011419367],"about_ca_topic_score_codex":0.000064759115,"about_ca_topic_score_gemma":0.000022807688,"teacher_disagreement_score":0.015072427,"about_ca_system_score_codex":0.00014642434,"about_ca_system_score_gemma":0.00013499848,"threshold_uncertainty_score":0.7198899},"labels":[],"label_agreement":null},{"id":"W4388589743","doi":"10.1093/neuonc/noad179.0467","title":"EPCO-02. DNA METHYLATION PROFILING OF BRAIN METASTASIS REVEALS UNDERLING TUMOR RECURRENCE SIGNAL AND ASSOCIATED PATHWAYS","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto; University Health Network","funders":"","keywords":"DNA methylation; CpG site; Methylation; Epigenetics; Biology; Differentially methylated regions; Cancer research; Metastasis; Molecular biology; Computational biology; Oncology; DNA; Cancer; Medicine; Genetics; Gene expression; Gene","score_opus":0.04339248786605172,"score_gpt":0.3123219602283687,"score_spread":0.268929472362317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388589743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99588364,0.00073925394,0.0019441636,0.00035998426,0.00020683925,0.00029377258,0.00005584579,0.000031641674,0.00048483754],"genre_scores_gemma":[0.9975248,0.0004305869,0.001428331,0.00019661053,0.00009596989,0.000027430508,0.00024610534,0.000026631,0.000023538229],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981452,0.00053051516,0.00043730333,0.00043273525,0.00016850852,0.00028568655],"domain_scores_gemma":[0.99876094,0.00044308716,0.00034541546,0.00019820669,0.00016692819,0.00008539485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012421046,0.00016138842,0.000312012,0.00012806078,0.000098159355,0.000015212855,0.00012304446,0.00020771287,0.000010993436],"category_scores_gemma":[0.0014663152,0.00016713448,0.00007940364,0.0003288374,0.000089481495,0.000007168976,0.00013218043,0.00015340098,0.0000052950522],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004418776,0.000042205134,0.002113932,0.000027756578,0.000038906288,0.000008430188,0.00009860758,0.00025506847,0.9781642,0.00017023267,0.00015606254,0.01888039],"study_design_scores_gemma":[0.0005608001,0.0009941295,0.0036945955,0.000015276837,0.000045702967,0.000003933274,0.00011151045,0.0012507902,0.98799294,0.0019498849,0.003211993,0.00016843229],"about_ca_topic_score_codex":0.000008217887,"about_ca_topic_score_gemma":0.00001871393,"teacher_disagreement_score":0.018711956,"about_ca_system_score_codex":0.000031684758,"about_ca_system_score_gemma":0.000157619,"threshold_uncertainty_score":0.6815547},"labels":[],"label_agreement":null},{"id":"W4388590013","doi":"10.1093/neuonc/noad179.0587","title":"IMMU-55. THERAPEUTIC WINDOW ENABLING ERADICATION OF RESIDUAL GLIOMA STEM CELLS BY INTRACRANIAL NK CELL AND EXTRACELLULAR VESICLE-MEDIATED THERAPY FOLLOWING TEMOZOLOMIDE-INDUCED TUMOUR DEPOPULATION","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Temozolomide; Glioma; Cancer research; Stem cell; Adjuvant; Immunology; Biology; Medicine; Cell biology","score_opus":0.023373059182646913,"score_gpt":0.2933260544799681,"score_spread":0.2699529952973212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388590013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99542004,0.0033248903,0.00007734724,0.00026323993,0.00023744539,0.00055883196,0.00003220187,0.000037574435,0.00004842705],"genre_scores_gemma":[0.997806,0.0015439991,0.00005578588,0.00009185189,0.00014391655,0.00006276568,0.00022425814,0.000045485875,0.000025948459],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981509,0.0003396411,0.00038056102,0.00048774775,0.00023622706,0.00040492896],"domain_scores_gemma":[0.99919486,0.00015100907,0.00020658222,0.00026167277,0.00005869871,0.00012718509],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031818316,0.00020701608,0.0002825128,0.00014182494,0.000132602,0.00002726067,0.00017204315,0.0002612194,0.000008444883],"category_scores_gemma":[0.000033707973,0.0002006003,0.000094304436,0.00029008268,0.00006398845,0.000015853597,0.000073941934,0.00017715787,0.000016553853],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056042406,0.00016079767,0.001994162,0.000019334495,0.00008946358,0.000104967905,0.0001111762,0.00001722596,0.975783,0.0000031259385,0.000261296,0.020895056],"study_design_scores_gemma":[0.003343109,0.0013774834,0.0017504928,0.000006913767,0.00003221888,0.00002419848,0.00014524028,0.0002090221,0.9906189,0.000027928618,0.0023086485,0.00015587223],"about_ca_topic_score_codex":0.00017155659,"about_ca_topic_score_gemma":0.000040877785,"teacher_disagreement_score":0.020739185,"about_ca_system_score_codex":0.00006639671,"about_ca_system_score_gemma":0.00020214506,"threshold_uncertainty_score":0.81802434},"labels":[],"label_agreement":null},{"id":"W4388590014","doi":"10.1093/neuonc/noad179.0159","title":"CSIG-03. SHH PATHWAY ACTIVATION IN DEDIFFERENTIATION DURING TUMOUR PROGRESSION IN MPNST","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto; McMaster University","funders":"","keywords":"Cancer research; Biology; Neural crest; Wnt signaling pathway; Transcription factor; Cell biology; Signal transduction; Biochemistry","score_opus":0.014827794039939602,"score_gpt":0.284706817355861,"score_spread":0.2698790233159214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388590014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975981,0.000023080791,0.000052995772,0.0008829436,0.00032265656,0.0003509502,0.0000024059855,0.000040245308,0.00072661514],"genre_scores_gemma":[0.99905705,0.0000716847,0.00007079597,0.00018901186,0.0002028681,0.00012413865,0.00019911473,0.000019661697,0.00006564575],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99880296,0.00019495776,0.00027977896,0.0003443667,0.000120891535,0.000257074],"domain_scores_gemma":[0.99962515,0.000027773249,0.00011153668,0.00015353612,0.000034154473,0.00004782444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019699708,0.0001219818,0.00014152109,0.00022845452,0.000050220864,0.000013699436,0.00011344629,0.00023401357,0.000016774642],"category_scores_gemma":[0.00029319583,0.00012156554,0.000037640308,0.00034949026,0.000029627072,0.000013377806,0.000112175294,0.0001876368,0.00003721533],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011208095,0.00009197117,0.010538624,0.000015081066,0.0000023826885,0.000016083195,0.0000793879,0.000043913857,0.9792401,0.000038925205,0.0003792999,0.009442105],"study_design_scores_gemma":[0.0011299531,0.00025940986,0.066145726,0.00002572531,0.0000014757999,0.0000057100215,0.00007010066,0.00024796152,0.92292076,0.0000631335,0.009012027,0.00011798439],"about_ca_topic_score_codex":0.000011786853,"about_ca_topic_score_gemma":0.000117437216,"teacher_disagreement_score":0.056319352,"about_ca_system_score_codex":0.00008314441,"about_ca_system_score_gemma":0.000108150554,"threshold_uncertainty_score":0.4957299},"labels":[],"label_agreement":null},{"id":"W4388590026","doi":"10.1093/neuonc/noad179.0157","title":"CSIG-01. DEFINING THE INVOLVEMENT OF THE PERIVASCULAR NICHE IN BRAIN TUMOR METASTASES","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Biology; Intravasation; Pathology; Wnt signaling pathway; Metastasis; Cancer research; Medicine; Cancer; Signal transduction; Cell biology","score_opus":0.03762858983162251,"score_gpt":0.31109616535680085,"score_spread":0.2734675755251783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388590026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.961686,0.0008243639,0.0000029946327,0.035253406,0.00040557003,0.0005745905,0.000010425949,0.000041278672,0.0012013714],"genre_scores_gemma":[0.9862348,0.00018999045,0.00006836904,0.013139943,0.00007192074,0.00022436219,0.000008078301,0.000024372479,0.000038205366],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99840766,0.0003769697,0.0003563368,0.0002664716,0.00029354182,0.00029902547],"domain_scores_gemma":[0.99873245,0.00057984365,0.00012725135,0.00046477854,0.000043962114,0.000051703308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000816351,0.0001321009,0.0003845703,0.00009651495,0.00008175495,0.000007755988,0.00025941583,0.000059951395,0.00014199782],"category_scores_gemma":[0.00057598116,0.00007324152,0.00019561787,0.00070326705,0.0001824363,0.000026100626,0.00023921116,0.0003360352,0.000031909527],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048574636,0.000935887,0.30986172,0.00034302013,0.00036691132,0.0003988036,0.006192617,0.00046520893,0.52749825,0.004829141,0.102753,0.04586972],"study_design_scores_gemma":[0.0036493249,0.001862634,0.18241379,0.00013118563,0.0003323231,0.00009546843,0.004219329,0.0006524208,0.10693748,0.00020024515,0.69931394,0.00019187047],"about_ca_topic_score_codex":0.00015860643,"about_ca_topic_score_gemma":0.00026521625,"teacher_disagreement_score":0.59656096,"about_ca_system_score_codex":0.00010085571,"about_ca_system_score_gemma":0.00028983317,"threshold_uncertainty_score":0.29867026},"labels":[],"label_agreement":null},{"id":"W4388590054","doi":"10.1093/neuonc/noad179.0340","title":"CTNI-58. UPDATED RESULTS AND MOLECULAR SUBGROUP ANALYSES FROM THE RANDOMIZED PHASE 3 MIRAGE TRIAL ON MARIZOMIB IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; Princess Margaret Cancer Centre; Centre hospitalier universitaire de Québec; Centre Hospitalier de l’Université de Montréal; Health Sciences Centre; Queen's University; McMaster University; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Temozolomide; Medicine; Concomitant; Internal medicine; Oncology; Interim analysis; Randomized controlled trial; Chemotherapy; Isocitrate dehydrogenase; O-6-methylguanine-DNA methyltransferase; Radiation therapy; Methyltransferase; Biology","score_opus":0.022321352402795216,"score_gpt":0.32043109964655014,"score_spread":0.29810974724375494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388590054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917272,0.00007179561,0.000004314502,0.004248791,0.00030400837,0.0031235884,0.00014935766,0.00008972587,0.00028122574],"genre_scores_gemma":[0.99644786,0.00008962258,0.00006359573,0.0022054948,0.000097969525,0.00041562668,0.00063026097,0.00004148402,0.000008078015],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9970926,0.000935599,0.0006007576,0.0006226192,0.00036683024,0.00038159185],"domain_scores_gemma":[0.9949972,0.004017108,0.0002547524,0.0004855151,0.0000734151,0.00017202375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004153804,0.00031037047,0.0010923883,0.00029636838,0.00008386906,0.000033622502,0.00012633648,0.00017507319,0.000057787765],"category_scores_gemma":[0.0012839519,0.00017930211,0.00016007338,0.0007133014,0.00019077677,0.000048141865,0.0000797021,0.00030259127,0.000042465505],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9620015,0.0028990996,0.003959481,0.0000046091855,0.00043163783,0.004641921,0.00036148177,0.00006357163,0.013772229,0.000025485353,0.006482609,0.0053563667],"study_design_scores_gemma":[0.95861614,0.011676377,0.016042627,0.00004517921,0.00068070315,0.0000047221224,0.00006253873,0.00045223086,0.008635044,0.000046081976,0.00358015,0.00015819445],"about_ca_topic_score_codex":0.0004445798,"about_ca_topic_score_gemma":0.0003234523,"teacher_disagreement_score":0.012083147,"about_ca_system_score_codex":0.00013442698,"about_ca_system_score_gemma":0.00012345993,"threshold_uncertainty_score":0.73117274},"labels":[],"label_agreement":null},{"id":"W4388590067","doi":"10.1093/neuonc/noad179.0613","title":"INNV-24. MACHINE LEARNING-BASED SPECTROSCOPIC TISSUE DIFFERENTIATION IN FLUORESCENCE-GUIDED NEUROSURGERY","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Optical Imaging and Spectroscopy Techniques","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Artificial intelligence; Principal component analysis; Computer science; Pattern recognition (psychology); Hyperspectral imaging; Dimensionality reduction; Random forest; Fluorophore; Glioma; Fluorescence; Physics; Biology; Optics; Cancer research","score_opus":0.03009660723060128,"score_gpt":0.3440383126285565,"score_spread":0.31394170539795524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388590067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97579175,0.000058161317,0.000824582,0.017151562,0.0009210853,0.0006379031,0.000004541664,0.0014117246,0.0031987063],"genre_scores_gemma":[0.995104,0.000212771,0.0014122261,0.00225976,0.00020566955,0.0000845158,0.0001228654,0.00006375302,0.0005344474],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977919,0.00032025293,0.0004937486,0.000518095,0.00028641723,0.0005896244],"domain_scores_gemma":[0.99880034,0.00051771966,0.00012273176,0.00032595557,0.00006452214,0.00016874651],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032753026,0.00024049683,0.0005889482,0.00060039357,0.000082135986,0.000030276438,0.00013409469,0.00020397842,0.00018969082],"category_scores_gemma":[0.0011167972,0.0002249885,0.000088337045,0.00087707094,0.00013642712,0.00006522697,0.00007473918,0.00088186463,0.00019133929],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001632718,0.00031097795,0.12943573,0.00006525736,0.000007022537,0.000997557,0.000064818436,0.000050683997,0.85720664,0.00013309583,0.008116006,0.0034489667],"study_design_scores_gemma":[0.002960453,0.0037133724,0.09101331,0.00011341478,0.00008064079,0.00012656952,0.000020231477,0.05516543,0.7667516,0.00042476968,0.079262055,0.00036819637],"about_ca_topic_score_codex":0.0000800017,"about_ca_topic_score_gemma":0.00002962552,"teacher_disagreement_score":0.090455055,"about_ca_system_score_codex":0.00022927043,"about_ca_system_score_gemma":0.00021300805,"threshold_uncertainty_score":0.9174765},"labels":[],"label_agreement":null},{"id":"W4388590430","doi":"10.1093/neuonc/noad179.0569","title":"IMMU-37. TARGETING NON-CATALYTIC ACTIVATORS OF THE PROTEASOME DECREASES TUMOR GROWTH AND ENHANCES ANTIGEN PRESENTATION IN GLIOBLASTOMA","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Neurosciences, Mental Health and Addiction; Government of Canada; University of Calgary","funders":"","keywords":"Proteasome; Proteostasis; Biology; Cancer research; Cell biology; Neural stem cell; Stem cell; Activator (genetics); Downregulation and upregulation; In vivo; Biochemistry; Receptor","score_opus":0.01052500384115085,"score_gpt":0.2665183434337563,"score_spread":0.25599333959260545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388590430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982658,0.0001495982,0.000011847699,0.00027752918,0.00016806644,0.0006201637,0.000013548407,0.000016607253,0.0004768549],"genre_scores_gemma":[0.9992555,0.00021043268,0.00007230198,0.00015955577,0.00011770572,0.00012569406,0.000017807279,0.000020852614,0.000020176012],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988007,0.0002128894,0.00026273212,0.00033335117,0.000121766796,0.00026856558],"domain_scores_gemma":[0.999404,0.00011626062,0.00018792156,0.0001895421,0.000042566895,0.000059684484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022336676,0.00014072933,0.00020200759,0.00007361108,0.00008024715,0.000011244744,0.00021519212,0.000115129806,0.000011003661],"category_scores_gemma":[0.00067214353,0.00011353231,0.000060121605,0.00032036076,0.00016459158,0.000010538341,0.00024887625,0.00013932983,0.0000083808545],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016942425,0.000053927164,0.019716064,0.000062344814,0.000013323133,0.000014113431,0.00019955765,0.0000087790895,0.9783799,0.000014236592,0.00029144823,0.0010768536],"study_design_scores_gemma":[0.0005259707,0.0005613937,0.018150032,0.000024150331,0.000007845316,0.000025035612,0.00025554703,0.00008884809,0.9781114,0.00011314809,0.0020275505,0.00010907814],"about_ca_topic_score_codex":0.0000476308,"about_ca_topic_score_gemma":0.00003783757,"teacher_disagreement_score":0.0017361022,"about_ca_system_score_codex":0.000014047757,"about_ca_system_score_gemma":0.00017838345,"threshold_uncertainty_score":0.46297133},"labels":[],"label_agreement":null},{"id":"W4388590481","doi":"10.1093/neuonc/noad179.1001","title":"SURG-02. SURGICAL OUTCOME OF SUPRATENTORIAL MENINGIOMA PATIENTS AGED ≥80 YEARS – RETROSPECTIVE INTERNATIONAL MULTICENTER STUDY","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Neurosurgery; Meningioma; Population; Surgery; Radiology","score_opus":0.03787618942484005,"score_gpt":0.34054426142688743,"score_spread":0.3026680720020474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388590481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98842216,0.000003391967,0.000002800101,0.00042423903,0.00549233,0.00092762004,0.000020426181,0.00011307334,0.0045939377],"genre_scores_gemma":[0.9986154,0.0000026302564,0.000071572445,0.00006139031,0.00052985264,0.000056171622,0.00009270987,0.000028366507,0.0005419071],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975351,0.000292643,0.000669137,0.0004668614,0.00068854867,0.00034768233],"domain_scores_gemma":[0.99880874,0.00028477094,0.00024369924,0.0003030709,0.00021740703,0.00014230498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006137246,0.0001830421,0.00057639304,0.00039516378,0.000052099454,0.000017693283,0.0002188582,0.00012135021,0.00034896898],"category_scores_gemma":[0.0004868265,0.00016881162,0.00016694887,0.00041626283,0.00007570716,0.00008141652,0.0003014837,0.00028795682,0.00016478341],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015698698,0.0013352759,0.97822267,0.000014506711,0.00024035147,0.007178906,0.0012631763,0.0000055850633,0.0035737837,0.00012277837,0.005767255,0.0007058713],"study_design_scores_gemma":[0.012939075,0.0033867112,0.9583949,0.000010310643,0.00014736406,0.000033008197,0.0005035846,0.000169138,0.00026167114,0.000013283298,0.024002746,0.00013820095],"about_ca_topic_score_codex":0.000047360856,"about_ca_topic_score_gemma":0.000012647918,"teacher_disagreement_score":0.019827735,"about_ca_system_score_codex":0.0002621462,"about_ca_system_score_gemma":0.000051407285,"threshold_uncertainty_score":0.6883938},"labels":[],"label_agreement":null},{"id":"W4388590565","doi":"10.1093/neuonc/noad179.0472","title":"EPCO-08. CONVERGENCE OF NON-CODING SOMATIC MUTATIONS ON CANCER DRIVER PLEXUSES IN PEDIATRIC HIGH-GRADE GLIOMA","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Epigenetics; Biology; Pediatric cancer; Somatic cell; Genetics; Gene; Germline mutation; Glioma; Cancer; Mutation","score_opus":0.03378009687224769,"score_gpt":0.3344156060484884,"score_spread":0.3006355091762407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388590565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99503785,0.00010053831,0.0000042402394,0.0032715523,0.0007397544,0.00050021155,0.000025446436,0.00006129138,0.00025911615],"genre_scores_gemma":[0.9982871,0.00074291526,0.00009031971,0.00038607544,0.00014168651,0.00029036868,0.000024632569,0.000024657118,0.0000122602],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987044,0.00008404382,0.00037573447,0.00030634514,0.0002203329,0.00030914953],"domain_scores_gemma":[0.9985869,0.0008777373,0.0001606328,0.00021763713,0.000050894876,0.00010617904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000091202885,0.0001570639,0.0004442349,0.00061808754,0.000052018462,0.0000047999442,0.000092988914,0.00011210269,0.00023736588],"category_scores_gemma":[0.00017155868,0.0001375981,0.00008188162,0.0009522532,0.000068196474,0.00004639576,0.00004743602,0.00015742598,0.0002322894],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000103777646,0.0015352727,0.54562074,0.00024821213,0.00008418132,0.0028550527,0.0014163159,0.0011663421,0.43741453,0.0005477727,0.0057919757,0.0032158156],"study_design_scores_gemma":[0.005695415,0.0013776174,0.845238,0.00007901466,0.0003153854,0.000042771197,0.00022228193,0.0015036355,0.1442934,0.0002173682,0.00085573166,0.00015941061],"about_ca_topic_score_codex":0.0002461341,"about_ca_topic_score_gemma":0.00021339813,"teacher_disagreement_score":0.29961723,"about_ca_system_score_codex":0.00019568969,"about_ca_system_score_gemma":0.00023369787,"threshold_uncertainty_score":0.56110877},"labels":[],"label_agreement":null},{"id":"W4388590604","doi":"10.1093/neuonc/noad179.1078","title":"TMIC-12. RAB27 REGULATION OF VASCULAR WALL INTEGRITY MEDIATES T-CELL INFILTERATION IN GLIOBLASTOMA","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Biology; Angiogenesis; Cell biology; Tumor microenvironment; Microvesicles; Cell type; Exosome; Vascular permeability; Cancer research; Pathology; Cell; Immune system; Immunology; microRNA; Medicine; Endocrinology; Gene","score_opus":0.012215200247837609,"score_gpt":0.2658197568793628,"score_spread":0.2536045566315252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388590604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976511,0.00023868847,0.0002239456,0.00034389098,0.00029454802,0.00030523475,0.000013342584,0.0000378745,0.0008913803],"genre_scores_gemma":[0.9986273,0.00027017505,0.00032075524,0.00026293285,0.00015092937,0.000042322106,0.00020940277,0.000031021704,0.00008517183],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99832135,0.0003671039,0.0004380418,0.00042009645,0.00017860002,0.00027479988],"domain_scores_gemma":[0.99909073,0.00010636709,0.00018089163,0.00043564176,0.000096396645,0.00008997281],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046876352,0.00016625944,0.0002402994,0.00018350528,0.000035167104,0.000010053895,0.00024098562,0.00034586815,0.000040090985],"category_scores_gemma":[0.0004464284,0.00017785351,0.00011811465,0.00026716717,0.00011652693,0.0000104271885,0.00016424278,0.00022718581,0.00004942371],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020016824,0.00019164407,0.0055672782,0.000045519355,0.000013321072,0.00002743758,0.00016878857,0.000645009,0.988246,0.00006830866,0.0022806195,0.0025458778],"study_design_scores_gemma":[0.0014900906,0.0008289589,0.008806771,0.000011716371,0.0000243271,0.000009634274,0.000068382506,0.0028073115,0.95266616,0.00050870044,0.03259939,0.00017857747],"about_ca_topic_score_codex":0.000023228873,"about_ca_topic_score_gemma":0.0002084565,"teacher_disagreement_score":0.035579886,"about_ca_system_score_codex":0.00005153193,"about_ca_system_score_gemma":0.0001859049,"threshold_uncertainty_score":0.72526556},"labels":[],"label_agreement":null},{"id":"W4388590609","doi":"10.1093/neuonc/noad179.0135","title":"STEM-09. EXPLORING THE ROLE OF <i>TP53</i> IN REDOX REGULATION AND RESPONSE OF GLIOBLASTOMA STEM CELLS TO ROS-INDUCING AGENTS","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Gene knockdown; Auranofin; Thioredoxin; Cancer research; Stem cell; Neurosphere; Reactive oxygen species; Radioresistance; Glutathione; Biology; Chemistry; Molecular biology; Cell culture; Oxidative stress; Cell biology; Immunology; Biochemistry; Cellular differentiation; Gene; Enzyme; Genetics","score_opus":0.030610390358254237,"score_gpt":0.298693212859479,"score_spread":0.2680828225012247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388590609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990365,0.00013783731,0.0000045164834,0.00025162956,0.00010757182,0.00032888964,0.000024147816,0.0000075522275,0.00010137848],"genre_scores_gemma":[0.9994976,0.00019209653,0.00001812613,0.00007037747,0.000036455298,0.00008538258,0.0000038474636,0.00001639871,0.000079750185],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988043,0.00031600744,0.00023252402,0.00027512785,0.00014049381,0.00023158838],"domain_scores_gemma":[0.9993748,0.00014262904,0.0000871622,0.00027752132,0.000046383655,0.00007149929],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038877167,0.00009449691,0.00017310565,0.00012923918,0.000040389747,0.0000064656124,0.0001318986,0.000074739866,0.000002959418],"category_scores_gemma":[0.000043694617,0.00008066411,0.000039818595,0.0002905336,0.00005740208,0.000006290622,0.0002155861,0.00007942506,0.0000060417865],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021371336,0.00004583769,0.0024532673,0.000013223334,0.000018453828,0.0000208145,0.00050747395,0.00028805557,0.95896065,0.000005745906,0.00032607713,0.035223287],"study_design_scores_gemma":[0.0007323436,0.0017328121,0.008579853,0.000017488503,0.000007688856,0.00000906764,0.00043552578,0.00007853585,0.9711513,0.000018178649,0.017180549,0.00005663463],"about_ca_topic_score_codex":0.00011649176,"about_ca_topic_score_gemma":0.00027338392,"teacher_disagreement_score":0.03516665,"about_ca_system_score_codex":0.00005052179,"about_ca_system_score_gemma":0.00011874182,"threshold_uncertainty_score":0.3289387},"labels":[],"label_agreement":null},{"id":"W4388590642","doi":"10.1093/neuonc/noad179.0134","title":"STEM-08. OVERCOMING GLIOBLASTOMA STEM CELL RESISTANCE TO RADIATION THROUGH TARGETING THIOREDOXIN REDUCTASE 1","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Redox biology and oxidative stress","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Radioresistance; Cancer research; Stem cell; RAD51; Viability assay; Thioredoxin reductase; Reactive oxygen species; DNA damage; Thioredoxin; Biology; Auranofin; Chemistry; Molecular biology; Immunology; Oxidative stress; Cell; Cell culture; Cell biology; Biochemistry; DNA; Genetics","score_opus":0.013996015384087592,"score_gpt":0.2814658345402434,"score_spread":0.2674698191561558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388590642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908184,0.00064268266,0.0003525437,0.0017044594,0.0011022103,0.00043372458,0.00013606697,0.000092665614,0.00471729],"genre_scores_gemma":[0.994471,0.00050741306,0.0005688323,0.001675145,0.0007392715,0.00008819909,0.00018677044,0.000049451868,0.0017139225],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974665,0.0005238913,0.00046452665,0.00082406856,0.0001455179,0.0005754616],"domain_scores_gemma":[0.99885756,0.00019910512,0.00024950947,0.00045949066,0.00009583955,0.00013849273],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00043942078,0.00027198222,0.0003238967,0.000101369085,0.00024229863,0.000022758946,0.00035986074,0.0004202779,0.000014967184],"category_scores_gemma":[0.00013722722,0.00027184648,0.00011654966,0.00041224135,0.00012708429,0.000014427188,0.00027859348,0.00027110789,0.0001881909],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080404436,0.000048977425,0.00033089312,0.000023233815,0.000023806762,0.00008008827,0.00046427554,0.0002859612,0.9147878,0.0000861133,0.07867891,0.00438584],"study_design_scores_gemma":[0.0006209125,0.00071390567,0.000121886704,0.000007940296,0.000011850429,0.000008983735,0.00054936705,0.000020609405,0.6178338,0.00003715751,0.37988958,0.0001840309],"about_ca_topic_score_codex":0.000005988417,"about_ca_topic_score_gemma":0.00004474345,"teacher_disagreement_score":0.30121067,"about_ca_system_score_codex":0.00007357811,"about_ca_system_score_gemma":0.00016595397,"threshold_uncertainty_score":0.99997336},"labels":[],"label_agreement":null},{"id":"W4388590663","doi":"10.1093/neuonc/noad179.0357","title":"CTNI-75. EFFICACY AND SAFETY OF LAROTRECTINIB IN PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS: AN UPDATED ANALYSIS","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bayer (Canada); Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Trk receptor; Internal medicine; Glioma; Oncology; Clinical endpoint; Gastroenterology; Clinical trial; Surgery; Receptor; Neurotrophin; Cancer research","score_opus":0.009833608865202266,"score_gpt":0.25464255903679917,"score_spread":0.2448089501715969,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388590663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978362,0.000039151753,0.0000023798684,0.0004156084,0.00015586833,0.0011346278,0.00007481323,0.00011875869,0.00022259365],"genre_scores_gemma":[0.9983317,0.00004093175,0.00016943603,0.00015725859,0.000050052477,0.00005554704,0.001152154,0.0000357379,0.0000071779145],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99774593,0.0004016703,0.0005524306,0.00055589876,0.00030095654,0.00044312968],"domain_scores_gemma":[0.9987513,0.00021701361,0.00025698871,0.00038711366,0.000119784294,0.00026781193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018864915,0.00025013165,0.0009446307,0.0006239646,0.00007504467,0.000011185736,0.000090840316,0.00015598696,0.0000795467],"category_scores_gemma":[0.0000611343,0.00019073712,0.00009682153,0.0015902583,0.000093244045,0.00007441354,0.00008242941,0.0002100518,0.000013555032],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005254722,0.0034098853,0.9372909,0.000112266636,0.00039740722,0.000786603,0.00054757955,0.00026241477,0.027029278,0.000026200894,0.0005243709,0.024358394],"study_design_scores_gemma":[0.013770424,0.005020139,0.9748805,0.000098685414,0.00081776123,0.000017504268,0.0002450274,0.00033507156,0.0033088236,6.2844265e-7,0.0013589885,0.00014641698],"about_ca_topic_score_codex":0.00028958695,"about_ca_topic_score_gemma":0.00018114477,"teacher_disagreement_score":0.03758965,"about_ca_system_score_codex":0.00040705586,"about_ca_system_score_gemma":0.00013388078,"threshold_uncertainty_score":0.77780336},"labels":[],"label_agreement":null},{"id":"W4388590676","doi":"10.1093/neuonc/noad179.0476","title":"EPCO-13. CNMF-SNS, A FRAMEWORK FOR UNSUPERVISED INTEGRATION OF MULTIOMICS DATA, IDENTIFIES INVASION AND RECURRENCE ASSOCIATED PROGRAMS IN GBM","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Bioinformatics and Genomic Networks","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Metadata; Computational biology; Computer science; Data integration; Biology; Data mining; World Wide Web","score_opus":0.06679155015222803,"score_gpt":0.32222876892496793,"score_spread":0.2554372187727399,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388590676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925205,0.00025093625,0.005344884,0.00042686448,0.000553679,0.0007063266,0.00011759909,0.000021123493,0.000058100737],"genre_scores_gemma":[0.9911911,0.0014232226,0.0044268486,0.00026010766,0.00010318336,0.000081162085,0.0024722938,0.000020296267,0.000021769401],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9988377,0.00009485459,0.00041142598,0.0003300634,0.00007709089,0.0002488324],"domain_scores_gemma":[0.99909115,0.00019961133,0.00020933269,0.0003605432,0.00008916041,0.000050205635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057655,0.00013221939,0.00024329085,0.000083162646,0.00005409575,0.000025344363,0.00027811874,0.0003992559,0.0000018823616],"category_scores_gemma":[0.00083135307,0.00012847291,0.000041674815,0.00022822373,0.00010696244,0.000012848195,0.00030698057,0.0001915921,0.0000027933045],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041546632,0.0002906452,0.0060744216,0.0001451589,0.00006822206,0.000006549854,0.0016436226,0.00011398203,0.67589384,0.000681179,0.0056309556,0.30903596],"study_design_scores_gemma":[0.01922727,0.013071637,0.037662175,0.0012783172,0.0004100137,0.000088482164,0.009837998,0.45524362,0.22084042,0.048956882,0.19058785,0.002795316],"about_ca_topic_score_codex":0.000027882908,"about_ca_topic_score_gemma":0.00071784266,"teacher_disagreement_score":0.45512965,"about_ca_system_score_codex":0.000023780336,"about_ca_system_score_gemma":0.000110050656,"threshold_uncertainty_score":0.52389735},"labels":[],"label_agreement":null},{"id":"W4388590696","doi":"10.1093/neuonc/noad179.0862","title":"EXTH-08. IMMUNOTHERAPEUTIC TARGETING OF FIBROBLAST ACTIVATION PROTEIN (FAP) IN TREATMENT REFRACTORY GLIOBLASTOMA USING NOVEL CAR-T CELL THERAPY","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Fibroblast activation protein, alpha; Chimeric antigen receptor; Cancer research; U87; Medicine; Stromal cell; Glioma; Antigen; Immunotherapy; Immunology; Cancer; Internal medicine; Immune system","score_opus":0.05985623119210558,"score_gpt":0.3477529791566311,"score_spread":0.2878967479645255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388590696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961199,0.0001598675,0.000063545165,0.00056317425,0.00010449805,0.001844372,0.000008469899,0.00011034217,0.0010258164],"genre_scores_gemma":[0.99775547,0.0003457909,0.00051737926,0.0002345872,0.0002101186,0.00018021128,0.000023106002,0.00011491116,0.00061841676],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975609,0.00031398414,0.0005967502,0.0005062265,0.0004120387,0.00061008596],"domain_scores_gemma":[0.9984575,0.0005677078,0.00027253048,0.0004545919,0.00013954735,0.000108106484],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003692518,0.00029499715,0.00064103544,0.0006592913,0.000082487364,0.000013780935,0.00016431794,0.00029376688,0.0007357519],"category_scores_gemma":[0.00009282708,0.00026528945,0.00016554938,0.0009757852,0.00014521903,0.00011170366,0.00006889742,0.00047944146,0.000038367343],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004019271,0.0010049092,0.00060666486,0.0000865617,0.00006191549,0.00007867858,0.001628575,0.00026457105,0.9538509,0.0000057650004,0.000031115553,0.03836102],"study_design_scores_gemma":[0.007764572,0.0077484557,0.0014278883,0.00015455113,0.000014169429,0.00003453178,0.0005126943,0.0017130645,0.9421493,0.000018141835,0.038287595,0.00017502884],"about_ca_topic_score_codex":0.0003947012,"about_ca_topic_score_gemma":0.000040479055,"teacher_disagreement_score":0.03825648,"about_ca_system_score_codex":0.0011687129,"about_ca_system_score_gemma":0.0007115383,"threshold_uncertainty_score":0.9999799},"labels":[],"label_agreement":null},{"id":"W4388590720","doi":"10.1093/neuonc/noad179.0675","title":"PATH-45. OUTCOMES OF AN IRRADIATION SPARING APPROACH IN MEDULLOBLASTOMA BY SUBGROUP IN YOUNG CHILDREN: AN INSTITUTIONAL REVIEW","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Children's Hospital; BC Cancer Agency","funders":"","keywords":"Medulloblastoma; Medicine; Neurocognitive; Radiation therapy; Subgroup analysis; Salvage therapy; Pediatrics; Internal medicine; Surgery; Chemotherapy; Confidence interval; Cognition; Pathology","score_opus":0.022755631577075493,"score_gpt":0.30447300663911453,"score_spread":0.28171737506203903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388590720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963875,0.00087312073,0.0000028481024,0.0010579721,0.00015851262,0.0007622436,0.000021072376,0.000048286285,0.00068843964],"genre_scores_gemma":[0.9969002,0.0013915566,0.00019760376,0.0007314814,0.000041770014,0.0002015571,0.0005160425,0.000017329954,0.0000024384158],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99846333,0.00020966974,0.00047084488,0.00037061283,0.00022726787,0.00025828698],"domain_scores_gemma":[0.9993585,0.000105426676,0.00013248288,0.00025414742,0.000030692234,0.00011876226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003828071,0.00015727319,0.00058671803,0.0002969828,0.000033323737,0.0000050672497,0.00010164329,0.00012993759,0.000022701668],"category_scores_gemma":[0.00016478088,0.000137382,0.00006551975,0.00055376557,0.00006166956,0.00013826381,0.000042878564,0.00020675252,0.00001525537],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044934943,0.0018516501,0.9791242,0.00014354082,0.000025406447,0.0001747864,0.00018073284,0.00008694295,0.0069453316,0.00031758146,0.0003143307,0.010790587],"study_design_scores_gemma":[0.0028662472,0.0008267,0.99400413,0.0001333896,0.000057734993,0.0001303431,0.000035051915,0.000962996,0.0003994944,0.000021800062,0.00046749366,0.000094638715],"about_ca_topic_score_codex":0.0003928813,"about_ca_topic_score_gemma":0.0005426011,"teacher_disagreement_score":0.014879935,"about_ca_system_score_codex":0.00023082008,"about_ca_system_score_gemma":0.00013236287,"threshold_uncertainty_score":0.5602275},"labels":[],"label_agreement":null},{"id":"W4388590859","doi":"10.1093/neuonc/noad179.0796","title":"NCMP-12. PREVALENCE OF RADIONECROSIS IN RECURRENT GLIOBLASTOMA","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital de l'Enfant-Jésus","funders":"","keywords":"Medicine; Radiological weapon; Temozolomide; Radiation therapy; Surgery; Glioblastoma; Retrospective cohort study; Demographics; Chemotherapy","score_opus":0.028426229317967334,"score_gpt":0.3184327131447918,"score_spread":0.2900064838268245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388590859","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936441,0.00030603923,0.0000010141824,0.0039202687,0.0004971131,0.00047079418,0.000018740491,0.00007145666,0.0010704393],"genre_scores_gemma":[0.99802554,0.0012938028,0.00007689977,0.00031005513,0.000057108235,0.00015419257,0.000008164025,0.000018853085,0.000055358963],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987282,0.00011623535,0.0003509016,0.0003178647,0.00019588316,0.00029092553],"domain_scores_gemma":[0.999007,0.00043663813,0.00011141297,0.00028208442,0.000049692506,0.00011316028],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017744178,0.00013175653,0.00040761073,0.00033413604,0.000025384696,0.0000033269853,0.00009433286,0.000115855226,0.00015526125],"category_scores_gemma":[0.00026409488,0.00010171434,0.0001017862,0.0005200054,0.00008383157,0.00003337225,0.00007511834,0.00016559823,0.00014296766],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013871264,0.0033940177,0.37472504,0.0006457088,0.00008978877,0.0028575996,0.0012979094,0.00006794997,0.43391517,0.00029885452,0.02426534,0.15705551],"study_design_scores_gemma":[0.009762822,0.014565797,0.65704757,0.00035999704,0.0002700271,0.00029700852,0.00015437469,0.0007140588,0.19845493,0.00015335293,0.117985494,0.00023456215],"about_ca_topic_score_codex":0.00002021414,"about_ca_topic_score_gemma":0.00008381689,"teacher_disagreement_score":0.28232253,"about_ca_system_score_codex":0.00016852518,"about_ca_system_score_gemma":0.00012736303,"threshold_uncertainty_score":0.41477904},"labels":[],"label_agreement":null},{"id":"W4388591133","doi":"10.1093/neuonc/noad179.1147","title":"TMIC-82. SPATIAL AND SINGLE-CELL PROTEOMIC LANDSCAPING OF THE HYPOXIC MICROENVIRONMENT IN GLIOBLASTOMA","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Western Hospital; The Scarborough Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Mass cytometry; Biology; Immune system; Hypoxia (environmental); Tumor microenvironment; Pathology; Cancer research; Angiogenesis; Cell; Immunohistochemistry; Tumor hypoxia; Immunology; Medicine; Radiation therapy; Phenotype; Internal medicine; Chemistry","score_opus":0.009624555154845863,"score_gpt":0.2251201950069586,"score_spread":0.21549563985211273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388591133","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974305,0.0006039615,0.000022532704,0.00039912635,0.00081871514,0.0003704505,0.0000155197,0.000009414611,0.0003297493],"genre_scores_gemma":[0.9980444,0.0009231931,0.000059936476,0.00037812957,0.00041994732,0.000045043,0.0000060989314,0.00002277059,0.00010049881],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998956,0.00013896562,0.00023169261,0.00032275316,0.00008741238,0.0002631362],"domain_scores_gemma":[0.9995192,0.000030749376,0.00012289088,0.00026485103,0.000012782399,0.000049480666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014446116,0.00013103923,0.00021027477,0.00006802882,0.000043293952,0.0000063779516,0.0001675054,0.00015967997,0.000012385844],"category_scores_gemma":[0.000059439964,0.00011094995,0.00006556385,0.0001195223,0.0001320491,0.0000025636025,0.00026219903,0.00013627588,0.000008109468],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014730188,0.00008072237,0.002109691,0.000023901985,0.000007064776,0.000004130051,0.00012029117,0.00005599042,0.9890985,0.0000021404937,0.0013183356,0.0070319464],"study_design_scores_gemma":[0.0012923437,0.0005581357,0.008625379,0.0000091898655,0.000015444759,0.000030769286,0.000047295285,0.00005951572,0.8304092,0.000014313035,0.15883587,0.00010250648],"about_ca_topic_score_codex":0.00003875612,"about_ca_topic_score_gemma":0.00024416376,"teacher_disagreement_score":0.15868925,"about_ca_system_score_codex":0.000027837508,"about_ca_system_score_gemma":0.00009294291,"threshold_uncertainty_score":0.45244077},"labels":[],"label_agreement":null},{"id":"W4388794664","doi":"10.1093/neuonc/noad179.1202","title":"LTBK-06. IMPACT OF VORASIDENIB TREATMENT ON MUTANT <i>IDH1</i> OR <i>IDH2</i> DIFFUSE GLIOMA TUMOR GROWTH RATE: RESULTS FROM THE RANDOMIZED, DOUBLE-BLIND, PHASE 3 INDIGO STUDY","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre; Toronto General Hospital","funders":"","keywords":"Placebo; Medicine; Magnetic resonance imaging; Glioma; Isocitrate dehydrogenase; Nuclear medicine; IDH1; IDH2; Randomized controlled trial; Internal medicine; Urology; Radiology; Pathology; Nuclear magnetic resonance; Mutant","score_opus":0.05801742463777383,"score_gpt":0.36938723975326787,"score_spread":0.31136981511549405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388794664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851285,0.00013048248,0.0000010586386,0.004583248,0.00063244975,0.007946505,0.00087246357,0.00022006649,0.00048521266],"genre_scores_gemma":[0.995926,0.00036286595,0.000015837377,0.00095388887,0.000443228,0.0016825278,0.0004632988,0.000108225846,0.00004411601],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9944525,0.0014640235,0.0015093016,0.0011140801,0.0006506959,0.0008094294],"domain_scores_gemma":[0.98722196,0.010002156,0.0008168195,0.0012818231,0.00023796823,0.0004392507],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00097056956,0.0007712429,0.0024685026,0.00049294985,0.00025310274,0.0000637551,0.00038470092,0.00022214379,0.00012255178],"category_scores_gemma":[0.0014217203,0.0003803506,0.00087564945,0.0014106077,0.00032996398,0.00009813539,0.00016704174,0.00042059724,0.00033659633],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7917454,0.02803424,0.0043698293,0.000013860099,0.0024167397,0.020778185,0.003512981,0.000053311,0.13941874,0.000037042297,0.0076380153,0.0019816635],"study_design_scores_gemma":[0.8518507,0.03051522,0.0036104196,0.000068469395,0.0023335468,0.00027081955,0.0008187401,0.00010170743,0.10850366,0.00006911462,0.0015681288,0.00028947566],"about_ca_topic_score_codex":0.0030442753,"about_ca_topic_score_gemma":0.0006973184,"teacher_disagreement_score":0.060105298,"about_ca_system_score_codex":0.0006951905,"about_ca_system_score_gemma":0.0008707488,"threshold_uncertainty_score":0.9998648},"labels":[],"label_agreement":null},{"id":"W4389776001","doi":"10.1093/neuonc/noad215","title":"Stereotactic radiosurgery for nonfunctioning pituitary tumor: A multicenter study of new pituitary hormone deficiency","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"Institut Servier; Servier; Hospices Civils de Lyon","keywords":"Medicine; Interquartile range; Radiosurgery; Hazard ratio; Hypopituitarism; Confidence interval; Internal medicine; Pituitary tumors; Nuclear medicine; Urology; Radiation therapy","score_opus":0.03862930551718622,"score_gpt":0.3120743884343426,"score_spread":0.27344508291715636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389776001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99437296,0.0005849675,0.00010339899,0.0009378978,0.0009722149,0.0017489456,0.000020671901,0.00016032581,0.0010986328],"genre_scores_gemma":[0.9978626,0.00012147686,0.00024365564,0.0010847975,0.00019402774,0.00016590198,0.000074637916,0.000049405568,0.0002035183],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979774,0.000106275365,0.0005746768,0.0005258119,0.00028341688,0.0005324673],"domain_scores_gemma":[0.9983865,0.0006626661,0.00020062261,0.00040798122,0.00009643171,0.0002458245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023259246,0.00026540412,0.0007149499,0.00038526295,0.00015970528,0.000009212944,0.0001203144,0.000098355566,0.000056917215],"category_scores_gemma":[0.00028891017,0.00022655618,0.00020140149,0.00046664424,0.000056826895,0.00014043385,0.000088109875,0.00021525833,0.00007584324],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009956426,0.015733825,0.80341893,0.00028187488,0.0010545048,0.0048579606,0.007555509,0.00024035062,0.0337197,0.0000404463,0.07731552,0.045824923],"study_design_scores_gemma":[0.07283911,0.050096188,0.8187609,0.00009427289,0.0024244916,0.0007149911,0.009624347,0.002806325,0.00064750254,0.00045594873,0.040788833,0.00074712874],"about_ca_topic_score_codex":0.0002779769,"about_ca_topic_score_gemma":0.00008284613,"teacher_disagreement_score":0.062882684,"about_ca_system_score_codex":0.0001186507,"about_ca_system_score_gemma":0.00035985443,"threshold_uncertainty_score":0.92386925},"labels":[],"label_agreement":null},{"id":"W4389800287","doi":"10.1093/neuonc/noad230","title":"Postoperative cerebellar mutism syndrome is an acquired autism-like network disturbance","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Fetal and Pediatric Neurological Disorders","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Ontario Brain Institute; SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Autism; Lesion; Connectome; Neuroscience; Prefrontal cortex; Psychology; Autism spectrum disorder; Medicine; Functional connectivity; Psychiatry; Cognition","score_opus":0.027043237060381572,"score_gpt":0.2876712719687268,"score_spread":0.26062803490834524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389800287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95452446,0.00046914836,0.000017307873,0.03436081,0.0020312548,0.000740791,0.000045815515,0.0005368525,0.0072735674],"genre_scores_gemma":[0.95150495,0.000740138,0.00012124161,0.04540719,0.00034957365,0.00006907239,0.00011318505,0.0000531667,0.0016414654],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99743104,0.00032380965,0.00039835478,0.00077048235,0.0002989135,0.00077741186],"domain_scores_gemma":[0.9985629,0.00042676638,0.00011706847,0.0004616423,0.000050676514,0.0003809877],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019646215,0.00030837272,0.0006621441,0.000106022846,0.00023280524,0.000019351586,0.00025142962,0.00036596003,0.000706499],"category_scores_gemma":[0.00012936968,0.00025272148,0.00016197082,0.00090255187,0.00026503185,0.000114938375,0.00018952125,0.00044839107,0.0011165766],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033282926,0.0021610686,0.050316256,0.00023366229,0.00033415208,0.03996762,0.004257228,0.0008734154,0.0728745,0.003601113,0.74302506,0.07902763],"study_design_scores_gemma":[0.002908041,0.01187746,0.21571387,0.000013777358,0.00017767276,0.0016491027,0.00011375683,0.0018555009,0.00013453943,0.0021361082,0.7629803,0.00043990527],"about_ca_topic_score_codex":0.00003767166,"about_ca_topic_score_gemma":0.00001840263,"teacher_disagreement_score":0.16539761,"about_ca_system_score_codex":0.00006488712,"about_ca_system_score_gemma":0.00017047458,"threshold_uncertainty_score":0.9999925},"labels":[],"label_agreement":null},{"id":"W4390132029","doi":"10.1093/neuonc/noad253","title":"Management of sporadic intracanalicular vestibular schwannomas: A critical review and International Stereotactic Radiosurgery Society (ISRS) practice guidelines","year":2023,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Radiosurgery; Medicine; Schwannoma; Guideline; Meta-analysis; Acoustic neuroma; Facial nerve; Radiology; Surgery; Internal medicine; Radiation therapy; Pathology","score_opus":0.15592663211883456,"score_gpt":0.44663820355659334,"score_spread":0.2907115714377588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390132029","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000023388293,0.976349,0.000097740274,0.018343335,0.0010690046,0.0020889041,0.000042490217,0.000115018134,0.0018711505],"genre_scores_gemma":[0.0000064870287,0.98602086,0.009213423,0.0033296212,0.0004239971,0.00031683393,0.00020045978,0.0001172583,0.00037107206],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.994946,0.0005664911,0.0023120712,0.0009943058,0.00067597936,0.0005051315],"domain_scores_gemma":[0.99564433,0.0014744798,0.0010636038,0.00080576167,0.0006794026,0.00033240463],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0023755445,0.0006093322,0.0033501454,0.00036798982,0.00008507174,0.000042450447,0.0004145747,0.0003958396,0.00017698247],"category_scores_gemma":[0.003422439,0.0005247714,0.0006531657,0.0007502489,0.0002887852,0.00019239546,0.00055257644,0.0008473716,0.00008602056],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006085931,0.00039221914,0.0000062523523,0.22874168,0.0048518907,0.034128886,0.000046013953,6.6242006e-7,0.00001000062,0.002782879,0.093012854,0.6359658],"study_design_scores_gemma":[0.00047182527,0.00045379906,0.0000055020855,0.029657012,0.017496368,0.009413559,0.000097978394,0.00004341538,4.165504e-7,0.000042290678,0.9419989,0.00031892763],"about_ca_topic_score_codex":0.0000163248,"about_ca_topic_score_gemma":3.7939168e-7,"teacher_disagreement_score":0.848986,"about_ca_system_score_codex":0.00037099287,"about_ca_system_score_gemma":0.00055452617,"threshold_uncertainty_score":0.9997204},"labels":[],"label_agreement":null},{"id":"W4390237156","doi":"10.1093/neuonc/noad227","title":"Consensus framework for conducting phase I/II clinical trials for children, adolescents, and young adults with pediatric low-grade glioma: Guidelines established by the International Pediatric Low-Grade Glioma Coalition Clinical Trial Working Group","year":2023,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Brain Tumour Charity; Pediatric Brain Tumor Foundation","keywords":"Clinical trial; Medicine; Clinical endpoint; Pace; Quality of life (healthcare); Glioma; Dosing; Clinical study design; Intensive care medicine; Pediatrics; Internal medicine; Nursing","score_opus":0.20088572179948258,"score_gpt":0.4618926606091563,"score_spread":0.26100693880967374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390237156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97052276,0.0008725847,0.00047121124,0.012301855,0.007833694,0.0073822346,0.00039170348,0.00021824334,0.0000057009884],"genre_scores_gemma":[0.97644424,0.0013034029,0.0027906718,0.0014613788,0.015673656,0.0013031188,0.00090629526,0.00011167915,0.0000055682617],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99257463,0.0013110186,0.0034032494,0.0013197219,0.0006074674,0.0007839154],"domain_scores_gemma":[0.9787002,0.017990004,0.0018410264,0.00050238054,0.0005353022,0.00043107267],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0069745835,0.0005303448,0.0017659669,0.0004844418,0.000508967,0.000145067,0.0003544914,0.0007646171,0.000015412896],"category_scores_gemma":[0.029681,0.00036672177,0.00071757275,0.0009534395,0.00028403004,0.00010875645,0.00020457774,0.0008329547,0.0000061094966],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19542255,0.022188148,0.45582813,0.00045308511,0.001464038,0.001029266,0.00045815262,0.000019791823,0.0036430755,0.0005527159,0.26284805,0.056092996],"study_design_scores_gemma":[0.9059367,0.04473115,0.020240014,0.0006563974,0.00850078,0.0014684935,0.0011263047,0.0034522032,0.0015720481,0.0008194193,0.010265748,0.0012307189],"about_ca_topic_score_codex":0.00003840351,"about_ca_topic_score_gemma":0.00003189494,"teacher_disagreement_score":0.7105142,"about_ca_system_score_codex":0.00012628002,"about_ca_system_score_gemma":0.00040910792,"threshold_uncertainty_score":0.99987847},"labels":[],"label_agreement":null},{"id":"W4391048911","doi":"10.1093/neuonc/noad239","title":"Nuclear translocation matters: Role of FABP7 in driving glioblastoma stemness and invasion: Reply to Mu et al.","year":2024,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"Glioblastoma; Library science; Medicine; Oncology; Internal medicine; Cancer research; Computer science","score_opus":0.01550966452913645,"score_gpt":0.2800069366418131,"score_spread":0.26449727211267665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391048911","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.30680427,0.00038168638,0.0000013874395,0.6914869,0.0003459632,0.000666771,0.000014521009,0.000043751297,0.00025472752],"genre_scores_gemma":[0.170341,0.00024980176,0.00012062662,0.8287557,0.00023191166,0.00015282287,0.00003919524,0.00009184244,0.000017127222],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99799323,0.00022309335,0.00052664534,0.0006910086,0.00027127194,0.00029473315],"domain_scores_gemma":[0.99885875,0.00041965948,0.00014679384,0.00041178876,0.00006181568,0.000101217796],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019843395,0.00029622865,0.0008088799,0.0005839109,0.000025438427,0.000026455347,0.00011522324,0.00039719976,0.00007619189],"category_scores_gemma":[0.000054527773,0.0002647085,0.00011044771,0.00030229636,0.00006650914,0.00005561958,0.00009683138,0.0008926954,0.00007613683],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015046477,0.00027346483,0.0013221134,0.00035716244,0.000091640075,0.004367489,0.0014887692,0.000005601633,0.10575782,0.00002854521,0.8707434,0.0154135125],"study_design_scores_gemma":[0.001441415,0.0021777095,0.0013059982,0.000823644,0.00018207317,0.0005502512,0.00018849433,0.000046597546,0.006680563,0.00003685929,0.9863954,0.0001709533],"about_ca_topic_score_codex":0.00012313807,"about_ca_topic_score_gemma":0.00017146532,"teacher_disagreement_score":0.13726875,"about_ca_system_score_codex":0.00020052335,"about_ca_system_score_gemma":0.00013812419,"threshold_uncertainty_score":0.9999805},"labels":[],"label_agreement":null},{"id":"W4391050603","doi":"10.1093/neuonc/noae009","title":"Prognostic value of DNA methylation subclassification, aneuploidy, and <i>CDKN2A/B</i> homozygous deletion in predicting clinical outcome of IDH mutant astrocytomas","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Gray Family Foundation; National Institute of Neurological Disorders and Stroke; NYU Grossman School of Medicine; National Cancer Institute; National Institutes of Health; Friedberg Charitable Foundation; Saitama Medical University; Making Headway Foundation; Deutsches Krebsforschungszentrum","keywords":"CDKN2A; Aneuploidy; Cancer research; DNA methylation; Biology; Mutant; Methylation; Molecular biology; DNA; Genetics; Gene; Chromosome; Gene expression","score_opus":0.045960270906536475,"score_gpt":0.36291175620368443,"score_spread":0.31695148529714795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391050603","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996065,0.0006414904,0.0001521553,0.001758884,0.0003672863,0.00074437703,0.000017662938,0.000057461053,0.00019567719],"genre_scores_gemma":[0.9988612,0.00020480853,0.0005795518,0.000117597076,0.00009717646,0.00008250539,0.00003143132,0.00002350673,0.0000022120385],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99788547,0.00027912343,0.0010401686,0.0003928353,0.00021015044,0.0001922798],"domain_scores_gemma":[0.9976855,0.0016417964,0.00025794457,0.0002014077,0.00011433411,0.00009900817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006546588,0.0001469586,0.0005808859,0.00026997048,0.000025350784,0.000008283802,0.000054682743,0.0001964254,0.00001102349],"category_scores_gemma":[0.0009436949,0.00012420617,0.00010715442,0.00035211517,0.00014887858,0.00006675707,0.000043805296,0.00027239442,0.0000046045084],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015295373,0.0007409257,0.7534726,0.00023739423,0.00005858122,0.00039232994,0.00021040982,0.00002610089,0.21948202,0.0005191351,0.00003749611,0.02467002],"study_design_scores_gemma":[0.003375024,0.0045226878,0.92517316,0.00021277588,0.00059658394,0.0005396273,0.00014090764,0.0075839893,0.055683106,0.00018110708,0.0018758798,0.00011515602],"about_ca_topic_score_codex":0.00003867383,"about_ca_topic_score_gemma":0.000044404493,"teacher_disagreement_score":0.17170052,"about_ca_system_score_codex":0.000115398136,"about_ca_system_score_gemma":0.00017806827,"threshold_uncertainty_score":0.50649804},"labels":[],"label_agreement":null},{"id":"W4391212727","doi":"10.1093/neuonc/noae013","title":"Invasive growth of brain metastases is linked to CHI3L1 release from pSTAT3-positive astrocytes","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute; University of Toronto; Université de Montréal; McGill University Health Centre; University of British Columbia; McGill University","funders":"Canadian Institutes of Health Research; Terry Fox Foundation; Fondation du cancer du sein du Québec","keywords":"Cancer research; Astrocyte; Brain cancer; Neuroscience; Medicine; Chemistry; Biology; Internal medicine; Cancer; Central nervous system","score_opus":0.021984281394992415,"score_gpt":0.30962978465020535,"score_spread":0.28764550325521293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391212727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9571254,0.0016731393,0.000695481,0.034899775,0.0006142398,0.0011470186,0.0020872392,0.00014027506,0.0016174342],"genre_scores_gemma":[0.97385544,0.00018213285,0.007664675,0.017370166,0.00032547477,0.00010057739,0.00033388598,0.000060394505,0.0001072708],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99765193,0.0005654714,0.00046695973,0.0006616257,0.00028074367,0.00037324382],"domain_scores_gemma":[0.9948053,0.004193628,0.00011144227,0.000365167,0.00015644726,0.00036801677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028003432,0.0003009553,0.0007724233,0.00027240269,0.00007520014,0.000023200828,0.00013136824,0.00013567168,0.0006835176],"category_scores_gemma":[0.0012941058,0.00024385781,0.00027651296,0.00040903687,0.00013730719,0.00008125057,0.00012860858,0.0004847658,0.00027158653],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003164945,0.0018003847,0.0020511437,0.00035331975,0.0024591961,0.0118611,0.006474578,0.000015974521,0.7916322,0.0034723673,0.103489034,0.07322577],"study_design_scores_gemma":[0.0066508423,0.019420905,0.011641325,0.00051120174,0.002654276,0.0006096704,0.0013325758,0.00016472726,0.80230945,0.0014513094,0.15276323,0.0004904538],"about_ca_topic_score_codex":0.00056619174,"about_ca_topic_score_gemma":0.000117440286,"teacher_disagreement_score":0.07273532,"about_ca_system_score_codex":0.00019178329,"about_ca_system_score_gemma":0.00059792976,"threshold_uncertainty_score":0.9944233},"labels":[],"label_agreement":null},{"id":"W4391680089","doi":"10.1093/neuonc/noae015","title":"Unraveling the complexity of the senescence-associated secretory phenotype in adamantinomatous craniopharyngioma using multimodal machine learning analysis","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Cancer Research UK; National Institutes of Health; National Center for Advancing Translational Sciences; Brain Tumour Charity; National Institute for Health and Care Research; U.S. National Library of Medicine","keywords":"Senescence; Biology; Wnt signaling pathway; Phenotype; Cell biology; PI3K/AKT/mTOR pathway; Gene expression; Signal transduction; Cancer research; Cytokine; Gene; Immunology; Genetics","score_opus":0.04077302181136114,"score_gpt":0.3044155289531641,"score_spread":0.26364250714180293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391680089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99630314,0.0012982229,0.0001413168,0.0009008828,0.0003072604,0.00030166275,0.000021372662,0.000050266528,0.0006758551],"genre_scores_gemma":[0.9993863,0.00006053478,0.00012824447,0.00029833912,0.000040727195,0.0000053782314,0.00003717405,0.000019615345,0.000023656425],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99851215,0.00038238385,0.00034409744,0.00028655116,0.00020915955,0.00026567501],"domain_scores_gemma":[0.9992211,0.00033400216,0.00012506219,0.00021746993,0.00005069071,0.00005166148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000262721,0.00016330965,0.00048147253,0.00019117318,0.00015828942,0.000012118247,0.00013620895,0.000113515576,0.00008088608],"category_scores_gemma":[0.00017390832,0.00009571189,0.0002472019,0.0010304616,0.00022478451,0.00004046497,0.0000979227,0.000438129,0.0000055303576],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021038293,0.00046463162,0.9295196,0.0000688641,0.00088508305,0.00066470506,0.0014584024,0.0031693869,0.06066687,0.00015557537,0.000019286092,0.0027172023],"study_design_scores_gemma":[0.002044765,0.0002622839,0.4985907,0.00007081779,0.0014910102,0.00008676944,0.00026369758,0.4958668,0.0005681355,0.00020073491,0.0004405102,0.00011377757],"about_ca_topic_score_codex":0.0024943475,"about_ca_topic_score_gemma":0.0014043221,"teacher_disagreement_score":0.49269742,"about_ca_system_score_codex":0.00015307707,"about_ca_system_score_gemma":0.00023466074,"threshold_uncertainty_score":0.39030176},"labels":[],"label_agreement":null},{"id":"W4391727359","doi":"10.1093/neuonc/noae004","title":"The greatest challenge for pediatric low-grade glioma","year":2024,"lang":"en","type":"editorial","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"American Lebanese Syrian Associated Charities","keywords":"Glioma; Medicine; Psychology; Cancer research","score_opus":0.021680342177018194,"score_gpt":0.31999787418122827,"score_spread":0.2983175320042101,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391727359","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004917284,0.014309021,0.0000012136192,0.01620558,0.95972335,0.0021744275,0.00041848904,0.00022171167,0.0020288983],"genre_scores_gemma":[0.0059092287,0.011894419,0.00004325701,0.00023013198,0.978548,0.002335537,0.00051304966,0.00022492715,0.00030148248],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969866,0.00013571182,0.00059899857,0.0009341536,0.00060268346,0.00074185216],"domain_scores_gemma":[0.99010575,0.008336067,0.00027604727,0.00070734497,0.0002983678,0.000276409],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00033391433,0.0005654149,0.0010113295,0.00032615164,0.00025719765,0.00008273919,0.0003439217,0.001424171,0.000033505043],"category_scores_gemma":[0.0015697439,0.00036094614,0.00055737264,0.00033821663,0.0001282731,0.000030281155,0.00016983856,0.001182268,0.0003770683],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026812239,0.00083018705,0.00006275295,0.0005037045,0.0002622443,0.0030683663,0.00009254382,3.5072645e-7,0.0007529928,0.00018510282,0.9869342,0.0070394278],"study_design_scores_gemma":[0.003959194,0.0051173153,0.000026036203,0.000063465784,0.0021566881,0.000104036124,0.000026465714,0.00001790784,0.0005124463,0.0003234388,0.9874434,0.0002496087],"about_ca_topic_score_codex":0.000029758095,"about_ca_topic_score_gemma":0.00010618648,"teacher_disagreement_score":0.018824594,"about_ca_system_score_codex":0.000545685,"about_ca_system_score_gemma":0.0012059276,"threshold_uncertainty_score":0.99988425},"labels":[],"label_agreement":null},{"id":"W4392091868","doi":"10.1093/neuonc/noae011","title":"Cancer stem cell hypothesis 2.0 in glioblastoma: Where are we now and where are we going?","year":2024,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Institute of Neurological Disorders and Stroke; National Cancer Institute; National Institutes of Health; Canadian Institutes of Health Research; Case Comprehensive Cancer Center, Case Western Reserve University","keywords":"Cancer stem cell; Biology; Phenotype; Stem cell; Tumor initiation; Glioblastoma; Cancer; Computational biology; Neuroscience; Population; Cancer research; Carcinogenesis; Genetics; Gene; Medicine","score_opus":0.056584379339052374,"score_gpt":0.336925615272217,"score_spread":0.2803412359331646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392091868","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014494178,0.98370886,0.0000011196013,0.010484987,0.001911161,0.0015331301,0.00032641116,0.0001149377,0.0017744724],"genre_scores_gemma":[0.000054637003,0.99203134,0.00006668944,0.00061952055,0.0010298337,0.0005523777,0.0000047579815,0.00026345343,0.0053774],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.996017,0.00044606937,0.0010351114,0.0013774605,0.0003580919,0.0007663047],"domain_scores_gemma":[0.99751014,0.0005356591,0.00077622914,0.0006880824,0.00009072122,0.00039917193],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025304168,0.000916025,0.0042242203,0.00060454186,0.0000683291,0.000056627814,0.00029684862,0.0009697615,0.0004101405],"category_scores_gemma":[0.000019998692,0.0007223913,0.0006456914,0.0008138063,0.00019814611,0.000063444495,0.0003033381,0.0018143128,0.00033401145],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011295414,0.00017716957,0.00009229147,0.08563822,0.00017598552,0.003295092,0.00015775353,9.401692e-7,0.00009555844,0.0000029470204,0.14752385,0.76272726],"study_design_scores_gemma":[0.0011811157,0.00068249955,0.000004838221,0.03261988,0.0039860005,0.00068033405,0.00030431093,0.0000049934188,0.00006582385,0.000009532325,0.9599629,0.00049776933],"about_ca_topic_score_codex":0.000092747265,"about_ca_topic_score_gemma":0.014942809,"teacher_disagreement_score":0.812439,"about_ca_system_score_codex":0.0011540924,"about_ca_system_score_gemma":0.0015308779,"threshold_uncertainty_score":0.99952275},"labels":[],"label_agreement":null},{"id":"W4392383461","doi":"10.1093/neuonc/noad260","title":"Novel radiotherapeutic strategies in the management of brain metastases: Challenging the dogma","year":2024,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Varian Medical Systems","keywords":"Medicine; Neuroscience; Intensive care medicine; Medical physics; Psychology","score_opus":0.09528532878963727,"score_gpt":0.4073076194701921,"score_spread":0.31202229068055487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392383461","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000009857728,0.98739177,0.00018873763,0.0054927687,0.00045913382,0.0025975902,0.00007338751,0.000032421292,0.0037543233],"genre_scores_gemma":[0.00021455677,0.9964895,0.00070296135,0.0016424716,0.00017530887,0.000569173,0.000063455016,0.00007340603,0.00006916638],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971078,0.00084769574,0.0007867919,0.0005239101,0.0003408128,0.00039297636],"domain_scores_gemma":[0.99748695,0.0013209948,0.00029473586,0.00082359964,0.000022014343,0.000051717478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013810929,0.00048644576,0.0018189842,0.0002621531,0.000062909065,0.00004167094,0.00045597547,0.00019634377,0.00007007555],"category_scores_gemma":[0.000020212692,0.00021919691,0.00066633767,0.00061325374,0.00018612217,0.000033716246,0.00013124634,0.000856078,0.000039434617],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030236108,0.0005621917,2.1915692e-7,0.019099155,0.0023592508,0.0020738114,0.00061761227,0.000008257296,0.000012851281,0.03054838,0.001177514,0.94351053],"study_design_scores_gemma":[0.00097465684,0.00082478684,0.000003711881,0.0032473363,0.008423625,0.0015722344,0.0018847903,0.00001984668,9.86759e-7,0.00014587525,0.9827619,0.00014020976],"about_ca_topic_score_codex":0.000033636315,"about_ca_topic_score_gemma":0.000027460588,"teacher_disagreement_score":0.9815844,"about_ca_system_score_codex":0.0002302401,"about_ca_system_score_gemma":0.0004163003,"threshold_uncertainty_score":0.8938591},"labels":[],"label_agreement":null},{"id":"W4392383663","doi":"10.1093/neuonc/noad258","title":"Evolving concepts in margin strategies and adaptive radiotherapy for glioblastoma: A new future is on the horizon","year":2024,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; Royal Victoria Regional Health Centre; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Margin (machine learning); Horizon; Glioblastoma; Computer science; Data science; Biology; Machine learning; Cancer research; Physics; Astronomy","score_opus":0.046336094332469165,"score_gpt":0.3727056468891048,"score_spread":0.32636955255663563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392383663","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003751862,0.9883583,0.0000060710017,0.0065418435,0.0008669245,0.0031900965,0.000067841815,0.000044389035,0.00054930116],"genre_scores_gemma":[0.00038878203,0.99594295,0.0001785145,0.0010770455,0.0013426903,0.00090036483,0.000018525023,0.00009221644,0.000058926365],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981564,0.00023354674,0.00042714246,0.00066458236,0.00015982625,0.00035849947],"domain_scores_gemma":[0.99781674,0.0014921075,0.00019731557,0.00032080355,0.00004031889,0.00013273538],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016069664,0.0005126579,0.0017612021,0.00028050094,0.00006172523,0.00007699257,0.00013569114,0.0004917986,0.00010585333],"category_scores_gemma":[0.000056992823,0.00028556093,0.00038012222,0.00033249648,0.00010106021,0.000052978226,0.000045768804,0.0006830779,0.00002283161],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021337028,0.00020303915,0.0000027794374,0.0018394851,0.0004200284,0.0007065407,0.0006189869,3.0293532e-7,0.00004391127,0.0039120186,0.072968766,0.9190708],"study_design_scores_gemma":[0.0018877566,0.008963522,0.0000069712723,0.0034480514,0.0012558093,0.00029463408,0.0005842337,0.000031512005,0.000018164403,0.00019427498,0.9831265,0.00018852527],"about_ca_topic_score_codex":0.000025085861,"about_ca_topic_score_gemma":0.00010174041,"teacher_disagreement_score":0.91888225,"about_ca_system_score_codex":0.0005067152,"about_ca_system_score_gemma":0.0011989097,"threshold_uncertainty_score":0.99995965},"labels":[],"label_agreement":null},{"id":"W4392383680","doi":"10.1093/neuonc/noae002","title":"Pushing the boundaries of radiation technology for the management of central nervous system tumors","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"Varian Medical Systems","keywords":"Central nervous system; Neuroscience; Medicine; Biology","score_opus":0.014237464976619069,"score_gpt":0.28129883759956553,"score_spread":0.2670613726229465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392383680","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9357445,0.0076883817,0.0007621451,0.048765298,0.0024162072,0.0027334136,0.000038143367,0.00015739971,0.0016944834],"genre_scores_gemma":[0.9991307,0.00017384652,0.00015849058,0.00014194947,0.00008152365,0.00028102013,0.0000062208746,0.000015082918,0.000011134189],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999187,0.000042060987,0.00028272558,0.00016836521,0.00012118692,0.00019864814],"domain_scores_gemma":[0.9991022,0.00046792065,0.000109805886,0.00025365924,0.000041926793,0.00002449037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018232674,0.00009334934,0.00025804885,0.000106249216,0.00011990714,0.000022050266,0.00012203644,0.00007361039,0.000007489899],"category_scores_gemma":[0.000038115093,0.00004942243,0.000106960906,0.00025116495,0.00023863782,0.000022823451,0.00005333622,0.00010981952,0.0000030493252],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031166163,0.00041954586,0.005414161,0.0022199065,0.0013842237,0.0006791093,0.0016951989,0.00023914888,0.030420838,0.33289897,0.0059833904,0.6183339],"study_design_scores_gemma":[0.0035203565,0.003175944,0.02697494,0.00061263825,0.0027603651,0.00066164223,0.0072684875,0.0051687476,0.12897226,0.0009088681,0.8198281,0.00014765337],"about_ca_topic_score_codex":0.00003284974,"about_ca_topic_score_gemma":0.00001190312,"teacher_disagreement_score":0.8138447,"about_ca_system_score_codex":0.00015914197,"about_ca_system_score_gemma":0.00012917932,"threshold_uncertainty_score":0.20153882},"labels":[],"label_agreement":null},{"id":"W4392383953","doi":"10.1093/neuonc/noad225","title":"Stereotactic body radiation therapy for spinal metastases: A new standard of care","year":2024,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Radiosurgery; Radiation therapy; Standard of care; Radiology; Surgery","score_opus":0.06956092265825706,"score_gpt":0.42341474750623,"score_spread":0.3538538248479729,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392383953","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00001605212,0.99064714,0.00020685414,0.00066730886,0.0012068155,0.005641493,0.0006250279,0.00007621853,0.00091307],"genre_scores_gemma":[0.000042823824,0.99613446,0.0010354723,0.0007423942,0.0004822166,0.00048309707,0.0006829113,0.0001368705,0.00025975905],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970281,0.0004228726,0.0010457187,0.00068053574,0.00046282372,0.000359962],"domain_scores_gemma":[0.9977275,0.0004750501,0.0007064347,0.00064117694,0.0001696145,0.00028021447],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040515,0.00051452767,0.0031522743,0.00056068914,0.00003509416,0.000029744959,0.00023590488,0.00023819738,0.0002841472],"category_scores_gemma":[0.00051483145,0.00039184463,0.0010531275,0.0003713118,0.0000688689,0.00006167855,0.00008532317,0.00044704668,0.000059709968],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017029657,0.00016024314,0.0000016606964,0.057566434,0.0011626525,0.00032962163,0.00013145118,8.69752e-8,0.000010342455,0.00039364348,0.030351099,0.9081898],"study_design_scores_gemma":[0.003345733,0.012330275,0.0000025990207,0.0028444175,0.01792985,0.00009180859,0.00008911016,0.0000050835347,0.000009711176,0.00007809785,0.9630504,0.00022289838],"about_ca_topic_score_codex":0.000010807855,"about_ca_topic_score_gemma":0.0000042336583,"teacher_disagreement_score":0.9326993,"about_ca_system_score_codex":0.00045753538,"about_ca_system_score_gemma":0.0035153409,"threshold_uncertainty_score":0.9998534},"labels":[],"label_agreement":null},{"id":"W4392617890","doi":"10.1093/neuonc/noae041","title":"Executive summary of the American Radium Society appropriate use criteria for brain metastases in epidermal growth factor receptor mutated-mutated and ALK-fusion non-small cell lung cancer","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital","funders":"","keywords":"Medicine; Lung cancer; Oncology; Radiation therapy; Anaplastic lymphoma kinase; Internal medicine; Epidermal growth factor receptor; Precision medicine; Cancer; Pathology","score_opus":0.02122577001766642,"score_gpt":0.3476098907851175,"score_spread":0.3263841207674511,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392617890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885623,0.00076659635,0.00025515282,0.0069269883,0.00066256104,0.0017735037,0.00085989444,0.00005023814,0.00014275957],"genre_scores_gemma":[0.9923806,0.00081918295,0.0023926883,0.003182006,0.0001469632,0.00046317672,0.00016934355,0.000067028996,0.00037900297],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984922,0.00023581469,0.00036855915,0.00045702542,0.00011786866,0.00032854316],"domain_scores_gemma":[0.9984925,0.00094018294,0.00016645835,0.00016814312,0.00012367636,0.00010905373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001481372,0.00022893996,0.0005444827,0.00010427526,0.00008571269,0.00002561832,0.000085824155,0.000093574454,0.000031413427],"category_scores_gemma":[0.00012737156,0.00015638757,0.0001819605,0.0003781696,0.00024859855,0.00011536928,0.00008462761,0.00025400473,8.519564e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087969715,0.00042301556,0.013212413,0.0008151694,0.0004899952,0.00011550458,0.009589868,0.000034207216,0.9211351,0.000028634984,0.042826578,0.010449768],"study_design_scores_gemma":[0.021634478,0.0065591456,0.074592076,0.001269597,0.0042243977,0.00022101143,0.0050178804,0.027783053,0.71424353,0.00017028968,0.14320607,0.0010784952],"about_ca_topic_score_codex":0.0021098368,"about_ca_topic_score_gemma":0.00023811319,"teacher_disagreement_score":0.20689164,"about_ca_system_score_codex":0.0003613218,"about_ca_system_score_gemma":0.00072256796,"threshold_uncertainty_score":0.63773},"labels":[],"label_agreement":null},{"id":"W4392951258","doi":"10.1093/neuonc/noae053","title":"Marizomib for patients with newly diagnosed glioblastoma: A randomized phase 3 trial","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Ottawa; Université Laval; Centre Hospitalier de l’Université de Montréal; Queen's University; McMaster University; University of Toronto; Sunnybrook Health Science Centre","funders":"National Cancer Institute; Institut National de la Santé et de la Recherche Médicale; European Organisation for Research and Treatment of Cancer; Centre National de la Recherche Scientifique; University of Ottawa","keywords":"Glioblastoma; Randomized controlled trial; Medicine; Oncology; Internal medicine; Cancer research","score_opus":0.0115263114028471,"score_gpt":0.28380151986380736,"score_spread":0.27227520846096026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392951258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872371,0.0004173052,0.0036149735,0.0005808945,0.0017153032,0.0043493747,0.00018187809,0.00008746627,0.0018157109],"genre_scores_gemma":[0.99282366,0.0001139487,0.0016345177,0.0012326825,0.0013259886,0.002201005,0.00035544703,0.0000872749,0.0002254924],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99824876,0.00032163548,0.00035029394,0.00057242264,0.00013567467,0.0003712208],"domain_scores_gemma":[0.9987694,0.00060349493,0.00010874902,0.00027411172,0.000108543245,0.00013568824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003948762,0.0002465002,0.00050084636,0.00008546481,0.00008490194,0.00004986347,0.00018776249,0.00027821958,0.00006688869],"category_scores_gemma":[0.0007164477,0.00018858482,0.00025906632,0.00011439791,0.00016669779,0.000006501133,0.00008363945,0.00017315979,0.000026484347],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.79038185,0.00077514525,0.0000120701525,0.000054424265,0.00016263669,0.000064362444,0.000098105935,0.000004902677,0.16562961,0.00027714472,0.009644343,0.03289541],"study_design_scores_gemma":[0.554594,0.0143388845,0.0000011089061,0.000011486095,0.0001071177,0.000012392774,0.000008250611,0.00018312031,0.05381339,0.00012451918,0.37662366,0.00018210804],"about_ca_topic_score_codex":0.00000523187,"about_ca_topic_score_gemma":0.000019492685,"teacher_disagreement_score":0.36697933,"about_ca_system_score_codex":0.00003298236,"about_ca_system_score_gemma":0.00035547986,"threshold_uncertainty_score":0.7690266},"labels":[],"label_agreement":null},{"id":"W4396592399","doi":"10.1093/neuonc/noae082","title":"Meningioma: International Consortium on Meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patients","year":2024,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":134,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University of British Columbia; University Health Network","funders":"National Cancer Institute","keywords":"Meningioma; Consensus conference; Medicine; Medical physics; Library science; Computer science; Pathology; Internal medicine","score_opus":0.1883482153606337,"score_gpt":0.4648894672680111,"score_spread":0.27654125190737744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396592399","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007625867,0.9830362,0.0000013101046,0.002799797,0.0023400625,0.00496383,0.00024950283,0.00006828325,0.005778437],"genre_scores_gemma":[0.0001272901,0.9954604,0.00035726314,0.00041916553,0.00027698366,0.0008026787,0.0005990187,0.00007583562,0.0018813724],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959629,0.0004828186,0.0010987462,0.0014202467,0.00051686313,0.00051840744],"domain_scores_gemma":[0.99660397,0.0019004621,0.00050320197,0.0005081232,0.0001532691,0.00033099318],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010756927,0.0006121325,0.0022080515,0.0006851475,0.00020686058,0.00011248525,0.00020397049,0.00028725888,0.000041000392],"category_scores_gemma":[0.0009179106,0.00042647295,0.00042396388,0.00032583132,0.00048263505,0.00004168351,0.000170905,0.00046155145,0.000087598506],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040002662,0.00041866733,0.000027897358,0.020365179,0.00064136105,0.0016929122,0.00007509157,9.406112e-8,0.0000052716446,0.0013940401,0.038568273,0.9364112],"study_design_scores_gemma":[0.001912055,0.0076331026,0.000005635311,0.016503215,0.0029053404,0.00044399657,0.00002105744,0.0000169748,0.000004375204,0.00006459942,0.97021383,0.00027579273],"about_ca_topic_score_codex":0.0000033424417,"about_ca_topic_score_gemma":0.0000035568733,"teacher_disagreement_score":0.9361354,"about_ca_system_score_codex":0.0005875187,"about_ca_system_score_gemma":0.00047726269,"threshold_uncertainty_score":0.9998187},"labels":[],"label_agreement":null},{"id":"W4396903194","doi":"10.1093/neuonc/noae074","title":"Resistance, rebound, and recurrence regrowth patterns in pediatric low-grade glioma treated by MAPK inhibition: A modified Delphi approach to build international consensus-based definitions—International Pediatric Low-Grade Glioma Coalition","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Rigshospitalet; Novartis Pharmaceuticals Corporation; University College London; Great Ormond Street Hospital for Children; National Institute for Health and Care Research; Pediatric Brain Tumor Foundation","keywords":"Medicine; Glioma; Oncology; Natural history; Internal medicine; Targeted therapy; Clinical trial; Cancer research; Cancer","score_opus":0.03238611905169145,"score_gpt":0.29302353762105454,"score_spread":0.26063741856936307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396903194","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97958803,0.0009352104,0.00031241094,0.013477684,0.0010190314,0.0011834784,0.00107449,0.00021248093,0.0021971602],"genre_scores_gemma":[0.9939822,0.0008002572,0.00088609126,0.0009805746,0.0006754326,0.0008456955,0.0017405592,0.00006618805,0.00002299717],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99641234,0.00030356983,0.0009033667,0.0011754114,0.0006733992,0.0005319084],"domain_scores_gemma":[0.99791867,0.0009007155,0.00022852774,0.00034496578,0.00024497925,0.0003621673],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032356763,0.00046154158,0.00057229144,0.0018355038,0.00013359456,0.00015832152,0.00020315728,0.00034630133,0.00005966731],"category_scores_gemma":[0.00030889653,0.0004554506,0.00017703397,0.0014921131,0.00012404587,0.00014970715,0.00010111481,0.0005145777,0.00004434239],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00802578,0.030535506,0.4826515,0.0036319701,0.00085567153,0.038038407,0.0024291284,0.0005666794,0.14316168,0.024976103,0.26161793,0.0035096451],"study_design_scores_gemma":[0.17919068,0.015927382,0.45090938,0.005226535,0.0077210735,0.018888168,0.0023823169,0.047793344,0.15466307,0.012809753,0.09516566,0.009322629],"about_ca_topic_score_codex":0.000100679994,"about_ca_topic_score_gemma":0.00013882277,"teacher_disagreement_score":0.1711649,"about_ca_system_score_codex":0.00075622654,"about_ca_system_score_gemma":0.00035838675,"threshold_uncertainty_score":0.9997897},"labels":[],"label_agreement":null},{"id":"W4399760403","doi":"10.1093/neuonc/noae064.406","title":"LGG-13. UNRAVELING THE SPATIAL TUMOR MICROENVIRONMENT OF PEDIATRIC LOW-GRADE GLIOMAS USING IMAGING MASS CYTOMETRY","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Mass cytometry; Tumor microenvironment; Cancer research; Flow cytometry; Medicine; Pathology; Chemistry; Tumor cells; Immunology; Phenotype","score_opus":0.018915989341028092,"score_gpt":0.29306601255437925,"score_spread":0.27415002321335113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399760403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98869294,0.005005297,0.00075595645,0.0034538393,0.001231449,0.0005328789,0.000021301285,0.00006400424,0.00024231902],"genre_scores_gemma":[0.9972137,0.0003349491,0.00064800883,0.0008508972,0.0008443058,0.000036501686,0.000010087127,0.000056332385,0.0000051754528],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981891,0.00014389155,0.0004718247,0.0004615421,0.0003221774,0.0004115002],"domain_scores_gemma":[0.9987596,0.0005664699,0.00015190103,0.0003555795,0.00003259404,0.00013383974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023946776,0.00024511752,0.0004429633,0.00043350298,0.000101964135,0.000030089328,0.00014135966,0.000077892226,0.0001327688],"category_scores_gemma":[0.00009411334,0.0001730874,0.00021315033,0.0005491935,0.00013440459,0.00004931537,0.00012149327,0.00033938815,0.00005743994],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006705364,0.0004894708,0.08174055,0.00017232439,0.000108803535,0.0041853054,0.00025021302,0.00016311729,0.90476435,0.000031300595,0.00052207266,0.0075054336],"study_design_scores_gemma":[0.008207666,0.002188877,0.07830455,0.00033826663,0.0044575934,0.0043347497,0.00089273154,0.03962814,0.8144523,0.0002288329,0.046246596,0.0007197043],"about_ca_topic_score_codex":0.00013562317,"about_ca_topic_score_gemma":0.0000090256335,"teacher_disagreement_score":0.090312056,"about_ca_system_score_codex":0.00039092443,"about_ca_system_score_gemma":0.00022591192,"threshold_uncertainty_score":0.70583},"labels":[],"label_agreement":null},{"id":"W4399760496","doi":"10.1093/neuonc/noae064.680","title":"OTHR-09. HEALTHCARE PROVIDERS’ PERSPECTIVES ON MALAYSIA-SINGAPORE VIRTUAL PEDIATRIC NEURO-ONCOLOGY TUMOR BOARD MEETING","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Pediatric oncology; Health care; Medicine; Internal medicine; Political science; Cancer","score_opus":0.03170460768437626,"score_gpt":0.33953480912128253,"score_spread":0.30783020143690626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399760496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.799387,0.0045786165,0.000065307824,0.17477086,0.0063127046,0.0020486799,0.00007134283,0.0012556979,0.011509791],"genre_scores_gemma":[0.9552434,0.0009257372,0.00073150423,0.03497408,0.0073425923,0.00023866101,0.00004019243,0.00028888218,0.00021492246],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9923159,0.001758752,0.0014005267,0.002146247,0.0010101345,0.0013684576],"domain_scores_gemma":[0.9929392,0.0044403644,0.00051617844,0.0009666716,0.00032142483,0.0008161702],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0013746696,0.00078477035,0.0016822909,0.0008956475,0.0003504161,0.00011789396,0.0004903455,0.00060486037,0.00023774468],"category_scores_gemma":[0.003175019,0.00076767284,0.000536247,0.0011256054,0.00046049946,0.00027471146,0.000333333,0.0028803605,0.0005547709],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011988867,0.0074726786,0.047251403,0.0071934997,0.0012018889,0.046770282,0.19970664,0.00065418694,0.12983155,0.024180308,0.37587145,0.14787725],"study_design_scores_gemma":[0.007944787,0.044219222,0.006055691,0.00064604054,0.0011740788,0.0050184918,0.047626264,0.001674948,0.003296124,0.0006547156,0.88000953,0.0016800783],"about_ca_topic_score_codex":0.00054635055,"about_ca_topic_score_gemma":0.0002887343,"teacher_disagreement_score":0.5041381,"about_ca_system_score_codex":0.0017744459,"about_ca_system_score_gemma":0.0043877177,"threshold_uncertainty_score":0.99947745},"labels":[],"label_agreement":null},{"id":"W4399760686","doi":"10.1093/neuonc/noae064.129","title":"DIPG-76. PEDIATRIC PATIENTS WITH DIFFUSE MIDLINE GLIOMA DEMONSTRATE AN UNEXPECTED PREVALENCE OF GERMLINE VARIANTS IN HOMOLOGOUS RECOMBINATION GENES","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal; McGill University Health Centre","funders":"","keywords":"Germline; Homologous recombination; Recombination; Gene; Genetics; Homologous chromosome; Biology","score_opus":0.013922105843938893,"score_gpt":0.2785072447483076,"score_spread":0.26458513890436874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399760686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99682575,0.0011152175,0.0000128261245,0.0006006794,0.00042953185,0.00076858804,0.00005347634,0.00009106029,0.00010284944],"genre_scores_gemma":[0.99869615,0.00047329068,0.00038441387,0.00007996347,0.000102534694,0.00011361081,0.000102230515,0.000037188995,0.000010608924],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982115,0.00022925546,0.0004946214,0.00052701705,0.00024069697,0.00029693116],"domain_scores_gemma":[0.99885935,0.0003501347,0.00016387907,0.0003041862,0.00018157352,0.00014088314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013809092,0.00022464163,0.0004569382,0.00056028215,0.00003497919,0.000013868412,0.00010988967,0.0001785587,0.00007479081],"category_scores_gemma":[0.00013267114,0.00017130875,0.00006043304,0.0008513684,0.00008093855,0.00013366311,0.000042936193,0.00021252478,0.00001275358],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053787424,0.009308596,0.8930402,0.0004317385,0.00007659708,0.0034194845,0.00030064187,0.000025745821,0.063874535,0.00009020466,0.00010378344,0.028790612],"study_design_scores_gemma":[0.008060827,0.0075092544,0.9710599,0.00008588154,0.00049022463,0.00014783679,0.000020336161,0.00090618804,0.011351756,0.00008778982,0.00012406404,0.00015590059],"about_ca_topic_score_codex":0.000041372597,"about_ca_topic_score_gemma":0.00007264712,"teacher_disagreement_score":0.07801975,"about_ca_system_score_codex":0.00016482887,"about_ca_system_score_gemma":0.00024179499,"threshold_uncertainty_score":0.6985768},"labels":[],"label_agreement":null},{"id":"W4399783279","doi":"10.1093/neuonc/noae064.742","title":"LMIC-25. EXPANDING THE PEDIATRIC NEURO-ONCOLOGY TELECONFERENCE EXPERIENCES, A LUXURY, OR A NECESSITY?","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Advances in Oncology and Radiotherapy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"","keywords":"Teleconference; Pediatric oncology; Medicine; Oncology; Internal medicine; Computer science; Multimedia; Cancer","score_opus":0.030467687468952266,"score_gpt":0.38827274808532236,"score_spread":0.3578050606163701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399783279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8694109,0.013298619,0.006783776,0.04880377,0.023942346,0.002550328,0.000025012972,0.0011824934,0.034002777],"genre_scores_gemma":[0.95051324,0.011385842,0.0025981888,0.026511012,0.0063707195,0.00089963095,0.000015518699,0.00013069423,0.0015751629],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.996047,0.00073279405,0.00078653434,0.0011130797,0.00035740517,0.00096318964],"domain_scores_gemma":[0.9927232,0.005890344,0.00026781994,0.0006805238,0.00011193961,0.00032616509],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000675989,0.00048399618,0.0010094693,0.00038934333,0.00049597863,0.00006990881,0.0007017833,0.00068981934,0.0020423909],"category_scores_gemma":[0.0010507769,0.000297872,0.00023948716,0.0010433173,0.0009445941,0.00029842154,0.00022100317,0.001827592,0.00026064846],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054142047,0.0018567208,0.021288026,0.00057343626,0.0003965314,0.029755704,0.042778835,0.00006514106,0.17081796,0.004178848,0.15645845,0.56641614],"study_design_scores_gemma":[0.002319317,0.0068203877,0.00048132637,0.00003890482,0.00028138063,0.0117271645,0.0034984455,0.0009766459,0.0017429625,0.00041800475,0.97132957,0.0003659016],"about_ca_topic_score_codex":0.000016438467,"about_ca_topic_score_gemma":0.000057498735,"teacher_disagreement_score":0.81487113,"about_ca_system_score_codex":0.0006425002,"about_ca_system_score_gemma":0.0028407616,"threshold_uncertainty_score":0.99994737},"labels":[],"label_agreement":null},{"id":"W4399783330","doi":"10.1093/neuonc/noae064.737","title":"LMIC-20. REAL-WORLD EXPERIENCE IN DEALING WITH CHILDREN WITH SUSPECTED CENTRAL NERVOUS SYSTEM (CNS) TUMORS AT THE CHILDREN’S HOSPITAL LAHORE (UCHS), PAKISTAN","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Advances in Oncology and Radiotherapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Central nervous system; Medicine; Pediatrics; Internal medicine","score_opus":0.008549059024879003,"score_gpt":0.3198964566380918,"score_spread":0.3113473976132128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399783330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888157,0.0016568138,0.00012497463,0.002991221,0.00083726406,0.0014838602,0.000033723478,0.00038422563,0.0036722154],"genre_scores_gemma":[0.9965718,0.0004991979,0.0005704322,0.0009008183,0.00081445783,0.00016317892,0.00007022412,0.00010150601,0.0003084065],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972862,0.00023594896,0.0004952775,0.0008588403,0.00031767882,0.0008060516],"domain_scores_gemma":[0.99852836,0.00045571892,0.00018821901,0.00055572705,0.00005774441,0.00021422516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018637074,0.00040806417,0.00070863473,0.00020351513,0.00026871025,0.000032616244,0.0003141466,0.00020687537,0.00012236997],"category_scores_gemma":[0.000028445074,0.0002424967,0.00009373923,0.000692078,0.00084542506,0.00012230151,0.00008128383,0.0009968851,0.000017837887],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028332674,0.00037714353,0.95735455,0.00008536118,0.0003357194,0.0075120004,0.008050003,0.0008484602,0.0051129414,0.0045280033,0.0011253704,0.011837196],"study_design_scores_gemma":[0.0070501566,0.009244455,0.92404544,0.0007323605,0.00034786988,0.019036584,0.00281977,0.0007743124,0.0027278538,0.00003779133,0.032346025,0.0008373505],"about_ca_topic_score_codex":0.00043357842,"about_ca_topic_score_gemma":0.005878274,"teacher_disagreement_score":0.03330906,"about_ca_system_score_codex":0.0016242256,"about_ca_system_score_gemma":0.0005416621,"threshold_uncertainty_score":0.9888728},"labels":[],"label_agreement":null},{"id":"W4399783502","doi":"10.1093/neuonc/noae064.743","title":"LMIC-26. DEVELOPMENT OF THE ST. JUDE GLOBAL VIRTUAL PEDIATRIC NEURO-ONCOLOGY FELLOWSHIP (VPNOF): INCREASING PEDIATRIC NEURO-ONCOLOGY CAPACITY IN LOW- AND MIDDLE- INCOME COUNTRIES (LMIC)","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Pediatric oncology; Medicine; Low and middle income countries; Oncology; Internal medicine; Developing country; Cancer; Biology","score_opus":0.03429775718912896,"score_gpt":0.2978717037872885,"score_spread":0.2635739465981595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399783502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9748047,0.0024053764,0.00007908004,0.01216705,0.006599506,0.001957577,0.00017017701,0.0004064986,0.001410031],"genre_scores_gemma":[0.98467445,0.0013555695,0.0011820096,0.009983074,0.0024131339,0.00015928404,0.000027428545,0.00018325407,0.000021773358],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98837274,0.0038088001,0.0029690342,0.0019382577,0.0012677503,0.0016433923],"domain_scores_gemma":[0.98751056,0.009267978,0.0010587138,0.0010709405,0.00035808657,0.0007337121],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.003582203,0.0010321228,0.002503644,0.0009452447,0.0004101712,0.00009646468,0.001011406,0.0012617465,0.00012313723],"category_scores_gemma":[0.004745269,0.0009284512,0.00039665512,0.002451804,0.001141376,0.00036049678,0.0012967845,0.0027047428,0.000112831476],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006212691,0.0028199682,0.9211082,0.0062903264,0.00041028156,0.0036997062,0.02230122,0.00019384609,0.01727377,0.0025468508,0.0051789465,0.011964197],"study_design_scores_gemma":[0.021158539,0.011524415,0.6845049,0.0009946305,0.0026767293,0.009453552,0.0028905382,0.0011570979,0.004387781,0.0013975267,0.25718904,0.002665246],"about_ca_topic_score_codex":0.00076028093,"about_ca_topic_score_gemma":0.0037736648,"teacher_disagreement_score":0.25201008,"about_ca_system_score_codex":0.002821741,"about_ca_system_score_gemma":0.008855331,"threshold_uncertainty_score":0.99959606},"labels":[],"label_agreement":null},{"id":"W4399783760","doi":"10.1093/neuonc/noae064.457","title":"MDB-08. MYC AND TGFΒ PROMOTE GROUP 3 MEDULLOBLASTOMA TUMOR RESISTANCE THROUGH DEREGULATION OF POLYCOMB TARGETS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"","keywords":"Medulloblastoma; Deregulation; Polycomb-group proteins; Cancer research; Transforming growth factor; Cell biology; Medicine; Biology; Gene; Repressor; Genetics; Market economy; Transcription factor; Economics","score_opus":0.01444555046815065,"score_gpt":0.28894290607598183,"score_spread":0.2744973556078312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399783760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9791694,0.006066239,0.000054397788,0.009103653,0.00058923906,0.00071515155,0.000021300393,0.00011383436,0.004166733],"genre_scores_gemma":[0.9969525,0.00018961783,0.0017868467,0.000728006,0.00014157267,0.00008175668,0.00002189269,0.000034814304,0.00006299744],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99867654,0.00009503025,0.00034122114,0.0004268317,0.00020101565,0.000259386],"domain_scores_gemma":[0.9991812,0.0003063759,0.000104080835,0.0002460952,0.00005584047,0.00010640961],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011737109,0.00018470228,0.00043857386,0.00011194976,0.000057701025,0.000015483198,0.000057186993,0.000111866466,0.000112937465],"category_scores_gemma":[0.00010662977,0.00014985641,0.00008940859,0.00023204049,0.00014562703,0.00009948518,0.00005464193,0.00016338678,0.000035343586],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007487904,0.0010544962,0.007465498,0.0007343762,0.0002802216,0.0035888688,0.0018319772,0.0000039628694,0.9350466,0.009967601,0.016444903,0.022832703],"study_design_scores_gemma":[0.005750066,0.005223205,0.062641636,0.00054051424,0.00070357585,0.0011663263,0.00017633585,0.0006308298,0.36747813,0.0047115306,0.55063534,0.00034250715],"about_ca_topic_score_codex":0.000025317415,"about_ca_topic_score_gemma":0.00009125613,"teacher_disagreement_score":0.5675685,"about_ca_system_score_codex":0.00012531766,"about_ca_system_score_gemma":0.000115825234,"threshold_uncertainty_score":0.6110967},"labels":[],"label_agreement":null},{"id":"W4399784033","doi":"10.1093/neuonc/noae064.540","title":"MDB-92. EFFECT OF REDUCED-DOSE CRANIOSPINAL IRRADIATION AND REDUCED-DOSE ADJUVANT CHEMOTHERAPY ON CHILDREN AND ADOLESCENTS WITH WNT MEDULLOBLASTOMA WITHOUT RESIDUAL OR METASTATIC DISEASE: RESULTS FROM THE SJMB12 CLINICAL TRIAL","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Centre Hospitalier Universitaire Sainte-Justine; Alberta Children's Hospital","funders":"","keywords":"Medulloblastoma; Medicine; Adjuvant; Chemotherapy; Oncology; Adjuvant chemotherapy; Clinical trial; Disease; Internal medicine; Cancer research; Cancer","score_opus":0.0278449845270876,"score_gpt":0.3569852122955307,"score_spread":0.3291402277684431,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399784033","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860642,0.0013270674,0.0000011197228,0.008744049,0.00070245133,0.0028202971,0.00025666817,0.00006649677,0.000017658478],"genre_scores_gemma":[0.99718785,0.000726008,0.00010570644,0.0008532419,0.00079019513,0.00013597339,0.00012926456,0.00006240567,0.000009370927],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9965644,0.0009785471,0.0007781948,0.0009007893,0.0004555176,0.0003225845],"domain_scores_gemma":[0.99664414,0.0020906397,0.0003611739,0.00047988683,0.000055567936,0.0003686194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007086311,0.00038938216,0.0009778943,0.00012895679,0.000103124876,0.000048643986,0.00012261036,0.0001308255,0.000017936083],"category_scores_gemma":[0.0011568184,0.00020403536,0.00014167964,0.00022491951,0.00036246656,0.000071418486,0.000056390734,0.00046934368,0.0000077919385],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7618201,0.0035975806,0.04541375,0.0001827915,0.0013804929,0.002132008,0.0010049565,0.000016782658,0.01157393,0.000035074503,0.0059900642,0.16685247],"study_design_scores_gemma":[0.13261448,0.04063352,0.8195493,0.00083741616,0.0017986819,0.00024858597,0.0000266111,0.00018856101,0.0033556693,0.000034265777,0.0005197343,0.00019313766],"about_ca_topic_score_codex":0.00008070981,"about_ca_topic_score_gemma":0.00004372197,"teacher_disagreement_score":0.7741356,"about_ca_system_score_codex":0.00009913747,"about_ca_system_score_gemma":0.0004582364,"threshold_uncertainty_score":0.832032},"labels":[],"label_agreement":null},{"id":"W4399784911","doi":"10.1093/neuonc/noae064.594","title":"QOL-06. RECURRENCE PATTERNS AND SURVEILLANCE IMAGING IN PEDIATRIC BRAIN TUMOR SURVIVORS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Brain tumor; Neuroimaging; Medicine; Pathology; Psychiatry","score_opus":0.014480491537026536,"score_gpt":0.29580501014737265,"score_spread":0.28132451861034613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399784911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9814252,0.0033620684,0.000010852799,0.013323397,0.0007577707,0.00031594277,0.000025300622,0.00008132765,0.00069813826],"genre_scores_gemma":[0.99694234,0.001094824,0.00003682127,0.0015544236,0.00024356722,0.00007013798,0.000019686535,0.000025972182,0.00001220301],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998606,0.00017916426,0.00026707698,0.0004866882,0.00013582363,0.00032521365],"domain_scores_gemma":[0.99844456,0.0011605617,0.000048098744,0.0001846879,0.000030180567,0.00013193265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030296264,0.00016995968,0.0003395004,0.0002810166,0.000031553394,0.00003079859,0.000064586864,0.000054398784,0.000052439693],"category_scores_gemma":[0.00026660872,0.00014562994,0.000053269985,0.0003516789,0.000046821377,0.00006118774,0.0000715797,0.00027051874,0.000055798737],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023458813,0.00018856008,0.95841265,0.00012568377,0.000007661426,0.0051152897,0.00020892298,0.0000016599935,0.0027236417,0.000063927706,0.0035725175,0.029556032],"study_design_scores_gemma":[0.0015612948,0.0004408033,0.95176333,0.00006123899,0.000040838877,0.00069609017,0.000068291614,0.000669415,0.00049660983,0.00007376502,0.043968532,0.00015977253],"about_ca_topic_score_codex":0.00023873191,"about_ca_topic_score_gemma":0.00093417213,"teacher_disagreement_score":0.040396016,"about_ca_system_score_codex":0.00012927326,"about_ca_system_score_gemma":0.00014963809,"threshold_uncertainty_score":0.59386164},"labels":[],"label_agreement":null},{"id":"W4399784988","doi":"10.1093/neuonc/noae064.480","title":"MDB-31. THE CLINICAL SIGNIFICANCE OF SUB-TOTAL SURGICAL RESECTION IN CHILDHOOD MEDULLOBLASTOMA: A MULTI-COHORT ANALYSIS OF 1100 PATIENTS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Cohort; Surgical resection; Resection; Medicine; Clinical significance; Pediatrics; Surgery; Internal medicine; Pathology","score_opus":0.024510492161660288,"score_gpt":0.3455398177984323,"score_spread":0.321029325636772,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399784988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970585,0.00032433163,0.000003927161,0.0008753244,0.0005162784,0.00076222763,0.000036054913,0.000024873341,0.0003985012],"genre_scores_gemma":[0.99931675,0.00026887018,0.000047369333,0.00009023501,0.00008501638,0.0001272017,0.000040682204,0.000016854361,0.0000070404644],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99770135,0.000418584,0.0008694623,0.00046152607,0.0003178702,0.00023119748],"domain_scores_gemma":[0.997589,0.0016619373,0.00018915828,0.00033549313,0.00012301774,0.00010137762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005853826,0.00015567926,0.0008498388,0.00043907895,0.000028243958,0.000006087972,0.000098150354,0.00020237533,0.00005154335],"category_scores_gemma":[0.0004222948,0.00010234604,0.00044394092,0.0013554741,0.00021839603,0.00003526789,0.0000661972,0.00038969846,0.000011184332],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005253087,0.0061283573,0.9745894,0.00003623586,0.0013033409,0.0005278794,0.00030437746,0.00014122544,0.005029989,0.00007198455,0.00044831878,0.010893595],"study_design_scores_gemma":[0.003800224,0.0028690402,0.98202014,0.000042883385,0.0017684925,0.0000336608,0.00006123766,0.0019793143,0.005792593,0.0000067981114,0.0015553002,0.00007032225],"about_ca_topic_score_codex":0.00015778038,"about_ca_topic_score_gemma":0.0004158634,"teacher_disagreement_score":0.010823273,"about_ca_system_score_codex":0.00015393375,"about_ca_system_score_gemma":0.00024802182,"threshold_uncertainty_score":0.41735506},"labels":[],"label_agreement":null},{"id":"W4399785207","doi":"10.1093/neuonc/noae064.599","title":"QOL-11. LATE MORBIDITY AND MORTALITY IN SURVIVORS OF CHILDHOOD EPENDYMOMA: A REPORT FROM THE CHILDHOOD CANCER SURVIVOR STUDY (CCSS)","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Childhood cancer; Ependymoma; Medicine; Late childhood; Pediatrics; Cancer; Psychology; Developmental psychology; Internal medicine; Surgery","score_opus":0.04004659183636042,"score_gpt":0.3575714754479581,"score_spread":0.3175248836115977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399785207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9826221,0.002758392,0.000012950474,0.008207311,0.0027300406,0.0022887269,0.00037806024,0.00021422561,0.00078820105],"genre_scores_gemma":[0.99635303,0.000586949,0.00004843046,0.0016658052,0.00090094254,0.00021844762,0.00007478094,0.000102886464,0.000048722504],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9937275,0.001537429,0.0016941915,0.0014458052,0.0009403704,0.0006547054],"domain_scores_gemma":[0.9952208,0.0024664213,0.00048071943,0.0013763795,0.0001481855,0.00030752155],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0030091698,0.0005447934,0.0016427954,0.00023981961,0.00013252131,0.000055834196,0.00043820287,0.00034709883,0.00027892765],"category_scores_gemma":[0.0011794154,0.0004269865,0.00027440718,0.00081979204,0.00034289566,0.00019826162,0.00044180243,0.0013044875,0.000015848971],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017230448,0.0026521934,0.968316,0.0001620997,0.0005834513,0.004613369,0.017368762,0.000022818567,0.0012672682,0.000053998076,0.00093617616,0.0038515634],"study_design_scores_gemma":[0.0030574386,0.0008924374,0.98393136,0.0002477634,0.0005971385,0.0005526769,0.002274316,0.00009269986,0.0006788385,0.00032055815,0.007007909,0.00034683128],"about_ca_topic_score_codex":0.1445501,"about_ca_topic_score_gemma":0.31919736,"teacher_disagreement_score":0.17464724,"about_ca_system_score_codex":0.00026208535,"about_ca_system_score_gemma":0.0013850363,"threshold_uncertainty_score":0.9998182},"labels":[],"label_agreement":null},{"id":"W4399785372","doi":"10.1093/neuonc/noae064.516","title":"MDB-67. MEDULLOBLASTOMA MOLECULAR SUBGROUPING AND OUTCOMES DATA OF A SINGLE CENTER FROM A LOW-MIDDLE-INCOME COUNTRY","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Center (category theory); Medulloblastoma; Middle income country; Low and middle income countries; Single Center; Low income; Geography; Political science; Demographic economics; Economic growth; Medicine; Economics; Developing country; Internal medicine","score_opus":0.031074163528177233,"score_gpt":0.30538341735320534,"score_spread":0.27430925382502813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399785372","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99197865,0.0025403413,0.000036843267,0.0033037735,0.0006911428,0.00035904956,0.00035094505,0.00008481399,0.0006544714],"genre_scores_gemma":[0.997265,0.00013438947,0.0004958623,0.0017092482,0.00009695539,0.000028079035,0.00021998676,0.00004338668,0.0000071262157],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99838483,0.0000930927,0.00038662483,0.0005988956,0.0002477035,0.00028884652],"domain_scores_gemma":[0.99839294,0.0006384585,0.00008887072,0.00066961476,0.000043450083,0.0001666947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011728386,0.00022253183,0.0006032012,0.00016406183,0.000034163833,0.000033751618,0.00018056735,0.00015583617,0.00009427076],"category_scores_gemma":[0.00018219562,0.00017700541,0.000085946565,0.00017756778,0.00013569262,0.00010223649,0.00033667558,0.0001999906,0.000029105717],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027030078,0.0020758742,0.29651302,0.00050274696,0.0008533816,0.010227838,0.0005259787,0.0000026922364,0.6734046,0.0005546925,0.0014059291,0.013663001],"study_design_scores_gemma":[0.037048098,0.012309751,0.33618283,0.0055715134,0.0056923176,0.00426458,0.00137365,0.0077296146,0.28028372,0.0013106058,0.30652857,0.001704723],"about_ca_topic_score_codex":0.00012805662,"about_ca_topic_score_gemma":0.000107697844,"teacher_disagreement_score":0.39312083,"about_ca_system_score_codex":0.00012856093,"about_ca_system_score_gemma":0.00013049756,"threshold_uncertainty_score":0.7218071},"labels":[],"label_agreement":null},{"id":"W4399785410","doi":"10.1093/neuonc/noae064.524","title":"MDB-75. MOLECULAR PATHOLOGY, TREATMENT AND PROGNOSIS OF INFANT SONIC HEDGEHOG MEDULLOBLASTOMA: A GLOBAL MULTI-COHORT STUDY","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Sonic hedgehog; Cohort; Medicine; Pathology; Pediatrics; Oncology; Biology; Genetics","score_opus":0.017728028246070605,"score_gpt":0.31267845243534237,"score_spread":0.29495042418927175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399785410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99057174,0.0065254183,0.0002698192,0.0002968378,0.0004985628,0.0012817293,0.00007934726,0.00007121164,0.00040533504],"genre_scores_gemma":[0.99777263,0.0006197099,0.0007206952,0.00021710129,0.000115284565,0.00045829228,0.00002579105,0.000043931537,0.000026531461],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974873,0.00041591257,0.00048743683,0.0009992039,0.00015274384,0.00045742074],"domain_scores_gemma":[0.9991048,0.00008742058,0.000117799784,0.00043479286,0.00011305404,0.00014214987],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003572096,0.00038208332,0.0006286537,0.0000916188,0.00008753623,0.000024132325,0.0002052844,0.00030382542,0.000007471643],"category_scores_gemma":[0.00022720057,0.00032857573,0.00017951481,0.00022611741,0.00035834766,0.0000051179018,0.0003583736,0.00015668273,0.000013678815],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013773321,0.0011731827,0.15654883,0.000058707974,0.00063642964,0.0009461338,0.00055913924,0.00003137104,0.82980984,0.00005560359,0.00021920906,0.009823801],"study_design_scores_gemma":[0.0076346933,0.039226465,0.11476862,0.00008843619,0.0015638785,0.001623689,0.002106824,0.0005911011,0.76151687,0.00008794882,0.06956916,0.0012223318],"about_ca_topic_score_codex":0.00008208519,"about_ca_topic_score_gemma":0.0002815735,"teacher_disagreement_score":0.06934996,"about_ca_system_score_codex":0.0001361926,"about_ca_system_score_gemma":0.00033395723,"threshold_uncertainty_score":0.9999166},"labels":[],"label_agreement":null},{"id":"W4399785510","doi":"10.1093/neuonc/noae064.520","title":"MDB-71. IDENTIFICATION AND DESCRIPTION OF A NOVEL TYPE OF MEDULLOBLASTOMA","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Identification (biology); Type (biology); Computer science; Medicine; Biology; Pathology","score_opus":0.04954582884353479,"score_gpt":0.3300709417756912,"score_spread":0.2805251129321564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399785510","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99613774,0.00088717707,0.000091811766,0.0015601749,0.00048230917,0.0002159074,0.000009358188,0.00002410415,0.0005914416],"genre_scores_gemma":[0.9993192,0.0001932594,0.00027597518,0.00010074548,0.000042269883,0.000017799379,0.000011666771,0.000010364148,0.000028735854],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993983,0.000025928573,0.00023027994,0.00016822142,0.00009847656,0.00007878145],"domain_scores_gemma":[0.9995285,0.0001408629,0.000070581256,0.00012519104,0.000089830224,0.00004499299],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009586383,0.00006499685,0.00020762248,0.00013826785,0.000012049525,0.0000054641987,0.000025914054,0.00007416042,0.00003522813],"category_scores_gemma":[0.000108925306,0.00005362578,0.000039604853,0.00018513664,0.000071459566,0.000039926414,0.000021129103,0.00006426514,0.000011058385],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009541133,0.00047002092,0.005089123,0.00013311124,0.00005300211,0.00004608756,0.00026380256,0.0000024261856,0.9763749,0.0010531625,0.0012832409,0.015135662],"study_design_scores_gemma":[0.0039128745,0.005395235,0.1737949,0.00025873506,0.00081395026,0.00065679586,0.00026292022,0.0028456422,0.75606483,0.0002893579,0.055574603,0.00013017935],"about_ca_topic_score_codex":0.000024218707,"about_ca_topic_score_gemma":0.000016680422,"teacher_disagreement_score":0.22031015,"about_ca_system_score_codex":0.000050111303,"about_ca_system_score_gemma":0.00008860945,"threshold_uncertainty_score":0.21867958},"labels":[],"label_agreement":null},{"id":"W4399785658","doi":"10.1093/neuonc/noae064.402","title":"LGG-09. REBOUND GROWTH AFTER MAPKI WITHDRAWAL INVOLVES RAPID MAPK REACTIVATION AND CYTOKINE-MEDIATED MICROGLIA RECRUITMENT IN PEDIATRIC LOW-GRADE GLIOMA MODEL","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Brain Tumour Research; Universitätsklinikum Heidelberg; Hospital for Sick Children; Murdoch Children's Research Institute; McGill University Health Centre; Deutsches Krebsforschungszentrum; Broad Institute; Brigham and Women's Hospital; McGill University; Deutschen Konsortium für Translationale Krebsforschung; Children’s Hospital of Wisconsin Research Institute","keywords":"Microglia; MAPK/ERK pathway; Glioma; Cytokine; Medicine; Cancer research; Immunology; Biology; Signal transduction; Cell biology; Inflammation","score_opus":0.028960789535693962,"score_gpt":0.2913320260027335,"score_spread":0.2623712364670395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399785658","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98781645,0.0032712289,0.000015545385,0.006192407,0.0005407773,0.0015022506,0.00005583296,0.00015260818,0.00045290717],"genre_scores_gemma":[0.9943586,0.0024275493,0.00046352734,0.0011863464,0.0003700849,0.0009578354,0.00013528393,0.00007499276,0.000025764088],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976257,0.00016323288,0.00056824595,0.00082596444,0.00030364626,0.00051320373],"domain_scores_gemma":[0.9987098,0.0005178025,0.000121228884,0.00031130677,0.00008702303,0.0002528645],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024648843,0.00038530707,0.00059568265,0.0008748977,0.00006216708,0.00006908012,0.00009076282,0.00033972657,0.00004406136],"category_scores_gemma":[0.00014804554,0.00032505443,0.000117319,0.0007620151,0.000117646574,0.00020948125,0.00010654855,0.00047436974,0.00006391593],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014811043,0.0026022762,0.10007372,0.0006778076,0.00020614231,0.011819839,0.0019909781,0.000020395037,0.86417127,0.00042900132,0.0066501773,0.0098773],"study_design_scores_gemma":[0.03942556,0.013164422,0.3804249,0.0010317591,0.0029514423,0.003722327,0.0006451476,0.021920342,0.45282587,0.0046044607,0.076928444,0.0023553504],"about_ca_topic_score_codex":0.00007742259,"about_ca_topic_score_gemma":0.000111887566,"teacher_disagreement_score":0.4113454,"about_ca_system_score_codex":0.0005768716,"about_ca_system_score_gemma":0.00038244447,"threshold_uncertainty_score":0.9999201},"labels":[],"label_agreement":null},{"id":"W4399785672","doi":"10.1093/neuonc/noae064.405","title":"LGG-12. INTEGRATED CLINICAL AND MOLECULAR CHARACTERIZATION OF 200 DISSEMINATED PEDIATRIC LOW-GRADE GLIOMAS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Queen Elizabeth II Health Sciences Centre; University of Alberta; Izaak Walton Killam Health Centre; Western University; McMaster Children's Hospital; BC Children's Hospital; Dalhousie University; Hamilton Health Sciences; Stollery Children's Hospital; Hospital for Sick Children","funders":"","keywords":"Characterization (materials science); Medicine; Materials science; Nanotechnology","score_opus":0.018311074113078595,"score_gpt":0.329719354058822,"score_spread":0.31140827994574344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399785672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949711,0.0009264467,0.000043186923,0.0025868502,0.00065338373,0.00041789757,0.000033106997,0.00009273308,0.00027530242],"genre_scores_gemma":[0.9977208,0.0013567256,0.000077160454,0.00042233625,0.00015554353,0.00004132718,0.00017283975,0.000032491076,0.000020792877],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9985879,0.0001723798,0.0005016514,0.00039524303,0.00014290612,0.00019990643],"domain_scores_gemma":[0.99909383,0.00035339993,0.000104287756,0.00019810864,0.00008358094,0.00016681643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017200378,0.00017085987,0.00047211017,0.00028221318,0.000024128085,0.000016488286,0.000055378612,0.00023572458,0.000084343985],"category_scores_gemma":[0.0002472704,0.0001334322,0.00011597195,0.00047688108,0.00011262345,0.00004899133,0.00004597256,0.00026180086,0.000026861853],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014747753,0.001031217,0.10649127,0.00015588272,0.0001031721,0.003052341,0.00011292678,3.3714213e-7,0.86827487,0.0002365197,0.000960613,0.019433377],"study_design_scores_gemma":[0.008124344,0.007890725,0.45514262,0.00032126543,0.0024192326,0.0010488135,0.000097111246,0.0030225082,0.4311174,0.00013191199,0.09022119,0.0004629046],"about_ca_topic_score_codex":0.0000098657065,"about_ca_topic_score_gemma":0.0000034268953,"teacher_disagreement_score":0.4371575,"about_ca_system_score_codex":0.0000510418,"about_ca_system_score_gemma":0.0001795633,"threshold_uncertainty_score":0.5441207},"labels":[],"label_agreement":null},{"id":"W4399785764","doi":"10.1093/neuonc/noae064.404","title":"LGG-11. UNDERSTANDING THE TRANSCRIPTIONAL HETEROGENEITY OF PEDIATRIC LOW-GRADE GLIOMAS AND ITS IMPLICATION FOR TUMOR PATHOPHYSIOLOGY","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"ATP Synthase and ATPases Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Pathophysiology; Glioma; Neuroscience; Medicine; Bioinformatics; Biology; Internal medicine; Cancer research","score_opus":0.04970402409740556,"score_gpt":0.3416704531739886,"score_spread":0.29196642907658304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399785764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99168164,0.0030723463,0.0032161947,0.0012084579,0.00022568893,0.00040450858,0.00012964218,0.0000138190135,0.000047693167],"genre_scores_gemma":[0.99812865,0.000827051,0.00006304021,0.00026857146,0.0005013046,0.00011115276,0.000067893154,0.00002125385,0.00001107475],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989386,0.00014182164,0.0002103734,0.00037328422,0.000092071896,0.00024383675],"domain_scores_gemma":[0.99942446,0.00023914801,0.00005593467,0.00016388524,0.000052994597,0.00006357635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020096728,0.00011916732,0.00015806894,0.000071688526,0.00011071497,0.000014658453,0.00015191654,0.0001368148,0.000009674438],"category_scores_gemma":[0.00008985509,0.00009135834,0.000115615374,0.00013093092,0.00011685324,0.0000058530463,0.00007096285,0.0001108921,0.0000028427369],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011673365,0.000056424953,0.00022502239,0.00011214857,0.000028719442,0.000010275661,0.000041956868,0.000015661763,0.99551725,0.0027327396,0.0004842105,0.00065883255],"study_design_scores_gemma":[0.0010404644,0.00201321,0.0014680297,0.000009890462,0.0001197169,0.00009130215,0.00018603295,0.0022582707,0.9479779,0.0026057824,0.041996434,0.00023297861],"about_ca_topic_score_codex":0.000002782979,"about_ca_topic_score_gemma":0.000012978016,"teacher_disagreement_score":0.047539387,"about_ca_system_score_codex":0.000034658075,"about_ca_system_score_gemma":0.00018440846,"threshold_uncertainty_score":0.37254852},"labels":[],"label_agreement":null},{"id":"W4399785848","doi":"10.1093/neuonc/noae064.279","title":"GCT-24. ISOLATED PITUITARY STALK THICKENING","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stollery Children's Hospital; Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"Thickening; Pituitary stalk; Stalk; Anatomy; Medicine; Internal medicine; Pituitary gland; Biology; Chemistry; Polymer science; Hormone","score_opus":0.02164818797106968,"score_gpt":0.3038675953850749,"score_spread":0.28221940741400525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399785848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9075152,0.007560876,0.00027785733,0.011251718,0.0030245432,0.00062560884,0.000034738285,0.00068881596,0.0690206],"genre_scores_gemma":[0.99422944,0.00049775495,0.0003231439,0.00373887,0.00026876334,0.00003439508,0.000101444304,0.000045944405,0.0007602209],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986626,0.00008036956,0.00025992526,0.00043595527,0.00017323934,0.00038792286],"domain_scores_gemma":[0.99922335,0.0002561855,0.000033263208,0.00025188577,0.00003788151,0.00019745663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009940526,0.00020823987,0.00037622903,0.0001679215,0.00009382251,0.00002267573,0.00008120586,0.00020658385,0.0005270863],"category_scores_gemma":[0.00006371762,0.00016247177,0.00013805398,0.0002594247,0.000074607306,0.000111843605,0.00006698335,0.00045641218,0.0006342646],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003297209,0.003165861,0.06603508,0.00065877114,0.0018147145,0.07814957,0.0063266633,0.000049728096,0.20226733,0.003024065,0.24013609,0.3950749],"study_design_scores_gemma":[0.0045548887,0.006217444,0.00410793,0.00012043236,0.00055768644,0.0020963687,0.0003882197,0.0030967263,0.0011471981,0.0018093099,0.9755891,0.0003146936],"about_ca_topic_score_codex":0.000079217294,"about_ca_topic_score_gemma":0.000037629314,"teacher_disagreement_score":0.735453,"about_ca_system_score_codex":0.00012681706,"about_ca_system_score_gemma":0.00034033062,"threshold_uncertainty_score":0.81524},"labels":[],"label_agreement":null},{"id":"W4399785874","doi":"10.1093/neuonc/noae064.278","title":"GCT-23. LONG-TERM FOLLOW-UP AND SURVIVALS OF PATIENTS WITH LOCALIZED CENTRAL NERVOUS SYSTEM NON-GERMINOMATOUS GERM CELL TUMORS (NGGCT) ENROLLED ON ACNS1123: A CHILDREN’S ONCOLOGY GROUP (COG) STUDY","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"","keywords":"Cog; Medicine; Central nervous system; Oncology; Germ cell tumors; Internal medicine; Term (time); Germ cell; Pediatrics; Biology; Chemotherapy; Genetics","score_opus":0.010139871985898325,"score_gpt":0.2608826823328361,"score_spread":0.2507428103469378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399785874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917554,0.00044596128,0.000012452316,0.00018455638,0.0013669439,0.0052337693,0.00009193906,0.00018531708,0.00072365795],"genre_scores_gemma":[0.99853903,0.00004702978,0.000046559617,0.0002983566,0.00017581134,0.0005838022,0.00015470442,0.0001259588,0.000028765555],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955889,0.00078194035,0.0010267664,0.0011517473,0.0005915613,0.00085909665],"domain_scores_gemma":[0.99720454,0.001024047,0.00045565603,0.000654797,0.00015827084,0.00050270394],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00037608127,0.0006596542,0.0020442833,0.00047413344,0.00013734025,0.000048883532,0.0002263069,0.00033903331,0.000053852433],"category_scores_gemma":[0.000070743925,0.00047482285,0.00027601162,0.00042946005,0.00020979288,0.00008422227,0.00017775515,0.0004800611,0.000053518754],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042516654,0.010634579,0.955991,0.000576237,0.0010144844,0.010377417,0.0014717217,0.000016409891,0.0027695822,0.00004529704,0.00044474774,0.012406812],"study_design_scores_gemma":[0.037653647,0.036142606,0.91951877,0.000315642,0.0021121867,0.000542716,0.00031154064,0.00013914437,0.0024638313,0.00000234231,0.0004211981,0.00037636232],"about_ca_topic_score_codex":0.00022807479,"about_ca_topic_score_gemma":0.00029993008,"teacher_disagreement_score":0.036472265,"about_ca_system_score_codex":0.0006420315,"about_ca_system_score_gemma":0.00049951643,"threshold_uncertainty_score":0.99977034},"labels":[],"label_agreement":null},{"id":"W4399785926","doi":"10.1093/neuonc/noae064.426","title":"LGG-34. THE LANDSCAPE OF GLIOMAS IN CHILDREN, ADOLESCENTS AND YOUNG ADULTS REVEALS INSIGHTS ON GLIOMAGENESIS: A CANADIAN ADOLESCENTS AND YOUNG ADULTS NEURO-ONCOLOGY NETWORK (CANON) STUDY","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre; Hospital for Sick Children; Stollery Children's Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Young adult; Glioma; Pediatrics; Oncology; Internal medicine; Cancer research","score_opus":0.010137694195403434,"score_gpt":0.2572078656732736,"score_spread":0.24707017147787014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399785926","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872571,0.0056392285,3.304936e-7,0.0014453555,0.0014992097,0.0034546487,0.000051386363,0.00007680095,0.0005758908],"genre_scores_gemma":[0.9962734,0.0011289052,0.00001583631,0.001673816,0.0004691198,0.00030186307,0.000034693676,0.00009511828,0.000007272728],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99566674,0.0008316955,0.0008970371,0.0012286213,0.00044578317,0.0009301195],"domain_scores_gemma":[0.9979744,0.00035586406,0.00024793227,0.00065205124,0.00014484746,0.0006249208],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042085734,0.0005911308,0.0011314541,0.0009138022,0.00023110972,0.00006591851,0.0002832472,0.00039934556,0.000020693227],"category_scores_gemma":[0.00021445144,0.00043539345,0.00013988474,0.0011779891,0.00022479061,0.00011384554,0.00021526609,0.0007226959,0.000023820425],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016063651,0.0019802828,0.96284676,0.00022119816,0.00023935977,0.005872343,0.0027588778,0.0000141865185,0.0025177489,0.00007901081,0.002415536,0.019448318],"study_design_scores_gemma":[0.011338459,0.008031601,0.97324324,0.0014147926,0.0005366971,0.0016014923,0.00074320904,0.00028624927,0.00034158787,0.000034213153,0.0021072302,0.00032123228],"about_ca_topic_score_codex":0.013834501,"about_ca_topic_score_gemma":0.18775313,"teacher_disagreement_score":0.17391862,"about_ca_system_score_codex":0.00044057626,"about_ca_system_score_gemma":0.00057727087,"threshold_uncertainty_score":0.9998098},"labels":[],"label_agreement":null},{"id":"W4399786010","doi":"10.1093/neuonc/noae064.431","title":"LGG-40. TYPE II RAF INHIBITOR TOVORAFENIB IN RELAPSED/REFRACTORY PEDIATRIC LOW-GRADE GLIOMA (PLGG): REVERSIBLE DECREASES IN GROWTH VELOCITY IN THE PHASE 2 FIREFLY-1 TRIAL","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Children's Hospital; McGill University Health Centre; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; Université Laval","funders":"University of California, San Francisco; Medical School, University of Michigan; Université de Montréal; Rigshospitalet; Humboldt-Universität zu Berlin; Centre Hospitalier Universitaire de Québec; Great Ormond Street Institute of Child Health; Great Ormond Street Hospital for Children; Tel Aviv University; Seoul National University; College of Medicine, Seoul National University; Gentofte Hospital; Yonsei University; Newcastle University; Cancer Research Institute; Texas Children's Hospital; McGill University; McGill University Health Centre; Deutsches Krebsforschungszentrum; Freie Universität Berlin; Université Laval","keywords":"Refractory (planetary science); Glioma; Internal medicine; Medicine; Firefly protocol; Gastroenterology; Oncology; Cancer research; Biology","score_opus":0.02920981703444509,"score_gpt":0.3246425832411657,"score_spread":0.2954327662067206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399786010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98718214,0.0029153575,3.6550728e-7,0.0055096233,0.0018357368,0.0016051956,0.000020277412,0.00008193701,0.00084934785],"genre_scores_gemma":[0.99657494,0.0009115566,0.000056854988,0.0010619302,0.0009864565,0.00029045876,0.000055087316,0.000045628556,0.000017081242],"study_design_codex":"case_report","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9969598,0.00063498446,0.0007438843,0.0007000632,0.00038784603,0.0005734112],"domain_scores_gemma":[0.9972872,0.0019436256,0.00012941546,0.0003966914,0.000059935886,0.00018311148],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007144066,0.00034103883,0.0007209664,0.0010253743,0.00008641694,0.00003349342,0.00023481315,0.00038452455,0.0001717509],"category_scores_gemma":[0.0012893981,0.0002551767,0.00018265755,0.0023142216,0.00009668014,0.00013761428,0.00012765467,0.00089369254,0.00008955628],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14504144,0.10423663,0.12071274,0.001495946,0.00035471347,0.19762604,0.011997095,0.000063659165,0.17974406,0.0014305484,0.18996051,0.047336612],"study_design_scores_gemma":[0.60533154,0.060665626,0.059057765,0.0008982076,0.001573881,0.0017017486,0.0013522854,0.0010673337,0.047673266,0.0014428874,0.21757974,0.0016557255],"about_ca_topic_score_codex":0.00043333095,"about_ca_topic_score_gemma":0.00057785335,"teacher_disagreement_score":0.46029007,"about_ca_system_score_codex":0.00074777193,"about_ca_system_score_gemma":0.00090612366,"threshold_uncertainty_score":0.99999005},"labels":[],"label_agreement":null},{"id":"W4399786324","doi":"10.1093/neuonc/noae064.286","title":"HGG-02. LONG-TERM EFFICACY AND SAFETY OF LAROTRECTINIB IN PEDIATRIC PATIENTS WITH TRK FUSION PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS: AN UPDATED ANALYSIS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bayer (Canada); BC Children's Hospital; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Trk receptor; Medicine; Central nervous system; Term (time); Oncology; Neuroscience; Internal medicine; Psychology; Neurotrophin","score_opus":0.008770957790696442,"score_gpt":0.2604579846732377,"score_spread":0.2516870268825413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399786324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978122,0.00044146486,0.000007546494,0.00018107325,0.0002154514,0.0009414972,0.000043222277,0.00009137716,0.0002661587],"genre_scores_gemma":[0.9990379,0.00011518437,0.0000635482,0.000096764736,0.00010798486,0.00003837085,0.0005039679,0.00003254509,0.0000036955562],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99805903,0.00024930708,0.00051741657,0.00055811624,0.0002622432,0.0003539012],"domain_scores_gemma":[0.9989935,0.00024340063,0.00015895638,0.0002993344,0.00008372798,0.00022106887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014039499,0.00023643168,0.0007945419,0.0006665651,0.000046830643,0.00002011782,0.00007897448,0.00014404899,0.000046142228],"category_scores_gemma":[0.000027178132,0.00017194351,0.00010109018,0.0012733055,0.000053856762,0.00008930046,0.0000652868,0.00023610724,0.000005720436],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013731496,0.002087601,0.9726017,0.00032043358,0.00029030105,0.002112042,0.00036961422,0.000089159024,0.0016004229,0.000014265999,0.00007507673,0.019066228],"study_design_scores_gemma":[0.006280031,0.0033479698,0.9868422,0.00010482968,0.0023450872,0.00007231274,0.000038609665,0.00027304242,0.0004277644,5.019599e-7,0.00013968843,0.00012793727],"about_ca_topic_score_codex":0.00008242845,"about_ca_topic_score_gemma":0.00020471419,"teacher_disagreement_score":0.01893829,"about_ca_system_score_codex":0.00034236096,"about_ca_system_score_gemma":0.00020098659,"threshold_uncertainty_score":0.7011653},"labels":[],"label_agreement":null},{"id":"W4399786782","doi":"10.1093/neuonc/noae064.512","title":"MDB-63. AN INTERNATIONAL META-ANALYSIS OF SHH MEDULLOBLASTOMA SUBTYPES DEFINES A CLINICALLY SIGNIFICANT HIGH-RISK VARIANT OF SHH-SUBTYPE 3","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; Montreal Clinical Research Institute","funders":"","keywords":"Medulloblastoma; Meta-analysis; Oncology; Internal medicine; Medicine; Cancer research; Biology","score_opus":0.054452805042927245,"score_gpt":0.35286293143572417,"score_spread":0.2984101263927969,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399786782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914311,0.000676344,0.000135501,0.0050308276,0.00084013597,0.0003792429,0.0003701992,0.00007293887,0.0010636806],"genre_scores_gemma":[0.99660236,0.000480671,0.0019125537,0.0005758979,0.00014180277,0.00009091891,0.0001274407,0.000034822846,0.00003355351],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9970602,0.00039587953,0.0011497445,0.0006675133,0.00047099675,0.00025570559],"domain_scores_gemma":[0.9963768,0.0020058425,0.00047208185,0.0005948164,0.00035449726,0.0001959214],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006907237,0.00026643384,0.0017963197,0.00070619833,0.000034105953,0.000020687854,0.0002686954,0.00022188673,0.0017014729],"category_scores_gemma":[0.00075602357,0.00018544386,0.0011558294,0.00084441795,0.00019964874,0.000085733445,0.00010357975,0.00027847625,0.00004483774],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033986687,0.012308474,0.20222844,0.0002471969,0.42622796,0.0072902427,0.0014211969,0.0016676539,0.2819245,0.028010558,0.0037349844,0.03154013],"study_design_scores_gemma":[0.004753547,0.017632868,0.21119642,0.000042391686,0.67424077,0.00023975865,0.00022156208,0.010387619,0.045963954,0.0012754893,0.03351045,0.00053514546],"about_ca_topic_score_codex":0.0005766144,"about_ca_topic_score_gemma":0.00035027135,"teacher_disagreement_score":0.24801283,"about_ca_system_score_codex":0.00009122059,"about_ca_system_score_gemma":0.00038097263,"threshold_uncertainty_score":0.99921113},"labels":[],"label_agreement":null},{"id":"W4399786829","doi":"10.1093/neuonc/noae064.666","title":"NURS-18. GERMINOMA PATIENTS – MORE PRONE TO PSYCHIATRIC DISORDERS, ALLERGIES, AND WEIGHT PROBLEMS? AN INSTITUTIONAL REVIEW","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Infrared Thermography in Medicine","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Psychiatry; Medicine; Allergy; Pediatrics; Psychology; Immunology","score_opus":0.01508636337774292,"score_gpt":0.31023694844692534,"score_spread":0.2951505850691824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399786829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8213603,0.071355924,0.00015297128,0.06665164,0.005696925,0.007080474,0.00009247341,0.00060959795,0.026999714],"genre_scores_gemma":[0.8585908,0.056985628,0.0074691763,0.07041193,0.0032396961,0.0016498448,0.00088780234,0.00027017726,0.0004949639],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978345,0.00014703567,0.0005195233,0.00066769903,0.0004139756,0.00041724474],"domain_scores_gemma":[0.99888283,0.000120913595,0.00008741588,0.00041370833,0.00012247439,0.0003726487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002706054,0.00029757834,0.00056693575,0.00042394496,0.00012275802,0.000015620737,0.00017565537,0.0001909155,0.00034116488],"category_scores_gemma":[0.00019708823,0.00023569385,0.00009753406,0.0008012075,0.00028089082,0.00015509009,0.000084895146,0.0005381041,0.0000611309],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072613085,0.0027648956,0.06959924,0.009495645,0.00033545357,0.0008897128,0.0027309547,0.000012470416,0.006648227,0.003588892,0.36064586,0.5425625],"study_design_scores_gemma":[0.0020060195,0.0048803524,0.049830485,0.0012248757,0.00034159466,0.0004623553,0.00003255492,0.00010569805,0.000025802752,0.00042659344,0.9404036,0.0002600943],"about_ca_topic_score_codex":0.000014632715,"about_ca_topic_score_gemma":0.000014943617,"teacher_disagreement_score":0.5797577,"about_ca_system_score_codex":0.00014349406,"about_ca_system_score_gemma":0.0004584825,"threshold_uncertainty_score":0.96113163},"labels":[],"label_agreement":null},{"id":"W4399786833","doi":"10.1093/neuonc/noae064.511","title":"MDB-62. SUBGROUP AND SUBTYPE-SPECIFIC OUTCOMES IN METASTATIC INFANT MEDULLOBLASTOMA","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medulloblastoma; Medicine; Oncology; Pediatrics; Internal medicine; Cancer research","score_opus":0.025812783386054815,"score_gpt":0.311856198046107,"score_spread":0.2860434146600522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399786833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9834352,0.0040940014,0.000006442812,0.009361917,0.00075587886,0.0005159831,0.00001457882,0.00009743481,0.0017185621],"genre_scores_gemma":[0.9974014,0.0007982339,0.0002831803,0.0012118567,0.000067910405,0.00014078074,0.0000141876135,0.000036152433,0.0000462929],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985333,0.00012243184,0.00036120243,0.00046174703,0.00018557106,0.00033574784],"domain_scores_gemma":[0.9986086,0.00089713983,0.000047142625,0.00024681253,0.000028909019,0.00017140167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019236011,0.00021774354,0.0006124072,0.00035933632,0.000035382523,0.000035543868,0.00006349106,0.000098018405,0.0002120311],"category_scores_gemma":[0.00011927474,0.00016012578,0.00009989613,0.0003117718,0.0001102084,0.00007066189,0.00006853375,0.00028361107,0.00016669641],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055178883,0.0027642343,0.63235176,0.00036328402,0.00059025624,0.039424263,0.002391034,0.000010764397,0.18125904,0.013413762,0.016333904,0.11054593],"study_design_scores_gemma":[0.0066622393,0.0037440923,0.38323876,0.00014164501,0.00043458116,0.0018773151,0.00029169934,0.00052154885,0.011161758,0.0008405806,0.5907563,0.0003294827],"about_ca_topic_score_codex":0.00006637493,"about_ca_topic_score_gemma":0.0002574853,"teacher_disagreement_score":0.5744224,"about_ca_system_score_codex":0.00018579394,"about_ca_system_score_gemma":0.00013866404,"threshold_uncertainty_score":0.652974},"labels":[],"label_agreement":null},{"id":"W4399786848","doi":"10.1093/neuonc/noae064.576","title":"NFS-18. LOWER BODY SURFACE AREA IS ASSOCIATED WITH INCREASED LIKELIHOOD OF PLEXIFORM NEUROFIBROMA RESPONSE TO MEK INHIBITION","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Plexiform neurofibroma; Chemistry; Medicine; Neurofibroma; Pathology; Neurofibromatosis","score_opus":0.022692542437214247,"score_gpt":0.2870040665296568,"score_spread":0.2643115240924426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399786848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98874915,0.00011776934,0.000027925505,0.0065848622,0.00050030055,0.00085777,0.0002323775,0.00033014122,0.0025996827],"genre_scores_gemma":[0.99437946,0.000021103293,0.0002565491,0.004850121,0.00009263549,0.000039685754,0.00006709633,0.000112803136,0.00018055075],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99681646,0.00054617034,0.00068679743,0.0007802671,0.00057905406,0.00059128006],"domain_scores_gemma":[0.9966465,0.0018814527,0.00019974638,0.00055041263,0.00026385172,0.00045802115],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005927229,0.00038951784,0.0008777307,0.00037481947,0.00009525775,0.00005055539,0.00013541285,0.00028403127,0.00052848604],"category_scores_gemma":[0.0010780835,0.00032112002,0.00021566625,0.0010263929,0.00016168237,0.00017337686,0.00013063988,0.0005086036,0.0001286299],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010134908,0.0006132209,0.0020300078,0.00010908522,0.00010926274,0.009035596,0.00036582604,0.0000072871194,0.94324076,0.000045638797,0.033938,0.0003704294],"study_design_scores_gemma":[0.006676918,0.045731355,0.051972326,0.001090138,0.00067997194,0.0046123746,0.00023719943,0.0010500592,0.8011118,0.000116583185,0.08603294,0.0006882886],"about_ca_topic_score_codex":0.000069001566,"about_ca_topic_score_gemma":0.000024007695,"teacher_disagreement_score":0.1421289,"about_ca_system_score_codex":0.00024686486,"about_ca_system_score_gemma":0.0009046724,"threshold_uncertainty_score":0.99992406},"labels":[],"label_agreement":null},{"id":"W4399786851","doi":"10.1093/neuonc/noae064.498","title":"MDB-49. OUTCOMES OF SONIC HEDGEHOG (SHH) MEDULLOBLASTOMA (MB) IN CHILDREN AND ADULTS TREATED WITH RISK-ADAPTED THERAPY ON A PROSPECTIVE INTERNATIONAL PROTOCOL (SJMB12)","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Hedgehog Signaling Pathway Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Sonic hedgehog; Medulloblastoma; Medicine; Protocol (science); Oncology; Internal medicine; Pediatrics; Pathology; Biology; Genetics; Gene; Alternative medicine","score_opus":0.008117846420133063,"score_gpt":0.2833669149260139,"score_spread":0.2752490685058808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399786851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867542,0.00014179596,0.000018564457,0.00032586456,0.000093053975,0.0119427405,0.000075073505,0.0000463843,0.00060232065],"genre_scores_gemma":[0.99080515,0.00014320786,0.00012759546,0.00018434526,0.00010423734,0.008516098,0.00003075361,0.000044207558,0.000044383625],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983839,0.00019371543,0.00032318663,0.0006610298,0.00017496418,0.00026321935],"domain_scores_gemma":[0.99933296,0.00011363875,0.00015065887,0.00023009744,0.00011151807,0.0000611306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017393683,0.00027950027,0.0003831401,0.00017271058,0.000048929116,0.000018469309,0.0001906683,0.00020155491,0.000014046561],"category_scores_gemma":[0.00015139832,0.00020569183,0.00007672478,0.00018583483,0.00021299317,0.000006888789,0.00010591956,0.00028115846,0.0000067061846],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052325455,0.00072946155,0.6964429,0.000038191352,0.000844562,0.0000951558,0.00091072323,0.00009106409,0.26634023,0.00007772833,0.00041338953,0.028784046],"study_design_scores_gemma":[0.009298636,0.013515112,0.6746002,0.00012686155,0.000046452722,0.00012836955,0.0001344139,0.00028399087,0.28974563,0.000057214187,0.011652554,0.00041057932],"about_ca_topic_score_codex":0.00007973016,"about_ca_topic_score_gemma":0.00032764426,"teacher_disagreement_score":0.028373467,"about_ca_system_score_codex":0.00007387355,"about_ca_system_score_gemma":0.00018696862,"threshold_uncertainty_score":0.83878696},"labels":[],"label_agreement":null},{"id":"W4399786914","doi":"10.1093/neuonc/noae064.260","title":"GCT-05. UPDATED REPORT ON TREATMENT MODALITIES IN METASTATIC GERMINOMA IN CHILDREN: A MULTI-INSTITUTIONAL ANALYSIS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; Alberta Children's Hospital; Hospital for Sick Children","funders":"","keywords":"Germinoma; Modalities; Medicine; Treatment modality; Oncology; Pediatrics; Radiology; Internal medicine; Radiation therapy; Sociology; Social science","score_opus":0.035750149504011806,"score_gpt":0.33929040188067017,"score_spread":0.3035402523766584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399786914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928005,0.00049514545,0.000024972036,0.0048968485,0.00019942108,0.0007256896,0.00006475281,0.00007530133,0.0007174026],"genre_scores_gemma":[0.9976882,0.00010341077,0.00038945605,0.00084132754,0.000059610065,0.00033632535,0.0005063646,0.000019101832,0.000056239372],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982069,0.00015404979,0.0005379945,0.00061134715,0.00019940513,0.00029028775],"domain_scores_gemma":[0.99924386,0.0002403398,0.000075076685,0.00027688793,0.000026861873,0.00013696284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001304369,0.00026881203,0.0007862548,0.0009147312,0.00003556522,0.000020914924,0.00005405329,0.0000942796,0.00015604237],"category_scores_gemma":[0.000091463735,0.00018814011,0.00026573663,0.00095652754,0.00008432269,0.00005614191,0.00002711846,0.00019200904,0.00008172283],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000471528,0.008406292,0.77424604,0.000041103798,0.003954462,0.17468973,0.0011459553,0.0034240806,0.0076150927,0.0020722996,0.0008542218,0.023079228],"study_design_scores_gemma":[0.012124065,0.0044753454,0.92060405,0.00007418748,0.0039725024,0.004747313,0.00014943794,0.020610157,0.0083433045,0.00010456327,0.024445513,0.00034953887],"about_ca_topic_score_codex":0.0006961066,"about_ca_topic_score_gemma":0.0007460672,"teacher_disagreement_score":0.16994241,"about_ca_system_score_codex":0.0010150187,"about_ca_system_score_gemma":0.0004787613,"threshold_uncertainty_score":0.7672131},"labels":[],"label_agreement":null},{"id":"W4399786936","doi":"10.1093/neuonc/noae064.323","title":"HGG-39. CLINICAL CHARACTERISTICS AND SURVIVAL OUTCOMES OF DIFFUSE HEMISPHERIC GLIOMA, H3 G34-MUTANT: INTERIM RESULTS OF A MULTICENTRE INTERNATIONAL STUDY","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; BC Children's Hospital; Université Laval; Centre Hospitalier de l’Université de Montréal; Dalhousie University; Centre Hospitalier Universitaire Sainte-Justine; CancerCare Manitoba; Queen Elizabeth II Health Sciences Centre; Quadrise Canada Corporation (Canada); Izaak Walton Killam Health Centre; Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"Interim; Medicine; Glioma; Oncology; Internal medicine; Cancer research; Political science","score_opus":0.046199313113795486,"score_gpt":0.3845902446688563,"score_spread":0.3383909315550608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399786936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948184,0.00013289755,0.0000051253905,0.0015998463,0.0020833644,0.00057714724,0.00016010225,0.00004218025,0.0005809302],"genre_scores_gemma":[0.99923337,0.00021977523,0.00013717682,0.0001447412,0.00015154255,0.000032123146,0.00003267122,0.00002628257,0.00002231685],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99786294,0.00020567885,0.0010237092,0.00044334625,0.00027513664,0.00018921298],"domain_scores_gemma":[0.99743617,0.0017032282,0.00026896814,0.00030123178,0.00014642756,0.00014398055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033635017,0.00020163263,0.0008903382,0.000130893,0.000020386024,0.000016015214,0.00013100245,0.00013363206,0.000066550834],"category_scores_gemma":[0.0011143443,0.00015141751,0.00016673043,0.00016864036,0.00016655841,0.000036735393,0.00019616932,0.0002451976,0.000011396678],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023127457,0.010439259,0.8412463,0.00013150167,0.0010276021,0.003724229,0.0016569977,4.6246834e-7,0.10218718,0.000078874575,0.00036183122,0.036833003],"study_design_scores_gemma":[0.019199742,0.005812385,0.95092356,0.00013503403,0.00080248545,0.00017676454,0.0009264671,0.00077353476,0.007099991,0.000010952861,0.013978477,0.00016058277],"about_ca_topic_score_codex":0.000049508235,"about_ca_topic_score_gemma":0.000047220565,"teacher_disagreement_score":0.10967727,"about_ca_system_score_codex":0.00008102414,"about_ca_system_score_gemma":0.000116089956,"threshold_uncertainty_score":0.6174627},"labels":[],"label_agreement":null},{"id":"W4399787104","doi":"10.1093/neuonc/noae064.191","title":"ETMR-21. PRIMARY DIFFUSE LEPTOMENINGEAL MELANOMATOSIS (PDLM) ASSOCIATED WITH INTRACRANIAL BLEEDING AND RAPID PROGRESSION IN A CHILD","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Children's Hospital","funders":"","keywords":"Intracranial bleeding; Medicine; Intracranial Hemorrhages; Radiology; Surgery; Subarachnoid hemorrhage","score_opus":0.01343723688936166,"score_gpt":0.28390391634341383,"score_spread":0.2704666794540522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98843914,0.002150327,0.000016067981,0.0058829626,0.00028772117,0.0007191591,0.000014562423,0.00016251592,0.0023275581],"genre_scores_gemma":[0.9975602,0.00043315373,0.00062384846,0.0009434177,0.00018328908,0.0001185921,0.00006542459,0.000048356287,0.000023737079],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9983989,0.0002002701,0.00029729493,0.0004851389,0.00023817593,0.00038020435],"domain_scores_gemma":[0.9990734,0.0005018573,0.00008247491,0.00014538532,0.00002823605,0.00016866102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033779294,0.00023126272,0.0005339811,0.00024005392,0.00008550997,0.000040554674,0.000054370415,0.00018817479,0.0000671055],"category_scores_gemma":[0.00011417666,0.00016186562,0.000060874594,0.00034371574,0.00012304002,0.00008980126,0.000076447206,0.00052500266,0.000009363727],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034510994,0.004382229,0.09476134,0.000574175,0.0009863349,0.03258619,0.0043627797,0.0000041199423,0.094246015,0.0003162197,0.002082436,0.7622471],"study_design_scores_gemma":[0.0960141,0.07696114,0.5393584,0.0062895925,0.0054275147,0.029045261,0.0015161036,0.006565558,0.01780123,0.0002834012,0.2185362,0.002201533],"about_ca_topic_score_codex":0.00001443463,"about_ca_topic_score_gemma":0.000030868552,"teacher_disagreement_score":0.7600455,"about_ca_system_score_codex":0.00031964105,"about_ca_system_score_gemma":0.00018327286,"threshold_uncertainty_score":0.66006887},"labels":[],"label_agreement":null},{"id":"W4399787125","doi":"10.1093/neuonc/noae064.109","title":"DIPG-56. BRAINSTEM TUMOR BIOPSY: A SINGLE INSTITUTE EXPERIENCE OF SAFETY AND FEASIBILITY IN A LOW-MIDDLE INCOME COUNTRY (LMIC)","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; Hospital for Sick Children","funders":"","keywords":"Brainstem; Low and middle income countries; Medicine; Biopsy; Pathology; Economic growth; Developing country; Internal medicine; Economics","score_opus":0.035673579392464565,"score_gpt":0.31156417013293825,"score_spread":0.2758905907404737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943309,0.0011719699,0.0000092637165,0.0012102851,0.0006294271,0.000655972,0.00003943912,0.00006718129,0.0018855954],"genre_scores_gemma":[0.99894845,0.00009337272,0.00015075592,0.0006161109,0.000073887226,0.00007412227,0.00001287516,0.000019957188,0.000010448546],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99842346,0.00010026337,0.0004907783,0.0005225765,0.00017913071,0.00028382082],"domain_scores_gemma":[0.9990301,0.00035744428,0.00008691085,0.00032430366,0.000047697384,0.0001535335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019601955,0.00019307139,0.0005688725,0.00020060547,0.000042799475,0.000018515566,0.00008698612,0.000120460434,0.00003607673],"category_scores_gemma":[0.00025636313,0.00015847628,0.0000863647,0.0004582223,0.0003636616,0.00013336675,0.00011946705,0.00022030786,0.000011371937],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00145285,0.0040206076,0.43995112,0.00147749,0.00012479926,0.01165995,0.005404885,0.000019925958,0.521987,0.003522449,0.00010812623,0.010270797],"study_design_scores_gemma":[0.021681204,0.008615053,0.76385343,0.003741648,0.0004929582,0.005653148,0.002162339,0.0026546784,0.080835715,0.0005753298,0.10883902,0.0008954522],"about_ca_topic_score_codex":0.00015688375,"about_ca_topic_score_gemma":0.00027218208,"teacher_disagreement_score":0.4411513,"about_ca_system_score_codex":0.00045285403,"about_ca_system_score_gemma":0.00032521918,"threshold_uncertainty_score":0.64624757},"labels":[],"label_agreement":null},{"id":"W4399787129","doi":"10.1093/neuonc/noae064.312","title":"HGG-28. THE IMPACT OF CMMRD IN HIGH-GRADE GLIOMA PATIENTS, A RETROSPECTIVE ANALYSIS OF 7 YEARS IN LMIC; AN IRRDC STUDY","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Glioma; Medicine; Oncology; Internal medicine; Cancer research","score_opus":0.01784094156722224,"score_gpt":0.3405402765137991,"score_spread":0.3226993349465769,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984194,0.00012892614,2.5828277e-7,0.00035109627,0.00013483944,0.0007866898,0.000058393394,0.000016469563,0.000103900464],"genre_scores_gemma":[0.9997616,0.000032776814,0.00001376945,0.00004079149,0.00002576574,0.00007484474,0.000030330579,0.000018554636,0.000001585617],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983471,0.0003361218,0.00047131488,0.00037722854,0.00024420852,0.00022402476],"domain_scores_gemma":[0.9989538,0.00038439027,0.00013085347,0.00039363294,0.00006828332,0.00006902518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026281262,0.00015500718,0.0007942404,0.0010853069,0.000013014293,0.000008043506,0.0001223231,0.00009551355,0.0000797127],"category_scores_gemma":[0.00014048931,0.000092319126,0.00023163286,0.0024774545,0.00008398591,0.000052387644,0.00005969477,0.000242671,0.00000430078],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020962492,0.0070696,0.9653654,0.000009784314,0.0010293248,0.0010952015,0.003428064,0.00017980955,0.017663172,0.00006229308,0.00016582415,0.003721911],"study_design_scores_gemma":[0.0033707165,0.008894057,0.98406726,0.000021075795,0.0010104624,0.00000758643,0.00053760083,0.000499983,0.0014122035,0.00007222493,0.000043849475,0.00006299248],"about_ca_topic_score_codex":0.0039712437,"about_ca_topic_score_gemma":0.0029424073,"teacher_disagreement_score":0.018701857,"about_ca_system_score_codex":0.0005705862,"about_ca_system_score_gemma":0.00015157093,"threshold_uncertainty_score":0.6003359},"labels":[],"label_agreement":null},{"id":"W4399787164","doi":"10.1093/neuonc/noae064.632","title":"QOL-44. EARLY SEVERE HEARING LOSS IN CANADIAN CHILDREN WITH CENTRAL NERVOUS SYSTEM TUMORS: A POPULATION-BASED COHORT STUDY","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Hearing, Cochlea, Tinnitus, Genetics","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; Izaak Walton Killam Health Centre; Centre hospitalier universitaire de Québec; Alberta Children's Hospital; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Cohort; Medicine; Hearing loss; Audiology; Central nervous system; Cohort study; Pediatrics; Internal medicine","score_opus":0.01797742612512392,"score_gpt":0.2694619551868979,"score_spread":0.251484529061774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787164","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953661,0.000025821384,0.000016869222,0.00044382192,0.00072992634,0.0020459609,0.000037304577,0.00031393926,0.0010202863],"genre_scores_gemma":[0.99863726,0.0000023540688,0.00007806776,0.0007976367,0.00021753713,0.00011366239,0.000010871322,0.000103973696,0.00003864294],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957693,0.0007007938,0.0005676801,0.0011554277,0.00050086254,0.0013058907],"domain_scores_gemma":[0.99829483,0.0003838343,0.00010533085,0.0005789406,0.000042513562,0.000594575],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004222141,0.00035080992,0.0005153871,0.00056893606,0.00022871923,0.00020485501,0.00046969345,0.0001893314,0.000032328913],"category_scores_gemma":[0.00032286576,0.00034869148,0.00006422505,0.0010396361,0.00009885826,0.00014576934,0.00010291865,0.0008371544,0.00010637162],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005114357,0.00012900913,0.98424965,0.000046929967,0.0000132446385,0.0037155822,0.00068529433,0.0064162235,0.0033855056,0.000134935,0.000052976236,0.0011195332],"study_design_scores_gemma":[0.000791214,0.001006244,0.98929715,0.000094122755,0.00004097568,0.0008217781,0.00007741455,0.0057343775,0.0008519299,0.000004574228,0.0009381679,0.00034203005],"about_ca_topic_score_codex":0.33132985,"about_ca_topic_score_gemma":0.33996248,"teacher_disagreement_score":0.008632626,"about_ca_system_score_codex":0.0018416056,"about_ca_system_score_gemma":0.0022341073,"threshold_uncertainty_score":0.9998965},"labels":[],"label_agreement":null},{"id":"W4399787174","doi":"10.1093/neuonc/noae064.145","title":"DIPG-92. IMMUNE ACTIVATION STUDIES WITH THE NEOANTIGEN-BASED PEPTIDE VACCINE RHSC-DIPGVAX DEMONSTRATE ANTIBODY-MEDIATED RESPONSES AND EPITOPE SPREADING IN PEDIATRIC PATIENTS WITH DIFFUSE INTRINSIC PONTINE GLIOMAS (DIPG)","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Epitope; Medicine; Antibody; Immune escape; Immune system; Peptide; Cancer research; Immunology; Biology","score_opus":0.010677600450379772,"score_gpt":0.26603344979007026,"score_spread":0.25535584933969047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9722565,0.02267203,0.00006833488,0.0031078144,0.000649831,0.0009710142,0.000029834937,0.00018834713,0.00005631778],"genre_scores_gemma":[0.99508756,0.0037614764,0.000044611745,0.00050691277,0.00007308419,0.00010917676,0.00014809158,0.00008120048,0.00018788503],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99619955,0.0015484847,0.00068615825,0.0007164407,0.0001173274,0.00073201617],"domain_scores_gemma":[0.99379355,0.0051556528,0.000335301,0.00047067713,0.0002067481,0.000038070135],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007142247,0.0005424699,0.0008306265,0.0008465597,0.0004339574,0.00007712354,0.0003314886,0.00033438767,0.00005614857],"category_scores_gemma":[0.0006570481,0.00033564155,0.00008878876,0.0012288595,0.0004899088,0.00033353758,0.00014285785,0.0009750652,0.00006104688],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021815775,0.0006506118,0.08583457,0.00011962189,0.00057777186,0.00027055238,0.0016558011,0.000021730608,0.865951,0.000047312562,0.00056096085,0.022494296],"study_design_scores_gemma":[0.021695329,0.010653653,0.76905274,0.00043563338,0.00053992873,0.00032701183,0.0011181504,0.00005203348,0.14396894,0.000026747575,0.051135153,0.0009946488],"about_ca_topic_score_codex":0.00009054379,"about_ca_topic_score_gemma":0.00012555745,"teacher_disagreement_score":0.72198206,"about_ca_system_score_codex":0.00015192467,"about_ca_system_score_gemma":0.0004739118,"threshold_uncertainty_score":0.9999096},"labels":[],"label_agreement":null},{"id":"W4399787182","doi":"10.1093/neuonc/noae064.144","title":"DIPG-91. CLINICAL, RADIOGRAPHIC, HISTOPATHOLOGIC, AND MOLECULAR CHARACTERISTICS OF LONG-TERM SURVIVORS OF DIFFUSE INTRINSIC PONTINE GLIOMA-AN UPDATE FROM THE INTERNATIONAL AND EUROPEAN SOCIETY FOR PEDIATRIC ONCOLOGY DIPG REGISTRIES (IDIPGR/SIOPE-DIPGR)","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Hospital for Sick Children","funders":"","keywords":"Medicine; Pediatric oncology; Radiography; Oncology; Radiology; Pathology; Pediatrics; Internal medicine; Cancer","score_opus":0.02751790419075425,"score_gpt":0.3174674727999535,"score_spread":0.2899495686091993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787182","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98634666,0.004644481,0.00013542155,0.006124827,0.0015152605,0.00071057363,0.00037104468,0.000059523114,0.00009223347],"genre_scores_gemma":[0.9854625,0.0117294,0.0005694597,0.0011749045,0.000637313,0.000056523855,0.00030955762,0.000053277075,0.000007072895],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99732023,0.0004741353,0.0010066893,0.0006910051,0.00022849569,0.00027944698],"domain_scores_gemma":[0.9962574,0.0023233027,0.0005411018,0.0004768965,0.00021577816,0.00018550326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096584344,0.00029814552,0.0009421705,0.00019121227,0.00008800796,0.000042393767,0.0002851694,0.0002419307,0.000021688804],"category_scores_gemma":[0.0006808259,0.00021008897,0.0004018603,0.00027567855,0.0007365093,0.00007032729,0.00030766396,0.00037310156,0.0000026635469],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011304707,0.0028571414,0.74483204,0.00025693732,0.0008503915,0.0038536037,0.0009166306,3.5573427e-7,0.11223907,0.0005570673,0.0041993745,0.12830693],"study_design_scores_gemma":[0.007993421,0.0073348046,0.9258264,0.000081272956,0.003084691,0.0005889463,0.00013926676,0.000095313226,0.0038942061,0.00020961775,0.050442345,0.00030973213],"about_ca_topic_score_codex":0.00005574717,"about_ca_topic_score_gemma":0.00006978666,"teacher_disagreement_score":0.18099435,"about_ca_system_score_codex":0.000077606506,"about_ca_system_score_gemma":0.00018683539,"threshold_uncertainty_score":0.85671794},"labels":[],"label_agreement":null},{"id":"W4399787188","doi":"10.1093/neuonc/noae064.771","title":"RADT-11. PROTON BEAM THERAPY (PBT) FOR CENTRAL NERVOUS SYSTEM (CNS) TUMOURS IN CHILDREN: A CANADIAN PEDIATRIC BRAIN TUMOUR CONSORTIUM STUDY","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiation Therapy and Dosimetry","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; BC Children's Hospital; Centre Hospitalier de l’Université de Montréal; Université Laval; McGill University Health Centre; Université du Québec à Montréal; Dalhousie University; Centre Hospitalier Universitaire Sainte-Justine; London Health Sciences Centre; Western University; CancerCare Manitoba; Izaak Walton Killam Health Centre; Alberta Children's Hospital; University of Alberta; University of Saskatchewan; Princess Margaret Cancer Centre; University of Calgary; University of British Columbia","funders":"","keywords":"Central nervous system; Medicine; Proton therapy; Pediatrics; Oncology; Internal medicine; Radiation therapy","score_opus":0.014696614127688561,"score_gpt":0.2931227222297732,"score_spread":0.2784261081020846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9827152,0.0014565832,0.00002633994,0.0048501748,0.0013414937,0.009010135,0.000069015085,0.00023233342,0.0002987541],"genre_scores_gemma":[0.9939041,0.00009578572,0.00003663052,0.0034238433,0.0014121751,0.00089383323,0.000052866213,0.000087557826,0.000093192626],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971891,0.00040974817,0.00064295094,0.00067491294,0.00024719562,0.0008360916],"domain_scores_gemma":[0.9983944,0.0005862521,0.00012949243,0.0003155294,0.000067002875,0.0005072925],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00070776645,0.0003168649,0.0006538566,0.0008725233,0.00012249735,0.000058774705,0.00020723374,0.000262806,0.00007583118],"category_scores_gemma":[0.00020506232,0.00028485752,0.00017806399,0.0007659739,0.000054604872,0.00010079201,0.000018206974,0.00051793124,0.0000431985],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008286863,0.00086460967,0.9697293,0.00027085704,0.00012590256,0.0011925177,0.0020794151,0.0001079247,0.0075910375,0.0002078065,0.011335561,0.0056663924],"study_design_scores_gemma":[0.014305928,0.009880125,0.9040066,0.00005902675,0.0002768927,0.0015137385,0.0013869823,0.0016200821,0.0036309033,0.000029902592,0.06272206,0.00056773995],"about_ca_topic_score_codex":0.0076109553,"about_ca_topic_score_gemma":0.0055409023,"teacher_disagreement_score":0.06572267,"about_ca_system_score_codex":0.0009468099,"about_ca_system_score_gemma":0.0024131632,"threshold_uncertainty_score":0.99996036},"labels":[],"label_agreement":null},{"id":"W4399787197","doi":"10.1093/neuonc/noae064.634","title":"QOL-46. EFFECTIVENESS OF A TELEREHABILITATION PROGRAM TO IMPROVE VISUAL PERCEPTION IN CHILDREN AND ADOLESCENTS WITH HEMIANOPIA CONSECUTIVE TO A BRAIN TUMOUR","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Ophthalmology and Visual Impairment Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Toronto Western Hospital; Hospital for Sick Children","funders":"","keywords":"Telerehabilitation; Medicine; Visual field; Visual impairment; Physical medicine and rehabilitation; Audiology; Intervention (counseling); Population; Physical therapy; Telemedicine; Health care; Ophthalmology","score_opus":0.008795789715740935,"score_gpt":0.35925771076009033,"score_spread":0.3504619210443494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946023,0.00003797309,0.000047085407,0.0018067617,0.00012839401,0.003254511,0.000009842638,0.000061581166,0.000051555944],"genre_scores_gemma":[0.99869215,0.0000045304405,0.00028234298,0.0005312449,0.00004656681,0.0004069535,0.0000073780166,0.000020252159,0.000008555336],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986071,0.00035437115,0.0002216445,0.00045611506,0.00011377735,0.00024699527],"domain_scores_gemma":[0.9992577,0.00041484798,0.000037801972,0.00008601407,0.000083920284,0.000119748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036825068,0.00016869043,0.00043141472,0.00025826617,0.00003541222,0.000008020535,0.000038112983,0.0001296209,0.0000060853777],"category_scores_gemma":[0.00036899545,0.00013644746,0.000037463888,0.00035195166,0.0001773846,0.00005516185,0.00007534304,0.00025584552,0.000014540591],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004018597,0.0011710955,0.54674995,0.0006114549,0.000057212495,0.000081523,0.0020831097,0.000002647757,0.422525,0.000015577316,0.00008966782,0.022594215],"study_design_scores_gemma":[0.0022480343,0.05006095,0.94106257,0.00074120134,0.0000692849,0.0003421905,0.0004491991,0.0000502388,0.004787901,0.000019440044,0.00005876476,0.00011021371],"about_ca_topic_score_codex":0.00006528489,"about_ca_topic_score_gemma":0.000015787617,"teacher_disagreement_score":0.41773707,"about_ca_system_score_codex":0.0001822222,"about_ca_system_score_gemma":0.00015084901,"threshold_uncertainty_score":0.5564166},"labels":[],"label_agreement":null},{"id":"W4399787272","doi":"10.1093/neuonc/noae064.412","title":"LGG-19. SLIPPED CAPITAL FEMORAL EPIPHYSIS (SCFE): A RARE ADVERSE EVENT ASSOCIATED WITH FGFR TYROSINE KINASE INHIBITOR THERAPY IN A CHILD","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Slipped capital femoral epiphysis; Medicine; Surgery; Adverse effect; Shunt (medical); Fibroblast growth factor receptor 1; Tyrosine-kinase inhibitor; Internal medicine; Cancer; Fibroblast growth factor; Femoral head","score_opus":0.011924171234979785,"score_gpt":0.28162160052856083,"score_spread":0.26969742929358104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99524087,0.0008858009,0.000029035138,0.0020569358,0.00036648198,0.0006880947,0.00010789781,0.00007548015,0.0005493949],"genre_scores_gemma":[0.99793124,0.00021503943,0.000061499275,0.0006823266,0.00036408368,0.00015413579,0.000327202,0.00009303692,0.00017143172],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99732065,0.00045889712,0.00036619962,0.000837451,0.0003213526,0.00069546804],"domain_scores_gemma":[0.9990214,0.00013095178,0.00009526512,0.00040614032,0.00011265765,0.00023356493],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002659493,0.00035126382,0.00039877446,0.00023679512,0.000096715,0.00004146588,0.00029867626,0.00039433964,0.00010882356],"category_scores_gemma":[0.00035265915,0.00029886363,0.00018761838,0.0005474196,0.00021905503,0.000017072753,0.00022185594,0.00062485924,0.00005699522],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013967596,0.00057996693,0.005165112,0.000046860492,0.00014443653,0.0012809116,0.0004113458,0.000103947685,0.98311394,0.000041654715,0.0036175153,0.00409754],"study_design_scores_gemma":[0.013239023,0.020913815,0.040430512,0.00037135792,0.000083314,0.00056198484,0.00058335287,0.0009465012,0.76607525,0.00009871058,0.15528584,0.0014103509],"about_ca_topic_score_codex":0.00009869698,"about_ca_topic_score_gemma":0.00063209585,"teacher_disagreement_score":0.2170387,"about_ca_system_score_codex":0.00027127392,"about_ca_system_score_gemma":0.0006113216,"threshold_uncertainty_score":0.99994636},"labels":[],"label_agreement":null},{"id":"W4399787325","doi":"10.1093/neuonc/noae064.291","title":"HGG-07. INVESTIGATING THE ROLE OF SENESCENCE IN PEDIATRIC HIGH-GRADE GLIOMAS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University Health Centre","funders":"","keywords":"Senescence; Neuroscience; Medicine; Psychology; Internal medicine","score_opus":0.01940519275454203,"score_gpt":0.2896968689154964,"score_spread":0.27029167616095434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848289,0.0044992594,0.0000015865648,0.00846,0.00044765245,0.00034810885,0.0000050956205,0.000056757257,0.0013526264],"genre_scores_gemma":[0.99837947,0.00038131428,0.00020303285,0.0006282343,0.00029386417,0.00008005248,0.0000056279187,0.000022047856,0.000006330795],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987867,0.0001465384,0.0003255094,0.00029871165,0.00019040566,0.00025214578],"domain_scores_gemma":[0.99867386,0.00087453565,0.000078093406,0.00024559643,0.000033785684,0.00009412261],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019464466,0.0001384812,0.00031133922,0.00022729982,0.00003780186,0.000012585003,0.00010974961,0.00011205331,0.00004232716],"category_scores_gemma":[0.0002442926,0.00009173772,0.00007908566,0.0006908965,0.00010561053,0.00004176651,0.00007347768,0.0002889683,0.00006700028],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029769013,0.0006379678,0.42292577,0.00015922582,0.000044212364,0.0017546186,0.0010941079,0.000047528094,0.5389258,0.0045111887,0.0013357349,0.02853408],"study_design_scores_gemma":[0.005186739,0.0033830018,0.41442984,0.000275848,0.00094959565,0.0010736274,0.0009452142,0.003671454,0.47177315,0.005909466,0.09200519,0.000396876],"about_ca_topic_score_codex":0.00018763467,"about_ca_topic_score_gemma":0.00007702078,"teacher_disagreement_score":0.09066946,"about_ca_system_score_codex":0.000116019735,"about_ca_system_score_gemma":0.00027406105,"threshold_uncertainty_score":0.37409556},"labels":[],"label_agreement":null},{"id":"W4399787335","doi":"10.1093/neuonc/noae064.294","title":"HGG-10. YAP1-MAML2 FUSION IN YOUNG CHILDREN WITH PEDIATRIC HIGH-GRADE GLIOMA: A CASE REPORT","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université Laval; B.C. Women's Hospital & Health Centre; BC Children's Hospital","funders":"","keywords":"Medicine; Neurooncology; Oncology; Lomustine; Dabrafenib; Chemotherapy; Debulking; Internal medicine; Pediatrics; Pathology; Cancer; Vincristine; Cyclophosphamide","score_opus":0.005524020834230137,"score_gpt":0.24881238843044562,"score_spread":0.24328836759621547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787335","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942153,0.0019631172,0.00004143562,0.0006606573,0.00082026003,0.00028607168,0.000014731699,0.00005077101,0.0019476288],"genre_scores_gemma":[0.99751866,0.0008207078,0.00011827174,0.00017792184,0.0007516414,0.00005166472,0.0001240935,0.000043436947,0.0003935872],"study_design_codex":"bench_or_experimental","study_design_gemma":"case_report","domain_scores_codex":[0.998384,0.00011614978,0.00032729824,0.0006730716,0.0001417411,0.00035772892],"domain_scores_gemma":[0.9993945,0.000030502568,0.00009928828,0.00031133043,0.000043342552,0.000121052915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016543177,0.00022079994,0.0002377279,0.00018352731,0.00007095807,0.0000264935,0.0001400267,0.00040064985,0.000045306257],"category_scores_gemma":[0.000048410642,0.0001681148,0.00008935381,0.0004529454,0.000087576416,0.0000066168645,0.00011875218,0.00038218175,0.000032733635],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004423976,0.00026714278,0.014179003,0.00006530023,0.00015255768,0.23608981,0.00015304054,0.00043625402,0.7275761,0.00005316053,0.015108564,0.0054766946],"study_design_scores_gemma":[0.0045343833,0.005705763,0.00925191,0.0000528648,0.00044829637,0.7287383,0.00011300767,0.00022143815,0.14524524,0.000107315864,0.104563735,0.0010177155],"about_ca_topic_score_codex":0.00040896787,"about_ca_topic_score_gemma":0.00050765096,"teacher_disagreement_score":0.5823308,"about_ca_system_score_codex":0.00008283503,"about_ca_system_score_gemma":0.000378925,"threshold_uncertainty_score":0.68555224},"labels":[],"label_agreement":null},{"id":"W4399787342","doi":"10.1093/neuonc/noae064.295","title":"HGG-11. TRANS-SPECIES STUDY OF IDH-MUTANT REPLICATION-REPAIR DEFICIENT HIGH-GRADE GLIOMAS (RRD-HGG) AND RESPONSE TO COMBINED TARGETED AND IMMUNOTHERAPY: AN IRRDC STUDY","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Mutant; Immunotherapy; Replication (statistics); Cancer research; Biology; Virology; Genetics; Gene; Immune system","score_opus":0.027479780797774703,"score_gpt":0.3212379657217738,"score_spread":0.29375818492399913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884505,0.0012996403,0.000005507738,0.0060776854,0.00031426718,0.0035346802,0.000041215408,0.0002451814,0.000031276304],"genre_scores_gemma":[0.998653,0.00012330967,0.00013967206,0.00042724892,0.00004260738,0.0005192648,0.000014550267,0.000059327776,0.0000210333],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9969435,0.0007372447,0.0006504277,0.0009798361,0.00036601326,0.00032299777],"domain_scores_gemma":[0.9976868,0.0009186245,0.00010578558,0.0009114784,0.00012751442,0.0002497691],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00077221816,0.00031718393,0.000771069,0.00052620185,0.00014988892,0.000044241937,0.00012834957,0.00012102731,0.000052827825],"category_scores_gemma":[0.00017247819,0.00025397344,0.00008823441,0.00066881336,0.00013567647,0.00006976305,0.00007809047,0.00019836915,0.0000054956367],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052858973,0.015023486,0.061769247,0.000048859016,0.00044375498,0.0016082634,0.018709978,0.000012718339,0.89290184,0.00029556395,0.00036198765,0.0035383806],"study_design_scores_gemma":[0.016725803,0.072318934,0.8412698,0.000049728143,0.0007306209,0.0002575368,0.010402456,0.00019981303,0.035717912,0.000050894887,0.021977136,0.00029935662],"about_ca_topic_score_codex":0.00029354118,"about_ca_topic_score_gemma":0.0005114009,"teacher_disagreement_score":0.85718393,"about_ca_system_score_codex":0.00019104259,"about_ca_system_score_gemma":0.00016692426,"threshold_uncertainty_score":0.99999124},"labels":[],"label_agreement":null},{"id":"W4399787348","doi":"10.1093/neuonc/noae064.297","title":"HGG-13. INFANT-TYPE HEMISPHERIC GLIOMA (IHG): AN INDIVIDUAL PATIENT DATA META-ANALYSIS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medicine; Oncology; Internal medicine; Multivariate analysis; Glioma; Cohort; Radiation therapy; Fusion gene; Chemotherapy; Gene; Cancer research; Biology","score_opus":0.11487717057612667,"score_gpt":0.3663949881683763,"score_spread":0.2515178175922496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787348","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98147553,0.009305912,0.00001619554,0.0052410723,0.00082929817,0.0006257936,0.00036041462,0.00024375202,0.0019020389],"genre_scores_gemma":[0.99445695,0.0001379429,0.00078569836,0.0029158469,0.00019089371,0.00011851885,0.0013133283,0.000052708892,0.000028132967],"study_design_codex":"meta_analysis","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971248,0.00028761936,0.0005567647,0.0010719888,0.0005143724,0.00044449084],"domain_scores_gemma":[0.9972664,0.0005272402,0.00013225335,0.0015960992,0.00011584435,0.0003621342],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00031983937,0.0003423066,0.0012946501,0.0003972713,0.000087381464,0.000091212765,0.00041091724,0.00022023752,0.002637746],"category_scores_gemma":[0.00020804933,0.00024601555,0.00054967543,0.001801993,0.000096256896,0.0002051265,0.00043383925,0.00034727788,0.00026224434],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007166075,0.008870078,0.024322214,0.0002355325,0.47759676,0.041405953,0.0033110608,0.00045191482,0.14779307,0.00056299655,0.15315329,0.14158054],"study_design_scores_gemma":[0.0014598402,0.0055992734,0.004724556,0.0000065767467,0.4366571,0.0008026968,0.00022336103,0.002663167,0.013704359,0.00006301965,0.5337243,0.00037174934],"about_ca_topic_score_codex":0.00020059761,"about_ca_topic_score_gemma":0.00033793613,"teacher_disagreement_score":0.380571,"about_ca_system_score_codex":0.00011166262,"about_ca_system_score_gemma":0.00033493154,"threshold_uncertainty_score":0.9999992},"labels":[],"label_agreement":null},{"id":"W4399787357","doi":"10.1093/neuonc/noae064.203","title":"EPEN-01. DISTINCT RELAPSE PATTERN ACROSS MOLECULAR EPENDYMOMA TYPES","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"thermodynamics and calorimetric analyses","field":"Chemistry","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Ependymoma; Biology; Psychology; Medicine; Evolutionary biology; Pathology","score_opus":0.013917177201926863,"score_gpt":0.2991686772891252,"score_spread":0.28525150008719835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787357","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94462013,0.0017486204,0.0024677275,0.0012454488,0.0010054677,0.000072321134,0.00014124422,0.0003326074,0.048366427],"genre_scores_gemma":[0.99803627,0.00006138421,0.000041822837,0.00045865378,0.0003897737,0.000023888848,0.0000573911,0.00007174067,0.0008590902],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.998325,0.00006137413,0.00032974067,0.00058387365,0.00022852396,0.00047151992],"domain_scores_gemma":[0.998828,0.00044855193,0.00008297148,0.0004487654,0.000042888245,0.00014882413],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015270217,0.00024799473,0.00035049734,0.00007258089,0.00010038796,0.00009395391,0.0003854505,0.0002926048,0.0017987076],"category_scores_gemma":[0.00016986228,0.0002242048,0.00021690885,0.0003246106,0.00011712042,0.00006502179,0.00023397805,0.0005566395,0.00059863913],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000074515214,0.00021892093,0.0009718075,0.00017759985,0.00025912284,0.012970053,0.00038208126,0.00004819189,0.6709406,0.001476895,0.0033994783,0.30908075],"study_design_scores_gemma":[0.0011315547,0.00040571226,0.0005466024,0.00006744114,0.00035689483,0.0012668074,0.00029995927,0.0134348115,0.08353411,0.0023505704,0.89579344,0.00081209384],"about_ca_topic_score_codex":0.00012993398,"about_ca_topic_score_gemma":0.000056602694,"teacher_disagreement_score":0.89239395,"about_ca_system_score_codex":0.00018012858,"about_ca_system_score_gemma":0.00012428514,"threshold_uncertainty_score":0.9991138},"labels":[],"label_agreement":null},{"id":"W4399787377","doi":"10.1093/neuonc/noae064.442","title":"LGG-51. SYSTEMIC IMMUNE TOXICITY OF BRAF AND MEK-INHIBITORS IN CHILDREN: A PAN-CANADIAN SERIES","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre hospitalier de l'Université Laval; Princess Margaret Cancer Centre; Université Laval; Hospital for Sick Children","funders":"","keywords":"Medicine; Concomitant; Discontinuation; Adverse effect; MAPK/ERK pathway; Internal medicine; Pediatrics; Kinase","score_opus":0.008781556336678464,"score_gpt":0.25566027662338725,"score_spread":0.2468787202867088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787377","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98683906,0.00647785,3.7117854e-7,0.004301304,0.00042447742,0.00059338653,0.00004109028,0.00004032065,0.00128212],"genre_scores_gemma":[0.99884576,0.0005469355,0.000030385077,0.0003438327,0.00010865642,0.00006690892,0.000016334885,0.000023646251,0.000017558932],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988317,0.00010234551,0.00035970728,0.0003158494,0.00010899221,0.0002814254],"domain_scores_gemma":[0.99936604,0.00017409082,0.000055049066,0.00020361734,0.00002976533,0.00017145449],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014838886,0.00015977654,0.00049369514,0.00035127896,0.000035916284,0.000015008873,0.000056062425,0.00016911761,0.000056927835],"category_scores_gemma":[0.000088215194,0.00013348057,0.00008047446,0.0002796187,0.000107886204,0.00006403353,0.000042923297,0.00021005694,0.000019312982],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012853961,0.00046530113,0.40486392,0.00032491444,0.00023336793,0.0027717433,0.001016078,0.0000054094808,0.54984426,0.0012180742,0.0026529578,0.03647543],"study_design_scores_gemma":[0.0069016647,0.006486146,0.5882948,0.0012565947,0.00064497447,0.0119232265,0.0008987142,0.0001589039,0.34826723,0.00023511569,0.034447152,0.00048543973],"about_ca_topic_score_codex":0.0072381524,"about_ca_topic_score_gemma":0.012230076,"teacher_disagreement_score":0.20157701,"about_ca_system_score_codex":0.00022867785,"about_ca_system_score_gemma":0.00040121793,"threshold_uncertainty_score":0.9993727},"labels":[],"label_agreement":null},{"id":"W4399787378","doi":"10.1093/neuonc/noae064.250","title":"METB-09. VARIANT WORKBENCH IN THE KIDS FIRST PROGRAM FACILITATES GENOMIC DISCOVERIES IN PEDIATRIC NEURO-ONCOLOGY RESEARCH","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Workbench; Pediatric oncology; Computational biology; Oncology; Medicine; Computer science; Internal medicine; Biology; Artificial intelligence; Cancer","score_opus":0.07026701302173444,"score_gpt":0.40057277913916634,"score_spread":0.3303057661174319,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787378","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.879077,0.0046604406,0.00002097518,0.104297526,0.0022185894,0.0031525593,0.000048768004,0.00024614105,0.0062779547],"genre_scores_gemma":[0.9892625,0.0027158982,0.00052654685,0.004215179,0.0016982066,0.0013180419,0.00005111935,0.000098491524,0.00011402382],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99155486,0.0035171243,0.001268736,0.0013172348,0.00093726104,0.0014048022],"domain_scores_gemma":[0.9865191,0.011991933,0.00014022841,0.0009505193,0.00012540672,0.00027283689],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0056086993,0.00045026885,0.0011018221,0.0011601514,0.0002170857,0.00015837258,0.0008358494,0.0005141883,0.00020062453],"category_scores_gemma":[0.003411906,0.000352186,0.00023691371,0.0028636262,0.00072900765,0.0002439961,0.00050219323,0.0032943727,0.0003070402],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063919444,0.012594912,0.25776836,0.005696212,0.00042744176,0.05193855,0.22708437,0.00057124085,0.023491196,0.010503571,0.13557348,0.26795873],"study_design_scores_gemma":[0.0029924028,0.008656534,0.08787696,0.00012813498,0.00016055582,0.0011408833,0.0056565613,0.00052006054,0.00016892771,0.0018739278,0.89038384,0.00044120575],"about_ca_topic_score_codex":0.0016187882,"about_ca_topic_score_gemma":0.010011553,"teacher_disagreement_score":0.7548104,"about_ca_system_score_codex":0.0010737912,"about_ca_system_score_gemma":0.0026266798,"threshold_uncertainty_score":0.999893},"labels":[],"label_agreement":null},{"id":"W4399787410","doi":"10.1093/neuonc/noae064.112","title":"DIPG-59. RADIATION-INDUCED DIPG IN A CHILD PREVIOUSLY IRRADIATED FOR CRANIOPHARYNGIOMA: CASE REPORT AND LITERATURE REVIEW","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Craniopharyngioma; Medicine; Headaches; Radiation therapy; Vomiting; Glioma; Surgery; Nuclear medicine","score_opus":0.017562463598306426,"score_gpt":0.32611490147488,"score_spread":0.30855243787657355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7386119,0.23300463,0.000002468038,0.023455855,0.00075055327,0.0033196942,0.00005075827,0.00013092735,0.0006732192],"genre_scores_gemma":[0.9638857,0.030392123,0.00014409648,0.00386808,0.00033074137,0.001048239,0.00023969372,0.000057093974,0.00003422594],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9982253,0.00012754533,0.0005606017,0.0006311982,0.00012422077,0.0003311828],"domain_scores_gemma":[0.99874806,0.0005106009,0.000116363735,0.00033379407,0.00007728008,0.00021387302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003318335,0.00025372487,0.00068398326,0.00025941347,0.00007602976,0.000044796416,0.000049603135,0.00021426687,0.0000355333],"category_scores_gemma":[0.00060430187,0.00020060664,0.00016824462,0.000582989,0.000031274885,0.00010562741,0.000034099638,0.00032819805,0.0000118622975],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013061402,0.0006997193,0.0020316443,0.00316813,0.00018711087,0.9188748,0.0006542358,7.9490104e-7,0.009999428,0.00022582398,0.016021362,0.04800632],"study_design_scores_gemma":[0.006951594,0.002918001,0.008763337,0.0055401116,0.0012546956,0.6940819,0.000027907057,0.00041265605,0.001457441,0.00009852427,0.2781495,0.00034436872],"about_ca_topic_score_codex":0.00003160966,"about_ca_topic_score_gemma":0.00005572197,"teacher_disagreement_score":0.2621281,"about_ca_system_score_codex":0.00019921895,"about_ca_system_score_gemma":0.00020453654,"threshold_uncertainty_score":0.8180501},"labels":[],"label_agreement":null},{"id":"W4399787415","doi":"10.1093/neuonc/noae064.455","title":"MDB-06. ALTERNATIVE SPLICING MEDIATED BY OTX2 DRIVES THE DEVELOPMENT OF GROUP 3 MEDULLOBLASTOMA","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"RNA modifications and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; McGill University; University of Manitoba; Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Group (periodic table); RNA splicing; Alternative splicing; Computer science; Biology; Chemistry; Genetics; Gene","score_opus":0.012632861009094722,"score_gpt":0.28346698657588854,"score_spread":0.2708341255667938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897363,0.0018054896,0.0037224868,0.0013764912,0.00050415855,0.00022285206,0.000033890512,0.00002421739,0.0025741044],"genre_scores_gemma":[0.99790424,0.00041468922,0.00052316254,0.00054184074,0.00018312948,0.0000961003,0.00010749139,0.000023489838,0.00020583927],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989554,0.00011026697,0.00028569932,0.00033368706,0.00012298934,0.00019193543],"domain_scores_gemma":[0.999454,0.000112655754,0.00009338195,0.00022949366,0.000057606347,0.000052828425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001914513,0.00013030125,0.00014762349,0.000041756175,0.00008614541,0.000015623498,0.0002653639,0.000121718964,0.000037454658],"category_scores_gemma":[0.00006456641,0.0000943897,0.00005990543,0.00012853816,0.0001483511,0.000004118355,0.00011367322,0.00014145233,0.000028895358],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026792177,0.000051066072,0.000104471925,0.000013461686,0.00007493565,0.0000041985995,0.0006037644,0.000017242091,0.96923333,0.00026204082,0.010115955,0.019492716],"study_design_scores_gemma":[0.00018266698,0.00020570189,0.00023979411,0.000009141818,0.000014270342,0.000011992466,0.0001756684,0.00020709132,0.43224868,0.000034401197,0.566591,0.00007960051],"about_ca_topic_score_codex":0.000012912034,"about_ca_topic_score_gemma":0.00007524882,"teacher_disagreement_score":0.55647504,"about_ca_system_score_codex":0.00005016435,"about_ca_system_score_gemma":0.00024185475,"threshold_uncertainty_score":0.38491005},"labels":[],"label_agreement":null},{"id":"W4399787448","doi":"10.1093/neuonc/noae064.449","title":"LGG-60. DISTRIBUTION AND CLINICAL SIGNIFICANCE OF FGFR ALTERATIONS IN PEDIATRIC AND AYA GLIOMAS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; Centre Hospitalier Universitaire Sainte-Justine; Hospital for Sick Children; CancerCare Manitoba; Agricultural Research Institute of Ontario; University of Toronto; Université Laval; University of Alberta","funders":"","keywords":"Medicine; Cohort; Fibroblast growth factor receptor; Young adult; Oncology; Glioma; Internal medicine; Adjuvant therapy; Population; Chemotherapy; Cancer research; Fibroblast growth factor; Receptor","score_opus":0.01645547678036938,"score_gpt":0.3184839624679051,"score_spread":0.3020284856875357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98858017,0.008393568,0.00046702183,0.00052442175,0.0014259699,0.0001944105,0.00008264145,0.000010646359,0.00032114884],"genre_scores_gemma":[0.9855392,0.012661163,0.000111423935,0.0001743395,0.0013574616,0.000025508594,0.000076205884,0.000011220195,0.000043497217],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989575,0.0001495546,0.00031432242,0.00036442975,0.00005719583,0.0001569939],"domain_scores_gemma":[0.9995578,0.00012797811,0.000060748738,0.00013892991,0.000039400747,0.000075165946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002519461,0.000098278695,0.00020531352,0.000056126988,0.000030119973,0.000015307545,0.000060810788,0.00019588691,0.0000058018777],"category_scores_gemma":[0.00020388054,0.00009669824,0.000050565843,0.00015272423,0.0001425745,0.000005985477,0.00007418098,0.00016150725,0.0000019393774],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023196344,0.0001989647,0.014845102,0.00011816034,0.000032376014,0.00003637637,0.00012205097,0.000019321904,0.91292715,0.00095202186,0.010428076,0.060088422],"study_design_scores_gemma":[0.0014403695,0.0013020996,0.064433955,0.000010854284,0.00013535951,0.000112254085,0.000045720964,0.00042909736,0.026358206,0.00027511548,0.9052332,0.00022376396],"about_ca_topic_score_codex":0.000027463135,"about_ca_topic_score_gemma":0.00017785926,"teacher_disagreement_score":0.89480513,"about_ca_system_score_codex":0.0000135750415,"about_ca_system_score_gemma":0.00021199505,"threshold_uncertainty_score":0.39432397},"labels":[],"label_agreement":null},{"id":"W4399787498","doi":"10.1093/neuonc/noae064.726","title":"LMIC-09. CRADLE TO CRAYON: THE IMPACT OF COLLABORATION ON PEDIATRIC CENTRAL NERVOUS SYSTEM TUMORS IN GHANA","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Biomedical and Engineering Education","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Central nervous system; Medicine; Internal medicine","score_opus":0.008381989423736746,"score_gpt":0.2600119523311023,"score_spread":0.25162996290736556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99376374,0.00029465838,0.00037094488,0.0010104834,0.0028750096,0.00025550937,0.000018581874,0.00022340854,0.0011876327],"genre_scores_gemma":[0.99923545,0.000024935372,0.00006050409,0.000043774588,0.00055386644,0.000039646926,0.0000070988845,0.000025139887,0.000009605833],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9991883,0.00004759063,0.00024531188,0.00015190379,0.000112266505,0.0002546436],"domain_scores_gemma":[0.9995328,0.00018609973,0.000018346707,0.0001441723,0.000020775855,0.00009780597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012820777,0.00011892681,0.00017682162,0.00022332347,0.000017134626,0.00002057674,0.00012417915,0.000107306034,0.000017777747],"category_scores_gemma":[0.000057400262,0.000085752756,0.000049904134,0.00094931724,0.0000146341235,0.000045804158,0.000014826066,0.00024023557,0.000052650055],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009716291,0.00023659824,0.0010021377,0.001956163,0.00007183653,0.00024211952,0.0066524753,0.8033689,0.0753763,0.0019305532,0.063932426,0.04513329],"study_design_scores_gemma":[0.0011298789,0.003844485,0.10634065,0.0003807399,0.00012561181,0.00025313575,0.002273467,0.84190744,0.0069792597,0.000097400385,0.03581962,0.0008483117],"about_ca_topic_score_codex":0.00007882684,"about_ca_topic_score_gemma":0.000023396662,"teacher_disagreement_score":0.10533851,"about_ca_system_score_codex":0.0005599859,"about_ca_system_score_gemma":0.0001664421,"threshold_uncertainty_score":0.3496896},"labels":[],"label_agreement":null},{"id":"W4399787504","doi":"10.1093/neuonc/noae064.378","title":"IMMU-07. COMBINED PD1 AND LAG3 INHIBITION IN PRECLINICAL MODELS AND PATIENTS WITH DNA REPLICATION REPAIR DEFICIENT GLIOBLASTOMA (RRD-GBM): AN IRRDC STUDY","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"Cancer research; Immune checkpoint; Immune system; CD8; Immunotherapy; Medicine; Nestin; Biology; Immunology; Stem cell; Neural stem cell; Cell biology","score_opus":0.030716375058360914,"score_gpt":0.3307876099051599,"score_spread":0.300071234846799,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787504","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963283,0.00022060778,0.000007718812,0.0011211288,0.00012506217,0.0017805177,0.000012029454,0.00015312004,0.0002515277],"genre_scores_gemma":[0.9990408,0.000058794707,0.00011416787,0.00034713108,0.000032461296,0.00032232562,0.000048435588,0.000030851188,0.0000050736858],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980769,0.00022823208,0.00042745538,0.0008289061,0.00021851527,0.00022000156],"domain_scores_gemma":[0.99889636,0.0003170388,0.00008602022,0.00045051545,0.0000897385,0.00016035265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032282397,0.00018941275,0.00039611434,0.00020730907,0.00006275785,0.000030057116,0.000030140738,0.00013436454,0.000010729268],"category_scores_gemma":[0.000106005085,0.00014539441,0.000039628994,0.0002483393,0.00009668813,0.00015357636,0.00007960306,0.00022682211,0.0000083434625],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006183342,0.028047884,0.899236,0.00022344885,0.00023584567,0.0024311892,0.0038650185,0.0001516563,0.017351212,0.0011255163,0.0010052138,0.040143646],"study_design_scores_gemma":[0.018811489,0.06326351,0.8990272,0.00020376092,0.000485081,0.0002280078,0.00040490428,0.012607433,0.0030664979,0.00044935127,0.0011734371,0.00027930396],"about_ca_topic_score_codex":0.000040727802,"about_ca_topic_score_gemma":0.00019248965,"teacher_disagreement_score":0.039864343,"about_ca_system_score_codex":0.00015774647,"about_ca_system_score_gemma":0.0000899195,"threshold_uncertainty_score":0.59290123},"labels":[],"label_agreement":null},{"id":"W4399787533","doi":"10.1093/neuonc/noae064.582","title":"NFS-24. TUMOR VOLUME IN NEWLY DIAGNOSED OPTIC PATHWAY GLIOMAS ASSOCIATED WITH NF1 (NF1-OPG): PRELIMINARY RESULTS FROM THE INTERNATIONAL MULTICENTER NF1-OPG NATURAL HISTORY STUDY","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Natural history; Medicine; Volume (thermodynamics); Multicenter study; Oncology; Internal medicine; Physics","score_opus":0.02273708099177605,"score_gpt":0.2661632712251791,"score_spread":0.24342619023340303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9833097,0.0012070097,0.0000017972555,0.0069329976,0.005354751,0.0014816258,0.00017670116,0.00026373868,0.0012716815],"genre_scores_gemma":[0.9950444,0.00002125765,0.00014317888,0.0029020584,0.0005759536,0.00021293273,0.00023855572,0.00009965201,0.0007620071],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.996021,0.00074947276,0.00089908857,0.0010637195,0.00071492716,0.0005518285],"domain_scores_gemma":[0.9948639,0.0038467112,0.00029850437,0.0006209858,0.00017636988,0.00019352672],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005402065,0.0004414903,0.00072387117,0.0003118616,0.00010302203,0.000084920524,0.0005054612,0.00018192995,0.00022267309],"category_scores_gemma":[0.0016406798,0.0003088543,0.00018796111,0.0003800806,0.00023679767,0.00023579468,0.00029896013,0.0012798427,0.00012091978],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032802206,0.011283404,0.18935698,0.000113021,0.0017384182,0.29145125,0.021706063,0.00013301012,0.20159161,0.00010408569,0.24305151,0.006668435],"study_design_scores_gemma":[0.032875326,0.02224426,0.7494948,0.0008975209,0.0010209713,0.002254748,0.0033078983,0.01789818,0.00238207,0.000021641246,0.16671361,0.0008889676],"about_ca_topic_score_codex":0.00058476237,"about_ca_topic_score_gemma":0.00087252294,"teacher_disagreement_score":0.5601378,"about_ca_system_score_codex":0.0012158273,"about_ca_system_score_gemma":0.00074346864,"threshold_uncertainty_score":0.99993634},"labels":[],"label_agreement":null},{"id":"W4399787571","doi":"10.1093/neuonc/noae064.023","title":"BIOM-03. IMMUNO-ONCOLOGIC PROFILING OF PEDIATRIC BRAIN TUMORS REVEALS MAJOR CLINICAL SIGNIFICANCE OF THE TUMOR IMMUNE MICROENVIRONMENT","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; Alberta Hospital Edmonton; Hospital for Sick Children","funders":"","keywords":"Profiling (computer programming); Tumor microenvironment; Immune system; Medicine; Cancer research; Biology; Immunology; Computer science","score_opus":0.028606927554040353,"score_gpt":0.32830821660162207,"score_spread":0.2997012890475817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9796292,0.00941409,0.000023387784,0.006347197,0.0021339483,0.0016008015,0.000059327478,0.00006262399,0.0007293899],"genre_scores_gemma":[0.9944815,0.0014583142,0.0007816337,0.0023282275,0.0005066421,0.00010792264,0.0000113052465,0.00005324377,0.000271215],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9962021,0.0007076585,0.001736564,0.00058396603,0.0003423915,0.00042733358],"domain_scores_gemma":[0.99681073,0.0016367051,0.00068540714,0.00070773286,0.000068240675,0.00009116316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017674587,0.00028157333,0.00097634934,0.00018511341,0.00007842531,0.000010412349,0.00044102306,0.00024493758,0.00025474536],"category_scores_gemma":[0.00054586824,0.00019172014,0.0006388608,0.00073175726,0.0007794521,0.000051543495,0.00020555506,0.0006900248,0.000037316317],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020628637,0.00054277276,0.019899063,0.00046282844,0.00017936174,0.00018596713,0.00017117789,0.0000032108057,0.96430767,0.00005865613,0.003694793,0.00843163],"study_design_scores_gemma":[0.0073797433,0.010252654,0.18523805,0.00040072133,0.00095738715,0.0007891101,0.00055870006,0.00012680386,0.70001215,0.00020460639,0.09359927,0.00048081175],"about_ca_topic_score_codex":0.00006215302,"about_ca_topic_score_gemma":0.00000503629,"teacher_disagreement_score":0.26429555,"about_ca_system_score_codex":0.0003324116,"about_ca_system_score_gemma":0.0009952559,"threshold_uncertainty_score":0.781812},"labels":[],"label_agreement":null},{"id":"W4399787597","doi":"10.1093/neuonc/noae064.458","title":"MDB-09. WNT AND GROUP 4 MEDULLOBLASTOMAS OF EARLY CHILDHOOD TREATED WITH HIGH DOSE CHEMOTHERAPY AND CRANIOSPINAL IRRADIATION SPARING APPROACH","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; CancerCare Manitoba; BC Children's Hospital; London Health Sciences Centre; Alberta Children's Hospital; University of Alberta Hospital; Izaak Walton Killam Health Centre","funders":"","keywords":"Medulloblastoma; Chemotherapy; Medicine; Oncology; Internal medicine; Cancer research","score_opus":0.010728644035745626,"score_gpt":0.24696240476272938,"score_spread":0.23623376072698374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787597","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965055,0.0009115521,0.00001973614,0.001235142,0.00007160406,0.00054861425,0.000006446511,0.00007217472,0.0006292024],"genre_scores_gemma":[0.9984138,0.0003630222,0.00074065133,0.00025253807,0.00009512327,0.00007288182,0.000019521996,0.000035698347,0.00000676299],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99898785,0.000053602274,0.00020936722,0.00040186293,0.0001479242,0.00019937703],"domain_scores_gemma":[0.9995017,0.00012202748,0.00007157959,0.00014103834,0.000029679226,0.00013394929],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008201989,0.00018930358,0.00041479533,0.00016314209,0.000046192417,0.000025109593,0.000034450797,0.00012187936,0.000019326508],"category_scores_gemma":[0.0000133909525,0.00013622026,0.00004027682,0.0002080165,0.0001117205,0.000070433896,0.00002271231,0.00016397212,0.0000027597282],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024105236,0.0040589855,0.41053697,0.00048624436,0.0011638243,0.0014013174,0.004979465,0.000025676101,0.32602903,0.0040904353,0.0002646998,0.24455285],"study_design_scores_gemma":[0.0069002933,0.008611735,0.9745321,0.00008400278,0.0003214274,0.0007286115,0.00006261335,0.0003108406,0.0070811226,0.00008084225,0.0011600443,0.00012631042],"about_ca_topic_score_codex":0.00016926367,"about_ca_topic_score_gemma":0.000020798234,"teacher_disagreement_score":0.5639952,"about_ca_system_score_codex":0.00007286572,"about_ca_system_score_gemma":0.00007057545,"threshold_uncertainty_score":0.5554901},"labels":[],"label_agreement":null},{"id":"W4399787615","doi":"10.1093/neuonc/noae064.441","title":"LGG-50. POOR RESPONSE TO MEKI RE-INITIATION IN PEDIATRIC LOW-GRADE GLIOMA AFTER TREATMENT DISCONTINUATION. A PLGG TASKFORCE STUDY","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal; University of Calgary; University of Alberta; Hospital for Sick Children","funders":"","keywords":"Discontinuation; Medicine; Glioma; Internal medicine; Cancer research","score_opus":0.02396260610034954,"score_gpt":0.3312306650524043,"score_spread":0.3072680589520547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9812667,0.0007669821,0.000008286698,0.014111031,0.000674348,0.00261065,0.00003807214,0.00013423996,0.00038968725],"genre_scores_gemma":[0.9957406,0.000092422015,0.00011715364,0.0010555479,0.0004100777,0.0024039159,0.000036906284,0.00005759609,0.00008576548],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99737173,0.00056296634,0.0005711979,0.00074116903,0.00033252902,0.00042039147],"domain_scores_gemma":[0.998124,0.0010867291,0.00008222587,0.0003968171,0.000061559236,0.0002486497],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039987214,0.00032470108,0.0005579954,0.0009853553,0.000058289657,0.000059548056,0.00008208983,0.0001537185,0.00016235266],"category_scores_gemma":[0.0003329507,0.0002540896,0.0001574431,0.0009735578,0.000026046097,0.0001230151,0.00006789667,0.00019194829,0.0003718142],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025902783,0.040563278,0.49307927,0.00018224213,0.00063673285,0.09331219,0.031239593,0.00025009894,0.255391,0.00018021767,0.011706894,0.047555696],"study_design_scores_gemma":[0.021564558,0.04380262,0.8613551,0.00016062551,0.0018663482,0.0004030291,0.0025479514,0.00047123872,0.019195445,0.00006781415,0.04793533,0.000629933],"about_ca_topic_score_codex":0.00009920076,"about_ca_topic_score_gemma":0.00075420697,"teacher_disagreement_score":0.36827582,"about_ca_system_score_codex":0.0010889473,"about_ca_system_score_gemma":0.00037047282,"threshold_uncertainty_score":0.9999911},"labels":[],"label_agreement":null},{"id":"W4399787616","doi":"10.1093/neuonc/noae064.200","title":"ETMR-30. CLINICAL AND MOLECULAR CHARACTERIZATION OF<i>DICER</i>-MUTANT CENTRAL NERVOUS SYSTEM SARCOMA","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"","keywords":"Dicer; Mutant; Central nervous system; Cancer research; Biology; Neuroscience; Genetics; Gene; RNA interference; RNA","score_opus":0.020045079287449124,"score_gpt":0.31177580615531464,"score_spread":0.2917307268678655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933282,0.00068719493,0.00009721872,0.0033004386,0.0011287627,0.00048710714,0.000030086465,0.000108905944,0.0008320721],"genre_scores_gemma":[0.9983326,0.00036588736,0.00007412861,0.00087208906,0.00023782287,0.000036849564,0.000045373166,0.0000309786,0.0000042775882],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984925,0.00019842396,0.0005027647,0.00038306887,0.00016380424,0.00025944246],"domain_scores_gemma":[0.99919116,0.00023778426,0.00009864131,0.00021479893,0.00005440951,0.0002032301],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017225619,0.00015617303,0.0005169059,0.00010199189,0.00003074171,0.000019398356,0.000053880827,0.00019127314,0.000046086367],"category_scores_gemma":[0.00006614487,0.00012432384,0.00013573421,0.00015626659,0.00011519484,0.00003980445,0.000056388122,0.00021281812,0.000038242124],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012492864,0.00044408074,0.02356417,0.00031654682,0.00016304298,0.006323276,0.0001360182,9.2664135e-7,0.9060357,0.0027755073,0.00020782805,0.059907958],"study_design_scores_gemma":[0.009248908,0.00957537,0.38477755,0.0008680824,0.0023438823,0.0052817217,0.00021172497,0.0067979936,0.3268633,0.000088094566,0.25345507,0.0004883116],"about_ca_topic_score_codex":0.000015782336,"about_ca_topic_score_gemma":0.0000020990833,"teacher_disagreement_score":0.57917243,"about_ca_system_score_codex":0.00009647178,"about_ca_system_score_gemma":0.00017587928,"threshold_uncertainty_score":0.50697786},"labels":[],"label_agreement":null},{"id":"W4399787623","doi":"10.1093/neuonc/noae064.272","title":"GCT-17. EXPLORING NEW THRESHOLDS FOR BETA-HCG IN CENTRAL NERVOUS SYSTEM GERMINOMA","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Chemokine receptors and signaling","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Germinoma; Central nervous system; BETA (programming language); Medicine; Neuroscience; Internal medicine; Psychology; Computer science; Radiation therapy","score_opus":0.07287621574597153,"score_gpt":0.3185463476945076,"score_spread":0.2456701319485361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787623","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98128283,0.0016758667,0.0004786308,0.0039220736,0.004369739,0.0008270087,0.000009471733,0.0002873085,0.0071470467],"genre_scores_gemma":[0.9946253,0.00008020336,0.0004897282,0.00058660156,0.0033326847,0.00015147052,0.000022678301,0.00007106688,0.000640271],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982146,0.000046502737,0.00047350684,0.00048949907,0.00017340224,0.00060248893],"domain_scores_gemma":[0.998973,0.00043776017,0.000056969762,0.00022819133,0.00003563412,0.0002684499],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021428816,0.00021955327,0.0005995574,0.00021547648,0.000047465655,0.000034558998,0.00011818163,0.00020499928,0.00013279806],"category_scores_gemma":[0.00006431685,0.00019455477,0.00022046661,0.00026721144,0.000033900684,0.00010538484,0.00006224005,0.0004113806,0.000035096167],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012695548,0.0003324211,0.014552478,0.0022834267,0.00019921674,0.005910633,0.0040596584,0.0003606456,0.57798797,0.0043501398,0.09924559,0.28944826],"study_design_scores_gemma":[0.0029248106,0.0014066793,0.0018502746,0.00044677904,0.00023953678,0.0014655865,0.00051552226,0.005524548,0.04840339,0.00009666169,0.9368274,0.00029876223],"about_ca_topic_score_codex":0.00007154256,"about_ca_topic_score_gemma":0.000055377775,"teacher_disagreement_score":0.8375819,"about_ca_system_score_codex":0.00053588493,"about_ca_system_score_gemma":0.00050931954,"threshold_uncertainty_score":0.7933713},"labels":[],"label_agreement":null},{"id":"W4399787624","doi":"10.1093/neuonc/noae064.198","title":"ETMR-28. EVALUATING THERAPEUTIC APPROACHES IN EMBRYONAL TUMORS WITH PLAGL1 AND PLAGL2 AMPLIFICATION AND UNRAVELING MOLECULAR PARALLELS IN EPIGENETICALLY RELATED TUMORS WITH PLAG1-ALTERATIONS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Kruppel-like factors research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Parallels; Biology; Cancer research","score_opus":0.04808041833156861,"score_gpt":0.33018004007067625,"score_spread":0.28209962173910763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99460244,0.001251717,0.0019262903,0.0010529008,0.000035283243,0.00070536946,0.0000110939645,0.000023604964,0.00039128348],"genre_scores_gemma":[0.9978165,0.00015264236,0.0014541328,0.0001892515,0.000034460278,0.00016039192,0.00010776967,0.000056222092,0.000028608589],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99750656,0.0004968141,0.0004306145,0.00084320665,0.0002670523,0.0004557271],"domain_scores_gemma":[0.9991997,0.00025563364,0.00007996476,0.0002654382,0.00006683102,0.00013246646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006121102,0.00026712005,0.00030506402,0.0002592881,0.00008473621,0.00009266901,0.00015679917,0.00026288014,0.000011279328],"category_scores_gemma":[0.00016449389,0.00022460503,0.000027901619,0.0003585228,0.00030440203,0.000017004022,0.00010950903,0.00057354546,0.000003602068],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046372536,0.00011209849,0.014796964,0.000074407355,0.000058248716,0.00023696966,0.00069552107,0.005803684,0.96921074,0.0008537576,0.0000069117445,0.0076869936],"study_design_scores_gemma":[0.012470834,0.021155225,0.18994474,0.0008959501,0.00027236965,0.0036803656,0.0037465426,0.19816534,0.5608667,0.0033309285,0.0028276888,0.002643311],"about_ca_topic_score_codex":0.000036714955,"about_ca_topic_score_gemma":0.00027554037,"teacher_disagreement_score":0.40834403,"about_ca_system_score_codex":0.000081905455,"about_ca_system_score_gemma":0.00060840504,"threshold_uncertainty_score":0.91591275},"labels":[],"label_agreement":null},{"id":"W4399787675","doi":"10.1093/neuonc/noae064.161","title":"TRLS-08. ROVER: A PHASE 1/2 TRIAL IN PROGRESS OF AVAPRITINIB IN PEDIATRIC PATIENTS WITH SOLID TUMORS DEPENDENT ON KIT OR PDGFRA SIGNALING","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"PDGFRA; Cancer research; Medicine; Internal medicine; Oncology","score_opus":0.03006075930259937,"score_gpt":0.37202751995279526,"score_spread":0.3419667606501959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955952,0.00021698837,0.0000045903826,0.00039805088,0.00049525144,0.002458877,0.000024091469,0.000057448593,0.0007494602],"genre_scores_gemma":[0.99873996,0.000066495675,0.000099869176,0.00025095328,0.00048347955,0.00020086851,0.000029259025,0.000064864784,0.000064256164],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9965871,0.00033412545,0.00087726914,0.0006826835,0.00084395375,0.00067485165],"domain_scores_gemma":[0.9977942,0.0013756062,0.00016454063,0.0003484185,0.00010747272,0.00020973285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006414945,0.00026332928,0.00083086564,0.0008487095,0.000025977844,0.000023229355,0.0002240006,0.0002365401,0.0002197795],"category_scores_gemma":[0.0008029319,0.00019373091,0.00009174534,0.00097543537,0.00015510051,0.00009024065,0.000121878045,0.00086008455,0.00005052271],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.7628812,0.023379909,0.027702602,0.0037388941,0.0002026569,0.055971973,0.004202611,0.0010808229,0.009536425,0.00016487917,0.0024839218,0.10865409],"study_design_scores_gemma":[0.8912848,0.078622974,0.0012231626,0.0008309436,0.00025884222,0.00035355016,0.00025012338,0.010238722,0.012789284,0.000044763052,0.0036314903,0.00047135254],"about_ca_topic_score_codex":0.00010008942,"about_ca_topic_score_gemma":0.00015178016,"teacher_disagreement_score":0.12840357,"about_ca_system_score_codex":0.006350927,"about_ca_system_score_gemma":0.012346128,"threshold_uncertainty_score":0.9974635},"labels":[],"label_agreement":null},{"id":"W4399787683","doi":"10.1093/neuonc/noae064.700","title":"OTHR-30. THE CLINICAL AND BIOLOGICAL LANDSCAPE OF CNS CANCERS IN CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY: AN IRRDC COHORT STUDY","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Hospital for Sick Children; Princess Margaret Cancer Centre; Sinai Health System; Occupational Cancer Research Centre","funders":"","keywords":"Cohort; Medicine; Oncology; Internal medicine","score_opus":0.06269165643510391,"score_gpt":0.3841950514050217,"score_spread":0.32150339496991776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913284,0.0009950437,0.000011758713,0.0011326252,0.0012888538,0.0009820699,0.000015753212,0.000077108525,0.00416834],"genre_scores_gemma":[0.9984438,0.0003123996,0.00018442477,0.00076228747,0.00017244753,0.00009738931,0.000005289835,0.000009921147,0.000012053346],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99798876,0.00045595,0.00054410996,0.000545981,0.00022544085,0.0002397436],"domain_scores_gemma":[0.9983049,0.001175477,0.000065189786,0.00027478635,0.00006714989,0.00011250284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011661415,0.0001452628,0.00048959913,0.0000874638,0.000050267252,0.000008626143,0.00013258898,0.00021667333,0.0003364118],"category_scores_gemma":[0.0005504079,0.000091034235,0.00008509624,0.0002554139,0.001561223,0.000024324667,0.000102453996,0.00055227743,0.000011593533],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003116879,0.00040798867,0.99039173,0.00002569251,0.000047294758,0.00027392042,0.0004973689,0.000037903035,0.003110447,0.0005958992,0.0017739771,0.0025260723],"study_design_scores_gemma":[0.0015314601,0.008136113,0.96372944,0.00002644902,0.00012856557,0.00033399666,0.0009265733,0.0011242763,0.00012355438,0.0001797894,0.02364405,0.00011573821],"about_ca_topic_score_codex":0.0001199092,"about_ca_topic_score_gemma":0.0003639993,"teacher_disagreement_score":0.026662316,"about_ca_system_score_codex":0.0001508138,"about_ca_system_score_gemma":0.001395389,"threshold_uncertainty_score":0.57523906},"labels":[],"label_agreement":null},{"id":"W4399787702","doi":"10.1093/neuonc/noae064.031","title":"BIOM-12. LIQUID BIOPSIES IN CNS TUMORS: A COMBINED APPROACH TO PROFILING CSF","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; Sunnybrook Hospital; Izaak Walton Killam Health Centre; Hospital for Sick Children; McMaster University; London Health Sciences Centre; BC Children's Hospital; University of Toronto; University of Alberta","funders":"","keywords":"Profiling (computer programming); Liquid biopsy; Pathology; Medicine; Cancer research; Computer science; Internal medicine; Cancer","score_opus":0.039325480299829935,"score_gpt":0.3195016982892759,"score_spread":0.2801762179894459,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9672373,0.0010014259,0.000026005939,0.01335578,0.0005693311,0.0012728611,0.000014340484,0.00023644435,0.016286535],"genre_scores_gemma":[0.9938726,0.00008264856,0.0019676355,0.0030324599,0.00021138051,0.00065838953,0.00004472908,0.000047959813,0.00008224378],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983345,0.00011866683,0.0003764334,0.0005724672,0.00017747575,0.00042041548],"domain_scores_gemma":[0.9990209,0.00040325584,0.000037515998,0.00030012612,0.000041374326,0.0001968673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020320283,0.00022400537,0.00053123344,0.0004448945,0.000041447598,0.00003240106,0.00011137324,0.00015098877,0.000041141633],"category_scores_gemma":[0.0002088935,0.00017854184,0.00011545931,0.00053385744,0.00007177499,0.000055559954,0.000111706664,0.00029814272,0.00022204568],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042484505,0.013785364,0.08426266,0.0010492558,0.00044537254,0.019563915,0.0065458757,0.00009917339,0.7846165,0.011393302,0.022225024,0.051765114],"study_design_scores_gemma":[0.01540691,0.03632566,0.043645367,0.0011509679,0.0007713606,0.004168584,0.002621641,0.0065089636,0.3486179,0.0005406259,0.5389876,0.0012544426],"about_ca_topic_score_codex":0.00008246708,"about_ca_topic_score_gemma":0.00003094011,"teacher_disagreement_score":0.51676255,"about_ca_system_score_codex":0.00031745076,"about_ca_system_score_gemma":0.0003067035,"threshold_uncertainty_score":0.7280725},"labels":[],"label_agreement":null},{"id":"W4399787706","doi":"10.1093/neuonc/noae064.691","title":"OTHR-21. DEVELOPING A NEURO-ONCOLOGY PROGRAM FOR ADOLESCENTS AND YOUNG ADULTS IN CANADA – THE CANON EXPERIENCE","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University Health Network; London Health Sciences Centre; Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"Canon; Medicine; Oncology; Internal medicine; Psychology; Art; Literature","score_opus":0.027241688650517695,"score_gpt":0.3375838640222208,"score_spread":0.3103421753717031,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95698357,0.0013256456,0.000100190184,0.034033693,0.0038769802,0.002939815,0.000026424987,0.00015553672,0.0005581329],"genre_scores_gemma":[0.9796983,0.0002862594,0.0007700285,0.017635742,0.0005013177,0.0010031958,0.00001545461,0.00006556813,0.000024139781],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99692,0.0003764501,0.0007139763,0.0008515373,0.00037362744,0.0007643905],"domain_scores_gemma":[0.99790776,0.0011895976,0.00015281998,0.0003835807,0.00011245937,0.00025376212],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00047109084,0.00032018547,0.0006824502,0.0001494004,0.00014734967,0.00004375083,0.0002913529,0.00020150612,0.000017236996],"category_scores_gemma":[0.0008832809,0.0002633848,0.00008137446,0.0004564167,0.00023611764,0.000103234226,0.00018724322,0.0007268346,0.000005021681],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034456695,0.00073021505,0.19249941,0.0030071223,0.00013727328,0.0039157835,0.046588294,0.000013619731,0.018958284,0.0006186929,0.021434067,0.70865154],"study_design_scores_gemma":[0.0052980487,0.0029335534,0.081841104,0.0009646457,0.00011371384,0.0018256885,0.006227066,0.002108362,0.002342219,0.00010462703,0.89572287,0.00051810965],"about_ca_topic_score_codex":0.3199347,"about_ca_topic_score_gemma":0.92163384,"teacher_disagreement_score":0.8742888,"about_ca_system_score_codex":0.0017456131,"about_ca_system_score_gemma":0.008338306,"threshold_uncertainty_score":0.9999818},"labels":[],"label_agreement":null},{"id":"W4399787756","doi":"10.1093/neuonc/noae064.579","title":"NFS-21. DEMOGRAPHIC, CLINICAL AND IMAGING CHARACTERISTICS OF NEWLY DIAGNOSED OPTIC PATHWAY GLIOMAS ASSOCIATED WITH NF1: RESULTS FROM THE INTERNATIONAL MULTICENTER NF1-OPG NATURAL HISTORY STUDY","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Natural history; Medicine; Natural history study; Neuroimaging; Multicenter study; Internal medicine; Psychiatry","score_opus":0.028352382888624877,"score_gpt":0.29930930877971246,"score_spread":0.27095692589108755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787756","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99100184,0.0007723969,0.0000039579586,0.0039533842,0.0031368814,0.0005972234,0.00016826975,0.00010265822,0.00026336487],"genre_scores_gemma":[0.9974726,0.00009577527,0.00014979679,0.0016567509,0.00039709898,0.000026220105,0.00011605656,0.000044818942,0.000040880663],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973167,0.00051975437,0.0008856771,0.00062425935,0.00039756866,0.000256052],"domain_scores_gemma":[0.99356055,0.005418938,0.00033048066,0.00035664364,0.00019472094,0.00013864756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006221289,0.00024408485,0.00061319786,0.00016559912,0.0000661992,0.000047098612,0.0002260117,0.000115057424,0.000037050377],"category_scores_gemma":[0.0020006741,0.00016116606,0.00015242478,0.0001785034,0.0004392078,0.000110898036,0.00017324009,0.000765513,0.000006606995],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004029963,0.002038919,0.88494307,0.000032392636,0.0007894113,0.018089356,0.002472549,5.475626e-7,0.0653513,0.00005859935,0.010167235,0.012026655],"study_design_scores_gemma":[0.009091297,0.0024189136,0.9615401,0.00023365443,0.0005906579,0.00039676562,0.0005133524,0.0028175178,0.00033220203,0.000008375195,0.021862736,0.00019441356],"about_ca_topic_score_codex":0.00010479072,"about_ca_topic_score_gemma":0.00010041485,"teacher_disagreement_score":0.07659704,"about_ca_system_score_codex":0.0001355656,"about_ca_system_score_gemma":0.00030589238,"threshold_uncertainty_score":0.6572161},"labels":[],"label_agreement":null},{"id":"W4399787812","doi":"10.1093/neuonc/noae064.085","title":"DIPG-32. NEOANTIGEN HEAT SHOCK PROTEIN VACCINE, RHSC-DIPGVAX, IS ASSOCIATED WITH INCREASED VACCINE-INDUCED B CELLS AND BCR/TCR REPERTOIRE DIVERSITY IN PEDIATRIC PATIENTS WITH DIFFUSE MIDLINE GLIOMAS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"","keywords":"breakpoint cluster region; Repertoire; T-cell receptor; Heat shock protein; Immunology; Medicine; Virology; Biology; Immune system; Receptor; Genetics; T cell; Gene","score_opus":0.009175616349071639,"score_gpt":0.22077338426460397,"score_spread":0.21159776791553234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931864,0.0037278451,0.000008911563,0.0006881564,0.0005485554,0.0013866012,0.00010689709,0.0002248906,0.00012170219],"genre_scores_gemma":[0.9980529,0.00044881346,0.000023573271,0.0007337075,0.000050472318,0.000077094344,0.00015822059,0.000083251325,0.00037196564],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9963206,0.0011431879,0.00060882943,0.0009606419,0.00013573276,0.000831023],"domain_scores_gemma":[0.9981392,0.0008773701,0.00020929663,0.0005184091,0.00017552673,0.00008018114],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00037752176,0.0005799895,0.0009295671,0.0006463121,0.00049455836,0.00005322199,0.0004098685,0.0007095261,0.00027766617],"category_scores_gemma":[0.00021182006,0.00044166937,0.000116593204,0.0009745838,0.00010900687,0.00029422683,0.0004024284,0.0010159526,0.00008693517],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013072379,0.0020508708,0.17447022,0.00010650603,0.00059202354,0.00079614215,0.0022688105,0.000003351198,0.79982823,0.000010571543,0.0021792348,0.0046216366],"study_design_scores_gemma":[0.044695523,0.016675169,0.58257383,0.00036112146,0.0007940179,0.00033557691,0.000291086,0.0000632658,0.3243524,0.000035977522,0.02818225,0.0016397497],"about_ca_topic_score_codex":0.0006073948,"about_ca_topic_score_gemma":0.0004439842,"teacher_disagreement_score":0.47547585,"about_ca_system_score_codex":0.0002640391,"about_ca_system_score_gemma":0.00039710532,"threshold_uncertainty_score":0.9998035},"labels":[],"label_agreement":null},{"id":"W4399787813","doi":"10.1093/neuonc/noae064.003","title":"ATRT-03. PRIMARY DIFFUSE LEPTOMENINGEAL ATYPICAL TERATOID/RHABDOID TUMOR (ATRT) OF CHILDHOOD DEMONSTRATING UNEXPECTED IMPROVEMENT UPON CESSATION OF CONVENTIONAL THERAPY FOR PRESUMED PROGRESSION; A MOLECULARLY CHARACTERIZED CASE REPORT","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Atypical teratoid rhabdoid tumor; Medicine; Pathology; Oncology; Immunohistochemistry","score_opus":0.01137535861243506,"score_gpt":0.2981042778859546,"score_spread":0.28672891927351957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99427235,0.00082622207,0.0031029875,0.00017812187,0.00040135684,0.0010224043,0.00007931879,0.000042365144,0.000074856864],"genre_scores_gemma":[0.99484634,0.00007895013,0.0037161168,0.00014092843,0.00026397212,0.00036630378,0.00052942924,0.000042736414,0.000015228334],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99798566,0.00015038173,0.0008109885,0.0005650156,0.00022740725,0.0002605438],"domain_scores_gemma":[0.9988455,0.00010331487,0.0004663519,0.00029407814,0.00020704183,0.00008370504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003247179,0.00022401004,0.0003831602,0.000079928235,0.000081511724,0.000026794463,0.00013212851,0.00020814007,0.00001778777],"category_scores_gemma":[0.0001652958,0.00019934638,0.00023911736,0.00011450401,0.00010464049,0.000013278665,0.00008020388,0.00017459954,5.0580394e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010695839,0.0005396414,0.00041162627,0.00017670743,0.00015373607,0.00063723925,0.000169496,0.000014830778,0.9703932,0.000023116807,0.000074467316,0.026336368],"study_design_scores_gemma":[0.00453577,0.0034977384,0.0012893392,0.00011459867,0.00008090016,0.0037477433,0.00006589987,0.0027964625,0.9810434,0.0000502675,0.0025408752,0.00023702439],"about_ca_topic_score_codex":0.000009844167,"about_ca_topic_score_gemma":0.0000052142263,"teacher_disagreement_score":0.026099343,"about_ca_system_score_codex":0.000063705986,"about_ca_system_score_gemma":0.00066746055,"threshold_uncertainty_score":0.812911},"labels":[],"label_agreement":null},{"id":"W4399787827","doi":"10.1093/neuonc/noae064.139","title":"DIPG-86. INVESTIGATING THE TUMOR ENVIRONMENT AND SIGNALING DEPENDENCIES DRIVING DIFFUSE MIDLINE GLIOMA TUMOR INITIATION, PROGRESSION, AND RESISTANCE: A COMPREHENSIVE APPROACH LEVERAGING BULK MULTIOMICS DECONVOLUTION AND SINGLE-CELL OMICS VALIDATION","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Deconvolution; Omics; Glioma; Cell; Computational biology; Cancer research; Medicine; Biology; Computer science; Bioinformatics; Genetics","score_opus":0.021655528524746264,"score_gpt":0.25115165998225814,"score_spread":0.22949613145751188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98907,0.006554551,0.0032311263,0.00045033873,0.0001708361,0.0004171667,0.00002401438,0.000021901165,0.000060094313],"genre_scores_gemma":[0.9901134,0.00095328724,0.007941535,0.0005641833,0.00022580086,0.00006333252,0.00009667646,0.000036152316,0.0000056345734],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986232,0.00014803253,0.00033323583,0.00054142904,0.00011878209,0.00023532913],"domain_scores_gemma":[0.99906605,0.00041526562,0.00018285305,0.00017163703,0.00006032669,0.00010384625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024315683,0.00020903128,0.00019709386,0.00007094488,0.00029701766,0.00015847251,0.00008720957,0.000106858235,0.0000011727183],"category_scores_gemma":[0.00025367495,0.00018697033,0.000031549003,0.000077519224,0.0002871198,0.000018967841,0.0002593406,0.00019648293,5.593961e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004062705,0.000067133864,0.0027516247,0.00012777817,0.000020961694,0.000023968914,0.0008439272,0.00049460225,0.9940192,0.00013122731,0.000089947236,0.0013890007],"study_design_scores_gemma":[0.0032665299,0.0009549887,0.0045406,0.0001916433,0.0002890351,0.00082125334,0.0022089928,0.045323044,0.9008632,0.0010533566,0.039663147,0.000824235],"about_ca_topic_score_codex":0.000009103794,"about_ca_topic_score_gemma":0.000017536644,"teacher_disagreement_score":0.09315603,"about_ca_system_score_codex":0.000071633855,"about_ca_system_score_gemma":0.00012238204,"threshold_uncertainty_score":0.7624428},"labels":[],"label_agreement":null},{"id":"W4399787842","doi":"10.1093/neuonc/noae064.183","title":"ETMR-13. MARROW-ABLATIVE CONSOLIDATION CHEMOTHERAPY WITH AUTOLOGOUS HEMATOPOIETIC PROGENITOR CELL RESCUE (HDCT) DECREASES THE DEVELOPMENT OF CHOROID PLEXUS CARCINOMA (CPC)-SPECIFIC RELAPSE IN HIGH-RISK TP53-MUTATED (GERMLINE OR SOMATIC) YOUNG CHILDREN WITH NEWLY DIAGNOSED CPC","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital","funders":"","keywords":"Medicine; Ablative case; Somatic cell; Progenitor cell; Oncology; Bone marrow; Internal medicine; Stem cell; Radiation therapy; Biology; Gene","score_opus":0.013433519201668012,"score_gpt":0.25818499136866385,"score_spread":0.24475147216699583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99341965,0.0013747538,0.00007807584,0.0011898126,0.00019123162,0.0033974228,0.000044477278,0.00015792566,0.00014663476],"genre_scores_gemma":[0.99358594,0.00033551452,0.004467841,0.00021640428,0.000112308764,0.00094292004,0.00020105985,0.000113649,0.000024377534],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99676526,0.00044707494,0.00093359256,0.00082325994,0.0004715876,0.0005592003],"domain_scores_gemma":[0.9974151,0.0012070305,0.00038812624,0.0005728551,0.00019900805,0.00021785086],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032794333,0.00053131167,0.0009867667,0.00036206175,0.00017698627,0.000051872914,0.0002142459,0.0002474201,0.00016033392],"category_scores_gemma":[0.0001381935,0.00030096906,0.00010088509,0.0008898859,0.000312329,0.00011073907,0.00006262161,0.00051095354,0.00003188736],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009399714,0.0062969765,0.8540271,0.00043911143,0.0015307994,0.0074204225,0.019610524,0.0004075405,0.07174046,0.00015557159,0.0021161225,0.026855659],"study_design_scores_gemma":[0.022074625,0.0065765367,0.629792,0.00046092994,0.000812939,0.0021227992,0.0013756864,0.0008253368,0.33421484,0.00004902963,0.0011982955,0.00049697544],"about_ca_topic_score_codex":0.0004916251,"about_ca_topic_score_gemma":0.0023356252,"teacher_disagreement_score":0.2624744,"about_ca_system_score_codex":0.00053497165,"about_ca_system_score_gemma":0.0014643567,"threshold_uncertainty_score":0.99994427},"labels":[],"label_agreement":null},{"id":"W4399787848","doi":"10.1093/neuonc/noae064.068","title":"DIPG-15. NOVEL CNS SENSING SYNNOTCH-CAR T CELLS FOR TARGETING DIFFUSE MIDLINE GLIOMA","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; University of Toronto","funders":"","keywords":"Glioma; Medicine; Neuroscience; Cancer research; Biology","score_opus":0.04177343121070988,"score_gpt":0.34884445503677874,"score_spread":0.3070710238260689,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97117305,0.0008681054,0.004816709,0.01204001,0.0039043948,0.002005384,0.0000903498,0.00053203787,0.004569991],"genre_scores_gemma":[0.9765047,0.00027525783,0.010501718,0.0043779323,0.004404365,0.000088654335,0.00012478081,0.00034361082,0.0033790255],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.997177,0.00015798328,0.00055627903,0.0007990615,0.00042029045,0.00088936416],"domain_scores_gemma":[0.9964679,0.0024107993,0.00008739903,0.00047434293,0.00022921654,0.0003303765],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007098914,0.0003225987,0.00068766356,0.00042257408,0.00014635046,0.00007338413,0.00019017424,0.0003421135,0.0006986011],"category_scores_gemma":[0.0006657834,0.0002918875,0.00032223546,0.00056426454,0.00020121128,0.00008186459,0.00017771989,0.00084896624,0.00017801023],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072220044,0.00034743347,0.00005051358,0.00031806584,0.00011984476,0.001788562,0.0005176082,0.000014992486,0.94826174,0.00009526596,0.016565338,0.031198416],"study_design_scores_gemma":[0.0028441993,0.0012882524,0.000017323991,0.000065769724,0.0001261982,0.00073449337,0.0001457011,0.014795364,0.40097266,0.000048624748,0.57877976,0.00018163164],"about_ca_topic_score_codex":0.00003357187,"about_ca_topic_score_gemma":0.00001918033,"teacher_disagreement_score":0.56221443,"about_ca_system_score_codex":0.00041229586,"about_ca_system_score_gemma":0.0004791855,"threshold_uncertainty_score":0.9999533},"labels":[],"label_agreement":null},{"id":"W4399787930","doi":"10.1093/neuonc/noae064.120","title":"DIPG-67. RE-IRRADIATION PRACTICES AND OUTCOMES IN PATIENTS WITH DIPG/DMG: A REPORT FROM THE INTERNATIONAL DIPG REGISTRY","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; Hospital for Sick Children","funders":"","keywords":"Medicine","score_opus":0.0337108376477026,"score_gpt":0.37432074616300565,"score_spread":0.34060990851530304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787930","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9398683,0.00015301093,0.000021600497,0.05172594,0.0002992234,0.00034547958,0.000032721706,0.000055237026,0.007498491],"genre_scores_gemma":[0.9967664,0.00007558855,0.00022292149,0.0021086235,0.0002841785,0.00009561415,0.00014990792,0.000015829106,0.00028094088],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989112,0.000052212436,0.0002867481,0.00038271115,0.00023013946,0.00013697783],"domain_scores_gemma":[0.99817616,0.0011958153,0.00020754417,0.00027885783,0.000052022442,0.00008960031],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017539719,0.00011871736,0.00019626238,0.000032313852,0.000052540036,0.000046983794,0.00012373673,0.00010749971,0.00010134554],"category_scores_gemma":[0.001035421,0.0000769029,0.000034007986,0.00013041432,0.0001195069,0.00012315712,0.000053762797,0.00047707293,0.000013785799],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044150194,0.0004420619,0.96481645,0.000041175954,0.00014302561,0.00071018725,0.00030678598,0.000004927902,0.01975097,0.00021031096,0.0049409326,0.008191667],"study_design_scores_gemma":[0.0015179527,0.00017594264,0.6226239,0.000041191208,0.00016719205,0.00017101501,0.000102997874,0.00048061207,0.001285489,0.00016572609,0.37316748,0.00010043454],"about_ca_topic_score_codex":0.000057312143,"about_ca_topic_score_gemma":0.000027850048,"teacher_disagreement_score":0.36822656,"about_ca_system_score_codex":0.00012584233,"about_ca_system_score_gemma":0.00015348752,"threshold_uncertainty_score":0.31360093},"labels":[],"label_agreement":null},{"id":"W4399787937","doi":"10.1093/neuonc/noae064.045","title":"CP-07. FEASIBILITY, TOLERABILITY AND FIRST EXPERIENCE OF INTRACYSTIC TREATMENT WITH PEGINTERFERON ALFA-2A IN PATIENTS WITH CYSTIC CRANIOPHARYNGIOMA","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"Tolerability; Craniopharyngioma; Medicine; Peginterferon alfa-2a; Internal medicine; Surgery; Ribavirin; Adverse effect; Virology","score_opus":0.015902674095488286,"score_gpt":0.28322842089823497,"score_spread":0.2673257468027467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99717206,0.000525029,0.00003644663,0.000534044,0.00013378247,0.0010158692,0.000028942988,0.00004125482,0.00051257893],"genre_scores_gemma":[0.99947566,0.00006245959,0.00017835961,0.00009441817,0.000019646608,0.00010020465,0.00003118213,0.00002160689,0.000016480515],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986034,0.00007612931,0.00031430708,0.00055934733,0.00017427628,0.00027251532],"domain_scores_gemma":[0.99912906,0.0003069061,0.00005927082,0.00030346247,0.000053170355,0.00014811699],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000058426656,0.00024534253,0.0005660849,0.00011896413,0.00004291321,0.0000127791345,0.00005947899,0.000082923405,0.000081895494],"category_scores_gemma":[0.000045536734,0.00015136004,0.00004474709,0.00018777001,0.00024184874,0.00011140469,0.0000377784,0.00012507783,0.000009132197],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005641661,0.0029799885,0.9784698,0.00023483059,0.000088800574,0.00093088695,0.0024499374,0.000012561016,0.0004378963,0.000019190426,0.000020500866,0.00871393],"study_design_scores_gemma":[0.013537651,0.039389785,0.94413626,0.0002312931,0.00028737396,0.00023547963,0.00026373565,0.00038310327,0.0003320498,0.00010749088,0.0009117573,0.0001840002],"about_ca_topic_score_codex":0.0003142824,"about_ca_topic_score_gemma":0.00065448147,"teacher_disagreement_score":0.036409795,"about_ca_system_score_codex":0.00033245047,"about_ca_system_score_gemma":0.00019081883,"threshold_uncertainty_score":0.6172283},"labels":[],"label_agreement":null},{"id":"W4399787963","doi":"10.1093/neuonc/noae064.041","title":"CP-03. EXTRACELLULAR MATRIX REMODELING REVEALS NON-CELL AUTONOMOUS TUMOR FORMATION MECHANISM IN ADAMANTINOMATOUS CRANIOPHARYNGIOMAS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Mechanism (biology); Extracellular matrix; Cell biology; Chemistry; Matrix (chemical analysis); Biology; Physics","score_opus":0.015858918191849907,"score_gpt":0.28345932259239526,"score_spread":0.26760040440054533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98351157,0.005475206,0.002092146,0.0011771604,0.0007818905,0.0009659451,0.000016662982,0.00022329028,0.0057561174],"genre_scores_gemma":[0.9964106,0.0002738685,0.0019415141,0.0005156224,0.00014105014,0.00007269157,0.00008084779,0.000057362653,0.0005064263],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9981031,0.00009455181,0.0006125605,0.0004944818,0.00020718356,0.0004881476],"domain_scores_gemma":[0.99923694,0.00014910962,0.00010759411,0.00029569582,0.000043899974,0.00016676207],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026738507,0.0002777489,0.0005513865,0.00037840693,0.000095353666,0.000034708613,0.000117438016,0.00019469409,0.00011587341],"category_scores_gemma":[0.00003798254,0.00024691146,0.00015873472,0.0003014473,0.00002643031,0.00024536822,0.00006271603,0.00035922584,0.00051004416],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005094427,0.0011954501,0.0017194967,0.00088809617,0.000065985616,0.027191717,0.0019334874,0.00021884534,0.95343155,0.0016882535,0.0022862223,0.008871449],"study_design_scores_gemma":[0.039039847,0.010938788,0.0049238647,0.0012638385,0.0018055909,0.022983924,0.0016632079,0.64665174,0.107564084,0.026065692,0.13492431,0.002175113],"about_ca_topic_score_codex":0.00008658578,"about_ca_topic_score_gemma":0.000022326676,"teacher_disagreement_score":0.84586746,"about_ca_system_score_codex":0.00025984872,"about_ca_system_score_gemma":0.00029167513,"threshold_uncertainty_score":0.99999833},"labels":[],"label_agreement":null},{"id":"W4399787981","doi":"10.1093/neuonc/noae064.228","title":"EPEN-26. DRUG SCREENING IN PATIENT-DERIVED MODELS OF POSTERIOR FOSSA A EPENDYMOMA REVEALS NOVEL PHARMACOLOGICAL VULNERABILITIES","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Ependymoma; Posterior fossa; Drug; Medicine; Computational biology; Computer science; Biology; Pharmacology; Radiology","score_opus":0.04859920495729063,"score_gpt":0.32903128993282044,"score_spread":0.2804320849755298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399787981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99073,0.0012243005,0.00007881413,0.0051152133,0.0005162198,0.0010402023,0.000060363083,0.00013568591,0.0010992144],"genre_scores_gemma":[0.996247,0.00007521033,0.001637531,0.0015317329,0.000096615935,0.00032850073,0.000016064407,0.000048618964,0.000018712852],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977473,0.0002473307,0.0007116339,0.0005728309,0.0002742155,0.00044668926],"domain_scores_gemma":[0.99834687,0.0010055931,0.00012948668,0.0002398345,0.00009885507,0.00017936666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027824874,0.0002714223,0.0007919818,0.000307736,0.00005108503,0.00002183141,0.00012484977,0.00018127338,0.00025939365],"category_scores_gemma":[0.00017777171,0.00021481942,0.0002065196,0.00029988584,0.00016185889,0.0001477881,0.00017574774,0.00041348382,0.00002113322],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061741774,0.0015655702,0.0019848535,0.00015076966,0.00015062165,0.005331929,0.001951219,0.00026845516,0.9359155,0.00038996703,0.0010675497,0.050606094],"study_design_scores_gemma":[0.025096446,0.013916837,0.021397807,0.0012031324,0.0013834966,0.0061736843,0.0028182624,0.025251973,0.88316685,0.0028492415,0.01574216,0.0010001165],"about_ca_topic_score_codex":0.00015944107,"about_ca_topic_score_gemma":0.00005281611,"teacher_disagreement_score":0.05274871,"about_ca_system_score_codex":0.00018317459,"about_ca_system_score_gemma":0.00020059523,"threshold_uncertainty_score":0.8760082},"labels":[],"label_agreement":null},{"id":"W4399788046","doi":"10.1093/neuonc/noae064.229","title":"EPEN-27. GAINING A CLUE FROM 1Q: A HIGH-RISK CHROMOSOMAL GAIN IN PEDIATRIC POSTERIOR FOSSA EPENDYMOMA","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Ependymoma; Posterior fossa; Medicine; Radiology","score_opus":0.017279964879323657,"score_gpt":0.2906174167592925,"score_spread":0.27333745187996883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399788046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870929,0.002947016,0.00000815549,0.0055515463,0.0019530524,0.00074008584,0.00012744003,0.00019960746,0.001380198],"genre_scores_gemma":[0.99597806,0.0005436537,0.0004668606,0.001382219,0.0011844148,0.00022610732,0.000102268554,0.00008078562,0.00003564141],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972484,0.00035680638,0.0006043754,0.00087106903,0.00030122648,0.00061810086],"domain_scores_gemma":[0.997769,0.0013322561,0.00014120585,0.00043264133,0.000047906244,0.00027700598],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026366787,0.00036038135,0.0007835369,0.00049973215,0.0000758769,0.00006045273,0.00016386349,0.00034280107,0.00054784823],"category_scores_gemma":[0.00034007532,0.00031148997,0.00019946176,0.00057985436,0.0000659989,0.000112967115,0.00018530234,0.00068708643,0.00065635284],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012021008,0.0032718298,0.47615498,0.00026353658,0.00043410194,0.18190302,0.003992491,0.000057584744,0.10852987,0.0004642971,0.015586372,0.20813979],"study_design_scores_gemma":[0.030774368,0.017144468,0.81778204,0.0005269275,0.003249421,0.00603672,0.00073668285,0.0035997727,0.033446893,0.0018901239,0.08347208,0.0013405127],"about_ca_topic_score_codex":0.0011515428,"about_ca_topic_score_gemma":0.00071523583,"teacher_disagreement_score":0.34162703,"about_ca_system_score_codex":0.00043413645,"about_ca_system_score_gemma":0.00047384636,"threshold_uncertainty_score":0.9999337},"labels":[],"label_agreement":null},{"id":"W4399788059","doi":"10.1093/neuonc/noae064.230","title":"EPEN-28. NOVEL TARGET IDENTIFICATION IN RECURRENT POSTERIOR FOSSA EPENDYMOMA GROUP A","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Ependymoma; Posterior fossa; Identification (biology); Group (periodic table); Medicine; Surgery; Biology; Chemistry; Botany","score_opus":0.029043228449110312,"score_gpt":0.32400332458535563,"score_spread":0.2949600961362453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399788059","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9813951,0.0018266191,0.00008840242,0.01203742,0.0023308971,0.00088828924,0.00004480596,0.00012297377,0.001265486],"genre_scores_gemma":[0.9977907,0.0001087919,0.00042771196,0.00089988124,0.0002158395,0.0003548458,0.00011992458,0.000037640682,0.000044643428],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.998327,0.0000928936,0.00047168235,0.0005673099,0.00021138549,0.00032973604],"domain_scores_gemma":[0.99916786,0.00024622082,0.00008154106,0.00031435923,0.00004777124,0.00014225923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002496664,0.00019722815,0.0003899823,0.0003332672,0.000042947668,0.000048799906,0.000103925784,0.00016691172,0.0002339876],"category_scores_gemma":[0.00014105659,0.00017000284,0.00012773255,0.00036885767,0.00005254201,0.00010644039,0.00007845251,0.00030216418,0.00035585283],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002941688,0.0027185786,0.0053189374,0.00015923959,0.00008647973,0.0066272523,0.00073641865,0.000003940599,0.8331887,0.0013967364,0.004593944,0.14487562],"study_design_scores_gemma":[0.011026383,0.0068698945,0.2533223,0.0005060704,0.0005176468,0.005908477,0.00029767142,0.0033143142,0.08767161,0.0008080379,0.6291851,0.000572476],"about_ca_topic_score_codex":0.00006383267,"about_ca_topic_score_gemma":0.00014303219,"teacher_disagreement_score":0.7455171,"about_ca_system_score_codex":0.00041854862,"about_ca_system_score_gemma":0.00016140733,"threshold_uncertainty_score":0.6932515},"labels":[],"label_agreement":null},{"id":"W4399788453","doi":"10.1093/neuonc/noae064.611","title":"QOL-23. POTENTIAL MYELIN REPAIR AFTER IRRADIATED PEDIATRIC BRAIN TUMOR: A MAGNETIZATION TRANSFER IMAGING ANALYSIS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Advanced MRI Techniques and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hospital for Sick Children","funders":"","keywords":"Magnetization transfer; Myelin; Medicine; Magnetic resonance imaging; Nuclear magnetic resonance; Neuroscience; Psychology; Radiology; Internal medicine; Physics; Central nervous system","score_opus":0.007680952033568629,"score_gpt":0.2979096014245667,"score_spread":0.2902286493909981,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399788453","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43780294,0.0029475112,0.5171665,0.033204567,0.0006049647,0.0018418474,0.00013385301,0.0033543124,0.0029435146],"genre_scores_gemma":[0.9838137,0.00037182658,0.009209276,0.005070709,0.00064212235,0.00033944772,0.00018408359,0.000060942875,0.00030787787],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.998451,0.000093999035,0.00041169024,0.000565336,0.0001725149,0.0003054471],"domain_scores_gemma":[0.99924856,0.00014381026,0.000036504953,0.00033314427,0.00008935363,0.00014859547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016941372,0.00018699777,0.0003611323,0.00056686095,0.00006580416,0.000023609786,0.00008310605,0.00011365741,0.0004941586],"category_scores_gemma":[0.000060293765,0.00017696794,0.00032626392,0.0015918019,0.00006449388,0.000096969765,0.000033363005,0.00037010174,0.00009334297],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014452962,0.0014655786,0.030750368,0.0005941424,0.00051686086,0.010871026,0.0014600592,0.0041874032,0.7459795,0.0031139709,0.07810224,0.12151356],"study_design_scores_gemma":[0.0021150555,0.001375914,0.040772095,0.000036523714,0.0076442612,0.0009118422,0.00013039276,0.23485701,0.0027567958,0.0010650486,0.70762587,0.0007091705],"about_ca_topic_score_codex":0.0000147138635,"about_ca_topic_score_gemma":0.00001862935,"teacher_disagreement_score":0.7432227,"about_ca_system_score_codex":0.00014060552,"about_ca_system_score_gemma":0.00018262267,"threshold_uncertainty_score":0.7216543},"labels":[],"label_agreement":null},{"id":"W4399812090","doi":"10.1093/neuonc/noae064.780","title":"Author Index","year":2024,"lang":"en","type":"paratext","venue":"Neuro-Oncology","topic":"","field":"","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Nuclear Safety Commission","keywords":"Index (typography); Computer science; World Wide Web","score_opus":0.04177445664300288,"score_gpt":0.3591699679761732,"score_spread":0.3173955113331703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399812090","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012339344,0.0035658437,0.00003770075,0.005360273,0.06169325,0.0011585691,0.0018415692,0.0008196151,0.9242892],"genre_scores_gemma":[0.02050204,0.00035620827,0.00021121945,0.006765715,0.010700605,0.0008264467,0.0014261391,0.002208893,0.95700276],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99404603,0.0011538811,0.0009631631,0.0018743533,0.0006686292,0.0012939357],"domain_scores_gemma":[0.99651283,0.0010226236,0.0005598866,0.0012569609,0.00020103606,0.00044666277],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.00058517425,0.0009983456,0.0016871014,0.0012044347,0.00013532994,0.00014907368,0.0012236614,0.0029243513,0.02591469],"category_scores_gemma":[0.00045398087,0.0009882514,0.000468689,0.0010950519,0.00044704563,0.0001016195,0.0009460035,0.0048726145,0.8796553],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018093771,0.000171792,0.0000074614213,0.00020321184,0.00016593766,0.0019612305,0.0002458154,0.00008830222,0.058601994,0.0002687089,0.93185484,0.0062497538],"study_design_scores_gemma":[0.00065765844,0.0009354514,0.000016276805,0.00007132216,0.00028260043,0.0007407425,0.000035988887,0.00021722207,0.0011935749,0.00029151994,0.9948195,0.0007381021],"about_ca_topic_score_codex":0.00008479051,"about_ca_topic_score_gemma":0.00014032288,"teacher_disagreement_score":0.85374063,"about_ca_system_score_codex":0.0015994331,"about_ca_system_score_gemma":0.0031594306,"threshold_uncertainty_score":0.9992568},"labels":[],"label_agreement":null},{"id":"W4399899541","doi":"10.1093/neuonc/noae103","title":"Leptomeningeal metastases from solid tumors: A Society for Neuro-Oncology and American Society of Clinical Oncology consensus review on clinical management and future directions","year":2024,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"National Cancer Institute; National Institutes of Health; American Society of Clinical Oncology","keywords":"Clinical Oncology; Medicine; Oncology; Internal medicine; Cancer","score_opus":0.15340276550253168,"score_gpt":0.493052051049666,"score_spread":0.3396492855471343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399899541","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003407366,0.9712094,0.000021983662,0.017578555,0.0027562368,0.0056356606,0.0017614572,0.00014370351,0.00055225333],"genre_scores_gemma":[0.000013568297,0.9582607,0.02116451,0.015631452,0.0028032751,0.0012128974,0.0006458233,0.00017468716,0.000093070346],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9889403,0.0032507612,0.004267899,0.002316385,0.00040729257,0.00081737986],"domain_scores_gemma":[0.97969073,0.01577465,0.0026531895,0.0009366379,0.00021735042,0.000727445],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0034550785,0.0011312638,0.011452997,0.00019368147,0.00021351477,0.000027120012,0.00028203777,0.0011020016,0.00007922335],"category_scores_gemma":[0.00076025655,0.0008152152,0.004734131,0.0006165043,0.0020954763,0.000032523356,0.0005727084,0.0026172253,0.00002748845],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004129132,0.0016860556,0.00003419254,0.01704559,0.006349404,0.00079835876,0.00008338468,7.244373e-8,0.0000032322944,0.00014671516,0.1730278,0.8004123],"study_design_scores_gemma":[0.004210117,0.023133593,0.000061367056,0.005037674,0.040731654,0.0012367507,0.00041717553,0.000028245582,9.757368e-7,0.000049844424,0.9246542,0.000438427],"about_ca_topic_score_codex":0.00005498846,"about_ca_topic_score_gemma":0.0000358409,"teacher_disagreement_score":0.79997385,"about_ca_system_score_codex":0.0004980755,"about_ca_system_score_gemma":0.0021509468,"threshold_uncertainty_score":0.9996838},"labels":[],"label_agreement":null},{"id":"W4399973113","doi":"10.1093/neuonc/noae108","title":"No benefit from TMZ treatment in glioblastoma with truly unmethylated <i>MGMT</i> promoter: Reanalysis of the CE.6 and the pooled Nordic/NOA-08 trials in elderly glioblastoma patients","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Canadian Cancer Society Research Institute; Deutschen Konsortium für Translationale Krebsforschung; Universität Zürich; Centre Hospitalier Universitaire Vaudois; Umeå Universitet; Linköpings Universitet; Université de Lausanne; European Organisation for Research and Treatment of Cancer; Deutsches Krebsforschungszentrum","keywords":"Temozolomide; Methyltransferase; Oncology; Medicine; Internal medicine; Clinical trial; O-6-methylguanine-DNA methyltransferase; Population; Radiation therapy; DNA methylation; Glioblastoma; Chemotherapy; Methylation; Cancer research; Biology; Gene; Genetics; Gene expression","score_opus":0.01213492661300165,"score_gpt":0.27164213802023135,"score_spread":0.2595072114072297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399973113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912515,0.001040467,0.000001378047,0.0043207095,0.00029995167,0.0024356379,0.00011176862,0.000041437535,0.0004971031],"genre_scores_gemma":[0.99849635,0.00037030454,0.00005682244,0.00042195673,0.0000837621,0.00045748043,0.000023791614,0.000048370024,0.00004116066],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961481,0.0011889609,0.0011384812,0.0007106557,0.00041542732,0.0003983818],"domain_scores_gemma":[0.99564457,0.0030620338,0.00039103295,0.0006394714,0.00013461482,0.0001282835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007267152,0.00041657657,0.0017889279,0.0004406583,0.00007111727,0.000046035453,0.00018776063,0.00024040436,0.000097083066],"category_scores_gemma":[0.0005814068,0.00019687807,0.00036326516,0.0011475014,0.00027810253,0.00008320307,0.000102166065,0.00034071165,0.000021840286],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04744128,0.011830211,0.47361743,0.00024079216,0.0057163597,0.004114457,0.009039516,0.0003679863,0.0773679,0.00035428637,0.00096788106,0.3689419],"study_design_scores_gemma":[0.23499255,0.100559585,0.3560656,0.0023341272,0.01581489,0.0003388261,0.0009936074,0.0061447164,0.24280752,0.0017787003,0.03689978,0.0012700998],"about_ca_topic_score_codex":0.0016465259,"about_ca_topic_score_gemma":0.008299069,"teacher_disagreement_score":0.3676718,"about_ca_system_score_codex":0.0004366024,"about_ca_system_score_gemma":0.0002781625,"threshold_uncertainty_score":0.8028455},"labels":[],"label_agreement":null},{"id":"W4400448150","doi":"10.1093/neuonc/noae120","title":"A kinome drug screen identifies multi-TKI synergies and ERBB2 signaling as a therapeutic vulnerability in MYC/TYR subgroup atypical teratoid rhabdoid tumors","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Ontario Institute for Cancer Research; University of Toronto; Hospital for Sick Children","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research","keywords":"Cancer research; Biology; PI3K/AKT/mTOR pathway; Kinase; MAPK/ERK pathway; Signal transduction; Cell biology","score_opus":0.01707681928460649,"score_gpt":0.3037402657138452,"score_spread":0.28666344642923874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400448150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98987263,0.008188735,0.0002909403,0.000757269,0.00039998442,0.00027063242,0.000020349938,0.00006635743,0.00013308293],"genre_scores_gemma":[0.99784535,0.00060804805,0.0002789779,0.0007954561,0.00021937072,0.00007674724,0.000048389073,0.000035405956,0.00009222957],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99794984,0.00034631937,0.00042175342,0.00076464284,0.00013986476,0.00037760485],"domain_scores_gemma":[0.9992708,0.00019272212,0.00006471562,0.0003167064,0.000052094514,0.00010295922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004469451,0.00025871405,0.00034724083,0.0001050233,0.00010357086,0.000100011006,0.00020366987,0.00023900987,0.000043461925],"category_scores_gemma":[0.00014968177,0.00023797645,0.00011803896,0.00015974844,0.0002463962,0.000013526762,0.00018452576,0.000400836,0.000021151405],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024612655,0.00011330074,0.003166411,0.00010593764,0.000044790566,0.00012437878,0.0005796647,0.0003848985,0.9824459,0.00011863978,0.00030316762,0.012366816],"study_design_scores_gemma":[0.004706365,0.0023824903,0.008982058,0.00040101836,0.00019983939,0.0011546807,0.0020401166,0.024356456,0.8478149,0.003112093,0.10313385,0.0017161276],"about_ca_topic_score_codex":0.00023630289,"about_ca_topic_score_gemma":0.0003930035,"teacher_disagreement_score":0.13463096,"about_ca_system_score_codex":0.000077753044,"about_ca_system_score_gemma":0.00026955435,"threshold_uncertainty_score":0.9704398},"labels":[],"label_agreement":null},{"id":"W4400811773","doi":"10.1093/neuonc/noae133","title":"Risk of new tumor, carotid stenosis, and stroke after stereotactic radiosurgery for pituitary tumor: A multicenter study of 2254 patients with imaging follow-up","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Université de Sherbrooke","funders":"Institut Servier; Servier; Hospices Civils de Lyon","keywords":"Radiosurgery; Medicine; Stenosis; Internal medicine; Stroke (engine); Radiology; Cardiology; Radiation therapy","score_opus":0.010106235952071455,"score_gpt":0.259128630144173,"score_spread":0.24902239419210154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400811773","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961258,0.0009262102,0.000028033968,0.00015791306,0.00057530805,0.001870354,0.000189111,0.00003352212,0.00009371851],"genre_scores_gemma":[0.9990537,0.00005460081,0.00022874337,0.0003541253,0.00005823119,0.00013547974,0.000026147876,0.000047498612,0.000041480966],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984141,0.000120682256,0.00045073967,0.00046390088,0.00023770714,0.00031287616],"domain_scores_gemma":[0.99879473,0.00045481412,0.00018152766,0.0002811171,0.00010761035,0.00018017818],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000110713634,0.00025783354,0.00071125984,0.00023218435,0.00004407138,0.000011883527,0.000063141764,0.000038976777,0.000028074806],"category_scores_gemma":[0.00009146618,0.00018345244,0.00013427307,0.00012287362,0.00007477217,0.00014346091,0.000062486586,0.0001819938,0.000002228036],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045163934,0.0021660537,0.9850351,0.00026033918,0.000675929,0.00047388027,0.0017974605,0.000001942923,0.00035588045,0.0000010479848,0.00067368324,0.004042247],"study_design_scores_gemma":[0.029227434,0.00989435,0.9554435,0.00016543808,0.0023387459,0.00005835239,0.001027599,0.00015803576,0.00027191298,0.00002143642,0.0012109844,0.00018222547],"about_ca_topic_score_codex":0.0003846907,"about_ca_topic_score_gemma":0.00015945494,"teacher_disagreement_score":0.029591657,"about_ca_system_score_codex":0.000069919595,"about_ca_system_score_gemma":0.00020762015,"threshold_uncertainty_score":0.74809736},"labels":[],"label_agreement":null},{"id":"W4401103260","doi":"10.1093/neuonc/noae128","title":"SNO-EANO-EURACAN consensus on management of pineal parenchymal tumors","year":2024,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto; Princess Margaret Cancer Centre; Mental Health Research Canada; Hospital for Sick Children","funders":"Health and Medical Research Fund","keywords":"Medicine; Parenchyma; Papillary tumor; Pathology","score_opus":0.06826265927675501,"score_gpt":0.3813802784144904,"score_spread":0.3131176191377354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401103260","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008550421,0.9689142,2.342127e-7,0.0012268109,0.0015872605,0.002185833,0.00016143083,0.00010922934,0.024959952],"genre_scores_gemma":[0.0013999674,0.99669933,0.00014032563,0.00043360307,0.0003109398,0.00048225198,0.00019845845,0.000109996174,0.00022513702],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.996984,0.00027405476,0.0010458698,0.000843265,0.00037978528,0.00047301155],"domain_scores_gemma":[0.997949,0.0005719406,0.00046846832,0.00069788005,0.00006417259,0.00024850646],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018029015,0.00063393434,0.0029020053,0.00048054976,0.00004314595,0.000013337622,0.00020413712,0.00037376603,0.00018011282],"category_scores_gemma":[0.000060537204,0.0004425796,0.0007970671,0.0004504923,0.00016939231,0.000008294319,0.00019767195,0.0006851445,0.0005957855],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007122675,0.0011661864,0.00002329447,0.021170035,0.0012245399,0.024513872,0.000028700151,0.0000010750647,0.000019651838,0.0019073233,0.032486115,0.91738796],"study_design_scores_gemma":[0.0013113717,0.0032981457,0.000038674996,0.010461914,0.007897761,0.0013006954,0.00003430052,0.000004160412,0.000047653255,0.000025529165,0.9753397,0.00024009001],"about_ca_topic_score_codex":0.00001980365,"about_ca_topic_score_gemma":0.0000052217156,"teacher_disagreement_score":0.94285357,"about_ca_system_score_codex":0.0004882474,"about_ca_system_score_gemma":0.00052058353,"threshold_uncertainty_score":0.9998026},"labels":[],"label_agreement":null},{"id":"W4401200548","doi":"10.1093/neuonc/noae142","title":"A comparative analysis of IDH-mutant glioma in pediatric, young adult, and older adult patients","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"National Institutes of Health; National Cancer Institute; Dana-Farber Cancer Institute; Pediatric Low Grade Astrocytoma Foundation; Pediatric Brain Tumor Foundation","keywords":"Glioma; Mutant; Medicine; Gerontology; Oncology; Biology; Genetics; Gene","score_opus":0.014357171846603017,"score_gpt":0.3071908395523446,"score_spread":0.2928336677057416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401200548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966906,0.00066246954,0.0000032144844,0.0007877045,0.00025785321,0.00045265284,0.00005245971,0.000028924323,0.0010641611],"genre_scores_gemma":[0.99904096,0.00039793237,0.00006028963,0.000300044,0.00005500626,0.000082809085,0.00004837738,0.000011921032,0.0000026358782],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99863356,0.000112865215,0.0004176075,0.00040459403,0.00020728355,0.00022406355],"domain_scores_gemma":[0.9989852,0.0004266037,0.000099742494,0.00017019366,0.00020150609,0.00011678038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006936506,0.00017101786,0.000745656,0.00088157854,0.000024027382,0.000012389027,0.000050238148,0.0001211889,0.000057495974],"category_scores_gemma":[0.00010937285,0.00013345892,0.0001381438,0.0013908426,0.00006585709,0.00005202281,0.000052664785,0.00017723626,0.000014301164],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018572347,0.0015332323,0.9717921,0.00010414743,0.00065600616,0.0013488183,0.0030357135,0.000014171314,0.017812934,0.00033886053,0.00079784426,0.0023804181],"study_design_scores_gemma":[0.0046833763,0.0019028948,0.9762176,0.000051337684,0.003872581,0.00005231567,0.00031156946,0.0029575245,0.009342153,0.000025607267,0.00044561512,0.00013740618],"about_ca_topic_score_codex":0.00019710086,"about_ca_topic_score_gemma":0.00080745865,"teacher_disagreement_score":0.008470781,"about_ca_system_score_codex":0.00013337529,"about_ca_system_score_gemma":0.0000957629,"threshold_uncertainty_score":0.5442297},"labels":[],"label_agreement":null},{"id":"W4401200574","doi":"10.1093/neuonc/noae143","title":"Temozolomide use in elderly patients with MGMT promoter unmethylated glioblastoma: Is it finally time to dismount a dead horse?","year":2024,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Temozolomide; Glioblastoma; Horse; Oncology; Medicine; Cancer research; Biology","score_opus":0.016065409108778447,"score_gpt":0.270192571550423,"score_spread":0.2541271624416445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401200574","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5621679,0.000059961538,9.831375e-7,0.4344904,0.00033829137,0.0022157703,0.00016879359,0.00009673318,0.00046120872],"genre_scores_gemma":[0.062857084,0.000028046654,0.00050265784,0.9302491,0.00093226833,0.0012837487,0.00075189985,0.00041689782,0.0029782834],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957735,0.00030950241,0.00080834056,0.0014674724,0.0006745101,0.0009666605],"domain_scores_gemma":[0.9977045,0.0006547266,0.00026213058,0.00083027093,0.0002699802,0.00027837552],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001370896,0.0008460255,0.0015147193,0.001006123,0.000059065977,0.000105628154,0.00027462587,0.0013289311,0.00079971453],"category_scores_gemma":[0.00021654075,0.000625334,0.00025558614,0.0007734769,0.000118418786,0.000121646735,0.0002169618,0.0022593068,0.003997634],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010669885,0.0013562727,0.0076886644,0.00018957474,0.00041793787,0.03129521,0.00047096476,0.0000043685864,0.0018354433,9.0705e-7,0.9508077,0.004866007],"study_design_scores_gemma":[0.0055482485,0.01958726,0.008405724,0.000614368,0.0009289919,0.00024299105,0.000007240847,0.000032581476,0.001246346,0.000017954852,0.96282035,0.00054796017],"about_ca_topic_score_codex":0.00016087676,"about_ca_topic_score_gemma":0.00031078357,"teacher_disagreement_score":0.4993108,"about_ca_system_score_codex":0.0010542577,"about_ca_system_score_gemma":0.0005178732,"threshold_uncertainty_score":0.9999676},"labels":[],"label_agreement":null},{"id":"W4401793465","doi":"10.1093/neuonc/noae166","title":"Distinct relapse pattern across molecular ependymoma types","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute; Universitätsklinikum Hamburg-Eppendorf; National Institutes of Health; Universitätsklinikum Heidelberg; Aarhus Universitetshospital; Medizinische Universität Wien; Hospital for Sick Children; CERN; Deutsche Forschungsgemeinschaft; Deutsches Krebsforschungszentrum; Rheinische Friedrich-Wilhelms-Universität Bonn; Universität Wien; Universitätsklinikum Essen; Deutschen Konsortium für Translationale Krebsforschung; Aarhus Universitet","keywords":"Ependymoma; Medicine; Internal medicine; Cohort; Gastroenterology; Pathology; Oncology","score_opus":0.017766836948739862,"score_gpt":0.3247350209039006,"score_spread":0.30696818395516073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401793465","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9801466,0.0018443123,0.000083080755,0.010366408,0.0011448793,0.0003150932,0.000036559723,0.00018881362,0.0058742776],"genre_scores_gemma":[0.9973118,0.000055296114,0.000061977094,0.0020994109,0.00020266253,0.00009419336,0.000040537703,0.00004519976,0.0000889446],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99876463,0.00007699104,0.00022103357,0.00042358704,0.00016926334,0.00034447052],"domain_scores_gemma":[0.9991628,0.0002884294,0.000036335252,0.00030804912,0.00004010767,0.00016431473],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00010293632,0.00017691757,0.00032197186,0.000066913744,0.00005811222,0.000035443034,0.00008168778,0.00014772487,0.00034159503],"category_scores_gemma":[0.0001126764,0.00013703712,0.00015070623,0.00017437366,0.0000756025,0.000037701808,0.000091447444,0.00026320643,0.0008970282],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001577256,0.0013060748,0.032311015,0.00021601243,0.00042063897,0.15172032,0.0009183157,0.000007371218,0.26552796,0.0010018103,0.023236154,0.5231766],"study_design_scores_gemma":[0.0032255296,0.0031214142,0.0317017,0.00013741592,0.0005233892,0.004576706,0.00009658573,0.0005500389,0.08624458,0.00033366913,0.8691989,0.00029007424],"about_ca_topic_score_codex":0.000043884243,"about_ca_topic_score_gemma":0.000050289666,"teacher_disagreement_score":0.84596276,"about_ca_system_score_codex":0.00015294168,"about_ca_system_score_gemma":0.000112090995,"threshold_uncertainty_score":0.9998809},"labels":[],"label_agreement":null},{"id":"W4401984414","doi":"10.1093/neuonc/noae171","title":"NANO-LM: An updated scorecard for the clinical assessment of patients with leptomeningeal metastases","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"National Cancer Institute; Robert H. Lurie Comprehensive Cancer Center; Università degli Studi di Torino; Universität Zürich; Medizinische Universität Wien; Memorial Sloan-Kettering Cancer Center; University of Toronto; Universität Wien; University of Texas MD Anderson Cancer Center; Northwestern University","keywords":"Balanced scorecard; Medicine; Nano-; Medical physics; Radiology; Internal medicine; Business; Engineering","score_opus":0.05619876028713701,"score_gpt":0.41040174623150216,"score_spread":0.35420298594436517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401984414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99045426,0.00028613457,0.001837234,0.00312717,0.001257679,0.0020028653,0.00044294458,0.00009557964,0.0004961596],"genre_scores_gemma":[0.98822474,0.000052591804,0.009469084,0.0012179388,0.00019599767,0.00017245623,0.0005883964,0.000042965214,0.000035846195],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998159,0.00036185264,0.0004921185,0.00043713045,0.0002753521,0.00027454385],"domain_scores_gemma":[0.9977805,0.0013562735,0.00014075855,0.00039594554,0.00017281844,0.00015368548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069770287,0.0001918408,0.0005940387,0.000087790686,0.000078180085,0.000020250693,0.00012086439,0.00009564906,0.00020189832],"category_scores_gemma":[0.000079907244,0.00010132164,0.00020475293,0.00020214953,0.00021740448,0.000070790884,0.00005477725,0.00026336795,0.000006195463],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007195778,0.009626956,0.24666159,0.00036774948,0.0061261416,0.0008558647,0.00047400838,0.00014043004,0.00705137,0.0061764102,0.05265342,0.6626703],"study_design_scores_gemma":[0.011285422,0.046790227,0.122306116,0.00005923354,0.0045027244,0.0000901332,0.00021201717,0.0019233171,0.0019600664,0.00008995084,0.8105514,0.00022941291],"about_ca_topic_score_codex":0.000016841128,"about_ca_topic_score_gemma":0.000021564123,"teacher_disagreement_score":0.757898,"about_ca_system_score_codex":0.000096937816,"about_ca_system_score_gemma":0.00059594563,"threshold_uncertainty_score":0.41317764},"labels":[],"label_agreement":null},{"id":"W4402118551","doi":"10.1093/neuonc/noae170","title":"cIMPACT-NOW update 8: Clarifications on molecular risk parameters and recommendations for WHO grading of meningiomas","year":2024,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute","keywords":"Grading (engineering); Medicine; Medical physics; Psychology; Engineering","score_opus":0.0883324755852867,"score_gpt":0.3992109467485592,"score_spread":0.3108784711632725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402118551","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010282785,0.98119205,0.001577599,0.0068420433,0.0011060595,0.0043667625,0.00040764344,0.00013195112,0.0033476069],"genre_scores_gemma":[0.00044085176,0.9896379,0.00795623,0.0003065863,0.000096942436,0.0007255936,0.0005066725,0.00011795554,0.00021123301],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997485,0.00040113466,0.00089047087,0.00069594226,0.00017572814,0.0003517255],"domain_scores_gemma":[0.9975691,0.0009468652,0.00062473264,0.0005938128,0.000063807085,0.00020169509],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005891921,0.00041454617,0.0017430141,0.0007831828,0.00012296128,0.000038990005,0.0001864517,0.00037921718,0.00002661751],"category_scores_gemma":[0.0003695862,0.00034234978,0.0005423303,0.00039718032,0.0001091616,0.000041921976,0.00010818938,0.00070376304,0.000043941764],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000076632816,0.0002003175,0.0000049972355,0.009177644,0.001350241,0.0005007399,0.00018647798,0.000003057301,0.00026607403,0.010149407,0.06715963,0.9109248],"study_design_scores_gemma":[0.0005210683,0.001419567,0.0000020257037,0.002259216,0.007481277,0.00038122036,0.00003532695,0.00013204351,0.000091807495,0.0005603917,0.9868955,0.00022058033],"about_ca_topic_score_codex":0.000006621043,"about_ca_topic_score_gemma":0.0000014623316,"teacher_disagreement_score":0.91973585,"about_ca_system_score_codex":0.00021006505,"about_ca_system_score_gemma":0.00025979205,"threshold_uncertainty_score":0.99990284},"labels":[],"label_agreement":null},{"id":"W4402553041","doi":"10.1093/neuonc/noae157","title":"<i>MGMT</i> promoter methylation and survival following chemotherapy for WHO grade 4 IDH-mutant astrocytoma","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Methylation; Astrocytoma; Mutant; Cancer research; Biology; Chemotherapy; Oncology; Medicine; Genetics; Glioblastoma; Gene","score_opus":0.026463147145407376,"score_gpt":0.32856589179060314,"score_spread":0.30210274464519576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402553041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9796949,0.0009074856,0.0004599692,0.015860153,0.0011909268,0.0011196797,0.000015121876,0.00013125378,0.00062053115],"genre_scores_gemma":[0.9967058,0.0001371036,0.0010199923,0.0014211595,0.0003613856,0.0002440791,0.00002718107,0.00005243589,0.000030886047],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988444,0.00007332183,0.00023483482,0.00041668455,0.00015264929,0.000278118],"domain_scores_gemma":[0.99912256,0.00052263815,0.00004462204,0.00015429623,0.000035283385,0.00012061394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021861527,0.00018267079,0.00042207737,0.000117043615,0.00007124777,0.00004348558,0.00004239587,0.00014554088,0.000024966697],"category_scores_gemma":[0.00006912481,0.00014326622,0.00017079111,0.00014660956,0.0000375548,0.0000815329,0.000024970816,0.00015445112,0.000009807718],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003713288,0.0004066691,0.006193125,0.00013937037,0.00035899194,0.000863861,0.0006465398,0.0000019654385,0.8823822,0.0007779661,0.0021024768,0.10575551],"study_design_scores_gemma":[0.010954516,0.0072493674,0.00719246,0.00014759185,0.0007347872,0.0003293379,0.0001127014,0.0025950447,0.4396129,0.000999071,0.52980334,0.00026891753],"about_ca_topic_score_codex":0.000007203765,"about_ca_topic_score_gemma":0.000020563491,"teacher_disagreement_score":0.52770084,"about_ca_system_score_codex":0.00013263668,"about_ca_system_score_gemma":0.000109747976,"threshold_uncertainty_score":0.5842227},"labels":[],"label_agreement":null},{"id":"W4402574381","doi":"10.1093/neuonc/noae194","title":"“Splice of Life”: How RNA is Rewriting the Meningioma Story","year":2024,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Rewriting; Meningioma; splice; Computational biology; RNA; Biology; Medicine; Computer science; Genetics; Programming language; Gene; Pathology","score_opus":0.030859038646492826,"score_gpt":0.2928308399295469,"score_spread":0.2619718012830541,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402574381","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.032719485,0.0050728554,0.0000011937683,0.9508055,0.0015825238,0.0007580936,0.00006730429,0.00009183124,0.0089012],"genre_scores_gemma":[0.0716578,0.0005066744,0.00011495869,0.9206753,0.005775657,0.00032238307,0.00008745912,0.00013190412,0.0007278572],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976343,0.00036483005,0.0004097936,0.00065896317,0.00045957475,0.000472537],"domain_scores_gemma":[0.99674094,0.0018696246,0.00038637247,0.0007502668,0.00014026873,0.0001125025],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00028709482,0.00039796717,0.000997913,0.00027340322,0.00010897098,0.000023041719,0.00027753456,0.0008693965,0.0001833832],"category_scores_gemma":[0.0003835094,0.00026626798,0.00043182858,0.000265506,0.00021861086,0.00002979777,0.00018569732,0.0025096484,0.00015166157],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003797863,0.00011275493,0.00019525197,0.00037520746,0.00046318196,0.005499686,0.0004801593,3.1217147e-7,0.018653909,0.000038192764,0.9682289,0.0059144697],"study_design_scores_gemma":[0.0011139336,0.0011333149,0.00012597212,0.0002045402,0.0011886695,0.0004301908,0.00014520672,0.000018434248,0.0064721294,0.00003215521,0.98896784,0.00016763325],"about_ca_topic_score_codex":0.00003416984,"about_ca_topic_score_gemma":0.0000067878896,"teacher_disagreement_score":0.038938314,"about_ca_system_score_codex":0.0002733555,"about_ca_system_score_gemma":0.0004890764,"threshold_uncertainty_score":0.99997896},"labels":[],"label_agreement":null},{"id":"W4403194748","doi":"10.1093/neuonc/noae206","title":"EZH2 functional dichotomy in reactive oxygen species-stratified glioblastoma","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Research Foundation Singapore","keywords":"RELB; EZH2; Reactive oxygen species; Biology; Cancer research; Phenotype; Methylation; Cell biology; Genetics; NFKB1; Transcription factor; Gene","score_opus":0.02789442078578806,"score_gpt":0.2959887971987281,"score_spread":0.26809437641294004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403194748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9492746,0.00039513217,0.000014600734,0.010099331,0.0012885133,0.00058002933,0.000024703733,0.00013584495,0.038187247],"genre_scores_gemma":[0.99754524,0.00007479804,0.000070684415,0.0012416316,0.0005143998,0.00021945762,0.000046070996,0.000030225594,0.0002575029],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986049,0.0000930354,0.00029163223,0.00047831878,0.00023013355,0.00030198737],"domain_scores_gemma":[0.99895793,0.00057134667,0.000044818524,0.00022765216,0.00005146322,0.00014678226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012163567,0.00018929149,0.00038261013,0.00031848493,0.00004614995,0.000028678212,0.00006059037,0.00016920803,0.0008799764],"category_scores_gemma":[0.00011090471,0.00015547489,0.00012827905,0.00041832228,0.00008526501,0.00008296042,0.000040951916,0.00039229522,0.00037682988],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013176117,0.0018399435,0.017424062,0.00007914665,0.00027925352,0.016831176,0.00058864144,0.000024191197,0.8649129,0.004954748,0.0670374,0.0247109],"study_design_scores_gemma":[0.004067647,0.0032894851,0.17074363,0.00008877816,0.00018476385,0.0010056798,0.00022231704,0.00035669628,0.058596425,0.00045257976,0.76080513,0.00018688712],"about_ca_topic_score_codex":0.000027249407,"about_ca_topic_score_gemma":0.00021333595,"teacher_disagreement_score":0.8063165,"about_ca_system_score_codex":0.00049093476,"about_ca_system_score_gemma":0.00037005742,"threshold_uncertainty_score":0.9635124},"labels":[],"label_agreement":null},{"id":"W4403341017","doi":"10.1093/neuonc/noae204","title":"Pediatric cranial stereotactic radiosurgery: Meta-analysis and international stereotactic radiosurgery society practice guidelines","year":2024,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Vascular Malformations Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Radiosurgery; Medicine; MEDLINE; Medical literature; Medical record; Craniopharyngioma; Radiology; Medical physics; Radiation therapy; Pathology","score_opus":0.1760418275465362,"score_gpt":0.4361398566304072,"score_spread":0.26009802908387103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403341017","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006234562,0.98462397,0.000055673034,0.010861752,0.0021043166,0.001345326,0.0001864281,0.00014230581,0.00061788736],"genre_scores_gemma":[0.00010368461,0.9905508,0.002184127,0.004015229,0.0015087852,0.00072342396,0.00051084574,0.00012983594,0.00027327036],"study_design_codex":"meta_analysis","study_design_gemma":"not_applicable","domain_scores_codex":[0.99436146,0.00090682646,0.0022972722,0.0011936413,0.0007299751,0.0005108027],"domain_scores_gemma":[0.99245995,0.004185988,0.0013829148,0.0008843974,0.0007370186,0.00034975403],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001713061,0.00092431623,0.0062282444,0.0013404742,0.00015777853,0.00023225872,0.0002651139,0.00067069643,0.0006442077],"category_scores_gemma":[0.0023979964,0.0006380625,0.008233829,0.0016960411,0.00009483447,0.00043498463,0.0002769905,0.0011474212,0.00029111476],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055073335,0.0011852582,0.00020749313,0.006925903,0.53466386,0.002612587,0.00022199686,0.00000368163,8.7493595e-7,0.00006272044,0.07583055,0.37823],"study_design_scores_gemma":[0.00036692212,0.00015740057,0.000012656393,0.000065083805,0.4605042,0.0035851153,0.000024940111,0.000059085112,1.745395e-7,0.000003821064,0.53499603,0.00022456089],"about_ca_topic_score_codex":0.000042730186,"about_ca_topic_score_gemma":0.000009246793,"teacher_disagreement_score":0.45916548,"about_ca_system_score_codex":0.0007522097,"about_ca_system_score_gemma":0.0014019873,"threshold_uncertainty_score":0.9996071},"labels":[],"label_agreement":null},{"id":"W4403438489","doi":"10.1093/neuonc/noae158.084","title":"USING CCA-MRI TO PREDICT RESPONSE TO STEREOTACTIC RADIOSURGERY IN PATIENTS WITH BRAIN METASTASES","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Tumor Detection and Classification","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; Royal Ottawa Mental Health Centre","funders":"","keywords":"Radiosurgery; Medicine; Stereotactic radiotherapy; Medical physics; Radiology; Nuclear medicine; Radiation therapy","score_opus":0.04691854705204666,"score_gpt":0.31659494103873714,"score_spread":0.26967639398669047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403438489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98780954,0.0000074120367,0.0008869201,0.008819796,0.0012662741,0.0006996365,0.000035922927,0.00017868905,0.00029581133],"genre_scores_gemma":[0.98962873,0.0000016979359,0.00026292313,0.009823896,0.000063939,0.00007597431,0.0000019555432,0.000042388292,0.00009849953],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99681365,0.0014362106,0.00033978687,0.00072768045,0.0003103411,0.00037230214],"domain_scores_gemma":[0.996605,0.0027331393,0.000071210925,0.00033429096,0.00003727311,0.00021910835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066331425,0.00018113706,0.00025518247,0.00068396056,0.000092989045,0.00009298537,0.00018458332,0.000074441974,0.000079079255],"category_scores_gemma":[0.002838535,0.00016142815,0.000047695637,0.0014006884,0.00006993332,0.00022651695,0.00007655315,0.0003030574,0.0001317738],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037893,0.00026776193,0.0029596086,0.000020916614,0.0000067629144,0.00049655495,0.0006285588,0.00048812822,0.97232866,0.00011107613,0.003997996,0.014904655],"study_design_scores_gemma":[0.002636611,0.006334363,0.09341593,0.00013534997,0.00005798889,0.00047953834,0.00018521449,0.004443139,0.17325394,0.000058351074,0.7183384,0.0006612346],"about_ca_topic_score_codex":0.000011009385,"about_ca_topic_score_gemma":0.000025669879,"teacher_disagreement_score":0.79907477,"about_ca_system_score_codex":0.0004099571,"about_ca_system_score_gemma":0.00029906025,"threshold_uncertainty_score":0.6582849},"labels":[],"label_agreement":null},{"id":"W4403483237","doi":"10.1093/neuonc/noae144.300","title":"P17.13.B NANO-LM: AN UPDATED SCORECARD FOR THE CLINICAL ASSESSMENT OF PATIENTS WITH LEPTOMENINGEAL METASTASES","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Balanced scorecard; Nano-; Medicine; Medical physics; Radiology; Internal medicine; Engineering; Process management; Chemical engineering","score_opus":0.055074635300159845,"score_gpt":0.4087459070068606,"score_spread":0.35367127170670076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403483237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904367,0.00030496583,0.0016110367,0.0031018928,0.0013403079,0.0020757269,0.0004883982,0.000103486615,0.0005374946],"genre_scores_gemma":[0.9893053,0.000063224135,0.008076852,0.001355711,0.00022671215,0.0001987665,0.00067871786,0.000050838324,0.000043853233],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99787444,0.00041677282,0.0005656769,0.00050399336,0.00031831153,0.0003207869],"domain_scores_gemma":[0.99751383,0.001489221,0.00016707847,0.00045425873,0.00019610042,0.00017952104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007756421,0.00022597592,0.00068095216,0.000102690494,0.000091560214,0.00002436485,0.00014329949,0.000113229726,0.00023594548],"category_scores_gemma":[0.00009478986,0.000121708945,0.00023573053,0.00023261357,0.00024857154,0.000082542385,0.000066623026,0.00030774102,0.0000077874],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007895046,0.010399698,0.2895061,0.00041657087,0.0066904943,0.0010112585,0.0005639353,0.00019331046,0.0068255477,0.004887909,0.058672026,0.6129381],"study_design_scores_gemma":[0.013420141,0.050970234,0.15066601,0.00007574841,0.0052490886,0.000112178364,0.00026760495,0.0023612257,0.0020669855,0.000108068,0.7744116,0.00029107096],"about_ca_topic_score_codex":0.000026809546,"about_ca_topic_score_gemma":0.000038673177,"teacher_disagreement_score":0.7157396,"about_ca_system_score_codex":0.0001116067,"about_ca_system_score_gemma":0.0006573486,"threshold_uncertainty_score":0.49631467},"labels":[],"label_agreement":null},{"id":"W4403509708","doi":"10.1093/neuonc/noae144.492","title":"P27.30.B VALIDATING THE NEUROLOGIC ASSESSMENT IN NEURO-ONCOLOGY SCALE FOR VIRTUAL VISITS: A PILOT STUDY","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Scale (ratio); Medicine; Medical physics; Oncology; Geography; Cartography","score_opus":0.04977349197660855,"score_gpt":0.37233928372797476,"score_spread":0.32256579175136624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403509708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96341294,0.000278055,0.0001178699,0.027279232,0.0023578354,0.004190218,0.000032929795,0.0002393805,0.0020915456],"genre_scores_gemma":[0.98772687,0.00007584235,0.00027365287,0.008902669,0.0005468615,0.0023326993,0.000030109197,0.00008892345,0.000022362861],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99574274,0.001072814,0.0008548262,0.0011419887,0.00039154696,0.0007961053],"domain_scores_gemma":[0.99295145,0.0058762445,0.00018815842,0.0006592428,0.00011265492,0.00021224689],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011394327,0.00044658457,0.0009601559,0.00037212914,0.0002416333,0.000097146505,0.00036065603,0.00018867517,0.00020060064],"category_scores_gemma":[0.000639455,0.0003029314,0.0001975379,0.0006175702,0.00014928001,0.0001055494,0.00032639178,0.0010491437,0.00010743985],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028925508,0.036607467,0.23613547,0.00026445393,0.000613546,0.020726398,0.0045607374,0.0009189545,0.49850827,0.0031111583,0.021823652,0.17383735],"study_design_scores_gemma":[0.030831778,0.35988387,0.17573191,0.000120416335,0.0024483276,0.0022264274,0.005247801,0.016692283,0.006534397,0.0008215785,0.3985282,0.0009330201],"about_ca_topic_score_codex":0.000085480526,"about_ca_topic_score_gemma":0.00032797054,"teacher_disagreement_score":0.49197388,"about_ca_system_score_codex":0.0005616907,"about_ca_system_score_gemma":0.0007134025,"threshold_uncertainty_score":0.9999423},"labels":[],"label_agreement":null},{"id":"W4403510173","doi":"10.1093/neuonc/noae144.265","title":"P14.14.A INTRA-ARTERIAL CHEMOTHERAPY TREATMENT FOR RELAPSING GLIOBLASTOMA: RESULTS FROM A FIVE-YEAR SERIES","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Glioblastoma; Series (stratigraphy); Chemotherapy; Medicine; Oncology; Internal medicine; Cancer research; Geology","score_opus":0.020377283237840178,"score_gpt":0.3025474898477629,"score_spread":0.28217020660992276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403510173","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9671739,0.0007175171,0.00003436507,0.02481144,0.0032954891,0.0013186297,0.00051320664,0.00029104904,0.0018444179],"genre_scores_gemma":[0.9921372,0.00087332894,0.0023657575,0.0014024569,0.0020318918,0.0005088525,0.00026641658,0.0001016694,0.00031240884],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99829024,0.00008162883,0.00042099354,0.0006729273,0.00015117288,0.00038306473],"domain_scores_gemma":[0.9985049,0.00081320404,0.00008684585,0.00035859333,0.000065571825,0.00017090238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000096959135,0.00029920187,0.0005893202,0.0001478662,0.00010403298,0.000064580934,0.00007302377,0.0002394243,0.00018210239],"category_scores_gemma":[0.00014116798,0.00022988034,0.00024620385,0.00017090491,0.00009670193,0.00009572835,0.000026685862,0.00014318756,0.00012308499],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025174698,0.0023461855,0.0002193821,0.00007625252,0.001056311,0.0034575795,0.0072868485,0.000011369133,0.71235174,0.00069900724,0.08646253,0.1608581],"study_design_scores_gemma":[0.024781168,0.016338946,0.00044428767,0.00015458408,0.0005618452,0.00026341862,0.0003732546,0.00030745054,0.18646842,0.0006402733,0.7694401,0.0002262365],"about_ca_topic_score_codex":0.00009475867,"about_ca_topic_score_gemma":0.00012614016,"teacher_disagreement_score":0.6829776,"about_ca_system_score_codex":0.0005245718,"about_ca_system_score_gemma":0.0002855428,"threshold_uncertainty_score":0.93742484},"labels":[],"label_agreement":null},{"id":"W4403510301","doi":"10.1093/neuonc/noae144.081","title":"OS10.5.A MINIMALLY INVASIVE BRAIN METASTASES ARE CHARACTERIZED BY AN ACTIVE, ANTI-CANCER IMMUNE INFILTRATE","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Montreal Neurological Institute and Hospital; McGill University Health Centre; McGill University","funders":"","keywords":"Immune system; Brain cancer; Medicine; Cancer; Pathology; Immunology; Internal medicine","score_opus":0.040304973291413936,"score_gpt":0.36759510682662466,"score_spread":0.32729013353521075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403510301","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9747592,0.0010968057,0.000034400742,0.020613756,0.00020622741,0.0006132295,0.0005897661,0.00021042093,0.00187616],"genre_scores_gemma":[0.9884555,0.0011604782,0.00015729907,0.00804392,0.00054447795,0.00058676663,0.00041048424,0.00005383276,0.0005872775],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984468,0.0001555349,0.00035507025,0.0005405517,0.00015613514,0.00034590176],"domain_scores_gemma":[0.9985046,0.00069448946,0.000119916345,0.0003012822,0.000080539714,0.0002991905],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001409653,0.0002360286,0.0005371369,0.00006547315,0.00009869967,0.000041565603,0.00017510413,0.00018213339,0.0010896666],"category_scores_gemma":[0.0001675111,0.00021071442,0.00013013065,0.00030319623,0.00021780131,0.00018715061,0.000051614657,0.0006046006,0.000111377565],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037868627,0.00039470653,0.00011747013,0.00020832638,0.00014044682,0.00034885114,0.00009587953,0.0000012805143,0.9756233,0.000035569363,0.0059698718,0.016685607],"study_design_scores_gemma":[0.0008630326,0.00026693448,0.0005826066,0.000031793526,0.00015228725,0.00014934078,0.00007619055,0.00006333775,0.6053039,0.000014200954,0.39238063,0.00011579309],"about_ca_topic_score_codex":0.0000074972236,"about_ca_topic_score_gemma":0.0000028593988,"teacher_disagreement_score":0.38641074,"about_ca_system_score_codex":0.00012129108,"about_ca_system_score_gemma":0.00042079898,"threshold_uncertainty_score":0.99982345},"labels":[],"label_agreement":null},{"id":"W4403510351","doi":"10.1093/neuonc/noae144.454","title":"P26.06.B EVALUATION OF THE ANTITUMOR EFFECT OF A CHEMOTHERAPY-LOADED DEVICE FOR THE TREATMENT OF PRIMARY BRAIN TUMORS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Victoria; Université de Sherbrooke","funders":"","keywords":"Chemotherapy; Medicine; Primary (astronomy); Oncology; Internal medicine; Physics","score_opus":0.028062297360796733,"score_gpt":0.3183576420683153,"score_spread":0.29029534470751855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403510351","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99398756,0.00084342365,0.00004492283,0.002336468,0.0006542918,0.0019394152,0.000050014038,0.000028335544,0.000115568386],"genre_scores_gemma":[0.99914,0.000028210492,0.00010561432,0.0003618494,0.00007561091,0.00024472145,0.0000030447882,0.000021554877,0.000019394343],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99783367,0.0009028496,0.00043264794,0.00027543117,0.00034955033,0.00020584585],"domain_scores_gemma":[0.9945731,0.0045649665,0.0002587614,0.00042447564,0.0001509817,0.000027676302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018630313,0.00014656321,0.00042062646,0.00006288431,0.000055992707,0.000011380596,0.00028955305,0.000062769635,0.000078920886],"category_scores_gemma":[0.00039573575,0.00007858221,0.00018314584,0.00028528975,0.00026853674,0.00006528762,0.000039931496,0.00005473704,0.000012525739],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043780613,0.00024079582,0.00024278254,0.00018203515,0.000031488027,0.0000030742628,0.00063840405,0.0004390969,0.9780428,0.000081372746,0.00058215455,0.019078206],"study_design_scores_gemma":[0.0022262007,0.0030830288,0.0010580193,0.00004516695,0.00029568153,0.000013558751,0.000034010973,0.0041596857,0.9849742,0.00009175099,0.0039586956,0.000059972073],"about_ca_topic_score_codex":0.000058052163,"about_ca_topic_score_gemma":0.000017820794,"teacher_disagreement_score":0.019018235,"about_ca_system_score_codex":0.00025073337,"about_ca_system_score_gemma":0.00060370436,"threshold_uncertainty_score":0.32044896},"labels":[],"label_agreement":null},{"id":"W4403510885","doi":"10.1093/neuonc/noae144.156","title":"P08.03.A CSF-BASED PROTEOMIC BIOMARKERS OF RESPONSE TO MULTI-AGENT INTRAVENTRICULAR CHEMOTHERAPY IN CNS LYMPHOMA","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Advanced Proteomics Techniques and Applications","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Lymphoma; Chemotherapy; Oncology; Pathology; Internal medicine","score_opus":0.015716096674965742,"score_gpt":0.3112791570470995,"score_spread":0.29556306037213376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403510885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9732804,0.00009925216,0.019505018,0.005334335,0.00008019824,0.0009979435,0.000058526428,0.00023797728,0.0004063557],"genre_scores_gemma":[0.92426246,0.000071930735,0.0732306,0.0009519563,0.000056056997,0.0012562975,0.000017841912,0.00007197273,0.00008087707],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99845433,0.00009636239,0.00046389687,0.0005253268,0.00013084878,0.00032922067],"domain_scores_gemma":[0.99893886,0.00031051168,0.000110685076,0.00046857595,0.0000512233,0.00012015782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031165284,0.0002106248,0.0003118479,0.00024640415,0.000040688497,0.000017977927,0.000317783,0.0002480808,0.00018747864],"category_scores_gemma":[0.00016003802,0.00021296543,0.00011930531,0.00051553635,0.000094227944,0.000039543072,0.00007486519,0.00020733156,0.00004259796],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010539893,0.00034283026,0.00021187472,0.00008416301,0.000020785279,0.0001495461,0.00015250372,0.00015252741,0.9746658,0.00011578521,0.00044376528,0.02260638],"study_design_scores_gemma":[0.0013391632,0.00021468099,0.0002496758,0.00006198821,0.000011982677,0.000030721985,0.000032763957,0.0036401297,0.8621792,0.00018758661,0.13187686,0.00017525481],"about_ca_topic_score_codex":0.000039222625,"about_ca_topic_score_gemma":0.000008457185,"teacher_disagreement_score":0.13143308,"about_ca_system_score_codex":0.00057284546,"about_ca_system_score_gemma":0.0003846348,"threshold_uncertainty_score":0.86844784},"labels":[],"label_agreement":null},{"id":"W4403511081","doi":"10.1093/neuonc/noae144.458","title":"P26.10.B OPTIMIZING DELIVERY OF CHEMOTHERAPEUTIC AGENTS BY INTRA-ARTERIAL INFUSION IN GLIOBLASTOMA","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke","funders":"","keywords":"Glioblastoma; Medicine; Pharmacology; Oncology; Cancer research","score_opus":0.015655462176887965,"score_gpt":0.2705744865291922,"score_spread":0.25491902435230424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403511081","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99606305,0.00030475712,0.00008308756,0.0006692336,0.0019692096,0.0003062135,0.000034766526,0.00015261785,0.00041706837],"genre_scores_gemma":[0.99822134,0.000083992876,0.0004717238,0.00094619783,0.00015421126,0.00003521403,0.0000047584667,0.00004467337,0.00003787523],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99771976,0.00035871883,0.00061872456,0.0005498684,0.00025701412,0.0004959121],"domain_scores_gemma":[0.99888855,0.0004943887,0.0001334752,0.0003093574,0.00006218292,0.00011202192],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004760603,0.00022465335,0.0004219122,0.00024961805,0.000050768398,0.000063612286,0.00034761688,0.00020642822,0.0021419267],"category_scores_gemma":[0.00007868005,0.00022264743,0.000083446124,0.00044165665,0.00019512254,0.00029825655,0.00018163252,0.00022557161,0.00060914387],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006728947,0.00025177072,0.000028582714,0.000059073063,0.00000823976,0.00018224849,0.00057708967,0.00026566433,0.97967756,0.000031984102,0.006215617,0.012029293],"study_design_scores_gemma":[0.0012997196,0.0011118308,0.000025756546,0.00006192506,0.000031252705,0.000045330442,0.00007939391,0.0053866254,0.9695698,0.00007251107,0.022128744,0.00018712958],"about_ca_topic_score_codex":0.000072422554,"about_ca_topic_score_gemma":0.000043935797,"teacher_disagreement_score":0.015913127,"about_ca_system_score_codex":0.00026637598,"about_ca_system_score_gemma":0.0002809818,"threshold_uncertainty_score":0.99877024},"labels":[],"label_agreement":null},{"id":"W4403511284","doi":"10.1093/neuonc/noae144.079","title":"OS09.7.A GBM AGILE PLATFORM TRIAL FOR NEWLY DIAGNOSED AND RECURRENT GBM: RESULTS OF FIRST EXPERIMENTAL ARM, REGORAFENIB","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Regorafenib; Agile software development; Medicine; Oncology; Computer science; Internal medicine; Software engineering","score_opus":0.07117241439050807,"score_gpt":0.39326491584887086,"score_spread":0.32209250145836277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403511284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97754836,0.0018184381,0.000052932264,0.009369736,0.0010384533,0.0019419286,0.00020910452,0.00012234287,0.007898691],"genre_scores_gemma":[0.99719745,0.00033355397,0.00040971464,0.00035955638,0.0008619992,0.000518375,0.00010559867,0.000025916119,0.0001878342],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.998712,0.000022033943,0.0004610388,0.00042929198,0.00013364587,0.0002420002],"domain_scores_gemma":[0.99806577,0.0013553143,0.00009053007,0.00023186141,0.000043516404,0.00021301776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017824525,0.0001581068,0.00037453146,0.000051854677,0.000079156765,0.000014966754,0.000093177296,0.00017510644,0.00008972317],"category_scores_gemma":[0.0003908559,0.00013896223,0.00012161219,0.00014731608,0.0001820406,0.00005453686,0.000049664483,0.00029011443,0.000010251281],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06282381,0.002114256,0.00002254612,0.0005989149,0.0001074646,0.0002463361,0.0010411071,0.000006401498,0.81066835,0.0013523782,0.08711171,0.033906728],"study_design_scores_gemma":[0.040086087,0.0032466585,0.000011612674,0.000056152578,0.00011934214,0.00011126609,0.00013188107,0.0011000129,0.3264054,0.00011506912,0.6285171,0.00009939654],"about_ca_topic_score_codex":0.0000064752066,"about_ca_topic_score_gemma":0.0000039111246,"teacher_disagreement_score":0.5414054,"about_ca_system_score_codex":0.000113288566,"about_ca_system_score_gemma":0.00014919142,"threshold_uncertainty_score":0.56667155},"labels":[],"label_agreement":null},{"id":"W4403511401","doi":"10.1093/neuonc/noae144.085","title":"OS11.7.A DELETION OF MONOCARBOXYLATE TRANSPORTER 1 IN MYELOID CELLS FAVOURS GLIOBLASTOMA DEVELOPMENT","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National de la Recherche Scientifique","funders":"","keywords":"Immune system; Microglia; Myeloid; Transporter; Tumor microenvironment; Cancer research; Biology; Haematopoiesis; Phenotype; Immunology; Inflammation; Chemistry; Cell biology; Stem cell; Biochemistry; Gene","score_opus":0.015043837969478127,"score_gpt":0.27479423660356317,"score_spread":0.25975039863408506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403511401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948511,0.0007890299,0.000039770504,0.0020599542,0.0005461916,0.00043974127,0.0000067620476,0.000065445354,0.0012019775],"genre_scores_gemma":[0.99860704,0.00023911701,0.0004983705,0.00043219948,0.000050952618,0.00010442424,0.000015329177,0.000030988904,0.000021599952],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99864775,0.00005988376,0.00046448622,0.00036042352,0.00018405638,0.00028337727],"domain_scores_gemma":[0.9994589,0.00015608732,0.00006250772,0.00016880107,0.00004081637,0.00011289745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014719485,0.0001796455,0.00042449974,0.00035758002,0.00001982998,0.000007334156,0.00006354412,0.00016471131,0.0001349812],"category_scores_gemma":[0.0000117093705,0.00015200504,0.000106956715,0.00031598873,0.00005301001,0.000044587337,0.000019074609,0.00021721827,0.00009087945],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034659932,0.0009058787,0.009655582,0.00017264471,0.00011566902,0.0036207198,0.0016281323,0.00007249046,0.84301376,0.000104122686,0.0009628601,0.13940153],"study_design_scores_gemma":[0.002945951,0.0021665182,0.055530246,0.0002162272,0.00018176013,0.00017331493,0.0001158908,0.00039006167,0.7827291,0.00005441249,0.15531898,0.00017755385],"about_ca_topic_score_codex":0.000023925535,"about_ca_topic_score_gemma":0.00017329579,"teacher_disagreement_score":0.1543561,"about_ca_system_score_codex":0.00027331273,"about_ca_system_score_gemma":0.00031339153,"threshold_uncertainty_score":0.61985856},"labels":[],"label_agreement":null},{"id":"W4403511685","doi":"10.1093/neuonc/noae144.013","title":"KS03.5.A EVALUATION OF VAL-083 IN GBM AGILE, A PHASE 3 REGISTRATION PLATFORM TRIAL FOR NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; McGill University Health Centre; University of Toronto","funders":"","keywords":"Glioblastoma; Agile software development; Medicine; Phase (matter); Oncology; Cancer research; Medical physics; Internal medicine; Computer science; Software engineering; Chemistry","score_opus":0.07161932857619517,"score_gpt":0.400097296983522,"score_spread":0.3284779684073268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403511685","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99139047,0.0010005231,0.00003394316,0.0028267396,0.0010561916,0.003174529,0.00003978852,0.0000362172,0.00044158867],"genre_scores_gemma":[0.998007,0.00024253252,0.00015107846,0.00014131688,0.0002820734,0.0010713316,0.00007644832,0.000020533103,0.000007675495],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9984977,0.00011616075,0.0004964007,0.00037871095,0.00031025588,0.00020076691],"domain_scores_gemma":[0.9984601,0.0009751948,0.00014237285,0.0001767133,0.00015149715,0.0000941214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007474617,0.00015402252,0.000407108,0.00029207004,0.00003155151,0.000019049987,0.00003925742,0.00015449914,0.000049169226],"category_scores_gemma":[0.00088952214,0.00011854814,0.000105015344,0.00024802325,0.0000575907,0.0000968564,0.0000195526,0.00014143877,0.0000050333892],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04444001,0.0042250245,0.00032798684,0.00026409185,0.00012739003,0.0004171262,0.0011389403,0.000035677553,0.066767365,0.0009923772,0.008301021,0.872963],"study_design_scores_gemma":[0.6456524,0.10330628,0.00272887,0.00060812826,0.0024117301,0.000306915,0.0004057004,0.04922915,0.0772138,0.002870274,0.11488692,0.000379802],"about_ca_topic_score_codex":0.000029162495,"about_ca_topic_score_gemma":0.0003826391,"teacher_disagreement_score":0.8725832,"about_ca_system_score_codex":0.00030901155,"about_ca_system_score_gemma":0.0004871623,"threshold_uncertainty_score":0.4834253},"labels":[],"label_agreement":null},{"id":"W4403511868","doi":"10.1093/neuonc/noae144.174","title":"P09.15.A SATURATION TRANSFER MRI ENABLES EARLY DETECTION OF CANCER LESIONS IN THE CNS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Infrared Thermography in Medicine","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Saturation (graph theory); Medicine; Biomedical engineering; Nuclear magnetic resonance; Pathology; Mathematics; Physics","score_opus":0.019387561248837365,"score_gpt":0.3114161613789614,"score_spread":0.292028600130124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403511868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98284966,0.0018837366,0.000636968,0.008857585,0.0012637941,0.0006570006,0.000012917083,0.0000742345,0.0037641244],"genre_scores_gemma":[0.99682546,0.00076256174,0.00005188565,0.0017411839,0.00042537358,0.00012793251,0.000007707964,0.000023175762,0.00003474316],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99871933,0.00024406989,0.0003344323,0.00023669707,0.00024589262,0.000219596],"domain_scores_gemma":[0.9991223,0.0005033784,0.000031249525,0.00022656452,0.000069554684,0.000046942863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035903254,0.00012738205,0.00027664684,0.000332127,0.000050294006,0.000008900246,0.000106216605,0.00019628153,0.00019196596],"category_scores_gemma":[0.00009817303,0.00008367887,0.00010429329,0.0006889976,0.00015949747,0.00007170632,0.000010067535,0.00061955204,0.000010886862],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024231004,0.00009364582,0.0011878425,0.000106128056,0.00004136393,0.00020523513,0.0052788816,0.000020510217,0.8972815,0.00045414548,0.0007273114,0.094361074],"study_design_scores_gemma":[0.005035917,0.008386238,0.20271082,0.00077596435,0.0011356514,0.000782371,0.0032523428,0.0014462977,0.44312167,0.0013167702,0.33164525,0.00039069215],"about_ca_topic_score_codex":0.00035813125,"about_ca_topic_score_gemma":0.0006466554,"teacher_disagreement_score":0.4541599,"about_ca_system_score_codex":0.00010295128,"about_ca_system_score_gemma":0.00021353616,"threshold_uncertainty_score":0.3412325},"labels":[],"label_agreement":null},{"id":"W4403511991","doi":"10.1093/neuonc/noae144.216","title":"P12.03.B CAN COGNITIVE PERFORMANCE PREDICT NEUROTOXICITY INCIDENCE FOLLOWING CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY FOR LYMPHOMA?","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chimeric antigen receptor; Neurotoxicity; Lymphoma; Incidence (geometry); Cognition; Antigen; B-cell lymphoma; Medicine; Immunology; Cancer research; Oncology; Internal medicine; T cell; Mathematics; Immune system; Toxicity; Psychiatry","score_opus":0.02217804031714789,"score_gpt":0.3119823217989977,"score_spread":0.28980428148184983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403511991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832854,0.0024599484,0.00022575074,0.0023708295,0.0033655672,0.0035986311,0.00011770779,0.00044047963,0.0041356543],"genre_scores_gemma":[0.9863111,0.0054389783,0.00017620249,0.0057143318,0.0007958339,0.0010646654,0.00006374212,0.00011500077,0.00032018794],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99724615,0.00019454653,0.0005121024,0.00090489874,0.00039123656,0.00075106847],"domain_scores_gemma":[0.99773115,0.0014050541,0.00015947834,0.00024401242,0.00023183145,0.00022849262],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003625836,0.00043774335,0.00073748804,0.00028303373,0.00032689507,0.000039693325,0.00018299054,0.00023657565,0.00012526137],"category_scores_gemma":[0.0005166504,0.00039426927,0.0003453675,0.0006497819,0.00027147538,0.00019627303,0.00012716198,0.00047122463,0.0001452131],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005495847,0.0012545371,0.06073402,0.0006889454,0.0010244666,0.00080053165,0.0042294045,0.000013500529,0.5725196,0.0000103561015,0.017516425,0.33571234],"study_design_scores_gemma":[0.026220001,0.03936799,0.10547396,0.0017376293,0.0013424655,0.00083149015,0.0013183269,0.005545584,0.40850994,0.000064500615,0.40818304,0.0014050801],"about_ca_topic_score_codex":0.00005468538,"about_ca_topic_score_gemma":0.000019444258,"teacher_disagreement_score":0.3906666,"about_ca_system_score_codex":0.00051930646,"about_ca_system_score_gemma":0.0009990484,"threshold_uncertainty_score":0.9998509},"labels":[],"label_agreement":null},{"id":"W4403512422","doi":"10.1093/neuonc/noae144.473","title":"P27.11.A GLOBAL EXPANSION OF GBM AGILE: A PHASE 2/3 ADAPTIVE PLATFORM TRIAL TO EVALUATE MULTIPLE REGIMENS IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Glioblastoma; Agile software development; Medicine; Phase (matter); Oncology; Internal medicine; Computer science; Cancer research; Software engineering; Physics","score_opus":0.35388210331361186,"score_gpt":0.5455905287246768,"score_spread":0.19170842541106498,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403512422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.979399,0.00010755528,0.011166737,0.001053543,0.0042037372,0.003054207,0.00044626766,0.00013445741,0.00043447965],"genre_scores_gemma":[0.69093657,0.00013409709,0.30690292,0.00059204816,0.00077290944,0.0005582986,0.000004221192,0.000078972625,0.000019960666],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.995032,0.001590437,0.0015673987,0.00082319404,0.0004935442,0.0004934304],"domain_scores_gemma":[0.9231426,0.07570939,0.00029962842,0.00041264758,0.00013600884,0.00029974576],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0032414317,0.0003245823,0.0012723767,0.00019698702,0.00004520445,0.000030088255,0.00026019,0.00037987615,0.00012156782],"category_scores_gemma":[0.103140146,0.00025736363,0.00016938009,0.00062645925,0.00023272193,0.00009133754,0.00032078632,0.000499944,0.000032849315],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16194424,0.0032166021,0.00012934729,0.00035977826,0.0001517726,0.0018449763,0.0021127944,0.000030097506,0.019267019,0.030597202,0.015908433,0.76443774],"study_design_scores_gemma":[0.24314214,0.08980405,0.00028858308,0.0010965025,0.0007560972,0.00014606616,0.00071965915,0.02257892,0.01260144,0.60418,0.023696546,0.000990018],"about_ca_topic_score_codex":0.000042316373,"about_ca_topic_score_gemma":0.00037575592,"teacher_disagreement_score":0.7634477,"about_ca_system_score_codex":0.0003522579,"about_ca_system_score_gemma":0.00041166737,"threshold_uncertainty_score":0.99998784},"labels":[],"label_agreement":null},{"id":"W4403512568","doi":"10.1093/neuonc/noae144.188","title":"P10.12.B DEEP LEARNING-BASED NORMALIZATION AND UNMIXING OF HYPERSPECTRAL IMAGES FOR BRAIN TUMOR SURGERY","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Tumor Detection and Classification","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Hyperspectral imaging; Normalization (sociology); Artificial intelligence; Spatial normalization; Computer science; Deep learning; Computer vision; Pattern recognition (psychology); Medicine; Sociology","score_opus":0.03192292005977731,"score_gpt":0.29285854920819937,"score_spread":0.26093562914842205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403512568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8464774,0.00045885984,0.11607517,0.02629751,0.003770583,0.0013979374,0.000045417553,0.0010948144,0.0043822937],"genre_scores_gemma":[0.9974239,0.000033443346,0.00032725497,0.001891085,0.000114419425,0.0000618547,0.0000065041977,0.000031231608,0.00011033019],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985842,0.00034966643,0.00028552668,0.00042385136,0.00012948782,0.00022724924],"domain_scores_gemma":[0.9963289,0.0033136837,0.00013468102,0.00011443377,0.000044033834,0.00006427497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040790945,0.000120478864,0.00021196088,0.00024325108,0.00014175373,0.000052456908,0.0000839023,0.00007153244,0.000050068935],"category_scores_gemma":[0.0027219749,0.00012103278,0.000088700355,0.00030948748,0.00018185897,0.00014415977,0.000021015143,0.00020816442,0.000010176913],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000087941415,0.000045321318,0.00027403925,0.00010428665,0.0000024707695,0.00003233498,0.00016599058,0.00024710718,0.9767602,0.0012901122,0.0011312177,0.019858992],"study_design_scores_gemma":[0.00041115546,0.0004907699,0.0011652966,0.000020222209,0.000022395601,0.00017805418,0.00013626926,0.08378154,0.8139174,0.0002444468,0.09947968,0.00015274169],"about_ca_topic_score_codex":0.0000049247133,"about_ca_topic_score_gemma":0.000009005221,"teacher_disagreement_score":0.16284277,"about_ca_system_score_codex":0.000072917326,"about_ca_system_score_gemma":0.00014666058,"threshold_uncertainty_score":0.49355736},"labels":[],"label_agreement":null},{"id":"W4403512673","doi":"10.1093/neuonc/noae144.253","title":"P14.02.B A MULTICENTER, RANDOMIZED, CONTROLLED TRIAL OF FOCUSED-ULTRASOUND-MEDIATED BLOOD-BRAIN BARRIER DISRUPTION PLUS SYSTEMIC PEMBROLIZUMAB FOR PATIENTS WITH NSCLC BRAIN METASTASES (LIMITLESS)","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Pembrolizumab; Medicine; Randomized controlled trial; Oncology; Internal medicine; Cancer; Immunotherapy","score_opus":0.01179688764908209,"score_gpt":0.28621758925858,"score_spread":0.2744207016094979,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403512673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96467555,0.0018601419,0.001765936,0.0029454194,0.0017691655,0.025357928,0.0010629903,0.00021804335,0.0003448267],"genre_scores_gemma":[0.99242246,0.00016257791,0.00090755266,0.0010035278,0.00034852207,0.004158088,0.00070193876,0.00011659724,0.00017872165],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9948704,0.0017871347,0.001411939,0.00077357073,0.0005771379,0.00057978736],"domain_scores_gemma":[0.9797204,0.01865137,0.0005795259,0.00042274198,0.00032669015,0.0002992416],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015909269,0.00054003793,0.003316299,0.00039712884,0.00010325567,0.000050668965,0.0001546197,0.0002645243,0.0001348136],"category_scores_gemma":[0.006213967,0.0003374996,0.0010058632,0.00029794502,0.00037965938,0.00012758742,0.000048805607,0.00033708138,0.000023842835],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9751125,0.0026717202,0.00011797167,0.0005722235,0.0037691072,0.00031626484,0.00052503863,0.00003118177,0.010733017,0.0006249822,0.0018217303,0.0037042731],"study_design_scores_gemma":[0.97001344,0.013525254,0.000028784283,0.00032952736,0.0075924867,0.00021122229,0.00014716701,0.0014061565,0.0005186808,0.00004860459,0.005920536,0.000258126],"about_ca_topic_score_codex":0.00005874363,"about_ca_topic_score_gemma":0.00003993477,"teacher_disagreement_score":0.027746925,"about_ca_system_score_codex":0.00029609876,"about_ca_system_score_gemma":0.00079257204,"threshold_uncertainty_score":0.99990773},"labels":[],"label_agreement":null},{"id":"W4403512977","doi":"10.1093/neuonc/noae144.256","title":"P14.05.A A PROSPECTIVE, MULTICENTER TRIAL OF FOCUSED ULTRASOUND FOR BLOOD-BRAIN BARRIER DISRUPTION FOR LIQUID BIOPSY IN GLIOBLASTOMA (LIBERATE)","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Ultrasound and Hyperthermia Applications","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Glioblastoma; Focused ultrasound; Medicine; Blood–brain barrier; Multicenter study; Multicenter trial; Ultrasound; Biopsy; Radiology; Internal medicine; Randomized controlled trial; Cancer research; Central nervous system","score_opus":0.01171061866547595,"score_gpt":0.2741897330267077,"score_spread":0.2624791143612317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403512977","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883481,0.0001394729,0.0059894025,0.0005542849,0.0010384173,0.002987295,0.00024441205,0.00027150768,0.000427068],"genre_scores_gemma":[0.9949627,0.00003501953,0.0016139172,0.00012255234,0.00042078874,0.0026537175,0.000026973035,0.00008754141,0.00007677498],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99875337,0.00004716601,0.00043197235,0.00035482502,0.00008489821,0.00032774903],"domain_scores_gemma":[0.997788,0.0018332062,0.000046824858,0.00019887472,0.000061008654,0.000072062794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019836746,0.0001982809,0.00034157062,0.00019520197,0.000051121155,0.000036007586,0.00013809477,0.00021508643,0.000030968742],"category_scores_gemma":[0.00026987022,0.00019123171,0.00016463296,0.00027332787,0.00007077252,0.00012093558,0.000013914512,0.0001946035,0.000010690158],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060430528,0.0002945795,0.00004366631,0.00017674525,0.00008102421,0.000008138909,0.0010411202,0.00031471677,0.98715574,0.0017014752,0.00079968217,0.0023400602],"study_design_scores_gemma":[0.08492917,0.0127176,0.00027425252,0.00013201429,0.0004483579,0.00018398603,0.00029369516,0.02109505,0.4764646,0.0031378588,0.39943945,0.0008839694],"about_ca_topic_score_codex":0.0000063311663,"about_ca_topic_score_gemma":0.00011070223,"teacher_disagreement_score":0.51069117,"about_ca_system_score_codex":0.000114046845,"about_ca_system_score_gemma":0.000084538464,"threshold_uncertainty_score":0.77982026},"labels":[],"label_agreement":null},{"id":"W4403513063","doi":"10.1093/neuonc/noae144.005","title":"PL02.3.A MOLECULAR CLASSIFICATION TO REFINE SURGICAL AND RADIOTHERAPEUTIC DECISION MAKING IN MENINGIOMA","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University Health Network; University of Toronto","funders":"","keywords":"Meningioma; Medicine; Medical physics; Computer science; Radiology","score_opus":0.03670693701165599,"score_gpt":0.36549188449885317,"score_spread":0.32878494748719717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403513063","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9799158,0.0018092506,0.002887439,0.0073129754,0.0003823808,0.0004781489,9.423502e-7,0.00009904966,0.007114027],"genre_scores_gemma":[0.99404985,0.000033535624,0.004929312,0.00070719386,0.00009949484,0.000056296845,0.000004732476,0.000027389282,0.00009220809],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985524,0.00012888701,0.00034398012,0.00049223745,0.00021687878,0.00026561238],"domain_scores_gemma":[0.9992304,0.0003475622,0.000034604287,0.00023981671,0.00002420886,0.00012343153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004205285,0.00014544156,0.00031499896,0.00047773053,0.0000345004,0.000040390598,0.00007896521,0.00012966822,0.000082479026],"category_scores_gemma":[0.00009433769,0.00012860657,0.00005395006,0.0004920022,0.000038802646,0.00004829979,0.00008033143,0.00023467008,0.000054324777],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010368432,0.00013784328,0.0019319046,0.00010760105,0.00005732079,0.03984485,0.0007632231,0.000037834416,0.49898168,0.01933562,0.0015042949,0.436261],"study_design_scores_gemma":[0.0033473086,0.0032369236,0.018425664,0.00054968306,0.00019340428,0.008821843,0.0001648073,0.027369292,0.0031042793,0.0009566346,0.93346316,0.0003670098],"about_ca_topic_score_codex":0.0000042706815,"about_ca_topic_score_gemma":0.0000037750399,"teacher_disagreement_score":0.93195885,"about_ca_system_score_codex":0.00021966113,"about_ca_system_score_gemma":0.00007281644,"threshold_uncertainty_score":0.5244424},"labels":[],"label_agreement":null},{"id":"W4403518724","doi":"10.1093/neuonc/noae144.401","title":"P20.14.A METASTATIC EPITHELIOD SOLITARY FIBROUS TUMOR","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Soft tissue tumor case studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Solitary fibrous tumor; Metastatic tumor; Medicine; Metastasis; Internal medicine; Biology; Cancer; Cell biology","score_opus":0.03246371963430006,"score_gpt":0.33713715722534193,"score_spread":0.3046734375910419,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403518724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8650926,0.026992464,0.00020195168,0.041061223,0.007054167,0.0019128047,0.00012888834,0.0020093396,0.055546563],"genre_scores_gemma":[0.9854752,0.0003211621,0.0026812858,0.008630655,0.0010923898,0.00018585875,0.000027141752,0.0001354617,0.0014508843],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978613,0.00020326748,0.00045434604,0.0006005613,0.00031239528,0.00056807726],"domain_scores_gemma":[0.9977669,0.0014136003,0.000064087435,0.00042774598,0.000096734555,0.00023089365],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002888533,0.00030064234,0.0007652163,0.0002879695,0.000101878075,0.000021466507,0.00013340381,0.00007042017,0.0006766249],"category_scores_gemma":[0.00090899644,0.000251005,0.00020708598,0.0004377402,0.00027407298,0.00008906085,0.00016742919,0.00059764937,0.0022013881],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009728805,0.0008095497,0.0016387292,0.0018862494,0.0011068785,0.20462254,0.0049582343,0.000016304957,0.28731045,0.0028583894,0.39822724,0.09559254],"study_design_scores_gemma":[0.001789301,0.003940373,0.0013142701,0.00014864805,0.0008745653,0.020986529,0.0007240596,0.0004581569,0.00785467,0.0012600769,0.9603394,0.000309941],"about_ca_topic_score_codex":0.000053240132,"about_ca_topic_score_gemma":0.000024859031,"teacher_disagreement_score":0.56211215,"about_ca_system_score_codex":0.00025547532,"about_ca_system_score_gemma":0.00046274558,"threshold_uncertainty_score":0.9999942},"labels":[],"label_agreement":null},{"id":"W4403713387","doi":"10.1093/neuonc/noae186","title":"Central nervous system tumors in adolescents and young adults: A Society for Neuro-Oncology Consensus Review on diagnosis, management, and future directions","year":2024,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Princess Margaret Cancer Centre; Hospital for Sick Children; University of Toronto; Sunnybrook Health Science Centre","funders":"Cancer Research UK","keywords":"Medicine; Medulloblastoma; Germ cell tumors; Population; Oncology; Brain tumor; Ependymoma; Clinical trial; Cancer; Multidisciplinary approach; Internal medicine; Pathology; Chemotherapy","score_opus":0.025426289152954605,"score_gpt":0.32491509859269035,"score_spread":0.29948880943973577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403713387","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00046425717,0.9826985,4.4710757e-7,0.0037664166,0.0030029463,0.009142153,0.00030925483,0.00016694688,0.00044909547],"genre_scores_gemma":[0.00043372667,0.989527,0.00012092488,0.0025209244,0.0008347768,0.0062265387,0.00016337921,0.00015593541,0.000016820733],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955777,0.0005514319,0.0012633164,0.0015073258,0.00025113416,0.00084908603],"domain_scores_gemma":[0.99766785,0.00076528586,0.0005426059,0.00052268856,0.00008486128,0.0004167046],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032773448,0.00091600546,0.0037370902,0.00039253608,0.00016529359,0.000043097603,0.00016465924,0.00068882626,0.000008232148],"category_scores_gemma":[0.0001421522,0.00069666683,0.0009728647,0.0006300977,0.00018307594,0.000030407728,0.0002191958,0.0010498185,0.000020057303],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000110450936,0.00089910807,0.0006759231,0.19275717,0.00056802575,0.004441312,0.00011949698,9.6897e-8,0.0000012674169,0.00022509944,0.035182733,0.7650193],"study_design_scores_gemma":[0.0031190235,0.0018714801,0.00046147266,0.096972674,0.009160535,0.0038726013,0.00023410612,0.00001817444,8.2281093e-7,0.0000034970208,0.88392514,0.0003604895],"about_ca_topic_score_codex":0.00004502348,"about_ca_topic_score_gemma":0.0001392415,"teacher_disagreement_score":0.84874237,"about_ca_system_score_codex":0.0013414935,"about_ca_system_score_gemma":0.0003735917,"threshold_uncertainty_score":0.99954844},"labels":[],"label_agreement":null},{"id":"W4404110331","doi":"10.1093/neuonc/noae236","title":"Validation and next-generation update of a DNA methylation–based recurrence predictor for meningioma: A multicenter prospective study","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Center for Biomedical Informatics and Information Technology, National Cancer Institute; Canadian Institutes of Health Research; University of Pennsylvania; Deutschen Konsortium für Translationale Krebsforschung; Freie Universität Berlin; National Cancer Institute; Humboldt-Universität zu Berlin; Deutsches Krebsforschungszentrum; Division of Cancer Epidemiology and Genetics, National Cancer Institute; Pennsylvania State University; Vanderbilt University; Vanderbilt University Medical Center","keywords":"Meningioma; DNA methylation; Methylation; Medicine; Oncology; Internal medicine; Computational biology; DNA; Biology; Genetics; Surgery; Gene","score_opus":0.06262276848569368,"score_gpt":0.3403999430935071,"score_spread":0.27777717460781337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404110331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867286,0.00019665291,0.0076483465,0.0014706237,0.00061656535,0.0029647725,0.000018250423,0.00007522501,0.0002809367],"genre_scores_gemma":[0.99535036,0.000004058235,0.0037673377,0.00009469657,0.00018330183,0.00047330154,0.000073799696,0.000017505907,0.000035644036],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99872255,0.00014969325,0.0003679064,0.00041832292,0.00018884873,0.00015265857],"domain_scores_gemma":[0.9992159,0.00027718075,0.00011516879,0.0001667766,0.0001578178,0.00006717906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004635562,0.0001324684,0.00028165706,0.00023165475,0.00006324671,0.000039128026,0.00004940857,0.0000679042,0.000031323718],"category_scores_gemma":[0.00027094834,0.00011509597,0.00005816777,0.00021752906,0.00004604154,0.00015593025,0.000038239086,0.00010594297,0.0000045460797],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011126586,0.00089313684,0.0072254036,0.00040540422,0.00025785068,0.0002186681,0.0046263714,0.000053052325,0.9665282,0.0012158192,0.0016342317,0.01582921],"study_design_scores_gemma":[0.019726267,0.026972068,0.023821907,0.00027270446,0.002950237,0.00017335976,0.001401003,0.4588245,0.4219379,0.00056358625,0.042773157,0.0005833075],"about_ca_topic_score_codex":0.0000042261545,"about_ca_topic_score_gemma":0.0000028302109,"teacher_disagreement_score":0.5445903,"about_ca_system_score_codex":0.00010363214,"about_ca_system_score_gemma":0.00012128088,"threshold_uncertainty_score":0.46934775},"labels":[],"label_agreement":null},{"id":"W4404230670","doi":"10.1093/neuonc/noae165.0733","title":"PATH-34. IT NEVER RAINS BUT IT POURS - DIAGNOSING ANAPLASTIC PLEOMORPHIC XANTHASTROCYTOMA TWICE IN A FORTNIGHT - OUR EXPERIENCE IN A RESOURCE CONSTRAINED SETTING","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Parasites and Host Interactions","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"ASTER","funders":"","keywords":"Path (computing); Resource (disambiguation); Medicine; Computer science; Computer network","score_opus":0.03072457366236028,"score_gpt":0.3389251647075505,"score_spread":0.30820059104519026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404230670","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9812668,0.00066905946,0.00022497807,0.01299331,0.0016860443,0.0004294816,0.00010618851,0.0001328055,0.0024913643],"genre_scores_gemma":[0.99489975,0.00005914543,0.00013182104,0.0041323015,0.00011034225,0.00015615823,0.00007046747,0.00003853626,0.00040145803],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99706054,0.00057383423,0.0007003836,0.0007346406,0.000064764354,0.0008658435],"domain_scores_gemma":[0.9971213,0.0023406043,0.00016003022,0.00026905158,0.000040049865,0.000068981135],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033218792,0.00032826499,0.0005424063,0.0005445683,0.00019447863,0.000058076195,0.00030836693,0.0004444256,0.00040562756],"category_scores_gemma":[0.00079692027,0.00032962326,0.00013307607,0.00051219726,0.00023912013,0.00031049133,0.00015621229,0.0013138673,0.0003427565],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007794217,0.00045467238,0.0090344045,0.000050725568,0.000101085396,0.005087112,0.014051591,0.00019654556,0.94094074,0.00056946336,0.02336277,0.0053714854],"study_design_scores_gemma":[0.0052772244,0.0026696592,0.009137704,0.0007811106,0.00012538617,0.008182555,0.047193393,0.0025997083,0.022090934,0.00007764226,0.9009709,0.00089381967],"about_ca_topic_score_codex":0.00030446338,"about_ca_topic_score_gemma":0.0014966888,"teacher_disagreement_score":0.91884977,"about_ca_system_score_codex":0.0003888286,"about_ca_system_score_gemma":0.0004243492,"threshold_uncertainty_score":0.9999156},"labels":[],"label_agreement":null},{"id":"W4404230690","doi":"10.1093/neuonc/noae165.0970","title":"EXTH-39. A BENCH-TOP MODEL FOR THE OPTIMIZATION OF ULTRASOUND PARAMETERS FOR SONODYNAMIC THERAPY OF GLIOBLASTOMA","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Ultrasound and Hyperthermia Applications","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Sonodynamic therapy; Glioblastoma; Ultrasound; Medicine; Cancer research; Radiology","score_opus":0.018690383364374886,"score_gpt":0.26797522763803067,"score_spread":0.24928484427365577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404230690","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1561213,0.0007098314,0.84101355,0.00037555053,0.0003030832,0.0009770452,0.00015886364,0.00012595959,0.00021479455],"genre_scores_gemma":[0.9814289,0.0009890508,0.016656075,0.00012497212,0.000051720344,0.00065750757,0.000020798738,0.00005289677,0.000018029992],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9993347,0.000015821865,0.00025574362,0.00016494398,0.000060069957,0.00016875676],"domain_scores_gemma":[0.99756765,0.0021015813,0.000045627017,0.00020200312,0.000056461373,0.0000266491],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010572679,0.00011762053,0.00020284297,0.00007603261,0.000051182098,0.00001521763,0.00017292611,0.00011007293,0.000011981612],"category_scores_gemma":[0.00004865884,0.00009176623,0.0001318454,0.000157213,0.00007811607,0.000056554753,0.000007111861,0.00009373476,0.0000011617609],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045314744,0.000034056262,0.000004969869,0.000051294246,0.00005802483,1.3459731e-7,0.0005391961,0.70297533,0.2806914,0.001253647,0.00042650494,0.013920134],"study_design_scores_gemma":[0.00038444359,0.0003137913,0.000008365299,0.000007267671,0.00004917593,0.000010954738,0.00007729437,0.9722245,0.013520079,0.0011488022,0.012173875,0.000081450555],"about_ca_topic_score_codex":0.0000040516693,"about_ca_topic_score_gemma":0.000013195412,"teacher_disagreement_score":0.82530767,"about_ca_system_score_codex":0.00004540175,"about_ca_system_score_gemma":0.000072092516,"threshold_uncertainty_score":0.37421185},"labels":[],"label_agreement":null},{"id":"W4404230706","doi":"10.1093/neuonc/noae165.0967","title":"EXTH-36. SHIFTING FROM EPIGENETICS TO THE EPICHAPEROME: HSP90 AS A THERAPEUTIC TARGET FOR H3K27M DIFFUSE MIDLINE GLIOMA (DMG)","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; SickKids Foundation","funders":"","keywords":"Epigenetics; Hsp90; Glioma; Medicine; Cancer research; Biology; Heat shock protein; Genetics","score_opus":0.02822209775957269,"score_gpt":0.3418564886060926,"score_spread":0.3136343908465199,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404230706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9610492,0.006105159,0.009882126,0.019122133,0.0011049373,0.0018240554,0.00022968414,0.00008109037,0.000601625],"genre_scores_gemma":[0.98803014,0.00042298,0.0033069784,0.0047681467,0.0018664773,0.0008183061,0.00019366319,0.0001421959,0.00045110902],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99699587,0.00047234553,0.00045961727,0.0009651481,0.00029577623,0.0008112463],"domain_scores_gemma":[0.997994,0.0006818133,0.000055262306,0.0008356928,0.0001520794,0.0002811334],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00059966196,0.00033344023,0.00035815386,0.00011262044,0.00024064808,0.00011177178,0.0007729162,0.0004434017,0.00019462412],"category_scores_gemma":[0.0010212528,0.00025793907,0.00021375204,0.0003509689,0.00014766301,0.000006360579,0.0005054316,0.00044781074,0.00025143055],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038721084,0.00014921335,0.000078697965,0.000033826866,0.00012012126,0.00011224723,0.00034348018,0.00006200667,0.9402371,0.00013308613,0.0036650384,0.054677974],"study_design_scores_gemma":[0.00055848487,0.0022253238,0.00010754153,0.000011928692,0.00003165756,0.00004714922,0.000066290406,0.00096031657,0.3810539,0.00064430153,0.6140963,0.00019684645],"about_ca_topic_score_codex":0.000073855226,"about_ca_topic_score_gemma":0.00016397811,"teacher_disagreement_score":0.6104312,"about_ca_system_score_codex":0.000094756375,"about_ca_system_score_gemma":0.0005768725,"threshold_uncertainty_score":0.9999873},"labels":[],"label_agreement":null},{"id":"W4404230715","doi":"10.1093/neuonc/noae165.0531","title":"DDDR-46. TARGETING TRANSGLUTAMINASE 2 (TGM2) ENHANCES SENSITIVITY OF GLIOBLASTOMA CELL LINES TO RADIOTHERAPY AND TEMOZOLOMIDE","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Blood properties and coagulation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Temozolomide; Glioblastoma; Tissue transglutaminase; Radiation therapy; Sensitivity (control systems); Cancer research; Medicine; Chemistry; Internal medicine; Enzyme","score_opus":0.01276079973339035,"score_gpt":0.27864743829705646,"score_spread":0.2658866385636661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404230715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894543,0.0029438122,0.0009247051,0.00534022,0.0004440649,0.00036630983,0.000006016994,0.000085003194,0.00043553452],"genre_scores_gemma":[0.996211,0.00044208055,0.0014250242,0.0013601885,0.00039461502,0.0000151063405,0.0000031704528,0.00002966901,0.0001191296],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988552,0.00018559057,0.0002916875,0.00032968866,0.00012637035,0.00021151008],"domain_scores_gemma":[0.99923766,0.00039936724,0.000052453113,0.00013085379,0.000063659434,0.000115997056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033684628,0.00014868888,0.0004056115,0.00012435683,0.000047686437,0.000014339528,0.000035626665,0.00013340762,0.0000561898],"category_scores_gemma":[0.00008294455,0.0001198655,0.00007178306,0.00020226295,0.00008774539,0.00006609497,0.000023480916,0.00019697424,0.000012252256],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006415242,0.00009756067,0.0003361653,0.00024722575,0.000025785415,0.00023405002,0.0013334265,0.000039066905,0.8883307,0.000015927748,0.00076840015,0.10793015],"study_design_scores_gemma":[0.00085650163,0.003899442,0.0008485793,0.00008641414,0.00011191805,0.00026282013,0.0002646077,0.006171804,0.89777726,0.000015732745,0.08957472,0.0001301852],"about_ca_topic_score_codex":0.000059735296,"about_ca_topic_score_gemma":0.000060534574,"teacher_disagreement_score":0.10779997,"about_ca_system_score_codex":0.000045032208,"about_ca_system_score_gemma":0.0001177932,"threshold_uncertainty_score":0.48879734},"labels":[],"label_agreement":null},{"id":"W4404230722","doi":"10.1093/neuonc/noae165.1257","title":"TMIC-80. HIGH-DIMENSIONAL HISTOPATHOLOGIC EVALUATION OF THE HYPOXIC TUMOR MICROENVIRONMENT IN GLIOBLASTOMA","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto; University Health Network","funders":"","keywords":"Glioblastoma; Tumor microenvironment; Pathology; Medicine; Cancer research; Tumor cells","score_opus":0.012878047212027259,"score_gpt":0.26305098526134585,"score_spread":0.2501729380493186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404230722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867623,0.00789851,0.000014601586,0.0007329528,0.0037968815,0.0003864821,0.000027279302,0.000010712027,0.00037031688],"genre_scores_gemma":[0.997719,0.00028769037,0.00011385936,0.0010746854,0.00057946076,0.00008638775,0.000014071532,0.000022667577,0.000102170525],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998276,0.00043860625,0.00031370958,0.00045972323,0.00027145675,0.00024048139],"domain_scores_gemma":[0.9993946,0.00004533516,0.00010554852,0.00036014232,0.00004789648,0.00004647485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059208105,0.00015945907,0.00022566596,0.00008144543,0.000041410756,0.0000067850015,0.00021156196,0.00015612453,0.00011579519],"category_scores_gemma":[0.00014769884,0.00012484714,0.00012416167,0.00014070427,0.00018461466,0.0000040383575,0.00019250796,0.00019909538,0.000022061173],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011006304,0.00010998322,0.00013948885,0.000015265843,0.0000110394885,0.000013241421,0.000053756146,0.00069192314,0.9742634,0.0000633714,0.005056646,0.01947177],"study_design_scores_gemma":[0.0012454388,0.0007250146,0.010021084,0.00002156055,0.00011648621,0.0003011747,0.000027172442,0.0005892671,0.5611267,0.00028843683,0.42536753,0.00017012932],"about_ca_topic_score_codex":0.00002284752,"about_ca_topic_score_gemma":0.0001353438,"teacher_disagreement_score":0.42031088,"about_ca_system_score_codex":0.00016300299,"about_ca_system_score_gemma":0.00042233162,"threshold_uncertainty_score":0.5091119},"labels":[],"label_agreement":null},{"id":"W4404230724","doi":"10.1093/neuonc/noae165.0960","title":"EXTH-29. EVALUATION OF THE ANTITUMOR EFFECT OF A CHEMOTHERAPY-LOADED DEVICE FOR THE TREATMENT OF PRIMARY BRAIN TUMORS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; Université de Sherbrooke","funders":"","keywords":"Primary (astronomy); Chemotherapy; Medicine; Brain tumor; Oncology; Internal medicine; Cancer research; Pathology; Physics","score_opus":0.02879134635896587,"score_gpt":0.3189839866964344,"score_spread":0.29019264033746855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404230724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99403936,0.0009019967,0.00005085495,0.002105449,0.00075452856,0.0019292093,0.000046438217,0.000027388362,0.00014476402],"genre_scores_gemma":[0.99915946,0.000030113297,0.00010197697,0.00033482502,0.00007579703,0.00025542916,0.0000024420758,0.000021166808,0.000018814982],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99779564,0.0009084344,0.00043107016,0.0002756713,0.00038661665,0.0002025528],"domain_scores_gemma":[0.9946255,0.004523635,0.00024987038,0.00042651978,0.00014701443,0.000027445658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018199135,0.00014584808,0.0004180339,0.0000612937,0.000054786295,0.000011374323,0.00028829352,0.00006151243,0.0000964268],"category_scores_gemma":[0.0003766035,0.00007813173,0.00017908982,0.00027496443,0.0002623481,0.00006610442,0.000039442075,0.00005542336,0.00000989276],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005457913,0.00024336565,0.00017719046,0.00017520839,0.000029309604,0.0000032334958,0.0006424741,0.00040265417,0.9710443,0.00006500147,0.00046723653,0.026204221],"study_design_scores_gemma":[0.0022498607,0.0033054973,0.0010464598,0.00004486679,0.0002836109,0.000013789067,0.000032366657,0.0036225005,0.98557097,0.000080434664,0.0036900337,0.00005963578],"about_ca_topic_score_codex":0.000048856367,"about_ca_topic_score_gemma":0.000017659555,"teacher_disagreement_score":0.026144585,"about_ca_system_score_codex":0.0002454193,"about_ca_system_score_gemma":0.0005844786,"threshold_uncertainty_score":0.31861195},"labels":[],"label_agreement":null},{"id":"W4404230727","doi":"10.1093/neuonc/noae165.0607","title":"IMMU-14. TRANS-SPECIES ANALYSIS OF REPLICATION-REPAIR DEFICIENT (RRD) MEDULLOBLASTOMA AND RESPONSE TO IMMUNE CHECKPOINT INHIBITION: AN IRRDC REPORT","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Hospital for Sick Children","funders":"","keywords":"Immune checkpoint; Replication (statistics); Immune system; Cancer research; Biology; Immunotherapy; Immunology; Virology","score_opus":0.0242567763184399,"score_gpt":0.3205111076496576,"score_spread":0.2962543313312177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404230727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9806319,0.0011335337,0.00008096454,0.01609022,0.00022802212,0.0006291816,0.000050688068,0.00019028525,0.0009651923],"genre_scores_gemma":[0.99821013,0.00014159945,0.0006210887,0.00045231223,0.000057479832,0.00024476813,0.00011079064,0.00002985921,0.00013199348],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9974578,0.00023897343,0.0008575839,0.0008586355,0.0003240079,0.0002629748],"domain_scores_gemma":[0.9977963,0.0005421923,0.0001543983,0.001039785,0.00021706846,0.00025028051],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009753209,0.00021878441,0.00074478966,0.00086611026,0.00008269686,0.000024061394,0.00006871642,0.00015093427,0.00022504764],"category_scores_gemma":[0.0005001472,0.00018587286,0.0003898606,0.001427158,0.00015795312,0.00007006844,0.00006175642,0.00017519253,0.000015922435],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001471969,0.0010308641,0.0041946736,0.00005974356,0.000824626,0.0038559271,0.0018564925,0.000071818766,0.9811712,0.00041680585,0.00067617046,0.0043697245],"study_design_scores_gemma":[0.002070593,0.006966774,0.43514374,0.00012532862,0.004426655,0.002636793,0.00078916794,0.0010435804,0.37600783,0.000057699777,0.17044601,0.00028583815],"about_ca_topic_score_codex":0.00005729019,"about_ca_topic_score_gemma":0.00009541782,"teacher_disagreement_score":0.60516334,"about_ca_system_score_codex":0.0002948758,"about_ca_system_score_gemma":0.0002787572,"threshold_uncertainty_score":0.75796753},"labels":[],"label_agreement":null},{"id":"W4404230728","doi":"10.1093/neuonc/noae165.0955","title":"EXTH-24. THERAPEUTIC TARGETING OF MISLOCALIZED NUCLEAR ENVELOPE PROTEINS IN<i>MYC</i>-DRIVEN GROUP 3 MEDULLOBLASTOMA","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; National Research Council Canada; University of Toronto; McMaster University; Hamilton Health Sciences","funders":"","keywords":"Medulloblastoma; Envelope (radar); Group (periodic table); Cancer research; Neuroscience; Biology; Chemistry; Computer science; Telecommunications","score_opus":0.00980264798282271,"score_gpt":0.2538272993630138,"score_spread":0.24402465138019108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404230728","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99253863,0.0018867113,0.0012234198,0.00095437065,0.0007987868,0.00067781075,0.00003283901,0.00006371261,0.0018237155],"genre_scores_gemma":[0.9951636,0.0010614758,0.002087697,0.0011809573,0.00022476903,0.000067731235,0.00006940238,0.000076868586,0.000067489644],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981744,0.00026781592,0.00046323845,0.00056539814,0.00012948619,0.00039965863],"domain_scores_gemma":[0.999377,0.000067425324,0.00010352549,0.00031274743,0.00005347551,0.000085821775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024617603,0.00023582365,0.00035656284,0.00011938844,0.00004929982,0.000022670134,0.00032498725,0.00038063413,0.000085755746],"category_scores_gemma":[0.00008438637,0.00022676899,0.00015842535,0.00020098746,0.00015773294,0.00000768926,0.00020960695,0.00032804714,0.000028634897],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020365334,0.00017513483,0.00039445292,0.00009644655,0.000061821345,0.000078380515,0.00028057696,0.000041143365,0.98219883,0.00051088294,0.0015243088,0.0144343665],"study_design_scores_gemma":[0.0011569185,0.0015649447,0.00022589805,0.000056280405,0.000044986118,0.00011297075,0.00017326517,0.0017163763,0.22908789,0.00015756575,0.7654,0.0003029178],"about_ca_topic_score_codex":0.000040979266,"about_ca_topic_score_gemma":0.00017116393,"teacher_disagreement_score":0.76387566,"about_ca_system_score_codex":0.00005994895,"about_ca_system_score_gemma":0.00021138575,"threshold_uncertainty_score":0.9247371},"labels":[],"label_agreement":null},{"id":"W4404230732","doi":"10.1093/neuonc/noae165.0956","title":"EXTH-25. OPTIMIZATION OF NEW CHEMOTHERAPEUTIC AGENTS BY INTRA-ARTERIAL INFUSION IN GLIOBLASTOMAS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Medicine; Pharmacology; Chemotherapeutic drugs; Cancer research; Internal medicine; Chemotherapy","score_opus":0.025620880079863576,"score_gpt":0.3435177750892911,"score_spread":0.3178968950094275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404230732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98381937,0.00093024096,0.00051501975,0.007421059,0.0026016743,0.0006962076,0.000013853748,0.00009993906,0.0039026188],"genre_scores_gemma":[0.9947598,0.00091206544,0.00039437844,0.0027745334,0.0005195531,0.000034188393,0.00006237861,0.00003761009,0.0005054709],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990179,0.00008470571,0.00030980812,0.00027007566,0.00011278767,0.00020475304],"domain_scores_gemma":[0.9995719,0.00012731928,0.00006252182,0.0001159841,0.000023951172,0.00009831284],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00007486301,0.0001387898,0.0003381351,0.0001939648,0.000015852527,0.000007789869,0.0000635346,0.00017807884,0.0023327796],"category_scores_gemma":[0.000019060943,0.00012766453,0.00006272405,0.0002957694,0.000057359284,0.000060289654,0.000031348027,0.00019536423,0.000036509602],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015446325,0.00057182886,0.00064466824,0.00007944997,0.000071021335,0.00017699318,0.001195999,0.00025998912,0.86732,0.000025684662,0.054606643,0.0735031],"study_design_scores_gemma":[0.01362872,0.008172602,0.0013519255,0.00010775496,0.00042340354,0.00025987084,0.000060198992,0.014228654,0.15630277,0.000116104435,0.80511993,0.00022809362],"about_ca_topic_score_codex":0.00009569407,"about_ca_topic_score_gemma":0.000051789586,"teacher_disagreement_score":0.75051326,"about_ca_system_score_codex":0.00023639936,"about_ca_system_score_gemma":0.00035140404,"threshold_uncertainty_score":0.9985792},"labels":[],"label_agreement":null},{"id":"W4404230737","doi":"10.1093/neuonc/noae165.0037","title":"EPCO-38. IDENTIFYING THE MOLECULAR SIGNATURE OF INFILTRATING EDGE IN GLIOBLASTOMA AS DRIVERS OF TUMOUR INVASION AND RECURRENCE","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"ATP Synthase and ATPases Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Glioblastoma; Signature (topology); Pathology; Biology; Medicine; Oncology; Cancer research; Mathematics","score_opus":0.018283488072068584,"score_gpt":0.3235120622537771,"score_spread":0.3052285741817085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404230737","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99470276,0.003518427,0.00014519601,0.0004048044,0.00014459479,0.00019546646,0.000010710542,0.0000062607373,0.0008717835],"genre_scores_gemma":[0.9988713,0.0008103168,0.000093108894,0.000121667494,0.000055087632,0.00001283291,0.0000072179537,0.000014568237,0.000013863557],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988258,0.0002385791,0.00025536353,0.00031940266,0.00015788144,0.00020299327],"domain_scores_gemma":[0.9994157,0.00020246246,0.000081168415,0.00019037262,0.00006068347,0.000049608258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003031675,0.000115313735,0.00018205686,0.00010380326,0.00003875074,0.000015729509,0.00021504569,0.00018476708,0.00001819381],"category_scores_gemma":[0.00043357853,0.0000919448,0.00006739279,0.0002507868,0.00022151589,0.000008533696,0.00024557632,0.00033439233,0.0000031176655],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008324303,0.00003390778,0.00041185977,0.00010242944,0.000017954082,0.00015747109,0.000323942,0.000040219755,0.98801196,0.0003102806,0.00028802958,0.010218714],"study_design_scores_gemma":[0.0002641229,0.000970236,0.0002311635,0.00009994681,0.000012926212,0.000048008853,0.0005098411,0.00030217058,0.9898419,0.00017335589,0.0074632075,0.00008311954],"about_ca_topic_score_codex":0.000026182353,"about_ca_topic_score_gemma":0.000037230093,"teacher_disagreement_score":0.010135595,"about_ca_system_score_codex":0.000016050491,"about_ca_system_score_gemma":0.00024120505,"threshold_uncertainty_score":0.37494},"labels":[],"label_agreement":null},{"id":"W4404230748","doi":"10.1093/neuonc/noae165.1252","title":"TMIC-75. ICAM-1 PROMOTES AN IMMUNOSUPPRESSIVE LANDSCAPE IN GLIOBLASTOMAS BY REGULATING THE PHENOTYPIC POLARIZATION STATE OF TUMOR ASSOCIATED MACROPHAGES","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Signaling Pathways in Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Western Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Phenotype; ICAM-1; Glioblastoma; Cancer research; Polarization (electrochemistry); Biology; Immunology; Chemistry; Genetics; Gene; Cell adhesion molecule","score_opus":0.007259614208771409,"score_gpt":0.25993952079567284,"score_spread":0.2526799065869014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404230748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99690086,0.0018322547,0.0000872177,0.00023491021,0.00027159555,0.0003140565,0.00015434434,0.000042069507,0.0001626669],"genre_scores_gemma":[0.999187,0.000022530587,0.000085058346,0.00024035269,0.00008349912,0.000039312315,0.00024208504,0.000043559245,0.000056613637],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982978,0.00051595713,0.00035234643,0.0004154855,0.00014057537,0.00027779807],"domain_scores_gemma":[0.99917716,0.00017452316,0.00018538801,0.00031943066,0.00008642415,0.00005710332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003158452,0.00017262706,0.00021107403,0.00006200371,0.00006753516,0.000035537923,0.00028979455,0.00013677184,0.000029379706],"category_scores_gemma":[0.00060251635,0.00014261766,0.000067248424,0.0002434326,0.00013081385,0.000010795888,0.00013895243,0.0002274234,0.0000043271234],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017741689,0.00016188029,0.0029459607,0.00003155136,0.000046765723,0.00004564687,0.00038516728,0.00029468173,0.9913497,0.000021188696,0.00082634256,0.003713704],"study_design_scores_gemma":[0.0006730291,0.0010612195,0.0026377048,0.00004519715,0.000041666637,0.000026212547,0.00008906263,0.0031136363,0.98982775,0.00029818696,0.0020187162,0.00016760279],"about_ca_topic_score_codex":0.000027209546,"about_ca_topic_score_gemma":0.000048054128,"teacher_disagreement_score":0.0035461013,"about_ca_system_score_codex":0.000039112878,"about_ca_system_score_gemma":0.00019706362,"threshold_uncertainty_score":0.5815779},"labels":[],"label_agreement":null},{"id":"W4404230811","doi":"10.1093/neuonc/noae165.0789","title":"NIMG-23. A NOVEL APPROACH TO PERFUSION MRI STUDIES IN BRAIN TUMOR PATIENTS USING ENDOGENOUS DEOXYHEMOGLOBIN AS A CONTRAST AGENT: A PROOF-OF-CONCEPT STUDY","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Hydrogen's biological and therapeutic effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Proof of concept; Contrast (vision); Endogeny; Medicine; Perfusion; Magnetic resonance imaging; Neuroscience; Internal medicine; Computer science; Radiology; Artificial intelligence; Psychology","score_opus":0.09303234986110322,"score_gpt":0.3537981192688025,"score_spread":0.2607657694076993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404230811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923168,0.0011198213,0.0002779264,0.0005610483,0.00053039554,0.004360236,0.000019987185,0.00007804814,0.00073577405],"genre_scores_gemma":[0.99599427,0.000009574611,0.00052215916,0.0030416131,0.00013914652,0.00021791295,0.000013586626,0.000039215003,0.000022504135],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973818,0.00041468558,0.0006071717,0.0007553016,0.00030808465,0.00053294783],"domain_scores_gemma":[0.99862546,0.0006838865,0.00011212206,0.00025511446,0.00012485312,0.00019858892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004889657,0.00033061218,0.0009727992,0.0002515848,0.00007474519,0.00001247593,0.00017217324,0.0001602793,0.000017855642],"category_scores_gemma":[0.0006897532,0.00023480186,0.00013567,0.00064954476,0.0002021958,0.000042428917,0.00023241172,0.00044132062,0.000025321255],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017561348,0.0133576775,0.009146503,0.00047797326,0.00039060262,0.002432453,0.028233612,0.0005200031,0.91627526,0.00023442158,0.00008035504,0.027094975],"study_design_scores_gemma":[0.08911385,0.24551938,0.012722043,0.003234971,0.0027338064,0.008515821,0.025746144,0.021192899,0.544814,0.0013562761,0.04182174,0.0032291054],"about_ca_topic_score_codex":0.00008767606,"about_ca_topic_score_gemma":0.00002032715,"teacher_disagreement_score":0.37146133,"about_ca_system_score_codex":0.00046825313,"about_ca_system_score_gemma":0.00037676914,"threshold_uncertainty_score":0.9574942},"labels":[],"label_agreement":null},{"id":"W4404230824","doi":"10.1093/neuonc/noae165.0657","title":"IMMU-65. TARGETING AXONAL GUIDANCE DEPENDENCIES IN GLIOBLASTOMA WITH ROBO1 CAR T CELLS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; National Research Council Canada; McMaster University","funders":"","keywords":"Glioblastoma; Cancer research; Neuroscience; Computer science; Computational biology; Biology","score_opus":0.012816616305450066,"score_gpt":0.2739697940066686,"score_spread":0.26115317770121854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404230824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98948836,0.002544251,0.000026128186,0.0034893677,0.0006545815,0.00045208193,0.000038695318,0.00013885695,0.0031676895],"genre_scores_gemma":[0.9975013,0.00011531205,0.0009550697,0.00088757026,0.00022681679,0.0001854769,0.000016793841,0.000043363616,0.00006825596],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984168,0.00009991183,0.0003174687,0.00048859057,0.00025320347,0.00042402314],"domain_scores_gemma":[0.99895215,0.0005756876,0.00006186864,0.00021193372,0.00006382198,0.00013451668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015824565,0.00022186707,0.0004231077,0.0002295587,0.000053104766,0.000028379362,0.0000976712,0.00014565034,0.00054748665],"category_scores_gemma":[0.00009488256,0.0001659669,0.00008992523,0.00038175,0.00009406096,0.00007631169,0.000067212604,0.00037163065,0.00021152932],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048122997,0.0007242483,0.0162996,0.00016291205,0.00013681254,0.026893515,0.00076146313,0.0004235314,0.9010295,0.0003371343,0.039121427,0.013628594],"study_design_scores_gemma":[0.003879946,0.0058561736,0.007279511,0.00041594708,0.0002309555,0.0015910591,0.00048338535,0.0014612194,0.49241328,0.00006534262,0.48597667,0.00034652243],"about_ca_topic_score_codex":0.00006799017,"about_ca_topic_score_gemma":0.00034310514,"teacher_disagreement_score":0.44685525,"about_ca_system_score_codex":0.00032335919,"about_ca_system_score_gemma":0.00037388163,"threshold_uncertainty_score":0.6767934},"labels":[],"label_agreement":null},{"id":"W4404230831","doi":"10.1093/neuonc/noae165.0411","title":"CTNI-44. NCT03643549 PHASE IB/II TRIAL: EFFICACY, SAFETY, AND BIOLOGICAL MECHANISMS OF OBJECTIVE RESPONSES IN RECURRENT GBM PATIENTS WITH UNMETHYLATED MGMT PROMOTER TREATED WITH SEQUENTIAL BORTEZOMIB AND TEMOZOLOMIDE","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Temozolomide; Bortezomib; Medicine; Oncology; Phases of clinical research; Internal medicine; Glioblastoma; Cancer research; Pharmacology; Clinical trial; Multiple myeloma","score_opus":0.025475230966699052,"score_gpt":0.3209164149299225,"score_spread":0.29544118396322344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404230831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99491495,0.00027629352,0.00007132549,0.00049078406,0.00022067662,0.0035409047,0.00010303076,0.00012896932,0.0002530459],"genre_scores_gemma":[0.9985914,0.00025998297,0.00055189076,0.00013086219,0.000049574828,0.00012916594,0.00017467387,0.000060366958,0.000052037187],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99686366,0.00073889305,0.00067841035,0.00096172176,0.00028790068,0.00046939967],"domain_scores_gemma":[0.9981192,0.0009854168,0.00022961202,0.00031638722,0.00012331497,0.00022611282],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039654737,0.00044549463,0.0010967391,0.00040890055,0.00008645124,0.000019856167,0.000090301626,0.00037745893,0.00007737516],"category_scores_gemma":[0.00038325565,0.00028265468,0.00007072051,0.00053441204,0.00043970806,0.00010141218,0.00015269396,0.00057704595,0.000004928652],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.722494,0.007232577,0.0116937505,0.00020171667,0.00097431336,0.0039317994,0.0017391724,0.0000058824885,0.14454313,0.00022065704,0.000076357144,0.10688662],"study_design_scores_gemma":[0.5882612,0.29144973,0.046367414,0.0009633675,0.0017341024,0.0011271911,0.0002386583,0.0008456613,0.063557774,0.0003433364,0.0042585973,0.00085297925],"about_ca_topic_score_codex":0.00011728896,"about_ca_topic_score_gemma":0.00008681151,"teacher_disagreement_score":0.28421715,"about_ca_system_score_codex":0.0009151388,"about_ca_system_score_gemma":0.0008909261,"threshold_uncertainty_score":0.99996257},"labels":[],"label_agreement":null},{"id":"W4404230846","doi":"10.1093/neuonc/noae165.1282","title":"TMOD-18. FUNCTIONAL DISSECTION OF RECURRENT COPY-NUMBER-ALTERATIONS INFORMS MECHANISMS OF LOW-GRADE-GLIOMA PROGRESSION","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Glioma; Dissection (medical); Medicine; Cancer research; Biology; Neuroscience; Surgery","score_opus":0.029448219150672625,"score_gpt":0.3430704509514019,"score_spread":0.31362223180072923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404230846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907465,0.00026330742,0.0012723508,0.0022908675,0.0024697585,0.00078074925,0.000043857806,0.00010050743,0.0020320914],"genre_scores_gemma":[0.99878454,0.0000746911,0.00048801908,0.00009658697,0.00015381105,0.00021089747,0.00014928354,0.000021313132,0.000020870291],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986743,0.00005950141,0.0004832227,0.0002794883,0.0003161356,0.000187368],"domain_scores_gemma":[0.99913055,0.00025009422,0.00015332205,0.00020076368,0.00015271416,0.0001125444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012483913,0.00016163982,0.00036257014,0.0002378667,0.00006169287,0.000013091828,0.000049485217,0.00015455288,0.00053550105],"category_scores_gemma":[0.000082837716,0.00011891352,0.0001679608,0.00042583872,0.00008061463,0.00010496421,0.000045991146,0.00019837965,0.00004773177],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046371852,0.0028536257,0.005151832,0.00048295638,0.0002007302,0.00032443664,0.00035726163,0.00004598926,0.909442,0.015644366,0.007474823,0.057558265],"study_design_scores_gemma":[0.0030401805,0.0063838838,0.008630172,0.00054415496,0.0003848268,0.0010113801,0.00014561274,0.0015726277,0.9598048,0.002536578,0.015777476,0.00016830652],"about_ca_topic_score_codex":0.000009982776,"about_ca_topic_score_gemma":0.000014948471,"teacher_disagreement_score":0.057389956,"about_ca_system_score_codex":0.00016671969,"about_ca_system_score_gemma":0.00025899257,"threshold_uncertainty_score":0.5863361},"labels":[],"label_agreement":null},{"id":"W4404230872","doi":"10.1093/neuonc/noae165.1285","title":"TMOD-21. MOUSE MODEL TO CONDITIONALLY EXPRESS A DIFFUSE MIDLINE GLIOMA DERIVED MUTATION IN THE ONCOGENIC PHOSPHATASE PPM1D","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Mutation; Glioma; Biology; Cancer research; Genetics; Gene","score_opus":0.014511212398814154,"score_gpt":0.2831384317947988,"score_spread":0.26862721939598466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404230872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873299,0.00072456413,0.008970882,0.0016506854,0.00024102448,0.0005431012,0.0003518194,0.00003177709,0.0001562671],"genre_scores_gemma":[0.99090654,0.00021606352,0.0011111926,0.0061831637,0.00021380151,0.00027719626,0.0009329651,0.000042269978,0.000116829295],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99851704,0.00017814295,0.0003157004,0.0005277643,0.00014509972,0.00031627325],"domain_scores_gemma":[0.9992983,0.00010855203,0.0000556963,0.00037578456,0.00006443035,0.000097271026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019968736,0.00020776324,0.00019518875,0.000110386245,0.000067323104,0.0000494744,0.0003515667,0.00023780025,0.000019169298],"category_scores_gemma":[0.00011748077,0.00017652221,0.000112060494,0.000178663,0.00007405159,0.000010261979,0.00014103811,0.0002216894,0.00004596395],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019240918,0.0002809583,0.000012774973,0.000022015976,0.000030238833,0.00025044914,0.00043300592,0.0040152883,0.9849369,0.00041957528,0.0078957705,0.001510617],"study_design_scores_gemma":[0.001449542,0.0008021477,0.00005358016,0.000013771728,0.000052186453,0.00027566217,0.00014798185,0.019304909,0.90449286,0.00027061522,0.0728618,0.00027495617],"about_ca_topic_score_codex":0.000023620776,"about_ca_topic_score_gemma":0.00017053855,"teacher_disagreement_score":0.080444045,"about_ca_system_score_codex":0.00006717608,"about_ca_system_score_gemma":0.0002929209,"threshold_uncertainty_score":0.7198367},"labels":[],"label_agreement":null},{"id":"W4404230874","doi":"10.1093/neuonc/noae165.0629","title":"IMMU-36. MULTI-OMIC CHARACTERIZATION OF A SYNGENEIC MOUSE CANCER STEM CELL MODEL OF GBM FOR PRECLINICAL APPLICATIONS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Standards Association; University of Calgary","funders":"","keywords":"Cancer; Cancer research; Computational biology; Cancer stem cell; Biology; Genetics","score_opus":0.07576980243174139,"score_gpt":0.3765004190004864,"score_spread":0.300730616568745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404230874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92922205,0.0016791653,0.0619059,0.00214538,0.0006917226,0.0027362453,0.0012283023,0.000084557796,0.0003066706],"genre_scores_gemma":[0.99054605,0.002959679,0.0028739406,0.0006326826,0.00024398287,0.0012536338,0.00010326273,0.00005951615,0.0013272351],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988534,0.000042618336,0.0005122751,0.0003232754,0.0000998517,0.00016857692],"domain_scores_gemma":[0.9991239,0.00020266688,0.00018632459,0.000267427,0.0001359529,0.000083771105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014838413,0.000117002106,0.00046381986,0.00010889425,0.000022252329,0.0000041831863,0.00009147513,0.00014558804,0.000040964915],"category_scores_gemma":[0.000014298559,0.00010593732,0.00017155593,0.00015077932,0.000090891604,0.00003687911,0.000039332157,0.0001527381,0.0000063612683],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035481434,0.00037591287,0.00007338637,0.00081249984,0.000052469546,0.0000015725034,0.00023934297,0.00028278198,0.9281456,0.00009280854,0.00029004924,0.0692788],"study_design_scores_gemma":[0.002043122,0.0007282696,0.000142127,0.000052267624,0.00056553,0.0000082091165,0.000035430985,0.05662883,0.8070288,0.000015372192,0.13264638,0.00010569813],"about_ca_topic_score_codex":0.000029690822,"about_ca_topic_score_gemma":0.000025830132,"teacher_disagreement_score":0.13235633,"about_ca_system_score_codex":0.00011824526,"about_ca_system_score_gemma":0.0006875512,"threshold_uncertainty_score":0.43199983},"labels":[],"label_agreement":null},{"id":"W4404230928","doi":"10.1093/neuonc/noae165.0511","title":"DDDR-26. IDENTIFICATION OF MODULATORS OF IDH INHIBITOR SENSITIVITY IN<i>IDH</i>-MUTATED DIFFUSE GLIOMAS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Princess Margaret Cancer Centre; McGill University","funders":"","keywords":"Identification (biology); Sensitivity (control systems); Biology; Botany; Engineering","score_opus":0.016454271741290286,"score_gpt":0.2981942380691827,"score_spread":0.28173996632789244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404230928","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963194,0.0003774108,0.000023077331,0.0016383389,0.00078229106,0.0005249221,0.000029779441,0.00009079241,0.0002139947],"genre_scores_gemma":[0.99953455,0.00008259717,0.00005069633,0.00012678804,0.000089351044,0.000044842596,0.00002521836,0.000037671867,0.000008287051],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982993,0.00017638611,0.00064556533,0.00039498007,0.00024049202,0.00024328254],"domain_scores_gemma":[0.9987971,0.00046922915,0.00018022355,0.00032754353,0.00012566194,0.000100222824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032970562,0.00017109925,0.0005548794,0.00046296426,0.000022380453,0.000009320755,0.000049829676,0.0001821553,0.000021074771],"category_scores_gemma":[0.00021846844,0.0001484546,0.00014268648,0.0006840828,0.00013480875,0.00007798259,0.00006226953,0.00019620282,0.000035140893],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014663105,0.0016596487,0.02683391,0.00019172103,0.000087711844,0.0017127523,0.00050979026,0.000049867976,0.9602317,0.00034687214,0.00062181114,0.0076075387],"study_design_scores_gemma":[0.0027438407,0.00082053745,0.09870511,0.00012746213,0.0002257596,0.00020508416,0.000104257204,0.0024426877,0.8923032,0.0001477935,0.0020705813,0.000103647755],"about_ca_topic_score_codex":0.0001255074,"about_ca_topic_score_gemma":0.00011930107,"teacher_disagreement_score":0.071871206,"about_ca_system_score_codex":0.00019964922,"about_ca_system_score_gemma":0.00018629576,"threshold_uncertainty_score":0.6053803},"labels":[],"label_agreement":null},{"id":"W4404236532","doi":"10.1093/neuonc/noae165.0526","title":"DDDR-41. A GENOME-WIDE CRISPR/CAS9 SCREEN IN GLIOBLASTOMA STEM CELLS UNVEILS SYNTHETIC LETHAL INTERACTIONS AND RESISTANCE MECHANISMS OF JIN001, A BLOOD-BRAIN BARRIER-PENETRANT HSP90 INHIBITOR","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Computational Drug Discovery Methods","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"CRISPR; Penetrant (biochemical); Blood–brain barrier; Glioblastoma; Biology; Cancer research; Neuroscience; Genetics; Gene; Central nervous system; Biotechnology","score_opus":0.016338885421779872,"score_gpt":0.28882862749890476,"score_spread":0.2724897420771249,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404236532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5939738,0.0006236777,0.39533702,0.0062580258,0.0018742984,0.00072989985,0.000082834034,0.00020626938,0.00091416977],"genre_scores_gemma":[0.9677781,0.00003137553,0.030927762,0.0008793218,0.00010242173,0.000078173696,0.0000015075949,0.000044440927,0.00015689878],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99593353,0.0012941336,0.000786307,0.0010530909,0.00042965036,0.000503297],"domain_scores_gemma":[0.9928032,0.0061184154,0.00020023495,0.0005559744,0.000110647125,0.00021149428],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011521709,0.00032605405,0.00057150633,0.0007302604,0.00010163197,0.00016862091,0.0007434232,0.0001597564,0.0000349238],"category_scores_gemma":[0.0002670684,0.00033816858,0.00014747938,0.0010387839,0.00019145332,0.0005370383,0.0005552256,0.0006091396,0.000030369292],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021132061,0.0003192041,0.000032953893,0.00023407946,0.00008387921,0.0019807129,0.003249031,0.0031315617,0.9318012,0.047137916,0.00075049367,0.01106767],"study_design_scores_gemma":[0.0026255676,0.003222479,0.0008739872,0.0006595421,0.00016334691,0.001293561,0.0008156411,0.119054526,0.7664069,0.05580537,0.047877748,0.0012013448],"about_ca_topic_score_codex":0.000045790526,"about_ca_topic_score_gemma":0.0004399419,"teacher_disagreement_score":0.3738043,"about_ca_system_score_codex":0.00021734755,"about_ca_system_score_gemma":0.0006217294,"threshold_uncertainty_score":0.999907},"labels":[],"label_agreement":null},{"id":"W4404236533","doi":"10.1093/neuonc/noae165.0377","title":"CTNI-09. TYPE II RAF INHIBITOR TOVORAFENIB IN RELAPSED/REFRACTORY (R/R) PEDIATRIC LOW-GRADE GLIOMA (PLGG): RESULTS FROM PATIENTS ON A DRUG HOLIDAY (DH) IN THE PHASE 2 FIREFLY-1 TRIAL","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Children's Hospital; Université Laval; McGill University Health Centre; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Refractory (planetary science); Medicine; Internal medicine; Glioma; Firefly protocol; Drug; Oncology; Pharmacology; Cancer research; Biology","score_opus":0.024914131407601892,"score_gpt":0.31721692825927367,"score_spread":0.29230279685167176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404236533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854103,0.0009100459,8.100181e-8,0.0054896357,0.004481983,0.0021251894,0.00022402078,0.0001038792,0.0012548948],"genre_scores_gemma":[0.9958063,0.0002831104,0.0000201442,0.00134196,0.0018337257,0.00028905954,0.0003291496,0.00006563111,0.00003092949],"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99617064,0.0007248839,0.0009946505,0.0009521824,0.0005840265,0.00057361386],"domain_scores_gemma":[0.9960275,0.002826336,0.00021995693,0.00065871724,0.00006830588,0.00019913154],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000567544,0.0004192103,0.0007384127,0.00077582133,0.00010781158,0.000047784884,0.00026691885,0.0003759146,0.000090749665],"category_scores_gemma":[0.0012104076,0.00029125245,0.00021563083,0.0013199125,0.00007838201,0.000099451216,0.00012496742,0.0010391033,0.0002655038],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.28888768,0.119976014,0.021091826,0.00028496567,0.00039411295,0.06107111,0.032460805,0.00009550381,0.067946635,0.00019413762,0.3087961,0.09880113],"study_design_scores_gemma":[0.63096637,0.049044725,0.02441763,0.00046258201,0.00089698995,0.00008590695,0.00052760687,0.00036051238,0.018552478,0.00027664547,0.27353355,0.00087500067],"about_ca_topic_score_codex":0.0002949504,"about_ca_topic_score_gemma":0.0002052997,"teacher_disagreement_score":0.34207872,"about_ca_system_score_codex":0.0005823341,"about_ca_system_score_gemma":0.00045604625,"threshold_uncertainty_score":0.999954},"labels":[],"label_agreement":null},{"id":"W4404236611","doi":"10.1093/neuonc/noae165.0905","title":"NCOG-23. CLINICIAN AND PATIENT REPORTED OUTCOMES IN YOUNG ADULTS WITH GLIOBLASTOMA: RESULTS FROM A MULTIMODAL PROSPECTIVE STUDY","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Glioblastoma; Multimodal therapy; Medicine; Prospective cohort study; Pediatrics; Internal medicine; Cancer research","score_opus":0.015290227991696576,"score_gpt":0.30961974280847127,"score_spread":0.2943295148167747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404236611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935893,0.00019344302,7.116913e-7,0.002187319,0.00055923866,0.0025025152,0.00007029782,0.00013357188,0.00076364685],"genre_scores_gemma":[0.9988936,0.000030949395,0.00018744632,0.0003137475,0.00007526322,0.00042098056,0.00002604135,0.000040625087,0.000011343635],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99755704,0.00016224195,0.00072682323,0.00095845055,0.00028574516,0.00030967107],"domain_scores_gemma":[0.9983092,0.0008600323,0.00018049586,0.00038266595,0.00010153829,0.00016606263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015477186,0.00028182095,0.00072468224,0.00025717597,0.000053123225,0.000030794614,0.000052015905,0.00014577666,0.000010561557],"category_scores_gemma":[0.00048691398,0.00019171953,0.00007288396,0.00033813258,0.00009064456,0.00007330896,0.00008708289,0.00039957959,0.000020375408],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070858523,0.005390498,0.9310556,0.000015480638,0.00042345532,0.02692317,0.012615651,0.00000634986,0.001123092,0.000006452534,0.00025112712,0.015103247],"study_design_scores_gemma":[0.025177082,0.028530233,0.938841,0.0001850831,0.00040730272,0.00033038337,0.0038539325,0.0004528509,0.0011579589,0.000027248645,0.0008528543,0.00018408766],"about_ca_topic_score_codex":0.001568663,"about_ca_topic_score_gemma":0.012182571,"teacher_disagreement_score":0.026592785,"about_ca_system_score_codex":0.00028735687,"about_ca_system_score_gemma":0.00019595046,"threshold_uncertainty_score":0.78180957},"labels":[],"label_agreement":null},{"id":"W4404236652","doi":"10.1093/neuonc/noae165.1045","title":"QOL-10. AN ASSESSMENT TOOL FOR MEASURING CAREGIVERS’ DEATH ANXIETY IN PRIMARY BRAIN TUMOR: A CONFIRMATORY FACTOR ANALYSIS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Confirmatory factor analysis; Death anxiety; Clinical psychology; Anxiety; Psychology; Medicine; Psychiatry; Structural equation modeling; Statistics","score_opus":0.1193444174506611,"score_gpt":0.43382880282938596,"score_spread":0.31448438537872486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404236652","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898568,0.0009755332,0.0014681582,0.001145753,0.00039275223,0.00066144386,0.00012613149,0.000117529125,0.005255925],"genre_scores_gemma":[0.9946614,0.00022465378,0.0027854696,0.0017531805,0.00018703827,0.000116118514,0.00012764451,0.000035197587,0.00010928756],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99825484,0.00022722495,0.00042664242,0.0004919579,0.00026830597,0.0003310577],"domain_scores_gemma":[0.99832827,0.00097237254,0.00010419488,0.00030036375,0.00015538828,0.00013938938],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036388327,0.00020818246,0.0007997912,0.00044693035,0.00003797927,0.000018421046,0.00013443577,0.0001461346,0.0001629634],"category_scores_gemma":[0.00027730502,0.000192064,0.0002913979,0.00044259673,0.000071555005,0.00013608928,0.000055639208,0.00031565365,0.000007978075],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008952073,0.0006164452,0.6060995,0.0013438358,0.0015303747,0.0014977445,0.009176449,0.00016164179,0.33877409,0.0006289048,0.007339384,0.031936407],"study_design_scores_gemma":[0.0037841722,0.0023770828,0.16937295,0.00030724888,0.0013713851,0.000059960257,0.0017636392,0.0047951215,0.01262803,0.000056475397,0.803079,0.00040495262],"about_ca_topic_score_codex":0.00009337949,"about_ca_topic_score_gemma":0.00015043294,"teacher_disagreement_score":0.7957396,"about_ca_system_score_codex":0.0007536353,"about_ca_system_score_gemma":0.00082977937,"threshold_uncertainty_score":0.7832143},"labels":[],"label_agreement":null},{"id":"W4404236710","doi":"10.1093/neuonc/noae165.0885","title":"NCOG-03. DESCRIPTIVE ANALYSIS AND OUTCOME COMPARISON BETWEEN PATIENTS WITH GLIOBLASTOMA MULTIFORME WHO RECEIVE 15 VERSUS 30 FRACTIONS OF RADIOTHERAPY: A RETROSPECTIVE CHART REVIEW","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre; Queen's University","funders":"","keywords":"Glioblastoma; Radiation therapy; Medicine; Chart; Descriptive statistics; Oncology; Internal medicine; Statistics; Mathematics; Cancer research","score_opus":0.031224744082871677,"score_gpt":0.3401410186669304,"score_spread":0.30891627458405874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404236710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99003685,0.005569624,0.00010830126,0.002032697,0.0003016634,0.0011845696,0.00016779942,0.00007198524,0.0005265066],"genre_scores_gemma":[0.99681056,0.0020739662,0.00046805586,0.000313689,0.000088535984,0.00013275511,0.0000649863,0.000035300265,0.000012127889],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99821335,0.00015626833,0.00053208607,0.00052868965,0.00030502037,0.00026461147],"domain_scores_gemma":[0.9983792,0.0006033129,0.0002643925,0.0003017497,0.00026986236,0.00018152552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014380654,0.00026693463,0.0014273474,0.00043382408,0.000081078244,0.000017041708,0.000067611974,0.00013794441,0.00023367091],"category_scores_gemma":[0.00018084401,0.00019429949,0.0002241219,0.0011020701,0.00016258727,0.000110732704,0.0000355919,0.0003549573,0.000027473781],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074918667,0.0007086419,0.9702601,0.00024256975,0.0037513527,0.00008911926,0.0008747024,0.0000030587728,0.00044539428,0.000023661467,0.0017931357,0.021059077],"study_design_scores_gemma":[0.0066886037,0.012183406,0.938006,0.0005520218,0.00891963,0.000010408437,0.00020641061,0.00026914393,0.0013104298,0.000006001843,0.031644028,0.00020393403],"about_ca_topic_score_codex":0.000106667896,"about_ca_topic_score_gemma":0.00020941607,"teacher_disagreement_score":0.03225412,"about_ca_system_score_codex":0.00063166325,"about_ca_system_score_gemma":0.000096756135,"threshold_uncertainty_score":0.7923303},"labels":[],"label_agreement":null},{"id":"W4404236764","doi":"10.1093/neuonc/noae165.0064","title":"ANGI-05. UNSUPERVISED DECONVOLUTION OF SPATIOTEMPORAL HETEROGENEITY REVEALS HIGH-RESOLUTION INVASION STATES IN GLIOBLASTOMA","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of Calgary","funders":"","keywords":"Glioblastoma; Deconvolution; Tumour heterogeneity; High resolution; Tumor heterogeneity; Biology; Computer science; Geography; Cancer research; Remote sensing; Cancer; Genetics; Algorithm","score_opus":0.01976993667904103,"score_gpt":0.3105037646722247,"score_spread":0.29073382799318365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404236764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99694765,0.0016473656,0.00020858392,0.00041407262,0.00028342032,0.00031535915,0.000094187366,0.000019794412,0.00006955546],"genre_scores_gemma":[0.99843097,0.0008549741,0.00015944813,0.00013097284,0.00010446527,0.000053620442,0.00022572721,0.000020344869,0.000019502111],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99862456,0.00024670723,0.00029114442,0.00040635065,0.00014024977,0.00029097238],"domain_scores_gemma":[0.99950373,0.00005522449,0.00006121744,0.00022873134,0.00006126106,0.00008983156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021008121,0.00013790469,0.00020852133,0.0001573116,0.000035038134,0.000014099717,0.0001190401,0.00018847366,0.000026477597],"category_scores_gemma":[0.00007869429,0.00013167376,0.00008567211,0.00020019578,0.00009398088,0.000011565014,0.00011554301,0.00012754544,0.000018137638],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070633955,0.00018263717,0.008878484,0.00007103406,0.000046734094,0.00011466788,0.000051415358,0.00018255375,0.9743589,0.000048224636,0.0025799656,0.012779034],"study_design_scores_gemma":[0.0019167243,0.005002122,0.011623775,0.000051503623,0.000024357014,0.000062708015,0.000029506953,0.0012407558,0.95414793,0.0004232855,0.025306314,0.0001709939],"about_ca_topic_score_codex":0.0008264791,"about_ca_topic_score_gemma":0.004315681,"teacher_disagreement_score":0.022726348,"about_ca_system_score_codex":0.00016364985,"about_ca_system_score_gemma":0.00026158884,"threshold_uncertainty_score":0.53695},"labels":[],"label_agreement":null},{"id":"W4404236800","doi":"10.1093/neuonc/noae165.1053","title":"QOL-18. MANAGING CANCER AND LIVING MEANINGFULLY (CALM) IN PRIMARY AND SECONDARY MALIGNANT BRAIN TUMOR PATIENTS: INTERIM ANALYSIS OF A PHASE IIC RANDOMIZED CONTROL PILOT TRIAL","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Interim analysis; Interim; Medicine; Randomized controlled trial; Oncology; Brain cancer; Cancer; Internal medicine; History","score_opus":0.14298452950604917,"score_gpt":0.4139463736709291,"score_spread":0.27096184416487995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404236800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9779412,0.004879832,0.001455446,0.01104103,0.0011031651,0.0019179002,0.00042075574,0.00004125894,0.0011993723],"genre_scores_gemma":[0.9863547,0.00043424612,0.00021447217,0.012317056,0.00016002773,0.00042683774,0.000025717763,0.00003803069,0.000028916718],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99357486,0.0012018663,0.0039703916,0.0007854488,0.00008504237,0.00038241647],"domain_scores_gemma":[0.9897593,0.008287166,0.0015047467,0.00025029367,0.000047677837,0.0001507675],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.013332227,0.00024590423,0.0029146217,0.0014290581,0.000075026,0.00008364671,0.00016082986,0.000113077054,0.0004029818],"category_scores_gemma":[0.0043892683,0.00027608144,0.00020003904,0.0004598126,0.000213018,0.00034930327,0.00011667633,0.00033169542,0.000014600659],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.57373196,0.009157157,0.09931325,0.01568671,0.017556077,0.00053699623,0.06915572,0.0028840348,0.0058870213,0.114716604,0.019738479,0.071636006],"study_design_scores_gemma":[0.8433908,0.0042116805,0.009900585,0.00073853147,0.0008903442,0.000020480284,0.00083639164,0.12134347,0.000015447229,0.004479994,0.013342514,0.0008297344],"about_ca_topic_score_codex":0.0012623254,"about_ca_topic_score_gemma":0.00063308433,"teacher_disagreement_score":0.2696589,"about_ca_system_score_codex":0.00079221575,"about_ca_system_score_gemma":0.0004541988,"threshold_uncertainty_score":0.9999691},"labels":[],"label_agreement":null},{"id":"W4404236843","doi":"10.1093/neuonc/noae165.0982","title":"EXTH-51. ENHANCING GLIOBLASTOMA TREATMENT: ALLOGENEIC CAR-T CELLS OVERCOMES FUNCTIONAL DEFICITS OF PATIENT-DERIVED AUTOLOGOUS PRODUCTS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University Medical Centre; University of Toronto; McMaster University","funders":"","keywords":"Glioblastoma; Cancer research; Medicine","score_opus":0.02533520469584187,"score_gpt":0.29759105269736946,"score_spread":0.2722558480015276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404236843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920336,0.0014949106,0.000026053332,0.0017952637,0.0016936833,0.0011387311,0.000023513308,0.00019955047,0.0015946655],"genre_scores_gemma":[0.9968767,0.00052540307,0.00034941966,0.0004773915,0.00043676177,0.00012841327,0.00003755826,0.00008699095,0.001081346],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99736935,0.00025952494,0.0005362391,0.00079025305,0.0004708583,0.0005737756],"domain_scores_gemma":[0.9982419,0.0006719806,0.00011272987,0.0005045184,0.0002565897,0.00021228315],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001652744,0.00032670682,0.00077065954,0.00044842451,0.000080393605,0.000021285237,0.00010249979,0.0002879209,0.0015029251],"category_scores_gemma":[0.00017458148,0.00027390974,0.00025627602,0.00055737415,0.00022496963,0.000072688184,0.000106430634,0.0004180797,0.00014227096],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019042845,0.00056422816,0.00031699231,0.00023587575,0.00027039973,0.001409669,0.0012771473,0.000055204928,0.9135594,0.000043438038,0.0011774285,0.07918595],"study_design_scores_gemma":[0.0016047426,0.01190836,0.00088024413,0.000047879115,0.00018949262,0.0016837128,0.0001688939,0.00012167901,0.84507066,0.000024170273,0.13814984,0.0001503263],"about_ca_topic_score_codex":0.000049495604,"about_ca_topic_score_gemma":0.00008285135,"teacher_disagreement_score":0.13697241,"about_ca_system_score_codex":0.000771415,"about_ca_system_score_gemma":0.0014185372,"threshold_uncertainty_score":0.99997133},"labels":[],"label_agreement":null},{"id":"W4404236871","doi":"10.1093/neuonc/noae165.1304","title":"Author Index","year":2024,"lang":"en","type":"paratext","venue":"Neuro-Oncology","topic":"","field":"","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Nuclear Safety Commission","keywords":"Index (typography); Computer science; World Wide Web","score_opus":0.04177445664300288,"score_gpt":0.3591699679761732,"score_spread":0.3173955113331703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404236871","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012339344,0.0035658437,0.00003770075,0.005360273,0.06169325,0.0011585691,0.0018415692,0.0008196151,0.9242892],"genre_scores_gemma":[0.02050204,0.00035620827,0.00021121945,0.006765715,0.010700605,0.0008264467,0.0014261391,0.002208893,0.95700276],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99404603,0.0011538811,0.0009631631,0.0018743533,0.0006686292,0.0012939357],"domain_scores_gemma":[0.99651283,0.0010226236,0.0005598866,0.0012569609,0.00020103606,0.00044666277],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.00058517425,0.0009983456,0.0016871014,0.0012044347,0.00013532994,0.00014907368,0.0012236614,0.0029243513,0.02591469],"category_scores_gemma":[0.00045398087,0.0009882514,0.000468689,0.0010950519,0.00044704563,0.0001016195,0.0009460035,0.0048726145,0.8796553],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018093771,0.000171792,0.0000074614213,0.00020321184,0.00016593766,0.0019612305,0.0002458154,0.00008830222,0.058601994,0.0002687089,0.93185484,0.0062497538],"study_design_scores_gemma":[0.00065765844,0.0009354514,0.000016276805,0.00007132216,0.00028260043,0.0007407425,0.000035988887,0.00021722207,0.0011935749,0.00029151994,0.9948195,0.0007381021],"about_ca_topic_score_codex":0.00008479051,"about_ca_topic_score_gemma":0.00014032288,"teacher_disagreement_score":0.85374063,"about_ca_system_score_codex":0.0015994331,"about_ca_system_score_gemma":0.0031594306,"threshold_uncertainty_score":0.9992568},"labels":[],"label_agreement":null},{"id":"W4404236916","doi":"10.1093/neuonc/noae165.1195","title":"TMIC-17. TARGETING THE FLUIDIC FORCE-SENSING MECHANISM TO TREAT BRAIN TUMOR METASTASIS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"3D Printing in Biomedical Research","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Mechanism (biology); Fluidics; Neuroscience; Metastasis; Nanotechnology; Medicine; Engineering; Biology; Materials science; Cancer; Physics; Aerospace engineering; Internal medicine","score_opus":0.023364234611637193,"score_gpt":0.3053918151395524,"score_spread":0.2820275805279152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404236916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7105028,0.0040295892,0.11650814,0.08399498,0.010382801,0.0027273395,0.00008120165,0.0049926634,0.06678047],"genre_scores_gemma":[0.98691005,0.00012122109,0.006668168,0.004487178,0.00094238075,0.00006610034,0.000010467652,0.00018385619,0.0006105686],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976837,0.0002867788,0.00037961546,0.0004480428,0.00041429413,0.0007875747],"domain_scores_gemma":[0.9963157,0.0029857,0.000021495107,0.00036353062,0.00004657677,0.00026695116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012936047,0.00024311077,0.00032223584,0.0002761601,0.00015692045,0.00012292842,0.0004384997,0.0001342391,0.0003310375],"category_scores_gemma":[0.0017320517,0.00018373782,0.00013048085,0.00070371095,0.000098187746,0.00007090286,0.00030151944,0.00080630236,0.00057919906],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010456275,0.00000880937,0.0000014383288,0.0000848658,0.000034455737,0.0005091819,0.00045852846,0.00037102017,0.8177144,0.0010121989,0.083249,0.09654567],"study_design_scores_gemma":[0.0002101853,0.00026586174,0.0000061011806,0.00004601794,0.00004198301,0.00021988714,0.00019055913,0.06354954,0.2669779,0.0012406431,0.6670309,0.00022042694],"about_ca_topic_score_codex":0.000025003077,"about_ca_topic_score_gemma":0.00001201939,"teacher_disagreement_score":0.5837819,"about_ca_system_score_codex":0.0003220495,"about_ca_system_score_gemma":0.00013303642,"threshold_uncertainty_score":0.7492611},"labels":[],"label_agreement":null},{"id":"W4404236986","doi":"10.1093/neuonc/noae165.1056","title":"QOL-21. PSYCHOMETRIC VALIDATION OF THE FEAR OF CANCER RECURRENCE INVENTORY FOR PRIMARY BRAIN TUMOR PATIENTS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Chicoutimi","funders":"","keywords":"Brain tumor; Cancer recurrence; Clinical psychology; Psychology; Medicine; Cancer; Oncology; Internal medicine; Psychiatry","score_opus":0.03047491309852898,"score_gpt":0.34415229642449047,"score_spread":0.3136773833259615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404236986","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98642313,0.0016423855,0.00006459665,0.005307965,0.0033360177,0.0015709469,0.00012823397,0.00003472152,0.0014920189],"genre_scores_gemma":[0.9968659,0.0003372505,0.00008001893,0.0021008486,0.00017689158,0.00026450458,0.000021095913,0.000027250484,0.00012623229],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987891,0.00010706184,0.00037472547,0.00027557067,0.0002655981,0.00018799874],"domain_scores_gemma":[0.99865,0.0006051743,0.00022862654,0.00017156445,0.00029882594,0.000045785266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002092358,0.00012400816,0.00034648523,0.0002827506,0.000043895998,0.0000034809898,0.000107518215,0.00007493877,0.000051492912],"category_scores_gemma":[0.0010608655,0.00009258307,0.00014214325,0.0008625842,0.0001993364,0.00005348327,0.00007722689,0.0002317357,0.0000052121513],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025623615,0.0019630585,0.44386932,0.0042244648,0.00071228447,0.0000151882905,0.0027562594,0.00007317605,0.15007833,0.00030286098,0.13172844,0.26171425],"study_design_scores_gemma":[0.011101763,0.010483962,0.656157,0.0019358222,0.0011774527,0.000034062534,0.0002142948,0.0002084511,0.10955945,0.0009166623,0.20786001,0.00035108894],"about_ca_topic_score_codex":0.0000497215,"about_ca_topic_score_gemma":0.000017180966,"teacher_disagreement_score":0.26136315,"about_ca_system_score_codex":0.00051798386,"about_ca_system_score_gemma":0.0006402956,"threshold_uncertainty_score":0.3775428},"labels":[],"label_agreement":null},{"id":"W4404236989","doi":"10.1093/neuonc/noae165.1068","title":"RBIO-02. DEVELOPMENT OF FLASH-CAR RADIOIMMUNOTHERAPY FOR PEDIATRIC BRAIN TUMORS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Advanced Radiotherapy Techniques","field":"Physics and Astronomy","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Radioimmunotherapy; Flash (photography); Medicine; Physics; Immunology","score_opus":0.013585652492482973,"score_gpt":0.31251624213741663,"score_spread":0.2989305896449337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404236989","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2981048,0.0020881032,0.69059134,0.0016085692,0.0014325129,0.001746642,0.00009485012,0.000527341,0.0038058625],"genre_scores_gemma":[0.62196445,0.00023021323,0.3718296,0.0013406374,0.0023256594,0.0011132244,0.00009457337,0.00028708656,0.00081452174],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99871886,0.00006818869,0.00043939977,0.00035262344,0.00010675841,0.00031414363],"domain_scores_gemma":[0.9989397,0.0005997349,0.0001357868,0.00022191319,0.000048687878,0.000054180404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021533985,0.00020511456,0.00036983212,0.00017727935,0.00007824554,0.000017443752,0.0002193214,0.0000821246,0.00021202711],"category_scores_gemma":[0.000012145569,0.00019309702,0.0001494341,0.00024061404,0.00006326957,0.00009202721,0.000032719992,0.00020852932,0.00001071677],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013905854,0.00019968869,0.0024750866,0.000099080185,0.00013645961,0.00001108407,0.0016823293,0.000035883808,0.5573723,0.010684425,0.0123191,0.41484553],"study_design_scores_gemma":[0.00063103734,0.0005992654,0.00017287175,0.00001321285,0.000019561003,0.0000057522643,0.00003530504,0.00028368676,0.11567153,0.0017073579,0.88065845,0.0002019757],"about_ca_topic_score_codex":0.0000046322752,"about_ca_topic_score_gemma":7.428423e-7,"teacher_disagreement_score":0.86833936,"about_ca_system_score_codex":0.0001257803,"about_ca_system_score_gemma":0.00049170357,"threshold_uncertainty_score":0.78742677},"labels":[],"label_agreement":null},{"id":"W4404237010","doi":"10.1093/neuonc/noae165.0256","title":"CSIG-07. JAK1/STAT1/3 COOPERATES WITH THE CIC-FUSIONS TO DRIVE CIC-REARRANGED SARCOMAS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Mechanisms and Therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Cancer research; Medicine","score_opus":0.01905711853716609,"score_gpt":0.31082484847666025,"score_spread":0.2917677299394942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7694633,0.0024348653,0.0019941283,0.1981016,0.0025073255,0.002320568,0.00006524643,0.0005133234,0.022599671],"genre_scores_gemma":[0.96475065,0.00032730252,0.0006772003,0.030852593,0.00084127916,0.00027535006,0.00002021418,0.000099580175,0.002155825],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984411,0.00014758468,0.00022212489,0.0004982108,0.00025954752,0.00043144132],"domain_scores_gemma":[0.9986511,0.0004800171,0.00003958928,0.0004424115,0.00013798577,0.00024888432],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021674621,0.00024176834,0.00042475865,0.0001430284,0.00019904434,0.000058134974,0.00018901612,0.00013591729,0.0014477588],"category_scores_gemma":[0.00006005738,0.00014248042,0.00010043113,0.0005261068,0.00012724246,0.000053561595,0.00008429887,0.00056400505,0.0005013562],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009829401,0.00017960381,0.00011326958,0.000036409565,0.00016042046,0.0014459069,0.006048146,0.000033343676,0.8795342,0.005976182,0.052837703,0.052651912],"study_design_scores_gemma":[0.0015190124,0.004586893,0.00034529794,0.00006974009,0.00014795743,0.0005540458,0.0007346645,0.00021119165,0.02146571,0.00019916886,0.9699894,0.00017688605],"about_ca_topic_score_codex":0.00012343304,"about_ca_topic_score_gemma":0.0006822342,"teacher_disagreement_score":0.91715175,"about_ca_system_score_codex":0.00020630038,"about_ca_system_score_gemma":0.00083913974,"threshold_uncertainty_score":0.99946505},"labels":[],"label_agreement":null},{"id":"W4404237017","doi":"10.1093/neuonc/noae165.0946","title":"EXTH-15. AN EGFRVIII RNA-LNP VACCINE PROTOTYPE ACHIEVES TUMOUR CLEARANCE IN A GBM MOUSE MODEL","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Providence Health Care","funders":"","keywords":"Cancer research; Virology; RNA; Immunology; Medicine; Biology; Genetics","score_opus":0.025147403641010424,"score_gpt":0.3374182770290223,"score_spread":0.31227087338801185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99424654,0.0012339662,0.00030041448,0.0018917422,0.00018647172,0.0009315592,0.000035878063,0.00008347573,0.0010899508],"genre_scores_gemma":[0.99586964,0.00071891694,0.0004131032,0.0014441648,0.00036754957,0.00030740423,0.00006091784,0.00011155642,0.0007067563],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99753195,0.0004226817,0.00035674605,0.00087049155,0.00021038578,0.0006077714],"domain_scores_gemma":[0.9990088,0.000049005394,0.000054488813,0.0006174922,0.00007856603,0.00019166328],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00047263375,0.00028222994,0.00032423178,0.00018681571,0.00007994569,0.000054364846,0.00054361566,0.00035217527,0.00009296122],"category_scores_gemma":[0.000110846915,0.00027157433,0.000104801555,0.00026505932,0.000086612265,0.000017840548,0.0002169636,0.0005978864,0.00012596605],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067301,0.00028329564,0.000068024645,0.000047119487,0.000027692113,0.0001568823,0.00013754051,0.0022667143,0.9715361,0.00005940489,0.0012871505,0.017399952],"study_design_scores_gemma":[0.0016298906,0.012377155,0.00016043676,0.000018423612,0.000014764937,0.00008729656,0.000053497126,0.026359878,0.90952355,0.00026527213,0.04914182,0.00036802253],"about_ca_topic_score_codex":0.000020897834,"about_ca_topic_score_gemma":0.0009274327,"teacher_disagreement_score":0.062012583,"about_ca_system_score_codex":0.00008439217,"about_ca_system_score_gemma":0.0005418958,"threshold_uncertainty_score":0.99997365},"labels":[],"label_agreement":null},{"id":"W4404237029","doi":"10.1093/neuonc/noae165.0050","title":"EPCO-51. A MULTI-OMIC ANALYSIS OF REGIONAL HETEROGENEITY IN GLIOBLASTOMA","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"ATP Synthase and ATPases Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Public Health","funders":"","keywords":"Glioblastoma; Computational biology; Biology; Cancer research","score_opus":0.03463462110902515,"score_gpt":0.36445497332715104,"score_spread":0.3298203522181259,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997244,0.0011574632,0.0005031062,0.0005702877,0.00012123477,0.00013505713,0.00005176431,0.000014681129,0.00020238858],"genre_scores_gemma":[0.99867225,0.00045860035,0.00016996676,0.00041740944,0.00010602436,0.00003246546,0.00005857689,0.000020413838,0.00006426911],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985326,0.00022603586,0.00030317623,0.00049296516,0.00014699866,0.0002982387],"domain_scores_gemma":[0.9993652,0.00012333518,0.000052909676,0.00031572543,0.000052761643,0.00009006465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022748661,0.0001392326,0.0003199476,0.00038809844,0.0000273717,0.000012223288,0.00022289898,0.00023107487,0.00007316883],"category_scores_gemma":[0.00011022442,0.00013168064,0.0002641276,0.0006422516,0.0001581979,0.000004143613,0.00017047486,0.00019857356,0.000024455623],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023905114,0.00019038167,0.005230802,0.00002510584,0.00034743498,0.00019532663,0.000051679857,0.00035071548,0.98445356,0.000034294626,0.0011863001,0.0076953196],"study_design_scores_gemma":[0.00092031737,0.0015564326,0.0060827537,0.000017357257,0.0002461873,0.00004104022,0.000073018084,0.013810012,0.77966785,0.00001478258,0.19733281,0.0002374242],"about_ca_topic_score_codex":0.00006463573,"about_ca_topic_score_gemma":0.0011951613,"teacher_disagreement_score":0.20478572,"about_ca_system_score_codex":0.000051186464,"about_ca_system_score_gemma":0.00025900843,"threshold_uncertainty_score":0.5369781},"labels":[],"label_agreement":null},{"id":"W4404237036","doi":"10.1093/neuonc/noae165.0062","title":"ANGI-03. GLIOMA STEM CELLS INDUCE VASECTASIA – A NON-ANGIOGENIC BRAIN TUMOUR NEOVASCULARIZATION PROCESS DRIVEN BY INTERCELLULAR EGFR TRANSFER THROUGH EXTRACELLULAR VESICLES","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Tissue Engineering and Regenerative Medicine","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; McGill University","funders":"","keywords":"Extracellular vesicles; Glioma; Intracellular; Angiogenesis; Extracellular; Neovascularization; Vesicle; Cell biology; Chemistry; Cancer research; Biology; Biochemistry","score_opus":0.016196066025127447,"score_gpt":0.27475513739553614,"score_spread":0.2585590713704087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237036","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89536047,0.023102537,0.07328984,0.0049524717,0.0016917255,0.0009907024,0.00003498386,0.0003932084,0.0001840647],"genre_scores_gemma":[0.9966346,0.00016415496,0.00040464645,0.00036895263,0.00089473935,0.000108022505,0.00016451316,0.00015309667,0.0011072804],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974203,0.00023215433,0.0005639179,0.0008110763,0.00042159396,0.000550918],"domain_scores_gemma":[0.998967,0.00023101932,0.00005293593,0.0003768072,0.000116399206,0.00025582104],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031123354,0.0004485,0.0007499868,0.00028674336,0.0001024226,0.000043920518,0.00022046392,0.00040610755,0.00014715562],"category_scores_gemma":[0.000048124224,0.0003767545,0.00029916083,0.0008652672,0.00016864302,0.00016368715,0.00003813624,0.00073804776,0.00015016062],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008147241,0.00024434354,0.000050272258,0.00048003468,0.00028118226,0.0031191786,0.004563784,0.00040259052,0.9778822,0.00022190504,0.00693759,0.005735426],"study_design_scores_gemma":[0.0018935613,0.0017575024,0.000043133416,0.0002912746,0.00046644337,0.001095662,0.00045907428,0.007070405,0.8611583,0.000016304464,0.12542674,0.00032160684],"about_ca_topic_score_codex":0.000024559193,"about_ca_topic_score_gemma":0.0000056105537,"teacher_disagreement_score":0.118489146,"about_ca_system_score_codex":0.00022737219,"about_ca_system_score_gemma":0.0003202947,"threshold_uncertainty_score":0.99986845},"labels":[],"label_agreement":null},{"id":"W4404237050","doi":"10.1093/neuonc/noae165.0660","title":"IMMU-69. THERAPEUTIC WINDOW ENABLING ERADICATION OF RESIDUAL GLIOMA STEM CELLS BY INTRACRANIAL NK CELL THERAPY FOLLOWING TEMOZOLOMIDE-INDUCED TUMOUR DEPOPULATION – A POSSIBLE ROLE OF CYTOTOXIC EXTRACELLULAR VESICLES","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Temozolomide; Extracellular vesicles; Cytotoxic T cell; Glioma; Cancer research; Glioblastoma; Stem cell; Cell; Chemistry; Medicine; Cell biology; Biology; In vitro","score_opus":0.01328378312796306,"score_gpt":0.26588070287668286,"score_spread":0.2525969197487198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9645542,0.033096444,0.00081488444,0.00011319994,0.0004941711,0.00070674444,0.00003994442,0.000059287806,0.000121127225],"genre_scores_gemma":[0.998253,0.00055325136,0.0005669428,0.00006761066,0.00026399817,0.000054996,0.00009647841,0.00010732813,0.000036410882],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99691904,0.0005862607,0.00090583146,0.0007716019,0.00035768957,0.00045958668],"domain_scores_gemma":[0.99853754,0.00019604497,0.0004389421,0.00058116514,0.00010037514,0.00014595129],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005754924,0.0003617046,0.00047493866,0.00021723329,0.00011264515,0.0000488032,0.00046495095,0.0004916609,0.000022320832],"category_scores_gemma":[0.00004193956,0.00037084665,0.00032026673,0.00036763967,0.0001257825,0.00003650113,0.000109252265,0.00031836453,0.000011695403],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051335787,0.00043875622,0.0005378561,0.000140648,0.00013317133,0.000110405665,0.00029453612,0.00013577903,0.9756091,0.000057042344,0.00009146479,0.021937847],"study_design_scores_gemma":[0.00138567,0.0013332474,0.00025612715,0.000052287287,0.0001253889,0.00005004997,0.0003466455,0.0009650169,0.9935049,0.00024399838,0.0014332682,0.0003034359],"about_ca_topic_score_codex":0.00003967916,"about_ca_topic_score_gemma":0.000005508421,"teacher_disagreement_score":0.03369879,"about_ca_system_score_codex":0.00008244,"about_ca_system_score_gemma":0.00045770215,"threshold_uncertainty_score":0.99987435},"labels":[],"label_agreement":null},{"id":"W4404237082","doi":"10.1093/neuonc/noae165.0122","title":"BIOM-50. SERIAL INTRACRANIAL CEREBROSPINAL CELL-FREE DNA FOR DISEASE MONITORING IN PATIENTS WITH GLIOMAS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Cerebrospinal fluid; Brain Cell; Medicine; Brain disease; Pathology; Disease; Biology; Neuroscience","score_opus":0.012699836978594694,"score_gpt":0.27613591978354546,"score_spread":0.2634360828049508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99390733,0.00023584964,0.000019193141,0.0019544158,0.002360043,0.0011525957,0.00009815495,0.000087752516,0.00018469067],"genre_scores_gemma":[0.99776065,0.000018919362,0.0006427211,0.0001474931,0.00097021693,0.00034012995,0.000058793972,0.000052515912,0.000008554997],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985897,0.00004873475,0.0002730007,0.00047757078,0.00022348273,0.00038749323],"domain_scores_gemma":[0.99910724,0.00020916053,0.00005365188,0.00030391364,0.00006642385,0.00025963003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007136786,0.00021813618,0.00034814142,0.0002345809,0.000058701477,0.000037755013,0.00011317155,0.00011978436,0.000040990064],"category_scores_gemma":[0.00008127613,0.00016877193,0.00010093622,0.0002608125,0.000058707017,0.000085946216,0.00006967594,0.00017163974,0.000026788406],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013279258,0.0058310726,0.84166616,0.00058262394,0.00018198967,0.005259843,0.00034387023,0.000025792888,0.08763984,0.00022899934,0.0045308145,0.04042971],"study_design_scores_gemma":[0.04482571,0.017864777,0.8444592,0.00035854784,0.0009087767,0.000056888803,0.00007207492,0.0003783502,0.032291487,0.00031012675,0.057995252,0.00047881625],"about_ca_topic_score_codex":0.00003040344,"about_ca_topic_score_gemma":0.000022065302,"teacher_disagreement_score":0.055348348,"about_ca_system_score_codex":0.00030180963,"about_ca_system_score_gemma":0.00027191264,"threshold_uncertainty_score":0.68823195},"labels":[],"label_agreement":null},{"id":"W4404237084","doi":"10.1093/neuonc/noae165.0234","title":"STEM-08. LIPID SATURATION HOMEOSTASIS PRESENTS A TARGETABLE VULNERABILITY IN MYC-AMPLIFIED GROUP 3 MEDULLOBLASTOMA","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medulloblastoma; Homeostasis; Saturation (graph theory); Vulnerability (computing); Biology; Internal medicine; Cancer research; Medicine; Cell biology; Computer science; Mathematics; Computer security; Combinatorics","score_opus":0.016299259136220132,"score_gpt":0.2873422987769701,"score_spread":0.27104303964074994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9588378,0.008341732,0.0007904524,0.0013761891,0.026785566,0.00090622494,0.00012019124,0.000109170294,0.0027326867],"genre_scores_gemma":[0.9850717,0.002014675,0.0003193316,0.0010627173,0.010461536,0.000282424,0.00021764584,0.000064041174,0.00050593563],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974548,0.00044422082,0.00047640305,0.00088705093,0.00020992043,0.00052755343],"domain_scores_gemma":[0.99903816,0.00012637796,0.00009093785,0.0005071712,0.00007659793,0.00016077909],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004801936,0.0002782419,0.00041378336,0.00015595497,0.000086003,0.000065214736,0.00026651117,0.00041977604,0.00009569642],"category_scores_gemma":[0.00016224854,0.00026949434,0.00016472621,0.00032419688,0.00013003111,0.000022659697,0.00019372188,0.0003997502,0.00005676409],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040947038,0.00020147953,0.0008407929,0.0000935047,0.000046829926,0.0000046068258,0.0002266663,0.000085156236,0.8841516,0.00025090025,0.052417383,0.06127164],"study_design_scores_gemma":[0.00096449145,0.000591839,0.0020872627,0.000014707528,0.00003680248,0.000051931558,0.00010287365,0.00021919775,0.047995597,0.00011514008,0.9475734,0.0002467134],"about_ca_topic_score_codex":0.00014477581,"about_ca_topic_score_gemma":0.00093617826,"teacher_disagreement_score":0.8951561,"about_ca_system_score_codex":0.00013372416,"about_ca_system_score_gemma":0.00037393,"threshold_uncertainty_score":0.99997574},"labels":[],"label_agreement":null},{"id":"W4404237093","doi":"10.1093/neuonc/noae165.0439","title":"CTNI-72. VAL-083 IN PATIENTS WITH RECURRENT GLIOBLASTOMA TREATED UNDER EXPANDED ACCESS PROGRAM","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"University of Texas MD Anderson Cancer Center","keywords":"Glioblastoma; Medicine; Computer science; Cancer research","score_opus":0.02444994315947624,"score_gpt":0.3381895540139563,"score_spread":0.31373961085448004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932169,0.0002540108,0.0000036299116,0.0026974815,0.0005528476,0.0018095034,0.000015218377,0.00028772073,0.0011627091],"genre_scores_gemma":[0.99833435,0.000062870386,0.000088986366,0.00053974293,0.0000901999,0.0007198771,0.00007892307,0.000054285432,0.00003077279],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99814135,0.00013125347,0.00034046496,0.0005998391,0.00029183197,0.0004952565],"domain_scores_gemma":[0.9990955,0.0002319019,0.00007274675,0.00029745194,0.00009990132,0.0002025109],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000081709564,0.00029286416,0.00050733564,0.0003771712,0.00004755099,0.0000685584,0.0001198548,0.00017325376,0.0001560706],"category_scores_gemma":[0.000035290734,0.00017540692,0.000097798875,0.00071742194,0.0000864267,0.00012798388,0.00009322259,0.0003188527,0.00008188191],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004012658,0.011406395,0.4582248,0.00015888887,0.00033672483,0.0033519866,0.00038918026,0.000032024003,0.001771391,0.00012653106,0.005704461,0.51448494],"study_design_scores_gemma":[0.02306952,0.046866894,0.8309758,0.0005611551,0.0006994482,0.00018163811,0.000087398934,0.00061262876,0.010878304,0.00013678249,0.08545435,0.00047608744],"about_ca_topic_score_codex":0.000037921945,"about_ca_topic_score_gemma":0.00022159834,"teacher_disagreement_score":0.5140089,"about_ca_system_score_codex":0.00045710334,"about_ca_system_score_gemma":0.00022427252,"threshold_uncertainty_score":0.71528864},"labels":[],"label_agreement":null},{"id":"W4404237122","doi":"10.1093/neuonc/noae165.0527","title":"DDDR-42. LEVERAGING GENOME-WIDE CRISPR/CAS9 KNOCKOUT DRUG SCREENS TO IDENTIFY SENSITIZERS FOR PROTEOSOME INHIBITORS IN GLIOBLASTOMA","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"CRISPR; Glioblastoma; Drug discovery; Computational biology; Drug; Genome; Drug target; Cancer research; Biology; Genetics; Pharmacology; Bioinformatics; Gene","score_opus":0.014976858419600407,"score_gpt":0.3048440016401705,"score_spread":0.2898671432205701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98456234,0.00061201054,0.0031410947,0.007036995,0.0016969204,0.002011916,0.0000579042,0.000118937685,0.00076188584],"genre_scores_gemma":[0.992345,0.00005767977,0.0010175825,0.0043742736,0.0010004195,0.00043279037,0.00007855188,0.00009342947,0.00060029473],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974363,0.00023285847,0.0005531609,0.00094262447,0.00020671809,0.00062832993],"domain_scores_gemma":[0.99899286,0.00014820264,0.00009809074,0.00040234084,0.00011894046,0.00023958301],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005142966,0.00032922413,0.0003580356,0.00040759615,0.00012523845,0.00010431792,0.00027370112,0.00030320065,0.000026971435],"category_scores_gemma":[0.00058521033,0.00034597202,0.00020746609,0.0004079766,0.00009534136,0.000022374443,0.00027705834,0.0003499076,0.00010625012],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028266598,0.00006219501,0.00024956203,0.000074423886,0.00003247777,0.0001475274,0.00038470447,0.00014105844,0.96097714,0.000052693737,0.029456578,0.008138973],"study_design_scores_gemma":[0.00062455895,0.0006561719,0.0002702355,0.000040658146,0.00001565824,0.00006217384,0.00020407453,0.00015257318,0.5645003,0.00007219341,0.4331367,0.00026472812],"about_ca_topic_score_codex":0.000039336246,"about_ca_topic_score_gemma":0.00019327659,"teacher_disagreement_score":0.40368012,"about_ca_system_score_codex":0.00018590357,"about_ca_system_score_gemma":0.00035947145,"threshold_uncertainty_score":0.9998992},"labels":[],"label_agreement":null},{"id":"W4404237137","doi":"10.1093/neuonc/noae165.1265","title":"TMOD-01. EGFR AMPLIFICATION ACCOMPANIES ADAPTATION TO MITOGEN-INDUCED DEFECTIVE MITOSIS IN PDGFA","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Mitosis; Adaptation (eye); Cell biology; Computer science; Cancer research; Biology; Neuroscience","score_opus":0.024785124473883608,"score_gpt":0.29833751854341223,"score_spread":0.27355239406952864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907165,0.00045703127,0.0048788525,0.0010517667,0.0012923562,0.00052593416,0.000023636123,0.00004900659,0.0010049132],"genre_scores_gemma":[0.99703395,0.0002541167,0.0007193884,0.0011898947,0.00036377006,0.00019145904,0.00012718479,0.00004276004,0.00007746711],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984272,0.00019016163,0.00031125164,0.0006499026,0.00010240291,0.00031908596],"domain_scores_gemma":[0.9993453,0.000098632714,0.00006171158,0.00031885362,0.000077448785,0.00009804629],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001692438,0.00020521971,0.00022603422,0.00018927497,0.000059272148,0.000046105102,0.00021314404,0.00031200467,0.0000161575],"category_scores_gemma":[0.00015850751,0.00021626025,0.00010909575,0.00030353395,0.000036523423,0.000010602873,0.000119988574,0.0002177745,0.00011194012],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012446548,0.000082397775,0.000321821,0.000020696238,0.000034216693,0.000012471445,0.0008034972,0.00026454046,0.9660894,0.00023885297,0.0021752692,0.029832318],"study_design_scores_gemma":[0.00060107734,0.0011065778,0.0027601458,0.00002758357,0.000049683156,0.000059208025,0.0007734219,0.0015516558,0.76669127,0.0001719511,0.22585939,0.0003480725],"about_ca_topic_score_codex":0.000123144,"about_ca_topic_score_gemma":0.0010980308,"teacher_disagreement_score":0.22368412,"about_ca_system_score_codex":0.00015536955,"about_ca_system_score_gemma":0.00024146016,"threshold_uncertainty_score":0.8818837},"labels":[],"label_agreement":null},{"id":"W4404237190","doi":"10.1093/neuonc/noae165.0375","title":"CTNI-07. LONG-TERM EFFICACY AND SAFETY OF LAROTRECTINIB IN PATIENTS WITH TRK FUSION PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS: AN UPDATED ANALYSIS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Trk receptor; Central nervous system; Medicine; Term (time); Neuroscience; Internal medicine; Biology; Neurotrophin","score_opus":0.009264451921468471,"score_gpt":0.26307294993444813,"score_spread":0.25380849801297967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979322,0.00023360529,0.000008434508,0.00023962503,0.00018320154,0.0009507853,0.000042047886,0.000088499146,0.00032159925],"genre_scores_gemma":[0.99911356,0.000037367772,0.00007066379,0.00013049226,0.000054136788,0.000034396933,0.0005238946,0.000030874064,0.0000045954257],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981684,0.00024339203,0.00047718824,0.00053152133,0.0002447923,0.00033467225],"domain_scores_gemma":[0.9990809,0.00018982904,0.00013391321,0.00031435548,0.00007437414,0.00020661613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001325658,0.00022541244,0.00080412964,0.00045711303,0.00004510464,0.000019060606,0.00007386585,0.0001366087,0.00007349194],"category_scores_gemma":[0.000021237121,0.00016235224,0.00009597852,0.0007958027,0.000074662945,0.000083357234,0.000061773826,0.00021845946,0.0000075230323],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022494558,0.0022329108,0.95688456,0.00023032253,0.00052630604,0.0020630395,0.00042237627,0.00009190413,0.0046064695,0.000023949728,0.00007156532,0.030597119],"study_design_scores_gemma":[0.007230847,0.003934224,0.9851971,0.00022459116,0.0015175418,0.00007834456,0.000051215276,0.0003033665,0.0010591402,5.3423184e-7,0.00028207654,0.00012096564],"about_ca_topic_score_codex":0.00011058137,"about_ca_topic_score_gemma":0.00019867158,"teacher_disagreement_score":0.030476153,"about_ca_system_score_codex":0.00036200084,"about_ca_system_score_gemma":0.00015854446,"threshold_uncertainty_score":0.6620532},"labels":[],"label_agreement":null},{"id":"W4404237224","doi":"10.1093/neuonc/noae165.0307","title":"RADT-23. MOLECULAR PROFILING OF GLIOMAS: INSIGHTS INTO RADIONECROSIS AND PSEUDOPROGRESSION THROUGH NEXT-GENERATION SEQUENCING","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Profiling (computer programming); Medicine; Computer science","score_opus":0.05263591488240864,"score_gpt":0.3246426146994567,"score_spread":0.27200669981704806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.981184,0.01489831,0.00036104003,0.002013266,0.00051389,0.0005782732,0.0000019435386,0.000089072666,0.00036020044],"genre_scores_gemma":[0.99157643,0.0010361053,0.006538061,0.0004814784,0.00016811183,0.00011356608,0.000049296203,0.00003430921,0.0000026217474],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998637,0.00012952974,0.000361073,0.00045758366,0.00021557827,0.00019923726],"domain_scores_gemma":[0.99932766,0.00016862444,0.00009182714,0.00022210398,0.00008680555,0.00010298384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001135342,0.00018955168,0.00040406763,0.00019654109,0.00009083419,0.00003870254,0.000050258084,0.00018497718,0.000014674763],"category_scores_gemma":[0.0001001731,0.00014576913,0.0000944341,0.00036234193,0.000111477144,0.00017594673,0.00006258798,0.0001832765,0.000009991885],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048026817,0.00017080273,0.0010340536,0.00019932825,0.000087950946,0.0015450396,0.0015393863,0.000027279439,0.9697711,0.0020653273,0.00024985443,0.023261856],"study_design_scores_gemma":[0.0012491535,0.0013576829,0.000114791095,0.00020554531,0.00026376,0.00039301446,0.00018518529,0.0068423124,0.9824816,0.00048958865,0.0063055237,0.00011187027],"about_ca_topic_score_codex":0.00005017912,"about_ca_topic_score_gemma":0.000012780195,"teacher_disagreement_score":0.023149986,"about_ca_system_score_codex":0.00026251707,"about_ca_system_score_gemma":0.00023897679,"threshold_uncertainty_score":0.59442925},"labels":[],"label_agreement":null},{"id":"W4404237229","doi":"10.1093/neuonc/noae165.0235","title":"STEM-09. A GROUP 3 MEDULLOBLASTOMA STEM CELL PROGRAM IS MAINTAINED BY OTX2-MEDIATED ALTERNATIVE SPLICING","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Pluripotent Stem Cells Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; McGill University; University of Toronto; University of Manitoba","funders":"","keywords":"Medulloblastoma; Stem cell; RNA splicing; Group (periodic table); Biology; Alternative splicing; Cell biology; Genetics; Chemistry; Gene; Exon; RNA","score_opus":0.01256463644469216,"score_gpt":0.2906526383074274,"score_spread":0.27808800186273525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845629,0.0022919227,0.0008420596,0.0021806064,0.0010655347,0.0016046179,0.0002165663,0.00024328077,0.0069925142],"genre_scores_gemma":[0.9925361,0.0008590134,0.00028949956,0.0016013067,0.0004971409,0.0004454168,0.0002903387,0.00013965911,0.0033414837],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965197,0.00049848575,0.00047691684,0.0011604924,0.00043006413,0.0009143657],"domain_scores_gemma":[0.9986475,0.00024611014,0.00013207449,0.0005132739,0.00012396269,0.0003370947],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00043500532,0.00039678856,0.0004086965,0.000179638,0.00012025691,0.000102335885,0.00059545593,0.00046278568,0.00009620135],"category_scores_gemma":[0.000028138818,0.00037188866,0.00020142546,0.00038213228,0.00022195023,0.000012964837,0.0005049566,0.0005799873,0.00043224107],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023995558,0.00032518656,0.00013813548,0.00013595758,0.00011850748,0.0004800966,0.00020215838,0.000011937494,0.91398877,0.00003250843,0.038579687,0.0457471],"study_design_scores_gemma":[0.000842249,0.0031712004,0.000015052209,0.000022190532,0.00003034292,0.00010101823,0.00017518713,0.0025468315,0.464476,0.000015256693,0.52835,0.00025471667],"about_ca_topic_score_codex":0.000057072262,"about_ca_topic_score_gemma":0.000039211765,"teacher_disagreement_score":0.4897703,"about_ca_system_score_codex":0.0002186393,"about_ca_system_score_gemma":0.0003255616,"threshold_uncertainty_score":0.9998733},"labels":[],"label_agreement":null},{"id":"W4404237231","doi":"10.1093/neuonc/noae165.0909","title":"NCOG-27. HIGHER LEVELS OF SERUM ICAM-1 AND IL-10 ARE ASSOCIATED WITH COGNITIVE DYSFUNCTION IN BOTH IDH-WILDTYPE AND IDH-MUTANT GLIOMA","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Inflammation biomarkers and pathways","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Wild type; Mutant; Glioma; Biology; Cancer research; Genetics; Gene","score_opus":0.01978293145703199,"score_gpt":0.24633273726975163,"score_spread":0.22654980581271963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237231","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937095,0.0011896909,0.000022893044,0.0008132357,0.0009839587,0.0003357843,0.00041986202,0.000075387245,0.002449676],"genre_scores_gemma":[0.999087,0.000081771774,0.000011238288,0.0003220253,0.000034096687,0.000019372383,0.000053003023,0.000024108163,0.0003674344],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984359,0.000448425,0.0003504526,0.00041113188,0.000048388134,0.00030568597],"domain_scores_gemma":[0.9987509,0.0008039015,0.00019617577,0.00010412546,0.000112774804,0.000032075823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035165963,0.00020836316,0.00042362482,0.00024815893,0.00009199771,0.000019051651,0.0000646721,0.00050610333,0.00062728423],"category_scores_gemma":[0.0001571509,0.00017123345,0.000038024733,0.00032246526,0.0003703938,0.00011848023,0.00007068394,0.00037631267,0.000048462363],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087940163,0.00011287002,0.011282941,0.000066802255,0.0002516406,0.00038198073,0.0007853144,0.0000010624516,0.9716603,0.00057790545,0.0012362931,0.012763484],"study_design_scores_gemma":[0.012389865,0.006370564,0.6416751,0.0007476794,0.0004469577,0.0012099587,0.0015171609,0.00010746766,0.22153243,0.0008340043,0.112346135,0.00082265993],"about_ca_topic_score_codex":0.000021713138,"about_ca_topic_score_gemma":0.00026153342,"teacher_disagreement_score":0.75012785,"about_ca_system_score_codex":0.00007168038,"about_ca_system_score_gemma":0.00014928066,"threshold_uncertainty_score":0.6982697},"labels":[],"label_agreement":null},{"id":"W4404237248","doi":"10.1093/neuonc/noae165.0684","title":"INNV-22. CEREBELLOPONTINE EPIDERMOID CYST TO SQUAMOUS CELL CARCINOMA: MALIGNANT TRANSFORMATION, LEPTOMENINGEAL CARCINOMATOSIS, AND MANAGEMENT","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Medicine; Cerebellopontine angle; Basal cell; Epidermoid cyst; Epidermoid carcinoma; Malignant transformation; Pathology; Radiology; Magnetic resonance imaging","score_opus":0.014177353836299183,"score_gpt":0.27130949722804276,"score_spread":0.25713214339174356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.965056,0.0024888765,0.00012178221,0.014116882,0.00065450696,0.0015273577,0.000041698946,0.00018171075,0.01581116],"genre_scores_gemma":[0.9961822,0.00029695427,0.00055002875,0.0021384193,0.00016841637,0.00039926742,0.00006907858,0.000059094407,0.00013652854],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978958,0.00011058731,0.0005433197,0.00064132083,0.00027410508,0.00053488405],"domain_scores_gemma":[0.9989125,0.00023592451,0.0000619437,0.0003285759,0.000069141606,0.00039191966],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021756504,0.0003343859,0.0005639899,0.00048106635,0.00012848641,0.000060211936,0.0001060754,0.00014958577,0.00013077832],"category_scores_gemma":[0.000019677687,0.0002790646,0.0001287835,0.00043728697,0.00006536809,0.000102095844,0.00010494752,0.00022078697,0.00018274994],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011624634,0.0042723953,0.08630895,0.006254599,0.00049310934,0.04418295,0.016602712,0.00008864047,0.5604951,0.010088083,0.13606995,0.1339811],"study_design_scores_gemma":[0.008976854,0.0050897393,0.053440876,0.00014999388,0.0013006557,0.0032121083,0.00097082806,0.0008656879,0.12721592,0.000092982154,0.79810923,0.00057513587],"about_ca_topic_score_codex":0.00009477476,"about_ca_topic_score_gemma":0.000043256234,"teacher_disagreement_score":0.6620393,"about_ca_system_score_codex":0.00031109096,"about_ca_system_score_gemma":0.00011531473,"threshold_uncertainty_score":0.99996614},"labels":[],"label_agreement":null},{"id":"W4404237266","doi":"10.1093/neuonc/noae165.0209","title":"CNSC-53. SHH ACTIVATION IN DEDIFFERENTIATION DURING TUMOR PROGRESSION IN MPNST","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Cancer research; Medicine; Chemistry","score_opus":0.01016793389450418,"score_gpt":0.28793598823608246,"score_spread":0.2777680543415783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975262,0.00012037863,0.00027404245,0.00039655255,0.00060817046,0.00033043415,0.0000020482978,0.000048150418,0.00069397985],"genre_scores_gemma":[0.9990074,0.000045765795,0.00029117565,0.00018676269,0.00022021597,0.00011434786,0.00005894344,0.000029589612,0.000045810644],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99873346,0.0001625845,0.00025806858,0.00045347086,0.00011175785,0.00028063683],"domain_scores_gemma":[0.9996516,0.000035265664,0.00006125131,0.00018208312,0.000021836686,0.000047962003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018514792,0.00013693416,0.00015043569,0.00018490989,0.000028485727,0.000022848046,0.000116217125,0.00020421138,0.000024815236],"category_scores_gemma":[0.00014754808,0.00013550189,0.00004773812,0.00019931,0.000026202642,0.000012049749,0.00011927358,0.00022939988,0.000018585652],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012669398,0.000108940316,0.0028035087,0.000050919676,0.00000574593,0.000083253224,0.000108049644,0.000031309628,0.9826859,0.000109022956,0.0001152737,0.013771369],"study_design_scores_gemma":[0.00070150464,0.0004425019,0.008298362,0.00006881226,0.000005929306,0.00004369779,0.000048530448,0.001098422,0.980229,0.00018190639,0.008743951,0.0001373801],"about_ca_topic_score_codex":0.000010187932,"about_ca_topic_score_gemma":0.000120411256,"teacher_disagreement_score":0.013633989,"about_ca_system_score_codex":0.00015093082,"about_ca_system_score_gemma":0.0001481571,"threshold_uncertainty_score":0.5525607},"labels":[],"label_agreement":null},{"id":"W4404237278","doi":"10.1093/neuonc/noae165.0144","title":"BIOM-72. INTEGRATION OF ULTRASENSITIVE ELECTROLUMINESCENT IMMUNOASSAY AND CELL-FREE DNAMETHYLATION ANALYSIS FOR NON-INVASIVE MONITORING OF ADULT DIFFUSE GLIOMAS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Advanced biosensing and bioanalysis techniques","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Electroluminescence; Immunoassay; Medicine; Materials science; Nanotechnology; Immunology; Antibody","score_opus":0.008749751292167129,"score_gpt":0.28253661744148817,"score_spread":0.273786866149321,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9676923,0.00033278123,0.031291906,0.0001643774,0.00011100504,0.00025046186,0.00007382333,0.000023040806,0.000060304435],"genre_scores_gemma":[0.9900526,0.00090385706,0.008678898,0.00003283717,0.00011860273,0.000019085488,0.00015983586,0.000017958395,0.000016341135],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99884367,0.0001004659,0.00037289466,0.00039770128,0.00010142299,0.00018387126],"domain_scores_gemma":[0.9988288,0.0002287473,0.00022426172,0.00028960008,0.00038856073,0.000040004852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017647978,0.00016681348,0.000363024,0.00030471722,0.000046032117,0.000012527454,0.00009859249,0.00022525009,3.093436e-7],"category_scores_gemma":[0.0004035575,0.00014611207,0.00023107279,0.00048782516,0.00013963945,0.000008059841,0.000059851205,0.00009848347,1.2282722e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021579386,0.00011295654,0.0011573776,0.00006147949,0.0003117874,0.000005248632,0.00011713409,0.000007261213,0.9911806,0.000023550812,0.00006585346,0.006740981],"study_design_scores_gemma":[0.00047351466,0.0013103844,0.00058098824,0.000028290979,0.0006175309,0.000009143852,0.00023952109,0.00093163765,0.995385,0.000060740596,0.00023810571,0.00012513669],"about_ca_topic_score_codex":0.000036609286,"about_ca_topic_score_gemma":0.000074728116,"teacher_disagreement_score":0.02261301,"about_ca_system_score_codex":0.000039812185,"about_ca_system_score_gemma":0.000084554194,"threshold_uncertainty_score":0.59582776},"labels":[],"label_agreement":null},{"id":"W4404237283","doi":"10.1093/neuonc/noae165.1191","title":"TMIC-13. INTEGRATING SNRNASEQ AND SPATIAL TRANSCRIPTOME (ST) SHOWS DIVERSE TRANSCRIPTOMIC LANDSCAPE FOR TUMOR MICROENVIRONMENT (TME) IN INTRACRANIAL GERMINOMAS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Transcriptome; Tumor microenvironment; Biology; Computational biology; Evolutionary biology; Cancer research; Gene; Genetics; Tumor cells; Gene expression","score_opus":0.01602132791858902,"score_gpt":0.2706089686518943,"score_spread":0.2545876407333053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916657,0.0015382238,0.00025375563,0.0035759057,0.0010097227,0.0014142924,0.00020958537,0.000078786376,0.00025401695],"genre_scores_gemma":[0.99708325,0.000246142,0.0005279999,0.001270206,0.00035806638,0.00036105575,0.00007762653,0.000056483663,0.00001914565],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99809855,0.00010175805,0.0004936146,0.00066674774,0.00015961687,0.00047968817],"domain_scores_gemma":[0.9991795,0.00035491094,0.00005301495,0.00018826663,0.00001845399,0.00020584607],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019608781,0.00033009244,0.0006334968,0.00028465598,0.0000804002,0.000044964698,0.00009307076,0.00016967008,0.00030628376],"category_scores_gemma":[0.000046487694,0.00027634032,0.0002007116,0.00012558396,0.00012124363,0.000090840615,0.000030632815,0.000383071,0.000021254116],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009423024,0.0009345439,0.017676823,0.00026111974,0.00012308943,0.0052858796,0.002184318,0.00001020158,0.8777625,0.000116627256,0.0016842213,0.09301835],"study_design_scores_gemma":[0.07696217,0.024308743,0.11264349,0.0011677042,0.004019127,0.0086521795,0.0052538477,0.06533851,0.1895054,0.00057875004,0.50946724,0.0021028572],"about_ca_topic_score_codex":0.00024413655,"about_ca_topic_score_gemma":0.002038604,"teacher_disagreement_score":0.6882571,"about_ca_system_score_codex":0.00030576478,"about_ca_system_score_gemma":0.00015707412,"threshold_uncertainty_score":0.9999689},"labels":[],"label_agreement":null},{"id":"W4404237303","doi":"10.1093/neuonc/noae165.1033","title":"QLTI-19. PEDIATRIC NEURO-ONCOLOGISTS NAVIGATING AN ADULT WORLD: A TALE OF TWO CENTERS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Pediatrics","score_opus":0.03230364447811652,"score_gpt":0.3779923748733064,"score_spread":0.3456887303951899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9712825,0.0011220174,0.00015088888,0.016308423,0.0042268,0.000944017,0.00007225422,0.0006106755,0.005282443],"genre_scores_gemma":[0.9766452,0.00032251855,0.0020218357,0.018087573,0.00253219,0.00008414278,0.000070756185,0.00012796861,0.000107866916],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955063,0.0008066,0.0012072204,0.0010620126,0.00066529,0.0007526029],"domain_scores_gemma":[0.9957872,0.002205589,0.00040823678,0.00076621986,0.00022811492,0.00060462067],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00083025714,0.00042980953,0.0010610762,0.00046467184,0.00011874047,0.000046303383,0.00042005416,0.00023595693,0.00025041323],"category_scores_gemma":[0.0015985627,0.00042410544,0.00033688443,0.0013467765,0.00034634015,0.00025479434,0.00024886843,0.0014717065,0.00012035493],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029723358,0.0054758256,0.31179303,0.0061650807,0.00055763853,0.01146444,0.025350187,0.00038923346,0.39254627,0.0054914095,0.10251248,0.13528208],"study_design_scores_gemma":[0.03911798,0.03987801,0.06272847,0.0022053912,0.0040908097,0.008251468,0.0060035703,0.011790725,0.039970677,0.002450424,0.7797044,0.00380805],"about_ca_topic_score_codex":0.00083395303,"about_ca_topic_score_gemma":0.0012992203,"teacher_disagreement_score":0.6771919,"about_ca_system_score_codex":0.00044409832,"about_ca_system_score_gemma":0.0012439698,"threshold_uncertainty_score":0.99982107},"labels":[],"label_agreement":null},{"id":"W4404237307","doi":"10.1093/neuonc/noae165.0406","title":"CTNI-39. UPDATE ON GBM AGILE: A GLOBAL, PHASE 2/3 ADAPTIVE PLATFORM TRIAL TO EVALUATE MULTIPLE REGIMENS IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Glioblastoma; Agile software development; Medicine; Computer science; Oncology; Internal medicine; Cancer research; Software engineering","score_opus":0.044634207610980435,"score_gpt":0.36553796943474026,"score_spread":0.32090376182375985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237307","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9823418,0.0007608763,0.000008456535,0.01102769,0.0018773142,0.0029348677,0.00015332426,0.00013803558,0.00075758115],"genre_scores_gemma":[0.9954381,0.00040483274,0.00021820361,0.0026225823,0.00036774907,0.000852447,0.00003888524,0.00004385644,0.000013334419],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99741006,0.00019752278,0.0005361996,0.00090439845,0.00037825754,0.0005735741],"domain_scores_gemma":[0.9978876,0.0010989449,0.00010165378,0.0003787943,0.00007709818,0.00045591732],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003325448,0.00038967052,0.0007523889,0.00036834952,0.00007367888,0.000050410814,0.000111460635,0.000220146,0.00011115748],"category_scores_gemma":[0.000631514,0.0002904105,0.0001490305,0.0006422477,0.00008771751,0.000098861085,0.00013018199,0.00039855947,0.0002904523],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21418162,0.010598435,0.0013882606,0.00009563864,0.00042856304,0.02564042,0.0015626546,0.00011675602,0.017565988,0.0015461558,0.06391783,0.66295767],"study_design_scores_gemma":[0.36551112,0.14345004,0.00358605,0.0007070184,0.00082508917,0.00061132375,0.00038108483,0.007138703,0.011902138,0.00039202467,0.46484047,0.0006549635],"about_ca_topic_score_codex":0.000089633155,"about_ca_topic_score_gemma":0.00088903145,"teacher_disagreement_score":0.66230273,"about_ca_system_score_codex":0.0009149113,"about_ca_system_score_gemma":0.00038180905,"threshold_uncertainty_score":0.9999548},"labels":[],"label_agreement":null},{"id":"W4404237320","doi":"10.1093/neuonc/noae165.0027","title":"EPCO-28. UNVEILING INVASIVE MECHANISMS OF GLIOBLASTOMA CELLS THROUGH MULTIMODAL SINGLE-CELL SEQUENCING","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Glioblastoma; Neuroscience; Biology; Cancer research","score_opus":0.016842466162759882,"score_gpt":0.257278388518656,"score_spread":0.2404359223558961,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237320","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97811157,0.0016008131,0.012169118,0.0003006248,0.0024333254,0.00037294315,0.00012604464,0.000049027774,0.0048365477],"genre_scores_gemma":[0.9924796,0.00072304736,0.0050149937,0.0011725769,0.00041971114,0.000023555056,0.000036227582,0.00006352926,0.00006675895],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984215,0.000098233984,0.0003924828,0.000586073,0.00013196726,0.00036977962],"domain_scores_gemma":[0.9989587,0.00034964897,0.00013829028,0.00035089662,0.00010518965,0.000097253906],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015236929,0.00023683425,0.0003086795,0.00007604349,0.00006094846,0.00003179619,0.00025000685,0.00032843594,0.000041786076],"category_scores_gemma":[0.00017496427,0.00024903542,0.00017154666,0.00015370453,0.00012282752,0.000007710332,0.00025102048,0.00022337247,0.000036152367],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010807354,0.00010468519,0.000013689218,0.00010307591,0.00003772958,0.00015645644,0.00029118557,0.0014949938,0.9933621,0.0006245808,0.0017043189,0.0019990935],"study_design_scores_gemma":[0.00056069787,0.0026388397,0.0000017729111,0.000028868017,0.0000538365,0.000069921116,0.00021809332,0.00069540297,0.93806654,0.0010285378,0.056422427,0.00021504512],"about_ca_topic_score_codex":0.000062923005,"about_ca_topic_score_gemma":0.00014681263,"teacher_disagreement_score":0.05529556,"about_ca_system_score_codex":0.00016249878,"about_ca_system_score_gemma":0.0007938848,"threshold_uncertainty_score":0.9999962},"labels":[],"label_agreement":null},{"id":"W4404237342","doi":"10.1093/neuonc/noae165.0308","title":"RADT-24. WALLERIAN DEGENERATION OF THE CORTICOSPINAL TRACT IN GLIOMAS: A RETROSPECTIVE ANALYSIS AND A SYSTEMATIC REVIEW OF MOTOR FUNCTION IN ELOQUENT AREAS POST-RADIATION THERAPY. HOW IMPORTANT IS MOTOR FUNCTION FOR PATIENTS WITH GLIOMAS IN RADIATION THERAPY?","year":2024,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Corticospinal tract; Wallerian degeneration; Motor function; Medicine; Physical medicine and rehabilitation; Neuroscience; Magnetic resonance imaging; Anatomy; Psychology; Radiology","score_opus":0.017728065537044223,"score_gpt":0.28856885068861193,"score_spread":0.27084078515156773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237342","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19636002,0.79089236,0.000009457282,0.00034330113,0.000326356,0.011907473,0.00014518884,0.000012027822,0.0000038067512],"genre_scores_gemma":[0.20253709,0.7931978,0.000015041093,0.00018344031,0.00005050998,0.003581364,0.00038232037,0.000049212227,0.0000032331425],"study_design_codex":"systematic_review","study_design_gemma":"observational","domain_scores_codex":[0.99608946,0.0007591423,0.0017433622,0.0006862212,0.00046596382,0.0002558442],"domain_scores_gemma":[0.996848,0.00028766468,0.002017737,0.00046788892,0.0003058995,0.00007285154],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006865314,0.00048594608,0.003036651,0.0015255081,0.000036971232,0.000025875288,0.00009833349,0.0003439747,0.000015879237],"category_scores_gemma":[0.00035146732,0.00028886195,0.0006066772,0.0023815695,0.00004900317,0.000121189034,0.0000200016,0.00029068568,5.0347387e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040689074,0.008550338,0.21112524,0.44370022,0.006632036,0.00015052622,0.0013882838,0.0000038468415,0.0020311696,0.00011458252,0.000090111746,0.32214475],"study_design_scores_gemma":[0.016090339,0.03392141,0.74526536,0.16028565,0.034324337,0.000099488665,0.00014913939,0.00064597896,0.00018940686,0.000045495406,0.008221341,0.00076207187],"about_ca_topic_score_codex":0.00014304102,"about_ca_topic_score_gemma":0.0003673056,"teacher_disagreement_score":0.5341401,"about_ca_system_score_codex":0.0012289586,"about_ca_system_score_gemma":0.00048143018,"threshold_uncertainty_score":0.99995637},"labels":[],"label_agreement":null},{"id":"W4404237353","doi":"10.1093/neuonc/noae165.1299","title":"TMOD-35. EGFRVIII OVEREXPRESSION AND LOSS OF MOUSE SPECIFIC CDKN2A IN GLIAL CELLS LEADS TO SPONTANEOUS GLIOMAGENESIS IN A NOVEL MOUSE MODEL","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"CDKN2A; Cancer research; Cell biology; Biology; Chemistry; Genetics; Gene","score_opus":0.018662322432263994,"score_gpt":0.300250370571499,"score_spread":0.281588048139235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99783903,0.00079211005,0.00019414726,0.00016129931,0.00010335297,0.0003965094,0.00023063016,0.000011954731,0.00027096504],"genre_scores_gemma":[0.9976706,0.0010206753,0.0005218146,0.00018171158,0.00008667487,0.000066625114,0.000032088432,0.00003847012,0.0003813642],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984989,0.000082531056,0.00028477324,0.0005964525,0.0001477363,0.00038958422],"domain_scores_gemma":[0.999422,0.00005645125,0.000038119626,0.00029642694,0.000031773878,0.0001552054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001180084,0.00019338589,0.0002831716,0.00024120067,0.00002447464,0.000022838074,0.00017679065,0.00021583254,0.000016532475],"category_scores_gemma":[0.00003578144,0.00018667676,0.000064902604,0.0002016248,0.0000921806,0.000008181857,0.0002655864,0.00017231551,0.000011402657],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015973552,0.0003731638,0.00041902548,0.00005688375,0.000015307021,0.00089328835,0.00018518305,0.0019058181,0.99100107,0.0000208848,0.00088167423,0.002650365],"study_design_scores_gemma":[0.0018386925,0.001265095,0.00009330595,0.000037176775,0.0000073362917,0.00019309585,0.000024014198,0.0016063169,0.9826886,0.000022661317,0.012055948,0.00016773817],"about_ca_topic_score_codex":0.00031732413,"about_ca_topic_score_gemma":0.0015918271,"teacher_disagreement_score":0.011174274,"about_ca_system_score_codex":0.00017202133,"about_ca_system_score_gemma":0.00031239146,"threshold_uncertainty_score":0.7612457},"labels":[],"label_agreement":null},{"id":"W4404237401","doi":"10.1093/neuonc/noae165.0381","title":"CTNI-14. RADIOTHERAPY VERSUS TMZ FOR HIGH-RISK LOW-GRADE GLIOMA. FINAL RESULTS AFTER MEDIAN FOLLOW-UP OF 13 YEARS OF PHASE III EORTC/NCIC-CTG/TROG/MRC-CTU (EORTC 22033-26033) STUDY","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Queen's University; BC Cancer Agency","funders":"","keywords":"Medicine; Internal medicine; Radiation therapy; Glioma; Oncology","score_opus":0.029446798593411656,"score_gpt":0.3416222584285629,"score_spread":0.31217545983515127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881182,0.0018597569,0.000040710554,0.0017503982,0.0040843305,0.003166936,0.00070353755,0.000116891475,0.00015926285],"genre_scores_gemma":[0.99682164,0.00045018378,0.000598965,0.0002389987,0.0006323832,0.00092833565,0.00014657991,0.00011429615,0.0000686383],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9962122,0.0002996616,0.0012167376,0.000978091,0.00061943376,0.00067388115],"domain_scores_gemma":[0.9960923,0.0020760077,0.00042626495,0.0008475201,0.00020767635,0.00035023113],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00057447015,0.00047751167,0.0014322127,0.00066390645,0.00007377072,0.000025626076,0.00027773582,0.00034429907,0.00020160215],"category_scores_gemma":[0.000519954,0.00042014153,0.0005311636,0.00068816514,0.00028517094,0.00010753558,0.00008308279,0.00042421414,0.000024183453],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20439743,0.03613939,0.016805368,0.00081492076,0.008008055,0.029139515,0.016088868,0.00010330145,0.28675297,0.0005206554,0.04579098,0.35543856],"study_design_scores_gemma":[0.53861475,0.14595684,0.042522408,0.0005206825,0.008043443,0.00045158912,0.0017380083,0.0012490945,0.13975249,0.00035850474,0.11955617,0.0012360117],"about_ca_topic_score_codex":0.0005141801,"about_ca_topic_score_gemma":0.0009307978,"teacher_disagreement_score":0.35420254,"about_ca_system_score_codex":0.0003493131,"about_ca_system_score_gemma":0.00052323344,"threshold_uncertainty_score":0.99982506},"labels":[],"label_agreement":null},{"id":"W4404237411","doi":"10.1093/neuonc/noae165.0678","title":"INNV-15. A PIVOTAL, MULTICENTER TRIAL OF FOCUSED ULTRASOUND FOR BLOOD-BRAIN BARRIER DISRUPTION FOR PLASMA-BASED LIQUID BIOPSY IN PATIENTS WITH GLIOBLASTOMA (LIBERATE)","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Advanced Radiotherapy Techniques","field":"Physics and Astronomy","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Glioblastoma; Focused ultrasound; Blood–brain barrier; Liquid biopsy; Medicine; Biopsy; Ultrasound; Brain biopsy; Multicenter trial; Multicenter study; Radiology; Pathology; Internal medicine; Cancer research; Randomized controlled trial; Central nervous system; Cancer","score_opus":0.007935530442875571,"score_gpt":0.2828799126506333,"score_spread":0.2749443822077577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9385202,0.000010419787,0.05726049,0.00022783717,0.00039346114,0.0030566226,0.0003827502,0.00009352361,0.000054691995],"genre_scores_gemma":[0.9818824,0.0000010824546,0.016039016,0.00017878655,0.00027007225,0.0014058127,0.000107796885,0.00008971148,0.00002535483],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984866,0.00011510291,0.0004565792,0.0004610397,0.00012674219,0.0003539826],"domain_scores_gemma":[0.99795973,0.0014493197,0.00018850602,0.00022265587,0.00010887625,0.00007091899],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016267333,0.00025500983,0.00042582655,0.0002194916,0.000054894226,0.000029479354,0.0001466164,0.00013045753,0.00005281743],"category_scores_gemma":[0.00006698167,0.00021825962,0.00015691198,0.00022603074,0.00011747789,0.00017234475,0.000017082422,0.00019634388,9.802158e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2912917,0.0050071925,0.010860394,0.00029742726,0.0004317727,0.000018297957,0.0011456159,0.00052358664,0.64952946,0.0024702323,0.001373991,0.03705032],"study_design_scores_gemma":[0.2669182,0.089144416,0.00043242713,0.0002651899,0.0003354232,0.0000049247456,0.00008801402,0.00986078,0.5451575,0.0010313741,0.08570037,0.0010614108],"about_ca_topic_score_codex":0.000010673115,"about_ca_topic_score_gemma":0.00001532024,"teacher_disagreement_score":0.10437198,"about_ca_system_score_codex":0.00008775532,"about_ca_system_score_gemma":0.00019038114,"threshold_uncertainty_score":0.89003694},"labels":[],"label_agreement":null},{"id":"W4404237499","doi":"10.1093/neuonc/noae165.1079","title":"RTID-03. A MULTICENTER, RANDOMIZED, CONTROLLED TRIAL OF FOCUSED-ULTRASOUND-MEDIATED BLOOD-BRAIN BARRIER DISRUPTION PLUS SYSTEMIC PEMBROLIZUMAB FOR PATIENTS WITH NSCLC BRAIN METASTASES (LIMITLESS)","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Pembrolizumab; Medicine; Randomized controlled trial; Internal medicine; Oncology; Blood–brain barrier; Cancer; Immunotherapy; Central nervous system","score_opus":0.011956561376987723,"score_gpt":0.286510960461027,"score_spread":0.2745543990840392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237499","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9677933,0.0016798418,0.0014675701,0.0024081795,0.0016139176,0.023546059,0.00095952686,0.00020139426,0.00033020254],"genre_scores_gemma":[0.9924355,0.00015075094,0.0009287784,0.0009963705,0.000337954,0.0041883737,0.00067024084,0.000113805385,0.00017821716],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99489933,0.0017692662,0.0014198766,0.00076508085,0.00056965026,0.0005768033],"domain_scores_gemma":[0.9793562,0.019008234,0.0005793013,0.00041827068,0.0003382754,0.0002996644],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015902822,0.0005315199,0.0032594432,0.00038882566,0.00010307784,0.000049929957,0.00015153758,0.00025676397,0.00013575726],"category_scores_gemma":[0.0066992,0.00033161475,0.00097691,0.00030685266,0.00031948055,0.00012939773,0.00004821712,0.00032808067,0.000029670264],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97478634,0.0026928787,0.00014081445,0.00057599304,0.0036975835,0.00030642416,0.0005195349,0.000034017983,0.012024498,0.0005322334,0.0017260199,0.0029636894],"study_design_scores_gemma":[0.97041017,0.013204863,0.000031095715,0.00033031031,0.007468427,0.00020035631,0.00014816066,0.0014973157,0.00056905946,0.000038614588,0.005847039,0.00025460884],"about_ca_topic_score_codex":0.000056428533,"about_ca_topic_score_gemma":0.00004053503,"teacher_disagreement_score":0.0246422,"about_ca_system_score_codex":0.00029419782,"about_ca_system_score_gemma":0.00080168364,"threshold_uncertainty_score":0.9999136},"labels":[],"label_agreement":null},{"id":"W4404237571","doi":"10.1093/neuonc/noae165.0563","title":"EPID-27. THE INCIDENCE OF BRAIN METASTASIS IN GASTROINTESTINAL CANCER ACCORDING TO PRIMARY SITE AND STAGE: A 15-YEAR SINGLE INSTITUTIONAL ANALYSIS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Southlake Regional Health Center; Princess Margaret Cancer Centre","funders":"","keywords":"Stage (stratigraphy); Incidence (geometry); Brain metastasis; Cancer; Medicine; Metastasis; Gastrointestinal cancer; Oncology; Internal medicine; Colorectal cancer; Biology","score_opus":0.03285760923445909,"score_gpt":0.3376853058823464,"score_spread":0.30482769664788734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97965616,0.0008308561,0.001989807,0.016412426,0.00011919918,0.00040160684,0.00013388916,0.000026231193,0.00042983802],"genre_scores_gemma":[0.9903907,0.00005535525,0.0060052625,0.0033199412,0.00007692221,0.00005665154,0.000025847936,0.000013370934,0.00005595752],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99851084,0.00028473724,0.00034140912,0.00038750214,0.0002270801,0.00024840957],"domain_scores_gemma":[0.99824023,0.0012794223,0.00008030144,0.00021543082,0.0000636961,0.000120894256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006819592,0.00015198532,0.00048670874,0.00039222438,0.00006140097,0.00002185869,0.00008415364,0.000038546492,0.00015665106],"category_scores_gemma":[0.00060703343,0.000105961444,0.00013009053,0.0010820712,0.00017056485,0.00008047816,0.00014345156,0.00030323732,0.000010760065],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011889979,0.0007821451,0.58444154,0.0004452873,0.001124125,0.004326472,0.0013614702,0.0045390707,0.29142493,0.0016026527,0.0024223512,0.10634096],"study_design_scores_gemma":[0.008066915,0.012643331,0.78477997,0.0015596517,0.008587229,0.004549977,0.0033608642,0.008347056,0.015456045,0.0003284338,0.15146418,0.0008563408],"about_ca_topic_score_codex":0.0007090396,"about_ca_topic_score_gemma":0.0010879574,"teacher_disagreement_score":0.27596888,"about_ca_system_score_codex":0.00034583773,"about_ca_system_score_gemma":0.00049148785,"threshold_uncertainty_score":0.43209824},"labels":[],"label_agreement":null},{"id":"W4404237574","doi":"10.1093/neuonc/noae165.0566","title":"EPID-30. THE COST OF HOSPITAL-BASED CARE AMONG CANADIAN PATIENTS WITH MALIGNANT CENTRAL NERVOUS SYSTEM TUMOURS IN COMPARISON TO THOSE WITH LUNG AND COLORECTAL CANCERS IN THE YEAR PRECEDING THEIR CANCER DIAGNOSIS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services; University of Alberta","funders":"","keywords":"Medicine; Colorectal cancer; Oncology; Lung; Lung cancer; Central nervous system; Internal medicine; Cancer","score_opus":0.013385779181110757,"score_gpt":0.23594317967590042,"score_spread":0.22255740049478967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99251556,0.0018001389,0.000020960215,0.0013113846,0.0006940102,0.0013574627,0.0005649736,0.0000125623965,0.0017229208],"genre_scores_gemma":[0.9985336,0.00014046735,0.000016400398,0.00044855606,0.00007277761,0.0007424291,0.000010711951,0.00003291484,0.0000021407943],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985397,0.00006128288,0.00043340906,0.0004044555,0.00004402609,0.0005171349],"domain_scores_gemma":[0.99915564,0.0002689253,0.00020858941,0.00017965033,0.000041314277,0.00014587697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025833037,0.00019878561,0.00051361433,0.00021359962,0.000118301316,0.000103512895,0.0002629749,0.000105500294,0.000020741574],"category_scores_gemma":[0.00004766614,0.00013409209,0.000041161846,0.0003580865,0.00015542103,0.00012856182,0.000028675711,0.0002955686,0.0000033666713],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010227265,0.00003142901,0.979437,0.00007866368,0.000022168495,0.000026607659,0.009324839,0.006503925,0.0000010782499,0.00070800993,0.00070380565,0.0030602308],"study_design_scores_gemma":[0.0009125027,0.00094710157,0.98191863,0.00029656047,0.000020975674,0.0000012019108,0.003970903,0.0030817646,0.00007503487,0.000009418905,0.0085457545,0.00022011975],"about_ca_topic_score_codex":0.18233238,"about_ca_topic_score_gemma":0.56344277,"teacher_disagreement_score":0.38111037,"about_ca_system_score_codex":0.0021311163,"about_ca_system_score_gemma":0.0006136464,"threshold_uncertainty_score":0.82311255},"labels":[],"label_agreement":null},{"id":"W4404237580","doi":"10.1093/neuonc/noae165.0324","title":"RADT-40. EVALUATION OF SMALLER CLINICAL TARGET VOLUMES AND PATTERNS OF PROGRESSION IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA TO INFORM FUTURE DIRECTIONS IN RADIATION TREATMENT PLANNING","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Credit Valley Hospital; Trillium Health Centre","funders":"","keywords":"Glioblastoma; Radiation treatment planning; Medicine; Radiation therapy; Radiation oncology; Medical physics; Oncology; Internal medicine; Cancer research","score_opus":0.027465133829638645,"score_gpt":0.36281263169263633,"score_spread":0.33534749786299767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963459,0.0007103904,0.000004583294,0.0010331654,0.00034242313,0.0014642299,0.000020180538,0.000018347355,0.00006080624],"genre_scores_gemma":[0.99902123,0.00019138283,0.00024608435,0.00007348765,0.00007991577,0.0003184299,0.000052801228,0.000015040029,0.0000016186235],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986406,0.00017581438,0.00048323604,0.00027314576,0.00027614587,0.00015108682],"domain_scores_gemma":[0.9992073,0.00033542071,0.00012976566,0.00013078016,0.00010802796,0.000088691755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002843087,0.0001374941,0.0004103362,0.00040362947,0.000021630909,0.000007171117,0.000027202495,0.00013370304,0.000026651269],"category_scores_gemma":[0.00013671629,0.00009684167,0.00004860695,0.00035212006,0.000027915858,0.00007629943,0.000022485528,0.000120726625,0.0000017401129],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073001813,0.0012401247,0.6557069,0.00003124784,0.00004537321,0.00005271949,0.0013487454,0.00015863906,0.00013370022,0.0000043142154,0.00006458964,0.34048367],"study_design_scores_gemma":[0.010748389,0.011639485,0.96694654,0.0002864998,0.00016633864,0.000005752842,0.000190157,0.0017652047,0.0014447967,0.0000049468376,0.006734049,0.00006781804],"about_ca_topic_score_codex":0.00006889969,"about_ca_topic_score_gemma":0.0004299633,"teacher_disagreement_score":0.34041584,"about_ca_system_score_codex":0.0003187237,"about_ca_system_score_gemma":0.00021031924,"threshold_uncertainty_score":0.39490888},"labels":[],"label_agreement":null},{"id":"W4404237582","doi":"10.1093/neuonc/noae165.0033","title":"EPCO-34. DECIPHERING THE LONGITUDINAL TRAJECTORIES OF GLIOBLASTOMA BY INTEGRATIVE SINGLE-CELL GENOMICS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Glioblastoma; Biology; Computational biology; Neuroscience; Evolutionary biology; Cancer research","score_opus":0.016061784743276332,"score_gpt":0.2519497478516496,"score_spread":0.23588796310837326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862155,0.0034893162,0.004695121,0.00038533477,0.0014061558,0.00022234957,0.00006258905,0.000037324156,0.0034863215],"genre_scores_gemma":[0.99826884,0.00041523983,0.00039048606,0.0002737807,0.00035224098,0.000022583243,0.000030125504,0.0000497857,0.00019689447],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99863386,0.00014364306,0.00034529978,0.00045277085,0.00011912568,0.00030529418],"domain_scores_gemma":[0.9992629,0.00019979148,0.000092040755,0.00028803846,0.000083988016,0.00007322902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016206912,0.00024635205,0.000282776,0.000044833017,0.000093580704,0.0000434134,0.00033598626,0.00025057234,0.000030082774],"category_scores_gemma":[0.00007927432,0.00018258,0.00017798871,0.00016602136,0.00031877044,0.000007509836,0.00009468383,0.000305557,0.000009842406],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002820263,0.00016910091,0.000411199,0.000038310533,0.000063237996,0.00002473606,0.0005636702,0.000053788393,0.9857577,0.000110683926,0.0040122154,0.008513305],"study_design_scores_gemma":[0.00030989526,0.0019698995,0.000034298526,0.0000123077425,0.000046196354,0.000056341578,0.00029933656,0.00019683376,0.7471728,0.00004604368,0.24971147,0.00014458147],"about_ca_topic_score_codex":0.000045861238,"about_ca_topic_score_gemma":0.0002722997,"teacher_disagreement_score":0.24569926,"about_ca_system_score_codex":0.00010111756,"about_ca_system_score_gemma":0.0002301487,"threshold_uncertainty_score":0.7445396},"labels":[],"label_agreement":null},{"id":"W4404237602","doi":"10.1093/neuonc/noae165.0081","title":"BIOM-08. LEVERAGING CSF PROTEOMICS TO OPTIMIZE CNS LYMPHOMA MANAGEMENT","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Proteomics; Lymphoma; Computational biology; Computer science; Medicine; Immunology; Biology; Gene; Genetics","score_opus":0.026041957325661006,"score_gpt":0.30502791185521955,"score_spread":0.27898595452955854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237602","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8388227,0.0011291349,0.0016964275,0.066147275,0.0038258205,0.0041313516,0.000039118157,0.00079106237,0.08341711],"genre_scores_gemma":[0.95881575,0.00065433333,0.023478817,0.014115545,0.0005161692,0.001075226,0.000039461996,0.0000917027,0.0012129644],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982113,0.000071892966,0.00033523052,0.0006650155,0.00023981016,0.00047670314],"domain_scores_gemma":[0.9989697,0.00022278006,0.00004355733,0.0004237422,0.000046138288,0.0002940827],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001595898,0.00026474404,0.0004339508,0.00029695427,0.00009037452,0.00007075426,0.00013947446,0.00013460313,0.00023029259],"category_scores_gemma":[0.000051208408,0.0002192077,0.00016393693,0.00037123018,0.00004995805,0.00006830451,0.00020957604,0.00010142645,0.0012503795],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007044338,0.0021149917,0.0026644247,0.0004234633,0.0008274385,0.024609271,0.0013865378,0.00020600563,0.04811941,0.0043097613,0.102688976,0.81194526],"study_design_scores_gemma":[0.0046592243,0.001750901,0.0049564796,0.00016169458,0.00043831536,0.0009914002,0.00015625314,0.0010981729,0.022800466,0.00014943989,0.96259105,0.00024658456],"about_ca_topic_score_codex":0.00004367817,"about_ca_topic_score_gemma":0.0000058728997,"teacher_disagreement_score":0.8599021,"about_ca_system_score_codex":0.0011095834,"about_ca_system_score_gemma":0.00027404074,"threshold_uncertainty_score":0.9995273},"labels":[],"label_agreement":null},{"id":"W4404237684","doi":"10.1093/neuonc/noae165.0848","title":"NIMG-84. BELZUTIFAN REDUCTION OF CEREBRAL BLOOD FLOW IN VHL-ASSOCIATED HEMANGIOBLASTOMA PREDICTS RESPONSE TO TREATMENT","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Cerebral blood flow; Reduction (mathematics); Medicine; Cardiology; Internal medicine; Mathematics","score_opus":0.010186188364043485,"score_gpt":0.2693476324826886,"score_spread":0.2591614441186451,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993058,0.0018088239,0.000023763841,0.0011524546,0.0028449248,0.00043723706,0.00010088137,0.000057636033,0.0005162632],"genre_scores_gemma":[0.9970035,0.0005190082,0.00025714745,0.0002247321,0.0010826167,0.00009870433,0.00007656794,0.000042946136,0.0006948036],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982161,0.0003486455,0.0003613716,0.00056433055,0.00013713098,0.00037240123],"domain_scores_gemma":[0.99932516,0.00006879329,0.0000783584,0.00032059968,0.00006543874,0.00014165022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029959125,0.00021498495,0.0003544676,0.00021543277,0.000037244958,0.000013800316,0.00014274001,0.00032116674,0.00002608935],"category_scores_gemma":[0.0002446134,0.00020958079,0.00016180059,0.00032639882,0.000077825694,0.0000063996354,0.000092069364,0.00013976333,0.000019078057],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016667107,0.00046652596,0.00016074469,0.000016343876,0.000113585724,0.000039450602,0.0006092505,0.00018577297,0.96928906,0.000015752306,0.007969464,0.019467313],"study_design_scores_gemma":[0.0020933712,0.0057725646,0.0028041299,0.000030128487,0.000130173,0.00016152505,0.00008689957,0.000137585,0.5246251,0.0000216745,0.4639562,0.00018064462],"about_ca_topic_score_codex":0.000094327945,"about_ca_topic_score_gemma":0.0005308688,"teacher_disagreement_score":0.45598674,"about_ca_system_score_codex":0.00015085482,"about_ca_system_score_gemma":0.0005376428,"threshold_uncertainty_score":0.85464567},"labels":[],"label_agreement":null},{"id":"W4404237690","doi":"10.1093/neuonc/noae165.0420","title":"CTNI-53. A GLOBAL, RANDOMIZED, DOUBLE-BLINDED, PHASE 3 STUDY OF VORASIDENIB VERSUS PLACEBO IN PATIENTS WITH ADULT-TYPE DIFFUSE GLIOMA WITH AN IDH1/2 MUTATION (INDIGO): UPDATED EFFICACY RESULTS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre; Toronto General Hospital","funders":"","keywords":"Placebo; Glioma; Double blinded; Medicine; Internal medicine; IDH1; Troponin I; Oncology; Mutation; Pathology; Biology; Genetics; Cancer research; Myocardial infarction","score_opus":0.027410436379942817,"score_gpt":0.3456325533764556,"score_spread":0.31822211699651276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99207574,0.000072596325,0.000004966967,0.00047635418,0.00053990225,0.0063905576,0.000060636532,0.00013873336,0.00024048163],"genre_scores_gemma":[0.99889123,0.0000131518145,0.00012336904,0.000088032284,0.00006502836,0.00032331937,0.00043902537,0.00005475672,0.0000020656446],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9967486,0.00053879945,0.00083984,0.00084305723,0.00060854113,0.00042110996],"domain_scores_gemma":[0.997537,0.0008707283,0.00032981648,0.0005600411,0.0004499646,0.00025243466],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002843751,0.00040963743,0.0011670105,0.00047409913,0.000066734734,0.000050791194,0.00015299085,0.00019344488,0.000023761026],"category_scores_gemma":[0.00033070802,0.00027314204,0.000087005654,0.0014674169,0.00017440939,0.00020533301,0.000052365685,0.0003096329,0.000026339852],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9406039,0.032113753,0.012524171,0.00004414269,0.0007886947,0.0063435957,0.0024213318,0.00019640195,0.0006411595,0.00005589029,0.00021133796,0.004055596],"study_design_scores_gemma":[0.9214687,0.061550133,0.011980087,0.00013370499,0.0014928742,0.000100199046,0.00084564165,0.00050278654,0.0015484602,0.000007556846,0.00014388839,0.00022598285],"about_ca_topic_score_codex":0.0006770012,"about_ca_topic_score_gemma":0.0018460097,"teacher_disagreement_score":0.029436378,"about_ca_system_score_codex":0.0004143696,"about_ca_system_score_gemma":0.00044627115,"threshold_uncertainty_score":0.9999721},"labels":[],"label_agreement":null},{"id":"W4404237702","doi":"10.1093/neuonc/noae165.0606","title":"IMMU-13. TRANS-SPECIES STUDY OF IDH-MUTANT REPLICATION-REPAIR DEFICIENT HIGH-GRADE GLIOMAS (RRD-HGG) AND RESPONSE TO COMBINED TARGETED AND IMMUNOTHERAPY: AN IRRDC STUDY","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Mutant; Immunotherapy; Replication (statistics); Cancer research; Biology; Medicine; Immune system; Virology; Immunology; Genetics; Gene","score_opus":0.026173590907149172,"score_gpt":0.31945960694186926,"score_spread":0.2932860160347201,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890443,0.0018435005,0.0000053878966,0.00490936,0.00032307368,0.003557021,0.00004040428,0.00023870416,0.000038228736],"genre_scores_gemma":[0.9986854,0.00016103838,0.00011928138,0.00036588035,0.00004113535,0.00053263013,0.000014834898,0.000060199745,0.000019564586],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9969389,0.00073104183,0.00067110214,0.00097475894,0.0003596087,0.0003246168],"domain_scores_gemma":[0.99768907,0.00090034015,0.00010771342,0.0009359826,0.00013088682,0.00023598233],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00078922475,0.00032060163,0.00078366767,0.0005283864,0.00015299283,0.000044817836,0.00013167273,0.00012195182,0.000050279985],"category_scores_gemma":[0.00016870964,0.00025678318,0.00009093842,0.0006926837,0.00013722393,0.000072881456,0.000082107275,0.00022357349,0.00000593828],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006538257,0.014335897,0.041097254,0.000046192643,0.0005302395,0.0014624309,0.01955601,0.000013751511,0.9114042,0.00019694657,0.00025655472,0.004562284],"study_design_scores_gemma":[0.01593454,0.077258006,0.84787726,0.000048882102,0.00068532693,0.00024600574,0.0104119815,0.00018823742,0.034755457,0.000050261533,0.012260595,0.00028341074],"about_ca_topic_score_codex":0.00031221594,"about_ca_topic_score_gemma":0.00030896004,"teacher_disagreement_score":0.8766487,"about_ca_system_score_codex":0.00018801946,"about_ca_system_score_gemma":0.00017106421,"threshold_uncertainty_score":0.99998844},"labels":[],"label_agreement":null},{"id":"W4404237720","doi":"10.1093/neuonc/noae165.1041","title":"QOL-06. OPTIMIZING NEUROFIBROMATOSIS CARE: A COMPREHENSIVE ECONOMIC EVALUATION OF A SPECIALIZED EXPERTISE CENTER’S IMPACT ON PATIENT OUTCOMES","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université Laval; Université de Montréal","funders":"","keywords":"Center (category theory); Neurofibromatosis; Medicine; Quality of life (healthcare); Gerontology; Nursing; Pathology","score_opus":0.05008768357515468,"score_gpt":0.3594361160678967,"score_spread":0.309348432492742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906032,0.0009432166,0.0000054616457,0.0014856687,0.0017523703,0.0012365106,0.00013293022,0.00015509255,0.0036855508],"genre_scores_gemma":[0.99815446,0.00011557931,0.00025000185,0.0010367713,0.00016150797,0.00012444334,0.00006687628,0.000081295875,0.000009087452],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99693966,0.00062026293,0.00080524327,0.00069285836,0.0005367909,0.00040517907],"domain_scores_gemma":[0.9980471,0.0007308767,0.00024109035,0.00053948065,0.00020366268,0.00023778735],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015252219,0.0003986256,0.0010318545,0.00042094014,0.00007818913,0.000053107033,0.0001348415,0.00016807899,0.00038444827],"category_scores_gemma":[0.00016186954,0.00031292273,0.00057555217,0.00017733798,0.00011479783,0.00013189086,0.000114932365,0.0003003914,0.00015749941],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036071185,0.0013502609,0.017396936,0.0005662979,0.0006955208,0.0025144238,0.007855965,0.002454878,0.83660036,0.00041822233,0.038535573,0.08800446],"study_design_scores_gemma":[0.03959538,0.055514123,0.10097621,0.001879996,0.0035252545,0.008055084,0.0051134746,0.05511176,0.4755965,0.00017671606,0.25225183,0.0022036775],"about_ca_topic_score_codex":0.00007027135,"about_ca_topic_score_gemma":0.0000058021765,"teacher_disagreement_score":0.36100385,"about_ca_system_score_codex":0.0009307921,"about_ca_system_score_gemma":0.0007190291,"threshold_uncertainty_score":0.9999323},"labels":[],"label_agreement":null},{"id":"W4404237730","doi":"10.1093/neuonc/noae165.0685","title":"INNV-23. UNDERSTANDING THE BURDEN OF MIDH1/2 DIFFUSE GLIOMA AND THE COMPLEXITY OF NAVIGATING THE PATIENT PATHWAY: INSIGHTS FROM PATIENTS AND CAREGIVERS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Brain Tumour Foundation of Canada","funders":"","keywords":"Glioma; Medicine; Psychology; Cancer research","score_opus":0.04093549528277272,"score_gpt":0.2766028338466548,"score_spread":0.23566733856388208,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98808414,0.0018670917,0.0000070495425,0.008624838,0.00029460402,0.00070636964,0.00006049918,0.00001638574,0.00033900392],"genre_scores_gemma":[0.99940896,0.00013383316,0.000021941514,0.00030891318,0.00005850127,0.000033184795,0.000019152998,0.000014927951,5.885277e-7],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9987459,0.00030640647,0.00031436063,0.00024725124,0.00024040429,0.00014567153],"domain_scores_gemma":[0.99742174,0.0020305351,0.00017522642,0.00024971733,0.00006545895,0.000057297308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000089135465,0.00015077084,0.00036804721,0.000046655536,0.00017824044,0.000023599152,0.00009620278,0.00007333859,0.000007945774],"category_scores_gemma":[0.00013983359,0.00006623293,0.00007837532,0.00019845921,0.0012862117,0.000036827558,0.0001780803,0.00026621472,0.0000010243479],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031018867,0.0025298337,0.035573795,0.00066034304,0.0026781359,0.0014466924,0.4646615,0.00008368341,0.2923783,0.098583,0.00348359,0.09481923],"study_design_scores_gemma":[0.11568722,0.024411032,0.10783878,0.0043844017,0.007416751,0.00075404363,0.31472364,0.030330103,0.23125571,0.115185924,0.046434354,0.0015780532],"about_ca_topic_score_codex":0.00084739487,"about_ca_topic_score_gemma":0.000086275824,"teacher_disagreement_score":0.14993785,"about_ca_system_score_codex":0.0001127517,"about_ca_system_score_gemma":0.00006915096,"threshold_uncertainty_score":0.47391003},"labels":[],"label_agreement":null},{"id":"W4404237739","doi":"10.1093/neuonc/noae165.0444","title":"CTNI-77. PHASE 1 DOSE FINDING STUDY EVALUATING THE SAFETY, TOLERABILITY, AND EFFICACY OF IOPOFOSINE I 131 IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS WITH INOPERABLE RELAPSED OR REFRACTORY HIGH-GRADE GLIOMAS: A TRIAL-IN-PROGRESS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Tolerability; Medicine; Refractory (planetary science); Oncology; Internal medicine; Adverse effect; Materials science","score_opus":0.03368687855500614,"score_gpt":0.36609094977179135,"score_spread":0.3324040712167852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903044,0.0027885393,5.7210906e-7,0.001307063,0.00028696627,0.0052250195,0.000015644699,0.000044898014,0.000026894142],"genre_scores_gemma":[0.9989756,0.00031040373,0.00010432187,0.0001025313,0.00010538542,0.00033830313,0.000017137056,0.000042037835,0.000004314333],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969644,0.00071982207,0.0007943956,0.00076306745,0.000374939,0.00038340504],"domain_scores_gemma":[0.9981936,0.0010002925,0.00019159229,0.00042191084,0.000064930784,0.00012762437],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010635117,0.0003107861,0.00088524644,0.00037265688,0.00010852807,0.000046373367,0.000118099895,0.0001409668,0.000022148133],"category_scores_gemma":[0.00052275066,0.00018284694,0.00005382357,0.0007426369,0.0002271553,0.000108512664,0.00015266916,0.000540836,0.0000014768915],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12577058,0.02495505,0.68684024,0.00036048843,0.00032129313,0.0021447921,0.0070319776,0.000030692467,0.013168401,0.000033641158,0.000063167754,0.1392797],"study_design_scores_gemma":[0.3143697,0.057883237,0.6217488,0.001434557,0.0006699767,0.000545517,0.0010195855,0.0009355789,0.0010225824,0.000011634198,0.00012727505,0.00023155291],"about_ca_topic_score_codex":0.0004522241,"about_ca_topic_score_gemma":0.00077465567,"teacher_disagreement_score":0.18859911,"about_ca_system_score_codex":0.00025940363,"about_ca_system_score_gemma":0.00029465187,"threshold_uncertainty_score":0.7456282},"labels":[],"label_agreement":null},{"id":"W4404237749","doi":"10.1093/neuonc/noae165.0098","title":"BIOM-25. MOLECULAR PROFILING PREDICTS EARLY AND LATE PROGRESSION IN GLIOBLASTOMA","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; St. Michael's Hospital; University of Toronto; SickKids Foundation; Hospital for Sick Children; Ontario Institute for Cancer Research","funders":"","keywords":"Glioblastoma; Profiling (computer programming); Cancer research; Computational biology; Oncology; Medicine; Biology; Computer science; Programming language","score_opus":0.013040131393637109,"score_gpt":0.30873377450495776,"score_spread":0.2956936431113206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99169165,0.002682849,0.0000063405337,0.0034328115,0.00034557364,0.00072011695,0.0000054872007,0.00013249883,0.0009826696],"genre_scores_gemma":[0.9988422,0.00015165079,0.00033424204,0.00038033826,0.000074148746,0.00016870764,0.0000064756387,0.00003162676,0.000010646218],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988308,0.000084723826,0.00022715944,0.00041460484,0.00016070376,0.00028201286],"domain_scores_gemma":[0.9994843,0.00014526234,0.000036924423,0.00015785101,0.000028979723,0.0001466541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012281373,0.00015601215,0.0002848564,0.0002789695,0.00002985048,0.000029608223,0.00004320021,0.00016437432,0.000019352754],"category_scores_gemma":[0.000071993214,0.00011979022,0.00005242559,0.0003012808,0.00007349834,0.00005937701,0.000074659554,0.00024111304,0.000040733506],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020230503,0.0004455434,0.040920276,0.00014998642,0.000053964024,0.0163325,0.00032764697,0.0000045060056,0.8588193,0.00044503118,0.00018072105,0.08211822],"study_design_scores_gemma":[0.0074384357,0.013744636,0.07180599,0.0009777985,0.00036706062,0.0012938314,0.0000624197,0.0049855425,0.84033644,0.00051691383,0.05814217,0.00032877762],"about_ca_topic_score_codex":0.0000127623325,"about_ca_topic_score_gemma":0.000011517237,"teacher_disagreement_score":0.08178944,"about_ca_system_score_codex":0.000103882536,"about_ca_system_score_gemma":0.00012466144,"threshold_uncertainty_score":0.4884903},"labels":[],"label_agreement":null},{"id":"W4404237753","doi":"10.1093/neuonc/noae165.1172","title":"TMET-34. PYROPTOSIS IS AN ACQUIRED VULNERABILITY OF BRAIN METASTASES","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University; Discovery Centre","funders":"","keywords":"Pyroptosis; Vulnerability (computing); Neuroscience; Medicine; Computer science; Biology; Internal medicine; Computer security; Inflammation","score_opus":0.031098934585338245,"score_gpt":0.3408959726596121,"score_spread":0.30979703807427383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97258645,0.0020373224,0.00023486008,0.01600896,0.0014798534,0.00061557884,0.00055882096,0.00025348595,0.006224654],"genre_scores_gemma":[0.9931972,0.0001044242,0.00046908308,0.0054380945,0.00044302444,0.000046294528,0.00008512656,0.000043738833,0.00017303386],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99789166,0.0004017764,0.00049834326,0.0005893589,0.00027814647,0.00034068557],"domain_scores_gemma":[0.9984349,0.0005274416,0.00008526404,0.0005192513,0.00013983274,0.0002933092],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00043280466,0.00022704981,0.0006339269,0.00019284865,0.00006819087,0.000022372833,0.00016820322,0.0001916806,0.0013615242],"category_scores_gemma":[0.00035170378,0.00019100627,0.00035642943,0.00033104778,0.00029808327,0.0001840706,0.00009661018,0.00023857364,0.00007500873],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003641748,0.0010745729,0.0006257652,0.0006833831,0.00019680471,0.00078286655,0.00062346045,0.000004134115,0.91509867,0.0019420612,0.033679128,0.041647427],"study_design_scores_gemma":[0.0021234911,0.043532003,0.0026219385,0.0003337474,0.0016061319,0.00068222877,0.000788851,0.003916008,0.15115067,0.0013034169,0.79142946,0.00051203155],"about_ca_topic_score_codex":0.00015242152,"about_ca_topic_score_gemma":0.000010697494,"teacher_disagreement_score":0.76394796,"about_ca_system_score_codex":0.00019764852,"about_ca_system_score_gemma":0.0004894408,"threshold_uncertainty_score":0.99955136},"labels":[],"label_agreement":null},{"id":"W4404237783","doi":"10.1093/neuonc/noae165.0562","title":"EPID-26. STEREOTACTIC RADIOSURGERY FOR CRANIAL NERVE METASTASES: A SINGLE INSTITUTION EXPERIENCE","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Radiosurgery; Medicine; Radiology; Medical physics; Radiation therapy","score_opus":0.05668305401001557,"score_gpt":0.3472880838732518,"score_spread":0.2906050298632362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96512854,0.0030940557,0.0106560765,0.01065494,0.0060183373,0.0020469187,0.00014287236,0.0005381279,0.0017201557],"genre_scores_gemma":[0.9929397,0.000074095704,0.0031779278,0.0025424757,0.0006457066,0.0004132885,0.000054800294,0.00005443884,0.000097562035],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982236,0.00020577988,0.00041485237,0.0005513682,0.0001949869,0.00040939564],"domain_scores_gemma":[0.9981494,0.0011670013,0.00008534887,0.0003207438,0.000068913774,0.00020862279],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035324736,0.00023525713,0.0005443221,0.00019049415,0.000120016644,0.000051815547,0.000080183876,0.00012754418,0.00019431964],"category_scores_gemma":[0.00053347094,0.00018833183,0.00029812346,0.0002746326,0.00016773892,0.00018910444,0.00004412677,0.00021576282,0.00009224496],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003808409,0.004112224,0.0013446906,0.0010732797,0.0011552194,0.022326695,0.0036019552,0.00006585334,0.37426662,0.009767396,0.03688765,0.54159],"study_design_scores_gemma":[0.0033755633,0.0054628607,0.00026241253,0.00009831035,0.0008634805,0.0037029523,0.00028132054,0.00083395094,0.020671546,0.00030050505,0.96391684,0.00023027726],"about_ca_topic_score_codex":0.00004328722,"about_ca_topic_score_gemma":0.000017410413,"teacher_disagreement_score":0.9270292,"about_ca_system_score_codex":0.00038143818,"about_ca_system_score_gemma":0.00046578777,"threshold_uncertainty_score":0.76799494},"labels":[],"label_agreement":null},{"id":"W4404237802","doi":"10.1093/neuonc/noae165.0569","title":"EPID-33. EPITHELOID SARCOMA IN A LONG-TERM SURVIVOR OF AN ATYPICAL TERATOID / RHABDOID TUMOR WITH RHABDOID TUMOR PREDISPOSITION SYNDROME","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Chromatin Remodeling and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Atypical teratoid rhabdoid tumor; Sarcoma; Pathology; Medicine; Term (time); Immunohistochemistry; Astronomy","score_opus":0.008175095435983533,"score_gpt":0.27334286161396504,"score_spread":0.2651677661779815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99672633,0.00091922795,0.0007446471,0.00032254518,0.0004324688,0.0004182604,0.00009730087,0.00006079433,0.00027844464],"genre_scores_gemma":[0.99799603,0.0000969274,0.00068542047,0.00059471116,0.0002381375,0.00009964998,0.00017893004,0.00006902696,0.000041147086],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99773735,0.00032867986,0.0005169713,0.0007699723,0.0002091072,0.00043793442],"domain_scores_gemma":[0.99904096,0.00009000912,0.00013305972,0.0004838284,0.00009278862,0.00015934248],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030508416,0.00030207244,0.00047072946,0.00014964219,0.000055932112,0.00003500926,0.0002970794,0.00018711624,0.00005552314],"category_scores_gemma":[0.00006361946,0.00026275156,0.00012261185,0.00024967696,0.0002084285,0.000019036323,0.00012038423,0.0003448401,0.000016417034],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012626954,0.00046478547,0.0074947686,0.00027490087,0.000057906745,0.001860987,0.0001259385,0.00026865417,0.97946966,0.000035415655,0.00018168986,0.008502579],"study_design_scores_gemma":[0.0051860046,0.019330652,0.07662603,0.00072131184,0.00018878264,0.018450307,0.00016904733,0.0073116487,0.861645,0.00020898411,0.008928622,0.0012336374],"about_ca_topic_score_codex":0.00005926785,"about_ca_topic_score_gemma":0.00051048485,"teacher_disagreement_score":0.1178247,"about_ca_system_score_codex":0.00011308388,"about_ca_system_score_gemma":0.00049812376,"threshold_uncertainty_score":0.9999825},"labels":[],"label_agreement":null},{"id":"W4404237883","doi":"10.1093/neuonc/noae165.1162","title":"TMET-24. MULTI-OMIC CHARACTERIZATION OF THE TEMPORAL METABOLIC ADAPTATIONS UNDERPINNING THERAPY RESISTANCE AND TUMOR RECURRENCE IN GLIOBLASTOMA","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; CancerCare Manitoba; University of Manitoba","funders":"","keywords":"Glioblastoma; Underpinning; Resistance (ecology); Neuroscience; Medicine; Biology; Cancer research; Ecology; Engineering","score_opus":0.021073900754398835,"score_gpt":0.2835700286311456,"score_spread":0.26249612787674675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98305374,0.013279255,0.0005250547,0.00078115857,0.001892487,0.00032104217,0.000047217734,0.000015051351,0.000084963554],"genre_scores_gemma":[0.991224,0.0071935006,0.0003296031,0.0006418887,0.00035573012,0.00006436256,0.000019972334,0.000023462602,0.00014751387],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99892116,0.00020290917,0.0002674378,0.00034514672,0.000083519146,0.00017982598],"domain_scores_gemma":[0.9995286,0.000044464097,0.00011744819,0.00022006694,0.000049495226,0.000039921644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017041332,0.00013301137,0.00021334493,0.000090385925,0.000057217538,0.000019586338,0.00015146004,0.000102414204,0.000006372757],"category_scores_gemma":[0.00009420535,0.00010934613,0.00006443283,0.00028517857,0.00014592559,0.0000112974285,0.0000688249,0.00017012317,0.0000014525915],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013229754,0.000047804144,0.00070456683,0.000016427286,0.000016645397,0.0000027669687,0.00028922976,0.000009009076,0.9777939,0.0002900283,0.00024824296,0.020449113],"study_design_scores_gemma":[0.00083586667,0.00017523037,0.024177795,0.000036318463,0.000020673315,0.000027819773,0.000060925253,0.00027990577,0.22610939,0.00005708837,0.74809176,0.0001272397],"about_ca_topic_score_codex":0.000025514466,"about_ca_topic_score_gemma":0.0006285407,"teacher_disagreement_score":0.7516845,"about_ca_system_score_codex":0.000017978817,"about_ca_system_score_gemma":0.0003090591,"threshold_uncertainty_score":0.4459006},"labels":[],"label_agreement":null},{"id":"W4404237915","doi":"10.1093/neuonc/noae165.0654","title":"IMMU-62. INVIGORATING EFFECTOR IMMUNE CELLS WITH HIGHLY SELECTIVE IL-2R AGONISTS AND POTENTIAL SYNERGY WITH TUMOR TARGETING THERAPEUTICS FOR TREATMENT OF GLIOBLASTOMAS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pharma Medica Research (Canada)","funders":"","keywords":"Effector; Immune system; Cancer research; Medicine; Immunology","score_opus":0.006984292440468937,"score_gpt":0.2409440363658122,"score_spread":0.23395974392534324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404237915","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97573143,0.020603694,0.00081469736,0.0003835704,0.0010106789,0.0010937898,0.00010947241,0.00015234917,0.00010029925],"genre_scores_gemma":[0.9976212,0.0008011901,0.0006455657,0.00017225614,0.00007702733,0.00024773245,0.00007160749,0.00009747029,0.00026595083],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99755627,0.00067153334,0.00052044314,0.00058513344,0.000060872968,0.0006057325],"domain_scores_gemma":[0.9976418,0.0016032327,0.0002976268,0.00026950613,0.00015916413,0.00002867953],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000251209,0.0004609015,0.0008814442,0.0002303697,0.0003478684,0.00004716296,0.00017292309,0.00028528305,0.000032151824],"category_scores_gemma":[0.000031470296,0.00031743702,0.00015628815,0.0002873448,0.000570679,0.00013186438,0.00004931374,0.00027208752,0.000018466057],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012008594,0.00039009485,0.00006458726,0.00010761743,0.0013456712,0.00014004565,0.001954765,0.00006720832,0.96218157,0.00014212109,0.00010564683,0.02149208],"study_design_scores_gemma":[0.004455177,0.0284718,0.00021779766,0.00008978195,0.0003567104,0.0007712056,0.0003303977,0.000117662996,0.863435,0.000017319799,0.101429306,0.0003078697],"about_ca_topic_score_codex":0.00011534924,"about_ca_topic_score_gemma":0.000025403724,"teacher_disagreement_score":0.10132366,"about_ca_system_score_codex":0.00018312396,"about_ca_system_score_gemma":0.0004718584,"threshold_uncertainty_score":0.99992776},"labels":[],"label_agreement":null},{"id":"W4404238060","doi":"10.1093/neuonc/noae165.0243","title":"STEM-17. THE UROKINASE RECEPTOR AS A NOVEL IMMUNOTHERAPEUTIC TARGET IN BRAIN CANCERS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University of Toronto; McMaster University","funders":"","keywords":"Urokinase receptor; Receptor; Cancer research; Medicine; Oncology; Internal medicine; Biology","score_opus":0.01951022704912398,"score_gpt":0.28925094475637886,"score_spread":0.2697407177072549,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404238060","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93674207,0.012227071,0.0005294053,0.022733431,0.002660792,0.0012756776,0.00014222098,0.00010535068,0.023583954],"genre_scores_gemma":[0.9752043,0.000641612,0.00033093742,0.020335468,0.000641202,0.00035337394,0.00006745858,0.00008058937,0.0023450635],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.998481,0.00026345789,0.00026256588,0.0004865676,0.000117253716,0.00038918288],"domain_scores_gemma":[0.9992741,0.00019395055,0.000059187136,0.0003706213,0.000031328385,0.000070843285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004283467,0.00020214406,0.00019800372,0.00007137855,0.000078579724,0.000041611016,0.0003392634,0.00025688513,0.0002648301],"category_scores_gemma":[0.00007805858,0.00015820844,0.0001120085,0.00021738805,0.0001529433,0.000005135074,0.00012904494,0.0003830318,0.00011651706],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018648386,0.000056204248,0.000065512286,0.00002215156,0.000040536986,0.00004576981,0.0003806277,0.00005848344,0.96440756,0.00045477744,0.013366021,0.020915855],"study_design_scores_gemma":[0.00047210083,0.0007613764,0.000025943686,0.000014243746,0.000008141312,0.000089389345,0.000101862606,0.0001504065,0.28925058,0.00011687666,0.70887715,0.00013190821],"about_ca_topic_score_codex":0.00010951134,"about_ca_topic_score_gemma":0.00013536541,"teacher_disagreement_score":0.69551116,"about_ca_system_score_codex":0.00013518453,"about_ca_system_score_gemma":0.00076731323,"threshold_uncertainty_score":0.64515525},"labels":[],"label_agreement":null},{"id":"W4404238107","doi":"10.1093/neuonc/noae165.0019","title":"EPCO-20. MUTANT IDH INHIBITORS INDUCE LINEAGE DIFFERENTIATION IN IDH-MUTANT OLIGODENDROGLIOMA","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University Health Network; Princess Margaret Cancer Centre; Montreal Neurological Institute and Hospital","funders":"","keywords":"Oligodendroglioma; Mutant; Lineage (genetic); Biology; Genetics; Gene; Glioma; Astrocytoma","score_opus":0.02048866232450902,"score_gpt":0.3009695805885792,"score_spread":0.2804809182640702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404238107","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871095,0.0010800431,0.000017100629,0.0067942175,0.0022684922,0.00078326924,0.000031959764,0.00020397757,0.0017114705],"genre_scores_gemma":[0.99766266,0.0003213445,0.00006492497,0.0009589907,0.00060878694,0.0002119196,0.00008023326,0.00006608941,0.00002505773],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99757373,0.00019315643,0.00064261927,0.000684066,0.00034453484,0.00056187046],"domain_scores_gemma":[0.99872965,0.0005068499,0.000111553134,0.00035704378,0.00006353802,0.00023138494],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00023639706,0.00032762886,0.0006257076,0.00064699637,0.000069804206,0.000053763717,0.00011652481,0.0003645955,0.00021136053],"category_scores_gemma":[0.00019501589,0.0002673308,0.00019071621,0.0007657486,0.00007929743,0.00011878142,0.00012249574,0.00059774105,0.00027094572],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011572166,0.0014011665,0.019203616,0.00011731252,0.00011801691,0.012299055,0.00073575694,0.00001656164,0.93803364,0.0008527461,0.0014737406,0.02563265],"study_design_scores_gemma":[0.005344734,0.0024005587,0.02608277,0.00035434967,0.00042371269,0.0013605746,0.00021200646,0.0029712731,0.8754008,0.00021082464,0.084870525,0.00036789698],"about_ca_topic_score_codex":0.00006464114,"about_ca_topic_score_gemma":0.0001872884,"teacher_disagreement_score":0.083396785,"about_ca_system_score_codex":0.0006146332,"about_ca_system_score_gemma":0.00030236595,"threshold_uncertainty_score":0.9999779},"labels":[],"label_agreement":null},{"id":"W4404238114","doi":"10.1093/neuonc/noae165.1159","title":"TMET-21. METABOLIC PROFILING OF MENINGIOMA REVEALS NOVEL SUBGROUP-SPECIFIC BIOLOGIC INSIGHTS AND OUTCOME DEPENDENCIES","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Medical Imaging and Pathology Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Profiling (computer programming); Computational biology; Medicine; Biology; Computer science; Programming language","score_opus":0.08379690202335066,"score_gpt":0.353893869957009,"score_spread":0.27009696793365834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404238114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9467639,0.042912036,0.0005791812,0.0036257461,0.0013725747,0.00041841378,0.000015181318,0.00019150635,0.004121485],"genre_scores_gemma":[0.9896087,0.0019660348,0.0064285584,0.001444223,0.00029316076,0.00005059656,0.000013396269,0.000024133777,0.00017121094],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99804515,0.00020407024,0.0006180975,0.0005550809,0.0002130988,0.00036452847],"domain_scores_gemma":[0.99806905,0.0012787231,0.00012539615,0.0002629207,0.00010428343,0.00015960472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006121739,0.00024339186,0.00097060314,0.00032273002,0.00009686399,0.000012813973,0.00011945264,0.00025561516,0.000031856303],"category_scores_gemma":[0.0009224822,0.00016670335,0.00012358066,0.00036214534,0.00067659665,0.000058603975,0.00016060627,0.0005570925,0.00003050914],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007832392,0.00012653052,0.0550489,0.00022918356,0.00013659944,0.0009888645,0.0010229067,4.6382473e-7,0.92788696,0.006416207,0.0008581051,0.007206928],"study_design_scores_gemma":[0.006817435,0.0072073615,0.11887673,0.0004937465,0.0018628474,0.010890255,0.0025707362,0.0006160572,0.20111714,0.0039773313,0.644531,0.001039333],"about_ca_topic_score_codex":0.000010081831,"about_ca_topic_score_gemma":0.0000043568307,"teacher_disagreement_score":0.72676986,"about_ca_system_score_codex":0.000037447677,"about_ca_system_score_gemma":0.00010842504,"threshold_uncertainty_score":0.6797965},"labels":[],"label_agreement":null},{"id":"W4404239768","doi":"10.1093/neuonc/noae209","title":"Point/Counterpoint: The role of reirradiation in recurrent glioblastoma","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Counterpoint; Glioblastoma; Point (geometry); Medicine; Psychology; Cancer research; Mathematics","score_opus":0.010952364814358953,"score_gpt":0.2908120409110211,"score_spread":0.2798596760966621,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404239768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9757405,0.003115323,0.0000028494612,0.0144817205,0.0007520127,0.0004883084,0.00001042763,0.00004686772,0.0053619887],"genre_scores_gemma":[0.99888974,0.00027529986,0.00002678913,0.0005567536,0.0001259586,0.00009351477,0.000006680092,0.000015812959,0.000009451695],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990867,0.000104669474,0.00027851126,0.00022306734,0.00014055068,0.00016649882],"domain_scores_gemma":[0.99922913,0.00041911504,0.00005852977,0.00020741041,0.000035533434,0.000050305323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018018739,0.00010316234,0.00024065614,0.00018989887,0.00002025167,0.000010026365,0.00006563017,0.00007948378,0.00011691205],"category_scores_gemma":[0.000109534,0.00005996457,0.00009105314,0.00029396988,0.000053920267,0.000042688403,0.000035263725,0.00021138393,0.00008176598],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011396491,0.0019369985,0.021378295,0.00015120926,0.00016370721,0.0016311129,0.0030724595,0.000040858733,0.2462117,0.010442802,0.011328379,0.70250285],"study_design_scores_gemma":[0.002894734,0.008868832,0.024813589,0.00029847815,0.0002503557,0.0004894432,0.0006939395,0.0070916554,0.102124564,0.0026764933,0.8496466,0.00015129868],"about_ca_topic_score_codex":0.0000381665,"about_ca_topic_score_gemma":0.00022253979,"teacher_disagreement_score":0.8383182,"about_ca_system_score_codex":0.00021867559,"about_ca_system_score_gemma":0.00013936879,"threshold_uncertainty_score":0.24452841},"labels":[],"label_agreement":null},{"id":"W4404256899","doi":"10.1093/neuonc/noae165.0500","title":"DDDR-15. UTILIZING DEEP DOCKING AND ARTIFICIAL INTELLIGENCE FOR THE DISCOVERY OF NOVEL PARP1-SELECTIVE INHIBITORS FOR USE AGAINST BRAIN TUMORS","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Computational Drug Discovery Methods","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver Biotech (Canada)","funders":"","keywords":"Docking (animal); Computer science; Artificial intelligence; PARP1; Drug discovery; Computational biology; Neuroscience; Bioinformatics; Biology; Medicine; Poly ADP ribose polymerase","score_opus":0.08396599421269625,"score_gpt":0.36564170173414756,"score_spread":0.2816757075214513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404256899","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09223025,0.00021054652,0.9020544,0.0029002405,0.001591534,0.00085685705,0.00003169278,0.000072511044,0.000051923762],"genre_scores_gemma":[0.92470604,0.000021313881,0.07362807,0.0010972958,0.0003183523,0.00018885512,0.000005402503,0.000029040126,0.000005652853],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9979975,0.00022985367,0.00052834814,0.00066991366,0.00020964137,0.00036469754],"domain_scores_gemma":[0.97516835,0.024191326,0.00017227665,0.0002667634,0.00014380757,0.000057503792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011112854,0.00020400679,0.0003137807,0.00020451916,0.00021307588,0.00035390357,0.0005041575,0.000090504254,5.5706107e-7],"category_scores_gemma":[0.0019407361,0.00016538023,0.00016423978,0.00056107686,0.00021553486,0.0008627771,0.00037222952,0.00025568606,8.1536075e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016055407,0.00015182664,0.000045515553,0.000116332674,0.00006807388,0.000018458248,0.0033780846,0.061287776,0.079661086,0.25810948,0.00042156628,0.5965813],"study_design_scores_gemma":[0.00015528021,0.0004435593,0.00016592997,0.000050996765,0.000025195297,0.000040717012,0.00030413637,0.9357472,0.034821473,0.022177147,0.0058969506,0.00017140195],"about_ca_topic_score_codex":0.000018784855,"about_ca_topic_score_gemma":0.000059972794,"teacher_disagreement_score":0.87445945,"about_ca_system_score_codex":0.00012968197,"about_ca_system_score_gemma":0.0004503338,"threshold_uncertainty_score":0.674401},"labels":[],"label_agreement":null},{"id":"W4404256900","doi":"10.1093/neuonc/noae165.0279","title":"CSIG-30. EXPLORING THE ROLE OF CAPICUA (CIC) IN RESISTANCE MECHANISMS OF MEK INHIBITORS IN GLIOBLASTOMA","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Fungal Biology and Applications","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Glioblastoma; Resistance (ecology); Cancer research; Chemistry; Medicine; Biology; Ecology","score_opus":0.019683876283176607,"score_gpt":0.2775548213384806,"score_spread":0.257870945055304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404256900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904703,0.001121658,0.000025219844,0.0045619127,0.00029484183,0.00034687636,0.000010711852,0.000029319308,0.0031391685],"genre_scores_gemma":[0.999173,0.00013951832,0.00015110684,0.00023930494,0.00006562399,0.00017456072,0.0000019199836,0.000012411607,0.000042551896],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99905866,0.00012327512,0.00033288207,0.00022682601,0.000087188186,0.00017117],"domain_scores_gemma":[0.99903786,0.00062071835,0.00006392108,0.0002134586,0.000030689072,0.00003335698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027101018,0.000090804206,0.000281945,0.00016715858,0.000020677917,0.0000017454242,0.00011440253,0.00012059802,0.00003805725],"category_scores_gemma":[0.00015037022,0.00006733906,0.000051226903,0.00044034788,0.00013904415,0.00003500851,0.000052650983,0.00037038428,0.000017935155],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022431415,0.000110981135,0.0011485073,0.00006349338,0.000010705873,0.00007387022,0.0008974908,0.000012374158,0.9689635,0.023671761,0.00037300726,0.0044499827],"study_design_scores_gemma":[0.00057650503,0.0007793807,0.0025853561,0.00016058302,0.00003042521,0.00003235514,0.0011235671,0.000111250025,0.91889966,0.008834472,0.066795394,0.00007107802],"about_ca_topic_score_codex":0.000036022408,"about_ca_topic_score_gemma":0.00048615536,"teacher_disagreement_score":0.06642239,"about_ca_system_score_codex":0.00006994556,"about_ca_system_score_gemma":0.00013637404,"threshold_uncertainty_score":0.2746007},"labels":[],"label_agreement":null},{"id":"W4404256912","doi":"10.1093/neuonc/noae165.0887","title":"NCOG-05. HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN THE PHASE 2 FIREFLY-1 (PNOC026) TRIAL OF THE TYPE II RAF INHIBITOR TOVORAFENIB IN RELAPSED/REFRACTORY (R/R) PEDIATRIC LOW-GRADE GLIOMA (PLGG)","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal; McGill University Health Centre; Montreal Children's Hospital; Université Laval","funders":"","keywords":"Refractory (planetary science); Medicine; Quality of life (healthcare); Firefly protocol; Glioma; Health related quality of life; Phases of clinical research; Internal medicine; Oncology; Clinical trial; Cancer research; Biology; Disease","score_opus":0.05657136340757306,"score_gpt":0.39200850832082756,"score_spread":0.3354371449132545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404256912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9841646,0.0016269822,3.1899611e-7,0.009576342,0.0018520848,0.002208717,0.000049969047,0.000050014456,0.00047099264],"genre_scores_gemma":[0.99819165,0.00038920928,0.000014145429,0.0008162321,0.00036245285,0.000087350185,0.000019970417,0.000044031673,0.00007492591],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99409586,0.0024602253,0.0015566858,0.00054508203,0.00075793394,0.0005842388],"domain_scores_gemma":[0.9961169,0.0024103862,0.0004500355,0.0006865609,0.00010076909,0.00023536797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001645435,0.00028247482,0.0009899106,0.0005699531,0.00010641164,0.000011339731,0.00038317658,0.00030980993,0.00009840679],"category_scores_gemma":[0.0025570355,0.0001744163,0.00027242902,0.0022106927,0.0002596656,0.000081308805,0.00020262123,0.0013828679,0.000032711698],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.29233152,0.053142365,0.016545434,0.0034125864,0.000522758,0.008771376,0.013185526,0.000057876146,0.5280984,0.0006853648,0.047233682,0.036013078],"study_design_scores_gemma":[0.6775303,0.15755312,0.069113664,0.00083331054,0.00064608763,0.0009541258,0.0012461643,0.0007076681,0.037788797,0.0011029403,0.051529087,0.0009947239],"about_ca_topic_score_codex":0.0005202022,"about_ca_topic_score_gemma":0.00033158666,"teacher_disagreement_score":0.49030963,"about_ca_system_score_codex":0.00033778758,"about_ca_system_score_gemma":0.0025310165,"threshold_uncertainty_score":0.711249},"labels":[],"label_agreement":null},{"id":"W4404256951","doi":"10.1093/neuonc/noae165.0605","title":"IMMU-12. TRANSLATING COMBINED PD1 AND LAG3 INHIBITION FROM PRECLINICAL MODELS TO PATIENTS WITH REFRACTORY, DNA REPLICATION REPAIR DEFICIENT (RRD) GLIOBLASTOMA: AN IRRDC STUDY","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Hospital for Sick Children","funders":"","keywords":"Glioblastoma; Refractory (planetary science); Replication (statistics); Cancer research; DNA repair; Chemistry; Medicine; DNA; Biology; Virology; Biochemistry; Astrobiology","score_opus":0.03824706815394288,"score_gpt":0.3245622237392192,"score_spread":0.2863151555852763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404256951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952464,0.00013308799,0.00005832707,0.001461182,0.00022651748,0.0021479228,0.000048593498,0.00030501705,0.00037295735],"genre_scores_gemma":[0.99822485,0.0000150348205,0.00059990777,0.00051334937,0.00008713112,0.0003637999,0.0001408357,0.000050615723,0.0000044845806],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975574,0.00026320037,0.0005436948,0.0010432644,0.00033039076,0.000262028],"domain_scores_gemma":[0.9984098,0.00045600164,0.00011186199,0.00063565135,0.00012639385,0.0002602553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028072056,0.00024056454,0.00047104285,0.00017533486,0.00010927012,0.000040450952,0.000057113255,0.00015824445,0.00002232323],"category_scores_gemma":[0.0001053471,0.00018808103,0.00007935166,0.00023751873,0.0000557263,0.00017724565,0.000056069824,0.0002799894,0.000017072894],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017711535,0.06314564,0.46432742,0.00026303908,0.0010764337,0.002632149,0.026837029,0.0006349611,0.20715031,0.00069507986,0.0030584713,0.21246794],"study_design_scores_gemma":[0.036773413,0.16873378,0.7461362,0.0006299169,0.002408692,0.00011197625,0.0015559364,0.020012906,0.013162156,0.0007302543,0.008854574,0.00089022896],"about_ca_topic_score_codex":0.00015443588,"about_ca_topic_score_gemma":0.0005288313,"teacher_disagreement_score":0.28180876,"about_ca_system_score_codex":0.00020411279,"about_ca_system_score_gemma":0.00011612059,"threshold_uncertainty_score":0.7669722},"labels":[],"label_agreement":null},{"id":"W4404498282","doi":"10.1093/neuonc/noae247","title":"Phase 2 trial of veliparib, local irradiation, and temozolomide in patients with newly diagnosed high-grade glioma: a Children’s Oncology Group study","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute; Sidney Kimmel Comprehensive Cancer Center; School of Medicine and Public Health, University of Wisconsin-Madison; University of Texas MD Anderson Cancer Center; Weill Cornell Medical College; Texas Children's Hospital; McGill University; Johns Hopkins University; Department of Laboratory Medicine and Pathology, University of Washington; University of Washington; St. Jude Children's Research Hospital; Massachusetts General Hospital; Memorial Sloan-Kettering Cancer Center; Syracuse University; Nationwide Children's Hospital; St. Baldrick's Foundation","keywords":"Veliparib; Temozolomide; Medicine; Internal medicine; Oncology; Radiation therapy; Interim analysis; Glioma; Chemotherapy; Clinical trial; Surgery; Poly ADP ribose polymerase; Cancer research; Biology","score_opus":0.012553696643349103,"score_gpt":0.29570241881858506,"score_spread":0.28314872217523596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404498282","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936674,0.0003324272,0.00001634656,0.0015798295,0.00070943247,0.0035189944,0.00004852702,0.00006645915,0.000060575378],"genre_scores_gemma":[0.998539,0.00006232536,0.00014856146,0.00032662303,0.00019788944,0.0005538761,0.00012499826,0.000045336514,0.0000014269691],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99753267,0.0004030274,0.0006877601,0.0006740923,0.00032397333,0.00037850952],"domain_scores_gemma":[0.9981855,0.0010209922,0.00018966213,0.0003112435,0.000076162665,0.00021645085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002686639,0.000301777,0.0009697414,0.0005389617,0.000054262375,0.000019181112,0.00009986982,0.00024047891,0.000036458514],"category_scores_gemma":[0.00018933819,0.00022960214,0.00007994818,0.00056131283,0.00021401538,0.00009784343,0.00007416554,0.00036041177,0.000011544519],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0741494,0.12836605,0.57732147,0.000098763696,0.0010372659,0.008159855,0.0027253167,0.00006105444,0.004578224,0.00043127825,0.0031513448,0.19992001],"study_design_scores_gemma":[0.4149075,0.10962285,0.47083318,0.000046694586,0.00070724654,0.000096551244,0.00020719857,0.00011739592,0.0005400763,0.000038780447,0.0027009014,0.00018163849],"about_ca_topic_score_codex":0.00060109684,"about_ca_topic_score_gemma":0.00077651127,"teacher_disagreement_score":0.3407581,"about_ca_system_score_codex":0.0004835891,"about_ca_system_score_gemma":0.0003627724,"threshold_uncertainty_score":0.9362903},"labels":[],"label_agreement":null},{"id":"W4404610971","doi":"10.1093/neuonc/noae165.1302","title":"LTBK-02. EVALUATION OF PAXALISIB IN GBM AGILE PHASE 3 REGISTRATION PLATFORM TRIAL FOR NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital; University of Toronto","funders":"","keywords":"Glioblastoma; Agile software development; Medicine; Computer science; Oncology; Internal medicine; Cancer research; Software engineering","score_opus":0.043452400168828856,"score_gpt":0.3679641266827876,"score_spread":0.32451172651395876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404610971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950432,0.00081452786,0.00041060522,0.0006629043,0.0010739178,0.0014302464,0.00004947931,0.00001489495,0.00050019956],"genre_scores_gemma":[0.99839467,0.00022856997,0.0001889677,0.0001398814,0.00042618692,0.00035705202,0.00021651632,0.000015902553,0.000032264776],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99880165,0.00014713929,0.00038375228,0.00034750398,0.00017065731,0.00014928654],"domain_scores_gemma":[0.99940544,0.00012344653,0.00013227333,0.00016048894,0.00012681604,0.00005151441],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077520515,0.00011692467,0.00017324327,0.000109246714,0.000031793617,0.000022289189,0.00007485472,0.00020794889,0.000020688629],"category_scores_gemma":[0.00089689484,0.000103481034,0.00006656818,0.00011848134,0.000063872874,0.00001503798,0.00003390484,0.00010281266,0.0000017437192],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010127354,0.00028107723,0.000012108298,0.00004933004,0.000017235356,0.0000062844747,0.00013262009,0.000022951657,0.71689403,0.00037734097,0.008567053,0.2635126],"study_design_scores_gemma":[0.054404877,0.016346851,0.000035351324,0.0000456754,0.00007538152,0.000022148773,0.00010939325,0.00811702,0.6441396,0.00081290794,0.2756989,0.00019190919],"about_ca_topic_score_codex":0.000010864978,"about_ca_topic_score_gemma":0.0002468404,"teacher_disagreement_score":0.26713187,"about_ca_system_score_codex":0.000060353064,"about_ca_system_score_gemma":0.00035961444,"threshold_uncertainty_score":0.4219834},"labels":[],"label_agreement":null},{"id":"W4404611180","doi":"10.1093/neuonc/noae165.1301","title":"LTBK-01. PHASE 3 STELLAR STUDY SHOWS EFLORNITHINE IMPROVES OVERALL SURVIVAL (OS) AND PROGRESSION FREE SURVIVAL (PFS) IN PATIENTS WITH RECURRENT 2021 WHO ASTROCYTOMA, IDH-MUTANT GRADE 3","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; CancerCare Manitoba","funders":"","keywords":"Eflornithine; Astrocytoma; Mutant; Oncology; Progression-free survival; Overall survival; Internal medicine; Medicine; Cancer research; Biology; Glioblastoma; Genetics; Gene; Biochemistry; Enzyme","score_opus":0.012283294393354871,"score_gpt":0.29378386261228306,"score_spread":0.2815005682189282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404611180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903818,0.003569279,0.000041658383,0.00020820378,0.00407512,0.0013135055,0.00018244346,0.000033352524,0.00019468035],"genre_scores_gemma":[0.99658567,0.001109302,0.00015477971,0.00015837039,0.0015215656,0.0001375748,0.00018522002,0.000080464284,0.0000670324],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99693376,0.0004848857,0.00049433485,0.0010648776,0.0004370564,0.00058507075],"domain_scores_gemma":[0.99884045,0.000095012256,0.00015200852,0.00056458375,0.00011227366,0.00023569058],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004712622,0.0004365647,0.00062651245,0.00015079092,0.000099556295,0.00008308215,0.00031444014,0.00028141937,0.000038216025],"category_scores_gemma":[0.00015008655,0.00035208653,0.000095546595,0.00021322744,0.00015779815,0.000023045557,0.0004341513,0.0005215491,0.00000443373],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007894146,0.004112367,0.03428569,0.00015173903,0.00027157416,0.00022790254,0.0008688963,0.00001610118,0.73025656,0.00003638882,0.0025066917,0.21937197],"study_design_scores_gemma":[0.055125114,0.054963067,0.058674738,0.00021910199,0.00048179278,0.00009519485,0.000940528,0.00040463032,0.060670823,0.00010129665,0.76663494,0.0016887638],"about_ca_topic_score_codex":0.00003608735,"about_ca_topic_score_gemma":0.0013600431,"teacher_disagreement_score":0.76412827,"about_ca_system_score_codex":0.000075748656,"about_ca_system_score_gemma":0.00032344292,"threshold_uncertainty_score":0.9998931},"labels":[],"label_agreement":null},{"id":"W4405495024","doi":"10.1093/neuonc/noae230","title":"Molecular classification predicts response to surgery and radiotherapy","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Cancer Institute","keywords":"Neurosurgery; Medicine; Library science; Family medicine; Gerontology; General surgery; Surgery","score_opus":0.036492437577884354,"score_gpt":0.3216921471036243,"score_spread":0.28519970952574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405495024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95870477,0.0010478667,0.0016349094,0.035227895,0.0006230626,0.00043743974,0.0000022812703,0.00020917054,0.0021125842],"genre_scores_gemma":[0.99591464,0.00006363559,0.00077943614,0.0027451757,0.00014398068,0.00007127979,0.000007138666,0.000028709108,0.00024600988],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988243,0.00025250897,0.00021496907,0.00035451146,0.00015799639,0.00019572672],"domain_scores_gemma":[0.998893,0.0006297779,0.000026912965,0.00024013579,0.000028970793,0.00018118047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006258427,0.0001074305,0.0002434904,0.00032512937,0.000034433495,0.00003102218,0.000045941324,0.000091982954,0.00004784613],"category_scores_gemma":[0.0002911099,0.0000962002,0.000056153673,0.0002647542,0.00004405026,0.000040478553,0.00003263257,0.00014131393,0.000049637412],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014772828,0.0000502669,0.00067553064,0.000068234076,0.00005119636,0.006555614,0.00040293715,0.000004419369,0.9070407,0.0007236037,0.03825964,0.04469055],"study_design_scores_gemma":[0.00055404275,0.0014931931,0.023277769,0.000057910507,0.00008193212,0.001317138,0.00006652525,0.0037387377,0.008341855,0.000046869118,0.9609044,0.00011958606],"about_ca_topic_score_codex":0.0000026904042,"about_ca_topic_score_gemma":3.6085046e-7,"teacher_disagreement_score":0.9226448,"about_ca_system_score_codex":0.00012661611,"about_ca_system_score_gemma":0.00018419953,"threshold_uncertainty_score":0.39229304},"labels":[],"label_agreement":null},{"id":"W4405595687","doi":"10.1093/neuonc/noae274","title":"Radiographic and visual response to the type II RAF inhibitor tovorafenib in children with relapsed/refractory optic pathway glioma in the FIREFLY-1 trial","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Children's Hospital; McGill University Health Centre; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"National Health and Medical Research Council; Perelman School of Medicine, University of Pennsylvania; Universitätsklinikum Heidelberg; Freie Universität Berlin; Humboldt-Universität zu Berlin; University of Pennsylvania; Region Hovedstaden; Deutsches Krebsforschungszentrum; Université de Montréal; Children's National Hospital; Rigshospitalet; Deutschen Konsortium für Translationale Krebsforschung; Great Ormond Street Hospital for Children; National Institute for Health and Care Research; Gentofte Hospital; Yonsei University; University of New South Wales; Cancer Institute NSW; Medical Research Council; Department of Health and Social Care; Seattle Children's Research Institute; Great Ormond Street Institute of Child Health; Newcastle University; Texas Children's Hospital; Medical School, University of Michigan; McGill University; McGill University Health Centre; Children's Hospital of Philadelphia","keywords":"Medicine; Glioma; Refractory (planetary science); Tolerability; Internal medicine; Oncology; Subgroup analysis; Surgery; Adverse effect; Cancer research; Confidence interval","score_opus":0.014594908283033897,"score_gpt":0.29364954422103867,"score_spread":0.2790546359380048,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405595687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9801619,0.001736735,3.8747214e-7,0.015328683,0.0005459215,0.0020391052,0.000008100136,0.000045434073,0.00013375634],"genre_scores_gemma":[0.99770445,0.00011694557,0.000028918785,0.0013795951,0.00035982317,0.00035471015,0.000010636329,0.00003426086,0.000010691105],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99783045,0.00077304384,0.0003287357,0.00047176838,0.00026363911,0.00033235145],"domain_scores_gemma":[0.99809873,0.0013979633,0.00005282253,0.00030595323,0.000030364712,0.000114147944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009145313,0.00022578445,0.00038914898,0.0005577982,0.00010772088,0.000043882003,0.000130748,0.00016832433,0.000025377414],"category_scores_gemma":[0.00035986936,0.000115980845,0.00007684338,0.001355259,0.00012989645,0.00005967898,0.00008525768,0.0005230648,0.00002344307],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3964716,0.010958979,0.11710891,0.0000928246,0.0008142307,0.031765543,0.016741412,0.00007549589,0.31347665,0.00063320284,0.017125076,0.0947361],"study_design_scores_gemma":[0.13335624,0.11118148,0.522138,0.00038439466,0.0006358403,0.0055558053,0.0008817519,0.00025554706,0.006918849,0.00006344729,0.21802689,0.0006017394],"about_ca_topic_score_codex":0.00006220415,"about_ca_topic_score_gemma":0.00018876875,"teacher_disagreement_score":0.40502912,"about_ca_system_score_codex":0.00014344256,"about_ca_system_score_gemma":0.00034094043,"threshold_uncertainty_score":0.47295618},"labels":[],"label_agreement":null},{"id":"W4405724778","doi":"10.1093/neuonc/noae269","title":"VGLL fusions define a new class of intraparenchymal central nervous system schwannoma","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; SickKids Foundation","funders":"Brain Tumour Charity","keywords":"Schwannoma; Pathology; Medicine; Biology","score_opus":0.025656764633169776,"score_gpt":0.2852317805831701,"score_spread":0.2595750159500003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405724778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.975807,0.0015064264,0.000100313904,0.005043097,0.0024600811,0.0005249153,0.000067553745,0.00041483587,0.014075764],"genre_scores_gemma":[0.99748117,0.00006963547,0.0006976785,0.000644637,0.00075613265,0.000024765306,0.00003302057,0.000062002604,0.00023094512],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.997568,0.00018586172,0.00073027425,0.00058319425,0.00033071038,0.00060192565],"domain_scores_gemma":[0.9983061,0.0004771039,0.0001373287,0.00048141234,0.00009357786,0.0005045023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014040279,0.000290799,0.0008019135,0.0003102658,0.00008291228,0.000038129565,0.00018920473,0.0002619903,0.00026264216],"category_scores_gemma":[0.00018657597,0.00024346476,0.00029494741,0.0005540992,0.00015937435,0.00009606026,0.00014425983,0.0005446067,0.00015357527],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005823445,0.00036769814,0.0028044176,0.00093211187,0.00013103125,0.014092014,0.000524249,0.000017397178,0.84423983,0.018298771,0.08150937,0.036500763],"study_design_scores_gemma":[0.0037116946,0.010103725,0.021556174,0.0009208997,0.00085476175,0.033622343,0.0007459519,0.0034091347,0.07592753,0.00013457482,0.8484623,0.0005509084],"about_ca_topic_score_codex":0.00012919198,"about_ca_topic_score_gemma":0.000027118125,"teacher_disagreement_score":0.7683123,"about_ca_system_score_codex":0.00019951559,"about_ca_system_score_gemma":0.0013364417,"threshold_uncertainty_score":0.9928205},"labels":[],"label_agreement":null},{"id":"W4405740627","doi":"10.1093/neuonc/noae271","title":"Hippocampal avoidance prophylactic cranial irradiation (HA-PCI) for small-cell lung cancer better preserves white matter networks compared to conventional PCI","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"KWF Kankerbestrijding; Vlaamse regering; Vlaamse Liga Tegen Kanker; Fonds NutsOhra","keywords":"Conventional PCI; Prophylactic cranial irradiation; Hippocampal formation; Neurocognitive; White matter; Hippocampus; Medicine; Neuropsychology; Neuroscience; Cardiology; Internal medicine; Cognition; Psychology; Radiology; Magnetic resonance imaging","score_opus":0.029815567915925222,"score_gpt":0.35491882690403387,"score_spread":0.32510325898810866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405740627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85036093,0.006829117,0.006233015,0.11865244,0.0065295417,0.007576598,0.00022106242,0.00034109314,0.0032562292],"genre_scores_gemma":[0.9809607,0.00014388683,0.0012760207,0.009304821,0.003193489,0.0028809963,0.0000823862,0.00009865311,0.0020589994],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99747634,0.0002293911,0.00045575792,0.00072940305,0.00038374934,0.000725383],"domain_scores_gemma":[0.9983215,0.00073183514,0.00010461524,0.0003084004,0.00027196825,0.0002617278],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032671876,0.00028896655,0.0005589748,0.00020815432,0.00017791968,0.00009016949,0.00022154597,0.00015410842,0.00077643665],"category_scores_gemma":[0.00013581103,0.00025586772,0.00019019237,0.0003152629,0.00013853975,0.0001478232,0.00017021822,0.0006232006,0.00012241155],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004692327,0.00046368176,0.24745142,0.004074461,0.00056824525,0.00041026963,0.0016764016,0.0033627623,0.0412689,0.000062975574,0.68780106,0.008167471],"study_design_scores_gemma":[0.012386344,0.0040051728,0.17932059,0.0006076754,0.0012049216,0.00026926378,0.00016493688,0.12226855,0.0018232228,0.00029747214,0.6767208,0.00093106495],"about_ca_topic_score_codex":0.000086510176,"about_ca_topic_score_gemma":0.00027181153,"teacher_disagreement_score":0.13059984,"about_ca_system_score_codex":0.00083166885,"about_ca_system_score_gemma":0.00069312326,"threshold_uncertainty_score":0.99998933},"labels":[],"label_agreement":null},{"id":"W4405815401","doi":"10.1093/neuonc/noae259","title":"The role of vorasidenib in the treatment of isocitrate dehydrogenase-mutant glioma","year":2024,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute; Sapienza Università di Roma; University of California, San Francisco; Sylvester Comprehensive Cancer Center, University of Miami Health Systems; Brigham and Women's Hospital","keywords":"Isocitrate dehydrogenase; Neurocognitive; IDH1; Glioma; Medicine; Mutant; Oncology; Radiation therapy; Chemotherapy; Internal medicine; Cancer research; Cognition; Biology; Psychiatry; Enzyme; Genetics; Gene","score_opus":0.041258751362526346,"score_gpt":0.36264464731136686,"score_spread":0.32138589594884054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405815401","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016243936,0.97917676,4.659382e-8,0.00082577596,0.00034332898,0.0021597557,0.00008620028,0.000017745662,0.0011464723],"genre_scores_gemma":[0.017268743,0.9814968,0.000010314689,0.00006496302,0.00015296684,0.0009062642,0.000036760048,0.000056076802,0.0000071287745],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972301,0.0006339953,0.0010386452,0.00043484132,0.00029986494,0.00036251318],"domain_scores_gemma":[0.9966639,0.0019717894,0.0004994816,0.00072565244,0.000059340513,0.0000798304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030322123,0.0004541737,0.0022078548,0.00026057792,0.000057506237,0.000015796875,0.0002902358,0.00033819824,0.000022191716],"category_scores_gemma":[0.00008011319,0.00019341946,0.0009784808,0.00068234146,0.00021520663,0.000014250207,0.000046663612,0.00030326835,0.00006197803],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007496259,0.002576071,0.00008106907,0.0018244805,0.0009993957,0.00370971,0.000711524,6.90538e-7,0.003986637,0.0009772525,0.00049290253,0.9845653],"study_design_scores_gemma":[0.0010281581,0.004058953,0.00000804893,0.0011837896,0.00529685,0.0009933972,0.0002188662,0.0000083210125,0.004812402,0.00022802631,0.982053,0.000110191104],"about_ca_topic_score_codex":0.00010357731,"about_ca_topic_score_gemma":0.00020443596,"teacher_disagreement_score":0.9844551,"about_ca_system_score_codex":0.00044536273,"about_ca_system_score_gemma":0.0008079329,"threshold_uncertainty_score":0.78874165},"labels":[],"label_agreement":null},{"id":"W4405923527","doi":"10.1093/neuonc/noae276","title":"A hitchhiker’s guide to cerebrospinal fluid biomarkers for neuro-oncology","year":2024,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"School of Medicine, Duke University; National Institutes of Health; Center for Clinical and Translational Science, Mayo Clinic; University of California, Los Angeles; Universitätsklinikum Heidelberg; University of Pennsylvania; Deutschen Konsortium für Translationale Krebsforschung; National Institute of Neurological Disorders and Stroke; National Institute of General Medical Sciences; Massachusetts General Hospital; National Cancer Institute; Center for Individualized Medicine, Mayo Clinic; University of Toronto; Deutsches Krebsforschungszentrum; David Geffen School of Medicine, University of California, Los Angeles; Pennsylvania State University","keywords":"Medicine; Internal medicine; Oncology; Clinical Oncology; Cancer","score_opus":0.05875035359369118,"score_gpt":0.4047582591843036,"score_spread":0.3460079055906124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405923527","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000070741466,0.96617514,0.00005266855,0.0111052,0.006881763,0.008539818,0.00046233815,0.00037450442,0.0063378206],"genre_scores_gemma":[0.000024370933,0.9787555,0.0025499791,0.0084172925,0.001938857,0.0069434596,0.00050258095,0.0004416124,0.0004263539],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99329793,0.0005584669,0.0020233185,0.0022311197,0.0004688416,0.0014203191],"domain_scores_gemma":[0.99419564,0.002601428,0.0005850874,0.0012929827,0.0002825151,0.001042331],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0005807612,0.0013852109,0.005472327,0.001258941,0.0001878067,0.00007747073,0.0006220931,0.0015014958,0.00028740906],"category_scores_gemma":[0.001340568,0.0010610267,0.0021800827,0.0011196748,0.00021402369,0.000059072587,0.00054667256,0.0010144587,0.0019615137],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023999841,0.00074679515,0.00000977298,0.0062011788,0.0010105004,0.0037493068,0.000050053208,4.6020824e-7,0.0014182937,0.00021578546,0.4149204,0.5714375],"study_design_scores_gemma":[0.0030864442,0.012064365,0.000006798065,0.0028866057,0.012426962,0.004537931,0.000032786695,0.000018404968,0.00013001196,0.000039853123,0.9641131,0.0006567293],"about_ca_topic_score_codex":0.00006338907,"about_ca_topic_score_gemma":0.00009078289,"teacher_disagreement_score":0.57078075,"about_ca_system_score_codex":0.0025626626,"about_ca_system_score_gemma":0.004172255,"threshold_uncertainty_score":0.99988985},"labels":[],"label_agreement":null},{"id":"W4406169707","doi":"10.1093/neuonc/noae242","title":"Development and validation of a molecular classifier of meningiomas","year":2024,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University of British Columbia; University Health Network","funders":"Division of Cancer Epidemiology and Genetics, National Cancer Institute; Moonshot Research and Development Program; National Cancer Institute; Canadian Institutes of Health Research; Cancer Moonshot; School of Medicine, University of North Carolina at Chapel Hill; Broad Institute; University of Oklahoma Health Sciences Center; NRG Oncology; University Health Network Foundation; Leidos; Vanderbilt University Medical Center; Princess Margaret Hospital Foundation; Deutsches Krebsforschungszentrum; National Institutes of Health; School of Medicine, Case Western Reserve University; Brain Tumour Charity; University of Oklahoma; Case Comprehensive Cancer Center, Case Western Reserve University; Center for Biomedical Informatics and Information Technology, National Cancer Institute; Deutschen Konsortium für Translationale Krebsforschung; University of Pennsylvania; Vanderbilt University; Congress of Neurological Surgeons; Pennsylvania State University; V Foundation for Cancer Research; University of Toronto; Case Western Reserve University; Faculty of Medicine, University of British Columbia; U.S. Department of Health and Human Services","keywords":"DNA methylation; Biology; Methylation; Exome; Exome sequencing; Cell cycle; Computational biology; Bioinformatics; Oncology; Cancer research; DNA; Cell; Genetics; Medicine; Gene; Mutation; Gene expression","score_opus":0.03588568600568398,"score_gpt":0.30792197312331504,"score_spread":0.27203628711763106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406169707","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842647,0.00037522774,0.0008840317,0.00081233424,0.00019884812,0.00022471556,9.2267896e-7,0.000030154417,0.013209117],"genre_scores_gemma":[0.9918621,0.0000065712593,0.007867472,0.00007226124,0.000021486108,0.000018124805,0.000008287816,0.000012980507,0.00013068368],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99914974,0.0000508328,0.00031593107,0.00019952189,0.00016746581,0.00011653699],"domain_scores_gemma":[0.9996136,0.000087444954,0.000069373265,0.00012643135,0.000045018976,0.000058154168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022560016,0.000083829524,0.0002514359,0.00019746865,0.000015128335,0.00000552948,0.00004056204,0.00007085697,0.00005127877],"category_scores_gemma":[0.00005377235,0.00007308265,0.000042231433,0.00017124899,0.000057326157,0.000030414509,0.00006379168,0.00008616595,0.0000075850553],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008143404,0.000065657856,0.00040781093,0.00032431274,0.00010175127,0.0013382671,0.001108528,0.0000035245612,0.9650893,0.004897094,0.00059105013,0.025991276],"study_design_scores_gemma":[0.00064443046,0.00072642206,0.0010689574,0.000084367864,0.00015720993,0.00037987652,0.00015935747,0.00037090594,0.83674234,0.00015068575,0.15944271,0.000072708506],"about_ca_topic_score_codex":0.0000025535467,"about_ca_topic_score_gemma":3.280957e-7,"teacher_disagreement_score":0.15885165,"about_ca_system_score_codex":0.000045147506,"about_ca_system_score_gemma":0.00015768272,"threshold_uncertainty_score":0.2980224},"labels":[],"label_agreement":null},{"id":"W4406278654","doi":"10.1093/neuonc/noaf008","title":"Disease stage-specific role of the mitochondrial pyruvate carrier suppresses differentiation in temozolomide and radiation-treated glioblastoma","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Health Sciences Centre; CancerCare Manitoba; Manitoba Beekeepers' Association; Research Institute in Oncology and Hematology; University of Manitoba","funders":"Genome British Columbia; University of Victoria; Natural Sciences and Engineering Research Council of Canada; Ottawa Hospital Research Institute; Manitoba Medical Service Foundation; Canadian Institutes of Health Research; Cancer Research Society; University of Ottawa; Health Sciences Centre Foundation","keywords":"Temozolomide; Glycolysis; Cancer research; Gene silencing; Mitochondrion; Warburg effect; In vivo; Medicine; Biology; Internal medicine; Glioblastoma; Cell biology; Metabolism; Biochemistry; Gene; Genetics","score_opus":0.007786239043487632,"score_gpt":0.2577072860093345,"score_spread":0.24992104696584688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406278654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949867,0.0010755744,0.0000030270267,0.0024538534,0.00044212124,0.0006989422,0.00006940176,0.00001995338,0.00025040135],"genre_scores_gemma":[0.9992735,0.00023212095,0.000013994344,0.00022923671,0.000059765312,0.00011236384,0.000023105895,0.000011367602,0.00004454121],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998978,0.00016756353,0.00028948302,0.00027251834,0.00012426867,0.00016812612],"domain_scores_gemma":[0.99912375,0.00034049846,0.00011623129,0.00027619957,0.000057290123,0.00008603881],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003515803,0.00013458508,0.0003110869,0.00018329988,0.000057907546,0.000012213228,0.00007098667,0.000093837865,0.00005582717],"category_scores_gemma":[0.00019108712,0.000095117684,0.00007221749,0.00028990593,0.00009710072,0.00004256259,0.00006581113,0.00012403415,0.0000019336837],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009825879,0.0005170304,0.5004347,0.000035002085,0.000052700878,0.000057420122,0.0001788313,0.00003775238,0.48895,0.0004425943,0.0010245543,0.0072868355],"study_design_scores_gemma":[0.005091385,0.00033506955,0.6661755,0.00004599219,0.00016673502,0.0000029390915,0.00009814685,0.00026834017,0.29475254,0.00023994266,0.032758486,0.0000649263],"about_ca_topic_score_codex":0.00006537981,"about_ca_topic_score_gemma":0.00014381802,"teacher_disagreement_score":0.19419745,"about_ca_system_score_codex":0.00012987564,"about_ca_system_score_gemma":0.00014638813,"threshold_uncertainty_score":0.38787866},"labels":[],"label_agreement":null},{"id":"W4406784536","doi":"10.1093/neuonc/noae281","title":"Metabolic profiling of meningioma reveals novel subgroup-specific biologic insights and outcome dependencies","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Cancer Institute; Canadian Institutes of Health Research; University of Toronto","keywords":"Metabolite; Internal medicine; Oncology; Subgroup analysis; High-performance liquid chromatography; Cohort; Metabolomics; Bioinformatics; Cancer research; Biology; Chemistry; Medicine; Meta-analysis; Chromatography","score_opus":0.056162312556043405,"score_gpt":0.32373493145011356,"score_spread":0.26757261889407014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406784536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.977116,0.0034224938,0.00087063434,0.0011081515,0.00057878223,0.0007500453,0.000004628275,0.00008093246,0.01606833],"genre_scores_gemma":[0.99167943,0.00013124685,0.0071283528,0.00057325984,0.000076683486,0.000060155624,0.000011812334,0.000014242406,0.00032484665],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99811107,0.00014964321,0.0007140578,0.00049815665,0.000194335,0.00033276054],"domain_scores_gemma":[0.99872696,0.0004190633,0.00023505536,0.00038945483,0.00012287522,0.00010658641],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044857553,0.00022889195,0.00086948526,0.00049488264,0.00010127769,0.0000152464545,0.00017392075,0.00020127666,0.000031109274],"category_scores_gemma":[0.00031051337,0.00017936243,0.000115650495,0.00047653756,0.00019202445,0.00006842709,0.00024620222,0.00026355824,0.000009998935],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002173752,0.00017334307,0.0448047,0.00014243406,0.000105708365,0.00042313855,0.00023678382,0.0000024079739,0.8978897,0.05302809,0.000318074,0.0026582628],"study_design_scores_gemma":[0.010710172,0.0039941072,0.24805358,0.0001892438,0.0010837349,0.0016706699,0.0017391769,0.0005162045,0.4330662,0.003917912,0.29431522,0.00074381614],"about_ca_topic_score_codex":0.000012153425,"about_ca_topic_score_gemma":0.0000036674262,"teacher_disagreement_score":0.46482348,"about_ca_system_score_codex":0.000060628845,"about_ca_system_score_gemma":0.00009244566,"threshold_uncertainty_score":0.7314187},"labels":[],"label_agreement":null},{"id":"W4406923721","doi":"10.1093/neuonc/noaf011","title":"Nanoparticle encapsulation enables systemic IGF-Trap delivery to inhibit intracerebral glioma growth","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; SNC-Lavalin (Canada); McGill University","funders":"","keywords":"Glioma; In vivo; Drug delivery; Cancer research; Medicine; U87; Pharmacology; Systemic administration; Chemistry; Biology","score_opus":0.014598613550200243,"score_gpt":0.27288309391589965,"score_spread":0.2582844803656994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406923721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98653924,0.0004259154,0.00023033639,0.005458829,0.0010507146,0.00094421033,0.000008887167,0.00023570262,0.005106169],"genre_scores_gemma":[0.99333864,0.00006597469,0.0003417968,0.00569722,0.00025128954,0.00010012646,0.000020601232,0.00003728847,0.00014705925],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975472,0.00021547412,0.00072359206,0.00059734785,0.00029033306,0.00062605465],"domain_scores_gemma":[0.9984778,0.00034339062,0.00013944395,0.00040434278,0.00030433104,0.00033070173],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00029347563,0.00029621756,0.00062699395,0.0005709779,0.00016678854,0.000036189092,0.00019775891,0.00033779332,0.000078729856],"category_scores_gemma":[0.0006198677,0.00027749446,0.00014629871,0.0010532109,0.00009977743,0.00022595636,0.00015691004,0.00040104988,0.00028616734],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006267675,0.0002757494,0.019279053,0.00015006975,0.00006186446,0.00028714814,0.00055403635,0.000014395307,0.9579775,0.0020771937,0.011676972,0.0070192753],"study_design_scores_gemma":[0.0044059204,0.0030432297,0.02618356,0.00019567464,0.00030895058,0.0006509794,0.00060820393,0.0005559179,0.938023,0.00059410254,0.02505102,0.00037945187],"about_ca_topic_score_codex":0.00012304736,"about_ca_topic_score_gemma":0.000030145644,"teacher_disagreement_score":0.019954486,"about_ca_system_score_codex":0.00042673288,"about_ca_system_score_gemma":0.0005643819,"threshold_uncertainty_score":0.9999677},"labels":[],"label_agreement":null},{"id":"W4407594521","doi":"10.1093/neuonc/noaf033","title":"The proteomic landscape of diffuse midline glioma highlights the therapeutic potential of non-histone protein methyltransferases","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto; University of New Brunswick; SickKids Foundation; Hospital for Sick Children","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research","keywords":"Methyltransferase; Methylation; Gene knockdown; Histone; Phosphorylation; Kinase; Epigenetics; Biology; Cancer research; DNA methylation; Cell biology; Protein kinase A; Proteomics; Chemistry; Biochemistry; DNA; Apoptosis; Gene expression; Gene","score_opus":0.011196170626314053,"score_gpt":0.29554985226223884,"score_spread":0.2843536816359248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407594521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97205096,0.0016620737,0.00010925431,0.022953715,0.00032553382,0.0022331125,0.000014839699,0.00002465964,0.0006258566],"genre_scores_gemma":[0.9985254,0.0002945727,0.000110334215,0.0004211766,0.00007659522,0.00048218464,0.000008178156,0.000019502031,0.00006204569],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99843013,0.0002811094,0.00051320874,0.0002720736,0.00023812096,0.00026534084],"domain_scores_gemma":[0.9984632,0.0005943445,0.00018643358,0.00054227706,0.00015712045,0.000056629033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024608543,0.00020092158,0.00055208505,0.00015547928,0.00016287484,0.000009174621,0.0002475139,0.00013501885,0.000037909052],"category_scores_gemma":[0.00009585276,0.00009875638,0.00022001874,0.0003768507,0.00034740337,0.000023083152,0.000053929823,0.00021071549,0.0000056127683],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010764237,0.001707037,0.0007621871,0.0000845288,0.00032772694,0.0001326748,0.00016312252,0.0000077012,0.98532754,0.001279392,0.0005485282,0.008583146],"study_design_scores_gemma":[0.006381497,0.002238313,0.013750577,0.0000730096,0.00063410524,0.00006116886,0.00008985515,0.00017674794,0.962334,0.00029737694,0.013884893,0.00007847083],"about_ca_topic_score_codex":0.00008699442,"about_ca_topic_score_gemma":0.00005473922,"teacher_disagreement_score":0.026474455,"about_ca_system_score_codex":0.00006126034,"about_ca_system_score_gemma":0.0002960985,"threshold_uncertainty_score":0.40271685},"labels":[],"label_agreement":null},{"id":"W4407676040","doi":"10.1093/neuonc/noaf020","title":"Unveiling spatial heterogeneity in medulloblastoma: A multi-omics analysis of cellular state and geographical organization","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; SickKids Foundation; Hospital for Sick Children","funders":"National Key Research and Development Program of China; Natural Science Foundation of Beijing Municipality; National Natural Science Foundation of China","keywords":"Biology; Transcriptome; Spatial organization; Stem cell; Progenitor cell; Computational biology; Progenitor; Evolutionary biology; Chromatin; Medulloblastoma; Cell type; Cellular differentiation; Genetics; Cell; Neuroscience; Gene; Gene expression","score_opus":0.011812771542231476,"score_gpt":0.2859893608720139,"score_spread":0.2741765893297824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407676040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99702656,0.0001807909,0.0017127481,0.00066554983,0.00009488817,0.0002657795,0.000013168535,0.000014454891,0.000026061125],"genre_scores_gemma":[0.99900925,0.00017374168,0.00040566444,0.00033358528,0.000008767522,0.000013571777,0.000043959946,0.000009163024,0.000002312471],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990176,0.00011670485,0.00033447202,0.00028502152,0.00009020211,0.00015600851],"domain_scores_gemma":[0.99935263,0.00021096025,0.00009606856,0.00016666832,0.00010343702,0.00007022729],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000117583484,0.00011154437,0.0005074773,0.0006856389,0.000030326912,0.000005667427,0.000042216736,0.00011927571,0.000025545618],"category_scores_gemma":[0.00019088207,0.00010164024,0.00007910432,0.0013567376,0.000083797735,0.000018155602,0.000065818356,0.00012139618,0.0000016958336],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008198677,0.00078761205,0.72394884,0.000022582068,0.0003787436,0.00012272199,0.00010232036,0.00034597985,0.2709667,0.000031843552,0.000009136132,0.0032015266],"study_design_scores_gemma":[0.004404944,0.0004722724,0.712109,0.000015933127,0.0015772618,0.000008555034,0.000043578617,0.0149626015,0.26580077,0.000011945622,0.00051808666,0.000074980184],"about_ca_topic_score_codex":0.0002515853,"about_ca_topic_score_gemma":0.0016403219,"teacher_disagreement_score":0.014616622,"about_ca_system_score_codex":0.000084504645,"about_ca_system_score_gemma":0.00010088191,"threshold_uncertainty_score":0.41447687},"labels":[],"label_agreement":null},{"id":"W4407743909","doi":"10.1093/neuonc/noaf043","title":"End-of-life care in glioblastoma: A population-based study","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Queen's University; University Health Network","funders":"Canadian Institutes of Health Research; Ministry of Health, Ontario","keywords":"Medicine; Palliative care; End-of-life care; Cohort; Retrospective cohort study; Socioeconomic status; Population; Emergency medicine; Health care; Ambulatory care; Cohort study; Internal medicine; Environmental health; Nursing","score_opus":0.06266760885602997,"score_gpt":0.41663574266437003,"score_spread":0.3539681338083401,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407743909","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932603,0.00096600846,0.000033992605,0.00079589535,0.00038946755,0.0006007282,0.000011735781,0.0000341306,0.003907696],"genre_scores_gemma":[0.9983417,0.000026683505,0.000308215,0.0011708429,0.00005432534,0.00004676526,0.000015020284,0.0000128227,0.000023663177],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986209,0.00022878566,0.0005037015,0.00026876453,0.00018693451,0.00019087511],"domain_scores_gemma":[0.9984575,0.00086160505,0.0001473862,0.00027993895,0.00018273278,0.000070838054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013299326,0.00013872937,0.0006560856,0.00042219585,0.000023455566,0.0000021249048,0.00011099129,0.00013390098,0.00006760764],"category_scores_gemma":[0.0010884738,0.00012994358,0.000090774585,0.0005492026,0.000056786645,0.000025829755,0.000047054804,0.00022412719,0.0000060560405],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010933605,0.0006876107,0.9806654,0.00019380219,0.00004184631,0.0001272545,0.0023193085,0.00012424079,0.0060457815,0.00012173268,0.00032518967,0.008254471],"study_design_scores_gemma":[0.018610734,0.011152885,0.82723206,0.00067861966,0.00033850892,0.000004414627,0.013824086,0.0004039096,0.022290405,0.000088582725,0.10510405,0.0002717413],"about_ca_topic_score_codex":0.0005499289,"about_ca_topic_score_gemma":0.0021980302,"teacher_disagreement_score":0.15343334,"about_ca_system_score_codex":0.00021301323,"about_ca_system_score_gemma":0.0008195142,"threshold_uncertainty_score":0.52989453},"labels":[],"label_agreement":null},{"id":"W4407814863","doi":"10.1093/neuonc/noaf047","title":"A molecular array for 10-second diagnosis of common spinal tumor types with picosecond infrared laser mass spectrometry","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Drug Policy Research Network; Ontario Institute for Cancer Research; St. Michael's Hospital; Canada Research Chairs; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Schwannoma; Meningioma; Medicine; Differential diagnosis; Paraganglioma; Radiology; Pathology","score_opus":0.011726473160360148,"score_gpt":0.2870683786378405,"score_spread":0.2753419054774804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407814863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857273,0.0006239258,0.00015629725,0.0017460416,0.00016976446,0.00095823384,0.000060085462,0.000034219098,0.010524138],"genre_scores_gemma":[0.994045,0.000026550335,0.0023167862,0.0027336886,0.00005146223,0.00061561423,0.00003481134,0.000029960582,0.00014610606],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99877447,0.00007173264,0.000340726,0.0003684349,0.00013606872,0.00030859854],"domain_scores_gemma":[0.9987429,0.00047700424,0.00017061437,0.0003638303,0.0001314561,0.00011421457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000948151,0.00021367893,0.00069888093,0.00031569775,0.000047103993,0.000011656801,0.00011826241,0.00011363186,0.000719153],"category_scores_gemma":[0.00014896732,0.00017139681,0.00015244799,0.0003586656,0.00011565168,0.000038257156,0.00003225458,0.00016249593,0.00001539743],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032524923,0.0035815423,0.16534138,0.00059515366,0.00090441614,0.001575034,0.0000820975,0.00002510231,0.80323356,0.0011791363,0.015721783,0.004508294],"study_design_scores_gemma":[0.0067362883,0.009370688,0.020769209,0.00011076294,0.0005197102,0.00006312693,0.000061745464,0.000015177608,0.889656,0.0006343318,0.07193141,0.00013153585],"about_ca_topic_score_codex":0.000010396605,"about_ca_topic_score_gemma":0.00006353952,"teacher_disagreement_score":0.14457217,"about_ca_system_score_codex":0.00015294527,"about_ca_system_score_gemma":0.00025891172,"threshold_uncertainty_score":0.78742206},"labels":[],"label_agreement":null},{"id":"W4408129593","doi":"10.1093/neuonc/noaf058","title":"Applications of artificial intelligence and advanced imaging in pediatric diffuse midline glioma","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"","keywords":"Glioma; Medicine; Artificial intelligence; Medical physics; Computer science; Cancer research","score_opus":0.01590989652841043,"score_gpt":0.3218934579429215,"score_spread":0.3059835614145111,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408129593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920078,0.0012900605,0.0010138189,0.0042645177,0.00011531496,0.0005622791,0.0000050075605,0.000022550661,0.0007186438],"genre_scores_gemma":[0.99810225,0.00049239874,0.00075066567,0.00038671689,0.00005240298,0.00019882689,0.000006376717,0.0000072272187,0.000003132417],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99918956,0.000038011814,0.00031858357,0.00024196846,0.00006544516,0.00014642041],"domain_scores_gemma":[0.99924976,0.0003808402,0.00007856711,0.00018017743,0.000056826964,0.000053846463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000072012655,0.000090909445,0.00026127364,0.00037400948,0.000027555157,0.0000039880833,0.00005399403,0.00005099311,0.000012222553],"category_scores_gemma":[0.00013195249,0.00008294168,0.000034988127,0.00056139275,0.00007130904,0.000025586047,0.000055779095,0.0001061949,0.000005216443],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017252401,0.0022811333,0.16876966,0.00009032906,0.000011666769,0.00022433682,0.00013936378,0.00002268297,0.21736123,0.0033727544,0.00011874064,0.6074356],"study_design_scores_gemma":[0.011072854,0.0025404948,0.34870714,0.00015961645,0.0011602561,0.0003556816,0.0012140201,0.0054896404,0.5600086,0.014415204,0.054317735,0.0005587896],"about_ca_topic_score_codex":0.000018403734,"about_ca_topic_score_gemma":0.00005374198,"teacher_disagreement_score":0.6068768,"about_ca_system_score_codex":0.00006212849,"about_ca_system_score_gemma":0.0001001241,"threshold_uncertainty_score":0.33822638},"labels":[],"label_agreement":null},{"id":"W4408245823","doi":"10.1093/neuonc/noaf046","title":"High-resolution proteomic analysis of medulloblastoma clinical samples identifies therapy-resistant subgroups and MYC immunohistochemistry as a powerful outcome predictor","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Université de Montréal; Children's & Women's Health Centre of British Columbia; BC Children's Hospital; University of Manitoba; Juravinski Cancer Centre; University of British Columbia; McMaster University Medical Centre; Dalhousie University; Hamilton Health Sciences; Centre Hospitalier Universitaire Sainte-Justine; McMaster University; Spinal Cord Injury BC; SickKids Foundation; BC Cancer Agency","funders":"Terry Fox Research Institute","keywords":"Medulloblastoma; Immunohistochemistry; Oncology; Biology; Internal medicine; Medicine; Cancer research","score_opus":0.024680752986722742,"score_gpt":0.3502271976136253,"score_spread":0.3255464446269026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408245823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943057,0.0016497889,0.000031596483,0.0024034665,0.000415666,0.00075372047,0.000069099064,0.00005678046,0.0003141871],"genre_scores_gemma":[0.9982017,0.000461439,0.00027046597,0.0006927249,0.00007023166,0.0001378496,0.00007456522,0.000017113467,0.000073899966],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9976914,0.0002308209,0.0010060396,0.0005477288,0.0002489064,0.00027513414],"domain_scores_gemma":[0.9979654,0.00083553005,0.00037123752,0.0005292976,0.00016590283,0.00013264004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040721704,0.00024100496,0.0011648424,0.00040376929,0.0000839512,0.000018177334,0.00014271724,0.00029635255,0.00015857976],"category_scores_gemma":[0.0005859286,0.00019655724,0.00039051787,0.0005567722,0.00039044165,0.000041922805,0.000113752205,0.00026190456,0.000007648308],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019978117,0.0011408714,0.2700453,0.00006883425,0.0021882222,0.00012198734,0.00010102122,0.0000068187564,0.7211246,0.0002725037,0.0011092759,0.0018227451],"study_design_scores_gemma":[0.0068455753,0.0027162684,0.84141785,0.00006984667,0.0040093157,0.00003142519,0.00015006552,0.00013619493,0.13949005,0.00020305258,0.0047648116,0.00016556346],"about_ca_topic_score_codex":0.00034543037,"about_ca_topic_score_gemma":0.000060433835,"teacher_disagreement_score":0.5816345,"about_ca_system_score_codex":0.00022171295,"about_ca_system_score_gemma":0.00027896877,"threshold_uncertainty_score":0.8015372},"labels":[],"label_agreement":null},{"id":"W4408344009","doi":"10.1093/neuonc/noaf061","title":"Germline analysis of an international cohort of pediatric diffuse midline glioma patients","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; McGill University; McGill Genome Centre; Université de Montréal; McGill University Health Centre","funders":"Medical Research Future Fund; Australian Lions Childhood Cancer Research Foundation","keywords":"Germline; PALB2; Germline mutation; Carcinogenesis; Genetics; Cancer research; Medicine; Glioma; Exome sequencing; Biology; Cancer; Oncology; Gene; Mutation","score_opus":0.012607284383609597,"score_gpt":0.31591087409045465,"score_spread":0.30330358970684507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408344009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99742293,0.000056555255,0.000010735722,0.0007062404,0.0004215456,0.00029536514,0.00008823618,0.000017341925,0.0009810441],"genre_scores_gemma":[0.9987936,0.00014071792,0.00023486877,0.00036027146,0.00008161781,0.000033177916,0.00033072394,0.00000877584,0.00001623726],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99874777,0.000077869445,0.0005233684,0.00027611965,0.00024033728,0.00013453315],"domain_scores_gemma":[0.9987193,0.00027440174,0.0002569412,0.00032563973,0.00034035236,0.0000833627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010228286,0.000120063065,0.0006223917,0.0010964017,0.000018146267,0.0000029599762,0.00013336334,0.0001060193,0.00015694836],"category_scores_gemma":[0.00026953558,0.000091203605,0.00020302039,0.0011066432,0.00005531173,0.000041897594,0.00007188133,0.000087109205,0.0000029320993],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002744502,0.0069764797,0.96642274,0.000022688846,0.001384841,0.000104475985,0.00004515508,0.00003588693,0.017410325,0.000075426644,0.0003939459,0.0068536047],"study_design_scores_gemma":[0.005136095,0.0011651142,0.97066635,0.000005419355,0.0051152557,0.0000032938804,0.000009683331,0.00090073026,0.01466254,0.0000139068325,0.0022689658,0.00005262918],"about_ca_topic_score_codex":0.00006182312,"about_ca_topic_score_gemma":0.000046106983,"teacher_disagreement_score":0.0068009757,"about_ca_system_score_codex":0.000100008656,"about_ca_system_score_gemma":0.00010792701,"threshold_uncertainty_score":0.37191752},"labels":[],"label_agreement":null},{"id":"W4408762849","doi":"10.1093/neuonc/noaf079","title":"A multi-institutional phase 1 clinical trial exploring upfront multimodal standard of care and combined immunotherapies for newly diagnosed glioblastoma","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institutes of Health; ECOG-ACRIN Cancer Research Group; Mallinckrodt Pharmaceuticals; Society for Immunotherapy of Cancer; Regeneron Pharmaceuticals; Genentech; University of Pittsburgh; American College of Radiology Imaging Network; EMD Serono; International Association for the Study of Lung Cancer; Gilead Sciences; National Cancer Institute; Brigham and Women's Hospital; Daiichi Sankyo Europe; Sanofi; G1 Therapeutics; Celgene; Bristol-Myers Squibb; AstraZeneca; Bill and Melinda Gates Foundation; Amgen; University of Texas MD Anderson Cancer Center; Pfizer","keywords":"Medicine; Nivolumab; Regimen; Immunotherapy; Immune system; Oncology; Clinical trial; Internal medicine; Temozolomide; Adjuvant; Immunology; Chemotherapy","score_opus":0.06658925152181847,"score_gpt":0.39503148754060874,"score_spread":0.3284422360187903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408762849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924711,0.0013319757,0.0006650074,0.0012763634,0.0016080323,0.002327026,0.0001924212,0.000052131974,0.00007597173],"genre_scores_gemma":[0.9912825,0.00044113497,0.0065781474,0.00042807712,0.00016162074,0.0010387145,0.00004538473,0.000019207484,0.00000516911],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9983881,0.00013749635,0.00067768415,0.0003996151,0.00015213618,0.00024493877],"domain_scores_gemma":[0.9976533,0.0015807961,0.00017218273,0.00024147068,0.00023404957,0.00011818035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021425325,0.00021459877,0.00091739214,0.00018503625,0.00013234145,0.000012433621,0.00008104129,0.00017425139,0.000024718669],"category_scores_gemma":[0.0008333242,0.00017204417,0.00027741262,0.000118443626,0.00028014396,0.000064177555,0.000062288455,0.00017671105,0.0000014890882],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4157758,0.009183567,0.008232921,0.0002967014,0.0007643599,0.0005554293,0.0015457569,0.000034498396,0.051927015,0.00089775765,0.000998621,0.50978756],"study_design_scores_gemma":[0.77425057,0.084387384,0.005198462,0.00017030301,0.00067930797,0.000025053483,0.0009412279,0.0011357003,0.03243168,0.000041529645,0.10054409,0.00019470541],"about_ca_topic_score_codex":0.000026379874,"about_ca_topic_score_gemma":0.00016660559,"teacher_disagreement_score":0.5095929,"about_ca_system_score_codex":0.00019695872,"about_ca_system_score_gemma":0.0005881211,"threshold_uncertainty_score":0.70157576},"labels":[],"label_agreement":null},{"id":"W4409212271","doi":"10.1093/neuonc/noaf092","title":"Salvage therapies for first relapse of SHH medulloblastoma in early childhood","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Université de Montréal; Hospital for Sick Children; BC Children's Hospital; Université Laval; University of British Columbia; London Health Sciences Centre; University of Toronto; Western University; Nova Scotia Health Authority; Izaak Walton Killam Health Centre; Alberta Children's Hospital; University of Calgary; Children's Hospital of Western Ontario; Centre Hospitalier Universitaire Sainte-Justine; Dalhousie University","funders":"","keywords":"Medicine; Medulloblastoma; Hazard ratio; Vismodegib; Radiation therapy; Oncology; Proportional hazards model; Internal medicine; Chemotherapy; Salvage therapy; Cohort; Surgery; Pathology; Confidence interval","score_opus":0.011501372273330717,"score_gpt":0.28328866239599615,"score_spread":0.27178729012266545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409212271","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9828456,0.00079318625,0.00001261745,0.012625071,0.00034647918,0.00088146346,0.000014921745,0.000032677053,0.0024479774],"genre_scores_gemma":[0.9975229,0.00016532952,0.0003386668,0.0015686688,0.00004787338,0.00029801304,0.000008239103,0.00001772918,0.000032575048],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990298,0.000056862234,0.00032333896,0.0002652887,0.00009332138,0.00023139364],"domain_scores_gemma":[0.9987581,0.0007831807,0.00009168342,0.0002539709,0.00005722086,0.000055854107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011476001,0.00013763455,0.00047215048,0.00025069955,0.00004148415,0.000004730256,0.0000901776,0.00014948759,0.00003642643],"category_scores_gemma":[0.00024823687,0.00011296924,0.0001303288,0.00025270466,0.00007860164,0.00002949734,0.000042743704,0.0001410258,0.000009298813],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020886848,0.0112826815,0.63668996,0.00035663467,0.00081977627,0.0008773592,0.009302312,0.00003402655,0.18562947,0.012280736,0.021932552,0.118705794],"study_design_scores_gemma":[0.013227063,0.005077033,0.8248393,0.00016146696,0.00022626256,0.00003685624,0.0002683819,0.00003084732,0.05266761,0.000983402,0.10236429,0.00011747332],"about_ca_topic_score_codex":0.000047252983,"about_ca_topic_score_gemma":0.00030112217,"teacher_disagreement_score":0.18814935,"about_ca_system_score_codex":0.000110962894,"about_ca_system_score_gemma":0.00017456673,"threshold_uncertainty_score":0.46067518},"labels":[],"label_agreement":null},{"id":"W4410050820","doi":"10.1093/neuonc/noaf118","title":"Response Assessment in Neuro-Oncology (RANO) 2009–2025: Broad scope and implementation—A progress report","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"University of Colorado School of Medicine, Anschutz Medical Campus; National Cancer Institute; Faculty of Medicine and Health, University of Sydney; Faculty of Medicine and Health, University of Leeds; Advanced Accelerator Applications; University of California, San Francisco; Leids Universitair Medisch Centrum; University of Texas MD Anderson Cancer Center; National Institutes of Health; Eli Lilly and Company; Parker Institute for Cancer Immunotherapy; Aptitude Health; EMD Serono; Deutschen Konsortium für Translationale Krebsforschung; LEO Pharma; Universität zu Köln; Massachusetts General Hospital; Universitätsklinikum Köln; Alexion Pharmaceuticals; Cure Brain Cancer Foundation; Children's Hospital Colorado; Moffitt Cancer Center; Universiteit Leiden; Seagen; Agios Pharmaceuticals; Les Laboratories Pierre Fabre; AstraZeneca; Novocure; Department of Radiology and Biomedical Imaging, University of California, San Francisco; Amgen; Elekta; Universitätsspital Zürich; Erasmus Universiteit Rotterdam; Memorial Sloan-Kettering Cancer Center; University of Toronto; School of Medicine, Indiana University; Children's Healthcare of Atlanta; National Institute of Neurological Disorders and Stroke; Break Through Cancer; Aflac; U.S. Department of Defense; Bristol-Myers Squibb; University of Leeds; Dana-Farber Cancer Institute; Florida International University; Servier; Incyte; Pfizer; Università degli Studi di Torino; Virginia Commonwealth University; Gilead Sciences; Emory University; Brigham and Women's Hospital","keywords":"Scope (computer science); Variety (cybernetics); Medical physics; Clinical trial; Medicine; Engineering; Psychology; Computer science; Artificial intelligence; Pathology","score_opus":0.023350228916086173,"score_gpt":0.40557643795815995,"score_spread":0.3822262090420738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410050820","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9297765,0.0011784055,0.0000183535,0.06075555,0.0009778617,0.002136099,0.000020964955,0.000090170506,0.0050460994],"genre_scores_gemma":[0.9873461,0.0006293981,0.0015500372,0.008980292,0.00009391406,0.0011573001,0.000073327756,0.000040321866,0.00012929598],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99632347,0.00095616,0.0009561287,0.00087861775,0.00029088816,0.00059471437],"domain_scores_gemma":[0.9972713,0.0014726901,0.00030994834,0.0005501067,0.00016858461,0.00022739437],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010830584,0.00032912494,0.00086083484,0.00064638676,0.0001384923,0.000037504167,0.00013900868,0.00027484735,0.00025490343],"category_scores_gemma":[0.00045877064,0.00029942213,0.00011102655,0.0006451482,0.00023792837,0.00009991974,0.00023113261,0.000509057,0.000021497397],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032849405,0.0030388152,0.5989461,0.00010230519,0.00021244698,0.032615427,0.00041238774,0.000007968864,0.1620268,0.0008249665,0.035296593,0.16323128],"study_design_scores_gemma":[0.011564544,0.0041720406,0.49162915,0.00006164136,0.00026153694,0.0016031795,0.00038444472,0.00005846206,0.009983252,0.00010452294,0.4799984,0.00017880964],"about_ca_topic_score_codex":0.00014562199,"about_ca_topic_score_gemma":0.0004838863,"teacher_disagreement_score":0.44470182,"about_ca_system_score_codex":0.0008078931,"about_ca_system_score_gemma":0.0021060146,"threshold_uncertainty_score":0.9999458},"labels":[],"label_agreement":null},{"id":"W4410050909","doi":"10.1093/neuonc/noaf094","title":"Mind over microbes: targeting the gut–brain axis to improve treatment of pediatric low-grade glioma","year":2025,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Diet and metabolism studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Glioma; Medicine; Neuroscience; Psychology; Cancer research","score_opus":0.016342993199156,"score_gpt":0.29809387383277824,"score_spread":0.28175088063362225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410050909","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16769634,0.0049001984,0.000007488408,0.81303364,0.006356671,0.002381672,0.0002599949,0.000052526866,0.0053114407],"genre_scores_gemma":[0.005445951,0.0031869155,0.0009711607,0.9497004,0.029716332,0.0007013424,0.0002733772,0.0001761211,0.009828401],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99706286,0.0002965216,0.000766799,0.00080009946,0.0003374045,0.00073630654],"domain_scores_gemma":[0.9968555,0.0017893779,0.00040811888,0.0006721654,0.00016655218,0.00010831545],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021166028,0.0005833473,0.0016002444,0.0005230302,0.000121232406,0.000015816899,0.00030719108,0.00077484397,0.00015548393],"category_scores_gemma":[0.0006921905,0.00038080197,0.00051129586,0.00057193823,0.00016774899,0.000026328855,0.00024128227,0.0008767109,0.00007004583],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001512197,0.00031579105,0.00038830112,0.00028555607,0.00028949615,0.0009660597,0.0013177597,4.9081905e-7,0.17318004,0.0000034136483,0.81473196,0.008369887],"study_design_scores_gemma":[0.002416857,0.0023743324,0.0006320861,0.000032349308,0.0013711909,0.000027035387,0.00014320998,0.0000018372817,0.010111966,0.000013662785,0.98263264,0.00024284468],"about_ca_topic_score_codex":0.000105980915,"about_ca_topic_score_gemma":0.000017154392,"teacher_disagreement_score":0.16790064,"about_ca_system_score_codex":0.00027837386,"about_ca_system_score_gemma":0.0006115689,"threshold_uncertainty_score":0.9998644},"labels":[],"label_agreement":null},{"id":"W4410217009","doi":"10.1093/neuonc/noaf119","title":"Consortium trial demonstrates efficacy of selumetinib in pediatric low-grade glioma","year":2025,"lang":"en","type":"letter","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Selumetinib; Medicine; Glioma; Oncology; Internal medicine; Cancer research; Cancer","score_opus":0.02496946037831344,"score_gpt":0.31313543801832894,"score_spread":0.2881659776400155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410217009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6943782,0.00075924065,7.354981e-7,0.29734492,0.00222718,0.0023808118,0.0000740611,0.00007040708,0.002764459],"genre_scores_gemma":[0.624569,0.0017442094,0.00038455444,0.3605859,0.01041698,0.0010785174,0.0008726365,0.00018423464,0.00016395195],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99622357,0.0005993425,0.00125598,0.00084647717,0.00041983998,0.0006547619],"domain_scores_gemma":[0.99399036,0.004508321,0.0006162553,0.0006226913,0.0001354092,0.00012698182],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0002573547,0.0005274121,0.0019242543,0.0013132863,0.000040273746,0.000015243225,0.00027379626,0.0016266042,0.00016887784],"category_scores_gemma":[0.0010323974,0.00046465368,0.00048603697,0.0009462103,0.00019839179,0.00002865218,0.000116484334,0.0018975398,0.0000528129],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067459205,0.004318784,0.019334547,0.0007512223,0.00027601435,0.02365432,0.00007290659,0.000005240829,0.007823034,0.00002410527,0.9337698,0.0032240606],"study_design_scores_gemma":[0.20525469,0.008358789,0.009503872,0.0002745277,0.0033560272,0.0005254272,0.00002713664,0.000019234369,0.020385347,0.000065406864,0.75163555,0.0005939993],"about_ca_topic_score_codex":0.000063132145,"about_ca_topic_score_gemma":0.000024136061,"teacher_disagreement_score":0.19850877,"about_ca_system_score_codex":0.00026216335,"about_ca_system_score_gemma":0.0014769009,"threshold_uncertainty_score":0.99978054},"labels":[],"label_agreement":null},{"id":"W4410761938","doi":"10.1093/neuonc/noaf125","title":"Postoperative radiotherapy in subtotally resected recurrent WHO grade 1 meningiomas with intermediate-/high-risk molecular profiles","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Medizinischen Fakultät Heidelberg, Universität Heidelberg","keywords":"Medicine; Progression-free survival; Radiation therapy; Meningioma; Proportional hazards model; Internal medicine; Clinical endpoint; Retrospective cohort study; Grading (engineering); Oncology; Tumor progression; Surgery; Overall survival; Cancer; Clinical trial; Biology","score_opus":0.011924677539155184,"score_gpt":0.29274558824570135,"score_spread":0.2808209107065462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410761938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98573494,0.0005981795,0.0006965311,0.0068533295,0.00047143706,0.0015942096,0.000009112622,0.0001089028,0.0039333613],"genre_scores_gemma":[0.99507654,0.00011459188,0.002578286,0.0014051545,0.000069301,0.00030771174,0.00005403631,0.000045543282,0.00034884294],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9973243,0.0006442474,0.0005183269,0.0006925744,0.00030975352,0.00051080115],"domain_scores_gemma":[0.99879616,0.00026488648,0.00018389925,0.0004637585,0.00013999909,0.00015130622],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00034623293,0.00033059475,0.00074209005,0.00067204895,0.00009180878,0.00003430828,0.00023121055,0.00019002131,0.00008572008],"category_scores_gemma":[0.00024649908,0.00026201573,0.00009261436,0.0008388921,0.00019718503,0.00008236983,0.00011826349,0.00067271927,0.000010822472],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011481232,0.0016733219,0.050882835,0.0002543826,0.000932056,0.031792887,0.0055565014,0.00022911244,0.84457177,0.008692671,0.013774913,0.030158294],"study_design_scores_gemma":[0.06249794,0.074461766,0.35475478,0.0018635752,0.0013116155,0.0024109602,0.0028092435,0.008742381,0.34622663,0.0014004551,0.14140752,0.002113143],"about_ca_topic_score_codex":0.00012397987,"about_ca_topic_score_gemma":0.00010538242,"teacher_disagreement_score":0.49834517,"about_ca_system_score_codex":0.00043242532,"about_ca_system_score_gemma":0.00041678117,"threshold_uncertainty_score":0.9999832},"labels":[],"label_agreement":null},{"id":"W4411163591","doi":"10.1093/neuonc/noaf132","title":"Phase 3 randomized trial of high-dose methotrexate for young children with high-risk embryonal brain tumors: A report from the Children’s Oncology Group","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute; Canadian Institutes of Health Research; National Institutes of Health; Canada Research Chairs","keywords":"Methotrexate; Medicine; Internal medicine; Chemotherapy; Clinical endpoint; Phases of clinical research; Gastroenterology; Oncology; Surgery; Randomized controlled trial","score_opus":0.013146549451630617,"score_gpt":0.3143747379784106,"score_spread":0.30122818852677996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411163591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9745021,0.00037642586,0.00072340755,0.013708653,0.0012092524,0.008563409,0.00045766364,0.00008631045,0.0003728209],"genre_scores_gemma":[0.9883948,0.00017447607,0.0038545704,0.002766529,0.00083868473,0.0027662148,0.0010874334,0.00006070562,0.000056606084],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9950425,0.0018021067,0.0013441866,0.00092983287,0.00036268958,0.0005186641],"domain_scores_gemma":[0.98753405,0.009987747,0.0012355917,0.0008575186,0.00020521674,0.00017986729],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018685688,0.00046487348,0.0026331816,0.0002499452,0.0002082782,0.000023055998,0.00029786155,0.0003380064,0.00010437932],"category_scores_gemma":[0.0034793688,0.00027688986,0.00059004634,0.00037129264,0.0005352118,0.00006262043,0.00013452608,0.0005388463,0.000006060404],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.90954006,0.010408022,0.011682057,0.00001545597,0.0044286856,0.0010078663,0.0003174775,0.00001794138,0.011807478,0.0015915526,0.015094353,0.034089033],"study_design_scores_gemma":[0.9347356,0.01472348,0.031125994,0.00006780596,0.0050600525,0.00080225564,0.000042485564,0.00005961189,0.007855186,0.0013782397,0.003939826,0.00020947037],"about_ca_topic_score_codex":0.004724375,"about_ca_topic_score_gemma":0.0007769087,"teacher_disagreement_score":0.03387956,"about_ca_system_score_codex":0.0002918139,"about_ca_system_score_gemma":0.0009339126,"threshold_uncertainty_score":0.99996835},"labels":[],"label_agreement":null},{"id":"W4411321230","doi":"10.1093/neuonc/noaf145","title":"Glioportal: a comprehensive transcriptomic resource unveiling ligand-mediated mesenchymal transition in glioblastoma","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Research Foundation Singapore","keywords":"Mesenchymal stem cell; Biology; Cancer research; Transcriptome; Computational biology; Phenotype; Gene knockdown; Cell biology; Gene; Gene expression; Genetics","score_opus":0.014917777567835062,"score_gpt":0.28987392668638795,"score_spread":0.2749561491185529,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411321230","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9846054,0.0006451702,0.000029737013,0.011216618,0.0003569573,0.0008366958,0.000018091443,0.00013642036,0.0021549396],"genre_scores_gemma":[0.9937115,0.0001281989,0.00006636707,0.005789071,0.000075079624,0.00013402895,0.000053084987,0.00002910295,0.000013572179],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99811155,0.00019251466,0.00053908094,0.0005200644,0.00020141309,0.0004354069],"domain_scores_gemma":[0.99885505,0.0005330059,0.00008949856,0.00027444158,0.00009077973,0.00015723667],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012261138,0.00026415224,0.00069976796,0.00062606233,0.000075159485,0.000013851712,0.00009646705,0.00029120944,0.000050448412],"category_scores_gemma":[0.000087626715,0.00024744036,0.00018321403,0.0007884265,0.00012866837,0.000058350262,0.00002314424,0.00043382603,0.00003605139],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021206543,0.001767593,0.007879919,0.00011916133,0.00015761958,0.004924145,0.0019185464,0.00020489407,0.97045636,0.00021584086,0.0031373505,0.0070979316],"study_design_scores_gemma":[0.047077518,0.008501719,0.06325477,0.0007087121,0.0010265745,0.0011092547,0.004146219,0.005051001,0.5411851,0.0003103911,0.32694525,0.00068351656],"about_ca_topic_score_codex":0.0000717143,"about_ca_topic_score_gemma":0.00033656272,"teacher_disagreement_score":0.42927125,"about_ca_system_score_codex":0.00030726395,"about_ca_system_score_gemma":0.0003008896,"threshold_uncertainty_score":0.9999978},"labels":[],"label_agreement":null},{"id":"W4411358292","doi":"10.1093/neuonc/noaf146","title":"Cranial radiotherapy profoundly affects glia without inducing widespread cellular senescence","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"KWF Kankerbestrijding; ZonMw","keywords":"Senescence; Radiation therapy; Immunohistochemistry; Pathology; Biology; Medicine; Internal medicine","score_opus":0.01720059588350463,"score_gpt":0.31279402011934593,"score_spread":0.2955934242358413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411358292","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9780688,0.0010946715,0.004569363,0.005642116,0.0036106417,0.0014143604,0.000004847405,0.00038301066,0.0052121533],"genre_scores_gemma":[0.98638725,0.00036434192,0.0025082855,0.008957996,0.0006997835,0.000073929135,0.000012477019,0.00006365029,0.00093231234],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972132,0.00038589438,0.0004658822,0.0008507508,0.00035778992,0.0007264783],"domain_scores_gemma":[0.9980254,0.00065339595,0.00018721713,0.00071444554,0.00014983343,0.0002697112],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040376323,0.00039953494,0.000888785,0.00035362932,0.00022179657,0.000042503325,0.0003182462,0.0004303558,0.00013138044],"category_scores_gemma":[0.0005650831,0.00036837155,0.0001661734,0.0006889657,0.00032338756,0.00014114832,0.00009013147,0.00079495535,0.00006587407],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009339372,0.00034097937,0.05406739,0.00018606745,0.00007430773,0.0008833953,0.00063887093,0.000005089174,0.90116036,0.0003012129,0.0037808528,0.03762756],"study_design_scores_gemma":[0.009493037,0.003410906,0.028078875,0.000526513,0.00033688406,0.00073574454,0.0002869726,0.0012256026,0.5683977,0.00018976371,0.3866161,0.00070192065],"about_ca_topic_score_codex":0.00014902733,"about_ca_topic_score_gemma":0.00009499478,"teacher_disagreement_score":0.38283524,"about_ca_system_score_codex":0.00043357885,"about_ca_system_score_gemma":0.0011259797,"threshold_uncertainty_score":0.9998768},"labels":[],"label_agreement":null},{"id":"W4412356022","doi":"10.1093/neuonc/noaf165","title":"RANO seizure working group-Tumor-Related Epilepsy Assessment Tool (RANO-TREAT) to assess seizure control for glioma treatment trials and clinical practice","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Foundation; University of British Columbia; BC Cancer Agency","funders":"National Center for Advancing Translational Sciences; National Institutes of Health; National Cancer Institute; Cleveland Clinic; Medac; Eisai; Les Laboratories Pierre Fabre; LEO Pharma; Incyte; Novocure; Moffitt Cancer Center; Memorial Sloan-Kettering Cancer Center; Servier; Pfizer","keywords":"Cohort; Medicine; Glioma; Epilepsy; Post-hoc analysis; Clinical trial; Cohort study; Physical therapy; Internal medicine; Psychiatry","score_opus":0.07208005475233031,"score_gpt":0.4388090640026441,"score_spread":0.36672900925031376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412356022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90165246,0.0021487952,0.0030421086,0.06635413,0.0039689965,0.014540745,0.00019515096,0.00033611362,0.007761479],"genre_scores_gemma":[0.9761778,0.00053195003,0.007494626,0.012064697,0.0006127123,0.0027681293,0.00011497813,0.000081279446,0.00015379925],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9932863,0.0023198323,0.002000753,0.0012713238,0.00036710408,0.00075468945],"domain_scores_gemma":[0.97619593,0.021585036,0.00072762655,0.00069986616,0.00033940963,0.00045210382],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0030970818,0.0006259339,0.0028359445,0.00042489942,0.0003051972,0.000112649395,0.0001735394,0.0005776671,0.000078936595],"category_scores_gemma":[0.005254283,0.00047316923,0.0006871472,0.0005808589,0.0001312261,0.00013754009,0.00010420396,0.000489538,0.000024637719],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023805296,0.021531235,0.1410724,0.00024034808,0.009144354,0.0139801735,0.00044848572,0.00010288217,0.092536785,0.009930462,0.028977634,0.65822995],"study_design_scores_gemma":[0.10547762,0.023720106,0.03991144,0.00031169783,0.012121732,0.001371254,0.0004606114,0.0009952146,0.003643529,0.0003324221,0.81109077,0.0005636052],"about_ca_topic_score_codex":0.00007046191,"about_ca_topic_score_gemma":0.00007138665,"teacher_disagreement_score":0.78211313,"about_ca_system_score_codex":0.0009915885,"about_ca_system_score_gemma":0.00092753716,"threshold_uncertainty_score":0.999772},"labels":[],"label_agreement":null},{"id":"W4412654330","doi":"10.1093/neuonc/noaf150","title":"Erratum to: High-resolution proteomic analysis of medulloblastoma clinical samples identifies therapy-resistant subgroups and MYC immunohistochemistry as a powerful outcome predictor","year":2025,"lang":"en","type":"erratum","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Terry Fox Research Institute","keywords":"Medulloblastoma; Immunohistochemistry; High resolution; Oncology; Internal medicine; Medicine; Biology; Pathology; History","score_opus":0.025443729800560703,"score_gpt":0.3476445139960351,"score_spread":0.3222007841954744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412654330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97361714,0.00550248,0.00001596347,0.0038548196,0.01084188,0.0022302028,0.00073129055,0.000118758246,0.0030874473],"genre_scores_gemma":[0.970512,0.004925793,0.000588029,0.0032546006,0.001633261,0.0011236819,0.0029978673,0.00017447797,0.014790293],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9948085,0.00047597912,0.0020597822,0.0013836178,0.00067208556,0.0006000691],"domain_scores_gemma":[0.9958246,0.0010187759,0.0010685753,0.001254962,0.0004376249,0.00039549204],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0006281785,0.00072641106,0.003304321,0.0010952663,0.00013969911,0.000049729457,0.00040508737,0.001512711,0.0002745081],"category_scores_gemma":[0.0014700724,0.0006200534,0.00099402,0.001039642,0.0004968237,0.00005237996,0.00034749924,0.0012997604,0.000019586172],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044135856,0.0024564702,0.029969666,0.0005561447,0.008611991,0.0006875702,0.0002677421,0.000007179439,0.32702938,0.00008070774,0.6242725,0.0016470536],"study_design_scores_gemma":[0.012377767,0.01458586,0.52150583,0.0010308318,0.025497017,0.00014782879,0.0003102872,0.00014581242,0.024111828,0.00024969524,0.3988486,0.0011886754],"about_ca_topic_score_codex":0.0007081308,"about_ca_topic_score_gemma":0.00023128497,"teacher_disagreement_score":0.49153614,"about_ca_system_score_codex":0.00064020447,"about_ca_system_score_gemma":0.0013911724,"threshold_uncertainty_score":0.9997835},"labels":[],"label_agreement":null},{"id":"W4412690588","doi":"10.1093/neuonc/noaf164","title":"Point/counterpoint: Upfront BRAF inhibition for adult BRAF-mutant high-grade gliomas","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Université de Montréal; Sunnybrook Health Science Centre; Centre Hospitalier Universitaire Sainte-Justine","funders":"Medac; Servier; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Erasmus Universiteit Rotterdam; Springworks Therapeutics; Novocure; Alexion Pharmaceuticals; Eisai; Daiichi Sankyo Europe; Sanofi; GlaxoSmithKline; Pfizer","keywords":"Counterpoint; Mutant; Oncology; Medicine; Internal medicine; Cancer research; Biology; Psychology; Genetics; Gene","score_opus":0.012304426537141373,"score_gpt":0.29382266277975,"score_spread":0.28151823624260863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412690588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9216581,0.00038557642,0.0005026112,0.07021608,0.0017787283,0.0019601218,0.000099652294,0.00020135769,0.003197746],"genre_scores_gemma":[0.97743595,0.0001428235,0.00085062225,0.020318061,0.0003012931,0.0006532785,0.00015614225,0.000044764456,0.00009704376],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980142,0.00010894329,0.0005399138,0.0006263535,0.0002070268,0.0005035558],"domain_scores_gemma":[0.998397,0.00049222505,0.00017134918,0.00043553626,0.00032150967,0.00018236098],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015632425,0.00030672987,0.00067782373,0.000380347,0.00014686288,0.000029950943,0.00010148355,0.00027784516,0.00013162711],"category_scores_gemma":[0.000462968,0.0002619437,0.00025651336,0.00034273442,0.00011339257,0.00009484229,0.000089698755,0.0002452391,0.00009067674],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010997346,0.0036856022,0.0029155281,0.00023741488,0.0003537148,0.0021478287,0.0002882858,0.000012181483,0.85465664,0.023602411,0.08322509,0.027775567],"study_design_scores_gemma":[0.02750165,0.0073007075,0.0093463585,0.00034092928,0.0010222452,0.00089785986,0.00030045817,0.00068842404,0.64806944,0.0053125904,0.29881248,0.0004068463],"about_ca_topic_score_codex":0.00013264098,"about_ca_topic_score_gemma":0.00028471736,"teacher_disagreement_score":0.21558738,"about_ca_system_score_codex":0.0005668596,"about_ca_system_score_gemma":0.00030826236,"threshold_uncertainty_score":0.99998325},"labels":[],"label_agreement":null},{"id":"W4413859329","doi":"10.1093/neuonc/noaf140","title":"Preanalytical variables and analytes in liquid biopsy approach for brain tumors: A comprehensive review and recommendations from the RANO Group and the Brain Liquid Biopsy Consortium","year":2025,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; McGill University","funders":"University of California, San Francisco; University of Texas MD Anderson Cancer Center; Medac; Daiichi Sankyo Europe; National Cancer Institute; Servier; Universitat Autònoma de Barcelona; Università degli Studi di Torino; Universität Zürich; Umeå Universitet; Bar-Ilan University; McGill University; University of Leeds; ViewRay; Moffitt Cancer Center; Apollomics; Sidney Kimmel Comprehensive Cancer Center; Pfizer; Incyte; AstraZeneca; Novocure; Cancer Research UK; Boston Scientific Corporation; Karyopharm Therapeutics; Wayne State University; University of Illinois at Urbana-Champaign; Michigan State University; Amgen; College of Engineering, Michigan State University; Johns Hopkins University; Henry Ford Health System; Vrije Universiteit Amsterdam; Focused Ultrasound Foundation; University of Sussex; Alexion Pharmaceuticals; Eli Lilly and Company","keywords":"Liquid biopsy; Biopsy; Brain biopsy; Analyte; Medicine; Brain tumor; Medical physics; Pathology; Internal medicine; Chemistry; Chromatography; Cancer","score_opus":0.026180657650948704,"score_gpt":0.3238853874818349,"score_spread":0.2977047298308862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413859329","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001420789,0.9833896,0.0011111374,0.011164572,0.000131767,0.0027633542,0.0010491227,0.000008309711,0.00024001847],"genre_scores_gemma":[0.00006052551,0.98585075,0.001442149,0.010199994,0.00023965452,0.0008035138,0.0013384861,0.00003755282,0.00002739052],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99671656,0.001175125,0.0008093098,0.0008975035,0.00006972586,0.00033177846],"domain_scores_gemma":[0.99076486,0.008107935,0.0003881199,0.0005455908,0.00008661613,0.000106901156],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000898156,0.00044750873,0.0017227426,0.00008988384,0.00017300392,0.00006749038,0.00034613904,0.0004212287,0.000009359257],"category_scores_gemma":[0.0023567134,0.0002915779,0.00023385738,0.00024558837,0.00071489793,0.0000052219048,0.00057439506,0.0003943531,4.1761467e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006827362,0.0013545288,0.00010286463,0.07620512,0.0049085263,0.00011737354,0.00075240387,0.000015774585,0.010397338,0.03515499,0.23056376,0.63359994],"study_design_scores_gemma":[0.0016801968,0.0006755739,0.0000052137216,0.0016073134,0.0015822772,0.00021930008,0.00006403823,0.000067022156,0.000013864498,0.00017207106,0.99362016,0.0002929539],"about_ca_topic_score_codex":0.000116799725,"about_ca_topic_score_gemma":0.000088516266,"teacher_disagreement_score":0.7630564,"about_ca_system_score_codex":0.00004080502,"about_ca_system_score_gemma":0.00048248374,"threshold_uncertainty_score":0.9999536},"labels":[],"label_agreement":null},{"id":"W4413927588","doi":"10.1093/neuonc/noaf185.063","title":"DEVELOPING A NOVEL HUMAN MODEL OF MINIMAL RESIDUAL DISEASE IN GLIOBLASTOMA","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Computational Drug Discovery Methods","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Glioblastoma; Minimal residual disease; Residual; Cancer research; Computer science; Computational biology; Biology; Medicine; Internal medicine; Leukemia; Algorithm","score_opus":0.05322905011578462,"score_gpt":0.3661837462940857,"score_spread":0.3129546961783011,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413927588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.49846545,0.000020484265,0.4972757,0.0030707184,0.00021566899,0.00013897364,0.0000057176526,0.000040760842,0.00076652184],"genre_scores_gemma":[0.84487486,0.0000021436033,0.15370753,0.0013236704,0.000026612583,0.000028821207,0.0000013243791,0.000007563761,0.00002747842],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.998378,0.00025684614,0.00043963172,0.00045692132,0.00021087947,0.00025777004],"domain_scores_gemma":[0.9984574,0.000922933,0.00012307847,0.00033295192,0.000094087256,0.000069564674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004020219,0.00013255513,0.00027503513,0.00043067534,0.000060974053,0.000025404213,0.0007636271,0.00007029039,0.000001836248],"category_scores_gemma":[0.00038265626,0.00014645891,0.000056136327,0.0006781089,0.0000921161,0.0002218856,0.000719121,0.0001911067,0.000002563598],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018357199,0.00034799406,0.0012982179,0.000060430324,0.000013281415,0.00007925254,0.0006047016,0.25771165,0.11239006,0.6154457,0.00041618224,0.011448992],"study_design_scores_gemma":[0.0012023343,0.0002152116,0.013487493,0.00004838791,0.000009578241,0.0000064322307,0.000017239832,0.9212802,0.010056994,0.05226404,0.0012346503,0.00017743216],"about_ca_topic_score_codex":0.00001858297,"about_ca_topic_score_gemma":0.000068235575,"teacher_disagreement_score":0.66356856,"about_ca_system_score_codex":0.0002118211,"about_ca_system_score_gemma":0.0017424221,"threshold_uncertainty_score":0.5972421},"labels":[],"label_agreement":null},{"id":"W4413945759","doi":"10.1093/neuonc/noaf185.085","title":"CHILDHOOD CENTRAL NERVOUS SYSTEM TUMOURS IN A MAJOR CENTER IN GHANA: PRESENTATION AND OUTCOMES","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"","keywords":"Presentation (obstetrics); Central nervous system; Center (category theory); Medicine; Pediatrics; Surgery; Internal medicine","score_opus":0.00993748609862119,"score_gpt":0.28807498670040543,"score_spread":0.2781375006017842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413945759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871844,0.00023133484,0.0000022833792,0.0091829635,0.00041370597,0.0007676834,0.0000072803336,0.000030451049,0.0021799167],"genre_scores_gemma":[0.99848217,0.000026648644,0.00006844287,0.0012176752,0.00003082156,0.00012907274,0.00001619628,0.000010436361,0.000018555598],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99891984,0.00013144327,0.00028704724,0.00027988988,0.00009000511,0.00029174084],"domain_scores_gemma":[0.99951184,0.00019958444,0.000055381068,0.00013656974,0.000017700524,0.0000789208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007023694,0.0001297634,0.0004028562,0.0002973671,0.000024182245,0.000011167306,0.000045595287,0.000095789466,0.000009335228],"category_scores_gemma":[0.000080873084,0.00010636825,0.000049049086,0.00020935491,0.000030944426,0.00003948083,0.00004937473,0.0001575122,0.0000061996852],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009843484,0.0010408297,0.98794466,0.00007073603,0.000033681976,0.0011994448,0.00050238264,0.0000063344455,0.0012921564,0.0004705281,0.00046754463,0.0068732654],"study_design_scores_gemma":[0.008935963,0.0003012705,0.9875094,0.00010101902,0.00007304776,0.00010561954,0.0008116062,0.00011614667,0.0013318578,0.000018626093,0.0006377616,0.000057655838],"about_ca_topic_score_codex":0.00029170644,"about_ca_topic_score_gemma":0.0009965008,"teacher_disagreement_score":0.01129777,"about_ca_system_score_codex":0.00032019257,"about_ca_system_score_gemma":0.000101743135,"threshold_uncertainty_score":0.43375713},"labels":[],"label_agreement":null},{"id":"W4413970429","doi":"10.1093/neuonc/noaf200","title":"Glioblastoma tumor microtubes and brain fatty acid-binding protein: Path to directional infiltration","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Peroxisome Proliferator-Activated Receptors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"Neurosphere; Cancer research; Protein kinase C; Cell migration; Cell biology; Phosphorylation; Chemistry; Cell; Biology; Cellular differentiation; Gene; Biochemistry","score_opus":0.006785381770277491,"score_gpt":0.2610406630873003,"score_spread":0.2542552813170228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413970429","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945882,0.000100246165,0.0007090938,0.00259388,0.00043126225,0.0005788984,0.000023623033,0.000043527893,0.00093127636],"genre_scores_gemma":[0.9946954,0.000018843264,0.0013485473,0.0032140627,0.00022616194,0.00025160046,0.000033765555,0.00002423585,0.00018733459],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99865955,0.00019937173,0.00023924228,0.000518918,0.000094328985,0.00028857158],"domain_scores_gemma":[0.99947476,0.000050964576,0.00007562753,0.00019307868,0.00008730171,0.000118245945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016555864,0.00019648783,0.00020864846,0.0001526164,0.00016151856,0.000037094513,0.0001404443,0.00022947286,0.000023985725],"category_scores_gemma":[0.0004959627,0.00019931076,0.000051311057,0.0002374926,0.000091582544,0.000009872687,0.00018033439,0.00020945325,0.000016293756],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036151093,0.000077348544,0.002379687,0.000023625487,0.000034385277,0.000009608847,0.00004466405,0.000005440715,0.9883399,0.000059171532,0.004720045,0.003944583],"study_design_scores_gemma":[0.0005166095,0.0010329753,0.00033486696,0.00001656851,0.000007908617,0.00006780495,0.000045256395,0.000010698965,0.85951155,0.000025375404,0.13828368,0.00014672801],"about_ca_topic_score_codex":0.000006693484,"about_ca_topic_score_gemma":0.000048468573,"teacher_disagreement_score":0.13356364,"about_ca_system_score_codex":0.000084160165,"about_ca_system_score_gemma":0.00027478335,"threshold_uncertainty_score":0.8127657},"labels":[],"label_agreement":null},{"id":"W4414786598","doi":"10.1093/neuonc/noaf193.335","title":"P10.24.A TARGETING NON-GENETIC KINASE-DEPENDENT SIGNALING TO PREVENT GROUP 3 MEDULLOBLASTOMA RECURRENCE","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; University of Manitoba","funders":"","keywords":"Medulloblastoma; Hedgehog signaling pathway; Downregulation and upregulation; Signal transduction; Kinase; Sonic hedgehog; In vivo; Hedgehog","score_opus":0.017074041001101076,"score_gpt":0.3307893227200309,"score_spread":0.3137152817189298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414786598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9766443,0.0012093487,0.000815777,0.007900912,0.004699068,0.001712734,0.000014726927,0.00015406615,0.0068490896],"genre_scores_gemma":[0.98664397,0.0002503784,0.0024702272,0.008889004,0.0005535438,0.00042470283,0.000023622137,0.00003859857,0.00070595875],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99772984,0.00024664562,0.0005192719,0.0006833311,0.00023573895,0.0005851997],"domain_scores_gemma":[0.99866414,0.0004986876,0.000138897,0.00029106325,0.00010967111,0.00029752808],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00027382627,0.0002902285,0.000589683,0.00028377873,0.00014073987,0.000015974163,0.00022870193,0.00020066943,0.0005802691],"category_scores_gemma":[0.00018564859,0.0002787107,0.00014402214,0.00044842673,0.00007662887,0.00004030891,0.00020735516,0.00046929935,0.00019308426],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009065035,0.0013669183,0.0043690484,0.000119947676,0.00014034807,0.00081859017,0.0005219749,0.00019341949,0.89866954,0.00004864097,0.032995116,0.059849955],"study_design_scores_gemma":[0.0061592287,0.009843656,0.005474398,0.00024336891,0.0008128368,0.0002211971,0.00025999348,0.000509131,0.37662894,0.00022397847,0.5991838,0.00043946214],"about_ca_topic_score_codex":0.0000806977,"about_ca_topic_score_gemma":0.00009970948,"teacher_disagreement_score":0.5661887,"about_ca_system_score_codex":0.0005956869,"about_ca_system_score_gemma":0.0005064297,"threshold_uncertainty_score":0.9999665},"labels":[],"label_agreement":null},{"id":"W4414786640","doi":"10.1093/neuonc/noaf193.347","title":"P11.08.A CLINICAL OUTCOMES AND BIOMARKER SHIFTING OF BREAST CANCER BRAIN METASTASES - A SINGLE INSTITUTION EXPERIENCE","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Breast cancer; Univariate analysis; Medical diagnosis; Multivariate analysis; Retrospective cohort study; Disease; Stage (stratigraphy); Biomarker; Cancer; Biopsy","score_opus":0.06649048133591225,"score_gpt":0.41339939881573173,"score_spread":0.3469089174798195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414786640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.982747,0.0005830506,0.00029083167,0.014004835,0.00062948075,0.00039015026,0.000078768324,0.00003882016,0.0012370386],"genre_scores_gemma":[0.99247307,0.0001474328,0.0013501657,0.005838327,0.000048411734,0.000059342798,0.000012081814,0.000010279925,0.000060907587],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99839586,0.00031868686,0.000542556,0.00038212535,0.00013427931,0.00022651447],"domain_scores_gemma":[0.9982318,0.0011468672,0.00017747228,0.00024708465,0.00007951767,0.00011721203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041832164,0.00016488392,0.00063301064,0.00013614482,0.000078952515,0.000009907752,0.00006878342,0.000118957345,0.00012133675],"category_scores_gemma":[0.0007696379,0.00012393699,0.00014109409,0.00024643395,0.00042666006,0.00007246091,0.00011314254,0.0001603965,0.0000035131804],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007890595,0.0014894925,0.64437526,0.00010705093,0.00041800467,0.00030939656,0.00034085492,0.000003573804,0.0420503,0.0010614098,0.002426579,0.306629],"study_design_scores_gemma":[0.006729883,0.0013013337,0.88820255,0.00013314422,0.0006289859,0.000313831,0.00047359668,0.00013322114,0.004237035,0.000070363385,0.09761912,0.00015691586],"about_ca_topic_score_codex":0.00027387374,"about_ca_topic_score_gemma":0.00013284312,"teacher_disagreement_score":0.3064721,"about_ca_system_score_codex":0.000101846716,"about_ca_system_score_gemma":0.00033149996,"threshold_uncertainty_score":0.50540036},"labels":[],"label_agreement":null},{"id":"W4414786745","doi":"10.1093/neuonc/noaf193.353","title":"P11.14.A STEREOTACTIC RADIOSURGERY FOR OVARIAN CANCER BRAIN METASTASES: AN INTERNATIONAL RADIOSURGERY RESEARCH FOUNDATION RETROSPECTIVE STUDY","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Université de Sherbrooke","funders":"","keywords":"Radiosurgery; Retrospective cohort study; Radiation therapy; Proportional hazards model; Ovarian cancer; Cancer; Brain metastasis; Stage (stratigraphy)","score_opus":0.07695695061213587,"score_gpt":0.4343764193359165,"score_spread":0.3574194687237806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414786745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96559846,0.00014581223,0.00016625247,0.026068147,0.003189202,0.002871508,0.000075235395,0.00008229537,0.0018031059],"genre_scores_gemma":[0.99452007,0.000107651635,0.00026579367,0.0021939322,0.00053611794,0.0019837422,0.00015235455,0.000039470444,0.00020087732],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967719,0.0009277799,0.0005296135,0.0007874266,0.0005001731,0.00048315746],"domain_scores_gemma":[0.9956373,0.002751563,0.00017568172,0.00052949635,0.00072308275,0.00018288061],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020347044,0.00022980128,0.00067615253,0.0009063701,0.00027293348,0.00008875167,0.00019222898,0.00014437319,0.00039174315],"category_scores_gemma":[0.0023959475,0.000207239,0.00017837925,0.00066776306,0.00012667579,0.0002766873,0.00009696294,0.00041366817,0.000018324428],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035110316,0.01114006,0.7849357,0.00008012895,0.0024437446,0.0014114566,0.0013069452,0.00002049939,0.04538963,0.0044446215,0.044564687,0.10075147],"study_design_scores_gemma":[0.017542327,0.0066610053,0.65387547,0.000102603146,0.0008634613,0.00014808994,0.0013843274,0.0006901655,0.00558413,0.0011128429,0.31172287,0.00031270026],"about_ca_topic_score_codex":0.0003394381,"about_ca_topic_score_gemma":0.00043480634,"teacher_disagreement_score":0.26715818,"about_ca_system_score_codex":0.0017605274,"about_ca_system_score_gemma":0.0010032556,"threshold_uncertainty_score":0.8450961},"labels":[],"label_agreement":null},{"id":"W4414792234","doi":"10.1093/neuonc/noaf193.071","title":"OS09.5.A RECURRENT COPY NUMBER ALTERATIONS DRIVE IDH-MUTANT ASTROCYTOMA DEVELOPMENT AND PROGRESSION","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"","keywords":"Glioma; Astrocytoma; Tumor progression; Gene; Somatic cell; Anaplastic astrocytoma; PDGFRA; Disease","score_opus":0.01893816173263653,"score_gpt":0.3463564281134819,"score_spread":0.32741826638084537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414792234","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98636055,0.00030196484,0.00009199869,0.0071842386,0.00059365784,0.00082563,0.0000061438086,0.00006996882,0.004565867],"genre_scores_gemma":[0.99348676,0.0001265748,0.0043522674,0.0014366539,0.000073402254,0.0004209857,0.000045760607,0.000014077128,0.000043504613],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987751,0.00009174542,0.00032455585,0.00038352516,0.00015916477,0.0002658607],"domain_scores_gemma":[0.99925876,0.0002076591,0.00009055495,0.00018471487,0.000102492515,0.00015580907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008908304,0.00018086247,0.00034676533,0.00011410513,0.00018063694,0.000024024781,0.000051886753,0.000121953795,0.000108204105],"category_scores_gemma":[0.000085813954,0.00014105054,0.000049007398,0.00018134154,0.00007648784,0.00004028101,0.00010210643,0.00019939139,0.00007325949],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008478261,0.0032142326,0.20269929,0.000120873025,0.0003017456,0.0014435799,0.0013684978,0.000004391953,0.116146006,0.0030178414,0.017697081,0.65313864],"study_design_scores_gemma":[0.0062614703,0.0020294476,0.032729767,0.00027074147,0.0002490171,0.0003793785,0.00015419899,0.00013140719,0.30558437,0.0000894647,0.65194434,0.00017640897],"about_ca_topic_score_codex":0.0000027780286,"about_ca_topic_score_gemma":0.000042221312,"teacher_disagreement_score":0.6529622,"about_ca_system_score_codex":0.00028862958,"about_ca_system_score_gemma":0.00044600578,"threshold_uncertainty_score":0.5751874},"labels":[],"label_agreement":null},{"id":"W4414792320","doi":"10.1093/neuonc/noaf193.050","title":"OS05.2.A DECIPHERING THE LONGITUDINAL TRAJECTORIES OF GLIOBLASTOMA ECOSYSTEMS BY INTEGRATIVE SINGLE-CELL GENOMICS","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Glioblastoma; Transcriptome; Genomics; Tumor progression; Tumor microenvironment; Cell; Genome; Disease; Gene","score_opus":0.012389790786707575,"score_gpt":0.24498699842656246,"score_spread":0.2325972076398549,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414792320","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985579,0.0012410334,0.005528346,0.0002995979,0.0012809436,0.000306292,0.0000490635,0.000020397427,0.005695283],"genre_scores_gemma":[0.9986628,0.00019623937,0.00025048602,0.00037239137,0.00016848781,0.00003141982,0.000027453014,0.000028002058,0.0002626748],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99855083,0.00020748157,0.0004265716,0.00041489163,0.000100034784,0.0003001979],"domain_scores_gemma":[0.99907255,0.0001923333,0.00018154636,0.00036120342,0.0001346959,0.000057654615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018171243,0.00024404594,0.0003612402,0.000052162977,0.00012922712,0.000025959003,0.00041423275,0.0002749112,0.000014026301],"category_scores_gemma":[0.0001160744,0.00018867354,0.0001605626,0.00018033177,0.00024394473,0.0000053718186,0.0001124637,0.0002436466,0.0000034989848],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043236424,0.00025085465,0.002366209,0.000038611026,0.000068571775,0.000006046119,0.000273599,0.00007692485,0.9889314,0.000100959354,0.004296752,0.0031576701],"study_design_scores_gemma":[0.0007044918,0.0014331434,0.00007702414,0.000014534761,0.000045114197,0.000018320767,0.0003838657,0.00014420011,0.79845566,0.000034046283,0.19855615,0.00013343914],"about_ca_topic_score_codex":0.000093149676,"about_ca_topic_score_gemma":0.0010527371,"teacher_disagreement_score":0.1942594,"about_ca_system_score_codex":0.00010524312,"about_ca_system_score_gemma":0.00026014826,"threshold_uncertainty_score":0.7693884},"labels":[],"label_agreement":null},{"id":"W4414792344","doi":"10.1093/neuonc/noaf193.531","title":"P17.15.A ASSOCIATION OF PROTON PUMP INHIBITOR USE WITH OUTCOME OF PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"ATP Synthase and ATPases Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Temozolomide; Adverse effect; Radiation therapy; Clinical trial; O-6-methylguanine-DNA methyltransferase; Proton-pump inhibitor; Aldehyde dehydrogenase; Drug; Meta-analysis","score_opus":0.01038101766363703,"score_gpt":0.28790605452536744,"score_spread":0.2775250368617304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414792344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981801,0.000016138469,0.00016178533,0.00024545455,0.00008245176,0.00088575203,0.000063754946,0.000009541411,0.0003550075],"genre_scores_gemma":[0.99898463,0.000023636025,0.00023600446,0.00027957896,0.000050455215,0.00012137872,0.000057649293,0.00002038838,0.00022626636],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986118,0.00019511986,0.00033686153,0.00032108405,0.00026924265,0.0002658582],"domain_scores_gemma":[0.9987188,0.00021085686,0.00030599188,0.00030375086,0.00039816252,0.00006246518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014289805,0.00015159705,0.00032367997,0.00010524542,0.000042384505,0.000010102747,0.00016653497,0.00023021182,0.000015765818],"category_scores_gemma":[0.00058072776,0.00011725147,0.00006578728,0.000236114,0.00011632494,0.000010564622,0.00012734682,0.00016196202,0.0000026265573],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018690568,0.00045960527,0.68464047,0.000070593975,0.00008696272,0.00001309636,0.00002563465,0.000037353846,0.31065556,0.000011114912,0.00072191074,0.001408663],"study_design_scores_gemma":[0.0050980756,0.00780373,0.08474596,0.00003842628,0.00006490526,9.4082606e-7,0.000045955338,0.000022020531,0.85718644,0.000004862185,0.044831365,0.00015730225],"about_ca_topic_score_codex":0.00005087476,"about_ca_topic_score_gemma":0.00023648792,"teacher_disagreement_score":0.59989446,"about_ca_system_score_codex":0.00006952728,"about_ca_system_score_gemma":0.00029036668,"threshold_uncertainty_score":0.4781376},"labels":[],"label_agreement":null},{"id":"W4414792352","doi":"10.1093/neuonc/noaf193.562","title":"P17.46.B CLINICAL FEATURES AND MOLECULAR PROFILING USING NEXT GENERATION SEQUENCING AMONG GLIOMA PATIENTS: RETROSPECTIVE REVIEW FROM A QUATERNARY BRAIN TUMOUR CENTER IN CANADA","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Oligodendroglioma; Glioma; Astrocytoma; DNA sequencing; Molecular diagnostics; Methylation; Ependymoma; Glioblastoma","score_opus":0.040926911083442936,"score_gpt":0.32980325569837243,"score_spread":0.2888763446149295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414792352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99094605,0.0034670134,0.000010441772,0.003919572,0.0005365497,0.00095450645,0.000023052102,0.000014610394,0.00012820952],"genre_scores_gemma":[0.9884135,0.000666513,0.00044307357,0.010207762,0.00009907255,0.000058727557,0.00009083814,0.000018829158,0.0000016669245],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99801046,0.00043897616,0.00057209923,0.00053093623,0.0001885338,0.00025899537],"domain_scores_gemma":[0.99909395,0.00027532835,0.00018877062,0.0002124538,0.000113883456,0.00011560427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020402556,0.00019571828,0.0006379695,0.00012216168,0.000057893736,0.000018796753,0.000064335516,0.00012250693,0.000011955661],"category_scores_gemma":[0.0006872551,0.00015779055,0.00007635903,0.00024015008,0.000049566126,0.000082126215,0.00008830806,0.00034511884,8.1778546e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005809601,0.00019142918,0.81615746,0.00008617841,0.000068957575,0.0020941873,0.00004093337,0.0000081846765,0.1756998,0.000013604806,0.0016124089,0.0039687334],"study_design_scores_gemma":[0.00822036,0.00092931883,0.8985136,0.0024544722,0.0004788185,0.00012862537,0.0001636037,0.004629387,0.08326753,0.00007529786,0.000831937,0.0003070071],"about_ca_topic_score_codex":0.22791496,"about_ca_topic_score_gemma":0.24969457,"teacher_disagreement_score":0.09243227,"about_ca_system_score_codex":0.001828678,"about_ca_system_score_gemma":0.0010306458,"threshold_uncertainty_score":0.7772264},"labels":[],"label_agreement":null},{"id":"W4414792375","doi":"10.1093/neuonc/noaf193.512","title":"P15.22.B UNMASKING SOCIOECONOMIC INEQUITIES IN GLIOBLASTOMA CARE: A SYSTEMATIC REVIEW OF BARRIERS TO PALLIATIVE AND SUPPORTIVE SERVICES IN ASIA","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Psychosocial; Palliative care; Socioeconomic status; Quality of life (healthcare); Thematic analysis; Distress; MEDLINE; Checklist; Health equity","score_opus":0.03139480794895311,"score_gpt":0.3881658198020412,"score_spread":0.35677101185308807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414792375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9631461,0.03120827,0.0000064020255,0.0018339233,0.0001574514,0.0014587909,0.00002347705,0.00001533913,0.0021502562],"genre_scores_gemma":[0.9860096,0.008816197,0.00012335982,0.004812815,0.000019238034,0.0001771781,0.000006630427,0.000013750448,0.000021262498],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9981185,0.00032228042,0.0009166603,0.00029552326,0.000110825385,0.00023621754],"domain_scores_gemma":[0.99827355,0.0009089036,0.00034620715,0.00020009035,0.00016160634,0.000109656175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037353308,0.00018220667,0.0015401902,0.00039686068,0.000019101526,0.0000040648965,0.00012904067,0.00013005262,0.000046030244],"category_scores_gemma":[0.0012046086,0.00016616011,0.00008067526,0.00032424074,0.00011441502,0.00006472836,0.00011645221,0.00021198612,0.000004876835],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058551924,0.00008056857,0.22249897,0.6724222,0.00021780537,0.0002586975,0.095031925,0.000012834592,0.0071134665,0.0007454446,0.00034581785,0.0006867576],"study_design_scores_gemma":[0.0066843415,0.005046092,0.022366982,0.66005987,0.0011403088,0.00003332519,0.26100928,0.00018101047,0.03737036,0.00042675744,0.005126227,0.0005554169],"about_ca_topic_score_codex":0.00017828582,"about_ca_topic_score_gemma":0.00093782356,"teacher_disagreement_score":0.20013198,"about_ca_system_score_codex":0.00040181453,"about_ca_system_score_gemma":0.00057800626,"threshold_uncertainty_score":0.67758125},"labels":[],"label_agreement":null},{"id":"W4414792402","doi":"10.1093/neuonc/noaf193.231","title":"P05.26.B FLUOROPHORE ABUNDANCE VERSUS HISTOLOGICAL CELLULARITY IN FLUORESCENCE-GUIDED GLIOMA SURGERY","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Glioma; Fluorophore; Cell; Protoporphyrin IX; Anaplastic astrocytoma; Fluorescence; Astrocytoma; Gliosarcoma","score_opus":0.050919830117507406,"score_gpt":0.326479383981415,"score_spread":0.2755595538639076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414792402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9791446,0.0016156925,0.000009237199,0.010787506,0.002417552,0.0005569943,0.000005859374,0.00016435607,0.005298202],"genre_scores_gemma":[0.9975373,0.00025505168,0.00044096878,0.0013821915,0.00011879863,0.00017416744,0.000023493114,0.000026822947,0.000041182233],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975565,0.00030803503,0.00061904243,0.0006942368,0.0002468399,0.00057533634],"domain_scores_gemma":[0.9972645,0.0017733803,0.0001411671,0.00052063406,0.00010876187,0.00019157214],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031113368,0.00028932697,0.0009400077,0.00044658122,0.00010232872,0.00001609283,0.00017519838,0.0004045024,0.00017059235],"category_scores_gemma":[0.0011221387,0.0002502786,0.00024636797,0.0007720444,0.0002590374,0.00004872432,0.00013630341,0.00048112555,0.0001252702],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035363564,0.0048546186,0.24420798,0.00018941514,0.00018312901,0.030208025,0.00018379814,0.00001557009,0.5770404,0.0022475247,0.086672455,0.050660755],"study_design_scores_gemma":[0.02073835,0.0028325936,0.22571951,0.00023771066,0.0005216814,0.0006856342,0.00016270617,0.0004921858,0.32122195,0.00063239026,0.42614338,0.00061191584],"about_ca_topic_score_codex":0.00022565416,"about_ca_topic_score_gemma":0.0001406429,"teacher_disagreement_score":0.33947092,"about_ca_system_score_codex":0.0008612123,"about_ca_system_score_gemma":0.00062418985,"threshold_uncertainty_score":0.99999493},"labels":[],"label_agreement":null},{"id":"W4414792411","doi":"10.1093/neuonc/noaf193.112","title":"P01.32.B A RECURRENT SINGLE NUCLEOTIDE MUTATION IN TBR1 PROMOTES STEMNESS IN GROUP 4 MEDULLOBLASTOMA","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Microtubule and mitosis dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"European Commission","keywords":"Medulloblastoma; Transcriptome; Transcription factor; Mutant; Cerebellum; Phenotype; Downregulation and upregulation; Mutation; Gene","score_opus":0.009770740140287885,"score_gpt":0.2683114939061042,"score_spread":0.2585407537658163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414792411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99488556,0.0004096631,0.00034942784,0.000665922,0.00073715445,0.00050933775,0.00000951576,0.000018695946,0.0024147327],"genre_scores_gemma":[0.9981996,0.00016814667,0.0003439173,0.000898736,0.00009372076,0.00011351749,0.00009377571,0.000022494467,0.000066092114],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983868,0.0002639016,0.00041027367,0.00051397155,0.00007868547,0.00034636672],"domain_scores_gemma":[0.9994464,0.00007171695,0.00011039268,0.00026841625,0.000051796123,0.00005129227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022385514,0.00018886762,0.00027928667,0.00020328273,0.0000371716,0.000017626782,0.00021997353,0.00029559486,0.00001050947],"category_scores_gemma":[0.00018414589,0.00020217638,0.00006745455,0.0002961499,0.000078122546,0.0000071340414,0.0001645221,0.00023457537,0.000009348241],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023251658,0.0005947812,0.0028219782,0.000049627724,0.00001316731,0.00007195124,0.00019969909,0.000037483485,0.9425883,0.00016871972,0.00059209374,0.052629653],"study_design_scores_gemma":[0.004642349,0.003592201,0.006047951,0.0001704399,0.00004195783,0.0001116811,0.0006922789,0.0014642625,0.6921635,0.00044861727,0.2900766,0.0005480938],"about_ca_topic_score_codex":0.00005634979,"about_ca_topic_score_gemma":0.0039800894,"teacher_disagreement_score":0.28948453,"about_ca_system_score_codex":0.00011532227,"about_ca_system_score_gemma":0.00017979197,"threshold_uncertainty_score":0.8244513},"labels":[],"label_agreement":null},{"id":"W4414792454","doi":"10.1093/neuonc/noaf193.186","title":"P03.27.B FLUID-SUPPRESSED APTW IMAGING BEFORE AND AFTER SURGERY IN GLIOBLASTOMA: A PROOF-OF-CONCEPT FOR DETECTING INFILTRATIVE AND RESIDUAL TUMOR BEYOND CONTRAST ENHANCEMENT","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"","keywords":"Glioblastoma; Brain tumor; Magnetic resonance imaging; Contrast enhancement; Neuroimaging; Resection; Medical imaging","score_opus":0.011502625635285197,"score_gpt":0.3061267638836265,"score_spread":0.29462413824834127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414792454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97776663,0.00038637558,0.008239643,0.011345609,0.00013032656,0.0017756914,0.00002522757,0.0000550134,0.0002754598],"genre_scores_gemma":[0.9920608,0.00001666869,0.0044656075,0.0025026407,0.00007455807,0.00082657946,0.000008489865,0.000016454844,0.000028194358],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99864066,0.00008213181,0.0004908442,0.00038561097,0.00010735507,0.0002934189],"domain_scores_gemma":[0.9983428,0.0011260303,0.00013996573,0.00017975543,0.00010958801,0.00010187146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003574262,0.00016011884,0.0005193814,0.00020970604,0.000058371214,0.000013341753,0.000058746587,0.00006769984,0.000016888289],"category_scores_gemma":[0.00078507134,0.00014344382,0.00004600354,0.00020469127,0.00036194964,0.00006559193,0.00009175124,0.0002662337,2.3028022e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017338856,0.0005427965,0.032633606,0.00072785746,0.00006498696,0.00020248168,0.0020441262,8.643377e-7,0.7983288,0.0006515941,0.009249712,0.15381926],"study_design_scores_gemma":[0.0033809757,0.00134372,0.0038083857,0.0005233651,0.00016441011,0.00017427845,0.00054710417,0.0028201225,0.96701264,0.0018135491,0.018213661,0.0001977806],"about_ca_topic_score_codex":0.000022025699,"about_ca_topic_score_gemma":0.00009932707,"teacher_disagreement_score":0.16868383,"about_ca_system_score_codex":0.000064786815,"about_ca_system_score_gemma":0.00026038804,"threshold_uncertainty_score":0.5849469},"labels":[],"label_agreement":null},{"id":"W4414792521","doi":"10.1093/neuonc/noaf193.426","title":"P12.47.B MOLECULAR PROFILING OF GLIOMAS: INSIGHTS INTO RADIONECROSIS AND PSEUDOPROGRESSION THROUGH NEXT-GENERATION SEQUENCING","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; McGill University","funders":"","keywords":"Cancer; PTEN; Radiation therapy; Gene duplication; Proportional hazards model; Disease","score_opus":0.04435703932988823,"score_gpt":0.32481505474238676,"score_spread":0.28045801541249854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414792521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906761,0.0047263307,0.0004622426,0.0022832432,0.0003425493,0.00064286677,0.0000011868616,0.000046160076,0.00081930106],"genre_scores_gemma":[0.9908714,0.00057879015,0.007195672,0.001114843,0.00006581646,0.00012330171,0.000029488816,0.00001757896,0.0000030592325],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9987165,0.00014225424,0.00037896534,0.00040242902,0.00016854571,0.0001913587],"domain_scores_gemma":[0.9992241,0.00015377496,0.00014772582,0.00026244269,0.00013525152,0.00007666637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009875958,0.0001776289,0.00044778758,0.00020932138,0.00012089693,0.000019619274,0.000059271966,0.00019318881,0.000009264415],"category_scores_gemma":[0.00017030683,0.0001434645,0.00007992097,0.00038153786,0.00011635551,0.0001205558,0.00008087884,0.00015286116,0.0000026399023],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008208586,0.00027886155,0.006723939,0.0001160167,0.00008039616,0.00036044692,0.0006855636,0.000031637,0.97109216,0.0034162495,0.00017658432,0.01695603],"study_design_scores_gemma":[0.002358799,0.0009566282,0.000492998,0.00014445247,0.00024371603,0.000078965655,0.00021058199,0.0025168222,0.9885792,0.00061331154,0.0037128201,0.0000916648],"about_ca_topic_score_codex":0.000099406185,"about_ca_topic_score_gemma":0.000021705742,"teacher_disagreement_score":0.01748705,"about_ca_system_score_codex":0.00033887214,"about_ca_system_score_gemma":0.0002635982,"threshold_uncertainty_score":0.5850313},"labels":[],"label_agreement":null},{"id":"W4414792538","doi":"10.1093/neuonc/noaf193.423","title":"P12.44.A ADJUVANT CHEMORADIOTHERAPY WITH PROCARBAZINE, LOMUSTINE, AND VINCRISTINE (PCV) OR TEMOZOLOMIDE FOR 1P/19Q CO-DELETED ANAPLASTIC OLIGODENDROGLIOMA: A NETWORK META-ANALYSIS","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Temozolomide; Vincristine; Anaplastic astrocytoma; Hazard ratio; Dacarbazine; Radiation therapy; Oligodendroglioma; Progression-free survival; Lomustine","score_opus":0.04225360596508551,"score_gpt":0.33984166414267825,"score_spread":0.2975880581775927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414792538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9270823,0.019642243,0.010151199,0.027461842,0.0006700655,0.010225051,0.00040787543,0.0006824905,0.0036769372],"genre_scores_gemma":[0.9793761,0.00041386072,0.0106171705,0.0063581797,0.00032052828,0.0021344826,0.00021607544,0.00010136789,0.00046228245],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9969539,0.00018791498,0.00077164604,0.0010424056,0.00029306117,0.0007510808],"domain_scores_gemma":[0.99639916,0.002006721,0.00036636216,0.0006303423,0.00028185998,0.0003155304],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032307795,0.00059080747,0.0032614344,0.00061555946,0.0002218687,0.00004726768,0.00017763558,0.0002737134,0.0002206229],"category_scores_gemma":[0.00037403437,0.00037214952,0.0006193535,0.0019050428,0.00024181874,0.000062177714,0.00006007581,0.00028882048,0.0000070421015],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.057926405,0.010082647,0.07419203,0.0019807674,0.5289606,0.014453579,0.00068821263,0.006195862,0.10000393,0.0021040665,0.17037301,0.03303892],"study_design_scores_gemma":[0.046285346,0.026354978,0.015871594,0.000090177295,0.6143493,0.0020882708,0.00018885621,0.024930663,0.026694188,0.00018060402,0.24172533,0.0012407079],"about_ca_topic_score_codex":0.00007349877,"about_ca_topic_score_gemma":0.00070765737,"teacher_disagreement_score":0.08538872,"about_ca_system_score_codex":0.00023599577,"about_ca_system_score_gemma":0.00051256036,"threshold_uncertainty_score":0.99987304},"labels":[],"label_agreement":null},{"id":"W4414792733","doi":"10.1093/neuonc/noaf193.444","title":"P13.03.B MCM2 HIGHLIGHTS A SUBSET OF AGGRESSIVE MENINGIOMAS WITH ENHANCED PROLIFERATION","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immunohistochemistry; Transcriptome; Meningioma; Cell cycle; Cell; Gene; Intracellular","score_opus":0.014750046057824635,"score_gpt":0.2922900020745486,"score_spread":0.27753995601672393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414792733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9484256,0.00012838734,0.0013805783,0.0049207923,0.00039772625,0.000983185,0.0000035026649,0.000083167,0.04367708],"genre_scores_gemma":[0.99614084,0.000014123569,0.0018206423,0.0005160148,0.000097192526,0.00015622187,0.000034917586,0.00001861254,0.0012014356],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99847364,0.00014735553,0.00042040352,0.00040911802,0.00026049447,0.00028899725],"domain_scores_gemma":[0.9986764,0.00017591062,0.00046183402,0.0003734514,0.00021519943,0.00009716111],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016549244,0.00019443248,0.00053712126,0.00031402492,0.000085312524,0.000011988044,0.00012716326,0.00014125813,0.00008336742],"category_scores_gemma":[0.00019789797,0.00014772551,0.00007350775,0.00044265774,0.00011833172,0.000070272654,0.00007273818,0.00018542806,0.000027354923],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033368424,0.00053496595,0.003616212,0.00030243688,0.00033777268,0.0035833365,0.0013001626,0.000038450984,0.9587599,0.013911414,0.009443187,0.004835313],"study_design_scores_gemma":[0.007964223,0.0073998426,0.007689642,0.00037249722,0.0006454883,0.0006177946,0.0002884083,0.00052017526,0.90441173,0.00047727558,0.069331184,0.00028173762],"about_ca_topic_score_codex":0.000009059313,"about_ca_topic_score_gemma":0.000017118808,"teacher_disagreement_score":0.059887994,"about_ca_system_score_codex":0.000119261495,"about_ca_system_score_gemma":0.0003415584,"threshold_uncertainty_score":0.6024072},"labels":[],"label_agreement":null},{"id":"W4414792770","doi":"10.1093/neuonc/noaf193.041","title":"OS04.2.A FINAL CLINICAL AND MOLECULAR ANALYSIS OF THE EORTC RANDOMIZED PHASE III INTERGROUP CATNON TRIAL ON CONCURRENT AND ADJUVANT TEMOZOLOMIDE IN ANAPLASTIC GLIOMA WITHOUT 1P/19Q CODELETION.","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Temozolomide; Glioma; Isocitrate dehydrogenase; Anaplastic astrocytoma; Hazard ratio; Interim analysis; Population; IDH1","score_opus":0.02905064331493146,"score_gpt":0.3800105721582071,"score_spread":0.35095992884327565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414792770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99406284,0.0008845534,0.00015498589,0.002339446,0.0005777553,0.0017312559,0.000018454024,0.000013731271,0.00021696354],"genre_scores_gemma":[0.9984701,0.00030811797,0.000035759378,0.00090152817,0.000034587978,0.00020816972,0.000023067492,0.000010640128,0.000008020443],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9970049,0.0010335705,0.0010391446,0.00050588505,0.00019721792,0.00021926127],"domain_scores_gemma":[0.9965696,0.0025846648,0.00032896962,0.00031737902,0.0000784078,0.000120977806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007815475,0.0002284131,0.0019067918,0.0005434136,0.000052006988,0.000009981094,0.000094261515,0.00018519105,0.000027216494],"category_scores_gemma":[0.0014099607,0.00014640098,0.00037915318,0.00063065224,0.00061955466,0.000022132197,0.00011287251,0.0003332699,9.633584e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.87562406,0.006806473,0.06723142,0.00006630028,0.003375698,0.0010228797,0.000294148,0.00012785103,0.014963968,0.0022691363,0.0007331032,0.027484965],"study_design_scores_gemma":[0.95902884,0.0056776623,0.014589118,0.00016666167,0.007330819,0.00004010072,0.00006156575,0.008328783,0.0038448395,0.00010664137,0.00069781754,0.00012715744],"about_ca_topic_score_codex":0.00007486857,"about_ca_topic_score_gemma":0.0002793876,"teacher_disagreement_score":0.083404765,"about_ca_system_score_codex":0.00008833421,"about_ca_system_score_gemma":0.00019866157,"threshold_uncertainty_score":0.59700584},"labels":[],"label_agreement":null},{"id":"W4414799604","doi":"10.1093/neuonc/noaf193.251","title":"P07.05.A AWAKE CRANIOTOMY FOR ELOQUENT GLIOMA: A SINGLE CENTER COHORT REVIEW","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre hospitalier universitaire de Québec","funders":"","keywords":"Single Center; Perioperative; Craniotomy; Awake craniotomy; Resection; Cohort","score_opus":0.02501823637289909,"score_gpt":0.3330505212646943,"score_spread":0.30803228489179524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414799604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.67415124,0.04545598,0.00037312377,0.16402352,0.006873257,0.016683027,0.000165863,0.00050289975,0.0917711],"genre_scores_gemma":[0.9176944,0.005782319,0.0012306287,0.06943644,0.0004482182,0.0044889115,0.00023256171,0.000089137786,0.00059738534],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99831617,0.000114427865,0.00047179897,0.00051381957,0.00016575836,0.0004180242],"domain_scores_gemma":[0.99864906,0.00043137072,0.00012779562,0.00045998307,0.00016896485,0.0001627956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021600351,0.00023912304,0.00077407336,0.00017200479,0.00008952365,0.000013662964,0.000118768716,0.00015545604,0.00022617246],"category_scores_gemma":[0.00029352136,0.00019384419,0.00029097815,0.00031524702,0.00007104921,0.000030025143,0.000077185075,0.0001597845,0.000075812786],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037758518,0.009025469,0.07953934,0.0023044555,0.00081737264,0.0028105825,0.00008862751,9.1378746e-7,0.117717795,0.0021975026,0.6998444,0.0852759],"study_design_scores_gemma":[0.006276599,0.0015741386,0.0065647457,0.00076897664,0.00088493543,0.00046372836,0.000014904897,0.000012184707,0.011890552,0.0000809819,0.9713404,0.00012785259],"about_ca_topic_score_codex":0.000020636357,"about_ca_topic_score_gemma":0.000018921297,"teacher_disagreement_score":0.27149594,"about_ca_system_score_codex":0.00038132153,"about_ca_system_score_gemma":0.00023970261,"threshold_uncertainty_score":0.79047364},"labels":[],"label_agreement":null},{"id":"W4414799658","doi":"10.1093/neuonc/noaf193.014","title":"JS07.6.A AGE-APPROPRIATE MODELS OF PAEDIATRIC BRAIN TUMOURS REVEAL THE INFLUENCE OF AGE ON TUMOUR-IMMUNE INTERACTION.","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill Genome Centre; Jewish General Hospital","funders":"","keywords":"Immune system; CD8; Tumor microenvironment; Juvenile; Immunotherapy; Cytotoxic T cell; Major histocompatibility complex; Cancer; Genetically modified mouse","score_opus":0.01980280638120635,"score_gpt":0.30412466016659784,"score_spread":0.2843218537853915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414799658","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9809816,0.00054274,0.000048608905,0.010609796,0.0006854975,0.0006302315,0.0000112931775,0.00003567726,0.006454556],"genre_scores_gemma":[0.9937625,0.00041867694,0.00010212254,0.005111136,0.00009063148,0.00004511845,0.00000791076,0.000018959827,0.00044297823],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981845,0.00034165257,0.00070688885,0.00029005395,0.00022882072,0.00024806889],"domain_scores_gemma":[0.9978924,0.0010602614,0.00041019346,0.00046590425,0.00012590417,0.00004534512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059255864,0.00018239196,0.00056972733,0.00028008936,0.00006614518,0.0000074696804,0.0002877462,0.00015597994,0.000033490585],"category_scores_gemma":[0.00039579283,0.00013008577,0.0002302217,0.00061345665,0.00032617155,0.00007399718,0.0000903276,0.00051276345,0.0000058738183],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063365726,0.00036415184,0.000499415,0.00014160396,0.00012238508,0.00014336455,0.00074823765,0.0014254276,0.96325463,0.0005263679,0.0053533223,0.021084545],"study_design_scores_gemma":[0.031165127,0.017614221,0.32613915,0.0013995484,0.0012767882,0.00058226526,0.002189149,0.0019462793,0.4662622,0.0072765583,0.14323686,0.0009118732],"about_ca_topic_score_codex":0.00028423694,"about_ca_topic_score_gemma":0.000033500633,"teacher_disagreement_score":0.4969924,"about_ca_system_score_codex":0.00017542203,"about_ca_system_score_gemma":0.00039862504,"threshold_uncertainty_score":0.5304744},"labels":[],"label_agreement":null},{"id":"W4414799802","doi":"10.1093/neuonc/noaf193.274","title":"P08.06.B THE EGFL7-INTEGRIN Β2 AXIS: A NOVEL REGULATOR OF IMMUNE EVASION IN GLIOBLASTOMA","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"IONICS Mass Spectrometry (Canada)","funders":"","keywords":"Immune system; Glioma; Tumor microenvironment; Mass cytometry; Flow cytometry; Immunotherapy; Acquired immune system; Glioblastoma","score_opus":0.011449052611020425,"score_gpt":0.27236964154308785,"score_spread":0.26092058893206743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414799802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9656204,0.00975465,0.00019139932,0.0052878866,0.0065425285,0.0009839019,0.00002636959,0.00010681636,0.011486059],"genre_scores_gemma":[0.99559337,0.0003065108,0.000088403845,0.0015701945,0.00004304189,0.00012249664,0.000012231763,0.000031181353,0.0022325786],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973336,0.0006174456,0.000907443,0.0005064096,0.00006242984,0.0005727025],"domain_scores_gemma":[0.9973,0.0013018083,0.0003521055,0.0008902612,0.00013971276,0.000016083544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006789376,0.00029159436,0.000715966,0.00034465015,0.00014491254,0.000007940832,0.0008467476,0.0006897437,0.0004100676],"category_scores_gemma":[0.00055224646,0.00022365399,0.00020885472,0.00063249015,0.00075784954,0.000069051785,0.00051479606,0.0011519414,0.00024604416],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001037616,0.0004104739,0.0006448472,0.000039022703,0.00010494693,0.000015998383,0.00060589035,0.000044240933,0.97319174,0.0027143275,0.00846746,0.012723455],"study_design_scores_gemma":[0.0030070953,0.00063945266,0.004279282,0.000087693326,0.00004769539,0.00011590711,0.000396052,0.000020866788,0.59368736,0.00021025553,0.39736858,0.00013976046],"about_ca_topic_score_codex":0.00023963342,"about_ca_topic_score_gemma":0.00026309036,"teacher_disagreement_score":0.3889011,"about_ca_system_score_codex":0.00032800972,"about_ca_system_score_gemma":0.00046027984,"threshold_uncertainty_score":0.9120345},"labels":[],"label_agreement":null},{"id":"W4414799819","doi":"10.1093/neuonc/noaf193.070","title":"OS09.4.A EARLY TUMOR VOLUME CHANGES PREDICT CLINICAL OUTCOMES IN MIDH1/2 GLIOMA: POST-HOC RESULTS FROM THE PHASE 3 INDIGO TRIAL","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre; Toronto General Hospital","funders":"","keywords":"Confidence interval; Magnetic resonance imaging; Hazard ratio; Proportional hazards model; Placebo; Volume (thermodynamics); Isocitrate dehydrogenase; Clinical trial","score_opus":0.043440440036110334,"score_gpt":0.37701988069536574,"score_spread":0.3335794406592554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414799819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9346957,0.00034478348,9.84129e-7,0.05825625,0.0030924797,0.0021211489,0.00049263827,0.000093821625,0.0009021859],"genre_scores_gemma":[0.9888453,0.00011741156,0.00008010765,0.009443839,0.0008089228,0.0003951752,0.00016938537,0.00003081068,0.000109041546],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965825,0.0007459379,0.0010736736,0.0007723059,0.00031771144,0.00050784426],"domain_scores_gemma":[0.9934153,0.005171258,0.000320553,0.0007692479,0.00012283912,0.00020078939],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007501036,0.00031976888,0.0011184522,0.00029030742,0.00011352258,0.000037339123,0.00032591936,0.00033833997,0.000095703035],"category_scores_gemma":[0.003639672,0.0002081304,0.0003057693,0.0004705297,0.00024796155,0.00005728562,0.00020212236,0.0006770044,0.000114473856],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24555938,0.020259313,0.55243134,0.000025135925,0.0010107541,0.012596007,0.0018809141,0.0000018788161,0.0118898135,0.00013255421,0.06048542,0.0937275],"study_design_scores_gemma":[0.36037493,0.025410593,0.4502328,0.0000817272,0.00068867917,0.00004938607,0.00026548468,0.000061634986,0.0016970627,0.00009720457,0.16083811,0.00020237491],"about_ca_topic_score_codex":0.00087110937,"about_ca_topic_score_gemma":0.0016764367,"teacher_disagreement_score":0.11481555,"about_ca_system_score_codex":0.00021109036,"about_ca_system_score_gemma":0.0005695546,"threshold_uncertainty_score":0.84873116},"labels":[],"label_agreement":null},{"id":"W4414799864","doi":"10.1093/neuonc/noaf193.209","title":"P05.04.B ENRICHMENT AND ANALYTICAL METHODS IN CSF PROTEOMICS: EACH NAIL NEEDS A DIFFERENT HAMMER","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Advanced Proteomics Techniques and Applications","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Cohort; Coefficient of variation; Reproducibility; Peptide; Nanoparticle tracking analysis; Cohort study","score_opus":0.02322882610921426,"score_gpt":0.3779779979675576,"score_spread":0.3547491718583433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414799864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.69980234,0.00034907306,0.2377264,0.010296852,0.00014183698,0.001269939,0.000022429866,0.00029523947,0.050095912],"genre_scores_gemma":[0.6122524,0.0006751235,0.37939903,0.0025441474,0.00016007616,0.0030196197,0.000030254969,0.00006321132,0.0018561076],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985372,0.000105050545,0.0004368833,0.00045595874,0.00008205719,0.00038286595],"domain_scores_gemma":[0.9988267,0.0004972019,0.000110736655,0.00042151002,0.000041358726,0.00010253524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022940409,0.00022040533,0.00042652147,0.00018254337,0.00008993703,0.000025312585,0.00024298247,0.00029579477,0.000118724485],"category_scores_gemma":[0.00018121129,0.00020595347,0.000070197726,0.00029301885,0.00014263009,0.000042808202,0.0003317544,0.00064269896,0.000004177807],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000092724746,0.00032085736,0.0031653387,0.000064878855,0.000024776558,0.000013560816,0.00016216018,0.000013857401,0.89855564,0.017727448,0.0007223142,0.079136446],"study_design_scores_gemma":[0.0015330255,0.00018103742,0.00049193203,0.00004151804,0.00007635588,0.00003535699,0.00025662256,0.0067665726,0.6136341,0.018048042,0.35859093,0.00034452495],"about_ca_topic_score_codex":0.000026734217,"about_ca_topic_score_gemma":0.000013528512,"teacher_disagreement_score":0.3578686,"about_ca_system_score_codex":0.00030553882,"about_ca_system_score_gemma":0.000104250015,"threshold_uncertainty_score":0.8398539},"labels":[],"label_agreement":null},{"id":"W4414800130","doi":"10.1093/neuonc/noaf193.466","title":"P14.05.B CAR T-CELL THERAPY DOES NOT LEAD TO MEDIUM-TERM NEUROCOGNITIVE DETERIORATION IN PATIENTS WITH CENTRAL NERVOUS SYSTEM LYMPHOMAS. A LOC NETWORK STUDY","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Gene Regulatory Network Analysis","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Neurocognitive; Neuropsychology; Neurotoxicity; Central nervous system; Lymphoma; Primary central nervous system lymphoma","score_opus":0.005836706736002294,"score_gpt":0.23210302602825794,"score_spread":0.22626631929225566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414800130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99689764,0.000107604865,0.00024441618,0.00017164185,0.0007622397,0.0015582684,0.000012590522,0.00003479637,0.00021077799],"genre_scores_gemma":[0.9974794,0.00003689076,0.00009895518,0.0016586037,0.0003204278,0.00022106653,0.00007600237,0.00004786267,0.00006080703],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99702084,0.0007178788,0.0004958938,0.000886917,0.00023907867,0.00063940487],"domain_scores_gemma":[0.9988382,0.000062409315,0.00020846161,0.00052690704,0.00021542037,0.00014858825],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002029127,0.0003638917,0.00053614547,0.00016200816,0.00012961778,0.000039649727,0.00033693443,0.00024769106,0.0000049093924],"category_scores_gemma":[0.000031883046,0.0002891883,0.000108015534,0.0005066452,0.00007614457,0.0000086860155,0.00019434054,0.00016692518,0.0000068062927],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037511713,0.0012210043,0.629108,0.000044772416,0.0002642034,0.0001789391,0.0005414838,0.0060144328,0.33557865,0.0000045845513,0.00086231274,0.022430448],"study_design_scores_gemma":[0.01212247,0.011127237,0.8711086,0.00005995949,0.00031731956,0.000014442367,0.0009455171,0.00046017583,0.09583071,0.000005697177,0.0072498852,0.00075796805],"about_ca_topic_score_codex":0.000044165365,"about_ca_topic_score_gemma":0.0010166625,"teacher_disagreement_score":0.24200064,"about_ca_system_score_codex":0.00020398494,"about_ca_system_score_gemma":0.00034619236,"threshold_uncertainty_score":0.999956},"labels":[],"label_agreement":null},{"id":"W4414800137","doi":"10.1093/neuonc/noaf193.011","title":"JS05.6.A EXPLORATORY ANALYSES FROM PHASE 3 INDIGO STUDY SUGGEST POTENTIAL MECHANISM OF SEIZURE CONTROL THROUGH TUMOR VOLUME REDUCTION UNDER TREATMENT WITH VORASIDENIB","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"","keywords":"Placebo; Confidence interval; Glioma; Exploratory analysis; Astrocytoma; Brain tumor; Phases of clinical research","score_opus":0.032921942262096396,"score_gpt":0.39499049717856516,"score_spread":0.3620685549164688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414800137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884587,0.00039657057,0.005375811,0.0021664,0.00074393395,0.0019076185,0.00017059184,0.00008746245,0.0006929023],"genre_scores_gemma":[0.99778765,0.00005344755,0.00045824778,0.0006868002,0.00019597891,0.00039088188,0.0001316353,0.000030565086,0.00026480338],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9983418,0.00025608085,0.0004152734,0.0005177976,0.00022948644,0.00023954445],"domain_scores_gemma":[0.99892735,0.00010418896,0.00025844845,0.00040592923,0.00020914956,0.00009493637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000602012,0.00026547833,0.0007488831,0.00018475401,0.00014057531,0.000015711892,0.000078289944,0.00010647659,0.00015770253],"category_scores_gemma":[0.000021452726,0.00019405554,0.000120689125,0.00031926268,0.000116489806,0.00014057869,0.00002308729,0.00016377808,0.000013175661],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0137976585,0.034919187,0.012748107,0.00008038056,0.015313608,0.0045908866,0.013837993,0.0012078983,0.8858549,0.000885158,0.002940859,0.01382337],"study_design_scores_gemma":[0.3401969,0.15587243,0.020217154,0.0003137761,0.06577363,0.0009403654,0.09783529,0.0013783459,0.28356984,0.004104402,0.028547354,0.0012505209],"about_ca_topic_score_codex":0.0012071773,"about_ca_topic_score_gemma":0.00028325772,"teacher_disagreement_score":0.6022851,"about_ca_system_score_codex":0.000632552,"about_ca_system_score_gemma":0.0012697979,"threshold_uncertainty_score":0.7913355},"labels":[],"label_agreement":null},{"id":"W4414800233","doi":"10.1093/neuonc/noaf193.286","title":"P08.18.B PROSPECTIVE EVALUATION OF NEUROLOGICAL SAFETY AFTER ANTI-BCMA CAR T-CELL THERAPY IN A SINGLE-CENTRE COHORT","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Neurocognitive; Cohort; Prospective cohort study; Neurotoxicity; Cognition; Post-concussion syndrome; Neurological examination; Cohort study","score_opus":0.04003583211486778,"score_gpt":0.350929074696149,"score_spread":0.3108932425812812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414800233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9558937,0.0004220261,0.000009677396,0.0030276724,0.00036414928,0.0033631548,0.000008635724,0.00004528286,0.03686569],"genre_scores_gemma":[0.9966176,0.0003074555,0.00006811855,0.0020812433,0.00010364876,0.00023678389,0.000013504866,0.000029855673,0.00054179394],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9963411,0.001273542,0.0005582251,0.0006671432,0.00069032534,0.0004696545],"domain_scores_gemma":[0.99802613,0.0006985769,0.0001291311,0.0004884873,0.00055167533,0.00010600998],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013588984,0.00023078757,0.0007371477,0.00036039823,0.000040083403,0.000010358313,0.00017827307,0.00034952365,0.0032723332],"category_scores_gemma":[0.00053822366,0.00019813376,0.00015558989,0.00072388106,0.00026481575,0.000050252806,0.000113216964,0.000733878,0.000022942642],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056883837,0.001486071,0.45405844,0.000028256443,0.00005096028,0.00019013364,0.00034086453,0.000034683442,0.50252396,0.000021113396,0.00041453546,0.035162598],"study_design_scores_gemma":[0.017070783,0.0067055193,0.8357001,0.00004086447,0.00017697578,0.000054427466,0.00012597152,0.0018674304,0.10043535,0.0002625492,0.03737109,0.00018892447],"about_ca_topic_score_codex":0.000032079683,"about_ca_topic_score_gemma":0.00007524597,"teacher_disagreement_score":0.4020886,"about_ca_system_score_codex":0.0006206073,"about_ca_system_score_gemma":0.00089254964,"threshold_uncertainty_score":0.9976388},"labels":[],"label_agreement":null},{"id":"W4414800255","doi":"10.1093/neuonc/noaf193.522","title":"P17.06.A VORASIDENIB AS MAINTENANCE TREATMENT AFTER FIRST-LINE CHEMORADIOTHERAPY IN IDH-MUTANT GRADE 2/3 ASTROCYTOMA: STUDY PROTOCOL FOR THE PLACEBO-CONTROLLED, TRIPLE-BLIND, RANDOMIZED PHASE III STUDY EORTC-2427 (VIGOR)","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba","funders":"","keywords":"Randomized controlled trial; Clinical endpoint; Discontinuation; Quality of life (healthcare); Radiation therapy; Placebo; Chemoradiotherapy; Maintenance therapy","score_opus":0.04164772387309838,"score_gpt":0.42070722184840514,"score_spread":0.37905949797530675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414800255","genre_codex":"protocol","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"protocol","genre_consensus":"protocol","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.39446858,0.00012512883,0.00054506934,0.0056018177,0.0002553333,0.5986131,0.000029481209,0.00009752487,0.00026397314],"genre_scores_gemma":[0.4789835,0.000045168148,0.00012411087,0.0004986884,0.0001722179,0.5191782,0.000012685818,0.000050141985,0.0009352863],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9934706,0.0016686816,0.0017064983,0.0012279016,0.00067098974,0.0012553463],"domain_scores_gemma":[0.9922075,0.005641051,0.0004664063,0.0010663519,0.00027900646,0.00033963725],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022470988,0.0008143572,0.0036328395,0.00059937785,0.00036732436,0.00008489755,0.00042824884,0.00024506813,0.00021245418],"category_scores_gemma":[0.00186679,0.0004566312,0.00071366044,0.0006815606,0.00031359438,0.00010801563,0.00013597576,0.00064427854,0.00003271249],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.92789096,0.037043262,0.011516718,0.00007031089,0.0024320884,0.00424211,0.0017557794,0.000038563237,0.0011457299,0.000018893139,0.0004417844,0.0134038],"study_design_scores_gemma":[0.938738,0.037885442,0.0009585603,0.00007057254,0.0010936278,0.00013674378,0.001379541,0.004240812,0.0014715148,0.00008078924,0.013682808,0.00026161276],"about_ca_topic_score_codex":0.0004629676,"about_ca_topic_score_gemma":0.0033907655,"teacher_disagreement_score":0.08451491,"about_ca_system_score_codex":0.0014558553,"about_ca_system_score_gemma":0.0013346813,"threshold_uncertainty_score":0.9997885},"labels":[],"label_agreement":null},{"id":"W4414800269","doi":"10.1093/neuonc/noaf193.404","title":"P12.25.B A GLOBAL PHASE 3, OPEN-LABEL, RANDOMIZED-CONTROLLED STUDY FOR NEWLY-DIAGNOSED, MGMT UNMETHYLATED GLIOBLASTOMA, COMPARING NIRAPARIB VS STANDARD OF CARE TEMOZOLOMIDE TREATMENT.","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Temozolomide; Phases of clinical research; Methyltransferase; Progressive disease; Standard of care; PARP inhibitor; Radiation therapy; Biomarker","score_opus":0.027819427787130615,"score_gpt":0.38072159493650665,"score_spread":0.35290216714937606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414800269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9651342,0.0026699174,0.00010789583,0.00266967,0.0009219574,0.02399562,0.00026799043,0.00017252055,0.0040602535],"genre_scores_gemma":[0.99141246,0.0002683451,0.0011218011,0.00072149694,0.00009368688,0.0061903675,0.000097019816,0.00004862844,0.000046186895],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9952548,0.0010434265,0.0016804441,0.0009752447,0.0003584836,0.0006875964],"domain_scores_gemma":[0.9930486,0.004563178,0.00072537415,0.0007734722,0.0005923241,0.0002970433],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00075560034,0.00066624867,0.006480595,0.00040182567,0.0002653384,0.00008254786,0.00040998208,0.00030440695,0.00005453299],"category_scores_gemma":[0.0015304656,0.00048915687,0.0006351914,0.0007183452,0.00025219377,0.000115092946,0.00026098287,0.00022064598,0.000011860777],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9076316,0.026443437,0.014282993,0.00014310984,0.005251504,0.0013537683,0.00090885675,0.000085124215,0.006582387,0.0011108678,0.0034485734,0.032757815],"study_design_scores_gemma":[0.9077272,0.061297342,0.00027720476,0.00013610901,0.007172738,0.000038613904,0.0014922846,0.0012441803,0.008960446,0.00018483572,0.011206159,0.00026292139],"about_ca_topic_score_codex":0.0005118206,"about_ca_topic_score_gemma":0.002092005,"teacher_disagreement_score":0.034853905,"about_ca_system_score_codex":0.0014977355,"about_ca_system_score_gemma":0.0011881598,"threshold_uncertainty_score":0.99975604},"labels":[],"label_agreement":null},{"id":"W4414874442","doi":"10.1093/neuonc/noaf226","title":"Intracranial metastases from solid tumors: Call to action and consensus from the Society for Neuro-Oncology and American Society of Clinical Oncology collaborative","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"Apollomics; Incyte; Novocure; Regeneron Pharmaceuticals; American Society of Clinical Oncology; Servier; EpicentRx; Pfizer","keywords":"Translational research; Call to action; Clinical Oncology; Clinical research; Clinical trial; Alternative medicine; Patient advocacy; Population","score_opus":0.06291692731623424,"score_gpt":0.4209590622161835,"score_spread":0.3580421348999493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414874442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9157853,0.0006612349,0.0010488739,0.07752537,0.00096063386,0.0021043692,0.0016597506,0.000051189414,0.00020329279],"genre_scores_gemma":[0.85812867,0.0022620677,0.07610223,0.061523613,0.0011801057,0.00043616557,0.00026684543,0.00006163584,0.00003869644],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960451,0.0012889794,0.0011218706,0.0009053837,0.00019036816,0.00044829564],"domain_scores_gemma":[0.97813016,0.020107727,0.00068538764,0.00040170987,0.00037052602,0.00030449964],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000988211,0.0003601344,0.0020024534,0.000053295596,0.0002356777,0.000021062055,0.00015077293,0.000366556,0.00003443493],"category_scores_gemma":[0.0017881035,0.00026322438,0.0005292002,0.0003840943,0.0015666276,0.00003987282,0.0002458241,0.0006929841,0.0000033318781],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012388826,0.0025934214,0.018347858,0.00008852133,0.004319938,0.0002889649,0.0036832197,0.000020865698,0.13877878,0.00035156583,0.19684993,0.6222881],"study_design_scores_gemma":[0.020133726,0.02772891,0.04602944,0.00005524659,0.0043634702,0.00017960196,0.015576474,0.0018523298,0.00534876,0.00068855006,0.87769896,0.00034453068],"about_ca_topic_score_codex":0.0012058836,"about_ca_topic_score_gemma":0.0015690353,"teacher_disagreement_score":0.680849,"about_ca_system_score_codex":0.00026925522,"about_ca_system_score_gemma":0.0020191541,"threshold_uncertainty_score":0.999982},"labels":[],"label_agreement":null},{"id":"W4415402114","doi":"10.1093/neuonc/noaf245","title":"Integrated clinical and molecular landscape of disseminated pediatric low-grade glioma","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Alberta Hospital; McMaster Children's Hospital; London Health Sciences Centre; University of Toronto; Western University; Université Laval; BC Children's Hospital; Queen Elizabeth II Health Sciences Centre; Children's Hospital of Western Ontario; SickKids Foundation; Dalhousie University; Princess Margaret Cancer Centre; Stollery Children's Hospital; Hospital for Sick Children","funders":"Canadian Institutes of Health Research; Hospital for Sick Children; Sick Kids Foundation; Pediatric Brain Tumor Foundation","keywords":"Clinical trial; Glioma; Cohort; MEDLINE; Disease","score_opus":0.01502408833485379,"score_gpt":0.33541743817531294,"score_spread":0.32039334984045914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415402114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993667,0.0013122844,0.000018231725,0.0026034946,0.00033356185,0.00034292895,0.00001000674,0.00004481108,0.0016676581],"genre_scores_gemma":[0.99852794,0.00048149462,0.00020743482,0.00064667396,0.00004847245,0.00003391889,0.00002719812,0.000013847263,0.0000130260105],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99873203,0.00016978652,0.0005055533,0.0002882614,0.00010714855,0.0001972025],"domain_scores_gemma":[0.99877703,0.0006112726,0.00012377898,0.00024453105,0.00010945027,0.00013393794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016781084,0.0001526951,0.0005688542,0.00029355547,0.000027443726,0.000006213177,0.00007413556,0.00022927638,0.000045405435],"category_scores_gemma":[0.00045239978,0.00011765763,0.00011904647,0.000602361,0.00012533317,0.000017654726,0.000072501316,0.00023816347,0.0000082344095],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034364368,0.002159649,0.66405827,0.000112327165,0.0001531624,0.0019169041,0.000060091574,0.0000013867873,0.3061519,0.00043660746,0.00924252,0.015363545],"study_design_scores_gemma":[0.024233747,0.0070774904,0.49312916,0.00019181057,0.0026724841,0.00048579712,0.00042073295,0.0008688358,0.4312059,0.00037201867,0.038970467,0.000371571],"about_ca_topic_score_codex":0.000013607076,"about_ca_topic_score_gemma":0.000006005612,"teacher_disagreement_score":0.17092912,"about_ca_system_score_codex":0.000028838374,"about_ca_system_score_gemma":0.00019914034,"threshold_uncertainty_score":0.4797939},"labels":[],"label_agreement":null},{"id":"W4415648353","doi":"10.1093/neuonc/noaf247","title":"International Stereotactic Radiosurgery Society (ISRS) practice guidelines for radiosurgery in recurrent high-grade glioma","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Radiosurgery; Clinical Practice; Glioma; Gamma knife; MEDLINE","score_opus":0.059861271810178404,"score_gpt":0.39197572893148275,"score_spread":0.33211445712130433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415648353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.649035,0.002197081,0.00024394118,0.33435252,0.01012314,0.0017020227,0.000058999245,0.00013573097,0.0021515717],"genre_scores_gemma":[0.9348765,0.0036626984,0.0133008715,0.04483324,0.0014577148,0.0014093816,0.0002568788,0.00008123732,0.00012146619],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975559,0.00019703602,0.0009137731,0.0006005175,0.00029576698,0.0004370235],"domain_scores_gemma":[0.9942383,0.00424427,0.0003230791,0.000362981,0.0006940742,0.00013727896],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00077693764,0.00027847642,0.0007212108,0.00042071036,0.000082538296,0.000037118472,0.00016150126,0.00024306738,0.000075071766],"category_scores_gemma":[0.005504888,0.00024847686,0.00039565828,0.0004961895,0.00007845511,0.00018653406,0.00009620588,0.00032166112,0.00001517397],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018655118,0.0057980972,0.021735106,0.00018704304,0.001102169,0.0021350454,0.00030091242,0.000051490566,0.08961001,0.0017008894,0.71856743,0.1569463],"study_design_scores_gemma":[0.00815164,0.00064458576,0.005273695,0.00015197654,0.0004208571,0.00055214745,0.0002674284,0.0010108692,0.010789475,0.0001668597,0.9723804,0.00019008722],"about_ca_topic_score_codex":0.00006585266,"about_ca_topic_score_gemma":0.000020981322,"teacher_disagreement_score":0.28951928,"about_ca_system_score_codex":0.00081314676,"about_ca_system_score_gemma":0.0005938649,"threshold_uncertainty_score":0.9999967},"labels":[],"label_agreement":null},{"id":"W4415938647","doi":"10.1093/neuonc/noaf255","title":"Reflecting on scientific growth and innovation as the Society for Neuro-Oncology turns 30","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Subspecialty; Profiling (computer programming); Data sharing; Patient care; Neuroimaging; Scientific progress; Emerging technologies; Scientific discovery","score_opus":0.05714682114220617,"score_gpt":0.3854376150473039,"score_spread":0.32829079390509774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415938647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9107833,0.00022126491,0.000046330253,0.073236704,0.0017845914,0.0013294744,0.000008684092,0.00007665807,0.012512986],"genre_scores_gemma":[0.9712839,0.00009073764,0.00037279283,0.027575105,0.00022124955,0.0002874505,0.000029313576,0.000023417928,0.0001160445],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99838835,0.00013564405,0.00037449322,0.00057491247,0.00016292551,0.0003636671],"domain_scores_gemma":[0.99669224,0.002488421,0.00018484419,0.00030784938,0.0002622676,0.000064351545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005227953,0.0001923714,0.00037904145,0.00029722103,0.0004393598,0.000058655598,0.000118025324,0.00021666904,0.000027564929],"category_scores_gemma":[0.0015396262,0.00013430126,0.00017110065,0.0011006994,0.00027730255,0.00004802287,0.00010475625,0.00037233852,0.000019592462],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045120492,0.0011212695,0.006251786,0.00013861641,0.00025412146,0.00011519563,0.0016018291,0.00000737613,0.8396102,0.046520974,0.055806674,0.048120745],"study_design_scores_gemma":[0.007201581,0.005938813,0.004953804,0.00005320688,0.0005329847,0.00020117707,0.0006086177,0.00037593982,0.109699115,0.004925365,0.8653402,0.00016920705],"about_ca_topic_score_codex":0.000014187216,"about_ca_topic_score_gemma":0.000019713832,"teacher_disagreement_score":0.80953354,"about_ca_system_score_codex":0.0002539124,"about_ca_system_score_gemma":0.0005276407,"threshold_uncertainty_score":0.54766464},"labels":[],"label_agreement":null},{"id":"W4416084780","doi":"10.1093/neuonc/noaf201.0201","title":"BIOM-113. TERT EXPRESSION IN MENINGIOMAS PREDICTS PROGRESSION-FREE SURVIVAL INDEPENDENT OF TERT PROMOTER MUTATION","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Hospital for Sick Children; University of British Columbia; University Health Network","funders":"","keywords":"Sanger sequencing; Meningioma; Gene expression; Proportional hazards model; Gene; Mutation; Survival analysis","score_opus":0.02132271782543062,"score_gpt":0.32050051350574615,"score_spread":0.29917779568031555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416084780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97260594,0.00012512226,0.00063126546,0.002940352,0.001049916,0.0015146802,0.0000062218305,0.000095065145,0.021031445],"genre_scores_gemma":[0.9961312,0.0000058332603,0.0028124927,0.00019557294,0.00008738335,0.00020318279,0.0000419599,0.000025488655,0.00049692957],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974943,0.0003130168,0.00073477154,0.00054183276,0.00053292984,0.00038317824],"domain_scores_gemma":[0.9987031,0.0002118433,0.00025697166,0.00059195864,0.0001150686,0.000121042205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063961063,0.00023325217,0.0005678337,0.0005866629,0.000069659036,0.000019291569,0.0002934071,0.0002715015,0.00009407376],"category_scores_gemma":[0.000352892,0.00019085579,0.0000995744,0.00049214077,0.00010593009,0.00011287846,0.00042255985,0.00031668565,0.000008724709],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017888641,0.0013325261,0.042022854,0.00056772423,0.00011109722,0.0062835203,0.0013502608,0.000013475914,0.9051377,0.0002450711,0.0057535875,0.03539328],"study_design_scores_gemma":[0.02641211,0.008284251,0.20867468,0.002378302,0.0004975326,0.0010886843,0.00097218057,0.002931458,0.7077819,0.0021295582,0.03820924,0.00064007274],"about_ca_topic_score_codex":0.000029204268,"about_ca_topic_score_gemma":0.000015468202,"teacher_disagreement_score":0.19735582,"about_ca_system_score_codex":0.00018796632,"about_ca_system_score_gemma":0.00025639255,"threshold_uncertainty_score":0.7782873},"labels":[],"label_agreement":null},{"id":"W4416084782","doi":"10.1093/neuonc/noaf201.0127","title":"BIOM-39. PLASMA PROTEOMICS REVEAL KEY PRELIMINARY BIOMARKERS FOR GLIOBLASTOMA PROGRESSION AND DIFFERENTIAL DIAGNOSIS","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Hospital for Sick Children; University Health Network; University of Toronto","funders":"","keywords":"Glioblastoma; Receiver operating characteristic; Proteomics; Differential diagnosis; Disease; Brain tumor; Random forest","score_opus":0.014782224832700877,"score_gpt":0.3087694840929666,"score_spread":0.29398725926026575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416084782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98263204,0.00041409497,0.00008040643,0.012111891,0.0007720916,0.0034175436,0.000051413408,0.000104490944,0.0004160027],"genre_scores_gemma":[0.99213487,0.0002251658,0.00306138,0.00067017146,0.00015749046,0.0036239147,0.00004786151,0.000039179697,0.000039955597],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983015,0.000116917996,0.00039394788,0.00060884806,0.00015661075,0.00042214396],"domain_scores_gemma":[0.9984504,0.0007952413,0.00015913327,0.00029502966,0.00009950115,0.00020069123],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011454546,0.00028943332,0.0005631122,0.0003276149,0.00018784612,0.00003029095,0.00010461561,0.00032285816,0.000028197424],"category_scores_gemma":[0.00031915095,0.00023042443,0.00015815152,0.0002524999,0.00019165243,0.000054871252,0.00017707015,0.00017361534,0.0000072715293],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012415602,0.004163593,0.10474317,0.00060858426,0.0005879588,0.00062473345,0.00024238224,0.0000013297977,0.49139488,0.00042992408,0.039193705,0.34559417],"study_design_scores_gemma":[0.021992778,0.025809828,0.09136617,0.00059778756,0.0014441037,0.00035575335,0.000117153526,0.001504463,0.75254893,0.0002840848,0.10358286,0.0003960599],"about_ca_topic_score_codex":0.000010301693,"about_ca_topic_score_gemma":0.00001820037,"teacher_disagreement_score":0.3451981,"about_ca_system_score_codex":0.00019279096,"about_ca_system_score_gemma":0.00020667785,"threshold_uncertainty_score":0.93964356},"labels":[],"label_agreement":null},{"id":"W4416084814","doi":"10.1093/neuonc/noaf201.0077","title":"ANGI-11. MESENCHYMAL STEM CELLS AND PERIVASCULAR STROMA ARE ASSOCIATED WITH MICROVASCULAR PROLIFERATION, IMMUNOSUPPRESSION, AND POOR OUTCOME IN GLIOMA","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Mesenchymal stem cell; PDGFRB; Stromal cell; Glioma; Transcriptome; Immune system; CD34; Stem cell; Single-cell analysis; Gene signature","score_opus":0.01031928836619211,"score_gpt":0.23751077976274843,"score_spread":0.2271914913965563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416084814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997287,0.0012062214,0.0001892442,0.00058293494,0.00018868003,0.00042741917,0.000018706556,0.000019926652,0.0000799113],"genre_scores_gemma":[0.99867624,0.0001541191,0.00020261155,0.00072751445,0.000045515513,0.000040650553,0.000040357252,0.000026211666,0.00008679485],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99838215,0.00029856272,0.00035023564,0.0005450339,0.00011396581,0.00031005364],"domain_scores_gemma":[0.99937856,0.000056572047,0.00011481385,0.0002620771,0.000108805296,0.0000791687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023505153,0.00024106605,0.0004043967,0.000116786716,0.00012492249,0.000046142995,0.00014910578,0.00035395694,0.0000046504074],"category_scores_gemma":[0.00005705357,0.00021041262,0.000074969044,0.0001719834,0.00016304922,0.00001037104,0.00011429985,0.00019538857,6.974783e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016008617,0.00014936591,0.18792407,0.000033661374,0.00008223375,0.00007170811,0.00008378396,0.000028991912,0.81053144,0.00001644934,0.00022294307,0.0006952657],"study_design_scores_gemma":[0.0053861123,0.0010713248,0.062077977,0.000068577974,0.0001292319,0.000109082685,0.0003486527,0.00031404934,0.9043438,0.000016737002,0.025760671,0.00037382336],"about_ca_topic_score_codex":0.000041674677,"about_ca_topic_score_gemma":0.00035510556,"teacher_disagreement_score":0.12584609,"about_ca_system_score_codex":0.00005128935,"about_ca_system_score_gemma":0.00014592479,"threshold_uncertainty_score":0.8580377},"labels":[],"label_agreement":null},{"id":"W4416084826","doi":"10.1093/neuonc/noaf201.0005","title":"EPCO-05. AN ONCOGENIC PHOTORECEPTOR PROGRAM UNIFIES DISTINCT CENTRAL NERVOUS SYSTEM TUMORS","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"","keywords":"Transcriptome; Transcription factor; Central nervous system; Medulloblastoma; Retinoblastoma; Transcription (linguistics); Phenotype; Reprogramming","score_opus":0.016908538348562766,"score_gpt":0.30849067851333123,"score_spread":0.29158214016476847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416084826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98543847,0.0002866267,0.0000067097526,0.0019682357,0.002368672,0.0017055406,0.000029069026,0.0004973912,0.00769929],"genre_scores_gemma":[0.9976438,0.00003067902,0.00029637024,0.0008348823,0.00029804753,0.0005988605,0.00011277238,0.000038508035,0.00014608043],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978485,0.00025165896,0.0004617966,0.0005772842,0.00021505165,0.0006456952],"domain_scores_gemma":[0.99861944,0.00026477338,0.00014637185,0.0004999997,0.0001130089,0.0003564356],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00012462812,0.00030668476,0.0007060202,0.0001910019,0.00015562976,0.000038136783,0.00018426417,0.00020840575,0.00010826338],"category_scores_gemma":[0.00012612062,0.0002465785,0.00020649483,0.00037039784,0.000161311,0.000060676608,0.00008785261,0.00028464515,0.000067747176],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017154128,0.012526477,0.20356667,0.0008988751,0.0007954695,0.010859619,0.0009681407,0.000030783463,0.17470576,0.005583429,0.03443125,0.5539181],"study_design_scores_gemma":[0.009163559,0.012917851,0.18361624,0.00031195083,0.0012160043,0.0011767739,0.0014147139,0.0010138043,0.076340266,0.000048332044,0.71231043,0.00047009418],"about_ca_topic_score_codex":0.00018033493,"about_ca_topic_score_gemma":0.00012960538,"teacher_disagreement_score":0.67787915,"about_ca_system_score_codex":0.00076369767,"about_ca_system_score_gemma":0.00056745124,"threshold_uncertainty_score":0.9999986},"labels":[],"label_agreement":null},{"id":"W4416084848","doi":"10.1093/neuonc/noaf201.0115","title":"BIOM-27. PREDICTIVE BIOMARKERS OF BRAIN METASTASIS IN TRIPLE-NEGATIVE BREAST CANCER: CLINICOPATHOLOGICAL CORRELATES AND EMERGING EVIDENCE","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Brain metastasis; Breast cancer; Metastasis; STAT3; Disease; Estrogen receptor; Transcription factor; Carcinogenesis","score_opus":0.035446838863150365,"score_gpt":0.37253579089007793,"score_spread":0.33708895202692757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416084848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9568922,0.0049154325,0.0003936814,0.034591448,0.00085375976,0.0013546803,0.0002714849,0.0000522029,0.0006751201],"genre_scores_gemma":[0.9938853,0.0028947368,0.0009769745,0.0020121937,0.0000359561,0.000121956306,0.0000099781855,0.00001407515,0.000048851725],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975334,0.000779559,0.00062967365,0.0005726894,0.00016383074,0.0003208729],"domain_scores_gemma":[0.99545467,0.003801445,0.0002576944,0.0002418001,0.00011898533,0.00012539019],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008387568,0.00023199004,0.0008576872,0.0003712971,0.000056552835,0.000007061333,0.000104362465,0.00019471422,0.0001232007],"category_scores_gemma":[0.0016911919,0.00018031803,0.00013830027,0.0007243725,0.00049194944,0.00009007557,0.00014825696,0.00034658736,0.0000033328563],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010345867,0.0015084173,0.59059197,0.00028354969,0.0007903988,0.0016894386,0.0011876738,0.000046321627,0.032692924,0.00053759007,0.005456173,0.3548697],"study_design_scores_gemma":[0.020906404,0.012484858,0.93561566,0.0016415444,0.0024184706,0.0012587206,0.0032024006,0.00410841,0.010330857,0.001420165,0.006157563,0.0004549788],"about_ca_topic_score_codex":0.00033990855,"about_ca_topic_score_gemma":0.00014016675,"teacher_disagreement_score":0.35441473,"about_ca_system_score_codex":0.00022617976,"about_ca_system_score_gemma":0.00042362456,"threshold_uncertainty_score":0.7353156},"labels":[],"label_agreement":null},{"id":"W4416084863","doi":"10.1093/neuonc/noaf201.0097","title":"BIOM-09. PROGNOSTIC AND PREDICTIVE MARKERS FOR OUTCOME IN PATIENTS WITH IDHMT TUMORS TREATED IN THE EORTC CATNON TRIAL ON ADJUVANT AND/OR CONCURRENT TEMOZOLOMIDE IN ANAPLASTIC ASTROCYTOMA","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Temozolomide; Anaplastic astrocytoma; Grading (engineering); Astrocytoma; Glioma; Radiation therapy; CDKN2A; PTEN; Adjuvant","score_opus":0.018923936981932708,"score_gpt":0.3035092186765667,"score_spread":0.284585281694634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416084863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99296254,0.00006622726,0.000003815207,0.0009846473,0.00020288913,0.005603401,0.00007136596,0.000015064607,0.000090021866],"genre_scores_gemma":[0.998018,0.000016908343,0.000022026466,0.0004044452,0.000020897673,0.001430259,0.00006845536,0.000015436794,0.0000035672958],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982873,0.0002647887,0.00048875646,0.00046573294,0.00015179566,0.000341587],"domain_scores_gemma":[0.9973351,0.0022597497,0.00013152212,0.00015358646,0.00004091229,0.000079134414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021813251,0.00024415314,0.00066018366,0.00047010763,0.000040580453,0.000013168922,0.00006870593,0.00011686831,0.0000036905765],"category_scores_gemma":[0.0007469416,0.00014033947,0.000038401777,0.00040480925,0.00013436169,0.00003617285,0.000036785375,0.00024189922,7.9021e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13911207,0.0023214333,0.84417266,0.000060757677,0.00004966178,0.00046804507,0.00021266675,0.0000153383,0.00005076451,0.000028740653,0.00010178587,0.013406107],"study_design_scores_gemma":[0.12879933,0.054038193,0.8155432,0.00022985142,0.00018857565,0.000015039326,0.00022685893,0.0005077456,0.00013216086,0.00000853252,0.00022271954,0.000087807726],"about_ca_topic_score_codex":0.00007131297,"about_ca_topic_score_gemma":0.0015035748,"teacher_disagreement_score":0.05171676,"about_ca_system_score_codex":0.0003183293,"about_ca_system_score_gemma":0.00016829789,"threshold_uncertainty_score":0.57228774},"labels":[],"label_agreement":null},{"id":"W4416084867","doi":"10.1093/neuonc/noaf201.0602","title":"DNAR-11. Differential DNA Damage and Repair burden in proliferating neural progenitor cells","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"","keywords":"DNA damage; DNA repair; Chromatin; Homologous recombination; RAD51; Neural stem cell; DNA; Progenitor cell","score_opus":0.018330492004844823,"score_gpt":0.3216161726590021,"score_spread":0.3032856806541573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416084867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874703,0.00011935573,0.000028530409,0.008104384,0.0011249186,0.0009908191,0.000008232756,0.00018058016,0.0019728553],"genre_scores_gemma":[0.994532,0.000043337153,0.00048655365,0.0036234187,0.00073522126,0.00022413088,0.000013053375,0.000028905219,0.00031337052],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982707,0.00028364026,0.0004472653,0.00047953433,0.00016108878,0.00035777644],"domain_scores_gemma":[0.9991437,0.00027985199,0.00010425017,0.00028769622,0.00006708884,0.00011739792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016164286,0.0001992532,0.00046177043,0.00022067557,0.00008745467,0.000020765156,0.00009322965,0.00020735788,0.00011437607],"category_scores_gemma":[0.000120220626,0.00018861835,0.0000853492,0.0002457979,0.00015970488,0.000069545684,0.0001023607,0.00044980366,0.0000095817795],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056366005,0.00018133005,0.015640656,0.00013197173,0.000028084267,0.0003631651,0.00054390816,0.000010851917,0.97371936,0.00013651657,0.0039178315,0.0047626696],"study_design_scores_gemma":[0.021001806,0.0031980749,0.027913166,0.000283885,0.00023239819,0.00044811884,0.00057990226,0.014407146,0.6736019,0.00029890644,0.25749198,0.00054268533],"about_ca_topic_score_codex":0.000040733496,"about_ca_topic_score_gemma":0.00006706678,"teacher_disagreement_score":0.30011743,"about_ca_system_score_codex":0.0002125408,"about_ca_system_score_gemma":0.00027638744,"threshold_uncertainty_score":0.7691633},"labels":[],"label_agreement":null},{"id":"W4416084900","doi":"10.1093/neuonc/noaf201.0060","title":"EPCO-61. INTEGRATIVE MULTI-OMICS ANALYSIS OF GLIOBLASTOMA IDENTIFIES DRIVERS OF TUMOR AGGRESSION AND RECURRENCE","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Hospital for Sick Children; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Glioma; Glioblastoma; Brain tumor; Precision medicine; Reprogramming; Cancer; Gene","score_opus":0.016273148387245612,"score_gpt":0.3281350211774062,"score_spread":0.31186187279016064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416084900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978412,0.0007319173,0.00007578061,0.00056832697,0.00023364814,0.0002678553,0.000044749406,0.000012762964,0.00022376374],"genre_scores_gemma":[0.9985267,0.0007238932,0.00049569417,0.00018432364,0.0000073782744,0.000025536283,0.000010999422,0.000005544685,0.00001994918],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989949,0.0001169683,0.0003542505,0.00028570098,0.00011706045,0.00013114848],"domain_scores_gemma":[0.99866575,0.0005681261,0.00028797772,0.00021921184,0.00019527964,0.000063668325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009902111,0.00013543385,0.0007013963,0.0006390848,0.000045939385,0.0000058949836,0.00007583385,0.000083496605,0.00003913123],"category_scores_gemma":[0.00044791197,0.00010164229,0.00015339702,0.0007798867,0.00032372636,0.000037181355,0.00009201925,0.00012981078,0.0000014861303],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073288963,0.0015315826,0.27407607,0.00012438615,0.0015836187,0.00031173506,0.0021698503,0.00004800109,0.67851895,0.00034630884,0.0014714374,0.039085165],"study_design_scores_gemma":[0.0042299596,0.0021681408,0.11856393,0.00049102854,0.004141798,0.000021932907,0.0016318873,0.0032572215,0.86285233,0.00007196386,0.0024568848,0.00011291761],"about_ca_topic_score_codex":0.00006781941,"about_ca_topic_score_gemma":0.00031464794,"teacher_disagreement_score":0.18433337,"about_ca_system_score_codex":0.00008552519,"about_ca_system_score_gemma":0.00015378813,"threshold_uncertainty_score":0.41448522},"labels":[],"label_agreement":null},{"id":"W4416084925","doi":"10.1093/neuonc/noaf201.0166","title":"BIOM-78. DNA-METHYLATION PROFILING OF PAN-CANCER BRAIN METASTASES REVEALS EPIGENETIC SIGNATURE ASSOCIATED WITH IMPROVED PATIENT OUTCOMES","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Epigenetics; DNA methylation; Concordance; Gene expression profiling; Methylation; Genotyping; Survival analysis; Gene signature","score_opus":0.018158547686560448,"score_gpt":0.32018162722143945,"score_spread":0.302023079534879,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416084925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843596,0.0018074734,0.0005352183,0.010182926,0.00043827333,0.0019211118,0.00025680973,0.00007650366,0.000422086],"genre_scores_gemma":[0.99134505,0.00008724687,0.0029761977,0.0049432013,0.000028300634,0.0002407175,0.00018533754,0.0000329623,0.00016099682],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99775136,0.0005760816,0.0005934274,0.00046899272,0.00025332774,0.0003568156],"domain_scores_gemma":[0.99726236,0.0015464409,0.00047362654,0.00035438457,0.0002643427,0.000098869605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040427461,0.0002854963,0.0009131294,0.00024282822,0.00008023762,0.000009602291,0.00009179003,0.00022478536,0.00007860758],"category_scores_gemma":[0.0011424993,0.00019735775,0.00017935333,0.00054609333,0.00012355414,0.000045155393,0.00006374265,0.00029433472,0.0000026130624],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006972549,0.001232052,0.043382384,0.00013803958,0.0012852687,0.00013358006,0.0002038952,0.000067702334,0.8421549,0.00023920598,0.001335396,0.10913028],"study_design_scores_gemma":[0.011316562,0.010075705,0.11938625,0.00033543474,0.002652167,0.000022068374,0.0003993238,0.00034438216,0.8396949,0.00046145575,0.014923065,0.00038865083],"about_ca_topic_score_codex":0.000075992924,"about_ca_topic_score_gemma":0.0001059465,"teacher_disagreement_score":0.10874163,"about_ca_system_score_codex":0.00027139403,"about_ca_system_score_gemma":0.000491914,"threshold_uncertainty_score":0.8048015},"labels":[],"label_agreement":null},{"id":"W4416084933","doi":"10.1093/neuonc/noaf201.0463","title":"CTIM-06. NIACIN MODULATES IMMUNE RESPONSES IN A PHASE I DOSE-ESCALATION CLINICAL TRIAL OF NEWLY DIAGNOSED GLIOBLASTOMA","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Calgary","funders":"","keywords":"Niacin; Immune system; Clinical trial; Cytokine; Immunosuppression; Immunotherapy; Leukapheresis; Immunosenescence; Myeloid","score_opus":0.02979607474415171,"score_gpt":0.3701827246806268,"score_spread":0.3403866499364751,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416084933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871378,0.0019664152,0.00008008974,0.0013249802,0.0068006692,0.0011398934,0.000025930478,0.000087163295,0.0014370764],"genre_scores_gemma":[0.99748766,0.00057227846,0.00013613391,0.0006349289,0.00010216997,0.0001548861,0.000045239347,0.000030108115,0.0008365937],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99421483,0.0027416823,0.0018221467,0.0006329178,0.0000621826,0.0005262349],"domain_scores_gemma":[0.9924742,0.0061100274,0.0005676478,0.0006887282,0.00013175257,0.00002763301],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014759242,0.00029677225,0.0011577975,0.0005419049,0.00010440317,0.000009701256,0.00047161206,0.0010249102,0.00034574955],"category_scores_gemma":[0.0030809718,0.0002962193,0.0002918872,0.00060050434,0.00070219534,0.00010949036,0.0002617604,0.0010537828,0.0001913024],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15312664,0.0027048683,0.0019658147,0.00002494458,0.00014166394,0.00008051279,0.00032259792,0.000058718728,0.76024055,0.00019911039,0.0043426943,0.076791875],"study_design_scores_gemma":[0.31472927,0.015261734,0.016277416,0.0001149961,0.00018777206,0.000059548,0.00023754635,0.00014285349,0.42002976,0.00049128436,0.2320648,0.00040303337],"about_ca_topic_score_codex":0.00013828982,"about_ca_topic_score_gemma":0.00012297461,"teacher_disagreement_score":0.34021083,"about_ca_system_score_codex":0.00021758188,"about_ca_system_score_gemma":0.00076716475,"threshold_uncertainty_score":0.999949},"labels":[],"label_agreement":null},{"id":"W4416084950","doi":"10.1093/neuonc/noaf201.0096","title":"BIOM-08. CHROMOSOME 1P LOSS AND 1Q GAIN ARE HIGHLY PROGNOSTIC AND CAN INFORM WHO GRADING OF MENINGIOMA","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of Toronto","funders":"","keywords":"CDKN2B; CDKN2A; Grading (engineering); Meningioma; Cohort; Chromosome; Chromosome 22; Proportional hazards model","score_opus":0.01804516890103231,"score_gpt":0.2830084576079969,"score_spread":0.2649632887069646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416084950","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985528,0.00043543865,0.000044205823,0.005893098,0.00029145888,0.0006774245,0.00001033642,0.00006001362,0.0070600417],"genre_scores_gemma":[0.9984727,0.000053979707,0.0003186029,0.00068366097,0.000068176,0.000049303166,0.000012791786,0.000015658357,0.00032516496],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998598,0.000076911274,0.00043418756,0.00036643396,0.0001791106,0.00034539722],"domain_scores_gemma":[0.9989664,0.00034263602,0.00020236244,0.00025334753,0.00007197527,0.00016328099],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024963438,0.00020496793,0.0006035877,0.00042658424,0.00010328357,0.000022756172,0.00010258966,0.0001467599,0.000017522794],"category_scores_gemma":[0.00029003064,0.00018415778,0.000052173404,0.0003352162,0.00024735503,0.0000669311,0.00021696817,0.00019558854,0.0000030165552],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012329544,0.0006029983,0.4518852,0.00360271,0.0008159131,0.015038241,0.004761826,0.000009709163,0.42135772,0.020589221,0.01546703,0.064636454],"study_design_scores_gemma":[0.024917796,0.016321518,0.5167322,0.0024017645,0.0027066546,0.0075645368,0.0045278617,0.0042084013,0.14558671,0.0031722263,0.2703819,0.0014783937],"about_ca_topic_score_codex":0.000044555676,"about_ca_topic_score_gemma":0.000022690441,"teacher_disagreement_score":0.27577102,"about_ca_system_score_codex":0.00009644497,"about_ca_system_score_gemma":0.0001413368,"threshold_uncertainty_score":0.7509736},"labels":[],"label_agreement":null},{"id":"W4416084963","doi":"10.1093/neuonc/noaf201.0422","title":"RADT-53. IMPACT OF SMALLER CLINICAL TARGET VOLUME EXPANSIONS FOR THE RADIATION TREATMENT OF NEWLY DIAGNOSED GLIOBLASTOMA","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Radiation therapy; Cohort; Retrospective cohort study; Glioblastoma; Radiation treatment planning; Abnormality; Cohort study; Disease","score_opus":0.03473264108856151,"score_gpt":0.38082863405487455,"score_spread":0.34609599296631305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416084963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887946,0.00126196,0.0002580557,0.006580557,0.000740446,0.0019063746,0.000090090085,0.000028084265,0.00033980457],"genre_scores_gemma":[0.99715567,0.0011685039,0.0004789802,0.00044269784,0.0001704201,0.00046098078,0.00003670197,0.000020664016,0.000065378845],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99839824,0.00020030989,0.00069533894,0.00031502306,0.00012826885,0.00026281283],"domain_scores_gemma":[0.99503094,0.003908495,0.000302258,0.00046926833,0.00016835121,0.00012067739],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019604075,0.00020113526,0.00080954254,0.00017217266,0.00007689134,0.0000049191444,0.00010589472,0.000204047,0.00014109125],"category_scores_gemma":[0.00065728836,0.000120095436,0.0006878772,0.00026546512,0.00016312928,0.00002929809,0.00003245262,0.000097632095,0.000008939207],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041488586,0.01252975,0.5524792,0.000060046346,0.0020545647,0.0001784267,0.0007123512,0.000729866,0.04497644,0.00037112107,0.051276308,0.33048308],"study_design_scores_gemma":[0.0293889,0.042740572,0.72300255,0.000052301228,0.001642967,0.000031922125,0.00018788587,0.0036405225,0.037103858,0.00014588739,0.16192101,0.00014161528],"about_ca_topic_score_codex":0.00018441655,"about_ca_topic_score_gemma":0.00007527588,"teacher_disagreement_score":0.33034146,"about_ca_system_score_codex":0.0002953578,"about_ca_system_score_gemma":0.00067760964,"threshold_uncertainty_score":0.48973498},"labels":[],"label_agreement":null},{"id":"W4416084970","doi":"10.1093/neuonc/noaf201.0591","title":"CTP-19. Molecular characterization of the SJMB12 clinical trial for children and young adults with newly diagnosed medulloblastoma","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Centre Hospitalier Universitaire Sainte-Justine; Alberta Children's Hospital","funders":"","keywords":"Germline; PTCH1; Medulloblastoma; Germline mutation; Exome sequencing; Exon; Gene; Clinical trial; Exome","score_opus":0.01346328353725241,"score_gpt":0.3111997749173576,"score_spread":0.2977364913801052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416084970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913522,0.000068963476,0.00011875888,0.004878392,0.0006549186,0.0027511881,0.000037218808,0.0000230421,0.000115292285],"genre_scores_gemma":[0.9970242,0.00009943348,0.000180417,0.0021573044,0.00013585857,0.00030785752,0.0000653119,0.000017399983,0.000012222847],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876016,0.00017540678,0.00041569603,0.00034153135,0.00013105215,0.00017613544],"domain_scores_gemma":[0.9987975,0.0004967922,0.00022426195,0.00028847074,0.00010063577,0.000092378665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016395516,0.0001442501,0.0004668076,0.00007770333,0.00006379653,0.0000084874455,0.0000910194,0.0001649708,0.000007186641],"category_scores_gemma":[0.0005778784,0.000090711015,0.0001331563,0.00018237192,0.00015150815,0.000027379605,0.00005909302,0.00013901107,9.655848e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10271495,0.005924305,0.59458303,0.00017518143,0.0008996575,0.00026373033,0.00055703183,0.000008837988,0.1676731,0.0015335887,0.0023525553,0.123314016],"study_design_scores_gemma":[0.18582626,0.009109107,0.7672859,0.00010567885,0.0008166547,0.0000771579,0.000029683482,0.00009008621,0.032724556,0.00003744622,0.003794326,0.00010314934],"about_ca_topic_score_codex":0.000032278364,"about_ca_topic_score_gemma":0.00006162358,"teacher_disagreement_score":0.17270285,"about_ca_system_score_codex":0.00004487283,"about_ca_system_score_gemma":0.0002754312,"threshold_uncertainty_score":0.36990878},"labels":[],"label_agreement":null},{"id":"W4416085230","doi":"10.1093/neuonc/noaf201.1135","title":"IMG-56. Primary tumor type influences anatomical destination in large metastases to the brain and shows a preference for the posterior fossa","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Radiosurgery; Melanoma; Primary tumor; Lung; Posterior fossa; Brain metastasis; Lesion; Posterior cranial fossa","score_opus":0.03588076848827815,"score_gpt":0.34060595360510065,"score_spread":0.3047251851168225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416085230","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94481647,0.0010215596,0.00029092364,0.051349606,0.00022979872,0.0019146224,0.00007762511,0.000023215427,0.00027619582],"genre_scores_gemma":[0.9682802,0.000045754863,0.0013722557,0.029799834,0.00005494716,0.000357784,0.000021751513,0.000009972059,0.00005752149],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99885464,0.00025873177,0.00024198923,0.00029151895,0.000106156054,0.0002469541],"domain_scores_gemma":[0.9969926,0.002566363,0.000063564985,0.00023269952,0.000081619364,0.000063178566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062724226,0.00013220604,0.00029438874,0.00009930483,0.00012146223,0.000025662092,0.00013102307,0.000050410177,0.000024400406],"category_scores_gemma":[0.0013887985,0.00007183748,0.00005605218,0.00028206932,0.000089408415,0.000043870696,0.00013356241,0.00017098355,0.00000483293],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008795506,0.0020486857,0.11622255,0.00048020575,0.0006147698,0.00058332947,0.00225222,0.0000771916,0.13598283,0.0149587365,0.038360037,0.67962396],"study_design_scores_gemma":[0.0077423407,0.00588892,0.45848507,0.00011890773,0.000751117,0.00037192757,0.00073286035,0.0012058653,0.0044391,0.0011098156,0.5189329,0.0002211988],"about_ca_topic_score_codex":0.000052847176,"about_ca_topic_score_gemma":0.0007176401,"teacher_disagreement_score":0.67940277,"about_ca_system_score_codex":0.00010180249,"about_ca_system_score_gemma":0.00032595708,"threshold_uncertainty_score":0.29294473},"labels":[],"label_agreement":null},{"id":"W4416085232","doi":"10.1093/neuonc/noaf201.1737","title":"TMET-46. Investigating metabolic dependencies during the evolution of glioblastoma","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Phenotype; Glioblastoma; Reprogramming; Mitochondrion; Disease; Cancer; Stem cell; Gene deletion; Metabolic stability","score_opus":0.008222305155592906,"score_gpt":0.25902600891243377,"score_spread":0.25080370375684086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416085232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850541,0.0088629145,0.000310602,0.00046671415,0.0018081551,0.00023452997,0.000012515845,0.000021383774,0.0032291051],"genre_scores_gemma":[0.99693686,0.00080755557,0.00028186283,0.0006929418,0.0008073066,0.00005593074,0.000004733293,0.000016646769,0.0003961746],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986816,0.00023540707,0.00032208106,0.00033981426,0.0001309803,0.00029009368],"domain_scores_gemma":[0.99915254,0.00007659966,0.00017981156,0.00040958825,0.00012246,0.000059004575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025587736,0.00015970135,0.0002855319,0.00010837505,0.00016041938,0.000011814001,0.00031238902,0.0002002921,0.0000129638975],"category_scores_gemma":[0.0005435012,0.00013119658,0.00013253374,0.00030013616,0.00026735917,0.0000061376068,0.00025193224,0.00020211803,0.000004633936],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008821104,0.000035995305,0.0017040384,0.000027810482,0.000054853303,0.0000012257187,0.000099405355,0.000108885375,0.98908174,0.0014645237,0.0012621086,0.0060712122],"study_design_scores_gemma":[0.0006836267,0.00017659458,0.011023035,0.000008737623,0.00007393383,0.000040792453,0.00028395333,0.000036813908,0.63401353,0.0002498571,0.35331002,0.00009910088],"about_ca_topic_score_codex":0.00013045123,"about_ca_topic_score_gemma":0.00046856352,"teacher_disagreement_score":0.3550682,"about_ca_system_score_codex":0.000051668263,"about_ca_system_score_gemma":0.0005395112,"threshold_uncertainty_score":0.5350041},"labels":[],"label_agreement":null},{"id":"W4416085259","doi":"10.1093/neuonc/noaf201.1278","title":"NCOG-11. Factors influencing social competence in adolescents and young adults surviving pediatric brain tumors treated with radiation therapy: A scoping review","year":2025,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Social competence; Social skills; Cognition; Formative assessment; Population; Competence (human resources); Checklist; Young adult","score_opus":0.036964899492369745,"score_gpt":0.3592557865811217,"score_spread":0.322290887088752,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416085259","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04878635,0.9450376,0.000004050152,0.00047789756,0.00036112193,0.005086863,0.000029375082,0.0001326806,0.00008405831],"genre_scores_gemma":[0.006692454,0.9895758,0.000025088539,0.0027867057,0.00045159113,0.00023407325,0.0001294044,0.00009790323,0.0000069478306],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99352384,0.0023676234,0.001750606,0.0011432256,0.0005605329,0.0006541896],"domain_scores_gemma":[0.9962308,0.001566763,0.0014007087,0.00042528563,0.00015125012,0.00022522922],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011386675,0.00081238436,0.0045428327,0.00076217233,0.00017335505,0.000037199774,0.00030313325,0.0005221393,0.000015975143],"category_scores_gemma":[0.001526722,0.00068574154,0.0003245955,0.001630395,0.00013068049,0.00015731015,0.00015291576,0.0012259721,0.0000046868668],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015447356,0.00025928958,0.2225429,0.36303285,0.00009003852,0.0002475744,0.0020557137,3.3384921e-7,0.0000046597734,0.0000032909413,0.00018442847,0.41142443],"study_design_scores_gemma":[0.005741797,0.0012611597,0.06180548,0.90608674,0.0015044508,0.00030075666,0.00026611701,0.00000417171,0.0000029748676,0.0000014576373,0.021975268,0.0010496126],"about_ca_topic_score_codex":0.0012768536,"about_ca_topic_score_gemma":0.0035867821,"teacher_disagreement_score":0.54305387,"about_ca_system_score_codex":0.00080869085,"about_ca_system_score_gemma":0.0036199233,"threshold_uncertainty_score":0.9995594},"labels":[],"label_agreement":null},{"id":"W4416085285","doi":"10.1093/neuonc/noaf201.1114","title":"IMG-35. Targeted blood-nerve-barrier opening for the delivery of MEK inhibitor selumetinib in peripheral nerve sheath tumours using focused ultrasound","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Ultrasound and Hyperthermia Applications","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Sciatic nerve; Selumetinib; Neurofibromatosis; Adverse effect; Malignant peripheral nerve sheath tumor; Nerve sheath neoplasm; Peripheral; Ultrasound","score_opus":0.016410562931266987,"score_gpt":0.26292544764626946,"score_spread":0.24651488471500246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416085285","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99329996,0.00093895517,0.003164835,0.00026278765,0.0005898252,0.00084818713,0.00006344887,0.00012158351,0.0007103994],"genre_scores_gemma":[0.9949429,0.00007504497,0.004144628,0.00027980015,0.00017298001,0.00025680184,0.00001764663,0.000059467486,0.00005075277],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984934,0.00012050856,0.000524821,0.00031835467,0.00011448378,0.00042848726],"domain_scores_gemma":[0.99757123,0.0018561733,0.00008989298,0.00032377464,0.000090431095,0.00006846949],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002946364,0.00024021526,0.00044485094,0.00016282462,0.00018277325,0.000041446277,0.0003535343,0.00020203674,0.00005588026],"category_scores_gemma":[0.00018977774,0.00021124675,0.00015799893,0.0004768088,0.00012822326,0.00011906278,0.000049594848,0.00037492678,0.0000020492753],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000066094624,0.000095935335,0.0045444127,0.000051187802,0.00008867609,0.00000956235,0.00074943097,0.018839465,0.97251934,0.00032573487,0.00039922612,0.0023109538],"study_design_scores_gemma":[0.011825727,0.0009812154,0.011825788,0.00022947657,0.0012856317,0.00023687271,0.0029508001,0.11604237,0.7345728,0.00095019897,0.117748275,0.0013508046],"about_ca_topic_score_codex":0.00017223156,"about_ca_topic_score_gemma":0.0002701223,"teacher_disagreement_score":0.23794648,"about_ca_system_score_codex":0.00014590535,"about_ca_system_score_gemma":0.00022765972,"threshold_uncertainty_score":0.8614392},"labels":[],"label_agreement":null},{"id":"W4416085315","doi":"10.1093/neuonc/noaf201.1333","title":"NCOG-66. ‘Core outcome set’ for leptomeningeal disease (LeptoCOS): a multi-disciplinary, international, consensus effort","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Randomized controlled trial; Outcome (game theory); Clinical trial; Systematic review; Disease; Meta-analysis","score_opus":0.12044128569535015,"score_gpt":0.44523600348808906,"score_spread":0.32479471779273894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416085315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90423876,0.0004680983,0.002272456,0.07478815,0.0051333704,0.0056922296,0.0006416525,0.00032385575,0.0064414325],"genre_scores_gemma":[0.9762007,0.00003580564,0.012181555,0.006534939,0.0003424994,0.0011020855,0.00044997543,0.00005142778,0.003101025],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981968,0.0000706395,0.0005379263,0.0005781593,0.00020139644,0.0004151195],"domain_scores_gemma":[0.99822086,0.0007263029,0.00016200976,0.00041456957,0.00016798942,0.00030828742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002655269,0.0002780555,0.00058562827,0.00024317885,0.00015766386,0.00001915712,0.00018275017,0.00014067159,0.00016525335],"category_scores_gemma":[0.00046775848,0.0002326554,0.00031882076,0.00017185968,0.00017502964,0.00003035392,0.00020560881,0.0002606177,0.000053150725],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0153297605,0.0068494948,0.7218502,0.00092551514,0.001996633,0.008700105,0.00092635007,0.00021755589,0.018711638,0.009263398,0.147256,0.06797331],"study_design_scores_gemma":[0.030353263,0.003627761,0.0682359,0.00013131995,0.001572626,0.00039401118,0.00047389872,0.0075314385,0.0009309069,0.0011025966,0.88522655,0.00041971187],"about_ca_topic_score_codex":0.000016173206,"about_ca_topic_score_gemma":0.000027513388,"teacher_disagreement_score":0.7379706,"about_ca_system_score_codex":0.0003781505,"about_ca_system_score_gemma":0.00048269457,"threshold_uncertainty_score":0.94874114},"labels":[],"label_agreement":null},{"id":"W4416085317","doi":"10.1093/neuonc/noaf201.1152","title":"IMG-73. Functional connectivity alterations in disorders of consciousness: a systematic review and exploratory coordinate-based meta-analysis","year":2025,"lang":"en","type":"review","venue":"Neuro-Oncology","topic":"Traumatic Brain Injury Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Minimally conscious state; Persistent vegetative state; Functional connectivity; Default mode network; Functional magnetic resonance imaging; Wakefulness; Precuneus; Brain mapping; Neuroimaging; Prefrontal cortex","score_opus":0.155851679966577,"score_gpt":0.4102132863960282,"score_spread":0.2543616064294512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416085317","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000079442425,0.98958176,0.00048803442,0.0021037299,0.00011587528,0.006931789,0.00021692058,0.000040642433,0.000513287],"genre_scores_gemma":[0.0006609046,0.99193674,0.000127736,0.0013557273,0.0000170222,0.0055452045,0.00020642321,0.000041537,0.00010869198],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9914986,0.004793471,0.0020881975,0.0007998866,0.00046820776,0.0003516491],"domain_scores_gemma":[0.9849821,0.012552506,0.000960873,0.0009892433,0.0003474295,0.0001678699],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0025696866,0.00052448676,0.012867857,0.0016569623,0.000079538884,0.000018407281,0.0002449388,0.00040928271,0.00048676046],"category_scores_gemma":[0.0054508075,0.0003850972,0.0020290283,0.0026751691,0.0003935745,0.0000741826,0.00012701667,0.0009286272,0.000018641073],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035106634,0.00045754187,0.000024945357,0.95946354,0.03475187,0.000047513757,0.000037292,0.0000066188195,0.000003388681,0.00023455816,0.00093203137,0.004005593],"study_design_scores_gemma":[0.0012558583,0.0006512068,0.000012572513,0.05917412,0.89203835,0.000088596316,0.000076473945,0.000099507815,0.0000017977732,0.00006292905,0.04617672,0.0003618828],"about_ca_topic_score_codex":0.000039126182,"about_ca_topic_score_gemma":0.0005611771,"teacher_disagreement_score":0.9002894,"about_ca_system_score_codex":0.0003387656,"about_ca_system_score_gemma":0.003041923,"threshold_uncertainty_score":0.9998601},"labels":[],"label_agreement":null},{"id":"W4416085335","doi":"10.1093/neuonc/noaf201.1397","title":"EXTH-64. Allogeneic CAR-DNT cell therapy to overcome spatial heterogeneity in glioblastoma","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Fonds Wetenschappelijk Onderzoek","keywords":"Chimeric antigen receptor; Cytotoxicity; Cytotoxic T cell; Cell therapy; In vitro; Glioblastoma; Immunotherapy; CD19; Antigen; Cell","score_opus":0.02928261303002896,"score_gpt":0.35076667718269267,"score_spread":0.32148406415266373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416085335","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98363173,0.00045750715,0.000116568764,0.0046157744,0.00095532543,0.0015867099,0.000011953615,0.000095028336,0.008529425],"genre_scores_gemma":[0.9866341,0.00046165354,0.00014150805,0.0106719,0.00034006883,0.00022384505,0.000007413712,0.000059937636,0.0014596167],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968774,0.0005696946,0.00053665094,0.0007862076,0.0004261501,0.0008039492],"domain_scores_gemma":[0.99812853,0.0005293288,0.00007469296,0.00080214,0.00013795524,0.00032734935],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00049559504,0.00032301285,0.00078980107,0.0006909996,0.000075165415,0.000024522025,0.00038592832,0.000362446,0.0014943033],"category_scores_gemma":[0.00015145882,0.00030435703,0.00021167063,0.00079916604,0.00012967945,0.000043303648,0.00027384248,0.0007477268,0.00018841811],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044060033,0.00067645963,0.026948119,0.000039501214,0.000048195387,0.00074964424,0.0003584541,0.000056808272,0.8790224,0.00001681697,0.0018861934,0.0857914],"study_design_scores_gemma":[0.006077971,0.004990905,0.032653015,0.000022475164,0.00002187947,0.000098527926,0.000047159006,0.00013593977,0.5566103,0.00004444919,0.39910161,0.00019576316],"about_ca_topic_score_codex":0.0007430923,"about_ca_topic_score_gemma":0.0029739828,"teacher_disagreement_score":0.39721543,"about_ca_system_score_codex":0.00082676986,"about_ca_system_score_gemma":0.00078820024,"threshold_uncertainty_score":0.9999409},"labels":[],"label_agreement":null},{"id":"W4416085345","doi":"10.1093/neuonc/noaf201.1068","title":"PTHP-11. Assessment of Molecular Tools in Pediatric, Adolescent and Young Adult Meningioma Highlights Unique Biology and Underscores the Need for Lifespan Precision in Neuro-Oncology","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Meningioma; Young adult; DNA methylation; Cohort; Brain tumor; Precision medicine; Methylation; Clinical Practice","score_opus":0.02481008278023731,"score_gpt":0.3387759911833526,"score_spread":0.3139659084031153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416085345","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97463185,0.00046568655,0.0020006387,0.017715698,0.0006060443,0.002499101,0.0000078888515,0.00003282552,0.0020402635],"genre_scores_gemma":[0.99533176,0.00052325684,0.0020008164,0.0016957851,0.00007881499,0.00029359473,0.000021737316,0.000023876568,0.000030333396],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99700075,0.0008034581,0.0008650738,0.00068822753,0.00015303527,0.0004894556],"domain_scores_gemma":[0.9972171,0.0018282016,0.0002960363,0.00039338286,0.00014394488,0.00012133722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008260145,0.00029789927,0.0008665305,0.0007887231,0.00008403686,0.000024334815,0.0002309687,0.0003559204,0.0000049051155],"category_scores_gemma":[0.00073524896,0.0002293689,0.000090901485,0.0005389052,0.00021883262,0.00007515114,0.00035392947,0.0004187241,4.8040835e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023313812,0.001181428,0.5254288,0.0007680425,0.0001287409,0.0019095795,0.0011933479,0.00012483519,0.3477609,0.102230564,0.00273146,0.014210969],"study_design_scores_gemma":[0.028960355,0.014410574,0.8647452,0.00036854326,0.0010608623,0.0007823303,0.0018098681,0.009412371,0.023837881,0.008107382,0.045703027,0.00080159557],"about_ca_topic_score_codex":0.00013510174,"about_ca_topic_score_gemma":0.0004577658,"teacher_disagreement_score":0.33931643,"about_ca_system_score_codex":0.0002560201,"about_ca_system_score_gemma":0.00043255652,"threshold_uncertainty_score":0.9353392},"labels":[],"label_agreement":null},{"id":"W4416085364","doi":"10.1093/neuonc/noaf201.1178","title":"IMG-99. Volumetric tumor growth rate (TGR) modeling predicts clinical outcomes in patients with Grade 2, isocitrate dehydrogenase 1/2 mutant (mIDH1/2) glioma receiving vorasidenib or placebo in the Phase 3 INDIGO trial","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre; Toronto General Hospital","funders":"","keywords":"Glioma; Placebo; Isocitrate dehydrogenase; Confidence interval; Proportional hazards model; Multivariate analysis; Clinical trial; Astrocytoma; Oligodendroglioma","score_opus":0.04054604603426565,"score_gpt":0.3550506624591637,"score_spread":0.3145046164248981,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416085364","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922753,0.00010559227,0.000032879165,0.0021988775,0.00084207574,0.004307723,0.000038590686,0.00007461964,0.00012431496],"genre_scores_gemma":[0.99631906,0.000077941324,0.00014655077,0.0025170888,0.0001358796,0.0006970519,0.0000469855,0.000052614858,0.0000068523373],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99462163,0.001591383,0.0015827591,0.0009051201,0.00051080744,0.0007883103],"domain_scores_gemma":[0.9947187,0.003897149,0.0004296726,0.0005561537,0.00016309725,0.00023526847],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001651412,0.00048472878,0.0014228909,0.0011750277,0.00015574343,0.000061982755,0.00036699988,0.00030985134,0.00003180857],"category_scores_gemma":[0.0040741977,0.00029335832,0.00025704643,0.002331387,0.00016347786,0.00016792835,0.00012334184,0.0009751341,0.000014694697],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07621042,0.016781744,0.8929422,0.000065686494,0.00033248056,0.008188786,0.00060946407,0.00030462933,0.0007826627,0.00004151633,0.00034088772,0.0033995432],"study_design_scores_gemma":[0.71842325,0.027779415,0.228792,0.00036534754,0.001252041,0.0001649528,0.0005105966,0.018317671,0.0030612412,0.00027352234,0.00042847972,0.00063150516],"about_ca_topic_score_codex":0.00024033528,"about_ca_topic_score_gemma":0.0008988233,"teacher_disagreement_score":0.6641502,"about_ca_system_score_codex":0.0004899012,"about_ca_system_score_gemma":0.0010235722,"threshold_uncertainty_score":0.99995184},"labels":[],"label_agreement":null},{"id":"W4416085425","doi":"10.1093/neuonc/noaf201.1402","title":"EXTH-69. CD155 regulates tumor growth and immune evasion in diffuse midline glioma","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"FOXO transcription factor regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"TIGIT; Gene silencing; Immune system; Glioma; Small hairpin RNA; Immune checkpoint; Apoptosis; Flow cytometry","score_opus":0.00881963845761368,"score_gpt":0.2583106986159113,"score_spread":0.24949106015829764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416085425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99545795,0.0010199307,0.000120393146,0.0015937772,0.0004036136,0.0002887144,0.000007607283,0.000028273476,0.0010797685],"genre_scores_gemma":[0.9985722,0.0001896365,0.00023938598,0.00069956237,0.000070765986,0.0000309726,0.00008351438,0.000019987545,0.00009402158],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99865806,0.00019193607,0.00035233994,0.00046011977,0.00008759474,0.00024996768],"domain_scores_gemma":[0.9994451,0.000060276096,0.0000860044,0.00028846794,0.000059276314,0.00006089469],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014358704,0.00018357002,0.0002545733,0.00019131051,0.00006212745,0.000017725146,0.00015107104,0.00023617278,0.000019364998],"category_scores_gemma":[0.00018799692,0.00018407474,0.00006554986,0.00022178995,0.00014747804,0.000008933425,0.00010928512,0.00015563512,0.0000058221503],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003528189,0.00022707759,0.003264621,0.000035789966,0.000014951584,0.000034863642,0.000046044366,0.00001139871,0.99325764,0.0003750445,0.00039741574,0.0019823452],"study_design_scores_gemma":[0.0033546533,0.00055238686,0.05134712,0.000021514035,0.000023387374,0.00006887515,0.000038679216,0.00019260393,0.918187,0.00045284882,0.025591712,0.00016919065],"about_ca_topic_score_codex":0.000038469243,"about_ca_topic_score_gemma":0.0000823823,"teacher_disagreement_score":0.0750706,"about_ca_system_score_codex":0.000039732626,"about_ca_system_score_gemma":0.00009118517,"threshold_uncertainty_score":0.750635},"labels":[],"label_agreement":null},{"id":"W4416085461","doi":"10.1093/neuonc/noaf201.1436","title":"EXTH-103. A prototype mRNA LNP neoantigen vaccine remodels the tumour microenvironment of a syngeneic model of glioblastoma","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Providence Health Care; University of Calgary","funders":"","keywords":"Immune system; Tumor microenvironment; CD8; Temozolomide; Chemokine; Immunotherapy; Cytotoxic T cell; T cell; Adoptive cell transfer","score_opus":0.017035598104492858,"score_gpt":0.28097348341996087,"score_spread":0.263937885315468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416085461","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98833513,0.0009010752,0.0001706605,0.0065872027,0.0001304687,0.0021820734,0.0000208277,0.000025082958,0.0016474556],"genre_scores_gemma":[0.99733627,0.00042128455,0.0005935647,0.0011476026,0.000043751566,0.00035051117,0.000004925747,0.00002661842,0.00007548774],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99837345,0.00013679794,0.00057899475,0.0003833467,0.00022195978,0.0003054342],"domain_scores_gemma":[0.99873465,0.00022465157,0.00026117428,0.0005979152,0.00009410535,0.00008752157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001837522,0.00022834804,0.0006937309,0.00019602902,0.000063539024,0.00000431172,0.00021761356,0.0001394839,0.000073082956],"category_scores_gemma":[0.0000819659,0.00015355147,0.00018234961,0.00027923548,0.00010988838,0.000029908142,0.00016861172,0.00020508873,0.000017122957],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014495808,0.0016977213,0.005104625,0.00014281632,0.00022367756,0.00010952108,0.00026678608,0.0014002671,0.9748664,0.00044576934,0.0017046739,0.012588142],"study_design_scores_gemma":[0.005901014,0.0052929064,0.010336425,0.00017091584,0.0007650719,0.00012764672,0.00009465912,0.013442768,0.9539167,0.00054724934,0.009264554,0.00014005872],"about_ca_topic_score_codex":0.000037092235,"about_ca_topic_score_gemma":0.000040835872,"teacher_disagreement_score":0.020949688,"about_ca_system_score_codex":0.00016594575,"about_ca_system_score_gemma":0.00032752214,"threshold_uncertainty_score":0.62616473},"labels":[],"label_agreement":null},{"id":"W4416085464","doi":"10.1093/neuonc/noaf201.1022","title":"PATH-70. Neuropath-IHC: a deep neural network for virtual immunohistochemistry from digital whole slide images of CNS tumors","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"AI in cancer detection","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Immunohistochemistry; Interpretability; OLIG2; Glioblastoma; Sensitivity (control systems); Gene expression; Lineage markers","score_opus":0.008345121883805378,"score_gpt":0.2592310332279975,"score_spread":0.25088591134419214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416085464","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38050923,0.00066224433,0.60245836,0.0030088525,0.008019616,0.0008959692,0.0001840113,0.00052659685,0.0037351395],"genre_scores_gemma":[0.9923065,0.00001680965,0.0054277414,0.0014084534,0.00047490041,0.00015236823,0.000027013532,0.00003487042,0.0001513881],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976573,0.00015120815,0.00062111765,0.0008121657,0.00022501351,0.0005332206],"domain_scores_gemma":[0.9972101,0.0012917796,0.00037452328,0.00085310475,0.00016911543,0.00010139712],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017326519,0.00028826742,0.0005131082,0.00009801813,0.00018622457,0.00011864865,0.0012412345,0.0001879312,0.000008947355],"category_scores_gemma":[0.00038258565,0.0003136288,0.00021717035,0.0005059136,0.00022242682,0.00045462025,0.00064048654,0.00043169456,0.000013232256],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028578565,0.00016111591,0.00075618806,0.00004346318,0.000041126066,0.00011798833,0.000292138,0.0033692964,0.8071122,0.0006316438,0.01060568,0.17658335],"study_design_scores_gemma":[0.0075443457,0.0082119275,0.0082297465,0.00021573712,0.00022766297,0.00041138873,0.0004132664,0.31769827,0.44279823,0.016392868,0.19609655,0.0017599876],"about_ca_topic_score_codex":0.000040244853,"about_ca_topic_score_gemma":0.0000059529043,"teacher_disagreement_score":0.6117972,"about_ca_system_score_codex":0.00026212877,"about_ca_system_score_gemma":0.0003477479,"threshold_uncertainty_score":0.9999316},"labels":[],"label_agreement":null},{"id":"W4416085530","doi":"10.1093/neuonc/noaf201.1066","title":"PTHP-09. High-resolution proteomic analysis of medulloblastoma clinical samples identifies MYC immunohistochemistry as a powerful outcome predictor outperforming genetic amplification detection","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Dalhousie University; University of Toronto; BC Children's Hospital; BC Cancer Agency; University of Manitoba; BC Cancer Foundation; Spinal Cord Injury BC; McMaster University","funders":"","keywords":"Medulloblastoma; Immunohistochemistry; Biomarker; Targeted therapy; Wnt signaling pathway; Confidence interval","score_opus":0.025580828199294987,"score_gpt":0.35324615708224105,"score_spread":0.3276653288829461,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416085530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958127,0.00033527767,0.0010147374,0.0007787102,0.00077559124,0.0009040314,0.000031114847,0.00008361308,0.00026420198],"genre_scores_gemma":[0.99847066,0.00012535,0.00060857786,0.00025085686,0.000100972524,0.00026051403,0.00009729104,0.000019808784,0.000065978704],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9973902,0.00020696253,0.0012458984,0.00058830186,0.00028225002,0.00028639392],"domain_scores_gemma":[0.9979235,0.0005416086,0.000544099,0.00062485976,0.00024913508,0.00011681218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038723677,0.00023501477,0.0009111501,0.00060699455,0.00012445997,0.00001850229,0.00015920865,0.0003601617,0.000103906415],"category_scores_gemma":[0.0011585762,0.00021713629,0.00043648024,0.00079738826,0.00022815776,0.000059027843,0.00009237224,0.00030927986,0.00003145398],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057168776,0.00074048934,0.22248267,0.000090104186,0.0011145234,0.000028335286,0.00008493074,0.00012487709,0.763422,0.000044719545,0.00013040236,0.011165269],"study_design_scores_gemma":[0.0025727015,0.0012778355,0.7103779,0.000052396877,0.0049315044,0.000038897142,0.00011701094,0.0014386756,0.2775058,0.00008395996,0.0014701516,0.0001332235],"about_ca_topic_score_codex":0.00034732738,"about_ca_topic_score_gemma":0.00009227734,"teacher_disagreement_score":0.4878952,"about_ca_system_score_codex":0.0005286816,"about_ca_system_score_gemma":0.00030782606,"threshold_uncertainty_score":0.8854561},"labels":[],"label_agreement":null},{"id":"W4416085532","doi":"10.1093/neuonc/noaf201.1061","title":"PTHP-04. Integrated clinical and molecular landscape of 269 disseminated pediatric low-grade glioma","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Epigenetics; Malignancy; Cohort; Glioma; Chemotherapy; Central nervous system; Precision medicine","score_opus":0.014579578834798797,"score_gpt":0.33574457712214506,"score_spread":0.32116499828734624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416085532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924518,0.0016464886,0.000020052674,0.0031022234,0.00042533278,0.00043209924,0.000013867294,0.000057769616,0.001850386],"genre_scores_gemma":[0.99808145,0.0006587329,0.00021367072,0.0008552915,0.000067479996,0.000044155906,0.000040022867,0.000018852921,0.000020370468],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984073,0.00021625531,0.0006184771,0.00036538477,0.00013833572,0.00025424306],"domain_scores_gemma":[0.9984934,0.00073089974,0.00016194045,0.0003078482,0.00013504004,0.00017091274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020793022,0.00019745475,0.0006989668,0.00036364282,0.00003722811,0.000008643554,0.00009838714,0.00029317656,0.00005474017],"category_scores_gemma":[0.0005508911,0.00015263274,0.00015106345,0.0007412201,0.0001628156,0.000023718056,0.00009284278,0.00030797883,0.000011677673],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051294244,0.0029878737,0.6765549,0.00016351746,0.00022637473,0.002906231,0.00009009634,0.0000032275348,0.28508076,0.0005952881,0.013563167,0.017315583],"study_design_scores_gemma":[0.031096522,0.009410123,0.48565426,0.00026725224,0.0035833812,0.00067812373,0.0005471565,0.0010689618,0.41429108,0.00042847157,0.052435096,0.00053954776],"about_ca_topic_score_codex":0.000021043004,"about_ca_topic_score_gemma":0.000010269439,"teacher_disagreement_score":0.19090065,"about_ca_system_score_codex":0.000039065915,"about_ca_system_score_gemma":0.0002479232,"threshold_uncertainty_score":0.6224182},"labels":[],"label_agreement":null},{"id":"W4416085626","doi":"10.1093/neuonc/noaf201.1491","title":"QLTI-14. Enhancing Awareness and Use of Support Services for Adolescents and Young Adults with High-Grade Glioma: Evaluating 1-Minute Videos and Centralized Resource Navigator","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Resource (disambiguation); Focus group; Psychological intervention; Young adult; Perception; Standardization","score_opus":0.02789915426306975,"score_gpt":0.34236100862684726,"score_spread":0.3144618543637775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416085626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99515194,0.00045593633,0.00014309712,0.002300189,0.00032258255,0.0014806321,0.0000642893,0.00006425923,0.00001709671],"genre_scores_gemma":[0.9942971,0.00012994246,0.0027524407,0.0025061334,0.00011844684,0.00007922266,0.000048314425,0.000042637486,0.000025759695],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975292,0.00031836145,0.0006678074,0.00070690457,0.000348663,0.00042905676],"domain_scores_gemma":[0.99798584,0.0008087628,0.0003877881,0.00033429047,0.00023368878,0.00024960702],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000612111,0.00029436007,0.00090837444,0.00017534023,0.00016789921,0.000038848848,0.0001049462,0.00020732457,0.000004414564],"category_scores_gemma":[0.00042802392,0.00026904527,0.000051259372,0.00024040334,0.00023200069,0.00017041138,0.00017494519,0.00026305002,2.897806e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014236159,0.00067205937,0.59199345,0.011987548,0.00033651502,0.00022252067,0.01601462,0.0000099345525,0.3482256,0.000088924004,0.0007179357,0.015494725],"study_design_scores_gemma":[0.08603594,0.0122801205,0.6189787,0.011626768,0.0027567744,0.0015503728,0.008428659,0.0027837807,0.22937231,0.00014314835,0.024866069,0.001177402],"about_ca_topic_score_codex":0.0011576717,"about_ca_topic_score_gemma":0.0022752213,"teacher_disagreement_score":0.11885329,"about_ca_system_score_codex":0.00008552918,"about_ca_system_score_gemma":0.000408869,"threshold_uncertainty_score":0.99997616},"labels":[],"label_agreement":null},{"id":"W4416085639","doi":"10.1093/neuonc/noaf201.1375","title":"EXTH-41. A bench-top model for the sonodynamic therapy of medulloblastoma","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Ultrasound and Hyperthermia Applications","field":"Engineering","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Sonodynamic therapy; Intracellular; Apoptosis; Ultrasound; Viability assay; Programmed cell death","score_opus":0.01475132279999933,"score_gpt":0.27103054795066545,"score_spread":0.2562792251506661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416085639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6190313,0.0018582066,0.35316128,0.005726704,0.00086638896,0.0015821824,0.00008756143,0.00039178907,0.01729457],"genre_scores_gemma":[0.99668,0.00071409735,0.0011224892,0.0008637667,0.00004765383,0.00042611404,0.0000052002965,0.000023664345,0.00011699626],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99941754,0.000017427368,0.00019133465,0.0001411481,0.000049787657,0.00018272919],"domain_scores_gemma":[0.99890393,0.0007220777,0.000031127765,0.00027644332,0.000041034986,0.00002535917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007477495,0.000107562606,0.00018528437,0.00005904023,0.000082251885,0.000008181247,0.00025614785,0.00010571387,0.000019668021],"category_scores_gemma":[0.000025893214,0.00008185684,0.00008659586,0.00014510924,0.00007118618,0.000027560189,0.000018564944,0.00013719688,0.0000058976266],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048641574,0.000105456704,0.00008594556,0.000027734677,0.00009364308,5.68339e-7,0.0007079453,0.07441098,0.7972004,0.013593269,0.004185954,0.10953947],"study_design_scores_gemma":[0.00065759197,0.0000941987,0.00022087697,0.000003906843,0.000028459046,0.000005531712,0.00008230832,0.7878881,0.008683067,0.0032370088,0.19901505,0.00008391114],"about_ca_topic_score_codex":0.000006388557,"about_ca_topic_score_gemma":0.00006083035,"teacher_disagreement_score":0.7885173,"about_ca_system_score_codex":0.000048219477,"about_ca_system_score_gemma":0.00009581039,"threshold_uncertainty_score":0.3338025},"labels":[],"label_agreement":null},{"id":"W4416085660","doi":"10.1093/neuonc/noaf201.1392","title":"EXTH-59. Supporting development of novel brain tumour therapies through global collaboration: early insights from a novel therapeutics accelerator","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cooke Aquaculture (Canada)","funders":"","keywords":"Multidisciplinary approach; Clinical trial; Process (computing); Drug development; Brain cancer","score_opus":0.028491215492830436,"score_gpt":0.32341595017229774,"score_spread":0.2949247346794673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416085660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9744671,0.0006237275,0.018754723,0.0027117624,0.00064899964,0.0004091465,0.00006676922,0.000029450513,0.0022883418],"genre_scores_gemma":[0.9790623,0.00004194159,0.014645967,0.0057786927,0.00018679201,0.000058548707,0.00012662057,0.000017685035,0.00008141544],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984568,0.00010116988,0.0005921637,0.00044282887,0.00016799622,0.00023907256],"domain_scores_gemma":[0.99900824,0.000070917486,0.0003177508,0.00028470313,0.00026741368,0.000050949435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011545388,0.00022037818,0.0002946355,0.0000433018,0.00014520789,0.00004251872,0.00029373067,0.00030362722,0.000021962489],"category_scores_gemma":[0.00014023659,0.0002072697,0.000070458176,0.00032709987,0.000117097334,0.00001899092,0.00016975177,0.000133326,0.0000043828745],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016612365,0.00030083064,0.0008136064,0.000009523228,0.00011736312,0.0000022822794,0.00091912696,0.0000055220353,0.98968166,0.0015706699,0.0012110763,0.0052022077],"study_design_scores_gemma":[0.0014486205,0.000273744,0.0021888507,0.000012089953,0.000017078204,0.0000028546815,0.0004649089,0.00003070943,0.7005372,0.0001551904,0.29472178,0.00014694736],"about_ca_topic_score_codex":0.000028368528,"about_ca_topic_score_gemma":0.00020587139,"teacher_disagreement_score":0.2935107,"about_ca_system_score_codex":0.00008795514,"about_ca_system_score_gemma":0.0012715829,"threshold_uncertainty_score":0.8452213},"labels":[],"label_agreement":null},{"id":"W4416085666","doi":"10.1093/neuonc/noaf201.1053","title":"PATH-101. Neuropath-AI, a histopathology-based deep learning classifier for CNS tumors, achieves and improves human neuropathologist-level performance","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Tumor Detection and Classification","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Classifier (UML); Deep learning; Limiting; Pattern recognition (psychology); Artificial neural network; Probabilistic classification","score_opus":0.043727238303425627,"score_gpt":0.3035716370540142,"score_spread":0.25984439875058857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416085666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9766793,0.00007580478,0.0097128395,0.005767797,0.0017456801,0.0011976857,0.00003333856,0.0006306101,0.004156894],"genre_scores_gemma":[0.98304164,0.000057004403,0.00047152906,0.014572257,0.0001361608,0.0004698667,0.000016447419,0.00007005637,0.0011650331],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9956766,0.0012235731,0.00070226303,0.0014546015,0.00022011677,0.00072289194],"domain_scores_gemma":[0.99736124,0.0013162736,0.00044841907,0.00057069206,0.000130431,0.00017295606],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006433129,0.00044301798,0.0005678348,0.0004371936,0.0011774638,0.00011476254,0.00050897297,0.0003066185,0.000021313987],"category_scores_gemma":[0.0028960593,0.0004406317,0.00016063474,0.0005193812,0.000899483,0.00024143043,0.00020263519,0.0012105335,0.000028955921],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028783455,0.00020723876,0.0022919485,0.00011528544,0.0000016833757,0.00013343699,0.00013257725,0.000053740256,0.9444187,0.0028003033,0.0003695695,0.04918767],"study_design_scores_gemma":[0.0054063387,0.0076560187,0.14067543,0.00006924132,0.0001448255,0.0010001117,0.00024613162,0.06446637,0.4184641,0.00094402186,0.35984528,0.0010821371],"about_ca_topic_score_codex":0.0000045105066,"about_ca_topic_score_gemma":0.000015835476,"teacher_disagreement_score":0.5259546,"about_ca_system_score_codex":0.00018565138,"about_ca_system_score_gemma":0.0002627298,"threshold_uncertainty_score":0.99980456},"labels":[],"label_agreement":null},{"id":"W4416085702","doi":"10.1093/neuonc/noaf201.1479","title":"QLTI-02. Management of adverse events occurring with MAPK-directed therapies in patients with pediatric low-grade glioma: Recommendations from an expert Delphi consensus initiative","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation","funders":"","keywords":"Delphi method; Adverse effect; Pharmacovigilance; Tolerability; Health professionals; Health care; MEDLINE; Alternative medicine","score_opus":0.02160847441616567,"score_gpt":0.3100461480209018,"score_spread":0.28843767360473616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416085702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965544,0.00016845127,0.000018749182,0.0013321372,0.00021377718,0.0011322002,0.00008132792,0.00006710121,0.00043190047],"genre_scores_gemma":[0.99603957,0.000109939974,0.002507516,0.00085671426,0.000026060397,0.0002590294,0.00017476181,0.000024034096,0.0000024012757],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984508,0.0002361007,0.00040089522,0.00043532753,0.0002098236,0.00026704787],"domain_scores_gemma":[0.99882096,0.00037300563,0.00022835999,0.00031762588,0.00016363831,0.00009641913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000067300236,0.00023977355,0.0004813163,0.0004667926,0.00006903808,0.0000031757281,0.00010168119,0.00009553365,0.00005777511],"category_scores_gemma":[0.00002845259,0.00018278466,0.000048197195,0.00071702653,0.000071647555,0.00006940096,0.00006475417,0.00016800466,0.0000043838877],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019111391,0.0067319735,0.9822628,0.00005998395,0.0005897963,0.0006661214,0.0017787033,0.000029476174,0.0005753133,0.00008376176,0.0005199708,0.0047909846],"study_design_scores_gemma":[0.024460195,0.0028761914,0.9663473,0.0002887201,0.000501284,0.0000060932166,0.002077277,0.00008200787,0.002287251,0.000054905864,0.0008239855,0.00019479233],"about_ca_topic_score_codex":0.00014300479,"about_ca_topic_score_gemma":0.00023951434,"teacher_disagreement_score":0.022549056,"about_ca_system_score_codex":0.0002369851,"about_ca_system_score_gemma":0.00014442745,"threshold_uncertainty_score":0.7453742},"labels":[],"label_agreement":null},{"id":"W4416085714","doi":"10.1093/neuonc/noaf201.1149","title":"IMG-70. Cerebrovascular disease in pediatric and adult patients with neurofibromatosis type 1: prevalence and characterization","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Moyamoya disease diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Centre Hospitalier de l’Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Ectasia; Moyamoya disease; Magnetic resonance angiography; Neurofibromatosis; Stenosis; Magnetic resonance imaging; Retrospective cohort study; Stroke (engine); Arterial dissection","score_opus":0.005161079378469327,"score_gpt":0.23742101306058128,"score_spread":0.23225993368211195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416085714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99741334,0.00036553672,0.0000026846544,0.0011491526,0.00009979199,0.0007505853,0.000028574359,0.00002801467,0.00016230406],"genre_scores_gemma":[0.99485266,0.003450878,0.00002921263,0.0014076806,0.000028917133,0.000095715564,0.0000946648,0.000014902485,0.000025386],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99903435,0.00009760051,0.00018350538,0.00038691083,0.00012862532,0.00016899609],"domain_scores_gemma":[0.99934757,0.000105902815,0.000063640466,0.00019524366,0.00010149303,0.00018615011],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000032865264,0.00014653862,0.00025420438,0.00016037136,0.000043098673,0.000014104394,0.000035111283,0.000062548774,0.00001810198],"category_scores_gemma":[0.00014362897,0.000117197225,0.000027170547,0.00024151336,0.000046661575,0.00006943301,0.000054063832,0.00009405328,0.0000047495155],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055209664,0.0007384599,0.9944405,0.0004668012,0.000025315881,0.000075458884,0.00004763871,7.0621235e-7,0.00050451636,0.000054927063,0.000070523216,0.0030230302],"study_design_scores_gemma":[0.0036833019,0.0007880908,0.99393404,0.000060797745,0.0005001829,0.000003194346,0.0000029967682,0.000060157145,0.00011748146,0.000010770964,0.0007572188,0.000081769635],"about_ca_topic_score_codex":0.000011391124,"about_ca_topic_score_gemma":0.0000061084816,"teacher_disagreement_score":0.0031312052,"about_ca_system_score_codex":0.000048559952,"about_ca_system_score_gemma":0.000137369,"threshold_uncertainty_score":0.47791642},"labels":[],"label_agreement":null},{"id":"W4416085772","doi":"10.1093/neuonc/noaf201.1146","title":"IMG-67. Confirmatory clinical trial evaluating diagnostic performance of confocal laser endomicroscopy (cCeLL - Ex vivo) for intraoperative brain tumor diagnosis","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Brain tumor; Glioma; Diagnostic accuracy; Clinical trial; Clinical endpoint; Medical imaging; Prospective cohort study","score_opus":0.07703608728317805,"score_gpt":0.4650945993323546,"score_spread":0.3880585120491765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416085772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880692,0.00093438564,0.000055647026,0.0033745195,0.0012776789,0.0046522175,0.00010171294,0.000041089937,0.0014936],"genre_scores_gemma":[0.9908924,0.00053116353,0.0005982179,0.005196769,0.00046190587,0.0020376013,0.00003557313,0.000031174663,0.00021520002],"study_design_codex":"randomized_trial","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99681634,0.0007652541,0.0010381482,0.00055344915,0.00029948313,0.0005273264],"domain_scores_gemma":[0.97937113,0.019397372,0.00027144232,0.00035107398,0.0003478627,0.00026112178],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0013477877,0.0002589855,0.0010446553,0.00015833069,0.0001309537,0.000017653068,0.00019252449,0.00019576175,0.00043453628],"category_scores_gemma":[0.00991894,0.00021679104,0.0002761716,0.00017925478,0.0005096572,0.00007656483,0.00011590252,0.0005606346,0.000041507246],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.49964282,0.008906817,0.194113,0.0017621489,0.0013921579,0.0014119325,0.0011807077,0.000102946426,0.082677975,0.0008249228,0.10120142,0.10678315],"study_design_scores_gemma":[0.2604849,0.08912003,0.004513228,0.00029581334,0.00065745314,0.0000584279,0.00023783262,0.002877786,0.60015136,0.00007190868,0.041269545,0.00026172446],"about_ca_topic_score_codex":0.000056277284,"about_ca_topic_score_gemma":0.000036595407,"teacher_disagreement_score":0.51747334,"about_ca_system_score_codex":0.0003253754,"about_ca_system_score_gemma":0.0024396277,"threshold_uncertainty_score":0.99842095},"labels":[],"label_agreement":null},{"id":"W4416085782","doi":"10.1093/neuonc/noaf201.1072","title":"PTHP-15. Enhancing Medulloblastoma Classification: Integrating IHC and DNA Methylation Data from the SJMB12 Clinical Trial","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Centre Hospitalier Universitaire Sainte-Justine; Alberta Children's Hospital","funders":"","keywords":"Medulloblastoma; Immunohistochemistry; Concordance; Wnt signaling pathway; DNA methylation; Methylation","score_opus":0.12773643792734002,"score_gpt":0.4261634033892406,"score_spread":0.29842696546190056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416085782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9609926,0.00066936185,0.0006512534,0.031809382,0.0018606831,0.00097212155,0.00003333117,0.00006369236,0.0029476194],"genre_scores_gemma":[0.99364424,0.00023301049,0.001093839,0.0038096202,0.00086330966,0.00010267773,0.00021450502,0.00001503091,0.000023758894],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976748,0.0006306883,0.0007150566,0.00061167515,0.00017343622,0.00019434212],"domain_scores_gemma":[0.9921603,0.006554214,0.0002479653,0.00085246423,0.000085739855,0.0000992998],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009548171,0.00016493666,0.00048808198,0.00007295753,0.00017290228,0.00004010626,0.00024128759,0.00023099573,0.00009675441],"category_scores_gemma":[0.0036782753,0.00010779579,0.00008241418,0.00022724147,0.0001634492,0.000089698246,0.00025790406,0.00043293243,0.000032766948],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009710944,0.0018400988,0.032017503,0.00002769672,0.00058539235,0.00017050424,0.00061225996,0.000002224108,0.19531173,0.002930121,0.044871468,0.7119201],"study_design_scores_gemma":[0.10325613,0.0057205176,0.20994358,0.00027836778,0.0025842786,0.00007216119,0.0024105129,0.0101348525,0.029197263,0.001452715,0.63457537,0.00037422893],"about_ca_topic_score_codex":0.00007291793,"about_ca_topic_score_gemma":0.00075904385,"teacher_disagreement_score":0.7115458,"about_ca_system_score_codex":0.0001006674,"about_ca_system_score_gemma":0.00036410117,"threshold_uncertainty_score":0.4403505},"labels":[],"label_agreement":null},{"id":"W4416085830","doi":"10.1093/neuonc/noaf201.1850","title":"TMIC-96. Integrated multi-omics reveals distinct hypoxic sub-niches and associated epigenomic and genomic alterations in glioblastoma","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Epigenomics; Transcriptome; Hypoxia (environmental); Tumor microenvironment; Glioblastoma; Immune system; Gene; Phylogenetic tree; Cell","score_opus":0.01926231134976417,"score_gpt":0.29202998911878514,"score_spread":0.27276767776902094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416085830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950113,0.0010429759,0.000022368187,0.0026123843,0.00022554194,0.0007866063,0.00006218167,0.00005458963,0.00018201726],"genre_scores_gemma":[0.99779934,0.00057561725,0.00022940774,0.0011116341,0.000028293918,0.00012814633,0.000053016884,0.000025113071,0.0000494584],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99841464,0.00024813478,0.0004714526,0.00047580377,0.00006384475,0.00032612472],"domain_scores_gemma":[0.99866354,0.000777827,0.00013826766,0.00021651185,0.00006961146,0.00013425604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022122258,0.00023861723,0.0006140785,0.0003505204,0.00011792314,0.00003298838,0.000069022724,0.0002214551,0.000013662545],"category_scores_gemma":[0.00062042323,0.00021519058,0.000058318336,0.00030997492,0.00013439464,0.000045661047,0.000100646,0.00030001486,0.000011600718],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028632817,0.0009076042,0.30678043,0.000032768025,0.00012924409,0.00036521174,0.0003713935,0.000011920515,0.68079895,0.0001386501,0.00069112476,0.009486391],"study_design_scores_gemma":[0.011751298,0.0016688217,0.9263977,0.00012854318,0.0003673845,0.00016212175,0.00025565512,0.0032396468,0.05095067,0.00027359425,0.0045352736,0.00026933188],"about_ca_topic_score_codex":0.00013849694,"about_ca_topic_score_gemma":0.0028688326,"teacher_disagreement_score":0.62984824,"about_ca_system_score_codex":0.00055331655,"about_ca_system_score_gemma":0.0002509173,"threshold_uncertainty_score":0.8775217},"labels":[],"label_agreement":null},{"id":"W4416085853","doi":"10.1093/neuonc/noaf201.1281","title":"NCOG-14. Deficits in Gait Quantified by Large Language Model-derived NANO Scores Predict Survival in High-grade Glioma","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Bevacizumab; Proportional hazards model; Gait; Survival analysis; Clinical endpoint; Repeated measures design; Cohort","score_opus":0.0190088820304761,"score_gpt":0.3001738062878479,"score_spread":0.28116492425737183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416085853","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991446,0.0010778607,0.000062230196,0.0038791636,0.00062334334,0.0008847127,0.00011733326,0.000103377424,0.0018059548],"genre_scores_gemma":[0.9977128,0.00016557443,0.00016809361,0.0013834469,0.00004522633,0.00024797575,0.00016775208,0.000036843925,0.000072284805],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975748,0.00030155375,0.00056707335,0.0006518911,0.00026071232,0.00064397603],"domain_scores_gemma":[0.99869263,0.00056207826,0.000115579,0.00043371503,0.00005595722,0.00014005213],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00029856572,0.000306115,0.0008294402,0.00058787694,0.000059102138,0.00001887327,0.00018661504,0.0003347936,0.000065510634],"category_scores_gemma":[0.00034803434,0.00027355118,0.000111914545,0.0007291604,0.0000838412,0.00006492751,0.00013586982,0.0003890559,0.000029089315],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058168196,0.003503011,0.10465869,0.00007113601,0.00006940102,0.0029084543,0.0005783756,0.00022037943,0.87654364,0.0013991757,0.0077744247,0.0016916454],"study_design_scores_gemma":[0.06453069,0.0029119276,0.15274046,0.00052955205,0.00046558358,0.0001474779,0.0012424504,0.015118604,0.74853927,0.00057870627,0.012407749,0.00078751246],"about_ca_topic_score_codex":0.0006434911,"about_ca_topic_score_gemma":0.003545244,"teacher_disagreement_score":0.12800434,"about_ca_system_score_codex":0.00033092583,"about_ca_system_score_gemma":0.00030749696,"threshold_uncertainty_score":0.9999717},"labels":[],"label_agreement":null},{"id":"W4416098832","doi":"10.1093/neuonc/noaf252","title":"Assessment of molecular tools in pediatric, adolescent, and young adult meningioma highlights the need for lifespan precision in neuro-oncology","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University of British Columbia; Thompson Rivers University; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Young adult; Precision medicine; MEDLINE; Divergence (linguistics); Disease","score_opus":0.022098865427625587,"score_gpt":0.32783157276396185,"score_spread":0.3057327073363363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416098832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97376674,0.00032644864,0.0011628954,0.0134328455,0.0009775385,0.0027852242,0.0000067625983,0.000037573438,0.007503989],"genre_scores_gemma":[0.9953267,0.00021822077,0.002003145,0.0018520482,0.000118492564,0.00036345338,0.000017119177,0.0000265536,0.00007426622],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9969937,0.0005860514,0.00096508703,0.00065129006,0.00029534032,0.0005085334],"domain_scores_gemma":[0.9974581,0.0014528332,0.00031651766,0.00048238866,0.00017223891,0.00011793771],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008740353,0.00028375385,0.00084894215,0.0007614909,0.00007742421,0.000026764385,0.00029316804,0.00028463933,0.000010451769],"category_scores_gemma":[0.000936684,0.00022297072,0.00013381941,0.0007246612,0.000109012464,0.0000909504,0.00030827185,0.00048087092,0.0000018191082],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003168495,0.0022021057,0.37569815,0.0009977834,0.00014676314,0.004786552,0.0014213466,0.00020107273,0.54236716,0.030330945,0.008776385,0.02990324],"study_design_scores_gemma":[0.023351267,0.008183834,0.87817895,0.0002738256,0.0008324873,0.00048458576,0.00092528225,0.0083327405,0.015556373,0.0011353754,0.062230628,0.00051463983],"about_ca_topic_score_codex":0.00005456086,"about_ca_topic_score_gemma":0.00011285882,"teacher_disagreement_score":0.52681077,"about_ca_system_score_codex":0.00030684588,"about_ca_system_score_gemma":0.00047009063,"threshold_uncertainty_score":0.9092482},"labels":[],"label_agreement":null},{"id":"W4416098852","doi":"10.1093/neuonc/noaf264","title":"A systematic study of molecular diagnosis, treatment, and prognosis in infant-type hemispheric glioma: An individual patient data meta-analysis of 164 patients","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute; NIHR Great Ormond Street Hospital Biomedical Research Centre; Nationales Centrum für Tumorerkrankungen Heidelberg; Great Ormond Street Institute of Child Health; Université de Genève; CRIS Cancer Foundation; Cancer Research UK; Deutsches Krebsforschungszentrum; St. Jude Children's Research Hospital; New York State Department of Health; American Lebanese Syrian Associated Charities; National Institute on Handicapped Research","keywords":"Patient data; Focus (optics); Patient care; Primary care; MEDLINE; Disease","score_opus":0.06564283970459622,"score_gpt":0.35073784239529965,"score_spread":0.2850950026907034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416098852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99291205,0.0032556597,7.323802e-7,0.00013657933,0.0000666094,0.003402779,0.00015778848,0.000015586336,0.000052220304],"genre_scores_gemma":[0.99809873,0.0001200978,0.00012573996,0.0001387456,0.0000031028271,0.001247638,0.00024726018,0.000017904435,7.6896396e-7],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9968563,0.0007198385,0.0011260682,0.0007067756,0.00034569978,0.0002453276],"domain_scores_gemma":[0.997301,0.0007648856,0.00054712076,0.0010591812,0.00020761394,0.00012023612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026274228,0.0003084601,0.0026781207,0.00078552455,0.000033795553,0.000013588206,0.0002461079,0.00012997826,0.00003679376],"category_scores_gemma":[0.00045307408,0.0002187708,0.00025883107,0.0020550205,0.00007249313,0.00008741243,0.00029676507,0.00009617002,7.2287446e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020944199,0.034501296,0.8558895,0.0009115488,0.1010989,0.00037877992,0.0018253389,0.00006915298,0.0034989128,0.000012428238,0.00005589027,0.0015487949],"study_design_scores_gemma":[0.011321559,0.03181794,0.24651109,0.00017829088,0.6824745,0.000014294073,0.002054049,0.00040745197,0.02485971,0.000009408672,0.000094141215,0.00025755985],"about_ca_topic_score_codex":0.0006804444,"about_ca_topic_score_gemma":0.00085893704,"teacher_disagreement_score":0.60937846,"about_ca_system_score_codex":0.00011437374,"about_ca_system_score_gemma":0.00014206032,"threshold_uncertainty_score":0.89212143},"labels":[],"label_agreement":null},{"id":"W4416139653","doi":"10.1093/neuonc/noaf201.1686","title":"TIP-26. A phase II study evaluating the safety, efficacy, and intracranial activity of tarlatamab in recurrent/refractory <i>IDH</i> -mutant gliomas (TARGID)","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Clinical endpoint; Cohort; Refractory (planetary science); Phases of clinical research; Population; Glioma; Progressive disease; Cytotoxic T cell; Astrocytoma","score_opus":0.03478204104979758,"score_gpt":0.3822289957258793,"score_spread":0.3474469546760817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416139653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992026,0.0005547163,0.000006864104,0.004039303,0.0005610398,0.002194678,0.00002242124,0.000044680408,0.0005503065],"genre_scores_gemma":[0.9990963,0.00014750235,0.000062192514,0.00041297326,0.00009228323,0.0001544717,0.0000059635845,0.000024466692,0.0000038741746],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.997541,0.000693799,0.0005789189,0.0005281511,0.000316068,0.00034203156],"domain_scores_gemma":[0.9972684,0.0018243908,0.00025029367,0.00045302403,0.00010217596,0.000101738886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084619824,0.00026017905,0.0007677171,0.00027352583,0.00018629842,0.000012533379,0.0001546805,0.00014742592,0.00004855947],"category_scores_gemma":[0.0008086295,0.00018381675,0.000087912835,0.000575565,0.00017762218,0.00006796724,0.00029029744,0.0005288737,0.0000045661895],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00751273,0.023063216,0.012451346,0.000049258724,0.00020347386,0.0008017303,0.0016212167,0.00000974787,0.4860035,0.0000517519,0.0002492354,0.4679828],"study_design_scores_gemma":[0.25221515,0.21998921,0.3891029,0.00058615225,0.0036614654,0.0006221867,0.002292468,0.006255209,0.09700456,0.00031912883,0.027170902,0.0007806527],"about_ca_topic_score_codex":0.00014486218,"about_ca_topic_score_gemma":0.0003574799,"teacher_disagreement_score":0.46720213,"about_ca_system_score_codex":0.00026667607,"about_ca_system_score_gemma":0.0004500631,"threshold_uncertainty_score":0.749583},"labels":[],"label_agreement":null},{"id":"W4416139683","doi":"10.1093/neuonc/noaf201.1806","title":"TMIC-51. D-serine facilitates aggressive migration and stemness of recurrent glioblastoma cells by interacting with host endothelial cells","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Amino Acid Enzymes and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Manitoba; Health Sciences Centre","funders":"","keywords":"Gene silencing; Angiogenesis; Endothelial stem cell; Endothelium; Stem cell; Tumor microenvironment; Endogeny; Receptor","score_opus":0.00496196013001678,"score_gpt":0.24776453154945785,"score_spread":0.24280257141944106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416139683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964847,0.0011953036,0.0004917399,0.00022431332,0.0007986441,0.00027079022,0.00016209249,0.000010502622,0.0003619179],"genre_scores_gemma":[0.99730617,0.0014413022,0.000354996,0.00026831415,0.00009991306,0.000034472152,0.000042273983,0.000017039065,0.00043552177],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988804,0.00013717053,0.00029117925,0.00038888238,0.00008088816,0.00022151208],"domain_scores_gemma":[0.9992042,0.00010884137,0.00029997577,0.00020876479,0.00011490304,0.00006329753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000092289505,0.00019187818,0.00030064897,0.00006490524,0.00005469462,0.0000135574965,0.00013297088,0.0001509132,0.000012792828],"category_scores_gemma":[0.0000909194,0.00014837035,0.00005079978,0.000088067296,0.00014387228,0.000008131683,0.00013867152,0.00014683692,0.0000023152065],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000877576,0.00009864813,0.0003185209,0.00006109044,0.0000420443,0.00001071345,0.00020699817,0.00002006441,0.9818582,0.000018239003,0.0030371782,0.013450739],"study_design_scores_gemma":[0.0008236139,0.0015187057,0.00008591256,0.000032272153,0.000032538028,0.000019992816,0.00025806652,0.0000571827,0.7402298,0.0000026964822,0.25683713,0.00010210562],"about_ca_topic_score_codex":0.000045751112,"about_ca_topic_score_gemma":0.00020094955,"teacher_disagreement_score":0.25379995,"about_ca_system_score_codex":0.000017018441,"about_ca_system_score_gemma":0.000098734105,"threshold_uncertainty_score":0.60503674},"labels":[],"label_agreement":null},{"id":"W4416139690","doi":"10.1093/neuonc/noaf201.1523","title":"QOL-22. Prognostic associations of the G8 geriatric screening tool in the EORTC Brain Tumor Group trials 1608 and 1709 in newly diagnosed glioblastoma","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Frailty in Older Adults","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Glioblastoma; Clinical trial; Brain tumor; Temozolomide; Randomized controlled trial; Karnofsky Performance Status","score_opus":0.03033635684256785,"score_gpt":0.3248015901651453,"score_spread":0.29446523332257746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416139690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9647352,0.000237018,0.0000650607,0.030774793,0.0005081246,0.0027115506,0.00003316014,0.000036094025,0.0008989695],"genre_scores_gemma":[0.9918787,0.000040163803,0.00033512292,0.0071566217,0.00016912607,0.00031524277,0.000010550482,0.000020542042,0.000073966796],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956831,0.0021713988,0.0010249445,0.00037884954,0.00031207147,0.00042963529],"domain_scores_gemma":[0.98100054,0.017998938,0.00044795638,0.00042020835,0.00008362426,0.00004872971],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0027423494,0.00020377415,0.0008543462,0.00039287875,0.00009164638,0.000024992101,0.00031472289,0.00020068063,0.000030577165],"category_scores_gemma":[0.0396068,0.00013697184,0.00014227486,0.0014341595,0.00016618695,0.000080487465,0.00016551156,0.0006705364,0.0000035258727],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095530855,0.001290593,0.8678354,0.00019275765,0.00011611579,0.0007404708,0.0036324086,0.00009641096,0.04581329,0.0015748715,0.0272375,0.05051489],"study_design_scores_gemma":[0.009768339,0.0012232505,0.9792347,0.00017894966,0.00019226955,0.00009219683,0.0005385886,0.00039939684,0.0006158816,0.00050104636,0.0071378183,0.00011754739],"about_ca_topic_score_codex":0.00028550418,"about_ca_topic_score_gemma":0.002552491,"teacher_disagreement_score":0.11139933,"about_ca_system_score_codex":0.00020337511,"about_ca_system_score_gemma":0.0004576069,"threshold_uncertainty_score":0.96848303},"labels":[],"label_agreement":null},{"id":"W4416139698","doi":"10.1093/neuonc/noaf201.1707","title":"TMET-16. 3D spectroscopic imaging detects hidden peritumoral activity in gliomas","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital; McGill University","funders":"","keywords":"Magnetic resonance spectroscopic imaging; Metabolite; Fluid-attenuated inversion recovery; Astrocytoma; Radiation therapy; Metabolic activity","score_opus":0.014688137707619129,"score_gpt":0.31222160082128064,"score_spread":0.2975334631136615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416139698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97020566,0.0005491752,0.000022905078,0.011086328,0.00067708833,0.0005595226,0.0000029008274,0.000087254,0.01680919],"genre_scores_gemma":[0.99676955,0.00005142513,0.00038649136,0.0024536317,0.00011225026,0.00014432438,0.0000051993375,0.000021217982,0.00005590824],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99848855,0.00017000621,0.00024678683,0.00048129685,0.00014901152,0.0004643498],"domain_scores_gemma":[0.9990896,0.00031886925,0.00007772123,0.0003514204,0.000041739764,0.000120645745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012611861,0.00021829492,0.0005592081,0.00046507287,0.00007309388,0.000021671902,0.00010722798,0.00010987254,0.00015919944],"category_scores_gemma":[0.00020281386,0.00019872209,0.00010435257,0.0005356175,0.0000980116,0.00007543561,0.000117029675,0.0003573508,0.000063324456],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002614421,0.0011560733,0.27110773,0.000051009825,0.000043662618,0.0040156054,0.000097781616,0.0000011822247,0.62641245,0.00029362092,0.0013475977,0.09521184],"study_design_scores_gemma":[0.010258115,0.0013914173,0.40544745,0.00011427982,0.00023813461,0.00029843667,0.000113099675,0.00037611352,0.5463532,0.00050934363,0.034671318,0.00022908645],"about_ca_topic_score_codex":0.00026060574,"about_ca_topic_score_gemma":0.0004794645,"teacher_disagreement_score":0.13433972,"about_ca_system_score_codex":0.0008547928,"about_ca_system_score_gemma":0.0003570132,"threshold_uncertainty_score":0.81036514},"labels":[],"label_agreement":null},{"id":"W4416139719","doi":"10.1093/neuonc/noaf201.1913","title":"TMOD-40. Genetic drivers shape tumor phenotype and composition of the tumor microenvironment in syngeneic mouse models of glioblastoma","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Calgary Laboratory Services; Institute of Cancer Research; McGill University Health Centre; University of Calgary","funders":"","keywords":"Nestin; Tumor microenvironment; Phenotype; Mesenchymal stem cell; Transcriptome; Glioblastoma; Electroporation; Infiltration (HVAC); Microglia; Glioma","score_opus":0.009516309209264478,"score_gpt":0.24198111032530098,"score_spread":0.2324648011160365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416139719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99739474,0.00050153205,0.000013437896,0.0010974287,0.000098493016,0.0006110038,0.000016380498,0.000008135009,0.00025882115],"genre_scores_gemma":[0.9986187,0.0001410425,0.00030274186,0.00086133013,0.000010500682,0.000046167566,0.000002549801,0.000012057221,0.0000048934317],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990312,0.00011388156,0.00031688638,0.0002500269,0.00012250603,0.0001655356],"domain_scores_gemma":[0.9993939,0.00013419891,0.00014181831,0.00025255824,0.000027174206,0.00005039311],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005094563,0.00013176775,0.00038724774,0.00014029807,0.000031642823,0.0000025568593,0.00009002227,0.00005320866,0.000028467985],"category_scores_gemma":[0.000015671061,0.00010086396,0.000070598,0.0001645761,0.00018483025,0.000021846063,0.0001153178,0.00011216741,0.0000023067025],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042736795,0.0011043571,0.032695916,0.000093206705,0.0000590467,0.00013371138,0.00020507645,0.0014921415,0.9598957,0.000145575,0.00013977033,0.003608145],"study_design_scores_gemma":[0.005987411,0.0021835538,0.2662463,0.00015164484,0.00037876196,0.00010281752,0.00012658956,0.010182431,0.7137781,0.00021283353,0.00054109714,0.000108496235],"about_ca_topic_score_codex":0.0000404037,"about_ca_topic_score_gemma":0.000046874193,"teacher_disagreement_score":0.2461176,"about_ca_system_score_codex":0.0001736488,"about_ca_system_score_gemma":0.00009163193,"threshold_uncertainty_score":0.41131127},"labels":[],"label_agreement":null},{"id":"W4416139731","doi":"10.1093/neuonc/noaf201.1708","title":"TMET-17. Elongation control of mRNA translation drives Group 3 medulloblastoma adaptation to nutrient deprivation","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer, Hypoxia, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; BC Cancer Foundation; Spinal Cord Injury BC; BC Cancer Agency","funders":"","keywords":"Gene knockdown; Translation (biology); Messenger RNA; Mitochondrion; Oxidative phosphorylation; Protein biosynthesis","score_opus":0.010340248302348585,"score_gpt":0.2642208441382736,"score_spread":0.25388059583592504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416139731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7035991,0.0010720721,0.28957322,0.0016481229,0.0019260263,0.0008524742,0.000028835086,0.000027004911,0.001273116],"genre_scores_gemma":[0.99500597,0.00040862584,0.0022149715,0.0015644027,0.0004780213,0.0001225885,0.0001308145,0.000014947159,0.000059673992],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987361,0.00018452424,0.00038369253,0.0003634933,0.00013955974,0.00019263175],"domain_scores_gemma":[0.99925494,0.00008987418,0.00017570211,0.0002365725,0.00017479053,0.00006810541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021131428,0.00014418866,0.00025309424,0.00017183548,0.00006544278,0.000009551615,0.0001332152,0.00021958968,0.000012216985],"category_scores_gemma":[0.000203541,0.00015482277,0.000099018325,0.00025422615,0.00005876756,0.000010498283,0.000029288605,0.000093863935,0.0000038072662],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060264196,0.00011057868,0.0002655821,0.000015503341,0.000037795704,4.4247216e-7,0.0002673936,0.0009985894,0.87551236,0.0007890898,0.0013072921,0.12009272],"study_design_scores_gemma":[0.0030827965,0.0010140889,0.0060954173,0.000015383068,0.00009706317,0.0000057581797,0.0001585202,0.0012587862,0.39746025,0.00033795947,0.59032017,0.00015378276],"about_ca_topic_score_codex":0.000029976685,"about_ca_topic_score_gemma":0.000263083,"teacher_disagreement_score":0.5890129,"about_ca_system_score_codex":0.000045409368,"about_ca_system_score_gemma":0.00018651527,"threshold_uncertainty_score":0.63134897},"labels":[],"label_agreement":null},{"id":"W4416139776","doi":"10.1093/neuonc/noaf201.1568","title":"SURG-11. Efficacy of Radiosurgery with and without Angioembolization:A Subgroup Analysis of Effectiveness in Ruptured versusUnruptured Arteriovenous Malformations.An Updated Systematic Review and Meta-Analysis","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Vascular Malformations Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Radiosurgery; Embolization; Percutaneous; Arteriovenous malformation; Subgroup analysis; Intracranial Arteriovenous Malformations","score_opus":0.021905808510599367,"score_gpt":0.31402274195693275,"score_spread":0.2921169334463334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416139776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97869253,0.017169617,0.00076982536,0.00053641916,0.000023867904,0.002629683,0.000056080422,0.000027358361,0.000094596544],"genre_scores_gemma":[0.99751216,0.0010279098,0.00024583426,0.0004976668,0.0000020988366,0.00025338202,0.00044614697,0.000010525844,0.0000042961938],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99757755,0.00085744576,0.00089985237,0.00030600125,0.00020082238,0.00015833342],"domain_scores_gemma":[0.99810255,0.00054582994,0.00049237313,0.0005300376,0.00024870297,0.0000805007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007925766,0.00022440369,0.0039060847,0.0014241239,0.000048350666,0.000012957233,0.0000708608,0.00011352167,0.00004305121],"category_scores_gemma":[0.0001576281,0.0001540945,0.0005407228,0.0032533251,0.000107808104,0.00014592713,0.000030790907,0.00009053982,3.8131125e-7],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007640308,0.0034580708,0.37683198,0.07524915,0.5372122,0.00008099073,0.0015221261,0.0024432142,0.0011485856,0.0010656025,0.00004580804,0.00017827014],"study_design_scores_gemma":[0.002472718,0.0004322628,0.20752385,0.0004882251,0.7870927,0.000037583046,0.00009646684,0.0013381763,0.00036088444,0.000003321824,0.000041950196,0.000111868525],"about_ca_topic_score_codex":0.00009953123,"about_ca_topic_score_gemma":0.00037404004,"teacher_disagreement_score":0.2498805,"about_ca_system_score_codex":0.0000875527,"about_ca_system_score_gemma":0.00011596475,"threshold_uncertainty_score":0.6283791},"labels":[],"label_agreement":null},{"id":"W4416139836","doi":"10.1093/neuonc/noaf201.1630","title":"SURG-76. Glowing Tumours: Implementation and utilization of 5-ALA at a Toronto academic neurosurgical center","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network","funders":"","keywords":"Presentation (obstetrics); Class (philosophy); Process (computing); Resection; Center (category theory)","score_opus":0.03456363198173339,"score_gpt":0.3809601138570502,"score_spread":0.3463964818753168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416139836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931622,0.0007888641,0.000015602905,0.0032055834,0.00034753108,0.00045820745,0.000013837404,0.000029623992,0.0019785122],"genre_scores_gemma":[0.99741775,0.00098489,0.000040369367,0.001362209,0.00005425981,0.000049036567,0.000057484565,0.000011647549,0.000022358],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99889904,0.00013572609,0.0003524654,0.00027901505,0.00013220166,0.00020154404],"domain_scores_gemma":[0.99932843,0.0002841262,0.0001073228,0.00013947353,0.00005523524,0.00008540449],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012403603,0.00012375599,0.00032533432,0.000076355456,0.000058156536,0.0000053990802,0.00004441364,0.0001227799,0.00017010073],"category_scores_gemma":[0.000070684815,0.00010842443,0.000068168345,0.000111231406,0.000055319626,0.00007299092,0.000100180056,0.00010956882,0.0000032955013],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029057977,0.0003494563,0.78659683,0.000055279153,0.00004695539,0.00012721415,0.00031486203,0.0000013237757,0.16883825,0.0007128852,0.0044925157,0.038173817],"study_design_scores_gemma":[0.012866092,0.0017194791,0.6961542,0.000105410625,0.00045275653,0.000236918,0.00059989764,0.0002372902,0.1297932,0.00008793547,0.1575971,0.00014978783],"about_ca_topic_score_codex":0.000118318916,"about_ca_topic_score_gemma":0.00030827345,"teacher_disagreement_score":0.15310457,"about_ca_system_score_codex":0.00030228295,"about_ca_system_score_gemma":0.00008351354,"threshold_uncertainty_score":0.44214198},"labels":[],"label_agreement":null},{"id":"W4416139854","doi":"10.1093/neuonc/noaf201.1873","title":"TMIC-120. Investigating EGFRvIII mRNA LNP vaccine-induced re-programming of the GBM TME using the 10x Genomics Visium HD platform","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Providence Health Care; University of Calgary","funders":"","keywords":"Tumor microenvironment; Immune system; Transcriptome; Cytotoxic T cell; Immunotherapy; Messenger RNA; Cancer; Cancer immunotherapy; Cancer vaccine","score_opus":0.05131430558547638,"score_gpt":0.3314214146380487,"score_spread":0.2801071090525723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416139854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854986,0.0002988823,0.000015807049,0.009529317,0.0010801939,0.0010762019,0.000005360767,0.000050806666,0.0024447998],"genre_scores_gemma":[0.9935178,0.000051055285,0.0011538904,0.0048746117,0.00027021774,0.00007049251,0.0000066530256,0.00003770467,0.000017570439],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99806,0.00016287134,0.0006566423,0.00041373202,0.00024026721,0.00046650556],"domain_scores_gemma":[0.99774784,0.00083592173,0.00041099993,0.0007446916,0.00014169734,0.00011883823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003911252,0.00027570233,0.00060616096,0.0001439309,0.00035077115,0.000030955965,0.00034482018,0.00023352377,0.00002863808],"category_scores_gemma":[0.00060224364,0.00016657195,0.00023443135,0.0006030052,0.00012350602,0.0000621408,0.00034225648,0.0005288997,0.0000064292253],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010044671,0.00045309344,0.036655296,0.000097080345,0.00023338135,0.00010422435,0.0011743451,0.0001395863,0.9010472,0.0010889464,0.00073648256,0.058169898],"study_design_scores_gemma":[0.010416249,0.001955596,0.03208109,0.0004688286,0.0018555935,0.00043308985,0.003535946,0.006185547,0.83197814,0.0011526562,0.10950745,0.00042980447],"about_ca_topic_score_codex":0.00027563842,"about_ca_topic_score_gemma":0.00025503745,"teacher_disagreement_score":0.10877097,"about_ca_system_score_codex":0.0004583452,"about_ca_system_score_gemma":0.0006130473,"threshold_uncertainty_score":0.6792607},"labels":[],"label_agreement":null},{"id":"W4416139856","doi":"10.1093/neuonc/noaf201.1900","title":"TMOD-26. EGFRvIII overexpression and loss of mouse specific CDKN2A in glial cells leads to spontaneous gliomagenesis in a novel mouse model","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Immunohistochemistry; Glioma; Downregulation and upregulation; Neurosphere; Immune system; Genetically modified mouse; Tumor microenvironment; Microglia; Infiltration (HVAC)","score_opus":0.020069842241522903,"score_gpt":0.2880632902448911,"score_spread":0.26799344800336816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416139856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996718,0.0002386075,0.00007653233,0.0012498486,0.00015699353,0.000876129,0.00006101965,0.00003764001,0.000585234],"genre_scores_gemma":[0.9970075,0.00028334424,0.0012206747,0.0011028533,0.00004061628,0.000108047636,0.0000068304994,0.00003971184,0.00019041423],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981887,0.00009387127,0.0005453785,0.00058643834,0.00018832718,0.0003973099],"domain_scores_gemma":[0.99890274,0.0003405561,0.00010279291,0.0004189835,0.00006640956,0.00016853487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014681085,0.00026290535,0.0007466795,0.00069412595,0.00003366985,0.000011517989,0.00013640287,0.00025540154,0.000027091655],"category_scores_gemma":[0.00009268229,0.00024131338,0.00008433547,0.000473548,0.00009180477,0.000050369035,0.0001949409,0.00022828119,0.000014465085],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019811285,0.002609904,0.009559559,0.000088924324,0.000018277364,0.0022982508,0.0004891087,0.0030565197,0.9764072,0.00015805554,0.001184266,0.0021488578],"study_design_scores_gemma":[0.011108565,0.0014368222,0.0046118037,0.0002008587,0.00006691632,0.0002598101,0.000104846775,0.003666594,0.97423923,0.0000485761,0.004039096,0.00021685667],"about_ca_topic_score_codex":0.00022361797,"about_ca_topic_score_gemma":0.0005682458,"teacher_disagreement_score":0.009127437,"about_ca_system_score_codex":0.00044825705,"about_ca_system_score_gemma":0.00026769104,"threshold_uncertainty_score":0.9840474},"labels":[],"label_agreement":null},{"id":"W4416139866","doi":"10.1093/neuonc/noaf201.1721","title":"TMET-30. Uncovering the metabolic programs underlying malignant cell state heterogeneity in glioblastoma","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Single-cell and spatial transcriptomics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Glycolysis; Transcriptome; Metabolomics; Cell; Oxidative phosphorylation; Cancer cell; Anaerobic glycolysis; Tumor microenvironment; Regulator; microRNA; Bioenergetics","score_opus":0.023675922068753342,"score_gpt":0.28060594652652726,"score_spread":0.2569300244577739,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416139866","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99442077,0.0013888072,0.0012121745,0.00033500188,0.00072142214,0.00044275934,0.00000769048,0.000029062992,0.0014423222],"genre_scores_gemma":[0.99724156,0.00064178806,0.00020120779,0.001630898,0.00006950431,0.00007675491,0.000011941322,0.000028839188,0.00009750007],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982422,0.0002981669,0.00036628923,0.00050664885,0.00011021952,0.00047647877],"domain_scores_gemma":[0.9993033,0.00006686993,0.00010073268,0.0004095308,0.00005093252,0.000068658366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029766967,0.00023473926,0.0003029065,0.00008581253,0.00012669226,0.000045316374,0.0003739572,0.00020436896,0.0000075241655],"category_scores_gemma":[0.00004583861,0.00018816847,0.00013774187,0.00026633547,0.00013485103,0.0000055652185,0.00017720397,0.00027898408,0.000010735232],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022070094,0.00024057688,0.0070014,0.000026524633,0.000039755145,0.000038192877,0.000108551176,0.00063002424,0.9516739,0.000054548498,0.000099442004,0.039866377],"study_design_scores_gemma":[0.0013535297,0.00083549024,0.0014344266,0.000014253352,0.00003988839,0.000020372216,0.00009712055,0.00031586332,0.76868135,0.00016935074,0.22683227,0.00020609016],"about_ca_topic_score_codex":0.0001474368,"about_ca_topic_score_gemma":0.0014854519,"teacher_disagreement_score":0.22673282,"about_ca_system_score_codex":0.0000569691,"about_ca_system_score_gemma":0.00024489683,"threshold_uncertainty_score":0.76732874},"labels":[],"label_agreement":null},{"id":"W4416139869","doi":"10.1093/neuonc/noaf201.1789","title":"TMIC-34. Targeting mechanically regulated cell state in glioblastoma","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cellular Mechanics and Interactions","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Mesenchymal stem cell; Focal adhesion; Cell; Gene knockdown; Cell adhesion; Cell growth; Lipid raft; Regulator; Kinase","score_opus":0.005803517068367627,"score_gpt":0.25599007105091554,"score_spread":0.2501865539825479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416139869","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9809717,0.00036694307,0.005987303,0.001048005,0.0013517912,0.0003969353,0.000014634812,0.000040347895,0.009822365],"genre_scores_gemma":[0.99604493,0.00026785885,0.00046269415,0.0018747387,0.00008643953,0.00004261883,0.000044496923,0.00002831353,0.0011478995],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99844563,0.00019966284,0.0004112236,0.00050069694,0.00008101803,0.0003617422],"domain_scores_gemma":[0.99930716,0.00006235268,0.00012372833,0.00033245873,0.00009838119,0.00007590087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025364137,0.00017820668,0.00023553897,0.0001476963,0.00007249447,0.00002052099,0.00025009058,0.00026234644,0.000087341396],"category_scores_gemma":[0.00019300243,0.0001902981,0.00010648223,0.00025006413,0.000030770418,0.000004975596,0.00025166498,0.00031596166,0.000033586348],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002503296,0.00018242681,0.00003838955,0.000012356466,0.000017393239,0.00004730925,0.000028944976,0.00010175618,0.98827904,0.00039455917,0.0074823587,0.0031651298],"study_design_scores_gemma":[0.00068336475,0.0006435767,0.000013734098,0.000007902765,0.000009914237,0.000013702229,0.000047058205,0.0011263704,0.66893584,0.00057505985,0.32782736,0.0001161129],"about_ca_topic_score_codex":0.00004757913,"about_ca_topic_score_gemma":0.00030171254,"teacher_disagreement_score":0.320345,"about_ca_system_score_codex":0.000089569556,"about_ca_system_score_gemma":0.00023921204,"threshold_uncertainty_score":0.77601314},"labels":[],"label_agreement":null},{"id":"W4416139878","doi":"10.1093/neuonc/noaf201.1670","title":"TIP-10. Update on GBM AGILE: A global, phase 2/3 adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Agile software development; Clinical trial; Glioblastoma; Randomization; Phases of clinical research; Drug development; Disease; Clinical endpoint; Biomarker","score_opus":0.03798152204161998,"score_gpt":0.36510367710203295,"score_spread":0.327122155060413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416139878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9821471,0.00027494648,0.000008392558,0.011031564,0.0010788501,0.0030849809,0.00009430978,0.000073969415,0.0022059053],"genre_scores_gemma":[0.99352944,0.00022094921,0.00022822841,0.004883979,0.0001652286,0.0008661964,0.000037583508,0.000024108198,0.00004426362],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9976339,0.00021370078,0.000544312,0.00078129885,0.00029499005,0.00053182925],"domain_scores_gemma":[0.9979381,0.0010183998,0.00015347067,0.00043080066,0.00012208182,0.0003371454],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00029271957,0.00035863815,0.0008103601,0.00037188904,0.000091960035,0.000025766536,0.00012703764,0.00022199834,0.00012691326],"category_scores_gemma":[0.0010628521,0.00027931313,0.00012467853,0.0006542899,0.000090276866,0.00006612173,0.00015551857,0.00030140244,0.00015839122],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3804718,0.014650407,0.003500674,0.00005236279,0.00036354753,0.0058700102,0.0005953095,0.000116036106,0.0092054615,0.001271073,0.115840934,0.46806237],"study_design_scores_gemma":[0.50844103,0.0907949,0.0071354173,0.0004007415,0.000605633,0.000109407636,0.00028320178,0.0021070945,0.0125095695,0.00031445,0.37685856,0.00044001112],"about_ca_topic_score_codex":0.00008834494,"about_ca_topic_score_gemma":0.0010669259,"teacher_disagreement_score":0.46762237,"about_ca_system_score_codex":0.000865731,"about_ca_system_score_gemma":0.00040760913,"threshold_uncertainty_score":0.9999659},"labels":[],"label_agreement":null},{"id":"W4416139896","doi":"10.1093/neuonc/noaf201.1666","title":"TIP-06. A global, open-label, randomized Phase 3 trial evaluating niraparib compared to standard temozolomide therapy in patients with newly diagnosed, MGMT-unmethylated glioblastoma","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Temozolomide; Clinical endpoint; Radiation therapy; Clinical trial; Phases of clinical research; Randomized controlled trial; Quality of life (healthcare); Progression-free survival","score_opus":0.04044565151742892,"score_gpt":0.39377617492435807,"score_spread":0.35333052340692916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416139896","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97962016,0.00027625033,0.000069413996,0.003542462,0.0006880156,0.014446299,0.000101847945,0.000102111575,0.0011534588],"genre_scores_gemma":[0.9898935,0.000092038776,0.001959936,0.0052732183,0.00007662094,0.0025205927,0.000120344244,0.000046236866,0.000017534629],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9950761,0.0015350948,0.0011668376,0.00093764946,0.0006008375,0.00068348367],"domain_scores_gemma":[0.99577504,0.0023835357,0.00040763858,0.0006445831,0.00045042796,0.00033877403],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012049187,0.00051307486,0.0025144343,0.00041714037,0.00017005736,0.0001091424,0.0003988937,0.00025563847,0.00012717293],"category_scores_gemma":[0.0020111483,0.0003766504,0.0001464698,0.0014410247,0.00018210767,0.00013487512,0.00024042321,0.00035927907,0.00004165809],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.89790463,0.012277835,0.017911842,0.00001589083,0.00058181066,0.0004771532,0.00023951936,0.00008181778,0.0042683557,0.00007028672,0.0071622846,0.059008565],"study_design_scores_gemma":[0.93070066,0.053317845,0.002251256,0.00018448551,0.00045943417,0.000007576673,0.000064723754,0.00042011292,0.0031151716,0.00009929188,0.009108577,0.00027084255],"about_ca_topic_score_codex":0.00031611012,"about_ca_topic_score_gemma":0.00051137037,"teacher_disagreement_score":0.05873772,"about_ca_system_score_codex":0.0010475885,"about_ca_system_score_gemma":0.0011545885,"threshold_uncertainty_score":0.9998686},"labels":[],"label_agreement":null},{"id":"W4416139905","doi":"10.1093/neuonc/noaf201.1650","title":"SURG-98. Clinical outcomes, operational metrics, and translational insights derived from trials of MR-guided, transcranial, microbubble-enhanced focused ultrasound for brain tumors: a 2010-2025 evidence analysis","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Ultrasound and Hyperthermia Applications","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Clinical trial; Profiling (computer programming); Focused ultrasound; Translational research; Leverage (statistics); Sonodynamic therapy; Brain disease; Biomarker discovery","score_opus":0.08247454757040577,"score_gpt":0.3645137889073145,"score_spread":0.2820392413369087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416139905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7440968,0.0014981678,0.24922949,0.0027397748,0.00048023977,0.001115202,0.0005412635,0.00010377928,0.00019526425],"genre_scores_gemma":[0.9819876,0.00077171664,0.0155108115,0.0009442232,0.00016175363,0.0002600378,0.00027414048,0.000029443527,0.000060285493],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9967488,0.00052194315,0.0017521048,0.0005312286,0.00019139214,0.00025449856],"domain_scores_gemma":[0.9673021,0.031844705,0.00021419162,0.00031366173,0.00021376791,0.00011161711],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011481056,0.0002789325,0.0015207237,0.0005060212,0.00014068489,0.000052731222,0.00028806832,0.00032980213,0.00018666674],"category_scores_gemma":[0.0029356093,0.00025883282,0.00058094197,0.000995291,0.00018116206,0.0001808363,0.000014573064,0.00026999754,0.0000042807974],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025010123,0.00021279775,0.0143949175,0.000051517738,0.0016059353,0.0000018239631,0.00044118546,0.002571266,0.9734509,0.0008051177,0.0030484085,0.0031660001],"study_design_scores_gemma":[0.033066265,0.0014474794,0.45860893,0.0003041912,0.013216786,0.000019631909,0.00038634267,0.03175423,0.30722672,0.010621506,0.141007,0.0023409198],"about_ca_topic_score_codex":0.00015682683,"about_ca_topic_score_gemma":0.00080224616,"teacher_disagreement_score":0.66622424,"about_ca_system_score_codex":0.000051940395,"about_ca_system_score_gemma":0.0003929123,"threshold_uncertainty_score":0.9999864},"labels":[],"label_agreement":null},{"id":"W4416139917","doi":"10.1093/neuonc/noaf201.1269","title":"NCOG-02. Conquering Infant Medulloblastoma in Resource-Limited Settings: Challenges, Opportunities, and Treatment Outcomes","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medulloblastoma; Radiation therapy; Chemotherapy; Disease; Karnofsky Performance Status; Clinical trial","score_opus":0.04901578176062894,"score_gpt":0.3103657034203307,"score_spread":0.2613499216597018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416139917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90987366,0.0034395892,8.9389545e-7,0.06775528,0.00023381725,0.00082614593,0.000017190354,0.0001108272,0.0177426],"genre_scores_gemma":[0.9854162,0.0063072843,0.00017869782,0.0073907604,0.00005637663,0.0003969013,0.00004350338,0.00003392702,0.00017635146],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99828774,0.00018673149,0.00046361293,0.0005007611,0.00014530006,0.00041583428],"domain_scores_gemma":[0.99834734,0.00092881685,0.000119067845,0.000357957,0.000048077247,0.00019872177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018354265,0.00030785118,0.0008262602,0.00048030287,0.00007658061,0.000016659173,0.00007396418,0.00021621068,0.00004236773],"category_scores_gemma":[0.0002159238,0.0002447501,0.0000927849,0.00017098647,0.00012791873,0.000044967062,0.000114961724,0.00020055176,0.000007673311],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084757886,0.0038030702,0.24108909,0.00023513599,0.0008225498,0.011214231,0.0032782154,0.000019206967,0.014924668,0.005061184,0.006364789,0.7123403],"study_design_scores_gemma":[0.009440877,0.0026899553,0.09555387,0.00017280504,0.00026655864,0.00023952639,0.0020697112,0.00010961329,0.003519547,0.000047751873,0.885706,0.00018379338],"about_ca_topic_score_codex":0.00013175774,"about_ca_topic_score_gemma":0.0005546057,"teacher_disagreement_score":0.8793412,"about_ca_system_score_codex":0.00052907167,"about_ca_system_score_gemma":0.00028383205,"threshold_uncertainty_score":0.99806184},"labels":[],"label_agreement":null},{"id":"W4416139920","doi":"10.1093/neuonc/noaf201.1690","title":"TIP-30. Molecularly-guided phase 2 umbrella trial for children and young adults with newly-diagnosed high-grade glioma (HGG) including diffuse intrinsic pontine glioma (DIPG): CONNECT TarGeT (Targeted pediatric HGG therapy) trial in progress","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Young adult; Temozolomide; Clinical trial; Glioma; Everolimus; Immunotherapy; Brain tumor; Precision medicine","score_opus":0.019165966009403828,"score_gpt":0.31466261587175115,"score_spread":0.2954966498623473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416139920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97882843,0.0035050416,0.000047021884,0.0030951207,0.0014484004,0.012716812,0.000108789965,0.00020084792,0.000049556715],"genre_scores_gemma":[0.9931353,0.00059043686,0.0010882282,0.0006858766,0.001184532,0.0027684069,0.0004203411,0.00012069058,0.0000061991404],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9953516,0.0005722673,0.0012400134,0.001376123,0.0004668475,0.0009931454],"domain_scores_gemma":[0.99676114,0.0014088814,0.00056675577,0.0006334039,0.0002593208,0.0003705237],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00052845624,0.0007615997,0.0017556587,0.0014173125,0.00025357492,0.000105764906,0.00030125148,0.00050653337,0.00003953699],"category_scores_gemma":[0.0010284069,0.0006137776,0.00028688574,0.0015934624,0.00021848966,0.00014284467,0.00018284547,0.00051770156,0.0000050651224],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8259335,0.032200783,0.03984509,0.0002278235,0.00129699,0.007881696,0.0009132327,0.000015349908,0.05055549,0.00032974698,0.008312086,0.032488175],"study_design_scores_gemma":[0.91480285,0.03471976,0.010268598,0.00011105749,0.0008972229,0.00035667373,0.00005919639,0.00019916464,0.036488887,0.00010749298,0.0014563148,0.0005328008],"about_ca_topic_score_codex":0.00035428244,"about_ca_topic_score_gemma":0.00014635856,"teacher_disagreement_score":0.088869296,"about_ca_system_score_codex":0.00032716992,"about_ca_system_score_gemma":0.0006351415,"threshold_uncertainty_score":0.99963135},"labels":[],"label_agreement":null},{"id":"W4416139928","doi":"10.1093/neuonc/noaf201.1673","title":"TIP-13. Advancing Patient-Centered Neurological Trials in Canada through Scientific Innovation and Operational Excellence at The Clinical Research Unit at The Montreal Neurological Institute and Hospital","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Genomics and Rare Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"","keywords":"Excellence; Unit (ring theory); Center of excellence; Clinical trial; Timeline; Cru; Research ethics; Patient recruitment; Certification","score_opus":0.07025444855511315,"score_gpt":0.36733944811234004,"score_spread":0.2970849995572269,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416139928","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98381424,0.00079767755,0.000012130822,0.013345113,0.001070941,0.0006206724,0.00005418525,0.000003908051,0.00028111605],"genre_scores_gemma":[0.9938119,0.0006695788,0.000028869887,0.0051055592,0.000105608844,0.00006334401,0.00011399461,0.0000071580225,0.00009396949],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99639195,0.0017194449,0.0006433733,0.0006957339,0.00019963937,0.00034983372],"domain_scores_gemma":[0.99815005,0.0011259692,0.00014741125,0.00032618528,0.00018581633,0.000064548374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017992656,0.00014799948,0.00028997706,0.00005534904,0.0006257609,0.000063462554,0.00026732552,0.00016544406,0.000017102107],"category_scores_gemma":[0.0034286822,0.000089056775,0.000048106984,0.0003002648,0.00095182064,0.000010952678,0.0010397964,0.0003827442,0.0000016417233],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045819264,0.0009119412,0.6580548,0.000035758167,0.00009949191,0.0006428334,0.0003690966,0.0013396001,0.17844851,0.0014291146,0.081903785,0.07218311],"study_design_scores_gemma":[0.0036044042,0.0030261297,0.31958285,0.000011854832,0.000043454358,0.0001372864,0.00032351274,0.0012842572,0.0026949374,0.0007980671,0.6682105,0.00028276013],"about_ca_topic_score_codex":0.009938067,"about_ca_topic_score_gemma":0.29858705,"teacher_disagreement_score":0.5863067,"about_ca_system_score_codex":0.000064463944,"about_ca_system_score_gemma":0.0012545084,"threshold_uncertainty_score":0.99665487},"labels":[],"label_agreement":null},{"id":"W4416139954","doi":"10.1093/neuonc/noaf201.1653","title":"SURG-101. A pilot study of laser interstitial thermal therapy (LITT) followed by hypofractionated radiation therapy (hypoRT) for patients with recurrent gliomas","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Regimen; Radiation therapy; Clinical endpoint; Salvage therapy; Glioma; Biopsy; Radiography","score_opus":0.022240299469711965,"score_gpt":0.3055888615957714,"score_spread":0.28334856212605947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416139954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99396414,0.00031951637,0.000011840344,0.0012478364,0.0007871006,0.003319955,0.000047403988,0.000050979146,0.00025124574],"genre_scores_gemma":[0.9978248,0.00020083738,0.00002662752,0.000837251,0.000069974594,0.00077758555,0.00021374287,0.00003098221,0.000018208812],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984733,0.00020467884,0.0004254983,0.0004029342,0.00024758387,0.00024603214],"domain_scores_gemma":[0.9985051,0.00058867596,0.00027601392,0.00026754758,0.00028115403,0.00008146336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013556458,0.00023732398,0.00052245485,0.00024170837,0.00008819321,0.000011723137,0.00009170745,0.00008325022,0.00006847513],"category_scores_gemma":[0.000081699756,0.00016882384,0.00009332961,0.00032311233,0.00005693669,0.00008879829,0.000021013044,0.00014528685,0.0000029494768],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.061524715,0.087641165,0.437847,0.000040517112,0.0020473222,0.00011177808,0.0008738672,0.00004218445,0.1136831,0.00003877722,0.030456118,0.26569346],"study_design_scores_gemma":[0.14051443,0.18825506,0.41993508,0.00006540373,0.00051499245,0.000007971488,0.00035594322,0.000094599236,0.09973382,0.000026819149,0.15014517,0.0003506943],"about_ca_topic_score_codex":0.0001045714,"about_ca_topic_score_gemma":0.000060430633,"teacher_disagreement_score":0.26534277,"about_ca_system_score_codex":0.0002184092,"about_ca_system_score_gemma":0.00021145445,"threshold_uncertainty_score":0.6884436},"labels":[],"label_agreement":null},{"id":"W4416139978","doi":"10.1093/neuonc/noaf201.1530","title":"QOL-29. Evaluating the effectiveness of a tailored exercise intervention on neuro-oncology patient outcomes","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Patient Safety Institute; Alberta Health Services; Kelowna General Hospital; University of Alberta; University of Calgary","funders":"","keywords":"Intervention (counseling); Quality of life (healthcare); Aerobic exercise; Coaching; Health coaching; Physical activity; Randomized controlled trial; Minimal clinically important difference; Psychological intervention","score_opus":0.02859414818323603,"score_gpt":0.3691638314954812,"score_spread":0.3405696833122452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416139978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97976637,0.000338786,0.00015640909,0.0037722238,0.0044670654,0.0017842175,0.000011239586,0.000078225596,0.009625464],"genre_scores_gemma":[0.99539554,0.0000598022,0.000033885382,0.0038171853,0.00006662571,0.00049918523,0.000019802874,0.00003072897,0.0000772143],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9958495,0.0022520178,0.00065432314,0.0005244758,0.00036564973,0.00035403363],"domain_scores_gemma":[0.99393964,0.004738488,0.00032848766,0.00060620456,0.0002962044,0.00009100028],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013528542,0.0002667682,0.0009232092,0.00025975116,0.000116101706,0.000011635552,0.00024200436,0.00025351375,0.00009996628],"category_scores_gemma":[0.0018499688,0.00019053147,0.00039704883,0.00045924645,0.00021001142,0.000046211368,0.00021498866,0.00062642107,0.000023829198],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018721255,0.001919719,0.041202568,0.0008978987,0.00025415263,0.00021101617,0.002459371,0.00022044517,0.27198827,0.0014759366,0.0019182295,0.65873116],"study_design_scores_gemma":[0.03779635,0.099763714,0.41132295,0.003298156,0.0034638941,0.00027046283,0.00794946,0.0026010496,0.24626736,0.0038431685,0.18237966,0.001043776],"about_ca_topic_score_codex":0.00031371994,"about_ca_topic_score_gemma":0.0003102025,"teacher_disagreement_score":0.65768737,"about_ca_system_score_codex":0.00048610693,"about_ca_system_score_gemma":0.0004505226,"threshold_uncertainty_score":0.7769648},"labels":[],"label_agreement":null},{"id":"W4416140053","doi":"10.1093/neuonc/noaf201.1317","title":"NCOG-50. Correlation of tract-based diffusion metrics with visuospatial function following glioma surgery","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Advanced Neuroimaging Techniques and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Diffusion MRI; White matter; Arcuate fasciculus; Fractional anisotropy; Superior longitudinal fasciculus; Tractography; Fasciculus; Inferior longitudinal fasciculus; Human Connectome Project; Glioma","score_opus":0.03657880437120672,"score_gpt":0.3415430757264585,"score_spread":0.3049642713552518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416140053","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.61258644,0.00005595636,0.38262618,0.0020852282,0.00041376674,0.0005373651,0.0000039433253,0.00021773041,0.0014734099],"genre_scores_gemma":[0.99326956,0.000022490374,0.005431717,0.001041069,0.00005201975,0.00007702176,0.00005044304,0.000023676892,0.00003198861],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99887025,0.00007963668,0.00036349395,0.00031283623,0.00019930961,0.00017446141],"domain_scores_gemma":[0.99814403,0.0011460627,0.00023110604,0.0003014442,0.00011658337,0.00006075957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016957287,0.00013919424,0.00039579888,0.0005195222,0.00009538305,0.0000057164634,0.000061945226,0.00013789111,0.00001576856],"category_scores_gemma":[0.00034663524,0.00012199803,0.00013826803,0.0010636584,0.000065837114,0.00006714529,0.000029348925,0.00027848865,0.0000032585688],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012696984,0.0011137973,0.11468654,0.00009269567,0.0000326942,0.0001334848,0.000024538373,0.0002629058,0.80288804,0.0008238239,0.002670778,0.07600098],"study_design_scores_gemma":[0.009570355,0.0072864317,0.24212752,0.00053048565,0.0019206147,0.00029091886,0.00014977682,0.041660186,0.313305,0.0014280671,0.38105524,0.00067544007],"about_ca_topic_score_codex":0.00003038228,"about_ca_topic_score_gemma":0.00000549356,"teacher_disagreement_score":0.48958308,"about_ca_system_score_codex":0.00011888698,"about_ca_system_score_gemma":0.00028606437,"threshold_uncertainty_score":0.49749354},"labels":[],"label_agreement":null},{"id":"W4416140055","doi":"10.1093/neuonc/noaf201.1825","title":"TMIC-70. Integrative spatiotemporal proteomic and metabolomic characterization of immune infiltration following intracranial injection of oncolytic immunotherapy in glioblastoma patients","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Oncolytic virus; Immune system; Cytotoxic T cell; Immunotherapy; Tumor microenvironment; CD8; Proteomics; Metabolomics","score_opus":0.005301657349595734,"score_gpt":0.27805255078400554,"score_spread":0.2727508934344098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416140055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99828786,0.00010022322,0.00041721208,0.000073627845,0.00021468205,0.0007854701,0.000026077561,0.0000045255447,0.0000903453],"genre_scores_gemma":[0.9993551,0.00023809867,0.00010090697,0.00004642676,0.00002405209,0.000092694696,0.00011982968,0.000010478571,0.000012433801],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989166,0.00020417356,0.00041538198,0.0002349963,0.00008951658,0.00013930944],"domain_scores_gemma":[0.9994835,0.000027867085,0.00023382225,0.00013770827,0.00009453216,0.00002252224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014688753,0.00012507205,0.0002916117,0.00019598987,0.00003267312,0.000007592696,0.00008063847,0.00015083682,0.0000047372955],"category_scores_gemma":[0.00011628154,0.000118316864,0.0000708113,0.00021047972,0.00007788665,0.000018580768,0.000049652557,0.0001174129,4.306265e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023225972,0.00027942195,0.035041895,0.000022861856,0.00008007705,0.0000021047395,0.00018861204,0.0000060038683,0.93431264,0.00001863786,0.0000056098365,0.02771955],"study_design_scores_gemma":[0.0036165677,0.0034410057,0.10856156,0.00003278372,0.000019118295,0.0000031190339,0.000037600843,0.00011632991,0.8837968,0.000050333172,0.0002546781,0.00007008575],"about_ca_topic_score_codex":0.00035758317,"about_ca_topic_score_gemma":0.00043525363,"teacher_disagreement_score":0.07351967,"about_ca_system_score_codex":0.00010038475,"about_ca_system_score_gemma":0.0002938267,"threshold_uncertainty_score":0.48248217},"labels":[],"label_agreement":null},{"id":"W4416140056","doi":"10.1093/neuonc/noaf201.1921","title":"Author Index","year":2025,"lang":"en","type":"paratext","venue":"Neuro-Oncology","topic":"","field":"","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Nuclear Safety Commission; Santen","keywords":"","score_opus":0.03510670332541381,"score_gpt":0.35557166706374466,"score_spread":0.32046496373833083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416140056","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004916524,0.0010681362,0.00012651576,0.004060565,0.03284981,0.0012325029,0.0014083235,0.00042448673,0.958338],"genre_scores_gemma":[0.006009266,0.00025431643,0.00026900563,0.009415645,0.0034876454,0.000626491,0.0012878815,0.00063336093,0.9780164],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99388885,0.0016663887,0.0009948482,0.0016413857,0.0005574173,0.0012511308],"domain_scores_gemma":[0.995359,0.0016783837,0.00083261094,0.0014608793,0.00031989435,0.00034924204],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.00053683674,0.00092938537,0.0018890768,0.0012761558,0.00020571229,0.000077579476,0.0014960512,0.0030499583,0.024220856],"category_scores_gemma":[0.0009728524,0.0009877026,0.00040504185,0.0011559948,0.00041088293,0.0000952062,0.0009349661,0.0036673201,0.5240618],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031228154,0.0002701345,0.00003467593,0.00013498374,0.0001375505,0.0004972702,0.00011040389,0.00013773717,0.028525157,0.00020370346,0.9593262,0.010309897],"study_design_scores_gemma":[0.0013049771,0.0006809458,0.00006867286,0.00006140191,0.00019608643,0.00015830417,0.000027742495,0.00013258841,0.0013036644,0.00010034227,0.9953287,0.00063656433],"about_ca_topic_score_codex":0.00012316553,"about_ca_topic_score_gemma":0.00012993658,"teacher_disagreement_score":0.49984095,"about_ca_system_score_codex":0.0015433095,"about_ca_system_score_gemma":0.0050952914,"threshold_uncertainty_score":0.9992573},"labels":[],"label_agreement":null},{"id":"W4416140086","doi":"10.1093/neuonc/noaf201.1647","title":"SURG-95. Spectral Imaging and AI for Brain Tumor Characterization: Toward Data-Driven Surgical Guidance","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Optical Imaging and Spectroscopy Techniques","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Hyperspectral imaging; Normalization (sociology); Deep learning; Pattern recognition (psychology); Brain tumor; Spatial normalization; Ground truth; Workflow; Margin (machine learning)","score_opus":0.025355784364852536,"score_gpt":0.3689936778659026,"score_spread":0.34363789350105006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416140086","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.30869827,0.00096679013,0.073752105,0.59426016,0.0018321286,0.0026156593,0.00030870715,0.0013245211,0.016241675],"genre_scores_gemma":[0.89932525,0.00043757624,0.037944872,0.058704987,0.0015687243,0.000205336,0.00072493503,0.00009224246,0.0009960751],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984987,0.00010211193,0.000343699,0.00056700234,0.00010966328,0.0003788686],"domain_scores_gemma":[0.99872106,0.0005323125,0.0000740275,0.0004423178,0.00010061775,0.00012968293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000324988,0.00017525934,0.0004950808,0.000104981584,0.00008759459,0.000049586273,0.00020220858,0.00007707973,0.000045678647],"category_scores_gemma":[0.00051778526,0.00016143286,0.00005930973,0.00017328266,0.00022726279,0.00015570079,0.00019478286,0.00033674514,0.000004837584],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008899517,0.00037258992,0.037351936,0.00026708236,0.000058149795,0.00124495,0.00010550576,4.2138998e-7,0.8173992,0.013135686,0.10065989,0.028514633],"study_design_scores_gemma":[0.0023766127,0.0006589053,0.0071982853,0.00008962101,0.00012342278,0.00069759705,0.000023735574,0.016669001,0.02458087,0.0006970095,0.946685,0.00019991159],"about_ca_topic_score_codex":0.0000104473365,"about_ca_topic_score_gemma":0.000002924493,"teacher_disagreement_score":0.8460251,"about_ca_system_score_codex":0.0000960128,"about_ca_system_score_gemma":0.00028256234,"threshold_uncertainty_score":0.6583041},"labels":[],"label_agreement":null},{"id":"W4416140091","doi":"10.1093/neuonc/noaf201.1794","title":"TMIC-39. Investigating the role of PDGF-AA in invasive melanoma brain metastases","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital; McGill University; McGill University Health Centre","funders":"","keywords":"Melanoma; Autocrine signalling; Crosstalk; Paracrine signalling; Cancer; Cancer cell; Signal transduction; Cell","score_opus":0.021126449497303707,"score_gpt":0.30625345175927376,"score_spread":0.2851270022619701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416140091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95690745,0.0014229692,0.000017946111,0.02995849,0.00021379594,0.0007882384,0.000037319318,0.000031116804,0.010622703],"genre_scores_gemma":[0.98652315,0.000066875284,0.001504919,0.011550356,0.000059310085,0.00010746127,0.000031733784,0.000017878385,0.00013833081],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99809057,0.0006586836,0.00047533223,0.00032265732,0.00015994719,0.00029281466],"domain_scores_gemma":[0.99669874,0.002557546,0.00018733524,0.000401144,0.000066485656,0.00008873133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055400113,0.00018305304,0.00057193625,0.00020176104,0.00006480813,0.000008166863,0.00016558106,0.000107703796,0.00010710357],"category_scores_gemma":[0.0018957936,0.0001248327,0.000128417,0.00046571912,0.00025579182,0.000039855844,0.00014583865,0.00033704238,0.000016240767],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040385834,0.0010869914,0.08880279,0.000185666,0.0004942197,0.0008026962,0.0019737862,0.00008946989,0.7309311,0.020746233,0.012113114,0.14237009],"study_design_scores_gemma":[0.009299284,0.004251307,0.041337736,0.000296072,0.00086700544,0.00041987118,0.005097816,0.00041793138,0.46073198,0.013632062,0.46336493,0.00028400435],"about_ca_topic_score_codex":0.00042392933,"about_ca_topic_score_gemma":0.000523437,"teacher_disagreement_score":0.4512518,"about_ca_system_score_codex":0.0001311984,"about_ca_system_score_gemma":0.0006860055,"threshold_uncertainty_score":0.509053},"labels":[],"label_agreement":null},{"id":"W4416140097","doi":"10.1093/neuonc/noaf201.1676","title":"TIP-16. Low and Intermediate Grade Glioma Umbrella Study of Molecular Guided TherapieS (LUMOS2) study","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; BC Cancer Foundation; Princess Margaret Cancer Centre; BC Cancer Agency; Université de Montréal; University of British Columbia; Hospital for Sick Children; University of Toronto; CancerCare Manitoba; Queen's University","funders":"","keywords":"Clinical trial; Randomization; Glioma; Precision medicine; Randomized controlled trial; Profiling (computer programming)","score_opus":0.023251069622055733,"score_gpt":0.33389264270034047,"score_spread":0.3106415730782847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416140097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941349,0.0008581612,0.0000043152413,0.0016694592,0.00041420077,0.0018732919,0.0000038991357,0.000049776416,0.0009920205],"genre_scores_gemma":[0.998663,0.00009921907,0.000028140512,0.00090048945,0.000036642366,0.000219524,0.000004406107,0.00002522841,0.0000233493],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9981775,0.0003497472,0.00049843907,0.00048351937,0.00022767365,0.0002631156],"domain_scores_gemma":[0.99878097,0.0003613668,0.00015500638,0.00047903956,0.00011422536,0.000109392786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019477158,0.0002449033,0.0007393924,0.00033933698,0.000063319734,0.000015030568,0.00014135626,0.00010556055,0.000034197543],"category_scores_gemma":[0.00015122686,0.00019561141,0.000087870954,0.00037650808,0.00012913725,0.000027634986,0.00018675913,0.00018818106,0.000007352454],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005674213,0.028559992,0.45929754,0.0001357066,0.0014809791,0.005990859,0.005854787,0.000009185669,0.4716101,0.00016506108,0.0027748893,0.023553472],"study_design_scores_gemma":[0.06002569,0.048161965,0.63073534,0.00021443228,0.0027054104,0.00036933055,0.017600123,0.000097791155,0.23076552,0.00053069205,0.008319365,0.0004743557],"about_ca_topic_score_codex":0.00016459948,"about_ca_topic_score_gemma":0.00015824425,"teacher_disagreement_score":0.24084458,"about_ca_system_score_codex":0.000106989064,"about_ca_system_score_gemma":0.00011118019,"threshold_uncertainty_score":0.7976802},"labels":[],"label_agreement":null},{"id":"W4416140109","doi":"10.1093/neuonc/noaf201.1426","title":"EXTH-93. Combination of ALK2 and cholesterol targeting agents exploits linked genetic and metabolic dependencies in diffuse midline glioma","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Cholesterol; Metabolomics; In vivo; Enzyme; Genome editing; Proteomics; CRISPR; Metabolic pathway","score_opus":0.02225998556977041,"score_gpt":0.29938744611548274,"score_spread":0.2771274605457123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416140109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99419105,0.003168517,0.000010236184,0.0017471698,0.0001724552,0.00054271787,0.000004546793,0.000020034737,0.00014328911],"genre_scores_gemma":[0.997542,0.0012810323,0.00028727177,0.0007377139,0.000024205901,0.000094219155,0.000012319684,0.000013731434,0.0000074617788],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988302,0.00014687968,0.00038538163,0.00030810648,0.00012914039,0.00020030065],"domain_scores_gemma":[0.9992835,0.0002819915,0.000120690056,0.00015498276,0.00007455238,0.000084263476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013034878,0.00015428066,0.00048618723,0.0003661529,0.00004169246,0.000011419825,0.000054163207,0.0001314451,0.000010935012],"category_scores_gemma":[0.0002490392,0.00013634792,0.00003712966,0.00025475645,0.00008590521,0.000052472526,0.00010138369,0.00013618772,0.0000017039945],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012280572,0.0017816683,0.3617725,0.00011320555,0.00007180933,0.0003411265,0.00067303295,0.0000052317378,0.607626,0.0001802993,0.00014622921,0.027166039],"study_design_scores_gemma":[0.013410965,0.0006968797,0.8845536,0.00007511816,0.00022797486,0.00007760562,0.00019472562,0.0005706679,0.09752446,0.00015104213,0.0024294015,0.000087571694],"about_ca_topic_score_codex":0.00006769284,"about_ca_topic_score_gemma":0.00008666937,"teacher_disagreement_score":0.5227811,"about_ca_system_score_codex":0.000045205354,"about_ca_system_score_gemma":0.000057935806,"threshold_uncertainty_score":0.5560107},"labels":[],"label_agreement":null},{"id":"W4416140125","doi":"10.1093/neuonc/noaf201.0942","title":"INNV-53. Precision Medicine in Pediatric Neuro-Oncology-Experience from a tertiary care center in Canada","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Dabrafenib; Adverse effect; Cohort; Precision medicine; Cancer; Radiation therapy; Retrospective cohort study; Tertiary care","score_opus":0.01146706880917872,"score_gpt":0.2928871973995187,"score_spread":0.28142012859034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416140125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97540057,0.0021108764,0.000003877005,0.015448871,0.0020816294,0.0009872385,0.000030618,0.000036194175,0.0039001154],"genre_scores_gemma":[0.9843758,0.0009882856,0.000085958185,0.0138371205,0.00025281662,0.00033978993,0.00008398299,0.00002752688,0.000008720733],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996951,0.0003996894,0.00085545244,0.0008463142,0.00035382345,0.0005937243],"domain_scores_gemma":[0.997122,0.0018206822,0.00017545401,0.00053540943,0.000110596535,0.00023586983],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013207964,0.0003431853,0.0009171795,0.00063944183,0.000060756178,0.0000070622077,0.0002857084,0.00027302327,0.00021260636],"category_scores_gemma":[0.0007775438,0.00028273452,0.00007425981,0.0009013078,0.00012579434,0.000076036944,0.00023727024,0.0006650217,0.000016544669],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033430458,0.00069549156,0.93403184,0.00004576957,0.000018263268,0.006190277,0.0024261705,0.000027820699,0.014544086,0.000010715484,0.011616253,0.030058984],"study_design_scores_gemma":[0.0122554,0.0011011622,0.8827444,0.00015009932,0.00014121082,0.00007620047,0.0023426556,0.00015982518,0.0038151643,0.0000471966,0.09697159,0.00019513766],"about_ca_topic_score_codex":0.37675792,"about_ca_topic_score_gemma":0.7661541,"teacher_disagreement_score":0.38939622,"about_ca_system_score_codex":0.002952686,"about_ca_system_score_gemma":0.002847348,"threshold_uncertainty_score":0.9999625},"labels":[],"label_agreement":null},{"id":"W4416140129","doi":"10.1093/neuonc/noaf201.1796","title":"TMIC-41. Anti-Robo1/2 monoclonal antibodies as a novel macrophage-based immunotherapy for glioblastoma","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Immune system; Monoclonal antibody; Immunotherapy; Tumor microenvironment; Glioma; Melanoma; Microglia; Lymphatic system; Antigen; Radioimmunotherapy","score_opus":0.018050214931597003,"score_gpt":0.3275249651756882,"score_spread":0.3094747502440912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416140129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9780998,0.0011873752,0.0010286247,0.014404871,0.0010158898,0.0014658074,0.00007646782,0.00014437592,0.002576773],"genre_scores_gemma":[0.9818713,0.00021398105,0.0037414068,0.0132699115,0.00016598306,0.00046205972,0.000047404475,0.000053852928,0.00017406816],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983044,0.000066544584,0.0004200585,0.00054548186,0.0001745395,0.00048893446],"domain_scores_gemma":[0.99828607,0.00083203067,0.0001470231,0.00042625397,0.00018514939,0.00012346702],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014230062,0.00031456506,0.0007306301,0.0003535789,0.00018027968,0.000029602432,0.00016309797,0.00024402415,0.0001618876],"category_scores_gemma":[0.00018938596,0.00026878782,0.00031324523,0.0003163466,0.00016442421,0.000043370645,0.000053649266,0.00021751528,0.00006126916],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022846754,0.0027099003,0.012009905,0.00009138576,0.0003539349,0.0005218129,0.00009107311,0.00009332454,0.93616265,0.0014772594,0.009147425,0.035056625],"study_design_scores_gemma":[0.023286745,0.0061443215,0.020966694,0.00010712706,0.00033591362,0.00021568159,0.00006115945,0.001165467,0.6468371,0.00024127748,0.3003862,0.00025231406],"about_ca_topic_score_codex":0.0000560636,"about_ca_topic_score_gemma":0.00003150067,"teacher_disagreement_score":0.29123875,"about_ca_system_score_codex":0.00023653154,"about_ca_system_score_gemma":0.0006154146,"threshold_uncertainty_score":0.99997646},"labels":[],"label_agreement":null},{"id":"W4416140204","doi":"10.1093/neuonc/noaf201.0554","title":"CTNI-58. UPDATED RESULTS OF PHASE 3 STELLAR TRIAL: EFLORNITHINE IMPROVES OVERALL SURVIVAL AND BLINDED INDEPENDENT CENTRAL REVIEW DETERMINED PROGRESSION FREE SURVIVAL IN PATIENTS WITH RECURRENT WHO 2021 GRADE 3 IDH-MUTANT ASTROCYTOMA","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Manitoba","funders":"","keywords":"Lomustine; Eflornithine; Progression-free survival; Astrocytoma; Clinical endpoint; Overall survival; Anaplastic astrocytoma; Log-rank test","score_opus":0.022739871299676917,"score_gpt":0.3294818697341074,"score_spread":0.3067419984344305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416140204","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903665,0.0016601334,0.0000032440546,0.0020902194,0.0009994701,0.004425222,0.00019660694,0.00003336281,0.00022521507],"genre_scores_gemma":[0.9965348,0.0022714771,0.00018177711,0.00028745184,0.000091242626,0.00017286053,0.00041414343,0.00003669103,0.000009508976],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99599004,0.0006929485,0.0012630767,0.0008013721,0.0006757592,0.0005768094],"domain_scores_gemma":[0.9977093,0.00044551346,0.00063894055,0.00066277146,0.00026869067,0.0002747925],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00058915274,0.0004412737,0.0015276436,0.0003147942,0.000063010404,0.000021996435,0.00021109352,0.00025254485,0.000038030696],"category_scores_gemma":[0.0007524606,0.00031502752,0.000135861,0.0005150711,0.00013852138,0.00009601501,0.00024033326,0.00049485726,0.0000014196513],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.50211215,0.03447447,0.14210747,0.0019089725,0.00087401434,0.0023052518,0.00038848646,0.000005363697,0.040255953,0.00012843982,0.0033569674,0.27208245],"study_design_scores_gemma":[0.73598135,0.04865481,0.16850413,0.0040302896,0.0012838126,0.000031226475,0.000059781243,0.000194473,0.028314602,0.000045643355,0.012433095,0.0004668049],"about_ca_topic_score_codex":0.000050887564,"about_ca_topic_score_gemma":0.00030402892,"teacher_disagreement_score":0.27161565,"about_ca_system_score_codex":0.00029498895,"about_ca_system_score_gemma":0.0004616434,"threshold_uncertainty_score":0.9999302},"labels":[],"label_agreement":null},{"id":"W4416140212","doi":"10.1093/neuonc/noaf201.0977","title":"PATH-25. Identifying the molecular signature of infiltrating edge cells in glioblastoma as drivers of tumour invasion and recurrence","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network; St. Michael's Hospital; Structural Genomics Consortium; Hospital for Sick Children","funders":"","keywords":"Gene signature; Context (archaeology); Glioblastoma; Gene; Gene expression; Cell; Tumour heterogeneity; Population","score_opus":0.013567383767596223,"score_gpt":0.2887506073867453,"score_spread":0.2751832236191491,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416140212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99601597,0.0010046827,0.000013125443,0.0011722523,0.00021751775,0.00041530142,0.0000045197144,0.000008310288,0.0011483391],"genre_scores_gemma":[0.99903965,0.0002712565,0.00013482264,0.000508395,0.000011112861,0.000022677283,0.0000018172915,0.000007040847,0.000003217666],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99900454,0.0001643846,0.00030924924,0.00023169575,0.00013910199,0.00015101596],"domain_scores_gemma":[0.9989707,0.0005546771,0.00017280396,0.00018232147,0.000076626966,0.00004289584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017567983,0.00011498407,0.0003370831,0.00018552439,0.00003520807,0.000005716564,0.00009432584,0.0001223438,0.000012434034],"category_scores_gemma":[0.00030904004,0.00008504869,0.000061285864,0.00036002696,0.0001200142,0.00003552477,0.00010245675,0.0002679866,0.0000018630001],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008624472,0.00025123046,0.013601158,0.00013652412,0.000025421912,0.00041347125,0.00074968516,0.00002136119,0.9769568,0.00080707704,0.00031531666,0.006635704],"study_design_scores_gemma":[0.0019538628,0.0011821819,0.015513613,0.00039731854,0.00010930079,0.000041936728,0.00071748596,0.00011554728,0.97869605,0.00028983413,0.00092686655,0.000056031313],"about_ca_topic_score_codex":0.000051297295,"about_ca_topic_score_gemma":0.00004329488,"teacher_disagreement_score":0.0065796725,"about_ca_system_score_codex":0.000054228927,"about_ca_system_score_gemma":0.00016554915,"threshold_uncertainty_score":0.3468185},"labels":[],"label_agreement":null},{"id":"W4416140227","doi":"10.1093/neuonc/noaf201.1168","title":"IMG-89. Volumetric (3D) compared with traditional bidirectional (2D) assessment in patients with Grade 2, isocitrate dehydrogenase 1/2 mutant (mIDH1/2) glioma receiving vorasidenib or placebo in the Phase 3 INDIGO trial","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre; Toronto General Hospital","funders":"","keywords":"Placebo; Concordance; Glioma; Kappa; Correlation","score_opus":0.03688663681545817,"score_gpt":0.3277187121549753,"score_spread":0.2908320753395171,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416140227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934543,0.000058136837,0.0000380598,0.0020373806,0.0004488594,0.0031433757,0.00008685816,0.00004818027,0.0006848988],"genre_scores_gemma":[0.9968403,0.000018111039,0.00062127603,0.000971179,0.00012495302,0.001153434,0.00023036131,0.000032014836,0.000008348572],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967757,0.00069104956,0.00068139326,0.00063878566,0.00070124416,0.0005118701],"domain_scores_gemma":[0.9972401,0.0018824711,0.00028364768,0.0003215327,0.00012661387,0.000145611],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005092537,0.00036264738,0.0007665153,0.0011211566,0.00018281411,0.000054011467,0.00019232267,0.00017792091,0.00015624326],"category_scores_gemma":[0.0002389754,0.00022239017,0.0001006425,0.0025676687,0.00016804883,0.00013107956,0.000034953948,0.00065733277,0.0000065213767],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18975061,0.059261072,0.7169979,0.00011182109,0.0009089835,0.010406771,0.001305226,0.0009584976,0.0064653424,0.00040289864,0.0027016306,0.0107292],"study_design_scores_gemma":[0.4834152,0.022362197,0.48382014,0.0002545745,0.00062509865,0.00043941347,0.0005603495,0.0019530428,0.0031465709,0.00011200727,0.0028898667,0.00042154174],"about_ca_topic_score_codex":0.00017837602,"about_ca_topic_score_gemma":0.0014057724,"teacher_disagreement_score":0.29366457,"about_ca_system_score_codex":0.0010181358,"about_ca_system_score_gemma":0.001554296,"threshold_uncertainty_score":0.9068808},"labels":[],"label_agreement":null},{"id":"W4416140239","doi":"10.1093/neuonc/noaf201.1770","title":"TMIC-15. Reactive Oligodendrocytes Promote Glioblastoma Progression via CCL5/CCR5-Mediated Glioma Stem Cell Maintenance","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; McMaster University; University of Toronto","funders":"","keywords":"Paracrine signalling; Glioma; Phenotype; Tumor microenvironment; Tumor progression; Stem cell; Cell culture; Gene knockdown; Cytokine","score_opus":0.010080827340512665,"score_gpt":0.2869629500960002,"score_spread":0.2768821227554875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416140239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9808851,0.0008999851,0.000056163924,0.0050574224,0.00092184363,0.0019222748,0.000027209391,0.00030697693,0.009923046],"genre_scores_gemma":[0.9969529,0.00014000194,0.00039944187,0.0015117107,0.00014218455,0.0005406201,0.000037473397,0.0000608246,0.0002148692],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971162,0.00025595893,0.00060362316,0.0009011219,0.00035967582,0.00076339336],"domain_scores_gemma":[0.99778485,0.0006421702,0.0003483027,0.000623381,0.00028608844,0.0003151992],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019867721,0.00045771507,0.0008869596,0.00048051457,0.00017061632,0.000030066985,0.00023746645,0.00041872406,0.000085852225],"category_scores_gemma":[0.00014167879,0.0003610813,0.00022054414,0.00084277696,0.00019594052,0.000114015966,0.00021214271,0.0005219791,0.00029538485],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017872754,0.0032009801,0.005101477,0.00017225691,0.00017775048,0.0060856733,0.00037043125,0.000003525871,0.90791094,0.00013894048,0.010891876,0.06415887],"study_design_scores_gemma":[0.008130457,0.0052320836,0.0043078386,0.00031968302,0.00034654158,0.000713163,0.00018547827,0.0005732534,0.8784952,0.00009509344,0.101336494,0.00026467108],"about_ca_topic_score_codex":0.00003090806,"about_ca_topic_score_gemma":0.000054480402,"teacher_disagreement_score":0.09044462,"about_ca_system_score_codex":0.00068473327,"about_ca_system_score_gemma":0.0005040182,"threshold_uncertainty_score":0.9998841},"labels":[],"label_agreement":null},{"id":"W4416140285","doi":"10.1093/neuonc/noaf201.1031","title":"PATH-79. High-grade astrocytoma with piloid features (HGAP) comprehensive update: histological grading, molecular markers and clinical outcomes","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"ATRX; Histopathology; Cohort; Immunohistochemistry; Progression-free survival; Astrocytoma; Neurofibromatosis; CDKN2A","score_opus":0.0190740232175289,"score_gpt":0.3251838339024767,"score_spread":0.3061098106849478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416140285","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97693485,0.0011140904,0.00006248752,0.019562708,0.0005646542,0.00073058397,0.000014889145,0.000119171724,0.0008965807],"genre_scores_gemma":[0.9831781,0.0003865888,0.0027133252,0.013461389,0.000051675706,0.00009524868,0.00004413231,0.00002795971,0.00004161926],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99774384,0.00037035008,0.0004741891,0.0007367858,0.00023305506,0.00044178066],"domain_scores_gemma":[0.9979409,0.0010687844,0.0001810328,0.00041656528,0.00010625157,0.00028648393],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00011653755,0.00036243716,0.0011058178,0.00018730844,0.0001224007,0.000023892644,0.00013899297,0.00033411942,0.0000501075],"category_scores_gemma":[0.00022408026,0.00024556223,0.00020370191,0.00021090412,0.00048278214,0.000036362275,0.00015360651,0.00058752595,0.000015993995],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035503702,0.0028326532,0.89061624,0.00007586328,0.0013718101,0.014736147,0.0000524048,0.000004836303,0.017925512,0.0042440956,0.040704284,0.023885794],"study_design_scores_gemma":[0.01286995,0.008158557,0.8833963,0.000055563174,0.0011084208,0.0007871348,0.00010220515,0.00002106388,0.003672326,0.0002042896,0.08939378,0.00023040766],"about_ca_topic_score_codex":0.000049346647,"about_ca_topic_score_gemma":0.00004613093,"teacher_disagreement_score":0.048689492,"about_ca_system_score_codex":0.00020335555,"about_ca_system_score_gemma":0.0001894211,"threshold_uncertainty_score":0.99999964},"labels":[],"label_agreement":null},{"id":"W4416140351","doi":"10.1093/neuonc/noaf201.0557","title":"CTNI-61. A PHASE 2 STUDY OF ERDAFITINIB IN PATIENTS WITH RECURRENT OR PROGRESSIVE IDH-WILD TYPE GLIOMA WITH FGFR-TACC GENE FUSIONS: SAFETY RUN-IN COHORT RESULTS","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Cohort; Tolerability; Adverse effect; Glioma; Performance status; Phases of clinical research","score_opus":0.014434922151624108,"score_gpt":0.3330471567387479,"score_spread":0.3186122345871238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416140351","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961307,0.00010821628,0.0000072594585,0.00017266137,0.00014455587,0.002818949,0.000103104016,0.000014416459,0.00050010683],"genre_scores_gemma":[0.9990287,0.000043791475,0.00023604566,0.0000998365,0.000040218674,0.00022951128,0.0002491154,0.000035167835,0.000037604677],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969718,0.00056722644,0.0006874518,0.0008718021,0.00037519148,0.00052654726],"domain_scores_gemma":[0.9983809,0.00018092479,0.0002813131,0.0006400415,0.00039902327,0.000117777374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035288068,0.000298,0.0005328579,0.00036087568,0.00008152247,0.000017394188,0.00038996892,0.00024557835,0.000025214771],"category_scores_gemma":[0.0006569367,0.00021720832,0.000038113154,0.0010335889,0.00023040139,0.000010480336,0.00037763585,0.00042920854,0.000003632986],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15871787,0.013909166,0.54097617,0.000115752795,0.0002749941,0.00090645545,0.00068628794,0.00015394861,0.27032918,0.000011673742,0.0009521929,0.012966289],"study_design_scores_gemma":[0.094442375,0.14773397,0.6213316,0.00042310273,0.00013815255,0.00006409997,0.0007886349,0.00012239216,0.11338124,0.000007888932,0.020789858,0.00077670004],"about_ca_topic_score_codex":0.00009292149,"about_ca_topic_score_gemma":0.0013278103,"teacher_disagreement_score":0.15694794,"about_ca_system_score_codex":0.000113676644,"about_ca_system_score_gemma":0.0009953458,"threshold_uncertainty_score":0.8857498},"labels":[],"label_agreement":null},{"id":"W4416140366","doi":"10.1093/neuonc/noaf201.1473","title":"EXTH-142. Quantitative surfaceome profiling of high-risk medulloblastoma prioritizes the oncofetal antigen GPC2 for potent CAR-T cell therapy","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; BC Children's Hospital; BC Cancer Agency; McMaster University","funders":"","keywords":"Medulloblastoma; Antigen; Potency; Disease; Tumor antigen; Immunotherapy; Cell","score_opus":0.034950985266482486,"score_gpt":0.3582756843886205,"score_spread":0.323324699122138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416140366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98464346,0.0019197604,0.00077299133,0.0044138003,0.0010302649,0.0035903703,0.0001163829,0.00008406987,0.0034289013],"genre_scores_gemma":[0.9892466,0.0035157457,0.004220604,0.00090804603,0.00021474682,0.0002884172,0.000033461776,0.000078018194,0.0014943291],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968122,0.0007400062,0.00067180116,0.00062383525,0.00049172645,0.0006603998],"domain_scores_gemma":[0.9947976,0.0034988692,0.00031088272,0.0006693839,0.0005832757,0.0001400215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011353703,0.00032139776,0.0009458889,0.00027887616,0.00023274004,0.000023530829,0.00042539262,0.00029101883,0.00020251694],"category_scores_gemma":[0.0005652262,0.00022901814,0.00035194634,0.0005538873,0.0005260479,0.00006351017,0.00015274477,0.00074539275,0.000017463442],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056624347,0.0005952867,0.006004405,0.00014112522,0.000302905,0.000060586433,0.0010598949,0.000076280485,0.94001997,0.0010402974,0.00087430753,0.044162538],"study_design_scores_gemma":[0.008973045,0.010400625,0.007910933,0.000056126377,0.00016958508,0.000043625034,0.0019557022,0.0008551797,0.88437355,0.00075005845,0.0842912,0.00022040233],"about_ca_topic_score_codex":0.00036161987,"about_ca_topic_score_gemma":0.00011538968,"teacher_disagreement_score":0.08341689,"about_ca_system_score_codex":0.00027525172,"about_ca_system_score_gemma":0.0012741288,"threshold_uncertainty_score":0.9339089},"labels":[],"label_agreement":null},{"id":"W4416140407","doi":"10.1093/neuonc/noaf201.0988","title":"PATH-36. DNA copy number clustering reveals alterations that influence survival in primary IDH-mutant astrocytoma patients","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Copy-number variation; Copy number analysis; Loss of heterozygosity; Astrocytoma; Glioma; Chromosome; Gene dosage; Germline","score_opus":0.015906125555648194,"score_gpt":0.30068785266664916,"score_spread":0.28478172711100097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416140407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900106,0.000041490766,0.00004813554,0.0019468504,0.0007361982,0.0008280689,0.000027616126,0.000056251407,0.0063047553],"genre_scores_gemma":[0.99491614,0.00007498984,0.0003796908,0.0042237123,0.00005030881,0.00023991447,0.00006580156,0.000021349966,0.000028084825],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981945,0.00022478898,0.00046901236,0.00044574018,0.00023895173,0.00042697135],"domain_scores_gemma":[0.99876124,0.00051589287,0.00013561874,0.00034306257,0.000117151896,0.00012706018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017082067,0.0002223952,0.0005556208,0.00017121863,0.00010495111,0.000026299813,0.0001192783,0.00016542203,0.000071746064],"category_scores_gemma":[0.00021113174,0.00020071695,0.00008860113,0.00031375754,0.00006878537,0.00011756628,0.0001831015,0.00028361203,0.000069834976],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004076385,0.0011137738,0.9229587,0.00008072407,0.000047585643,0.000594921,0.00019780193,0.000040308976,0.06820276,0.000115719165,0.0009350136,0.0053050653],"study_design_scores_gemma":[0.007249637,0.001002427,0.9654556,0.00021192105,0.000107298285,0.000056951332,0.000056787983,0.00009662628,0.015929919,0.00007447087,0.009605375,0.00015297807],"about_ca_topic_score_codex":0.000051743926,"about_ca_topic_score_gemma":0.00019178953,"teacher_disagreement_score":0.05227284,"about_ca_system_score_codex":0.00061776675,"about_ca_system_score_gemma":0.00027102855,"threshold_uncertainty_score":0.8185},"labels":[],"label_agreement":null},{"id":"W4416140417","doi":"10.1093/neuonc/noaf201.0702","title":"DDDR-65. Dynamic and multi-omic profiling of glioblastoma to guide personalized medicine","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University","funders":"","keywords":"Temozolomide; Personalized medicine; Glioblastoma; Chemoradiotherapy; Precision medicine; Tumor microenvironment; Regimen; Profiling (computer programming)","score_opus":0.018691193942410724,"score_gpt":0.35068278174986006,"score_spread":0.33199158780744936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416140417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97225606,0.0010789831,0.00022363516,0.023009794,0.00039847646,0.0009286079,0.0000108614095,0.00005331362,0.00204024],"genre_scores_gemma":[0.99036753,0.00022394866,0.003802968,0.005138862,0.00005223124,0.0001324105,0.000009811771,0.000023396284,0.00024881324],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99864435,0.000096355194,0.000435067,0.00040951694,0.00015256907,0.00026214283],"domain_scores_gemma":[0.99885553,0.00046249773,0.00010999363,0.00027100233,0.00013201988,0.00016895398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018798656,0.00019061181,0.0006876709,0.000364588,0.000054708562,0.0000038124886,0.000085813655,0.00013170484,0.000081630606],"category_scores_gemma":[0.00057745026,0.00014895403,0.00007477912,0.00031399025,0.00019948433,0.000021436548,0.00009951589,0.00015284274,0.000014821821],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007420233,0.00059848354,0.021667259,0.00015318124,0.00015869082,0.00040405462,0.0006101268,0.0000072301805,0.9449919,0.00069662347,0.0047272877,0.02524313],"study_design_scores_gemma":[0.06715304,0.021461844,0.08595184,0.0012774703,0.0023792204,0.0010145162,0.0030898931,0.010252184,0.53405863,0.00024010615,0.27250403,0.00061719486],"about_ca_topic_score_codex":0.0000800335,"about_ca_topic_score_gemma":0.00012714858,"teacher_disagreement_score":0.41093326,"about_ca_system_score_codex":0.00023576058,"about_ca_system_score_gemma":0.00022496554,"threshold_uncertainty_score":0.6074169},"labels":[],"label_agreement":null},{"id":"W4416140500","doi":"10.1093/neuonc/noaf201.0960","title":"PATH-08. Establishing the utility of deep-learning for H&amp;E-based meningioma molecular classification and outcome prediction","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Machine Learning in Bioinformatics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Deep learning; Classifier (UML); Leverage (statistics); Precision medicine; Correlation; Predictive modelling; Neuroimaging; Genomics","score_opus":0.01880609155948536,"score_gpt":0.30846736329931845,"score_spread":0.2896612717398331,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416140500","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.73412645,0.00024187911,0.2587568,0.0015700875,0.00036717864,0.0006442752,0.000016676171,0.000042745545,0.004233907],"genre_scores_gemma":[0.9929569,0.000020005593,0.005977605,0.0007303224,0.000045192297,0.000071337345,0.00014862345,0.000012951518,0.000037060632],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987068,0.0002891319,0.00043179246,0.00026874407,0.00010698326,0.00019651113],"domain_scores_gemma":[0.9988286,0.00038069338,0.0002707151,0.00033982474,0.00014085748,0.00003931147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007273948,0.00013695599,0.00019677749,0.00007182972,0.00016431931,0.0000286771,0.00020362738,0.00023829282,0.0000070812803],"category_scores_gemma":[0.002403054,0.0001155484,0.000085532425,0.00013127459,0.00014727048,0.000007583086,0.00011304071,0.00025896778,7.7698627e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024941258,0.00006660677,0.1041862,0.00021405063,0.00004780843,9.56697e-7,0.00018075856,0.0010355811,0.8605977,0.0006630512,0.00082149525,0.031936374],"study_design_scores_gemma":[0.0025471968,0.001343906,0.061481997,0.000030808234,0.00020557143,0.000025621202,0.0003922833,0.37576705,0.07818911,0.00031217327,0.4794292,0.00027511225],"about_ca_topic_score_codex":0.000007715309,"about_ca_topic_score_gemma":0.000012371715,"teacher_disagreement_score":0.7824086,"about_ca_system_score_codex":0.000023832165,"about_ca_system_score_gemma":0.000101118334,"threshold_uncertainty_score":0.4711927},"labels":[],"label_agreement":null},{"id":"W4416140576","doi":"10.1093/neuonc/noaf201.0771","title":"DISP-10. The global landscape of glioblastoma clinical trials: A missing map for low- and middle-income countries","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Clinical trial; Glioblastoma; Missing data; Life expectancy; Protocol (science); MEDLINE","score_opus":0.31193223258731584,"score_gpt":0.5823887126944874,"score_spread":0.2704564801071716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416140576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.68801135,0.003201764,0.001065041,0.28875214,0.0036118168,0.0033531417,0.00019496323,0.00011141216,0.011698391],"genre_scores_gemma":[0.9821639,0.0015242021,0.0016231261,0.012172718,0.0010788566,0.00013733766,0.000008618475,0.000034069257,0.0012571707],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99547726,0.0015625376,0.0016265926,0.00049277075,0.0004453627,0.00039545176],"domain_scores_gemma":[0.8349088,0.16309425,0.00044750093,0.0006244308,0.000685084,0.00023995257],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.016580984,0.00016517178,0.0012232781,0.0000821574,0.00015005562,0.00003411532,0.0003315811,0.00074446213,0.00012469868],"category_scores_gemma":[0.14665817,0.00010616294,0.00031037608,0.00026581725,0.0012927644,0.000034351047,0.0003296597,0.0012198582,0.00001699194],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.123775564,0.0033675306,0.43691024,0.0181893,0.0019507192,0.00072703994,0.000865113,0.000010681703,0.0045965784,0.23331243,0.05326438,0.12303043],"study_design_scores_gemma":[0.0331465,0.02137559,0.034649257,0.0037879217,0.0014571975,0.00017697584,0.0008723296,0.0037253983,0.0030874272,0.11926343,0.7780596,0.00039838513],"about_ca_topic_score_codex":0.000010247418,"about_ca_topic_score_gemma":0.00017435157,"teacher_disagreement_score":0.7247952,"about_ca_system_score_codex":0.00010170931,"about_ca_system_score_gemma":0.0019068548,"threshold_uncertainty_score":0.8605299},"labels":[],"label_agreement":null},{"id":"W4416140708","doi":"10.1093/neuonc/noaf201.0865","title":"IMMU-67. On-Treatment Spatiotemporal Profiling of Glioblastoma During Oncolytic ImmunoTherapy","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Oncolytic virus; Immune system; Immunotherapy; Glioblastoma; Tumor microenvironment; Transcriptome; Myeloid; Herpes simplex virus; Proteomics","score_opus":0.015345016377177457,"score_gpt":0.327979117982267,"score_spread":0.31263410160508953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416140708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99512583,0.00060590904,0.00005803818,0.00065876916,0.0003196658,0.0006485675,0.000018362787,0.00002691325,0.0025379427],"genre_scores_gemma":[0.99776775,0.0005999729,0.00025009565,0.0005664819,0.00015808293,0.00013164211,0.00002664667,0.00004210294,0.00045720607],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9981982,0.00029942414,0.00040332414,0.00051132665,0.0001769398,0.0004107517],"domain_scores_gemma":[0.99889874,0.000101595266,0.00015640799,0.0006521598,0.00011857009,0.00007251047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002085628,0.00025924534,0.00037579538,0.00020723716,0.000115776165,0.000013122347,0.00032481682,0.00026070685,0.000051031642],"category_scores_gemma":[0.00007909038,0.00023505061,0.00018128398,0.00022854593,0.00016501847,0.00000386468,0.00011228221,0.00019204122,0.000023388504],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010952798,0.00046871498,0.001399263,0.000028321592,0.00017260616,0.000033827506,0.00006160795,0.0002590157,0.9633033,0.000043634667,0.00013291958,0.023143964],"study_design_scores_gemma":[0.0031818044,0.021833073,0.0005986675,0.000017922353,0.000015156846,0.000012992305,0.000047681806,0.00006980499,0.95797575,0.000043232034,0.016053915,0.00015000527],"about_ca_topic_score_codex":0.00002738295,"about_ca_topic_score_gemma":0.00013594743,"teacher_disagreement_score":0.02299396,"about_ca_system_score_codex":0.00026710905,"about_ca_system_score_gemma":0.0007832844,"threshold_uncertainty_score":0.95850855},"labels":[],"label_agreement":null},{"id":"W4416140781","doi":"10.1093/neuonc/noaf201.0924","title":"INNV-35. Artificial intelligence in Neuro-Oncology: Mapping the field","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Google (Canada)","funders":"","keywords":"Metadata; Field (mathematics); Deep learning; Python (programming language); Precision medicine; Key (lock); Generative grammar","score_opus":0.03112628055538892,"score_gpt":0.35447840790261126,"score_spread":0.32335212734722235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416140781","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3174873,0.00058968825,0.027941236,0.57450193,0.0058632307,0.0013309479,0.00000218736,0.00023752918,0.07204596],"genre_scores_gemma":[0.8603871,0.00036412114,0.0016894734,0.13662313,0.00064002734,0.00008604738,0.000006760795,0.000031914697,0.00017142892],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99757797,0.00047897827,0.00068963657,0.0005079585,0.00021259024,0.00053287786],"domain_scores_gemma":[0.9946386,0.0045556347,0.0001544909,0.00044741418,0.00006666298,0.0001371935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009889208,0.00021682713,0.000570149,0.00038433526,0.00016939103,0.00003243677,0.00040735558,0.00030194444,0.00016983124],"category_scores_gemma":[0.0065160724,0.00016615124,0.00012334775,0.00080565794,0.00031338024,0.000053813612,0.0002593252,0.0022360578,0.00006164705],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003141637,0.000325231,0.0077928593,0.000057819394,0.00003706913,0.0011134659,0.0009464833,0.0001932274,0.09291055,0.0073613906,0.019399736,0.869548],"study_design_scores_gemma":[0.00078555115,0.0010557865,0.0032484164,0.00011549192,0.00008001549,0.00031329808,0.0008036642,0.033756513,0.004864965,0.005147774,0.9496429,0.00018564447],"about_ca_topic_score_codex":0.00013012458,"about_ca_topic_score_gemma":0.00008205383,"teacher_disagreement_score":0.93024313,"about_ca_system_score_codex":0.0002375888,"about_ca_system_score_gemma":0.0006583217,"threshold_uncertainty_score":0.97146827},"labels":[],"label_agreement":null},{"id":"W4416140904","doi":"10.1093/neuonc/noaf201.0359","title":"CSIG-25. EXPLORING THE ROLE OF THE CIC/YY1 COMPLEX IN MODULATING SENSITIVITY OF MEK INHIBITORS IN GLIOBLASTOMA","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"MAPK/ERK pathway; Effector; Transcription factor; Suppressor; Kinase; Transcription (linguistics); Downregulation and upregulation; Cell growth; Signal transduction","score_opus":0.019920383563121712,"score_gpt":0.25587932083091514,"score_spread":0.23595893726779343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416140904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961415,0.000102748876,0.000046963913,0.00032846947,0.00034262193,0.00024301044,0.000009200714,0.0000047230983,0.002780786],"genre_scores_gemma":[0.9995485,0.000020717574,0.00007757472,0.00023159944,0.000069963484,0.000029409759,0.0000028317236,0.000009871938,0.000009508105],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99853057,0.0005557841,0.00036287907,0.0002473489,0.000091442314,0.00021199632],"domain_scores_gemma":[0.9992157,0.0002267269,0.0001472887,0.00034261338,0.000046371744,0.000021304588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044453438,0.00011887672,0.00025495797,0.00008150428,0.000044227396,0.0000033824256,0.00018863489,0.00012294829,0.000002752696],"category_scores_gemma":[0.00034664874,0.00008683893,0.000085458494,0.00026940284,0.00014248295,0.000004118234,0.00032685537,0.00020018667,5.358647e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000879786,0.00007951699,0.026308365,0.000018144514,0.000009309523,0.000008545873,0.0002657461,0.0005913794,0.9553563,0.000421531,0.000076954304,0.016776208],"study_design_scores_gemma":[0.0005245651,0.00025606705,0.033080436,0.00003136329,0.000008718015,0.000012844197,0.00052487437,0.0010680602,0.9490621,0.0002332346,0.015124814,0.0000729393],"about_ca_topic_score_codex":0.00018618896,"about_ca_topic_score_gemma":0.0015904421,"teacher_disagreement_score":0.016703269,"about_ca_system_score_codex":0.000028894434,"about_ca_system_score_gemma":0.00013604517,"threshold_uncertainty_score":0.35411888},"labels":[],"label_agreement":null},{"id":"W4416140911","doi":"10.1093/neuonc/noaf201.0852","title":"IMMU-54. Leveraging deep immunopeptidomics to identify tumor antigens from glioblastoma tissue samples","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"vaccines and immunoinformatics approaches","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Major histocompatibility complex; Antigen; Human leukocyte antigen; Glioblastoma; Immunotherapy; MHC class I; Proteomics; Genome; Cancer immunotherapy; Gene expression profiling","score_opus":0.015128322723410114,"score_gpt":0.29169795155872513,"score_spread":0.276569628835315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416140911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9828701,0.00090520986,0.011702902,0.00073171005,0.0011320687,0.0004332647,0.00004607096,0.00004050178,0.00213816],"genre_scores_gemma":[0.9892689,0.00022954436,0.0054862793,0.0043056076,0.00028761727,0.000060404676,0.00016499929,0.000043039683,0.00015360159],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982018,0.000113693095,0.0005676163,0.0005089297,0.0001180974,0.00048990117],"domain_scores_gemma":[0.9988399,0.000094006165,0.00016610892,0.0006800701,0.00011396635,0.00010595477],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020475105,0.00030122758,0.00042132026,0.00015117976,0.00020392469,0.00009310733,0.0005891768,0.00022730016,0.00006282406],"category_scores_gemma":[0.00025029026,0.00030707294,0.00013321785,0.00023063665,0.000063522195,0.000013800563,0.0006895634,0.00024806082,0.00010730471],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033718752,0.00008259307,0.0007654226,0.000018969147,0.00010703257,0.00001753496,0.0003567065,0.00018514792,0.97053635,0.000097518656,0.004956259,0.022539282],"study_design_scores_gemma":[0.001099627,0.00069350627,0.004619699,0.000018860703,0.00004797005,0.000052925814,0.00044436817,0.0003222817,0.58622164,0.00018718593,0.40600723,0.00028473142],"about_ca_topic_score_codex":0.0001475023,"about_ca_topic_score_gemma":0.00012465596,"teacher_disagreement_score":0.40105098,"about_ca_system_score_codex":0.0000714755,"about_ca_system_score_gemma":0.00023312563,"threshold_uncertainty_score":0.99993813},"labels":[],"label_agreement":null},{"id":"W4416140935","doi":"10.1093/neuonc/noaf201.0790","title":"DISP-30. Impact of distance traveled for clinical trial participation on clinical outcomes in patients with glioblastoma","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Glioblastoma; Clinical trial; Cohort; Proportional hazards model; Residence; Retrospective cohort study; Karnofsky Performance Status; Cohort study","score_opus":0.3575693211475629,"score_gpt":0.6375715611309188,"score_spread":0.28000223998335594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416140935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927173,0.000005540553,0.00035580847,0.0025380254,0.000894044,0.0026246111,0.000038542144,0.000024446157,0.0008016536],"genre_scores_gemma":[0.9976718,0.00006372876,0.00030606863,0.0014188578,0.00017153507,0.00020056115,0.00001683112,0.000026240381,0.00012440735],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950695,0.0010105086,0.0022123994,0.0006577329,0.00059017,0.00045969556],"domain_scores_gemma":[0.9312482,0.06683477,0.00046495462,0.0006483186,0.0005533595,0.00025042729],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0048446567,0.00019900869,0.001394349,0.00018346054,0.00004323535,0.000008701441,0.0002552298,0.0007768711,0.00006136376],"category_scores_gemma":[0.08218694,0.00013481121,0.0005150307,0.0003335097,0.00063006475,0.00004095124,0.00008754368,0.0020187348,0.000013383755],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24511266,0.006334158,0.7269365,0.000055388107,0.000136698,0.000014674177,0.00003115993,0.0000068471954,0.0000203366,0.0011967438,0.00047669694,0.019678116],"study_design_scores_gemma":[0.11537199,0.093615316,0.7881436,0.00009968251,0.00010650709,1.9044926e-7,0.000009463004,0.00016691686,0.000044798606,0.0012228701,0.0011354744,0.000083209576],"about_ca_topic_score_codex":0.000015706171,"about_ca_topic_score_gemma":0.00035033107,"teacher_disagreement_score":0.12974067,"about_ca_system_score_codex":0.00026221934,"about_ca_system_score_gemma":0.0017198798,"threshold_uncertainty_score":0.9255442},"labels":[],"label_agreement":null},{"id":"W4416140939","doi":"10.1093/neuonc/noaf201.0046","title":"EPCO-47. DISSECTING MYC-DRIVEN EPIGENETIC MECHANISMS THAT PROMOTE GROUP 3 MEDULLOBLASTOMA UTILIZING HUMANIZED IPSC MODELS","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"H3K4me3; Epigenetics; Medulloblastoma; Neural stem cell; Chromatin; Histone; Polycomb-group proteins; Induced pluripotent stem cell; Effector; PRC2","score_opus":0.0376564264573605,"score_gpt":0.3122048493021556,"score_spread":0.2745484228447951,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416140939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.978905,0.0006841897,0.0039252336,0.0034379577,0.0016159276,0.0018006335,0.000010085806,0.00032683273,0.0092940945],"genre_scores_gemma":[0.9941051,0.00017645828,0.0032386438,0.0017989726,0.00013133342,0.00037520757,0.000029805715,0.00006838106,0.00007607244],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973628,0.00025842284,0.0005190907,0.00083364465,0.00033534612,0.000690722],"domain_scores_gemma":[0.99828446,0.0005236845,0.00021860584,0.0005790869,0.0001498971,0.0002442575],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025566734,0.00040443623,0.00087595155,0.00034819025,0.00030638458,0.000041652886,0.00023669188,0.0003139157,0.00015558014],"category_scores_gemma":[0.0002455789,0.00035465625,0.0002621714,0.0003899098,0.00009729894,0.000105640574,0.00024456327,0.00043425802,0.00005258714],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005136398,0.0023182502,0.0035029291,0.00021167214,0.00050436886,0.0019913896,0.0011881074,0.00024664533,0.90167445,0.029031632,0.00097103405,0.05784588],"study_design_scores_gemma":[0.03194481,0.01203462,0.01414492,0.0011965504,0.0032017904,0.000986119,0.0027790265,0.05492883,0.79893833,0.04890862,0.02953046,0.0014059169],"about_ca_topic_score_codex":0.000055063425,"about_ca_topic_score_gemma":0.00018080854,"teacher_disagreement_score":0.10273612,"about_ca_system_score_codex":0.00041496384,"about_ca_system_score_gemma":0.00021277762,"threshold_uncertainty_score":0.99989057},"labels":[],"label_agreement":null},{"id":"W4416140966","doi":"10.1093/neuonc/noaf201.0506","title":"CTNI-09. VORASIDENIB AS MAINTENANCE TREATMENT AFTER FIRST-LINE CHEMORADIOTHERAPY IN IDH-MUTANT GRADE 2/3 ASTROCYTOMA: STUDY PROTOCOL FOR THE PLACEBO-CONTROLLED, TRIPLE-BLIND, RANDOMIZED PHASE III STUDY EORTC-2427 (VIGOR)","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Children's Hospital Research Institute of Manitoba","funders":"","keywords":"Randomized controlled trial; Clinical endpoint; Radiation therapy; Placebo; Chemoradiotherapy; Clinical trial; Quality of life (healthcare); Intention-to-treat analysis; Maintenance therapy","score_opus":0.03381051816741617,"score_gpt":0.3980270223201019,"score_spread":0.36421650415268575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416140966","genre_codex":"protocol","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"protocol","genre_consensus":"protocol","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.30362347,0.00023039037,0.001382486,0.010532808,0.0005373538,0.68333477,0.000039909537,0.00011002044,0.00020877583],"genre_scores_gemma":[0.41628256,0.00004503465,0.00026994228,0.0012567104,0.00022229804,0.58126277,0.000011178213,0.00005872182,0.00059077935],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9937506,0.0016711286,0.0018801831,0.0012232002,0.0004924959,0.0009824352],"domain_scores_gemma":[0.9927752,0.0051000887,0.0006018417,0.0010897517,0.00020009078,0.00023304454],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0026845422,0.00086840277,0.004024908,0.00044616766,0.00032369446,0.00007223451,0.00034502504,0.00022503834,0.00022897418],"category_scores_gemma":[0.00092263764,0.0004819507,0.00086526753,0.0006140004,0.0002699593,0.000086886044,0.00010600251,0.0005297146,0.000017039358],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9320013,0.04008854,0.0025887804,0.000062982705,0.002641233,0.0032845708,0.001954895,0.00008782842,0.0004676098,0.00006831999,0.00049436936,0.016259557],"study_design_scores_gemma":[0.9179182,0.04461824,0.0002694998,0.0000673393,0.0026859576,0.00018808086,0.0019075549,0.0017073106,0.00092704286,0.00013717578,0.029289693,0.0002839203],"about_ca_topic_score_codex":0.00032262373,"about_ca_topic_score_gemma":0.0025027005,"teacher_disagreement_score":0.11265909,"about_ca_system_score_codex":0.0011649515,"about_ca_system_score_gemma":0.000972342,"threshold_uncertainty_score":0.9997632},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"randomized_trial","genre":"protocol","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"randomized_trial","genre":"protocol","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W4416140972","doi":"10.1093/neuonc/noaf201.0589","title":"CTP-17. Clinical stability following tovorafenib treatment in relapsed/refractory pediatric low-grade glioma: updated results from the phase 2 FIREFLY-1 trial","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Clinical trial; Radiography; Drug; Retrospective cohort study; Phases of clinical research; Drug holiday","score_opus":0.041871743802711574,"score_gpt":0.35258401359150787,"score_spread":0.3107122697887963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416140972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912273,0.00055223395,0.000024758847,0.0012149086,0.003525315,0.0011374035,0.00026349755,0.00004150945,0.0020130598],"genre_scores_gemma":[0.99633473,0.00024903243,0.00010382184,0.00094107364,0.0013528009,0.00013462258,0.00074477005,0.000025129042,0.00011401405],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957239,0.0014345596,0.001154209,0.0010450833,0.00016419803,0.00047801726],"domain_scores_gemma":[0.99727523,0.0012258919,0.0002925803,0.0010085327,0.00005183097,0.00014594792],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00096478156,0.00033366997,0.00061252376,0.000089752466,0.00014529467,0.000025231231,0.00044619647,0.0006901506,0.000029637375],"category_scores_gemma":[0.0015347628,0.0002515287,0.00041547988,0.00033918355,0.00012690446,0.0000069655985,0.00022525205,0.00045001862,0.0000195321],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08443938,0.008940071,0.012085029,0.000014366155,0.00026080976,0.0009663,0.0003753812,0.000022647066,0.8424478,0.00003415287,0.03260132,0.017812734],"study_design_scores_gemma":[0.24304365,0.014396757,0.0037264414,0.000010840193,0.00042051263,0.000011468517,0.00018952979,0.000105133724,0.13542517,0.00016375007,0.60200036,0.0005063738],"about_ca_topic_score_codex":0.0002229301,"about_ca_topic_score_gemma":0.0006508855,"teacher_disagreement_score":0.70702267,"about_ca_system_score_codex":0.00016147629,"about_ca_system_score_gemma":0.0010229354,"threshold_uncertainty_score":0.9999937},"labels":[],"label_agreement":null},{"id":"W4416141003","doi":"10.1093/neuonc/noaf201.0122","title":"BIOM-34. GENOMIC ANALYSIS OF CSF CTDNA IN LUNG CANCER-RELATED LEPTOMENINGEAL METASTASES","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Aneuploidy; Lung cancer; Chemotherapy; Allele; Mutation; Lung","score_opus":0.013977656757288275,"score_gpt":0.3812545465734455,"score_spread":0.3672768898161572,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416141003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848391,0.001970074,0.000040111896,0.0029316463,0.000406395,0.0004527875,0.00008779641,0.000048272632,0.009223852],"genre_scores_gemma":[0.9979423,0.00037980778,0.00031837734,0.0008278038,0.000021003765,0.00011066565,0.000099943165,0.000011992305,0.0002881067],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99884343,0.0001104852,0.0004262838,0.00029922667,0.000098214514,0.00022237899],"domain_scores_gemma":[0.9992525,0.0002285536,0.0001473532,0.00022612992,0.00007961276,0.00006583136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000107123094,0.0001313424,0.0006502697,0.0009835771,0.000040832918,0.0000050436124,0.00008132131,0.000108446904,0.00032017057],"category_scores_gemma":[0.00005517761,0.000115135816,0.00016030666,0.0016908782,0.00007054365,0.000038642283,0.000044313896,0.00015444841,0.0000040712807],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058753183,0.0017514793,0.5303958,0.00025162412,0.016971081,0.0005119878,0.0037291602,0.0026492996,0.39796698,0.00133179,0.0048120255,0.0390412],"study_design_scores_gemma":[0.020596096,0.0021763456,0.7044829,0.00019823751,0.07224838,0.000042440523,0.0012360653,0.018307526,0.027116148,0.00015803786,0.15294698,0.00049081934],"about_ca_topic_score_codex":0.0012788951,"about_ca_topic_score_gemma":0.0008421611,"teacher_disagreement_score":0.37085083,"about_ca_system_score_codex":0.0008855779,"about_ca_system_score_gemma":0.0008642429,"threshold_uncertainty_score":0.46951023},"labels":[],"label_agreement":null},{"id":"W4416141004","doi":"10.1093/neuonc/noaf201.0150","title":"BIOM-62. BASELINE NEUROLOGICAL FUNCTION ASSESSED BY NANO PREDICTS PROGRESSION-FREE SURVIVAL IN GLIOBLASTOMA","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Glioblastoma; Cohort; Overall survival; Proportional hazards model; Glioma; Progression-free survival; Survival analysis; Karnofsky Performance Status","score_opus":0.01523134519484571,"score_gpt":0.30476237852017724,"score_spread":0.28953103332533153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416141004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96995884,0.0005392442,0.00011439437,0.023387076,0.0018344388,0.0010508205,0.00004074572,0.0002178163,0.002856601],"genre_scores_gemma":[0.9938572,0.00011852115,0.00014144891,0.005197175,0.0001647669,0.000360898,0.000072543524,0.000027684464,0.000059749353],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99737585,0.0005475723,0.000527643,0.0007055692,0.0003527819,0.0004905629],"domain_scores_gemma":[0.99781954,0.0011649935,0.00013983046,0.0005542698,0.00012277046,0.0001985725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044795018,0.00029299283,0.00064397446,0.00037478373,0.00009043902,0.000021658598,0.00020352172,0.00040360648,0.00019177175],"category_scores_gemma":[0.0012627252,0.00022501782,0.00012502116,0.0007804981,0.00013722846,0.00007164836,0.00021156172,0.0004273514,0.00004123974],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004831669,0.00881935,0.27950916,0.00009259148,0.0001303226,0.0027841842,0.000035657264,0.000016357955,0.49831808,0.0004823307,0.123102665,0.081877634],"study_design_scores_gemma":[0.03388881,0.027470361,0.20291618,0.00020835554,0.00062223384,0.00025200375,0.00006519648,0.0030039723,0.08024203,0.0005632164,0.6503297,0.0004379673],"about_ca_topic_score_codex":0.000022674329,"about_ca_topic_score_gemma":0.000118906304,"teacher_disagreement_score":0.52722704,"about_ca_system_score_codex":0.0001605318,"about_ca_system_score_gemma":0.000310115,"threshold_uncertainty_score":0.91759604},"labels":[],"label_agreement":null},{"id":"W4416141005","doi":"10.1093/neuonc/noaf201.0588","title":"CTP-16. ONC201 (Dordaviprone) in the treatment of Diffuse Midline Glioma of the Pons in children: single center experience from Canada","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Single Center; Radiation therapy; Glioma; Chemotherapy; Progression-free survival; Biopsy; Clinical trial","score_opus":0.016292870814488897,"score_gpt":0.277693541229457,"score_spread":0.2614006704149681,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416141005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914211,0.0005323298,5.0249724e-7,0.006269409,0.0002941811,0.000831598,0.00007400034,0.0000049260416,0.00057193206],"genre_scores_gemma":[0.99842596,0.00008366152,0.000022876575,0.0012505846,0.000030159725,0.00014286936,0.000024160743,0.000008985732,0.00001072536],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998695,0.00020925111,0.00040928327,0.0002689665,0.00018739204,0.00023009925],"domain_scores_gemma":[0.9988297,0.00045586794,0.0001340128,0.0005058867,0.000032759825,0.00004177949],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000047678215,0.00016395655,0.0004483746,0.00011358077,0.000033462133,0.0000036088643,0.0001982484,0.000080052094,0.000036241454],"category_scores_gemma":[0.000078922414,0.00009056219,0.000093931005,0.00040619212,0.00013056137,0.000017668046,0.000048392052,0.00010792162,7.3666155e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020811043,0.009707229,0.88787746,0.0000075156736,0.000059707734,0.00021806294,0.0018695496,0.0000073908373,0.09478289,0.000044626904,0.00052755966,0.0046898895],"study_design_scores_gemma":[0.009043932,0.0013595516,0.7795427,0.000060322614,0.000106245956,0.000048071994,0.0006804473,0.000014327682,0.19978519,0.000028097256,0.009265751,0.00006540617],"about_ca_topic_score_codex":0.27856582,"about_ca_topic_score_gemma":0.49192688,"teacher_disagreement_score":0.21336105,"about_ca_system_score_codex":0.00065959163,"about_ca_system_score_gemma":0.00043068433,"threshold_uncertainty_score":0.72623825},"labels":[],"label_agreement":null},{"id":"W4416141008","doi":"10.1093/neuonc/noaf201.0596","title":"DNAR-05. Discovery and development of a novel CNS-penetrating ATR inhibitor","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Variation Biotechnologies (Canada)","funders":"","keywords":"Drug discovery; Adept; In vivo; Kinase; Cancer therapy; Mechanism (biology); Cancer","score_opus":0.03693012742183182,"score_gpt":0.3397739218535768,"score_spread":0.302843794431745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416141008","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98364687,0.0003403968,0.003259522,0.003671982,0.00087333133,0.00044085408,0.000010692443,0.000049893013,0.0077064657],"genre_scores_gemma":[0.9804361,0.00006572461,0.013469196,0.0053650467,0.00020958207,0.000078021956,0.00001381807,0.00002091075,0.0003415875],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99877733,0.00005311514,0.00048130905,0.00031287468,0.00015952089,0.00021587673],"domain_scores_gemma":[0.9991641,0.0003356426,0.0001550619,0.00019187083,0.00007871089,0.00007460088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019832153,0.00014479924,0.00038497202,0.00015860565,0.00007992703,0.000011215377,0.00006898068,0.0001390344,0.000036928526],"category_scores_gemma":[0.00013431096,0.00013555602,0.000044556506,0.00018972633,0.0001545881,0.00008452154,0.00008593607,0.00023920272,0.000004460056],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003745636,0.0002822216,0.0052074757,0.00012620796,0.000053855423,0.000028519553,0.000677958,0.0000051607494,0.96238905,0.00045512477,0.0033102585,0.027089588],"study_design_scores_gemma":[0.010473749,0.0011735844,0.015006575,0.00035270012,0.000071874434,0.0002146602,0.00057257165,0.00011997871,0.6097637,0.00009454001,0.36193597,0.0002200965],"about_ca_topic_score_codex":0.000009998758,"about_ca_topic_score_gemma":0.000032741544,"teacher_disagreement_score":0.3586257,"about_ca_system_score_codex":0.00021697073,"about_ca_system_score_gemma":0.00095428363,"threshold_uncertainty_score":0.5527814},"labels":[],"label_agreement":null},{"id":"W4416141026","doi":"10.1093/neuonc/noaf201.0119","title":"BIOM-31. PLASMA CELL-FREE DNA METHYLOME PREDICTS RESPONSE TO COMBINED PARP AND IMMUNE CHECKPOINT INHIBITION IN IDH-MUTANT GLIOMA","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Public Health","funders":"","keywords":"Olaparib; Immune checkpoint; DNA methylation; PARP inhibitor; Durvalumab; Glioma; Immune system; Biomarker; Epigenetics","score_opus":0.016935772640992556,"score_gpt":0.3065460026243378,"score_spread":0.28961022998334524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416141026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95071393,0.00028804716,0.00013921062,0.042609014,0.0009574514,0.0014938157,0.00006043974,0.00021024235,0.0035278685],"genre_scores_gemma":[0.9928464,0.0001542813,0.00065612147,0.0056271735,0.00011207385,0.00040249364,0.000028242908,0.000045928915,0.00012727913],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967171,0.00070241524,0.00095813477,0.00071149686,0.0003155726,0.00059530506],"domain_scores_gemma":[0.99738044,0.0012443817,0.00021215178,0.00074075547,0.00014578222,0.00027652268],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013625607,0.00032994043,0.00081417133,0.0010970915,0.00011303193,0.000025025818,0.00017103786,0.00040354402,0.0000770053],"category_scores_gemma":[0.0011689446,0.0003331625,0.00011061337,0.0012434211,0.00026080248,0.00010115456,0.00031812134,0.0005843862,0.0000554703],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021939307,0.00053477,0.0002806891,0.00010457553,0.00003916663,0.0013495102,0.0008275747,0.0000139814365,0.96777076,0.00020551971,0.005306046,0.0016281164],"study_design_scores_gemma":[0.022422336,0.0045521962,0.005808679,0.0002270684,0.00006779093,0.00037112707,0.00023365012,0.00021356695,0.92135495,0.0010963506,0.043430947,0.00022131183],"about_ca_topic_score_codex":0.000055945056,"about_ca_topic_score_gemma":0.000051728675,"teacher_disagreement_score":0.04641577,"about_ca_system_score_codex":0.00093180814,"about_ca_system_score_gemma":0.00086022564,"threshold_uncertainty_score":0.999912},"labels":[],"label_agreement":null},{"id":"W4416141066","doi":"10.1093/neuonc/noaf201.0597","title":"DNAR-06. Discovery and development of novel CNS-penetrating PARP1-selective inhibitors","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"EMD Serono","keywords":"Drug discovery; PARP1; Poly ADP ribose polymerase; Drug development; Drug; Docking (animal); In vivo; Decoy","score_opus":0.03169128465356363,"score_gpt":0.33538403359929386,"score_spread":0.30369274894573023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416141066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9799614,0.00035801475,0.002821075,0.0024430281,0.0006119929,0.0005644116,0.000010033474,0.00005707009,0.013172955],"genre_scores_gemma":[0.9896546,0.00007716186,0.0068675554,0.002929786,0.0001492595,0.00010024924,0.000015551921,0.00001998137,0.00018586322],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99862653,0.00007639618,0.0005077319,0.00036480383,0.00017333582,0.000251221],"domain_scores_gemma":[0.998992,0.00044725114,0.00019085837,0.00017445516,0.00011752906,0.00007787547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022539035,0.00016788402,0.00042883086,0.00019576662,0.000101931706,0.000011271422,0.000069949274,0.00015876871,0.000018008725],"category_scores_gemma":[0.00018282286,0.00015884342,0.000047536403,0.00028881777,0.00018483704,0.00009934282,0.00007564779,0.0003079855,0.000004334929],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036336627,0.0003400354,0.012979959,0.00009479047,0.00008694525,0.000018137109,0.0012479754,0.0000078732055,0.9600408,0.00045282752,0.003487836,0.020879474],"study_design_scores_gemma":[0.0074791103,0.0010286235,0.025784474,0.00026037908,0.00007194121,0.00011917045,0.00068289455,0.00008720551,0.79157084,0.00016923428,0.17252746,0.00021863755],"about_ca_topic_score_codex":0.000016318088,"about_ca_topic_score_gemma":0.000044348428,"teacher_disagreement_score":0.16903964,"about_ca_system_score_codex":0.000330892,"about_ca_system_score_gemma":0.0011396272,"threshold_uncertainty_score":0.64774466},"labels":[],"label_agreement":null},{"id":"W4416141088","doi":"10.1093/neuonc/noaf201.0207","title":"BIOS-06. INCIDENCE RATE OF BRAIN METASTASES AMONG WOMEN WITH GYNECOLOGICAL CANCERS: A SYSTEMATIC REVIEW AND META-ANALYSIS","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre; Kingston Health Sciences Centre","funders":"","keywords":"Incidence (geometry); Meta-analysis; Ovarian cancer; Systematic review; Cancer","score_opus":0.03481340492711157,"score_gpt":0.3324645522201437,"score_spread":0.29765114729303216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416141088","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7952928,0.14423719,0.0009620646,0.047679055,0.00010101372,0.010020759,0.00034262633,0.0001494452,0.001215028],"genre_scores_gemma":[0.96898276,0.0022505505,0.0011962104,0.025792181,0.000007507502,0.0013899929,0.000023476101,0.000015364307,0.00034194606],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9968212,0.0014565925,0.0007297042,0.00050398003,0.00017516087,0.00031335824],"domain_scores_gemma":[0.9960673,0.0025837473,0.00046487726,0.0005485441,0.00016411566,0.00017143534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015258701,0.0002763097,0.004021153,0.0002683594,0.000052183677,0.000012227667,0.00013104675,0.00009031133,0.000528306],"category_scores_gemma":[0.0015292127,0.0001529809,0.00038662966,0.0011076787,0.00030692716,0.00005978075,0.00009963283,0.00019146356,0.00000530063],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011297979,0.001961802,0.010714043,0.25012645,0.7157199,0.004247224,0.001107428,0.00017331162,0.0041519883,0.0022220747,0.007826977,0.00061900535],"study_design_scores_gemma":[0.0018490228,0.004077669,0.0037810195,0.0007844579,0.9861892,0.00014247566,0.0004398062,0.000060735976,0.0005734063,0.00009609377,0.001808288,0.00019786783],"about_ca_topic_score_codex":0.00020299898,"about_ca_topic_score_gemma":0.00037808818,"teacher_disagreement_score":0.27046925,"about_ca_system_score_codex":0.0002794106,"about_ca_system_score_gemma":0.00036896276,"threshold_uncertainty_score":0.62383795},"labels":[],"label_agreement":null},{"id":"W4416141092","doi":"10.1093/neuonc/noaf201.0154","title":"BIOM-66. MODERN MOLECULAR PROFILING RECONTEXTUALIZES THE RTOG-0539 TRIAL AND REVEALS HIDDEN HIGH-RISK AND RADIOTHERAPY RESISTANT MENINGIOMAS","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Grading (engineering); Meningioma; Epigenetics; Radiation therapy; Molecular biomarkers; Gene expression profiling; DNA methylation; Adjuvant; Cohort; Histone deacetylase","score_opus":0.02086159222899891,"score_gpt":0.3046712411534526,"score_spread":0.2838096489244537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416141092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9782428,0.006168107,0.0013752318,0.008333723,0.00060150266,0.0019879625,0.000009711263,0.00009379435,0.0031871437],"genre_scores_gemma":[0.9919983,0.0005657865,0.0046978923,0.0016791199,0.00021588679,0.00018333372,0.000011385424,0.000040783132,0.00060751126],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99746925,0.0006809418,0.00057978986,0.00064478884,0.0002329085,0.0003923189],"domain_scores_gemma":[0.9983368,0.0006968334,0.00023662743,0.00052131386,0.000072245246,0.00013616946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010001442,0.00027630455,0.00069357624,0.00026936468,0.0002654176,0.00006827219,0.00017588507,0.00020638543,0.000030510977],"category_scores_gemma":[0.00045221284,0.0001977978,0.00010366871,0.00028116084,0.00024043686,0.00006065217,0.00015745187,0.00034353917,0.0000029991345],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029257597,0.00018770264,0.0013176803,0.00016399274,0.00059151446,0.0019027286,0.0011590687,0.0000042552097,0.8397654,0.015575758,0.00490598,0.1051683],"study_design_scores_gemma":[0.33290505,0.03516009,0.008637623,0.0007529167,0.0053978614,0.0025118263,0.0032033774,0.010009647,0.12451778,0.05981056,0.41488072,0.0022125388],"about_ca_topic_score_codex":0.00010347488,"about_ca_topic_score_gemma":0.000011420592,"teacher_disagreement_score":0.71524763,"about_ca_system_score_codex":0.000114178096,"about_ca_system_score_gemma":0.000152168,"threshold_uncertainty_score":0.806596},"labels":[],"label_agreement":null},{"id":"W4416141099","doi":"10.1093/neuonc/noaf201.0686","title":"DDDR-49. IGF1R inhibition arrests meningioma growth","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Ceritinib; Insulin-like growth factor 1 receptor; Ex vivo; Regulator; In vivo; Cell growth; Cell; Receptor","score_opus":0.019656819798956112,"score_gpt":0.30648237286723223,"score_spread":0.2868255530682761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416141099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7651516,0.0001630912,0.0005382023,0.014563438,0.0012999453,0.00059230655,0.000002564369,0.0002085332,0.21748032],"genre_scores_gemma":[0.9937716,0.000016945633,0.0008604042,0.0037087237,0.00025297827,0.00009597889,0.000035023655,0.000020999316,0.0012373397],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982715,0.00017128547,0.0004213586,0.00048312914,0.00024198987,0.0004107061],"domain_scores_gemma":[0.9990123,0.00023218681,0.000117688156,0.0003631686,0.00011710093,0.00015754954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029779354,0.00020999857,0.00044113048,0.00042853013,0.00013291696,0.0000253177,0.00011691957,0.000196491,0.00016702687],"category_scores_gemma":[0.00032884345,0.00019805323,0.00013031565,0.00051018404,0.00010087102,0.0000851765,0.00016725088,0.00032794362,0.00020157127],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085361104,0.0006061986,0.008609255,0.00027261715,0.00019493175,0.012736538,0.00049713586,0.0000068671766,0.7542869,0.028955897,0.17754525,0.0154347895],"study_design_scores_gemma":[0.007224805,0.0030884892,0.023972167,0.00020072528,0.00054680853,0.0015697875,0.00031676743,0.00046657634,0.085093275,0.004348049,0.8727622,0.00041037655],"about_ca_topic_score_codex":0.000027847907,"about_ca_topic_score_gemma":0.000008722949,"teacher_disagreement_score":0.6952169,"about_ca_system_score_codex":0.00023079122,"about_ca_system_score_gemma":0.00021847636,"threshold_uncertainty_score":0.80763763},"labels":[],"label_agreement":null},{"id":"W4416141128","doi":"10.1093/neuonc/noaf201.0209","title":"BIOS-08. TREATMENT STRATEGIES FOR PATIENTS WITH LEPTOMENINGEAL METASTATIC DISEASE (LMD): A NETWORK META-ANALYSIS (NMA) OF RANDOMIZED CONTROLLED TRIALS","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Randomized controlled trial; Confidence interval; ThioTEPA; Hazard ratio; Radiation therapy; Meta-analysis; Frequentist inference; Survival analysis","score_opus":0.07223634040234676,"score_gpt":0.3764491733524966,"score_spread":0.30421283295014984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416141128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7236521,0.043223426,0.071199015,0.030787215,0.0021982586,0.1188713,0.0038116134,0.0004446936,0.0058123786],"genre_scores_gemma":[0.98212117,0.0001956151,0.008753916,0.0010574707,0.000074141266,0.0070083244,0.00044455047,0.000032016396,0.0003127741],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99315065,0.0035608085,0.0019221164,0.00057408883,0.00035473288,0.00043759355],"domain_scores_gemma":[0.98148096,0.01610646,0.0012958951,0.0005202873,0.0003613038,0.00023511666],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0029992245,0.00049066806,0.014891257,0.00048423998,0.00010995649,0.00003485565,0.00010148022,0.00007153343,0.00033883296],"category_scores_gemma":[0.0018938448,0.00023798828,0.0064629964,0.00064759684,0.00023490371,0.000059088543,0.00003065406,0.00009747104,0.0000025094748],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.46828663,0.0027975107,0.001019065,0.0000905122,0.52094567,0.00009796312,0.000082445746,0.0019245071,0.00006131616,0.0025822287,0.0004476032,0.0016645083],"study_design_scores_gemma":[0.39778283,0.0039709564,0.00020486576,0.0000076064757,0.5942265,0.00000129997,0.00007436853,0.0006684632,0.000055878085,0.0006299981,0.0022763554,0.00010090121],"about_ca_topic_score_codex":0.000050290815,"about_ca_topic_score_gemma":0.000052122625,"teacher_disagreement_score":0.2584691,"about_ca_system_score_codex":0.00016874372,"about_ca_system_score_gemma":0.001022332,"threshold_uncertainty_score":0.9997337},"labels":[],"label_agreement":null},{"id":"W4416141169","doi":"10.1093/neuonc/noaf201.0051","title":"EPCO-52. MACHINE LEARNING AND MULTI-OMIC ANALYSIS IDENTIFY A MICROENVIRONMENT-DRIVEN MENINGIOMA RISK CONTINUUM UNDERLYING MOLECULAR CLASSIFICATIONS","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"DNA methylation; Epigenetics; Meningioma; Random forest; Epigenomics; Clinical Practice; Brain tumor; Methylation","score_opus":0.030959269597705872,"score_gpt":0.3384206186877567,"score_spread":0.3074613490900508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416141169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.954495,0.0010387338,0.037467062,0.0031886012,0.00018390114,0.00064806844,0.0000115334715,0.00011833559,0.0028487288],"genre_scores_gemma":[0.9909964,0.00020155714,0.0068211923,0.00038635518,0.000020493659,0.00008654971,0.00008840393,0.000027354334,0.001371695],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99763644,0.0004856712,0.0005533722,0.00072058715,0.00019449879,0.00040943493],"domain_scores_gemma":[0.99874616,0.00030100287,0.00031499722,0.0004173445,0.000047600395,0.00017289173],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036796893,0.00026682092,0.00067525386,0.00080967677,0.0003333668,0.000060929062,0.00016231881,0.00017616988,0.000121480356],"category_scores_gemma":[0.00026228908,0.0002705541,0.0002445106,0.00072093314,0.00017906314,0.0000650949,0.0002505453,0.00056810805,0.00003980809],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013708544,0.0003004614,0.17953213,0.00005451137,0.0017565185,0.0011511868,0.00044794712,0.00024981075,0.80737513,0.00032053364,0.00047359476,0.008201085],"study_design_scores_gemma":[0.014849446,0.0020235698,0.49043366,0.00013080743,0.022097038,0.0005849845,0.0023475369,0.17446536,0.020430878,0.00025838506,0.27140284,0.0009754729],"about_ca_topic_score_codex":0.00007821342,"about_ca_topic_score_gemma":0.00007458646,"teacher_disagreement_score":0.78694427,"about_ca_system_score_codex":0.00022792035,"about_ca_system_score_gemma":0.000069448375,"threshold_uncertainty_score":0.99997467},"labels":[],"label_agreement":null},{"id":"W4416141195","doi":"10.1093/neuonc/noaf201.0189","title":"BIOM-101. STRATIFICATION OF GLIOBLASTOMA PROGRESSORS USING MULTI-OMIC PROFILING AND GRAPH NEURAL NETWORKS","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; Orthopaedic Innovation Centre; University of Toronto","funders":"","keywords":"Interpretability; Glioblastoma; Concordance; CDKN2A; Gene expression profiling; Proportional hazards model; Gene; Cohort; PTEN","score_opus":0.029176490203311107,"score_gpt":0.3341762339109622,"score_spread":0.3049997437076511,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416141195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99651754,0.00074164476,0.00032752517,0.0011186063,0.00032988604,0.00082833023,0.0000044327917,0.000044283333,0.000087751316],"genre_scores_gemma":[0.99821025,0.000067887704,0.001314551,0.00026711661,0.000044598204,0.00006566456,0.000012308381,0.000014617188,0.0000030326048],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989275,0.00008977755,0.0003480339,0.00032343602,0.000087940796,0.00022331189],"domain_scores_gemma":[0.9992627,0.0001795584,0.000174806,0.00020988441,0.0000955294,0.000077533485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000101287435,0.0001509578,0.0003634713,0.0002486964,0.000076390286,0.000012823332,0.000055362936,0.00015516898,0.0000060360817],"category_scores_gemma":[0.00006981758,0.00012890904,0.00007101986,0.00035890588,0.00016553733,0.00004511263,0.000045698733,0.00015873305,6.9109876e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042436458,0.0011040365,0.14834686,0.0001254757,0.00013670385,0.00015400535,0.00011432958,0.0009575268,0.7898557,0.00045893938,0.00008783805,0.05823424],"study_design_scores_gemma":[0.009955397,0.004772103,0.06645064,0.00020662408,0.000964134,0.00029477305,0.00034940685,0.3457985,0.5700318,0.00011639486,0.0007888458,0.00027137893],"about_ca_topic_score_codex":0.00002426298,"about_ca_topic_score_gemma":0.000030919397,"teacher_disagreement_score":0.34484097,"about_ca_system_score_codex":0.00007197344,"about_ca_system_score_gemma":0.000099082834,"threshold_uncertainty_score":0.5256758},"labels":[],"label_agreement":null},{"id":"W4416141247","doi":"10.1093/neuonc/noaf201.0260","title":"CNSC-52. SPEECH-DERIVED LINGUISTIC AND SPECTRAL FEATURES PREDICT MOLECULAR SUBTYPES OF ADULT-TYPE DIFFUSE GLIOMAS","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Correlation; Glioma; Classifier (UML); Spectral density; Boosting (machine learning); Spectral analysis","score_opus":0.008765657759795565,"score_gpt":0.28065856036420267,"score_spread":0.2718929026044071,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416141247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986688,0.0019386096,0.000008945807,0.002601528,0.00063758733,0.0005030864,0.000011990552,0.00006831427,0.0075419247],"genre_scores_gemma":[0.9974909,0.0004239214,0.00061081635,0.0012335274,0.000115498304,0.000023792772,0.00002194411,0.000023653505,0.000055964152],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.998743,0.00009813763,0.00030151702,0.00039766295,0.00016898579,0.00029072684],"domain_scores_gemma":[0.9988499,0.00034252126,0.00010926609,0.00034142952,0.00021379537,0.00014303693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005777222,0.00021867138,0.0005653856,0.00024842692,0.00005120547,0.000012134416,0.00009722109,0.00019365521,0.00003722105],"category_scores_gemma":[0.0010177718,0.00018160016,0.000104752915,0.00031517554,0.0001914705,0.000017755197,0.00008574724,0.0002310928,0.0000075925077],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009814808,0.00159217,0.06360118,0.0001778915,0.00033638306,0.0042292904,0.0003087504,0.000004049749,0.91390246,0.003807835,0.0025300952,0.008528387],"study_design_scores_gemma":[0.010060253,0.0047172615,0.15126388,0.00017311332,0.0011163619,0.000511324,0.0000979437,0.0001282369,0.81616,0.0013421817,0.014217789,0.00021161584],"about_ca_topic_score_codex":0.00007638612,"about_ca_topic_score_gemma":0.000060373106,"teacher_disagreement_score":0.097742446,"about_ca_system_score_codex":0.000085432766,"about_ca_system_score_gemma":0.0002123712,"threshold_uncertainty_score":0.74054396},"labels":[],"label_agreement":null},{"id":"W4416141248","doi":"10.1093/neuonc/noaf201.0003","title":"EPCO-03. COMPARATIVE ANALYSIS OF CSF PROTEOMIC TECHNIQUES FOR BRAIN TUMOR RESEARCH","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Extracellular vesicles in disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Proteomics; Peptide; Extracellular vesicles; Biomarker; Brain tumor; Biomarker discovery; Quantitative proteomics; Microvesicles","score_opus":0.0407274363080798,"score_gpt":0.4109815912301637,"score_spread":0.3702541549220839,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416141248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9821106,0.000473503,0.0047532874,0.0016759991,0.00011241723,0.0017064618,0.000121837096,0.000031710504,0.009014135],"genre_scores_gemma":[0.9926273,0.00003007559,0.005057707,0.0010270559,0.00009101886,0.00058608764,0.00013915806,0.000015865653,0.00042572405],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979604,0.00062449725,0.00038650932,0.0005362164,0.0001453797,0.00034701175],"domain_scores_gemma":[0.99835336,0.0004052341,0.00014942948,0.0005738794,0.00043726224,0.00008081764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090935366,0.00015081346,0.0004415853,0.00042882984,0.0001037528,0.000013684735,0.00044483267,0.00020189896,0.000023576673],"category_scores_gemma":[0.0009852804,0.00015278431,0.00023870984,0.0007519442,0.00041963288,0.0000039708852,0.0002651281,0.00021897434,0.0000048387315],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005756364,0.0002690133,0.0009771346,0.00004743529,0.00035821146,0.000010008149,0.000074086965,0.000034777386,0.9734609,0.0011274908,0.020904941,0.0021603242],"study_design_scores_gemma":[0.0004422681,0.0009358925,0.00057102484,0.000007756836,0.00019405731,0.0000023120256,0.000100906465,0.00044586693,0.8136327,0.00049842603,0.18306904,0.00009971652],"about_ca_topic_score_codex":0.000015727144,"about_ca_topic_score_gemma":0.00006227653,"teacher_disagreement_score":0.16216409,"about_ca_system_score_codex":0.00007066692,"about_ca_system_score_gemma":0.0005084274,"threshold_uncertainty_score":0.6230364},"labels":[],"label_agreement":null},{"id":"W4416141251","doi":"10.1093/neuonc/noaf201.0179","title":"BIOM-91. RELATIONSHIPS BETWEEN LYMPHOCYTE COUNTS AND CLINICAL OUTCOMES IN PATIENTS WITH GLIOMAS TREATED WITH PEMBROLIZUMAB","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Pembrolizumab; Dexamethasone; Lymphocyte; Oligodendroglioma; Glioma; Astrocytoma; Retrospective cohort study; Survival analysis; Immunotherapy","score_opus":0.029703320931364432,"score_gpt":0.3256042706365583,"score_spread":0.29590094970519387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416141251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99361634,0.00005914188,0.000002726379,0.0009964848,0.00007837717,0.0004812337,0.000015449219,0.000035877652,0.0047143684],"genre_scores_gemma":[0.99934894,0.000031741998,0.00011044251,0.0003308413,0.000019663597,0.00003489327,0.000049583887,0.000014706149,0.000059178372],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989704,0.00014850647,0.00028804925,0.00029251835,0.0001242938,0.00017623648],"domain_scores_gemma":[0.99886775,0.00068121095,0.00008454674,0.00020045174,0.00006806942,0.000097955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009781827,0.00014316777,0.0004636615,0.00022940793,0.000053480722,0.000008767315,0.00004192609,0.00016437212,0.00001966],"category_scores_gemma":[0.00012689049,0.00009217288,0.00003633634,0.00030984284,0.00012040342,0.000033338583,0.000028741004,0.00017996939,0.00002644064],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006683603,0.00065411977,0.9878692,0.00000934434,0.00016797044,0.000169662,0.000022049775,5.306927e-7,0.0000087808785,0.000079114536,0.00036558596,0.009985305],"study_design_scores_gemma":[0.01843413,0.0021407607,0.96997994,0.000039122446,0.00033470974,0.000008210258,0.000012754454,0.000009858482,0.000074891825,0.000017056213,0.008876981,0.00007156485],"about_ca_topic_score_codex":0.00004663045,"about_ca_topic_score_gemma":0.00009944889,"teacher_disagreement_score":0.017889217,"about_ca_system_score_codex":0.00020358671,"about_ca_system_score_gemma":0.00021259474,"threshold_uncertainty_score":0.37587008},"labels":[],"label_agreement":null},{"id":"W4416141254","doi":"10.1093/neuonc/noaf201.0893","title":"INNV-04. Association of proton pump inhibitor use with outcome of patients with newly diagnosed glioblastoma","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Temozolomide; Radiation therapy; Drug; Proton-pump inhibitor; Multivariate analysis; Glioblastoma; Methyltransferase; Clinical trial","score_opus":0.0116556074457168,"score_gpt":0.27359647713406204,"score_spread":0.26194086968834523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416141254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995842,0.0000119663655,0.000009493731,0.0013755509,0.00016897809,0.0021721832,0.00003611814,0.00003257049,0.00035113303],"genre_scores_gemma":[0.99857646,0.000009531947,0.0002747386,0.0006523183,0.000029066017,0.00036448796,0.000026197333,0.000022116581,0.00004507167],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99850905,0.00012765624,0.00047789485,0.0002904972,0.00035906813,0.00023581306],"domain_scores_gemma":[0.99793583,0.00071753695,0.0005108979,0.00028903838,0.0004656428,0.00008106725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010915809,0.00018660109,0.0006581353,0.0002617735,0.00003395037,0.000007946613,0.00006965176,0.00017056287,0.000022760614],"category_scores_gemma":[0.0005458996,0.00012800102,0.00007454345,0.00046923792,0.00007456327,0.0000925123,0.00004795594,0.00017388111,0.000004855408],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002165205,0.003070975,0.98482186,0.00014428097,0.00021990795,0.00010426375,0.00014987205,0.000020453994,0.00641047,0.00005752985,0.0007729235,0.0020622665],"study_design_scores_gemma":[0.018321645,0.010932091,0.8649916,0.00014729232,0.00043949136,0.0000033166848,0.00003976798,0.000014168728,0.09524483,0.0000072304542,0.009760164,0.000098414166],"about_ca_topic_score_codex":0.00010329352,"about_ca_topic_score_gemma":0.00028644936,"teacher_disagreement_score":0.119830266,"about_ca_system_score_codex":0.00036755408,"about_ca_system_score_gemma":0.00023645288,"threshold_uncertainty_score":0.521973},"labels":[],"label_agreement":null},{"id":"W4416141268","doi":"10.1093/neuonc/noaf201.0738","title":"EPID-06. The Key LARGO study: Building an international resource for glioblastoma epidemiology","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Glioblastoma; Epidemiology; Observational study; Generalizability theory; Key (lock); Quality of life (healthcare)","score_opus":0.04506775287228802,"score_gpt":0.3889975794355337,"score_spread":0.34392982656324567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416141268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93297625,0.00020005043,0.00040277085,0.061013576,0.0009287858,0.0014481199,0.000017973332,0.00008373435,0.0029287278],"genre_scores_gemma":[0.98004353,0.00003393186,0.00091646705,0.017772136,0.0004395691,0.00064361905,0.000025320021,0.0000235239,0.000101875055],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99793446,0.0005861835,0.0004657034,0.0005201819,0.000117197,0.00037629335],"domain_scores_gemma":[0.99479187,0.004316014,0.00016334311,0.0004918296,0.00012262003,0.00011434428],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009968759,0.000186138,0.00054358225,0.00021155344,0.00019625458,0.000012917992,0.0003088475,0.00015748705,0.00005001723],"category_scores_gemma":[0.0024931247,0.00012643018,0.00015500799,0.00019703049,0.00011736332,0.000050178816,0.00015910853,0.00026580715,0.000019180397],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003220094,0.008705,0.6571633,0.000054108954,0.0013188617,0.0007834382,0.0017793652,0.00038668327,0.038123768,0.034940872,0.10215843,0.15136608],"study_design_scores_gemma":[0.0057870196,0.0052659237,0.057325307,0.000022596636,0.00031863482,0.00012130984,0.00050701166,0.0009149067,0.0034698138,0.00097597594,0.9251947,0.00009685061],"about_ca_topic_score_codex":0.00003682309,"about_ca_topic_score_gemma":0.00013183763,"teacher_disagreement_score":0.8230362,"about_ca_system_score_codex":0.00023246913,"about_ca_system_score_gemma":0.00014580278,"threshold_uncertainty_score":0.5155673},"labels":[],"label_agreement":null},{"id":"W4416141274","doi":"10.1093/neuonc/noaf201.0761","title":"EPID-31. Days alive and at home in glioblastoma patients across age groups: a population-based study in Ontario, Canada","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; McMaster University; Institute for Clinical Evaluative Sciences","funders":"","keywords":"Glioblastoma; Retrospective cohort study; Cohort; Cohort study; Logistic regression; Frailty Index; Complication; Overall survival; Young adult","score_opus":0.012881039061514936,"score_gpt":0.2847675831838275,"score_spread":0.27188654412231256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416141274","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972746,0.000040669613,2.0780564e-7,0.0008545759,0.00038357894,0.0012164498,0.00002103255,0.000013837207,0.00019504754],"genre_scores_gemma":[0.99746364,0.0000024151477,0.000012492661,0.002187417,0.000011449125,0.00022612949,0.000056497935,0.000012678362,0.000027250355],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99849933,0.00015028818,0.00039326353,0.00043230376,0.00018059122,0.00034419965],"domain_scores_gemma":[0.99904704,0.00048460925,0.00008937069,0.00023015513,0.000039884337,0.00010896406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011156044,0.00018615105,0.00052087643,0.00019609572,0.00007467052,0.000010221119,0.00006661964,0.000102994316,0.000037259008],"category_scores_gemma":[0.00012448347,0.00017029325,0.00003359086,0.00029206704,0.000029036366,0.000026805688,0.00010685301,0.00022040332,0.000002194142],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053165894,0.0022030852,0.9901274,0.000018277928,0.000032178803,0.0031175716,0.0010300704,0.000058482663,0.0002477789,0.000007540034,0.0005686884,0.002057286],"study_design_scores_gemma":[0.013077754,0.0021493468,0.9818551,0.00004188574,0.000051371077,0.000005268892,0.0002677078,0.00004271706,0.00023049898,0.000018936278,0.0021589268,0.00010046573],"about_ca_topic_score_codex":0.91220796,"about_ca_topic_score_gemma":0.9995644,"teacher_disagreement_score":0.087356456,"about_ca_system_score_codex":0.0035043927,"about_ca_system_score_gemma":0.00067054835,"threshold_uncertainty_score":0.9163865},"labels":[],"label_agreement":null},{"id":"W4416141275","doi":"10.1093/neuonc/noaf201.0172","title":"BIOM-84. MGMT METHYLATION STATUS REMAINS LARGELY UNCHANGED IN RECURRENT GLIOMA AND INFLUENCES RE-TREATMENT WITH TEMOZOLOMIDE","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Government of New Brunswick","funders":"","keywords":"Temozolomide; Methylation; DNA methylation; Cohort; Biomarker; Glioma; Methyltransferase; O-6-methylguanine-DNA methyltransferase","score_opus":0.028938293878342753,"score_gpt":0.3345602313429151,"score_spread":0.3056219374645724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416141275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864026,0.0024763348,0.000009489947,0.007979716,0.0002537578,0.0010405334,0.000015825903,0.000057294495,0.0017645035],"genre_scores_gemma":[0.9966876,0.0015128414,0.0005539612,0.00079850905,0.000046860652,0.00031904952,0.000045817327,0.000017031092,0.000018331766],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982956,0.00024378113,0.00035987105,0.0005171365,0.0001692663,0.00041432682],"domain_scores_gemma":[0.99879533,0.0005391745,0.00014182008,0.00027673988,0.00008674275,0.00016019114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018210015,0.00025355179,0.00056646817,0.0005433083,0.00008662505,0.000020414038,0.000050922663,0.00016546769,0.000029544763],"category_scores_gemma":[0.0001551226,0.00017706002,0.00005413247,0.00067280687,0.0001224313,0.0000704761,0.000051425504,0.00015607357,0.000012705891],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017122229,0.002347037,0.60048956,0.00008725663,0.00028932162,0.0021508886,0.0010644051,0.000015965605,0.21806951,0.00048306104,0.00063915725,0.1726516],"study_design_scores_gemma":[0.026926644,0.022653647,0.5855607,0.00041223303,0.0009307334,0.00021222544,0.0010790109,0.00033505945,0.15351994,0.000583038,0.20736025,0.00042651882],"about_ca_topic_score_codex":0.00033607194,"about_ca_topic_score_gemma":0.0050004134,"teacher_disagreement_score":0.2067211,"about_ca_system_score_codex":0.00068866584,"about_ca_system_score_gemma":0.00036211396,"threshold_uncertainty_score":0.7220298},"labels":[],"label_agreement":null},{"id":"W4416141311","doi":"10.1093/neuonc/noaf201.0246","title":"CNSC-38. TARGETING UNC5B INDUCES BLOOD-BRAIN BARRIER PERMEABILITY AND IMPROVES CHEMOTHERAPY DELIVERY AND EFFICACY IN GLIOBLASTOMA","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Barrier Structure and Function Studies","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Blood–brain barrier; Glioblastoma; Doxorubicin; Drug delivery; Ubiquitin ligase; Central nervous system; Regulator; Stem cell; Targeted drug delivery","score_opus":0.012921244383024087,"score_gpt":0.27453452701741915,"score_spread":0.26161328263439504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416141311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926472,0.00044102775,0.000010195808,0.0043034363,0.00067214976,0.00035547448,0.000008337637,0.00008019566,0.001482014],"genre_scores_gemma":[0.990082,0.00031393694,0.00006714653,0.009310708,0.00009842094,0.00003315705,3.702743e-7,0.000015899846,0.00007830718],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979327,0.0003816811,0.0003650699,0.0008108976,0.00013052653,0.0003791556],"domain_scores_gemma":[0.99756795,0.0019661495,0.00010632078,0.00021405259,0.000044492703,0.000101025726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030993146,0.00024790657,0.00042724994,0.00020795868,0.00029748504,0.000054016396,0.00015776977,0.00020912605,0.00003431014],"category_scores_gemma":[0.0021050526,0.0002191931,0.000048539474,0.0004263452,0.00059027114,0.0001621612,0.00023979548,0.00046893378,0.0000022243235],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028464216,0.00009438839,0.0050710924,0.000029150751,0.000012995454,0.00003503195,0.0013871161,0.0000016491298,0.95037925,0.00026598142,0.0007892173,0.041649494],"study_design_scores_gemma":[0.0059484825,0.0017753148,0.057634126,0.000026408374,0.000059272836,0.000115617964,0.001191421,0.00025356197,0.8003485,0.0013808114,0.13078503,0.00048141545],"about_ca_topic_score_codex":0.000026199306,"about_ca_topic_score_gemma":0.000052330088,"teacher_disagreement_score":0.1500307,"about_ca_system_score_codex":0.00004527604,"about_ca_system_score_gemma":0.00013727952,"threshold_uncertainty_score":0.89384353},"labels":[],"label_agreement":null},{"id":"W4416141356","doi":"10.1093/neuonc/noaf201.0098","title":"BIOM-10. PREDICTION OF BRAIN METASTASIS DEVELOPMENT FROM LUNG ADENOCARCINOMA USING DNA METHYLOMES AND THEIR NON-INVASIVE DETECTION IN CSF AND PLASMA","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Thompson Rivers University","funders":"","keywords":"DNA methylation; Nomogram; Cerebrospinal fluid; Adenocarcinoma; Lung cancer; Stage (stratigraphy); Brain metastasis","score_opus":0.02482775322553555,"score_gpt":0.28683923490703,"score_spread":0.26201148168149446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416141356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958837,0.0012209669,0.0010795107,0.00080895086,0.0002181476,0.00057409005,0.00006375666,0.00002041663,0.00013042985],"genre_scores_gemma":[0.99553394,0.00015062746,0.0037964766,0.00037331553,0.000033905977,0.00004569448,0.000035010133,0.000014913083,0.000016086147],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9986424,0.00024652368,0.00040385668,0.00040897058,0.00009688352,0.00020136611],"domain_scores_gemma":[0.99856824,0.0009806136,0.00014146886,0.00016408293,0.00006235913,0.00008325996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029396586,0.00019738018,0.0005467011,0.00039189568,0.00007790254,0.000010219393,0.000040478135,0.00015177586,0.000026935837],"category_scores_gemma":[0.00024937108,0.0001609577,0.000052028892,0.000293767,0.00011278578,0.00006699978,0.000095546406,0.00015799035,9.0348993e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064508384,0.00025451992,0.039268035,0.00016031953,0.00052349234,0.00011967947,0.0017661193,0.000011583156,0.79834676,0.000018130895,0.00010632089,0.15877995],"study_design_scores_gemma":[0.0057646683,0.001157734,0.17883809,0.00013618673,0.00049639476,0.0001387438,0.001335812,0.003434861,0.8048112,0.00011718388,0.0036494727,0.000119655546],"about_ca_topic_score_codex":0.000218877,"about_ca_topic_score_gemma":0.00033162578,"teacher_disagreement_score":0.1586603,"about_ca_system_score_codex":0.00025126457,"about_ca_system_score_gemma":0.00031594405,"threshold_uncertainty_score":0.65636647},"labels":[],"label_agreement":null},{"id":"W4416141369","doi":"10.1093/neuonc/noaf201.0312","title":"STEM-04. LONGITUDINAL DNA METHYLATION CHANGE FUELS DISEASE PROGRESSION THROUGH ALTERED CELL STATE DIFFERENTIATION IN IDH-MUTANT GLIOMA","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"DNA methylation; Epigenetics; CpG site; Bisulfite sequencing; Methylation; Glioma; Differentially methylated regions; Epigenetics of physical exercise; Histone","score_opus":0.04711558661739263,"score_gpt":0.34393171104174813,"score_spread":0.2968161244243555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416141369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898355,0.0013456978,0.0001473002,0.0054842546,0.00086230406,0.0017818173,0.00003052253,0.00007639663,0.0004362047],"genre_scores_gemma":[0.9979702,0.00032436344,0.000097147466,0.00064468064,0.00013042537,0.00067432056,0.000119723074,0.000025042187,0.000014052584],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9979777,0.0003095432,0.00047303562,0.00055229384,0.00027125477,0.00041619147],"domain_scores_gemma":[0.9989304,0.00026124885,0.0002247296,0.00033009585,0.00009690215,0.00015661414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015573131,0.00025436023,0.0004913534,0.000339338,0.00009759668,0.00002643881,0.00008790149,0.00013701114,0.000055851768],"category_scores_gemma":[0.000051120765,0.0002057686,0.0001150468,0.00050418696,0.000056097455,0.00017500657,0.00010836171,0.00021712005,0.000027290691],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014182023,0.0035796068,0.23594819,0.00032278366,0.00007803393,0.0017059956,0.0008558279,0.000012262563,0.66202515,0.00024495317,0.00039343425,0.09341556],"study_design_scores_gemma":[0.009522435,0.0015990663,0.55080074,0.0002881038,0.00043460095,0.00002188865,0.00008756927,0.000805791,0.4298253,0.0009331149,0.0054626204,0.00021879045],"about_ca_topic_score_codex":0.00004170881,"about_ca_topic_score_gemma":0.00009115855,"teacher_disagreement_score":0.31485254,"about_ca_system_score_codex":0.00041814044,"about_ca_system_score_gemma":0.0001732057,"threshold_uncertainty_score":0.8391},"labels":[],"label_agreement":null},{"id":"W4416141370","doi":"10.1093/neuonc/noaf201.0350","title":"CSIG-16. CIC-FUSION ONCOPROTEINS COOPERATE WITH JAK/STAT1/3 SIGNALING TO DRIVE CIC-REARRANGED SARCOMA","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Toronto; University Health Network","funders":"","keywords":"Transcription factor; Effector; Histone; Fusion protein; STAT1; Promoter; Transcription (linguistics); H3K4me3","score_opus":0.016739496154207032,"score_gpt":0.29848277607129087,"score_spread":0.2817432799170838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416141370","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9665,0.00027645307,0.0003962264,0.018015647,0.00045097887,0.0019194183,0.00001788253,0.00015798288,0.012265408],"genre_scores_gemma":[0.98565984,0.000059519058,0.0013834588,0.011871937,0.00016770844,0.000447317,0.000044684166,0.00005237276,0.00031313638],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99773556,0.00023791814,0.00042527105,0.0007164713,0.00031221507,0.00057254644],"domain_scores_gemma":[0.99825716,0.00045119898,0.00012023263,0.00052629865,0.0002940112,0.0003511017],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002066335,0.00035808972,0.0007799281,0.00037979096,0.00023739735,0.00003990031,0.00017240713,0.0002197818,0.00036766482],"category_scores_gemma":[0.0001897526,0.00027153819,0.00012161769,0.0007702225,0.00010377252,0.00006200996,0.00014444455,0.0004055876,0.00020860748],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001763802,0.0015848381,0.0130133815,0.000064797416,0.00023817435,0.002755212,0.00083574693,0.00015752407,0.92491055,0.00050774665,0.008098664,0.046069592],"study_design_scores_gemma":[0.015109431,0.01196824,0.01062356,0.00047691003,0.00064079236,0.0002855166,0.0006751942,0.00017519627,0.5818892,0.00008870856,0.37762833,0.000438946],"about_ca_topic_score_codex":0.0002610082,"about_ca_topic_score_gemma":0.00068661675,"teacher_disagreement_score":0.36952966,"about_ca_system_score_codex":0.00070972426,"about_ca_system_score_gemma":0.00082742574,"threshold_uncertainty_score":0.99997365},"labels":[],"label_agreement":null},{"id":"W4416141378","doi":"10.1093/neuonc/noaf201.0309","title":"STEM-01. AN OSMR-CLIC1 CROSS TALK DRIVES KEY ONCOGENIC PATHWAYS IN GLIOBLASTOMA","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of Toronto; University of Ottawa","funders":"","keywords":"Signal transduction; Downregulation and upregulation; Phosphorylation; STAT3; Receptor; Transcription factor; HEK 293 cells; Activator (genetics)","score_opus":0.028922849844034117,"score_gpt":0.33722473561364363,"score_spread":0.30830188576960954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416141378","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9793742,0.00016408363,0.00010638311,0.0018195702,0.0016299052,0.0005005501,0.000032298976,0.00018667572,0.016186364],"genre_scores_gemma":[0.99474883,0.00006950238,0.00017630919,0.0039524194,0.00033292026,0.00009728572,0.000019743678,0.000041028547,0.0005619837],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977623,0.00025381692,0.00065686833,0.00062616647,0.0001979774,0.0005028511],"domain_scores_gemma":[0.99846536,0.0004643679,0.00016045482,0.00055146316,0.00014602375,0.00021231182],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026686885,0.00026991486,0.0006275154,0.00049613835,0.00014922522,0.00004523474,0.0002357759,0.00030498303,0.00043891752],"category_scores_gemma":[0.00021181713,0.0002571749,0.00020204148,0.0005697513,0.00018543492,0.00018846868,0.00014102987,0.0007866061,0.00013414651],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091908185,0.00097142917,0.0073504304,0.000050176055,0.000047406487,0.00095746026,0.00083475624,0.0000811245,0.96156096,0.0010517888,0.0024323699,0.023743015],"study_design_scores_gemma":[0.0053989803,0.0072613303,0.014968847,0.00016332559,0.000118361495,0.0008159882,0.00076618086,0.0013232962,0.40430334,0.00034982132,0.5642087,0.000321865],"about_ca_topic_score_codex":0.00013349969,"about_ca_topic_score_gemma":0.00077557075,"teacher_disagreement_score":0.5617763,"about_ca_system_score_codex":0.00038106286,"about_ca_system_score_gemma":0.0006845223,"threshold_uncertainty_score":0.999988},"labels":[],"label_agreement":null},{"id":"W4416141380","doi":"10.1093/neuonc/noaf201.0304","title":"CNSC-97. ELECTROCORTICOGRAPHIC ANALYSIS AND DETECTION OF SPEECH NETWORKS IN GLIOMA-INFILTRATED CORTEX","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatoon City Hospital","funders":"","keywords":"Electrocorticography; Auditory cortex; Human brain; Cortex (anatomy); Electrophysiology; Decoding methods; Electroencephalography; Brain mapping; Encoding (memory); Neural activity","score_opus":0.011568924734751714,"score_gpt":0.30870041116965763,"score_spread":0.2971314864349059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416141380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99576885,0.0005639224,0.00086207205,0.00051100686,0.00006899468,0.00045082683,0.0000013592037,0.000031027852,0.0017419708],"genre_scores_gemma":[0.9988638,0.0007190945,0.00008600149,0.00019391911,0.000029459758,0.000047918602,0.000015857393,0.000007885546,0.00003606829],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9987172,0.0001784207,0.00034346513,0.00030584092,0.00013191957,0.000323144],"domain_scores_gemma":[0.9991529,0.0003238231,0.000088016466,0.00021563732,0.00010618206,0.000113434944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001910868,0.00012100122,0.0005174947,0.0011917955,0.000037698966,0.0000070300316,0.000050932296,0.00017002734,0.000039448347],"category_scores_gemma":[0.00015018068,0.00010619212,0.000111074725,0.0032720345,0.00012387715,0.000027967864,0.000031870768,0.00034159873,0.0000025976342],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000885851,0.00029481246,0.40186784,0.000026381911,0.00053759216,0.00054540834,0.000018907549,0.000021165151,0.49405932,0.000036517253,0.000018289064,0.10168791],"study_design_scores_gemma":[0.0040212283,0.004302466,0.86713094,0.000023542863,0.001280765,0.00014613767,0.000049999577,0.009139841,0.11266284,0.00017387455,0.000974018,0.00009435642],"about_ca_topic_score_codex":0.00035650717,"about_ca_topic_score_gemma":0.0023656748,"teacher_disagreement_score":0.4652631,"about_ca_system_score_codex":0.000105862884,"about_ca_system_score_gemma":0.00018138872,"threshold_uncertainty_score":0.4330389},"labels":[],"label_agreement":null},{"id":"W4416141391","doi":"10.1093/neuonc/noaf201.0331","title":"STEM-24. SINGLE CELL CRISPR/CAS-9 LINEAGE TRACING REVEALS EVOLUTIONARY FITNESS, EXPANSION AND PLASTICITY AXES IN ADULT DIFFUSE GLIOMAS","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Lineage (genetic); Transcriptome; Gene; Glioma; Phylogenetic tree; RNA; Gene expression profiling; Phenotype; Cell","score_opus":0.019319277979320752,"score_gpt":0.2822541338996811,"score_spread":0.26293485592036037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416141391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932061,0.001091278,0.00007392093,0.0030273804,0.00054716883,0.0006394687,0.000022867103,0.00007439422,0.0013174469],"genre_scores_gemma":[0.9974976,0.00027239718,0.00041871844,0.0014546621,0.000106030304,0.00011438508,0.000018227393,0.000024351571,0.00009362954],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99818665,0.00020820447,0.0004978829,0.0005473564,0.00018098006,0.00037895376],"domain_scores_gemma":[0.99814606,0.0012069794,0.00013276712,0.00024396241,0.00011611018,0.00015409483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001072838,0.00025418872,0.00061303214,0.00038004856,0.00011921166,0.000018313034,0.000079573634,0.00026049957,0.000027511418],"category_scores_gemma":[0.0002758603,0.00022206604,0.00008530865,0.0003946748,0.00011752861,0.000091001726,0.0001177747,0.00031462315,0.000014563637],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005946162,0.0053622485,0.19201092,0.0003522052,0.000040614017,0.0025124466,0.000529871,0.000053326152,0.78463876,0.0001977492,0.006865381,0.00684187],"study_design_scores_gemma":[0.023658432,0.004395127,0.3539828,0.000855338,0.00059683656,0.00043943242,0.0009984862,0.002393107,0.59812564,0.0002369052,0.013835471,0.0004824407],"about_ca_topic_score_codex":0.000104967,"about_ca_topic_score_gemma":0.00020901687,"teacher_disagreement_score":0.18651313,"about_ca_system_score_codex":0.00033665576,"about_ca_system_score_gemma":0.00016318903,"threshold_uncertainty_score":0.90555906},"labels":[],"label_agreement":null},{"id":"W4416141406","doi":"10.1093/neuonc/noaf201.0101","title":"BIOM-13. A GENOME-WIDE IN VIVO CRISPR ACTIVATION SCREEN IDENTIFIES BACE1 AS A THERAPEUTIC VULNERABILITY OF LUNG CANCER BRAIN METASTASIS","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Concordia University of Edmonton; University of Calgary; Hospital for Sick Children; McMaster University","funders":"","keywords":"Brain metastasis; CRISPR; In vivo; Metastasis; Lung cancer; Cancer; Brain tumor; Epidermal growth factor receptor","score_opus":0.027708638321145618,"score_gpt":0.36905291240828736,"score_spread":0.34134427408714174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416141406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9655501,0.0013042395,0.00092447,0.028623255,0.00029094462,0.0013098351,0.00007142362,0.000043543714,0.0018821639],"genre_scores_gemma":[0.9908764,0.00022342609,0.000311593,0.007940109,0.000047754416,0.0002561498,0.000026992293,0.00002281818,0.00029475483],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976872,0.0006844344,0.00056180207,0.0005079292,0.00022562499,0.0003329949],"domain_scores_gemma":[0.99763197,0.0014655691,0.00020455132,0.00046672538,0.00014334574,0.0000878652],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068252784,0.00023095806,0.00072914903,0.00040599785,0.00007306946,0.000014255078,0.00013621508,0.00015998102,0.0007504757],"category_scores_gemma":[0.00064216193,0.00019523331,0.00017797563,0.00070199446,0.00017007027,0.000096252654,0.00009397165,0.00029908484,0.0000060324396],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020671606,0.0017598209,0.12896954,0.00048274102,0.0011647921,0.0001762033,0.0010574494,0.00014407125,0.8015355,0.0008563053,0.0047473046,0.0570391],"study_design_scores_gemma":[0.011328446,0.0024611636,0.3362091,0.00023889862,0.0016966339,0.000047848727,0.00096780655,0.00063939276,0.5180123,0.0020894695,0.12591629,0.00039266056],"about_ca_topic_score_codex":0.0030343027,"about_ca_topic_score_gemma":0.0013262152,"teacher_disagreement_score":0.2835232,"about_ca_system_score_codex":0.0005066644,"about_ca_system_score_gemma":0.0006368101,"threshold_uncertainty_score":0.8217183},"labels":[],"label_agreement":null},{"id":"W4416141420","doi":"10.1093/neuonc/noaf201.0197","title":"BIOM-109. IMAGE-DERIVED FEATURES IMPROVE PROGNOSTIC MODELING IN POST-SURGICAL PATIENTS WITH IDH WILD-TYPE GLIOBLASTOMA","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Glioblastoma; Proportional hazards model; Glioma; Cohort; Survival analysis; Isocitrate dehydrogenase; Radiomics; Prognostic model; Cancer","score_opus":0.008705603915652012,"score_gpt":0.2707867205129449,"score_spread":0.2620811165972929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416141420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993187,0.00028626056,0.000012969586,0.0033336135,0.0004688748,0.0013053574,0.000015576046,0.00009247578,0.0012978488],"genre_scores_gemma":[0.99773926,0.000045075987,0.00048509162,0.001390874,0.000068514855,0.00016183109,0.000055614022,0.00003633017,0.000017420312],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982003,0.0001300121,0.0003651779,0.00059132726,0.00023878342,0.00047441458],"domain_scores_gemma":[0.99876803,0.00035785924,0.00009891662,0.00032722438,0.00028578858,0.0001621982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008194556,0.00029686524,0.0005896242,0.0003720393,0.000080334714,0.000027585682,0.00012088588,0.0002387788,0.000036426038],"category_scores_gemma":[0.00030072455,0.00021686632,0.00009277153,0.00055994414,0.0001154676,0.0000821313,0.000114105474,0.00038932488,0.000026602784],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017300086,0.012940582,0.3663523,0.00026868517,0.0006907473,0.011099802,0.0007451671,0.00045034656,0.48538637,0.00032336093,0.0020636155,0.102378964],"study_design_scores_gemma":[0.14626588,0.090964966,0.53822446,0.0014165031,0.0033371786,0.001027208,0.000914155,0.022972194,0.16736443,0.00055203045,0.02482172,0.0021392596],"about_ca_topic_score_codex":0.0000890451,"about_ca_topic_score_gemma":0.0001686283,"teacher_disagreement_score":0.31802192,"about_ca_system_score_codex":0.00024609602,"about_ca_system_score_gemma":0.0003985627,"threshold_uncertainty_score":0.8843552},"labels":[],"label_agreement":null},{"id":"W4416141431","doi":"10.1093/neuonc/noaf201.0593","title":"DNAR-02. Nuclear potassium governs nuclear integrity and tumour growth in medulloblastoma","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medulloblastoma; Potassium channel; Nuclear pore; Potassium; Cytoplasm; Immune system; Cell nucleus; Nuclear DNA","score_opus":0.009771844142138776,"score_gpt":0.25743455742530286,"score_spread":0.24766271328316408,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416141431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9594464,0.0006980856,0.000006519077,0.01117107,0.0018325308,0.00027422162,0.000025193727,0.00013907927,0.026406925],"genre_scores_gemma":[0.9927647,0.00030854854,0.000055787576,0.0056891483,0.000026836353,0.000013784204,0.000010520392,0.000033789187,0.0010968768],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.997457,0.0009581816,0.00046227954,0.0005265271,0.000039062248,0.00055693125],"domain_scores_gemma":[0.998702,0.00080407335,0.0001266773,0.0002526829,0.00007434035,0.00004023511],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00034333163,0.00028083203,0.0005763206,0.00031369948,0.00018180543,0.000027331862,0.00040017732,0.0006332471,0.00076342514],"category_scores_gemma":[0.00095923984,0.00026392358,0.000105424995,0.00024176802,0.00050151825,0.00011592773,0.00044489515,0.0015439705,0.00067906955],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023035216,0.00034232636,0.0011696547,0.000031150936,0.000071785726,0.00011554152,0.0007265979,2.8472888e-7,0.9379873,0.016144328,0.035373036,0.0057344628],"study_design_scores_gemma":[0.0036594283,0.0021837286,0.022948803,0.00007615783,0.000057586894,0.00062851666,0.0016321649,0.000030681684,0.096582994,0.0004230866,0.8714433,0.0003335865],"about_ca_topic_score_codex":0.00036936585,"about_ca_topic_score_gemma":0.00017399299,"teacher_disagreement_score":0.8414043,"about_ca_system_score_codex":0.0002468192,"about_ca_system_score_gemma":0.00020383812,"threshold_uncertainty_score":0.9999813},"labels":[],"label_agreement":null},{"id":"W4416141494","doi":"10.1093/neuonc/noaf201.0247","title":"CNSC-39. USE OF MAGNETIC RESONANCE-GUIDED FOCUSED ULTRASOUND IN THE TREATMENT OF DIFFUSE INTRINSIC PONTINE GLIOMA","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Ultrasound and Hyperthermia Applications","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"National Institutes of Health","keywords":"Focused ultrasound; Drug delivery; Glioma; Immune system; Targeted drug delivery; Sonication; Immunohistochemistry; Ultrasound","score_opus":0.022605286734880537,"score_gpt":0.260732491401749,"score_spread":0.23812720466686843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416141494","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99571747,0.0012003994,0.00007612678,0.00043318045,0.00015372856,0.0004775707,0.000030353089,0.000054658412,0.0018564877],"genre_scores_gemma":[0.99781096,0.0012949682,0.0004508939,0.00015813389,0.000038775426,0.0001639919,0.0000089492005,0.000019229921,0.00005408956],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990114,0.00010070246,0.0004121745,0.00017818142,0.00008976652,0.00020776466],"domain_scores_gemma":[0.99766463,0.0017796804,0.0000541195,0.00043475794,0.00003973283,0.000027065053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006721389,0.00015249656,0.00034637642,0.00018282403,0.00003097881,0.00001135819,0.00020770839,0.00011232699,0.000035659457],"category_scores_gemma":[0.0001183197,0.000116879484,0.00008057051,0.0005718674,0.00011040522,0.00004125501,0.00001190709,0.00011106539,0.0000060497036],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006306549,0.0010337005,0.0063344473,0.000030834177,0.00002703101,0.000025832991,0.00136866,0.0002272373,0.89366674,0.0017379036,0.0014109152,0.094073616],"study_design_scores_gemma":[0.0042046453,0.001363564,0.06571948,0.00002506439,0.00012934943,0.00006971482,0.0001470455,0.00045238016,0.0631018,0.0004872812,0.8641122,0.0001874567],"about_ca_topic_score_codex":0.0001264679,"about_ca_topic_score_gemma":0.0003053264,"teacher_disagreement_score":0.8627013,"about_ca_system_score_codex":0.0000951958,"about_ca_system_score_gemma":0.000056409397,"threshold_uncertainty_score":0.4766207},"labels":[],"label_agreement":null},{"id":"W4416141508","doi":"10.1093/neuonc/noaf201.0054","title":"EPCO-55. ALTERNATIVE RNA SPLICING ANALYSIS IDENTIFIES PATTERNS UNDERLYING MALIGNANT TRANSFORMATION AND THERAPEUTIC RESPONSE IN PERIPHERAL NERVE TUMORS","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Neurofibromatosis and Schwannoma Cases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Selumetinib; Transcriptome; Malignant transformation; Exon; Neurofibromatosis; Alternative splicing; SOX10; Melanoma; Exon skipping","score_opus":0.03727218106995333,"score_gpt":0.33433195140870003,"score_spread":0.2970597703387467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416141508","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99390835,0.00019881937,0.0010403487,0.0036743283,0.0001957883,0.00041379622,0.0000115842595,0.00004501891,0.00051199464],"genre_scores_gemma":[0.9980012,0.000097129414,0.000044052555,0.0016930759,0.000023501672,0.000045515004,0.000011250128,0.000016945609,0.00006730542],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9979744,0.00060673663,0.0005470729,0.0003940781,0.00017869487,0.00029900894],"domain_scores_gemma":[0.9988496,0.0006533085,0.00013461926,0.00022530192,0.000056094912,0.00008111093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045524118,0.0002011828,0.0006043383,0.00074561284,0.000115437586,0.000055840814,0.00009479969,0.000101983336,0.00004960953],"category_scores_gemma":[0.000090137924,0.00017649784,0.00015270272,0.00063851353,0.00008719361,0.00013549182,0.00004425403,0.00028991158,0.0000034032232],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031485665,0.00018389021,0.06561149,0.00015407329,0.00032960958,0.0016779761,0.004902587,0.00038234718,0.9118107,0.0006256322,0.000026101687,0.011147021],"study_design_scores_gemma":[0.004955143,0.0021489055,0.83415157,0.0003271188,0.0012632677,0.00063694833,0.0056189387,0.018454086,0.13069622,0.00047744883,0.00089816505,0.00037218595],"about_ca_topic_score_codex":0.00028612412,"about_ca_topic_score_gemma":0.00021480315,"teacher_disagreement_score":0.7811145,"about_ca_system_score_codex":0.0001880416,"about_ca_system_score_gemma":0.00014661749,"threshold_uncertainty_score":0.7197373},"labels":[],"label_agreement":null},{"id":"W4416141534","doi":"10.1093/neuonc/noaf201.0334","title":"STEM-27. TRACING THE ORIGINS OF H3.3K27M MUTANT DIFFUSE MIDLINE GLIOMA","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Forebrain; Hindbrain; Glioma; Corticogenesis; Neurogenesis; Fate mapping; Mutant; Mutation","score_opus":0.022660209580777045,"score_gpt":0.3102490899853226,"score_spread":0.28758888040454555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416141534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97799253,0.00069219846,0.00003204892,0.016272284,0.0009632782,0.0006484976,0.000018420717,0.000054848857,0.0033259033],"genre_scores_gemma":[0.9972459,0.00016797402,0.000081617116,0.0022116287,0.00012231272,0.00007618607,0.000007906996,0.000020292715,0.000066190856],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985454,0.00015934127,0.0004594361,0.00032938126,0.00019702502,0.00030939083],"domain_scores_gemma":[0.99818057,0.0009371658,0.00016144806,0.0005112928,0.00010843521,0.00010107574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017844205,0.00019733129,0.00057302666,0.0002123585,0.000091587375,0.000010377423,0.00016227823,0.00014619625,0.000080410704],"category_scores_gemma":[0.00012346989,0.0001227298,0.00017732783,0.00048910815,0.00015393234,0.000030991305,0.00008301668,0.00025174502,0.00003215051],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003832974,0.0030428863,0.017640973,0.00010852236,0.0002768795,0.0017900583,0.00046451378,0.000020859019,0.9344146,0.0060759075,0.0039819055,0.031799592],"study_design_scores_gemma":[0.009719626,0.0021779689,0.012512433,0.00013234439,0.00083651935,0.00046124426,0.00041203338,0.0003453527,0.634489,0.00018492481,0.3385837,0.00014487516],"about_ca_topic_score_codex":0.00010285569,"about_ca_topic_score_gemma":0.000093486095,"teacher_disagreement_score":0.3346018,"about_ca_system_score_codex":0.0003152824,"about_ca_system_score_gemma":0.0002872027,"threshold_uncertainty_score":0.5004776},"labels":[],"label_agreement":null},{"id":"W4416141550","doi":"10.1093/neuonc/noaf201.0145","title":"BIOM-57. ANTITHROMBOTIC THERAPY IN PATIENTS WITH BRAIN TUMORS","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Antithrombotic; Cancer; Thrombosis; Guideline; Incidence (geometry); Renal cell carcinoma; Retrospective cohort study; Melanoma; Systemic therapy","score_opus":0.011765947489114572,"score_gpt":0.28788856277564506,"score_spread":0.2761226152865305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416141550","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9728694,0.000068199486,0.000031982174,0.011702877,0.00041560468,0.0011117157,0.0000024426652,0.00006519917,0.013732566],"genre_scores_gemma":[0.9773059,0.0001435366,0.00019820691,0.02207401,0.00004463305,0.00007020093,0.000017919616,0.000025114881,0.00012046957],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986539,0.0001215844,0.00029379057,0.0003913793,0.00018112236,0.00035823407],"domain_scores_gemma":[0.999242,0.00018891405,0.00008624151,0.00033612188,0.00006824498,0.00007847014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001638166,0.0001810454,0.00062973826,0.00034457812,0.00005358053,0.000013068677,0.00013280922,0.00010294389,0.00014124304],"category_scores_gemma":[0.00009863254,0.00014015508,0.00005515116,0.000505811,0.00011268621,0.00005309474,0.000074072756,0.00022795516,0.000045904286],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009130335,0.0071253907,0.8370669,0.00013659515,0.00023689154,0.00044984982,0.0005882485,0.000045171964,0.01026561,0.003485541,0.053751335,0.08593545],"study_design_scores_gemma":[0.0072469474,0.0048356145,0.8810023,0.000094466115,0.00005136247,0.0000037650834,0.00007385168,0.000025757929,0.0009997127,0.00010617091,0.10543763,0.00012242026],"about_ca_topic_score_codex":0.00010584619,"about_ca_topic_score_gemma":0.000077263,"teacher_disagreement_score":0.08581303,"about_ca_system_score_codex":0.0001747728,"about_ca_system_score_gemma":0.0002276517,"threshold_uncertainty_score":0.5715358},"labels":[],"label_agreement":null},{"id":"W4416376916","doi":"10.1093/neuonc/noaf237","title":"A framework for using DNA methylation-based modelling for the clinical management of cranial meningioma","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University of British Columbia; University Health Network","funders":"Canadian Institutes of Health Research; Brain Tumour Charity","keywords":"Meningioma; DNA; MEDLINE; Adjuvant; Identification (biology); DNA sequencing","score_opus":0.14314955257997855,"score_gpt":0.4345056984295856,"score_spread":0.291356145849607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416376916","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12717417,0.00013992656,0.86390924,0.004145191,0.0011112305,0.0023031996,0.0000070009423,0.000036458754,0.0011735538],"genre_scores_gemma":[0.65623957,0.000007430881,0.34219363,0.0009675885,0.00021558616,0.00026737945,0.000009671773,0.000020461677,0.000078672696],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9982843,0.00012820451,0.0007412694,0.00038019335,0.00017528345,0.00029075172],"domain_scores_gemma":[0.995012,0.004102789,0.00025662527,0.00040856577,0.0001589881,0.00006105681],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011859258,0.00015604225,0.0005086618,0.00016457122,0.00018305871,0.00001388165,0.00019340395,0.00019384509,0.000019019173],"category_scores_gemma":[0.00028152426,0.000121346406,0.00034058077,0.00027737426,0.00010253248,0.00002540404,0.00007450702,0.0001897386,0.0000012596033],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017409384,0.0019577476,0.0017291555,0.0032279459,0.0035692065,0.0005151546,0.0006311823,0.097227104,0.027260311,0.66725177,0.0053206403,0.17390038],"study_design_scores_gemma":[0.006039742,0.0016793432,0.00025995664,0.00021186599,0.0021482378,0.000011195614,0.00027385817,0.9047449,0.0035643957,0.014462457,0.0664558,0.00014820603],"about_ca_topic_score_codex":0.000005042745,"about_ca_topic_score_gemma":7.1622765e-7,"teacher_disagreement_score":0.8075178,"about_ca_system_score_codex":0.00009099821,"about_ca_system_score_gemma":0.00019976878,"threshold_uncertainty_score":0.49483627},"labels":[],"label_agreement":null},{"id":"W7117146517","doi":"10.1093/neuonc/noaf283","title":"Molecular and clinical stratification of astroblastomas: Three distinct fusion-defined groups informing risk-adapted treatment strategies","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Brain Tumour Charity; Deutsches Krebsforschungszentrum","keywords":"Identification (biology); Risk stratification; Clinical trial; Therapeutic approach; Precision medicine; MEDLINE","score_opus":0.0231861082479438,"score_gpt":0.3266195862632819,"score_spread":0.3034334780153381,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117146517","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99376935,0.00025786526,0.0007343761,0.0012372235,0.00018753269,0.00067832065,0.0000188751,0.000048330745,0.0030681202],"genre_scores_gemma":[0.9987209,0.00021308668,0.0007851327,0.00010228502,0.000034260378,0.00008279624,0.000046006848,0.0000118981925,0.0000036201834],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9985726,0.00012735058,0.0006262004,0.0003398524,0.00013684861,0.000197189],"domain_scores_gemma":[0.9984226,0.00073509436,0.0002989109,0.00033125785,0.000103763006,0.00010832704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016576915,0.00019860001,0.0005588926,0.00014813735,0.00008063979,0.000017384365,0.00006142561,0.00017813708,0.000023568235],"category_scores_gemma":[0.00026084922,0.00015148683,0.00013983196,0.00019305896,0.00016802494,0.00006038367,0.00005408166,0.0001672383,0.000004881339],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001072857,0.0032311163,0.39196408,0.00008467465,0.0006445391,0.0003646817,0.0002173103,0.0000665673,0.14301504,0.015197078,0.00013348805,0.44400856],"study_design_scores_gemma":[0.013764808,0.015128182,0.9227381,0.0001308018,0.0018271413,0.000084748724,0.0007868502,0.0022076045,0.033166848,0.0024577514,0.007485062,0.00022214033],"about_ca_topic_score_codex":0.00013100072,"about_ca_topic_score_gemma":0.0007229816,"teacher_disagreement_score":0.530774,"about_ca_system_score_codex":0.00012795517,"about_ca_system_score_gemma":0.00039547347,"threshold_uncertainty_score":0.61774534},"labels":[],"label_agreement":null}]}